data_2n7h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n7h _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.516 0.198 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.17 114.5 18.43 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.414 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -97.3 119.2 35.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.664 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.496 HG21 ' CG2' ' B' ' 156' ' ' VAL . 19.5 m -136.58 158.25 37.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.584 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.12 115.94 22.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.607 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.63 -79.61 0.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.851 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' B' ' 56' ' ' ILE . . . -148.55 -145.94 4.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.903 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.421 ' HG1' ' HA ' ' B' ' 29' ' ' ASP . 15.0 p -142.05 145.14 34.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.0 0.428 . . . . 0.0 111.24 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.5 t -127.83 119.5 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.245 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.46 113.16 25.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.386 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.75 90.68 5.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.799 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.11 120.72 32.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.367 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.05 170.5 32.64 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.91 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.633 ' HG3' ' O ' ' B' ' 146' ' ' GLY . 21.4 tt0 -160.61 129.19 4.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.402 . . . . 0.0 110.364 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.706 HG21 HG12 ' B' ' 99' ' ' VAL . 2.2 t -89.66 136.95 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.191 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.635 ' O ' HG22 ' B' ' 39' ' ' THR . 34.3 m -136.37 -160.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.781 0.324 . . . . 0.0 111.134 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.571 ' HA ' HG21 ' B' ' 39' ' ' THR . 1.5 t-20 -91.95 177.08 6.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.013 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.445 ' HB2' ' HB1' ' B' ' 40' ' ' ALA . . . -90.25 49.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.064 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -122.17 -39.66 2.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.394 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.84 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -162.15 146.38 12.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.943 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.02 121.65 14.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.607 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 2.5 p -63.71 143.5 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.054 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.52 ' HB3' ' HB2' ' A' ' 27' ' ' SER . 13.5 t70 -72.9 154.62 40.5 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.581 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.589 ' O ' HG21 ' A' ' 28' ' ' VAL . . . -54.31 -53.89 47.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.354 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.54 1.03 88.67 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.88 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.52 ' HB2' ' HB3' ' A' ' 24' ' ' ASP . 7.9 t -99.28 -16.66 18.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.879 0.371 . . . . 0.0 110.836 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.589 HG21 ' O ' ' A' ' 25' ' ' ALA . 10.9 t -53.18 -50.84 44.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.355 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -114.06 126.16 54.79 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.973 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -125.61 135.6 52.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.051 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.92 109.11 21.91 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.128 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.51 115.14 48.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.086 0.47 . . . . 0.0 110.475 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.17 124.72 50.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.662 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.24 -42.31 23.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.602 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.1 -165.42 12.15 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.574 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -93.57 119.21 32.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.62 0.248 . . . . 0.0 110.854 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' A' ' 137' ' ' TYR . 8.2 p -104.88 133.95 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.871 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.93 137.65 36.93 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.667 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.456 ' HA ' ' HB1' ' A' ' 143' ' ' ALA . 0.2 OUTLIER -62.5 -49.42 75.45 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.767 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.55 -33.48 54.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.026 0.441 . . . . 0.0 110.872 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.97 -31.38 61.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.114 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.684 ' HG ' ' HB3' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -114.04 39.82 2.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.619 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.24 33.94 3.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.396 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.657 ' HB2' ' HB2' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -124.48 142.87 50.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.346 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.22 95.69 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 0.0 111.146 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.4 33.69 5.84 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.152 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.657 ' HB2' ' HB2' ' A' ' 44' ' ' GLN . . . -78.83 143.55 35.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.981 0.42 . . . . 0.0 111.958 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.504 ' HB ' ' HD2' ' A' ' 136' ' ' ARG . 18.1 p -131.67 131.93 43.55 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.902 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 1.3 m -103.78 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.548 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -57.78 141.9 47.29 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' A' ' 136' ' ' ARG . . . -99.07 125.51 44.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.393 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 135' ' ' ALA . 24.8 m -76.51 150.99 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.956 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.34 143.29 16.43 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -171.48 140.44 1.39 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.844 0.354 . . . . 0.0 110.925 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -136.32 138.56 41.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.582 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -88.42 116.79 30.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.554 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.8 ' HA ' HG23 ' A' ' 130' ' ' THR . 5.0 mp0 -69.36 138.31 53.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.629 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -145.6 91.66 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.287 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.513 ' HA ' HG22 ' A' ' 128' ' ' THR . 8.2 p30 -78.43 176.89 8.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.938 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.793 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.84 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 10.5 m -133.87 147.78 51.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.76 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.71 161.93 20.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.321 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -111.79 -34.18 6.1 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -72.54 -28.18 62.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.037 0.446 . . . . 0.0 111.718 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.18 -58.54 4.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.703 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . . . -132.2 126.07 32.67 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.575 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -42.15 7.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.954 0.407 . . . . 0.0 110.943 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.24 156.83 18.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.517 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.757 ' HB3' ' HB ' ' A' ' 122' ' ' THR . . . -146.63 133.23 19.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.57 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 118' ' ' PHE . . . -113.38 155.11 25.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.104 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.629 HG13 HG21 ' A' ' 131' ' ' ILE . 2.0 t -136.4 148.57 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.684 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 155' ' ' LYS . . . -152.9 163.48 39.7 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.6 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.23 142.28 50.57 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 122.409 -0.182 . . . . 0.0 111.16 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.634 HD22 ' HG3' ' D' ' 57' ' ' GLN . 1.4 tt -109.16 119.05 38.35 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.066 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.697 ' HA3' HD22 ' A' ' 113' ' ' LEU . . . -162.74 -161.92 12.93 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.769 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.619 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.3 OUTLIER -120.92 162.92 19.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.578 0.228 . . . . 0.0 110.779 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -83.57 139.08 33.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.934 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 79' ' ' ASP . 11.1 tt -66.09 -47.61 84.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.987 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.552 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -134.46 46.69 2.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.849 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' D' ' 105' ' ' ASP . . . 64.49 -84.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.078 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.77 -36.4 40.9 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.603 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.43 69.2 10.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.888 0.375 . . . . 0.0 110.523 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.669 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -74.1 -7.51 52.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.487 -179.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.609 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 30.0 p-10 -74.74 -25.39 59.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.334 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.499 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 6.4 t -104.92 143.84 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.169 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.612 HD21 ' H ' ' A' ' 76' ' ' THR . 0.3 OUTLIER -74.8 160.86 30.17 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.338 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.525 ' HB2' ' HB ' ' A' ' 76' ' ' THR . . . -103.64 179.85 4.15 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.874 0.369 . . . . 0.0 111.712 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.686 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 1.3 mm? -66.58 171.29 5.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.045 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.518 ' HG3' ' HB2' ' A' ' 149' ' ' ASN . 1.3 mm-40 -68.61 -83.7 0.03 OUTLIER 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.265 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.12 19.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.959 0.409 . . . . 0.0 111.451 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 95' ' ' SER . 3.2 m -90.16 86.28 6.5 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.545 ' HB3' HG11 ' D' ' 52' ' ' VAL . . . -61.16 -24.99 66.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.631 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.4 41.25 3.52 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.66 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -174.96 0.69 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.858 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.686 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . 1.9 m -89.26 -173.59 4.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.773 0.321 . . . . 0.0 110.71 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.409 ' HB3' HG22 ' A' ' 99' ' ' VAL . . . -100.99 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.4 ' O ' HG21 ' A' ' 99' ' ' VAL . 3.0 m -131.06 123.92 29.72 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.299 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.21 29.43 18.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.459 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 96' ' ' ALA . 1.7 t -125.31 129.33 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.835 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.85 -171.06 21.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.442 HG12 HD13 ' A' ' 86' ' ' LEU . 1.9 p -122.97 116.71 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.204 0.526 . . . . 0.0 111.69 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.542 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 2.8 tt0 -81.74 151.45 27.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.915 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.457 HD11 ' HG ' ' A' ' 113' ' ' LEU . 1.0 OUTLIER -114.82 123.84 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.531 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.72 125.18 50.55 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.658 0.266 . . . . 0.0 111.013 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.706 ' HB3' HG23 ' A' ' 107' ' ' THR . 13.6 t0 -77.57 143.07 38.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.672 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.694 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -62.73 -14.86 49.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.742 0.306 . . . . 0.0 111.043 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.706 HG23 ' HB3' ' A' ' 105' ' ' ASP . 8.8 t -63.04 -20.94 65.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.012 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.28 -43.57 1.36 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.735 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.69 160.71 14.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.767 0.318 . . . . 0.0 111.082 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.36 133.16 40.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.125 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 12.3 tp -95.54 160.94 14.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.373 0.606 . . . . 0.0 110.531 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 2.9 t -110.21 136.81 48.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.076 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.697 HD22 ' HA3' ' A' ' 75' ' ' GLY . 1.4 mt -70.25 89.64 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.76 0.314 . . . . 0.0 110.689 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -18.43 6.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.487 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -62.25 0.88 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.664 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.619 ' HB1' ' OD1' ' D' ' 129' ' ' ASN . . . -92.95 18.23 9.43 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.993 0.425 . . . . 0.0 111.659 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.97 72.58 10.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.065 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' A' ' 155' ' ' LYS . 78.4 m-85 -92.32 89.77 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.799 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 54.6 m -130.56 73.11 1.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.91 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.21 142.32 21.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.682 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.98 68.56 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.208 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.757 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -81.51 133.14 35.35 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.684 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.7 m -87.6 124.13 33.19 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.681 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 63' ' ' THR . 4.1 tp -97.3 119.32 35.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.648 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -113.71 171.91 7.29 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.587 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.48 109.75 16.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.647 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.82 -133.8 4.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.714 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.513 HG22 ' HA ' ' A' ' 59' ' ' ASN . 46.1 m -110.5 86.75 2.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.742 0.306 . . . . 0.0 110.794 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -69.34 155.07 41.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.829 0.347 . . . . 0.0 111.162 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.8 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -142.79 137.07 29.44 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.089 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.629 HG21 HG13 ' A' ' 71' ' ' VAL . 6.9 mt -100.25 109.12 55.66 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.694 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.5 Cg_endo -81.76 148.25 15.67 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.721 1.614 . . . . 0.0 112.536 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.409 ' CZ ' ' HA ' ' A' ' 105' ' ' ASP . 0.5 OUTLIER -158.82 145.31 17.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.908 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -111.24 160.4 17.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.024 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 102' ' ' GLN . . . -155.98 97.82 1.84 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.951 0.405 . . . . 0.0 111.613 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.533 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 14.4 ptt180 -101.57 173.61 6.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.41 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.542 ' HB3' HD22 ' A' ' 42' ' ' LEU . 1.8 m-85 -83.64 135.04 34.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.134 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.407 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 1.7 t80 -128.86 128.18 43.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.022 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.684 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . . . -108.52 138.0 45.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.817 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.519 HG22 ' HB2' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -89.94 -9.56 48.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.494 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.31 -95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.963 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.71 101.49 11.33 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.513 0.197 . . . . 0.0 110.737 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -61.36 144.35 54.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.749 0.309 . . . . 0.0 111.378 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.608 HG22 ' CD ' ' A' ' 145' ' ' PRO . 99.2 m -123.94 153.15 67.42 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.22 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.608 ' CD ' HG22 ' A' ' 144' ' ' THR . 1.3 Cg_endo -83.01 144.78 12.14 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.523 2.149 . . . . 0.0 111.989 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.3 -116.09 0.7 Allowed Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.503 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 94' ' ' GLY . . . -119.73 132.37 55.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.892 0.377 . . . . 0.0 111.361 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.37 43.36 3.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.13 0.491 . . . . 0.0 110.414 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.518 ' HB2' ' HG3' ' A' ' 89' ' ' GLN . 1.1 m120 -95.68 150.88 19.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.586 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -168.5 -178.63 3.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.017 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.78 153.0 39.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.238 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -141.22 151.12 43.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.239 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.66 133.73 54.55 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.71 148.72 28.82 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.093 0.473 . . . . 0.0 110.112 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.533 ' HE3' ' HB ' ' D' ' 128' ' ' THR . 11.2 mmtt -135.02 139.43 44.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.949 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.52 141.3 43.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.778 0.323 . . . . 0.0 111.685 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -128.78 128.97 45.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.318 0.58 . . . . 0.0 110.358 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.71 128.59 51.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.565 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.33 0.109 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.37 88.99 0.04 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.588 0.232 . . . . 0.0 111.022 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.18 114.49 18.41 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.402 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -97.31 119.19 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.65 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.503 HG21 ' CG2' ' C' ' 156' ' ' VAL . 19.4 m -136.58 158.24 37.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.525 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.16 115.99 22.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.552 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.64 -79.61 0.13 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.873 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.483 ' HA3' ' CD1' ' C' ' 56' ' ' ILE . . . -148.56 -145.9 4.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.879 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.415 ' HG1' ' HA ' ' C' ' 29' ' ' ASP . 14.9 p -142.11 145.12 33.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.052 0.453 . . . . 0.0 111.225 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 32.5 t -127.8 119.51 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.267 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.44 113.14 25.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.377 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.7 90.72 5.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.814 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.15 120.71 32.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.337 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.02 170.48 32.62 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.908 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' C' ' 146' ' ' GLY . 21.4 tt0 -160.59 129.19 4.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.975 0.417 . . . . 0.0 110.395 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.712 HG21 HG12 ' C' ' 99' ' ' VAL . 2.2 t -89.66 136.93 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.226 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.619 ' O ' HG22 ' C' ' 39' ' ' THR . 34.3 m -136.35 -160.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.785 0.326 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . 0.574 ' HA ' HG21 ' C' ' 39' ' ' THR . 1.5 t-20 -91.93 177.02 6.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.977 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.441 ' HB2' ' HB1' ' C' ' 40' ' ' ALA . . . -90.21 49.67 1.73 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.053 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' B' ' 61' ' ' CYS . . . -122.19 -39.67 2.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.437 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.841 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.5 OUTLIER -162.13 146.38 12.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.959 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.04 121.62 14.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.595 ' HA ' ' HG ' ' B' ' 58' ' ' LEU . 2.4 p -63.71 143.54 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.037 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 13.6 t70 -72.94 154.65 40.46 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.582 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.578 ' O ' HG21 ' B' ' 28' ' ' VAL . . . -54.33 -53.88 47.86 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.341 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.55 1.05 88.65 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.868 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' B' ' 24' ' ' ASP . 7.9 t -99.29 -16.68 18.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.872 0.367 . . . . 0.0 110.826 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.578 HG21 ' O ' ' B' ' 25' ' ' ALA . 10.7 t -53.14 -50.85 43.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.377 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . 0.421 ' HA ' ' HG1' ' A' ' 9' ' ' THR . 39.9 t0 -114.08 126.19 54.82 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.972 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' GLN . . . . . 0.405 HE22 ' HA ' ' B' ' 56' ' ' ILE . 3.7 mt-30 -125.61 135.57 52.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.064 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.92 109.17 21.95 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.117 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.57 115.16 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 0.0 110.463 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.2 124.74 50.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.631 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.26 -42.34 23.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.596 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.13 -165.34 12.14 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.557 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.606 ' HG2' HG12 ' A' ' 17' ' ' VAL . 3.7 mt-30 -93.65 119.24 32.42 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.64 0.257 . . . . 0.0 110.834 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' B' ' 137' ' ' TYR . 8.2 p -104.91 133.94 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.87 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.92 137.62 36.93 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.668 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -62.53 -49.38 75.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.762 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 19' ' ' ALA . . . -53.52 -33.5 54.74 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.01 0.433 . . . . 0.0 110.865 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.97 -31.33 61.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.112 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.7 ' HG ' ' HB3' ' B' ' 139' ' ' ALA . 0.6 OUTLIER -114.07 39.81 2.64 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.613 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.2 33.96 3.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.448 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . 0.659 ' HB2' ' HB2' ' B' ' 47' ' ' ALA . 0.3 OUTLIER -124.48 142.88 50.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.344 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.25 95.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.371 . . . . 0.0 111.148 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.43 33.63 5.85 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.139 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.659 ' HB2' ' HB2' ' B' ' 44' ' ' GLN . . . -78.87 143.5 35.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.418 . . . . 0.0 111.949 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.488 ' HB ' ' HD2' ' B' ' 136' ' ' ARG . 18.1 p -131.61 131.9 43.62 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.895 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' SER . . . . . 0.496 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 1.3 m -103.75 -167.22 1.34 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.572 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -57.82 141.91 47.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.863 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . 0.516 ' HB1' ' HB3' ' B' ' 136' ' ' ARG . . . -99.05 125.52 44.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.377 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.512 HG22 ' O ' ' B' ' 135' ' ' ALA . 24.8 m -76.53 151.0 6.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.961 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.36 143.28 16.44 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.527 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -171.47 140.44 1.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.801 0.334 . . . . 0.0 110.936 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -136.33 138.6 41.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.571 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.486 ' CD1' ' HA3' ' A' ' 8' ' ' GLY . 0.7 OUTLIER -88.45 116.79 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.542 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . 0.794 ' HA ' HG23 ' B' ' 130' ' ' THR . 5.0 mp0 -69.38 138.31 53.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.802 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.629 ' HB3' ' SG ' ' B' ' 21' ' ' CYS . 0.3 OUTLIER -145.58 91.67 2.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.276 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 8.2 p30 -78.43 176.86 8.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.912 0.387 . . . . 0.0 110.915 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.92 81.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' CYS . . . . . 0.841 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 10.4 m -133.85 147.8 51.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.78 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.7 161.91 20.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.349 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.491 HG23 ' O ' ' B' ' 124' ' ' LEU . 0.0 OUTLIER -111.75 -34.19 6.1 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -72.52 -28.2 62.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.072 0.463 . . . . 0.0 111.735 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.18 -58.56 4.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.658 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . . . -132.22 126.06 32.62 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.592 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.39 -42.09 7.13 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.956 0.407 . . . . 0.0 110.954 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . 0.439 ' HD2' ' HA ' ' B' ' 68' ' ' LYS . 1.2 tptp -89.28 156.8 18.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.465 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.742 ' HB3' ' HB ' ' B' ' 122' ' ' THR . . . -146.61 133.21 19.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.609 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' B' ' 118' ' ' PHE . . . -113.35 155.11 25.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.137 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.624 HG13 HG21 ' B' ' 131' ' ' ILE . 2.0 t -136.39 148.53 27.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.725 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -152.9 163.51 39.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.553 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.23 142.25 50.58 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 122.411 -0.181 . . . . 0.0 111.207 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.631 HD22 ' HG3' ' E' ' 57' ' ' GLN . 1.4 tt -109.12 119.05 38.36 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.053 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . 0.707 ' HA3' HD22 ' B' ' 113' ' ' LEU . . . -162.74 -161.9 12.89 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.757 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.625 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.3 OUTLIER -120.97 162.92 19.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.59 0.233 . . . . 0.0 110.788 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . 0.68 ' HB1' ' HA ' ' B' ' 83' ' ' THR . . . -83.54 139.08 33.1 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.936 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.565 HG23 ' N ' ' B' ' 79' ' ' ASP . 11.1 tt -66.09 -47.64 84.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.973 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.565 ' N ' HG23 ' B' ' 78' ' ' ILE . 0.2 OUTLIER -134.42 46.69 2.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.891 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' E' ' 105' ' ' ASP . . . 64.48 -83.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.096 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.79 -36.42 41.17 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.576 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.4 69.19 10.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.541 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' THR . . . . . 0.68 ' HA ' ' HB1' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -74.08 -7.53 52.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.549 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . 0.586 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 30.1 p-10 -74.69 -25.4 59.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.383 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.5 HG12 HD12 ' B' ' 78' ' ' ILE . 6.4 t -104.92 143.88 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.17 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . 0.623 HD21 ' H ' ' B' ' 76' ' ' THR . 0.3 OUTLIER -74.84 160.89 30.11 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.265 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.53 ' HB2' ' HB ' ' B' ' 76' ' ' THR . . . -103.66 179.88 4.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.861 0.363 . . . . 0.0 111.702 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.682 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 1.3 mm? -66.59 171.3 5.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.038 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . 0.518 ' HG3' ' HB2' ' B' ' 149' ' ' ASN . 1.3 mm-40 -68.57 -83.75 0.03 OUTLIER 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.275 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 5.9 p -169.11 19.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.907 0.384 . . . . 0.0 111.426 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' B' ' 95' ' ' SER . 3.2 m -90.13 86.26 6.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.562 ' HB3' HG11 ' E' ' 52' ' ' VAL . . . -61.1 -25.03 66.68 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.652 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.42 41.31 3.5 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.638 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' B' ' 147' ' ' ALA . . . -175.03 0.72 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.828 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' SER . . . . . 0.682 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . 1.9 m -89.28 -173.58 4.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.784 0.326 . . . . 0.0 110.71 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . 0.688 ' CB ' HG23 ' A' ' 16' ' ' VAL . . . -100.97 -177.3 3.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 3.0 m -131.03 123.94 29.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.301 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 61.18 29.46 18.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.462 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . 0.706 HG12 HG21 ' A' ' 16' ' ' VAL . 1.7 t -125.31 129.33 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.86 -171.15 21.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.515 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . 0.442 HG12 HD13 ' B' ' 86' ' ' LEU . 1.9 p -122.89 116.72 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.208 0.528 . . . . 0.0 111.682 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.532 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 2.8 tt0 -81.77 151.46 27.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.923 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.461 HD11 ' HG ' ' B' ' 113' ' ' LEU . 1.0 OUTLIER -114.83 123.82 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.511 179.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.68 125.17 50.52 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.645 0.26 . . . . 0.0 111.041 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . 0.726 ' HB3' HG23 ' B' ' 107' ' ' THR . 13.6 t0 -77.61 143.12 38.5 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.659 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . 0.722 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -62.75 -14.88 49.93 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.722 0.296 . . . . 0.0 111.048 179.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' THR . . . . . 0.726 HG23 ' HB3' ' B' ' 105' ' ' ASP . 8.8 t -62.97 -20.96 65.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.024 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.3 -43.57 1.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.729 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.7 160.71 14.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.327 . . . . 0.0 111.088 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.35 133.18 40.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.122 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.64 ' HB2' ' HB2' ' B' ' 105' ' ' ASP . 12.3 tp -95.56 160.9 14.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.401 0.619 . . . . 0.0 110.469 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 2.9 t -110.19 136.8 48.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.075 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.707 HD22 ' HA3' ' B' ' 75' ' ' GLY . 1.4 mt -70.22 89.59 0.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.764 0.316 . . . . 0.0 110.655 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.34 -18.46 6.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.509 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.3 -62.27 0.87 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.645 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . 0.623 ' HB1' ' OD1' ' E' ' 129' ' ' ASN . . . -92.95 18.23 9.44 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.023 0.44 . . . . 0.0 111.668 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.91 72.53 10.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.039 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' B' ' 155' ' ' LYS . 78.3 m-85 -92.35 89.8 6.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.775 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 55.1 m -130.58 73.15 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.23 142.29 21.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.691 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -103.96 68.55 0.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.194 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.742 ' HB ' ' HB3' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -81.43 133.16 35.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.72 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 8.7 m -87.61 124.14 33.21 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.687 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.491 ' O ' HG23 ' B' ' 63' ' ' THR . 4.1 tp -97.33 119.34 35.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.633 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -113.74 171.94 7.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.573 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.5 109.76 16.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.646 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.8 -133.79 4.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.712 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 46.4 m -110.53 86.75 2.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.759 0.314 . . . . 0.0 110.807 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.32 155.05 41.06 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.222 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.794 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -142.76 137.1 29.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.092 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' ILE . . . . . 0.624 HG21 HG13 ' B' ' 71' ' ' VAL . 6.9 mt -100.26 109.07 55.53 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' PRO . . . . . 0.722 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.73 148.26 15.73 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 121.666 1.577 . . . . 0.0 112.543 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' B' ' 105' ' ' ASP . 0.5 OUTLIER -158.8 145.32 17.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.921 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -111.24 160.4 17.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.034 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' B' ' 102' ' ' GLN . . . -156.0 97.79 1.84 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.956 0.408 . . . . 0.0 111.589 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . 0.516 ' HB3' ' HB1' ' B' ' 51' ' ' ALA . 14.4 ptt180 -101.54 173.59 6.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.405 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . 0.549 ' HB3' HD22 ' B' ' 42' ' ' LEU . 1.8 m-85 -83.62 135.04 34.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.181 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . 0.406 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 1.8 t80 -128.88 128.18 43.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.988 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.7 ' HB3' ' HG ' ' B' ' 42' ' ' LEU . . . -108.53 138.0 45.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.86 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' THR . . . . . 0.531 HG22 ' HB2' ' B' ' 79' ' ' ASP . 0.3 OUTLIER -89.96 -9.55 48.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.478 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.3 -95.23 0.1 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.951 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.74 101.52 11.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.514 0.197 . . . . 0.0 110.744 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 42' ' ' LEU . . . -61.39 144.35 54.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.73 0.3 . . . . 0.0 111.379 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.612 HG22 ' CD ' ' B' ' 145' ' ' PRO . 99.2 m -123.95 153.17 67.47 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.196 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.612 ' CD ' HG22 ' B' ' 144' ' ' THR . 1.3 Cg_endo -83.04 144.78 12.11 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.519 2.146 . . . . 0.0 112.006 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . 0.633 ' O ' ' HG3' ' A' ' 15' ' ' GLU . . . 157.3 -116.09 0.7 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.494 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' B' ' 94' ' ' GLY . . . -119.75 132.4 55.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.903 0.382 . . . . 0.0 111.316 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' ALA . . . . . 0.519 ' HB2' HG22 ' A' ' 16' ' ' VAL . . . -125.39 43.33 3.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.16 0.505 . . . . 0.0 110.417 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.518 ' HB2' ' HG3' ' B' ' 89' ' ' GLN . 1.1 m120 -95.65 150.88 19.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.573 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -168.49 -178.63 3.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.03 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.77 152.98 39.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.261 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -141.2 151.11 43.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.264 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.69 133.75 54.56 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' PHE . . . . . 0.457 ' HB3' ' H ' ' A' ' 8' ' ' GLY . 0.1 OUTLIER -81.65 148.68 28.91 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.053 0.454 . . . . 0.0 110.158 -179.062 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . 0.537 ' HB3' ' CZ ' ' B' ' 118' ' ' PHE . 11.2 mmtt -135.03 139.49 44.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.928 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' VAL . . . . . 0.496 ' CG2' HG21 ' A' ' 5' ' ' VAL . 3.1 m -134.55 141.27 43.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.776 0.322 . . . . 0.0 111.698 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -128.79 128.96 45.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.346 0.593 . . . . 0.0 110.353 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.72 128.62 51.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.583 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.841 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.261 0.077 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.4 88.97 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.004 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.19 114.48 18.39 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.436 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -97.26 119.19 35.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.644 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . 0.498 HG21 ' CG2' ' D' ' 156' ' ' VAL . 19.5 m -136.56 158.26 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.63 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.15 115.99 22.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.578 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.66 -79.58 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.876 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' D' ' 56' ' ' ILE . . . -148.55 -145.97 4.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.898 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' THR . . . . . 0.401 ' HG1' ' HA ' ' D' ' 29' ' ' ASP . 15.2 p -142.03 145.12 34.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.956 0.408 . . . . 0.0 111.32 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 32.0 t -127.82 119.53 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.26 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.43 113.17 25.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.391 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -95.75 90.66 5.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.792 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.1 120.73 32.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.357 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.04 170.48 32.63 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.918 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' GLU . . . . . 0.634 ' HG3' ' O ' ' D' ' 146' ' ' GLY . 21.4 tt0 -160.6 129.19 4.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.987 0.423 . . . . 0.0 110.368 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.719 HG21 HG12 ' D' ' 99' ' ' VAL . 2.2 t -89.66 136.91 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.246 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.641 ' O ' HG22 ' D' ' 39' ' ' THR . 34.3 m -136.35 -160.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.767 0.318 . . . . 0.0 111.147 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . 0.585 ' HA ' HG21 ' D' ' 39' ' ' THR . 1.5 t-20 -91.98 177.01 6.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.998 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . 0.438 ' HB2' ' HB1' ' D' ' 40' ' ' ALA . . . -90.16 49.59 1.73 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.038 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' C' ' 61' ' ' CYS . . . -122.16 -39.69 2.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.398 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' CYS . . . . . 0.831 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.5 OUTLIER -162.13 146.39 12.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.943 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.05 121.61 14.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.141 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . 0.588 ' HA ' ' HG ' ' C' ' 58' ' ' LEU . 2.4 p -63.67 143.5 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.049 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' C' ' 27' ' ' SER . 13.5 t70 -72.88 154.6 40.52 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.597 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.592 ' O ' HG21 ' C' ' 28' ' ' VAL . . . -54.3 -53.88 47.84 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.345 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.56 1.03 88.71 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.874 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' SER . . . . . 0.529 ' HB2' ' HB3' ' C' ' 24' ' ' ASP . 7.9 t -99.3 -16.63 18.41 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.879 0.371 . . . . 0.0 110.842 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.592 HG21 ' O ' ' C' ' 25' ' ' ALA . 10.8 t -53.18 -50.83 44.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.35 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . 0.415 ' HA ' ' HG1' ' B' ' 9' ' ' THR . 40.0 t0 -114.07 126.19 54.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.98 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' GLN . . . . . 0.406 HE22 ' HA ' ' C' ' 56' ' ' ILE . 3.7 mt-30 -125.64 135.58 52.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.063 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.91 109.11 21.9 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.13 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.5 115.15 48.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.132 0.491 . . . . 0.0 110.464 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.17 124.73 50.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.667 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.26 -42.28 23.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.584 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.08 -165.39 12.15 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.583 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . 0.608 ' HG2' HG12 ' B' ' 17' ' ' VAL . 3.7 mt-30 -93.62 119.2 32.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.626 0.25 . . . . 0.0 110.841 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . 0.416 ' HB ' ' CE2' ' C' ' 137' ' ' TYR . 8.2 p -104.86 133.95 47.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.897 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.9 137.65 36.95 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.689 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.619 HG22 ' O ' ' B' ' 17' ' ' VAL . 0.2 OUTLIER -62.51 -49.43 75.37 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.75 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.441 ' HB1' ' HB2' ' B' ' 19' ' ' ALA . . . -53.56 -33.48 54.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.994 0.426 . . . . 0.0 110.837 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.97 -31.31 61.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.11 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.692 ' HG ' ' HB3' ' C' ' 139' ' ' ALA . 0.6 OUTLIER -114.12 39.84 2.64 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.642 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.24 33.95 3.28 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.386 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . 0.649 ' HB2' ' HB2' ' C' ' 47' ' ' ALA . 0.3 OUTLIER -124.51 142.92 50.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.289 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.26 95.7 0.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.145 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.41 33.72 5.83 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.126 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' C' ' 44' ' ' GLN . . . -78.93 143.52 35.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.976 0.417 . . . . 0.0 111.928 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' THR . . . . . 0.494 ' HB ' ' HD2' ' C' ' 136' ' ' ARG . 18.1 p -131.63 131.94 43.62 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.884 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.494 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 1.3 m -103.82 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.524 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -57.76 141.86 47.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . 0.534 ' HB1' ' HB3' ' C' ' 136' ' ' ARG . . . -99.03 125.48 44.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.379 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . 0.502 HG22 ' O ' ' C' ' 135' ' ' ALA . 24.7 m -76.51 150.98 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.956 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.3 143.27 16.41 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.572 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -171.49 140.45 1.39 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.771 0.319 . . . . 0.0 110.895 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -136.33 138.62 41.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.541 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.483 ' CD1' ' HA3' ' B' ' 8' ' ' GLY . 0.7 OUTLIER -88.47 116.77 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.554 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.815 ' HA ' HG23 ' C' ' 130' ' ' THR . 5.0 mp0 -69.33 138.29 53.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.794 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . 0.621 ' HB3' ' SG ' ' C' ' 21' ' ' CYS . 0.3 OUTLIER -145.62 91.65 2.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.281 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . 0.509 ' HA ' HG22 ' C' ' 128' ' ' THR . 8.2 p30 -78.46 176.86 8.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.946 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.81 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' CYS . . . . . 0.831 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 10.4 m -133.87 147.74 51.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.798 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.67 161.92 20.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.341 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.501 HG23 ' O ' ' C' ' 124' ' ' LEU . 0.0 OUTLIER -111.77 -34.19 6.1 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -72.59 -28.14 62.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.045 0.45 . . . . 0.0 111.725 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -73.15 -58.55 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.733 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' C' ' 20' ' ' ALA . . . -132.21 126.07 32.64 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.58 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.33 -42.19 7.1 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.964 0.411 . . . . 0.0 110.938 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' C' ' 68' ' ' LYS . 1.2 tptp -89.22 156.85 18.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.502 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.766 ' HB3' ' HB ' ' C' ' 122' ' ' THR . . . -146.65 133.18 19.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.596 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' C' ' 118' ' ' PHE . . . -113.31 155.11 25.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.165 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . 0.62 HG13 HG21 ' C' ' 131' ' ' ILE . 2.0 t -136.4 148.54 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.7 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -152.88 163.49 39.68 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.579 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.24 142.28 50.57 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.468 0.175 . . . . 0.0 111.197 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.638 HD22 ' HG3' ' F' ' 57' ' ' GLN . 1.4 tt -109.17 119.04 38.33 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.052 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . 0.705 ' HA3' HD22 ' C' ' 113' ' ' LEU . . . -162.74 -161.82 12.79 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.736 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' THR . . . . . 0.619 ' H ' HD21 ' C' ' 86' ' ' LEU . 0.3 OUTLIER -121.04 162.91 19.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.624 0.25 . . . . 0.0 110.762 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . 0.677 ' HB1' ' HA ' ' C' ' 83' ' ' THR . . . -83.54 139.08 33.1 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.933 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . 0.565 HG23 ' N ' ' C' ' 79' ' ' ASP . 11.1 tt -66.08 -47.59 84.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.94 0.4 . . . . 0.0 111.007 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' ASP . . . . . 0.565 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.2 OUTLIER -134.45 46.62 2.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.862 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' F' ' 105' ' ' ASP . . . 64.49 -84.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.075 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.75 -36.39 40.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.61 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.5 69.24 10.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.924 0.393 . . . . 0.0 110.51 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' THR . . . . . 0.677 ' HA ' ' HB1' ' C' ' 77' ' ' ALA . 0.2 OUTLIER -74.13 -7.49 52.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.51 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' ASN . . . . . 0.606 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 30.0 p-10 -74.7 -25.4 59.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.36 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.496 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 6.4 t -104.92 143.81 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.148 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.619 HD21 ' H ' ' C' ' 76' ' ' THR . 0.3 OUTLIER -74.78 160.88 30.16 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.308 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.523 ' HB2' ' HB ' ' C' ' 76' ' ' THR . . . -103.67 179.87 4.15 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.897 0.379 . . . . 0.0 111.685 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.675 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 1.3 mm? -66.58 171.29 5.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' GLN . . . . . 0.491 ' HG3' ' HB2' ' C' ' 149' ' ' ASN . 1.3 mm-40 -68.61 -83.74 0.03 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.279 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 5.9 p -169.08 19.14 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.941 0.4 . . . . 0.0 111.426 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' C' ' 95' ' ' SER . 3.3 m -90.15 86.26 6.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.897 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' ALA . . . . . 0.552 ' HB3' HG11 ' F' ' 52' ' ' VAL . . . -61.13 -25.01 66.69 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.637 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.39 41.22 3.53 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.669 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' C' ' 147' ' ' ALA . . . -175.0 0.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.87 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' SER . . . . . 0.675 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 1.9 m -89.24 -173.58 4.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.813 0.34 . . . . 0.0 110.691 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' ALA . . . . . 0.693 ' CB ' HG23 ' B' ' 16' ' ' VAL . . . -100.98 -177.25 3.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 3.0 m -131.11 123.96 29.73 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.303 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.17 29.46 18.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.467 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 99' ' ' VAL . . . . . 0.712 HG12 HG21 ' B' ' 16' ' ' VAL . 1.7 t -125.32 129.35 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.818 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.84 -171.04 21.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.508 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' VAL . . . . . 0.453 HG12 HD13 ' C' ' 86' ' ' LEU . 1.9 p -122.97 116.73 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.213 0.53 . . . . 0.0 111.679 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 102' ' ' GLN . . . . . 0.532 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 2.8 tt0 -81.75 151.42 27.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.936 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . 0.477 HD11 ' HG ' ' C' ' 113' ' ' LEU . 1.0 OUTLIER -114.8 123.81 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.563 179.464 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.69 125.17 50.53 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.638 0.256 . . . . 0.0 111.002 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . 0.707 ' HB3' HG23 ' C' ' 107' ' ' THR . 13.6 t0 -77.58 143.05 38.62 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.695 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 106' ' ' ARG . . . . . 0.72 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -62.64 -14.94 49.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.757 0.313 . . . . 0.0 111.063 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 107' ' ' THR . . . . . 0.707 HG23 ' HB3' ' C' ' 105' ' ' ASP . 8.8 t -62.96 -20.97 65.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.27 -43.58 1.36 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.727 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.71 160.71 14.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.789 0.328 . . . . 0.0 111.08 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.37 133.16 40.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.085 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 111' ' ' LEU . . . . . 0.655 ' HB2' ' HB2' ' C' ' 105' ' ' ASP . 12.3 tp -95.5 160.94 14.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.378 0.608 . . . . 0.0 110.554 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 112' ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 2.9 t -110.22 136.79 48.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.068 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.705 HD22 ' HA3' ' C' ' 75' ' ' GLY . 1.4 mt -70.22 89.61 0.65 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.751 0.31 . . . . 0.0 110.685 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.34 -18.44 6.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.472 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.32 -62.24 0.87 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.683 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 116' ' ' ALA . . . . . 0.621 ' HB1' ' OD1' ' F' ' 129' ' ' ASN . . . -92.94 18.21 9.45 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 121.042 0.448 . . . . 0.0 111.696 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.98 72.59 10.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.049 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 118' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' C' ' 155' ' ' LYS . 78.1 m-85 -92.37 89.75 6.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.765 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 55.1 m -130.54 73.12 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.938 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.22 142.28 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.651 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -103.98 68.51 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.199 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.766 ' HB ' ' HB3' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -81.43 133.13 35.36 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.71 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 8.6 m -87.6 124.12 33.18 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.697 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . 0.501 ' O ' HG23 ' C' ' 63' ' ' THR . 4.1 tp -97.3 119.29 35.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.655 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -113.69 171.9 7.3 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.586 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.48 109.72 16.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.618 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.85 -133.79 4.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.714 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 128' ' ' THR . . . . . 0.509 HG22 ' HA ' ' C' ' 59' ' ' ASN . 46.4 m -110.52 86.78 2.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.722 0.296 . . . . 0.0 110.779 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 129' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.38 155.06 41.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.866 0.365 . . . . 0.0 111.143 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 130' ' ' THR . . . . . 0.815 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -142.79 137.09 29.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.086 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 131' ' ' ILE . . . . . 0.62 HG21 HG13 ' C' ' 71' ' ' VAL . 6.9 mt -100.3 109.13 55.81 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 132' ' ' PRO . . . . . 0.72 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.5 Cg_endo -81.76 148.25 15.68 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.668 1.579 . . . . 0.0 112.546 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' C' ' 105' ' ' ASP . 0.5 OUTLIER -158.81 145.27 17.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.933 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -111.23 160.41 17.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.052 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' C' ' 102' ' ' GLN . . . -155.97 97.81 1.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.945 0.402 . . . . 0.0 111.609 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . 0.534 ' HB3' ' HB1' ' C' ' 51' ' ' ALA . 14.4 ptt180 -101.57 173.59 6.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.4 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 137' ' ' TYR . . . . . 0.525 ' HB3' HD22 ' C' ' 42' ' ' LEU . 1.8 m-85 -83.66 135.04 34.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.121 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 138' ' ' PHE . . . . . 0.405 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 1.8 t80 -128.86 128.16 43.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.235 0.541 . . . . 0.0 112.01 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 139' ' ' ALA . . . . . 0.692 ' HB3' ' HG ' ' C' ' 42' ' ' LEU . . . -108.5 138.01 45.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.83 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 140' ' ' THR . . . . . 0.52 HG22 ' HB2' ' C' ' 79' ' ' ASP . 0.3 OUTLIER -90.0 -9.54 48.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.458 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.3 -95.25 0.1 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.0 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.74 101.49 11.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.51 0.195 . . . . 0.0 110.704 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 143' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' C' ' 42' ' ' LEU . . . -61.36 144.36 54.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.758 0.313 . . . . 0.0 111.368 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 144' ' ' THR . . . . . 0.612 HG22 ' CD ' ' C' ' 145' ' ' PRO . 99.2 m -123.96 153.14 67.5 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.211 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 145' ' ' PRO . . . . . 0.612 ' CD ' HG22 ' C' ' 144' ' ' THR . 1.3 Cg_endo -82.99 144.78 12.17 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.49 2.127 . . . . 0.0 111.999 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 146' ' ' GLY . . . . . 0.624 ' O ' ' HG3' ' B' ' 15' ' ' GLU . . . 157.3 -116.09 0.7 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.468 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 147' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' C' ' 94' ' ' GLY . . . -119.72 132.37 55.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 111.387 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 148' ' ' ALA . . . . . 0.528 ' HB2' HG22 ' B' ' 16' ' ' VAL . . . -125.38 43.36 3.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.136 0.493 . . . . 0.0 110.383 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 149' ' ' ASN . . . . . 0.491 ' HB2' ' HG3' ' C' ' 89' ' ' GLN . 1.1 m120 -95.68 150.86 19.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.635 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 150' ' ' ALA . . . . . . . . . . . . . . . -168.45 -178.65 3.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.012 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.76 153.0 39.71 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.274 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 152' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -141.21 151.12 43.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.243 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.69 133.76 54.55 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 154' ' ' PHE . . . . . 0.472 ' HB3' ' H ' ' B' ' 8' ' ' GLY . 0.1 OUTLIER -81.71 148.68 28.84 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.036 0.446 . . . . 0.0 110.136 -179.05 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 155' ' ' LYS . . . . . 0.537 ' HB3' ' CZ ' ' C' ' 118' ' ' PHE . 11.2 mmtt -135.01 139.43 44.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.945 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 156' ' ' VAL . . . . . 0.503 ' CG2' HG21 ' B' ' 5' ' ' VAL . 3.1 m -134.52 141.3 43.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.82 0.343 . . . . 0.0 111.685 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -128.78 129.0 45.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.326 0.584 . . . . 0.0 110.34 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.7 128.6 51.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.563 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.834 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.331 0.11 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.41 88.94 0.04 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.567 0.222 . . . . 0.0 111.024 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.16 114.54 18.49 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.378 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -97.35 119.2 35.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.638 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . 0.495 HG21 ' CG2' ' E' ' 156' ' ' VAL . 19.5 m -136.6 158.24 37.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.582 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.12 115.95 22.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.626 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.66 -79.57 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.876 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . 0.476 ' HA3' ' CD1' ' E' ' 56' ' ' ILE . . . -148.55 -145.94 4.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.892 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 9' ' ' THR . . . . . 0.408 ' HG1' ' HA ' ' E' ' 29' ' ' ASP . 15.0 p -142.05 145.11 33.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.028 0.442 . . . . 0.0 111.238 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 32.6 t -127.8 119.49 51.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.259 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -92.42 113.19 25.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.387 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.76 90.65 5.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.08 120.74 32.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.297 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.07 170.46 32.64 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.901 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' E' ' 146' ' ' GLY . 21.4 tt0 -160.59 129.23 4.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.98 0.419 . . . . 0.0 110.382 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.709 HG21 HG12 ' E' ' 99' ' ' VAL . 2.2 t -89.67 136.92 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.233 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . 0.629 ' O ' HG22 ' E' ' 39' ' ' THR . 34.3 m -136.35 -160.77 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.77 0.319 . . . . 0.0 111.162 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' ASN . . . . . 0.573 ' HA ' HG21 ' E' ' 39' ' ' THR . 1.5 t-20 -91.93 176.98 6.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.009 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' ALA . . . . . 0.439 ' HB2' ' HB1' ' E' ' 40' ' ' ALA . . . -90.18 49.63 1.73 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.085 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' D' ' 61' ' ' CYS . . . -122.18 -39.65 2.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.403 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.5 OUTLIER -162.17 146.35 12.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.946 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.97 121.68 14.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . 0.609 ' HA ' ' HG ' ' D' ' 58' ' ' LEU . 2.5 p -63.75 143.51 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' D' ' 27' ' ' SER . 13.6 t70 -72.97 154.64 40.44 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.549 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.583 ' O ' HG21 ' D' ' 28' ' ' VAL . . . -54.3 -53.89 47.65 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.336 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.54 1.03 88.67 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.911 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' D' ' 24' ' ' ASP . 7.9 t -99.28 -16.66 18.41 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.873 0.368 . . . . 0.0 110.829 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . 0.583 HG21 ' O ' ' D' ' 25' ' ' ALA . 10.9 t -53.19 -50.81 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.338 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' ASP . . . . . 0.401 ' HA ' ' HG1' ' C' ' 9' ' ' THR . 39.9 t0 -114.12 126.15 54.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.987 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -125.58 135.58 52.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.063 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.93 109.17 21.95 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.132 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.57 115.13 48.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.144 0.497 . . . . 0.0 110.458 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.17 124.73 50.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.671 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.435 ' HB3' ' HB1' ' A' ' 92' ' ' ALA . 1.9 mp -80.24 -42.29 23.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.62 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.08 -165.38 12.15 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.574 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' GLN . . . . . 0.596 ' HG2' HG12 ' C' ' 17' ' ' VAL . 3.7 mt-30 -93.62 119.23 32.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.635 0.255 . . . . 0.0 110.83 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' D' ' 137' ' ' TYR . 8.2 p -104.92 133.95 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.884 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.96 137.66 36.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.628 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.641 HG22 ' O ' ' C' ' 17' ' ' VAL . 0.2 OUTLIER -62.52 -49.39 75.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.764 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' C' ' 19' ' ' ALA . . . -53.53 -33.5 54.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.051 0.453 . . . . 0.0 110.85 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.97 -31.38 61.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.116 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.689 ' HG ' ' HB3' ' D' ' 139' ' ' ALA . 0.6 OUTLIER -114.01 39.79 2.63 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.662 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.22 33.94 3.28 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.391 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' GLN . . . . . 0.659 ' HB2' ' HB2' ' D' ' 47' ' ' ALA . 0.3 OUTLIER -124.46 142.88 50.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.323 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.2 95.67 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.0 111.138 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.37 33.72 5.84 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.152 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.659 ' HB2' ' HB2' ' D' ' 44' ' ' GLN . . . -78.94 143.56 35.68 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.991 0.424 . . . . 0.0 111.955 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' THR . . . . . 0.503 ' HB ' ' HD2' ' D' ' 136' ' ' ARG . 18.2 p -131.64 131.96 43.62 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.869 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 1.3 m -103.82 -167.2 1.34 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.541 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 3.9 t -57.77 141.92 47.19 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.872 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' ALA . . . . . 0.535 ' HB1' ' HB3' ' D' ' 136' ' ' ARG . . . -99.06 125.5 44.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.369 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' VAL . . . . . 0.545 HG11 ' HB3' ' A' ' 92' ' ' ALA . 24.8 m -76.53 150.96 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.953 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.26 143.26 16.39 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.598 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -171.48 140.42 1.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.796 0.331 . . . . 0.0 110.972 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' ASN . . . . . 0.585 HD21 ' HG1' ' A' ' 76' ' ' THR . 17.0 p30 -136.3 138.58 41.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.603 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.486 ' CD1' ' HA3' ' C' ' 8' ' ' GLY . 0.7 OUTLIER -88.38 116.76 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.588 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' GLN . . . . . 0.789 ' HA ' HG23 ' D' ' 130' ' ' THR . 5.0 mp0 -69.35 138.32 53.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.78 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . 0.627 ' HB3' ' SG ' ' D' ' 21' ' ' CYS . 0.3 OUTLIER -145.62 91.69 2.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.292 -179.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . 0.506 ' HA ' HG22 ' D' ' 128' ' ' THR . 8.2 p30 -78.39 176.86 8.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.906 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.9 81.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.798 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 10.4 m -133.82 147.77 51.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.798 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.67 161.92 20.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.328 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.498 HG23 ' O ' ' D' ' 124' ' ' LEU . 0.0 OUTLIER -111.76 -34.2 6.1 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.088 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -72.57 -28.14 62.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.017 0.437 . . . . 0.0 111.72 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 59.4 t -73.25 -58.47 4.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.696 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.483 ' HB2' ' HB3' ' D' ' 20' ' ' ALA . . . -132.17 126.06 32.7 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.571 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.4 -42.08 7.13 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.955 0.407 . . . . 0.0 110.964 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.29 156.85 18.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.457 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' ALA . . . . . 0.741 ' HB3' ' HB ' ' D' ' 122' ' ' THR . . . -146.66 133.21 19.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.556 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' D' ' 118' ' ' PHE . . . -113.34 155.12 25.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.144 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . 0.64 HG13 HG21 ' D' ' 131' ' ' ILE . 2.0 t -136.41 148.56 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.641 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 72' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' D' ' 155' ' ' LYS . . . -152.87 163.5 39.64 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.573 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.26 142.31 50.56 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 122.4 -0.187 . . . . 0.0 111.161 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 74' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 1.4 tt -109.21 119.04 38.3 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.071 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . 0.694 ' HA3' HD22 ' D' ' 113' ' ' LEU . . . -162.72 -161.88 12.86 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.786 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 76' ' ' THR . . . . . 0.601 ' H ' HD21 ' D' ' 86' ' ' LEU . 0.3 OUTLIER -120.97 162.91 19.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.545 0.212 . . . . 0.0 110.78 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . 0.685 ' HB1' ' HA ' ' D' ' 83' ' ' THR . . . -83.55 139.06 33.11 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.967 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 78' ' ' ILE . . . . . 0.566 HG23 ' N ' ' D' ' 79' ' ' ASP . 11.1 tt -66.05 -47.63 84.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.948 0.404 . . . . 0.0 111.003 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . 0.566 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.2 OUTLIER -134.44 46.68 2.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.813 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.47 -83.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.072 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.78 -36.39 41.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.62 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.42 69.25 10.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.375 . . . . 0.0 110.546 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 83' ' ' THR . . . . . 0.685 ' HA ' ' HB1' ' D' ' 77' ' ' ALA . 0.2 OUTLIER -74.12 -7.52 52.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.544 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . 0.61 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 30.1 p-10 -74.71 -25.4 59.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.332 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.495 HG12 HD12 ' D' ' 78' ' ' ILE . 6.4 t -104.91 143.85 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.161 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.601 HD21 ' H ' ' D' ' 76' ' ' THR . 0.3 OUTLIER -74.8 160.88 30.14 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.31 179.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.526 ' HB2' ' HB ' ' D' ' 76' ' ' THR . . . -103.62 179.85 4.15 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.857 0.36 . . . . 0.0 111.739 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.697 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 1.3 mm? -66.59 171.3 5.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.071 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 89' ' ' GLN . . . . . 0.516 ' HG3' ' HB2' ' D' ' 149' ' ' ASN . 1.3 mm-40 -68.57 -83.76 0.03 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.25 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.14 19.17 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.937 0.399 . . . . 0.0 111.447 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 91' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' D' ' 95' ' ' SER . 3.3 m -90.16 86.24 6.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.927 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.16 -24.98 66.7 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.598 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.37 41.25 3.52 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.686 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 94' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' D' ' 147' ' ' ALA . . . -175.01 0.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.866 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 95' ' ' SER . . . . . 0.697 ' HB3' ' HG ' ' D' ' 88' ' ' LEU . 1.9 m -89.24 -173.57 4.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.751 0.31 . . . . 0.0 110.724 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 96' ' ' ALA . . . . . 0.694 ' CB ' HG23 ' C' ' 16' ' ' VAL . . . -101.0 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.849 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 97' ' ' THR . . . . . 0.404 ' O ' HG21 ' D' ' 99' ' ' VAL . 3.0 m -131.1 123.87 29.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.319 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.26 29.44 18.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.444 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 99' ' ' VAL . . . . . 0.719 HG12 HG21 ' C' ' 16' ' ' VAL . 1.7 t -125.34 129.32 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.822 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.87 -171.11 21.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.522 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 101' ' ' VAL . . . . . 0.437 HG12 HD13 ' D' ' 86' ' ' LEU . 1.9 p -122.96 116.74 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.256 0.55 . . . . 0.0 111.694 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 102' ' ' GLN . . . . . 0.548 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 2.8 tt0 -81.76 151.43 27.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.915 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 103' ' ' ILE . . . . . 0.477 HD11 ' HG ' ' D' ' 113' ' ' LEU . 1.0 OUTLIER -114.79 123.82 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.575 179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.73 125.19 50.57 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.661 0.267 . . . . 0.0 110.986 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . 0.71 ' HB3' HG23 ' D' ' 107' ' ' THR . 13.6 t0 -77.61 143.12 38.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.693 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 106' ' ' ARG . . . . . 0.699 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -62.72 -14.93 50.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.748 0.308 . . . . 0.0 111.029 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 107' ' ' THR . . . . . 0.71 HG23 ' HB3' ' D' ' 105' ' ' ASP . 8.8 t -62.98 -20.95 65.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.013 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.25 -43.54 1.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.735 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.72 160.7 14.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.83 0.348 . . . . 0.0 111.093 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.33 133.18 40.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 111' ' ' LEU . . . . . 0.656 ' HB2' ' HB2' ' D' ' 105' ' ' ASP . 12.3 tp -95.53 160.91 14.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.397 0.618 . . . . 0.0 110.477 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 112' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 2.9 t -110.23 136.79 48.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.046 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 113' ' ' LEU . . . . . 0.694 HD22 ' HA3' ' D' ' 75' ' ' GLY . 1.4 mt -70.2 89.55 0.65 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.702 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.29 -18.44 6.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.515 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.31 -62.28 0.87 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.619 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.93 18.26 9.37 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.958 0.408 . . . . 0.0 111.638 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.98 72.57 10.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' D' ' 155' ' ' LYS . 78.1 m-85 -92.35 89.75 6.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.792 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 55.5 m -130.55 73.19 1.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.86 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.24 142.3 21.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.695 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.95 68.51 0.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.208 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.741 ' HB ' ' HB3' ' D' ' 69' ' ' ALA . 0.0 OUTLIER -81.45 133.11 35.36 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.722 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 8.5 m -87.51 124.1 33.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.77 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . 0.498 ' O ' HG23 ' D' ' 63' ' ' THR . 4.1 tp -97.3 119.27 35.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.677 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -113.66 171.91 7.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.599 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.47 109.75 16.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.648 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.8 -133.78 4.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.705 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 128' ' ' THR . . . . . 0.533 ' HB ' ' HE3' ' A' ' 155' ' ' LYS . 46.5 m -110.54 86.77 2.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.731 0.3 . . . . 0.0 110.757 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 129' ' ' ASN . . . . . 0.619 ' OD1' ' HB1' ' A' ' 116' ' ' ALA . 1.1 t30 -69.36 155.07 41.04 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.825 0.345 . . . . 0.0 111.199 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 130' ' ' THR . . . . . 0.789 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.2 OUTLIER -142.8 137.08 29.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.066 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 131' ' ' ILE . . . . . 0.64 HG21 HG13 ' D' ' 71' ' ' VAL . 6.9 mt -100.26 109.13 55.7 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 132' ' ' PRO . . . . . 0.699 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.5 Cg_endo -81.78 148.29 15.66 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.673 1.582 . . . . 0.0 112.526 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . 0.412 ' CZ ' ' HA ' ' D' ' 105' ' ' ASP . 0.5 OUTLIER -158.85 145.28 16.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.913 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -111.23 160.4 17.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.041 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' D' ' 102' ' ' GLN . . . -155.99 97.82 1.84 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.96 0.41 . . . . 0.0 111.629 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 136' ' ' ARG . . . . . 0.535 ' HB3' ' HB1' ' D' ' 51' ' ' ALA . 14.4 ptt180 -101.57 173.64 6.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.417 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 137' ' ' TYR . . . . . 0.541 ' HB3' HD22 ' D' ' 42' ' ' LEU . 1.8 m-85 -83.64 135.01 34.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.142 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 138' ' ' PHE . . . . . 0.408 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 1.8 t80 -128.85 128.21 43.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.283 0.563 . . . . 0.0 112.013 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 139' ' ' ALA . . . . . 0.689 ' HB3' ' HG ' ' D' ' 42' ' ' LEU . . . -108.54 137.99 45.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.874 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 140' ' ' THR . . . . . 0.527 HG22 ' HB2' ' D' ' 79' ' ' ASP . 0.3 OUTLIER -89.93 -9.57 48.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.48 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.31 -95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.999 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.74 101.5 11.33 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.526 0.203 . . . . 0.0 110.708 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 143' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' D' ' 42' ' ' LEU . . . -61.35 144.35 54.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.752 0.311 . . . . 0.0 111.395 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 144' ' ' THR . . . . . 0.603 HG22 ' CD ' ' D' ' 145' ' ' PRO . 99.2 m -123.96 153.15 67.5 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.217 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 145' ' ' PRO . . . . . 0.603 ' CD ' HG22 ' D' ' 144' ' ' THR . 1.3 Cg_endo -82.97 144.71 12.17 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.56 2.173 . . . . 0.0 111.987 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 146' ' ' GLY . . . . . 0.634 ' O ' ' HG3' ' C' ' 15' ' ' GLU . . . 157.32 -116.1 0.7 Allowed Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.479 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 147' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' D' ' 94' ' ' GLY . . . -119.71 132.38 55.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.376 . . . . 0.0 111.37 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 148' ' ' ALA . . . . . 0.529 ' HB2' HG22 ' C' ' 16' ' ' VAL . . . -125.37 43.37 3.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.397 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 149' ' ' ASN . . . . . 0.516 ' HB2' ' HG3' ' D' ' 89' ' ' GLN . 1.1 m120 -95.68 150.86 19.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.593 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 150' ' ' ALA . . . . . . . . . . . . . . . -168.45 -178.64 3.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.987 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.77 152.98 39.68 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.251 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 152' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -141.2 151.1 43.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.257 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.63 133.7 54.53 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 154' ' ' PHE . . . . . 0.46 ' HB3' ' H ' ' C' ' 8' ' ' GLY . 0.1 OUTLIER -81.68 148.73 28.85 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.07 0.462 . . . . 0.0 110.137 -179.043 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 155' ' ' LYS . . . . . 0.531 ' HB3' ' CZ ' ' D' ' 118' ' ' PHE . 11.2 mmtt -135.06 139.45 44.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.924 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 156' ' ' VAL . . . . . 0.498 ' CG2' HG21 ' C' ' 5' ' ' VAL . 3.1 m -134.53 141.3 43.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.783 0.325 . . . . 0.0 111.687 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 157' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -128.78 128.97 45.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.31 0.576 . . . . 0.0 110.363 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.73 128.58 51.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.552 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.85 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.281 0.086 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.37 88.93 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.028 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.14 114.5 18.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.446 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -97.29 119.17 35.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.685 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . 0.502 HG21 ' CG2' ' F' ' 156' ' ' VAL . 19.6 m -136.56 158.25 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.605 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.13 116.01 22.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.59 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.74 -79.55 0.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.846 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . 0.491 ' HA3' ' CD1' ' F' ' 56' ' ' ILE . . . -148.56 -145.96 4.24 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.882 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 9' ' ' THR . . . . . 0.409 ' HG1' ' HA ' ' F' ' 29' ' ' ASP . 15.2 p -141.99 145.15 34.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.963 0.411 . . . . 0.0 111.302 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 32.5 t -127.83 119.49 51.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.262 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.4 113.16 25.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.374 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.76 90.66 5.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.814 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.08 120.74 32.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.342 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.06 170.53 32.65 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.933 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 15' ' ' GLU . . . . . 0.632 ' HG3' ' O ' ' F' ' 146' ' ' GLY . 21.4 tt0 -160.62 129.19 4.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 110.333 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 16' ' ' VAL . . . . . 0.706 HG21 HG12 ' F' ' 99' ' ' VAL . 2.2 t -89.66 136.92 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.25 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . 0.626 ' O ' HG22 ' F' ' 39' ' ' THR . 34.3 m -136.35 -160.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.774 0.321 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . 0.575 ' HA ' HG21 ' F' ' 39' ' ' THR . 1.5 t-20 -91.95 177.01 6.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.03 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 19' ' ' ALA . . . . . 0.448 ' HB2' ' HB1' ' F' ' 40' ' ' ALA . . . -90.15 49.64 1.73 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' E' ' 61' ' ' CYS . . . -122.16 -39.73 2.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.384 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 21' ' ' CYS . . . . . 0.84 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.5 OUTLIER -162.09 146.41 12.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.905 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.05 121.6 14.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.104 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 23' ' ' VAL . . . . . 0.594 ' HA ' ' HG ' ' E' ' 58' ' ' LEU . 2.5 p -63.68 143.52 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 24' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' E' ' 27' ' ' SER . 13.5 t70 -72.92 154.61 40.49 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.595 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . 0.591 ' O ' HG21 ' E' ' 28' ' ' VAL . . . -54.32 -53.83 48.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.358 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.59 1.03 88.75 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.875 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 27' ' ' SER . . . . . 0.519 ' HB2' ' HB3' ' E' ' 24' ' ' ASP . 7.9 t -99.28 -16.67 18.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.891 0.376 . . . . 0.0 110.849 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 28' ' ' VAL . . . . . 0.591 HG21 ' O ' ' E' ' 25' ' ' ALA . 10.9 t -53.18 -50.82 44.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.329 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 29' ' ' ASP . . . . . 0.408 ' HA ' ' HG1' ' D' ' 9' ' ' THR . 40.0 t0 -114.13 126.17 54.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.987 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 30' ' ' GLN . . . . . 0.406 HE22 ' HA ' ' E' ' 56' ' ' ILE . 3.7 mt-30 -125.6 135.56 52.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.062 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.92 109.14 21.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.1 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.55 115.11 48.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.11 0.481 . . . . 0.0 110.435 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.15 124.75 50.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.66 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.441 ' HB3' ' HB1' ' B' ' 92' ' ' ALA . 1.9 mp -80.21 -42.33 23.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.624 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.1 -165.39 12.15 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.592 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 36' ' ' GLN . . . . . 0.61 ' HG2' HG12 ' D' ' 17' ' ' VAL . 3.7 mt-30 -93.61 119.2 32.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.642 0.258 . . . . 0.0 110.837 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' E' ' 137' ' ' TYR . 8.2 p -104.89 133.94 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.856 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.9 137.65 36.95 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.694 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 39' ' ' THR . . . . . 0.629 HG22 ' O ' ' D' ' 17' ' ' VAL . 0.2 OUTLIER -62.55 -49.39 75.49 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.747 179.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . 0.439 ' HB1' ' HB2' ' D' ' 19' ' ' ALA . . . -53.55 -33.47 54.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.0 0.428 . . . . 0.0 110.857 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.97 -31.33 61.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.113 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.706 ' HG ' ' HB3' ' E' ' 139' ' ' ALA . 0.6 OUTLIER -114.09 39.83 2.64 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.617 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.28 33.96 3.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.385 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 44' ' ' GLN . . . . . 0.659 ' HB2' ' HB2' ' E' ' 47' ' ' ALA . 0.3 OUTLIER -124.47 142.85 51.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.346 179.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.24 95.73 0.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.896 0.379 . . . . 0.0 111.156 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.35 33.71 5.84 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.191 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 47' ' ' ALA . . . . . 0.659 ' HB2' ' HB2' ' E' ' 44' ' ' GLN . . . -78.9 143.51 35.81 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 111.968 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 48' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' E' ' 136' ' ' ARG . 18.1 p -131.62 131.97 43.65 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.882 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 1.3 m -103.8 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.556 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 50' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 3.9 t -57.83 141.9 47.51 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.853 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 51' ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' E' ' 136' ' ' ARG . . . -99.05 125.53 44.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.426 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 52' ' ' VAL . . . . . 0.562 HG11 ' HB3' ' B' ' 92' ' ' ALA . 24.7 m -76.51 150.95 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.27 143.26 16.39 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.588 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -171.49 140.46 1.39 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.821 0.343 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 55' ' ' ASN . . . . . 0.586 HD21 ' HG1' ' B' ' 76' ' ' THR . 17.0 p30 -136.32 138.59 41.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.598 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 56' ' ' ILE . . . . . 0.476 ' CD1' ' HA3' ' D' ' 8' ' ' GLY . 0.7 OUTLIER -88.43 116.76 30.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.568 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 57' ' ' GLN . . . . . 0.784 ' HA ' HG23 ' E' ' 130' ' ' THR . 5.0 mp0 -69.35 138.3 53.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.787 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . 0.63 ' HB3' ' SG ' ' E' ' 21' ' ' CYS . 0.3 OUTLIER -145.57 91.62 2.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.284 -179.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 8.1 p30 -78.4 176.83 8.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.943 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 61' ' ' CYS . . . . . 0.84 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 10.4 m -133.84 147.78 51.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.796 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.68 161.94 20.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.328 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 63' ' ' THR . . . . . 0.489 HG23 ' O ' ' E' ' 124' ' ' LEU . 0.0 OUTLIER -111.79 -34.2 6.09 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.082 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -72.56 -28.15 62.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.008 0.433 . . . . 0.0 111.704 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.19 -58.55 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.667 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 66' ' ' ALA . . . . . 0.483 ' HB2' ' HB3' ' E' ' 20' ' ' ALA . . . -132.21 126.05 32.61 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.567 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.38 -42.08 7.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.972 0.415 . . . . 0.0 110.968 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.31 156.83 18.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.456 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 69' ' ' ALA . . . . . 0.727 ' HB3' ' HB ' ' E' ' 122' ' ' THR . . . -146.61 133.21 19.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.572 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' E' ' 118' ' ' PHE . . . -113.33 155.11 25.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.156 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . 0.621 HG13 HG21 ' E' ' 131' ' ' ILE . 2.0 t -136.39 148.6 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.655 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -152.93 163.51 39.66 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.563 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.25 142.24 50.57 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 122.408 -0.183 . . . . 0.0 111.179 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 74' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 1.4 tt -109.21 119.08 38.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.053 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . 0.711 ' HA3' HD22 ' E' ' 113' ' ' LEU . . . -162.72 -161.89 12.87 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.777 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 76' ' ' THR . . . . . 0.611 ' H ' HD21 ' E' ' 86' ' ' LEU . 0.3 OUTLIER -120.95 162.94 19.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.605 0.241 . . . . 0.0 110.773 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 77' ' ' ALA . . . . . 0.676 ' HB1' ' HA ' ' E' ' 83' ' ' THR . . . -83.55 139.07 33.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.955 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 78' ' ' ILE . . . . . 0.564 HG23 ' N ' ' E' ' 79' ' ' ASP . 11.1 tt -66.09 -47.6 84.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.979 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 79' ' ' ASP . . . . . 0.564 ' N ' HG23 ' E' ' 78' ' ' ILE . 0.2 OUTLIER -134.5 46.68 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.847 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.54 -84.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.74 -36.43 40.75 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.609 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.44 69.26 10.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.891 0.377 . . . . 0.0 110.547 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 83' ' ' THR . . . . . 0.676 ' HA ' ' HB1' ' E' ' 77' ' ' ALA . 0.2 OUTLIER -74.15 -7.44 52.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.528 -179.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 84' ' ' ASN . . . . . 0.589 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 30.0 p-10 -74.77 -25.4 59.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.336 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.506 HG12 HD12 ' E' ' 78' ' ' ILE . 6.4 t -104.88 143.86 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.188 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 86' ' ' LEU . . . . . 0.611 HD21 ' H ' ' E' ' 76' ' ' THR . 0.3 OUTLIER -74.82 160.86 30.15 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.292 179.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 87' ' ' ALA . . . . . 0.537 ' HB2' ' HB ' ' E' ' 76' ' ' THR . . . -103.61 179.87 4.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.907 0.384 . . . . 0.0 111.725 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.684 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 1.3 mm? -66.6 171.28 5.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 89' ' ' GLN . . . . . 0.512 ' HG3' ' HB2' ' E' ' 149' ' ' ASN . 1.3 mm-40 -68.55 -83.78 0.03 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.253 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.09 19.13 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.935 0.398 . . . . 0.0 111.44 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 91' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' E' ' 95' ' ' SER . 3.2 m -90.15 86.23 6.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.09 -25.02 66.66 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.66 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.39 41.26 3.52 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.66 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 94' ' ' GLY . . . . . 0.574 ' O ' ' HB3' ' E' ' 147' ' ' ALA . . . -174.99 0.72 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.872 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 95' ' ' SER . . . . . 0.684 ' HB3' ' HG ' ' E' ' 88' ' ' LEU . 1.9 m -89.3 -173.57 4.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 110.722 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 96' ' ' ALA . . . . . 0.696 ' CB ' HG23 ' D' ' 16' ' ' VAL . . . -100.96 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 3.0 m -131.09 123.91 29.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.315 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.17 29.48 18.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.46 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 99' ' ' VAL . . . . . 0.709 HG12 HG21 ' D' ' 16' ' ' VAL . 1.7 t -125.29 129.33 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.809 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.85 -171.09 21.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.504 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 101' ' ' VAL . . . . . 0.445 HG12 HD13 ' E' ' 86' ' ' LEU . 1.9 p -122.93 116.73 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.195 0.522 . . . . 0.0 111.679 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 102' ' ' GLN . . . . . 0.542 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 2.8 tt0 -81.77 151.45 27.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.931 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 103' ' ' ILE . . . . . 0.451 HD11 ' HG ' ' E' ' 113' ' ' LEU . 1.0 OUTLIER -114.79 123.83 70.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.515 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.71 125.18 50.55 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.704 0.288 . . . . 0.0 111.003 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . 0.724 ' HB3' HG23 ' E' ' 107' ' ' THR . 13.6 t0 -77.58 143.04 38.62 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.715 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 106' ' ' ARG . . . . . 0.721 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -62.67 -14.91 49.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.705 0.288 . . . . 0.0 111.025 179.47 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 107' ' ' THR . . . . . 0.724 HG23 ' HB3' ' E' ' 105' ' ' ASP . 8.8 t -63.01 -20.96 65.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.011 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.28 -43.51 1.37 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.745 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.75 160.67 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.083 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.36 133.14 40.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.088 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 111' ' ' LEU . . . . . 0.623 ' HB2' ' HB2' ' E' ' 105' ' ' ASP . 12.3 tp -95.5 160.97 14.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.389 0.614 . . . . 0.0 110.511 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 112' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 2.8 t -110.26 136.79 48.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.043 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 113' ' ' LEU . . . . . 0.711 HD22 ' HA3' ' E' ' 75' ' ' GLY . 1.4 mt -70.22 89.6 0.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.745 0.307 . . . . 0.0 110.663 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -18.45 6.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.463 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -62.26 0.88 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.67 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.96 18.22 9.45 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.99 0.424 . . . . 0.0 111.651 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.92 72.55 10.41 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.058 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 118' ' ' PHE . . . . . 0.541 ' CZ ' ' HB3' ' E' ' 155' ' ' LYS . 78.1 m-85 -92.34 89.78 6.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 55.2 m -130.6 73.2 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.25 142.28 21.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.691 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.98 68.57 0.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.144 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 122' ' ' THR . . . . . 0.727 ' HB ' ' HB3' ' E' ' 69' ' ' ALA . 0.0 OUTLIER -81.5 133.12 35.35 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.688 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 8.6 m -87.55 124.13 33.17 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.713 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . 0.489 ' O ' HG23 ' E' ' 63' ' ' THR . 4.2 tp -97.33 119.33 35.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.632 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -113.68 171.89 7.31 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.609 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.49 109.8 16.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.637 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.77 -133.81 4.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.71 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 128' ' ' THR . . . . . 0.52 ' HB ' ' HE3' ' B' ' 155' ' ' LYS . 46.2 m -110.52 86.76 2.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.767 0.317 . . . . 0.0 110.79 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 129' ' ' ASN . . . . . 0.623 ' OD1' ' HB1' ' B' ' 116' ' ' ALA . 1.2 t30 -69.37 155.05 41.07 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.822 0.344 . . . . 0.0 111.16 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 130' ' ' THR . . . . . 0.784 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.2 OUTLIER -142.78 137.07 29.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.1 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 131' ' ' ILE . . . . . 0.621 HG21 HG13 ' E' ' 71' ' ' VAL . 6.9 mt -100.23 109.05 55.39 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 132' ' ' PRO . . . . . 0.721 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.5 Cg_endo -81.7 148.24 15.77 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.718 1.612 . . . . 0.0 112.525 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 133' ' ' PHE . . . . . 0.415 ' CZ ' ' HA ' ' E' ' 105' ' ' ASP . 0.5 OUTLIER -158.8 145.3 17.06 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.924 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -111.23 160.43 16.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.041 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 135' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' E' ' 102' ' ' GLN . . . -155.98 97.8 1.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.9 0.381 . . . . 0.0 111.621 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 136' ' ' ARG . . . . . 0.531 ' HB3' ' HB1' ' E' ' 51' ' ' ALA . 14.4 ptt180 -101.57 173.6 6.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.412 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 137' ' ' TYR . . . . . 0.539 ' HB3' HD22 ' E' ' 42' ' ' LEU . 1.8 m-85 -83.66 135.03 34.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.144 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 138' ' ' PHE . . . . . 0.407 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 1.7 t80 -128.84 128.16 43.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.055 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 139' ' ' ALA . . . . . 0.706 ' HB3' ' HG ' ' E' ' 42' ' ' LEU . . . -108.51 137.96 45.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.836 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 140' ' ' THR . . . . . 0.526 HG22 ' HB2' ' E' ' 79' ' ' ASP . 0.3 OUTLIER -89.92 -9.54 48.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.49 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.28 -95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.947 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.71 101.52 11.36 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.529 0.204 . . . . 0.0 110.735 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 143' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' E' ' 42' ' ' LEU . . . -61.39 144.38 54.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.788 0.328 . . . . 0.0 111.336 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 144' ' ' THR . . . . . 0.608 HG22 ' CD ' ' E' ' 145' ' ' PRO . 99.2 m -123.95 153.15 67.46 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.236 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 145' ' ' PRO . . . . . 0.608 ' CD ' HG22 ' E' ' 144' ' ' THR . 1.4 Cg_endo -82.97 144.76 12.18 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.561 2.174 . . . . 0.0 111.979 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 146' ' ' GLY . . . . . 0.636 ' O ' ' HG3' ' D' ' 15' ' ' GLU . . . 157.3 -116.09 0.7 Allowed Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.49 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 147' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' E' ' 94' ' ' GLY . . . -119.72 132.38 55.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.871 0.367 . . . . 0.0 111.403 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 148' ' ' ALA . . . . . 0.52 ' HB2' HG22 ' D' ' 16' ' ' VAL . . . -125.39 43.36 3.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.112 0.482 . . . . 0.0 110.379 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 149' ' ' ASN . . . . . 0.512 ' HB2' ' HG3' ' E' ' 89' ' ' GLN . 1.1 m120 -95.67 150.86 19.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.609 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 150' ' ' ALA . . . . . . . . . . . . . . . -168.47 -178.63 3.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.009 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.76 152.99 39.7 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.228 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 152' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -141.2 151.12 43.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.206 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.66 133.74 54.54 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 154' ' ' PHE . . . . . 0.462 ' HB3' ' H ' ' D' ' 8' ' ' GLY . 0.1 OUTLIER -81.72 148.72 28.82 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.103 0.478 . . . . 0.0 110.114 -179.05 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 155' ' ' LYS . . . . . 0.541 ' HB3' ' CZ ' ' E' ' 118' ' ' PHE . 11.3 mmtt -135.02 139.49 44.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.931 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 156' ' ' VAL . . . . . 0.495 ' CG2' HG21 ' D' ' 5' ' ' VAL . 3.1 m -134.51 141.3 43.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.687 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 157' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -128.8 128.97 45.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.29 0.567 . . . . 0.0 110.373 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.69 128.58 51.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.536 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.331 0.11 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.4 88.96 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.568 0.223 . . . . 0.0 111.008 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.17 114.47 18.39 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.396 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -97.26 119.23 35.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.664 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 m -136.61 158.25 37.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.562 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.18 115.99 22.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.581 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.59 -79.63 0.13 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.878 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.56 -145.95 4.24 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.904 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 15.2 p -142.02 145.12 34.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.944 0.402 . . . . 0.0 111.314 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 32.0 t -127.84 119.47 51.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.226 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -92.4 113.18 25.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.407 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -95.8 90.65 5.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.794 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.09 120.76 32.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.343 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.09 170.48 32.66 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.934 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -160.59 129.18 4.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.957 0.408 . . . . 0.0 110.36 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.67 136.91 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.254 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.34 -160.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.786 0.327 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.93 177.02 6.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.967 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.22 49.62 1.73 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.064 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' F' ' 61' ' ' CYS . . . -122.15 -39.71 2.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.437 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 21' ' ' CYS . . . . . 0.834 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.5 OUTLIER -162.12 146.39 12.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.943 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.02 121.61 14.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 23' ' ' VAL . . . . . 0.589 ' HA ' ' HG ' ' F' ' 58' ' ' LEU . 2.5 p -63.7 143.49 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 24' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' F' ' 27' ' ' SER . 13.5 t70 -72.87 154.61 40.52 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.59 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . 0.588 ' O ' HG21 ' F' ' 28' ' ' VAL . . . -54.32 -53.87 48.01 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.335 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.56 1.03 88.7 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.863 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 27' ' ' SER . . . . . 0.525 ' HB2' ' HB3' ' F' ' 24' ' ' ASP . 7.9 t -99.32 -16.59 18.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.842 0.354 . . . . 0.0 110.814 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 28' ' ' VAL . . . . . 0.588 HG21 ' O ' ' F' ' 25' ' ' ALA . 10.9 t -53.24 -50.78 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.324 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 29' ' ' ASP . . . . . 0.409 ' HA ' ' HG1' ' E' ' 9' ' ' THR . 39.9 t0 -114.12 126.1 54.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.995 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 30' ' ' GLN . . . . . 0.405 HE22 ' HA ' ' F' ' 56' ' ' ILE . 3.7 mt-30 -125.57 135.65 52.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.059 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.93 109.18 21.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.091 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -115.59 115.12 48.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.148 0.499 . . . . 0.0 110.416 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -105.19 124.67 49.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.665 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 34' ' ' LEU . . . . . 0.428 ' HB3' ' HB1' ' C' ' 92' ' ' ALA . 1.9 mp -80.2 -42.29 23.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.603 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.08 -165.35 12.14 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.579 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 36' ' ' GLN . . . . . 0.592 ' HG2' HG12 ' E' ' 17' ' ' VAL . 3.7 mt-30 -93.67 119.16 32.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.657 0.265 . . . . 0.0 110.851 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.418 ' HB ' ' CE2' ' F' ' 137' ' ' TYR . 8.2 p -104.84 133.97 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.93 137.62 36.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.687 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 39' ' ' THR . . . . . 0.626 HG22 ' O ' ' E' ' 17' ' ' VAL . 0.2 OUTLIER -62.45 -49.46 75.34 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.775 179.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' E' ' 19' ' ' ALA . . . -53.53 -33.48 54.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.983 0.42 . . . . 0.0 110.829 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -31.37 61.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.113 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . 0.715 ' HG ' ' HB3' ' F' ' 139' ' ' ALA . 0.6 OUTLIER -114.02 39.82 2.63 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.611 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.25 33.93 3.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.388 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 44' ' ' GLN . . . . . 0.653 ' HB2' ' HB2' ' F' ' 47' ' ' ALA . 0.3 OUTLIER -124.46 142.84 51.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.366 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.22 95.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.867 0.365 . . . . 0.0 111.161 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.41 33.67 5.85 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.149 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 47' ' ' ALA . . . . . 0.653 ' HB2' ' HB2' ' F' ' 44' ' ' GLN . . . -78.79 143.51 36.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.979 0.418 . . . . 0.0 111.973 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 48' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' F' ' 136' ' ' ARG . 18.1 p -131.63 132.0 43.66 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.899 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 49' ' ' SER . . . . . 0.501 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 1.3 m -103.81 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.504 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 50' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 3.9 t -57.81 141.91 47.42 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 51' ' ' ALA . . . . . 0.523 ' HB1' ' HB3' ' F' ' 136' ' ' ARG . . . -99.03 125.5 44.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.376 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 52' ' ' VAL . . . . . 0.552 HG11 ' HB3' ' C' ' 92' ' ' ALA . 24.9 m -76.53 150.97 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.959 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.3 143.25 16.41 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.583 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 54' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -171.47 140.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.839 0.352 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 55' ' ' ASN . . . . . 0.577 HD21 ' HG1' ' C' ' 76' ' ' THR . 17.0 p30 -136.35 138.61 41.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.535 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 56' ' ' ILE . . . . . 0.491 ' CD1' ' HA3' ' E' ' 8' ' ' GLY . 0.7 OUTLIER -88.42 116.76 30.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.57 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 57' ' ' GLN . . . . . 0.819 ' HA ' HG23 ' F' ' 130' ' ' THR . 5.0 mp0 -69.39 138.31 53.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.803 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . 0.621 ' HB3' ' SG ' ' F' ' 21' ' ' CYS . 0.3 OUTLIER -145.58 91.67 2.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.284 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 59' ' ' ASN . . . . . 0.518 ' HA ' HG22 ' F' ' 128' ' ' THR . 8.2 p30 -78.43 176.87 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.925 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.86 0.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.792 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 61' ' ' CYS . . . . . 0.834 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 10.4 m -133.83 147.8 51.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.779 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.71 161.93 20.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.318 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 63' ' ' THR . . . . . 0.498 HG23 ' O ' ' F' ' 124' ' ' LEU . 0.0 OUTLIER -111.73 -34.25 6.09 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -72.53 -28.2 62.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.04 0.448 . . . . 0.0 111.728 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -73.13 -58.58 4.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.703 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 66' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' F' ' 20' ' ' ALA . . . -132.19 126.09 32.74 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.569 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.32 -42.17 7.12 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.95 0.405 . . . . 0.0 110.954 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 68' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' F' ' 68' ' ' LYS . 1.2 tptp -89.3 156.82 18.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.478 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 69' ' ' ALA . . . . . 0.75 ' HB3' ' HB ' ' F' ' 122' ' ' THR . . . -146.63 133.19 19.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.588 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 70' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' F' ' 118' ' ' PHE . . . -113.31 155.12 25.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.156 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 71' ' ' VAL . . . . . 0.63 HG13 HG21 ' F' ' 131' ' ' ILE . 2.0 t -136.4 148.56 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.69 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -152.9 163.49 39.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.55 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.25 142.3 50.57 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 121.247 -0.181 . . . . 0.0 111.186 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 74' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 1.4 tt -109.18 119.04 38.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.055 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . 0.697 ' HA3' HD22 ' F' ' 113' ' ' LEU . . . -162.72 -161.87 12.84 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.759 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 76' ' ' THR . . . . . 0.604 ' H ' HD21 ' F' ' 86' ' ' LEU . 0.3 OUTLIER -120.99 162.89 19.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.585 0.231 . . . . 0.0 110.775 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 77' ' ' ALA . . . . . 0.675 ' HB1' ' HA ' ' F' ' 83' ' ' THR . . . -83.53 139.08 33.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.937 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 78' ' ' ILE . . . . . 0.554 HG23 ' N ' ' F' ' 79' ' ' ASP . 11.1 tt -66.06 -47.66 84.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.981 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 79' ' ' ASP . . . . . 0.554 ' N ' HG23 ' F' ' 78' ' ' ILE . 0.2 OUTLIER -134.44 46.68 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.857 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.48 -84.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.76 -36.42 40.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.58 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.49 69.27 10.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.918 0.39 . . . . 0.0 110.52 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 83' ' ' THR . . . . . 0.675 ' HA ' ' HB1' ' F' ' 77' ' ' ALA . 0.2 OUTLIER -74.11 -7.51 52.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.527 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 84' ' ' ASN . . . . . 0.607 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 30.1 p-10 -74.7 -25.44 59.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.338 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 85' ' ' VAL . . . . . 0.492 HG12 HD12 ' F' ' 78' ' ' ILE . 6.4 t -104.89 143.86 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.152 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 86' ' ' LEU . . . . . 0.604 HD21 ' H ' ' F' ' 76' ' ' THR . 0.3 OUTLIER -74.83 160.88 30.13 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.263 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 87' ' ' ALA . . . . . 0.533 ' HB2' ' HB ' ' F' ' 76' ' ' THR . . . -103.66 179.86 4.15 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.902 0.382 . . . . 0.0 111.698 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . 0.681 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 1.3 mm? -66.56 171.27 5.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.019 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 89' ' ' GLN . . . . . 0.5 ' HG3' ' HB2' ' F' ' 149' ' ' ASN . 1.3 mm-40 -68.58 -83.74 0.03 OUTLIER 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.262 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.13 19.15 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.975 0.416 . . . . 0.0 111.459 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 91' ' ' SER . . . . . 0.493 ' O ' ' HB2' ' F' ' 95' ' ' SER . 3.3 m -90.17 86.21 6.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.936 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.06 -25.03 66.65 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.663 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.37 41.23 3.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.647 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 94' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' F' ' 147' ' ' ALA . . . -175.02 0.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.852 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 95' ' ' SER . . . . . 0.681 ' HB3' ' HG ' ' F' ' 88' ' ' LEU . 1.9 m -89.28 -173.6 4.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 110.667 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 96' ' ' ALA . . . . . 0.683 ' CB ' HG23 ' E' ' 16' ' ' VAL . . . -101.01 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.846 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 97' ' ' THR . . . . . 0.401 ' O ' HG21 ' F' ' 99' ' ' VAL . 3.0 m -131.04 123.92 29.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.322 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.18 29.46 18.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.479 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 99' ' ' VAL . . . . . 0.706 HG12 HG21 ' E' ' 16' ' ' VAL . 1.7 t -125.29 129.29 73.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.824 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.8 -171.07 21.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.516 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 101' ' ' VAL . . . . . 0.452 HG12 HD13 ' F' ' 86' ' ' LEU . 1.9 p -122.98 116.72 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.238 0.542 . . . . 0.0 111.703 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 102' ' ' GLN . . . . . 0.539 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 2.8 tt0 -81.75 151.45 27.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.942 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 103' ' ' ILE . . . . . 0.464 HD11 ' HG ' ' F' ' 113' ' ' LEU . 1.0 OUTLIER -114.81 123.85 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.525 179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.72 125.16 50.53 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.647 0.261 . . . . 0.0 111.011 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . 0.712 ' HB3' HG23 ' F' ' 107' ' ' THR . 13.5 t0 -77.54 143.07 38.68 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.683 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 106' ' ' ARG . . . . . 0.717 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -62.76 -14.82 49.43 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.756 0.312 . . . . 0.0 111.053 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 107' ' ' THR . . . . . 0.712 HG23 ' HB3' ' F' ' 105' ' ' ASP . 8.8 t -63.03 -20.93 65.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.038 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.25 -43.53 1.36 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.748 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.7 160.69 14.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.753 0.311 . . . . 0.0 111.109 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.32 133.17 40.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 111' ' ' LEU . . . . . 0.656 ' HB2' ' HB2' ' F' ' 105' ' ' ASP . 12.3 tp -95.52 160.89 14.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.381 0.61 . . . . 0.0 110.52 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 112' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 2.9 t -110.19 136.79 48.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.093 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 113' ' ' LEU . . . . . 0.697 HD22 ' HA3' ' F' ' 75' ' ' GLY . 1.4 mt -70.2 89.59 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.299 . . . . 0.0 110.65 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -18.46 6.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.482 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.29 -62.26 0.88 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.647 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.97 18.25 9.43 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-O 121.008 0.432 . . . . 0.0 111.661 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.92 72.54 10.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.015 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 118' ' ' PHE . . . . . 0.535 ' CZ ' ' HB3' ' F' ' 155' ' ' LYS . 78.2 m-85 -92.31 89.74 6.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.775 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 54.8 m -130.51 73.13 1.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.914 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.23 142.34 21.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.676 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -104.02 68.54 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.165 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 122' ' ' THR . . . . . 0.75 ' HB ' ' HB3' ' F' ' 69' ' ' ALA . 0.0 OUTLIER -81.45 133.12 35.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.721 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 8.5 m -87.55 124.12 33.16 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.738 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . 0.498 ' O ' HG23 ' F' ' 63' ' ' THR . 4.1 tp -97.31 119.29 35.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.672 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -113.71 171.93 7.29 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.581 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.5 109.74 16.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.656 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.84 -133.84 4.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.733 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 128' ' ' THR . . . . . 0.529 ' HB ' ' HE3' ' C' ' 155' ' ' LYS . 46.4 m -110.49 86.71 2.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.743 0.306 . . . . 0.0 110.811 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 129' ' ' ASN . . . . . 0.621 ' OD1' ' HB1' ' C' ' 116' ' ' ALA . 1.1 t30 -69.3 155.07 41.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.179 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 130' ' ' THR . . . . . 0.819 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.2 OUTLIER -142.79 137.08 29.45 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.099 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 131' ' ' ILE . . . . . 0.63 HG21 HG13 ' F' ' 71' ' ' VAL . 6.9 mt -100.25 109.09 55.57 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 132' ' ' PRO . . . . . 0.717 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.5 Cg_endo -81.72 148.26 15.74 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.721 1.614 . . . . 0.0 112.543 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 133' ' ' PHE . . . . . 0.418 ' CZ ' ' HA ' ' F' ' 105' ' ' ASP . 0.5 OUTLIER -158.86 145.29 16.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.903 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -111.23 160.43 16.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.042 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 135' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' F' ' 102' ' ' GLN . . . -156.03 97.82 1.83 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.995 0.426 . . . . 0.0 111.597 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 136' ' ' ARG . . . . . 0.523 ' HB3' ' HB1' ' F' ' 51' ' ' ALA . 14.4 ptt180 -101.5 173.6 6.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.407 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 137' ' ' TYR . . . . . 0.535 ' HB3' HD22 ' F' ' 42' ' ' LEU . 1.8 m-85 -83.65 135.03 34.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.168 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 138' ' ' PHE . . . . . 0.408 ' HB3' ' CG1' ' F' ' 85' ' ' VAL . 1.8 t80 -128.87 128.23 43.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.282 0.563 . . . . 0.0 111.972 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 139' ' ' ALA . . . . . 0.715 ' HB3' ' HG ' ' F' ' 42' ' ' LEU . . . -108.58 137.97 45.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.854 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 140' ' ' THR . . . . . 0.53 HG22 ' HB2' ' F' ' 79' ' ' ASP . 0.3 OUTLIER -89.93 -9.56 48.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.477 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.32 -95.22 0.1 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.996 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.75 101.47 11.3 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.529 0.204 . . . . 0.0 110.741 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 143' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' F' ' 42' ' ' LEU . . . -61.35 144.33 54.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.715 0.293 . . . . 0.0 111.409 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 144' ' ' THR . . . . . 0.607 ' CG2' ' CD ' ' F' ' 145' ' ' PRO . 99.1 m -123.92 153.17 67.35 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.216 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 145' ' ' PRO . . . . . 0.607 ' CD ' ' CG2' ' F' ' 144' ' ' THR . 1.3 Cg_endo -83.03 144.79 12.13 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.567 2.178 . . . . 0.0 111.98 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 146' ' ' GLY . . . . . 0.632 ' O ' ' HG3' ' E' ' 15' ' ' GLU . . . 157.27 -116.08 0.7 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.473 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 147' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' F' ' 94' ' ' GLY . . . -119.73 132.44 55.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.899 0.38 . . . . 0.0 111.335 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 148' ' ' ALA . . . . . 0.531 ' HB2' HG22 ' E' ' 16' ' ' VAL . . . -125.44 43.36 3.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.12 0.486 . . . . 0.0 110.387 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 149' ' ' ASN . . . . . 0.5 ' HB2' ' HG3' ' F' ' 89' ' ' GLN . 1.1 m120 -95.69 150.86 19.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.623 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 150' ' ' ALA . . . . . . . . . . . . . . . -168.44 -178.63 3.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.992 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.77 153.01 39.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.253 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 152' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -141.22 151.11 43.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.258 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.68 133.74 54.56 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 154' ' ' PHE . . . . . 0.465 ' HB3' ' H ' ' E' ' 8' ' ' GLY . 0.1 OUTLIER -81.73 148.72 28.8 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.103 0.478 . . . . 0.0 110.11 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' F' F ' 155' ' ' LYS . . . . . 0.535 ' HB3' ' CZ ' ' F' ' 118' ' ' PHE . 11.2 mmtt -135.01 139.47 44.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.945 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 156' ' ' VAL . . . . . 0.502 ' CG2' HG21 ' E' ' 5' ' ' VAL . 3.1 m -134.53 141.27 43.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.702 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 157' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -128.77 129.0 45.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.328 0.585 . . . . 0.0 110.37 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.71 128.61 51.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.546 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.591 0.234 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' B' ' 157' ' ' GLN . 5.5 m -122.99 116.19 23.14 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.406 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.515 HG21 ' CA ' ' E' ' 127' ' ' GLY . 1.8 m -99.6 117.26 33.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.573 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m -144.49 158.02 14.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.557 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' B' ' 154' ' ' PHE . 13.0 t30 -78.68 123.76 27.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.73 -71.18 1.0 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.822 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.493 ' H ' ' HB3' ' B' ' 154' ' ' PHE . . . -152.72 -147.04 4.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.759 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.5 p -148.72 134.43 18.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.022 0.439 . . . . 0.0 111.249 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.33 124.39 72.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.186 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.615 ' HA ' ' OD1' ' B' ' 151' ' ' ASP . 57.5 t-80 -91.58 116.17 28.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.323 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -96.83 105.48 17.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -104.61 118.71 37.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.507 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.32 172.92 30.82 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.952 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.717 ' O ' ' HA ' ' B' ' 36' ' ' GLN . 25.8 tt0 -160.39 135.93 8.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.965 0.412 . . . . 0.0 110.425 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.891 HG12 ' O ' ' B' ' 144' ' ' THR . 43.4 t -96.78 132.73 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.272 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.752 HG12 ' HG2' ' B' ' 36' ' ' GLN . 18.5 m -133.82 -177.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.805 0.336 . . . . 0.0 111.068 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.635 ' HA ' HG22 ' B' ' 39' ' ' THR . 0.3 OUTLIER -75.7 -170.26 1.25 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.017 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.79 45.37 0.98 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.125 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.714 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . . . -121.26 -24.8 5.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.415 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.919 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -168.91 140.68 2.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.792 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.455 ' HB1' ' HB2' ' A' ' 60' ' ' ASP . . . -132.87 116.95 17.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.452 HG11 ' HB2' ' B' ' 36' ' ' GLN . 0.5 OUTLIER -67.03 146.23 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.011 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -80.34 152.03 29.16 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.55 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' B' ' 33' ' ' GLN . . . -62.76 -40.06 96.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.39 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.88 2.72 85.9 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.891 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -106.23 -19.94 13.55 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.813 0.339 . . . . 0.0 110.793 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.8 t -47.43 -52.09 5.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.336 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.19 136.48 48.61 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.035 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.71 136.85 39.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.02 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.52 102.83 12.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.127 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.66 128.34 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.121 0.486 . . . . 0.0 110.51 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -114.75 123.06 48.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.615 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.45 -42.72 15.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.608 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.45 -167.44 13.2 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.603 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -96.75 124.51 40.75 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.654 0.264 . . . . 0.0 110.852 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.71 147.54 11.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.986 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.71 134.94 34.33 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.418 0.449 . . . . 0.0 111.725 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.544 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -60.07 -44.48 94.73 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.75 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.26 -36.88 61.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.095 0.474 . . . . 0.0 110.893 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.9 -35.8 62.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.168 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.759 HD22 ' HB3' ' A' ' 137' ' ' TYR . 2.9 mp -106.66 34.58 3.34 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.657 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 39' ' ' THR . . . -103.9 15.85 27.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.391 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.98 132.04 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.34 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' A' ' 140' ' ' THR . 6.8 tt0 -56.56 108.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.827 0.346 . . . . 0.0 111.106 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.93 25.93 10.11 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.121 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.49 137.75 48.42 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.546 HG22 ' HE ' ' A' ' 136' ' ' ARG . 7.3 p -136.94 122.73 19.96 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.913 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 136' ' ' ARG . 53.9 m -100.07 -175.18 2.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.649 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 t -55.65 137.29 49.56 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.808 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 136' ' ' ARG . . . -92.32 133.57 35.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.342 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.2 m -76.76 162.48 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.52 141.14 16.76 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.643 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.47 ' HE2' ' HB1' ' A' ' 135' ' ' ALA . 39.3 p90 -173.76 137.75 0.61 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.79 0.329 . . . . 0.0 110.933 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -136.49 145.85 45.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.682 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.492 HG21 ' HB ' ' A' ' 131' ' ' ILE . 1.2 tp -91.04 116.79 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.663 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.644 ' HA ' HG23 ' A' ' 130' ' ' THR . 1.3 mp0 -72.93 128.65 36.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.813 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.437 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -137.35 89.13 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.225 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.716 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 9.8 p30 -74.79 176.47 7.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.039 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.455 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 0.9 OUTLIER 58.97 74.78 0.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.889 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.919 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 36.5 m -126.31 148.83 49.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -121.58 169.75 10.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.318 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.25 -32.66 4.91 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.48 -28.0 56.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.261 0.553 . . . . 0.0 111.753 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.5 t -73.63 -56.69 8.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.68 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.714 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . . . -134.99 122.76 22.31 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.652 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.54 -50.11 5.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.894 0.378 . . . . 0.0 110.936 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' HA ' ' HZ2' ' A' ' 68' ' ' LYS . 1.8 tptp -89.75 152.15 21.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.529 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 122' ' ' THR . . . -144.24 137.87 27.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.582 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.41 157.28 22.11 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.092 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 131' ' ' ILE . 1.8 t -138.75 149.97 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.668 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.86 155.13 37.52 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.565 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.453 ' CB ' HD11 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -125.05 136.69 53.93 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.644 0.259 . . . . 0.0 111.004 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.583 HD13 ' HG1' ' D' ' 130' ' ' THR . 0.9 OUTLIER -97.2 136.13 38.15 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.017 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.435 ' HA3' ' HB3' ' A' ' 113' ' ' LEU . . . -174.0 -172.91 39.69 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.762 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.657 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.2 OUTLIER -118.66 144.6 46.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.485 0.183 . . . . 0.0 110.835 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.554 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -62.52 138.62 58.51 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.925 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.539 HG23 ' N ' ' A' ' 79' ' ' ASP . 5.7 tt -71.63 -45.56 66.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.932 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.539 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -133.13 42.47 3.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.857 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 79' ' ' ASP . . . 70.12 -80.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.977 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.06 -29.78 68.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.552 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.415 ' HB3' HG22 ' A' ' 78' ' ' ILE . 1.7 m80 -89.77 69.41 7.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 110.445 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.554 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -74.52 -16.17 60.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.576 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.721 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 20.7 p-10 -66.26 -19.05 65.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.267 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.47 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 13.4 t -113.65 133.81 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.198 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.582 ' HA ' ' O ' ' A' ' 76' ' ' THR . 0.4 OUTLIER -67.89 161.48 26.27 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.466 ' H ' HD23 ' A' ' 86' ' ' LEU . . . -103.54 -174.65 2.6 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.869 0.366 . . . . 0.0 111.787 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.658 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 0.3 OUTLIER -67.38 165.22 16.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.084 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.495 ' CG ' ' HB2' ' A' ' 149' ' ' ASN . 5.7 mm-40 -63.43 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.815 0.34 . . . . 0.0 111.3 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.415 ' O ' HG13 ' D' ' 52' ' ' VAL . 2.3 p -165.45 3.66 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 111.492 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.686 ' HA ' ' HB3' ' C' ' 25' ' ' ALA . 0.7 OUTLIER -80.03 79.74 6.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.486 ' HB3' HG11 ' D' ' 52' ' ' VAL . . . -57.08 -24.72 56.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.885 0.374 . . . . 0.0 111.658 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.18 33.94 5.25 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.682 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.8 0.44 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.943 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.688 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 38.4 m -96.8 177.94 5.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.877 0.37 . . . . 0.0 110.64 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.47 -178.71 7.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.804 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.493 ' HB ' ' OG1' ' A' ' 144' ' ' THR . 2.0 m -134.53 119.01 17.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.338 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 97' ' ' THR . 32.6 m-20 68.85 34.41 3.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.388 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.415 ' CA ' HD11 ' A' ' 78' ' ' ILE . 0.4 OUTLIER -138.03 130.79 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.808 179.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.11 -170.55 18.84 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.568 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.72 114.48 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.014 0.526 . . . . 0.0 111.719 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 0.8 OUTLIER -87.33 150.21 24.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.912 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.568 HG12 ' HG ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -114.98 135.96 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.53 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.28 133.57 55.04 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.675 0.274 . . . . 0.0 111.03 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.733 ' HB3' HG23 ' A' ' 107' ' ' THR . 6.1 t0 -82.36 149.75 27.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.664 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.761 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.4 OUTLIER -67.85 -16.25 64.0 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.8 0.333 . . . . 0.0 111.053 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.733 HG23 ' HB3' ' A' ' 105' ' ' ASP . 8.8 t -63.67 -28.35 69.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.033 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.417 ' N ' HG22 ' A' ' 107' ' ' THR . . . 134.0 -40.48 1.58 Allowed Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.661 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.51 163.09 14.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.815 0.34 . . . . 0.0 111.049 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.17 133.36 35.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 117' ' ' THR . 4.8 tp -96.74 150.02 21.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.407 0.622 . . . . 0.0 110.526 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 1.9 t -98.37 141.78 30.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.156 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.568 ' HG ' HG12 ' A' ' 103' ' ' ILE . 1.6 mt -76.43 89.48 3.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.783 0.325 . . . . 0.0 110.704 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.08 -18.19 5.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.554 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.79 -60.58 0.46 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.616 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' D' ' 129' ' ' ASN . . . -96.46 26.98 4.03 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.04 0.448 . . . . 0.0 111.69 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.554 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -87.04 74.86 9.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.148 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.45 ' CE2' ' HA ' ' A' ' 116' ' ' ALA . 62.7 m-85 -94.88 92.86 7.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.819 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.8 m -136.32 68.92 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.81 150.19 28.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.622 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.25 67.66 0.7 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.171 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.542 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -79.15 114.71 18.31 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.747 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -73.94 127.96 34.24 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.724 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 66' ' ' ALA . 4.0 tp -92.08 132.14 36.81 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.64 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.12 151.12 49.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.58 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 3.1 t30 -69.12 111.99 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.636 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.61 -138.83 8.65 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.672 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.716 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 87.8 m -98.84 82.5 2.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.633 0.254 . . . . 0.0 110.724 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.431 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 2.3 t30 -71.82 148.19 46.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.949 0.404 . . . . 0.0 111.062 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.644 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -138.67 148.57 44.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.119 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.492 ' HB ' HG21 ' A' ' 56' ' ' ILE . 15.6 mt -110.0 112.23 57.93 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.761 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.4 Cg_endo -81.82 136.98 9.7 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.629 1.553 . . . . 0.0 112.564 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.0 136.09 19.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.718 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -111.43 158.4 19.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.04 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 102' ' ' GLN . . . -154.19 111.35 3.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.951 0.405 . . . . 0.0 111.63 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.546 ' HE ' HG22 ' A' ' 48' ' ' THR . 19.8 ptt180 -108.93 174.09 6.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.344 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.759 ' HB3' HD22 ' A' ' 42' ' ' LEU . 1.7 m-85 -81.37 137.67 35.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.14 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -131.61 124.15 29.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.2 0.524 . . . . 0.0 112.072 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.687 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . . . -108.47 130.17 55.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.839 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.51 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -77.46 -27.95 52.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.495 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.49 -96.51 0.11 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.981 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.93 98.46 8.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.623 0.211 . . . . 0.0 110.722 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -56.6 148.89 18.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.746 0.308 . . . . 0.0 111.413 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.724 HG22 ' CD ' ' A' ' 145' ' ' PRO . 90.1 m -125.41 156.96 69.48 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.219 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.724 ' CD ' HG22 ' A' ' 144' ' ' THR . 1.4 Cg_endo -83.45 136.3 7.51 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.517 2.145 . . . . 0.0 111.925 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 163.56 -127.56 1.7 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.474 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.688 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -110.92 132.88 53.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.863 0.364 . . . . 0.0 111.363 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.24 43.69 2.93 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.133 0.492 . . . . 0.0 110.451 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.495 ' HB2' ' CG ' ' A' ' 89' ' ' GLN . 9.3 m120 -92.27 144.28 25.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.529 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.64 178.81 9.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.0 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -146.94 145.01 29.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.255 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -133.74 139.74 46.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.169 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.1 135.29 42.8 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.58 152.18 27.34 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.005 0.431 . . . . 0.0 110.188 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.403 ' HE3' ' HB ' ' D' ' 128' ' ' THR . 15.2 mmtm -134.18 146.84 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.916 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.09 140.71 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.857 0.36 . . . . 0.0 111.626 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.54 132.73 39.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.281 0.562 . . . . 0.0 110.45 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 21' ' ' CYS . 11.1 m-85 -107.3 128.05 54.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.49 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.873 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 111.147 0.054 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' C' ' 158' ' ' TYR . . . 52.78 88.29 0.03 OUTLIER 'General case' 0 C--O 1.232 0.15 0 O-C-N 123.154 0.284 . . . . 0.0 111.039 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' C' ' 157' ' ' GLN . 5.5 m -122.92 116.22 23.24 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.379 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.503 HG21 ' CA ' ' F' ' 127' ' ' GLY . 1.8 m -99.68 117.18 33.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.563 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -144.41 158.09 15.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.577 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' C' ' 154' ' ' PHE . 13.1 t30 -78.74 123.81 27.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.54 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.77 -71.24 1.0 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.836 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.494 ' H ' ' HB3' ' C' ' 154' ' ' PHE . . . -152.66 -147.05 4.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.84 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 24.5 p -148.69 134.44 18.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.969 0.414 . . . . 0.0 111.318 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.39 124.34 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.147 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' HIS . . . . . 0.629 ' HA ' ' OD1' ' C' ' 151' ' ' ASP . 57.4 t-80 -91.47 116.2 28.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.337 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -96.88 105.53 17.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.738 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -104.62 118.72 37.28 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.474 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.3 172.9 30.81 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.936 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.727 ' O ' ' HA ' ' C' ' 36' ' ' GLN . 25.8 tt0 -160.38 135.95 8.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.911 0.386 . . . . 0.0 110.398 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.91 HG12 ' O ' ' C' ' 144' ' ' THR . 43.7 t -96.87 132.79 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.204 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.753 HG12 ' HG2' ' C' ' 36' ' ' GLN . 18.1 m -133.88 -177.12 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.934 0.397 . . . . 0.0 110.98 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . 0.623 ' HA ' HG22 ' C' ' 39' ' ' THR . 0.3 OUTLIER -75.85 -170.34 1.32 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.931 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.76 45.51 0.97 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.084 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.734 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . . . -121.34 -24.85 5.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.386 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER -168.81 140.64 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.864 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' B' ' 60' ' ' ASP . . . -132.79 116.97 17.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.082 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' C' ' 36' ' ' GLN . 0.5 OUTLIER -67.05 146.22 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.034 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -80.33 152.09 29.15 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.562 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' C' ' 33' ' ' GLN . . . -62.84 -39.95 95.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.417 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.9 2.65 85.83 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.844 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -106.26 -19.89 13.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.826 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 39.8 t -47.36 -52.22 5.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.336 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.15 136.43 48.66 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.036 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.63 136.86 39.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.066 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.53 102.87 12.77 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.062 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 26.0 t -107.69 128.25 63.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.527 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 10.8 mt-30 -114.7 123.07 48.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.652 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.43 -42.71 15.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.61 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.44 -167.44 13.2 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.581 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.752 ' HG2' HG12 ' A' ' 17' ' ' VAL . 3.7 mt-30 -96.7 124.47 40.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.613 0.244 . . . . 0.0 110.892 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.78 147.53 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.93 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.67 134.95 34.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.026 0.441 . . . . 0.0 111.669 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.635 HG22 ' HA ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -60.07 -44.49 94.7 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.739 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.29 -36.84 61.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.184 0.516 . . . . 0.0 110.919 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.83 -35.86 62.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.223 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.756 HD22 ' HB3' ' B' ' 137' ' ' TYR . 2.9 mp -106.69 34.58 3.34 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.626 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' B' ' 39' ' ' THR . . . -103.95 15.88 27.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.329 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.0 132.08 56.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.299 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' B' ' 140' ' ' THR . 6.7 tt0 -56.58 108.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.846 0.355 . . . . 0.0 111.076 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.95 25.9 10.12 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.144 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.42 137.77 48.57 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.551 HG22 ' HE ' ' B' ' 136' ' ' ARG . 7.3 p -136.98 122.75 19.93 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.927 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' B' ' 136' ' ' ARG . 53.4 m -100.09 -175.21 2.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.644 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.9 t -55.67 137.33 49.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.799 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' B' ' 136' ' ' ARG . . . -92.29 133.46 35.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.327 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 m -76.71 162.54 4.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.49 141.16 16.78 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.592 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . 0.482 ' HE2' ' HB1' ' B' ' 135' ' ' ALA . 39.4 p90 -173.76 137.77 0.62 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.804 0.335 . . . . 0.0 110.934 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -136.56 145.83 45.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.603 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.502 HG21 ' HB ' ' B' ' 131' ' ' ILE . 1.2 tp -91.03 116.77 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.607 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . 0.655 ' HA ' HG23 ' B' ' 130' ' ' THR . 1.3 mp0 -72.93 128.58 35.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.79 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' B' ' 23' ' ' VAL . 0.3 OUTLIER -137.31 89.17 2.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.242 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.708 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 9.8 p30 -74.81 176.53 6.98 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.012 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . 0.47 ' HB2' ' HB1' ' B' ' 22' ' ' ALA . 0.9 OUTLIER 58.93 74.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 36.8 m -126.32 148.86 49.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.804 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -121.58 169.77 10.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.281 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.27 -32.69 4.89 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -76.52 -27.94 56.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.169 0.509 . . . . 0.0 111.72 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.66 -56.69 8.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.677 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.734 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . . . -135.02 122.74 22.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.674 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -50.04 5.13 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.89 0.376 . . . . 0.0 110.923 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . 0.513 ' HA ' ' HZ2' ' B' ' 68' ' ' LYS . 1.8 tptp -89.76 152.12 21.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.574 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' B' ' 122' ' ' THR . . . -144.25 137.8 27.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.604 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.35 157.25 22.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.11 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.483 HG11 HG21 ' B' ' 131' ' ' ILE . 1.8 t -138.78 149.96 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.656 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.82 155.11 37.52 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.596 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.46 ' CB ' HD11 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -125.04 136.68 53.92 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.634 0.254 . . . . 0.0 110.969 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.569 HD13 ' OG1' ' E' ' 130' ' ' THR . 0.9 OUTLIER -97.15 136.1 38.15 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.032 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . 0.446 ' CA ' ' HB3' ' B' ' 113' ' ' LEU . . . -174.02 -172.95 39.74 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.731 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.669 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.2 OUTLIER -118.63 144.55 46.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.537 0.208 . . . . 0.0 110.831 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . 0.533 ' HB1' ' HA ' ' B' ' 83' ' ' THR . . . -62.48 138.53 58.48 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.958 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.537 HG23 ' N ' ' B' ' 79' ' ' ASP . 5.7 tt -71.55 -45.59 67.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.884 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.537 ' N ' HG23 ' B' ' 78' ' ' ILE . 0.3 OUTLIER -133.19 42.54 3.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.818 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' B' ' 79' ' ' ASP . . . 70.04 -80.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.056 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.08 -29.71 68.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.56 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.407 ' HB3' HG22 ' B' ' 78' ' ' ILE . 1.6 m80 -89.87 69.39 7.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.418 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' THR . . . . . 0.533 ' HA ' ' HB1' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -74.47 -16.2 60.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.604 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . 0.713 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 20.8 p-10 -66.11 -19.16 65.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.334 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.472 ' HB ' ' CG2' ' B' ' 78' ' ' ILE . 13.5 t -113.6 133.83 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.173 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . 0.597 ' HA ' ' O ' ' B' ' 76' ' ' THR . 0.4 OUTLIER -67.83 161.53 26.04 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.463 ' H ' HD23 ' B' ' 86' ' ' LEU . . . -103.61 -174.72 2.61 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.866 0.365 . . . . 0.0 111.772 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.648 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 0.3 OUTLIER -67.36 165.21 16.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.049 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . 0.495 ' CG ' ' HB2' ' B' ' 149' ' ' ASN . 5.7 mm-40 -63.42 -79.73 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.33 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' SER . . . . . 0.413 ' O ' HG13 ' E' ' 52' ' ' VAL . 2.3 p -165.48 3.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 111.549 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' SER . . . . . 0.69 ' HA ' ' HB3' ' D' ' 25' ' ' ALA . 0.7 OUTLIER -80.16 79.73 6.68 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.492 ' HB3' HG11 ' E' ' 52' ' ' VAL . . . -57.05 -24.76 56.15 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.868 0.366 . . . . 0.0 111.617 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.2 33.99 5.24 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.692 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.77 0.42 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.911 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' SER . . . . . 0.687 ' HA ' ' HB3' ' B' ' 147' ' ' ALA . 38.4 m -96.8 177.93 5.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.873 0.368 . . . . 0.0 110.622 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.54 -178.65 7.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.806 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' B' ' 98' ' ' ASN . 2.0 m -134.42 119.05 18.09 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.379 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' B' ' 97' ' ' THR . 32.5 m-20 68.68 34.53 3.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.441 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . 0.461 HG12 HG21 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -138.13 130.85 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.784 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.14 -170.63 18.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.539 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.61 114.48 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.017 0.527 . . . . 0.0 111.766 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 0.8 OUTLIER -87.4 150.24 23.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.92 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.567 HG12 ' HG ' ' B' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 135.99 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.471 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.31 133.59 55.05 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.654 0.264 . . . . 0.0 110.988 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . 0.733 ' HB3' HG23 ' B' ' 107' ' ' THR . 6.1 t0 -82.29 149.75 27.63 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.725 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . 0.75 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.4 OUTLIER -67.82 -16.26 64.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.811 0.339 . . . . 0.0 111.103 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' THR . . . . . 0.733 HG23 ' HB3' ' B' ' 105' ' ' ASP . 8.8 t -63.69 -28.39 69.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.006 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' GLY . . . . . 0.419 ' N ' HG22 ' B' ' 107' ' ' THR . . . 134.08 -40.55 1.57 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.662 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.48 163.12 14.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.819 0.342 . . . . 0.0 111.052 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.12 133.35 35.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.204 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.563 HD23 ' O ' ' B' ' 117' ' ' THR . 4.8 tp -96.69 150.0 21.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.413 0.625 . . . . 0.0 110.539 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.713 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 1.9 t -98.48 141.76 30.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.177 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.567 ' HG ' HG12 ' B' ' 103' ' ' ILE . 1.6 mt -76.36 89.4 3.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.741 0.305 . . . . 0.0 110.746 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.07 -18.14 5.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.503 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.8 -60.65 0.46 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.588 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' E' ' 129' ' ' ASN . . . -96.5 27.03 4.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.035 0.445 . . . . 0.0 111.632 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' THR . . . . . 0.563 ' O ' HD23 ' B' ' 111' ' ' LEU . 0.0 OUTLIER -87.07 74.89 9.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.164 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' B' ' 116' ' ' ALA . 62.6 m-85 -94.92 92.89 7.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 25.5 m -136.33 68.93 1.43 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.86 150.29 28.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.557 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -107.34 67.63 0.7 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.206 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.556 ' O ' ' HB3' ' B' ' 69' ' ' ALA . 0.2 OUTLIER -79.15 114.71 18.31 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.757 -179.549 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 12.0 m -73.98 128.02 34.41 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.713 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.594 HD22 ' O ' ' B' ' 66' ' ' ALA . 4.0 tp -92.11 132.17 36.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.614 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.17 151.09 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.583 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' B' ' 61' ' ' CYS . 3.1 t30 -69.03 111.97 5.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.627 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.55 -138.96 8.75 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.643 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.708 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 87.7 m -98.71 82.55 2.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.637 0.256 . . . . 0.0 110.792 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . 0.439 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 2.3 t30 -71.76 148.14 46.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.805 0.336 . . . . 0.0 111.188 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.655 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -138.64 148.61 44.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' ILE . . . . . 0.502 ' HB ' HG21 ' B' ' 56' ' ' ILE . 15.6 mt -110.01 112.22 57.91 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' PRO . . . . . 0.75 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.83 137.03 9.72 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.574 1.516 . . . . 0.0 112.578 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.03 136.02 19.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.739 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -111.45 158.41 19.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.033 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' B' ' 102' ' ' GLN . . . -154.15 111.33 3.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.924 0.392 . . . . 0.0 111.633 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . 0.551 ' HE ' HG22 ' B' ' 48' ' ' THR . 19.8 ptt180 -108.94 174.11 6.02 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.375 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . 0.756 ' HB3' HD22 ' B' ' 42' ' ' LEU . 1.7 m-85 -81.4 137.64 35.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.047 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -131.53 124.14 29.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.104 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.665 ' HB3' ' HG ' ' B' ' 42' ' ' LEU . . . -108.51 130.16 55.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.834 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' THR . . . . . 0.511 HG22 ' HB2' ' B' ' 79' ' ' ASP . 0.2 OUTLIER -77.44 -27.9 52.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.571 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.48 -96.52 0.11 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.006 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.99 98.49 8.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.572 0.225 . . . . 0.0 110.666 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' B' ' 42' ' ' LEU . . . -56.64 148.93 18.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.742 0.306 . . . . 0.0 111.418 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.891 ' O ' HG12 ' A' ' 16' ' ' VAL . 90.5 m -125.44 156.95 69.57 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.208 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.73 ' CD ' HG22 ' B' ' 144' ' ' THR . 1.4 Cg_endo -83.42 136.28 7.53 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.52 2.147 . . . . 0.0 111.974 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . 0.554 ' O ' ' HG3' ' A' ' 15' ' ' GLU . . . 163.64 -127.57 1.69 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.51 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . 0.687 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -110.93 132.92 53.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.829 0.347 . . . . 0.0 111.328 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.28 43.75 2.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.422 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.495 ' HB2' ' CG ' ' B' ' 89' ' ' GLN . 9.3 m120 -92.34 144.32 25.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.506 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.68 178.85 9.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.968 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . 0.615 ' OD1' ' HA ' ' A' ' 11' ' ' HIS . 15.7 t70 -146.97 145.03 29.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.218 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -133.79 139.73 46.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.18 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.04 135.25 42.79 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' PHE . . . . . 0.493 ' HB3' ' H ' ' A' ' 8' ' ' GLY . 0.2 OUTLIER -81.52 152.16 27.42 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.118 0.485 . . . . 0.0 110.125 -179.082 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . 0.418 ' HE3' ' HB ' ' E' ' 128' ' ' THR . 15.2 mmtm -134.22 146.84 50.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.877 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.07 140.77 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.8 0.333 . . . . 0.0 111.617 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 3' ' ' THR . 0.9 OUTLIER -134.52 132.67 39.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.272 0.558 . . . . 0.0 110.485 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' B' ' 21' ' ' CYS . 10.9 m-85 -107.22 128.01 54.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.557 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.907 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 120.222 0.058 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.76 88.35 0.03 OUTLIER 'General case' 0 C--O 1.232 0.163 0 O-C-N 123.141 0.275 . . . . 0.0 111.015 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 3' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' D' ' 157' ' ' GLN . 5.5 m -123.0 116.28 23.27 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.381 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -99.66 117.16 33.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.6 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -144.45 157.96 14.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.626 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' D' ' 154' ' ' PHE . 13.2 t30 -78.66 123.75 27.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.582 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.7 -71.24 1.0 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.819 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . 0.484 ' H ' ' HB3' ' D' ' 154' ' ' PHE . . . -152.7 -147.01 4.49 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.773 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 24.1 p -148.75 134.51 18.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.053 0.454 . . . . 0.0 111.243 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.35 124.33 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.201 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' HIS . . . . . 0.624 ' HA ' ' OD1' ' D' ' 151' ' ' ASP . 57.4 t-80 -91.51 116.13 28.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.308 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -96.8 105.49 17.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.824 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -104.66 118.67 37.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.484 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.22 172.94 30.76 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.98 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' GLU . . . . . 0.725 ' O ' ' HA ' ' D' ' 36' ' ' GLN . 25.7 tt0 -160.39 135.93 8.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.913 0.387 . . . . 0.0 110.459 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.918 HG12 ' O ' ' D' ' 144' ' ' THR . 43.8 t -96.86 132.85 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.168 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.744 HG12 ' HG2' ' D' ' 36' ' ' GLN . 18.2 m -133.97 -177.21 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.93 0.395 . . . . 0.0 110.965 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . 0.617 ' HA ' HG22 ' D' ' 39' ' ' THR . 0.3 OUTLIER -75.75 -170.28 1.27 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.977 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.82 45.5 0.97 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.073 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . 0.734 ' HB3' ' HB2' ' C' ' 66' ' ' ALA . . . -121.31 -24.85 5.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.383 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' CYS . . . . . 0.902 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER -168.87 140.69 2.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.864 -179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' C' ' 60' ' ' ASP . . . -132.82 117.02 17.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.041 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' D' ' 36' ' ' GLN . 0.5 OUTLIER -67.11 146.26 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.113 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -80.4 152.11 29.02 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.545 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.686 ' HB3' ' HA ' ' A' ' 91' ' ' SER . . . -62.77 -40.02 95.97 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.483 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.91 2.67 85.83 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.886 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -106.14 -20.05 13.53 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.872 0.368 . . . . 0.0 110.817 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 39.7 t -47.31 -52.15 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.324 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.21 136.42 48.71 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.995 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.72 136.91 39.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.017 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.56 102.86 12.76 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.074 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 26.1 t -107.66 128.34 62.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.051 0.453 . . . . 0.0 110.485 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' B' ' 25' ' ' ALA . 10.6 mt-30 -114.78 123.16 48.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.603 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.49 -42.74 15.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.593 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.5 -167.42 13.17 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.613 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . 0.753 ' HG2' HG12 ' B' ' 17' ' ' VAL . 3.7 mt-30 -96.77 124.42 40.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.586 0.231 . . . . 0.0 110.882 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.73 147.59 11.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.946 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.76 134.97 34.31 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.67 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.623 HG22 ' HA ' ' B' ' 18' ' ' ASN . 0.0 OUTLIER -60.1 -44.37 94.88 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.798 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.41 -36.74 61.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.063 0.458 . . . . 0.0 110.835 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.97 -35.73 62.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.191 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.737 HD22 ' HB3' ' C' ' 137' ' ' TYR . 2.9 mp -106.71 34.56 3.36 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.646 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' C' ' 39' ' ' THR . . . -103.97 15.82 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.334 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.96 132.05 56.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.359 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' C' ' 140' ' ' THR . 6.8 tt0 -56.54 108.8 0.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.806 0.336 . . . . 0.0 111.107 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.89 25.96 10.12 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.152 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.49 137.8 48.45 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' THR . . . . . 0.549 HG22 ' HE ' ' C' ' 136' ' ' ARG . 7.4 p -137.01 122.77 19.93 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.864 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' C' ' 136' ' ' ARG . 54.0 m -100.09 -175.16 2.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.655 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 2.8 t -55.63 137.3 49.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.811 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . 0.467 ' CA ' ' HB3' ' C' ' 136' ' ' ARG . . . -92.4 133.48 35.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.34 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . . . . . . . . . 26.4 m -76.7 162.51 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.56 141.2 16.79 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.519 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . 0.479 ' HE2' ' HB1' ' C' ' 135' ' ' ALA . 39.4 p90 -173.74 137.73 0.62 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.721 0.296 . . . . 0.0 111.015 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -136.5 145.74 45.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.647 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.503 HG21 ' HB ' ' C' ' 131' ' ' ILE . 1.2 tp -90.92 116.76 32.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.68 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.641 ' HA ' HG23 ' C' ' 130' ' ' THR . 1.3 mp0 -72.9 128.55 35.83 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . 0.429 ' HG ' ' HA ' ' C' ' 23' ' ' VAL . 0.3 OUTLIER -137.28 89.18 2.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.284 -179.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . 0.691 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 9.8 p30 -74.82 176.46 7.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.013 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' ASP . . . . . 0.472 ' HB2' ' HB1' ' C' ' 22' ' ' ALA . 0.8 OUTLIER 58.92 74.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.818 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' CYS . . . . . 0.902 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 36.3 m -126.34 148.91 49.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -121.63 169.72 10.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.35 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.26 -32.7 4.89 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.52 -27.88 56.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 111.765 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.6 -56.81 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.64 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . 0.734 ' HB2' ' HB3' ' C' ' 20' ' ' ALA . . . -134.98 122.7 22.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.65 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.45 -50.1 5.14 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.861 0.362 . . . . 0.0 110.997 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' LYS . . . . . 0.508 ' HA ' ' HZ2' ' C' ' 68' ' ' LYS . 1.8 tptp -89.78 152.14 21.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.558 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' C' ' 122' ' ' THR . . . -144.26 137.84 27.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.575 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.41 157.24 22.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.073 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . 0.488 HG11 HG21 ' C' ' 131' ' ' ILE . 1.8 t -138.74 149.94 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.665 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.82 155.1 37.51 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.59 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' PHE . . . . . 0.466 ' CB ' HD11 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -124.99 136.66 53.93 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.012 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.572 HD13 ' OG1' ' F' ' 130' ' ' THR . 0.9 OUTLIER -97.16 136.17 38.07 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.994 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' C' ' 113' ' ' LEU . . . -174.01 -172.95 39.74 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.817 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' THR . . . . . 0.661 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.2 OUTLIER -118.67 144.54 46.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.551 0.215 . . . . 0.0 110.796 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . 0.554 ' HB1' ' HA ' ' C' ' 83' ' ' THR . . . -62.5 138.6 58.5 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.913 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . 0.55 HG23 ' N ' ' C' ' 79' ' ' ASP . 5.7 tt -71.66 -45.54 66.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.85 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' ASP . . . . . 0.55 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.3 OUTLIER -133.15 42.47 3.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' C' ' 79' ' ' ASP . . . 70.19 -80.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.032 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.11 -29.68 68.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.609 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . 0.407 ' HB3' HG22 ' C' ' 78' ' ' ILE . 1.7 m80 -89.84 69.39 7.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.832 0.349 . . . . 0.0 110.424 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' THR . . . . . 0.554 ' HA ' ' HB1' ' C' ' 77' ' ' ALA . 0.2 OUTLIER -74.55 -16.13 60.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.604 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' ASN . . . . . 0.73 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 20.8 p-10 -66.18 -19.04 65.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.336 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.475 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 13.5 t -113.66 133.86 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.128 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.596 ' HA ' ' O ' ' C' ' 76' ' ' THR . 0.4 OUTLIER -67.91 161.53 26.22 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.267 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.462 ' H ' HD23 ' C' ' 86' ' ' LEU . . . -103.58 -174.66 2.6 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.862 0.363 . . . . 0.0 111.764 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.649 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 0.3 OUTLIER -67.4 165.17 17.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.116 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' GLN . . . . . 0.501 ' CG ' ' HB2' ' C' ' 149' ' ' ASN . 5.7 mm-40 -63.36 -79.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.365 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' SER . . . . . 0.411 ' O ' HG13 ' F' ' 52' ' ' VAL . 2.3 p -165.52 3.61 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.01 0.433 . . . . 0.0 111.579 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' SER . . . . . 0.688 ' HA ' ' HB3' ' E' ' 25' ' ' ALA . 0.7 OUTLIER -80.09 79.83 6.59 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' ALA . . . . . 0.503 ' HB3' HG11 ' F' ' 52' ' ' VAL . . . -57.09 -24.79 56.49 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.891 0.377 . . . . 0.0 111.634 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.17 33.94 5.25 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.69 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.85 0.46 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.937 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' SER . . . . . 0.68 ' HA ' ' HB3' ' C' ' 147' ' ' ALA . 38.6 m -96.78 177.94 5.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 110.607 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.52 -178.73 7.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.784 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' THR . . . . . 0.492 ' HB ' ' OG1' ' C' ' 144' ' ' THR . 2.0 m -134.44 119.02 18.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.369 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' C' ' 97' ' ' THR . 32.8 m-20 68.78 34.48 3.33 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.457 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 99' ' ' VAL . . . . . 0.476 HG12 HG21 ' B' ' 16' ' ' VAL . 0.4 OUTLIER -138.12 130.85 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.727 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.21 -170.63 19.01 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.566 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.62 114.51 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 123.028 0.531 . . . . 0.0 111.717 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 102' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 0.8 OUTLIER -87.39 150.2 23.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.923 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . 0.566 HG12 ' HG ' ' C' ' 113' ' ' LEU . 0.8 OUTLIER -114.94 136.07 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.481 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.37 133.52 55.11 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.711 0.291 . . . . 0.0 111.032 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . 0.733 ' HB3' HG23 ' C' ' 107' ' ' THR . 6.1 t0 -82.24 149.74 27.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.674 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 106' ' ' ARG . . . . . 0.76 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.4 OUTLIER -67.87 -16.23 63.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.795 0.331 . . . . 0.0 111.058 179.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 107' ' ' THR . . . . . 0.733 HG23 ' HB3' ' C' ' 105' ' ' ASP . 8.8 t -63.62 -28.39 69.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.043 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 108' ' ' GLY . . . . . 0.404 ' N ' HG22 ' C' ' 107' ' ' THR . . . 133.97 -40.46 1.58 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.717 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.54 163.08 14.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.822 0.344 . . . . 0.0 110.999 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.14 133.36 35.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.198 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 111' ' ' LEU . . . . . 0.548 HD23 ' O ' ' C' ' 117' ' ' THR . 4.8 tp -96.72 149.98 21.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.368 0.604 . . . . 0.0 110.603 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 112' ' ' THR . . . . . 0.73 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 1.9 t -98.43 141.73 30.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.566 ' HG ' HG12 ' C' ' 103' ' ' ILE . 1.6 mt -76.39 89.48 3.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.808 0.337 . . . . 0.0 110.727 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.15 -18.06 5.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.697 0.284 . . . . 0.0 111.525 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.78 -60.63 0.46 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.559 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 116' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' F' ' 129' ' ' ASN . . . -96.46 26.96 4.04 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.996 0.427 . . . . 0.0 111.636 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 117' ' ' THR . . . . . 0.548 ' O ' HD23 ' C' ' 111' ' ' LEU . 0.0 OUTLIER -87.04 74.81 9.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.157 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 118' ' ' PHE . . . . . 0.448 ' CE2' ' HA ' ' C' ' 116' ' ' ALA . 62.8 m-85 -94.93 92.93 7.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.812 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 25.6 m -136.35 68.94 1.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.831 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.83 150.27 28.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.646 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.34 67.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.178 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.554 ' O ' ' HB3' ' C' ' 69' ' ' ALA . 0.2 OUTLIER -79.19 114.71 18.35 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.7 -179.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -74.02 128.04 34.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.729 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . 0.573 HD22 ' O ' ' C' ' 66' ' ' ALA . 4.0 tp -92.14 132.19 36.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.594 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.13 151.01 49.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.641 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 126' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' C' ' 61' ' ' CYS . 3.1 t30 -69.05 112.11 5.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.632 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.43 -138.93 8.77 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.756 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 128' ' ' THR . . . . . 0.691 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 87.0 m -98.72 82.54 2.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.642 0.258 . . . . 0.0 110.827 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 129' ' ' ASN . . . . . 0.431 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 2.3 t30 -71.84 148.13 46.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.89 0.376 . . . . 0.0 111.145 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 130' ' ' THR . . . . . 0.641 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -138.57 148.57 44.33 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.209 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 131' ' ' ILE . . . . . 0.503 ' HB ' HG21 ' C' ' 56' ' ' ILE . 15.7 mt -110.03 112.27 57.83 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 132' ' ' PRO . . . . . 0.76 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.6 Cg_endo -81.8 137.02 9.75 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.599 1.532 . . . . 0.0 112.566 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.01 136.09 19.94 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.727 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -111.5 158.38 19.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.081 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' C' ' 102' ' ' GLN . . . -154.18 111.36 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.969 0.414 . . . . 0.0 111.64 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . 0.549 ' HE ' HG22 ' C' ' 48' ' ' THR . 19.8 ptt180 -108.89 174.06 6.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.385 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 137' ' ' TYR . . . . . 0.737 ' HB3' HD22 ' C' ' 42' ' ' LEU . 1.7 m-85 -81.41 137.73 35.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.103 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -131.58 124.13 29.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.092 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 139' ' ' ALA . . . . . 0.673 ' HB3' ' HG ' ' C' ' 42' ' ' LEU . . . -108.48 130.19 55.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.824 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 140' ' ' THR . . . . . 0.504 HG22 ' HB2' ' C' ' 79' ' ' ASP . 0.2 OUTLIER -77.46 -27.93 52.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.518 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.5 -96.54 0.11 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.955 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.95 98.49 8.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.578 0.227 . . . . 0.0 110.714 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 143' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' C' ' 42' ' ' LEU . . . -56.56 148.92 18.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.757 0.313 . . . . 0.0 111.364 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 144' ' ' THR . . . . . 0.91 ' O ' HG12 ' B' ' 16' ' ' VAL . 91.0 m -125.43 156.99 69.5 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.247 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 145' ' ' PRO . . . . . 0.731 ' CD ' HG22 ' C' ' 144' ' ' THR . 1.5 Cg_endo -83.38 136.17 7.51 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.631 2.22 . . . . 0.0 111.987 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 146' ' ' GLY . . . . . 0.556 ' O ' ' HG3' ' B' ' 15' ' ' GLU . . . 163.62 -127.57 1.69 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.429 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 147' ' ' ALA . . . . . 0.68 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -110.88 132.9 53.81 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.763 0.316 . . . . 0.0 111.369 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.28 43.78 2.91 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.107 0.479 . . . . 0.0 110.438 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 149' ' ' ASN . . . . . 0.501 ' HB2' ' CG ' ' C' ' 89' ' ' GLN . 9.2 m120 -92.33 144.27 25.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.511 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.66 178.88 9.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.989 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 151' ' ' ASP . . . . . 0.629 ' OD1' ' HA ' ' B' ' 11' ' ' HIS . 15.6 t70 -146.98 145.02 29.6 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.298 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 152' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -133.75 139.78 46.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.273 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.11 135.28 42.83 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 154' ' ' PHE . . . . . 0.494 ' HB3' ' H ' ' B' ' 8' ' ' GLY . 0.2 OUTLIER -81.54 152.17 27.4 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.06 0.457 . . . . 0.0 110.136 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 155' ' ' LYS . . . . . 0.415 ' HE3' ' HB ' ' F' ' 128' ' ' THR . 15.2 mmtm -134.24 146.87 50.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.934 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.18 140.79 37.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.859 0.362 . . . . 0.0 111.622 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 157' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' B' ' 3' ' ' THR . 0.9 OUTLIER -134.53 132.68 39.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.335 0.588 . . . . 0.0 110.406 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 158' ' ' TYR . . . . . 0.536 ' CE1' ' HB2' ' C' ' 21' ' ' CYS . 11.0 m-85 -107.35 128.04 54.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.541 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.823 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.267 0.079 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' E' ' 158' ' ' TYR . . . 52.85 88.35 0.03 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.976 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 3' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' E' ' 157' ' ' GLN . 5.4 m -123.0 116.2 23.16 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.413 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -99.6 117.22 33.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.582 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -144.44 158.03 15.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.655 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 6' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' E' ' 154' ' ' PHE . 13.2 t30 -78.71 123.75 27.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.597 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.83 -71.1 1.02 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.792 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . 0.49 ' H ' ' HB3' ' E' ' 154' ' ' PHE . . . -152.75 -146.98 4.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.806 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 24.1 p -148.76 134.49 18.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.011 0.434 . . . . 0.0 111.258 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.4 124.37 72.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.159 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' HIS . . . . . 0.611 ' HA ' ' OD1' ' E' ' 151' ' ' ASP . 57.3 t-80 -91.52 116.17 28.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.292 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -96.84 105.49 17.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.814 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' LYS . . . . . 0.4 ' HG2' ' ND2' ' E' ' 149' ' ' ASN . 5.1 tttm -104.64 118.73 37.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.422 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.31 172.93 30.82 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.945 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' GLU . . . . . 0.731 ' O ' ' HA ' ' E' ' 36' ' ' GLN . 25.8 tt0 -160.36 135.96 8.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.943 0.401 . . . . 0.0 110.339 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.911 HG12 ' O ' ' E' ' 144' ' ' THR . 43.2 t -96.79 132.81 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.25 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . 0.741 HG12 ' HG2' ' E' ' 36' ' ' GLN . 18.2 m -133.91 -177.16 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.897 0.38 . . . . 0.0 111.008 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' ASN . . . . . 0.627 ' HA ' HG22 ' E' ' 39' ' ' THR . 0.3 OUTLIER -75.74 -170.37 1.3 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.932 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.74 45.41 0.98 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.029 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.71 ' HB3' ' HB2' ' D' ' 66' ' ' ALA . . . -121.36 -24.78 5.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.369 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' CYS . . . . . 0.918 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER -168.82 140.65 2.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.881 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . 0.458 ' HB1' ' HB2' ' D' ' 60' ' ' ASP . . . -132.8 116.99 17.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.068 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' E' ' 36' ' ' GLN . 0.5 OUTLIER -67.05 146.18 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.044 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -80.33 152.04 29.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.58 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.69 ' HB3' ' HA ' ' B' ' 91' ' ' SER . . . -62.69 -40.07 95.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.464 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.91 2.64 85.81 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.867 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -106.17 -19.94 13.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.845 0.355 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 39.8 t -47.42 -52.1 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.344 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.19 136.41 48.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.032 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.72 136.92 39.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.035 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.48 102.77 12.69 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.057 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 25.7 t -107.64 128.29 62.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.058 0.456 . . . . 0.0 110.56 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' C' ' 25' ' ' ALA . 10.6 mt-30 -114.75 123.03 48.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.614 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.4 -42.71 15.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.684 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.55 -167.43 13.16 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.618 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' GLN . . . . . 0.744 ' HG2' HG12 ' C' ' 17' ' ' VAL . 3.7 mt-30 -96.79 124.58 40.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.618 0.247 . . . . 0.0 110.845 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.86 147.52 11.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.822 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.77 134.98 34.3 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.661 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.617 HG22 ' HA ' ' C' ' 18' ' ' ASN . 0.0 OUTLIER -60.04 -44.42 94.66 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.828 179.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.35 -36.78 61.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.135 0.493 . . . . 0.0 110.92 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.94 -35.86 62.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.135 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.758 HD22 ' HB3' ' D' ' 137' ' ' TYR . 2.9 mp -106.6 34.55 3.35 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.614 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' D' ' 39' ' ' THR . . . -103.9 15.8 27.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.32 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.94 132.09 56.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.323 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' D' ' 140' ' ' THR . 6.8 tt0 -56.55 108.78 0.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.744 0.307 . . . . 0.0 111.117 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.95 25.88 10.14 Favored Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.136 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.48 137.76 48.45 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.963 0.411 . . . . 0.0 112.058 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' THR . . . . . 0.549 HG22 ' HE ' ' D' ' 136' ' ' ARG . 7.3 p -137.01 122.77 19.93 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.92 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' D' ' 136' ' ' ARG . 53.4 m -100.12 -175.19 2.88 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.606 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 2.9 t -55.59 137.31 49.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.808 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' ALA . . . . . 0.468 ' CA ' ' HB3' ' D' ' 136' ' ' ARG . . . -92.41 133.51 35.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.348 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' VAL . . . . . 0.486 HG11 ' HB3' ' A' ' 92' ' ' ALA . 26.6 m -76.76 162.47 4.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.49 141.16 16.78 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.552 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . 0.478 ' HE2' ' HB1' ' D' ' 135' ' ' ALA . 39.4 p90 -173.74 137.79 0.62 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.783 0.325 . . . . 0.0 110.965 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -136.5 145.81 45.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.681 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.493 HG21 ' HB ' ' D' ' 131' ' ' ILE . 1.2 tp -90.95 116.76 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.627 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' GLN . . . . . 0.646 ' HA ' HG23 ' D' ' 130' ' ' THR . 1.3 mp0 -72.87 128.59 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.803 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . 0.438 ' HG ' ' HA ' ' D' ' 23' ' ' VAL . 0.3 OUTLIER -137.31 89.11 2.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.264 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . 0.704 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 9.8 p30 -74.76 176.54 6.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.951 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' ASP . . . . . 0.458 ' HB2' ' HB1' ' D' ' 22' ' ' ALA . 0.9 OUTLIER 58.9 74.79 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.888 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' CYS . . . . . 0.918 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 36.6 m -126.33 148.89 49.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.808 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.61 169.78 10.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.317 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.32 -32.63 4.9 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -76.57 -27.89 56.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.197 0.522 . . . . 0.0 111.742 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.57 -56.83 8.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.677 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.71 ' HB2' ' HB3' ' D' ' 20' ' ' ALA . . . -134.93 122.77 22.39 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.647 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.57 -50.02 5.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.921 0.391 . . . . 0.0 110.977 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' LYS . . . . . 0.513 ' HA ' ' HZ2' ' D' ' 68' ' ' LYS . 1.8 tptp -89.84 152.12 21.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.517 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' D' ' 122' ' ' THR . . . -144.22 137.86 27.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.586 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.41 157.23 22.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.078 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . 0.483 HG11 HG21 ' D' ' 131' ' ' ILE . 1.8 t -138.7 150.0 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.638 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.8 155.11 37.54 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.624 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 73' ' ' PHE . . . . . 0.451 ' CB ' HD11 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -125.08 136.69 53.9 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.651 0.262 . . . . 0.0 111.012 179.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 74' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.9 OUTLIER -97.19 136.12 38.16 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.978 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . 0.441 ' CA ' ' HB3' ' D' ' 113' ' ' LEU . . . -174.03 -172.96 39.76 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.744 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 76' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.2 OUTLIER -118.72 144.57 46.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.552 0.215 . . . . 0.0 110.801 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . 0.553 ' HB1' ' HA ' ' D' ' 83' ' ' THR . . . -62.47 138.53 58.48 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.91 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 78' ' ' ILE . . . . . 0.549 HG23 ' N ' ' D' ' 79' ' ' ASP . 5.7 tt -71.52 -45.65 67.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.893 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . 0.549 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.3 OUTLIER -133.15 42.55 3.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.771 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' D' ' 79' ' ' ASP . . . 70.16 -80.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.11 -29.7 68.89 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.529 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . 0.415 ' HB3' HG22 ' D' ' 78' ' ' ILE . 1.7 m80 -89.82 69.39 7.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.754 0.311 . . . . 0.0 110.436 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 83' ' ' THR . . . . . 0.553 ' HA ' ' HB1' ' D' ' 77' ' ' ALA . 0.2 OUTLIER -74.56 -16.15 60.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.6 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . 0.727 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 20.8 p-10 -66.24 -19.08 65.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.261 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.463 ' HB ' ' CG2' ' D' ' 78' ' ' ILE . 13.4 t -113.57 133.84 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.179 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.593 ' HA ' ' O ' ' D' ' 76' ' ' THR . 0.4 OUTLIER -67.87 161.47 26.27 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.466 ' H ' HD23 ' D' ' 86' ' ' LEU . . . -103.59 -174.72 2.61 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.837 0.351 . . . . 0.0 111.79 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.656 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 0.3 OUTLIER -67.33 165.23 16.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.104 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 89' ' ' GLN . . . . . 0.506 ' CG ' ' HB2' ' D' ' 149' ' ' ASN . 5.7 mm-40 -63.43 -79.76 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.323 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -165.46 3.78 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.051 0.453 . . . . 0.0 111.6 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 91' ' ' SER . . . . . 0.688 ' HA ' ' HB3' ' F' ' 25' ' ' ALA . 0.7 OUTLIER -80.09 79.72 6.6 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.06 -24.77 56.27 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.815 0.341 . . . . 0.0 111.606 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.13 33.89 5.27 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.731 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.75 0.43 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.935 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 95' ' ' SER . . . . . 0.685 ' HA ' ' HB3' ' D' ' 147' ' ' ALA . 38.7 m -96.7 177.94 5.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 110.679 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.52 -178.7 7.06 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.796 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 97' ' ' THR . . . . . 0.491 ' HB ' ' OG1' ' D' ' 144' ' ' THR . 2.0 m -134.41 119.08 18.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.354 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 98' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' D' ' 97' ' ' THR . 32.4 m-20 68.67 34.56 3.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.439 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 99' ' ' VAL . . . . . 0.481 HG12 HG21 ' C' ' 16' ' ' VAL . 0.4 OUTLIER -138.16 130.81 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.755 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.15 -170.62 18.95 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.539 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.66 114.49 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.036 0.534 . . . . 0.0 111.654 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 102' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 0.8 OUTLIER -87.36 150.22 23.98 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.887 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 103' ' ' ILE . . . . . 0.561 HG12 ' HG ' ' D' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 136.07 52.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.461 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.34 133.47 55.12 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.636 0.255 . . . . 0.0 111.053 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . 0.729 ' HB3' HG23 ' D' ' 107' ' ' THR . 6.1 t0 -82.21 149.77 27.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.725 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 106' ' ' ARG . . . . . 0.765 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.4 OUTLIER -67.89 -16.23 63.98 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.729 0.3 . . . . 0.0 111.046 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 107' ' ' THR . . . . . 0.729 HG23 ' HB3' ' D' ' 105' ' ' ASP . 8.8 t -63.65 -28.42 69.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.039 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 108' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' A' ' 80' ' ' ALA . . . 134.01 -40.41 1.59 Allowed Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.64 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.46 163.06 14.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.777 0.322 . . . . 0.0 111.054 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.08 133.3 35.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.207 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 111' ' ' LEU . . . . . 0.563 HD23 ' O ' ' D' ' 117' ' ' THR . 4.8 tp -96.73 150.06 21.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.356 0.598 . . . . 0.0 110.516 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 112' ' ' THR . . . . . 0.727 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 1.9 t -98.53 141.72 31.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.098 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 113' ' ' LEU . . . . . 0.561 ' HG ' HG12 ' D' ' 103' ' ' ILE . 1.6 mt -76.34 89.51 3.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.735 0.302 . . . . 0.0 110.765 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.15 -18.19 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.652 0.263 . . . . 0.0 111.497 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.82 -60.65 0.46 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.618 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 116' ' ' ALA . . . . . 0.446 ' HA ' ' CE2' ' D' ' 118' ' ' PHE . . . -96.43 26.94 4.04 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.948 0.404 . . . . 0.0 111.631 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 117' ' ' THR . . . . . 0.563 ' O ' HD23 ' D' ' 111' ' ' LEU . 0.0 OUTLIER -87.02 74.89 9.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.199 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.446 ' CE2' ' HA ' ' D' ' 116' ' ' ALA . 63.1 m-85 -94.94 92.86 7.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.834 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 25.5 m -136.27 68.9 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.81 150.23 28.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.616 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -107.3 67.71 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.135 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.554 ' O ' ' HB3' ' D' ' 69' ' ' ALA . 0.2 OUTLIER -79.23 114.67 18.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.735 -179.576 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -73.97 127.94 34.2 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.756 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . 0.583 HD22 ' O ' ' D' ' 66' ' ' ALA . 4.0 tp -92.01 132.14 36.77 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.649 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.09 151.14 49.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.6 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 126' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' D' ' 61' ' ' CYS . 3.1 t30 -69.1 112.08 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.613 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.55 -138.91 8.72 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.659 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 128' ' ' THR . . . . . 0.704 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 87.7 m -98.81 82.58 2.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.642 0.258 . . . . 0.0 110.729 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 129' ' ' ASN . . . . . 0.478 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 2.3 t30 -71.88 148.16 46.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.937 0.398 . . . . 0.0 111.06 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 130' ' ' THR . . . . . 0.646 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.2 OUTLIER -138.57 148.64 44.41 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.161 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 131' ' ' ILE . . . . . 0.493 ' HB ' HG21 ' D' ' 56' ' ' ILE . 15.8 mt -110.09 112.28 57.7 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 132' ' ' PRO . . . . . 0.765 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.5 Cg_endo -81.77 136.97 9.76 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.677 1.585 . . . . 0.0 112.597 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.04 136.06 19.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.676 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -111.42 158.34 19.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.055 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' D' ' 102' ' ' GLN . . . -154.18 111.29 3.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.935 0.397 . . . . 0.0 111.637 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 136' ' ' ARG . . . . . 0.549 ' HE ' HG22 ' D' ' 48' ' ' THR . 19.8 ptt180 -108.85 174.21 5.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.346 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 137' ' ' TYR . . . . . 0.758 ' HB3' HD22 ' D' ' 42' ' ' LEU . 1.7 m-85 -81.53 137.68 35.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.03 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -131.55 124.11 29.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.136 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 139' ' ' ALA . . . . . 0.676 ' HB3' ' HG ' ' D' ' 42' ' ' LEU . . . -108.42 130.28 55.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.855 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 140' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' D' ' 45' ' ' GLU . 0.2 OUTLIER -77.49 -28.02 52.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.535 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.41 -96.47 0.11 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.879 -0.676 . . . . 0.0 113.057 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.03 98.49 8.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.551 0.215 . . . . 0.0 110.697 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 143' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' D' ' 42' ' ' LEU . . . -56.59 148.91 18.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.758 0.313 . . . . 0.0 111.404 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 144' ' ' THR . . . . . 0.918 ' O ' HG12 ' C' ' 16' ' ' VAL . 91.6 m -125.38 156.93 69.45 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.288 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 145' ' ' PRO . . . . . 0.718 ' CD ' HG22 ' D' ' 144' ' ' THR . 1.5 Cg_endo -83.28 136.18 7.63 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.584 2.189 . . . . 0.0 111.989 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 146' ' ' GLY . . . . . 0.554 ' O ' ' HG3' ' C' ' 15' ' ' GLU . . . 163.58 -127.53 1.69 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.472 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 147' ' ' ALA . . . . . 0.685 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -110.98 132.88 53.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.842 0.354 . . . . 0.0 111.354 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.25 43.74 2.92 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.148 0.499 . . . . 0.0 110.43 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 149' ' ' ASN . . . . . 0.506 ' HB2' ' CG ' ' D' ' 89' ' ' GLN . 9.2 m120 -92.34 144.25 25.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.499 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.6 178.93 9.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.975 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 151' ' ' ASP . . . . . 0.624 ' OD1' ' HA ' ' C' ' 11' ' ' HIS . 15.6 t70 -147.03 145.02 29.55 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.226 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 152' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -133.76 139.71 46.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.198 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.99 135.26 42.73 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 154' ' ' PHE . . . . . 0.484 ' HB3' ' H ' ' C' ' 8' ' ' GLY . 0.2 OUTLIER -81.56 152.16 27.37 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.054 0.454 . . . . 0.0 110.136 -179.123 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -134.25 146.88 50.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.908 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.09 140.78 37.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.786 0.326 . . . . 0.0 111.626 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 157' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' C' ' 3' ' ' THR . 0.9 OUTLIER -134.54 132.65 39.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.297 0.57 . . . . 0.0 110.425 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 158' ' ' TYR . . . . . 0.542 ' CE1' ' HB2' ' D' ' 21' ' ' CYS . 11.0 m-85 -107.25 128.05 54.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.514 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.849 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.249 0.071 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 2' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' F' ' 158' ' ' TYR . . . 52.85 88.26 0.03 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.994 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 3' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' F' ' 157' ' ' GLN . 5.5 m -122.92 116.29 23.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.385 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -99.69 117.17 33.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.521 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -144.42 157.99 15.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.618 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 6' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' F' ' 154' ' ' PHE . 13.2 t30 -78.62 123.81 27.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.58 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.83 -71.15 1.01 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.827 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . 0.49 ' H ' ' HB3' ' F' ' 154' ' ' PHE . . . -152.7 -146.96 4.48 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.816 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 9' ' ' THR . . . . . . . . . . . . . 24.4 p -148.75 134.42 18.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.005 0.431 . . . . 0.0 111.268 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.33 124.38 72.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.169 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 11' ' ' HIS . . . . . 0.619 ' HA ' ' OD1' ' F' ' 151' ' ' ASP . 57.4 t-80 -91.56 116.2 28.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.306 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -96.78 105.47 17.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.753 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -104.58 118.69 37.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.512 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.27 172.89 30.79 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.924 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 15' ' ' GLU . . . . . 0.723 ' O ' ' HA ' ' F' ' 36' ' ' GLN . 25.8 tt0 -160.3 135.95 8.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.896 0.379 . . . . 0.0 110.384 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 16' ' ' VAL . . . . . 0.917 HG12 ' O ' ' F' ' 144' ' ' THR . 43.2 t -96.83 132.78 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.243 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . 0.747 HG12 ' HG2' ' F' ' 36' ' ' GLN . 18.2 m -133.91 -177.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.878 0.371 . . . . 0.0 111.007 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . 0.624 ' HA ' HG22 ' F' ' 39' ' ' THR . 0.3 OUTLIER -75.76 -170.28 1.28 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.894 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.73 45.35 0.98 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.078 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.736 ' HB3' ' HB2' ' E' ' 66' ' ' ALA . . . -121.24 -24.9 5.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.424 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 21' ' ' CYS . . . . . 0.918 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER -168.8 140.69 2.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.888 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 22' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' E' ' 60' ' ' ASP . . . -132.86 116.95 17.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.066 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 23' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' F' ' 36' ' ' GLN . 0.5 OUTLIER -67.03 146.26 13.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.101 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -80.37 152.08 29.08 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.547 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . 0.688 ' HB3' ' HA ' ' C' ' 91' ' ' SER . . . -62.77 -40.06 96.12 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.419 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.93 2.72 85.83 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.891 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -106.23 -19.86 13.57 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.823 0.344 . . . . 0.0 110.825 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 28' ' ' VAL . . . . . . . . . . . . . 39.7 t -47.4 -52.16 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.35 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.21 136.45 48.66 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.029 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.73 136.84 39.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.014 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.44 102.89 12.82 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.042 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.69 128.25 63.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.068 0.461 . . . . 0.0 110.547 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 33' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' D' ' 25' ' ' ALA . 10.7 mt-30 -114.64 123.02 48.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.693 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.45 -42.72 15.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.581 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.51 -167.45 13.18 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.587 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 36' ' ' GLN . . . . . 0.741 ' HG2' HG12 ' D' ' 17' ' ' VAL . 3.7 mt-30 -96.77 124.45 40.75 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.589 0.233 . . . . 0.0 110.927 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.77 147.52 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.848 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.68 134.93 34.34 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.698 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 39' ' ' THR . . . . . 0.627 HG22 ' HA ' ' D' ' 18' ' ' ASN . 0.0 OUTLIER -59.99 -44.48 94.49 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.815 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.25 -36.96 61.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.081 0.467 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.85 -35.83 62.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.165 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.756 HD22 ' HB3' ' E' ' 137' ' ' TYR . 3.0 mp -106.59 34.51 3.37 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.667 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 43' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' E' ' 39' ' ' THR . . . -103.92 15.84 27.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.375 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.99 132.07 56.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.283 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' E' ' 140' ' ' THR . 6.8 tt0 -56.5 108.69 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.766 0.317 . . . . 0.0 111.124 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.96 25.97 10.05 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.09 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.49 137.75 48.43 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 48' ' ' THR . . . . . 0.557 HG22 ' HE ' ' E' ' 136' ' ' ARG . 7.4 p -137.0 122.71 19.86 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.898 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' E' ' 136' ' ' ARG . 54.2 m -100.02 -175.25 2.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.659 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 50' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 2.8 t -55.63 137.28 49.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.787 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 51' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' E' ' 136' ' ' ARG . . . -92.28 133.56 35.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.344 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 52' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' B' ' 92' ' ' ALA . 26.2 m -76.78 162.48 4.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.52 141.17 16.78 Favored Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.538 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 54' ' ' PHE . . . . . 0.465 ' CE2' ' HB1' ' E' ' 135' ' ' ALA . 39.3 p90 -173.74 137.8 0.62 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.758 0.313 . . . . 0.0 110.941 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 55' ' ' ASN . . . . . 0.408 HD21 ' HG1' ' B' ' 76' ' ' THR . 18.0 p30 -136.44 145.83 45.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.692 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 56' ' ' ILE . . . . . 0.502 HG21 ' HB ' ' E' ' 131' ' ' ILE . 1.2 tp -91.04 116.8 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.617 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 57' ' ' GLN . . . . . 0.653 ' HA ' HG23 ' E' ' 130' ' ' THR . 1.3 mp0 -72.87 128.65 36.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.78 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . 0.438 ' HG ' ' HA ' ' E' ' 23' ' ' VAL . 0.3 OUTLIER -137.39 89.2 2.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.236 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . 0.68 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 9.8 p30 -74.9 176.51 7.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.985 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 60' ' ' ASP . . . . . 0.469 ' HB2' ' HB1' ' E' ' 22' ' ' ALA . 0.9 OUTLIER 58.98 74.85 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.775 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 61' ' ' CYS . . . . . 0.918 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 36.8 m -126.37 148.87 49.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -121.58 169.77 10.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.317 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.27 -32.69 4.89 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.55 -27.95 56.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.155 0.502 . . . . 0.0 111.685 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.58 -56.76 8.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.702 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 66' ' ' ALA . . . . . 0.736 ' HB2' ' HB3' ' E' ' 20' ' ' ALA . . . -134.94 122.75 22.35 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.672 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.62 -50.02 5.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.927 0.394 . . . . 0.0 110.932 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 68' ' ' LYS . . . . . 0.515 ' HA ' ' HZ2' ' E' ' 68' ' ' LYS . 1.8 tptp -89.75 152.09 21.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.567 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 69' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' E' ' 122' ' ' THR . . . -144.25 137.9 27.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.521 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.41 157.22 22.19 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.094 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . 0.471 HG11 HG21 ' E' ' 131' ' ' ILE . 1.8 t -138.75 150.06 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.649 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.87 155.03 37.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.57 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 73' ' ' PHE . . . . . 0.452 ' CB ' HD11 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -124.98 136.66 53.94 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.592 0.234 . . . . 0.0 111.071 179.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 74' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.9 OUTLIER -97.21 136.13 38.16 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.011 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' E' ' 113' ' ' LEU . . . -174.01 -172.94 39.72 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.735 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 76' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.2 OUTLIER -118.71 144.53 46.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.497 0.189 . . . . 0.0 110.826 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 77' ' ' ALA . . . . . 0.545 ' HB1' ' HA ' ' E' ' 83' ' ' THR . . . -62.42 138.51 58.47 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.963 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 78' ' ' ILE . . . . . 0.55 HG23 ' N ' ' E' ' 79' ' ' ASP . 5.7 tt -71.6 -45.59 66.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.843 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 79' ' ' ASP . . . . . 0.55 ' N ' HG23 ' E' ' 78' ' ' ILE . 0.3 OUTLIER -133.11 42.49 3.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.833 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' E' ' 79' ' ' ASP . . . 70.09 -80.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.002 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.15 -29.64 68.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.584 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 82' ' ' HIS . . . . . 0.402 ' HB3' HG22 ' E' ' 78' ' ' ILE . 1.7 m80 -89.9 69.45 7.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.874 0.369 . . . . 0.0 110.414 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 83' ' ' THR . . . . . 0.545 ' HA ' ' HB1' ' E' ' 77' ' ' ALA . 0.2 OUTLIER -74.55 -16.16 60.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.585 -179.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 84' ' ' ASN . . . . . 0.714 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 20.7 p-10 -66.2 -19.09 65.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.292 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.472 ' HB ' ' CG2' ' E' ' 78' ' ' ILE . 13.4 t -113.56 133.81 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.188 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 86' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' E' ' 76' ' ' THR . 0.4 OUTLIER -67.81 161.6 25.85 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 87' ' ' ALA . . . . . 0.464 ' H ' HD23 ' E' ' 86' ' ' LEU . . . -103.63 -174.75 2.62 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.936 0.398 . . . . 0.0 111.727 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.649 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 0.3 OUTLIER -67.37 165.18 16.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.082 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 89' ' ' GLN . . . . . 0.49 ' CG ' ' HB2' ' E' ' 149' ' ' ASN . 5.7 mm-40 -63.41 -79.7 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.376 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -165.49 3.7 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.019 0.437 . . . . 0.0 111.538 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.04 79.77 6.54 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.923 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.14 -24.69 55.98 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.853 0.359 . . . . 0.0 111.573 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.22 34.0 5.23 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.689 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.88 0.47 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.952 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 95' ' ' SER . . . . . 0.688 ' HA ' ' HB3' ' E' ' 147' ' ' ALA . 38.4 m -96.84 177.94 5.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.915 0.388 . . . . 0.0 110.598 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.46 -178.72 7.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.797 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 97' ' ' THR . . . . . 0.494 ' HB ' ' OG1' ' E' ' 144' ' ' THR . 2.0 m -134.44 119.06 18.09 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.373 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 98' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' E' ' 97' ' ' THR . 32.8 m-20 68.76 34.4 3.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.471 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 99' ' ' VAL . . . . . 0.462 HG12 HG21 ' D' ' 16' ' ' VAL . 0.4 OUTLIER -138.06 130.85 40.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.796 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.08 -170.57 18.85 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.538 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.7 114.47 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.028 0.531 . . . . 0.0 111.749 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 102' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 0.8 OUTLIER -87.37 150.24 23.95 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.877 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 103' ' ' ILE . . . . . 0.573 HG12 ' HG ' ' E' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 136.01 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.417 179.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.31 133.52 55.08 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.7 0.286 . . . . 0.0 111.073 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . 0.733 ' HB3' HG23 ' E' ' 107' ' ' THR . 6.1 t0 -82.27 149.76 27.65 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.655 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 106' ' ' ARG . . . . . 0.751 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.4 OUTLIER -67.88 -16.2 63.97 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.762 0.315 . . . . 0.0 111.065 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 107' ' ' THR . . . . . 0.733 HG23 ' HB3' ' E' ' 105' ' ' ASP . 8.9 t -63.72 -28.35 69.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.003 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 108' ' ' GLY . . . . . 0.425 ' N ' HG22 ' E' ' 107' ' ' THR . . . 134.0 -40.54 1.57 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.684 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.42 163.04 14.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 0.0 111.039 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.09 133.36 35.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.229 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 111' ' ' LEU . . . . . 0.559 HD23 ' O ' ' E' ' 117' ' ' THR . 4.8 tp -96.72 150.03 21.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.383 0.611 . . . . 0.0 110.5 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 112' ' ' THR . . . . . 0.714 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 1.9 t -98.42 141.7 30.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.183 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 113' ' ' LEU . . . . . 0.573 ' HG ' HG12 ' E' ' 103' ' ' ILE . 1.6 mt -76.33 89.36 3.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.758 0.313 . . . . 0.0 110.758 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.0 -18.21 5.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.652 0.263 . . . . 0.0 111.52 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.78 -60.65 0.46 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.681 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 116' ' ' ALA . . . . . 0.451 ' HA ' ' CE2' ' E' ' 118' ' ' PHE . . . -96.48 27.04 4.01 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.028 0.442 . . . . 0.0 111.641 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 117' ' ' THR . . . . . 0.559 ' O ' HD23 ' E' ' 111' ' ' LEU . 0.0 OUTLIER -87.11 74.86 9.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.13 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 118' ' ' PHE . . . . . 0.451 ' CE2' ' HA ' ' E' ' 116' ' ' ALA . 62.8 m-85 -94.87 92.89 7.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.823 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 25.7 m -136.32 68.85 1.43 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.829 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.84 150.31 28.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.579 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.39 67.73 0.7 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.083 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 122' ' ' THR . . . . . 0.555 ' O ' ' HB3' ' E' ' 69' ' ' ALA . 0.2 OUTLIER -79.19 114.74 18.37 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.704 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -74.02 127.98 34.31 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.676 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . 0.581 HD22 ' O ' ' E' ' 66' ' ' ALA . 4.0 tp -92.04 132.17 36.76 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.651 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.13 151.1 49.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.608 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 126' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' E' ' 61' ' ' CYS . 3.1 t30 -69.1 112.08 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.668 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 127' ' ' GLY . . . . . 0.515 ' CA ' HG21 ' A' ' 4' ' ' THR . . . 142.56 -138.85 8.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.724 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 128' ' ' THR . . . . . 0.68 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 87.4 m -98.85 82.49 2.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.676 0.274 . . . . 0.0 110.84 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 129' ' ' ASN . . . . . 0.475 ' HA ' ' HB1' ' B' ' 116' ' ' ALA . 2.3 t30 -71.82 148.18 46.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.938 0.399 . . . . 0.0 111.07 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 130' ' ' THR . . . . . 0.653 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.2 OUTLIER -138.63 148.6 44.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.138 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 131' ' ' ILE . . . . . 0.502 ' HB ' HG21 ' E' ' 56' ' ' ILE . 15.6 mt -109.96 112.2 58.04 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 132' ' ' PRO . . . . . 0.751 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.5 Cg_endo -81.77 137.01 9.78 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.671 1.581 . . . . 0.0 112.585 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.06 135.98 19.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.782 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -111.44 158.36 19.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.076 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 135' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' E' ' 102' ' ' GLN . . . -154.16 111.36 3.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.979 0.419 . . . . 0.0 111.616 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 136' ' ' ARG . . . . . 0.557 ' HE ' HG22 ' E' ' 48' ' ' THR . 19.8 ptt180 -108.91 174.1 6.02 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.375 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 137' ' ' TYR . . . . . 0.756 ' HB3' HD22 ' E' ' 42' ' ' LEU . 1.7 m-85 -81.41 137.68 35.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.067 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -131.52 124.14 29.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.14 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 139' ' ' ALA . . . . . 0.68 ' HB3' ' HG ' ' E' ' 42' ' ' LEU . . . -108.49 130.23 55.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.815 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 140' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' E' ' 45' ' ' GLU . 0.2 OUTLIER -77.47 -27.96 52.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.537 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.46 -96.46 0.11 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.971 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.02 98.46 8.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.606 0.203 . . . . 0.0 110.623 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 143' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' E' ' 42' ' ' LEU . . . -56.59 148.86 18.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 111.373 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 144' ' ' THR . . . . . 0.911 ' O ' HG12 ' D' ' 16' ' ' VAL . 93.2 m -125.35 156.93 69.4 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.316 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 145' ' ' PRO . . . . . 0.728 ' CD ' ' CG2' ' E' ' 144' ' ' THR . 1.4 Cg_endo -83.34 136.27 7.61 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.507 2.138 . . . . 0.0 111.993 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 146' ' ' GLY . . . . . 0.559 ' O ' ' HG3' ' D' ' 15' ' ' GLU . . . 163.56 -127.57 1.7 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.434 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 147' ' ' ALA . . . . . 0.688 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -110.94 132.94 53.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.921 0.391 . . . . 0.0 111.291 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.29 43.71 2.93 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.421 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 149' ' ' ASN . . . . . 0.49 ' HB2' ' CG ' ' E' ' 89' ' ' GLN . 9.2 m120 -92.32 144.25 25.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.535 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.58 178.94 9.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.939 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 151' ' ' ASP . . . . . 0.611 ' OD1' ' HA ' ' D' ' 11' ' ' HIS . 15.7 t70 -147.05 145.01 29.52 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.201 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 152' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -133.76 139.8 46.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.196 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.14 135.25 42.91 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 154' ' ' PHE . . . . . 0.49 ' HB3' ' H ' ' D' ' 8' ' ' GLY . 0.2 OUTLIER -81.51 152.1 27.47 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.094 0.473 . . . . 0.0 110.148 -179.086 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -134.2 146.84 50.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.947 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.11 140.8 37.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.765 0.317 . . . . 0.0 111.64 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 157' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' D' ' 3' ' ' THR . 0.9 OUTLIER -134.55 132.63 39.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.291 0.567 . . . . 0.0 110.434 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 158' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' E' ' 21' ' ' CYS . 11.0 m-85 -107.23 128.05 54.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.58 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.839 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.26 0.076 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.67 88.39 0.03 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.051 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 5.5 m -122.95 116.28 23.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.358 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -99.69 117.29 33.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.51 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -144.49 158.03 14.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.596 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -78.73 123.71 27.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.586 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.67 -71.21 1.0 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.855 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.68 -146.93 4.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.825 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 24.5 p -148.77 134.4 18.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.998 0.428 . . . . 0.0 111.278 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.36 124.37 72.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.185 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -91.55 116.27 28.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.282 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -96.92 105.54 17.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.726 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -104.65 118.74 37.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.437 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.29 172.88 30.8 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.975 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -160.32 135.98 8.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.961 0.41 . . . . 0.0 110.405 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 43.4 t -96.86 132.79 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.281 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 17' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.89 -177.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.802 0.334 . . . . 0.0 111.019 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -75.72 -170.31 1.27 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.017 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.76 45.43 0.98 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.065 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . 0.734 ' HB3' ' HB2' ' F' ' 66' ' ' ALA . . . -121.29 -24.84 5.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.401 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 21' ' ' CYS . . . . . 0.904 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER -168.86 140.7 2.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.816 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 22' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' F' ' 60' ' ' ASP . . . -132.9 116.91 17.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.05 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 23' ' ' VAL . . . . . 0.43 ' HA ' ' HG ' ' F' ' 58' ' ' LEU . 0.5 OUTLIER -67.06 146.24 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.108 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -80.45 152.06 28.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.542 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . 0.688 ' HB3' ' HA ' ' D' ' 91' ' ' SER . . . -62.71 -40.05 95.94 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.445 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.87 2.64 85.87 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.872 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 23.0 t -106.19 -19.95 13.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.849 0.357 . . . . 0.0 110.867 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 39.9 t -47.31 -52.2 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.354 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.15 136.42 48.67 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.045 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.69 136.86 39.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.004 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.56 102.85 12.74 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.07 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.64 128.27 62.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.052 0.453 . . . . 0.0 110.51 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 33' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' E' ' 25' ' ' ALA . 10.6 mt-30 -114.75 123.09 48.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.677 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.47 -42.68 15.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.604 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.42 -167.44 13.21 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.604 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 36' ' ' GLN . . . . . 0.747 ' HG2' HG12 ' E' ' 17' ' ' VAL . 3.7 mt-30 -96.77 124.41 40.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.615 0.245 . . . . 0.0 110.885 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.72 147.54 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.895 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.64 134.94 34.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.682 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 39' ' ' THR . . . . . 0.624 HG22 ' HA ' ' E' ' 18' ' ' ASN . 0.0 OUTLIER -60.06 -44.45 94.71 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.797 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.23 -36.94 61.58 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.101 0.477 . . . . 0.0 110.91 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.79 -35.91 62.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.185 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . 0.738 HD22 ' HB3' ' F' ' 137' ' ' TYR . 2.9 mp -106.63 34.53 3.36 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.602 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 43' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' F' ' 39' ' ' THR . . . -103.87 15.8 27.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.307 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.94 132.05 56.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.337 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' F' ' 140' ' ' THR . 6.8 tt0 -56.53 108.74 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 111.172 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.93 25.93 10.11 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.16 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.5 137.73 48.39 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 48' ' ' THR . . . . . 0.537 HG22 ' HE ' ' F' ' 136' ' ' ARG . 7.3 p -136.96 122.76 19.97 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.881 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 49' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' F' ' 136' ' ' ARG . 53.4 m -100.05 -175.23 2.89 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.61 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 50' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' C' ' 92' ' ' ALA . 2.8 t -55.62 137.3 49.38 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.819 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 51' ' ' ALA . . . . . 0.469 ' CA ' ' HB3' ' F' ' 136' ' ' ARG . . . -92.35 133.45 35.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.331 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 52' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' C' ' 92' ' ' ALA . 26.2 m -76.68 162.51 4.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.54 141.17 16.77 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.605 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 54' ' ' PHE . . . . . 0.467 ' HE2' ' HB1' ' F' ' 135' ' ' ALA . 39.3 p90 -173.76 137.81 0.62 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.796 0.331 . . . . 0.0 110.985 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -136.56 145.88 45.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.604 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 56' ' ' ILE . . . . . 0.502 HG21 ' HB ' ' F' ' 131' ' ' ILE . 1.2 tp -91.1 116.79 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.643 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 57' ' ' GLN . . . . . 0.642 ' HA ' HG23 ' F' ' 130' ' ' THR . 1.3 mp0 -72.86 128.55 35.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.812 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . 0.43 ' HG ' ' HA ' ' F' ' 23' ' ' VAL . 0.3 OUTLIER -137.34 89.14 2.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.275 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 59' ' ' ASN . . . . . 0.712 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 9.8 p30 -74.75 176.46 7.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.956 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 60' ' ' ASP . . . . . 0.475 ' HB2' ' HB1' ' F' ' 22' ' ' ALA . 0.8 OUTLIER 58.98 74.77 0.43 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.834 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 61' ' ' CYS . . . . . 0.904 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 36.8 m -126.34 148.91 49.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.8 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -121.62 169.74 10.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.285 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.32 -32.6 4.91 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.58 -27.92 56.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.266 0.555 . . . . 0.0 111.752 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.54 -56.81 8.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.715 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 66' ' ' ALA . . . . . 0.734 ' HB2' ' HB3' ' F' ' 20' ' ' ALA . . . -134.93 122.77 22.39 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.693 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.55 -50.11 5.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.932 0.396 . . . . 0.0 110.931 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 68' ' ' LYS . . . . . 0.497 ' HA ' ' HZ2' ' F' ' 68' ' ' LYS . 1.8 tptp -89.76 152.12 21.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.556 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 69' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' F' ' 122' ' ' THR . . . -144.25 137.8 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.559 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.38 157.26 22.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.087 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 71' ' ' VAL . . . . . 0.487 HG11 HG21 ' F' ' 131' ' ' ILE . 1.8 t -138.75 150.06 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.638 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.87 155.05 37.35 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.593 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 73' ' ' PHE . . . . . 0.468 ' CB ' HD11 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -125.02 136.62 53.88 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.549 0.214 . . . . 0.0 111.056 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 74' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.9 OUTLIER -97.17 136.11 38.16 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.019 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' F' ' 113' ' ' LEU . . . -174.0 -172.94 39.72 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.761 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 76' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.2 OUTLIER -118.73 144.53 46.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.553 0.216 . . . . 0.0 110.785 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 77' ' ' ALA . . . . . 0.542 ' HB1' ' HA ' ' F' ' 83' ' ' THR . . . -62.46 138.59 58.49 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.94 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 78' ' ' ILE . . . . . 0.542 HG23 ' N ' ' F' ' 79' ' ' ASP . 5.7 tt -71.66 -45.56 66.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.85 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 79' ' ' ASP . . . . . 0.542 ' N ' HG23 ' F' ' 78' ' ' ILE . 0.3 OUTLIER -133.11 42.45 3.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.793 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 80' ' ' ALA . . . . . 0.478 ' HB1' ' O ' ' F' ' 79' ' ' ASP . . . 70.16 -80.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.06 -29.68 68.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.64 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 82' ' ' HIS . . . . . 0.412 ' HB3' HG22 ' F' ' 78' ' ' ILE . 1.7 m80 -89.87 69.38 7.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.813 0.34 . . . . 0.0 110.426 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 83' ' ' THR . . . . . 0.542 ' HA ' ' HB1' ' F' ' 77' ' ' ALA . 0.2 OUTLIER -74.53 -16.12 60.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.631 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 84' ' ' ASN . . . . . 0.726 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 20.7 p-10 -66.25 -19.05 65.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.285 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 85' ' ' VAL . . . . . 0.47 HG23 ' HB2' ' F' ' 102' ' ' GLN . 13.4 t -113.6 133.8 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.202 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 86' ' ' LEU . . . . . 0.588 ' HA ' ' O ' ' F' ' 76' ' ' THR . 0.4 OUTLIER -67.73 161.54 25.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 87' ' ' ALA . . . . . 0.462 ' H ' HD23 ' F' ' 86' ' ' LEU . . . -103.66 -174.71 2.61 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.84 0.352 . . . . 0.0 111.756 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . 0.644 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 0.3 OUTLIER -67.36 165.22 16.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.069 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 89' ' ' GLN . . . . . 0.499 ' CG ' ' HB2' ' F' ' 149' ' ' ASN . 5.6 mm-40 -63.54 -79.67 0.03 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.302 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -165.48 3.73 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.003 0.43 . . . . 0.0 111.487 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.08 79.75 6.59 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.17 -24.63 55.69 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.849 0.357 . . . . 0.0 111.608 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.2 33.99 5.24 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.653 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.85 0.44 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.958 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 95' ' ' SER . . . . . 0.675 ' HA ' ' HB3' ' F' ' 147' ' ' ALA . 38.4 m -96.73 177.95 5.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.86 0.362 . . . . 0.0 110.612 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.46 -178.65 7.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 97' ' ' THR . . . . . 0.493 ' HB ' ' OG1' ' F' ' 144' ' ' THR . 2.0 m -134.55 119.04 17.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.341 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 98' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' F' ' 97' ' ' THR . 32.6 m-20 68.75 34.48 3.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.433 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 99' ' ' VAL . . . . . 0.469 HG12 HG21 ' E' ' 16' ' ' VAL . 0.4 OUTLIER -138.08 130.88 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.765 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.21 -170.6 18.97 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.537 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.64 114.44 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.008 0.523 . . . . 0.0 111.737 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 102' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 0.8 OUTLIER -87.35 150.24 23.97 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 103' ' ' ILE . . . . . 0.572 HG12 ' HG ' ' F' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 136.01 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.474 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.39 133.56 55.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.705 0.288 . . . . 0.0 111.028 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . 0.733 ' HB3' HG23 ' F' ' 107' ' ' THR . 6.1 t0 -82.23 149.72 27.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.749 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 106' ' ' ARG . . . . . 0.76 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.4 OUTLIER -67.87 -16.24 64.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.798 0.332 . . . . 0.0 111.098 179.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 107' ' ' THR . . . . . 0.733 HG23 ' HB3' ' F' ' 105' ' ' ASP . 8.8 t -63.59 -28.46 69.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.979 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 108' ' ' GLY . . . . . 0.421 ' N ' HG22 ' F' ' 107' ' ' THR . . . 134.04 -40.55 1.57 Allowed Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.616 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.43 163.04 14.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.811 0.339 . . . . 0.0 111.038 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.18 133.4 35.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 111' ' ' LEU . . . . . 0.56 HD23 ' O ' ' F' ' 117' ' ' THR . 4.8 tp -96.66 149.94 21.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.386 0.612 . . . . 0.0 110.558 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 112' ' ' THR . . . . . 0.726 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 1.9 t -98.48 141.7 31.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.085 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 113' ' ' LEU . . . . . 0.572 ' HG ' HG12 ' F' ' 103' ' ' ILE . 1.6 mt -76.33 89.47 3.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.744 0.307 . . . . 0.0 110.761 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.09 -18.22 5.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.67 0.271 . . . . 0.0 111.52 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.86 -60.68 0.45 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.529 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 116' ' ' ALA . . . . . 0.449 ' HA ' ' CE2' ' F' ' 118' ' ' PHE . . . -96.44 26.97 4.03 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.041 0.448 . . . . 0.0 111.683 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 117' ' ' THR . . . . . 0.56 ' O ' HD23 ' F' ' 111' ' ' LEU . 0.0 OUTLIER -87.01 74.85 9.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.155 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 118' ' ' PHE . . . . . 0.449 ' CE2' ' HA ' ' F' ' 116' ' ' ALA . 63.3 m-85 -94.97 92.96 7.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.768 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 25.6 m -136.35 68.9 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.796 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.81 150.29 28.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.629 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.34 67.6 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.136 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 122' ' ' THR . . . . . 0.549 ' O ' ' HB3' ' F' ' 69' ' ' ALA . 0.2 OUTLIER -79.15 114.66 18.27 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.69 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 12.1 m -73.95 127.97 34.29 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.742 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . 0.593 HD22 ' O ' ' F' ' 66' ' ' ALA . 4.0 tp -92.11 132.21 36.77 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.602 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.1 151.07 49.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.63 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 126' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' F' ' 61' ' ' CYS . 3.1 t30 -69.1 112.05 5.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 110.646 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 127' ' ' GLY . . . . . 0.503 ' CA ' HG21 ' B' ' 4' ' ' THR . . . 142.51 -138.9 8.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.687 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 128' ' ' THR . . . . . 0.712 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 87.7 m -98.76 82.59 2.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.664 0.269 . . . . 0.0 110.792 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 129' ' ' ASN . . . . . 0.471 ' HA ' ' HB1' ' C' ' 116' ' ' ALA . 2.3 t30 -71.85 148.19 46.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.893 0.377 . . . . 0.0 111.094 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 130' ' ' THR . . . . . 0.642 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.2 OUTLIER -138.63 148.66 44.34 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.154 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 131' ' ' ILE . . . . . 0.502 ' HB ' HG21 ' F' ' 56' ' ' ILE . 15.6 mt -110.05 112.17 57.86 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 132' ' ' PRO . . . . . 0.76 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.6 Cg_endo -81.78 136.98 9.75 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.612 1.541 . . . . 0.0 112.587 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.0 136.1 19.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.773 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -111.42 158.45 19.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.037 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 135' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' F' ' 102' ' ' GLN . . . -154.2 111.35 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.924 0.392 . . . . 0.0 111.674 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 136' ' ' ARG . . . . . 0.537 ' HE ' HG22 ' F' ' 48' ' ' THR . 19.8 ptt180 -108.86 174.0 6.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.382 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 137' ' ' TYR . . . . . 0.738 ' HB3' HD22 ' F' ' 42' ' ' LEU . 1.7 m-85 -81.37 137.62 35.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.122 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -131.51 124.16 29.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.096 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 139' ' ' ALA . . . . . 0.666 ' HB3' ' HG ' ' F' ' 42' ' ' LEU . . . -108.52 130.15 55.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.868 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 140' ' ' THR . . . . . 0.513 HG22 ' HB2' ' F' ' 79' ' ' ASP . 0.2 OUTLIER -77.37 -28.01 52.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.557 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.46 -96.41 0.11 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.005 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.01 98.51 8.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.583 0.23 . . . . 0.0 110.648 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 143' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' F' ' 42' ' ' LEU . . . -56.66 148.92 18.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.674 0.274 . . . . 0.0 111.377 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 144' ' ' THR . . . . . 0.917 ' O ' HG12 ' E' ' 16' ' ' VAL . 90.3 m -125.48 157.0 69.61 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.213 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 145' ' ' PRO . . . . . 0.728 ' CD ' ' CG2' ' F' ' 144' ' ' THR . 1.4 Cg_endo -83.36 136.22 7.56 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.552 2.168 . . . . 0.0 111.978 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 146' ' ' GLY . . . . . 0.564 ' O ' ' HG3' ' E' ' 15' ' ' GLU . . . 163.61 -127.56 1.69 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.457 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 147' ' ' ALA . . . . . 0.675 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -110.85 132.92 53.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.864 0.364 . . . . 0.0 111.414 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.25 43.65 2.94 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.126 0.489 . . . . 0.0 110.459 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 149' ' ' ASN . . . . . 0.499 ' HB2' ' CG ' ' F' ' 89' ' ' GLN . 9.3 m120 -92.34 144.28 25.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.54 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.6 178.9 9.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.995 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 151' ' ' ASP . . . . . 0.619 ' OD1' ' HA ' ' E' ' 11' ' ' HIS . 15.7 t70 -147.02 144.97 29.54 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.215 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 152' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -133.73 139.76 46.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.114 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.07 135.26 42.81 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 154' ' ' PHE . . . . . 0.49 ' HB3' ' H ' ' E' ' 8' ' ' GLY . 0.2 OUTLIER -81.58 152.13 27.36 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.013 0.435 . . . . 0.0 110.152 -179.052 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -134.22 146.86 50.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.897 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 156' ' ' VAL . . . . . . . . . . . . . 33.0 m -139.14 140.76 37.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.853 0.359 . . . . 0.0 111.632 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 157' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' E' ' 3' ' ' THR . 0.9 OUTLIER -134.5 132.74 39.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.266 0.555 . . . . 0.0 110.42 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 158' ' ' TYR . . . . . 0.541 ' CE1' ' HB2' ' F' ' 21' ' ' CYS . 10.9 m-85 -107.31 128.1 54.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.493 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.886 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.17 0 CA-C-O 120.546 0.213 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.8 m -117.36 119.27 34.6 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.397 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.674 HG22 ' HG3' ' B' ' 157' ' ' GLN . 4.0 m -98.41 127.22 44.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.515 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.14 171.02 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.6 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.04 114.69 23.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.601 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.511 ' HA3' HG11 ' B' ' 156' ' ' VAL . . . -69.65 -57.77 6.98 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.791 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.52 -144.6 4.08 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.9 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -155.69 140.51 17.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.818 0.342 . . . . 0.0 111.4 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.484 HG13 HG21 ' B' ' 32' ' ' VAL . 29.9 t -130.38 117.55 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.26 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.55 117.05 29.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.336 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -89.96 107.12 18.92 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.8 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.76 113.28 26.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.45 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.421 ' HA3' ' OH ' ' B' ' 137' ' ' TYR . . . -144.43 166.99 27.12 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.889 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.675 ' CG ' ' O ' ' B' ' 146' ' ' GLY . 30.2 tt0 -155.66 135.23 12.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.053 0.454 . . . . 0.0 110.286 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.938 HG12 ' O ' ' B' ' 144' ' ' THR . 66.4 t -96.59 138.38 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.293 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.559 HG21 HE21 ' B' ' 36' ' ' GLN . 2.6 m -140.85 -173.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.832 0.349 . . . . 0.0 110.977 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.467 ' HA ' HG22 ' B' ' 39' ' ' THR . 1.0 OUTLIER -80.15 173.46 12.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.034 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HA ' ' HB3' ' B' ' 38' ' ' ARG . . . -85.86 39.83 0.82 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.042 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . . . -114.36 -33.57 5.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.349 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.892 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.9 OUTLIER -161.16 149.97 16.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.953 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.64 112.08 4.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.07 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.647 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 3.1 p -59.9 153.42 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.065 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.76 152.76 28.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.674 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.52 80.83 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.349 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.81 15.75 61.93 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.939 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -113.06 -21.32 11.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.909 0.385 . . . . 0.0 110.815 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -44.61 -64.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.364 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.28 135.61 38.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.925 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.02 128.73 19.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.79 111.8 23.83 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.012 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.2 t -110.82 114.77 48.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.141 0.496 . . . . 0.0 110.494 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.68 124.51 46.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.649 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.602 HD21 HG21 ' A' ' 101' ' ' VAL . 0.9 OUTLIER -82.49 -45.73 14.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.619 179.428 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.37 -161.91 12.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.534 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -99.77 129.7 45.91 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.649 0.261 . . . . 0.0 110.828 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p -110.05 147.47 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.948 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 41' ' ' SER . 0.7 OUTLIER -86.76 131.24 34.19 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.94 0.4 . . . . 0.0 111.766 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 143' ' ' ALA . 4.8 t -54.1 -45.1 71.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.757 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.31 89.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.069 0.461 . . . . 0.0 110.875 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' A' ' 38' ' ' ARG . 0.4 OUTLIER -70.55 -23.19 62.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.19 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.674 HD22 ' HB3' ' A' ' 137' ' ' TYR . 1.4 mp -124.63 51.62 1.6 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.586 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.59 29.95 7.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.418 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.84 128.36 48.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.41 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 140' ' ' THR . 29.4 tt0 -52.88 102.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 111.097 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.405 ' HA2' ' HE1' ' A' ' 138' ' ' PHE . . . 96.05 39.01 4.42 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.126 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.1 146.72 31.74 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.62 125.01 19.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.95 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 32.4 m -101.91 -166.35 1.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.644 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.01 133.02 55.7 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.845 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' A' ' 136' ' ' ARG . . . -92.66 120.13 32.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.26 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 135' ' ' ALA . 18.3 m -65.71 162.59 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.946 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.85 124.11 5.27 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.592 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.591 ' HE2' ' HB1' ' A' ' 135' ' ' ALA . 54.0 p90 -155.9 146.56 21.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.684 0.278 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.699 ' HB2' HG21 ' A' ' 130' ' ' THR . 3.4 p30 -136.83 160.19 39.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.576 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 56' ' ' ILE . 1.6 tp -100.56 116.93 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.562 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.535 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -70.07 124.56 24.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.766 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.672 HD23 ' HB3' ' A' ' 21' ' ' CYS . 1.6 mp -133.72 87.44 2.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.23 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 4.9 p30 -73.61 174.54 8.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.949 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.82 79.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.818 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.892 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 93.6 m -127.59 159.37 34.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.428 ' O ' ' HG ' ' A' ' 124' ' ' LEU . 5.6 t70 -130.23 167.12 18.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.238 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.32 -41.7 3.44 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.51 -22.61 65.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.047 0.451 . . . . 0.0 111.735 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.3 t -70.43 -74.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.601 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . . . -120.75 131.36 54.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.571 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -48.58 6.13 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.863 0.363 . . . . 0.0 110.997 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.6 ' HE3' ' HB3' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -96.18 161.58 13.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.556 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.17 124.58 6.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.606 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.35 154.98 18.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.094 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.575 HG13 HD11 ' A' ' 131' ' ' ILE . 2.3 t -132.76 148.31 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.696 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.64 150.12 35.76 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.599 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.543 ' CB ' HD11 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -119.92 137.02 54.29 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.568 0.223 . . . . 0.0 111.022 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.522 HD11 ' CE ' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -96.0 139.46 32.16 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.966 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 113' ' ' LEU . . . 178.5 179.84 48.48 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.733 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.546 ' H ' HD21 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -111.0 156.38 21.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.559 0.218 . . . . 0.0 110.807 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -73.78 131.34 41.46 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.338 -0.392 . . . . 0.0 112.02 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.636 ' CG2' ' HB ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -67.79 -41.36 85.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.808 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.14 40.79 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.791 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.547 ' HB2' ' HA2' ' D' ' 108' ' ' GLY . . . 66.4 -80.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.83 -24.94 43.2 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.663 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.07 64.03 1.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.957 0.408 . . . . 0.0 110.45 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.671 HG23 ' HD2' ' D' ' 106' ' ' ARG . 0.2 OUTLIER -68.5 -16.84 64.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.576 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.679 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 18.0 p-10 -70.46 -20.21 62.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.317 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.636 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 14.7 t -106.86 130.76 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.117 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.546 HD21 ' H ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -67.61 148.22 51.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.387 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.63 -167.52 1.88 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.842 0.353 . . . . 0.0 111.743 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.624 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 1.5 mm? -78.3 157.27 29.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.04 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.66 -78.37 0.02 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.354 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.564 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 0.4 OUTLIER -167.13 0.54 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.032 0.444 . . . . 0.0 111.425 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.599 ' HA ' ' HB3' ' C' ' 25' ' ' ALA . 1.7 m -71.89 83.02 0.92 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.679 ' HB1' ' HB3' ' D' ' 34' ' ' LEU . . . -66.75 -13.9 61.94 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.827 0.346 . . . . 0.0 111.643 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.71 27.61 5.21 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.609 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -166.74 15.76 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.903 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.624 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . 3.0 m -100.86 -172.78 2.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.833 0.349 . . . . 0.0 110.613 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.9 167.63 9.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.494 ' H ' ' HB ' ' A' ' 144' ' ' THR . 2.3 m -121.59 128.41 51.93 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.314 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' A' ' 141' ' ' GLY . 75.8 m-20 64.22 34.57 10.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.371 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.458 ' C ' HD11 ' A' ' 78' ' ' ILE . 0.5 OUTLIER -139.96 136.44 38.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.704 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.12 -156.83 8.33 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.546 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.602 HG21 HD21 ' A' ' 34' ' ' LEU . 3.2 p -137.82 116.72 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 122.942 0.497 . . . . 0.0 111.605 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 1.1 tt0 -91.91 150.39 21.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.841 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.543 HD11 ' CB ' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -113.86 131.3 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.531 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -106.2 130.15 54.12 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.646 0.26 . . . . 0.0 111.041 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.542 ' HB3' HG23 ' A' ' 107' ' ' THR . 5.1 t0 -76.08 156.99 33.39 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.661 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.752 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 3.5 ttp180 -71.29 -17.51 62.46 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.731 0.3 . . . . 0.0 111.03 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.542 HG23 ' HB3' ' A' ' 105' ' ' ASP . 6.2 t -67.29 -17.91 64.97 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.028 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.68 -45.61 1.17 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.78 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.1 163.11 23.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.737 0.303 . . . . 0.0 111.114 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -84.16 127.38 33.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.104 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.569 HD21 ' HZ ' ' A' ' 133' ' ' PHE . 12.1 tp -86.28 156.07 20.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.306 0.574 . . . . 0.0 110.6 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -106.17 139.09 41.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.179 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.432 ' HG ' HG12 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -73.89 76.4 1.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.691 0.281 . . . . 0.0 110.789 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.42 -17.17 14.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.625 0.25 . . . . 0.0 111.561 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.31 -51.77 1.24 Allowed Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.615 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.01 18.88 21.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.832 0.349 . . . . 0.0 111.544 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.81 84.68 7.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 95.7 m-85 -101.42 98.74 9.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.785 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.7 m -130.82 62.35 1.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.825 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.27 145.88 30.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.687 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.6 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . 3.5 mm-40 -121.43 71.32 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.177 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.73 134.78 34.73 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.715 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.2 m -83.83 113.69 21.11 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.683 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.65 HD13 ' SG ' ' A' ' 21' ' ' CYS . 18.9 tp -73.99 142.97 45.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.651 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.67 162.13 35.42 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.557 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.66 113.1 12.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.717 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.51 -139.95 9.53 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.752 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 6.7 m -101.64 96.76 7.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.726 0.298 . . . . 0.0 110.804 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -83.58 148.58 27.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.92 0.391 . . . . 0.0 111.086 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.699 HG21 ' HB2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -138.64 143.43 39.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.09 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.575 HD11 HG13 ' A' ' 71' ' ' VAL . 55.1 mt -104.63 112.39 65.33 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.752 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.6 Cg_endo -81.87 141.89 12.27 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.825 1.683 . . . . 0.0 112.522 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.569 ' HZ ' HD21 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -150.58 141.09 22.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.847 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.46 152.64 22.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.079 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.591 ' HB1' ' HE2' ' A' ' 54' ' ' PHE . . . -153.54 100.99 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 111.567 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.558 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 17.4 ptt180 -107.15 177.27 4.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.385 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.674 ' HB3' HD22 ' A' ' 42' ' ' LEU . 4.7 m-85 -85.96 124.15 32.09 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.011 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.494 ' HB3' HG11 ' A' ' 85' ' ' VAL . 1.2 t80 -118.93 112.38 19.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.024 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.67 ' HB3' HD21 ' A' ' 42' ' ' LEU . . . -102.96 133.91 47.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.867 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.608 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -81.1 -28.82 35.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.531 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 98' ' ' ASN . . . -160.18 -111.04 0.28 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.961 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.87 110.56 21.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.607 0.203 . . . . 0.0 110.77 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.471 ' O ' ' OG1' ' A' ' 39' ' ' THR . . . -65.63 134.21 52.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.763 0.316 . . . . 0.0 111.376 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.494 ' HB ' ' H ' ' A' ' 97' ' ' THR . 57.2 m -105.78 149.4 37.93 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.31 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.488 ' CD ' ' CG2' ' A' ' 144' ' ' THR . 1.4 Cg_endo -82.93 125.49 4.17 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.53 2.153 . . . . 0.0 112.057 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.8 -126.37 1.38 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.43 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 94' ' ' GLY . . . -111.07 128.4 55.86 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.729 0.3 . . . . 0.0 111.348 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.44 52.18 1.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 110.441 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.82 151.98 20.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.564 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.448 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -158.32 169.54 24.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.942 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -131.03 128.65 40.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.212 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -122.22 144.09 49.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.229 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.435 ' HB ' ' HZ1' ' A' ' 155' ' ' LYS . 0.6 OUTLIER -106.34 145.32 31.83 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.203 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -96.89 134.72 39.86 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.009 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.522 ' CE ' HD11 ' A' ' 74' ' ' LEU . 9.9 mmtt -124.26 148.13 47.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.902 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.19 144.78 33.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 111.733 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.48 126.09 28.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.279 0.561 . . . . 0.0 110.389 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.558 ' C ' ' HG3' ' A' ' 159' ' ' GLN . 5.1 m-85 -106.0 128.75 54.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.498 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.558 ' HG3' ' C ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.877 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.246 0.07 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.63 77.07 0.19 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.037 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 10.7 m -117.33 119.23 34.49 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.439 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.667 HG22 ' HG3' ' C' ' 157' ' ' GLN . 4.0 m -98.32 127.17 44.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.548 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.12 171.08 4.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.58 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.14 114.72 23.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.548 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . 0.505 ' HA3' HG11 ' C' ' 156' ' ' VAL . . . -69.84 -57.58 7.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.736 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.65 -144.63 4.09 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.989 -0.625 . . . . 0.0 111.854 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 17.0 p -155.64 140.45 17.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.826 0.346 . . . . 0.0 111.364 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.472 HG13 HG21 ' C' ' 32' ' ' VAL . 29.2 t -130.35 117.53 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.241 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -91.51 116.97 29.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.409 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -89.88 107.08 18.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.916 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.81 113.28 26.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.435 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.419 ' HA3' ' OH ' ' C' ' 137' ' ' TYR . . . -144.42 167.01 27.11 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.898 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.689 ' CG ' ' O ' ' C' ' 146' ' ' GLY . 30.3 tt0 -155.64 135.21 12.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.926 0.393 . . . . 0.0 110.318 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.928 HG12 ' O ' ' C' ' 144' ' ' THR . 66.2 t -96.54 138.35 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.304 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.57 HG21 HE21 ' C' ' 36' ' ' GLN . 2.7 m -140.78 -173.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 111.056 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . 0.471 ' HA ' HG22 ' C' ' 39' ' ' THR . 1.0 OUTLIER -80.12 173.48 12.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.074 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' C' ' 38' ' ' ARG . . . -85.82 39.71 0.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . . . -114.28 -33.53 5.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.434 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.894 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.9 OUTLIER -161.13 150.03 16.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.965 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.68 112.02 4.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.079 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.647 ' HA ' ' HA ' ' B' ' 58' ' ' LEU . 3.1 p -59.94 153.37 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.029 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.73 152.8 28.18 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.628 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.42 81.03 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.296 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.84 15.68 62.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.03 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.94 -21.35 11.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.937 0.398 . . . . 0.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 89.3 t -44.65 -64.82 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.316 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.26 135.71 38.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.958 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.06 128.73 19.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.061 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.74 111.81 23.82 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.029 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.484 HG21 HG13 ' A' ' 10' ' ' VAL . 4.2 t -110.85 114.76 48.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.074 0.464 . . . . 0.0 110.489 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.78 124.42 46.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.681 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.609 HD21 HG21 ' B' ' 101' ' ' VAL . 0.9 OUTLIER -82.4 -45.67 14.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.647 179.484 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.33 -161.88 12.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.572 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.601 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 1.8 mt-30 -99.87 129.68 45.99 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.619 0.247 . . . . 0.0 110.865 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.504 HG11 ' HA ' ' A' ' 16' ' ' VAL . 11.9 p -110.01 147.43 14.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.99 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.512 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -86.67 131.23 34.2 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.015 0.436 . . . . 0.0 111.786 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' B' ' 143' ' ' ALA . 4.8 t -54.18 -45.05 72.04 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.721 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.36 89.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.146 0.498 . . . . 0.0 110.933 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' B' ' 38' ' ' ARG . 0.4 OUTLIER -70.52 -23.22 62.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.169 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.695 HD22 ' HB3' ' B' ' 137' ' ' TYR . 1.4 mp -124.55 51.63 1.59 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.639 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.6 29.92 7.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.356 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.85 128.41 48.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.348 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.612 ' HA ' ' O ' ' B' ' 140' ' ' THR . 29.3 tt0 -52.95 103.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.815 0.34 . . . . 0.0 111.093 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.409 ' HA2' ' HE1' ' B' ' 138' ' ' PHE . . . 96.02 38.93 4.45 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.137 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.0 146.66 31.91 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.64 125.0 19.03 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.918 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 32.4 m -101.89 -166.28 1.28 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.604 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.99 133.02 55.7 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.871 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' B' ' 136' ' ' ARG . . . -92.67 120.21 32.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.264 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.48 HG22 ' O ' ' B' ' 135' ' ' ALA . 18.5 m -65.77 162.69 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.939 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.9 124.11 5.26 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.648 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . 0.588 ' HE2' ' HB1' ' B' ' 135' ' ' ALA . 53.9 p90 -155.87 146.64 22.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.719 0.295 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.702 ' HB2' HG21 ' B' ' 130' ' ' THR . 3.3 p30 -136.91 160.25 39.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.515 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.521 HG22 HD11 ' B' ' 58' ' ' LEU . 1.6 tp -100.71 117.0 45.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.516 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . 0.537 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -70.05 124.6 24.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.731 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.664 HD23 ' HB3' ' B' ' 21' ' ' CYS . 1.6 mp -133.82 87.5 2.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.184 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.556 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 4.9 p30 -73.63 174.57 8.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 57.72 79.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.811 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' CYS . . . . . 0.894 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 93.6 m -127.57 159.41 34.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.859 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . 0.431 ' O ' ' HG ' ' B' ' 124' ' ' LEU . 5.5 t70 -130.27 167.1 19.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.295 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.31 -41.71 3.44 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.51 -22.63 65.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.086 0.469 . . . . 0.0 111.723 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 82.4 t -70.44 -74.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.608 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.544 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . . . -120.67 131.3 54.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.665 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.22 -48.59 6.12 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.936 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . 0.601 ' HE3' ' HB3' ' B' ' 121' ' ' GLU . 0.1 OUTLIER -96.23 161.48 13.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.595 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.05 124.72 6.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.584 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.44 155.02 18.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.069 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.587 HG13 HD11 ' B' ' 131' ' ' ILE . 2.3 t -132.73 148.34 31.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.673 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.63 150.1 35.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.698 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.541 ' CB ' HD11 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -119.98 137.05 54.3 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.549 0.214 . . . . 0.0 111.055 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.517 HD11 ' CE ' ' B' ' 155' ' ' LYS . 0.9 OUTLIER -96.06 139.52 32.12 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.892 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . 0.407 ' CA ' ' HB3' ' B' ' 113' ' ' LEU . . . 178.45 179.82 48.44 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.807 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.552 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.3 OUTLIER -110.92 156.47 21.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.493 0.187 . . . . 0.0 110.848 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . 0.457 ' HB1' ' HA ' ' B' ' 83' ' ' THR . . . -73.83 131.35 41.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.029 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.645 ' CG2' ' HB ' ' B' ' 85' ' ' VAL . 0.9 OUTLIER -67.74 -41.37 85.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.823 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.15 40.65 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.81 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.544 ' HB2' ' HA2' ' E' ' 108' ' ' GLY . . . 66.49 -80.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.68 -24.99 42.19 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.725 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.06 64.03 1.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.451 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' THR . . . . . 0.699 HG23 ' HD2' ' E' ' 106' ' ' ARG . 0.2 OUTLIER -68.43 -16.9 64.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.567 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . 0.675 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 18.0 p-10 -70.44 -20.18 62.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.339 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.645 ' HB ' ' CG2' ' B' ' 78' ' ' ILE . 14.7 t -106.92 130.77 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.126 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . 0.548 HD21 ' H ' ' B' ' 76' ' ' THR . 0.5 OUTLIER -67.68 148.19 51.67 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.6 -167.58 1.9 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.736 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.619 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 1.5 mm? -78.22 157.26 29.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -78.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.356 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' SER . . . . . 0.577 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 0.4 OUTLIER -167.08 0.51 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.972 0.415 . . . . 0.0 111.459 179.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' SER . . . . . 0.599 ' HA ' ' HB3' ' D' ' 25' ' ' ALA . 1.7 m -71.95 83.03 0.94 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.746 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.69 ' HB1' ' HB3' ' E' ' 34' ' ' LEU . . . -66.62 -13.98 61.83 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.921 0.391 . . . . 0.0 111.749 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.69 27.59 5.21 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.567 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' B' ' 147' ' ' ALA . . . -166.69 15.63 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.899 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' SER . . . . . 0.619 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . 3.0 m -100.88 -172.85 2.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.842 0.353 . . . . 0.0 110.604 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.88 167.6 9.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.849 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.492 ' H ' ' HB ' ' B' ' 144' ' ' THR . 2.3 m -121.51 128.38 52.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.341 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . 0.415 ' HB3' ' H ' ' B' ' 141' ' ' GLY . 75.9 m-20 64.24 34.5 10.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.415 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . 0.463 ' C ' HD11 ' B' ' 78' ' ' ILE . 0.5 OUTLIER -139.92 136.46 38.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.744 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.08 -156.88 8.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.524 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . 0.609 HG21 HD21 ' B' ' 34' ' ' LEU . 3.2 p -137.8 116.71 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 123.011 0.525 . . . . 0.0 111.665 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.557 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 1.2 tt0 -91.94 150.39 21.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.847 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.55 HD13 ' HB3' ' B' ' 111' ' ' LEU . 0.5 OUTLIER -113.81 131.31 66.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.505 179.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 0.3 OUTLIER -106.26 130.17 54.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.733 0.302 . . . . 0.0 111.025 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . 0.533 ' HB3' HG23 ' B' ' 107' ' ' THR . 5.1 t0 -76.12 156.97 33.33 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.703 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . 0.721 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 3.4 ttp180 -71.2 -17.55 62.52 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 111.085 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' THR . . . . . 0.533 HG23 ' HB3' ' B' ' 105' ' ' ASP . 6.2 t -67.19 -18.02 65.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.071 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.73 -45.6 1.17 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.784 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.11 163.07 23.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.691 0.281 . . . . 0.0 111.172 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -84.13 127.4 33.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.577 HD21 ' HZ ' ' B' ' 133' ' ' PHE . 12.1 tp -86.28 156.12 20.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.323 0.582 . . . . 0.0 110.595 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 0.5 OUTLIER -106.25 139.16 41.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.167 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.421 ' HG ' HG12 ' B' ' 103' ' ' ILE . 1.0 OUTLIER -73.92 76.49 1.66 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.707 0.289 . . . . 0.0 110.718 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.45 -17.2 14.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.519 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -51.79 1.24 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.642 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.95 18.83 21.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.933 0.397 . . . . 0.0 111.604 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.84 84.71 7.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 95.7 m-85 -101.41 98.76 9.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.772 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 38.2 m -130.83 62.34 1.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.989 0.423 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.28 145.85 30.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.658 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.601 ' HB3' ' HE3' ' B' ' 68' ' ' LYS . 3.5 mm-40 -121.35 71.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.217 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.67 134.79 34.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.74 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 15.2 m -83.86 113.67 21.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.7 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.645 HD13 ' SG ' ' B' ' 21' ' ' CYS . 18.9 tp -73.98 142.92 45.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.649 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.55 162.13 35.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.53 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.8 113.13 12.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.65 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.59 -139.92 9.48 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.711 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 6.6 m -101.72 96.85 7.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.688 0.28 . . . . 0.0 110.8 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -83.67 148.61 27.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.898 0.38 . . . . 0.0 111.019 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.702 HG21 ' HB2' ' B' ' 55' ' ' ASN . 0.2 OUTLIER -138.65 143.32 39.18 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.16 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' ILE . . . . . 0.587 HD11 HG13 ' B' ' 71' ' ' VAL . 54.9 mt -104.51 112.34 65.35 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' PRO . . . . . 0.721 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.95 142.05 12.25 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.697 1.598 . . . . 0.0 112.503 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.577 ' HZ ' HD21 ' B' ' 111' ' ' LEU . 0.3 OUTLIER -150.68 141.12 22.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.851 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -104.48 152.63 22.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.107 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.588 ' HB1' ' HE2' ' B' ' 54' ' ' PHE . . . -153.57 101.09 2.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.949 0.404 . . . . 0.0 111.586 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . 0.561 ' HB3' ' HA ' ' B' ' 51' ' ' ALA . 17.5 ptt180 -107.19 177.28 4.9 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.436 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . 0.695 ' HB3' HD22 ' B' ' 42' ' ' LEU . 4.7 m-85 -85.96 124.08 32.02 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.019 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . 0.495 ' HB3' HG11 ' B' ' 85' ' ' VAL . 1.2 t80 -118.85 112.45 19.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.972 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.677 ' HB3' HD21 ' B' ' 42' ' ' LEU . . . -102.99 133.97 47.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.842 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 0.1 OUTLIER -81.11 -28.89 35.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.506 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . 0.415 ' H ' ' HB3' ' B' ' 98' ' ' ASN . . . -160.17 -111.07 0.28 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.894 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.91 110.54 21.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.502 0.191 . . . . 0.0 110.712 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' ALA . . . . . 0.471 ' O ' ' OG1' ' B' ' 39' ' ' THR . . . -65.57 134.22 52.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.781 0.325 . . . . 0.0 111.45 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.938 ' O ' HG12 ' A' ' 16' ' ' VAL . 57.2 m -105.81 149.46 38.01 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.309 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.493 ' CD ' ' CG2' ' B' ' 144' ' ' THR . 1.4 Cg_endo -82.95 125.47 4.16 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.592 2.195 . . . . 0.0 112.011 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . 0.675 ' O ' ' CG ' ' A' ' 15' ' ' GLU . . . 168.83 -126.3 1.37 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.423 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' B' ' 94' ' ' GLY . . . -111.12 128.45 55.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.817 0.342 . . . . 0.0 111.296 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.45 52.12 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.188 0.518 . . . . 0.0 110.474 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.74 151.92 20.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.607 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' B' ' 86' ' ' LEU . . . -158.23 169.51 24.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.982 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.9 128.69 41.06 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.289 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -122.25 144.07 49.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.153 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.425 ' HB ' ' HZ1' ' B' ' 155' ' ' LYS . 0.6 OUTLIER -106.36 145.32 31.83 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -96.88 134.63 39.96 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.095 0.474 . . . . 0.0 110.052 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . 0.517 ' CE ' HD11 ' B' ' 74' ' ' LEU . 9.9 mmtt -124.17 148.03 47.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.944 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' VAL . . . . . 0.511 HG11 ' HA3' ' A' ' 7' ' ' GLY . 30.0 m -135.04 144.85 33.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.81 0.338 . . . . 0.0 111.757 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.674 ' HG3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -134.5 126.14 28.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.215 0.531 . . . . 0.0 110.386 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' TYR . . . . . 0.568 ' C ' ' HG3' ' B' ' 159' ' ' GLN . 5.2 m-85 -106.05 128.77 54.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.494 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . 0.568 ' HG3' ' C ' ' B' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.898 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.284 0.088 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.66 77.09 0.19 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.007 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 10.9 m -117.39 119.31 34.71 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.394 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 4' ' ' THR . . . . . 0.668 HG22 ' HG3' ' D' ' 157' ' ' GLN . 4.0 m -98.36 127.2 44.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.538 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.14 170.99 4.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.574 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.05 114.75 23.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.611 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' GLY . . . . . 0.505 ' HA3' HG11 ' D' ' 156' ' ' VAL . . . -69.75 -57.64 7.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.801 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.56 -144.59 4.08 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.892 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -155.75 140.45 17.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.863 0.363 . . . . 0.0 111.396 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . 0.479 HG13 HG21 ' D' ' 32' ' ' VAL . 29.5 t -130.28 117.49 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.212 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.59 117.09 29.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.392 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -89.88 107.02 18.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.911 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.71 113.29 26.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.454 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . 0.424 ' HA3' ' OH ' ' D' ' 137' ' ' TYR . . . -144.37 167.0 27.09 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.889 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' GLU . . . . . 0.676 ' CG ' ' O ' ' D' ' 146' ' ' GLY . 30.2 tt0 -155.73 135.18 12.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.975 0.417 . . . . 0.0 110.343 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.941 HG12 ' O ' ' D' ' 144' ' ' THR . 66.5 t -96.53 138.35 21.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.317 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.562 HG21 HE21 ' D' ' 36' ' ' GLN . 2.6 m -140.85 -173.37 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 0.0 110.996 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . 0.481 ' HA ' HG22 ' D' ' 39' ' ' THR . 1.0 OUTLIER -80.09 173.46 12.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.967 -179.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . 0.528 ' HA ' ' HB3' ' D' ' 38' ' ' ARG . . . -85.8 39.74 0.82 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.089 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' C' ' 66' ' ' ALA . . . -114.24 -33.68 5.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.382 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' CYS . . . . . 0.902 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.9 OUTLIER -161.12 149.96 16.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.979 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.57 112.12 4.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.061 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . 0.641 ' HA ' ' HA ' ' C' ' 58' ' ' LEU . 3.1 p -59.97 153.4 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.04 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.76 152.83 28.12 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.624 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 91' ' ' SER . . . -57.58 -41.38 81.0 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.365 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.88 15.7 62.12 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.992 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.96 -21.39 11.14 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.927 0.394 . . . . 0.0 110.805 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 89.8 t -44.6 -64.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.334 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.26 135.61 38.94 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.913 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.0 128.8 19.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.043 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.71 111.71 23.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.111 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.472 HG21 HG13 ' B' ' 10' ' ' VAL . 4.2 t -110.74 114.79 48.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.103 0.478 . . . . 0.0 110.464 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.81 124.49 46.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.665 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.601 HD21 HG21 ' C' ' 101' ' ' VAL . 0.9 OUTLIER -82.5 -45.7 14.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.603 179.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.32 -161.83 12.84 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.612 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . 0.608 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 1.8 mt-30 -99.85 129.7 45.97 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.557 0.218 . . . . 0.0 110.873 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . 0.501 HG11 ' HA ' ' B' ' 16' ' ' VAL . 11.9 p -110.04 147.44 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.914 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' ARG . . . . . 0.522 ' HB3' ' HA ' ' B' ' 19' ' ' ALA . 0.7 OUTLIER -86.72 131.26 34.19 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.997 0.427 . . . . 0.0 111.804 179.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.471 HG22 ' HA ' ' B' ' 18' ' ' ASN . 4.8 t -54.12 -45.12 71.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.693 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.02 -39.36 89.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.114 0.483 . . . . 0.0 110.856 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' C' ' 38' ' ' ARG . 0.4 OUTLIER -70.63 -23.1 62.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.17 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' C' ' 139' ' ' ALA . 1.4 mp -124.61 51.58 1.6 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.583 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.66 29.95 7.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.326 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.84 128.45 48.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.32 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' C' ' 140' ' ' THR . 29.3 tt0 -53.0 102.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.114 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . 0.404 ' HA2' ' HE1' ' C' ' 138' ' ' PHE . . . 96.06 39.03 4.41 Favored Glycine 0 C--N 1.331 0.255 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.114 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.08 146.7 31.77 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.66 125.09 19.11 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.876 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 31.9 m -102.01 -166.27 1.27 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.625 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.96 133.03 55.71 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.836 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' C' ' 136' ' ' ARG . . . -92.74 120.21 32.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.299 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . 0.49 HG22 ' O ' ' C' ' 135' ' ' ALA . 18.4 m -65.76 162.63 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.974 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.86 124.15 5.28 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.609 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . 0.598 ' HE2' ' HB1' ' C' ' 135' ' ' ALA . 54.0 p90 -155.93 146.56 21.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.713 0.292 . . . . 0.0 110.932 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.692 ' HB2' HG21 ' C' ' 130' ' ' THR . 3.3 p30 -136.8 160.27 39.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.54 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.53 HG22 HD11 ' C' ' 58' ' ' LEU . 1.6 tp -100.68 116.95 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.502 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.519 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.0 OUTLIER -70.09 124.56 24.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.763 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . 0.672 HD23 ' HB3' ' C' ' 21' ' ' CYS . 1.6 mp -133.68 87.42 2.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.231 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . 0.559 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 4.9 p30 -73.67 174.54 8.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.918 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.8 79.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' CYS . . . . . 0.902 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 93.2 m -127.62 159.39 34.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.836 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . 0.433 ' O ' ' HG ' ' C' ' 124' ' ' LEU . 5.5 t70 -130.22 167.07 19.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.354 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.24 -41.75 3.44 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.5 -22.61 65.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.018 0.437 . . . . 0.0 111.714 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 81.4 t -70.4 -74.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.626 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . 0.54 ' HB2' ' HB3' ' C' ' 20' ' ' ALA . . . -120.71 131.34 54.49 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.656 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.19 -48.63 6.11 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.81 0.338 . . . . 0.0 110.924 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' LYS . . . . . 0.602 ' HE3' ' HB3' ' C' ' 121' ' ' GLU . 0.1 OUTLIER -96.22 161.54 13.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.561 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.1 124.66 6.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.608 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.44 154.98 18.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.054 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . 0.591 HG13 HD11 ' C' ' 131' ' ' ILE . 2.3 t -132.72 148.3 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.713 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.62 150.15 35.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.66 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' PHE . . . . . 0.522 ' CB ' HD11 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -119.95 137.0 54.31 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.077 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.52 HD11 ' CE ' ' C' ' 155' ' ' LYS . 0.9 OUTLIER -96.08 139.52 32.14 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.874 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' C' ' 113' ' ' LEU . . . 178.51 179.85 48.49 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.764 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' THR . . . . . 0.559 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.3 OUTLIER -110.94 156.42 21.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.545 0.212 . . . . 0.0 110.848 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' C' ' 83' ' ' THR . . . -73.76 131.26 41.39 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.365 -0.38 . . . . 0.0 112.023 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . 0.645 ' CG2' ' HB ' ' C' ' 85' ' ' VAL . 0.9 OUTLIER -67.69 -41.37 85.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.865 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.18 40.84 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.8 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . 0.539 ' HB2' ' HA2' ' F' ' 108' ' ' GLY . . . 66.35 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.027 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.66 -24.95 41.86 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.723 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.12 64.04 1.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.953 0.406 . . . . 0.0 110.469 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' THR . . . . . 0.699 HG23 ' HD2' ' F' ' 106' ' ' ARG . 0.2 OUTLIER -68.44 -16.99 64.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.53 -179.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' ASN . . . . . 0.688 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 18.0 p-10 -70.35 -20.28 62.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.361 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.645 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 14.7 t -106.91 130.75 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.158 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.536 HD21 ' H ' ' C' ' 76' ' ' THR . 0.5 OUTLIER -67.56 148.19 51.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.64 -167.49 1.87 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.764 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.623 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 1.5 mm? -78.37 157.29 29.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.114 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -78.34 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.345 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' SER . . . . . 0.566 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 0.5 OUTLIER -167.1 0.53 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.018 0.437 . . . . 0.0 111.48 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' SER . . . . . 0.594 ' HA ' ' HB3' ' E' ' 25' ' ' ALA . 1.7 m -71.92 83.02 0.93 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' ALA . . . . . 0.69 ' HB1' ' HB3' ' F' ' 34' ' ' LEU . . . -66.77 -13.88 61.95 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.879 0.371 . . . . 0.0 111.688 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.67 27.54 5.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.638 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' C' ' 147' ' ' ALA . . . -166.65 15.63 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.973 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' SER . . . . . 0.623 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 3.0 m -100.85 -172.84 2.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.766 0.317 . . . . 0.0 110.627 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.91 167.65 9.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' THR . . . . . 0.486 ' H ' ' HB ' ' C' ' 144' ' ' THR . 2.3 m -121.57 128.43 51.98 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.295 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . 0.419 ' HB3' ' H ' ' C' ' 141' ' ' GLY . 75.9 m-20 64.14 34.48 11.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.498 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 99' ' ' VAL . . . . . 0.464 ' C ' HD11 ' C' ' 78' ' ' ILE . 0.5 OUTLIER -139.87 136.6 38.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.709 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.19 -156.91 8.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.498 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' VAL . . . . . 0.601 HG21 HD21 ' C' ' 34' ' ' LEU . 3.2 p -137.81 116.77 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 122.951 0.5 . . . . 0.0 111.644 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 102' ' ' GLN . . . . . 0.571 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 1.1 tt0 -91.91 150.36 21.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.873 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' C' ' 111' ' ' LEU . 0.5 OUTLIER -113.76 131.31 65.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.601 179.415 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 0.3 OUTLIER -106.24 130.19 54.15 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.664 0.269 . . . . 0.0 111.054 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . 0.54 ' HB3' HG23 ' C' ' 107' ' ' THR . 5.1 t0 -76.2 157.0 33.12 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.694 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 106' ' ' ARG . . . . . 0.723 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 3.5 ttp180 -71.24 -17.44 62.5 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.763 0.316 . . . . 0.0 111.101 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 107' ' ' THR . . . . . 0.54 HG23 ' HB3' ' C' ' 105' ' ' ASP . 6.2 t -67.27 -17.99 65.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.069 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.75 -45.62 1.17 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.766 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.14 163.11 23.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.727 0.298 . . . . 0.0 111.159 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -84.15 127.39 33.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 111' ' ' LEU . . . . . 0.57 HD21 ' HZ ' ' C' ' 133' ' ' PHE . 12.1 tp -86.22 156.02 20.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.304 0.573 . . . . 0.0 110.638 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 112' ' ' THR . . . . . 0.688 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 0.5 OUTLIER -106.14 139.17 41.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.151 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.421 ' HB3' ' HA3' ' C' ' 75' ' ' GLY . 1.0 OUTLIER -73.91 76.43 1.65 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.679 0.276 . . . . 0.0 110.706 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.41 -17.17 14.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.558 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.27 -51.75 1.25 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.648 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.03 18.84 21.66 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.941 0.4 . . . . 0.0 111.554 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.8 84.6 7.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.057 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 118' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' C' ' 71' ' ' VAL . 95.7 m-85 -101.38 98.77 9.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.795 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 38.7 m -130.79 62.28 1.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.25 145.86 30.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.715 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . 0.602 ' HB3' ' HE3' ' C' ' 68' ' ' LYS . 3.5 mm-40 -121.39 71.25 0.95 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.217 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.69 134.77 34.75 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.703 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 14.8 m -83.79 113.66 21.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.776 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . 0.647 HD13 ' SG ' ' C' ' 21' ' ' CYS . 18.9 tp -74.0 142.9 45.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.657 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.57 162.1 35.41 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.573 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.73 113.2 12.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.7 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.48 -139.91 9.5 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.734 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 128' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 6.7 m -101.69 96.76 7.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.698 0.285 . . . . 0.0 110.773 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.59 148.48 27.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.895 0.379 . . . . 0.0 111.093 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 130' ' ' THR . . . . . 0.692 HG21 ' HB2' ' C' ' 55' ' ' ASN . 0.2 OUTLIER -138.55 143.43 39.45 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.207 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 131' ' ' ILE . . . . . 0.591 HD11 HG13 ' C' ' 71' ' ' VAL . 55.1 mt -104.62 112.41 65.34 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 132' ' ' PRO . . . . . 0.723 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.5 Cg_endo -81.95 141.98 12.2 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.719 1.612 . . . . 0.0 112.526 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.57 ' HZ ' HD21 ' C' ' 111' ' ' LEU . 0.3 OUTLIER -150.63 141.06 22.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.85 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.49 152.53 22.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.131 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . 0.598 ' HB1' ' HE2' ' C' ' 54' ' ' PHE . . . -153.52 101.08 2.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.98 0.419 . . . . 0.0 111.6 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . 0.56 ' HB3' ' HA ' ' C' ' 51' ' ' ALA . 17.5 ptt180 -107.18 177.2 4.92 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.42 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 137' ' ' TYR . . . . . 0.679 ' HB3' HD22 ' C' ' 42' ' ' LEU . 4.7 m-85 -85.93 124.15 32.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.008 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 138' ' ' PHE . . . . . 0.478 ' HB3' HG11 ' C' ' 85' ' ' VAL . 1.2 t80 -118.9 112.38 19.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.959 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 139' ' ' ALA . . . . . 0.69 ' HB3' HD21 ' C' ' 42' ' ' LEU . . . -102.97 133.95 47.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.873 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 140' ' ' THR . . . . . 0.608 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 0.1 OUTLIER -81.1 -28.9 35.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.529 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' C' ' 98' ' ' ASN . . . -160.15 -111.06 0.28 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.926 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.85 110.56 21.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.537 0.208 . . . . 0.0 110.766 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 143' ' ' ALA . . . . . 0.449 ' O ' ' OG1' ' C' ' 39' ' ' THR . . . -65.65 134.29 52.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.83 0.348 . . . . 0.0 111.343 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 144' ' ' THR . . . . . 0.928 ' O ' HG12 ' B' ' 16' ' ' VAL . 56.4 m -105.82 149.39 37.93 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.346 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 145' ' ' PRO . . . . . 0.49 ' CD ' ' CG2' ' C' ' 144' ' ' THR . 1.4 Cg_endo -82.91 125.54 4.2 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.497 2.131 . . . . 0.0 112.023 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 146' ' ' GLY . . . . . 0.689 ' O ' ' CG ' ' B' ' 15' ' ' GLU . . . 168.78 -126.33 1.38 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.407 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 147' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' C' ' 94' ' ' GLY . . . -111.07 128.43 55.87 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.758 0.313 . . . . 0.0 111.317 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.41 52.15 1.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.15 0.5 . . . . 0.0 110.492 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -98.78 151.93 20.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.597 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 150' ' ' ALA . . . . . 0.446 ' HB2' HD11 ' C' ' 86' ' ' LEU . . . -158.28 169.6 24.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.009 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -130.98 128.63 40.8 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.291 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 152' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -122.21 144.06 49.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.228 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 153' ' ' THR . . . . . 0.428 ' HB ' ' HZ1' ' C' ' 155' ' ' LYS . 0.6 OUTLIER -106.37 145.34 31.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -96.9 134.67 39.93 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.068 0.461 . . . . 0.0 110.019 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 155' ' ' LYS . . . . . 0.52 ' CE ' HD11 ' C' ' 74' ' ' LEU . 9.9 mmtt -124.15 148.14 47.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.895 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 156' ' ' VAL . . . . . 0.505 HG11 ' HA3' ' B' ' 7' ' ' GLY . 29.9 m -135.15 144.77 33.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.742 0.306 . . . . 0.0 111.791 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 157' ' ' GLN . . . . . 0.667 ' HG3' HG22 ' B' ' 4' ' ' THR . 0.0 OUTLIER -134.46 126.06 28.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.273 0.559 . . . . 0.0 110.399 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 158' ' ' TYR . . . . . 0.562 ' C ' ' HG3' ' C' ' 159' ' ' GLN . 5.2 m-85 -106.02 128.75 54.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.502 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . 0.562 ' HG3' ' C ' ' C' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 111.142 0.053 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.64 77.12 0.19 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.172 0.295 . . . . 0.0 110.983 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 3' ' ' THR . . . . . . . . . . . . . 10.9 m -117.41 119.32 34.75 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.387 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 4' ' ' THR . . . . . 0.675 HG22 ' HG3' ' E' ' 157' ' ' GLN . 4.0 m -98.37 127.21 44.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.535 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.1 171.03 4.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.601 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -86.02 114.61 23.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.599 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 7' ' ' GLY . . . . . 0.509 ' HA3' HG11 ' E' ' 156' ' ' VAL . . . -69.61 -57.71 7.05 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.813 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.59 -144.61 4.08 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.87 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -155.7 140.46 17.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 111.371 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' VAL . . . . . 0.473 HG13 HG21 ' E' ' 32' ' ' VAL . 30.1 t -130.34 117.48 39.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.294 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.5 116.98 29.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.349 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -89.86 107.08 18.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.883 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.75 113.32 26.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.451 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' GLY . . . . . 0.425 ' HA3' ' OH ' ' E' ' 137' ' ' TYR . . . -144.42 166.98 27.12 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.919 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' GLU . . . . . 0.676 ' CG ' ' O ' ' E' ' 146' ' ' GLY . 30.2 tt0 -155.68 135.2 12.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.966 0.412 . . . . 0.0 110.32 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.932 HG12 ' O ' ' E' ' 144' ' ' THR . 65.8 t -96.53 138.36 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.275 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . 0.569 HG21 HE21 ' E' ' 36' ' ' GLN . 2.7 m -140.85 -173.38 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.872 0.368 . . . . 0.0 111.002 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' ASN . . . . . 0.469 ' HA ' HG22 ' E' ' 39' ' ' THR . 1.0 OUTLIER -80.08 173.41 12.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.075 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' ALA . . . . . 0.518 ' HA ' ' HB3' ' E' ' 38' ' ' ARG . . . -85.82 39.76 0.82 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.041 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' D' ' 66' ' ' ALA . . . -114.31 -33.46 5.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.459 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' CYS . . . . . 0.887 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.9 OUTLIER -161.18 149.98 16.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.935 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.64 112.09 4.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.102 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . 0.641 ' HA ' ' HA ' ' D' ' 58' ' ' LEU . 3.0 p -59.93 153.34 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.082 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.68 152.75 28.27 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.686 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' B' ' 91' ' ' SER . . . -57.53 -41.46 80.93 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.357 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.81 15.7 62.06 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.968 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.95 -21.35 11.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.914 0.387 . . . . 0.0 110.814 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 90.1 t -44.58 -64.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.364 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.29 135.69 38.85 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.885 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.04 128.77 19.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.044 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.83 111.83 23.85 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.014 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . 0.479 HG21 HG13 ' C' ' 10' ' ' VAL . 4.2 t -110.82 114.81 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.139 0.495 . . . . 0.0 110.519 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.75 124.45 46.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.649 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.679 ' HB3' ' HB1' ' A' ' 92' ' ' ALA . 0.9 OUTLIER -82.49 -45.74 14.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.574 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.37 -161.86 12.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.571 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' GLN . . . . . 0.594 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 1.8 mt-30 -99.83 129.69 45.95 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.648 0.261 . . . . 0.0 110.881 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' C' ' 16' ' ' VAL . 12.0 p -110.02 147.44 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.995 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . 0.528 ' HB3' ' HA ' ' C' ' 19' ' ' ALA . 0.7 OUTLIER -86.78 131.29 34.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.053 0.454 . . . . 0.0 111.69 179.301 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.481 HG22 ' HA ' ' C' ' 18' ' ' ASN . 4.8 t -54.09 -45.13 71.71 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.753 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.93 -39.37 89.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.137 0.494 . . . . 0.0 110.939 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' D' ' 38' ' ' ARG . 0.4 OUTLIER -70.62 -23.15 62.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.134 -179.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.672 HD22 ' HB3' ' D' ' 137' ' ' TYR . 1.4 mp -124.59 51.57 1.6 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.669 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.59 29.9 7.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.38 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.84 128.46 48.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.33 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . 0.606 ' HA ' ' O ' ' D' ' 140' ' ' THR . 29.5 tt0 -52.95 103.05 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.871 0.367 . . . . 0.0 111.117 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . 0.407 ' HA2' ' HE1' ' D' ' 138' ' ' PHE . . . 95.94 39.03 4.44 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.193 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.98 146.66 31.92 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.63 124.97 19.01 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.973 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 32.3 m -101.9 -166.31 1.28 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.626 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.04 132.99 55.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.848 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' D' ' 136' ' ' ARG . . . -92.64 120.24 32.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.321 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 90' ' ' SER . 18.5 m -65.84 162.66 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.905 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.8 124.14 5.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.649 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . 0.589 ' HE2' ' HB1' ' D' ' 135' ' ' ALA . 54.0 p90 -155.93 146.55 21.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.705 0.288 . . . . 0.0 110.942 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' ASN . . . . . 0.701 ' HB2' HG21 ' D' ' 130' ' ' THR . 3.4 p30 -136.84 160.24 39.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.529 HG22 ' O ' ' D' ' 56' ' ' ILE . 1.6 tp -100.63 117.02 45.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.536 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' GLN . . . . . 0.535 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.0 OUTLIER -70.12 124.58 24.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.736 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . 0.674 HD23 ' HB3' ' D' ' 21' ' ' CYS . 1.6 mp -133.77 87.54 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.181 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . 0.563 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 4.9 p30 -73.65 174.61 8.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.006 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.81 79.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.815 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' CYS . . . . . 0.887 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 93.6 m -127.58 159.4 34.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.862 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . 0.427 ' O ' ' HG ' ' D' ' 124' ' ' LEU . 5.5 t70 -130.24 167.11 18.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.28 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.35 -41.66 3.44 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.47 -22.71 65.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.063 0.459 . . . . 0.0 111.723 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 81.5 t -70.38 -74.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.635 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' D' ' 20' ' ' ALA . . . -120.76 131.33 54.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.634 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.21 -48.54 6.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.857 0.361 . . . . 0.0 110.981 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' LYS . . . . . 0.599 ' HE3' ' HB3' ' D' ' 121' ' ' GLU . 0.1 OUTLIER -96.25 161.54 13.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.555 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.09 124.63 6.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.642 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.32 155.0 18.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.098 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . 0.587 HG13 HD11 ' D' ' 131' ' ' ILE . 2.3 t -132.75 148.22 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.745 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.57 150.18 35.93 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.59 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 73' ' ' PHE . . . . . 0.543 ' CB ' HD11 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -119.99 136.96 54.35 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.053 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 74' ' ' LEU . . . . . 0.516 HD11 ' CE ' ' D' ' 155' ' ' LYS . 0.9 OUTLIER -96.05 139.54 32.08 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.937 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' D' ' 113' ' ' LEU . . . 178.53 179.83 48.5 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.745 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 76' ' ' THR . . . . . 0.537 ' H ' HD21 ' D' ' 86' ' ' LEU . 0.3 OUTLIER -111.0 156.39 21.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.534 0.207 . . . . 0.0 110.832 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' D' ' 83' ' ' THR . . . -73.78 131.3 41.41 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.04 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 78' ' ' ILE . . . . . 0.641 ' CG2' ' HB ' ' D' ' 85' ' ' VAL . 0.9 OUTLIER -67.72 -41.3 85.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.874 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . 0.407 ' O ' ' HB1' ' D' ' 80' ' ' ALA . 0.6 OUTLIER -141.17 40.75 1.78 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.808 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' D' ' 79' ' ' ASP . . . 66.44 -80.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.7 -24.96 42.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.688 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -99.1 64.04 1.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.448 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 83' ' ' THR . . . . . 0.449 ' HA ' ' HB1' ' D' ' 77' ' ' ALA . 0.2 OUTLIER -68.5 -16.86 64.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.584 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . 0.681 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 18.0 p-10 -70.36 -20.3 62.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.359 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.641 ' HB ' ' CG2' ' D' ' 78' ' ' ILE . 14.7 t -106.87 130.74 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.136 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.537 HD21 ' H ' ' D' ' 76' ' ' THR . 0.5 OUTLIER -67.66 148.18 51.69 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.62 -167.54 1.89 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 111.713 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.625 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 1.5 mm? -78.32 157.23 29.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.094 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -78.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.418 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.18 0.6 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.971 0.415 . . . . 0.0 111.483 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 91' ' ' SER . . . . . 0.599 ' HA ' ' HB3' ' F' ' 25' ' ' ALA . 1.7 m -71.91 82.94 0.93 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.65 -13.96 61.84 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.917 0.389 . . . . 0.0 111.749 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.61 27.61 5.23 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.581 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 94' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' D' ' 147' ' ' ALA . . . -166.67 15.6 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.946 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 95' ' ' SER . . . . . 0.625 ' HB3' ' HG ' ' D' ' 88' ' ' LEU . 3.0 m -100.9 -172.81 2.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.715 0.293 . . . . 0.0 110.635 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.86 167.62 9.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 97' ' ' THR . . . . . 0.488 ' H ' ' HB ' ' D' ' 144' ' ' THR . 2.3 m -121.51 128.36 51.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.34 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 98' ' ' ASN . . . . . 0.413 ' HB3' ' H ' ' D' ' 141' ' ' GLY . 76.0 m-20 64.28 34.44 10.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.468 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 99' ' ' VAL . . . . . 0.463 ' C ' HD11 ' D' ' 78' ' ' ILE . 0.5 OUTLIER -139.92 136.46 38.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.738 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.08 -156.92 8.36 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.523 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 101' ' ' VAL . . . . . 0.577 HG21 HD21 ' D' ' 34' ' ' LEU . 3.2 p -137.8 116.8 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.132 0.491 . . . . 0.0 111.647 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 102' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 1.2 tt0 -91.86 150.35 21.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.847 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 103' ' ' ILE . . . . . 0.543 HD11 ' CB ' ' D' ' 73' ' ' PHE . 0.5 OUTLIER -113.85 131.34 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.494 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 104' ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 0.3 OUTLIER -106.29 130.16 54.19 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.68 0.276 . . . . 0.0 110.958 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . 0.539 ' HB3' HG23 ' D' ' 107' ' ' THR . 5.1 t0 -76.14 156.99 33.28 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.679 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 106' ' ' ARG . . . . . 0.75 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 3.5 ttp180 -71.19 -17.55 62.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.738 0.304 . . . . 0.0 111.078 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 107' ' ' THR . . . . . 0.539 HG23 ' HB3' ' D' ' 105' ' ' ASP . 6.2 t -67.17 -18.07 65.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.021 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 108' ' ' GLY . . . . . 0.547 ' HA2' ' HB2' ' A' ' 80' ' ' ALA . . . 123.7 -45.57 1.17 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.74 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.07 163.05 23.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.7 0.286 . . . . 0.0 111.154 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -84.13 127.41 33.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.08 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 111' ' ' LEU . . . . . 0.558 HD21 ' HZ ' ' D' ' 133' ' ' PHE . 12.1 tp -86.24 156.11 20.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.258 0.551 . . . . 0.0 110.633 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 112' ' ' THR . . . . . 0.681 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 0.5 OUTLIER -106.23 139.15 41.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.123 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 113' ' ' LEU . . . . . 0.428 ' HG ' HG12 ' D' ' 103' ' ' ILE . 1.0 OUTLIER -74.03 76.55 1.71 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.755 0.312 . . . . 0.0 110.742 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.54 -17.09 14.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.516 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.23 -51.86 1.25 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.664 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.99 18.86 21.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.858 0.361 . . . . 0.0 111.509 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.81 84.64 7.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.079 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' D' ' 71' ' ' VAL . 95.7 m-85 -101.37 98.77 9.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.759 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 38.1 m -130.77 62.33 1.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.28 145.74 30.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.735 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . 0.599 ' HB3' ' HE3' ' D' ' 68' ' ' LYS . 3.5 mm-40 -121.25 71.3 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.179 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 134.78 34.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.684 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 15.1 m -83.82 113.7 21.11 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.701 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . 0.65 HD13 ' SG ' ' D' ' 21' ' ' CYS . 19.0 tp -74.08 142.96 45.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.772 0.32 . . . . 0.0 110.61 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.53 162.12 35.32 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.59 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.8 113.18 12.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.684 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.54 -140.02 9.57 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.688 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 128' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 6.6 m -101.66 96.87 7.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 110.773 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.65 148.54 27.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.843 0.354 . . . . 0.0 111.097 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 130' ' ' THR . . . . . 0.701 HG21 ' HB2' ' D' ' 55' ' ' ASN . 0.2 OUTLIER -138.61 143.4 39.31 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.123 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 131' ' ' ILE . . . . . 0.587 HD11 HG13 ' D' ' 71' ' ' VAL . 55.1 mt -104.57 112.36 65.34 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 132' ' ' PRO . . . . . 0.75 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.4 Cg_endo -82.01 141.98 12.13 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.675 1.583 . . . . 0.0 112.458 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . 0.558 ' HZ ' HD21 ' D' ' 111' ' ' LEU . 0.3 OUTLIER -150.61 141.12 22.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.897 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.48 152.55 22.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.097 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . 0.589 ' HB1' ' HE2' ' D' ' 54' ' ' PHE . . . -153.53 101.08 2.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.954 0.407 . . . . 0.0 111.578 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 136' ' ' ARG . . . . . 0.558 ' HB3' ' HA ' ' D' ' 51' ' ' ALA . 17.5 ptt180 -107.18 177.19 4.92 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.379 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 137' ' ' TYR . . . . . 0.672 ' HB3' HD22 ' D' ' 42' ' ' LEU . 4.7 m-85 -85.92 124.04 31.94 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.089 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 138' ' ' PHE . . . . . 0.496 ' HB3' HG11 ' D' ' 85' ' ' VAL . 1.2 t80 -118.8 112.39 19.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.991 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 139' ' ' ALA . . . . . 0.666 ' HB3' HD21 ' D' ' 42' ' ' LEU . . . -102.97 134.0 47.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.828 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 140' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 0.1 OUTLIER -81.12 -28.86 34.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.507 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . 0.413 ' H ' ' HB3' ' D' ' 98' ' ' ASN . . . -160.19 -111.09 0.28 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.917 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.88 110.57 21.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.549 0.214 . . . . 0.0 110.744 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 143' ' ' ALA . . . . . 0.469 ' O ' ' OG1' ' D' ' 39' ' ' THR . . . -65.69 134.27 52.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 111.341 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 144' ' ' THR . . . . . 0.941 ' O ' HG12 ' C' ' 16' ' ' VAL . 56.4 m -105.8 149.42 37.96 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.341 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 145' ' ' PRO . . . . . 0.487 ' CD ' ' CG2' ' D' ' 144' ' ' THR . 1.3 Cg_endo -82.96 125.52 4.17 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.519 2.146 . . . . 0.0 112.001 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 146' ' ' GLY . . . . . 0.676 ' O ' ' CG ' ' C' ' 15' ' ' GLU . . . 168.8 -126.37 1.38 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.412 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 147' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' D' ' 94' ' ' GLY . . . -111.1 128.45 55.89 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.813 0.339 . . . . 0.0 111.322 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.46 52.14 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.15 0.5 . . . . 0.0 110.398 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -98.71 152.05 20.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.545 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 150' ' ' ALA . . . . . 0.443 ' HB2' HD11 ' D' ' 86' ' ' LEU . . . -158.38 169.46 24.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.959 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.96 128.67 40.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.256 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 152' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -122.19 144.06 49.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.251 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 153' ' ' THR . . . . . 0.422 ' HB ' ' HZ1' ' D' ' 155' ' ' LYS . 0.6 OUTLIER -106.34 145.34 31.8 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.209 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -96.84 134.67 39.84 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.052 0.454 . . . . 0.0 110.121 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 155' ' ' LYS . . . . . 0.516 ' CE ' HD11 ' D' ' 74' ' ' LEU . 9.9 mmtt -124.24 148.07 47.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.854 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 156' ' ' VAL . . . . . 0.505 HG11 ' HA3' ' C' ' 7' ' ' GLY . 29.7 m -135.06 144.83 33.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.783 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 157' ' ' GLN . . . . . 0.668 ' HG3' HG22 ' C' ' 4' ' ' THR . 0.0 OUTLIER -134.51 126.06 28.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.283 0.563 . . . . 0.0 110.36 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 158' ' ' TYR . . . . . 0.565 ' C ' ' HG3' ' D' ' 159' ' ' GLN . 5.2 m-85 -106.02 128.77 54.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.474 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 159' ' ' GLN . . . . . 0.565 ' HG3' ' C ' ' D' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 111.169 0.062 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.7 77.1 0.19 Allowed 'General case' 0 N--CA 1.462 0.146 0 O-C-N 123.1 0.25 . . . . 0.0 110.989 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 3' ' ' THR . . . . . . . . . . . . . 10.7 m -117.36 119.24 34.52 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.472 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 4' ' ' THR . . . . . 0.684 HG22 ' HG3' ' F' ' 157' ' ' GLN . 3.9 m -98.34 127.2 44.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.575 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.11 171.02 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.592 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -86.05 114.73 23.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.573 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 7' ' ' GLY . . . . . 0.511 ' HA3' HG11 ' F' ' 156' ' ' VAL . . . -69.67 -57.75 6.98 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.923 -0.655 . . . . 0.0 112.829 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.52 -144.6 4.08 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.901 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -155.73 140.46 17.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.855 0.36 . . . . 0.0 111.385 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 10' ' ' VAL . . . . . 0.483 HG13 HG21 ' F' ' 32' ' ' VAL . 30.0 t -130.31 117.45 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.238 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.5 117.0 29.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.435 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -89.79 107.11 18.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.84 113.26 26.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.449 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 14' ' ' GLY . . . . . 0.411 ' HA3' ' OH ' ' F' ' 137' ' ' TYR . . . -144.41 166.98 27.11 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.933 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 15' ' ' GLU . . . . . 0.685 ' CG ' ' O ' ' F' ' 146' ' ' GLY . 30.2 tt0 -155.7 135.17 12.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.985 0.421 . . . . 0.0 110.294 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 16' ' ' VAL . . . . . 0.944 HG12 ' O ' ' F' ' 144' ' ' THR . 66.1 t -96.48 138.31 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.264 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . 0.574 HG21 HE21 ' F' ' 36' ' ' GLN . 2.7 m -140.81 -173.34 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 111.06 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . 0.469 ' HA ' HG22 ' F' ' 39' ' ' THR . 1.0 OUTLIER -80.13 173.41 12.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.052 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 19' ' ' ALA . . . . . 0.517 ' HA ' ' HB3' ' F' ' 38' ' ' ARG . . . -85.73 39.73 0.81 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' E' ' 66' ' ' ALA . . . -114.34 -33.54 5.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.424 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 21' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.9 OUTLIER -161.13 150.01 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.933 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.6 112.1 4.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.02 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 23' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' E' ' 58' ' ' LEU . 3.1 p -60.02 153.41 4.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.989 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.76 152.81 28.12 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.665 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . 0.594 ' HB3' ' HA ' ' C' ' 91' ' ' SER . . . -57.5 -41.48 80.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.351 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.77 15.65 62.11 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.032 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -113.05 -21.2 11.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.902 0.382 . . . . 0.0 110.809 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -44.65 -64.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.298 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.23 135.69 38.8 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.957 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.02 128.78 19.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.059 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.78 111.79 23.82 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.058 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . 0.473 HG21 HG13 ' D' ' 10' ' ' VAL . 4.2 t -110.81 114.74 47.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.479 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.68 124.55 46.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.703 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.69 ' HB3' ' HB1' ' B' ' 92' ' ' ALA . 0.9 OUTLIER -82.54 -45.62 14.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.661 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.31 -161.86 12.83 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.583 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 36' ' ' GLN . . . . . 0.596 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 1.8 mt-30 -99.83 129.68 45.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.604 0.24 . . . . 0.0 110.862 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . 0.494 HG11 ' HA ' ' D' ' 16' ' ' VAL . 11.8 p -110.11 147.5 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.924 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . 0.518 ' HB3' ' HA ' ' D' ' 19' ' ' ALA . 0.7 OUTLIER -86.77 131.24 34.18 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.974 0.416 . . . . 0.0 111.765 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 39' ' ' THR . . . . . 0.469 HG22 ' HA ' ' D' ' 18' ' ' ASN . 4.8 t -54.08 -45.09 71.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.772 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.35 89.4 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.052 0.453 . . . . 0.0 110.854 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 41' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' E' ' 38' ' ' ARG . 0.4 OUTLIER -70.62 -23.16 62.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.178 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.694 HD22 ' HB3' ' E' ' 137' ' ' TYR . 1.4 mp -124.55 51.61 1.59 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.616 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.69 30.02 7.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.383 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.85 128.45 48.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.294 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' E' ' 140' ' ' THR . 29.5 tt0 -52.97 102.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.899 0.38 . . . . 0.0 111.139 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . 0.417 ' HA2' ' HE1' ' E' ' 138' ' ' PHE . . . 96.05 39.02 4.42 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.098 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.08 146.77 31.74 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.68 125.0 18.97 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.957 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 32.1 m -101.93 -166.31 1.28 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.589 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.99 133.04 55.72 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 51' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' E' ' 136' ' ' ARG . . . -92.7 120.21 32.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.237 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 52' ' ' VAL . . . . . 0.577 ' HB ' ' HA ' ' B' ' 90' ' ' SER . 18.5 m -65.78 162.69 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.86 124.08 5.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.688 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 54' ' ' PHE . . . . . 0.588 ' HE2' ' HB1' ' E' ' 135' ' ' ALA . 53.7 p90 -155.92 146.54 21.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.713 0.292 . . . . 0.0 110.951 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 55' ' ' ASN . . . . . 0.7 ' HB2' HG21 ' E' ' 130' ' ' THR . 3.4 p30 -136.79 160.31 39.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.529 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 56' ' ' ILE . . . . . 0.526 HG22 ' O ' ' E' ' 56' ' ' ILE . 1.6 tp -100.69 116.94 45.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.563 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 57' ' ' GLN . . . . . 0.541 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.0 OUTLIER -70.0 124.64 24.57 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.766 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . 0.668 HD23 ' HB3' ' E' ' 21' ' ' CYS . 1.6 mp -133.79 87.49 2.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.204 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . 0.554 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 4.9 p30 -73.62 174.56 8.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.98 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.86 79.3 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.734 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 61' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 93.4 m -127.62 159.44 34.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.88 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . 0.431 ' O ' ' HG ' ' E' ' 124' ' ' LEU . 5.6 t70 -130.3 167.1 19.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.226 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.26 -41.73 3.44 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.49 -22.64 65.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.013 0.435 . . . . 0.0 111.725 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 83.1 t -70.43 -74.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.593 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 66' ' ' ALA . . . . . 0.548 ' HB2' ' HB3' ' E' ' 20' ' ' ALA . . . -120.73 131.39 54.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.603 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.18 -48.6 6.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.956 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 68' ' ' LYS . . . . . 0.598 ' HE3' ' HB3' ' E' ' 121' ' ' GLU . 0.1 OUTLIER -96.23 161.51 13.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.09 124.67 6.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.633 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.39 154.98 18.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.098 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . 0.566 HG13 HD11 ' E' ' 131' ' ' ILE . 2.3 t -132.72 148.28 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.715 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.57 150.2 35.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.61 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 73' ' ' PHE . . . . . 0.541 ' CB ' HD11 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -119.98 136.97 54.34 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 121.214 -0.195 . . . . 0.0 111.051 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 74' ' ' LEU . . . . . 0.514 HD11 ' CE ' ' E' ' 155' ' ' LYS . 0.9 OUTLIER -95.95 139.48 32.08 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.956 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' E' ' 113' ' ' LEU . . . 178.5 179.84 48.48 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.797 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 76' ' ' THR . . . . . 0.543 ' H ' HD21 ' E' ' 86' ' ' LEU . 0.3 OUTLIER -110.98 156.37 21.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.449 0.166 . . . . 0.0 110.839 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 77' ' ' ALA . . . . . 0.46 ' HB1' ' HA ' ' E' ' 83' ' ' THR . . . -73.75 131.25 41.38 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.03 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 78' ' ' ILE . . . . . 0.643 ' CG2' ' HB ' ' E' ' 85' ' ' VAL . 0.9 OUTLIER -67.61 -41.48 85.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.831 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 79' ' ' ASP . . . . . 0.41 ' O ' ' HB1' ' E' ' 80' ' ' ALA . 0.6 OUTLIER -141.13 40.78 1.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' E' ' 79' ' ' ASP . . . 66.49 -80.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.003 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.73 -24.91 42.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.659 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -99.12 64.02 1.36 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 0.0 110.511 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 83' ' ' THR . . . . . 0.46 ' HA ' ' HB1' ' E' ' 77' ' ' ALA . 0.2 OUTLIER -68.48 -16.86 64.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.528 -179.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 84' ' ' ASN . . . . . 0.67 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 18.0 p-10 -70.41 -20.22 62.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.385 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.643 ' HB ' ' CG2' ' E' ' 78' ' ' ILE . 14.7 t -106.87 130.73 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.18 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 86' ' ' LEU . . . . . 0.543 HD21 ' H ' ' E' ' 76' ' ' THR . 0.5 OUTLIER -67.65 148.2 51.67 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.59 -167.52 1.88 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.846 0.355 . . . . 0.0 111.77 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.622 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 1.5 mm? -78.28 157.31 29.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -78.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.34 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.09 0.53 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.016 0.436 . . . . 0.0 111.462 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 91' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' E' ' 95' ' ' SER . 1.7 m -71.84 82.9 0.91 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.68 -13.92 61.85 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.872 0.368 . . . . 0.0 111.725 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.62 27.55 5.24 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.683 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 94' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' E' ' 147' ' ' ALA . . . -166.69 15.66 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.909 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 95' ' ' SER . . . . . 0.622 ' HB3' ' HG ' ' E' ' 88' ' ' LEU . 3.0 m -100.94 -172.8 2.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.782 0.325 . . . . 0.0 110.587 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.91 167.7 9.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.818 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 97' ' ' THR . . . . . 0.498 ' H ' ' HB ' ' E' ' 144' ' ' THR . 2.3 m -121.56 128.46 52.03 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.338 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 98' ' ' ASN . . . . . 0.413 ' HB3' ' H ' ' E' ' 141' ' ' GLY . 75.9 m-20 64.13 34.59 10.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.432 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 99' ' ' VAL . . . . . 0.46 ' C ' HD11 ' E' ' 78' ' ' ILE . 0.5 OUTLIER -139.96 136.44 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.745 179.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.12 -156.94 8.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.536 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 101' ' ' VAL . . . . . 0.602 HG21 HD21 ' E' ' 34' ' ' LEU . 3.2 p -137.76 116.69 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 122.971 0.508 . . . . 0.0 111.653 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 102' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 1.2 tt0 -91.86 150.37 21.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.943 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 103' ' ' ILE . . . . . 0.548 HD13 ' HB3' ' E' ' 111' ' ' LEU . 0.5 OUTLIER -113.81 131.35 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.535 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 104' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 0.3 OUTLIER -106.22 130.14 54.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.673 0.273 . . . . 0.0 110.997 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . 0.532 ' HB3' HG23 ' E' ' 107' ' ' THR . 5.1 t0 -76.11 156.99 33.33 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.739 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 106' ' ' ARG . . . . . 0.729 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 3.5 ttp180 -71.22 -17.51 62.5 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.795 0.331 . . . . 0.0 111.087 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 107' ' ' THR . . . . . 0.532 HG23 ' HB3' ' E' ' 105' ' ' ASP . 6.2 t -67.3 -17.94 64.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.997 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 108' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' B' ' 80' ' ' ALA . . . 123.73 -45.59 1.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.804 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.1 163.09 23.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.76 0.314 . . . . 0.0 111.12 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 110' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -84.14 127.37 33.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.064 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 111' ' ' LEU . . . . . 0.57 HD21 ' HZ ' ' E' ' 133' ' ' PHE . 12.1 tp -86.29 156.07 20.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.29 0.567 . . . . 0.0 110.596 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 112' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 0.5 OUTLIER -106.21 139.14 41.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.157 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 113' ' ' LEU . . . . . 0.427 ' HG ' HG12 ' E' ' 103' ' ' ILE . 1.0 OUTLIER -73.93 76.48 1.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 110.765 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.48 -17.17 14.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.511 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -51.8 1.24 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.638 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.95 18.77 21.75 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.929 0.395 . . . . 0.0 111.599 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.73 84.61 7.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 118' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' E' ' 71' ' ' VAL . 95.7 m-85 -101.39 98.77 9.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.795 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 39.2 m -130.84 62.46 1.61 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.3 145.82 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.704 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 121' ' ' GLU . . . . . 0.598 ' HB3' ' HE3' ' E' ' 68' ' ' LYS . 3.5 mm-40 -121.37 71.28 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.212 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.74 134.86 34.73 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.752 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 14.8 m -83.83 113.72 21.14 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.749 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . 0.646 HD13 ' SG ' ' E' ' 21' ' ' CYS . 18.9 tp -74.07 143.0 45.63 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.708 0.289 . . . . 0.0 110.619 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.61 162.03 35.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.624 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.72 113.24 12.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.675 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 127' ' ' GLY . . . . . 0.413 ' CA ' HG21 ' A' ' 4' ' ' THR . . . 142.49 -139.94 9.52 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.73 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 128' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 6.6 m -101.69 96.8 7.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.677 0.275 . . . . 0.0 110.755 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.64 148.49 27.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.897 0.379 . . . . 0.0 111.185 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 130' ' ' THR . . . . . 0.7 HG21 ' HB2' ' E' ' 55' ' ' ASN . 0.2 OUTLIER -138.55 143.46 39.46 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.081 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 131' ' ' ILE . . . . . 0.566 HD11 HG13 ' E' ' 71' ' ' VAL . 54.9 mt -104.57 112.3 65.33 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 132' ' ' PRO . . . . . 0.729 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.5 Cg_endo -81.93 141.93 12.21 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.737 1.624 . . . . 0.0 112.502 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 133' ' ' PHE . . . . . 0.57 ' HZ ' HD21 ' E' ' 111' ' ' LEU . 0.3 OUTLIER -150.59 141.1 22.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.829 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.52 152.6 22.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.111 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 135' ' ' ALA . . . . . 0.588 ' HB1' ' HE2' ' E' ' 54' ' ' PHE . . . -153.57 101.06 2.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 111.602 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 136' ' ' ARG . . . . . 0.562 ' HB3' ' HA ' ' E' ' 51' ' ' ALA . 17.4 ptt180 -107.18 177.24 4.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.408 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 137' ' ' TYR . . . . . 0.694 ' HB3' HD22 ' E' ' 42' ' ' LEU . 4.7 m-85 -85.98 124.12 32.08 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.027 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 138' ' ' PHE . . . . . 0.496 ' HB3' HG11 ' E' ' 85' ' ' VAL . 1.2 t80 -118.87 112.36 19.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.048 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 139' ' ' ALA . . . . . 0.673 ' HB3' HD21 ' E' ' 42' ' ' LEU . . . -102.93 133.94 47.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.882 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 140' ' ' THR . . . . . 0.607 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 0.1 OUTLIER -81.04 -28.92 35.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.553 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . 0.413 ' H ' ' HB3' ' E' ' 98' ' ' ASN . . . -160.21 -111.01 0.28 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.88 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.92 110.6 21.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.547 0.213 . . . . 0.0 110.703 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 143' ' ' ALA . . . . . 0.465 ' O ' ' OG1' ' E' ' 39' ' ' THR . . . -65.68 134.27 52.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 0.0 111.368 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 144' ' ' THR . . . . . 0.932 ' O ' HG12 ' D' ' 16' ' ' VAL . 56.9 m -105.87 149.43 38.01 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.304 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 145' ' ' PRO . . . . . 0.485 ' CD ' ' CG2' ' E' ' 144' ' ' THR . 1.4 Cg_endo -82.91 125.47 4.18 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.542 2.161 . . . . 0.0 112.028 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 146' ' ' GLY . . . . . 0.676 ' O ' ' CG ' ' D' ' 15' ' ' GLU . . . 168.79 -126.32 1.37 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.456 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 147' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' E' ' 94' ' ' GLY . . . -111.13 128.42 55.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.812 0.339 . . . . 0.0 111.294 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.45 52.15 1.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.115 0.483 . . . . 0.0 110.412 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.75 152.0 20.16 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.611 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 150' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' E' ' 86' ' ' LEU . . . -158.29 169.56 24.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.946 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.99 128.64 40.8 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.258 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 152' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -122.17 144.08 49.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.269 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 153' ' ' THR . . . . . 0.43 ' HB ' ' HZ1' ' E' ' 155' ' ' LYS . 0.6 OUTLIER -106.34 145.34 31.81 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.182 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -96.9 134.69 39.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.077 0.465 . . . . 0.0 110.069 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 155' ' ' LYS . . . . . 0.514 ' CE ' HD11 ' E' ' 74' ' ' LEU . 9.9 mmtt -124.22 148.08 47.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.863 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 156' ' ' VAL . . . . . 0.509 HG11 ' HA3' ' D' ' 7' ' ' GLY . 29.9 m -135.15 144.79 33.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.82 0.343 . . . . 0.0 111.685 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 157' ' ' GLN . . . . . 0.675 ' HG3' HG22 ' D' ' 4' ' ' THR . 0.0 OUTLIER -134.49 126.11 28.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.223 0.535 . . . . 0.0 110.362 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 158' ' ' TYR . . . . . 0.568 ' C ' ' HG3' ' E' ' 159' ' ' GLN . 5.2 m-85 -106.01 128.71 54.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.525 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 159' ' ' GLN . . . . . 0.568 ' HG3' ' C ' ' E' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.914 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 120.296 0.093 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.69 77.11 0.19 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.979 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 10.7 m -117.4 119.27 34.57 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.372 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 4.0 m -98.39 127.21 44.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.503 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.1 171.0 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.629 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.07 114.75 23.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.163 0.506 . . . . 0.0 110.602 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.79 -57.6 7.03 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.786 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.62 -144.64 4.1 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.884 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -155.7 140.41 17.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.872 0.367 . . . . 0.0 111.375 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 29.7 t -130.26 117.52 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.274 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.51 117.03 29.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.423 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -89.89 107.05 18.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.826 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.76 113.3 26.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.491 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -144.41 166.98 27.11 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.916 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -155.65 135.26 12.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.975 0.417 . . . . 0.0 110.341 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 16' ' ' VAL . . . . . 0.447 HG13 ' N ' ' F' ' 17' ' ' VAL . 66.0 t -96.63 138.3 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.248 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 17' ' ' VAL . . . . . 0.447 ' N ' HG13 ' F' ' 16' ' ' VAL . 2.6 m -140.8 -173.3 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 0.0 111.008 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.15 173.42 12.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.094 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.76 39.74 0.81 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.064 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' F' ' 66' ' ' ALA . . . -114.29 -33.57 5.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.445 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 21' ' ' CYS . . . . . 0.901 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.9 OUTLIER -161.18 150.04 16.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.971 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.69 112.08 4.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.105 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 23' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' F' ' 58' ' ' LEU . 3.1 p -59.97 153.34 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.01 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.72 152.8 28.19 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.647 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' D' ' 91' ' ' SER . . . -57.52 -41.55 81.11 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.292 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.72 15.72 61.91 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.984 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.98 -21.36 11.15 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.967 0.413 . . . . 0.0 110.848 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 90.1 t -44.55 -64.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.357 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.29 135.6 38.97 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.976 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.0 128.74 19.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.82 111.85 23.86 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.152 -0.477 . . . . 0.0 112.048 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . 0.483 HG21 HG13 ' E' ' 10' ' ' VAL . 4.2 t -110.88 114.7 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.168 0.508 . . . . 0.0 110.506 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.67 124.51 46.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.643 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 34' ' ' LEU . . . . . 0.69 ' HB3' ' HB1' ' C' ' 92' ' ' ALA . 0.9 OUTLIER -82.54 -45.65 14.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.578 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.31 -161.95 12.8 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.618 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 36' ' ' GLN . . . . . 0.601 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 1.8 mt-30 -99.79 129.65 45.92 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.622 0.248 . . . . 0.0 110.922 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.497 HG11 ' HA ' ' E' ' 16' ' ' VAL . 11.8 p -109.98 147.5 14.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.954 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 38' ' ' ARG . . . . . 0.517 ' HB3' ' HA ' ' E' ' 19' ' ' ALA . 0.7 OUTLIER -86.79 131.19 34.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.0 0.429 . . . . 0.0 111.8 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 39' ' ' THR . . . . . 0.469 HG22 ' HA ' ' E' ' 18' ' ' ASN . 4.8 t -54.03 -45.16 71.5 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.758 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.92 -39.39 89.2 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.078 0.466 . . . . 0.0 110.943 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 41' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' F' ' 38' ' ' ARG . 0.4 OUTLIER -70.54 -23.22 62.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.157 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' F' ' 139' ' ' ALA . 1.4 mp -124.59 51.54 1.6 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.651 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.6 30.0 7.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.43 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.86 128.49 48.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.308 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . 0.614 ' HA ' ' O ' ' F' ' 140' ' ' THR . 29.2 tt0 -53.05 103.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 111.072 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . 0.404 ' HA2' ' HE1' ' F' ' 138' ' ' PHE . . . 96.01 39.05 4.42 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.101 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.14 146.68 31.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.64 125.1 19.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.897 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 49' ' ' SER . . . . . . . . . . . . . 32.5 m -101.98 -166.29 1.28 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.614 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.98 133.06 55.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.869 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 51' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' F' ' 136' ' ' ARG . . . -92.72 120.18 32.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.726 0.298 . . . . 0.0 111.246 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 52' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' C' ' 90' ' ' SER . 18.6 m -65.85 162.67 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.888 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.83 124.07 5.26 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.635 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 54' ' ' PHE . . . . . 0.596 ' HE2' ' HB1' ' F' ' 135' ' ' ALA . 54.1 p90 -155.86 146.56 22.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.643 0.258 . . . . 0.0 111.027 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 55' ' ' ASN . . . . . 0.693 ' HB2' HG21 ' F' ' 130' ' ' THR . 3.3 p30 -136.87 160.26 39.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.528 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 56' ' ' ILE . . . . . 0.53 HG22 HD11 ' F' ' 58' ' ' LEU . 1.6 tp -100.65 116.91 45.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.555 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 57' ' ' GLN . . . . . 0.521 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.0 OUTLIER -70.04 124.61 24.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.76 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . 0.672 HD23 ' HB3' ' F' ' 21' ' ' CYS . 1.6 mp -133.77 87.48 2.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.216 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 59' ' ' ASN . . . . . 0.559 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 4.9 p30 -73.69 174.57 8.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.931 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.82 79.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.763 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 61' ' ' CYS . . . . . 0.901 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 93.2 m -127.66 159.43 34.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.817 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . 0.422 ' O ' ' HG ' ' F' ' 124' ' ' LEU . 5.5 t70 -130.27 167.07 19.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.288 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.24 -41.7 3.45 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.57 -22.63 65.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.989 0.423 . . . . 0.0 111.694 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 82.8 t -70.4 -74.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.657 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 66' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' F' ' 20' ' ' ALA . . . -120.75 131.34 54.45 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.629 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.24 -48.62 6.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.907 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 68' ' ' LYS . . . . . 0.6 ' HE3' ' HB3' ' F' ' 121' ' ' GLU . 0.1 OUTLIER -96.2 161.51 13.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.617 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.09 124.72 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.641 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.46 154.97 18.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.061 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 71' ' ' VAL . . . . . 0.587 HG13 HD11 ' F' ' 131' ' ' ILE . 2.3 t -132.73 148.33 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.69 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.6 150.15 35.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.644 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 73' ' ' PHE . . . . . 0.52 ' CB ' HD11 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -119.91 137.02 54.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.488 0.185 . . . . 0.0 111.059 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 74' ' ' LEU . . . . . 0.527 HD11 ' CE ' ' F' ' 155' ' ' LYS . 0.9 OUTLIER -96.14 139.5 32.21 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.918 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' F' ' 113' ' ' LEU . . . 178.54 179.81 48.49 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.833 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 76' ' ' THR . . . . . 0.543 ' H ' HD21 ' F' ' 86' ' ' LEU . 0.3 OUTLIER -110.9 156.42 21.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.507 0.194 . . . . 0.0 110.856 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 77' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' F' ' 83' ' ' THR . . . -73.81 131.26 41.35 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 78' ' ' ILE . . . . . 0.639 ' CG2' ' HB ' ' F' ' 85' ' ' VAL . 0.9 OUTLIER -67.69 -41.45 85.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.799 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.12 40.77 1.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.773 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 66.45 -80.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.996 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.65 -24.99 41.92 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.696 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.01 63.93 1.37 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.851 0.358 . . . . 0.0 110.455 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 83' ' ' THR . . . . . 0.446 ' HA ' ' HB1' ' F' ' 77' ' ' ALA . 0.2 OUTLIER -68.5 -16.79 64.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.535 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 84' ' ' ASN . . . . . 0.688 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 18.0 p-10 -70.42 -20.25 62.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.329 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 85' ' ' VAL . . . . . 0.639 ' HB ' ' CG2' ' F' ' 78' ' ' ILE . 14.6 t -106.92 130.7 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.165 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 86' ' ' LEU . . . . . 0.543 HD21 ' H ' ' F' ' 76' ' ' THR . 0.5 OUTLIER -67.61 148.21 51.71 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.65 -167.47 1.87 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.87 0.367 . . . . 0.0 111.732 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . 0.621 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 1.5 mm? -78.34 157.22 29.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.054 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.61 -78.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.345 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.05 0.47 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.021 0.438 . . . . 0.0 111.469 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 91' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' F' ' 95' ' ' SER . 1.7 m -71.82 82.93 0.91 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.66 -13.95 61.87 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.863 0.364 . . . . 0.0 111.688 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.64 27.61 5.23 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.632 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 94' ' ' GLY . . . . . 0.553 ' O ' ' HB3' ' F' ' 147' ' ' ALA . . . -166.63 15.59 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.487 -0.864 . . . . 0.0 112.928 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 95' ' ' SER . . . . . 0.621 ' HB3' ' HG ' ' F' ' 88' ' ' LEU . 3.0 m -100.86 -172.82 2.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.713 0.292 . . . . 0.0 110.639 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.89 167.66 9.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.788 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 97' ' ' THR . . . . . 0.486 ' H ' ' HB ' ' F' ' 144' ' ' THR . 2.3 m -121.59 128.3 51.82 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.343 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 98' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' F' ' 141' ' ' GLY . 75.9 m-20 64.27 34.56 10.65 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.415 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 99' ' ' VAL . . . . . 0.46 ' C ' HD11 ' F' ' 78' ' ' ILE . 0.5 OUTLIER -139.99 136.5 38.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.683 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.13 -156.87 8.34 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.577 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 101' ' ' VAL . . . . . 0.601 HG21 HD21 ' F' ' 34' ' ' LEU . 3.2 p -137.77 116.72 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 122.973 0.509 . . . . 0.0 111.616 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 102' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 1.2 tt0 -91.93 150.43 21.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 103' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' F' ' 111' ' ' LEU . 0.5 OUTLIER -113.87 131.32 66.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.542 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 104' ' ' LEU . . . . . 0.519 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 0.3 OUTLIER -106.29 130.1 54.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.645 0.259 . . . . 0.0 111.014 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . 0.537 ' HB3' HG23 ' F' ' 107' ' ' THR . 5.1 t0 -76.02 156.97 33.54 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.697 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 106' ' ' ARG . . . . . 0.732 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 3.5 ttp180 -71.31 -17.47 62.45 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.691 0.281 . . . . 0.0 111.061 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 107' ' ' THR . . . . . 0.537 HG23 ' HB3' ' F' ' 105' ' ' ASP . 6.2 t -67.19 -18.03 65.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 108' ' ' GLY . . . . . 0.539 ' HA2' ' HB2' ' C' ' 80' ' ' ALA . . . 123.74 -45.63 1.17 Allowed Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.748 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.09 163.12 23.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.671 0.272 . . . . 0.0 111.181 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 110' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -84.16 127.45 33.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.067 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 111' ' ' LEU . . . . . 0.577 HD21 ' HZ ' ' F' ' 133' ' ' PHE . 12.1 tp -86.28 156.18 20.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.317 0.58 . . . . 0.0 110.614 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 112' ' ' THR . . . . . 0.688 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 0.5 OUTLIER -106.31 139.09 41.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.095 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 113' ' ' LEU . . . . . 0.417 ' HB3' ' HA3' ' F' ' 75' ' ' GLY . 1.0 OUTLIER -73.92 76.49 1.66 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.697 0.284 . . . . 0.0 110.746 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.45 -17.2 14.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.507 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.25 -51.8 1.25 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.647 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.05 18.89 21.57 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.918 0.39 . . . . 0.0 111.52 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.77 84.64 7.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 118' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' F' ' 71' ' ' VAL . 95.7 m-85 -101.42 98.74 9.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.741 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 39.3 m -130.84 62.44 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.802 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.3 145.83 30.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.655 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 121' ' ' GLU . . . . . 0.6 ' HB3' ' HE3' ' F' ' 68' ' ' LYS . 3.5 mm-40 -121.34 71.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.223 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 134.7 34.72 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.738 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 15.2 m -83.81 113.68 21.09 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.739 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . 0.645 HD13 ' SG ' ' F' ' 21' ' ' CYS . 19.0 tp -74.01 142.96 45.75 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.751 0.31 . . . . 0.0 110.589 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.59 162.02 35.63 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.615 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.66 113.12 12.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.718 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 127' ' ' GLY . . . . . 0.418 ' CA ' HG21 ' B' ' 4' ' ' THR . . . 142.55 -139.9 9.48 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.779 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 128' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 6.7 m -101.75 96.78 7.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.726 0.298 . . . . 0.0 110.795 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.61 148.56 27.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.925 0.393 . . . . 0.0 111.112 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 130' ' ' THR . . . . . 0.693 HG21 ' HB2' ' F' ' 55' ' ' ASN . 0.2 OUTLIER -138.57 143.4 39.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.158 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 131' ' ' ILE . . . . . 0.587 HD11 HG13 ' F' ' 71' ' ' VAL . 54.9 mt -104.66 112.45 65.33 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 132' ' ' PRO . . . . . 0.732 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.4 Cg_endo -81.93 141.94 12.22 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.758 1.639 . . . . 0.0 112.492 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 133' ' ' PHE . . . . . 0.577 ' HZ ' HD21 ' F' ' 111' ' ' LEU . 0.3 OUTLIER -150.67 141.1 22.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.845 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -104.48 152.63 22.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.091 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 135' ' ' ALA . . . . . 0.596 ' HB1' ' HE2' ' F' ' 54' ' ' PHE . . . -153.54 101.03 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.931 0.396 . . . . 0.0 111.615 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 136' ' ' ARG . . . . . 0.558 ' HB3' ' HA ' ' F' ' 51' ' ' ALA . 17.4 ptt180 -107.11 177.32 4.89 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.428 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 137' ' ' TYR . . . . . 0.682 ' HB3' HD22 ' F' ' 42' ' ' LEU . 4.6 m-85 -86.02 124.08 32.06 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.979 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 138' ' ' PHE . . . . . 0.48 ' HB3' HG11 ' F' ' 85' ' ' VAL . 1.2 t80 -118.81 112.38 19.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.016 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 139' ' ' ALA . . . . . 0.688 ' HB3' HD21 ' F' ' 42' ' ' LEU . . . -102.95 133.95 47.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.921 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 140' ' ' THR . . . . . 0.614 ' O ' ' HA ' ' F' ' 45' ' ' GLU . 0.1 OUTLIER -81.05 -28.89 35.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.547 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' F' ' 98' ' ' ASN . . . -160.18 -111.11 0.28 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.864 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.78 110.61 21.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.511 0.196 . . . . 0.0 110.784 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 143' ' ' ALA . . . . . 0.463 ' O ' ' OG1' ' F' ' 39' ' ' THR . . . -65.69 134.31 52.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 111.336 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 144' ' ' THR . . . . . 0.944 ' O ' HG12 ' E' ' 16' ' ' VAL . 56.7 m -105.9 149.42 38.01 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.268 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 145' ' ' PRO . . . . . 0.483 ' CD ' ' CG2' ' F' ' 144' ' ' THR . 1.5 Cg_endo -82.84 125.45 4.22 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.541 2.161 . . . . 0.0 112.03 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 146' ' ' GLY . . . . . 0.685 ' O ' ' CG ' ' E' ' 15' ' ' GLU . . . 168.77 -126.32 1.37 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.418 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 147' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' F' ' 94' ' ' GLY . . . -111.05 128.46 55.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.772 0.32 . . . . 0.0 111.355 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.48 52.09 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.162 0.506 . . . . 0.0 110.402 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -98.68 151.94 20.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.627 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 150' ' ' ALA . . . . . 0.445 ' HB2' HD11 ' F' ' 86' ' ' LEU . . . -158.27 169.51 24.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.986 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.93 128.67 40.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.249 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 152' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -122.21 144.04 49.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.233 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 153' ' ' THR . . . . . 0.436 ' HB ' ' HZ1' ' F' ' 155' ' ' LYS . 0.6 OUTLIER -106.3 145.38 31.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -96.98 134.69 40.0 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.107 0.48 . . . . 0.0 110.053 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 155' ' ' LYS . . . . . 0.527 ' CE ' HD11 ' F' ' 74' ' ' LEU . 9.9 mmtt -124.22 148.06 47.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.88 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 156' ' ' VAL . . . . . 0.511 HG11 ' HA3' ' E' ' 7' ' ' GLY . 29.8 m -135.12 144.85 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.818 0.342 . . . . 0.0 111.787 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 157' ' ' GLN . . . . . 0.684 ' HG3' HG22 ' E' ' 4' ' ' THR . 0.0 OUTLIER -134.54 126.04 28.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.304 0.573 . . . . 0.0 110.362 -179.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 158' ' ' TYR . . . . . 0.561 ' C ' ' HG3' ' F' ' 159' ' ' GLN . 5.2 m-85 -106.0 128.73 54.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.559 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 159' ' ' GLN . . . . . 0.561 ' HG3' ' C ' ' F' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.259 -0.876 . . . . 0.0 110.817 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.54 0.209 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' B' ' 157' ' ' GLN . 4.9 m -114.68 127.37 55.72 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.431 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.3 m -117.71 106.76 13.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.704 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.9 174.61 12.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.58 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.1 119.87 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.528 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.27 -49.49 15.47 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.827 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.3 -154.89 11.32 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.866 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 p -142.39 140.01 31.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.949 0.404 . . . . 0.0 111.223 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.69 113.82 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.23 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.08 110.32 20.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.404 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.24 111.56 22.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.75 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.507 ' HE3' HG11 ' A' ' 28' ' ' VAL . 3.6 tmtm? -102.98 110.59 22.56 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.438 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.26 168.33 22.63 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.952 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' B' ' 36' ' ' GLN . 3.6 tt0 -158.98 133.08 7.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.898 0.38 . . . . 0.0 110.417 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.647 HG21 HG12 ' B' ' 99' ' ' VAL . 13.0 t -99.64 143.17 13.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.25 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.568 HG22 ' O ' ' B' ' 37' ' ' VAL . 3.9 m -141.41 -172.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.912 0.387 . . . . 0.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.537 ' HA ' HG22 ' B' ' 39' ' ' THR . 0.6 OUTLIER -89.46 -176.97 5.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.083 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.87 46.94 1.36 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.055 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . . . -127.75 -29.98 2.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.443 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 1.01 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -163.11 158.45 21.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.907 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.39 118.53 2.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.026 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -66.27 153.1 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.025 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.75 158.75 20.64 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.603 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.03 -34.4 74.79 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.347 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.1 12.99 63.72 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.91 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.77 -22.4 10.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.791 0.329 . . . . 0.0 110.77 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.507 HG11 ' HE3' ' A' ' 13' ' ' LYS . 19.6 t -43.93 -64.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.359 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.05 135.83 41.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.968 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.17 125.72 20.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.088 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.76 106.53 18.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.066 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.74 117.06 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.074 0.464 . . . . 0.0 110.418 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.7 131.03 45.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.584 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.77 -47.37 7.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.586 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.41 -163.53 12.16 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.562 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -101.07 126.62 47.77 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.684 0.278 . . . . 0.0 110.833 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.453 HG13 ' CE1' ' A' ' 137' ' ' TYR . 14.9 p -110.42 146.84 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.923 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.406 ' H ' ' HG3' ' A' ' 38' ' ' ARG . 2.8 mtp180 -82.85 139.18 33.62 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.74 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 143' ' ' ALA . 5.4 t -62.79 -37.42 86.6 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.746 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.46 71.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.108 0.48 . . . . 0.0 110.829 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.03 -17.76 45.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.112 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.623 HD21 ' HB3' ' A' ' 139' ' ' ALA . 4.3 mp -125.65 33.1 5.17 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.668 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.74 18.87 18.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.312 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.87 130.3 52.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.431 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 140' ' ' THR . 22.5 tt0 -56.38 107.38 0.37 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.866 0.365 . . . . 0.0 111.016 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.53 30.57 5.84 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.214 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 138' ' ' PHE . . . -76.57 136.65 39.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 112.081 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 52.3 p -134.87 134.73 41.04 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.869 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 70.9 m -108.79 -168.22 1.32 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.637 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.0 t -63.89 128.45 35.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.795 0.331 . . . . 0.0 110.799 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 134' ' ' GLN . . . -80.41 130.0 34.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.436 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.584 HG11 ' O ' ' A' ' 135' ' ' ALA . 2.8 m -74.84 151.22 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.925 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.98 119.22 5.67 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.577 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -153.86 152.09 30.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.729 0.3 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -148.74 162.94 38.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.633 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 56' ' ' ILE . 1.2 tp -105.98 114.82 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.548 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.794 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -70.69 124.53 24.48 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.721 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -132.32 88.81 2.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.203 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -75.31 169.47 18.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.895 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.409 ' CG ' ' HD2' ' B' ' 38' ' ' ARG . 0.4 OUTLIER 66.39 68.23 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.773 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 1.01 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 56.3 m -117.11 155.03 30.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.763 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.595 ' HB2' HH22 ' B' ' 38' ' ' ARG . 20.0 t70 -135.76 155.69 49.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.214 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -111.15 -34.23 6.24 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.141 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.08 -22.13 66.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 0.0 111.755 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.6 -59.54 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.696 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . . . -116.84 129.18 55.92 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.646 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -60.31 2.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.856 0.36 . . . . 0.0 110.964 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HZ1' ' HA ' ' A' ' 123' ' ' THR . 0.2 OUTLIER -105.28 -175.33 2.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.499 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.0 131.36 9.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.52 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.04 151.14 25.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.036 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.619 HG13 HD11 ' A' ' 131' ' ' ILE . 2.0 t -129.46 158.31 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.714 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.563 ' HA ' HD23 ' A' ' 111' ' ' LEU . . . -152.66 143.09 22.62 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.579 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.43 ' HB3' HD23 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -112.32 141.47 46.0 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.683 0.278 . . . . 0.0 111.019 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.575 HD22 HG22 ' D' ' 130' ' ' THR . 0.3 OUTLIER -107.64 139.47 42.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.012 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.75 -179.54 46.85 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.816 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.763 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.3 OUTLIER -103.85 156.35 17.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.634 0.254 . . . . 0.0 110.823 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.34 118.35 21.17 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.93 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' A' ' 82' ' ' HIS . 0.4 OUTLIER -59.03 -29.11 40.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.81 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.74 50.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.805 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.22 -89.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.079 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.07 -32.55 42.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.584 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.564 ' HB3' HG22 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -81.12 62.84 5.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.892 0.377 . . . . 0.0 110.384 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.436 HG23 ' HD2' ' D' ' 106' ' ' ARG . 0.2 OUTLIER -74.63 -18.18 60.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.585 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.692 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 20.4 p-10 -75.91 -7.48 54.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.266 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.483 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 24.1 t -117.7 124.22 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.214 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 150' ' ' ALA . 0.5 OUTLIER -66.19 139.33 58.11 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.278 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 150' ' ' ALA . . . -84.85 -165.42 1.19 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.705 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.758 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 0.7 OUTLIER -71.91 168.67 17.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.963 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.86 -79.24 0.06 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.335 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.767 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 2.4 p -168.84 6.0 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.016 0.436 . . . . 0.0 111.545 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.607 ' O ' ' HB2' ' A' ' 95' ' ' SER . 69.8 m -77.57 83.27 3.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.906 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' D' ' 50' ' ' SER . . . -55.07 -34.65 63.78 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.882 0.373 . . . . 0.0 111.626 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.27 31.51 6.31 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.604 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.641 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -156.59 7.46 0.23 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.919 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.758 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -110.78 -174.32 2.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.921 0.391 . . . . 0.0 110.588 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -97.75 179.07 4.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.968 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.737 ' H ' ' HB ' ' A' ' 144' ' ' THR . 1.1 m -132.31 125.97 32.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.331 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 97' ' ' THR . 66.2 m-20 66.61 25.88 9.87 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.45 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.421 ' C ' HD11 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -127.66 130.4 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.657 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.14 -161.35 10.74 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.508 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.84 131.94 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.096 0.559 . . . . 0.0 111.825 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.71 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 1.5 tt0 -98.48 151.44 20.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.923 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.525 ' N ' ' HG2' ' A' ' 102' ' ' GLN . 0.3 OUTLIER -117.34 128.62 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.542 179.485 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.792 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -103.01 133.51 48.01 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.713 0.292 . . . . 0.0 111.034 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.543 ' HB3' HG23 ' A' ' 107' ' ' THR . 7.1 t0 -87.71 158.39 18.82 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.659 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -70.47 -27.67 64.41 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.78 0.324 . . . . 0.0 111.081 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.543 HG23 ' HB3' ' A' ' 105' ' ' ASP . 2.8 t -51.76 -25.67 8.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.047 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.08 -39.18 1.74 Allowed Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.603 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.33 157.97 17.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 111.032 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.792 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -70.33 137.12 50.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.079 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.563 HD23 ' HA ' ' A' ' 72' ' ' ALA . 13.5 tp -87.54 158.41 18.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.29 0.567 . . . . 0.0 110.555 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -101.74 142.0 33.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.116 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' A' ' 73' ' ' PHE . 1.9 mt -82.41 65.57 7.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.71 0.291 . . . . 0.0 110.702 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.09 -14.93 21.23 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.52 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.25 -54.16 0.7 Allowed Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.596 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.2 28.92 8.27 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.016 0.436 . . . . 0.0 111.651 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.72 76.54 8.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.169 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.586 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 91.6 m-85 -91.01 96.75 10.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.743 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 68.0 m -132.67 78.25 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.7 136.9 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.667 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.01 76.2 0.98 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.275 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.83 135.51 33.68 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.732 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.493 ' HA ' ' HZ1' ' A' ' 68' ' ' LYS . 11.7 m -77.08 96.35 4.42 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.71 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.498 ' HA ' HD12 ' A' ' 124' ' ' LEU . 10.8 tp -68.21 132.95 48.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.567 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.48 ' HA ' ' HG1' ' A' ' 63' ' ' THR . 2.3 m120 -128.46 166.86 17.95 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.582 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -79.45 105.75 10.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.656 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.03 -137.04 5.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.749 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 3.7 m -103.61 83.47 2.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.753 0.311 . . . . 0.0 110.825 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.671 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 1.7 t30 -71.03 139.88 50.6 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.911 0.386 . . . . 0.0 111.158 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.794 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -133.95 139.66 46.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.158 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.619 HD11 HG13 ' A' ' 71' ' ' VAL . 61.7 mt -98.07 110.53 56.29 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -81.8 135.15 8.79 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.777 1.651 . . . . 0.0 112.528 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.72 152.71 41.63 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.791 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.64 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 50.6 mt-30 -119.0 156.85 28.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.067 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.71 ' HA ' ' O ' ' A' ' 102' ' ' GLN . . . -151.39 101.79 2.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.372 . . . . 0.0 111.65 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.6 168.37 9.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.364 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -80.11 123.26 27.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.194 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 1.3 t80 -126.16 119.13 26.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.026 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.623 ' HB3' HD21 ' A' ' 42' ' ' LEU . . . -112.02 125.2 53.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.888 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -68.93 -48.19 63.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.51 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -133.1 -120.0 2.08 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.043 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.42 111.94 18.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.597 0.237 . . . . 0.0 110.68 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -61.89 113.82 3.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.781 0.324 . . . . 0.0 111.447 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.737 ' HB ' ' H ' ' A' ' 97' ' ' THR . 75.1 m -88.31 145.25 35.43 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.32 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.83 134.26 7.2 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.458 2.106 . . . . 0.0 111.987 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.87 -135.59 4.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.553 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.641 ' HB3' ' O ' ' A' ' 94' ' ' GLY . . . -96.21 134.21 39.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.889 0.376 . . . . 0.0 111.301 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.78 50.5 2.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.135 0.493 . . . . 0.0 110.499 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -99.01 146.17 26.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.503 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.552 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -154.99 174.12 15.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.932 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -139.33 128.45 23.82 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.16 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.46 ' HB3' HD12 ' A' ' 86' ' ' LEU . . . -118.4 133.29 56.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.159 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.92 147.41 22.99 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.25 130.28 53.42 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.131 0.491 . . . . 0.0 110.07 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.554 ' HE2' HD11 ' A' ' 74' ' ' LEU . 11.3 mmtt -126.69 143.99 51.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.871 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.4 151.9 34.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.645 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.36 121.12 13.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.263 0.554 . . . . 0.0 110.404 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 21' ' ' CYS . 1.2 m-85 -98.28 121.65 40.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.548 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.822 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 111.188 0.07 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.62 71.07 0.5 Allowed 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.148 0.28 . . . . 0.0 110.93 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' C' ' 157' ' ' GLN . 4.9 m -114.67 127.43 55.76 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.464 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 20.5 m -117.75 106.85 13.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.623 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.0 174.66 12.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.612 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.13 119.89 36.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.501 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.23 -49.55 15.42 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.835 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.28 -154.87 11.3 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.845 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -142.41 140.04 31.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.974 0.416 . . . . 0.0 111.224 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.76 113.82 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.177 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.08 110.3 20.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.365 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -90.18 111.53 22.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.78 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.498 ' HE3' HG11 ' B' ' 28' ' ' VAL . 3.6 tmtm? -102.96 110.52 22.46 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.49 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.19 168.35 22.59 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.0 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' C' ' 36' ' ' GLN . 3.6 tt0 -159.01 133.06 7.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.473 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.645 HG21 HG12 ' C' ' 99' ' ' VAL . 13.1 t -99.62 143.22 13.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.25 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.571 HG22 ' O ' ' C' ' 37' ' ' VAL . 3.9 m -141.48 -172.15 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.838 0.352 . . . . 0.0 110.992 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . 0.549 ' HA ' HG22 ' C' ' 39' ' ' THR . 0.6 OUTLIER -89.43 -177.02 5.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.083 -179.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.77 46.91 1.36 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . . . -127.77 -29.93 2.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.498 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER -163.18 158.41 21.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.94 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.39 118.54 2.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.041 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' B' ' 58' ' ' LEU . 0.8 OUTLIER -66.27 153.05 8.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.018 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.75 158.73 20.65 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.582 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.02 -34.39 74.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.345 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.14 13.07 63.6 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.914 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.81 -22.43 10.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.84 0.353 . . . . 0.0 110.782 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.498 HG11 ' HE3' ' B' ' 13' ' ' LYS . 19.8 t -44.08 -64.21 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.348 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.09 135.85 41.89 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.005 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.15 125.67 20.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.058 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.8 106.54 18.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.058 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.68 117.07 53.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.455 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.71 131.05 45.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.597 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.8 -47.32 7.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.658 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.34 -163.61 12.15 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.561 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.67 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 3.7 mt-30 -100.98 126.6 47.65 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.65 0.262 . . . . 0.0 110.817 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.568 ' O ' HG22 ' A' ' 17' ' ' VAL . 14.9 p -110.4 146.89 15.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.9 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.595 HH22 ' HB2' ' A' ' 62' ' ' ASP . 2.9 mtp180 -82.92 139.17 33.53 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.655 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.537 HG22 ' HA ' ' A' ' 18' ' ' ASN . 5.4 t -62.77 -37.44 86.67 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.778 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.45 71.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.072 0.463 . . . . 0.0 110.818 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.05 -17.75 45.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.171 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.637 HD21 ' HB3' ' B' ' 139' ' ' ALA . 4.3 mp -125.66 33.11 5.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.662 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.74 18.89 18.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.341 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.92 130.26 52.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.387 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' B' ' 140' ' ' THR . 22.5 tt0 -56.27 107.29 0.35 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.832 0.349 . . . . 0.0 111.095 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.52 30.56 5.84 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.195 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' B' ' 138' ' ' PHE . . . -76.6 136.76 39.22 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.986 0.422 . . . . 0.0 112.093 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' B' ' 137' ' ' TYR . 51.6 p -134.99 134.69 40.74 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.822 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 70.8 m -108.74 -168.14 1.31 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.65 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 23.3 t -63.93 128.44 35.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.774 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' B' ' 134' ' ' GLN . . . -80.41 129.96 34.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.451 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.591 HG11 ' O ' ' B' ' 135' ' ' ALA . 2.8 m -74.87 151.26 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.922 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.05 119.25 5.67 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.512 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.81 152.12 30.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.783 0.325 . . . . 0.0 110.951 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -148.75 162.96 38.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.661 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.449 HG22 ' O ' ' B' ' 56' ' ' ILE . 1.2 tp -105.94 114.87 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.573 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . 0.808 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -70.72 124.51 24.46 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.749 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 0.2 OUTLIER -132.32 88.78 2.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.242 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.571 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 0.1 OUTLIER -75.31 169.44 18.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' C' ' 38' ' ' ARG . 0.4 OUTLIER 66.38 68.25 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.788 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 56.3 m -117.11 155.0 30.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.816 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . 0.585 ' HB2' HH22 ' C' ' 38' ' ' ARG . 19.9 t70 -135.74 155.65 50.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.311 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.495 HG23 ' O ' ' B' ' 124' ' ' LEU . 0.2 OUTLIER -111.11 -34.17 6.26 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.12 -22.17 66.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.008 0.433 . . . . 0.0 111.735 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.54 -59.54 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.767 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.417 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . . . -116.76 129.16 55.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.706 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.16 -60.29 2.2 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.921 0.391 . . . . 0.0 111.019 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . 0.512 ' HZ1' ' HA ' ' B' ' 123' ' ' THR . 0.2 OUTLIER -105.26 -175.38 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.479 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.96 131.3 9.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.55 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.95 151.2 24.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.067 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.615 HG13 HD11 ' B' ' 131' ' ' ILE . 2.0 t -129.45 158.31 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.788 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.566 ' HA ' HD23 ' B' ' 111' ' ' LEU . . . -152.73 143.1 22.57 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.558 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' B' ' 113' ' ' LEU . 0.1 OUTLIER -112.3 141.49 45.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.648 0.261 . . . . 0.0 111.034 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.587 HD22 HG22 ' E' ' 130' ' ' THR . 0.3 OUTLIER -107.67 139.51 42.13 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.966 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.76 -179.46 46.91 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.851 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.745 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.3 OUTLIER -103.96 156.33 17.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.602 0.239 . . . . 0.0 110.782 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.33 118.42 21.23 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.943 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.562 HG22 ' HB3' ' B' ' 82' ' ' HIS . 0.4 OUTLIER -59.05 -29.07 40.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.75 50.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.14 -89.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.118 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.06 -32.49 42.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.652 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.562 ' HB3' HG22 ' B' ' 78' ' ' ILE . 0.3 OUTLIER -81.15 62.83 5.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.938 0.399 . . . . 0.0 110.43 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' THR . . . . . 0.461 HG23 ' HD2' ' E' ' 106' ' ' ARG . 0.2 OUTLIER -74.65 -18.13 60.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.557 -179.578 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . 0.686 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 20.4 p-10 -76.01 -7.38 54.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.279 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.482 ' HB ' ' CG2' ' B' ' 78' ' ' ILE . 23.9 t -117.68 124.12 72.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.235 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' B' ' 150' ' ' ALA . 0.5 OUTLIER -66.21 139.34 58.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' B' ' 150' ' ' ALA . . . -84.87 -165.42 1.19 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.674 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.739 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 0.7 OUTLIER -71.86 168.67 17.41 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.086 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.94 -79.18 0.06 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.279 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' SER . . . . . 0.752 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 2.4 p -168.88 5.91 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.048 0.452 . . . . 0.0 111.572 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' SER . . . . . 0.606 ' O ' ' HB2' ' B' ' 95' ' ' SER . 69.9 m -77.56 83.22 3.96 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.952 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' E' ' 50' ' ' SER . . . -55.02 -34.68 63.69 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.88 0.372 . . . . 0.0 111.617 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.22 31.49 6.33 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.571 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . 0.632 ' O ' ' HB3' ' B' ' 147' ' ' ALA . . . -156.58 7.49 0.23 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.943 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' SER . . . . . 0.739 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . 0.6 OUTLIER -110.73 -174.33 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.943 0.401 . . . . 0.0 110.581 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . 0.457 ' CB ' HG23 ' A' ' 16' ' ' VAL . . . -97.83 179.09 4.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.914 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.761 ' H ' ' HB ' ' B' ' 144' ' ' THR . 1.1 m -132.42 125.99 32.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.296 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' B' ' 97' ' ' THR . 66.1 m-20 66.66 25.84 9.79 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.422 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . 0.647 HG12 HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -127.69 130.44 70.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.686 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.08 -161.36 10.74 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.535 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.87 131.97 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 123.056 0.542 . . . . 0.0 111.756 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.721 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 1.5 tt0 -98.52 151.49 20.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.901 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.524 ' N ' ' HG2' ' B' ' 102' ' ' GLN . 0.3 OUTLIER -117.36 128.67 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.513 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . 0.784 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 0.3 OUTLIER -103.03 133.55 47.97 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.707 0.289 . . . . 0.0 111.01 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . 0.529 ' HB3' HG23 ' B' ' 107' ' ' THR . 7.2 t0 -87.78 158.46 18.76 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.601 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -70.47 -27.75 64.46 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.733 0.301 . . . . 0.0 111.026 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' THR . . . . . 0.529 HG23 ' HB3' ' B' ' 105' ' ' ASP . 2.8 t -51.73 -25.74 8.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.036 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.26 -39.25 1.73 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.58 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.31 158.05 17.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 0.0 111.0 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.784 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -70.36 137.11 50.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.063 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' B' ' 72' ' ' ALA . 13.5 tp -87.55 158.29 18.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.333 0.587 . . . . 0.0 110.563 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 0.5 OUTLIER -101.62 141.96 33.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.147 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' B' ' 73' ' ' PHE . 1.9 mt -82.32 65.54 7.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.734 0.302 . . . . 0.0 110.801 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.08 -14.94 21.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.542 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.28 -54.18 0.7 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.623 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.19 28.99 8.2 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.02 0.438 . . . . 0.0 111.69 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.8 76.6 7.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.124 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 91.4 m-85 -91.06 96.77 10.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.747 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 68.6 m -132.64 78.32 1.79 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.797 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.76 136.81 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.703 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -114.97 76.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.252 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.93 135.6 33.61 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.691 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.512 ' HA ' ' HZ1' ' B' ' 68' ' ' LYS . 11.8 m -77.12 96.28 4.44 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.703 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' B' ' 124' ' ' LEU . 10.8 tp -68.12 132.94 48.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.589 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . 0.489 ' HA ' ' HG1' ' B' ' 63' ' ' THR . 2.3 m120 -128.47 166.74 18.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.601 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' B' ' 61' ' ' CYS . 6.2 t30 -79.38 105.78 10.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.697 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.03 -137.06 5.22 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.675 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 3.7 m -103.63 83.47 2.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.707 0.289 . . . . 0.0 110.773 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . 0.671 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 1.7 t30 -71.09 139.84 50.48 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.979 0.418 . . . . 0.0 111.148 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.808 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -133.91 139.6 46.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.133 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' ILE . . . . . 0.615 HD11 HG13 ' B' ' 71' ' ' VAL . 61.8 mt -97.99 110.48 55.93 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -81.74 135.13 8.85 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.75 1.633 . . . . 0.0 112.574 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.76 152.65 41.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.756 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' GLN . . . . . 0.639 ' HB3' ' HB3' ' B' ' 51' ' ' ALA . 50.5 mt-30 -118.96 156.9 28.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.065 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.721 ' HA ' ' O ' ' B' ' 102' ' ' GLN . . . -151.41 101.66 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.352 . . . . 0.0 111.659 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.58 168.33 9.17 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.35 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' B' ' 48' ' ' THR . 0.3 OUTLIER -80.06 123.32 27.75 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.173 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' B' ' 47' ' ' ALA . 1.3 t80 -126.2 119.12 26.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.948 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.637 ' HB3' HD21 ' B' ' 42' ' ' LEU . . . -111.99 125.16 53.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.919 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.22 63.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.507 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -133.1 -119.99 2.08 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.111 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.4 111.95 18.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.558 0.218 . . . . 0.0 110.738 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -61.91 113.82 3.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.784 0.326 . . . . 0.0 111.409 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.761 ' HB ' ' H ' ' B' ' 97' ' ' THR . 74.1 m -88.25 145.23 35.47 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.302 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 144' ' ' THR . 1.3 Cg_endo -82.82 134.19 7.17 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.546 2.164 . . . . 0.0 112.019 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.88 -135.58 4.41 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.529 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' B' ' 94' ' ' GLY . . . -96.16 134.2 39.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.86 0.362 . . . . 0.0 111.361 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.81 50.45 2.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.207 0.527 . . . . 0.0 110.506 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.438 HD21 ' HG2' ' A' ' 13' ' ' LYS . 3.4 m120 -98.93 146.15 26.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.551 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.558 ' HB2' HD11 ' B' ' 86' ' ' LEU . . . -154.91 174.08 15.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.883 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -139.31 128.49 23.93 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.171 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . 0.443 ' HB3' HD12 ' B' ' 86' ' ' LEU . . . -118.45 133.27 56.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.169 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.93 147.39 23.0 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.27 130.32 53.43 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.195 0.521 . . . . 0.0 110.037 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . 0.554 ' HE2' HD11 ' B' ' 74' ' ' LEU . 11.2 mmtt -126.64 143.89 51.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.931 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.42 151.89 34.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.746 0.307 . . . . 0.0 111.709 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.663 ' HA ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -141.39 121.1 13.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.32 0.581 . . . . 0.0 110.342 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' TYR . . . . . 0.575 ' CD2' ' HB ' ' A' ' 3' ' ' THR . 1.2 m-85 -98.21 121.64 40.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.577 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.86 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 111.176 0.065 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.59 71.06 0.5 Allowed 'General case' 0 C--O 1.232 0.132 0 O-C-N 123.122 0.264 . . . . 0.0 111.023 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 3' ' ' THR . . . . . 0.667 ' O ' ' HA ' ' D' ' 157' ' ' GLN . 4.9 m -114.71 127.42 55.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.447 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 20.8 m -117.84 106.77 13.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.609 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.92 174.65 12.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.615 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.07 119.82 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.607 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.17 -49.5 15.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.835 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.32 -154.92 11.36 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.854 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -142.4 139.98 31.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.927 0.394 . . . . 0.0 111.292 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.74 113.93 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.155 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -87.16 110.3 20.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.313 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.23 111.54 22.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.776 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . 0.497 ' HE3' HG11 ' C' ' 28' ' ' VAL . 3.7 tmtm? -102.94 110.61 22.59 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.435 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.32 168.38 22.64 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.058 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' GLU . . . . . 0.662 ' O ' ' HA ' ' D' ' 36' ' ' GLN . 3.6 tt0 -159.01 133.09 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 0.0 110.413 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.633 HG21 HG12 ' D' ' 99' ' ' VAL . 13.3 t -99.74 143.27 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.203 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.57 HG22 ' O ' ' D' ' 37' ' ' VAL . 4.0 m -141.42 -172.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 111.074 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . 0.539 ' HA ' HG22 ' D' ' 39' ' ' THR . 0.6 OUTLIER -89.56 -176.94 5.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.058 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.8 46.84 1.36 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.039 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' C' ' 66' ' ' ALA . . . -127.76 -29.96 2.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.924 0.392 . . . . 0.0 111.485 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' CYS . . . . . 1.0 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER -163.12 158.33 21.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.996 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.33 118.62 2.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.042 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' C' ' 58' ' ' LEU . 0.8 OUTLIER -66.28 153.07 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.086 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.78 158.73 20.62 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.613 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 91' ' ' SER . . . -61.01 -34.4 74.77 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.316 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.16 13.07 63.58 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.887 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.8 -22.44 10.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.801 0.334 . . . . 0.0 110.733 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.497 HG11 ' HE3' ' C' ' 13' ' ' LYS . 19.8 t -43.98 -64.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.336 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.04 135.83 41.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.949 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.21 125.72 20.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.066 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.74 106.53 18.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.15 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.75 117.05 53.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.067 0.461 . . . . 0.0 110.482 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.69 131.05 45.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.576 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.81 -47.31 7.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.607 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.33 -163.6 12.15 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.551 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . 0.673 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 3.7 mt-30 -100.98 126.59 47.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.634 0.255 . . . . 0.0 110.841 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . 0.571 ' O ' HG22 ' B' ' 17' ' ' VAL . 14.9 p -110.4 146.8 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.926 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' ARG . . . . . 0.585 HH22 ' HB2' ' B' ' 62' ' ' ASP . 2.8 mtp180 -82.8 139.08 33.74 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.757 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.549 HG22 ' HA ' ' B' ' 18' ' ' ASN . 5.5 t -62.74 -37.42 86.5 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.778 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.47 -31.49 71.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.125 0.488 . . . . 0.0 110.847 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.04 -17.73 45.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.102 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' C' ' 139' ' ' ALA . 4.3 mp -125.72 33.11 5.16 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.604 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.76 18.96 18.03 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.372 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.96 130.23 52.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.355 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' C' ' 140' ' ' THR . 22.5 tt0 -56.27 107.33 0.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.883 0.373 . . . . 0.0 111.088 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.6 30.51 5.83 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.133 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' C' ' 138' ' ' PHE . . . -76.58 136.62 39.25 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' C' ' 137' ' ' TYR . 52.2 p -134.91 134.73 40.95 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.848 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 71.1 m -108.76 -168.15 1.31 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.665 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 23.1 t -63.96 128.46 35.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.854 0.359 . . . . 0.0 110.756 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . 0.627 ' HB3' ' HB3' ' C' ' 134' ' ' GLN . . . -80.4 129.98 34.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.43 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . 0.592 HG11 ' O ' ' C' ' 135' ' ' ALA . 2.8 m -74.86 151.21 6.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.993 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.01 119.26 5.68 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.547 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.91 152.08 30.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.731 0.301 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -148.72 162.95 38.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.694 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.445 HG22 ' O ' ' C' ' 56' ' ' ILE . 1.2 tp -105.96 114.82 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.534 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.805 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.0 OUTLIER -70.67 124.54 24.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.703 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' C' ' 23' ' ' VAL . 0.2 OUTLIER -132.34 88.79 2.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.235 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 0.1 OUTLIER -75.28 169.44 18.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' D' ' 38' ' ' ARG . 0.4 OUTLIER 66.37 68.24 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.802 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' CYS . . . . . 1.0 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 56.3 m -117.13 155.04 30.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.809 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . 0.591 ' HB2' HH22 ' D' ' 38' ' ' ARG . 20.0 t70 -135.8 155.63 50.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.25 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.484 HG23 ' O ' ' C' ' 124' ' ' LEU . 0.2 OUTLIER -111.08 -34.22 6.25 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.121 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.13 -22.12 66.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.012 0.434 . . . . 0.0 111.705 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.57 -59.65 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.669 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' C' ' 20' ' ' ALA . . . -116.69 129.1 55.93 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.72 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.13 -60.28 2.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.914 0.388 . . . . 0.0 111.033 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' LYS . . . . . 0.491 ' HZ1' ' HA ' ' C' ' 123' ' ' THR . 0.2 OUTLIER -105.23 -175.34 2.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.49 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.93 131.38 9.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.604 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.05 151.18 24.99 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.841 0.353 . . . . 0.0 111.056 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . 0.623 HG13 HD11 ' C' ' 131' ' ' ILE . 2.0 t -129.47 158.32 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.766 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . 0.554 ' HA ' HD23 ' C' ' 111' ' ' LEU . . . -152.66 143.06 22.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.61 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' PHE . . . . . 0.431 ' HB3' HD23 ' C' ' 113' ' ' LEU . 0.1 OUTLIER -112.29 141.5 45.92 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.643 0.259 . . . . 0.0 111.068 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.571 HD22 HG22 ' F' ' 130' ' ' THR . 0.3 OUTLIER -107.71 139.45 42.26 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.955 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.79 -179.48 46.92 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.837 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' THR . . . . . 0.743 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.3 OUTLIER -103.97 156.38 17.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.607 0.241 . . . . 0.0 110.811 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.37 118.38 21.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.981 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . 0.568 HG22 ' HB3' ' C' ' 82' ' ' HIS . 0.4 OUTLIER -59.02 -29.09 40.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.887 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' ASP . . . . . 0.409 ' HB2' HG22 ' C' ' 140' ' ' THR . 0.1 OUTLIER -151.76 50.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.822 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.25 -89.9 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.069 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.06 -32.59 42.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.573 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . 0.568 ' HB3' HG22 ' C' ' 78' ' ' ILE . 0.3 OUTLIER -81.04 62.78 5.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.856 0.36 . . . . 0.0 110.438 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' THR . . . . . 0.458 HG23 ' HD2' ' F' ' 106' ' ' ARG . 0.2 OUTLIER -74.58 -18.21 60.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.61 -179.612 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' ASN . . . . . 0.693 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 20.4 p-10 -75.86 -7.49 54.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.329 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.487 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 23.9 t -117.68 124.16 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.217 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' C' ' 150' ' ' ALA . 0.5 OUTLIER -66.14 139.36 58.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.697 0.284 . . . . 0.0 110.244 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' C' ' 150' ' ' ALA . . . -84.9 -165.44 1.2 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.605 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.747 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 0.7 OUTLIER -71.88 168.65 17.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.012 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.93 -79.17 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.337 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' SER . . . . . 0.766 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 2.3 p -168.86 5.95 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 111.525 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' C' ' 95' ' ' SER . 69.7 m -77.54 83.21 3.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.971 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' F' ' 50' ' ' SER . . . -54.99 -34.67 63.59 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.89 0.376 . . . . 0.0 111.63 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.29 31.48 6.32 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.586 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' GLY . . . . . 0.634 ' O ' ' HB3' ' C' ' 147' ' ' ALA . . . -156.59 7.48 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.94 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' SER . . . . . 0.747 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 0.6 OUTLIER -110.74 -174.32 2.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.888 0.375 . . . . 0.0 110.612 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' ALA . . . . . 0.456 ' CB ' HG23 ' B' ' 16' ' ' VAL . . . -97.76 179.0 4.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' THR . . . . . 0.751 ' H ' ' HB ' ' C' ' 144' ' ' THR . 1.1 m -132.29 125.98 32.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.356 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' C' ' 97' ' ' THR . 66.0 m-20 66.57 25.92 9.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.396 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 99' ' ' VAL . . . . . 0.645 HG12 HG21 ' B' ' 16' ' ' VAL . 0.2 OUTLIER -127.7 130.37 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.705 179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.07 -161.39 10.76 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.501 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.88 131.95 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 123.094 0.558 . . . . 0.0 111.866 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 102' ' ' GLN . . . . . 0.712 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 1.5 tt0 -98.49 151.46 20.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.897 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . 0.524 ' N ' ' HG2' ' C' ' 102' ' ' GLN . 0.3 OUTLIER -117.33 128.64 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.58 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' LEU . . . . . 0.787 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 0.3 OUTLIER -102.98 133.46 48.05 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.654 0.264 . . . . 0.0 111.033 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . 0.542 ' HB3' HG23 ' C' ' 107' ' ' THR . 7.2 t0 -87.74 158.44 18.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.636 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -70.5 -27.72 64.42 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.714 0.293 . . . . 0.0 111.02 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 107' ' ' THR . . . . . 0.542 HG23 ' HB3' ' C' ' 105' ' ' ASP . 2.8 t -51.68 -25.68 7.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.096 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.16 -39.29 1.73 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.617 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.26 157.99 17.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.351 . . . . 0.0 111.065 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.787 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -70.32 137.07 50.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.111 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 111' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' C' ' 72' ' ' ALA . 13.5 tp -87.56 158.47 18.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.382 0.611 . . . . 0.0 110.499 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 112' ' ' THR . . . . . 0.693 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 0.5 OUTLIER -101.76 141.97 33.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.123 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' C' ' 73' ' ' PHE . 1.9 mt -82.43 65.6 7.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 0.0 110.708 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.08 -14.93 21.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.528 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.19 -54.11 0.71 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.678 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.17 28.83 8.35 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.017 0.437 . . . . 0.0 111.721 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.72 76.6 8.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.24 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 118' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' C' ' 71' ' ' VAL . 91.3 m-85 -91.13 96.77 10.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.724 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 68.6 m -132.65 78.25 1.79 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.818 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.67 136.88 3.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.692 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.02 76.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.267 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.88 135.56 33.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.703 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 123' ' ' THR . . . . . 0.491 ' HA ' ' HZ1' ' C' ' 68' ' ' LYS . 11.8 m -77.05 96.33 4.4 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.73 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . 0.484 ' O ' HG23 ' C' ' 63' ' ' THR . 10.8 tp -68.25 132.92 47.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.627 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 125' ' ' ASN . . . . . 0.47 ' HA ' ' HG1' ' C' ' 63' ' ' THR . 2.2 m120 -128.49 166.83 18.02 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.569 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 126' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' C' ' 61' ' ' CYS . 6.3 t30 -79.43 105.76 10.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.696 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.05 -137.06 5.22 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.655 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 128' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 3.7 m -103.62 83.49 2.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.688 0.28 . . . . 0.0 110.778 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 129' ' ' ASN . . . . . 0.666 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 1.7 t30 -71.12 139.92 50.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.959 0.409 . . . . 0.0 111.099 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 130' ' ' THR . . . . . 0.805 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -134.0 139.7 46.23 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.024 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 131' ' ' ILE . . . . . 0.623 HD11 HG13 ' C' ' 71' ' ' VAL . 61.9 mt -98.07 110.55 56.37 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 132' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -81.79 135.13 8.78 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.753 1.635 . . . . 0.0 112.596 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.71 152.67 41.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.773 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 134' ' ' GLN . . . . . 0.627 ' HB3' ' HB3' ' C' ' 51' ' ' ALA . 50.6 mt-30 -119.01 156.9 28.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.07 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . 0.712 ' HA ' ' O ' ' C' ' 102' ' ' GLN . . . -151.43 101.67 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 0.0 111.633 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.61 168.28 9.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.359 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 137' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' C' ' 48' ' ' THR . 0.3 OUTLIER -79.98 123.23 27.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.192 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 138' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' C' ' 47' ' ' ALA . 1.3 t80 -126.11 119.05 26.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.085 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 139' ' ' ALA . . . . . 0.64 ' HB3' HD21 ' C' ' 42' ' ' LEU . . . -111.95 125.21 53.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.954 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 140' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.17 64.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.543 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -133.15 -120.0 2.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.043 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.43 111.89 18.19 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.559 0.219 . . . . 0.0 110.708 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 143' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -61.88 113.78 2.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.794 0.331 . . . . 0.0 111.39 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 144' ' ' THR . . . . . 0.751 ' HB ' ' H ' ' C' ' 97' ' ' THR . 75.5 m -88.18 145.24 35.65 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.366 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.87 134.19 7.12 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.499 2.132 . . . . 0.0 112.005 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.93 -135.55 4.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.502 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 147' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' C' ' 94' ' ' GLY . . . -96.24 134.23 39.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.881 0.372 . . . . 0.0 111.336 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.85 50.49 2.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.161 0.505 . . . . 0.0 110.456 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 149' ' ' ASN . . . . . 0.436 HD21 ' HG2' ' B' ' 13' ' ' LYS . 3.5 m120 -98.95 146.15 26.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.555 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 150' ' ' ALA . . . . . 0.56 ' HB2' HD11 ' C' ' 86' ' ' LEU . . . -154.9 174.11 15.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.986 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -139.28 128.48 23.95 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.186 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 152' ' ' ALA . . . . . 0.46 ' HB3' HD12 ' C' ' 86' ' ' LEU . . . -118.43 133.35 55.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.11 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.97 147.41 22.98 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.26 130.25 53.44 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.125 0.488 . . . . 0.0 110.062 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 155' ' ' LYS . . . . . 0.564 ' HE2' HD11 ' C' ' 74' ' ' LEU . 11.2 mmtt -126.67 143.9 51.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.954 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 156' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.35 151.92 34.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.69 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 157' ' ' GLN . . . . . 0.663 ' HA ' ' O ' ' B' ' 3' ' ' THR . 0.0 OUTLIER -141.34 121.15 13.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.298 0.57 . . . . 0.0 110.37 -179.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 158' ' ' TYR . . . . . 0.574 ' CD2' ' HB ' ' B' ' 3' ' ' THR . 1.2 m-85 -98.26 121.63 40.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.56 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.808 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 111.261 0.097 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.62 71.14 0.5 Allowed 'General case' 0 N--CA 1.462 0.157 0 O-C-N 123.107 0.254 . . . . 0.0 110.96 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 3' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' E' ' 157' ' ' GLN . 4.8 m -114.68 127.32 55.69 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.475 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 20.2 m -117.7 106.77 13.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.633 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.91 174.64 12.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.567 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.13 119.83 36.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.586 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.2 -49.49 15.71 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.839 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.26 -154.82 11.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.848 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -142.49 140.04 31.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.983 0.421 . . . . 0.0 111.176 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.73 113.89 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.151 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.14 110.39 20.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.363 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.3 111.48 22.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.74 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' LYS . . . . . 0.507 ' HE3' HG11 ' D' ' 28' ' ' VAL . 3.6 tmtm? -102.96 110.5 22.44 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.453 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.19 168.31 22.6 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.014 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' E' ' 36' ' ' GLN . 3.6 tt0 -158.99 133.07 7.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.93 0.395 . . . . 0.0 110.4 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.647 HG21 HG12 ' E' ' 99' ' ' VAL . 13.2 t -99.65 143.14 14.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.286 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . 0.566 HG22 ' O ' ' E' ' 37' ' ' VAL . 3.9 m -141.33 -172.11 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.862 0.363 . . . . 0.0 111.074 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' ASN . . . . . 0.533 ' HA ' HG22 ' E' ' 39' ' ' THR . 0.6 OUTLIER -89.49 -176.91 5.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.034 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.87 46.95 1.36 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.106 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' D' ' 66' ' ' ALA . . . -127.77 -29.97 2.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' CYS . . . . . 1.006 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER -163.14 158.38 21.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.915 -179.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.35 118.54 2.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.103 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' D' ' 58' ' ' LEU . 0.8 OUTLIER -66.25 152.99 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.065 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -84.68 158.77 20.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.611 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.448 ' HB3' ' HA ' ' B' ' 91' ' ' SER . . . -61.03 -34.47 74.9 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.344 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.05 13.03 63.77 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.929 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.78 -22.43 10.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.776 0.322 . . . . 0.0 110.773 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . 0.507 HG11 ' HE3' ' D' ' 13' ' ' LYS . 19.8 t -44.04 -64.25 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.339 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.04 135.9 41.74 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.932 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -139.26 125.64 20.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.049 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.77 106.56 18.84 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.044 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.78 117.08 53.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.105 0.478 . . . . 0.0 110.431 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.74 131.09 45.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.527 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.8 -47.35 7.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.631 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.38 -163.56 12.16 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.564 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' GLN . . . . . 0.662 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 3.7 mt-30 -101.0 126.61 47.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.703 0.287 . . . . 0.0 110.83 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.57 ' O ' HG22 ' C' ' 17' ' ' VAL . 14.9 p -110.42 146.83 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.934 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . 0.591 HH22 ' HB2' ' C' ' 62' ' ' ASP . 2.9 mtp180 -82.87 139.17 33.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.7 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.539 HG22 ' HA ' ' C' ' 18' ' ' ASN . 5.4 t -62.78 -37.53 87.03 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.745 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.4 -31.5 71.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.125 0.488 . . . . 0.0 110.896 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.99 -17.77 45.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.165 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' D' ' 139' ' ' ALA . 4.3 mp -125.66 33.11 5.17 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.609 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.76 18.9 18.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.298 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.94 130.26 52.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.34 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' D' ' 140' ' ' THR . 22.5 tt0 -56.29 107.32 0.36 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.884 0.373 . . . . 0.0 111.088 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.62 30.5 5.84 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.111 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' D' ' 138' ' ' PHE . . . -76.56 136.71 39.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.973 0.415 . . . . 0.0 112.109 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' D' ' 137' ' ' TYR . 52.3 p -134.94 134.71 40.88 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.879 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 70.7 m -108.76 -168.16 1.31 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.641 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 23.3 t -63.99 128.52 36.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.743 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' D' ' 134' ' ' GLN . . . -80.42 130.02 34.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.467 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' VAL . . . . . 0.767 ' HB ' ' HA ' ' A' ' 90' ' ' SER . 2.8 m -74.85 151.28 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.04 119.23 5.66 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.516 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -153.9 152.12 30.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.788 0.328 . . . . 0.0 110.837 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -148.77 162.94 38.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.693 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.46 HG22 ' O ' ' D' ' 56' ' ' ILE . 1.2 tp -105.91 114.76 46.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.563 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' GLN . . . . . 0.794 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.0 OUTLIER -70.65 124.51 24.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.744 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . 0.534 ' HA ' ' HA ' ' D' ' 23' ' ' VAL . 0.2 OUTLIER -132.28 88.69 2.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.281 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . 0.587 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 0.1 OUTLIER -75.25 169.47 17.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' ASP . . . . . 0.404 ' CG ' ' HD2' ' E' ' 38' ' ' ARG . 0.4 OUTLIER 66.26 68.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.78 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' CYS . . . . . 1.006 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 56.2 m -117.13 155.07 29.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . 0.589 ' HB2' HH22 ' E' ' 38' ' ' ARG . 19.9 t70 -135.75 155.66 50.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.277 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.492 HG23 ' O ' ' D' ' 124' ' ' LEU . 0.2 OUTLIER -111.11 -34.25 6.24 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.05 -22.14 66.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.952 0.406 . . . . 0.0 111.729 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.62 -59.49 2.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.74 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' D' ' 20' ' ' ALA . . . -116.82 129.16 55.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.623 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -60.23 2.22 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.878 0.371 . . . . 0.0 111.001 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' LYS . . . . . 0.501 ' HZ1' ' HA ' ' D' ' 123' ' ' THR . 0.2 OUTLIER -105.21 -175.34 2.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.456 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.96 131.36 9.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.59 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.96 151.18 24.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.104 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . 0.604 HG13 HD11 ' D' ' 131' ' ' ILE . 2.0 t -129.52 158.3 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.754 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 72' ' ' ALA . . . . . 0.566 ' HA ' HD23 ' D' ' 111' ' ' LEU . . . -152.68 143.08 22.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.584 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 73' ' ' PHE . . . . . 0.432 ' HB3' HD23 ' D' ' 113' ' ' LEU . 0.1 OUTLIER -112.33 141.46 46.02 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.691 0.281 . . . . 0.0 111.004 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 74' ' ' LEU . . . . . 0.552 HD11 ' HE2' ' D' ' 155' ' ' LYS . 0.3 OUTLIER -107.69 139.52 42.13 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.018 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.79 -179.44 46.94 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.816 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 76' ' ' THR . . . . . 0.522 ' H ' HD21 ' D' ' 86' ' ' LEU . 0.3 OUTLIER -103.98 156.28 17.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.613 0.245 . . . . 0.0 110.767 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.3 118.38 21.17 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.969 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 78' ' ' ILE . . . . . 0.563 HG22 ' HB3' ' D' ' 82' ' ' HIS . 0.4 OUTLIER -59.01 -29.1 40.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.76 50.47 0.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.774 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.17 -89.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.09 -32.51 42.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.621 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . 0.563 ' HB3' HG22 ' D' ' 78' ' ' ILE . 0.3 OUTLIER -81.08 62.86 5.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 110.406 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.63 -18.18 60.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.558 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . 0.694 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 20.4 p-10 -76.04 -7.4 54.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.176 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.485 ' HB ' ' CG2' ' D' ' 78' ' ' ILE . 24.0 t -117.73 124.14 72.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.243 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.551 HD11 ' HB2' ' D' ' 150' ' ' ALA . 0.5 OUTLIER -66.15 139.35 58.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.713 0.292 . . . . 0.0 110.243 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' D' ' 150' ' ' ALA . . . -84.88 -165.44 1.2 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.693 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.756 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 0.7 OUTLIER -71.84 168.65 17.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.067 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.96 -79.23 0.06 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.263 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -168.81 5.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.986 0.422 . . . . 0.0 111.472 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 91' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' D' ' 95' ' ' SER . 70.3 m -77.47 83.22 3.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.11 -34.62 63.84 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.878 0.371 . . . . 0.0 111.633 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.24 31.5 6.32 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.687 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 94' ' ' GLY . . . . . 0.634 ' O ' ' HB3' ' D' ' 147' ' ' ALA . . . -156.57 7.39 0.23 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.881 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 95' ' ' SER . . . . . 0.756 ' HB3' ' HG ' ' D' ' 88' ' ' LEU . 0.6 OUTLIER -110.71 -174.33 2.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 110.651 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 96' ' ' ALA . . . . . 0.458 ' CB ' HG23 ' C' ' 16' ' ' VAL . . . -97.78 179.01 4.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.931 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 97' ' ' THR . . . . . 0.725 ' H ' ' HB ' ' D' ' 144' ' ' THR . 1.1 m -132.24 125.92 32.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.369 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 98' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' D' ' 97' ' ' THR . 66.0 m-20 66.68 25.87 9.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.38 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 99' ' ' VAL . . . . . 0.633 HG12 HG21 ' C' ' 16' ' ' VAL . 0.2 OUTLIER -127.66 130.34 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.691 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.13 -161.38 10.76 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.485 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.84 131.94 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 123.12 0.568 . . . . 0.0 111.842 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 102' ' ' GLN . . . . . 0.716 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 1.5 tt0 -98.52 151.45 20.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.906 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 103' ' ' ILE . . . . . 0.525 ' N ' ' HG2' ' D' ' 102' ' ' GLN . 0.3 OUTLIER -117.3 128.65 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.499 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 104' ' ' LEU . . . . . 0.785 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 0.3 OUTLIER -102.94 133.5 47.94 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.559 0.219 . . . . 0.0 111.051 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . 0.545 ' HB3' HG23 ' D' ' 107' ' ' THR . 7.1 t0 -87.73 158.47 18.79 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.685 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 106' ' ' ARG . . . . . 0.436 ' HD2' HG23 ' A' ' 83' ' ' THR . 7.9 ttp85 -70.56 -27.71 64.34 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.806 0.336 . . . . 0.0 111.047 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 107' ' ' THR . . . . . 0.545 HG23 ' HB3' ' D' ' 105' ' ' ASP . 2.8 t -51.69 -25.7 7.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.09 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.19 -39.27 1.73 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.557 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.27 158.0 17.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.352 . . . . 0.0 111.013 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.785 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -70.37 137.17 50.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.099 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 111' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' D' ' 72' ' ' ALA . 13.5 tp -87.56 158.35 18.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.304 0.574 . . . . 0.0 110.529 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 112' ' ' THR . . . . . 0.694 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 0.5 OUTLIER -101.72 142.01 33.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.095 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 113' ' ' LEU . . . . . 0.432 HD23 ' HB3' ' D' ' 73' ' ' PHE . 1.9 mt -82.45 65.63 7.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 0.0 110.775 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.07 -15.01 21.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.485 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.23 -54.14 0.71 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.705 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.16 28.88 8.31 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.068 0.461 . . . . 0.0 111.756 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.81 76.62 7.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.186 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' D' ' 71' ' ' VAL . 91.5 m-85 -91.06 96.79 10.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.733 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 67.8 m -132.69 78.31 1.79 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.704 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.7 136.85 3.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.717 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -115.02 76.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.307 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.98 135.54 33.62 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.662 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.501 ' HA ' ' HZ1' ' D' ' 68' ' ' LYS . 11.7 m -77.05 96.33 4.4 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.764 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . 0.492 ' O ' HG23 ' D' ' 63' ' ' THR . 10.8 tp -68.15 132.92 48.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.628 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 125' ' ' ASN . . . . . 0.471 ' HA ' ' HG1' ' D' ' 63' ' ' THR . 2.3 m120 -128.49 166.81 18.06 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.561 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 126' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' D' ' 61' ' ' CYS . 6.2 t30 -79.44 105.76 10.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.665 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.03 -136.99 5.19 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.734 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 128' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 3.7 m -103.72 83.44 2.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.716 0.293 . . . . 0.0 110.808 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 129' ' ' ASN . . . . . 0.672 ' HB2' ' SG ' ' D' ' 61' ' ' CYS . 1.7 t30 -71.04 139.85 50.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.899 0.38 . . . . 0.0 111.17 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 130' ' ' THR . . . . . 0.794 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.2 OUTLIER -133.92 139.57 46.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.147 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 131' ' ' ILE . . . . . 0.604 HD11 HG13 ' D' ' 71' ' ' VAL . 61.8 mt -97.9 110.49 55.83 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 132' ' ' PRO . . . . . 0.763 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 7.6 Cg_endo -81.88 135.18 8.72 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.772 1.648 . . . . 0.0 112.562 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . 0.474 ' O ' HG21 ' A' ' 76' ' ' THR . 0.6 OUTLIER -143.74 152.65 41.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.802 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 134' ' ' GLN . . . . . 0.638 ' HB3' ' HB3' ' D' ' 51' ' ' ALA . 50.6 mt-30 -118.94 156.95 28.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.092 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' D' ' 102' ' ' GLN . . . -151.42 101.71 2.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 111.648 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.56 168.29 9.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.352 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 137' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' D' ' 48' ' ' THR . 0.3 OUTLIER -80.11 123.34 27.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.149 179.533 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 138' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' D' ' 47' ' ' ALA . 1.3 t80 -126.19 119.05 26.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.998 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 139' ' ' ALA . . . . . 0.631 ' HB3' HD21 ' D' ' 42' ' ' LEU . . . -111.98 125.17 53.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.904 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 140' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.23 63.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.494 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -133.06 -120.03 2.08 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.137 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.36 111.94 18.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.628 0.252 . . . . 0.0 110.718 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 143' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -61.96 113.84 3.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.82 0.343 . . . . 0.0 111.377 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 144' ' ' THR . . . . . 0.725 ' HB ' ' H ' ' D' ' 97' ' ' THR . 75.4 m -88.27 145.28 35.56 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.323 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.86 134.17 7.12 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.533 2.156 . . . . 0.0 111.992 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.93 -135.63 4.42 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.499 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 147' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' D' ' 94' ' ' GLY . . . -96.13 134.26 39.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.905 0.383 . . . . 0.0 111.362 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.89 50.51 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.413 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 149' ' ' ASN . . . . . 0.43 HD21 ' HG2' ' C' ' 13' ' ' LYS . 3.5 m120 -98.99 146.14 26.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.489 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 150' ' ' ALA . . . . . 0.551 ' HB2' HD11 ' D' ' 86' ' ' LEU . . . -154.95 174.17 15.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.92 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -139.34 128.4 23.74 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.184 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 152' ' ' ALA . . . . . 0.454 ' HB3' HD12 ' D' ' 86' ' ' LEU . . . -118.37 133.34 55.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.126 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.97 147.42 22.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.27 130.33 53.43 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.169 0.509 . . . . 0.0 110.022 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 155' ' ' LYS . . . . . 0.552 ' HE2' HD11 ' D' ' 74' ' ' LEU . 11.3 mmtt -126.67 143.97 51.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.945 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 156' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.45 151.87 34.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.85 0.357 . . . . 0.0 111.643 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 157' ' ' GLN . . . . . 0.667 ' HA ' ' O ' ' C' ' 3' ' ' THR . 0.0 OUTLIER -141.36 121.22 13.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.295 0.569 . . . . 0.0 110.372 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 158' ' ' TYR . . . . . 0.566 ' CD2' ' HB ' ' C' ' 3' ' ' THR . 1.2 m-85 -98.29 121.67 40.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.564 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.804 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 111.27 0.1 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.64 71.06 0.51 Allowed 'General case' 0 N--CA 1.462 0.149 0 O-C-N 123.109 0.256 . . . . 0.0 110.959 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 3' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' F' ' 157' ' ' GLN . 4.9 m -114.7 127.36 55.71 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.499 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 20.8 m -117.74 106.86 13.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.577 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.98 174.66 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.601 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.05 119.81 36.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.581 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.2 -49.49 15.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.822 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.32 -154.88 11.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.755 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -142.43 139.95 31.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.904 0.383 . . . . 0.0 111.291 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.71 113.83 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.161 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.11 110.32 20.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.36 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.21 111.51 22.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.752 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 13' ' ' LYS . . . . . 0.501 ' HE3' HG11 ' E' ' 28' ' ' VAL . 3.6 tmtm? -102.98 110.56 22.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.488 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.22 168.36 22.59 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.053 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 15' ' ' GLU . . . . . 0.674 ' O ' ' HA ' ' F' ' 36' ' ' GLN . 3.6 tt0 -159.02 133.08 7.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.923 0.392 . . . . 0.0 110.438 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 16' ' ' VAL . . . . . 0.646 HG21 HG12 ' F' ' 99' ' ' VAL . 13.2 t -99.67 143.15 14.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.261 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . 0.573 HG22 ' O ' ' F' ' 37' ' ' VAL . 3.9 m -141.34 -172.13 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.874 0.368 . . . . 0.0 111.057 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . 0.551 ' HA ' HG22 ' F' ' 39' ' ' THR . 0.6 OUTLIER -89.48 -176.96 5.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.046 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.73 46.85 1.36 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' E' ' 66' ' ' ALA . . . -127.77 -30.0 2.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.9 0.381 . . . . 0.0 111.466 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 21' ' ' CYS . . . . . 1.014 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER -163.07 158.45 22.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.943 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.42 118.49 2.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.044 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 23' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' E' ' 58' ' ' LEU . 0.8 OUTLIER -66.23 153.02 8.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.05 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.7 158.74 20.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.59 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' C' ' 91' ' ' SER . . . -61.04 -34.34 74.72 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.388 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.18 13.07 63.54 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.936 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.76 -22.44 10.7 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.798 0.333 . . . . 0.0 110.746 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 28' ' ' VAL . . . . . 0.501 HG11 ' HE3' ' E' ' 13' ' ' LYS . 19.8 t -44.02 -64.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.319 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.0 135.72 42.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.02 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -139.11 125.72 20.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.78 106.53 18.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.108 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.78 117.06 53.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.147 0.499 . . . . 0.0 110.44 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.67 131.01 45.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.61 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.75 -47.29 7.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.682 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.3 -163.61 12.15 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.573 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 36' ' ' GLN . . . . . 0.673 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 3.7 mt-30 -100.97 126.61 47.64 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.717 0.294 . . . . 0.0 110.842 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . 0.566 ' O ' HG22 ' D' ' 17' ' ' VAL . 14.9 p -110.38 146.85 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.983 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . 0.589 HH22 ' HB2' ' D' ' 62' ' ' ASP . 2.9 mtp180 -82.96 139.23 33.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.632 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 39' ' ' THR . . . . . 0.533 HG22 ' HA ' ' D' ' 18' ' ' ASN . 5.4 t -62.78 -37.52 86.99 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.724 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.48 -31.47 71.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.12 0.486 . . . . 0.0 110.867 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.99 -17.74 45.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.196 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.617 HD21 ' HB3' ' E' ' 139' ' ' ALA . 4.3 mp -125.68 33.05 5.18 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.631 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.71 18.86 18.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.333 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.92 130.29 52.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.309 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' E' ' 140' ' ' THR . 22.4 tt0 -56.35 107.38 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.362 . . . . 0.0 111.059 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.52 30.53 5.85 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.183 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 47' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' E' ' 138' ' ' PHE . . . -76.61 136.75 39.21 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.976 0.417 . . . . 0.0 112.123 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 48' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' E' ' 137' ' ' TYR . 52.2 p -134.96 134.69 40.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.888 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 71.6 m -108.82 -168.21 1.32 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.565 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 50' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 23.1 t -63.9 128.43 35.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.783 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 51' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' E' ' 134' ' ' GLN . . . -80.38 129.99 34.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.447 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 52' ' ' VAL . . . . . 0.752 ' HB ' ' HA ' ' B' ' 90' ' ' SER . 2.8 m -74.87 151.22 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.9 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.01 119.22 5.67 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.578 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.85 152.1 30.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.728 0.299 . . . . 0.0 110.966 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -148.77 162.89 38.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.653 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 56' ' ' ILE . . . . . 0.447 HG21 ' HB ' ' E' ' 131' ' ' ILE . 1.2 tp -105.87 114.86 46.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.567 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 57' ' ' GLN . . . . . 0.809 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.0 OUTLIER -70.72 124.58 24.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.695 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . 0.536 ' HA ' ' HA ' ' E' ' 23' ' ' VAL . 0.2 OUTLIER -132.36 88.76 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.242 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . 0.582 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 0.1 OUTLIER -75.34 169.41 18.11 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 60' ' ' ASP . . . . . 0.408 ' CG ' ' HD2' ' F' ' 38' ' ' ARG . 0.4 OUTLIER 66.38 68.3 0.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.746 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 61' ' ' CYS . . . . . 1.014 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 56.1 m -117.15 155.03 30.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.797 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . 0.591 ' HB2' HH22 ' F' ' 38' ' ' ARG . 20.1 t70 -135.8 155.65 50.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.274 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 63' ' ' THR . . . . . 0.495 HG23 ' O ' ' E' ' 124' ' ' LEU . 0.2 OUTLIER -111.08 -34.22 6.25 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.12 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.05 -22.18 66.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.067 0.46 . . . . 0.0 111.718 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.63 -59.49 2.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.709 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 66' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' E' ' 20' ' ' ALA . . . -116.86 129.18 55.91 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.628 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -60.35 2.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.896 0.379 . . . . 0.0 110.978 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 68' ' ' LYS . . . . . 0.51 ' HZ1' ' HA ' ' E' ' 123' ' ' THR . 0.2 OUTLIER -105.15 -175.37 2.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.537 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.96 131.32 9.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.588 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.97 151.19 24.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.073 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . 0.618 HG13 HD11 ' E' ' 131' ' ' ILE . 2.0 t -129.44 158.35 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.778 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . 0.566 ' HA ' HD23 ' E' ' 111' ' ' LEU . . . -152.71 143.06 22.56 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.599 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 73' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' E' ' 113' ' ' LEU . 0.1 OUTLIER -112.29 141.43 46.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.542 0.21 . . . . 0.0 111.105 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 74' ' ' LEU . . . . . 0.557 HD11 ' HE2' ' E' ' 155' ' ' LYS . 0.3 OUTLIER -107.7 139.49 42.18 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.992 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.76 -179.43 46.92 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.815 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 76' ' ' THR . . . . . 0.508 ' H ' HD21 ' E' ' 86' ' ' LEU . 0.4 OUTLIER -104.01 156.34 17.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.619 0.247 . . . . 0.0 110.79 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.35 118.37 21.19 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.934 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 78' ' ' ILE . . . . . 0.566 HG22 ' HB3' ' E' ' 82' ' ' HIS . 0.4 OUTLIER -58.97 -29.14 40.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.895 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.72 50.4 0.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.838 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.25 -89.9 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.103 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.03 -32.53 42.53 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.64 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 82' ' ' HIS . . . . . 0.566 ' HB3' HG22 ' E' ' 78' ' ' ILE . 0.3 OUTLIER -81.12 62.81 5.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.826 0.346 . . . . 0.0 110.376 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -18.09 60.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.599 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 84' ' ' ASN . . . . . 0.688 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 20.4 p-10 -76.1 -7.37 54.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.239 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.471 ' HB ' ' CG2' ' E' ' 78' ' ' ILE . 23.8 t -117.75 124.14 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.172 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 86' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' E' ' 150' ' ' ALA . 0.5 OUTLIER -66.14 139.38 58.14 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.262 179.409 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 87' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' E' ' 150' ' ' ALA . . . -84.92 -165.41 1.19 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.667 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.743 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 0.7 OUTLIER -71.92 168.64 17.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.977 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.89 -79.23 0.06 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.308 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p -168.81 5.94 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.918 0.389 . . . . 0.0 111.506 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 91' ' ' SER . . . . . 0.606 ' O ' ' HB2' ' E' ' 95' ' ' SER . 70.2 m -77.57 83.22 3.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.07 -34.7 63.83 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.875 0.369 . . . . 0.0 111.57 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.23 31.5 6.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.635 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 94' ' ' GLY . . . . . 0.644 ' O ' ' HB3' ' E' ' 147' ' ' ALA . . . -156.58 7.44 0.23 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.965 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 95' ' ' SER . . . . . 0.743 ' HB3' ' HG ' ' E' ' 88' ' ' LEU . 0.6 OUTLIER -110.69 -174.32 2.45 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.911 0.386 . . . . 0.0 110.669 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 96' ' ' ALA . . . . . 0.462 ' CB ' HG23 ' D' ' 16' ' ' VAL . . . -97.76 178.96 4.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 97' ' ' THR . . . . . 0.763 ' H ' ' HB ' ' E' ' 144' ' ' THR . 1.1 m -132.25 125.99 32.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.368 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 98' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' E' ' 97' ' ' THR . 66.1 m-20 66.64 25.84 9.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.45 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 99' ' ' VAL . . . . . 0.647 HG12 HG21 ' D' ' 16' ' ' VAL . 0.2 OUTLIER -127.74 130.37 70.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.691 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.15 -161.38 10.77 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.463 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.89 131.97 64.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.025 0.53 . . . . 0.0 111.773 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 102' ' ' GLN . . . . . 0.714 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 1.5 tt0 -98.48 151.47 20.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.882 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 103' ' ' ILE . . . . . 0.526 ' N ' ' HG2' ' E' ' 102' ' ' GLN . 0.3 OUTLIER -117.36 128.73 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.498 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 104' ' ' LEU . . . . . 0.78 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 0.3 OUTLIER -103.03 133.5 48.05 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.62 0.248 . . . . 0.0 111.108 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . 0.528 ' HB3' HG23 ' E' ' 107' ' ' THR . 7.1 t0 -87.73 158.37 18.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.67 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 106' ' ' ARG . . . . . 0.461 ' HD2' HG23 ' B' ' 83' ' ' THR . 7.9 ttp85 -70.49 -27.68 64.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.778 0.323 . . . . 0.0 111.096 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 107' ' ' THR . . . . . 0.528 HG23 ' HB3' ' E' ' 105' ' ' ASP . 2.8 t -51.71 -25.72 7.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.058 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.21 -39.31 1.72 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.572 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.25 158.01 17.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 111.074 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 110' ' ' ALA . . . . . 0.78 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -70.36 137.17 50.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 111' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' E' ' 72' ' ' ALA . 13.5 tp -87.52 158.31 18.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.347 0.594 . . . . 0.0 110.49 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 112' ' ' THR . . . . . 0.688 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 0.5 OUTLIER -101.73 141.98 33.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.107 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 113' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' E' ' 73' ' ' PHE . 1.9 mt -82.43 65.61 7.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 110.778 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.04 -15.05 21.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.478 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.29 -54.21 0.7 Allowed Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.668 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.06 28.79 8.39 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.028 0.442 . . . . 0.0 111.741 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.74 76.66 7.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.225 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 118' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' E' ' 71' ' ' VAL . 91.6 m-85 -91.11 96.75 10.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.781 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 68.6 m -132.62 78.24 1.79 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.828 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.67 136.91 3.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.662 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.06 76.21 0.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.294 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.88 135.59 33.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.674 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 123' ' ' THR . . . . . 0.51 ' HA ' ' HZ1' ' E' ' 68' ' ' LYS . 11.8 m -77.09 96.36 4.43 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.738 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . 0.495 ' O ' HG23 ' E' ' 63' ' ' THR . 10.8 tp -68.24 132.97 48.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.591 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 125' ' ' ASN . . . . . 0.493 ' HA ' ' HG1' ' E' ' 63' ' ' THR . 2.3 m120 -128.5 166.78 18.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.603 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 126' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' E' ' 61' ' ' CYS . 6.3 t30 -79.4 105.66 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.683 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.08 -137.08 5.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.652 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 128' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 3.7 m -103.65 83.44 2.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.688 0.28 . . . . 0.0 110.832 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 129' ' ' ASN . . . . . 0.671 ' HB2' ' SG ' ' E' ' 61' ' ' CYS . 1.7 t30 -71.0 139.87 50.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.905 0.383 . . . . 0.0 111.163 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 130' ' ' THR . . . . . 0.809 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.2 OUTLIER -133.91 139.66 46.3 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.161 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 131' ' ' ILE . . . . . 0.618 HD11 HG13 ' E' ' 71' ' ' VAL . 61.8 mt -98.03 110.48 56.01 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 132' ' ' PRO . . . . . 0.745 ' HB3' ' HA ' ' B' ' 76' ' ' THR . 7.6 Cg_endo -81.86 135.16 8.73 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 121.792 1.661 . . . . 0.0 112.533 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 133' ' ' PHE . . . . . 0.474 ' O ' HG21 ' B' ' 76' ' ' THR . 0.6 OUTLIER -143.76 152.64 41.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.815 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 134' ' ' GLN . . . . . 0.638 ' HB3' ' HB3' ' E' ' 51' ' ' ALA . 50.5 mt-30 -118.97 156.86 28.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.099 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 135' ' ' ALA . . . . . 0.714 ' HA ' ' O ' ' E' ' 102' ' ' GLN . . . -151.39 101.71 2.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 111.649 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.58 168.32 9.17 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.404 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 137' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' E' ' 48' ' ' THR . 0.3 OUTLIER -80.04 123.24 27.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.175 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 138' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' E' ' 47' ' ' ALA . 1.3 t80 -126.13 119.13 26.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.064 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 139' ' ' ALA . . . . . 0.617 ' HB3' HD21 ' E' ' 42' ' ' LEU . . . -111.98 125.22 53.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.867 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 140' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 0.2 OUTLIER -68.89 -48.24 63.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.546 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -133.1 -119.96 2.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.085 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.42 111.96 18.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.612 0.244 . . . . 0.0 110.718 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 143' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -61.95 113.89 3.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.803 0.335 . . . . 0.0 111.361 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 144' ' ' THR . . . . . 0.763 ' HB ' ' H ' ' E' ' 97' ' ' THR . 73.7 m -88.34 145.31 35.49 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.324 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 145' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' E' ' 144' ' ' THR . 1.3 Cg_endo -82.86 134.22 7.14 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.463 2.109 . . . . 0.0 112.019 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.87 -135.62 4.43 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.535 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 147' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' E' ' 94' ' ' GLY . . . -96.12 134.19 39.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.392 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.8 50.51 2.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.131 0.491 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 149' ' ' ASN . . . . . 0.433 HD21 ' HG2' ' D' ' 13' ' ' LYS . 3.5 m120 -98.97 146.13 26.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.501 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 150' ' ' ALA . . . . . 0.556 ' HB2' HD11 ' E' ' 86' ' ' LEU . . . -154.96 174.13 15.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.875 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -139.3 128.45 23.88 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.192 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 152' ' ' ALA . . . . . 0.45 ' HB3' HD12 ' E' ' 86' ' ' LEU . . . -118.41 133.29 56.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.193 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.91 147.36 23.03 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.22 130.3 53.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.182 0.515 . . . . 0.0 110.054 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 155' ' ' LYS . . . . . 0.557 ' HE2' HD11 ' E' ' 74' ' ' LEU . 11.2 mmtt -126.63 143.91 51.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.911 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 156' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.42 151.82 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.775 0.322 . . . . 0.0 111.729 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 157' ' ' GLN . . . . . 0.664 ' HA ' ' O ' ' D' ' 3' ' ' THR . 0.0 OUTLIER -141.34 121.19 13.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.326 0.584 . . . . 0.0 110.341 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 158' ' ' TYR . . . . . 0.568 ' CD2' ' HB ' ' D' ' 3' ' ' THR . 1.2 m-85 -98.31 121.66 40.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.532 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.82 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.251 0.072 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.72 71.03 0.51 Allowed 'General case' 0 CA--C 1.528 0.124 0 O-C-N 123.11 0.256 . . . . 0.0 110.972 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 4.9 m -114.69 127.38 55.73 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.433 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 20.7 m -117.82 106.74 13.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.587 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.86 174.71 12.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.577 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -97.11 119.89 36.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.553 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.34 -49.41 15.47 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.834 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.27 -154.87 11.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.862 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -142.46 140.07 31.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.985 0.421 . . . . 0.0 111.222 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.79 113.8 41.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.18 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -87.07 110.35 20.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.358 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -90.32 111.55 22.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.744 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 13' ' ' LYS . . . . . 0.498 ' HE3' HG11 ' F' ' 28' ' ' VAL . 3.7 tmtm? -102.97 110.6 22.58 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.39 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.25 168.38 22.6 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.962 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -159.09 133.02 7.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.893 0.378 . . . . 0.0 110.446 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 13.1 t -99.62 143.19 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.258 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.41 -172.12 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.867 0.365 . . . . 0.0 110.987 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.51 -177.0 5.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.073 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.83 47.01 1.37 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.073 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' F' ' 66' ' ' ALA . . . -127.77 -29.98 2.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.434 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 21' ' ' CYS . . . . . 1.006 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER -163.19 158.33 21.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.906 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.34 118.61 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.045 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 23' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' F' ' 58' ' ' LEU . 0.8 OUTLIER -66.29 153.06 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.986 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -84.82 158.72 20.58 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.606 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' D' ' 91' ' ' SER . . . -60.99 -34.43 74.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.386 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.08 13.11 63.65 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.97 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.83 -22.43 10.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.796 0.332 . . . . 0.0 110.701 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 28' ' ' VAL . . . . . 0.498 HG11 ' HE3' ' F' ' 13' ' ' LYS . 19.8 t -44.05 -64.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.368 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.1 135.92 41.78 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.925 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.23 125.72 20.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.008 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.79 106.51 18.79 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.06 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.76 117.05 53.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.196 0.522 . . . . 0.0 110.445 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.66 131.06 45.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.607 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.79 -47.41 7.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.616 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.39 -163.62 12.15 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.581 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 36' ' ' GLN . . . . . 0.674 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 3.7 mt-30 -100.97 126.59 47.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.688 0.28 . . . . 0.0 110.863 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.573 ' O ' HG22 ' E' ' 17' ' ' VAL . 14.9 p -110.36 146.84 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.912 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 38' ' ' ARG . . . . . 0.591 HH22 ' HB2' ' E' ' 62' ' ' ASP . 2.8 mtp180 -82.9 139.14 33.59 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.678 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 39' ' ' THR . . . . . 0.551 HG22 ' HA ' ' E' ' 18' ' ' ASN . 5.4 t -62.71 -37.51 86.78 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.762 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.46 -31.49 71.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.095 0.474 . . . . 0.0 110.837 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.03 -17.73 45.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.147 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . 0.634 HD21 ' HB3' ' F' ' 139' ' ' ALA . 4.3 mp -125.69 33.08 5.17 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.671 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.7 18.84 18.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.365 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.95 130.36 52.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.313 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' F' ' 140' ' ' THR . 22.5 tt0 -56.36 107.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.864 0.364 . . . . 0.0 111.027 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.64 30.42 5.86 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.179 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 47' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' F' ' 138' ' ' PHE . . . -76.57 136.7 39.26 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.95 0.405 . . . . 0.0 112.071 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 48' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' F' ' 137' ' ' TYR . 52.3 p -134.92 134.66 40.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.891 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 49' ' ' SER . . . . . 0.515 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 70.8 m -108.68 -168.23 1.32 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.657 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 50' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' C' ' 92' ' ' ALA . 23.1 t -63.89 128.47 35.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.807 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 51' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' F' ' 134' ' ' GLN . . . -80.44 130.02 34.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.406 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 52' ' ' VAL . . . . . 0.766 ' HB ' ' HA ' ' C' ' 90' ' ' SER . 2.8 m -74.84 151.25 6.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.97 119.21 5.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.622 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.86 152.1 30.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.711 0.291 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -148.77 162.99 38.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.643 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 56' ' ' ILE . . . . . 0.449 HG22 ' O ' ' F' ' 56' ' ' ILE . 1.2 tp -105.92 114.76 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.585 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 57' ' ' GLN . . . . . 0.805 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.0 OUTLIER -70.61 124.51 24.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.761 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' F' ' 23' ' ' VAL . 0.2 OUTLIER -132.35 88.81 2.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.192 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 59' ' ' ASN . . . . . 0.57 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 0.1 OUTLIER -75.35 169.52 17.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.34 68.26 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.787 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 61' ' ' CYS . . . . . 1.006 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 56.3 m -117.13 155.02 30.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.829 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -135.8 155.67 49.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.227 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 63' ' ' THR . . . . . 0.482 HG23 ' O ' ' F' ' 124' ' ' LEU . 0.2 OUTLIER -111.13 -34.23 6.24 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.09 -22.1 66.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.069 0.461 . . . . 0.0 111.759 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.61 -59.56 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.744 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 66' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' F' ' 20' ' ' ALA . . . -116.74 129.12 55.93 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.617 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -60.27 2.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.959 0.409 . . . . 0.0 111.052 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 68' ' ' LYS . . . . . 0.507 ' HZ1' ' HA ' ' F' ' 123' ' ' THR . 0.2 OUTLIER -105.22 -175.41 2.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.47 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.93 131.34 9.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.607 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.02 151.19 24.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.025 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 71' ' ' VAL . . . . . 0.618 HG13 HD11 ' F' ' 131' ' ' ILE . 2.0 t -129.48 158.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.704 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 72' ' ' ALA . . . . . 0.555 ' HA ' HD23 ' F' ' 111' ' ' LEU . . . -152.66 143.02 22.57 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.626 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 73' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' F' ' 113' ' ' LEU . 0.1 OUTLIER -112.23 141.44 45.94 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.663 0.268 . . . . 0.0 111.049 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 74' ' ' LEU . . . . . 0.574 HD11 ' HE2' ' F' ' 155' ' ' LYS . 0.3 OUTLIER -107.63 139.54 42.01 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.981 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.76 -179.51 46.87 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.83 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 76' ' ' THR . . . . . 0.523 ' H ' HD21 ' F' ' 86' ' ' LEU . 0.3 OUTLIER -103.92 156.34 17.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.535 0.207 . . . . 0.0 110.819 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.34 118.44 21.25 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.877 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 78' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' F' ' 82' ' ' HIS . 0.4 OUTLIER -59.1 -29.08 40.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.834 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 79' ' ' ASP . . . . . 0.407 ' HB2' HG22 ' F' ' 140' ' ' THR . 0.1 OUTLIER -151.7 50.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.781 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.2 -89.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.095 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.09 -32.54 42.97 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.596 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 82' ' ' HIS . . . . . 0.564 ' HB3' HG22 ' F' ' 78' ' ' ILE . 0.3 OUTLIER -81.14 62.86 5.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.886 0.374 . . . . 0.0 110.414 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.53 -18.23 60.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.633 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 84' ' ' ASN . . . . . 0.69 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 20.4 p-10 -76.02 -7.4 54.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.258 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 85' ' ' VAL . . . . . 0.486 ' HB ' ' CG2' ' F' ' 78' ' ' ILE . 23.8 t -117.72 124.14 72.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.224 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 86' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' F' ' 150' ' ' ALA . 0.5 OUTLIER -66.18 139.38 58.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.715 0.293 . . . . 0.0 110.266 179.454 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 87' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' F' ' 150' ' ' ALA . . . -84.85 -165.37 1.17 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.741 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . 0.742 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 0.7 OUTLIER -71.87 168.65 17.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.056 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.91 -79.18 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.351 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p -168.87 6.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 111.549 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 91' ' ' SER . . . . . 0.601 ' O ' ' HB2' ' F' ' 95' ' ' SER . 69.4 m -77.62 83.24 4.01 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.04 -34.67 63.73 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.606 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.26 31.5 6.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.58 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 94' ' ' GLY . . . . . 0.636 ' O ' ' HB3' ' F' ' 147' ' ' ALA . . . -156.63 7.59 0.23 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.907 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 95' ' ' SER . . . . . 0.742 ' HB3' ' HG ' ' F' ' 88' ' ' LEU . 0.6 OUTLIER -110.87 -174.32 2.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.834 0.349 . . . . 0.0 110.553 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 96' ' ' ALA . . . . . 0.459 ' CB ' HG23 ' E' ' 16' ' ' VAL . . . -97.76 179.0 4.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 97' ' ' THR . . . . . 0.749 ' H ' ' HB ' ' F' ' 144' ' ' THR . 1.1 m -132.32 125.98 32.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.316 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 98' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' F' ' 97' ' ' THR . 66.1 m-20 66.66 25.8 9.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.451 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 99' ' ' VAL . . . . . 0.646 HG12 HG21 ' E' ' 16' ' ' VAL . 0.2 OUTLIER -127.66 130.35 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.711 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.11 -161.37 10.75 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.492 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.89 131.88 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.122 0.569 . . . . 0.0 111.868 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 102' ' ' GLN . . . . . 0.712 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 1.5 tt0 -98.41 151.52 20.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.897 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 103' ' ' ILE . . . . . 0.519 ' N ' ' HG2' ' F' ' 102' ' ' GLN . 0.3 OUTLIER -117.36 128.65 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.503 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 104' ' ' LEU . . . . . 0.794 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 0.3 OUTLIER -103.04 133.52 48.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.647 0.261 . . . . 0.0 111.083 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . 0.535 ' HB3' HG23 ' F' ' 107' ' ' THR . 7.2 t0 -87.71 158.37 18.83 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.658 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 106' ' ' ARG . . . . . 0.458 ' HD2' HG23 ' C' ' 83' ' ' THR . 7.9 ttp85 -70.4 -27.75 64.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.778 0.323 . . . . 0.0 111.082 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 107' ' ' THR . . . . . 0.535 HG23 ' HB3' ' F' ' 105' ' ' ASP . 2.8 t -51.72 -25.72 7.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.056 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.26 -39.37 1.71 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.574 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.26 158.01 17.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 0.0 111.079 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 110' ' ' ALA . . . . . 0.794 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -70.3 137.11 50.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.034 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 111' ' ' LEU . . . . . 0.555 HD23 ' HA ' ' F' ' 72' ' ' ALA . 13.5 tp -87.53 158.38 18.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.338 0.589 . . . . 0.0 110.533 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 112' ' ' THR . . . . . 0.69 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 0.5 OUTLIER -101.76 141.93 33.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.107 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 113' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' F' ' 73' ' ' PHE . 1.9 mt -82.33 65.58 7.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.7 0.286 . . . . 0.0 110.725 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.08 -14.97 21.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.521 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.21 -54.11 0.71 Allowed Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.661 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.19 28.97 8.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.066 0.46 . . . . 0.0 111.719 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.85 76.61 7.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.17 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 118' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' F' ' 71' ' ' VAL . 91.6 m-85 -91.07 96.77 10.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.746 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 67.8 m -132.6 78.22 1.79 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.764 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.7 136.97 3.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.688 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.09 76.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.276 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.9 135.59 33.62 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.635 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 123' ' ' THR . . . . . 0.507 ' HA ' ' HZ1' ' F' ' 68' ' ' LYS . 12.0 m -77.09 96.25 4.41 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.763 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . 0.488 ' HA ' HD12 ' F' ' 124' ' ' LEU . 10.8 tp -68.19 132.97 48.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.582 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 125' ' ' ASN . . . . . 0.471 ' HA ' ' HG1' ' F' ' 63' ' ' THR . 2.2 m120 -128.47 166.77 18.12 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.552 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -79.41 105.74 10.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.743 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.02 -137.09 5.24 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.689 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 128' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 3.7 m -103.59 83.45 2.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.686 0.279 . . . . 0.0 110.847 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 129' ' ' ASN . . . . . 0.677 ' HB2' ' SG ' ' F' ' 61' ' ' CYS . 1.7 t30 -70.98 139.87 50.7 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.887 0.375 . . . . 0.0 111.165 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 130' ' ' THR . . . . . 0.805 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.2 OUTLIER -133.96 139.69 46.27 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.109 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 131' ' ' ILE . . . . . 0.618 HD11 HG13 ' F' ' 71' ' ' VAL . 61.8 mt -98.08 110.55 56.39 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 132' ' ' PRO . . . . . 0.743 ' HB3' ' HA ' ' C' ' 76' ' ' THR . 7.6 Cg_endo -81.82 135.13 8.76 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.796 1.664 . . . . 0.0 112.558 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 133' ' ' PHE . . . . . 0.468 ' O ' HG21 ' C' ' 76' ' ' THR . 0.6 OUTLIER -143.74 152.68 41.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.727 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 134' ' ' GLN . . . . . 0.63 ' HB3' ' HB3' ' F' ' 51' ' ' ALA . 50.5 mt-30 -119.0 156.9 28.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.096 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 135' ' ' ALA . . . . . 0.712 ' HA ' ' O ' ' F' ' 102' ' ' GLN . . . -151.42 101.69 2.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.808 0.337 . . . . 0.0 111.641 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.59 168.33 9.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.373 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 137' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' F' ' 48' ' ' THR . 0.3 OUTLIER -80.09 123.3 27.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.113 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 138' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' F' ' 47' ' ' ALA . 1.3 t80 -126.18 119.05 26.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.051 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 139' ' ' ALA . . . . . 0.634 ' HB3' HD21 ' F' ' 42' ' ' LEU . . . -111.98 125.17 53.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.853 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 140' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' F' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.26 63.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.508 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -133.09 -120.05 2.08 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.058 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.27 111.91 18.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.548 0.213 . . . . 0.0 110.815 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 143' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -61.91 113.86 3.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.815 0.341 . . . . 0.0 111.405 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 144' ' ' THR . . . . . 0.749 ' HB ' ' H ' ' F' ' 97' ' ' THR . 75.1 m -88.28 145.22 35.4 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.317 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.81 134.17 7.17 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.524 2.149 . . . . 0.0 111.978 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.94 -135.59 4.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.537 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 147' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' F' ' 94' ' ' GLY . . . -96.21 134.2 39.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.966 0.412 . . . . 0.0 111.312 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.82 50.48 2.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.184 0.516 . . . . 0.0 110.469 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 149' ' ' ASN . . . . . 0.435 HD21 ' HG2' ' E' ' 13' ' ' LYS . 3.5 m120 -98.92 146.16 26.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.491 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 150' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' F' ' 86' ' ' LEU . . . -154.91 174.12 15.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.876 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -139.34 128.49 23.87 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.225 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 152' ' ' ALA . . . . . 0.443 ' HB3' HD12 ' F' ' 86' ' ' LEU . . . -118.41 133.38 55.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.159 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.02 147.42 22.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.24 130.28 53.42 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.143 0.497 . . . . 0.0 110.085 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 155' ' ' LYS . . . . . 0.574 ' HE2' HD11 ' F' ' 74' ' ' LEU . 11.3 mmtt -126.71 144.02 51.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.874 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 156' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.42 151.9 34.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.677 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 157' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' E' ' 3' ' ' THR . 0.0 OUTLIER -141.35 121.18 13.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.237 0.542 . . . . 0.0 110.365 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 158' ' ' TYR . . . . . 0.57 ' CD2' ' HB ' ' E' ' 3' ' ' THR . 1.2 m-85 -98.25 121.65 40.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.539 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.802 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.658 ' H ' ' HA ' ' B' ' 159' ' ' GLN . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.533 0.206 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.575 ' OG1' ' HB2' ' B' ' 158' ' ' TYR . 6.2 p -117.73 97.5 5.88 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.499 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.615 HG23 ' HB2' ' B' ' 157' ' ' GLN . 68.4 p -87.86 108.7 19.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.576 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.573 HG12 HG12 ' B' ' 17' ' ' VAL . 15.4 m -126.63 172.77 13.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.592 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -77.2 110.77 12.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.587 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.69 -59.41 7.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.772 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.56 151.71 14.94 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.818 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.418 HG21 ' N ' ' A' ' 10' ' ' VAL . 24.2 m -103.54 143.13 33.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 111.279 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.477 HG22 ' HE1' ' A' ' 12' ' ' PHE . 1.2 m -130.94 115.61 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.208 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.62 105.77 14.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.398 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.477 ' HE1' HG22 ' A' ' 10' ' ' VAL . 52.1 m-85 -83.25 105.55 14.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.782 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.52 145.05 41.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.455 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.75 -179.72 42.55 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.958 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.15 134.23 22.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.0 110.376 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' B' ' 145' ' ' PRO . 3.3 t -90.85 127.14 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.286 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.506 HG11 ' HG2' ' B' ' 36' ' ' GLN . 12.1 m -126.25 168.77 18.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -100.42 81.79 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.154 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.439 ' HA ' ' HG2' ' B' ' 38' ' ' ARG . . . 53.3 58.17 5.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.071 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.484 ' HB3' HG21 ' A' ' 17' ' ' VAL . . . -108.55 -62.86 1.4 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.36 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.914 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.9 OUTLIER -171.56 -159.94 0.16 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.915 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.6 ' HA ' ' HB2' ' B' ' 36' ' ' GLN . . . -156.88 74.01 0.78 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.781 ' HB ' HD22 ' A' ' 58' ' ' LEU . 7.4 p -45.35 140.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.42 140.74 58.9 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.661 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.36 -51.15 69.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.311 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.11 -18.04 74.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.919 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.96 -6.39 58.04 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.832 0.349 . . . . 0.0 110.786 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.448 HG12 ' HG2' ' B' ' 33' ' ' GLN . 50.9 t -72.63 -36.37 53.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.426 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.95 110.82 14.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.969 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.78 146.05 48.6 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.033 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.21 113.84 27.67 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.127 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.08 121.93 57.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.108 0.48 . . . . 0.0 110.448 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.86 106.41 17.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.683 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.481 ' HA ' HD11 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -64.79 -44.74 89.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.592 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.62 -156.9 15.99 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.568 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -91.07 107.01 18.91 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.596 0.236 . . . . 0.0 110.847 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.3 t -92.34 120.63 41.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.918 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 -85.71 132.49 34.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.746 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.0 p -71.45 -23.32 61.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.756 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.03 -19.19 64.88 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.965 0.412 . . . . 0.0 110.793 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.8 t -90.53 -36.55 14.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.183 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.594 ' HB2' ' HB1' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -121.52 70.52 0.94 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.58 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 142' ' ' ALA . . . -104.76 28.18 7.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.38 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.681 ' HG3' ' HB1' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -150.58 142.01 23.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.384 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.428 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 2.7 tt0 -62.7 101.79 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.777 0.322 . . . . 0.0 111.136 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.3 4.27 8.41 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.062 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.681 ' HB1' ' HG3' ' A' ' 44' ' ' GLN . . . -91.76 121.2 33.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.002 0.43 . . . . 0.0 111.985 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 5.8 t -110.3 151.2 27.68 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.806 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -95.7 -57.62 2.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.594 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.24 -174.88 4.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.853 0.359 . . . . 0.0 110.817 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.68 ' HB3' ' HG2' ' A' ' 136' ' ' ARG . . . -127.05 143.87 51.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.387 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.85 116.86 51.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.972 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.19 122.64 6.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.67 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -128.58 138.83 52.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.33 . . . . 0.0 110.978 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.57 HD21 HG21 ' A' ' 130' ' ' THR . 1.6 m120 -117.86 150.95 38.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.657 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.569 ' HB ' HG13 ' A' ' 131' ' ' ILE . 9.3 mm -106.78 103.67 15.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.57 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.21 132.23 52.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.783 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.781 HD22 ' HB ' ' A' ' 23' ' ' VAL . 1.0 OUTLIER -137.31 151.87 49.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.256 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -138.45 171.27 14.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.983 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 5.9 m-20 50.1 68.42 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.914 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -106.59 141.14 38.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.764 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.84 117.89 33.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.24 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.7 p -91.12 -13.18 33.52 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.62 -38.95 82.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.069 0.462 . . . . 0.0 111.765 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.65 -54.11 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.645 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.7 84.31 3.35 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.582 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.98 -41.21 10.13 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.805 0.336 . . . . 0.0 111.023 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.63 159.96 17.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.518 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.7 160.4 39.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.616 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.02 152.91 45.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.133 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.89 136.54 53.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.722 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.0 107.45 5.04 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.555 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CD2' HD12 ' A' ' 103' ' ' ILE . 43.1 t80 -73.65 136.66 43.86 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.605 0.24 . . . . 0.0 111.025 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.751 HD11 ' HG2' ' D' ' 57' ' ' GLN . 6.6 tt -113.56 111.41 21.84 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.978 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.696 ' HA3' HD12 ' A' ' 113' ' ' LEU . . . -131.29 -178.49 15.5 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.864 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.462 HG21 ' O ' ' D' ' 53' ' ' GLY . 0.2 OUTLIER -104.32 137.58 42.0 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.461 0.172 . . . . 0.0 110.857 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.98 114.78 23.89 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.992 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.596 ' O ' ' HG2' ' D' ' 134' ' ' GLN . 1.2 tt -95.7 -36.73 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.867 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.459 ' HB3' ' CG2' ' A' ' 140' ' ' THR . 0.4 OUTLIER -143.38 130.23 20.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.746 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.92 -7.18 47.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.046 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.33 -29.19 68.39 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.587 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.34 -32.64 4.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.88 0.371 . . . . 0.0 110.459 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.5 m 60.49 19.42 9.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.589 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.612 ' HB3' ' HG2' ' A' ' 102' ' ' GLN . 0.6 OUTLIER -139.37 -16.99 1.03 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.296 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.697 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 0.9 OUTLIER -66.67 118.02 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.244 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.537 ' HA ' HD21 ' A' ' 113' ' ' LEU . 10.7 tp -69.72 144.17 52.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.264 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.2 138.09 36.78 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.917 0.389 . . . . 0.0 111.721 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.662 ' HB3' ' HA ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -84.95 -146.62 0.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.068 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.53 155.02 0.58 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.268 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.4 p -86.73 -11.92 49.75 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.923 0.392 . . . . 0.0 111.503 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.42 114.08 5.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' D' ' 50' ' ' SER . . . -83.38 22.19 1.06 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.951 0.405 . . . . 0.0 111.683 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.21 21.97 1.21 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.698 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.64 -32.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.017 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.628 ' HA ' ' HB1' ' A' ' 147' ' ' ALA . 15.9 t -65.14 166.73 9.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.866 0.365 . . . . 0.0 110.616 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.65 163.44 15.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.665 HG21 ' HB1' ' D' ' 51' ' ' ALA . 0.0 OUTLIER -135.42 169.66 17.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.34 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 57.4 29.34 16.78 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.383 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.508 ' HB ' ' CB ' ' A' ' 143' ' ' ALA . 7.2 p -156.38 150.6 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.825 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.697 ' HA3' ' HB ' ' A' ' 85' ' ' VAL . . . -164.2 176.93 40.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.609 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.63 111.29 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.018 0.527 . . . . 0.0 111.713 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.612 ' HG2' ' HB3' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -75.97 179.75 5.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.958 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 113' ' ' LEU . 6.0 pt -150.36 116.54 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.457 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 12.9 tp -97.22 122.54 40.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.724 0.297 . . . . 0.0 111.068 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.91 150.08 42.92 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.739 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.509 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -71.43 -17.58 62.38 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.824 0.345 . . . . 0.0 111.121 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 76.1 p -76.62 -37.22 56.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.11 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.52 -68.81 0.32 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.732 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.61 123.2 18.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.795 0.331 . . . . 0.0 111.129 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.74 117.99 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.184 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 tp -67.87 144.1 55.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.43 0.633 . . . . 0.0 110.491 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.42 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -75.11 140.45 43.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.071 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.696 HD12 ' HA3' ' A' ' 75' ' ' GLY . 1.3 tp -85.18 97.75 10.08 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.701 0.286 . . . . 0.0 110.668 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -152.78 -59.01 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.645 0.26 . . . . 0.0 111.582 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.556 ' HA3' ' OG1' ' D' ' 130' ' ' THR . . . 135.73 -26.63 3.14 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.615 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.534 ' HB1' ' HA ' ' D' ' 129' ' ' ASN . . . -101.27 28.78 5.15 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.994 0.426 . . . . 0.0 111.692 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.58 67.34 0.72 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.075 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.4 81.0 8.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.737 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.04 97.45 3.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.0 t -165.54 144.79 6.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.587 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.28 50.22 0.9 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.204 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.8 94.18 5.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.715 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.69 110.38 12.47 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.679 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.598 ' HG ' ' ND2' ' A' ' 129' ' ' ASN . 0.3 OUTLIER -70.2 154.15 42.26 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.578 179.42 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.6 144.77 51.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.552 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.74 125.67 24.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.653 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.1 -102.01 1.1 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.725 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 58' ' ' LEU . 86.9 m -106.23 128.45 53.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.655 0.264 . . . . 0.0 110.831 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.598 ' ND2' ' HG ' ' A' ' 124' ' ' LEU . 20.1 t-20 -121.15 158.13 28.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.874 0.368 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.57 HG21 HD21 ' A' ' 55' ' ' ASN . 0.2 OUTLIER -155.81 143.08 19.27 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.996 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -115.22 110.79 45.14 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.509 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.4 Cg_endo -82.21 151.85 15.95 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.618 1.546 . . . . 0.0 112.5 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.01 146.77 17.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.797 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.8 OUTLIER -114.38 145.83 41.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.108 179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.77 91.17 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 111.679 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.68 ' HG2' ' HB3' ' A' ' 51' ' ' ALA . 28.0 mtm-85 -88.34 153.6 21.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.405 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 48' ' ' THR . 0.7 OUTLIER -91.29 111.06 22.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.071 179.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.594 ' CD1' ' HB2' ' A' ' 102' ' ' GLN . 8.8 m-85 -108.08 172.19 6.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.962 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -123.42 143.65 50.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.851 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.459 ' CG2' ' HB3' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -98.73 44.39 1.03 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.565 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.48 89.07 1.07 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.978 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . . . 60.09 88.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.709 0.255 . . . . 0.0 110.689 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.514 ' HB2' HD12 ' A' ' 42' ' ' LEU . . . -70.61 161.73 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.405 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 158.73 60.65 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.226 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.76 149.18 12.55 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.54 2.16 . . . . 0.0 112.06 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.72 -119.73 0.86 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.479 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.628 ' HB1' ' HA ' ' A' ' 95' ' ' SER . . . -123.94 127.71 48.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.861 0.362 . . . . 0.0 111.417 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.662 ' HA ' ' HB3' ' A' ' 88' ' ' LEU . . . -120.85 67.17 0.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.117 0.484 . . . . 0.0 110.389 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -128.47 114.77 17.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.6 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -158.83 146.97 18.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.984 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.39 140.3 32.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.171 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.19 169.28 17.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.176 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' A' ' 74' ' ' LEU . 9.3 t -155.11 150.52 27.25 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.435 ' HE1' HG13 ' A' ' 56' ' ' ILE . 1.1 p90 -118.97 149.27 41.91 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.121 0.486 . . . . 0.0 110.083 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.668 ' HD2' HG21 ' D' ' 128' ' ' THR . 4.7 mttt -113.53 156.68 23.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.869 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.533 HG13 HD12 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -136.48 137.98 47.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.684 -179.058 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -107.5 128.03 54.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.318 0.58 . . . . 0.0 110.37 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -107.87 107.43 18.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.542 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.851 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.209 0.052 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . 0.661 ' H ' ' HA ' ' C' ' 159' ' ' GLN . . . 65.84 74.75 0.36 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.579 0.228 . . . . 0.0 110.98 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.587 ' OG1' ' HB2' ' C' ' 158' ' ' TYR . 6.2 p -117.74 97.56 5.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.46 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.613 HG23 ' HB2' ' C' ' 157' ' ' GLN . 67.9 p -87.91 108.61 19.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.527 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.567 HG12 HG12 ' C' ' 17' ' ' VAL . 15.4 m -126.51 172.75 13.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.59 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -77.24 110.86 12.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.494 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.76 -59.42 7.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.765 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.56 151.64 14.79 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.81 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.416 HG21 ' N ' ' B' ' 10' ' ' VAL . 24.2 m -103.44 143.09 33.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 111.357 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.485 HG22 ' HE1' ' B' ' 12' ' ' PHE . 1.2 m -130.98 115.63 30.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.186 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.65 105.71 14.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.349 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . 0.485 ' HE1' HG22 ' B' ' 10' ' ' VAL . 52.2 m-85 -83.17 105.47 14.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.783 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.46 145.07 41.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.446 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.74 -179.69 42.57 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.932 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.19 134.27 22.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.94 0.4 . . . . 0.0 110.306 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.458 ' HB ' ' HA ' ' C' ' 145' ' ' PRO . 3.3 t -90.9 127.16 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.264 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.573 HG12 HG12 ' A' ' 5' ' ' VAL . 12.1 m -126.25 168.75 18.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.86 0.362 . . . . 0.0 111.037 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.48 81.82 2.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.12 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.424 ' HA ' ' HG2' ' C' ' 38' ' ' ARG . . . 53.38 58.15 5.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.997 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.49 ' HB3' HG21 ' B' ' 17' ' ' VAL . . . -108.57 -62.82 1.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.442 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.9 OUTLIER -171.54 -159.86 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.914 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.603 ' HA ' ' HB2' ' C' ' 36' ' ' GLN . . . -156.84 74.07 0.79 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.799 ' HB ' HD22 ' B' ' 58' ' ' LEU . 7.4 p -45.44 140.62 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.958 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.43 140.81 58.91 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.642 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.44 -51.15 69.5 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.307 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.08 -18.01 74.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.964 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -88.0 -6.32 58.05 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.827 0.346 . . . . 0.0 110.756 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.442 HG12 ' HG2' ' C' ' 33' ' ' GLN . 50.5 t -72.78 -36.31 52.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.359 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.03 110.85 14.03 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.002 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.85 146.01 48.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.021 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.19 113.84 27.68 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.128 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.08 121.91 57.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.105 0.478 . . . . 0.0 110.475 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.448 ' HG2' HG12 ' A' ' 28' ' ' VAL . 0.6 OUTLIER -101.84 106.37 17.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.721 -179.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.507 HD11 ' HA ' ' B' ' 34' ' ' LEU . 0.6 OUTLIER -64.69 -44.75 89.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.642 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.58 -156.91 16.0 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.558 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.6 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 3.7 mt-30 -91.1 106.98 18.9 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.629 0.252 . . . . 0.0 110.851 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 t -92.32 120.59 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.938 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.439 ' HG2' ' HA ' ' A' ' 19' ' ' ALA . 4.6 mtm105 -85.67 132.51 34.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.71 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 29.4 p -71.54 -23.21 61.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.755 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.08 -19.06 64.83 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.996 0.427 . . . . 0.0 110.844 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -90.6 -36.6 14.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.167 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.588 ' HB2' ' HB1' ' B' ' 139' ' ' ALA . 0.2 OUTLIER -121.48 70.54 0.94 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.61 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' B' ' 142' ' ' ALA . . . -104.7 28.11 7.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.423 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . 0.675 ' HG3' ' HB1' ' B' ' 47' ' ' ALA . 0.0 OUTLIER -150.53 141.99 23.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.45 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.429 ' HG3' ' HA ' ' B' ' 140' ' ' THR . 2.7 tt0 -62.66 101.8 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.769 0.319 . . . . 0.0 111.104 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.26 4.26 8.44 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.099 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.675 ' HB1' ' HG3' ' B' ' 44' ' ' GLN . . . -91.74 121.32 33.27 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.982 0.42 . . . . 0.0 112.015 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' B' ' 137' ' ' TYR . 5.8 t -110.41 151.22 27.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.786 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -95.69 -57.67 2.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.596 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.23 -174.85 4.69 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.76 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . 0.667 ' HB3' ' HG2' ' B' ' 136' ' ' ARG . . . -127.05 143.86 51.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.315 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.9 116.91 51.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.959 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.25 122.67 6.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.66 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -128.62 138.86 52.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.784 0.326 . . . . 0.0 111.0 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.573 HD21 HG21 ' B' ' 130' ' ' THR . 1.6 m120 -117.85 150.93 38.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.677 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.578 ' HB ' HG13 ' B' ' 131' ' ' ILE . 9.3 mm -106.77 103.66 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.607 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -61.15 132.27 53.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.798 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.799 HD22 ' HB ' ' B' ' 23' ' ' VAL . 1.0 OUTLIER -137.39 151.86 49.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.208 -179.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -138.38 171.34 14.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.972 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' B' ' 21' ' ' CYS . 5.9 m-20 49.98 68.48 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 0.0 OUTLIER -106.63 141.08 38.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.8 117.88 33.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.231 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.3 p -91.26 -13.02 33.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.69 -38.89 82.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.114 0.483 . . . . 0.0 111.79 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 76.4 t -107.75 -54.07 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.618 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' B' ' 158' ' ' TYR . . . -97.66 84.39 3.38 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.583 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -41.25 10.05 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.949 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.6 159.96 17.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.529 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.68 160.45 39.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.609 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.09 152.91 45.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.97 136.54 53.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.688 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.02 107.53 5.06 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.556 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.443 ' CD2' HD12 ' B' ' 103' ' ' ILE . 43.2 t80 -73.75 136.69 43.68 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.562 0.22 . . . . 0.0 111.02 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.734 HD11 ' HG2' ' E' ' 57' ' ' GLN . 6.6 tt -113.55 111.44 21.9 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.98 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . 0.697 ' HA3' HD12 ' B' ' 113' ' ' LEU . . . -131.38 -178.6 15.56 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.841 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.456 HG21 ' O ' ' E' ' 53' ' ' GLY . 0.2 OUTLIER -104.28 137.61 41.94 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.478 0.18 . . . . 0.0 110.844 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.98 114.77 23.87 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.895 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.591 ' O ' ' HG2' ' E' ' 134' ' ' GLN . 1.2 tt -95.76 -36.75 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.782 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.456 ' HB3' ' CG2' ' B' ' 140' ' ' THR . 0.4 OUTLIER -143.33 130.22 20.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.93 -7.26 47.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.21 -29.31 68.33 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.665 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 -32.67 4.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.945 0.402 . . . . 0.0 110.502 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' THR . . . . . . . . . . . . . 3.5 m 60.52 19.39 9.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.633 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . 0.619 ' HB3' ' HG2' ' B' ' 102' ' ' GLN . 0.6 OUTLIER -139.35 -17.03 1.03 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.312 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.687 ' HB ' ' HA3' ' B' ' 100' ' ' GLY . 0.9 OUTLIER -66.65 118.08 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.2 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . 0.555 ' HA ' HD21 ' B' ' 113' ' ' LEU . 10.7 tp -69.75 144.13 52.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.374 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.05 137.98 36.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.868 0.366 . . . . 0.0 111.773 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.662 ' HB3' ' HA ' ' B' ' 148' ' ' ALA . 0.0 OUTLIER -84.99 -146.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.11 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' B' ' 149' ' ' ASN . 0.0 OUTLIER -48.59 155.09 0.58 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.256 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 32.5 p -86.79 -11.91 49.58 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.971 0.415 . . . . 0.0 111.496 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.41 114.13 5.19 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.952 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' E' ' 50' ' ' SER . . . -83.45 22.24 1.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.907 0.384 . . . . 0.0 111.653 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.26 21.98 1.2 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.679 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.65 -32.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.024 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' SER . . . . . 0.646 ' HA ' ' HB1' ' B' ' 147' ' ' ALA . 15.9 t -65.08 166.68 9.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.791 0.329 . . . . 0.0 110.666 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.64 163.46 15.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.875 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.662 HG21 ' HB1' ' E' ' 51' ' ' ALA . 0.0 OUTLIER -135.4 169.65 17.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.322 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 57.36 29.36 16.76 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.349 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . 0.509 ' HB ' ' CB ' ' B' ' 143' ' ' ALA . 7.2 p -156.42 150.54 10.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.794 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . 0.687 ' HA3' ' HB ' ' B' ' 85' ' ' VAL . . . -164.17 176.95 40.07 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.541 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.63 111.32 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 123.038 0.535 . . . . 0.0 111.666 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.619 ' HG2' ' HB3' ' B' ' 84' ' ' ASN . 0.0 OUTLIER -75.99 179.75 5.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.955 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' B' ' 113' ' ' LEU . 6.0 pt -150.34 116.59 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.474 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' B' ' 134' ' ' GLN . 12.8 tp -97.31 122.61 40.54 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.765 0.317 . . . . 0.0 110.967 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.88 150.13 42.68 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.639 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . 0.508 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -71.5 -17.55 62.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.763 0.316 . . . . 0.0 111.098 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 75.8 p -76.64 -37.29 56.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.081 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.55 -68.72 0.32 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.689 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.67 123.26 18.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.831 0.348 . . . . 0.0 111.1 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.77 117.98 2.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.18 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 tp -67.82 144.1 55.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.417 0.627 . . . . 0.0 110.494 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.419 ' HA ' ' ND2' ' B' ' 84' ' ' ASN . 0.2 OUTLIER -75.14 140.51 43.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.079 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.697 HD12 ' HA3' ' B' ' 75' ' ' GLY . 1.3 tp -85.2 97.75 10.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.693 0.282 . . . . 0.0 110.619 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -152.83 -58.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.584 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . 0.553 ' HA3' ' OG1' ' E' ' 130' ' ' THR . . . 135.73 -26.58 3.15 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.632 -0.795 . . . . 0.0 112.67 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . 0.55 ' HB1' ' HA ' ' E' ' 129' ' ' ASN . . . -101.35 28.81 5.16 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.998 0.427 . . . . 0.0 111.641 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.57 67.28 0.72 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.059 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.42 81.02 8.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.803 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.06 97.47 3.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.794 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 1.9 t -165.61 144.79 6.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.546 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.34 50.36 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.139 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.79 94.18 5.73 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.676 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.73 110.31 12.46 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.723 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.6 ' HG ' ' ND2' ' B' ' 129' ' ' ASN . 0.3 OUTLIER -70.13 154.09 42.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.657 179.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -131.51 144.76 51.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.629 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.71 125.64 24.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.688 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.09 -102.06 1.11 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.734 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.402 HG22 ' O ' ' B' ' 58' ' ' LEU . 86.9 m -106.16 128.48 53.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.633 0.254 . . . . 0.0 110.859 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . 0.6 ' ND2' ' HG ' ' B' ' 124' ' ' LEU . 20.1 t-20 -121.14 158.18 28.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.896 0.379 . . . . 0.0 111.126 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.573 HG21 HD21 ' B' ' 55' ' ' ASN . 0.2 OUTLIER -155.82 143.08 19.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.982 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' ILE . . . . . 0.578 HG13 ' HB ' ' B' ' 56' ' ' ILE . 0.1 OUTLIER -115.16 110.64 45.43 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' PRO . . . . . 0.508 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -82.14 151.83 16.1 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.609 1.539 . . . . 0.0 112.553 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.01 146.76 17.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.852 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' B' ' 104' ' ' LEU . 0.8 OUTLIER -114.28 145.9 41.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.088 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.89 91.13 1.9 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.913 0.387 . . . . 0.0 111.686 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . 0.667 ' HG2' ' HB3' ' B' ' 51' ' ' ALA . 28.1 mtm-85 -88.33 153.59 21.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.374 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . 0.601 ' O ' ' HA ' ' B' ' 48' ' ' THR . 0.7 OUTLIER -91.24 111.01 22.31 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.129 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . 0.595 ' CD1' ' HB2' ' B' ' 102' ' ' GLN . 8.8 m-85 -108.08 172.17 6.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.029 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.588 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -123.43 143.68 49.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.862 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' THR . . . . . 0.456 ' CG2' ' HB3' ' B' ' 79' ' ' ASP . 0.2 OUTLIER -98.81 44.36 1.03 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.47 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.57 89.08 1.08 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.929 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' B' ' 43' ' ' ALA . . . 59.94 88.1 0.08 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.745 0.272 . . . . 0.0 110.777 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' ALA . . . . . 0.509 ' CB ' ' HB ' ' B' ' 99' ' ' VAL . . . -70.63 161.7 30.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.815 0.34 . . . . 0.0 111.379 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 158.73 60.64 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.213 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.448 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 1.4 Cg_endo -83.81 149.22 12.49 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.502 2.135 . . . . 0.0 112.057 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.69 -119.78 0.86 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.483 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . 0.646 ' HB1' ' HA ' ' B' ' 95' ' ' SER . . . -123.95 127.67 48.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.874 0.369 . . . . 0.0 111.413 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' ALA . . . . . 0.662 ' HA ' ' HB3' ' B' ' 88' ' ' LEU . . . -120.8 67.16 0.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.428 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' B' ' 89' ' ' GLN . 47.5 t-20 -128.45 114.75 17.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.637 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -158.77 147.05 18.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.034 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.45 140.3 32.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.121 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.19 169.31 17.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.208 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' B' ' 74' ' ' LEU . 9.4 t -155.13 150.49 27.19 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' PHE . . . . . 0.433 ' HE1' HG13 ' B' ' 56' ' ' ILE . 1.1 p90 -119.03 149.21 42.05 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.024 0.44 . . . . 0.0 110.107 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . 0.675 ' HD2' HG21 ' E' ' 128' ' ' THR . 4.7 mttt -113.42 156.56 23.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.914 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' VAL . . . . . 0.546 HG13 HD12 ' B' ' 131' ' ' ILE . 0.2 OUTLIER -136.43 138.02 47.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.699 -179.116 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.615 ' HB2' HG23 ' A' ' 4' ' ' THR . 64.1 tt0 -107.46 128.02 54.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.285 0.564 . . . . 0.0 110.369 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' TYR . . . . . 0.575 ' HB2' ' OG1' ' A' ' 3' ' ' THR . 60.9 m-85 -107.81 107.37 18.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.519 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . 0.658 ' HA ' ' H ' ' A' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.272 0.082 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . 0.644 ' H ' ' HA ' ' D' ' 159' ' ' GLN . . . 65.93 74.7 0.36 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.529 0.204 . . . . 0.0 110.929 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 3' ' ' THR . . . . . 0.58 ' OG1' ' HB2' ' D' ' 158' ' ' TYR . 6.0 p -117.74 97.5 5.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.479 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 4' ' ' THR . . . . . 0.638 HG23 ' HB2' ' D' ' 157' ' ' GLN . 67.8 p -87.92 108.74 19.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.529 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . 0.57 HG12 HG12 ' D' ' 17' ' ' VAL . 15.4 m -126.61 172.71 13.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.571 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.15 110.76 12.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.567 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.73 -59.37 7.71 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.792 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.5 151.71 15.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.827 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' THR . . . . . 0.401 HG21 ' N ' ' C' ' 10' ' ' VAL . 24.1 m -103.48 143.11 33.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.855 0.36 . . . . 0.0 111.313 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . 0.476 HG22 ' HE1' ' C' ' 12' ' ' PHE . 1.1 m -130.97 115.65 30.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.134 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -83.62 105.72 14.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.367 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' PHE . . . . . 0.476 ' HE1' HG22 ' C' ' 10' ' ' VAL . 52.2 m-85 -83.19 105.46 14.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.756 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.39 145.06 41.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.422 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.71 -179.68 42.56 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.974 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.23 134.27 22.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.971 0.415 . . . . 0.0 110.358 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.462 HG13 ' HA ' ' D' ' 145' ' ' PRO . 3.3 t -90.92 127.11 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.238 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.567 HG12 HG12 ' B' ' 5' ' ' VAL . 12.1 m -126.23 168.82 18.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.831 0.348 . . . . 0.0 111.022 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.53 81.88 2.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.046 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' D' ' 38' ' ' ARG . . . 53.27 58.24 5.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.015 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . 0.49 ' HB3' HG21 ' C' ' 17' ' ' VAL . . . -108.61 -62.8 1.41 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.385 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.9 OUTLIER -171.57 -159.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.957 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . 0.593 ' HA ' ' HB2' ' D' ' 36' ' ' GLN . . . -156.88 74.0 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.059 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . 0.787 ' HB ' HD22 ' C' ' 58' ' ' LEU . 7.4 p -45.3 140.56 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.061 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.45 140.79 58.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.615 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.43 -51.16 69.43 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.287 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.03 -18.04 74.23 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.966 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -88.0 -6.27 58.07 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.807 0.337 . . . . 0.0 110.794 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.435 HG12 ' HG2' ' D' ' 33' ' ' GLN . 50.7 t -72.74 -36.43 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.332 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.94 110.92 14.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.95 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.86 146.05 48.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.987 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.18 113.84 27.68 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.113 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.13 121.92 57.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 110.404 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.442 ' HG2' HG12 ' B' ' 28' ' ' VAL . 0.6 OUTLIER -101.85 106.42 17.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.641 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.428 HD11 ' HA ' ' C' ' 34' ' ' LEU . 0.6 OUTLIER -64.79 -44.73 89.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.555 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.61 -156.8 16.03 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.6 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . 0.603 ' HB2' ' HA ' ' B' ' 22' ' ' ALA . 3.7 mt-30 -91.09 106.93 18.86 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.663 0.268 . . . . 0.0 110.922 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 4.3 t -92.28 120.51 41.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.94 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' ARG . . . . . 0.424 ' HG2' ' HA ' ' B' ' 19' ' ' ALA . 4.6 mtm105 -85.59 132.49 34.17 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.759 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 29.1 p -71.48 -23.34 61.79 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.768 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.93 -19.2 64.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.935 0.397 . . . . 0.0 110.817 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 13.8 t -90.61 -36.56 14.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.159 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.586 ' HB2' ' HB1' ' C' ' 139' ' ' ALA . 0.2 OUTLIER -121.45 70.55 0.94 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.623 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' C' ' 142' ' ' ALA . . . -104.79 28.16 7.37 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.379 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . 0.676 ' HG3' ' HB1' ' C' ' 47' ' ' ALA . 0.0 OUTLIER -150.62 141.93 23.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.402 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . 0.446 ' HG3' ' HA ' ' C' ' 140' ' ' THR . 2.7 tt0 -62.62 101.78 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.764 0.316 . . . . 0.0 111.133 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.24 4.25 8.46 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.094 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.676 ' HB1' ' HG3' ' C' ' 44' ' ' GLN . . . -91.73 121.33 33.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.942 0.401 . . . . 0.0 112.016 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' C' ' 137' ' ' TYR . 5.8 t -110.41 151.16 27.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.815 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -95.66 -57.68 2.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.544 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.2 -174.88 4.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.87 0.367 . . . . 0.0 110.8 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . 0.664 ' HB3' ' HG2' ' C' ' 136' ' ' ARG . . . -127.06 143.82 51.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.395 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.85 116.85 51.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.006 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.16 122.61 6.19 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.685 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -128.58 138.82 52.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 111.022 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.578 HD21 HG21 ' C' ' 130' ' ' THR . 1.6 m120 -117.8 150.98 38.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.621 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.579 ' HB ' HG13 ' C' ' 131' ' ' ILE . 9.2 mm -106.83 103.64 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.617 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -61.07 132.25 53.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.751 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . 0.787 HD22 ' HB ' ' C' ' 23' ' ' VAL . 1.0 OUTLIER -137.44 151.81 48.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.244 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -138.35 171.39 14.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.962 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' C' ' 21' ' ' CYS . 5.9 m-20 49.97 68.51 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.791 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 0.0 OUTLIER -106.62 141.07 38.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.794 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.79 117.83 33.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.254 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 23.5 p -91.13 -13.1 33.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.58 -39.02 82.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.14 0.495 . . . . 0.0 111.76 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 75.8 t -107.63 -54.15 6.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.627 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.7 84.38 3.37 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.596 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.02 -41.27 10.08 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.911 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.69 159.98 17.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.459 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.71 160.38 39.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.612 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.01 153.01 44.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.18 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.95 136.46 54.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.73 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.95 107.4 5.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.618 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' PHE . . . . . 0.447 ' CD2' HD12 ' C' ' 103' ' ' ILE . 43.0 t80 -73.57 136.68 44.02 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.502 0.191 . . . . 0.0 111.082 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.737 HD11 ' HG2' ' F' ' 57' ' ' GLN . 6.6 tt -113.6 111.4 21.81 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.003 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . 0.694 ' HA3' HD12 ' C' ' 113' ' ' LEU . . . -131.35 -178.54 15.53 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.765 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' THR . . . . . 0.47 HG21 ' O ' ' F' ' 53' ' ' GLY . 0.2 OUTLIER -104.28 137.55 42.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.5 0.191 . . . . 0.0 110.878 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.93 114.81 23.88 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.997 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . 0.597 ' O ' ' HG2' ' F' ' 134' ' ' GLN . 1.2 tt -95.75 -36.72 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' ASP . . . . . 0.457 ' HB3' ' CG2' ' C' ' 140' ' ' THR . 0.4 OUTLIER -143.39 130.28 20.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.722 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.95 -7.2 47.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.97 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.3 -29.18 68.28 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.637 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.31 -32.73 4.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.903 0.382 . . . . 0.0 110.432 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 3.5 m 60.59 19.41 9.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.574 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' ASN . . . . . 0.618 ' HB3' ' HG2' ' C' ' 102' ' ' GLN . 0.6 OUTLIER -139.39 -16.94 1.03 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.314 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.684 ' HB ' ' HA3' ' C' ' 100' ' ' GLY . 0.8 OUTLIER -66.71 118.08 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.172 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.558 ' HA ' HD21 ' C' ' 113' ' ' LEU . 10.7 tp -69.79 144.14 52.75 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.27 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.07 138.0 36.89 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.777 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.667 ' HB3' ' HA ' ' C' ' 148' ' ' ALA . 0.0 OUTLIER -84.99 -146.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.068 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' C' ' 149' ' ' ASN . 0.0 OUTLIER -48.48 155.02 0.57 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.312 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 33.1 p -86.79 -11.87 49.7 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.991 0.424 . . . . 0.0 111.489 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.42 114.08 5.16 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' ALA . . . . . 0.556 ' HA ' ' HB3' ' F' ' 50' ' ' SER . . . -83.38 22.25 1.05 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.919 0.39 . . . . 0.0 111.728 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.28 21.98 1.2 Allowed 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.699 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.75 -32.23 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.974 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' SER . . . . . 0.644 ' HA ' ' HB1' ' C' ' 147' ' ' ALA . 16.0 t -65.15 166.71 9.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.805 0.336 . . . . 0.0 110.682 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.64 163.46 15.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.892 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' THR . . . . . 0.657 HG21 ' HB1' ' F' ' 51' ' ' ALA . 0.0 OUTLIER -135.37 169.63 17.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.347 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 57.35 29.36 16.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.378 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 99' ' ' VAL . . . . . 0.506 ' HB ' ' CB ' ' C' ' 143' ' ' ALA . 7.2 p -156.35 150.57 10.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.839 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . 0.684 ' HA3' ' HB ' ' C' ' 85' ' ' VAL . . . -164.19 176.93 40.08 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.584 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.6 111.29 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.06 0.544 . . . . 0.0 111.74 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 102' ' ' GLN . . . . . 0.618 ' HG2' ' HB3' ' C' ' 84' ' ' ASN . 0.0 OUTLIER -75.98 179.73 5.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.979 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . 0.534 HD13 ' HA ' ' C' ' 113' ' ' LEU . 6.0 pt -150.35 116.62 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.418 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' C' ' 134' ' ' GLN . 12.8 tp -97.23 122.55 40.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.676 0.274 . . . . 0.0 111.015 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.96 150.07 43.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.718 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 106' ' ' ARG . . . . . 0.527 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -71.47 -17.56 62.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.793 0.33 . . . . 0.0 111.087 179.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 74.3 p -76.52 -37.29 56.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.152 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.55 -68.74 0.32 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.705 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.69 123.27 18.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.811 0.339 . . . . 0.0 111.14 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.66 117.98 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 tp -67.83 144.06 55.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.473 0.654 . . . . 0.0 110.502 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 112' ' ' THR . . . . . 0.426 ' HA ' ' ND2' ' C' ' 84' ' ' ASN . 0.2 OUTLIER -75.08 140.43 43.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.127 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.694 HD12 ' HA3' ' C' ' 75' ' ' GLY . 1.3 tp -85.18 97.75 10.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 110.62 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -152.79 -59.03 0.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.68 0.276 . . . . 0.0 111.555 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . 0.567 ' HA3' ' OG1' ' F' ' 130' ' ' THR . . . 135.77 -26.63 3.14 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.577 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 116' ' ' ALA . . . . . 0.549 ' HB1' ' HA ' ' F' ' 129' ' ' ASN . . . -101.36 28.78 5.19 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.055 0.455 . . . . 0.0 111.656 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.56 67.31 0.72 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.05 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.38 80.96 8.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.77 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.96 97.46 3.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 2.0 t -165.59 144.83 6.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.6 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.34 50.4 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.144 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.88 94.11 5.78 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.685 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.73 110.4 12.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.729 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . 0.598 ' HG ' ' ND2' ' C' ' 129' ' ' ASN . 0.3 OUTLIER -70.13 154.13 42.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.65 179.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -131.58 144.73 51.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.623 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.77 125.66 24.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.663 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.1 -102.02 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.715 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 128' ' ' THR . . . . . 0.409 HG22 ' O ' ' C' ' 58' ' ' LEU . 86.4 m -106.23 128.55 54.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.652 0.263 . . . . 0.0 110.786 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 129' ' ' ASN . . . . . 0.598 ' ND2' ' HG ' ' C' ' 124' ' ' LEU . 20.1 t-20 -121.19 158.14 28.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.902 0.382 . . . . 0.0 111.116 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 130' ' ' THR . . . . . 0.578 HG21 HD21 ' C' ' 55' ' ' ASN . 0.2 OUTLIER -155.79 143.09 19.3 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.986 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 131' ' ' ILE . . . . . 0.579 HG13 ' HB ' ' C' ' 56' ' ' ILE . 0.1 OUTLIER -115.22 110.73 45.2 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 132' ' ' PRO . . . . . 0.527 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.5 Cg_endo -82.1 151.77 16.18 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.632 1.554 . . . . 0.0 112.573 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.02 146.79 17.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 134' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' C' ' 104' ' ' LEU . 0.8 OUTLIER -114.4 145.8 41.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.088 179.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.76 91.22 1.92 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 111.674 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . 0.664 ' HG2' ' HB3' ' C' ' 51' ' ' ALA . 28.0 mtm-85 -88.33 153.55 21.11 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.345 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 137' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' C' ' 48' ' ' THR . 0.7 OUTLIER -91.22 111.04 22.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.103 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 138' ' ' PHE . . . . . 0.584 ' CD1' ' HB2' ' C' ' 102' ' ' GLN . 8.8 m-85 -108.13 172.21 6.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.939 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 139' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -123.45 143.6 50.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.87 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 140' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' C' ' 79' ' ' ASP . 0.2 OUTLIER -98.71 44.47 1.03 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.529 179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.5 89.06 1.07 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.936 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 142' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' C' ' 43' ' ' ALA . . . 60.02 88.09 0.08 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.7 0.25 . . . . 0.0 110.693 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 143' ' ' ALA . . . . . 0.516 ' HB2' HD12 ' C' ' 42' ' ' LEU . . . -70.64 161.75 30.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.775 0.321 . . . . 0.0 111.444 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.49 158.71 60.73 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.191 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 145' ' ' PRO . . . . . 0.458 ' HA ' ' HB ' ' B' ' 16' ' ' VAL . 1.5 Cg_endo -83.72 149.25 12.63 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.501 2.134 . . . . 0.0 112.072 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.7 -119.76 0.86 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.52 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 147' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' C' ' 95' ' ' SER . . . -123.91 127.71 48.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.828 0.346 . . . . 0.0 111.418 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 148' ' ' ALA . . . . . 0.667 ' HA ' ' HB3' ' C' ' 88' ' ' LEU . . . -120.83 67.19 0.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.41 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 149' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' C' ' 89' ' ' GLN . 47.3 t-20 -128.49 114.78 17.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.599 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 150' ' ' ALA . . . . . . . . . . . . . . . -158.87 146.93 18.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.0 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.33 140.31 32.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.148 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.26 169.23 17.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.18 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 153' ' ' THR . . . . . 0.443 ' O ' ' HB3' ' C' ' 74' ' ' LEU . 9.3 t -155.09 150.54 27.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 154' ' ' PHE . . . . . 0.426 ' HE1' HG13 ' C' ' 56' ' ' ILE . 1.1 p90 -119.05 149.21 42.05 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.077 0.465 . . . . 0.0 110.075 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 155' ' ' LYS . . . . . 0.674 ' HD2' HG21 ' F' ' 128' ' ' THR . 4.7 mttt -113.48 156.64 23.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.908 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 156' ' ' VAL . . . . . 0.547 HG13 HD12 ' C' ' 131' ' ' ILE . 0.2 OUTLIER -136.45 138.03 47.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.663 -179.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 157' ' ' GLN . . . . . 0.613 ' HB2' HG23 ' B' ' 4' ' ' THR . 64.1 tt0 -107.5 128.05 54.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.363 0.601 . . . . 0.0 110.365 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 158' ' ' TYR . . . . . 0.587 ' HB2' ' OG1' ' B' ' 3' ' ' THR . 60.9 m-85 -107.85 107.46 18.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.541 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . 0.661 ' HA ' ' H ' ' B' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.884 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.312 0.101 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . 0.646 ' H ' ' HA ' ' E' ' 159' ' ' GLN . . . 65.87 74.72 0.36 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.937 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 3' ' ' THR . . . . . 0.58 ' OG1' ' HB2' ' E' ' 158' ' ' TYR . 6.2 p -117.71 97.48 5.88 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.489 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 4' ' ' THR . . . . . 0.627 HG23 ' HB2' ' E' ' 157' ' ' GLN . 68.1 p -87.87 108.72 19.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.559 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . 0.571 HG12 HG12 ' E' ' 17' ' ' VAL . 15.3 m -126.63 172.74 13.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.612 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.13 110.81 12.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.566 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.67 -59.51 7.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.747 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.52 151.68 14.92 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.809 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 9' ' ' THR . . . . . 0.408 HG21 ' N ' ' D' ' 10' ' ' VAL . 24.2 m -103.45 143.08 33.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 111.319 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' VAL . . . . . 0.476 HG22 ' HE1' ' D' ' 12' ' ' PHE . 1.1 m -130.93 115.63 30.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.182 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.63 105.67 14.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.392 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' PHE . . . . . 0.476 ' HE1' HG22 ' D' ' 10' ' ' VAL . 52.0 m-85 -83.21 105.47 14.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.8 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.41 145.13 41.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.452 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.74 -179.67 42.58 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.98 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.26 134.2 22.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.937 0.399 . . . . 0.0 110.406 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.456 HG13 ' HA ' ' E' ' 145' ' ' PRO . 3.3 t -90.9 127.2 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.174 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . 0.57 HG12 HG12 ' C' ' 5' ' ' VAL . 12.1 m -126.31 168.78 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.929 0.395 . . . . 0.0 111.025 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.49 81.85 2.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.092 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' E' ' 38' ' ' ARG . . . 53.31 58.19 5.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.057 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.483 ' HB3' HG21 ' D' ' 17' ' ' VAL . . . -108.6 -62.83 1.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.36 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' CYS . . . . . 0.911 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.9 OUTLIER -171.53 -159.88 0.16 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . 0.597 ' HA ' ' HB2' ' E' ' 36' ' ' GLN . . . -156.86 74.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.098 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . 0.775 ' HB ' HD22 ' D' ' 58' ' ' LEU . 7.4 p -45.36 140.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.081 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.49 140.79 58.91 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.656 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.4 -51.14 69.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.302 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.11 -17.98 74.33 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.937 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.96 -6.42 58.03 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.859 0.362 . . . . 0.0 110.818 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . 0.446 HG12 ' HG2' ' E' ' 33' ' ' GLN . 50.5 t -72.7 -36.36 52.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.364 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.0 110.88 14.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.008 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.76 146.07 48.57 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.977 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.25 113.83 27.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.084 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.15 121.91 57.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.149 0.499 . . . . 0.0 110.433 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.435 ' HG2' HG12 ' C' ' 28' ' ' VAL . 0.6 OUTLIER -101.84 106.37 17.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.669 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.5 ' HA ' HD11 ' D' ' 34' ' ' LEU . 0.6 OUTLIER -64.73 -44.74 89.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.595 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.6 -156.91 15.99 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.54 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' GLN . . . . . 0.593 ' HB2' ' HA ' ' C' ' 22' ' ' ALA . 3.7 mt-30 -91.06 106.95 18.88 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.656 0.265 . . . . 0.0 110.899 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 t -92.29 120.63 41.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.839 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' C' ' 19' ' ' ALA . 4.6 mtm105 -85.68 132.46 34.14 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.742 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' THR . . . . . . . . . . . . . 29.5 p -71.5 -23.23 61.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.753 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.13 -19.07 64.79 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.974 0.416 . . . . 0.0 110.823 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -90.59 -36.65 14.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.16 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.582 ' HB2' ' HB1' ' D' ' 139' ' ' ALA . 0.2 OUTLIER -121.44 70.62 0.94 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.555 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' D' ' 142' ' ' ALA . . . -104.79 28.18 7.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.392 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' GLN . . . . . 0.682 ' HG3' ' HB1' ' D' ' 47' ' ' ALA . 0.0 OUTLIER -150.59 141.92 23.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.437 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . 0.424 ' HG3' ' HA ' ' D' ' 140' ' ' THR . 2.7 tt0 -62.69 101.78 0.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.819 0.342 . . . . 0.0 111.145 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.29 4.23 8.43 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.115 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.682 ' HB1' ' HG3' ' D' ' 44' ' ' GLN . . . -91.67 121.28 33.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.932 0.396 . . . . 0.0 112.03 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' D' ' 137' ' ' TYR . 5.9 t -110.42 151.18 27.8 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.826 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 5.1 t -95.62 -57.59 2.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.632 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.547 ' HB3' ' HA ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -148.23 -174.85 4.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.875 0.369 . . . . 0.0 110.756 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' ALA . . . . . 0.665 ' HB1' HG21 ' A' ' 97' ' ' THR . . . -127.11 143.86 51.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.352 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.84 116.86 51.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.974 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . 0.462 ' O ' HG21 ' A' ' 76' ' ' THR . . . -111.15 122.67 6.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.699 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -128.63 138.84 52.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.812 0.339 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' ASN . . . . . 0.573 HD21 HG21 ' D' ' 130' ' ' THR . 1.6 m120 -117.86 150.99 38.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.585 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.569 ' HB ' HG13 ' D' ' 131' ' ' ILE . 9.3 mm -106.86 103.77 15.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.547 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' GLN . . . . . 0.751 ' HG2' HD11 ' A' ' 74' ' ' LEU . 75.8 mt-30 -61.11 132.28 53.23 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.788 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . 0.775 HD22 ' HB ' ' D' ' 23' ' ' VAL . 1.0 OUTLIER -137.49 151.81 48.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.205 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -138.32 171.36 14.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.977 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' D' ' 21' ' ' CYS . 5.9 m-20 50.0 68.55 0.73 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.743 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' CYS . . . . . 0.911 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 0.0 OUTLIER -106.67 141.11 38.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.792 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.78 117.83 33.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.254 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 23.4 p -91.21 -13.04 33.55 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -38.98 82.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.081 0.467 . . . . 0.0 111.707 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 75.8 t -107.67 -54.11 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.64 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' D' ' 158' ' ' TYR . . . -97.69 84.32 3.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.576 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.05 -41.23 10.08 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.955 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.57 159.99 17.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.517 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.7 160.4 39.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.586 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.07 152.94 45.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.157 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.9 136.55 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.699 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.04 107.46 5.03 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.565 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 73' ' ' PHE . . . . . 0.44 ' CD2' HD12 ' D' ' 103' ' ' ILE . 42.9 t80 -73.62 136.61 43.92 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.532 0.206 . . . . 0.0 111.06 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 74' ' ' LEU . . . . . 0.536 HD13 ' HE3' ' D' ' 155' ' ' LYS . 6.6 tt -113.55 111.39 21.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.006 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . 0.702 ' HA3' HD12 ' D' ' 113' ' ' LEU . . . -131.26 -178.5 15.5 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.883 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.37 137.54 42.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.493 0.187 . . . . 0.0 110.825 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.96 114.74 23.84 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.961 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 78' ' ' ILE . . . . . 0.449 ' H ' HG23 ' D' ' 78' ' ' ILE . 1.2 tt -95.74 -36.78 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.842 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . 0.454 ' HB3' ' CG2' ' D' ' 140' ' ' THR . 0.4 OUTLIER -143.32 130.19 20.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.8 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.83 -7.28 47.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.991 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.37 -29.14 68.38 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.557 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.33 -32.61 4.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.482 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 3.5 m 60.47 19.43 9.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.58 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . 0.599 ' HB3' ' HG2' ' D' ' 102' ' ' GLN . 0.6 OUTLIER -139.31 -16.94 1.04 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.409 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.687 ' HB ' ' HA3' ' D' ' 100' ' ' GLY . 0.9 OUTLIER -66.77 118.03 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.206 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.537 ' HA ' HD21 ' D' ' 113' ' ' LEU . 10.7 tp -69.7 144.13 52.91 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.275 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.14 138.06 36.84 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.892 0.377 . . . . 0.0 111.71 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.674 ' HB3' ' HA ' ' D' ' 148' ' ' ALA . 0.0 OUTLIER -84.96 -146.62 0.1 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.079 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 89' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' D' ' 149' ' ' ASN . 0.0 OUTLIER -48.48 155.03 0.57 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.293 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 32.4 p -86.77 -11.91 49.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.533 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 8.2 t -66.43 114.15 5.22 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.34 22.09 1.07 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.932 0.396 . . . . 0.0 111.706 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.2 21.97 1.21 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.73 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.7 -32.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.957 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 95' ' ' SER . . . . . 0.652 ' HA ' ' HB1' ' D' ' 147' ' ' ALA . 15.8 t -65.16 166.64 9.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 110.654 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.59 163.53 15.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.45 169.7 17.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.276 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 98' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 57.26 29.42 16.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.38 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 99' ' ' VAL . . . . . 0.497 ' HB ' ' CB ' ' D' ' 143' ' ' ALA . 7.1 p -156.39 150.54 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 100' ' ' GLY . . . . . 0.687 ' HA3' ' HB ' ' D' ' 85' ' ' VAL . . . -164.14 176.95 40.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.587 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.62 111.32 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 123.078 0.551 . . . . 0.0 111.663 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 102' ' ' GLN . . . . . 0.599 ' HG2' ' HB3' ' D' ' 84' ' ' ASN . 0.0 OUTLIER -76.0 179.72 5.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.942 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 103' ' ' ILE . . . . . 0.53 HD13 ' HA ' ' D' ' 113' ' ' LEU . 6.0 pt -150.33 116.56 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.43 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 104' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' D' ' 134' ' ' GLN . 12.8 tp -97.21 122.55 40.36 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 111.068 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.91 150.11 42.86 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.65 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 106' ' ' ARG . . . . . 0.513 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -71.5 -17.54 62.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.846 0.355 . . . . 0.0 111.102 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 107' ' ' THR . . . . . . . . . . . . . 76.1 p -76.62 -37.29 56.62 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.111 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.57 -68.74 0.32 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.677 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.55 123.17 18.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.772 0.32 . . . . 0.0 111.191 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.79 118.0 2.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.939 0.4 . . . . 0.0 111.15 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 tp -67.88 144.09 55.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.43 0.633 . . . . 0.0 110.46 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 112' ' ' THR . . . . . 0.424 ' HA ' ' ND2' ' D' ' 84' ' ' ASN . 0.2 OUTLIER -75.15 140.46 43.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.095 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 113' ' ' LEU . . . . . 0.702 HD12 ' HA3' ' D' ' 75' ' ' GLY . 1.3 tp -85.15 97.78 10.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.748 0.308 . . . . 0.0 110.596 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -152.83 -59.07 0.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.65 0.262 . . . . 0.0 111.494 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.77 -26.61 3.14 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.552 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.34 28.82 5.15 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.045 0.45 . . . . 0.0 111.676 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.57 67.38 0.72 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.03 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.43 80.89 8.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.739 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.95 97.55 3.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.881 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 2.0 t -165.66 144.79 6.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.531 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.32 50.34 0.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.204 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.81 94.11 5.73 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.714 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.69 110.26 12.38 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.69 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . 0.593 ' HG ' ' ND2' ' D' ' 129' ' ' ASN . 0.3 OUTLIER -70.1 154.1 42.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.558 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.58 144.77 51.32 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.584 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.75 125.63 24.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.645 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.1 -101.99 1.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.701 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 128' ' ' THR . . . . . 0.668 HG21 ' HD2' ' A' ' 155' ' ' LYS . 86.6 m -106.25 128.5 54.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.662 0.267 . . . . 0.0 110.773 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 129' ' ' ASN . . . . . 0.593 ' ND2' ' HG ' ' D' ' 124' ' ' LEU . 20.1 t-20 -121.15 158.25 28.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.874 0.368 . . . . 0.0 111.109 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 130' ' ' THR . . . . . 0.573 HG21 HD21 ' D' ' 55' ' ' ASN . 0.2 OUTLIER -155.87 143.08 19.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.057 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 131' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' D' ' 56' ' ' ILE . 0.1 OUTLIER -115.28 110.75 45.05 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 132' ' ' PRO . . . . . 0.513 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.4 Cg_endo -82.16 151.83 16.06 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.666 1.577 . . . . 0.0 112.499 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.07 146.72 17.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 134' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 78' ' ' ILE . 0.8 OUTLIER -114.36 145.92 41.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.031 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.85 91.09 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.41 . . . . 0.0 111.735 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 136' ' ' ARG . . . . . 0.665 ' HG2' ' HB3' ' D' ' 51' ' ' ALA . 28.1 mtm-85 -88.32 153.52 21.13 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.443 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 137' ' ' TYR . . . . . 0.604 ' O ' ' HA ' ' D' ' 48' ' ' THR . 0.7 OUTLIER -91.1 110.96 22.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.173 179.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 138' ' ' PHE . . . . . 0.594 ' CD1' ' HB2' ' D' ' 102' ' ' GLN . 8.8 m-85 -108.08 172.16 6.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.253 0.549 . . . . 0.0 111.971 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 139' ' ' ALA . . . . . 0.582 ' HB1' ' HB2' ' D' ' 42' ' ' LEU . . . -123.39 143.64 49.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.89 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 140' ' ' THR . . . . . 0.454 ' CG2' ' HB3' ' D' ' 79' ' ' ASP . 0.2 OUTLIER -98.78 44.46 1.03 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.514 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.54 88.97 1.08 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.966 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' D' ' 43' ' ' ALA . . . 60.08 88.04 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.745 0.273 . . . . 0.0 110.73 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 143' ' ' ALA . . . . . 0.509 ' HB2' HD12 ' D' ' 42' ' ' LEU . . . -70.59 161.73 30.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.784 0.326 . . . . 0.0 111.479 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.54 158.77 60.69 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.203 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 145' ' ' PRO . . . . . 0.462 ' HA ' HG13 ' C' ' 16' ' ' VAL . 1.4 Cg_endo -83.83 149.22 12.47 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.491 2.127 . . . . 0.0 111.995 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.71 -119.75 0.86 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.519 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 147' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' D' ' 95' ' ' SER . . . -123.95 127.65 48.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.799 0.333 . . . . 0.0 111.452 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 148' ' ' ALA . . . . . 0.674 ' HA ' ' HB3' ' D' ' 88' ' ' LEU . . . -120.86 67.2 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.124 0.488 . . . . 0.0 110.376 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 149' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' D' ' 89' ' ' GLN . 47.5 t-20 -128.54 114.77 17.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.607 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 150' ' ' ALA . . . . . . . . . . . . . . . -158.8 147.01 18.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.994 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.4 140.31 32.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.173 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.2 169.29 17.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.183 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 153' ' ' THR . . . . . 0.456 ' O ' ' HB3' ' D' ' 74' ' ' LEU . 9.3 t -155.15 150.52 27.2 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 154' ' ' PHE . . . . . 0.435 ' HE1' HG13 ' D' ' 56' ' ' ILE . 1.1 p90 -119.06 149.25 41.98 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.066 0.46 . . . . 0.0 110.059 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 155' ' ' LYS . . . . . 0.536 ' HE3' HD13 ' D' ' 74' ' ' LEU . 4.7 mttt -113.48 156.67 23.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.924 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 156' ' ' VAL . . . . . 0.544 HG13 HD12 ' D' ' 131' ' ' ILE . 0.2 OUTLIER -136.49 138.04 47.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.627 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 157' ' ' GLN . . . . . 0.638 ' HB2' HG23 ' C' ' 4' ' ' THR . 64.1 tt0 -107.41 128.01 54.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.27 0.557 . . . . 0.0 110.37 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 158' ' ' TYR . . . . . 0.58 ' HB2' ' OG1' ' C' ' 3' ' ' THR . 61.0 m-85 -107.85 107.45 18.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.49 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 159' ' ' GLN . . . . . 0.644 ' HA ' ' H ' ' C' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 120.281 0.086 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 2' ' ' ALA . . . . . 0.668 ' H ' ' HA ' ' F' ' 159' ' ' GLN . . . 65.96 74.63 0.36 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.978 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 3' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' F' ' 158' ' ' TYR . 6.1 p -117.74 97.53 5.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.482 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 4' ' ' THR . . . . . 0.614 HG23 ' HB2' ' F' ' 157' ' ' GLN . 68.3 p -87.89 108.67 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.562 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . 0.576 HG12 HG12 ' F' ' 17' ' ' VAL . 15.4 m -126.59 172.75 13.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.627 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.16 110.86 12.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.567 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.85 -59.37 7.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.737 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.59 151.7 14.91 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.804 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 9' ' ' THR . . . . . 0.414 HG21 ' N ' ' E' ' 10' ' ' VAL . 24.2 m -103.46 143.1 33.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.799 0.333 . . . . 0.0 111.316 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 10' ' ' VAL . . . . . 0.483 HG22 ' HE1' ' E' ' 12' ' ' PHE . 1.1 m -130.97 115.67 31.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.171 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.65 105.78 14.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.347 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 12' ' ' PHE . . . . . 0.483 ' HE1' HG22 ' E' ' 10' ' ' VAL . 52.3 m-85 -83.15 105.5 14.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.804 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.45 145.04 41.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.4 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.75 -179.59 42.63 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.942 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.27 134.21 22.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.913 0.387 . . . . 0.0 110.35 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 16' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' F' ' 145' ' ' PRO . 3.3 t -90.93 127.11 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.232 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . 0.571 HG12 HG12 ' D' ' 5' ' ' VAL . 11.9 m -126.22 168.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.811 0.339 . . . . 0.0 111.08 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.43 81.78 2.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.133 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 19' ' ' ALA . . . . . 0.426 ' HA ' ' HG2' ' F' ' 38' ' ' ARG . . . 53.35 58.15 5.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.078 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.49 ' HB3' HG21 ' E' ' 17' ' ' VAL . . . -108.58 -62.8 1.41 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.44 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 21' ' ' CYS . . . . . 0.915 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.9 OUTLIER -171.54 -159.87 0.16 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.946 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 22' ' ' ALA . . . . . 0.597 ' HA ' ' HB2' ' F' ' 36' ' ' GLN . . . -156.86 74.05 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 23' ' ' VAL . . . . . 0.794 ' HB ' HD22 ' E' ' 58' ' ' LEU . 7.4 p -45.38 140.6 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.06 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.45 140.82 58.91 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.614 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.08 69.83 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.288 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.13 -17.97 74.36 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.939 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.99 -6.37 58.03 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.843 0.354 . . . . 0.0 110.757 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 28' ' ' VAL . . . . . 0.447 HG12 ' HG2' ' F' ' 33' ' ' GLN . 50.5 t -72.7 -36.34 52.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.365 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.02 110.81 13.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.984 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.79 146.01 48.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.994 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.15 113.77 27.56 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.132 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.03 121.98 57.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.175 0.512 . . . . 0.0 110.398 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 33' ' ' GLN . . . . . 0.446 ' HG2' HG12 ' D' ' 28' ' ' VAL . 0.6 OUTLIER -101.95 106.44 17.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.623 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.505 HD11 ' HA ' ' E' ' 34' ' ' LEU . 0.6 OUTLIER -64.75 -44.73 89.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.643 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.53 -156.86 16.05 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.587 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 36' ' ' GLN . . . . . 0.597 ' HB2' ' HA ' ' D' ' 22' ' ' ALA . 3.7 mt-30 -91.11 106.93 18.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.656 0.265 . . . . 0.0 110.828 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 t -92.33 120.61 41.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.874 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' D' ' 19' ' ' ALA . 4.5 mtm105 -85.65 132.49 34.15 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.756 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 39' ' ' THR . . . . . . . . . . . . . 29.5 p -71.49 -23.37 61.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.733 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.1 64.89 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.987 0.422 . . . . 0.0 110.842 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -90.61 -36.53 14.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.181 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.592 ' HB2' ' HB1' ' E' ' 139' ' ' ALA . 0.2 OUTLIER -121.47 70.58 0.94 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.621 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 43' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' E' ' 142' ' ' ALA . . . -104.74 28.17 7.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.49 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 44' ' ' GLN . . . . . 0.689 ' HG3' ' HB1' ' E' ' 47' ' ' ALA . 0.0 OUTLIER -150.57 141.95 23.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.469 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . 0.426 ' HG3' ' HA ' ' E' ' 140' ' ' THR . 2.7 tt0 -62.74 101.81 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 111.111 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.33 4.22 8.41 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.121 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 47' ' ' ALA . . . . . 0.689 ' HB1' ' HG3' ' E' ' 44' ' ' GLN . . . -91.78 121.24 33.23 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.008 0.433 . . . . 0.0 111.966 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 48' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' E' ' 137' ' ' TYR . 5.9 t -110.35 151.18 27.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.868 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 5.1 t -95.59 -57.66 2.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.62 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 50' ' ' SER . . . . . 0.558 ' HB3' ' HA ' ' B' ' 92' ' ' ALA . 0.2 OUTLIER -148.31 -174.82 4.69 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.918 0.389 . . . . 0.0 110.739 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 51' ' ' ALA . . . . . 0.681 ' HB3' ' HG2' ' E' ' 136' ' ' ARG . . . -127.09 143.83 51.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.359 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 52' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.85 116.81 51.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 53' ' ' GLY . . . . . 0.456 ' O ' HG21 ' B' ' 76' ' ' THR . . . -111.18 122.69 6.22 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.653 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -128.63 138.79 52.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 111.001 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 55' ' ' ASN . . . . . 0.565 HD21 HG21 ' E' ' 130' ' ' THR . 1.5 m120 -117.82 150.9 38.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.654 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 56' ' ' ILE . . . . . 0.579 ' HB ' HG13 ' E' ' 131' ' ' ILE . 9.2 mm -106.77 103.72 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.549 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 57' ' ' GLN . . . . . 0.734 ' HG2' HD11 ' B' ' 74' ' ' LEU . 75.8 mt-30 -61.13 132.26 53.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.774 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . 0.794 HD22 ' HB ' ' E' ' 23' ' ' VAL . 1.0 OUTLIER -137.47 151.8 48.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.223 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -138.33 171.35 14.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.98 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 60' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' E' ' 21' ' ' CYS . 6.0 m-20 50.01 68.47 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.83 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 61' ' ' CYS . . . . . 0.915 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 0.0 OUTLIER -106.63 141.09 38.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.95 0.405 . . . . 0.0 110.722 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.74 117.79 33.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.288 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 23.4 p -91.11 -13.18 33.55 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.6 -38.85 82.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.071 0.462 . . . . 0.0 111.849 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 76.4 t -107.71 -54.14 6.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.612 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 66' ' ' ALA . . . . . 0.409 ' HB1' ' HB3' ' E' ' 158' ' ' TYR . . . -97.72 84.3 3.35 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.581 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.98 -41.26 10.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.97 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.65 159.99 17.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.457 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.76 160.38 39.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.582 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.05 152.93 45.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.102 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.9 136.53 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.714 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.0 107.5 5.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.61 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 73' ' ' PHE . . . . . 0.442 ' CD2' HD12 ' E' ' 103' ' ' ILE . 43.2 t80 -73.7 136.72 43.77 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.569 0.224 . . . . 0.0 110.995 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 74' ' ' LEU . . . . . 0.54 HD13 ' HE3' ' E' ' 155' ' ' LYS . 6.6 tt -113.61 111.39 21.78 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.947 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . 0.709 ' HA3' HD12 ' E' ' 113' ' ' LEU . . . -131.29 -178.55 15.53 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.843 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.28 137.54 42.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.479 0.18 . . . . 0.0 110.837 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.97 114.81 23.91 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.021 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 78' ' ' ILE . . . . . 0.407 HD13 HD11 ' E' ' 88' ' ' LEU . 1.2 tt -95.77 -36.73 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.825 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 79' ' ' ASP . . . . . 0.46 ' HB3' ' CG2' ' E' ' 140' ' ' THR . 0.4 OUTLIER -143.36 130.21 20.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.756 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.89 -7.23 47.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.04 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.28 -29.25 68.38 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.606 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.34 -32.62 4.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 110.442 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 3.5 m 60.53 19.46 9.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.574 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 84' ' ' ASN . . . . . 0.6 ' HB3' ' HG2' ' E' ' 102' ' ' GLN . 0.6 OUTLIER -139.43 -16.94 1.02 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.323 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.684 ' HB ' ' HA3' ' E' ' 100' ' ' GLY . 0.9 OUTLIER -66.69 117.99 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.243 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 86' ' ' LEU . . . . . 0.555 ' HA ' HD21 ' E' ' 113' ' ' LEU . 10.6 tp -69.71 144.15 52.89 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.291 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.1 138.06 36.87 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.892 0.377 . . . . 0.0 111.677 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.673 ' HB3' ' HA ' ' E' ' 148' ' ' ALA . 0.0 OUTLIER -85.0 -146.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.115 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.54 155.04 0.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.807 0.337 . . . . 0.0 111.263 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 31.9 p -86.71 -11.9 49.84 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.549 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.43 114.05 5.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.975 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.35 22.17 1.06 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.007 0.432 . . . . 0.0 111.714 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.28 22.05 1.19 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.729 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.7 -32.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.537 -0.84 . . . . 0.0 113.001 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 95' ' ' SER . . . . . 0.64 ' HA ' ' HB1' ' E' ' 147' ' ' ALA . 15.8 t -65.12 166.7 9.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.652 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.67 163.43 15.13 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.85 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.35 169.68 17.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.378 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 98' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 57.32 29.37 16.72 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.415 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 99' ' ' VAL . . . . . 0.502 ' HB ' ' CB ' ' E' ' 143' ' ' ALA . 7.1 p -156.46 150.6 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.75 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 100' ' ' GLY . . . . . 0.684 ' HA3' ' HB ' ' E' ' 85' ' ' VAL . . . -164.18 176.85 40.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.583 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.63 111.36 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.011 0.524 . . . . 0.0 111.709 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 102' ' ' GLN . . . . . 0.6 ' HG2' ' HB3' ' E' ' 84' ' ' ASN . 0.0 OUTLIER -76.02 179.75 5.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.943 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 103' ' ' ILE . . . . . 0.526 HD13 ' HA ' ' E' ' 113' ' ' LEU . 5.9 pt -150.39 116.56 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.387 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 104' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' E' ' 134' ' ' GLN . 12.9 tp -97.21 122.54 40.35 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.714 0.292 . . . . 0.0 111.095 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.91 150.16 42.74 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.724 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 106' ' ' ARG . . . . . 0.502 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -71.48 -17.6 62.35 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.792 0.33 . . . . 0.0 111.076 179.527 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 75.4 p -76.62 -37.23 56.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.129 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.52 -68.76 0.32 Allowed Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.715 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.66 123.23 18.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.83 0.348 . . . . 0.0 111.106 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.7 118.01 2.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 tp -67.91 144.12 55.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.39 0.614 . . . . 0.0 110.528 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 112' ' ' THR . . . . . 0.42 ' HA ' ' ND2' ' E' ' 84' ' ' ASN . 0.2 OUTLIER -75.13 140.48 43.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.133 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 113' ' ' LEU . . . . . 0.709 HD12 ' HA3' ' E' ' 75' ' ' GLY . 1.3 tp -85.25 97.79 10.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.732 0.301 . . . . 0.0 110.606 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -152.81 -58.94 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.579 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.75 -26.62 3.14 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.583 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.42 28.85 5.16 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.007 0.432 . . . . 0.0 111.626 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.59 67.31 0.72 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.087 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -82.44 81.07 8.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.709 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.13 97.47 3.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.872 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 1.9 t -165.5 144.77 6.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.597 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.28 50.35 0.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.214 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.88 94.11 5.78 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.713 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.63 110.38 12.4 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.741 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . 0.601 ' HG ' ' ND2' ' E' ' 129' ' ' ASN . 0.3 OUTLIER -70.19 154.13 42.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.567 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.62 144.75 51.28 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.564 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.75 125.69 24.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.647 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.03 -102.0 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.737 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 128' ' ' THR . . . . . 0.675 HG21 ' HD2' ' B' ' 155' ' ' LYS . 87.1 m -106.21 128.46 53.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.604 0.24 . . . . 0.0 110.849 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 129' ' ' ASN . . . . . 0.601 ' ND2' ' HG ' ' E' ' 124' ' ' LEU . 20.1 t-20 -121.15 158.18 28.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.881 0.372 . . . . 0.0 111.147 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 130' ' ' THR . . . . . 0.565 HG21 HD21 ' E' ' 55' ' ' ASN . 0.2 OUTLIER -155.83 143.1 19.26 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.009 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 131' ' ' ILE . . . . . 0.579 HG13 ' HB ' ' E' ' 56' ' ' ILE . 0.1 OUTLIER -115.23 110.83 45.07 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 132' ' ' PRO . . . . . 0.502 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.3 Cg_endo -82.21 151.86 15.96 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.634 1.556 . . . . 0.0 112.548 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.08 146.79 17.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.795 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 134' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' B' ' 78' ' ' ILE . 0.8 OUTLIER -114.37 145.87 41.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.068 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.87 91.14 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.962 0.41 . . . . 0.0 111.713 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 136' ' ' ARG . . . . . 0.681 ' HG2' ' HB3' ' E' ' 51' ' ' ALA . 28.2 mtm-85 -88.27 153.54 21.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.41 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 137' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' E' ' 48' ' ' THR . 0.7 OUTLIER -91.26 111.14 22.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.059 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 138' ' ' PHE . . . . . 0.593 ' CD1' ' HB2' ' E' ' 102' ' ' GLN . 8.7 m-85 -108.22 172.21 6.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.968 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 139' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' E' ' 42' ' ' LEU . . . -123.47 143.64 50.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.823 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 140' ' ' THR . . . . . 0.46 ' CG2' ' HB3' ' E' ' 79' ' ' ASP . 0.2 OUTLIER -98.72 44.43 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.567 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.51 89.07 1.07 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.963 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 142' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' E' ' 43' ' ' ALA . . . 60.03 88.04 0.08 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.696 0.248 . . . . 0.0 110.769 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 143' ' ' ALA . . . . . 0.514 ' HB2' HD12 ' E' ' 42' ' ' LEU . . . -70.62 161.73 30.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 111.458 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 158.73 60.65 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.23 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 145' ' ' PRO . . . . . 0.456 ' HA ' HG13 ' D' ' 16' ' ' VAL . 1.4 Cg_endo -83.76 149.23 12.57 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.569 2.179 . . . . 0.0 112.022 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.69 -119.72 0.86 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.582 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 147' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' E' ' 95' ' ' SER . . . -123.95 127.73 48.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.877 0.37 . . . . 0.0 111.384 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 148' ' ' ALA . . . . . 0.673 ' HA ' ' HB3' ' E' ' 88' ' ' LEU . . . -120.85 67.16 0.86 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.434 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -128.51 114.82 17.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.594 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 150' ' ' ALA . . . . . . . . . . . . . . . -158.85 147.0 18.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.03 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.48 140.28 32.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.218 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.21 169.23 17.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.149 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 153' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' E' ' 74' ' ' LEU . 9.4 t -155.06 150.54 27.35 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 154' ' ' PHE . . . . . 0.436 ' HE1' HG13 ' E' ' 56' ' ' ILE . 1.1 p90 -119.05 149.3 41.9 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.1 0.476 . . . . 0.0 110.025 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 155' ' ' LYS . . . . . 0.54 ' HE3' HD13 ' E' ' 74' ' ' LEU . 4.7 mttt -113.53 156.74 23.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.85 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 156' ' ' VAL . . . . . 0.537 HG13 HD12 ' E' ' 131' ' ' ILE . 0.2 OUTLIER -136.51 138.01 47.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.653 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 157' ' ' GLN . . . . . 0.627 ' HB2' HG23 ' D' ' 4' ' ' THR . 64.1 tt0 -107.46 128.05 54.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.307 0.575 . . . . 0.0 110.328 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 158' ' ' TYR . . . . . 0.58 ' HB2' ' OG1' ' D' ' 3' ' ' THR . 61.0 m-85 -107.89 107.5 18.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.531 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 159' ' ' GLN . . . . . 0.646 ' HA ' ' H ' ' D' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.276 0.084 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.82 74.75 0.36 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.973 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 6.2 p -117.75 97.53 5.9 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.504 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 69.1 p -87.84 108.64 19.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.592 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.55 172.72 13.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.618 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -77.24 110.85 12.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.572 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.79 -59.37 7.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.75 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.56 151.71 14.96 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.763 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 9' ' ' THR . . . . . 0.405 HG21 ' N ' ' F' ' 10' ' ' VAL . 24.2 m -103.53 143.09 33.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 111.253 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 10' ' ' VAL . . . . . 0.477 HG22 ' HE1' ' F' ' 12' ' ' PHE . 1.2 m -130.92 115.62 30.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.241 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -83.59 105.79 14.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.397 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 12' ' ' PHE . . . . . 0.477 ' HE1' HG22 ' F' ' 10' ' ' VAL . 52.2 m-85 -83.21 105.5 14.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.76 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.49 145.09 41.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.43 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.75 -179.64 42.6 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.969 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.27 134.18 22.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.387 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 t -90.92 127.19 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.257 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 17' ' ' VAL . . . . . 0.576 HG12 HG12 ' E' ' 5' ' ' VAL . 12.0 m -126.25 168.74 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.887 0.375 . . . . 0.0 111.042 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -100.42 81.83 2.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.149 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.23 58.27 5.43 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.05 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . 0.488 ' HB3' HG21 ' F' ' 17' ' ' VAL . . . -108.61 -62.85 1.41 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.376 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 21' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.9 OUTLIER -171.57 -159.92 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.86 74.0 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.085 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 23' ' ' VAL . . . . . 0.795 ' HB ' HD22 ' F' ' 58' ' ' LEU . 7.4 p -45.35 140.64 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.015 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.45 140.79 58.91 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.679 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.41 -51.08 69.7 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.341 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.14 -18.06 74.45 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.871 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.94 -6.37 58.06 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.865 0.364 . . . . 0.0 110.835 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 50.6 t -72.66 -36.39 53.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.403 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.92 110.88 14.13 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.84 146.04 48.66 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.982 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.17 113.84 27.67 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.208 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.11 121.95 57.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.141 0.496 . . . . 0.0 110.457 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 33' ' ' GLN . . . . . 0.447 ' HG2' HG12 ' E' ' 28' ' ' VAL . 0.6 OUTLIER -101.83 106.39 17.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.633 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 34' ' ' LEU . . . . . 0.542 ' HA ' HD11 ' F' ' 34' ' ' LEU . 0.6 OUTLIER -64.77 -44.69 89.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.62 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.53 -156.97 16.01 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.561 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 36' ' ' GLN . . . . . 0.597 ' HB2' ' HA ' ' E' ' 22' ' ' ALA . 3.7 mt-30 -91.04 106.97 18.89 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.628 0.251 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 t -92.35 120.55 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.92 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 38' ' ' ARG . . . . . 0.426 ' HG2' ' HA ' ' E' ' 19' ' ' ALA . 4.5 mtm105 -85.59 132.5 34.17 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.753 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 39' ' ' THR . . . . . . . . . . . . . 29.4 p -71.56 -23.22 61.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.729 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.04 -19.19 64.87 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.007 0.432 . . . . 0.0 110.815 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 13.8 t -90.54 -36.6 14.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.16 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . 0.597 ' HB2' ' HB1' ' F' ' 139' ' ' ALA . 0.2 OUTLIER -121.43 70.56 0.94 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.648 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 43' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' F' ' 142' ' ' ALA . . . -104.82 28.11 7.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.331 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 44' ' ' GLN . . . . . 0.695 ' HG3' ' HB1' ' F' ' 47' ' ' ALA . 0.0 OUTLIER -150.54 142.01 23.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.392 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . 0.446 ' HG3' ' HA ' ' F' ' 140' ' ' THR . 2.7 tt0 -62.71 101.84 0.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.786 0.326 . . . . 0.0 111.084 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.21 4.27 8.47 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.197 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 47' ' ' ALA . . . . . 0.695 ' HB1' ' HG3' ' F' ' 44' ' ' GLN . . . -91.8 121.33 33.32 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.953 0.406 . . . . 0.0 111.981 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 48' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' F' ' 137' ' ' TYR . 5.9 t -110.41 151.13 27.86 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.836 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 49' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 5.2 t -95.63 -57.6 2.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.6 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 50' ' ' SER . . . . . 0.556 ' HB3' ' HA ' ' C' ' 92' ' ' ALA . 0.2 OUTLIER -148.24 -174.81 4.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.806 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 51' ' ' ALA . . . . . 0.659 ' HB3' ' HG2' ' F' ' 136' ' ' ARG . . . -127.13 143.84 51.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.284 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 52' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.84 116.87 51.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.015 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 53' ' ' GLY . . . . . 0.47 ' O ' HG21 ' C' ' 76' ' ' THR . . . -111.18 122.69 6.21 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.648 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -128.63 138.85 52.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 0.0 110.934 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 55' ' ' ASN . . . . . 0.583 HD21 HG21 ' F' ' 130' ' ' THR . 1.6 m120 -117.88 150.97 38.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.607 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 56' ' ' ILE . . . . . 0.579 ' HB ' HG13 ' F' ' 131' ' ' ILE . 9.3 mm -106.82 103.7 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.585 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 57' ' ' GLN . . . . . 0.737 ' HG2' HD11 ' C' ' 74' ' ' LEU . 75.9 mt-30 -61.13 132.22 53.04 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.769 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . 0.795 HD22 ' HB ' ' F' ' 23' ' ' VAL . 1.0 OUTLIER -137.4 151.74 48.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.253 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -138.3 171.43 14.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.026 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 60' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' F' ' 21' ' ' CYS . 5.9 m-20 49.95 68.52 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.812 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 61' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 0.0 OUTLIER -106.68 141.08 38.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.984 0.421 . . . . 0.0 110.736 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.74 117.83 33.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.266 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 23.4 p -91.15 -13.16 33.49 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.61 -38.95 82.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.033 0.444 . . . . 0.0 111.753 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 76.2 t -107.64 -54.1 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.65 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.76 84.33 3.34 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.604 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.97 -41.26 10.1 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.969 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.64 159.97 17.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.436 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.73 160.41 39.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.592 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.03 152.9 45.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.156 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.95 136.55 53.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.682 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.04 107.46 5.03 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.525 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 73' ' ' PHE . . . . . 0.448 ' CD2' HD12 ' F' ' 103' ' ' ILE . 43.0 t80 -73.63 136.7 43.91 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.58 0.228 . . . . 0.0 111.049 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 74' ' ' LEU . . . . . 0.524 HD13 ' HE3' ' F' ' 155' ' ' LYS . 6.6 tt -113.62 111.4 21.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.939 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . 0.683 ' HA3' HD12 ' F' ' 113' ' ' LEU . . . -131.31 -178.55 15.53 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.836 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.32 137.62 41.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.51 0.195 . . . . 0.0 110.79 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.02 114.73 23.88 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.935 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 78' ' ' ILE . . . . . 0.408 HD13 HD11 ' F' ' 88' ' ' LEU . 1.2 tt -95.69 -36.75 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.866 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 79' ' ' ASP . . . . . 0.451 ' HB3' ' CG2' ' F' ' 140' ' ' THR . 0.4 OUTLIER -143.38 130.26 20.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.752 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.94 -7.23 47.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.973 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.31 -29.2 68.34 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.636 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 -32.73 4.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.863 0.364 . . . . 0.0 110.455 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 3.4 m 60.55 19.37 9.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.632 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 84' ' ' ASN . . . . . 0.603 ' HB3' ' HG2' ' F' ' 102' ' ' GLN . 0.6 OUTLIER -139.36 -16.92 1.03 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.413 179.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 85' ' ' VAL . . . . . 0.679 ' HB ' ' HA3' ' F' ' 100' ' ' GLY . 0.8 OUTLIER -66.71 117.97 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.196 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 86' ' ' LEU . . . . . 0.558 ' HA ' HD21 ' F' ' 113' ' ' LEU . 10.7 tp -69.67 144.1 52.98 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.36 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.1 138.03 36.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.904 0.383 . . . . 0.0 111.762 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . 0.657 ' HB3' ' HA ' ' F' ' 148' ' ' ALA . 0.0 OUTLIER -84.94 -146.55 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.083 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 89' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' F' ' 149' ' ' ASN . 0.0 OUTLIER -48.66 155.1 0.59 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 32.8 p -86.78 -11.97 49.47 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.403 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.38 114.04 5.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.976 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.34 22.21 1.05 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.877 0.37 . . . . 0.0 111.667 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.28 22.06 1.19 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.692 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.69 -32.28 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.053 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 95' ' ' SER . . . . . 0.635 ' HA ' ' HB1' ' F' ' 147' ' ' ALA . 16.0 t -65.14 166.69 9.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.345 . . . . 0.0 110.616 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.61 163.49 15.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.87 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.41 169.61 17.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.329 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 98' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 57.36 29.36 16.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.414 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 99' ' ' VAL . . . . . 0.507 ' HB ' ' CB ' ' F' ' 143' ' ' ALA . 7.0 p -156.38 150.6 10.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.77 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 100' ' ' GLY . . . . . 0.679 ' HA3' ' HB ' ' F' ' 85' ' ' VAL . . . -164.22 176.96 40.11 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.604 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.66 111.37 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 123.04 0.536 . . . . 0.0 111.706 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 102' ' ' GLN . . . . . 0.603 ' HG2' ' HB3' ' F' ' 84' ' ' ASN . 0.0 OUTLIER -76.04 179.68 5.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.922 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 103' ' ' ILE . . . . . 0.521 HD13 ' HA ' ' F' ' 113' ' ' LEU . 6.0 pt -150.34 116.57 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.464 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 104' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' F' ' 134' ' ' GLN . 12.8 tp -97.18 122.53 40.3 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.743 0.306 . . . . 0.0 111.075 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -62.89 150.12 42.72 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.696 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 106' ' ' ARG . . . . . 0.527 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -71.38 -17.69 62.4 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.772 0.32 . . . . 0.0 111.052 179.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 75.7 p -76.61 -37.28 56.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.08 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.57 -68.77 0.32 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.685 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.68 123.27 18.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.875 0.369 . . . . 0.0 111.105 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.7 117.98 2.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 tp -67.77 144.04 55.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.429 0.633 . . . . 0.0 110.532 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 112' ' ' THR . . . . . 0.423 ' HA ' ' ND2' ' F' ' 84' ' ' ASN . 0.2 OUTLIER -75.08 140.46 43.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.13 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 113' ' ' LEU . . . . . 0.683 HD12 ' HA3' ' F' ' 75' ' ' GLY . 1.3 tp -85.22 97.85 10.15 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.764 0.316 . . . . 0.0 110.582 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -152.8 -59.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.674 0.273 . . . . 0.0 111.595 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.79 -26.66 3.13 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.61 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.28 28.74 5.19 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.643 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.57 67.39 0.72 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.052 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.43 80.95 8.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.735 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.01 97.5 3.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.803 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 1.9 t -165.53 144.8 6.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.576 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.29 50.36 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.232 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.87 94.12 5.78 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.659 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.73 110.35 12.5 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.643 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . 0.596 ' HG ' ' ND2' ' F' ' 129' ' ' ASN . 0.3 OUTLIER -70.13 154.15 42.27 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.579 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.62 144.77 51.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.552 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.76 125.64 24.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.667 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.03 -101.93 1.1 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.749 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 128' ' ' THR . . . . . 0.674 HG21 ' HD2' ' C' ' 155' ' ' LYS . 86.0 m -106.32 128.5 54.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.672 0.272 . . . . 0.0 110.782 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 129' ' ' ASN . . . . . 0.596 ' ND2' ' HG ' ' F' ' 124' ' ' LEU . 20.1 t-20 -121.08 158.21 28.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.129 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 130' ' ' THR . . . . . 0.583 HG21 HD21 ' F' ' 55' ' ' ASN . 0.2 OUTLIER -155.9 143.07 19.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.014 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 131' ' ' ILE . . . . . 0.579 HG13 ' HB ' ' F' ' 56' ' ' ILE . 0.1 OUTLIER -115.19 110.74 45.24 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 132' ' ' PRO . . . . . 0.527 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.4 Cg_endo -82.12 151.88 16.16 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.597 1.531 . . . . 0.0 112.514 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.0 146.76 17.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.84 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 134' ' ' GLN . . . . . 0.597 ' HG2' ' O ' ' C' ' 78' ' ' ILE . 0.8 OUTLIER -114.41 145.95 41.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.093 179.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.85 91.15 1.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 0.0 111.682 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 136' ' ' ARG . . . . . 0.659 ' HG2' ' HB3' ' F' ' 51' ' ' ALA . 28.0 mtm-85 -88.33 153.56 21.1 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.403 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 137' ' ' TYR . . . . . 0.595 ' O ' ' HA ' ' F' ' 48' ' ' THR . 0.7 OUTLIER -91.19 111.03 22.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.101 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 138' ' ' PHE . . . . . 0.595 ' CD1' ' HB2' ' F' ' 102' ' ' GLN . 8.8 m-85 -108.11 172.17 6.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.978 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 139' ' ' ALA . . . . . 0.597 ' HB1' ' HB2' ' F' ' 42' ' ' LEU . . . -123.41 143.71 49.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.807 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 140' ' ' THR . . . . . 0.451 ' CG2' ' HB3' ' F' ' 79' ' ' ASP . 0.2 OUTLIER -98.85 44.5 1.03 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.501 179.753 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.45 89.13 1.07 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.946 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 142' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' F' ' 43' ' ' ALA . . . 60.04 88.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.678 0.239 . . . . 0.0 110.694 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 143' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' F' ' 42' ' ' LEU . . . -70.54 161.72 30.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.783 0.325 . . . . 0.0 111.431 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.46 158.65 60.88 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.292 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 145' ' ' PRO . . . . . 0.456 ' HA ' ' HB ' ' E' ' 16' ' ' VAL . 1.4 Cg_endo -83.75 149.19 12.58 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.499 2.132 . . . . 0.0 112.079 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.71 -119.73 0.86 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.563 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 147' ' ' ALA . . . . . 0.635 ' HB1' ' HA ' ' F' ' 95' ' ' SER . . . -123.92 127.64 48.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 111.48 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 148' ' ' ALA . . . . . 0.657 ' HA ' ' HB3' ' F' ' 88' ' ' LEU . . . -120.77 67.1 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.139 0.495 . . . . 0.0 110.449 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 149' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' F' ' 89' ' ' GLN . 47.4 t-20 -128.47 114.73 17.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.667 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 150' ' ' ALA . . . . . . . . . . . . . . . -158.77 146.92 18.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.056 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.37 140.29 32.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.181 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.23 169.29 17.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.216 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 153' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' F' ' 74' ' ' LEU . 9.4 t -155.09 150.56 27.33 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 154' ' ' PHE . . . . . 0.427 ' HE1' HG13 ' F' ' 56' ' ' ILE . 1.1 p90 -119.06 149.24 42.0 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.089 0.471 . . . . 0.0 110.103 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 155' ' ' LYS . . . . . 0.524 ' HE3' HD13 ' F' ' 74' ' ' LEU . 4.7 mttt -113.5 156.67 23.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.886 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 156' ' ' VAL . . . . . 0.538 HG13 HD12 ' F' ' 131' ' ' ILE . 0.2 OUTLIER -136.5 138.05 47.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.667 -179.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 157' ' ' GLN . . . . . 0.614 ' HB2' HG23 ' E' ' 4' ' ' THR . 64.1 tt0 -107.5 127.99 54.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.307 0.575 . . . . 0.0 110.344 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 158' ' ' TYR . . . . . 0.581 ' HB2' ' OG1' ' E' ' 3' ' ' THR . 60.9 m-85 -107.82 107.43 18.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.565 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 159' ' ' GLN . . . . . 0.668 ' HA ' ' H ' ' E' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.903 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.58 ' H ' ' HA ' ' B' ' 159' ' ' GLN . . . . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.557 0.218 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' B' ' 157' ' ' GLN . 0.2 OUTLIER -103.08 110.35 22.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.419 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.37 136.14 38.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.55 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.598 HG13 ' HA2' ' C' ' 146' ' ' GLY . 0.0 OUTLIER -152.01 -175.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.61 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.51 130.04 38.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.677 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.53 ' HA2' HG22 ' B' ' 156' ' ' VAL . . . -98.77 -59.25 0.91 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.822 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.37 166.16 27.94 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.897 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.609 ' HA ' HG22 ' B' ' 153' ' ' THR . 26.8 m -94.36 121.11 35.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.904 0.383 . . . . 0.0 111.287 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.65 115.59 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.223 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -99.55 137.45 38.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.369 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 76.0 m-85 -127.49 97.73 4.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.22 175.8 6.56 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.428 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.91 149.49 5.78 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.923 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.33 108.63 13.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.776 0.322 . . . . 0.0 110.358 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.865 HG13 ' O ' ' B' ' 144' ' ' THR . 23.5 t -86.67 129.15 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.203 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.488 HG21 ' HB1' ' A' ' 22' ' ' ALA . 18.8 m -127.38 163.5 30.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.041 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -86.0 61.52 6.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.07 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.528 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . 44.93 52.63 8.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -127.29 -54.51 1.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.407 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER 177.7 111.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.866 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.76 ' HB2' ' HA ' ' B' ' 36' ' ' GLN . . . -105.63 126.08 51.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.073 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 28' ' ' VAL . 5.7 p -56.86 145.64 7.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.055 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.609 ' O ' HG22 ' A' ' 28' ' ' VAL . 4.0 m-20 -74.83 147.23 41.34 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.696 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.67 -43.66 17.87 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.34 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.98 -20.0 60.16 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.84 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.2 t -79.54 -26.07 41.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.863 0.363 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 24' ' ' ASP . 57.5 t -49.19 -48.46 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.331 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.84 93.08 5.36 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.023 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.63 116.42 28.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.009 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 p -95.6 115.62 27.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.151 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.6 t -117.18 101.16 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.131 0.491 . . . . 0.0 110.402 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -105.62 126.96 52.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.655 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.26 -55.62 11.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.63 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.03 -111.6 3.91 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.519 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.11 115.28 16.76 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.514 0.197 . . . . 0.0 110.875 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.0 t -131.01 105.8 11.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.875 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -96.64 154.12 17.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.757 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.76 ' HA ' HD12 ' A' ' 42' ' ' LEU . 8.2 p -78.75 -19.84 51.35 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.759 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -19.52 65.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.066 0.46 . . . . 0.0 110.885 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.7 p -92.0 -21.27 20.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.207 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.76 HD12 ' HA ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -139.14 62.36 1.54 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.58 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.69 ' HA ' ' HA ' ' A' ' 142' ' ' ALA . . . -101.13 9.12 42.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.321 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.19 136.0 24.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.37 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.59 ' N ' ' HA2' ' A' ' 141' ' ' GLY . 16.5 tt0 -58.48 121.37 10.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.915 0.388 . . . . 0.0 111.082 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.28 -25.46 8.23 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.149 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.75 137.29 58.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.939 0.4 . . . . 0.0 112.034 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 5.9 t -133.92 157.99 44.59 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.955 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.93 -166.21 1.09 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.621 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.8 m -65.23 156.19 32.68 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.767 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 134' ' ' GLN . . . -90.45 126.66 35.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.324 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.43 HG12 ' HD2' ' A' ' 54' ' ' PHE . 62.4 t -75.68 118.52 21.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.79 135.6 13.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.731 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 133' ' ' PHE . 46.2 p90 -170.74 142.1 1.92 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.915 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.662 ' HA ' ' O ' ' A' ' 131' ' ' ILE . 11.5 p30 -126.52 163.92 22.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.602 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.624 HG21 HD22 ' A' ' 58' ' ' LEU . 20.9 mm -105.13 120.03 55.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.525 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.553 ' HA ' HG21 ' A' ' 130' ' ' THR . 0.0 OUTLIER -82.15 115.66 21.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.712 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.624 HD22 HG21 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -128.24 107.46 9.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.288 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.37 176.97 8.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.889 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.05 66.13 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.797 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 3.3 m -109.69 154.48 22.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.679 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.514 ' HA ' ' OD1' ' A' ' 126' ' ' ASN . 0.5 OUTLIER -154.71 138.3 16.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.263 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.622 ' HG1' ' HA ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -97.54 -11.9 23.19 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -72.27 -48.69 40.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.003 0.43 . . . . 0.0 111.713 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.528 HG23 ' HB1' ' A' ' 19' ' ' ALA . 10.8 t -69.1 -48.6 68.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.695 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 63' ' ' THR . . . -138.02 153.26 49.39 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.599 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.19 18.66 4.48 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.95 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 10.6 tppt? -142.88 149.9 39.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.486 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.0 110.72 4.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.661 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 121' ' ' GLU . . . -108.05 169.99 8.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.1 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.38 150.98 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.61 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 116' ' ' ALA . . . -135.62 100.13 4.4 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.58 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.586 ' HB2' HD22 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -77.42 133.98 38.52 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.571 0.224 . . . . 0.0 111.107 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.17 115.05 20.48 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.025 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.31 -173.23 26.45 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.729 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.78 ' HG1' ' HB3' ' D' ' 55' ' ' ASN . 7.0 m -112.59 149.03 33.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.583 0.23 . . . . 0.0 110.755 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 85' ' ' VAL . . . -98.97 133.81 42.72 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.942 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.78 ' HB ' ' HA ' ' A' ' 87' ' ' ALA . 16.1 tt -72.93 -37.98 55.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.17 167.64 12.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.834 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' D' ' 106' ' ' ARG . . . -70.17 -53.83 15.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.073 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.35 28.63 6.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.595 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.796 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 10.2 m170 -111.33 -45.62 3.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.369 . . . . 0.0 110.427 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.562 ' HB ' HG22 ' A' ' 112' ' ' THR . 0.0 OUTLIER 46.42 -86.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.589 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -42.28 -42.4 3.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.239 179.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.796 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 21.3 t -61.29 126.57 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.093 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.558 ' HG ' ' CD2' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -81.25 164.41 22.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.78 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . . . -104.78 -177.49 3.38 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.672 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.491 ' HA ' HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -85.09 -174.57 5.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.982 179.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.57 -170.71 3.24 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.372 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.629 ' HA ' ' CG1' ' D' ' 52' ' ' VAL . 27.4 p -74.77 7.81 2.84 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.914 0.387 . . . . 0.0 111.462 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 0.8 OUTLIER -96.96 80.39 2.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.771 ' HB1' HD21 ' D' ' 34' ' ' LEU . . . -66.87 -41.13 87.76 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.624 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.533 ' HB1' ' O ' ' D' ' 36' ' ' GLN . . . -103.73 25.96 9.16 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.675 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.8 -22.63 0.33 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.929 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.418 ' HB3' ' HB2' ' A' ' 91' ' ' SER . 1.0 OUTLIER -107.68 175.18 5.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.906 0.384 . . . . 0.0 110.587 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.38 177.12 2.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -138.58 167.86 21.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.21 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.587 ' HA ' ' HB ' ' A' ' 140' ' ' THR . 32.4 m-80 44.19 51.65 7.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.502 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.628 ' HB ' ' HB3' ' A' ' 143' ' ' ALA . 6.0 p -169.38 124.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.72 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.61 -164.74 11.5 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.634 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.416 HG23 ' CE1' ' A' ' 137' ' ' TYR . 3.5 t -124.8 91.16 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 122.97 0.508 . . . . 0.0 111.722 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.679 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER -71.4 116.65 11.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.885 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 6.6 mt -89.64 120.59 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.492 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 1.0 OUTLIER -95.88 152.31 18.61 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.691 0.281 . . . . 0.0 111.092 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.425 ' O ' HD23 ' A' ' 104' ' ' LEU . 8.5 t0 -100.16 159.99 14.68 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.613 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.511 ' CZ ' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -68.71 -13.73 62.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.92 0.39 . . . . 0.0 111.146 179.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.404 ' HG1' ' HB3' ' A' ' 105' ' ' ASP . 44.6 p -74.41 -18.87 60.59 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.067 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.99 -40.11 2.23 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.664 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.41 164.67 13.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.781 0.324 . . . . 0.0 111.099 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -77.37 139.68 39.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.132 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.65 HD21 ' HB ' ' A' ' 117' ' ' THR . 5.9 tt -84.18 128.58 34.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.458 0.647 . . . . 0.0 110.506 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.562 HG22 ' HB ' ' A' ' 83' ' ' THR . 1.4 m -68.11 132.38 47.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.1 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.558 ' CD2' ' HG ' ' A' ' 86' ' ' LEU . 4.7 mp -88.04 99.83 12.46 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.621 0.248 . . . . 0.0 110.741 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' D' ' 130' ' ' THR . 0.8 OUTLIER -144.13 -32.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.502 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.46 -81.3 0.21 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.625 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' D' ' 125' ' ' ASN . . . -97.22 64.1 1.9 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.959 0.409 . . . . 0.0 111.603 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.65 ' HB ' HD21 ' A' ' 111' ' ' LEU . 2.8 m -94.4 72.39 3.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.141 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -66.76 119.04 11.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.835 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.89 -49.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.852 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.57 84.69 6.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.547 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 70' ' ' ALA . 3.5 mt-10 -110.2 86.95 2.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.29 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.99 159.3 17.68 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.815 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -66.96 138.39 57.23 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.727 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.55 159.49 19.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.622 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.622 ' HA ' ' HG1' ' A' ' 63' ' ' THR . 0.3 OUTLIER -147.58 176.19 10.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.588 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' A' ' 62' ' ' ASP . 0.9 OUTLIER -85.93 161.49 19.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.697 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.53 -121.0 5.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.775 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 74.4 m -119.54 140.31 50.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.682 0.277 . . . . 0.0 110.768 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -133.73 154.67 50.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.117 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 27.9 p -133.41 154.33 50.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.164 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.662 ' O ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -111.09 116.9 50.93 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 106' ' ' ARG . 7.5 Cg_endo -81.24 129.48 6.78 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.614 1.543 . . . . 0.0 112.581 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.446 ' HB3' ' CE1' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -140.89 146.9 38.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.794 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.507 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 19.3 mm-40 -116.5 158.33 23.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.011 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . . . -159.42 105.53 1.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.914 0.388 . . . . 0.0 111.524 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.7 172.61 6.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.414 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.416 ' CE1' HG23 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -98.2 147.79 24.25 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.131 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.444 ' CG ' HG21 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -127.67 159.03 35.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.277 0.561 . . . . 0.0 111.923 -179.192 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -116.33 141.24 48.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.936 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.587 ' HB ' ' HA ' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -107.75 27.23 9.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.482 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.59 ' HA2' ' N ' ' A' ' 45' ' ' GLU . . . 97.55 83.6 1.71 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.971 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.69 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . . . 57.88 93.47 0.03 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.688 0.244 . . . . 0.0 110.746 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.628 ' HB3' ' HB ' ' A' ' 99' ' ' VAL . . . -80.0 165.37 22.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 111.403 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.7 p -108.34 168.87 7.22 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.153 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.61 133.54 6.14 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.569 2.179 . . . . 0.0 111.979 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.55 -119.24 0.81 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.471 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.81 121.7 13.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.894 0.378 . . . . 0.0 111.281 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.34 85.68 3.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.442 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -104.55 131.21 52.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.601 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 87' ' ' ALA . . . -136.08 148.44 48.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.935 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.17 120.17 20.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.216 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.63 140.05 24.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.159 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.6 p -105.2 171.21 7.44 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.601 ' HZ ' HG23 ' A' ' 56' ' ' ILE . 13.7 p90 -138.2 147.39 43.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.038 0.447 . . . . 0.0 110.119 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.432 ' HG3' ' HB ' ' D' ' 128' ' ' THR . 13.6 mmtt -100.89 172.01 7.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.901 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.483 ' HB ' ' CZ ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -135.51 111.4 12.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.82 0.343 . . . . 0.0 111.728 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -109.04 141.26 41.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.346 0.593 . . . . 0.0 110.414 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.483 ' CZ ' ' HB ' ' A' ' 156' ' ' VAL . 23.1 m-85 -135.36 105.58 6.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.583 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.589 ' HB3' ' HB3' ' A' ' 68' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.92 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . 0.589 ' H ' ' HA ' ' C' ' 159' ' ' GLN . . . 56.58 88.57 0.05 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.056 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' C' ' 157' ' ' GLN . 0.2 OUTLIER -103.08 110.38 22.29 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.393 179.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 136.18 38.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.552 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.6 HG13 ' HA2' ' D' ' 146' ' ' GLY . 0.0 OUTLIER -152.05 -175.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.591 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.43 130.04 38.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.666 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . 0.526 ' HA2' HG22 ' C' ' 156' ' ' VAL . . . -98.8 -59.33 0.91 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.756 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.4 166.2 28.04 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.894 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' THR . . . . . 0.616 ' HA ' HG22 ' C' ' 153' ' ' THR . 26.7 m -94.38 121.1 35.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.89 0.376 . . . . 0.0 111.269 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.69 115.64 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.24 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -99.54 137.55 37.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.351 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' C' ' 32' ' ' VAL . 76.0 m-85 -127.61 97.71 4.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.22 175.78 6.57 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.472 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.01 149.4 5.75 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.941 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.24 108.68 14.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.852 0.358 . . . . 0.0 110.414 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.856 HG13 ' O ' ' C' ' 144' ' ' THR . 23.6 t -86.71 129.19 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.175 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.481 HG21 ' CB ' ' B' ' 22' ' ' ALA . 18.7 m -127.45 163.51 30.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.033 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -85.95 61.35 6.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.027 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.527 ' HB1' HG23 ' B' ' 65' ' ' VAL . . . 45.02 52.64 8.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.053 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' B' ' 61' ' ' CYS . . . -127.24 -54.54 1.37 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.451 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.1 OUTLIER 177.73 111.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.893 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.751 ' HB2' ' HA ' ' C' ' 36' ' ' GLN . . . -105.67 126.05 51.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.083 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.452 HG11 HG21 ' B' ' 28' ' ' VAL . 5.7 p -56.81 145.61 7.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.035 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.611 ' O ' HG22 ' B' ' 28' ' ' VAL . 4.0 m-20 -74.82 147.27 41.32 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.68 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.8 -43.57 18.47 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.323 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.97 -20.07 60.06 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.809 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 45.3 t -79.58 -26.01 41.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.611 HG22 ' O ' ' B' ' 24' ' ' ASP . 57.4 t -49.21 -48.46 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.344 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.86 93.08 5.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.031 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.61 116.36 28.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.026 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.55 115.67 27.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.209 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 12' ' ' PHE . 1.7 t -117.23 101.07 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.182 0.515 . . . . 0.0 110.429 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -105.58 126.93 52.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.715 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.15 -55.66 11.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.62 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.02 -111.65 3.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.539 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.76 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -77.05 115.29 16.71 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.501 0.191 . . . . 0.0 110.907 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 68.4 t -131.05 105.86 11.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.833 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.6 154.05 17.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.782 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.776 ' HA ' HD12 ' B' ' 42' ' ' LEU . 8.2 p -78.77 -19.79 51.4 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.702 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.51 -19.53 65.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.144 0.497 . . . . 0.0 110.899 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 96.5 p -92.01 -21.27 20.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.19 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.776 HD12 ' HA ' ' B' ' 39' ' ' THR . 0.2 OUTLIER -139.0 62.27 1.54 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.707 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.7 ' HA ' ' HA ' ' B' ' 142' ' ' ALA . . . -101.09 9.14 42.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.363 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.19 136.03 24.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.335 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.574 ' N ' ' HA2' ' B' ' 141' ' ' GLY . 16.5 tt0 -58.59 121.33 10.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 111.154 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.4 -25.54 8.14 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.166 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.67 137.19 58.2 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.91 158.04 44.45 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.904 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -166.19 1.09 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.598 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 48.9 m -65.2 156.13 32.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.816 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . 0.521 ' HB1' ' HB3' ' B' ' 134' ' ' GLN . . . -90.5 126.7 36.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.339 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.427 HG12 ' HD2' ' B' ' 54' ' ' PHE . 63.2 t -75.6 118.5 21.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.019 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.79 135.74 13.86 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.626 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' B' ' 133' ' ' PHE . 46.3 p90 -170.85 142.08 1.86 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.815 0.341 . . . . 0.0 110.905 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.661 ' HA ' ' O ' ' B' ' 131' ' ' ILE . 11.5 p30 -126.52 163.93 22.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.54 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.641 HG21 HD22 ' B' ' 58' ' ' LEU . 20.7 mm -105.17 119.97 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.503 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . 0.57 ' HA ' HG21 ' B' ' 130' ' ' THR . 0.0 OUTLIER -82.16 115.74 21.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.731 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.641 HD22 HG21 ' B' ' 56' ' ' ILE . 0.0 OUTLIER -128.33 107.47 9.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.252 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.37 176.99 8.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.86 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.03 66.21 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.714 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 3.3 m -109.73 154.46 22.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.711 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . 0.521 ' HA ' ' OD1' ' B' ' 126' ' ' ASN . 0.5 OUTLIER -154.74 138.26 15.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.271 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.614 ' HG1' ' HA ' ' B' ' 125' ' ' ASN . 0.2 OUTLIER -97.55 -11.81 23.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.08 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.25 -48.68 40.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.115 0.483 . . . . 0.0 111.78 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . 0.527 HG23 ' HB1' ' B' ' 19' ' ' ALA . 10.6 t -69.02 -48.7 68.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.764 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' B' ' 63' ' ' THR . . . -137.93 153.36 49.5 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.637 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.29 18.67 4.43 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.868 0.366 . . . . 0.0 110.906 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . 0.588 ' HB3' ' HB3' ' B' ' 159' ' ' GLN . 10.6 tppt? -142.9 149.93 39.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.469 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.03 110.72 4.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.687 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' B' ' 121' ' ' GLU . . . -108.1 169.92 8.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.05 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.35 150.93 35.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.63 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.62 100.16 4.41 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.518 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.586 ' HB2' HD22 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -77.35 133.84 38.63 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.572 0.225 . . . . 0.0 111.189 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.15 115.16 20.67 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.984 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.37 -173.24 26.53 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.777 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.779 ' HG1' ' HB3' ' E' ' 55' ' ' ASN . 7.0 m -112.6 149.04 33.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.565 0.221 . . . . 0.0 110.755 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' B' ' 85' ' ' VAL . . . -98.99 133.78 42.77 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.908 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.768 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 16.1 tt -72.91 -37.94 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.16 167.58 12.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.836 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' E' ' 106' ' ' ARG . . . -70.11 -53.85 15.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.42 28.74 6.08 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.564 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.791 ' HB3' ' HB ' ' B' ' 85' ' ' VAL . 10.2 m170 -111.38 -45.62 3.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.45 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' THR . . . . . 0.563 ' HB ' HG22 ' B' ' 112' ' ' THR . 0.0 OUTLIER 46.41 -86.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.59 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' B' ' 82' ' ' HIS . 0.0 OUTLIER -42.3 -42.35 3.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.299 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.791 ' HB ' ' HB3' ' B' ' 82' ' ' HIS . 21.3 t -61.33 126.62 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.145 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . 0.559 ' HG ' ' CD2' ' B' ' 113' ' ' LEU . 0.2 OUTLIER -81.31 164.33 22.27 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.281 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.768 ' HA ' ' HB ' ' B' ' 78' ' ' ILE . . . -104.74 -177.52 3.39 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.841 0.353 . . . . 0.0 111.67 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.495 ' HA ' HD12 ' B' ' 88' ' ' LEU . 0.1 OUTLIER -85.03 -174.51 5.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.052 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.63 -170.68 3.22 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.394 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' SER . . . . . 0.647 ' HA ' ' CG1' ' E' ' 52' ' ' VAL . 27.4 p -74.85 7.95 2.8 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.92 0.39 . . . . 0.0 111.408 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.07 80.4 2.95 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.761 ' HB1' HD21 ' E' ' 34' ' ' LEU . . . -66.83 -41.18 87.87 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.841 0.353 . . . . 0.0 111.664 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . 0.529 ' HB1' ' O ' ' E' ' 36' ' ' GLN . . . -103.76 26.07 9.05 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.698 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.81 -22.66 0.33 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.922 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.64 175.21 5.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.93 0.395 . . . . 0.0 110.606 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.53 177.18 3.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.848 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.455 HG22 ' H ' ' B' ' 98' ' ' ASN . 0.2 OUTLIER -138.59 167.89 20.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.27 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . 0.577 ' HA ' ' HB ' ' B' ' 140' ' ' THR . 32.2 m-80 44.12 51.63 7.2 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.53 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . 0.631 ' HB ' ' HB3' ' B' ' 143' ' ' ALA . 6.1 p -169.31 124.12 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.823 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.5 -164.68 11.5 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.619 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . 0.412 HG23 ' CE1' ' B' ' 137' ' ' TYR . 3.5 t -124.86 91.12 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 122.925 0.49 . . . . 0.0 111.695 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.689 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 0.6 OUTLIER -71.42 116.58 11.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.919 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 6.6 mt -89.51 120.63 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.534 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . 0.485 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 1.0 OUTLIER -95.88 152.31 18.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.758 0.313 . . . . 0.0 111.041 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . 0.424 ' O ' HD23 ' B' ' 104' ' ' LEU . 8.6 t0 -100.23 160.12 14.58 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.573 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . 0.509 ' CZ ' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -68.83 -13.69 62.56 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.858 0.361 . . . . 0.0 111.032 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 44.8 p -74.45 -18.85 60.58 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.03 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.93 -40.15 2.22 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.659 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.34 164.69 13.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.774 0.321 . . . . 0.0 111.078 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -77.37 139.65 39.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.643 HD21 ' HB ' ' B' ' 117' ' ' THR . 5.9 tt -84.09 128.59 34.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.438 0.637 . . . . 0.0 110.462 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.563 HG22 ' HB ' ' B' ' 83' ' ' THR . 1.4 m -68.13 132.38 47.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.111 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.559 ' CD2' ' HG ' ' B' ' 86' ' ' LEU . 4.7 mp -88.1 99.74 12.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.726 0.298 . . . . 0.0 110.748 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . 0.504 ' O ' ' O ' ' E' ' 130' ' ' THR . 0.8 OUTLIER -144.1 -32.34 0.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.495 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.44 -81.23 0.21 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.68 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' E' ' 125' ' ' ASN . . . -97.24 64.02 1.88 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.986 0.422 . . . . 0.0 111.602 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' THR . . . . . 0.643 ' HB ' HD21 ' B' ' 111' ' ' LEU . 2.8 m -94.28 72.28 3.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.212 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.73 119.05 11.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.82 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.96 -48.97 0.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.57 84.68 6.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.559 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' B' ' 70' ' ' ALA . 3.5 mt-10 -110.19 87.0 2.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.227 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.09 159.32 17.6 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.802 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -67.0 138.35 57.18 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.666 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.49 159.5 19.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.665 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . 0.614 ' HA ' ' HG1' ' B' ' 63' ' ' THR . 0.3 OUTLIER -147.62 176.25 10.23 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.602 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' ASN . . . . . 0.521 ' OD1' ' HA ' ' B' ' 62' ' ' ASP . 0.9 OUTLIER -85.94 161.49 19.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.641 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.5 -121.03 5.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.756 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 73.2 m -119.5 140.32 50.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.661 0.267 . . . . 0.0 110.779 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -133.76 154.63 50.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.06 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.57 HG21 ' HA ' ' B' ' 57' ' ' GLN . 28.4 p -133.32 154.25 50.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.217 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' ILE . . . . . 0.661 ' O ' ' HA ' ' B' ' 55' ' ' ASN . 1.0 OUTLIER -110.95 116.89 51.22 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' PRO . . . . . 0.509 ' HG2' ' CZ ' ' B' ' 106' ' ' ARG . 7.6 Cg_endo -81.2 129.46 6.79 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 121.672 1.581 . . . . 0.0 112.594 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.448 ' HB3' ' CE1' ' B' ' 54' ' ' PHE . 0.1 OUTLIER -140.9 146.84 37.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.78 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' GLN . . . . . 0.521 ' HB3' ' HB1' ' B' ' 51' ' ' ALA . 19.5 mm-40 -116.57 158.38 23.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.022 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -159.41 105.52 1.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 111.515 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.71 172.55 6.74 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.417 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' B' ' 101' ' ' VAL . 0.7 OUTLIER -98.25 147.75 24.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.081 179.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . 0.442 ' CG ' HG21 ' B' ' 85' ' ' VAL . 0.3 OUTLIER -127.6 159.01 35.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.031 -179.212 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -116.26 141.33 48.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.913 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' THR . . . . . 0.577 ' HB ' ' HA ' ' B' ' 98' ' ' ASN . 0.3 OUTLIER -107.86 27.27 9.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.467 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . 0.574 ' HA2' ' N ' ' B' ' 45' ' ' GLU . . . 97.49 83.6 1.7 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.015 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . 0.7 ' HA ' ' HA ' ' B' ' 43' ' ' ALA . . . 57.89 93.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.607 0.204 . . . . 0.0 110.821 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' ALA . . . . . 0.631 ' HB3' ' HB ' ' B' ' 99' ' ' VAL . . . -80.05 165.51 22.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.709 0.29 . . . . 0.0 111.448 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.865 ' O ' HG13 ' A' ' 16' ' ' VAL . 29.6 p -108.43 168.81 7.29 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.204 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.66 133.52 6.09 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.579 2.186 . . . . 0.0 111.987 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.61 -119.22 0.81 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.427 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.82 121.64 13.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.842 0.353 . . . . 0.0 111.306 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.32 85.7 3.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.5 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -104.6 131.23 52.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.56 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' B' ' 87' ' ' ALA . . . -136.1 148.47 48.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.949 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -133.19 120.21 20.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.197 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.61 140.01 24.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.199 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 9' ' ' THR . 70.7 p -105.16 171.18 7.46 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' PHE . . . . . 0.609 ' HZ ' HG23 ' B' ' 56' ' ' ILE . 13.6 p90 -138.16 147.44 43.86 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.104 0.478 . . . . 0.0 110.124 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . 0.446 ' HG3' ' HB ' ' E' ' 128' ' ' THR . 13.6 mmtt -100.94 172.02 7.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.892 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' VAL . . . . . 0.53 HG22 ' HA2' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -135.51 111.38 12.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.738 0.304 . . . . 0.0 111.681 -179.043 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' A' ' 3' ' ' THR . 1.8 tt0 -109.06 141.28 41.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.369 0.604 . . . . 0.0 110.383 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' TYR . . . . . 0.48 ' CZ ' ' HB ' ' B' ' 156' ' ' VAL . 23.2 m-85 -135.39 105.55 6.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.553 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . 0.588 ' HB3' ' HB3' ' B' ' 68' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.855 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . 0.572 ' H ' ' HA ' ' D' ' 159' ' ' GLN . . . 56.66 88.58 0.05 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.988 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 3' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' D' ' 157' ' ' GLN . 0.2 OUTLIER -103.05 110.38 22.28 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.428 179.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.4 136.24 38.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.523 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . 0.604 HG13 ' HA2' ' E' ' 146' ' ' GLY . 0.0 OUTLIER -152.08 -175.28 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.63 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.54 130.08 38.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.595 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' GLY . . . . . 0.531 ' HA2' HG22 ' D' ' 156' ' ' VAL . . . -98.81 -59.29 0.91 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.804 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.41 166.23 28.08 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.864 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' THR . . . . . 0.613 ' HA ' HG22 ' D' ' 153' ' ' THR . 27.0 m -94.46 121.16 35.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 111.219 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.6 115.61 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.258 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -99.56 137.51 37.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.311 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' PHE . . . . . 0.573 ' HA ' ' O ' ' D' ' 32' ' ' VAL . 75.8 m-85 -127.56 97.73 4.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.21 175.84 6.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.442 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.93 149.46 5.77 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.914 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.28 108.58 13.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.773 0.321 . . . . 0.0 110.432 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.86 HG13 ' O ' ' D' ' 144' ' ' THR . 23.1 t -86.6 129.07 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.283 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.484 HG21 ' HB1' ' C' ' 22' ' ' ALA . 18.7 m -127.39 163.55 30.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.826 0.346 . . . . 0.0 110.993 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -86.0 61.41 6.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.069 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . 0.514 ' HB1' HG23 ' C' ' 65' ' ' VAL . . . 44.95 52.64 8.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' C' ' 61' ' ' CYS . . . -127.29 -54.43 1.36 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.467 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.1 OUTLIER 177.73 111.65 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.92 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . 0.755 ' HB2' ' HA ' ' D' ' 36' ' ' GLN . . . -105.64 126.06 51.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . 0.429 HG11 HG21 ' C' ' 28' ' ' VAL . 5.7 p -56.8 145.66 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.022 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.602 ' O ' HG22 ' C' ' 28' ' ' VAL . 4.0 m-20 -74.86 147.24 41.27 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.693 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.78 -43.64 18.43 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.337 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.88 -20.01 60.32 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.946 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 45.2 t -79.62 -26.04 41.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.857 0.36 . . . . 0.0 110.833 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.602 HG22 ' O ' ' C' ' 24' ' ' ASP . 57.5 t -49.08 -48.58 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.341 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.82 93.07 5.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.069 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.59 116.41 28.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.994 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 9.1 p -95.63 115.66 27.75 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.115 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' B' ' 12' ' ' PHE . 1.7 t -117.19 101.1 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.059 0.457 . . . . 0.0 110.438 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.55 126.9 52.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.688 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.19 -55.71 11.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.611 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.06 -111.71 3.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.471 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . 0.751 ' HA ' ' HB2' ' B' ' 22' ' ' ALA . 0.0 OUTLIER -77.02 115.32 16.72 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.516 0.198 . . . . 0.0 110.894 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' B' ' 16' ' ' VAL . 67.2 t -130.99 105.83 11.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.881 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.71 154.1 17.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.748 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.753 ' HA ' HD12 ' C' ' 42' ' ' LEU . 8.3 p -78.7 -19.86 51.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.779 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.53 -19.49 65.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 110.879 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 97.5 p -92.06 -21.26 20.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.143 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.753 HD12 ' HA ' ' C' ' 39' ' ' THR . 0.2 OUTLIER -139.06 62.31 1.54 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.62 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . 0.699 ' HA ' ' HA ' ' C' ' 142' ' ' ALA . . . -101.26 9.2 42.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.23 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.25 136.07 24.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.306 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . 0.589 ' N ' ' HA2' ' C' ' 141' ' ' GLY . 16.5 tt0 -58.54 121.32 10.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 111.139 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.32 -25.43 8.22 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.189 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.8 137.27 58.22 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.937 0.398 . . . . 0.0 112.034 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.9 158.0 44.55 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.935 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.92 -166.23 1.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.627 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 48.8 m -65.18 156.25 32.35 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.782 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' C' ' 134' ' ' GLN . . . -90.56 126.63 36.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.309 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . 0.429 HG12 ' HD2' ' C' ' 54' ' ' PHE . 62.9 t -75.64 118.52 21.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.982 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.85 135.71 13.81 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.632 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' C' ' 133' ' ' PHE . 46.3 p90 -170.76 142.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.755 0.312 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.662 ' HA ' ' O ' ' C' ' 131' ' ' ILE . 11.5 p30 -126.56 163.91 22.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.569 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.622 HG21 HD22 ' C' ' 58' ' ' LEU . 20.8 mm -105.1 119.89 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.519 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.577 ' HA ' HG21 ' C' ' 130' ' ' THR . 0.0 OUTLIER -82.09 115.69 21.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.761 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . 0.622 HD22 HG21 ' C' ' 56' ' ' ILE . 0.0 OUTLIER -128.23 107.45 9.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.295 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.36 176.99 8.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.954 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.03 66.24 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.734 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 3.3 m -109.75 154.4 22.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.668 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . 0.507 ' HA ' ' OD1' ' C' ' 126' ' ' ASN . 0.5 OUTLIER -154.65 138.33 16.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.295 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.601 ' HG1' ' HA ' ' C' ' 125' ' ' ASN . 0.2 OUTLIER -97.54 -11.9 23.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.07 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -72.26 -48.71 40.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.026 0.441 . . . . 0.0 111.732 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . 0.514 HG23 ' HB1' ' C' ' 19' ' ' ALA . 10.6 t -69.0 -48.73 68.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.716 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' C' ' 63' ' ' THR . . . -137.93 153.36 49.5 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.672 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.28 18.67 4.43 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.847 0.356 . . . . 0.0 110.878 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' LYS . . . . . 0.6 ' HB3' ' HB3' ' C' ' 159' ' ' GLN . 10.6 tppt? -142.9 149.95 39.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.41 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.02 110.71 4.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.671 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' C' ' 121' ' ' GLU . . . -108.07 169.97 8.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.083 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.38 150.96 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.632 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.55 100.06 4.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.62 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' PHE . . . . . 0.581 ' HB2' HD22 ' C' ' 111' ' ' LEU . 0.2 OUTLIER -77.41 133.95 38.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.552 0.215 . . . . 0.0 111.117 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.15 115.08 20.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.968 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.42 -173.24 26.57 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.761 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' THR . . . . . 0.779 ' HG1' ' HB3' ' F' ' 55' ' ' ASN . 7.1 m -112.61 149.0 33.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.618 0.247 . . . . 0.0 110.737 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' C' ' 85' ' ' VAL . . . -98.96 133.78 42.73 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.936 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . 0.757 ' HB ' ' HA ' ' C' ' 87' ' ' ALA . 16.1 tt -72.89 -38.01 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.13 167.61 12.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.802 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' F' ' 106' ' ' ARG . . . -70.21 -53.78 15.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.08 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.4 28.66 6.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.546 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . 0.806 ' HB3' ' HB ' ' C' ' 85' ' ' VAL . 10.2 m170 -111.3 -45.67 3.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.46 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' THR . . . . . 0.568 ' HB ' HG22 ' C' ' 112' ' ' THR . 0.0 OUTLIER 46.48 -86.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.552 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' C' ' 82' ' ' HIS . 0.0 OUTLIER -42.19 -42.48 3.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.277 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.806 ' HB ' ' HB3' ' C' ' 82' ' ' HIS . 21.3 t -61.25 126.56 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.148 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.553 ' HG ' ' CD2' ' C' ' 113' ' ' LEU . 0.2 OUTLIER -81.22 164.39 22.32 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.413 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.757 ' HA ' ' HB ' ' C' ' 78' ' ' ILE . . . -104.79 -177.54 3.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.84 0.352 . . . . 0.0 111.661 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.479 ' HA ' HD12 ' C' ' 88' ' ' LEU . 0.2 OUTLIER -85.03 -174.53 5.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.049 179.469 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.63 -170.66 3.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.317 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' SER . . . . . 0.635 ' HA ' ' CG1' ' F' ' 52' ' ' VAL . 26.9 p -74.85 7.85 2.86 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.989 0.423 . . . . 0.0 111.408 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' C' ' 95' ' ' SER . 0.8 OUTLIER -96.97 80.45 2.98 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.84 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' ALA . . . . . 0.738 ' HB1' HD21 ' F' ' 34' ' ' LEU . . . -66.83 -41.24 87.78 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.853 0.359 . . . . 0.0 111.618 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' ALA . . . . . 0.529 ' HB1' ' O ' ' F' ' 36' ' ' GLN . . . -103.7 25.98 9.12 Favored 'General case' 0 N--CA 1.46 0.068 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.707 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.83 -22.69 0.33 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.947 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' C' ' 91' ' ' SER . 1.0 OUTLIER -107.66 175.18 5.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.913 0.387 . . . . 0.0 110.593 179.544 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.41 177.1 3.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' THR . . . . . 0.444 HG22 ' H ' ' C' ' 98' ' ' ASN . 0.2 OUTLIER -138.52 167.88 20.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.269 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . 0.577 ' HA ' ' HB ' ' C' ' 140' ' ' THR . 32.5 m-80 44.17 51.7 7.26 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.48 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 99' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' C' ' 143' ' ' ALA . 6.0 p -169.39 124.12 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.767 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.55 -164.72 11.5 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.638 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' VAL . . . . . 0.417 HG23 ' CE1' ' C' ' 137' ' ' TYR . 3.4 t -124.77 91.15 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 122.975 0.51 . . . . 0.0 111.7 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 102' ' ' GLN . . . . . 0.673 ' HA ' ' HA ' ' C' ' 85' ' ' VAL . 0.6 OUTLIER -71.45 116.63 12.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.858 -179.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 6.6 mt -89.68 120.61 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.445 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' LEU . . . . . 0.49 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 1.0 OUTLIER -95.81 152.27 18.63 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.689 0.28 . . . . 0.0 111.164 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . 0.424 ' O ' HD23 ' C' ' 104' ' ' LEU . 8.5 t0 -100.16 160.07 14.62 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.601 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 106' ' ' ARG . . . . . 0.511 ' CZ ' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -68.8 -13.68 62.55 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.827 0.346 . . . . 0.0 111.066 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 45.0 p -74.37 -18.92 60.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.081 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.91 -40.01 2.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.71 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.41 164.71 13.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.816 0.341 . . . . 0.0 111.116 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -77.35 139.58 39.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.174 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 111' ' ' LEU . . . . . 0.65 HD21 ' HB ' ' C' ' 117' ' ' THR . 5.9 tt -84.08 128.48 34.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.435 0.636 . . . . 0.0 110.519 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 112' ' ' THR . . . . . 0.568 HG22 ' HB ' ' C' ' 83' ' ' THR . 1.4 m -68.14 132.39 47.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.126 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.553 ' CD2' ' HG ' ' C' ' 86' ' ' LEU . 4.7 mp -87.99 99.69 12.35 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.791 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 114' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' F' ' 130' ' ' THR . 0.8 OUTLIER -144.03 -32.49 0.43 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.626 0.25 . . . . 0.0 111.568 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.5 -81.25 0.21 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.669 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 116' ' ' ALA . . . . . 0.439 ' HB3' ' HB3' ' F' ' 125' ' ' ASN . . . -97.25 64.0 1.88 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.975 0.417 . . . . 0.0 111.659 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 117' ' ' THR . . . . . 0.65 ' HB ' HD21 ' C' ' 111' ' ' LEU . 2.8 m -94.26 72.28 3.88 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.18 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -66.69 119.04 11.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.9 t -143.95 -48.96 0.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.809 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 3.0 m -88.57 84.7 6.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.584 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' C' ' 70' ' ' ALA . 3.5 mt-10 -110.25 86.92 2.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.287 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.95 159.27 17.73 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -66.93 138.34 57.21 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.699 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.56 159.48 19.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.636 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 125' ' ' ASN . . . . . 0.601 ' HA ' ' HG1' ' C' ' 63' ' ' THR . 0.3 OUTLIER -147.56 176.28 10.19 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.562 179.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 126' ' ' ASN . . . . . 0.507 ' OD1' ' HA ' ' C' ' 62' ' ' ASP . 0.9 OUTLIER -85.92 161.52 19.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.681 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.5 -121.0 5.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.756 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 72.4 m -119.47 140.36 50.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.675 0.274 . . . . 0.0 110.815 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 129' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -133.8 154.64 50.86 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.876 0.37 . . . . 0.0 111.087 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 130' ' ' THR . . . . . 0.577 HG21 ' HA ' ' C' ' 57' ' ' GLN . 28.0 p -133.37 154.29 50.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.133 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 131' ' ' ILE . . . . . 0.662 ' O ' ' HA ' ' C' ' 55' ' ' ASN . 1.0 OUTLIER -111.0 116.84 51.19 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 132' ' ' PRO . . . . . 0.511 ' HG2' ' CZ ' ' C' ' 106' ' ' ARG . 7.7 Cg_endo -81.12 129.4 6.83 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.662 1.574 . . . . 0.0 112.675 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.447 ' HB3' ' CE1' ' C' ' 54' ' ' PHE . 0.1 OUTLIER -140.87 146.89 38.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.813 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 134' ' ' GLN . . . . . 0.508 ' HB3' ' HB1' ' C' ' 51' ' ' ALA . 19.4 mm-40 -116.47 158.39 23.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.043 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -159.48 105.53 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.91 0.386 . . . . 0.0 111.545 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.72 172.5 6.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.399 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 137' ' ' TYR . . . . . 0.417 ' CE1' HG23 ' C' ' 101' ' ' VAL . 0.7 OUTLIER -98.16 147.72 24.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.128 179.489 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 138' ' ' PHE . . . . . 0.44 ' CG ' HG21 ' C' ' 85' ' ' VAL . 0.3 OUTLIER -127.58 158.99 35.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.057 -179.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 139' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' C' ' 42' ' ' LEU . . . -116.27 141.28 48.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.934 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 140' ' ' THR . . . . . 0.577 ' HB ' ' HA ' ' C' ' 98' ' ' ASN . 0.2 OUTLIER -107.83 27.23 9.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.471 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . 0.589 ' HA2' ' N ' ' C' ' 45' ' ' GLU . . . 97.63 83.59 1.71 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.97 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 142' ' ' ALA . . . . . 0.699 ' HA ' ' HA ' ' C' ' 43' ' ' ALA . . . 57.9 93.41 0.03 OUTLIER 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.666 0.233 . . . . 0.0 110.8 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 143' ' ' ALA . . . . . 0.608 ' HB3' ' HB ' ' C' ' 99' ' ' VAL . . . -80.02 165.38 22.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.764 0.316 . . . . 0.0 111.392 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 144' ' ' THR . . . . . 0.856 ' O ' HG13 ' B' ' 16' ' ' VAL . 29.8 p -108.35 168.87 7.22 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.228 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 145' ' ' PRO . . . . . 0.445 ' HG2' HG21 ' A' ' 3' ' ' THR . 1.4 Cg_endo -83.68 133.56 6.09 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.533 2.155 . . . . 0.0 112.015 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 146' ' ' GLY . . . . . 0.598 ' HA2' HG13 ' A' ' 5' ' ' VAL . . . 169.6 -119.25 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.477 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.8 121.73 13.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.887 0.375 . . . . 0.0 111.339 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.42 85.71 3.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.419 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -104.61 131.24 52.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.548 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 150' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' C' ' 87' ' ' ALA . . . -136.06 148.51 48.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.971 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.24 120.19 20.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.205 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.64 140.0 24.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.207 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 153' ' ' THR . . . . . 0.616 HG22 ' HA ' ' B' ' 9' ' ' THR . 70.7 p -105.16 171.19 7.45 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 154' ' ' PHE . . . . . 0.616 ' HZ ' HG23 ' C' ' 56' ' ' ILE . 13.9 p90 -138.21 147.41 43.73 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.114 0.483 . . . . 0.0 110.074 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 155' ' ' LYS . . . . . 0.439 ' HG3' ' HB ' ' F' ' 128' ' ' THR . 13.7 mmtt -100.89 171.94 7.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.936 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 156' ' ' VAL . . . . . 0.526 HG22 ' HA2' ' B' ' 7' ' ' GLY . 0.4 OUTLIER -135.47 111.41 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.84 0.352 . . . . 0.0 111.716 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 157' ' ' GLN . . . . . 0.541 ' HA ' ' O ' ' B' ' 3' ' ' THR . 1.8 tt0 -108.96 141.29 41.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.349 0.595 . . . . 0.0 110.409 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 158' ' ' TYR . . . . . 0.478 ' CZ ' ' HB ' ' C' ' 156' ' ' VAL . 23.0 m-85 -135.37 105.47 6.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.595 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . 0.6 ' HB3' ' HB3' ' C' ' 68' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 111.495 0.183 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . 0.576 ' H ' ' HA ' ' E' ' 159' ' ' GLN . . . 56.69 88.54 0.05 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.713 -0.222 . . . . 0.0 110.963 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 3' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' E' ' 157' ' ' GLN . 0.2 OUTLIER -103.08 110.38 22.29 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.383 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.36 136.2 38.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.592 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . 0.594 HG13 ' HA2' ' F' ' 146' ' ' GLY . 0.0 OUTLIER -152.05 -175.35 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.562 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.44 130.05 38.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.685 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 7' ' ' GLY . . . . . 0.529 ' HA2' HG22 ' E' ' 156' ' ' VAL . . . -98.81 -59.23 0.91 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.8 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.34 166.18 27.93 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.868 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 9' ' ' THR . . . . . 0.602 ' HA ' HG22 ' E' ' 153' ' ' THR . 27.0 m -94.38 121.15 35.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 0.0 111.197 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.73 115.61 36.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.208 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -99.54 137.51 37.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.374 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' E' ' 32' ' ' VAL . 76.0 m-85 -127.6 97.74 4.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.792 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.31 175.76 6.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.428 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.0 149.45 5.77 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.948 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.29 108.58 13.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.855 0.359 . . . . 0.0 110.35 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.853 HG13 ' O ' ' E' ' 144' ' ' THR . 23.5 t -86.59 129.1 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.243 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . 0.476 HG21 ' CB ' ' D' ' 22' ' ' ALA . 18.8 m -127.35 163.54 30.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.815 0.34 . . . . 0.0 111.011 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -85.97 61.4 6.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.052 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' ALA . . . . . 0.524 ' HB1' HG23 ' D' ' 65' ' ' VAL . . . 44.88 52.64 7.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' D' ' 61' ' ' CYS . . . -127.22 -54.42 1.37 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.49 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.1 OUTLIER 177.64 111.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.879 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . 0.76 ' HB2' ' HA ' ' E' ' 36' ' ' GLN . . . -105.69 126.06 51.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.108 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . 0.444 HG11 HG21 ' D' ' 28' ' ' VAL . 5.7 p -56.81 145.65 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.003 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . 0.611 ' O ' HG22 ' D' ' 28' ' ' VAL . 4.0 m-20 -74.77 147.26 41.44 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.692 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.74 -43.62 18.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.396 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.96 -20.01 60.17 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.863 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 45.1 t -79.54 -26.12 41.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.899 0.381 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . 0.611 HG22 ' O ' ' D' ' 24' ' ' ASP . 57.3 t -49.1 -48.53 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.33 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.82 93.01 5.32 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.093 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.55 116.42 28.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.038 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.66 115.62 27.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.173 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' C' ' 12' ' ' PHE . 1.6 t -117.14 101.08 11.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.072 0.463 . . . . 0.0 110.469 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.58 126.97 52.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.698 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.771 HD21 ' HB1' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -68.2 -55.67 11.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.653 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.02 -111.69 3.94 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.498 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' GLN . . . . . 0.755 ' HA ' ' HB2' ' C' ' 22' ' ' ALA . 0.0 OUTLIER -77.04 115.26 16.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.513 0.197 . . . . 0.0 110.947 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' C' ' 16' ' ' VAL . 67.6 t -131.0 105.83 11.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.888 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.67 154.1 17.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.722 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.751 ' HA ' HD12 ' D' ' 42' ' ' LEU . 8.3 p -78.7 -19.86 51.43 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.775 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -19.53 65.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.14 0.495 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 96.8 p -92.05 -21.2 20.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.184 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.751 HD12 ' HA ' ' D' ' 39' ' ' THR . 0.2 OUTLIER -139.08 62.25 1.54 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.602 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . 0.698 ' HA ' ' HA ' ' D' ' 142' ' ' ALA . . . -101.15 9.17 42.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.36 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.17 136.06 24.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.359 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . 0.589 ' N ' ' HA2' ' D' ' 141' ' ' GLY . 16.4 tt0 -58.53 121.37 10.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 0.0 111.133 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.25 -25.44 8.25 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.209 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.75 137.22 58.21 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.83 158.07 44.32 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.95 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.529 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -109.05 -166.23 1.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.512 179.388 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.61 ' HB2' ' HA ' ' A' ' 92' ' ' ALA . 48.9 m -65.17 156.11 32.79 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.769 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' D' ' 134' ' ' GLN . . . -90.46 126.7 35.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.358 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' VAL . . . . . 0.629 ' CG1' ' HA ' ' A' ' 90' ' ' SER . 63.2 t -75.66 118.53 21.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.999 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.84 135.69 13.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.672 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' D' ' 133' ' ' PHE . 46.3 p90 -170.77 142.11 1.9 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' ASN . . . . . 0.78 ' HB3' ' HG1' ' A' ' 76' ' ' THR . 11.6 p30 -126.58 163.88 22.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.526 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.618 HG21 HD22 ' D' ' 58' ' ' LEU . 20.7 mm -105.08 119.93 54.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.516 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' GLN . . . . . 0.567 ' HA ' HG21 ' D' ' 130' ' ' THR . 0.0 OUTLIER -82.15 115.65 21.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.761 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . 0.618 HD22 HG21 ' D' ' 56' ' ' ILE . 0.0 OUTLIER -128.21 107.42 9.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.298 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.35 177.0 8.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.951 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.11 66.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.756 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 3.3 m -109.66 154.39 22.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.742 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . 0.51 ' HA ' ' OD1' ' D' ' 126' ' ' ASN . 0.5 OUTLIER -154.66 138.37 16.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.214 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.618 ' HG1' ' HA ' ' D' ' 125' ' ' ASN . 0.2 OUTLIER -97.64 -11.82 23.14 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.19 -48.82 40.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.03 0.443 . . . . 0.0 111.746 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . 0.524 HG23 ' HB1' ' D' ' 19' ' ' ALA . 10.5 t -68.92 -48.71 68.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.742 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' D' ' 63' ' ' THR . . . -137.97 153.32 49.46 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.637 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.27 18.68 4.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.926 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' LYS . . . . . 0.601 ' HB3' ' HB3' ' D' ' 159' ' ' GLN . 10.6 tppt? -142.84 149.9 39.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.573 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.97 110.75 4.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.633 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' D' ' 121' ' ' GLU . . . -108.06 169.95 8.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.131 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.4 150.96 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.642 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 72' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' D' ' 116' ' ' ALA . . . -135.57 100.1 4.4 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.555 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 73' ' ' PHE . . . . . 0.586 ' HB2' HD22 ' D' ' 111' ' ' LEU . 0.2 OUTLIER -77.46 133.94 38.49 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.599 0.238 . . . . 0.0 111.128 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.15 115.08 20.53 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.932 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.35 -173.22 26.48 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.821 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -112.62 149.06 33.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.681 0.277 . . . . 0.0 110.739 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' D' ' 85' ' ' VAL . . . -98.95 133.79 42.72 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.939 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 78' ' ' ILE . . . . . 0.78 ' HB ' ' HA ' ' D' ' 87' ' ' ALA . 16.1 tt -72.96 -37.95 55.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.89 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.21 167.63 12.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.834 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.22 -53.83 15.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.08 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.36 28.71 6.07 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.536 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . 0.813 ' HB3' ' HB ' ' D' ' 85' ' ' VAL . 10.3 m170 -111.33 -45.7 3.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.928 0.394 . . . . 0.0 110.453 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 83' ' ' THR . . . . . 0.558 ' HB ' HG22 ' D' ' 112' ' ' THR . 0.0 OUTLIER 46.39 -86.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.603 -179.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' D' ' 82' ' ' HIS . 0.0 OUTLIER -42.19 -42.46 3.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.268 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.813 ' HB ' ' HB3' ' D' ' 82' ' ' HIS . 21.3 t -61.3 126.53 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.135 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.557 ' HG ' ' CD2' ' D' ' 113' ' ' LEU . 0.2 OUTLIER -81.22 164.42 22.3 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.432 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.78 ' HA ' ' HB ' ' D' ' 78' ' ' ILE . . . -104.84 -177.53 3.39 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.852 0.358 . . . . 0.0 111.618 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' D' ' 88' ' ' LEU . 0.2 OUTLIER -85.01 -174.53 5.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.009 179.528 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.64 -170.72 3.24 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.367 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 27.8 p -74.76 7.87 2.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.905 0.383 . . . . 0.0 111.46 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 91' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' D' ' 95' ' ' SER . 0.8 OUTLIER -97.06 80.41 2.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.84 -41.2 87.81 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.82 0.343 . . . . 0.0 111.636 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.72 26.01 9.1 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.682 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.77 -22.64 0.33 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.892 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 95' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' D' ' 91' ' ' SER . 1.0 OUTLIER -107.65 175.18 5.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 110.661 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.35 177.1 2.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 97' ' ' THR . . . . . 0.442 HG22 ' H ' ' D' ' 98' ' ' ASN . 0.2 OUTLIER -138.6 167.85 21.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.278 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 98' ' ' ASN . . . . . 0.587 ' HA ' ' HB ' ' D' ' 140' ' ' THR . 32.4 m-80 44.2 51.68 7.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.489 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 99' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' D' ' 143' ' ' ALA . 6.0 p -169.34 124.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.702 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.61 -164.65 11.47 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.58 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 101' ' ' VAL . . . . . 0.411 HG23 ' CE1' ' D' ' 137' ' ' TYR . 3.4 t -124.84 91.13 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.202 0.525 . . . . 0.0 111.73 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 102' ' ' GLN . . . . . 0.681 ' HA ' ' HA ' ' D' ' 85' ' ' VAL . 0.6 OUTLIER -71.43 116.65 12.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.857 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 103' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' D' ' 135' ' ' ALA . 6.6 mt -89.61 120.64 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.457 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 104' ' ' LEU . . . . . 0.499 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 1.0 OUTLIER -95.84 152.32 18.6 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.691 0.281 . . . . 0.0 111.126 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . 0.428 ' O ' HD23 ' D' ' 104' ' ' LEU . 8.5 t0 -100.14 160.09 14.6 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.629 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 106' ' ' ARG . . . . . 0.511 ' CZ ' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -68.89 -13.6 62.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.835 0.35 . . . . 0.0 111.075 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 107' ' ' THR . . . . . 0.404 ' HG1' ' HB3' ' D' ' 105' ' ' ASP . 45.3 p -74.42 -18.9 60.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.144 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.0 -40.15 2.22 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.669 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.3 164.7 13.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.338 . . . . 0.0 111.119 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -77.4 139.66 39.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.148 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 111' ' ' LEU . . . . . 0.652 HD21 ' HB ' ' D' ' 117' ' ' THR . 5.9 tt -84.18 128.59 34.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.404 0.621 . . . . 0.0 110.503 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 112' ' ' THR . . . . . 0.558 HG22 ' HB ' ' D' ' 83' ' ' THR . 1.4 m -68.13 132.36 47.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.17 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 113' ' ' LEU . . . . . 0.557 ' CD2' ' HG ' ' D' ' 86' ' ' LEU . 4.7 mp -88.06 99.74 12.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.693 0.282 . . . . 0.0 110.737 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.06 -32.43 0.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.539 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.45 -81.29 0.21 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.666 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 116' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' D' ' 72' ' ' ALA . . . -97.23 64.12 1.89 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.0 0.429 . . . . 0.0 111.624 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 117' ' ' THR . . . . . 0.652 ' HB ' HD21 ' D' ' 111' ' ' LEU . 2.8 m -94.42 72.31 3.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.76 119.07 11.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.828 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.89 -49.03 0.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.57 84.75 6.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.575 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' D' ' 70' ' ' ALA . 3.6 mt-10 -110.16 86.94 2.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.268 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.0 159.32 17.66 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.83 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -67.07 138.33 57.07 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.68 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.47 159.46 19.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.68 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 125' ' ' ASN . . . . . 0.618 ' HA ' ' HG1' ' D' ' 63' ' ' THR . 0.3 OUTLIER -147.55 176.28 10.19 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.635 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 126' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' D' ' 62' ' ' ASP . 0.9 OUTLIER -85.98 161.52 18.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.639 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.53 -121.06 5.73 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.764 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 128' ' ' THR . . . . . 0.432 ' HB ' ' HG3' ' A' ' 155' ' ' LYS . 74.1 m -119.5 140.3 50.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.659 0.266 . . . . 0.0 110.765 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 129' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -133.74 154.63 50.83 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.912 0.387 . . . . 0.0 111.087 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 130' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' D' ' 56' ' ' ILE . 28.2 p -133.36 154.32 50.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.167 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 131' ' ' ILE . . . . . 0.666 ' O ' ' HA ' ' D' ' 55' ' ' ASN . 1.0 OUTLIER -111.07 116.86 51.01 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 132' ' ' PRO . . . . . 0.597 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 7.7 Cg_endo -81.11 129.36 6.82 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.704 1.603 . . . . 0.0 112.667 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . 0.446 ' HB3' ' CE1' ' D' ' 54' ' ' PHE . 0.1 OUTLIER -140.87 146.87 38.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.81 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 134' ' ' GLN . . . . . 0.512 ' HB3' ' HB1' ' D' ' 51' ' ' ALA . 19.5 mm-40 -116.48 158.4 23.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.979 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' D' ' 103' ' ' ILE . . . -159.48 105.61 1.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.931 0.396 . . . . 0.0 111.539 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.68 172.57 6.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.405 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 137' ' ' TYR . . . . . 0.411 ' CE1' HG23 ' D' ' 101' ' ' VAL . 0.7 OUTLIER -98.23 147.72 24.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.086 179.493 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 138' ' ' PHE . . . . . 0.434 ' CG ' HG21 ' D' ' 85' ' ' VAL . 0.3 OUTLIER -127.58 159.05 35.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.005 -179.231 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 139' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' D' ' 42' ' ' LEU . . . -116.36 141.31 48.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.85 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 140' ' ' THR . . . . . 0.587 ' HB ' ' HA ' ' D' ' 98' ' ' ASN . 0.2 OUTLIER -107.78 27.2 9.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.496 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . 0.589 ' HA2' ' N ' ' D' ' 45' ' ' GLU . . . 97.55 83.6 1.71 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.014 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . 0.698 ' HA ' ' HA ' ' D' ' 43' ' ' ALA . . . 57.87 93.49 0.03 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.7 0.25 . . . . 0.0 110.759 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 143' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' D' ' 99' ' ' VAL . . . -79.97 165.44 22.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 111.375 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 144' ' ' THR . . . . . 0.86 ' O ' HG13 ' C' ' 16' ' ' VAL . 29.4 p -108.37 168.85 7.25 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.234 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 145' ' ' PRO . . . . . 0.463 ' HG2' HG21 ' B' ' 3' ' ' THR . 1.3 Cg_endo -83.62 133.56 6.14 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.544 2.162 . . . . 0.0 112.002 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 146' ' ' GLY . . . . . 0.6 ' HA2' HG13 ' B' ' 5' ' ' VAL . . . 169.56 -119.25 0.81 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.477 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.84 121.69 13.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.787 0.327 . . . . 0.0 111.327 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.33 85.7 3.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.14 0.495 . . . . 0.0 110.506 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -104.57 131.21 52.25 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.597 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 150' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' D' ' 87' ' ' ALA . . . -136.08 148.49 48.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.951 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.16 120.24 20.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.194 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.7 140.0 24.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.164 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 153' ' ' THR . . . . . 0.613 HG22 ' HA ' ' C' ' 9' ' ' THR . 70.7 p -105.2 171.18 7.46 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 154' ' ' PHE . . . . . 0.616 ' HZ ' HG23 ' D' ' 56' ' ' ILE . 13.5 p90 -138.18 147.4 43.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.138 0.494 . . . . 0.0 110.112 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -100.9 171.92 7.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.912 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 156' ' ' VAL . . . . . 0.531 HG22 ' HA2' ' C' ' 7' ' ' GLY . 0.4 OUTLIER -135.4 111.42 12.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.714 -179.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 157' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' C' ' 3' ' ' THR . 1.8 tt0 -109.03 141.32 41.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.273 0.559 . . . . 0.0 110.398 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 158' ' ' TYR . . . . . 0.473 ' CZ ' ' HB ' ' D' ' 156' ' ' VAL . 23.1 m-85 -135.43 105.43 6.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.555 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 159' ' ' GLN . . . . . 0.601 ' HB3' ' HB3' ' D' ' 68' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.899 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 111.48 0.178 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 2' ' ' ALA . . . . . 0.584 ' H ' ' HA ' ' F' ' 159' ' ' GLN . . . 56.56 88.6 0.05 OUTLIER 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.038 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 3' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' F' ' 157' ' ' GLN . 0.2 OUTLIER -103.14 110.34 22.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.411 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.31 136.26 38.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.57 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.11 -175.28 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.616 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.54 130.06 38.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.646 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 7' ' ' GLY . . . . . 0.522 ' HA2' HG22 ' F' ' 156' ' ' VAL . . . -98.73 -59.38 0.91 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.805 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.38 166.23 28.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.806 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 9' ' ' THR . . . . . 0.596 ' HA ' HG22 ' F' ' 153' ' ' THR . 27.0 m -94.47 121.18 35.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.939 0.4 . . . . 0.0 111.205 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.69 115.58 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.21 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -99.52 137.56 37.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.327 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 12' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' F' ' 32' ' ' VAL . 76.2 m-85 -127.61 97.78 4.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.815 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.3 175.8 6.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.378 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.97 149.46 5.77 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.91 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.29 108.61 13.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 110.345 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 16' ' ' VAL . . . . . 0.862 HG13 ' O ' ' F' ' 144' ' ' THR . 23.4 t -86.62 129.16 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.213 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . 0.482 HG21 ' HB1' ' E' ' 22' ' ' ALA . 18.7 m -127.43 163.53 30.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.787 0.327 . . . . 0.0 111.028 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -85.95 61.36 6.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.032 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 19' ' ' ALA . . . . . 0.527 ' HB1' HG23 ' E' ' 65' ' ' VAL . . . 45.0 52.64 8.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.051 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' E' ' 61' ' ' CYS . . . -127.27 -54.47 1.37 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.426 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 21' ' ' CYS . . . . . 0.889 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.1 OUTLIER 177.68 111.67 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.901 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 22' ' ' ALA . . . . . 0.759 ' HB2' ' HA ' ' F' ' 36' ' ' GLN . . . -105.71 126.0 51.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 23' ' ' VAL . . . . . 0.449 HG11 HG21 ' E' ' 28' ' ' VAL . 5.6 p -56.86 145.68 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.003 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 24' ' ' ASP . . . . . 0.612 ' O ' HG22 ' E' ' 28' ' ' VAL . 3.9 m-20 -74.9 147.28 41.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.652 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.73 -43.71 18.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.331 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.85 -20.06 60.27 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.865 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 45.1 t -79.58 -26.09 41.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.872 0.367 . . . . 0.0 110.851 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 28' ' ' VAL . . . . . 0.612 HG22 ' O ' ' E' ' 24' ' ' ASP . 57.8 t -49.13 -48.49 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.361 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.89 93.09 5.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.976 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.63 116.38 28.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.04 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.54 115.58 27.63 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.178 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' D' ' 12' ' ' PHE . 1.7 t -117.17 101.14 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.168 0.509 . . . . 0.0 110.463 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.58 126.91 52.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.711 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.761 HD21 ' HB1' ' B' ' 92' ' ' ALA . 0.3 OUTLIER -68.15 -55.71 11.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.619 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.03 -111.69 3.93 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.471 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 36' ' ' GLN . . . . . 0.76 ' HA ' ' HB2' ' D' ' 22' ' ' ALA . 0.0 OUTLIER -77.02 115.34 16.73 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.524 0.202 . . . . 0.0 110.902 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' D' ' 16' ' ' VAL . 67.5 t -131.11 105.85 11.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.819 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.6 154.11 17.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.77 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 39' ' ' THR . . . . . 0.773 ' HA ' HD12 ' E' ' 42' ' ' LEU . 8.4 p -78.71 -19.92 51.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.753 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.38 -19.58 65.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.125 0.488 . . . . 0.0 110.923 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 97.1 p -92.01 -21.24 20.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.156 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.773 HD12 ' HA ' ' E' ' 39' ' ' THR . 0.2 OUTLIER -139.06 62.39 1.54 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.661 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 43' ' ' ALA . . . . . 0.701 ' HA ' ' HA ' ' E' ' 142' ' ' ALA . . . -101.23 9.12 42.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.246 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.15 136.02 24.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.32 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . 0.588 ' N ' ' HA2' ' E' ' 141' ' ' GLY . 16.5 tt0 -58.5 121.24 10.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 0.0 111.159 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.36 -25.47 8.19 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.196 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.66 137.24 58.22 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.93 157.93 44.75 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.919 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' B' ' 92' ' ' ALA . 0.0 OUTLIER -108.97 -166.19 1.09 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.583 179.321 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 50' ' ' SER . . . . . 0.604 ' HB2' ' HA ' ' B' ' 92' ' ' ALA . 48.7 m -65.22 156.23 32.53 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.789 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 51' ' ' ALA . . . . . 0.523 ' HB1' ' HB3' ' E' ' 134' ' ' GLN . . . -90.57 126.66 36.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.274 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 52' ' ' VAL . . . . . 0.647 ' CG1' ' HA ' ' B' ' 90' ' ' SER . 63.3 t -75.61 118.46 21.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.016 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.78 135.65 13.77 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.663 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 54' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' E' ' 133' ' ' PHE . 46.2 p90 -170.77 142.04 1.89 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.831 0.348 . . . . 0.0 110.907 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 55' ' ' ASN . . . . . 0.779 ' HB3' ' HG1' ' B' ' 76' ' ' THR . 11.6 p30 -126.5 163.87 22.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.621 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 56' ' ' ILE . . . . . 0.641 HG21 HD22 ' E' ' 58' ' ' LEU . 21.0 mm -105.1 119.93 54.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.52 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 57' ' ' GLN . . . . . 0.576 ' HA ' HG21 ' E' ' 130' ' ' THR . 0.0 OUTLIER -82.18 115.74 21.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.744 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . 0.641 HD22 HG21 ' E' ' 56' ' ' ILE . 0.0 OUTLIER -128.28 107.45 9.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.267 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.34 177.09 8.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.924 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 62.95 66.13 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.818 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 61' ' ' CYS . . . . . 0.889 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 3.3 m -109.65 154.42 22.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.785 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . 0.505 ' HA ' ' OD1' ' E' ' 126' ' ' ASN . 0.5 OUTLIER -154.68 138.35 16.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.258 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 63' ' ' THR . . . . . 0.625 ' HG1' ' HA ' ' E' ' 125' ' ' ASN . 0.2 OUTLIER -97.63 -11.81 23.17 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.131 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.23 -48.72 40.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.993 0.425 . . . . 0.0 111.733 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . 0.527 HG23 ' HB1' ' E' ' 19' ' ' ALA . 10.7 t -69.02 -48.67 68.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.712 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 66' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' E' ' 63' ' ' THR . . . -137.94 153.39 49.49 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.616 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.3 18.62 4.43 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.802 0.334 . . . . 0.0 110.91 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 68' ' ' LYS . . . . . 0.589 ' HB3' ' HB3' ' E' ' 159' ' ' GLN . 10.6 tppt? -142.83 149.94 39.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.448 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.01 110.65 4.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.729 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' E' ' 121' ' ' GLU . . . -108.01 169.92 8.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.067 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.34 150.95 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.681 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' E' ' 116' ' ' ALA . . . -135.59 100.13 4.4 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.528 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 73' ' ' PHE . . . . . 0.587 ' HB2' HD22 ' E' ' 111' ' ' LEU . 0.2 OUTLIER -77.39 133.94 38.56 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.594 0.235 . . . . 0.0 111.136 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.17 115.06 20.49 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.971 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.35 -173.22 26.48 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.79 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 76' ' ' THR . . . . . 0.4 HG23 ' N ' ' E' ' 77' ' ' ALA . 7.0 m -112.66 149.03 33.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.624 0.25 . . . . 0.0 110.715 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 77' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' E' ' 85' ' ' VAL . . . -98.95 133.8 42.71 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.852 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 78' ' ' ILE . . . . . 0.775 ' HB ' ' HA ' ' E' ' 87' ' ' ALA . 16.1 tt -72.95 -37.98 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.19 167.6 12.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.907 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.09 -53.86 15.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.4 28.67 6.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.597 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 82' ' ' HIS . . . . . 0.807 ' HB3' ' HB ' ' E' ' 85' ' ' VAL . 10.2 m170 -111.36 -45.57 3.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 0.0 110.446 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 83' ' ' THR . . . . . 0.563 ' HB ' HG22 ' E' ' 112' ' ' THR . 0.0 OUTLIER 46.4 -86.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.567 -179.524 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 84' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' E' ' 82' ' ' HIS . 0.0 OUTLIER -42.17 -42.4 2.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.402 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.807 ' HB ' ' HB3' ' E' ' 82' ' ' HIS . 21.3 t -61.25 126.57 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.151 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 86' ' ' LEU . . . . . 0.561 ' HG ' ' CD2' ' E' ' 113' ' ' LEU . 0.2 OUTLIER -81.23 164.4 22.31 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 87' ' ' ALA . . . . . 0.775 ' HA ' ' HB ' ' E' ' 78' ' ' ILE . . . -104.77 -177.51 3.39 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.688 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.458 ' HA ' HD12 ' E' ' 88' ' ' LEU . 0.2 OUTLIER -85.03 -174.56 5.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.974 179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.59 -170.73 3.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.401 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 27.5 p -74.67 7.73 2.85 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.96 0.41 . . . . 0.0 111.464 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.93 80.42 2.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.86 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.87 -41.17 87.7 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.849 0.356 . . . . 0.0 111.623 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.7 25.94 9.17 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.664 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.8 -22.63 0.33 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.889 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.71 175.2 5.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.928 0.394 . . . . 0.0 110.597 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.37 177.08 3.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 97' ' ' THR . . . . . 0.453 HG22 ' H ' ' E' ' 98' ' ' ASN . 0.2 OUTLIER -138.56 167.87 21.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.305 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 98' ' ' ASN . . . . . 0.571 ' HA ' ' HB ' ' E' ' 140' ' ' THR . 32.4 m-80 44.15 51.68 7.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.526 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 99' ' ' VAL . . . . . 0.633 ' HB ' ' HB3' ' E' ' 143' ' ' ALA . 6.0 p -169.36 124.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.753 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.53 -164.65 11.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.594 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 101' ' ' VAL . . . . . 0.411 HG23 ' CE1' ' E' ' 137' ' ' TYR . 3.5 t -124.9 91.07 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 122.997 0.519 . . . . 0.0 111.735 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 102' ' ' GLN . . . . . 0.685 ' HA ' ' HA ' ' E' ' 85' ' ' VAL . 0.6 OUTLIER -71.38 116.65 11.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.901 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 103' ' ' ILE . . . . . . . . . . . . . 6.5 mt -89.66 120.59 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.511 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 104' ' ' LEU . . . . . 0.489 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 1.0 OUTLIER -95.85 152.32 18.6 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.738 0.304 . . . . 0.0 111.105 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . 0.414 ' O ' HD23 ' E' ' 104' ' ' LEU . 8.5 t0 -100.08 160.07 14.61 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.553 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 106' ' ' ARG . . . . . 0.51 ' CZ ' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -68.81 -13.7 62.56 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.83 0.348 . . . . 0.0 111.064 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 44.8 p -74.4 -18.95 60.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.097 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.0 -40.12 2.23 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.639 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.36 164.63 13.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.774 0.321 . . . . 0.0 111.116 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 110' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -77.38 139.66 39.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.128 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 111' ' ' LEU . . . . . 0.642 HD21 ' HB ' ' E' ' 117' ' ' THR . 5.9 tt -84.16 128.58 34.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.449 0.642 . . . . 0.0 110.477 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 112' ' ' THR . . . . . 0.563 HG22 ' HB ' ' E' ' 83' ' ' THR . 1.4 m -68.13 132.38 47.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.081 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 113' ' ' LEU . . . . . 0.561 ' CD2' ' HG ' ' E' ' 86' ' ' LEU . 4.7 mp -88.12 99.79 12.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.723 0.297 . . . . 0.0 110.699 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.09 -32.4 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.528 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.42 -81.24 0.21 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.645 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 116' ' ' ALA . . . . . 0.401 ' HA ' ' HB3' ' E' ' 72' ' ' ALA . . . -97.24 64.03 1.88 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.038 0.447 . . . . 0.0 111.678 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 117' ' ' THR . . . . . 0.642 ' HB ' HD21 ' E' ' 111' ' ' LEU . 2.8 m -94.37 72.48 3.83 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.165 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.84 119.09 11.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.783 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.92 -49.03 0.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.83 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 3.0 m -88.55 84.73 6.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.573 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 121' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' E' ' 70' ' ' ALA . 3.5 mt-10 -110.26 86.95 2.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.263 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.06 159.32 17.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.801 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 2.5 t -67.04 138.38 57.14 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.734 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.53 159.54 19.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.636 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 125' ' ' ASN . . . . . 0.625 ' HA ' ' HG1' ' E' ' 63' ' ' THR . 0.3 OUTLIER -147.66 176.22 10.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.595 179.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 126' ' ' ASN . . . . . 0.505 ' OD1' ' HA ' ' E' ' 62' ' ' ASP . 0.9 OUTLIER -85.89 161.47 19.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.703 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.51 -121.01 5.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.718 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 128' ' ' THR . . . . . 0.446 ' HB ' ' HG3' ' B' ' 155' ' ' LYS . 72.4 m -119.47 140.33 50.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.75 0.309 . . . . 0.0 110.788 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 129' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -133.77 154.62 50.85 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.112 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 130' ' ' THR . . . . . 0.576 HG21 ' HA ' ' E' ' 57' ' ' GLN . 28.0 p -133.41 154.24 50.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.188 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 131' ' ' ILE . . . . . 0.661 ' O ' ' HA ' ' E' ' 55' ' ' ASN . 1.0 OUTLIER -110.88 116.79 51.49 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 132' ' ' PRO . . . . . 0.609 ' HB3' ' HA ' ' B' ' 76' ' ' THR . 7.6 Cg_endo -81.15 129.38 6.8 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.663 1.576 . . . . 0.0 112.667 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 133' ' ' PHE . . . . . 0.448 ' HB3' ' CE1' ' E' ' 54' ' ' PHE . 0.1 OUTLIER -140.81 146.89 38.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.796 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 134' ' ' GLN . . . . . 0.523 ' HB3' ' HB1' ' E' ' 51' ' ' ALA . 19.3 mm-40 -116.49 158.33 23.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.033 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -159.47 105.48 1.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.898 0.38 . . . . 0.0 111.589 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.67 172.53 6.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.457 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 137' ' ' TYR . . . . . 0.411 ' CE1' HG23 ' E' ' 101' ' ' VAL . 0.7 OUTLIER -98.18 147.77 24.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.051 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 138' ' ' PHE . . . . . 0.441 ' CG ' HG21 ' E' ' 85' ' ' VAL . 0.3 OUTLIER -127.65 159.0 36.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.994 -179.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 139' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' E' ' 42' ' ' LEU . . . -116.31 141.27 48.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.897 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 140' ' ' THR . . . . . 0.571 ' HB ' ' HA ' ' E' ' 98' ' ' ASN . 0.2 OUTLIER -107.81 27.22 9.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.499 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . 0.588 ' HA2' ' N ' ' E' ' 45' ' ' GLU . . . 97.5 83.57 1.7 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.031 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 142' ' ' ALA . . . . . 0.701 ' HA ' ' HA ' ' E' ' 43' ' ' ALA . . . 57.98 93.41 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.67 0.235 . . . . 0.0 110.765 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 143' ' ' ALA . . . . . 0.633 ' HB3' ' HB ' ' E' ' 99' ' ' VAL . . . -79.94 165.51 22.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.733 0.301 . . . . 0.0 111.453 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 144' ' ' THR . . . . . 0.853 ' O ' HG13 ' D' ' 16' ' ' VAL . 29.6 p -108.49 168.86 7.22 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.202 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 145' ' ' PRO . . . . . 0.458 ' HG2' HG21 ' C' ' 3' ' ' THR . 1.4 Cg_endo -83.59 133.54 6.16 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.572 2.181 . . . . 0.0 111.981 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 146' ' ' GLY . . . . . 0.604 ' HA2' HG13 ' C' ' 5' ' ' VAL . . . 169.55 -119.23 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.475 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.8 121.7 13.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.904 0.383 . . . . 0.0 111.382 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.34 85.68 3.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.541 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -104.58 131.25 52.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.58 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 150' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' E' ' 87' ' ' ALA . . . -136.1 148.51 48.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.94 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.18 120.23 20.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.213 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.69 139.99 24.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.171 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 153' ' ' THR . . . . . 0.602 HG22 ' HA ' ' D' ' 9' ' ' THR . 71.0 p -105.21 171.17 7.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 154' ' ' PHE . . . . . 0.602 ' HZ ' HG23 ' E' ' 56' ' ' ILE . 13.6 p90 -138.18 147.39 43.78 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 110.143 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -100.92 171.94 7.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.919 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 156' ' ' VAL . . . . . 0.529 HG22 ' HA2' ' D' ' 7' ' ' GLY . 0.4 OUTLIER -135.44 111.37 12.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.754 0.311 . . . . 0.0 111.789 -179.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 157' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' D' ' 3' ' ' THR . 1.8 tt0 -108.97 141.28 41.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.312 0.577 . . . . 0.0 110.438 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 158' ' ' TYR . . . . . 0.479 ' CZ ' ' HB ' ' E' ' 156' ' ' VAL . 23.0 m-85 -135.36 105.52 6.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.613 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 159' ' ' GLN . . . . . 0.589 ' HB3' ' HB3' ' E' ' 68' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.903 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.57 88.66 0.05 OUTLIER 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.095 0.247 . . . . 0.0 110.995 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.11 110.45 22.4 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.397 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.49 136.11 38.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.534 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.99 -175.31 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.601 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.57 130.1 38.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.665 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.8 -59.26 0.91 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.794 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.4 166.22 28.06 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.899 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 26.9 m -94.44 121.15 35.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 111.196 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.68 115.66 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.229 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -99.55 137.5 37.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.361 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -127.62 97.8 4.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.748 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.26 175.74 6.58 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.458 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.04 149.48 5.78 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.897 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.32 108.6 13.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 110.407 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 23.4 t -86.61 129.15 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.183 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 17' ' ' VAL . . . . . 0.479 HG21 ' HB1' ' F' ' 22' ' ' ALA . 18.7 m -127.39 163.54 30.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.06 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -85.93 61.37 6.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.041 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 19' ' ' ALA . . . . . 0.515 ' HB1' HG23 ' F' ' 65' ' ' VAL . . . 44.99 52.6 8.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' F' ' 61' ' ' CYS . . . -127.3 -54.42 1.36 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.44 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 21' ' ' CYS . . . . . 0.884 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.1 OUTLIER 177.68 111.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.962 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 22' ' ' ALA . . . . . 0.479 ' HB1' HG21 ' F' ' 17' ' ' VAL . . . -105.69 126.09 51.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.053 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 23' ' ' VAL . . . . . 0.436 HG11 HG21 ' F' ' 28' ' ' VAL . 5.6 p -56.83 145.68 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.968 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 24' ' ' ASP . . . . . 0.621 ' O ' HG22 ' F' ' 28' ' ' VAL . 4.0 m-20 -74.86 147.24 41.27 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.66 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.77 -43.61 18.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.32 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.92 -20.01 60.25 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.896 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 45.6 t -79.6 -26.08 41.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 28' ' ' VAL . . . . . 0.621 HG22 ' O ' ' F' ' 24' ' ' ASP . 57.4 t -49.16 -48.52 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.279 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.84 93.04 5.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.965 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.54 116.42 28.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.035 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.62 115.63 27.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.155 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' E' ' 12' ' ' PHE . 1.7 t -117.21 101.1 11.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.133 0.492 . . . . 0.0 110.426 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.6 126.91 52.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.671 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 34' ' ' LEU . . . . . 0.738 HD21 ' HB1' ' C' ' 92' ' ' ALA . 0.3 OUTLIER -68.15 -55.65 11.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.659 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.97 -111.67 3.93 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.555 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 36' ' ' GLN . . . . . 0.759 ' HA ' ' HB2' ' E' ' 22' ' ' ALA . 0.0 OUTLIER -77.0 115.28 16.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.52 0.2 . . . . 0.0 110.928 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' E' ' 16' ' ' VAL . 67.6 t -131.03 105.87 11.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.779 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.68 154.12 17.46 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.762 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 39' ' ' THR . . . . . 0.76 ' HA ' HD12 ' F' ' 42' ' ' LEU . 8.0 p -78.8 -19.81 51.25 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.724 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.42 -19.54 65.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.085 0.469 . . . . 0.0 110.913 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 96.6 p -92.08 -21.23 20.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.182 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . 0.76 HD12 ' HA ' ' F' ' 39' ' ' THR . 0.2 OUTLIER -139.0 62.28 1.54 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.686 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 43' ' ' ALA . . . . . 0.689 ' HA ' ' HA ' ' F' ' 142' ' ' ALA . . . -101.15 9.21 42.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.321 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.25 136.0 24.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.36 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . 0.582 ' N ' ' HA2' ' F' ' 141' ' ' GLY . 16.5 tt0 -58.6 121.36 10.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.942 0.401 . . . . 0.0 111.109 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.32 -25.4 8.23 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.139 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.86 137.25 58.22 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.909 0.385 . . . . 0.0 112.018 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 48' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' F' ' 137' ' ' TYR . 5.9 t -133.85 157.98 44.56 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.945 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 49' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' C' ' 92' ' ' ALA . 0.0 OUTLIER -108.92 -166.16 1.09 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.642 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 50' ' ' SER . . . . . 0.589 ' HB2' ' HA ' ' C' ' 92' ' ' ALA . 48.9 m -65.2 156.15 32.73 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.818 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 51' ' ' ALA . . . . . 0.513 ' HB1' ' HB3' ' F' ' 134' ' ' GLN . . . -90.47 126.73 36.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.32 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 52' ' ' VAL . . . . . 0.635 ' CG1' ' HA ' ' C' ' 90' ' ' SER . 63.1 t -75.66 118.55 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.981 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.78 135.68 13.8 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.687 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 54' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' F' ' 133' ' ' PHE . 46.3 p90 -170.76 142.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.83 0.348 . . . . 0.0 110.948 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 55' ' ' ASN . . . . . 0.779 ' HB3' ' HG1' ' C' ' 76' ' ' THR . 11.5 p30 -126.59 163.95 22.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 56' ' ' ILE . . . . . 0.627 HG21 HD22 ' F' ' 58' ' ' LEU . 20.8 mm -105.16 119.91 54.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.516 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 57' ' ' GLN . . . . . 0.567 ' HA ' HG21 ' F' ' 130' ' ' THR . 0.0 OUTLIER -82.09 115.69 21.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.736 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . 0.627 HD22 HG21 ' F' ' 56' ' ' ILE . 0.0 OUTLIER -128.25 107.45 9.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.261 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.38 177.0 8.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.902 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 63.06 66.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.782 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 61' ' ' CYS . . . . . 0.884 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 3.3 m -109.68 154.42 22.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.729 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . 0.521 ' HA ' ' OD1' ' F' ' 126' ' ' ASN . 0.5 OUTLIER -154.66 138.33 16.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.234 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 63' ' ' THR . . . . . 0.602 ' HG1' ' HA ' ' F' ' 125' ' ' ASN . 0.2 OUTLIER -97.57 -11.85 23.2 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.13 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.21 -48.78 40.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.095 0.474 . . . . 0.0 111.764 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . 0.515 HG23 ' HB1' ' F' ' 19' ' ' ALA . 10.6 t -69.02 -48.66 68.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.729 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 66' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' F' ' 63' ' ' THR . . . -137.97 153.4 49.45 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.64 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.25 18.59 4.45 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.907 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 68' ' ' LYS . . . . . 0.588 ' HB3' ' HB3' ' F' ' 159' ' ' GLN . 10.6 tppt? -142.87 149.89 39.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.444 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.01 110.71 4.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.714 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 70' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' F' ' 121' ' ' GLU . . . -108.05 169.95 8.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.034 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.37 150.95 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.647 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.57 100.11 4.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.558 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 73' ' ' PHE . . . . . 0.581 ' HB2' HD22 ' F' ' 111' ' ' LEU . 0.2 OUTLIER -77.46 133.94 38.49 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.552 0.215 . . . . 0.0 111.154 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.16 115.11 20.58 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.975 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.34 -173.22 26.47 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.77 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 7.1 m -112.68 149.04 33.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.647 0.261 . . . . 0.0 110.726 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 77' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' F' ' 85' ' ' VAL . . . -98.91 133.72 42.79 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.002 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 78' ' ' ILE . . . . . 0.754 ' HB ' ' HA ' ' F' ' 87' ' ' ALA . 16.1 tt -72.89 -37.99 55.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.907 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.17 167.62 12.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.832 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.2 -53.86 15.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.027 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.34 28.73 6.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.6 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 82' ' ' HIS . . . . . 0.809 ' HB3' ' HB ' ' F' ' 85' ' ' VAL . 10.2 m170 -111.35 -45.62 3.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 0.0 110.434 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 83' ' ' THR . . . . . 0.572 ' HB ' HG22 ' F' ' 112' ' ' THR . 0.0 OUTLIER 46.43 -86.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.577 -179.559 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 84' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' F' ' 82' ' ' HIS . 0.0 OUTLIER -42.19 -42.4 3.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.343 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 85' ' ' VAL . . . . . 0.809 ' HB ' ' HB3' ' F' ' 82' ' ' HIS . 21.3 t -61.35 126.54 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.165 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 86' ' ' LEU . . . . . 0.551 ' HG ' ' CD2' ' F' ' 113' ' ' LEU . 0.2 OUTLIER -81.19 164.41 22.34 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.247 179.493 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 87' ' ' ALA . . . . . 0.754 ' HA ' ' HB ' ' F' ' 78' ' ' ILE . . . -104.83 -177.58 3.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.903 0.383 . . . . 0.0 111.644 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' F' ' 88' ' ' LEU . 0.2 OUTLIER -85.02 -174.53 5.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.68 -170.69 3.23 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.356 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 27.9 p -74.74 7.76 2.86 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 111.42 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 91' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' F' ' 95' ' ' SER . 0.8 OUTLIER -96.91 80.37 3.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.86 -41.16 87.8 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.858 0.361 . . . . 0.0 111.606 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.74 26.0 9.12 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.687 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.78 -22.78 0.33 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.902 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 95' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' F' ' 91' ' ' SER . 1.0 OUTLIER -107.65 175.24 5.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.929 0.395 . . . . 0.0 110.646 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.51 177.11 3.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.849 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 97' ' ' THR . . . . . 0.45 HG22 ' H ' ' F' ' 98' ' ' ASN . 0.2 OUTLIER -138.53 167.78 21.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.277 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 98' ' ' ASN . . . . . 0.582 ' HA ' ' HB ' ' F' ' 140' ' ' THR . 32.5 m-80 44.15 51.69 7.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.515 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 99' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' F' ' 143' ' ' ALA . 6.0 p -169.37 124.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.787 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.55 -164.72 11.5 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.616 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 101' ' ' VAL . . . . . 0.416 HG23 ' CE1' ' F' ' 137' ' ' TYR . 3.5 t -124.85 91.12 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.192 0.52 . . . . 0.0 111.758 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 102' ' ' GLN . . . . . 0.679 ' HA ' ' HA ' ' F' ' 85' ' ' VAL . 0.6 OUTLIER -71.37 116.61 11.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.836 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 103' ' ' ILE . . . . . . . . . . . . . 6.6 mt -89.59 120.62 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.5 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 104' ' ' LEU . . . . . 0.49 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 1.0 OUTLIER -95.81 152.3 18.61 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.679 0.276 . . . . 0.0 111.083 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . 0.428 ' O ' HD23 ' F' ' 104' ' ' LEU . 8.5 t0 -100.11 160.07 14.61 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.645 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 106' ' ' ARG . . . . . 0.509 ' CZ ' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -68.79 -13.71 62.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.873 0.368 . . . . 0.0 111.082 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 44.9 p -74.37 -18.96 60.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.075 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.0 -40.08 2.23 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.682 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.32 164.68 13.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 0.0 111.107 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 110' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -77.36 139.63 39.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.1 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 111' ' ' LEU . . . . . 0.641 HD21 ' HB ' ' F' ' 117' ' ' THR . 5.9 tt -84.13 128.55 34.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.469 0.652 . . . . 0.0 110.477 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 112' ' ' THR . . . . . 0.572 HG22 ' HB ' ' F' ' 83' ' ' THR . 1.4 m -68.14 132.41 47.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.133 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 113' ' ' LEU . . . . . 0.551 ' CD2' ' HG ' ' F' ' 86' ' ' LEU . 4.8 mp -88.06 99.69 12.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.684 0.278 . . . . 0.0 110.778 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.04 -32.48 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.628 0.252 . . . . 0.0 111.541 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.53 -81.37 0.21 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.575 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -97.1 63.99 1.92 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.986 0.422 . . . . 0.0 111.649 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 117' ' ' THR . . . . . 0.641 ' HB ' HD21 ' F' ' 111' ' ' LEU . 2.8 m -94.29 72.35 3.87 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.169 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.79 119.12 11.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.821 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.95 -49.05 0.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.778 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.55 84.69 6.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.606 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 121' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' F' ' 70' ' ' ALA . 3.6 mt-10 -110.23 87.06 2.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.236 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.04 159.27 17.66 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.802 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -67.01 138.34 57.15 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.654 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.47 159.44 19.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.692 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 125' ' ' ASN . . . . . 0.602 ' HA ' ' HG1' ' F' ' 63' ' ' THR . 0.3 OUTLIER -147.53 176.28 10.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.64 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 126' ' ' ASN . . . . . 0.521 ' OD1' ' HA ' ' F' ' 62' ' ' ASP . 0.9 OUTLIER -85.91 161.5 19.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.667 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.46 -121.07 5.72 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.718 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 128' ' ' THR . . . . . 0.439 ' HB ' ' HG3' ' C' ' 155' ' ' LYS . 72.0 m -119.42 140.28 50.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.714 0.292 . . . . 0.0 110.821 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 129' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -133.68 154.66 50.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.883 0.373 . . . . 0.0 111.122 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 130' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' F' ' 56' ' ' ILE . 28.0 p -133.4 154.3 50.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.091 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 131' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' F' ' 55' ' ' ASN . 1.0 OUTLIER -111.02 116.8 51.2 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 132' ' ' PRO . . . . . 0.611 ' HB3' ' HA ' ' C' ' 76' ' ' THR . 7.6 Cg_endo -81.14 129.43 6.83 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.665 1.576 . . . . 0.0 112.641 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 133' ' ' PHE . . . . . 0.448 ' HB3' ' CE1' ' F' ' 54' ' ' PHE . 0.1 OUTLIER -140.86 146.86 38.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.807 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 134' ' ' GLN . . . . . 0.513 ' HB3' ' HB1' ' F' ' 51' ' ' ALA . 19.2 mm-40 -116.52 158.34 23.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.008 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -159.37 105.45 1.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.847 0.356 . . . . 0.0 111.533 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.66 172.54 6.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.439 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 137' ' ' TYR . . . . . 0.416 ' CE1' HG23 ' F' ' 101' ' ' VAL . 0.7 OUTLIER -98.18 147.82 24.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.066 179.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 138' ' ' PHE . . . . . 0.442 ' CG ' HG21 ' F' ' 85' ' ' VAL . 0.3 OUTLIER -127.68 159.02 36.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.949 -179.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 139' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' F' ' 42' ' ' LEU . . . -116.3 141.21 48.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.9 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 140' ' ' THR . . . . . 0.582 ' HB ' ' HA ' ' F' ' 98' ' ' ASN . 0.2 OUTLIER -107.79 27.22 9.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.462 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . 0.582 ' HA2' ' N ' ' F' ' 45' ' ' GLU . . . 97.56 83.56 1.7 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.846 -0.693 . . . . 0.0 113.025 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 142' ' ' ALA . . . . . 0.689 ' HA ' ' HA ' ' F' ' 43' ' ' ALA . . . 57.9 93.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.531 0.205 . . . . 0.0 110.813 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 143' ' ' ALA . . . . . 0.613 ' HB3' ' HB ' ' F' ' 99' ' ' VAL . . . -80.01 165.42 22.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.772 0.32 . . . . 0.0 111.37 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 144' ' ' THR . . . . . 0.862 ' O ' HG13 ' E' ' 16' ' ' VAL . 29.8 p -108.42 168.86 7.23 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.196 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 145' ' ' PRO . . . . . 0.449 ' HG2' HG21 ' D' ' 3' ' ' THR . 1.3 Cg_endo -83.58 133.56 6.18 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.56 2.174 . . . . 0.0 112.007 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 146' ' ' GLY . . . . . 0.594 ' HA2' HG13 ' D' ' 5' ' ' VAL . . . 169.53 -119.22 0.81 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.456 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.85 121.7 13.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.866 0.365 . . . . 0.0 111.27 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.35 85.65 3.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.485 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -104.5 131.29 52.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.581 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 150' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' F' ' 87' ' ' ALA . . . -136.14 148.49 48.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.958 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.18 120.21 20.89 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.226 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.65 140.02 24.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.188 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 153' ' ' THR . . . . . 0.596 HG22 ' HA ' ' E' ' 9' ' ' THR . 70.5 p -105.24 171.13 7.48 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 154' ' ' PHE . . . . . 0.618 ' HZ ' HG23 ' F' ' 56' ' ' ILE . 13.7 p90 -138.13 147.42 43.92 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.152 0.501 . . . . 0.0 110.054 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -100.91 171.93 7.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.928 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 156' ' ' VAL . . . . . 0.522 HG22 ' HA2' ' E' ' 7' ' ' GLY . 0.4 OUTLIER -135.48 111.44 12.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.813 0.34 . . . . 0.0 111.717 -179.136 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 157' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' E' ' 3' ' ' THR . 1.8 tt0 -109.01 141.24 41.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.318 0.58 . . . . 0.0 110.431 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 158' ' ' TYR . . . . . 0.475 ' CZ ' ' HB ' ' F' ' 156' ' ' VAL . 23.0 m-85 -135.38 105.44 6.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.613 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 159' ' ' GLN . . . . . 0.588 ' HB3' ' HB3' ' F' ' 68' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.522 0.201 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' B' ' 158' ' ' TYR . 7.3 m -104.81 78.63 1.45 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.493 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.34 122.36 29.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.543 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 m -137.91 162.94 30.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.564 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.415 ' HB3' ' OE2' ' B' ' 15' ' ' GLU . 44.1 t-20 -84.29 114.57 21.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.626 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.48 ' HA3' ' CZ ' ' B' ' 154' ' ' PHE . . . -83.43 -41.48 8.39 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.719 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.446 ' N ' ' CE1' ' B' ' 154' ' ' PHE . . . -175.59 162.29 31.55 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.863 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.0 m -90.75 137.84 32.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.929 0.395 . . . . 0.0 111.282 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.46 114.34 46.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.163 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.458 ' HB2' HG21 ' B' ' 31' ' ' THR . 4.6 m80 -99.37 148.58 24.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.33 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.792 ' HB3' HD22 ' B' ' 34' ' ' LEU . 60.8 m-85 -133.8 113.09 11.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.731 ' HG2' ' HA ' ' B' ' 33' ' ' GLN . 0.0 OUTLIER -107.19 105.94 16.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.332 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.25 169.46 28.91 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.999 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.529 ' HB2' ' HG3' ' B' ' 36' ' ' GLN . 33.6 mt-10 -140.73 -171.02 3.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.839 0.352 . . . . 0.0 110.4 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.534 ' HB ' ' O ' ' B' ' 144' ' ' THR . 0.5 OUTLIER -139.24 152.86 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.209 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -137.51 155.37 31.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.87 0.367 . . . . 0.0 111.061 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -85.23 53.1 2.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.041 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.667 ' HA ' ' HG2' ' B' ' 38' ' ' ARG . . . 61.46 92.67 0.05 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.066 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.591 ' H ' ' HG2' ' B' ' 38' ' ' ARG . . . -164.77 -47.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.476 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.914 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 1.6 m -159.8 176.83 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.009 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' B' ' 36' ' ' GLN . . . -147.27 111.93 5.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.137 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.0 t -67.37 143.19 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.989 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.55 ' O ' HG23 ' A' ' 28' ' ' VAL . 17.0 m-20 -91.18 168.05 11.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.63 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.31 -50.0 74.31 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.468 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.42 -16.62 73.76 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.923 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.32 -24.36 29.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.907 0.384 . . . . 0.0 110.77 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 24' ' ' ASP . 85.6 t -58.09 -37.24 60.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.33 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -140.38 106.02 5.12 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.03 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.542 ' NE2' HD12 ' A' ' 56' ' ' ILE . 5.4 mt-30 -109.07 106.97 17.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.125 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.8 95.63 9.03 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.019 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 51.6 t -85.84 138.25 19.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.055 0.455 . . . . 0.0 110.358 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -113.15 132.6 55.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.701 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.431 ' HA ' HD11 ' A' ' 34' ' ' LEU . 1.9 mm? -94.54 -71.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.594 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.87 -111.32 0.72 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.518 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -160.96 105.77 1.37 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.61 0.243 . . . . 0.0 110.879 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 m -91.1 142.35 13.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.978 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.05 162.53 23.73 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.771 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.5 p -80.35 -16.92 53.43 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.761 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.73 -31.26 63.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.073 0.463 . . . . 0.0 110.828 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.01 -28.48 39.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.145 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 1.7 mp -133.14 70.05 1.47 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.67 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.67 11.21 36.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.448 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.04 146.83 27.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.341 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.48 121.25 13.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.369 . . . . 0.0 111.091 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.52 -10.39 12.77 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.179 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 138' ' ' PHE . . . -68.83 142.22 54.92 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -134.69 140.86 46.31 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.904 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.0 m -106.04 -152.77 0.48 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.569 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.9 178.57 1.05 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.908 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.05 168.9 15.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.733 0.301 . . . . 0.0 111.308 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.533 HG22 ' HB3' ' A' ' 135' ' ' ALA . 14.9 m -118.1 132.22 68.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.21 107.67 3.57 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.633 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -140.34 132.03 27.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.764 0.316 . . . . 0.0 110.914 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 131' ' ' ILE . 1.6 p-10 -117.8 176.89 4.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.628 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.542 HD12 ' NE2' ' A' ' 30' ' ' GLN . 51.7 mm -119.05 121.74 67.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.478 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.37 122.59 30.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.829 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.606 HD11 HD13 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -131.08 93.72 3.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.228 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.1 160.85 28.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.899 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.2 87.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.756 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.914 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 69.8 m -120.52 131.87 54.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.75 97.87 9.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.255 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 1.5 m -77.41 -20.0 55.26 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.04 -27.53 68.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.023 0.439 . . . . 0.0 111.719 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.42 -35.71 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.626 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 63' ' ' THR . . . -131.03 131.29 44.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.642 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.45 -37.32 7.65 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.909 0.385 . . . . 0.0 110.932 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -121.72 171.37 8.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.553 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.55 136.15 15.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.587 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 157' ' ' GLN . . . -94.57 157.97 15.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.028 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.38 106.24 20.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.713 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.554 ' HB1' ' HB3' ' A' ' 155' ' ' LYS . . . -109.58 164.26 12.69 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.619 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.442 ' CE2' HG12 ' A' ' 103' ' ' ILE . 6.6 t80 -142.2 141.1 32.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.497 0.189 . . . . 0.0 111.129 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.627 ' CG ' ' HG1' ' D' ' 130' ' ' THR . 0.1 OUTLIER -122.7 103.35 8.61 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.008 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.554 ' HA3' HD22 ' A' ' 113' ' ' LEU . . . -153.44 -166.37 14.55 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.895 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.48 136.26 46.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.535 0.207 . . . . 0.0 110.726 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.605 ' H ' ' HB3' ' D' ' 132' ' ' PRO . . . -81.4 156.08 25.6 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.845 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.576 HG21 ' HB ' ' A' ' 85' ' ' VAL . 3.1 tt -92.51 -20.69 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.773 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.15 179.76 0.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.829 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.0 -33.81 44.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.974 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.42 -43.91 95.55 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.618 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.465 ' NE2' ' O ' ' A' ' 139' ' ' ALA . 43.7 m-70 -97.8 -64.41 1.04 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.827 0.346 . . . . 0.0 110.47 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 m 62.36 7.83 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.623 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.612 ' HB3' ' HB2' ' A' ' 110' ' ' ALA . 6.5 m120 -115.11 -25.47 8.09 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.238 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . 0.5 OUTLIER -79.56 143.74 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.189 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.652 HD11 ' HB1' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -76.68 148.6 36.73 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.251 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.9 178.22 4.4 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.85 0.357 . . . . 0.0 111.651 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.591 HD11 ' HB3' ' D' ' 51' ' ' ALA . 0.0 OUTLIER -84.66 176.23 8.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.116 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.522 ' HB3' ' HB2' ' A' ' 149' ' ' ASN . 22.8 pt20 -75.33 178.72 5.64 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.32 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.567 ' O ' HG11 ' D' ' 52' ' ' VAL . 1.0 OUTLIER -73.36 -11.46 60.49 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.989 0.423 . . . . 0.0 111.411 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 0.3 OUTLIER -64.68 87.26 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.931 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.89 -7.14 53.83 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.879 0.371 . . . . 0.0 111.667 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.11 19.91 4.07 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.644 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.62 -15.6 0.16 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.897 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 1.0 OUTLIER -97.35 174.98 6.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.906 0.384 . . . . 0.0 110.619 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.464 ' O ' HD21 ' A' ' 88' ' ' LEU . . . -114.12 157.87 22.03 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.823 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.96 162.73 15.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.319 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 69.26 41.66 1.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.415 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.801 ' HB ' ' HB3' ' A' ' 143' ' ' ALA . 10.3 p -177.67 130.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.827 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.06 179.45 28.6 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.623 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 1.6 t -98.98 95.34 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.026 0.531 . . . . 0.0 111.71 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.773 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 1.9 tt0 -69.87 159.83 32.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.881 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.609 HD13 HD23 ' A' ' 113' ' ' LEU . 0.9 OUTLIER -121.72 98.38 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.513 179.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 1.1 tp -84.65 119.36 25.15 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.716 0.293 . . . . 0.0 111.122 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.24 158.12 31.92 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.642 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.532 ' HB2' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -61.2 -33.93 74.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.87 0.366 . . . . 0.0 111.043 179.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.546 HG21 ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -48.75 -38.17 20.96 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.013 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.69 -88.87 0.11 Allowed Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.591 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.421 ' HA ' HD12 ' A' ' 104' ' ' LEU . . . -79.19 -176.33 5.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.868 0.366 . . . . 0.0 111.104 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.672 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -79.9 143.93 33.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.126 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.14 157.54 17.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.387 0.613 . . . . 0.0 110.522 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.4 m -81.04 150.46 28.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.201 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.609 HD23 HD13 ' A' ' 103' ' ' ILE . 3.0 mp -102.75 57.7 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.757 0.313 . . . . 0.0 110.72 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.43 19.65 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.532 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.26 -93.1 0.88 Allowed Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.631 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' D' ' 125' ' ' ASN . . . -102.71 69.67 1.08 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.028 0.442 . . . . 0.0 111.596 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 5.8 p -89.69 97.3 11.11 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.19 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.15 102.81 5.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.752 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.416 ' HB2' ' H ' ' A' ' 120' ' ' SER . 0.8 OUTLIER -119.4 -82.69 0.65 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.546 ' HA ' HG21 ' A' ' 107' ' ' THR . 0.1 OUTLIER -63.26 100.87 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.611 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.9 79.11 7.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.228 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.576 HG21 ' HG2' ' A' ' 132' ' ' PRO . 4.7 p -82.55 159.18 22.85 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.769 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.432 HG23 ' N ' ' A' ' 124' ' ' LEU . 16.2 m -85.28 139.74 31.38 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.764 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.432 ' N ' HG23 ' A' ' 123' ' ' THR . 0.4 OUTLIER -92.46 136.18 33.43 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.69 0.281 . . . . 0.0 110.591 179.42 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -120.86 143.57 48.83 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.604 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.13 148.93 34.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.688 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.66 -106.17 2.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.704 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -85.15 153.24 22.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.731 0.3 . . . . 0.0 110.804 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.562 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 23.2 t-20 -148.45 120.7 8.37 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.942 0.401 . . . . 0.0 111.109 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.21 147.26 27.67 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.139 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.606 HD13 HD11 ' A' ' 58' ' ' LEU . 89.8 mt -116.61 119.25 36.08 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.576 ' HG2' HG21 ' A' ' 122' ' ' THR . 7.7 Cg_endo -80.83 119.06 3.54 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 121.704 1.602 . . . . 0.0 112.574 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.04 147.35 29.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.783 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.15 155.94 47.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.043 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.533 ' HB3' HG22 ' A' ' 52' ' ' VAL . . . -140.07 115.66 10.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.882 0.372 . . . . 0.0 111.639 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.27 148.98 31.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.477 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.6 151.29 45.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.158 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -144.52 164.56 30.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.002 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -124.43 145.76 49.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.783 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.481 ' OG1' HG12 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -117.84 13.0 14.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.48 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.79 79.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.919 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.64 92.15 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.598 0.199 . . . . 0.0 110.788 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.801 ' HB3' ' HB ' ' A' ' 99' ' ' VAL . . . -64.08 154.78 33.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.704 0.288 . . . . 0.0 111.38 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.9 p -116.68 166.17 13.42 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.29 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.27 151.49 12.16 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.474 2.116 . . . . 0.0 112.018 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.6 -106.33 0.46 Allowed Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.417 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.06 163.26 32.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.834 0.349 . . . . 0.0 111.411 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.98 79.93 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.504 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 89' ' ' GLN . 87.1 m-20 -99.98 142.51 31.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.51 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . . . -127.81 168.98 14.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.073 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.53 110.04 0.86 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.2 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.652 ' HB1' HD11 ' A' ' 86' ' ' LEU . . . -146.99 145.4 29.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.118 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.67 164.17 13.26 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.486 ' HE2' HG11 ' A' ' 156' ' ' VAL . 15.4 p90 -110.83 151.6 27.63 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.061 0.458 . . . . 0.0 110.162 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.554 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -109.7 160.84 15.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.961 -178.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.486 HG11 ' HE2' ' A' ' 154' ' ' PHE . 1.5 m -142.14 112.91 3.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.756 0.312 . . . . 0.0 111.699 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.626 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -91.87 124.41 35.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.295 0.569 . . . . 0.0 110.447 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.577 ' HH ' HD21 ' A' ' 58' ' ' LEU . 57.4 m-85 -117.13 135.48 53.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.515 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.889 179.894 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.55 100.24 0.04 OUTLIER 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.0 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' C' ' 158' ' ' TYR . 7.4 m -104.81 78.6 1.44 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.416 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.33 122.39 29.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.533 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 m -137.93 162.86 30.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.539 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . 0.425 ' HB3' ' OE2' ' C' ' 15' ' ' GLU . 44.0 t-20 -84.28 114.48 21.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.692 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . 0.495 ' HA3' ' CZ ' ' C' ' 154' ' ' PHE . . . -83.3 -41.54 8.43 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.703 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.444 ' N ' ' CE1' ' C' ' 154' ' ' PHE . . . -175.56 162.32 31.61 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.824 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 99.2 m -90.81 137.91 31.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.925 0.393 . . . . 0.0 111.264 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.402 HG11 ' CZ ' ' B' ' 12' ' ' PHE . 2.7 t -110.49 114.27 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.241 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' HIS . . . . . 0.457 ' HB2' HG21 ' C' ' 31' ' ' THR . 4.5 m80 -99.31 148.54 24.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.364 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . 0.79 ' HB3' HD22 ' C' ' 34' ' ' LEU . 60.6 m-85 -133.8 113.1 11.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.714 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.731 ' HG2' ' HA ' ' C' ' 33' ' ' GLN . 0.0 OUTLIER -107.19 105.86 16.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.392 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.18 169.45 28.87 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.99 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.524 ' HB2' ' HG3' ' C' ' 36' ' ' GLN . 33.8 mt-10 -140.73 -171.08 3.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.85 0.357 . . . . 0.0 110.425 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' C' ' 144' ' ' THR . 0.5 OUTLIER -139.21 152.81 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.222 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.518 HG23 ' HG3' ' C' ' 38' ' ' ARG . 0.0 OUTLIER -137.42 155.43 31.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.834 0.35 . . . . 0.0 111.031 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -85.25 53.12 2.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.956 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.651 ' HA ' ' HG2' ' C' ' 38' ' ' ARG . . . 61.37 92.7 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.111 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.578 ' H ' ' HG2' ' C' ' 38' ' ' ARG . . . -164.74 -47.65 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.447 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.912 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 1.6 m -159.83 176.82 11.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.009 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' C' ' 36' ' ' GLN . . . -147.24 111.89 5.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.15 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 7' ' ' GLY . 43.1 t -67.3 143.08 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.052 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.539 ' O ' HG23 ' B' ' 28' ' ' VAL . 16.9 m-20 -91.11 168.16 11.83 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.622 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.02 74.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.39 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.4 -16.62 73.72 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.92 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.35 -24.38 29.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.921 0.391 . . . . 0.0 110.782 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.539 HG23 ' O ' ' B' ' 24' ' ' ASP . 86.1 t -58.14 -37.13 60.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.339 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -140.35 106.08 5.14 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.997 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' GLN . . . . . 0.531 ' NE2' HD12 ' B' ' 56' ' ' ILE . 5.4 mt-30 -109.03 106.92 17.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.12 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' THR . . . . . 0.458 HG21 ' HB2' ' A' ' 11' ' ' HIS . 0.2 OUTLIER -84.74 95.55 8.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.069 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 51.2 t -85.76 138.21 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 110.451 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.731 ' HA ' ' HG2' ' A' ' 13' ' ' LYS . 3.2 mt-30 -113.18 132.54 55.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.64 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.792 HD22 ' HB3' ' A' ' 12' ' ' PHE . 1.8 mm? -94.45 -71.54 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.625 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.88 -111.3 0.71 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.524 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.529 ' HG3' ' HB2' ' A' ' 15' ' ' GLU . 3.6 tt0 -161.0 105.74 1.36 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.653 0.263 . . . . 0.0 110.919 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 16' ' ' VAL . 5.7 m -91.06 142.35 13.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.966 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.667 ' HG2' ' HA ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -81.07 162.49 23.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.707 179.248 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 82.5 p -80.35 -16.85 53.58 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.784 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.77 -31.17 63.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.175 0.512 . . . . 0.0 110.899 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.04 -28.49 39.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.12 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.629 ' HB3' ' HB2' ' B' ' 139' ' ' ALA . 1.7 mp -133.23 70.09 1.47 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.673 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.65 11.17 36.39 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.432 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.06 146.82 27.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.371 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.49 121.25 13.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 0.0 111.099 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.55 -10.4 12.72 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.15 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' B' ' 138' ' ' PHE . . . -68.85 142.27 54.87 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.851 0.357 . . . . 0.0 111.951 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 6.8 t -134.77 140.82 46.2 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.846 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -106.06 -152.77 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.52 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.86 178.54 1.05 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.03 168.92 15.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.349 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.539 HG22 ' HB3' ' B' ' 135' ' ' ALA . 14.5 m -118.0 132.26 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.977 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.27 107.61 3.56 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.623 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -140.34 132.06 27.35 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.812 0.339 . . . . 0.0 110.871 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' B' ' 131' ' ' ILE . 1.6 p-10 -117.78 176.81 5.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.636 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.531 HD12 ' NE2' ' B' ' 30' ' ' GLN . 51.8 mm -119.05 121.73 67.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.556 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.35 122.78 30.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.753 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.607 HD11 HD13 ' B' ' 131' ' ' ILE . 0.9 OUTLIER -131.27 93.71 3.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.246 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.03 160.89 28.75 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.17 87.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.745 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' CYS . . . . . 0.912 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 69.9 m -120.44 131.88 54.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.71 97.9 9.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.269 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' B' ' 66' ' ' ALA . 1.5 m -77.47 -19.96 55.14 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.06 -27.48 68.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 111.768 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.39 -35.76 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.643 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' B' ' 63' ' ' THR . . . -131.05 131.28 44.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.64 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.46 -37.31 7.65 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.892 0.377 . . . . 0.0 110.948 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -121.69 171.39 8.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.56 136.1 15.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.552 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' B' ' 157' ' ' GLN . . . -94.5 158.04 15.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.062 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.41 106.28 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.679 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.545 ' HB1' ' HB3' ' B' ' 155' ' ' LYS . . . -109.6 164.29 12.67 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.65 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.441 ' CE2' HG12 ' B' ' 103' ' ' ILE . 6.5 t80 -142.27 141.03 32.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.502 0.191 . . . . 0.0 111.174 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.627 ' CG ' ' HG1' ' E' ' 130' ' ' THR . 0.1 OUTLIER -122.71 103.38 8.62 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.993 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . 0.572 ' HA3' HD22 ' B' ' 113' ' ' LEU . . . -153.45 -166.37 14.56 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.875 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.54 136.3 46.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.585 0.231 . . . . 0.0 110.709 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . 0.602 ' H ' ' HB3' ' E' ' 132' ' ' PRO . . . -81.52 156.13 25.42 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.879 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.574 HG21 ' HB ' ' B' ' 85' ' ' VAL . 3.1 tt -92.51 -20.71 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.811 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.18 179.76 0.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.818 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.91 -33.89 45.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.007 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.44 -43.84 95.64 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.6 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.452 ' NE2' ' O ' ' B' ' 139' ' ' ALA . 43.5 m-70 -97.86 -64.38 1.04 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.829 0.347 . . . . 0.0 110.435 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' THR . . . . . . . . . . . . . 1.2 m 62.33 7.83 2.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.647 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . 0.602 ' HB3' ' HB2' ' B' ' 110' ' ' ALA . 6.5 m120 -115.15 -25.41 8.09 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.203 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' B' ' 102' ' ' GLN . 0.5 OUTLIER -79.62 143.75 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.152 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . 0.65 HD11 ' HB1' ' B' ' 152' ' ' ALA . 0.3 OUTLIER -76.69 148.52 36.77 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.306 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.8 178.15 4.39 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.876 0.369 . . . . 0.0 111.734 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' E' ' 51' ' ' ALA . 0.0 OUTLIER -84.6 176.13 8.8 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.071 179.386 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . 0.519 ' HB3' ' HB2' ' B' ' 149' ' ' ASN . 22.8 pt20 -75.19 178.62 5.62 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.355 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' SER . . . . . 0.567 ' O ' HG11 ' E' ' 52' ' ' VAL . 1.0 OUTLIER -73.34 -11.44 60.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.023 0.44 . . . . 0.0 111.409 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' B' ' 95' ' ' SER . 0.3 OUTLIER -64.72 87.27 0.06 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.909 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.86 -7.2 53.93 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.633 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.09 19.87 4.07 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.641 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.66 -15.53 0.16 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.932 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' B' ' 91' ' ' SER . 1.0 OUTLIER -97.32 174.96 6.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.898 0.38 . . . . 0.0 110.583 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . 0.468 ' O ' HD21 ' B' ' 88' ' ' LEU . . . -114.13 157.88 22.02 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.83 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.03 162.7 15.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.308 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 69.42 41.5 1.3 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.46 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . 0.793 ' HB ' ' HB3' ' B' ' 143' ' ' ALA . 10.4 p -177.62 130.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.825 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.04 179.52 28.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.598 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' B' ' 86' ' ' LEU . 1.6 t -99.15 95.33 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.009 0.524 . . . . 0.0 111.672 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.772 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 1.9 tt0 -69.85 159.82 32.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.954 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.603 HD13 HD23 ' B' ' 113' ' ' LEU . 0.9 OUTLIER -121.69 98.41 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.56 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . 0.677 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 1.1 tp -84.8 119.38 25.23 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.792 0.33 . . . . 0.0 111.113 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.18 158.04 32.09 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.643 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . 0.533 ' HB2' ' HB2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -61.05 -33.93 74.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.913 0.387 . . . . 0.0 111.117 179.42 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' THR . . . . . 0.551 HG21 ' HA ' ' B' ' 120' ' ' SER . 0.0 OUTLIER -48.76 -38.25 21.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.972 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.73 -88.78 0.11 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.59 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' B' ' 104' ' ' LEU . . . -79.2 -176.35 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.892 0.377 . . . . 0.0 111.066 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.677 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -79.98 143.94 33.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.09 157.56 17.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.363 0.601 . . . . 0.0 110.561 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 29.7 m -81.12 150.43 28.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.111 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.603 HD23 HD13 ' B' ' 103' ' ' ILE . 3.0 mp -102.7 57.66 0.78 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.691 0.281 . . . . 0.0 110.738 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.49 19.67 15.23 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.477 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.24 -93.05 0.88 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.634 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' E' ' 125' ' ' ASN . . . -102.71 69.66 1.08 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.03 0.443 . . . . 0.0 111.592 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' B' ' 72' ' ' ALA . 5.9 p -89.62 97.22 11.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.142 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.17 102.82 5.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.764 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.44 -82.74 0.65 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' SER . . . . . 0.551 ' HA ' HG21 ' B' ' 107' ' ' THR . 0.1 OUTLIER -63.22 100.93 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.614 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -88.87 79.02 7.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.143 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.589 HG21 ' HG2' ' B' ' 132' ' ' PRO . 4.6 p -82.52 159.17 22.9 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.737 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.459 HG23 ' N ' ' B' ' 124' ' ' LEU . 16.0 m -85.33 139.71 31.37 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.746 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.459 ' N ' HG23 ' B' ' 123' ' ' THR . 0.4 OUTLIER -92.36 136.15 33.44 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.609 179.39 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -120.8 143.56 48.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.644 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.2 148.95 34.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 110.63 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.67 -106.11 2.29 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.746 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -85.16 153.16 22.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.812 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . 0.574 ' HB3' ' HB2' ' B' ' 58' ' ' LEU . 23.1 t-20 -148.4 120.76 8.43 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.93 0.395 . . . . 0.0 111.112 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.24 147.26 27.68 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.151 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' ILE . . . . . 0.607 HD13 HD11 ' B' ' 58' ' ' LEU . 89.9 mt -116.58 119.19 36.23 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' PRO . . . . . 0.589 ' HG2' HG21 ' B' ' 122' ' ' THR . 7.6 Cg_endo -80.79 119.14 3.57 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.632 1.555 . . . . 0.0 112.535 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.05 147.3 29.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.775 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.13 155.88 47.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.04 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.539 ' HB3' HG22 ' B' ' 52' ' ' VAL . . . -140.06 115.67 10.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.648 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.26 148.93 31.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.535 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.48 151.27 45.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.119 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' B' ' 47' ' ' ALA . 0.2 OUTLIER -144.52 164.58 30.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.033 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.629 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -124.45 145.68 49.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.809 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' THR . . . . . 0.481 ' OG1' HG12 ' B' ' 78' ' ' ILE . 0.2 OUTLIER -117.77 13.01 14.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.545 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.83 79.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.97 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.73 92.14 0.02 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.619 0.21 . . . . 0.0 110.769 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' ALA . . . . . 0.793 ' HB3' ' HB ' ' B' ' 99' ' ' VAL . . . -64.08 154.8 33.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.698 0.285 . . . . 0.0 111.393 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.534 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 39.3 p -116.76 166.22 13.34 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.223 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.414 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 1.4 Cg_endo -84.27 151.5 12.16 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.467 2.112 . . . . 0.0 111.976 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.62 -106.29 0.46 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.401 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.06 163.32 32.72 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.839 0.352 . . . . 0.0 111.386 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -166.01 79.93 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.546 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' B' ' 89' ' ' GLN . 87.2 m-20 -99.92 142.47 31.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.557 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . 0.581 ' HB3' ' HB3' ' B' ' 86' ' ' LEU . . . -127.76 169.02 14.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.01 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . 0.407 ' OD2' ' HD2' ' A' ' 11' ' ' HIS . 4.2 t70 -165.6 109.94 0.85 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.261 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . 0.65 ' HB1' HD11 ' B' ' 86' ' ' LEU . . . -147.02 145.45 29.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.14 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.66 164.22 13.24 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' PHE . . . . . 0.494 ' HE2' HG11 ' B' ' 156' ' ' VAL . 15.4 p90 -110.89 151.66 27.63 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.141 0.496 . . . . 0.0 110.137 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . 0.545 ' HB3' ' HB1' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -109.75 160.88 15.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.932 -178.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' VAL . . . . . 0.494 HG11 ' HE2' ' B' ' 154' ' ' PHE . 1.4 m -142.1 112.92 3.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.786 0.326 . . . . 0.0 111.706 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.621 ' HB3' ' HB2' ' B' ' 70' ' ' ALA . 0.3 OUTLIER -91.87 124.44 35.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.352 0.596 . . . . 0.0 110.426 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' TYR . . . . . 0.577 ' HH ' HD21 ' B' ' 58' ' ' LEU . 57.3 m-85 -117.19 135.54 53.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.525 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.866 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.55 100.26 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.984 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 3' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' D' ' 158' ' ' TYR . 7.4 m -104.82 78.63 1.45 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.406 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.31 122.39 29.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.599 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 m -137.94 162.94 30.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.472 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' ASN . . . . . 0.421 ' HB3' ' OE2' ' D' ' 15' ' ' GLU . 44.0 t-20 -84.37 114.55 21.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.615 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' D' ' 154' ' ' PHE . . . -83.47 -41.39 8.42 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.679 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . 0.443 ' N ' ' CE1' ' D' ' 154' ' ' PHE . . . -175.61 162.26 31.49 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.908 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' D' ' 153' ' ' THR . 99.2 m -90.79 137.92 31.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.981 0.42 . . . . 0.0 111.231 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.46 114.23 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.233 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' HIS . . . . . 0.438 ' HB2' HG21 ' D' ' 31' ' ' THR . 4.5 m80 -99.29 148.56 24.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.347 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' PHE . . . . . 0.812 ' HB3' HD22 ' D' ' 34' ' ' LEU . 60.8 m-85 -133.83 113.07 11.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.723 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . 0.707 ' HG2' ' HA ' ' D' ' 33' ' ' GLN . 0.0 OUTLIER -107.14 105.86 16.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.395 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.18 169.44 28.87 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.992 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' GLU . . . . . 0.53 ' HB2' ' HG3' ' D' ' 36' ' ' GLN . 33.8 mt-10 -140.73 -171.07 3.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.913 0.387 . . . . 0.0 110.391 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.532 ' HB ' ' O ' ' D' ' 144' ' ' THR . 0.5 OUTLIER -139.24 152.77 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.251 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.518 HG23 ' HG3' ' D' ' 38' ' ' ARG . 0.0 OUTLIER -137.42 155.35 31.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.888 0.375 . . . . 0.0 111.047 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -85.13 53.11 2.63 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . 0.655 ' HA ' ' HG2' ' D' ' 38' ' ' ARG . . . 61.33 92.74 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.098 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . 0.594 ' H ' ' HG2' ' D' ' 38' ' ' ARG . . . -164.8 -47.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.438 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 1.6 m -159.81 176.83 11.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.951 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' D' ' 36' ' ' GLN . . . -147.28 111.99 5.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.115 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . 0.462 HG11 ' O ' ' B' ' 7' ' ' GLY . 43.0 t -67.44 143.22 15.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.015 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.548 ' O ' HG23 ' C' ' 28' ' ' VAL . 17.0 m-20 -91.2 168.1 11.86 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.629 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.36 -50.0 74.35 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.42 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.38 -16.64 73.69 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.907 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' SER . . . . . 0.408 ' HA ' HE21 ' C' ' 30' ' ' GLN . 0.4 OUTLIER -84.31 -24.44 29.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.876 0.37 . . . . 0.0 110.742 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.548 HG23 ' O ' ' C' ' 24' ' ' ASP . 85.1 t -58.04 -37.23 60.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.359 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -140.37 105.91 5.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.043 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' GLN . . . . . 0.532 ' NE2' HD12 ' C' ' 56' ' ' ILE . 5.4 mt-30 -108.95 106.95 17.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.155 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' THR . . . . . 0.457 HG21 ' HB2' ' B' ' 11' ' ' HIS . 0.2 OUTLIER -84.79 95.6 9.02 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.047 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 51.7 t -85.82 138.24 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.099 0.476 . . . . 0.0 110.37 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.731 ' HA ' ' HG2' ' B' ' 13' ' ' LYS . 3.2 mt-30 -113.2 132.6 55.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.651 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.79 HD22 ' HB3' ' B' ' 12' ' ' PHE . 1.8 mm? -94.53 -71.43 0.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.627 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.83 -111.31 0.72 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.544 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . 0.524 ' HG3' ' HB2' ' B' ' 15' ' ' GLU . 3.6 tt0 -161.06 105.84 1.35 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.721 0.296 . . . . 0.0 110.874 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . 0.462 ' O ' HG13 ' B' ' 16' ' ' VAL . 5.6 m -91.15 142.37 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.937 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' ARG . . . . . 0.651 ' HG2' ' HA ' ' B' ' 19' ' ' ALA . 0.7 OUTLIER -81.18 162.55 23.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.694 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 82.6 p -80.39 -16.79 53.66 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.765 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.81 -31.16 63.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.157 0.503 . . . . 0.0 110.839 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -28.5 39.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.11 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.613 ' HB3' ' HB2' ' C' ' 139' ' ' ALA . 1.7 mp -133.21 70.13 1.47 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.601 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.67 11.18 36.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.5 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.01 146.83 27.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.466 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.5 121.28 13.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.871 0.367 . . . . 0.0 111.152 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.52 -10.47 12.75 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.114 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' C' ' 138' ' ' PHE . . . -68.78 142.21 54.98 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.874 0.369 . . . . 0.0 111.976 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 6.8 t -134.75 140.81 46.21 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.852 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 17.0 m -105.96 -152.79 0.48 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.56 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 1.4 t -65.94 178.6 1.06 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.859 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.11 168.82 15.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.805 0.336 . . . . 0.0 111.28 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' C' ' 135' ' ' ALA . 14.7 m -117.98 132.24 68.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.21 107.62 3.57 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.683 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -140.31 132.09 27.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.741 0.305 . . . . 0.0 110.932 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' C' ' 131' ' ' ILE . 1.5 p-10 -117.83 176.83 5.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.565 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.532 HD12 ' NE2' ' C' ' 30' ' ' GLN . 51.7 mm -119.02 121.68 67.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.533 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.29 122.71 30.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.826 0.346 . . . . 0.0 110.831 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . 0.604 HD11 HD13 ' C' ' 131' ' ' ILE . 0.9 OUTLIER -131.23 93.75 3.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.08 160.82 28.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.871 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.26 87.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.74 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 70.2 m -120.52 131.8 54.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.813 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.61 97.91 9.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.343 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' C' ' 66' ' ' ALA . 1.5 m -77.44 -19.96 55.23 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.04 -27.56 68.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.978 0.418 . . . . 0.0 111.711 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 16.9 t -95.36 -35.76 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.613 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' C' ' 63' ' ' THR . . . -130.9 131.29 44.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.706 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.45 -37.27 7.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.912 0.387 . . . . 0.0 110.983 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -121.74 171.36 8.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.503 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.58 136.15 15.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.593 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.623 ' HB2' ' HB3' ' C' ' 157' ' ' GLN . . . -94.52 157.99 15.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.086 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.44 106.28 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.693 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' C' ' 155' ' ' LYS . . . -109.6 164.31 12.65 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.597 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' PHE . . . . . 0.437 ' CE2' HG12 ' C' ' 103' ' ' ILE . 6.6 t80 -142.26 141.03 32.42 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.147 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.615 ' CD1' ' HG1' ' F' ' 130' ' ' THR . 0.1 OUTLIER -122.66 103.37 8.63 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.981 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . 0.559 ' HA3' HD22 ' C' ' 113' ' ' LEU . . . -153.47 -166.38 14.58 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.909 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.5 136.27 46.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.574 0.226 . . . . 0.0 110.746 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . 0.611 ' H ' ' HB3' ' F' ' 132' ' ' PRO . . . -81.39 156.08 25.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.878 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . 0.585 HG21 ' HB ' ' C' ' 85' ' ' VAL . 3.1 tt -92.56 -20.65 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.796 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.15 179.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.821 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.02 -33.76 44.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.988 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.39 -44.0 95.45 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.564 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . 0.465 ' NE2' ' O ' ' C' ' 139' ' ' ALA . 43.3 m-70 -97.74 -64.42 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.787 0.327 . . . . 0.0 110.47 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 1.2 m 62.32 7.81 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.597 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' ASN . . . . . 0.619 ' HB3' ' HB2' ' C' ' 110' ' ' ALA . 6.6 m120 -115.02 -25.51 8.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.308 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.786 ' HA ' ' HA ' ' C' ' 102' ' ' GLN . 0.5 OUTLIER -79.53 143.63 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.214 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.656 HD11 ' HB1' ' C' ' 152' ' ' ALA . 0.3 OUTLIER -76.59 148.57 36.9 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.294 179.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.87 178.25 4.37 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.721 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.586 HD11 ' HB3' ' F' ' 51' ' ' ALA . 0.0 OUTLIER -84.71 176.19 8.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.124 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' GLN . . . . . 0.523 ' HB3' ' HB2' ' C' ' 149' ' ' ASN . 22.9 pt20 -75.18 178.69 5.56 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.352 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' SER . . . . . 0.561 ' O ' HG11 ' F' ' 52' ' ' VAL . 1.0 OUTLIER -73.36 -11.45 60.49 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.002 0.429 . . . . 0.0 111.461 179.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' SER . . . . . 0.478 ' HB3' ' HB3' ' C' ' 95' ' ' SER . 0.3 OUTLIER -64.72 87.27 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.92 -7.09 53.75 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.688 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.15 19.92 4.06 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.614 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.64 -15.6 0.16 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.96 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' SER . . . . . 0.478 ' HB3' ' HB3' ' C' ' 91' ' ' SER . 1.0 OUTLIER -97.35 174.93 6.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 110.594 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' ALA . . . . . 0.472 ' O ' HD21 ' C' ' 88' ' ' LEU . . . -114.06 157.85 22.0 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.9 162.78 15.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.325 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 69.33 41.52 1.32 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.366 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 99' ' ' VAL . . . . . 0.808 ' HB ' ' HB3' ' C' ' 143' ' ' ALA . 10.3 p -177.58 130.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.06 179.45 28.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.604 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' C' ' 86' ' ' LEU . 1.6 t -99.07 95.27 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.072 0.549 . . . . 0.0 111.703 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 102' ' ' GLN . . . . . 0.786 ' HA ' ' HA ' ' C' ' 85' ' ' VAL . 1.9 tt0 -69.88 159.8 33.0 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.9 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . 0.603 HD13 HD23 ' C' ' 113' ' ' LEU . 0.9 OUTLIER -121.66 98.36 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.574 179.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' LEU . . . . . 0.673 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 1.1 tp -84.64 119.36 25.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.695 0.283 . . . . 0.0 111.148 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.13 158.08 32.12 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.677 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 106' ' ' ARG . . . . . 0.534 ' HB2' ' HB2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -61.13 -33.93 74.18 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.914 0.388 . . . . 0.0 111.085 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 107' ' ' THR . . . . . 0.562 HG21 ' HA ' ' C' ' 120' ' ' SER . 0.0 OUTLIER -48.8 -38.22 21.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.972 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.75 -88.82 0.11 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.544 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 109' ' ' ALA . . . . . 0.411 ' HA ' HD12 ' C' ' 104' ' ' LEU . . . -79.17 -176.32 5.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.82 0.343 . . . . 0.0 111.143 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.673 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -79.98 143.89 33.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.136 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.07 157.51 17.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.389 0.614 . . . . 0.0 110.557 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 112' ' ' THR . . . . . . . . . . . . . 29.9 m -81.13 150.45 28.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.154 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.603 HD23 HD13 ' C' ' 103' ' ' ILE . 3.0 mp -102.68 57.64 0.78 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.675 0.274 . . . . 0.0 110.742 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.48 19.72 15.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.562 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.18 -93.08 0.88 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.647 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 116' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' F' ' 125' ' ' ASN . . . -102.73 69.58 1.08 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.097 0.475 . . . . 0.0 111.631 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 117' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' C' ' 72' ' ' ALA . 5.9 p -89.62 97.25 11.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.196 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.13 102.72 5.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.723 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.43 -82.69 0.65 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 120' ' ' SER . . . . . 0.562 ' HA ' HG21 ' C' ' 107' ' ' THR . 0.1 OUTLIER -63.16 100.87 0.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.715 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.82 79.01 7.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.208 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.574 HG21 ' HG2' ' C' ' 132' ' ' PRO . 4.5 p -82.56 159.1 22.85 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.729 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 123' ' ' THR . . . . . 0.45 HG23 ' N ' ' C' ' 124' ' ' LEU . 16.3 m -85.17 139.71 31.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.825 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . 0.45 ' N ' HG23 ' C' ' 123' ' ' THR . 0.4 OUTLIER -92.42 136.15 33.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.811 0.338 . . . . 0.0 110.548 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -120.77 143.55 48.76 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.653 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.14 148.94 34.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.742 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.76 -106.21 2.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.692 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -85.2 153.25 22.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.734 0.302 . . . . 0.0 110.74 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 129' ' ' ASN . . . . . 0.565 ' HB3' ' HB2' ' C' ' 58' ' ' LEU . 23.2 t-20 -148.45 120.72 8.38 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.898 0.38 . . . . 0.0 111.112 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.18 147.33 27.58 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.132 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 131' ' ' ILE . . . . . 0.604 HD13 HD11 ' C' ' 58' ' ' LEU . 89.8 mt -116.62 119.27 36.02 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 132' ' ' PRO . . . . . 0.574 ' HG2' HG21 ' C' ' 122' ' ' THR . 7.6 Cg_endo -80.92 119.17 3.53 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 121.652 1.568 . . . . 0.0 112.548 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.12 147.27 29.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.762 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.09 155.98 47.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.02 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . 0.538 ' HB3' HG22 ' C' ' 52' ' ' VAL . . . -140.09 115.7 10.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.93 0.395 . . . . 0.0 111.579 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.26 149.02 31.63 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.432 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.67 151.32 45.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.068 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 138' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' C' ' 47' ' ' ALA . 0.2 OUTLIER -144.55 164.56 30.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.924 -179.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 139' ' ' ALA . . . . . 0.613 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -124.41 145.74 49.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.923 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 140' ' ' THR . . . . . 0.482 ' OG1' HG12 ' C' ' 78' ' ' ILE . 0.2 OUTLIER -117.8 12.89 14.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.516 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.87 79.82 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.895 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.7 92.11 0.02 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.595 0.197 . . . . 0.0 110.796 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 143' ' ' ALA . . . . . 0.808 ' HB3' ' HB ' ' C' ' 99' ' ' VAL . . . -64.11 154.83 33.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.75 0.31 . . . . 0.0 111.403 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 144' ' ' THR . . . . . 0.528 ' O ' ' HB ' ' B' ' 16' ' ' VAL . 39.8 p -116.75 166.22 13.34 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.181 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 145' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' B' ' 16' ' ' VAL . 1.3 Cg_endo -84.28 151.4 12.13 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.468 2.112 . . . . 0.0 111.993 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.7 -106.23 0.45 Allowed Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.403 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.13 163.23 32.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.764 0.316 . . . . 0.0 111.411 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.89 79.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.502 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 149' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' C' ' 89' ' ' GLN . 87.1 m-20 -99.92 142.47 31.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.576 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 150' ' ' ALA . . . . . 0.582 ' HB3' ' HB3' ' C' ' 86' ' ' LEU . . . -127.77 168.96 14.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.052 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 151' ' ' ASP . . . . . 0.408 ' OD2' ' HD2' ' B' ' 11' ' ' HIS . 4.2 t70 -165.54 109.99 0.86 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.267 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 152' ' ' ALA . . . . . 0.656 ' HB1' HD11 ' C' ' 86' ' ' LEU . . . -146.94 145.42 29.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.148 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.61 164.18 13.26 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 154' ' ' PHE . . . . . 0.495 ' CZ ' ' HA3' ' B' ' 7' ' ' GLY . 15.2 p90 -110.87 151.52 27.77 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.157 0.503 . . . . 0.0 110.187 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 155' ' ' LYS . . . . . 0.543 ' HB3' ' HB1' ' C' ' 72' ' ' ALA . 0.0 OUTLIER -109.6 160.95 15.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.943 -178.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 156' ' ' VAL . . . . . 0.489 HG11 ' HE2' ' C' ' 154' ' ' PHE . 1.5 m -142.17 112.9 3.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.761 0.315 . . . . 0.0 111.715 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 157' ' ' GLN . . . . . 0.623 ' HB3' ' HB2' ' C' ' 70' ' ' ALA . 0.3 OUTLIER -91.88 124.38 35.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.36 0.6 . . . . 0.0 110.46 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 158' ' ' TYR . . . . . 0.567 ' HH ' HD21 ' C' ' 58' ' ' LEU . 57.6 m-85 -117.18 135.47 53.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.493 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.914 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.53 100.1 0.04 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.064 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 3' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' E' ' 158' ' ' TYR . 7.3 m -104.74 78.63 1.46 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.48 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.27 122.44 29.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.528 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.95 162.93 30.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.533 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 6' ' ' ASN . . . . . 0.424 ' HB3' ' OE2' ' E' ' 15' ' ' GLU . 44.0 t-20 -84.34 114.56 21.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.594 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 7' ' ' GLY . . . . . 0.484 ' HA3' ' CZ ' ' E' ' 154' ' ' PHE . . . -83.41 -41.48 8.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.683 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . 0.447 ' N ' ' CE1' ' E' ' 154' ' ' PHE . . . -175.64 162.28 31.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.847 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 9' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' E' ' 153' ' ' THR . 98.8 m -90.74 137.81 32.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.92 0.39 . . . . 0.0 111.28 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' VAL . . . . . 0.4 HG11 ' CZ ' ' D' ' 12' ' ' PHE . 2.7 t -110.43 114.28 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.254 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' HIS . . . . . 0.455 ' HB2' HG21 ' E' ' 31' ' ' THR . 4.6 m80 -99.38 148.49 24.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.312 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' PHE . . . . . 0.818 ' HB3' HD22 ' E' ' 34' ' ' LEU . 60.7 m-85 -133.74 113.08 11.92 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.824 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' LYS . . . . . 0.714 ' HG2' ' HA ' ' E' ' 33' ' ' GLN . 0.0 OUTLIER -107.12 105.82 16.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.39 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.17 169.48 28.86 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.958 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' GLU . . . . . 0.528 ' HB2' ' HG3' ' E' ' 36' ' ' GLN . 33.6 mt-10 -140.75 -171.05 3.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.849 0.357 . . . . 0.0 110.431 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.532 ' HB ' ' O ' ' E' ' 144' ' ' THR . 0.5 OUTLIER -139.23 152.88 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.144 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . 0.52 HG23 ' HG3' ' E' ' 38' ' ' ARG . 0.0 OUTLIER -137.47 155.39 31.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.856 0.36 . . . . 0.0 111.069 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -85.19 53.06 2.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.011 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' ALA . . . . . 0.671 ' HA ' ' HG2' ' E' ' 38' ' ' ARG . . . 61.41 92.64 0.05 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.112 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.586 ' H ' ' HG2' ' E' ' 38' ' ' ARG . . . -164.72 -47.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.469 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 1.6 m -159.86 176.77 11.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.989 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' E' ' 36' ' ' GLN . . . -147.22 111.91 5.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.157 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . 0.47 HG11 ' O ' ' C' ' 7' ' ' GLY . 43.2 t -67.29 143.08 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.004 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . 0.548 ' O ' HG23 ' D' ' 28' ' ' VAL . 17.0 m-20 -91.16 168.15 11.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.619 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.37 -50.02 74.31 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.443 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.38 -16.61 73.67 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.967 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' SER . . . . . 0.402 ' HA ' HE21 ' D' ' 30' ' ' GLN . 0.4 OUTLIER -84.32 -24.44 29.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.892 0.377 . . . . 0.0 110.763 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . 0.548 HG23 ' O ' ' D' ' 24' ' ' ASP . 85.6 t -58.1 -37.19 60.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.346 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -140.41 105.98 5.1 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.033 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' GLN . . . . . 0.536 ' NE2' HD12 ' D' ' 56' ' ' ILE . 5.4 mt-30 -109.08 106.95 17.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.106 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' THR . . . . . 0.438 HG21 ' HB2' ' C' ' 11' ' ' HIS . 0.2 OUTLIER -84.74 95.56 8.98 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.096 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 51.9 t -85.76 138.17 19.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.11 0.481 . . . . 0.0 110.388 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.707 ' HA ' ' HG2' ' C' ' 13' ' ' LYS . 3.1 mt-30 -113.11 132.59 55.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.688 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' C' ' 12' ' ' PHE . 1.8 mm? -94.47 -71.48 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.64 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.83 -111.33 0.72 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.526 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' GLN . . . . . 0.53 ' HG3' ' HB2' ' C' ' 15' ' ' GLU . 3.6 tt0 -160.96 105.83 1.37 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.648 0.261 . . . . 0.0 110.884 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.449 ' O ' HG13 ' C' ' 16' ' ' VAL . 5.6 m -91.15 142.42 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.878 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . 0.655 ' HG2' ' HA ' ' C' ' 19' ' ' ALA . 0.7 OUTLIER -81.11 162.53 23.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.759 179.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' THR . . . . . . . . . . . . . 82.4 p -80.34 -16.94 53.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.788 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.71 -31.23 63.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.166 0.508 . . . . 0.0 110.919 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.11 -28.42 39.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.116 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.608 ' HB3' ' HB2' ' D' ' 139' ' ' ALA . 1.7 mp -133.16 70.19 1.47 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.625 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.71 11.21 36.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.424 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.06 146.85 27.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.38 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.48 121.22 13.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.56 -10.4 12.71 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.09 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' D' ' 138' ' ' PHE . . . -68.8 142.17 54.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.905 0.383 . . . . 0.0 111.97 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -134.72 140.84 46.26 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.816 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 16.8 m -106.02 -152.76 0.48 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.587 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 1.4 t -65.91 178.64 1.04 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.813 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' ALA . . . . . 0.591 ' HB3' HD11 ' A' ' 88' ' ' LEU . . . -129.16 168.9 15.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.283 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 90' ' ' SER . 14.7 m -118.02 132.25 68.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 88' ' ' LEU . . . -95.2 107.59 3.56 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.647 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -140.28 132.05 27.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.707 0.289 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' D' ' 131' ' ' ILE . 1.6 p-10 -117.81 176.83 5.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.57 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.536 HD12 ' NE2' ' D' ' 30' ' ' GLN . 51.7 mm -118.98 121.7 67.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.532 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' GLN . . . . . 0.56 ' HG2' HD12 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -86.32 122.66 30.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.778 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . 0.608 HD11 HD13 ' D' ' 131' ' ' ILE . 0.9 OUTLIER -131.2 93.71 3.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.234 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.98 160.91 28.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.912 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.12 87.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.76 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 70.1 m -120.55 131.81 54.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.808 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.61 97.87 9.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.308 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' D' ' 66' ' ' ALA . 1.5 m -77.41 -19.98 55.31 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.06 -27.54 68.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.975 0.417 . . . . 0.0 111.701 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.4 -35.75 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.608 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' D' ' 63' ' ' THR . . . -130.94 131.24 44.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.716 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.41 -37.35 7.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.885 0.374 . . . . 0.0 110.954 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -121.69 171.4 8.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.577 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.55 136.13 15.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.555 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' D' ' 157' ' ' GLN . . . -94.49 157.95 15.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.087 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 38.1 t -110.42 106.31 20.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.655 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 72' ' ' ALA . . . . . 0.55 ' HB1' ' HB3' ' D' ' 155' ' ' LYS . . . -109.64 164.24 12.72 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.575 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 73' ' ' PHE . . . . . 0.441 ' CE2' HG12 ' D' ' 103' ' ' ILE . 6.5 t80 -142.21 141.11 32.51 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.564 0.221 . . . . 0.0 111.15 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 74' ' ' LEU . . . . . 0.428 HD22 ' NZ ' ' D' ' 155' ' ' LYS . 0.1 OUTLIER -122.72 103.37 8.61 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.991 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . 0.557 ' HA3' HD22 ' D' ' 113' ' ' LEU . . . -153.46 -166.43 14.62 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.889 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.46 136.37 46.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.611 0.243 . . . . 0.0 110.695 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.54 156.12 25.4 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.88 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 78' ' ' ILE . . . . . 0.581 HG21 ' HB ' ' D' ' 85' ' ' VAL . 3.0 tt -92.52 -20.67 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.83 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.15 179.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.825 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.95 -33.85 44.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.975 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.51 -43.82 95.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.595 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . 0.459 ' NE2' ' O ' ' D' ' 139' ' ' ALA . 43.6 m-70 -97.78 -64.48 1.04 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.862 0.363 . . . . 0.0 110.438 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 1.2 m 62.45 7.77 2.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.582 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . 0.619 ' HB3' ' HB2' ' D' ' 110' ' ' ALA . 6.5 m120 -115.08 -25.41 8.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.329 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.762 ' HA ' ' HA ' ' D' ' 102' ' ' GLN . 0.5 OUTLIER -79.58 143.68 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.171 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.652 HD11 ' HB1' ' D' ' 152' ' ' ALA . 0.3 OUTLIER -76.63 148.53 36.86 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.27 179.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.8 178.2 4.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.894 0.378 . . . . 0.0 111.716 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.463 HD21 ' O ' ' D' ' 96' ' ' ALA . 0.0 OUTLIER -84.67 176.16 8.75 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.096 179.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 89' ' ' GLN . . . . . 0.507 ' HB3' ' HB2' ' D' ' 149' ' ' ASN . 22.8 pt20 -75.24 178.71 5.58 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.38 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.36 -11.5 60.5 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 111.428 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 91' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' D' ' 95' ' ' SER . 0.3 OUTLIER -64.62 87.24 0.05 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.891 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.88 -7.15 53.83 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.921 0.391 . . . . 0.0 111.697 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.14 19.96 4.06 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.674 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.62 -15.58 0.16 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.942 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 95' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' D' ' 91' ' ' SER . 1.0 OUTLIER -97.33 174.89 6.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.9 0.381 . . . . 0.0 110.59 179.558 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 96' ' ' ALA . . . . . 0.463 ' O ' HD21 ' D' ' 88' ' ' LEU . . . -114.05 157.88 21.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.82 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.9 162.72 15.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.305 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 98' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 69.29 41.62 1.32 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.387 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 99' ' ' VAL . . . . . 0.803 ' HB ' ' HB3' ' D' ' 143' ' ' ALA . 10.1 p -177.64 130.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.792 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.12 179.45 28.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.552 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 101' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' D' ' 86' ' ' LEU . 1.6 t -99.0 95.29 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 123.078 0.551 . . . . 0.0 111.681 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 102' ' ' GLN . . . . . 0.762 ' HA ' ' HA ' ' D' ' 85' ' ' VAL . 1.9 tt0 -69.84 159.79 32.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.892 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 103' ' ' ILE . . . . . 0.617 HD13 HD23 ' D' ' 113' ' ' LEU . 0.9 OUTLIER -121.7 98.45 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.522 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 104' ' ' LEU . . . . . 0.675 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 1.1 tp -84.75 119.38 25.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.755 0.312 . . . . 0.0 111.095 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.18 158.09 32.04 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.68 0.276 . . . . 0.0 111.646 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 106' ' ' ARG . . . . . 0.534 ' HB2' ' HB2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -61.19 -33.92 74.23 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.902 0.382 . . . . 0.0 111.048 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 107' ' ' THR . . . . . 0.547 HG21 ' HA ' ' D' ' 120' ' ' SER . 0.0 OUTLIER -48.72 -38.19 20.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.027 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.68 -88.81 0.11 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.603 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 109' ' ' ALA . . . . . 0.424 ' HA ' HD12 ' D' ' 104' ' ' LEU . . . -79.16 -176.35 5.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.867 0.365 . . . . 0.0 111.139 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.675 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -79.96 143.93 33.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.098 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.08 157.58 17.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.386 0.612 . . . . 0.0 110.534 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 112' ' ' THR . . . . . . . . . . . . . 30.0 m -81.22 150.47 28.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.099 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 113' ' ' LEU . . . . . 0.617 HD23 HD13 ' D' ' 103' ' ' ILE . 2.9 mp -102.72 57.67 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.721 0.296 . . . . 0.0 110.742 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.42 19.57 15.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.552 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.23 -93.04 0.88 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.665 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.68 69.61 1.08 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.021 0.438 . . . . 0.0 111.564 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 117' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' D' ' 72' ' ' ALA . 5.8 p -89.69 97.34 11.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.2 102.83 5.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.786 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.45 -82.72 0.65 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 120' ' ' SER . . . . . 0.547 ' HA ' HG21 ' D' ' 107' ' ' THR . 0.1 OUTLIER -63.2 100.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.614 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.86 79.05 7.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.234 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.573 HG21 ' HG2' ' D' ' 132' ' ' PRO . 4.4 p -82.61 159.15 22.78 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.719 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.439 HG23 ' N ' ' D' ' 124' ' ' LEU . 16.2 m -85.2 139.68 31.47 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.8 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . 0.439 ' N ' HG23 ' D' ' 123' ' ' THR . 0.4 OUTLIER -92.34 136.1 33.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.65 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 125' ' ' ASN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 116' ' ' ALA . 25.1 m120 -120.78 143.67 48.7 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.622 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.19 148.98 34.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.638 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.61 -106.12 2.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.75 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 128' ' ' THR . . . . . 0.412 ' HB ' ' HD3' ' A' ' 155' ' ' LYS . 1.9 m -85.15 153.14 22.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.654 0.264 . . . . 0.0 110.817 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 129' ' ' ASN . . . . . 0.564 ' HB3' ' HB2' ' D' ' 58' ' ' LEU . 23.3 t-20 -148.39 120.68 8.39 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.874 0.368 . . . . 0.0 111.125 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 130' ' ' THR . . . . . 0.627 ' HG1' ' CG ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -104.15 147.33 27.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.164 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 131' ' ' ILE . . . . . 0.608 HD13 HD11 ' D' ' 58' ' ' LEU . 89.4 mt -116.59 119.15 36.25 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 132' ' ' PRO . . . . . 0.605 ' HB3' ' H ' ' A' ' 77' ' ' ALA . 7.5 Cg_endo -80.95 119.11 3.5 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.645 1.563 . . . . 0.0 112.546 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.01 147.36 29.53 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.795 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.17 155.87 47.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.021 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . 0.516 ' HB3' ' CG2' ' D' ' 52' ' ' VAL . . . -140.09 115.64 10.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.904 0.383 . . . . 0.0 111.575 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.27 149.01 31.66 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.543 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.52 151.27 45.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.132 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 138' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' D' ' 47' ' ' ALA . 0.2 OUTLIER -144.49 164.61 30.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.225 0.536 . . . . 0.0 111.993 -179.154 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 139' ' ' ALA . . . . . 0.608 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -124.5 145.71 49.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.901 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 140' ' ' THR . . . . . 0.477 HG22 HG23 ' D' ' 78' ' ' ILE . 0.2 OUTLIER -117.74 12.97 14.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.536 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.76 79.74 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.957 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.73 92.17 0.02 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.619 0.209 . . . . 0.0 110.716 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 143' ' ' ALA . . . . . 0.803 ' HB3' ' HB ' ' D' ' 99' ' ' VAL . . . -64.13 154.86 33.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 111.357 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 144' ' ' THR . . . . . 0.532 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 39.2 p -116.76 166.16 13.49 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.237 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 145' ' ' PRO . . . . . 0.424 ' HA ' ' HB ' ' C' ' 16' ' ' VAL . 1.3 Cg_endo -84.24 151.49 12.21 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.45 2.1 . . . . 0.0 111.98 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.65 -106.34 0.46 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.453 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.05 163.26 32.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.823 0.344 . . . . 0.0 111.354 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.96 79.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.59 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 149' ' ' ASN . . . . . 0.507 ' HB2' ' HB3' ' D' ' 89' ' ' GLN . 87.1 m-20 -99.97 142.45 31.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.569 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 150' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' D' ' 86' ' ' LEU . . . -127.72 168.99 14.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.969 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 151' ' ' ASP . . . . . 0.411 ' OD2' ' HD2' ' C' ' 11' ' ' HIS . 4.2 t70 -165.55 109.99 0.86 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.214 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 152' ' ' ALA . . . . . 0.652 ' HB1' HD11 ' D' ' 86' ' ' LEU . . . -147.01 145.44 29.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.086 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 153' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' C' ' 9' ' ' THR . 1.0 OUTLIER -93.72 164.23 13.22 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.252 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 154' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' C' ' 7' ' ' GLY . 15.1 p90 -110.92 151.61 27.7 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.147 0.499 . . . . 0.0 110.108 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 155' ' ' LYS . . . . . 0.55 ' HB3' ' HB1' ' D' ' 72' ' ' ALA . 0.0 OUTLIER -109.64 160.84 15.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.951 -178.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 156' ' ' VAL . . . . . 0.487 HG11 ' HE2' ' D' ' 154' ' ' PHE . 1.4 m -142.15 112.93 3.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.803 0.335 . . . . 0.0 111.687 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 157' ' ' GLN . . . . . 0.618 ' HB3' ' HB2' ' D' ' 70' ' ' ALA . 0.3 OUTLIER -91.78 124.4 35.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.264 0.555 . . . . 0.0 110.398 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 158' ' ' TYR . . . . . 0.571 ' HH ' HD21 ' D' ' 58' ' ' LEU . 57.6 m-85 -117.21 135.49 53.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.505 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.85 179.915 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.46 100.23 0.04 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.065 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 3' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' F' ' 158' ' ' TYR . 7.4 m -104.8 78.65 1.45 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.422 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.33 122.39 29.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.526 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 m -137.92 162.9 30.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.54 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 6' ' ' ASN . . . . . 0.423 ' HB3' ' OE2' ' F' ' 15' ' ' GLU . 44.0 t-20 -84.3 114.52 21.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.599 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 7' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' F' ' 154' ' ' PHE . . . -83.38 -41.52 8.4 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.684 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . 0.444 ' N ' ' CE1' ' F' ' 154' ' ' PHE . . . -175.56 162.29 31.57 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.889 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 9' ' ' THR . . . . . . . . . . . . . 98.9 m -90.78 137.86 32.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.992 0.425 . . . . 0.0 111.269 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 10' ' ' VAL . . . . . 0.4 HG11 ' CZ ' ' E' ' 12' ' ' PHE . 2.7 t -110.44 114.27 46.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.184 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 11' ' ' HIS . . . . . 0.456 ' HB2' HG21 ' F' ' 31' ' ' THR . 4.6 m80 -99.34 148.44 24.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.343 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 12' ' ' PHE . . . . . 0.811 ' HB3' HD22 ' F' ' 34' ' ' LEU . 60.9 m-85 -133.75 113.12 11.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.794 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 13' ' ' LYS . . . . . 0.735 ' HG2' ' HA ' ' F' ' 33' ' ' GLN . 0.0 OUTLIER -107.23 105.89 16.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.351 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.23 169.44 28.9 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.023 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 15' ' ' GLU . . . . . 0.539 ' HB2' ' HG3' ' F' ' 36' ' ' GLN . 33.7 mt-10 -140.76 -171.13 3.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.853 0.359 . . . . 0.0 110.39 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 16' ' ' VAL . . . . . 0.524 ' HB ' ' O ' ' F' ' 144' ' ' THR . 0.5 OUTLIER -139.15 152.82 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.205 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' F' ' 38' ' ' ARG . 0.0 OUTLIER -137.47 155.41 31.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.835 0.35 . . . . 0.0 111.038 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -85.23 53.02 2.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.005 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 19' ' ' ALA . . . . . 0.649 ' HA ' ' HG2' ' F' ' 38' ' ' ARG . . . 61.45 92.76 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.591 ' H ' ' HG2' ' F' ' 38' ' ' ARG . . . -164.84 -47.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.43 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 21' ' ' CYS . . . . . 0.915 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 1.6 m -159.76 176.89 11.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.951 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 22' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' F' ' 36' ' ' GLN . . . -147.29 111.9 5.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.13 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 23' ' ' VAL . . . . . 0.47 HG11 ' O ' ' D' ' 7' ' ' GLY . 43.1 t -67.31 143.14 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.998 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 24' ' ' ASP . . . . . 0.548 ' O ' HG23 ' E' ' 28' ' ' VAL . 17.1 m-20 -91.13 168.13 11.85 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.611 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.1 74.01 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.382 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.41 -16.64 73.74 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.929 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.3 -24.35 29.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.944 0.402 . . . . 0.0 110.837 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 28' ' ' VAL . . . . . 0.548 HG23 ' O ' ' E' ' 24' ' ' ASP . 85.0 t -58.08 -37.25 60.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.345 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -140.34 105.97 5.12 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.007 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 30' ' ' GLN . . . . . 0.535 ' NE2' HD12 ' E' ' 56' ' ' ILE . 5.4 mt-30 -109.0 106.95 17.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.12 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 31' ' ' THR . . . . . 0.455 HG21 ' HB2' ' D' ' 11' ' ' HIS . 0.2 OUTLIER -84.77 95.53 8.99 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.071 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 51.4 t -85.74 138.27 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.074 0.464 . . . . 0.0 110.382 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 33' ' ' GLN . . . . . 0.714 ' HA ' ' HG2' ' D' ' 13' ' ' LYS . 3.2 mt-30 -113.23 132.53 55.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.641 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.818 HD22 ' HB3' ' D' ' 12' ' ' PHE . 1.8 mm? -94.47 -71.46 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.628 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.85 -111.3 0.71 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.578 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 36' ' ' GLN . . . . . 0.528 ' HG3' ' HB2' ' D' ' 15' ' ' GLU . 3.6 tt0 -161.03 105.81 1.36 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.625 0.25 . . . . 0.0 110.897 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . 0.452 ' O ' HG13 ' D' ' 16' ' ' VAL . 5.7 m -91.13 142.4 13.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.011 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . 0.671 ' HG2' ' HA ' ' D' ' 19' ' ' ALA . 0.7 OUTLIER -81.11 162.6 23.63 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.691 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 39' ' ' THR . . . . . . . . . . . . . 82.6 p -80.47 -16.8 53.45 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.783 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.71 -31.22 63.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.197 0.522 . . . . 0.0 110.944 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.06 -28.47 39.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.113 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.628 ' HB3' ' HB2' ' E' ' 139' ' ' ALA . 1.7 mp -133.13 70.02 1.47 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.658 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.61 11.19 36.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.451 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.01 146.84 27.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.394 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.47 121.24 13.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 111.146 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.55 -10.37 12.73 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.195 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 47' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' E' ' 138' ' ' PHE . . . -68.86 142.22 54.88 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -134.76 140.81 46.2 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.826 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 16.9 m -106.01 -152.74 0.48 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.615 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.92 178.62 1.05 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.909 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 51' ' ' ALA . . . . . 0.588 ' HB3' HD11 ' B' ' 88' ' ' LEU . . . -129.1 168.81 15.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.784 0.326 . . . . 0.0 111.26 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 52' ' ' VAL . . . . . 0.567 HG11 ' O ' ' B' ' 90' ' ' SER . 14.7 m -117.97 132.2 68.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.955 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 53' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' B' ' 88' ' ' LEU . . . -95.18 107.61 3.57 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.627 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -140.28 132.06 27.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 55' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' E' ' 131' ' ' ILE . 1.5 p-10 -117.81 176.75 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.621 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 56' ' ' ILE . . . . . 0.535 HD12 ' NE2' ' E' ' 30' ' ' GLN . 51.6 mm -119.03 121.7 67.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.543 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 57' ' ' GLN . . . . . 0.578 ' HG2' HD12 ' B' ' 74' ' ' LEU . 0.0 OUTLIER -86.28 122.63 30.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.792 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . 0.608 HD11 HD13 ' E' ' 131' ' ' ILE . 0.9 OUTLIER -131.13 93.74 3.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.08 160.88 28.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.862 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.17 87.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.817 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 61' ' ' CYS . . . . . 0.915 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 70.1 m -120.53 131.84 54.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.783 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.58 97.82 9.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.366 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 63' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' E' ' 66' ' ' ALA . 1.5 m -77.39 -19.95 55.4 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.1 -27.5 68.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.02 0.438 . . . . 0.0 111.715 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.44 -35.75 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.624 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 66' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' E' ' 63' ' ' THR . . . -131.05 131.32 44.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.648 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.49 -37.26 7.66 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.947 0.403 . . . . 0.0 110.94 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -121.74 171.39 8.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.558 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.55 136.1 15.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.532 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . 0.628 ' HB2' ' HB3' ' E' ' 157' ' ' GLN . . . -94.54 158.01 15.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.065 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 38.4 t -110.35 106.23 20.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.71 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' E' ' 155' ' ' LYS . . . -109.58 164.36 12.6 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.594 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 73' ' ' PHE . . . . . 0.441 ' CE2' HG12 ' E' ' 103' ' ' ILE . 6.6 t80 -142.27 141.1 32.42 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.532 0.206 . . . . 0.0 111.131 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 74' ' ' LEU . . . . . 0.423 HD22 ' NZ ' ' E' ' 155' ' ' LYS . 0.1 OUTLIER -122.69 103.4 8.64 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.011 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . 0.568 ' HA3' HD22 ' E' ' 113' ' ' LEU . . . -153.5 -166.43 14.64 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.876 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.45 136.24 46.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.58 0.228 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.35 156.15 25.62 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.935 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 78' ' ' ILE . . . . . 0.584 HG21 ' HB ' ' E' ' 85' ' ' VAL . 3.1 tt -92.55 -20.67 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.881 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.15 179.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.808 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.88 -33.87 45.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.009 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.48 -43.87 95.68 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.555 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 82' ' ' HIS . . . . . 0.462 ' NE2' ' O ' ' E' ' 139' ' ' ALA . 43.5 m-70 -97.8 -64.37 1.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.849 0.356 . . . . 0.0 110.492 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 1.2 m 62.31 7.85 2.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.609 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 84' ' ' ASN . . . . . 0.586 ' HB3' ' HB2' ' E' ' 110' ' ' ALA . 6.5 m120 -115.13 -25.46 8.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.255 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' E' ' 102' ' ' GLN . 0.5 OUTLIER -79.58 143.71 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.177 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 86' ' ' LEU . . . . . 0.649 HD11 ' HB1' ' E' ' 152' ' ' ALA . 0.3 OUTLIER -76.68 148.54 36.78 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.294 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.83 178.23 4.36 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.909 0.385 . . . . 0.0 111.694 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.47 HD21 ' O ' ' E' ' 96' ' ' ALA . 0.0 OUTLIER -84.68 176.17 8.74 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.135 179.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 89' ' ' GLN . . . . . 0.513 ' HB3' ' HB2' ' E' ' 149' ' ' ASN . 22.9 pt20 -75.3 178.73 5.61 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.315 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.4 -11.42 60.47 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.999 0.428 . . . . 0.0 111.443 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 91' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' E' ' 95' ' ' SER . 0.3 OUTLIER -64.67 87.26 0.05 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.9 -7.13 53.8 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.909 0.385 . . . . 0.0 111.666 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.14 19.87 4.06 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.678 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.6 -15.6 0.16 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.924 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 95' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' E' ' 91' ' ' SER . 0.9 OUTLIER -97.28 174.95 6.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.886 0.374 . . . . 0.0 110.664 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 96' ' ' ALA . . . . . 0.47 ' O ' HD21 ' E' ' 88' ' ' LEU . . . -114.1 157.83 22.06 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.786 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.92 162.68 15.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.359 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 98' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 69.4 41.53 1.3 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.368 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 99' ' ' VAL . . . . . 0.778 ' HB ' ' HB3' ' E' ' 143' ' ' ALA . 10.5 p -177.6 130.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.872 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.15 179.47 28.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.521 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 101' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' E' ' 86' ' ' LEU . 1.6 t -99.08 95.27 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.085 0.554 . . . . 0.0 111.65 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 102' ' ' GLN . . . . . 0.774 ' HA ' ' HA ' ' E' ' 85' ' ' VAL . 1.9 tt0 -69.84 159.83 32.91 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.959 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 103' ' ' ILE . . . . . 0.624 HD13 HD23 ' E' ' 113' ' ' LEU . 0.9 OUTLIER -121.7 98.49 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.516 179.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 104' ' ' LEU . . . . . 0.681 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 1.1 tp -84.79 119.39 25.24 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.701 0.286 . . . . 0.0 111.046 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.17 158.1 32.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.693 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 106' ' ' ARG . . . . . 0.532 ' HB2' ' HB2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -61.21 -33.83 74.11 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.958 0.409 . . . . 0.0 111.102 179.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 107' ' ' THR . . . . . 0.544 HG21 ' HA ' ' E' ' 120' ' ' SER . 0.0 OUTLIER -48.8 -38.23 21.45 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.037 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.76 -88.84 0.11 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.598 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 109' ' ' ALA . . . . . 0.415 ' HA ' HD12 ' E' ' 104' ' ' LEU . . . -79.19 -176.39 5.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.863 0.363 . . . . 0.0 111.116 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 110' ' ' ALA . . . . . 0.681 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -79.86 143.88 33.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.221 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.14 157.55 17.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.361 0.601 . . . . 0.0 110.545 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 112' ' ' THR . . . . . . . . . . . . . 29.7 m -81.1 150.48 28.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.134 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 113' ' ' LEU . . . . . 0.624 HD23 HD13 ' E' ' 103' ' ' ILE . 3.0 mp -102.74 57.72 0.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.695 0.283 . . . . 0.0 110.719 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.4 19.58 15.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.566 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.19 -93.04 0.88 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.677 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.77 69.72 1.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.077 0.465 . . . . 0.0 111.566 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 117' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' E' ' 72' ' ' ALA . 6.0 p -89.67 97.25 11.08 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.169 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.06 102.84 5.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.809 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.48 -82.83 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 120' ' ' SER . . . . . 0.544 ' HA ' HG21 ' E' ' 107' ' ' THR . 0.1 OUTLIER -63.09 100.86 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.62 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -88.9 79.04 7.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.196 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 122' ' ' THR . . . . . 0.588 HG21 ' HG2' ' E' ' 132' ' ' PRO . 4.6 p -82.54 159.2 22.86 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.667 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 123' ' ' THR . . . . . 0.456 HG23 ' N ' ' E' ' 124' ' ' LEU . 16.1 m -85.27 139.72 31.4 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.731 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . 0.456 ' N ' HG23 ' E' ' 123' ' ' THR . 0.4 OUTLIER -92.45 136.14 33.46 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.746 0.308 . . . . 0.0 110.594 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 125' ' ' ASN . . . . . 0.449 ' HB3' ' HB2' ' B' ' 116' ' ' ALA . 25.0 m120 -120.77 143.59 48.73 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.613 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.16 148.91 34.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.639 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.71 -106.12 2.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.736 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 128' ' ' THR . . . . . 0.405 ' HB ' ' HD3' ' B' ' 155' ' ' LYS . 1.9 m -85.22 153.2 22.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.715 0.293 . . . . 0.0 110.812 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 129' ' ' ASN . . . . . 0.58 ' HB3' ' HB2' ' E' ' 58' ' ' LEU . 23.2 t-20 -148.42 120.73 8.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.955 0.407 . . . . 0.0 111.09 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 130' ' ' THR . . . . . 0.627 ' HG1' ' CG ' ' B' ' 74' ' ' LEU . 0.2 OUTLIER -104.17 147.3 27.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.147 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 131' ' ' ILE . . . . . 0.608 HD13 HD11 ' E' ' 58' ' ' LEU . 89.8 mt -116.65 119.17 36.11 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 132' ' ' PRO . . . . . 0.602 ' HB3' ' H ' ' B' ' 77' ' ' ALA . 7.6 Cg_endo -80.92 119.09 3.51 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.594 1.53 . . . . 0.0 112.553 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.99 147.33 29.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.739 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.15 155.96 47.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.066 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 135' ' ' ALA . . . . . 0.535 ' HB3' HG22 ' E' ' 52' ' ' VAL . . . -140.09 115.71 10.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.912 0.387 . . . . 0.0 111.632 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.34 148.99 31.78 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.479 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.53 151.31 45.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.113 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 138' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' E' ' 47' ' ' ALA . 0.2 OUTLIER -144.53 164.58 30.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.009 -179.13 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 139' ' ' ALA . . . . . 0.628 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -124.39 145.65 49.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.913 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 140' ' ' THR . . . . . 0.477 HG22 HG23 ' E' ' 78' ' ' ILE . 0.2 OUTLIER -117.78 12.95 14.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.513 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.85 79.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.914 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.74 92.14 0.02 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.608 0.204 . . . . 0.0 110.756 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 143' ' ' ALA . . . . . 0.778 ' HB3' ' HB ' ' E' ' 99' ' ' VAL . . . -64.1 154.77 33.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.675 0.274 . . . . 0.0 111.4 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 144' ' ' THR . . . . . 0.532 ' O ' ' HB ' ' D' ' 16' ' ' VAL . 39.1 p -116.68 166.2 13.33 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.244 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 145' ' ' PRO . . . . . 0.414 ' HA ' ' HB ' ' D' ' 16' ' ' VAL . 1.3 Cg_endo -84.33 151.42 12.06 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.495 2.13 . . . . 0.0 111.988 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.73 -106.32 0.46 Allowed Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.414 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.05 163.27 32.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.794 0.331 . . . . 0.0 111.408 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.91 79.88 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.508 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 149' ' ' ASN . . . . . 0.513 ' HB2' ' HB3' ' E' ' 89' ' ' GLN . 87.2 m-20 -99.9 142.48 31.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.557 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 150' ' ' ALA . . . . . 0.58 ' HB3' ' HB3' ' E' ' 86' ' ' LEU . . . -127.78 169.0 14.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.008 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 151' ' ' ASP . . . . . 0.409 ' OD2' ' HD2' ' D' ' 11' ' ' HIS . 4.2 t70 -165.55 110.04 0.86 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.201 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 152' ' ' ALA . . . . . 0.649 ' HB1' HD11 ' E' ' 86' ' ' LEU . . . -147.06 145.39 29.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.13 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 153' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' D' ' 9' ' ' THR . 1.0 OUTLIER -93.62 164.23 13.24 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 154' ' ' PHE . . . . . 0.496 ' HE2' HG11 ' E' ' 156' ' ' VAL . 15.1 p90 -110.98 151.59 27.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.193 0.521 . . . . 0.0 110.124 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 155' ' ' LYS . . . . . 0.538 ' HB3' ' HB1' ' E' ' 72' ' ' ALA . 0.0 OUTLIER -109.65 160.89 15.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.959 -178.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 156' ' ' VAL . . . . . 0.496 HG11 ' HE2' ' E' ' 154' ' ' PHE . 1.4 m -142.18 112.83 2.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.791 0.329 . . . . 0.0 111.678 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 157' ' ' GLN . . . . . 0.628 ' HB3' ' HB2' ' E' ' 70' ' ' ALA . 0.3 OUTLIER -91.83 124.39 35.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.338 0.59 . . . . 0.0 110.426 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 158' ' ' TYR . . . . . 0.568 ' HH ' HD21 ' E' ' 58' ' ' LEU . 57.6 m-85 -117.17 135.52 53.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.456 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.859 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.55 100.22 0.04 OUTLIER 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.05 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -104.84 78.6 1.44 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.406 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.27 122.41 29.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.659 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 m -137.95 162.89 30.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.567 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -84.28 114.5 21.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.717 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.34 -41.52 8.42 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.678 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.57 162.24 31.49 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.936 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 98.8 m -90.71 137.79 32.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.92 0.39 . . . . 0.0 111.277 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.39 114.28 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.219 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -99.33 148.55 24.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.295 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -133.79 113.03 11.84 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.75 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 13' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' F' ' 13' ' ' LYS . 0.0 OUTLIER -107.14 105.81 15.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.404 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.17 169.5 28.85 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.002 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 15' ' ' GLU . . . . . 0.423 ' OE2' ' HB3' ' E' ' 6' ' ' ASN . 33.5 mt-10 -140.78 -171.07 3.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.358 . . . . 0.0 110.429 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -139.21 152.82 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.197 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 17' ' ' VAL . . . . . 0.465 HG21 ' O ' ' F' ' 21' ' ' CYS . 0.0 OUTLIER -137.45 155.41 31.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.785 0.326 . . . . 0.0 111.037 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -85.16 52.98 2.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.08 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.43 92.69 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.11 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.75 -47.7 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.413 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 21' ' ' CYS . . . . . 0.906 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 1.6 m -159.74 176.86 11.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.983 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.3 112.0 5.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.155 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 23' ' ' VAL . . . . . 0.469 HG11 ' O ' ' E' ' 7' ' ' GLY . 42.8 t -67.39 143.17 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.946 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 24' ' ' ASP . . . . . 0.543 ' O ' HG23 ' F' ' 28' ' ' VAL . 17.0 m-20 -91.19 168.23 11.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.557 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.43 -50.0 74.44 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.455 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.35 -16.66 73.65 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.941 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 27' ' ' SER . . . . . 0.409 ' HA ' HE21 ' F' ' 30' ' ' GLN . 0.4 OUTLIER -84.32 -24.39 29.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.881 0.372 . . . . 0.0 110.767 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 28' ' ' VAL . . . . . 0.543 HG23 ' O ' ' F' ' 24' ' ' ASP . 85.4 t -58.12 -37.17 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.349 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -140.38 106.01 5.12 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.024 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 30' ' ' GLN . . . . . 0.528 ' NE2' HD12 ' F' ' 56' ' ' ILE . 5.4 mt-30 -109.06 106.95 17.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.089 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 31' ' ' THR . . . . . 0.456 HG21 ' HB2' ' E' ' 11' ' ' HIS . 0.2 OUTLIER -84.81 95.57 9.02 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.059 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 51.0 t -85.73 138.18 19.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.099 0.476 . . . . 0.0 110.378 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 33' ' ' GLN . . . . . 0.735 ' HA ' ' HG2' ' E' ' 13' ' ' LYS . 3.1 mt-30 -113.17 132.6 55.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.674 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 34' ' ' LEU . . . . . 0.811 HD22 ' HB3' ' E' ' 12' ' ' PHE . 1.8 mm? -94.51 -71.49 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.594 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.9 -111.31 0.71 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.512 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 36' ' ' GLN . . . . . 0.539 ' HG3' ' HB2' ' E' ' 15' ' ' GLU . 3.6 tt0 -160.96 105.75 1.37 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.573 0.225 . . . . 0.0 110.888 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.455 ' O ' HG13 ' E' ' 16' ' ' VAL . 5.6 m -91.1 142.45 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.904 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 38' ' ' ARG . . . . . 0.649 ' HG2' ' HA ' ' E' ' 19' ' ' ALA . 0.7 OUTLIER -81.09 162.52 23.69 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.723 179.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 39' ' ' THR . . . . . . . . . . . . . 82.5 p -80.4 -16.88 53.42 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.775 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.74 -31.27 63.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.115 0.483 . . . . 0.0 110.876 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.02 -28.51 39.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.121 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . 0.617 ' HB3' ' HB2' ' F' ' 139' ' ' ALA . 1.7 mp -133.11 70.05 1.47 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.686 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.65 11.2 36.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.445 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.07 146.84 27.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.394 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.43 121.24 13.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 111.158 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.57 -10.48 12.66 Favored Glycine 0 C--N 1.331 0.274 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.146 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 47' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' F' ' 138' ' ' PHE . . . -68.74 142.26 55.01 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 48' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' F' ' 137' ' ' TYR . 6.9 t -134.85 140.85 46.15 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.826 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -106.05 -152.75 0.48 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.519 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.91 178.52 1.07 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.881 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 51' ' ' ALA . . . . . 0.586 ' HB3' HD11 ' C' ' 88' ' ' LEU . . . -129.02 168.86 15.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.281 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 52' ' ' VAL . . . . . 0.561 HG11 ' O ' ' C' ' 90' ' ' SER . 14.6 m -117.94 132.21 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.028 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 53' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' C' ' 88' ' ' LEU . . . -95.22 107.68 3.58 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.654 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 54' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -140.35 132.12 27.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 55' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' F' ' 131' ' ' ILE . 1.6 p-10 -117.85 176.84 5.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.61 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 56' ' ' ILE . . . . . 0.528 HD12 ' NE2' ' F' ' 30' ' ' GLN . 51.8 mm -119.0 121.7 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.549 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 57' ' ' GLN . . . . . 0.561 ' HG2' HD12 ' C' ' 74' ' ' LEU . 0.0 OUTLIER -86.26 122.61 30.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.855 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . 0.604 HD11 HD13 ' F' ' 131' ' ' ILE . 0.9 OUTLIER -131.15 93.73 3.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.265 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.17 160.92 28.6 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.21 87.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.798 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 61' ' ' CYS . . . . . 0.906 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 69.8 m -120.41 131.88 54.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.65 97.91 9.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.321 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 63' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' F' ' 66' ' ' ALA . 1.5 m -77.52 -19.89 55.08 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -27.45 68.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.985 0.422 . . . . 0.0 111.689 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.41 -35.76 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.597 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 66' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' F' ' 63' ' ' THR . . . -131.01 131.31 44.26 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.624 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.52 -37.3 7.63 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.964 0.412 . . . . 0.0 110.933 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -121.72 171.38 8.91 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.606 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.52 136.06 15.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.575 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 70' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' F' ' 157' ' ' GLN . . . -94.47 157.92 15.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.101 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.36 106.25 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.682 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 72' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' F' ' 155' ' ' LYS . . . -109.53 164.35 12.6 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.64 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 73' ' ' PHE . . . . . 0.437 ' CE2' HG12 ' F' ' 103' ' ' ILE . 6.5 t80 -142.25 141.05 32.44 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.52 0.2 . . . . 0.0 111.151 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 74' ' ' LEU . . . . . 0.431 HD22 ' NZ ' ' F' ' 155' ' ' LYS . 0.1 OUTLIER -122.68 103.32 8.59 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.038 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . 0.562 ' HA3' HD22 ' F' ' 113' ' ' LEU . . . -153.42 -166.34 14.51 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.87 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.52 136.22 46.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.604 0.24 . . . . 0.0 110.714 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.4 156.09 25.58 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.925 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 78' ' ' ILE . . . . . 0.592 HG21 ' HB ' ' F' ' 85' ' ' VAL . 3.1 tt -92.51 -20.65 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.859 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.18 179.75 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.757 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.04 -33.76 44.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.48 -43.88 95.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.583 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 82' ' ' HIS . . . . . 0.466 ' NE2' ' O ' ' F' ' 139' ' ' ALA . 43.5 m-70 -97.83 -64.38 1.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.812 0.339 . . . . 0.0 110.436 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 1.2 m 62.35 7.83 2.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.582 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 84' ' ' ASN . . . . . 0.618 ' HB3' ' HB2' ' F' ' 110' ' ' ALA . 6.5 m120 -115.09 -25.48 8.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.32 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 85' ' ' VAL . . . . . 0.78 ' HA ' ' HA ' ' F' ' 102' ' ' GLN . 0.5 OUTLIER -79.53 143.75 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.199 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 86' ' ' LEU . . . . . 0.648 HD11 ' HB1' ' F' ' 152' ' ' ALA . 0.3 OUTLIER -76.62 148.57 36.87 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.392 179.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.87 178.22 4.39 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.799 0.333 . . . . 0.0 111.695 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . 0.478 ' H ' ' HG ' ' F' ' 88' ' ' LEU . 0.0 OUTLIER -84.72 176.2 8.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.069 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 89' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' F' ' 149' ' ' ASN . 22.8 pt20 -75.29 178.71 5.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.36 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.34 -11.48 60.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.052 0.454 . . . . 0.0 111.447 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 91' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' F' ' 95' ' ' SER . 0.3 OUTLIER -64.69 87.28 0.05 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.884 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.95 -7.12 53.84 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.961 0.41 . . . . 0.0 111.666 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.08 19.86 4.08 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.699 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.58 -15.62 0.16 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.895 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 95' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' F' ' 91' ' ' SER . 1.0 OUTLIER -97.34 174.97 6.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.934 0.397 . . . . 0.0 110.572 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 96' ' ' ALA . . . . . 0.47 ' O ' HD21 ' F' ' 88' ' ' LEU . . . -114.14 157.83 22.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.85 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.95 162.64 15.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.318 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 98' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 69.39 41.61 1.29 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.406 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 99' ' ' VAL . . . . . 0.79 ' HB ' ' HB3' ' F' ' 143' ' ' ALA . 10.4 p -177.65 130.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.8 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.1 179.46 28.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.523 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 101' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' F' ' 86' ' ' LEU . 1.6 t -99.07 95.28 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.068 0.547 . . . . 0.0 111.716 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 102' ' ' GLN . . . . . 0.78 ' HA ' ' HA ' ' F' ' 85' ' ' VAL . 1.9 tt0 -69.88 159.82 32.96 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.898 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 103' ' ' ILE . . . . . 0.606 HD13 HD23 ' F' ' 113' ' ' LEU . 0.9 OUTLIER -121.65 98.39 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.538 179.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 104' ' ' LEU . . . . . 0.69 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 1.1 tp -84.76 119.39 25.23 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 111.082 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.15 158.08 32.1 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.701 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 106' ' ' ARG . . . . . 0.535 ' HB2' ' HB2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -61.16 -33.86 74.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.881 0.372 . . . . 0.0 111.093 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 107' ' ' THR . . . . . 0.561 HG21 ' HA ' ' F' ' 120' ' ' SER . 0.0 OUTLIER -48.77 -38.18 21.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.094 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.7 -88.77 0.11 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.597 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 109' ' ' ALA . . . . . 0.417 ' HA ' HD12 ' F' ' 104' ' ' LEU . . . -79.23 -176.32 5.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.351 . . . . 0.0 111.111 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 110' ' ' ALA . . . . . 0.69 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -79.96 143.92 33.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.1 157.53 17.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.359 0.6 . . . . 0.0 110.566 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 112' ' ' THR . . . . . . . . . . . . . 29.5 m -81.13 150.4 28.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.127 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 113' ' ' LEU . . . . . 0.606 HD23 HD13 ' F' ' 103' ' ' ILE . 3.0 mp -102.75 57.77 0.78 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.737 0.303 . . . . 0.0 110.696 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.47 19.63 15.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.56 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.26 -93.11 0.88 Allowed Glycine 0 C--N 1.328 0.13 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.628 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.7 69.57 1.08 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.083 0.468 . . . . 0.0 111.589 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 117' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' F' ' 72' ' ' ALA . 5.8 p -89.65 97.28 11.11 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.145 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.08 102.77 5.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.736 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.5 -82.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 120' ' ' SER . . . . . 0.561 ' HA ' HG21 ' F' ' 107' ' ' THR . 0.1 OUTLIER -63.25 100.89 0.26 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.609 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.91 79.07 7.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.186 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 122' ' ' THR . . . . . 0.575 HG21 ' HG2' ' F' ' 132' ' ' PRO . 4.6 p -82.56 159.18 22.84 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.701 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 123' ' ' THR . . . . . 0.457 HG23 ' N ' ' F' ' 124' ' ' LEU . 16.1 m -85.29 139.73 31.37 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.708 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . 0.457 ' N ' HG23 ' F' ' 123' ' ' THR . 0.4 OUTLIER -92.42 136.13 33.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.617 179.362 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 125' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' C' ' 116' ' ' ALA . 25.0 m120 -120.78 143.65 48.71 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.577 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.27 148.95 34.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.626 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.68 -106.22 2.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.745 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 128' ' ' THR . . . . . 0.403 ' HB ' ' HD3' ' C' ' 155' ' ' LYS . 1.9 m -85.18 153.22 22.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.7 0.286 . . . . 0.0 110.757 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 129' ' ' ASN . . . . . 0.576 ' HB3' ' HB2' ' F' ' 58' ' ' LEU . 23.2 t-20 -148.43 120.71 8.39 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.909 0.385 . . . . 0.0 111.035 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 130' ' ' THR . . . . . 0.615 ' HG1' ' CD1' ' C' ' 74' ' ' LEU . 0.2 OUTLIER -104.19 147.33 27.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.14 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 131' ' ' ILE . . . . . 0.604 HD13 HD11 ' F' ' 58' ' ' LEU . 89.7 mt -116.64 119.18 36.12 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 132' ' ' PRO . . . . . 0.611 ' HB3' ' H ' ' C' ' 77' ' ' ALA . 7.6 Cg_endo -80.96 119.09 3.5 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 121.653 1.569 . . . . 0.0 112.531 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.98 147.29 29.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.756 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.09 155.92 47.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.041 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 135' ' ' ALA . . . . . 0.535 ' HB3' HG22 ' F' ' 52' ' ' VAL . . . -140.07 115.69 10.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.884 0.373 . . . . 0.0 111.598 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.32 149.02 31.72 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.479 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 137' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' F' ' 48' ' ' THR . 0.2 OUTLIER -70.64 151.3 45.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.073 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 138' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' F' ' 47' ' ' ALA . 0.2 OUTLIER -144.5 164.6 30.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.97 -179.121 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 139' ' ' ALA . . . . . 0.617 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -124.46 145.68 49.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.869 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 140' ' ' THR . . . . . 0.48 ' OG1' HG12 ' F' ' 78' ' ' ILE . 0.2 OUTLIER -117.75 12.99 14.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.512 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.81 79.83 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.874 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.59 92.19 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.62 0.21 . . . . 0.0 110.762 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 143' ' ' ALA . . . . . 0.79 ' HB3' ' HB ' ' F' ' 99' ' ' VAL . . . -64.1 154.81 33.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.756 0.312 . . . . 0.0 111.377 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 144' ' ' THR . . . . . 0.524 ' O ' ' HB ' ' E' ' 16' ' ' VAL . 39.4 p -116.71 166.21 13.33 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.208 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 145' ' ' PRO . . . . . 0.423 ' HA ' ' HB ' ' E' ' 16' ' ' VAL . 1.3 Cg_endo -84.29 151.47 12.14 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.445 2.097 . . . . 0.0 111.975 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.64 -106.23 0.45 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.443 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.11 163.26 32.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.783 0.325 . . . . 0.0 111.357 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.98 79.9 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.498 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 149' ' ' ASN . . . . . 0.504 ' HB2' ' HB3' ' F' ' 89' ' ' GLN . 87.2 m-20 -99.93 142.51 31.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.593 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 150' ' ' ALA . . . . . 0.583 ' HB3' ' HB3' ' F' ' 86' ' ' LEU . . . -127.83 169.06 14.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.042 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 151' ' ' ASP . . . . . 0.407 ' OD2' ' HD2' ' E' ' 11' ' ' HIS . 4.2 t70 -165.59 109.91 0.85 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.186 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 152' ' ' ALA . . . . . 0.648 ' HB1' HD11 ' F' ' 86' ' ' LEU . . . -146.95 145.4 29.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.123 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.63 164.17 13.26 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 154' ' ' PHE . . . . . 0.494 ' CZ ' ' HA3' ' E' ' 7' ' ' GLY . 15.0 p90 -110.87 151.61 27.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.178 0.513 . . . . 0.0 110.125 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 155' ' ' LYS . . . . . 0.533 ' HB3' ' HB1' ' F' ' 72' ' ' ALA . 0.0 OUTLIER -109.69 160.95 15.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.893 -178.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 156' ' ' VAL . . . . . 0.491 HG11 ' HE2' ' F' ' 154' ' ' PHE . 1.5 m -142.19 112.84 2.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.846 0.355 . . . . 0.0 111.688 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 157' ' ' GLN . . . . . 0.625 ' HB3' ' HB2' ' F' ' 70' ' ' ALA . 0.3 OUTLIER -91.82 124.46 35.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.276 0.56 . . . . 0.0 110.429 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 158' ' ' TYR . . . . . 0.567 ' HH ' HD21 ' F' ' 58' ' ' LEU . 57.5 m-85 -117.19 135.51 53.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.462 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.888 179.9 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.633 ' H ' ' HA ' ' B' ' 159' ' ' GLN . . . . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.649 0.261 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.532 HG23 HD21 ' B' ' 18' ' ' ASN . 90.2 m -118.7 111.08 18.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.379 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.719 HG22 ' HG3' ' B' ' 157' ' ' GLN . 0.2 OUTLIER -97.77 127.36 43.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.554 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.535 HG22 HG12 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -153.57 171.5 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.578 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.42 122.1 36.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.608 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.413 ' HA3' HG11 ' B' ' 156' ' ' VAL . . . -76.0 -52.18 6.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.855 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.42 -145.43 5.81 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.886 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.81 139.81 25.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 111.28 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.4 121.6 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.136 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.59 106.61 18.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.324 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.437 ' HZ ' ' CZ ' ' B' ' 54' ' ' PHE . 8.9 m-85 -90.65 107.61 19.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.577 ' HG2' HD21 ' B' ' 149' ' ' ASN . 0.1 OUTLIER -103.26 149.25 24.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.383 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.45 -179.07 47.54 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.902 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.64 ' HB3' ' HG3' ' B' ' 36' ' ' GLN . 0.1 OUTLIER -158.97 157.02 30.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.845 0.355 . . . . 0.0 110.394 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.8 t -113.71 132.23 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.245 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.764 HG13 ' HG2' ' B' ' 36' ' ' GLN . 5.5 m -136.88 176.58 7.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.887 0.375 . . . . 0.0 111.024 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.46 174.07 9.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.021 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 62' ' ' ASP . . . -83.37 35.35 0.49 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.066 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . . . -116.89 -15.93 10.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.429 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.476 ' HB3' ' HH ' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -179.98 155.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.97 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.76 126.48 5.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.052 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.713 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -60.87 162.49 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.037 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 27' ' ' SER . 18.6 t70 -97.6 161.0 13.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.588 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.31 95.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.353 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.47 12.76 69.0 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.935 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.539 ' HB3' ' HB3' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -113.79 -25.6 8.57 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.92 0.39 . . . . 0.0 110.837 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.6 t -41.04 -62.02 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.373 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.57 119.96 39.59 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.033 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -126.09 119.13 26.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.033 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.71 103.32 15.48 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.115 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.88 115.12 43.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.168 0.509 . . . . 0.0 110.475 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.53 112.61 24.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.671 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.86 -30.36 58.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.622 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.02 -170.25 27.44 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.562 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.46 141.8 28.05 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.653 0.263 . . . . 0.0 110.871 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.8 p -125.34 157.14 34.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.88 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.53 122.46 29.04 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.704 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -40.39 87.01 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.774 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.51 -35.88 68.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.06 0.457 . . . . 0.0 110.773 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.13 -21.51 33.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.162 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' A' ' 139' ' ' ALA . 3.2 mp -110.51 29.49 7.67 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.579 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 141' ' ' GLY . . . -108.19 25.46 11.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.387 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.66 159.96 23.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.414 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.644 ' HA ' ' O ' ' A' ' 140' ' ' THR . 11.1 tt0 -82.87 108.66 16.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 0.0 111.166 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.93 10.84 51.54 Favored Glycine 0 C--N 1.33 0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.18 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.58 123.48 20.17 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.957 0.408 . . . . 0.0 112.014 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -120.64 140.28 51.79 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.828 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 4.6 m -101.65 -167.01 1.36 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.614 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.64 139.7 53.59 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.783 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.86 133.99 35.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.369 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 135' ' ' ALA . 18.8 m -87.0 166.49 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.927 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.7 128.83 7.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.63 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 133' ' ' PHE . 40.7 p90 -160.23 134.48 7.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.731 0.3 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.43 ' OD1' ' CG2' ' A' ' 130' ' ' THR . 16.0 p30 -132.87 147.73 52.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.494 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.609 HG22 HD13 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -96.89 116.82 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.496 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.513 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -66.59 122.08 16.79 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.754 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.713 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -137.42 88.17 2.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.218 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.703 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 10.5 p30 -79.53 179.31 7.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.955 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.39 64.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 129' ' ' ASN . 4.4 m -110.53 163.23 13.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.839 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -140.14 155.02 47.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.287 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.24 -25.33 10.66 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -81.96 -16.38 50.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.156 0.503 . . . . 0.0 111.822 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 t -90.65 -48.41 14.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.662 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . . . -140.11 142.9 36.03 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.637 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.8 -53.79 2.6 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.846 0.355 . . . . 0.0 110.995 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -94.86 158.16 15.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.514 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 122' ' ' THR . . . -137.21 120.46 16.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.588 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 118' ' ' PHE . . . -97.57 129.17 44.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.096 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.542 HG13 HG21 ' A' ' 131' ' ' ILE . 15.9 t -113.05 152.23 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.672 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.421 ' H ' HG12 ' A' ' 71' ' ' VAL . . . -149.98 146.58 27.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.606 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.492 ' HB3' HD23 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -111.54 141.89 44.53 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.577 0.227 . . . . 0.0 111.067 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -105.7 103.31 12.8 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.934 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.418 ' HA3' HD22 ' A' ' 113' ' ' LEU . . . -149.87 -179.11 25.42 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.837 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.692 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.2 OUTLIER -105.16 157.79 17.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.57 0.224 . . . . 0.0 110.771 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.85 132.82 38.17 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.876 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.458 HG21 ' HB ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER -66.61 -39.87 84.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.21 53.55 1.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.788 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' D' ' 106' ' ' ARG . . . 61.42 -87.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.038 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.29 -36.55 53.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.594 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.43 ' HB2' HG22 ' A' ' 78' ' ' ILE . 78.0 m80 -81.34 59.93 4.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.865 0.364 . . . . 0.0 110.445 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -70.59 -20.41 62.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.483 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.877 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 26.5 p-10 -69.45 -13.73 62.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.29 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 102' ' ' GLN . 40.7 t -108.97 131.2 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.109 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.581 HD12 HD21 ' A' ' 113' ' ' LEU . 0.6 OUTLIER -70.05 142.81 52.65 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.305 179.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.91 -170.52 3.05 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.946 0.403 . . . . 0.0 111.709 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 88' ' ' LEU . 1.2 mm? -80.04 161.4 25.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.02 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.73 -80.32 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.31 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.436 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 6.6 p -171.33 0.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.95 0.405 . . . . 0.0 111.446 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.605 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 73.4 m -76.81 85.65 3.4 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.902 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' D' ' 50' ' ' SER . . . -60.98 -32.34 71.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.86 0.362 . . . . 0.0 111.641 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.79 30.52 6.85 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.627 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.78 -3.14 0.11 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.92 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 0.1 OUTLIER -107.57 -176.72 3.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.882 0.372 . . . . 0.0 110.652 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.54 172.68 8.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.796 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.603 ' H ' ' HB ' ' A' ' 144' ' ' THR . 1.7 m -126.95 140.47 52.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.29 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.425 ' HB3' ' H ' ' A' ' 141' ' ' GLY . 68.4 m-80 61.96 21.23 12.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.495 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.29 135.99 58.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.724 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.97 -160.62 10.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.531 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.499 HG11 ' HB2' ' A' ' 86' ' ' LEU . 4.4 p -145.96 109.88 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.173 0.511 . . . . 0.0 111.677 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.65 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.5 OUTLIER -84.37 147.38 27.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.936 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.607 HG12 ' HG ' ' A' ' 113' ' ' LEU . 1.2 pp -110.72 127.84 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.501 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 1.4 tp -97.37 132.95 42.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.686 0.279 . . . . 0.0 111.045 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.603 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . 4.0 t0 -80.82 143.61 32.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.675 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -65.46 -17.5 64.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.838 0.351 . . . . 0.0 111.083 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.509 HG23 ' HB3' ' A' ' 105' ' ' ASP . 13.2 t -66.89 -20.61 65.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.001 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.08 -71.77 0.44 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.68 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.53 160.02 31.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.819 0.343 . . . . 0.0 111.044 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -75.66 131.46 39.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 12.2 tp -88.1 154.18 20.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.351 0.596 . . . . 0.0 110.6 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.877 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -96.37 142.7 28.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.145 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.607 ' HG ' HG12 ' A' ' 103' ' ' ILE . 0.8 OUTLIER -80.79 63.65 5.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.715 0.293 . . . . 0.0 110.747 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.63 -30.63 17.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.547 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.506 ' HA3' ' OG1' ' D' ' 130' ' ' THR . . . 115.75 -43.6 1.64 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.721 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.46 24.39 13.03 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.011 0.434 . . . . 0.0 111.717 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.585 HG23 HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -82.22 68.35 8.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 157' ' ' GLN . 40.8 m-85 -82.19 71.96 9.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.744 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.71 81.11 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.797 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.75 131.75 13.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.604 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.403 ' O ' ' HE2' ' A' ' 68' ' ' LYS . 1.5 mm-40 -100.72 52.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.232 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -72.14 132.02 43.59 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.734 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.81 107.71 15.63 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.638 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.407 HD13 ' CB ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -88.27 126.53 35.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.563 179.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.494 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 1.1 m120 -120.62 -178.95 3.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.544 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.515 ' OD1' ' HA ' ' A' ' 62' ' ' ASP . 3.8 t30 -83.27 120.65 26.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.659 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.16 -121.79 2.53 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.686 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.703 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 75.6 m -122.14 103.41 8.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.7 0.286 . . . . 0.0 110.806 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.51 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 1.7 t30 -86.14 157.21 20.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.907 0.384 . . . . 0.0 111.144 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.513 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.3 OUTLIER -143.26 130.27 20.63 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.072 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.542 HG21 HG13 ' A' ' 71' ' ' VAL . 57.5 mt -84.21 104.24 4.04 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 7.6 Cg_endo -81.99 112.29 2.3 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.63 1.554 . . . . 0.0 112.629 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 54' ' ' PHE . 1.0 OUTLIER -126.67 158.32 36.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.856 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -126.01 156.04 40.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.083 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.472 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -148.22 105.18 3.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.96 0.409 . . . . 0.0 111.615 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.08 163.46 12.57 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.351 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.519 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 0.3 OUTLIER -81.71 119.73 24.22 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.099 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.84 142.62 39.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.213 0.53 . . . . 0.0 112.06 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.562 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . . . -132.96 136.0 45.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.904 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.644 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 25.2 p -96.58 -56.16 2.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.519 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -127.06 -129.88 3.31 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.044 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.91 107.12 12.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.647 0.224 . . . . 0.0 110.781 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -65.87 148.03 52.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.687 0.28 . . . . 0.0 111.466 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.603 ' HB ' ' H ' ' A' ' 97' ' ' THR . 48.5 m -114.82 144.68 32.42 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.284 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.417 ' HD2' HG22 ' A' ' 144' ' ' THR . 1.3 Cg_endo -81.9 130.98 6.84 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.521 2.147 . . . . 0.0 111.982 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 164.82 -116.28 0.69 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.492 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.62 150.39 29.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.826 0.346 . . . . 0.0 111.397 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.69 45.93 1.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.078 0.466 . . . . 0.0 110.402 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.96 141.07 30.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.505 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -153.72 162.6 41.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.959 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -133.99 135.37 43.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.252 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -134.1 152.51 51.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.174 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.9 m -104.13 148.96 25.68 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.29 141.89 35.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.108 0.48 . . . . 0.0 110.106 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.59 152.36 40.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.896 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.1 m -135.7 133.19 51.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.808 0.337 . . . . 0.0 111.704 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.544 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . 1.8 tt0 -130.91 119.77 22.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.271 0.557 . . . . 0.0 110.407 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.476 ' HH ' ' HB3' ' A' ' 21' ' ' CYS . 14.0 m-85 -101.95 113.31 26.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.57 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.414 ' NE2' ' HB3' ' A' ' 157' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.835 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' C' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.24 0.066 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . 0.632 ' H ' ' HA ' ' C' ' 159' ' ' GLN . . . 59.14 55.8 4.21 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.081 0.238 . . . . 0.0 110.992 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.54 HG23 HD21 ' C' ' 18' ' ' ASN . 89.7 m -118.64 111.08 18.09 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.467 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.696 HG21 ' HA2' ' F' ' 127' ' ' GLY . 0.2 OUTLIER -97.78 127.33 43.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.572 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.535 HG22 HG12 ' C' ' 17' ' ' VAL . 0.0 OUTLIER -153.54 171.53 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.582 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.48 122.09 36.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.562 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . 0.414 ' HA3' HG11 ' C' ' 156' ' ' VAL . . . -75.84 -52.34 6.47 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.861 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.43 -145.44 5.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.846 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.76 139.86 25.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 111.254 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 45.3 t -122.4 121.61 64.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.148 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -99.69 106.6 18.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.369 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . 0.42 ' HZ ' ' CZ ' ' C' ' 54' ' ' PHE . 8.8 m-85 -90.6 107.59 19.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.574 ' HG2' HD21 ' C' ' 149' ' ' ASN . 0.1 OUTLIER -103.26 149.21 24.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.376 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.42 -179.01 47.49 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.98 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.642 ' HB3' ' HG3' ' C' ' 36' ' ' GLN . 0.1 OUTLIER -158.97 157.04 30.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.915 0.388 . . . . 0.0 110.377 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.423 ' O ' HG11 ' A' ' 5' ' ' VAL . 18.0 t -113.77 132.25 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.199 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.761 HG13 ' HG2' ' C' ' 36' ' ' GLN . 5.5 m -136.9 176.56 7.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.11 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . 0.532 HD21 HG23 ' A' ' 3' ' ' THR . 0.4 OUTLIER -74.4 174.1 9.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.038 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' B' ' 62' ' ' ASP . . . -83.39 35.28 0.49 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.014 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.552 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . . . -116.81 -15.93 10.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.466 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.48 ' HB3' ' HH ' ' B' ' 158' ' ' TYR . 0.1 OUTLIER 180.0 155.23 0.59 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.915 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.69 126.42 5.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.074 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.707 ' HA ' ' HG ' ' B' ' 58' ' ' LEU . 0.7 OUTLIER -60.82 162.51 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.046 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' B' ' 27' ' ' SER . 18.5 t70 -97.56 161.0 13.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.634 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.45 96.27 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.346 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.39 12.75 69.08 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.953 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' SER . . . . . 0.539 ' HB3' ' HB3' ' B' ' 24' ' ' ASP . 0.6 OUTLIER -113.79 -25.54 8.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 9.8 t -41.17 -62.01 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.28 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.56 119.97 39.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.055 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -126.1 119.11 26.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.058 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.71 103.31 15.46 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.158 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.81 115.11 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.11 0.481 . . . . 0.0 110.445 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.53 112.63 24.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.592 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.86 -30.39 58.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.6 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.07 -170.23 27.36 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.622 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.764 ' HG2' HG13 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -93.55 141.72 28.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.595 0.235 . . . . 0.0 110.88 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 5.8 p -125.22 157.18 34.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.899 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.56 122.39 28.96 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.735 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -40.52 86.96 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.756 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.44 -35.84 68.31 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.112 0.482 . . . . 0.0 110.842 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.1 -21.55 33.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.175 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' B' ' 139' ' ' ALA . 3.2 mp -110.5 29.49 7.66 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.666 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' B' ' 141' ' ' GLY . . . -108.26 25.55 11.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.364 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.81 159.99 23.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.299 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' B' ' 140' ' ' THR . 11.0 tt0 -82.88 108.65 16.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 111.19 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.95 10.83 51.5 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.202 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.62 123.51 20.29 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -120.69 140.24 51.89 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.928 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 4.6 m -101.56 -166.97 1.35 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.686 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.74 139.71 53.38 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.784 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.77 134.01 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.321 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.473 HG22 ' O ' ' B' ' 135' ' ' ALA . 18.8 m -87.07 166.44 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.911 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.69 128.83 7.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.634 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . 0.437 ' CZ ' ' HZ ' ' A' ' 12' ' ' PHE . 40.6 p90 -160.23 134.5 7.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.793 0.33 . . . . 0.0 110.932 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.43 ' OD1' ' CG2' ' B' ' 130' ' ' THR . 15.9 p30 -132.79 147.69 52.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.58 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.61 HG22 HD13 ' B' ' 58' ' ' LEU . 1.0 OUTLIER -96.75 116.78 39.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.589 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . 0.514 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -66.6 122.01 16.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.724 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.707 ' HG ' ' HA ' ' B' ' 23' ' ' VAL . 0.2 OUTLIER -137.45 88.23 2.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.247 -179.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.699 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 10.6 p30 -79.63 179.35 7.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.877 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.3 64.37 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.837 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' B' ' 129' ' ' ASN . 4.4 m -110.48 163.27 13.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.808 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' B' ' 19' ' ' ALA . 0.5 OUTLIER -140.18 155.04 47.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.275 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.23 -25.35 10.65 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -82.02 -16.33 50.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.067 0.46 . . . . 0.0 111.736 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -90.66 -48.49 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.661 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.552 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . . . -140.1 142.94 36.04 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.624 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.79 -53.89 2.59 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.842 0.353 . . . . 0.0 110.912 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' B' ' 121' ' ' GLU . 0.1 OUTLIER -94.77 158.16 15.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.519 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' B' ' 122' ' ' THR . . . -137.17 120.44 16.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.637 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' B' ' 118' ' ' PHE . . . -97.57 129.13 44.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.124 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.529 HG13 HG21 ' B' ' 131' ' ' ILE . 15.9 t -113.04 152.28 14.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.73 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.425 ' H ' HG12 ' B' ' 71' ' ' VAL . . . -149.99 146.57 27.09 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.554 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.482 ' HB3' HD23 ' B' ' 113' ' ' LEU . 0.1 OUTLIER -111.58 141.92 44.55 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.591 0.234 . . . . 0.0 111.098 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' B' ' 152' ' ' ALA . 0.8 OUTLIER -105.62 103.33 12.82 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.96 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . 0.419 ' HA3' HD22 ' B' ' 113' ' ' LEU . . . -149.91 -179.05 25.4 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.814 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.668 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.2 OUTLIER -105.25 157.78 17.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.533 0.206 . . . . 0.0 110.725 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.86 132.75 38.12 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.898 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.466 HG21 ' HB ' ' B' ' 85' ' ' VAL . 0.6 OUTLIER -66.68 -39.76 84.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.2 53.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' E' ' 106' ' ' ARG . . . 61.32 -87.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.03 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.33 -36.5 53.17 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.602 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.417 ' HB2' HG22 ' B' ' 78' ' ' ILE . 78.0 m80 -81.39 59.98 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.36 . . . . 0.0 110.447 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -70.61 -20.49 62.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.512 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . 0.863 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 26.6 p-10 -69.29 -13.74 62.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.352 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.651 HG23 ' HB2' ' B' ' 102' ' ' GLN . 40.8 t -108.97 131.15 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.127 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . 0.573 HD12 HD21 ' B' ' 113' ' ' LEU . 0.6 OUTLIER -70.11 142.84 52.53 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.014 -0.275 . . . . 0.0 110.308 179.42 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.97 -170.53 3.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.891 0.377 . . . . 0.0 111.752 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -80.04 161.43 25.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.037 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.78 -80.24 0.01 OUTLIER 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.315 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' SER . . . . . 0.457 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 6.5 p -171.42 0.5 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.993 0.425 . . . . 0.0 111.504 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' SER . . . . . 0.597 ' HA ' ' HB2' ' D' ' 25' ' ' ALA . 73.5 m -76.86 85.55 3.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.921 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.88 -32.33 71.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.968 0.413 . . . . 0.0 111.733 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.75 30.47 6.88 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.7 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.74 -3.22 0.11 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.945 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' B' ' 91' ' ' SER . 0.1 OUTLIER -107.5 -176.78 3.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 110.661 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.39 172.67 8.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.848 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.603 ' H ' ' HB ' ' B' ' 144' ' ' THR . 1.7 m -127.01 140.36 52.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.339 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . 0.431 ' HB3' ' H ' ' B' ' 141' ' ' GLY . 68.4 m-80 62.05 21.3 12.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.441 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.38 135.98 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.723 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.0 -160.77 10.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.569 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' B' ' 86' ' ' LEU . 4.5 p -145.84 109.85 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 122.974 0.51 . . . . 0.0 111.767 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.651 ' HB2' HG23 ' B' ' 85' ' ' VAL . 0.5 OUTLIER -84.33 147.33 27.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.881 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.599 HG12 ' HG ' ' B' ' 113' ' ' LEU . 1.2 pp -110.69 127.88 67.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.515 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . 0.584 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 1.4 tp -97.46 132.95 42.67 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.637 0.256 . . . . 0.0 111.003 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . 0.593 ' HB2' ' HB2' ' B' ' 111' ' ' LEU . 4.0 t0 -80.76 143.59 32.79 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.739 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -65.43 -17.55 64.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.817 0.341 . . . . 0.0 111.061 179.509 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' THR . . . . . 0.502 HG23 ' HB3' ' B' ' 105' ' ' ASP . 13.2 t -66.84 -20.65 65.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.011 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.05 -71.61 0.44 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.769 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.51 159.93 31.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.768 0.318 . . . . 0.0 111.139 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -75.54 131.49 40.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.162 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.594 HD12 HG23 ' B' ' 117' ' ' THR . 12.2 tp -88.1 154.22 20.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.331 0.586 . . . . 0.0 110.553 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.863 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 0.4 OUTLIER -96.43 142.71 28.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.155 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.599 ' HG ' HG12 ' B' ' 103' ' ' ILE . 0.8 OUTLIER -80.82 63.68 5.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.771 0.32 . . . . 0.0 110.708 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.63 -30.6 17.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.573 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . 0.51 ' HA3' ' OG1' ' E' ' 130' ' ' THR . . . 115.76 -43.58 1.64 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.617 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.58 24.43 12.97 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.006 0.431 . . . . 0.0 111.634 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' THR . . . . . 0.594 HG23 HD12 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -82.12 68.28 8.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.13 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.529 ' CD1' ' HB2' ' B' ' 157' ' ' GLN . 41.2 m-85 -82.15 71.93 9.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.798 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.74 80.98 1.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.831 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.62 131.75 13.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.614 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . 0.412 ' O ' ' HE2' ' B' ' 68' ' ' LYS . 1.5 mm-40 -100.74 52.15 0.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.151 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' B' ' 69' ' ' ALA . 0.2 OUTLIER -72.14 131.92 43.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.738 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.62 107.59 15.37 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.774 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.407 HD13 ' CB ' ' B' ' 69' ' ' ALA . 1.0 OUTLIER -88.18 126.54 35.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.604 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . 0.481 ' O ' ' HB3' ' B' ' 61' ' ' CYS . 1.1 m120 -120.65 -178.92 3.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.577 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' ASN . . . . . 0.513 ' OD1' ' HA ' ' B' ' 62' ' ' ASP . 3.7 t30 -83.27 120.64 26.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.732 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.13 -121.78 2.53 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.683 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.699 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 75.5 m -122.14 103.38 8.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.734 0.302 . . . . 0.0 110.783 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . 0.504 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 1.7 t30 -86.14 157.28 20.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.157 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.514 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.3 OUTLIER -143.32 130.22 20.51 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.064 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' ILE . . . . . 0.529 HG21 HG13 ' B' ' 71' ' ' VAL . 57.3 mt -84.09 104.22 3.96 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -82.09 112.48 2.3 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.611 1.541 . . . . 0.0 112.54 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.405 ' HB3' ' CZ ' ' B' ' 54' ' ' PHE . 1.0 OUTLIER -126.77 158.21 37.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.826 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -126.01 156.05 40.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.024 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.473 ' O ' HG22 ' B' ' 52' ' ' VAL . . . -148.17 105.12 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.922 0.391 . . . . 0.0 111.659 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -99.04 163.44 12.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.436 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 0.3 OUTLIER -81.67 119.75 24.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.085 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.9 142.69 39.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.247 0.546 . . . . 0.0 112.012 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.561 ' HB3' ' HG ' ' B' ' 42' ' ' LEU . . . -132.97 136.0 45.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.918 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' THR . . . . . 0.649 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 25.3 p -96.53 -56.24 2.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.527 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' B' ' 43' ' ' ALA . . . -127.06 -129.83 3.3 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.03 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.01 107.15 12.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.682 0.241 . . . . 0.0 110.695 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' B' ' 97' ' ' THR . . . -65.94 148.12 52.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.765 0.317 . . . . 0.0 111.447 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.603 ' HB ' ' H ' ' B' ' 97' ' ' THR . 48.5 m -114.84 144.65 32.37 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.36 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.418 ' HD2' HG22 ' B' ' 144' ' ' THR . 1.3 Cg_endo -81.9 130.95 6.83 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.551 2.168 . . . . 0.0 111.967 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . 0.591 ' O ' ' HG3' ' A' ' 15' ' ' GLU . . . 164.86 -116.2 0.69 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.466 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . 0.612 ' HA ' ' HG3' ' A' ' 15' ' ' GLU . . . -110.77 150.34 29.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.932 0.396 . . . . 0.0 111.279 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.6 45.87 1.6 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.108 0.48 . . . . 0.0 110.479 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.577 HD21 ' HG2' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -96.86 141.02 30.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.609 -179.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -153.75 162.55 41.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.013 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.91 135.46 43.62 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.179 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -134.18 152.51 51.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.157 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 4.0 m -104.12 148.91 25.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.23 141.81 35.25 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.087 0.47 . . . . 0.0 110.141 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.53 152.34 40.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.905 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' VAL . . . . . 0.413 HG11 ' HA3' ' A' ' 7' ' ' GLY . 20.2 m -135.76 133.17 51.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 111.705 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.719 ' HG3' HG22 ' A' ' 4' ' ' THR . 1.8 tt0 -130.89 119.8 22.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.269 0.557 . . . . 0.0 110.405 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' TYR . . . . . 0.48 ' HH ' ' HB3' ' B' ' 21' ' ' CYS . 14.0 m-85 -101.97 113.19 26.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.564 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . 0.633 ' HA ' ' H ' ' A' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.852 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 1' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' D' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.232 0.063 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . 0.649 ' H ' ' HA ' ' D' ' 159' ' ' GLN . . . 59.07 55.84 4.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.592 0.234 . . . . 0.0 111.018 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 3' ' ' THR . . . . . 0.513 HG23 HD21 ' D' ' 18' ' ' ASN . 89.2 m -118.61 111.1 18.13 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.448 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 4' ' ' THR . . . . . 0.685 HG22 ' HG3' ' D' ' 157' ' ' GLN . 0.2 OUTLIER -97.78 127.3 43.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.609 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . 0.542 HG22 HG12 ' D' ' 17' ' ' VAL . 0.0 OUTLIER -153.53 171.52 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.589 179.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.39 122.13 36.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.592 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' GLY . . . . . 0.419 ' HA3' HG11 ' D' ' 156' ' ' VAL . . . -75.96 -52.3 6.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.817 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.4 -145.56 5.86 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.889 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.75 139.83 25.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.975 0.417 . . . . 0.0 111.277 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.38 121.65 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.152 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -99.71 106.6 18.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.309 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' PHE . . . . . 0.43 ' HZ ' ' CZ ' ' D' ' 54' ' ' PHE . 8.9 m-85 -90.59 107.62 19.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.783 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . 0.57 ' HG2' HD21 ' D' ' 149' ' ' ASN . 0.1 OUTLIER -103.34 149.23 24.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.337 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.39 -179.08 47.5 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.922 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' GLU . . . . . 0.63 ' HB3' ' HG3' ' D' ' 36' ' ' GLN . 0.1 OUTLIER -158.96 157.1 30.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.906 0.384 . . . . 0.0 110.311 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.423 ' O ' HG11 ' B' ' 5' ' ' VAL . 17.9 t -113.79 132.08 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.284 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.75 HG13 ' HG2' ' D' ' 36' ' ' GLN . 5.4 m -136.78 176.62 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.803 0.335 . . . . 0.0 111.058 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . 0.54 HD21 HG23 ' B' ' 3' ' ' THR . 0.4 OUTLIER -74.42 174.15 9.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.058 -179.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' C' ' 62' ' ' ASP . . . -83.47 35.43 0.5 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.075 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' C' ' 66' ' ' ALA . . . -116.92 -15.94 10.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.435 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' CYS . . . . . 0.486 ' HB3' ' HH ' ' C' ' 158' ' ' TYR . 0.1 OUTLIER -179.94 155.31 0.6 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.91 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.78 126.37 5.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . 0.71 ' HA ' ' HG ' ' C' ' 58' ' ' LEU . 0.7 OUTLIER -60.74 162.53 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.112 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' C' ' 27' ' ' SER . 18.7 t70 -97.66 161.0 13.97 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.577 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.605 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -64.07 -40.37 96.12 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.389 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.43 12.79 68.96 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.91 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' C' ' 24' ' ' ASP . 0.6 OUTLIER -113.87 -25.52 8.58 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.865 0.364 . . . . 0.0 110.808 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 9.8 t -41.15 -61.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.35 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.55 119.95 39.56 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.085 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -126.14 119.15 26.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.984 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.69 103.32 15.48 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.078 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.86 115.13 43.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.145 0.498 . . . . 0.0 110.493 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.51 112.59 24.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.656 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.8 -30.4 59.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.692 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.03 -170.17 27.36 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.613 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . 0.761 ' HG2' HG13 ' B' ' 17' ' ' VAL . 0.4 OUTLIER -93.51 141.7 28.17 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.522 0.201 . . . . 0.0 110.887 -179.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 5.7 p -125.29 157.11 34.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.916 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.53 122.41 28.98 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.727 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -40.44 87.01 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.754 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.46 -35.87 68.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.05 0.452 . . . . 0.0 110.797 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.19 -21.39 33.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.16 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' C' ' 139' ' ' ALA . 3.2 mp -110.51 29.45 7.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.566 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' C' ' 141' ' ' GLY . . . -108.2 25.45 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.321 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.74 159.92 23.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.341 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' C' ' 140' ' ' THR . 11.0 tt0 -82.8 108.68 16.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.853 0.358 . . . . 0.0 111.168 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.9 10.91 51.52 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.163 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.76 123.49 20.27 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.933 0.396 . . . . 0.0 112.061 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -120.65 140.25 51.84 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.874 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 4.6 m -101.62 -167.02 1.36 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.611 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.68 139.65 53.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.786 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' C' ' 134' ' ' GLN . . . -82.82 133.95 35.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.309 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . 0.476 HG22 ' O ' ' C' ' 135' ' ' ALA . 18.7 m -86.94 166.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.016 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.74 128.76 7.94 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.637 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . 0.42 ' CZ ' ' HZ ' ' B' ' 12' ' ' PHE . 40.7 p90 -160.17 134.48 7.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.429 ' OD1' ' CG2' ' C' ' 130' ' ' THR . 15.8 p30 -132.75 147.73 52.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.583 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.595 HG12 HD12 ' C' ' 58' ' ' LEU . 1.0 OUTLIER -96.75 116.7 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.621 -179.749 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.525 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.0 OUTLIER -66.58 122.06 16.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.696 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . 0.71 ' HG ' ' HA ' ' C' ' 23' ' ' VAL . 0.2 OUTLIER -137.43 88.17 2.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.23 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . 0.706 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 10.5 p30 -79.6 179.4 7.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.88 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.3 64.46 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.783 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' C' ' 129' ' ' ASN . 4.4 m -110.53 163.26 13.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.786 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . 0.569 ' HB2' ' O ' ' C' ' 19' ' ' ALA . 0.5 OUTLIER -140.21 155.07 47.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.254 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.34 -25.31 10.63 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -82.08 -16.25 50.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.061 0.458 . . . . 0.0 111.745 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 t -90.66 -48.46 14.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.661 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . 0.547 ' HB2' ' HB3' ' C' ' 20' ' ' ALA . . . -140.11 142.9 36.02 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.639 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.82 -53.81 2.6 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.847 0.356 . . . . 0.0 110.971 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' C' ' 121' ' ' GLU . 0.1 OUTLIER -94.79 158.16 15.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.491 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' C' ' 122' ' ' THR . . . -137.22 120.47 16.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.611 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.407 ' HB2' ' HB3' ' C' ' 118' ' ' PHE . . . -97.54 129.03 44.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.137 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . 0.528 HG13 HG21 ' C' ' 131' ' ' ILE . 15.8 t -112.96 152.24 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.718 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . 0.423 ' H ' HG12 ' C' ' 71' ' ' VAL . . . -150.01 146.63 27.1 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.588 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' PHE . . . . . 0.491 ' HB3' HD23 ' C' ' 113' ' ' LEU . 0.1 OUTLIER -111.53 141.88 44.54 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.5 0.191 . . . . 0.0 111.092 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' C' ' 152' ' ' ALA . 0.8 OUTLIER -105.72 103.24 12.7 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.974 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . 0.421 ' HA3' HD22 ' C' ' 113' ' ' LEU . . . -149.88 -179.11 25.43 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.789 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' THR . . . . . 0.674 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.2 OUTLIER -105.15 157.85 16.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.595 0.236 . . . . 0.0 110.73 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.89 132.79 38.1 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.881 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . 0.447 HG21 ' HB ' ' C' ' 85' ' ' VAL . 0.6 OUTLIER -66.58 -39.88 84.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.19 53.58 1.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.824 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' F' ' 106' ' ' ARG . . . 61.42 -87.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.065 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.37 -36.51 53.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.576 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . 0.426 ' HB2' HG22 ' C' ' 78' ' ' ILE . 78.0 m80 -81.37 59.97 4.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.883 0.373 . . . . 0.0 110.451 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -70.53 -20.53 62.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.49 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' ASN . . . . . 0.876 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 26.6 p-10 -69.34 -13.73 62.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.334 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' C' ' 102' ' ' GLN . 40.9 t -109.0 131.15 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.129 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.579 HD12 HD21 ' C' ' 113' ' ' LEU . 0.6 OUTLIER -70.07 142.85 52.61 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.324 179.42 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.0 -170.58 3.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.882 0.372 . . . . 0.0 111.71 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -79.89 161.44 25.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.102 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.75 -80.33 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.34 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' SER . . . . . 0.458 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 6.6 p -171.34 0.49 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.949 0.404 . . . . 0.0 111.481 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' SER . . . . . 0.62 ' HA ' ' HB2' ' E' ' 25' ' ' ALA . 73.5 m -76.84 85.66 3.42 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.23 71.86 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.876 0.369 . . . . 0.0 111.649 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.86 30.47 6.87 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.642 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.64 -3.26 0.11 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.947 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' SER . . . . . 0.598 ' HB2' ' HB2' ' C' ' 91' ' ' SER . 0.1 OUTLIER -107.54 -176.71 3.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.834 0.35 . . . . 0.0 110.656 179.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.49 172.58 8.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' THR . . . . . 0.587 ' H ' ' HB ' ' C' ' 144' ' ' THR . 1.6 m -126.93 140.4 52.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.351 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . 0.43 ' HB3' ' H ' ' C' ' 141' ' ' GLY . 68.4 m-80 61.96 21.39 12.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.472 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.44 136.0 58.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.727 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.94 -160.74 10.18 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.532 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' VAL . . . . . 0.501 HG11 ' HB2' ' C' ' 86' ' ' LEU . 4.5 p -145.94 109.85 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.067 0.547 . . . . 0.0 111.758 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 102' ' ' GLN . . . . . 0.659 ' HB2' HG23 ' C' ' 85' ' ' VAL . 0.5 OUTLIER -84.27 147.38 27.26 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.93 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . 0.589 HG12 ' HG ' ' C' ' 113' ' ' LEU . 1.2 pp -110.79 127.86 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.529 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' LEU . . . . . 0.585 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 1.4 tp -97.43 132.94 42.66 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.663 0.268 . . . . 0.0 111.02 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . 0.583 ' HB2' ' HB2' ' C' ' 111' ' ' LEU . 4.0 t0 -80.78 143.58 32.77 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.688 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 106' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -65.42 -17.53 64.61 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.815 0.341 . . . . 0.0 111.043 179.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 107' ' ' THR . . . . . 0.51 HG23 ' HB3' ' C' ' 105' ' ' ASP . 13.2 t -66.83 -20.59 65.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.028 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.08 -71.85 0.44 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.682 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.5 159.97 31.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.825 0.345 . . . . 0.0 111.11 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.585 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -75.54 131.52 40.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 111' ' ' LEU . . . . . 0.586 HD12 HG23 ' C' ' 117' ' ' THR . 12.2 tp -88.14 154.22 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.379 0.609 . . . . 0.0 110.514 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 112' ' ' THR . . . . . 0.876 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 0.4 OUTLIER -96.37 142.66 28.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.147 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.589 ' HG ' HG12 ' C' ' 103' ' ' ILE . 0.8 OUTLIER -80.76 63.61 5.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.783 0.325 . . . . 0.0 110.761 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.7 -30.54 17.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.547 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . 0.512 ' HA3' ' OG1' ' F' ' 130' ' ' THR . . . 115.76 -43.57 1.65 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.595 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.49 24.33 13.11 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.003 0.43 . . . . 0.0 111.679 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 117' ' ' THR . . . . . 0.586 HG23 HD12 ' C' ' 111' ' ' LEU . 0.2 OUTLIER -82.15 68.37 8.52 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.118 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 118' ' ' PHE . . . . . 0.543 ' CD1' ' HB2' ' C' ' 157' ' ' GLN . 41.0 m-85 -82.2 72.0 9.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.801 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.76 80.99 1.86 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.65 131.75 13.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.606 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . 0.411 ' O ' ' HE2' ' C' ' 68' ' ' LYS . 1.5 mm-40 -100.76 52.2 0.86 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.212 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' C' ' 69' ' ' ALA . 0.2 OUTLIER -72.11 131.89 43.45 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.75 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.7 107.65 15.49 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.745 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . 0.404 HD13 ' CB ' ' C' ' 69' ' ' ALA . 1.0 OUTLIER -88.26 126.58 35.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.561 179.465 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 125' ' ' ASN . . . . . 0.492 ' O ' ' HB3' ' C' ' 61' ' ' CYS . 1.1 m120 -120.66 -178.93 3.84 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.525 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 126' ' ' ASN . . . . . 0.513 ' OD1' ' HA ' ' C' ' 62' ' ' ASP . 3.8 t30 -83.25 120.61 26.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.784 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.18 -121.67 2.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.659 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 128' ' ' THR . . . . . 0.706 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 76.5 m -122.21 103.37 8.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.746 0.308 . . . . 0.0 110.78 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 129' ' ' ASN . . . . . 0.504 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 1.8 t30 -86.21 157.26 20.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.896 0.379 . . . . 0.0 111.091 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 130' ' ' THR . . . . . 0.525 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.3 OUTLIER -143.29 130.17 20.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.104 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 131' ' ' ILE . . . . . 0.528 HG21 HG13 ' C' ' 71' ' ' VAL . 56.8 mt -83.97 104.14 3.79 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 132' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' C' ' 106' ' ' ARG . 7.6 Cg_endo -82.0 112.34 2.31 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.673 1.582 . . . . 0.0 112.582 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.414 ' HB3' ' CZ ' ' C' ' 54' ' ' PHE . 1.0 OUTLIER -126.7 158.29 36.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.828 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 134' ' ' GLN . . . . . 0.401 ' HB3' ' HB3' ' C' ' 51' ' ' ALA . 16.0 mt-30 -126.0 156.1 40.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.059 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . 0.476 ' O ' HG22 ' C' ' 52' ' ' VAL . . . -148.15 105.14 3.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 0.0 111.609 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.05 163.36 12.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.416 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 137' ' ' TYR . . . . . 0.521 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 0.3 OUTLIER -81.64 119.71 24.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.116 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.91 142.68 39.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.982 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 139' ' ' ALA . . . . . 0.561 ' HB3' ' HG ' ' C' ' 42' ' ' LEU . . . -132.98 136.04 45.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.851 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 140' ' ' THR . . . . . 0.649 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 25.1 p -96.6 -56.21 2.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.476 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . 0.43 ' H ' ' HB3' ' C' ' 98' ' ' ASN . . . -127.06 -129.84 3.3 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.013 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.03 107.14 12.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.631 0.216 . . . . 0.0 110.702 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 143' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' C' ' 97' ' ' THR . . . -65.89 148.09 52.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.753 0.311 . . . . 0.0 111.434 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 144' ' ' THR . . . . . 0.587 ' HB ' ' H ' ' C' ' 97' ' ' THR . 47.8 m -114.87 144.67 32.42 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.307 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 145' ' ' PRO . . . . . 0.427 ' HD2' HG22 ' C' ' 144' ' ' THR . 1.3 Cg_endo -81.96 130.97 6.78 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.479 2.119 . . . . 0.0 112.009 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 146' ' ' GLY . . . . . 0.6 ' O ' ' HG3' ' B' ' 15' ' ' GLU . . . 164.89 -116.26 0.69 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.438 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 147' ' ' ALA . . . . . 0.6 ' HA ' ' HG3' ' B' ' 15' ' ' GLU . . . -110.67 150.37 29.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 111.351 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.67 45.89 1.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.46 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 149' ' ' ASN . . . . . 0.574 HD21 ' HG2' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -96.83 141.0 30.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.618 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 150' ' ' ALA . . . . . . . . . . . . . . . -153.7 162.62 41.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.047 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.93 135.5 43.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.198 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 152' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -134.16 152.51 51.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.23 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 4.0 m -104.15 148.91 25.74 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.23 141.83 35.21 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.136 0.493 . . . . 0.0 110.165 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.54 152.41 40.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.916 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 156' ' ' VAL . . . . . 0.414 HG11 ' HA3' ' B' ' 7' ' ' GLY . 19.9 m -135.74 133.22 51.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.798 0.332 . . . . 0.0 111.684 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 157' ' ' GLN . . . . . 0.687 ' HG3' HG22 ' B' ' 4' ' ' THR . 1.8 tt0 -130.96 119.78 22.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.326 0.584 . . . . 0.0 110.397 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 158' ' ' TYR . . . . . 0.486 ' HH ' ' HB3' ' C' ' 21' ' ' CYS . 14.1 m-85 -101.93 113.24 26.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.577 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . 0.632 ' HA ' ' H ' ' B' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.836 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 1' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' E' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 111.105 0.039 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . 0.638 ' H ' ' HA ' ' E' ' 159' ' ' GLN . . . 59.11 55.8 4.22 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 123.104 0.253 . . . . 0.0 111.035 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 3' ' ' THR . . . . . 0.53 HG23 HD21 ' E' ' 18' ' ' ASN . 89.7 m -118.64 111.07 18.08 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.422 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 4' ' ' THR . . . . . 0.716 HG22 ' HG3' ' E' ' 157' ' ' GLN . 0.2 OUTLIER -97.76 127.33 43.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.524 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . 0.531 HG22 HG12 ' E' ' 17' ' ' VAL . 0.0 OUTLIER -153.53 171.46 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.634 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.37 122.09 36.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.637 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 7' ' ' GLY . . . . . 0.415 ' HA3' HG11 ' E' ' 156' ' ' VAL . . . -76.0 -52.23 6.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.802 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.46 -145.46 5.83 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.829 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.82 139.74 25.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.905 0.383 . . . . 0.0 111.299 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.33 121.63 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.125 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -99.65 106.66 18.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.361 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' PHE . . . . . 0.43 ' HZ ' ' CZ ' ' E' ' 54' ' ' PHE . 8.9 m-85 -90.65 107.59 19.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.797 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' LYS . . . . . 0.559 ' HG2' HD21 ' E' ' 149' ' ' ASN . 0.1 OUTLIER -103.29 149.18 24.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.404 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.42 -179.05 47.51 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.946 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' GLU . . . . . 0.641 ' HB3' ' HG3' ' E' ' 36' ' ' GLN . 0.1 OUTLIER -158.93 157.01 30.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.912 0.387 . . . . 0.0 110.358 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.421 ' O ' HG11 ' C' ' 5' ' ' VAL . 17.8 t -113.7 132.19 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.249 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . 0.751 HG13 ' HG2' ' E' ' 36' ' ' GLN . 5.5 m -136.85 176.58 7.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.829 0.347 . . . . 0.0 111.008 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' ASN . . . . . 0.513 HD21 HG23 ' C' ' 3' ' ' THR . 0.4 OUTLIER -74.36 174.11 9.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.068 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' D' ' 62' ' ' ASP . . . -83.4 35.32 0.49 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.059 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . 0.55 ' HB3' ' HB2' ' D' ' 66' ' ' ALA . . . -116.92 -15.9 10.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.398 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' CYS . . . . . 0.478 ' HB3' ' HH ' ' D' ' 158' ' ' TYR . 0.1 OUTLIER -179.99 155.22 0.59 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.962 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.67 126.47 5.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.077 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . 0.712 ' HA ' ' HG ' ' D' ' 58' ' ' LEU . 0.7 OUTLIER -60.9 162.44 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.057 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' D' ' 27' ' ' SER . 18.7 t70 -97.58 160.97 14.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.623 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.597 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -64.11 -40.25 95.79 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.398 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.49 12.75 69.02 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.914 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' SER . . . . . 0.529 ' HB3' ' HB3' ' D' ' 24' ' ' ASP . 0.6 OUTLIER -113.84 -25.47 8.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.846 0.355 . . . . 0.0 110.787 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 10.0 t -41.15 -61.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.306 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.64 120.0 39.65 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.03 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -126.07 119.1 26.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.024 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.76 103.33 15.47 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.083 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.88 115.1 43.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.163 0.506 . . . . 0.0 110.424 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.5 112.56 24.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.646 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.83 -30.34 58.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.626 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.98 -170.23 27.49 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.571 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' GLN . . . . . 0.75 ' HG2' HG13 ' C' ' 17' ' ' VAL . 0.4 OUTLIER -93.48 141.79 28.07 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.526 0.203 . . . . 0.0 110.944 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 5.8 p -125.3 157.14 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.827 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.58 122.39 28.97 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.729 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -40.47 86.94 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.753 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.48 -35.82 68.39 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.053 0.454 . . . . 0.0 110.8 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -21.44 33.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.133 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' D' ' 139' ' ' ALA . 3.3 mp -110.5 29.51 7.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.623 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' D' ' 141' ' ' GLY . . . -108.24 25.44 11.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.34 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.71 159.97 23.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.38 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' D' ' 140' ' ' THR . 11.1 tt0 -82.94 108.73 16.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.916 0.388 . . . . 0.0 111.127 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.97 10.78 51.51 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.116 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.66 123.47 20.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.94 0.4 . . . . 0.0 111.974 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 77.5 p -120.64 140.3 51.77 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.879 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 4.6 m -101.68 -167.02 1.36 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.61 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 8.1 t -69.63 139.64 53.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.791 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.79 133.99 35.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.335 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' VAL . . . . . 0.472 HG22 ' O ' ' D' ' 135' ' ' ALA . 18.9 m -87.04 166.48 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.896 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.77 128.87 7.99 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.614 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . 0.43 ' CZ ' ' HZ ' ' C' ' 12' ' ' PHE . 40.6 p90 -160.2 134.44 7.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.756 0.312 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' ASN . . . . . 0.426 ' OD1' ' CG2' ' D' ' 130' ' ' THR . 15.9 p30 -132.75 147.67 52.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.623 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.605 HG12 HD12 ' D' ' 58' ' ' LEU . 1.0 OUTLIER -96.74 116.75 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.567 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' GLN . . . . . 0.514 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.0 OUTLIER -66.61 122.04 16.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.744 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . 0.712 ' HG ' ' HA ' ' D' ' 23' ' ' VAL . 0.2 OUTLIER -137.4 88.17 2.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . 0.725 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 10.6 p30 -79.58 179.37 7.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.925 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.35 64.37 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.812 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' D' ' 129' ' ' ASN . 4.4 m -110.48 163.26 13.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.954 0.406 . . . . 0.0 110.761 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' D' ' 19' ' ' ALA . 0.5 OUTLIER -140.22 155.07 47.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.237 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.25 -25.36 10.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -81.99 -16.41 50.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.083 0.468 . . . . 0.0 111.703 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 t -90.61 -48.48 14.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.696 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.55 ' HB2' ' HB3' ' D' ' 20' ' ' ALA . . . -140.12 142.9 36.01 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.639 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.79 -53.82 2.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.848 0.356 . . . . 0.0 110.941 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' D' ' 121' ' ' GLU . 0.1 OUTLIER -94.86 158.1 15.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.482 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' D' ' 122' ' ' THR . . . -137.14 120.48 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.621 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' D' ' 118' ' ' PHE . . . -97.62 129.1 44.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.06 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . 0.543 HG13 HG21 ' D' ' 131' ' ' ILE . 15.9 t -112.99 152.28 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.671 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 72' ' ' ALA . . . . . 0.421 ' H ' HG12 ' D' ' 71' ' ' VAL . . . -150.05 146.61 27.06 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.522 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 73' ' ' PHE . . . . . 0.493 ' HB3' HD23 ' D' ' 113' ' ' LEU . 0.1 OUTLIER -111.53 141.94 44.46 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.536 0.208 . . . . 0.0 111.092 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 74' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.8 OUTLIER -105.71 103.35 12.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.916 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . 0.42 ' HA3' HD22 ' D' ' 113' ' ' LEU . . . -149.96 -179.11 25.5 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.806 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 157.84 17.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.558 0.218 . . . . 0.0 110.732 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.9 132.75 38.07 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.87 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 78' ' ' ILE . . . . . 0.456 HG21 ' HB ' ' D' ' 85' ' ' VAL . 0.6 OUTLIER -66.61 -39.79 84.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.22 53.53 1.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.826 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.39 -87.54 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.33 -36.53 53.26 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.58 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . 0.43 ' HB2' HG22 ' D' ' 78' ' ' ILE . 77.9 m80 -81.31 59.99 4.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.472 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -70.58 -20.53 62.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.575 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . 0.874 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 26.6 p-10 -69.35 -13.7 62.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.296 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.644 HG23 ' HB2' ' D' ' 102' ' ' GLN . 40.8 t -108.96 131.1 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.203 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.582 HD12 HD21 ' D' ' 113' ' ' LEU . 0.6 OUTLIER -70.02 142.89 52.69 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.323 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.02 -170.5 3.06 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.884 0.373 . . . . 0.0 111.688 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' D' ' 88' ' ' LEU . 1.2 mm? -80.02 161.44 25.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.022 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.76 -80.25 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.357 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 6.5 p -171.41 0.48 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 111.445 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 91' ' ' SER . . . . . 0.608 ' HA ' ' HB2' ' F' ' 25' ' ' ALA . 73.4 m -76.83 85.55 3.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.912 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.87 -32.32 71.76 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.655 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.83 30.45 6.88 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.641 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.71 -3.12 0.11 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.953 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 95' ' ' SER . . . . . 0.585 ' HB2' ' HB2' ' D' ' 91' ' ' SER . 0.1 OUTLIER -107.57 -176.79 3.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 110.638 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.56 172.58 8.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.811 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 97' ' ' THR . . . . . 0.597 ' H ' ' HB ' ' D' ' 144' ' ' THR . 1.7 m -126.86 140.43 52.36 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.288 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 98' ' ' ASN . . . . . 0.428 ' HB3' ' H ' ' D' ' 141' ' ' GLY . 68.3 m-80 61.95 21.36 12.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.427 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.35 136.02 58.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.742 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.0 -160.77 10.21 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.513 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 101' ' ' VAL . . . . . 0.511 HG11 ' HB2' ' D' ' 86' ' ' LEU . 4.5 p -145.9 109.85 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.168 0.509 . . . . 0.0 111.762 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 102' ' ' GLN . . . . . 0.644 ' HB2' HG23 ' D' ' 85' ' ' VAL . 0.5 OUTLIER -84.31 147.36 27.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.93 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 103' ' ' ILE . . . . . 0.608 HG12 ' HG ' ' D' ' 113' ' ' LEU . 1.2 pp -110.73 127.81 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.49 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 104' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 1.4 tp -97.37 132.92 42.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.676 0.274 . . . . 0.0 111.093 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . 0.6 ' HB2' ' HB2' ' D' ' 111' ' ' LEU . 4.0 t0 -80.81 143.62 32.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.669 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 106' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -65.47 -17.44 64.56 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.762 0.315 . . . . 0.0 111.101 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 107' ' ' THR . . . . . 0.51 HG23 ' HB3' ' D' ' 105' ' ' ASP . 13.3 t -66.87 -20.59 65.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.052 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.07 -71.78 0.44 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.674 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.48 159.93 31.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.829 0.347 . . . . 0.0 111.111 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -75.56 131.47 40.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.126 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 111' ' ' LEU . . . . . 0.6 ' HB2' ' HB2' ' D' ' 105' ' ' ASP . 12.2 tp -88.13 154.21 20.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.372 0.606 . . . . 0.0 110.63 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 112' ' ' THR . . . . . 0.874 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 0.4 OUTLIER -96.42 142.74 28.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.082 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 113' ' ' LEU . . . . . 0.608 ' HG ' HG12 ' D' ' 103' ' ' ILE . 0.8 OUTLIER -80.82 63.68 5.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.738 0.304 . . . . 0.0 110.704 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.65 -30.66 17.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.648 0.261 . . . . 0.0 111.55 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.79 -43.6 1.64 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.593 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.56 24.38 13.04 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.996 0.427 . . . . 0.0 111.614 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 117' ' ' THR . . . . . 0.585 HG23 HD12 ' D' ' 111' ' ' LEU . 0.2 OUTLIER -82.12 68.35 8.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' D' ' 157' ' ' GLN . 40.8 m-85 -82.21 71.98 9.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.754 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.71 80.99 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.58 131.75 13.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.576 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . 0.409 ' O ' ' HE2' ' D' ' 68' ' ' LYS . 1.5 mm-40 -100.77 52.11 0.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.222 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' D' ' 69' ' ' ALA . 0.2 OUTLIER -72.06 131.91 43.5 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.73 -179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.69 107.62 15.46 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.742 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . 0.401 HD13 ' CB ' ' D' ' 69' ' ' ALA . 1.0 OUTLIER -88.22 126.58 35.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.558 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 125' ' ' ASN . . . . . 0.483 ' O ' ' HB3' ' D' ' 61' ' ' CYS . 1.1 m120 -120.69 -178.94 3.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.575 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 126' ' ' ASN . . . . . 0.507 ' OD1' ' HA ' ' D' ' 62' ' ' ASP . 3.8 t30 -83.23 120.71 26.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.662 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.08 -121.72 2.52 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.709 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 128' ' ' THR . . . . . 0.725 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 75.8 m -122.21 103.42 8.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.711 0.291 . . . . 0.0 110.77 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 129' ' ' ASN . . . . . 0.51 ' HB2' ' SG ' ' D' ' 61' ' ' CYS . 1.7 t30 -86.14 157.23 20.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.172 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 130' ' ' THR . . . . . 0.514 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.3 OUTLIER -143.28 130.17 20.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.136 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 131' ' ' ILE . . . . . 0.543 HG21 HG13 ' D' ' 71' ' ' VAL . 57.0 mt -84.0 104.11 3.77 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 132' ' ' PRO . . . . . 0.692 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 7.6 Cg_endo -81.99 112.34 2.31 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.646 1.564 . . . . 0.0 112.568 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . 0.417 ' HB3' ' CZ ' ' D' ' 54' ' ' PHE . 1.0 OUTLIER -126.68 158.25 36.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.863 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -125.96 156.09 40.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.116 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . 0.472 ' O ' HG22 ' D' ' 52' ' ' VAL . . . -148.22 105.12 3.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.947 0.404 . . . . 0.0 111.587 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -99.07 163.48 12.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.357 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 137' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 0.3 OUTLIER -81.79 119.7 24.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.101 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.84 142.68 39.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.056 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 139' ' ' ALA . . . . . 0.561 ' HB3' ' HG ' ' D' ' 42' ' ' LEU . . . -132.92 136.05 45.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.904 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 140' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 25.1 p -96.66 -56.14 2.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.474 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' D' ' 43' ' ' ALA . . . -127.11 -129.87 3.3 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.988 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.98 107.05 12.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.652 0.226 . . . . 0.0 110.779 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 143' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' D' ' 97' ' ' THR . . . -65.85 148.09 52.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.714 0.292 . . . . 0.0 111.441 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 144' ' ' THR . . . . . 0.597 ' HB ' ' H ' ' D' ' 97' ' ' THR . 48.6 m -114.79 144.69 32.42 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.297 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 145' ' ' PRO . . . . . 0.428 ' HD2' HG22 ' D' ' 144' ' ' THR . 1.3 Cg_endo -81.97 130.91 6.75 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.573 2.182 . . . . 0.0 111.972 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 146' ' ' GLY . . . . . 0.599 ' O ' ' HG3' ' C' ' 15' ' ' GLU . . . 164.89 -116.25 0.69 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.439 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 147' ' ' ALA . . . . . 0.614 ' HA ' ' HG3' ' C' ' 15' ' ' GLU . . . -110.66 150.4 29.06 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.808 0.337 . . . . 0.0 111.339 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.65 45.88 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.45 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 149' ' ' ASN . . . . . 0.57 HD21 ' HG2' ' C' ' 13' ' ' LYS . 0.2 OUTLIER -96.85 141.06 30.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.578 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 150' ' ' ALA . . . . . . . . . . . . . . . -153.74 162.54 41.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.962 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.87 135.49 43.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.239 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 152' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -134.19 152.49 51.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.217 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 153' ' ' THR . . . . . . . . . . . . . 4.0 m -104.09 148.92 25.7 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.25 141.83 35.22 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.106 0.479 . . . . 0.0 110.113 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.57 152.39 40.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.921 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 156' ' ' VAL . . . . . 0.419 HG11 ' HA3' ' C' ' 7' ' ' GLY . 20.0 m -135.74 133.16 51.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.809 0.337 . . . . 0.0 111.635 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 157' ' ' GLN . . . . . 0.685 ' HG3' HG22 ' C' ' 4' ' ' THR . 1.8 tt0 -130.9 119.74 22.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.302 0.572 . . . . 0.0 110.417 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 158' ' ' TYR . . . . . 0.478 ' HH ' ' HB3' ' D' ' 21' ' ' CYS . 14.1 m-85 -101.94 113.31 26.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.587 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 159' ' ' GLN . . . . . 0.649 ' HA ' ' H ' ' C' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.839 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 1' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' F' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 111.108 0.04 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 2' ' ' ALA . . . . . 0.629 ' H ' ' HA ' ' F' ' 159' ' ' GLN . . . 59.16 55.73 4.23 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.106 0.254 . . . . 0.0 111.035 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 3' ' ' THR . . . . . 0.54 HG23 HD21 ' F' ' 18' ' ' ASN . 89.5 m -118.64 111.1 18.11 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.443 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 4' ' ' THR . . . . . 0.697 HG22 ' HG3' ' F' ' 157' ' ' GLN . 0.2 OUTLIER -97.79 127.38 43.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.575 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . 0.54 HG22 HG12 ' F' ' 17' ' ' VAL . 0.0 OUTLIER -153.57 171.46 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.594 179.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.38 122.07 36.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 7' ' ' GLY . . . . . 0.413 ' HA3' HG11 ' F' ' 156' ' ' VAL . . . -75.83 -52.37 6.46 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.859 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.41 -145.53 5.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.868 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.69 139.85 25.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 0.0 111.283 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.43 121.63 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.121 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.71 106.64 18.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.326 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 12' ' ' PHE . . . . . 0.434 ' HZ ' ' CZ ' ' F' ' 54' ' ' PHE . 8.9 m-85 -90.65 107.66 19.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 13' ' ' LYS . . . . . 0.57 ' HG2' HD21 ' F' ' 149' ' ' ASN . 0.1 OUTLIER -103.29 149.18 24.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.384 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.43 -179.03 47.51 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.971 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 15' ' ' GLU . . . . . 0.632 ' HB3' ' HG3' ' F' ' 36' ' ' GLN . 0.1 OUTLIER -158.96 157.01 30.49 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.849 0.357 . . . . 0.0 110.381 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 16' ' ' VAL . . . . . 0.421 ' O ' HG11 ' D' ' 5' ' ' VAL . 18.1 t -113.77 132.21 63.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.148 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . 0.755 HG13 ' HG2' ' F' ' 36' ' ' GLN . 5.6 m -136.84 176.55 7.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 111.107 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . 0.53 HD21 HG23 ' D' ' 3' ' ' THR . 0.4 OUTLIER -74.36 174.11 9.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.012 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 19' ' ' ALA . . . . . 0.564 ' O ' ' HB2' ' E' ' 62' ' ' ASP . . . -83.45 35.38 0.5 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' E' ' 66' ' ' ALA . . . -116.93 -15.9 10.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.412 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 21' ' ' CYS . . . . . 0.485 ' HB3' ' HH ' ' E' ' 158' ' ' TYR . 0.1 OUTLIER -179.99 155.26 0.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.961 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.74 126.43 5.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 23' ' ' VAL . . . . . 0.698 ' HA ' ' HG ' ' E' ' 58' ' ' LEU . 0.7 OUTLIER -60.85 162.54 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.083 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 24' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' E' ' 27' ' ' SER . 18.6 t70 -97.66 160.99 13.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.595 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -64.12 -40.33 95.97 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.365 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.41 12.73 69.09 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.9 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 27' ' ' SER . . . . . 0.534 ' HB3' ' HB3' ' E' ' 24' ' ' ASP . 0.6 OUTLIER -113.84 -25.51 8.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.836 0.35 . . . . 0.0 110.785 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 28' ' ' VAL . . . . . . . . . . . . . 9.7 t -41.14 -61.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.336 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.64 120.01 39.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.013 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -126.11 119.14 26.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.01 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.79 103.29 15.43 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.107 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.82 115.11 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.144 0.497 . . . . 0.0 110.534 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.45 112.6 24.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.601 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mp -75.87 -30.4 58.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.615 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.08 -170.2 27.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.581 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 36' ' ' GLN . . . . . 0.751 ' HG2' HG13 ' D' ' 17' ' ' VAL . 0.4 OUTLIER -93.47 141.71 28.15 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.608 0.242 . . . . 0.0 110.89 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 5.8 p -125.24 157.13 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.914 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.55 122.43 29.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.799 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -40.42 87.1 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.736 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.44 -35.86 68.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.125 0.488 . . . . 0.0 110.87 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -21.54 33.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.14 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' E' ' 139' ' ' ALA . 3.2 mp -110.49 29.38 7.76 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.621 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 43' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' E' ' 141' ' ' GLY . . . -108.16 25.53 11.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.357 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.72 160.0 23.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.342 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' E' ' 140' ' ' THR . 11.1 tt0 -82.92 108.64 16.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 111.131 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.94 10.9 51.39 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.145 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.75 123.47 20.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.943 0.401 . . . . 0.0 111.997 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -120.59 140.27 51.77 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.837 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.529 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 4.6 m -101.6 -167.01 1.36 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.625 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.66 139.7 53.55 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.774 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.87 134.03 35.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.348 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 52' ' ' VAL . . . . . 0.471 HG22 ' O ' ' E' ' 135' ' ' ALA . 18.8 m -87.01 166.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.962 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.75 128.89 8.01 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.628 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 54' ' ' PHE . . . . . 0.43 ' CZ ' ' HZ ' ' D' ' 12' ' ' PHE . 40.7 p90 -160.29 134.44 7.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.79 0.329 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 55' ' ' ASN . . . . . 0.434 ' OD1' ' CG2' ' E' ' 130' ' ' THR . 15.9 p30 -132.75 147.75 52.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.636 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 56' ' ' ILE . . . . . 0.61 HG22 HD13 ' E' ' 58' ' ' LEU . 1.0 OUTLIER -96.83 116.85 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.521 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 57' ' ' GLN . . . . . 0.513 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.0 OUTLIER -66.58 122.07 16.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.704 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . 0.698 ' HG ' ' HA ' ' E' ' 23' ' ' VAL . 0.2 OUTLIER -137.49 88.12 2.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.213 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . 0.707 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 10.6 p30 -79.6 179.29 7.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.89 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.42 64.42 0.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.779 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 61' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' E' ' 129' ' ' ASN . 4.4 m -110.56 163.2 13.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.755 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . 0.564 ' HB2' ' O ' ' E' ' 19' ' ' ALA . 0.5 OUTLIER -140.14 155.0 47.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.344 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.2 -25.42 10.63 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.95 -16.35 50.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.127 0.489 . . . . 0.0 111.754 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -90.68 -48.41 14.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.68 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 66' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' E' ' 20' ' ' ALA . . . -140.16 142.92 35.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.575 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.82 -53.86 2.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.866 0.365 . . . . 0.0 110.918 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 68' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' E' ' 121' ' ' GLU . 0.1 OUTLIER -94.75 158.13 15.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.549 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 69' ' ' ALA . . . . . 0.439 ' HB3' ' HB ' ' E' ' 122' ' ' THR . . . -137.19 120.42 16.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.649 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . 0.416 ' HB2' ' HB3' ' E' ' 118' ' ' PHE . . . -97.54 129.13 44.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.111 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . 0.532 HG13 HG21 ' E' ' 131' ' ' ILE . 15.7 t -112.97 152.23 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.749 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . 0.427 ' H ' HG12 ' E' ' 71' ' ' VAL . . . -150.01 146.65 27.12 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.52 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 73' ' ' PHE . . . . . 0.485 ' HB3' HD23 ' E' ' 113' ' ' LEU . 0.1 OUTLIER -111.58 141.86 44.63 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.525 0.202 . . . . 0.0 111.063 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 74' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.8 OUTLIER -105.67 103.38 12.88 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.962 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' E' ' 113' ' ' LEU . . . -149.95 -179.11 25.49 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.813 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.22 157.8 17.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.554 0.216 . . . . 0.0 110.761 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.91 132.75 38.06 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.849 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 78' ' ' ILE . . . . . 0.466 HG21 ' HB ' ' E' ' 85' ' ' VAL . 0.6 OUTLIER -66.55 -39.82 84.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.911 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.23 53.59 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.844 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.36 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.013 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.28 -36.59 53.16 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.566 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 82' ' ' HIS . . . . . 0.416 ' HB2' HG22 ' E' ' 78' ' ' ILE . 77.9 m80 -81.34 59.98 4.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 110.473 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -70.56 -20.5 62.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.533 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 84' ' ' ASN . . . . . 0.859 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 26.5 p-10 -69.34 -13.75 62.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.297 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' E' ' 102' ' ' GLN . 40.8 t -109.01 131.12 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.153 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 86' ' ' LEU . . . . . 0.577 HD12 HD21 ' E' ' 113' ' ' LEU . 0.6 OUTLIER -69.99 142.87 52.74 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.05 -170.49 3.06 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.937 0.399 . . . . 0.0 111.668 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -80.01 161.4 25.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.985 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.67 -80.34 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.322 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 6.4 p -171.35 0.34 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.958 0.409 . . . . 0.0 111.449 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 91' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' E' ' 95' ' ' SER . 73.5 m -76.78 85.64 3.38 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.35 71.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.942 0.401 . . . . 0.0 111.653 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.82 30.45 6.89 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.611 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.72 -3.15 0.11 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.941 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 95' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' E' ' 91' ' ' SER . 0.1 OUTLIER -107.57 -176.76 3.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.838 0.351 . . . . 0.0 110.641 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.46 172.6 8.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 97' ' ' THR . . . . . 0.61 ' H ' ' HB ' ' E' ' 144' ' ' THR . 1.6 m -126.9 140.44 52.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.348 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 98' ' ' ASN . . . . . 0.421 ' HB3' ' H ' ' E' ' 141' ' ' GLY . 68.3 m-80 61.96 21.33 12.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.45 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.33 135.98 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.746 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.0 -160.73 10.19 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.583 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 101' ' ' VAL . . . . . 0.487 HG11 ' HB2' ' E' ' 86' ' ' LEU . 4.5 p -145.88 109.89 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.181 0.515 . . . . 0.0 111.715 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 102' ' ' GLN . . . . . 0.66 ' HB2' HG23 ' E' ' 85' ' ' VAL . 0.5 OUTLIER -84.34 147.3 27.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.849 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 103' ' ' ILE . . . . . 0.589 HG12 ' HG ' ' E' ' 113' ' ' LEU . 1.2 pp -110.68 127.86 67.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.476 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 104' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 1.4 tp -97.46 132.99 42.64 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.705 0.288 . . . . 0.0 111.021 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' E' ' 111' ' ' LEU . 4.0 t0 -80.84 143.62 32.64 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.662 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 106' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' B' ' 80' ' ' ALA . 0.0 OUTLIER -65.42 -17.52 64.61 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.813 0.34 . . . . 0.0 111.084 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 107' ' ' THR . . . . . 0.501 HG23 ' HB3' ' E' ' 105' ' ' ASP . 13.3 t -66.81 -20.63 65.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.03 -71.71 0.44 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.741 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.52 159.95 31.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.842 0.353 . . . . 0.0 111.061 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 110' ' ' ALA . . . . . 0.587 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -75.56 131.52 40.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.076 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 111' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' E' ' 105' ' ' ASP . 12.2 tp -88.17 154.18 20.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.369 0.604 . . . . 0.0 110.549 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 112' ' ' THR . . . . . 0.859 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 0.4 OUTLIER -96.36 142.75 28.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.09 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 113' ' ' LEU . . . . . 0.589 ' HG ' HG12 ' E' ' 103' ' ' ILE . 0.8 OUTLIER -80.82 63.64 5.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.745 0.307 . . . . 0.0 110.716 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.62 -30.65 17.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.541 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.76 -43.58 1.64 Allowed Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.627 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.56 24.38 13.04 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.011 0.434 . . . . 0.0 111.626 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 117' ' ' THR . . . . . 0.592 HG23 HD12 ' E' ' 111' ' ' LEU . 0.2 OUTLIER -82.11 68.41 8.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.115 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 118' ' ' PHE . . . . . 0.53 ' CD1' ' HB2' ' E' ' 157' ' ' GLN . 41.0 m-85 -82.25 71.92 9.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.769 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.62 80.95 1.85 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.848 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.61 131.7 13.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.611 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 121' ' ' GLU . . . . . 0.411 ' O ' ' HE2' ' E' ' 68' ' ' LYS . 1.5 mm-40 -100.72 52.12 0.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.215 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 122' ' ' THR . . . . . 0.439 ' HB ' ' HB3' ' E' ' 69' ' ' ALA . 0.2 OUTLIER -72.07 131.93 43.53 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.713 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.75 107.69 15.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.675 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . 0.4 HD13 ' CB ' ' E' ' 69' ' ' ALA . 1.0 OUTLIER -88.31 126.53 35.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.537 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 125' ' ' ASN . . . . . 0.488 ' O ' ' HB3' ' E' ' 61' ' ' CYS . 1.1 m120 -120.58 -178.92 3.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.552 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 126' ' ' ASN . . . . . 0.512 ' OD1' ' HA ' ' E' ' 62' ' ' ASP . 3.7 t30 -83.29 120.66 26.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.735 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 127' ' ' GLY . . . . . 0.69 ' HA2' HG21 ' A' ' 4' ' ' THR . . . 136.16 -121.77 2.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.697 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 128' ' ' THR . . . . . 0.707 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 76.7 m -122.19 103.38 8.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.705 0.288 . . . . 0.0 110.764 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 129' ' ' ASN . . . . . 0.509 ' HB2' ' SG ' ' E' ' 61' ' ' CYS . 1.7 t30 -86.06 157.33 20.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.902 0.382 . . . . 0.0 111.127 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 130' ' ' THR . . . . . 0.513 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.3 OUTLIER -143.4 130.2 20.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.029 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 131' ' ' ILE . . . . . 0.532 HG21 HG13 ' E' ' 71' ' ' VAL . 57.4 mt -84.06 104.15 3.85 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 132' ' ' PRO . . . . . 0.668 ' HB3' ' HA ' ' B' ' 76' ' ' THR . 7.5 Cg_endo -82.05 112.41 2.3 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 121.609 1.539 . . . . 0.0 112.574 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 133' ' ' PHE . . . . . 0.408 ' HB3' ' CZ ' ' E' ' 54' ' ' PHE . 1.0 OUTLIER -126.64 158.26 36.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.88 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -126.02 156.08 40.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.095 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 135' ' ' ALA . . . . . 0.471 ' O ' HG22 ' E' ' 52' ' ' VAL . . . -148.23 105.08 3.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 111.613 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.04 163.47 12.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.415 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 137' ' ' TYR . . . . . 0.529 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 0.3 OUTLIER -81.79 119.75 24.28 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.064 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.86 142.63 39.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.067 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 139' ' ' ALA . . . . . 0.555 ' HB3' ' HG ' ' E' ' 42' ' ' LEU . . . -132.9 136.05 45.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.849 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 140' ' ' THR . . . . . 0.63 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 25.5 p -96.63 -56.16 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.534 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' E' ' 43' ' ' ALA . . . -127.14 -129.88 3.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.976 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.97 107.13 12.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.631 0.215 . . . . 0.0 110.782 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 143' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' E' ' 97' ' ' THR . . . -65.88 148.08 52.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.68 0.276 . . . . 0.0 111.447 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 144' ' ' THR . . . . . 0.61 ' HB ' ' H ' ' E' ' 97' ' ' THR . 48.0 m -114.85 144.74 32.55 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.275 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 145' ' ' PRO . . . . . 0.416 ' HD2' HG22 ' E' ' 144' ' ' THR . 1.3 Cg_endo -82.0 131.0 6.76 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.499 2.133 . . . . 0.0 111.978 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 146' ' ' GLY . . . . . 0.58 ' O ' ' HG3' ' D' ' 15' ' ' GLU . . . 164.85 -116.25 0.69 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.435 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 147' ' ' ALA . . . . . 0.623 ' HA ' ' HG3' ' D' ' 15' ' ' GLU . . . -110.65 150.38 29.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.862 0.363 . . . . 0.0 111.304 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.63 45.92 1.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.449 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 149' ' ' ASN . . . . . 0.559 HD21 ' HG2' ' D' ' 13' ' ' LYS . 0.2 OUTLIER -96.97 141.0 30.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.54 -179.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 150' ' ' ALA . . . . . . . . . . . . . . . -153.67 162.59 41.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.006 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.95 135.43 43.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.271 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 152' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -134.17 152.54 51.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.228 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 153' ' ' THR . . . . . . . . . . . . . 4.0 m -104.19 148.92 25.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.21 141.88 35.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.088 0.47 . . . . 0.0 110.11 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.59 152.39 40.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.863 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 156' ' ' VAL . . . . . 0.415 HG11 ' HA3' ' D' ' 7' ' ' GLY . 20.2 m -135.75 133.17 51.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.789 0.328 . . . . 0.0 111.674 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 157' ' ' GLN . . . . . 0.716 ' HG3' HG22 ' D' ' 4' ' ' THR . 1.8 tt0 -130.92 119.82 22.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.318 0.58 . . . . 0.0 110.383 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 158' ' ' TYR . . . . . 0.485 ' HH ' ' HB3' ' E' ' 21' ' ' CYS . 14.2 m-85 -101.99 113.31 26.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.491 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 159' ' ' GLN . . . . . 0.638 ' HA ' ' H ' ' D' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.849 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.266 0.079 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.05 55.85 4.24 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.69 0.281 . . . . 0.0 111.075 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 89.7 m -118.7 111.11 18.09 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.445 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.79 127.26 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.588 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.48 171.5 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.551 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.42 122.08 36.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.62 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.95 -52.27 6.46 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.834 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.46 -145.52 5.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.888 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.72 139.8 25.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 0.0 111.296 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.37 121.6 64.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.149 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.72 106.56 18.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.392 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -90.52 107.69 19.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.842 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.28 149.15 25.0 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.457 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.47 -179.05 47.54 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.947 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.88 157.02 30.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.929 0.395 . . . . 0.0 110.368 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 16' ' ' VAL . . . . . 0.42 ' O ' HG11 ' E' ' 5' ' ' VAL . 18.0 t -113.73 132.19 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.225 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 17' ' ' VAL . . . . . 0.54 HG12 HG22 ' E' ' 5' ' ' VAL . 5.5 m -136.88 176.58 7.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.883 0.373 . . . . 0.0 110.991 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 18' ' ' ASN . . . . . 0.54 HD21 HG23 ' E' ' 3' ' ' THR . 0.4 OUTLIER -74.45 174.13 9.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.036 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 19' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' F' ' 62' ' ' ASP . . . -83.43 35.37 0.5 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.036 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' F' ' 66' ' ' ALA . . . -116.95 -15.9 10.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.422 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 21' ' ' CYS . . . . . 0.486 ' HB3' ' HH ' ' F' ' 158' ' ' TYR . 0.1 OUTLIER -179.98 155.29 0.6 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.961 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.76 126.38 5.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.078 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 23' ' ' VAL . . . . . 0.714 ' HA ' ' HG ' ' F' ' 58' ' ' LEU . 0.7 OUTLIER -60.77 162.46 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.087 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 24' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' F' ' 27' ' ' SER . 18.6 t70 -97.61 161.02 13.97 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.615 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . 0.608 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -64.1 -40.39 96.1 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.348 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.37 12.74 69.09 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.927 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 27' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' F' ' 24' ' ' ASP . 0.6 OUTLIER -113.88 -25.46 8.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.825 0.345 . . . . 0.0 110.813 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 9.6 t -41.16 -61.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.37 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.59 119.9 39.49 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.061 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -126.02 119.07 26.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.057 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.7 103.3 15.46 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.118 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.89 115.13 43.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.147 0.499 . . . . 0.0 110.463 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.51 112.62 24.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.7 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.86 -30.37 58.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.646 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.03 -170.22 27.41 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.625 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 36' ' ' GLN . . . . . 0.755 ' HG2' HG13 ' E' ' 17' ' ' VAL . 0.4 OUTLIER -93.54 141.74 28.12 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.628 0.251 . . . . 0.0 110.909 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 5.7 p -125.29 157.1 34.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.97 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.49 122.44 28.99 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.732 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -40.36 87.06 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.784 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.81 68.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.053 0.454 . . . . 0.0 110.866 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.14 -21.5 33.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.125 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . 0.564 ' HG ' ' HB3' ' F' ' 139' ' ' ALA . 3.2 mp -110.52 29.47 7.68 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.59 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 43' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' F' ' 141' ' ' GLY . . . -108.24 25.52 11.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.322 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.74 159.96 23.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.386 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' F' ' 140' ' ' THR . 11.0 tt0 -82.86 108.69 16.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 0.0 111.155 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.9 10.86 51.59 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.157 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.67 123.42 20.03 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 77.5 p -120.59 140.29 51.73 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.922 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 49' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 4.6 m -101.63 -167.0 1.36 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.602 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.77 139.73 53.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.859 0.361 . . . . 0.0 110.751 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 51' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' F' ' 134' ' ' GLN . . . -82.78 134.03 35.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.362 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 52' ' ' VAL . . . . . 0.477 HG22 ' O ' ' F' ' 135' ' ' ALA . 18.7 m -87.06 166.5 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.972 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.78 128.92 8.01 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.585 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 54' ' ' PHE . . . . . 0.434 ' CZ ' ' HZ ' ' E' ' 12' ' ' PHE . 40.8 p90 -160.28 134.42 7.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.775 0.322 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 55' ' ' ASN . . . . . 0.43 ' OD1' ' CG2' ' F' ' 130' ' ' THR . 15.8 p30 -132.73 147.69 52.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.621 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 56' ' ' ILE . . . . . 0.596 HG12 HD12 ' F' ' 58' ' ' LEU . 1.0 OUTLIER -96.8 116.79 39.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.539 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 57' ' ' GLN . . . . . 0.524 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.0 OUTLIER -66.61 122.12 16.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.703 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . 0.714 ' HG ' ' HA ' ' F' ' 23' ' ' VAL . 0.2 OUTLIER -137.51 88.12 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 -179.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 59' ' ' ASN . . . . . 0.701 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 10.6 p30 -79.49 179.32 7.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.935 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.29 64.46 0.96 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.818 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 61' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' F' ' 129' ' ' ASN . 4.4 m -110.55 163.25 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.821 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . 0.569 ' HB2' ' O ' ' F' ' 19' ' ' ALA . 0.5 OUTLIER -140.19 155.01 47.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.235 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.23 -25.44 10.61 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.89 -16.42 50.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.126 0.489 . . . . 0.0 111.734 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -90.68 -48.46 14.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.627 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 66' ' ' ALA . . . . . 0.548 ' HB2' ' HB3' ' F' ' 20' ' ' ALA . . . -140.13 142.97 35.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.569 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.85 -53.81 2.6 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.882 0.372 . . . . 0.0 110.978 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 68' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' F' ' 121' ' ' GLU . 0.1 OUTLIER -94.85 158.09 15.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.492 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 69' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' F' ' 122' ' ' THR . . . -137.17 120.47 16.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.592 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 70' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' F' ' 118' ' ' PHE . . . -97.57 129.07 44.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.153 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 71' ' ' VAL . . . . . 0.526 HG13 HG21 ' F' ' 131' ' ' ILE . 15.9 t -112.92 152.24 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.708 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 72' ' ' ALA . . . . . 0.432 ' H ' HG12 ' F' ' 71' ' ' VAL . . . -150.02 146.62 27.1 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.56 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 73' ' ' PHE . . . . . 0.491 ' HB3' HD23 ' F' ' 113' ' ' LEU . 0.1 OUTLIER -111.5 141.88 44.5 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.557 0.218 . . . . 0.0 111.078 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 74' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.8 OUTLIER -105.7 103.32 12.8 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.934 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . 0.423 ' HA3' HD22 ' F' ' 113' ' ' LEU . . . -149.87 -179.08 25.4 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.83 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.2 157.83 17.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.501 0.191 . . . . 0.0 110.766 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.91 132.77 38.06 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.929 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 78' ' ' ILE . . . . . 0.449 HG21 ' HB ' ' F' ' 85' ' ' VAL . 0.6 OUTLIER -66.6 -39.83 84.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.15 53.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.38 -87.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.048 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.34 -36.52 53.24 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.603 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 82' ' ' HIS . . . . . 0.425 ' HB2' HG22 ' F' ' 78' ' ' ILE . 77.8 m80 -81.3 59.87 4.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.357 . . . . 0.0 110.484 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -70.58 -20.38 62.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.537 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 84' ' ' ASN . . . . . 0.881 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 26.5 p-10 -69.47 -13.67 62.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.284 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 85' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' F' ' 102' ' ' GLN . 40.8 t -109.01 131.16 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.152 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 86' ' ' LEU . . . . . 0.577 HD12 HD21 ' F' ' 113' ' ' LEU . 0.6 OUTLIER -70.09 142.85 52.58 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.03 -170.51 3.06 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.873 0.368 . . . . 0.0 111.666 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' F' ' 88' ' ' LEU . 1.2 mm? -79.98 161.39 25.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.963 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.75 -80.24 0.01 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.386 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 6.4 p -171.39 0.44 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.943 0.402 . . . . 0.0 111.391 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 91' ' ' SER . . . . . 0.599 ' HB2' ' HB2' ' F' ' 95' ' ' SER . 73.6 m -76.81 85.58 3.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.839 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.28 71.78 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.888 0.375 . . . . 0.0 111.67 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.89 30.49 6.85 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.61 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.76 -3.13 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.934 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 95' ' ' SER . . . . . 0.599 ' HB2' ' HB2' ' F' ' 91' ' ' SER . 0.1 OUTLIER -107.51 -176.67 3.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.366 . . . . 0.0 110.679 179.482 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.6 172.66 8.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.81 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 97' ' ' THR . . . . . 0.594 ' H ' ' HB ' ' F' ' 144' ' ' THR . 1.6 m -126.95 140.37 52.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.331 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 98' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' F' ' 141' ' ' GLY . 68.3 m-80 62.0 21.31 12.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.454 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.38 135.97 58.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.714 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.94 -160.67 10.14 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.552 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 101' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' F' ' 86' ' ' LEU . 4.5 p -145.93 109.86 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.171 0.51 . . . . 0.0 111.729 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 102' ' ' GLN . . . . . 0.656 ' HB2' HG23 ' F' ' 85' ' ' VAL . 0.5 OUTLIER -84.29 147.35 27.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.885 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 103' ' ' ILE . . . . . 0.598 HG12 ' HG ' ' F' ' 113' ' ' LEU . 1.2 pp -110.74 127.87 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.489 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 104' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 1.4 tp -97.46 133.0 42.63 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.711 0.291 . . . . 0.0 111.017 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . 0.58 ' HB2' ' HB2' ' F' ' 111' ' ' LEU . 4.0 t0 -80.81 143.57 32.73 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.706 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 106' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' C' ' 80' ' ' ALA . 0.0 OUTLIER -65.48 -17.48 64.59 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.802 0.334 . . . . 0.0 111.023 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 107' ' ' THR . . . . . 0.506 HG23 ' HB3' ' F' ' 105' ' ' ASP . 13.2 t -66.79 -20.73 66.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.973 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.07 -71.81 0.44 Allowed Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.669 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.39 160.01 31.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.826 0.346 . . . . 0.0 111.098 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 110' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -75.59 131.38 39.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 111' ' ' LEU . . . . . 0.588 HD12 HG23 ' F' ' 117' ' ' THR . 12.2 tp -88.06 154.17 20.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.359 0.6 . . . . 0.0 110.572 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 112' ' ' THR . . . . . 0.881 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 0.4 OUTLIER -96.41 142.69 28.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.062 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 113' ' ' LEU . . . . . 0.598 ' HG ' HG12 ' F' ' 103' ' ' ILE . 0.8 OUTLIER -80.76 63.61 5.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.723 0.297 . . . . 0.0 110.77 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.58 -30.6 17.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.611 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.73 -43.59 1.64 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.686 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.61 24.43 12.97 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.988 0.423 . . . . 0.0 111.608 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 117' ' ' THR . . . . . 0.588 HG23 HD12 ' F' ' 111' ' ' LEU . 0.2 OUTLIER -82.12 68.25 8.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.16 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 118' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' F' ' 157' ' ' GLN . 40.9 m-85 -82.07 71.93 9.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.759 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.74 81.02 1.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.66 131.74 13.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.557 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 121' ' ' GLU . . . . . 0.414 ' O ' ' HE2' ' F' ' 68' ' ' LYS . 1.5 mm-40 -100.7 52.1 0.87 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.197 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 122' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' F' ' 69' ' ' ALA . 0.2 OUTLIER -72.14 131.98 43.54 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.78 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.63 107.54 15.35 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.771 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . 0.408 HD13 ' CB ' ' F' ' 69' ' ' ALA . 1.0 OUTLIER -88.23 126.58 35.23 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.59 179.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 125' ' ' ASN . . . . . 0.486 ' O ' ' HB3' ' F' ' 61' ' ' CYS . 1.1 m120 -120.65 -178.99 3.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.542 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 126' ' ' ASN . . . . . 0.499 ' OD1' ' HA ' ' F' ' 62' ' ' ASP . 3.8 t30 -83.25 120.68 26.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.695 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 127' ' ' GLY . . . . . 0.696 ' HA2' HG21 ' B' ' 4' ' ' THR . . . 136.12 -121.77 2.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.657 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 128' ' ' THR . . . . . 0.701 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 76.3 m -122.12 103.44 8.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.727 0.299 . . . . 0.0 110.807 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 129' ' ' ASN . . . . . 0.504 ' HB2' ' SG ' ' F' ' 61' ' ' CYS . 1.8 t30 -86.18 157.26 20.03 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.857 0.36 . . . . 0.0 111.086 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 130' ' ' THR . . . . . 0.524 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.3 OUTLIER -143.34 130.14 20.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.162 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 131' ' ' ILE . . . . . 0.526 HG21 HG13 ' F' ' 71' ' ' VAL . 57.3 mt -83.97 104.14 3.79 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 132' ' ' PRO . . . . . 0.674 ' HB3' ' HA ' ' C' ' 76' ' ' THR . 7.5 Cg_endo -82.08 112.45 2.3 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.535 1.49 . . . . 0.0 112.548 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 133' ' ' PHE . . . . . 0.411 ' HB3' ' CZ ' ' F' ' 54' ' ' PHE . 1.0 OUTLIER -126.69 158.27 36.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.856 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 134' ' ' GLN . . . . . 0.4 ' HB3' ' HB3' ' F' ' 51' ' ' ALA . 15.9 mt-30 -125.97 156.01 40.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.119 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 135' ' ' ALA . . . . . 0.477 ' O ' HG22 ' F' ' 52' ' ' VAL . . . -148.14 105.15 3.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 111.609 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.11 163.46 12.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.375 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 137' ' ' TYR . . . . . 0.507 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 0.3 OUTLIER -81.72 119.69 24.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.131 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.82 142.69 39.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.275 0.56 . . . . 0.0 112.058 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 139' ' ' ALA . . . . . 0.564 ' HB3' ' HG ' ' F' ' 42' ' ' LEU . . . -132.94 136.05 45.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.831 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 140' ' ' THR . . . . . 0.643 ' O ' ' HA ' ' F' ' 45' ' ' GLU . 24.9 p -96.65 -56.26 2.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.423 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . 0.434 ' H ' ' HB3' ' F' ' 98' ' ' ASN . . . -127.04 -129.91 3.31 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.973 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.94 107.15 12.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.521 0.201 . . . . 0.0 110.741 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 143' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' F' ' 97' ' ' THR . . . -65.89 148.07 52.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.686 0.279 . . . . 0.0 111.44 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 144' ' ' THR . . . . . 0.594 ' HB ' ' H ' ' F' ' 97' ' ' THR . 48.0 m -114.88 144.72 32.52 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.262 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 145' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' F' ' 144' ' ' THR . 1.4 Cg_endo -81.96 130.96 6.78 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.549 2.166 . . . . 0.0 111.953 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 146' ' ' GLY . . . . . 0.603 ' O ' ' HG3' ' E' ' 15' ' ' GLU . . . 164.82 -116.27 0.69 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.452 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 147' ' ' ALA . . . . . 0.619 ' HA ' ' HG3' ' E' ' 15' ' ' GLU . . . -110.65 150.4 29.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.866 0.365 . . . . 0.0 111.28 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.65 45.82 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.128 0.49 . . . . 0.0 110.513 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 149' ' ' ASN . . . . . 0.57 HD21 ' HG2' ' E' ' 13' ' ' LYS . 0.2 OUTLIER -96.85 141.02 30.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.535 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 150' ' ' ALA . . . . . . . . . . . . . . . -153.71 162.53 41.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.958 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.85 135.46 43.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.225 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 152' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -134.16 152.51 51.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.17 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 153' ' ' THR . . . . . . . . . . . . . 4.0 m -104.16 148.95 25.7 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.29 141.87 35.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.047 0.451 . . . . 0.0 110.155 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -122.57 152.41 40.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.89 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 156' ' ' VAL . . . . . 0.413 HG11 ' HA3' ' E' ' 7' ' ' GLY . 20.1 m -135.72 133.13 51.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.79 0.329 . . . . 0.0 111.683 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 157' ' ' GLN . . . . . 0.697 ' HG3' HG22 ' E' ' 4' ' ' THR . 1.8 tt0 -130.95 119.86 22.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.339 0.59 . . . . 0.0 110.342 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 158' ' ' TYR . . . . . 0.486 ' HH ' ' HB3' ' F' ' 21' ' ' CYS . 14.1 m-85 -102.0 113.28 26.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.523 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 159' ' ' GLN . . . . . 0.629 ' HA ' ' H ' ' E' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.85 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.569 0.223 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.38 87.58 6.08 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.475 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.604 ' HB ' ' HA3' ' E' ' 127' ' ' GLY . 3.5 m -90.46 115.43 27.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.602 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 m -127.21 166.97 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.604 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.603 ' HA ' ' HE2' ' B' ' 155' ' ' LYS . 19.9 t30 -83.06 115.15 21.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.517 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.33 -71.5 1.06 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.884 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.24 172.78 34.74 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.907 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 m -95.47 136.96 35.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.409 . . . . 0.0 111.305 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.689 HG11 ' CE2' ' A' ' 12' ' ' PHE . 40.2 t -120.84 130.68 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.218 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.518 ' O ' ' HB ' ' B' ' 32' ' ' VAL . 1.3 m80 -103.78 158.0 16.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.459 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.689 ' CE2' HG11 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -145.81 89.57 1.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.426 ' HG2' ' HA ' ' B' ' 33' ' ' GLN . 0.0 OUTLIER -79.97 135.19 36.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.41 179.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.57 178.39 42.07 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.958 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.643 ' HG2' ' HA ' ' B' ' 147' ' ' ALA . 2.6 mt-10 -156.8 -177.93 6.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.368 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.504 HG21 HG23 ' B' ' 37' ' ' VAL . 2.7 t -142.24 150.13 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.233 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.507 HG11 ' HE2' ' A' ' 158' ' ' TYR . 4.1 m -141.7 168.61 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.333 . . . . 0.0 111.066 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.02 74.73 4.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.058 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.88 91.86 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.027 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.46 -50.98 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.433 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER 179.82 -179.68 0.47 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.965 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.587 ' HA ' ' HB3' ' B' ' 36' ' ' GLN . . . -136.2 116.43 13.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.085 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.2 t -67.08 120.15 13.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.026 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.39 150.49 46.25 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.585 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.37 -50.22 31.54 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.326 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.27 -31.8 81.71 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.895 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.04 -16.02 63.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.929 0.395 . . . . 0.0 110.847 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.5 t -72.96 -43.59 58.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.41 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.39 106.04 10.32 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -116.65 134.03 55.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.074 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.49 96.04 6.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.058 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.3 t -89.46 131.25 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.131 0.491 . . . . 0.0 110.488 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.95 106.41 16.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.618 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.727 HD22 HG13 ' A' ' 101' ' ' VAL . 0.4 OUTLIER -73.8 -40.87 63.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.649 179.372 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.95 -122.46 6.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.595 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -144.52 153.95 42.38 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.699 0.285 . . . . 0.0 110.862 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.454 HG12 ' CD2' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -128.57 146.35 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.86 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.23 145.97 26.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.717 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.7 p -57.8 -23.02 50.47 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.719 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.93 -33.21 61.94 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.096 0.474 . . . . 0.0 110.844 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -31.15 69.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.124 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -130.76 86.42 2.37 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.649 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.7 36.2 4.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.37 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.64 150.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.337 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.78 134.83 54.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 111.136 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.79 -14.16 53.14 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.137 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 138' ' ' PHE . . . -57.2 129.86 43.64 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.938 0.399 . . . . 0.0 112.002 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.459 ' HB ' ' CE1' ' A' ' 138' ' ' PHE . 14.3 t -130.59 143.31 50.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.909 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.572 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 68.4 m -111.97 -157.16 0.61 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.552 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.9 t -74.62 150.15 39.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.784 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.53 ' HB3' ' NE2' ' A' ' 134' ' ' GLN . . . -103.2 146.64 28.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.322 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 22.4 m -83.38 148.34 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.4 121.21 6.21 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.6 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -153.83 125.56 7.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.28 156.17 20.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.609 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.6 mm -104.08 135.37 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.486 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.64 125.99 48.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.765 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 129' ' ' ASN . 4.3 mp -131.7 100.0 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.273 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.49 174.81 11.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.946 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.8 65.19 1.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.792 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 60.7 m -98.66 142.94 29.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.59 109.25 15.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.269 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.44 29.54 1.69 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.03 -59.1 2.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.029 0.443 . . . . 0.0 111.819 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.28 -39.8 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.706 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.69 101.39 10.7 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.593 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.6 p -90.54 -28.82 18.25 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.902 0.382 . . . . 0.0 110.95 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.4 166.99 16.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.513 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.9 149.77 29.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.572 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 157' ' ' GLN . . . -112.85 159.79 18.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.092 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.2 t -108.04 123.25 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.689 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.476 ' HB2' ' CB ' ' A' ' 155' ' ' LYS . . . -124.64 168.95 12.44 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.596 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.436 ' CB ' HD11 ' A' ' 111' ' ' LEU . 17.1 t80 -150.59 144.39 25.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.535 0.207 . . . . 0.0 111.168 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.574 HD21 HD22 ' D' ' 55' ' ' ASN . 0.4 OUTLIER -121.56 88.64 2.97 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.989 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.69 164.72 24.65 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.773 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -78.54 147.73 33.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.544 0.211 . . . . 0.0 110.779 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.495 ' H ' ' HB3' ' D' ' 132' ' ' PRO . . . -95.7 140.34 30.65 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.959 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.624 HG12 HG22 ' A' ' 140' ' ' THR . 1.1 tt -78.71 -33.05 16.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.851 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.22 179.22 7.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.838 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.68 -27.87 36.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.059 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.25 -32.22 72.21 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.552 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -97.33 -72.69 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 0.0 110.464 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.85 -7.24 1.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.586 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -108.7 -19.13 13.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.364 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.545 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 50.2 t -80.65 132.03 32.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.124 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.666 ' HA ' ' O ' ' A' ' 76' ' ' THR . 0.4 OUTLIER -76.52 134.95 39.31 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.355 179.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.629 ' HB1' ' HB ' ' A' ' 76' ' ' THR . . . -62.28 165.18 6.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.828 0.347 . . . . 0.0 111.682 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.427 HD13 HG21 ' A' ' 97' ' ' THR . 0.1 OUTLIER -65.75 171.65 4.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.029 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.47 ' OE1' ' HB3' ' A' ' 91' ' ' SER . 8.0 pt20 -72.45 175.75 5.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.349 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.464 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 0.5 OUTLIER -76.06 -21.26 56.97 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.997 0.427 . . . . 0.0 111.492 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.47 ' HB3' ' OE1' ' A' ' 89' ' ' GLN . 32.0 t -80.92 67.56 6.87 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.435 ' HA ' ' OG ' ' A' ' 95' ' ' SER . . . -72.27 -9.74 58.87 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.901 0.381 . . . . 0.0 111.668 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.552 ' HB1' ' HB2' ' C' ' 22' ' ' ALA . . . -68.08 -22.91 64.9 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.632 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.39 6.76 2.5 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.932 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.674 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 30.7 p -93.73 150.75 20.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.637 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.69 167.21 18.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.834 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.427 HG21 HD13 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -118.65 165.15 14.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.366 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.514 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 85.0 m-20 63.29 45.43 5.0 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.494 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.65 ' HB ' ' HB3' ' A' ' 143' ' ' ALA . 3.5 p -170.63 131.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.787 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.08 -175.96 21.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.556 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.727 HG13 HD22 ' A' ' 34' ' ' LEU . 76.3 t -104.14 91.84 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 122.971 0.509 . . . . 0.0 111.745 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -67.86 131.21 45.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.44 110.52 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.498 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 5.5 tp -91.23 149.94 21.55 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.709 0.29 . . . . 0.0 111.027 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.95 174.68 5.79 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.631 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.524 ' HB3' ' HG ' ' A' ' 120' ' ' SER . 1.5 ttt180 -72.49 -18.63 61.65 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.719 0.295 . . . . 0.0 110.989 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.0 p -69.25 -9.6 53.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.033 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.97 -48.44 0.95 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.625 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.94 163.54 15.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 0.0 111.062 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -70.39 125.51 27.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.174 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.436 HD11 ' CB ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -65.36 147.61 53.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.367 0.603 . . . . 0.0 110.564 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.03 144.58 45.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.131 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.521 ' N ' HD11 ' A' ' 113' ' ' LEU . 10.2 mp -100.28 89.94 4.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.769 0.319 . . . . 0.0 110.663 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.525 ' HB2' HG21 ' A' ' 117' ' ' THR . 4.1 m-20 -142.42 11.37 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.657 0.265 . . . . 0.0 111.555 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.91 -78.09 0.69 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.669 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.27 61.54 0.73 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.973 0.416 . . . . 0.0 111.662 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.525 HG21 ' HB2' ' A' ' 114' ' ' ASP . 17.6 p -93.35 95.84 9.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.131 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.79 110.0 5.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.9 m -120.35 -72.92 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.773 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.524 ' HG ' ' HB3' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -92.4 113.03 25.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.602 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -99.47 97.53 8.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.207 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.5 132.71 37.52 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.775 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 124' ' ' LEU . 22.1 m -60.89 146.12 47.75 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.727 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.438 ' N ' HG23 ' A' ' 123' ' ' THR . 0.2 OUTLIER -85.48 156.56 20.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.562 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.78 142.75 40.88 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.54 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.94 113.63 6.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.74 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.59 -90.08 0.32 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.744 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.0 m -124.88 152.77 43.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.745 0.307 . . . . 0.0 110.798 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.528 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 17.1 t-20 -123.0 147.52 46.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.19 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.3 m -126.12 135.7 52.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.098 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.4 mt -114.03 115.65 45.47 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -81.7 115.71 2.81 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.629 1.553 . . . . 0.0 112.567 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.58 150.81 46.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.825 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.53 ' NE2' ' HB3' ' A' ' 51' ' ' ALA . 1.2 mt-30 -142.48 166.67 24.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.029 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 102' ' ' GLN . . . -158.13 102.94 1.81 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 111.654 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -94.68 -173.4 3.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.396 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.572 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 3.8 m-85 -100.78 152.87 19.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.068 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -147.37 160.73 42.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.998 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.425 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -126.86 149.61 49.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.925 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.624 HG22 HG12 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -115.34 27.83 9.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.461 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.4 66.75 0.2 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.955 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.99 88.59 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.602 0.239 . . . . 0.0 110.744 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.65 ' HB3' ' HB ' ' A' ' 99' ' ' VAL . . . -60.19 156.88 14.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.709 0.29 . . . . 0.0 111.452 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.536 ' HB ' ' CD ' ' A' ' 145' ' ' PRO . 77.3 p -112.26 173.02 3.08 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.218 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.536 ' CD ' ' HB ' ' A' ' 144' ' ' THR . 1.3 Cg_endo -84.51 145.16 10.45 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.518 2.145 . . . . 0.0 111.995 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.44 -112.7 0.55 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.512 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -124.93 167.67 14.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.892 0.377 . . . . 0.0 111.275 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -157.19 57.54 0.52 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.411 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.85 132.73 36.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.539 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.47 163.13 28.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.937 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.45 125.58 1.83 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.231 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.638 ' HB1' HD11 ' A' ' 86' ' ' LEU . . . -154.57 165.79 35.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.244 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.9 163.18 12.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -119.01 134.6 55.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.102 0.477 . . . . 0.0 110.102 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.476 ' CB ' ' HB2' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -95.64 166.24 11.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.913 -178.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.24 112.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.793 0.33 . . . . 0.0 111.657 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -88.77 138.81 31.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.278 0.561 . . . . 0.0 110.403 -179.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.507 ' HE2' HG11 ' A' ' 17' ' ' VAL . 22.5 m-85 -127.65 113.16 15.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.568 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.976 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.241 0.067 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.94 68.26 0.88 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.645 0.26 . . . . 0.0 111.06 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.33 87.63 6.12 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.454 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.596 ' HB ' ' HA3' ' F' ' 127' ' ' GLY . 3.5 m -90.35 115.47 27.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.571 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -127.34 167.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.588 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . 0.625 ' HA ' ' HE2' ' C' ' 155' ' ' LYS . 20.2 t30 -82.95 115.11 21.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.577 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.39 -71.48 1.06 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.827 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.31 172.78 34.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.909 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 33.3 m -95.52 137.01 35.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.941 0.4 . . . . 0.0 111.253 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.676 HG11 ' CE2' ' B' ' 12' ' ' PHE . 40.4 t -120.8 130.76 74.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.173 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' HIS . . . . . 0.528 ' O ' ' HB ' ' C' ' 32' ' ' VAL . 1.3 m80 -103.92 157.97 16.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.41 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . 0.676 ' CE2' HG11 ' B' ' 10' ' ' VAL . 0.5 OUTLIER -145.82 89.67 1.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.823 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' C' ' 33' ' ' GLN . 0.0 OUTLIER -80.04 135.21 36.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.431 179.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.57 178.38 42.08 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.953 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.644 ' HG2' ' HA ' ' C' ' 147' ' ' ALA . 2.6 mt-10 -156.78 -177.86 6.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.385 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.493 HG21 HG23 ' C' ' 37' ' ' VAL . 2.7 t -142.35 150.1 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.235 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.524 HG11 ' HE2' ' B' ' 158' ' ' TYR . 4.1 m -141.73 168.57 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.856 0.36 . . . . 0.0 110.996 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -92.93 74.78 4.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.039 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.78 91.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.045 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.42 -51.07 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.421 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER 179.83 -179.8 0.48 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.996 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.578 ' HA ' ' HB3' ' C' ' 36' ' ' GLN . . . -136.14 116.5 13.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.138 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.07 120.15 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.003 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.36 150.45 46.26 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.605 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.38 -50.1 32.1 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.388 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.36 -31.79 81.55 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.841 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.07 -15.98 63.58 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.879 0.371 . . . . 0.0 110.831 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -72.96 -43.68 58.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.375 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.36 106.11 10.4 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.005 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -116.68 134.03 55.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.49 96.09 6.27 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.057 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.518 ' HB ' ' O ' ' A' ' 11' ' ' HIS . 69.3 t -89.53 131.27 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.15 0.5 . . . . 0.0 110.456 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.426 ' HA ' ' HG2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -108.97 106.48 16.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.637 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.726 HD22 HG13 ' B' ' 101' ' ' VAL . 0.4 OUTLIER -73.79 -40.89 63.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.66 179.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.89 -122.41 6.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.601 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 16.3 tt0 -144.6 153.85 42.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.586 0.231 . . . . 0.0 110.939 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.504 HG23 HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -128.5 146.32 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.909 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.25 146.0 26.07 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.7 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 40.9 p -57.78 -22.99 50.12 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.713 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.01 -33.22 61.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.013 0.435 . . . . 0.0 110.809 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -31.1 69.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.174 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.424 ' HB3' ' HB2' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -130.83 86.34 2.36 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.604 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.64 36.19 4.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.357 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 177.56 150.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.392 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.79 134.81 54.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.884 0.373 . . . . 0.0 111.103 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.79 -14.19 53.12 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.218 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' B' ' 138' ' ' PHE . . . -57.19 129.8 43.36 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.451 ' HB ' ' CE1' ' B' ' 138' ' ' PHE . 14.3 t -130.55 143.34 50.69 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.864 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' SER . . . . . 0.58 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 68.6 m -111.95 -157.2 0.61 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.579 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 27.5 t -74.46 150.13 40.05 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . 0.53 ' HB3' ' NE2' ' B' ' 134' ' ' GLN . . . -103.28 146.61 28.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.328 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' B' ' 134' ' ' GLN . 22.0 m -83.31 148.31 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.981 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.35 121.21 6.22 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.638 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -153.81 125.52 7.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.737 0.303 . . . . 0.0 110.955 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.23 156.22 20.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.626 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 22.5 mm -104.04 135.35 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.51 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.75 126.05 48.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.771 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' B' ' 129' ' ' ASN . 4.3 mp -131.62 99.91 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.275 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.43 174.79 11.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.71 65.24 1.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.809 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' B' ' 21' ' ' CYS . 60.6 m -98.64 142.86 29.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.822 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.58 109.22 15.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.329 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.37 29.53 1.67 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . 0.442 HD21 ' HA ' ' B' ' 64' ' ' ASN . 0.1 OUTLIER -90.0 -59.16 2.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.039 0.447 . . . . 0.0 111.726 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.29 -39.82 13.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.71 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.58 101.3 10.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.614 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.1 p -90.58 -28.74 18.27 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.872 0.367 . . . . 0.0 110.971 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.49 166.94 16.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.523 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.82 149.8 29.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.646 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' B' ' 157' ' ' GLN . . . -112.88 159.77 18.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.097 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 51.1 t -108.06 123.25 63.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.693 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.492 ' HB2' ' CB ' ' B' ' 155' ' ' LYS . . . -124.6 168.96 12.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.563 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.427 ' CB ' HD11 ' B' ' 111' ' ' LEU . 17.2 t80 -150.59 144.37 25.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.533 0.206 . . . . 0.0 111.205 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.585 HD21 HD22 ' E' ' 55' ' ' ASN . 0.4 OUTLIER -121.42 88.57 2.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.033 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.75 164.7 24.67 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.813 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.653 ' O ' ' HA ' ' B' ' 86' ' ' LEU . 0.6 OUTLIER -78.51 147.76 33.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.531 0.205 . . . . 0.0 110.775 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . 0.488 ' H ' ' HB3' ' E' ' 132' ' ' PRO . . . -95.79 140.32 30.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.887 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.637 HG12 HG22 ' B' ' 140' ' ' THR . 1.2 tt -78.7 -33.09 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.873 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.16 179.21 7.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.848 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.66 -27.84 37.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.26 -32.21 72.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.603 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -97.38 -72.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 0.0 110.475 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.77 -7.13 1.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.599 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -108.8 -19.1 13.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.329 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.55 ' HB ' ' CG2' ' B' ' 78' ' ' ILE . 49.8 t -80.53 132.06 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.183 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . 0.653 ' HA ' ' O ' ' B' ' 76' ' ' THR . 0.4 OUTLIER -76.61 134.91 39.2 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.283 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.637 ' HB1' ' HB ' ' B' ' 76' ' ' THR . . . -62.21 165.16 6.09 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.939 0.399 . . . . 0.0 111.678 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . 0.434 HD13 HG21 ' B' ' 97' ' ' THR . 0.1 OUTLIER -65.72 171.7 4.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . 0.466 ' OE1' ' HB3' ' B' ' 91' ' ' SER . 8.0 pt20 -72.54 175.76 6.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.349 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' SER . . . . . 0.461 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 0.5 OUTLIER -76.04 -21.24 57.02 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.984 0.421 . . . . 0.0 111.492 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' SER . . . . . 0.466 ' HB3' ' OE1' ' B' ' 89' ' ' GLN . 32.1 t -80.94 67.53 6.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . 0.433 ' HA ' ' OG ' ' B' ' 95' ' ' SER . . . -72.29 -9.66 58.77 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.637 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . 0.559 ' HB1' ' HB2' ' D' ' 22' ' ' ALA . . . -68.05 -22.9 64.93 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.653 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.46 6.73 2.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.917 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' SER . . . . . 0.697 ' HA ' ' HB3' ' B' ' 147' ' ' ALA . 30.5 p -93.69 150.79 20.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.851 0.358 . . . . 0.0 110.632 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.79 167.19 18.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.434 HG21 HD13 ' B' ' 88' ' ' LEU . 0.2 OUTLIER -118.6 165.18 14.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.366 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . 0.499 ' HA ' ' OG1' ' B' ' 140' ' ' THR . 85.0 m-20 63.17 45.54 5.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.465 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' B' ' 143' ' ' ALA . 3.5 p -170.63 131.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.76 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.11 -176.02 21.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.529 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . 0.726 HG13 HD22 ' B' ' 34' ' ' LEU . 75.8 t -104.06 91.85 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 122.946 0.498 . . . . 0.0 111.79 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 0.0 OUTLIER -67.83 131.18 45.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.919 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.4 110.53 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.526 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 5.5 tp -91.22 149.99 21.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.628 0.251 . . . . 0.0 111.053 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.95 174.62 5.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.652 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . 0.517 ' HB3' ' HG ' ' B' ' 120' ' ' SER . 1.5 ttt180 -72.44 -18.54 61.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.796 0.331 . . . . 0.0 111.079 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 46.0 p -69.36 -9.57 54.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.005 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.02 -48.43 0.95 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.671 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.91 163.57 15.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 0.0 111.154 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -70.45 125.52 27.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.427 HD11 ' CB ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -65.35 147.59 53.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.321 0.581 . . . . 0.0 110.607 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.99 144.56 45.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.136 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.519 ' N ' HD11 ' B' ' 113' ' ' LEU . 10.2 mp -100.29 89.82 4.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.762 0.315 . . . . 0.0 110.682 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . 0.527 ' HB2' HG21 ' B' ' 117' ' ' THR . 4.1 m-20 -142.36 11.47 1.92 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.668 0.27 . . . . 0.0 111.621 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.92 -78.14 0.69 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.576 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.26 61.56 0.73 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.976 0.417 . . . . 0.0 111.629 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' THR . . . . . 0.527 HG21 ' HB2' ' B' ' 114' ' ' ASP . 17.7 p -93.38 95.82 9.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.123 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.77 109.97 5.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.781 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.32 -72.89 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' SER . . . . . 0.517 ' HG ' ' HB3' ' B' ' 106' ' ' ARG . 0.1 OUTLIER -92.52 113.07 25.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.583 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.43 97.54 8.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.204 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.47 132.68 37.51 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.761 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' THR . . . . . 0.432 HG23 ' N ' ' B' ' 124' ' ' LEU . 22.2 m -60.92 146.19 47.63 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.74 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . 0.432 ' N ' HG23 ' B' ' 123' ' ' THR . 0.2 OUTLIER -85.48 156.5 20.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.595 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.77 142.8 40.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.515 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.01 113.61 6.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.732 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.59 -90.03 0.32 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.73 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 6.1 m -124.88 152.82 43.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.677 0.275 . . . . 0.0 110.815 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . 0.529 ' HB3' ' HB2' ' B' ' 58' ' ' LEU . 17.0 t-20 -123.04 147.6 46.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.963 0.411 . . . . 0.0 111.096 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.3 m -126.19 135.61 51.84 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.085 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' ILE . . . . . . . . . . . . . 58.6 mt -113.95 115.72 45.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -81.74 115.68 2.79 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.67 1.58 . . . . 0.0 112.598 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.58 150.84 46.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.806 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' GLN . . . . . 0.53 ' NE2' ' HB3' ' B' ' 51' ' ' ALA . 1.2 mt-30 -142.46 166.75 23.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.034 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' B' ' 102' ' ' GLN . . . -158.22 102.88 1.79 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 0.0 111.626 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' B' ' 51' ' ' ALA . 0.2 OUTLIER -94.67 -173.41 3.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.439 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . 0.58 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 3.8 m-85 -100.83 152.83 20.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.074 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' B' ' 47' ' ' ALA . 0.2 OUTLIER -147.32 160.81 42.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.002 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -126.92 149.65 49.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.876 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' THR . . . . . 0.637 HG22 HG12 ' B' ' 78' ' ' ILE . 0.0 OUTLIER -115.41 27.86 9.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.453 179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.46 66.86 0.2 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.879 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.94 88.62 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.568 0.223 . . . . 0.0 110.69 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' ALA . . . . . 0.661 ' HB3' ' HB ' ' B' ' 99' ' ' VAL . . . -60.25 156.94 14.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.764 0.316 . . . . 0.0 111.407 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.534 ' HB ' ' CD ' ' B' ' 145' ' ' PRO . 76.5 p -112.23 173.04 3.07 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.236 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.534 ' CD ' ' HB ' ' B' ' 144' ' ' THR . 1.3 Cg_endo -84.55 145.23 10.43 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.552 2.168 . . . . 0.0 111.979 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.37 -112.73 0.55 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.521 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -125.02 167.62 14.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.826 0.346 . . . . 0.0 111.308 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' ALA . . . . . 0.473 ' HB3' HG22 ' A' ' 16' ' ' VAL . . . -157.16 57.52 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.459 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -91.84 132.72 36.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.582 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.4 163.13 28.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.023 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.44 125.61 1.83 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.25 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . 0.652 ' HB1' HD11 ' B' ' 86' ' ' LEU . . . -154.51 165.82 35.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.211 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.92 163.11 12.77 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -119.01 134.6 55.09 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.181 0.515 . . . . 0.0 110.069 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . 0.603 ' HE2' ' HA ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -95.57 166.26 11.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.923 -178.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.29 112.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.81 0.338 . . . . 0.0 111.663 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.5 ' HB3' ' HB2' ' B' ' 70' ' ' ALA . 0.2 OUTLIER -88.73 138.88 31.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.286 0.565 . . . . 0.0 110.423 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' TYR . . . . . 0.524 ' HE2' HG11 ' B' ' 17' ' ' VAL . 22.6 m-85 -127.73 113.11 15.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.554 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.937 179.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.304 0.097 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.96 68.25 0.88 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.62 0.248 . . . . 0.0 110.999 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.31 87.69 6.15 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.46 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 4' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' D' ' 157' ' ' GLN . 3.5 m -90.51 115.49 27.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.55 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 m -127.3 167.01 22.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.589 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' ASN . . . . . 0.62 ' HA ' ' HE2' ' D' ' 155' ' ' LYS . 19.9 t30 -83.06 115.16 21.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.507 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.34 -71.53 1.06 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.828 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.28 172.75 34.76 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.931 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 33.2 m -95.5 137.0 35.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.972 0.415 . . . . 0.0 111.219 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . 0.687 HG11 ' CE2' ' C' ' 12' ' ' PHE . 40.1 t -120.78 130.75 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.225 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' HIS . . . . . 0.528 ' O ' ' HB ' ' D' ' 32' ' ' VAL . 1.3 m80 -103.86 157.99 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.392 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' PHE . . . . . 0.687 ' CE2' HG11 ' C' ' 10' ' ' VAL . 0.6 OUTLIER -145.91 89.67 1.91 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.793 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . 0.437 ' HG2' ' HA ' ' D' ' 33' ' ' GLN . 0.0 OUTLIER -80.04 135.15 36.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.437 179.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.5 178.43 42.02 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.898 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' GLU . . . . . 0.655 ' HG2' ' HA ' ' D' ' 147' ' ' ALA . 2.6 mt-10 -156.87 -177.98 7.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.382 . . . . 0.0 110.327 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' D' ' 148' ' ' ALA . 2.7 t -142.24 150.13 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.253 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.526 HG11 ' HE2' ' C' ' 158' ' ' TYR . 4.1 m -141.72 168.57 15.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 111.025 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.04 74.77 4.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.068 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.82 91.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.011 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.49 -50.97 0.08 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.475 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER 179.87 -179.77 0.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.019 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . 0.583 ' HA ' ' HB3' ' D' ' 36' ' ' GLN . . . -136.16 116.43 13.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.168 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 69.0 t -67.02 120.15 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.043 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.46 150.47 46.49 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.59 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.35 -50.16 31.58 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.343 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.34 -31.77 81.51 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.897 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.09 -15.93 63.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -72.94 -43.67 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.36 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.44 106.08 10.34 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -116.67 133.98 55.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.026 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.5 96.07 6.25 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.069 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' B' ' 11' ' ' HIS . 69.5 t -89.45 131.24 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.154 0.502 . . . . 0.0 110.434 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.423 ' HA ' ' HG2' ' B' ' 13' ' ' LYS . 0.3 OUTLIER -109.02 106.46 16.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.582 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.724 HD22 HG13 ' C' ' 101' ' ' VAL . 0.4 OUTLIER -73.82 -40.89 63.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.642 179.368 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.98 -122.45 6.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.556 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . 0.578 ' HB3' ' HA ' ' B' ' 22' ' ' ALA . 16.2 tt0 -144.55 153.9 42.31 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.621 0.248 . . . . 0.0 110.913 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . 0.493 HG23 HG21 ' B' ' 16' ' ' VAL . 0.0 OUTLIER -128.51 146.3 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.848 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.22 145.96 26.1 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.772 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 41.0 p -57.73 -23.03 49.87 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.777 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.94 -33.2 61.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.056 0.455 . . . . 0.0 110.833 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.0 -31.21 69.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.142 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' C' ' 139' ' ' ALA . 0.0 OUTLIER -130.77 86.41 2.37 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.65 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.68 36.14 4.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.371 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.6 150.89 0.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.343 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.8 134.84 54.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.337 . . . . 0.0 111.135 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.74 -14.08 53.35 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.143 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' C' ' 138' ' ' PHE . . . -57.27 129.86 43.63 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' THR . . . . . 0.463 ' HB ' ' CE1' ' C' ' 138' ' ' PHE . 14.3 t -130.57 143.31 50.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.903 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.576 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 68.6 m -111.96 -157.23 0.61 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.565 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.402 ' H ' ' HB3' ' C' ' 49' ' ' SER . 27.7 t -74.59 150.13 39.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.816 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . 0.536 ' HB3' ' NE2' ' C' ' 134' ' ' GLN . . . -103.24 146.65 28.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.344 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' C' ' 134' ' ' GLN . 22.2 m -83.35 148.35 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.42 121.17 6.19 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.645 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -153.79 125.59 7.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.777 0.322 . . . . 0.0 110.933 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.35 156.17 20.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.543 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 22.4 mm -103.9 135.28 42.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.635 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.7 126.04 48.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.755 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . 0.531 ' HB2' ' HB3' ' C' ' 129' ' ' ASN . 4.3 mp -131.57 100.0 4.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.298 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.41 174.82 11.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.943 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.68 65.28 1.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.804 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' C' ' 21' ' ' CYS . 60.7 m -98.73 142.98 29.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.796 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.66 109.25 15.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.303 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.43 29.47 1.7 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.93 -59.19 2.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.015 0.436 . . . . 0.0 111.752 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.29 -39.87 13.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.654 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.61 101.34 10.67 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.629 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 31.1 p -90.54 -28.83 18.24 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 110.962 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.36 167.05 16.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.531 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.91 149.84 29.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.599 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' C' ' 157' ' ' GLN . . . -112.98 159.74 18.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.104 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.1 123.31 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.678 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . 0.493 ' HB2' ' CB ' ' C' ' 155' ' ' LYS . . . -124.65 169.0 12.38 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.55 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' PHE . . . . . 0.439 ' CB ' HD11 ' C' ' 111' ' ' LEU . 17.2 t80 -150.6 144.39 25.24 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.54 0.21 . . . . 0.0 111.104 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.561 HD21 HD22 ' F' ' 55' ' ' ASN . 0.4 OUTLIER -121.46 88.62 2.97 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.976 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.78 164.7 24.68 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.779 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' THR . . . . . 0.646 ' O ' ' HA ' ' C' ' 86' ' ' LEU . 0.6 OUTLIER -78.55 147.77 33.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.571 0.224 . . . . 0.0 110.76 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . 0.48 ' H ' ' HB3' ' F' ' 132' ' ' PRO . . . -95.73 140.26 30.79 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.934 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . 0.639 HG12 HG22 ' C' ' 140' ' ' THR . 1.1 tt -78.61 -33.18 16.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.86 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.17 179.28 6.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.69 -27.9 36.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.006 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.15 -32.24 72.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.671 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -97.32 -72.73 0.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 0.0 110.49 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 5.6 m 74.9 -7.25 1.78 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.563 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -108.77 -19.13 13.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.329 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.556 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 49.9 t -80.58 132.01 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.162 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.661 HD11 ' HB1' ' C' ' 152' ' ' ALA . 0.4 OUTLIER -76.58 134.98 39.23 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.991 -0.283 . . . . 0.0 110.279 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.639 ' HB1' ' HB ' ' C' ' 76' ' ' THR . . . -62.34 165.16 6.27 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.903 0.382 . . . . 0.0 111.676 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.418 HD13 HG21 ' C' ' 97' ' ' THR . 0.0 OUTLIER -65.72 171.74 4.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.069 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' GLN . . . . . 0.46 ' OE1' ' HB3' ' C' ' 91' ' ' SER . 8.1 pt20 -72.45 175.71 6.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.409 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' SER . . . . . 0.45 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 0.5 OUTLIER -75.98 -21.26 57.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.984 0.421 . . . . 0.0 111.518 179.414 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' SER . . . . . 0.46 ' HB3' ' OE1' ' C' ' 89' ' ' GLN . 32.1 t -80.95 67.6 6.92 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.811 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' ALA . . . . . 0.439 ' HA ' ' OG ' ' C' ' 95' ' ' SER . . . -72.28 -9.71 58.83 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.912 0.387 . . . . 0.0 111.681 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' E' ' 22' ' ' ALA . . . -68.14 -22.77 64.85 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.615 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.54 6.75 2.46 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.895 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' SER . . . . . 0.692 ' HA ' ' HB3' ' C' ' 147' ' ' ALA . 31.5 p -93.72 150.82 20.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.851 0.358 . . . . 0.0 110.625 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.79 167.14 18.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' THR . . . . . 0.418 HG21 HD13 ' C' ' 88' ' ' LEU . 0.2 OUTLIER -118.58 165.16 14.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.367 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . 0.513 ' HA ' ' OG1' ' C' ' 140' ' ' THR . 85.1 m-20 63.24 45.5 5.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.443 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 99' ' ' VAL . . . . . 0.672 ' HB ' ' HB3' ' C' ' 143' ' ' ALA . 3.5 p -170.65 131.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.762 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.03 -175.94 21.14 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.531 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' VAL . . . . . 0.724 HG13 HD22 ' C' ' 34' ' ' LEU . 76.0 t -104.14 91.88 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 122.981 0.512 . . . . 0.0 111.723 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 102' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' C' ' 85' ' ' VAL . 0.0 OUTLIER -67.95 131.16 44.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.916 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.34 110.56 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.535 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 5.4 tp -91.22 149.94 21.55 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.625 0.25 . . . . 0.0 111.086 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.9 174.68 5.79 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.71 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 106' ' ' ARG . . . . . 0.517 ' HB3' ' HG ' ' C' ' 120' ' ' SER . 1.5 ttt180 -72.53 -18.45 61.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.79 0.329 . . . . 0.0 111.106 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 46.2 p -69.36 -9.67 54.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.996 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.99 -48.34 0.96 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.69 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.95 163.57 15.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 111.072 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -70.49 125.62 27.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.123 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 111' ' ' LEU . . . . . 0.439 HD11 ' CB ' ' C' ' 73' ' ' PHE . 0.0 OUTLIER -65.41 147.65 53.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.356 0.598 . . . . 0.0 110.557 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 112' ' ' THR . . . . . 0.402 ' HB ' ' CG2' ' C' ' 117' ' ' THR . 0.2 OUTLIER -74.11 144.63 44.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.113 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . 0.517 ' N ' HD11 ' C' ' 113' ' ' LEU . 10.2 mp -100.36 89.84 4.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.799 0.333 . . . . 0.0 110.718 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 114' ' ' ASP . . . . . 0.535 ' HB2' HG21 ' C' ' 117' ' ' THR . 4.0 m-20 -142.37 11.5 1.92 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.51 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.82 -78.08 0.7 Allowed Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.638 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.24 61.52 0.73 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.013 0.435 . . . . 0.0 111.686 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 117' ' ' THR . . . . . 0.535 HG21 ' HB2' ' C' ' 114' ' ' ASP . 17.6 p -93.4 95.9 9.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.081 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.86 110.02 5.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.787 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 13.9 m -120.4 -72.85 0.67 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 120' ' ' SER . . . . . 0.517 ' HG ' ' HB3' ' C' ' 106' ' ' ARG . 0.1 OUTLIER -92.42 113.04 25.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.666 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -99.39 97.52 8.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.186 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.45 132.71 37.46 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.752 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 123' ' ' THR . . . . . 0.439 HG23 ' N ' ' C' ' 124' ' ' LEU . 22.0 m -60.89 146.15 47.65 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.708 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . 0.439 ' N ' HG23 ' C' ' 123' ' ' THR . 0.2 OUTLIER -85.41 156.52 20.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.634 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.82 142.73 40.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.575 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.9 113.69 6.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.742 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.5 -90.01 0.32 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.702 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 6.1 m -124.91 152.82 43.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.692 0.282 . . . . 0.0 110.815 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 129' ' ' ASN . . . . . 0.531 ' HB3' ' HB2' ' C' ' 58' ' ' LEU . 17.1 t-20 -123.06 147.53 46.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 4.3 m -126.19 135.65 51.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.094 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 131' ' ' ILE . . . . . . . . . . . . . 58.2 mt -113.95 115.68 45.63 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 132' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -81.74 115.72 2.79 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 121.635 1.557 . . . . 0.0 112.54 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.57 150.8 46.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.828 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 134' ' ' GLN . . . . . 0.536 ' NE2' ' HB3' ' C' ' 51' ' ' ALA . 1.2 mt-30 -142.4 166.74 23.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.032 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' C' ' 102' ' ' GLN . . . -158.22 102.92 1.79 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.927 0.394 . . . . 0.0 111.622 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' C' ' 51' ' ' ALA . 0.1 OUTLIER -94.69 -173.47 3.02 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.408 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 137' ' ' TYR . . . . . 0.576 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 3.8 m-85 -100.72 152.83 20.0 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.147 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 138' ' ' PHE . . . . . 0.545 ' HA ' ' O ' ' C' ' 47' ' ' ALA . 0.2 OUTLIER -147.3 160.73 42.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.026 -179.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 139' ' ' ALA . . . . . 0.417 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -126.85 149.63 49.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.915 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 140' ' ' THR . . . . . 0.639 HG22 HG12 ' C' ' 78' ' ' ILE . 0.0 OUTLIER -115.33 27.87 9.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.472 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.37 66.79 0.2 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.947 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.93 88.63 0.09 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.58 0.229 . . . . 0.0 110.769 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 143' ' ' ALA . . . . . 0.672 ' HB3' ' HB ' ' C' ' 99' ' ' VAL . . . -60.25 156.86 14.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.758 0.313 . . . . 0.0 111.4 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 144' ' ' THR . . . . . 0.542 ' HB ' ' CD ' ' C' ' 145' ' ' PRO . 77.3 p -112.2 173.05 3.07 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.254 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 145' ' ' PRO . . . . . 0.542 ' CD ' ' HB ' ' C' ' 144' ' ' THR . 1.3 Cg_endo -84.55 145.24 10.43 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.57 2.18 . . . . 0.0 111.923 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.31 -112.7 0.55 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.508 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 147' ' ' ALA . . . . . 0.692 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -124.92 167.68 14.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.913 0.387 . . . . 0.0 111.296 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 148' ' ' ALA . . . . . 0.483 ' HB3' HG22 ' B' ' 16' ' ' VAL . . . -157.19 57.45 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.466 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -91.81 132.71 36.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.53 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.41 163.16 28.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.988 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.45 125.59 1.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.244 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 152' ' ' ALA . . . . . 0.661 ' HB1' HD11 ' C' ' 86' ' ' LEU . . . -154.57 165.78 35.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.264 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.88 163.17 12.72 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -119.02 134.57 55.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.061 0.458 . . . . 0.0 110.155 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 155' ' ' LYS . . . . . 0.625 ' HE2' ' HA ' ' B' ' 6' ' ' ASN . 0.0 OUTLIER -95.62 166.28 11.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.914 -178.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.22 112.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.754 0.312 . . . . 0.0 111.713 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 157' ' ' GLN . . . . . 0.499 ' HB3' ' HB2' ' C' ' 70' ' ' ALA . 0.2 OUTLIER -88.67 138.83 31.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.235 0.54 . . . . 0.0 110.385 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 158' ' ' TYR . . . . . 0.526 ' HE2' HG11 ' C' ' 17' ' ' VAL . 22.6 m-85 -127.76 113.21 15.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.523 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.913 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.248 0.07 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.96 68.35 0.87 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.935 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 3' ' ' THR . . . . . . . . . . . . . 7.5 m -92.39 87.63 6.09 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.439 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 4' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' E' ' 157' ' ' GLN . 3.5 m -90.39 115.48 27.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.542 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -127.3 167.02 22.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.565 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 6' ' ' ASN . . . . . 0.615 ' HA ' ' HE2' ' E' ' 155' ' ' LYS . 20.0 t30 -83.02 115.19 21.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.554 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.43 -71.49 1.06 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.806 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.3 172.75 34.77 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.897 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 33.1 m -95.45 136.94 35.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.918 0.39 . . . . 0.0 111.265 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' VAL . . . . . 0.686 HG11 ' CE2' ' D' ' 12' ' ' PHE . 40.0 t -120.83 130.73 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.171 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' HIS . . . . . 0.526 ' O ' ' HB ' ' E' ' 32' ' ' VAL . 1.3 m80 -103.83 157.98 16.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.327 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' PHE . . . . . 0.686 ' CE2' HG11 ' D' ' 10' ' ' VAL . 0.6 OUTLIER -145.87 89.68 1.92 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.76 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' E' ' 33' ' ' GLN . 0.0 OUTLIER -79.98 135.16 36.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.436 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.54 178.42 42.04 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.948 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' GLU . . . . . 0.665 ' HG2' ' HA ' ' E' ' 147' ' ' ALA . 2.5 mt-10 -156.79 -177.92 6.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.833 0.349 . . . . 0.0 110.414 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.494 HG21 HG23 ' E' ' 37' ' ' VAL . 2.7 t -142.24 150.16 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.27 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . 0.527 HG11 ' HE2' ' D' ' 158' ' ' TYR . 4.2 m -141.76 168.53 14.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.86 0.362 . . . . 0.0 111.034 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -92.98 74.75 4.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.066 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.83 91.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.057 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.43 -51.06 0.09 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.402 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER 179.88 -179.78 0.48 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.005 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . 0.583 ' HA ' ' HB3' ' E' ' 36' ' ' GLN . . . -136.17 116.41 13.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.16 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 69.3 t -67.01 120.21 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.42 150.47 46.39 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.573 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.36 -50.16 31.66 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.42 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.26 -31.82 81.79 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.93 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.09 -15.95 63.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.868 0.366 . . . . 0.0 110.821 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.04 -43.56 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.334 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.41 106.1 10.36 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.999 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -116.68 133.95 55.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.032 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.48 96.05 6.24 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.042 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' C' ' 11' ' ' HIS . 68.9 t -89.39 131.28 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.161 0.505 . . . . 0.0 110.469 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.437 ' HA ' ' HG2' ' C' ' 13' ' ' LYS . 0.3 OUTLIER -109.05 106.5 16.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.603 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.73 HD22 HG13 ' D' ' 101' ' ' VAL . 0.4 OUTLIER -73.85 -40.88 62.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.678 179.391 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.0 -122.47 6.75 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.522 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' GLN . . . . . 0.583 ' HB3' ' HA ' ' C' ' 22' ' ' ALA . 16.3 tt0 -144.55 153.83 42.23 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.566 0.222 . . . . 0.0 110.874 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.484 HG23 HG21 ' C' ' 16' ' ' VAL . 0.0 OUTLIER -128.46 146.32 34.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.911 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.2 145.99 26.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.768 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' THR . . . . . . . . . . . . . 40.8 p -57.74 -23.06 50.09 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.743 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.97 -33.23 61.87 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.053 0.454 . . . . 0.0 110.8 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.02 -31.21 69.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.134 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' D' ' 139' ' ' ALA . 0.0 OUTLIER -130.72 86.37 2.37 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.69 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.71 36.27 4.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.346 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.56 150.82 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.38 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.75 134.83 55.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.0 111.175 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.78 -14.22 53.16 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.213 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' D' ' 138' ' ' PHE . . . -57.14 129.86 43.61 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' THR . . . . . 0.456 ' HB ' ' CE1' ' D' ' 138' ' ' PHE . 14.4 t -130.61 143.35 50.69 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.878 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 68.8 m -111.96 -157.21 0.61 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.596 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 27.7 t -74.55 150.06 39.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.834 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' ALA . . . . . 0.533 ' HB3' ' NE2' ' D' ' 134' ' ' GLN . . . -103.19 146.64 28.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.326 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' A' ' 90' ' ' SER . 22.3 m -83.37 148.33 5.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.909 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.38 121.21 6.21 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.633 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -153.88 125.54 7.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.855 0.36 . . . . 0.0 110.898 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' ASN . . . . . 0.574 HD22 HD21 ' A' ' 74' ' ' LEU . 1.9 p-10 -109.28 156.24 20.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.492 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . . . . . . . . . 22.6 mm -104.05 135.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.534 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' GLN . . . . . 0.49 ' HG3' HD22 ' A' ' 74' ' ' LEU . 2.2 tt0 -101.66 126.01 48.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.753 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . 0.524 ' HB2' ' HB3' ' D' ' 129' ' ' ASN . 4.3 mp -131.62 99.97 4.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.275 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.46 174.73 11.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.902 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.8 65.26 1.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.782 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' D' ' 21' ' ' CYS . 60.7 m -98.71 142.92 29.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.746 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.6 109.2 15.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.301 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.43 29.65 1.66 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 64' ' ' ASN . . . . . 0.474 HD21 ' HA ' ' D' ' 64' ' ' ASN . 0.1 OUTLIER -90.06 -59.27 2.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.069 0.462 . . . . 0.0 111.752 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.18 -39.8 13.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.732 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.64 101.39 10.71 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.586 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 31.3 p -90.58 -28.76 18.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.885 0.374 . . . . 0.0 110.999 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.49 166.91 16.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.482 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.8 149.82 29.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.664 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' D' ' 157' ' ' GLN . . . -112.91 159.77 18.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.101 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 52.4 t -108.08 123.31 63.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.662 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 72' ' ' ALA . . . . . 0.476 ' HB2' ' CB ' ' D' ' 155' ' ' LYS . . . -124.61 168.92 12.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.622 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 73' ' ' PHE . . . . . 0.438 ' CB ' HD11 ' D' ' 111' ' ' LEU . 17.2 t80 -150.62 144.41 25.23 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.585 0.231 . . . . 0.0 111.133 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.5 88.6 2.97 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.999 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.74 164.72 24.67 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.759 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 76' ' ' THR . . . . . 0.659 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.6 OUTLIER -78.56 147.76 33.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.565 0.222 . . . . 0.0 110.774 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.82 140.32 30.77 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.912 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 78' ' ' ILE . . . . . 0.625 HG12 HG22 ' D' ' 140' ' ' THR . 1.1 tt -78.65 -33.11 16.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.921 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.16 179.27 7.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.859 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.69 -27.91 36.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.059 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.17 -32.29 72.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.619 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -97.28 -72.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.482 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.86 -7.22 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.592 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -108.79 -19.1 13.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.287 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.551 ' HB ' ' CG2' ' D' ' 78' ' ' ILE . 50.3 t -80.65 131.98 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.134 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.659 ' HA ' ' O ' ' D' ' 76' ' ' THR . 0.4 OUTLIER -76.52 134.96 39.31 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.32 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.62 ' HB1' ' HB ' ' D' ' 76' ' ' THR . . . -62.31 165.19 6.2 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.889 0.376 . . . . 0.0 111.669 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . 0.451 ' H ' ' HG ' ' D' ' 88' ' ' LEU . 0.1 OUTLIER -65.75 171.69 4.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.056 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 89' ' ' GLN . . . . . 0.468 ' OE1' ' HB3' ' D' ' 91' ' ' SER . 8.1 pt20 -72.48 175.67 6.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.412 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.98 -21.19 57.22 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.071 0.462 . . . . 0.0 111.521 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 91' ' ' SER . . . . . 0.468 ' HB3' ' OE1' ' D' ' 89' ' ' GLN . 32.1 t -81.02 67.64 7.01 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.825 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 92' ' ' ALA . . . . . 0.433 ' HA ' ' OG ' ' D' ' 95' ' ' SER . . . -72.33 -9.7 58.84 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.943 0.401 . . . . 0.0 111.682 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 93' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' F' ' 22' ' ' ALA . . . -68.06 -22.88 64.92 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.615 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.51 6.78 2.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.911 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 95' ' ' SER . . . . . 0.682 ' HA ' ' HB3' ' D' ' 147' ' ' ALA . 31.6 p -93.77 150.86 20.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.846 0.355 . . . . 0.0 110.599 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.82 167.24 18.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.834 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 97' ' ' THR . . . . . 0.424 HG21 HD13 ' D' ' 88' ' ' LEU . 0.2 OUTLIER -118.68 165.16 14.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.295 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 98' ' ' ASN . . . . . 0.513 ' HA ' ' OG1' ' D' ' 140' ' ' THR . 85.0 m-20 63.3 45.46 4.98 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.434 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 99' ' ' VAL . . . . . 0.654 ' HB ' ' HB3' ' D' ' 143' ' ' ALA . 3.4 p -170.67 131.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.784 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.05 -175.92 21.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.54 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 101' ' ' VAL . . . . . 0.73 HG13 HD22 ' D' ' 34' ' ' LEU . 76.4 t -104.2 91.91 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.187 0.518 . . . . 0.0 111.669 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 102' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' D' ' 85' ' ' VAL . 0.0 OUTLIER -67.9 131.25 45.16 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.877 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.47 110.64 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.468 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 104' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 5.5 tp -91.33 149.96 21.51 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.633 0.254 . . . . 0.0 111.056 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.87 174.65 5.8 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.714 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 106' ' ' ARG . . . . . 0.505 ' HB3' ' HG ' ' D' ' 120' ' ' SER . 1.5 ttt180 -72.47 -18.55 61.67 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.714 0.293 . . . . 0.0 111.033 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 107' ' ' THR . . . . . . . . . . . . . 46.3 p -69.33 -9.58 53.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.06 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.98 -48.41 0.96 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.643 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.92 163.56 15.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.063 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -70.47 125.57 27.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.155 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 111' ' ' LEU . . . . . 0.438 HD11 ' CB ' ' D' ' 73' ' ' PHE . 0.0 OUTLIER -65.33 147.64 53.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.328 0.585 . . . . 0.0 110.593 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.1 144.61 44.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.085 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 113' ' ' LEU . . . . . 0.514 ' N ' HD11 ' D' ' 113' ' ' LEU . 10.2 mp -100.34 89.89 4.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.727 0.298 . . . . 0.0 110.686 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 114' ' ' ASP . . . . . 0.522 ' HB2' HG21 ' D' ' 117' ' ' THR . 4.0 m-20 -142.37 11.44 1.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.569 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.88 -78.06 0.69 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.624 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.26 61.49 0.73 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.999 0.428 . . . . 0.0 111.706 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 117' ' ' THR . . . . . 0.522 HG21 ' HB2' ' D' ' 114' ' ' ASP . 17.5 p -93.41 95.86 9.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.131 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.81 110.05 5.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.746 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.39 -72.9 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.878 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 120' ' ' SER . . . . . 0.505 ' HG ' ' HB3' ' D' ' 106' ' ' ARG . 0.1 OUTLIER -92.45 113.05 25.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.622 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -99.44 97.56 8.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.191 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.5 132.74 37.49 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.752 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 123' ' ' THR . . . . . 0.438 HG23 ' N ' ' D' ' 124' ' ' LEU . 22.1 m -60.94 146.11 47.96 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.709 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . 0.438 ' N ' HG23 ' D' ' 123' ' ' THR . 0.2 OUTLIER -85.34 156.49 20.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.632 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.81 142.74 40.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.577 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.97 113.7 6.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.689 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.51 -90.05 0.32 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.701 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 128' ' ' THR . . . . . 0.429 ' HB ' ' HD3' ' A' ' 155' ' ' LYS . 6.2 m -124.94 152.86 43.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.734 0.302 . . . . 0.0 110.82 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 129' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' D' ' 58' ' ' LEU . 17.1 t-20 -123.06 147.56 46.57 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.866 0.365 . . . . 0.0 111.158 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 130' ' ' THR . . . . . 0.484 ' OG1' HD11 ' A' ' 74' ' ' LEU . 4.3 m -126.22 135.71 51.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.05 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 131' ' ' ILE . . . . . . . . . . . . . 58.5 mt -114.01 115.7 45.48 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 132' ' ' PRO . . . . . 0.495 ' HB3' ' H ' ' A' ' 77' ' ' ALA . 7.5 Cg_endo -81.67 115.71 2.82 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 121.703 1.602 . . . . 0.0 112.545 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.59 150.79 46.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.802 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 134' ' ' GLN . . . . . 0.533 ' NE2' ' HB3' ' D' ' 51' ' ' ALA . 1.3 mt-30 -142.5 166.61 24.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.081 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' D' ' 102' ' ' GLN . . . -158.14 102.9 1.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.922 0.392 . . . . 0.0 111.638 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 136' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' D' ' 51' ' ' ALA . 0.2 OUTLIER -94.67 -173.41 3.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.415 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 137' ' ' TYR . . . . . 0.575 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 3.8 m-85 -100.82 152.86 20.0 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.09 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 138' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' D' ' 47' ' ' ALA . 0.2 OUTLIER -147.33 160.73 42.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.083 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 139' ' ' ALA . . . . . 0.418 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -126.82 149.71 49.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.895 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 140' ' ' THR . . . . . 0.625 HG22 HG12 ' D' ' 78' ' ' ILE . 0.0 OUTLIER -115.4 27.79 9.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.402 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.38 66.86 0.2 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.888 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.92 88.61 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.576 0.188 . . . . 0.0 110.759 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 143' ' ' ALA . . . . . 0.654 ' HB3' ' HB ' ' D' ' 99' ' ' VAL . . . -60.2 156.9 14.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.709 0.29 . . . . 0.0 111.438 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 144' ' ' THR . . . . . 0.538 ' HB ' ' CD ' ' D' ' 145' ' ' PRO . 76.9 p -112.21 173.08 3.05 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.213 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 145' ' ' PRO . . . . . 0.538 ' CD ' ' HB ' ' D' ' 144' ' ' THR . 1.3 Cg_endo -84.58 145.2 10.38 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.565 2.177 . . . . 0.0 111.937 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.38 -112.72 0.55 Allowed Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.555 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 147' ' ' ALA . . . . . 0.682 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -124.92 167.69 14.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.812 0.339 . . . . 0.0 111.394 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 148' ' ' ALA . . . . . 0.487 ' HB3' HG22 ' C' ' 16' ' ' VAL . . . -157.22 57.54 0.51 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.103 0.478 . . . . 0.0 110.468 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.87 132.74 36.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.534 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.48 163.12 28.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.027 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.39 125.6 1.85 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.282 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 152' ' ' ALA . . . . . 0.65 ' HB1' HD11 ' D' ' 86' ' ' LEU . . . -154.59 165.78 35.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.173 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.84 163.16 12.72 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -119.0 134.48 55.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.023 0.439 . . . . 0.0 110.2 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 155' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' C' ' 6' ' ' ASN . 0.0 OUTLIER -95.61 166.3 11.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.91 -178.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.25 112.83 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.832 0.348 . . . . 0.0 111.638 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 157' ' ' GLN . . . . . 0.502 ' HB3' ' HB2' ' D' ' 70' ' ' ALA . 0.2 OUTLIER -88.82 138.84 31.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.331 0.586 . . . . 0.0 110.393 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 158' ' ' TYR . . . . . 0.527 ' HE2' HG11 ' D' ' 17' ' ' VAL . 22.5 m-85 -127.65 113.16 15.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.519 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.962 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.261 0.076 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.0 68.24 0.88 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.587 0.232 . . . . 0.0 111.022 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -92.31 87.66 6.13 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.473 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 4' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' F' ' 157' ' ' GLN . 3.5 m -90.5 115.48 27.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.545 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 m -127.22 167.0 22.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.583 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 6' ' ' ASN . . . . . 0.624 ' HA ' ' HE2' ' F' ' 155' ' ' LYS . 20.0 t30 -83.04 115.14 21.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.497 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.41 -71.45 1.07 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.853 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.29 172.78 34.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.049 -0.595 . . . . 0.0 111.931 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 9' ' ' THR . . . . . . . . . . . . . 33.4 m -95.49 137.03 35.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.916 0.389 . . . . 0.0 111.284 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 10' ' ' VAL . . . . . 0.676 HG11 ' CE2' ' E' ' 12' ' ' PHE . 40.2 t -120.85 130.68 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.185 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 11' ' ' HIS . . . . . 0.523 ' O ' ' HB ' ' F' ' 32' ' ' VAL . 1.3 m80 -103.82 157.99 16.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.397 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 12' ' ' PHE . . . . . 0.676 ' CE2' HG11 ' E' ' 10' ' ' VAL . 0.6 OUTLIER -145.84 89.66 1.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 13' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' F' ' 33' ' ' GLN . 0.0 OUTLIER -79.95 135.21 36.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.477 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.56 178.38 42.07 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.898 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 15' ' ' GLU . . . . . 0.663 ' HG2' ' HA ' ' F' ' 147' ' ' ALA . 2.6 mt-10 -156.81 -177.9 6.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.938 0.399 . . . . 0.0 110.357 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 16' ' ' VAL . . . . . 0.488 HG21 HG23 ' F' ' 37' ' ' VAL . 2.7 t -142.29 150.13 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.239 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . 0.524 HG11 ' HE2' ' E' ' 158' ' ' TYR . 4.1 m -141.71 168.61 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.832 0.349 . . . . 0.0 111.083 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.06 74.74 4.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.087 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.89 91.89 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.5 -51.01 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.432 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 21' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER 179.82 -179.79 0.47 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.986 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 22' ' ' ALA . . . . . 0.586 ' HA ' ' HB3' ' F' ' 36' ' ' GLN . . . -136.16 116.43 13.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.146 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 23' ' ' VAL . . . . . . . . . . . . . 67.7 t -67.01 120.14 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.38 150.49 46.21 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.602 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.38 -50.18 31.7 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.355 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.3 -31.77 81.58 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.918 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.02 -16.05 63.62 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.902 0.382 . . . . 0.0 110.859 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 28' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.93 -43.61 59.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.401 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.44 106.09 10.35 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -116.62 133.99 55.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.5 96.03 6.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.095 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' D' ' 11' ' ' HIS . 69.6 t -89.45 131.27 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.215 0.531 . . . . 0.0 110.437 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 33' ' ' GLN . . . . . 0.432 ' HA ' ' HG2' ' D' ' 13' ' ' LYS . 0.3 OUTLIER -108.99 106.48 16.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.599 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.716 HD22 HG13 ' E' ' 101' ' ' VAL . 0.4 OUTLIER -73.89 -40.93 62.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.552 179.419 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.04 -122.48 6.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.564 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 36' ' ' GLN . . . . . 0.583 ' HB3' ' HA ' ' D' ' 22' ' ' ALA . 16.3 tt0 -144.51 153.98 42.43 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.633 0.254 . . . . 0.0 110.881 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . 0.494 HG23 HG21 ' D' ' 16' ' ' VAL . 0.0 OUTLIER -128.57 146.33 34.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.873 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.19 146.0 26.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.731 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 39' ' ' THR . . . . . . . . . . . . . 40.9 p -57.79 -23.07 50.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.709 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.98 -33.21 61.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.013 0.435 . . . . 0.0 110.791 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.03 -31.15 69.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.222 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' E' ' 139' ' ' ALA . 0.0 OUTLIER -130.76 86.44 2.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.598 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.66 36.16 4.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.337 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.59 150.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.365 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.78 134.88 55.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 0.0 111.118 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.8 -14.28 53.07 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.146 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 47' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' E' ' 138' ' ' PHE . . . -57.22 129.92 43.9 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.938 0.399 . . . . 0.0 112.043 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 48' ' ' THR . . . . . 0.46 ' HB ' ' CE1' ' E' ' 138' ' ' PHE . 14.3 t -130.67 143.29 50.65 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.874 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 68.9 m -111.87 -157.14 0.61 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.625 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 50' ' ' SER . . . . . 0.415 ' H ' ' HB3' ' E' ' 49' ' ' SER . 27.5 t -74.58 150.05 39.86 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.865 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 51' ' ' ALA . . . . . 0.537 ' HB3' ' NE2' ' E' ' 134' ' ' GLN . . . -103.22 146.63 28.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.334 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 52' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' B' ' 90' ' ' SER . 22.1 m -83.41 148.37 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 53' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' B' ' 88' ' ' LEU . . . -108.44 121.27 6.22 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.601 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -153.87 125.57 7.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.797 0.332 . . . . 0.0 110.949 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 55' ' ' ASN . . . . . 0.585 HD22 HD21 ' B' ' 74' ' ' LEU . 1.9 p-10 -109.33 156.19 20.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.59 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 56' ' ' ILE . . . . . . . . . . . . . 22.4 mm -103.95 135.29 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.565 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 57' ' ' GLN . . . . . 0.493 ' HG3' HD22 ' B' ' 74' ' ' LEU . 2.2 tt0 -101.72 125.99 48.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.75 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' E' ' 129' ' ' ASN . 4.3 mp -131.6 99.9 4.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.326 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.32 174.72 11.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.966 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.74 65.3 1.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.79 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 61' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' E' ' 21' ' ' CYS . 60.7 m -98.71 142.94 29.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.792 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.64 109.25 15.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.266 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.47 29.59 1.68 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.99 -59.26 2.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.085 0.469 . . . . 0.0 111.727 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.25 -39.84 13.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.666 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.6 101.34 10.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.597 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 30.8 p -90.56 -28.79 18.25 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.38 167.08 16.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.509 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.95 149.75 29.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.617 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' E' ' 157' ' ' GLN . . . -112.88 159.75 18.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.1 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 52.2 t -108.09 123.29 63.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.665 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . 0.491 ' HB2' ' CB ' ' E' ' 155' ' ' LYS . . . -124.63 168.92 12.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.615 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 73' ' ' PHE . . . . . 0.432 ' CB ' HD11 ' E' ' 111' ' ' LEU . 17.2 t80 -150.63 144.4 25.21 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.601 0.239 . . . . 0.0 111.1 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.46 88.64 2.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.989 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.76 164.7 24.67 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.816 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 76' ' ' THR . . . . . 0.653 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.6 OUTLIER -78.57 147.72 33.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.595 0.236 . . . . 0.0 110.708 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.68 140.29 30.71 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.961 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 78' ' ' ILE . . . . . 0.633 HG12 HG22 ' E' ' 140' ' ' THR . 1.1 tt -78.58 -33.16 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.914 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.18 179.18 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.904 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.58 -27.96 37.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.059 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.21 -32.22 72.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.633 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -97.29 -72.81 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.931 0.396 . . . . 0.0 110.461 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.88 -7.15 1.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.593 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -108.83 -19.1 13.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.325 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' E' ' 102' ' ' GLN . 49.6 t -80.55 132.07 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.152 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 86' ' ' LEU . . . . . 0.653 ' HA ' ' O ' ' E' ' 76' ' ' THR . 0.4 OUTLIER -76.63 134.96 39.16 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.304 179.398 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 87' ' ' ALA . . . . . 0.639 ' HB1' ' HB ' ' E' ' 76' ' ' THR . . . -62.25 165.21 6.1 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.867 0.365 . . . . 0.0 111.645 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . 0.435 HD13 HG21 ' E' ' 97' ' ' THR . 0.1 OUTLIER -65.86 171.79 4.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.998 179.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 89' ' ' GLN . . . . . 0.465 ' OE1' ' HB3' ' E' ' 91' ' ' SER . 8.0 pt20 -72.56 175.71 6.09 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.425 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.04 -21.18 57.1 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.009 0.433 . . . . 0.0 111.498 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 91' ' ' SER . . . . . 0.465 ' HB3' ' OE1' ' E' ' 89' ' ' GLN . 32.0 t -80.91 67.49 6.82 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 92' ' ' ALA . . . . . 0.44 ' HA ' ' OG ' ' E' ' 95' ' ' SER . . . -72.18 -9.77 58.88 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.969 0.414 . . . . 0.0 111.723 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.04 -22.88 64.93 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.669 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.46 6.75 2.48 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.946 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 95' ' ' SER . . . . . 0.68 ' HA ' ' HB3' ' E' ' 147' ' ' ALA . 31.0 p -93.73 150.78 20.11 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.821 0.343 . . . . 0.0 110.688 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.77 167.22 18.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.876 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 97' ' ' THR . . . . . 0.435 HG21 HD13 ' E' ' 88' ' ' LEU . 0.2 OUTLIER -118.66 165.09 14.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.365 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 98' ' ' ASN . . . . . 0.502 ' HA ' ' OG1' ' E' ' 140' ' ' THR . 85.0 m-20 63.36 45.42 4.93 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.443 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 99' ' ' VAL . . . . . 0.658 ' HB ' ' HB3' ' E' ' 143' ' ' ALA . 3.4 p -170.64 131.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.692 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.04 -175.99 21.18 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.54 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 101' ' ' VAL . . . . . 0.716 HG13 HD22 ' E' ' 34' ' ' LEU . 76.3 t -104.07 91.83 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 122.994 0.517 . . . . 0.0 111.708 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 102' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' E' ' 85' ' ' VAL . 0.0 OUTLIER -67.9 131.21 45.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.42 110.62 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.475 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 104' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 5.5 tp -91.3 149.93 21.53 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.699 0.285 . . . . 0.0 111.029 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.9 174.65 5.8 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.701 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 106' ' ' ARG . . . . . 0.521 ' HB3' ' HG ' ' E' ' 120' ' ' SER . 1.5 ttt180 -72.53 -18.4 61.65 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.759 0.314 . . . . 0.0 111.067 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 46.2 p -69.41 -9.63 54.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.99 -48.38 0.96 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.636 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.88 163.58 15.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 111.11 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 110' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -70.53 125.59 27.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 111' ' ' LEU . . . . . 0.432 HD11 ' CB ' ' E' ' 73' ' ' PHE . 0.0 OUTLIER -65.38 147.57 53.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.353 0.596 . . . . 0.0 110.557 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.03 144.57 45.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.157 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 113' ' ' LEU . . . . . 0.521 ' N ' HD11 ' E' ' 113' ' ' LEU . 10.2 mp -100.26 89.82 4.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.776 0.322 . . . . 0.0 110.753 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 114' ' ' ASP . . . . . 0.527 ' HB2' HG21 ' E' ' 117' ' ' THR . 4.1 m-20 -142.34 11.43 1.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.685 0.279 . . . . 0.0 111.623 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.87 -78.1 0.7 Allowed Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.619 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.29 61.63 0.73 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.976 0.417 . . . . 0.0 111.666 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 117' ' ' THR . . . . . 0.527 HG21 ' HB2' ' E' ' 114' ' ' ASP . 17.6 p -93.5 95.87 9.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.114 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.74 109.92 5.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.819 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.26 -72.96 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 120' ' ' SER . . . . . 0.521 ' HG ' ' HB3' ' E' ' 106' ' ' ARG . 0.1 OUTLIER -92.43 113.09 25.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.638 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -99.47 97.51 8.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.184 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.45 132.74 37.42 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.724 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 123' ' ' THR . . . . . 0.427 HG23 ' N ' ' E' ' 124' ' ' LEU . 22.3 m -61.01 146.13 48.2 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.691 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . 0.427 ' N ' HG23 ' E' ' 123' ' ' THR . 0.2 OUTLIER -85.41 156.49 20.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.645 179.419 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.83 142.78 40.78 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.542 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.91 113.69 6.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.717 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 127' ' ' GLY . . . . . 0.604 ' HA3' ' HB ' ' A' ' 4' ' ' THR . . . 128.45 -89.97 0.32 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.731 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 128' ' ' THR . . . . . 0.425 ' HB ' ' HD3' ' B' ' 155' ' ' LYS . 6.2 m -124.92 152.83 43.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.73 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 129' ' ' ASN . . . . . 0.522 ' HB3' ' HB2' ' E' ' 58' ' ' LEU . 17.0 t-20 -123.08 147.54 46.61 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.122 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 130' ' ' THR . . . . . 0.488 ' OG1' HD11 ' B' ' 74' ' ' LEU . 4.3 m -126.13 135.76 52.07 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.043 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 131' ' ' ILE . . . . . . . . . . . . . 58.4 mt -114.04 115.61 45.46 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 132' ' ' PRO . . . . . 0.488 ' HB3' ' H ' ' B' ' 77' ' ' ALA . 7.5 Cg_endo -81.69 115.69 2.81 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.698 1.599 . . . . 0.0 112.566 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.6 150.79 46.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.807 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 134' ' ' GLN . . . . . 0.537 ' NE2' ' HB3' ' E' ' 51' ' ' ALA . 1.2 mt-30 -142.44 166.71 23.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.034 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 135' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' E' ' 102' ' ' GLN . . . -158.17 102.93 1.8 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.382 . . . . 0.0 111.636 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 136' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' E' ' 51' ' ' ALA . 0.1 OUTLIER -94.72 -173.42 3.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.352 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 137' ' ' TYR . . . . . 0.57 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 3.7 m-85 -100.86 152.87 20.0 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.082 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 138' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' E' ' 47' ' ' ALA . 0.2 OUTLIER -147.35 160.73 42.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.072 -179.183 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 139' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -126.82 149.67 49.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.885 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 140' ' ' THR . . . . . 0.633 HG22 HG12 ' E' ' 78' ' ' ILE . 0.0 OUTLIER -115.35 27.84 9.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.484 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.4 66.79 0.2 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.951 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.91 88.61 0.09 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.604 0.24 . . . . 0.0 110.742 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 143' ' ' ALA . . . . . 0.658 ' HB3' ' HB ' ' E' ' 99' ' ' VAL . . . -60.21 156.89 14.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.751 0.31 . . . . 0.0 111.424 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 144' ' ' THR . . . . . 0.545 ' HB ' ' CD ' ' E' ' 145' ' ' PRO . 77.0 p -112.18 173.05 3.07 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.305 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 145' ' ' PRO . . . . . 0.545 ' CD ' ' HB ' ' E' ' 144' ' ' THR . 1.4 Cg_endo -84.6 145.25 10.37 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.477 2.118 . . . . 0.0 112.029 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.37 -112.73 0.55 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.56 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 147' ' ' ALA . . . . . 0.68 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -124.98 167.66 14.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.88 0.371 . . . . 0.0 111.337 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 148' ' ' ALA . . . . . 0.471 ' HB3' HG22 ' D' ' 16' ' ' VAL . . . -157.13 57.46 0.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.497 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.86 132.74 36.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.559 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.42 163.13 28.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.037 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.48 125.65 1.82 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.184 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 152' ' ' ALA . . . . . 0.65 ' HB1' HD11 ' E' ' 86' ' ' LEU . . . -154.61 165.71 35.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.204 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.83 163.13 12.74 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -119.04 134.56 55.12 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.094 0.473 . . . . 0.0 110.108 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 155' ' ' LYS . . . . . 0.615 ' HE2' ' HA ' ' D' ' 6' ' ' ASN . 0.0 OUTLIER -95.48 166.25 11.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.928 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.33 112.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.888 0.375 . . . . 0.0 111.641 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 157' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' E' ' 70' ' ' ALA . 0.2 OUTLIER -88.76 138.85 31.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.242 0.544 . . . . 0.0 110.404 -179.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 158' ' ' TYR . . . . . 0.524 ' HE2' HG11 ' E' ' 17' ' ' VAL . 22.5 m-85 -127.71 113.15 15.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.512 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.909 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.226 0.06 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.0 68.24 0.88 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.552 0.215 . . . . 0.0 111.049 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.36 87.66 6.11 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.469 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m -90.49 115.46 27.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.591 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -127.28 166.93 23.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.588 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -82.99 115.23 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.524 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.48 -71.45 1.07 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.801 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.3 172.78 34.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.918 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 33.2 m -95.49 136.96 35.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.399 . . . . 0.0 111.265 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 10' ' ' VAL . . . . . 0.685 HG11 ' CE2' ' F' ' 12' ' ' PHE . 40.3 t -120.82 130.72 74.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.194 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -103.84 157.96 16.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.432 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 12' ' ' PHE . . . . . 0.685 ' CE2' HG11 ' F' ' 10' ' ' VAL . 0.5 OUTLIER -145.84 89.63 1.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 13' ' ' LYS . . . . . 0.431 ' H ' ' HG2' ' F' ' 13' ' ' LYS . 0.0 OUTLIER -79.97 135.19 36.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.431 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.56 178.38 42.08 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.853 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -156.84 -177.93 6.98 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.862 0.363 . . . . 0.0 110.345 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.25 150.15 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.222 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 17' ' ' VAL . . . . . 0.524 HG11 ' HE2' ' F' ' 158' ' ' TYR . 4.1 m -141.7 168.6 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.876 0.37 . . . . 0.0 111.025 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.02 74.66 4.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.05 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.95 91.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.035 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.46 -51.0 0.09 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.423 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 21' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER 179.88 -179.72 0.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.974 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 22' ' ' ALA . . . . . 0.548 ' HB2' ' HB1' ' D' ' 93' ' ' ALA . . . -136.18 116.51 13.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.161 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 23' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.1 120.23 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.995 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.47 150.45 46.54 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.564 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.39 -50.07 32.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.343 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.37 -31.73 81.33 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.936 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.1 -15.99 63.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.923 0.392 . . . . 0.0 110.851 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.99 -43.63 58.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.379 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.41 106.15 10.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.994 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -116.78 134.05 55.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.03 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.47 96.12 6.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.083 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . 0.523 ' HB ' ' O ' ' E' ' 11' ' ' HIS . 69.3 t -89.53 131.24 37.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 33' ' ' GLN . . . . . 0.417 ' HA ' ' HG2' ' E' ' 13' ' ' LYS . 0.3 OUTLIER -108.95 106.49 16.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.616 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 34' ' ' LEU . . . . . 0.728 HD22 HG13 ' F' ' 101' ' ' VAL . 0.4 OUTLIER -73.86 -40.91 62.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.637 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.01 -122.45 6.74 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.559 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 36' ' ' GLN . . . . . 0.586 ' HB3' ' HA ' ' E' ' 22' ' ' ALA . 16.1 tt0 -144.55 153.87 42.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.658 0.265 . . . . 0.0 110.936 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.488 HG23 HG21 ' E' ' 16' ' ' VAL . 0.0 OUTLIER -128.46 146.29 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.963 -179.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.2 145.94 26.11 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.764 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 39' ' ' THR . . . . . . . . . . . . . 40.8 p -57.7 -23.06 49.75 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.721 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.07 -33.09 61.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.022 0.439 . . . . 0.0 110.805 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -31.11 69.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.208 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' F' ' 139' ' ' ALA . 0.0 OUTLIER -130.78 86.44 2.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.622 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.7 36.23 4.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.411 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 177.6 150.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.324 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.72 134.85 55.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.34 . . . . 0.0 111.116 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.74 -14.21 53.3 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.215 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 47' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' F' ' 138' ' ' PHE . . . -57.22 129.91 43.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.927 0.394 . . . . 0.0 112.052 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 48' ' ' THR . . . . . 0.46 ' HB ' ' CE1' ' F' ' 138' ' ' PHE . 14.3 t -130.66 143.35 50.69 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.861 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 49' ' ' SER . . . . . 0.585 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 68.8 m -111.98 -157.21 0.61 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.604 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 27.7 t -74.59 150.12 39.81 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.856 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 51' ' ' ALA . . . . . 0.53 ' HB3' ' NE2' ' F' ' 134' ' ' GLN . . . -103.19 146.7 28.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.301 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 52' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' C' ' 90' ' ' SER . 22.2 m -83.45 148.35 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.915 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.4 121.2 6.2 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.628 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 54' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -153.88 125.55 7.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.852 0.358 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 55' ' ' ASN . . . . . 0.561 HD22 HD21 ' C' ' 74' ' ' LEU . 1.9 p-10 -109.26 156.17 20.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.533 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 56' ' ' ILE . . . . . . . . . . . . . 22.4 mm -103.96 135.38 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.583 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 57' ' ' GLN . . . . . 0.502 ' HG3' HD22 ' C' ' 74' ' ' LEU . 2.2 tt0 -101.75 126.07 48.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.713 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . 0.525 ' HB2' ' HB3' ' F' ' 129' ' ' ASN . 4.3 mp -131.65 99.96 4.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.286 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.4 174.82 11.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.982 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.71 65.21 1.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.83 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 61' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' F' ' 21' ' ' CYS . 60.6 m -98.68 142.98 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.813 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.68 109.21 15.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.261 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.42 29.57 1.68 Allowed 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 64' ' ' ASN . . . . . 0.436 HD21 ' HA ' ' F' ' 64' ' ' ASN . 0.1 OUTLIER -90.05 -59.21 2.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.028 0.442 . . . . 0.0 111.679 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.2 -39.93 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.662 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.58 101.36 10.69 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.543 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 30.9 p -90.59 -28.71 18.27 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.857 0.36 . . . . 0.0 110.963 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.52 166.94 16.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.491 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.79 149.88 29.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.583 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 70' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' F' ' 157' ' ' GLN . . . -112.98 159.74 18.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.164 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 51.4 t -108.02 123.28 63.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.689 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 72' ' ' ALA . . . . . 0.491 ' HB2' ' CB ' ' F' ' 155' ' ' LYS . . . -124.71 168.99 12.42 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.484 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 73' ' ' PHE . . . . . 0.436 ' CB ' HD11 ' F' ' 111' ' ' LEU . 17.2 t80 -150.58 144.47 25.3 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.562 0.22 . . . . 0.0 111.147 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.58 88.61 2.97 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.989 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.74 164.65 24.67 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.777 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 76' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.6 OUTLIER -78.51 147.8 33.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.547 0.213 . . . . 0.0 110.786 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.78 140.38 30.66 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.838 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 78' ' ' ILE . . . . . 0.638 HG12 HG22 ' F' ' 140' ' ' THR . 1.1 tt -78.7 -33.15 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.16 179.23 7.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.833 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.71 -27.78 36.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.036 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.3 -32.18 72.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.586 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -97.33 -72.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.877 0.37 . . . . 0.0 110.446 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.87 -7.21 1.79 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.582 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -108.81 -19.08 13.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.311 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 85' ' ' VAL . . . . . 0.557 ' HB ' ' CG2' ' F' ' 78' ' ' ILE . 50.4 t -80.71 132.02 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.206 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 86' ' ' LEU . . . . . 0.665 HD11 ' HB1' ' F' ' 152' ' ' ALA . 0.4 OUTLIER -76.55 135.0 39.26 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.255 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 87' ' ' ALA . . . . . 0.635 ' HB1' ' HB ' ' F' ' 76' ' ' THR . . . -62.27 165.15 6.18 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.923 0.392 . . . . 0.0 111.691 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . 0.447 ' H ' ' HG ' ' F' ' 88' ' ' LEU . 0.1 OUTLIER -65.76 171.78 4.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.018 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 89' ' ' GLN . . . . . 0.468 ' OE1' ' HB3' ' F' ' 91' ' ' SER . 8.0 pt20 -72.56 175.74 6.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.427 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.02 -21.22 57.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.002 0.43 . . . . 0.0 111.474 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 91' ' ' SER . . . . . 0.468 ' HB3' ' OE1' ' F' ' 89' ' ' GLN . 32.1 t -81.02 67.6 6.99 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 92' ' ' ALA . . . . . 0.434 ' HA ' ' OG ' ' F' ' 95' ' ' SER . . . -72.35 -9.67 58.81 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.576 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.04 -22.86 64.94 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.683 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.47 6.71 2.47 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.86 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 95' ' ' SER . . . . . 0.695 ' HA ' ' HB3' ' F' ' 147' ' ' ALA . 30.8 p -93.71 150.78 20.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.854 0.359 . . . . 0.0 110.674 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.71 167.18 18.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 97' ' ' THR . . . . . 0.425 HG21 HD13 ' F' ' 88' ' ' LEU . 0.2 OUTLIER -118.64 165.19 14.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.314 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 98' ' ' ASN . . . . . 0.512 ' HA ' ' OG1' ' F' ' 140' ' ' THR . 85.1 m-20 63.2 45.5 5.06 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.489 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 99' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' F' ' 143' ' ' ALA . 3.4 p -170.65 131.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.72 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.02 -175.94 21.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.511 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 101' ' ' VAL . . . . . 0.728 HG13 HD22 ' F' ' 34' ' ' LEU . 76.4 t -104.19 91.9 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 122.979 0.512 . . . . 0.0 111.656 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 102' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' F' ' 85' ' ' VAL . 0.0 OUTLIER -67.88 131.18 45.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.898 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.45 110.52 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.497 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 104' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 5.5 tp -91.15 149.98 21.57 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.656 0.265 . . . . 0.0 111.078 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.94 174.55 5.84 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.631 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 106' ' ' ARG . . . . . 0.509 ' HB3' ' HG ' ' F' ' 120' ' ' SER . 1.5 ttt180 -72.45 -18.46 61.69 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.75 0.309 . . . . 0.0 111.075 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 46.2 p -69.35 -9.66 54.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.999 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.0 -48.33 0.96 Allowed Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.671 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.96 163.57 15.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.779 0.323 . . . . 0.0 111.089 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 110' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -70.52 125.59 27.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 111' ' ' LEU . . . . . 0.436 HD11 ' CB ' ' F' ' 73' ' ' PHE . 0.0 OUTLIER -65.43 147.7 52.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.419 0.628 . . . . 0.0 110.558 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.16 144.67 44.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.12 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 113' ' ' LEU . . . . . 0.513 ' N ' HD11 ' F' ' 113' ' ' LEU . 10.2 mp -100.35 89.97 4.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 110.644 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 114' ' ' ASP . . . . . 0.523 ' HB2' HG21 ' F' ' 117' ' ' THR . 4.1 m-20 -142.41 11.41 1.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.691 0.281 . . . . 0.0 111.6 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.91 -78.16 0.69 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.611 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.29 61.61 0.73 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.966 0.412 . . . . 0.0 111.62 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 117' ' ' THR . . . . . 0.523 HG21 ' HB2' ' F' ' 114' ' ' ASP . 17.6 p -93.42 95.84 9.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.126 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.77 110.0 5.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.794 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.4 -72.91 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.833 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 120' ' ' SER . . . . . 0.509 ' HG ' ' HB3' ' F' ' 106' ' ' ARG . 0.1 OUTLIER -92.49 113.04 25.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.665 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.36 97.42 8.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.25 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.47 132.66 37.52 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.787 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 123' ' ' THR . . . . . 0.441 HG23 ' N ' ' F' ' 124' ' ' LEU . 21.8 m -60.81 146.15 47.26 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.762 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . 0.441 ' N ' HG23 ' F' ' 123' ' ' THR . 0.2 OUTLIER -85.51 156.6 20.71 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.547 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.91 142.71 40.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.474 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.9 113.73 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.704 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 127' ' ' GLY . . . . . 0.596 ' HA3' ' HB ' ' B' ' 4' ' ' THR . . . 128.44 -90.01 0.32 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.693 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 128' ' ' THR . . . . . 0.434 ' HB ' ' HD3' ' C' ' 155' ' ' LYS . 6.2 m -124.92 152.86 43.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.704 0.287 . . . . 0.0 110.751 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 129' ' ' ASN . . . . . 0.525 ' HB3' ' HB2' ' F' ' 58' ' ' LEU . 17.0 t-20 -123.09 147.58 46.59 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.926 0.394 . . . . 0.0 111.113 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 130' ' ' THR . . . . . 0.489 ' OG1' HD11 ' C' ' 74' ' ' LEU . 4.3 m -126.16 135.69 51.96 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.03 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 131' ' ' ILE . . . . . . . . . . . . . 58.6 mt -114.05 115.68 45.38 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 132' ' ' PRO . . . . . 0.48 ' HB3' ' H ' ' C' ' 77' ' ' ALA . 7.5 Cg_endo -81.7 115.71 2.81 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.604 1.536 . . . . 0.0 112.572 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.57 150.79 46.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.823 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 134' ' ' GLN . . . . . 0.53 ' NE2' ' HB3' ' F' ' 51' ' ' ALA . 1.2 mt-30 -142.39 166.72 23.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.086 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 135' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' F' ' 102' ' ' GLN . . . -158.21 102.9 1.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.972 0.415 . . . . 0.0 111.587 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 136' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' F' ' 51' ' ' ALA . 0.2 OUTLIER -94.67 -173.46 3.02 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.397 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 137' ' ' TYR . . . . . 0.585 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 3.8 m-85 -100.76 152.82 20.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.115 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 138' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' F' ' 47' ' ' ALA . 0.2 OUTLIER -147.28 160.8 42.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.046 -179.227 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 139' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -126.88 149.63 49.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.86 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 140' ' ' THR . . . . . 0.638 HG22 HG12 ' F' ' 78' ' ' ILE . 0.0 OUTLIER -115.33 27.83 9.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.491 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.39 66.76 0.2 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.948 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . 63.0 88.57 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.615 0.207 . . . . 0.0 110.747 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 143' ' ' ALA . . . . . 0.671 ' HB3' ' HB ' ' F' ' 99' ' ' VAL . . . -60.22 156.88 14.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.728 0.299 . . . . 0.0 111.431 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 144' ' ' THR . . . . . 0.538 ' HB ' ' CD ' ' F' ' 145' ' ' PRO . 77.4 p -112.17 173.07 3.06 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.243 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 145' ' ' PRO . . . . . 0.538 ' CD ' ' HB ' ' F' ' 144' ' ' THR . 1.4 Cg_endo -84.6 145.22 10.36 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.543 2.162 . . . . 0.0 111.922 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.42 -112.77 0.55 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.495 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 147' ' ' ALA . . . . . 0.695 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -124.98 167.68 14.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.903 0.382 . . . . 0.0 111.337 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 148' ' ' ALA . . . . . 0.479 ' HB3' HG22 ' E' ' 16' ' ' VAL . . . -157.16 57.49 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.403 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.89 132.71 36.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.514 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.41 163.12 28.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.008 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.44 125.63 1.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.205 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 152' ' ' ALA . . . . . 0.665 ' HB1' HD11 ' F' ' 86' ' ' LEU . . . -154.57 165.79 35.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.215 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.83 163.17 12.71 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -119.03 134.53 55.14 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.116 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 155' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' E' ' 6' ' ' ASN . 0.0 OUTLIER -95.51 166.21 11.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.951 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.23 112.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.771 0.32 . . . . 0.0 111.684 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 157' ' ' GLN . . . . . 0.492 ' HB3' ' HB2' ' F' ' 70' ' ' ALA . 0.2 OUTLIER -88.74 138.79 31.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.264 0.554 . . . . 0.0 110.404 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 158' ' ' TYR . . . . . 0.524 ' HE2' HG11 ' F' ' 17' ' ' VAL . 22.5 m-85 -127.63 113.2 15.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.503 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.924 179.981 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.552 0.215 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.458 HG23 ' HB2' ' B' ' 18' ' ' ASN . 57.4 m -111.23 101.02 9.55 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.46 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.462 ' HA ' ' HG2' ' B' ' 157' ' ' GLN . 60.6 m -86.71 131.93 34.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.56 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.401 HG11 HG12 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -161.18 168.04 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.525 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -100.1 118.78 37.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.539 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.4 -56.31 6.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.748 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.94 -145.38 4.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.873 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.0 142.05 29.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.933 0.397 . . . . 0.0 111.284 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.464 HG23 ' CZ ' ' B' ' 73' ' ' PHE . 44.2 t -121.65 107.32 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.176 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.75 111.0 21.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.386 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.415 ' HB3' HD12 ' B' ' 34' ' ' LEU . 32.0 m-85 -87.61 113.52 23.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.775 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.12 118.61 36.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.412 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.56 175.53 39.77 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.909 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.759 ' HA ' ' HB3' ' B' ' 148' ' ' ALA . 0.1 OUTLIER -151.27 162.14 41.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.946 0.403 . . . . 0.0 110.31 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' B' ' 145' ' ' PRO . 2.2 t -114.94 119.43 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.29 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.51 HG21 ' HA ' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -121.33 168.14 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.818 0.342 . . . . 0.0 111.064 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.438 ' HA ' HG22 ' B' ' 39' ' ' THR . 1.3 t-20 -68.46 -175.27 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.004 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.435 ' O ' HG21 ' A' ' 65' ' ' VAL . . . -91.14 52.66 2.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.93 -15.74 1.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.335 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.929 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -176.88 147.6 0.6 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.975 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.51 ' HA ' HG21 ' A' ' 17' ' ' VAL . . . -152.62 110.08 3.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.046 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -52.97 159.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.032 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.37 164.48 14.31 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.578 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.07 -52.29 65.89 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.397 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.43 11.92 66.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.858 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.5 t -96.23 -30.79 13.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.989 0.423 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.405 ' H ' HG21 ' A' ' 28' ' ' VAL . 11.4 t -49.88 -71.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.311 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.54 104.4 15.27 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.02 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.509 HE22 ' HA ' ' A' ' 56' ' ' ILE . 41.6 mt-30 -112.23 140.41 46.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.104 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.79 110.16 21.47 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.067 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.18 108.35 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.167 0.508 . . . . 0.0 110.42 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.59 112.5 22.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.638 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp -81.15 -41.82 21.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.572 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.67 -171.08 21.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.649 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -93.6 145.95 24.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.565 0.222 . . . . 0.0 110.912 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 38' ' ' ARG . 5.0 p -124.86 169.88 15.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.95 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.409 ' H ' HG23 ' A' ' 37' ' ' VAL . 5.2 mtt-85 -98.95 121.42 40.88 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.717 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.87 -31.06 71.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.738 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.56 -39.3 84.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.999 0.428 . . . . 0.0 110.81 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.3 m -81.32 -10.35 59.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.204 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.554 ' HG ' ' HB3' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -129.36 40.51 3.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.556 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.601 ' HA ' ' H ' ' A' ' 143' ' ' ALA . . . -111.86 10.88 20.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.366 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.53 145.55 48.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.329 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 140' ' ' THR . 18.2 tt0 -63.34 121.17 13.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 111.159 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.02 14.54 33.51 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.15 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.26 121.2 19.0 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.434 HG22 ' CE2' ' A' ' 138' ' ' PHE . 15.0 p -129.97 133.84 47.06 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.893 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 57.8 m -112.52 -166.75 1.11 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.625 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.2 t -59.08 149.48 27.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.818 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.82 153.57 17.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.347 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.483 HG23 ' HD1' ' A' ' 54' ' ' PHE . 3.7 m -103.37 130.31 53.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.98 121.53 6.57 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.619 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.585 ' HE1' ' HB1' ' A' ' 135' ' ' ALA . 52.3 p90 -153.7 136.41 15.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.779 0.323 . . . . 0.0 110.955 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 131' ' ' ILE . 24.7 p30 -133.59 141.3 47.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.679 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.535 HG21 ' HB ' ' A' ' 131' ' ' ILE . 1.2 tt -85.13 126.49 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.622 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.611 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.1 OUTLIER -75.77 119.39 19.72 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.773 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -130.69 87.31 2.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.316 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.705 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 5.0 p30 -77.18 173.72 11.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.981 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.492 ' HB3' ' HE ' ' B' ' 38' ' ' ARG . 41.5 m-20 62.82 66.38 0.76 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.929 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 34.4 m -115.64 161.96 17.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.732 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.496 ' HA ' ' OD1' ' A' ' 126' ' ' ASN . 0.2 OUTLIER -145.94 157.82 43.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.289 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -107.5 -16.74 14.29 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.13 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.39 -33.63 32.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.062 0.458 . . . . 0.0 111.763 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 19' ' ' ALA . 20.1 t -75.21 -41.56 44.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.665 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.91 146.75 29.15 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.558 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.83 -39.37 3.73 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.895 0.378 . . . . 0.0 110.92 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.31 159.53 15.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.477 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.649 ' HB3' ' HB ' ' A' ' 122' ' ' THR . . . -147.2 118.88 8.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.616 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' ' 118' ' ' PHE . . . -96.84 140.72 30.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.096 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.52 HG13 HG21 ' A' ' 131' ' ' ILE . 3.1 t -118.43 139.71 44.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.798 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.54 133.92 29.86 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.523 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.425 ' HB2' HD11 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -101.26 138.04 38.8 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.575 0.226 . . . . 0.0 111.15 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.473 ' CD2' HG22 ' D' ' 130' ' ' THR . 6.6 tt -100.99 91.02 4.38 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.001 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.37 -167.37 11.32 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.87 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.657 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -116.75 159.52 22.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.64 0.257 . . . . 0.0 110.752 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.411 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -83.96 137.96 33.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.996 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.747 HG21 ' HB ' ' A' ' 85' ' ' VAL . 9.0 tt -77.17 -40.52 29.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.88 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -141.18 55.24 1.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.852 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 52.85 -84.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.081 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -60.1 -16.12 39.58 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.577 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.482 ' O ' HG22 ' A' ' 78' ' ' ILE . 24.5 m80 -100.6 56.74 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.597 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.432 ' HB ' ' OG1' ' A' ' 112' ' ' THR . 1.1 m -71.36 -22.46 61.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.537 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.721 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 8.6 p-10 -57.23 -18.68 17.12 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.338 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.747 ' HB ' HG21 ' A' ' 78' ' ' ILE . 11.6 t -115.19 133.31 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.213 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.657 ' HA ' ' O ' ' A' ' 76' ' ' THR . 0.8 OUTLIER -72.93 154.12 40.69 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.347 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.529 ' H ' HD23 ' A' ' 86' ' ' LEU . . . -90.72 -161.37 0.8 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.846 0.355 . . . . 0.0 111.793 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.31 6.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.974 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.65 -83.92 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.312 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.26 20.53 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.415 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.731 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 1.5 m -86.59 79.34 8.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.75 -31.51 38.42 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.916 0.389 . . . . 0.0 111.672 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' D' ' 36' ' ' GLN . . . -128.09 54.53 1.72 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.615 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.89 -17.27 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.975 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.731 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 0.9 OUTLIER -89.47 177.19 6.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.797 0.332 . . . . 0.0 110.622 179.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.69 175.24 8.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.777 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -137.51 137.98 39.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.269 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 97' ' ' THR . 74.0 m-80 71.69 17.64 5.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.434 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.99 148.93 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.728 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.28 -176.74 35.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.46 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.468 ' O ' HG11 ' A' ' 101' ' ' VAL . 7.7 p -125.58 111.02 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 122.993 0.517 . . . . 0.0 111.718 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.606 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 0.9 OUTLIER -81.53 147.74 29.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.873 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.447 HD13 ' HE2' ' A' ' 133' ' ' PHE . 0.9 OUTLIER -123.76 115.94 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.489 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.726 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -88.7 140.55 29.34 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.621 0.248 . . . . 0.0 111.031 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . 2.1 t70 -89.37 152.0 21.75 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.68 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.655 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -71.74 -21.08 61.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.816 0.341 . . . . 0.0 111.101 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.596 ' HB ' ' HA ' ' A' ' 120' ' ' SER . 5.8 t -62.89 -21.94 66.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.064 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.69 -83.09 0.19 Allowed Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.611 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.69 170.67 15.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.776 0.322 . . . . 0.0 111.098 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.726 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -74.82 138.64 42.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.224 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.61 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 5.1 tp -94.53 153.38 17.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.343 0.592 . . . . 0.0 110.568 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 6.2 t -93.68 148.24 22.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.171 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mp -89.51 64.78 6.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.77 0.319 . . . . 0.0 110.771 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.535 ' HB2' ' OG1' ' A' ' 117' ' ' THR . 0.5 OUTLIER -95.04 -16.1 22.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.606 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.531 ' HA3' ' OG1' ' D' ' 130' ' ' THR . . . 104.44 -56.28 0.56 Allowed Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.66 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' D' ' 125' ' ' ASN . . . -103.56 29.08 5.95 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.994 0.426 . . . . 0.0 111.667 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.535 ' OG1' ' HB2' ' A' ' 114' ' ' ASP . 3.4 m -87.19 65.85 9.01 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.105 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.435 ' HE2' ' HA3' ' D' ' 127' ' ' GLY . 48.3 m-85 -77.69 73.45 4.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.5 70.78 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.596 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 0.7 OUTLIER -148.63 126.09 11.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.681 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.05 53.21 2.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.25 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.649 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -74.06 128.34 35.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.75 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.36 117.89 25.45 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.703 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.402 ' O ' HG23 ' A' ' 63' ' ' THR . 4.3 tp -88.51 134.76 33.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.719 0.295 . . . . 0.0 110.538 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.21 163.1 26.33 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.672 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 62' ' ' ASP . 1.5 t30 -67.61 125.33 25.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.669 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.61 -141.04 12.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.687 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 6.3 m -101.73 92.47 4.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.647 0.26 . . . . 0.0 110.729 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . 0.518 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 1.2 t30 -76.54 145.03 39.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.926 0.393 . . . . 0.0 111.13 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.611 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -134.63 131.81 38.24 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.049 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.535 ' HB ' HG21 ' A' ' 56' ' ' ILE . 28.4 mt -87.43 109.82 29.03 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.655 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.4 Cg_endo -81.65 112.12 2.38 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.578 1.518 . . . . 0.0 112.608 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.447 ' HE2' HD13 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -129.28 138.22 51.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.881 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 28.2 mt-30 -110.1 157.5 19.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.062 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 102' ' ' GLN . . . -152.68 107.91 3.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.97 0.414 . . . . 0.0 111.585 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -102.51 174.4 5.92 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.36 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.478 ' HB3' HD22 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -85.96 120.88 27.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.083 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.507 ' HB3' HG12 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -117.67 139.6 50.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.076 -179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.554 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . . . -129.88 145.66 51.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.914 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 16.5 p -104.43 -53.4 2.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.483 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.76 -121.48 3.26 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.989 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.12 112.83 24.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.517 0.199 . . . . 0.0 110.719 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.601 ' H ' ' HA ' ' A' ' 43' ' ' ALA . . . -61.68 150.85 35.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.805 0.336 . . . . 0.0 111.519 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.585 HG22 ' CD ' ' A' ' 145' ' ' PRO . 60.0 m -126.79 151.49 73.67 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.26 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.585 ' CD ' HG22 ' A' ' 144' ' ' THR . 1.4 Cg_endo -83.03 140.23 9.92 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.573 2.182 . . . . 0.0 111.963 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.9 -138.1 6.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.539 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -87.21 144.99 26.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.898 0.38 . . . . 0.0 111.367 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.73 38.87 1.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.527 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.05 153.48 22.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.505 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -161.87 171.28 17.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.04 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.42 126.8 7.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.239 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.616 ' HB3' HD12 ' A' ' 86' ' ' LEU . . . -125.35 142.85 51.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.249 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.86 133.17 34.89 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.47 ' HD1' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -86.45 127.87 34.89 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.119 0.485 . . . . 0.0 110.079 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.49 150.51 29.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.962 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.447 HG13 HD12 ' A' ' 131' ' ' ILE . 14.2 m -136.23 144.48 32.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.863 0.363 . . . . 0.0 111.571 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.571 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -136.19 132.76 36.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.32 0.581 . . . . 0.0 110.386 -179.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.475 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 5.5 m-85 -117.41 119.77 36.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.516 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' C' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.23 0.062 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.19 64.9 1.55 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.086 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' THR . . . . . 0.461 HG23 ' HB2' ' C' ' 18' ' ' ASN . 59.0 m -111.21 100.99 9.53 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.05 0.452 . . . . 0.0 111.536 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.475 ' HA ' ' HG2' ' C' ' 157' ' ' GLN . 60.1 m -86.72 131.91 34.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.545 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -161.09 168.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.532 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.17 118.75 37.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.571 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.32 -56.32 6.97 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.759 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.97 -145.36 4.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.923 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.99 142.1 29.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.927 0.394 . . . . 0.0 111.302 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.464 HG23 ' CZ ' ' C' ' 73' ' ' PHE . 44.1 t -121.66 107.37 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.198 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.81 110.95 21.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.365 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . 0.405 ' HB3' HD12 ' C' ' 34' ' ' LEU . 31.8 m-85 -87.58 113.58 23.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.794 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 118.55 36.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.338 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.51 175.6 39.73 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.973 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.751 ' HA ' ' HB3' ' C' ' 148' ' ' ALA . 0.1 OUTLIER -151.36 162.08 41.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.967 0.413 . . . . 0.0 110.302 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' C' ' 145' ' ' PRO . 2.2 t -114.95 119.38 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.268 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.497 HG21 ' HA ' ' B' ' 22' ' ' ALA . 0.3 OUTLIER -121.28 168.1 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.887 0.375 . . . . 0.0 111.017 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . 0.458 ' HB2' HG23 ' A' ' 3' ' ' THR . 1.3 t-20 -68.54 -175.25 0.63 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.91 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.448 ' O ' HG21 ' B' ' 65' ' ' VAL . . . -91.1 52.61 2.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.233 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.95 -15.64 1.32 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.39 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER -176.95 147.63 0.59 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.965 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.497 ' HA ' HG21 ' B' ' 17' ' ' VAL . . . -152.63 110.04 3.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.084 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' B' ' 58' ' ' LEU . 0.3 OUTLIER -53.0 159.07 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.39 164.47 14.3 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.563 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.99 -52.39 65.44 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.369 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.33 11.91 66.35 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.916 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 18.4 t -96.25 -30.78 13.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.894 0.378 . . . . 0.0 110.908 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.406 ' H ' HG21 ' B' ' 28' ' ' VAL . 11.3 t -49.89 -71.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.341 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.55 104.36 15.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.012 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' GLN . . . . . 0.523 HE22 ' HA ' ' B' ' 56' ' ' ILE . 41.8 mt-30 -112.21 140.34 46.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.082 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.82 110.13 21.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.054 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.13 108.42 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.157 0.503 . . . . 0.0 110.44 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.66 112.43 22.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.63 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 12' ' ' PHE . 5.2 mp -81.12 -41.82 21.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.625 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.76 -171.05 21.51 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.603 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 2.4 mt-30 -93.69 145.88 24.25 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.602 0.239 . . . . 0.0 110.908 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.418 HG23 ' H ' ' B' ' 38' ' ' ARG . 5.0 p -124.8 169.89 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.94 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.492 ' HE ' ' HB3' ' A' ' 60' ' ' ASP . 5.1 mtt-85 -98.95 121.5 40.99 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.68 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -62.01 -31.0 71.34 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.705 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.28 84.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.91 0.386 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 70.9 m -81.31 -10.39 59.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.149 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' B' ' 139' ' ' ALA . 0.6 OUTLIER -129.27 40.48 3.61 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.59 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ALA . . . . . 0.607 ' HA ' ' H ' ' B' ' 143' ' ' ALA . . . -111.86 10.94 20.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.333 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.56 145.52 48.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.326 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' B' ' 140' ' ' THR . 18.2 tt0 -63.3 121.15 13.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.81 0.338 . . . . 0.0 111.133 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.05 14.49 33.56 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.163 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.36 121.19 19.08 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' THR . . . . . 0.439 HG22 ' CE2' ' B' ' 138' ' ' PHE . 15.1 p -130.01 133.8 47.0 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.86 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' SER . . . . . 0.446 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 57.8 m -112.47 -166.68 1.1 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.592 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 36.2 t -59.07 149.52 27.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.76 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.84 153.59 17.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.397 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' B' ' 134' ' ' GLN . 3.7 m -103.42 130.31 53.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.92 121.45 6.53 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.64 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . 0.581 ' HE1' ' HB1' ' B' ' 135' ' ' ALA . 52.1 p90 -153.64 136.41 15.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.816 0.341 . . . . 0.0 110.962 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' B' ' 131' ' ' ILE . 24.8 p30 -133.58 141.31 47.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.707 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.523 ' HA ' HE22 ' B' ' 30' ' ' GLN . 1.2 tt -85.19 126.45 40.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.59 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . 0.617 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.1 OUTLIER -75.79 119.38 19.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.711 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 0.2 OUTLIER -130.64 87.34 2.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.299 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ASN . . . . . 0.706 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 5.1 p30 -77.29 173.71 11.59 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.955 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ASP . . . . . 0.503 ' HB3' ' HE ' ' C' ' 38' ' ' ARG . 41.6 m-20 62.85 66.43 0.75 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.878 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 34.4 m -115.71 161.96 17.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.736 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ASP . . . . . 0.491 ' HA ' ' OD1' ' B' ' 126' ' ' ASN . 0.2 OUTLIER -145.91 157.86 43.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.35 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.54 -16.71 14.29 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.4 -33.7 32.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.057 0.456 . . . . 0.0 111.737 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' VAL . . . . . 0.448 HG21 ' O ' ' B' ' 19' ' ' ALA . 20.0 t -75.12 -41.62 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.675 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.94 146.75 29.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.55 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.75 -39.43 3.74 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.893 0.378 . . . . 0.0 110.951 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.31 159.55 15.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.456 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' ALA . . . . . 0.649 ' HB3' ' HB ' ' B' ' 122' ' ' THR . . . -147.18 118.88 8.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.608 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' B' ' 118' ' ' PHE . . . -96.84 140.79 30.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.025 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.51 HG13 HG21 ' B' ' 131' ' ' ILE . 3.1 t -118.52 139.69 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.762 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.52 133.93 29.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.595 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' PHE . . . . . 0.464 ' CZ ' HG23 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -101.28 138.06 38.8 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.623 0.249 . . . . 0.0 111.116 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.472 ' CD2' HG22 ' E' ' 130' ' ' THR . 6.6 tt -101.05 91.12 4.41 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.003 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.38 -167.4 11.32 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.886 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' THR . . . . . 0.654 ' O ' ' HA ' ' B' ' 86' ' ' LEU . 0.3 OUTLIER -116.7 159.45 22.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.58 0.229 . . . . 0.0 110.761 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . 0.408 ' HB1' ' HA ' ' B' ' 83' ' ' THR . . . -83.84 137.92 33.46 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.013 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.757 HG21 ' HB ' ' B' ' 85' ' ' VAL . 9.0 tt -77.16 -40.47 29.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.894 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' B' ' 81' ' ' GLY . 0.1 OUTLIER -141.26 55.26 1.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.786 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . 0.428 ' HB1' ' H ' ' B' ' 81' ' ' GLY . . . 52.93 -84.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.008 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' B' ' 79' ' ' ASP . . . -60.07 -16.11 39.27 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.62 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' HIS . . . . . 0.488 ' O ' HG22 ' B' ' 78' ' ' ILE . 24.2 m80 -100.54 56.68 0.9 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.925 0.393 . . . . 0.0 110.619 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' THR . . . . . 0.434 ' HB ' ' OG1' ' B' ' 112' ' ' THR . 1.1 m -71.33 -22.42 61.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.587 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . 0.72 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 8.6 p-10 -57.23 -18.71 17.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.305 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.757 ' HB ' HG21 ' B' ' 78' ' ' ILE . 11.5 t -115.18 133.45 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.211 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' LEU . . . . . 0.654 ' HA ' ' O ' ' B' ' 76' ' ' THR . 0.8 OUTLIER -73.01 154.03 40.66 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.352 179.362 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.535 ' H ' HD23 ' B' ' 86' ' ' LEU . . . -90.69 -161.34 0.79 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.823 0.344 . . . . 0.0 111.793 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.23 6.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.016 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.65 -83.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.31 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.26 20.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.453 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' SER . . . . . 0.751 ' HB2' ' HB2' ' B' ' 95' ' ' SER . 1.5 m -86.53 79.35 8.97 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.71 -31.56 38.36 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.808 0.337 . . . . 0.0 111.642 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' E' ' 36' ' ' GLN . . . -128.02 54.4 1.72 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.663 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.87 -17.3 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.934 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' SER . . . . . 0.751 ' HB2' ' HB2' ' B' ' 91' ' ' SER . 0.9 OUTLIER -89.35 177.21 6.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.768 0.318 . . . . 0.0 110.703 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.71 175.31 8.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.785 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' B' ' 98' ' ' ASN . 0.2 OUTLIER -137.61 137.94 39.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.25 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' B' ' 97' ' ' THR . 74.0 m-80 71.78 17.6 5.38 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.444 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.95 149.0 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.672 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.44 -176.76 35.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.441 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . 0.459 ' O ' HG11 ' B' ' 101' ' ' VAL . 7.7 p -125.56 111.1 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 122.974 0.51 . . . . 0.0 111.678 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' GLN . . . . . 0.599 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 0.9 OUTLIER -81.67 147.68 29.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.789 -179.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' ILE . . . . . 0.456 HD13 ' HE2' ' B' ' 133' ' ' PHE . 0.9 OUTLIER -123.64 115.91 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.54 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' LEU . . . . . 0.694 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 0.4 OUTLIER -88.68 140.5 29.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.614 0.245 . . . . 0.0 111.036 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' ASP . . . . . 0.601 ' HB2' ' HB2' ' B' ' 111' ' ' LEU . 2.1 t70 -89.31 152.01 21.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.708 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' ARG . . . . . 0.642 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -71.8 -21.03 61.76 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.752 0.31 . . . . 0.0 111.027 179.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' THR . . . . . 0.599 ' HB ' ' HA ' ' B' ' 120' ' ' SER . 5.8 t -62.91 -21.94 66.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.007 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.64 -83.02 0.19 Allowed Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.662 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.69 170.72 15.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.767 0.318 . . . . 0.0 111.05 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.694 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -74.94 138.68 42.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.186 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' B' ' 105' ' ' ASP . 5.1 tp -94.53 153.47 17.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.385 0.612 . . . . 0.0 110.571 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' THR . . . . . 0.72 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 6.2 t -93.68 148.28 22.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.105 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mp -89.64 64.9 6.74 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.783 0.325 . . . . 0.0 110.722 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ASP . . . . . 0.532 ' HB2' ' OG1' ' B' ' 117' ' ' THR . 0.5 OUTLIER -95.07 -16.07 22.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.62 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' GLY . . . . . 0.541 ' HA3' ' OG1' ' E' ' 130' ' ' THR . . . 104.43 -56.24 0.57 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.637 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' E' ' 125' ' ' ASN . . . -103.61 29.0 6.03 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.029 0.442 . . . . 0.0 111.714 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' THR . . . . . 0.532 ' OG1' ' HB2' ' B' ' 114' ' ' ASP . 3.4 m -87.08 65.85 9.1 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.142 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' PHE . . . . . 0.428 ' HE2' ' HA3' ' E' ' 127' ' ' GLY . 48.3 m-85 -77.65 73.4 4.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.772 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.53 70.86 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' SER . . . . . 0.599 ' HA ' ' HB ' ' B' ' 107' ' ' THR . 0.7 OUTLIER -148.69 126.11 11.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.673 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.07 53.18 2.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.232 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.649 ' HB ' ' HB3' ' B' ' 69' ' ' ALA . 0.2 OUTLIER -73.97 128.28 35.1 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.732 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.33 117.97 25.47 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.675 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.51 134.8 33.76 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.548 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.28 163.06 26.49 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.637 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' ASN . . . . . 0.491 ' OD1' ' HA ' ' B' ' 62' ' ' ASP . 1.5 t30 -67.58 125.43 26.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.66 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.58 -141.06 12.22 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.664 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' THR . . . . . 0.706 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 6.3 m -101.74 92.34 4.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.673 0.273 . . . . 0.0 110.788 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ASN . . . . . 0.521 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 1.2 t30 -76.44 145.01 39.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.164 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.617 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.0 OUTLIER -134.62 131.81 38.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.073 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' ILE . . . . . 0.52 ' HB ' HG21 ' B' ' 56' ' ' ILE . 28.4 mt -87.41 109.8 28.86 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' PRO . . . . . 0.642 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.6 Cg_endo -81.52 112.06 2.4 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 121.645 1.563 . . . . 0.0 112.608 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.456 ' HE2' HD13 ' B' ' 103' ' ' ILE . 0.3 OUTLIER -129.3 138.24 51.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.875 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' B' ' 52' ' ' VAL . 28.1 mt-30 -110.13 157.48 19.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.035 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' B' ' 102' ' ' GLN . . . -152.66 107.84 3.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.905 0.383 . . . . 0.0 111.602 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -102.5 174.38 5.93 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.376 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . 0.467 ' HB3' HD22 ' B' ' 42' ' ' LEU . 0.6 OUTLIER -85.97 120.87 27.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.105 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . 0.494 ' HB3' HG12 ' B' ' 85' ' ' VAL . 0.2 OUTLIER -117.66 139.57 50.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.062 -179.181 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' ALA . . . . . 0.557 ' HB3' ' HG ' ' B' ' 42' ' ' LEU . . . -129.86 145.57 51.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.913 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 16.7 p -104.32 -53.41 2.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.513 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.75 -121.54 3.27 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.027 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.04 112.88 24.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.573 0.225 . . . . 0.0 110.729 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' ALA . . . . . 0.607 ' H ' ' HA ' ' B' ' 43' ' ' ALA . . . -61.69 150.86 35.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.783 0.325 . . . . 0.0 111.481 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.6 HG22 ' CD ' ' B' ' 145' ' ' PRO . 59.6 m -126.79 151.51 73.72 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.274 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.6 ' CD ' HG22 ' B' ' 144' ' ' THR . 1.3 Cg_endo -83.06 140.24 9.9 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.626 2.218 . . . . 0.0 111.945 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.91 -138.09 6.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.518 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' ALA . . . . . 0.563 ' HA ' ' HG3' ' A' ' 15' ' ' GLU . . . -87.2 144.99 26.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.925 0.393 . . . . 0.0 111.351 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' ALA . . . . . 0.759 ' HB3' ' HA ' ' A' ' 15' ' ' GLU . . . -140.7 38.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.566 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.09 153.59 21.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.546 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -161.88 171.24 18.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.041 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.45 126.79 7.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.251 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' ALA . . . . . 0.626 ' HB3' HD12 ' B' ' 86' ' ' LEU . . . -125.32 142.78 51.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.259 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.83 133.18 34.87 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.41 127.85 34.88 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.118 0.485 . . . . 0.0 110.137 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.54 150.53 29.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.882 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' VAL . . . . . 0.434 HG13 HD12 ' B' ' 131' ' ' ILE . 14.3 m -136.19 144.47 33.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.614 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -136.17 132.75 36.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.253 0.549 . . . . 0.0 110.442 -179.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' TYR . . . . . 0.474 ' OH ' ' HB3' ' B' ' 21' ' ' CYS . 5.5 m-85 -117.45 119.7 35.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.514 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.881 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 1' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' D' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 111.123 0.045 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.26 65.02 1.5 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.598 0.237 . . . . 0.0 110.96 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 3' ' ' THR . . . . . 0.461 HG23 ' HB2' ' D' ' 18' ' ' ASN . 57.2 m -111.23 101.0 9.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.471 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 4' ' ' THR . . . . . 0.481 ' HA ' ' HG2' ' D' ' 157' ' ' GLN . 61.6 m -86.63 131.85 34.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.67 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . 0.407 HG11 HG12 ' D' ' 17' ' ' VAL . 0.0 OUTLIER -161.11 168.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.607 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.09 118.68 36.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.616 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.26 -56.38 6.96 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.752 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.97 -145.38 4.66 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.909 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.02 142.06 29.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.399 . . . . 0.0 111.292 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' VAL . . . . . 0.472 HG23 ' CZ ' ' D' ' 73' ' ' PHE . 44.0 t -121.59 107.33 19.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.211 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.73 110.97 21.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.424 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' PHE . . . . . 0.409 ' HB3' HD12 ' D' ' 34' ' ' LEU . 32.0 m-85 -87.59 113.59 23.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.713 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.19 118.53 36.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.379 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.54 175.58 39.76 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.974 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' GLU . . . . . 0.742 ' HA ' ' HB3' ' D' ' 148' ' ' ALA . 0.1 OUTLIER -151.36 162.16 41.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.967 0.413 . . . . 0.0 110.263 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' D' ' 145' ' ' PRO . 2.2 t -115.08 119.48 61.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.153 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' VAL . . . . . 0.508 HG21 ' HA ' ' C' ' 22' ' ' ALA . 0.3 OUTLIER -121.31 168.1 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.808 0.337 . . . . 0.0 111.063 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' ASN . . . . . 0.461 ' HB2' HG23 ' B' ' 3' ' ' THR . 1.3 t-20 -68.5 -175.24 0.63 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.976 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . 0.448 ' O ' HG21 ' C' ' 65' ' ' VAL . . . -91.11 52.63 2.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.93 -15.76 1.32 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.361 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' CYS . . . . . 0.927 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER -176.91 147.64 0.6 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.926 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . 0.508 ' HA ' HG21 ' C' ' 17' ' ' VAL . . . -152.59 110.04 3.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.097 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' C' ' 58' ' ' LEU . 0.3 OUTLIER -53.08 159.07 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.01 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -90.32 164.46 14.34 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.614 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -57.01 -52.39 65.47 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.357 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.38 11.97 66.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.912 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 18.3 t -96.29 -30.78 13.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.889 0.376 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.414 ' H ' HG21 ' C' ' 28' ' ' VAL . 11.2 t -49.76 -71.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.341 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.52 104.31 15.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.086 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' GLN . . . . . 0.518 HE22 ' HA ' ' C' ' 56' ' ' ILE . 41.7 mt-30 -112.19 140.36 46.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.113 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.8 110.07 21.35 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.142 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -108.04 108.4 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.118 0.485 . . . . 0.0 110.386 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.67 112.42 22.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.687 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' LEU . . . . . 0.405 HD12 ' HB3' ' B' ' 12' ' ' PHE . 5.3 mp -81.03 -41.8 22.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.699 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.72 -171.12 21.61 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.604 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' GLN . . . . . 0.541 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 2.4 mt-30 -93.67 145.91 24.21 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.62 0.247 . . . . 0.0 110.913 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . 0.4 HG23 ' H ' ' C' ' 38' ' ' ARG . 5.0 p -124.84 169.94 15.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.94 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' ARG . . . . . 0.503 ' HE ' ' HB3' ' B' ' 60' ' ' ASP . 5.2 mtt-85 -98.93 121.37 40.79 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.71 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' THR . . . . . 0.434 HG22 ' HA ' ' B' ' 18' ' ' ASN . 0.6 OUTLIER -61.96 -30.94 71.27 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.717 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.61 -39.3 84.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.909 0.385 . . . . 0.0 110.764 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 71.3 m -81.29 -10.4 59.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.163 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' C' ' 139' ' ' ALA . 0.6 OUTLIER -129.34 40.45 3.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.577 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' ALA . . . . . 0.599 ' HA ' ' H ' ' C' ' 143' ' ' ALA . . . -111.89 10.91 20.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.355 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.51 145.52 48.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.372 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' C' ' 140' ' ' THR . 18.1 tt0 -63.26 121.12 12.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.814 0.34 . . . . 0.0 111.204 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.07 14.4 33.77 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.14 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.21 121.19 18.93 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' THR . . . . . 0.443 HG22 ' CE2' ' C' ' 138' ' ' PHE . 14.9 p -129.98 133.77 47.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.908 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.455 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 57.8 m -112.44 -166.73 1.1 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.59 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 36.1 t -59.06 149.46 27.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.801 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.82 153.64 17.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.369 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' VAL . . . . . 0.489 HG23 ' HD1' ' C' ' 54' ' ' PHE . 3.7 m -103.44 130.4 53.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.97 121.43 6.53 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.662 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . 0.58 ' HE1' ' HB1' ' C' ' 135' ' ' ALA . 52.2 p90 -153.65 136.39 15.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.776 0.322 . . . . 0.0 110.986 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' C' ' 131' ' ' ILE . 24.7 p30 -133.54 141.33 47.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.637 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.529 HG21 ' HB ' ' C' ' 131' ' ' ILE . 1.2 tt -85.17 126.52 40.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.62 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.624 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.1 OUTLIER -75.88 119.4 19.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.713 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' C' ' 23' ' ' VAL . 0.2 OUTLIER -130.63 87.29 2.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.254 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' ASN . . . . . 0.708 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 5.1 p30 -77.15 173.7 11.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.998 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' ASP . . . . . 0.499 ' HB3' ' HE ' ' D' ' 38' ' ' ARG . 41.3 m-20 62.83 66.4 0.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' CYS . . . . . 0.927 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 34.5 m -115.68 161.98 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.742 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' ASP . . . . . 0.498 ' HA ' ' OD1' ' C' ' 126' ' ' ASN . 0.2 OUTLIER -145.94 157.85 43.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.3 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.54 -16.65 14.31 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -81.35 -33.67 32.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.124 0.488 . . . . 0.0 111.817 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' VAL . . . . . 0.448 HG21 ' O ' ' C' ' 19' ' ' ALA . 20.0 t -75.14 -41.68 44.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.661 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.84 146.79 29.24 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.595 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.84 -39.35 3.73 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.897 0.379 . . . . 0.0 110.95 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.22 159.54 15.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.467 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' C' ' 122' ' ' THR . . . -147.24 118.87 7.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.578 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' ALA . . . . . 0.405 ' CB ' ' HB3' ' C' ' 118' ' ' PHE . . . -96.81 140.79 30.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.847 0.356 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' VAL . . . . . 0.524 HG13 HG21 ' C' ' 131' ' ' ILE . 3.1 t -118.51 139.74 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.732 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.54 133.91 29.84 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.521 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' PHE . . . . . 0.464 ' CZ ' HG23 ' B' ' 10' ' ' VAL . 0.1 OUTLIER -101.25 138.08 38.74 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.538 0.209 . . . . 0.0 111.185 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' LEU . . . . . 0.472 ' CD2' HG22 ' F' ' 130' ' ' THR . 6.6 tt -101.06 91.09 4.4 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.982 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.37 -167.37 11.32 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.871 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' THR . . . . . 0.656 ' O ' ' HA ' ' C' ' 86' ' ' LEU . 0.3 OUTLIER -116.67 159.53 22.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.557 0.218 . . . . 0.0 110.796 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' C' ' 83' ' ' THR . . . -83.95 137.95 33.38 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.942 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' ILE . . . . . 0.728 HG21 ' HB ' ' C' ' 85' ' ' VAL . 8.9 tt -77.18 -40.5 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.905 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -141.18 55.31 1.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.796 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' ALA . . . . . 0.447 ' HB1' ' H ' ' C' ' 81' ' ' GLY . . . 52.86 -84.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.051 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' C' ' 79' ' ' ASP . . . -60.09 -16.09 39.36 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.621 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' HIS . . . . . 0.487 ' O ' HG22 ' C' ' 78' ' ' ILE . 24.2 m80 -100.64 56.76 0.9 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.931 0.396 . . . . 0.0 110.584 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' THR . . . . . 0.442 ' HB ' ' OG1' ' C' ' 112' ' ' THR . 1.1 m -71.33 -22.44 61.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.584 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' ASN . . . . . 0.717 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 8.6 p-10 -57.18 -18.72 16.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.341 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.728 ' HB ' HG21 ' C' ' 78' ' ' ILE . 11.6 t -115.19 133.34 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.219 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' LEU . . . . . 0.656 ' HA ' ' O ' ' C' ' 76' ' ' THR . 0.8 OUTLIER -72.96 154.12 40.67 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.523 ' H ' HD23 ' C' ' 86' ' ' LEU . . . -90.76 -161.4 0.8 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.777 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.27 6.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.966 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.72 -83.84 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.317 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.27 20.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.985 0.421 . . . . 0.0 111.468 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' SER . . . . . 0.757 ' HB2' ' HB2' ' C' ' 95' ' ' SER . 1.5 m -86.58 79.25 8.98 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.67 -31.56 37.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.831 0.348 . . . . 0.0 111.611 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.1 54.49 1.72 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.661 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.9 -17.23 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.067 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' SER . . . . . 0.757 ' HB2' ' HB2' ' C' ' 91' ' ' SER . 0.9 OUTLIER -89.43 177.22 6.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.707 0.289 . . . . 0.0 110.65 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.77 175.3 8.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.759 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' C' ' 98' ' ' ASN . 0.2 OUTLIER -137.55 137.98 39.14 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.215 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 98' ' ' ASN . . . . . 0.536 ' HB2' ' O ' ' C' ' 97' ' ' THR . 74.0 m-80 71.69 17.63 5.46 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.465 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.9 148.96 26.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.741 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.39 -176.77 35.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.464 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' VAL . . . . . 0.465 HG11 ' O ' ' C' ' 101' ' ' VAL . 7.7 p -125.58 111.03 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.01 0.524 . . . . 0.0 111.711 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 102' ' ' GLN . . . . . 0.606 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 0.9 OUTLIER -81.54 147.75 29.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 -179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' ILE . . . . . 0.454 HD13 ' HE2' ' C' ' 133' ' ' PHE . 0.9 OUTLIER -123.77 115.94 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.489 179.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' LEU . . . . . 0.714 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 0.4 OUTLIER -88.73 140.53 29.35 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.634 0.254 . . . . 0.0 111.052 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 105' ' ' ASP . . . . . 0.584 ' HB2' ' HB2' ' C' ' 111' ' ' LEU . 2.1 t70 -89.36 152.06 21.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.711 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 106' ' ' ARG . . . . . 0.628 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -71.76 -21.05 61.79 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.785 0.326 . . . . 0.0 111.075 179.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 107' ' ' THR . . . . . 0.597 ' HB ' ' HA ' ' C' ' 120' ' ' SER . 5.8 t -62.99 -21.84 66.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.959 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.72 -83.08 0.19 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.669 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.73 170.66 15.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.833 0.349 . . . . 0.0 111.033 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.714 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -74.77 138.57 42.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 111' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' C' ' 105' ' ' ASP . 5.1 tp -94.45 153.41 17.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.363 0.601 . . . . 0.0 110.557 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 112' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 6.2 t -93.7 148.22 22.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.084 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mp -89.51 64.82 6.82 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.729 0.3 . . . . 0.0 110.715 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 114' ' ' ASP . . . . . 0.519 ' HB2' ' OG1' ' C' ' 117' ' ' THR . 0.5 OUTLIER -95.11 -16.05 22.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.588 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 115' ' ' GLY . . . . . 0.539 ' HA3' ' OG1' ' F' ' 130' ' ' THR . . . 104.41 -56.27 0.57 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.64 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 116' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' F' ' 125' ' ' ASN . . . -103.57 29.01 6.0 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.049 0.452 . . . . 0.0 111.709 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 117' ' ' THR . . . . . 0.519 ' OG1' ' HB2' ' C' ' 114' ' ' ASP . 3.4 m -87.27 65.87 8.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.145 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 118' ' ' PHE . . . . . 0.43 ' HE2' ' HA3' ' F' ' 127' ' ' GLY . 48.5 m-85 -77.66 73.47 4.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.792 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.57 70.83 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.837 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 120' ' ' SER . . . . . 0.597 ' HA ' ' HB ' ' C' ' 107' ' ' THR . 0.7 OUTLIER -148.68 126.15 11.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.15 53.25 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.202 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.641 ' HB ' ' HB3' ' C' ' 69' ' ' ALA . 0.2 OUTLIER -73.93 128.31 35.18 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.698 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.44 117.94 25.55 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.719 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.51 134.78 33.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.781 0.324 . . . . 0.0 110.489 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.26 163.07 26.45 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.674 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 126' ' ' ASN . . . . . 0.498 ' OD1' ' HA ' ' C' ' 62' ' ' ASP . 1.5 t30 -67.54 125.37 25.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.82 0.343 . . . . 0.0 110.687 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.62 -141.01 12.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.659 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 128' ' ' THR . . . . . 0.708 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 6.3 m -101.73 92.41 4.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.673 0.273 . . . . 0.0 110.778 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 129' ' ' ASN . . . . . 0.506 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 1.2 t30 -76.52 145.02 39.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.946 0.403 . . . . 0.0 111.119 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 130' ' ' THR . . . . . 0.624 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.0 OUTLIER -134.62 131.78 38.22 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.042 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 131' ' ' ILE . . . . . 0.529 ' HB ' HG21 ' C' ' 56' ' ' ILE . 28.3 mt -87.33 109.79 28.49 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 132' ' ' PRO . . . . . 0.628 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.4 Cg_endo -81.67 112.17 2.38 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.585 1.524 . . . . 0.0 112.53 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.454 ' HE2' HD13 ' C' ' 103' ' ' ILE . 0.3 OUTLIER -129.36 138.28 51.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.804 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 134' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' C' ' 52' ' ' VAL . 28.2 mt-30 -110.11 157.53 19.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.986 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 135' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' C' ' 102' ' ' GLN . . . -152.67 107.93 3.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.975 0.417 . . . . 0.0 111.608 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -102.54 174.41 5.91 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.338 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 137' ' ' TYR . . . . . 0.481 ' HB3' HD22 ' C' ' 42' ' ' LEU . 0.6 OUTLIER -86.08 120.9 27.96 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.069 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 138' ' ' PHE . . . . . 0.497 ' HB3' HG12 ' C' ' 85' ' ' VAL . 0.2 OUTLIER -117.66 139.61 50.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.006 -179.134 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 139' ' ' ALA . . . . . 0.562 ' HB3' ' HG ' ' C' ' 42' ' ' LEU . . . -129.93 145.66 51.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.875 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 140' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 16.5 p -104.38 -53.43 2.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.478 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.7 -121.56 3.27 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.024 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.1 112.97 24.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.59 0.233 . . . . 0.0 110.693 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 143' ' ' ALA . . . . . 0.599 ' H ' ' HA ' ' C' ' 43' ' ' ALA . . . -61.82 150.95 35.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.772 0.32 . . . . 0.0 111.42 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 144' ' ' THR . . . . . 0.595 HG22 ' CD ' ' C' ' 145' ' ' PRO . 58.2 m -126.89 151.51 73.96 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.199 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 145' ' ' PRO . . . . . 0.595 ' CD ' HG22 ' C' ' 144' ' ' THR . 1.3 Cg_endo -83.07 140.2 9.87 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.528 2.152 . . . . 0.0 111.936 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.94 -137.98 6.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.574 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 147' ' ' ALA . . . . . 0.578 ' HA ' ' HG3' ' B' ' 15' ' ' GLU . . . -87.23 145.07 26.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.984 0.421 . . . . 0.0 111.307 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 148' ' ' ALA . . . . . 0.751 ' HB3' ' HA ' ' B' ' 15' ' ' GLU . . . -140.76 38.83 1.83 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.0 153.52 22.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.486 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 150' ' ' ALA . . . . . . . . . . . . . . . -161.87 171.23 18.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.019 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.4 126.79 7.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.328 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 152' ' ' ALA . . . . . 0.615 ' HB3' HD12 ' C' ' 86' ' ' LEU . . . -125.31 142.8 51.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.328 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.85 133.17 34.88 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 154' ' ' PHE . . . . . 0.489 ' HD1' ' HA ' ' C' ' 154' ' ' PHE . 0.0 OUTLIER -86.44 127.85 34.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.104 0.478 . . . . 0.0 110.113 -178.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -111.43 150.52 29.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.921 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 156' ' ' VAL . . . . . 0.453 HG13 HD12 ' C' ' 131' ' ' ILE . 14.3 m -136.23 144.46 33.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.859 0.361 . . . . 0.0 111.582 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 157' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -136.16 132.73 36.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.34 0.59 . . . . 0.0 110.391 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 158' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' C' ' 21' ' ' CYS . 5.6 m-85 -117.45 119.8 36.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.51 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 159' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' B' ' 1' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.33 -0.843 . . . . 0.0 110.799 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 1' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' E' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.235 0.064 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.26 64.86 1.57 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.627 0.251 . . . . 0.0 111.065 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 3' ' ' THR . . . . . 0.453 HG23 ' HB2' ' E' ' 18' ' ' ASN . 57.9 m -111.17 100.96 9.52 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.524 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 4' ' ' THR . . . . . 0.479 ' HA ' ' HG2' ' E' ' 157' ' ' GLN . 61.6 m -86.59 131.91 34.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.609 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . 0.401 HG11 HG12 ' E' ' 17' ' ' VAL . 0.0 OUTLIER -161.16 168.06 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.523 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.19 118.71 37.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.584 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.31 -56.3 7.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.76 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.94 -145.34 4.65 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.919 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.02 142.09 29.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 0.0 111.282 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' VAL . . . . . 0.465 HG23 ' CZ ' ' E' ' 73' ' ' PHE . 43.8 t -121.66 107.27 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.168 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.7 111.03 21.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.366 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' PHE . . . . . 0.41 ' HB3' HD12 ' E' ' 34' ' ' LEU . 32.1 m-85 -87.63 113.53 23.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.777 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.13 118.54 36.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.405 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.48 175.61 39.71 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.887 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' GLU . . . . . 0.76 ' HA ' ' HB3' ' E' ' 148' ' ' ALA . 0.1 OUTLIER -151.38 162.12 41.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.946 0.403 . . . . 0.0 110.313 179.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' E' ' 145' ' ' PRO . 2.2 t -114.99 119.45 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.214 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' VAL . . . . . 0.518 HG21 ' HA ' ' D' ' 22' ' ' ALA . 0.3 OUTLIER -121.32 168.05 14.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.815 0.341 . . . . 0.0 111.07 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' ASN . . . . . 0.461 ' HB2' HG23 ' C' ' 3' ' ' THR . 1.3 t-20 -68.44 -175.21 0.62 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.984 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' ALA . . . . . 0.443 ' O ' HG21 ' D' ' 65' ' ' VAL . . . -91.24 52.67 2.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.89 -15.71 1.33 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.374 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' CYS . . . . . 0.929 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER -176.91 147.59 0.6 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.928 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . 0.518 ' HA ' HG21 ' D' ' 17' ' ' VAL . . . -152.64 110.04 3.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.114 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' D' ' 58' ' ' LEU . 0.3 OUTLIER -52.97 159.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.023 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -90.38 164.5 14.29 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.6 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -57.0 -52.38 65.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.365 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.36 11.87 66.56 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.872 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 18.7 t -96.14 -30.86 13.28 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.904 0.383 . . . . 0.0 110.929 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . 0.412 ' H ' HG21 ' D' ' 28' ' ' VAL . 11.3 t -49.83 -71.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.355 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.59 104.34 15.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.044 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' GLN . . . . . 0.509 HE22 ' HA ' ' D' ' 56' ' ' ILE . 41.7 mt-30 -112.14 140.3 46.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.071 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.77 110.18 21.5 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.028 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.13 108.36 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.155 0.503 . . . . 0.0 110.453 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.56 112.46 22.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.685 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' LEU . . . . . 0.409 HD12 ' HB3' ' C' ' 12' ' ' PHE . 5.2 mp -81.19 -41.72 21.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.673 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.64 -171.05 21.62 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.626 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' GLN . . . . . 0.535 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 2.4 mt-30 -93.57 145.93 24.17 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.524 0.202 . . . . 0.0 110.979 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 p -124.84 169.89 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.991 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' ARG . . . . . 0.499 ' HE ' ' HB3' ' C' ' 60' ' ' ASP . 5.2 mtt-85 -98.88 121.42 40.8 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.714 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' THR . . . . . 0.429 HG22 ' HA ' ' C' ' 18' ' ' ASN . 0.6 OUTLIER -62.01 -31.01 71.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.672 179.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.25 84.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.992 0.425 . . . . 0.0 110.852 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 71.1 m -81.31 -10.45 59.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.139 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.535 ' HG ' ' HB3' ' D' ' 139' ' ' ALA . 0.6 OUTLIER -129.25 40.42 3.62 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.607 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' ALA . . . . . 0.604 ' HA ' ' H ' ' D' ' 143' ' ' ALA . . . -111.83 10.91 20.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.363 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.51 145.49 48.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.369 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' D' ' 140' ' ' THR . 18.2 tt0 -63.34 121.26 13.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.11 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.05 14.38 33.9 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.155 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.17 121.22 18.93 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' THR . . . . . 0.433 HG22 ' CE2' ' D' ' 138' ' ' PHE . 14.9 p -130.04 133.79 46.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.919 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 57.8 m -112.46 -166.73 1.1 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.607 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 36.3 t -59.11 149.47 27.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.897 0.379 . . . . 0.0 110.768 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.76 153.64 17.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.404 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' D' ' 134' ' ' GLN . 3.7 m -103.41 130.33 53.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.96 121.5 6.56 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.576 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . 0.589 ' HE1' ' HB1' ' D' ' 135' ' ' ALA . 52.3 p90 -153.71 136.44 15.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.816 0.341 . . . . 0.0 110.94 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' D' ' 131' ' ' ILE . 24.7 p30 -133.57 141.33 47.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.628 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' ILE . . . . . 0.535 HG21 ' HB ' ' D' ' 131' ' ' ILE . 1.2 tt -85.06 126.42 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.645 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' GLN . . . . . 0.601 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.1 OUTLIER -75.73 119.41 19.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.742 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' D' ' 23' ' ' VAL . 0.2 OUTLIER -130.68 87.36 2.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.258 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' ASN . . . . . 0.707 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 5.0 p30 -77.3 173.64 11.68 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.956 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' ASP . . . . . 0.501 ' HB3' ' HE ' ' E' ' 38' ' ' ARG . 41.3 m-20 62.91 66.4 0.75 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.844 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' CYS . . . . . 0.929 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 34.6 m -115.69 161.98 17.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.714 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' ASP . . . . . 0.502 ' HA ' ' OD1' ' D' ' 126' ' ' ASN . 0.2 OUTLIER -145.88 157.92 43.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.323 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.401 HG23 ' O ' ' D' ' 124' ' ' LEU . 0.0 OUTLIER -107.59 -16.67 14.3 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -81.42 -33.65 32.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.028 0.442 . . . . 0.0 111.708 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 65' ' ' VAL . . . . . 0.443 HG21 ' O ' ' D' ' 19' ' ' ALA . 20.0 t -75.19 -41.6 44.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.629 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.93 146.7 29.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.553 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.77 -39.3 3.76 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.972 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.3 159.58 15.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.477 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' ALA . . . . . 0.63 ' HB3' ' HB ' ' D' ' 122' ' ' THR . . . -147.19 118.82 7.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.649 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' D' ' 118' ' ' PHE . . . -96.83 140.74 30.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.093 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' VAL . . . . . 0.526 HG13 HG21 ' D' ' 131' ' ' ILE . 3.1 t -118.5 139.71 44.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.784 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.56 133.94 29.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.522 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 73' ' ' PHE . . . . . 0.472 ' CZ ' HG23 ' C' ' 10' ' ' VAL . 0.1 OUTLIER -101.21 137.97 38.86 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.509 0.195 . . . . 0.0 111.243 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 74' ' ' LEU . . . . . 0.408 ' O ' HD23 ' D' ' 74' ' ' LEU . 6.6 tt -100.97 91.08 4.41 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.011 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.43 -167.38 11.31 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.891 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 76' ' ' THR . . . . . 0.668 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.3 OUTLIER -116.68 159.56 22.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.585 0.231 . . . . 0.0 110.761 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . 0.424 ' HB1' ' HA ' ' D' ' 83' ' ' THR . . . -83.96 137.85 33.42 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.018 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 78' ' ' ILE . . . . . 0.732 HG21 ' HB ' ' D' ' 85' ' ' VAL . 9.0 tt -77.13 -40.48 30.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.882 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 79' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' D' ' 81' ' ' GLY . 0.1 OUTLIER -141.22 55.21 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.848 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 52.87 -84.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.075 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' D' ' 79' ' ' ASP . . . -60.09 -16.05 39.19 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.663 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 82' ' ' HIS . . . . . 0.485 ' O ' HG22 ' D' ' 78' ' ' ILE . 24.2 m80 -100.64 56.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 110.568 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 83' ' ' THR . . . . . 0.441 ' HB ' ' OG1' ' D' ' 112' ' ' THR . 1.1 m -71.41 -22.42 61.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.563 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 84' ' ' ASN . . . . . 0.721 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 8.6 p-10 -57.17 -18.67 16.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.359 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.732 ' HB ' HG21 ' D' ' 78' ' ' ILE . 11.6 t -115.24 133.34 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.227 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 86' ' ' LEU . . . . . 0.668 ' HA ' ' O ' ' D' ' 76' ' ' THR . 0.8 OUTLIER -72.93 154.06 40.71 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.341 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.531 ' H ' HD23 ' D' ' 86' ' ' LEU . . . -90.66 -161.41 0.8 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.837 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.69 -178.27 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.01 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -83.88 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.339 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.33 20.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.998 0.427 . . . . 0.0 111.49 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 91' ' ' SER . . . . . 0.733 ' HB2' ' HB2' ' D' ' 95' ' ' SER . 1.5 m -86.6 79.35 8.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.73 -31.49 38.2 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.913 0.387 . . . . 0.0 111.71 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.08 54.43 1.72 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.646 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.9 -17.29 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.931 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 95' ' ' SER . . . . . 0.733 ' HB2' ' HB2' ' D' ' 91' ' ' SER . 0.9 OUTLIER -89.39 177.16 6.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.75 0.309 . . . . 0.0 110.661 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.76 175.3 8.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.812 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 97' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' D' ' 98' ' ' ASN . 0.2 OUTLIER -137.52 138.03 39.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.263 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 98' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' D' ' 97' ' ' THR . 74.0 m-80 71.63 17.6 5.53 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.52 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.86 148.94 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.733 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.35 -176.74 35.65 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.436 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 101' ' ' VAL . . . . . 0.467 HG11 ' O ' ' D' ' 101' ' ' VAL . 7.7 p -125.59 111.01 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 122.968 0.507 . . . . 0.0 111.759 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 102' ' ' GLN . . . . . 0.611 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 0.9 OUTLIER -81.53 147.71 29.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 103' ' ' ILE . . . . . 0.448 HD13 ' HE2' ' D' ' 133' ' ' PHE . 0.9 OUTLIER -123.74 115.92 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.478 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 104' ' ' LEU . . . . . 0.725 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 0.4 OUTLIER -88.69 140.52 29.37 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.693 0.283 . . . . 0.0 111.051 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 105' ' ' ASP . . . . . 0.594 ' HB2' ' HB2' ' D' ' 111' ' ' LEU . 2.1 t70 -89.26 151.98 21.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.693 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 106' ' ' ARG . . . . . 0.654 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -71.78 -21.07 61.77 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.805 0.336 . . . . 0.0 111.07 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 107' ' ' THR . . . . . 0.601 ' HB ' ' HA ' ' D' ' 120' ' ' SER . 5.8 t -62.9 -21.91 66.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.97 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.68 -83.02 0.19 Allowed Glycine 0 CA--C 1.517 0.219 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.722 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.74 170.7 15.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.834 0.349 . . . . 0.0 111.106 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.725 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -74.84 138.61 42.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.183 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 111' ' ' LEU . . . . . 0.594 ' HB2' ' HB2' ' D' ' 105' ' ' ASP . 5.1 tp -94.37 153.41 17.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.276 0.56 . . . . 0.0 110.604 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 112' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 6.2 t -93.72 148.33 22.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.046 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mp -89.7 64.87 6.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.894 0.378 . . . . 0.0 110.758 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 114' ' ' ASP . . . . . 0.52 ' HB2' ' OG1' ' D' ' 117' ' ' THR . 0.5 OUTLIER -94.98 -16.15 22.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.648 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.49 -56.26 0.56 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.693 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.53 29.05 5.96 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.949 0.404 . . . . 0.0 111.719 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 117' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' D' ' 114' ' ' ASP . 3.4 m -87.26 65.92 8.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.041 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 118' ' ' PHE . . . . . 0.411 ' CD1' ' HB2' ' D' ' 157' ' ' GLN . 48.5 m-85 -77.69 73.42 4.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.808 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.49 70.79 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 120' ' ' SER . . . . . 0.601 ' HA ' ' HB ' ' D' ' 107' ' ' THR . 0.7 OUTLIER -148.64 126.07 11.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.67 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.08 53.27 2.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.198 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' D' ' 69' ' ' ALA . 0.2 OUTLIER -74.04 128.32 35.22 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.715 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.36 117.9 25.45 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.765 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 124' ' ' LEU . . . . . 0.401 ' O ' HG23 ' D' ' 63' ' ' THR . 4.3 tp -88.52 134.8 33.76 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.831 0.348 . . . . 0.0 110.524 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 125' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -129.24 163.09 26.37 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.654 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 126' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' D' ' 62' ' ' ASP . 1.5 t30 -67.6 125.37 25.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.7 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 127' ' ' GLY . . . . . 0.435 ' HA3' ' HE2' ' A' ' 118' ' ' PHE . . . 128.62 -140.97 12.14 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.718 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 128' ' ' THR . . . . . 0.707 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 6.3 m -101.8 92.45 4.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.672 0.272 . . . . 0.0 110.772 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 129' ' ' ASN . . . . . 0.516 ' HB2' ' SG ' ' D' ' 61' ' ' CYS . 1.2 t30 -76.5 145.04 39.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.92 0.391 . . . . 0.0 111.147 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 130' ' ' THR . . . . . 0.601 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.0 OUTLIER -134.68 131.79 38.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.063 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 131' ' ' ILE . . . . . 0.535 ' HB ' HG21 ' D' ' 56' ' ' ILE . 28.2 mt -87.32 109.73 28.01 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 132' ' ' PRO . . . . . 0.654 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.5 Cg_endo -81.57 112.13 2.4 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.599 1.533 . . . . 0.0 112.576 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . 0.448 ' HE2' HD13 ' D' ' 103' ' ' ILE . 0.3 OUTLIER -129.35 138.2 51.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.844 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 134' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' D' ' 52' ' ' VAL . 28.3 mt-30 -110.1 157.55 19.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.99 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 135' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' D' ' 102' ' ' GLN . . . -152.68 107.92 3.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 111.568 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -102.53 174.34 5.94 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.381 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 137' ' ' TYR . . . . . 0.476 ' HB3' HD22 ' D' ' 42' ' ' LEU . 0.6 OUTLIER -85.99 120.81 27.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.097 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 138' ' ' PHE . . . . . 0.499 ' HB3' HG12 ' D' ' 85' ' ' VAL . 0.2 OUTLIER -117.62 139.56 50.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.079 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 139' ' ' ALA . . . . . 0.535 ' HB3' ' HG ' ' D' ' 42' ' ' LEU . . . -129.88 145.64 51.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.851 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 140' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 16.3 p -104.46 -53.43 2.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.407 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.67 -121.52 3.27 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.014 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.08 112.92 24.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.568 0.223 . . . . 0.0 110.676 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 143' ' ' ALA . . . . . 0.604 ' H ' ' HA ' ' D' ' 43' ' ' ALA . . . -61.78 150.86 35.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.755 0.312 . . . . 0.0 111.453 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 144' ' ' THR . . . . . 0.594 HG22 ' CD ' ' D' ' 145' ' ' PRO . 60.4 m -126.81 151.52 73.77 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.274 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 145' ' ' PRO . . . . . 0.594 ' CD ' HG22 ' D' ' 144' ' ' THR . 1.3 Cg_endo -83.08 140.2 9.85 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.613 2.208 . . . . 0.0 111.941 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.94 -138.14 6.59 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.485 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 147' ' ' ALA . . . . . 0.571 ' HA ' ' HG3' ' C' ' 15' ' ' GLU . . . -87.14 145.02 26.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.912 0.387 . . . . 0.0 111.378 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 148' ' ' ALA . . . . . 0.742 ' HB3' ' HA ' ' C' ' 15' ' ' GLU . . . -140.73 38.79 1.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.545 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.1 153.53 22.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.48 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 150' ' ' ALA . . . . . . . . . . . . . . . -161.86 171.25 18.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.048 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.42 126.8 7.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.242 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 152' ' ' ALA . . . . . 0.616 ' HB3' HD12 ' D' ' 86' ' ' LEU . . . -125.31 142.85 51.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.257 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 153' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.84 133.17 34.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 154' ' ' PHE . . . . . 0.488 ' HD1' ' HA ' ' D' ' 154' ' ' PHE . 0.0 OUTLIER -86.46 127.88 34.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.042 0.449 . . . . 0.0 110.096 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.48 150.57 29.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.958 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 156' ' ' VAL . . . . . 0.45 HG13 HD12 ' D' ' 131' ' ' ILE . 14.4 m -136.24 144.39 33.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.826 0.346 . . . . 0.0 111.594 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 157' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' D' ' 69' ' ' ALA . 0.0 OUTLIER -136.16 132.74 36.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.268 0.556 . . . . 0.0 110.415 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 158' ' ' TYR . . . . . 0.47 ' OH ' ' HB3' ' D' ' 21' ' ' CYS . 5.5 m-85 -117.42 119.78 36.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.505 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 159' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' C' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.844 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 1' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' F' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 120.209 0.052 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.21 64.86 1.57 Allowed 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.126 0.266 . . . . 0.0 111.079 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 3' ' ' THR . . . . . 0.448 HG23 ' HB2' ' F' ' 18' ' ' ASN . 57.8 m -111.17 101.03 9.58 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.42 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 4' ' ' THR . . . . . 0.458 ' HA ' ' HG2' ' F' ' 157' ' ' GLN . 60.0 m -86.72 131.91 34.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.539 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -161.15 168.05 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.513 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.15 118.76 37.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.58 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.36 -56.26 7.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.759 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.01 -145.36 4.66 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.883 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.01 142.07 29.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.288 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 10' ' ' VAL . . . . . 0.463 HG23 ' CZ ' ' F' ' 73' ' ' PHE . 44.0 t -121.64 107.31 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.17 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.72 110.93 21.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.431 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 12' ' ' PHE . . . . . 0.413 ' HB3' HD12 ' F' ' 34' ' ' LEU . 32.2 m-85 -87.54 113.48 23.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.15 118.54 36.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.443 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.49 175.49 39.72 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.946 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 15' ' ' GLU . . . . . 0.751 ' HA ' ' HB3' ' F' ' 148' ' ' ALA . 0.1 OUTLIER -151.29 162.13 41.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.994 0.426 . . . . 0.0 110.303 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 16' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' F' ' 145' ' ' PRO . 2.2 t -114.97 119.33 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.265 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 17' ' ' VAL . . . . . 0.497 HG21 ' HA ' ' E' ' 22' ' ' ALA . 0.3 OUTLIER -121.26 168.06 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.843 0.354 . . . . 0.0 111.039 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 18' ' ' ASN . . . . . 0.453 ' HB2' HG23 ' D' ' 3' ' ' THR . 1.3 t-20 -68.38 -175.26 0.61 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.01 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 19' ' ' ALA . . . . . 0.447 ' O ' HG21 ' E' ' 65' ' ' VAL . . . -91.12 52.59 2.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.95 -15.66 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.357 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 21' ' ' CYS . . . . . 0.923 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER -176.96 147.55 0.58 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.981 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 22' ' ' ALA . . . . . 0.497 ' HA ' HG21 ' E' ' 17' ' ' VAL . . . -152.57 110.05 3.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 23' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' E' ' 58' ' ' LEU . 0.3 OUTLIER -53.0 159.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.011 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -90.37 164.46 14.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.592 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 25' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -56.91 -52.42 65.24 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.402 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.35 11.9 66.43 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.881 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 18.3 t -96.21 -30.77 13.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.895 0.379 . . . . 0.0 110.917 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 28' ' ' VAL . . . . . . . . . . . . . 11.2 t -49.84 -71.71 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.38 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.47 104.29 15.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 30' ' ' GLN . . . . . 0.516 HE22 ' HA ' ' E' ' 56' ' ' ILE . 41.8 mt-30 -112.17 140.4 46.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.07 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.83 110.16 21.46 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.301 -0.409 . . . . 0.0 112.045 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.17 108.46 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.136 0.493 . . . . 0.0 110.434 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.65 112.47 22.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 34' ' ' LEU . . . . . 0.41 HD12 ' HB3' ' D' ' 12' ' ' PHE . 5.3 mp -81.17 -41.8 21.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.67 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.72 -171.02 21.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.632 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 36' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 2.4 mt-30 -93.62 145.9 24.21 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.502 0.192 . . . . 0.0 110.969 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . 0.415 HG23 ' H ' ' E' ' 38' ' ' ARG . 5.0 p -124.82 169.88 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.942 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 38' ' ' ARG . . . . . 0.501 ' HE ' ' HB3' ' D' ' 60' ' ' ASP . 5.2 mtt-85 -98.94 121.45 40.91 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.701 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 39' ' ' THR . . . . . 0.44 HG22 ' HA ' ' D' ' 18' ' ' ASN . 0.6 OUTLIER -61.99 -31.03 71.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.675 179.521 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.3 85.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.987 0.422 . . . . 0.0 110.85 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 70.5 m -81.36 -10.3 59.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.128 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 42' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' E' ' 139' ' ' ALA . 0.6 OUTLIER -129.33 40.34 3.62 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.571 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 43' ' ' ALA . . . . . 0.607 ' HA ' ' H ' ' E' ' 143' ' ' ALA . . . -111.87 10.98 20.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.392 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.6 145.47 48.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.35 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 45' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' E' ' 140' ' ' THR . 18.2 tt0 -63.28 121.17 13.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.367 . . . . 0.0 111.109 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.03 14.48 33.67 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.113 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.14 121.19 18.86 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 48' ' ' THR . . . . . 0.443 HG22 ' CE2' ' E' ' 138' ' ' PHE . 14.9 p -130.03 133.72 46.93 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.906 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 49' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 57.9 m -112.43 -166.69 1.1 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.623 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 36.3 t -59.03 149.5 27.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.774 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.84 153.6 17.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.386 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 52' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' E' ' 134' ' ' GLN . 3.7 m -103.45 130.34 53.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.877 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.94 121.4 6.52 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.612 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 54' ' ' PHE . . . . . 0.59 ' HE1' ' HB1' ' E' ' 135' ' ' ALA . 52.2 p90 -153.6 136.44 15.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 110.97 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 55' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' E' ' 131' ' ' ILE . 24.7 p30 -133.55 141.39 47.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.682 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 56' ' ' ILE . . . . . 0.525 HG21 ' HB ' ' E' ' 131' ' ' ILE . 1.2 tt -85.18 126.43 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.627 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 57' ' ' GLN . . . . . 0.601 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.1 OUTLIER -75.8 119.45 19.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.732 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 58' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' E' ' 23' ' ' VAL . 0.2 OUTLIER -130.75 87.34 2.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.214 -179.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 59' ' ' ASN . . . . . 0.714 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 5.1 p30 -77.2 173.71 11.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.991 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 60' ' ' ASP . . . . . 0.495 ' HB3' ' HE ' ' F' ' 38' ' ' ARG . 41.6 m-20 62.89 66.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 61' ' ' CYS . . . . . 0.923 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 34.5 m -115.66 161.98 17.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.74 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 62' ' ' ASP . . . . . 0.501 ' HA ' ' OD1' ' E' ' 126' ' ' ASN . 0.2 OUTLIER -145.91 157.82 43.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.333 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 63' ' ' THR . . . . . 0.4 HG23 ' O ' ' E' ' 124' ' ' LEU . 0.0 OUTLIER -107.51 -16.65 14.31 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.186 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.4 -33.63 32.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.055 0.455 . . . . 0.0 111.755 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 65' ' ' VAL . . . . . 0.447 HG21 ' O ' ' E' ' 19' ' ' ALA . 20.0 t -75.19 -41.55 44.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.668 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.94 146.76 29.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.528 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -39.25 3.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.008 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.32 159.61 15.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.431 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 69' ' ' ALA . . . . . 0.63 ' HB3' ' HB ' ' E' ' 122' ' ' THR . . . -147.26 118.87 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.612 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.9 140.81 30.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.063 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 71' ' ' VAL . . . . . 0.512 HG13 HG21 ' E' ' 131' ' ' ILE . 3.1 t -118.57 139.74 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.714 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.56 133.9 29.78 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.533 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 73' ' ' PHE . . . . . 0.465 ' CZ ' HG23 ' D' ' 10' ' ' VAL . 0.1 OUTLIER -101.16 138.01 38.76 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 122.388 -0.195 . . . . 0.0 111.185 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 74' ' ' LEU . . . . . 0.41 ' O ' HD23 ' E' ' 74' ' ' LEU . 6.6 tt -100.98 91.02 4.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.028 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.37 -167.37 11.32 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.872 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 76' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.3 OUTLIER -116.71 159.48 22.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.631 0.253 . . . . 0.0 110.729 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 77' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' E' ' 83' ' ' THR . . . -83.94 137.94 33.39 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.024 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 78' ' ' ILE . . . . . 0.745 HG21 ' HB ' ' E' ' 85' ' ' VAL . 8.9 tt -77.18 -40.48 29.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.911 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 79' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' E' ' 81' ' ' GLY . 0.1 OUTLIER -141.22 55.26 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.882 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 80' ' ' ALA . . . . . 0.459 ' HB1' ' H ' ' E' ' 81' ' ' GLY . . . 52.88 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 81' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' E' ' 79' ' ' ASP . . . -60.09 -15.99 38.89 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.652 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 82' ' ' HIS . . . . . 0.488 ' O ' HG22 ' E' ' 78' ' ' ILE . 24.2 m80 -100.68 56.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.929 0.395 . . . . 0.0 110.557 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 83' ' ' THR . . . . . 0.434 ' HB ' ' OG1' ' E' ' 112' ' ' THR . 1.1 m -71.32 -22.53 61.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.574 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 84' ' ' ASN . . . . . 0.717 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 8.6 p-10 -57.2 -18.62 16.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.347 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 85' ' ' VAL . . . . . 0.745 ' HB ' HG21 ' E' ' 78' ' ' ILE . 11.6 t -115.23 133.36 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.205 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 86' ' ' LEU . . . . . 0.663 ' HA ' ' O ' ' E' ' 76' ' ' THR . 0.8 OUTLIER -72.95 154.01 40.72 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.368 179.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 87' ' ' ALA . . . . . 0.536 ' H ' HD23 ' E' ' 86' ' ' LEU . . . -90.67 -161.35 0.79 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.872 0.367 . . . . 0.0 111.781 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.74 -178.24 6.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.925 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.72 -83.82 0.04 OUTLIER 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.364 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.35 20.49 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.989 0.423 . . . . 0.0 111.464 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 91' ' ' SER . . . . . 0.744 ' HB2' ' HB2' ' E' ' 95' ' ' SER . 1.5 m -86.56 79.3 8.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.7 -31.54 38.14 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.867 0.365 . . . . 0.0 111.624 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.05 54.43 1.72 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.671 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.86 -17.34 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.02 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 95' ' ' SER . . . . . 0.744 ' HB2' ' HB2' ' E' ' 91' ' ' SER . 0.9 OUTLIER -89.41 177.2 6.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.804 0.335 . . . . 0.0 110.67 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.68 175.19 8.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.795 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 97' ' ' THR . . . . . 0.534 ' O ' ' HB2' ' E' ' 98' ' ' ASN . 0.2 OUTLIER -137.5 138.01 39.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.275 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 98' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' E' ' 97' ' ' THR . 74.0 m-80 71.71 17.52 5.46 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.532 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.87 149.0 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.719 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.34 -176.75 35.65 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.447 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 101' ' ' VAL . . . . . 0.453 HG11 ' O ' ' E' ' 101' ' ' VAL . 7.7 p -125.63 111.04 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.003 0.521 . . . . 0.0 111.736 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 102' ' ' GLN . . . . . 0.606 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 0.9 OUTLIER -81.58 147.67 29.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.878 -179.67 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 103' ' ' ILE . . . . . 0.449 HD13 ' HE2' ' E' ' 133' ' ' PHE . 0.9 OUTLIER -123.64 115.95 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.55 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 104' ' ' LEU . . . . . 0.699 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 0.4 OUTLIER -88.77 140.51 29.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.688 0.28 . . . . 0.0 111.02 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 105' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' E' ' 111' ' ' LEU . 2.1 t70 -89.28 152.02 21.79 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.661 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 106' ' ' ARG . . . . . 0.647 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -71.79 -21.02 61.77 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.819 0.343 . . . . 0.0 111.119 179.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 107' ' ' THR . . . . . 0.602 ' HB ' ' HA ' ' E' ' 120' ' ' SER . 5.8 t -62.89 -21.98 66.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.981 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.69 -83.05 0.19 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.626 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.66 170.68 15.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 111.105 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 110' ' ' ALA . . . . . 0.699 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -74.85 138.63 42.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.227 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 111' ' ' LEU . . . . . 0.586 ' HB2' ' HB2' ' E' ' 105' ' ' ASP . 5.0 tp -94.45 153.45 17.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.366 0.603 . . . . 0.0 110.577 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 112' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 6.2 t -93.78 148.29 22.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.049 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mp -89.53 64.82 6.81 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.773 0.32 . . . . 0.0 110.742 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 114' ' ' ASP . . . . . 0.535 ' HB2' ' OG1' ' E' ' 117' ' ' THR . 0.5 OUTLIER -95.1 -15.95 23.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.662 0.268 . . . . 0.0 111.665 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.34 -56.25 0.57 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.682 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.58 29.05 5.98 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.983 0.42 . . . . 0.0 111.679 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 117' ' ' THR . . . . . 0.535 ' OG1' ' HB2' ' E' ' 114' ' ' ASP . 3.4 m -87.11 65.82 9.06 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.153 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 118' ' ' PHE . . . . . 0.411 ' CD1' ' HB2' ' E' ' 157' ' ' GLN . 48.3 m-85 -77.67 73.39 4.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.814 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.54 70.85 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 120' ' ' SER . . . . . 0.602 ' HA ' ' HB ' ' E' ' 107' ' ' THR . 0.7 OUTLIER -148.66 126.08 11.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.679 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.06 53.23 2.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.203 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 122' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' E' ' 69' ' ' ALA . 0.2 OUTLIER -74.04 128.31 35.2 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.67 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 4.5 m -86.29 118.0 25.46 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.759 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 124' ' ' LEU . . . . . 0.4 ' O ' HG23 ' E' ' 63' ' ' THR . 4.3 tp -88.61 134.82 33.77 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.779 0.323 . . . . 0.0 110.482 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 125' ' ' ASN . . . . . 0.516 ' HB3' ' O ' ' B' ' 116' ' ' ALA . 0.3 OUTLIER -129.3 163.08 26.47 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.662 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 126' ' ' ASN . . . . . 0.501 ' OD1' ' HA ' ' E' ' 62' ' ' ASP . 1.5 t30 -67.56 125.34 25.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.653 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 127' ' ' GLY . . . . . 0.428 ' HA3' ' HE2' ' B' ' 118' ' ' PHE . . . 128.59 -140.97 12.14 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.686 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 128' ' ' THR . . . . . 0.714 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 6.3 m -101.76 92.5 4.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.666 0.27 . . . . 0.0 110.752 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 129' ' ' ASN . . . . . 0.517 ' HB2' ' SG ' ' E' ' 61' ' ' CYS . 1.2 t30 -76.58 144.98 39.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.89 0.376 . . . . 0.0 111.099 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 130' ' ' THR . . . . . 0.601 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.0 OUTLIER -134.63 131.81 38.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.05 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 131' ' ' ILE . . . . . 0.525 ' HB ' HG21 ' E' ' 56' ' ' ILE . 28.3 mt -87.34 109.74 28.16 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 132' ' ' PRO . . . . . 0.647 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.4 Cg_endo -81.61 112.15 2.39 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 121.604 1.536 . . . . 0.0 112.544 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 133' ' ' PHE . . . . . 0.449 ' HE2' HD13 ' E' ' 103' ' ' ILE . 0.3 OUTLIER -129.32 138.21 51.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.849 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 134' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' E' ' 52' ' ' VAL . 28.1 mt-30 -110.03 157.49 19.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.075 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 135' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' E' ' 102' ' ' GLN . . . -152.65 107.85 3.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 111.636 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -102.58 174.34 5.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.338 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 137' ' ' TYR . . . . . 0.479 ' HB3' HD22 ' E' ' 42' ' ' LEU . 0.6 OUTLIER -85.9 120.86 27.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.036 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 138' ' ' PHE . . . . . 0.484 ' HB3' HG12 ' E' ' 85' ' ' VAL . 0.2 OUTLIER -117.68 139.64 50.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.001 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 139' ' ' ALA . . . . . 0.562 ' HB3' ' HG ' ' E' ' 42' ' ' LEU . . . -129.95 145.62 51.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.915 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 140' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 16.5 p -104.45 -53.33 2.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.464 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.8 -121.49 3.25 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.983 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.07 112.91 24.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.572 0.225 . . . . 0.0 110.723 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 143' ' ' ALA . . . . . 0.607 ' H ' ' HA ' ' E' ' 43' ' ' ALA . . . -61.79 150.89 35.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.794 0.33 . . . . 0.0 111.406 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 144' ' ' THR . . . . . 0.595 HG22 ' CD ' ' E' ' 145' ' ' PRO . 59.8 m -126.81 151.59 73.89 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.261 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 145' ' ' PRO . . . . . 0.595 ' CD ' HG22 ' E' ' 144' ' ' THR . 1.3 Cg_endo -83.09 140.15 9.82 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.59 2.193 . . . . 0.0 111.956 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.98 -138.01 6.52 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.521 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 147' ' ' ALA . . . . . 0.554 ' HA ' ' HG3' ' D' ' 15' ' ' GLU . . . -87.22 145.01 26.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.941 0.4 . . . . 0.0 111.329 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 148' ' ' ALA . . . . . 0.76 ' HB3' ' HA ' ' D' ' 15' ' ' GLU . . . -140.74 38.84 1.83 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.589 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.09 153.5 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.47 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 150' ' ' ALA . . . . . . . . . . . . . . . -161.88 171.21 18.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.966 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.42 126.84 7.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.232 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 152' ' ' ALA . . . . . 0.625 ' HB3' HD12 ' E' ' 86' ' ' LEU . . . -125.36 142.81 51.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.252 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 153' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.88 133.2 34.89 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 154' ' ' PHE . . . . . 0.435 ' HD1' ' HA ' ' E' ' 154' ' ' PHE . 0.0 OUTLIER -86.41 127.84 34.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.016 0.436 . . . . 0.0 110.148 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.41 150.55 29.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.96 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 156' ' ' VAL . . . . . 0.443 HG13 HD12 ' E' ' 131' ' ' ILE . 14.2 m -136.23 144.44 33.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.863 0.363 . . . . 0.0 111.551 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 157' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' E' ' 69' ' ' ALA . 0.0 OUTLIER -136.17 132.76 36.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.24 0.543 . . . . 0.0 110.459 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 158' ' ' TYR . . . . . 0.475 ' OH ' ' HB3' ' E' ' 21' ' ' CYS . 5.5 m-85 -117.48 119.79 36.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.537 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 159' ' ' GLN . . . . . 0.512 ' HA ' ' HA ' ' D' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.223 0.059 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.22 64.84 1.57 Allowed 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.118 0.261 . . . . 0.0 111.033 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 58.2 m -111.12 101.06 9.61 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.487 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 60.3 m -86.73 131.92 34.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.586 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -161.16 168.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.48 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.13 118.82 37.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.548 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.38 -56.39 6.87 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.704 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.97 -145.36 4.66 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.877 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.02 142.0 29.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 111.311 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 44.0 t -121.58 107.36 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.18 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -88.78 110.95 21.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.421 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -87.55 113.5 23.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.759 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.16 118.63 36.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.354 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.56 175.48 39.78 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.958 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.26 162.15 41.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.957 0.408 . . . . 0.0 110.289 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.01 119.35 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.259 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 17' ' ' VAL . . . . . 0.502 HG21 ' HA ' ' F' ' 22' ' ' ALA . 0.3 OUTLIER -121.26 168.1 14.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 111.039 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 18' ' ' ASN . . . . . 0.448 ' HB2' HG23 ' E' ' 3' ' ' THR . 1.3 t-20 -68.45 -175.2 0.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.953 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 19' ' ' ALA . . . . . 0.442 ' O ' HG21 ' F' ' 65' ' ' VAL . . . -91.23 52.64 2.15 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.9 -15.72 1.33 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.351 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 21' ' ' CYS . . . . . 0.934 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER -176.87 147.61 0.61 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.987 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 22' ' ' ALA . . . . . 0.502 ' HA ' HG21 ' F' ' 17' ' ' VAL . . . -152.58 110.02 3.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 23' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' F' ' 58' ' ' LEU . 0.3 OUTLIER -52.98 159.07 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -90.36 164.49 14.31 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.613 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 25' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -57.0 -52.36 65.59 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.402 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.41 11.95 66.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.888 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 18.4 t -96.25 -30.71 13.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.911 0.386 . . . . 0.0 110.95 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 28' ' ' VAL . . . . . 0.437 ' H ' HG21 ' F' ' 28' ' ' VAL . 11.3 t -49.87 -71.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.299 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.54 104.31 15.19 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 30' ' ' GLN . . . . . 0.526 HE22 ' HA ' ' F' ' 56' ' ' ILE . 41.8 mt-30 -112.12 140.3 46.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.122 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.72 110.12 21.44 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.123 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.12 108.44 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.165 0.507 . . . . 0.0 110.429 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.61 112.39 22.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.634 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 34' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' E' ' 12' ' ' PHE . 5.3 mp -81.11 -41.83 21.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.611 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.69 -171.06 21.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.638 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 36' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 2.4 mt-30 -93.63 145.87 24.23 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.536 0.207 . . . . 0.0 110.919 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.41 HG23 ' H ' ' F' ' 38' ' ' ARG . 5.0 p -124.87 169.87 15.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.929 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 38' ' ' ARG . . . . . 0.495 ' HE ' ' HB3' ' E' ' 60' ' ' ASP . 5.2 mtt-85 -98.88 121.4 40.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.703 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 39' ' ' THR . . . . . 0.441 HG22 ' HA ' ' E' ' 18' ' ' ASN . 0.6 OUTLIER -61.94 -30.99 71.28 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.75 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.57 -39.33 84.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.008 0.432 . . . . 0.0 110.774 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 71.5 m -81.31 -10.32 59.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.2 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 42' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' F' ' 139' ' ' ALA . 0.6 OUTLIER -129.4 40.42 3.6 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.588 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 43' ' ' ALA . . . . . 0.612 ' HA ' ' H ' ' F' ' 143' ' ' ALA . . . -111.89 10.96 20.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.428 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.52 145.44 48.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.399 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 45' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' F' ' 140' ' ' THR . 18.1 tt0 -63.25 121.25 13.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.852 0.358 . . . . 0.0 111.095 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.97 14.44 33.91 Favored Glycine 0 C--N 1.33 0.249 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.176 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.16 121.21 18.91 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 48' ' ' THR . . . . . 0.435 HG22 ' CE2' ' F' ' 138' ' ' PHE . 15.1 p -130.04 133.8 46.97 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.848 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 49' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 57.9 m -112.47 -166.71 1.1 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.628 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 36.1 t -59.07 149.45 27.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.793 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.72 153.63 17.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.39 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 52' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' F' ' 134' ' ' GLN . 3.7 m -103.44 130.4 53.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.0 121.48 6.56 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.621 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 54' ' ' PHE . . . . . 0.577 ' HE1' ' HB1' ' F' ' 135' ' ' ALA . 52.3 p90 -153.64 136.45 15.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 110.955 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 55' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' F' ' 131' ' ' ILE . 24.8 p30 -133.56 141.33 47.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.685 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 56' ' ' ILE . . . . . 0.527 HG21 ' HB ' ' F' ' 131' ' ' ILE . 1.2 tt -85.15 126.49 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.634 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 57' ' ' GLN . . . . . 0.616 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.1 OUTLIER -75.83 119.38 19.74 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.752 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 58' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' F' ' 23' ' ' VAL . 0.2 OUTLIER -130.68 87.4 2.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.29 -179.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 59' ' ' ASN . . . . . 0.711 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 5.1 p30 -77.28 173.8 11.49 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.988 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 62.78 66.47 0.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 61' ' ' CYS . . . . . 0.934 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 34.6 m -115.8 161.91 18.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.659 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 62' ' ' ASP . . . . . 0.501 ' HA ' ' OD1' ' F' ' 126' ' ' ASN . 0.2 OUTLIER -145.87 157.86 43.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.322 -179.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.49 -16.73 14.29 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.3 -33.75 32.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.012 0.434 . . . . 0.0 111.689 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 65' ' ' VAL . . . . . 0.442 HG21 ' O ' ' F' ' 19' ' ' ALA . 20.1 t -75.14 -41.64 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.619 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.95 146.74 29.1 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.567 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -39.3 3.73 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.863 0.363 . . . . 0.0 110.945 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.28 159.56 15.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.446 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 69' ' ' ALA . . . . . 0.633 ' HB3' ' HB ' ' F' ' 122' ' ' THR . . . -147.22 118.81 7.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.6 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 70' ' ' ALA . . . . . 0.405 ' CB ' ' HB3' ' F' ' 118' ' ' PHE . . . -96.81 140.75 30.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.066 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 71' ' ' VAL . . . . . 0.52 HG13 HG21 ' F' ' 131' ' ' ILE . 3.1 t -118.55 139.79 44.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.713 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.58 133.91 29.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.562 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 73' ' ' PHE . . . . . 0.463 ' CZ ' HG23 ' E' ' 10' ' ' VAL . 0.1 OUTLIER -101.19 138.07 38.71 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 122.338 -0.226 . . . . 0.0 111.172 179.603 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 74' ' ' LEU . . . . . . . . . . . . . 6.6 tt -101.07 91.08 4.39 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.003 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.4 -167.41 11.32 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.869 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 76' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.3 OUTLIER -116.74 159.51 22.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.611 0.243 . . . . 0.0 110.701 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.93 137.93 33.41 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.984 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 78' ' ' ILE . . . . . 0.737 HG21 ' HB ' ' F' ' 85' ' ' VAL . 9.0 tt -77.14 -40.51 30.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.913 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 79' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' F' ' 81' ' ' GLY . 0.1 OUTLIER -141.22 55.24 1.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.82 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 52.94 -84.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.086 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 81' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' F' ' 79' ' ' ASP . . . -60.12 -16.02 39.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.611 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 82' ' ' HIS . . . . . 0.485 ' O ' HG22 ' F' ' 78' ' ' ILE . 24.2 m80 -100.64 56.69 0.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.912 0.386 . . . . 0.0 110.566 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 83' ' ' THR . . . . . 0.442 ' HB ' ' OG1' ' F' ' 112' ' ' THR . 1.1 m -71.35 -22.47 61.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.567 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 84' ' ' ASN . . . . . 0.717 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 8.6 p-10 -57.12 -18.75 16.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.409 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 85' ' ' VAL . . . . . 0.737 ' HB ' HG21 ' F' ' 78' ' ' ILE . 11.5 t -115.15 133.42 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.25 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 86' ' ' LEU . . . . . 0.662 ' HA ' ' O ' ' F' ' 76' ' ' THR . 0.8 OUTLIER -73.0 154.05 40.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 87' ' ' ALA . . . . . 0.528 ' H ' HD23 ' F' ' 86' ' ' LEU . . . -90.66 -161.41 0.8 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.823 0.344 . . . . 0.0 111.778 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.24 6.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.988 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.67 -83.95 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.282 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.26 20.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.443 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 91' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' F' ' 95' ' ' SER . 1.5 m -86.65 79.37 8.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.76 -31.45 38.29 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.832 0.349 . . . . 0.0 111.665 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.09 54.41 1.73 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.621 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.89 -17.2 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.946 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 95' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' F' ' 91' ' ' SER . 0.9 OUTLIER -89.39 177.25 6.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.777 0.323 . . . . 0.0 110.672 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.83 175.18 8.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.735 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 97' ' ' THR . . . . . 0.534 ' O ' ' HB2' ' F' ' 98' ' ' ASN . 0.2 OUTLIER -137.46 137.97 39.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.289 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 98' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' F' ' 97' ' ' THR . 74.0 m-80 71.75 17.6 5.4 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.433 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.97 149.01 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.701 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.32 -176.74 35.62 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.433 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 101' ' ' VAL . . . . . 0.463 HG11 ' O ' ' F' ' 101' ' ' VAL . 7.7 p -125.64 111.02 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 122.976 0.51 . . . . 0.0 111.735 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 102' ' ' GLN . . . . . 0.607 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 0.9 OUTLIER -81.59 147.68 29.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.883 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 103' ' ' ILE . . . . . 0.451 HD13 ' HE2' ' F' ' 133' ' ' PHE . 0.9 OUTLIER -123.64 115.86 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.566 179.502 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 104' ' ' LEU . . . . . 0.71 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 0.4 OUTLIER -88.63 140.5 29.39 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.661 0.267 . . . . 0.0 111.076 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 105' ' ' ASP . . . . . 0.604 ' HB2' ' HB2' ' F' ' 111' ' ' LEU . 2.1 t70 -89.29 151.99 21.8 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.68 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 106' ' ' ARG . . . . . 0.625 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -71.77 -21.11 61.78 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.73 0.3 . . . . 0.0 111.054 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 107' ' ' THR . . . . . 0.581 ' HB ' ' HA ' ' F' ' 120' ' ' SER . 5.9 t -62.88 -21.87 66.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.063 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.65 -83.03 0.19 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.695 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.69 170.67 15.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.751 0.31 . . . . 0.0 111.063 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 110' ' ' ALA . . . . . 0.71 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -74.85 138.61 42.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.225 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 111' ' ' LEU . . . . . 0.604 ' HB2' ' HB2' ' F' ' 105' ' ' ASP . 5.1 tp -94.47 153.4 17.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.329 0.585 . . . . 0.0 110.531 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 112' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 6.2 t -93.71 148.27 22.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.094 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mp -89.51 64.73 6.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.784 0.326 . . . . 0.0 110.777 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 114' ' ' ASP . . . . . 0.534 ' HB2' ' OG1' ' F' ' 117' ' ' THR . 0.5 OUTLIER -95.05 -15.96 23.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.723 0.297 . . . . 0.0 111.685 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.36 -56.21 0.57 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.691 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.59 29.07 5.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.961 0.41 . . . . 0.0 111.626 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 117' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' F' ' 114' ' ' ASP . 3.4 m -87.23 65.89 9.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.069 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 118' ' ' PHE . . . . . 0.413 ' CD1' ' HB2' ' F' ' 157' ' ' GLN . 48.5 m-85 -77.68 73.39 4.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.806 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.49 70.91 0.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 120' ' ' SER . . . . . 0.581 ' HA ' ' HB ' ' F' ' 107' ' ' THR . 0.7 OUTLIER -148.68 126.06 11.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.696 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.04 53.17 2.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.205 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 122' ' ' THR . . . . . 0.633 ' HB ' ' HB3' ' F' ' 69' ' ' ALA . 0.2 OUTLIER -73.97 128.32 35.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.765 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.35 117.86 25.42 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.772 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tp -88.45 134.79 33.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.761 0.315 . . . . 0.0 110.498 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 125' ' ' ASN . . . . . 0.516 ' HB3' ' O ' ' C' ' 116' ' ' ALA . 0.3 OUTLIER -129.3 163.09 26.43 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.63 179.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 126' ' ' ASN . . . . . 0.501 ' OD1' ' HA ' ' F' ' 62' ' ' ASP . 1.5 t30 -67.61 125.43 26.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.699 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 127' ' ' GLY . . . . . 0.43 ' HA3' ' HE2' ' C' ' 118' ' ' PHE . . . 128.55 -141.0 12.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.707 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 128' ' ' THR . . . . . 0.711 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 6.3 m -101.74 92.44 4.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.716 0.293 . . . . 0.0 110.809 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 129' ' ' ASN . . . . . 0.506 ' HB2' ' SG ' ' F' ' 61' ' ' CYS . 1.2 t30 -76.55 144.99 39.33 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.881 0.372 . . . . 0.0 111.14 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 130' ' ' THR . . . . . 0.616 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.0 OUTLIER -134.61 131.76 38.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.073 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 131' ' ' ILE . . . . . 0.527 ' HB ' HG21 ' F' ' 56' ' ' ILE . 28.1 mt -87.31 109.81 28.66 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 132' ' ' PRO . . . . . 0.625 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.4 Cg_endo -81.67 112.16 2.38 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.617 1.544 . . . . 0.0 112.558 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 133' ' ' PHE . . . . . 0.451 ' HE2' HD13 ' F' ' 103' ' ' ILE . 0.3 OUTLIER -129.36 138.21 51.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.842 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 134' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' F' ' 52' ' ' VAL . 28.2 mt-30 -110.08 157.5 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.007 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 135' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' F' ' 102' ' ' GLN . . . -152.69 107.87 3.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 111.606 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -102.47 174.37 5.93 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.378 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 137' ' ' TYR . . . . . 0.493 ' HB3' HD22 ' F' ' 42' ' ' LEU . 0.6 OUTLIER -86.04 120.83 27.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.08 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 138' ' ' PHE . . . . . 0.504 ' HB3' HG12 ' F' ' 85' ' ' VAL . 0.2 OUTLIER -117.64 139.67 50.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.056 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 139' ' ' ALA . . . . . 0.557 ' HB3' ' HG ' ' F' ' 42' ' ' LEU . . . -129.96 145.57 51.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.902 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 140' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' F' ' 45' ' ' GLU . 16.5 p -104.36 -53.38 2.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.511 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.73 -121.47 3.26 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.995 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.12 112.93 24.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.549 0.214 . . . . 0.0 110.649 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 143' ' ' ALA . . . . . 0.612 ' H ' ' HA ' ' F' ' 43' ' ' ALA . . . -61.73 150.88 35.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.76 0.314 . . . . 0.0 111.479 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 144' ' ' THR . . . . . 0.594 HG22 ' CD ' ' F' ' 145' ' ' PRO . 60.1 m -126.85 151.52 73.88 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.27 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 145' ' ' PRO . . . . . 0.594 ' CD ' HG22 ' F' ' 144' ' ' THR . 1.4 Cg_endo -82.96 140.14 9.96 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.573 2.182 . . . . 0.0 112.024 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.98 -138.07 6.55 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.529 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 147' ' ' ALA . . . . . 0.554 ' HA ' ' HG3' ' E' ' 15' ' ' GLU . . . -87.22 145.04 26.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.881 0.372 . . . . 0.0 111.344 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 148' ' ' ALA . . . . . 0.751 ' HB3' ' HA ' ' E' ' 15' ' ' GLU . . . -140.77 38.79 1.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.558 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.04 153.57 22.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.549 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 150' ' ' ALA . . . . . . . . . . . . . . . -161.92 171.2 18.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.997 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.41 126.79 7.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.193 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 152' ' ' ALA . . . . . 0.616 ' HB3' HD12 ' F' ' 86' ' ' LEU . . . -125.34 142.81 51.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.341 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 153' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.88 133.19 34.89 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 154' ' ' PHE . . . . . 0.504 ' HD1' ' HA ' ' F' ' 154' ' ' PHE . 0.0 OUTLIER -86.34 127.83 34.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.025 0.441 . . . . 0.0 110.131 -179.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.47 150.5 29.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.941 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 156' ' ' VAL . . . . . 0.455 HG13 HD12 ' F' ' 131' ' ' ILE . 14.5 m -136.19 144.42 33.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 111.597 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 157' ' ' GLN . . . . . 0.571 ' O ' ' HA ' ' F' ' 69' ' ' ALA . 0.0 OUTLIER -136.23 132.79 36.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.364 0.602 . . . . 0.0 110.382 -179.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 158' ' ' TYR . . . . . 0.462 ' OH ' ' HB3' ' F' ' 21' ' ' CYS . 5.5 m-85 -117.41 119.78 36.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.563 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 159' ' ' GLN . . . . . 0.506 ' HA ' ' HA ' ' E' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.867 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.327 0.108 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.37 88.97 0.04 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.034 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.17 114.5 18.43 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.414 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -97.3 119.2 35.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.664 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.496 HG21 ' CG2' ' B' ' 156' ' ' VAL . 19.5 m -136.58 158.25 37.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.584 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.12 115.94 22.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.607 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.63 -79.61 0.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.851 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' B' ' 56' ' ' ILE . . . -148.55 -145.94 4.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.903 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.421 ' HG1' ' HA ' ' B' ' 29' ' ' ASP . 15.0 p -142.05 145.14 34.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.0 0.428 . . . . 0.0 111.24 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.5 t -127.83 119.5 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.245 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.46 113.16 25.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.386 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.75 90.68 5.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.799 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.11 120.72 32.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.367 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.05 170.5 32.64 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.91 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.633 ' HG3' ' O ' ' B' ' 146' ' ' GLY . 21.4 tt0 -160.61 129.19 4.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.402 . . . . 0.0 110.364 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.706 HG21 HG12 ' B' ' 99' ' ' VAL . 2.2 t -89.66 136.95 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.191 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.635 ' O ' HG22 ' B' ' 39' ' ' THR . 34.3 m -136.37 -160.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.781 0.324 . . . . 0.0 111.134 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.571 ' HA ' HG21 ' B' ' 39' ' ' THR . 1.5 t-20 -91.95 177.08 6.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.013 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.445 ' HB2' ' HB1' ' B' ' 40' ' ' ALA . . . -90.25 49.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.064 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -122.17 -39.66 2.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.394 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.84 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -162.15 146.38 12.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.943 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.02 121.65 14.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.607 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 2.5 p -63.71 143.5 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.054 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.52 ' HB3' ' HB2' ' A' ' 27' ' ' SER . 13.5 t70 -72.9 154.62 40.5 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.581 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.589 ' O ' HG21 ' A' ' 28' ' ' VAL . . . -54.31 -53.89 47.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.354 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.54 1.03 88.67 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.88 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.52 ' HB2' ' HB3' ' A' ' 24' ' ' ASP . 7.9 t -99.28 -16.66 18.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.879 0.371 . . . . 0.0 110.836 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.589 HG21 ' O ' ' A' ' 25' ' ' ALA . 10.9 t -53.18 -50.84 44.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.355 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -114.06 126.16 54.79 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.973 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -125.61 135.6 52.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.051 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.92 109.11 21.91 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.128 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.51 115.14 48.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.086 0.47 . . . . 0.0 110.475 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.17 124.72 50.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.662 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.24 -42.31 23.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.602 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.1 -165.42 12.15 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.574 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -93.57 119.21 32.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.62 0.248 . . . . 0.0 110.854 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' A' ' 137' ' ' TYR . 8.2 p -104.88 133.95 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.871 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.93 137.65 36.93 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.667 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.456 ' HA ' ' HB1' ' A' ' 143' ' ' ALA . 0.2 OUTLIER -62.5 -49.42 75.45 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.767 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.55 -33.48 54.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.026 0.441 . . . . 0.0 110.872 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.97 -31.38 61.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.114 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.684 ' HG ' ' HB3' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -114.04 39.82 2.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.619 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.24 33.94 3.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.396 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.657 ' HB2' ' HB2' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -124.48 142.87 50.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.346 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.22 95.69 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 0.0 111.146 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.4 33.69 5.84 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.152 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.657 ' HB2' ' HB2' ' A' ' 44' ' ' GLN . . . -78.83 143.55 35.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.981 0.42 . . . . 0.0 111.958 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.504 ' HB ' ' HD2' ' A' ' 136' ' ' ARG . 18.1 p -131.67 131.93 43.55 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.902 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 1.3 m -103.78 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.548 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -57.78 141.9 47.29 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' A' ' 136' ' ' ARG . . . -99.07 125.51 44.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.393 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 135' ' ' ALA . 24.8 m -76.51 150.99 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.956 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.34 143.29 16.43 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -171.48 140.44 1.39 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.844 0.354 . . . . 0.0 110.925 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -136.32 138.56 41.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.582 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -88.42 116.79 30.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.554 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.8 ' HA ' HG23 ' A' ' 130' ' ' THR . 5.0 mp0 -69.36 138.31 53.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.629 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -145.6 91.66 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.287 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.513 ' HA ' HG22 ' A' ' 128' ' ' THR . 8.2 p30 -78.43 176.89 8.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.938 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.793 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.84 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 10.5 m -133.87 147.78 51.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.76 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.71 161.93 20.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.321 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -111.79 -34.18 6.1 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -72.54 -28.18 62.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.037 0.446 . . . . 0.0 111.718 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.18 -58.54 4.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.703 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . . . -132.2 126.07 32.67 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.575 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -42.15 7.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.954 0.407 . . . . 0.0 110.943 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.24 156.83 18.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.517 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.757 ' HB3' ' HB ' ' A' ' 122' ' ' THR . . . -146.63 133.23 19.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.57 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 118' ' ' PHE . . . -113.38 155.11 25.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.104 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.629 HG13 HG21 ' A' ' 131' ' ' ILE . 2.0 t -136.4 148.57 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.684 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.401 ' HB2' ' HB2' ' A' ' 155' ' ' LYS . . . -152.9 163.48 39.7 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.6 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.23 142.28 50.57 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 122.409 -0.182 . . . . 0.0 111.16 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.634 HD22 ' HG3' ' D' ' 57' ' ' GLN . 1.4 tt -109.16 119.05 38.35 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.066 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.697 ' HA3' HD22 ' A' ' 113' ' ' LEU . . . -162.74 -161.92 12.93 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.769 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.619 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.3 OUTLIER -120.92 162.92 19.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.578 0.228 . . . . 0.0 110.779 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.669 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -83.57 139.08 33.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.934 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 79' ' ' ASP . 11.1 tt -66.09 -47.61 84.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.987 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.552 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -134.46 46.69 2.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.849 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' D' ' 105' ' ' ASP . . . 64.49 -84.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.078 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.77 -36.4 40.9 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.603 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.43 69.2 10.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.888 0.375 . . . . 0.0 110.523 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.669 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -74.1 -7.51 52.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.487 -179.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.609 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 30.0 p-10 -74.74 -25.39 59.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.334 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.499 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 6.4 t -104.92 143.84 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.169 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.612 HD21 ' H ' ' A' ' 76' ' ' THR . 0.3 OUTLIER -74.8 160.86 30.17 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.338 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.525 ' HB2' ' HB ' ' A' ' 76' ' ' THR . . . -103.64 179.85 4.15 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.874 0.369 . . . . 0.0 111.712 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.686 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 1.3 mm? -66.58 171.29 5.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.045 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.518 ' HG3' ' HB2' ' A' ' 149' ' ' ASN . 1.3 mm-40 -68.61 -83.7 0.03 OUTLIER 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.265 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.12 19.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.959 0.409 . . . . 0.0 111.451 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 95' ' ' SER . 3.2 m -90.16 86.28 6.5 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.545 ' HB3' HG11 ' D' ' 52' ' ' VAL . . . -61.16 -24.99 66.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.631 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.4 41.25 3.52 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.66 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.57 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -174.96 0.69 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.858 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.686 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . 1.9 m -89.26 -173.59 4.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.773 0.321 . . . . 0.0 110.71 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.409 ' HB3' HG22 ' A' ' 99' ' ' VAL . . . -100.99 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.4 ' O ' HG21 ' A' ' 99' ' ' VAL . 3.0 m -131.06 123.92 29.72 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.299 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.21 29.43 18.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.459 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 96' ' ' ALA . 1.7 t -125.31 129.33 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.835 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.85 -171.06 21.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.442 HG12 HD13 ' A' ' 86' ' ' LEU . 1.9 p -122.97 116.71 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.204 0.526 . . . . 0.0 111.69 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.542 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 2.8 tt0 -81.74 151.45 27.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.915 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.457 HD11 ' HG ' ' A' ' 113' ' ' LEU . 1.0 OUTLIER -114.82 123.84 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.531 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.72 125.18 50.55 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.658 0.266 . . . . 0.0 111.013 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.706 ' HB3' HG23 ' A' ' 107' ' ' THR . 13.6 t0 -77.57 143.07 38.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.672 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.694 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -62.73 -14.86 49.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.742 0.306 . . . . 0.0 111.043 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.706 HG23 ' HB3' ' A' ' 105' ' ' ASP . 8.8 t -63.04 -20.94 65.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.012 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.28 -43.57 1.36 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.735 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.69 160.71 14.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.767 0.318 . . . . 0.0 111.082 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.36 133.16 40.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.125 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 12.3 tp -95.54 160.94 14.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.373 0.606 . . . . 0.0 110.531 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 2.9 t -110.21 136.81 48.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.076 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.697 HD22 ' HA3' ' A' ' 75' ' ' GLY . 1.4 mt -70.25 89.64 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.76 0.314 . . . . 0.0 110.689 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -18.43 6.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.487 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -62.25 0.88 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.664 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.619 ' HB1' ' OD1' ' D' ' 129' ' ' ASN . . . -92.95 18.23 9.43 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.993 0.425 . . . . 0.0 111.659 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.97 72.58 10.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.065 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' A' ' 155' ' ' LYS . 78.4 m-85 -92.32 89.77 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.799 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 54.6 m -130.56 73.11 1.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.91 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.21 142.32 21.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.682 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.98 68.56 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.208 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.757 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -81.51 133.14 35.35 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.684 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.7 m -87.6 124.13 33.19 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.681 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.498 ' O ' HG23 ' A' ' 63' ' ' THR . 4.1 tp -97.3 119.32 35.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.648 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -113.71 171.91 7.29 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.587 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.48 109.75 16.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.647 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.82 -133.8 4.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.714 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.513 HG22 ' HA ' ' A' ' 59' ' ' ASN . 46.1 m -110.5 86.75 2.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.742 0.306 . . . . 0.0 110.794 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -69.34 155.07 41.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.829 0.347 . . . . 0.0 111.162 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.8 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -142.79 137.07 29.44 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.089 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.629 HG21 HG13 ' A' ' 71' ' ' VAL . 6.9 mt -100.25 109.12 55.66 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.694 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.5 Cg_endo -81.76 148.25 15.67 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.721 1.614 . . . . 0.0 112.536 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.409 ' CZ ' ' HA ' ' A' ' 105' ' ' ASP . 0.5 OUTLIER -158.82 145.31 17.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.908 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -111.24 160.4 17.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.024 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 102' ' ' GLN . . . -155.98 97.82 1.84 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.951 0.405 . . . . 0.0 111.613 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.533 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 14.4 ptt180 -101.57 173.61 6.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.41 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.542 ' HB3' HD22 ' A' ' 42' ' ' LEU . 1.8 m-85 -83.64 135.04 34.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.134 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.407 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 1.7 t80 -128.86 128.18 43.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.022 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.684 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . . . -108.52 138.0 45.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.817 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.519 HG22 ' HB2' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -89.94 -9.56 48.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.494 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.31 -95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.963 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.71 101.49 11.33 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.513 0.197 . . . . 0.0 110.737 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -61.36 144.35 54.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.749 0.309 . . . . 0.0 111.378 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.608 HG22 ' CD ' ' A' ' 145' ' ' PRO . 99.2 m -123.94 153.15 67.42 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.22 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.608 ' CD ' HG22 ' A' ' 144' ' ' THR . 1.3 Cg_endo -83.01 144.78 12.14 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.523 2.149 . . . . 0.0 111.989 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.3 -116.09 0.7 Allowed Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.503 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 94' ' ' GLY . . . -119.73 132.37 55.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.892 0.377 . . . . 0.0 111.361 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.37 43.36 3.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.13 0.491 . . . . 0.0 110.414 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.518 ' HB2' ' HG3' ' A' ' 89' ' ' GLN . 1.1 m120 -95.68 150.88 19.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.586 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -168.5 -178.63 3.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.017 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.78 153.0 39.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.238 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -141.22 151.12 43.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.239 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.66 133.73 54.55 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.71 148.72 28.82 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.093 0.473 . . . . 0.0 110.112 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.533 ' HE3' ' HB ' ' D' ' 128' ' ' THR . 11.2 mmtt -135.02 139.43 44.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.949 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.1 m -134.52 141.3 43.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.778 0.323 . . . . 0.0 111.685 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -128.78 128.97 45.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.318 0.58 . . . . 0.0 110.358 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.71 128.59 51.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.565 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.33 0.109 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.37 88.99 0.04 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.588 0.232 . . . . 0.0 111.022 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.18 114.49 18.41 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.402 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -97.31 119.19 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.65 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.503 HG21 ' CG2' ' C' ' 156' ' ' VAL . 19.4 m -136.58 158.24 37.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.525 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.16 115.99 22.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.552 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.64 -79.61 0.13 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.873 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.483 ' HA3' ' CD1' ' C' ' 56' ' ' ILE . . . -148.56 -145.9 4.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.879 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.415 ' HG1' ' HA ' ' C' ' 29' ' ' ASP . 14.9 p -142.11 145.12 33.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.052 0.453 . . . . 0.0 111.225 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 32.5 t -127.8 119.51 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.267 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.44 113.14 25.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.377 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.7 90.72 5.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.814 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.15 120.71 32.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.337 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.02 170.48 32.62 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.908 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' C' ' 146' ' ' GLY . 21.4 tt0 -160.59 129.19 4.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.975 0.417 . . . . 0.0 110.395 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.712 HG21 HG12 ' C' ' 99' ' ' VAL . 2.2 t -89.66 136.93 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.226 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.619 ' O ' HG22 ' C' ' 39' ' ' THR . 34.3 m -136.35 -160.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.785 0.326 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . 0.574 ' HA ' HG21 ' C' ' 39' ' ' THR . 1.5 t-20 -91.93 177.02 6.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.977 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.441 ' HB2' ' HB1' ' C' ' 40' ' ' ALA . . . -90.21 49.67 1.73 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.053 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' B' ' 61' ' ' CYS . . . -122.19 -39.67 2.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.437 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.841 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.5 OUTLIER -162.13 146.38 12.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.959 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.04 121.62 14.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.595 ' HA ' ' HG ' ' B' ' 58' ' ' LEU . 2.4 p -63.71 143.54 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.037 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 13.6 t70 -72.94 154.65 40.46 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.582 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.578 ' O ' HG21 ' B' ' 28' ' ' VAL . . . -54.33 -53.88 47.86 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.341 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.55 1.05 88.65 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.868 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' B' ' 24' ' ' ASP . 7.9 t -99.29 -16.68 18.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.872 0.367 . . . . 0.0 110.826 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.578 HG21 ' O ' ' B' ' 25' ' ' ALA . 10.7 t -53.14 -50.85 43.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.377 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . 0.421 ' HA ' ' HG1' ' A' ' 9' ' ' THR . 39.9 t0 -114.08 126.19 54.82 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.972 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLN . . . . . 0.405 HE22 ' HA ' ' B' ' 56' ' ' ILE . 3.7 mt-30 -125.61 135.57 52.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.064 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.92 109.17 21.95 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.117 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.57 115.16 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 0.0 110.463 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.2 124.74 50.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.631 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.26 -42.34 23.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.596 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.13 -165.34 12.14 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.557 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.606 ' HG2' HG12 ' A' ' 17' ' ' VAL . 3.7 mt-30 -93.65 119.24 32.42 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.64 0.257 . . . . 0.0 110.834 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' B' ' 137' ' ' TYR . 8.2 p -104.91 133.94 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.87 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.92 137.62 36.93 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.668 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -62.53 -49.38 75.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.762 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 19' ' ' ALA . . . -53.52 -33.5 54.74 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.01 0.433 . . . . 0.0 110.865 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.97 -31.33 61.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.112 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.7 ' HG ' ' HB3' ' B' ' 139' ' ' ALA . 0.6 OUTLIER -114.07 39.81 2.64 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.613 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.2 33.96 3.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.448 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . 0.659 ' HB2' ' HB2' ' B' ' 47' ' ' ALA . 0.3 OUTLIER -124.48 142.88 50.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.344 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.25 95.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.371 . . . . 0.0 111.148 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.43 33.63 5.85 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.139 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.659 ' HB2' ' HB2' ' B' ' 44' ' ' GLN . . . -78.87 143.5 35.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.418 . . . . 0.0 111.949 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.488 ' HB ' ' HD2' ' B' ' 136' ' ' ARG . 18.1 p -131.61 131.9 43.62 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.895 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' SER . . . . . 0.496 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 1.3 m -103.75 -167.22 1.34 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.572 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -57.82 141.91 47.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.863 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . 0.516 ' HB1' ' HB3' ' B' ' 136' ' ' ARG . . . -99.05 125.52 44.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.377 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.512 HG22 ' O ' ' B' ' 135' ' ' ALA . 24.8 m -76.53 151.0 6.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.961 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.36 143.28 16.44 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.527 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -171.47 140.44 1.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.801 0.334 . . . . 0.0 110.936 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -136.33 138.6 41.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.571 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.486 ' CD1' ' HA3' ' A' ' 8' ' ' GLY . 0.7 OUTLIER -88.45 116.79 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.542 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . 0.794 ' HA ' HG23 ' B' ' 130' ' ' THR . 5.0 mp0 -69.38 138.31 53.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.802 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.629 ' HB3' ' SG ' ' B' ' 21' ' ' CYS . 0.3 OUTLIER -145.58 91.67 2.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.276 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 8.2 p30 -78.43 176.86 8.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.912 0.387 . . . . 0.0 110.915 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.92 81.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' CYS . . . . . 0.841 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 10.4 m -133.85 147.8 51.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.78 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.7 161.91 20.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.349 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.491 HG23 ' O ' ' B' ' 124' ' ' LEU . 0.0 OUTLIER -111.75 -34.19 6.1 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -72.52 -28.2 62.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.072 0.463 . . . . 0.0 111.735 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.18 -58.56 4.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.658 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . . . -132.22 126.06 32.62 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.592 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.39 -42.09 7.13 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.956 0.407 . . . . 0.0 110.954 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.439 ' HD2' ' HA ' ' B' ' 68' ' ' LYS . 1.2 tptp -89.28 156.8 18.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.465 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.742 ' HB3' ' HB ' ' B' ' 122' ' ' THR . . . -146.61 133.21 19.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.609 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' B' ' 118' ' ' PHE . . . -113.35 155.11 25.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.137 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.624 HG13 HG21 ' B' ' 131' ' ' ILE . 2.0 t -136.39 148.53 27.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.725 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -152.9 163.51 39.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.553 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.23 142.25 50.58 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 122.411 -0.181 . . . . 0.0 111.207 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.631 HD22 ' HG3' ' E' ' 57' ' ' GLN . 1.4 tt -109.12 119.05 38.36 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.053 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.707 ' HA3' HD22 ' B' ' 113' ' ' LEU . . . -162.74 -161.9 12.89 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.757 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.625 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.3 OUTLIER -120.97 162.92 19.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.59 0.233 . . . . 0.0 110.788 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . 0.68 ' HB1' ' HA ' ' B' ' 83' ' ' THR . . . -83.54 139.08 33.1 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.936 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.565 HG23 ' N ' ' B' ' 79' ' ' ASP . 11.1 tt -66.09 -47.64 84.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.973 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.565 ' N ' HG23 ' B' ' 78' ' ' ILE . 0.2 OUTLIER -134.42 46.69 2.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.891 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' E' ' 105' ' ' ASP . . . 64.48 -83.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.096 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.79 -36.42 41.17 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.576 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.4 69.19 10.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.541 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' THR . . . . . 0.68 ' HA ' ' HB1' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -74.08 -7.53 52.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.549 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . 0.586 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 30.1 p-10 -74.69 -25.4 59.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.383 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.5 HG12 HD12 ' B' ' 78' ' ' ILE . 6.4 t -104.92 143.88 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.17 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . 0.623 HD21 ' H ' ' B' ' 76' ' ' THR . 0.3 OUTLIER -74.84 160.89 30.11 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.265 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.53 ' HB2' ' HB ' ' B' ' 76' ' ' THR . . . -103.66 179.88 4.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.861 0.363 . . . . 0.0 111.702 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.682 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 1.3 mm? -66.59 171.3 5.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.038 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . 0.518 ' HG3' ' HB2' ' B' ' 149' ' ' ASN . 1.3 mm-40 -68.57 -83.75 0.03 OUTLIER 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.275 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 5.9 p -169.11 19.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.907 0.384 . . . . 0.0 111.426 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' B' ' 95' ' ' SER . 3.2 m -90.13 86.26 6.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.562 ' HB3' HG11 ' E' ' 52' ' ' VAL . . . -61.1 -25.03 66.68 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.652 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.42 41.31 3.5 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.638 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' B' ' 147' ' ' ALA . . . -175.03 0.72 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.828 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' SER . . . . . 0.682 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . 1.9 m -89.28 -173.58 4.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.784 0.326 . . . . 0.0 110.71 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . 0.688 ' CB ' HG23 ' A' ' 16' ' ' VAL . . . -100.97 -177.3 3.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 3.0 m -131.03 123.94 29.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.301 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 61.18 29.46 18.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.462 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.706 HG12 HG21 ' A' ' 16' ' ' VAL . 1.7 t -125.31 129.33 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.86 -171.15 21.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.515 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . 0.442 HG12 HD13 ' B' ' 86' ' ' LEU . 1.9 p -122.89 116.72 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.208 0.528 . . . . 0.0 111.682 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.532 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 2.8 tt0 -81.77 151.46 27.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.923 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.461 HD11 ' HG ' ' B' ' 113' ' ' LEU . 1.0 OUTLIER -114.83 123.82 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.511 179.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.68 125.17 50.52 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.645 0.26 . . . . 0.0 111.041 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . 0.726 ' HB3' HG23 ' B' ' 107' ' ' THR . 13.6 t0 -77.61 143.12 38.5 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.659 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . 0.722 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -62.75 -14.88 49.93 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.722 0.296 . . . . 0.0 111.048 179.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' THR . . . . . 0.726 HG23 ' HB3' ' B' ' 105' ' ' ASP . 8.8 t -62.97 -20.96 65.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.024 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.3 -43.57 1.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.729 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.7 160.71 14.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.327 . . . . 0.0 111.088 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.35 133.18 40.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.122 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.64 ' HB2' ' HB2' ' B' ' 105' ' ' ASP . 12.3 tp -95.56 160.9 14.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.401 0.619 . . . . 0.0 110.469 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 2.9 t -110.19 136.8 48.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.075 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.707 HD22 ' HA3' ' B' ' 75' ' ' GLY . 1.4 mt -70.22 89.59 0.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.764 0.316 . . . . 0.0 110.655 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.34 -18.46 6.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.509 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.3 -62.27 0.87 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.645 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . 0.623 ' HB1' ' OD1' ' E' ' 129' ' ' ASN . . . -92.95 18.23 9.44 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.023 0.44 . . . . 0.0 111.668 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.91 72.53 10.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.039 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' B' ' 155' ' ' LYS . 78.3 m-85 -92.35 89.8 6.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.775 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 55.1 m -130.58 73.15 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.23 142.29 21.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.691 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -103.96 68.55 0.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.194 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.742 ' HB ' ' HB3' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -81.43 133.16 35.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.72 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 8.7 m -87.61 124.14 33.21 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.687 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.491 ' O ' HG23 ' B' ' 63' ' ' THR . 4.1 tp -97.33 119.34 35.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.633 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -113.74 171.94 7.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.573 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.5 109.76 16.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.646 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.8 -133.79 4.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.712 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 46.4 m -110.53 86.75 2.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.759 0.314 . . . . 0.0 110.807 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.32 155.05 41.06 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.222 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.794 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -142.76 137.1 29.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.092 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' ILE . . . . . 0.624 HG21 HG13 ' B' ' 71' ' ' VAL . 6.9 mt -100.26 109.07 55.53 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' PRO . . . . . 0.722 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.73 148.26 15.73 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 121.666 1.577 . . . . 0.0 112.543 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' B' ' 105' ' ' ASP . 0.5 OUTLIER -158.8 145.32 17.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.921 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -111.24 160.4 17.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.034 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' B' ' 102' ' ' GLN . . . -156.0 97.79 1.84 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.956 0.408 . . . . 0.0 111.589 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . 0.516 ' HB3' ' HB1' ' B' ' 51' ' ' ALA . 14.4 ptt180 -101.54 173.59 6.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.405 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . 0.549 ' HB3' HD22 ' B' ' 42' ' ' LEU . 1.8 m-85 -83.62 135.04 34.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.181 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . 0.406 ' HB3' ' CG1' ' B' ' 85' ' ' VAL . 1.8 t80 -128.88 128.18 43.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.988 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.7 ' HB3' ' HG ' ' B' ' 42' ' ' LEU . . . -108.53 138.0 45.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.86 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' THR . . . . . 0.531 HG22 ' HB2' ' B' ' 79' ' ' ASP . 0.3 OUTLIER -89.96 -9.55 48.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.478 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.3 -95.23 0.1 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.951 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.74 101.52 11.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.514 0.197 . . . . 0.0 110.744 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 42' ' ' LEU . . . -61.39 144.35 54.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.73 0.3 . . . . 0.0 111.379 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.612 HG22 ' CD ' ' B' ' 145' ' ' PRO . 99.2 m -123.95 153.17 67.47 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.196 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.612 ' CD ' HG22 ' B' ' 144' ' ' THR . 1.3 Cg_endo -83.04 144.78 12.11 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.519 2.146 . . . . 0.0 112.006 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . 0.633 ' O ' ' HG3' ' A' ' 15' ' ' GLU . . . 157.3 -116.09 0.7 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.494 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' B' ' 94' ' ' GLY . . . -119.75 132.4 55.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.903 0.382 . . . . 0.0 111.316 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . 0.519 ' HB2' HG22 ' A' ' 16' ' ' VAL . . . -125.39 43.33 3.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.16 0.505 . . . . 0.0 110.417 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.518 ' HB2' ' HG3' ' B' ' 89' ' ' GLN . 1.1 m120 -95.65 150.88 19.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.573 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -168.49 -178.63 3.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.03 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.77 152.98 39.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.261 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -141.2 151.11 43.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.264 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.69 133.75 54.56 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.457 ' HB3' ' H ' ' A' ' 8' ' ' GLY . 0.1 OUTLIER -81.65 148.68 28.91 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.053 0.454 . . . . 0.0 110.158 -179.062 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.537 ' HB3' ' CZ ' ' B' ' 118' ' ' PHE . 11.2 mmtt -135.03 139.49 44.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.928 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' VAL . . . . . 0.496 ' CG2' HG21 ' A' ' 5' ' ' VAL . 3.1 m -134.55 141.27 43.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.776 0.322 . . . . 0.0 111.698 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -128.79 128.96 45.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.346 0.593 . . . . 0.0 110.353 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.72 128.62 51.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.583 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.841 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.261 0.077 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.4 88.97 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.004 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.19 114.48 18.39 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.436 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -97.26 119.19 35.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.644 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . 0.498 HG21 ' CG2' ' D' ' 156' ' ' VAL . 19.5 m -136.56 158.26 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.63 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.15 115.99 22.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.578 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.66 -79.58 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.876 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' D' ' 56' ' ' ILE . . . -148.55 -145.97 4.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.898 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' THR . . . . . 0.401 ' HG1' ' HA ' ' D' ' 29' ' ' ASP . 15.2 p -142.03 145.12 34.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.956 0.408 . . . . 0.0 111.32 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 32.0 t -127.82 119.53 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.26 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.43 113.17 25.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.391 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -95.75 90.66 5.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.792 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.1 120.73 32.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.357 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.04 170.48 32.63 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.918 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' GLU . . . . . 0.634 ' HG3' ' O ' ' D' ' 146' ' ' GLY . 21.4 tt0 -160.6 129.19 4.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.987 0.423 . . . . 0.0 110.368 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.719 HG21 HG12 ' D' ' 99' ' ' VAL . 2.2 t -89.66 136.91 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.246 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.641 ' O ' HG22 ' D' ' 39' ' ' THR . 34.3 m -136.35 -160.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.767 0.318 . . . . 0.0 111.147 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . 0.585 ' HA ' HG21 ' D' ' 39' ' ' THR . 1.5 t-20 -91.98 177.01 6.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.998 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . 0.438 ' HB2' ' HB1' ' D' ' 40' ' ' ALA . . . -90.16 49.59 1.73 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.038 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' C' ' 61' ' ' CYS . . . -122.16 -39.69 2.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.398 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' CYS . . . . . 0.831 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.5 OUTLIER -162.13 146.39 12.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.943 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.05 121.61 14.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.141 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . 0.588 ' HA ' ' HG ' ' C' ' 58' ' ' LEU . 2.4 p -63.67 143.5 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.049 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' C' ' 27' ' ' SER . 13.5 t70 -72.88 154.6 40.52 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.597 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.592 ' O ' HG21 ' C' ' 28' ' ' VAL . . . -54.3 -53.88 47.84 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.345 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.56 1.03 88.71 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.874 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' SER . . . . . 0.529 ' HB2' ' HB3' ' C' ' 24' ' ' ASP . 7.9 t -99.3 -16.63 18.41 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.879 0.371 . . . . 0.0 110.842 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.592 HG21 ' O ' ' C' ' 25' ' ' ALA . 10.8 t -53.18 -50.83 44.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.35 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . 0.415 ' HA ' ' HG1' ' B' ' 9' ' ' THR . 40.0 t0 -114.07 126.19 54.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.98 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' GLN . . . . . 0.406 HE22 ' HA ' ' C' ' 56' ' ' ILE . 3.7 mt-30 -125.64 135.58 52.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.063 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.91 109.11 21.9 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.13 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.5 115.15 48.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.132 0.491 . . . . 0.0 110.464 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.17 124.73 50.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.667 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.26 -42.28 23.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.584 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.08 -165.39 12.15 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.583 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . 0.608 ' HG2' HG12 ' B' ' 17' ' ' VAL . 3.7 mt-30 -93.62 119.2 32.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.626 0.25 . . . . 0.0 110.841 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . 0.416 ' HB ' ' CE2' ' C' ' 137' ' ' TYR . 8.2 p -104.86 133.95 47.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.897 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.9 137.65 36.95 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.689 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.619 HG22 ' O ' ' B' ' 17' ' ' VAL . 0.2 OUTLIER -62.51 -49.43 75.37 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.75 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.441 ' HB1' ' HB2' ' B' ' 19' ' ' ALA . . . -53.56 -33.48 54.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.994 0.426 . . . . 0.0 110.837 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.97 -31.31 61.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.11 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.692 ' HG ' ' HB3' ' C' ' 139' ' ' ALA . 0.6 OUTLIER -114.12 39.84 2.64 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.642 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.24 33.95 3.28 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.386 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . 0.649 ' HB2' ' HB2' ' C' ' 47' ' ' ALA . 0.3 OUTLIER -124.51 142.92 50.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.289 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.26 95.7 0.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.145 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.41 33.72 5.83 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.126 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' C' ' 44' ' ' GLN . . . -78.93 143.52 35.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.976 0.417 . . . . 0.0 111.928 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' THR . . . . . 0.494 ' HB ' ' HD2' ' C' ' 136' ' ' ARG . 18.1 p -131.63 131.94 43.62 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.884 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.494 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 1.3 m -103.82 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.524 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -57.76 141.86 47.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . 0.534 ' HB1' ' HB3' ' C' ' 136' ' ' ARG . . . -99.03 125.48 44.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.379 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . 0.502 HG22 ' O ' ' C' ' 135' ' ' ALA . 24.7 m -76.51 150.98 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.956 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.3 143.27 16.41 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.572 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -171.49 140.45 1.39 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.771 0.319 . . . . 0.0 110.895 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -136.33 138.62 41.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.541 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.483 ' CD1' ' HA3' ' B' ' 8' ' ' GLY . 0.7 OUTLIER -88.47 116.77 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.554 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.815 ' HA ' HG23 ' C' ' 130' ' ' THR . 5.0 mp0 -69.33 138.29 53.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.794 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . 0.621 ' HB3' ' SG ' ' C' ' 21' ' ' CYS . 0.3 OUTLIER -145.62 91.65 2.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.281 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . 0.509 ' HA ' HG22 ' C' ' 128' ' ' THR . 8.2 p30 -78.46 176.86 8.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.946 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.81 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' CYS . . . . . 0.831 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 10.4 m -133.87 147.74 51.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.798 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.67 161.92 20.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.341 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.501 HG23 ' O ' ' C' ' 124' ' ' LEU . 0.0 OUTLIER -111.77 -34.19 6.1 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -72.59 -28.14 62.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.045 0.45 . . . . 0.0 111.725 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -73.15 -58.55 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.733 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' C' ' 20' ' ' ALA . . . -132.21 126.07 32.64 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.58 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.33 -42.19 7.1 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.964 0.411 . . . . 0.0 110.938 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' C' ' 68' ' ' LYS . 1.2 tptp -89.22 156.85 18.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.502 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.766 ' HB3' ' HB ' ' C' ' 122' ' ' THR . . . -146.65 133.18 19.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.596 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' C' ' 118' ' ' PHE . . . -113.31 155.11 25.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.165 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . 0.62 HG13 HG21 ' C' ' 131' ' ' ILE . 2.0 t -136.4 148.54 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.7 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -152.88 163.49 39.68 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.579 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.24 142.28 50.57 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.468 0.175 . . . . 0.0 111.197 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.638 HD22 ' HG3' ' F' ' 57' ' ' GLN . 1.4 tt -109.17 119.04 38.33 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.052 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . 0.705 ' HA3' HD22 ' C' ' 113' ' ' LEU . . . -162.74 -161.82 12.79 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.736 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' THR . . . . . 0.619 ' H ' HD21 ' C' ' 86' ' ' LEU . 0.3 OUTLIER -121.04 162.91 19.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.624 0.25 . . . . 0.0 110.762 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . 0.677 ' HB1' ' HA ' ' C' ' 83' ' ' THR . . . -83.54 139.08 33.1 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.933 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . 0.565 HG23 ' N ' ' C' ' 79' ' ' ASP . 11.1 tt -66.08 -47.59 84.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.94 0.4 . . . . 0.0 111.007 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' ASP . . . . . 0.565 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.2 OUTLIER -134.45 46.62 2.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.862 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' F' ' 105' ' ' ASP . . . 64.49 -84.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.075 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.75 -36.39 40.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.61 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.5 69.24 10.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.924 0.393 . . . . 0.0 110.51 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' THR . . . . . 0.677 ' HA ' ' HB1' ' C' ' 77' ' ' ALA . 0.2 OUTLIER -74.13 -7.49 52.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.51 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' ASN . . . . . 0.606 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 30.0 p-10 -74.7 -25.4 59.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.36 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.496 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 6.4 t -104.92 143.81 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.148 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.619 HD21 ' H ' ' C' ' 76' ' ' THR . 0.3 OUTLIER -74.78 160.88 30.16 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.308 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.523 ' HB2' ' HB ' ' C' ' 76' ' ' THR . . . -103.67 179.87 4.15 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.897 0.379 . . . . 0.0 111.685 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.675 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 1.3 mm? -66.58 171.29 5.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' GLN . . . . . 0.491 ' HG3' ' HB2' ' C' ' 149' ' ' ASN . 1.3 mm-40 -68.61 -83.74 0.03 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.279 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 5.9 p -169.08 19.14 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.941 0.4 . . . . 0.0 111.426 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' C' ' 95' ' ' SER . 3.3 m -90.15 86.26 6.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.897 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' ALA . . . . . 0.552 ' HB3' HG11 ' F' ' 52' ' ' VAL . . . -61.13 -25.01 66.69 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.637 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.39 41.22 3.53 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.669 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' GLY . . . . . 0.576 ' O ' ' HB3' ' C' ' 147' ' ' ALA . . . -175.0 0.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.87 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' SER . . . . . 0.675 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 1.9 m -89.24 -173.58 4.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.813 0.34 . . . . 0.0 110.691 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . 0.693 ' CB ' HG23 ' B' ' 16' ' ' VAL . . . -100.98 -177.25 3.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 3.0 m -131.11 123.96 29.73 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.303 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.17 29.46 18.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.467 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' VAL . . . . . 0.712 HG12 HG21 ' B' ' 16' ' ' VAL . 1.7 t -125.32 129.35 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.818 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.84 -171.04 21.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.508 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' VAL . . . . . 0.453 HG12 HD13 ' C' ' 86' ' ' LEU . 1.9 p -122.97 116.73 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.213 0.53 . . . . 0.0 111.679 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' GLN . . . . . 0.532 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 2.8 tt0 -81.75 151.42 27.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.936 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . 0.477 HD11 ' HG ' ' C' ' 113' ' ' LEU . 1.0 OUTLIER -114.8 123.81 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.563 179.464 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.69 125.17 50.53 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.638 0.256 . . . . 0.0 111.002 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . 0.707 ' HB3' HG23 ' C' ' 107' ' ' THR . 13.6 t0 -77.58 143.05 38.62 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.695 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . 0.72 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -62.64 -14.94 49.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.757 0.313 . . . . 0.0 111.063 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' THR . . . . . 0.707 HG23 ' HB3' ' C' ' 105' ' ' ASP . 8.8 t -62.96 -20.97 65.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.27 -43.58 1.36 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.727 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.71 160.71 14.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.789 0.328 . . . . 0.0 111.08 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.37 133.16 40.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.085 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' LEU . . . . . 0.655 ' HB2' ' HB2' ' C' ' 105' ' ' ASP . 12.3 tp -95.5 160.94 14.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.378 0.608 . . . . 0.0 110.554 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' THR . . . . . 0.606 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 2.9 t -110.22 136.79 48.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.068 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.705 HD22 ' HA3' ' C' ' 75' ' ' GLY . 1.4 mt -70.22 89.61 0.65 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.751 0.31 . . . . 0.0 110.685 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.34 -18.44 6.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.472 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.32 -62.24 0.87 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.683 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' ALA . . . . . 0.621 ' HB1' ' OD1' ' F' ' 129' ' ' ASN . . . -92.94 18.21 9.45 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 121.042 0.448 . . . . 0.0 111.696 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.98 72.59 10.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.049 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' C' ' 155' ' ' LYS . 78.1 m-85 -92.37 89.75 6.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.765 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 55.1 m -130.54 73.12 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.938 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.22 142.28 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.651 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -103.98 68.51 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.199 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.766 ' HB ' ' HB3' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -81.43 133.13 35.36 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.71 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 8.6 m -87.6 124.12 33.18 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.697 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . 0.501 ' O ' HG23 ' C' ' 63' ' ' THR . 4.1 tp -97.3 119.29 35.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.655 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -113.69 171.9 7.3 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.586 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.48 109.72 16.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.618 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.85 -133.79 4.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.714 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' THR . . . . . 0.509 HG22 ' HA ' ' C' ' 59' ' ' ASN . 46.4 m -110.52 86.78 2.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.722 0.296 . . . . 0.0 110.779 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.38 155.06 41.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.866 0.365 . . . . 0.0 111.143 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' THR . . . . . 0.815 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -142.79 137.09 29.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.086 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 131' ' ' ILE . . . . . 0.62 HG21 HG13 ' C' ' 71' ' ' VAL . 6.9 mt -100.3 109.13 55.81 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 132' ' ' PRO . . . . . 0.72 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.5 Cg_endo -81.76 148.25 15.68 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.668 1.579 . . . . 0.0 112.546 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' C' ' 105' ' ' ASP . 0.5 OUTLIER -158.81 145.27 17.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.933 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -111.23 160.41 17.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.052 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' C' ' 102' ' ' GLN . . . -155.97 97.81 1.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.945 0.402 . . . . 0.0 111.609 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . 0.534 ' HB3' ' HB1' ' C' ' 51' ' ' ALA . 14.4 ptt180 -101.57 173.59 6.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.4 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 137' ' ' TYR . . . . . 0.525 ' HB3' HD22 ' C' ' 42' ' ' LEU . 1.8 m-85 -83.66 135.04 34.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.121 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 138' ' ' PHE . . . . . 0.405 ' HB3' ' CG1' ' C' ' 85' ' ' VAL . 1.8 t80 -128.86 128.16 43.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.235 0.541 . . . . 0.0 112.01 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 139' ' ' ALA . . . . . 0.692 ' HB3' ' HG ' ' C' ' 42' ' ' LEU . . . -108.5 138.01 45.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.83 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 140' ' ' THR . . . . . 0.52 HG22 ' HB2' ' C' ' 79' ' ' ASP . 0.3 OUTLIER -90.0 -9.54 48.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.458 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.3 -95.25 0.1 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.0 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.74 101.49 11.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.51 0.195 . . . . 0.0 110.704 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 143' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' C' ' 42' ' ' LEU . . . -61.36 144.36 54.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.758 0.313 . . . . 0.0 111.368 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 144' ' ' THR . . . . . 0.612 HG22 ' CD ' ' C' ' 145' ' ' PRO . 99.2 m -123.96 153.14 67.5 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.211 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 145' ' ' PRO . . . . . 0.612 ' CD ' HG22 ' C' ' 144' ' ' THR . 1.3 Cg_endo -82.99 144.78 12.17 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.49 2.127 . . . . 0.0 111.999 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . 0.624 ' O ' ' HG3' ' B' ' 15' ' ' GLU . . . 157.3 -116.09 0.7 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.468 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 147' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' C' ' 94' ' ' GLY . . . -119.72 132.37 55.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 111.387 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 148' ' ' ALA . . . . . 0.528 ' HB2' HG22 ' B' ' 16' ' ' VAL . . . -125.38 43.36 3.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.136 0.493 . . . . 0.0 110.383 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 149' ' ' ASN . . . . . 0.491 ' HB2' ' HG3' ' C' ' 89' ' ' GLN . 1.1 m120 -95.68 150.86 19.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.635 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 150' ' ' ALA . . . . . . . . . . . . . . . -168.45 -178.65 3.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.012 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.76 153.0 39.71 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.274 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -141.21 151.12 43.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.243 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.69 133.76 54.55 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 154' ' ' PHE . . . . . 0.472 ' HB3' ' H ' ' B' ' 8' ' ' GLY . 0.1 OUTLIER -81.71 148.68 28.84 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.036 0.446 . . . . 0.0 110.136 -179.05 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . 0.537 ' HB3' ' CZ ' ' C' ' 118' ' ' PHE . 11.2 mmtt -135.01 139.43 44.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.945 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 156' ' ' VAL . . . . . 0.503 ' CG2' HG21 ' B' ' 5' ' ' VAL . 3.1 m -134.52 141.3 43.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.82 0.343 . . . . 0.0 111.685 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -128.78 129.0 45.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.326 0.584 . . . . 0.0 110.34 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.7 128.6 51.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.563 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.834 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.331 0.11 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.41 88.94 0.04 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.567 0.222 . . . . 0.0 111.024 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.16 114.54 18.49 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.378 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -97.35 119.2 35.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.638 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . 0.495 HG21 ' CG2' ' E' ' 156' ' ' VAL . 19.5 m -136.6 158.24 37.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.582 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.12 115.95 22.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.626 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.66 -79.57 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.876 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . 0.476 ' HA3' ' CD1' ' E' ' 56' ' ' ILE . . . -148.55 -145.94 4.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.892 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' THR . . . . . 0.408 ' HG1' ' HA ' ' E' ' 29' ' ' ASP . 15.0 p -142.05 145.11 33.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.028 0.442 . . . . 0.0 111.238 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 32.6 t -127.8 119.49 51.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.259 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -92.42 113.19 25.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.387 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.76 90.65 5.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.08 120.74 32.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.297 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.07 170.46 32.64 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.901 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' E' ' 146' ' ' GLY . 21.4 tt0 -160.59 129.23 4.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.98 0.419 . . . . 0.0 110.382 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.709 HG21 HG12 ' E' ' 99' ' ' VAL . 2.2 t -89.67 136.92 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.233 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . 0.629 ' O ' HG22 ' E' ' 39' ' ' THR . 34.3 m -136.35 -160.77 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.77 0.319 . . . . 0.0 111.162 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' ASN . . . . . 0.573 ' HA ' HG21 ' E' ' 39' ' ' THR . 1.5 t-20 -91.93 176.98 6.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.009 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' ALA . . . . . 0.439 ' HB2' ' HB1' ' E' ' 40' ' ' ALA . . . -90.18 49.63 1.73 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.085 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' D' ' 61' ' ' CYS . . . -122.18 -39.65 2.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.403 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.5 OUTLIER -162.17 146.35 12.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.946 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.97 121.68 14.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . 0.609 ' HA ' ' HG ' ' D' ' 58' ' ' LEU . 2.5 p -63.75 143.51 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' D' ' 27' ' ' SER . 13.6 t70 -72.97 154.64 40.44 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.549 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.583 ' O ' HG21 ' D' ' 28' ' ' VAL . . . -54.3 -53.89 47.65 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.336 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.54 1.03 88.67 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.911 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' D' ' 24' ' ' ASP . 7.9 t -99.28 -16.66 18.41 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.873 0.368 . . . . 0.0 110.829 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . 0.583 HG21 ' O ' ' D' ' 25' ' ' ALA . 10.9 t -53.19 -50.81 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.338 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' ASP . . . . . 0.401 ' HA ' ' HG1' ' C' ' 9' ' ' THR . 39.9 t0 -114.12 126.15 54.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.987 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -125.58 135.58 52.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.063 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.93 109.17 21.95 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.132 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.57 115.13 48.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.144 0.497 . . . . 0.0 110.458 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.17 124.73 50.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.671 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.435 ' HB3' ' HB1' ' A' ' 92' ' ' ALA . 1.9 mp -80.24 -42.29 23.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.62 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.08 -165.38 12.15 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.574 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' GLN . . . . . 0.596 ' HG2' HG12 ' C' ' 17' ' ' VAL . 3.7 mt-30 -93.62 119.23 32.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.635 0.255 . . . . 0.0 110.83 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' D' ' 137' ' ' TYR . 8.2 p -104.92 133.95 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.884 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.96 137.66 36.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.628 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.641 HG22 ' O ' ' C' ' 17' ' ' VAL . 0.2 OUTLIER -62.52 -49.39 75.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.764 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' C' ' 19' ' ' ALA . . . -53.53 -33.5 54.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.051 0.453 . . . . 0.0 110.85 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.97 -31.38 61.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.116 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.689 ' HG ' ' HB3' ' D' ' 139' ' ' ALA . 0.6 OUTLIER -114.01 39.79 2.63 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.662 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.22 33.94 3.28 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.391 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' GLN . . . . . 0.659 ' HB2' ' HB2' ' D' ' 47' ' ' ALA . 0.3 OUTLIER -124.46 142.88 50.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.323 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.2 95.67 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.0 111.138 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.37 33.72 5.84 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.152 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.659 ' HB2' ' HB2' ' D' ' 44' ' ' GLN . . . -78.94 143.56 35.68 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.991 0.424 . . . . 0.0 111.955 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' THR . . . . . 0.503 ' HB ' ' HD2' ' D' ' 136' ' ' ARG . 18.2 p -131.64 131.96 43.62 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.869 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 1.3 m -103.82 -167.2 1.34 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.541 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 3.9 t -57.77 141.92 47.19 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.872 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' ALA . . . . . 0.535 ' HB1' ' HB3' ' D' ' 136' ' ' ARG . . . -99.06 125.5 44.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.369 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' VAL . . . . . 0.545 HG11 ' HB3' ' A' ' 92' ' ' ALA . 24.8 m -76.53 150.96 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.953 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.26 143.26 16.39 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.598 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -171.48 140.42 1.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.796 0.331 . . . . 0.0 110.972 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' ASN . . . . . 0.585 HD21 ' HG1' ' A' ' 76' ' ' THR . 17.0 p30 -136.3 138.58 41.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.603 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.486 ' CD1' ' HA3' ' C' ' 8' ' ' GLY . 0.7 OUTLIER -88.38 116.76 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.588 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' GLN . . . . . 0.789 ' HA ' HG23 ' D' ' 130' ' ' THR . 5.0 mp0 -69.35 138.32 53.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.78 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . 0.627 ' HB3' ' SG ' ' D' ' 21' ' ' CYS . 0.3 OUTLIER -145.62 91.69 2.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.292 -179.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . 0.506 ' HA ' HG22 ' D' ' 128' ' ' THR . 8.2 p30 -78.39 176.86 8.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.906 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.9 81.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.798 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 10.4 m -133.82 147.77 51.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.798 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.67 161.92 20.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.328 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.498 HG23 ' O ' ' D' ' 124' ' ' LEU . 0.0 OUTLIER -111.76 -34.2 6.1 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.088 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -72.57 -28.14 62.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.017 0.437 . . . . 0.0 111.72 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 59.4 t -73.25 -58.47 4.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.696 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.483 ' HB2' ' HB3' ' D' ' 20' ' ' ALA . . . -132.17 126.06 32.7 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.571 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.4 -42.08 7.13 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.955 0.407 . . . . 0.0 110.964 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.29 156.85 18.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.457 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' ALA . . . . . 0.741 ' HB3' ' HB ' ' D' ' 122' ' ' THR . . . -146.66 133.21 19.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.556 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' D' ' 118' ' ' PHE . . . -113.34 155.12 25.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.144 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . 0.64 HG13 HG21 ' D' ' 131' ' ' ILE . 2.0 t -136.41 148.56 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.641 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' D' ' 155' ' ' LYS . . . -152.87 163.5 39.64 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.573 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.26 142.31 50.56 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 122.4 -0.187 . . . . 0.0 111.161 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 1.4 tt -109.21 119.04 38.3 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.071 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . 0.694 ' HA3' HD22 ' D' ' 113' ' ' LEU . . . -162.72 -161.88 12.86 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.786 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' THR . . . . . 0.601 ' H ' HD21 ' D' ' 86' ' ' LEU . 0.3 OUTLIER -120.97 162.91 19.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.545 0.212 . . . . 0.0 110.78 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . 0.685 ' HB1' ' HA ' ' D' ' 83' ' ' THR . . . -83.55 139.06 33.11 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.967 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' ILE . . . . . 0.566 HG23 ' N ' ' D' ' 79' ' ' ASP . 11.1 tt -66.05 -47.63 84.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.948 0.404 . . . . 0.0 111.003 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . 0.566 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.2 OUTLIER -134.44 46.68 2.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.813 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.47 -83.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.072 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.78 -36.39 41.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.62 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.42 69.25 10.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.375 . . . . 0.0 110.546 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' THR . . . . . 0.685 ' HA ' ' HB1' ' D' ' 77' ' ' ALA . 0.2 OUTLIER -74.12 -7.52 52.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.544 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . 0.61 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 30.1 p-10 -74.71 -25.4 59.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.332 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.495 HG12 HD12 ' D' ' 78' ' ' ILE . 6.4 t -104.91 143.85 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.161 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.601 HD21 ' H ' ' D' ' 76' ' ' THR . 0.3 OUTLIER -74.8 160.88 30.14 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.31 179.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.526 ' HB2' ' HB ' ' D' ' 76' ' ' THR . . . -103.62 179.85 4.15 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.857 0.36 . . . . 0.0 111.739 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.697 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 1.3 mm? -66.59 171.3 5.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.071 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' GLN . . . . . 0.516 ' HG3' ' HB2' ' D' ' 149' ' ' ASN . 1.3 mm-40 -68.57 -83.76 0.03 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.25 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.14 19.17 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.937 0.399 . . . . 0.0 111.447 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' D' ' 95' ' ' SER . 3.3 m -90.16 86.24 6.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.927 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.16 -24.98 66.7 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.598 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.37 41.25 3.52 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.686 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' D' ' 147' ' ' ALA . . . -175.01 0.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.866 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 95' ' ' SER . . . . . 0.697 ' HB3' ' HG ' ' D' ' 88' ' ' LEU . 1.9 m -89.24 -173.57 4.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.751 0.31 . . . . 0.0 110.724 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 96' ' ' ALA . . . . . 0.694 ' CB ' HG23 ' C' ' 16' ' ' VAL . . . -101.0 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.849 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 97' ' ' THR . . . . . 0.404 ' O ' HG21 ' D' ' 99' ' ' VAL . 3.0 m -131.1 123.87 29.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.319 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.26 29.44 18.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.444 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 99' ' ' VAL . . . . . 0.719 HG12 HG21 ' C' ' 16' ' ' VAL . 1.7 t -125.34 129.32 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.822 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.87 -171.11 21.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.522 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 101' ' ' VAL . . . . . 0.437 HG12 HD13 ' D' ' 86' ' ' LEU . 1.9 p -122.96 116.74 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.256 0.55 . . . . 0.0 111.694 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 102' ' ' GLN . . . . . 0.548 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 2.8 tt0 -81.76 151.43 27.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.915 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 103' ' ' ILE . . . . . 0.477 HD11 ' HG ' ' D' ' 113' ' ' LEU . 1.0 OUTLIER -114.79 123.82 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.575 179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.73 125.19 50.57 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.661 0.267 . . . . 0.0 110.986 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . 0.71 ' HB3' HG23 ' D' ' 107' ' ' THR . 13.6 t0 -77.61 143.12 38.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.693 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 106' ' ' ARG . . . . . 0.699 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -62.72 -14.93 50.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.748 0.308 . . . . 0.0 111.029 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 107' ' ' THR . . . . . 0.71 HG23 ' HB3' ' D' ' 105' ' ' ASP . 8.8 t -62.98 -20.95 65.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.013 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.25 -43.54 1.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.735 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.72 160.7 14.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.83 0.348 . . . . 0.0 111.093 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.33 133.18 40.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 111' ' ' LEU . . . . . 0.656 ' HB2' ' HB2' ' D' ' 105' ' ' ASP . 12.3 tp -95.53 160.91 14.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.397 0.618 . . . . 0.0 110.477 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 112' ' ' THR . . . . . 0.61 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 2.9 t -110.23 136.79 48.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.046 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 113' ' ' LEU . . . . . 0.694 HD22 ' HA3' ' D' ' 75' ' ' GLY . 1.4 mt -70.2 89.55 0.65 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.702 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.29 -18.44 6.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.515 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.31 -62.28 0.87 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.619 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.93 18.26 9.37 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.958 0.408 . . . . 0.0 111.638 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.98 72.57 10.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' D' ' 155' ' ' LYS . 78.1 m-85 -92.35 89.75 6.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.792 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 55.5 m -130.55 73.19 1.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.86 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.24 142.3 21.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.695 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.95 68.51 0.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.208 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.741 ' HB ' ' HB3' ' D' ' 69' ' ' ALA . 0.0 OUTLIER -81.45 133.11 35.36 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.722 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 8.5 m -87.51 124.1 33.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.77 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . 0.498 ' O ' HG23 ' D' ' 63' ' ' THR . 4.1 tp -97.3 119.27 35.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.677 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -113.66 171.91 7.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.599 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.47 109.75 16.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.648 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.8 -133.78 4.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.705 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 128' ' ' THR . . . . . 0.533 ' HB ' ' HE3' ' A' ' 155' ' ' LYS . 46.5 m -110.54 86.77 2.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.731 0.3 . . . . 0.0 110.757 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 129' ' ' ASN . . . . . 0.619 ' OD1' ' HB1' ' A' ' 116' ' ' ALA . 1.1 t30 -69.36 155.07 41.04 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.825 0.345 . . . . 0.0 111.199 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 130' ' ' THR . . . . . 0.789 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.2 OUTLIER -142.8 137.08 29.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.066 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 131' ' ' ILE . . . . . 0.64 HG21 HG13 ' D' ' 71' ' ' VAL . 6.9 mt -100.26 109.13 55.7 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 132' ' ' PRO . . . . . 0.699 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.5 Cg_endo -81.78 148.29 15.66 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.673 1.582 . . . . 0.0 112.526 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.412 ' CZ ' ' HA ' ' D' ' 105' ' ' ASP . 0.5 OUTLIER -158.85 145.28 16.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.913 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -111.23 160.4 17.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.041 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' D' ' 102' ' ' GLN . . . -155.99 97.82 1.84 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.96 0.41 . . . . 0.0 111.629 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 136' ' ' ARG . . . . . 0.535 ' HB3' ' HB1' ' D' ' 51' ' ' ALA . 14.4 ptt180 -101.57 173.64 6.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.417 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 137' ' ' TYR . . . . . 0.541 ' HB3' HD22 ' D' ' 42' ' ' LEU . 1.8 m-85 -83.64 135.01 34.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.142 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 138' ' ' PHE . . . . . 0.408 ' HB3' ' CG1' ' D' ' 85' ' ' VAL . 1.8 t80 -128.85 128.21 43.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.283 0.563 . . . . 0.0 112.013 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 139' ' ' ALA . . . . . 0.689 ' HB3' ' HG ' ' D' ' 42' ' ' LEU . . . -108.54 137.99 45.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.874 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 140' ' ' THR . . . . . 0.527 HG22 ' HB2' ' D' ' 79' ' ' ASP . 0.3 OUTLIER -89.93 -9.57 48.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.48 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.31 -95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.999 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.74 101.5 11.33 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.526 0.203 . . . . 0.0 110.708 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 143' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' D' ' 42' ' ' LEU . . . -61.35 144.35 54.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.752 0.311 . . . . 0.0 111.395 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 144' ' ' THR . . . . . 0.603 HG22 ' CD ' ' D' ' 145' ' ' PRO . 99.2 m -123.96 153.15 67.5 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.217 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 145' ' ' PRO . . . . . 0.603 ' CD ' HG22 ' D' ' 144' ' ' THR . 1.3 Cg_endo -82.97 144.71 12.17 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.56 2.173 . . . . 0.0 111.987 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . 0.634 ' O ' ' HG3' ' C' ' 15' ' ' GLU . . . 157.32 -116.1 0.7 Allowed Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.479 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 147' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' D' ' 94' ' ' GLY . . . -119.71 132.38 55.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.376 . . . . 0.0 111.37 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 148' ' ' ALA . . . . . 0.529 ' HB2' HG22 ' C' ' 16' ' ' VAL . . . -125.37 43.37 3.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.397 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 149' ' ' ASN . . . . . 0.516 ' HB2' ' HG3' ' D' ' 89' ' ' GLN . 1.1 m120 -95.68 150.86 19.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.593 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 150' ' ' ALA . . . . . . . . . . . . . . . -168.45 -178.64 3.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.987 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.77 152.98 39.68 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.251 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 152' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -141.2 151.1 43.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.257 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.63 133.7 54.53 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 154' ' ' PHE . . . . . 0.46 ' HB3' ' H ' ' C' ' 8' ' ' GLY . 0.1 OUTLIER -81.68 148.73 28.85 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.07 0.462 . . . . 0.0 110.137 -179.043 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . 0.531 ' HB3' ' CZ ' ' D' ' 118' ' ' PHE . 11.2 mmtt -135.06 139.45 44.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.924 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 156' ' ' VAL . . . . . 0.498 ' CG2' HG21 ' C' ' 5' ' ' VAL . 3.1 m -134.53 141.3 43.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.783 0.325 . . . . 0.0 111.687 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 157' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -128.78 128.97 45.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.31 0.576 . . . . 0.0 110.363 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.73 128.58 51.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.552 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.85 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.281 0.086 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.37 88.93 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.028 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.14 114.5 18.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.446 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -97.29 119.17 35.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.685 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . 0.502 HG21 ' CG2' ' F' ' 156' ' ' VAL . 19.6 m -136.56 158.25 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.605 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.13 116.01 22.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.59 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.74 -79.55 0.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.846 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . 0.491 ' HA3' ' CD1' ' F' ' 56' ' ' ILE . . . -148.56 -145.96 4.24 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.882 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 9' ' ' THR . . . . . 0.409 ' HG1' ' HA ' ' F' ' 29' ' ' ASP . 15.2 p -141.99 145.15 34.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.963 0.411 . . . . 0.0 111.302 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 32.5 t -127.83 119.49 51.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.262 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.4 113.16 25.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.374 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.76 90.66 5.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.814 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.08 120.74 32.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.342 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.06 170.53 32.65 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.933 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 15' ' ' GLU . . . . . 0.632 ' HG3' ' O ' ' F' ' 146' ' ' GLY . 21.4 tt0 -160.62 129.19 4.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 110.333 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 16' ' ' VAL . . . . . 0.706 HG21 HG12 ' F' ' 99' ' ' VAL . 2.2 t -89.66 136.92 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.25 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . 0.626 ' O ' HG22 ' F' ' 39' ' ' THR . 34.3 m -136.35 -160.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.774 0.321 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . 0.575 ' HA ' HG21 ' F' ' 39' ' ' THR . 1.5 t-20 -91.95 177.01 6.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.03 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 19' ' ' ALA . . . . . 0.448 ' HB2' ' HB1' ' F' ' 40' ' ' ALA . . . -90.15 49.64 1.73 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' E' ' 61' ' ' CYS . . . -122.16 -39.73 2.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.384 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 21' ' ' CYS . . . . . 0.84 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.5 OUTLIER -162.09 146.41 12.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.905 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.05 121.6 14.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.104 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 23' ' ' VAL . . . . . 0.594 ' HA ' ' HG ' ' E' ' 58' ' ' LEU . 2.5 p -63.68 143.52 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 24' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' E' ' 27' ' ' SER . 13.5 t70 -72.92 154.61 40.49 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.595 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . 0.591 ' O ' HG21 ' E' ' 28' ' ' VAL . . . -54.32 -53.83 48.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.358 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.59 1.03 88.75 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.875 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 27' ' ' SER . . . . . 0.519 ' HB2' ' HB3' ' E' ' 24' ' ' ASP . 7.9 t -99.28 -16.67 18.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.891 0.376 . . . . 0.0 110.849 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 28' ' ' VAL . . . . . 0.591 HG21 ' O ' ' E' ' 25' ' ' ALA . 10.9 t -53.18 -50.82 44.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.329 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 29' ' ' ASP . . . . . 0.408 ' HA ' ' HG1' ' D' ' 9' ' ' THR . 40.0 t0 -114.13 126.17 54.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.987 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 30' ' ' GLN . . . . . 0.406 HE22 ' HA ' ' E' ' 56' ' ' ILE . 3.7 mt-30 -125.6 135.56 52.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.062 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.92 109.14 21.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.1 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.55 115.11 48.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.11 0.481 . . . . 0.0 110.435 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.15 124.75 50.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.66 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.441 ' HB3' ' HB1' ' B' ' 92' ' ' ALA . 1.9 mp -80.21 -42.33 23.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.624 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.1 -165.39 12.15 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.592 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 36' ' ' GLN . . . . . 0.61 ' HG2' HG12 ' D' ' 17' ' ' VAL . 3.7 mt-30 -93.61 119.2 32.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.642 0.258 . . . . 0.0 110.837 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' E' ' 137' ' ' TYR . 8.2 p -104.89 133.94 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.856 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.9 137.65 36.95 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.694 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 39' ' ' THR . . . . . 0.629 HG22 ' O ' ' D' ' 17' ' ' VAL . 0.2 OUTLIER -62.55 -49.39 75.49 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.747 179.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . 0.439 ' HB1' ' HB2' ' D' ' 19' ' ' ALA . . . -53.55 -33.47 54.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.0 0.428 . . . . 0.0 110.857 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.97 -31.33 61.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.113 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.706 ' HG ' ' HB3' ' E' ' 139' ' ' ALA . 0.6 OUTLIER -114.09 39.83 2.64 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.617 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.28 33.96 3.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.385 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 44' ' ' GLN . . . . . 0.659 ' HB2' ' HB2' ' E' ' 47' ' ' ALA . 0.3 OUTLIER -124.47 142.85 51.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.346 179.541 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.24 95.73 0.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.896 0.379 . . . . 0.0 111.156 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.35 33.71 5.84 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.191 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 47' ' ' ALA . . . . . 0.659 ' HB2' ' HB2' ' E' ' 44' ' ' GLN . . . -78.9 143.51 35.81 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 111.968 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 48' ' ' THR . . . . . 0.486 ' HB ' ' HD2' ' E' ' 136' ' ' ARG . 18.1 p -131.62 131.97 43.65 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.882 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.497 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 1.3 m -103.8 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.556 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 50' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 3.9 t -57.83 141.9 47.51 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.853 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 51' ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' E' ' 136' ' ' ARG . . . -99.05 125.53 44.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.426 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 52' ' ' VAL . . . . . 0.562 HG11 ' HB3' ' B' ' 92' ' ' ALA . 24.7 m -76.51 150.95 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.27 143.26 16.39 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.588 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -171.49 140.46 1.39 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.821 0.343 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 55' ' ' ASN . . . . . 0.586 HD21 ' HG1' ' B' ' 76' ' ' THR . 17.0 p30 -136.32 138.59 41.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.598 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 56' ' ' ILE . . . . . 0.476 ' CD1' ' HA3' ' D' ' 8' ' ' GLY . 0.7 OUTLIER -88.43 116.76 30.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.568 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 57' ' ' GLN . . . . . 0.784 ' HA ' HG23 ' E' ' 130' ' ' THR . 5.0 mp0 -69.35 138.3 53.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.787 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . 0.63 ' HB3' ' SG ' ' E' ' 21' ' ' CYS . 0.3 OUTLIER -145.57 91.62 2.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.284 -179.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . 0.518 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 8.1 p30 -78.4 176.83 8.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.943 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 61' ' ' CYS . . . . . 0.84 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 10.4 m -133.84 147.78 51.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.796 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.68 161.94 20.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.328 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 63' ' ' THR . . . . . 0.489 HG23 ' O ' ' E' ' 124' ' ' LEU . 0.0 OUTLIER -111.79 -34.2 6.09 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.082 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -72.56 -28.15 62.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.008 0.433 . . . . 0.0 111.704 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.19 -58.55 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.667 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . 0.483 ' HB2' ' HB3' ' E' ' 20' ' ' ALA . . . -132.21 126.05 32.61 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.567 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.38 -42.08 7.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.972 0.415 . . . . 0.0 110.968 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.31 156.83 18.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.456 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 69' ' ' ALA . . . . . 0.727 ' HB3' ' HB ' ' E' ' 122' ' ' THR . . . -146.61 133.21 19.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.572 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' E' ' 118' ' ' PHE . . . -113.33 155.11 25.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.156 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . 0.621 HG13 HG21 ' E' ' 131' ' ' ILE . 2.0 t -136.39 148.6 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.655 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -152.93 163.51 39.66 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.563 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.25 142.24 50.57 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 122.408 -0.183 . . . . 0.0 111.179 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 74' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 1.4 tt -109.21 119.08 38.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.053 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . 0.711 ' HA3' HD22 ' E' ' 113' ' ' LEU . . . -162.72 -161.89 12.87 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.777 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 76' ' ' THR . . . . . 0.611 ' H ' HD21 ' E' ' 86' ' ' LEU . 0.3 OUTLIER -120.95 162.94 19.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.605 0.241 . . . . 0.0 110.773 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 77' ' ' ALA . . . . . 0.676 ' HB1' ' HA ' ' E' ' 83' ' ' THR . . . -83.55 139.07 33.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.955 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 78' ' ' ILE . . . . . 0.564 HG23 ' N ' ' E' ' 79' ' ' ASP . 11.1 tt -66.09 -47.6 84.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.979 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 79' ' ' ASP . . . . . 0.564 ' N ' HG23 ' E' ' 78' ' ' ILE . 0.2 OUTLIER -134.5 46.68 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.847 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.54 -84.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.74 -36.43 40.75 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.609 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.44 69.26 10.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.891 0.377 . . . . 0.0 110.547 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 83' ' ' THR . . . . . 0.676 ' HA ' ' HB1' ' E' ' 77' ' ' ALA . 0.2 OUTLIER -74.15 -7.44 52.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.528 -179.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 84' ' ' ASN . . . . . 0.589 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 30.0 p-10 -74.77 -25.4 59.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.336 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.506 HG12 HD12 ' E' ' 78' ' ' ILE . 6.4 t -104.88 143.86 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.188 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 86' ' ' LEU . . . . . 0.611 HD21 ' H ' ' E' ' 76' ' ' THR . 0.3 OUTLIER -74.82 160.86 30.15 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.292 179.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 87' ' ' ALA . . . . . 0.537 ' HB2' ' HB ' ' E' ' 76' ' ' THR . . . -103.61 179.87 4.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.907 0.384 . . . . 0.0 111.725 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.684 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 1.3 mm? -66.6 171.28 5.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 89' ' ' GLN . . . . . 0.512 ' HG3' ' HB2' ' E' ' 149' ' ' ASN . 1.3 mm-40 -68.55 -83.78 0.03 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.253 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.09 19.13 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.935 0.398 . . . . 0.0 111.44 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 91' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' E' ' 95' ' ' SER . 3.2 m -90.15 86.23 6.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.09 -25.02 66.66 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.66 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.39 41.26 3.52 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.66 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 94' ' ' GLY . . . . . 0.574 ' O ' ' HB3' ' E' ' 147' ' ' ALA . . . -174.99 0.72 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.872 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 95' ' ' SER . . . . . 0.684 ' HB3' ' HG ' ' E' ' 88' ' ' LEU . 1.9 m -89.3 -173.57 4.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 110.722 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 96' ' ' ALA . . . . . 0.696 ' CB ' HG23 ' D' ' 16' ' ' VAL . . . -100.96 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 3.0 m -131.09 123.91 29.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.315 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.17 29.48 18.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.46 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 99' ' ' VAL . . . . . 0.709 HG12 HG21 ' D' ' 16' ' ' VAL . 1.7 t -125.29 129.33 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.809 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.85 -171.09 21.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.504 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 101' ' ' VAL . . . . . 0.445 HG12 HD13 ' E' ' 86' ' ' LEU . 1.9 p -122.93 116.73 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.195 0.522 . . . . 0.0 111.679 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 102' ' ' GLN . . . . . 0.542 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 2.8 tt0 -81.77 151.45 27.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.931 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 103' ' ' ILE . . . . . 0.451 HD11 ' HG ' ' E' ' 113' ' ' LEU . 1.0 OUTLIER -114.79 123.83 70.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.515 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.71 125.18 50.55 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.704 0.288 . . . . 0.0 111.003 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . 0.724 ' HB3' HG23 ' E' ' 107' ' ' THR . 13.6 t0 -77.58 143.04 38.62 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.715 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 106' ' ' ARG . . . . . 0.721 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -62.67 -14.91 49.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.705 0.288 . . . . 0.0 111.025 179.47 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 107' ' ' THR . . . . . 0.724 HG23 ' HB3' ' E' ' 105' ' ' ASP . 8.8 t -63.01 -20.96 65.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.011 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.28 -43.51 1.37 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.745 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.75 160.67 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.083 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.36 133.14 40.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.088 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.623 ' HB2' ' HB2' ' E' ' 105' ' ' ASP . 12.3 tp -95.5 160.97 14.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.389 0.614 . . . . 0.0 110.511 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 112' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 2.8 t -110.26 136.79 48.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.043 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 113' ' ' LEU . . . . . 0.711 HD22 ' HA3' ' E' ' 75' ' ' GLY . 1.4 mt -70.22 89.6 0.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.745 0.307 . . . . 0.0 110.663 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -18.45 6.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.463 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -62.26 0.88 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.67 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.96 18.22 9.45 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.99 0.424 . . . . 0.0 111.651 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.92 72.55 10.41 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.058 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . 0.541 ' CZ ' ' HB3' ' E' ' 155' ' ' LYS . 78.1 m-85 -92.34 89.78 6.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 55.2 m -130.6 73.2 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.25 142.28 21.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.691 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.98 68.57 0.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.144 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 122' ' ' THR . . . . . 0.727 ' HB ' ' HB3' ' E' ' 69' ' ' ALA . 0.0 OUTLIER -81.5 133.12 35.35 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.688 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 8.6 m -87.55 124.13 33.17 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.713 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . 0.489 ' O ' HG23 ' E' ' 63' ' ' THR . 4.2 tp -97.33 119.33 35.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.632 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -113.68 171.89 7.31 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.609 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.49 109.8 16.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.637 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.77 -133.81 4.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.71 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 128' ' ' THR . . . . . 0.52 ' HB ' ' HE3' ' B' ' 155' ' ' LYS . 46.2 m -110.52 86.76 2.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.767 0.317 . . . . 0.0 110.79 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 129' ' ' ASN . . . . . 0.623 ' OD1' ' HB1' ' B' ' 116' ' ' ALA . 1.2 t30 -69.37 155.05 41.07 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.822 0.344 . . . . 0.0 111.16 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 130' ' ' THR . . . . . 0.784 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.2 OUTLIER -142.78 137.07 29.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.1 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 131' ' ' ILE . . . . . 0.621 HG21 HG13 ' E' ' 71' ' ' VAL . 6.9 mt -100.23 109.05 55.39 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 132' ' ' PRO . . . . . 0.721 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.5 Cg_endo -81.7 148.24 15.77 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.718 1.612 . . . . 0.0 112.525 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 133' ' ' PHE . . . . . 0.415 ' CZ ' ' HA ' ' E' ' 105' ' ' ASP . 0.5 OUTLIER -158.8 145.3 17.06 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.924 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -111.23 160.43 16.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.041 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' E' ' 102' ' ' GLN . . . -155.98 97.8 1.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.9 0.381 . . . . 0.0 111.621 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 136' ' ' ARG . . . . . 0.531 ' HB3' ' HB1' ' E' ' 51' ' ' ALA . 14.4 ptt180 -101.57 173.6 6.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.412 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 137' ' ' TYR . . . . . 0.539 ' HB3' HD22 ' E' ' 42' ' ' LEU . 1.8 m-85 -83.66 135.03 34.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.144 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 138' ' ' PHE . . . . . 0.407 ' HB3' ' CG1' ' E' ' 85' ' ' VAL . 1.7 t80 -128.84 128.16 43.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.055 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 139' ' ' ALA . . . . . 0.706 ' HB3' ' HG ' ' E' ' 42' ' ' LEU . . . -108.51 137.96 45.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.836 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 140' ' ' THR . . . . . 0.526 HG22 ' HB2' ' E' ' 79' ' ' ASP . 0.3 OUTLIER -89.92 -9.54 48.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.49 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.28 -95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.947 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.71 101.52 11.36 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.529 0.204 . . . . 0.0 110.735 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 143' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' E' ' 42' ' ' LEU . . . -61.39 144.38 54.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.788 0.328 . . . . 0.0 111.336 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 144' ' ' THR . . . . . 0.608 HG22 ' CD ' ' E' ' 145' ' ' PRO . 99.2 m -123.95 153.15 67.46 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.236 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 145' ' ' PRO . . . . . 0.608 ' CD ' HG22 ' E' ' 144' ' ' THR . 1.4 Cg_endo -82.97 144.76 12.18 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.561 2.174 . . . . 0.0 111.979 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 146' ' ' GLY . . . . . 0.636 ' O ' ' HG3' ' D' ' 15' ' ' GLU . . . 157.3 -116.09 0.7 Allowed Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.49 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 147' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' E' ' 94' ' ' GLY . . . -119.72 132.38 55.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.871 0.367 . . . . 0.0 111.403 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 148' ' ' ALA . . . . . 0.52 ' HB2' HG22 ' D' ' 16' ' ' VAL . . . -125.39 43.36 3.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.112 0.482 . . . . 0.0 110.379 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 149' ' ' ASN . . . . . 0.512 ' HB2' ' HG3' ' E' ' 89' ' ' GLN . 1.1 m120 -95.67 150.86 19.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.609 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 150' ' ' ALA . . . . . . . . . . . . . . . -168.47 -178.63 3.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.009 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.76 152.99 39.7 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.228 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 152' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -141.2 151.12 43.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.206 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.66 133.74 54.54 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 154' ' ' PHE . . . . . 0.462 ' HB3' ' H ' ' D' ' 8' ' ' GLY . 0.1 OUTLIER -81.72 148.72 28.82 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.103 0.478 . . . . 0.0 110.114 -179.05 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . 0.541 ' HB3' ' CZ ' ' E' ' 118' ' ' PHE . 11.3 mmtt -135.02 139.49 44.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.931 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 156' ' ' VAL . . . . . 0.495 ' CG2' HG21 ' D' ' 5' ' ' VAL . 3.1 m -134.51 141.3 43.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.687 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 157' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -128.8 128.97 45.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.29 0.567 . . . . 0.0 110.373 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.69 128.58 51.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.536 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.331 0.11 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.4 88.96 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.568 0.223 . . . . 0.0 111.008 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.17 114.47 18.39 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.396 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -97.26 119.23 35.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.664 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 m -136.61 158.25 37.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.562 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.18 115.99 22.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.581 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.59 -79.63 0.13 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.878 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.56 -145.95 4.24 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.904 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 15.2 p -142.02 145.12 34.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.944 0.402 . . . . 0.0 111.314 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 32.0 t -127.84 119.47 51.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.226 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -92.4 113.18 25.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.407 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -95.8 90.65 5.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.794 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.09 120.76 32.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.343 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.09 170.48 32.66 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.934 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -160.59 129.18 4.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.957 0.408 . . . . 0.0 110.36 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.67 136.91 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.254 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.34 -160.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.786 0.327 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.93 177.02 6.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.967 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.22 49.62 1.73 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.064 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' F' ' 61' ' ' CYS . . . -122.15 -39.71 2.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.437 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 21' ' ' CYS . . . . . 0.834 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.5 OUTLIER -162.12 146.39 12.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.943 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.02 121.61 14.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 23' ' ' VAL . . . . . 0.589 ' HA ' ' HG ' ' F' ' 58' ' ' LEU . 2.5 p -63.7 143.49 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 24' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' F' ' 27' ' ' SER . 13.5 t70 -72.87 154.61 40.52 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.59 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . 0.588 ' O ' HG21 ' F' ' 28' ' ' VAL . . . -54.32 -53.87 48.01 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.335 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.56 1.03 88.7 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.863 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 27' ' ' SER . . . . . 0.525 ' HB2' ' HB3' ' F' ' 24' ' ' ASP . 7.9 t -99.32 -16.59 18.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.842 0.354 . . . . 0.0 110.814 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 28' ' ' VAL . . . . . 0.588 HG21 ' O ' ' F' ' 25' ' ' ALA . 10.9 t -53.24 -50.78 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.324 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 29' ' ' ASP . . . . . 0.409 ' HA ' ' HG1' ' E' ' 9' ' ' THR . 39.9 t0 -114.12 126.1 54.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.995 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 30' ' ' GLN . . . . . 0.405 HE22 ' HA ' ' F' ' 56' ' ' ILE . 3.7 mt-30 -125.57 135.65 52.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.059 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.93 109.18 21.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.091 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -115.59 115.12 48.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.148 0.499 . . . . 0.0 110.416 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -105.19 124.67 49.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.665 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 34' ' ' LEU . . . . . 0.428 ' HB3' ' HB1' ' C' ' 92' ' ' ALA . 1.9 mp -80.2 -42.29 23.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.603 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.08 -165.35 12.14 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.579 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 36' ' ' GLN . . . . . 0.592 ' HG2' HG12 ' E' ' 17' ' ' VAL . 3.7 mt-30 -93.67 119.16 32.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.657 0.265 . . . . 0.0 110.851 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.418 ' HB ' ' CE2' ' F' ' 137' ' ' TYR . 8.2 p -104.84 133.97 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.93 137.62 36.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.687 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 39' ' ' THR . . . . . 0.626 HG22 ' O ' ' E' ' 17' ' ' VAL . 0.2 OUTLIER -62.45 -49.46 75.34 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.775 179.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' E' ' 19' ' ' ALA . . . -53.53 -33.48 54.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.983 0.42 . . . . 0.0 110.829 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -31.37 61.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.113 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . 0.715 ' HG ' ' HB3' ' F' ' 139' ' ' ALA . 0.6 OUTLIER -114.02 39.82 2.63 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.611 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.25 33.93 3.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.388 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 44' ' ' GLN . . . . . 0.653 ' HB2' ' HB2' ' F' ' 47' ' ' ALA . 0.3 OUTLIER -124.46 142.84 51.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.366 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.22 95.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.867 0.365 . . . . 0.0 111.161 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.41 33.67 5.85 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.149 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 47' ' ' ALA . . . . . 0.653 ' HB2' ' HB2' ' F' ' 44' ' ' GLN . . . -78.79 143.51 36.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.979 0.418 . . . . 0.0 111.973 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 48' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' F' ' 136' ' ' ARG . 18.1 p -131.63 132.0 43.66 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.899 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 49' ' ' SER . . . . . 0.501 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 1.3 m -103.81 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.504 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 50' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 3.9 t -57.81 141.91 47.42 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 51' ' ' ALA . . . . . 0.523 ' HB1' ' HB3' ' F' ' 136' ' ' ARG . . . -99.03 125.5 44.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.376 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 52' ' ' VAL . . . . . 0.552 HG11 ' HB3' ' C' ' 92' ' ' ALA . 24.9 m -76.53 150.97 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.959 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.3 143.25 16.41 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.583 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 54' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -171.47 140.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.839 0.352 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 55' ' ' ASN . . . . . 0.577 HD21 ' HG1' ' C' ' 76' ' ' THR . 17.0 p30 -136.35 138.61 41.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.535 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 56' ' ' ILE . . . . . 0.491 ' CD1' ' HA3' ' E' ' 8' ' ' GLY . 0.7 OUTLIER -88.42 116.76 30.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.57 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 57' ' ' GLN . . . . . 0.819 ' HA ' HG23 ' F' ' 130' ' ' THR . 5.0 mp0 -69.39 138.31 53.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.803 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . 0.621 ' HB3' ' SG ' ' F' ' 21' ' ' CYS . 0.3 OUTLIER -145.58 91.67 2.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.284 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 59' ' ' ASN . . . . . 0.518 ' HA ' HG22 ' F' ' 128' ' ' THR . 8.2 p30 -78.43 176.87 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.925 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.86 0.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.792 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 61' ' ' CYS . . . . . 0.834 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 10.4 m -133.83 147.8 51.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.779 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.71 161.93 20.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.318 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 63' ' ' THR . . . . . 0.498 HG23 ' O ' ' F' ' 124' ' ' LEU . 0.0 OUTLIER -111.73 -34.25 6.09 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -72.53 -28.2 62.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.04 0.448 . . . . 0.0 111.728 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -73.13 -58.58 4.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.703 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 66' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' F' ' 20' ' ' ALA . . . -132.19 126.09 32.74 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.569 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.32 -42.17 7.12 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.95 0.405 . . . . 0.0 110.954 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 68' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' F' ' 68' ' ' LYS . 1.2 tptp -89.3 156.82 18.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.478 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 69' ' ' ALA . . . . . 0.75 ' HB3' ' HB ' ' F' ' 122' ' ' THR . . . -146.63 133.19 19.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.588 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 70' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' F' ' 118' ' ' PHE . . . -113.31 155.12 25.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.156 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 71' ' ' VAL . . . . . 0.63 HG13 HG21 ' F' ' 131' ' ' ILE . 2.0 t -136.4 148.56 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.69 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -152.9 163.49 39.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.55 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 73' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.25 142.3 50.57 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 121.247 -0.181 . . . . 0.0 111.186 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 74' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 1.4 tt -109.18 119.04 38.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.055 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . 0.697 ' HA3' HD22 ' F' ' 113' ' ' LEU . . . -162.72 -161.87 12.84 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.759 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 76' ' ' THR . . . . . 0.604 ' H ' HD21 ' F' ' 86' ' ' LEU . 0.3 OUTLIER -120.99 162.89 19.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.585 0.231 . . . . 0.0 110.775 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 77' ' ' ALA . . . . . 0.675 ' HB1' ' HA ' ' F' ' 83' ' ' THR . . . -83.53 139.08 33.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.937 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 78' ' ' ILE . . . . . 0.554 HG23 ' N ' ' F' ' 79' ' ' ASP . 11.1 tt -66.06 -47.66 84.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.981 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 79' ' ' ASP . . . . . 0.554 ' N ' HG23 ' F' ' 78' ' ' ILE . 0.2 OUTLIER -134.44 46.68 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.857 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.48 -84.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.76 -36.42 40.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.58 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.49 69.27 10.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.918 0.39 . . . . 0.0 110.52 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 83' ' ' THR . . . . . 0.675 ' HA ' ' HB1' ' F' ' 77' ' ' ALA . 0.2 OUTLIER -74.11 -7.51 52.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.527 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 84' ' ' ASN . . . . . 0.607 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 30.1 p-10 -74.7 -25.44 59.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.338 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 85' ' ' VAL . . . . . 0.492 HG12 HD12 ' F' ' 78' ' ' ILE . 6.4 t -104.89 143.86 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.152 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 86' ' ' LEU . . . . . 0.604 HD21 ' H ' ' F' ' 76' ' ' THR . 0.3 OUTLIER -74.83 160.88 30.13 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.263 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 87' ' ' ALA . . . . . 0.533 ' HB2' ' HB ' ' F' ' 76' ' ' THR . . . -103.66 179.86 4.15 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.902 0.382 . . . . 0.0 111.698 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . 0.681 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 1.3 mm? -66.56 171.27 5.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.019 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 89' ' ' GLN . . . . . 0.5 ' HG3' ' HB2' ' F' ' 149' ' ' ASN . 1.3 mm-40 -68.58 -83.74 0.03 OUTLIER 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.262 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.13 19.15 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.975 0.416 . . . . 0.0 111.459 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 91' ' ' SER . . . . . 0.493 ' O ' ' HB2' ' F' ' 95' ' ' SER . 3.3 m -90.17 86.21 6.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.936 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.06 -25.03 66.65 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.663 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.37 41.23 3.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.647 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 94' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' F' ' 147' ' ' ALA . . . -175.02 0.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.852 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 95' ' ' SER . . . . . 0.681 ' HB3' ' HG ' ' F' ' 88' ' ' LEU . 1.9 m -89.28 -173.6 4.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 110.667 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 96' ' ' ALA . . . . . 0.683 ' CB ' HG23 ' E' ' 16' ' ' VAL . . . -101.01 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.846 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 97' ' ' THR . . . . . 0.401 ' O ' HG21 ' F' ' 99' ' ' VAL . 3.0 m -131.04 123.92 29.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.322 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.18 29.46 18.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.479 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 99' ' ' VAL . . . . . 0.706 HG12 HG21 ' E' ' 16' ' ' VAL . 1.7 t -125.29 129.29 73.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.824 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.8 -171.07 21.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.516 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 101' ' ' VAL . . . . . 0.452 HG12 HD13 ' F' ' 86' ' ' LEU . 1.9 p -122.98 116.72 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.238 0.542 . . . . 0.0 111.703 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 102' ' ' GLN . . . . . 0.539 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 2.8 tt0 -81.75 151.45 27.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.942 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 103' ' ' ILE . . . . . 0.464 HD11 ' HG ' ' F' ' 113' ' ' LEU . 1.0 OUTLIER -114.81 123.85 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.525 179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.72 125.16 50.53 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.647 0.261 . . . . 0.0 111.011 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . 0.712 ' HB3' HG23 ' F' ' 107' ' ' THR . 13.5 t0 -77.54 143.07 38.68 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.683 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 106' ' ' ARG . . . . . 0.717 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -62.76 -14.82 49.43 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.756 0.312 . . . . 0.0 111.053 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 107' ' ' THR . . . . . 0.712 HG23 ' HB3' ' F' ' 105' ' ' ASP . 8.8 t -63.03 -20.93 65.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.038 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.25 -43.53 1.36 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.748 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.7 160.69 14.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.753 0.311 . . . . 0.0 111.109 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.32 133.17 40.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . 0.656 ' HB2' ' HB2' ' F' ' 105' ' ' ASP . 12.3 tp -95.52 160.89 14.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.381 0.61 . . . . 0.0 110.52 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 112' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 2.9 t -110.19 136.79 48.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.093 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 113' ' ' LEU . . . . . 0.697 HD22 ' HA3' ' F' ' 75' ' ' GLY . 1.4 mt -70.2 89.59 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.299 . . . . 0.0 110.65 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -18.46 6.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.482 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.29 -62.26 0.88 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.647 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.97 18.25 9.43 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-O 121.008 0.432 . . . . 0.0 111.661 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.92 72.54 10.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.015 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . 0.535 ' CZ ' ' HB3' ' F' ' 155' ' ' LYS . 78.2 m-85 -92.31 89.74 6.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.775 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 54.8 m -130.51 73.13 1.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.914 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.23 142.34 21.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.676 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -104.02 68.54 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.165 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 122' ' ' THR . . . . . 0.75 ' HB ' ' HB3' ' F' ' 69' ' ' ALA . 0.0 OUTLIER -81.45 133.12 35.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.721 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 8.5 m -87.55 124.12 33.16 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.738 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . 0.498 ' O ' HG23 ' F' ' 63' ' ' THR . 4.1 tp -97.31 119.29 35.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.672 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -113.71 171.93 7.29 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.581 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.5 109.74 16.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.656 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.84 -133.84 4.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.733 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 128' ' ' THR . . . . . 0.529 ' HB ' ' HE3' ' C' ' 155' ' ' LYS . 46.4 m -110.49 86.71 2.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.743 0.306 . . . . 0.0 110.811 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 129' ' ' ASN . . . . . 0.621 ' OD1' ' HB1' ' C' ' 116' ' ' ALA . 1.1 t30 -69.3 155.07 41.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.179 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 130' ' ' THR . . . . . 0.819 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.2 OUTLIER -142.79 137.08 29.45 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.099 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 131' ' ' ILE . . . . . 0.63 HG21 HG13 ' F' ' 71' ' ' VAL . 6.9 mt -100.25 109.09 55.57 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 132' ' ' PRO . . . . . 0.717 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.5 Cg_endo -81.72 148.26 15.74 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.721 1.614 . . . . 0.0 112.543 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 133' ' ' PHE . . . . . 0.418 ' CZ ' ' HA ' ' F' ' 105' ' ' ASP . 0.5 OUTLIER -158.86 145.29 16.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.903 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -111.23 160.43 16.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.042 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' F' ' 102' ' ' GLN . . . -156.03 97.82 1.83 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.995 0.426 . . . . 0.0 111.597 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 136' ' ' ARG . . . . . 0.523 ' HB3' ' HB1' ' F' ' 51' ' ' ALA . 14.4 ptt180 -101.5 173.6 6.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.407 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 137' ' ' TYR . . . . . 0.535 ' HB3' HD22 ' F' ' 42' ' ' LEU . 1.8 m-85 -83.65 135.03 34.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.168 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 138' ' ' PHE . . . . . 0.408 ' HB3' ' CG1' ' F' ' 85' ' ' VAL . 1.8 t80 -128.87 128.23 43.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.282 0.563 . . . . 0.0 111.972 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 139' ' ' ALA . . . . . 0.715 ' HB3' ' HG ' ' F' ' 42' ' ' LEU . . . -108.58 137.97 45.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.854 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 140' ' ' THR . . . . . 0.53 HG22 ' HB2' ' F' ' 79' ' ' ASP . 0.3 OUTLIER -89.93 -9.56 48.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.477 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.32 -95.22 0.1 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.996 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.75 101.47 11.3 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.529 0.204 . . . . 0.0 110.741 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 143' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' F' ' 42' ' ' LEU . . . -61.35 144.33 54.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.715 0.293 . . . . 0.0 111.409 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 144' ' ' THR . . . . . 0.607 ' CG2' ' CD ' ' F' ' 145' ' ' PRO . 99.1 m -123.92 153.17 67.35 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.216 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 145' ' ' PRO . . . . . 0.607 ' CD ' ' CG2' ' F' ' 144' ' ' THR . 1.3 Cg_endo -83.03 144.79 12.13 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.567 2.178 . . . . 0.0 111.98 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 146' ' ' GLY . . . . . 0.632 ' O ' ' HG3' ' E' ' 15' ' ' GLU . . . 157.27 -116.08 0.7 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.473 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 147' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' F' ' 94' ' ' GLY . . . -119.73 132.44 55.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.899 0.38 . . . . 0.0 111.335 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 148' ' ' ALA . . . . . 0.531 ' HB2' HG22 ' E' ' 16' ' ' VAL . . . -125.44 43.36 3.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.12 0.486 . . . . 0.0 110.387 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 149' ' ' ASN . . . . . 0.5 ' HB2' ' HG3' ' F' ' 89' ' ' GLN . 1.1 m120 -95.69 150.86 19.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.623 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 150' ' ' ALA . . . . . . . . . . . . . . . -168.44 -178.63 3.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.992 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.77 153.01 39.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.253 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 152' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -141.22 151.11 43.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.258 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.68 133.74 54.56 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 154' ' ' PHE . . . . . 0.465 ' HB3' ' H ' ' E' ' 8' ' ' GLY . 0.1 OUTLIER -81.73 148.72 28.8 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.103 0.478 . . . . 0.0 110.11 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . 0.535 ' HB3' ' CZ ' ' F' ' 118' ' ' PHE . 11.2 mmtt -135.01 139.47 44.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.945 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 156' ' ' VAL . . . . . 0.502 ' CG2' HG21 ' E' ' 5' ' ' VAL . 3.1 m -134.53 141.27 43.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.702 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 157' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -128.77 129.0 45.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.328 0.585 . . . . 0.0 110.37 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.71 128.61 51.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.546 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 111.103 0.038 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.73 88.35 0.03 OUTLIER 'General case' 0 C--O 1.232 0.146 0 O-C-N 123.196 0.31 . . . . 0.0 111.026 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' B' ' 157' ' ' GLN . 5.5 m -122.99 116.19 23.14 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.406 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.515 HG21 ' CA ' ' E' ' 127' ' ' GLY . 1.8 m -99.6 117.26 33.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.573 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 m -144.49 158.02 14.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.557 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' B' ' 154' ' ' PHE . 13.0 t30 -78.68 123.76 27.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.73 -71.18 1.0 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.822 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.493 ' H ' ' HB3' ' B' ' 154' ' ' PHE . . . -152.72 -147.04 4.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.759 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.5 p -148.72 134.43 18.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.022 0.439 . . . . 0.0 111.249 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.33 124.39 72.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.186 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.615 ' HA ' ' OD1' ' B' ' 151' ' ' ASP . 57.5 t-80 -91.58 116.17 28.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.323 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -96.83 105.48 17.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -104.61 118.71 37.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.507 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.32 172.92 30.82 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.952 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.717 ' O ' ' HA ' ' B' ' 36' ' ' GLN . 25.8 tt0 -160.39 135.93 8.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.965 0.412 . . . . 0.0 110.425 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.891 HG12 ' O ' ' B' ' 144' ' ' THR . 43.4 t -96.78 132.73 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.272 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.752 HG12 ' HG2' ' B' ' 36' ' ' GLN . 18.5 m -133.82 -177.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.805 0.336 . . . . 0.0 111.068 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.635 ' HA ' HG22 ' B' ' 39' ' ' THR . 0.3 OUTLIER -75.7 -170.26 1.25 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.017 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.79 45.37 0.98 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.125 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.714 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . . . -121.26 -24.8 5.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.415 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.919 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -168.91 140.68 2.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.792 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.455 ' HB1' ' HB2' ' A' ' 60' ' ' ASP . . . -132.87 116.95 17.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.452 HG11 ' HB2' ' B' ' 36' ' ' GLN . 0.5 OUTLIER -67.03 146.23 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.011 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -80.34 152.03 29.16 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.55 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' B' ' 33' ' ' GLN . . . -62.76 -40.06 96.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.39 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.88 2.72 85.9 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.891 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -106.23 -19.94 13.55 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.813 0.339 . . . . 0.0 110.793 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.8 t -47.43 -52.09 5.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.336 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.19 136.48 48.61 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.035 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.71 136.85 39.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.02 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.52 102.83 12.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.127 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.66 128.34 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.121 0.486 . . . . 0.0 110.51 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -114.75 123.06 48.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.615 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.45 -42.72 15.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.608 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.45 -167.44 13.2 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.603 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -96.75 124.51 40.75 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.654 0.264 . . . . 0.0 110.852 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.71 147.54 11.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.986 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.71 134.94 34.33 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.418 0.449 . . . . 0.0 111.725 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.544 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -60.07 -44.48 94.73 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.75 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.26 -36.88 61.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.095 0.474 . . . . 0.0 110.893 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.9 -35.8 62.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.168 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.759 HD22 ' HB3' ' A' ' 137' ' ' TYR . 2.9 mp -106.66 34.58 3.34 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.657 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 39' ' ' THR . . . -103.9 15.85 27.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.391 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.98 132.04 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.34 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' A' ' 140' ' ' THR . 6.8 tt0 -56.56 108.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.827 0.346 . . . . 0.0 111.106 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.93 25.93 10.11 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.121 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.49 137.75 48.42 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.546 HG22 ' HE ' ' A' ' 136' ' ' ARG . 7.3 p -136.94 122.73 19.96 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.913 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 136' ' ' ARG . 53.9 m -100.07 -175.18 2.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.649 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 t -55.65 137.29 49.56 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.808 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.465 ' HB1' ' HB3' ' A' ' 136' ' ' ARG . . . -92.32 133.57 35.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.342 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.2 m -76.76 162.48 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.52 141.14 16.76 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.643 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.47 ' HE2' ' HB1' ' A' ' 135' ' ' ALA . 39.3 p90 -173.76 137.75 0.61 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.79 0.329 . . . . 0.0 110.933 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -136.49 145.85 45.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.682 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.492 HG21 ' HB ' ' A' ' 131' ' ' ILE . 1.2 tp -91.04 116.79 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.663 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.644 ' HA ' HG23 ' A' ' 130' ' ' THR . 1.3 mp0 -72.93 128.65 36.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.813 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.437 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -137.35 89.13 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.225 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.716 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 9.8 p30 -74.79 176.47 7.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.039 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.455 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 0.9 OUTLIER 58.97 74.78 0.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.889 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.919 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 36.5 m -126.31 148.83 49.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -121.58 169.75 10.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.318 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.25 -32.66 4.91 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.48 -28.0 56.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.261 0.553 . . . . 0.0 111.753 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.5 t -73.63 -56.69 8.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.68 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.714 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . . . -134.99 122.76 22.31 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.652 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.54 -50.11 5.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.894 0.378 . . . . 0.0 110.936 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' HA ' ' HZ2' ' A' ' 68' ' ' LYS . 1.8 tptp -89.75 152.15 21.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.529 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 122' ' ' THR . . . -144.24 137.87 27.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.582 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.41 157.28 22.11 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.092 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 131' ' ' ILE . 1.8 t -138.75 149.97 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.668 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.86 155.13 37.52 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.565 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.453 ' CB ' HD11 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -125.05 136.69 53.93 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.644 0.259 . . . . 0.0 111.004 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.583 HD13 ' HG1' ' D' ' 130' ' ' THR . 0.9 OUTLIER -97.2 136.13 38.15 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.017 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.435 ' HA3' ' HB3' ' A' ' 113' ' ' LEU . . . -174.0 -172.91 39.69 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.762 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.657 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.2 OUTLIER -118.66 144.6 46.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.485 0.183 . . . . 0.0 110.835 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.554 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -62.52 138.62 58.51 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.925 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.539 HG23 ' N ' ' A' ' 79' ' ' ASP . 5.7 tt -71.63 -45.56 66.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.932 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.539 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -133.13 42.47 3.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.857 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 79' ' ' ASP . . . 70.12 -80.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.977 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.06 -29.78 68.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.552 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.415 ' HB3' HG22 ' A' ' 78' ' ' ILE . 1.7 m80 -89.77 69.41 7.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 110.445 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.554 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -74.52 -16.17 60.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.576 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.721 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 20.7 p-10 -66.26 -19.05 65.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.267 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.47 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 13.4 t -113.65 133.81 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.198 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.582 ' HA ' ' O ' ' A' ' 76' ' ' THR . 0.4 OUTLIER -67.89 161.48 26.27 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.466 ' H ' HD23 ' A' ' 86' ' ' LEU . . . -103.54 -174.65 2.6 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.869 0.366 . . . . 0.0 111.787 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.658 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 0.3 OUTLIER -67.38 165.22 16.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.084 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.495 ' CG ' ' HB2' ' A' ' 149' ' ' ASN . 5.7 mm-40 -63.43 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.815 0.34 . . . . 0.0 111.3 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.415 ' O ' HG13 ' D' ' 52' ' ' VAL . 2.3 p -165.45 3.66 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 111.492 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.686 ' HA ' ' HB3' ' C' ' 25' ' ' ALA . 0.7 OUTLIER -80.03 79.74 6.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.486 ' HB3' HG11 ' D' ' 52' ' ' VAL . . . -57.08 -24.72 56.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.885 0.374 . . . . 0.0 111.658 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.18 33.94 5.25 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.682 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.8 0.44 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.943 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.688 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 38.4 m -96.8 177.94 5.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.877 0.37 . . . . 0.0 110.64 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.47 -178.71 7.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.804 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.493 ' HB ' ' OG1' ' A' ' 144' ' ' THR . 2.0 m -134.53 119.01 17.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.338 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 97' ' ' THR . 32.6 m-20 68.85 34.41 3.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.388 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.415 ' CA ' HD11 ' A' ' 78' ' ' ILE . 0.4 OUTLIER -138.03 130.79 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.808 179.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.11 -170.55 18.84 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.568 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.72 114.48 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.014 0.526 . . . . 0.0 111.719 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.48 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 0.8 OUTLIER -87.33 150.21 24.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.912 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.568 HG12 ' HG ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -114.98 135.96 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.53 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.28 133.57 55.04 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.675 0.274 . . . . 0.0 111.03 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.733 ' HB3' HG23 ' A' ' 107' ' ' THR . 6.1 t0 -82.36 149.75 27.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.664 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.761 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.4 OUTLIER -67.85 -16.25 64.0 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.8 0.333 . . . . 0.0 111.053 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.733 HG23 ' HB3' ' A' ' 105' ' ' ASP . 8.8 t -63.67 -28.35 69.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.033 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.417 ' N ' HG22 ' A' ' 107' ' ' THR . . . 134.0 -40.48 1.58 Allowed Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.661 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.51 163.09 14.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.815 0.34 . . . . 0.0 111.049 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.17 133.36 35.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 117' ' ' THR . 4.8 tp -96.74 150.02 21.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.407 0.622 . . . . 0.0 110.526 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 1.9 t -98.37 141.78 30.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.156 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.568 ' HG ' HG12 ' A' ' 103' ' ' ILE . 1.6 mt -76.43 89.48 3.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.783 0.325 . . . . 0.0 110.704 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.08 -18.19 5.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.554 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.79 -60.58 0.46 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.616 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.478 ' HB1' ' HA ' ' D' ' 129' ' ' ASN . . . -96.46 26.98 4.03 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.04 0.448 . . . . 0.0 111.69 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.554 ' O ' HD23 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -87.04 74.86 9.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.148 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.45 ' CE2' ' HA ' ' A' ' 116' ' ' ALA . 62.7 m-85 -94.88 92.86 7.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.819 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.8 m -136.32 68.92 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.81 150.19 28.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.622 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.25 67.66 0.7 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.171 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.542 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -79.15 114.71 18.31 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.747 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -73.94 127.96 34.24 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.724 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 66' ' ' ALA . 4.0 tp -92.08 132.14 36.81 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.64 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.12 151.12 49.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.58 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 3.1 t30 -69.12 111.99 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.636 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.61 -138.83 8.65 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.672 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.716 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 87.8 m -98.84 82.5 2.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.633 0.254 . . . . 0.0 110.724 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.431 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 2.3 t30 -71.82 148.19 46.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.949 0.404 . . . . 0.0 111.062 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.644 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -138.67 148.57 44.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.119 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.492 ' HB ' HG21 ' A' ' 56' ' ' ILE . 15.6 mt -110.0 112.23 57.93 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.761 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.4 Cg_endo -81.82 136.98 9.7 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.629 1.553 . . . . 0.0 112.564 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.0 136.09 19.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.718 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -111.43 158.4 19.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.04 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 102' ' ' GLN . . . -154.19 111.35 3.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.951 0.405 . . . . 0.0 111.63 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.546 ' HE ' HG22 ' A' ' 48' ' ' THR . 19.8 ptt180 -108.93 174.09 6.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.344 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.759 ' HB3' HD22 ' A' ' 42' ' ' LEU . 1.7 m-85 -81.37 137.67 35.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.14 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -131.61 124.15 29.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.2 0.524 . . . . 0.0 112.072 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.687 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . . . -108.47 130.17 55.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.839 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.51 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -77.46 -27.95 52.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.495 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.49 -96.51 0.11 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.981 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.93 98.46 8.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.623 0.211 . . . . 0.0 110.722 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 42' ' ' LEU . . . -56.6 148.89 18.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.746 0.308 . . . . 0.0 111.413 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.724 HG22 ' CD ' ' A' ' 145' ' ' PRO . 90.1 m -125.41 156.96 69.48 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.219 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.724 ' CD ' HG22 ' A' ' 144' ' ' THR . 1.4 Cg_endo -83.45 136.3 7.51 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.517 2.145 . . . . 0.0 111.925 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 163.56 -127.56 1.7 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.474 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.688 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -110.92 132.88 53.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.863 0.364 . . . . 0.0 111.363 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.24 43.69 2.93 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.133 0.492 . . . . 0.0 110.451 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.495 ' HB2' ' CG ' ' A' ' 89' ' ' GLN . 9.3 m120 -92.27 144.28 25.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.529 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.64 178.81 9.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.0 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -146.94 145.01 29.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.255 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -133.74 139.74 46.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.169 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.1 135.29 42.8 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.58 152.18 27.34 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.005 0.431 . . . . 0.0 110.188 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.403 ' HE3' ' HB ' ' D' ' 128' ' ' THR . 15.2 mmtm -134.18 146.84 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.916 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.09 140.71 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.857 0.36 . . . . 0.0 111.626 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -134.54 132.73 39.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.281 0.562 . . . . 0.0 110.45 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 21' ' ' CYS . 11.1 m-85 -107.3 128.05 54.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.49 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.873 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 111.147 0.054 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' C' ' 158' ' ' TYR . . . 52.78 88.29 0.03 OUTLIER 'General case' 0 C--O 1.232 0.15 0 O-C-N 123.154 0.284 . . . . 0.0 111.039 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' C' ' 157' ' ' GLN . 5.5 m -122.92 116.22 23.24 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.379 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.503 HG21 ' CA ' ' F' ' 127' ' ' GLY . 1.8 m -99.68 117.18 33.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.563 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -144.41 158.09 15.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.577 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' C' ' 154' ' ' PHE . 13.1 t30 -78.74 123.81 27.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.54 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.77 -71.24 1.0 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.836 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.494 ' H ' ' HB3' ' C' ' 154' ' ' PHE . . . -152.66 -147.05 4.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.84 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 24.5 p -148.69 134.44 18.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.969 0.414 . . . . 0.0 111.318 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.39 124.34 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.147 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' HIS . . . . . 0.629 ' HA ' ' OD1' ' C' ' 151' ' ' ASP . 57.4 t-80 -91.47 116.2 28.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.337 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -96.88 105.53 17.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.738 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -104.62 118.72 37.28 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.474 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.3 172.9 30.81 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.936 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.727 ' O ' ' HA ' ' C' ' 36' ' ' GLN . 25.8 tt0 -160.38 135.95 8.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.911 0.386 . . . . 0.0 110.398 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.91 HG12 ' O ' ' C' ' 144' ' ' THR . 43.7 t -96.87 132.79 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.204 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.753 HG12 ' HG2' ' C' ' 36' ' ' GLN . 18.1 m -133.88 -177.12 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.934 0.397 . . . . 0.0 110.98 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . 0.623 ' HA ' HG22 ' C' ' 39' ' ' THR . 0.3 OUTLIER -75.85 -170.34 1.32 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.931 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.76 45.51 0.97 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.084 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.734 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . . . -121.34 -24.85 5.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.386 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER -168.81 140.64 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.864 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' B' ' 60' ' ' ASP . . . -132.79 116.97 17.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.082 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' C' ' 36' ' ' GLN . 0.5 OUTLIER -67.05 146.22 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.034 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -80.33 152.09 29.15 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.562 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' C' ' 33' ' ' GLN . . . -62.84 -39.95 95.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.417 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.9 2.65 85.83 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.844 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -106.26 -19.89 13.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.826 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 39.8 t -47.36 -52.22 5.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.336 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.15 136.43 48.66 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.036 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.63 136.86 39.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.066 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.53 102.87 12.77 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.062 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 26.0 t -107.69 128.25 63.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.527 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 10.8 mt-30 -114.7 123.07 48.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.652 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.43 -42.71 15.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.61 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.44 -167.44 13.2 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.581 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.752 ' HG2' HG12 ' A' ' 17' ' ' VAL . 3.7 mt-30 -96.7 124.47 40.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.613 0.244 . . . . 0.0 110.892 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.78 147.53 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.93 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.67 134.95 34.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.026 0.441 . . . . 0.0 111.669 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.635 HG22 ' HA ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -60.07 -44.49 94.7 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.739 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.29 -36.84 61.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.184 0.516 . . . . 0.0 110.919 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.83 -35.86 62.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.223 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.756 HD22 ' HB3' ' B' ' 137' ' ' TYR . 2.9 mp -106.69 34.58 3.34 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.626 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' B' ' 39' ' ' THR . . . -103.95 15.88 27.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.329 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.0 132.08 56.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.299 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' B' ' 140' ' ' THR . 6.7 tt0 -56.58 108.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.846 0.355 . . . . 0.0 111.076 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.95 25.9 10.12 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.144 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.42 137.77 48.57 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.551 HG22 ' HE ' ' B' ' 136' ' ' ARG . 7.3 p -136.98 122.75 19.93 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.927 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' B' ' 136' ' ' ARG . 53.4 m -100.09 -175.21 2.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.644 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.9 t -55.67 137.33 49.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.799 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' B' ' 136' ' ' ARG . . . -92.29 133.46 35.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.327 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 m -76.71 162.54 4.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.49 141.16 16.78 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.592 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . 0.482 ' HE2' ' HB1' ' B' ' 135' ' ' ALA . 39.4 p90 -173.76 137.77 0.62 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.804 0.335 . . . . 0.0 110.934 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -136.56 145.83 45.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.603 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.502 HG21 ' HB ' ' B' ' 131' ' ' ILE . 1.2 tp -91.03 116.77 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.607 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . 0.655 ' HA ' HG23 ' B' ' 130' ' ' THR . 1.3 mp0 -72.93 128.58 35.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.79 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' B' ' 23' ' ' VAL . 0.3 OUTLIER -137.31 89.17 2.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.242 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.708 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 9.8 p30 -74.81 176.53 6.98 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.012 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . 0.47 ' HB2' ' HB1' ' B' ' 22' ' ' ALA . 0.9 OUTLIER 58.93 74.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 36.8 m -126.32 148.86 49.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.804 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -121.58 169.77 10.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.281 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.27 -32.69 4.89 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -76.52 -27.94 56.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.169 0.509 . . . . 0.0 111.72 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.66 -56.69 8.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.677 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.734 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . . . -135.02 122.74 22.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.674 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -50.04 5.13 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.89 0.376 . . . . 0.0 110.923 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.513 ' HA ' ' HZ2' ' B' ' 68' ' ' LYS . 1.8 tptp -89.76 152.12 21.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.574 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' B' ' 122' ' ' THR . . . -144.25 137.8 27.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.604 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.35 157.25 22.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.11 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.483 HG11 HG21 ' B' ' 131' ' ' ILE . 1.8 t -138.78 149.96 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.656 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.82 155.11 37.52 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.596 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.46 ' CB ' HD11 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -125.04 136.68 53.92 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.634 0.254 . . . . 0.0 110.969 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.569 HD13 ' OG1' ' E' ' 130' ' ' THR . 0.9 OUTLIER -97.15 136.1 38.15 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.032 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.446 ' CA ' ' HB3' ' B' ' 113' ' ' LEU . . . -174.02 -172.95 39.74 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.731 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.669 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.2 OUTLIER -118.63 144.55 46.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.537 0.208 . . . . 0.0 110.831 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . 0.533 ' HB1' ' HA ' ' B' ' 83' ' ' THR . . . -62.48 138.53 58.48 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.958 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.537 HG23 ' N ' ' B' ' 79' ' ' ASP . 5.7 tt -71.55 -45.59 67.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.884 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.537 ' N ' HG23 ' B' ' 78' ' ' ILE . 0.3 OUTLIER -133.19 42.54 3.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.818 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.479 ' HB1' ' O ' ' B' ' 79' ' ' ASP . . . 70.04 -80.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.056 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.08 -29.71 68.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.56 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.407 ' HB3' HG22 ' B' ' 78' ' ' ILE . 1.6 m80 -89.87 69.39 7.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.418 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' THR . . . . . 0.533 ' HA ' ' HB1' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -74.47 -16.2 60.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.604 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . 0.713 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 20.8 p-10 -66.11 -19.16 65.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.334 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.472 ' HB ' ' CG2' ' B' ' 78' ' ' ILE . 13.5 t -113.6 133.83 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.173 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . 0.597 ' HA ' ' O ' ' B' ' 76' ' ' THR . 0.4 OUTLIER -67.83 161.53 26.04 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.463 ' H ' HD23 ' B' ' 86' ' ' LEU . . . -103.61 -174.72 2.61 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.866 0.365 . . . . 0.0 111.772 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.648 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 0.3 OUTLIER -67.36 165.21 16.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.049 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . 0.495 ' CG ' ' HB2' ' B' ' 149' ' ' ASN . 5.7 mm-40 -63.42 -79.73 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.33 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' SER . . . . . 0.413 ' O ' HG13 ' E' ' 52' ' ' VAL . 2.3 p -165.48 3.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 111.549 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' SER . . . . . 0.69 ' HA ' ' HB3' ' D' ' 25' ' ' ALA . 0.7 OUTLIER -80.16 79.73 6.68 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.492 ' HB3' HG11 ' E' ' 52' ' ' VAL . . . -57.05 -24.76 56.15 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.868 0.366 . . . . 0.0 111.617 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.2 33.99 5.24 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.692 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.77 0.42 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.911 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' SER . . . . . 0.687 ' HA ' ' HB3' ' B' ' 147' ' ' ALA . 38.4 m -96.8 177.93 5.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.873 0.368 . . . . 0.0 110.622 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.54 -178.65 7.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.806 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' B' ' 98' ' ' ASN . 2.0 m -134.42 119.05 18.09 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.379 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' B' ' 97' ' ' THR . 32.5 m-20 68.68 34.53 3.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.441 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.461 HG12 HG21 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -138.13 130.85 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.784 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.14 -170.63 18.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.539 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.61 114.48 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.017 0.527 . . . . 0.0 111.766 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 0.8 OUTLIER -87.4 150.24 23.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.92 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.567 HG12 ' HG ' ' B' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 135.99 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.471 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.31 133.59 55.05 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.654 0.264 . . . . 0.0 110.988 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . 0.733 ' HB3' HG23 ' B' ' 107' ' ' THR . 6.1 t0 -82.29 149.75 27.63 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.725 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . 0.75 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.4 OUTLIER -67.82 -16.26 64.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.811 0.339 . . . . 0.0 111.103 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' THR . . . . . 0.733 HG23 ' HB3' ' B' ' 105' ' ' ASP . 8.8 t -63.69 -28.39 69.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.006 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' GLY . . . . . 0.419 ' N ' HG22 ' B' ' 107' ' ' THR . . . 134.08 -40.55 1.57 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.662 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.48 163.12 14.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.819 0.342 . . . . 0.0 111.052 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.12 133.35 35.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.204 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.563 HD23 ' O ' ' B' ' 117' ' ' THR . 4.8 tp -96.69 150.0 21.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.413 0.625 . . . . 0.0 110.539 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.713 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 1.9 t -98.48 141.76 30.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.177 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.567 ' HG ' HG12 ' B' ' 103' ' ' ILE . 1.6 mt -76.36 89.4 3.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.741 0.305 . . . . 0.0 110.746 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.07 -18.14 5.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.503 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.8 -60.65 0.46 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.588 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' E' ' 129' ' ' ASN . . . -96.5 27.03 4.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.035 0.445 . . . . 0.0 111.632 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' THR . . . . . 0.563 ' O ' HD23 ' B' ' 111' ' ' LEU . 0.0 OUTLIER -87.07 74.89 9.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.164 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' B' ' 116' ' ' ALA . 62.6 m-85 -94.92 92.89 7.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 25.5 m -136.33 68.93 1.43 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.86 150.29 28.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.557 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -107.34 67.63 0.7 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.206 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.556 ' O ' ' HB3' ' B' ' 69' ' ' ALA . 0.2 OUTLIER -79.15 114.71 18.31 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.757 -179.549 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 12.0 m -73.98 128.02 34.41 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.713 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.594 HD22 ' O ' ' B' ' 66' ' ' ALA . 4.0 tp -92.11 132.17 36.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.614 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.17 151.09 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.583 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' B' ' 61' ' ' CYS . 3.1 t30 -69.03 111.97 5.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.627 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.55 -138.96 8.75 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.643 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.708 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 87.7 m -98.71 82.55 2.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.637 0.256 . . . . 0.0 110.792 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . 0.439 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 2.3 t30 -71.76 148.14 46.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.805 0.336 . . . . 0.0 111.188 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.655 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -138.64 148.61 44.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' ILE . . . . . 0.502 ' HB ' HG21 ' B' ' 56' ' ' ILE . 15.6 mt -110.01 112.22 57.91 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' PRO . . . . . 0.75 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.83 137.03 9.72 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.574 1.516 . . . . 0.0 112.578 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.03 136.02 19.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.739 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -111.45 158.41 19.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.033 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' B' ' 102' ' ' GLN . . . -154.15 111.33 3.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.924 0.392 . . . . 0.0 111.633 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . 0.551 ' HE ' HG22 ' B' ' 48' ' ' THR . 19.8 ptt180 -108.94 174.11 6.02 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.375 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . 0.756 ' HB3' HD22 ' B' ' 42' ' ' LEU . 1.7 m-85 -81.4 137.64 35.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.047 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -131.53 124.14 29.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.104 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.665 ' HB3' ' HG ' ' B' ' 42' ' ' LEU . . . -108.51 130.16 55.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.834 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' THR . . . . . 0.511 HG22 ' HB2' ' B' ' 79' ' ' ASP . 0.2 OUTLIER -77.44 -27.9 52.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.571 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.48 -96.52 0.11 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.006 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.99 98.49 8.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.572 0.225 . . . . 0.0 110.666 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' B' ' 42' ' ' LEU . . . -56.64 148.93 18.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.742 0.306 . . . . 0.0 111.418 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.891 ' O ' HG12 ' A' ' 16' ' ' VAL . 90.5 m -125.44 156.95 69.57 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.208 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.73 ' CD ' HG22 ' B' ' 144' ' ' THR . 1.4 Cg_endo -83.42 136.28 7.53 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.52 2.147 . . . . 0.0 111.974 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . 0.554 ' O ' ' HG3' ' A' ' 15' ' ' GLU . . . 163.64 -127.57 1.69 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.51 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . 0.687 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -110.93 132.92 53.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.829 0.347 . . . . 0.0 111.328 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.28 43.75 2.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.422 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.495 ' HB2' ' CG ' ' B' ' 89' ' ' GLN . 9.3 m120 -92.34 144.32 25.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.506 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.68 178.85 9.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.968 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . 0.615 ' OD1' ' HA ' ' A' ' 11' ' ' HIS . 15.7 t70 -146.97 145.03 29.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.218 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -133.79 139.73 46.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.18 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.04 135.25 42.79 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.493 ' HB3' ' H ' ' A' ' 8' ' ' GLY . 0.2 OUTLIER -81.52 152.16 27.42 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.118 0.485 . . . . 0.0 110.125 -179.082 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.418 ' HE3' ' HB ' ' E' ' 128' ' ' THR . 15.2 mmtm -134.22 146.84 50.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.877 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.07 140.77 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.8 0.333 . . . . 0.0 111.617 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 3' ' ' THR . 0.9 OUTLIER -134.52 132.67 39.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.272 0.558 . . . . 0.0 110.485 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' B' ' 21' ' ' CYS . 10.9 m-85 -107.22 128.01 54.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.557 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.907 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 120.222 0.058 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.76 88.35 0.03 OUTLIER 'General case' 0 C--O 1.232 0.163 0 O-C-N 123.141 0.275 . . . . 0.0 111.015 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' D' ' 157' ' ' GLN . 5.5 m -123.0 116.28 23.27 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.381 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -99.66 117.16 33.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.6 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -144.45 157.96 14.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.626 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' D' ' 154' ' ' PHE . 13.2 t30 -78.66 123.75 27.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.582 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.7 -71.24 1.0 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.819 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . 0.484 ' H ' ' HB3' ' D' ' 154' ' ' PHE . . . -152.7 -147.01 4.49 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.773 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 24.1 p -148.75 134.51 18.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.053 0.454 . . . . 0.0 111.243 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.35 124.33 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.201 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' HIS . . . . . 0.624 ' HA ' ' OD1' ' D' ' 151' ' ' ASP . 57.4 t-80 -91.51 116.13 28.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.308 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -96.8 105.49 17.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.824 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -104.66 118.67 37.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.484 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.22 172.94 30.76 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.98 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' GLU . . . . . 0.725 ' O ' ' HA ' ' D' ' 36' ' ' GLN . 25.7 tt0 -160.39 135.93 8.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.913 0.387 . . . . 0.0 110.459 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.918 HG12 ' O ' ' D' ' 144' ' ' THR . 43.8 t -96.86 132.85 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.168 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.744 HG12 ' HG2' ' D' ' 36' ' ' GLN . 18.2 m -133.97 -177.21 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.93 0.395 . . . . 0.0 110.965 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . 0.617 ' HA ' HG22 ' D' ' 39' ' ' THR . 0.3 OUTLIER -75.75 -170.28 1.27 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.977 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.82 45.5 0.97 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.073 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . 0.734 ' HB3' ' HB2' ' C' ' 66' ' ' ALA . . . -121.31 -24.85 5.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.383 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' CYS . . . . . 0.902 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER -168.87 140.69 2.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.864 -179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' C' ' 60' ' ' ASP . . . -132.82 117.02 17.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.041 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' D' ' 36' ' ' GLN . 0.5 OUTLIER -67.11 146.26 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.113 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -80.4 152.11 29.02 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.545 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.686 ' HB3' ' HA ' ' A' ' 91' ' ' SER . . . -62.77 -40.02 95.97 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.483 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.91 2.67 85.83 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.886 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -106.14 -20.05 13.53 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.872 0.368 . . . . 0.0 110.817 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 39.7 t -47.31 -52.15 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.324 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.21 136.42 48.71 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.995 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.72 136.91 39.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.017 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.56 102.86 12.76 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.074 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 26.1 t -107.66 128.34 62.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.051 0.453 . . . . 0.0 110.485 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' B' ' 25' ' ' ALA . 10.6 mt-30 -114.78 123.16 48.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.603 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.49 -42.74 15.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.593 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.5 -167.42 13.17 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.613 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . 0.753 ' HG2' HG12 ' B' ' 17' ' ' VAL . 3.7 mt-30 -96.77 124.42 40.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.586 0.231 . . . . 0.0 110.882 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.73 147.59 11.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.946 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.76 134.97 34.31 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.67 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.623 HG22 ' HA ' ' B' ' 18' ' ' ASN . 0.0 OUTLIER -60.1 -44.37 94.88 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.798 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.41 -36.74 61.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.063 0.458 . . . . 0.0 110.835 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.97 -35.73 62.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.191 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.737 HD22 ' HB3' ' C' ' 137' ' ' TYR . 2.9 mp -106.71 34.56 3.36 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.646 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' C' ' 39' ' ' THR . . . -103.97 15.82 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.334 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.96 132.05 56.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.359 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' C' ' 140' ' ' THR . 6.8 tt0 -56.54 108.8 0.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.806 0.336 . . . . 0.0 111.107 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.89 25.96 10.12 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.152 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.49 137.8 48.45 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' THR . . . . . 0.549 HG22 ' HE ' ' C' ' 136' ' ' ARG . 7.4 p -137.01 122.77 19.93 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.864 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' C' ' 136' ' ' ARG . 54.0 m -100.09 -175.16 2.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.655 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 2.8 t -55.63 137.3 49.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.811 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . 0.467 ' CA ' ' HB3' ' C' ' 136' ' ' ARG . . . -92.4 133.48 35.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.34 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . . . . . . . . . 26.4 m -76.7 162.51 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.56 141.2 16.79 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.519 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . 0.479 ' HE2' ' HB1' ' C' ' 135' ' ' ALA . 39.4 p90 -173.74 137.73 0.62 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.721 0.296 . . . . 0.0 111.015 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -136.5 145.74 45.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.647 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.503 HG21 ' HB ' ' C' ' 131' ' ' ILE . 1.2 tp -90.92 116.76 32.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.68 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.641 ' HA ' HG23 ' C' ' 130' ' ' THR . 1.3 mp0 -72.9 128.55 35.83 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . 0.429 ' HG ' ' HA ' ' C' ' 23' ' ' VAL . 0.3 OUTLIER -137.28 89.18 2.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.284 -179.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . 0.691 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 9.8 p30 -74.82 176.46 7.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.013 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' ASP . . . . . 0.472 ' HB2' ' HB1' ' C' ' 22' ' ' ALA . 0.8 OUTLIER 58.92 74.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.818 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' CYS . . . . . 0.902 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 36.3 m -126.34 148.91 49.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -121.63 169.72 10.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.35 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.26 -32.7 4.89 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.52 -27.88 56.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 111.765 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.6 -56.81 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.64 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . 0.734 ' HB2' ' HB3' ' C' ' 20' ' ' ALA . . . -134.98 122.7 22.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.65 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.45 -50.1 5.14 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.861 0.362 . . . . 0.0 110.997 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' LYS . . . . . 0.508 ' HA ' ' HZ2' ' C' ' 68' ' ' LYS . 1.8 tptp -89.78 152.14 21.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.558 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' C' ' 122' ' ' THR . . . -144.26 137.84 27.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.575 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.41 157.24 22.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.073 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . 0.488 HG11 HG21 ' C' ' 131' ' ' ILE . 1.8 t -138.74 149.94 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.665 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.82 155.1 37.51 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.59 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' PHE . . . . . 0.466 ' CB ' HD11 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -124.99 136.66 53.93 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.012 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.572 HD13 ' OG1' ' F' ' 130' ' ' THR . 0.9 OUTLIER -97.16 136.17 38.07 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.994 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . 0.447 ' CA ' ' HB3' ' C' ' 113' ' ' LEU . . . -174.01 -172.95 39.74 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.817 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' THR . . . . . 0.661 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.2 OUTLIER -118.67 144.54 46.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.551 0.215 . . . . 0.0 110.796 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . 0.554 ' HB1' ' HA ' ' C' ' 83' ' ' THR . . . -62.5 138.6 58.5 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.913 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . 0.55 HG23 ' N ' ' C' ' 79' ' ' ASP . 5.7 tt -71.66 -45.54 66.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.85 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' ASP . . . . . 0.55 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.3 OUTLIER -133.15 42.47 3.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' C' ' 79' ' ' ASP . . . 70.19 -80.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.032 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.11 -29.68 68.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.609 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . 0.407 ' HB3' HG22 ' C' ' 78' ' ' ILE . 1.7 m80 -89.84 69.39 7.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.832 0.349 . . . . 0.0 110.424 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' THR . . . . . 0.554 ' HA ' ' HB1' ' C' ' 77' ' ' ALA . 0.2 OUTLIER -74.55 -16.13 60.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.604 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' ASN . . . . . 0.73 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 20.8 p-10 -66.18 -19.04 65.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.336 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.475 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 13.5 t -113.66 133.86 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.128 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.596 ' HA ' ' O ' ' C' ' 76' ' ' THR . 0.4 OUTLIER -67.91 161.53 26.22 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.267 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.462 ' H ' HD23 ' C' ' 86' ' ' LEU . . . -103.58 -174.66 2.6 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.862 0.363 . . . . 0.0 111.764 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.649 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 0.3 OUTLIER -67.4 165.17 17.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.116 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' GLN . . . . . 0.501 ' CG ' ' HB2' ' C' ' 149' ' ' ASN . 5.7 mm-40 -63.36 -79.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.365 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' SER . . . . . 0.411 ' O ' HG13 ' F' ' 52' ' ' VAL . 2.3 p -165.52 3.61 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.01 0.433 . . . . 0.0 111.579 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' SER . . . . . 0.688 ' HA ' ' HB3' ' E' ' 25' ' ' ALA . 0.7 OUTLIER -80.09 79.83 6.59 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' ALA . . . . . 0.503 ' HB3' HG11 ' F' ' 52' ' ' VAL . . . -57.09 -24.79 56.49 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.891 0.377 . . . . 0.0 111.634 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.17 33.94 5.25 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.69 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.85 0.46 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.937 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' SER . . . . . 0.68 ' HA ' ' HB3' ' C' ' 147' ' ' ALA . 38.6 m -96.78 177.94 5.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 110.607 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.52 -178.73 7.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.784 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' THR . . . . . 0.492 ' HB ' ' OG1' ' C' ' 144' ' ' THR . 2.0 m -134.44 119.02 18.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.369 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' C' ' 97' ' ' THR . 32.8 m-20 68.78 34.48 3.33 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.457 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' VAL . . . . . 0.476 HG12 HG21 ' B' ' 16' ' ' VAL . 0.4 OUTLIER -138.12 130.85 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.727 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.21 -170.63 19.01 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.566 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.62 114.51 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 123.028 0.531 . . . . 0.0 111.717 -179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 0.8 OUTLIER -87.39 150.2 23.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.923 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . 0.566 HG12 ' HG ' ' C' ' 113' ' ' LEU . 0.8 OUTLIER -114.94 136.07 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.481 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.37 133.52 55.11 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.711 0.291 . . . . 0.0 111.032 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . 0.733 ' HB3' HG23 ' C' ' 107' ' ' THR . 6.1 t0 -82.24 149.74 27.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.674 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . 0.76 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.4 OUTLIER -67.87 -16.23 63.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.795 0.331 . . . . 0.0 111.058 179.537 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' THR . . . . . 0.733 HG23 ' HB3' ' C' ' 105' ' ' ASP . 8.8 t -63.62 -28.39 69.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.043 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . 0.404 ' N ' HG22 ' C' ' 107' ' ' THR . . . 133.97 -40.46 1.58 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.717 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.54 163.08 14.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.822 0.344 . . . . 0.0 110.999 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.14 133.36 35.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.198 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' LEU . . . . . 0.548 HD23 ' O ' ' C' ' 117' ' ' THR . 4.8 tp -96.72 149.98 21.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.368 0.604 . . . . 0.0 110.603 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' THR . . . . . 0.73 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 1.9 t -98.43 141.73 30.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.566 ' HG ' HG12 ' C' ' 103' ' ' ILE . 1.6 mt -76.39 89.48 3.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.808 0.337 . . . . 0.0 110.727 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.15 -18.06 5.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.697 0.284 . . . . 0.0 111.525 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.78 -60.63 0.46 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.559 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' F' ' 129' ' ' ASN . . . -96.46 26.96 4.04 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.996 0.427 . . . . 0.0 111.636 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' THR . . . . . 0.548 ' O ' HD23 ' C' ' 111' ' ' LEU . 0.0 OUTLIER -87.04 74.81 9.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.157 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' PHE . . . . . 0.448 ' CE2' ' HA ' ' C' ' 116' ' ' ALA . 62.8 m-85 -94.93 92.93 7.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.812 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 25.6 m -136.35 68.94 1.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.831 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.83 150.27 28.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.646 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.34 67.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.178 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.554 ' O ' ' HB3' ' C' ' 69' ' ' ALA . 0.2 OUTLIER -79.19 114.71 18.35 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.7 -179.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -74.02 128.04 34.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.729 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . 0.573 HD22 ' O ' ' C' ' 66' ' ' ALA . 4.0 tp -92.14 132.19 36.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.594 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.13 151.01 49.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.641 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' C' ' 61' ' ' CYS . 3.1 t30 -69.05 112.11 5.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.632 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.43 -138.93 8.77 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.756 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' THR . . . . . 0.691 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 87.0 m -98.72 82.54 2.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.642 0.258 . . . . 0.0 110.827 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 129' ' ' ASN . . . . . 0.431 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 2.3 t30 -71.84 148.13 46.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.89 0.376 . . . . 0.0 111.145 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 130' ' ' THR . . . . . 0.641 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -138.57 148.57 44.33 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.209 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 131' ' ' ILE . . . . . 0.503 ' HB ' HG21 ' C' ' 56' ' ' ILE . 15.7 mt -110.03 112.27 57.83 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 132' ' ' PRO . . . . . 0.76 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.6 Cg_endo -81.8 137.02 9.75 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.599 1.532 . . . . 0.0 112.566 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.01 136.09 19.94 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.727 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -111.5 158.38 19.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.081 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' C' ' 102' ' ' GLN . . . -154.18 111.36 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.969 0.414 . . . . 0.0 111.64 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . 0.549 ' HE ' HG22 ' C' ' 48' ' ' THR . 19.8 ptt180 -108.89 174.06 6.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.385 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 137' ' ' TYR . . . . . 0.737 ' HB3' HD22 ' C' ' 42' ' ' LEU . 1.7 m-85 -81.41 137.73 35.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.103 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -131.58 124.13 29.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.092 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 139' ' ' ALA . . . . . 0.673 ' HB3' ' HG ' ' C' ' 42' ' ' LEU . . . -108.48 130.19 55.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.824 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 140' ' ' THR . . . . . 0.504 HG22 ' HB2' ' C' ' 79' ' ' ASP . 0.2 OUTLIER -77.46 -27.93 52.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.518 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.5 -96.54 0.11 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.955 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.95 98.49 8.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.578 0.227 . . . . 0.0 110.714 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 143' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' C' ' 42' ' ' LEU . . . -56.56 148.92 18.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.757 0.313 . . . . 0.0 111.364 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 144' ' ' THR . . . . . 0.91 ' O ' HG12 ' B' ' 16' ' ' VAL . 91.0 m -125.43 156.99 69.5 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.247 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 145' ' ' PRO . . . . . 0.731 ' CD ' HG22 ' C' ' 144' ' ' THR . 1.5 Cg_endo -83.38 136.17 7.51 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.631 2.22 . . . . 0.0 111.987 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . 0.556 ' O ' ' HG3' ' B' ' 15' ' ' GLU . . . 163.62 -127.57 1.69 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.429 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 147' ' ' ALA . . . . . 0.68 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -110.88 132.9 53.81 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.763 0.316 . . . . 0.0 111.369 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.28 43.78 2.91 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.107 0.479 . . . . 0.0 110.438 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 149' ' ' ASN . . . . . 0.501 ' HB2' ' CG ' ' C' ' 89' ' ' GLN . 9.2 m120 -92.33 144.27 25.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.511 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.66 178.88 9.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.989 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 151' ' ' ASP . . . . . 0.629 ' OD1' ' HA ' ' B' ' 11' ' ' HIS . 15.6 t70 -146.98 145.02 29.6 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.298 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -133.75 139.78 46.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.273 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.11 135.28 42.83 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 154' ' ' PHE . . . . . 0.494 ' HB3' ' H ' ' B' ' 8' ' ' GLY . 0.2 OUTLIER -81.54 152.17 27.4 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.06 0.457 . . . . 0.0 110.136 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . 0.415 ' HE3' ' HB ' ' F' ' 128' ' ' THR . 15.2 mmtm -134.24 146.87 50.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.934 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.18 140.79 37.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.859 0.362 . . . . 0.0 111.622 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' B' ' 3' ' ' THR . 0.9 OUTLIER -134.53 132.68 39.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.335 0.588 . . . . 0.0 110.406 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . 0.536 ' CE1' ' HB2' ' C' ' 21' ' ' CYS . 11.0 m-85 -107.35 128.04 54.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.541 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.823 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.267 0.079 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' E' ' 158' ' ' TYR . . . 52.85 88.35 0.03 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.976 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' E' ' 157' ' ' GLN . 5.4 m -123.0 116.2 23.16 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.413 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -99.6 117.22 33.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.582 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -144.44 158.03 15.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.655 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' E' ' 154' ' ' PHE . 13.2 t30 -78.71 123.75 27.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.597 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.83 -71.1 1.02 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.792 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . 0.49 ' H ' ' HB3' ' E' ' 154' ' ' PHE . . . -152.75 -146.98 4.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.806 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 24.1 p -148.76 134.49 18.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.011 0.434 . . . . 0.0 111.258 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.4 124.37 72.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.159 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' HIS . . . . . 0.611 ' HA ' ' OD1' ' E' ' 151' ' ' ASP . 57.3 t-80 -91.52 116.17 28.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.292 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -96.84 105.49 17.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.814 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' LYS . . . . . 0.4 ' HG2' ' ND2' ' E' ' 149' ' ' ASN . 5.1 tttm -104.64 118.73 37.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.422 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.31 172.93 30.82 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.945 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' GLU . . . . . 0.731 ' O ' ' HA ' ' E' ' 36' ' ' GLN . 25.8 tt0 -160.36 135.96 8.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.943 0.401 . . . . 0.0 110.339 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.911 HG12 ' O ' ' E' ' 144' ' ' THR . 43.2 t -96.79 132.81 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.25 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . 0.741 HG12 ' HG2' ' E' ' 36' ' ' GLN . 18.2 m -133.91 -177.16 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.897 0.38 . . . . 0.0 111.008 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' ASN . . . . . 0.627 ' HA ' HG22 ' E' ' 39' ' ' THR . 0.3 OUTLIER -75.74 -170.37 1.3 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.932 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.74 45.41 0.98 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.029 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.71 ' HB3' ' HB2' ' D' ' 66' ' ' ALA . . . -121.36 -24.78 5.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.369 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' CYS . . . . . 0.918 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER -168.82 140.65 2.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.881 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . 0.458 ' HB1' ' HB2' ' D' ' 60' ' ' ASP . . . -132.8 116.99 17.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.068 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' E' ' 36' ' ' GLN . 0.5 OUTLIER -67.05 146.18 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.044 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -80.33 152.04 29.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.58 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.69 ' HB3' ' HA ' ' B' ' 91' ' ' SER . . . -62.69 -40.07 95.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.464 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.91 2.64 85.81 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.867 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -106.17 -19.94 13.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.845 0.355 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 39.8 t -47.42 -52.1 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.344 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.19 136.41 48.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.032 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.72 136.92 39.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.035 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.48 102.77 12.69 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.057 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 25.7 t -107.64 128.29 62.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.058 0.456 . . . . 0.0 110.56 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' C' ' 25' ' ' ALA . 10.6 mt-30 -114.75 123.03 48.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.614 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.4 -42.71 15.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.684 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.55 -167.43 13.16 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.618 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' GLN . . . . . 0.744 ' HG2' HG12 ' C' ' 17' ' ' VAL . 3.7 mt-30 -96.79 124.58 40.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.618 0.247 . . . . 0.0 110.845 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.86 147.52 11.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.822 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.77 134.98 34.3 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.661 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.617 HG22 ' HA ' ' C' ' 18' ' ' ASN . 0.0 OUTLIER -60.04 -44.42 94.66 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.828 179.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.35 -36.78 61.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.135 0.493 . . . . 0.0 110.92 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.94 -35.86 62.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.135 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.758 HD22 ' HB3' ' D' ' 137' ' ' TYR . 2.9 mp -106.6 34.55 3.35 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.614 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' D' ' 39' ' ' THR . . . -103.9 15.8 27.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.32 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.94 132.09 56.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.323 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' D' ' 140' ' ' THR . 6.8 tt0 -56.55 108.78 0.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.744 0.307 . . . . 0.0 111.117 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.95 25.88 10.14 Favored Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.136 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.48 137.76 48.45 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.963 0.411 . . . . 0.0 112.058 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' THR . . . . . 0.549 HG22 ' HE ' ' D' ' 136' ' ' ARG . 7.3 p -137.01 122.77 19.93 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.92 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' D' ' 136' ' ' ARG . 53.4 m -100.12 -175.19 2.88 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.606 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 2.9 t -55.59 137.31 49.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.808 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' ALA . . . . . 0.468 ' CA ' ' HB3' ' D' ' 136' ' ' ARG . . . -92.41 133.51 35.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.348 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' VAL . . . . . 0.486 HG11 ' HB3' ' A' ' 92' ' ' ALA . 26.6 m -76.76 162.47 4.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.49 141.16 16.78 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.552 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . 0.478 ' HE2' ' HB1' ' D' ' 135' ' ' ALA . 39.4 p90 -173.74 137.79 0.62 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.783 0.325 . . . . 0.0 110.965 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -136.5 145.81 45.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.681 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.493 HG21 ' HB ' ' D' ' 131' ' ' ILE . 1.2 tp -90.95 116.76 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.627 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' GLN . . . . . 0.646 ' HA ' HG23 ' D' ' 130' ' ' THR . 1.3 mp0 -72.87 128.59 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.803 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . 0.438 ' HG ' ' HA ' ' D' ' 23' ' ' VAL . 0.3 OUTLIER -137.31 89.11 2.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.264 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . 0.704 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 9.8 p30 -74.76 176.54 6.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.951 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' ASP . . . . . 0.458 ' HB2' ' HB1' ' D' ' 22' ' ' ALA . 0.9 OUTLIER 58.9 74.79 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.888 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' CYS . . . . . 0.918 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 36.6 m -126.33 148.89 49.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.808 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -121.61 169.78 10.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.317 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.32 -32.63 4.9 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -76.57 -27.89 56.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.197 0.522 . . . . 0.0 111.742 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.57 -56.83 8.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.677 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.71 ' HB2' ' HB3' ' D' ' 20' ' ' ALA . . . -134.93 122.77 22.39 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.647 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.57 -50.02 5.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.921 0.391 . . . . 0.0 110.977 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' LYS . . . . . 0.513 ' HA ' ' HZ2' ' D' ' 68' ' ' LYS . 1.8 tptp -89.84 152.12 21.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.517 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' D' ' 122' ' ' THR . . . -144.22 137.86 27.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.586 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.41 157.23 22.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.078 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . 0.483 HG11 HG21 ' D' ' 131' ' ' ILE . 1.8 t -138.7 150.0 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.638 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.8 155.11 37.54 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.624 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' PHE . . . . . 0.451 ' CB ' HD11 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -125.08 136.69 53.9 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.651 0.262 . . . . 0.0 111.012 179.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.9 OUTLIER -97.19 136.12 38.16 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.978 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . 0.441 ' CA ' ' HB3' ' D' ' 113' ' ' LEU . . . -174.03 -172.96 39.76 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.744 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.2 OUTLIER -118.72 144.57 46.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.552 0.215 . . . . 0.0 110.801 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . 0.553 ' HB1' ' HA ' ' D' ' 83' ' ' THR . . . -62.47 138.53 58.48 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.91 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 78' ' ' ILE . . . . . 0.549 HG23 ' N ' ' D' ' 79' ' ' ASP . 5.7 tt -71.52 -45.65 67.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.893 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . 0.549 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.3 OUTLIER -133.15 42.55 3.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.771 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' D' ' 79' ' ' ASP . . . 70.16 -80.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.11 -29.7 68.89 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.529 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . 0.415 ' HB3' HG22 ' D' ' 78' ' ' ILE . 1.7 m80 -89.82 69.39 7.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.754 0.311 . . . . 0.0 110.436 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 83' ' ' THR . . . . . 0.553 ' HA ' ' HB1' ' D' ' 77' ' ' ALA . 0.2 OUTLIER -74.56 -16.15 60.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.6 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . 0.727 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 20.8 p-10 -66.24 -19.08 65.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.261 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.463 ' HB ' ' CG2' ' D' ' 78' ' ' ILE . 13.4 t -113.57 133.84 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.179 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.593 ' HA ' ' O ' ' D' ' 76' ' ' THR . 0.4 OUTLIER -67.87 161.47 26.27 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.466 ' H ' HD23 ' D' ' 86' ' ' LEU . . . -103.59 -174.72 2.61 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.837 0.351 . . . . 0.0 111.79 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.656 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 0.3 OUTLIER -67.33 165.23 16.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.104 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 89' ' ' GLN . . . . . 0.506 ' CG ' ' HB2' ' D' ' 149' ' ' ASN . 5.7 mm-40 -63.43 -79.76 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.323 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -165.46 3.78 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.051 0.453 . . . . 0.0 111.6 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 91' ' ' SER . . . . . 0.688 ' HA ' ' HB3' ' F' ' 25' ' ' ALA . 0.7 OUTLIER -80.09 79.72 6.6 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.06 -24.77 56.27 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.815 0.341 . . . . 0.0 111.606 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.13 33.89 5.27 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.731 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.75 0.43 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.935 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 95' ' ' SER . . . . . 0.685 ' HA ' ' HB3' ' D' ' 147' ' ' ALA . 38.7 m -96.7 177.94 5.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 110.679 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.52 -178.7 7.06 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.796 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 97' ' ' THR . . . . . 0.491 ' HB ' ' OG1' ' D' ' 144' ' ' THR . 2.0 m -134.41 119.08 18.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.354 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 98' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' D' ' 97' ' ' THR . 32.4 m-20 68.67 34.56 3.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.439 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 99' ' ' VAL . . . . . 0.481 HG12 HG21 ' C' ' 16' ' ' VAL . 0.4 OUTLIER -138.16 130.81 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.755 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.15 -170.62 18.95 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.539 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.66 114.49 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.036 0.534 . . . . 0.0 111.654 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 102' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 0.8 OUTLIER -87.36 150.22 23.98 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.887 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 103' ' ' ILE . . . . . 0.561 HG12 ' HG ' ' D' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 136.07 52.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.461 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.34 133.47 55.12 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.636 0.255 . . . . 0.0 111.053 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . 0.729 ' HB3' HG23 ' D' ' 107' ' ' THR . 6.1 t0 -82.21 149.77 27.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.725 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 106' ' ' ARG . . . . . 0.765 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.4 OUTLIER -67.89 -16.23 63.98 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.729 0.3 . . . . 0.0 111.046 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 107' ' ' THR . . . . . 0.729 HG23 ' HB3' ' D' ' 105' ' ' ASP . 8.8 t -63.65 -28.42 69.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.039 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 108' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' A' ' 80' ' ' ALA . . . 134.01 -40.41 1.59 Allowed Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.64 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.46 163.06 14.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.777 0.322 . . . . 0.0 111.054 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.08 133.3 35.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.207 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 111' ' ' LEU . . . . . 0.563 HD23 ' O ' ' D' ' 117' ' ' THR . 4.8 tp -96.73 150.06 21.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.356 0.598 . . . . 0.0 110.516 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 112' ' ' THR . . . . . 0.727 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 1.9 t -98.53 141.72 31.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.098 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 113' ' ' LEU . . . . . 0.561 ' HG ' HG12 ' D' ' 103' ' ' ILE . 1.6 mt -76.34 89.51 3.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.735 0.302 . . . . 0.0 110.765 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.15 -18.19 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.652 0.263 . . . . 0.0 111.497 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.82 -60.65 0.46 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.618 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 116' ' ' ALA . . . . . 0.446 ' HA ' ' CE2' ' D' ' 118' ' ' PHE . . . -96.43 26.94 4.04 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.948 0.404 . . . . 0.0 111.631 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 117' ' ' THR . . . . . 0.563 ' O ' HD23 ' D' ' 111' ' ' LEU . 0.0 OUTLIER -87.02 74.89 9.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.199 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.446 ' CE2' ' HA ' ' D' ' 116' ' ' ALA . 63.1 m-85 -94.94 92.86 7.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.834 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 25.5 m -136.27 68.9 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.81 150.23 28.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.616 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -107.3 67.71 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.135 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.554 ' O ' ' HB3' ' D' ' 69' ' ' ALA . 0.2 OUTLIER -79.23 114.67 18.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.735 -179.576 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -73.97 127.94 34.2 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.756 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . 0.583 HD22 ' O ' ' D' ' 66' ' ' ALA . 4.0 tp -92.01 132.14 36.77 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.649 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.09 151.14 49.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.6 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 126' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' D' ' 61' ' ' CYS . 3.1 t30 -69.1 112.08 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.613 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.55 -138.91 8.72 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.659 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 128' ' ' THR . . . . . 0.704 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 87.7 m -98.81 82.58 2.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.642 0.258 . . . . 0.0 110.729 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 129' ' ' ASN . . . . . 0.478 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 2.3 t30 -71.88 148.16 46.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.937 0.398 . . . . 0.0 111.06 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 130' ' ' THR . . . . . 0.646 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.2 OUTLIER -138.57 148.64 44.41 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.161 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 131' ' ' ILE . . . . . 0.493 ' HB ' HG21 ' D' ' 56' ' ' ILE . 15.8 mt -110.09 112.28 57.7 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 132' ' ' PRO . . . . . 0.765 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.5 Cg_endo -81.77 136.97 9.76 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.677 1.585 . . . . 0.0 112.597 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.04 136.06 19.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.676 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -111.42 158.34 19.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.055 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' D' ' 102' ' ' GLN . . . -154.18 111.29 3.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.935 0.397 . . . . 0.0 111.637 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 136' ' ' ARG . . . . . 0.549 ' HE ' HG22 ' D' ' 48' ' ' THR . 19.8 ptt180 -108.85 174.21 5.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.346 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 137' ' ' TYR . . . . . 0.758 ' HB3' HD22 ' D' ' 42' ' ' LEU . 1.7 m-85 -81.53 137.68 35.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.03 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -131.55 124.11 29.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.136 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 139' ' ' ALA . . . . . 0.676 ' HB3' ' HG ' ' D' ' 42' ' ' LEU . . . -108.42 130.28 55.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.855 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 140' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' D' ' 45' ' ' GLU . 0.2 OUTLIER -77.49 -28.02 52.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.535 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.41 -96.47 0.11 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.879 -0.676 . . . . 0.0 113.057 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.03 98.49 8.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.551 0.215 . . . . 0.0 110.697 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 143' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' D' ' 42' ' ' LEU . . . -56.59 148.91 18.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.758 0.313 . . . . 0.0 111.404 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 144' ' ' THR . . . . . 0.918 ' O ' HG12 ' C' ' 16' ' ' VAL . 91.6 m -125.38 156.93 69.45 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.288 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 145' ' ' PRO . . . . . 0.718 ' CD ' HG22 ' D' ' 144' ' ' THR . 1.5 Cg_endo -83.28 136.18 7.63 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.584 2.189 . . . . 0.0 111.989 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . 0.554 ' O ' ' HG3' ' C' ' 15' ' ' GLU . . . 163.58 -127.53 1.69 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.472 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 147' ' ' ALA . . . . . 0.685 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -110.98 132.88 53.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.842 0.354 . . . . 0.0 111.354 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.25 43.74 2.92 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.148 0.499 . . . . 0.0 110.43 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 149' ' ' ASN . . . . . 0.506 ' HB2' ' CG ' ' D' ' 89' ' ' GLN . 9.2 m120 -92.34 144.25 25.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.499 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.6 178.93 9.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.975 178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 151' ' ' ASP . . . . . 0.624 ' OD1' ' HA ' ' C' ' 11' ' ' HIS . 15.6 t70 -147.03 145.02 29.55 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.226 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 152' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -133.76 139.71 46.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.198 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.99 135.26 42.73 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 154' ' ' PHE . . . . . 0.484 ' HB3' ' H ' ' C' ' 8' ' ' GLY . 0.2 OUTLIER -81.56 152.16 27.37 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.054 0.454 . . . . 0.0 110.136 -179.123 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -134.25 146.88 50.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.908 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.09 140.78 37.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.786 0.326 . . . . 0.0 111.626 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 157' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' C' ' 3' ' ' THR . 0.9 OUTLIER -134.54 132.65 39.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.297 0.57 . . . . 0.0 110.425 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . 0.542 ' CE1' ' HB2' ' D' ' 21' ' ' CYS . 11.0 m-85 -107.25 128.05 54.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.514 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.849 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.249 0.071 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' F' ' 158' ' ' TYR . . . 52.85 88.26 0.03 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.994 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 3' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' F' ' 157' ' ' GLN . 5.5 m -122.92 116.29 23.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.385 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -99.69 117.17 33.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.521 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -144.42 157.99 15.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.618 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 6' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' F' ' 154' ' ' PHE . 13.2 t30 -78.62 123.81 27.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.58 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.83 -71.15 1.01 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.827 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . 0.49 ' H ' ' HB3' ' F' ' 154' ' ' PHE . . . -152.7 -146.96 4.48 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.816 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 9' ' ' THR . . . . . . . . . . . . . 24.4 p -148.75 134.42 18.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.005 0.431 . . . . 0.0 111.268 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.33 124.38 72.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.169 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 11' ' ' HIS . . . . . 0.619 ' HA ' ' OD1' ' F' ' 151' ' ' ASP . 57.4 t-80 -91.56 116.2 28.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.306 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -96.78 105.47 17.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.753 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -104.58 118.69 37.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.512 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.27 172.89 30.79 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.924 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 15' ' ' GLU . . . . . 0.723 ' O ' ' HA ' ' F' ' 36' ' ' GLN . 25.8 tt0 -160.3 135.95 8.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.896 0.379 . . . . 0.0 110.384 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 16' ' ' VAL . . . . . 0.917 HG12 ' O ' ' F' ' 144' ' ' THR . 43.2 t -96.83 132.78 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.243 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . 0.747 HG12 ' HG2' ' F' ' 36' ' ' GLN . 18.2 m -133.91 -177.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.878 0.371 . . . . 0.0 111.007 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . 0.624 ' HA ' HG22 ' F' ' 39' ' ' THR . 0.3 OUTLIER -75.76 -170.28 1.28 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.894 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.73 45.35 0.98 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.078 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.736 ' HB3' ' HB2' ' E' ' 66' ' ' ALA . . . -121.24 -24.9 5.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.424 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 21' ' ' CYS . . . . . 0.918 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER -168.8 140.69 2.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.888 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 22' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' E' ' 60' ' ' ASP . . . -132.86 116.95 17.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.066 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 23' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' F' ' 36' ' ' GLN . 0.5 OUTLIER -67.03 146.26 13.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.101 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -80.37 152.08 29.08 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.547 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . 0.688 ' HB3' ' HA ' ' C' ' 91' ' ' SER . . . -62.77 -40.06 96.12 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.419 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.93 2.72 85.83 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.891 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -106.23 -19.86 13.57 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.823 0.344 . . . . 0.0 110.825 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 28' ' ' VAL . . . . . . . . . . . . . 39.7 t -47.4 -52.16 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.35 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.21 136.45 48.66 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.029 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.73 136.84 39.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.014 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.44 102.89 12.82 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.042 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.69 128.25 63.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.068 0.461 . . . . 0.0 110.547 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 33' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' D' ' 25' ' ' ALA . 10.7 mt-30 -114.64 123.02 48.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.693 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.45 -42.72 15.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.581 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.51 -167.45 13.18 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.587 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 36' ' ' GLN . . . . . 0.741 ' HG2' HG12 ' D' ' 17' ' ' VAL . 3.7 mt-30 -96.77 124.45 40.75 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.589 0.233 . . . . 0.0 110.927 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.77 147.52 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.848 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.68 134.93 34.34 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.698 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 39' ' ' THR . . . . . 0.627 HG22 ' HA ' ' D' ' 18' ' ' ASN . 0.0 OUTLIER -59.99 -44.48 94.49 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.815 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.25 -36.96 61.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.081 0.467 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.85 -35.83 62.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.165 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.756 HD22 ' HB3' ' E' ' 137' ' ' TYR . 3.0 mp -106.59 34.51 3.37 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.667 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 43' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' E' ' 39' ' ' THR . . . -103.92 15.84 27.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.375 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.99 132.07 56.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.283 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' E' ' 140' ' ' THR . 6.8 tt0 -56.5 108.69 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.766 0.317 . . . . 0.0 111.124 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.96 25.97 10.05 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.09 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.49 137.75 48.43 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 48' ' ' THR . . . . . 0.557 HG22 ' HE ' ' E' ' 136' ' ' ARG . 7.4 p -137.0 122.71 19.86 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.898 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' E' ' 136' ' ' ARG . 54.2 m -100.02 -175.25 2.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.659 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 50' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 2.8 t -55.63 137.28 49.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.787 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 51' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' E' ' 136' ' ' ARG . . . -92.28 133.56 35.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.344 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 52' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' B' ' 92' ' ' ALA . 26.2 m -76.78 162.48 4.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.52 141.17 16.78 Favored Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.538 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 54' ' ' PHE . . . . . 0.465 ' CE2' ' HB1' ' E' ' 135' ' ' ALA . 39.3 p90 -173.74 137.8 0.62 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.758 0.313 . . . . 0.0 110.941 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 55' ' ' ASN . . . . . 0.408 HD21 ' HG1' ' B' ' 76' ' ' THR . 18.0 p30 -136.44 145.83 45.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.692 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 56' ' ' ILE . . . . . 0.502 HG21 ' HB ' ' E' ' 131' ' ' ILE . 1.2 tp -91.04 116.8 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.617 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 57' ' ' GLN . . . . . 0.653 ' HA ' HG23 ' E' ' 130' ' ' THR . 1.3 mp0 -72.87 128.65 36.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.78 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . 0.438 ' HG ' ' HA ' ' E' ' 23' ' ' VAL . 0.3 OUTLIER -137.39 89.2 2.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.236 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . 0.68 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 9.8 p30 -74.9 176.51 7.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.985 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 60' ' ' ASP . . . . . 0.469 ' HB2' ' HB1' ' E' ' 22' ' ' ALA . 0.9 OUTLIER 58.98 74.85 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.775 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 61' ' ' CYS . . . . . 0.918 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 36.8 m -126.37 148.87 49.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -121.58 169.77 10.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.317 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.27 -32.69 4.89 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.55 -27.95 56.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.155 0.502 . . . . 0.0 111.685 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.58 -56.76 8.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.702 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . 0.736 ' HB2' ' HB3' ' E' ' 20' ' ' ALA . . . -134.94 122.75 22.35 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.672 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.62 -50.02 5.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.927 0.394 . . . . 0.0 110.932 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 68' ' ' LYS . . . . . 0.515 ' HA ' ' HZ2' ' E' ' 68' ' ' LYS . 1.8 tptp -89.75 152.09 21.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.567 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 69' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' E' ' 122' ' ' THR . . . -144.25 137.9 27.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.521 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.41 157.22 22.19 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.094 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . 0.471 HG11 HG21 ' E' ' 131' ' ' ILE . 1.8 t -138.75 150.06 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.649 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.87 155.03 37.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.57 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 73' ' ' PHE . . . . . 0.452 ' CB ' HD11 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -124.98 136.66 53.94 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.592 0.234 . . . . 0.0 111.071 179.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 74' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.9 OUTLIER -97.21 136.13 38.16 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.011 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' E' ' 113' ' ' LEU . . . -174.01 -172.94 39.72 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.735 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 76' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.2 OUTLIER -118.71 144.53 46.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.497 0.189 . . . . 0.0 110.826 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 77' ' ' ALA . . . . . 0.545 ' HB1' ' HA ' ' E' ' 83' ' ' THR . . . -62.42 138.51 58.47 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.963 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 78' ' ' ILE . . . . . 0.55 HG23 ' N ' ' E' ' 79' ' ' ASP . 5.7 tt -71.6 -45.59 66.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.843 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 79' ' ' ASP . . . . . 0.55 ' N ' HG23 ' E' ' 78' ' ' ILE . 0.3 OUTLIER -133.11 42.49 3.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.833 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' E' ' 79' ' ' ASP . . . 70.09 -80.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.002 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.15 -29.64 68.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.584 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 82' ' ' HIS . . . . . 0.402 ' HB3' HG22 ' E' ' 78' ' ' ILE . 1.7 m80 -89.9 69.45 7.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.874 0.369 . . . . 0.0 110.414 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 83' ' ' THR . . . . . 0.545 ' HA ' ' HB1' ' E' ' 77' ' ' ALA . 0.2 OUTLIER -74.55 -16.16 60.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.585 -179.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 84' ' ' ASN . . . . . 0.714 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 20.7 p-10 -66.2 -19.09 65.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.292 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.472 ' HB ' ' CG2' ' E' ' 78' ' ' ILE . 13.4 t -113.56 133.81 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.188 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 86' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' E' ' 76' ' ' THR . 0.4 OUTLIER -67.81 161.6 25.85 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 87' ' ' ALA . . . . . 0.464 ' H ' HD23 ' E' ' 86' ' ' LEU . . . -103.63 -174.75 2.62 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.936 0.398 . . . . 0.0 111.727 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.649 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 0.3 OUTLIER -67.37 165.18 16.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.082 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 89' ' ' GLN . . . . . 0.49 ' CG ' ' HB2' ' E' ' 149' ' ' ASN . 5.7 mm-40 -63.41 -79.7 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.376 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -165.49 3.7 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.019 0.437 . . . . 0.0 111.538 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.04 79.77 6.54 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.923 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.14 -24.69 55.98 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.853 0.359 . . . . 0.0 111.573 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.22 34.0 5.23 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.689 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.88 0.47 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.952 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 95' ' ' SER . . . . . 0.688 ' HA ' ' HB3' ' E' ' 147' ' ' ALA . 38.4 m -96.84 177.94 5.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.915 0.388 . . . . 0.0 110.598 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.46 -178.72 7.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.797 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 97' ' ' THR . . . . . 0.494 ' HB ' ' OG1' ' E' ' 144' ' ' THR . 2.0 m -134.44 119.06 18.09 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.373 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 98' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' E' ' 97' ' ' THR . 32.8 m-20 68.76 34.4 3.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.471 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 99' ' ' VAL . . . . . 0.462 HG12 HG21 ' D' ' 16' ' ' VAL . 0.4 OUTLIER -138.06 130.85 40.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.796 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.08 -170.57 18.85 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.538 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.7 114.47 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.028 0.531 . . . . 0.0 111.749 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 102' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 0.8 OUTLIER -87.37 150.24 23.95 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.877 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 103' ' ' ILE . . . . . 0.573 HG12 ' HG ' ' E' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 136.01 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.417 179.496 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.31 133.52 55.08 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.7 0.286 . . . . 0.0 111.073 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . 0.733 ' HB3' HG23 ' E' ' 107' ' ' THR . 6.1 t0 -82.27 149.76 27.65 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.655 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 106' ' ' ARG . . . . . 0.751 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.4 OUTLIER -67.88 -16.2 63.97 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.762 0.315 . . . . 0.0 111.065 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 107' ' ' THR . . . . . 0.733 HG23 ' HB3' ' E' ' 105' ' ' ASP . 8.9 t -63.72 -28.35 69.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.003 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 108' ' ' GLY . . . . . 0.425 ' N ' HG22 ' E' ' 107' ' ' THR . . . 134.0 -40.54 1.57 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.684 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.42 163.04 14.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 0.0 111.039 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.09 133.36 35.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.229 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.559 HD23 ' O ' ' E' ' 117' ' ' THR . 4.8 tp -96.72 150.03 21.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.383 0.611 . . . . 0.0 110.5 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 112' ' ' THR . . . . . 0.714 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 1.9 t -98.42 141.7 30.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.183 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 113' ' ' LEU . . . . . 0.573 ' HG ' HG12 ' E' ' 103' ' ' ILE . 1.6 mt -76.33 89.36 3.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.758 0.313 . . . . 0.0 110.758 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.0 -18.21 5.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.652 0.263 . . . . 0.0 111.52 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.78 -60.65 0.46 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.681 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 116' ' ' ALA . . . . . 0.451 ' HA ' ' CE2' ' E' ' 118' ' ' PHE . . . -96.48 27.04 4.01 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.028 0.442 . . . . 0.0 111.641 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 117' ' ' THR . . . . . 0.559 ' O ' HD23 ' E' ' 111' ' ' LEU . 0.0 OUTLIER -87.11 74.86 9.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.13 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . 0.451 ' CE2' ' HA ' ' E' ' 116' ' ' ALA . 62.8 m-85 -94.87 92.89 7.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.823 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 25.7 m -136.32 68.85 1.43 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.829 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.84 150.31 28.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.579 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.39 67.73 0.7 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.083 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 122' ' ' THR . . . . . 0.555 ' O ' ' HB3' ' E' ' 69' ' ' ALA . 0.2 OUTLIER -79.19 114.74 18.37 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.704 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -74.02 127.98 34.31 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.676 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . 0.581 HD22 ' O ' ' E' ' 66' ' ' ALA . 4.0 tp -92.04 132.17 36.76 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.651 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.13 151.1 49.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.608 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . 0.443 ' HA ' ' O ' ' E' ' 61' ' ' CYS . 3.1 t30 -69.1 112.08 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.668 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . 0.515 ' CA ' HG21 ' A' ' 4' ' ' THR . . . 142.56 -138.85 8.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.724 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 128' ' ' THR . . . . . 0.68 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 87.4 m -98.85 82.49 2.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.676 0.274 . . . . 0.0 110.84 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 129' ' ' ASN . . . . . 0.475 ' HA ' ' HB1' ' B' ' 116' ' ' ALA . 2.3 t30 -71.82 148.18 46.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.938 0.399 . . . . 0.0 111.07 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 130' ' ' THR . . . . . 0.653 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.2 OUTLIER -138.63 148.6 44.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.138 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 131' ' ' ILE . . . . . 0.502 ' HB ' HG21 ' E' ' 56' ' ' ILE . 15.6 mt -109.96 112.2 58.04 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 132' ' ' PRO . . . . . 0.751 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.5 Cg_endo -81.77 137.01 9.78 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.671 1.581 . . . . 0.0 112.585 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.06 135.98 19.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.782 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -111.44 158.36 19.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.076 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' E' ' 102' ' ' GLN . . . -154.16 111.36 3.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.979 0.419 . . . . 0.0 111.616 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 136' ' ' ARG . . . . . 0.557 ' HE ' HG22 ' E' ' 48' ' ' THR . 19.8 ptt180 -108.91 174.1 6.02 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.375 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 137' ' ' TYR . . . . . 0.756 ' HB3' HD22 ' E' ' 42' ' ' LEU . 1.7 m-85 -81.41 137.68 35.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.067 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -131.52 124.14 29.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.14 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 139' ' ' ALA . . . . . 0.68 ' HB3' ' HG ' ' E' ' 42' ' ' LEU . . . -108.49 130.23 55.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.815 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 140' ' ' THR . . . . . 0.505 ' O ' ' HG3' ' E' ' 45' ' ' GLU . 0.2 OUTLIER -77.47 -27.96 52.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.537 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.46 -96.46 0.11 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.971 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.02 98.46 8.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.606 0.203 . . . . 0.0 110.623 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 143' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' E' ' 42' ' ' LEU . . . -56.59 148.86 18.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 111.373 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 144' ' ' THR . . . . . 0.911 ' O ' HG12 ' D' ' 16' ' ' VAL . 93.2 m -125.35 156.93 69.4 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.316 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 145' ' ' PRO . . . . . 0.728 ' CD ' ' CG2' ' E' ' 144' ' ' THR . 1.4 Cg_endo -83.34 136.27 7.61 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.507 2.138 . . . . 0.0 111.993 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 146' ' ' GLY . . . . . 0.559 ' O ' ' HG3' ' D' ' 15' ' ' GLU . . . 163.56 -127.57 1.7 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.434 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 147' ' ' ALA . . . . . 0.688 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -110.94 132.94 53.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.921 0.391 . . . . 0.0 111.291 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.29 43.71 2.93 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.421 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 149' ' ' ASN . . . . . 0.49 ' HB2' ' CG ' ' E' ' 89' ' ' GLN . 9.2 m120 -92.32 144.25 25.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.535 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.58 178.94 9.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.939 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 151' ' ' ASP . . . . . 0.611 ' OD1' ' HA ' ' D' ' 11' ' ' HIS . 15.7 t70 -147.05 145.01 29.52 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.201 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 152' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -133.76 139.8 46.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.196 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.14 135.25 42.91 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 154' ' ' PHE . . . . . 0.49 ' HB3' ' H ' ' D' ' 8' ' ' GLY . 0.2 OUTLIER -81.51 152.1 27.47 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.094 0.473 . . . . 0.0 110.148 -179.086 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -134.2 146.84 50.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.947 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.11 140.8 37.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.765 0.317 . . . . 0.0 111.64 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 157' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' D' ' 3' ' ' THR . 0.9 OUTLIER -134.55 132.63 39.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.291 0.567 . . . . 0.0 110.434 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' E' ' 21' ' ' CYS . 11.0 m-85 -107.23 128.05 54.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.58 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.839 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.26 0.076 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.67 88.39 0.03 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.051 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 5.5 m -122.95 116.28 23.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.358 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -99.69 117.29 33.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.51 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -144.49 158.03 14.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.596 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -78.73 123.71 27.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.586 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.67 -71.21 1.0 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.855 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.68 -146.93 4.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.825 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 24.5 p -148.77 134.4 18.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.998 0.428 . . . . 0.0 111.278 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.36 124.37 72.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.185 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -91.55 116.27 28.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.282 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -96.92 105.54 17.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.726 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -104.65 118.74 37.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.437 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.29 172.88 30.8 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.975 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -160.32 135.98 8.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.961 0.41 . . . . 0.0 110.405 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 43.4 t -96.86 132.79 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.281 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 17' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.89 -177.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.802 0.334 . . . . 0.0 111.019 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -75.72 -170.31 1.27 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.017 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.76 45.43 0.98 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.065 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . 0.734 ' HB3' ' HB2' ' F' ' 66' ' ' ALA . . . -121.29 -24.84 5.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.401 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 21' ' ' CYS . . . . . 0.904 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER -168.86 140.7 2.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.816 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 22' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' F' ' 60' ' ' ASP . . . -132.9 116.91 17.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.05 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 23' ' ' VAL . . . . . 0.43 ' HA ' ' HG ' ' F' ' 58' ' ' LEU . 0.5 OUTLIER -67.06 146.24 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.108 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -80.45 152.06 28.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.542 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . 0.688 ' HB3' ' HA ' ' D' ' 91' ' ' SER . . . -62.71 -40.05 95.94 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.445 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.87 2.64 85.87 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.872 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 23.0 t -106.19 -19.95 13.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.849 0.357 . . . . 0.0 110.867 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 39.9 t -47.31 -52.2 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.354 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.15 136.42 48.67 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.045 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.69 136.86 39.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.004 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.56 102.85 12.74 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.07 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.64 128.27 62.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.052 0.453 . . . . 0.0 110.51 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 33' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' E' ' 25' ' ' ALA . 10.6 mt-30 -114.75 123.09 48.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.677 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.47 -42.68 15.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.604 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.42 -167.44 13.21 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.604 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 36' ' ' GLN . . . . . 0.747 ' HG2' HG12 ' E' ' 17' ' ' VAL . 3.7 mt-30 -96.77 124.41 40.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.615 0.245 . . . . 0.0 110.885 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.72 147.54 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.895 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.64 134.94 34.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.682 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 39' ' ' THR . . . . . 0.624 HG22 ' HA ' ' E' ' 18' ' ' ASN . 0.0 OUTLIER -60.06 -44.45 94.71 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.797 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.23 -36.94 61.58 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.101 0.477 . . . . 0.0 110.91 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.79 -35.91 62.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.185 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . 0.738 HD22 ' HB3' ' F' ' 137' ' ' TYR . 2.9 mp -106.63 34.53 3.36 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.602 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 43' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' F' ' 39' ' ' THR . . . -103.87 15.8 27.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.307 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.94 132.05 56.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.337 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' F' ' 140' ' ' THR . 6.8 tt0 -56.53 108.74 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 111.172 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.93 25.93 10.11 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.16 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.5 137.73 48.39 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 48' ' ' THR . . . . . 0.537 HG22 ' HE ' ' F' ' 136' ' ' ARG . 7.3 p -136.96 122.76 19.97 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.881 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 49' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' F' ' 136' ' ' ARG . 53.4 m -100.05 -175.23 2.89 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.61 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 50' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' C' ' 92' ' ' ALA . 2.8 t -55.62 137.3 49.38 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.819 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 51' ' ' ALA . . . . . 0.469 ' CA ' ' HB3' ' F' ' 136' ' ' ARG . . . -92.35 133.45 35.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.331 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 52' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' C' ' 92' ' ' ALA . 26.2 m -76.68 162.51 4.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.54 141.17 16.77 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.605 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 54' ' ' PHE . . . . . 0.467 ' HE2' ' HB1' ' F' ' 135' ' ' ALA . 39.3 p90 -173.76 137.81 0.62 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.796 0.331 . . . . 0.0 110.985 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -136.56 145.88 45.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.604 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 56' ' ' ILE . . . . . 0.502 HG21 ' HB ' ' F' ' 131' ' ' ILE . 1.2 tp -91.1 116.79 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.643 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 57' ' ' GLN . . . . . 0.642 ' HA ' HG23 ' F' ' 130' ' ' THR . 1.3 mp0 -72.86 128.55 35.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.812 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . 0.43 ' HG ' ' HA ' ' F' ' 23' ' ' VAL . 0.3 OUTLIER -137.34 89.14 2.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.275 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 59' ' ' ASN . . . . . 0.712 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 9.8 p30 -74.75 176.46 7.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.956 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 60' ' ' ASP . . . . . 0.475 ' HB2' ' HB1' ' F' ' 22' ' ' ALA . 0.8 OUTLIER 58.98 74.77 0.43 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.834 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 61' ' ' CYS . . . . . 0.904 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 36.8 m -126.34 148.91 49.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.8 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -121.62 169.74 10.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.285 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.32 -32.6 4.91 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.58 -27.92 56.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.266 0.555 . . . . 0.0 111.752 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.54 -56.81 8.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.715 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 66' ' ' ALA . . . . . 0.734 ' HB2' ' HB3' ' F' ' 20' ' ' ALA . . . -134.93 122.77 22.39 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.693 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.55 -50.11 5.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.932 0.396 . . . . 0.0 110.931 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 68' ' ' LYS . . . . . 0.497 ' HA ' ' HZ2' ' F' ' 68' ' ' LYS . 1.8 tptp -89.76 152.12 21.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.556 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 69' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' F' ' 122' ' ' THR . . . -144.25 137.8 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.559 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.38 157.26 22.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.087 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 71' ' ' VAL . . . . . 0.487 HG11 HG21 ' F' ' 131' ' ' ILE . 1.8 t -138.75 150.06 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.638 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.87 155.05 37.35 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.593 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 73' ' ' PHE . . . . . 0.468 ' CB ' HD11 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -125.02 136.62 53.88 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.549 0.214 . . . . 0.0 111.056 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 74' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.9 OUTLIER -97.17 136.11 38.16 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.019 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' F' ' 113' ' ' LEU . . . -174.0 -172.94 39.72 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.761 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 76' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.2 OUTLIER -118.73 144.53 46.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.553 0.216 . . . . 0.0 110.785 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 77' ' ' ALA . . . . . 0.542 ' HB1' ' HA ' ' F' ' 83' ' ' THR . . . -62.46 138.59 58.49 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.94 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 78' ' ' ILE . . . . . 0.542 HG23 ' N ' ' F' ' 79' ' ' ASP . 5.7 tt -71.66 -45.56 66.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.85 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 79' ' ' ASP . . . . . 0.542 ' N ' HG23 ' F' ' 78' ' ' ILE . 0.3 OUTLIER -133.11 42.45 3.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.793 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 80' ' ' ALA . . . . . 0.478 ' HB1' ' O ' ' F' ' 79' ' ' ASP . . . 70.16 -80.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.06 -29.68 68.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.64 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 82' ' ' HIS . . . . . 0.412 ' HB3' HG22 ' F' ' 78' ' ' ILE . 1.7 m80 -89.87 69.38 7.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.813 0.34 . . . . 0.0 110.426 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 83' ' ' THR . . . . . 0.542 ' HA ' ' HB1' ' F' ' 77' ' ' ALA . 0.2 OUTLIER -74.53 -16.12 60.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.631 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 84' ' ' ASN . . . . . 0.726 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 20.7 p-10 -66.25 -19.05 65.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.285 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 85' ' ' VAL . . . . . 0.47 HG23 ' HB2' ' F' ' 102' ' ' GLN . 13.4 t -113.6 133.8 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.202 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 86' ' ' LEU . . . . . 0.588 ' HA ' ' O ' ' F' ' 76' ' ' THR . 0.4 OUTLIER -67.73 161.54 25.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 87' ' ' ALA . . . . . 0.462 ' H ' HD23 ' F' ' 86' ' ' LEU . . . -103.66 -174.71 2.61 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.84 0.352 . . . . 0.0 111.756 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . 0.644 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 0.3 OUTLIER -67.36 165.22 16.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.069 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 89' ' ' GLN . . . . . 0.499 ' CG ' ' HB2' ' F' ' 149' ' ' ASN . 5.6 mm-40 -63.54 -79.67 0.03 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.302 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -165.48 3.73 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.003 0.43 . . . . 0.0 111.487 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.08 79.75 6.59 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.17 -24.63 55.69 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.849 0.357 . . . . 0.0 111.608 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.2 33.99 5.24 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.653 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.85 0.44 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.958 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 95' ' ' SER . . . . . 0.675 ' HA ' ' HB3' ' F' ' 147' ' ' ALA . 38.4 m -96.73 177.95 5.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.86 0.362 . . . . 0.0 110.612 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.46 -178.65 7.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 97' ' ' THR . . . . . 0.493 ' HB ' ' OG1' ' F' ' 144' ' ' THR . 2.0 m -134.55 119.04 17.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.341 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 98' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' F' ' 97' ' ' THR . 32.6 m-20 68.75 34.48 3.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.433 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 99' ' ' VAL . . . . . 0.469 HG12 HG21 ' E' ' 16' ' ' VAL . 0.4 OUTLIER -138.08 130.88 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.765 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.21 -170.6 18.97 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.537 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.64 114.44 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.008 0.523 . . . . 0.0 111.737 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 102' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 0.8 OUTLIER -87.35 150.24 23.97 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 103' ' ' ILE . . . . . 0.572 HG12 ' HG ' ' F' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 136.01 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.474 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.39 133.56 55.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.705 0.288 . . . . 0.0 111.028 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . 0.733 ' HB3' HG23 ' F' ' 107' ' ' THR . 6.1 t0 -82.23 149.72 27.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.749 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 106' ' ' ARG . . . . . 0.76 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.4 OUTLIER -67.87 -16.24 64.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.798 0.332 . . . . 0.0 111.098 179.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 107' ' ' THR . . . . . 0.733 HG23 ' HB3' ' F' ' 105' ' ' ASP . 8.8 t -63.59 -28.46 69.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.979 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 108' ' ' GLY . . . . . 0.421 ' N ' HG22 ' F' ' 107' ' ' THR . . . 134.04 -40.55 1.57 Allowed Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.616 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.43 163.04 14.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.811 0.339 . . . . 0.0 111.038 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.18 133.4 35.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . 0.56 HD23 ' O ' ' F' ' 117' ' ' THR . 4.8 tp -96.66 149.94 21.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.386 0.612 . . . . 0.0 110.558 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 112' ' ' THR . . . . . 0.726 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 1.9 t -98.48 141.7 31.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.085 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 113' ' ' LEU . . . . . 0.572 ' HG ' HG12 ' F' ' 103' ' ' ILE . 1.6 mt -76.33 89.47 3.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.744 0.307 . . . . 0.0 110.761 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.09 -18.22 5.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.67 0.271 . . . . 0.0 111.52 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.86 -60.68 0.45 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.529 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 116' ' ' ALA . . . . . 0.449 ' HA ' ' CE2' ' F' ' 118' ' ' PHE . . . -96.44 26.97 4.03 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.041 0.448 . . . . 0.0 111.683 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 117' ' ' THR . . . . . 0.56 ' O ' HD23 ' F' ' 111' ' ' LEU . 0.0 OUTLIER -87.01 74.85 9.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.155 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . 0.449 ' CE2' ' HA ' ' F' ' 116' ' ' ALA . 63.3 m-85 -94.97 92.96 7.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.768 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 25.6 m -136.35 68.9 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.796 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.81 150.29 28.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.629 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.34 67.6 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.136 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 122' ' ' THR . . . . . 0.549 ' O ' ' HB3' ' F' ' 69' ' ' ALA . 0.2 OUTLIER -79.15 114.66 18.27 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.69 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 12.1 m -73.95 127.97 34.29 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.742 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . 0.593 HD22 ' O ' ' F' ' 66' ' ' ALA . 4.0 tp -92.11 132.21 36.77 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.602 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.1 151.07 49.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.63 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' F' ' 61' ' ' CYS . 3.1 t30 -69.1 112.05 5.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 110.646 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . 0.503 ' CA ' HG21 ' B' ' 4' ' ' THR . . . 142.51 -138.9 8.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.687 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 128' ' ' THR . . . . . 0.712 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 87.7 m -98.76 82.59 2.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.664 0.269 . . . . 0.0 110.792 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 129' ' ' ASN . . . . . 0.471 ' HA ' ' HB1' ' C' ' 116' ' ' ALA . 2.3 t30 -71.85 148.19 46.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.893 0.377 . . . . 0.0 111.094 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 130' ' ' THR . . . . . 0.642 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.2 OUTLIER -138.63 148.66 44.34 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.154 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 131' ' ' ILE . . . . . 0.502 ' HB ' HG21 ' F' ' 56' ' ' ILE . 15.6 mt -110.05 112.17 57.86 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 132' ' ' PRO . . . . . 0.76 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.6 Cg_endo -81.78 136.98 9.75 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.612 1.541 . . . . 0.0 112.587 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.0 136.1 19.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.773 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -111.42 158.45 19.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.037 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' F' ' 102' ' ' GLN . . . -154.2 111.35 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.924 0.392 . . . . 0.0 111.674 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 136' ' ' ARG . . . . . 0.537 ' HE ' HG22 ' F' ' 48' ' ' THR . 19.8 ptt180 -108.86 174.0 6.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.382 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 137' ' ' TYR . . . . . 0.738 ' HB3' HD22 ' F' ' 42' ' ' LEU . 1.7 m-85 -81.37 137.62 35.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.122 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 138' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -131.51 124.16 29.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.096 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 139' ' ' ALA . . . . . 0.666 ' HB3' ' HG ' ' F' ' 42' ' ' LEU . . . -108.52 130.15 55.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.868 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 140' ' ' THR . . . . . 0.513 HG22 ' HB2' ' F' ' 79' ' ' ASP . 0.2 OUTLIER -77.37 -28.01 52.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.557 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.46 -96.41 0.11 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.005 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.01 98.51 8.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.583 0.23 . . . . 0.0 110.648 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 143' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' F' ' 42' ' ' LEU . . . -56.66 148.92 18.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.674 0.274 . . . . 0.0 111.377 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 144' ' ' THR . . . . . 0.917 ' O ' HG12 ' E' ' 16' ' ' VAL . 90.3 m -125.48 157.0 69.61 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.213 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 145' ' ' PRO . . . . . 0.728 ' CD ' ' CG2' ' F' ' 144' ' ' THR . 1.4 Cg_endo -83.36 136.22 7.56 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.552 2.168 . . . . 0.0 111.978 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 146' ' ' GLY . . . . . 0.564 ' O ' ' HG3' ' E' ' 15' ' ' GLU . . . 163.61 -127.56 1.69 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.457 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 147' ' ' ALA . . . . . 0.675 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -110.85 132.92 53.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.864 0.364 . . . . 0.0 111.414 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.25 43.65 2.94 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.126 0.489 . . . . 0.0 110.459 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 149' ' ' ASN . . . . . 0.499 ' HB2' ' CG ' ' F' ' 89' ' ' GLN . 9.3 m120 -92.34 144.28 25.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.54 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 150' ' ' ALA . . . . . . . . . . . . . . . -160.6 178.9 9.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.995 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 151' ' ' ASP . . . . . 0.619 ' OD1' ' HA ' ' E' ' 11' ' ' HIS . 15.7 t70 -147.02 144.97 29.54 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.215 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 152' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -133.73 139.76 46.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.114 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.07 135.26 42.81 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 154' ' ' PHE . . . . . 0.49 ' HB3' ' H ' ' E' ' 8' ' ' GLY . 0.2 OUTLIER -81.58 152.13 27.36 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.013 0.435 . . . . 0.0 110.152 -179.052 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -134.22 146.86 50.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.897 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 156' ' ' VAL . . . . . . . . . . . . . 33.0 m -139.14 140.76 37.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.853 0.359 . . . . 0.0 111.632 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 157' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' E' ' 3' ' ' THR . 0.9 OUTLIER -134.5 132.74 39.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.266 0.555 . . . . 0.0 110.42 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . 0.541 ' CE1' ' HB2' ' F' ' 21' ' ' CYS . 10.9 m-85 -107.31 128.1 54.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.493 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.886 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 120.168 0.032 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.65 77.1 0.19 Allowed 'General case' 0 N--CA 1.462 0.17 0 O-C-N 123.132 0.27 . . . . 0.0 110.976 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.8 m -117.36 119.27 34.6 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.397 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.674 HG22 ' HG3' ' B' ' 157' ' ' GLN . 4.0 m -98.41 127.22 44.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.515 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.14 171.02 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.6 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.04 114.69 23.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.601 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.511 ' HA3' HG11 ' B' ' 156' ' ' VAL . . . -69.65 -57.77 6.98 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.791 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.52 -144.6 4.08 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.9 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -155.69 140.51 17.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.818 0.342 . . . . 0.0 111.4 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.484 HG13 HG21 ' B' ' 32' ' ' VAL . 29.9 t -130.38 117.55 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.26 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.55 117.05 29.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.336 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -89.96 107.12 18.92 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.8 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.76 113.28 26.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.45 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.421 ' HA3' ' OH ' ' B' ' 137' ' ' TYR . . . -144.43 166.99 27.12 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.889 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.675 ' CG ' ' O ' ' B' ' 146' ' ' GLY . 30.2 tt0 -155.66 135.23 12.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.053 0.454 . . . . 0.0 110.286 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.938 HG12 ' O ' ' B' ' 144' ' ' THR . 66.4 t -96.59 138.38 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.293 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.559 HG21 HE21 ' B' ' 36' ' ' GLN . 2.6 m -140.85 -173.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.832 0.349 . . . . 0.0 110.977 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.467 ' HA ' HG22 ' B' ' 39' ' ' THR . 1.0 OUTLIER -80.15 173.46 12.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.034 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HA ' ' HB3' ' B' ' 38' ' ' ARG . . . -85.86 39.83 0.82 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.042 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . . . -114.36 -33.57 5.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.349 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.892 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.9 OUTLIER -161.16 149.97 16.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.953 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.64 112.08 4.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.07 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.647 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 3.1 p -59.9 153.42 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.065 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.76 152.76 28.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.674 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.52 80.83 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.349 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.81 15.75 61.93 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.939 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -113.06 -21.32 11.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.909 0.385 . . . . 0.0 110.815 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -44.61 -64.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.364 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.28 135.61 38.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.925 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.02 128.73 19.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.79 111.8 23.83 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.012 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.2 t -110.82 114.77 48.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.141 0.496 . . . . 0.0 110.494 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.68 124.51 46.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.649 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.602 HD21 HG21 ' A' ' 101' ' ' VAL . 0.9 OUTLIER -82.49 -45.73 14.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.619 179.428 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.37 -161.91 12.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.534 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -99.77 129.7 45.91 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.649 0.261 . . . . 0.0 110.828 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p -110.05 147.47 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.948 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 41' ' ' SER . 0.7 OUTLIER -86.76 131.24 34.19 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.94 0.4 . . . . 0.0 111.766 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 143' ' ' ALA . 4.8 t -54.1 -45.1 71.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.757 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.31 89.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.069 0.461 . . . . 0.0 110.875 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' A' ' 38' ' ' ARG . 0.4 OUTLIER -70.55 -23.19 62.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.19 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.674 HD22 ' HB3' ' A' ' 137' ' ' TYR . 1.4 mp -124.63 51.62 1.6 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.586 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.59 29.95 7.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.418 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.84 128.36 48.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.41 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 140' ' ' THR . 29.4 tt0 -52.88 102.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 111.097 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.405 ' HA2' ' HE1' ' A' ' 138' ' ' PHE . . . 96.05 39.01 4.42 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.126 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.1 146.72 31.74 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.62 125.01 19.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.95 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 32.4 m -101.91 -166.35 1.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.644 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.01 133.02 55.7 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.845 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' A' ' 136' ' ' ARG . . . -92.66 120.13 32.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.26 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 135' ' ' ALA . 18.3 m -65.71 162.59 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.946 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.85 124.11 5.27 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.592 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.591 ' HE2' ' HB1' ' A' ' 135' ' ' ALA . 54.0 p90 -155.9 146.56 21.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.684 0.278 . . . . 0.0 110.948 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.699 ' HB2' HG21 ' A' ' 130' ' ' THR . 3.4 p30 -136.83 160.19 39.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.576 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 56' ' ' ILE . 1.6 tp -100.56 116.93 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.562 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.535 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -70.07 124.56 24.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.766 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.672 HD23 ' HB3' ' A' ' 21' ' ' CYS . 1.6 mp -133.72 87.44 2.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.23 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 4.9 p30 -73.61 174.54 8.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.949 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.82 79.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.818 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.892 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 93.6 m -127.59 159.37 34.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.428 ' O ' ' HG ' ' A' ' 124' ' ' LEU . 5.6 t70 -130.23 167.12 18.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.238 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.32 -41.7 3.44 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.51 -22.61 65.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.047 0.451 . . . . 0.0 111.735 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.3 t -70.43 -74.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.601 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . . . -120.75 131.36 54.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.571 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -48.58 6.13 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.863 0.363 . . . . 0.0 110.997 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.6 ' HE3' ' HB3' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -96.18 161.58 13.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.556 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.17 124.58 6.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.606 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.35 154.98 18.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.094 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.575 HG13 HD11 ' A' ' 131' ' ' ILE . 2.3 t -132.76 148.31 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.696 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.64 150.12 35.76 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.599 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.543 ' CB ' HD11 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -119.92 137.02 54.29 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.568 0.223 . . . . 0.0 111.022 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.522 HD11 ' CE ' ' A' ' 155' ' ' LYS . 0.9 OUTLIER -96.0 139.46 32.16 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.966 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 113' ' ' LEU . . . 178.5 179.84 48.48 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.733 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.546 ' H ' HD21 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -111.0 156.38 21.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.559 0.218 . . . . 0.0 110.807 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -73.78 131.34 41.46 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.338 -0.392 . . . . 0.0 112.02 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.636 ' CG2' ' HB ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -67.79 -41.36 85.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.808 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.14 40.79 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.791 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.547 ' HB2' ' HA2' ' D' ' 108' ' ' GLY . . . 66.4 -80.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.83 -24.94 43.2 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.663 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.07 64.03 1.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.957 0.408 . . . . 0.0 110.45 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.671 HG23 ' HD2' ' D' ' 106' ' ' ARG . 0.2 OUTLIER -68.5 -16.84 64.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.576 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.679 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 18.0 p-10 -70.46 -20.21 62.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.317 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.636 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 14.7 t -106.86 130.76 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.117 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.546 HD21 ' H ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -67.61 148.22 51.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.387 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.63 -167.52 1.88 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.842 0.353 . . . . 0.0 111.743 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.624 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 1.5 mm? -78.3 157.27 29.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.04 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.66 -78.37 0.02 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.354 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.564 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 0.4 OUTLIER -167.13 0.54 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.032 0.444 . . . . 0.0 111.425 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.599 ' HA ' ' HB3' ' C' ' 25' ' ' ALA . 1.7 m -71.89 83.02 0.92 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.679 ' HB1' ' HB3' ' D' ' 34' ' ' LEU . . . -66.75 -13.9 61.94 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.827 0.346 . . . . 0.0 111.643 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.71 27.61 5.21 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.609 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.556 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -166.74 15.76 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.903 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.624 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . 3.0 m -100.86 -172.78 2.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.833 0.349 . . . . 0.0 110.613 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.9 167.63 9.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.494 ' H ' ' HB ' ' A' ' 144' ' ' THR . 2.3 m -121.59 128.41 51.93 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.314 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' A' ' 141' ' ' GLY . 75.8 m-20 64.22 34.57 10.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.371 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.458 ' C ' HD11 ' A' ' 78' ' ' ILE . 0.5 OUTLIER -139.96 136.44 38.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.704 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.12 -156.83 8.33 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.546 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.602 HG21 HD21 ' A' ' 34' ' ' LEU . 3.2 p -137.82 116.72 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 122.942 0.497 . . . . 0.0 111.605 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 1.1 tt0 -91.91 150.39 21.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.841 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.543 HD11 ' CB ' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -113.86 131.3 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.531 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -106.2 130.15 54.12 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.646 0.26 . . . . 0.0 111.041 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.542 ' HB3' HG23 ' A' ' 107' ' ' THR . 5.1 t0 -76.08 156.99 33.39 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.661 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.752 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 3.5 ttp180 -71.29 -17.51 62.46 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.731 0.3 . . . . 0.0 111.03 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.542 HG23 ' HB3' ' A' ' 105' ' ' ASP . 6.2 t -67.29 -17.91 64.97 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.028 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.68 -45.61 1.17 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.78 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.1 163.11 23.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.737 0.303 . . . . 0.0 111.114 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -84.16 127.38 33.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.104 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.569 HD21 ' HZ ' ' A' ' 133' ' ' PHE . 12.1 tp -86.28 156.07 20.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.306 0.574 . . . . 0.0 110.6 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -106.17 139.09 41.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.179 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.432 ' HG ' HG12 ' A' ' 103' ' ' ILE . 1.0 OUTLIER -73.89 76.4 1.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.691 0.281 . . . . 0.0 110.789 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.42 -17.17 14.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.625 0.25 . . . . 0.0 111.561 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.31 -51.77 1.24 Allowed Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.615 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.01 18.88 21.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.832 0.349 . . . . 0.0 111.544 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.81 84.68 7.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 95.7 m-85 -101.42 98.74 9.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.785 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.7 m -130.82 62.35 1.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.825 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.27 145.88 30.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.687 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.6 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . 3.5 mm-40 -121.43 71.32 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.177 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.73 134.78 34.73 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.715 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.2 m -83.83 113.69 21.11 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.683 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.65 HD13 ' SG ' ' A' ' 21' ' ' CYS . 18.9 tp -73.99 142.97 45.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.651 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.67 162.13 35.42 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.557 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.66 113.1 12.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.717 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.51 -139.95 9.53 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.752 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 6.7 m -101.64 96.76 7.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.726 0.298 . . . . 0.0 110.804 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -83.58 148.58 27.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.92 0.391 . . . . 0.0 111.086 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.699 HG21 ' HB2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -138.64 143.43 39.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.09 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.575 HD11 HG13 ' A' ' 71' ' ' VAL . 55.1 mt -104.63 112.39 65.33 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.752 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.6 Cg_endo -81.87 141.89 12.27 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.825 1.683 . . . . 0.0 112.522 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.569 ' HZ ' HD21 ' A' ' 111' ' ' LEU . 0.3 OUTLIER -150.58 141.09 22.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.847 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.46 152.64 22.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.079 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.591 ' HB1' ' HE2' ' A' ' 54' ' ' PHE . . . -153.54 100.99 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 111.567 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.558 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 17.4 ptt180 -107.15 177.27 4.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.385 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.674 ' HB3' HD22 ' A' ' 42' ' ' LEU . 4.7 m-85 -85.96 124.15 32.09 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.011 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.494 ' HB3' HG11 ' A' ' 85' ' ' VAL . 1.2 t80 -118.93 112.38 19.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.024 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.67 ' HB3' HD21 ' A' ' 42' ' ' LEU . . . -102.96 133.91 47.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.867 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.608 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -81.1 -28.82 35.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.531 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' A' ' 98' ' ' ASN . . . -160.18 -111.04 0.28 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.961 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.87 110.56 21.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.607 0.203 . . . . 0.0 110.77 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.471 ' O ' ' OG1' ' A' ' 39' ' ' THR . . . -65.63 134.21 52.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.763 0.316 . . . . 0.0 111.376 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.494 ' HB ' ' H ' ' A' ' 97' ' ' THR . 57.2 m -105.78 149.4 37.93 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.31 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.488 ' CD ' ' CG2' ' A' ' 144' ' ' THR . 1.4 Cg_endo -82.93 125.49 4.17 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.53 2.153 . . . . 0.0 112.057 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.8 -126.37 1.38 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.43 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 94' ' ' GLY . . . -111.07 128.4 55.86 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.729 0.3 . . . . 0.0 111.348 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.44 52.18 1.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 110.441 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.82 151.98 20.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.564 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.448 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -158.32 169.54 24.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.942 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -131.03 128.65 40.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.212 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -122.22 144.09 49.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.229 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.435 ' HB ' ' HZ1' ' A' ' 155' ' ' LYS . 0.6 OUTLIER -106.34 145.32 31.83 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.203 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -96.89 134.72 39.86 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.009 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.522 ' CE ' HD11 ' A' ' 74' ' ' LEU . 9.9 mmtt -124.26 148.13 47.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.902 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.19 144.78 33.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 111.733 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.48 126.09 28.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.279 0.561 . . . . 0.0 110.389 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.558 ' C ' ' HG3' ' A' ' 159' ' ' GLN . 5.1 m-85 -106.0 128.75 54.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.498 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.558 ' HG3' ' C ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.877 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.246 0.07 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.63 77.07 0.19 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.037 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 10.7 m -117.33 119.23 34.49 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.439 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.667 HG22 ' HG3' ' C' ' 157' ' ' GLN . 4.0 m -98.32 127.17 44.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.548 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.12 171.08 4.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.58 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.14 114.72 23.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.548 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . 0.505 ' HA3' HG11 ' C' ' 156' ' ' VAL . . . -69.84 -57.58 7.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.736 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.65 -144.63 4.09 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.989 -0.625 . . . . 0.0 111.854 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 17.0 p -155.64 140.45 17.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.826 0.346 . . . . 0.0 111.364 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.472 HG13 HG21 ' C' ' 32' ' ' VAL . 29.2 t -130.35 117.53 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.241 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -91.51 116.97 29.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.409 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -89.88 107.08 18.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.916 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.81 113.28 26.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.435 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.419 ' HA3' ' OH ' ' C' ' 137' ' ' TYR . . . -144.42 167.01 27.11 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.898 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.689 ' CG ' ' O ' ' C' ' 146' ' ' GLY . 30.3 tt0 -155.64 135.21 12.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.926 0.393 . . . . 0.0 110.318 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.928 HG12 ' O ' ' C' ' 144' ' ' THR . 66.2 t -96.54 138.35 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.304 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.57 HG21 HE21 ' C' ' 36' ' ' GLN . 2.7 m -140.78 -173.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 111.056 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . 0.471 ' HA ' HG22 ' C' ' 39' ' ' THR . 1.0 OUTLIER -80.12 173.48 12.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.074 -179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' C' ' 38' ' ' ARG . . . -85.82 39.71 0.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . . . -114.28 -33.53 5.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.434 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.894 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.9 OUTLIER -161.13 150.03 16.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.965 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.68 112.02 4.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.079 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.647 ' HA ' ' HA ' ' B' ' 58' ' ' LEU . 3.1 p -59.94 153.37 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.029 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.73 152.8 28.18 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.628 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.42 81.03 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.296 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.84 15.68 62.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.03 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.94 -21.35 11.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.937 0.398 . . . . 0.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 89.3 t -44.65 -64.82 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.316 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.26 135.71 38.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.958 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.06 128.73 19.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.061 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.74 111.81 23.82 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.029 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.484 HG21 HG13 ' A' ' 10' ' ' VAL . 4.2 t -110.85 114.76 48.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.074 0.464 . . . . 0.0 110.489 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.78 124.42 46.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.681 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.609 HD21 HG21 ' B' ' 101' ' ' VAL . 0.9 OUTLIER -82.4 -45.67 14.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.647 179.484 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.33 -161.88 12.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.572 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.601 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 1.8 mt-30 -99.87 129.68 45.99 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.619 0.247 . . . . 0.0 110.865 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.504 HG11 ' HA ' ' A' ' 16' ' ' VAL . 11.9 p -110.01 147.43 14.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.99 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.512 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -86.67 131.23 34.2 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.015 0.436 . . . . 0.0 111.786 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' B' ' 143' ' ' ALA . 4.8 t -54.18 -45.05 72.04 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.721 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.99 -39.36 89.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.146 0.498 . . . . 0.0 110.933 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' B' ' 38' ' ' ARG . 0.4 OUTLIER -70.52 -23.22 62.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.169 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.695 HD22 ' HB3' ' B' ' 137' ' ' TYR . 1.4 mp -124.55 51.63 1.59 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.639 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.6 29.92 7.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.356 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.85 128.41 48.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.348 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.612 ' HA ' ' O ' ' B' ' 140' ' ' THR . 29.3 tt0 -52.95 103.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.815 0.34 . . . . 0.0 111.093 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.409 ' HA2' ' HE1' ' B' ' 138' ' ' PHE . . . 96.02 38.93 4.45 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.137 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.0 146.66 31.91 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.64 125.0 19.03 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.918 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 32.4 m -101.89 -166.28 1.28 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.604 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.99 133.02 55.7 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.871 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' B' ' 136' ' ' ARG . . . -92.67 120.21 32.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.264 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.48 HG22 ' O ' ' B' ' 135' ' ' ALA . 18.5 m -65.77 162.69 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.939 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.9 124.11 5.26 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.648 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . 0.588 ' HE2' ' HB1' ' B' ' 135' ' ' ALA . 53.9 p90 -155.87 146.64 22.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.719 0.295 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.702 ' HB2' HG21 ' B' ' 130' ' ' THR . 3.3 p30 -136.91 160.25 39.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.515 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.521 HG22 HD11 ' B' ' 58' ' ' LEU . 1.6 tp -100.71 117.0 45.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.516 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . 0.537 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -70.05 124.6 24.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.731 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.664 HD23 ' HB3' ' B' ' 21' ' ' CYS . 1.6 mp -133.82 87.5 2.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.184 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.556 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 4.9 p30 -73.63 174.57 8.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 57.72 79.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.811 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' CYS . . . . . 0.894 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 93.6 m -127.57 159.41 34.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.859 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . 0.431 ' O ' ' HG ' ' B' ' 124' ' ' LEU . 5.5 t70 -130.27 167.1 19.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.295 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.31 -41.71 3.44 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.51 -22.63 65.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.086 0.469 . . . . 0.0 111.723 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 82.4 t -70.44 -74.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.608 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.544 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . . . -120.67 131.3 54.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.665 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.22 -48.59 6.12 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.936 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.601 ' HE3' ' HB3' ' B' ' 121' ' ' GLU . 0.1 OUTLIER -96.23 161.48 13.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.595 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.05 124.72 6.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.584 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.44 155.02 18.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.069 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.587 HG13 HD11 ' B' ' 131' ' ' ILE . 2.3 t -132.73 148.34 31.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.673 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.63 150.1 35.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.698 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.541 ' CB ' HD11 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -119.98 137.05 54.3 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.549 0.214 . . . . 0.0 111.055 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.517 HD11 ' CE ' ' B' ' 155' ' ' LYS . 0.9 OUTLIER -96.06 139.52 32.12 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.892 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.407 ' CA ' ' HB3' ' B' ' 113' ' ' LEU . . . 178.45 179.82 48.44 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.807 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.552 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.3 OUTLIER -110.92 156.47 21.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.493 0.187 . . . . 0.0 110.848 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . 0.457 ' HB1' ' HA ' ' B' ' 83' ' ' THR . . . -73.83 131.35 41.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.029 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.645 ' CG2' ' HB ' ' B' ' 85' ' ' VAL . 0.9 OUTLIER -67.74 -41.37 85.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.823 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.15 40.65 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.81 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.544 ' HB2' ' HA2' ' E' ' 108' ' ' GLY . . . 66.49 -80.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.68 -24.99 42.19 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.725 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.06 64.03 1.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.451 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' THR . . . . . 0.699 HG23 ' HD2' ' E' ' 106' ' ' ARG . 0.2 OUTLIER -68.43 -16.9 64.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.567 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . 0.675 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 18.0 p-10 -70.44 -20.18 62.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.339 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.645 ' HB ' ' CG2' ' B' ' 78' ' ' ILE . 14.7 t -106.92 130.77 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.126 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . 0.548 HD21 ' H ' ' B' ' 76' ' ' THR . 0.5 OUTLIER -67.68 148.19 51.67 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.6 -167.58 1.9 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.736 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.619 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 1.5 mm? -78.22 157.26 29.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -78.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.356 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' SER . . . . . 0.577 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 0.4 OUTLIER -167.08 0.51 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.972 0.415 . . . . 0.0 111.459 179.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' SER . . . . . 0.599 ' HA ' ' HB3' ' D' ' 25' ' ' ALA . 1.7 m -71.95 83.03 0.94 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.746 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.69 ' HB1' ' HB3' ' E' ' 34' ' ' LEU . . . -66.62 -13.98 61.83 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.921 0.391 . . . . 0.0 111.749 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.69 27.59 5.21 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.567 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' B' ' 147' ' ' ALA . . . -166.69 15.63 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.899 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' SER . . . . . 0.619 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . 3.0 m -100.88 -172.85 2.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.842 0.353 . . . . 0.0 110.604 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.88 167.6 9.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.849 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.492 ' H ' ' HB ' ' B' ' 144' ' ' THR . 2.3 m -121.51 128.38 52.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.341 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . 0.415 ' HB3' ' H ' ' B' ' 141' ' ' GLY . 75.9 m-20 64.24 34.5 10.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.415 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.463 ' C ' HD11 ' B' ' 78' ' ' ILE . 0.5 OUTLIER -139.92 136.46 38.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.744 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.08 -156.88 8.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.524 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . 0.609 HG21 HD21 ' B' ' 34' ' ' LEU . 3.2 p -137.8 116.71 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 123.011 0.525 . . . . 0.0 111.665 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.557 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 1.2 tt0 -91.94 150.39 21.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.847 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.55 HD13 ' HB3' ' B' ' 111' ' ' LEU . 0.5 OUTLIER -113.81 131.31 66.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.505 179.487 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 0.3 OUTLIER -106.26 130.17 54.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.733 0.302 . . . . 0.0 111.025 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . 0.533 ' HB3' HG23 ' B' ' 107' ' ' THR . 5.1 t0 -76.12 156.97 33.33 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.703 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . 0.721 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 3.4 ttp180 -71.2 -17.55 62.52 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 111.085 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' THR . . . . . 0.533 HG23 ' HB3' ' B' ' 105' ' ' ASP . 6.2 t -67.19 -18.02 65.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.071 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.73 -45.6 1.17 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.784 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.11 163.07 23.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.691 0.281 . . . . 0.0 111.172 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -84.13 127.4 33.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.577 HD21 ' HZ ' ' B' ' 133' ' ' PHE . 12.1 tp -86.28 156.12 20.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.323 0.582 . . . . 0.0 110.595 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.675 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 0.5 OUTLIER -106.25 139.16 41.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.167 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.421 ' HG ' HG12 ' B' ' 103' ' ' ILE . 1.0 OUTLIER -73.92 76.49 1.66 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.707 0.289 . . . . 0.0 110.718 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.45 -17.2 14.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.519 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -51.79 1.24 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.642 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.95 18.83 21.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.933 0.397 . . . . 0.0 111.604 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.84 84.71 7.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 95.7 m-85 -101.41 98.76 9.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.772 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 38.2 m -130.83 62.34 1.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.989 0.423 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.28 145.85 30.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.658 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.601 ' HB3' ' HE3' ' B' ' 68' ' ' LYS . 3.5 mm-40 -121.35 71.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.217 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.67 134.79 34.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.74 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 15.2 m -83.86 113.67 21.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.7 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.645 HD13 ' SG ' ' B' ' 21' ' ' CYS . 18.9 tp -73.98 142.92 45.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.649 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.55 162.13 35.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.53 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.8 113.13 12.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.65 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.59 -139.92 9.48 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.711 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 6.6 m -101.72 96.85 7.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.688 0.28 . . . . 0.0 110.8 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -83.67 148.61 27.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.898 0.38 . . . . 0.0 111.019 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.702 HG21 ' HB2' ' B' ' 55' ' ' ASN . 0.2 OUTLIER -138.65 143.32 39.18 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.16 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' ILE . . . . . 0.587 HD11 HG13 ' B' ' 71' ' ' VAL . 54.9 mt -104.51 112.34 65.35 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' PRO . . . . . 0.721 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.95 142.05 12.25 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.697 1.598 . . . . 0.0 112.503 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.577 ' HZ ' HD21 ' B' ' 111' ' ' LEU . 0.3 OUTLIER -150.68 141.12 22.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.851 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -104.48 152.63 22.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.107 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.588 ' HB1' ' HE2' ' B' ' 54' ' ' PHE . . . -153.57 101.09 2.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.949 0.404 . . . . 0.0 111.586 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . 0.561 ' HB3' ' HA ' ' B' ' 51' ' ' ALA . 17.5 ptt180 -107.19 177.28 4.9 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.436 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . 0.695 ' HB3' HD22 ' B' ' 42' ' ' LEU . 4.7 m-85 -85.96 124.08 32.02 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.019 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . 0.495 ' HB3' HG11 ' B' ' 85' ' ' VAL . 1.2 t80 -118.85 112.45 19.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.972 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.677 ' HB3' HD21 ' B' ' 42' ' ' LEU . . . -102.99 133.97 47.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.842 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 0.1 OUTLIER -81.11 -28.89 35.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.506 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . 0.415 ' H ' ' HB3' ' B' ' 98' ' ' ASN . . . -160.17 -111.07 0.28 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.894 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.91 110.54 21.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.502 0.191 . . . . 0.0 110.712 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' ALA . . . . . 0.471 ' O ' ' OG1' ' B' ' 39' ' ' THR . . . -65.57 134.22 52.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.781 0.325 . . . . 0.0 111.45 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.938 ' O ' HG12 ' A' ' 16' ' ' VAL . 57.2 m -105.81 149.46 38.01 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.309 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.493 ' CD ' ' CG2' ' B' ' 144' ' ' THR . 1.4 Cg_endo -82.95 125.47 4.16 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.592 2.195 . . . . 0.0 112.011 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . 0.675 ' O ' ' CG ' ' A' ' 15' ' ' GLU . . . 168.83 -126.3 1.37 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.423 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' B' ' 94' ' ' GLY . . . -111.12 128.45 55.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.817 0.342 . . . . 0.0 111.296 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.45 52.12 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.188 0.518 . . . . 0.0 110.474 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.74 151.92 20.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.607 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' B' ' 86' ' ' LEU . . . -158.23 169.51 24.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.982 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.9 128.69 41.06 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.289 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -122.25 144.07 49.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.153 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.425 ' HB ' ' HZ1' ' B' ' 155' ' ' LYS . 0.6 OUTLIER -106.36 145.32 31.83 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -96.88 134.63 39.96 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.095 0.474 . . . . 0.0 110.052 -179.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.517 ' CE ' HD11 ' B' ' 74' ' ' LEU . 9.9 mmtt -124.17 148.03 47.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.944 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' VAL . . . . . 0.511 HG11 ' HA3' ' A' ' 7' ' ' GLY . 30.0 m -135.04 144.85 33.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.81 0.338 . . . . 0.0 111.757 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.674 ' HG3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -134.5 126.14 28.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.215 0.531 . . . . 0.0 110.386 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . 0.568 ' C ' ' HG3' ' B' ' 159' ' ' GLN . 5.2 m-85 -106.05 128.77 54.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.494 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . 0.568 ' HG3' ' C ' ' B' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.898 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.284 0.088 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.66 77.09 0.19 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.007 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 10.9 m -117.39 119.31 34.71 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.394 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' THR . . . . . 0.668 HG22 ' HG3' ' D' ' 157' ' ' GLN . 4.0 m -98.36 127.2 44.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.538 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.14 170.99 4.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.574 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.05 114.75 23.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.611 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . 0.505 ' HA3' HG11 ' D' ' 156' ' ' VAL . . . -69.75 -57.64 7.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.801 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.56 -144.59 4.08 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.892 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -155.75 140.45 17.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.863 0.363 . . . . 0.0 111.396 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.479 HG13 HG21 ' D' ' 32' ' ' VAL . 29.5 t -130.28 117.49 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.212 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.59 117.09 29.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.392 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -89.88 107.02 18.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.911 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.71 113.29 26.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.454 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . 0.424 ' HA3' ' OH ' ' D' ' 137' ' ' TYR . . . -144.37 167.0 27.09 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.889 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' GLU . . . . . 0.676 ' CG ' ' O ' ' D' ' 146' ' ' GLY . 30.2 tt0 -155.73 135.18 12.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.975 0.417 . . . . 0.0 110.343 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.941 HG12 ' O ' ' D' ' 144' ' ' THR . 66.5 t -96.53 138.35 21.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.317 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.562 HG21 HE21 ' D' ' 36' ' ' GLN . 2.6 m -140.85 -173.37 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 0.0 110.996 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . 0.481 ' HA ' HG22 ' D' ' 39' ' ' THR . 1.0 OUTLIER -80.09 173.46 12.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.967 -179.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . 0.528 ' HA ' ' HB3' ' D' ' 38' ' ' ARG . . . -85.8 39.74 0.82 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.089 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' C' ' 66' ' ' ALA . . . -114.24 -33.68 5.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.382 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' CYS . . . . . 0.902 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.9 OUTLIER -161.12 149.96 16.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.979 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.57 112.12 4.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.061 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . 0.641 ' HA ' ' HA ' ' C' ' 58' ' ' LEU . 3.1 p -59.97 153.4 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.04 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.76 152.83 28.12 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.624 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 91' ' ' SER . . . -57.58 -41.38 81.0 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.365 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.88 15.7 62.12 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.992 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.96 -21.39 11.14 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.927 0.394 . . . . 0.0 110.805 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 89.8 t -44.6 -64.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.334 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.26 135.61 38.94 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.913 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.0 128.8 19.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.043 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.71 111.71 23.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.111 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.472 HG21 HG13 ' B' ' 10' ' ' VAL . 4.2 t -110.74 114.79 48.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.103 0.478 . . . . 0.0 110.464 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.81 124.49 46.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.665 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.601 HD21 HG21 ' C' ' 101' ' ' VAL . 0.9 OUTLIER -82.5 -45.7 14.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.603 179.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.32 -161.83 12.84 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.612 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . 0.608 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 1.8 mt-30 -99.85 129.7 45.97 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.557 0.218 . . . . 0.0 110.873 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . 0.501 HG11 ' HA ' ' B' ' 16' ' ' VAL . 11.9 p -110.04 147.44 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.914 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' ARG . . . . . 0.522 ' HB3' ' HA ' ' B' ' 19' ' ' ALA . 0.7 OUTLIER -86.72 131.26 34.19 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.997 0.427 . . . . 0.0 111.804 179.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.471 HG22 ' HA ' ' B' ' 18' ' ' ASN . 4.8 t -54.12 -45.12 71.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.693 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.02 -39.36 89.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.114 0.483 . . . . 0.0 110.856 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' C' ' 38' ' ' ARG . 0.4 OUTLIER -70.63 -23.1 62.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.17 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' C' ' 139' ' ' ALA . 1.4 mp -124.61 51.58 1.6 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.583 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.66 29.95 7.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.326 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.84 128.45 48.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.32 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' C' ' 140' ' ' THR . 29.3 tt0 -53.0 102.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.114 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . 0.404 ' HA2' ' HE1' ' C' ' 138' ' ' PHE . . . 96.06 39.03 4.41 Favored Glycine 0 C--N 1.331 0.255 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.114 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.08 146.7 31.77 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.66 125.09 19.11 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.876 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 31.9 m -102.01 -166.27 1.27 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.625 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.96 133.03 55.71 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.836 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' C' ' 136' ' ' ARG . . . -92.74 120.21 32.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.299 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . 0.49 HG22 ' O ' ' C' ' 135' ' ' ALA . 18.4 m -65.76 162.63 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.974 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.86 124.15 5.28 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.609 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . 0.598 ' HE2' ' HB1' ' C' ' 135' ' ' ALA . 54.0 p90 -155.93 146.56 21.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.713 0.292 . . . . 0.0 110.932 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.692 ' HB2' HG21 ' C' ' 130' ' ' THR . 3.3 p30 -136.8 160.27 39.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.54 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.53 HG22 HD11 ' C' ' 58' ' ' LEU . 1.6 tp -100.68 116.95 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.502 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.519 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.0 OUTLIER -70.09 124.56 24.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.763 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . 0.672 HD23 ' HB3' ' C' ' 21' ' ' CYS . 1.6 mp -133.68 87.42 2.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.231 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . 0.559 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 4.9 p30 -73.67 174.54 8.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.918 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.8 79.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' CYS . . . . . 0.902 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 93.2 m -127.62 159.39 34.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.836 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . 0.433 ' O ' ' HG ' ' C' ' 124' ' ' LEU . 5.5 t70 -130.22 167.07 19.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.354 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.24 -41.75 3.44 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.5 -22.61 65.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.018 0.437 . . . . 0.0 111.714 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 81.4 t -70.4 -74.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.626 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . 0.54 ' HB2' ' HB3' ' C' ' 20' ' ' ALA . . . -120.71 131.34 54.49 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.656 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.19 -48.63 6.11 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.81 0.338 . . . . 0.0 110.924 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' LYS . . . . . 0.602 ' HE3' ' HB3' ' C' ' 121' ' ' GLU . 0.1 OUTLIER -96.22 161.54 13.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.561 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.1 124.66 6.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.608 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.44 154.98 18.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.054 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . 0.591 HG13 HD11 ' C' ' 131' ' ' ILE . 2.3 t -132.72 148.3 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.713 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.62 150.15 35.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.66 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' PHE . . . . . 0.522 ' CB ' HD11 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -119.95 137.0 54.31 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.077 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.52 HD11 ' CE ' ' C' ' 155' ' ' LYS . 0.9 OUTLIER -96.08 139.52 32.14 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.874 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' C' ' 113' ' ' LEU . . . 178.51 179.85 48.49 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.764 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' THR . . . . . 0.559 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.3 OUTLIER -110.94 156.42 21.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.545 0.212 . . . . 0.0 110.848 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' C' ' 83' ' ' THR . . . -73.76 131.26 41.39 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.365 -0.38 . . . . 0.0 112.023 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . 0.645 ' CG2' ' HB ' ' C' ' 85' ' ' VAL . 0.9 OUTLIER -67.69 -41.37 85.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.865 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.18 40.84 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.8 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . 0.539 ' HB2' ' HA2' ' F' ' 108' ' ' GLY . . . 66.35 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.027 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.66 -24.95 41.86 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.723 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.12 64.04 1.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.953 0.406 . . . . 0.0 110.469 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' THR . . . . . 0.699 HG23 ' HD2' ' F' ' 106' ' ' ARG . 0.2 OUTLIER -68.44 -16.99 64.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.53 -179.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' ASN . . . . . 0.688 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 18.0 p-10 -70.35 -20.28 62.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.361 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.645 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 14.7 t -106.91 130.75 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.158 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.536 HD21 ' H ' ' C' ' 76' ' ' THR . 0.5 OUTLIER -67.56 148.19 51.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.431 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.64 -167.49 1.87 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.764 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.623 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 1.5 mm? -78.37 157.29 29.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.114 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -78.34 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.345 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' SER . . . . . 0.566 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 0.5 OUTLIER -167.1 0.53 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.018 0.437 . . . . 0.0 111.48 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' SER . . . . . 0.594 ' HA ' ' HB3' ' E' ' 25' ' ' ALA . 1.7 m -71.92 83.02 0.93 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' ALA . . . . . 0.69 ' HB1' ' HB3' ' F' ' 34' ' ' LEU . . . -66.77 -13.88 61.95 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.879 0.371 . . . . 0.0 111.688 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.67 27.54 5.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.638 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' C' ' 147' ' ' ALA . . . -166.65 15.63 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.973 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' SER . . . . . 0.623 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 3.0 m -100.85 -172.84 2.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.766 0.317 . . . . 0.0 110.627 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.91 167.65 9.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' THR . . . . . 0.486 ' H ' ' HB ' ' C' ' 144' ' ' THR . 2.3 m -121.57 128.43 51.98 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.295 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . 0.419 ' HB3' ' H ' ' C' ' 141' ' ' GLY . 75.9 m-20 64.14 34.48 11.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.498 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' VAL . . . . . 0.464 ' C ' HD11 ' C' ' 78' ' ' ILE . 0.5 OUTLIER -139.87 136.6 38.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.709 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.19 -156.91 8.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.498 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' VAL . . . . . 0.601 HG21 HD21 ' C' ' 34' ' ' LEU . 3.2 p -137.81 116.77 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 122.951 0.5 . . . . 0.0 111.644 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' GLN . . . . . 0.571 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 1.1 tt0 -91.91 150.36 21.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.873 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' C' ' 111' ' ' LEU . 0.5 OUTLIER -113.76 131.31 65.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.601 179.415 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 0.3 OUTLIER -106.24 130.19 54.15 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.664 0.269 . . . . 0.0 111.054 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . 0.54 ' HB3' HG23 ' C' ' 107' ' ' THR . 5.1 t0 -76.2 157.0 33.12 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.694 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . 0.723 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 3.5 ttp180 -71.24 -17.44 62.5 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.763 0.316 . . . . 0.0 111.101 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' THR . . . . . 0.54 HG23 ' HB3' ' C' ' 105' ' ' ASP . 6.2 t -67.27 -17.99 65.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.069 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.75 -45.62 1.17 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.766 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.14 163.11 23.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.727 0.298 . . . . 0.0 111.159 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -84.15 127.39 33.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' LEU . . . . . 0.57 HD21 ' HZ ' ' C' ' 133' ' ' PHE . 12.1 tp -86.22 156.02 20.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.304 0.573 . . . . 0.0 110.638 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' THR . . . . . 0.688 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 0.5 OUTLIER -106.14 139.17 41.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.151 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.421 ' HB3' ' HA3' ' C' ' 75' ' ' GLY . 1.0 OUTLIER -73.91 76.43 1.65 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.679 0.276 . . . . 0.0 110.706 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.41 -17.17 14.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.558 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.27 -51.75 1.25 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.648 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.03 18.84 21.66 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.941 0.4 . . . . 0.0 111.554 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.8 84.6 7.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.057 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' C' ' 71' ' ' VAL . 95.7 m-85 -101.38 98.77 9.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.795 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 38.7 m -130.79 62.28 1.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.25 145.86 30.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.715 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . 0.602 ' HB3' ' HE3' ' C' ' 68' ' ' LYS . 3.5 mm-40 -121.39 71.25 0.95 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.217 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.69 134.77 34.75 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.703 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 14.8 m -83.79 113.66 21.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.776 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . 0.647 HD13 ' SG ' ' C' ' 21' ' ' CYS . 18.9 tp -74.0 142.9 45.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.657 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.57 162.1 35.41 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.573 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.73 113.2 12.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.7 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.48 -139.91 9.5 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.734 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 6.7 m -101.69 96.76 7.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.698 0.285 . . . . 0.0 110.773 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.59 148.48 27.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.895 0.379 . . . . 0.0 111.093 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 130' ' ' THR . . . . . 0.692 HG21 ' HB2' ' C' ' 55' ' ' ASN . 0.2 OUTLIER -138.55 143.43 39.45 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.207 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 131' ' ' ILE . . . . . 0.591 HD11 HG13 ' C' ' 71' ' ' VAL . 55.1 mt -104.62 112.41 65.34 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 132' ' ' PRO . . . . . 0.723 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.5 Cg_endo -81.95 141.98 12.2 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.719 1.612 . . . . 0.0 112.526 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.57 ' HZ ' HD21 ' C' ' 111' ' ' LEU . 0.3 OUTLIER -150.63 141.06 22.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.85 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.49 152.53 22.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.131 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.598 ' HB1' ' HE2' ' C' ' 54' ' ' PHE . . . -153.52 101.08 2.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.98 0.419 . . . . 0.0 111.6 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . 0.56 ' HB3' ' HA ' ' C' ' 51' ' ' ALA . 17.5 ptt180 -107.18 177.2 4.92 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.42 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 137' ' ' TYR . . . . . 0.679 ' HB3' HD22 ' C' ' 42' ' ' LEU . 4.7 m-85 -85.93 124.15 32.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.008 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 138' ' ' PHE . . . . . 0.478 ' HB3' HG11 ' C' ' 85' ' ' VAL . 1.2 t80 -118.9 112.38 19.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.959 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 139' ' ' ALA . . . . . 0.69 ' HB3' HD21 ' C' ' 42' ' ' LEU . . . -102.97 133.95 47.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.873 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 140' ' ' THR . . . . . 0.608 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 0.1 OUTLIER -81.1 -28.9 35.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.529 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' C' ' 98' ' ' ASN . . . -160.15 -111.06 0.28 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.926 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.85 110.56 21.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.537 0.208 . . . . 0.0 110.766 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 143' ' ' ALA . . . . . 0.449 ' O ' ' OG1' ' C' ' 39' ' ' THR . . . -65.65 134.29 52.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.83 0.348 . . . . 0.0 111.343 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 144' ' ' THR . . . . . 0.928 ' O ' HG12 ' B' ' 16' ' ' VAL . 56.4 m -105.82 149.39 37.93 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.346 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 145' ' ' PRO . . . . . 0.49 ' CD ' ' CG2' ' C' ' 144' ' ' THR . 1.4 Cg_endo -82.91 125.54 4.2 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.497 2.131 . . . . 0.0 112.023 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . 0.689 ' O ' ' CG ' ' B' ' 15' ' ' GLU . . . 168.78 -126.33 1.38 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.407 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 147' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' C' ' 94' ' ' GLY . . . -111.07 128.43 55.87 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.758 0.313 . . . . 0.0 111.317 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.41 52.15 1.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.15 0.5 . . . . 0.0 110.492 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -98.78 151.93 20.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.597 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 150' ' ' ALA . . . . . 0.446 ' HB2' HD11 ' C' ' 86' ' ' LEU . . . -158.28 169.6 24.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.009 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -130.98 128.63 40.8 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.291 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -122.21 144.06 49.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.228 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 153' ' ' THR . . . . . 0.428 ' HB ' ' HZ1' ' C' ' 155' ' ' LYS . 0.6 OUTLIER -106.37 145.34 31.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -96.9 134.67 39.93 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.068 0.461 . . . . 0.0 110.019 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . 0.52 ' CE ' HD11 ' C' ' 74' ' ' LEU . 9.9 mmtt -124.15 148.14 47.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.895 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 156' ' ' VAL . . . . . 0.505 HG11 ' HA3' ' B' ' 7' ' ' GLY . 29.9 m -135.15 144.77 33.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.742 0.306 . . . . 0.0 111.791 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . 0.667 ' HG3' HG22 ' B' ' 4' ' ' THR . 0.0 OUTLIER -134.46 126.06 28.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.273 0.559 . . . . 0.0 110.399 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . 0.562 ' C ' ' HG3' ' C' ' 159' ' ' GLN . 5.2 m-85 -106.02 128.75 54.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.502 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . 0.562 ' HG3' ' C ' ' C' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 111.142 0.053 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.64 77.12 0.19 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.172 0.295 . . . . 0.0 110.983 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' THR . . . . . . . . . . . . . 10.9 m -117.41 119.32 34.75 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.387 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' THR . . . . . 0.675 HG22 ' HG3' ' E' ' 157' ' ' GLN . 4.0 m -98.37 127.21 44.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.535 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.1 171.03 4.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.601 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -86.02 114.61 23.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.599 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' GLY . . . . . 0.509 ' HA3' HG11 ' E' ' 156' ' ' VAL . . . -69.61 -57.71 7.05 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.813 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.59 -144.61 4.08 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.87 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -155.7 140.46 17.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 111.371 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' VAL . . . . . 0.473 HG13 HG21 ' E' ' 32' ' ' VAL . 30.1 t -130.34 117.48 39.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.294 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.5 116.98 29.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.349 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -89.86 107.08 18.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.883 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.75 113.32 26.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.451 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' GLY . . . . . 0.425 ' HA3' ' OH ' ' E' ' 137' ' ' TYR . . . -144.42 166.98 27.12 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.919 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' GLU . . . . . 0.676 ' CG ' ' O ' ' E' ' 146' ' ' GLY . 30.2 tt0 -155.68 135.2 12.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.966 0.412 . . . . 0.0 110.32 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.932 HG12 ' O ' ' E' ' 144' ' ' THR . 65.8 t -96.53 138.36 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.275 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . 0.569 HG21 HE21 ' E' ' 36' ' ' GLN . 2.7 m -140.85 -173.38 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.872 0.368 . . . . 0.0 111.002 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' ASN . . . . . 0.469 ' HA ' HG22 ' E' ' 39' ' ' THR . 1.0 OUTLIER -80.08 173.41 12.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.075 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' ALA . . . . . 0.518 ' HA ' ' HB3' ' E' ' 38' ' ' ARG . . . -85.82 39.76 0.82 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.041 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' D' ' 66' ' ' ALA . . . -114.31 -33.46 5.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.459 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' CYS . . . . . 0.887 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.9 OUTLIER -161.18 149.98 16.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.935 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.64 112.09 4.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.102 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . 0.641 ' HA ' ' HA ' ' D' ' 58' ' ' LEU . 3.0 p -59.93 153.34 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.082 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.68 152.75 28.27 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.686 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' B' ' 91' ' ' SER . . . -57.53 -41.46 80.93 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.357 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.81 15.7 62.06 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.968 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.95 -21.35 11.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.914 0.387 . . . . 0.0 110.814 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 90.1 t -44.58 -64.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.364 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.29 135.69 38.85 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.885 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.04 128.77 19.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.044 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.83 111.83 23.85 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.014 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . 0.479 HG21 HG13 ' C' ' 10' ' ' VAL . 4.2 t -110.82 114.81 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.139 0.495 . . . . 0.0 110.519 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.75 124.45 46.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.649 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.679 ' HB3' ' HB1' ' A' ' 92' ' ' ALA . 0.9 OUTLIER -82.49 -45.74 14.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.574 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.37 -161.86 12.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.571 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' GLN . . . . . 0.594 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 1.8 mt-30 -99.83 129.69 45.95 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.648 0.261 . . . . 0.0 110.881 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' C' ' 16' ' ' VAL . 12.0 p -110.02 147.44 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.995 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . 0.528 ' HB3' ' HA ' ' C' ' 19' ' ' ALA . 0.7 OUTLIER -86.78 131.29 34.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.053 0.454 . . . . 0.0 111.69 179.301 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.481 HG22 ' HA ' ' C' ' 18' ' ' ASN . 4.8 t -54.09 -45.13 71.71 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.753 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.93 -39.37 89.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.137 0.494 . . . . 0.0 110.939 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' D' ' 38' ' ' ARG . 0.4 OUTLIER -70.62 -23.15 62.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.134 -179.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.672 HD22 ' HB3' ' D' ' 137' ' ' TYR . 1.4 mp -124.59 51.57 1.6 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.669 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.59 29.9 7.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.38 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.84 128.46 48.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.33 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . 0.606 ' HA ' ' O ' ' D' ' 140' ' ' THR . 29.5 tt0 -52.95 103.05 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.871 0.367 . . . . 0.0 111.117 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . 0.407 ' HA2' ' HE1' ' D' ' 138' ' ' PHE . . . 95.94 39.03 4.44 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.193 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.98 146.66 31.92 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.63 124.97 19.01 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.973 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 32.3 m -101.9 -166.31 1.28 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.626 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.04 132.99 55.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.848 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' D' ' 136' ' ' ARG . . . -92.64 120.24 32.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.321 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 90' ' ' SER . 18.5 m -65.84 162.66 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.905 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.8 124.14 5.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.649 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . 0.589 ' HE2' ' HB1' ' D' ' 135' ' ' ALA . 54.0 p90 -155.93 146.55 21.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.705 0.288 . . . . 0.0 110.942 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' ASN . . . . . 0.701 ' HB2' HG21 ' D' ' 130' ' ' THR . 3.4 p30 -136.84 160.24 39.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.529 HG22 ' O ' ' D' ' 56' ' ' ILE . 1.6 tp -100.63 117.02 45.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.536 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' GLN . . . . . 0.535 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.0 OUTLIER -70.12 124.58 24.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.736 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . 0.674 HD23 ' HB3' ' D' ' 21' ' ' CYS . 1.6 mp -133.77 87.54 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.181 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . 0.563 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 4.9 p30 -73.65 174.61 8.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.006 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.81 79.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.815 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' CYS . . . . . 0.887 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 93.6 m -127.58 159.4 34.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.862 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . 0.427 ' O ' ' HG ' ' D' ' 124' ' ' LEU . 5.5 t70 -130.24 167.11 18.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.28 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.35 -41.66 3.44 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.47 -22.71 65.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.063 0.459 . . . . 0.0 111.723 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 81.5 t -70.38 -74.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.635 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' D' ' 20' ' ' ALA . . . -120.76 131.33 54.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.634 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.21 -48.54 6.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.857 0.361 . . . . 0.0 110.981 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' LYS . . . . . 0.599 ' HE3' ' HB3' ' D' ' 121' ' ' GLU . 0.1 OUTLIER -96.25 161.54 13.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.555 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.09 124.63 6.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.642 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.32 155.0 18.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.098 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . 0.587 HG13 HD11 ' D' ' 131' ' ' ILE . 2.3 t -132.75 148.22 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.745 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.57 150.18 35.93 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.59 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' PHE . . . . . 0.543 ' CB ' HD11 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -119.99 136.96 54.35 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.053 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' LEU . . . . . 0.516 HD11 ' CE ' ' D' ' 155' ' ' LYS . 0.9 OUTLIER -96.05 139.54 32.08 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.937 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' D' ' 113' ' ' LEU . . . 178.53 179.83 48.5 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.745 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' THR . . . . . 0.537 ' H ' HD21 ' D' ' 86' ' ' LEU . 0.3 OUTLIER -111.0 156.39 21.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.534 0.207 . . . . 0.0 110.832 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' D' ' 83' ' ' THR . . . -73.78 131.3 41.41 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.04 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 78' ' ' ILE . . . . . 0.641 ' CG2' ' HB ' ' D' ' 85' ' ' VAL . 0.9 OUTLIER -67.72 -41.3 85.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.874 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . 0.407 ' O ' ' HB1' ' D' ' 80' ' ' ALA . 0.6 OUTLIER -141.17 40.75 1.78 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.808 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' D' ' 79' ' ' ASP . . . 66.44 -80.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.7 -24.96 42.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.688 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -99.1 64.04 1.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.448 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 83' ' ' THR . . . . . 0.449 ' HA ' ' HB1' ' D' ' 77' ' ' ALA . 0.2 OUTLIER -68.5 -16.86 64.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.584 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . 0.681 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 18.0 p-10 -70.36 -20.3 62.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.359 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.641 ' HB ' ' CG2' ' D' ' 78' ' ' ILE . 14.7 t -106.87 130.74 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.136 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.537 HD21 ' H ' ' D' ' 76' ' ' THR . 0.5 OUTLIER -67.66 148.18 51.69 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.62 -167.54 1.89 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 111.713 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.625 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 1.5 mm? -78.32 157.23 29.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.094 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -78.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.418 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.18 0.6 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.971 0.415 . . . . 0.0 111.483 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 91' ' ' SER . . . . . 0.599 ' HA ' ' HB3' ' F' ' 25' ' ' ALA . 1.7 m -71.91 82.94 0.93 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.65 -13.96 61.84 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.917 0.389 . . . . 0.0 111.749 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.61 27.61 5.23 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.581 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 94' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' D' ' 147' ' ' ALA . . . -166.67 15.6 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.946 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 95' ' ' SER . . . . . 0.625 ' HB3' ' HG ' ' D' ' 88' ' ' LEU . 3.0 m -100.9 -172.81 2.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.715 0.293 . . . . 0.0 110.635 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.86 167.62 9.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 97' ' ' THR . . . . . 0.488 ' H ' ' HB ' ' D' ' 144' ' ' THR . 2.3 m -121.51 128.36 51.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.34 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 98' ' ' ASN . . . . . 0.413 ' HB3' ' H ' ' D' ' 141' ' ' GLY . 76.0 m-20 64.28 34.44 10.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.468 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 99' ' ' VAL . . . . . 0.463 ' C ' HD11 ' D' ' 78' ' ' ILE . 0.5 OUTLIER -139.92 136.46 38.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.738 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.08 -156.92 8.36 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.523 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 101' ' ' VAL . . . . . 0.577 HG21 HD21 ' D' ' 34' ' ' LEU . 3.2 p -137.8 116.8 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.132 0.491 . . . . 0.0 111.647 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 102' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 1.2 tt0 -91.86 150.35 21.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.847 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 103' ' ' ILE . . . . . 0.543 HD11 ' CB ' ' D' ' 73' ' ' PHE . 0.5 OUTLIER -113.85 131.34 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.494 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 104' ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 0.3 OUTLIER -106.29 130.16 54.19 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.68 0.276 . . . . 0.0 110.958 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . 0.539 ' HB3' HG23 ' D' ' 107' ' ' THR . 5.1 t0 -76.14 156.99 33.28 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.679 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 106' ' ' ARG . . . . . 0.75 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 3.5 ttp180 -71.19 -17.55 62.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.738 0.304 . . . . 0.0 111.078 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 107' ' ' THR . . . . . 0.539 HG23 ' HB3' ' D' ' 105' ' ' ASP . 6.2 t -67.17 -18.07 65.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.021 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 108' ' ' GLY . . . . . 0.547 ' HA2' ' HB2' ' A' ' 80' ' ' ALA . . . 123.7 -45.57 1.17 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.74 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.07 163.05 23.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.7 0.286 . . . . 0.0 111.154 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -84.13 127.41 33.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.08 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 111' ' ' LEU . . . . . 0.558 HD21 ' HZ ' ' D' ' 133' ' ' PHE . 12.1 tp -86.24 156.11 20.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.258 0.551 . . . . 0.0 110.633 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 112' ' ' THR . . . . . 0.681 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 0.5 OUTLIER -106.23 139.15 41.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.123 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 113' ' ' LEU . . . . . 0.428 ' HG ' HG12 ' D' ' 103' ' ' ILE . 1.0 OUTLIER -74.03 76.55 1.71 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.755 0.312 . . . . 0.0 110.742 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.54 -17.09 14.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.516 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.23 -51.86 1.25 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.664 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.99 18.86 21.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.858 0.361 . . . . 0.0 111.509 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.81 84.64 7.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.079 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' D' ' 71' ' ' VAL . 95.7 m-85 -101.37 98.77 9.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.759 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 38.1 m -130.77 62.33 1.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.28 145.74 30.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.735 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . 0.599 ' HB3' ' HE3' ' D' ' 68' ' ' LYS . 3.5 mm-40 -121.25 71.3 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.179 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 134.78 34.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.684 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 15.1 m -83.82 113.7 21.11 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.701 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . 0.65 HD13 ' SG ' ' D' ' 21' ' ' CYS . 19.0 tp -74.08 142.96 45.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.772 0.32 . . . . 0.0 110.61 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.53 162.12 35.32 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.59 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.8 113.18 12.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.684 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.54 -140.02 9.57 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.688 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 128' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 6.6 m -101.66 96.87 7.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 110.773 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.65 148.54 27.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.843 0.354 . . . . 0.0 111.097 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 130' ' ' THR . . . . . 0.701 HG21 ' HB2' ' D' ' 55' ' ' ASN . 0.2 OUTLIER -138.61 143.4 39.31 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.123 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 131' ' ' ILE . . . . . 0.587 HD11 HG13 ' D' ' 71' ' ' VAL . 55.1 mt -104.57 112.36 65.34 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 132' ' ' PRO . . . . . 0.75 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.4 Cg_endo -82.01 141.98 12.13 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.675 1.583 . . . . 0.0 112.458 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.558 ' HZ ' HD21 ' D' ' 111' ' ' LEU . 0.3 OUTLIER -150.61 141.12 22.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.897 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.48 152.55 22.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.097 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.589 ' HB1' ' HE2' ' D' ' 54' ' ' PHE . . . -153.53 101.08 2.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.954 0.407 . . . . 0.0 111.578 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 136' ' ' ARG . . . . . 0.558 ' HB3' ' HA ' ' D' ' 51' ' ' ALA . 17.5 ptt180 -107.18 177.19 4.92 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.379 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 137' ' ' TYR . . . . . 0.672 ' HB3' HD22 ' D' ' 42' ' ' LEU . 4.7 m-85 -85.92 124.04 31.94 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.089 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 138' ' ' PHE . . . . . 0.496 ' HB3' HG11 ' D' ' 85' ' ' VAL . 1.2 t80 -118.8 112.39 19.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.991 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 139' ' ' ALA . . . . . 0.666 ' HB3' HD21 ' D' ' 42' ' ' LEU . . . -102.97 134.0 47.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.828 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 140' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 0.1 OUTLIER -81.12 -28.86 34.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.507 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . 0.413 ' H ' ' HB3' ' D' ' 98' ' ' ASN . . . -160.19 -111.09 0.28 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.917 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.88 110.57 21.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.549 0.214 . . . . 0.0 110.744 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 143' ' ' ALA . . . . . 0.469 ' O ' ' OG1' ' D' ' 39' ' ' THR . . . -65.69 134.27 52.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 111.341 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 144' ' ' THR . . . . . 0.941 ' O ' HG12 ' C' ' 16' ' ' VAL . 56.4 m -105.8 149.42 37.96 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.341 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 145' ' ' PRO . . . . . 0.487 ' CD ' ' CG2' ' D' ' 144' ' ' THR . 1.3 Cg_endo -82.96 125.52 4.17 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.519 2.146 . . . . 0.0 112.001 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . 0.676 ' O ' ' CG ' ' C' ' 15' ' ' GLU . . . 168.8 -126.37 1.38 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.412 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 147' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' D' ' 94' ' ' GLY . . . -111.1 128.45 55.89 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.813 0.339 . . . . 0.0 111.322 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.46 52.14 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.15 0.5 . . . . 0.0 110.398 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -98.71 152.05 20.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.545 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 150' ' ' ALA . . . . . 0.443 ' HB2' HD11 ' D' ' 86' ' ' LEU . . . -158.38 169.46 24.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.959 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.96 128.67 40.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.256 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 152' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -122.19 144.06 49.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.251 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 153' ' ' THR . . . . . 0.422 ' HB ' ' HZ1' ' D' ' 155' ' ' LYS . 0.6 OUTLIER -106.34 145.34 31.8 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.209 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -96.84 134.67 39.84 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.052 0.454 . . . . 0.0 110.121 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . 0.516 ' CE ' HD11 ' D' ' 74' ' ' LEU . 9.9 mmtt -124.24 148.07 47.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.854 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 156' ' ' VAL . . . . . 0.505 HG11 ' HA3' ' C' ' 7' ' ' GLY . 29.7 m -135.06 144.83 33.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.783 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 157' ' ' GLN . . . . . 0.668 ' HG3' HG22 ' C' ' 4' ' ' THR . 0.0 OUTLIER -134.51 126.06 28.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.283 0.563 . . . . 0.0 110.36 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . 0.565 ' C ' ' HG3' ' D' ' 159' ' ' GLN . 5.2 m-85 -106.02 128.77 54.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.474 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 159' ' ' GLN . . . . . 0.565 ' HG3' ' C ' ' D' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 111.169 0.062 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.7 77.1 0.19 Allowed 'General case' 0 N--CA 1.462 0.146 0 O-C-N 123.1 0.25 . . . . 0.0 110.989 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 3' ' ' THR . . . . . . . . . . . . . 10.7 m -117.36 119.24 34.52 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.472 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 4' ' ' THR . . . . . 0.684 HG22 ' HG3' ' F' ' 157' ' ' GLN . 3.9 m -98.34 127.2 44.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.575 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.11 171.02 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.592 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -86.05 114.73 23.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.573 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 7' ' ' GLY . . . . . 0.511 ' HA3' HG11 ' F' ' 156' ' ' VAL . . . -69.67 -57.75 6.98 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.923 -0.655 . . . . 0.0 112.829 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.52 -144.6 4.08 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.901 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -155.73 140.46 17.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.855 0.36 . . . . 0.0 111.385 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 10' ' ' VAL . . . . . 0.483 HG13 HG21 ' F' ' 32' ' ' VAL . 30.0 t -130.31 117.45 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.238 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.5 117.0 29.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.435 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -89.79 107.11 18.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.84 113.26 26.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.449 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 14' ' ' GLY . . . . . 0.411 ' HA3' ' OH ' ' F' ' 137' ' ' TYR . . . -144.41 166.98 27.11 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.933 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 15' ' ' GLU . . . . . 0.685 ' CG ' ' O ' ' F' ' 146' ' ' GLY . 30.2 tt0 -155.7 135.17 12.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.985 0.421 . . . . 0.0 110.294 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 16' ' ' VAL . . . . . 0.944 HG12 ' O ' ' F' ' 144' ' ' THR . 66.1 t -96.48 138.31 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.264 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . 0.574 HG21 HE21 ' F' ' 36' ' ' GLN . 2.7 m -140.81 -173.34 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 111.06 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . 0.469 ' HA ' HG22 ' F' ' 39' ' ' THR . 1.0 OUTLIER -80.13 173.41 12.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.052 -179.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 19' ' ' ALA . . . . . 0.517 ' HA ' ' HB3' ' F' ' 38' ' ' ARG . . . -85.73 39.73 0.81 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' E' ' 66' ' ' ALA . . . -114.34 -33.54 5.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.424 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 21' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.9 OUTLIER -161.13 150.01 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.933 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.6 112.1 4.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.02 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 23' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' E' ' 58' ' ' LEU . 3.1 p -60.02 153.41 4.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.989 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.76 152.81 28.12 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.665 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . 0.594 ' HB3' ' HA ' ' C' ' 91' ' ' SER . . . -57.5 -41.48 80.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.351 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.77 15.65 62.11 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.032 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -113.05 -21.2 11.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.902 0.382 . . . . 0.0 110.809 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -44.65 -64.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.298 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.23 135.69 38.8 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.957 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.02 128.78 19.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.059 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.78 111.79 23.82 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.058 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . 0.473 HG21 HG13 ' D' ' 10' ' ' VAL . 4.2 t -110.81 114.74 47.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.479 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.68 124.55 46.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.703 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.69 ' HB3' ' HB1' ' B' ' 92' ' ' ALA . 0.9 OUTLIER -82.54 -45.62 14.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.661 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.31 -161.86 12.83 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.583 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 36' ' ' GLN . . . . . 0.596 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 1.8 mt-30 -99.83 129.68 45.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.604 0.24 . . . . 0.0 110.862 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . 0.494 HG11 ' HA ' ' D' ' 16' ' ' VAL . 11.8 p -110.11 147.5 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.924 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . 0.518 ' HB3' ' HA ' ' D' ' 19' ' ' ALA . 0.7 OUTLIER -86.77 131.24 34.18 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.974 0.416 . . . . 0.0 111.765 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 39' ' ' THR . . . . . 0.469 HG22 ' HA ' ' D' ' 18' ' ' ASN . 4.8 t -54.08 -45.09 71.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.772 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.35 89.4 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.052 0.453 . . . . 0.0 110.854 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 41' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' E' ' 38' ' ' ARG . 0.4 OUTLIER -70.62 -23.16 62.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.178 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.694 HD22 ' HB3' ' E' ' 137' ' ' TYR . 1.4 mp -124.55 51.61 1.59 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.616 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.69 30.02 7.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.383 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.85 128.45 48.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.294 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . 0.607 ' HA ' ' O ' ' E' ' 140' ' ' THR . 29.5 tt0 -52.97 102.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.899 0.38 . . . . 0.0 111.139 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . 0.417 ' HA2' ' HE1' ' E' ' 138' ' ' PHE . . . 96.05 39.02 4.42 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.098 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.08 146.77 31.74 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.68 125.0 18.97 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.957 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 32.1 m -101.93 -166.31 1.28 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.589 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.99 133.04 55.72 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 51' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' E' ' 136' ' ' ARG . . . -92.7 120.21 32.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.237 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 52' ' ' VAL . . . . . 0.577 ' HB ' ' HA ' ' B' ' 90' ' ' SER . 18.5 m -65.78 162.69 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.86 124.08 5.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.688 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 54' ' ' PHE . . . . . 0.588 ' HE2' ' HB1' ' E' ' 135' ' ' ALA . 53.7 p90 -155.92 146.54 21.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.713 0.292 . . . . 0.0 110.951 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 55' ' ' ASN . . . . . 0.7 ' HB2' HG21 ' E' ' 130' ' ' THR . 3.4 p30 -136.79 160.31 39.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.529 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 56' ' ' ILE . . . . . 0.526 HG22 ' O ' ' E' ' 56' ' ' ILE . 1.6 tp -100.69 116.94 45.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.563 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 57' ' ' GLN . . . . . 0.541 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.0 OUTLIER -70.0 124.64 24.57 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.766 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . 0.668 HD23 ' HB3' ' E' ' 21' ' ' CYS . 1.6 mp -133.79 87.49 2.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.204 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . 0.554 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 4.9 p30 -73.62 174.56 8.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.98 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.86 79.3 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.734 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 61' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 93.4 m -127.62 159.44 34.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.88 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . 0.431 ' O ' ' HG ' ' E' ' 124' ' ' LEU . 5.6 t70 -130.3 167.1 19.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.226 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.26 -41.73 3.44 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.49 -22.64 65.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.013 0.435 . . . . 0.0 111.725 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 83.1 t -70.43 -74.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.593 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . 0.548 ' HB2' ' HB3' ' E' ' 20' ' ' ALA . . . -120.73 131.39 54.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.603 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.18 -48.6 6.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.956 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 68' ' ' LYS . . . . . 0.598 ' HE3' ' HB3' ' E' ' 121' ' ' GLU . 0.1 OUTLIER -96.23 161.51 13.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.09 124.67 6.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.633 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.39 154.98 18.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.098 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . 0.566 HG13 HD11 ' E' ' 131' ' ' ILE . 2.3 t -132.72 148.28 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.715 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.57 150.2 35.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.61 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 73' ' ' PHE . . . . . 0.541 ' CB ' HD11 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -119.98 136.97 54.34 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 121.214 -0.195 . . . . 0.0 111.051 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 74' ' ' LEU . . . . . 0.514 HD11 ' CE ' ' E' ' 155' ' ' LYS . 0.9 OUTLIER -95.95 139.48 32.08 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.956 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' E' ' 113' ' ' LEU . . . 178.5 179.84 48.48 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.797 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 76' ' ' THR . . . . . 0.543 ' H ' HD21 ' E' ' 86' ' ' LEU . 0.3 OUTLIER -110.98 156.37 21.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.449 0.166 . . . . 0.0 110.839 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 77' ' ' ALA . . . . . 0.46 ' HB1' ' HA ' ' E' ' 83' ' ' THR . . . -73.75 131.25 41.38 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.03 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 78' ' ' ILE . . . . . 0.643 ' CG2' ' HB ' ' E' ' 85' ' ' VAL . 0.9 OUTLIER -67.61 -41.48 85.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.831 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 79' ' ' ASP . . . . . 0.41 ' O ' ' HB1' ' E' ' 80' ' ' ALA . 0.6 OUTLIER -141.13 40.78 1.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' E' ' 79' ' ' ASP . . . 66.49 -80.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.003 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.73 -24.91 42.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.659 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -99.12 64.02 1.36 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 0.0 110.511 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 83' ' ' THR . . . . . 0.46 ' HA ' ' HB1' ' E' ' 77' ' ' ALA . 0.2 OUTLIER -68.48 -16.86 64.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.528 -179.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 84' ' ' ASN . . . . . 0.67 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 18.0 p-10 -70.41 -20.22 62.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.385 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.643 ' HB ' ' CG2' ' E' ' 78' ' ' ILE . 14.7 t -106.87 130.73 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.18 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 86' ' ' LEU . . . . . 0.543 HD21 ' H ' ' E' ' 76' ' ' THR . 0.5 OUTLIER -67.65 148.2 51.67 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.59 -167.52 1.88 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.846 0.355 . . . . 0.0 111.77 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.622 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 1.5 mm? -78.28 157.31 29.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -78.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.34 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.09 0.53 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.016 0.436 . . . . 0.0 111.462 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 91' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' E' ' 95' ' ' SER . 1.7 m -71.84 82.9 0.91 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.68 -13.92 61.85 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.872 0.368 . . . . 0.0 111.725 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.62 27.55 5.24 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.683 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 94' ' ' GLY . . . . . 0.555 ' O ' ' HB3' ' E' ' 147' ' ' ALA . . . -166.69 15.66 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.909 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 95' ' ' SER . . . . . 0.622 ' HB3' ' HG ' ' E' ' 88' ' ' LEU . 3.0 m -100.94 -172.8 2.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.782 0.325 . . . . 0.0 110.587 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.91 167.7 9.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.818 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 97' ' ' THR . . . . . 0.498 ' H ' ' HB ' ' E' ' 144' ' ' THR . 2.3 m -121.56 128.46 52.03 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.338 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 98' ' ' ASN . . . . . 0.413 ' HB3' ' H ' ' E' ' 141' ' ' GLY . 75.9 m-20 64.13 34.59 10.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.432 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 99' ' ' VAL . . . . . 0.46 ' C ' HD11 ' E' ' 78' ' ' ILE . 0.5 OUTLIER -139.96 136.44 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.745 179.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.12 -156.94 8.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.536 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 101' ' ' VAL . . . . . 0.602 HG21 HD21 ' E' ' 34' ' ' LEU . 3.2 p -137.76 116.69 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 122.971 0.508 . . . . 0.0 111.653 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 102' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 1.2 tt0 -91.86 150.37 21.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.943 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 103' ' ' ILE . . . . . 0.548 HD13 ' HB3' ' E' ' 111' ' ' LEU . 0.5 OUTLIER -113.81 131.35 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.535 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 104' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 0.3 OUTLIER -106.22 130.14 54.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.673 0.273 . . . . 0.0 110.997 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . 0.532 ' HB3' HG23 ' E' ' 107' ' ' THR . 5.1 t0 -76.11 156.99 33.33 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.739 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 106' ' ' ARG . . . . . 0.729 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 3.5 ttp180 -71.22 -17.51 62.5 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.795 0.331 . . . . 0.0 111.087 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 107' ' ' THR . . . . . 0.532 HG23 ' HB3' ' E' ' 105' ' ' ASP . 6.2 t -67.3 -17.94 64.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.997 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 108' ' ' GLY . . . . . 0.544 ' HA2' ' HB2' ' B' ' 80' ' ' ALA . . . 123.73 -45.59 1.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.804 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.1 163.09 23.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.76 0.314 . . . . 0.0 111.12 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -84.14 127.37 33.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.064 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.57 HD21 ' HZ ' ' E' ' 133' ' ' PHE . 12.1 tp -86.29 156.07 20.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.29 0.567 . . . . 0.0 110.596 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 112' ' ' THR . . . . . 0.67 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 0.5 OUTLIER -106.21 139.14 41.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.157 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 113' ' ' LEU . . . . . 0.427 ' HG ' HG12 ' E' ' 103' ' ' ILE . 1.0 OUTLIER -73.93 76.48 1.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 110.765 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.48 -17.17 14.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.511 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -51.8 1.24 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.638 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.95 18.77 21.75 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.929 0.395 . . . . 0.0 111.599 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.73 84.61 7.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' E' ' 71' ' ' VAL . 95.7 m-85 -101.39 98.77 9.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.795 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 39.2 m -130.84 62.46 1.61 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.3 145.82 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.704 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 121' ' ' GLU . . . . . 0.598 ' HB3' ' HE3' ' E' ' 68' ' ' LYS . 3.5 mm-40 -121.37 71.28 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.212 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.74 134.86 34.73 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.752 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 14.8 m -83.83 113.72 21.14 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.749 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . 0.646 HD13 ' SG ' ' E' ' 21' ' ' CYS . 18.9 tp -74.07 143.0 45.63 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.708 0.289 . . . . 0.0 110.619 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.61 162.03 35.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.624 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.72 113.24 12.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.675 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . 0.413 ' CA ' HG21 ' A' ' 4' ' ' THR . . . 142.49 -139.94 9.52 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.73 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 128' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 6.6 m -101.69 96.8 7.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.677 0.275 . . . . 0.0 110.755 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.64 148.49 27.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.897 0.379 . . . . 0.0 111.185 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 130' ' ' THR . . . . . 0.7 HG21 ' HB2' ' E' ' 55' ' ' ASN . 0.2 OUTLIER -138.55 143.46 39.46 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.081 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 131' ' ' ILE . . . . . 0.566 HD11 HG13 ' E' ' 71' ' ' VAL . 54.9 mt -104.57 112.3 65.33 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 132' ' ' PRO . . . . . 0.729 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.5 Cg_endo -81.93 141.93 12.21 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.737 1.624 . . . . 0.0 112.502 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 133' ' ' PHE . . . . . 0.57 ' HZ ' HD21 ' E' ' 111' ' ' LEU . 0.3 OUTLIER -150.59 141.1 22.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.829 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.52 152.6 22.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.111 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . 0.588 ' HB1' ' HE2' ' E' ' 54' ' ' PHE . . . -153.57 101.06 2.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 111.602 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 136' ' ' ARG . . . . . 0.562 ' HB3' ' HA ' ' E' ' 51' ' ' ALA . 17.4 ptt180 -107.18 177.24 4.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.408 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 137' ' ' TYR . . . . . 0.694 ' HB3' HD22 ' E' ' 42' ' ' LEU . 4.7 m-85 -85.98 124.12 32.08 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.027 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 138' ' ' PHE . . . . . 0.496 ' HB3' HG11 ' E' ' 85' ' ' VAL . 1.2 t80 -118.87 112.36 19.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.048 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 139' ' ' ALA . . . . . 0.673 ' HB3' HD21 ' E' ' 42' ' ' LEU . . . -102.93 133.94 47.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.882 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 140' ' ' THR . . . . . 0.607 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 0.1 OUTLIER -81.04 -28.92 35.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.553 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . 0.413 ' H ' ' HB3' ' E' ' 98' ' ' ASN . . . -160.21 -111.01 0.28 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.88 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.92 110.6 21.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.547 0.213 . . . . 0.0 110.703 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 143' ' ' ALA . . . . . 0.465 ' O ' ' OG1' ' E' ' 39' ' ' THR . . . -65.68 134.27 52.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 0.0 111.368 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 144' ' ' THR . . . . . 0.932 ' O ' HG12 ' D' ' 16' ' ' VAL . 56.9 m -105.87 149.43 38.01 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.304 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 145' ' ' PRO . . . . . 0.485 ' CD ' ' CG2' ' E' ' 144' ' ' THR . 1.4 Cg_endo -82.91 125.47 4.18 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.542 2.161 . . . . 0.0 112.028 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 146' ' ' GLY . . . . . 0.676 ' O ' ' CG ' ' D' ' 15' ' ' GLU . . . 168.79 -126.32 1.37 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.456 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 147' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' E' ' 94' ' ' GLY . . . -111.13 128.42 55.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.812 0.339 . . . . 0.0 111.294 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.45 52.15 1.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.115 0.483 . . . . 0.0 110.412 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.75 152.0 20.16 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.611 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 150' ' ' ALA . . . . . 0.46 ' HB2' HD11 ' E' ' 86' ' ' LEU . . . -158.29 169.56 24.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.946 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.99 128.64 40.8 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.258 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 152' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -122.17 144.08 49.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.269 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 153' ' ' THR . . . . . 0.43 ' HB ' ' HZ1' ' E' ' 155' ' ' LYS . 0.6 OUTLIER -106.34 145.34 31.81 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.182 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -96.9 134.69 39.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.077 0.465 . . . . 0.0 110.069 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . 0.514 ' CE ' HD11 ' E' ' 74' ' ' LEU . 9.9 mmtt -124.22 148.08 47.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.863 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 156' ' ' VAL . . . . . 0.509 HG11 ' HA3' ' D' ' 7' ' ' GLY . 29.9 m -135.15 144.79 33.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.82 0.343 . . . . 0.0 111.685 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 157' ' ' GLN . . . . . 0.675 ' HG3' HG22 ' D' ' 4' ' ' THR . 0.0 OUTLIER -134.49 126.11 28.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.223 0.535 . . . . 0.0 110.362 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . 0.568 ' C ' ' HG3' ' E' ' 159' ' ' GLN . 5.2 m-85 -106.01 128.71 54.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.525 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 159' ' ' GLN . . . . . 0.568 ' HG3' ' C ' ' E' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.914 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 120.296 0.093 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.69 77.11 0.19 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.979 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 10.7 m -117.4 119.27 34.57 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.372 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 4.0 m -98.39 127.21 44.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.503 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.1 171.0 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.629 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.07 114.75 23.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.163 0.506 . . . . 0.0 110.602 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.79 -57.6 7.03 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.786 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -163.62 -144.64 4.1 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.884 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -155.7 140.41 17.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.872 0.367 . . . . 0.0 111.375 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 29.7 t -130.26 117.52 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.274 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.51 117.03 29.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.423 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -89.89 107.05 18.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.826 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.76 113.3 26.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.491 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -144.41 166.98 27.11 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.916 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -155.65 135.26 12.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.975 0.417 . . . . 0.0 110.341 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 16' ' ' VAL . . . . . 0.447 HG13 ' N ' ' F' ' 17' ' ' VAL . 66.0 t -96.63 138.3 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.248 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 17' ' ' VAL . . . . . 0.447 ' N ' HG13 ' F' ' 16' ' ' VAL . 2.6 m -140.8 -173.3 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 0.0 111.008 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.15 173.42 12.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.094 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.76 39.74 0.81 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.064 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' F' ' 66' ' ' ALA . . . -114.29 -33.57 5.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.445 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 21' ' ' CYS . . . . . 0.901 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.9 OUTLIER -161.18 150.04 16.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.971 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.69 112.08 4.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.105 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 23' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' F' ' 58' ' ' LEU . 3.1 p -59.97 153.34 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.01 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.72 152.8 28.19 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.647 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' D' ' 91' ' ' SER . . . -57.52 -41.55 81.11 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.292 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.72 15.72 61.91 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.984 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.98 -21.36 11.15 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.967 0.413 . . . . 0.0 110.848 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 90.1 t -44.55 -64.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.357 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.29 135.6 38.97 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.976 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.0 128.74 19.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.82 111.85 23.86 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.152 -0.477 . . . . 0.0 112.048 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . 0.483 HG21 HG13 ' E' ' 10' ' ' VAL . 4.2 t -110.88 114.7 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.168 0.508 . . . . 0.0 110.506 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.67 124.51 46.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.643 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 34' ' ' LEU . . . . . 0.69 ' HB3' ' HB1' ' C' ' 92' ' ' ALA . 0.9 OUTLIER -82.54 -45.65 14.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.578 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.31 -161.95 12.8 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.618 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 36' ' ' GLN . . . . . 0.601 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 1.8 mt-30 -99.79 129.65 45.92 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.622 0.248 . . . . 0.0 110.922 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.497 HG11 ' HA ' ' E' ' 16' ' ' VAL . 11.8 p -109.98 147.5 14.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.954 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 38' ' ' ARG . . . . . 0.517 ' HB3' ' HA ' ' E' ' 19' ' ' ALA . 0.7 OUTLIER -86.79 131.19 34.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.0 0.429 . . . . 0.0 111.8 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 39' ' ' THR . . . . . 0.469 HG22 ' HA ' ' E' ' 18' ' ' ASN . 4.8 t -54.03 -45.16 71.5 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.758 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.92 -39.39 89.2 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.078 0.466 . . . . 0.0 110.943 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 41' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' F' ' 38' ' ' ARG . 0.4 OUTLIER -70.54 -23.22 62.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.157 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' F' ' 139' ' ' ALA . 1.4 mp -124.59 51.54 1.6 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.651 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.6 30.0 7.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.43 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.86 128.49 48.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.308 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . 0.614 ' HA ' ' O ' ' F' ' 140' ' ' THR . 29.2 tt0 -53.05 103.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 111.072 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . 0.404 ' HA2' ' HE1' ' F' ' 138' ' ' PHE . . . 96.01 39.05 4.42 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.101 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.14 146.68 31.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.64 125.1 19.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.897 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 49' ' ' SER . . . . . . . . . . . . . 32.5 m -101.98 -166.29 1.28 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.614 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.98 133.06 55.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.869 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 51' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' F' ' 136' ' ' ARG . . . -92.72 120.18 32.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.726 0.298 . . . . 0.0 111.246 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 52' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' C' ' 90' ' ' SER . 18.6 m -65.85 162.67 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.888 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.83 124.07 5.26 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.635 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 54' ' ' PHE . . . . . 0.596 ' HE2' ' HB1' ' F' ' 135' ' ' ALA . 54.1 p90 -155.86 146.56 22.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.643 0.258 . . . . 0.0 111.027 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 55' ' ' ASN . . . . . 0.693 ' HB2' HG21 ' F' ' 130' ' ' THR . 3.3 p30 -136.87 160.26 39.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.528 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 56' ' ' ILE . . . . . 0.53 HG22 HD11 ' F' ' 58' ' ' LEU . 1.6 tp -100.65 116.91 45.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.555 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 57' ' ' GLN . . . . . 0.521 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.0 OUTLIER -70.04 124.61 24.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.76 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . 0.672 HD23 ' HB3' ' F' ' 21' ' ' CYS . 1.6 mp -133.77 87.48 2.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.216 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 59' ' ' ASN . . . . . 0.559 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 4.9 p30 -73.69 174.57 8.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.931 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.82 79.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.763 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 61' ' ' CYS . . . . . 0.901 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 93.2 m -127.66 159.43 34.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.817 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . 0.422 ' O ' ' HG ' ' F' ' 124' ' ' LEU . 5.5 t70 -130.27 167.07 19.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.288 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.24 -41.7 3.45 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.57 -22.63 65.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.989 0.423 . . . . 0.0 111.694 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 82.8 t -70.4 -74.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.657 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 66' ' ' ALA . . . . . 0.534 ' HB2' ' HB3' ' F' ' 20' ' ' ALA . . . -120.75 131.34 54.45 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.629 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.24 -48.62 6.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.907 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 68' ' ' LYS . . . . . 0.6 ' HE3' ' HB3' ' F' ' 121' ' ' GLU . 0.1 OUTLIER -96.2 161.51 13.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.617 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.09 124.72 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.641 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.46 154.97 18.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.061 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 71' ' ' VAL . . . . . 0.587 HG13 HD11 ' F' ' 131' ' ' ILE . 2.3 t -132.73 148.33 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.69 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -145.6 150.15 35.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.644 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 73' ' ' PHE . . . . . 0.52 ' CB ' HD11 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -119.91 137.02 54.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.488 0.185 . . . . 0.0 111.059 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 74' ' ' LEU . . . . . 0.527 HD11 ' CE ' ' F' ' 155' ' ' LYS . 0.9 OUTLIER -96.14 139.5 32.21 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.918 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' F' ' 113' ' ' LEU . . . 178.54 179.81 48.49 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.833 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 76' ' ' THR . . . . . 0.543 ' H ' HD21 ' F' ' 86' ' ' LEU . 0.3 OUTLIER -110.9 156.42 21.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.507 0.194 . . . . 0.0 110.856 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 77' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' F' ' 83' ' ' THR . . . -73.81 131.26 41.35 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 78' ' ' ILE . . . . . 0.639 ' CG2' ' HB ' ' F' ' 85' ' ' VAL . 0.9 OUTLIER -67.69 -41.45 85.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.799 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.12 40.77 1.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.773 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 66.45 -80.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.996 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.65 -24.99 41.92 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.696 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.01 63.93 1.37 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.851 0.358 . . . . 0.0 110.455 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 83' ' ' THR . . . . . 0.446 ' HA ' ' HB1' ' F' ' 77' ' ' ALA . 0.2 OUTLIER -68.5 -16.79 64.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.535 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 84' ' ' ASN . . . . . 0.688 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 18.0 p-10 -70.42 -20.25 62.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.329 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 85' ' ' VAL . . . . . 0.639 ' HB ' ' CG2' ' F' ' 78' ' ' ILE . 14.6 t -106.92 130.7 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.165 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 86' ' ' LEU . . . . . 0.543 HD21 ' H ' ' F' ' 76' ' ' THR . 0.5 OUTLIER -67.61 148.21 51.71 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -89.65 -167.47 1.87 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.87 0.367 . . . . 0.0 111.732 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . 0.621 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 1.5 mm? -78.34 157.22 29.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.054 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.61 -78.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.345 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.05 0.47 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.021 0.438 . . . . 0.0 111.469 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 91' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' F' ' 95' ' ' SER . 1.7 m -71.82 82.93 0.91 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.66 -13.95 61.87 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.863 0.364 . . . . 0.0 111.688 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.64 27.61 5.23 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.632 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 94' ' ' GLY . . . . . 0.553 ' O ' ' HB3' ' F' ' 147' ' ' ALA . . . -166.63 15.59 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.487 -0.864 . . . . 0.0 112.928 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 95' ' ' SER . . . . . 0.621 ' HB3' ' HG ' ' F' ' 88' ' ' LEU . 3.0 m -100.86 -172.82 2.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.713 0.292 . . . . 0.0 110.639 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.89 167.66 9.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.788 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 97' ' ' THR . . . . . 0.486 ' H ' ' HB ' ' F' ' 144' ' ' THR . 2.3 m -121.59 128.3 51.82 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.343 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 98' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' F' ' 141' ' ' GLY . 75.9 m-20 64.27 34.56 10.65 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.415 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 99' ' ' VAL . . . . . 0.46 ' C ' HD11 ' F' ' 78' ' ' ILE . 0.5 OUTLIER -139.99 136.5 38.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.683 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.13 -156.87 8.34 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.577 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 101' ' ' VAL . . . . . 0.601 HG21 HD21 ' F' ' 34' ' ' LEU . 3.2 p -137.77 116.72 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 122.973 0.509 . . . . 0.0 111.616 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 102' ' ' GLN . . . . . 0.576 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 1.2 tt0 -91.93 150.43 21.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 103' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' F' ' 111' ' ' LEU . 0.5 OUTLIER -113.87 131.32 66.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.542 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 104' ' ' LEU . . . . . 0.519 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 0.3 OUTLIER -106.29 130.1 54.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.645 0.259 . . . . 0.0 111.014 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . 0.537 ' HB3' HG23 ' F' ' 107' ' ' THR . 5.1 t0 -76.02 156.97 33.54 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.697 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 106' ' ' ARG . . . . . 0.732 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 3.5 ttp180 -71.31 -17.47 62.45 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.691 0.281 . . . . 0.0 111.061 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 107' ' ' THR . . . . . 0.537 HG23 ' HB3' ' F' ' 105' ' ' ASP . 6.2 t -67.19 -18.03 65.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 108' ' ' GLY . . . . . 0.539 ' HA2' ' HB2' ' C' ' 80' ' ' ALA . . . 123.74 -45.63 1.17 Allowed Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.748 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.09 163.12 23.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.671 0.272 . . . . 0.0 111.181 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -84.16 127.45 33.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.067 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . 0.577 HD21 ' HZ ' ' F' ' 133' ' ' PHE . 12.1 tp -86.28 156.18 20.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.317 0.58 . . . . 0.0 110.614 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 112' ' ' THR . . . . . 0.688 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 0.5 OUTLIER -106.31 139.09 41.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.095 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 113' ' ' LEU . . . . . 0.417 ' HB3' ' HA3' ' F' ' 75' ' ' GLY . 1.0 OUTLIER -73.92 76.49 1.66 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.697 0.284 . . . . 0.0 110.746 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.45 -17.2 14.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.507 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.25 -51.8 1.25 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.647 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.05 18.89 21.57 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.918 0.39 . . . . 0.0 111.52 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.77 84.64 7.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' F' ' 71' ' ' VAL . 95.7 m-85 -101.42 98.74 9.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.741 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 39.3 m -130.84 62.44 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.802 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.3 145.83 30.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.655 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 121' ' ' GLU . . . . . 0.6 ' HB3' ' HE3' ' F' ' 68' ' ' LYS . 3.5 mm-40 -121.34 71.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.223 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 134.7 34.72 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.738 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 15.2 m -83.81 113.68 21.09 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.739 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . 0.645 HD13 ' SG ' ' F' ' 21' ' ' CYS . 19.0 tp -74.01 142.96 45.75 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.751 0.31 . . . . 0.0 110.589 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.59 162.02 35.63 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.615 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.66 113.12 12.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.718 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . 0.418 ' CA ' HG21 ' B' ' 4' ' ' THR . . . 142.55 -139.9 9.48 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.779 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 128' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 6.7 m -101.75 96.78 7.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.726 0.298 . . . . 0.0 110.795 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.61 148.56 27.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.925 0.393 . . . . 0.0 111.112 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 130' ' ' THR . . . . . 0.693 HG21 ' HB2' ' F' ' 55' ' ' ASN . 0.2 OUTLIER -138.57 143.4 39.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.158 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 131' ' ' ILE . . . . . 0.587 HD11 HG13 ' F' ' 71' ' ' VAL . 54.9 mt -104.66 112.45 65.33 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 132' ' ' PRO . . . . . 0.732 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.4 Cg_endo -81.93 141.94 12.22 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.758 1.639 . . . . 0.0 112.492 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 133' ' ' PHE . . . . . 0.577 ' HZ ' HD21 ' F' ' 111' ' ' LEU . 0.3 OUTLIER -150.67 141.1 22.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.845 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -104.48 152.63 22.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.091 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . 0.596 ' HB1' ' HE2' ' F' ' 54' ' ' PHE . . . -153.54 101.03 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.931 0.396 . . . . 0.0 111.615 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 136' ' ' ARG . . . . . 0.558 ' HB3' ' HA ' ' F' ' 51' ' ' ALA . 17.4 ptt180 -107.11 177.32 4.89 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.428 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 137' ' ' TYR . . . . . 0.682 ' HB3' HD22 ' F' ' 42' ' ' LEU . 4.6 m-85 -86.02 124.08 32.06 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.979 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 138' ' ' PHE . . . . . 0.48 ' HB3' HG11 ' F' ' 85' ' ' VAL . 1.2 t80 -118.81 112.38 19.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.016 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 139' ' ' ALA . . . . . 0.688 ' HB3' HD21 ' F' ' 42' ' ' LEU . . . -102.95 133.95 47.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.921 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 140' ' ' THR . . . . . 0.614 ' O ' ' HA ' ' F' ' 45' ' ' GLU . 0.1 OUTLIER -81.05 -28.89 35.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.547 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . 0.409 ' H ' ' HB3' ' F' ' 98' ' ' ASN . . . -160.18 -111.11 0.28 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.864 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.78 110.61 21.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.511 0.196 . . . . 0.0 110.784 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 143' ' ' ALA . . . . . 0.463 ' O ' ' OG1' ' F' ' 39' ' ' THR . . . -65.69 134.31 52.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 111.336 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 144' ' ' THR . . . . . 0.944 ' O ' HG12 ' E' ' 16' ' ' VAL . 56.7 m -105.9 149.42 38.01 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.268 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 145' ' ' PRO . . . . . 0.483 ' CD ' ' CG2' ' F' ' 144' ' ' THR . 1.5 Cg_endo -82.84 125.45 4.22 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.541 2.161 . . . . 0.0 112.03 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 146' ' ' GLY . . . . . 0.685 ' O ' ' CG ' ' E' ' 15' ' ' GLU . . . 168.77 -126.32 1.37 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.418 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 147' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' F' ' 94' ' ' GLY . . . -111.05 128.46 55.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.772 0.32 . . . . 0.0 111.355 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.48 52.09 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.162 0.506 . . . . 0.0 110.402 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -98.68 151.94 20.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.627 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 150' ' ' ALA . . . . . 0.445 ' HB2' HD11 ' F' ' 86' ' ' LEU . . . -158.27 169.51 24.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.986 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.93 128.67 40.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.249 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 152' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -122.21 144.04 49.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.233 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 153' ' ' THR . . . . . 0.436 ' HB ' ' HZ1' ' F' ' 155' ' ' LYS . 0.6 OUTLIER -106.3 145.38 31.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -96.98 134.69 40.0 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.107 0.48 . . . . 0.0 110.053 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . 0.527 ' CE ' HD11 ' F' ' 74' ' ' LEU . 9.9 mmtt -124.22 148.06 47.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.88 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 156' ' ' VAL . . . . . 0.511 HG11 ' HA3' ' E' ' 7' ' ' GLY . 29.8 m -135.12 144.85 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.818 0.342 . . . . 0.0 111.787 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 157' ' ' GLN . . . . . 0.684 ' HG3' HG22 ' E' ' 4' ' ' THR . 0.0 OUTLIER -134.54 126.04 28.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.304 0.573 . . . . 0.0 110.362 -179.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . 0.561 ' C ' ' HG3' ' F' ' 159' ' ' GLN . 5.2 m-85 -106.0 128.73 54.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.559 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 159' ' ' GLN . . . . . 0.561 ' HG3' ' C ' ' F' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.259 -0.876 . . . . 0.0 110.817 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.258 0.075 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.61 71.05 0.5 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.992 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' B' ' 157' ' ' GLN . 4.9 m -114.68 127.37 55.72 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.431 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.3 m -117.71 106.76 13.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.704 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.9 174.61 12.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.58 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.1 119.87 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.528 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.27 -49.49 15.47 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.827 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.3 -154.89 11.32 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.866 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.6 p -142.39 140.01 31.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.949 0.404 . . . . 0.0 111.223 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.69 113.82 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.23 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.08 110.32 20.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.404 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.24 111.56 22.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.75 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.507 ' HE3' HG11 ' A' ' 28' ' ' VAL . 3.6 tmtm? -102.98 110.59 22.56 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.438 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.26 168.33 22.63 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.952 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' B' ' 36' ' ' GLN . 3.6 tt0 -158.98 133.08 7.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.898 0.38 . . . . 0.0 110.417 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.647 HG21 HG12 ' B' ' 99' ' ' VAL . 13.0 t -99.64 143.17 13.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.25 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.568 HG22 ' O ' ' B' ' 37' ' ' VAL . 3.9 m -141.41 -172.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.912 0.387 . . . . 0.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.537 ' HA ' HG22 ' B' ' 39' ' ' THR . 0.6 OUTLIER -89.46 -176.97 5.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.083 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.87 46.94 1.36 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.055 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . . . -127.75 -29.98 2.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.443 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 1.01 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -163.11 158.45 21.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.907 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.39 118.53 2.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.026 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -66.27 153.1 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.025 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.75 158.75 20.64 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.603 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.03 -34.4 74.79 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.347 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.1 12.99 63.72 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.91 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.77 -22.4 10.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.791 0.329 . . . . 0.0 110.77 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.507 HG11 ' HE3' ' A' ' 13' ' ' LYS . 19.6 t -43.93 -64.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.359 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.05 135.83 41.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.968 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.17 125.72 20.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.088 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.76 106.53 18.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.066 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.74 117.06 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.074 0.464 . . . . 0.0 110.418 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.7 131.03 45.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.584 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.77 -47.37 7.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.586 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.41 -163.53 12.16 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.562 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -101.07 126.62 47.77 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.684 0.278 . . . . 0.0 110.833 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.453 HG13 ' CE1' ' A' ' 137' ' ' TYR . 14.9 p -110.42 146.84 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.923 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.406 ' H ' ' HG3' ' A' ' 38' ' ' ARG . 2.8 mtp180 -82.85 139.18 33.62 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.74 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 143' ' ' ALA . 5.4 t -62.79 -37.42 86.6 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.746 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.46 71.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.108 0.48 . . . . 0.0 110.829 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.03 -17.76 45.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.112 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.623 HD21 ' HB3' ' A' ' 139' ' ' ALA . 4.3 mp -125.65 33.1 5.17 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.668 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.74 18.87 18.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.312 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.87 130.3 52.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.431 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 140' ' ' THR . 22.5 tt0 -56.38 107.38 0.37 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.866 0.365 . . . . 0.0 111.016 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.53 30.57 5.84 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.214 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 138' ' ' PHE . . . -76.57 136.65 39.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 112.081 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 52.3 p -134.87 134.73 41.04 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.869 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 70.9 m -108.79 -168.22 1.32 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.637 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.0 t -63.89 128.45 35.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.795 0.331 . . . . 0.0 110.799 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.64 ' HB3' ' HB3' ' A' ' 134' ' ' GLN . . . -80.41 130.0 34.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.436 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.584 HG11 ' O ' ' A' ' 135' ' ' ALA . 2.8 m -74.84 151.22 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.925 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.98 119.22 5.67 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.577 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -153.86 152.09 30.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.729 0.3 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -148.74 162.94 38.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.633 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 56' ' ' ILE . 1.2 tp -105.98 114.82 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.548 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.794 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -70.69 124.53 24.48 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.721 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -132.32 88.81 2.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.203 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -75.31 169.47 18.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.895 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.409 ' CG ' ' HD2' ' B' ' 38' ' ' ARG . 0.4 OUTLIER 66.39 68.23 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.773 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 1.01 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 56.3 m -117.11 155.03 30.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.763 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.595 ' HB2' HH22 ' B' ' 38' ' ' ARG . 20.0 t70 -135.76 155.69 49.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.214 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -111.15 -34.23 6.24 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.141 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.08 -22.13 66.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 0.0 111.755 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.6 -59.54 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.696 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . . . -116.84 129.18 55.92 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.646 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -60.31 2.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.856 0.36 . . . . 0.0 110.964 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.493 ' HZ1' ' HA ' ' A' ' 123' ' ' THR . 0.2 OUTLIER -105.28 -175.33 2.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.499 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.0 131.36 9.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.52 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.04 151.14 25.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.036 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.619 HG13 HD11 ' A' ' 131' ' ' ILE . 2.0 t -129.46 158.31 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.714 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.563 ' HA ' HD23 ' A' ' 111' ' ' LEU . . . -152.66 143.09 22.62 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.579 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.43 ' HB3' HD23 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -112.32 141.47 46.0 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.683 0.278 . . . . 0.0 111.019 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.575 HD22 HG22 ' D' ' 130' ' ' THR . 0.3 OUTLIER -107.64 139.47 42.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.012 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.75 -179.54 46.85 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.816 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.763 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.3 OUTLIER -103.85 156.35 17.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.634 0.254 . . . . 0.0 110.823 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.34 118.35 21.17 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.93 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' A' ' 82' ' ' HIS . 0.4 OUTLIER -59.03 -29.11 40.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.81 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.74 50.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.805 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.22 -89.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.079 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.07 -32.55 42.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.584 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.564 ' HB3' HG22 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -81.12 62.84 5.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.892 0.377 . . . . 0.0 110.384 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.436 HG23 ' HD2' ' D' ' 106' ' ' ARG . 0.2 OUTLIER -74.63 -18.18 60.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.585 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.692 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 20.4 p-10 -75.91 -7.48 54.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.266 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.483 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 24.1 t -117.7 124.22 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.214 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 150' ' ' ALA . 0.5 OUTLIER -66.19 139.33 58.11 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.278 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 150' ' ' ALA . . . -84.85 -165.42 1.19 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.705 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.758 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 0.7 OUTLIER -71.91 168.67 17.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.963 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.86 -79.24 0.06 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.335 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.767 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 2.4 p -168.84 6.0 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.016 0.436 . . . . 0.0 111.545 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.607 ' O ' ' HB2' ' A' ' 95' ' ' SER . 69.8 m -77.57 83.27 3.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.906 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' D' ' 50' ' ' SER . . . -55.07 -34.65 63.78 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.882 0.373 . . . . 0.0 111.626 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.27 31.51 6.31 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.604 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.641 ' O ' ' HB3' ' A' ' 147' ' ' ALA . . . -156.59 7.46 0.23 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.919 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.758 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -110.78 -174.32 2.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.921 0.391 . . . . 0.0 110.588 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -97.75 179.07 4.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.968 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.737 ' H ' ' HB ' ' A' ' 144' ' ' THR . 1.1 m -132.31 125.97 32.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.331 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 97' ' ' THR . 66.2 m-20 66.61 25.88 9.87 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.45 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.421 ' C ' HD11 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -127.66 130.4 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.657 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.14 -161.35 10.74 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.508 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.84 131.94 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.096 0.559 . . . . 0.0 111.825 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.71 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 1.5 tt0 -98.48 151.44 20.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.923 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.525 ' N ' ' HG2' ' A' ' 102' ' ' GLN . 0.3 OUTLIER -117.34 128.62 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.542 179.485 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.792 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -103.01 133.51 48.01 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.713 0.292 . . . . 0.0 111.034 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.543 ' HB3' HG23 ' A' ' 107' ' ' THR . 7.1 t0 -87.71 158.39 18.82 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.659 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -70.47 -27.67 64.41 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.78 0.324 . . . . 0.0 111.081 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.543 HG23 ' HB3' ' A' ' 105' ' ' ASP . 2.8 t -51.76 -25.67 8.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.047 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.08 -39.18 1.74 Allowed Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.603 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.33 157.97 17.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 111.032 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.792 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -70.33 137.12 50.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.079 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.563 HD23 ' HA ' ' A' ' 72' ' ' ALA . 13.5 tp -87.54 158.41 18.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.29 0.567 . . . . 0.0 110.555 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.692 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.5 OUTLIER -101.74 142.0 33.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.116 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' A' ' 73' ' ' PHE . 1.9 mt -82.41 65.57 7.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.71 0.291 . . . . 0.0 110.702 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.09 -14.93 21.23 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.52 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.25 -54.16 0.7 Allowed Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.596 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.2 28.92 8.27 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.016 0.436 . . . . 0.0 111.651 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.72 76.54 8.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.169 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.586 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 91.6 m-85 -91.01 96.75 10.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.743 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 68.0 m -132.67 78.25 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.7 136.9 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.667 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.01 76.2 0.98 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.275 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.83 135.51 33.68 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.732 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.493 ' HA ' ' HZ1' ' A' ' 68' ' ' LYS . 11.7 m -77.08 96.35 4.42 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.71 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.498 ' HA ' HD12 ' A' ' 124' ' ' LEU . 10.8 tp -68.21 132.95 48.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.567 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.48 ' HA ' ' HG1' ' A' ' 63' ' ' THR . 2.3 m120 -128.46 166.86 17.95 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.582 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -79.45 105.75 10.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.656 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.03 -137.04 5.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.749 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 3.7 m -103.61 83.47 2.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.753 0.311 . . . . 0.0 110.825 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.671 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 1.7 t30 -71.03 139.88 50.6 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.911 0.386 . . . . 0.0 111.158 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.794 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -133.95 139.66 46.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.158 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.619 HD11 HG13 ' A' ' 71' ' ' VAL . 61.7 mt -98.07 110.53 56.29 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -81.8 135.15 8.79 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.777 1.651 . . . . 0.0 112.528 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.72 152.71 41.63 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.791 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.64 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 50.6 mt-30 -119.0 156.85 28.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.067 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.71 ' HA ' ' O ' ' A' ' 102' ' ' GLN . . . -151.39 101.79 2.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.372 . . . . 0.0 111.65 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.6 168.37 9.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.364 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -80.11 123.26 27.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.194 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 1.3 t80 -126.16 119.13 26.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.026 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.623 ' HB3' HD21 ' A' ' 42' ' ' LEU . . . -112.02 125.2 53.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.888 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -68.93 -48.19 63.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.51 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -133.1 -120.0 2.08 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.043 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.42 111.94 18.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.597 0.237 . . . . 0.0 110.68 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -61.89 113.82 3.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.781 0.324 . . . . 0.0 111.447 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.737 ' HB ' ' H ' ' A' ' 97' ' ' THR . 75.1 m -88.31 145.25 35.43 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.32 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.83 134.26 7.2 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.458 2.106 . . . . 0.0 111.987 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.87 -135.59 4.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.553 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.641 ' HB3' ' O ' ' A' ' 94' ' ' GLY . . . -96.21 134.21 39.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.889 0.376 . . . . 0.0 111.301 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.78 50.5 2.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.135 0.493 . . . . 0.0 110.499 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -99.01 146.17 26.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.503 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.552 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -154.99 174.12 15.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.932 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -139.33 128.45 23.82 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.16 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.46 ' HB3' HD12 ' A' ' 86' ' ' LEU . . . -118.4 133.29 56.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.159 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.92 147.41 22.99 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.25 130.28 53.42 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.131 0.491 . . . . 0.0 110.07 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.554 ' HE2' HD11 ' A' ' 74' ' ' LEU . 11.3 mmtt -126.69 143.99 51.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.871 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.4 151.9 34.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.645 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.36 121.12 13.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.263 0.554 . . . . 0.0 110.404 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 21' ' ' CYS . 1.2 m-85 -98.28 121.65 40.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.548 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.822 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 111.188 0.07 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.62 71.07 0.5 Allowed 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.148 0.28 . . . . 0.0 110.93 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' C' ' 157' ' ' GLN . 4.9 m -114.67 127.43 55.76 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.464 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 20.5 m -117.75 106.85 13.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.623 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.0 174.66 12.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.612 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.13 119.89 36.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.501 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.23 -49.55 15.42 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.835 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.28 -154.87 11.3 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.845 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -142.41 140.04 31.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.974 0.416 . . . . 0.0 111.224 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.76 113.82 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.177 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.08 110.3 20.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.365 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -90.18 111.53 22.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.78 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.498 ' HE3' HG11 ' B' ' 28' ' ' VAL . 3.6 tmtm? -102.96 110.52 22.46 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.49 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.19 168.35 22.59 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.0 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' C' ' 36' ' ' GLN . 3.6 tt0 -159.01 133.06 7.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.473 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.645 HG21 HG12 ' C' ' 99' ' ' VAL . 13.1 t -99.62 143.22 13.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.25 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.571 HG22 ' O ' ' C' ' 37' ' ' VAL . 3.9 m -141.48 -172.15 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.838 0.352 . . . . 0.0 110.992 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . 0.549 ' HA ' HG22 ' C' ' 39' ' ' THR . 0.6 OUTLIER -89.43 -177.02 5.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.083 -179.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.77 46.91 1.36 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . . . -127.77 -29.93 2.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.498 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER -163.18 158.41 21.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.94 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.39 118.54 2.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.041 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' B' ' 58' ' ' LEU . 0.8 OUTLIER -66.27 153.05 8.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.018 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.75 158.73 20.65 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.582 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.02 -34.39 74.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.345 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.14 13.07 63.6 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.914 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.81 -22.43 10.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.84 0.353 . . . . 0.0 110.782 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.498 HG11 ' HE3' ' B' ' 13' ' ' LYS . 19.8 t -44.08 -64.21 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.348 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.09 135.85 41.89 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.005 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.15 125.67 20.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.058 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.8 106.54 18.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.058 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.68 117.07 53.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.455 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.71 131.05 45.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.597 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.8 -47.32 7.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.658 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.34 -163.61 12.15 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.561 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.67 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 3.7 mt-30 -100.98 126.6 47.65 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.65 0.262 . . . . 0.0 110.817 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.568 ' O ' HG22 ' A' ' 17' ' ' VAL . 14.9 p -110.4 146.89 15.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.9 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.595 HH22 ' HB2' ' A' ' 62' ' ' ASP . 2.9 mtp180 -82.92 139.17 33.53 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.655 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.537 HG22 ' HA ' ' A' ' 18' ' ' ASN . 5.4 t -62.77 -37.44 86.67 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.778 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.45 71.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.072 0.463 . . . . 0.0 110.818 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.05 -17.75 45.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.171 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.637 HD21 ' HB3' ' B' ' 139' ' ' ALA . 4.3 mp -125.66 33.11 5.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.662 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.74 18.89 18.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.341 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.92 130.26 52.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.387 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' B' ' 140' ' ' THR . 22.5 tt0 -56.27 107.29 0.35 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.832 0.349 . . . . 0.0 111.095 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.52 30.56 5.84 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.195 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' B' ' 138' ' ' PHE . . . -76.6 136.76 39.22 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.986 0.422 . . . . 0.0 112.093 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' B' ' 137' ' ' TYR . 51.6 p -134.99 134.69 40.74 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.822 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 70.8 m -108.74 -168.14 1.31 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.65 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 23.3 t -63.93 128.44 35.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.774 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' B' ' 134' ' ' GLN . . . -80.41 129.96 34.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.451 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.591 HG11 ' O ' ' B' ' 135' ' ' ALA . 2.8 m -74.87 151.26 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.922 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.05 119.25 5.67 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.512 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.81 152.12 30.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.783 0.325 . . . . 0.0 110.951 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -148.75 162.96 38.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.661 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.449 HG22 ' O ' ' B' ' 56' ' ' ILE . 1.2 tp -105.94 114.87 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.573 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . 0.808 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -70.72 124.51 24.46 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.749 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 0.2 OUTLIER -132.32 88.78 2.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.242 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.571 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 0.1 OUTLIER -75.31 169.44 18.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' C' ' 38' ' ' ARG . 0.4 OUTLIER 66.38 68.25 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.788 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 56.3 m -117.11 155.0 30.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.816 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . 0.585 ' HB2' HH22 ' C' ' 38' ' ' ARG . 19.9 t70 -135.74 155.65 50.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.311 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.495 HG23 ' O ' ' B' ' 124' ' ' LEU . 0.2 OUTLIER -111.11 -34.17 6.26 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.12 -22.17 66.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.008 0.433 . . . . 0.0 111.735 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.54 -59.54 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.767 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.417 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . . . -116.76 129.16 55.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.706 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.16 -60.29 2.2 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.921 0.391 . . . . 0.0 111.019 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.512 ' HZ1' ' HA ' ' B' ' 123' ' ' THR . 0.2 OUTLIER -105.26 -175.38 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.479 179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.96 131.3 9.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.55 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.95 151.2 24.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.067 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.615 HG13 HD11 ' B' ' 131' ' ' ILE . 2.0 t -129.45 158.31 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.788 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.566 ' HA ' HD23 ' B' ' 111' ' ' LEU . . . -152.73 143.1 22.57 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.558 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' B' ' 113' ' ' LEU . 0.1 OUTLIER -112.3 141.49 45.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.648 0.261 . . . . 0.0 111.034 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.587 HD22 HG22 ' E' ' 130' ' ' THR . 0.3 OUTLIER -107.67 139.51 42.13 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.966 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.76 -179.46 46.91 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.851 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.745 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.3 OUTLIER -103.96 156.33 17.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.602 0.239 . . . . 0.0 110.782 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.33 118.42 21.23 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.943 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.562 HG22 ' HB3' ' B' ' 82' ' ' HIS . 0.4 OUTLIER -59.05 -29.07 40.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.75 50.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.14 -89.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.118 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.06 -32.49 42.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.652 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.562 ' HB3' HG22 ' B' ' 78' ' ' ILE . 0.3 OUTLIER -81.15 62.83 5.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.938 0.399 . . . . 0.0 110.43 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' THR . . . . . 0.461 HG23 ' HD2' ' E' ' 106' ' ' ARG . 0.2 OUTLIER -74.65 -18.13 60.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.557 -179.578 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . 0.686 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 20.4 p-10 -76.01 -7.38 54.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.279 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.482 ' HB ' ' CG2' ' B' ' 78' ' ' ILE . 23.9 t -117.68 124.12 72.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.235 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' B' ' 150' ' ' ALA . 0.5 OUTLIER -66.21 139.34 58.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' B' ' 150' ' ' ALA . . . -84.87 -165.42 1.19 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.674 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.739 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 0.7 OUTLIER -71.86 168.67 17.41 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.086 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.94 -79.18 0.06 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.279 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' SER . . . . . 0.752 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 2.4 p -168.88 5.91 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.048 0.452 . . . . 0.0 111.572 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' SER . . . . . 0.606 ' O ' ' HB2' ' B' ' 95' ' ' SER . 69.9 m -77.56 83.22 3.96 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.952 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' E' ' 50' ' ' SER . . . -55.02 -34.68 63.69 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.88 0.372 . . . . 0.0 111.617 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.22 31.49 6.33 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.571 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . 0.632 ' O ' ' HB3' ' B' ' 147' ' ' ALA . . . -156.58 7.49 0.23 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.943 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' SER . . . . . 0.739 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . 0.6 OUTLIER -110.73 -174.33 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.943 0.401 . . . . 0.0 110.581 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . 0.457 ' CB ' HG23 ' A' ' 16' ' ' VAL . . . -97.83 179.09 4.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.914 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.761 ' H ' ' HB ' ' B' ' 144' ' ' THR . 1.1 m -132.42 125.99 32.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.296 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' B' ' 97' ' ' THR . 66.1 m-20 66.66 25.84 9.79 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.422 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.647 HG12 HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -127.69 130.44 70.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.686 179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.08 -161.36 10.74 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.535 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.87 131.97 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 123.056 0.542 . . . . 0.0 111.756 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.721 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 1.5 tt0 -98.52 151.49 20.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.901 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.524 ' N ' ' HG2' ' B' ' 102' ' ' GLN . 0.3 OUTLIER -117.36 128.67 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.513 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . 0.784 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 0.3 OUTLIER -103.03 133.55 47.97 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.707 0.289 . . . . 0.0 111.01 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . 0.529 ' HB3' HG23 ' B' ' 107' ' ' THR . 7.2 t0 -87.78 158.46 18.76 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.601 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -70.47 -27.75 64.46 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.733 0.301 . . . . 0.0 111.026 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' THR . . . . . 0.529 HG23 ' HB3' ' B' ' 105' ' ' ASP . 2.8 t -51.73 -25.74 8.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.036 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.26 -39.25 1.73 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.58 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.31 158.05 17.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 0.0 111.0 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.784 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -70.36 137.11 50.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.063 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' B' ' 72' ' ' ALA . 13.5 tp -87.55 158.29 18.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.333 0.587 . . . . 0.0 110.563 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 0.5 OUTLIER -101.62 141.96 33.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.147 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' B' ' 73' ' ' PHE . 1.9 mt -82.32 65.54 7.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.734 0.302 . . . . 0.0 110.801 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.08 -14.94 21.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.542 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.28 -54.18 0.7 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.623 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.19 28.99 8.2 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.02 0.438 . . . . 0.0 111.69 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.8 76.6 7.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.124 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 91.4 m-85 -91.06 96.77 10.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.747 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 68.6 m -132.64 78.32 1.79 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.797 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.76 136.81 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.703 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -114.97 76.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.252 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.93 135.6 33.61 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.691 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.512 ' HA ' ' HZ1' ' B' ' 68' ' ' LYS . 11.8 m -77.12 96.28 4.44 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.703 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' B' ' 124' ' ' LEU . 10.8 tp -68.12 132.94 48.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.589 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.489 ' HA ' ' HG1' ' B' ' 63' ' ' THR . 2.3 m120 -128.47 166.74 18.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.601 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' B' ' 61' ' ' CYS . 6.2 t30 -79.38 105.78 10.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.697 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.03 -137.06 5.22 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.675 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 3.7 m -103.63 83.47 2.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.707 0.289 . . . . 0.0 110.773 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . 0.671 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 1.7 t30 -71.09 139.84 50.48 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.979 0.418 . . . . 0.0 111.148 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.808 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -133.91 139.6 46.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.133 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' ILE . . . . . 0.615 HD11 HG13 ' B' ' 71' ' ' VAL . 61.8 mt -97.99 110.48 55.93 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -81.74 135.13 8.85 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.75 1.633 . . . . 0.0 112.574 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.76 152.65 41.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.756 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' GLN . . . . . 0.639 ' HB3' ' HB3' ' B' ' 51' ' ' ALA . 50.5 mt-30 -118.96 156.9 28.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.065 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.721 ' HA ' ' O ' ' B' ' 102' ' ' GLN . . . -151.41 101.66 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.352 . . . . 0.0 111.659 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.58 168.33 9.17 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.35 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' B' ' 48' ' ' THR . 0.3 OUTLIER -80.06 123.32 27.75 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.173 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' B' ' 47' ' ' ALA . 1.3 t80 -126.2 119.12 26.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.948 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.637 ' HB3' HD21 ' B' ' 42' ' ' LEU . . . -111.99 125.16 53.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.919 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.22 63.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.507 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -133.1 -119.99 2.08 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.111 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.4 111.95 18.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.558 0.218 . . . . 0.0 110.738 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -61.91 113.82 3.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.784 0.326 . . . . 0.0 111.409 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.761 ' HB ' ' H ' ' B' ' 97' ' ' THR . 74.1 m -88.25 145.23 35.47 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.302 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 144' ' ' THR . 1.3 Cg_endo -82.82 134.19 7.17 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.546 2.164 . . . . 0.0 112.019 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.88 -135.58 4.41 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.529 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . 0.632 ' HB3' ' O ' ' B' ' 94' ' ' GLY . . . -96.16 134.2 39.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.86 0.362 . . . . 0.0 111.361 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.81 50.45 2.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.207 0.527 . . . . 0.0 110.506 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.438 HD21 ' HG2' ' A' ' 13' ' ' LYS . 3.4 m120 -98.93 146.15 26.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.551 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.558 ' HB2' HD11 ' B' ' 86' ' ' LEU . . . -154.91 174.08 15.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.883 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -139.31 128.49 23.93 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.171 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . 0.443 ' HB3' HD12 ' B' ' 86' ' ' LEU . . . -118.45 133.27 56.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.169 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.93 147.39 23.0 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.27 130.32 53.43 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.195 0.521 . . . . 0.0 110.037 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.554 ' HE2' HD11 ' B' ' 74' ' ' LEU . 11.2 mmtt -126.64 143.89 51.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.931 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.42 151.89 34.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.746 0.307 . . . . 0.0 111.709 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.663 ' HA ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -141.39 121.1 13.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.32 0.581 . . . . 0.0 110.342 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . 0.575 ' CD2' ' HB ' ' A' ' 3' ' ' THR . 1.2 m-85 -98.21 121.64 40.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.577 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.86 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 111.176 0.065 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.59 71.06 0.5 Allowed 'General case' 0 C--O 1.232 0.132 0 O-C-N 123.122 0.264 . . . . 0.0 111.023 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' THR . . . . . 0.667 ' O ' ' HA ' ' D' ' 157' ' ' GLN . 4.9 m -114.71 127.42 55.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.447 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 20.8 m -117.84 106.77 13.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.609 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.92 174.65 12.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.615 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.07 119.82 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.607 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.17 -49.5 15.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.835 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.32 -154.92 11.36 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.854 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -142.4 139.98 31.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.927 0.394 . . . . 0.0 111.292 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.74 113.93 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.155 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -87.16 110.3 20.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.313 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.23 111.54 22.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.776 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . 0.497 ' HE3' HG11 ' C' ' 28' ' ' VAL . 3.7 tmtm? -102.94 110.61 22.59 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.435 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.32 168.38 22.64 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.058 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' GLU . . . . . 0.662 ' O ' ' HA ' ' D' ' 36' ' ' GLN . 3.6 tt0 -159.01 133.09 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 0.0 110.413 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.633 HG21 HG12 ' D' ' 99' ' ' VAL . 13.3 t -99.74 143.27 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.203 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.57 HG22 ' O ' ' D' ' 37' ' ' VAL . 4.0 m -141.42 -172.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 111.074 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . 0.539 ' HA ' HG22 ' D' ' 39' ' ' THR . 0.6 OUTLIER -89.56 -176.94 5.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.058 -179.658 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.8 46.84 1.36 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.039 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' C' ' 66' ' ' ALA . . . -127.76 -29.96 2.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.924 0.392 . . . . 0.0 111.485 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' CYS . . . . . 1.0 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER -163.12 158.33 21.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.996 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.33 118.62 2.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.042 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' C' ' 58' ' ' LEU . 0.8 OUTLIER -66.28 153.07 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.086 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.78 158.73 20.62 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.613 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 91' ' ' SER . . . -61.01 -34.4 74.77 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.316 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.16 13.07 63.58 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.887 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.8 -22.44 10.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.801 0.334 . . . . 0.0 110.733 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.497 HG11 ' HE3' ' C' ' 13' ' ' LYS . 19.8 t -43.98 -64.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.336 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.04 135.83 41.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.949 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.21 125.72 20.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.066 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.74 106.53 18.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.15 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.75 117.05 53.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.067 0.461 . . . . 0.0 110.482 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.69 131.05 45.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.576 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.81 -47.31 7.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.607 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.33 -163.6 12.15 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.551 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . 0.673 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 3.7 mt-30 -100.98 126.59 47.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.634 0.255 . . . . 0.0 110.841 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . 0.571 ' O ' HG22 ' B' ' 17' ' ' VAL . 14.9 p -110.4 146.8 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.926 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' ARG . . . . . 0.585 HH22 ' HB2' ' B' ' 62' ' ' ASP . 2.8 mtp180 -82.8 139.08 33.74 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.757 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.549 HG22 ' HA ' ' B' ' 18' ' ' ASN . 5.5 t -62.74 -37.42 86.5 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.778 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.47 -31.49 71.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.125 0.488 . . . . 0.0 110.847 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.04 -17.73 45.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.102 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.64 HD21 ' HB3' ' C' ' 139' ' ' ALA . 4.3 mp -125.72 33.11 5.16 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.604 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.76 18.96 18.03 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.372 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.96 130.23 52.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.355 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' C' ' 140' ' ' THR . 22.5 tt0 -56.27 107.33 0.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.883 0.373 . . . . 0.0 111.088 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.6 30.51 5.83 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.133 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' C' ' 138' ' ' PHE . . . -76.58 136.62 39.25 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' C' ' 137' ' ' TYR . 52.2 p -134.91 134.73 40.95 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.848 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 71.1 m -108.76 -168.15 1.31 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.665 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 23.1 t -63.96 128.46 35.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.854 0.359 . . . . 0.0 110.756 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . 0.627 ' HB3' ' HB3' ' C' ' 134' ' ' GLN . . . -80.4 129.98 34.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.43 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . 0.592 HG11 ' O ' ' C' ' 135' ' ' ALA . 2.8 m -74.86 151.21 6.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.993 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.01 119.26 5.68 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.547 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.91 152.08 30.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.731 0.301 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -148.72 162.95 38.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.694 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.445 HG22 ' O ' ' C' ' 56' ' ' ILE . 1.2 tp -105.96 114.82 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.534 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.805 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.0 OUTLIER -70.67 124.54 24.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.703 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' C' ' 23' ' ' VAL . 0.2 OUTLIER -132.34 88.79 2.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.235 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 0.1 OUTLIER -75.28 169.44 18.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' D' ' 38' ' ' ARG . 0.4 OUTLIER 66.37 68.24 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.802 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' CYS . . . . . 1.0 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 56.3 m -117.13 155.04 30.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.809 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . 0.591 ' HB2' HH22 ' D' ' 38' ' ' ARG . 20.0 t70 -135.8 155.63 50.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.25 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.484 HG23 ' O ' ' C' ' 124' ' ' LEU . 0.2 OUTLIER -111.08 -34.22 6.25 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.121 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.13 -22.12 66.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.012 0.434 . . . . 0.0 111.705 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.57 -59.65 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.669 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' C' ' 20' ' ' ALA . . . -116.69 129.1 55.93 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.72 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.13 -60.28 2.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.914 0.388 . . . . 0.0 111.033 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' LYS . . . . . 0.491 ' HZ1' ' HA ' ' C' ' 123' ' ' THR . 0.2 OUTLIER -105.23 -175.34 2.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.49 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.93 131.38 9.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.604 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.05 151.18 24.99 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.841 0.353 . . . . 0.0 111.056 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . 0.623 HG13 HD11 ' C' ' 131' ' ' ILE . 2.0 t -129.47 158.32 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.766 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . 0.554 ' HA ' HD23 ' C' ' 111' ' ' LEU . . . -152.66 143.06 22.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.61 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' PHE . . . . . 0.431 ' HB3' HD23 ' C' ' 113' ' ' LEU . 0.1 OUTLIER -112.29 141.5 45.92 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.643 0.259 . . . . 0.0 111.068 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.571 HD22 HG22 ' F' ' 130' ' ' THR . 0.3 OUTLIER -107.71 139.45 42.26 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.955 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.79 -179.48 46.92 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.837 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' THR . . . . . 0.743 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.3 OUTLIER -103.97 156.38 17.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.607 0.241 . . . . 0.0 110.811 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.37 118.38 21.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.981 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . 0.568 HG22 ' HB3' ' C' ' 82' ' ' HIS . 0.4 OUTLIER -59.02 -29.09 40.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.887 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' ASP . . . . . 0.409 ' HB2' HG22 ' C' ' 140' ' ' THR . 0.1 OUTLIER -151.76 50.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.822 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.25 -89.9 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.069 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.06 -32.59 42.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.573 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . 0.568 ' HB3' HG22 ' C' ' 78' ' ' ILE . 0.3 OUTLIER -81.04 62.78 5.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.856 0.36 . . . . 0.0 110.438 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' THR . . . . . 0.458 HG23 ' HD2' ' F' ' 106' ' ' ARG . 0.2 OUTLIER -74.58 -18.21 60.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.61 -179.612 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' ASN . . . . . 0.693 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 20.4 p-10 -75.86 -7.49 54.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.329 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.487 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 23.9 t -117.68 124.16 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.217 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' C' ' 150' ' ' ALA . 0.5 OUTLIER -66.14 139.36 58.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.697 0.284 . . . . 0.0 110.244 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' C' ' 150' ' ' ALA . . . -84.9 -165.44 1.2 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.605 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.747 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 0.7 OUTLIER -71.88 168.65 17.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.012 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.93 -79.17 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.337 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' SER . . . . . 0.766 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 2.3 p -168.86 5.95 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 111.525 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' C' ' 95' ' ' SER . 69.7 m -77.54 83.21 3.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.971 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' F' ' 50' ' ' SER . . . -54.99 -34.67 63.59 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.89 0.376 . . . . 0.0 111.63 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.29 31.48 6.32 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.586 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' GLY . . . . . 0.634 ' O ' ' HB3' ' C' ' 147' ' ' ALA . . . -156.59 7.48 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.94 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' SER . . . . . 0.747 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 0.6 OUTLIER -110.74 -174.32 2.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.888 0.375 . . . . 0.0 110.612 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . 0.456 ' CB ' HG23 ' B' ' 16' ' ' VAL . . . -97.76 179.0 4.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' THR . . . . . 0.751 ' H ' ' HB ' ' C' ' 144' ' ' THR . 1.1 m -132.29 125.98 32.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.356 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' C' ' 97' ' ' THR . 66.0 m-20 66.57 25.92 9.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.396 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' VAL . . . . . 0.645 HG12 HG21 ' B' ' 16' ' ' VAL . 0.2 OUTLIER -127.7 130.37 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.705 179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.07 -161.39 10.76 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.501 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.88 131.95 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 123.094 0.558 . . . . 0.0 111.866 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' GLN . . . . . 0.712 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 1.5 tt0 -98.49 151.46 20.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.897 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . 0.524 ' N ' ' HG2' ' C' ' 102' ' ' GLN . 0.3 OUTLIER -117.33 128.64 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.58 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' LEU . . . . . 0.787 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 0.3 OUTLIER -102.98 133.46 48.05 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.654 0.264 . . . . 0.0 111.033 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . 0.542 ' HB3' HG23 ' C' ' 107' ' ' THR . 7.2 t0 -87.74 158.44 18.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.636 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -70.5 -27.72 64.42 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.714 0.293 . . . . 0.0 111.02 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' THR . . . . . 0.542 HG23 ' HB3' ' C' ' 105' ' ' ASP . 2.8 t -51.68 -25.68 7.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.096 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.16 -39.29 1.73 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.617 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.26 157.99 17.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.351 . . . . 0.0 111.065 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.787 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -70.32 137.07 50.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.111 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' LEU . . . . . 0.554 HD23 ' HA ' ' C' ' 72' ' ' ALA . 13.5 tp -87.56 158.47 18.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.382 0.611 . . . . 0.0 110.499 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' THR . . . . . 0.693 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 0.5 OUTLIER -101.76 141.97 33.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.123 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' C' ' 73' ' ' PHE . 1.9 mt -82.43 65.6 7.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 0.0 110.708 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.08 -14.93 21.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.528 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.19 -54.11 0.71 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.678 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.17 28.83 8.35 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.017 0.437 . . . . 0.0 111.721 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.72 76.6 8.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.24 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' C' ' 71' ' ' VAL . 91.3 m-85 -91.13 96.77 10.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.724 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 68.6 m -132.65 78.25 1.79 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.818 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.67 136.88 3.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.692 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.02 76.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.267 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.88 135.56 33.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.703 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' THR . . . . . 0.491 ' HA ' ' HZ1' ' C' ' 68' ' ' LYS . 11.8 m -77.05 96.33 4.4 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.73 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . 0.484 ' O ' HG23 ' C' ' 63' ' ' THR . 10.8 tp -68.25 132.92 47.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.627 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . 0.47 ' HA ' ' HG1' ' C' ' 63' ' ' THR . 2.2 m120 -128.49 166.83 18.02 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.569 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' C' ' 61' ' ' CYS . 6.3 t30 -79.43 105.76 10.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.696 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.05 -137.06 5.22 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.655 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 3.7 m -103.62 83.49 2.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.688 0.28 . . . . 0.0 110.778 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 129' ' ' ASN . . . . . 0.666 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 1.7 t30 -71.12 139.92 50.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.959 0.409 . . . . 0.0 111.099 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 130' ' ' THR . . . . . 0.805 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -134.0 139.7 46.23 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.024 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 131' ' ' ILE . . . . . 0.623 HD11 HG13 ' C' ' 71' ' ' VAL . 61.9 mt -98.07 110.55 56.37 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 132' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -81.79 135.13 8.78 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.753 1.635 . . . . 0.0 112.596 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.71 152.67 41.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.773 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 134' ' ' GLN . . . . . 0.627 ' HB3' ' HB3' ' C' ' 51' ' ' ALA . 50.6 mt-30 -119.01 156.9 28.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.07 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.712 ' HA ' ' O ' ' C' ' 102' ' ' GLN . . . -151.43 101.67 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 0.0 111.633 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.61 168.28 9.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.359 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 137' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' C' ' 48' ' ' THR . 0.3 OUTLIER -79.98 123.23 27.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.192 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 138' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' C' ' 47' ' ' ALA . 1.3 t80 -126.11 119.05 26.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.085 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 139' ' ' ALA . . . . . 0.64 ' HB3' HD21 ' C' ' 42' ' ' LEU . . . -111.95 125.21 53.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.954 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 140' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.17 64.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.543 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -133.15 -120.0 2.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.043 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.43 111.89 18.19 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.559 0.219 . . . . 0.0 110.708 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 143' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -61.88 113.78 2.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.794 0.331 . . . . 0.0 111.39 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 144' ' ' THR . . . . . 0.751 ' HB ' ' H ' ' C' ' 97' ' ' THR . 75.5 m -88.18 145.24 35.65 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.366 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.87 134.19 7.12 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.499 2.132 . . . . 0.0 112.005 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.93 -135.55 4.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.502 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 147' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' C' ' 94' ' ' GLY . . . -96.24 134.23 39.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.881 0.372 . . . . 0.0 111.336 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.85 50.49 2.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.161 0.505 . . . . 0.0 110.456 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 149' ' ' ASN . . . . . 0.436 HD21 ' HG2' ' B' ' 13' ' ' LYS . 3.5 m120 -98.95 146.15 26.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.555 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 150' ' ' ALA . . . . . 0.56 ' HB2' HD11 ' C' ' 86' ' ' LEU . . . -154.9 174.11 15.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.986 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -139.28 128.48 23.95 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.186 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . 0.46 ' HB3' HD12 ' C' ' 86' ' ' LEU . . . -118.43 133.35 55.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.11 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.97 147.41 22.98 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.26 130.25 53.44 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.125 0.488 . . . . 0.0 110.062 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . 0.564 ' HE2' HD11 ' C' ' 74' ' ' LEU . 11.2 mmtt -126.67 143.9 51.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.954 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 156' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.35 151.92 34.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.69 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . 0.663 ' HA ' ' O ' ' B' ' 3' ' ' THR . 0.0 OUTLIER -141.34 121.15 13.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.298 0.57 . . . . 0.0 110.37 -179.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . 0.574 ' CD2' ' HB ' ' B' ' 3' ' ' THR . 1.2 m-85 -98.26 121.63 40.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.56 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.808 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 111.261 0.097 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.62 71.14 0.5 Allowed 'General case' 0 N--CA 1.462 0.157 0 O-C-N 123.107 0.254 . . . . 0.0 110.96 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' E' ' 157' ' ' GLN . 4.8 m -114.68 127.32 55.69 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.475 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 20.2 m -117.7 106.77 13.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.633 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.91 174.64 12.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.567 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.13 119.83 36.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.586 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.2 -49.49 15.71 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.839 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.26 -154.82 11.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.848 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -142.49 140.04 31.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.983 0.421 . . . . 0.0 111.176 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.73 113.89 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.151 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.14 110.39 20.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.363 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.3 111.48 22.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.74 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' LYS . . . . . 0.507 ' HE3' HG11 ' D' ' 28' ' ' VAL . 3.6 tmtm? -102.96 110.5 22.44 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.453 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.19 168.31 22.6 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.014 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' E' ' 36' ' ' GLN . 3.6 tt0 -158.99 133.07 7.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.93 0.395 . . . . 0.0 110.4 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.647 HG21 HG12 ' E' ' 99' ' ' VAL . 13.2 t -99.65 143.14 14.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.286 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . 0.566 HG22 ' O ' ' E' ' 37' ' ' VAL . 3.9 m -141.33 -172.11 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.862 0.363 . . . . 0.0 111.074 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' ASN . . . . . 0.533 ' HA ' HG22 ' E' ' 39' ' ' THR . 0.6 OUTLIER -89.49 -176.91 5.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.034 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.87 46.95 1.36 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.106 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' D' ' 66' ' ' ALA . . . -127.77 -29.97 2.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' CYS . . . . . 1.006 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER -163.14 158.38 21.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.915 -179.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.35 118.54 2.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.103 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' D' ' 58' ' ' LEU . 0.8 OUTLIER -66.25 152.99 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.065 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -84.68 158.77 20.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.611 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.448 ' HB3' ' HA ' ' B' ' 91' ' ' SER . . . -61.03 -34.47 74.9 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.344 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.05 13.03 63.77 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.929 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.78 -22.43 10.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.776 0.322 . . . . 0.0 110.773 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . 0.507 HG11 ' HE3' ' D' ' 13' ' ' LYS . 19.8 t -44.04 -64.25 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.339 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.04 135.9 41.74 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.932 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -139.26 125.64 20.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.049 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.77 106.56 18.84 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.044 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.78 117.08 53.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.105 0.478 . . . . 0.0 110.431 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.74 131.09 45.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.527 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.8 -47.35 7.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.631 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.38 -163.56 12.16 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.564 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' GLN . . . . . 0.662 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 3.7 mt-30 -101.0 126.61 47.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.703 0.287 . . . . 0.0 110.83 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.57 ' O ' HG22 ' C' ' 17' ' ' VAL . 14.9 p -110.42 146.83 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.934 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . 0.591 HH22 ' HB2' ' C' ' 62' ' ' ASP . 2.9 mtp180 -82.87 139.17 33.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.7 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.539 HG22 ' HA ' ' C' ' 18' ' ' ASN . 5.4 t -62.78 -37.53 87.03 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.745 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.4 -31.5 71.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.125 0.488 . . . . 0.0 110.896 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.99 -17.77 45.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.165 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' D' ' 139' ' ' ALA . 4.3 mp -125.66 33.11 5.17 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.609 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.76 18.9 18.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.298 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.94 130.26 52.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.34 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' D' ' 140' ' ' THR . 22.5 tt0 -56.29 107.32 0.36 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.884 0.373 . . . . 0.0 111.088 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.62 30.5 5.84 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.111 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' D' ' 138' ' ' PHE . . . -76.56 136.71 39.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.973 0.415 . . . . 0.0 112.109 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' D' ' 137' ' ' TYR . 52.3 p -134.94 134.71 40.88 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.879 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 70.7 m -108.76 -168.16 1.31 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.641 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 23.3 t -63.99 128.52 36.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.743 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' D' ' 134' ' ' GLN . . . -80.42 130.02 34.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.467 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' VAL . . . . . 0.767 ' HB ' ' HA ' ' A' ' 90' ' ' SER . 2.8 m -74.85 151.28 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.04 119.23 5.66 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.516 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -153.9 152.12 30.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.788 0.328 . . . . 0.0 110.837 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -148.77 162.94 38.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.693 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.46 HG22 ' O ' ' D' ' 56' ' ' ILE . 1.2 tp -105.91 114.76 46.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.563 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' GLN . . . . . 0.794 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.0 OUTLIER -70.65 124.51 24.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.744 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . 0.534 ' HA ' ' HA ' ' D' ' 23' ' ' VAL . 0.2 OUTLIER -132.28 88.69 2.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.281 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . 0.587 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 0.1 OUTLIER -75.25 169.47 17.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' ASP . . . . . 0.404 ' CG ' ' HD2' ' E' ' 38' ' ' ARG . 0.4 OUTLIER 66.26 68.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.78 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' CYS . . . . . 1.006 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 56.2 m -117.13 155.07 29.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . 0.589 ' HB2' HH22 ' E' ' 38' ' ' ARG . 19.9 t70 -135.75 155.66 50.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.277 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.492 HG23 ' O ' ' D' ' 124' ' ' LEU . 0.2 OUTLIER -111.11 -34.25 6.24 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.05 -22.14 66.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.952 0.406 . . . . 0.0 111.729 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.62 -59.49 2.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.74 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' D' ' 20' ' ' ALA . . . -116.82 129.16 55.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.623 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -60.23 2.22 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.878 0.371 . . . . 0.0 111.001 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' LYS . . . . . 0.501 ' HZ1' ' HA ' ' D' ' 123' ' ' THR . 0.2 OUTLIER -105.21 -175.34 2.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.456 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.96 131.36 9.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.59 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.96 151.18 24.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.104 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . 0.604 HG13 HD11 ' D' ' 131' ' ' ILE . 2.0 t -129.52 158.3 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.754 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' ALA . . . . . 0.566 ' HA ' HD23 ' D' ' 111' ' ' LEU . . . -152.68 143.08 22.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.584 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' PHE . . . . . 0.432 ' HB3' HD23 ' D' ' 113' ' ' LEU . 0.1 OUTLIER -112.33 141.46 46.02 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.691 0.281 . . . . 0.0 111.004 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' LEU . . . . . 0.552 HD11 ' HE2' ' D' ' 155' ' ' LYS . 0.3 OUTLIER -107.69 139.52 42.13 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.018 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.79 -179.44 46.94 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.816 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' THR . . . . . 0.522 ' H ' HD21 ' D' ' 86' ' ' LEU . 0.3 OUTLIER -103.98 156.28 17.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.613 0.245 . . . . 0.0 110.767 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.3 118.38 21.17 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.969 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 78' ' ' ILE . . . . . 0.563 HG22 ' HB3' ' D' ' 82' ' ' HIS . 0.4 OUTLIER -59.01 -29.1 40.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.76 50.47 0.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.774 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.17 -89.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.09 -32.51 42.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.621 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . 0.563 ' HB3' HG22 ' D' ' 78' ' ' ILE . 0.3 OUTLIER -81.08 62.86 5.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 110.406 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.63 -18.18 60.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.558 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . 0.694 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 20.4 p-10 -76.04 -7.4 54.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.176 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.485 ' HB ' ' CG2' ' D' ' 78' ' ' ILE . 24.0 t -117.73 124.14 72.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.243 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.551 HD11 ' HB2' ' D' ' 150' ' ' ALA . 0.5 OUTLIER -66.15 139.35 58.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.713 0.292 . . . . 0.0 110.243 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' D' ' 150' ' ' ALA . . . -84.88 -165.44 1.2 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.693 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.756 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 0.7 OUTLIER -71.84 168.65 17.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.067 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.96 -79.23 0.06 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.263 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -168.81 5.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.986 0.422 . . . . 0.0 111.472 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 91' ' ' SER . . . . . 0.596 ' O ' ' HB2' ' D' ' 95' ' ' SER . 70.3 m -77.47 83.22 3.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.11 -34.62 63.84 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.878 0.371 . . . . 0.0 111.633 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.24 31.5 6.32 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.687 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 94' ' ' GLY . . . . . 0.634 ' O ' ' HB3' ' D' ' 147' ' ' ALA . . . -156.57 7.39 0.23 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.881 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 95' ' ' SER . . . . . 0.756 ' HB3' ' HG ' ' D' ' 88' ' ' LEU . 0.6 OUTLIER -110.71 -174.33 2.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 110.651 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 96' ' ' ALA . . . . . 0.458 ' CB ' HG23 ' C' ' 16' ' ' VAL . . . -97.78 179.01 4.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.931 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 97' ' ' THR . . . . . 0.725 ' H ' ' HB ' ' D' ' 144' ' ' THR . 1.1 m -132.24 125.92 32.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.369 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 98' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' D' ' 97' ' ' THR . 66.0 m-20 66.68 25.87 9.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.38 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 99' ' ' VAL . . . . . 0.633 HG12 HG21 ' C' ' 16' ' ' VAL . 0.2 OUTLIER -127.66 130.34 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.691 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.13 -161.38 10.76 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.485 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.84 131.94 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 123.12 0.568 . . . . 0.0 111.842 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 102' ' ' GLN . . . . . 0.716 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 1.5 tt0 -98.52 151.45 20.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.906 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 103' ' ' ILE . . . . . 0.525 ' N ' ' HG2' ' D' ' 102' ' ' GLN . 0.3 OUTLIER -117.3 128.65 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.499 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 104' ' ' LEU . . . . . 0.785 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 0.3 OUTLIER -102.94 133.5 47.94 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.559 0.219 . . . . 0.0 111.051 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . 0.545 ' HB3' HG23 ' D' ' 107' ' ' THR . 7.1 t0 -87.73 158.47 18.79 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.685 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 106' ' ' ARG . . . . . 0.436 ' HD2' HG23 ' A' ' 83' ' ' THR . 7.9 ttp85 -70.56 -27.71 64.34 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.806 0.336 . . . . 0.0 111.047 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 107' ' ' THR . . . . . 0.545 HG23 ' HB3' ' D' ' 105' ' ' ASP . 2.8 t -51.69 -25.7 7.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.09 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.19 -39.27 1.73 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.557 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.27 158.0 17.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.352 . . . . 0.0 111.013 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.785 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -70.37 137.17 50.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.099 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 111' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' D' ' 72' ' ' ALA . 13.5 tp -87.56 158.35 18.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.304 0.574 . . . . 0.0 110.529 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 112' ' ' THR . . . . . 0.694 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 0.5 OUTLIER -101.72 142.01 33.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.095 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 113' ' ' LEU . . . . . 0.432 HD23 ' HB3' ' D' ' 73' ' ' PHE . 1.9 mt -82.45 65.63 7.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 0.0 110.775 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.07 -15.01 21.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.485 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.23 -54.14 0.71 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.705 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.16 28.88 8.31 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.068 0.461 . . . . 0.0 111.756 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.81 76.62 7.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.186 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' D' ' 71' ' ' VAL . 91.5 m-85 -91.06 96.79 10.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.733 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 67.8 m -132.69 78.31 1.79 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.704 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.7 136.85 3.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.717 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -115.02 76.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.307 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.98 135.54 33.62 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.662 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.501 ' HA ' ' HZ1' ' D' ' 68' ' ' LYS . 11.7 m -77.05 96.33 4.4 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.764 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . 0.492 ' O ' HG23 ' D' ' 63' ' ' THR . 10.8 tp -68.15 132.92 48.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.628 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 125' ' ' ASN . . . . . 0.471 ' HA ' ' HG1' ' D' ' 63' ' ' THR . 2.3 m120 -128.49 166.81 18.06 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.561 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 126' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' D' ' 61' ' ' CYS . 6.2 t30 -79.44 105.76 10.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.665 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.03 -136.99 5.19 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.734 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 128' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 3.7 m -103.72 83.44 2.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.716 0.293 . . . . 0.0 110.808 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 129' ' ' ASN . . . . . 0.672 ' HB2' ' SG ' ' D' ' 61' ' ' CYS . 1.7 t30 -71.04 139.85 50.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.899 0.38 . . . . 0.0 111.17 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 130' ' ' THR . . . . . 0.794 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.2 OUTLIER -133.92 139.57 46.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.147 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 131' ' ' ILE . . . . . 0.604 HD11 HG13 ' D' ' 71' ' ' VAL . 61.8 mt -97.9 110.49 55.83 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 132' ' ' PRO . . . . . 0.763 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 7.6 Cg_endo -81.88 135.18 8.72 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.772 1.648 . . . . 0.0 112.562 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.474 ' O ' HG21 ' A' ' 76' ' ' THR . 0.6 OUTLIER -143.74 152.65 41.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.802 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 134' ' ' GLN . . . . . 0.638 ' HB3' ' HB3' ' D' ' 51' ' ' ALA . 50.6 mt-30 -118.94 156.95 28.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.092 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' D' ' 102' ' ' GLN . . . -151.42 101.71 2.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 111.648 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.56 168.29 9.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.352 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 137' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' D' ' 48' ' ' THR . 0.3 OUTLIER -80.11 123.34 27.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.149 179.533 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 138' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' D' ' 47' ' ' ALA . 1.3 t80 -126.19 119.05 26.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.998 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 139' ' ' ALA . . . . . 0.631 ' HB3' HD21 ' D' ' 42' ' ' LEU . . . -111.98 125.17 53.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.904 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 140' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.23 63.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.494 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -133.06 -120.03 2.08 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.137 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.36 111.94 18.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.628 0.252 . . . . 0.0 110.718 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 143' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -61.96 113.84 3.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.82 0.343 . . . . 0.0 111.377 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 144' ' ' THR . . . . . 0.725 ' HB ' ' H ' ' D' ' 97' ' ' THR . 75.4 m -88.27 145.28 35.56 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.323 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.86 134.17 7.12 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.533 2.156 . . . . 0.0 111.992 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.93 -135.63 4.42 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.499 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 147' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' D' ' 94' ' ' GLY . . . -96.13 134.26 39.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.905 0.383 . . . . 0.0 111.362 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.89 50.51 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.413 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 149' ' ' ASN . . . . . 0.43 HD21 ' HG2' ' C' ' 13' ' ' LYS . 3.5 m120 -98.99 146.14 26.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.489 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 150' ' ' ALA . . . . . 0.551 ' HB2' HD11 ' D' ' 86' ' ' LEU . . . -154.95 174.17 15.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.92 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -139.34 128.4 23.74 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.184 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 152' ' ' ALA . . . . . 0.454 ' HB3' HD12 ' D' ' 86' ' ' LEU . . . -118.37 133.34 55.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.126 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.97 147.42 22.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.27 130.33 53.43 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.169 0.509 . . . . 0.0 110.022 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . 0.552 ' HE2' HD11 ' D' ' 74' ' ' LEU . 11.3 mmtt -126.67 143.97 51.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.945 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 156' ' ' VAL . . . . . . . . . . . . . 27.4 m -127.45 151.87 34.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.85 0.357 . . . . 0.0 111.643 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 157' ' ' GLN . . . . . 0.667 ' HA ' ' O ' ' C' ' 3' ' ' THR . 0.0 OUTLIER -141.36 121.22 13.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.295 0.569 . . . . 0.0 110.372 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . 0.566 ' CD2' ' HB ' ' C' ' 3' ' ' THR . 1.2 m-85 -98.29 121.67 40.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.564 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.804 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 111.27 0.1 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.64 71.06 0.51 Allowed 'General case' 0 N--CA 1.462 0.149 0 O-C-N 123.109 0.256 . . . . 0.0 110.959 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 3' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' F' ' 157' ' ' GLN . 4.9 m -114.7 127.36 55.71 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.499 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 20.8 m -117.74 106.86 13.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.577 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.98 174.66 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.601 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.05 119.81 36.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.581 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.2 -49.49 15.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.822 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.32 -154.88 11.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.755 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -142.43 139.95 31.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.904 0.383 . . . . 0.0 111.291 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.71 113.83 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.161 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.11 110.32 20.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.36 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.21 111.51 22.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.752 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 13' ' ' LYS . . . . . 0.501 ' HE3' HG11 ' E' ' 28' ' ' VAL . 3.6 tmtm? -102.98 110.56 22.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.488 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.22 168.36 22.59 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.053 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 15' ' ' GLU . . . . . 0.674 ' O ' ' HA ' ' F' ' 36' ' ' GLN . 3.6 tt0 -159.02 133.08 7.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.923 0.392 . . . . 0.0 110.438 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 16' ' ' VAL . . . . . 0.646 HG21 HG12 ' F' ' 99' ' ' VAL . 13.2 t -99.67 143.15 14.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.261 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . 0.573 HG22 ' O ' ' F' ' 37' ' ' VAL . 3.9 m -141.34 -172.13 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.874 0.368 . . . . 0.0 111.057 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . 0.551 ' HA ' HG22 ' F' ' 39' ' ' THR . 0.6 OUTLIER -89.48 -176.96 5.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.046 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.73 46.85 1.36 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' E' ' 66' ' ' ALA . . . -127.77 -30.0 2.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.9 0.381 . . . . 0.0 111.466 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 21' ' ' CYS . . . . . 1.014 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER -163.07 158.45 22.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.943 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.42 118.49 2.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.044 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 23' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' E' ' 58' ' ' LEU . 0.8 OUTLIER -66.23 153.02 8.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.05 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.7 158.74 20.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.59 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' C' ' 91' ' ' SER . . . -61.04 -34.34 74.72 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.388 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.18 13.07 63.54 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.936 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.76 -22.44 10.7 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.798 0.333 . . . . 0.0 110.746 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 28' ' ' VAL . . . . . 0.501 HG11 ' HE3' ' E' ' 13' ' ' LYS . 19.8 t -44.02 -64.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.319 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.0 135.72 42.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.02 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -139.11 125.72 20.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.78 106.53 18.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.108 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.78 117.06 53.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.147 0.499 . . . . 0.0 110.44 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.67 131.01 45.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.61 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.75 -47.29 7.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.682 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.3 -163.61 12.15 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.573 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 36' ' ' GLN . . . . . 0.673 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 3.7 mt-30 -100.97 126.61 47.64 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.717 0.294 . . . . 0.0 110.842 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . 0.566 ' O ' HG22 ' D' ' 17' ' ' VAL . 14.9 p -110.38 146.85 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.983 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . 0.589 HH22 ' HB2' ' D' ' 62' ' ' ASP . 2.9 mtp180 -82.96 139.23 33.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.632 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 39' ' ' THR . . . . . 0.533 HG22 ' HA ' ' D' ' 18' ' ' ASN . 5.4 t -62.78 -37.52 86.99 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.724 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.48 -31.47 71.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.12 0.486 . . . . 0.0 110.867 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.99 -17.74 45.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.196 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.617 HD21 ' HB3' ' E' ' 139' ' ' ALA . 4.3 mp -125.68 33.05 5.18 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.631 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.71 18.86 18.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.333 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.92 130.29 52.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.309 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' E' ' 140' ' ' THR . 22.4 tt0 -56.35 107.38 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.362 . . . . 0.0 111.059 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.52 30.53 5.85 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.183 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 47' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' E' ' 138' ' ' PHE . . . -76.61 136.75 39.21 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.976 0.417 . . . . 0.0 112.123 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 48' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' E' ' 137' ' ' TYR . 52.2 p -134.96 134.69 40.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.888 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 71.6 m -108.82 -168.21 1.32 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.565 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 50' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 23.1 t -63.9 128.43 35.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.783 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 51' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' E' ' 134' ' ' GLN . . . -80.38 129.99 34.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.447 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 52' ' ' VAL . . . . . 0.752 ' HB ' ' HA ' ' B' ' 90' ' ' SER . 2.8 m -74.87 151.22 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.9 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.01 119.22 5.67 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.578 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.85 152.1 30.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.728 0.299 . . . . 0.0 110.966 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -148.77 162.89 38.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.653 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 56' ' ' ILE . . . . . 0.447 HG21 ' HB ' ' E' ' 131' ' ' ILE . 1.2 tp -105.87 114.86 46.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.567 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 57' ' ' GLN . . . . . 0.809 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.0 OUTLIER -70.72 124.58 24.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.695 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . 0.536 ' HA ' ' HA ' ' E' ' 23' ' ' VAL . 0.2 OUTLIER -132.36 88.76 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.242 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . 0.582 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 0.1 OUTLIER -75.34 169.41 18.11 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 60' ' ' ASP . . . . . 0.408 ' CG ' ' HD2' ' F' ' 38' ' ' ARG . 0.4 OUTLIER 66.38 68.3 0.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.746 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 61' ' ' CYS . . . . . 1.014 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 56.1 m -117.15 155.03 30.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.797 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . 0.591 ' HB2' HH22 ' F' ' 38' ' ' ARG . 20.1 t70 -135.8 155.65 50.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.274 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 63' ' ' THR . . . . . 0.495 HG23 ' O ' ' E' ' 124' ' ' LEU . 0.2 OUTLIER -111.08 -34.22 6.25 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.12 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.05 -22.18 66.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.067 0.46 . . . . 0.0 111.718 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.63 -59.49 2.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.709 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' E' ' 20' ' ' ALA . . . -116.86 129.18 55.91 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.628 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -60.35 2.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.896 0.379 . . . . 0.0 110.978 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 68' ' ' LYS . . . . . 0.51 ' HZ1' ' HA ' ' E' ' 123' ' ' THR . 0.2 OUTLIER -105.15 -175.37 2.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.537 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.96 131.32 9.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.588 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.97 151.19 24.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.073 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . 0.618 HG13 HD11 ' E' ' 131' ' ' ILE . 2.0 t -129.44 158.35 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.778 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . 0.566 ' HA ' HD23 ' E' ' 111' ' ' LEU . . . -152.71 143.06 22.56 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.599 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 73' ' ' PHE . . . . . 0.425 ' O ' ' HA ' ' E' ' 113' ' ' LEU . 0.1 OUTLIER -112.29 141.43 46.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.542 0.21 . . . . 0.0 111.105 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 74' ' ' LEU . . . . . 0.557 HD11 ' HE2' ' E' ' 155' ' ' LYS . 0.3 OUTLIER -107.7 139.49 42.18 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.992 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.76 -179.43 46.92 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.815 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 76' ' ' THR . . . . . 0.508 ' H ' HD21 ' E' ' 86' ' ' LEU . 0.4 OUTLIER -104.01 156.34 17.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.619 0.247 . . . . 0.0 110.79 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.35 118.37 21.19 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.934 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 78' ' ' ILE . . . . . 0.566 HG22 ' HB3' ' E' ' 82' ' ' HIS . 0.4 OUTLIER -58.97 -29.14 40.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.895 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 79' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.72 50.4 0.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.838 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.25 -89.9 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.103 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.03 -32.53 42.53 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.64 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 82' ' ' HIS . . . . . 0.566 ' HB3' HG22 ' E' ' 78' ' ' ILE . 0.3 OUTLIER -81.12 62.81 5.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.826 0.346 . . . . 0.0 110.376 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -18.09 60.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.599 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 84' ' ' ASN . . . . . 0.688 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 20.4 p-10 -76.1 -7.37 54.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.239 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.471 ' HB ' ' CG2' ' E' ' 78' ' ' ILE . 23.8 t -117.75 124.14 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.172 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 86' ' ' LEU . . . . . 0.556 HD11 ' HB2' ' E' ' 150' ' ' ALA . 0.5 OUTLIER -66.14 139.38 58.14 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.262 179.409 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 87' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' E' ' 150' ' ' ALA . . . -84.92 -165.41 1.19 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.667 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.743 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 0.7 OUTLIER -71.92 168.64 17.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.977 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.89 -79.23 0.06 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.308 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p -168.81 5.94 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.918 0.389 . . . . 0.0 111.506 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 91' ' ' SER . . . . . 0.606 ' O ' ' HB2' ' E' ' 95' ' ' SER . 70.2 m -77.57 83.22 3.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.07 -34.7 63.83 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.875 0.369 . . . . 0.0 111.57 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.23 31.5 6.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.635 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 94' ' ' GLY . . . . . 0.644 ' O ' ' HB3' ' E' ' 147' ' ' ALA . . . -156.58 7.44 0.23 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.965 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 95' ' ' SER . . . . . 0.743 ' HB3' ' HG ' ' E' ' 88' ' ' LEU . 0.6 OUTLIER -110.69 -174.32 2.45 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.911 0.386 . . . . 0.0 110.669 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 96' ' ' ALA . . . . . 0.462 ' CB ' HG23 ' D' ' 16' ' ' VAL . . . -97.76 178.96 4.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 97' ' ' THR . . . . . 0.763 ' H ' ' HB ' ' E' ' 144' ' ' THR . 1.1 m -132.25 125.99 32.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.368 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 98' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' E' ' 97' ' ' THR . 66.1 m-20 66.64 25.84 9.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.45 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 99' ' ' VAL . . . . . 0.647 HG12 HG21 ' D' ' 16' ' ' VAL . 0.2 OUTLIER -127.74 130.37 70.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.691 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.15 -161.38 10.77 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.463 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.89 131.97 64.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.025 0.53 . . . . 0.0 111.773 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 102' ' ' GLN . . . . . 0.714 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 1.5 tt0 -98.48 151.47 20.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.882 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 103' ' ' ILE . . . . . 0.526 ' N ' ' HG2' ' E' ' 102' ' ' GLN . 0.3 OUTLIER -117.36 128.73 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.498 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 104' ' ' LEU . . . . . 0.78 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 0.3 OUTLIER -103.03 133.5 48.05 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.62 0.248 . . . . 0.0 111.108 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . 0.528 ' HB3' HG23 ' E' ' 107' ' ' THR . 7.1 t0 -87.73 158.37 18.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.67 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 106' ' ' ARG . . . . . 0.461 ' HD2' HG23 ' B' ' 83' ' ' THR . 7.9 ttp85 -70.49 -27.68 64.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.778 0.323 . . . . 0.0 111.096 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 107' ' ' THR . . . . . 0.528 HG23 ' HB3' ' E' ' 105' ' ' ASP . 2.8 t -51.71 -25.72 7.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.058 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.21 -39.31 1.72 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.572 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.25 158.01 17.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 111.074 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . 0.78 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -70.36 137.17 50.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' E' ' 72' ' ' ALA . 13.5 tp -87.52 158.31 18.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.347 0.594 . . . . 0.0 110.49 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 112' ' ' THR . . . . . 0.688 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 0.5 OUTLIER -101.73 141.98 33.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.107 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 113' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' E' ' 73' ' ' PHE . 1.9 mt -82.43 65.61 7.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 110.778 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.04 -15.05 21.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.478 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.29 -54.21 0.7 Allowed Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.668 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.06 28.79 8.39 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.028 0.442 . . . . 0.0 111.741 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.74 76.66 7.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.225 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' E' ' 71' ' ' VAL . 91.6 m-85 -91.11 96.75 10.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.781 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 68.6 m -132.62 78.24 1.79 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.828 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.67 136.91 3.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.662 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.06 76.21 0.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.294 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.88 135.59 33.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.674 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 123' ' ' THR . . . . . 0.51 ' HA ' ' HZ1' ' E' ' 68' ' ' LYS . 11.8 m -77.09 96.36 4.43 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.738 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . 0.495 ' O ' HG23 ' E' ' 63' ' ' THR . 10.8 tp -68.24 132.97 48.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.591 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 125' ' ' ASN . . . . . 0.493 ' HA ' ' HG1' ' E' ' 63' ' ' THR . 2.3 m120 -128.5 166.78 18.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.603 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' E' ' 61' ' ' CYS . 6.3 t30 -79.4 105.66 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.683 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.08 -137.08 5.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.652 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 128' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 3.7 m -103.65 83.44 2.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.688 0.28 . . . . 0.0 110.832 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 129' ' ' ASN . . . . . 0.671 ' HB2' ' SG ' ' E' ' 61' ' ' CYS . 1.7 t30 -71.0 139.87 50.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.905 0.383 . . . . 0.0 111.163 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 130' ' ' THR . . . . . 0.809 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.2 OUTLIER -133.91 139.66 46.3 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.161 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 131' ' ' ILE . . . . . 0.618 HD11 HG13 ' E' ' 71' ' ' VAL . 61.8 mt -98.03 110.48 56.01 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 132' ' ' PRO . . . . . 0.745 ' HB3' ' HA ' ' B' ' 76' ' ' THR . 7.6 Cg_endo -81.86 135.16 8.73 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 121.792 1.661 . . . . 0.0 112.533 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 133' ' ' PHE . . . . . 0.474 ' O ' HG21 ' B' ' 76' ' ' THR . 0.6 OUTLIER -143.76 152.64 41.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.815 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 134' ' ' GLN . . . . . 0.638 ' HB3' ' HB3' ' E' ' 51' ' ' ALA . 50.5 mt-30 -118.97 156.86 28.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.099 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . 0.714 ' HA ' ' O ' ' E' ' 102' ' ' GLN . . . -151.39 101.71 2.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 111.649 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.58 168.32 9.17 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.404 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 137' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' E' ' 48' ' ' THR . 0.3 OUTLIER -80.04 123.24 27.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.175 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 138' ' ' PHE . . . . . 0.466 ' HA ' ' O ' ' E' ' 47' ' ' ALA . 1.3 t80 -126.13 119.13 26.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.064 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 139' ' ' ALA . . . . . 0.617 ' HB3' HD21 ' E' ' 42' ' ' LEU . . . -111.98 125.22 53.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.867 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 140' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 0.2 OUTLIER -68.89 -48.24 63.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.546 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -133.1 -119.96 2.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.085 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.42 111.96 18.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.612 0.244 . . . . 0.0 110.718 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 143' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -61.95 113.89 3.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.803 0.335 . . . . 0.0 111.361 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 144' ' ' THR . . . . . 0.763 ' HB ' ' H ' ' E' ' 97' ' ' THR . 73.7 m -88.34 145.31 35.49 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.324 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 145' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' E' ' 144' ' ' THR . 1.3 Cg_endo -82.86 134.22 7.14 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.463 2.109 . . . . 0.0 112.019 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.87 -135.62 4.43 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.535 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 147' ' ' ALA . . . . . 0.644 ' HB3' ' O ' ' E' ' 94' ' ' GLY . . . -96.12 134.19 39.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.392 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.8 50.51 2.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.131 0.491 . . . . 0.0 110.474 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 149' ' ' ASN . . . . . 0.433 HD21 ' HG2' ' D' ' 13' ' ' LYS . 3.5 m120 -98.97 146.13 26.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.501 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 150' ' ' ALA . . . . . 0.556 ' HB2' HD11 ' E' ' 86' ' ' LEU . . . -154.96 174.13 15.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.875 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -139.3 128.45 23.88 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.192 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 152' ' ' ALA . . . . . 0.45 ' HB3' HD12 ' E' ' 86' ' ' LEU . . . -118.41 133.29 56.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.193 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.91 147.36 23.03 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.22 130.3 53.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.182 0.515 . . . . 0.0 110.054 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . 0.557 ' HE2' HD11 ' E' ' 74' ' ' LEU . 11.2 mmtt -126.63 143.91 51.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.911 -178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 156' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.42 151.82 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.775 0.322 . . . . 0.0 111.729 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 157' ' ' GLN . . . . . 0.664 ' HA ' ' O ' ' D' ' 3' ' ' THR . 0.0 OUTLIER -141.34 121.19 13.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.326 0.584 . . . . 0.0 110.341 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . 0.568 ' CD2' ' HB ' ' D' ' 3' ' ' THR . 1.2 m-85 -98.31 121.66 40.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.532 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.82 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.251 0.072 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.72 71.03 0.51 Allowed 'General case' 0 CA--C 1.528 0.124 0 O-C-N 123.11 0.256 . . . . 0.0 110.972 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 4.9 m -114.69 127.38 55.73 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.433 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 20.7 m -117.82 106.74 13.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.587 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.86 174.71 12.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.577 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -97.11 119.89 36.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.553 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.34 -49.41 15.47 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.834 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.27 -154.87 11.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.862 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -142.46 140.07 31.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.985 0.421 . . . . 0.0 111.222 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.79 113.8 41.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.18 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -87.07 110.35 20.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.358 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -90.32 111.55 22.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.744 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 13' ' ' LYS . . . . . 0.498 ' HE3' HG11 ' F' ' 28' ' ' VAL . 3.7 tmtm? -102.97 110.6 22.58 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.39 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.25 168.38 22.6 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.962 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -159.09 133.02 7.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.893 0.378 . . . . 0.0 110.446 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 13.1 t -99.62 143.19 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.258 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.41 -172.12 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.867 0.365 . . . . 0.0 110.987 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.51 -177.0 5.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.073 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.83 47.01 1.37 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.073 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' F' ' 66' ' ' ALA . . . -127.77 -29.98 2.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.434 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 21' ' ' CYS . . . . . 1.006 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER -163.19 158.33 21.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.906 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.34 118.61 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.045 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 23' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' F' ' 58' ' ' LEU . 0.8 OUTLIER -66.29 153.06 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.986 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -84.82 158.72 20.58 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.606 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' D' ' 91' ' ' SER . . . -60.99 -34.43 74.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.386 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.08 13.11 63.65 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.97 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.83 -22.43 10.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.796 0.332 . . . . 0.0 110.701 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 28' ' ' VAL . . . . . 0.498 HG11 ' HE3' ' F' ' 13' ' ' LYS . 19.8 t -44.05 -64.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.368 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.1 135.92 41.78 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.925 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.23 125.72 20.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.008 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.79 106.51 18.79 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.06 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.76 117.05 53.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.196 0.522 . . . . 0.0 110.445 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.66 131.06 45.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.607 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.79 -47.41 7.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.616 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.39 -163.62 12.15 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.581 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 36' ' ' GLN . . . . . 0.674 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 3.7 mt-30 -100.97 126.59 47.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.688 0.28 . . . . 0.0 110.863 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.573 ' O ' HG22 ' E' ' 17' ' ' VAL . 14.9 p -110.36 146.84 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.912 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 38' ' ' ARG . . . . . 0.591 HH22 ' HB2' ' E' ' 62' ' ' ASP . 2.8 mtp180 -82.9 139.14 33.59 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.678 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 39' ' ' THR . . . . . 0.551 HG22 ' HA ' ' E' ' 18' ' ' ASN . 5.4 t -62.71 -37.51 86.78 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.762 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.46 -31.49 71.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.095 0.474 . . . . 0.0 110.837 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.03 -17.73 45.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.147 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . 0.634 HD21 ' HB3' ' F' ' 139' ' ' ALA . 4.3 mp -125.69 33.08 5.17 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.671 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.7 18.84 18.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.365 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.95 130.36 52.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.313 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . 0.478 ' HG3' ' O ' ' F' ' 140' ' ' THR . 22.5 tt0 -56.36 107.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.864 0.364 . . . . 0.0 111.027 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.64 30.42 5.86 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.179 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 47' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' F' ' 138' ' ' PHE . . . -76.57 136.7 39.26 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.95 0.405 . . . . 0.0 112.071 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 48' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' F' ' 137' ' ' TYR . 52.3 p -134.92 134.66 40.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.891 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 49' ' ' SER . . . . . 0.515 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 70.8 m -108.68 -168.23 1.32 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.657 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 50' ' ' SER . . . . . 0.563 ' O ' ' HA ' ' C' ' 92' ' ' ALA . 23.1 t -63.89 128.47 35.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.807 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 51' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' F' ' 134' ' ' GLN . . . -80.44 130.02 34.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.406 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 52' ' ' VAL . . . . . 0.766 ' HB ' ' HA ' ' C' ' 90' ' ' SER . 2.8 m -74.84 151.25 6.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.97 119.21 5.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.622 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.86 152.1 30.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.711 0.291 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -148.77 162.99 38.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.643 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 56' ' ' ILE . . . . . 0.449 HG22 ' O ' ' F' ' 56' ' ' ILE . 1.2 tp -105.92 114.76 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.585 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 57' ' ' GLN . . . . . 0.805 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.0 OUTLIER -70.61 124.51 24.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.761 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' F' ' 23' ' ' VAL . 0.2 OUTLIER -132.35 88.81 2.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.192 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 59' ' ' ASN . . . . . 0.57 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 0.1 OUTLIER -75.35 169.52 17.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.34 68.26 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.787 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 61' ' ' CYS . . . . . 1.006 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 56.3 m -117.13 155.02 30.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.829 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -135.8 155.67 49.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.227 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 63' ' ' THR . . . . . 0.482 HG23 ' O ' ' F' ' 124' ' ' LEU . 0.2 OUTLIER -111.13 -34.23 6.24 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.09 -22.1 66.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.069 0.461 . . . . 0.0 111.759 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.61 -59.56 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.744 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 66' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' F' ' 20' ' ' ALA . . . -116.74 129.12 55.93 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.617 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -60.27 2.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.959 0.409 . . . . 0.0 111.052 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 68' ' ' LYS . . . . . 0.507 ' HZ1' ' HA ' ' F' ' 123' ' ' THR . 0.2 OUTLIER -105.22 -175.41 2.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.47 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.93 131.34 9.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.607 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.02 151.19 24.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.025 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 71' ' ' VAL . . . . . 0.618 HG13 HD11 ' F' ' 131' ' ' ILE . 2.0 t -129.48 158.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.704 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 72' ' ' ALA . . . . . 0.555 ' HA ' HD23 ' F' ' 111' ' ' LEU . . . -152.66 143.02 22.57 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.626 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 73' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' F' ' 113' ' ' LEU . 0.1 OUTLIER -112.23 141.44 45.94 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.663 0.268 . . . . 0.0 111.049 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 74' ' ' LEU . . . . . 0.574 HD11 ' HE2' ' F' ' 155' ' ' LYS . 0.3 OUTLIER -107.63 139.54 42.01 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.981 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.76 -179.51 46.87 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.83 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 76' ' ' THR . . . . . 0.523 ' H ' HD21 ' F' ' 86' ' ' LEU . 0.3 OUTLIER -103.92 156.34 17.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.535 0.207 . . . . 0.0 110.819 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.34 118.44 21.25 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.877 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 78' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' F' ' 82' ' ' HIS . 0.4 OUTLIER -59.1 -29.08 40.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.834 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 79' ' ' ASP . . . . . 0.407 ' HB2' HG22 ' F' ' 140' ' ' THR . 0.1 OUTLIER -151.7 50.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.781 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.2 -89.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.095 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.09 -32.54 42.97 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.596 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 82' ' ' HIS . . . . . 0.564 ' HB3' HG22 ' F' ' 78' ' ' ILE . 0.3 OUTLIER -81.14 62.86 5.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.886 0.374 . . . . 0.0 110.414 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.53 -18.23 60.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.633 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 84' ' ' ASN . . . . . 0.69 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 20.4 p-10 -76.02 -7.4 54.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.258 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 85' ' ' VAL . . . . . 0.486 ' HB ' ' CG2' ' F' ' 78' ' ' ILE . 23.8 t -117.72 124.14 72.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.224 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 86' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' F' ' 150' ' ' ALA . 0.5 OUTLIER -66.18 139.38 58.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.715 0.293 . . . . 0.0 110.266 179.454 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 87' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' F' ' 150' ' ' ALA . . . -84.85 -165.37 1.17 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.741 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . 0.742 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 0.7 OUTLIER -71.87 168.65 17.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.056 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.91 -79.18 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.351 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p -168.87 6.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 111.549 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 91' ' ' SER . . . . . 0.601 ' O ' ' HB2' ' F' ' 95' ' ' SER . 69.4 m -77.62 83.24 4.01 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.04 -34.67 63.73 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.606 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.26 31.5 6.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.58 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 94' ' ' GLY . . . . . 0.636 ' O ' ' HB3' ' F' ' 147' ' ' ALA . . . -156.63 7.59 0.23 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.907 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 95' ' ' SER . . . . . 0.742 ' HB3' ' HG ' ' F' ' 88' ' ' LEU . 0.6 OUTLIER -110.87 -174.32 2.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.834 0.349 . . . . 0.0 110.553 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 96' ' ' ALA . . . . . 0.459 ' CB ' HG23 ' E' ' 16' ' ' VAL . . . -97.76 179.0 4.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 97' ' ' THR . . . . . 0.749 ' H ' ' HB ' ' F' ' 144' ' ' THR . 1.1 m -132.32 125.98 32.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.316 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 98' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' F' ' 97' ' ' THR . 66.1 m-20 66.66 25.8 9.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.451 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 99' ' ' VAL . . . . . 0.646 HG12 HG21 ' E' ' 16' ' ' VAL . 0.2 OUTLIER -127.66 130.35 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.711 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.11 -161.37 10.75 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.492 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 101' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -130.89 131.88 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.122 0.569 . . . . 0.0 111.868 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 102' ' ' GLN . . . . . 0.712 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 1.5 tt0 -98.41 151.52 20.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.897 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 103' ' ' ILE . . . . . 0.519 ' N ' ' HG2' ' F' ' 102' ' ' GLN . 0.3 OUTLIER -117.36 128.65 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.503 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 104' ' ' LEU . . . . . 0.794 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 0.3 OUTLIER -103.04 133.52 48.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.647 0.261 . . . . 0.0 111.083 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . 0.535 ' HB3' HG23 ' F' ' 107' ' ' THR . 7.2 t0 -87.71 158.37 18.83 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.658 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 106' ' ' ARG . . . . . 0.458 ' HD2' HG23 ' C' ' 83' ' ' THR . 7.9 ttp85 -70.4 -27.75 64.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.778 0.323 . . . . 0.0 111.082 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 107' ' ' THR . . . . . 0.535 HG23 ' HB3' ' F' ' 105' ' ' ASP . 2.8 t -51.72 -25.72 7.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.056 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.26 -39.37 1.71 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.574 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.26 158.01 17.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 0.0 111.079 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . 0.794 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -70.3 137.11 50.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.034 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . 0.555 HD23 ' HA ' ' F' ' 72' ' ' ALA . 13.5 tp -87.53 158.38 18.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.338 0.589 . . . . 0.0 110.533 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 112' ' ' THR . . . . . 0.69 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 0.5 OUTLIER -101.76 141.93 33.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.107 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 113' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' F' ' 73' ' ' PHE . 1.9 mt -82.33 65.58 7.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.7 0.286 . . . . 0.0 110.725 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.08 -14.97 21.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.521 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.21 -54.11 0.71 Allowed Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.661 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.19 28.97 8.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.066 0.46 . . . . 0.0 111.719 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 117' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.85 76.61 7.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.17 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . 0.596 ' HA ' ' O ' ' F' ' 71' ' ' VAL . 91.6 m-85 -91.07 96.77 10.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.746 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 67.8 m -132.6 78.22 1.79 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.764 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.7 136.97 3.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.688 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.09 76.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.276 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.9 135.59 33.62 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.635 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 123' ' ' THR . . . . . 0.507 ' HA ' ' HZ1' ' F' ' 68' ' ' LYS . 12.0 m -77.09 96.25 4.41 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.763 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . 0.488 ' HA ' HD12 ' F' ' 124' ' ' LEU . 10.8 tp -68.19 132.97 48.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.582 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 125' ' ' ASN . . . . . 0.471 ' HA ' ' HG1' ' F' ' 63' ' ' THR . 2.2 m120 -128.47 166.77 18.12 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.552 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -79.41 105.74 10.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.743 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.02 -137.09 5.24 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.689 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 128' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 3.7 m -103.59 83.45 2.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.686 0.279 . . . . 0.0 110.847 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 129' ' ' ASN . . . . . 0.677 ' HB2' ' SG ' ' F' ' 61' ' ' CYS . 1.7 t30 -70.98 139.87 50.7 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.887 0.375 . . . . 0.0 111.165 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 130' ' ' THR . . . . . 0.805 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.2 OUTLIER -133.96 139.69 46.27 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.109 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 131' ' ' ILE . . . . . 0.618 HD11 HG13 ' F' ' 71' ' ' VAL . 61.8 mt -98.08 110.55 56.39 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 132' ' ' PRO . . . . . 0.743 ' HB3' ' HA ' ' C' ' 76' ' ' THR . 7.6 Cg_endo -81.82 135.13 8.76 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.796 1.664 . . . . 0.0 112.558 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 133' ' ' PHE . . . . . 0.468 ' O ' HG21 ' C' ' 76' ' ' THR . 0.6 OUTLIER -143.74 152.68 41.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.727 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 134' ' ' GLN . . . . . 0.63 ' HB3' ' HB3' ' F' ' 51' ' ' ALA . 50.5 mt-30 -119.0 156.9 28.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.096 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . 0.712 ' HA ' ' O ' ' F' ' 102' ' ' GLN . . . -151.42 101.69 2.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.808 0.337 . . . . 0.0 111.641 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.59 168.33 9.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.373 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 137' ' ' TYR . . . . . 0.48 ' O ' ' HA ' ' F' ' 48' ' ' THR . 0.3 OUTLIER -80.09 123.3 27.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.113 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 138' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' F' ' 47' ' ' ALA . 1.3 t80 -126.18 119.05 26.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.051 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 139' ' ' ALA . . . . . 0.634 ' HB3' HD21 ' F' ' 42' ' ' LEU . . . -111.98 125.17 53.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.853 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 140' ' ' THR . . . . . 0.478 ' O ' ' HG3' ' F' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.26 63.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.508 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -133.09 -120.05 2.08 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.058 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.27 111.91 18.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.548 0.213 . . . . 0.0 110.815 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 143' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -61.91 113.86 3.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.815 0.341 . . . . 0.0 111.405 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 144' ' ' THR . . . . . 0.749 ' HB ' ' H ' ' F' ' 97' ' ' THR . 75.1 m -88.28 145.22 35.4 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.317 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.81 134.17 7.17 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.524 2.149 . . . . 0.0 111.978 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.94 -135.59 4.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.537 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 147' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' F' ' 94' ' ' GLY . . . -96.21 134.2 39.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.966 0.412 . . . . 0.0 111.312 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.82 50.48 2.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.184 0.516 . . . . 0.0 110.469 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 149' ' ' ASN . . . . . 0.435 HD21 ' HG2' ' E' ' 13' ' ' LYS . 3.5 m120 -98.92 146.16 26.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.491 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 150' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' F' ' 86' ' ' LEU . . . -154.91 174.12 15.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.876 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -139.34 128.49 23.87 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.225 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 152' ' ' ALA . . . . . 0.443 ' HB3' HD12 ' F' ' 86' ' ' LEU . . . -118.41 133.38 55.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.159 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.02 147.42 22.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.24 130.28 53.42 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.143 0.497 . . . . 0.0 110.085 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . 0.574 ' HE2' HD11 ' F' ' 74' ' ' LEU . 11.3 mmtt -126.71 144.02 51.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.874 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 156' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.42 151.9 34.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.677 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 157' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' E' ' 3' ' ' THR . 0.0 OUTLIER -141.35 121.18 13.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.237 0.542 . . . . 0.0 110.365 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . 0.57 ' CD2' ' HB ' ' E' ' 3' ' ' THR . 1.2 m-85 -98.25 121.65 40.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.539 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.802 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.213 0.054 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.658 ' H ' ' HA ' ' B' ' 159' ' ' GLN . . . 65.93 74.71 0.36 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.533 0.206 . . . . 0.0 110.94 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.575 ' OG1' ' HB2' ' B' ' 158' ' ' TYR . 6.2 p -117.73 97.5 5.88 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.499 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.615 HG23 ' HB2' ' B' ' 157' ' ' GLN . 68.4 p -87.86 108.7 19.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.576 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.573 HG12 HG12 ' B' ' 17' ' ' VAL . 15.4 m -126.63 172.77 13.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.592 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -77.2 110.77 12.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.587 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.69 -59.41 7.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.772 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.56 151.71 14.94 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.818 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.418 HG21 ' N ' ' A' ' 10' ' ' VAL . 24.2 m -103.54 143.13 33.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 111.279 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.477 HG22 ' HE1' ' A' ' 12' ' ' PHE . 1.2 m -130.94 115.61 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.208 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.62 105.77 14.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.398 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.477 ' HE1' HG22 ' A' ' 10' ' ' VAL . 52.1 m-85 -83.25 105.55 14.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.782 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.52 145.05 41.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.455 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.75 -179.72 42.55 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.958 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.15 134.23 22.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.0 110.376 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' B' ' 145' ' ' PRO . 3.3 t -90.85 127.14 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.286 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.506 HG11 ' HG2' ' B' ' 36' ' ' GLN . 12.1 m -126.25 168.77 18.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -100.42 81.79 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.154 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.439 ' HA ' ' HG2' ' B' ' 38' ' ' ARG . . . 53.3 58.17 5.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.071 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.484 ' HB3' HG21 ' A' ' 17' ' ' VAL . . . -108.55 -62.86 1.4 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.36 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.914 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.9 OUTLIER -171.56 -159.94 0.16 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.915 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.6 ' HA ' ' HB2' ' B' ' 36' ' ' GLN . . . -156.88 74.01 0.78 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.781 ' HB ' HD22 ' A' ' 58' ' ' LEU . 7.4 p -45.35 140.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.42 140.74 58.9 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.661 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.36 -51.15 69.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.311 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.11 -18.04 74.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.919 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.96 -6.39 58.04 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.832 0.349 . . . . 0.0 110.786 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.448 HG12 ' HG2' ' B' ' 33' ' ' GLN . 50.9 t -72.63 -36.37 53.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.426 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.95 110.82 14.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.969 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.78 146.05 48.6 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.033 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.21 113.84 27.67 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.127 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.08 121.93 57.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.108 0.48 . . . . 0.0 110.448 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.86 106.41 17.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.683 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.481 ' HA ' HD11 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -64.79 -44.74 89.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.592 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.62 -156.9 15.99 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.568 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -91.07 107.01 18.91 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.596 0.236 . . . . 0.0 110.847 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.3 t -92.34 120.63 41.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.918 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 -85.71 132.49 34.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.746 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.0 p -71.45 -23.32 61.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.756 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.03 -19.19 64.88 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.965 0.412 . . . . 0.0 110.793 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.8 t -90.53 -36.55 14.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.183 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.594 ' HB2' ' HB1' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -121.52 70.52 0.94 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.58 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 142' ' ' ALA . . . -104.76 28.18 7.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.38 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.681 ' HG3' ' HB1' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -150.58 142.01 23.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.384 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.428 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 2.7 tt0 -62.7 101.79 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.777 0.322 . . . . 0.0 111.136 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.3 4.27 8.41 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.062 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.681 ' HB1' ' HG3' ' A' ' 44' ' ' GLN . . . -91.76 121.2 33.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.002 0.43 . . . . 0.0 111.985 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 5.8 t -110.3 151.2 27.68 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.806 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -95.7 -57.62 2.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.594 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.24 -174.88 4.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.853 0.359 . . . . 0.0 110.817 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.68 ' HB3' ' HG2' ' A' ' 136' ' ' ARG . . . -127.05 143.87 51.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.387 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.85 116.86 51.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.972 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.19 122.64 6.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.67 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -128.58 138.83 52.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.33 . . . . 0.0 110.978 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.57 HD21 HG21 ' A' ' 130' ' ' THR . 1.6 m120 -117.86 150.95 38.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.657 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.569 ' HB ' HG13 ' A' ' 131' ' ' ILE . 9.3 mm -106.78 103.67 15.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.57 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.21 132.23 52.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.783 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.781 HD22 ' HB ' ' A' ' 23' ' ' VAL . 1.0 OUTLIER -137.31 151.87 49.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.256 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -138.45 171.27 14.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.983 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 5.9 m-20 50.1 68.42 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.914 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -106.59 141.14 38.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.764 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.84 117.89 33.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.24 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.7 p -91.12 -13.18 33.52 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.62 -38.95 82.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.069 0.462 . . . . 0.0 111.765 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.65 -54.11 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.645 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.7 84.31 3.35 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.582 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.98 -41.21 10.13 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.805 0.336 . . . . 0.0 111.023 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.63 159.96 17.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.518 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.7 160.4 39.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.616 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.02 152.91 45.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.133 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.89 136.54 53.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.722 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.0 107.45 5.04 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.555 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CD2' HD12 ' A' ' 103' ' ' ILE . 43.1 t80 -73.65 136.66 43.86 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.605 0.24 . . . . 0.0 111.025 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.751 HD11 ' HG2' ' D' ' 57' ' ' GLN . 6.6 tt -113.56 111.41 21.84 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.978 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.696 ' HA3' HD12 ' A' ' 113' ' ' LEU . . . -131.29 -178.49 15.5 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.864 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.462 HG21 ' O ' ' D' ' 53' ' ' GLY . 0.2 OUTLIER -104.32 137.58 42.0 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.461 0.172 . . . . 0.0 110.857 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.98 114.78 23.89 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.992 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.596 ' O ' ' HG2' ' D' ' 134' ' ' GLN . 1.2 tt -95.7 -36.73 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.867 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.459 ' HB3' ' CG2' ' A' ' 140' ' ' THR . 0.4 OUTLIER -143.38 130.23 20.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.746 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.92 -7.18 47.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.046 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.33 -29.19 68.39 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.587 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.34 -32.64 4.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.88 0.371 . . . . 0.0 110.459 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.5 m 60.49 19.42 9.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.589 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.612 ' HB3' ' HG2' ' A' ' 102' ' ' GLN . 0.6 OUTLIER -139.37 -16.99 1.03 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.296 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.697 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 0.9 OUTLIER -66.67 118.02 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.244 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.537 ' HA ' HD21 ' A' ' 113' ' ' LEU . 10.7 tp -69.72 144.17 52.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.264 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.2 138.09 36.78 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.917 0.389 . . . . 0.0 111.721 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.662 ' HB3' ' HA ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -84.95 -146.62 0.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.068 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.53 155.02 0.58 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.268 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.4 p -86.73 -11.92 49.75 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.923 0.392 . . . . 0.0 111.503 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.42 114.08 5.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' D' ' 50' ' ' SER . . . -83.38 22.19 1.06 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.951 0.405 . . . . 0.0 111.683 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.21 21.97 1.21 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.698 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.64 -32.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.017 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.628 ' HA ' ' HB1' ' A' ' 147' ' ' ALA . 15.9 t -65.14 166.73 9.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.866 0.365 . . . . 0.0 110.616 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.65 163.44 15.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.665 HG21 ' HB1' ' D' ' 51' ' ' ALA . 0.0 OUTLIER -135.42 169.66 17.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.34 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 57.4 29.34 16.78 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.383 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.508 ' HB ' ' CB ' ' A' ' 143' ' ' ALA . 7.2 p -156.38 150.6 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.825 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.697 ' HA3' ' HB ' ' A' ' 85' ' ' VAL . . . -164.2 176.93 40.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.609 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.63 111.29 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.018 0.527 . . . . 0.0 111.713 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.612 ' HG2' ' HB3' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -75.97 179.75 5.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.958 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' A' ' 113' ' ' LEU . 6.0 pt -150.36 116.54 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.457 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 12.9 tp -97.22 122.54 40.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.724 0.297 . . . . 0.0 111.068 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.91 150.08 42.92 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.739 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.509 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -71.43 -17.58 62.38 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.824 0.345 . . . . 0.0 111.121 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 76.1 p -76.62 -37.22 56.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.11 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.52 -68.81 0.32 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.732 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.61 123.2 18.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.795 0.331 . . . . 0.0 111.129 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.74 117.99 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.184 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 tp -67.87 144.1 55.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.43 0.633 . . . . 0.0 110.491 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.42 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -75.11 140.45 43.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.071 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.696 HD12 ' HA3' ' A' ' 75' ' ' GLY . 1.3 tp -85.18 97.75 10.08 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.701 0.286 . . . . 0.0 110.668 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -152.78 -59.01 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.645 0.26 . . . . 0.0 111.582 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.556 ' HA3' ' OG1' ' D' ' 130' ' ' THR . . . 135.73 -26.63 3.14 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.615 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.534 ' HB1' ' HA ' ' D' ' 129' ' ' ASN . . . -101.27 28.78 5.15 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.994 0.426 . . . . 0.0 111.692 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.58 67.34 0.72 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.075 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.4 81.0 8.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.737 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.04 97.45 3.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.0 t -165.54 144.79 6.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.587 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.28 50.22 0.9 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.204 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.8 94.18 5.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.715 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.69 110.38 12.47 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.679 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.598 ' HG ' ' ND2' ' A' ' 129' ' ' ASN . 0.3 OUTLIER -70.2 154.15 42.26 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.578 179.42 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.6 144.77 51.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.552 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.74 125.67 24.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.653 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.1 -102.01 1.1 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.725 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 58' ' ' LEU . 86.9 m -106.23 128.45 53.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.655 0.264 . . . . 0.0 110.831 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.598 ' ND2' ' HG ' ' A' ' 124' ' ' LEU . 20.1 t-20 -121.15 158.13 28.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.874 0.368 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.57 HG21 HD21 ' A' ' 55' ' ' ASN . 0.2 OUTLIER -155.81 143.08 19.27 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.996 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER -115.22 110.79 45.14 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.509 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.4 Cg_endo -82.21 151.85 15.95 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.618 1.546 . . . . 0.0 112.5 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.01 146.77 17.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.797 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.8 OUTLIER -114.38 145.83 41.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.108 179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.77 91.17 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 111.679 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.68 ' HG2' ' HB3' ' A' ' 51' ' ' ALA . 28.0 mtm-85 -88.34 153.6 21.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.405 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 48' ' ' THR . 0.7 OUTLIER -91.29 111.06 22.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.071 179.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.594 ' CD1' ' HB2' ' A' ' 102' ' ' GLN . 8.8 m-85 -108.08 172.19 6.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.962 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -123.42 143.65 50.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.851 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.459 ' CG2' ' HB3' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -98.73 44.39 1.03 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.565 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.48 89.07 1.07 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.978 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . . . 60.09 88.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.709 0.255 . . . . 0.0 110.689 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.514 ' HB2' HD12 ' A' ' 42' ' ' LEU . . . -70.61 161.73 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.405 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 158.73 60.65 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.226 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.76 149.18 12.55 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.54 2.16 . . . . 0.0 112.06 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.72 -119.73 0.86 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.479 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.628 ' HB1' ' HA ' ' A' ' 95' ' ' SER . . . -123.94 127.71 48.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.861 0.362 . . . . 0.0 111.417 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.662 ' HA ' ' HB3' ' A' ' 88' ' ' LEU . . . -120.85 67.17 0.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.117 0.484 . . . . 0.0 110.389 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -128.47 114.77 17.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.6 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -158.83 146.97 18.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.984 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.39 140.3 32.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.171 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.19 169.28 17.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.176 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' A' ' 74' ' ' LEU . 9.3 t -155.11 150.52 27.25 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.435 ' HE1' HG13 ' A' ' 56' ' ' ILE . 1.1 p90 -118.97 149.27 41.91 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.121 0.486 . . . . 0.0 110.083 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.668 ' HD2' HG21 ' D' ' 128' ' ' THR . 4.7 mttt -113.53 156.68 23.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.869 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.533 HG13 HD12 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -136.48 137.98 47.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.684 -179.058 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -107.5 128.03 54.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.318 0.58 . . . . 0.0 110.37 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -107.87 107.43 18.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.542 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.851 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.209 0.052 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.661 ' H ' ' HA ' ' C' ' 159' ' ' GLN . . . 65.84 74.75 0.36 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.579 0.228 . . . . 0.0 110.98 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.587 ' OG1' ' HB2' ' C' ' 158' ' ' TYR . 6.2 p -117.74 97.56 5.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.46 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.613 HG23 ' HB2' ' C' ' 157' ' ' GLN . 67.9 p -87.91 108.61 19.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.527 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.567 HG12 HG12 ' C' ' 17' ' ' VAL . 15.4 m -126.51 172.75 13.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.59 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -77.24 110.86 12.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.494 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.76 -59.42 7.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.765 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.56 151.64 14.79 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.81 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.416 HG21 ' N ' ' B' ' 10' ' ' VAL . 24.2 m -103.44 143.09 33.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 111.357 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.485 HG22 ' HE1' ' B' ' 12' ' ' PHE . 1.2 m -130.98 115.63 30.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.186 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.65 105.71 14.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.349 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . 0.485 ' HE1' HG22 ' B' ' 10' ' ' VAL . 52.2 m-85 -83.17 105.47 14.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.783 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.46 145.07 41.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.446 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.74 -179.69 42.57 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.932 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.19 134.27 22.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.94 0.4 . . . . 0.0 110.306 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.458 ' HB ' ' HA ' ' C' ' 145' ' ' PRO . 3.3 t -90.9 127.16 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.264 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.573 HG12 HG12 ' A' ' 5' ' ' VAL . 12.1 m -126.25 168.75 18.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.86 0.362 . . . . 0.0 111.037 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.48 81.82 2.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.12 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.424 ' HA ' ' HG2' ' C' ' 38' ' ' ARG . . . 53.38 58.15 5.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.997 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.49 ' HB3' HG21 ' B' ' 17' ' ' VAL . . . -108.57 -62.82 1.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.442 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.9 OUTLIER -171.54 -159.86 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.914 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.603 ' HA ' ' HB2' ' C' ' 36' ' ' GLN . . . -156.84 74.07 0.79 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.799 ' HB ' HD22 ' B' ' 58' ' ' LEU . 7.4 p -45.44 140.62 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.958 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.43 140.81 58.91 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.642 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.44 -51.15 69.5 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.307 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.08 -18.01 74.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.964 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -88.0 -6.32 58.05 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.827 0.346 . . . . 0.0 110.756 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.442 HG12 ' HG2' ' C' ' 33' ' ' GLN . 50.5 t -72.78 -36.31 52.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.359 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.03 110.85 14.03 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.002 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.85 146.01 48.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.021 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.19 113.84 27.68 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.128 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.08 121.91 57.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.105 0.478 . . . . 0.0 110.475 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.448 ' HG2' HG12 ' A' ' 28' ' ' VAL . 0.6 OUTLIER -101.84 106.37 17.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.721 -179.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.507 HD11 ' HA ' ' B' ' 34' ' ' LEU . 0.6 OUTLIER -64.69 -44.75 89.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.642 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.58 -156.91 16.0 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.558 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.6 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 3.7 mt-30 -91.1 106.98 18.9 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.629 0.252 . . . . 0.0 110.851 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 t -92.32 120.59 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.938 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.439 ' HG2' ' HA ' ' A' ' 19' ' ' ALA . 4.6 mtm105 -85.67 132.51 34.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.71 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 29.4 p -71.54 -23.21 61.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.755 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.08 -19.06 64.83 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.996 0.427 . . . . 0.0 110.844 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -90.6 -36.6 14.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.167 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.588 ' HB2' ' HB1' ' B' ' 139' ' ' ALA . 0.2 OUTLIER -121.48 70.54 0.94 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.61 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' B' ' 142' ' ' ALA . . . -104.7 28.11 7.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.423 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . 0.675 ' HG3' ' HB1' ' B' ' 47' ' ' ALA . 0.0 OUTLIER -150.53 141.99 23.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.45 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.429 ' HG3' ' HA ' ' B' ' 140' ' ' THR . 2.7 tt0 -62.66 101.8 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.769 0.319 . . . . 0.0 111.104 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.26 4.26 8.44 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.099 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.675 ' HB1' ' HG3' ' B' ' 44' ' ' GLN . . . -91.74 121.32 33.27 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.982 0.42 . . . . 0.0 112.015 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' B' ' 137' ' ' TYR . 5.8 t -110.41 151.22 27.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.786 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -95.69 -57.67 2.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.596 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.23 -174.85 4.69 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.76 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . 0.667 ' HB3' ' HG2' ' B' ' 136' ' ' ARG . . . -127.05 143.86 51.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.315 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.9 116.91 51.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.959 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.25 122.67 6.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.66 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -128.62 138.86 52.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.784 0.326 . . . . 0.0 111.0 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.573 HD21 HG21 ' B' ' 130' ' ' THR . 1.6 m120 -117.85 150.93 38.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.677 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.578 ' HB ' HG13 ' B' ' 131' ' ' ILE . 9.3 mm -106.77 103.66 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.607 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -61.15 132.27 53.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.798 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.799 HD22 ' HB ' ' B' ' 23' ' ' VAL . 1.0 OUTLIER -137.39 151.86 49.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.208 -179.677 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -138.38 171.34 14.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.972 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' B' ' 21' ' ' CYS . 5.9 m-20 49.98 68.48 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 0.0 OUTLIER -106.63 141.08 38.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.8 117.88 33.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.231 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.3 p -91.26 -13.02 33.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.69 -38.89 82.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.114 0.483 . . . . 0.0 111.79 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 76.4 t -107.75 -54.07 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.618 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' B' ' 158' ' ' TYR . . . -97.66 84.39 3.38 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.583 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -41.25 10.05 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.949 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.6 159.96 17.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.529 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.68 160.45 39.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.609 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.09 152.91 45.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.97 136.54 53.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.688 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.02 107.53 5.06 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.556 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.443 ' CD2' HD12 ' B' ' 103' ' ' ILE . 43.2 t80 -73.75 136.69 43.68 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.562 0.22 . . . . 0.0 111.02 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.734 HD11 ' HG2' ' E' ' 57' ' ' GLN . 6.6 tt -113.55 111.44 21.9 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.98 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.697 ' HA3' HD12 ' B' ' 113' ' ' LEU . . . -131.38 -178.6 15.56 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.841 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.456 HG21 ' O ' ' E' ' 53' ' ' GLY . 0.2 OUTLIER -104.28 137.61 41.94 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.478 0.18 . . . . 0.0 110.844 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.98 114.77 23.87 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.895 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.591 ' O ' ' HG2' ' E' ' 134' ' ' GLN . 1.2 tt -95.76 -36.75 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.782 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.456 ' HB3' ' CG2' ' B' ' 140' ' ' THR . 0.4 OUTLIER -143.33 130.22 20.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.93 -7.26 47.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.21 -29.31 68.33 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.665 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 -32.67 4.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.945 0.402 . . . . 0.0 110.502 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' THR . . . . . . . . . . . . . 3.5 m 60.52 19.39 9.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.633 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . 0.619 ' HB3' ' HG2' ' B' ' 102' ' ' GLN . 0.6 OUTLIER -139.35 -17.03 1.03 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.312 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.687 ' HB ' ' HA3' ' B' ' 100' ' ' GLY . 0.9 OUTLIER -66.65 118.08 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.2 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . 0.555 ' HA ' HD21 ' B' ' 113' ' ' LEU . 10.7 tp -69.75 144.13 52.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.374 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.05 137.98 36.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.868 0.366 . . . . 0.0 111.773 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.662 ' HB3' ' HA ' ' B' ' 148' ' ' ALA . 0.0 OUTLIER -84.99 -146.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.11 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' B' ' 149' ' ' ASN . 0.0 OUTLIER -48.59 155.09 0.58 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.256 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 32.5 p -86.79 -11.91 49.58 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.971 0.415 . . . . 0.0 111.496 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.41 114.13 5.19 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.952 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.558 ' HA ' ' HB3' ' E' ' 50' ' ' SER . . . -83.45 22.24 1.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.907 0.384 . . . . 0.0 111.653 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.26 21.98 1.2 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.679 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.65 -32.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.024 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' SER . . . . . 0.646 ' HA ' ' HB1' ' B' ' 147' ' ' ALA . 15.9 t -65.08 166.68 9.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.791 0.329 . . . . 0.0 110.666 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.64 163.46 15.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.875 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.662 HG21 ' HB1' ' E' ' 51' ' ' ALA . 0.0 OUTLIER -135.4 169.65 17.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.322 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 57.36 29.36 16.76 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.349 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.509 ' HB ' ' CB ' ' B' ' 143' ' ' ALA . 7.2 p -156.42 150.54 10.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.794 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . 0.687 ' HA3' ' HB ' ' B' ' 85' ' ' VAL . . . -164.17 176.95 40.07 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.541 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.63 111.32 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 123.038 0.535 . . . . 0.0 111.666 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.619 ' HG2' ' HB3' ' B' ' 84' ' ' ASN . 0.0 OUTLIER -75.99 179.75 5.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.955 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.524 HD13 ' HA ' ' B' ' 113' ' ' LEU . 6.0 pt -150.34 116.59 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.474 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' B' ' 134' ' ' GLN . 12.8 tp -97.31 122.61 40.54 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.765 0.317 . . . . 0.0 110.967 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.88 150.13 42.68 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.639 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . 0.508 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -71.5 -17.55 62.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.763 0.316 . . . . 0.0 111.098 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 75.8 p -76.64 -37.29 56.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.081 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.55 -68.72 0.32 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.689 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.67 123.26 18.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.831 0.348 . . . . 0.0 111.1 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.77 117.98 2.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.18 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 tp -67.82 144.1 55.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.417 0.627 . . . . 0.0 110.494 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.419 ' HA ' ' ND2' ' B' ' 84' ' ' ASN . 0.2 OUTLIER -75.14 140.51 43.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.079 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.697 HD12 ' HA3' ' B' ' 75' ' ' GLY . 1.3 tp -85.2 97.75 10.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.693 0.282 . . . . 0.0 110.619 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -152.83 -58.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.584 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . 0.553 ' HA3' ' OG1' ' E' ' 130' ' ' THR . . . 135.73 -26.58 3.15 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.632 -0.795 . . . . 0.0 112.67 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . 0.55 ' HB1' ' HA ' ' E' ' 129' ' ' ASN . . . -101.35 28.81 5.16 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.998 0.427 . . . . 0.0 111.641 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.57 67.28 0.72 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.059 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.42 81.02 8.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.803 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.06 97.47 3.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.794 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 1.9 t -165.61 144.79 6.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.546 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.34 50.36 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.139 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.79 94.18 5.73 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.676 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.73 110.31 12.46 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.723 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.6 ' HG ' ' ND2' ' B' ' 129' ' ' ASN . 0.3 OUTLIER -70.13 154.09 42.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.657 179.414 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -131.51 144.76 51.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.629 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.71 125.64 24.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.688 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.09 -102.06 1.11 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.734 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.402 HG22 ' O ' ' B' ' 58' ' ' LEU . 86.9 m -106.16 128.48 53.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.633 0.254 . . . . 0.0 110.859 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . 0.6 ' ND2' ' HG ' ' B' ' 124' ' ' LEU . 20.1 t-20 -121.14 158.18 28.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.896 0.379 . . . . 0.0 111.126 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.573 HG21 HD21 ' B' ' 55' ' ' ASN . 0.2 OUTLIER -155.82 143.08 19.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.982 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' ILE . . . . . 0.578 HG13 ' HB ' ' B' ' 56' ' ' ILE . 0.1 OUTLIER -115.16 110.64 45.43 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' PRO . . . . . 0.508 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -82.14 151.83 16.1 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.609 1.539 . . . . 0.0 112.553 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.01 146.76 17.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.852 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' B' ' 104' ' ' LEU . 0.8 OUTLIER -114.28 145.9 41.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.088 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.89 91.13 1.9 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.913 0.387 . . . . 0.0 111.686 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . 0.667 ' HG2' ' HB3' ' B' ' 51' ' ' ALA . 28.1 mtm-85 -88.33 153.59 21.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.374 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . 0.601 ' O ' ' HA ' ' B' ' 48' ' ' THR . 0.7 OUTLIER -91.24 111.01 22.31 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.129 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . 0.595 ' CD1' ' HB2' ' B' ' 102' ' ' GLN . 8.8 m-85 -108.08 172.17 6.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.029 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.588 ' HB1' ' HB2' ' B' ' 42' ' ' LEU . . . -123.43 143.68 49.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.862 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' THR . . . . . 0.456 ' CG2' ' HB3' ' B' ' 79' ' ' ASP . 0.2 OUTLIER -98.81 44.36 1.03 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.47 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.57 89.08 1.08 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.929 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' B' ' 43' ' ' ALA . . . 59.94 88.1 0.08 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.745 0.272 . . . . 0.0 110.777 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' ALA . . . . . 0.509 ' CB ' ' HB ' ' B' ' 99' ' ' VAL . . . -70.63 161.7 30.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.815 0.34 . . . . 0.0 111.379 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 158.73 60.64 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.213 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.448 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 1.4 Cg_endo -83.81 149.22 12.49 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.502 2.135 . . . . 0.0 112.057 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.69 -119.78 0.86 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.483 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . 0.646 ' HB1' ' HA ' ' B' ' 95' ' ' SER . . . -123.95 127.67 48.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.874 0.369 . . . . 0.0 111.413 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . 0.662 ' HA ' ' HB3' ' B' ' 88' ' ' LEU . . . -120.8 67.16 0.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.428 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' B' ' 89' ' ' GLN . 47.5 t-20 -128.45 114.75 17.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.637 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -158.77 147.05 18.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.034 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.45 140.3 32.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.121 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.19 169.31 17.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.208 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' B' ' 74' ' ' LEU . 9.4 t -155.13 150.49 27.19 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.433 ' HE1' HG13 ' B' ' 56' ' ' ILE . 1.1 p90 -119.03 149.21 42.05 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.024 0.44 . . . . 0.0 110.107 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.675 ' HD2' HG21 ' E' ' 128' ' ' THR . 4.7 mttt -113.42 156.56 23.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.914 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' VAL . . . . . 0.546 HG13 HD12 ' B' ' 131' ' ' ILE . 0.2 OUTLIER -136.43 138.02 47.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.699 -179.116 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.615 ' HB2' HG23 ' A' ' 4' ' ' THR . 64.1 tt0 -107.46 128.02 54.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.285 0.564 . . . . 0.0 110.369 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . 0.575 ' HB2' ' OG1' ' A' ' 3' ' ' THR . 60.9 m-85 -107.81 107.37 18.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.519 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . 0.658 ' HA ' ' H ' ' A' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.272 0.082 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.644 ' H ' ' HA ' ' D' ' 159' ' ' GLN . . . 65.93 74.7 0.36 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.529 0.204 . . . . 0.0 110.929 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' THR . . . . . 0.58 ' OG1' ' HB2' ' D' ' 158' ' ' TYR . 6.0 p -117.74 97.5 5.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.479 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' THR . . . . . 0.638 HG23 ' HB2' ' D' ' 157' ' ' GLN . 67.8 p -87.92 108.74 19.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.529 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . 0.57 HG12 HG12 ' D' ' 17' ' ' VAL . 15.4 m -126.61 172.71 13.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.571 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.15 110.76 12.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.567 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.73 -59.37 7.71 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.792 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.5 151.71 15.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.827 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' THR . . . . . 0.401 HG21 ' N ' ' C' ' 10' ' ' VAL . 24.1 m -103.48 143.11 33.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.855 0.36 . . . . 0.0 111.313 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.476 HG22 ' HE1' ' C' ' 12' ' ' PHE . 1.1 m -130.97 115.65 30.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.134 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -83.62 105.72 14.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.367 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' PHE . . . . . 0.476 ' HE1' HG22 ' C' ' 10' ' ' VAL . 52.2 m-85 -83.19 105.46 14.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.756 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.39 145.06 41.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.422 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.71 -179.68 42.56 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.974 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.23 134.27 22.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.971 0.415 . . . . 0.0 110.358 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.462 HG13 ' HA ' ' D' ' 145' ' ' PRO . 3.3 t -90.92 127.11 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.238 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.567 HG12 HG12 ' B' ' 5' ' ' VAL . 12.1 m -126.23 168.82 18.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.831 0.348 . . . . 0.0 111.022 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.53 81.88 2.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.046 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' D' ' 38' ' ' ARG . . . 53.27 58.24 5.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.015 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . 0.49 ' HB3' HG21 ' C' ' 17' ' ' VAL . . . -108.61 -62.8 1.41 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.385 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.9 OUTLIER -171.57 -159.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.957 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . 0.593 ' HA ' ' HB2' ' D' ' 36' ' ' GLN . . . -156.88 74.0 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.059 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . 0.787 ' HB ' HD22 ' C' ' 58' ' ' LEU . 7.4 p -45.3 140.56 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.061 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.45 140.79 58.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.615 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.43 -51.16 69.43 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.287 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.03 -18.04 74.23 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.966 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -88.0 -6.27 58.07 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.807 0.337 . . . . 0.0 110.794 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.435 HG12 ' HG2' ' D' ' 33' ' ' GLN . 50.7 t -72.74 -36.43 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.332 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.94 110.92 14.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.95 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.86 146.05 48.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.987 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.18 113.84 27.68 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.113 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.13 121.92 57.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 110.404 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.442 ' HG2' HG12 ' B' ' 28' ' ' VAL . 0.6 OUTLIER -101.85 106.42 17.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.641 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.428 HD11 ' HA ' ' C' ' 34' ' ' LEU . 0.6 OUTLIER -64.79 -44.73 89.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.555 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.61 -156.8 16.03 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.6 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . 0.603 ' HB2' ' HA ' ' B' ' 22' ' ' ALA . 3.7 mt-30 -91.09 106.93 18.86 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.663 0.268 . . . . 0.0 110.922 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 4.3 t -92.28 120.51 41.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.94 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' ARG . . . . . 0.424 ' HG2' ' HA ' ' B' ' 19' ' ' ALA . 4.6 mtm105 -85.59 132.49 34.17 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.759 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 29.1 p -71.48 -23.34 61.79 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.768 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.93 -19.2 64.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.935 0.397 . . . . 0.0 110.817 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 13.8 t -90.61 -36.56 14.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.159 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.586 ' HB2' ' HB1' ' C' ' 139' ' ' ALA . 0.2 OUTLIER -121.45 70.55 0.94 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.623 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' C' ' 142' ' ' ALA . . . -104.79 28.16 7.37 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.379 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . 0.676 ' HG3' ' HB1' ' C' ' 47' ' ' ALA . 0.0 OUTLIER -150.62 141.93 23.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.402 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . 0.446 ' HG3' ' HA ' ' C' ' 140' ' ' THR . 2.7 tt0 -62.62 101.78 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.764 0.316 . . . . 0.0 111.133 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.24 4.25 8.46 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.094 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.676 ' HB1' ' HG3' ' C' ' 44' ' ' GLN . . . -91.73 121.33 33.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.942 0.401 . . . . 0.0 112.016 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' C' ' 137' ' ' TYR . 5.8 t -110.41 151.16 27.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.815 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -95.66 -57.68 2.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.544 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.2 -174.88 4.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.87 0.367 . . . . 0.0 110.8 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . 0.664 ' HB3' ' HG2' ' C' ' 136' ' ' ARG . . . -127.06 143.82 51.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.395 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.85 116.85 51.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.006 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.16 122.61 6.19 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.685 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -128.58 138.82 52.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 111.022 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.578 HD21 HG21 ' C' ' 130' ' ' THR . 1.6 m120 -117.8 150.98 38.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.621 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.579 ' HB ' HG13 ' C' ' 131' ' ' ILE . 9.2 mm -106.83 103.64 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.617 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -61.07 132.25 53.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.751 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . 0.787 HD22 ' HB ' ' C' ' 23' ' ' VAL . 1.0 OUTLIER -137.44 151.81 48.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.244 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -138.35 171.39 14.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.962 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' ASP . . . . . 0.428 ' O ' ' HA ' ' C' ' 21' ' ' CYS . 5.9 m-20 49.97 68.51 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.791 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 0.0 OUTLIER -106.62 141.07 38.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.794 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.79 117.83 33.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.254 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 23.5 p -91.13 -13.1 33.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.58 -39.02 82.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.14 0.495 . . . . 0.0 111.76 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 75.8 t -107.63 -54.15 6.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.627 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.7 84.38 3.37 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.596 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.02 -41.27 10.08 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.911 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.69 159.98 17.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.459 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.71 160.38 39.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.612 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.01 153.01 44.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.18 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.95 136.46 54.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.73 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.95 107.4 5.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.618 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' PHE . . . . . 0.447 ' CD2' HD12 ' C' ' 103' ' ' ILE . 43.0 t80 -73.57 136.68 44.02 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.502 0.191 . . . . 0.0 111.082 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.737 HD11 ' HG2' ' F' ' 57' ' ' GLN . 6.6 tt -113.6 111.4 21.81 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.003 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . 0.694 ' HA3' HD12 ' C' ' 113' ' ' LEU . . . -131.35 -178.54 15.53 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.765 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' THR . . . . . 0.47 HG21 ' O ' ' F' ' 53' ' ' GLY . 0.2 OUTLIER -104.28 137.55 42.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.5 0.191 . . . . 0.0 110.878 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.93 114.81 23.88 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.997 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . 0.597 ' O ' ' HG2' ' F' ' 134' ' ' GLN . 1.2 tt -95.75 -36.72 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' ASP . . . . . 0.457 ' HB3' ' CG2' ' C' ' 140' ' ' THR . 0.4 OUTLIER -143.39 130.28 20.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.722 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.95 -7.2 47.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.97 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.3 -29.18 68.28 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.637 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.31 -32.73 4.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.903 0.382 . . . . 0.0 110.432 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 3.5 m 60.59 19.41 9.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.574 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' ASN . . . . . 0.618 ' HB3' ' HG2' ' C' ' 102' ' ' GLN . 0.6 OUTLIER -139.39 -16.94 1.03 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.314 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.684 ' HB ' ' HA3' ' C' ' 100' ' ' GLY . 0.8 OUTLIER -66.71 118.08 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.172 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.558 ' HA ' HD21 ' C' ' 113' ' ' LEU . 10.7 tp -69.79 144.14 52.75 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.27 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.07 138.0 36.89 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.777 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.667 ' HB3' ' HA ' ' C' ' 148' ' ' ALA . 0.0 OUTLIER -84.99 -146.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.068 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' C' ' 149' ' ' ASN . 0.0 OUTLIER -48.48 155.02 0.57 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.312 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 33.1 p -86.79 -11.87 49.7 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.991 0.424 . . . . 0.0 111.489 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.42 114.08 5.16 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' ALA . . . . . 0.556 ' HA ' ' HB3' ' F' ' 50' ' ' SER . . . -83.38 22.25 1.05 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.919 0.39 . . . . 0.0 111.728 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.28 21.98 1.2 Allowed 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.699 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.75 -32.23 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.974 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' SER . . . . . 0.644 ' HA ' ' HB1' ' C' ' 147' ' ' ALA . 16.0 t -65.15 166.71 9.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.805 0.336 . . . . 0.0 110.682 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.64 163.46 15.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.892 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' THR . . . . . 0.657 HG21 ' HB1' ' F' ' 51' ' ' ALA . 0.0 OUTLIER -135.37 169.63 17.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.347 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 57.35 29.36 16.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.378 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' VAL . . . . . 0.506 ' HB ' ' CB ' ' C' ' 143' ' ' ALA . 7.2 p -156.35 150.57 10.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.839 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . 0.684 ' HA3' ' HB ' ' C' ' 85' ' ' VAL . . . -164.19 176.93 40.08 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.584 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.6 111.29 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.06 0.544 . . . . 0.0 111.74 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' GLN . . . . . 0.618 ' HG2' ' HB3' ' C' ' 84' ' ' ASN . 0.0 OUTLIER -75.98 179.73 5.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.979 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . 0.534 HD13 ' HA ' ' C' ' 113' ' ' LEU . 6.0 pt -150.35 116.62 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.418 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' C' ' 134' ' ' GLN . 12.8 tp -97.23 122.55 40.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.676 0.274 . . . . 0.0 111.015 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.96 150.07 43.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.718 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . 0.527 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -71.47 -17.56 62.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.793 0.33 . . . . 0.0 111.087 179.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 74.3 p -76.52 -37.29 56.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.152 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.55 -68.74 0.32 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.705 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.69 123.27 18.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.811 0.339 . . . . 0.0 111.14 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.66 117.98 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 tp -67.83 144.06 55.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.473 0.654 . . . . 0.0 110.502 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' THR . . . . . 0.426 ' HA ' ' ND2' ' C' ' 84' ' ' ASN . 0.2 OUTLIER -75.08 140.43 43.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.127 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.694 HD12 ' HA3' ' C' ' 75' ' ' GLY . 1.3 tp -85.18 97.75 10.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 110.62 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -152.79 -59.03 0.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.68 0.276 . . . . 0.0 111.555 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . 0.567 ' HA3' ' OG1' ' F' ' 130' ' ' THR . . . 135.77 -26.63 3.14 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.577 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' ALA . . . . . 0.549 ' HB1' ' HA ' ' F' ' 129' ' ' ASN . . . -101.36 28.78 5.19 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.055 0.455 . . . . 0.0 111.656 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.56 67.31 0.72 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.05 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.38 80.96 8.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.77 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.96 97.46 3.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 2.0 t -165.59 144.83 6.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.6 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.34 50.4 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.144 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.88 94.11 5.78 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.685 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.73 110.4 12.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.729 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . 0.598 ' HG ' ' ND2' ' C' ' 129' ' ' ASN . 0.3 OUTLIER -70.13 154.13 42.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.65 179.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -131.58 144.73 51.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.623 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.77 125.66 24.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.663 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.1 -102.02 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.715 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' THR . . . . . 0.409 HG22 ' O ' ' C' ' 58' ' ' LEU . 86.4 m -106.23 128.55 54.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.652 0.263 . . . . 0.0 110.786 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 129' ' ' ASN . . . . . 0.598 ' ND2' ' HG ' ' C' ' 124' ' ' LEU . 20.1 t-20 -121.19 158.14 28.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.902 0.382 . . . . 0.0 111.116 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 130' ' ' THR . . . . . 0.578 HG21 HD21 ' C' ' 55' ' ' ASN . 0.2 OUTLIER -155.79 143.09 19.3 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.986 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 131' ' ' ILE . . . . . 0.579 HG13 ' HB ' ' C' ' 56' ' ' ILE . 0.1 OUTLIER -115.22 110.73 45.2 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 132' ' ' PRO . . . . . 0.527 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.5 Cg_endo -82.1 151.77 16.18 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.632 1.554 . . . . 0.0 112.573 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.02 146.79 17.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 134' ' ' GLN . . . . . 0.493 ' HB2' ' O ' ' C' ' 104' ' ' LEU . 0.8 OUTLIER -114.4 145.8 41.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.088 179.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.76 91.22 1.92 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 111.674 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . 0.664 ' HG2' ' HB3' ' C' ' 51' ' ' ALA . 28.0 mtm-85 -88.33 153.55 21.11 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.345 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 137' ' ' TYR . . . . . 0.594 ' O ' ' HA ' ' C' ' 48' ' ' THR . 0.7 OUTLIER -91.22 111.04 22.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.103 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 138' ' ' PHE . . . . . 0.584 ' CD1' ' HB2' ' C' ' 102' ' ' GLN . 8.8 m-85 -108.13 172.21 6.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.939 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 139' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' C' ' 42' ' ' LEU . . . -123.45 143.6 50.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.87 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 140' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' C' ' 79' ' ' ASP . 0.2 OUTLIER -98.71 44.47 1.03 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.529 179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.5 89.06 1.07 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.936 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 142' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' C' ' 43' ' ' ALA . . . 60.02 88.09 0.08 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.7 0.25 . . . . 0.0 110.693 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 143' ' ' ALA . . . . . 0.516 ' HB2' HD12 ' C' ' 42' ' ' LEU . . . -70.64 161.75 30.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.775 0.321 . . . . 0.0 111.444 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.49 158.71 60.73 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.191 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 145' ' ' PRO . . . . . 0.458 ' HA ' ' HB ' ' B' ' 16' ' ' VAL . 1.5 Cg_endo -83.72 149.25 12.63 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.501 2.134 . . . . 0.0 112.072 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.7 -119.76 0.86 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.52 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 147' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' C' ' 95' ' ' SER . . . -123.91 127.71 48.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.828 0.346 . . . . 0.0 111.418 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 148' ' ' ALA . . . . . 0.667 ' HA ' ' HB3' ' C' ' 88' ' ' LEU . . . -120.83 67.19 0.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.41 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 149' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' C' ' 89' ' ' GLN . 47.3 t-20 -128.49 114.78 17.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.599 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 150' ' ' ALA . . . . . . . . . . . . . . . -158.87 146.93 18.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.0 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.33 140.31 32.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.148 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.26 169.23 17.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.18 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 153' ' ' THR . . . . . 0.443 ' O ' ' HB3' ' C' ' 74' ' ' LEU . 9.3 t -155.09 150.54 27.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 154' ' ' PHE . . . . . 0.426 ' HE1' HG13 ' C' ' 56' ' ' ILE . 1.1 p90 -119.05 149.21 42.05 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.077 0.465 . . . . 0.0 110.075 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . 0.674 ' HD2' HG21 ' F' ' 128' ' ' THR . 4.7 mttt -113.48 156.64 23.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.908 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 156' ' ' VAL . . . . . 0.547 HG13 HD12 ' C' ' 131' ' ' ILE . 0.2 OUTLIER -136.45 138.03 47.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.663 -179.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . 0.613 ' HB2' HG23 ' B' ' 4' ' ' THR . 64.1 tt0 -107.5 128.05 54.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.363 0.601 . . . . 0.0 110.365 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . 0.587 ' HB2' ' OG1' ' B' ' 3' ' ' THR . 60.9 m-85 -107.85 107.46 18.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.541 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . 0.661 ' HA ' ' H ' ' B' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.884 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.312 0.101 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . 0.646 ' H ' ' HA ' ' E' ' 159' ' ' GLN . . . 65.87 74.72 0.36 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.937 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' THR . . . . . 0.58 ' OG1' ' HB2' ' E' ' 158' ' ' TYR . 6.2 p -117.71 97.48 5.88 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.489 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' THR . . . . . 0.627 HG23 ' HB2' ' E' ' 157' ' ' GLN . 68.1 p -87.87 108.72 19.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.559 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . 0.571 HG12 HG12 ' E' ' 17' ' ' VAL . 15.3 m -126.63 172.74 13.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.612 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.13 110.81 12.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.566 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.67 -59.51 7.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.747 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.52 151.68 14.92 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.809 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' THR . . . . . 0.408 HG21 ' N ' ' D' ' 10' ' ' VAL . 24.2 m -103.45 143.08 33.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 111.319 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' VAL . . . . . 0.476 HG22 ' HE1' ' D' ' 12' ' ' PHE . 1.1 m -130.93 115.63 30.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.182 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.63 105.67 14.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.392 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' PHE . . . . . 0.476 ' HE1' HG22 ' D' ' 10' ' ' VAL . 52.0 m-85 -83.21 105.47 14.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.8 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.41 145.13 41.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.452 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.74 -179.67 42.58 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.98 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.26 134.2 22.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.937 0.399 . . . . 0.0 110.406 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.456 HG13 ' HA ' ' E' ' 145' ' ' PRO . 3.3 t -90.9 127.2 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.174 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . 0.57 HG12 HG12 ' C' ' 5' ' ' VAL . 12.1 m -126.31 168.78 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.929 0.395 . . . . 0.0 111.025 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.49 81.85 2.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.092 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' ALA . . . . . 0.44 ' HA ' ' HG2' ' E' ' 38' ' ' ARG . . . 53.31 58.19 5.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.057 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.483 ' HB3' HG21 ' D' ' 17' ' ' VAL . . . -108.6 -62.83 1.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.36 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' CYS . . . . . 0.911 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.9 OUTLIER -171.53 -159.88 0.16 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . 0.597 ' HA ' ' HB2' ' E' ' 36' ' ' GLN . . . -156.86 74.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.098 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . 0.775 ' HB ' HD22 ' D' ' 58' ' ' LEU . 7.4 p -45.36 140.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.081 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.49 140.79 58.91 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.656 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.4 -51.14 69.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.302 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.11 -17.98 74.33 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.937 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.96 -6.42 58.03 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.859 0.362 . . . . 0.0 110.818 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . 0.446 HG12 ' HG2' ' E' ' 33' ' ' GLN . 50.5 t -72.7 -36.36 52.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.364 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.0 110.88 14.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.008 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.76 146.07 48.57 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.977 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.25 113.83 27.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.084 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.15 121.91 57.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.149 0.499 . . . . 0.0 110.433 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.435 ' HG2' HG12 ' C' ' 28' ' ' VAL . 0.6 OUTLIER -101.84 106.37 17.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.669 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.5 ' HA ' HD11 ' D' ' 34' ' ' LEU . 0.6 OUTLIER -64.73 -44.74 89.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.595 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.6 -156.91 15.99 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.54 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' GLN . . . . . 0.593 ' HB2' ' HA ' ' C' ' 22' ' ' ALA . 3.7 mt-30 -91.06 106.95 18.88 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.656 0.265 . . . . 0.0 110.899 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 t -92.29 120.63 41.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.839 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' C' ' 19' ' ' ALA . 4.6 mtm105 -85.68 132.46 34.14 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.742 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' THR . . . . . . . . . . . . . 29.5 p -71.5 -23.23 61.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.753 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.13 -19.07 64.79 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.974 0.416 . . . . 0.0 110.823 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -90.59 -36.65 14.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.16 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.582 ' HB2' ' HB1' ' D' ' 139' ' ' ALA . 0.2 OUTLIER -121.44 70.62 0.94 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.555 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' D' ' 142' ' ' ALA . . . -104.79 28.18 7.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.392 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' GLN . . . . . 0.682 ' HG3' ' HB1' ' D' ' 47' ' ' ALA . 0.0 OUTLIER -150.59 141.92 23.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.437 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . 0.424 ' HG3' ' HA ' ' D' ' 140' ' ' THR . 2.7 tt0 -62.69 101.78 0.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.819 0.342 . . . . 0.0 111.145 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.29 4.23 8.43 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.115 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.682 ' HB1' ' HG3' ' D' ' 44' ' ' GLN . . . -91.67 121.28 33.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.932 0.396 . . . . 0.0 112.03 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' D' ' 137' ' ' TYR . 5.9 t -110.42 151.18 27.8 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.826 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 5.1 t -95.62 -57.59 2.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.632 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.547 ' HB3' ' HA ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -148.23 -174.85 4.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.875 0.369 . . . . 0.0 110.756 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' ALA . . . . . 0.665 ' HB1' HG21 ' A' ' 97' ' ' THR . . . -127.11 143.86 51.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.352 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.84 116.86 51.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.974 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . 0.462 ' O ' HG21 ' A' ' 76' ' ' THR . . . -111.15 122.67 6.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.699 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -128.63 138.84 52.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.812 0.339 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' ASN . . . . . 0.573 HD21 HG21 ' D' ' 130' ' ' THR . 1.6 m120 -117.86 150.99 38.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.585 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.569 ' HB ' HG13 ' D' ' 131' ' ' ILE . 9.3 mm -106.86 103.77 15.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.547 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' GLN . . . . . 0.751 ' HG2' HD11 ' A' ' 74' ' ' LEU . 75.8 mt-30 -61.11 132.28 53.23 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.788 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . 0.775 HD22 ' HB ' ' D' ' 23' ' ' VAL . 1.0 OUTLIER -137.49 151.81 48.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.205 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -138.32 171.36 14.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.977 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' D' ' 21' ' ' CYS . 5.9 m-20 50.0 68.55 0.73 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.743 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' CYS . . . . . 0.911 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 0.0 OUTLIER -106.67 141.11 38.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.792 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.78 117.83 33.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.254 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 23.4 p -91.21 -13.04 33.55 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -38.98 82.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.081 0.467 . . . . 0.0 111.707 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 75.8 t -107.67 -54.11 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.64 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' D' ' 158' ' ' TYR . . . -97.69 84.32 3.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.576 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.05 -41.23 10.08 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.955 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.57 159.99 17.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.517 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.7 160.4 39.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.586 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.07 152.94 45.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.157 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.9 136.55 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.699 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.04 107.46 5.03 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.565 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' PHE . . . . . 0.44 ' CD2' HD12 ' D' ' 103' ' ' ILE . 42.9 t80 -73.62 136.61 43.92 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.532 0.206 . . . . 0.0 111.06 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' LEU . . . . . 0.536 HD13 ' HE3' ' D' ' 155' ' ' LYS . 6.6 tt -113.55 111.39 21.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.006 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . 0.702 ' HA3' HD12 ' D' ' 113' ' ' LEU . . . -131.26 -178.5 15.5 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.883 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.37 137.54 42.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.493 0.187 . . . . 0.0 110.825 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.96 114.74 23.84 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.961 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 78' ' ' ILE . . . . . 0.449 ' H ' HG23 ' D' ' 78' ' ' ILE . 1.2 tt -95.74 -36.78 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.842 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . 0.454 ' HB3' ' CG2' ' D' ' 140' ' ' THR . 0.4 OUTLIER -143.32 130.19 20.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.8 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.83 -7.28 47.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.991 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.37 -29.14 68.38 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.557 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.33 -32.61 4.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.482 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 3.5 m 60.47 19.43 9.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.58 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . 0.599 ' HB3' ' HG2' ' D' ' 102' ' ' GLN . 0.6 OUTLIER -139.31 -16.94 1.04 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.409 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.687 ' HB ' ' HA3' ' D' ' 100' ' ' GLY . 0.9 OUTLIER -66.77 118.03 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.206 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.537 ' HA ' HD21 ' D' ' 113' ' ' LEU . 10.7 tp -69.7 144.13 52.91 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.275 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.14 138.06 36.84 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.892 0.377 . . . . 0.0 111.71 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.674 ' HB3' ' HA ' ' D' ' 148' ' ' ALA . 0.0 OUTLIER -84.96 -146.62 0.1 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.079 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 89' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' D' ' 149' ' ' ASN . 0.0 OUTLIER -48.48 155.03 0.57 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.293 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 32.4 p -86.77 -11.91 49.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.533 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 8.2 t -66.43 114.15 5.22 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.34 22.09 1.07 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.932 0.396 . . . . 0.0 111.706 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.2 21.97 1.21 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.73 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.7 -32.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.957 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 95' ' ' SER . . . . . 0.652 ' HA ' ' HB1' ' D' ' 147' ' ' ALA . 15.8 t -65.16 166.64 9.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 110.654 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.59 163.53 15.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.827 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.45 169.7 17.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.276 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 98' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 57.26 29.42 16.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.38 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 99' ' ' VAL . . . . . 0.497 ' HB ' ' CB ' ' D' ' 143' ' ' ALA . 7.1 p -156.39 150.54 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 100' ' ' GLY . . . . . 0.687 ' HA3' ' HB ' ' D' ' 85' ' ' VAL . . . -164.14 176.95 40.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.587 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.62 111.32 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 123.078 0.551 . . . . 0.0 111.663 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 102' ' ' GLN . . . . . 0.599 ' HG2' ' HB3' ' D' ' 84' ' ' ASN . 0.0 OUTLIER -76.0 179.72 5.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.942 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 103' ' ' ILE . . . . . 0.53 HD13 ' HA ' ' D' ' 113' ' ' LEU . 6.0 pt -150.33 116.56 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.43 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 104' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' D' ' 134' ' ' GLN . 12.8 tp -97.21 122.55 40.36 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 111.068 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.91 150.11 42.86 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.65 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 106' ' ' ARG . . . . . 0.513 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -71.5 -17.54 62.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.846 0.355 . . . . 0.0 111.102 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 107' ' ' THR . . . . . . . . . . . . . 76.1 p -76.62 -37.29 56.62 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.111 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.57 -68.74 0.32 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.677 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.55 123.17 18.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.772 0.32 . . . . 0.0 111.191 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.79 118.0 2.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.939 0.4 . . . . 0.0 111.15 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 tp -67.88 144.09 55.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.43 0.633 . . . . 0.0 110.46 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 112' ' ' THR . . . . . 0.424 ' HA ' ' ND2' ' D' ' 84' ' ' ASN . 0.2 OUTLIER -75.15 140.46 43.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.095 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 113' ' ' LEU . . . . . 0.702 HD12 ' HA3' ' D' ' 75' ' ' GLY . 1.3 tp -85.15 97.78 10.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.748 0.308 . . . . 0.0 110.596 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -152.83 -59.07 0.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.65 0.262 . . . . 0.0 111.494 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.77 -26.61 3.14 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.552 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.34 28.82 5.15 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.045 0.45 . . . . 0.0 111.676 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.57 67.38 0.72 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.03 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.43 80.89 8.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.739 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.95 97.55 3.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.881 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 2.0 t -165.66 144.79 6.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.531 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.32 50.34 0.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.204 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.81 94.11 5.73 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.714 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.69 110.26 12.38 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.69 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . 0.593 ' HG ' ' ND2' ' D' ' 129' ' ' ASN . 0.3 OUTLIER -70.1 154.1 42.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.558 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.58 144.77 51.32 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.584 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.75 125.63 24.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.645 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.1 -101.99 1.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.701 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 128' ' ' THR . . . . . 0.668 HG21 ' HD2' ' A' ' 155' ' ' LYS . 86.6 m -106.25 128.5 54.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.662 0.267 . . . . 0.0 110.773 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 129' ' ' ASN . . . . . 0.593 ' ND2' ' HG ' ' D' ' 124' ' ' LEU . 20.1 t-20 -121.15 158.25 28.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.874 0.368 . . . . 0.0 111.109 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 130' ' ' THR . . . . . 0.573 HG21 HD21 ' D' ' 55' ' ' ASN . 0.2 OUTLIER -155.87 143.08 19.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.057 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 131' ' ' ILE . . . . . 0.569 HG13 ' HB ' ' D' ' 56' ' ' ILE . 0.1 OUTLIER -115.28 110.75 45.05 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 132' ' ' PRO . . . . . 0.513 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.4 Cg_endo -82.16 151.83 16.06 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.666 1.577 . . . . 0.0 112.499 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.07 146.72 17.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 134' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' A' ' 78' ' ' ILE . 0.8 OUTLIER -114.36 145.92 41.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.031 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.85 91.09 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.41 . . . . 0.0 111.735 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 136' ' ' ARG . . . . . 0.665 ' HG2' ' HB3' ' D' ' 51' ' ' ALA . 28.1 mtm-85 -88.32 153.52 21.13 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.443 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 137' ' ' TYR . . . . . 0.604 ' O ' ' HA ' ' D' ' 48' ' ' THR . 0.7 OUTLIER -91.1 110.96 22.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.173 179.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 138' ' ' PHE . . . . . 0.594 ' CD1' ' HB2' ' D' ' 102' ' ' GLN . 8.8 m-85 -108.08 172.16 6.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.253 0.549 . . . . 0.0 111.971 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 139' ' ' ALA . . . . . 0.582 ' HB1' ' HB2' ' D' ' 42' ' ' LEU . . . -123.39 143.64 49.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.89 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 140' ' ' THR . . . . . 0.454 ' CG2' ' HB3' ' D' ' 79' ' ' ASP . 0.2 OUTLIER -98.78 44.46 1.03 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.514 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.54 88.97 1.08 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.966 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' D' ' 43' ' ' ALA . . . 60.08 88.04 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.745 0.273 . . . . 0.0 110.73 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 143' ' ' ALA . . . . . 0.509 ' HB2' HD12 ' D' ' 42' ' ' LEU . . . -70.59 161.73 30.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.784 0.326 . . . . 0.0 111.479 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.54 158.77 60.69 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.203 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 145' ' ' PRO . . . . . 0.462 ' HA ' HG13 ' C' ' 16' ' ' VAL . 1.4 Cg_endo -83.83 149.22 12.47 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.491 2.127 . . . . 0.0 111.995 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.71 -119.75 0.86 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.519 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 147' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' D' ' 95' ' ' SER . . . -123.95 127.65 48.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.799 0.333 . . . . 0.0 111.452 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 148' ' ' ALA . . . . . 0.674 ' HA ' ' HB3' ' D' ' 88' ' ' LEU . . . -120.86 67.2 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.124 0.488 . . . . 0.0 110.376 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 149' ' ' ASN . . . . . 0.403 ' O ' ' HA ' ' D' ' 89' ' ' GLN . 47.5 t-20 -128.54 114.77 17.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.607 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 150' ' ' ALA . . . . . . . . . . . . . . . -158.8 147.01 18.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.994 179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.4 140.31 32.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.173 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.2 169.29 17.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.183 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 153' ' ' THR . . . . . 0.456 ' O ' ' HB3' ' D' ' 74' ' ' LEU . 9.3 t -155.15 150.52 27.2 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 154' ' ' PHE . . . . . 0.435 ' HE1' HG13 ' D' ' 56' ' ' ILE . 1.1 p90 -119.06 149.25 41.98 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.066 0.46 . . . . 0.0 110.059 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . 0.536 ' HE3' HD13 ' D' ' 74' ' ' LEU . 4.7 mttt -113.48 156.67 23.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.924 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 156' ' ' VAL . . . . . 0.544 HG13 HD12 ' D' ' 131' ' ' ILE . 0.2 OUTLIER -136.49 138.04 47.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.627 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 157' ' ' GLN . . . . . 0.638 ' HB2' HG23 ' C' ' 4' ' ' THR . 64.1 tt0 -107.41 128.01 54.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.27 0.557 . . . . 0.0 110.37 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . 0.58 ' HB2' ' OG1' ' C' ' 3' ' ' THR . 61.0 m-85 -107.85 107.45 18.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.49 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 159' ' ' GLN . . . . . 0.644 ' HA ' ' H ' ' C' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 120.281 0.086 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . 0.668 ' H ' ' HA ' ' F' ' 159' ' ' GLN . . . 65.96 74.63 0.36 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.978 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 3' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' F' ' 158' ' ' TYR . 6.1 p -117.74 97.53 5.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.482 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 4' ' ' THR . . . . . 0.614 HG23 ' HB2' ' F' ' 157' ' ' GLN . 68.3 p -87.89 108.67 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.562 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . 0.576 HG12 HG12 ' F' ' 17' ' ' VAL . 15.4 m -126.59 172.75 13.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.627 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.16 110.86 12.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.567 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.85 -59.37 7.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.737 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.59 151.7 14.91 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.804 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 9' ' ' THR . . . . . 0.414 HG21 ' N ' ' E' ' 10' ' ' VAL . 24.2 m -103.46 143.1 33.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.799 0.333 . . . . 0.0 111.316 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 10' ' ' VAL . . . . . 0.483 HG22 ' HE1' ' E' ' 12' ' ' PHE . 1.1 m -130.97 115.67 31.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.171 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.65 105.78 14.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.347 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 12' ' ' PHE . . . . . 0.483 ' HE1' HG22 ' E' ' 10' ' ' VAL . 52.3 m-85 -83.15 105.5 14.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.804 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.45 145.04 41.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.4 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.75 -179.59 42.63 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.942 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.27 134.21 22.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.913 0.387 . . . . 0.0 110.35 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 16' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' F' ' 145' ' ' PRO . 3.3 t -90.93 127.11 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.232 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . 0.571 HG12 HG12 ' D' ' 5' ' ' VAL . 11.9 m -126.22 168.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.811 0.339 . . . . 0.0 111.08 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.43 81.78 2.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.133 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 19' ' ' ALA . . . . . 0.426 ' HA ' ' HG2' ' F' ' 38' ' ' ARG . . . 53.35 58.15 5.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.078 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.49 ' HB3' HG21 ' E' ' 17' ' ' VAL . . . -108.58 -62.8 1.41 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.44 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 21' ' ' CYS . . . . . 0.915 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.9 OUTLIER -171.54 -159.87 0.16 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.946 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 22' ' ' ALA . . . . . 0.597 ' HA ' ' HB2' ' F' ' 36' ' ' GLN . . . -156.86 74.05 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 23' ' ' VAL . . . . . 0.794 ' HB ' HD22 ' E' ' 58' ' ' LEU . 7.4 p -45.38 140.6 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.06 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.45 140.82 58.91 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.614 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.08 69.83 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.288 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.13 -17.97 74.36 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.939 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.99 -6.37 58.03 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.843 0.354 . . . . 0.0 110.757 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 28' ' ' VAL . . . . . 0.447 HG12 ' HG2' ' F' ' 33' ' ' GLN . 50.5 t -72.7 -36.34 52.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.365 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.02 110.81 13.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.984 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.79 146.01 48.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.994 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.15 113.77 27.56 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.132 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.03 121.98 57.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.175 0.512 . . . . 0.0 110.398 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 33' ' ' GLN . . . . . 0.446 ' HG2' HG12 ' D' ' 28' ' ' VAL . 0.6 OUTLIER -101.95 106.44 17.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.623 -179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.505 HD11 ' HA ' ' E' ' 34' ' ' LEU . 0.6 OUTLIER -64.75 -44.73 89.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.643 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.53 -156.86 16.05 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.587 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 36' ' ' GLN . . . . . 0.597 ' HB2' ' HA ' ' D' ' 22' ' ' ALA . 3.7 mt-30 -91.11 106.93 18.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.656 0.265 . . . . 0.0 110.828 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 t -92.33 120.61 41.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.874 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' D' ' 19' ' ' ALA . 4.5 mtm105 -85.65 132.49 34.15 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.756 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 39' ' ' THR . . . . . . . . . . . . . 29.5 p -71.49 -23.37 61.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.733 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.0 -19.1 64.89 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.987 0.422 . . . . 0.0 110.842 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -90.61 -36.53 14.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.181 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.592 ' HB2' ' HB1' ' E' ' 139' ' ' ALA . 0.2 OUTLIER -121.47 70.58 0.94 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.621 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 43' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' E' ' 142' ' ' ALA . . . -104.74 28.17 7.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.49 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 44' ' ' GLN . . . . . 0.689 ' HG3' ' HB1' ' E' ' 47' ' ' ALA . 0.0 OUTLIER -150.57 141.95 23.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.469 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . 0.426 ' HG3' ' HA ' ' E' ' 140' ' ' THR . 2.7 tt0 -62.74 101.81 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 111.111 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.33 4.22 8.41 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.121 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 47' ' ' ALA . . . . . 0.689 ' HB1' ' HG3' ' E' ' 44' ' ' GLN . . . -91.78 121.24 33.23 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.008 0.433 . . . . 0.0 111.966 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 48' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' E' ' 137' ' ' TYR . 5.9 t -110.35 151.18 27.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.868 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 5.1 t -95.59 -57.66 2.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.62 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 50' ' ' SER . . . . . 0.558 ' HB3' ' HA ' ' B' ' 92' ' ' ALA . 0.2 OUTLIER -148.31 -174.82 4.69 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.918 0.389 . . . . 0.0 110.739 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 51' ' ' ALA . . . . . 0.681 ' HB3' ' HG2' ' E' ' 136' ' ' ARG . . . -127.09 143.83 51.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.359 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 52' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.85 116.81 51.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 53' ' ' GLY . . . . . 0.456 ' O ' HG21 ' B' ' 76' ' ' THR . . . -111.18 122.69 6.22 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.653 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -128.63 138.79 52.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 111.001 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 55' ' ' ASN . . . . . 0.565 HD21 HG21 ' E' ' 130' ' ' THR . 1.5 m120 -117.82 150.9 38.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.654 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 56' ' ' ILE . . . . . 0.579 ' HB ' HG13 ' E' ' 131' ' ' ILE . 9.2 mm -106.77 103.72 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.549 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 57' ' ' GLN . . . . . 0.734 ' HG2' HD11 ' B' ' 74' ' ' LEU . 75.8 mt-30 -61.13 132.26 53.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.774 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . 0.794 HD22 ' HB ' ' E' ' 23' ' ' VAL . 1.0 OUTLIER -137.47 151.8 48.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.223 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -138.33 171.35 14.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.98 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 60' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' E' ' 21' ' ' CYS . 6.0 m-20 50.01 68.47 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.83 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 61' ' ' CYS . . . . . 0.915 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 0.0 OUTLIER -106.63 141.09 38.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.95 0.405 . . . . 0.0 110.722 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.74 117.79 33.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.288 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 23.4 p -91.11 -13.18 33.55 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.6 -38.85 82.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.071 0.462 . . . . 0.0 111.849 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 76.4 t -107.71 -54.14 6.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.612 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . 0.409 ' HB1' ' HB3' ' E' ' 158' ' ' TYR . . . -97.72 84.3 3.35 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.581 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.98 -41.26 10.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.97 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.65 159.99 17.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.457 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.76 160.38 39.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.582 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.05 152.93 45.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.102 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.9 136.53 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.714 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.0 107.5 5.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.61 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 73' ' ' PHE . . . . . 0.442 ' CD2' HD12 ' E' ' 103' ' ' ILE . 43.2 t80 -73.7 136.72 43.77 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.569 0.224 . . . . 0.0 110.995 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 74' ' ' LEU . . . . . 0.54 HD13 ' HE3' ' E' ' 155' ' ' LYS . 6.6 tt -113.61 111.39 21.78 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.947 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . 0.709 ' HA3' HD12 ' E' ' 113' ' ' LEU . . . -131.29 -178.55 15.53 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.843 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.28 137.54 42.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.479 0.18 . . . . 0.0 110.837 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.97 114.81 23.91 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.021 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 78' ' ' ILE . . . . . 0.407 HD13 HD11 ' E' ' 88' ' ' LEU . 1.2 tt -95.77 -36.73 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.825 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 79' ' ' ASP . . . . . 0.46 ' HB3' ' CG2' ' E' ' 140' ' ' THR . 0.4 OUTLIER -143.36 130.21 20.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.756 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.89 -7.23 47.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.04 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.28 -29.25 68.38 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.606 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.34 -32.62 4.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 110.442 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 3.5 m 60.53 19.46 9.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.574 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 84' ' ' ASN . . . . . 0.6 ' HB3' ' HG2' ' E' ' 102' ' ' GLN . 0.6 OUTLIER -139.43 -16.94 1.02 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.323 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.684 ' HB ' ' HA3' ' E' ' 100' ' ' GLY . 0.9 OUTLIER -66.69 117.99 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.243 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 86' ' ' LEU . . . . . 0.555 ' HA ' HD21 ' E' ' 113' ' ' LEU . 10.6 tp -69.71 144.15 52.89 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.291 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.1 138.06 36.87 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.892 0.377 . . . . 0.0 111.677 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.673 ' HB3' ' HA ' ' E' ' 148' ' ' ALA . 0.0 OUTLIER -85.0 -146.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.115 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.54 155.04 0.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.807 0.337 . . . . 0.0 111.263 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 31.9 p -86.71 -11.9 49.84 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.549 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.43 114.05 5.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.975 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.35 22.17 1.06 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.007 0.432 . . . . 0.0 111.714 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.28 22.05 1.19 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.729 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.7 -32.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.537 -0.84 . . . . 0.0 113.001 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 95' ' ' SER . . . . . 0.64 ' HA ' ' HB1' ' E' ' 147' ' ' ALA . 15.8 t -65.12 166.7 9.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.652 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.67 163.43 15.13 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.85 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.35 169.68 17.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.378 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 98' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 57.32 29.37 16.72 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.415 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 99' ' ' VAL . . . . . 0.502 ' HB ' ' CB ' ' E' ' 143' ' ' ALA . 7.1 p -156.46 150.6 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.75 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 100' ' ' GLY . . . . . 0.684 ' HA3' ' HB ' ' E' ' 85' ' ' VAL . . . -164.18 176.85 40.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.583 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.63 111.36 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.011 0.524 . . . . 0.0 111.709 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 102' ' ' GLN . . . . . 0.6 ' HG2' ' HB3' ' E' ' 84' ' ' ASN . 0.0 OUTLIER -76.02 179.75 5.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.943 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 103' ' ' ILE . . . . . 0.526 HD13 ' HA ' ' E' ' 113' ' ' LEU . 5.9 pt -150.39 116.56 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.387 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 104' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' E' ' 134' ' ' GLN . 12.9 tp -97.21 122.54 40.35 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.714 0.292 . . . . 0.0 111.095 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.91 150.16 42.74 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.724 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 106' ' ' ARG . . . . . 0.502 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -71.48 -17.6 62.35 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.792 0.33 . . . . 0.0 111.076 179.527 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 75.4 p -76.62 -37.23 56.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.129 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.52 -68.76 0.32 Allowed Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.715 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.66 123.23 18.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.83 0.348 . . . . 0.0 111.106 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.7 118.01 2.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 tp -67.91 144.12 55.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.39 0.614 . . . . 0.0 110.528 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 112' ' ' THR . . . . . 0.42 ' HA ' ' ND2' ' E' ' 84' ' ' ASN . 0.2 OUTLIER -75.13 140.48 43.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.133 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 113' ' ' LEU . . . . . 0.709 HD12 ' HA3' ' E' ' 75' ' ' GLY . 1.3 tp -85.25 97.79 10.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.732 0.301 . . . . 0.0 110.606 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -152.81 -58.94 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.579 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.75 -26.62 3.14 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.583 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.42 28.85 5.16 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.007 0.432 . . . . 0.0 111.626 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.59 67.31 0.72 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.087 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -82.44 81.07 8.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.709 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.13 97.47 3.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.872 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 1.9 t -165.5 144.77 6.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.597 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.28 50.35 0.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.214 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.88 94.11 5.78 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.713 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.63 110.38 12.4 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.741 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . 0.601 ' HG ' ' ND2' ' E' ' 129' ' ' ASN . 0.3 OUTLIER -70.19 154.13 42.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.567 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.62 144.75 51.28 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.564 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.75 125.69 24.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.647 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.03 -102.0 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.737 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 128' ' ' THR . . . . . 0.675 HG21 ' HD2' ' B' ' 155' ' ' LYS . 87.1 m -106.21 128.46 53.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.604 0.24 . . . . 0.0 110.849 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 129' ' ' ASN . . . . . 0.601 ' ND2' ' HG ' ' E' ' 124' ' ' LEU . 20.1 t-20 -121.15 158.18 28.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.881 0.372 . . . . 0.0 111.147 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 130' ' ' THR . . . . . 0.565 HG21 HD21 ' E' ' 55' ' ' ASN . 0.2 OUTLIER -155.83 143.1 19.26 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.009 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 131' ' ' ILE . . . . . 0.579 HG13 ' HB ' ' E' ' 56' ' ' ILE . 0.1 OUTLIER -115.23 110.83 45.07 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 132' ' ' PRO . . . . . 0.502 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.3 Cg_endo -82.21 151.86 15.96 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.634 1.556 . . . . 0.0 112.548 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.08 146.79 17.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.795 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 134' ' ' GLN . . . . . 0.591 ' HG2' ' O ' ' B' ' 78' ' ' ILE . 0.8 OUTLIER -114.37 145.87 41.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.068 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.87 91.14 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.962 0.41 . . . . 0.0 111.713 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 136' ' ' ARG . . . . . 0.681 ' HG2' ' HB3' ' E' ' 51' ' ' ALA . 28.2 mtm-85 -88.27 153.54 21.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.41 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 137' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' E' ' 48' ' ' THR . 0.7 OUTLIER -91.26 111.14 22.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.059 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 138' ' ' PHE . . . . . 0.593 ' CD1' ' HB2' ' E' ' 102' ' ' GLN . 8.7 m-85 -108.22 172.21 6.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.968 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 139' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' E' ' 42' ' ' LEU . . . -123.47 143.64 50.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.823 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 140' ' ' THR . . . . . 0.46 ' CG2' ' HB3' ' E' ' 79' ' ' ASP . 0.2 OUTLIER -98.72 44.43 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.567 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.51 89.07 1.07 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.963 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 142' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' E' ' 43' ' ' ALA . . . 60.03 88.04 0.08 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.696 0.248 . . . . 0.0 110.769 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 143' ' ' ALA . . . . . 0.514 ' HB2' HD12 ' E' ' 42' ' ' LEU . . . -70.62 161.73 30.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 111.458 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 158.73 60.65 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.23 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 145' ' ' PRO . . . . . 0.456 ' HA ' HG13 ' D' ' 16' ' ' VAL . 1.4 Cg_endo -83.76 149.23 12.57 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.569 2.179 . . . . 0.0 112.022 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.69 -119.72 0.86 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.582 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 147' ' ' ALA . . . . . 0.64 ' HB1' ' HA ' ' E' ' 95' ' ' SER . . . -123.95 127.73 48.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.877 0.37 . . . . 0.0 111.384 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 148' ' ' ALA . . . . . 0.673 ' HA ' ' HB3' ' E' ' 88' ' ' LEU . . . -120.85 67.16 0.86 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.434 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -128.51 114.82 17.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.594 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 150' ' ' ALA . . . . . . . . . . . . . . . -158.85 147.0 18.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.03 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.48 140.28 32.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.218 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.21 169.23 17.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.149 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 153' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' E' ' 74' ' ' LEU . 9.4 t -155.06 150.54 27.35 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 154' ' ' PHE . . . . . 0.436 ' HE1' HG13 ' E' ' 56' ' ' ILE . 1.1 p90 -119.05 149.3 41.9 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.1 0.476 . . . . 0.0 110.025 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . 0.54 ' HE3' HD13 ' E' ' 74' ' ' LEU . 4.7 mttt -113.53 156.74 23.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.85 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 156' ' ' VAL . . . . . 0.537 HG13 HD12 ' E' ' 131' ' ' ILE . 0.2 OUTLIER -136.51 138.01 47.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.653 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 157' ' ' GLN . . . . . 0.627 ' HB2' HG23 ' D' ' 4' ' ' THR . 64.1 tt0 -107.46 128.05 54.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.307 0.575 . . . . 0.0 110.328 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . 0.58 ' HB2' ' OG1' ' D' ' 3' ' ' THR . 61.0 m-85 -107.89 107.5 18.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.531 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 159' ' ' GLN . . . . . 0.646 ' HA ' ' H ' ' D' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.276 0.084 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.82 74.75 0.36 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.973 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 6.2 p -117.75 97.53 5.9 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.504 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 69.1 p -87.84 108.64 19.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.592 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.55 172.72 13.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.618 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -77.24 110.85 12.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.572 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.79 -59.37 7.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.75 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.56 151.71 14.96 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.763 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 9' ' ' THR . . . . . 0.405 HG21 ' N ' ' F' ' 10' ' ' VAL . 24.2 m -103.53 143.09 33.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 111.253 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 10' ' ' VAL . . . . . 0.477 HG22 ' HE1' ' F' ' 12' ' ' PHE . 1.2 m -130.92 115.62 30.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.241 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -83.59 105.79 14.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.397 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 12' ' ' PHE . . . . . 0.477 ' HE1' HG22 ' F' ' 10' ' ' VAL . 52.2 m-85 -83.21 105.5 14.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.76 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.49 145.09 41.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.43 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.75 -179.64 42.6 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.969 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.27 134.18 22.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.387 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 t -90.92 127.19 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.257 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 17' ' ' VAL . . . . . 0.576 HG12 HG12 ' E' ' 5' ' ' VAL . 12.0 m -126.25 168.74 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.887 0.375 . . . . 0.0 111.042 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -100.42 81.83 2.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.149 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.23 58.27 5.43 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.05 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . 0.488 ' HB3' HG21 ' F' ' 17' ' ' VAL . . . -108.61 -62.85 1.41 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.376 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 21' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.9 OUTLIER -171.57 -159.92 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.86 74.0 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.085 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 23' ' ' VAL . . . . . 0.795 ' HB ' HD22 ' F' ' 58' ' ' LEU . 7.4 p -45.35 140.64 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.015 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.45 140.79 58.91 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.679 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.41 -51.08 69.7 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.341 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.14 -18.06 74.45 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.871 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.94 -6.37 58.06 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.865 0.364 . . . . 0.0 110.835 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 50.6 t -72.66 -36.39 53.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.403 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.92 110.88 14.13 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.84 146.04 48.66 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.982 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.17 113.84 27.67 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.208 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.11 121.95 57.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.141 0.496 . . . . 0.0 110.457 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 33' ' ' GLN . . . . . 0.447 ' HG2' HG12 ' E' ' 28' ' ' VAL . 0.6 OUTLIER -101.83 106.39 17.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.633 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 34' ' ' LEU . . . . . 0.542 ' HA ' HD11 ' F' ' 34' ' ' LEU . 0.6 OUTLIER -64.77 -44.69 89.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.62 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.53 -156.97 16.01 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.561 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 36' ' ' GLN . . . . . 0.597 ' HB2' ' HA ' ' E' ' 22' ' ' ALA . 3.7 mt-30 -91.04 106.97 18.89 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.628 0.251 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 t -92.35 120.55 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.92 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 38' ' ' ARG . . . . . 0.426 ' HG2' ' HA ' ' E' ' 19' ' ' ALA . 4.5 mtm105 -85.59 132.5 34.17 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.753 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 39' ' ' THR . . . . . . . . . . . . . 29.4 p -71.56 -23.22 61.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.729 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.04 -19.19 64.87 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.007 0.432 . . . . 0.0 110.815 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 13.8 t -90.54 -36.6 14.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.16 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . 0.597 ' HB2' ' HB1' ' F' ' 139' ' ' ALA . 0.2 OUTLIER -121.43 70.56 0.94 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.648 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 43' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' F' ' 142' ' ' ALA . . . -104.82 28.11 7.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.331 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 44' ' ' GLN . . . . . 0.695 ' HG3' ' HB1' ' F' ' 47' ' ' ALA . 0.0 OUTLIER -150.54 142.01 23.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.392 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . 0.446 ' HG3' ' HA ' ' F' ' 140' ' ' THR . 2.7 tt0 -62.71 101.84 0.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.786 0.326 . . . . 0.0 111.084 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.21 4.27 8.47 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.197 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 47' ' ' ALA . . . . . 0.695 ' HB1' ' HG3' ' F' ' 44' ' ' GLN . . . -91.8 121.33 33.32 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.953 0.406 . . . . 0.0 111.981 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 48' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' F' ' 137' ' ' TYR . 5.9 t -110.41 151.13 27.86 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.836 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 49' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 5.2 t -95.63 -57.6 2.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.6 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 50' ' ' SER . . . . . 0.556 ' HB3' ' HA ' ' C' ' 92' ' ' ALA . 0.2 OUTLIER -148.24 -174.81 4.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.806 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 51' ' ' ALA . . . . . 0.659 ' HB3' ' HG2' ' F' ' 136' ' ' ARG . . . -127.13 143.84 51.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.284 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 52' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.84 116.87 51.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.015 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 53' ' ' GLY . . . . . 0.47 ' O ' HG21 ' C' ' 76' ' ' THR . . . -111.18 122.69 6.21 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.648 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -128.63 138.85 52.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 0.0 110.934 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 55' ' ' ASN . . . . . 0.583 HD21 HG21 ' F' ' 130' ' ' THR . 1.6 m120 -117.88 150.97 38.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.607 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 56' ' ' ILE . . . . . 0.579 ' HB ' HG13 ' F' ' 131' ' ' ILE . 9.3 mm -106.82 103.7 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.585 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 57' ' ' GLN . . . . . 0.737 ' HG2' HD11 ' C' ' 74' ' ' LEU . 75.9 mt-30 -61.13 132.22 53.04 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.769 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . 0.795 HD22 ' HB ' ' F' ' 23' ' ' VAL . 1.0 OUTLIER -137.4 151.74 48.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.253 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -138.3 171.43 14.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.026 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 60' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' F' ' 21' ' ' CYS . 5.9 m-20 49.95 68.52 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.812 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 61' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 0.0 OUTLIER -106.68 141.08 38.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.984 0.421 . . . . 0.0 110.736 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.74 117.83 33.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.266 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 23.4 p -91.15 -13.16 33.49 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.61 -38.95 82.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.033 0.444 . . . . 0.0 111.753 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 76.2 t -107.64 -54.1 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.65 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.76 84.33 3.34 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.604 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.97 -41.26 10.1 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.969 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.64 159.97 17.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.436 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.73 160.41 39.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.592 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.03 152.9 45.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.156 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.95 136.55 53.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.682 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.04 107.46 5.03 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.525 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 73' ' ' PHE . . . . . 0.448 ' CD2' HD12 ' F' ' 103' ' ' ILE . 43.0 t80 -73.63 136.7 43.91 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.58 0.228 . . . . 0.0 111.049 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 74' ' ' LEU . . . . . 0.524 HD13 ' HE3' ' F' ' 155' ' ' LYS . 6.6 tt -113.62 111.4 21.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.939 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . 0.683 ' HA3' HD12 ' F' ' 113' ' ' LEU . . . -131.31 -178.55 15.53 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.836 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.32 137.62 41.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.51 0.195 . . . . 0.0 110.79 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.02 114.73 23.88 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.935 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 78' ' ' ILE . . . . . 0.408 HD13 HD11 ' F' ' 88' ' ' LEU . 1.2 tt -95.69 -36.75 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.866 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 79' ' ' ASP . . . . . 0.451 ' HB3' ' CG2' ' F' ' 140' ' ' THR . 0.4 OUTLIER -143.38 130.26 20.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.752 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.94 -7.23 47.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.973 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.31 -29.2 68.34 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.636 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 -32.73 4.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.863 0.364 . . . . 0.0 110.455 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 3.4 m 60.55 19.37 9.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.632 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 84' ' ' ASN . . . . . 0.603 ' HB3' ' HG2' ' F' ' 102' ' ' GLN . 0.6 OUTLIER -139.36 -16.92 1.03 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.413 179.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 85' ' ' VAL . . . . . 0.679 ' HB ' ' HA3' ' F' ' 100' ' ' GLY . 0.8 OUTLIER -66.71 117.97 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.196 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 86' ' ' LEU . . . . . 0.558 ' HA ' HD21 ' F' ' 113' ' ' LEU . 10.7 tp -69.67 144.1 52.98 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.36 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.1 138.03 36.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.904 0.383 . . . . 0.0 111.762 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . 0.657 ' HB3' ' HA ' ' F' ' 148' ' ' ALA . 0.0 OUTLIER -84.94 -146.55 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.083 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 89' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' F' ' 149' ' ' ASN . 0.0 OUTLIER -48.66 155.1 0.59 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 32.8 p -86.78 -11.97 49.47 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.403 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.38 114.04 5.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.976 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.34 22.21 1.05 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.877 0.37 . . . . 0.0 111.667 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.28 22.06 1.19 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.692 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.69 -32.28 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.053 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 95' ' ' SER . . . . . 0.635 ' HA ' ' HB1' ' F' ' 147' ' ' ALA . 16.0 t -65.14 166.69 9.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.345 . . . . 0.0 110.616 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.61 163.49 15.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.87 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.41 169.61 17.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.329 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 98' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 57.36 29.36 16.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.414 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 99' ' ' VAL . . . . . 0.507 ' HB ' ' CB ' ' F' ' 143' ' ' ALA . 7.0 p -156.38 150.6 10.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.77 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 100' ' ' GLY . . . . . 0.679 ' HA3' ' HB ' ' F' ' 85' ' ' VAL . . . -164.22 176.96 40.11 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.604 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -107.66 111.37 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 123.04 0.536 . . . . 0.0 111.706 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 102' ' ' GLN . . . . . 0.603 ' HG2' ' HB3' ' F' ' 84' ' ' ASN . 0.0 OUTLIER -76.04 179.68 5.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.922 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 103' ' ' ILE . . . . . 0.521 HD13 ' HA ' ' F' ' 113' ' ' LEU . 6.0 pt -150.34 116.57 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.464 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 104' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' F' ' 134' ' ' GLN . 12.8 tp -97.18 122.53 40.3 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.743 0.306 . . . . 0.0 111.075 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -62.89 150.12 42.72 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.696 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 106' ' ' ARG . . . . . 0.527 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -71.38 -17.69 62.4 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.772 0.32 . . . . 0.0 111.052 179.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 75.7 p -76.61 -37.28 56.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.08 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.57 -68.77 0.32 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.685 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.68 123.27 18.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.875 0.369 . . . . 0.0 111.105 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.7 117.98 2.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 tp -67.77 144.04 55.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.429 0.633 . . . . 0.0 110.532 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 112' ' ' THR . . . . . 0.423 ' HA ' ' ND2' ' F' ' 84' ' ' ASN . 0.2 OUTLIER -75.08 140.46 43.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.13 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 113' ' ' LEU . . . . . 0.683 HD12 ' HA3' ' F' ' 75' ' ' GLY . 1.3 tp -85.22 97.85 10.15 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.764 0.316 . . . . 0.0 110.582 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -152.8 -59.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.674 0.273 . . . . 0.0 111.595 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.79 -26.66 3.13 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.61 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.28 28.74 5.19 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.643 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 117' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.57 67.39 0.72 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.052 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.43 80.95 8.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.735 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.01 97.5 3.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.803 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 1.9 t -165.53 144.8 6.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.576 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.29 50.36 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.232 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.87 94.12 5.78 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.659 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.73 110.35 12.5 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.643 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . 0.596 ' HG ' ' ND2' ' F' ' 129' ' ' ASN . 0.3 OUTLIER -70.13 154.15 42.27 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.579 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.62 144.77 51.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.552 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.76 125.64 24.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.667 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.03 -101.93 1.1 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.749 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 128' ' ' THR . . . . . 0.674 HG21 ' HD2' ' C' ' 155' ' ' LYS . 86.0 m -106.32 128.5 54.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.672 0.272 . . . . 0.0 110.782 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 129' ' ' ASN . . . . . 0.596 ' ND2' ' HG ' ' F' ' 124' ' ' LEU . 20.1 t-20 -121.08 158.21 28.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.129 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 130' ' ' THR . . . . . 0.583 HG21 HD21 ' F' ' 55' ' ' ASN . 0.2 OUTLIER -155.9 143.07 19.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.014 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 131' ' ' ILE . . . . . 0.579 HG13 ' HB ' ' F' ' 56' ' ' ILE . 0.1 OUTLIER -115.19 110.74 45.24 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 132' ' ' PRO . . . . . 0.527 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.4 Cg_endo -82.12 151.88 16.16 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.597 1.531 . . . . 0.0 112.514 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.0 146.76 17.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.84 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 134' ' ' GLN . . . . . 0.597 ' HG2' ' O ' ' C' ' 78' ' ' ILE . 0.8 OUTLIER -114.41 145.95 41.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.093 179.277 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.85 91.15 1.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 0.0 111.682 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 136' ' ' ARG . . . . . 0.659 ' HG2' ' HB3' ' F' ' 51' ' ' ALA . 28.0 mtm-85 -88.33 153.56 21.1 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.403 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 137' ' ' TYR . . . . . 0.595 ' O ' ' HA ' ' F' ' 48' ' ' THR . 0.7 OUTLIER -91.19 111.03 22.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.101 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 138' ' ' PHE . . . . . 0.595 ' CD1' ' HB2' ' F' ' 102' ' ' GLN . 8.8 m-85 -108.11 172.17 6.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.978 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 139' ' ' ALA . . . . . 0.597 ' HB1' ' HB2' ' F' ' 42' ' ' LEU . . . -123.41 143.71 49.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.807 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 140' ' ' THR . . . . . 0.451 ' CG2' ' HB3' ' F' ' 79' ' ' ASP . 0.2 OUTLIER -98.85 44.5 1.03 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.501 179.753 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.45 89.13 1.07 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.946 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 142' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' F' ' 43' ' ' ALA . . . 60.04 88.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.678 0.239 . . . . 0.0 110.694 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 143' ' ' ALA . . . . . 0.512 ' HB2' HD12 ' F' ' 42' ' ' LEU . . . -70.54 161.72 30.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.783 0.325 . . . . 0.0 111.431 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.46 158.65 60.88 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.292 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 145' ' ' PRO . . . . . 0.456 ' HA ' ' HB ' ' E' ' 16' ' ' VAL . 1.4 Cg_endo -83.75 149.19 12.58 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.499 2.132 . . . . 0.0 112.079 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.71 -119.73 0.86 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.563 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 147' ' ' ALA . . . . . 0.635 ' HB1' ' HA ' ' F' ' 95' ' ' SER . . . -123.92 127.64 48.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 111.48 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 148' ' ' ALA . . . . . 0.657 ' HA ' ' HB3' ' F' ' 88' ' ' LEU . . . -120.77 67.1 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.139 0.495 . . . . 0.0 110.449 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 149' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' F' ' 89' ' ' GLN . 47.4 t-20 -128.47 114.73 17.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.667 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 150' ' ' ALA . . . . . . . . . . . . . . . -158.77 146.92 18.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.056 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.37 140.29 32.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.181 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.23 169.29 17.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.216 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 153' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' F' ' 74' ' ' LEU . 9.4 t -155.09 150.56 27.33 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 154' ' ' PHE . . . . . 0.427 ' HE1' HG13 ' F' ' 56' ' ' ILE . 1.1 p90 -119.06 149.24 42.0 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.089 0.471 . . . . 0.0 110.103 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . 0.524 ' HE3' HD13 ' F' ' 74' ' ' LEU . 4.7 mttt -113.5 156.67 23.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.886 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 156' ' ' VAL . . . . . 0.538 HG13 HD12 ' F' ' 131' ' ' ILE . 0.2 OUTLIER -136.5 138.05 47.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.667 -179.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 157' ' ' GLN . . . . . 0.614 ' HB2' HG23 ' E' ' 4' ' ' THR . 64.1 tt0 -107.5 127.99 54.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.307 0.575 . . . . 0.0 110.344 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . 0.581 ' HB2' ' OG1' ' E' ' 3' ' ' THR . 60.9 m-85 -107.82 107.43 18.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.565 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 159' ' ' GLN . . . . . 0.668 ' HA ' ' H ' ' E' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.903 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.58 ' H ' ' HA ' ' B' ' 159' ' ' GLN . . . 56.66 88.54 0.05 OUTLIER 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.052 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' B' ' 157' ' ' GLN . 0.2 OUTLIER -103.08 110.35 22.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.419 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.37 136.14 38.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.55 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.598 HG13 ' HA2' ' C' ' 146' ' ' GLY . 0.0 OUTLIER -152.01 -175.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.61 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.51 130.04 38.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.677 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.53 ' HA2' HG22 ' B' ' 156' ' ' VAL . . . -98.77 -59.25 0.91 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.822 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.37 166.16 27.94 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.897 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.609 ' HA ' HG22 ' B' ' 153' ' ' THR . 26.8 m -94.36 121.11 35.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.904 0.383 . . . . 0.0 111.287 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.65 115.59 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.223 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -99.55 137.45 38.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.369 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 76.0 m-85 -127.49 97.73 4.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.22 175.8 6.56 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.428 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.91 149.49 5.78 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.923 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.33 108.63 13.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.776 0.322 . . . . 0.0 110.358 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.865 HG13 ' O ' ' B' ' 144' ' ' THR . 23.5 t -86.67 129.15 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.203 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.488 HG21 ' HB1' ' A' ' 22' ' ' ALA . 18.8 m -127.38 163.5 30.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.041 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -86.0 61.52 6.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.07 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.528 ' HB1' HG23 ' A' ' 65' ' ' VAL . . . 44.93 52.63 8.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -127.29 -54.51 1.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.407 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER 177.7 111.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.866 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.76 ' HB2' ' HA ' ' B' ' 36' ' ' GLN . . . -105.63 126.08 51.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.073 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.437 HG11 HG21 ' A' ' 28' ' ' VAL . 5.7 p -56.86 145.64 7.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.055 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.609 ' O ' HG22 ' A' ' 28' ' ' VAL . 4.0 m-20 -74.83 147.23 41.34 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.696 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.67 -43.66 17.87 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.34 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.98 -20.0 60.16 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.84 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.2 t -79.54 -26.07 41.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.863 0.363 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 24' ' ' ASP . 57.5 t -49.19 -48.46 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.331 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.84 93.08 5.36 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.023 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.63 116.42 28.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.009 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 p -95.6 115.62 27.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.151 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.6 t -117.18 101.16 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.131 0.491 . . . . 0.0 110.402 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -105.62 126.96 52.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.655 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.26 -55.62 11.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.63 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.03 -111.6 3.91 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.519 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.11 115.28 16.76 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.514 0.197 . . . . 0.0 110.875 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.0 t -131.01 105.8 11.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.875 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -96.64 154.12 17.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.757 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.76 ' HA ' HD12 ' A' ' 42' ' ' LEU . 8.2 p -78.75 -19.84 51.35 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.759 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -19.52 65.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.066 0.46 . . . . 0.0 110.885 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.7 p -92.0 -21.27 20.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.207 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.76 HD12 ' HA ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -139.14 62.36 1.54 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.58 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.69 ' HA ' ' HA ' ' A' ' 142' ' ' ALA . . . -101.13 9.12 42.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.321 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.19 136.0 24.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.37 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.59 ' N ' ' HA2' ' A' ' 141' ' ' GLY . 16.5 tt0 -58.48 121.37 10.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.915 0.388 . . . . 0.0 111.082 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.28 -25.46 8.23 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.149 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.75 137.29 58.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.939 0.4 . . . . 0.0 112.034 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 5.9 t -133.92 157.99 44.59 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.955 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.93 -166.21 1.09 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.621 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.8 m -65.23 156.19 32.68 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.767 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 134' ' ' GLN . . . -90.45 126.66 35.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.324 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.43 HG12 ' HD2' ' A' ' 54' ' ' PHE . 62.4 t -75.68 118.52 21.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.79 135.6 13.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.731 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 133' ' ' PHE . 46.2 p90 -170.74 142.1 1.92 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.915 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.662 ' HA ' ' O ' ' A' ' 131' ' ' ILE . 11.5 p30 -126.52 163.92 22.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.602 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.624 HG21 HD22 ' A' ' 58' ' ' LEU . 20.9 mm -105.13 120.03 55.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.525 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.553 ' HA ' HG21 ' A' ' 130' ' ' THR . 0.0 OUTLIER -82.15 115.66 21.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.712 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.624 HD22 HG21 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -128.24 107.46 9.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.288 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.37 176.97 8.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.889 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.05 66.13 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.797 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 3.3 m -109.69 154.48 22.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.679 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.514 ' HA ' ' OD1' ' A' ' 126' ' ' ASN . 0.5 OUTLIER -154.71 138.3 16.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.263 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.622 ' HG1' ' HA ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -97.54 -11.9 23.19 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -72.27 -48.69 40.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.003 0.43 . . . . 0.0 111.713 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.528 HG23 ' HB1' ' A' ' 19' ' ' ALA . 10.8 t -69.1 -48.6 68.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.695 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 63' ' ' THR . . . -138.02 153.26 49.39 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.599 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.19 18.66 4.48 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.95 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.589 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 10.6 tppt? -142.88 149.9 39.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.486 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.0 110.72 4.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.661 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 121' ' ' GLU . . . -108.05 169.99 8.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.1 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.38 150.98 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.61 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 116' ' ' ALA . . . -135.62 100.13 4.4 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.58 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.586 ' HB2' HD22 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -77.42 133.98 38.52 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.571 0.224 . . . . 0.0 111.107 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.17 115.05 20.48 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.025 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.31 -173.23 26.45 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.729 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.78 ' HG1' ' HB3' ' D' ' 55' ' ' ASN . 7.0 m -112.59 149.03 33.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.583 0.23 . . . . 0.0 110.755 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 85' ' ' VAL . . . -98.97 133.81 42.72 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.942 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.78 ' HB ' ' HA ' ' A' ' 87' ' ' ALA . 16.1 tt -72.93 -37.98 55.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.17 167.64 12.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.834 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' D' ' 106' ' ' ARG . . . -70.17 -53.83 15.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.073 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.35 28.63 6.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.595 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.796 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 10.2 m170 -111.33 -45.62 3.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.369 . . . . 0.0 110.427 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.562 ' HB ' HG22 ' A' ' 112' ' ' THR . 0.0 OUTLIER 46.42 -86.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.589 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -42.28 -42.4 3.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.239 179.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.796 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 21.3 t -61.29 126.57 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.093 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.558 ' HG ' ' CD2' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -81.25 164.41 22.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.78 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . . . -104.78 -177.49 3.38 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.672 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.491 ' HA ' HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -85.09 -174.57 5.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.982 179.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.57 -170.71 3.24 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.372 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.629 ' HA ' ' CG1' ' D' ' 52' ' ' VAL . 27.4 p -74.77 7.81 2.84 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.914 0.387 . . . . 0.0 111.462 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 0.8 OUTLIER -96.96 80.39 2.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.771 ' HB1' HD21 ' D' ' 34' ' ' LEU . . . -66.87 -41.13 87.76 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.624 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.533 ' HB1' ' O ' ' D' ' 36' ' ' GLN . . . -103.73 25.96 9.16 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.675 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.8 -22.63 0.33 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.929 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.418 ' HB3' ' HB2' ' A' ' 91' ' ' SER . 1.0 OUTLIER -107.68 175.18 5.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.906 0.384 . . . . 0.0 110.587 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.38 177.12 2.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -138.58 167.86 21.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.21 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.587 ' HA ' ' HB ' ' A' ' 140' ' ' THR . 32.4 m-80 44.19 51.65 7.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.502 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.628 ' HB ' ' HB3' ' A' ' 143' ' ' ALA . 6.0 p -169.38 124.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.72 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.61 -164.74 11.5 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.634 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.416 HG23 ' CE1' ' A' ' 137' ' ' TYR . 3.5 t -124.8 91.16 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 122.97 0.508 . . . . 0.0 111.722 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.679 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER -71.4 116.65 11.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.885 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 135' ' ' ALA . 6.6 mt -89.64 120.59 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.492 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 1.0 OUTLIER -95.88 152.31 18.61 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.691 0.281 . . . . 0.0 111.092 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.425 ' O ' HD23 ' A' ' 104' ' ' LEU . 8.5 t0 -100.16 159.99 14.68 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.613 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.511 ' CZ ' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -68.71 -13.73 62.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.92 0.39 . . . . 0.0 111.146 179.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.404 ' HG1' ' HB3' ' A' ' 105' ' ' ASP . 44.6 p -74.41 -18.87 60.59 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.067 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.99 -40.11 2.23 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.664 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.41 164.67 13.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.781 0.324 . . . . 0.0 111.099 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -77.37 139.68 39.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.132 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.65 HD21 ' HB ' ' A' ' 117' ' ' THR . 5.9 tt -84.18 128.58 34.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.458 0.647 . . . . 0.0 110.506 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.562 HG22 ' HB ' ' A' ' 83' ' ' THR . 1.4 m -68.11 132.38 47.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.1 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.558 ' CD2' ' HG ' ' A' ' 86' ' ' LEU . 4.7 mp -88.04 99.83 12.46 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.621 0.248 . . . . 0.0 110.741 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' D' ' 130' ' ' THR . 0.8 OUTLIER -144.13 -32.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.502 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.46 -81.3 0.21 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.625 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' D' ' 125' ' ' ASN . . . -97.22 64.1 1.9 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.959 0.409 . . . . 0.0 111.603 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.65 ' HB ' HD21 ' A' ' 111' ' ' LEU . 2.8 m -94.4 72.39 3.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.141 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -66.76 119.04 11.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.835 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.89 -49.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.852 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.57 84.69 6.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.547 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 70' ' ' ALA . 3.5 mt-10 -110.2 86.95 2.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.29 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.99 159.3 17.68 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.815 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -66.96 138.39 57.23 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.727 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.55 159.49 19.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.622 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.622 ' HA ' ' HG1' ' A' ' 63' ' ' THR . 0.3 OUTLIER -147.58 176.19 10.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.588 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' A' ' 62' ' ' ASP . 0.9 OUTLIER -85.93 161.49 19.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.697 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.53 -121.0 5.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.775 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 74.4 m -119.54 140.31 50.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.682 0.277 . . . . 0.0 110.768 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -133.73 154.67 50.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.117 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 56' ' ' ILE . 27.9 p -133.41 154.33 50.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.164 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.662 ' O ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -111.09 116.9 50.93 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 106' ' ' ARG . 7.5 Cg_endo -81.24 129.48 6.78 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.614 1.543 . . . . 0.0 112.581 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.446 ' HB3' ' CE1' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -140.89 146.9 38.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.794 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.507 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 19.3 mm-40 -116.5 158.33 23.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.011 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . . . -159.42 105.53 1.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.914 0.388 . . . . 0.0 111.524 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.7 172.61 6.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.414 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.416 ' CE1' HG23 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -98.2 147.79 24.25 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.131 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.444 ' CG ' HG21 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -127.67 159.03 35.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.277 0.561 . . . . 0.0 111.923 -179.192 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.422 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -116.33 141.24 48.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.936 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.587 ' HB ' ' HA ' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -107.75 27.23 9.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.482 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.59 ' HA2' ' N ' ' A' ' 45' ' ' GLU . . . 97.55 83.6 1.71 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.971 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.69 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . . . 57.88 93.47 0.03 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.688 0.244 . . . . 0.0 110.746 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.628 ' HB3' ' HB ' ' A' ' 99' ' ' VAL . . . -80.0 165.37 22.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 111.403 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.7 p -108.34 168.87 7.22 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.153 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.61 133.54 6.14 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.569 2.179 . . . . 0.0 111.979 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.55 -119.24 0.81 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.471 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.81 121.7 13.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.894 0.378 . . . . 0.0 111.281 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.34 85.68 3.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.442 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -104.55 131.21 52.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.601 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 87' ' ' ALA . . . -136.08 148.44 48.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.935 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.17 120.17 20.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.216 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.63 140.05 24.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.159 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.6 p -105.2 171.21 7.44 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.601 ' HZ ' HG23 ' A' ' 56' ' ' ILE . 13.7 p90 -138.2 147.39 43.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.038 0.447 . . . . 0.0 110.119 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.432 ' HG3' ' HB ' ' D' ' 128' ' ' THR . 13.6 mmtt -100.89 172.01 7.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.901 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.483 ' HB ' ' CZ ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -135.51 111.4 12.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.82 0.343 . . . . 0.0 111.728 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -109.04 141.26 41.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.346 0.593 . . . . 0.0 110.414 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.483 ' CZ ' ' HB ' ' A' ' 156' ' ' VAL . 23.1 m-85 -135.36 105.58 6.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.583 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.589 ' HB3' ' HB3' ' A' ' 68' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.92 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.589 ' H ' ' HA ' ' C' ' 159' ' ' GLN . . . 56.58 88.57 0.05 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.056 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' C' ' 157' ' ' GLN . 0.2 OUTLIER -103.08 110.38 22.29 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.393 179.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 136.18 38.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.552 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.6 HG13 ' HA2' ' D' ' 146' ' ' GLY . 0.0 OUTLIER -152.05 -175.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.591 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.43 130.04 38.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.666 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . 0.526 ' HA2' HG22 ' C' ' 156' ' ' VAL . . . -98.8 -59.33 0.91 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.756 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.4 166.2 28.04 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.894 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' THR . . . . . 0.616 ' HA ' HG22 ' C' ' 153' ' ' THR . 26.7 m -94.38 121.1 35.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.89 0.376 . . . . 0.0 111.269 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.69 115.64 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.24 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -99.54 137.55 37.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.351 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' C' ' 32' ' ' VAL . 76.0 m-85 -127.61 97.71 4.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.22 175.78 6.57 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.472 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.01 149.4 5.75 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.941 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.24 108.68 14.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.852 0.358 . . . . 0.0 110.414 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.856 HG13 ' O ' ' C' ' 144' ' ' THR . 23.6 t -86.71 129.19 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.175 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.481 HG21 ' CB ' ' B' ' 22' ' ' ALA . 18.7 m -127.45 163.51 30.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.033 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -85.95 61.35 6.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.027 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.527 ' HB1' HG23 ' B' ' 65' ' ' VAL . . . 45.02 52.64 8.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.053 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' B' ' 61' ' ' CYS . . . -127.24 -54.54 1.37 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.451 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.1 OUTLIER 177.73 111.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.893 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.751 ' HB2' ' HA ' ' C' ' 36' ' ' GLN . . . -105.67 126.05 51.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.083 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.452 HG11 HG21 ' B' ' 28' ' ' VAL . 5.7 p -56.81 145.61 7.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.035 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.611 ' O ' HG22 ' B' ' 28' ' ' VAL . 4.0 m-20 -74.82 147.27 41.32 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.68 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.8 -43.57 18.47 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.323 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.97 -20.07 60.06 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.809 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 45.3 t -79.58 -26.01 41.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.611 HG22 ' O ' ' B' ' 24' ' ' ASP . 57.4 t -49.21 -48.46 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.344 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.86 93.08 5.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.031 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.61 116.36 28.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.026 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.55 115.67 27.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.209 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 12' ' ' PHE . 1.7 t -117.23 101.07 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.182 0.515 . . . . 0.0 110.429 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -105.58 126.93 52.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.715 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.15 -55.66 11.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.62 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.02 -111.65 3.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.539 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.76 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -77.05 115.29 16.71 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.501 0.191 . . . . 0.0 110.907 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 68.4 t -131.05 105.86 11.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.833 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.6 154.05 17.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.782 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.776 ' HA ' HD12 ' B' ' 42' ' ' LEU . 8.2 p -78.77 -19.79 51.4 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.702 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.51 -19.53 65.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.144 0.497 . . . . 0.0 110.899 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 96.5 p -92.01 -21.27 20.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.19 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.776 HD12 ' HA ' ' B' ' 39' ' ' THR . 0.2 OUTLIER -139.0 62.27 1.54 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.707 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.7 ' HA ' ' HA ' ' B' ' 142' ' ' ALA . . . -101.09 9.14 42.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.363 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.19 136.03 24.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.335 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.574 ' N ' ' HA2' ' B' ' 141' ' ' GLY . 16.5 tt0 -58.59 121.33 10.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 111.154 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.4 -25.54 8.14 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.166 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.67 137.19 58.2 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.91 158.04 44.45 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.904 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -166.19 1.09 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.598 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 48.9 m -65.2 156.13 32.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.816 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . 0.521 ' HB1' ' HB3' ' B' ' 134' ' ' GLN . . . -90.5 126.7 36.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.339 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.427 HG12 ' HD2' ' B' ' 54' ' ' PHE . 63.2 t -75.6 118.5 21.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.019 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.79 135.74 13.86 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.626 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' B' ' 133' ' ' PHE . 46.3 p90 -170.85 142.08 1.86 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.815 0.341 . . . . 0.0 110.905 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.661 ' HA ' ' O ' ' B' ' 131' ' ' ILE . 11.5 p30 -126.52 163.93 22.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.54 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.641 HG21 HD22 ' B' ' 58' ' ' LEU . 20.7 mm -105.17 119.97 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.503 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . 0.57 ' HA ' HG21 ' B' ' 130' ' ' THR . 0.0 OUTLIER -82.16 115.74 21.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.731 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.641 HD22 HG21 ' B' ' 56' ' ' ILE . 0.0 OUTLIER -128.33 107.47 9.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.252 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.37 176.99 8.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.86 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.03 66.21 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.714 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 3.3 m -109.73 154.46 22.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.711 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . 0.521 ' HA ' ' OD1' ' B' ' 126' ' ' ASN . 0.5 OUTLIER -154.74 138.26 15.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.271 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.614 ' HG1' ' HA ' ' B' ' 125' ' ' ASN . 0.2 OUTLIER -97.55 -11.81 23.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.08 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.25 -48.68 40.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.115 0.483 . . . . 0.0 111.78 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . 0.527 HG23 ' HB1' ' B' ' 19' ' ' ALA . 10.6 t -69.02 -48.7 68.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.764 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' B' ' 63' ' ' THR . . . -137.93 153.36 49.5 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.637 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.29 18.67 4.43 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.868 0.366 . . . . 0.0 110.906 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.588 ' HB3' ' HB3' ' B' ' 159' ' ' GLN . 10.6 tppt? -142.9 149.93 39.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.469 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.03 110.72 4.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.687 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' B' ' 121' ' ' GLU . . . -108.1 169.92 8.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.05 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.35 150.93 35.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.63 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.62 100.16 4.41 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.518 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.586 ' HB2' HD22 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -77.35 133.84 38.63 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.572 0.225 . . . . 0.0 111.189 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.15 115.16 20.67 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.984 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.37 -173.24 26.53 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.777 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.779 ' HG1' ' HB3' ' E' ' 55' ' ' ASN . 7.0 m -112.6 149.04 33.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.565 0.221 . . . . 0.0 110.755 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' B' ' 85' ' ' VAL . . . -98.99 133.78 42.77 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.908 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.768 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 16.1 tt -72.91 -37.94 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.16 167.58 12.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.836 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' E' ' 106' ' ' ARG . . . -70.11 -53.85 15.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.42 28.74 6.08 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.564 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.791 ' HB3' ' HB ' ' B' ' 85' ' ' VAL . 10.2 m170 -111.38 -45.62 3.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.45 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' THR . . . . . 0.563 ' HB ' HG22 ' B' ' 112' ' ' THR . 0.0 OUTLIER 46.41 -86.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.59 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' B' ' 82' ' ' HIS . 0.0 OUTLIER -42.3 -42.35 3.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.299 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.791 ' HB ' ' HB3' ' B' ' 82' ' ' HIS . 21.3 t -61.33 126.62 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.145 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . 0.559 ' HG ' ' CD2' ' B' ' 113' ' ' LEU . 0.2 OUTLIER -81.31 164.33 22.27 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.281 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.768 ' HA ' ' HB ' ' B' ' 78' ' ' ILE . . . -104.74 -177.52 3.39 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.841 0.353 . . . . 0.0 111.67 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.495 ' HA ' HD12 ' B' ' 88' ' ' LEU . 0.1 OUTLIER -85.03 -174.51 5.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.052 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.63 -170.68 3.22 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.394 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' SER . . . . . 0.647 ' HA ' ' CG1' ' E' ' 52' ' ' VAL . 27.4 p -74.85 7.95 2.8 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.92 0.39 . . . . 0.0 111.408 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.07 80.4 2.95 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.761 ' HB1' HD21 ' E' ' 34' ' ' LEU . . . -66.83 -41.18 87.87 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.841 0.353 . . . . 0.0 111.664 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . 0.529 ' HB1' ' O ' ' E' ' 36' ' ' GLN . . . -103.76 26.07 9.05 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.698 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.81 -22.66 0.33 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.922 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.64 175.21 5.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.93 0.395 . . . . 0.0 110.606 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.53 177.18 3.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.848 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.455 HG22 ' H ' ' B' ' 98' ' ' ASN . 0.2 OUTLIER -138.59 167.89 20.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.27 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . 0.577 ' HA ' ' HB ' ' B' ' 140' ' ' THR . 32.2 m-80 44.12 51.63 7.2 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.53 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.631 ' HB ' ' HB3' ' B' ' 143' ' ' ALA . 6.1 p -169.31 124.12 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.823 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.5 -164.68 11.5 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.619 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . 0.412 HG23 ' CE1' ' B' ' 137' ' ' TYR . 3.5 t -124.86 91.12 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 122.925 0.49 . . . . 0.0 111.695 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.689 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 0.6 OUTLIER -71.42 116.58 11.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.919 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 6.6 mt -89.51 120.63 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.534 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . 0.485 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 1.0 OUTLIER -95.88 152.31 18.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.758 0.313 . . . . 0.0 111.041 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . 0.424 ' O ' HD23 ' B' ' 104' ' ' LEU . 8.6 t0 -100.23 160.12 14.58 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.573 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . 0.509 ' CZ ' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -68.83 -13.69 62.56 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.858 0.361 . . . . 0.0 111.032 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 44.8 p -74.45 -18.85 60.58 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.03 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.93 -40.15 2.22 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.659 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.34 164.69 13.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.774 0.321 . . . . 0.0 111.078 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -77.37 139.65 39.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.643 HD21 ' HB ' ' B' ' 117' ' ' THR . 5.9 tt -84.09 128.59 34.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.438 0.637 . . . . 0.0 110.462 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.563 HG22 ' HB ' ' B' ' 83' ' ' THR . 1.4 m -68.13 132.38 47.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.111 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.559 ' CD2' ' HG ' ' B' ' 86' ' ' LEU . 4.7 mp -88.1 99.74 12.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.726 0.298 . . . . 0.0 110.748 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . 0.504 ' O ' ' O ' ' E' ' 130' ' ' THR . 0.8 OUTLIER -144.1 -32.34 0.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.495 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.44 -81.23 0.21 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.68 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . 0.436 ' HB3' ' HB3' ' E' ' 125' ' ' ASN . . . -97.24 64.02 1.88 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.986 0.422 . . . . 0.0 111.602 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' THR . . . . . 0.643 ' HB ' HD21 ' B' ' 111' ' ' LEU . 2.8 m -94.28 72.28 3.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.212 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.73 119.05 11.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.82 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.96 -48.97 0.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.57 84.68 6.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.559 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' B' ' 70' ' ' ALA . 3.5 mt-10 -110.19 87.0 2.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.227 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.09 159.32 17.6 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.802 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -67.0 138.35 57.18 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.666 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.49 159.5 19.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.665 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.614 ' HA ' ' HG1' ' B' ' 63' ' ' THR . 0.3 OUTLIER -147.62 176.25 10.23 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.602 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' ASN . . . . . 0.521 ' OD1' ' HA ' ' B' ' 62' ' ' ASP . 0.9 OUTLIER -85.94 161.49 19.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.641 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.5 -121.03 5.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.756 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 73.2 m -119.5 140.32 50.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.661 0.267 . . . . 0.0 110.779 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -133.76 154.63 50.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.06 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.57 HG21 ' HA ' ' B' ' 57' ' ' GLN . 28.4 p -133.32 154.25 50.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.217 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' ILE . . . . . 0.661 ' O ' ' HA ' ' B' ' 55' ' ' ASN . 1.0 OUTLIER -110.95 116.89 51.22 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' PRO . . . . . 0.509 ' HG2' ' CZ ' ' B' ' 106' ' ' ARG . 7.6 Cg_endo -81.2 129.46 6.79 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 121.672 1.581 . . . . 0.0 112.594 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.448 ' HB3' ' CE1' ' B' ' 54' ' ' PHE . 0.1 OUTLIER -140.9 146.84 37.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.78 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' GLN . . . . . 0.521 ' HB3' ' HB1' ' B' ' 51' ' ' ALA . 19.5 mm-40 -116.57 158.38 23.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.022 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -159.41 105.52 1.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 111.515 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.71 172.55 6.74 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.417 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' B' ' 101' ' ' VAL . 0.7 OUTLIER -98.25 147.75 24.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.081 179.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . 0.442 ' CG ' HG21 ' B' ' 85' ' ' VAL . 0.3 OUTLIER -127.6 159.01 35.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.031 -179.212 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -116.26 141.33 48.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.913 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' THR . . . . . 0.577 ' HB ' ' HA ' ' B' ' 98' ' ' ASN . 0.3 OUTLIER -107.86 27.27 9.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.467 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . 0.574 ' HA2' ' N ' ' B' ' 45' ' ' GLU . . . 97.49 83.6 1.7 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.015 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . 0.7 ' HA ' ' HA ' ' B' ' 43' ' ' ALA . . . 57.89 93.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.607 0.204 . . . . 0.0 110.821 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' ALA . . . . . 0.631 ' HB3' ' HB ' ' B' ' 99' ' ' VAL . . . -80.05 165.51 22.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.709 0.29 . . . . 0.0 111.448 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.865 ' O ' HG13 ' A' ' 16' ' ' VAL . 29.6 p -108.43 168.81 7.29 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.204 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.66 133.52 6.09 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.579 2.186 . . . . 0.0 111.987 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.61 -119.22 0.81 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.427 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.82 121.64 13.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.842 0.353 . . . . 0.0 111.306 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.32 85.7 3.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.5 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -104.6 131.23 52.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.56 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' B' ' 87' ' ' ALA . . . -136.1 148.47 48.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.949 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -133.19 120.21 20.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.197 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.61 140.01 24.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.199 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 9' ' ' THR . 70.7 p -105.16 171.18 7.46 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.609 ' HZ ' HG23 ' B' ' 56' ' ' ILE . 13.6 p90 -138.16 147.44 43.86 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.104 0.478 . . . . 0.0 110.124 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.446 ' HG3' ' HB ' ' E' ' 128' ' ' THR . 13.6 mmtt -100.94 172.02 7.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.892 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' VAL . . . . . 0.53 HG22 ' HA2' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -135.51 111.38 12.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.738 0.304 . . . . 0.0 111.681 -179.043 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' A' ' 3' ' ' THR . 1.8 tt0 -109.06 141.28 41.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.369 0.604 . . . . 0.0 110.383 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . 0.48 ' CZ ' ' HB ' ' B' ' 156' ' ' VAL . 23.2 m-85 -135.39 105.55 6.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.553 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . 0.588 ' HB3' ' HB3' ' B' ' 68' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.855 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.572 ' H ' ' HA ' ' D' ' 159' ' ' GLN . . . 56.66 88.58 0.05 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.988 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' D' ' 157' ' ' GLN . 0.2 OUTLIER -103.05 110.38 22.28 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.428 179.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.4 136.24 38.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.523 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . 0.604 HG13 ' HA2' ' E' ' 146' ' ' GLY . 0.0 OUTLIER -152.08 -175.28 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.63 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.54 130.08 38.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.595 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . 0.531 ' HA2' HG22 ' D' ' 156' ' ' VAL . . . -98.81 -59.29 0.91 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.804 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.41 166.23 28.08 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.864 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' THR . . . . . 0.613 ' HA ' HG22 ' D' ' 153' ' ' THR . 27.0 m -94.46 121.16 35.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 111.219 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.6 115.61 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.258 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -99.56 137.51 37.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.311 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' PHE . . . . . 0.573 ' HA ' ' O ' ' D' ' 32' ' ' VAL . 75.8 m-85 -127.56 97.73 4.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.21 175.84 6.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.442 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.93 149.46 5.77 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.914 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.28 108.58 13.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.773 0.321 . . . . 0.0 110.432 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.86 HG13 ' O ' ' D' ' 144' ' ' THR . 23.1 t -86.6 129.07 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.283 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.484 HG21 ' HB1' ' C' ' 22' ' ' ALA . 18.7 m -127.39 163.55 30.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.826 0.346 . . . . 0.0 110.993 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -86.0 61.41 6.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.069 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . 0.514 ' HB1' HG23 ' C' ' 65' ' ' VAL . . . 44.95 52.64 8.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' C' ' 61' ' ' CYS . . . -127.29 -54.43 1.36 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.467 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.1 OUTLIER 177.73 111.65 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.92 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . 0.755 ' HB2' ' HA ' ' D' ' 36' ' ' GLN . . . -105.64 126.06 51.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . 0.429 HG11 HG21 ' C' ' 28' ' ' VAL . 5.7 p -56.8 145.66 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.022 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.602 ' O ' HG22 ' C' ' 28' ' ' VAL . 4.0 m-20 -74.86 147.24 41.27 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.693 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.78 -43.64 18.43 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.337 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.88 -20.01 60.32 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.946 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 45.2 t -79.62 -26.04 41.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.857 0.36 . . . . 0.0 110.833 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.602 HG22 ' O ' ' C' ' 24' ' ' ASP . 57.5 t -49.08 -48.58 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.341 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.82 93.07 5.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.069 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.59 116.41 28.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.994 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 9.1 p -95.63 115.66 27.75 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.115 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' B' ' 12' ' ' PHE . 1.7 t -117.19 101.1 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.059 0.457 . . . . 0.0 110.438 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.55 126.9 52.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.688 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.19 -55.71 11.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.611 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.06 -111.71 3.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.471 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . 0.751 ' HA ' ' HB2' ' B' ' 22' ' ' ALA . 0.0 OUTLIER -77.02 115.32 16.72 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.516 0.198 . . . . 0.0 110.894 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' B' ' 16' ' ' VAL . 67.2 t -130.99 105.83 11.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.881 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.71 154.1 17.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.748 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.753 ' HA ' HD12 ' C' ' 42' ' ' LEU . 8.3 p -78.7 -19.86 51.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.779 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.53 -19.49 65.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 110.879 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 97.5 p -92.06 -21.26 20.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.143 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.753 HD12 ' HA ' ' C' ' 39' ' ' THR . 0.2 OUTLIER -139.06 62.31 1.54 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.62 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . 0.699 ' HA ' ' HA ' ' C' ' 142' ' ' ALA . . . -101.26 9.2 42.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.23 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.25 136.07 24.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.306 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . 0.589 ' N ' ' HA2' ' C' ' 141' ' ' GLY . 16.5 tt0 -58.54 121.32 10.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 111.139 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.32 -25.43 8.22 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.189 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.8 137.27 58.22 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.937 0.398 . . . . 0.0 112.034 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.9 158.0 44.55 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.935 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.92 -166.23 1.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.627 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 48.8 m -65.18 156.25 32.35 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.782 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' C' ' 134' ' ' GLN . . . -90.56 126.63 36.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.309 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . 0.429 HG12 ' HD2' ' C' ' 54' ' ' PHE . 62.9 t -75.64 118.52 21.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.982 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.85 135.71 13.81 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.632 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' C' ' 133' ' ' PHE . 46.3 p90 -170.76 142.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.755 0.312 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.662 ' HA ' ' O ' ' C' ' 131' ' ' ILE . 11.5 p30 -126.56 163.91 22.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.569 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.622 HG21 HD22 ' C' ' 58' ' ' LEU . 20.8 mm -105.1 119.89 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.519 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.577 ' HA ' HG21 ' C' ' 130' ' ' THR . 0.0 OUTLIER -82.09 115.69 21.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.761 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . 0.622 HD22 HG21 ' C' ' 56' ' ' ILE . 0.0 OUTLIER -128.23 107.45 9.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.295 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.36 176.99 8.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.954 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.03 66.24 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.734 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 3.3 m -109.75 154.4 22.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.668 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . 0.507 ' HA ' ' OD1' ' C' ' 126' ' ' ASN . 0.5 OUTLIER -154.65 138.33 16.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.295 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.601 ' HG1' ' HA ' ' C' ' 125' ' ' ASN . 0.2 OUTLIER -97.54 -11.9 23.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.07 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -72.26 -48.71 40.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.026 0.441 . . . . 0.0 111.732 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . 0.514 HG23 ' HB1' ' C' ' 19' ' ' ALA . 10.6 t -69.0 -48.73 68.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.716 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' C' ' 63' ' ' THR . . . -137.93 153.36 49.5 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.672 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.28 18.67 4.43 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.847 0.356 . . . . 0.0 110.878 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' LYS . . . . . 0.6 ' HB3' ' HB3' ' C' ' 159' ' ' GLN . 10.6 tppt? -142.9 149.95 39.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.41 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.02 110.71 4.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.671 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' C' ' 121' ' ' GLU . . . -108.07 169.97 8.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.083 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.38 150.96 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.632 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.55 100.06 4.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.62 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' PHE . . . . . 0.581 ' HB2' HD22 ' C' ' 111' ' ' LEU . 0.2 OUTLIER -77.41 133.95 38.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.552 0.215 . . . . 0.0 111.117 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.15 115.08 20.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.968 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.42 -173.24 26.57 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.761 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' THR . . . . . 0.779 ' HG1' ' HB3' ' F' ' 55' ' ' ASN . 7.1 m -112.61 149.0 33.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.618 0.247 . . . . 0.0 110.737 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' C' ' 85' ' ' VAL . . . -98.96 133.78 42.73 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.936 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . 0.757 ' HB ' ' HA ' ' C' ' 87' ' ' ALA . 16.1 tt -72.89 -38.01 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.13 167.61 12.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.802 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' F' ' 106' ' ' ARG . . . -70.21 -53.78 15.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.08 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.4 28.66 6.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.546 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . 0.806 ' HB3' ' HB ' ' C' ' 85' ' ' VAL . 10.2 m170 -111.3 -45.67 3.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.46 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' THR . . . . . 0.568 ' HB ' HG22 ' C' ' 112' ' ' THR . 0.0 OUTLIER 46.48 -86.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.552 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' C' ' 82' ' ' HIS . 0.0 OUTLIER -42.19 -42.48 3.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.277 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.806 ' HB ' ' HB3' ' C' ' 82' ' ' HIS . 21.3 t -61.25 126.56 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.148 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.553 ' HG ' ' CD2' ' C' ' 113' ' ' LEU . 0.2 OUTLIER -81.22 164.39 22.32 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.413 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.757 ' HA ' ' HB ' ' C' ' 78' ' ' ILE . . . -104.79 -177.54 3.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.84 0.352 . . . . 0.0 111.661 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.479 ' HA ' HD12 ' C' ' 88' ' ' LEU . 0.2 OUTLIER -85.03 -174.53 5.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.049 179.469 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.63 -170.66 3.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.317 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' SER . . . . . 0.635 ' HA ' ' CG1' ' F' ' 52' ' ' VAL . 26.9 p -74.85 7.85 2.86 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.989 0.423 . . . . 0.0 111.408 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' C' ' 95' ' ' SER . 0.8 OUTLIER -96.97 80.45 2.98 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.84 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' ALA . . . . . 0.738 ' HB1' HD21 ' F' ' 34' ' ' LEU . . . -66.83 -41.24 87.78 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.853 0.359 . . . . 0.0 111.618 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' ALA . . . . . 0.529 ' HB1' ' O ' ' F' ' 36' ' ' GLN . . . -103.7 25.98 9.12 Favored 'General case' 0 N--CA 1.46 0.068 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.707 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.83 -22.69 0.33 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.947 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' C' ' 91' ' ' SER . 1.0 OUTLIER -107.66 175.18 5.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.913 0.387 . . . . 0.0 110.593 179.544 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.41 177.1 3.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' THR . . . . . 0.444 HG22 ' H ' ' C' ' 98' ' ' ASN . 0.2 OUTLIER -138.52 167.88 20.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.269 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . 0.577 ' HA ' ' HB ' ' C' ' 140' ' ' THR . 32.5 m-80 44.17 51.7 7.26 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.48 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' C' ' 143' ' ' ALA . 6.0 p -169.39 124.12 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.767 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.55 -164.72 11.5 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.638 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' VAL . . . . . 0.417 HG23 ' CE1' ' C' ' 137' ' ' TYR . 3.4 t -124.77 91.15 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 122.975 0.51 . . . . 0.0 111.7 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' GLN . . . . . 0.673 ' HA ' ' HA ' ' C' ' 85' ' ' VAL . 0.6 OUTLIER -71.45 116.63 12.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.858 -179.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 6.6 mt -89.68 120.61 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.445 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' LEU . . . . . 0.49 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 1.0 OUTLIER -95.81 152.27 18.63 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.689 0.28 . . . . 0.0 111.164 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . 0.424 ' O ' HD23 ' C' ' 104' ' ' LEU . 8.5 t0 -100.16 160.07 14.62 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.601 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . 0.511 ' CZ ' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -68.8 -13.68 62.55 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.827 0.346 . . . . 0.0 111.066 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 45.0 p -74.37 -18.92 60.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.081 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.91 -40.01 2.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.71 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.41 164.71 13.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.816 0.341 . . . . 0.0 111.116 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -77.35 139.58 39.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.174 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' LEU . . . . . 0.65 HD21 ' HB ' ' C' ' 117' ' ' THR . 5.9 tt -84.08 128.48 34.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.435 0.636 . . . . 0.0 110.519 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' THR . . . . . 0.568 HG22 ' HB ' ' C' ' 83' ' ' THR . 1.4 m -68.14 132.39 47.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.126 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.553 ' CD2' ' HG ' ' C' ' 86' ' ' LEU . 4.7 mp -87.99 99.69 12.35 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.791 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' F' ' 130' ' ' THR . 0.8 OUTLIER -144.03 -32.49 0.43 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.626 0.25 . . . . 0.0 111.568 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.5 -81.25 0.21 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.669 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' ALA . . . . . 0.439 ' HB3' ' HB3' ' F' ' 125' ' ' ASN . . . -97.25 64.0 1.88 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.975 0.417 . . . . 0.0 111.659 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' THR . . . . . 0.65 ' HB ' HD21 ' C' ' 111' ' ' LEU . 2.8 m -94.26 72.28 3.88 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.18 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -66.69 119.04 11.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.9 t -143.95 -48.96 0.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.809 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 3.0 m -88.57 84.7 6.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.584 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' C' ' 70' ' ' ALA . 3.5 mt-10 -110.25 86.92 2.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.287 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.95 159.27 17.73 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -66.93 138.34 57.21 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.699 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.56 159.48 19.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.636 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . 0.601 ' HA ' ' HG1' ' C' ' 63' ' ' THR . 0.3 OUTLIER -147.56 176.28 10.19 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.562 179.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' ASN . . . . . 0.507 ' OD1' ' HA ' ' C' ' 62' ' ' ASP . 0.9 OUTLIER -85.92 161.52 19.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.681 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.5 -121.0 5.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.756 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 72.4 m -119.47 140.36 50.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.675 0.274 . . . . 0.0 110.815 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 129' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -133.8 154.64 50.86 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.876 0.37 . . . . 0.0 111.087 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 130' ' ' THR . . . . . 0.577 HG21 ' HA ' ' C' ' 57' ' ' GLN . 28.0 p -133.37 154.29 50.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.133 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 131' ' ' ILE . . . . . 0.662 ' O ' ' HA ' ' C' ' 55' ' ' ASN . 1.0 OUTLIER -111.0 116.84 51.19 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 132' ' ' PRO . . . . . 0.511 ' HG2' ' CZ ' ' C' ' 106' ' ' ARG . 7.7 Cg_endo -81.12 129.4 6.83 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.662 1.574 . . . . 0.0 112.675 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.447 ' HB3' ' CE1' ' C' ' 54' ' ' PHE . 0.1 OUTLIER -140.87 146.89 38.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.813 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 134' ' ' GLN . . . . . 0.508 ' HB3' ' HB1' ' C' ' 51' ' ' ALA . 19.4 mm-40 -116.47 158.39 23.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.043 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -159.48 105.53 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.91 0.386 . . . . 0.0 111.545 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.72 172.5 6.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.399 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 137' ' ' TYR . . . . . 0.417 ' CE1' HG23 ' C' ' 101' ' ' VAL . 0.7 OUTLIER -98.16 147.72 24.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.128 179.489 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 138' ' ' PHE . . . . . 0.44 ' CG ' HG21 ' C' ' 85' ' ' VAL . 0.3 OUTLIER -127.58 158.99 35.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.057 -179.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 139' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' C' ' 42' ' ' LEU . . . -116.27 141.28 48.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.934 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 140' ' ' THR . . . . . 0.577 ' HB ' ' HA ' ' C' ' 98' ' ' ASN . 0.2 OUTLIER -107.83 27.23 9.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.471 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . 0.589 ' HA2' ' N ' ' C' ' 45' ' ' GLU . . . 97.63 83.59 1.71 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.97 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 142' ' ' ALA . . . . . 0.699 ' HA ' ' HA ' ' C' ' 43' ' ' ALA . . . 57.9 93.41 0.03 OUTLIER 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.666 0.233 . . . . 0.0 110.8 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 143' ' ' ALA . . . . . 0.608 ' HB3' ' HB ' ' C' ' 99' ' ' VAL . . . -80.02 165.38 22.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.764 0.316 . . . . 0.0 111.392 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 144' ' ' THR . . . . . 0.856 ' O ' HG13 ' B' ' 16' ' ' VAL . 29.8 p -108.35 168.87 7.22 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.228 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 145' ' ' PRO . . . . . 0.445 ' HG2' HG21 ' A' ' 3' ' ' THR . 1.4 Cg_endo -83.68 133.56 6.09 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.533 2.155 . . . . 0.0 112.015 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . 0.598 ' HA2' HG13 ' A' ' 5' ' ' VAL . . . 169.6 -119.25 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.477 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.8 121.73 13.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.887 0.375 . . . . 0.0 111.339 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.42 85.71 3.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.419 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -104.61 131.24 52.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.548 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 150' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' C' ' 87' ' ' ALA . . . -136.06 148.51 48.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.971 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.24 120.19 20.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.205 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.64 140.0 24.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.207 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 153' ' ' THR . . . . . 0.616 HG22 ' HA ' ' B' ' 9' ' ' THR . 70.7 p -105.16 171.19 7.45 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 154' ' ' PHE . . . . . 0.616 ' HZ ' HG23 ' C' ' 56' ' ' ILE . 13.9 p90 -138.21 147.41 43.73 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.114 0.483 . . . . 0.0 110.074 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . 0.439 ' HG3' ' HB ' ' F' ' 128' ' ' THR . 13.7 mmtt -100.89 171.94 7.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.936 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 156' ' ' VAL . . . . . 0.526 HG22 ' HA2' ' B' ' 7' ' ' GLY . 0.4 OUTLIER -135.47 111.41 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.84 0.352 . . . . 0.0 111.716 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . 0.541 ' HA ' ' O ' ' B' ' 3' ' ' THR . 1.8 tt0 -108.96 141.29 41.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.349 0.595 . . . . 0.0 110.409 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . 0.478 ' CZ ' ' HB ' ' C' ' 156' ' ' VAL . 23.0 m-85 -135.37 105.47 6.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.595 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . 0.6 ' HB3' ' HB3' ' C' ' 68' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 111.495 0.183 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . 0.576 ' H ' ' HA ' ' E' ' 159' ' ' GLN . . . 56.69 88.54 0.05 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.713 -0.222 . . . . 0.0 110.963 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' E' ' 157' ' ' GLN . 0.2 OUTLIER -103.08 110.38 22.29 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.383 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.36 136.2 38.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.592 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . 0.594 HG13 ' HA2' ' F' ' 146' ' ' GLY . 0.0 OUTLIER -152.05 -175.35 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.562 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.44 130.05 38.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.685 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' GLY . . . . . 0.529 ' HA2' HG22 ' E' ' 156' ' ' VAL . . . -98.81 -59.23 0.91 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.8 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.34 166.18 27.93 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.868 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' THR . . . . . 0.602 ' HA ' HG22 ' E' ' 153' ' ' THR . 27.0 m -94.38 121.15 35.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 0.0 111.197 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.73 115.61 36.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.208 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -99.54 137.51 37.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.374 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' E' ' 32' ' ' VAL . 76.0 m-85 -127.6 97.74 4.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.792 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.31 175.76 6.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.428 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.0 149.45 5.77 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.948 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.29 108.58 13.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.855 0.359 . . . . 0.0 110.35 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.853 HG13 ' O ' ' E' ' 144' ' ' THR . 23.5 t -86.59 129.1 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.243 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . 0.476 HG21 ' CB ' ' D' ' 22' ' ' ALA . 18.8 m -127.35 163.54 30.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.815 0.34 . . . . 0.0 111.011 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -85.97 61.4 6.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.052 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' ALA . . . . . 0.524 ' HB1' HG23 ' D' ' 65' ' ' VAL . . . 44.88 52.64 7.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' D' ' 61' ' ' CYS . . . -127.22 -54.42 1.37 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.49 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.1 OUTLIER 177.64 111.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.879 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . 0.76 ' HB2' ' HA ' ' E' ' 36' ' ' GLN . . . -105.69 126.06 51.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.108 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . 0.444 HG11 HG21 ' D' ' 28' ' ' VAL . 5.7 p -56.81 145.65 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.003 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.611 ' O ' HG22 ' D' ' 28' ' ' VAL . 4.0 m-20 -74.77 147.26 41.44 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.692 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.74 -43.62 18.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.396 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.96 -20.01 60.17 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.863 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 45.1 t -79.54 -26.12 41.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.899 0.381 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . 0.611 HG22 ' O ' ' D' ' 24' ' ' ASP . 57.3 t -49.1 -48.53 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.33 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.82 93.01 5.32 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.093 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.55 116.42 28.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.038 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.66 115.62 27.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.173 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' C' ' 12' ' ' PHE . 1.6 t -117.14 101.08 11.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.072 0.463 . . . . 0.0 110.469 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.58 126.97 52.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.698 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.771 HD21 ' HB1' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -68.2 -55.67 11.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.653 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.02 -111.69 3.94 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.498 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' GLN . . . . . 0.755 ' HA ' ' HB2' ' C' ' 22' ' ' ALA . 0.0 OUTLIER -77.04 115.26 16.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.513 0.197 . . . . 0.0 110.947 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' C' ' 16' ' ' VAL . 67.6 t -131.0 105.83 11.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.888 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.67 154.1 17.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.722 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.751 ' HA ' HD12 ' D' ' 42' ' ' LEU . 8.3 p -78.7 -19.86 51.43 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.775 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -19.53 65.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.14 0.495 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 96.8 p -92.05 -21.2 20.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.184 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.751 HD12 ' HA ' ' D' ' 39' ' ' THR . 0.2 OUTLIER -139.08 62.25 1.54 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.602 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . 0.698 ' HA ' ' HA ' ' D' ' 142' ' ' ALA . . . -101.15 9.17 42.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.36 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.17 136.06 24.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.359 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . 0.589 ' N ' ' HA2' ' D' ' 141' ' ' GLY . 16.4 tt0 -58.53 121.37 10.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 0.0 111.133 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.25 -25.44 8.25 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.209 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.75 137.22 58.21 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.83 158.07 44.32 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.95 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.529 ' HB2' ' HB2' ' A' ' 92' ' ' ALA . 0.0 OUTLIER -109.05 -166.23 1.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.512 179.388 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.61 ' HB2' ' HA ' ' A' ' 92' ' ' ALA . 48.9 m -65.17 156.11 32.79 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.769 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' D' ' 134' ' ' GLN . . . -90.46 126.7 35.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.358 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' VAL . . . . . 0.629 ' CG1' ' HA ' ' A' ' 90' ' ' SER . 63.2 t -75.66 118.53 21.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.999 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.84 135.69 13.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.672 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' D' ' 133' ' ' PHE . 46.3 p90 -170.77 142.11 1.9 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' ASN . . . . . 0.78 ' HB3' ' HG1' ' A' ' 76' ' ' THR . 11.6 p30 -126.58 163.88 22.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.526 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.618 HG21 HD22 ' D' ' 58' ' ' LEU . 20.7 mm -105.08 119.93 54.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.516 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' GLN . . . . . 0.567 ' HA ' HG21 ' D' ' 130' ' ' THR . 0.0 OUTLIER -82.15 115.65 21.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.761 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . 0.618 HD22 HG21 ' D' ' 56' ' ' ILE . 0.0 OUTLIER -128.21 107.42 9.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.298 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.35 177.0 8.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.951 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.11 66.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.756 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' CYS . . . . . 0.891 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 3.3 m -109.66 154.39 22.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.742 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . 0.51 ' HA ' ' OD1' ' D' ' 126' ' ' ASN . 0.5 OUTLIER -154.66 138.37 16.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.214 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.618 ' HG1' ' HA ' ' D' ' 125' ' ' ASN . 0.2 OUTLIER -97.64 -11.82 23.14 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.19 -48.82 40.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.03 0.443 . . . . 0.0 111.746 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . 0.524 HG23 ' HB1' ' D' ' 19' ' ' ALA . 10.5 t -68.92 -48.71 68.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.742 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' D' ' 63' ' ' THR . . . -137.97 153.32 49.46 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.637 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.27 18.68 4.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.926 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' LYS . . . . . 0.601 ' HB3' ' HB3' ' D' ' 159' ' ' GLN . 10.6 tppt? -142.84 149.9 39.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.573 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.97 110.75 4.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.633 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' D' ' 121' ' ' GLU . . . -108.06 169.95 8.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.131 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.4 150.96 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.642 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' D' ' 116' ' ' ALA . . . -135.57 100.1 4.4 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.555 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' PHE . . . . . 0.586 ' HB2' HD22 ' D' ' 111' ' ' LEU . 0.2 OUTLIER -77.46 133.94 38.49 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.599 0.238 . . . . 0.0 111.128 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.15 115.08 20.53 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.932 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.35 -173.22 26.48 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.821 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -112.62 149.06 33.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.681 0.277 . . . . 0.0 110.739 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' D' ' 85' ' ' VAL . . . -98.95 133.79 42.72 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.939 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 78' ' ' ILE . . . . . 0.78 ' HB ' ' HA ' ' D' ' 87' ' ' ALA . 16.1 tt -72.96 -37.95 55.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.89 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.21 167.63 12.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.834 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.22 -53.83 15.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.08 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.36 28.71 6.07 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.536 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . 0.813 ' HB3' ' HB ' ' D' ' 85' ' ' VAL . 10.3 m170 -111.33 -45.7 3.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.928 0.394 . . . . 0.0 110.453 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 83' ' ' THR . . . . . 0.558 ' HB ' HG22 ' D' ' 112' ' ' THR . 0.0 OUTLIER 46.39 -86.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.603 -179.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' D' ' 82' ' ' HIS . 0.0 OUTLIER -42.19 -42.46 3.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.268 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.813 ' HB ' ' HB3' ' D' ' 82' ' ' HIS . 21.3 t -61.3 126.53 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.135 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.557 ' HG ' ' CD2' ' D' ' 113' ' ' LEU . 0.2 OUTLIER -81.22 164.42 22.3 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.432 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.78 ' HA ' ' HB ' ' D' ' 78' ' ' ILE . . . -104.84 -177.53 3.39 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.852 0.358 . . . . 0.0 111.618 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.42 ' HA ' HD12 ' D' ' 88' ' ' LEU . 0.2 OUTLIER -85.01 -174.53 5.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.009 179.528 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.64 -170.72 3.24 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.367 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 27.8 p -74.76 7.87 2.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.905 0.383 . . . . 0.0 111.46 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 91' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' D' ' 95' ' ' SER . 0.8 OUTLIER -97.06 80.41 2.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.84 -41.2 87.81 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.82 0.343 . . . . 0.0 111.636 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.72 26.01 9.1 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.682 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.77 -22.64 0.33 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.892 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 95' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' D' ' 91' ' ' SER . 1.0 OUTLIER -107.65 175.18 5.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 110.661 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.35 177.1 2.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 97' ' ' THR . . . . . 0.442 HG22 ' H ' ' D' ' 98' ' ' ASN . 0.2 OUTLIER -138.6 167.85 21.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.278 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 98' ' ' ASN . . . . . 0.587 ' HA ' ' HB ' ' D' ' 140' ' ' THR . 32.4 m-80 44.2 51.68 7.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.489 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 99' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' D' ' 143' ' ' ALA . 6.0 p -169.34 124.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.702 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.61 -164.65 11.47 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.58 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 101' ' ' VAL . . . . . 0.411 HG23 ' CE1' ' D' ' 137' ' ' TYR . 3.4 t -124.84 91.13 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.202 0.525 . . . . 0.0 111.73 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 102' ' ' GLN . . . . . 0.681 ' HA ' ' HA ' ' D' ' 85' ' ' VAL . 0.6 OUTLIER -71.43 116.65 12.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.857 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 103' ' ' ILE . . . . . 0.412 ' HA ' ' HA ' ' D' ' 135' ' ' ALA . 6.6 mt -89.61 120.64 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.457 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 104' ' ' LEU . . . . . 0.499 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 1.0 OUTLIER -95.84 152.32 18.6 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.691 0.281 . . . . 0.0 111.126 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . 0.428 ' O ' HD23 ' D' ' 104' ' ' LEU . 8.5 t0 -100.14 160.09 14.6 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.629 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 106' ' ' ARG . . . . . 0.511 ' CZ ' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -68.89 -13.6 62.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.835 0.35 . . . . 0.0 111.075 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 107' ' ' THR . . . . . 0.404 ' HG1' ' HB3' ' D' ' 105' ' ' ASP . 45.3 p -74.42 -18.9 60.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.144 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.0 -40.15 2.22 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.669 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.3 164.7 13.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.338 . . . . 0.0 111.119 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -77.4 139.66 39.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.148 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 111' ' ' LEU . . . . . 0.652 HD21 ' HB ' ' D' ' 117' ' ' THR . 5.9 tt -84.18 128.59 34.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.404 0.621 . . . . 0.0 110.503 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 112' ' ' THR . . . . . 0.558 HG22 ' HB ' ' D' ' 83' ' ' THR . 1.4 m -68.13 132.36 47.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.17 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 113' ' ' LEU . . . . . 0.557 ' CD2' ' HG ' ' D' ' 86' ' ' LEU . 4.7 mp -88.06 99.74 12.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.693 0.282 . . . . 0.0 110.737 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.06 -32.43 0.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.539 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.45 -81.29 0.21 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.666 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 116' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' D' ' 72' ' ' ALA . . . -97.23 64.12 1.89 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.0 0.429 . . . . 0.0 111.624 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 117' ' ' THR . . . . . 0.652 ' HB ' HD21 ' D' ' 111' ' ' LEU . 2.8 m -94.42 72.31 3.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.76 119.07 11.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.828 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.89 -49.03 0.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.57 84.75 6.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.575 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' D' ' 70' ' ' ALA . 3.6 mt-10 -110.16 86.94 2.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.268 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.0 159.32 17.66 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.83 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -67.07 138.33 57.07 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.68 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.47 159.46 19.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.68 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 125' ' ' ASN . . . . . 0.618 ' HA ' ' HG1' ' D' ' 63' ' ' THR . 0.3 OUTLIER -147.55 176.28 10.19 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.635 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 126' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' D' ' 62' ' ' ASP . 0.9 OUTLIER -85.98 161.52 18.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.639 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.53 -121.06 5.73 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.764 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 128' ' ' THR . . . . . 0.432 ' HB ' ' HG3' ' A' ' 155' ' ' LYS . 74.1 m -119.5 140.3 50.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.659 0.266 . . . . 0.0 110.765 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 129' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -133.74 154.63 50.83 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.912 0.387 . . . . 0.0 111.087 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 130' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' D' ' 56' ' ' ILE . 28.2 p -133.36 154.32 50.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.167 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 131' ' ' ILE . . . . . 0.666 ' O ' ' HA ' ' D' ' 55' ' ' ASN . 1.0 OUTLIER -111.07 116.86 51.01 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 132' ' ' PRO . . . . . 0.597 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 7.7 Cg_endo -81.11 129.36 6.82 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.704 1.603 . . . . 0.0 112.667 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.446 ' HB3' ' CE1' ' D' ' 54' ' ' PHE . 0.1 OUTLIER -140.87 146.87 38.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.81 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 134' ' ' GLN . . . . . 0.512 ' HB3' ' HB1' ' D' ' 51' ' ' ALA . 19.5 mm-40 -116.48 158.4 23.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.979 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' D' ' 103' ' ' ILE . . . -159.48 105.61 1.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.931 0.396 . . . . 0.0 111.539 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.68 172.57 6.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.405 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 137' ' ' TYR . . . . . 0.411 ' CE1' HG23 ' D' ' 101' ' ' VAL . 0.7 OUTLIER -98.23 147.72 24.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.086 179.493 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 138' ' ' PHE . . . . . 0.434 ' CG ' HG21 ' D' ' 85' ' ' VAL . 0.3 OUTLIER -127.58 159.05 35.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.005 -179.231 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 139' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' D' ' 42' ' ' LEU . . . -116.36 141.31 48.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.85 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 140' ' ' THR . . . . . 0.587 ' HB ' ' HA ' ' D' ' 98' ' ' ASN . 0.2 OUTLIER -107.78 27.2 9.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.496 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . 0.589 ' HA2' ' N ' ' D' ' 45' ' ' GLU . . . 97.55 83.6 1.71 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.014 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . 0.698 ' HA ' ' HA ' ' D' ' 43' ' ' ALA . . . 57.87 93.49 0.03 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.7 0.25 . . . . 0.0 110.759 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 143' ' ' ALA . . . . . 0.624 ' HB3' ' HB ' ' D' ' 99' ' ' VAL . . . -79.97 165.44 22.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 111.375 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 144' ' ' THR . . . . . 0.86 ' O ' HG13 ' C' ' 16' ' ' VAL . 29.4 p -108.37 168.85 7.25 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.234 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 145' ' ' PRO . . . . . 0.463 ' HG2' HG21 ' B' ' 3' ' ' THR . 1.3 Cg_endo -83.62 133.56 6.14 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.544 2.162 . . . . 0.0 112.002 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . 0.6 ' HA2' HG13 ' B' ' 5' ' ' VAL . . . 169.56 -119.25 0.81 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.477 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.84 121.69 13.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.787 0.327 . . . . 0.0 111.327 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.33 85.7 3.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.14 0.495 . . . . 0.0 110.506 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -104.57 131.21 52.25 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.597 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 150' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' D' ' 87' ' ' ALA . . . -136.08 148.49 48.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.951 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.16 120.24 20.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.194 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.7 140.0 24.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.164 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 153' ' ' THR . . . . . 0.613 HG22 ' HA ' ' C' ' 9' ' ' THR . 70.7 p -105.2 171.18 7.46 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 154' ' ' PHE . . . . . 0.616 ' HZ ' HG23 ' D' ' 56' ' ' ILE . 13.5 p90 -138.18 147.4 43.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.138 0.494 . . . . 0.0 110.112 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -100.9 171.92 7.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.912 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 156' ' ' VAL . . . . . 0.531 HG22 ' HA2' ' C' ' 7' ' ' GLY . 0.4 OUTLIER -135.4 111.42 12.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.714 -179.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 157' ' ' GLN . . . . . 0.548 ' HA ' ' O ' ' C' ' 3' ' ' THR . 1.8 tt0 -109.03 141.32 41.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.273 0.559 . . . . 0.0 110.398 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . 0.473 ' CZ ' ' HB ' ' D' ' 156' ' ' VAL . 23.1 m-85 -135.43 105.43 6.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.555 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 159' ' ' GLN . . . . . 0.601 ' HB3' ' HB3' ' D' ' 68' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.899 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 111.48 0.178 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . 0.584 ' H ' ' HA ' ' F' ' 159' ' ' GLN . . . 56.56 88.6 0.05 OUTLIER 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.038 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 3' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' F' ' 157' ' ' GLN . 0.2 OUTLIER -103.14 110.34 22.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.411 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.31 136.26 38.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.57 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -152.11 -175.28 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.616 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.54 130.06 38.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.646 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 7' ' ' GLY . . . . . 0.522 ' HA2' HG22 ' F' ' 156' ' ' VAL . . . -98.73 -59.38 0.91 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.805 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.38 166.23 28.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.806 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 9' ' ' THR . . . . . 0.596 ' HA ' HG22 ' F' ' 153' ' ' THR . 27.0 m -94.47 121.18 35.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.939 0.4 . . . . 0.0 111.205 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.69 115.58 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.21 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -99.52 137.56 37.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.327 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 12' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' F' ' 32' ' ' VAL . 76.2 m-85 -127.61 97.78 4.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.815 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.3 175.8 6.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.378 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.97 149.46 5.77 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.91 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.29 108.61 13.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 110.345 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 16' ' ' VAL . . . . . 0.862 HG13 ' O ' ' F' ' 144' ' ' THR . 23.4 t -86.62 129.16 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.213 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . 0.482 HG21 ' HB1' ' E' ' 22' ' ' ALA . 18.7 m -127.43 163.53 30.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.787 0.327 . . . . 0.0 111.028 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -85.95 61.36 6.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.032 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 19' ' ' ALA . . . . . 0.527 ' HB1' HG23 ' E' ' 65' ' ' VAL . . . 45.0 52.64 8.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.051 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' E' ' 61' ' ' CYS . . . -127.27 -54.47 1.37 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.426 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 21' ' ' CYS . . . . . 0.889 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.1 OUTLIER 177.68 111.67 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.901 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 22' ' ' ALA . . . . . 0.759 ' HB2' ' HA ' ' F' ' 36' ' ' GLN . . . -105.71 126.0 51.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 23' ' ' VAL . . . . . 0.449 HG11 HG21 ' E' ' 28' ' ' VAL . 5.6 p -56.86 145.68 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.003 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 24' ' ' ASP . . . . . 0.612 ' O ' HG22 ' E' ' 28' ' ' VAL . 3.9 m-20 -74.9 147.28 41.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.652 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.73 -43.71 18.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.331 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.85 -20.06 60.27 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.865 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 45.1 t -79.58 -26.09 41.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.872 0.367 . . . . 0.0 110.851 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 28' ' ' VAL . . . . . 0.612 HG22 ' O ' ' E' ' 24' ' ' ASP . 57.8 t -49.13 -48.49 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.361 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.89 93.09 5.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.976 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.63 116.38 28.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.04 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.54 115.58 27.63 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.178 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' D' ' 12' ' ' PHE . 1.7 t -117.17 101.14 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.168 0.509 . . . . 0.0 110.463 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.58 126.91 52.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.711 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.761 HD21 ' HB1' ' B' ' 92' ' ' ALA . 0.3 OUTLIER -68.15 -55.71 11.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.619 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.03 -111.69 3.93 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.471 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 36' ' ' GLN . . . . . 0.76 ' HA ' ' HB2' ' D' ' 22' ' ' ALA . 0.0 OUTLIER -77.02 115.34 16.73 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.524 0.202 . . . . 0.0 110.902 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' D' ' 16' ' ' VAL . 67.5 t -131.11 105.85 11.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.819 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.6 154.11 17.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.77 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 39' ' ' THR . . . . . 0.773 ' HA ' HD12 ' E' ' 42' ' ' LEU . 8.4 p -78.71 -19.92 51.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.753 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.38 -19.58 65.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.125 0.488 . . . . 0.0 110.923 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 97.1 p -92.01 -21.24 20.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.156 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.773 HD12 ' HA ' ' E' ' 39' ' ' THR . 0.2 OUTLIER -139.06 62.39 1.54 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.661 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 43' ' ' ALA . . . . . 0.701 ' HA ' ' HA ' ' E' ' 142' ' ' ALA . . . -101.23 9.12 42.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.246 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.15 136.02 24.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.32 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . 0.588 ' N ' ' HA2' ' E' ' 141' ' ' GLY . 16.5 tt0 -58.5 121.24 10.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 0.0 111.159 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.36 -25.47 8.19 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.196 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.66 137.24 58.22 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.93 157.93 44.75 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.919 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' B' ' 92' ' ' ALA . 0.0 OUTLIER -108.97 -166.19 1.09 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.583 179.321 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 50' ' ' SER . . . . . 0.604 ' HB2' ' HA ' ' B' ' 92' ' ' ALA . 48.7 m -65.22 156.23 32.53 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.789 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 51' ' ' ALA . . . . . 0.523 ' HB1' ' HB3' ' E' ' 134' ' ' GLN . . . -90.57 126.66 36.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.274 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 52' ' ' VAL . . . . . 0.647 ' CG1' ' HA ' ' B' ' 90' ' ' SER . 63.3 t -75.61 118.46 21.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.016 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.78 135.65 13.77 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.663 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 54' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' E' ' 133' ' ' PHE . 46.2 p90 -170.77 142.04 1.89 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.831 0.348 . . . . 0.0 110.907 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 55' ' ' ASN . . . . . 0.779 ' HB3' ' HG1' ' B' ' 76' ' ' THR . 11.6 p30 -126.5 163.87 22.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.621 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 56' ' ' ILE . . . . . 0.641 HG21 HD22 ' E' ' 58' ' ' LEU . 21.0 mm -105.1 119.93 54.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.52 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 57' ' ' GLN . . . . . 0.576 ' HA ' HG21 ' E' ' 130' ' ' THR . 0.0 OUTLIER -82.18 115.74 21.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.744 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . 0.641 HD22 HG21 ' E' ' 56' ' ' ILE . 0.0 OUTLIER -128.28 107.45 9.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.267 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.34 177.09 8.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.924 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 62.95 66.13 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.818 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 61' ' ' CYS . . . . . 0.889 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 3.3 m -109.65 154.42 22.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.785 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . 0.505 ' HA ' ' OD1' ' E' ' 126' ' ' ASN . 0.5 OUTLIER -154.68 138.35 16.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.258 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 63' ' ' THR . . . . . 0.625 ' HG1' ' HA ' ' E' ' 125' ' ' ASN . 0.2 OUTLIER -97.63 -11.81 23.17 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.131 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.23 -48.72 40.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.993 0.425 . . . . 0.0 111.733 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . 0.527 HG23 ' HB1' ' E' ' 19' ' ' ALA . 10.7 t -69.02 -48.67 68.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.712 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' E' ' 63' ' ' THR . . . -137.94 153.39 49.49 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.616 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.3 18.62 4.43 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.802 0.334 . . . . 0.0 110.91 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 68' ' ' LYS . . . . . 0.589 ' HB3' ' HB3' ' E' ' 159' ' ' GLN . 10.6 tppt? -142.83 149.94 39.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.448 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.01 110.65 4.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.729 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' E' ' 121' ' ' GLU . . . -108.01 169.92 8.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.067 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.34 150.95 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.681 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' E' ' 116' ' ' ALA . . . -135.59 100.13 4.4 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.528 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 73' ' ' PHE . . . . . 0.587 ' HB2' HD22 ' E' ' 111' ' ' LEU . 0.2 OUTLIER -77.39 133.94 38.56 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.594 0.235 . . . . 0.0 111.136 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.17 115.06 20.49 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.971 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.35 -173.22 26.48 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.79 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 76' ' ' THR . . . . . 0.4 HG23 ' N ' ' E' ' 77' ' ' ALA . 7.0 m -112.66 149.03 33.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.624 0.25 . . . . 0.0 110.715 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 77' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' E' ' 85' ' ' VAL . . . -98.95 133.8 42.71 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.852 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 78' ' ' ILE . . . . . 0.775 ' HB ' ' HA ' ' E' ' 87' ' ' ALA . 16.1 tt -72.95 -37.98 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.19 167.6 12.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.907 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.09 -53.86 15.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.4 28.67 6.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.597 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 82' ' ' HIS . . . . . 0.807 ' HB3' ' HB ' ' E' ' 85' ' ' VAL . 10.2 m170 -111.36 -45.57 3.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 0.0 110.446 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 83' ' ' THR . . . . . 0.563 ' HB ' HG22 ' E' ' 112' ' ' THR . 0.0 OUTLIER 46.4 -86.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.567 -179.524 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 84' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' E' ' 82' ' ' HIS . 0.0 OUTLIER -42.17 -42.4 2.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.402 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.807 ' HB ' ' HB3' ' E' ' 82' ' ' HIS . 21.3 t -61.25 126.57 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.151 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 86' ' ' LEU . . . . . 0.561 ' HG ' ' CD2' ' E' ' 113' ' ' LEU . 0.2 OUTLIER -81.23 164.4 22.31 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 87' ' ' ALA . . . . . 0.775 ' HA ' ' HB ' ' E' ' 78' ' ' ILE . . . -104.77 -177.51 3.39 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.688 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.458 ' HA ' HD12 ' E' ' 88' ' ' LEU . 0.2 OUTLIER -85.03 -174.56 5.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.974 179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.59 -170.73 3.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.401 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 27.5 p -74.67 7.73 2.85 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.96 0.41 . . . . 0.0 111.464 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 91' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.93 80.42 2.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.86 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.87 -41.17 87.7 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.849 0.356 . . . . 0.0 111.623 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.7 25.94 9.17 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.664 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.8 -22.63 0.33 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.889 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 95' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.71 175.2 5.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.928 0.394 . . . . 0.0 110.597 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.37 177.08 3.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 97' ' ' THR . . . . . 0.453 HG22 ' H ' ' E' ' 98' ' ' ASN . 0.2 OUTLIER -138.56 167.87 21.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.305 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 98' ' ' ASN . . . . . 0.571 ' HA ' ' HB ' ' E' ' 140' ' ' THR . 32.4 m-80 44.15 51.68 7.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.526 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 99' ' ' VAL . . . . . 0.633 ' HB ' ' HB3' ' E' ' 143' ' ' ALA . 6.0 p -169.36 124.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.753 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.53 -164.65 11.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.594 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 101' ' ' VAL . . . . . 0.411 HG23 ' CE1' ' E' ' 137' ' ' TYR . 3.5 t -124.9 91.07 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 122.997 0.519 . . . . 0.0 111.735 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 102' ' ' GLN . . . . . 0.685 ' HA ' ' HA ' ' E' ' 85' ' ' VAL . 0.6 OUTLIER -71.38 116.65 11.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.901 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 103' ' ' ILE . . . . . . . . . . . . . 6.5 mt -89.66 120.59 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.511 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 104' ' ' LEU . . . . . 0.489 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 1.0 OUTLIER -95.85 152.32 18.6 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.738 0.304 . . . . 0.0 111.105 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . 0.414 ' O ' HD23 ' E' ' 104' ' ' LEU . 8.5 t0 -100.08 160.07 14.61 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.553 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 106' ' ' ARG . . . . . 0.51 ' CZ ' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -68.81 -13.7 62.56 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.83 0.348 . . . . 0.0 111.064 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 44.8 p -74.4 -18.95 60.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.097 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.0 -40.12 2.23 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.639 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.36 164.63 13.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.774 0.321 . . . . 0.0 111.116 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -77.38 139.66 39.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.128 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.642 HD21 ' HB ' ' E' ' 117' ' ' THR . 5.9 tt -84.16 128.58 34.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.449 0.642 . . . . 0.0 110.477 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 112' ' ' THR . . . . . 0.563 HG22 ' HB ' ' E' ' 83' ' ' THR . 1.4 m -68.13 132.38 47.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.081 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 113' ' ' LEU . . . . . 0.561 ' CD2' ' HG ' ' E' ' 86' ' ' LEU . 4.7 mp -88.12 99.79 12.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.723 0.297 . . . . 0.0 110.699 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.09 -32.4 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.528 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.42 -81.24 0.21 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.645 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 116' ' ' ALA . . . . . 0.401 ' HA ' ' HB3' ' E' ' 72' ' ' ALA . . . -97.24 64.03 1.88 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.038 0.447 . . . . 0.0 111.678 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 117' ' ' THR . . . . . 0.642 ' HB ' HD21 ' E' ' 111' ' ' LEU . 2.8 m -94.37 72.48 3.83 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.165 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.84 119.09 11.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.783 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.92 -49.03 0.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.83 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 3.0 m -88.55 84.73 6.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.573 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 121' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' E' ' 70' ' ' ALA . 3.5 mt-10 -110.26 86.95 2.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.263 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.06 159.32 17.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.801 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 2.5 t -67.04 138.38 57.14 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.734 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.53 159.54 19.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.636 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 125' ' ' ASN . . . . . 0.625 ' HA ' ' HG1' ' E' ' 63' ' ' THR . 0.3 OUTLIER -147.66 176.22 10.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.595 179.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . 0.505 ' OD1' ' HA ' ' E' ' 62' ' ' ASP . 0.9 OUTLIER -85.89 161.47 19.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.703 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.51 -121.01 5.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.718 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 128' ' ' THR . . . . . 0.446 ' HB ' ' HG3' ' B' ' 155' ' ' LYS . 72.4 m -119.47 140.33 50.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.75 0.309 . . . . 0.0 110.788 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 129' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -133.77 154.62 50.85 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.112 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 130' ' ' THR . . . . . 0.576 HG21 ' HA ' ' E' ' 57' ' ' GLN . 28.0 p -133.41 154.24 50.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.188 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 131' ' ' ILE . . . . . 0.661 ' O ' ' HA ' ' E' ' 55' ' ' ASN . 1.0 OUTLIER -110.88 116.79 51.49 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 132' ' ' PRO . . . . . 0.609 ' HB3' ' HA ' ' B' ' 76' ' ' THR . 7.6 Cg_endo -81.15 129.38 6.8 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.663 1.576 . . . . 0.0 112.667 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 133' ' ' PHE . . . . . 0.448 ' HB3' ' CE1' ' E' ' 54' ' ' PHE . 0.1 OUTLIER -140.81 146.89 38.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.796 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 134' ' ' GLN . . . . . 0.523 ' HB3' ' HB1' ' E' ' 51' ' ' ALA . 19.3 mm-40 -116.49 158.33 23.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.033 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -159.47 105.48 1.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.898 0.38 . . . . 0.0 111.589 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.67 172.53 6.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.457 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 137' ' ' TYR . . . . . 0.411 ' CE1' HG23 ' E' ' 101' ' ' VAL . 0.7 OUTLIER -98.18 147.77 24.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.051 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 138' ' ' PHE . . . . . 0.441 ' CG ' HG21 ' E' ' 85' ' ' VAL . 0.3 OUTLIER -127.65 159.0 36.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.994 -179.225 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 139' ' ' ALA . . . . . 0.42 ' HB2' ' HB2' ' E' ' 42' ' ' LEU . . . -116.31 141.27 48.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.897 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 140' ' ' THR . . . . . 0.571 ' HB ' ' HA ' ' E' ' 98' ' ' ASN . 0.2 OUTLIER -107.81 27.22 9.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.499 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . 0.588 ' HA2' ' N ' ' E' ' 45' ' ' GLU . . . 97.5 83.57 1.7 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.031 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 142' ' ' ALA . . . . . 0.701 ' HA ' ' HA ' ' E' ' 43' ' ' ALA . . . 57.98 93.41 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.67 0.235 . . . . 0.0 110.765 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 143' ' ' ALA . . . . . 0.633 ' HB3' ' HB ' ' E' ' 99' ' ' VAL . . . -79.94 165.51 22.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.733 0.301 . . . . 0.0 111.453 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 144' ' ' THR . . . . . 0.853 ' O ' HG13 ' D' ' 16' ' ' VAL . 29.6 p -108.49 168.86 7.22 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.202 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 145' ' ' PRO . . . . . 0.458 ' HG2' HG21 ' C' ' 3' ' ' THR . 1.4 Cg_endo -83.59 133.54 6.16 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.572 2.181 . . . . 0.0 111.981 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 146' ' ' GLY . . . . . 0.604 ' HA2' HG13 ' C' ' 5' ' ' VAL . . . 169.55 -119.23 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.475 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.8 121.7 13.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.904 0.383 . . . . 0.0 111.382 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.34 85.68 3.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.541 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -104.58 131.25 52.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.58 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 150' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' E' ' 87' ' ' ALA . . . -136.1 148.51 48.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.94 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.18 120.23 20.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.213 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.69 139.99 24.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.171 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 153' ' ' THR . . . . . 0.602 HG22 ' HA ' ' D' ' 9' ' ' THR . 71.0 p -105.21 171.17 7.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 154' ' ' PHE . . . . . 0.602 ' HZ ' HG23 ' E' ' 56' ' ' ILE . 13.6 p90 -138.18 147.39 43.78 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 110.143 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -100.92 171.94 7.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.919 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 156' ' ' VAL . . . . . 0.529 HG22 ' HA2' ' D' ' 7' ' ' GLY . 0.4 OUTLIER -135.44 111.37 12.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.754 0.311 . . . . 0.0 111.789 -179.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 157' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' D' ' 3' ' ' THR . 1.8 tt0 -108.97 141.28 41.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.312 0.577 . . . . 0.0 110.438 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . 0.479 ' CZ ' ' HB ' ' E' ' 156' ' ' VAL . 23.0 m-85 -135.36 105.52 6.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.613 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 159' ' ' GLN . . . . . 0.589 ' HB3' ' HB3' ' E' ' 68' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.903 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.57 88.66 0.05 OUTLIER 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.095 0.247 . . . . 0.0 110.995 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.11 110.45 22.4 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.397 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.49 136.11 38.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.534 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.99 -175.31 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.601 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.57 130.1 38.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.665 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.8 -59.26 0.91 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.794 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.4 166.22 28.06 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.899 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 26.9 m -94.44 121.15 35.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 111.196 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.68 115.66 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.229 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -99.55 137.5 37.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.361 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -127.62 97.8 4.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.748 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.26 175.74 6.58 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.458 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.04 149.48 5.78 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.897 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.32 108.6 13.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 110.407 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 23.4 t -86.61 129.15 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.183 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 17' ' ' VAL . . . . . 0.479 HG21 ' HB1' ' F' ' 22' ' ' ALA . 18.7 m -127.39 163.54 30.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.06 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -85.93 61.37 6.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.041 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 19' ' ' ALA . . . . . 0.515 ' HB1' HG23 ' F' ' 65' ' ' VAL . . . 44.99 52.6 8.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' F' ' 61' ' ' CYS . . . -127.3 -54.42 1.36 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.44 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 21' ' ' CYS . . . . . 0.884 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.1 OUTLIER 177.68 111.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.962 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 22' ' ' ALA . . . . . 0.479 ' HB1' HG21 ' F' ' 17' ' ' VAL . . . -105.69 126.09 51.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.053 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 23' ' ' VAL . . . . . 0.436 HG11 HG21 ' F' ' 28' ' ' VAL . 5.6 p -56.83 145.68 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.968 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 24' ' ' ASP . . . . . 0.621 ' O ' HG22 ' F' ' 28' ' ' VAL . 4.0 m-20 -74.86 147.24 41.27 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.66 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.77 -43.61 18.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.32 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.92 -20.01 60.25 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.896 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 45.6 t -79.6 -26.08 41.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 28' ' ' VAL . . . . . 0.621 HG22 ' O ' ' F' ' 24' ' ' ASP . 57.4 t -49.16 -48.52 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.279 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.84 93.04 5.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.965 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.54 116.42 28.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.035 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.62 115.63 27.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.155 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' E' ' 12' ' ' PHE . 1.7 t -117.21 101.1 11.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.133 0.492 . . . . 0.0 110.426 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.6 126.91 52.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.671 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 34' ' ' LEU . . . . . 0.738 HD21 ' HB1' ' C' ' 92' ' ' ALA . 0.3 OUTLIER -68.15 -55.65 11.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.659 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.97 -111.67 3.93 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.555 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 36' ' ' GLN . . . . . 0.759 ' HA ' ' HB2' ' E' ' 22' ' ' ALA . 0.0 OUTLIER -77.0 115.28 16.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.52 0.2 . . . . 0.0 110.928 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' E' ' 16' ' ' VAL . 67.6 t -131.03 105.87 11.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.779 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.68 154.12 17.46 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.762 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 39' ' ' THR . . . . . 0.76 ' HA ' HD12 ' F' ' 42' ' ' LEU . 8.0 p -78.8 -19.81 51.25 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.724 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.42 -19.54 65.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.085 0.469 . . . . 0.0 110.913 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 96.6 p -92.08 -21.23 20.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.182 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . 0.76 HD12 ' HA ' ' F' ' 39' ' ' THR . 0.2 OUTLIER -139.0 62.28 1.54 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.686 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 43' ' ' ALA . . . . . 0.689 ' HA ' ' HA ' ' F' ' 142' ' ' ALA . . . -101.15 9.21 42.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.321 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.25 136.0 24.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.36 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . 0.582 ' N ' ' HA2' ' F' ' 141' ' ' GLY . 16.5 tt0 -58.6 121.36 10.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.942 0.401 . . . . 0.0 111.109 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.32 -25.4 8.23 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.139 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.86 137.25 58.22 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.909 0.385 . . . . 0.0 112.018 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 48' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' F' ' 137' ' ' TYR . 5.9 t -133.85 157.98 44.56 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.945 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 49' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' C' ' 92' ' ' ALA . 0.0 OUTLIER -108.92 -166.16 1.09 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.642 179.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 50' ' ' SER . . . . . 0.589 ' HB2' ' HA ' ' C' ' 92' ' ' ALA . 48.9 m -65.2 156.15 32.73 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.818 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 51' ' ' ALA . . . . . 0.513 ' HB1' ' HB3' ' F' ' 134' ' ' GLN . . . -90.47 126.73 36.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.32 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 52' ' ' VAL . . . . . 0.635 ' CG1' ' HA ' ' C' ' 90' ' ' SER . 63.1 t -75.66 118.55 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.981 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.78 135.68 13.8 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.687 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 54' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' F' ' 133' ' ' PHE . 46.3 p90 -170.76 142.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.83 0.348 . . . . 0.0 110.948 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 55' ' ' ASN . . . . . 0.779 ' HB3' ' HG1' ' C' ' 76' ' ' THR . 11.5 p30 -126.59 163.95 22.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 56' ' ' ILE . . . . . 0.627 HG21 HD22 ' F' ' 58' ' ' LEU . 20.8 mm -105.16 119.91 54.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.516 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 57' ' ' GLN . . . . . 0.567 ' HA ' HG21 ' F' ' 130' ' ' THR . 0.0 OUTLIER -82.09 115.69 21.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.736 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . 0.627 HD22 HG21 ' F' ' 56' ' ' ILE . 0.0 OUTLIER -128.25 107.45 9.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.261 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.38 177.0 8.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.902 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 63.06 66.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.782 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 61' ' ' CYS . . . . . 0.884 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 3.3 m -109.68 154.42 22.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.729 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . 0.521 ' HA ' ' OD1' ' F' ' 126' ' ' ASN . 0.5 OUTLIER -154.66 138.33 16.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.234 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 63' ' ' THR . . . . . 0.602 ' HG1' ' HA ' ' F' ' 125' ' ' ASN . 0.2 OUTLIER -97.57 -11.85 23.2 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.13 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.21 -48.78 40.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.095 0.474 . . . . 0.0 111.764 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . 0.515 HG23 ' HB1' ' F' ' 19' ' ' ALA . 10.6 t -69.02 -48.66 68.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.729 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 66' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' F' ' 63' ' ' THR . . . -137.97 153.4 49.45 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.64 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.25 18.59 4.45 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.907 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 68' ' ' LYS . . . . . 0.588 ' HB3' ' HB3' ' F' ' 159' ' ' GLN . 10.6 tppt? -142.87 149.89 39.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.444 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.01 110.71 4.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.714 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 70' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' F' ' 121' ' ' GLU . . . -108.05 169.95 8.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.034 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -130.37 150.95 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.647 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -135.57 100.11 4.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.558 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 73' ' ' PHE . . . . . 0.581 ' HB2' HD22 ' F' ' 111' ' ' LEU . 0.2 OUTLIER -77.46 133.94 38.49 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.552 0.215 . . . . 0.0 111.154 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 74' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.16 115.11 20.58 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.975 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.34 -173.22 26.47 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.77 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 7.1 m -112.68 149.04 33.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.647 0.261 . . . . 0.0 110.726 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 77' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' F' ' 85' ' ' VAL . . . -98.91 133.72 42.79 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.002 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 78' ' ' ILE . . . . . 0.754 ' HB ' ' HA ' ' F' ' 87' ' ' ALA . 16.1 tt -72.89 -37.99 55.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.907 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.17 167.62 12.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.832 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.2 -53.86 15.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.027 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.34 28.73 6.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.6 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 82' ' ' HIS . . . . . 0.809 ' HB3' ' HB ' ' F' ' 85' ' ' VAL . 10.2 m170 -111.35 -45.62 3.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 0.0 110.434 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 83' ' ' THR . . . . . 0.572 ' HB ' HG22 ' F' ' 112' ' ' THR . 0.0 OUTLIER 46.43 -86.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.577 -179.559 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 84' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' F' ' 82' ' ' HIS . 0.0 OUTLIER -42.19 -42.4 3.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.343 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 85' ' ' VAL . . . . . 0.809 ' HB ' ' HB3' ' F' ' 82' ' ' HIS . 21.3 t -61.35 126.54 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.165 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 86' ' ' LEU . . . . . 0.551 ' HG ' ' CD2' ' F' ' 113' ' ' LEU . 0.2 OUTLIER -81.19 164.41 22.34 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.247 179.493 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 87' ' ' ALA . . . . . 0.754 ' HA ' ' HB ' ' F' ' 78' ' ' ILE . . . -104.83 -177.58 3.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.903 0.383 . . . . 0.0 111.644 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' F' ' 88' ' ' LEU . 0.2 OUTLIER -85.02 -174.53 5.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.68 -170.69 3.23 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.356 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 27.9 p -74.74 7.76 2.86 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 111.42 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 91' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' F' ' 95' ' ' SER . 0.8 OUTLIER -96.91 80.37 3.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.86 -41.16 87.8 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.858 0.361 . . . . 0.0 111.606 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.74 26.0 9.12 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.687 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.78 -22.78 0.33 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.902 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 95' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' F' ' 91' ' ' SER . 1.0 OUTLIER -107.65 175.24 5.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.929 0.395 . . . . 0.0 110.646 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.51 177.11 3.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.849 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 97' ' ' THR . . . . . 0.45 HG22 ' H ' ' F' ' 98' ' ' ASN . 0.2 OUTLIER -138.53 167.78 21.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.277 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 98' ' ' ASN . . . . . 0.582 ' HA ' ' HB ' ' F' ' 140' ' ' THR . 32.5 m-80 44.15 51.69 7.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.515 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 99' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' F' ' 143' ' ' ALA . 6.0 p -169.37 124.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.787 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.55 -164.72 11.5 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.616 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 101' ' ' VAL . . . . . 0.416 HG23 ' CE1' ' F' ' 137' ' ' TYR . 3.5 t -124.85 91.12 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.192 0.52 . . . . 0.0 111.758 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 102' ' ' GLN . . . . . 0.679 ' HA ' ' HA ' ' F' ' 85' ' ' VAL . 0.6 OUTLIER -71.37 116.61 11.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.836 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 103' ' ' ILE . . . . . . . . . . . . . 6.6 mt -89.59 120.62 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.5 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 104' ' ' LEU . . . . . 0.49 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 1.0 OUTLIER -95.81 152.3 18.61 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.679 0.276 . . . . 0.0 111.083 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . 0.428 ' O ' HD23 ' F' ' 104' ' ' LEU . 8.5 t0 -100.11 160.07 14.61 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.645 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 106' ' ' ARG . . . . . 0.509 ' CZ ' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -68.79 -13.71 62.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.873 0.368 . . . . 0.0 111.082 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 44.9 p -74.37 -18.96 60.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.075 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.0 -40.08 2.23 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.682 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.32 164.68 13.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 0.0 111.107 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -77.36 139.63 39.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.1 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . 0.641 HD21 ' HB ' ' F' ' 117' ' ' THR . 5.9 tt -84.13 128.55 34.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.469 0.652 . . . . 0.0 110.477 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 112' ' ' THR . . . . . 0.572 HG22 ' HB ' ' F' ' 83' ' ' THR . 1.4 m -68.14 132.41 47.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.133 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 113' ' ' LEU . . . . . 0.551 ' CD2' ' HG ' ' F' ' 86' ' ' LEU . 4.8 mp -88.06 99.69 12.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.684 0.278 . . . . 0.0 110.778 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.04 -32.48 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.628 0.252 . . . . 0.0 111.541 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 146.53 -81.37 0.21 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.575 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -97.1 63.99 1.92 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.986 0.422 . . . . 0.0 111.649 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 117' ' ' THR . . . . . 0.641 ' HB ' HD21 ' F' ' 111' ' ' LEU . 2.8 m -94.29 72.35 3.87 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.169 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.79 119.12 11.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.821 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.95 -49.05 0.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.778 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.55 84.69 6.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.606 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 121' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' F' ' 70' ' ' ALA . 3.6 mt-10 -110.23 87.06 2.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.236 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.04 159.27 17.66 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.802 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -67.01 138.34 57.15 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.654 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.47 159.44 19.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.692 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 125' ' ' ASN . . . . . 0.602 ' HA ' ' HG1' ' F' ' 63' ' ' THR . 0.3 OUTLIER -147.53 176.28 10.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.64 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . 0.521 ' OD1' ' HA ' ' F' ' 62' ' ' ASP . 0.9 OUTLIER -85.91 161.5 19.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.667 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.46 -121.07 5.72 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.718 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 128' ' ' THR . . . . . 0.439 ' HB ' ' HG3' ' C' ' 155' ' ' LYS . 72.0 m -119.42 140.28 50.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.714 0.292 . . . . 0.0 110.821 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 129' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -133.68 154.66 50.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.883 0.373 . . . . 0.0 111.122 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 130' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' F' ' 56' ' ' ILE . 28.0 p -133.4 154.3 50.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.091 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 131' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' F' ' 55' ' ' ASN . 1.0 OUTLIER -111.02 116.8 51.2 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 132' ' ' PRO . . . . . 0.611 ' HB3' ' HA ' ' C' ' 76' ' ' THR . 7.6 Cg_endo -81.14 129.43 6.83 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.665 1.576 . . . . 0.0 112.641 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 133' ' ' PHE . . . . . 0.448 ' HB3' ' CE1' ' F' ' 54' ' ' PHE . 0.1 OUTLIER -140.86 146.86 38.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.807 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 134' ' ' GLN . . . . . 0.513 ' HB3' ' HB1' ' F' ' 51' ' ' ALA . 19.2 mm-40 -116.52 158.34 23.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.008 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -159.37 105.45 1.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.847 0.356 . . . . 0.0 111.533 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.66 172.54 6.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.439 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 137' ' ' TYR . . . . . 0.416 ' CE1' HG23 ' F' ' 101' ' ' VAL . 0.7 OUTLIER -98.18 147.82 24.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.066 179.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 138' ' ' PHE . . . . . 0.442 ' CG ' HG21 ' F' ' 85' ' ' VAL . 0.3 OUTLIER -127.68 159.02 36.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.949 -179.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 139' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' F' ' 42' ' ' LEU . . . -116.3 141.21 48.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.9 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 140' ' ' THR . . . . . 0.582 ' HB ' ' HA ' ' F' ' 98' ' ' ASN . 0.2 OUTLIER -107.79 27.22 9.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.462 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . 0.582 ' HA2' ' N ' ' F' ' 45' ' ' GLU . . . 97.56 83.56 1.7 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.846 -0.693 . . . . 0.0 113.025 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 142' ' ' ALA . . . . . 0.689 ' HA ' ' HA ' ' F' ' 43' ' ' ALA . . . 57.9 93.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.531 0.205 . . . . 0.0 110.813 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 143' ' ' ALA . . . . . 0.613 ' HB3' ' HB ' ' F' ' 99' ' ' VAL . . . -80.01 165.42 22.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.772 0.32 . . . . 0.0 111.37 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 144' ' ' THR . . . . . 0.862 ' O ' HG13 ' E' ' 16' ' ' VAL . 29.8 p -108.42 168.86 7.23 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.196 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 145' ' ' PRO . . . . . 0.449 ' HG2' HG21 ' D' ' 3' ' ' THR . 1.3 Cg_endo -83.58 133.56 6.18 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.56 2.174 . . . . 0.0 112.007 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 146' ' ' GLY . . . . . 0.594 ' HA2' HG13 ' D' ' 5' ' ' VAL . . . 169.53 -119.22 0.81 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.456 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.85 121.7 13.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.866 0.365 . . . . 0.0 111.27 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.35 85.65 3.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.485 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -104.5 131.29 52.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.581 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 150' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' F' ' 87' ' ' ALA . . . -136.14 148.49 48.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.958 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.18 120.21 20.89 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.226 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.65 140.02 24.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.188 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 153' ' ' THR . . . . . 0.596 HG22 ' HA ' ' E' ' 9' ' ' THR . 70.5 p -105.24 171.13 7.48 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 154' ' ' PHE . . . . . 0.618 ' HZ ' HG23 ' F' ' 56' ' ' ILE . 13.7 p90 -138.13 147.42 43.92 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.152 0.501 . . . . 0.0 110.054 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -100.91 171.93 7.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.928 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 156' ' ' VAL . . . . . 0.522 HG22 ' HA2' ' E' ' 7' ' ' GLY . 0.4 OUTLIER -135.48 111.44 12.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.813 0.34 . . . . 0.0 111.717 -179.136 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 157' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' E' ' 3' ' ' THR . 1.8 tt0 -109.01 141.24 41.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.318 0.58 . . . . 0.0 110.431 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . 0.475 ' CZ ' ' HB ' ' F' ' 156' ' ' VAL . 23.0 m-85 -135.38 105.44 6.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.613 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 159' ' ' GLN . . . . . 0.588 ' HB3' ' HB3' ' F' ' 68' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.58 100.21 0.04 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.02 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' B' ' 158' ' ' TYR . 7.3 m -104.81 78.63 1.45 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.493 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.34 122.36 29.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.543 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 m -137.91 162.94 30.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.564 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.415 ' HB3' ' OE2' ' B' ' 15' ' ' GLU . 44.1 t-20 -84.29 114.57 21.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.626 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.48 ' HA3' ' CZ ' ' B' ' 154' ' ' PHE . . . -83.43 -41.48 8.39 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.719 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.446 ' N ' ' CE1' ' B' ' 154' ' ' PHE . . . -175.59 162.29 31.55 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.863 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.0 m -90.75 137.84 32.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.929 0.395 . . . . 0.0 111.282 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.46 114.34 46.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.163 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.458 ' HB2' HG21 ' B' ' 31' ' ' THR . 4.6 m80 -99.37 148.58 24.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.33 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.792 ' HB3' HD22 ' B' ' 34' ' ' LEU . 60.8 m-85 -133.8 113.09 11.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.731 ' HG2' ' HA ' ' B' ' 33' ' ' GLN . 0.0 OUTLIER -107.19 105.94 16.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.332 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.25 169.46 28.91 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.999 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.529 ' HB2' ' HG3' ' B' ' 36' ' ' GLN . 33.6 mt-10 -140.73 -171.02 3.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.839 0.352 . . . . 0.0 110.4 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.534 ' HB ' ' O ' ' B' ' 144' ' ' THR . 0.5 OUTLIER -139.24 152.86 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.209 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -137.51 155.37 31.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.87 0.367 . . . . 0.0 111.061 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -85.23 53.1 2.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.041 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.667 ' HA ' ' HG2' ' B' ' 38' ' ' ARG . . . 61.46 92.67 0.05 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.066 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.591 ' H ' ' HG2' ' B' ' 38' ' ' ARG . . . -164.77 -47.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.476 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.914 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 1.6 m -159.8 176.83 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.009 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' B' ' 36' ' ' GLN . . . -147.27 111.93 5.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.137 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.0 t -67.37 143.19 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.989 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.55 ' O ' HG23 ' A' ' 28' ' ' VAL . 17.0 m-20 -91.18 168.05 11.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.63 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.31 -50.0 74.31 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.468 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.42 -16.62 73.76 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.923 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.32 -24.36 29.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.907 0.384 . . . . 0.0 110.77 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 24' ' ' ASP . 85.6 t -58.09 -37.24 60.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.33 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -140.38 106.02 5.12 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.03 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.542 ' NE2' HD12 ' A' ' 56' ' ' ILE . 5.4 mt-30 -109.07 106.97 17.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.125 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.8 95.63 9.03 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.019 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 51.6 t -85.84 138.25 19.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.055 0.455 . . . . 0.0 110.358 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -113.15 132.6 55.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.701 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.431 ' HA ' HD11 ' A' ' 34' ' ' LEU . 1.9 mm? -94.54 -71.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.594 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.87 -111.32 0.72 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.518 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -160.96 105.77 1.37 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.61 0.243 . . . . 0.0 110.879 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 m -91.1 142.35 13.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.978 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -81.05 162.53 23.73 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.771 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.5 p -80.35 -16.92 53.43 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.761 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.73 -31.26 63.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.073 0.463 . . . . 0.0 110.828 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.01 -28.48 39.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.145 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.614 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 1.7 mp -133.14 70.05 1.47 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.67 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.67 11.21 36.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.448 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.04 146.83 27.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.341 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.48 121.25 13.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.369 . . . . 0.0 111.091 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.52 -10.39 12.77 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.179 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 138' ' ' PHE . . . -68.83 142.22 54.92 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -134.69 140.86 46.31 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.904 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.0 m -106.04 -152.77 0.48 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.569 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.9 178.57 1.05 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.908 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.05 168.9 15.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.733 0.301 . . . . 0.0 111.308 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.533 HG22 ' HB3' ' A' ' 135' ' ' ALA . 14.9 m -118.1 132.22 68.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.21 107.67 3.57 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.633 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -140.34 132.03 27.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.764 0.316 . . . . 0.0 110.914 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 131' ' ' ILE . 1.6 p-10 -117.8 176.89 4.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.628 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.542 HD12 ' NE2' ' A' ' 30' ' ' GLN . 51.7 mm -119.05 121.74 67.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.478 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.37 122.59 30.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.829 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.606 HD11 HD13 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -131.08 93.72 3.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.228 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.1 160.85 28.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.899 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.2 87.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.756 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.914 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 69.8 m -120.52 131.87 54.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.75 97.87 9.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.255 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 1.5 m -77.41 -20.0 55.26 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.04 -27.53 68.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.023 0.439 . . . . 0.0 111.719 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.42 -35.71 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.626 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 63' ' ' THR . . . -131.03 131.29 44.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.642 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.45 -37.32 7.65 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.909 0.385 . . . . 0.0 110.932 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -121.72 171.37 8.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.553 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.55 136.15 15.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.587 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 157' ' ' GLN . . . -94.57 157.97 15.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.028 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.38 106.24 20.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.713 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.554 ' HB1' ' HB3' ' A' ' 155' ' ' LYS . . . -109.58 164.26 12.69 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.619 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.442 ' CE2' HG12 ' A' ' 103' ' ' ILE . 6.6 t80 -142.2 141.1 32.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.497 0.189 . . . . 0.0 111.129 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.627 ' CG ' ' HG1' ' D' ' 130' ' ' THR . 0.1 OUTLIER -122.7 103.35 8.61 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.008 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.554 ' HA3' HD22 ' A' ' 113' ' ' LEU . . . -153.44 -166.37 14.55 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.895 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.48 136.26 46.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.535 0.207 . . . . 0.0 110.726 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.605 ' H ' ' HB3' ' D' ' 132' ' ' PRO . . . -81.4 156.08 25.6 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.845 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.576 HG21 ' HB ' ' A' ' 85' ' ' VAL . 3.1 tt -92.51 -20.69 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.773 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.15 179.76 0.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.829 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.0 -33.81 44.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.974 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.42 -43.91 95.55 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.618 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.465 ' NE2' ' O ' ' A' ' 139' ' ' ALA . 43.7 m-70 -97.8 -64.41 1.04 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.827 0.346 . . . . 0.0 110.47 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 m 62.36 7.83 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.623 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.612 ' HB3' ' HB2' ' A' ' 110' ' ' ALA . 6.5 m120 -115.11 -25.47 8.09 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.238 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . 0.5 OUTLIER -79.56 143.74 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.189 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.652 HD11 ' HB1' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -76.68 148.6 36.73 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.251 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.9 178.22 4.4 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.85 0.357 . . . . 0.0 111.651 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.591 HD11 ' HB3' ' D' ' 51' ' ' ALA . 0.0 OUTLIER -84.66 176.23 8.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.116 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.522 ' HB3' ' HB2' ' A' ' 149' ' ' ASN . 22.8 pt20 -75.33 178.72 5.64 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.32 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.567 ' O ' HG11 ' D' ' 52' ' ' VAL . 1.0 OUTLIER -73.36 -11.46 60.49 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.989 0.423 . . . . 0.0 111.411 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 0.3 OUTLIER -64.68 87.26 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.931 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.89 -7.14 53.83 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.879 0.371 . . . . 0.0 111.667 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.11 19.91 4.07 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.644 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.62 -15.6 0.16 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.897 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.472 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 1.0 OUTLIER -97.35 174.98 6.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.906 0.384 . . . . 0.0 110.619 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.464 ' O ' HD21 ' A' ' 88' ' ' LEU . . . -114.12 157.87 22.03 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.823 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.96 162.73 15.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.319 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 69.26 41.66 1.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.415 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.801 ' HB ' ' HB3' ' A' ' 143' ' ' ALA . 10.3 p -177.67 130.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.827 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.06 179.45 28.6 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.623 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 1.6 t -98.98 95.34 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.026 0.531 . . . . 0.0 111.71 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.773 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 1.9 tt0 -69.87 159.83 32.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.881 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.609 HD13 HD23 ' A' ' 113' ' ' LEU . 0.9 OUTLIER -121.72 98.38 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.513 179.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 1.1 tp -84.65 119.36 25.15 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.716 0.293 . . . . 0.0 111.122 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.24 158.12 31.92 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.642 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.532 ' HB2' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -61.2 -33.93 74.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.87 0.366 . . . . 0.0 111.043 179.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.546 HG21 ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -48.75 -38.17 20.96 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.013 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.69 -88.87 0.11 Allowed Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.591 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.421 ' HA ' HD12 ' A' ' 104' ' ' LEU . . . -79.19 -176.33 5.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.868 0.366 . . . . 0.0 111.104 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.672 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -79.9 143.93 33.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.126 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.14 157.54 17.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.387 0.613 . . . . 0.0 110.522 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.4 m -81.04 150.46 28.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.201 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.609 HD23 HD13 ' A' ' 103' ' ' ILE . 3.0 mp -102.75 57.7 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.757 0.313 . . . . 0.0 110.72 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.43 19.65 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.532 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.26 -93.1 0.88 Allowed Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.631 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' D' ' 125' ' ' ASN . . . -102.71 69.67 1.08 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.028 0.442 . . . . 0.0 111.596 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 5.8 p -89.69 97.3 11.11 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.19 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.15 102.81 5.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.752 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.416 ' HB2' ' H ' ' A' ' 120' ' ' SER . 0.8 OUTLIER -119.4 -82.69 0.65 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.546 ' HA ' HG21 ' A' ' 107' ' ' THR . 0.1 OUTLIER -63.26 100.87 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.611 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.9 79.11 7.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.228 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.576 HG21 ' HG2' ' A' ' 132' ' ' PRO . 4.7 p -82.55 159.18 22.85 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.769 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.432 HG23 ' N ' ' A' ' 124' ' ' LEU . 16.2 m -85.28 139.74 31.38 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.764 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.432 ' N ' HG23 ' A' ' 123' ' ' THR . 0.4 OUTLIER -92.46 136.18 33.43 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.69 0.281 . . . . 0.0 110.591 179.42 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -120.86 143.57 48.83 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.604 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.13 148.93 34.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.688 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.66 -106.17 2.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.704 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -85.15 153.24 22.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.731 0.3 . . . . 0.0 110.804 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.562 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 23.2 t-20 -148.45 120.7 8.37 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.942 0.401 . . . . 0.0 111.109 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.21 147.26 27.67 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.139 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.606 HD13 HD11 ' A' ' 58' ' ' LEU . 89.8 mt -116.61 119.25 36.08 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.576 ' HG2' HG21 ' A' ' 122' ' ' THR . 7.7 Cg_endo -80.83 119.06 3.54 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 121.704 1.602 . . . . 0.0 112.574 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.04 147.35 29.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.783 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.15 155.94 47.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.043 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.533 ' HB3' HG22 ' A' ' 52' ' ' VAL . . . -140.07 115.66 10.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.882 0.372 . . . . 0.0 111.639 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.27 148.98 31.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.477 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.6 151.29 45.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.158 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -144.52 164.56 30.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.002 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -124.43 145.76 49.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.783 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.481 ' OG1' HG12 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -117.84 13.0 14.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.48 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.79 79.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.919 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.64 92.15 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.598 0.199 . . . . 0.0 110.788 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.801 ' HB3' ' HB ' ' A' ' 99' ' ' VAL . . . -64.08 154.78 33.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.704 0.288 . . . . 0.0 111.38 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.9 p -116.68 166.17 13.42 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.29 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.27 151.49 12.16 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.474 2.116 . . . . 0.0 112.018 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.6 -106.33 0.46 Allowed Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.417 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.06 163.26 32.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.834 0.349 . . . . 0.0 111.411 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.98 79.93 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.504 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 89' ' ' GLN . 87.1 m-20 -99.98 142.51 31.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.51 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . . . -127.81 168.98 14.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.073 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.53 110.04 0.86 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.2 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.652 ' HB1' HD11 ' A' ' 86' ' ' LEU . . . -146.99 145.4 29.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.118 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.67 164.17 13.26 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.486 ' HE2' HG11 ' A' ' 156' ' ' VAL . 15.4 p90 -110.83 151.6 27.63 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.061 0.458 . . . . 0.0 110.162 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.554 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -109.7 160.84 15.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.961 -178.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.486 HG11 ' HE2' ' A' ' 154' ' ' PHE . 1.5 m -142.14 112.91 3.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.756 0.312 . . . . 0.0 111.699 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.626 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -91.87 124.41 35.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.295 0.569 . . . . 0.0 110.447 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.577 ' HH ' HD21 ' A' ' 58' ' ' LEU . 57.4 m-85 -117.13 135.48 53.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.515 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.889 179.894 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.55 100.24 0.04 OUTLIER 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.0 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' C' ' 158' ' ' TYR . 7.4 m -104.81 78.6 1.44 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.416 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.33 122.39 29.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.533 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 m -137.93 162.86 30.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.539 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.425 ' HB3' ' OE2' ' C' ' 15' ' ' GLU . 44.0 t-20 -84.28 114.48 21.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.692 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . 0.495 ' HA3' ' CZ ' ' C' ' 154' ' ' PHE . . . -83.3 -41.54 8.43 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.703 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.444 ' N ' ' CE1' ' C' ' 154' ' ' PHE . . . -175.56 162.32 31.61 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.824 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 99.2 m -90.81 137.91 31.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.925 0.393 . . . . 0.0 111.264 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.402 HG11 ' CZ ' ' B' ' 12' ' ' PHE . 2.7 t -110.49 114.27 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.241 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' HIS . . . . . 0.457 ' HB2' HG21 ' C' ' 31' ' ' THR . 4.5 m80 -99.31 148.54 24.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.364 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . 0.79 ' HB3' HD22 ' C' ' 34' ' ' LEU . 60.6 m-85 -133.8 113.1 11.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.714 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.731 ' HG2' ' HA ' ' C' ' 33' ' ' GLN . 0.0 OUTLIER -107.19 105.86 16.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.392 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.18 169.45 28.87 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.99 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.524 ' HB2' ' HG3' ' C' ' 36' ' ' GLN . 33.8 mt-10 -140.73 -171.08 3.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.85 0.357 . . . . 0.0 110.425 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' C' ' 144' ' ' THR . 0.5 OUTLIER -139.21 152.81 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.222 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.518 HG23 ' HG3' ' C' ' 38' ' ' ARG . 0.0 OUTLIER -137.42 155.43 31.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.834 0.35 . . . . 0.0 111.031 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -85.25 53.12 2.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.956 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.651 ' HA ' ' HG2' ' C' ' 38' ' ' ARG . . . 61.37 92.7 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.111 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.578 ' H ' ' HG2' ' C' ' 38' ' ' ARG . . . -164.74 -47.65 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.447 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.912 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 1.6 m -159.83 176.82 11.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.009 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' C' ' 36' ' ' GLN . . . -147.24 111.89 5.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.15 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 7' ' ' GLY . 43.1 t -67.3 143.08 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.052 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.539 ' O ' HG23 ' B' ' 28' ' ' VAL . 16.9 m-20 -91.11 168.16 11.83 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.622 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.02 74.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.39 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.4 -16.62 73.72 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.92 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.35 -24.38 29.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.921 0.391 . . . . 0.0 110.782 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.539 HG23 ' O ' ' B' ' 24' ' ' ASP . 86.1 t -58.14 -37.13 60.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.339 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -140.35 106.08 5.14 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.997 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' GLN . . . . . 0.531 ' NE2' HD12 ' B' ' 56' ' ' ILE . 5.4 mt-30 -109.03 106.92 17.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.12 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' THR . . . . . 0.458 HG21 ' HB2' ' A' ' 11' ' ' HIS . 0.2 OUTLIER -84.74 95.55 8.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.069 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 51.2 t -85.76 138.21 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 110.451 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.731 ' HA ' ' HG2' ' A' ' 13' ' ' LYS . 3.2 mt-30 -113.18 132.54 55.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.64 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.792 HD22 ' HB3' ' A' ' 12' ' ' PHE . 1.8 mm? -94.45 -71.54 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.625 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.88 -111.3 0.71 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.524 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.529 ' HG3' ' HB2' ' A' ' 15' ' ' GLU . 3.6 tt0 -161.0 105.74 1.36 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.653 0.263 . . . . 0.0 110.919 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 16' ' ' VAL . 5.7 m -91.06 142.35 13.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.966 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.667 ' HG2' ' HA ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -81.07 162.49 23.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.707 179.248 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 82.5 p -80.35 -16.85 53.58 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.784 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.77 -31.17 63.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.175 0.512 . . . . 0.0 110.899 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.04 -28.49 39.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.12 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.629 ' HB3' ' HB2' ' B' ' 139' ' ' ALA . 1.7 mp -133.23 70.09 1.47 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.673 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.65 11.17 36.39 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.432 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.06 146.82 27.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.371 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.49 121.25 13.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 0.0 111.099 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.55 -10.4 12.72 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.15 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' B' ' 138' ' ' PHE . . . -68.85 142.27 54.87 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.851 0.357 . . . . 0.0 111.951 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 6.8 t -134.77 140.82 46.2 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.846 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -106.06 -152.77 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.52 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.86 178.54 1.05 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.03 168.92 15.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.349 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.539 HG22 ' HB3' ' B' ' 135' ' ' ALA . 14.5 m -118.0 132.26 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.977 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.27 107.61 3.56 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.623 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -140.34 132.06 27.35 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.812 0.339 . . . . 0.0 110.871 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' B' ' 131' ' ' ILE . 1.6 p-10 -117.78 176.81 5.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.636 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.531 HD12 ' NE2' ' B' ' 30' ' ' GLN . 51.8 mm -119.05 121.73 67.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.556 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.35 122.78 30.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.753 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.607 HD11 HD13 ' B' ' 131' ' ' ILE . 0.9 OUTLIER -131.27 93.71 3.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.246 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.03 160.89 28.75 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.17 87.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.745 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' CYS . . . . . 0.912 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 69.9 m -120.44 131.88 54.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.71 97.9 9.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.269 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' B' ' 66' ' ' ALA . 1.5 m -77.47 -19.96 55.14 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.06 -27.48 68.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 111.768 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.39 -35.76 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.643 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' B' ' 63' ' ' THR . . . -131.05 131.28 44.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.64 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.46 -37.31 7.65 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.892 0.377 . . . . 0.0 110.948 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -121.69 171.39 8.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.56 136.1 15.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.552 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' B' ' 157' ' ' GLN . . . -94.5 158.04 15.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.062 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.41 106.28 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.679 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.545 ' HB1' ' HB3' ' B' ' 155' ' ' LYS . . . -109.6 164.29 12.67 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.65 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.441 ' CE2' HG12 ' B' ' 103' ' ' ILE . 6.5 t80 -142.27 141.03 32.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.502 0.191 . . . . 0.0 111.174 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.627 ' CG ' ' HG1' ' E' ' 130' ' ' THR . 0.1 OUTLIER -122.71 103.38 8.62 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.993 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.572 ' HA3' HD22 ' B' ' 113' ' ' LEU . . . -153.45 -166.37 14.56 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.875 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.54 136.3 46.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.585 0.231 . . . . 0.0 110.709 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . 0.602 ' H ' ' HB3' ' E' ' 132' ' ' PRO . . . -81.52 156.13 25.42 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.879 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.574 HG21 ' HB ' ' B' ' 85' ' ' VAL . 3.1 tt -92.51 -20.71 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.811 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.18 179.76 0.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.818 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.91 -33.89 45.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.007 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.44 -43.84 95.64 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.6 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.452 ' NE2' ' O ' ' B' ' 139' ' ' ALA . 43.5 m-70 -97.86 -64.38 1.04 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.829 0.347 . . . . 0.0 110.435 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' THR . . . . . . . . . . . . . 1.2 m 62.33 7.83 2.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.647 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . 0.602 ' HB3' ' HB2' ' B' ' 110' ' ' ALA . 6.5 m120 -115.15 -25.41 8.09 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.203 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' B' ' 102' ' ' GLN . 0.5 OUTLIER -79.62 143.75 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.152 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . 0.65 HD11 ' HB1' ' B' ' 152' ' ' ALA . 0.3 OUTLIER -76.69 148.52 36.77 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.306 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.8 178.15 4.39 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.876 0.369 . . . . 0.0 111.734 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.588 HD11 ' HB3' ' E' ' 51' ' ' ALA . 0.0 OUTLIER -84.6 176.13 8.8 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.071 179.386 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . 0.519 ' HB3' ' HB2' ' B' ' 149' ' ' ASN . 22.8 pt20 -75.19 178.62 5.62 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.355 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' SER . . . . . 0.567 ' O ' HG11 ' E' ' 52' ' ' VAL . 1.0 OUTLIER -73.34 -11.44 60.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.023 0.44 . . . . 0.0 111.409 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' B' ' 95' ' ' SER . 0.3 OUTLIER -64.72 87.27 0.06 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.909 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.86 -7.2 53.93 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.633 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.09 19.87 4.07 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.641 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.66 -15.53 0.16 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.932 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' B' ' 91' ' ' SER . 1.0 OUTLIER -97.32 174.96 6.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.898 0.38 . . . . 0.0 110.583 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . 0.468 ' O ' HD21 ' B' ' 88' ' ' LEU . . . -114.13 157.88 22.02 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.83 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.03 162.7 15.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.308 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 69.42 41.5 1.3 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.46 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.793 ' HB ' ' HB3' ' B' ' 143' ' ' ALA . 10.4 p -177.62 130.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.825 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.04 179.52 28.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.598 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' B' ' 86' ' ' LEU . 1.6 t -99.15 95.33 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.009 0.524 . . . . 0.0 111.672 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.772 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 1.9 tt0 -69.85 159.82 32.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.954 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.603 HD13 HD23 ' B' ' 113' ' ' LEU . 0.9 OUTLIER -121.69 98.41 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.56 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . 0.677 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 1.1 tp -84.8 119.38 25.23 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.792 0.33 . . . . 0.0 111.113 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.18 158.04 32.09 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.643 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . 0.533 ' HB2' ' HB2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -61.05 -33.93 74.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.913 0.387 . . . . 0.0 111.117 179.42 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' THR . . . . . 0.551 HG21 ' HA ' ' B' ' 120' ' ' SER . 0.0 OUTLIER -48.76 -38.25 21.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.972 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.73 -88.78 0.11 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.59 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' B' ' 104' ' ' LEU . . . -79.2 -176.35 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.892 0.377 . . . . 0.0 111.066 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.677 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -79.98 143.94 33.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.09 157.56 17.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.363 0.601 . . . . 0.0 110.561 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 29.7 m -81.12 150.43 28.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.111 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.603 HD23 HD13 ' B' ' 103' ' ' ILE . 3.0 mp -102.7 57.66 0.78 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.691 0.281 . . . . 0.0 110.738 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.49 19.67 15.23 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.477 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.24 -93.05 0.88 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.634 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' E' ' 125' ' ' ASN . . . -102.71 69.66 1.08 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.03 0.443 . . . . 0.0 111.592 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' B' ' 72' ' ' ALA . 5.9 p -89.62 97.22 11.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.142 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.17 102.82 5.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.764 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.44 -82.74 0.65 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' SER . . . . . 0.551 ' HA ' HG21 ' B' ' 107' ' ' THR . 0.1 OUTLIER -63.22 100.93 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.614 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -88.87 79.02 7.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.143 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.589 HG21 ' HG2' ' B' ' 132' ' ' PRO . 4.6 p -82.52 159.17 22.9 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.737 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.459 HG23 ' N ' ' B' ' 124' ' ' LEU . 16.0 m -85.33 139.71 31.37 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.746 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.459 ' N ' HG23 ' B' ' 123' ' ' THR . 0.4 OUTLIER -92.36 136.15 33.44 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.609 179.39 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -120.8 143.56 48.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.644 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.2 148.95 34.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 110.63 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.67 -106.11 2.29 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.746 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -85.16 153.16 22.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.812 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . 0.574 ' HB3' ' HB2' ' B' ' 58' ' ' LEU . 23.1 t-20 -148.4 120.76 8.43 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.93 0.395 . . . . 0.0 111.112 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.24 147.26 27.68 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.151 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' ILE . . . . . 0.607 HD13 HD11 ' B' ' 58' ' ' LEU . 89.9 mt -116.58 119.19 36.23 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' PRO . . . . . 0.589 ' HG2' HG21 ' B' ' 122' ' ' THR . 7.6 Cg_endo -80.79 119.14 3.57 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.632 1.555 . . . . 0.0 112.535 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.05 147.3 29.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.775 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.13 155.88 47.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.04 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.539 ' HB3' HG22 ' B' ' 52' ' ' VAL . . . -140.06 115.67 10.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.648 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.26 148.93 31.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.535 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.48 151.27 45.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.119 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' B' ' 47' ' ' ALA . 0.2 OUTLIER -144.52 164.58 30.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.033 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.629 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -124.45 145.68 49.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.809 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' THR . . . . . 0.481 ' OG1' HG12 ' B' ' 78' ' ' ILE . 0.2 OUTLIER -117.77 13.01 14.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.545 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.83 79.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.97 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.73 92.14 0.02 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.619 0.21 . . . . 0.0 110.769 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' ALA . . . . . 0.793 ' HB3' ' HB ' ' B' ' 99' ' ' VAL . . . -64.08 154.8 33.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.698 0.285 . . . . 0.0 111.393 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.534 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 39.3 p -116.76 166.22 13.34 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.223 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.414 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 1.4 Cg_endo -84.27 151.5 12.16 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.467 2.112 . . . . 0.0 111.976 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.62 -106.29 0.46 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.401 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.06 163.32 32.72 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.839 0.352 . . . . 0.0 111.386 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -166.01 79.93 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.546 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' B' ' 89' ' ' GLN . 87.2 m-20 -99.92 142.47 31.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.557 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . 0.581 ' HB3' ' HB3' ' B' ' 86' ' ' LEU . . . -127.76 169.02 14.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.01 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . 0.407 ' OD2' ' HD2' ' A' ' 11' ' ' HIS . 4.2 t70 -165.6 109.94 0.85 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.261 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . 0.65 ' HB1' HD11 ' B' ' 86' ' ' LEU . . . -147.02 145.45 29.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.14 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.66 164.22 13.24 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . 0.494 ' HE2' HG11 ' B' ' 156' ' ' VAL . 15.4 p90 -110.89 151.66 27.63 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.141 0.496 . . . . 0.0 110.137 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.545 ' HB3' ' HB1' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -109.75 160.88 15.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.932 -178.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' VAL . . . . . 0.494 HG11 ' HE2' ' B' ' 154' ' ' PHE . 1.4 m -142.1 112.92 3.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.786 0.326 . . . . 0.0 111.706 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.621 ' HB3' ' HB2' ' B' ' 70' ' ' ALA . 0.3 OUTLIER -91.87 124.44 35.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.352 0.596 . . . . 0.0 110.426 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . 0.577 ' HH ' HD21 ' B' ' 58' ' ' LEU . 57.3 m-85 -117.19 135.54 53.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.525 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.866 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.55 100.26 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.984 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' D' ' 158' ' ' TYR . 7.4 m -104.82 78.63 1.45 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.406 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.31 122.39 29.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.599 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 m -137.94 162.94 30.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.472 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . 0.421 ' HB3' ' OE2' ' D' ' 15' ' ' GLU . 44.0 t-20 -84.37 114.55 21.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.615 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' D' ' 154' ' ' PHE . . . -83.47 -41.39 8.42 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.679 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . 0.443 ' N ' ' CE1' ' D' ' 154' ' ' PHE . . . -175.61 162.26 31.49 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.908 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' D' ' 153' ' ' THR . 99.2 m -90.79 137.92 31.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.981 0.42 . . . . 0.0 111.231 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.46 114.23 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.233 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' HIS . . . . . 0.438 ' HB2' HG21 ' D' ' 31' ' ' THR . 4.5 m80 -99.29 148.56 24.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.347 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' PHE . . . . . 0.812 ' HB3' HD22 ' D' ' 34' ' ' LEU . 60.8 m-85 -133.83 113.07 11.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.723 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . 0.707 ' HG2' ' HA ' ' D' ' 33' ' ' GLN . 0.0 OUTLIER -107.14 105.86 16.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.395 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.18 169.44 28.87 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.992 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' GLU . . . . . 0.53 ' HB2' ' HG3' ' D' ' 36' ' ' GLN . 33.8 mt-10 -140.73 -171.07 3.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.913 0.387 . . . . 0.0 110.391 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.532 ' HB ' ' O ' ' D' ' 144' ' ' THR . 0.5 OUTLIER -139.24 152.77 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.251 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.518 HG23 ' HG3' ' D' ' 38' ' ' ARG . 0.0 OUTLIER -137.42 155.35 31.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.888 0.375 . . . . 0.0 111.047 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -85.13 53.11 2.63 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . 0.655 ' HA ' ' HG2' ' D' ' 38' ' ' ARG . . . 61.33 92.74 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.098 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . 0.594 ' H ' ' HG2' ' D' ' 38' ' ' ARG . . . -164.8 -47.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.438 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 1.6 m -159.81 176.83 11.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.951 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' D' ' 36' ' ' GLN . . . -147.28 111.99 5.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.115 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . 0.462 HG11 ' O ' ' B' ' 7' ' ' GLY . 43.0 t -67.44 143.22 15.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.015 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.548 ' O ' HG23 ' C' ' 28' ' ' VAL . 17.0 m-20 -91.2 168.1 11.86 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.629 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.36 -50.0 74.35 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.42 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.38 -16.64 73.69 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.907 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' SER . . . . . 0.408 ' HA ' HE21 ' C' ' 30' ' ' GLN . 0.4 OUTLIER -84.31 -24.44 29.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.876 0.37 . . . . 0.0 110.742 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.548 HG23 ' O ' ' C' ' 24' ' ' ASP . 85.1 t -58.04 -37.23 60.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.359 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -140.37 105.91 5.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.043 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' GLN . . . . . 0.532 ' NE2' HD12 ' C' ' 56' ' ' ILE . 5.4 mt-30 -108.95 106.95 17.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.155 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' THR . . . . . 0.457 HG21 ' HB2' ' B' ' 11' ' ' HIS . 0.2 OUTLIER -84.79 95.6 9.02 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.047 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 51.7 t -85.82 138.24 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.099 0.476 . . . . 0.0 110.37 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.731 ' HA ' ' HG2' ' B' ' 13' ' ' LYS . 3.2 mt-30 -113.2 132.6 55.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.651 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.79 HD22 ' HB3' ' B' ' 12' ' ' PHE . 1.8 mm? -94.53 -71.43 0.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.627 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.83 -111.31 0.72 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.544 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . 0.524 ' HG3' ' HB2' ' B' ' 15' ' ' GLU . 3.6 tt0 -161.06 105.84 1.35 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.721 0.296 . . . . 0.0 110.874 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . 0.462 ' O ' HG13 ' B' ' 16' ' ' VAL . 5.6 m -91.15 142.37 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.937 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' ARG . . . . . 0.651 ' HG2' ' HA ' ' B' ' 19' ' ' ALA . 0.7 OUTLIER -81.18 162.55 23.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.694 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 82.6 p -80.39 -16.79 53.66 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.765 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.81 -31.16 63.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.157 0.503 . . . . 0.0 110.839 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -28.5 39.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.11 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.613 ' HB3' ' HB2' ' C' ' 139' ' ' ALA . 1.7 mp -133.21 70.13 1.47 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.601 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.67 11.18 36.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.5 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.01 146.83 27.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.466 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.5 121.28 13.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.871 0.367 . . . . 0.0 111.152 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.52 -10.47 12.75 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.114 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' C' ' 138' ' ' PHE . . . -68.78 142.21 54.98 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.874 0.369 . . . . 0.0 111.976 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 6.8 t -134.75 140.81 46.21 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.852 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 17.0 m -105.96 -152.79 0.48 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.56 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 1.4 t -65.94 178.6 1.06 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.859 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.11 168.82 15.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.805 0.336 . . . . 0.0 111.28 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' C' ' 135' ' ' ALA . 14.7 m -117.98 132.24 68.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.21 107.62 3.57 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.683 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -140.31 132.09 27.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.741 0.305 . . . . 0.0 110.932 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' C' ' 131' ' ' ILE . 1.5 p-10 -117.83 176.83 5.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.565 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.532 HD12 ' NE2' ' C' ' 30' ' ' GLN . 51.7 mm -119.02 121.68 67.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.533 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.29 122.71 30.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.826 0.346 . . . . 0.0 110.831 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . 0.604 HD11 HD13 ' C' ' 131' ' ' ILE . 0.9 OUTLIER -131.23 93.75 3.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.08 160.82 28.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.871 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.26 87.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.74 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' CYS . . . . . 0.903 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 70.2 m -120.52 131.8 54.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.813 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.61 97.91 9.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.343 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' C' ' 66' ' ' ALA . 1.5 m -77.44 -19.96 55.23 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.04 -27.56 68.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.978 0.418 . . . . 0.0 111.711 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 16.9 t -95.36 -35.76 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.613 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' C' ' 63' ' ' THR . . . -130.9 131.29 44.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.706 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.45 -37.27 7.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.912 0.387 . . . . 0.0 110.983 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -121.74 171.36 8.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.503 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.58 136.15 15.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.593 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.623 ' HB2' ' HB3' ' C' ' 157' ' ' GLN . . . -94.52 157.99 15.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.086 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.44 106.28 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.693 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' C' ' 155' ' ' LYS . . . -109.6 164.31 12.65 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.597 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' PHE . . . . . 0.437 ' CE2' HG12 ' C' ' 103' ' ' ILE . 6.6 t80 -142.26 141.03 32.42 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.147 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.615 ' CD1' ' HG1' ' F' ' 130' ' ' THR . 0.1 OUTLIER -122.66 103.37 8.63 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.981 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . 0.559 ' HA3' HD22 ' C' ' 113' ' ' LEU . . . -153.47 -166.38 14.58 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.909 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.5 136.27 46.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.574 0.226 . . . . 0.0 110.746 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . 0.611 ' H ' ' HB3' ' F' ' 132' ' ' PRO . . . -81.39 156.08 25.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.878 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . 0.585 HG21 ' HB ' ' C' ' 85' ' ' VAL . 3.1 tt -92.56 -20.65 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.796 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.15 179.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.821 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.02 -33.76 44.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.988 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.39 -44.0 95.45 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.564 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . 0.465 ' NE2' ' O ' ' C' ' 139' ' ' ALA . 43.3 m-70 -97.74 -64.42 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.787 0.327 . . . . 0.0 110.47 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 1.2 m 62.32 7.81 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.597 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' ASN . . . . . 0.619 ' HB3' ' HB2' ' C' ' 110' ' ' ALA . 6.6 m120 -115.02 -25.51 8.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.308 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.786 ' HA ' ' HA ' ' C' ' 102' ' ' GLN . 0.5 OUTLIER -79.53 143.63 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.214 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.656 HD11 ' HB1' ' C' ' 152' ' ' ALA . 0.3 OUTLIER -76.59 148.57 36.9 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.294 179.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.87 178.25 4.37 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.721 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.586 HD11 ' HB3' ' F' ' 51' ' ' ALA . 0.0 OUTLIER -84.71 176.19 8.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.124 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' GLN . . . . . 0.523 ' HB3' ' HB2' ' C' ' 149' ' ' ASN . 22.9 pt20 -75.18 178.69 5.56 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.352 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' SER . . . . . 0.561 ' O ' HG11 ' F' ' 52' ' ' VAL . 1.0 OUTLIER -73.36 -11.45 60.49 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.002 0.429 . . . . 0.0 111.461 179.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' SER . . . . . 0.478 ' HB3' ' HB3' ' C' ' 95' ' ' SER . 0.3 OUTLIER -64.72 87.27 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.92 -7.09 53.75 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.688 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.15 19.92 4.06 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.614 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.64 -15.6 0.16 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.96 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' SER . . . . . 0.478 ' HB3' ' HB3' ' C' ' 91' ' ' SER . 1.0 OUTLIER -97.35 174.93 6.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 110.594 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . 0.472 ' O ' HD21 ' C' ' 88' ' ' LEU . . . -114.06 157.85 22.0 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.9 162.78 15.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.325 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 69.33 41.52 1.32 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.366 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' VAL . . . . . 0.808 ' HB ' ' HB3' ' C' ' 143' ' ' ALA . 10.3 p -177.58 130.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.06 179.45 28.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.604 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' C' ' 86' ' ' LEU . 1.6 t -99.07 95.27 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.072 0.549 . . . . 0.0 111.703 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' GLN . . . . . 0.786 ' HA ' ' HA ' ' C' ' 85' ' ' VAL . 1.9 tt0 -69.88 159.8 33.0 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.9 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . 0.603 HD13 HD23 ' C' ' 113' ' ' LEU . 0.9 OUTLIER -121.66 98.36 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.574 179.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' LEU . . . . . 0.673 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 1.1 tp -84.64 119.36 25.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.695 0.283 . . . . 0.0 111.148 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.13 158.08 32.12 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.677 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . 0.534 ' HB2' ' HB2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -61.13 -33.93 74.18 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.914 0.388 . . . . 0.0 111.085 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' THR . . . . . 0.562 HG21 ' HA ' ' C' ' 120' ' ' SER . 0.0 OUTLIER -48.8 -38.22 21.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.972 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.75 -88.82 0.11 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.544 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' ALA . . . . . 0.411 ' HA ' HD12 ' C' ' 104' ' ' LEU . . . -79.17 -176.32 5.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.82 0.343 . . . . 0.0 111.143 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.673 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -79.98 143.89 33.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.136 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.07 157.51 17.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.389 0.614 . . . . 0.0 110.557 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' THR . . . . . . . . . . . . . 29.9 m -81.13 150.45 28.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.154 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.603 HD23 HD13 ' C' ' 103' ' ' ILE . 3.0 mp -102.68 57.64 0.78 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.675 0.274 . . . . 0.0 110.742 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.48 19.72 15.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.562 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.18 -93.08 0.88 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.647 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' F' ' 125' ' ' ASN . . . -102.73 69.58 1.08 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.097 0.475 . . . . 0.0 111.631 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' C' ' 72' ' ' ALA . 5.9 p -89.62 97.25 11.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.196 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.13 102.72 5.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.723 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.43 -82.69 0.65 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' SER . . . . . 0.562 ' HA ' HG21 ' C' ' 107' ' ' THR . 0.1 OUTLIER -63.16 100.87 0.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.715 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.82 79.01 7.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.208 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.574 HG21 ' HG2' ' C' ' 132' ' ' PRO . 4.5 p -82.56 159.1 22.85 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.729 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' THR . . . . . 0.45 HG23 ' N ' ' C' ' 124' ' ' LEU . 16.3 m -85.17 139.71 31.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.825 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . 0.45 ' N ' HG23 ' C' ' 123' ' ' THR . 0.4 OUTLIER -92.42 136.15 33.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.811 0.338 . . . . 0.0 110.548 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -120.77 143.55 48.76 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.653 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.14 148.94 34.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.742 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.76 -106.21 2.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.692 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -85.2 153.25 22.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.734 0.302 . . . . 0.0 110.74 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 129' ' ' ASN . . . . . 0.565 ' HB3' ' HB2' ' C' ' 58' ' ' LEU . 23.2 t-20 -148.45 120.72 8.38 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.898 0.38 . . . . 0.0 111.112 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.18 147.33 27.58 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.132 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 131' ' ' ILE . . . . . 0.604 HD13 HD11 ' C' ' 58' ' ' LEU . 89.8 mt -116.62 119.27 36.02 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 132' ' ' PRO . . . . . 0.574 ' HG2' HG21 ' C' ' 122' ' ' THR . 7.6 Cg_endo -80.92 119.17 3.53 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 121.652 1.568 . . . . 0.0 112.548 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.12 147.27 29.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.762 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.09 155.98 47.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.02 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.538 ' HB3' HG22 ' C' ' 52' ' ' VAL . . . -140.09 115.7 10.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.93 0.395 . . . . 0.0 111.579 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.26 149.02 31.63 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.432 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.67 151.32 45.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.068 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 138' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' C' ' 47' ' ' ALA . 0.2 OUTLIER -144.55 164.56 30.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.924 -179.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 139' ' ' ALA . . . . . 0.613 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -124.41 145.74 49.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.923 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 140' ' ' THR . . . . . 0.482 ' OG1' HG12 ' C' ' 78' ' ' ILE . 0.2 OUTLIER -117.8 12.89 14.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.516 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.87 79.82 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.895 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.7 92.11 0.02 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.595 0.197 . . . . 0.0 110.796 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 143' ' ' ALA . . . . . 0.808 ' HB3' ' HB ' ' C' ' 99' ' ' VAL . . . -64.11 154.83 33.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.75 0.31 . . . . 0.0 111.403 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 144' ' ' THR . . . . . 0.528 ' O ' ' HB ' ' B' ' 16' ' ' VAL . 39.8 p -116.75 166.22 13.34 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.181 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 145' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' B' ' 16' ' ' VAL . 1.3 Cg_endo -84.28 151.4 12.13 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.468 2.112 . . . . 0.0 111.993 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.7 -106.23 0.45 Allowed Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.403 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.13 163.23 32.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.764 0.316 . . . . 0.0 111.411 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.89 79.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.502 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 149' ' ' ASN . . . . . 0.523 ' HB2' ' HB3' ' C' ' 89' ' ' GLN . 87.1 m-20 -99.92 142.47 31.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.576 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 150' ' ' ALA . . . . . 0.582 ' HB3' ' HB3' ' C' ' 86' ' ' LEU . . . -127.77 168.96 14.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.052 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 151' ' ' ASP . . . . . 0.408 ' OD2' ' HD2' ' B' ' 11' ' ' HIS . 4.2 t70 -165.54 109.99 0.86 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.267 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . 0.656 ' HB1' HD11 ' C' ' 86' ' ' LEU . . . -146.94 145.42 29.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.148 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.61 164.18 13.26 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 154' ' ' PHE . . . . . 0.495 ' CZ ' ' HA3' ' B' ' 7' ' ' GLY . 15.2 p90 -110.87 151.52 27.77 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.157 0.503 . . . . 0.0 110.187 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . 0.543 ' HB3' ' HB1' ' C' ' 72' ' ' ALA . 0.0 OUTLIER -109.6 160.95 15.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.943 -178.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 156' ' ' VAL . . . . . 0.489 HG11 ' HE2' ' C' ' 154' ' ' PHE . 1.5 m -142.17 112.9 3.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.761 0.315 . . . . 0.0 111.715 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . 0.623 ' HB3' ' HB2' ' C' ' 70' ' ' ALA . 0.3 OUTLIER -91.88 124.38 35.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.36 0.6 . . . . 0.0 110.46 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . 0.567 ' HH ' HD21 ' C' ' 58' ' ' LEU . 57.6 m-85 -117.18 135.47 53.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.493 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.914 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.53 100.1 0.04 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.064 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' E' ' 158' ' ' TYR . 7.3 m -104.74 78.63 1.46 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.48 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.27 122.44 29.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.528 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.95 162.93 30.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.533 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . 0.424 ' HB3' ' OE2' ' E' ' 15' ' ' GLU . 44.0 t-20 -84.34 114.56 21.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.594 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' GLY . . . . . 0.484 ' HA3' ' CZ ' ' E' ' 154' ' ' PHE . . . -83.41 -41.48 8.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.683 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . 0.447 ' N ' ' CE1' ' E' ' 154' ' ' PHE . . . -175.64 162.28 31.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.847 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' E' ' 153' ' ' THR . 98.8 m -90.74 137.81 32.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.92 0.39 . . . . 0.0 111.28 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' VAL . . . . . 0.4 HG11 ' CZ ' ' D' ' 12' ' ' PHE . 2.7 t -110.43 114.28 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.254 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' HIS . . . . . 0.455 ' HB2' HG21 ' E' ' 31' ' ' THR . 4.6 m80 -99.38 148.49 24.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.312 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' PHE . . . . . 0.818 ' HB3' HD22 ' E' ' 34' ' ' LEU . 60.7 m-85 -133.74 113.08 11.92 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.824 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' LYS . . . . . 0.714 ' HG2' ' HA ' ' E' ' 33' ' ' GLN . 0.0 OUTLIER -107.12 105.82 16.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.39 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.17 169.48 28.86 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.958 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' GLU . . . . . 0.528 ' HB2' ' HG3' ' E' ' 36' ' ' GLN . 33.6 mt-10 -140.75 -171.05 3.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.849 0.357 . . . . 0.0 110.431 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.532 ' HB ' ' O ' ' E' ' 144' ' ' THR . 0.5 OUTLIER -139.23 152.88 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.144 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . 0.52 HG23 ' HG3' ' E' ' 38' ' ' ARG . 0.0 OUTLIER -137.47 155.39 31.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.856 0.36 . . . . 0.0 111.069 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -85.19 53.06 2.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.011 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' ALA . . . . . 0.671 ' HA ' ' HG2' ' E' ' 38' ' ' ARG . . . 61.41 92.64 0.05 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.112 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.586 ' H ' ' HG2' ' E' ' 38' ' ' ARG . . . -164.72 -47.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.469 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 1.6 m -159.86 176.77 11.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.989 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' E' ' 36' ' ' GLN . . . -147.22 111.91 5.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.157 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . 0.47 HG11 ' O ' ' C' ' 7' ' ' GLY . 43.2 t -67.29 143.08 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.004 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.548 ' O ' HG23 ' D' ' 28' ' ' VAL . 17.0 m-20 -91.16 168.15 11.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.619 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.37 -50.02 74.31 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.443 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.38 -16.61 73.67 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.967 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' SER . . . . . 0.402 ' HA ' HE21 ' D' ' 30' ' ' GLN . 0.4 OUTLIER -84.32 -24.44 29.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.892 0.377 . . . . 0.0 110.763 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . 0.548 HG23 ' O ' ' D' ' 24' ' ' ASP . 85.6 t -58.1 -37.19 60.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.346 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -140.41 105.98 5.1 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.033 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' GLN . . . . . 0.536 ' NE2' HD12 ' D' ' 56' ' ' ILE . 5.4 mt-30 -109.08 106.95 17.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.106 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' THR . . . . . 0.438 HG21 ' HB2' ' C' ' 11' ' ' HIS . 0.2 OUTLIER -84.74 95.56 8.98 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.096 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 51.9 t -85.76 138.17 19.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.11 0.481 . . . . 0.0 110.388 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.707 ' HA ' ' HG2' ' C' ' 13' ' ' LYS . 3.1 mt-30 -113.11 132.59 55.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.688 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.812 HD22 ' HB3' ' C' ' 12' ' ' PHE . 1.8 mm? -94.47 -71.48 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.64 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.83 -111.33 0.72 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.526 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' GLN . . . . . 0.53 ' HG3' ' HB2' ' C' ' 15' ' ' GLU . 3.6 tt0 -160.96 105.83 1.37 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.648 0.261 . . . . 0.0 110.884 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.449 ' O ' HG13 ' C' ' 16' ' ' VAL . 5.6 m -91.15 142.42 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.878 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . 0.655 ' HG2' ' HA ' ' C' ' 19' ' ' ALA . 0.7 OUTLIER -81.11 162.53 23.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.759 179.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' THR . . . . . . . . . . . . . 82.4 p -80.34 -16.94 53.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.788 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.71 -31.23 63.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.166 0.508 . . . . 0.0 110.919 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.11 -28.42 39.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.116 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.608 ' HB3' ' HB2' ' D' ' 139' ' ' ALA . 1.7 mp -133.16 70.19 1.47 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.625 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.71 11.21 36.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.424 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.06 146.85 27.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.38 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.48 121.22 13.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.56 -10.4 12.71 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.09 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' D' ' 138' ' ' PHE . . . -68.8 142.17 54.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.905 0.383 . . . . 0.0 111.97 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -134.72 140.84 46.26 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.816 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 16.8 m -106.02 -152.76 0.48 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.587 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 1.4 t -65.91 178.64 1.04 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.813 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' ALA . . . . . 0.591 ' HB3' HD11 ' A' ' 88' ' ' LEU . . . -129.16 168.9 15.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.283 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 90' ' ' SER . 14.7 m -118.02 132.25 68.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 88' ' ' LEU . . . -95.2 107.59 3.56 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.647 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -140.28 132.05 27.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.707 0.289 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' D' ' 131' ' ' ILE . 1.6 p-10 -117.81 176.83 5.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.57 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.536 HD12 ' NE2' ' D' ' 30' ' ' GLN . 51.7 mm -118.98 121.7 67.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.532 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' GLN . . . . . 0.56 ' HG2' HD12 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -86.32 122.66 30.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.778 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . 0.608 HD11 HD13 ' D' ' 131' ' ' ILE . 0.9 OUTLIER -131.2 93.71 3.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.234 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -76.98 160.91 28.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.912 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.12 87.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.76 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' CYS . . . . . 0.913 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 70.1 m -120.55 131.81 54.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.808 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.61 97.87 9.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.308 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' D' ' 66' ' ' ALA . 1.5 m -77.41 -19.98 55.31 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.06 -27.54 68.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.975 0.417 . . . . 0.0 111.701 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.4 -35.75 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.608 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' D' ' 63' ' ' THR . . . -130.94 131.24 44.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.716 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.41 -37.35 7.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.885 0.374 . . . . 0.0 110.954 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -121.69 171.4 8.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.577 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.55 136.13 15.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.555 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' D' ' 157' ' ' GLN . . . -94.49 157.95 15.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.087 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 38.1 t -110.42 106.31 20.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.655 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' ALA . . . . . 0.55 ' HB1' ' HB3' ' D' ' 155' ' ' LYS . . . -109.64 164.24 12.72 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.575 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' PHE . . . . . 0.441 ' CE2' HG12 ' D' ' 103' ' ' ILE . 6.5 t80 -142.21 141.11 32.51 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.564 0.221 . . . . 0.0 111.15 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' LEU . . . . . 0.428 HD22 ' NZ ' ' D' ' 155' ' ' LYS . 0.1 OUTLIER -122.72 103.37 8.61 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.991 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . 0.557 ' HA3' HD22 ' D' ' 113' ' ' LEU . . . -153.46 -166.43 14.62 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.889 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.46 136.37 46.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.611 0.243 . . . . 0.0 110.695 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.54 156.12 25.4 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.88 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 78' ' ' ILE . . . . . 0.581 HG21 ' HB ' ' D' ' 85' ' ' VAL . 3.0 tt -92.52 -20.67 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.83 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.15 179.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.825 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.95 -33.85 44.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.975 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.51 -43.82 95.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.595 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . 0.459 ' NE2' ' O ' ' D' ' 139' ' ' ALA . 43.6 m-70 -97.78 -64.48 1.04 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.862 0.363 . . . . 0.0 110.438 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 1.2 m 62.45 7.77 2.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.582 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . 0.619 ' HB3' ' HB2' ' D' ' 110' ' ' ALA . 6.5 m120 -115.08 -25.41 8.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.329 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.762 ' HA ' ' HA ' ' D' ' 102' ' ' GLN . 0.5 OUTLIER -79.58 143.68 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.171 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.652 HD11 ' HB1' ' D' ' 152' ' ' ALA . 0.3 OUTLIER -76.63 148.53 36.86 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.27 179.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.8 178.2 4.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.894 0.378 . . . . 0.0 111.716 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.463 HD21 ' O ' ' D' ' 96' ' ' ALA . 0.0 OUTLIER -84.67 176.16 8.75 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.096 179.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 89' ' ' GLN . . . . . 0.507 ' HB3' ' HB2' ' D' ' 149' ' ' ASN . 22.8 pt20 -75.24 178.71 5.58 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.38 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.36 -11.5 60.5 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 111.428 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 91' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' D' ' 95' ' ' SER . 0.3 OUTLIER -64.62 87.24 0.05 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.891 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.88 -7.15 53.83 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.921 0.391 . . . . 0.0 111.697 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.14 19.96 4.06 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.674 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.62 -15.58 0.16 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.942 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 95' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' D' ' 91' ' ' SER . 1.0 OUTLIER -97.33 174.89 6.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.9 0.381 . . . . 0.0 110.59 179.558 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 96' ' ' ALA . . . . . 0.463 ' O ' HD21 ' D' ' 88' ' ' LEU . . . -114.05 157.88 21.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.82 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.9 162.72 15.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.305 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 98' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 69.29 41.62 1.32 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.387 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 99' ' ' VAL . . . . . 0.803 ' HB ' ' HB3' ' D' ' 143' ' ' ALA . 10.1 p -177.64 130.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.792 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.12 179.45 28.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.552 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 101' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' D' ' 86' ' ' LEU . 1.6 t -99.0 95.29 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 123.078 0.551 . . . . 0.0 111.681 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 102' ' ' GLN . . . . . 0.762 ' HA ' ' HA ' ' D' ' 85' ' ' VAL . 1.9 tt0 -69.84 159.79 32.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.892 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 103' ' ' ILE . . . . . 0.617 HD13 HD23 ' D' ' 113' ' ' LEU . 0.9 OUTLIER -121.7 98.45 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.522 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 104' ' ' LEU . . . . . 0.675 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 1.1 tp -84.75 119.38 25.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.755 0.312 . . . . 0.0 111.095 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.18 158.09 32.04 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.68 0.276 . . . . 0.0 111.646 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 106' ' ' ARG . . . . . 0.534 ' HB2' ' HB2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -61.19 -33.92 74.23 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.902 0.382 . . . . 0.0 111.048 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 107' ' ' THR . . . . . 0.547 HG21 ' HA ' ' D' ' 120' ' ' SER . 0.0 OUTLIER -48.72 -38.19 20.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.027 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.68 -88.81 0.11 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.603 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 109' ' ' ALA . . . . . 0.424 ' HA ' HD12 ' D' ' 104' ' ' LEU . . . -79.16 -176.35 5.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.867 0.365 . . . . 0.0 111.139 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.675 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -79.96 143.93 33.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.098 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.08 157.58 17.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.386 0.612 . . . . 0.0 110.534 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 112' ' ' THR . . . . . . . . . . . . . 30.0 m -81.22 150.47 28.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.099 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 113' ' ' LEU . . . . . 0.617 HD23 HD13 ' D' ' 103' ' ' ILE . 2.9 mp -102.72 57.67 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.721 0.296 . . . . 0.0 110.742 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.42 19.57 15.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.552 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.23 -93.04 0.88 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.665 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.68 69.61 1.08 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.021 0.438 . . . . 0.0 111.564 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 117' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' D' ' 72' ' ' ALA . 5.8 p -89.69 97.34 11.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.2 102.83 5.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.786 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.45 -82.72 0.65 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 120' ' ' SER . . . . . 0.547 ' HA ' HG21 ' D' ' 107' ' ' THR . 0.1 OUTLIER -63.2 100.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.614 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.86 79.05 7.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.234 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.573 HG21 ' HG2' ' D' ' 132' ' ' PRO . 4.4 p -82.61 159.15 22.78 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.719 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.439 HG23 ' N ' ' D' ' 124' ' ' LEU . 16.2 m -85.2 139.68 31.47 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.8 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . 0.439 ' N ' HG23 ' D' ' 123' ' ' THR . 0.4 OUTLIER -92.34 136.1 33.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.65 179.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 125' ' ' ASN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 116' ' ' ALA . 25.1 m120 -120.78 143.67 48.7 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.622 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.19 148.98 34.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.638 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.61 -106.12 2.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.75 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 128' ' ' THR . . . . . 0.412 ' HB ' ' HD3' ' A' ' 155' ' ' LYS . 1.9 m -85.15 153.14 22.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.654 0.264 . . . . 0.0 110.817 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 129' ' ' ASN . . . . . 0.564 ' HB3' ' HB2' ' D' ' 58' ' ' LEU . 23.3 t-20 -148.39 120.68 8.39 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.874 0.368 . . . . 0.0 111.125 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 130' ' ' THR . . . . . 0.627 ' HG1' ' CG ' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -104.15 147.33 27.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.164 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 131' ' ' ILE . . . . . 0.608 HD13 HD11 ' D' ' 58' ' ' LEU . 89.4 mt -116.59 119.15 36.25 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 132' ' ' PRO . . . . . 0.605 ' HB3' ' H ' ' A' ' 77' ' ' ALA . 7.5 Cg_endo -80.95 119.11 3.5 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.645 1.563 . . . . 0.0 112.546 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.01 147.36 29.53 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.795 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.17 155.87 47.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.021 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.516 ' HB3' ' CG2' ' D' ' 52' ' ' VAL . . . -140.09 115.64 10.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.904 0.383 . . . . 0.0 111.575 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.27 149.01 31.66 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.543 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.52 151.27 45.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.132 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 138' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' D' ' 47' ' ' ALA . 0.2 OUTLIER -144.49 164.61 30.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.225 0.536 . . . . 0.0 111.993 -179.154 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 139' ' ' ALA . . . . . 0.608 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -124.5 145.71 49.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.901 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 140' ' ' THR . . . . . 0.477 HG22 HG23 ' D' ' 78' ' ' ILE . 0.2 OUTLIER -117.74 12.97 14.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.536 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.76 79.74 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.957 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.73 92.17 0.02 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.619 0.209 . . . . 0.0 110.716 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 143' ' ' ALA . . . . . 0.803 ' HB3' ' HB ' ' D' ' 99' ' ' VAL . . . -64.13 154.86 33.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 111.357 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 144' ' ' THR . . . . . 0.532 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 39.2 p -116.76 166.16 13.49 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.237 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 145' ' ' PRO . . . . . 0.424 ' HA ' ' HB ' ' C' ' 16' ' ' VAL . 1.3 Cg_endo -84.24 151.49 12.21 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.45 2.1 . . . . 0.0 111.98 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.65 -106.34 0.46 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.453 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.05 163.26 32.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.823 0.344 . . . . 0.0 111.354 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.96 79.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.59 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 149' ' ' ASN . . . . . 0.507 ' HB2' ' HB3' ' D' ' 89' ' ' GLN . 87.1 m-20 -99.97 142.45 31.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.569 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 150' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' D' ' 86' ' ' LEU . . . -127.72 168.99 14.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.969 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 151' ' ' ASP . . . . . 0.411 ' OD2' ' HD2' ' C' ' 11' ' ' HIS . 4.2 t70 -165.55 109.99 0.86 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.214 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 152' ' ' ALA . . . . . 0.652 ' HB1' HD11 ' D' ' 86' ' ' LEU . . . -147.01 145.44 29.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.086 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 153' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' C' ' 9' ' ' THR . 1.0 OUTLIER -93.72 164.23 13.22 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.252 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 154' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' C' ' 7' ' ' GLY . 15.1 p90 -110.92 151.61 27.7 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.147 0.499 . . . . 0.0 110.108 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . 0.55 ' HB3' ' HB1' ' D' ' 72' ' ' ALA . 0.0 OUTLIER -109.64 160.84 15.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.951 -178.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 156' ' ' VAL . . . . . 0.487 HG11 ' HE2' ' D' ' 154' ' ' PHE . 1.4 m -142.15 112.93 3.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.803 0.335 . . . . 0.0 111.687 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 157' ' ' GLN . . . . . 0.618 ' HB3' ' HB2' ' D' ' 70' ' ' ALA . 0.3 OUTLIER -91.78 124.4 35.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.264 0.555 . . . . 0.0 110.398 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . 0.571 ' HH ' HD21 ' D' ' 58' ' ' LEU . 57.6 m-85 -117.21 135.49 53.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.505 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.85 179.915 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.46 100.23 0.04 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.065 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 3' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' F' ' 158' ' ' TYR . 7.4 m -104.8 78.65 1.45 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.422 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.33 122.39 29.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.526 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 m -137.92 162.9 30.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.54 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 6' ' ' ASN . . . . . 0.423 ' HB3' ' OE2' ' F' ' 15' ' ' GLU . 44.0 t-20 -84.3 114.52 21.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.599 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 7' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' F' ' 154' ' ' PHE . . . -83.38 -41.52 8.4 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.684 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . 0.444 ' N ' ' CE1' ' F' ' 154' ' ' PHE . . . -175.56 162.29 31.57 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.889 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 9' ' ' THR . . . . . . . . . . . . . 98.9 m -90.78 137.86 32.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.992 0.425 . . . . 0.0 111.269 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 10' ' ' VAL . . . . . 0.4 HG11 ' CZ ' ' E' ' 12' ' ' PHE . 2.7 t -110.44 114.27 46.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.184 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 11' ' ' HIS . . . . . 0.456 ' HB2' HG21 ' F' ' 31' ' ' THR . 4.6 m80 -99.34 148.44 24.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.343 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 12' ' ' PHE . . . . . 0.811 ' HB3' HD22 ' F' ' 34' ' ' LEU . 60.9 m-85 -133.75 113.12 11.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.794 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 13' ' ' LYS . . . . . 0.735 ' HG2' ' HA ' ' F' ' 33' ' ' GLN . 0.0 OUTLIER -107.23 105.89 16.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.351 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.23 169.44 28.9 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.023 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 15' ' ' GLU . . . . . 0.539 ' HB2' ' HG3' ' F' ' 36' ' ' GLN . 33.7 mt-10 -140.76 -171.13 3.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.853 0.359 . . . . 0.0 110.39 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 16' ' ' VAL . . . . . 0.524 ' HB ' ' O ' ' F' ' 144' ' ' THR . 0.5 OUTLIER -139.15 152.82 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.205 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' F' ' 38' ' ' ARG . 0.0 OUTLIER -137.47 155.41 31.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.835 0.35 . . . . 0.0 111.038 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -85.23 53.02 2.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.005 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 19' ' ' ALA . . . . . 0.649 ' HA ' ' HG2' ' F' ' 38' ' ' ARG . . . 61.45 92.76 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.591 ' H ' ' HG2' ' F' ' 38' ' ' ARG . . . -164.84 -47.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.43 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 21' ' ' CYS . . . . . 0.915 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 1.6 m -159.76 176.89 11.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.951 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 22' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' F' ' 36' ' ' GLN . . . -147.29 111.9 5.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.13 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 23' ' ' VAL . . . . . 0.47 HG11 ' O ' ' D' ' 7' ' ' GLY . 43.1 t -67.31 143.14 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.998 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 24' ' ' ASP . . . . . 0.548 ' O ' HG23 ' E' ' 28' ' ' VAL . 17.1 m-20 -91.13 168.13 11.85 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.611 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.1 74.01 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.382 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.41 -16.64 73.74 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.929 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.3 -24.35 29.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.944 0.402 . . . . 0.0 110.837 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 28' ' ' VAL . . . . . 0.548 HG23 ' O ' ' E' ' 24' ' ' ASP . 85.0 t -58.08 -37.25 60.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.345 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -140.34 105.97 5.12 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.007 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 30' ' ' GLN . . . . . 0.535 ' NE2' HD12 ' E' ' 56' ' ' ILE . 5.4 mt-30 -109.0 106.95 17.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.12 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 31' ' ' THR . . . . . 0.455 HG21 ' HB2' ' D' ' 11' ' ' HIS . 0.2 OUTLIER -84.77 95.53 8.99 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.071 179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 51.4 t -85.74 138.27 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.074 0.464 . . . . 0.0 110.382 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 33' ' ' GLN . . . . . 0.714 ' HA ' ' HG2' ' D' ' 13' ' ' LYS . 3.2 mt-30 -113.23 132.53 55.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.641 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.818 HD22 ' HB3' ' D' ' 12' ' ' PHE . 1.8 mm? -94.47 -71.46 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.628 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.85 -111.3 0.71 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.578 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 36' ' ' GLN . . . . . 0.528 ' HG3' ' HB2' ' D' ' 15' ' ' GLU . 3.6 tt0 -161.03 105.81 1.36 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.625 0.25 . . . . 0.0 110.897 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . 0.452 ' O ' HG13 ' D' ' 16' ' ' VAL . 5.7 m -91.13 142.4 13.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.011 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . 0.671 ' HG2' ' HA ' ' D' ' 19' ' ' ALA . 0.7 OUTLIER -81.11 162.6 23.63 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.691 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 39' ' ' THR . . . . . . . . . . . . . 82.6 p -80.47 -16.8 53.45 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.783 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.71 -31.22 63.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.197 0.522 . . . . 0.0 110.944 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.06 -28.47 39.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.113 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.628 ' HB3' ' HB2' ' E' ' 139' ' ' ALA . 1.7 mp -133.13 70.02 1.47 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.658 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.61 11.19 36.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.451 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.01 146.84 27.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.394 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.47 121.24 13.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 111.146 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.55 -10.37 12.73 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.195 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 47' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' E' ' 138' ' ' PHE . . . -68.86 142.22 54.88 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 6.9 t -134.76 140.81 46.2 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.826 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 16.9 m -106.01 -152.74 0.48 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.615 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.92 178.62 1.05 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.909 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 51' ' ' ALA . . . . . 0.588 ' HB3' HD11 ' B' ' 88' ' ' LEU . . . -129.1 168.81 15.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.784 0.326 . . . . 0.0 111.26 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 52' ' ' VAL . . . . . 0.567 HG11 ' O ' ' B' ' 90' ' ' SER . 14.7 m -117.97 132.2 68.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.955 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 53' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' B' ' 88' ' ' LEU . . . -95.18 107.61 3.57 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.627 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -140.28 132.06 27.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 55' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' E' ' 131' ' ' ILE . 1.5 p-10 -117.81 176.75 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.621 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 56' ' ' ILE . . . . . 0.535 HD12 ' NE2' ' E' ' 30' ' ' GLN . 51.6 mm -119.03 121.7 67.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.543 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 57' ' ' GLN . . . . . 0.578 ' HG2' HD12 ' B' ' 74' ' ' LEU . 0.0 OUTLIER -86.28 122.63 30.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.792 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . 0.608 HD11 HD13 ' E' ' 131' ' ' ILE . 0.9 OUTLIER -131.13 93.74 3.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.08 160.88 28.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.862 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.17 87.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.817 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 61' ' ' CYS . . . . . 0.915 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 70.1 m -120.53 131.84 54.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.783 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.58 97.82 9.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.366 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 63' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' E' ' 66' ' ' ALA . 1.5 m -77.39 -19.95 55.4 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.1 -27.5 68.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.02 0.438 . . . . 0.0 111.715 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.44 -35.75 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.624 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' E' ' 63' ' ' THR . . . -131.05 131.32 44.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.648 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.49 -37.26 7.66 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.947 0.403 . . . . 0.0 110.94 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -121.74 171.39 8.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.558 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.55 136.1 15.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.532 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . 0.628 ' HB2' ' HB3' ' E' ' 157' ' ' GLN . . . -94.54 158.01 15.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.065 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 38.4 t -110.35 106.23 20.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.71 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' E' ' 155' ' ' LYS . . . -109.58 164.36 12.6 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.594 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 73' ' ' PHE . . . . . 0.441 ' CE2' HG12 ' E' ' 103' ' ' ILE . 6.6 t80 -142.27 141.1 32.42 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.532 0.206 . . . . 0.0 111.131 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 74' ' ' LEU . . . . . 0.423 HD22 ' NZ ' ' E' ' 155' ' ' LYS . 0.1 OUTLIER -122.69 103.4 8.64 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.011 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . 0.568 ' HA3' HD22 ' E' ' 113' ' ' LEU . . . -153.5 -166.43 14.64 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.876 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.45 136.24 46.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.58 0.228 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.35 156.15 25.62 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.935 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 78' ' ' ILE . . . . . 0.584 HG21 ' HB ' ' E' ' 85' ' ' VAL . 3.1 tt -92.55 -20.67 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.881 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.15 179.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.808 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.88 -33.87 45.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.009 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.48 -43.87 95.68 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.555 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 82' ' ' HIS . . . . . 0.462 ' NE2' ' O ' ' E' ' 139' ' ' ALA . 43.5 m-70 -97.8 -64.37 1.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.849 0.356 . . . . 0.0 110.492 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 1.2 m 62.31 7.85 2.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.609 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 84' ' ' ASN . . . . . 0.586 ' HB3' ' HB2' ' E' ' 110' ' ' ALA . 6.5 m120 -115.13 -25.46 8.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.255 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' E' ' 102' ' ' GLN . 0.5 OUTLIER -79.58 143.71 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.177 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 86' ' ' LEU . . . . . 0.649 HD11 ' HB1' ' E' ' 152' ' ' ALA . 0.3 OUTLIER -76.68 148.54 36.78 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.294 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.83 178.23 4.36 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.909 0.385 . . . . 0.0 111.694 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.47 HD21 ' O ' ' E' ' 96' ' ' ALA . 0.0 OUTLIER -84.68 176.17 8.74 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.135 179.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 89' ' ' GLN . . . . . 0.513 ' HB3' ' HB2' ' E' ' 149' ' ' ASN . 22.9 pt20 -75.3 178.73 5.61 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.315 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.4 -11.42 60.47 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.999 0.428 . . . . 0.0 111.443 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 91' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' E' ' 95' ' ' SER . 0.3 OUTLIER -64.67 87.26 0.05 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.9 -7.13 53.8 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.909 0.385 . . . . 0.0 111.666 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.14 19.87 4.06 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.678 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.6 -15.6 0.16 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.924 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 95' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' E' ' 91' ' ' SER . 0.9 OUTLIER -97.28 174.95 6.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.886 0.374 . . . . 0.0 110.664 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 96' ' ' ALA . . . . . 0.47 ' O ' HD21 ' E' ' 88' ' ' LEU . . . -114.1 157.83 22.06 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.786 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.92 162.68 15.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.359 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 98' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 69.4 41.53 1.3 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.368 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 99' ' ' VAL . . . . . 0.778 ' HB ' ' HB3' ' E' ' 143' ' ' ALA . 10.5 p -177.6 130.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.872 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.15 179.47 28.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.521 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 101' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' E' ' 86' ' ' LEU . 1.6 t -99.08 95.27 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.085 0.554 . . . . 0.0 111.65 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 102' ' ' GLN . . . . . 0.774 ' HA ' ' HA ' ' E' ' 85' ' ' VAL . 1.9 tt0 -69.84 159.83 32.91 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.959 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 103' ' ' ILE . . . . . 0.624 HD13 HD23 ' E' ' 113' ' ' LEU . 0.9 OUTLIER -121.7 98.49 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.516 179.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 104' ' ' LEU . . . . . 0.681 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 1.1 tp -84.79 119.39 25.24 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.701 0.286 . . . . 0.0 111.046 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.17 158.1 32.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.693 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 106' ' ' ARG . . . . . 0.532 ' HB2' ' HB2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -61.21 -33.83 74.11 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.958 0.409 . . . . 0.0 111.102 179.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 107' ' ' THR . . . . . 0.544 HG21 ' HA ' ' E' ' 120' ' ' SER . 0.0 OUTLIER -48.8 -38.23 21.45 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.037 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.76 -88.84 0.11 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.598 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 109' ' ' ALA . . . . . 0.415 ' HA ' HD12 ' E' ' 104' ' ' LEU . . . -79.19 -176.39 5.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.863 0.363 . . . . 0.0 111.116 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . 0.681 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -79.86 143.88 33.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.221 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.14 157.55 17.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.361 0.601 . . . . 0.0 110.545 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 112' ' ' THR . . . . . . . . . . . . . 29.7 m -81.1 150.48 28.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.134 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 113' ' ' LEU . . . . . 0.624 HD23 HD13 ' E' ' 103' ' ' ILE . 3.0 mp -102.74 57.72 0.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.695 0.283 . . . . 0.0 110.719 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.4 19.58 15.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.566 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.19 -93.04 0.88 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.677 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.77 69.72 1.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.077 0.465 . . . . 0.0 111.566 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 117' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' E' ' 72' ' ' ALA . 6.0 p -89.67 97.25 11.08 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.169 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.06 102.84 5.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.809 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.48 -82.83 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 120' ' ' SER . . . . . 0.544 ' HA ' HG21 ' E' ' 107' ' ' THR . 0.1 OUTLIER -63.09 100.86 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.62 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -88.9 79.04 7.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.196 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 122' ' ' THR . . . . . 0.588 HG21 ' HG2' ' E' ' 132' ' ' PRO . 4.6 p -82.54 159.2 22.86 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.667 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 123' ' ' THR . . . . . 0.456 HG23 ' N ' ' E' ' 124' ' ' LEU . 16.1 m -85.27 139.72 31.4 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.731 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . 0.456 ' N ' HG23 ' E' ' 123' ' ' THR . 0.4 OUTLIER -92.45 136.14 33.46 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.746 0.308 . . . . 0.0 110.594 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 125' ' ' ASN . . . . . 0.449 ' HB3' ' HB2' ' B' ' 116' ' ' ALA . 25.0 m120 -120.77 143.59 48.73 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.613 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.16 148.91 34.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.639 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.71 -106.12 2.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.736 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 128' ' ' THR . . . . . 0.405 ' HB ' ' HD3' ' B' ' 155' ' ' LYS . 1.9 m -85.22 153.2 22.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.715 0.293 . . . . 0.0 110.812 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 129' ' ' ASN . . . . . 0.58 ' HB3' ' HB2' ' E' ' 58' ' ' LEU . 23.2 t-20 -148.42 120.73 8.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.955 0.407 . . . . 0.0 111.09 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 130' ' ' THR . . . . . 0.627 ' HG1' ' CG ' ' B' ' 74' ' ' LEU . 0.2 OUTLIER -104.17 147.3 27.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.147 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 131' ' ' ILE . . . . . 0.608 HD13 HD11 ' E' ' 58' ' ' LEU . 89.8 mt -116.65 119.17 36.11 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 132' ' ' PRO . . . . . 0.602 ' HB3' ' H ' ' B' ' 77' ' ' ALA . 7.6 Cg_endo -80.92 119.09 3.51 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.594 1.53 . . . . 0.0 112.553 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.99 147.33 29.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.739 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.15 155.96 47.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.066 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . 0.535 ' HB3' HG22 ' E' ' 52' ' ' VAL . . . -140.09 115.71 10.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.912 0.387 . . . . 0.0 111.632 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.34 148.99 31.78 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.479 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.53 151.31 45.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.113 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 138' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' E' ' 47' ' ' ALA . 0.2 OUTLIER -144.53 164.58 30.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.009 -179.13 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 139' ' ' ALA . . . . . 0.628 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -124.39 145.65 49.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.913 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 140' ' ' THR . . . . . 0.477 HG22 HG23 ' E' ' 78' ' ' ILE . 0.2 OUTLIER -117.78 12.95 14.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.513 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.85 79.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.914 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.74 92.14 0.02 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.608 0.204 . . . . 0.0 110.756 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 143' ' ' ALA . . . . . 0.778 ' HB3' ' HB ' ' E' ' 99' ' ' VAL . . . -64.1 154.77 33.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.675 0.274 . . . . 0.0 111.4 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 144' ' ' THR . . . . . 0.532 ' O ' ' HB ' ' D' ' 16' ' ' VAL . 39.1 p -116.68 166.2 13.33 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.244 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 145' ' ' PRO . . . . . 0.414 ' HA ' ' HB ' ' D' ' 16' ' ' VAL . 1.3 Cg_endo -84.33 151.42 12.06 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.495 2.13 . . . . 0.0 111.988 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.73 -106.32 0.46 Allowed Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.414 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.05 163.27 32.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.794 0.331 . . . . 0.0 111.408 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.91 79.88 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.508 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 149' ' ' ASN . . . . . 0.513 ' HB2' ' HB3' ' E' ' 89' ' ' GLN . 87.2 m-20 -99.9 142.48 31.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.557 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 150' ' ' ALA . . . . . 0.58 ' HB3' ' HB3' ' E' ' 86' ' ' LEU . . . -127.78 169.0 14.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.008 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 151' ' ' ASP . . . . . 0.409 ' OD2' ' HD2' ' D' ' 11' ' ' HIS . 4.2 t70 -165.55 110.04 0.86 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.201 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 152' ' ' ALA . . . . . 0.649 ' HB1' HD11 ' E' ' 86' ' ' LEU . . . -147.06 145.39 29.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.13 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 153' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' D' ' 9' ' ' THR . 1.0 OUTLIER -93.62 164.23 13.24 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 154' ' ' PHE . . . . . 0.496 ' HE2' HG11 ' E' ' 156' ' ' VAL . 15.1 p90 -110.98 151.59 27.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.193 0.521 . . . . 0.0 110.124 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . 0.538 ' HB3' ' HB1' ' E' ' 72' ' ' ALA . 0.0 OUTLIER -109.65 160.89 15.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.959 -178.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 156' ' ' VAL . . . . . 0.496 HG11 ' HE2' ' E' ' 154' ' ' PHE . 1.4 m -142.18 112.83 2.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.791 0.329 . . . . 0.0 111.678 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 157' ' ' GLN . . . . . 0.628 ' HB3' ' HB2' ' E' ' 70' ' ' ALA . 0.3 OUTLIER -91.83 124.39 35.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.338 0.59 . . . . 0.0 110.426 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . 0.568 ' HH ' HD21 ' E' ' 58' ' ' LEU . 57.6 m-85 -117.17 135.52 53.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.456 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.859 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.55 100.22 0.04 OUTLIER 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.05 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -104.84 78.6 1.44 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.406 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.27 122.41 29.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.659 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 m -137.95 162.89 30.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.567 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -84.28 114.5 21.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.717 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.34 -41.52 8.42 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.678 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.57 162.24 31.49 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.936 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 98.8 m -90.71 137.79 32.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.92 0.39 . . . . 0.0 111.277 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.39 114.28 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.219 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -99.33 148.55 24.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.295 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -133.79 113.03 11.84 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.75 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 13' ' ' LYS . . . . . 0.41 ' H ' ' HG2' ' F' ' 13' ' ' LYS . 0.0 OUTLIER -107.14 105.81 15.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.404 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.17 169.5 28.85 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.002 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 15' ' ' GLU . . . . . 0.423 ' OE2' ' HB3' ' E' ' 6' ' ' ASN . 33.5 mt-10 -140.78 -171.07 3.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.358 . . . . 0.0 110.429 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -139.21 152.82 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.197 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 17' ' ' VAL . . . . . 0.465 HG21 ' O ' ' F' ' 21' ' ' CYS . 0.0 OUTLIER -137.45 155.41 31.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.785 0.326 . . . . 0.0 111.037 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -85.16 52.98 2.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.08 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.43 92.69 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.11 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.75 -47.7 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.413 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 21' ' ' CYS . . . . . 0.906 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 1.6 m -159.74 176.86 11.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.983 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -147.3 112.0 5.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.155 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 23' ' ' VAL . . . . . 0.469 HG11 ' O ' ' E' ' 7' ' ' GLY . 42.8 t -67.39 143.17 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.946 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 24' ' ' ASP . . . . . 0.543 ' O ' HG23 ' F' ' 28' ' ' VAL . 17.0 m-20 -91.19 168.23 11.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.557 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.43 -50.0 74.44 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.455 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.35 -16.66 73.65 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.941 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 27' ' ' SER . . . . . 0.409 ' HA ' HE21 ' F' ' 30' ' ' GLN . 0.4 OUTLIER -84.32 -24.39 29.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.881 0.372 . . . . 0.0 110.767 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 28' ' ' VAL . . . . . 0.543 HG23 ' O ' ' F' ' 24' ' ' ASP . 85.4 t -58.12 -37.17 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.349 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -140.38 106.01 5.12 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.024 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 30' ' ' GLN . . . . . 0.528 ' NE2' HD12 ' F' ' 56' ' ' ILE . 5.4 mt-30 -109.06 106.95 17.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.089 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 31' ' ' THR . . . . . 0.456 HG21 ' HB2' ' E' ' 11' ' ' HIS . 0.2 OUTLIER -84.81 95.57 9.02 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.059 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 51.0 t -85.73 138.18 19.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.099 0.476 . . . . 0.0 110.378 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 33' ' ' GLN . . . . . 0.735 ' HA ' ' HG2' ' E' ' 13' ' ' LYS . 3.1 mt-30 -113.17 132.6 55.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.674 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 34' ' ' LEU . . . . . 0.811 HD22 ' HB3' ' E' ' 12' ' ' PHE . 1.8 mm? -94.51 -71.49 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.594 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.9 -111.31 0.71 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.512 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 36' ' ' GLN . . . . . 0.539 ' HG3' ' HB2' ' E' ' 15' ' ' GLU . 3.6 tt0 -160.96 105.75 1.37 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.573 0.225 . . . . 0.0 110.888 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.455 ' O ' HG13 ' E' ' 16' ' ' VAL . 5.6 m -91.1 142.45 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.904 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 38' ' ' ARG . . . . . 0.649 ' HG2' ' HA ' ' E' ' 19' ' ' ALA . 0.7 OUTLIER -81.09 162.52 23.69 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.723 179.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 39' ' ' THR . . . . . . . . . . . . . 82.5 p -80.4 -16.88 53.42 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.775 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.74 -31.27 63.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.115 0.483 . . . . 0.0 110.876 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.02 -28.51 39.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.121 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . 0.617 ' HB3' ' HB2' ' F' ' 139' ' ' ALA . 1.7 mp -133.11 70.05 1.47 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.686 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.65 11.2 36.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.445 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.07 146.84 27.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.394 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.43 121.24 13.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 111.158 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.57 -10.48 12.66 Favored Glycine 0 C--N 1.331 0.274 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.146 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 47' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' F' ' 138' ' ' PHE . . . -68.74 142.26 55.01 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 48' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' F' ' 137' ' ' TYR . 6.9 t -134.85 140.85 46.15 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.826 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -106.05 -152.75 0.48 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.519 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.91 178.52 1.07 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.881 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 51' ' ' ALA . . . . . 0.586 ' HB3' HD11 ' C' ' 88' ' ' LEU . . . -129.02 168.86 15.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.281 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 52' ' ' VAL . . . . . 0.561 HG11 ' O ' ' C' ' 90' ' ' SER . 14.6 m -117.94 132.21 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.028 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 53' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' C' ' 88' ' ' LEU . . . -95.22 107.68 3.58 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.654 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 54' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -140.35 132.12 27.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 55' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' F' ' 131' ' ' ILE . 1.6 p-10 -117.85 176.84 5.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.61 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 56' ' ' ILE . . . . . 0.528 HD12 ' NE2' ' F' ' 30' ' ' GLN . 51.8 mm -119.0 121.7 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.549 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 57' ' ' GLN . . . . . 0.561 ' HG2' HD12 ' C' ' 74' ' ' LEU . 0.0 OUTLIER -86.26 122.61 30.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.855 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . 0.604 HD11 HD13 ' F' ' 131' ' ' ILE . 0.9 OUTLIER -131.15 93.73 3.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.265 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.17 160.92 28.6 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.21 87.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.798 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 61' ' ' CYS . . . . . 0.906 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 69.8 m -120.41 131.88 54.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.65 97.91 9.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.321 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 63' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' F' ' 66' ' ' ALA . 1.5 m -77.52 -19.89 55.08 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -27.45 68.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.985 0.422 . . . . 0.0 111.689 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.41 -35.76 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.597 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 66' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' F' ' 63' ' ' THR . . . -131.01 131.31 44.26 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.624 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.52 -37.3 7.63 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.964 0.412 . . . . 0.0 110.933 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -121.72 171.38 8.91 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.606 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.52 136.06 15.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.575 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 70' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' F' ' 157' ' ' GLN . . . -94.47 157.92 15.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.101 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.36 106.25 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.682 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 72' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' F' ' 155' ' ' LYS . . . -109.53 164.35 12.6 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.64 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 73' ' ' PHE . . . . . 0.437 ' CE2' HG12 ' F' ' 103' ' ' ILE . 6.5 t80 -142.25 141.05 32.44 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.52 0.2 . . . . 0.0 111.151 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 74' ' ' LEU . . . . . 0.431 HD22 ' NZ ' ' F' ' 155' ' ' LYS . 0.1 OUTLIER -122.68 103.32 8.59 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.038 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . 0.562 ' HA3' HD22 ' F' ' 113' ' ' LEU . . . -153.42 -166.34 14.51 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.87 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.52 136.22 46.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.604 0.24 . . . . 0.0 110.714 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.4 156.09 25.58 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.925 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 78' ' ' ILE . . . . . 0.592 HG21 ' HB ' ' F' ' 85' ' ' VAL . 3.1 tt -92.51 -20.65 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.859 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 79' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.18 179.75 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.757 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.04 -33.76 44.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.48 -43.88 95.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.583 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 82' ' ' HIS . . . . . 0.466 ' NE2' ' O ' ' F' ' 139' ' ' ALA . 43.5 m-70 -97.83 -64.38 1.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.812 0.339 . . . . 0.0 110.436 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 1.2 m 62.35 7.83 2.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.582 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 84' ' ' ASN . . . . . 0.618 ' HB3' ' HB2' ' F' ' 110' ' ' ALA . 6.5 m120 -115.09 -25.48 8.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.32 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 85' ' ' VAL . . . . . 0.78 ' HA ' ' HA ' ' F' ' 102' ' ' GLN . 0.5 OUTLIER -79.53 143.75 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.199 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 86' ' ' LEU . . . . . 0.648 HD11 ' HB1' ' F' ' 152' ' ' ALA . 0.3 OUTLIER -76.62 148.57 36.87 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.392 179.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.87 178.22 4.39 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.799 0.333 . . . . 0.0 111.695 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . 0.478 ' H ' ' HG ' ' F' ' 88' ' ' LEU . 0.0 OUTLIER -84.72 176.2 8.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.069 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 89' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' F' ' 149' ' ' ASN . 22.8 pt20 -75.29 178.71 5.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.36 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.34 -11.48 60.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.052 0.454 . . . . 0.0 111.447 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 91' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' F' ' 95' ' ' SER . 0.3 OUTLIER -64.69 87.28 0.05 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.884 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.95 -7.12 53.84 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.961 0.41 . . . . 0.0 111.666 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.08 19.86 4.08 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.699 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.58 -15.62 0.16 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.895 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 95' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' F' ' 91' ' ' SER . 1.0 OUTLIER -97.34 174.97 6.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.934 0.397 . . . . 0.0 110.572 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 96' ' ' ALA . . . . . 0.47 ' O ' HD21 ' F' ' 88' ' ' LEU . . . -114.14 157.83 22.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.85 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.95 162.64 15.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.318 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 98' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 69.39 41.61 1.29 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.406 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 99' ' ' VAL . . . . . 0.79 ' HB ' ' HB3' ' F' ' 143' ' ' ALA . 10.4 p -177.65 130.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.8 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.1 179.46 28.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.523 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 101' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' F' ' 86' ' ' LEU . 1.6 t -99.07 95.28 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.068 0.547 . . . . 0.0 111.716 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 102' ' ' GLN . . . . . 0.78 ' HA ' ' HA ' ' F' ' 85' ' ' VAL . 1.9 tt0 -69.88 159.82 32.96 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.898 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 103' ' ' ILE . . . . . 0.606 HD13 HD23 ' F' ' 113' ' ' LEU . 0.9 OUTLIER -121.65 98.39 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.538 179.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 104' ' ' LEU . . . . . 0.69 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 1.1 tp -84.76 119.39 25.23 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 111.082 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.15 158.08 32.1 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.701 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 106' ' ' ARG . . . . . 0.535 ' HB2' ' HB2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -61.16 -33.86 74.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.881 0.372 . . . . 0.0 111.093 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 107' ' ' THR . . . . . 0.561 HG21 ' HA ' ' F' ' 120' ' ' SER . 0.0 OUTLIER -48.77 -38.18 21.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.094 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.7 -88.77 0.11 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.597 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 109' ' ' ALA . . . . . 0.417 ' HA ' HD12 ' F' ' 104' ' ' LEU . . . -79.23 -176.32 5.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.351 . . . . 0.0 111.111 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . 0.69 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -79.96 143.92 33.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.1 157.53 17.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.359 0.6 . . . . 0.0 110.566 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 112' ' ' THR . . . . . . . . . . . . . 29.5 m -81.13 150.4 28.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.127 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 113' ' ' LEU . . . . . 0.606 HD23 HD13 ' F' ' 103' ' ' ILE . 3.0 mp -102.75 57.77 0.78 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.737 0.303 . . . . 0.0 110.696 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.47 19.63 15.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.56 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.26 -93.11 0.88 Allowed Glycine 0 C--N 1.328 0.13 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.628 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.7 69.57 1.08 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.083 0.468 . . . . 0.0 111.589 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 117' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' F' ' 72' ' ' ALA . 5.8 p -89.65 97.28 11.11 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.145 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.08 102.77 5.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.736 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.5 -82.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 120' ' ' SER . . . . . 0.561 ' HA ' HG21 ' F' ' 107' ' ' THR . 0.1 OUTLIER -63.25 100.89 0.26 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.609 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.91 79.07 7.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.186 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 122' ' ' THR . . . . . 0.575 HG21 ' HG2' ' F' ' 132' ' ' PRO . 4.6 p -82.56 159.18 22.84 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.701 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 123' ' ' THR . . . . . 0.457 HG23 ' N ' ' F' ' 124' ' ' LEU . 16.1 m -85.29 139.73 31.37 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.708 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . 0.457 ' N ' HG23 ' F' ' 123' ' ' THR . 0.4 OUTLIER -92.42 136.13 33.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.617 179.362 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 125' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' C' ' 116' ' ' ALA . 25.0 m120 -120.78 143.65 48.71 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.577 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.27 148.95 34.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.626 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.68 -106.22 2.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.745 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 128' ' ' THR . . . . . 0.403 ' HB ' ' HD3' ' C' ' 155' ' ' LYS . 1.9 m -85.18 153.22 22.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.7 0.286 . . . . 0.0 110.757 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 129' ' ' ASN . . . . . 0.576 ' HB3' ' HB2' ' F' ' 58' ' ' LEU . 23.2 t-20 -148.43 120.71 8.39 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.909 0.385 . . . . 0.0 111.035 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 130' ' ' THR . . . . . 0.615 ' HG1' ' CD1' ' C' ' 74' ' ' LEU . 0.2 OUTLIER -104.19 147.33 27.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.14 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 131' ' ' ILE . . . . . 0.604 HD13 HD11 ' F' ' 58' ' ' LEU . 89.7 mt -116.64 119.18 36.12 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 132' ' ' PRO . . . . . 0.611 ' HB3' ' H ' ' C' ' 77' ' ' ALA . 7.6 Cg_endo -80.96 119.09 3.5 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 121.653 1.569 . . . . 0.0 112.531 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.98 147.29 29.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.756 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.09 155.92 47.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.041 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . 0.535 ' HB3' HG22 ' F' ' 52' ' ' VAL . . . -140.07 115.69 10.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.884 0.373 . . . . 0.0 111.598 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.32 149.02 31.72 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.479 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 137' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' F' ' 48' ' ' THR . 0.2 OUTLIER -70.64 151.3 45.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.073 179.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 138' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' F' ' 47' ' ' ALA . 0.2 OUTLIER -144.5 164.6 30.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.97 -179.121 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 139' ' ' ALA . . . . . 0.617 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -124.46 145.68 49.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.869 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 140' ' ' THR . . . . . 0.48 ' OG1' HG12 ' F' ' 78' ' ' ILE . 0.2 OUTLIER -117.75 12.99 14.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.512 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.81 79.83 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.874 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.59 92.19 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.62 0.21 . . . . 0.0 110.762 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 143' ' ' ALA . . . . . 0.79 ' HB3' ' HB ' ' F' ' 99' ' ' VAL . . . -64.1 154.81 33.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.756 0.312 . . . . 0.0 111.377 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 144' ' ' THR . . . . . 0.524 ' O ' ' HB ' ' E' ' 16' ' ' VAL . 39.4 p -116.71 166.21 13.33 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.208 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 145' ' ' PRO . . . . . 0.423 ' HA ' ' HB ' ' E' ' 16' ' ' VAL . 1.3 Cg_endo -84.29 151.47 12.14 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.445 2.097 . . . . 0.0 111.975 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.64 -106.23 0.45 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.443 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 147' ' ' ALA . . . . . . . . . . . . . . . -139.11 163.26 32.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.783 0.325 . . . . 0.0 111.357 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.98 79.9 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.498 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 149' ' ' ASN . . . . . 0.504 ' HB2' ' HB3' ' F' ' 89' ' ' GLN . 87.2 m-20 -99.93 142.51 31.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.593 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 150' ' ' ALA . . . . . 0.583 ' HB3' ' HB3' ' F' ' 86' ' ' LEU . . . -127.83 169.06 14.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.042 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 151' ' ' ASP . . . . . 0.407 ' OD2' ' HD2' ' E' ' 11' ' ' HIS . 4.2 t70 -165.59 109.91 0.85 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.186 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 152' ' ' ALA . . . . . 0.648 ' HB1' HD11 ' F' ' 86' ' ' LEU . . . -146.95 145.4 29.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.123 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.63 164.17 13.26 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 154' ' ' PHE . . . . . 0.494 ' CZ ' ' HA3' ' E' ' 7' ' ' GLY . 15.0 p90 -110.87 151.61 27.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.178 0.513 . . . . 0.0 110.125 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . 0.533 ' HB3' ' HB1' ' F' ' 72' ' ' ALA . 0.0 OUTLIER -109.69 160.95 15.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.893 -178.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 156' ' ' VAL . . . . . 0.491 HG11 ' HE2' ' F' ' 154' ' ' PHE . 1.5 m -142.19 112.84 2.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.846 0.355 . . . . 0.0 111.688 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 157' ' ' GLN . . . . . 0.625 ' HB3' ' HB2' ' F' ' 70' ' ' ALA . 0.3 OUTLIER -91.82 124.46 35.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.276 0.56 . . . . 0.0 110.429 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . 0.567 ' HH ' HD21 ' F' ' 58' ' ' LEU . 57.5 m-85 -117.19 135.51 53.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.462 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.888 179.9 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' B' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.254 0.073 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.633 ' H ' ' HA ' ' B' ' 159' ' ' GLN . . . 59.07 55.86 4.22 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.649 0.261 . . . . 0.0 111.027 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.532 HG23 HD21 ' B' ' 18' ' ' ASN . 90.2 m -118.7 111.08 18.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.379 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.719 HG22 ' HG3' ' B' ' 157' ' ' GLN . 0.2 OUTLIER -97.77 127.36 43.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.554 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.535 HG22 HG12 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -153.57 171.5 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.578 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.42 122.1 36.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.608 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.413 ' HA3' HG11 ' B' ' 156' ' ' VAL . . . -76.0 -52.18 6.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.855 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.42 -145.43 5.81 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.886 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.81 139.81 25.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 111.28 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.4 121.6 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.136 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.59 106.61 18.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.324 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.437 ' HZ ' ' CZ ' ' B' ' 54' ' ' PHE . 8.9 m-85 -90.65 107.61 19.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.577 ' HG2' HD21 ' B' ' 149' ' ' ASN . 0.1 OUTLIER -103.26 149.25 24.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.383 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.45 -179.07 47.54 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.902 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.64 ' HB3' ' HG3' ' B' ' 36' ' ' GLN . 0.1 OUTLIER -158.97 157.02 30.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.845 0.355 . . . . 0.0 110.394 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.8 t -113.71 132.23 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.245 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.764 HG13 ' HG2' ' B' ' 36' ' ' GLN . 5.5 m -136.88 176.58 7.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.887 0.375 . . . . 0.0 111.024 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.46 174.07 9.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.021 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 62' ' ' ASP . . . -83.37 35.35 0.49 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.066 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . . . -116.89 -15.93 10.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.429 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.476 ' HB3' ' HH ' ' A' ' 158' ' ' TYR . 0.1 OUTLIER -179.98 155.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.97 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.76 126.48 5.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.052 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.713 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -60.87 162.49 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.037 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 27' ' ' SER . 18.6 t70 -97.6 161.0 13.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.588 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.31 95.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.353 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.47 12.76 69.0 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.935 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.539 ' HB3' ' HB3' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -113.79 -25.6 8.57 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.92 0.39 . . . . 0.0 110.837 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.6 t -41.04 -62.02 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.373 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.57 119.96 39.59 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.033 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -126.09 119.13 26.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.033 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.71 103.32 15.48 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.115 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.88 115.12 43.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.168 0.509 . . . . 0.0 110.475 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.53 112.61 24.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.671 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.86 -30.36 58.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.622 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.02 -170.25 27.44 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.562 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.46 141.8 28.05 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.653 0.263 . . . . 0.0 110.871 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.8 p -125.34 157.14 34.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.88 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.53 122.46 29.04 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.704 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -40.39 87.01 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.774 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.51 -35.88 68.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.06 0.457 . . . . 0.0 110.773 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.13 -21.51 33.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.162 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' A' ' 139' ' ' ALA . 3.2 mp -110.51 29.49 7.67 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.579 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 141' ' ' GLY . . . -108.19 25.46 11.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.387 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.66 159.96 23.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.414 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.644 ' HA ' ' O ' ' A' ' 140' ' ' THR . 11.1 tt0 -82.87 108.66 16.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 0.0 111.166 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.93 10.84 51.54 Favored Glycine 0 C--N 1.33 0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.18 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.58 123.48 20.17 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.957 0.408 . . . . 0.0 112.014 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -120.64 140.28 51.79 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.828 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 4.6 m -101.65 -167.01 1.36 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.614 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.64 139.7 53.59 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.783 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.86 133.99 35.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.369 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 135' ' ' ALA . 18.8 m -87.0 166.49 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.927 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.7 128.83 7.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.63 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 133' ' ' PHE . 40.7 p90 -160.23 134.48 7.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.731 0.3 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.43 ' OD1' ' CG2' ' A' ' 130' ' ' THR . 16.0 p30 -132.87 147.73 52.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.494 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.609 HG22 HD13 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -96.89 116.82 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.496 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.513 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -66.59 122.08 16.79 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.754 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.713 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -137.42 88.17 2.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.218 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.703 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 10.5 p30 -79.53 179.31 7.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.955 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.39 64.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 129' ' ' ASN . 4.4 m -110.53 163.23 13.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.839 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -140.14 155.02 47.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.287 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.24 -25.33 10.66 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -81.96 -16.38 50.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.156 0.503 . . . . 0.0 111.822 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 t -90.65 -48.41 14.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.662 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' A' ' 20' ' ' ALA . . . -140.11 142.9 36.03 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.637 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.8 -53.79 2.6 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.846 0.355 . . . . 0.0 110.995 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -94.86 158.16 15.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.514 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' A' ' 122' ' ' THR . . . -137.21 120.46 16.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.588 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 118' ' ' PHE . . . -97.57 129.17 44.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.096 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.542 HG13 HG21 ' A' ' 131' ' ' ILE . 15.9 t -113.05 152.23 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.672 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.421 ' H ' HG12 ' A' ' 71' ' ' VAL . . . -149.98 146.58 27.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.606 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.492 ' HB3' HD23 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -111.54 141.89 44.53 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.577 0.227 . . . . 0.0 111.067 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -105.7 103.31 12.8 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.934 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.418 ' HA3' HD22 ' A' ' 113' ' ' LEU . . . -149.87 -179.11 25.42 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.837 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.692 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.2 OUTLIER -105.16 157.79 17.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.57 0.224 . . . . 0.0 110.771 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.85 132.82 38.17 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.876 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.458 HG21 ' HB ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER -66.61 -39.87 84.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.21 53.55 1.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.788 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' D' ' 106' ' ' ARG . . . 61.42 -87.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.038 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.29 -36.55 53.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.594 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.43 ' HB2' HG22 ' A' ' 78' ' ' ILE . 78.0 m80 -81.34 59.93 4.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.865 0.364 . . . . 0.0 110.445 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -70.59 -20.41 62.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.483 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.877 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 26.5 p-10 -69.45 -13.73 62.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.29 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 102' ' ' GLN . 40.7 t -108.97 131.2 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.109 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.581 HD12 HD21 ' A' ' 113' ' ' LEU . 0.6 OUTLIER -70.05 142.81 52.65 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.305 179.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.91 -170.52 3.05 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.946 0.403 . . . . 0.0 111.709 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 88' ' ' LEU . 1.2 mm? -80.04 161.4 25.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.02 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.73 -80.32 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.31 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.436 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 6.6 p -171.33 0.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.95 0.405 . . . . 0.0 111.446 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.605 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 73.4 m -76.81 85.65 3.4 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.902 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' D' ' 50' ' ' SER . . . -60.98 -32.34 71.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.86 0.362 . . . . 0.0 111.641 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.79 30.52 6.85 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.627 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.78 -3.14 0.11 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.92 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 0.1 OUTLIER -107.57 -176.72 3.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.882 0.372 . . . . 0.0 110.652 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.54 172.68 8.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.796 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.603 ' H ' ' HB ' ' A' ' 144' ' ' THR . 1.7 m -126.95 140.47 52.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.29 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.425 ' HB3' ' H ' ' A' ' 141' ' ' GLY . 68.4 m-80 61.96 21.23 12.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.495 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.29 135.99 58.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.724 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.97 -160.62 10.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.531 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.499 HG11 ' HB2' ' A' ' 86' ' ' LEU . 4.4 p -145.96 109.88 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.173 0.511 . . . . 0.0 111.677 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.65 ' HB2' HG23 ' A' ' 85' ' ' VAL . 0.5 OUTLIER -84.37 147.38 27.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.936 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.607 HG12 ' HG ' ' A' ' 113' ' ' LEU . 1.2 pp -110.72 127.84 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.501 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 1.4 tp -97.37 132.95 42.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.686 0.279 . . . . 0.0 111.045 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.603 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . 4.0 t0 -80.82 143.61 32.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.675 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -65.46 -17.5 64.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.838 0.351 . . . . 0.0 111.083 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.509 HG23 ' HB3' ' A' ' 105' ' ' ASP . 13.2 t -66.89 -20.61 65.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.001 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.08 -71.77 0.44 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.68 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.53 160.02 31.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.819 0.343 . . . . 0.0 111.044 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -75.66 131.46 39.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.603 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 12.2 tp -88.1 154.18 20.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.351 0.596 . . . . 0.0 110.6 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.877 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -96.37 142.7 28.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.145 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.607 ' HG ' HG12 ' A' ' 103' ' ' ILE . 0.8 OUTLIER -80.79 63.65 5.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.715 0.293 . . . . 0.0 110.747 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.63 -30.63 17.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.547 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.506 ' HA3' ' OG1' ' D' ' 130' ' ' THR . . . 115.75 -43.6 1.64 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.721 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.46 24.39 13.03 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.011 0.434 . . . . 0.0 111.717 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.585 HG23 HD12 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -82.22 68.35 8.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 157' ' ' GLN . 40.8 m-85 -82.19 71.96 9.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.744 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.71 81.11 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.797 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.75 131.75 13.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.604 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.403 ' O ' ' HE2' ' A' ' 68' ' ' LYS . 1.5 mm-40 -100.72 52.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.232 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -72.14 132.02 43.59 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.734 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.81 107.71 15.63 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.638 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.407 HD13 ' CB ' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -88.27 126.53 35.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.563 179.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.494 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 1.1 m120 -120.62 -178.95 3.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.544 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.515 ' OD1' ' HA ' ' A' ' 62' ' ' ASP . 3.8 t30 -83.27 120.65 26.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.659 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.16 -121.79 2.53 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.686 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.703 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 75.6 m -122.14 103.41 8.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.7 0.286 . . . . 0.0 110.806 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.51 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 1.7 t30 -86.14 157.21 20.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.907 0.384 . . . . 0.0 111.144 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.513 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.3 OUTLIER -143.26 130.27 20.63 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.072 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.542 HG21 HG13 ' A' ' 71' ' ' VAL . 57.5 mt -84.21 104.24 4.04 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 7.6 Cg_endo -81.99 112.29 2.3 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.63 1.554 . . . . 0.0 112.629 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 54' ' ' PHE . 1.0 OUTLIER -126.67 158.32 36.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.856 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -126.01 156.04 40.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.083 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.472 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -148.22 105.18 3.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.96 0.409 . . . . 0.0 111.615 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.08 163.46 12.57 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.351 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.519 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 0.3 OUTLIER -81.71 119.73 24.22 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.099 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.84 142.62 39.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.213 0.53 . . . . 0.0 112.06 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.562 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . . . -132.96 136.0 45.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.904 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.644 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 25.2 p -96.58 -56.16 2.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.519 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 43' ' ' ALA . . . -127.06 -129.88 3.31 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.044 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.91 107.12 12.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.647 0.224 . . . . 0.0 110.781 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -65.87 148.03 52.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.687 0.28 . . . . 0.0 111.466 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.603 ' HB ' ' H ' ' A' ' 97' ' ' THR . 48.5 m -114.82 144.68 32.42 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.284 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.417 ' HD2' HG22 ' A' ' 144' ' ' THR . 1.3 Cg_endo -81.9 130.98 6.84 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.521 2.147 . . . . 0.0 111.982 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 164.82 -116.28 0.69 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.492 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.62 150.39 29.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.826 0.346 . . . . 0.0 111.397 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.69 45.93 1.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.078 0.466 . . . . 0.0 110.402 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.96 141.07 30.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.505 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -153.72 162.6 41.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.959 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -133.99 135.37 43.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.252 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -134.1 152.51 51.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.174 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.9 m -104.13 148.96 25.68 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.29 141.89 35.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.108 0.48 . . . . 0.0 110.106 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.59 152.36 40.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.896 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.1 m -135.7 133.19 51.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.808 0.337 . . . . 0.0 111.704 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.544 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . 1.8 tt0 -130.91 119.77 22.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.271 0.557 . . . . 0.0 110.407 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.476 ' HH ' ' HB3' ' A' ' 21' ' ' CYS . 14.0 m-85 -101.95 113.31 26.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.57 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.414 ' NE2' ' HB3' ' A' ' 157' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.835 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' C' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.24 0.066 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.632 ' H ' ' HA ' ' C' ' 159' ' ' GLN . . . 59.14 55.8 4.21 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.081 0.238 . . . . 0.0 110.992 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.54 HG23 HD21 ' C' ' 18' ' ' ASN . 89.7 m -118.64 111.08 18.09 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.467 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.696 HG21 ' HA2' ' F' ' 127' ' ' GLY . 0.2 OUTLIER -97.78 127.33 43.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.572 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.535 HG22 HG12 ' C' ' 17' ' ' VAL . 0.0 OUTLIER -153.54 171.53 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.582 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.48 122.09 36.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.562 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . 0.414 ' HA3' HG11 ' C' ' 156' ' ' VAL . . . -75.84 -52.34 6.47 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.861 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.43 -145.44 5.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.846 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.76 139.86 25.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 111.254 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 45.3 t -122.4 121.61 64.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.148 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -99.69 106.6 18.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.369 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . 0.42 ' HZ ' ' CZ ' ' C' ' 54' ' ' PHE . 8.8 m-85 -90.6 107.59 19.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.574 ' HG2' HD21 ' C' ' 149' ' ' ASN . 0.1 OUTLIER -103.26 149.21 24.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.376 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.42 -179.01 47.49 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.98 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.642 ' HB3' ' HG3' ' C' ' 36' ' ' GLN . 0.1 OUTLIER -158.97 157.04 30.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.915 0.388 . . . . 0.0 110.377 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.423 ' O ' HG11 ' A' ' 5' ' ' VAL . 18.0 t -113.77 132.25 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.199 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.761 HG13 ' HG2' ' C' ' 36' ' ' GLN . 5.5 m -136.9 176.56 7.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.11 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . 0.532 HD21 HG23 ' A' ' 3' ' ' THR . 0.4 OUTLIER -74.4 174.1 9.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.038 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' B' ' 62' ' ' ASP . . . -83.39 35.28 0.49 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.014 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.552 ' HB3' ' HB2' ' B' ' 66' ' ' ALA . . . -116.81 -15.93 10.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.466 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.48 ' HB3' ' HH ' ' B' ' 158' ' ' TYR . 0.1 OUTLIER 180.0 155.23 0.59 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.915 -179.845 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.69 126.42 5.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.074 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.707 ' HA ' ' HG ' ' B' ' 58' ' ' LEU . 0.7 OUTLIER -60.82 162.51 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.046 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' B' ' 27' ' ' SER . 18.5 t70 -97.56 161.0 13.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.634 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.45 96.27 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.346 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.39 12.75 69.08 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.953 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' SER . . . . . 0.539 ' HB3' ' HB3' ' B' ' 24' ' ' ASP . 0.6 OUTLIER -113.79 -25.54 8.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 9.8 t -41.17 -62.01 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.28 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.56 119.97 39.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.055 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -126.1 119.11 26.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.058 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.71 103.31 15.46 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.158 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.81 115.11 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.11 0.481 . . . . 0.0 110.445 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.53 112.63 24.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.592 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.86 -30.39 58.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.6 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.07 -170.23 27.36 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.622 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.764 ' HG2' HG13 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -93.55 141.72 28.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.595 0.235 . . . . 0.0 110.88 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 5.8 p -125.22 157.18 34.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.899 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.56 122.39 28.96 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.735 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -40.52 86.96 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.756 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.44 -35.84 68.31 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.112 0.482 . . . . 0.0 110.842 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.1 -21.55 33.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.175 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' B' ' 139' ' ' ALA . 3.2 mp -110.5 29.49 7.66 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.666 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' B' ' 141' ' ' GLY . . . -108.26 25.55 11.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.364 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.81 159.99 23.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.299 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' B' ' 140' ' ' THR . 11.0 tt0 -82.88 108.65 16.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 111.19 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.95 10.83 51.5 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.202 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.62 123.51 20.29 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -120.69 140.24 51.89 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.928 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' SER . . . . . 0.508 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 4.6 m -101.56 -166.97 1.35 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.686 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.74 139.71 53.38 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.784 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.77 134.01 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.321 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.473 HG22 ' O ' ' B' ' 135' ' ' ALA . 18.8 m -87.07 166.44 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.911 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.69 128.83 7.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.634 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . 0.437 ' CZ ' ' HZ ' ' A' ' 12' ' ' PHE . 40.6 p90 -160.23 134.5 7.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.793 0.33 . . . . 0.0 110.932 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.43 ' OD1' ' CG2' ' B' ' 130' ' ' THR . 15.9 p30 -132.79 147.69 52.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.58 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.61 HG22 HD13 ' B' ' 58' ' ' LEU . 1.0 OUTLIER -96.75 116.78 39.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.589 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . 0.514 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -66.6 122.01 16.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.724 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.707 ' HG ' ' HA ' ' B' ' 23' ' ' VAL . 0.2 OUTLIER -137.45 88.23 2.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.247 -179.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.699 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 10.6 p30 -79.63 179.35 7.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.877 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.3 64.37 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.837 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' B' ' 129' ' ' ASN . 4.4 m -110.48 163.27 13.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.808 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' B' ' 19' ' ' ALA . 0.5 OUTLIER -140.18 155.04 47.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.275 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.23 -25.35 10.65 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -82.02 -16.33 50.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.067 0.46 . . . . 0.0 111.736 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -90.66 -48.49 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.661 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.552 ' HB2' ' HB3' ' B' ' 20' ' ' ALA . . . -140.1 142.94 36.04 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.624 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.79 -53.89 2.59 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.842 0.353 . . . . 0.0 110.912 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' B' ' 121' ' ' GLU . 0.1 OUTLIER -94.77 158.16 15.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.519 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' B' ' 122' ' ' THR . . . -137.17 120.44 16.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.637 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' B' ' 118' ' ' PHE . . . -97.57 129.13 44.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.124 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.529 HG13 HG21 ' B' ' 131' ' ' ILE . 15.9 t -113.04 152.28 14.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.73 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.425 ' H ' HG12 ' B' ' 71' ' ' VAL . . . -149.99 146.57 27.09 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.554 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.482 ' HB3' HD23 ' B' ' 113' ' ' LEU . 0.1 OUTLIER -111.58 141.92 44.55 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.591 0.234 . . . . 0.0 111.098 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' B' ' 152' ' ' ALA . 0.8 OUTLIER -105.62 103.33 12.82 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.96 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . 0.419 ' HA3' HD22 ' B' ' 113' ' ' LEU . . . -149.91 -179.05 25.4 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.814 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.668 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.2 OUTLIER -105.25 157.78 17.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.533 0.206 . . . . 0.0 110.725 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.86 132.75 38.12 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.898 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.466 HG21 ' HB ' ' B' ' 85' ' ' VAL . 0.6 OUTLIER -66.68 -39.76 84.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.2 53.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' E' ' 106' ' ' ARG . . . 61.32 -87.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.03 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.33 -36.5 53.17 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.602 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.417 ' HB2' HG22 ' B' ' 78' ' ' ILE . 78.0 m80 -81.39 59.98 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.36 . . . . 0.0 110.447 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -70.61 -20.49 62.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.512 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . 0.863 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 26.6 p-10 -69.29 -13.74 62.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.352 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.651 HG23 ' HB2' ' B' ' 102' ' ' GLN . 40.8 t -108.97 131.15 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.127 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . 0.573 HD12 HD21 ' B' ' 113' ' ' LEU . 0.6 OUTLIER -70.11 142.84 52.53 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.014 -0.275 . . . . 0.0 110.308 179.42 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.97 -170.53 3.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.891 0.377 . . . . 0.0 111.752 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -80.04 161.43 25.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.037 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.78 -80.24 0.01 OUTLIER 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.315 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' SER . . . . . 0.457 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 6.5 p -171.42 0.5 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.993 0.425 . . . . 0.0 111.504 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' SER . . . . . 0.597 ' HA ' ' HB2' ' D' ' 25' ' ' ALA . 73.5 m -76.86 85.55 3.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.921 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.88 -32.33 71.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.968 0.413 . . . . 0.0 111.733 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.75 30.47 6.88 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.7 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.74 -3.22 0.11 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.945 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' B' ' 91' ' ' SER . 0.1 OUTLIER -107.5 -176.78 3.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 110.661 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.39 172.67 8.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.848 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.603 ' H ' ' HB ' ' B' ' 144' ' ' THR . 1.7 m -127.01 140.36 52.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.339 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . 0.431 ' HB3' ' H ' ' B' ' 141' ' ' GLY . 68.4 m-80 62.05 21.3 12.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.441 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.38 135.98 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.723 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.0 -160.77 10.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.569 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' B' ' 86' ' ' LEU . 4.5 p -145.84 109.85 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 122.974 0.51 . . . . 0.0 111.767 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.651 ' HB2' HG23 ' B' ' 85' ' ' VAL . 0.5 OUTLIER -84.33 147.33 27.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.881 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.599 HG12 ' HG ' ' B' ' 113' ' ' LEU . 1.2 pp -110.69 127.88 67.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.515 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . 0.584 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 1.4 tp -97.46 132.95 42.67 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.637 0.256 . . . . 0.0 111.003 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . 0.593 ' HB2' ' HB2' ' B' ' 111' ' ' LEU . 4.0 t0 -80.76 143.59 32.79 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.739 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -65.43 -17.55 64.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.817 0.341 . . . . 0.0 111.061 179.509 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' THR . . . . . 0.502 HG23 ' HB3' ' B' ' 105' ' ' ASP . 13.2 t -66.84 -20.65 65.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.011 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.05 -71.61 0.44 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.769 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.51 159.93 31.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.768 0.318 . . . . 0.0 111.139 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -75.54 131.49 40.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.162 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.594 HD12 HG23 ' B' ' 117' ' ' THR . 12.2 tp -88.1 154.22 20.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.331 0.586 . . . . 0.0 110.553 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.863 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 0.4 OUTLIER -96.43 142.71 28.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.155 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.599 ' HG ' HG12 ' B' ' 103' ' ' ILE . 0.8 OUTLIER -80.82 63.68 5.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.771 0.32 . . . . 0.0 110.708 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.63 -30.6 17.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.573 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . 0.51 ' HA3' ' OG1' ' E' ' 130' ' ' THR . . . 115.76 -43.58 1.64 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.617 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.58 24.43 12.97 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.006 0.431 . . . . 0.0 111.634 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' THR . . . . . 0.594 HG23 HD12 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -82.12 68.28 8.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.13 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.529 ' CD1' ' HB2' ' B' ' 157' ' ' GLN . 41.2 m-85 -82.15 71.93 9.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.798 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.74 80.98 1.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.831 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.62 131.75 13.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.614 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . 0.412 ' O ' ' HE2' ' B' ' 68' ' ' LYS . 1.5 mm-40 -100.74 52.15 0.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.151 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' B' ' 69' ' ' ALA . 0.2 OUTLIER -72.14 131.92 43.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.738 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.62 107.59 15.37 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.774 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.407 HD13 ' CB ' ' B' ' 69' ' ' ALA . 1.0 OUTLIER -88.18 126.54 35.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.604 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . 0.481 ' O ' ' HB3' ' B' ' 61' ' ' CYS . 1.1 m120 -120.65 -178.92 3.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.577 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' ASN . . . . . 0.513 ' OD1' ' HA ' ' B' ' 62' ' ' ASP . 3.7 t30 -83.27 120.64 26.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.732 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.13 -121.78 2.53 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.683 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.699 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 75.5 m -122.14 103.38 8.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.734 0.302 . . . . 0.0 110.783 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . 0.504 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 1.7 t30 -86.14 157.28 20.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.157 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.514 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.3 OUTLIER -143.32 130.22 20.51 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.064 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' ILE . . . . . 0.529 HG21 HG13 ' B' ' 71' ' ' VAL . 57.3 mt -84.09 104.22 3.96 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -82.09 112.48 2.3 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.611 1.541 . . . . 0.0 112.54 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.405 ' HB3' ' CZ ' ' B' ' 54' ' ' PHE . 1.0 OUTLIER -126.77 158.21 37.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.826 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -126.01 156.05 40.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.024 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.473 ' O ' HG22 ' B' ' 52' ' ' VAL . . . -148.17 105.12 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.922 0.391 . . . . 0.0 111.659 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -99.04 163.44 12.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.436 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . 0.508 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 0.3 OUTLIER -81.67 119.75 24.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.085 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.9 142.69 39.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.247 0.546 . . . . 0.0 112.012 -179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.561 ' HB3' ' HG ' ' B' ' 42' ' ' LEU . . . -132.97 136.0 45.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.918 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' THR . . . . . 0.649 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 25.3 p -96.53 -56.24 2.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.527 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' B' ' 43' ' ' ALA . . . -127.06 -129.83 3.3 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.03 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.01 107.15 12.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.682 0.241 . . . . 0.0 110.695 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' B' ' 97' ' ' THR . . . -65.94 148.12 52.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.765 0.317 . . . . 0.0 111.447 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.603 ' HB ' ' H ' ' B' ' 97' ' ' THR . 48.5 m -114.84 144.65 32.37 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.36 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.418 ' HD2' HG22 ' B' ' 144' ' ' THR . 1.3 Cg_endo -81.9 130.95 6.83 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.551 2.168 . . . . 0.0 111.967 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . 0.591 ' O ' ' HG3' ' A' ' 15' ' ' GLU . . . 164.86 -116.2 0.69 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.466 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . 0.612 ' HA ' ' HG3' ' A' ' 15' ' ' GLU . . . -110.77 150.34 29.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.932 0.396 . . . . 0.0 111.279 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.6 45.87 1.6 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.108 0.48 . . . . 0.0 110.479 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.577 HD21 ' HG2' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -96.86 141.02 30.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.609 -179.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -153.75 162.55 41.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.013 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.91 135.46 43.62 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.179 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -134.18 152.51 51.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.157 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 4.0 m -104.12 148.91 25.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.23 141.81 35.25 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.087 0.47 . . . . 0.0 110.141 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.53 152.34 40.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.905 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' VAL . . . . . 0.413 HG11 ' HA3' ' A' ' 7' ' ' GLY . 20.2 m -135.76 133.17 51.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 111.705 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.719 ' HG3' HG22 ' A' ' 4' ' ' THR . 1.8 tt0 -130.89 119.8 22.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.269 0.557 . . . . 0.0 110.405 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . 0.48 ' HH ' ' HB3' ' B' ' 21' ' ' CYS . 14.0 m-85 -101.97 113.19 26.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.564 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . 0.633 ' HA ' ' H ' ' A' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.852 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' D' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.232 0.063 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.649 ' H ' ' HA ' ' D' ' 159' ' ' GLN . . . 59.07 55.84 4.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.592 0.234 . . . . 0.0 111.018 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' THR . . . . . 0.513 HG23 HD21 ' D' ' 18' ' ' ASN . 89.2 m -118.61 111.1 18.13 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.448 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' THR . . . . . 0.685 HG22 ' HG3' ' D' ' 157' ' ' GLN . 0.2 OUTLIER -97.78 127.3 43.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.609 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . 0.542 HG22 HG12 ' D' ' 17' ' ' VAL . 0.0 OUTLIER -153.53 171.52 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.589 179.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.39 122.13 36.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.592 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . 0.419 ' HA3' HG11 ' D' ' 156' ' ' VAL . . . -75.96 -52.3 6.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.817 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.4 -145.56 5.86 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.889 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.75 139.83 25.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.975 0.417 . . . . 0.0 111.277 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.38 121.65 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.152 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -99.71 106.6 18.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.309 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' PHE . . . . . 0.43 ' HZ ' ' CZ ' ' D' ' 54' ' ' PHE . 8.9 m-85 -90.59 107.62 19.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.783 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . 0.57 ' HG2' HD21 ' D' ' 149' ' ' ASN . 0.1 OUTLIER -103.34 149.23 24.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.337 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.39 -179.08 47.5 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.922 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' GLU . . . . . 0.63 ' HB3' ' HG3' ' D' ' 36' ' ' GLN . 0.1 OUTLIER -158.96 157.1 30.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.906 0.384 . . . . 0.0 110.311 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.423 ' O ' HG11 ' B' ' 5' ' ' VAL . 17.9 t -113.79 132.08 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.284 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.75 HG13 ' HG2' ' D' ' 36' ' ' GLN . 5.4 m -136.78 176.62 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.803 0.335 . . . . 0.0 111.058 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . 0.54 HD21 HG23 ' B' ' 3' ' ' THR . 0.4 OUTLIER -74.42 174.15 9.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.058 -179.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' C' ' 62' ' ' ASP . . . -83.47 35.43 0.5 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.075 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' C' ' 66' ' ' ALA . . . -116.92 -15.94 10.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.435 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' CYS . . . . . 0.486 ' HB3' ' HH ' ' C' ' 158' ' ' TYR . 0.1 OUTLIER -179.94 155.31 0.6 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.91 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.78 126.37 5.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . 0.71 ' HA ' ' HG ' ' C' ' 58' ' ' LEU . 0.7 OUTLIER -60.74 162.53 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.112 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' C' ' 27' ' ' SER . 18.7 t70 -97.66 161.0 13.97 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.577 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.605 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -64.07 -40.37 96.12 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.389 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.43 12.79 68.96 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.91 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' C' ' 24' ' ' ASP . 0.6 OUTLIER -113.87 -25.52 8.58 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.865 0.364 . . . . 0.0 110.808 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 9.8 t -41.15 -61.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.35 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.55 119.95 39.56 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.085 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -126.14 119.15 26.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.984 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.69 103.32 15.48 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.078 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.86 115.13 43.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.145 0.498 . . . . 0.0 110.493 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.51 112.59 24.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.656 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.8 -30.4 59.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.692 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.03 -170.17 27.36 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.613 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . 0.761 ' HG2' HG13 ' B' ' 17' ' ' VAL . 0.4 OUTLIER -93.51 141.7 28.17 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.522 0.201 . . . . 0.0 110.887 -179.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 5.7 p -125.29 157.11 34.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.916 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.53 122.41 28.98 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.727 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -40.44 87.01 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.754 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.46 -35.87 68.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.05 0.452 . . . . 0.0 110.797 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.19 -21.39 33.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.16 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' C' ' 139' ' ' ALA . 3.2 mp -110.51 29.45 7.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.566 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' C' ' 141' ' ' GLY . . . -108.2 25.45 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.321 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.74 159.92 23.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.341 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' C' ' 140' ' ' THR . 11.0 tt0 -82.8 108.68 16.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.853 0.358 . . . . 0.0 111.168 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.9 10.91 51.52 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.163 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.76 123.49 20.27 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.933 0.396 . . . . 0.0 112.061 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -120.65 140.25 51.84 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.874 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 4.6 m -101.62 -167.02 1.36 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.611 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.68 139.65 53.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.786 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' C' ' 134' ' ' GLN . . . -82.82 133.95 35.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.309 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . 0.476 HG22 ' O ' ' C' ' 135' ' ' ALA . 18.7 m -86.94 166.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.016 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.74 128.76 7.94 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.637 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . 0.42 ' CZ ' ' HZ ' ' B' ' 12' ' ' PHE . 40.7 p90 -160.17 134.48 7.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.429 ' OD1' ' CG2' ' C' ' 130' ' ' THR . 15.8 p30 -132.75 147.73 52.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.583 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.595 HG12 HD12 ' C' ' 58' ' ' LEU . 1.0 OUTLIER -96.75 116.7 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.621 -179.749 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.525 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.0 OUTLIER -66.58 122.06 16.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.696 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . 0.71 ' HG ' ' HA ' ' C' ' 23' ' ' VAL . 0.2 OUTLIER -137.43 88.17 2.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.23 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . 0.706 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 10.5 p30 -79.6 179.4 7.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.88 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.3 64.46 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.783 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' C' ' 129' ' ' ASN . 4.4 m -110.53 163.26 13.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.786 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . 0.569 ' HB2' ' O ' ' C' ' 19' ' ' ALA . 0.5 OUTLIER -140.21 155.07 47.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.254 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.34 -25.31 10.63 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -82.08 -16.25 50.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.061 0.458 . . . . 0.0 111.745 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 16.6 t -90.66 -48.46 14.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.661 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . 0.547 ' HB2' ' HB3' ' C' ' 20' ' ' ALA . . . -140.11 142.9 36.02 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.639 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.82 -53.81 2.6 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.847 0.356 . . . . 0.0 110.971 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' C' ' 121' ' ' GLU . 0.1 OUTLIER -94.79 158.16 15.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.491 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' C' ' 122' ' ' THR . . . -137.22 120.47 16.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.611 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.407 ' HB2' ' HB3' ' C' ' 118' ' ' PHE . . . -97.54 129.03 44.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.137 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . 0.528 HG13 HG21 ' C' ' 131' ' ' ILE . 15.8 t -112.96 152.24 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.718 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . 0.423 ' H ' HG12 ' C' ' 71' ' ' VAL . . . -150.01 146.63 27.1 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.588 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' PHE . . . . . 0.491 ' HB3' HD23 ' C' ' 113' ' ' LEU . 0.1 OUTLIER -111.53 141.88 44.54 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.5 0.191 . . . . 0.0 111.092 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' C' ' 152' ' ' ALA . 0.8 OUTLIER -105.72 103.24 12.7 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.974 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . 0.421 ' HA3' HD22 ' C' ' 113' ' ' LEU . . . -149.88 -179.11 25.43 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.789 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' THR . . . . . 0.674 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.2 OUTLIER -105.15 157.85 16.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.595 0.236 . . . . 0.0 110.73 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.89 132.79 38.1 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.881 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . 0.447 HG21 ' HB ' ' C' ' 85' ' ' VAL . 0.6 OUTLIER -66.58 -39.88 84.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.19 53.58 1.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.824 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' F' ' 106' ' ' ARG . . . 61.42 -87.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.065 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.37 -36.51 53.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.576 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . 0.426 ' HB2' HG22 ' C' ' 78' ' ' ILE . 78.0 m80 -81.37 59.97 4.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.883 0.373 . . . . 0.0 110.451 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -70.53 -20.53 62.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.49 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' ASN . . . . . 0.876 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 26.6 p-10 -69.34 -13.73 62.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.334 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' C' ' 102' ' ' GLN . 40.9 t -109.0 131.15 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.129 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.579 HD12 HD21 ' C' ' 113' ' ' LEU . 0.6 OUTLIER -70.07 142.85 52.61 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.324 179.42 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.0 -170.58 3.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.882 0.372 . . . . 0.0 111.71 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -79.89 161.44 25.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.102 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.75 -80.33 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.34 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' SER . . . . . 0.458 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 6.6 p -171.34 0.49 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.949 0.404 . . . . 0.0 111.481 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' SER . . . . . 0.62 ' HA ' ' HB2' ' E' ' 25' ' ' ALA . 73.5 m -76.84 85.66 3.42 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.23 71.86 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.876 0.369 . . . . 0.0 111.649 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.86 30.47 6.87 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.642 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.64 -3.26 0.11 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.947 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' SER . . . . . 0.598 ' HB2' ' HB2' ' C' ' 91' ' ' SER . 0.1 OUTLIER -107.54 -176.71 3.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.834 0.35 . . . . 0.0 110.656 179.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.49 172.58 8.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' THR . . . . . 0.587 ' H ' ' HB ' ' C' ' 144' ' ' THR . 1.6 m -126.93 140.4 52.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.351 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . 0.43 ' HB3' ' H ' ' C' ' 141' ' ' GLY . 68.4 m-80 61.96 21.39 12.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.472 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.44 136.0 58.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.727 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.94 -160.74 10.18 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.532 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' VAL . . . . . 0.501 HG11 ' HB2' ' C' ' 86' ' ' LEU . 4.5 p -145.94 109.85 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.067 0.547 . . . . 0.0 111.758 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' GLN . . . . . 0.659 ' HB2' HG23 ' C' ' 85' ' ' VAL . 0.5 OUTLIER -84.27 147.38 27.26 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.93 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . 0.589 HG12 ' HG ' ' C' ' 113' ' ' LEU . 1.2 pp -110.79 127.86 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.529 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' LEU . . . . . 0.585 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 1.4 tp -97.43 132.94 42.66 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.663 0.268 . . . . 0.0 111.02 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . 0.583 ' HB2' ' HB2' ' C' ' 111' ' ' LEU . 4.0 t0 -80.78 143.58 32.77 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.688 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -65.42 -17.53 64.61 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.815 0.341 . . . . 0.0 111.043 179.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' THR . . . . . 0.51 HG23 ' HB3' ' C' ' 105' ' ' ASP . 13.2 t -66.83 -20.59 65.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.028 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.08 -71.85 0.44 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.682 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.5 159.97 31.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.825 0.345 . . . . 0.0 111.11 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.585 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -75.54 131.52 40.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' LEU . . . . . 0.586 HD12 HG23 ' C' ' 117' ' ' THR . 12.2 tp -88.14 154.22 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.379 0.609 . . . . 0.0 110.514 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' THR . . . . . 0.876 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 0.4 OUTLIER -96.37 142.66 28.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.147 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.589 ' HG ' HG12 ' C' ' 103' ' ' ILE . 0.8 OUTLIER -80.76 63.61 5.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.783 0.325 . . . . 0.0 110.761 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.7 -30.54 17.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.547 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . 0.512 ' HA3' ' OG1' ' F' ' 130' ' ' THR . . . 115.76 -43.57 1.65 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.595 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.49 24.33 13.11 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.003 0.43 . . . . 0.0 111.679 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' THR . . . . . 0.586 HG23 HD12 ' C' ' 111' ' ' LEU . 0.2 OUTLIER -82.15 68.37 8.52 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.118 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' PHE . . . . . 0.543 ' CD1' ' HB2' ' C' ' 157' ' ' GLN . 41.0 m-85 -82.2 72.0 9.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.801 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.76 80.99 1.86 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.65 131.75 13.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.606 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . 0.411 ' O ' ' HE2' ' C' ' 68' ' ' LYS . 1.5 mm-40 -100.76 52.2 0.86 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.212 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' C' ' 69' ' ' ALA . 0.2 OUTLIER -72.11 131.89 43.45 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.75 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.7 107.65 15.49 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.745 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . 0.404 HD13 ' CB ' ' C' ' 69' ' ' ALA . 1.0 OUTLIER -88.26 126.58 35.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.561 179.465 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . 0.492 ' O ' ' HB3' ' C' ' 61' ' ' CYS . 1.1 m120 -120.66 -178.93 3.84 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.525 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' ASN . . . . . 0.513 ' OD1' ' HA ' ' C' ' 62' ' ' ASP . 3.8 t30 -83.25 120.61 26.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.784 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.18 -121.67 2.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.659 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' THR . . . . . 0.706 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 76.5 m -122.21 103.37 8.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.746 0.308 . . . . 0.0 110.78 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 129' ' ' ASN . . . . . 0.504 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 1.8 t30 -86.21 157.26 20.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.896 0.379 . . . . 0.0 111.091 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 130' ' ' THR . . . . . 0.525 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.3 OUTLIER -143.29 130.17 20.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.104 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 131' ' ' ILE . . . . . 0.528 HG21 HG13 ' C' ' 71' ' ' VAL . 56.8 mt -83.97 104.14 3.79 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 132' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' C' ' 106' ' ' ARG . 7.6 Cg_endo -82.0 112.34 2.31 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.673 1.582 . . . . 0.0 112.582 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.414 ' HB3' ' CZ ' ' C' ' 54' ' ' PHE . 1.0 OUTLIER -126.7 158.29 36.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.828 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 134' ' ' GLN . . . . . 0.401 ' HB3' ' HB3' ' C' ' 51' ' ' ALA . 16.0 mt-30 -126.0 156.1 40.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.059 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.476 ' O ' HG22 ' C' ' 52' ' ' VAL . . . -148.15 105.14 3.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 0.0 111.609 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.05 163.36 12.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.416 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 137' ' ' TYR . . . . . 0.521 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 0.3 OUTLIER -81.64 119.71 24.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.116 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.91 142.68 39.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.982 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 139' ' ' ALA . . . . . 0.561 ' HB3' ' HG ' ' C' ' 42' ' ' LEU . . . -132.98 136.04 45.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.851 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 140' ' ' THR . . . . . 0.649 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 25.1 p -96.6 -56.21 2.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.476 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . 0.43 ' H ' ' HB3' ' C' ' 98' ' ' ASN . . . -127.06 -129.84 3.3 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.013 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.03 107.14 12.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.631 0.216 . . . . 0.0 110.702 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 143' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' C' ' 97' ' ' THR . . . -65.89 148.09 52.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.753 0.311 . . . . 0.0 111.434 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 144' ' ' THR . . . . . 0.587 ' HB ' ' H ' ' C' ' 97' ' ' THR . 47.8 m -114.87 144.67 32.42 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.307 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 145' ' ' PRO . . . . . 0.427 ' HD2' HG22 ' C' ' 144' ' ' THR . 1.3 Cg_endo -81.96 130.97 6.78 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.479 2.119 . . . . 0.0 112.009 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . 0.6 ' O ' ' HG3' ' B' ' 15' ' ' GLU . . . 164.89 -116.26 0.69 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.438 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 147' ' ' ALA . . . . . 0.6 ' HA ' ' HG3' ' B' ' 15' ' ' GLU . . . -110.67 150.37 29.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 111.351 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.67 45.89 1.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.46 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 149' ' ' ASN . . . . . 0.574 HD21 ' HG2' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -96.83 141.0 30.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.618 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 150' ' ' ALA . . . . . . . . . . . . . . . -153.7 162.62 41.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.047 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.93 135.5 43.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.198 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -134.16 152.51 51.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.23 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 4.0 m -104.15 148.91 25.74 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.23 141.83 35.21 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.136 0.493 . . . . 0.0 110.165 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.54 152.41 40.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.916 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 156' ' ' VAL . . . . . 0.414 HG11 ' HA3' ' B' ' 7' ' ' GLY . 19.9 m -135.74 133.22 51.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.798 0.332 . . . . 0.0 111.684 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . 0.687 ' HG3' HG22 ' B' ' 4' ' ' THR . 1.8 tt0 -130.96 119.78 22.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.326 0.584 . . . . 0.0 110.397 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . 0.486 ' HH ' ' HB3' ' C' ' 21' ' ' CYS . 14.1 m-85 -101.93 113.24 26.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.577 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . 0.632 ' HA ' ' H ' ' B' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.836 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' E' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 111.105 0.039 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . 0.638 ' H ' ' HA ' ' E' ' 159' ' ' GLN . . . 59.11 55.8 4.22 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 123.104 0.253 . . . . 0.0 111.035 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' THR . . . . . 0.53 HG23 HD21 ' E' ' 18' ' ' ASN . 89.7 m -118.64 111.07 18.08 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.422 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' THR . . . . . 0.716 HG22 ' HG3' ' E' ' 157' ' ' GLN . 0.2 OUTLIER -97.76 127.33 43.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.524 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . 0.531 HG22 HG12 ' E' ' 17' ' ' VAL . 0.0 OUTLIER -153.53 171.46 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.634 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.37 122.09 36.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.637 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' GLY . . . . . 0.415 ' HA3' HG11 ' E' ' 156' ' ' VAL . . . -76.0 -52.23 6.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.802 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.46 -145.46 5.83 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.829 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.82 139.74 25.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.905 0.383 . . . . 0.0 111.299 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.33 121.63 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.125 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -99.65 106.66 18.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.361 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' PHE . . . . . 0.43 ' HZ ' ' CZ ' ' E' ' 54' ' ' PHE . 8.9 m-85 -90.65 107.59 19.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.797 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' LYS . . . . . 0.559 ' HG2' HD21 ' E' ' 149' ' ' ASN . 0.1 OUTLIER -103.29 149.18 24.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.404 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.42 -179.05 47.51 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.946 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' GLU . . . . . 0.641 ' HB3' ' HG3' ' E' ' 36' ' ' GLN . 0.1 OUTLIER -158.93 157.01 30.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.912 0.387 . . . . 0.0 110.358 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.421 ' O ' HG11 ' C' ' 5' ' ' VAL . 17.8 t -113.7 132.19 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.249 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . 0.751 HG13 ' HG2' ' E' ' 36' ' ' GLN . 5.5 m -136.85 176.58 7.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.829 0.347 . . . . 0.0 111.008 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' ASN . . . . . 0.513 HD21 HG23 ' C' ' 3' ' ' THR . 0.4 OUTLIER -74.36 174.11 9.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.068 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' D' ' 62' ' ' ASP . . . -83.4 35.32 0.49 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.059 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . 0.55 ' HB3' ' HB2' ' D' ' 66' ' ' ALA . . . -116.92 -15.9 10.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.398 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' CYS . . . . . 0.478 ' HB3' ' HH ' ' D' ' 158' ' ' TYR . 0.1 OUTLIER -179.99 155.22 0.59 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.962 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.67 126.47 5.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.077 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . 0.712 ' HA ' ' HG ' ' D' ' 58' ' ' LEU . 0.7 OUTLIER -60.9 162.44 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.057 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' D' ' 27' ' ' SER . 18.7 t70 -97.58 160.97 14.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.623 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.597 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -64.11 -40.25 95.79 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.398 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.49 12.75 69.02 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.914 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' SER . . . . . 0.529 ' HB3' ' HB3' ' D' ' 24' ' ' ASP . 0.6 OUTLIER -113.84 -25.47 8.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.846 0.355 . . . . 0.0 110.787 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 10.0 t -41.15 -61.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.306 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.64 120.0 39.65 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.03 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -126.07 119.1 26.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.024 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.76 103.33 15.47 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.083 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.88 115.1 43.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.163 0.506 . . . . 0.0 110.424 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.5 112.56 24.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.646 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.83 -30.34 58.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.626 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.98 -170.23 27.49 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.571 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' GLN . . . . . 0.75 ' HG2' HG13 ' C' ' 17' ' ' VAL . 0.4 OUTLIER -93.48 141.79 28.07 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.526 0.203 . . . . 0.0 110.944 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 5.8 p -125.3 157.14 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.827 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.58 122.39 28.97 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.729 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -40.47 86.94 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.753 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.48 -35.82 68.39 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.053 0.454 . . . . 0.0 110.8 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -21.44 33.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.133 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' D' ' 139' ' ' ALA . 3.3 mp -110.5 29.51 7.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.623 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' D' ' 141' ' ' GLY . . . -108.24 25.44 11.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.34 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.71 159.97 23.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.38 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' D' ' 140' ' ' THR . 11.1 tt0 -82.94 108.73 16.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.916 0.388 . . . . 0.0 111.127 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.97 10.78 51.51 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.116 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.66 123.47 20.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.94 0.4 . . . . 0.0 111.974 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 77.5 p -120.64 140.3 51.77 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.879 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 4.6 m -101.68 -167.02 1.36 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.61 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 8.1 t -69.63 139.64 53.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.791 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.79 133.99 35.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.335 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' VAL . . . . . 0.472 HG22 ' O ' ' D' ' 135' ' ' ALA . 18.9 m -87.04 166.48 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.896 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.77 128.87 7.99 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.614 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . 0.43 ' CZ ' ' HZ ' ' C' ' 12' ' ' PHE . 40.6 p90 -160.2 134.44 7.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.756 0.312 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' ASN . . . . . 0.426 ' OD1' ' CG2' ' D' ' 130' ' ' THR . 15.9 p30 -132.75 147.67 52.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.623 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.605 HG12 HD12 ' D' ' 58' ' ' LEU . 1.0 OUTLIER -96.74 116.75 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.567 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' GLN . . . . . 0.514 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.0 OUTLIER -66.61 122.04 16.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.744 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . 0.712 ' HG ' ' HA ' ' D' ' 23' ' ' VAL . 0.2 OUTLIER -137.4 88.17 2.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . 0.725 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 10.6 p30 -79.58 179.37 7.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.925 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.35 64.37 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.812 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' D' ' 129' ' ' ASN . 4.4 m -110.48 163.26 13.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.954 0.406 . . . . 0.0 110.761 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' D' ' 19' ' ' ALA . 0.5 OUTLIER -140.22 155.07 47.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.237 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.25 -25.36 10.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -81.99 -16.41 50.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.083 0.468 . . . . 0.0 111.703 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 t -90.61 -48.48 14.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.696 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.55 ' HB2' ' HB3' ' D' ' 20' ' ' ALA . . . -140.12 142.9 36.01 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.639 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.79 -53.82 2.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.848 0.356 . . . . 0.0 110.941 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' D' ' 121' ' ' GLU . 0.1 OUTLIER -94.86 158.1 15.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.482 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' ALA . . . . . 0.441 ' HB3' ' HB ' ' D' ' 122' ' ' THR . . . -137.14 120.48 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.621 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' D' ' 118' ' ' PHE . . . -97.62 129.1 44.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.06 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . 0.543 HG13 HG21 ' D' ' 131' ' ' ILE . 15.9 t -112.99 152.28 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.671 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' ALA . . . . . 0.421 ' H ' HG12 ' D' ' 71' ' ' VAL . . . -150.05 146.61 27.06 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.522 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' PHE . . . . . 0.493 ' HB3' HD23 ' D' ' 113' ' ' LEU . 0.1 OUTLIER -111.53 141.94 44.46 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.536 0.208 . . . . 0.0 111.092 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.8 OUTLIER -105.71 103.35 12.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.916 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . 0.42 ' HA3' HD22 ' D' ' 113' ' ' LEU . . . -149.96 -179.11 25.5 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.806 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 157.84 17.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.558 0.218 . . . . 0.0 110.732 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.9 132.75 38.07 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.87 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 78' ' ' ILE . . . . . 0.456 HG21 ' HB ' ' D' ' 85' ' ' VAL . 0.6 OUTLIER -66.61 -39.79 84.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.22 53.53 1.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.826 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.39 -87.54 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.33 -36.53 53.26 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.58 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . 0.43 ' HB2' HG22 ' D' ' 78' ' ' ILE . 77.9 m80 -81.31 59.99 4.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.472 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -70.58 -20.53 62.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.575 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . 0.874 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 26.6 p-10 -69.35 -13.7 62.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.296 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.644 HG23 ' HB2' ' D' ' 102' ' ' GLN . 40.8 t -108.96 131.1 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.203 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.582 HD12 HD21 ' D' ' 113' ' ' LEU . 0.6 OUTLIER -70.02 142.89 52.69 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.323 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.02 -170.5 3.06 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.884 0.373 . . . . 0.0 111.688 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' D' ' 88' ' ' LEU . 1.2 mm? -80.02 161.44 25.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.022 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.76 -80.25 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.357 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 6.5 p -171.41 0.48 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 111.445 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 91' ' ' SER . . . . . 0.608 ' HA ' ' HB2' ' F' ' 25' ' ' ALA . 73.4 m -76.83 85.55 3.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.912 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.87 -32.32 71.76 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.655 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.83 30.45 6.88 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.641 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.71 -3.12 0.11 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.953 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 95' ' ' SER . . . . . 0.585 ' HB2' ' HB2' ' D' ' 91' ' ' SER . 0.1 OUTLIER -107.57 -176.79 3.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 110.638 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.56 172.58 8.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.811 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 97' ' ' THR . . . . . 0.597 ' H ' ' HB ' ' D' ' 144' ' ' THR . 1.7 m -126.86 140.43 52.36 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.288 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 98' ' ' ASN . . . . . 0.428 ' HB3' ' H ' ' D' ' 141' ' ' GLY . 68.3 m-80 61.95 21.36 12.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.427 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.35 136.02 58.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.742 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.0 -160.77 10.21 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.513 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 101' ' ' VAL . . . . . 0.511 HG11 ' HB2' ' D' ' 86' ' ' LEU . 4.5 p -145.9 109.85 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.168 0.509 . . . . 0.0 111.762 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 102' ' ' GLN . . . . . 0.644 ' HB2' HG23 ' D' ' 85' ' ' VAL . 0.5 OUTLIER -84.31 147.36 27.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.93 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 103' ' ' ILE . . . . . 0.608 HG12 ' HG ' ' D' ' 113' ' ' LEU . 1.2 pp -110.73 127.81 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.49 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 104' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 1.4 tp -97.37 132.92 42.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.676 0.274 . . . . 0.0 111.093 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . 0.6 ' HB2' ' HB2' ' D' ' 111' ' ' LEU . 4.0 t0 -80.81 143.62 32.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.669 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 106' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -65.47 -17.44 64.56 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.762 0.315 . . . . 0.0 111.101 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 107' ' ' THR . . . . . 0.51 HG23 ' HB3' ' D' ' 105' ' ' ASP . 13.3 t -66.87 -20.59 65.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.052 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.07 -71.78 0.44 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.674 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.48 159.93 31.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.829 0.347 . . . . 0.0 111.111 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -75.56 131.47 40.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.126 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 111' ' ' LEU . . . . . 0.6 ' HB2' ' HB2' ' D' ' 105' ' ' ASP . 12.2 tp -88.13 154.21 20.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.372 0.606 . . . . 0.0 110.63 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 112' ' ' THR . . . . . 0.874 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 0.4 OUTLIER -96.42 142.74 28.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.082 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 113' ' ' LEU . . . . . 0.608 ' HG ' HG12 ' D' ' 103' ' ' ILE . 0.8 OUTLIER -80.82 63.68 5.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.738 0.304 . . . . 0.0 110.704 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.65 -30.66 17.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.648 0.261 . . . . 0.0 111.55 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.79 -43.6 1.64 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.593 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.56 24.38 13.04 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.996 0.427 . . . . 0.0 111.614 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 117' ' ' THR . . . . . 0.585 HG23 HD12 ' D' ' 111' ' ' LEU . 0.2 OUTLIER -82.12 68.35 8.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' D' ' 157' ' ' GLN . 40.8 m-85 -82.21 71.98 9.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.754 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.71 80.99 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.58 131.75 13.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.576 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . 0.409 ' O ' ' HE2' ' D' ' 68' ' ' LYS . 1.5 mm-40 -100.77 52.11 0.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.222 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' D' ' 69' ' ' ALA . 0.2 OUTLIER -72.06 131.91 43.5 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.73 -179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.69 107.62 15.46 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.742 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . 0.401 HD13 ' CB ' ' D' ' 69' ' ' ALA . 1.0 OUTLIER -88.22 126.58 35.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.558 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 125' ' ' ASN . . . . . 0.483 ' O ' ' HB3' ' D' ' 61' ' ' CYS . 1.1 m120 -120.69 -178.94 3.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.575 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 126' ' ' ASN . . . . . 0.507 ' OD1' ' HA ' ' D' ' 62' ' ' ASP . 3.8 t30 -83.23 120.71 26.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.662 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.08 -121.72 2.52 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.709 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 128' ' ' THR . . . . . 0.725 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 75.8 m -122.21 103.42 8.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.711 0.291 . . . . 0.0 110.77 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 129' ' ' ASN . . . . . 0.51 ' HB2' ' SG ' ' D' ' 61' ' ' CYS . 1.7 t30 -86.14 157.23 20.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.172 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 130' ' ' THR . . . . . 0.514 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.3 OUTLIER -143.28 130.17 20.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.136 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 131' ' ' ILE . . . . . 0.543 HG21 HG13 ' D' ' 71' ' ' VAL . 57.0 mt -84.0 104.11 3.77 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 132' ' ' PRO . . . . . 0.692 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 7.6 Cg_endo -81.99 112.34 2.31 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.646 1.564 . . . . 0.0 112.568 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.417 ' HB3' ' CZ ' ' D' ' 54' ' ' PHE . 1.0 OUTLIER -126.68 158.25 36.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.863 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -125.96 156.09 40.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.116 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.472 ' O ' HG22 ' D' ' 52' ' ' VAL . . . -148.22 105.12 3.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.947 0.404 . . . . 0.0 111.587 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -99.07 163.48 12.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.357 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 137' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 0.3 OUTLIER -81.79 119.7 24.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.101 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.84 142.68 39.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.056 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 139' ' ' ALA . . . . . 0.561 ' HB3' ' HG ' ' D' ' 42' ' ' LEU . . . -132.92 136.05 45.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.904 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 140' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 25.1 p -96.66 -56.14 2.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.474 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' D' ' 43' ' ' ALA . . . -127.11 -129.87 3.3 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.988 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.98 107.05 12.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.652 0.226 . . . . 0.0 110.779 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 143' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' D' ' 97' ' ' THR . . . -65.85 148.09 52.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.714 0.292 . . . . 0.0 111.441 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 144' ' ' THR . . . . . 0.597 ' HB ' ' H ' ' D' ' 97' ' ' THR . 48.6 m -114.79 144.69 32.42 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.297 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 145' ' ' PRO . . . . . 0.428 ' HD2' HG22 ' D' ' 144' ' ' THR . 1.3 Cg_endo -81.97 130.91 6.75 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.573 2.182 . . . . 0.0 111.972 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . 0.599 ' O ' ' HG3' ' C' ' 15' ' ' GLU . . . 164.89 -116.25 0.69 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.439 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 147' ' ' ALA . . . . . 0.614 ' HA ' ' HG3' ' C' ' 15' ' ' GLU . . . -110.66 150.4 29.06 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.808 0.337 . . . . 0.0 111.339 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.65 45.88 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.45 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 149' ' ' ASN . . . . . 0.57 HD21 ' HG2' ' C' ' 13' ' ' LYS . 0.2 OUTLIER -96.85 141.06 30.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.578 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 150' ' ' ALA . . . . . . . . . . . . . . . -153.74 162.54 41.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.962 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.87 135.49 43.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.239 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 152' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -134.19 152.49 51.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.217 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 153' ' ' THR . . . . . . . . . . . . . 4.0 m -104.09 148.92 25.7 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.25 141.83 35.22 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.106 0.479 . . . . 0.0 110.113 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.57 152.39 40.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.921 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 156' ' ' VAL . . . . . 0.419 HG11 ' HA3' ' C' ' 7' ' ' GLY . 20.0 m -135.74 133.16 51.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.809 0.337 . . . . 0.0 111.635 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 157' ' ' GLN . . . . . 0.685 ' HG3' HG22 ' C' ' 4' ' ' THR . 1.8 tt0 -130.9 119.74 22.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.302 0.572 . . . . 0.0 110.417 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . 0.478 ' HH ' ' HB3' ' D' ' 21' ' ' CYS . 14.1 m-85 -101.94 113.31 26.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.587 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 159' ' ' GLN . . . . . 0.649 ' HA ' ' H ' ' C' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.839 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' F' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 111.108 0.04 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . 0.629 ' H ' ' HA ' ' F' ' 159' ' ' GLN . . . 59.16 55.73 4.23 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.106 0.254 . . . . 0.0 111.035 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 3' ' ' THR . . . . . 0.54 HG23 HD21 ' F' ' 18' ' ' ASN . 89.5 m -118.64 111.1 18.11 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.443 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 4' ' ' THR . . . . . 0.697 HG22 ' HG3' ' F' ' 157' ' ' GLN . 0.2 OUTLIER -97.79 127.38 43.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.575 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . 0.54 HG22 HG12 ' F' ' 17' ' ' VAL . 0.0 OUTLIER -153.57 171.46 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.594 179.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.38 122.07 36.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 7' ' ' GLY . . . . . 0.413 ' HA3' HG11 ' F' ' 156' ' ' VAL . . . -75.83 -52.37 6.46 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.859 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.41 -145.53 5.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.868 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.69 139.85 25.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 0.0 111.283 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.43 121.63 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.121 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.71 106.64 18.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.326 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 12' ' ' PHE . . . . . 0.434 ' HZ ' ' CZ ' ' F' ' 54' ' ' PHE . 8.9 m-85 -90.65 107.66 19.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 13' ' ' LYS . . . . . 0.57 ' HG2' HD21 ' F' ' 149' ' ' ASN . 0.1 OUTLIER -103.29 149.18 24.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.384 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.43 -179.03 47.51 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.971 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 15' ' ' GLU . . . . . 0.632 ' HB3' ' HG3' ' F' ' 36' ' ' GLN . 0.1 OUTLIER -158.96 157.01 30.49 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.849 0.357 . . . . 0.0 110.381 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 16' ' ' VAL . . . . . 0.421 ' O ' HG11 ' D' ' 5' ' ' VAL . 18.1 t -113.77 132.21 63.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.148 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . 0.755 HG13 ' HG2' ' F' ' 36' ' ' GLN . 5.6 m -136.84 176.55 7.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 111.107 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . 0.53 HD21 HG23 ' D' ' 3' ' ' THR . 0.4 OUTLIER -74.36 174.11 9.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.012 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 19' ' ' ALA . . . . . 0.564 ' O ' ' HB2' ' E' ' 62' ' ' ASP . . . -83.45 35.38 0.5 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' E' ' 66' ' ' ALA . . . -116.93 -15.9 10.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.412 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 21' ' ' CYS . . . . . 0.485 ' HB3' ' HH ' ' E' ' 158' ' ' TYR . 0.1 OUTLIER -179.99 155.26 0.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.961 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.74 126.43 5.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 23' ' ' VAL . . . . . 0.698 ' HA ' ' HG ' ' E' ' 58' ' ' LEU . 0.7 OUTLIER -60.85 162.54 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.083 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 24' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' E' ' 27' ' ' SER . 18.6 t70 -97.66 160.99 13.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.595 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -64.12 -40.33 95.97 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.365 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.41 12.73 69.09 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.9 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 27' ' ' SER . . . . . 0.534 ' HB3' ' HB3' ' E' ' 24' ' ' ASP . 0.6 OUTLIER -113.84 -25.51 8.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.836 0.35 . . . . 0.0 110.785 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 28' ' ' VAL . . . . . . . . . . . . . 9.7 t -41.14 -61.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.336 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.64 120.01 39.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.013 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -126.11 119.14 26.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.01 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.79 103.29 15.43 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.107 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.82 115.11 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.144 0.497 . . . . 0.0 110.534 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.45 112.6 24.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.601 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mp -75.87 -30.4 58.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.615 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.08 -170.2 27.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.581 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 36' ' ' GLN . . . . . 0.751 ' HG2' HG13 ' D' ' 17' ' ' VAL . 0.4 OUTLIER -93.47 141.71 28.15 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.608 0.242 . . . . 0.0 110.89 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 5.8 p -125.24 157.13 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.914 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.55 122.43 29.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.799 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -40.42 87.1 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.736 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.44 -35.86 68.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.125 0.488 . . . . 0.0 110.87 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -21.54 33.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.14 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' E' ' 139' ' ' ALA . 3.2 mp -110.49 29.38 7.76 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.621 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 43' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' E' ' 141' ' ' GLY . . . -108.16 25.53 11.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.357 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.72 160.0 23.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.342 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' E' ' 140' ' ' THR . 11.1 tt0 -82.92 108.64 16.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 111.131 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.94 10.9 51.39 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.145 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.75 123.47 20.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.943 0.401 . . . . 0.0 111.997 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -120.59 140.27 51.77 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.837 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.529 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 4.6 m -101.6 -167.01 1.36 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.625 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.66 139.7 53.55 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.774 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.87 134.03 35.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.348 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 52' ' ' VAL . . . . . 0.471 HG22 ' O ' ' E' ' 135' ' ' ALA . 18.8 m -87.01 166.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.962 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.75 128.89 8.01 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.628 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 54' ' ' PHE . . . . . 0.43 ' CZ ' ' HZ ' ' D' ' 12' ' ' PHE . 40.7 p90 -160.29 134.44 7.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.79 0.329 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 55' ' ' ASN . . . . . 0.434 ' OD1' ' CG2' ' E' ' 130' ' ' THR . 15.9 p30 -132.75 147.75 52.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.636 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 56' ' ' ILE . . . . . 0.61 HG22 HD13 ' E' ' 58' ' ' LEU . 1.0 OUTLIER -96.83 116.85 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.521 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 57' ' ' GLN . . . . . 0.513 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.0 OUTLIER -66.58 122.07 16.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.704 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . 0.698 ' HG ' ' HA ' ' E' ' 23' ' ' VAL . 0.2 OUTLIER -137.49 88.12 2.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.213 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . 0.707 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 10.6 p30 -79.6 179.29 7.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.89 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.42 64.42 0.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.779 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 61' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' E' ' 129' ' ' ASN . 4.4 m -110.56 163.2 13.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.755 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . 0.564 ' HB2' ' O ' ' E' ' 19' ' ' ALA . 0.5 OUTLIER -140.14 155.0 47.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.344 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.2 -25.42 10.63 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.95 -16.35 50.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.127 0.489 . . . . 0.0 111.754 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -90.68 -48.41 14.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.68 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' E' ' 20' ' ' ALA . . . -140.16 142.92 35.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.575 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.82 -53.86 2.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.866 0.365 . . . . 0.0 110.918 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 68' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' E' ' 121' ' ' GLU . 0.1 OUTLIER -94.75 158.13 15.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.549 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 69' ' ' ALA . . . . . 0.439 ' HB3' ' HB ' ' E' ' 122' ' ' THR . . . -137.19 120.42 16.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.649 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . 0.416 ' HB2' ' HB3' ' E' ' 118' ' ' PHE . . . -97.54 129.13 44.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.111 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . 0.532 HG13 HG21 ' E' ' 131' ' ' ILE . 15.7 t -112.97 152.23 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.749 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . 0.427 ' H ' HG12 ' E' ' 71' ' ' VAL . . . -150.01 146.65 27.12 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.52 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 73' ' ' PHE . . . . . 0.485 ' HB3' HD23 ' E' ' 113' ' ' LEU . 0.1 OUTLIER -111.58 141.86 44.63 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.525 0.202 . . . . 0.0 111.063 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 74' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.8 OUTLIER -105.67 103.38 12.88 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.962 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' E' ' 113' ' ' LEU . . . -149.95 -179.11 25.49 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.813 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.22 157.8 17.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.554 0.216 . . . . 0.0 110.761 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.91 132.75 38.06 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.849 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 78' ' ' ILE . . . . . 0.466 HG21 ' HB ' ' E' ' 85' ' ' VAL . 0.6 OUTLIER -66.55 -39.82 84.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.911 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.23 53.59 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.844 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.36 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.013 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.28 -36.59 53.16 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.566 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 82' ' ' HIS . . . . . 0.416 ' HB2' HG22 ' E' ' 78' ' ' ILE . 77.9 m80 -81.34 59.98 4.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 110.473 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -70.56 -20.5 62.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.533 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 84' ' ' ASN . . . . . 0.859 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 26.5 p-10 -69.34 -13.75 62.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.297 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' E' ' 102' ' ' GLN . 40.8 t -109.01 131.12 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.153 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 86' ' ' LEU . . . . . 0.577 HD12 HD21 ' E' ' 113' ' ' LEU . 0.6 OUTLIER -69.99 142.87 52.74 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.05 -170.49 3.06 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.937 0.399 . . . . 0.0 111.668 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -80.01 161.4 25.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.985 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.67 -80.34 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.322 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 6.4 p -171.35 0.34 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.958 0.409 . . . . 0.0 111.449 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 91' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' E' ' 95' ' ' SER . 73.5 m -76.78 85.64 3.38 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.35 71.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.942 0.401 . . . . 0.0 111.653 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.82 30.45 6.89 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.611 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.72 -3.15 0.11 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.941 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 95' ' ' SER . . . . . 0.589 ' HB2' ' HB2' ' E' ' 91' ' ' SER . 0.1 OUTLIER -107.57 -176.76 3.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.838 0.351 . . . . 0.0 110.641 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.46 172.6 8.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 97' ' ' THR . . . . . 0.61 ' H ' ' HB ' ' E' ' 144' ' ' THR . 1.6 m -126.9 140.44 52.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.348 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 98' ' ' ASN . . . . . 0.421 ' HB3' ' H ' ' E' ' 141' ' ' GLY . 68.3 m-80 61.96 21.33 12.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.45 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.33 135.98 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.746 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.0 -160.73 10.19 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.583 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 101' ' ' VAL . . . . . 0.487 HG11 ' HB2' ' E' ' 86' ' ' LEU . 4.5 p -145.88 109.89 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.181 0.515 . . . . 0.0 111.715 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 102' ' ' GLN . . . . . 0.66 ' HB2' HG23 ' E' ' 85' ' ' VAL . 0.5 OUTLIER -84.34 147.3 27.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.849 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 103' ' ' ILE . . . . . 0.589 HG12 ' HG ' ' E' ' 113' ' ' LEU . 1.2 pp -110.68 127.86 67.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.476 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 104' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 1.4 tp -97.46 132.99 42.64 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.705 0.288 . . . . 0.0 111.021 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . 0.597 ' HB2' ' HB2' ' E' ' 111' ' ' LEU . 4.0 t0 -80.84 143.62 32.64 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.662 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 106' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' B' ' 80' ' ' ALA . 0.0 OUTLIER -65.42 -17.52 64.61 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.813 0.34 . . . . 0.0 111.084 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 107' ' ' THR . . . . . 0.501 HG23 ' HB3' ' E' ' 105' ' ' ASP . 13.3 t -66.81 -20.63 65.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.03 -71.71 0.44 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.741 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.52 159.95 31.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.842 0.353 . . . . 0.0 111.061 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . 0.587 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -75.56 131.52 40.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.076 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' E' ' 105' ' ' ASP . 12.2 tp -88.17 154.18 20.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.369 0.604 . . . . 0.0 110.549 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 112' ' ' THR . . . . . 0.859 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 0.4 OUTLIER -96.36 142.75 28.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.09 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 113' ' ' LEU . . . . . 0.589 ' HG ' HG12 ' E' ' 103' ' ' ILE . 0.8 OUTLIER -80.82 63.64 5.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.745 0.307 . . . . 0.0 110.716 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.62 -30.65 17.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.541 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.76 -43.58 1.64 Allowed Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.627 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.56 24.38 13.04 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.011 0.434 . . . . 0.0 111.626 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 117' ' ' THR . . . . . 0.592 HG23 HD12 ' E' ' 111' ' ' LEU . 0.2 OUTLIER -82.11 68.41 8.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.115 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . 0.53 ' CD1' ' HB2' ' E' ' 157' ' ' GLN . 41.0 m-85 -82.25 71.92 9.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.769 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.62 80.95 1.85 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.848 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.61 131.7 13.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.611 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 121' ' ' GLU . . . . . 0.411 ' O ' ' HE2' ' E' ' 68' ' ' LYS . 1.5 mm-40 -100.72 52.12 0.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.215 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 122' ' ' THR . . . . . 0.439 ' HB ' ' HB3' ' E' ' 69' ' ' ALA . 0.2 OUTLIER -72.07 131.93 43.53 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.713 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.75 107.69 15.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.675 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . 0.4 HD13 ' CB ' ' E' ' 69' ' ' ALA . 1.0 OUTLIER -88.31 126.53 35.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.537 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 125' ' ' ASN . . . . . 0.488 ' O ' ' HB3' ' E' ' 61' ' ' CYS . 1.1 m120 -120.58 -178.92 3.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.552 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . 0.512 ' OD1' ' HA ' ' E' ' 62' ' ' ASP . 3.7 t30 -83.29 120.66 26.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.735 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . 0.69 ' HA2' HG21 ' A' ' 4' ' ' THR . . . 136.16 -121.77 2.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.697 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 128' ' ' THR . . . . . 0.707 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 76.7 m -122.19 103.38 8.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.705 0.288 . . . . 0.0 110.764 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 129' ' ' ASN . . . . . 0.509 ' HB2' ' SG ' ' E' ' 61' ' ' CYS . 1.7 t30 -86.06 157.33 20.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.902 0.382 . . . . 0.0 111.127 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 130' ' ' THR . . . . . 0.513 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.3 OUTLIER -143.4 130.2 20.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.029 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 131' ' ' ILE . . . . . 0.532 HG21 HG13 ' E' ' 71' ' ' VAL . 57.4 mt -84.06 104.15 3.85 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 132' ' ' PRO . . . . . 0.668 ' HB3' ' HA ' ' B' ' 76' ' ' THR . 7.5 Cg_endo -82.05 112.41 2.3 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 121.609 1.539 . . . . 0.0 112.574 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 133' ' ' PHE . . . . . 0.408 ' HB3' ' CZ ' ' E' ' 54' ' ' PHE . 1.0 OUTLIER -126.64 158.26 36.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.88 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -126.02 156.08 40.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.095 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . 0.471 ' O ' HG22 ' E' ' 52' ' ' VAL . . . -148.23 105.08 3.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 111.613 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.04 163.47 12.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.415 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 137' ' ' TYR . . . . . 0.529 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 0.3 OUTLIER -81.79 119.75 24.28 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.064 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.86 142.63 39.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.067 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 139' ' ' ALA . . . . . 0.555 ' HB3' ' HG ' ' E' ' 42' ' ' LEU . . . -132.9 136.05 45.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.849 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 140' ' ' THR . . . . . 0.63 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 25.5 p -96.63 -56.16 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.534 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' E' ' 43' ' ' ALA . . . -127.14 -129.88 3.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.976 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.97 107.13 12.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.631 0.215 . . . . 0.0 110.782 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 143' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' E' ' 97' ' ' THR . . . -65.88 148.08 52.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.68 0.276 . . . . 0.0 111.447 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 144' ' ' THR . . . . . 0.61 ' HB ' ' H ' ' E' ' 97' ' ' THR . 48.0 m -114.85 144.74 32.55 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.275 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 145' ' ' PRO . . . . . 0.416 ' HD2' HG22 ' E' ' 144' ' ' THR . 1.3 Cg_endo -82.0 131.0 6.76 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.499 2.133 . . . . 0.0 111.978 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 146' ' ' GLY . . . . . 0.58 ' O ' ' HG3' ' D' ' 15' ' ' GLU . . . 164.85 -116.25 0.69 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.435 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 147' ' ' ALA . . . . . 0.623 ' HA ' ' HG3' ' D' ' 15' ' ' GLU . . . -110.65 150.38 29.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.862 0.363 . . . . 0.0 111.304 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.63 45.92 1.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.449 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 149' ' ' ASN . . . . . 0.559 HD21 ' HG2' ' D' ' 13' ' ' LYS . 0.2 OUTLIER -96.97 141.0 30.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.54 -179.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 150' ' ' ALA . . . . . . . . . . . . . . . -153.67 162.59 41.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.006 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.95 135.43 43.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.271 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 152' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -134.17 152.54 51.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.228 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 153' ' ' THR . . . . . . . . . . . . . 4.0 m -104.19 148.92 25.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.21 141.88 35.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.088 0.47 . . . . 0.0 110.11 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.59 152.39 40.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.863 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 156' ' ' VAL . . . . . 0.415 HG11 ' HA3' ' D' ' 7' ' ' GLY . 20.2 m -135.75 133.17 51.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.789 0.328 . . . . 0.0 111.674 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 157' ' ' GLN . . . . . 0.716 ' HG3' HG22 ' D' ' 4' ' ' THR . 1.8 tt0 -130.92 119.82 22.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.318 0.58 . . . . 0.0 110.383 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . 0.485 ' HH ' ' HB3' ' E' ' 21' ' ' CYS . 14.2 m-85 -101.99 113.31 26.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.491 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 159' ' ' GLN . . . . . 0.638 ' HA ' ' H ' ' D' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.849 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.266 0.079 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.05 55.85 4.24 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.69 0.281 . . . . 0.0 111.075 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 89.7 m -118.7 111.11 18.09 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.445 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.79 127.26 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.588 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.48 171.5 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.551 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.42 122.08 36.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.62 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.95 -52.27 6.46 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.834 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.46 -145.52 5.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.888 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.72 139.8 25.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 0.0 111.296 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.37 121.6 64.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.149 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.72 106.56 18.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.392 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -90.52 107.69 19.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.842 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.28 149.15 25.0 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.457 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.47 -179.05 47.54 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.947 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.88 157.02 30.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.929 0.395 . . . . 0.0 110.368 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 16' ' ' VAL . . . . . 0.42 ' O ' HG11 ' E' ' 5' ' ' VAL . 18.0 t -113.73 132.19 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.225 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 17' ' ' VAL . . . . . 0.54 HG12 HG22 ' E' ' 5' ' ' VAL . 5.5 m -136.88 176.58 7.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.883 0.373 . . . . 0.0 110.991 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 18' ' ' ASN . . . . . 0.54 HD21 HG23 ' E' ' 3' ' ' THR . 0.4 OUTLIER -74.45 174.13 9.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.036 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 19' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' F' ' 62' ' ' ASP . . . -83.43 35.37 0.5 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.036 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' F' ' 66' ' ' ALA . . . -116.95 -15.9 10.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.422 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 21' ' ' CYS . . . . . 0.486 ' HB3' ' HH ' ' F' ' 158' ' ' TYR . 0.1 OUTLIER -179.98 155.29 0.6 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.961 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.76 126.38 5.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.078 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 23' ' ' VAL . . . . . 0.714 ' HA ' ' HG ' ' F' ' 58' ' ' LEU . 0.7 OUTLIER -60.77 162.46 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.087 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 24' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' F' ' 27' ' ' SER . 18.6 t70 -97.61 161.02 13.97 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.615 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . 0.608 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -64.1 -40.39 96.1 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.348 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.37 12.74 69.09 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.927 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 27' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' F' ' 24' ' ' ASP . 0.6 OUTLIER -113.88 -25.46 8.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.825 0.345 . . . . 0.0 110.813 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 9.6 t -41.16 -61.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.37 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.59 119.9 39.49 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.061 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -126.02 119.07 26.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.057 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.7 103.3 15.46 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.118 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.89 115.13 43.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.147 0.499 . . . . 0.0 110.463 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.51 112.62 24.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.7 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.86 -30.37 58.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.646 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.03 -170.22 27.41 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.625 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 36' ' ' GLN . . . . . 0.755 ' HG2' HG13 ' E' ' 17' ' ' VAL . 0.4 OUTLIER -93.54 141.74 28.12 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.628 0.251 . . . . 0.0 110.909 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 5.7 p -125.29 157.1 34.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.97 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.49 122.44 28.99 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.732 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -40.36 87.06 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.784 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.81 68.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.053 0.454 . . . . 0.0 110.866 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.14 -21.5 33.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.125 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . 0.564 ' HG ' ' HB3' ' F' ' 139' ' ' ALA . 3.2 mp -110.52 29.47 7.68 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.59 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 43' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' F' ' 141' ' ' GLY . . . -108.24 25.52 11.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.322 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.74 159.96 23.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.386 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' F' ' 140' ' ' THR . 11.0 tt0 -82.86 108.69 16.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 0.0 111.155 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.9 10.86 51.59 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.157 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.67 123.42 20.03 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 77.5 p -120.59 140.29 51.73 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.922 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 49' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 4.6 m -101.63 -167.0 1.36 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.602 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.77 139.73 53.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.859 0.361 . . . . 0.0 110.751 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 51' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' F' ' 134' ' ' GLN . . . -82.78 134.03 35.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.362 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 52' ' ' VAL . . . . . 0.477 HG22 ' O ' ' F' ' 135' ' ' ALA . 18.7 m -87.06 166.5 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.972 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.78 128.92 8.01 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.585 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 54' ' ' PHE . . . . . 0.434 ' CZ ' ' HZ ' ' E' ' 12' ' ' PHE . 40.8 p90 -160.28 134.42 7.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.775 0.322 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 55' ' ' ASN . . . . . 0.43 ' OD1' ' CG2' ' F' ' 130' ' ' THR . 15.8 p30 -132.73 147.69 52.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.621 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 56' ' ' ILE . . . . . 0.596 HG12 HD12 ' F' ' 58' ' ' LEU . 1.0 OUTLIER -96.8 116.79 39.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.539 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 57' ' ' GLN . . . . . 0.524 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.0 OUTLIER -66.61 122.12 16.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.703 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . 0.714 ' HG ' ' HA ' ' F' ' 23' ' ' VAL . 0.2 OUTLIER -137.51 88.12 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 -179.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 59' ' ' ASN . . . . . 0.701 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 10.6 p30 -79.49 179.32 7.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.935 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.29 64.46 0.96 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.818 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 61' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' F' ' 129' ' ' ASN . 4.4 m -110.55 163.25 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.821 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . 0.569 ' HB2' ' O ' ' F' ' 19' ' ' ALA . 0.5 OUTLIER -140.19 155.01 47.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.235 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.23 -25.44 10.61 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.89 -16.42 50.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.126 0.489 . . . . 0.0 111.734 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -90.68 -48.46 14.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.627 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 66' ' ' ALA . . . . . 0.548 ' HB2' ' HB3' ' F' ' 20' ' ' ALA . . . -140.13 142.97 35.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.569 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.85 -53.81 2.6 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.882 0.372 . . . . 0.0 110.978 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 68' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' F' ' 121' ' ' GLU . 0.1 OUTLIER -94.85 158.09 15.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.492 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 69' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' F' ' 122' ' ' THR . . . -137.17 120.47 16.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.592 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 70' ' ' ALA . . . . . 0.421 ' HB2' ' HB3' ' F' ' 118' ' ' PHE . . . -97.57 129.07 44.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.153 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 71' ' ' VAL . . . . . 0.526 HG13 HG21 ' F' ' 131' ' ' ILE . 15.9 t -112.92 152.24 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.708 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 72' ' ' ALA . . . . . 0.432 ' H ' HG12 ' F' ' 71' ' ' VAL . . . -150.02 146.62 27.1 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.56 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 73' ' ' PHE . . . . . 0.491 ' HB3' HD23 ' F' ' 113' ' ' LEU . 0.1 OUTLIER -111.5 141.88 44.5 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.557 0.218 . . . . 0.0 111.078 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 74' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.8 OUTLIER -105.7 103.32 12.8 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.934 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . 0.423 ' HA3' HD22 ' F' ' 113' ' ' LEU . . . -149.87 -179.08 25.4 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.83 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.2 157.83 17.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.501 0.191 . . . . 0.0 110.766 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.91 132.77 38.06 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.929 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 78' ' ' ILE . . . . . 0.449 HG21 ' HB ' ' F' ' 85' ' ' VAL . 0.6 OUTLIER -66.6 -39.83 84.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.15 53.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.845 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.38 -87.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.048 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.34 -36.52 53.24 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.603 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 82' ' ' HIS . . . . . 0.425 ' HB2' HG22 ' F' ' 78' ' ' ILE . 77.8 m80 -81.3 59.87 4.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.357 . . . . 0.0 110.484 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -70.58 -20.38 62.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.537 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 84' ' ' ASN . . . . . 0.881 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 26.5 p-10 -69.47 -13.67 62.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.284 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 85' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' F' ' 102' ' ' GLN . 40.8 t -109.01 131.16 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.152 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 86' ' ' LEU . . . . . 0.577 HD12 HD21 ' F' ' 113' ' ' LEU . 0.6 OUTLIER -70.09 142.85 52.58 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.03 -170.51 3.06 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.873 0.368 . . . . 0.0 111.666 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' F' ' 88' ' ' LEU . 1.2 mm? -79.98 161.39 25.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.963 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.75 -80.24 0.01 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.386 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 6.4 p -171.39 0.44 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.943 0.402 . . . . 0.0 111.391 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 91' ' ' SER . . . . . 0.599 ' HB2' ' HB2' ' F' ' 95' ' ' SER . 73.6 m -76.81 85.58 3.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.839 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.28 71.78 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.888 0.375 . . . . 0.0 111.67 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.89 30.49 6.85 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.61 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.76 -3.13 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.934 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 95' ' ' SER . . . . . 0.599 ' HB2' ' HB2' ' F' ' 91' ' ' SER . 0.1 OUTLIER -107.51 -176.67 3.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.366 . . . . 0.0 110.679 179.482 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.6 172.66 8.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.81 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 97' ' ' THR . . . . . 0.594 ' H ' ' HB ' ' F' ' 144' ' ' THR . 1.6 m -126.95 140.37 52.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.331 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 98' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' F' ' 141' ' ' GLY . 68.3 m-80 62.0 21.31 12.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.454 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.38 135.97 58.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.714 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.94 -160.67 10.14 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.552 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 101' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' F' ' 86' ' ' LEU . 4.5 p -145.93 109.86 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.171 0.51 . . . . 0.0 111.729 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 102' ' ' GLN . . . . . 0.656 ' HB2' HG23 ' F' ' 85' ' ' VAL . 0.5 OUTLIER -84.29 147.35 27.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.885 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 103' ' ' ILE . . . . . 0.598 HG12 ' HG ' ' F' ' 113' ' ' LEU . 1.2 pp -110.74 127.87 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.489 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 104' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 1.4 tp -97.46 133.0 42.63 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.711 0.291 . . . . 0.0 111.017 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . 0.58 ' HB2' ' HB2' ' F' ' 111' ' ' LEU . 4.0 t0 -80.81 143.57 32.73 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.706 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 106' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' C' ' 80' ' ' ALA . 0.0 OUTLIER -65.48 -17.48 64.59 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.802 0.334 . . . . 0.0 111.023 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 107' ' ' THR . . . . . 0.506 HG23 ' HB3' ' F' ' 105' ' ' ASP . 13.2 t -66.79 -20.73 66.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.973 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.07 -71.81 0.44 Allowed Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.669 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.39 160.01 31.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.826 0.346 . . . . 0.0 111.098 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -75.59 131.38 39.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . 0.588 HD12 HG23 ' F' ' 117' ' ' THR . 12.2 tp -88.06 154.17 20.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.359 0.6 . . . . 0.0 110.572 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 112' ' ' THR . . . . . 0.881 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 0.4 OUTLIER -96.41 142.69 28.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.062 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 113' ' ' LEU . . . . . 0.598 ' HG ' HG12 ' F' ' 103' ' ' ILE . 0.8 OUTLIER -80.76 63.61 5.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.723 0.297 . . . . 0.0 110.77 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.58 -30.6 17.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.611 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.73 -43.59 1.64 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.686 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.61 24.43 12.97 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.988 0.423 . . . . 0.0 111.608 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 117' ' ' THR . . . . . 0.588 HG23 HD12 ' F' ' 111' ' ' LEU . 0.2 OUTLIER -82.12 68.25 8.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.16 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' F' ' 157' ' ' GLN . 40.9 m-85 -82.07 71.93 9.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.759 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.74 81.02 1.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.66 131.74 13.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.557 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 121' ' ' GLU . . . . . 0.414 ' O ' ' HE2' ' F' ' 68' ' ' LYS . 1.5 mm-40 -100.7 52.1 0.87 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.197 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 122' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' F' ' 69' ' ' ALA . 0.2 OUTLIER -72.14 131.98 43.54 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.78 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.63 107.54 15.35 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.771 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . 0.408 HD13 ' CB ' ' F' ' 69' ' ' ALA . 1.0 OUTLIER -88.23 126.58 35.23 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.59 179.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 125' ' ' ASN . . . . . 0.486 ' O ' ' HB3' ' F' ' 61' ' ' CYS . 1.1 m120 -120.65 -178.99 3.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.542 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . 0.499 ' OD1' ' HA ' ' F' ' 62' ' ' ASP . 3.8 t30 -83.25 120.68 26.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.695 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . 0.696 ' HA2' HG21 ' B' ' 4' ' ' THR . . . 136.12 -121.77 2.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.657 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 128' ' ' THR . . . . . 0.701 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 76.3 m -122.12 103.44 8.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.727 0.299 . . . . 0.0 110.807 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 129' ' ' ASN . . . . . 0.504 ' HB2' ' SG ' ' F' ' 61' ' ' CYS . 1.8 t30 -86.18 157.26 20.03 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.857 0.36 . . . . 0.0 111.086 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 130' ' ' THR . . . . . 0.524 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.3 OUTLIER -143.34 130.14 20.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.162 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 131' ' ' ILE . . . . . 0.526 HG21 HG13 ' F' ' 71' ' ' VAL . 57.3 mt -83.97 104.14 3.79 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 132' ' ' PRO . . . . . 0.674 ' HB3' ' HA ' ' C' ' 76' ' ' THR . 7.5 Cg_endo -82.08 112.45 2.3 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.535 1.49 . . . . 0.0 112.548 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 133' ' ' PHE . . . . . 0.411 ' HB3' ' CZ ' ' F' ' 54' ' ' PHE . 1.0 OUTLIER -126.69 158.27 36.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.856 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 134' ' ' GLN . . . . . 0.4 ' HB3' ' HB3' ' F' ' 51' ' ' ALA . 15.9 mt-30 -125.97 156.01 40.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.119 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . 0.477 ' O ' HG22 ' F' ' 52' ' ' VAL . . . -148.14 105.15 3.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 111.609 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.11 163.46 12.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.375 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 137' ' ' TYR . . . . . 0.507 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 0.3 OUTLIER -81.72 119.69 24.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.131 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.82 142.69 39.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.275 0.56 . . . . 0.0 112.058 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 139' ' ' ALA . . . . . 0.564 ' HB3' ' HG ' ' F' ' 42' ' ' LEU . . . -132.94 136.05 45.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.831 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 140' ' ' THR . . . . . 0.643 ' O ' ' HA ' ' F' ' 45' ' ' GLU . 24.9 p -96.65 -56.26 2.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.423 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . 0.434 ' H ' ' HB3' ' F' ' 98' ' ' ASN . . . -127.04 -129.91 3.31 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.973 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.94 107.15 12.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.521 0.201 . . . . 0.0 110.741 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 143' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' F' ' 97' ' ' THR . . . -65.89 148.07 52.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.686 0.279 . . . . 0.0 111.44 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 144' ' ' THR . . . . . 0.594 ' HB ' ' H ' ' F' ' 97' ' ' THR . 48.0 m -114.88 144.72 32.52 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.262 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 145' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' F' ' 144' ' ' THR . 1.4 Cg_endo -81.96 130.96 6.78 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.549 2.166 . . . . 0.0 111.953 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 146' ' ' GLY . . . . . 0.603 ' O ' ' HG3' ' E' ' 15' ' ' GLU . . . 164.82 -116.27 0.69 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.452 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 147' ' ' ALA . . . . . 0.619 ' HA ' ' HG3' ' E' ' 15' ' ' GLU . . . -110.65 150.4 29.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.866 0.365 . . . . 0.0 111.28 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.65 45.82 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.128 0.49 . . . . 0.0 110.513 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 149' ' ' ASN . . . . . 0.57 HD21 ' HG2' ' E' ' 13' ' ' LYS . 0.2 OUTLIER -96.85 141.02 30.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.535 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 150' ' ' ALA . . . . . . . . . . . . . . . -153.71 162.53 41.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.958 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.85 135.46 43.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.225 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 152' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -134.16 152.51 51.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.17 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 153' ' ' THR . . . . . . . . . . . . . 4.0 m -104.16 148.95 25.7 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.29 141.87 35.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.047 0.451 . . . . 0.0 110.155 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -122.57 152.41 40.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.89 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 156' ' ' VAL . . . . . 0.413 HG11 ' HA3' ' E' ' 7' ' ' GLY . 20.1 m -135.72 133.13 51.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.79 0.329 . . . . 0.0 111.683 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 157' ' ' GLN . . . . . 0.697 ' HG3' HG22 ' E' ' 4' ' ' THR . 1.8 tt0 -130.95 119.86 22.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.339 0.59 . . . . 0.0 110.342 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . 0.486 ' HH ' ' HB3' ' F' ' 21' ' ' CYS . 14.1 m-85 -102.0 113.28 26.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.523 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 159' ' ' GLN . . . . . 0.629 ' HA ' ' H ' ' E' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.85 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 120.245 0.069 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.93 68.38 0.87 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.569 0.223 . . . . 0.0 111.021 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.38 87.58 6.08 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.475 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.604 ' HB ' ' HA3' ' E' ' 127' ' ' GLY . 3.5 m -90.46 115.43 27.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.602 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 m -127.21 166.97 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.604 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.603 ' HA ' ' HE2' ' B' ' 155' ' ' LYS . 19.9 t30 -83.06 115.15 21.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.517 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.33 -71.5 1.06 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.884 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.24 172.78 34.74 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.907 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 m -95.47 136.96 35.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.409 . . . . 0.0 111.305 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.689 HG11 ' CE2' ' A' ' 12' ' ' PHE . 40.2 t -120.84 130.68 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.218 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.518 ' O ' ' HB ' ' B' ' 32' ' ' VAL . 1.3 m80 -103.78 158.0 16.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.459 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.689 ' CE2' HG11 ' A' ' 10' ' ' VAL . 0.6 OUTLIER -145.81 89.57 1.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.426 ' HG2' ' HA ' ' B' ' 33' ' ' GLN . 0.0 OUTLIER -79.97 135.19 36.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.41 179.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.57 178.39 42.07 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.958 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.643 ' HG2' ' HA ' ' B' ' 147' ' ' ALA . 2.6 mt-10 -156.8 -177.93 6.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.368 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.504 HG21 HG23 ' B' ' 37' ' ' VAL . 2.7 t -142.24 150.13 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.233 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.507 HG11 ' HE2' ' A' ' 158' ' ' TYR . 4.1 m -141.7 168.61 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.333 . . . . 0.0 111.066 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.02 74.73 4.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.058 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.88 91.86 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.027 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.46 -50.98 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.433 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER 179.82 -179.68 0.47 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.965 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.587 ' HA ' ' HB3' ' B' ' 36' ' ' GLN . . . -136.2 116.43 13.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.085 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.2 t -67.08 120.15 13.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.026 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.39 150.49 46.25 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.585 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.37 -50.22 31.54 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.326 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.27 -31.8 81.71 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.895 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.04 -16.02 63.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.929 0.395 . . . . 0.0 110.847 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.5 t -72.96 -43.59 58.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.41 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.39 106.04 10.32 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -116.65 134.03 55.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.074 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.49 96.04 6.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.058 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.3 t -89.46 131.25 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.131 0.491 . . . . 0.0 110.488 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.95 106.41 16.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.618 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.727 HD22 HG13 ' A' ' 101' ' ' VAL . 0.4 OUTLIER -73.8 -40.87 63.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.649 179.372 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.95 -122.46 6.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.595 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -144.52 153.95 42.38 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.699 0.285 . . . . 0.0 110.862 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.454 HG12 ' CD2' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -128.57 146.35 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.86 -179.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.23 145.97 26.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.717 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.7 p -57.8 -23.02 50.47 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.719 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.93 -33.21 61.94 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.096 0.474 . . . . 0.0 110.844 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -31.15 69.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.124 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -130.76 86.42 2.37 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.649 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.7 36.2 4.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.37 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.64 150.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.337 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.78 134.83 54.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 111.136 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.79 -14.16 53.14 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.137 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 138' ' ' PHE . . . -57.2 129.86 43.64 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.938 0.399 . . . . 0.0 112.002 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.459 ' HB ' ' CE1' ' A' ' 138' ' ' PHE . 14.3 t -130.59 143.31 50.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.909 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.572 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 68.4 m -111.97 -157.16 0.61 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.552 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.9 t -74.62 150.15 39.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.784 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.53 ' HB3' ' NE2' ' A' ' 134' ' ' GLN . . . -103.2 146.64 28.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.322 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 134' ' ' GLN . 22.4 m -83.38 148.34 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.4 121.21 6.21 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.6 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -153.83 125.56 7.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.28 156.17 20.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.609 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.6 mm -104.08 135.37 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.486 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.64 125.99 48.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.765 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 129' ' ' ASN . 4.3 mp -131.7 100.0 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.273 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.49 174.81 11.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.946 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.8 65.19 1.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.792 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 60.7 m -98.66 142.94 29.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.59 109.25 15.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.269 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.44 29.54 1.69 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.03 -59.1 2.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.029 0.443 . . . . 0.0 111.819 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.28 -39.8 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.706 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.69 101.39 10.7 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.593 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.6 p -90.54 -28.82 18.25 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.902 0.382 . . . . 0.0 110.95 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.4 166.99 16.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.513 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.9 149.77 29.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.572 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 157' ' ' GLN . . . -112.85 159.79 18.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.092 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.2 t -108.04 123.25 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.689 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.476 ' HB2' ' CB ' ' A' ' 155' ' ' LYS . . . -124.64 168.95 12.44 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.596 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.436 ' CB ' HD11 ' A' ' 111' ' ' LEU . 17.1 t80 -150.59 144.39 25.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.535 0.207 . . . . 0.0 111.168 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.574 HD21 HD22 ' D' ' 55' ' ' ASN . 0.4 OUTLIER -121.56 88.64 2.97 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.989 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.69 164.72 24.65 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.773 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -78.54 147.73 33.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.544 0.211 . . . . 0.0 110.779 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' H ' ' HB3' ' D' ' 132' ' ' PRO . . . -95.7 140.34 30.65 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.959 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.624 HG12 HG22 ' A' ' 140' ' ' THR . 1.1 tt -78.71 -33.05 16.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.851 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.22 179.22 7.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.838 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.68 -27.87 36.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.059 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.25 -32.22 72.21 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.552 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -97.33 -72.69 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 0.0 110.464 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.85 -7.24 1.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.586 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -108.7 -19.13 13.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.364 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.545 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 50.2 t -80.65 132.03 32.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.124 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.666 ' HA ' ' O ' ' A' ' 76' ' ' THR . 0.4 OUTLIER -76.52 134.95 39.31 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.355 179.381 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.629 ' HB1' ' HB ' ' A' ' 76' ' ' THR . . . -62.28 165.18 6.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.828 0.347 . . . . 0.0 111.682 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.427 HD13 HG21 ' A' ' 97' ' ' THR . 0.1 OUTLIER -65.75 171.65 4.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.029 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.47 ' OE1' ' HB3' ' A' ' 91' ' ' SER . 8.0 pt20 -72.45 175.75 5.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.349 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.464 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 0.5 OUTLIER -76.06 -21.26 56.97 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.997 0.427 . . . . 0.0 111.492 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.47 ' HB3' ' OE1' ' A' ' 89' ' ' GLN . 32.0 t -80.92 67.56 6.87 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.435 ' HA ' ' OG ' ' A' ' 95' ' ' SER . . . -72.27 -9.74 58.87 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.901 0.381 . . . . 0.0 111.668 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.552 ' HB1' ' HB2' ' C' ' 22' ' ' ALA . . . -68.08 -22.91 64.9 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.632 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.39 6.76 2.5 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.932 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.674 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 30.7 p -93.73 150.75 20.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.637 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.69 167.21 18.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.834 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.427 HG21 HD13 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -118.65 165.15 14.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.366 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.514 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 85.0 m-20 63.29 45.43 5.0 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.494 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.65 ' HB ' ' HB3' ' A' ' 143' ' ' ALA . 3.5 p -170.63 131.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.787 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.08 -175.96 21.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.556 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.727 HG13 HD22 ' A' ' 34' ' ' LEU . 76.3 t -104.14 91.84 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 122.971 0.509 . . . . 0.0 111.745 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -67.86 131.21 45.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.44 110.52 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.498 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 5.5 tp -91.23 149.94 21.55 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.709 0.29 . . . . 0.0 111.027 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.95 174.68 5.79 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.631 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.524 ' HB3' ' HG ' ' A' ' 120' ' ' SER . 1.5 ttt180 -72.49 -18.63 61.65 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.719 0.295 . . . . 0.0 110.989 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.0 p -69.25 -9.6 53.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.033 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.97 -48.44 0.95 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.625 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.94 163.54 15.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 0.0 111.062 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -70.39 125.51 27.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.174 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.436 HD11 ' CB ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -65.36 147.61 53.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.367 0.603 . . . . 0.0 110.564 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.03 144.58 45.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.131 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.521 ' N ' HD11 ' A' ' 113' ' ' LEU . 10.2 mp -100.28 89.94 4.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.769 0.319 . . . . 0.0 110.663 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.525 ' HB2' HG21 ' A' ' 117' ' ' THR . 4.1 m-20 -142.42 11.37 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.657 0.265 . . . . 0.0 111.555 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.91 -78.09 0.69 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.669 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.27 61.54 0.73 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.973 0.416 . . . . 0.0 111.662 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.525 HG21 ' HB2' ' A' ' 114' ' ' ASP . 17.6 p -93.35 95.84 9.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.131 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.79 110.0 5.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.9 m -120.35 -72.92 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.773 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.524 ' HG ' ' HB3' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -92.4 113.03 25.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.602 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -99.47 97.53 8.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.207 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.5 132.71 37.52 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.775 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 124' ' ' LEU . 22.1 m -60.89 146.12 47.75 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.727 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.438 ' N ' HG23 ' A' ' 123' ' ' THR . 0.2 OUTLIER -85.48 156.56 20.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.562 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.78 142.75 40.88 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.54 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.94 113.63 6.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.74 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.59 -90.08 0.32 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.744 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.0 m -124.88 152.77 43.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.745 0.307 . . . . 0.0 110.798 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.528 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 17.1 t-20 -123.0 147.52 46.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.19 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.3 m -126.12 135.7 52.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.098 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.4 mt -114.03 115.65 45.47 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -81.7 115.71 2.81 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.629 1.553 . . . . 0.0 112.567 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.58 150.81 46.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.825 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.53 ' NE2' ' HB3' ' A' ' 51' ' ' ALA . 1.2 mt-30 -142.48 166.67 24.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.029 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 102' ' ' GLN . . . -158.13 102.94 1.81 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 111.654 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -94.68 -173.4 3.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.396 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.572 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 3.8 m-85 -100.78 152.87 19.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.068 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -147.37 160.73 42.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.998 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.425 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -126.86 149.61 49.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.925 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.624 HG22 HG12 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -115.34 27.83 9.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.461 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.4 66.75 0.2 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.955 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.99 88.59 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.602 0.239 . . . . 0.0 110.744 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.65 ' HB3' ' HB ' ' A' ' 99' ' ' VAL . . . -60.19 156.88 14.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.709 0.29 . . . . 0.0 111.452 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.536 ' HB ' ' CD ' ' A' ' 145' ' ' PRO . 77.3 p -112.26 173.02 3.08 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.218 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.536 ' CD ' ' HB ' ' A' ' 144' ' ' THR . 1.3 Cg_endo -84.51 145.16 10.45 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.518 2.145 . . . . 0.0 111.995 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.44 -112.7 0.55 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.512 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -124.93 167.67 14.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.892 0.377 . . . . 0.0 111.275 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -157.19 57.54 0.52 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.411 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.85 132.73 36.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.539 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.47 163.13 28.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.937 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.45 125.58 1.83 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.231 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.638 ' HB1' HD11 ' A' ' 86' ' ' LEU . . . -154.57 165.79 35.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.244 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.9 163.18 12.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -119.01 134.6 55.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.102 0.477 . . . . 0.0 110.102 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.476 ' CB ' ' HB2' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -95.64 166.24 11.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.913 -178.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.24 112.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.793 0.33 . . . . 0.0 111.657 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -88.77 138.81 31.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.278 0.561 . . . . 0.0 110.403 -179.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.507 ' HE2' HG11 ' A' ' 17' ' ' VAL . 22.5 m-85 -127.65 113.16 15.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.568 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.976 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.241 0.067 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.94 68.26 0.88 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.645 0.26 . . . . 0.0 111.06 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.33 87.63 6.12 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.454 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.596 ' HB ' ' HA3' ' F' ' 127' ' ' GLY . 3.5 m -90.35 115.47 27.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.571 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -127.34 167.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.588 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.625 ' HA ' ' HE2' ' C' ' 155' ' ' LYS . 20.2 t30 -82.95 115.11 21.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.577 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.39 -71.48 1.06 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.827 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.31 172.78 34.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.909 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 33.3 m -95.52 137.01 35.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.941 0.4 . . . . 0.0 111.253 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.676 HG11 ' CE2' ' B' ' 12' ' ' PHE . 40.4 t -120.8 130.76 74.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.173 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' HIS . . . . . 0.528 ' O ' ' HB ' ' C' ' 32' ' ' VAL . 1.3 m80 -103.92 157.97 16.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.41 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . 0.676 ' CE2' HG11 ' B' ' 10' ' ' VAL . 0.5 OUTLIER -145.82 89.67 1.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.823 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' C' ' 33' ' ' GLN . 0.0 OUTLIER -80.04 135.21 36.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.431 179.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.57 178.38 42.08 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.953 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.644 ' HG2' ' HA ' ' C' ' 147' ' ' ALA . 2.6 mt-10 -156.78 -177.86 6.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.385 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.493 HG21 HG23 ' C' ' 37' ' ' VAL . 2.7 t -142.35 150.1 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.235 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.524 HG11 ' HE2' ' B' ' 158' ' ' TYR . 4.1 m -141.73 168.57 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.856 0.36 . . . . 0.0 110.996 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -92.93 74.78 4.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.039 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.78 91.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.045 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.42 -51.07 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.421 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER 179.83 -179.8 0.48 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.996 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.578 ' HA ' ' HB3' ' C' ' 36' ' ' GLN . . . -136.14 116.5 13.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.138 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.07 120.15 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.003 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.36 150.45 46.26 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.605 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.38 -50.1 32.1 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.388 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.36 -31.79 81.55 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.841 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.07 -15.98 63.58 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.879 0.371 . . . . 0.0 110.831 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -72.96 -43.68 58.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.375 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.36 106.11 10.4 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.005 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -116.68 134.03 55.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.49 96.09 6.27 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.057 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.518 ' HB ' ' O ' ' A' ' 11' ' ' HIS . 69.3 t -89.53 131.27 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.15 0.5 . . . . 0.0 110.456 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.426 ' HA ' ' HG2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -108.97 106.48 16.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.637 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.726 HD22 HG13 ' B' ' 101' ' ' VAL . 0.4 OUTLIER -73.79 -40.89 63.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.66 179.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.89 -122.41 6.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.601 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 16.3 tt0 -144.6 153.85 42.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.586 0.231 . . . . 0.0 110.939 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.504 HG23 HG21 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -128.5 146.32 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.909 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.25 146.0 26.07 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.7 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 40.9 p -57.78 -22.99 50.12 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.713 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.01 -33.22 61.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.013 0.435 . . . . 0.0 110.809 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -31.1 69.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.174 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.424 ' HB3' ' HB2' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -130.83 86.34 2.36 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.604 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.64 36.19 4.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.357 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 177.56 150.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.392 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.79 134.81 54.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.884 0.373 . . . . 0.0 111.103 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.79 -14.19 53.12 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.218 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' B' ' 138' ' ' PHE . . . -57.19 129.8 43.36 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.451 ' HB ' ' CE1' ' B' ' 138' ' ' PHE . 14.3 t -130.55 143.34 50.69 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.864 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' SER . . . . . 0.58 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 68.6 m -111.95 -157.2 0.61 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.579 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 27.5 t -74.46 150.13 40.05 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . 0.53 ' HB3' ' NE2' ' B' ' 134' ' ' GLN . . . -103.28 146.61 28.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.328 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' B' ' 134' ' ' GLN . 22.0 m -83.31 148.31 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.981 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.35 121.21 6.22 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.638 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -153.81 125.52 7.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.737 0.303 . . . . 0.0 110.955 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.23 156.22 20.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.626 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 22.5 mm -104.04 135.35 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.51 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.75 126.05 48.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.771 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' B' ' 129' ' ' ASN . 4.3 mp -131.62 99.91 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.275 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.43 174.79 11.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.71 65.24 1.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.809 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' B' ' 21' ' ' CYS . 60.6 m -98.64 142.86 29.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.822 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.58 109.22 15.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.329 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.37 29.53 1.67 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . 0.442 HD21 ' HA ' ' B' ' 64' ' ' ASN . 0.1 OUTLIER -90.0 -59.16 2.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.039 0.447 . . . . 0.0 111.726 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.29 -39.82 13.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.71 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.58 101.3 10.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.614 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.1 p -90.58 -28.74 18.27 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.872 0.367 . . . . 0.0 110.971 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.49 166.94 16.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.523 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.82 149.8 29.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.646 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' B' ' 157' ' ' GLN . . . -112.88 159.77 18.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.097 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 51.1 t -108.06 123.25 63.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.693 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.492 ' HB2' ' CB ' ' B' ' 155' ' ' LYS . . . -124.6 168.96 12.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.563 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.427 ' CB ' HD11 ' B' ' 111' ' ' LEU . 17.2 t80 -150.59 144.37 25.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.533 0.206 . . . . 0.0 111.205 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.585 HD21 HD22 ' E' ' 55' ' ' ASN . 0.4 OUTLIER -121.42 88.57 2.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.033 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.75 164.7 24.67 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.813 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.653 ' O ' ' HA ' ' B' ' 86' ' ' LEU . 0.6 OUTLIER -78.51 147.76 33.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.531 0.205 . . . . 0.0 110.775 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . 0.488 ' H ' ' HB3' ' E' ' 132' ' ' PRO . . . -95.79 140.32 30.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.887 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.637 HG12 HG22 ' B' ' 140' ' ' THR . 1.2 tt -78.7 -33.09 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.873 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.16 179.21 7.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.848 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.66 -27.84 37.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.26 -32.21 72.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.603 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -97.38 -72.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 0.0 110.475 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.77 -7.13 1.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.599 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -108.8 -19.1 13.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.329 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.55 ' HB ' ' CG2' ' B' ' 78' ' ' ILE . 49.8 t -80.53 132.06 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.183 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . 0.653 ' HA ' ' O ' ' B' ' 76' ' ' THR . 0.4 OUTLIER -76.61 134.91 39.2 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.283 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.637 ' HB1' ' HB ' ' B' ' 76' ' ' THR . . . -62.21 165.16 6.09 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.939 0.399 . . . . 0.0 111.678 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . 0.434 HD13 HG21 ' B' ' 97' ' ' THR . 0.1 OUTLIER -65.72 171.7 4.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . 0.466 ' OE1' ' HB3' ' B' ' 91' ' ' SER . 8.0 pt20 -72.54 175.76 6.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.349 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' SER . . . . . 0.461 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 0.5 OUTLIER -76.04 -21.24 57.02 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.984 0.421 . . . . 0.0 111.492 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' SER . . . . . 0.466 ' HB3' ' OE1' ' B' ' 89' ' ' GLN . 32.1 t -80.94 67.53 6.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.433 ' HA ' ' OG ' ' B' ' 95' ' ' SER . . . -72.29 -9.66 58.77 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.637 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . 0.559 ' HB1' ' HB2' ' D' ' 22' ' ' ALA . . . -68.05 -22.9 64.93 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.653 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.46 6.73 2.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.917 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' SER . . . . . 0.697 ' HA ' ' HB3' ' B' ' 147' ' ' ALA . 30.5 p -93.69 150.79 20.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.851 0.358 . . . . 0.0 110.632 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.79 167.19 18.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.434 HG21 HD13 ' B' ' 88' ' ' LEU . 0.2 OUTLIER -118.6 165.18 14.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.366 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . 0.499 ' HA ' ' OG1' ' B' ' 140' ' ' THR . 85.0 m-20 63.17 45.54 5.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.465 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' B' ' 143' ' ' ALA . 3.5 p -170.63 131.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.76 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.11 -176.02 21.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.529 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . 0.726 HG13 HD22 ' B' ' 34' ' ' LEU . 75.8 t -104.06 91.85 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 122.946 0.498 . . . . 0.0 111.79 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 0.0 OUTLIER -67.83 131.18 45.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.919 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.4 110.53 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.526 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 5.5 tp -91.22 149.99 21.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.628 0.251 . . . . 0.0 111.053 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.95 174.62 5.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.652 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . 0.517 ' HB3' ' HG ' ' B' ' 120' ' ' SER . 1.5 ttt180 -72.44 -18.54 61.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.796 0.331 . . . . 0.0 111.079 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 46.0 p -69.36 -9.57 54.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.005 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.02 -48.43 0.95 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.671 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.91 163.57 15.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 0.0 111.154 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -70.45 125.52 27.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.427 HD11 ' CB ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -65.35 147.59 53.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.321 0.581 . . . . 0.0 110.607 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.99 144.56 45.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.136 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.519 ' N ' HD11 ' B' ' 113' ' ' LEU . 10.2 mp -100.29 89.82 4.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.762 0.315 . . . . 0.0 110.682 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . 0.527 ' HB2' HG21 ' B' ' 117' ' ' THR . 4.1 m-20 -142.36 11.47 1.92 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.668 0.27 . . . . 0.0 111.621 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.92 -78.14 0.69 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.576 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.26 61.56 0.73 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.976 0.417 . . . . 0.0 111.629 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' THR . . . . . 0.527 HG21 ' HB2' ' B' ' 114' ' ' ASP . 17.7 p -93.38 95.82 9.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.123 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.77 109.97 5.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.781 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.32 -72.89 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' SER . . . . . 0.517 ' HG ' ' HB3' ' B' ' 106' ' ' ARG . 0.1 OUTLIER -92.52 113.07 25.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.583 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.43 97.54 8.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.204 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.47 132.68 37.51 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.761 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' THR . . . . . 0.432 HG23 ' N ' ' B' ' 124' ' ' LEU . 22.2 m -60.92 146.19 47.63 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.74 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.432 ' N ' HG23 ' B' ' 123' ' ' THR . 0.2 OUTLIER -85.48 156.5 20.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.595 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.77 142.8 40.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.515 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.01 113.61 6.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.732 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.59 -90.03 0.32 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.73 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 6.1 m -124.88 152.82 43.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.677 0.275 . . . . 0.0 110.815 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . 0.529 ' HB3' ' HB2' ' B' ' 58' ' ' LEU . 17.0 t-20 -123.04 147.6 46.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.963 0.411 . . . . 0.0 111.096 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.3 m -126.19 135.61 51.84 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.085 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' ILE . . . . . . . . . . . . . 58.6 mt -113.95 115.72 45.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -81.74 115.68 2.79 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.67 1.58 . . . . 0.0 112.598 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.58 150.84 46.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.806 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' GLN . . . . . 0.53 ' NE2' ' HB3' ' B' ' 51' ' ' ALA . 1.2 mt-30 -142.46 166.75 23.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.034 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' B' ' 102' ' ' GLN . . . -158.22 102.88 1.79 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 0.0 111.626 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' B' ' 51' ' ' ALA . 0.2 OUTLIER -94.67 -173.41 3.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.439 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . 0.58 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 3.8 m-85 -100.83 152.83 20.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.074 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' B' ' 47' ' ' ALA . 0.2 OUTLIER -147.32 160.81 42.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.002 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -126.92 149.65 49.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.876 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' THR . . . . . 0.637 HG22 HG12 ' B' ' 78' ' ' ILE . 0.0 OUTLIER -115.41 27.86 9.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.453 179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.46 66.86 0.2 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.879 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.94 88.62 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.568 0.223 . . . . 0.0 110.69 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' ALA . . . . . 0.661 ' HB3' ' HB ' ' B' ' 99' ' ' VAL . . . -60.25 156.94 14.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.764 0.316 . . . . 0.0 111.407 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.534 ' HB ' ' CD ' ' B' ' 145' ' ' PRO . 76.5 p -112.23 173.04 3.07 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.236 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.534 ' CD ' ' HB ' ' B' ' 144' ' ' THR . 1.3 Cg_endo -84.55 145.23 10.43 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.552 2.168 . . . . 0.0 111.979 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.37 -112.73 0.55 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.521 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -125.02 167.62 14.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.826 0.346 . . . . 0.0 111.308 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . 0.473 ' HB3' HG22 ' A' ' 16' ' ' VAL . . . -157.16 57.52 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.459 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -91.84 132.72 36.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.582 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.4 163.13 28.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.023 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.44 125.61 1.83 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.25 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . 0.652 ' HB1' HD11 ' B' ' 86' ' ' LEU . . . -154.51 165.82 35.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.211 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.92 163.11 12.77 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -119.01 134.6 55.09 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.181 0.515 . . . . 0.0 110.069 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . 0.603 ' HE2' ' HA ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -95.57 166.26 11.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.923 -178.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.29 112.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.81 0.338 . . . . 0.0 111.663 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.5 ' HB3' ' HB2' ' B' ' 70' ' ' ALA . 0.2 OUTLIER -88.73 138.88 31.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.286 0.565 . . . . 0.0 110.423 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . 0.524 ' HE2' HG11 ' B' ' 17' ' ' VAL . 22.6 m-85 -127.73 113.11 15.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.554 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.937 179.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.304 0.097 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.96 68.25 0.88 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.62 0.248 . . . . 0.0 110.999 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.31 87.69 6.15 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.46 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' D' ' 157' ' ' GLN . 3.5 m -90.51 115.49 27.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.55 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 m -127.3 167.01 22.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.589 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . 0.62 ' HA ' ' HE2' ' D' ' 155' ' ' LYS . 19.9 t30 -83.06 115.16 21.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.507 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.34 -71.53 1.06 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.828 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.28 172.75 34.76 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.931 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 33.2 m -95.5 137.0 35.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.972 0.415 . . . . 0.0 111.219 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.687 HG11 ' CE2' ' C' ' 12' ' ' PHE . 40.1 t -120.78 130.75 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.225 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' HIS . . . . . 0.528 ' O ' ' HB ' ' D' ' 32' ' ' VAL . 1.3 m80 -103.86 157.99 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.392 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' PHE . . . . . 0.687 ' CE2' HG11 ' C' ' 10' ' ' VAL . 0.6 OUTLIER -145.91 89.67 1.91 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.793 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . 0.437 ' HG2' ' HA ' ' D' ' 33' ' ' GLN . 0.0 OUTLIER -80.04 135.15 36.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.437 179.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.5 178.43 42.02 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.898 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' GLU . . . . . 0.655 ' HG2' ' HA ' ' D' ' 147' ' ' ALA . 2.6 mt-10 -156.87 -177.98 7.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.382 . . . . 0.0 110.327 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' D' ' 148' ' ' ALA . 2.7 t -142.24 150.13 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.253 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.526 HG11 ' HE2' ' C' ' 158' ' ' TYR . 4.1 m -141.72 168.57 15.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 111.025 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.04 74.77 4.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.068 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.82 91.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.011 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.49 -50.97 0.08 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.475 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER 179.87 -179.77 0.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.019 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . 0.583 ' HA ' ' HB3' ' D' ' 36' ' ' GLN . . . -136.16 116.43 13.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.168 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 69.0 t -67.02 120.15 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.043 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.46 150.47 46.49 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.59 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.35 -50.16 31.58 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.343 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.34 -31.77 81.51 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.897 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.09 -15.93 63.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -72.94 -43.67 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.36 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.44 106.08 10.34 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -116.67 133.98 55.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.026 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.5 96.07 6.25 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.069 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' B' ' 11' ' ' HIS . 69.5 t -89.45 131.24 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.154 0.502 . . . . 0.0 110.434 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.423 ' HA ' ' HG2' ' B' ' 13' ' ' LYS . 0.3 OUTLIER -109.02 106.46 16.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.582 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.724 HD22 HG13 ' C' ' 101' ' ' VAL . 0.4 OUTLIER -73.82 -40.89 63.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.642 179.368 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.98 -122.45 6.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.556 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . 0.578 ' HB3' ' HA ' ' B' ' 22' ' ' ALA . 16.2 tt0 -144.55 153.9 42.31 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.621 0.248 . . . . 0.0 110.913 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . 0.493 HG23 HG21 ' B' ' 16' ' ' VAL . 0.0 OUTLIER -128.51 146.3 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.848 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.22 145.96 26.1 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.772 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 41.0 p -57.73 -23.03 49.87 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.777 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.94 -33.2 61.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.056 0.455 . . . . 0.0 110.833 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.0 -31.21 69.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.142 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' C' ' 139' ' ' ALA . 0.0 OUTLIER -130.77 86.41 2.37 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.65 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.68 36.14 4.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.371 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.6 150.89 0.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.343 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.8 134.84 54.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.337 . . . . 0.0 111.135 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.74 -14.08 53.35 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.143 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' C' ' 138' ' ' PHE . . . -57.27 129.86 43.63 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' THR . . . . . 0.463 ' HB ' ' CE1' ' C' ' 138' ' ' PHE . 14.3 t -130.57 143.31 50.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.903 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.576 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 68.6 m -111.96 -157.23 0.61 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.565 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.402 ' H ' ' HB3' ' C' ' 49' ' ' SER . 27.7 t -74.59 150.13 39.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.816 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . 0.536 ' HB3' ' NE2' ' C' ' 134' ' ' GLN . . . -103.24 146.65 28.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.344 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' C' ' 134' ' ' GLN . 22.2 m -83.35 148.35 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.42 121.17 6.19 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.645 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -153.79 125.59 7.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.777 0.322 . . . . 0.0 110.933 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.35 156.17 20.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.543 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 22.4 mm -103.9 135.28 42.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.635 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.7 126.04 48.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.755 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . 0.531 ' HB2' ' HB3' ' C' ' 129' ' ' ASN . 4.3 mp -131.57 100.0 4.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.298 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.41 174.82 11.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.943 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.68 65.28 1.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.804 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' C' ' 21' ' ' CYS . 60.7 m -98.73 142.98 29.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.796 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.66 109.25 15.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.303 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.43 29.47 1.7 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.93 -59.19 2.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.015 0.436 . . . . 0.0 111.752 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.29 -39.87 13.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.654 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.61 101.34 10.67 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.629 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 31.1 p -90.54 -28.83 18.24 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 110.962 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.36 167.05 16.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.531 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.91 149.84 29.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.599 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' C' ' 157' ' ' GLN . . . -112.98 159.74 18.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.104 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.1 123.31 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.678 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . 0.493 ' HB2' ' CB ' ' C' ' 155' ' ' LYS . . . -124.65 169.0 12.38 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.55 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' PHE . . . . . 0.439 ' CB ' HD11 ' C' ' 111' ' ' LEU . 17.2 t80 -150.6 144.39 25.24 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.54 0.21 . . . . 0.0 111.104 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.561 HD21 HD22 ' F' ' 55' ' ' ASN . 0.4 OUTLIER -121.46 88.62 2.97 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.976 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.78 164.7 24.68 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.779 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' THR . . . . . 0.646 ' O ' ' HA ' ' C' ' 86' ' ' LEU . 0.6 OUTLIER -78.55 147.77 33.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.571 0.224 . . . . 0.0 110.76 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . 0.48 ' H ' ' HB3' ' F' ' 132' ' ' PRO . . . -95.73 140.26 30.79 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.934 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . 0.639 HG12 HG22 ' C' ' 140' ' ' THR . 1.1 tt -78.61 -33.18 16.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.86 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.17 179.28 6.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.69 -27.9 36.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.006 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.15 -32.24 72.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.671 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -97.32 -72.73 0.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 0.0 110.49 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 5.6 m 74.9 -7.25 1.78 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.563 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -108.77 -19.13 13.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.329 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.556 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 49.9 t -80.58 132.01 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.162 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.661 HD11 ' HB1' ' C' ' 152' ' ' ALA . 0.4 OUTLIER -76.58 134.98 39.23 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.991 -0.283 . . . . 0.0 110.279 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.639 ' HB1' ' HB ' ' C' ' 76' ' ' THR . . . -62.34 165.16 6.27 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.903 0.382 . . . . 0.0 111.676 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.418 HD13 HG21 ' C' ' 97' ' ' THR . 0.0 OUTLIER -65.72 171.74 4.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.069 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' GLN . . . . . 0.46 ' OE1' ' HB3' ' C' ' 91' ' ' SER . 8.1 pt20 -72.45 175.71 6.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.409 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' SER . . . . . 0.45 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 0.5 OUTLIER -75.98 -21.26 57.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.984 0.421 . . . . 0.0 111.518 179.414 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' SER . . . . . 0.46 ' HB3' ' OE1' ' C' ' 89' ' ' GLN . 32.1 t -80.95 67.6 6.92 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.811 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' ALA . . . . . 0.439 ' HA ' ' OG ' ' C' ' 95' ' ' SER . . . -72.28 -9.71 58.83 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.912 0.387 . . . . 0.0 111.681 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' E' ' 22' ' ' ALA . . . -68.14 -22.77 64.85 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.615 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.54 6.75 2.46 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.895 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' SER . . . . . 0.692 ' HA ' ' HB3' ' C' ' 147' ' ' ALA . 31.5 p -93.72 150.82 20.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.851 0.358 . . . . 0.0 110.625 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.79 167.14 18.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' THR . . . . . 0.418 HG21 HD13 ' C' ' 88' ' ' LEU . 0.2 OUTLIER -118.58 165.16 14.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.367 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . 0.513 ' HA ' ' OG1' ' C' ' 140' ' ' THR . 85.1 m-20 63.24 45.5 5.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.443 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' VAL . . . . . 0.672 ' HB ' ' HB3' ' C' ' 143' ' ' ALA . 3.5 p -170.65 131.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.762 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.03 -175.94 21.14 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.531 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' VAL . . . . . 0.724 HG13 HD22 ' C' ' 34' ' ' LEU . 76.0 t -104.14 91.88 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 122.981 0.512 . . . . 0.0 111.723 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' C' ' 85' ' ' VAL . 0.0 OUTLIER -67.95 131.16 44.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.916 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.34 110.56 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.535 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 5.4 tp -91.22 149.94 21.55 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.625 0.25 . . . . 0.0 111.086 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.9 174.68 5.79 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.71 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . 0.517 ' HB3' ' HG ' ' C' ' 120' ' ' SER . 1.5 ttt180 -72.53 -18.45 61.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.79 0.329 . . . . 0.0 111.106 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 46.2 p -69.36 -9.67 54.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.996 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.99 -48.34 0.96 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.69 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.95 163.57 15.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 111.072 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -70.49 125.62 27.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.123 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' LEU . . . . . 0.439 HD11 ' CB ' ' C' ' 73' ' ' PHE . 0.0 OUTLIER -65.41 147.65 53.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.356 0.598 . . . . 0.0 110.557 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' THR . . . . . 0.402 ' HB ' ' CG2' ' C' ' 117' ' ' THR . 0.2 OUTLIER -74.11 144.63 44.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.113 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . 0.517 ' N ' HD11 ' C' ' 113' ' ' LEU . 10.2 mp -100.36 89.84 4.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.799 0.333 . . . . 0.0 110.718 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' ASP . . . . . 0.535 ' HB2' HG21 ' C' ' 117' ' ' THR . 4.0 m-20 -142.37 11.5 1.92 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.51 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.82 -78.08 0.7 Allowed Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.638 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.24 61.52 0.73 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.013 0.435 . . . . 0.0 111.686 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' THR . . . . . 0.535 HG21 ' HB2' ' C' ' 114' ' ' ASP . 17.6 p -93.4 95.9 9.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.081 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.86 110.02 5.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.787 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 13.9 m -120.4 -72.85 0.67 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' SER . . . . . 0.517 ' HG ' ' HB3' ' C' ' 106' ' ' ARG . 0.1 OUTLIER -92.42 113.04 25.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.666 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -99.39 97.52 8.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.186 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.45 132.71 37.46 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.752 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' THR . . . . . 0.439 HG23 ' N ' ' C' ' 124' ' ' LEU . 22.0 m -60.89 146.15 47.65 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.708 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . 0.439 ' N ' HG23 ' C' ' 123' ' ' THR . 0.2 OUTLIER -85.41 156.52 20.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.634 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.82 142.73 40.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.575 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.9 113.69 6.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.742 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.5 -90.01 0.32 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.702 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 6.1 m -124.91 152.82 43.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.692 0.282 . . . . 0.0 110.815 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 129' ' ' ASN . . . . . 0.531 ' HB3' ' HB2' ' C' ' 58' ' ' LEU . 17.1 t-20 -123.06 147.53 46.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 4.3 m -126.19 135.65 51.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.094 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 131' ' ' ILE . . . . . . . . . . . . . 58.2 mt -113.95 115.68 45.63 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 132' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -81.74 115.72 2.79 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 121.635 1.557 . . . . 0.0 112.54 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.57 150.8 46.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.828 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 134' ' ' GLN . . . . . 0.536 ' NE2' ' HB3' ' C' ' 51' ' ' ALA . 1.2 mt-30 -142.4 166.74 23.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.032 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' C' ' 102' ' ' GLN . . . -158.22 102.92 1.79 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.927 0.394 . . . . 0.0 111.622 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' C' ' 51' ' ' ALA . 0.1 OUTLIER -94.69 -173.47 3.02 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.408 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 137' ' ' TYR . . . . . 0.576 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 3.8 m-85 -100.72 152.83 20.0 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.147 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 138' ' ' PHE . . . . . 0.545 ' HA ' ' O ' ' C' ' 47' ' ' ALA . 0.2 OUTLIER -147.3 160.73 42.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.026 -179.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 139' ' ' ALA . . . . . 0.417 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -126.85 149.63 49.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.915 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 140' ' ' THR . . . . . 0.639 HG22 HG12 ' C' ' 78' ' ' ILE . 0.0 OUTLIER -115.33 27.87 9.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.472 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.37 66.79 0.2 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.947 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.93 88.63 0.09 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.58 0.229 . . . . 0.0 110.769 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 143' ' ' ALA . . . . . 0.672 ' HB3' ' HB ' ' C' ' 99' ' ' VAL . . . -60.25 156.86 14.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.758 0.313 . . . . 0.0 111.4 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 144' ' ' THR . . . . . 0.542 ' HB ' ' CD ' ' C' ' 145' ' ' PRO . 77.3 p -112.2 173.05 3.07 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.254 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 145' ' ' PRO . . . . . 0.542 ' CD ' ' HB ' ' C' ' 144' ' ' THR . 1.3 Cg_endo -84.55 145.24 10.43 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.57 2.18 . . . . 0.0 111.923 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.31 -112.7 0.55 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.508 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 147' ' ' ALA . . . . . 0.692 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -124.92 167.68 14.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.913 0.387 . . . . 0.0 111.296 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 148' ' ' ALA . . . . . 0.483 ' HB3' HG22 ' B' ' 16' ' ' VAL . . . -157.19 57.45 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.466 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -91.81 132.71 36.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.53 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.41 163.16 28.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.988 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.45 125.59 1.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.244 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . 0.661 ' HB1' HD11 ' C' ' 86' ' ' LEU . . . -154.57 165.78 35.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.264 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.88 163.17 12.72 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -119.02 134.57 55.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.061 0.458 . . . . 0.0 110.155 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . 0.625 ' HE2' ' HA ' ' B' ' 6' ' ' ASN . 0.0 OUTLIER -95.62 166.28 11.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.914 -178.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.22 112.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.754 0.312 . . . . 0.0 111.713 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . 0.499 ' HB3' ' HB2' ' C' ' 70' ' ' ALA . 0.2 OUTLIER -88.67 138.83 31.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.235 0.54 . . . . 0.0 110.385 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . 0.526 ' HE2' HG11 ' C' ' 17' ' ' VAL . 22.6 m-85 -127.76 113.21 15.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.523 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.913 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.248 0.07 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.96 68.35 0.87 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.935 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' THR . . . . . . . . . . . . . 7.5 m -92.39 87.63 6.09 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.439 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' E' ' 157' ' ' GLN . 3.5 m -90.39 115.48 27.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.542 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -127.3 167.02 22.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.565 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . 0.615 ' HA ' ' HE2' ' E' ' 155' ' ' LYS . 20.0 t30 -83.02 115.19 21.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.554 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.43 -71.49 1.06 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.806 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.3 172.75 34.77 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.897 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 33.1 m -95.45 136.94 35.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.918 0.39 . . . . 0.0 111.265 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' VAL . . . . . 0.686 HG11 ' CE2' ' D' ' 12' ' ' PHE . 40.0 t -120.83 130.73 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.171 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' HIS . . . . . 0.526 ' O ' ' HB ' ' E' ' 32' ' ' VAL . 1.3 m80 -103.83 157.98 16.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.327 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' PHE . . . . . 0.686 ' CE2' HG11 ' D' ' 10' ' ' VAL . 0.6 OUTLIER -145.87 89.68 1.92 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.76 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' E' ' 33' ' ' GLN . 0.0 OUTLIER -79.98 135.16 36.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.436 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.54 178.42 42.04 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.948 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' GLU . . . . . 0.665 ' HG2' ' HA ' ' E' ' 147' ' ' ALA . 2.5 mt-10 -156.79 -177.92 6.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.833 0.349 . . . . 0.0 110.414 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.494 HG21 HG23 ' E' ' 37' ' ' VAL . 2.7 t -142.24 150.16 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.27 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . 0.527 HG11 ' HE2' ' D' ' 158' ' ' TYR . 4.2 m -141.76 168.53 14.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.86 0.362 . . . . 0.0 111.034 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -92.98 74.75 4.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.066 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.83 91.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.057 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.43 -51.06 0.09 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.402 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER 179.88 -179.78 0.48 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.005 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . 0.583 ' HA ' ' HB3' ' E' ' 36' ' ' GLN . . . -136.17 116.41 13.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.16 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 69.3 t -67.01 120.21 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.42 150.47 46.39 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.573 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.36 -50.16 31.66 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.42 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.26 -31.82 81.79 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.93 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.09 -15.95 63.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.868 0.366 . . . . 0.0 110.821 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.04 -43.56 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.334 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.41 106.1 10.36 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.999 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -116.68 133.95 55.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.032 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.48 96.05 6.24 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.042 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' C' ' 11' ' ' HIS . 68.9 t -89.39 131.28 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.161 0.505 . . . . 0.0 110.469 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.437 ' HA ' ' HG2' ' C' ' 13' ' ' LYS . 0.3 OUTLIER -109.05 106.5 16.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.603 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.73 HD22 HG13 ' D' ' 101' ' ' VAL . 0.4 OUTLIER -73.85 -40.88 62.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.678 179.391 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.0 -122.47 6.75 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.522 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' GLN . . . . . 0.583 ' HB3' ' HA ' ' C' ' 22' ' ' ALA . 16.3 tt0 -144.55 153.83 42.23 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.566 0.222 . . . . 0.0 110.874 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.484 HG23 HG21 ' C' ' 16' ' ' VAL . 0.0 OUTLIER -128.46 146.32 34.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.911 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.2 145.99 26.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.768 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' THR . . . . . . . . . . . . . 40.8 p -57.74 -23.06 50.09 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.743 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.97 -33.23 61.87 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.053 0.454 . . . . 0.0 110.8 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.02 -31.21 69.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.134 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' D' ' 139' ' ' ALA . 0.0 OUTLIER -130.72 86.37 2.37 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.69 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.71 36.27 4.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.346 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.56 150.82 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.38 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.75 134.83 55.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.0 111.175 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.78 -14.22 53.16 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.213 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' D' ' 138' ' ' PHE . . . -57.14 129.86 43.61 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' THR . . . . . 0.456 ' HB ' ' CE1' ' D' ' 138' ' ' PHE . 14.4 t -130.61 143.35 50.69 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.878 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 68.8 m -111.96 -157.21 0.61 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.596 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 27.7 t -74.55 150.06 39.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.834 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' ALA . . . . . 0.533 ' HB3' ' NE2' ' D' ' 134' ' ' GLN . . . -103.19 146.64 28.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.326 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' VAL . . . . . 0.464 ' HB ' ' HA ' ' A' ' 90' ' ' SER . 22.3 m -83.37 148.33 5.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.909 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.38 121.21 6.21 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.633 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -153.88 125.54 7.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.855 0.36 . . . . 0.0 110.898 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' ASN . . . . . 0.574 HD22 HD21 ' A' ' 74' ' ' LEU . 1.9 p-10 -109.28 156.24 20.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.492 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . . . . . . . . . 22.6 mm -104.05 135.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.534 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' GLN . . . . . 0.49 ' HG3' HD22 ' A' ' 74' ' ' LEU . 2.2 tt0 -101.66 126.01 48.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.753 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . 0.524 ' HB2' ' HB3' ' D' ' 129' ' ' ASN . 4.3 mp -131.62 99.97 4.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.275 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.46 174.73 11.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.902 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.8 65.26 1.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.782 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' D' ' 21' ' ' CYS . 60.7 m -98.71 142.92 29.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.746 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.6 109.2 15.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.301 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.43 29.65 1.66 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' ASN . . . . . 0.474 HD21 ' HA ' ' D' ' 64' ' ' ASN . 0.1 OUTLIER -90.06 -59.27 2.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.069 0.462 . . . . 0.0 111.752 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.18 -39.8 13.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.732 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.64 101.39 10.71 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.586 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 31.3 p -90.58 -28.76 18.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.885 0.374 . . . . 0.0 110.999 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.49 166.91 16.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.482 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.8 149.82 29.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.664 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' D' ' 157' ' ' GLN . . . -112.91 159.77 18.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.101 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 52.4 t -108.08 123.31 63.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.662 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' ALA . . . . . 0.476 ' HB2' ' CB ' ' D' ' 155' ' ' LYS . . . -124.61 168.92 12.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.622 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' PHE . . . . . 0.438 ' CB ' HD11 ' D' ' 111' ' ' LEU . 17.2 t80 -150.62 144.41 25.23 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.585 0.231 . . . . 0.0 111.133 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.5 88.6 2.97 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.999 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.74 164.72 24.67 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.759 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' THR . . . . . 0.659 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.6 OUTLIER -78.56 147.76 33.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.565 0.222 . . . . 0.0 110.774 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.82 140.32 30.77 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.912 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 78' ' ' ILE . . . . . 0.625 HG12 HG22 ' D' ' 140' ' ' THR . 1.1 tt -78.65 -33.11 16.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.921 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.16 179.27 7.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.859 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.69 -27.91 36.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.059 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.17 -32.29 72.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.619 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -97.28 -72.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.482 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.86 -7.22 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.592 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -108.79 -19.1 13.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.287 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.551 ' HB ' ' CG2' ' D' ' 78' ' ' ILE . 50.3 t -80.65 131.98 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.134 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.659 ' HA ' ' O ' ' D' ' 76' ' ' THR . 0.4 OUTLIER -76.52 134.96 39.31 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.32 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.62 ' HB1' ' HB ' ' D' ' 76' ' ' THR . . . -62.31 165.19 6.2 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.889 0.376 . . . . 0.0 111.669 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . 0.451 ' H ' ' HG ' ' D' ' 88' ' ' LEU . 0.1 OUTLIER -65.75 171.69 4.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.056 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 89' ' ' GLN . . . . . 0.468 ' OE1' ' HB3' ' D' ' 91' ' ' SER . 8.1 pt20 -72.48 175.67 6.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.412 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.98 -21.19 57.22 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.071 0.462 . . . . 0.0 111.521 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 91' ' ' SER . . . . . 0.468 ' HB3' ' OE1' ' D' ' 89' ' ' GLN . 32.1 t -81.02 67.64 7.01 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.825 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 92' ' ' ALA . . . . . 0.433 ' HA ' ' OG ' ' D' ' 95' ' ' SER . . . -72.33 -9.7 58.84 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.943 0.401 . . . . 0.0 111.682 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 93' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' F' ' 22' ' ' ALA . . . -68.06 -22.88 64.92 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.615 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.51 6.78 2.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.911 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 95' ' ' SER . . . . . 0.682 ' HA ' ' HB3' ' D' ' 147' ' ' ALA . 31.6 p -93.77 150.86 20.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.846 0.355 . . . . 0.0 110.599 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.82 167.24 18.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.834 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 97' ' ' THR . . . . . 0.424 HG21 HD13 ' D' ' 88' ' ' LEU . 0.2 OUTLIER -118.68 165.16 14.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.295 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 98' ' ' ASN . . . . . 0.513 ' HA ' ' OG1' ' D' ' 140' ' ' THR . 85.0 m-20 63.3 45.46 4.98 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.434 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 99' ' ' VAL . . . . . 0.654 ' HB ' ' HB3' ' D' ' 143' ' ' ALA . 3.4 p -170.67 131.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.784 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.05 -175.92 21.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.54 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 101' ' ' VAL . . . . . 0.73 HG13 HD22 ' D' ' 34' ' ' LEU . 76.4 t -104.2 91.91 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.187 0.518 . . . . 0.0 111.669 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 102' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' D' ' 85' ' ' VAL . 0.0 OUTLIER -67.9 131.25 45.16 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.877 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.47 110.64 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.468 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 104' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 5.5 tp -91.33 149.96 21.51 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.633 0.254 . . . . 0.0 111.056 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.87 174.65 5.8 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.714 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 106' ' ' ARG . . . . . 0.505 ' HB3' ' HG ' ' D' ' 120' ' ' SER . 1.5 ttt180 -72.47 -18.55 61.67 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.714 0.293 . . . . 0.0 111.033 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 107' ' ' THR . . . . . . . . . . . . . 46.3 p -69.33 -9.58 53.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.06 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.98 -48.41 0.96 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.643 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.92 163.56 15.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.063 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -70.47 125.57 27.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.155 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 111' ' ' LEU . . . . . 0.438 HD11 ' CB ' ' D' ' 73' ' ' PHE . 0.0 OUTLIER -65.33 147.64 53.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.328 0.585 . . . . 0.0 110.593 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.1 144.61 44.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.085 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 113' ' ' LEU . . . . . 0.514 ' N ' HD11 ' D' ' 113' ' ' LEU . 10.2 mp -100.34 89.89 4.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.727 0.298 . . . . 0.0 110.686 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 114' ' ' ASP . . . . . 0.522 ' HB2' HG21 ' D' ' 117' ' ' THR . 4.0 m-20 -142.37 11.44 1.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.569 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.88 -78.06 0.69 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.624 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.26 61.49 0.73 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.999 0.428 . . . . 0.0 111.706 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 117' ' ' THR . . . . . 0.522 HG21 ' HB2' ' D' ' 114' ' ' ASP . 17.5 p -93.41 95.86 9.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.131 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.81 110.05 5.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.746 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.39 -72.9 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.878 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 120' ' ' SER . . . . . 0.505 ' HG ' ' HB3' ' D' ' 106' ' ' ARG . 0.1 OUTLIER -92.45 113.05 25.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.622 179.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -99.44 97.56 8.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.191 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.5 132.74 37.49 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.752 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 123' ' ' THR . . . . . 0.438 HG23 ' N ' ' D' ' 124' ' ' LEU . 22.1 m -60.94 146.11 47.96 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.709 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . 0.438 ' N ' HG23 ' D' ' 123' ' ' THR . 0.2 OUTLIER -85.34 156.49 20.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.632 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.81 142.74 40.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.577 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.97 113.7 6.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.689 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.51 -90.05 0.32 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.701 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 128' ' ' THR . . . . . 0.429 ' HB ' ' HD3' ' A' ' 155' ' ' LYS . 6.2 m -124.94 152.86 43.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.734 0.302 . . . . 0.0 110.82 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 129' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' D' ' 58' ' ' LEU . 17.1 t-20 -123.06 147.56 46.57 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.866 0.365 . . . . 0.0 111.158 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 130' ' ' THR . . . . . 0.484 ' OG1' HD11 ' A' ' 74' ' ' LEU . 4.3 m -126.22 135.71 51.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.05 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 131' ' ' ILE . . . . . . . . . . . . . 58.5 mt -114.01 115.7 45.48 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 132' ' ' PRO . . . . . 0.495 ' HB3' ' H ' ' A' ' 77' ' ' ALA . 7.5 Cg_endo -81.67 115.71 2.82 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 121.703 1.602 . . . . 0.0 112.545 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.59 150.79 46.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.802 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 134' ' ' GLN . . . . . 0.533 ' NE2' ' HB3' ' D' ' 51' ' ' ALA . 1.3 mt-30 -142.5 166.61 24.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.081 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' D' ' 102' ' ' GLN . . . -158.14 102.9 1.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.922 0.392 . . . . 0.0 111.638 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 136' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' D' ' 51' ' ' ALA . 0.2 OUTLIER -94.67 -173.41 3.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.415 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 137' ' ' TYR . . . . . 0.575 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 3.8 m-85 -100.82 152.86 20.0 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.09 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 138' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' D' ' 47' ' ' ALA . 0.2 OUTLIER -147.33 160.73 42.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.083 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 139' ' ' ALA . . . . . 0.418 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -126.82 149.71 49.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.895 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 140' ' ' THR . . . . . 0.625 HG22 HG12 ' D' ' 78' ' ' ILE . 0.0 OUTLIER -115.4 27.79 9.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.402 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.38 66.86 0.2 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.888 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.92 88.61 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.576 0.188 . . . . 0.0 110.759 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 143' ' ' ALA . . . . . 0.654 ' HB3' ' HB ' ' D' ' 99' ' ' VAL . . . -60.2 156.9 14.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.709 0.29 . . . . 0.0 111.438 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 144' ' ' THR . . . . . 0.538 ' HB ' ' CD ' ' D' ' 145' ' ' PRO . 76.9 p -112.21 173.08 3.05 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.213 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 145' ' ' PRO . . . . . 0.538 ' CD ' ' HB ' ' D' ' 144' ' ' THR . 1.3 Cg_endo -84.58 145.2 10.38 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.565 2.177 . . . . 0.0 111.937 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.38 -112.72 0.55 Allowed Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.555 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 147' ' ' ALA . . . . . 0.682 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -124.92 167.69 14.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.812 0.339 . . . . 0.0 111.394 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 148' ' ' ALA . . . . . 0.487 ' HB3' HG22 ' C' ' 16' ' ' VAL . . . -157.22 57.54 0.51 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.103 0.478 . . . . 0.0 110.468 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.87 132.74 36.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.534 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.48 163.12 28.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.027 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.39 125.6 1.85 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.282 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 152' ' ' ALA . . . . . 0.65 ' HB1' HD11 ' D' ' 86' ' ' LEU . . . -154.59 165.78 35.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.173 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.84 163.16 12.72 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -119.0 134.48 55.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.023 0.439 . . . . 0.0 110.2 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' C' ' 6' ' ' ASN . 0.0 OUTLIER -95.61 166.3 11.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.91 -178.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.25 112.83 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.832 0.348 . . . . 0.0 111.638 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 157' ' ' GLN . . . . . 0.502 ' HB3' ' HB2' ' D' ' 70' ' ' ALA . 0.2 OUTLIER -88.82 138.84 31.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.331 0.586 . . . . 0.0 110.393 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . 0.527 ' HE2' HG11 ' D' ' 17' ' ' VAL . 22.5 m-85 -127.65 113.16 15.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.519 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.962 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.261 0.076 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.0 68.24 0.88 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.587 0.232 . . . . 0.0 111.022 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -92.31 87.66 6.13 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.473 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 4' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' F' ' 157' ' ' GLN . 3.5 m -90.5 115.48 27.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.545 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 m -127.22 167.0 22.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.583 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 6' ' ' ASN . . . . . 0.624 ' HA ' ' HE2' ' F' ' 155' ' ' LYS . 20.0 t30 -83.04 115.14 21.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.497 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.41 -71.45 1.07 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.853 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.29 172.78 34.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.049 -0.595 . . . . 0.0 111.931 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 9' ' ' THR . . . . . . . . . . . . . 33.4 m -95.49 137.03 35.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.916 0.389 . . . . 0.0 111.284 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 10' ' ' VAL . . . . . 0.676 HG11 ' CE2' ' E' ' 12' ' ' PHE . 40.2 t -120.85 130.68 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.185 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 11' ' ' HIS . . . . . 0.523 ' O ' ' HB ' ' F' ' 32' ' ' VAL . 1.3 m80 -103.82 157.99 16.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.397 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 12' ' ' PHE . . . . . 0.676 ' CE2' HG11 ' E' ' 10' ' ' VAL . 0.6 OUTLIER -145.84 89.66 1.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 13' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' F' ' 33' ' ' GLN . 0.0 OUTLIER -79.95 135.21 36.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.477 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.56 178.38 42.07 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.898 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 15' ' ' GLU . . . . . 0.663 ' HG2' ' HA ' ' F' ' 147' ' ' ALA . 2.6 mt-10 -156.81 -177.9 6.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.938 0.399 . . . . 0.0 110.357 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 16' ' ' VAL . . . . . 0.488 HG21 HG23 ' F' ' 37' ' ' VAL . 2.7 t -142.29 150.13 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.239 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . 0.524 HG11 ' HE2' ' E' ' 158' ' ' TYR . 4.1 m -141.71 168.61 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.832 0.349 . . . . 0.0 111.083 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.06 74.74 4.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.087 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.89 91.89 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.5 -51.01 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.432 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 21' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER 179.82 -179.79 0.47 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.986 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 22' ' ' ALA . . . . . 0.586 ' HA ' ' HB3' ' F' ' 36' ' ' GLN . . . -136.16 116.43 13.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.146 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 23' ' ' VAL . . . . . . . . . . . . . 67.7 t -67.01 120.14 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.38 150.49 46.21 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.602 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.38 -50.18 31.7 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.355 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.3 -31.77 81.58 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.918 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.02 -16.05 63.62 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.902 0.382 . . . . 0.0 110.859 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 28' ' ' VAL . . . . . . . . . . . . . 48.4 t -72.93 -43.61 59.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.401 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.44 106.09 10.35 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -116.62 133.99 55.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.5 96.03 6.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.095 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' D' ' 11' ' ' HIS . 69.6 t -89.45 131.27 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.215 0.531 . . . . 0.0 110.437 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 33' ' ' GLN . . . . . 0.432 ' HA ' ' HG2' ' D' ' 13' ' ' LYS . 0.3 OUTLIER -108.99 106.48 16.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.599 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.716 HD22 HG13 ' E' ' 101' ' ' VAL . 0.4 OUTLIER -73.89 -40.93 62.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.552 179.419 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.04 -122.48 6.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.564 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 36' ' ' GLN . . . . . 0.583 ' HB3' ' HA ' ' D' ' 22' ' ' ALA . 16.3 tt0 -144.51 153.98 42.43 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.633 0.254 . . . . 0.0 110.881 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . 0.494 HG23 HG21 ' D' ' 16' ' ' VAL . 0.0 OUTLIER -128.57 146.33 34.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.873 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.19 146.0 26.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.731 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 39' ' ' THR . . . . . . . . . . . . . 40.9 p -57.79 -23.07 50.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.709 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.98 -33.21 61.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.013 0.435 . . . . 0.0 110.791 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.03 -31.15 69.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.222 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' E' ' 139' ' ' ALA . 0.0 OUTLIER -130.76 86.44 2.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.598 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.66 36.16 4.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.337 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.59 150.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.365 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.78 134.88 55.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 0.0 111.118 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.8 -14.28 53.07 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.146 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 47' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' E' ' 138' ' ' PHE . . . -57.22 129.92 43.9 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.938 0.399 . . . . 0.0 112.043 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 48' ' ' THR . . . . . 0.46 ' HB ' ' CE1' ' E' ' 138' ' ' PHE . 14.3 t -130.67 143.29 50.65 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.874 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 68.9 m -111.87 -157.14 0.61 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.625 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 50' ' ' SER . . . . . 0.415 ' H ' ' HB3' ' E' ' 49' ' ' SER . 27.5 t -74.58 150.05 39.86 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.865 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 51' ' ' ALA . . . . . 0.537 ' HB3' ' NE2' ' E' ' 134' ' ' GLN . . . -103.22 146.63 28.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.334 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 52' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' B' ' 90' ' ' SER . 22.1 m -83.41 148.37 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 53' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' B' ' 88' ' ' LEU . . . -108.44 121.27 6.22 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.601 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -153.87 125.57 7.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.797 0.332 . . . . 0.0 110.949 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 55' ' ' ASN . . . . . 0.585 HD22 HD21 ' B' ' 74' ' ' LEU . 1.9 p-10 -109.33 156.19 20.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.59 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 56' ' ' ILE . . . . . . . . . . . . . 22.4 mm -103.95 135.29 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.565 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 57' ' ' GLN . . . . . 0.493 ' HG3' HD22 ' B' ' 74' ' ' LEU . 2.2 tt0 -101.72 125.99 48.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.75 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' E' ' 129' ' ' ASN . 4.3 mp -131.6 99.9 4.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.326 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.32 174.72 11.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.966 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.74 65.3 1.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.79 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 61' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' E' ' 21' ' ' CYS . 60.7 m -98.71 142.94 29.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.792 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.64 109.25 15.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.266 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.47 29.59 1.68 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.99 -59.26 2.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.085 0.469 . . . . 0.0 111.727 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.25 -39.84 13.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.666 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.6 101.34 10.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.597 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 30.8 p -90.56 -28.79 18.25 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.38 167.08 16.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.509 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.95 149.75 29.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.617 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' E' ' 157' ' ' GLN . . . -112.88 159.75 18.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.1 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 52.2 t -108.09 123.29 63.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.665 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . 0.491 ' HB2' ' CB ' ' E' ' 155' ' ' LYS . . . -124.63 168.92 12.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.615 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 73' ' ' PHE . . . . . 0.432 ' CB ' HD11 ' E' ' 111' ' ' LEU . 17.2 t80 -150.63 144.4 25.21 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.601 0.239 . . . . 0.0 111.1 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.46 88.64 2.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.989 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.76 164.7 24.67 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.816 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 76' ' ' THR . . . . . 0.653 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.6 OUTLIER -78.57 147.72 33.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.595 0.236 . . . . 0.0 110.708 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.68 140.29 30.71 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.961 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 78' ' ' ILE . . . . . 0.633 HG12 HG22 ' E' ' 140' ' ' THR . 1.1 tt -78.58 -33.16 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.914 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.18 179.18 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.904 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.58 -27.96 37.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.059 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.21 -32.22 72.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.633 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -97.29 -72.81 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.931 0.396 . . . . 0.0 110.461 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.88 -7.15 1.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.593 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -108.83 -19.1 13.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.325 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' E' ' 102' ' ' GLN . 49.6 t -80.55 132.07 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.152 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 86' ' ' LEU . . . . . 0.653 ' HA ' ' O ' ' E' ' 76' ' ' THR . 0.4 OUTLIER -76.63 134.96 39.16 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.304 179.398 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 87' ' ' ALA . . . . . 0.639 ' HB1' ' HB ' ' E' ' 76' ' ' THR . . . -62.25 165.21 6.1 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.867 0.365 . . . . 0.0 111.645 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . 0.435 HD13 HG21 ' E' ' 97' ' ' THR . 0.1 OUTLIER -65.86 171.79 4.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.998 179.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 89' ' ' GLN . . . . . 0.465 ' OE1' ' HB3' ' E' ' 91' ' ' SER . 8.0 pt20 -72.56 175.71 6.09 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.425 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.04 -21.18 57.1 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.009 0.433 . . . . 0.0 111.498 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 91' ' ' SER . . . . . 0.465 ' HB3' ' OE1' ' E' ' 89' ' ' GLN . 32.0 t -80.91 67.49 6.82 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 92' ' ' ALA . . . . . 0.44 ' HA ' ' OG ' ' E' ' 95' ' ' SER . . . -72.18 -9.77 58.88 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.969 0.414 . . . . 0.0 111.723 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.04 -22.88 64.93 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.669 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.46 6.75 2.48 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.946 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 95' ' ' SER . . . . . 0.68 ' HA ' ' HB3' ' E' ' 147' ' ' ALA . 31.0 p -93.73 150.78 20.11 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.821 0.343 . . . . 0.0 110.688 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.77 167.22 18.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.876 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 97' ' ' THR . . . . . 0.435 HG21 HD13 ' E' ' 88' ' ' LEU . 0.2 OUTLIER -118.66 165.09 14.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.365 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 98' ' ' ASN . . . . . 0.502 ' HA ' ' OG1' ' E' ' 140' ' ' THR . 85.0 m-20 63.36 45.42 4.93 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.443 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 99' ' ' VAL . . . . . 0.658 ' HB ' ' HB3' ' E' ' 143' ' ' ALA . 3.4 p -170.64 131.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.692 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.04 -175.99 21.18 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.54 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 101' ' ' VAL . . . . . 0.716 HG13 HD22 ' E' ' 34' ' ' LEU . 76.3 t -104.07 91.83 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 122.994 0.517 . . . . 0.0 111.708 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 102' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' E' ' 85' ' ' VAL . 0.0 OUTLIER -67.9 131.21 45.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.42 110.62 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.475 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 104' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 5.5 tp -91.3 149.93 21.53 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.699 0.285 . . . . 0.0 111.029 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.9 174.65 5.8 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.701 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 106' ' ' ARG . . . . . 0.521 ' HB3' ' HG ' ' E' ' 120' ' ' SER . 1.5 ttt180 -72.53 -18.4 61.65 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.759 0.314 . . . . 0.0 111.067 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 46.2 p -69.41 -9.63 54.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.99 -48.38 0.96 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.636 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.88 163.58 15.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 111.11 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -70.53 125.59 27.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.432 HD11 ' CB ' ' E' ' 73' ' ' PHE . 0.0 OUTLIER -65.38 147.57 53.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.353 0.596 . . . . 0.0 110.557 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.03 144.57 45.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.157 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 113' ' ' LEU . . . . . 0.521 ' N ' HD11 ' E' ' 113' ' ' LEU . 10.2 mp -100.26 89.82 4.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.776 0.322 . . . . 0.0 110.753 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 114' ' ' ASP . . . . . 0.527 ' HB2' HG21 ' E' ' 117' ' ' THR . 4.1 m-20 -142.34 11.43 1.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.685 0.279 . . . . 0.0 111.623 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.87 -78.1 0.7 Allowed Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.619 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.29 61.63 0.73 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.976 0.417 . . . . 0.0 111.666 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 117' ' ' THR . . . . . 0.527 HG21 ' HB2' ' E' ' 114' ' ' ASP . 17.6 p -93.5 95.87 9.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.114 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.74 109.92 5.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.819 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.26 -72.96 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 120' ' ' SER . . . . . 0.521 ' HG ' ' HB3' ' E' ' 106' ' ' ARG . 0.1 OUTLIER -92.43 113.09 25.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.638 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -99.47 97.51 8.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.184 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.45 132.74 37.42 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.724 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 123' ' ' THR . . . . . 0.427 HG23 ' N ' ' E' ' 124' ' ' LEU . 22.3 m -61.01 146.13 48.2 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.691 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . 0.427 ' N ' HG23 ' E' ' 123' ' ' THR . 0.2 OUTLIER -85.41 156.49 20.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.645 179.419 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.83 142.78 40.78 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.542 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.91 113.69 6.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.717 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . 0.604 ' HA3' ' HB ' ' A' ' 4' ' ' THR . . . 128.45 -89.97 0.32 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.731 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 128' ' ' THR . . . . . 0.425 ' HB ' ' HD3' ' B' ' 155' ' ' LYS . 6.2 m -124.92 152.83 43.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.73 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 129' ' ' ASN . . . . . 0.522 ' HB3' ' HB2' ' E' ' 58' ' ' LEU . 17.0 t-20 -123.08 147.54 46.61 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.122 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 130' ' ' THR . . . . . 0.488 ' OG1' HD11 ' B' ' 74' ' ' LEU . 4.3 m -126.13 135.76 52.07 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.043 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 131' ' ' ILE . . . . . . . . . . . . . 58.4 mt -114.04 115.61 45.46 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 132' ' ' PRO . . . . . 0.488 ' HB3' ' H ' ' B' ' 77' ' ' ALA . 7.5 Cg_endo -81.69 115.69 2.81 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.698 1.599 . . . . 0.0 112.566 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.6 150.79 46.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.807 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 134' ' ' GLN . . . . . 0.537 ' NE2' ' HB3' ' E' ' 51' ' ' ALA . 1.2 mt-30 -142.44 166.71 23.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.034 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' E' ' 102' ' ' GLN . . . -158.17 102.93 1.8 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.382 . . . . 0.0 111.636 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 136' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' E' ' 51' ' ' ALA . 0.1 OUTLIER -94.72 -173.42 3.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.352 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 137' ' ' TYR . . . . . 0.57 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 3.7 m-85 -100.86 152.87 20.0 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.082 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 138' ' ' PHE . . . . . 0.541 ' HA ' ' O ' ' E' ' 47' ' ' ALA . 0.2 OUTLIER -147.35 160.73 42.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.072 -179.183 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 139' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -126.82 149.67 49.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.885 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 140' ' ' THR . . . . . 0.633 HG22 HG12 ' E' ' 78' ' ' ILE . 0.0 OUTLIER -115.35 27.84 9.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.484 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.4 66.79 0.2 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.951 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.91 88.61 0.09 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.604 0.24 . . . . 0.0 110.742 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 143' ' ' ALA . . . . . 0.658 ' HB3' ' HB ' ' E' ' 99' ' ' VAL . . . -60.21 156.89 14.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.751 0.31 . . . . 0.0 111.424 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 144' ' ' THR . . . . . 0.545 ' HB ' ' CD ' ' E' ' 145' ' ' PRO . 77.0 p -112.18 173.05 3.07 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.305 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 145' ' ' PRO . . . . . 0.545 ' CD ' ' HB ' ' E' ' 144' ' ' THR . 1.4 Cg_endo -84.6 145.25 10.37 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.477 2.118 . . . . 0.0 112.029 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.37 -112.73 0.55 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.56 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 147' ' ' ALA . . . . . 0.68 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -124.98 167.66 14.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.88 0.371 . . . . 0.0 111.337 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 148' ' ' ALA . . . . . 0.471 ' HB3' HG22 ' D' ' 16' ' ' VAL . . . -157.13 57.46 0.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.497 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.86 132.74 36.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.559 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.42 163.13 28.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.037 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.48 125.65 1.82 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.184 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 152' ' ' ALA . . . . . 0.65 ' HB1' HD11 ' E' ' 86' ' ' LEU . . . -154.61 165.71 35.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.204 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.83 163.13 12.74 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -119.04 134.56 55.12 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.094 0.473 . . . . 0.0 110.108 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . 0.615 ' HE2' ' HA ' ' D' ' 6' ' ' ASN . 0.0 OUTLIER -95.48 166.25 11.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.928 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.33 112.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.888 0.375 . . . . 0.0 111.641 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 157' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' E' ' 70' ' ' ALA . 0.2 OUTLIER -88.76 138.85 31.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.242 0.544 . . . . 0.0 110.404 -179.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . 0.524 ' HE2' HG11 ' E' ' 17' ' ' VAL . 22.5 m-85 -127.71 113.15 15.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.512 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.909 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.226 0.06 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.0 68.24 0.88 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.552 0.215 . . . . 0.0 111.049 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.36 87.66 6.11 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.469 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m -90.49 115.46 27.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.591 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -127.28 166.93 23.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.588 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -82.99 115.23 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.524 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.48 -71.45 1.07 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.801 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.3 172.78 34.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.918 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 33.2 m -95.49 136.96 35.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.399 . . . . 0.0 111.265 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 10' ' ' VAL . . . . . 0.685 HG11 ' CE2' ' F' ' 12' ' ' PHE . 40.3 t -120.82 130.72 74.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.194 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -103.84 157.96 16.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.432 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 12' ' ' PHE . . . . . 0.685 ' CE2' HG11 ' F' ' 10' ' ' VAL . 0.5 OUTLIER -145.84 89.63 1.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 13' ' ' LYS . . . . . 0.431 ' H ' ' HG2' ' F' ' 13' ' ' LYS . 0.0 OUTLIER -79.97 135.19 36.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.431 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.56 178.38 42.08 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.853 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -156.84 -177.93 6.98 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.862 0.363 . . . . 0.0 110.345 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.25 150.15 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.222 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 17' ' ' VAL . . . . . 0.524 HG11 ' HE2' ' F' ' 158' ' ' TYR . 4.1 m -141.7 168.6 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.876 0.37 . . . . 0.0 111.025 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.02 74.66 4.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.05 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.95 91.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.035 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.46 -51.0 0.09 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.423 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 21' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER 179.88 -179.72 0.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.974 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 22' ' ' ALA . . . . . 0.548 ' HB2' ' HB1' ' D' ' 93' ' ' ALA . . . -136.18 116.51 13.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.161 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 23' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.1 120.23 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.995 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.47 150.45 46.54 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.564 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.39 -50.07 32.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.343 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.37 -31.73 81.33 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.936 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.1 -15.99 63.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.923 0.392 . . . . 0.0 110.851 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 48.7 t -72.99 -43.63 58.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.379 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.41 106.15 10.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.994 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -116.78 134.05 55.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.03 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.47 96.12 6.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.083 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . 0.523 ' HB ' ' O ' ' E' ' 11' ' ' HIS . 69.3 t -89.53 131.24 37.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 33' ' ' GLN . . . . . 0.417 ' HA ' ' HG2' ' E' ' 13' ' ' LYS . 0.3 OUTLIER -108.95 106.49 16.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.616 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 34' ' ' LEU . . . . . 0.728 HD22 HG13 ' F' ' 101' ' ' VAL . 0.4 OUTLIER -73.86 -40.91 62.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.637 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.01 -122.45 6.74 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.559 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 36' ' ' GLN . . . . . 0.586 ' HB3' ' HA ' ' E' ' 22' ' ' ALA . 16.1 tt0 -144.55 153.87 42.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.658 0.265 . . . . 0.0 110.936 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.488 HG23 HG21 ' E' ' 16' ' ' VAL . 0.0 OUTLIER -128.46 146.29 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.963 -179.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.2 145.94 26.11 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.764 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 39' ' ' THR . . . . . . . . . . . . . 40.8 p -57.7 -23.06 49.75 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.721 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.07 -33.09 61.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.022 0.439 . . . . 0.0 110.805 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -31.11 69.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.208 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' F' ' 139' ' ' ALA . 0.0 OUTLIER -130.78 86.44 2.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.622 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.7 36.23 4.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.411 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 177.6 150.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.324 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.72 134.85 55.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.34 . . . . 0.0 111.116 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.74 -14.21 53.3 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.215 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 47' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' F' ' 138' ' ' PHE . . . -57.22 129.91 43.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.927 0.394 . . . . 0.0 112.052 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 48' ' ' THR . . . . . 0.46 ' HB ' ' CE1' ' F' ' 138' ' ' PHE . 14.3 t -130.66 143.35 50.69 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.861 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 49' ' ' SER . . . . . 0.585 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 68.8 m -111.98 -157.21 0.61 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.604 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 27.7 t -74.59 150.12 39.81 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.856 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 51' ' ' ALA . . . . . 0.53 ' HB3' ' NE2' ' F' ' 134' ' ' GLN . . . -103.19 146.7 28.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.301 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 52' ' ' VAL . . . . . 0.45 ' HB ' ' HA ' ' C' ' 90' ' ' SER . 22.2 m -83.45 148.35 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.915 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.4 121.2 6.2 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.628 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 54' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -153.88 125.55 7.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.852 0.358 . . . . 0.0 110.889 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 55' ' ' ASN . . . . . 0.561 HD22 HD21 ' C' ' 74' ' ' LEU . 1.9 p-10 -109.26 156.17 20.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.533 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 56' ' ' ILE . . . . . . . . . . . . . 22.4 mm -103.96 135.38 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.583 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 57' ' ' GLN . . . . . 0.502 ' HG3' HD22 ' C' ' 74' ' ' LEU . 2.2 tt0 -101.75 126.07 48.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.713 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . 0.525 ' HB2' ' HB3' ' F' ' 129' ' ' ASN . 4.3 mp -131.65 99.96 4.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.286 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.4 174.82 11.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.982 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.71 65.21 1.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.83 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 61' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' F' ' 21' ' ' CYS . 60.6 m -98.68 142.98 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.813 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.68 109.21 15.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.261 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.42 29.57 1.68 Allowed 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 64' ' ' ASN . . . . . 0.436 HD21 ' HA ' ' F' ' 64' ' ' ASN . 0.1 OUTLIER -90.05 -59.21 2.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.028 0.442 . . . . 0.0 111.679 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.2 -39.93 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.662 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.58 101.36 10.69 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.543 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 30.9 p -90.59 -28.71 18.27 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.857 0.36 . . . . 0.0 110.963 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.52 166.94 16.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.491 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.79 149.88 29.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.583 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 70' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' F' ' 157' ' ' GLN . . . -112.98 159.74 18.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.164 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 51.4 t -108.02 123.28 63.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.689 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 72' ' ' ALA . . . . . 0.491 ' HB2' ' CB ' ' F' ' 155' ' ' LYS . . . -124.71 168.99 12.42 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.484 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 73' ' ' PHE . . . . . 0.436 ' CB ' HD11 ' F' ' 111' ' ' LEU . 17.2 t80 -150.58 144.47 25.3 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.562 0.22 . . . . 0.0 111.147 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.58 88.61 2.97 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.989 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.74 164.65 24.67 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.777 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 76' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.6 OUTLIER -78.51 147.8 33.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.547 0.213 . . . . 0.0 110.786 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.78 140.38 30.66 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.838 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 78' ' ' ILE . . . . . 0.638 HG12 HG22 ' F' ' 140' ' ' THR . 1.1 tt -78.7 -33.15 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.16 179.23 7.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.833 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.71 -27.78 36.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.036 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.3 -32.18 72.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.586 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -97.33 -72.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.877 0.37 . . . . 0.0 110.446 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.87 -7.21 1.79 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.582 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -108.81 -19.08 13.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.311 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 85' ' ' VAL . . . . . 0.557 ' HB ' ' CG2' ' F' ' 78' ' ' ILE . 50.4 t -80.71 132.02 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.206 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 86' ' ' LEU . . . . . 0.665 HD11 ' HB1' ' F' ' 152' ' ' ALA . 0.4 OUTLIER -76.55 135.0 39.26 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.255 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 87' ' ' ALA . . . . . 0.635 ' HB1' ' HB ' ' F' ' 76' ' ' THR . . . -62.27 165.15 6.18 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.923 0.392 . . . . 0.0 111.691 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . 0.447 ' H ' ' HG ' ' F' ' 88' ' ' LEU . 0.1 OUTLIER -65.76 171.78 4.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.018 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 89' ' ' GLN . . . . . 0.468 ' OE1' ' HB3' ' F' ' 91' ' ' SER . 8.0 pt20 -72.56 175.74 6.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.427 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.02 -21.22 57.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.002 0.43 . . . . 0.0 111.474 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 91' ' ' SER . . . . . 0.468 ' HB3' ' OE1' ' F' ' 89' ' ' GLN . 32.1 t -81.02 67.6 6.99 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 92' ' ' ALA . . . . . 0.434 ' HA ' ' OG ' ' F' ' 95' ' ' SER . . . -72.35 -9.67 58.81 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.576 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.04 -22.86 64.94 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.683 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.47 6.71 2.47 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.86 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 95' ' ' SER . . . . . 0.695 ' HA ' ' HB3' ' F' ' 147' ' ' ALA . 30.8 p -93.71 150.78 20.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.854 0.359 . . . . 0.0 110.674 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.71 167.18 18.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 97' ' ' THR . . . . . 0.425 HG21 HD13 ' F' ' 88' ' ' LEU . 0.2 OUTLIER -118.64 165.19 14.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.314 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 98' ' ' ASN . . . . . 0.512 ' HA ' ' OG1' ' F' ' 140' ' ' THR . 85.1 m-20 63.2 45.5 5.06 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.489 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 99' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' F' ' 143' ' ' ALA . 3.4 p -170.65 131.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.72 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.02 -175.94 21.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.511 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 101' ' ' VAL . . . . . 0.728 HG13 HD22 ' F' ' 34' ' ' LEU . 76.4 t -104.19 91.9 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 122.979 0.512 . . . . 0.0 111.656 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 102' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' F' ' 85' ' ' VAL . 0.0 OUTLIER -67.88 131.18 45.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.898 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 103' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -99.45 110.52 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.497 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 104' ' ' LEU . . . . . 0.442 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 5.5 tp -91.15 149.98 21.57 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.656 0.265 . . . . 0.0 111.078 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.94 174.55 5.84 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.631 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 106' ' ' ARG . . . . . 0.509 ' HB3' ' HG ' ' F' ' 120' ' ' SER . 1.5 ttt180 -72.45 -18.46 61.69 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.75 0.309 . . . . 0.0 111.075 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 46.2 p -69.35 -9.66 54.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.999 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.0 -48.33 0.96 Allowed Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.671 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.96 163.57 15.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.779 0.323 . . . . 0.0 111.089 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -70.52 125.59 27.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . 0.436 HD11 ' CB ' ' F' ' 73' ' ' PHE . 0.0 OUTLIER -65.43 147.7 52.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.419 0.628 . . . . 0.0 110.558 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.16 144.67 44.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.12 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 113' ' ' LEU . . . . . 0.513 ' N ' HD11 ' F' ' 113' ' ' LEU . 10.2 mp -100.35 89.97 4.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 110.644 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 114' ' ' ASP . . . . . 0.523 ' HB2' HG21 ' F' ' 117' ' ' THR . 4.1 m-20 -142.41 11.41 1.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.691 0.281 . . . . 0.0 111.6 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.91 -78.16 0.69 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.611 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.29 61.61 0.73 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.966 0.412 . . . . 0.0 111.62 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 117' ' ' THR . . . . . 0.523 HG21 ' HB2' ' F' ' 114' ' ' ASP . 17.6 p -93.42 95.84 9.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.126 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.77 110.0 5.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.794 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.4 -72.91 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.833 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 120' ' ' SER . . . . . 0.509 ' HG ' ' HB3' ' F' ' 106' ' ' ARG . 0.1 OUTLIER -92.49 113.04 25.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.665 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.36 97.42 8.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.25 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.47 132.66 37.52 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.787 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 123' ' ' THR . . . . . 0.441 HG23 ' N ' ' F' ' 124' ' ' LEU . 21.8 m -60.81 146.15 47.26 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.762 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . 0.441 ' N ' HG23 ' F' ' 123' ' ' THR . 0.2 OUTLIER -85.51 156.6 20.71 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.547 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.91 142.71 40.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.474 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.9 113.73 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.704 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . 0.596 ' HA3' ' HB ' ' B' ' 4' ' ' THR . . . 128.44 -90.01 0.32 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.693 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 128' ' ' THR . . . . . 0.434 ' HB ' ' HD3' ' C' ' 155' ' ' LYS . 6.2 m -124.92 152.86 43.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.704 0.287 . . . . 0.0 110.751 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 129' ' ' ASN . . . . . 0.525 ' HB3' ' HB2' ' F' ' 58' ' ' LEU . 17.0 t-20 -123.09 147.58 46.59 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.926 0.394 . . . . 0.0 111.113 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 130' ' ' THR . . . . . 0.489 ' OG1' HD11 ' C' ' 74' ' ' LEU . 4.3 m -126.16 135.69 51.96 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.03 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 131' ' ' ILE . . . . . . . . . . . . . 58.6 mt -114.05 115.68 45.38 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 132' ' ' PRO . . . . . 0.48 ' HB3' ' H ' ' C' ' 77' ' ' ALA . 7.5 Cg_endo -81.7 115.71 2.81 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.604 1.536 . . . . 0.0 112.572 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.57 150.79 46.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.823 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 134' ' ' GLN . . . . . 0.53 ' NE2' ' HB3' ' F' ' 51' ' ' ALA . 1.2 mt-30 -142.39 166.72 23.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.086 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' F' ' 102' ' ' GLN . . . -158.21 102.9 1.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.972 0.415 . . . . 0.0 111.587 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 136' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' F' ' 51' ' ' ALA . 0.2 OUTLIER -94.67 -173.46 3.02 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.397 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 137' ' ' TYR . . . . . 0.585 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 3.8 m-85 -100.76 152.82 20.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.115 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 138' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' F' ' 47' ' ' ALA . 0.2 OUTLIER -147.28 160.8 42.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.046 -179.227 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 139' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -126.88 149.63 49.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.86 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 140' ' ' THR . . . . . 0.638 HG22 HG12 ' F' ' 78' ' ' ILE . 0.0 OUTLIER -115.33 27.83 9.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.491 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.39 66.76 0.2 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.948 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . 63.0 88.57 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.615 0.207 . . . . 0.0 110.747 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 143' ' ' ALA . . . . . 0.671 ' HB3' ' HB ' ' F' ' 99' ' ' VAL . . . -60.22 156.88 14.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.728 0.299 . . . . 0.0 111.431 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 144' ' ' THR . . . . . 0.538 ' HB ' ' CD ' ' F' ' 145' ' ' PRO . 77.4 p -112.17 173.07 3.06 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.243 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 145' ' ' PRO . . . . . 0.538 ' CD ' ' HB ' ' F' ' 144' ' ' THR . 1.4 Cg_endo -84.6 145.22 10.36 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.543 2.162 . . . . 0.0 111.922 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.42 -112.77 0.55 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.495 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 147' ' ' ALA . . . . . 0.695 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -124.98 167.68 14.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.903 0.382 . . . . 0.0 111.337 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 148' ' ' ALA . . . . . 0.479 ' HB3' HG22 ' E' ' 16' ' ' VAL . . . -157.16 57.49 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.403 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.89 132.71 36.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.514 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.41 163.12 28.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.008 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.44 125.63 1.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.205 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 152' ' ' ALA . . . . . 0.665 ' HB1' HD11 ' F' ' 86' ' ' LEU . . . -154.57 165.79 35.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.215 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.83 163.17 12.71 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -119.03 134.53 55.14 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.116 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' E' ' 6' ' ' ASN . 0.0 OUTLIER -95.51 166.21 11.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.951 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.23 112.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.771 0.32 . . . . 0.0 111.684 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 157' ' ' GLN . . . . . 0.492 ' HB3' ' HB2' ' F' ' 70' ' ' ALA . 0.2 OUTLIER -88.74 138.79 31.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.264 0.554 . . . . 0.0 110.404 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . 0.524 ' HE2' HG11 ' F' ' 17' ' ' VAL . 22.5 m-85 -127.63 113.2 15.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.503 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.924 179.981 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' B' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 120.27 0.081 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.22 64.95 1.53 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.002 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.458 HG23 ' HB2' ' B' ' 18' ' ' ASN . 57.4 m -111.23 101.02 9.55 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.46 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.462 ' HA ' ' HG2' ' B' ' 157' ' ' GLN . 60.6 m -86.71 131.93 34.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.56 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.401 HG11 HG12 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -161.18 168.04 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.525 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -100.1 118.78 37.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.539 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.4 -56.31 6.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.748 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.94 -145.38 4.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.873 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.0 142.05 29.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.933 0.397 . . . . 0.0 111.284 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.464 HG23 ' CZ ' ' B' ' 73' ' ' PHE . 44.2 t -121.65 107.32 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.176 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.75 111.0 21.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.386 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.415 ' HB3' HD12 ' B' ' 34' ' ' LEU . 32.0 m-85 -87.61 113.52 23.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.775 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.12 118.61 36.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.412 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.56 175.53 39.77 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.909 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.759 ' HA ' ' HB3' ' B' ' 148' ' ' ALA . 0.1 OUTLIER -151.27 162.14 41.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.946 0.403 . . . . 0.0 110.31 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' B' ' 145' ' ' PRO . 2.2 t -114.94 119.43 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.29 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.51 HG21 ' HA ' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -121.33 168.14 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.818 0.342 . . . . 0.0 111.064 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.438 ' HA ' HG22 ' B' ' 39' ' ' THR . 1.3 t-20 -68.46 -175.27 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.004 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.435 ' O ' HG21 ' A' ' 65' ' ' VAL . . . -91.14 52.66 2.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.93 -15.74 1.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.335 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.929 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -176.88 147.6 0.6 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.975 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.51 ' HA ' HG21 ' A' ' 17' ' ' VAL . . . -152.62 110.08 3.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.046 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -52.97 159.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.032 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.37 164.48 14.31 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.578 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.07 -52.29 65.89 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.397 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.43 11.92 66.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.858 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.5 t -96.23 -30.79 13.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.989 0.423 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.405 ' H ' HG21 ' A' ' 28' ' ' VAL . 11.4 t -49.88 -71.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.311 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.54 104.4 15.27 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.02 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.509 HE22 ' HA ' ' A' ' 56' ' ' ILE . 41.6 mt-30 -112.23 140.41 46.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.104 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.79 110.16 21.47 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.067 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.18 108.35 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.167 0.508 . . . . 0.0 110.42 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.59 112.5 22.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.638 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 mp -81.15 -41.82 21.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.572 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.67 -171.08 21.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.649 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -93.6 145.95 24.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.565 0.222 . . . . 0.0 110.912 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 38' ' ' ARG . 5.0 p -124.86 169.88 15.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.95 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.409 ' H ' HG23 ' A' ' 37' ' ' VAL . 5.2 mtt-85 -98.95 121.42 40.88 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.717 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.87 -31.06 71.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.738 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.56 -39.3 84.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.999 0.428 . . . . 0.0 110.81 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.3 m -81.32 -10.35 59.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.204 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.554 ' HG ' ' HB3' ' A' ' 139' ' ' ALA . 0.6 OUTLIER -129.36 40.51 3.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.556 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.601 ' HA ' ' H ' ' A' ' 143' ' ' ALA . . . -111.86 10.88 20.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.366 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.53 145.55 48.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.329 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 140' ' ' THR . 18.2 tt0 -63.34 121.17 13.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 111.159 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.02 14.54 33.51 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.15 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.26 121.2 19.0 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.434 HG22 ' CE2' ' A' ' 138' ' ' PHE . 15.0 p -129.97 133.84 47.06 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.893 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 57.8 m -112.52 -166.75 1.11 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.625 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.2 t -59.08 149.48 27.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.818 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.82 153.57 17.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.347 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.483 HG23 ' HD1' ' A' ' 54' ' ' PHE . 3.7 m -103.37 130.31 53.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.98 121.53 6.57 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.619 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.585 ' HE1' ' HB1' ' A' ' 135' ' ' ALA . 52.3 p90 -153.7 136.41 15.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.779 0.323 . . . . 0.0 110.955 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 131' ' ' ILE . 24.7 p30 -133.59 141.3 47.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.679 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.535 HG21 ' HB ' ' A' ' 131' ' ' ILE . 1.2 tt -85.13 126.49 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.622 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.611 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.1 OUTLIER -75.77 119.39 19.72 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.773 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -130.69 87.31 2.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.316 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.705 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 5.0 p30 -77.18 173.72 11.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.981 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.492 ' HB3' ' HE ' ' B' ' 38' ' ' ARG . 41.5 m-20 62.82 66.38 0.76 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.929 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 34.4 m -115.64 161.96 17.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.732 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.496 ' HA ' ' OD1' ' A' ' 126' ' ' ASN . 0.2 OUTLIER -145.94 157.82 43.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.289 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -107.5 -16.74 14.29 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.13 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.39 -33.63 32.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.062 0.458 . . . . 0.0 111.763 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 19' ' ' ALA . 20.1 t -75.21 -41.56 44.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.665 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.91 146.75 29.15 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.558 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.83 -39.37 3.73 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.895 0.378 . . . . 0.0 110.92 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.31 159.53 15.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.477 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.649 ' HB3' ' HB ' ' A' ' 122' ' ' THR . . . -147.2 118.88 8.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.616 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' ' 118' ' ' PHE . . . -96.84 140.72 30.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.096 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.52 HG13 HG21 ' A' ' 131' ' ' ILE . 3.1 t -118.43 139.71 44.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.798 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.54 133.92 29.86 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.523 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.425 ' HB2' HD11 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -101.26 138.04 38.8 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.575 0.226 . . . . 0.0 111.15 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.473 ' CD2' HG22 ' D' ' 130' ' ' THR . 6.6 tt -100.99 91.02 4.38 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.001 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.37 -167.37 11.32 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.87 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.657 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -116.75 159.52 22.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.64 0.257 . . . . 0.0 110.752 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.411 ' HB1' ' HA ' ' A' ' 83' ' ' THR . . . -83.96 137.96 33.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.996 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.747 HG21 ' HB ' ' A' ' 85' ' ' VAL . 9.0 tt -77.17 -40.52 29.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.88 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -141.18 55.24 1.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.852 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 52.85 -84.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.081 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -60.1 -16.12 39.58 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.577 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.482 ' O ' HG22 ' A' ' 78' ' ' ILE . 24.5 m80 -100.6 56.74 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.597 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.432 ' HB ' ' OG1' ' A' ' 112' ' ' THR . 1.1 m -71.36 -22.46 61.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.537 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.721 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 8.6 p-10 -57.23 -18.68 17.12 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.338 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.747 ' HB ' HG21 ' A' ' 78' ' ' ILE . 11.6 t -115.19 133.31 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.213 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.657 ' HA ' ' O ' ' A' ' 76' ' ' THR . 0.8 OUTLIER -72.93 154.12 40.69 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.347 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.529 ' H ' HD23 ' A' ' 86' ' ' LEU . . . -90.72 -161.37 0.8 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.846 0.355 . . . . 0.0 111.793 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.31 6.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.974 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.65 -83.92 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.312 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.26 20.53 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.415 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.731 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 1.5 m -86.59 79.34 8.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.75 -31.51 38.42 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.916 0.389 . . . . 0.0 111.672 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' D' ' 36' ' ' GLN . . . -128.09 54.53 1.72 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.615 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.89 -17.27 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.975 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.731 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 0.9 OUTLIER -89.47 177.19 6.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.797 0.332 . . . . 0.0 110.622 179.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.69 175.24 8.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.777 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -137.51 137.98 39.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.269 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.532 ' HB2' ' O ' ' A' ' 97' ' ' THR . 74.0 m-80 71.69 17.64 5.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.434 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.99 148.93 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.728 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.28 -176.74 35.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.46 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.468 ' O ' HG11 ' A' ' 101' ' ' VAL . 7.7 p -125.58 111.02 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 122.993 0.517 . . . . 0.0 111.718 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.606 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 0.9 OUTLIER -81.53 147.74 29.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.873 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.447 HD13 ' HE2' ' A' ' 133' ' ' PHE . 0.9 OUTLIER -123.76 115.94 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.489 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.726 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -88.7 140.55 29.34 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.621 0.248 . . . . 0.0 111.031 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . 2.1 t70 -89.37 152.0 21.75 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.68 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.655 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -71.74 -21.08 61.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.816 0.341 . . . . 0.0 111.101 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.596 ' HB ' ' HA ' ' A' ' 120' ' ' SER . 5.8 t -62.89 -21.94 66.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.064 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.69 -83.09 0.19 Allowed Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.611 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.69 170.67 15.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.776 0.322 . . . . 0.0 111.098 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.726 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -74.82 138.64 42.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.224 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.61 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 5.1 tp -94.53 153.38 17.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.343 0.592 . . . . 0.0 110.568 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 6.2 t -93.68 148.24 22.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.171 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mp -89.51 64.78 6.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.77 0.319 . . . . 0.0 110.771 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.535 ' HB2' ' OG1' ' A' ' 117' ' ' THR . 0.5 OUTLIER -95.04 -16.1 22.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.606 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.531 ' HA3' ' OG1' ' D' ' 130' ' ' THR . . . 104.44 -56.28 0.56 Allowed Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.66 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' D' ' 125' ' ' ASN . . . -103.56 29.08 5.95 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.994 0.426 . . . . 0.0 111.667 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.535 ' OG1' ' HB2' ' A' ' 114' ' ' ASP . 3.4 m -87.19 65.85 9.01 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.105 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.435 ' HE2' ' HA3' ' D' ' 127' ' ' GLY . 48.3 m-85 -77.69 73.45 4.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.5 70.78 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.596 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 0.7 OUTLIER -148.63 126.09 11.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.681 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.05 53.21 2.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.25 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.649 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -74.06 128.34 35.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.75 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.36 117.89 25.45 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.703 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.402 ' O ' HG23 ' A' ' 63' ' ' THR . 4.3 tp -88.51 134.76 33.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.719 0.295 . . . . 0.0 110.538 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.21 163.1 26.33 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.672 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 62' ' ' ASP . 1.5 t30 -67.61 125.33 25.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.669 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.61 -141.04 12.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.687 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 6.3 m -101.73 92.47 4.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.647 0.26 . . . . 0.0 110.729 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.518 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 1.2 t30 -76.54 145.03 39.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.926 0.393 . . . . 0.0 111.13 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.611 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -134.63 131.81 38.24 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.049 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.535 ' HB ' HG21 ' A' ' 56' ' ' ILE . 28.4 mt -87.43 109.82 29.03 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.655 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.4 Cg_endo -81.65 112.12 2.38 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.578 1.518 . . . . 0.0 112.608 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.447 ' HE2' HD13 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -129.28 138.22 51.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.881 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 28.2 mt-30 -110.1 157.5 19.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.062 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 102' ' ' GLN . . . -152.68 107.91 3.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.97 0.414 . . . . 0.0 111.585 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -102.51 174.4 5.92 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.36 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.478 ' HB3' HD22 ' A' ' 42' ' ' LEU . 0.6 OUTLIER -85.96 120.88 27.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.083 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.507 ' HB3' HG12 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -117.67 139.6 50.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.076 -179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.554 ' HB3' ' HG ' ' A' ' 42' ' ' LEU . . . -129.88 145.66 51.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.914 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 16.5 p -104.43 -53.4 2.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.483 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.76 -121.48 3.26 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.989 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.12 112.83 24.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.517 0.199 . . . . 0.0 110.719 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.601 ' H ' ' HA ' ' A' ' 43' ' ' ALA . . . -61.68 150.85 35.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.805 0.336 . . . . 0.0 111.519 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.585 HG22 ' CD ' ' A' ' 145' ' ' PRO . 60.0 m -126.79 151.49 73.67 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.26 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.585 ' CD ' HG22 ' A' ' 144' ' ' THR . 1.4 Cg_endo -83.03 140.23 9.92 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.573 2.182 . . . . 0.0 111.963 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.9 -138.1 6.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.539 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -87.21 144.99 26.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.898 0.38 . . . . 0.0 111.367 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.73 38.87 1.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.527 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.05 153.48 22.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.505 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -161.87 171.28 17.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.04 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.42 126.8 7.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.239 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.616 ' HB3' HD12 ' A' ' 86' ' ' LEU . . . -125.35 142.85 51.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.249 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.86 133.17 34.89 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.47 ' HD1' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -86.45 127.87 34.89 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.119 0.485 . . . . 0.0 110.079 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.49 150.51 29.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.962 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.447 HG13 HD12 ' A' ' 131' ' ' ILE . 14.2 m -136.23 144.48 32.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.863 0.363 . . . . 0.0 111.571 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.571 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -136.19 132.76 36.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.32 0.581 . . . . 0.0 110.386 -179.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.475 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 5.5 m-85 -117.41 119.77 36.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.516 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' C' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.23 0.062 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.19 64.9 1.55 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.086 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' THR . . . . . 0.461 HG23 ' HB2' ' C' ' 18' ' ' ASN . 59.0 m -111.21 100.99 9.53 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.05 0.452 . . . . 0.0 111.536 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.475 ' HA ' ' HG2' ' C' ' 157' ' ' GLN . 60.1 m -86.72 131.91 34.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.545 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -161.09 168.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.532 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.17 118.75 37.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.571 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.32 -56.32 6.97 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.759 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.97 -145.36 4.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.923 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.99 142.1 29.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.927 0.394 . . . . 0.0 111.302 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.464 HG23 ' CZ ' ' C' ' 73' ' ' PHE . 44.1 t -121.66 107.37 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.198 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.81 110.95 21.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.365 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . 0.405 ' HB3' HD12 ' C' ' 34' ' ' LEU . 31.8 m-85 -87.58 113.58 23.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.794 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 118.55 36.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.338 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.51 175.6 39.73 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.973 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.751 ' HA ' ' HB3' ' C' ' 148' ' ' ALA . 0.1 OUTLIER -151.36 162.08 41.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.967 0.413 . . . . 0.0 110.302 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' C' ' 145' ' ' PRO . 2.2 t -114.95 119.38 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.268 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.497 HG21 ' HA ' ' B' ' 22' ' ' ALA . 0.3 OUTLIER -121.28 168.1 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.887 0.375 . . . . 0.0 111.017 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . 0.458 ' HB2' HG23 ' A' ' 3' ' ' THR . 1.3 t-20 -68.54 -175.25 0.63 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.91 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.448 ' O ' HG21 ' B' ' 65' ' ' VAL . . . -91.1 52.61 2.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.233 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.95 -15.64 1.32 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.39 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER -176.95 147.63 0.59 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.965 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.497 ' HA ' HG21 ' B' ' 17' ' ' VAL . . . -152.63 110.04 3.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.084 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' B' ' 58' ' ' LEU . 0.3 OUTLIER -53.0 159.07 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.39 164.47 14.3 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.563 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.99 -52.39 65.44 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.369 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.33 11.91 66.35 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.916 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 18.4 t -96.25 -30.78 13.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.894 0.378 . . . . 0.0 110.908 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.406 ' H ' HG21 ' B' ' 28' ' ' VAL . 11.3 t -49.89 -71.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.341 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.55 104.36 15.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.012 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' GLN . . . . . 0.523 HE22 ' HA ' ' B' ' 56' ' ' ILE . 41.8 mt-30 -112.21 140.34 46.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.082 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.82 110.13 21.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.054 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.13 108.42 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.157 0.503 . . . . 0.0 110.44 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.66 112.43 22.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.63 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 12' ' ' PHE . 5.2 mp -81.12 -41.82 21.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.625 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.76 -171.05 21.51 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.603 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 2.4 mt-30 -93.69 145.88 24.25 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.602 0.239 . . . . 0.0 110.908 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.418 HG23 ' H ' ' B' ' 38' ' ' ARG . 5.0 p -124.8 169.89 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.94 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.492 ' HE ' ' HB3' ' A' ' 60' ' ' ASP . 5.1 mtt-85 -98.95 121.5 40.99 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.68 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 18' ' ' ASN . 0.6 OUTLIER -62.01 -31.0 71.34 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.705 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.28 84.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.91 0.386 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 70.9 m -81.31 -10.39 59.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.149 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' B' ' 139' ' ' ALA . 0.6 OUTLIER -129.27 40.48 3.61 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.59 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ALA . . . . . 0.607 ' HA ' ' H ' ' B' ' 143' ' ' ALA . . . -111.86 10.94 20.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.333 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.56 145.52 48.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.326 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' B' ' 140' ' ' THR . 18.2 tt0 -63.3 121.15 13.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.81 0.338 . . . . 0.0 111.133 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.05 14.49 33.56 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.163 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.36 121.19 19.08 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' THR . . . . . 0.439 HG22 ' CE2' ' B' ' 138' ' ' PHE . 15.1 p -130.01 133.8 47.0 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.86 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' SER . . . . . 0.446 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 57.8 m -112.47 -166.68 1.1 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.592 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 36.2 t -59.07 149.52 27.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.76 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.84 153.59 17.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.397 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' B' ' 134' ' ' GLN . 3.7 m -103.42 130.31 53.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.92 121.45 6.53 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.64 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . 0.581 ' HE1' ' HB1' ' B' ' 135' ' ' ALA . 52.1 p90 -153.64 136.41 15.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.816 0.341 . . . . 0.0 110.962 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' B' ' 131' ' ' ILE . 24.8 p30 -133.58 141.31 47.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.707 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.523 ' HA ' HE22 ' B' ' 30' ' ' GLN . 1.2 tt -85.19 126.45 40.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.59 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . 0.617 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.1 OUTLIER -75.79 119.38 19.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.711 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.503 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 0.2 OUTLIER -130.64 87.34 2.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.299 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ASN . . . . . 0.706 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 5.1 p30 -77.29 173.71 11.59 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.955 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ASP . . . . . 0.503 ' HB3' ' HE ' ' C' ' 38' ' ' ARG . 41.6 m-20 62.85 66.43 0.75 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.878 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' CYS . . . . . 0.933 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 34.4 m -115.71 161.96 17.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.736 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ASP . . . . . 0.491 ' HA ' ' OD1' ' B' ' 126' ' ' ASN . 0.2 OUTLIER -145.91 157.86 43.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.35 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.54 -16.71 14.29 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.4 -33.7 32.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.057 0.456 . . . . 0.0 111.737 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . 0.448 HG21 ' O ' ' B' ' 19' ' ' ALA . 20.0 t -75.12 -41.62 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.675 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.94 146.75 29.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.55 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.75 -39.43 3.74 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.893 0.378 . . . . 0.0 110.951 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.31 159.55 15.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.456 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' ALA . . . . . 0.649 ' HB3' ' HB ' ' B' ' 122' ' ' THR . . . -147.18 118.88 8.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.608 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' B' ' 118' ' ' PHE . . . -96.84 140.79 30.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.025 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.51 HG13 HG21 ' B' ' 131' ' ' ILE . 3.1 t -118.52 139.69 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.762 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.52 133.93 29.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.595 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' PHE . . . . . 0.464 ' CZ ' HG23 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -101.28 138.06 38.8 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.623 0.249 . . . . 0.0 111.116 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.472 ' CD2' HG22 ' E' ' 130' ' ' THR . 6.6 tt -101.05 91.12 4.41 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.003 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.38 -167.4 11.32 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.886 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' THR . . . . . 0.654 ' O ' ' HA ' ' B' ' 86' ' ' LEU . 0.3 OUTLIER -116.7 159.45 22.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.58 0.229 . . . . 0.0 110.761 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . 0.408 ' HB1' ' HA ' ' B' ' 83' ' ' THR . . . -83.84 137.92 33.46 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.013 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.757 HG21 ' HB ' ' B' ' 85' ' ' VAL . 9.0 tt -77.16 -40.47 29.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.894 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' B' ' 81' ' ' GLY . 0.1 OUTLIER -141.26 55.26 1.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.786 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . 0.428 ' HB1' ' H ' ' B' ' 81' ' ' GLY . . . 52.93 -84.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.008 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' B' ' 79' ' ' ASP . . . -60.07 -16.11 39.27 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.62 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' HIS . . . . . 0.488 ' O ' HG22 ' B' ' 78' ' ' ILE . 24.2 m80 -100.54 56.68 0.9 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.925 0.393 . . . . 0.0 110.619 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' THR . . . . . 0.434 ' HB ' ' OG1' ' B' ' 112' ' ' THR . 1.1 m -71.33 -22.42 61.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.587 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . 0.72 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 8.6 p-10 -57.23 -18.71 17.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.305 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.757 ' HB ' HG21 ' B' ' 78' ' ' ILE . 11.5 t -115.18 133.45 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.211 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' LEU . . . . . 0.654 ' HA ' ' O ' ' B' ' 76' ' ' THR . 0.8 OUTLIER -73.01 154.03 40.66 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.352 179.362 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.535 ' H ' HD23 ' B' ' 86' ' ' LEU . . . -90.69 -161.34 0.79 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.823 0.344 . . . . 0.0 111.793 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.23 6.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.016 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.65 -83.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.31 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.26 20.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.453 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' SER . . . . . 0.751 ' HB2' ' HB2' ' B' ' 95' ' ' SER . 1.5 m -86.53 79.35 8.97 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.71 -31.56 38.36 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.808 0.337 . . . . 0.0 111.642 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' E' ' 36' ' ' GLN . . . -128.02 54.4 1.72 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.663 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.87 -17.3 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.934 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' SER . . . . . 0.751 ' HB2' ' HB2' ' B' ' 91' ' ' SER . 0.9 OUTLIER -89.35 177.21 6.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.768 0.318 . . . . 0.0 110.703 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.71 175.31 8.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.785 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' B' ' 98' ' ' ASN . 0.2 OUTLIER -137.61 137.94 39.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.25 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' B' ' 97' ' ' THR . 74.0 m-80 71.78 17.6 5.38 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.444 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.95 149.0 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.672 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.44 -176.76 35.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.441 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . 0.459 ' O ' HG11 ' B' ' 101' ' ' VAL . 7.7 p -125.56 111.1 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 122.974 0.51 . . . . 0.0 111.678 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' GLN . . . . . 0.599 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 0.9 OUTLIER -81.67 147.68 29.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.789 -179.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.456 HD13 ' HE2' ' B' ' 133' ' ' PHE . 0.9 OUTLIER -123.64 115.91 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.54 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' LEU . . . . . 0.694 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 0.4 OUTLIER -88.68 140.5 29.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.614 0.245 . . . . 0.0 111.036 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ASP . . . . . 0.601 ' HB2' ' HB2' ' B' ' 111' ' ' LEU . 2.1 t70 -89.31 152.01 21.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.708 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . 0.642 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -71.8 -21.03 61.76 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.752 0.31 . . . . 0.0 111.027 179.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' THR . . . . . 0.599 ' HB ' ' HA ' ' B' ' 120' ' ' SER . 5.8 t -62.91 -21.94 66.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.007 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.64 -83.02 0.19 Allowed Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.662 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.69 170.72 15.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.767 0.318 . . . . 0.0 111.05 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.694 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -74.94 138.68 42.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.186 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' B' ' 105' ' ' ASP . 5.1 tp -94.53 153.47 17.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.385 0.612 . . . . 0.0 110.571 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' THR . . . . . 0.72 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 6.2 t -93.68 148.28 22.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.105 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mp -89.64 64.9 6.74 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.783 0.325 . . . . 0.0 110.722 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ASP . . . . . 0.532 ' HB2' ' OG1' ' B' ' 117' ' ' THR . 0.5 OUTLIER -95.07 -16.07 22.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.62 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . 0.541 ' HA3' ' OG1' ' E' ' 130' ' ' THR . . . 104.43 -56.24 0.57 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.637 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' E' ' 125' ' ' ASN . . . -103.61 29.0 6.03 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.029 0.442 . . . . 0.0 111.714 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' THR . . . . . 0.532 ' OG1' ' HB2' ' B' ' 114' ' ' ASP . 3.4 m -87.08 65.85 9.1 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.142 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' PHE . . . . . 0.428 ' HE2' ' HA3' ' E' ' 127' ' ' GLY . 48.3 m-85 -77.65 73.4 4.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.772 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.53 70.86 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' SER . . . . . 0.599 ' HA ' ' HB ' ' B' ' 107' ' ' THR . 0.7 OUTLIER -148.69 126.11 11.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.673 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.07 53.18 2.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.232 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.649 ' HB ' ' HB3' ' B' ' 69' ' ' ALA . 0.2 OUTLIER -73.97 128.28 35.1 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.732 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.33 117.97 25.47 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.675 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.51 134.8 33.76 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.548 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.28 163.06 26.49 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.637 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' ASN . . . . . 0.491 ' OD1' ' HA ' ' B' ' 62' ' ' ASP . 1.5 t30 -67.58 125.43 26.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.66 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.58 -141.06 12.22 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.664 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' THR . . . . . 0.706 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 6.3 m -101.74 92.34 4.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.673 0.273 . . . . 0.0 110.788 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . 0.521 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 1.2 t30 -76.44 145.01 39.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.164 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.617 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.0 OUTLIER -134.62 131.81 38.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.073 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' ILE . . . . . 0.52 ' HB ' HG21 ' B' ' 56' ' ' ILE . 28.4 mt -87.41 109.8 28.86 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' PRO . . . . . 0.642 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.6 Cg_endo -81.52 112.06 2.4 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 121.645 1.563 . . . . 0.0 112.608 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.456 ' HE2' HD13 ' B' ' 103' ' ' ILE . 0.3 OUTLIER -129.3 138.24 51.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.875 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' B' ' 52' ' ' VAL . 28.1 mt-30 -110.13 157.48 19.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.035 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' B' ' 102' ' ' GLN . . . -152.66 107.84 3.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.905 0.383 . . . . 0.0 111.602 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -102.5 174.38 5.93 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.376 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . 0.467 ' HB3' HD22 ' B' ' 42' ' ' LEU . 0.6 OUTLIER -85.97 120.87 27.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.105 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . 0.494 ' HB3' HG12 ' B' ' 85' ' ' VAL . 0.2 OUTLIER -117.66 139.57 50.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.062 -179.181 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ALA . . . . . 0.557 ' HB3' ' HG ' ' B' ' 42' ' ' LEU . . . -129.86 145.57 51.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.913 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 16.7 p -104.32 -53.41 2.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.513 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.75 -121.54 3.27 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.027 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.04 112.88 24.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.573 0.225 . . . . 0.0 110.729 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' ALA . . . . . 0.607 ' H ' ' HA ' ' B' ' 43' ' ' ALA . . . -61.69 150.86 35.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.783 0.325 . . . . 0.0 111.481 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.6 HG22 ' CD ' ' B' ' 145' ' ' PRO . 59.6 m -126.79 151.51 73.72 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.274 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.6 ' CD ' HG22 ' B' ' 144' ' ' THR . 1.3 Cg_endo -83.06 140.24 9.9 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.626 2.218 . . . . 0.0 111.945 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.91 -138.09 6.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.518 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' ALA . . . . . 0.563 ' HA ' ' HG3' ' A' ' 15' ' ' GLU . . . -87.2 144.99 26.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.925 0.393 . . . . 0.0 111.351 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' ALA . . . . . 0.759 ' HB3' ' HA ' ' A' ' 15' ' ' GLU . . . -140.7 38.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.566 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.09 153.59 21.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.546 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -161.88 171.24 18.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.041 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.45 126.79 7.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.251 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . 0.626 ' HB3' HD12 ' B' ' 86' ' ' LEU . . . -125.32 142.78 51.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.259 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.83 133.18 34.87 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.41 127.85 34.88 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.118 0.485 . . . . 0.0 110.137 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.54 150.53 29.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.882 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' VAL . . . . . 0.434 HG13 HD12 ' B' ' 131' ' ' ILE . 14.3 m -136.19 144.47 33.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.614 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -136.17 132.75 36.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.253 0.549 . . . . 0.0 110.442 -179.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' TYR . . . . . 0.474 ' OH ' ' HB3' ' B' ' 21' ' ' CYS . 5.5 m-85 -117.45 119.7 35.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.514 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.881 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' D' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 111.123 0.045 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.26 65.02 1.5 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.598 0.237 . . . . 0.0 110.96 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' THR . . . . . 0.461 HG23 ' HB2' ' D' ' 18' ' ' ASN . 57.2 m -111.23 101.0 9.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.471 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' THR . . . . . 0.481 ' HA ' ' HG2' ' D' ' 157' ' ' GLN . 61.6 m -86.63 131.85 34.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.67 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . 0.407 HG11 HG12 ' D' ' 17' ' ' VAL . 0.0 OUTLIER -161.11 168.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.607 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.09 118.68 36.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.616 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.26 -56.38 6.96 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.752 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.97 -145.38 4.66 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.909 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.02 142.06 29.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.399 . . . . 0.0 111.292 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' VAL . . . . . 0.472 HG23 ' CZ ' ' D' ' 73' ' ' PHE . 44.0 t -121.59 107.33 19.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.211 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.73 110.97 21.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.424 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' PHE . . . . . 0.409 ' HB3' HD12 ' D' ' 34' ' ' LEU . 32.0 m-85 -87.59 113.59 23.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.713 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.19 118.53 36.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.379 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.54 175.58 39.76 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.974 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' GLU . . . . . 0.742 ' HA ' ' HB3' ' D' ' 148' ' ' ALA . 0.1 OUTLIER -151.36 162.16 41.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.967 0.413 . . . . 0.0 110.263 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' D' ' 145' ' ' PRO . 2.2 t -115.08 119.48 61.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.153 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' VAL . . . . . 0.508 HG21 ' HA ' ' C' ' 22' ' ' ALA . 0.3 OUTLIER -121.31 168.1 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.808 0.337 . . . . 0.0 111.063 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' ASN . . . . . 0.461 ' HB2' HG23 ' B' ' 3' ' ' THR . 1.3 t-20 -68.5 -175.24 0.63 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.976 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . 0.448 ' O ' HG21 ' C' ' 65' ' ' VAL . . . -91.11 52.63 2.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.93 -15.76 1.32 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.361 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' CYS . . . . . 0.927 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER -176.91 147.64 0.6 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.926 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . 0.508 ' HA ' HG21 ' C' ' 17' ' ' VAL . . . -152.59 110.04 3.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.097 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' C' ' 58' ' ' LEU . 0.3 OUTLIER -53.08 159.07 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.01 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -90.32 164.46 14.34 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.614 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.411 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -57.01 -52.39 65.47 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.357 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.38 11.97 66.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.912 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 18.3 t -96.29 -30.78 13.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.889 0.376 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.414 ' H ' HG21 ' C' ' 28' ' ' VAL . 11.2 t -49.76 -71.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.341 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.52 104.31 15.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.086 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' GLN . . . . . 0.518 HE22 ' HA ' ' C' ' 56' ' ' ILE . 41.7 mt-30 -112.19 140.36 46.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.113 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.8 110.07 21.35 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.142 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -108.04 108.4 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.118 0.485 . . . . 0.0 110.386 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.67 112.42 22.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.687 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' LEU . . . . . 0.405 HD12 ' HB3' ' B' ' 12' ' ' PHE . 5.3 mp -81.03 -41.8 22.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.699 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.72 -171.12 21.61 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.604 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' GLN . . . . . 0.541 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 2.4 mt-30 -93.67 145.91 24.21 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.62 0.247 . . . . 0.0 110.913 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . 0.4 HG23 ' H ' ' C' ' 38' ' ' ARG . 5.0 p -124.84 169.94 15.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.94 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' ARG . . . . . 0.503 ' HE ' ' HB3' ' B' ' 60' ' ' ASP . 5.2 mtt-85 -98.93 121.37 40.79 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.71 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' THR . . . . . 0.434 HG22 ' HA ' ' B' ' 18' ' ' ASN . 0.6 OUTLIER -61.96 -30.94 71.27 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.717 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.61 -39.3 84.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.909 0.385 . . . . 0.0 110.764 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 71.3 m -81.29 -10.4 59.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.163 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' C' ' 139' ' ' ALA . 0.6 OUTLIER -129.34 40.45 3.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.577 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' ALA . . . . . 0.599 ' HA ' ' H ' ' C' ' 143' ' ' ALA . . . -111.89 10.91 20.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.355 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.51 145.52 48.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.372 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' C' ' 140' ' ' THR . 18.1 tt0 -63.26 121.12 12.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.814 0.34 . . . . 0.0 111.204 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.07 14.4 33.77 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.14 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.21 121.19 18.93 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' THR . . . . . 0.443 HG22 ' CE2' ' C' ' 138' ' ' PHE . 14.9 p -129.98 133.77 47.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.908 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.455 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 57.8 m -112.44 -166.73 1.1 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.59 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 36.1 t -59.06 149.46 27.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.801 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.82 153.64 17.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.369 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . 0.489 HG23 ' HD1' ' C' ' 54' ' ' PHE . 3.7 m -103.44 130.4 53.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.97 121.43 6.53 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.662 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . 0.58 ' HE1' ' HB1' ' C' ' 135' ' ' ALA . 52.2 p90 -153.65 136.39 15.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.776 0.322 . . . . 0.0 110.986 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' C' ' 131' ' ' ILE . 24.7 p30 -133.54 141.33 47.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.637 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.529 HG21 ' HB ' ' C' ' 131' ' ' ILE . 1.2 tt -85.17 126.52 40.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.62 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.624 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.1 OUTLIER -75.88 119.4 19.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.713 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' C' ' 23' ' ' VAL . 0.2 OUTLIER -130.63 87.29 2.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.254 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . 0.708 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 5.1 p30 -77.15 173.7 11.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.998 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' ASP . . . . . 0.499 ' HB3' ' HE ' ' D' ' 38' ' ' ARG . 41.3 m-20 62.83 66.4 0.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' CYS . . . . . 0.927 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 34.5 m -115.68 161.98 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.742 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' ASP . . . . . 0.498 ' HA ' ' OD1' ' C' ' 126' ' ' ASN . 0.2 OUTLIER -145.94 157.85 43.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.3 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.54 -16.65 14.31 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -81.35 -33.67 32.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.124 0.488 . . . . 0.0 111.817 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' VAL . . . . . 0.448 HG21 ' O ' ' C' ' 19' ' ' ALA . 20.0 t -75.14 -41.68 44.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.661 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.84 146.79 29.24 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.595 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.84 -39.35 3.73 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.897 0.379 . . . . 0.0 110.95 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.22 159.54 15.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.467 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' C' ' 122' ' ' THR . . . -147.24 118.87 7.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.578 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' ALA . . . . . 0.405 ' CB ' ' HB3' ' C' ' 118' ' ' PHE . . . -96.81 140.79 30.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.847 0.356 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' VAL . . . . . 0.524 HG13 HG21 ' C' ' 131' ' ' ILE . 3.1 t -118.51 139.74 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.732 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.54 133.91 29.84 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.521 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' PHE . . . . . 0.464 ' CZ ' HG23 ' B' ' 10' ' ' VAL . 0.1 OUTLIER -101.25 138.08 38.74 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.538 0.209 . . . . 0.0 111.185 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . 0.472 ' CD2' HG22 ' F' ' 130' ' ' THR . 6.6 tt -101.06 91.09 4.4 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.982 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.37 -167.37 11.32 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.871 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' THR . . . . . 0.656 ' O ' ' HA ' ' C' ' 86' ' ' LEU . 0.3 OUTLIER -116.67 159.53 22.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.557 0.218 . . . . 0.0 110.796 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' C' ' 83' ' ' THR . . . -83.95 137.95 33.38 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.942 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' ILE . . . . . 0.728 HG21 ' HB ' ' C' ' 85' ' ' VAL . 8.9 tt -77.18 -40.5 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.905 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -141.18 55.31 1.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.796 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' ALA . . . . . 0.447 ' HB1' ' H ' ' C' ' 81' ' ' GLY . . . 52.86 -84.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.051 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' C' ' 79' ' ' ASP . . . -60.09 -16.09 39.36 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.621 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' HIS . . . . . 0.487 ' O ' HG22 ' C' ' 78' ' ' ILE . 24.2 m80 -100.64 56.76 0.9 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.931 0.396 . . . . 0.0 110.584 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' THR . . . . . 0.442 ' HB ' ' OG1' ' C' ' 112' ' ' THR . 1.1 m -71.33 -22.44 61.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.584 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' ASN . . . . . 0.717 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 8.6 p-10 -57.18 -18.72 16.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.341 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.728 ' HB ' HG21 ' C' ' 78' ' ' ILE . 11.6 t -115.19 133.34 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.219 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' LEU . . . . . 0.656 ' HA ' ' O ' ' C' ' 76' ' ' THR . 0.8 OUTLIER -72.96 154.12 40.67 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.523 ' H ' HD23 ' C' ' 86' ' ' LEU . . . -90.76 -161.4 0.8 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.777 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.27 6.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.966 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.72 -83.84 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.317 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.27 20.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.985 0.421 . . . . 0.0 111.468 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' SER . . . . . 0.757 ' HB2' ' HB2' ' C' ' 95' ' ' SER . 1.5 m -86.58 79.25 8.98 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.67 -31.56 37.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.831 0.348 . . . . 0.0 111.611 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.1 54.49 1.72 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.661 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.9 -17.23 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.067 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' SER . . . . . 0.757 ' HB2' ' HB2' ' C' ' 91' ' ' SER . 0.9 OUTLIER -89.43 177.22 6.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.707 0.289 . . . . 0.0 110.65 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.77 175.3 8.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.759 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' C' ' 98' ' ' ASN . 0.2 OUTLIER -137.55 137.98 39.14 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.215 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' ASN . . . . . 0.536 ' HB2' ' O ' ' C' ' 97' ' ' THR . 74.0 m-80 71.69 17.63 5.46 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.465 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.9 148.96 26.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.741 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.39 -176.77 35.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.464 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' VAL . . . . . 0.465 HG11 ' O ' ' C' ' 101' ' ' VAL . 7.7 p -125.58 111.03 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.01 0.524 . . . . 0.0 111.711 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' GLN . . . . . 0.606 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 0.9 OUTLIER -81.54 147.75 29.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 -179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' ILE . . . . . 0.454 HD13 ' HE2' ' C' ' 133' ' ' PHE . 0.9 OUTLIER -123.77 115.94 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.489 179.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' LEU . . . . . 0.714 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 0.4 OUTLIER -88.73 140.53 29.35 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.634 0.254 . . . . 0.0 111.052 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' ASP . . . . . 0.584 ' HB2' ' HB2' ' C' ' 111' ' ' LEU . 2.1 t70 -89.36 152.06 21.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.711 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' ARG . . . . . 0.628 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -71.76 -21.05 61.79 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.785 0.326 . . . . 0.0 111.075 179.456 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' THR . . . . . 0.597 ' HB ' ' HA ' ' C' ' 120' ' ' SER . 5.8 t -62.99 -21.84 66.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.959 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.72 -83.08 0.19 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.669 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.73 170.66 15.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.833 0.349 . . . . 0.0 111.033 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.714 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -74.77 138.57 42.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' C' ' 105' ' ' ASP . 5.1 tp -94.45 153.41 17.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.363 0.601 . . . . 0.0 110.557 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 6.2 t -93.7 148.22 22.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.084 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mp -89.51 64.82 6.82 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.729 0.3 . . . . 0.0 110.715 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' ASP . . . . . 0.519 ' HB2' ' OG1' ' C' ' 117' ' ' THR . 0.5 OUTLIER -95.11 -16.05 22.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.588 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . 0.539 ' HA3' ' OG1' ' F' ' 130' ' ' THR . . . 104.41 -56.27 0.57 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.64 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' F' ' 125' ' ' ASN . . . -103.57 29.01 6.0 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.049 0.452 . . . . 0.0 111.709 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' THR . . . . . 0.519 ' OG1' ' HB2' ' C' ' 114' ' ' ASP . 3.4 m -87.27 65.87 8.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.145 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' PHE . . . . . 0.43 ' HE2' ' HA3' ' F' ' 127' ' ' GLY . 48.5 m-85 -77.66 73.47 4.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.792 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.57 70.83 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.837 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' SER . . . . . 0.597 ' HA ' ' HB ' ' C' ' 107' ' ' THR . 0.7 OUTLIER -148.68 126.15 11.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.15 53.25 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.202 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.641 ' HB ' ' HB3' ' C' ' 69' ' ' ALA . 0.2 OUTLIER -73.93 128.31 35.18 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.698 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.44 117.94 25.55 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.719 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.51 134.78 33.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.781 0.324 . . . . 0.0 110.489 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.26 163.07 26.45 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.674 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' ASN . . . . . 0.498 ' OD1' ' HA ' ' C' ' 62' ' ' ASP . 1.5 t30 -67.54 125.37 25.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.82 0.343 . . . . 0.0 110.687 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.62 -141.01 12.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.659 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' THR . . . . . 0.708 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 6.3 m -101.73 92.41 4.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.673 0.273 . . . . 0.0 110.778 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 129' ' ' ASN . . . . . 0.506 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 1.2 t30 -76.52 145.02 39.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.946 0.403 . . . . 0.0 111.119 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 130' ' ' THR . . . . . 0.624 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.0 OUTLIER -134.62 131.78 38.22 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.042 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 131' ' ' ILE . . . . . 0.529 ' HB ' HG21 ' C' ' 56' ' ' ILE . 28.3 mt -87.33 109.79 28.49 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 132' ' ' PRO . . . . . 0.628 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.4 Cg_endo -81.67 112.17 2.38 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.585 1.524 . . . . 0.0 112.53 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.454 ' HE2' HD13 ' C' ' 103' ' ' ILE . 0.3 OUTLIER -129.36 138.28 51.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.804 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 134' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' C' ' 52' ' ' VAL . 28.2 mt-30 -110.11 157.53 19.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.986 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' C' ' 102' ' ' GLN . . . -152.67 107.93 3.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.975 0.417 . . . . 0.0 111.608 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -102.54 174.41 5.91 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.338 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 137' ' ' TYR . . . . . 0.481 ' HB3' HD22 ' C' ' 42' ' ' LEU . 0.6 OUTLIER -86.08 120.9 27.96 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.069 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 138' ' ' PHE . . . . . 0.497 ' HB3' HG12 ' C' ' 85' ' ' VAL . 0.2 OUTLIER -117.66 139.61 50.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.006 -179.134 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 139' ' ' ALA . . . . . 0.562 ' HB3' ' HG ' ' C' ' 42' ' ' LEU . . . -129.93 145.66 51.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.875 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 140' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 16.5 p -104.38 -53.43 2.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.478 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.7 -121.56 3.27 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.024 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.1 112.97 24.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.59 0.233 . . . . 0.0 110.693 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 143' ' ' ALA . . . . . 0.599 ' H ' ' HA ' ' C' ' 43' ' ' ALA . . . -61.82 150.95 35.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.772 0.32 . . . . 0.0 111.42 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 144' ' ' THR . . . . . 0.595 HG22 ' CD ' ' C' ' 145' ' ' PRO . 58.2 m -126.89 151.51 73.96 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.199 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 145' ' ' PRO . . . . . 0.595 ' CD ' HG22 ' C' ' 144' ' ' THR . 1.3 Cg_endo -83.07 140.2 9.87 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.528 2.152 . . . . 0.0 111.936 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.94 -137.98 6.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.574 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 147' ' ' ALA . . . . . 0.578 ' HA ' ' HG3' ' B' ' 15' ' ' GLU . . . -87.23 145.07 26.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.984 0.421 . . . . 0.0 111.307 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 148' ' ' ALA . . . . . 0.751 ' HB3' ' HA ' ' B' ' 15' ' ' GLU . . . -140.76 38.83 1.83 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.0 153.52 22.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.486 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 150' ' ' ALA . . . . . . . . . . . . . . . -161.87 171.23 18.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.019 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.4 126.79 7.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.328 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . 0.615 ' HB3' HD12 ' C' ' 86' ' ' LEU . . . -125.31 142.8 51.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.328 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.85 133.17 34.88 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 154' ' ' PHE . . . . . 0.489 ' HD1' ' HA ' ' C' ' 154' ' ' PHE . 0.0 OUTLIER -86.44 127.85 34.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.104 0.478 . . . . 0.0 110.113 -178.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -111.43 150.52 29.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.921 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 156' ' ' VAL . . . . . 0.453 HG13 HD12 ' C' ' 131' ' ' ILE . 14.3 m -136.23 144.46 33.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.859 0.361 . . . . 0.0 111.582 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -136.16 132.73 36.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.34 0.59 . . . . 0.0 110.391 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 158' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' C' ' 21' ' ' CYS . 5.6 m-85 -117.45 119.8 36.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.51 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 159' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' B' ' 1' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.33 -0.843 . . . . 0.0 110.799 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' E' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.235 0.064 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.26 64.86 1.57 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.627 0.251 . . . . 0.0 111.065 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' THR . . . . . 0.453 HG23 ' HB2' ' E' ' 18' ' ' ASN . 57.9 m -111.17 100.96 9.52 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.524 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' THR . . . . . 0.479 ' HA ' ' HG2' ' E' ' 157' ' ' GLN . 61.6 m -86.59 131.91 34.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.609 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . 0.401 HG11 HG12 ' E' ' 17' ' ' VAL . 0.0 OUTLIER -161.16 168.06 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.523 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.19 118.71 37.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.584 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.31 -56.3 7.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.76 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.94 -145.34 4.65 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.919 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.02 142.09 29.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 0.0 111.282 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' VAL . . . . . 0.465 HG23 ' CZ ' ' E' ' 73' ' ' PHE . 43.8 t -121.66 107.27 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.168 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.7 111.03 21.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.366 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' PHE . . . . . 0.41 ' HB3' HD12 ' E' ' 34' ' ' LEU . 32.1 m-85 -87.63 113.53 23.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.777 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.13 118.54 36.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.405 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.48 175.61 39.71 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.887 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' GLU . . . . . 0.76 ' HA ' ' HB3' ' E' ' 148' ' ' ALA . 0.1 OUTLIER -151.38 162.12 41.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.946 0.403 . . . . 0.0 110.313 179.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' E' ' 145' ' ' PRO . 2.2 t -114.99 119.45 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.214 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' VAL . . . . . 0.518 HG21 ' HA ' ' D' ' 22' ' ' ALA . 0.3 OUTLIER -121.32 168.05 14.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.815 0.341 . . . . 0.0 111.07 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' ASN . . . . . 0.461 ' HB2' HG23 ' C' ' 3' ' ' THR . 1.3 t-20 -68.44 -175.21 0.62 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.984 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' ALA . . . . . 0.443 ' O ' HG21 ' D' ' 65' ' ' VAL . . . -91.24 52.67 2.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.89 -15.71 1.33 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.374 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' CYS . . . . . 0.929 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER -176.91 147.59 0.6 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.928 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . 0.518 ' HA ' HG21 ' D' ' 17' ' ' VAL . . . -152.64 110.04 3.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.114 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' D' ' 58' ' ' LEU . 0.3 OUTLIER -52.97 159.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.023 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -90.38 164.5 14.29 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.6 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -57.0 -52.38 65.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.365 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.36 11.87 66.56 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.872 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 18.7 t -96.14 -30.86 13.28 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.904 0.383 . . . . 0.0 110.929 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . 0.412 ' H ' HG21 ' D' ' 28' ' ' VAL . 11.3 t -49.83 -71.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.355 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.59 104.34 15.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.044 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' GLN . . . . . 0.509 HE22 ' HA ' ' D' ' 56' ' ' ILE . 41.7 mt-30 -112.14 140.3 46.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.071 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.77 110.18 21.5 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.028 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.13 108.36 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.155 0.503 . . . . 0.0 110.453 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.56 112.46 22.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.685 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' LEU . . . . . 0.409 HD12 ' HB3' ' C' ' 12' ' ' PHE . 5.2 mp -81.19 -41.72 21.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.673 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.64 -171.05 21.62 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.626 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' GLN . . . . . 0.535 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 2.4 mt-30 -93.57 145.93 24.17 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.524 0.202 . . . . 0.0 110.979 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 4.9 p -124.84 169.89 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.991 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' ARG . . . . . 0.499 ' HE ' ' HB3' ' C' ' 60' ' ' ASP . 5.2 mtt-85 -98.88 121.42 40.8 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.714 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' THR . . . . . 0.429 HG22 ' HA ' ' C' ' 18' ' ' ASN . 0.6 OUTLIER -62.01 -31.01 71.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.672 179.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.25 84.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.992 0.425 . . . . 0.0 110.852 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 71.1 m -81.31 -10.45 59.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.139 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.535 ' HG ' ' HB3' ' D' ' 139' ' ' ALA . 0.6 OUTLIER -129.25 40.42 3.62 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.607 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' ALA . . . . . 0.604 ' HA ' ' H ' ' D' ' 143' ' ' ALA . . . -111.83 10.91 20.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.363 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.51 145.49 48.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.369 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' D' ' 140' ' ' THR . 18.2 tt0 -63.34 121.26 13.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.11 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.05 14.38 33.9 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.155 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.17 121.22 18.93 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' THR . . . . . 0.433 HG22 ' CE2' ' D' ' 138' ' ' PHE . 14.9 p -130.04 133.79 46.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.919 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 57.8 m -112.46 -166.73 1.1 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.607 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 36.3 t -59.11 149.47 27.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.897 0.379 . . . . 0.0 110.768 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.76 153.64 17.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.404 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' D' ' 134' ' ' GLN . 3.7 m -103.41 130.33 53.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.96 121.5 6.56 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.576 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . 0.589 ' HE1' ' HB1' ' D' ' 135' ' ' ALA . 52.3 p90 -153.71 136.44 15.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.816 0.341 . . . . 0.0 110.94 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' D' ' 131' ' ' ILE . 24.7 p30 -133.57 141.33 47.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.628 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' ILE . . . . . 0.535 HG21 ' HB ' ' D' ' 131' ' ' ILE . 1.2 tt -85.06 126.42 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.645 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' GLN . . . . . 0.601 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.1 OUTLIER -75.73 119.41 19.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.742 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' D' ' 23' ' ' VAL . 0.2 OUTLIER -130.68 87.36 2.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.258 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' ASN . . . . . 0.707 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 5.0 p30 -77.3 173.64 11.68 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.956 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' ASP . . . . . 0.501 ' HB3' ' HE ' ' E' ' 38' ' ' ARG . 41.3 m-20 62.91 66.4 0.75 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.844 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' CYS . . . . . 0.929 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 34.6 m -115.69 161.98 17.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.714 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' ASP . . . . . 0.502 ' HA ' ' OD1' ' D' ' 126' ' ' ASN . 0.2 OUTLIER -145.88 157.92 43.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.323 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.401 HG23 ' O ' ' D' ' 124' ' ' LEU . 0.0 OUTLIER -107.59 -16.67 14.3 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -81.42 -33.65 32.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.028 0.442 . . . . 0.0 111.708 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' VAL . . . . . 0.443 HG21 ' O ' ' D' ' 19' ' ' ALA . 20.0 t -75.19 -41.6 44.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.629 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.93 146.7 29.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.553 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.77 -39.3 3.76 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.972 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.3 159.58 15.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.477 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' ALA . . . . . 0.63 ' HB3' ' HB ' ' D' ' 122' ' ' THR . . . -147.19 118.82 7.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.649 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' D' ' 118' ' ' PHE . . . -96.83 140.74 30.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.093 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' VAL . . . . . 0.526 HG13 HG21 ' D' ' 131' ' ' ILE . 3.1 t -118.5 139.71 44.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.784 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.56 133.94 29.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.522 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' PHE . . . . . 0.472 ' CZ ' HG23 ' C' ' 10' ' ' VAL . 0.1 OUTLIER -101.21 137.97 38.86 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.509 0.195 . . . . 0.0 111.243 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' LEU . . . . . 0.408 ' O ' HD23 ' D' ' 74' ' ' LEU . 6.6 tt -100.97 91.08 4.41 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.011 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.43 -167.38 11.31 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.891 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' THR . . . . . 0.668 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.3 OUTLIER -116.68 159.56 22.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.585 0.231 . . . . 0.0 110.761 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . 0.424 ' HB1' ' HA ' ' D' ' 83' ' ' THR . . . -83.96 137.85 33.42 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.018 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 78' ' ' ILE . . . . . 0.732 HG21 ' HB ' ' D' ' 85' ' ' VAL . 9.0 tt -77.13 -40.48 30.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.882 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 79' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' D' ' 81' ' ' GLY . 0.1 OUTLIER -141.22 55.21 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.848 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 52.87 -84.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.075 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' D' ' 79' ' ' ASP . . . -60.09 -16.05 39.19 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.663 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 82' ' ' HIS . . . . . 0.485 ' O ' HG22 ' D' ' 78' ' ' ILE . 24.2 m80 -100.64 56.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 110.568 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 83' ' ' THR . . . . . 0.441 ' HB ' ' OG1' ' D' ' 112' ' ' THR . 1.1 m -71.41 -22.42 61.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.563 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 84' ' ' ASN . . . . . 0.721 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 8.6 p-10 -57.17 -18.67 16.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.359 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.732 ' HB ' HG21 ' D' ' 78' ' ' ILE . 11.6 t -115.24 133.34 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.227 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 86' ' ' LEU . . . . . 0.668 ' HA ' ' O ' ' D' ' 76' ' ' THR . 0.8 OUTLIER -72.93 154.06 40.71 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.341 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.531 ' H ' HD23 ' D' ' 86' ' ' LEU . . . -90.66 -161.41 0.8 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.837 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.69 -178.27 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.01 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -83.88 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.339 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.33 20.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.998 0.427 . . . . 0.0 111.49 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 91' ' ' SER . . . . . 0.733 ' HB2' ' HB2' ' D' ' 95' ' ' SER . 1.5 m -86.6 79.35 8.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.73 -31.49 38.2 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.913 0.387 . . . . 0.0 111.71 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.08 54.43 1.72 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.646 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.9 -17.29 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.931 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 95' ' ' SER . . . . . 0.733 ' HB2' ' HB2' ' D' ' 91' ' ' SER . 0.9 OUTLIER -89.39 177.16 6.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.75 0.309 . . . . 0.0 110.661 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.76 175.3 8.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.812 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 97' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' D' ' 98' ' ' ASN . 0.2 OUTLIER -137.52 138.03 39.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.263 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 98' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' D' ' 97' ' ' THR . 74.0 m-80 71.63 17.6 5.53 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.52 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.86 148.94 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.733 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.35 -176.74 35.65 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.436 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 101' ' ' VAL . . . . . 0.467 HG11 ' O ' ' D' ' 101' ' ' VAL . 7.7 p -125.59 111.01 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 122.968 0.507 . . . . 0.0 111.759 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 102' ' ' GLN . . . . . 0.611 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 0.9 OUTLIER -81.53 147.71 29.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 103' ' ' ILE . . . . . 0.448 HD13 ' HE2' ' D' ' 133' ' ' PHE . 0.9 OUTLIER -123.74 115.92 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.478 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 104' ' ' LEU . . . . . 0.725 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 0.4 OUTLIER -88.69 140.52 29.37 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.693 0.283 . . . . 0.0 111.051 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 105' ' ' ASP . . . . . 0.594 ' HB2' ' HB2' ' D' ' 111' ' ' LEU . 2.1 t70 -89.26 151.98 21.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.693 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 106' ' ' ARG . . . . . 0.654 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -71.78 -21.07 61.77 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.805 0.336 . . . . 0.0 111.07 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 107' ' ' THR . . . . . 0.601 ' HB ' ' HA ' ' D' ' 120' ' ' SER . 5.8 t -62.9 -21.91 66.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.97 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.68 -83.02 0.19 Allowed Glycine 0 CA--C 1.517 0.219 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.722 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.74 170.7 15.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.834 0.349 . . . . 0.0 111.106 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.725 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -74.84 138.61 42.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.183 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 111' ' ' LEU . . . . . 0.594 ' HB2' ' HB2' ' D' ' 105' ' ' ASP . 5.1 tp -94.37 153.41 17.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.276 0.56 . . . . 0.0 110.604 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 112' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 6.2 t -93.72 148.33 22.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.046 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mp -89.7 64.87 6.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.894 0.378 . . . . 0.0 110.758 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 114' ' ' ASP . . . . . 0.52 ' HB2' ' OG1' ' D' ' 117' ' ' THR . 0.5 OUTLIER -94.98 -16.15 22.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.648 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.49 -56.26 0.56 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.693 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.53 29.05 5.96 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.949 0.404 . . . . 0.0 111.719 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 117' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' D' ' 114' ' ' ASP . 3.4 m -87.26 65.92 8.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.041 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 118' ' ' PHE . . . . . 0.411 ' CD1' ' HB2' ' D' ' 157' ' ' GLN . 48.5 m-85 -77.69 73.42 4.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.808 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.49 70.79 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 120' ' ' SER . . . . . 0.601 ' HA ' ' HB ' ' D' ' 107' ' ' THR . 0.7 OUTLIER -148.64 126.07 11.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.67 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.08 53.27 2.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.198 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' D' ' 69' ' ' ALA . 0.2 OUTLIER -74.04 128.32 35.22 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.715 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.36 117.9 25.45 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.765 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 124' ' ' LEU . . . . . 0.401 ' O ' HG23 ' D' ' 63' ' ' THR . 4.3 tp -88.52 134.8 33.76 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.831 0.348 . . . . 0.0 110.524 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 125' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -129.24 163.09 26.37 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.654 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 126' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' D' ' 62' ' ' ASP . 1.5 t30 -67.6 125.37 25.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.7 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 127' ' ' GLY . . . . . 0.435 ' HA3' ' HE2' ' A' ' 118' ' ' PHE . . . 128.62 -140.97 12.14 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.718 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 128' ' ' THR . . . . . 0.707 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 6.3 m -101.8 92.45 4.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.672 0.272 . . . . 0.0 110.772 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 129' ' ' ASN . . . . . 0.516 ' HB2' ' SG ' ' D' ' 61' ' ' CYS . 1.2 t30 -76.5 145.04 39.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.92 0.391 . . . . 0.0 111.147 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 130' ' ' THR . . . . . 0.601 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.0 OUTLIER -134.68 131.79 38.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.063 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 131' ' ' ILE . . . . . 0.535 ' HB ' HG21 ' D' ' 56' ' ' ILE . 28.2 mt -87.32 109.73 28.01 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 132' ' ' PRO . . . . . 0.654 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.5 Cg_endo -81.57 112.13 2.4 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.599 1.533 . . . . 0.0 112.576 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.448 ' HE2' HD13 ' D' ' 103' ' ' ILE . 0.3 OUTLIER -129.35 138.2 51.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.844 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 134' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' D' ' 52' ' ' VAL . 28.3 mt-30 -110.1 157.55 19.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.99 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' D' ' 102' ' ' GLN . . . -152.68 107.92 3.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 111.568 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -102.53 174.34 5.94 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.381 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 137' ' ' TYR . . . . . 0.476 ' HB3' HD22 ' D' ' 42' ' ' LEU . 0.6 OUTLIER -85.99 120.81 27.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.097 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 138' ' ' PHE . . . . . 0.499 ' HB3' HG12 ' D' ' 85' ' ' VAL . 0.2 OUTLIER -117.62 139.56 50.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.079 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 139' ' ' ALA . . . . . 0.535 ' HB3' ' HG ' ' D' ' 42' ' ' LEU . . . -129.88 145.64 51.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.851 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 140' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 16.3 p -104.46 -53.43 2.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.407 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.67 -121.52 3.27 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.014 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.08 112.92 24.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.568 0.223 . . . . 0.0 110.676 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 143' ' ' ALA . . . . . 0.604 ' H ' ' HA ' ' D' ' 43' ' ' ALA . . . -61.78 150.86 35.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.755 0.312 . . . . 0.0 111.453 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 144' ' ' THR . . . . . 0.594 HG22 ' CD ' ' D' ' 145' ' ' PRO . 60.4 m -126.81 151.52 73.77 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.274 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 145' ' ' PRO . . . . . 0.594 ' CD ' HG22 ' D' ' 144' ' ' THR . 1.3 Cg_endo -83.08 140.2 9.85 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.613 2.208 . . . . 0.0 111.941 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.94 -138.14 6.59 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.485 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 147' ' ' ALA . . . . . 0.571 ' HA ' ' HG3' ' C' ' 15' ' ' GLU . . . -87.14 145.02 26.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.912 0.387 . . . . 0.0 111.378 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 148' ' ' ALA . . . . . 0.742 ' HB3' ' HA ' ' C' ' 15' ' ' GLU . . . -140.73 38.79 1.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.545 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.1 153.53 22.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.48 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 150' ' ' ALA . . . . . . . . . . . . . . . -161.86 171.25 18.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.048 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.42 126.8 7.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.242 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 152' ' ' ALA . . . . . 0.616 ' HB3' HD12 ' D' ' 86' ' ' LEU . . . -125.31 142.85 51.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.257 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 153' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -89.84 133.17 34.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 154' ' ' PHE . . . . . 0.488 ' HD1' ' HA ' ' D' ' 154' ' ' PHE . 0.0 OUTLIER -86.46 127.88 34.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.042 0.449 . . . . 0.0 110.096 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.48 150.57 29.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.958 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 156' ' ' VAL . . . . . 0.45 HG13 HD12 ' D' ' 131' ' ' ILE . 14.4 m -136.24 144.39 33.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.826 0.346 . . . . 0.0 111.594 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 157' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' D' ' 69' ' ' ALA . 0.0 OUTLIER -136.16 132.74 36.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.268 0.556 . . . . 0.0 110.415 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 158' ' ' TYR . . . . . 0.47 ' OH ' ' HB3' ' D' ' 21' ' ' CYS . 5.5 m-85 -117.42 119.78 36.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.505 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 159' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' C' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.844 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 1' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' F' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 120.209 0.052 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.21 64.86 1.57 Allowed 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.126 0.266 . . . . 0.0 111.079 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 3' ' ' THR . . . . . 0.448 HG23 ' HB2' ' F' ' 18' ' ' ASN . 57.8 m -111.17 101.03 9.58 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.42 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 4' ' ' THR . . . . . 0.458 ' HA ' ' HG2' ' F' ' 157' ' ' GLN . 60.0 m -86.72 131.91 34.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.539 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -161.15 168.05 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.513 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.15 118.76 37.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.58 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.36 -56.26 7.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.759 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.01 -145.36 4.66 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.883 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.01 142.07 29.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.288 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 10' ' ' VAL . . . . . 0.463 HG23 ' CZ ' ' F' ' 73' ' ' PHE . 44.0 t -121.64 107.31 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.17 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.72 110.93 21.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.431 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 12' ' ' PHE . . . . . 0.413 ' HB3' HD12 ' F' ' 34' ' ' LEU . 32.2 m-85 -87.54 113.48 23.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.15 118.54 36.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.443 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.49 175.49 39.72 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.946 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 15' ' ' GLU . . . . . 0.751 ' HA ' ' HB3' ' F' ' 148' ' ' ALA . 0.1 OUTLIER -151.29 162.13 41.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.994 0.426 . . . . 0.0 110.303 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 16' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' F' ' 145' ' ' PRO . 2.2 t -114.97 119.33 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.265 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 17' ' ' VAL . . . . . 0.497 HG21 ' HA ' ' E' ' 22' ' ' ALA . 0.3 OUTLIER -121.26 168.06 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.843 0.354 . . . . 0.0 111.039 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 18' ' ' ASN . . . . . 0.453 ' HB2' HG23 ' D' ' 3' ' ' THR . 1.3 t-20 -68.38 -175.26 0.61 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.01 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 19' ' ' ALA . . . . . 0.447 ' O ' HG21 ' E' ' 65' ' ' VAL . . . -91.12 52.59 2.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.95 -15.66 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.357 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 21' ' ' CYS . . . . . 0.923 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER -176.96 147.55 0.58 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.981 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 22' ' ' ALA . . . . . 0.497 ' HA ' HG21 ' E' ' 17' ' ' VAL . . . -152.57 110.05 3.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 23' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' E' ' 58' ' ' LEU . 0.3 OUTLIER -53.0 159.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.011 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -90.37 164.46 14.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.592 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 25' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -56.91 -52.42 65.24 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.402 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.35 11.9 66.43 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.881 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 18.3 t -96.21 -30.77 13.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.895 0.379 . . . . 0.0 110.917 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 28' ' ' VAL . . . . . . . . . . . . . 11.2 t -49.84 -71.71 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.38 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.47 104.29 15.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 30' ' ' GLN . . . . . 0.516 HE22 ' HA ' ' E' ' 56' ' ' ILE . 41.8 mt-30 -112.17 140.4 46.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.07 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.83 110.16 21.46 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.301 -0.409 . . . . 0.0 112.045 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.17 108.46 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.136 0.493 . . . . 0.0 110.434 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.65 112.47 22.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 34' ' ' LEU . . . . . 0.41 HD12 ' HB3' ' D' ' 12' ' ' PHE . 5.3 mp -81.17 -41.8 21.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.67 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.72 -171.02 21.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.632 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 36' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 2.4 mt-30 -93.62 145.9 24.21 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.502 0.192 . . . . 0.0 110.969 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . 0.415 HG23 ' H ' ' E' ' 38' ' ' ARG . 5.0 p -124.82 169.88 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.942 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 38' ' ' ARG . . . . . 0.501 ' HE ' ' HB3' ' D' ' 60' ' ' ASP . 5.2 mtt-85 -98.94 121.45 40.91 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.701 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 39' ' ' THR . . . . . 0.44 HG22 ' HA ' ' D' ' 18' ' ' ASN . 0.6 OUTLIER -61.99 -31.03 71.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.675 179.521 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.3 85.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.987 0.422 . . . . 0.0 110.85 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 70.5 m -81.36 -10.3 59.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.128 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 42' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' E' ' 139' ' ' ALA . 0.6 OUTLIER -129.33 40.34 3.62 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.571 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 43' ' ' ALA . . . . . 0.607 ' HA ' ' H ' ' E' ' 143' ' ' ALA . . . -111.87 10.98 20.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.392 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.6 145.47 48.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.35 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 45' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' E' ' 140' ' ' THR . 18.2 tt0 -63.28 121.17 13.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.367 . . . . 0.0 111.109 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.03 14.48 33.67 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.113 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.14 121.19 18.86 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 48' ' ' THR . . . . . 0.443 HG22 ' CE2' ' E' ' 138' ' ' PHE . 14.9 p -130.03 133.72 46.93 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.906 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 49' ' ' SER . . . . . 0.442 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 57.9 m -112.43 -166.69 1.1 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.623 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 36.3 t -59.03 149.5 27.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.774 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.84 153.6 17.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.386 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 52' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' E' ' 134' ' ' GLN . 3.7 m -103.45 130.34 53.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.877 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.94 121.4 6.52 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.612 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 54' ' ' PHE . . . . . 0.59 ' HE1' ' HB1' ' E' ' 135' ' ' ALA . 52.2 p90 -153.6 136.44 15.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 110.97 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 55' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' E' ' 131' ' ' ILE . 24.7 p30 -133.55 141.39 47.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.682 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 56' ' ' ILE . . . . . 0.525 HG21 ' HB ' ' E' ' 131' ' ' ILE . 1.2 tt -85.18 126.43 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.627 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 57' ' ' GLN . . . . . 0.601 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.1 OUTLIER -75.8 119.45 19.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.732 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 58' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' E' ' 23' ' ' VAL . 0.2 OUTLIER -130.75 87.34 2.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.214 -179.609 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 59' ' ' ASN . . . . . 0.714 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 5.1 p30 -77.2 173.71 11.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.991 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 60' ' ' ASP . . . . . 0.495 ' HB3' ' HE ' ' F' ' 38' ' ' ARG . 41.6 m-20 62.89 66.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 61' ' ' CYS . . . . . 0.923 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 34.5 m -115.66 161.98 17.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.74 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 62' ' ' ASP . . . . . 0.501 ' HA ' ' OD1' ' E' ' 126' ' ' ASN . 0.2 OUTLIER -145.91 157.82 43.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.333 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 63' ' ' THR . . . . . 0.4 HG23 ' O ' ' E' ' 124' ' ' LEU . 0.0 OUTLIER -107.51 -16.65 14.31 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.186 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.4 -33.63 32.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.055 0.455 . . . . 0.0 111.755 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 65' ' ' VAL . . . . . 0.447 HG21 ' O ' ' E' ' 19' ' ' ALA . 20.0 t -75.19 -41.55 44.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.668 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.94 146.76 29.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.528 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -39.25 3.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.008 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.32 159.61 15.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.431 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 69' ' ' ALA . . . . . 0.63 ' HB3' ' HB ' ' E' ' 122' ' ' THR . . . -147.26 118.87 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.612 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.9 140.81 30.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.063 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 71' ' ' VAL . . . . . 0.512 HG13 HG21 ' E' ' 131' ' ' ILE . 3.1 t -118.57 139.74 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.714 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.56 133.9 29.78 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.533 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 73' ' ' PHE . . . . . 0.465 ' CZ ' HG23 ' D' ' 10' ' ' VAL . 0.1 OUTLIER -101.16 138.01 38.76 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 122.388 -0.195 . . . . 0.0 111.185 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 74' ' ' LEU . . . . . 0.41 ' O ' HD23 ' E' ' 74' ' ' LEU . 6.6 tt -100.98 91.02 4.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.028 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.37 -167.37 11.32 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.872 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 76' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.3 OUTLIER -116.71 159.48 22.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.631 0.253 . . . . 0.0 110.729 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 77' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' E' ' 83' ' ' THR . . . -83.94 137.94 33.39 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.024 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 78' ' ' ILE . . . . . 0.745 HG21 ' HB ' ' E' ' 85' ' ' VAL . 8.9 tt -77.18 -40.48 29.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.911 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 79' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' E' ' 81' ' ' GLY . 0.1 OUTLIER -141.22 55.26 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.882 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 80' ' ' ALA . . . . . 0.459 ' HB1' ' H ' ' E' ' 81' ' ' GLY . . . 52.88 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 81' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' E' ' 79' ' ' ASP . . . -60.09 -15.99 38.89 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.652 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 82' ' ' HIS . . . . . 0.488 ' O ' HG22 ' E' ' 78' ' ' ILE . 24.2 m80 -100.68 56.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.929 0.395 . . . . 0.0 110.557 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 83' ' ' THR . . . . . 0.434 ' HB ' ' OG1' ' E' ' 112' ' ' THR . 1.1 m -71.32 -22.53 61.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.574 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 84' ' ' ASN . . . . . 0.717 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 8.6 p-10 -57.2 -18.62 16.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.347 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 85' ' ' VAL . . . . . 0.745 ' HB ' HG21 ' E' ' 78' ' ' ILE . 11.6 t -115.23 133.36 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.205 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 86' ' ' LEU . . . . . 0.663 ' HA ' ' O ' ' E' ' 76' ' ' THR . 0.8 OUTLIER -72.95 154.01 40.72 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.368 179.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 87' ' ' ALA . . . . . 0.536 ' H ' HD23 ' E' ' 86' ' ' LEU . . . -90.67 -161.35 0.79 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.872 0.367 . . . . 0.0 111.781 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.74 -178.24 6.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.925 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.72 -83.82 0.04 OUTLIER 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.364 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.35 20.49 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.989 0.423 . . . . 0.0 111.464 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 91' ' ' SER . . . . . 0.744 ' HB2' ' HB2' ' E' ' 95' ' ' SER . 1.5 m -86.56 79.3 8.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.7 -31.54 38.14 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.867 0.365 . . . . 0.0 111.624 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.05 54.43 1.72 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.671 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.86 -17.34 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.02 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 95' ' ' SER . . . . . 0.744 ' HB2' ' HB2' ' E' ' 91' ' ' SER . 0.9 OUTLIER -89.41 177.2 6.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.804 0.335 . . . . 0.0 110.67 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.68 175.19 8.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.795 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 97' ' ' THR . . . . . 0.534 ' O ' ' HB2' ' E' ' 98' ' ' ASN . 0.2 OUTLIER -137.5 138.01 39.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.275 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 98' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' E' ' 97' ' ' THR . 74.0 m-80 71.71 17.52 5.46 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.532 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.87 149.0 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.719 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.34 -176.75 35.65 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.447 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 101' ' ' VAL . . . . . 0.453 HG11 ' O ' ' E' ' 101' ' ' VAL . 7.7 p -125.63 111.04 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.003 0.521 . . . . 0.0 111.736 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 102' ' ' GLN . . . . . 0.606 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 0.9 OUTLIER -81.58 147.67 29.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.878 -179.67 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 103' ' ' ILE . . . . . 0.449 HD13 ' HE2' ' E' ' 133' ' ' PHE . 0.9 OUTLIER -123.64 115.95 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.55 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 104' ' ' LEU . . . . . 0.699 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 0.4 OUTLIER -88.77 140.51 29.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.688 0.28 . . . . 0.0 111.02 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 105' ' ' ASP . . . . . 0.586 ' HB2' ' HB2' ' E' ' 111' ' ' LEU . 2.1 t70 -89.28 152.02 21.79 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.661 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 106' ' ' ARG . . . . . 0.647 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -71.79 -21.02 61.77 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.819 0.343 . . . . 0.0 111.119 179.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 107' ' ' THR . . . . . 0.602 ' HB ' ' HA ' ' E' ' 120' ' ' SER . 5.8 t -62.89 -21.98 66.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.981 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.69 -83.05 0.19 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.626 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.66 170.68 15.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 111.105 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . 0.699 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -74.85 138.63 42.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.227 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 111' ' ' LEU . . . . . 0.586 ' HB2' ' HB2' ' E' ' 105' ' ' ASP . 5.0 tp -94.45 153.45 17.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.366 0.603 . . . . 0.0 110.577 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 112' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 6.2 t -93.78 148.29 22.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.049 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mp -89.53 64.82 6.81 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.773 0.32 . . . . 0.0 110.742 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 114' ' ' ASP . . . . . 0.535 ' HB2' ' OG1' ' E' ' 117' ' ' THR . 0.5 OUTLIER -95.1 -15.95 23.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.662 0.268 . . . . 0.0 111.665 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.34 -56.25 0.57 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.682 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.58 29.05 5.98 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.983 0.42 . . . . 0.0 111.679 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 117' ' ' THR . . . . . 0.535 ' OG1' ' HB2' ' E' ' 114' ' ' ASP . 3.4 m -87.11 65.82 9.06 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.153 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . 0.411 ' CD1' ' HB2' ' E' ' 157' ' ' GLN . 48.3 m-85 -77.67 73.39 4.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.814 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.54 70.85 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 120' ' ' SER . . . . . 0.602 ' HA ' ' HB ' ' E' ' 107' ' ' THR . 0.7 OUTLIER -148.66 126.08 11.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.679 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.06 53.23 2.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.203 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 122' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' E' ' 69' ' ' ALA . 0.2 OUTLIER -74.04 128.31 35.2 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.67 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 4.5 m -86.29 118.0 25.46 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.759 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 124' ' ' LEU . . . . . 0.4 ' O ' HG23 ' E' ' 63' ' ' THR . 4.3 tp -88.61 134.82 33.77 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.779 0.323 . . . . 0.0 110.482 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 125' ' ' ASN . . . . . 0.516 ' HB3' ' O ' ' B' ' 116' ' ' ALA . 0.3 OUTLIER -129.3 163.08 26.47 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.662 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . 0.501 ' OD1' ' HA ' ' E' ' 62' ' ' ASP . 1.5 t30 -67.56 125.34 25.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.653 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . 0.428 ' HA3' ' HE2' ' B' ' 118' ' ' PHE . . . 128.59 -140.97 12.14 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.686 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 128' ' ' THR . . . . . 0.714 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 6.3 m -101.76 92.5 4.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.666 0.27 . . . . 0.0 110.752 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 129' ' ' ASN . . . . . 0.517 ' HB2' ' SG ' ' E' ' 61' ' ' CYS . 1.2 t30 -76.58 144.98 39.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.89 0.376 . . . . 0.0 111.099 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 130' ' ' THR . . . . . 0.601 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.0 OUTLIER -134.63 131.81 38.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.05 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 131' ' ' ILE . . . . . 0.525 ' HB ' HG21 ' E' ' 56' ' ' ILE . 28.3 mt -87.34 109.74 28.16 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 132' ' ' PRO . . . . . 0.647 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.4 Cg_endo -81.61 112.15 2.39 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 121.604 1.536 . . . . 0.0 112.544 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 133' ' ' PHE . . . . . 0.449 ' HE2' HD13 ' E' ' 103' ' ' ILE . 0.3 OUTLIER -129.32 138.21 51.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.849 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 134' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' E' ' 52' ' ' VAL . 28.1 mt-30 -110.03 157.49 19.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.075 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' E' ' 102' ' ' GLN . . . -152.65 107.85 3.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 111.636 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -102.58 174.34 5.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.338 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 137' ' ' TYR . . . . . 0.479 ' HB3' HD22 ' E' ' 42' ' ' LEU . 0.6 OUTLIER -85.9 120.86 27.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.036 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 138' ' ' PHE . . . . . 0.484 ' HB3' HG12 ' E' ' 85' ' ' VAL . 0.2 OUTLIER -117.68 139.64 50.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.001 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 139' ' ' ALA . . . . . 0.562 ' HB3' ' HG ' ' E' ' 42' ' ' LEU . . . -129.95 145.62 51.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.915 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 140' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 16.5 p -104.45 -53.33 2.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.464 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.8 -121.49 3.25 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.983 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.07 112.91 24.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.572 0.225 . . . . 0.0 110.723 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 143' ' ' ALA . . . . . 0.607 ' H ' ' HA ' ' E' ' 43' ' ' ALA . . . -61.79 150.89 35.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.794 0.33 . . . . 0.0 111.406 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 144' ' ' THR . . . . . 0.595 HG22 ' CD ' ' E' ' 145' ' ' PRO . 59.8 m -126.81 151.59 73.89 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.261 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 145' ' ' PRO . . . . . 0.595 ' CD ' HG22 ' E' ' 144' ' ' THR . 1.3 Cg_endo -83.09 140.15 9.82 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.59 2.193 . . . . 0.0 111.956 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.98 -138.01 6.52 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.521 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 147' ' ' ALA . . . . . 0.554 ' HA ' ' HG3' ' D' ' 15' ' ' GLU . . . -87.22 145.01 26.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.941 0.4 . . . . 0.0 111.329 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 148' ' ' ALA . . . . . 0.76 ' HB3' ' HA ' ' D' ' 15' ' ' GLU . . . -140.74 38.84 1.83 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.589 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.09 153.5 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.47 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 150' ' ' ALA . . . . . . . . . . . . . . . -161.88 171.21 18.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.966 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.42 126.84 7.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.232 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 152' ' ' ALA . . . . . 0.625 ' HB3' HD12 ' E' ' 86' ' ' LEU . . . -125.36 142.81 51.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.252 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 153' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.88 133.2 34.89 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 154' ' ' PHE . . . . . 0.435 ' HD1' ' HA ' ' E' ' 154' ' ' PHE . 0.0 OUTLIER -86.41 127.84 34.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.016 0.436 . . . . 0.0 110.148 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.41 150.55 29.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.96 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 156' ' ' VAL . . . . . 0.443 HG13 HD12 ' E' ' 131' ' ' ILE . 14.2 m -136.23 144.44 33.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.863 0.363 . . . . 0.0 111.551 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 157' ' ' GLN . . . . . 0.57 ' O ' ' HA ' ' E' ' 69' ' ' ALA . 0.0 OUTLIER -136.17 132.76 36.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.24 0.543 . . . . 0.0 110.459 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 158' ' ' TYR . . . . . 0.475 ' OH ' ' HB3' ' E' ' 21' ' ' CYS . 5.5 m-85 -117.48 119.79 36.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.537 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 159' ' ' GLN . . . . . 0.512 ' HA ' ' HA ' ' D' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.223 0.059 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.22 64.84 1.57 Allowed 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.118 0.261 . . . . 0.0 111.033 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 58.2 m -111.12 101.06 9.61 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.487 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 60.3 m -86.73 131.92 34.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.586 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -161.16 168.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.48 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.13 118.82 37.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.548 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.38 -56.39 6.87 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.704 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.97 -145.36 4.66 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.877 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.02 142.0 29.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 111.311 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 44.0 t -121.58 107.36 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.18 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -88.78 110.95 21.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.421 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -87.55 113.5 23.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.759 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.16 118.63 36.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.354 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.56 175.48 39.78 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.958 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.26 162.15 41.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.957 0.408 . . . . 0.0 110.289 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.01 119.35 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.259 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 17' ' ' VAL . . . . . 0.502 HG21 ' HA ' ' F' ' 22' ' ' ALA . 0.3 OUTLIER -121.26 168.1 14.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 111.039 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 18' ' ' ASN . . . . . 0.448 ' HB2' HG23 ' E' ' 3' ' ' THR . 1.3 t-20 -68.45 -175.2 0.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.953 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 19' ' ' ALA . . . . . 0.442 ' O ' HG21 ' F' ' 65' ' ' VAL . . . -91.23 52.64 2.15 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.9 -15.72 1.33 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.351 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 21' ' ' CYS . . . . . 0.934 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER -176.87 147.61 0.61 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.987 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 22' ' ' ALA . . . . . 0.502 ' HA ' HG21 ' F' ' 17' ' ' VAL . . . -152.58 110.02 3.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 23' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' F' ' 58' ' ' LEU . 0.3 OUTLIER -52.98 159.07 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -90.36 164.49 14.31 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.613 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 25' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -57.0 -52.36 65.59 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.402 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.41 11.95 66.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.888 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 18.4 t -96.25 -30.71 13.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.911 0.386 . . . . 0.0 110.95 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 28' ' ' VAL . . . . . 0.437 ' H ' HG21 ' F' ' 28' ' ' VAL . 11.3 t -49.87 -71.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.299 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.54 104.31 15.19 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 30' ' ' GLN . . . . . 0.526 HE22 ' HA ' ' F' ' 56' ' ' ILE . 41.8 mt-30 -112.12 140.3 46.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.122 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.72 110.12 21.44 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.123 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.12 108.44 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.165 0.507 . . . . 0.0 110.429 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.61 112.39 22.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.634 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 34' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' E' ' 12' ' ' PHE . 5.3 mp -81.11 -41.83 21.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.611 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.69 -171.06 21.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.638 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 36' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 2.4 mt-30 -93.63 145.87 24.23 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.536 0.207 . . . . 0.0 110.919 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.41 HG23 ' H ' ' F' ' 38' ' ' ARG . 5.0 p -124.87 169.87 15.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.929 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 38' ' ' ARG . . . . . 0.495 ' HE ' ' HB3' ' E' ' 60' ' ' ASP . 5.2 mtt-85 -98.88 121.4 40.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.703 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 39' ' ' THR . . . . . 0.441 HG22 ' HA ' ' E' ' 18' ' ' ASN . 0.6 OUTLIER -61.94 -30.99 71.28 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.75 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.57 -39.33 84.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.008 0.432 . . . . 0.0 110.774 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 71.5 m -81.31 -10.32 59.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.2 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 42' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' F' ' 139' ' ' ALA . 0.6 OUTLIER -129.4 40.42 3.6 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.588 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 43' ' ' ALA . . . . . 0.612 ' HA ' ' H ' ' F' ' 143' ' ' ALA . . . -111.89 10.96 20.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.428 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.52 145.44 48.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.399 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 45' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' F' ' 140' ' ' THR . 18.1 tt0 -63.25 121.25 13.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.852 0.358 . . . . 0.0 111.095 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.97 14.44 33.91 Favored Glycine 0 C--N 1.33 0.249 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.176 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.16 121.21 18.91 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 48' ' ' THR . . . . . 0.435 HG22 ' CE2' ' F' ' 138' ' ' PHE . 15.1 p -130.04 133.8 46.97 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.848 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 49' ' ' SER . . . . . 0.452 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 57.9 m -112.47 -166.71 1.1 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.628 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 36.1 t -59.07 149.45 27.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.793 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.72 153.63 17.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.39 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 52' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' F' ' 134' ' ' GLN . 3.7 m -103.44 130.4 53.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.0 121.48 6.56 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.621 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 54' ' ' PHE . . . . . 0.577 ' HE1' ' HB1' ' F' ' 135' ' ' ALA . 52.3 p90 -153.64 136.45 15.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 110.955 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 55' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' F' ' 131' ' ' ILE . 24.8 p30 -133.56 141.33 47.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.685 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 56' ' ' ILE . . . . . 0.527 HG21 ' HB ' ' F' ' 131' ' ' ILE . 1.2 tt -85.15 126.49 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.634 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 57' ' ' GLN . . . . . 0.616 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.1 OUTLIER -75.83 119.38 19.74 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.752 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 58' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' F' ' 23' ' ' VAL . 0.2 OUTLIER -130.68 87.4 2.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.29 -179.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 59' ' ' ASN . . . . . 0.711 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 5.1 p30 -77.28 173.8 11.49 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.988 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 62.78 66.47 0.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 61' ' ' CYS . . . . . 0.934 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 34.6 m -115.8 161.91 18.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.659 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 62' ' ' ASP . . . . . 0.501 ' HA ' ' OD1' ' F' ' 126' ' ' ASN . 0.2 OUTLIER -145.87 157.86 43.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.322 -179.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.49 -16.73 14.29 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.3 -33.75 32.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.012 0.434 . . . . 0.0 111.689 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 65' ' ' VAL . . . . . 0.442 HG21 ' O ' ' F' ' 19' ' ' ALA . 20.1 t -75.14 -41.64 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.619 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.95 146.74 29.1 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.567 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -39.3 3.73 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.863 0.363 . . . . 0.0 110.945 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.28 159.56 15.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.446 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 69' ' ' ALA . . . . . 0.633 ' HB3' ' HB ' ' F' ' 122' ' ' THR . . . -147.22 118.81 7.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.6 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 70' ' ' ALA . . . . . 0.405 ' CB ' ' HB3' ' F' ' 118' ' ' PHE . . . -96.81 140.75 30.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.066 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 71' ' ' VAL . . . . . 0.52 HG13 HG21 ' F' ' 131' ' ' ILE . 3.1 t -118.55 139.79 44.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.713 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.58 133.91 29.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.562 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 73' ' ' PHE . . . . . 0.463 ' CZ ' HG23 ' E' ' 10' ' ' VAL . 0.1 OUTLIER -101.19 138.07 38.71 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 122.338 -0.226 . . . . 0.0 111.172 179.603 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 74' ' ' LEU . . . . . . . . . . . . . 6.6 tt -101.07 91.08 4.39 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.003 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.4 -167.41 11.32 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.869 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 76' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.3 OUTLIER -116.74 159.51 22.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.611 0.243 . . . . 0.0 110.701 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.93 137.93 33.41 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.984 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 78' ' ' ILE . . . . . 0.737 HG21 ' HB ' ' F' ' 85' ' ' VAL . 9.0 tt -77.14 -40.51 30.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.913 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 79' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' F' ' 81' ' ' GLY . 0.1 OUTLIER -141.22 55.24 1.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.82 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 52.94 -84.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.086 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 81' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' F' ' 79' ' ' ASP . . . -60.12 -16.02 39.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.611 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 82' ' ' HIS . . . . . 0.485 ' O ' HG22 ' F' ' 78' ' ' ILE . 24.2 m80 -100.64 56.69 0.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.912 0.386 . . . . 0.0 110.566 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 83' ' ' THR . . . . . 0.442 ' HB ' ' OG1' ' F' ' 112' ' ' THR . 1.1 m -71.35 -22.47 61.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.567 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 84' ' ' ASN . . . . . 0.717 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 8.6 p-10 -57.12 -18.75 16.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.409 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 85' ' ' VAL . . . . . 0.737 ' HB ' HG21 ' F' ' 78' ' ' ILE . 11.5 t -115.15 133.42 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.25 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 86' ' ' LEU . . . . . 0.662 ' HA ' ' O ' ' F' ' 76' ' ' THR . 0.8 OUTLIER -73.0 154.05 40.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 87' ' ' ALA . . . . . 0.528 ' H ' HD23 ' F' ' 86' ' ' LEU . . . -90.66 -161.41 0.8 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.823 0.344 . . . . 0.0 111.778 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.24 6.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.988 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.67 -83.95 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.282 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.26 20.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.443 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 91' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' F' ' 95' ' ' SER . 1.5 m -86.65 79.37 8.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.76 -31.45 38.29 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.832 0.349 . . . . 0.0 111.665 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.09 54.41 1.73 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.621 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.89 -17.2 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.946 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 95' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' F' ' 91' ' ' SER . 0.9 OUTLIER -89.39 177.25 6.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.777 0.323 . . . . 0.0 110.672 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.83 175.18 8.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.735 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 97' ' ' THR . . . . . 0.534 ' O ' ' HB2' ' F' ' 98' ' ' ASN . 0.2 OUTLIER -137.46 137.97 39.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.289 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 98' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' F' ' 97' ' ' THR . 74.0 m-80 71.75 17.6 5.4 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.433 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.97 149.01 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.701 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.32 -176.74 35.62 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.433 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 101' ' ' VAL . . . . . 0.463 HG11 ' O ' ' F' ' 101' ' ' VAL . 7.7 p -125.64 111.02 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 122.976 0.51 . . . . 0.0 111.735 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 102' ' ' GLN . . . . . 0.607 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 0.9 OUTLIER -81.59 147.68 29.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.883 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 103' ' ' ILE . . . . . 0.451 HD13 ' HE2' ' F' ' 133' ' ' PHE . 0.9 OUTLIER -123.64 115.86 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.566 179.502 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 104' ' ' LEU . . . . . 0.71 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 0.4 OUTLIER -88.63 140.5 29.39 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.661 0.267 . . . . 0.0 111.076 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 105' ' ' ASP . . . . . 0.604 ' HB2' ' HB2' ' F' ' 111' ' ' LEU . 2.1 t70 -89.29 151.99 21.8 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.68 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 106' ' ' ARG . . . . . 0.625 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -71.77 -21.11 61.78 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.73 0.3 . . . . 0.0 111.054 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 107' ' ' THR . . . . . 0.581 ' HB ' ' HA ' ' F' ' 120' ' ' SER . 5.9 t -62.88 -21.87 66.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.063 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.65 -83.03 0.19 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.695 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.69 170.67 15.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.751 0.31 . . . . 0.0 111.063 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . 0.71 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -74.85 138.61 42.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.225 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 111' ' ' LEU . . . . . 0.604 ' HB2' ' HB2' ' F' ' 105' ' ' ASP . 5.1 tp -94.47 153.4 17.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.329 0.585 . . . . 0.0 110.531 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 112' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 6.2 t -93.71 148.27 22.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.094 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mp -89.51 64.73 6.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.784 0.326 . . . . 0.0 110.777 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 114' ' ' ASP . . . . . 0.534 ' HB2' ' OG1' ' F' ' 117' ' ' THR . 0.5 OUTLIER -95.05 -15.96 23.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.723 0.297 . . . . 0.0 111.685 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.36 -56.21 0.57 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.691 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.59 29.07 5.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.961 0.41 . . . . 0.0 111.626 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 117' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' F' ' 114' ' ' ASP . 3.4 m -87.23 65.89 9.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.069 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . 0.413 ' CD1' ' HB2' ' F' ' 157' ' ' GLN . 48.5 m-85 -77.68 73.39 4.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.806 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.49 70.91 0.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 120' ' ' SER . . . . . 0.581 ' HA ' ' HB ' ' F' ' 107' ' ' THR . 0.7 OUTLIER -148.68 126.06 11.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.696 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.04 53.17 2.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.205 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 122' ' ' THR . . . . . 0.633 ' HB ' ' HB3' ' F' ' 69' ' ' ALA . 0.2 OUTLIER -73.97 128.32 35.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.765 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.35 117.86 25.42 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.772 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tp -88.45 134.79 33.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.761 0.315 . . . . 0.0 110.498 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 125' ' ' ASN . . . . . 0.516 ' HB3' ' O ' ' C' ' 116' ' ' ALA . 0.3 OUTLIER -129.3 163.09 26.43 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.63 179.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . 0.501 ' OD1' ' HA ' ' F' ' 62' ' ' ASP . 1.5 t30 -67.61 125.43 26.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.699 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . 0.43 ' HA3' ' HE2' ' C' ' 118' ' ' PHE . . . 128.55 -141.0 12.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.707 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 128' ' ' THR . . . . . 0.711 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 6.3 m -101.74 92.44 4.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.716 0.293 . . . . 0.0 110.809 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 129' ' ' ASN . . . . . 0.506 ' HB2' ' SG ' ' F' ' 61' ' ' CYS . 1.2 t30 -76.55 144.99 39.33 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.881 0.372 . . . . 0.0 111.14 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 130' ' ' THR . . . . . 0.616 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.0 OUTLIER -134.61 131.76 38.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.073 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 131' ' ' ILE . . . . . 0.527 ' HB ' HG21 ' F' ' 56' ' ' ILE . 28.1 mt -87.31 109.81 28.66 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 132' ' ' PRO . . . . . 0.625 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.4 Cg_endo -81.67 112.16 2.38 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.617 1.544 . . . . 0.0 112.558 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 133' ' ' PHE . . . . . 0.451 ' HE2' HD13 ' F' ' 103' ' ' ILE . 0.3 OUTLIER -129.36 138.21 51.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.842 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 134' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' F' ' 52' ' ' VAL . 28.2 mt-30 -110.08 157.5 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.007 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' F' ' 102' ' ' GLN . . . -152.69 107.87 3.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 111.606 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -102.47 174.37 5.93 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.378 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 137' ' ' TYR . . . . . 0.493 ' HB3' HD22 ' F' ' 42' ' ' LEU . 0.6 OUTLIER -86.04 120.83 27.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.08 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 138' ' ' PHE . . . . . 0.504 ' HB3' HG12 ' F' ' 85' ' ' VAL . 0.2 OUTLIER -117.64 139.67 50.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.056 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 139' ' ' ALA . . . . . 0.557 ' HB3' ' HG ' ' F' ' 42' ' ' LEU . . . -129.96 145.57 51.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.902 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 140' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' F' ' 45' ' ' GLU . 16.5 p -104.36 -53.38 2.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.511 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.73 -121.47 3.26 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.995 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.12 112.93 24.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.549 0.214 . . . . 0.0 110.649 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 143' ' ' ALA . . . . . 0.612 ' H ' ' HA ' ' F' ' 43' ' ' ALA . . . -61.73 150.88 35.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.76 0.314 . . . . 0.0 111.479 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 144' ' ' THR . . . . . 0.594 HG22 ' CD ' ' F' ' 145' ' ' PRO . 60.1 m -126.85 151.52 73.88 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.27 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 145' ' ' PRO . . . . . 0.594 ' CD ' HG22 ' F' ' 144' ' ' THR . 1.4 Cg_endo -82.96 140.14 9.96 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.573 2.182 . . . . 0.0 112.024 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.98 -138.07 6.55 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.529 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 147' ' ' ALA . . . . . 0.554 ' HA ' ' HG3' ' E' ' 15' ' ' GLU . . . -87.22 145.04 26.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.881 0.372 . . . . 0.0 111.344 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 148' ' ' ALA . . . . . 0.751 ' HB3' ' HA ' ' E' ' 15' ' ' GLU . . . -140.77 38.79 1.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.558 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.04 153.57 22.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.549 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 150' ' ' ALA . . . . . . . . . . . . . . . -161.92 171.2 18.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.997 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.41 126.79 7.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.193 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 152' ' ' ALA . . . . . 0.616 ' HB3' HD12 ' F' ' 86' ' ' LEU . . . -125.34 142.81 51.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.341 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 153' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.88 133.19 34.89 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 154' ' ' PHE . . . . . 0.504 ' HD1' ' HA ' ' F' ' 154' ' ' PHE . 0.0 OUTLIER -86.34 127.83 34.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.025 0.441 . . . . 0.0 110.131 -179.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.47 150.5 29.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.941 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 156' ' ' VAL . . . . . 0.455 HG13 HD12 ' F' ' 131' ' ' ILE . 14.5 m -136.19 144.42 33.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 111.597 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 157' ' ' GLN . . . . . 0.571 ' O ' ' HA ' ' F' ' 69' ' ' ALA . 0.0 OUTLIER -136.23 132.79 36.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.364 0.602 . . . . 0.0 110.382 -179.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 158' ' ' TYR . . . . . 0.462 ' OH ' ' HB3' ' F' ' 21' ' ' CYS . 5.5 m-85 -117.41 119.78 36.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.563 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 159' ' ' GLN . . . . . 0.506 ' HA ' ' HA ' ' E' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.867 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.516 0.198 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.17 114.5 18.43 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.414 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -97.3 119.2 35.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.664 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.654 HG23 HG22 ' B' ' 156' ' ' VAL . 19.5 m -136.58 158.25 37.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.584 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.12 115.94 22.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.607 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.63 -79.61 0.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.851 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.511 ' H ' ' HB3' ' B' ' 154' ' ' PHE . . . -148.55 -145.94 4.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.903 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.556 HG22 HG23 ' B' ' 153' ' ' THR . 15.0 p -142.05 145.14 34.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.0 0.428 . . . . 0.0 111.24 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.5 t -127.83 119.5 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.245 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.46 113.16 25.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.386 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.75 90.68 5.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.799 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.11 120.72 32.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.367 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.05 170.5 32.64 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.91 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.653 ' HG3' ' O ' ' B' ' 146' ' ' GLY . 21.4 tt0 -160.61 129.19 4.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.402 . . . . 0.0 110.364 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.792 HG13 HG13 ' B' ' 37' ' ' VAL . 2.2 t -89.66 136.95 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.191 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.771 ' O ' HG22 ' B' ' 39' ' ' THR . 34.3 m -136.37 -160.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.781 0.324 . . . . 0.0 111.134 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.95 177.08 6.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.013 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' B' ' 40' ' ' ALA . . . -90.25 49.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.064 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -122.17 -39.66 2.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.394 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.675 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -162.15 146.38 12.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.943 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.02 121.65 14.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.637 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 2.5 p -63.71 143.5 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.054 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.562 ' HB3' ' HB2' ' A' ' 27' ' ' SER . 13.5 t70 -72.9 154.62 40.5 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.581 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.446 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -54.31 -53.89 47.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.354 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.54 1.03 88.67 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.88 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.562 ' HB2' ' HB3' ' A' ' 24' ' ' ASP . 7.9 t -99.28 -16.66 18.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.879 0.371 . . . . 0.0 110.836 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 25' ' ' ALA . 10.9 t -53.18 -50.84 44.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.355 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -114.06 126.16 54.79 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.973 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.423 HE22 ' HA ' ' A' ' 56' ' ' ILE . 3.7 mt-30 -125.61 135.6 52.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.051 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.92 109.11 21.91 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.128 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.51 115.14 48.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.086 0.47 . . . . 0.0 110.475 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.17 124.72 50.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.662 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.24 -42.31 23.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.602 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.1 -165.42 12.15 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.574 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -93.57 119.21 32.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.62 0.248 . . . . 0.0 110.854 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 137' ' ' TYR . 8.2 p -104.88 133.95 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.871 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -79.93 137.65 36.93 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.667 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -49.42 75.45 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.767 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.55 -33.48 54.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.026 0.441 . . . . 0.0 110.872 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.38 61.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.114 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.622 ' O ' ' HB2' ' A' ' 143' ' ' ALA . 0.6 OUTLIER -114.04 39.82 2.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.619 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.24 33.94 3.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.396 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.664 ' HB2' ' HB2' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -124.48 142.87 50.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.346 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.22 95.69 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 0.0 111.146 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.4 33.69 5.84 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.152 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 44' ' ' GLN . . . -78.83 143.55 35.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.981 0.42 . . . . 0.0 111.958 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.507 ' HB ' ' HD2' ' A' ' 136' ' ' ARG . 18.1 p -131.67 131.93 43.55 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.902 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 1.3 m -103.78 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.548 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -57.78 141.9 47.29 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -99.07 125.51 44.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.393 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 135' ' ' ALA . 24.8 m -76.51 150.99 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.956 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.34 143.29 16.43 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.4 ' HE2' ' HB3' ' A' ' 135' ' ' ALA . 37.5 p90 -171.48 140.44 1.39 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.844 0.354 . . . . 0.0 110.925 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -136.32 138.56 41.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.582 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.534 HG23 ' O ' ' A' ' 56' ' ' ILE . 0.7 OUTLIER -88.42 116.79 30.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.554 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.85 ' HA ' HG23 ' A' ' 130' ' ' THR . 5.0 mp0 -69.36 138.31 53.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.643 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -145.6 91.66 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.287 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.529 ' HA ' HG23 ' A' ' 128' ' ' THR . 4.1 p-10 -78.43 176.89 8.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.938 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.793 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.675 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 10.5 m -133.87 147.78 51.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.76 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.71 161.93 20.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.321 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.63 HG23 ' HA ' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -111.79 -34.18 6.1 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.067 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -72.54 -28.18 62.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.037 0.446 . . . . 0.0 111.718 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.18 -58.54 4.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.703 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.2 126.07 32.67 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.575 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -42.15 7.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.954 0.407 . . . . 0.0 110.943 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.24 156.83 18.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.517 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' A' ' 122' ' ' THR . . . -146.63 133.23 19.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.57 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -113.38 155.11 25.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.104 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.791 HG11 HG21 ' A' ' 131' ' ' ILE . 2.0 t -136.4 148.57 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.684 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -152.9 163.48 39.7 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.6 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.441 ' CD1' ' HB1' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -130.23 142.28 50.57 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 122.409 -0.182 . . . . 0.0 111.16 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 152' ' ' ALA . 1.4 tt -109.16 119.05 38.35 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.066 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.825 ' HA3' HD22 ' A' ' 113' ' ' LEU . . . -162.74 -161.92 12.93 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.769 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.633 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.3 OUTLIER -120.92 162.92 19.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.578 0.228 . . . . 0.0 110.779 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' A' ' 87' ' ' ALA . . . -83.57 139.08 33.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.934 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.531 HG23 ' N ' ' A' ' 79' ' ' ASP . 11.1 tt -66.09 -47.61 84.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.987 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.531 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -134.46 46.69 2.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.849 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.608 ' HB1' ' O ' ' D' ' 105' ' ' ASP . . . 64.49 -84.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.078 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.77 -36.4 40.9 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.603 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.43 69.2 10.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.888 0.375 . . . . 0.0 110.523 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -74.1 -7.51 52.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.487 -179.447 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.625 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 30.0 p-10 -74.74 -25.39 59.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.334 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 138' ' ' PHE . 6.4 t -104.92 143.84 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.169 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.611 ' HG ' HD13 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -74.8 160.86 30.17 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.338 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.688 ' HB2' ' O ' ' A' ' 77' ' ' ALA . . . -103.64 179.85 4.15 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.874 0.369 . . . . 0.0 111.712 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.717 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 1.3 mm? -66.58 171.29 5.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.045 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.562 ' HG3' ' HB2' ' A' ' 149' ' ' ASN . 1.3 mm-40 -68.61 -83.7 0.03 OUTLIER 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.265 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.412 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 6.0 p -169.12 19.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.959 0.409 . . . . 0.0 111.451 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.542 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 3.2 m -90.16 86.28 6.5 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' D' ' 50' ' ' SER . . . -61.16 -24.99 66.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.631 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.4 41.25 3.52 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.66 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.96 0.69 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.858 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.85 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 1.9 m -89.26 -173.59 4.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.773 0.321 . . . . 0.0 110.71 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.425 ' HB3' HD11 ' A' ' 88' ' ' LEU . . . -100.99 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 99' ' ' VAL . 3.0 m -131.06 123.92 29.72 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.299 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.21 29.43 18.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.459 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 97' ' ' THR . 1.7 t -125.31 129.33 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.835 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.85 -171.06 21.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.522 ' CG2' ' HB1' ' A' ' 135' ' ' ALA . 1.9 p -122.97 116.71 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.204 0.526 . . . . 0.0 111.69 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.55 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 3.9 tt0 -81.74 151.45 27.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.915 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.82 123.84 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.531 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.506 HD13 ' OE1' ' A' ' 134' ' ' GLN . 0.5 OUTLIER -104.72 125.18 50.55 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.658 0.266 . . . . 0.0 111.013 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.805 ' HB3' HG22 ' A' ' 107' ' ' THR . 13.6 t0 -77.57 143.07 38.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.672 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.697 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -62.73 -14.86 49.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.742 0.306 . . . . 0.0 111.043 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.805 HG22 ' HB3' ' A' ' 105' ' ' ASP . 8.8 t -63.04 -20.94 65.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.012 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.28 -43.57 1.36 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.735 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.69 160.71 14.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.767 0.318 . . . . 0.0 111.082 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.36 133.16 40.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.125 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.659 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 12.3 tp -95.54 160.94 14.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.373 0.606 . . . . 0.0 110.531 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 2.9 t -110.21 136.81 48.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.076 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.825 HD22 ' HA3' ' A' ' 75' ' ' GLY . 1.4 mt -70.25 89.64 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.76 0.314 . . . . 0.0 110.689 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -18.43 6.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.487 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -62.25 0.88 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.664 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.566 ' HB3' ' OD1' ' D' ' 129' ' ' ASN . . . -92.95 18.23 9.43 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.993 0.425 . . . . 0.0 111.659 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.548 HG21 HG23 ' A' ' 112' ' ' THR . 0.0 OUTLIER -83.97 72.58 10.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.065 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.604 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 78.4 m-85 -92.32 89.77 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.799 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 54.6 m -130.56 73.11 1.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.91 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.21 142.32 21.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.682 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.98 68.56 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.208 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.642 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -81.51 133.14 35.35 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.684 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.7 m -87.6 124.13 33.19 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.681 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.3 119.32 35.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.648 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.63 ' HA ' HG23 ' A' ' 63' ' ' THR . 2.9 m120 -113.71 171.91 7.29 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.587 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.48 109.75 16.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.647 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.82 -133.8 4.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.714 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.529 HG23 ' HA ' ' A' ' 59' ' ' ASN . 46.1 m -110.5 86.75 2.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.742 0.306 . . . . 0.0 110.794 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -69.34 155.07 41.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.829 0.347 . . . . 0.0 111.162 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.85 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -142.79 137.07 29.44 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.089 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.791 HG21 HG11 ' A' ' 71' ' ' VAL . 6.9 mt -100.25 109.12 55.66 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.697 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.5 Cg_endo -81.76 148.25 15.67 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.721 1.614 . . . . 0.0 112.536 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.413 ' CZ ' ' HA ' ' A' ' 105' ' ' ASP . 0.5 OUTLIER -158.82 145.31 17.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.908 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.506 ' OE1' HD13 ' A' ' 104' ' ' LEU . 4.1 mt-30 -111.24 160.4 17.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.024 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.766 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -155.98 97.82 1.84 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.951 0.405 . . . . 0.0 111.613 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.507 ' HD2' ' HB ' ' A' ' 48' ' ' THR . 14.4 ptt180 -101.57 173.61 6.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.41 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 1.8 m-85 -83.64 135.04 34.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.134 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.602 ' HB3' HG11 ' A' ' 85' ' ' VAL . 1.7 t80 -128.86 128.18 43.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.022 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.454 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -108.52 138.0 45.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.817 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.529 HG21 ' HB2' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -89.94 -9.56 48.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.494 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.31 -95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.963 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.71 101.49 11.33 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.513 0.197 . . . . 0.0 110.737 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 42' ' ' LEU . . . -61.36 144.35 54.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.749 0.309 . . . . 0.0 111.378 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.602 ' CG2' ' CD ' ' A' ' 145' ' ' PRO . 99.2 m -123.94 153.15 67.42 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.22 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.602 ' CD ' ' CG2' ' A' ' 144' ' ' THR . 1.3 Cg_endo -83.01 144.78 12.14 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.523 2.149 . . . . 0.0 111.989 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.3 -116.09 0.7 Allowed Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.503 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.85 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -119.73 132.37 55.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.892 0.377 . . . . 0.0 111.361 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.37 43.36 3.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.13 0.491 . . . . 0.0 110.414 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.562 ' HB2' ' HG3' ' A' ' 89' ' ' GLN . 1.1 m120 -95.68 150.88 19.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.586 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.507 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -168.5 -178.63 3.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.017 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.78 153.0 39.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.238 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -141.22 151.12 43.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.239 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.66 133.73 54.55 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.71 148.72 28.82 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.093 0.473 . . . . 0.0 110.112 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 118' ' ' PHE . 11.2 mmtt -135.02 139.43 44.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.949 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.403 HG12 ' CD1' ' A' ' 131' ' ' ILE . 3.1 m -134.52 141.3 43.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.778 0.323 . . . . 0.0 111.685 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.547 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 3.8 tt0 -128.78 128.97 45.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.318 0.58 . . . . 0.0 110.358 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.71 128.59 51.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.565 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.33 0.109 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.37 88.99 0.04 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.588 0.232 . . . . 0.0 111.022 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.18 114.49 18.41 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.402 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -97.31 119.19 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.65 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.654 HG23 HG22 ' C' ' 156' ' ' VAL . 19.4 m -136.58 158.24 37.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.525 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.16 115.99 22.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.552 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.64 -79.61 0.13 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.873 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.514 ' H ' ' HB3' ' C' ' 154' ' ' PHE . . . -148.56 -145.9 4.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.879 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.561 HG22 HG23 ' C' ' 153' ' ' THR . 14.9 p -142.11 145.12 33.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.052 0.453 . . . . 0.0 111.225 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 32.5 t -127.8 119.51 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.267 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.44 113.14 25.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.377 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.7 90.72 5.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.814 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.15 120.71 32.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.337 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.02 170.48 32.62 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.908 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.642 ' HG3' ' O ' ' C' ' 146' ' ' GLY . 21.4 tt0 -160.59 129.19 4.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.975 0.417 . . . . 0.0 110.395 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.809 HG13 HG13 ' C' ' 37' ' ' VAL . 2.2 t -89.66 136.93 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.226 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.753 ' O ' HG22 ' C' ' 39' ' ' THR . 34.3 m -136.35 -160.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.785 0.326 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.93 177.02 6.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.977 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' C' ' 40' ' ' ALA . . . -90.21 49.67 1.73 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.053 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' B' ' 61' ' ' CYS . . . -122.19 -39.67 2.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.437 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.701 ' HG ' ' HG ' ' B' ' 61' ' ' CYS . 0.5 OUTLIER -162.13 146.38 12.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.959 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.04 121.62 14.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.623 ' HA ' ' HG ' ' B' ' 58' ' ' LEU . 2.4 p -63.71 143.54 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.037 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.561 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 13.6 t70 -72.94 154.65 40.46 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.582 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.439 ' O ' HG23 ' B' ' 28' ' ' VAL . . . -54.33 -53.88 47.86 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.341 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.55 1.05 88.65 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.868 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.561 ' HB2' ' HB3' ' B' ' 24' ' ' ASP . 7.9 t -99.29 -16.68 18.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.872 0.367 . . . . 0.0 110.826 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 25' ' ' ALA . 10.7 t -53.14 -50.85 43.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.377 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -114.08 126.19 54.82 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.972 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' GLN . . . . . 0.43 HE22 ' HA ' ' B' ' 56' ' ' ILE . 3.7 mt-30 -125.61 135.57 52.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.064 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.92 109.17 21.95 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.117 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.57 115.16 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 0.0 110.463 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.2 124.74 50.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.631 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.26 -42.34 23.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.596 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.13 -165.34 12.14 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.557 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.0 mt-30 -93.65 119.24 32.42 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.64 0.257 . . . . 0.0 110.834 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.792 HG13 HG13 ' A' ' 16' ' ' VAL . 8.2 p -104.91 133.94 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.87 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' B' ' 41' ' ' SER . 0.1 OUTLIER -79.92 137.62 36.93 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.668 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -62.53 -49.38 75.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.762 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . . . -53.52 -33.5 54.74 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.01 0.433 . . . . 0.0 110.865 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' B' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.33 61.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.112 -179.742 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' B' ' 143' ' ' ALA . 0.6 OUTLIER -114.07 39.81 2.64 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.613 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.2 33.96 3.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.448 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 0.667 ' HB2' ' HB2' ' B' ' 47' ' ' ALA . 0.3 OUTLIER -124.48 142.88 50.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.344 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.25 95.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.371 . . . . 0.0 111.148 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.43 33.63 5.85 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.139 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' B' ' 44' ' ' GLN . . . -78.87 143.5 35.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.418 . . . . 0.0 111.949 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.494 ' HB ' ' HD2' ' B' ' 136' ' ' ARG . 18.1 p -131.61 131.9 43.62 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.895 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 1.3 m -103.75 -167.22 1.34 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.572 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -57.82 141.91 47.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.863 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.465 ' HB2' ' HB3' ' B' ' 136' ' ' ARG . . . -99.05 125.52 44.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.377 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.773 HG22 ' O ' ' B' ' 135' ' ' ALA . 24.8 m -76.53 151.0 6.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.961 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.36 143.28 16.44 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.527 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -171.47 140.44 1.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.801 0.334 . . . . 0.0 110.936 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -136.33 138.6 41.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.571 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.542 HG23 ' O ' ' B' ' 56' ' ' ILE . 0.7 OUTLIER -88.45 116.79 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.542 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 57' ' ' GLN . . . . . 0.842 ' HA ' HG23 ' B' ' 130' ' ' THR . 5.0 mp0 -69.38 138.31 53.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.802 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.643 ' HB3' ' SG ' ' B' ' 21' ' ' CYS . 0.3 OUTLIER -145.58 91.67 2.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.276 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.525 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 4.1 p-10 -78.43 176.86 8.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.912 0.387 . . . . 0.0 110.915 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.92 81.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' CYS . . . . . 0.701 ' HG ' ' HG ' ' B' ' 21' ' ' CYS . 10.4 m -133.85 147.8 51.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.78 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.7 161.91 20.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.349 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.644 HG23 ' HA ' ' B' ' 125' ' ' ASN . 0.0 OUTLIER -111.75 -34.19 6.1 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.08 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -72.52 -28.2 62.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.072 0.463 . . . . 0.0 111.735 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.18 -58.56 4.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.658 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.22 126.06 32.62 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.592 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.39 -42.09 7.13 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.956 0.407 . . . . 0.0 110.954 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' LYS . . . . . 0.441 ' HD2' ' HA ' ' B' ' 68' ' ' LYS . 1.2 tptp -89.28 156.8 18.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.465 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.651 ' HB3' ' HB ' ' B' ' 122' ' ' THR . . . -146.61 133.21 19.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.609 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -113.35 155.11 25.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.137 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.763 HG11 HG21 ' B' ' 131' ' ' ILE . 2.0 t -136.39 148.53 27.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.725 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' B' ' 155' ' ' LYS . . . -152.9 163.51 39.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.553 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.441 ' CD1' ' HB1' ' B' ' 152' ' ' ALA . 0.2 OUTLIER -130.23 142.25 50.58 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 122.411 -0.181 . . . . 0.0 111.207 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' B' ' 152' ' ' ALA . 1.4 tt -109.12 119.05 38.36 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.053 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' GLY . . . . . 0.793 ' HA3' HD22 ' B' ' 113' ' ' LEU . . . -162.74 -161.9 12.89 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.757 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.64 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.3 OUTLIER -120.97 162.92 19.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.59 0.233 . . . . 0.0 110.788 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.694 ' O ' ' HB2' ' B' ' 87' ' ' ALA . . . -83.54 139.08 33.1 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.936 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.538 HG23 ' N ' ' B' ' 79' ' ' ASP . 11.1 tt -66.09 -47.64 84.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.973 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.542 ' HB2' HG21 ' B' ' 140' ' ' THR . 0.2 OUTLIER -134.42 46.69 2.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.891 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' E' ' 105' ' ' ASP . . . 64.48 -83.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.096 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.79 -36.42 41.17 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.576 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.4 69.19 10.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.541 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' THR . . . . . 0.477 HG23 ' HB2' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -74.08 -7.53 52.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.549 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ASN . . . . . 0.603 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 30.1 p-10 -74.69 -25.4 59.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.383 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.6 HG11 ' HB3' ' B' ' 138' ' ' PHE . 6.4 t -104.92 143.88 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.17 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.6 ' HG ' HD13 ' B' ' 113' ' ' LEU . 0.3 OUTLIER -74.84 160.89 30.11 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.265 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' B' ' 77' ' ' ALA . . . -103.66 179.88 4.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.861 0.363 . . . . 0.0 111.702 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.699 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 1.3 mm? -66.59 171.3 5.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.038 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' GLN . . . . . 0.563 ' HG3' ' HB2' ' B' ' 149' ' ' ASN . 1.3 mm-40 -68.57 -83.75 0.03 OUTLIER 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.275 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' SER . . . . . 0.409 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 5.9 p -169.11 19.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.907 0.384 . . . . 0.0 111.426 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' SER . . . . . 0.535 ' HA ' ' HB2' ' D' ' 25' ' ' ALA . 3.2 m -90.13 86.26 6.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.505 ' HB2' HG13 ' E' ' 52' ' ' VAL . . . -61.1 -25.03 66.68 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.652 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.42 41.31 3.5 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.638 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.03 0.72 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.828 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' SER . . . . . 0.846 ' HA ' ' HB3' ' B' ' 147' ' ' ALA . 1.9 m -89.28 -173.58 4.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.784 0.326 . . . . 0.0 110.71 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 96' ' ' ALA . . . . . 0.418 ' HB3' HD11 ' B' ' 88' ' ' LEU . . . -100.97 -177.3 3.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.409 ' O ' HG23 ' B' ' 99' ' ' VAL . 3.0 m -131.03 123.94 29.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.301 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 61.18 29.46 18.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.462 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 97' ' ' THR . 1.7 t -125.31 129.33 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.86 -171.15 21.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.515 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' B' ' 86' ' ' LEU . 1.9 p -122.89 116.72 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.208 0.528 . . . . 0.0 111.682 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 3.9 tt0 -81.77 151.46 27.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.923 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.83 123.82 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.511 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' LEU . . . . . 0.512 HD13 ' OE1' ' B' ' 134' ' ' GLN . 0.5 OUTLIER -104.68 125.17 50.52 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.645 0.26 . . . . 0.0 111.041 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ASP . . . . . 0.8 ' HB3' HG22 ' B' ' 107' ' ' THR . 13.6 t0 -77.61 143.12 38.5 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.659 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' ARG . . . . . 0.719 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -62.75 -14.88 49.93 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.722 0.296 . . . . 0.0 111.048 179.45 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.8 HG22 ' HB3' ' B' ' 105' ' ' ASP . 8.8 t -62.97 -20.96 65.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.024 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.3 -43.57 1.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.729 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.7 160.71 14.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.327 . . . . 0.0 111.088 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.35 133.18 40.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.122 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.66 ' HB2' ' HB2' ' B' ' 105' ' ' ASP . 12.3 tp -95.56 160.9 14.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.401 0.619 . . . . 0.0 110.469 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 2.9 t -110.19 136.8 48.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.075 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.793 HD22 ' HA3' ' B' ' 75' ' ' GLY . 1.4 mt -70.22 89.59 0.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.764 0.316 . . . . 0.0 110.655 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.34 -18.46 6.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.509 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.3 -62.27 0.87 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.645 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' ALA . . . . . 0.568 ' HB3' ' OD1' ' E' ' 129' ' ' ASN . . . -92.95 18.23 9.44 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.023 0.44 . . . . 0.0 111.668 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' THR . . . . . 0.546 HG21 HG23 ' B' ' 112' ' ' THR . 0.0 OUTLIER -83.91 72.53 10.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.039 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.588 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . 78.3 m-85 -92.35 89.8 6.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.775 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 55.1 m -130.58 73.15 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.23 142.29 21.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.691 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -103.96 68.55 0.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.194 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.651 ' HB ' ' HB3' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -81.43 133.16 35.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.72 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 8.7 m -87.61 124.14 33.21 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.687 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.33 119.34 35.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.633 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.644 ' HA ' HG23 ' B' ' 63' ' ' THR . 2.9 m120 -113.74 171.94 7.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.573 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.5 109.76 16.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.646 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.8 -133.79 4.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.712 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 46.4 m -110.53 86.75 2.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.759 0.314 . . . . 0.0 110.807 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.32 155.05 41.06 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.222 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.842 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -142.76 137.1 29.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.092 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 131' ' ' ILE . . . . . 0.763 HG21 HG11 ' B' ' 71' ' ' VAL . 6.9 mt -100.26 109.07 55.53 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 132' ' ' PRO . . . . . 0.719 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.73 148.26 15.73 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 121.666 1.577 . . . . 0.0 112.543 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' B' ' 105' ' ' ASP . 0.5 OUTLIER -158.8 145.32 17.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.921 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 134' ' ' GLN . . . . . 0.512 ' OE1' HD13 ' B' ' 104' ' ' LEU . 4.1 mt-30 -111.24 160.4 17.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.034 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.773 ' O ' HG22 ' B' ' 52' ' ' VAL . . . -156.0 97.79 1.84 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.956 0.408 . . . . 0.0 111.589 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 136' ' ' ARG . . . . . 0.494 ' HD2' ' HB ' ' B' ' 48' ' ' THR . 14.4 ptt180 -101.54 173.59 6.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.405 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 137' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 1.8 m-85 -83.62 135.04 34.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.181 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 138' ' ' PHE . . . . . 0.6 ' HB3' HG11 ' B' ' 85' ' ' VAL . 1.8 t80 -128.88 128.18 43.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.988 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.462 ' HB2' HD23 ' B' ' 42' ' ' LEU . . . -108.53 138.0 45.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.86 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 140' ' ' THR . . . . . 0.542 HG21 ' HB2' ' B' ' 79' ' ' ASP . 0.3 OUTLIER -89.96 -9.55 48.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.478 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.3 -95.23 0.1 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.951 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.74 101.52 11.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.514 0.197 . . . . 0.0 110.744 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 143' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 42' ' ' LEU . . . -61.39 144.35 54.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.73 0.3 . . . . 0.0 111.379 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.598 ' CG2' ' CD ' ' B' ' 145' ' ' PRO . 99.2 m -123.95 153.17 67.47 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.196 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 145' ' ' PRO . . . . . 0.598 ' CD ' ' CG2' ' B' ' 144' ' ' THR . 1.3 Cg_endo -83.04 144.78 12.11 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.519 2.146 . . . . 0.0 112.006 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 146' ' ' GLY . . . . . 0.653 ' O ' ' HG3' ' A' ' 15' ' ' GLU . . . 157.3 -116.09 0.7 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.494 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.846 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -119.75 132.4 55.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.903 0.382 . . . . 0.0 111.316 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 148' ' ' ALA . . . . . 0.606 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -125.39 43.33 3.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.16 0.505 . . . . 0.0 110.417 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.563 ' HB2' ' HG3' ' B' ' 89' ' ' GLN . 1.1 m120 -95.65 150.88 19.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.573 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.512 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -168.49 -178.63 3.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.03 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.77 152.98 39.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.261 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 152' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -141.2 151.11 43.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.264 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.556 HG23 HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -112.69 133.75 54.56 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 154' ' ' PHE . . . . . 0.511 ' HB3' ' H ' ' A' ' 8' ' ' GLY . 0.1 OUTLIER -81.65 148.68 28.91 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.053 0.454 . . . . 0.0 110.158 -179.062 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 155' ' ' LYS . . . . . 0.555 ' HB3' ' CZ ' ' B' ' 118' ' ' PHE . 11.2 mmtt -135.03 139.49 44.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.928 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 156' ' ' VAL . . . . . 0.654 HG22 HG23 ' A' ' 5' ' ' VAL . 3.1 m -134.55 141.27 43.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.776 0.322 . . . . 0.0 111.698 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.537 ' HB3' ' HB3' ' B' ' 70' ' ' ALA . 3.9 tt0 -128.79 128.96 45.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.346 0.593 . . . . 0.0 110.353 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.72 128.62 51.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.583 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.841 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.261 0.077 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.4 88.97 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.004 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.19 114.48 18.39 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.436 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -97.26 119.19 35.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.644 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.635 HG23 HG22 ' D' ' 156' ' ' VAL . 19.5 m -136.56 158.26 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.63 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.15 115.99 22.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.578 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.66 -79.58 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.876 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 8' ' ' GLY . . . . . 0.512 ' H ' ' HB3' ' D' ' 154' ' ' PHE . . . -148.55 -145.97 4.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.898 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 9' ' ' THR . . . . . 0.564 HG22 HG23 ' D' ' 153' ' ' THR . 15.2 p -142.03 145.12 34.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.956 0.408 . . . . 0.0 111.32 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 32.0 t -127.82 119.53 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.26 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.43 113.17 25.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.391 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -95.75 90.66 5.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.792 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.1 120.73 32.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.357 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.04 170.48 32.63 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.918 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 15' ' ' GLU . . . . . 0.653 ' HG3' ' O ' ' D' ' 146' ' ' GLY . 21.4 tt0 -160.6 129.19 4.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.987 0.423 . . . . 0.0 110.368 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.778 HG13 HG13 ' D' ' 37' ' ' VAL . 2.2 t -89.66 136.91 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.246 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.767 ' O ' HG22 ' D' ' 39' ' ' THR . 34.3 m -136.35 -160.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.767 0.318 . . . . 0.0 111.147 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.98 177.01 6.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.998 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' D' ' 40' ' ' ALA . . . -90.16 49.59 1.73 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.038 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 20' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' C' ' 61' ' ' CYS . . . -122.16 -39.69 2.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.398 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 21' ' ' CYS . . . . . 0.707 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.5 OUTLIER -162.13 146.39 12.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.943 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.05 121.61 14.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.141 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' VAL . . . . . 0.616 ' HA ' ' HG ' ' C' ' 58' ' ' LEU . 2.4 p -63.67 143.5 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.049 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' C' ' 27' ' ' SER . 13.5 t70 -72.88 154.6 40.52 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.597 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -54.3 -53.88 47.84 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.345 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.56 1.03 88.71 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.874 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' SER . . . . . 0.572 ' HB2' ' HB3' ' C' ' 24' ' ' ASP . 7.9 t -99.3 -16.63 18.41 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.879 0.371 . . . . 0.0 110.842 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.445 HG23 ' O ' ' C' ' 25' ' ' ALA . 10.8 t -53.18 -50.83 44.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.35 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -114.07 126.19 54.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.98 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 30' ' ' GLN . . . . . 0.43 HE22 ' HA ' ' C' ' 56' ' ' ILE . 3.7 mt-30 -125.64 135.58 52.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.063 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.91 109.11 21.9 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.13 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.5 115.15 48.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.132 0.491 . . . . 0.0 110.464 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.17 124.73 50.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.667 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.26 -42.28 23.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.584 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.08 -165.39 12.15 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.583 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' GLN . . . . . 0.588 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 4.1 mt-30 -93.62 119.2 32.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.626 0.25 . . . . 0.0 110.841 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.809 HG13 HG13 ' B' ' 16' ' ' VAL . 8.2 p -104.86 133.95 47.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.897 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 38' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' C' ' 41' ' ' SER . 0.1 OUTLIER -79.9 137.65 36.95 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.689 179.271 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.753 HG22 ' O ' ' B' ' 17' ' ' VAL . 0.2 OUTLIER -62.51 -49.43 75.37 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.75 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' B' ' 19' ' ' ALA . . . -53.56 -33.48 54.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.994 0.426 . . . . 0.0 110.837 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' C' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.31 61.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.11 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.622 ' O ' ' HB2' ' C' ' 143' ' ' ALA . 0.6 OUTLIER -114.12 39.84 2.64 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.642 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.24 33.95 3.28 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.386 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 44' ' ' GLN . . . . . 0.672 ' HB2' ' HB2' ' C' ' 47' ' ' ALA . 0.3 OUTLIER -124.51 142.92 50.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.289 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.26 95.7 0.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.145 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.41 33.72 5.83 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.126 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' C' ' 44' ' ' GLN . . . -78.93 143.52 35.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.976 0.417 . . . . 0.0 111.928 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 48' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' C' ' 136' ' ' ARG . 18.1 p -131.63 131.94 43.62 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.884 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.532 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 1.3 m -103.82 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.524 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -57.76 141.86 47.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' ALA . . . . . 0.489 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . . . -99.03 125.48 44.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.379 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.77 HG22 ' O ' ' C' ' 135' ' ' ALA . 24.7 m -76.51 150.98 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.956 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.3 143.27 16.41 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.572 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' PHE . . . . . 0.408 ' HE2' ' HB3' ' C' ' 135' ' ' ALA . 37.5 p90 -171.49 140.45 1.39 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.771 0.319 . . . . 0.0 110.895 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -136.33 138.62 41.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.541 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.541 HG23 ' O ' ' C' ' 56' ' ' ILE . 0.7 OUTLIER -88.47 116.77 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.554 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.846 ' HA ' HG23 ' C' ' 130' ' ' THR . 5.0 mp0 -69.33 138.29 53.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.794 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 58' ' ' LEU . . . . . 0.635 ' HB3' ' SG ' ' C' ' 21' ' ' CYS . 0.3 OUTLIER -145.62 91.65 2.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.281 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 59' ' ' ASN . . . . . 0.521 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 4.1 p-10 -78.46 176.86 8.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.946 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.81 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 61' ' ' CYS . . . . . 0.707 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 10.4 m -133.87 147.74 51.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.798 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.67 161.92 20.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.341 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.633 HG23 ' HA ' ' C' ' 125' ' ' ASN . 0.0 OUTLIER -111.77 -34.19 6.1 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -72.59 -28.14 62.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.045 0.45 . . . . 0.0 111.725 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -73.15 -58.55 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.733 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.21 126.07 32.64 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.58 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.33 -42.19 7.1 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.964 0.411 . . . . 0.0 110.938 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 68' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' C' ' 68' ' ' LYS . 1.2 tptp -89.22 156.85 18.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.502 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.64 ' HB3' ' HB ' ' C' ' 122' ' ' THR . . . -146.65 133.18 19.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.596 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.602 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -113.31 155.11 25.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.165 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 71' ' ' VAL . . . . . 0.752 HG11 HG21 ' C' ' 131' ' ' ILE . 2.0 t -136.4 148.54 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.7 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 72' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' C' ' 155' ' ' LYS . . . -152.88 163.49 39.68 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.579 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 73' ' ' PHE . . . . . 0.438 ' CD1' ' HB1' ' C' ' 152' ' ' ALA . 0.2 OUTLIER -130.24 142.28 50.57 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.468 0.175 . . . . 0.0 111.197 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' C' ' 152' ' ' ALA . 1.4 tt -109.17 119.04 38.33 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.052 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 75' ' ' GLY . . . . . 0.83 ' HA3' HD22 ' C' ' 113' ' ' LEU . . . -162.74 -161.82 12.79 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.736 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.631 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.3 OUTLIER -121.04 162.91 19.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.624 0.25 . . . . 0.0 110.762 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 77' ' ' ALA . . . . . 0.7 ' O ' ' HB2' ' C' ' 87' ' ' ALA . . . -83.54 139.08 33.1 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.933 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 78' ' ' ILE . . . . . 0.542 HG23 ' N ' ' C' ' 79' ' ' ASP . 11.1 tt -66.08 -47.59 84.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.94 0.4 . . . . 0.0 111.007 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 79' ' ' ASP . . . . . 0.542 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.2 OUTLIER -134.45 46.62 2.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.862 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 80' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' F' ' 105' ' ' ASP . . . 64.49 -84.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.075 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.75 -36.39 40.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.61 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.5 69.24 10.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.924 0.393 . . . . 0.0 110.51 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 83' ' ' THR . . . . . 0.484 HG23 ' HB2' ' C' ' 77' ' ' ALA . 0.2 OUTLIER -74.13 -7.49 52.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.51 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 84' ' ' ASN . . . . . 0.621 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 30.0 p-10 -74.7 -25.4 59.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.36 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.612 HG11 ' HB3' ' C' ' 138' ' ' PHE . 6.4 t -104.92 143.81 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.148 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.596 ' HG ' HD13 ' C' ' 113' ' ' LEU . 0.3 OUTLIER -74.78 160.88 30.16 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.308 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' C' ' 77' ' ' ALA . . . -103.67 179.87 4.15 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.897 0.379 . . . . 0.0 111.685 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.708 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 1.3 mm? -66.58 171.29 5.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 89' ' ' GLN . . . . . 0.536 ' HG3' ' HB2' ' C' ' 149' ' ' ASN . 1.3 mm-40 -68.61 -83.74 0.03 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.279 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 90' ' ' SER . . . . . 0.413 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 5.9 p -169.08 19.14 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.941 0.4 . . . . 0.0 111.426 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 91' ' ' SER . . . . . 0.537 ' HA ' ' HB2' ' E' ' 25' ' ' ALA . 3.3 m -90.15 86.26 6.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.897 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 92' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' F' ' 50' ' ' SER . . . -61.13 -25.01 66.69 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.637 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.39 41.22 3.53 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.669 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.0 0.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.87 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 95' ' ' SER . . . . . 0.834 ' HA ' ' HB3' ' C' ' 147' ' ' ALA . 1.9 m -89.24 -173.58 4.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.813 0.34 . . . . 0.0 110.691 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 96' ' ' ALA . . . . . 0.409 ' HB3' HD11 ' C' ' 88' ' ' LEU . . . -100.98 -177.25 3.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 3.0 m -131.11 123.96 29.73 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.303 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.17 29.46 18.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.467 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 1.7 t -125.32 129.35 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.818 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.84 -171.04 21.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.508 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 101' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' C' ' 86' ' ' LEU . 1.9 p -122.97 116.73 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.213 0.53 . . . . 0.0 111.679 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 102' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 3.9 tt0 -81.75 151.42 27.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.936 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.8 123.81 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.563 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 104' ' ' LEU . . . . . 0.508 HD13 ' OE1' ' C' ' 134' ' ' GLN . 0.5 OUTLIER -104.69 125.17 50.53 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.638 0.256 . . . . 0.0 111.002 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 105' ' ' ASP . . . . . 0.799 ' HB3' HG22 ' C' ' 107' ' ' THR . 13.6 t0 -77.58 143.05 38.62 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.695 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 106' ' ' ARG . . . . . 0.712 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -62.64 -14.94 49.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.757 0.313 . . . . 0.0 111.063 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 107' ' ' THR . . . . . 0.799 HG22 ' HB3' ' C' ' 105' ' ' ASP . 8.8 t -62.96 -20.97 65.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.27 -43.58 1.36 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.727 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.71 160.71 14.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.789 0.328 . . . . 0.0 111.08 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.37 133.16 40.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.085 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 111' ' ' LEU . . . . . 0.667 ' HB2' ' HB2' ' C' ' 105' ' ' ASP . 12.3 tp -95.5 160.94 14.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.378 0.608 . . . . 0.0 110.554 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 112' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 2.9 t -110.22 136.79 48.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.068 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.83 HD22 ' HA3' ' C' ' 75' ' ' GLY . 1.4 mt -70.22 89.61 0.65 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.751 0.31 . . . . 0.0 110.685 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.34 -18.44 6.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.472 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.32 -62.24 0.87 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.683 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 116' ' ' ALA . . . . . 0.564 ' HB3' ' OD1' ' F' ' 129' ' ' ASN . . . -92.94 18.21 9.45 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 121.042 0.448 . . . . 0.0 111.696 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 117' ' ' THR . . . . . 0.545 HG21 HG23 ' C' ' 112' ' ' THR . 0.0 OUTLIER -83.98 72.59 10.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.049 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 118' ' ' PHE . . . . . 0.602 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . 78.1 m-85 -92.37 89.75 6.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.765 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 55.1 m -130.54 73.12 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.938 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.22 142.28 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.651 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -103.98 68.51 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.199 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -81.43 133.13 35.36 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.71 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 8.6 m -87.6 124.12 33.18 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.697 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.3 119.29 35.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.655 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 125' ' ' ASN . . . . . 0.633 ' HA ' HG23 ' C' ' 63' ' ' THR . 2.9 m120 -113.69 171.9 7.3 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.586 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.48 109.72 16.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.618 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.85 -133.79 4.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.714 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 128' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 46.4 m -110.52 86.78 2.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.722 0.296 . . . . 0.0 110.779 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 129' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.38 155.06 41.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.866 0.365 . . . . 0.0 111.143 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 130' ' ' THR . . . . . 0.846 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -142.79 137.09 29.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.086 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 131' ' ' ILE . . . . . 0.752 HG21 HG11 ' C' ' 71' ' ' VAL . 6.9 mt -100.3 109.13 55.81 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 132' ' ' PRO . . . . . 0.712 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.5 Cg_endo -81.76 148.25 15.68 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.668 1.579 . . . . 0.0 112.546 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' C' ' 105' ' ' ASP . 0.5 OUTLIER -158.81 145.27 17.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.933 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 134' ' ' GLN . . . . . 0.508 ' OE1' HD13 ' C' ' 104' ' ' LEU . 4.1 mt-30 -111.23 160.41 17.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.052 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 135' ' ' ALA . . . . . 0.77 ' O ' HG22 ' C' ' 52' ' ' VAL . . . -155.97 97.81 1.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.945 0.402 . . . . 0.0 111.609 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.495 ' HD2' ' HB ' ' C' ' 48' ' ' THR . 14.4 ptt180 -101.57 173.59 6.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.4 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 137' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 1.8 m-85 -83.66 135.04 34.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.121 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 138' ' ' PHE . . . . . 0.612 ' HB3' HG11 ' C' ' 85' ' ' VAL . 1.8 t80 -128.86 128.16 43.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.235 0.541 . . . . 0.0 112.01 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 139' ' ' ALA . . . . . 0.473 ' HB2' HD23 ' C' ' 42' ' ' LEU . . . -108.5 138.01 45.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.83 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 140' ' ' THR . . . . . 0.542 HG21 ' HB2' ' C' ' 79' ' ' ASP . 0.3 OUTLIER -90.0 -9.54 48.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.458 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.3 -95.25 0.1 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.0 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.74 101.49 11.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.51 0.195 . . . . 0.0 110.704 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 143' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' C' ' 42' ' ' LEU . . . -61.36 144.36 54.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.758 0.313 . . . . 0.0 111.368 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 144' ' ' THR . . . . . 0.597 ' CG2' ' CD ' ' C' ' 145' ' ' PRO . 99.2 m -123.96 153.14 67.5 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.211 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 145' ' ' PRO . . . . . 0.597 ' CD ' ' CG2' ' C' ' 144' ' ' THR . 1.3 Cg_endo -82.99 144.78 12.17 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.49 2.127 . . . . 0.0 111.999 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 146' ' ' GLY . . . . . 0.642 ' O ' ' HG3' ' B' ' 15' ' ' GLU . . . 157.3 -116.09 0.7 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.468 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 147' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -119.72 132.37 55.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 111.387 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 148' ' ' ALA . . . . . 0.634 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -125.38 43.36 3.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.136 0.493 . . . . 0.0 110.383 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 149' ' ' ASN . . . . . 0.536 ' HB2' ' HG3' ' C' ' 89' ' ' GLN . 1.1 m120 -95.68 150.86 19.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.635 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 150' ' ' ALA . . . . . 0.506 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -168.45 -178.65 3.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.012 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.76 153.0 39.71 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.274 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 152' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -141.21 151.12 43.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.243 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 153' ' ' THR . . . . . 0.561 HG23 HG22 ' B' ' 9' ' ' THR . 0.2 OUTLIER -112.69 133.76 54.55 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 154' ' ' PHE . . . . . 0.514 ' HB3' ' H ' ' B' ' 8' ' ' GLY . 0.1 OUTLIER -81.71 148.68 28.84 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.036 0.446 . . . . 0.0 110.136 -179.05 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 155' ' ' LYS . . . . . 0.556 ' HB3' ' CZ ' ' C' ' 118' ' ' PHE . 11.2 mmtt -135.01 139.43 44.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.945 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 156' ' ' VAL . . . . . 0.654 HG22 HG23 ' B' ' 5' ' ' VAL . 3.1 m -134.52 141.3 43.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.82 0.343 . . . . 0.0 111.685 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 157' ' ' GLN . . . . . 0.559 ' HB3' ' HB3' ' C' ' 70' ' ' ALA . 3.9 tt0 -128.78 129.0 45.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.326 0.584 . . . . 0.0 110.34 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.7 128.6 51.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.563 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.834 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.331 0.11 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.41 88.94 0.04 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.567 0.222 . . . . 0.0 111.024 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.16 114.54 18.49 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.378 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -97.35 119.2 35.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.638 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.632 HG23 HG22 ' E' ' 156' ' ' VAL . 19.5 m -136.6 158.24 37.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.582 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.12 115.95 22.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.626 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.66 -79.57 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.876 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 8' ' ' GLY . . . . . 0.507 ' H ' ' HB3' ' E' ' 154' ' ' PHE . . . -148.55 -145.94 4.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.892 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 9' ' ' THR . . . . . 0.569 HG22 HG23 ' E' ' 153' ' ' THR . 15.0 p -142.05 145.11 33.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.028 0.442 . . . . 0.0 111.238 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 32.6 t -127.8 119.49 51.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.259 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -92.42 113.19 25.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.387 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.76 90.65 5.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.08 120.74 32.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.297 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.07 170.46 32.64 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.901 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 15' ' ' GLU . . . . . 0.656 ' HG3' ' O ' ' E' ' 146' ' ' GLY . 21.4 tt0 -160.59 129.23 4.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.98 0.419 . . . . 0.0 110.382 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.818 HG13 HG13 ' E' ' 37' ' ' VAL . 2.2 t -89.67 136.92 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.233 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.763 ' O ' HG22 ' E' ' 39' ' ' THR . 34.3 m -136.35 -160.77 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.77 0.319 . . . . 0.0 111.162 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.93 176.98 6.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.009 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 19' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' E' ' 40' ' ' ALA . . . -90.18 49.63 1.73 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.085 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' D' ' 61' ' ' CYS . . . -122.18 -39.65 2.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.403 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 21' ' ' CYS . . . . . 0.641 ' SG ' ' HB3' ' D' ' 58' ' ' LEU . 0.5 OUTLIER -162.17 146.35 12.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.946 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.97 121.68 14.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' VAL . . . . . 0.636 ' HA ' ' HG ' ' D' ' 58' ' ' LEU . 2.5 p -63.75 143.51 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' D' ' 27' ' ' SER . 13.6 t70 -72.97 154.64 40.44 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.549 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -54.3 -53.89 47.65 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.336 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.54 1.03 88.67 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.911 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' SER . . . . . 0.557 ' HB2' ' HB3' ' D' ' 24' ' ' ASP . 7.9 t -99.28 -16.66 18.41 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.873 0.368 . . . . 0.0 110.829 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 28' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 25' ' ' ALA . 10.9 t -53.19 -50.81 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.338 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -114.12 126.15 54.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.987 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 30' ' ' GLN . . . . . 0.415 HE22 ' HA ' ' D' ' 56' ' ' ILE . 3.7 mt-30 -125.58 135.58 52.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.063 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.93 109.17 21.95 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.132 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.57 115.13 48.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.144 0.497 . . . . 0.0 110.458 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.17 124.73 50.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.671 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.24 -42.29 23.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.62 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.08 -165.38 12.15 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.574 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 36' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 4.1 mt-30 -93.62 119.23 32.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.635 0.255 . . . . 0.0 110.83 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.778 HG13 HG13 ' C' ' 16' ' ' VAL . 8.2 p -104.92 133.95 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.884 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 38' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' D' ' 38' ' ' ARG . 0.1 OUTLIER -79.96 137.66 36.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.628 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.767 HG22 ' O ' ' C' ' 17' ' ' VAL . 0.2 OUTLIER -62.52 -49.39 75.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.764 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' C' ' 19' ' ' ALA . . . -53.53 -33.5 54.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.051 0.453 . . . . 0.0 110.85 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' D' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.38 61.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.116 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' D' ' 143' ' ' ALA . 0.6 OUTLIER -114.01 39.79 2.63 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.662 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.22 33.94 3.28 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.391 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 44' ' ' GLN . . . . . 0.67 ' HB2' ' HB2' ' D' ' 47' ' ' ALA . 0.3 OUTLIER -124.46 142.88 50.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.323 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.2 95.67 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.0 111.138 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.37 33.72 5.84 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.152 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.67 ' HB2' ' HB2' ' D' ' 44' ' ' GLN . . . -78.94 143.56 35.68 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.991 0.424 . . . . 0.0 111.955 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 48' ' ' THR . . . . . 0.507 ' HB ' ' HD2' ' D' ' 136' ' ' ARG . 18.2 p -131.64 131.96 43.62 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.869 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 1.3 m -103.82 -167.2 1.34 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.541 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.502 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 3.9 t -57.77 141.92 47.19 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.872 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 51' ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' D' ' 136' ' ' ARG . . . -99.06 125.5 44.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.369 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 52' ' ' VAL . . . . . 0.762 HG22 ' O ' ' D' ' 135' ' ' ALA . 24.8 m -76.53 150.96 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.953 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.26 143.26 16.39 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.598 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.402 ' HE2' ' HB3' ' D' ' 135' ' ' ALA . 37.5 p90 -171.48 140.42 1.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.796 0.331 . . . . 0.0 110.972 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 55' ' ' ASN . . . . . 0.46 ' HB3' HG23 ' A' ' 76' ' ' THR . 17.0 p30 -136.3 138.58 41.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.603 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.535 HG23 ' O ' ' D' ' 56' ' ' ILE . 0.7 OUTLIER -88.38 116.76 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.588 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 57' ' ' GLN . . . . . 0.841 ' HA ' HG23 ' D' ' 130' ' ' THR . 5.0 mp0 -69.35 138.32 53.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.78 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 58' ' ' LEU . . . . . 0.641 ' HB3' ' SG ' ' D' ' 21' ' ' CYS . 0.3 OUTLIER -145.62 91.69 2.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.292 -179.667 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 59' ' ' ASN . . . . . 0.527 ' HA ' HG23 ' D' ' 128' ' ' THR . 4.1 p-10 -78.39 176.86 8.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.906 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.9 81.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.798 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 61' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 10.4 m -133.82 147.77 51.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.798 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.67 161.92 20.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.328 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.632 HG23 ' HA ' ' D' ' 125' ' ' ASN . 0.0 OUTLIER -111.76 -34.2 6.1 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.088 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -72.57 -28.14 62.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.017 0.437 . . . . 0.0 111.72 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 59.4 t -73.25 -58.47 4.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.696 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.17 126.06 32.7 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.571 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.4 -42.08 7.13 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.955 0.407 . . . . 0.0 110.964 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.29 156.85 18.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.457 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 69' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' D' ' 122' ' ' THR . . . -146.66 133.21 19.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.556 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 70' ' ' ALA . . . . . 0.605 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -113.34 155.12 25.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.144 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 71' ' ' VAL . . . . . 0.775 HG11 HG21 ' D' ' 131' ' ' ILE . 2.0 t -136.41 148.56 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.641 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 72' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' D' ' 155' ' ' LYS . . . -152.87 163.5 39.64 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.573 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 73' ' ' PHE . . . . . 0.428 ' CD1' ' HB1' ' D' ' 152' ' ' ALA . 0.2 OUTLIER -130.26 142.31 50.56 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 122.4 -0.187 . . . . 0.0 111.161 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 74' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 1.4 tt -109.21 119.04 38.3 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.071 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 75' ' ' GLY . . . . . 0.828 ' HA3' HD22 ' D' ' 113' ' ' LEU . . . -162.72 -161.88 12.86 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.786 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 76' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.3 OUTLIER -120.97 162.91 19.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.545 0.212 . . . . 0.0 110.78 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' D' ' 87' ' ' ALA . . . -83.55 139.06 33.11 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.967 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 78' ' ' ILE . . . . . 0.54 HG23 ' N ' ' D' ' 79' ' ' ASP . 11.1 tt -66.05 -47.63 84.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.948 0.404 . . . . 0.0 111.003 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.54 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.2 OUTLIER -134.44 46.68 2.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.813 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.47 -83.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.072 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.78 -36.39 41.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.62 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.42 69.25 10.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.375 . . . . 0.0 110.546 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 83' ' ' THR . . . . . 0.488 HG23 ' HB2' ' D' ' 77' ' ' ALA . 0.2 OUTLIER -74.12 -7.52 52.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.544 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 84' ' ' ASN . . . . . 0.626 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 30.1 p-10 -74.71 -25.4 59.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.332 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.605 HG11 ' HB3' ' D' ' 138' ' ' PHE . 6.4 t -104.91 143.85 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.161 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.61 ' HG ' HD13 ' D' ' 113' ' ' LEU . 0.3 OUTLIER -74.8 160.88 30.14 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.31 179.433 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' D' ' 77' ' ' ALA . . . -103.62 179.85 4.15 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.857 0.36 . . . . 0.0 111.739 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.724 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 1.3 mm? -66.59 171.3 5.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.071 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 89' ' ' GLN . . . . . 0.561 ' HG3' ' HB2' ' D' ' 149' ' ' ASN . 1.3 mm-40 -68.57 -83.76 0.03 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.25 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.14 19.17 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.937 0.399 . . . . 0.0 111.447 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 91' ' ' SER . . . . . 0.541 ' HA ' ' HB2' ' F' ' 25' ' ' ALA . 3.3 m -90.16 86.24 6.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.927 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.16 -24.98 66.7 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.598 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.37 41.25 3.52 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.686 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.01 0.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.866 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 95' ' ' SER . . . . . 0.851 ' HA ' ' HB3' ' D' ' 147' ' ' ALA . 1.9 m -89.24 -173.57 4.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.751 0.31 . . . . 0.0 110.724 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 96' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' D' ' 88' ' ' LEU . . . -101.0 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.849 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 97' ' ' THR . . . . . 0.411 ' O ' HG23 ' D' ' 99' ' ' VAL . 3.0 m -131.1 123.87 29.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.319 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.26 29.44 18.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.444 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 99' ' ' VAL . . . . . 0.411 HG23 ' O ' ' D' ' 97' ' ' THR . 1.7 t -125.34 129.32 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.822 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.87 -171.11 21.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.522 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 101' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' D' ' 86' ' ' LEU . 1.9 p -122.96 116.74 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.256 0.55 . . . . 0.0 111.694 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 102' ' ' GLN . . . . . 0.557 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 3.9 tt0 -81.76 151.43 27.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.915 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.79 123.82 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.575 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 104' ' ' LEU . . . . . 0.536 HD22 ' HB2' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -104.73 125.19 50.57 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.661 0.267 . . . . 0.0 110.986 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 105' ' ' ASP . . . . . 0.81 ' HB3' HG22 ' D' ' 107' ' ' THR . 13.6 t0 -77.61 143.12 38.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.693 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 106' ' ' ARG . . . . . 0.694 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -62.72 -14.93 50.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.748 0.308 . . . . 0.0 111.029 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 107' ' ' THR . . . . . 0.81 HG22 ' HB3' ' D' ' 105' ' ' ASP . 8.8 t -62.98 -20.95 65.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.013 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.25 -43.54 1.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.735 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.72 160.7 14.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.83 0.348 . . . . 0.0 111.093 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.33 133.18 40.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 111' ' ' LEU . . . . . 0.667 ' HB2' ' HB2' ' D' ' 105' ' ' ASP . 12.3 tp -95.53 160.91 14.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.397 0.618 . . . . 0.0 110.477 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 112' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 2.9 t -110.23 136.79 48.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.046 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 113' ' ' LEU . . . . . 0.828 HD22 ' HA3' ' D' ' 75' ' ' GLY . 1.4 mt -70.2 89.55 0.65 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.702 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.29 -18.44 6.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.515 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.31 -62.28 0.87 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.619 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.93 18.26 9.37 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.958 0.408 . . . . 0.0 111.638 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 117' ' ' THR . . . . . 0.546 HG21 HG23 ' D' ' 112' ' ' THR . 0.0 OUTLIER -83.98 72.57 10.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.605 ' HB3' ' HB1' ' D' ' 70' ' ' ALA . 78.1 m-85 -92.35 89.75 6.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.792 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 55.5 m -130.55 73.19 1.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.86 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.24 142.3 21.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.695 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.95 68.51 0.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.208 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.639 ' HB ' ' HB3' ' D' ' 69' ' ' ALA . 0.0 OUTLIER -81.45 133.11 35.36 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.722 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 8.5 m -87.51 124.1 33.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.77 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.3 119.27 35.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.677 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 125' ' ' ASN . . . . . 0.632 ' HA ' HG23 ' D' ' 63' ' ' THR . 2.9 m120 -113.66 171.91 7.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.599 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.47 109.75 16.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.648 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.8 -133.78 4.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.705 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 128' ' ' THR . . . . . 0.533 ' HB ' ' HE3' ' A' ' 155' ' ' LYS . 46.5 m -110.54 86.77 2.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.731 0.3 . . . . 0.0 110.757 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 129' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' A' ' 116' ' ' ALA . 1.1 t30 -69.36 155.07 41.04 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.825 0.345 . . . . 0.0 111.199 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 130' ' ' THR . . . . . 0.841 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.2 OUTLIER -142.8 137.08 29.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.066 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 131' ' ' ILE . . . . . 0.775 HG21 HG11 ' D' ' 71' ' ' VAL . 6.9 mt -100.26 109.13 55.7 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 132' ' ' PRO . . . . . 0.694 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.5 Cg_endo -81.78 148.29 15.66 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.673 1.582 . . . . 0.0 112.526 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 133' ' ' PHE . . . . . 0.411 ' CZ ' ' HA ' ' D' ' 105' ' ' ASP . 0.5 OUTLIER -158.85 145.28 16.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.913 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 134' ' ' GLN . . . . . 0.511 ' OE1' HD13 ' D' ' 104' ' ' LEU . 4.1 mt-30 -111.23 160.4 17.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.041 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.762 ' O ' HG22 ' D' ' 52' ' ' VAL . . . -155.99 97.82 1.84 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.96 0.41 . . . . 0.0 111.629 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 136' ' ' ARG . . . . . 0.507 ' HD2' ' HB ' ' D' ' 48' ' ' THR . 14.4 ptt180 -101.57 173.64 6.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.417 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 137' ' ' TYR . . . . . 0.55 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 1.8 m-85 -83.64 135.01 34.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.142 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 138' ' ' PHE . . . . . 0.605 ' HB3' HG11 ' D' ' 85' ' ' VAL . 1.8 t80 -128.85 128.21 43.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.283 0.563 . . . . 0.0 112.013 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 139' ' ' ALA . . . . . 0.458 ' HB2' HD23 ' D' ' 42' ' ' LEU . . . -108.54 137.99 45.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.874 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 140' ' ' THR . . . . . 0.538 HG21 ' HB2' ' D' ' 79' ' ' ASP . 0.3 OUTLIER -89.93 -9.57 48.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.48 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.31 -95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.999 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.74 101.5 11.33 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.526 0.203 . . . . 0.0 110.708 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 143' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' D' ' 42' ' ' LEU . . . -61.35 144.35 54.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.752 0.311 . . . . 0.0 111.395 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 144' ' ' THR . . . . . 0.594 ' CG2' ' CD ' ' D' ' 145' ' ' PRO . 99.2 m -123.96 153.15 67.5 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.217 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 145' ' ' PRO . . . . . 0.594 ' CD ' ' CG2' ' D' ' 144' ' ' THR . 1.3 Cg_endo -82.97 144.71 12.17 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.56 2.173 . . . . 0.0 111.987 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 146' ' ' GLY . . . . . 0.653 ' O ' ' HG3' ' C' ' 15' ' ' GLU . . . 157.32 -116.1 0.7 Allowed Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.479 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 147' ' ' ALA . . . . . 0.851 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -119.71 132.38 55.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.376 . . . . 0.0 111.37 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 148' ' ' ALA . . . . . 0.627 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -125.37 43.37 3.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.397 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 149' ' ' ASN . . . . . 0.561 ' HB2' ' HG3' ' D' ' 89' ' ' GLN . 1.1 m120 -95.68 150.86 19.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.593 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 150' ' ' ALA . . . . . 0.507 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -168.45 -178.64 3.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.987 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.77 152.98 39.68 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.251 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 152' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -141.2 151.1 43.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.257 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 153' ' ' THR . . . . . 0.564 HG23 HG22 ' C' ' 9' ' ' THR . 0.2 OUTLIER -112.63 133.7 54.53 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 154' ' ' PHE . . . . . 0.512 ' HB3' ' H ' ' C' ' 8' ' ' GLY . 0.1 OUTLIER -81.68 148.73 28.85 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.07 0.462 . . . . 0.0 110.137 -179.043 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 155' ' ' LYS . . . . . 0.55 ' HB3' ' CZ ' ' D' ' 118' ' ' PHE . 11.2 mmtt -135.06 139.45 44.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.924 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 156' ' ' VAL . . . . . 0.635 HG22 HG23 ' C' ' 5' ' ' VAL . 3.1 m -134.53 141.3 43.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.783 0.325 . . . . 0.0 111.687 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 157' ' ' GLN . . . . . 0.531 ' HB3' ' HB3' ' D' ' 70' ' ' ALA . 3.8 tt0 -128.78 128.97 45.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.31 0.576 . . . . 0.0 110.363 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.73 128.58 51.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.552 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.85 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.281 0.086 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.37 88.93 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.028 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.14 114.5 18.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.446 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -97.29 119.17 35.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.685 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.647 HG23 HG22 ' F' ' 156' ' ' VAL . 19.6 m -136.56 158.25 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.605 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.13 116.01 22.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.59 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.74 -79.55 0.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.846 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 8' ' ' GLY . . . . . 0.501 ' H ' ' HB3' ' F' ' 154' ' ' PHE . . . -148.56 -145.96 4.24 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.882 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 9' ' ' THR . . . . . 0.565 HG22 HG23 ' F' ' 153' ' ' THR . 15.2 p -141.99 145.15 34.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.963 0.411 . . . . 0.0 111.302 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 32.5 t -127.83 119.49 51.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.262 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.4 113.16 25.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.374 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.76 90.66 5.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.814 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.08 120.74 32.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.342 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.06 170.53 32.65 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.933 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 15' ' ' GLU . . . . . 0.652 ' HG3' ' O ' ' F' ' 146' ' ' GLY . 21.4 tt0 -160.62 129.19 4.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 110.333 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 16' ' ' VAL . . . . . 0.784 HG13 HG13 ' F' ' 37' ' ' VAL . 2.2 t -89.66 136.92 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.25 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 17' ' ' VAL . . . . . 0.758 ' O ' HG22 ' F' ' 39' ' ' THR . 34.3 m -136.35 -160.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.774 0.321 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.95 177.01 6.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.03 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 19' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' F' ' 40' ' ' ALA . . . -90.15 49.64 1.73 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' E' ' 61' ' ' CYS . . . -122.16 -39.73 2.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.384 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 21' ' ' CYS . . . . . 0.644 ' SG ' ' HB3' ' E' ' 58' ' ' LEU . 0.5 OUTLIER -162.09 146.41 12.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.905 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.05 121.6 14.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.104 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 23' ' ' VAL . . . . . 0.621 ' HA ' ' HG ' ' E' ' 58' ' ' LEU . 2.5 p -63.68 143.52 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 24' ' ' ASP . . . . . 0.563 ' HB3' ' HB2' ' E' ' 27' ' ' SER . 13.5 t70 -72.92 154.61 40.49 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.595 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 25' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -54.32 -53.83 48.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.358 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.59 1.03 88.75 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.875 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 27' ' ' SER . . . . . 0.563 ' HB2' ' HB3' ' E' ' 24' ' ' ASP . 7.9 t -99.28 -16.67 18.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.891 0.376 . . . . 0.0 110.849 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 28' ' ' VAL . . . . . 0.446 HG23 ' O ' ' E' ' 25' ' ' ALA . 10.9 t -53.18 -50.82 44.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.329 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -114.13 126.17 54.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.987 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 30' ' ' GLN . . . . . 0.433 HE22 ' HA ' ' E' ' 56' ' ' ILE . 3.7 mt-30 -125.6 135.56 52.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.062 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.92 109.14 21.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.1 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.55 115.11 48.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.11 0.481 . . . . 0.0 110.435 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.15 124.75 50.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.66 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.21 -42.33 23.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.624 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.1 -165.39 12.15 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.592 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 36' ' ' GLN . . . . . 0.602 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 4.0 mt-30 -93.61 119.2 32.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.642 0.258 . . . . 0.0 110.837 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.818 HG13 HG13 ' D' ' 16' ' ' VAL . 8.2 p -104.89 133.94 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.856 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 38' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' E' ' 38' ' ' ARG . 0.1 OUTLIER -79.9 137.65 36.95 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.694 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 39' ' ' THR . . . . . 0.763 HG22 ' O ' ' D' ' 17' ' ' VAL . 0.2 OUTLIER -62.55 -49.39 75.49 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.747 179.465 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' D' ' 19' ' ' ALA . . . -53.55 -33.47 54.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.0 0.428 . . . . 0.0 110.857 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 41' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' E' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.33 61.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.113 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.606 ' O ' ' HB2' ' E' ' 143' ' ' ALA . 0.6 OUTLIER -114.09 39.83 2.64 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.617 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.28 33.96 3.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.385 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 44' ' ' GLN . . . . . 0.664 ' HB2' ' HB2' ' E' ' 47' ' ' ALA . 0.3 OUTLIER -124.47 142.85 51.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.346 179.541 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.24 95.73 0.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.896 0.379 . . . . 0.0 111.156 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.35 33.71 5.84 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.191 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 47' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' E' ' 44' ' ' GLN . . . -78.9 143.51 35.81 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 111.968 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 48' ' ' THR . . . . . 0.492 ' HB ' ' HD2' ' E' ' 136' ' ' ARG . 18.1 p -131.62 131.97 43.65 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.882 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 1.3 m -103.8 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.556 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 50' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 3.9 t -57.83 141.9 47.51 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.853 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 51' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' E' ' 136' ' ' ARG . . . -99.05 125.53 44.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.426 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 52' ' ' VAL . . . . . 0.764 HG22 ' O ' ' E' ' 135' ' ' ALA . 24.7 m -76.51 150.95 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.27 143.26 16.39 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.588 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -171.49 140.46 1.39 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.821 0.343 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 55' ' ' ASN . . . . . 0.458 ' HB3' HG23 ' B' ' 76' ' ' THR . 17.0 p30 -136.32 138.59 41.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.598 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 56' ' ' ILE . . . . . 0.538 HG23 ' O ' ' E' ' 56' ' ' ILE . 0.7 OUTLIER -88.43 116.76 30.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.568 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 57' ' ' GLN . . . . . 0.839 ' HA ' HG23 ' E' ' 130' ' ' THR . 5.0 mp0 -69.35 138.3 53.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.787 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 58' ' ' LEU . . . . . 0.644 ' HB3' ' SG ' ' E' ' 21' ' ' CYS . 0.3 OUTLIER -145.57 91.62 2.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.284 -179.602 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 59' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 4.1 p-10 -78.4 176.83 8.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.943 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 61' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' E' ' 20' ' ' ALA . 10.4 m -133.84 147.78 51.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.796 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.68 161.94 20.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.328 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 63' ' ' THR . . . . . 0.639 HG23 ' HA ' ' E' ' 125' ' ' ASN . 0.0 OUTLIER -111.79 -34.2 6.09 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.082 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -72.56 -28.15 62.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.008 0.433 . . . . 0.0 111.704 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.19 -58.55 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.667 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.21 126.05 32.61 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.567 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.38 -42.08 7.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.972 0.415 . . . . 0.0 110.968 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.31 156.83 18.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.456 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 69' ' ' ALA . . . . . 0.654 ' HB3' ' HB ' ' E' ' 122' ' ' THR . . . -146.61 133.21 19.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.572 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 70' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -113.33 155.11 25.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.156 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 71' ' ' VAL . . . . . 0.793 HG11 HG21 ' E' ' 131' ' ' ILE . 2.0 t -136.39 148.6 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.655 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 72' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' E' ' 155' ' ' LYS . . . -152.93 163.51 39.66 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.563 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 73' ' ' PHE . . . . . 0.442 ' CD1' ' HB1' ' E' ' 152' ' ' ALA . 0.2 OUTLIER -130.25 142.24 50.57 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 122.408 -0.183 . . . . 0.0 111.179 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 74' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 1.4 tt -109.21 119.08 38.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.053 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 75' ' ' GLY . . . . . 0.819 ' HA3' HD22 ' E' ' 113' ' ' LEU . . . -162.72 -161.89 12.87 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.777 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 76' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.3 OUTLIER -120.95 162.94 19.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.605 0.241 . . . . 0.0 110.773 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 77' ' ' ALA . . . . . 0.694 ' O ' ' HB2' ' E' ' 87' ' ' ALA . . . -83.55 139.07 33.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.955 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 78' ' ' ILE . . . . . 0.539 HG23 ' N ' ' E' ' 79' ' ' ASP . 11.1 tt -66.09 -47.6 84.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.979 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 79' ' ' ASP . . . . . 0.544 ' HB2' HG21 ' E' ' 140' ' ' THR . 0.2 OUTLIER -134.5 46.68 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.847 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.54 -84.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.74 -36.43 40.75 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.609 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.44 69.26 10.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.891 0.377 . . . . 0.0 110.547 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 83' ' ' THR . . . . . 0.476 HG23 ' HB2' ' E' ' 77' ' ' ALA . 0.2 OUTLIER -74.15 -7.44 52.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.528 -179.45 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 84' ' ' ASN . . . . . 0.605 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 30.0 p-10 -74.77 -25.4 59.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.336 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.613 HG11 ' HB3' ' E' ' 138' ' ' PHE . 6.4 t -104.88 143.86 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.188 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 86' ' ' LEU . . . . . 0.593 ' HG ' HD13 ' E' ' 113' ' ' LEU . 0.3 OUTLIER -74.82 160.86 30.15 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.292 179.477 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 87' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' E' ' 77' ' ' ALA . . . -103.61 179.87 4.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.907 0.384 . . . . 0.0 111.725 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.712 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 1.3 mm? -66.6 171.28 5.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 89' ' ' GLN . . . . . 0.555 ' HG3' ' HB2' ' E' ' 149' ' ' ASN . 1.3 mm-40 -68.55 -83.78 0.03 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.253 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.09 19.13 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.935 0.398 . . . . 0.0 111.44 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 91' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' E' ' 95' ' ' SER . 3.2 m -90.15 86.23 6.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.09 -25.02 66.66 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.66 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.39 41.26 3.52 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.66 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.99 0.72 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.872 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 95' ' ' SER . . . . . 0.853 ' HA ' ' HB3' ' E' ' 147' ' ' ALA . 1.9 m -89.3 -173.57 4.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 110.722 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 96' ' ' ALA . . . . . 0.419 ' HB3' HD11 ' E' ' 88' ' ' LEU . . . -100.96 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 97' ' ' THR . . . . . 0.413 ' O ' HG23 ' E' ' 99' ' ' VAL . 3.0 m -131.09 123.91 29.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.315 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.17 29.48 18.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.46 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 99' ' ' VAL . . . . . 0.413 HG23 ' O ' ' E' ' 97' ' ' THR . 1.7 t -125.29 129.33 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.809 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.85 -171.09 21.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.504 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 101' ' ' VAL . . . . . 0.521 ' CG2' ' HB1' ' E' ' 135' ' ' ALA . 1.9 p -122.93 116.73 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.195 0.522 . . . . 0.0 111.679 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 102' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 3.9 tt0 -81.77 151.45 27.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.931 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.79 123.83 70.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.515 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 104' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' B' ' 80' ' ' ALA . 0.5 OUTLIER -104.71 125.18 50.55 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.704 0.288 . . . . 0.0 111.003 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 105' ' ' ASP . . . . . 0.795 ' HB3' HG22 ' E' ' 107' ' ' THR . 13.6 t0 -77.58 143.04 38.62 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.715 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 106' ' ' ARG . . . . . 0.716 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -62.67 -14.91 49.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.705 0.288 . . . . 0.0 111.025 179.47 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 107' ' ' THR . . . . . 0.795 HG22 ' HB3' ' E' ' 105' ' ' ASP . 8.8 t -63.01 -20.96 65.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.011 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.28 -43.51 1.37 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.745 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.75 160.67 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.083 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.36 133.14 40.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.088 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 111' ' ' LEU . . . . . 0.645 ' HB2' ' HB2' ' E' ' 105' ' ' ASP . 12.3 tp -95.5 160.97 14.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.389 0.614 . . . . 0.0 110.511 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 112' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 2.8 t -110.26 136.79 48.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.043 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 113' ' ' LEU . . . . . 0.819 HD22 ' HA3' ' E' ' 75' ' ' GLY . 1.4 mt -70.22 89.6 0.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.745 0.307 . . . . 0.0 110.663 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -18.45 6.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.463 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -62.26 0.88 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.67 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.96 18.22 9.45 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.99 0.424 . . . . 0.0 111.651 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 117' ' ' THR . . . . . 0.545 HG21 HG23 ' E' ' 112' ' ' THR . 0.0 OUTLIER -83.92 72.55 10.41 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.058 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 118' ' ' PHE . . . . . 0.587 ' HB3' ' HB1' ' E' ' 70' ' ' ALA . 78.1 m-85 -92.34 89.78 6.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 55.2 m -130.6 73.2 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.25 142.28 21.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.691 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.98 68.57 0.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.144 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 122' ' ' THR . . . . . 0.654 ' HB ' ' HB3' ' E' ' 69' ' ' ALA . 0.0 OUTLIER -81.5 133.12 35.35 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.688 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 8.6 m -87.55 124.13 33.17 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.713 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tp -97.33 119.33 35.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.632 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 125' ' ' ASN . . . . . 0.639 ' HA ' HG23 ' E' ' 63' ' ' THR . 2.9 m120 -113.68 171.89 7.31 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.609 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.49 109.8 16.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.637 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.77 -133.81 4.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.71 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 128' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 46.2 m -110.52 86.76 2.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.767 0.317 . . . . 0.0 110.79 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 129' ' ' ASN . . . . . 0.568 ' OD1' ' HB3' ' B' ' 116' ' ' ALA . 1.2 t30 -69.37 155.05 41.07 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.822 0.344 . . . . 0.0 111.16 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 130' ' ' THR . . . . . 0.839 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.2 OUTLIER -142.78 137.07 29.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.1 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 131' ' ' ILE . . . . . 0.793 HG21 HG11 ' E' ' 71' ' ' VAL . 6.9 mt -100.23 109.05 55.39 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 132' ' ' PRO . . . . . 0.716 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.5 Cg_endo -81.7 148.24 15.77 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.718 1.612 . . . . 0.0 112.525 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 133' ' ' PHE . . . . . 0.414 ' CZ ' ' HA ' ' E' ' 105' ' ' ASP . 0.5 OUTLIER -158.8 145.3 17.06 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.924 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 134' ' ' GLN . . . . . 0.507 ' OE1' HD13 ' E' ' 104' ' ' LEU . 4.1 mt-30 -111.23 160.43 16.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.041 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 135' ' ' ALA . . . . . 0.764 ' O ' HG22 ' E' ' 52' ' ' VAL . . . -155.98 97.8 1.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.9 0.381 . . . . 0.0 111.621 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 136' ' ' ARG . . . . . 0.492 ' HD2' ' HB ' ' E' ' 48' ' ' THR . 14.4 ptt180 -101.57 173.6 6.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.412 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 137' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 1.8 m-85 -83.66 135.03 34.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.144 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 138' ' ' PHE . . . . . 0.613 ' HB3' HG11 ' E' ' 85' ' ' VAL . 1.7 t80 -128.84 128.16 43.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.055 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 139' ' ' ALA . . . . . 0.458 ' HB2' HD23 ' E' ' 42' ' ' LEU . . . -108.51 137.96 45.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.836 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 140' ' ' THR . . . . . 0.544 HG21 ' HB2' ' E' ' 79' ' ' ASP . 0.3 OUTLIER -89.92 -9.54 48.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.49 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.28 -95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.947 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.71 101.52 11.36 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.529 0.204 . . . . 0.0 110.735 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 143' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' E' ' 42' ' ' LEU . . . -61.39 144.38 54.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.788 0.328 . . . . 0.0 111.336 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 144' ' ' THR . . . . . 0.607 ' CG2' ' CD ' ' E' ' 145' ' ' PRO . 99.2 m -123.95 153.15 67.46 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.236 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 145' ' ' PRO . . . . . 0.607 ' CD ' ' CG2' ' E' ' 144' ' ' THR . 1.4 Cg_endo -82.97 144.76 12.18 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.561 2.174 . . . . 0.0 111.979 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 146' ' ' GLY . . . . . 0.656 ' O ' ' HG3' ' D' ' 15' ' ' GLU . . . 157.3 -116.09 0.7 Allowed Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.49 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 147' ' ' ALA . . . . . 0.853 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -119.72 132.38 55.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.871 0.367 . . . . 0.0 111.403 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 148' ' ' ALA . . . . . 0.606 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -125.39 43.36 3.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.112 0.482 . . . . 0.0 110.379 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 149' ' ' ASN . . . . . 0.555 ' HB2' ' HG3' ' E' ' 89' ' ' GLN . 1.1 m120 -95.67 150.86 19.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.609 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 150' ' ' ALA . . . . . 0.51 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -168.47 -178.63 3.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.009 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.76 152.99 39.7 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.228 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 152' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -141.2 151.12 43.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.206 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 153' ' ' THR . . . . . 0.569 HG23 HG22 ' D' ' 9' ' ' THR . 0.2 OUTLIER -112.66 133.74 54.54 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 154' ' ' PHE . . . . . 0.507 ' HB3' ' H ' ' D' ' 8' ' ' GLY . 0.1 OUTLIER -81.72 148.72 28.82 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.103 0.478 . . . . 0.0 110.114 -179.05 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 155' ' ' LYS . . . . . 0.558 ' HB3' ' CZ ' ' E' ' 118' ' ' PHE . 11.3 mmtt -135.02 139.49 44.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.931 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 156' ' ' VAL . . . . . 0.632 HG22 HG23 ' D' ' 5' ' ' VAL . 3.1 m -134.51 141.3 43.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.687 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 157' ' ' GLN . . . . . 0.547 ' HB3' ' HB3' ' E' ' 70' ' ' ALA . 3.8 tt0 -128.8 128.97 45.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.29 0.567 . . . . 0.0 110.373 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.69 128.58 51.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.536 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.331 0.11 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.4 88.96 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.568 0.223 . . . . 0.0 111.008 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.17 114.47 18.39 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.396 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -97.26 119.23 35.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.664 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 m -136.61 158.25 37.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.562 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.18 115.99 22.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.581 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.59 -79.63 0.13 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.878 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.56 -145.95 4.24 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.904 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 15.2 p -142.02 145.12 34.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.944 0.402 . . . . 0.0 111.314 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 32.0 t -127.84 119.47 51.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.226 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -92.4 113.18 25.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.407 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -95.8 90.65 5.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.794 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.09 120.76 32.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.343 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.09 170.48 32.66 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.934 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -160.59 129.18 4.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.957 0.408 . . . . 0.0 110.36 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.67 136.91 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.254 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.34 -160.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.786 0.327 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.93 177.02 6.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.967 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.22 49.62 1.73 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.064 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 20' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' F' ' 61' ' ' CYS . . . -122.15 -39.71 2.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.437 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 21' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' F' ' 58' ' ' LEU . 0.5 OUTLIER -162.12 146.39 12.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.943 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.02 121.61 14.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 23' ' ' VAL . . . . . 0.617 ' HA ' ' HG ' ' F' ' 58' ' ' LEU . 2.5 p -63.7 143.49 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 24' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' F' ' 27' ' ' SER . 13.5 t70 -72.87 154.61 40.52 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.59 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 25' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -54.32 -53.87 48.01 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.335 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.56 1.03 88.7 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.863 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 27' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' F' ' 24' ' ' ASP . 7.9 t -99.32 -16.59 18.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.842 0.354 . . . . 0.0 110.814 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 28' ' ' VAL . . . . . 0.441 HG23 ' O ' ' F' ' 25' ' ' ALA . 10.9 t -53.24 -50.78 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.324 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -114.12 126.1 54.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.995 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 30' ' ' GLN . . . . . 0.426 HE22 ' HA ' ' F' ' 56' ' ' ILE . 3.7 mt-30 -125.57 135.65 52.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.059 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.93 109.18 21.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.091 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -115.59 115.12 48.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.148 0.499 . . . . 0.0 110.416 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -105.19 124.67 49.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.665 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.2 -42.29 23.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.603 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.08 -165.35 12.14 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.579 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 36' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 4.0 mt-30 -93.67 119.16 32.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.657 0.265 . . . . 0.0 110.851 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.784 HG13 HG13 ' E' ' 16' ' ' VAL . 8.2 p -104.84 133.97 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 38' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' F' ' 41' ' ' SER . 0.1 OUTLIER -79.93 137.62 36.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.687 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 39' ' ' THR . . . . . 0.758 HG22 ' O ' ' E' ' 17' ' ' VAL . 0.2 OUTLIER -62.45 -49.46 75.34 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.775 179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 40' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' E' ' 19' ' ' ALA . . . -53.53 -33.48 54.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.983 0.42 . . . . 0.0 110.829 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 41' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' F' ' 38' ' ' ARG . 0.1 OUTLIER -74.98 -31.37 61.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.113 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 42' ' ' LEU . . . . . 0.617 ' O ' ' HB2' ' F' ' 143' ' ' ALA . 0.6 OUTLIER -114.02 39.82 2.63 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.611 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.25 33.93 3.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.388 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 44' ' ' GLN . . . . . 0.674 ' HB2' ' HB2' ' F' ' 47' ' ' ALA . 0.3 OUTLIER -124.46 142.84 51.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.366 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.22 95.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.867 0.365 . . . . 0.0 111.161 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.41 33.67 5.85 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.149 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 47' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' F' ' 44' ' ' GLN . . . -78.79 143.51 36.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.979 0.418 . . . . 0.0 111.973 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 48' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' F' ' 136' ' ' ARG . 18.1 p -131.63 132.0 43.66 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.899 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 49' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 1.3 m -103.81 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.504 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 50' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 3.9 t -57.81 141.91 47.42 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 51' ' ' ALA . . . . . 0.472 ' HB2' ' HB3' ' F' ' 136' ' ' ARG . . . -99.03 125.5 44.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.376 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 52' ' ' VAL . . . . . 0.764 HG22 ' O ' ' F' ' 135' ' ' ALA . 24.9 m -76.53 150.97 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.959 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.3 143.25 16.41 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.583 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 54' ' ' PHE . . . . . 0.406 ' HE2' ' HB3' ' F' ' 135' ' ' ALA . 37.4 p90 -171.47 140.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.839 0.352 . . . . 0.0 110.902 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 55' ' ' ASN . . . . . 0.465 ' HB3' HG23 ' C' ' 76' ' ' THR . 17.0 p30 -136.35 138.61 41.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.535 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 56' ' ' ILE . . . . . 0.54 HG23 ' O ' ' F' ' 56' ' ' ILE . 0.7 OUTLIER -88.42 116.76 30.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.57 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 57' ' ' GLN . . . . . 0.829 ' HA ' HG23 ' F' ' 130' ' ' THR . 5.0 mp0 -69.39 138.31 53.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.803 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 58' ' ' LEU . . . . . 0.636 ' HB3' ' SG ' ' F' ' 21' ' ' CYS . 0.3 OUTLIER -145.58 91.67 2.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.284 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 59' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 4.1 p-10 -78.43 176.87 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.925 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.86 0.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.792 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 61' ' ' CYS . . . . . 0.616 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 10.4 m -133.83 147.8 51.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.779 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.71 161.93 20.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.318 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 63' ' ' THR . . . . . 0.626 HG23 ' HA ' ' F' ' 125' ' ' ASN . 0.0 OUTLIER -111.73 -34.25 6.09 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -72.53 -28.2 62.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.04 0.448 . . . . 0.0 111.728 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -73.13 -58.58 4.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.703 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.19 126.09 32.74 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.569 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.32 -42.17 7.12 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.95 0.405 . . . . 0.0 110.954 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 68' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' F' ' 68' ' ' LYS . 1.2 tptp -89.3 156.82 18.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.478 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 69' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' F' ' 122' ' ' THR . . . -146.63 133.19 19.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.588 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 70' ' ' ALA . . . . . 0.6 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -113.31 155.12 25.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.156 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 71' ' ' VAL . . . . . 0.769 HG11 HG21 ' F' ' 131' ' ' ILE . 2.0 t -136.4 148.56 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.69 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 72' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' F' ' 155' ' ' LYS . . . -152.9 163.49 39.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.55 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 73' ' ' PHE . . . . . 0.444 ' CD1' ' HB1' ' F' ' 152' ' ' ALA . 0.2 OUTLIER -130.25 142.3 50.57 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 121.247 -0.181 . . . . 0.0 111.186 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 74' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 1.4 tt -109.18 119.04 38.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.055 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 75' ' ' GLY . . . . . 0.823 ' HA3' HD22 ' F' ' 113' ' ' LEU . . . -162.72 -161.87 12.84 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.759 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 76' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.3 OUTLIER -120.99 162.89 19.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.585 0.231 . . . . 0.0 110.775 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 77' ' ' ALA . . . . . 0.699 ' O ' ' HB2' ' F' ' 87' ' ' ALA . . . -83.53 139.08 33.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.937 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 78' ' ' ILE . . . . . 0.535 HG23 ' N ' ' F' ' 79' ' ' ASP . 11.1 tt -66.06 -47.66 84.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.981 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 79' ' ' ASP . . . . . 0.55 ' HB2' HG21 ' F' ' 140' ' ' THR . 0.2 OUTLIER -134.44 46.68 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.857 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.48 -84.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.76 -36.42 40.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.58 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.49 69.27 10.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.918 0.39 . . . . 0.0 110.52 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 83' ' ' THR . . . . . 0.48 HG23 ' HB2' ' F' ' 77' ' ' ALA . 0.2 OUTLIER -74.11 -7.51 52.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.527 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 84' ' ' ASN . . . . . 0.621 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 30.1 p-10 -74.7 -25.44 59.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.338 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 85' ' ' VAL . . . . . 0.598 HG11 ' HB3' ' F' ' 138' ' ' PHE . 6.4 t -104.89 143.86 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.152 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 86' ' ' LEU . . . . . 0.599 ' HG ' HD13 ' F' ' 113' ' ' LEU . 0.3 OUTLIER -74.83 160.88 30.13 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.263 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 87' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' F' ' 77' ' ' ALA . . . -103.66 179.86 4.15 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.902 0.382 . . . . 0.0 111.698 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 88' ' ' LEU . . . . . 0.712 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 1.3 mm? -66.56 171.27 5.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.019 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 89' ' ' GLN . . . . . 0.544 ' HG3' ' HB2' ' F' ' 149' ' ' ASN . 1.3 mm-40 -68.58 -83.74 0.03 OUTLIER 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.262 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.13 19.15 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.975 0.416 . . . . 0.0 111.459 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 91' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' F' ' 95' ' ' SER . 3.3 m -90.17 86.21 6.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.936 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.06 -25.03 66.65 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.663 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.37 41.23 3.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.647 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.02 0.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.852 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 95' ' ' SER . . . . . 0.835 ' HA ' ' HB3' ' F' ' 147' ' ' ALA . 1.9 m -89.28 -173.6 4.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 110.667 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 96' ' ' ALA . . . . . 0.423 ' HB3' HD11 ' F' ' 88' ' ' LEU . . . -101.01 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.846 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 3.0 m -131.04 123.92 29.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.322 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.18 29.46 18.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.479 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 1.7 t -125.29 129.29 73.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.824 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.8 -171.07 21.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.516 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 101' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' F' ' 86' ' ' LEU . 1.9 p -122.98 116.72 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.238 0.542 . . . . 0.0 111.703 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 102' ' ' GLN . . . . . 0.548 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 3.9 tt0 -81.75 151.45 27.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.942 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.81 123.85 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.525 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 104' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' C' ' 80' ' ' ALA . 0.5 OUTLIER -104.72 125.16 50.53 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.647 0.261 . . . . 0.0 111.011 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 105' ' ' ASP . . . . . 0.806 ' HB3' HG22 ' F' ' 107' ' ' THR . 13.5 t0 -77.54 143.07 38.68 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.683 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 106' ' ' ARG . . . . . 0.709 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -62.76 -14.82 49.43 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.756 0.312 . . . . 0.0 111.053 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 107' ' ' THR . . . . . 0.806 HG22 ' HB3' ' F' ' 105' ' ' ASP . 8.8 t -63.03 -20.93 65.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.038 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.25 -43.53 1.36 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.748 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.7 160.69 14.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.753 0.311 . . . . 0.0 111.109 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.32 133.17 40.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 111' ' ' LEU . . . . . 0.671 ' HB2' ' HB2' ' F' ' 105' ' ' ASP . 12.3 tp -95.52 160.89 14.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.381 0.61 . . . . 0.0 110.52 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 112' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 2.9 t -110.19 136.79 48.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.093 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 113' ' ' LEU . . . . . 0.823 HD22 ' HA3' ' F' ' 75' ' ' GLY . 1.4 mt -70.2 89.59 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.299 . . . . 0.0 110.65 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -18.46 6.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.482 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.29 -62.26 0.88 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.647 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.97 18.25 9.43 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-O 121.008 0.432 . . . . 0.0 111.661 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 117' ' ' THR . . . . . 0.546 HG21 HG23 ' F' ' 112' ' ' THR . 0.0 OUTLIER -83.92 72.54 10.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.015 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 118' ' ' PHE . . . . . 0.6 ' HB3' ' HB1' ' F' ' 70' ' ' ALA . 78.2 m-85 -92.31 89.74 6.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.775 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 54.8 m -130.51 73.13 1.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.914 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.23 142.34 21.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.676 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -104.02 68.54 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.165 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 122' ' ' THR . . . . . 0.641 ' HB ' ' HB3' ' F' ' 69' ' ' ALA . 0.0 OUTLIER -81.45 133.12 35.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.721 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 8.5 m -87.55 124.12 33.16 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.738 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.31 119.29 35.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.672 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 125' ' ' ASN . . . . . 0.626 ' HA ' HG23 ' F' ' 63' ' ' THR . 2.9 m120 -113.71 171.93 7.29 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.581 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.5 109.74 16.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.656 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.84 -133.84 4.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.733 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 128' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 46.4 m -110.49 86.71 2.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.743 0.306 . . . . 0.0 110.811 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 129' ' ' ASN . . . . . 0.564 ' OD1' ' HB3' ' C' ' 116' ' ' ALA . 1.1 t30 -69.3 155.07 41.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.179 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 130' ' ' THR . . . . . 0.829 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.2 OUTLIER -142.79 137.08 29.45 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.099 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 131' ' ' ILE . . . . . 0.769 HG21 HG11 ' F' ' 71' ' ' VAL . 6.9 mt -100.25 109.09 55.57 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 132' ' ' PRO . . . . . 0.709 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.5 Cg_endo -81.72 148.26 15.74 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.721 1.614 . . . . 0.0 112.543 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 133' ' ' PHE . . . . . 0.419 ' CZ ' ' HA ' ' F' ' 105' ' ' ASP . 0.5 OUTLIER -158.86 145.29 16.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.903 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 134' ' ' GLN . . . . . 0.515 ' OE1' HD13 ' F' ' 104' ' ' LEU . 4.1 mt-30 -111.23 160.43 16.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.042 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 135' ' ' ALA . . . . . 0.764 ' O ' HG22 ' F' ' 52' ' ' VAL . . . -156.03 97.82 1.83 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.995 0.426 . . . . 0.0 111.597 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 136' ' ' ARG . . . . . 0.498 ' HD2' ' HB ' ' F' ' 48' ' ' THR . 14.4 ptt180 -101.5 173.6 6.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.407 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 137' ' ' TYR . . . . . 0.539 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 1.8 m-85 -83.65 135.03 34.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.168 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 138' ' ' PHE . . . . . 0.598 ' HB3' HG11 ' F' ' 85' ' ' VAL . 1.8 t80 -128.87 128.23 43.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.282 0.563 . . . . 0.0 111.972 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 139' ' ' ALA . . . . . 0.472 ' HB2' HD23 ' F' ' 42' ' ' LEU . . . -108.58 137.97 45.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.854 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 140' ' ' THR . . . . . 0.55 HG21 ' HB2' ' F' ' 79' ' ' ASP . 0.3 OUTLIER -89.93 -9.56 48.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.477 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.32 -95.22 0.1 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.996 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.75 101.47 11.3 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.529 0.204 . . . . 0.0 110.741 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 143' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' F' ' 42' ' ' LEU . . . -61.35 144.33 54.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.715 0.293 . . . . 0.0 111.409 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 144' ' ' THR . . . . . 0.607 ' CG2' ' CD ' ' F' ' 145' ' ' PRO . 99.1 m -123.92 153.17 67.35 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.216 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 145' ' ' PRO . . . . . 0.607 ' CD ' ' CG2' ' F' ' 144' ' ' THR . 1.3 Cg_endo -83.03 144.79 12.13 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.567 2.178 . . . . 0.0 111.98 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 146' ' ' GLY . . . . . 0.652 ' O ' ' HG3' ' E' ' 15' ' ' GLU . . . 157.27 -116.08 0.7 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.473 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 147' ' ' ALA . . . . . 0.835 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -119.73 132.44 55.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.899 0.38 . . . . 0.0 111.335 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 148' ' ' ALA . . . . . 0.631 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -125.44 43.36 3.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.12 0.486 . . . . 0.0 110.387 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 149' ' ' ASN . . . . . 0.544 ' HB2' ' HG3' ' F' ' 89' ' ' GLN . 1.1 m120 -95.69 150.86 19.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.623 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 150' ' ' ALA . . . . . 0.508 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -168.44 -178.63 3.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.992 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.77 153.01 39.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.253 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 152' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -141.22 151.11 43.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.258 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 153' ' ' THR . . . . . 0.565 HG23 HG22 ' E' ' 9' ' ' THR . 0.2 OUTLIER -112.68 133.74 54.56 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.252 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 154' ' ' PHE . . . . . 0.501 ' HB3' ' H ' ' E' ' 8' ' ' GLY . 0.1 OUTLIER -81.73 148.72 28.8 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.103 0.478 . . . . 0.0 110.11 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 155' ' ' LYS . . . . . 0.553 ' HB3' ' CZ ' ' F' ' 118' ' ' PHE . 11.2 mmtt -135.01 139.47 44.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.945 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 156' ' ' VAL . . . . . 0.647 HG22 HG23 ' E' ' 5' ' ' VAL . 3.1 m -134.53 141.27 43.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.702 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 157' ' ' GLN . . . . . 0.555 ' HB3' ' HB3' ' F' ' 70' ' ' ALA . 3.8 tt0 -128.77 129.0 45.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.328 0.585 . . . . 0.0 110.37 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.71 128.61 51.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.546 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' B' ' 158' ' ' TYR . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.591 0.234 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' B' ' 157' ' ' GLN . 5.5 m -122.99 116.19 23.14 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.406 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.488 HG21 ' CA ' ' E' ' 127' ' ' GLY . 1.8 m -99.6 117.26 33.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.573 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.633 HG23 HG23 ' B' ' 156' ' ' VAL . 1.7 m -144.49 158.02 14.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.557 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' B' ' 154' ' ' PHE . 13.0 t30 -78.68 123.76 27.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.73 -71.18 1.0 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.822 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.543 ' H ' ' HB3' ' B' ' 154' ' ' PHE . . . -152.72 -147.04 4.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.759 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.965 HG22 HG23 ' B' ' 153' ' ' THR . 24.5 p -148.72 134.43 18.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.022 0.439 . . . . 0.0 111.249 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.33 124.39 72.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.186 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.624 ' HA ' ' OD1' ' B' ' 151' ' ' ASP . 57.5 t-80 -91.58 116.17 28.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.323 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -96.83 105.48 17.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -104.61 118.71 37.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.507 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.32 172.92 30.82 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.952 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.729 ' O ' ' HA ' ' B' ' 36' ' ' GLN . 25.8 tt0 -160.39 135.93 8.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.965 0.412 . . . . 0.0 110.425 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.778 HG23 ' HB2' ' B' ' 148' ' ' ALA . 43.4 t -96.78 132.73 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.272 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.564 HG11 ' OE1' ' B' ' 36' ' ' GLN . 18.5 m -133.82 -177.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.805 0.336 . . . . 0.0 111.068 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.567 ' HA ' HG22 ' B' ' 39' ' ' THR . 0.3 OUTLIER -75.7 -170.26 1.25 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.017 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.79 45.37 0.98 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.125 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.568 ' O ' HD21 ' A' ' 124' ' ' LEU . . . -121.26 -24.8 5.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.415 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -168.91 140.68 2.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.792 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 60' ' ' ASP . . . -132.87 116.95 17.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.741 HG12 ' HB2' ' B' ' 36' ' ' GLN . 0.5 OUTLIER -67.03 146.23 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.011 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.473 ' O ' HG23 ' A' ' 28' ' ' VAL . 12.9 t0 -80.34 152.03 29.16 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.55 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.06 96.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.39 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.88 2.72 85.9 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.891 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -106.23 -19.94 13.55 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.813 0.339 . . . . 0.0 110.793 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 24' ' ' ASP . 39.8 t -47.43 -52.09 5.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.336 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.19 136.48 48.61 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.035 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.71 136.85 39.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.02 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.52 102.83 12.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.127 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.66 128.34 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.121 0.486 . . . . 0.0 110.51 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -114.75 123.06 48.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.615 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.45 -42.72 15.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.608 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.45 -167.44 13.2 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.603 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -96.75 124.51 40.75 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.654 0.264 . . . . 0.0 110.852 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.71 147.54 11.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.986 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.71 134.94 34.33 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.418 0.449 . . . . 0.0 111.725 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -60.07 -44.48 94.73 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.75 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.26 -36.88 61.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.095 0.474 . . . . 0.0 110.893 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.9 -35.8 62.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.168 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.747 HD23 HG13 ' A' ' 99' ' ' VAL . 2.9 mp -106.66 34.58 3.34 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.657 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.9 15.85 27.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.391 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.98 132.04 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.34 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 140' ' ' THR . 6.8 tt0 -56.56 108.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.827 0.346 . . . . 0.0 111.106 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.93 25.93 10.11 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.121 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -71.49 137.75 48.42 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 p -136.94 122.73 19.96 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.913 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 136' ' ' ARG . 53.9 m -100.07 -175.18 2.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.649 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 t -55.65 137.29 49.56 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.808 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.476 ' CA ' ' HB3' ' A' ' 136' ' ' ARG . . . -92.32 133.57 35.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.342 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 135' ' ' ALA . 26.2 m -76.76 162.48 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.52 141.14 16.76 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.643 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -173.76 137.75 0.61 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.79 0.329 . . . . 0.0 110.933 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -136.49 145.85 45.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.682 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 56' ' ' ILE . 1.2 tp -91.04 116.79 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.663 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.73 ' HA ' HG23 ' A' ' 130' ' ' THR . 1.3 mp0 -72.93 128.65 36.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.813 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.459 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -137.35 89.13 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.225 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.731 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 9.8 p30 -74.79 176.47 7.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.039 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.515 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 0.9 OUTLIER 58.97 74.78 0.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.889 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 36.5 m -126.31 148.83 49.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.412 ' OD2' HG23 ' A' ' 65' ' ' VAL . 1.6 t70 -121.58 169.75 10.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.318 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.25 -32.66 4.91 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.48 -28.0 56.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.261 0.553 . . . . 0.0 111.753 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.412 HG23 ' OD2' ' A' ' 62' ' ' ASP . 25.5 t -73.63 -56.69 8.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.68 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.459 ' HB3' ' HB1' ' A' ' 20' ' ' ALA . . . -134.99 122.76 22.31 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.652 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.54 -50.11 5.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.894 0.378 . . . . 0.0 110.936 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.401 ' NZ ' ' HA ' ' A' ' 68' ' ' LYS . 1.8 tptp -89.75 152.15 21.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.529 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 122' ' ' THR . . . -144.24 137.87 27.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.582 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -113.41 157.28 22.11 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.092 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.739 HG11 HG21 ' A' ' 131' ' ' ILE . 1.8 t -138.75 149.97 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.668 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.86 155.13 37.52 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.565 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.543 ' CB ' HD13 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -125.05 136.69 53.93 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.644 0.259 . . . . 0.0 111.004 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.576 HD21 HG21 ' D' ' 130' ' ' THR . 0.9 OUTLIER -97.2 136.13 38.15 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.017 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.446 ' CA ' ' HB3' ' A' ' 113' ' ' LEU . . . -174.0 -172.91 39.69 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.762 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.667 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.2 OUTLIER -118.66 144.6 46.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.485 0.183 . . . . 0.0 110.835 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.639 ' HB2' HG23 ' A' ' 83' ' ' THR . . . -62.52 138.62 58.51 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.925 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.504 HG23 ' N ' ' A' ' 79' ' ' ASP . 5.7 tt -71.63 -45.56 66.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.932 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.504 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -133.13 42.47 3.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.857 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 79' ' ' ASP . . . 70.12 -80.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.977 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.06 -29.78 68.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.552 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.445 ' HB3' HG22 ' A' ' 78' ' ' ILE . 1.7 m80 -89.77 69.41 7.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 110.445 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.639 HG23 ' HB2' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -74.52 -16.17 60.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.576 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 20.7 p-10 -66.26 -19.05 65.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.267 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 138' ' ' PHE . 13.4 t -113.65 133.81 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.198 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.766 ' HG ' HD13 ' A' ' 113' ' ' LEU . 0.4 OUTLIER -67.89 161.48 26.27 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.529 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 77' ' ' ALA . . . -103.54 -174.65 2.6 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.869 0.366 . . . . 0.0 111.787 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.71 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 0.3 OUTLIER -67.38 165.22 16.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.084 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.518 ' CG ' ' HB2' ' A' ' 149' ' ' ASN . 3.6 mm100 -63.43 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.815 0.34 . . . . 0.0 111.3 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.454 ' O ' HG12 ' D' ' 52' ' ' VAL . 2.3 p -165.45 3.66 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 111.492 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.528 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 0.7 OUTLIER -80.03 79.74 6.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.525 ' HB2' HG13 ' D' ' 52' ' ' VAL . . . -57.08 -24.72 56.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.885 0.374 . . . . 0.0 111.658 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.18 33.94 5.25 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.682 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.8 0.44 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.943 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.71 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . 38.4 m -96.8 177.94 5.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.877 0.37 . . . . 0.0 110.64 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.47 -178.71 7.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.804 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.494 ' HB ' ' OG1' ' A' ' 144' ' ' THR . 2.0 m -134.53 119.01 17.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.338 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 97' ' ' THR . 32.6 m-20 68.85 34.41 3.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.388 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.747 HG13 HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -138.03 130.79 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.808 179.684 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.11 -170.55 18.84 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.568 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -119.72 114.48 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.014 0.526 . . . . 0.0 111.719 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 1.8 tt0 -87.33 150.21 24.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.912 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.551 HG12 ' HG ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -114.98 135.96 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.53 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.28 133.57 55.04 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.675 0.274 . . . . 0.0 111.03 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.858 ' HB3' HG22 ' A' ' 107' ' ' THR . 6.1 t0 -82.36 149.75 27.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.664 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.751 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.4 OUTLIER -67.85 -16.25 64.0 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.8 0.333 . . . . 0.0 111.053 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.858 HG22 ' HB3' ' A' ' 105' ' ' ASP . 8.8 t -63.67 -28.35 69.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.033 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.0 -40.48 1.58 Allowed Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.661 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.422 ' H ' HG23 ' A' ' 107' ' ' THR . . . -91.51 163.09 14.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.815 0.34 . . . . 0.0 111.049 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.17 133.36 35.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.563 HD21 ' O ' ' A' ' 117' ' ' THR . 4.8 tp -96.74 150.02 21.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.407 0.622 . . . . 0.0 110.526 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.855 HG23 HG21 ' A' ' 117' ' ' THR . 1.9 t -98.37 141.78 30.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.156 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.766 HD13 ' HG ' ' A' ' 86' ' ' LEU . 1.6 mt -76.43 89.48 3.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.783 0.325 . . . . 0.0 110.704 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.08 -18.19 5.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.554 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.79 -60.58 0.46 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.616 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.504 ' HB2' ' N ' ' D' ' 129' ' ' ASN . . . -96.46 26.98 4.03 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.04 0.448 . . . . 0.0 111.69 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.855 HG21 HG23 ' A' ' 112' ' ' THR . 0.0 OUTLIER -87.04 74.86 9.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.148 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.582 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 62.7 m-85 -94.88 92.86 7.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.819 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.8 m -136.32 68.92 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.81 150.19 28.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.622 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.25 67.66 0.7 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.171 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.6 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -79.15 114.71 18.31 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.747 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -73.94 127.96 34.24 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.724 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.568 HD21 ' O ' ' A' ' 20' ' ' ALA . 4.0 tp -92.08 132.14 36.81 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.64 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.12 151.12 49.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.58 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 3.1 t30 -69.12 111.99 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.636 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.61 -138.83 8.65 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.672 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.731 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 87.8 m -98.84 82.5 2.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.633 0.254 . . . . 0.0 110.724 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.456 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 2.3 t30 -71.82 148.19 46.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.949 0.404 . . . . 0.0 111.062 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.73 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -138.67 148.57 44.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.119 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.739 HG21 HG11 ' A' ' 71' ' ' VAL . 15.6 mt -110.0 112.23 57.93 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.751 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.4 Cg_endo -81.82 136.98 9.7 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.629 1.553 . . . . 0.0 112.564 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.0 136.09 19.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.718 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -111.43 158.4 19.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.04 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.675 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -154.19 111.35 3.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.951 0.405 . . . . 0.0 111.63 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.476 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . 19.8 ptt180 -108.93 174.09 6.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.344 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.695 ' HB3' HD21 ' A' ' 42' ' ' LEU . 1.7 m-85 -81.37 137.67 35.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.14 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.518 ' HB3' HG21 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -131.61 124.15 29.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.2 0.524 . . . . 0.0 112.072 -179.256 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -108.47 130.17 55.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.839 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -77.46 -27.95 52.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.495 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.49 -96.51 0.11 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.981 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.93 98.46 8.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.623 0.211 . . . . 0.0 110.722 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.548 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -56.6 148.89 18.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.746 0.308 . . . . 0.0 111.413 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.723 ' CG2' ' CD ' ' A' ' 145' ' ' PRO . 90.1 m -125.41 156.96 69.48 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.219 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.723 ' CD ' ' CG2' ' A' ' 144' ' ' THR . 1.4 Cg_endo -83.45 136.3 7.51 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.517 2.145 . . . . 0.0 111.925 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 163.56 -127.56 1.7 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.474 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.652 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -110.92 132.88 53.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.863 0.364 . . . . 0.0 111.363 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.24 43.69 2.93 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.133 0.492 . . . . 0.0 110.451 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.518 ' HB2' ' CG ' ' A' ' 89' ' ' GLN . 9.3 m120 -92.27 144.28 25.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.529 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.684 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -160.64 178.81 9.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.0 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -146.94 145.01 29.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.255 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -133.74 139.74 46.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.169 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.1 135.29 42.8 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.58 152.18 27.34 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.005 0.431 . . . . 0.0 110.188 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.413 ' HE3' ' HB ' ' D' ' 128' ' ' THR . 15.2 mmtm -134.18 146.84 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.916 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.09 140.71 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.857 0.36 . . . . 0.0 111.626 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.432 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -134.54 132.73 39.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.281 0.562 . . . . 0.0 110.45 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 21' ' ' CYS . 11.1 m-85 -107.3 128.05 54.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.49 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.873 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 111.147 0.054 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' C' ' 158' ' ' TYR . . . 52.78 88.29 0.03 OUTLIER 'General case' 0 C--O 1.232 0.15 0 O-C-N 123.154 0.284 . . . . 0.0 111.039 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' C' ' 157' ' ' GLN . 5.5 m -122.92 116.22 23.24 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.379 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.492 HG21 ' CA ' ' F' ' 127' ' ' GLY . 1.8 m -99.68 117.18 33.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.563 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.616 HG23 HG23 ' C' ' 156' ' ' VAL . 1.8 m -144.41 158.09 15.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.577 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' C' ' 154' ' ' PHE . 13.1 t30 -78.74 123.81 27.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.54 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.77 -71.24 1.0 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.836 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.531 ' H ' ' HB3' ' C' ' 154' ' ' PHE . . . -152.66 -147.05 4.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.84 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.954 HG22 HG23 ' C' ' 153' ' ' THR . 24.5 p -148.69 134.44 18.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.969 0.414 . . . . 0.0 111.318 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.39 124.34 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.147 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' HIS . . . . . 0.636 ' HA ' ' OD1' ' C' ' 151' ' ' ASP . 57.4 t-80 -91.47 116.2 28.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.337 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -96.88 105.53 17.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.738 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -104.62 118.72 37.28 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.474 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.3 172.9 30.81 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.936 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.738 ' O ' ' HA ' ' C' ' 36' ' ' GLN . 25.8 tt0 -160.38 135.95 8.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.911 0.386 . . . . 0.0 110.398 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.761 HG23 ' HB2' ' C' ' 148' ' ' ALA . 43.7 t -96.87 132.79 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.204 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.565 HG11 ' OE1' ' C' ' 36' ' ' GLN . 18.1 m -133.88 -177.12 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.934 0.397 . . . . 0.0 110.98 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ASN . . . . . 0.563 ' HA ' HG22 ' C' ' 39' ' ' THR . 0.3 OUTLIER -75.85 -170.34 1.32 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.931 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.76 45.51 0.97 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.084 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.577 ' O ' HD21 ' B' ' 124' ' ' LEU . . . -121.34 -24.85 5.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.386 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.716 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER -168.81 140.64 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.864 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' B' ' 60' ' ' ASP . . . -132.79 116.97 17.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.082 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.744 HG12 ' HB2' ' C' ' 36' ' ' GLN . 0.5 OUTLIER -67.05 146.22 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.034 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.473 ' O ' HG23 ' B' ' 28' ' ' VAL . 12.8 t0 -80.33 152.09 29.15 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.562 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.84 -39.95 95.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.417 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.9 2.65 85.83 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.844 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -106.26 -19.89 13.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.826 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 24' ' ' ASP . 39.8 t -47.36 -52.22 5.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.336 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.15 136.43 48.66 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.036 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.63 136.86 39.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.066 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.53 102.87 12.77 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.062 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 26.0 t -107.69 128.25 63.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.527 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -114.7 123.07 48.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.652 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.43 -42.71 15.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.61 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.44 -167.44 13.2 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.581 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.741 ' HB2' HG12 ' A' ' 23' ' ' VAL . 2.9 mt-30 -96.7 124.47 40.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.613 0.244 . . . . 0.0 110.892 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.78 147.53 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.93 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.67 134.95 34.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.026 0.441 . . . . 0.0 111.669 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -60.07 -44.49 94.7 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.739 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.29 -36.84 61.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.184 0.516 . . . . 0.0 110.919 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.83 -35.86 62.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.223 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.755 HD23 HG13 ' B' ' 99' ' ' VAL . 2.9 mp -106.69 34.58 3.34 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.626 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.95 15.88 27.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.329 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.0 132.08 56.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.299 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' B' ' 140' ' ' THR . 6.7 tt0 -56.58 108.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.846 0.355 . . . . 0.0 111.076 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.95 25.9 10.12 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.144 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' B' ' 139' ' ' ALA . . . -71.42 137.77 48.57 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 7.3 p -136.98 122.75 19.93 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.927 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' B' ' 136' ' ' ARG . 53.4 m -100.09 -175.21 2.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.644 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.9 t -55.67 137.33 49.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.799 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.481 ' CA ' ' HB3' ' B' ' 136' ' ' ARG . . . -92.29 133.46 35.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.327 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.683 HG22 ' O ' ' B' ' 135' ' ' ALA . 26.1 m -76.71 162.54 4.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.49 141.16 16.78 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.592 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -173.76 137.77 0.62 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.804 0.335 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -136.56 145.83 45.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.603 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.527 HG23 ' O ' ' B' ' 56' ' ' ILE . 1.2 tp -91.03 116.77 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.607 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' GLN . . . . . 0.722 ' HA ' HG23 ' B' ' 130' ' ' THR . 1.3 mp0 -72.93 128.58 35.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.79 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.457 ' HG ' ' HA ' ' B' ' 23' ' ' VAL . 0.3 OUTLIER -137.31 89.17 2.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.242 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.723 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 9.8 p30 -74.81 176.53 6.98 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.012 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ASP . . . . . 0.512 ' HB2' ' HB3' ' B' ' 22' ' ' ALA . 0.9 OUTLIER 58.93 74.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 61' ' ' CYS . . . . . 0.716 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 36.8 m -126.32 148.86 49.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.804 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ASP . . . . . 0.404 ' OD2' HG23 ' B' ' 65' ' ' VAL . 1.6 t70 -121.58 169.77 10.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.281 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.27 -32.69 4.89 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -76.52 -27.94 56.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.169 0.509 . . . . 0.0 111.72 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' VAL . . . . . 0.404 HG23 ' OD2' ' B' ' 62' ' ' ASP . 25.6 t -73.66 -56.69 8.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.677 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.466 ' HB3' ' HB1' ' B' ' 20' ' ' ALA . . . -135.02 122.74 22.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.674 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -50.04 5.13 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.89 0.376 . . . . 0.0 110.923 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -89.76 152.12 21.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.574 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' B' ' 122' ' ' THR . . . -144.25 137.8 27.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.604 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.603 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -113.35 157.25 22.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.11 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.754 HG11 HG21 ' B' ' 131' ' ' ILE . 1.8 t -138.78 149.96 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.656 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.82 155.11 37.52 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.596 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.545 ' CB ' HD13 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -125.04 136.68 53.92 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.634 0.254 . . . . 0.0 110.969 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.581 HD11 ' HG3' ' E' ' 57' ' ' GLN . 0.9 OUTLIER -97.15 136.1 38.15 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.032 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 75' ' ' GLY . . . . . 0.459 ' CA ' ' HB3' ' B' ' 113' ' ' LEU . . . -174.02 -172.95 39.74 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.731 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.677 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.2 OUTLIER -118.63 144.55 46.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.537 0.208 . . . . 0.0 110.831 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.652 ' HB2' HG23 ' B' ' 83' ' ' THR . . . -62.48 138.53 58.48 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.958 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.501 HG23 ' N ' ' B' ' 79' ' ' ASP . 5.7 tt -71.55 -45.59 67.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.884 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.501 ' N ' HG23 ' B' ' 78' ' ' ILE . 0.3 OUTLIER -133.19 42.54 3.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.818 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' B' ' 79' ' ' ASP . . . 70.04 -80.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.056 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.08 -29.71 68.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.56 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.422 ' HB3' HG22 ' B' ' 78' ' ' ILE . 1.6 m80 -89.87 69.39 7.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.418 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' THR . . . . . 0.652 HG23 ' HB2' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -74.47 -16.2 60.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.604 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ASN . . . . . 0.726 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 20.8 p-10 -66.11 -19.16 65.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.334 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' B' ' 138' ' ' PHE . 13.5 t -113.6 133.83 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.173 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.774 ' HG ' HD13 ' B' ' 113' ' ' LEU . 0.4 OUTLIER -67.83 161.53 26.04 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.458 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' B' ' 77' ' ' ALA . . . -103.61 -174.72 2.61 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.866 0.365 . . . . 0.0 111.772 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.703 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 0.3 OUTLIER -67.36 165.21 16.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.049 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 89' ' ' GLN . . . . . 0.519 ' CG ' ' HB2' ' B' ' 149' ' ' ASN . 3.6 mm100 -63.42 -79.73 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.33 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' SER . . . . . 0.45 ' O ' HG12 ' E' ' 52' ' ' VAL . 2.3 p -165.48 3.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 111.549 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' SER . . . . . 0.536 ' HA ' ' HB2' ' D' ' 25' ' ' ALA . 0.7 OUTLIER -80.16 79.73 6.68 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.501 ' HB2' HG13 ' E' ' 52' ' ' VAL . . . -57.05 -24.76 56.15 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.868 0.366 . . . . 0.0 111.617 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.2 33.99 5.24 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.692 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.77 0.42 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.911 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' SER . . . . . 0.703 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . 38.4 m -96.8 177.93 5.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.873 0.368 . . . . 0.0 110.622 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.54 -178.65 7.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.806 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' B' ' 98' ' ' ASN . 2.0 m -134.42 119.05 18.09 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.379 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 98' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' B' ' 97' ' ' THR . 32.5 m-20 68.68 34.53 3.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.441 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' VAL . . . . . 0.755 HG13 HD23 ' B' ' 42' ' ' LEU . 0.4 OUTLIER -138.13 130.85 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.784 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.14 -170.63 18.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.539 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' B' ' 86' ' ' LEU . 0.2 OUTLIER -119.61 114.48 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.017 0.527 . . . . 0.0 111.766 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 1.8 tt0 -87.4 150.24 23.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.92 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.55 HG12 ' HG ' ' B' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 135.99 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.471 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.31 133.59 55.05 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.654 0.264 . . . . 0.0 110.988 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ASP . . . . . 0.864 ' HB3' HG22 ' B' ' 107' ' ' THR . 6.1 t0 -82.29 149.75 27.63 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.725 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' ARG . . . . . 0.736 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.4 OUTLIER -67.82 -16.26 64.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.811 0.339 . . . . 0.0 111.103 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.864 HG22 ' HB3' ' B' ' 105' ' ' ASP . 8.8 t -63.69 -28.39 69.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.006 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.08 -40.55 1.57 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.662 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' ALA . . . . . 0.419 ' H ' HG23 ' B' ' 107' ' ' THR . . . -91.48 163.12 14.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.819 0.342 . . . . 0.0 111.052 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.12 133.35 35.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.204 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.564 HD21 ' O ' ' B' ' 117' ' ' THR . 4.8 tp -96.69 150.0 21.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.413 0.625 . . . . 0.0 110.539 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.864 HG23 HG21 ' B' ' 117' ' ' THR . 1.9 t -98.48 141.76 30.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.177 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.774 HD13 ' HG ' ' B' ' 86' ' ' LEU . 1.6 mt -76.36 89.4 3.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.741 0.305 . . . . 0.0 110.746 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.07 -18.14 5.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.503 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.8 -60.65 0.46 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.588 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' ALA . . . . . 0.501 ' HB2' ' N ' ' E' ' 129' ' ' ASN . . . -96.5 27.03 4.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.035 0.445 . . . . 0.0 111.632 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' THR . . . . . 0.864 HG21 HG23 ' B' ' 112' ' ' THR . 0.0 OUTLIER -87.07 74.89 9.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.164 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.603 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . 62.6 m-85 -94.92 92.89 7.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 25.5 m -136.33 68.93 1.43 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.86 150.29 28.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.557 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -107.34 67.63 0.7 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.206 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.614 ' O ' ' HB3' ' B' ' 69' ' ' ALA . 0.2 OUTLIER -79.15 114.71 18.31 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.757 -179.549 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 12.0 m -73.98 128.02 34.41 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.713 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.577 HD21 ' O ' ' B' ' 20' ' ' ALA . 4.0 tp -92.11 132.17 36.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.614 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.17 151.09 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.583 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' B' ' 61' ' ' CYS . 3.1 t30 -69.03 111.97 5.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.627 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.55 -138.96 8.75 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.643 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' THR . . . . . 0.723 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 87.7 m -98.71 82.55 2.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.637 0.256 . . . . 0.0 110.792 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ASN . . . . . 0.462 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 2.3 t30 -71.76 148.14 46.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.805 0.336 . . . . 0.0 111.188 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.722 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -138.64 148.61 44.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 131' ' ' ILE . . . . . 0.754 HG21 HG11 ' B' ' 71' ' ' VAL . 15.6 mt -110.01 112.22 57.91 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 132' ' ' PRO . . . . . 0.736 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.83 137.03 9.72 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.574 1.516 . . . . 0.0 112.578 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.03 136.02 19.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.739 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -111.45 158.41 19.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.033 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.683 ' O ' HG22 ' B' ' 52' ' ' VAL . . . -154.15 111.33 3.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.924 0.392 . . . . 0.0 111.633 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 136' ' ' ARG . . . . . 0.481 ' HB3' ' CA ' ' B' ' 51' ' ' ALA . 19.8 ptt180 -108.94 174.11 6.02 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.375 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 137' ' ' TYR . . . . . 0.686 ' HB3' HD21 ' B' ' 42' ' ' LEU . 1.7 m-85 -81.4 137.64 35.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.047 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 138' ' ' PHE . . . . . 0.517 ' HB3' HG21 ' B' ' 85' ' ' VAL . 0.9 OUTLIER -131.53 124.14 29.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.104 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' B' ' 47' ' ' ALA . . . -108.51 130.16 55.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.834 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 140' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' B' ' 45' ' ' GLU . 0.2 OUTLIER -77.44 -27.9 52.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.571 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.48 -96.52 0.11 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.006 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.99 98.49 8.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.572 0.225 . . . . 0.0 110.666 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 143' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -56.64 148.93 18.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.742 0.306 . . . . 0.0 111.418 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.724 ' CG2' ' CD ' ' B' ' 145' ' ' PRO . 90.5 m -125.44 156.95 69.57 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.208 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 145' ' ' PRO . . . . . 0.724 ' CD ' ' CG2' ' B' ' 144' ' ' THR . 1.4 Cg_endo -83.42 136.28 7.53 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.52 2.147 . . . . 0.0 111.974 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 146' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' A' ' 15' ' ' GLU . . . 163.64 -127.57 1.69 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.51 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.66 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -110.93 132.92 53.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.829 0.347 . . . . 0.0 111.328 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 148' ' ' ALA . . . . . 0.778 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -124.28 43.75 2.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.422 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.519 ' HB2' ' CG ' ' B' ' 89' ' ' GLN . 14.0 m-80 -92.34 144.32 25.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.506 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.692 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -160.68 178.85 9.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.968 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 151' ' ' ASP . . . . . 0.624 ' OD1' ' HA ' ' A' ' 11' ' ' HIS . 15.7 t70 -146.97 145.03 29.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.218 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 152' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -133.79 139.73 46.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.18 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.965 HG23 HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -101.04 135.25 42.79 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.131 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 154' ' ' PHE . . . . . 0.543 ' HB3' ' H ' ' A' ' 8' ' ' GLY . 0.2 OUTLIER -81.52 152.16 27.42 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.118 0.485 . . . . 0.0 110.125 -179.082 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 155' ' ' LYS . . . . . 0.424 ' HE3' ' HB ' ' E' ' 128' ' ' THR . 15.2 mmtm -134.22 146.84 50.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.877 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 156' ' ' VAL . . . . . 0.633 HG23 HG23 ' A' ' 5' ' ' VAL . 33.1 m -139.07 140.77 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.8 0.333 . . . . 0.0 111.617 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 3' ' ' THR . 0.1 OUTLIER -134.52 132.67 39.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.272 0.558 . . . . 0.0 110.485 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 158' ' ' TYR . . . . . 0.56 ' CE1' ' HB2' ' B' ' 21' ' ' CYS . 10.9 m-85 -107.22 128.01 54.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.557 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.907 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 120.222 0.058 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 2' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' D' ' 158' ' ' TYR . . . 52.76 88.35 0.03 OUTLIER 'General case' 0 C--O 1.232 0.163 0 O-C-N 123.141 0.275 . . . . 0.0 111.015 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' D' ' 157' ' ' GLN . 5.5 m -123.0 116.28 23.27 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.381 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -99.66 117.16 33.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.6 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.629 HG23 HG23 ' D' ' 156' ' ' VAL . 1.8 m -144.45 157.96 14.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.626 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 6' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' D' ' 154' ' ' PHE . 13.2 t30 -78.66 123.75 27.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.582 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.7 -71.24 1.0 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.819 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 8' ' ' GLY . . . . . 0.541 ' H ' ' HB3' ' D' ' 154' ' ' PHE . . . -152.7 -147.01 4.49 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.773 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 9' ' ' THR . . . . . 0.93 HG22 HG23 ' D' ' 153' ' ' THR . 24.1 p -148.75 134.51 18.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.053 0.454 . . . . 0.0 111.243 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.35 124.33 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.201 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 11' ' ' HIS . . . . . 0.632 ' HA ' ' OD1' ' D' ' 151' ' ' ASP . 57.4 t-80 -91.51 116.13 28.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.308 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -96.8 105.49 17.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.824 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -104.66 118.67 37.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.484 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.22 172.94 30.76 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.98 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 15' ' ' GLU . . . . . 0.738 ' O ' ' HA ' ' D' ' 36' ' ' GLN . 25.7 tt0 -160.39 135.93 8.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.913 0.387 . . . . 0.0 110.459 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.77 HG23 ' HB2' ' D' ' 148' ' ' ALA . 43.8 t -96.86 132.85 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.168 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.553 HG11 ' OE1' ' D' ' 36' ' ' GLN . 18.2 m -133.97 -177.21 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.93 0.395 . . . . 0.0 110.965 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 18' ' ' ASN . . . . . 0.569 ' HA ' HG22 ' D' ' 39' ' ' THR . 0.3 OUTLIER -75.75 -170.28 1.27 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.977 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.82 45.5 0.97 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.073 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 20' ' ' ALA . . . . . 0.559 ' O ' HD21 ' C' ' 124' ' ' LEU . . . -121.31 -24.85 5.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.383 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' CYS . . . . . 0.698 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER -168.87 140.69 2.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.864 -179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' HB2' ' C' ' 60' ' ' ASP . . . -132.82 117.02 17.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.041 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 23' ' ' VAL . . . . . 0.733 HG12 ' HB2' ' D' ' 36' ' ' GLN . 0.5 OUTLIER -67.11 146.26 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.113 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.466 ' O ' HG23 ' C' ' 28' ' ' VAL . 12.9 t0 -80.4 152.11 29.02 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.545 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.528 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -62.77 -40.02 95.97 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.483 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.91 2.67 85.83 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.886 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -106.14 -20.05 13.53 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.872 0.368 . . . . 0.0 110.817 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.466 HG23 ' O ' ' C' ' 24' ' ' ASP . 39.7 t -47.31 -52.15 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.324 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.21 136.42 48.71 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.995 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.72 136.91 39.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.017 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.56 102.86 12.76 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.074 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 26.1 t -107.66 128.34 62.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.051 0.453 . . . . 0.0 110.485 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -114.78 123.16 48.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.603 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.49 -42.74 15.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.593 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.5 -167.42 13.17 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.613 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' GLN . . . . . 0.744 ' HB2' HG12 ' B' ' 23' ' ' VAL . 2.9 mt-30 -96.77 124.42 40.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.586 0.231 . . . . 0.0 110.882 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.73 147.59 11.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.946 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.76 134.97 34.31 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.67 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.563 HG22 ' HA ' ' B' ' 18' ' ' ASN . 0.0 OUTLIER -60.1 -44.37 94.88 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.798 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.41 -36.74 61.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.063 0.458 . . . . 0.0 110.835 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.97 -35.73 62.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.191 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.751 HD23 HG13 ' C' ' 99' ' ' VAL . 2.9 mp -106.71 34.56 3.36 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.646 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.97 15.82 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.334 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.96 132.05 56.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.359 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 45' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' C' ' 140' ' ' THR . 6.8 tt0 -56.54 108.8 0.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.806 0.336 . . . . 0.0 111.107 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.89 25.96 10.12 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.152 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' C' ' 139' ' ' ALA . . . -71.49 137.8 48.45 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 7.4 p -137.01 122.77 19.93 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.864 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' C' ' 136' ' ' ARG . 54.0 m -100.09 -175.16 2.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.655 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 2.8 t -55.63 137.3 49.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.811 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' ALA . . . . . 0.481 ' CA ' ' HB3' ' C' ' 136' ' ' ARG . . . -92.4 133.48 35.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.34 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.68 HG22 ' O ' ' C' ' 135' ' ' ALA . 26.4 m -76.7 162.51 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.56 141.2 16.79 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.519 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -173.74 137.73 0.62 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.721 0.296 . . . . 0.0 111.015 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -136.5 145.74 45.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.647 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.532 HG23 ' O ' ' C' ' 56' ' ' ILE . 1.2 tp -90.92 116.76 32.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.68 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.704 ' HA ' HG23 ' C' ' 130' ' ' THR . 1.3 mp0 -72.9 128.55 35.83 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 58' ' ' LEU . . . . . 0.453 ' HG ' ' HA ' ' C' ' 23' ' ' VAL . 0.3 OUTLIER -137.28 89.18 2.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.284 -179.648 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 59' ' ' ASN . . . . . 0.709 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 9.8 p30 -74.82 176.46 7.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.013 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 60' ' ' ASP . . . . . 0.498 ' HB2' ' HB3' ' C' ' 22' ' ' ALA . 0.8 OUTLIER 58.92 74.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.818 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 61' ' ' CYS . . . . . 0.698 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 36.3 m -126.34 148.91 49.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 62' ' ' ASP . . . . . 0.403 ' OD2' HG23 ' C' ' 65' ' ' VAL . 1.6 t70 -121.63 169.72 10.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.35 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.26 -32.7 4.89 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.52 -27.88 56.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 111.765 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.403 HG23 ' OD2' ' C' ' 62' ' ' ASP . 25.6 t -73.6 -56.81 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.64 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 66' ' ' ALA . . . . . 0.466 ' HB3' ' HB1' ' C' ' 20' ' ' ALA . . . -134.98 122.7 22.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.65 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.45 -50.1 5.14 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.861 0.362 . . . . 0.0 110.997 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 68' ' ' LYS . . . . . 0.429 ' HA ' ' HZ3' ' C' ' 68' ' ' LYS . 1.8 tptp -89.78 152.14 21.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.558 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' C' ' 122' ' ' THR . . . -144.26 137.84 27.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.575 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -113.41 157.24 22.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.073 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 71' ' ' VAL . . . . . 0.736 HG11 HG21 ' C' ' 131' ' ' ILE . 1.8 t -138.74 149.94 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.665 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.82 155.1 37.51 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.59 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 73' ' ' PHE . . . . . 0.552 ' CB ' HD13 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -124.99 136.66 53.93 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.012 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.568 HD11 ' HG3' ' F' ' 57' ' ' GLN . 0.9 OUTLIER -97.16 136.17 38.07 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.994 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 75' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' C' ' 113' ' ' LEU . . . -174.01 -172.95 39.74 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.817 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.666 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.2 OUTLIER -118.67 144.54 46.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.551 0.215 . . . . 0.0 110.796 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 77' ' ' ALA . . . . . 0.637 ' HB2' HG23 ' C' ' 83' ' ' THR . . . -62.5 138.6 58.5 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.913 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 78' ' ' ILE . . . . . 0.508 HG23 ' N ' ' C' ' 79' ' ' ASP . 5.7 tt -71.66 -45.54 66.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.85 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 79' ' ' ASP . . . . . 0.508 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.3 OUTLIER -133.15 42.47 3.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 80' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' C' ' 79' ' ' ASP . . . 70.19 -80.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.032 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.11 -29.68 68.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.609 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 82' ' ' HIS . . . . . 0.432 ' HB3' HG22 ' C' ' 78' ' ' ILE . 1.7 m80 -89.84 69.39 7.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.832 0.349 . . . . 0.0 110.424 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 83' ' ' THR . . . . . 0.637 HG23 ' HB2' ' C' ' 77' ' ' ALA . 0.2 OUTLIER -74.55 -16.13 60.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.604 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 84' ' ' ASN . . . . . 0.746 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 20.8 p-10 -66.18 -19.04 65.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.336 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.523 HG21 ' HB3' ' C' ' 138' ' ' PHE . 13.5 t -113.66 133.86 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.128 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.773 ' HG ' HD13 ' C' ' 113' ' ' LEU . 0.4 OUTLIER -67.91 161.53 26.22 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.267 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' C' ' 77' ' ' ALA . . . -103.58 -174.66 2.6 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.862 0.363 . . . . 0.0 111.764 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.702 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 0.3 OUTLIER -67.4 165.17 17.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.116 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 89' ' ' GLN . . . . . 0.525 ' CG ' ' HB2' ' C' ' 149' ' ' ASN . 3.6 mm100 -63.36 -79.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.365 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 90' ' ' SER . . . . . 0.449 ' O ' HG12 ' F' ' 52' ' ' VAL . 2.3 p -165.52 3.61 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.01 0.433 . . . . 0.0 111.579 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 91' ' ' SER . . . . . 0.533 ' HA ' ' HB2' ' E' ' 25' ' ' ALA . 0.7 OUTLIER -80.09 79.83 6.59 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 92' ' ' ALA . . . . . 0.522 ' HB2' HG13 ' F' ' 52' ' ' VAL . . . -57.09 -24.79 56.49 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.891 0.377 . . . . 0.0 111.634 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.17 33.94 5.25 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.69 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.85 0.46 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.937 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 95' ' ' SER . . . . . 0.702 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 38.6 m -96.78 177.94 5.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 110.607 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.52 -178.73 7.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.784 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 97' ' ' THR . . . . . 0.495 ' HB ' ' OG1' ' C' ' 144' ' ' THR . 2.0 m -134.44 119.02 18.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.369 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 98' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' C' ' 97' ' ' THR . 32.8 m-20 68.78 34.48 3.33 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.457 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 99' ' ' VAL . . . . . 0.751 HG13 HD23 ' C' ' 42' ' ' LEU . 0.4 OUTLIER -138.12 130.85 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.727 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.21 -170.63 19.01 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.566 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 101' ' ' VAL . . . . . 0.59 HG13 ' HB2' ' C' ' 86' ' ' LEU . 0.2 OUTLIER -119.62 114.51 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 123.028 0.531 . . . . 0.0 111.717 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 102' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 1.8 tt0 -87.39 150.2 23.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.923 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.563 HG12 ' HG ' ' C' ' 113' ' ' LEU . 0.8 OUTLIER -114.94 136.07 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.481 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.37 133.52 55.11 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.711 0.291 . . . . 0.0 111.032 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 105' ' ' ASP . . . . . 0.838 ' HB3' HG22 ' C' ' 107' ' ' THR . 6.1 t0 -82.24 149.74 27.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.674 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 106' ' ' ARG . . . . . 0.757 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.4 OUTLIER -67.87 -16.23 63.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.795 0.331 . . . . 0.0 111.058 179.537 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 107' ' ' THR . . . . . 0.838 HG22 ' HB3' ' C' ' 105' ' ' ASP . 8.8 t -63.62 -28.39 69.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.043 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.97 -40.46 1.58 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.717 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 109' ' ' ALA . . . . . 0.416 ' H ' HG23 ' C' ' 107' ' ' THR . . . -91.54 163.08 14.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.822 0.344 . . . . 0.0 110.999 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.14 133.36 35.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.198 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 111' ' ' LEU . . . . . 0.563 HD21 ' O ' ' C' ' 117' ' ' THR . 4.8 tp -96.72 149.98 21.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.368 0.604 . . . . 0.0 110.603 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 112' ' ' THR . . . . . 0.848 HG23 HG21 ' C' ' 117' ' ' THR . 1.9 t -98.43 141.73 30.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.773 HD13 ' HG ' ' C' ' 86' ' ' LEU . 1.6 mt -76.39 89.48 3.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.808 0.337 . . . . 0.0 110.727 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.15 -18.06 5.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.697 0.284 . . . . 0.0 111.525 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.78 -60.63 0.46 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.559 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 116' ' ' ALA . . . . . 0.504 ' HB2' ' C ' ' F' ' 128' ' ' THR . . . -96.46 26.96 4.04 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.996 0.427 . . . . 0.0 111.636 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 117' ' ' THR . . . . . 0.848 HG21 HG23 ' C' ' 112' ' ' THR . 0.0 OUTLIER -87.04 74.81 9.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.157 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 118' ' ' PHE . . . . . 0.595 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . 62.8 m-85 -94.93 92.93 7.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.812 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 25.6 m -136.35 68.94 1.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.831 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.83 150.27 28.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.646 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.34 67.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.178 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' C' ' 69' ' ' ALA . 0.2 OUTLIER -79.19 114.71 18.35 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.7 -179.509 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -74.02 128.04 34.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.729 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 124' ' ' LEU . . . . . 0.559 HD21 ' O ' ' C' ' 20' ' ' ALA . 4.0 tp -92.14 132.19 36.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.594 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.13 151.01 49.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.641 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 126' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' C' ' 61' ' ' CYS . 3.1 t30 -69.05 112.11 5.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.632 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.43 -138.93 8.77 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.756 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 128' ' ' THR . . . . . 0.709 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 87.0 m -98.72 82.54 2.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.642 0.258 . . . . 0.0 110.827 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 129' ' ' ASN . . . . . 0.454 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 2.3 t30 -71.84 148.13 46.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.89 0.376 . . . . 0.0 111.145 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 130' ' ' THR . . . . . 0.704 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -138.57 148.57 44.33 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.209 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 131' ' ' ILE . . . . . 0.736 HG21 HG11 ' C' ' 71' ' ' VAL . 15.7 mt -110.03 112.27 57.83 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 132' ' ' PRO . . . . . 0.757 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.6 Cg_endo -81.8 137.02 9.75 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.599 1.532 . . . . 0.0 112.566 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.01 136.09 19.94 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.727 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -111.5 158.38 19.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.081 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 135' ' ' ALA . . . . . 0.68 ' O ' HG22 ' C' ' 52' ' ' VAL . . . -154.18 111.36 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.969 0.414 . . . . 0.0 111.64 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.481 ' HB3' ' CA ' ' C' ' 51' ' ' ALA . 19.8 ptt180 -108.89 174.06 6.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.385 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 137' ' ' TYR . . . . . 0.706 ' HB3' HD21 ' C' ' 42' ' ' LEU . 1.7 m-85 -81.41 137.73 35.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.103 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 138' ' ' PHE . . . . . 0.523 ' HB3' HG21 ' C' ' 85' ' ' VAL . 0.9 OUTLIER -131.58 124.13 29.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.092 -179.25 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 139' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' C' ' 47' ' ' ALA . . . -108.48 130.19 55.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.824 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 140' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' C' ' 45' ' ' GLU . 0.2 OUTLIER -77.46 -27.93 52.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.518 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.5 -96.54 0.11 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.955 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.95 98.49 8.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.578 0.227 . . . . 0.0 110.714 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 143' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -56.56 148.92 18.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.757 0.313 . . . . 0.0 111.364 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 144' ' ' THR . . . . . 0.715 ' CG2' ' CD ' ' C' ' 145' ' ' PRO . 91.0 m -125.43 156.99 69.5 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.247 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 145' ' ' PRO . . . . . 0.715 ' CD ' ' CG2' ' C' ' 144' ' ' THR . 1.5 Cg_endo -83.38 136.17 7.51 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.631 2.22 . . . . 0.0 111.987 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 146' ' ' GLY . . . . . 0.577 ' O ' ' HG3' ' B' ' 15' ' ' GLU . . . 163.62 -127.57 1.69 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.429 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 147' ' ' ALA . . . . . 0.659 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -110.88 132.9 53.81 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.763 0.316 . . . . 0.0 111.369 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 148' ' ' ALA . . . . . 0.761 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -124.28 43.78 2.91 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.107 0.479 . . . . 0.0 110.438 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 149' ' ' ASN . . . . . 0.525 ' HB2' ' CG ' ' C' ' 89' ' ' GLN . 13.8 m-80 -92.33 144.27 25.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.511 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 150' ' ' ALA . . . . . 0.695 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -160.66 178.88 9.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.989 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 151' ' ' ASP . . . . . 0.636 ' OD1' ' HA ' ' B' ' 11' ' ' HIS . 15.6 t70 -146.98 145.02 29.6 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.298 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 152' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -133.75 139.78 46.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.273 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 153' ' ' THR . . . . . 0.954 HG23 HG22 ' B' ' 9' ' ' THR . 0.2 OUTLIER -101.11 135.28 42.83 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.202 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 154' ' ' PHE . . . . . 0.531 ' HB3' ' H ' ' B' ' 8' ' ' GLY . 0.2 OUTLIER -81.54 152.17 27.4 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.06 0.457 . . . . 0.0 110.136 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 155' ' ' LYS . . . . . 0.419 ' HE3' ' HB ' ' F' ' 128' ' ' THR . 15.2 mmtm -134.24 146.87 50.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.934 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 156' ' ' VAL . . . . . 0.616 HG23 HG23 ' B' ' 5' ' ' VAL . 33.1 m -139.18 140.79 37.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.859 0.362 . . . . 0.0 111.622 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 157' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' B' ' 3' ' ' THR . 0.1 OUTLIER -134.53 132.68 39.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.335 0.588 . . . . 0.0 110.406 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 158' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' C' ' 21' ' ' CYS . 11.0 m-85 -107.35 128.04 54.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.541 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.823 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.267 0.079 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 2' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' E' ' 158' ' ' TYR . . . 52.85 88.35 0.03 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.976 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 3' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' E' ' 157' ' ' GLN . 5.4 m -123.0 116.2 23.16 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.413 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -99.6 117.22 33.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.582 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.629 HG23 HG23 ' E' ' 156' ' ' VAL . 1.8 m -144.44 158.03 15.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.655 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 6' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' E' ' 154' ' ' PHE . 13.2 t30 -78.71 123.75 27.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.597 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.83 -71.1 1.02 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.792 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 8' ' ' GLY . . . . . 0.522 ' H ' ' HB3' ' E' ' 154' ' ' PHE . . . -152.75 -146.98 4.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.806 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 9' ' ' THR . . . . . 0.932 HG22 HG23 ' E' ' 153' ' ' THR . 24.1 p -148.76 134.49 18.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.011 0.434 . . . . 0.0 111.258 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.4 124.37 72.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.159 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 11' ' ' HIS . . . . . 0.619 ' HA ' ' OD1' ' E' ' 151' ' ' ASP . 57.3 t-80 -91.52 116.17 28.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.292 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -96.84 105.49 17.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.814 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -104.64 118.73 37.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.422 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.31 172.93 30.82 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.945 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 15' ' ' GLU . . . . . 0.744 ' O ' ' HA ' ' E' ' 36' ' ' GLN . 25.8 tt0 -160.36 135.96 8.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.943 0.401 . . . . 0.0 110.339 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.777 HG23 ' HB2' ' E' ' 148' ' ' ALA . 43.2 t -96.79 132.81 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.25 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.563 HG11 ' OE1' ' E' ' 36' ' ' GLN . 18.2 m -133.91 -177.16 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.897 0.38 . . . . 0.0 111.008 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 18' ' ' ASN . . . . . 0.565 ' HA ' HG22 ' E' ' 39' ' ' THR . 0.3 OUTLIER -75.74 -170.37 1.3 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.932 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.74 45.41 0.98 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.029 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.576 ' O ' HD21 ' D' ' 124' ' ' LEU . . . -121.36 -24.78 5.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.369 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 21' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER -168.82 140.65 2.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.881 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 22' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' D' ' 60' ' ' ASP . . . -132.8 116.99 17.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.068 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 23' ' ' VAL . . . . . 0.738 HG12 ' HB2' ' E' ' 36' ' ' GLN . 0.5 OUTLIER -67.05 146.18 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.044 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.467 ' O ' HG23 ' D' ' 28' ' ' VAL . 12.9 t0 -80.33 152.04 29.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.58 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -62.69 -40.07 95.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.464 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.91 2.64 85.81 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.867 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -106.17 -19.94 13.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.845 0.355 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 28' ' ' VAL . . . . . 0.467 HG23 ' O ' ' D' ' 24' ' ' ASP . 39.8 t -47.42 -52.1 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.344 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.19 136.41 48.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.032 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.72 136.92 39.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.035 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.48 102.77 12.69 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.057 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 25.7 t -107.64 128.29 62.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.058 0.456 . . . . 0.0 110.56 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -114.75 123.03 48.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.614 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.4 -42.71 15.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.684 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.55 -167.43 13.16 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.618 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' GLN . . . . . 0.738 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 2.9 mt-30 -96.79 124.58 40.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.618 0.247 . . . . 0.0 110.845 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.86 147.52 11.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.822 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.77 134.98 34.3 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.661 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.569 HG22 ' HA ' ' C' ' 18' ' ' ASN . 0.0 OUTLIER -60.04 -44.42 94.66 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.828 179.321 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.35 -36.78 61.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.135 0.493 . . . . 0.0 110.92 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.94 -35.86 62.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.135 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.746 HD23 HG13 ' D' ' 99' ' ' VAL . 2.9 mp -106.6 34.55 3.35 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.614 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.9 15.8 27.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.32 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.94 132.09 56.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.323 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 45' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' D' ' 140' ' ' THR . 6.8 tt0 -56.55 108.78 0.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.744 0.307 . . . . 0.0 111.117 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.95 25.88 10.14 Favored Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.136 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' D' ' 139' ' ' ALA . . . -71.48 137.76 48.45 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.963 0.411 . . . . 0.0 112.058 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 7.3 p -137.01 122.77 19.93 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.92 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' D' ' 136' ' ' ARG . 53.4 m -100.12 -175.19 2.88 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.606 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 2.9 t -55.59 137.31 49.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.808 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 51' ' ' ALA . . . . . 0.48 ' CA ' ' HB3' ' D' ' 136' ' ' ARG . . . -92.41 133.51 35.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.348 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 52' ' ' VAL . . . . . 0.675 HG22 ' O ' ' D' ' 135' ' ' ALA . 26.6 m -76.76 162.47 4.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.49 141.16 16.78 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.552 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.569 ' H ' HG21 ' A' ' 76' ' ' THR . 39.4 p90 -173.74 137.79 0.62 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.783 0.325 . . . . 0.0 110.965 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 55' ' ' ASN . . . . . 0.501 ' OD1' HD21 ' A' ' 74' ' ' LEU . 17.9 p30 -136.5 145.81 45.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.681 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.532 HG23 ' O ' ' D' ' 56' ' ' ILE . 1.2 tp -90.95 116.76 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.627 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 57' ' ' GLN . . . . . 0.729 ' HA ' HG23 ' D' ' 130' ' ' THR . 1.3 mp0 -72.87 128.59 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.803 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 58' ' ' LEU . . . . . 0.46 ' HG ' ' HA ' ' D' ' 23' ' ' VAL . 0.3 OUTLIER -137.31 89.11 2.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.264 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 59' ' ' ASN . . . . . 0.722 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 9.8 p30 -74.76 176.54 6.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.951 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 60' ' ' ASP . . . . . 0.505 ' HB2' ' HB3' ' D' ' 22' ' ' ALA . 0.9 OUTLIER 58.9 74.79 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.888 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 61' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 36.6 m -126.33 148.89 49.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.808 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 62' ' ' ASP . . . . . 0.412 ' OD2' HG23 ' D' ' 65' ' ' VAL . 1.5 t70 -121.61 169.78 10.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.317 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.32 -32.63 4.9 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -76.57 -27.89 56.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.197 0.522 . . . . 0.0 111.742 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 65' ' ' VAL . . . . . 0.412 HG23 ' OD2' ' D' ' 62' ' ' ASP . 25.6 t -73.57 -56.83 8.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.677 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.458 ' HB3' ' HB1' ' D' ' 20' ' ' ALA . . . -134.93 122.77 22.39 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.647 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.57 -50.02 5.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.921 0.391 . . . . 0.0 110.977 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -89.84 152.12 21.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.517 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 69' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' D' ' 122' ' ' THR . . . -144.22 137.86 27.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.586 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 70' ' ' ALA . . . . . 0.596 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -113.41 157.23 22.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.078 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 71' ' ' VAL . . . . . 0.739 HG11 HG21 ' D' ' 131' ' ' ILE . 1.8 t -138.7 150.0 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.638 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.8 155.11 37.54 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.624 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 73' ' ' PHE . . . . . 0.546 ' CB ' HD13 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -125.08 136.69 53.9 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.651 0.262 . . . . 0.0 111.012 179.764 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 74' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.9 OUTLIER -97.19 136.12 38.16 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.978 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 75' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' D' ' 113' ' ' LEU . . . -174.03 -172.96 39.76 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.744 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 76' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.2 OUTLIER -118.72 144.57 46.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.552 0.215 . . . . 0.0 110.801 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.632 ' HB2' HG23 ' D' ' 83' ' ' THR . . . -62.47 138.53 58.48 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.91 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 78' ' ' ILE . . . . . 0.507 HG23 ' N ' ' D' ' 79' ' ' ASP . 5.7 tt -71.52 -45.65 67.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.893 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.507 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.3 OUTLIER -133.15 42.55 3.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.771 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 80' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' D' ' 79' ' ' ASP . . . 70.16 -80.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.11 -29.7 68.89 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.529 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 82' ' ' HIS . . . . . 0.445 ' HB3' HG22 ' D' ' 78' ' ' ILE . 1.7 m80 -89.82 69.39 7.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.754 0.311 . . . . 0.0 110.436 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 83' ' ' THR . . . . . 0.632 HG23 ' HB2' ' D' ' 77' ' ' ALA . 0.2 OUTLIER -74.56 -16.15 60.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.6 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 84' ' ' ASN . . . . . 0.746 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 20.8 p-10 -66.24 -19.08 65.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.261 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' D' ' 138' ' ' PHE . 13.4 t -113.57 133.84 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.179 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.765 ' HG ' HD13 ' D' ' 113' ' ' LEU . 0.4 OUTLIER -67.87 161.47 26.27 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' D' ' 77' ' ' ALA . . . -103.59 -174.72 2.61 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.837 0.351 . . . . 0.0 111.79 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.709 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 0.3 OUTLIER -67.33 165.23 16.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.104 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 89' ' ' GLN . . . . . 0.529 ' CG ' ' HB2' ' D' ' 149' ' ' ASN . 3.6 mm100 -63.43 -79.76 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.323 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -165.46 3.78 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.051 0.453 . . . . 0.0 111.6 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 91' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' F' ' 25' ' ' ALA . 0.7 OUTLIER -80.09 79.72 6.6 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.06 -24.77 56.27 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.815 0.341 . . . . 0.0 111.606 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.13 33.89 5.27 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.731 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.75 0.43 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.935 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 95' ' ' SER . . . . . 0.709 ' HB3' ' HG ' ' D' ' 88' ' ' LEU . 38.7 m -96.7 177.94 5.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 110.679 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.52 -178.7 7.06 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.796 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 97' ' ' THR . . . . . 0.493 ' HB ' ' OG1' ' D' ' 144' ' ' THR . 2.0 m -134.41 119.08 18.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.354 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 98' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' D' ' 97' ' ' THR . 32.4 m-20 68.67 34.56 3.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.439 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 99' ' ' VAL . . . . . 0.746 HG13 HD23 ' D' ' 42' ' ' LEU . 0.4 OUTLIER -138.16 130.81 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.755 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.15 -170.62 18.95 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.539 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 101' ' ' VAL . . . . . 0.589 HG13 ' HB2' ' D' ' 86' ' ' LEU . 0.2 OUTLIER -119.66 114.49 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.036 0.534 . . . . 0.0 111.654 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 102' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 1.8 tt0 -87.36 150.22 23.98 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.887 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 103' ' ' ILE . . . . . 0.554 HG12 ' HG ' ' D' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 136.07 52.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.461 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.34 133.47 55.12 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.636 0.255 . . . . 0.0 111.053 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 105' ' ' ASP . . . . . 0.854 ' HB3' HG22 ' D' ' 107' ' ' THR . 6.1 t0 -82.21 149.77 27.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.725 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 106' ' ' ARG . . . . . 0.754 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.4 OUTLIER -67.89 -16.23 63.98 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.729 0.3 . . . . 0.0 111.046 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 107' ' ' THR . . . . . 0.854 HG22 ' HB3' ' D' ' 105' ' ' ASP . 8.8 t -63.65 -28.42 69.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.039 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.01 -40.41 1.59 Allowed Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.64 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 109' ' ' ALA . . . . . 0.411 ' H ' HG23 ' D' ' 107' ' ' THR . . . -91.46 163.06 14.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.777 0.322 . . . . 0.0 111.054 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.08 133.3 35.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.207 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 111' ' ' LEU . . . . . 0.567 HD21 ' O ' ' D' ' 117' ' ' THR . 4.8 tp -96.73 150.06 21.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.356 0.598 . . . . 0.0 110.516 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 112' ' ' THR . . . . . 0.863 HG23 HG21 ' D' ' 117' ' ' THR . 1.9 t -98.53 141.72 31.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.098 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 113' ' ' LEU . . . . . 0.765 HD13 ' HG ' ' D' ' 86' ' ' LEU . 1.6 mt -76.34 89.51 3.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.735 0.302 . . . . 0.0 110.765 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.15 -18.19 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.652 0.263 . . . . 0.0 111.497 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.82 -60.65 0.46 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.618 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 116' ' ' ALA . . . . . 0.461 ' HA ' ' CE2' ' D' ' 118' ' ' PHE . . . -96.43 26.94 4.04 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.948 0.404 . . . . 0.0 111.631 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 117' ' ' THR . . . . . 0.863 HG21 HG23 ' D' ' 112' ' ' THR . 0.0 OUTLIER -87.02 74.89 9.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.199 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.596 ' HB3' ' HB1' ' D' ' 70' ' ' ALA . 63.1 m-85 -94.94 92.86 7.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.834 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 25.5 m -136.27 68.9 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.81 150.23 28.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.616 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -107.3 67.71 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.135 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.611 ' O ' ' HB3' ' D' ' 69' ' ' ALA . 0.2 OUTLIER -79.23 114.67 18.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.735 -179.576 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -73.97 127.94 34.2 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.756 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 124' ' ' LEU . . . . . 0.576 HD21 ' O ' ' D' ' 20' ' ' ALA . 4.0 tp -92.01 132.14 36.77 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.649 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.09 151.14 49.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.6 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 126' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' D' ' 61' ' ' CYS . 3.1 t30 -69.1 112.08 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.613 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.55 -138.91 8.72 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.659 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 128' ' ' THR . . . . . 0.722 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 87.7 m -98.81 82.58 2.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.642 0.258 . . . . 0.0 110.729 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 129' ' ' ASN . . . . . 0.504 ' N ' ' HB2' ' A' ' 116' ' ' ALA . 2.3 t30 -71.88 148.16 46.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.937 0.398 . . . . 0.0 111.06 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 130' ' ' THR . . . . . 0.729 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.2 OUTLIER -138.57 148.64 44.41 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.161 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 131' ' ' ILE . . . . . 0.739 HG21 HG11 ' D' ' 71' ' ' VAL . 15.8 mt -110.09 112.28 57.7 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 132' ' ' PRO . . . . . 0.754 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.5 Cg_endo -81.77 136.97 9.76 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.677 1.585 . . . . 0.0 112.597 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.04 136.06 19.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.676 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -111.42 158.34 19.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.055 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.675 ' O ' HG22 ' D' ' 52' ' ' VAL . . . -154.18 111.29 3.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.935 0.397 . . . . 0.0 111.637 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 136' ' ' ARG . . . . . 0.48 ' HB3' ' CA ' ' D' ' 51' ' ' ALA . 19.8 ptt180 -108.85 174.21 5.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.346 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 137' ' ' TYR . . . . . 0.696 ' HB3' HD21 ' D' ' 42' ' ' LEU . 1.7 m-85 -81.53 137.68 35.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.03 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 138' ' ' PHE . . . . . 0.529 ' HB3' HG21 ' D' ' 85' ' ' VAL . 0.9 OUTLIER -131.55 124.11 29.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.136 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 139' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' D' ' 47' ' ' ALA . . . -108.42 130.28 55.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.855 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 140' ' ' THR . . . . . 0.499 ' O ' ' HG3' ' D' ' 45' ' ' GLU . 0.2 OUTLIER -77.49 -28.02 52.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.535 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.41 -96.47 0.11 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.879 -0.676 . . . . 0.0 113.057 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.03 98.49 8.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.551 0.215 . . . . 0.0 110.697 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 143' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -56.59 148.91 18.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.758 0.313 . . . . 0.0 111.404 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 144' ' ' THR . . . . . 0.716 ' CG2' ' CD ' ' D' ' 145' ' ' PRO . 91.6 m -125.38 156.93 69.45 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.288 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 145' ' ' PRO . . . . . 0.716 ' CD ' ' CG2' ' D' ' 144' ' ' THR . 1.5 Cg_endo -83.28 136.18 7.63 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.584 2.189 . . . . 0.0 111.989 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 146' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' C' ' 15' ' ' GLU . . . 163.58 -127.53 1.69 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.472 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 147' ' ' ALA . . . . . 0.649 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -110.98 132.88 53.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.842 0.354 . . . . 0.0 111.354 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 148' ' ' ALA . . . . . 0.77 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -124.25 43.74 2.92 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.148 0.499 . . . . 0.0 110.43 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 149' ' ' ASN . . . . . 0.529 ' HB2' ' CG ' ' D' ' 89' ' ' GLN . 13.9 m-80 -92.34 144.25 25.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.499 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 150' ' ' ALA . . . . . 0.699 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -160.6 178.93 9.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.975 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 151' ' ' ASP . . . . . 0.632 ' OD1' ' HA ' ' C' ' 11' ' ' HIS . 15.6 t70 -147.03 145.02 29.55 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.226 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 152' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -133.76 139.71 46.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.198 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 153' ' ' THR . . . . . 0.93 HG23 HG22 ' C' ' 9' ' ' THR . 0.2 OUTLIER -100.99 135.26 42.73 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 154' ' ' PHE . . . . . 0.541 ' HB3' ' H ' ' C' ' 8' ' ' GLY . 0.2 OUTLIER -81.56 152.16 27.37 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.054 0.454 . . . . 0.0 110.136 -179.123 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 155' ' ' LYS . . . . . 0.407 ' O ' HG13 ' D' ' 71' ' ' VAL . 15.2 mmtm -134.25 146.88 50.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.908 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 156' ' ' VAL . . . . . 0.629 HG23 HG23 ' C' ' 5' ' ' VAL . 33.1 m -139.09 140.78 37.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.786 0.326 . . . . 0.0 111.626 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 157' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' C' ' 3' ' ' THR . 0.9 OUTLIER -134.54 132.65 39.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.297 0.57 . . . . 0.0 110.425 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 158' ' ' TYR . . . . . 0.567 ' CE1' ' HB2' ' D' ' 21' ' ' CYS . 11.0 m-85 -107.25 128.05 54.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.514 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.849 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.249 0.071 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 2' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' F' ' 158' ' ' TYR . . . 52.85 88.26 0.03 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.994 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 3' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' F' ' 157' ' ' GLN . 5.5 m -122.92 116.29 23.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.385 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -99.69 117.17 33.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.521 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.626 HG23 HG23 ' F' ' 156' ' ' VAL . 1.8 m -144.42 157.99 15.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.618 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 6' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' F' ' 154' ' ' PHE . 13.2 t30 -78.62 123.81 27.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.58 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.83 -71.15 1.01 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.827 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 8' ' ' GLY . . . . . 0.543 ' H ' ' HB3' ' F' ' 154' ' ' PHE . . . -152.7 -146.96 4.48 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.816 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 9' ' ' THR . . . . . 0.951 HG22 HG23 ' F' ' 153' ' ' THR . 24.4 p -148.75 134.42 18.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.005 0.431 . . . . 0.0 111.268 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.33 124.38 72.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.169 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 11' ' ' HIS . . . . . 0.627 ' HA ' ' OD1' ' F' ' 151' ' ' ASP . 57.4 t-80 -91.56 116.2 28.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.306 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -96.78 105.47 17.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.753 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -104.58 118.69 37.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.512 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.27 172.89 30.79 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.924 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 15' ' ' GLU . . . . . 0.735 ' O ' ' HA ' ' F' ' 36' ' ' GLN . 25.8 tt0 -160.3 135.95 8.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.896 0.379 . . . . 0.0 110.384 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 16' ' ' VAL . . . . . 0.764 HG23 ' HB2' ' F' ' 148' ' ' ALA . 43.2 t -96.83 132.78 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.243 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 17' ' ' VAL . . . . . 0.565 HG11 ' OE1' ' F' ' 36' ' ' GLN . 18.2 m -133.91 -177.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.878 0.371 . . . . 0.0 111.007 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 18' ' ' ASN . . . . . 0.563 ' HA ' HG22 ' F' ' 39' ' ' THR . 0.3 OUTLIER -75.76 -170.28 1.28 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.894 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.73 45.35 0.98 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.078 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.562 ' O ' HD21 ' E' ' 124' ' ' LEU . . . -121.24 -24.9 5.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.424 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 21' ' ' CYS . . . . . 0.857 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER -168.8 140.69 2.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.888 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 22' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' E' ' 60' ' ' ASP . . . -132.86 116.95 17.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.066 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 23' ' ' VAL . . . . . 0.745 HG12 ' HB2' ' F' ' 36' ' ' GLN . 0.5 OUTLIER -67.03 146.26 13.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.101 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 24' ' ' ASP . . . . . 0.474 ' O ' HG23 ' E' ' 28' ' ' VAL . 12.9 t0 -80.37 152.08 29.08 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.547 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 25' ' ' ALA . . . . . 0.533 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -62.77 -40.06 96.12 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.419 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.93 2.72 85.83 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.891 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -106.23 -19.86 13.57 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.823 0.344 . . . . 0.0 110.825 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 28' ' ' VAL . . . . . 0.474 HG23 ' O ' ' E' ' 24' ' ' ASP . 39.7 t -47.4 -52.16 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.35 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.21 136.45 48.66 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.029 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.73 136.84 39.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.014 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.44 102.89 12.82 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.042 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.69 128.25 63.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.068 0.461 . . . . 0.0 110.547 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -114.64 123.02 48.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.693 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.45 -42.72 15.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.581 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.51 -167.45 13.18 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.587 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 36' ' ' GLN . . . . . 0.744 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 2.9 mt-30 -96.77 124.45 40.75 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.589 0.233 . . . . 0.0 110.927 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.77 147.52 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.848 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.68 134.93 34.34 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.698 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 39' ' ' THR . . . . . 0.565 HG22 ' HA ' ' D' ' 18' ' ' ASN . 0.0 OUTLIER -59.99 -44.48 94.49 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.815 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.25 -36.96 61.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.081 0.467 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.85 -35.83 62.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.165 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.739 HD23 HG13 ' E' ' 99' ' ' VAL . 3.0 mp -106.59 34.51 3.37 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.667 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.92 15.84 27.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.375 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.99 132.07 56.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.283 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 45' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' E' ' 140' ' ' THR . 6.8 tt0 -56.5 108.69 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.766 0.317 . . . . 0.0 111.124 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.96 25.97 10.05 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.09 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 47' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' E' ' 139' ' ' ALA . . . -71.49 137.75 48.43 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 7.4 p -137.0 122.71 19.86 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.898 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' E' ' 136' ' ' ARG . 54.2 m -100.02 -175.25 2.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.659 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 50' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 2.8 t -55.63 137.28 49.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.787 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 51' ' ' ALA . . . . . 0.478 ' CA ' ' HB3' ' E' ' 136' ' ' ARG . . . -92.28 133.56 35.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.344 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 52' ' ' VAL . . . . . 0.686 HG22 ' O ' ' E' ' 135' ' ' ALA . 26.2 m -76.78 162.48 4.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.52 141.17 16.78 Favored Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.538 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 54' ' ' PHE . . . . . 0.556 ' H ' HG21 ' B' ' 76' ' ' THR . 39.3 p90 -173.74 137.8 0.62 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.758 0.313 . . . . 0.0 110.941 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 55' ' ' ASN . . . . . 0.496 ' OD1' HD21 ' B' ' 74' ' ' LEU . 18.0 p30 -136.44 145.83 45.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.692 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 56' ' ' ILE . . . . . 0.528 HG23 ' O ' ' E' ' 56' ' ' ILE . 1.2 tp -91.04 116.8 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.617 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 57' ' ' GLN . . . . . 0.726 ' HA ' HG23 ' E' ' 130' ' ' THR . 1.3 mp0 -72.87 128.65 36.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.78 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 58' ' ' LEU . . . . . 0.458 ' HG ' ' HA ' ' E' ' 23' ' ' VAL . 0.3 OUTLIER -137.39 89.2 2.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.236 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 59' ' ' ASN . . . . . 0.694 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 9.8 p30 -74.9 176.51 7.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.985 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 60' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' E' ' 22' ' ' ALA . 0.9 OUTLIER 58.98 74.85 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.775 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 61' ' ' CYS . . . . . 0.857 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 36.8 m -126.37 148.87 49.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 62' ' ' ASP . . . . . 0.407 ' OD2' HG23 ' E' ' 65' ' ' VAL . 1.6 t70 -121.58 169.77 10.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.317 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.27 -32.69 4.89 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.55 -27.95 56.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.155 0.502 . . . . 0.0 111.685 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 65' ' ' VAL . . . . . 0.407 HG23 ' OD2' ' E' ' 62' ' ' ASP . 25.6 t -73.58 -56.76 8.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.702 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 66' ' ' ALA . . . . . 0.465 ' HB3' ' HB1' ' E' ' 20' ' ' ALA . . . -134.94 122.75 22.35 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.672 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.62 -50.02 5.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.927 0.394 . . . . 0.0 110.932 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 68' ' ' LYS . . . . . 0.4 ' HA ' ' NZ ' ' E' ' 68' ' ' LYS . 1.8 tptp -89.75 152.09 21.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.567 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 69' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' E' ' 122' ' ' THR . . . -144.25 137.9 27.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.521 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 70' ' ' ALA . . . . . 0.599 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -113.41 157.22 22.19 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.094 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 71' ' ' VAL . . . . . 0.757 HG11 HG21 ' E' ' 131' ' ' ILE . 1.8 t -138.75 150.06 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.649 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.87 155.03 37.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.57 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 73' ' ' PHE . . . . . 0.557 ' CB ' HD13 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -124.98 136.66 53.94 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.592 0.234 . . . . 0.0 111.071 179.764 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 74' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.9 OUTLIER -97.21 136.13 38.16 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.011 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 75' ' ' GLY . . . . . 0.449 ' CA ' ' HB3' ' E' ' 113' ' ' LEU . . . -174.01 -172.94 39.72 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.735 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 76' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.2 OUTLIER -118.71 144.53 46.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.497 0.189 . . . . 0.0 110.826 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 77' ' ' ALA . . . . . 0.652 ' HB2' HG23 ' E' ' 83' ' ' THR . . . -62.42 138.51 58.47 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.963 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 78' ' ' ILE . . . . . 0.51 HG23 ' N ' ' E' ' 79' ' ' ASP . 5.7 tt -71.6 -45.59 66.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.843 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 79' ' ' ASP . . . . . 0.51 ' N ' HG23 ' E' ' 78' ' ' ILE . 0.3 OUTLIER -133.11 42.49 3.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.833 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 80' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' E' ' 79' ' ' ASP . . . 70.09 -80.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.002 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.15 -29.64 68.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.584 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 82' ' ' HIS . . . . . 0.425 ' HB3' HG22 ' E' ' 78' ' ' ILE . 1.7 m80 -89.9 69.45 7.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.874 0.369 . . . . 0.0 110.414 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 83' ' ' THR . . . . . 0.652 HG23 ' HB2' ' E' ' 77' ' ' ALA . 0.2 OUTLIER -74.55 -16.16 60.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.585 -179.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 84' ' ' ASN . . . . . 0.729 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 20.7 p-10 -66.2 -19.09 65.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.292 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' E' ' 138' ' ' PHE . 13.4 t -113.56 133.81 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.188 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 86' ' ' LEU . . . . . 0.775 ' HG ' HD13 ' E' ' 113' ' ' LEU . 0.4 OUTLIER -67.81 161.6 25.85 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 87' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' E' ' 77' ' ' ALA . . . -103.63 -174.75 2.62 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.936 0.398 . . . . 0.0 111.727 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.704 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 0.3 OUTLIER -67.37 165.18 16.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.082 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 89' ' ' GLN . . . . . 0.515 ' CG ' ' HB2' ' E' ' 149' ' ' ASN . 3.6 mm100 -63.41 -79.7 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.376 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -165.49 3.7 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.019 0.437 . . . . 0.0 111.538 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.04 79.77 6.54 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.923 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.14 -24.69 55.98 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.853 0.359 . . . . 0.0 111.573 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.22 34.0 5.23 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.689 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.88 0.47 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.952 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 95' ' ' SER . . . . . 0.704 ' HB3' ' HG ' ' E' ' 88' ' ' LEU . 38.4 m -96.84 177.94 5.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.915 0.388 . . . . 0.0 110.598 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.46 -178.72 7.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.797 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 97' ' ' THR . . . . . 0.497 ' HB ' ' OG1' ' E' ' 144' ' ' THR . 2.0 m -134.44 119.06 18.09 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.373 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 98' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' E' ' 97' ' ' THR . 32.8 m-20 68.76 34.4 3.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.471 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 99' ' ' VAL . . . . . 0.739 HG13 HD23 ' E' ' 42' ' ' LEU . 0.4 OUTLIER -138.06 130.85 40.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.796 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.08 -170.57 18.85 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.538 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 101' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' E' ' 86' ' ' LEU . 0.2 OUTLIER -119.7 114.47 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.028 0.531 . . . . 0.0 111.749 -179.713 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 102' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 1.8 tt0 -87.37 150.24 23.95 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.877 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 103' ' ' ILE . . . . . 0.557 HD13 ' CB ' ' E' ' 73' ' ' PHE . 0.8 OUTLIER -115.0 136.01 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.417 179.496 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.31 133.52 55.08 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.7 0.286 . . . . 0.0 111.073 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 105' ' ' ASP . . . . . 0.866 ' HB3' HG22 ' E' ' 107' ' ' THR . 6.1 t0 -82.27 149.76 27.65 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.655 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 106' ' ' ARG . . . . . 0.735 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.4 OUTLIER -67.88 -16.2 63.97 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.762 0.315 . . . . 0.0 111.065 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 107' ' ' THR . . . . . 0.866 HG22 ' HB3' ' E' ' 105' ' ' ASP . 8.9 t -63.72 -28.35 69.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.003 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.0 -40.54 1.57 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.684 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 109' ' ' ALA . . . . . 0.42 ' H ' HG23 ' E' ' 107' ' ' THR . . . -91.42 163.04 14.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 0.0 111.039 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.09 133.36 35.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.229 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 111' ' ' LEU . . . . . 0.571 HD21 ' O ' ' E' ' 117' ' ' THR . 4.8 tp -96.72 150.03 21.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.383 0.611 . . . . 0.0 110.5 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 112' ' ' THR . . . . . 0.866 HG23 HG21 ' E' ' 117' ' ' THR . 1.9 t -98.42 141.7 30.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.183 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 113' ' ' LEU . . . . . 0.775 HD13 ' HG ' ' E' ' 86' ' ' LEU . 1.6 mt -76.33 89.36 3.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.758 0.313 . . . . 0.0 110.758 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.0 -18.21 5.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.652 0.263 . . . . 0.0 111.52 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.78 -60.65 0.46 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.681 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 116' ' ' ALA . . . . . 0.463 ' HA ' ' CE2' ' E' ' 118' ' ' PHE . . . -96.48 27.04 4.01 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.028 0.442 . . . . 0.0 111.641 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 117' ' ' THR . . . . . 0.866 HG21 HG23 ' E' ' 112' ' ' THR . 0.0 OUTLIER -87.11 74.86 9.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.13 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 118' ' ' PHE . . . . . 0.599 ' HB3' ' HB1' ' E' ' 70' ' ' ALA . 62.8 m-85 -94.87 92.89 7.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.823 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 25.7 m -136.32 68.85 1.43 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.829 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.84 150.31 28.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.579 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.39 67.73 0.7 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.083 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 122' ' ' THR . . . . . 0.613 ' O ' ' HB3' ' E' ' 69' ' ' ALA . 0.2 OUTLIER -79.19 114.74 18.37 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.704 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -74.02 127.98 34.31 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.676 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 124' ' ' LEU . . . . . 0.562 HD21 ' O ' ' E' ' 20' ' ' ALA . 4.0 tp -92.04 132.17 36.76 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.651 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.13 151.1 49.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.608 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 126' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' E' ' 61' ' ' CYS . 3.1 t30 -69.1 112.08 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.668 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 127' ' ' GLY . . . . . 0.488 ' CA ' HG21 ' A' ' 4' ' ' THR . . . 142.56 -138.85 8.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.724 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 128' ' ' THR . . . . . 0.694 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 87.4 m -98.85 82.49 2.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.676 0.274 . . . . 0.0 110.84 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 129' ' ' ASN . . . . . 0.501 ' N ' ' HB2' ' B' ' 116' ' ' ALA . 2.3 t30 -71.82 148.18 46.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.938 0.399 . . . . 0.0 111.07 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 130' ' ' THR . . . . . 0.726 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.2 OUTLIER -138.63 148.6 44.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.138 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 131' ' ' ILE . . . . . 0.757 HG21 HG11 ' E' ' 71' ' ' VAL . 15.6 mt -109.96 112.2 58.04 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 132' ' ' PRO . . . . . 0.735 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.5 Cg_endo -81.77 137.01 9.78 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.671 1.581 . . . . 0.0 112.585 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.06 135.98 19.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.782 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -111.44 158.36 19.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.076 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 135' ' ' ALA . . . . . 0.686 ' O ' HG22 ' E' ' 52' ' ' VAL . . . -154.16 111.36 3.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.979 0.419 . . . . 0.0 111.616 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 136' ' ' ARG . . . . . 0.478 ' HB3' ' CA ' ' E' ' 51' ' ' ALA . 19.8 ptt180 -108.91 174.1 6.02 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.375 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 137' ' ' TYR . . . . . 0.701 ' HB3' HD21 ' E' ' 42' ' ' LEU . 1.7 m-85 -81.41 137.68 35.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.067 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 138' ' ' PHE . . . . . 0.514 ' HB3' HG21 ' E' ' 85' ' ' VAL . 0.9 OUTLIER -131.52 124.14 29.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.14 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 139' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' E' ' 47' ' ' ALA . . . -108.49 130.23 55.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.815 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 140' ' ' THR . . . . . 0.5 ' O ' ' HG3' ' E' ' 45' ' ' GLU . 0.2 OUTLIER -77.47 -27.96 52.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.537 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.46 -96.46 0.11 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.971 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.02 98.46 8.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.606 0.203 . . . . 0.0 110.623 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 143' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -56.59 148.86 18.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 111.373 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 144' ' ' THR . . . . . 0.728 ' CG2' ' CD ' ' E' ' 145' ' ' PRO . 93.2 m -125.35 156.93 69.4 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.316 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 145' ' ' PRO . . . . . 0.728 ' CD ' ' CG2' ' E' ' 144' ' ' THR . 1.4 Cg_endo -83.34 136.27 7.61 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.507 2.138 . . . . 0.0 111.993 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 146' ' ' GLY . . . . . 0.58 ' O ' ' HG3' ' D' ' 15' ' ' GLU . . . 163.56 -127.57 1.7 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.434 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 147' ' ' ALA . . . . . 0.645 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -110.94 132.94 53.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.921 0.391 . . . . 0.0 111.291 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 148' ' ' ALA . . . . . 0.777 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -124.29 43.71 2.93 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.421 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 149' ' ' ASN . . . . . 0.515 ' HB2' ' CG ' ' E' ' 89' ' ' GLN . 13.8 m-80 -92.32 144.25 25.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.535 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 150' ' ' ALA . . . . . 0.683 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -160.58 178.94 9.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.939 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 151' ' ' ASP . . . . . 0.619 ' OD1' ' HA ' ' D' ' 11' ' ' HIS . 15.7 t70 -147.05 145.01 29.52 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.201 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 152' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -133.76 139.8 46.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.196 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 153' ' ' THR . . . . . 0.932 HG23 HG22 ' D' ' 9' ' ' THR . 0.2 OUTLIER -101.14 135.25 42.91 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.144 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 154' ' ' PHE . . . . . 0.522 ' HB3' ' H ' ' D' ' 8' ' ' GLY . 0.2 OUTLIER -81.51 152.1 27.47 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.094 0.473 . . . . 0.0 110.148 -179.086 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 155' ' ' LYS . . . . . 0.407 ' O ' HG13 ' E' ' 71' ' ' VAL . 15.2 mmtm -134.2 146.84 50.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.947 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 156' ' ' VAL . . . . . 0.629 HG23 HG23 ' D' ' 5' ' ' VAL . 33.1 m -139.11 140.8 37.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.765 0.317 . . . . 0.0 111.64 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 157' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' D' ' 3' ' ' THR . 0.1 OUTLIER -134.55 132.63 39.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.291 0.567 . . . . 0.0 110.434 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 158' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' E' ' 21' ' ' CYS . 11.0 m-85 -107.23 128.05 54.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.58 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.839 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.26 0.076 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.67 88.39 0.03 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.051 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 5.5 m -122.95 116.28 23.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.358 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -99.69 117.29 33.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.51 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -144.49 158.03 14.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.596 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -78.73 123.71 27.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.586 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.67 -71.21 1.0 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.855 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.68 -146.93 4.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.825 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 24.5 p -148.77 134.4 18.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.998 0.428 . . . . 0.0 111.278 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.36 124.37 72.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.185 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -91.55 116.27 28.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.282 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -96.92 105.54 17.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.726 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -104.65 118.74 37.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.437 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.29 172.88 30.8 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.975 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -160.32 135.98 8.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.961 0.41 . . . . 0.0 110.405 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 43.4 t -96.86 132.79 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.281 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 17' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.89 -177.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.802 0.334 . . . . 0.0 111.019 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -75.72 -170.31 1.27 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.017 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.76 45.43 0.98 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.065 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 20' ' ' ALA . . . . . 0.571 ' O ' HD21 ' F' ' 124' ' ' LEU . . . -121.29 -24.84 5.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.401 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 21' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER -168.86 140.7 2.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.816 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 22' ' ' ALA . . . . . 0.493 ' HB3' ' HB2' ' F' ' 60' ' ' ASP . . . -132.9 116.91 17.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.05 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 23' ' ' VAL . . . . . 0.453 ' HA ' ' HG ' ' F' ' 58' ' ' LEU . 0.5 OUTLIER -67.06 146.24 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.108 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 24' ' ' ASP . . . . . 0.472 ' O ' HG23 ' F' ' 28' ' ' VAL . 12.9 t0 -80.45 152.06 28.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.542 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 25' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -62.71 -40.05 95.94 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.445 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.87 2.64 85.87 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.872 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 23.0 t -106.19 -19.95 13.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.849 0.357 . . . . 0.0 110.867 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 28' ' ' VAL . . . . . 0.472 HG23 ' O ' ' F' ' 24' ' ' ASP . 39.9 t -47.31 -52.2 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.354 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.15 136.42 48.67 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.045 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.69 136.86 39.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.004 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.56 102.85 12.74 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.07 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.64 128.27 62.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.052 0.453 . . . . 0.0 110.51 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -114.75 123.09 48.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.677 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.47 -42.68 15.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.604 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.42 -167.44 13.21 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.604 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 36' ' ' GLN . . . . . 0.745 ' HB2' HG12 ' E' ' 23' ' ' VAL . 2.9 mt-30 -96.77 124.41 40.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.615 0.245 . . . . 0.0 110.885 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.72 147.54 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.895 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.64 134.94 34.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.682 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 39' ' ' THR . . . . . 0.563 HG22 ' HA ' ' E' ' 18' ' ' ASN . 0.0 OUTLIER -60.06 -44.45 94.71 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.797 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.23 -36.94 61.58 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.101 0.477 . . . . 0.0 110.91 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.79 -35.91 62.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.185 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 42' ' ' LEU . . . . . 0.755 HD23 HG13 ' F' ' 99' ' ' VAL . 2.9 mp -106.63 34.53 3.36 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.602 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.87 15.8 27.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.307 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.94 132.05 56.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.337 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 45' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' F' ' 140' ' ' THR . 6.8 tt0 -56.53 108.74 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 111.172 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.93 25.93 10.11 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.16 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' F' ' 139' ' ' ALA . . . -71.5 137.73 48.39 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 7.3 p -136.96 122.76 19.97 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.881 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 49' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' F' ' 136' ' ' ARG . 53.4 m -100.05 -175.23 2.89 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.61 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 50' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' C' ' 92' ' ' ALA . 2.8 t -55.62 137.3 49.38 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.819 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 51' ' ' ALA . . . . . 0.482 ' CA ' ' HB3' ' F' ' 136' ' ' ARG . . . -92.35 133.45 35.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.331 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 52' ' ' VAL . . . . . 0.676 HG22 ' O ' ' F' ' 135' ' ' ALA . 26.2 m -76.68 162.51 4.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.54 141.17 16.77 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.605 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 54' ' ' PHE . . . . . 0.573 ' H ' HG21 ' C' ' 76' ' ' THR . 39.3 p90 -173.76 137.81 0.62 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.796 0.331 . . . . 0.0 110.985 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 55' ' ' ASN . . . . . 0.501 ' OD1' HD21 ' C' ' 74' ' ' LEU . 17.9 p30 -136.56 145.88 45.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.604 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 56' ' ' ILE . . . . . 0.529 HG23 ' O ' ' F' ' 56' ' ' ILE . 1.2 tp -91.1 116.79 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.643 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 57' ' ' GLN . . . . . 0.704 ' HA ' HG23 ' F' ' 130' ' ' THR . 1.3 mp0 -72.86 128.55 35.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.812 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 58' ' ' LEU . . . . . 0.453 ' HG ' ' HA ' ' F' ' 23' ' ' VAL . 0.3 OUTLIER -137.34 89.14 2.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.275 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 59' ' ' ASN . . . . . 0.727 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 9.8 p30 -74.75 176.46 7.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.956 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 60' ' ' ASP . . . . . 0.493 ' HB2' ' HB3' ' F' ' 22' ' ' ALA . 0.8 OUTLIER 58.98 74.77 0.43 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.834 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 61' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 36.8 m -126.34 148.91 49.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.8 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 62' ' ' ASP . . . . . 0.404 ' OD2' HG23 ' F' ' 65' ' ' VAL . 1.6 t70 -121.62 169.74 10.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.285 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.32 -32.6 4.91 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.58 -27.92 56.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.266 0.555 . . . . 0.0 111.752 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 65' ' ' VAL . . . . . 0.404 HG23 ' OD2' ' F' ' 62' ' ' ASP . 25.3 t -73.54 -56.81 8.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.715 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 66' ' ' ALA . . . . . 0.465 ' HB3' ' HB1' ' F' ' 20' ' ' ALA . . . -134.93 122.77 22.39 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.693 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.55 -50.11 5.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.932 0.396 . . . . 0.0 110.931 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 68' ' ' LYS . . . . . 0.401 ' NZ ' ' HA ' ' F' ' 68' ' ' LYS . 1.8 tptp -89.76 152.12 21.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.556 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 69' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' F' ' 122' ' ' THR . . . -144.25 137.8 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.559 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 70' ' ' ALA . . . . . 0.6 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -113.38 157.26 22.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.087 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 71' ' ' VAL . . . . . 0.74 HG11 HG21 ' F' ' 131' ' ' ILE . 1.8 t -138.75 150.06 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.638 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.87 155.05 37.35 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.593 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 73' ' ' PHE . . . . . 0.552 ' CB ' HD13 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -125.02 136.62 53.88 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.549 0.214 . . . . 0.0 111.056 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 74' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.9 OUTLIER -97.17 136.11 38.16 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.019 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 75' ' ' GLY . . . . . 0.454 ' CA ' ' HB3' ' F' ' 113' ' ' LEU . . . -174.0 -172.94 39.72 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.761 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 76' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.2 OUTLIER -118.73 144.53 46.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.553 0.216 . . . . 0.0 110.785 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 77' ' ' ALA . . . . . 0.634 ' HB2' HG23 ' F' ' 83' ' ' THR . . . -62.46 138.59 58.49 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.94 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 78' ' ' ILE . . . . . 0.496 HG23 ' N ' ' F' ' 79' ' ' ASP . 5.7 tt -71.66 -45.56 66.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.85 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 79' ' ' ASP . . . . . 0.496 ' N ' HG23 ' F' ' 78' ' ' ILE . 0.3 OUTLIER -133.11 42.45 3.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.793 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 80' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' F' ' 79' ' ' ASP . . . 70.16 -80.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.06 -29.68 68.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.64 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 82' ' ' HIS . . . . . 0.427 ' HB3' HG22 ' F' ' 78' ' ' ILE . 1.7 m80 -89.87 69.38 7.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.813 0.34 . . . . 0.0 110.426 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 83' ' ' THR . . . . . 0.634 HG23 ' HB2' ' F' ' 77' ' ' ALA . 0.2 OUTLIER -74.53 -16.12 60.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.631 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 84' ' ' ASN . . . . . 0.745 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 20.7 p-10 -66.25 -19.05 65.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.285 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 85' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' F' ' 138' ' ' PHE . 13.4 t -113.6 133.8 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.202 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 86' ' ' LEU . . . . . 0.773 ' HG ' HD13 ' F' ' 113' ' ' LEU . 0.4 OUTLIER -67.73 161.54 25.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 87' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' F' ' 77' ' ' ALA . . . -103.66 -174.71 2.61 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.84 0.352 . . . . 0.0 111.756 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 88' ' ' LEU . . . . . 0.7 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 0.3 OUTLIER -67.36 165.22 16.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.069 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 89' ' ' GLN . . . . . 0.523 ' CG ' ' HB2' ' F' ' 149' ' ' ASN . 3.6 mm100 -63.54 -79.67 0.03 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.302 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -165.48 3.73 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.003 0.43 . . . . 0.0 111.487 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.08 79.75 6.59 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.17 -24.63 55.69 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.849 0.357 . . . . 0.0 111.608 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.2 33.99 5.24 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.653 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.85 0.44 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.958 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 95' ' ' SER . . . . . 0.7 ' HB3' ' HG ' ' F' ' 88' ' ' LEU . 38.4 m -96.73 177.95 5.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.86 0.362 . . . . 0.0 110.612 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.46 -178.65 7.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 97' ' ' THR . . . . . 0.497 ' HB ' ' OG1' ' F' ' 144' ' ' THR . 2.0 m -134.55 119.04 17.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.341 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 98' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' F' ' 97' ' ' THR . 32.6 m-20 68.75 34.48 3.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.433 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 99' ' ' VAL . . . . . 0.755 HG13 HD23 ' F' ' 42' ' ' LEU . 0.4 OUTLIER -138.08 130.88 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.765 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.21 -170.6 18.97 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.537 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 101' ' ' VAL . . . . . 0.574 HG13 ' HB2' ' F' ' 86' ' ' LEU . 0.2 OUTLIER -119.64 114.44 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.008 0.523 . . . . 0.0 111.737 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 102' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 1.8 tt0 -87.35 150.24 23.97 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 103' ' ' ILE . . . . . 0.565 HG12 ' HG ' ' F' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 136.01 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.474 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.39 133.56 55.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.705 0.288 . . . . 0.0 111.028 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 105' ' ' ASP . . . . . 0.837 ' HB3' HG22 ' F' ' 107' ' ' THR . 6.1 t0 -82.23 149.72 27.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.749 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 106' ' ' ARG . . . . . 0.753 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.4 OUTLIER -67.87 -16.24 64.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.798 0.332 . . . . 0.0 111.098 179.558 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 107' ' ' THR . . . . . 0.837 HG22 ' HB3' ' F' ' 105' ' ' ASP . 8.8 t -63.59 -28.46 69.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.979 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.04 -40.55 1.57 Allowed Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.616 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 109' ' ' ALA . . . . . 0.416 ' H ' HG23 ' F' ' 107' ' ' THR . . . -91.43 163.04 14.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.811 0.339 . . . . 0.0 111.038 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.18 133.4 35.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 111' ' ' LEU . . . . . 0.571 HD21 ' O ' ' F' ' 117' ' ' THR . 4.8 tp -96.66 149.94 21.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.386 0.612 . . . . 0.0 110.558 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 112' ' ' THR . . . . . 0.842 HG23 HG21 ' F' ' 117' ' ' THR . 1.9 t -98.48 141.7 31.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.085 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 113' ' ' LEU . . . . . 0.773 HD13 ' HG ' ' F' ' 86' ' ' LEU . 1.6 mt -76.33 89.47 3.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.744 0.307 . . . . 0.0 110.761 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.09 -18.22 5.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.67 0.271 . . . . 0.0 111.52 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.86 -60.68 0.45 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.529 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 116' ' ' ALA . . . . . 0.463 ' HA ' ' CE2' ' F' ' 118' ' ' PHE . . . -96.44 26.97 4.03 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.041 0.448 . . . . 0.0 111.683 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 117' ' ' THR . . . . . 0.842 HG21 HG23 ' F' ' 112' ' ' THR . 0.0 OUTLIER -87.01 74.85 9.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.155 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 118' ' ' PHE . . . . . 0.6 ' HB3' ' HB1' ' F' ' 70' ' ' ALA . 63.3 m-85 -94.97 92.96 7.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.768 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 25.6 m -136.35 68.9 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.796 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.81 150.29 28.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.629 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.34 67.6 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.136 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 122' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' F' ' 69' ' ' ALA . 0.2 OUTLIER -79.15 114.66 18.27 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.69 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 12.1 m -73.95 127.97 34.29 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.742 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 124' ' ' LEU . . . . . 0.571 HD21 ' O ' ' F' ' 20' ' ' ALA . 4.0 tp -92.11 132.21 36.77 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.602 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.1 151.07 49.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.63 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 126' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' F' ' 61' ' ' CYS . 3.1 t30 -69.1 112.05 5.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 110.646 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 127' ' ' GLY . . . . . 0.492 ' CA ' HG21 ' B' ' 4' ' ' THR . . . 142.51 -138.9 8.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.687 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 128' ' ' THR . . . . . 0.727 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 87.7 m -98.76 82.59 2.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.664 0.269 . . . . 0.0 110.792 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 129' ' ' ASN . . . . . 0.495 ' N ' ' HB2' ' C' ' 116' ' ' ALA . 2.3 t30 -71.85 148.19 46.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.893 0.377 . . . . 0.0 111.094 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 130' ' ' THR . . . . . 0.704 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.2 OUTLIER -138.63 148.66 44.34 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.154 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 131' ' ' ILE . . . . . 0.74 HG21 HG11 ' F' ' 71' ' ' VAL . 15.6 mt -110.05 112.17 57.86 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 132' ' ' PRO . . . . . 0.753 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.6 Cg_endo -81.78 136.98 9.75 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.612 1.541 . . . . 0.0 112.587 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.0 136.1 19.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.773 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -111.42 158.45 19.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.037 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 135' ' ' ALA . . . . . 0.676 ' O ' HG22 ' F' ' 52' ' ' VAL . . . -154.2 111.35 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.924 0.392 . . . . 0.0 111.674 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 136' ' ' ARG . . . . . 0.482 ' HB3' ' CA ' ' F' ' 51' ' ' ALA . 19.8 ptt180 -108.86 174.0 6.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.382 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 137' ' ' TYR . . . . . 0.705 ' HB3' HD21 ' F' ' 42' ' ' LEU . 1.7 m-85 -81.37 137.62 35.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.122 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 138' ' ' PHE . . . . . 0.517 ' HB3' HG21 ' F' ' 85' ' ' VAL . 0.9 OUTLIER -131.51 124.16 29.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.096 -179.241 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 139' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' F' ' 47' ' ' ALA . . . -108.52 130.15 55.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.868 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 140' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' F' ' 45' ' ' GLU . 0.2 OUTLIER -77.37 -28.01 52.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.557 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.46 -96.41 0.11 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.005 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.01 98.51 8.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.583 0.23 . . . . 0.0 110.648 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 143' ' ' ALA . . . . . 0.567 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -56.66 148.92 18.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.674 0.274 . . . . 0.0 111.377 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 144' ' ' THR . . . . . 0.728 ' CG2' ' CD ' ' F' ' 145' ' ' PRO . 90.3 m -125.48 157.0 69.61 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.213 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 145' ' ' PRO . . . . . 0.728 ' CD ' ' CG2' ' F' ' 144' ' ' THR . 1.4 Cg_endo -83.36 136.22 7.56 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.552 2.168 . . . . 0.0 111.978 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 146' ' ' GLY . . . . . 0.585 ' O ' ' HG3' ' E' ' 15' ' ' GLU . . . 163.61 -127.56 1.69 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.457 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 147' ' ' ALA . . . . . 0.656 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -110.85 132.92 53.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.864 0.364 . . . . 0.0 111.414 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 148' ' ' ALA . . . . . 0.764 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -124.25 43.65 2.94 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.126 0.489 . . . . 0.0 110.459 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 149' ' ' ASN . . . . . 0.523 ' HB2' ' CG ' ' F' ' 89' ' ' GLN . 13.9 m-80 -92.34 144.28 25.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.54 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 150' ' ' ALA . . . . . 0.684 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -160.6 178.9 9.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.995 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 151' ' ' ASP . . . . . 0.627 ' OD1' ' HA ' ' E' ' 11' ' ' HIS . 15.7 t70 -147.02 144.97 29.54 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.215 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 152' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -133.73 139.76 46.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.114 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 153' ' ' THR . . . . . 0.951 HG23 HG22 ' E' ' 9' ' ' THR . 0.2 OUTLIER -101.07 135.26 42.81 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.078 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 154' ' ' PHE . . . . . 0.543 ' HB3' ' H ' ' E' ' 8' ' ' GLY . 0.2 OUTLIER -81.58 152.13 27.36 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.013 0.435 . . . . 0.0 110.152 -179.052 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 155' ' ' LYS . . . . . 0.413 ' O ' HG13 ' F' ' 71' ' ' VAL . 15.2 mmtm -134.22 146.86 50.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.897 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 156' ' ' VAL . . . . . 0.626 HG23 HG23 ' E' ' 5' ' ' VAL . 33.0 m -139.14 140.76 37.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.853 0.359 . . . . 0.0 111.632 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 157' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' E' ' 3' ' ' THR . 0.1 OUTLIER -134.5 132.74 39.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.266 0.555 . . . . 0.0 110.42 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 158' ' ' TYR . . . . . 0.567 ' CE1' ' HB2' ' F' ' 21' ' ' CYS . 10.9 m-85 -107.31 128.1 54.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.493 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.886 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.17 0 CA-C-O 120.546 0.213 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.8 m -117.36 119.27 34.6 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.397 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.683 HG23 ' HG3' ' B' ' 157' ' ' GLN . 4.0 m -98.41 127.22 44.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.515 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.921 HG21 HG12 ' B' ' 17' ' ' VAL . 1.6 m -146.14 171.02 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.6 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.04 114.69 23.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.601 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' B' ' 155' ' ' LYS . . . -69.65 -57.77 6.98 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.791 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 9' ' ' THR . . . -163.52 -144.6 4.08 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.9 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 1.04 HG22 HG23 ' B' ' 153' ' ' THR . 17.1 p -155.69 140.51 17.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.818 0.342 . . . . 0.0 111.4 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.561 HG13 HG23 ' B' ' 32' ' ' VAL . 29.9 t -130.38 117.55 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.26 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -91.55 117.05 29.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.336 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -89.96 107.12 18.92 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.8 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.76 113.28 26.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.45 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.44 ' HA3' ' OH ' ' B' ' 137' ' ' TYR . . . -144.43 166.99 27.12 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.889 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.675 ' CG ' ' O ' ' B' ' 146' ' ' GLY . 30.2 tt0 -155.66 135.23 12.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.053 0.454 . . . . 0.0 110.286 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.698 HG23 ' HB2' ' B' ' 148' ' ' ALA . 66.4 t -96.59 138.38 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.293 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.85 -173.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.832 0.349 . . . . 0.0 110.977 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.15 173.46 12.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.034 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' B' ' 38' ' ' ARG . . . -85.86 39.83 0.82 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.042 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.639 ' HB1' ' CD2' ' A' ' 124' ' ' LEU . . . -114.36 -33.57 5.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.349 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.739 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.9 OUTLIER -161.16 149.97 16.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.953 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.64 112.08 4.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.07 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.669 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 3.1 p -59.9 153.42 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.065 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.76 152.76 28.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.674 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.52 80.83 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.349 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.81 15.75 61.93 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.939 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -113.06 -21.32 11.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.909 0.385 . . . . 0.0 110.815 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -44.61 -64.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.364 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.28 135.61 38.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.925 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.02 128.73 19.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.79 111.8 23.83 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.012 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.2 t -110.82 114.77 48.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.141 0.496 . . . . 0.0 110.494 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.68 124.51 46.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.649 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.49 -45.73 14.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.619 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.37 -161.91 12.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.534 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -99.77 129.7 45.91 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.649 0.261 . . . . 0.0 110.828 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p -110.05 147.47 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.948 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.42 ' HB2' ' HB2' ' A' ' 41' ' ' SER . 0.7 OUTLIER -86.76 131.24 34.19 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.94 0.4 . . . . 0.0 111.766 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.708 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 4.8 t -54.1 -45.1 71.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.757 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.443 ' N ' HG23 ' A' ' 39' ' ' THR . . . -61.01 -39.31 89.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.069 0.461 . . . . 0.0 110.875 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 38' ' ' ARG . 0.4 OUTLIER -70.55 -23.19 62.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.19 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.675 HD23 ' HB2' ' A' ' 139' ' ' ALA . 1.4 mp -124.63 51.62 1.6 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.586 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.59 29.95 7.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.418 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.84 128.36 48.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.41 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 140' ' ' THR . 29.4 tt0 -52.88 102.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 111.097 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.415 ' HA2' ' HE1' ' A' ' 138' ' ' PHE . . . 96.05 39.01 4.42 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.126 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -80.1 146.72 31.74 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.62 125.01 19.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.95 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 32.4 m -101.91 -166.35 1.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.644 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.01 133.02 55.7 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.845 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 136' ' ' ARG . . . -92.66 120.13 32.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.26 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 135' ' ' ALA . 18.3 m -65.71 162.59 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.946 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.85 124.11 5.27 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.592 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -155.9 146.56 21.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.684 0.278 . . . . 0.0 110.948 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.564 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.4 p30 -136.83 160.19 39.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.576 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 56' ' ' ILE . 1.6 tp -100.56 116.93 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.562 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.61 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -70.07 124.56 24.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.766 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.669 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 1.6 mp -133.72 87.44 2.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.23 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 4.9 p30 -73.61 174.54 8.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.949 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.82 79.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.818 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.739 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 93.6 m -127.59 159.37 34.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.61 ' OD2' HG23 ' A' ' 65' ' ' VAL . 5.6 t70 -130.23 167.12 18.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.238 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.656 HG23 ' HA ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -114.32 -41.7 3.44 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.154 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.51 -22.61 65.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.047 0.451 . . . . 0.0 111.735 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.61 HG23 ' OD2' ' A' ' 62' ' ' ASP . 81.3 t -70.43 -74.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.601 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 124' ' ' LEU . . . -120.75 131.36 54.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.571 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -48.58 6.13 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.863 0.363 . . . . 0.0 110.997 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.631 ' HE3' ' HB3' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -96.18 161.58 13.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.556 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.17 124.58 6.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.606 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.725 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -100.35 154.98 18.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.094 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.851 HG11 HG21 ' A' ' 131' ' ' ILE . 2.3 t -132.76 148.31 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.696 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.442 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -145.64 150.12 35.76 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.599 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.558 ' HB2' HD13 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -119.92 137.02 54.29 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.568 0.223 . . . . 0.0 111.022 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.627 HD21 HG21 ' D' ' 130' ' ' THR . 0.9 OUTLIER -96.0 139.46 32.16 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.966 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' A' ' 113' ' ' LEU . . . 178.5 179.84 48.48 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.733 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.546 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.3 OUTLIER -111.0 156.38 21.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.559 0.218 . . . . 0.0 110.807 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.674 ' O ' ' HB2' ' A' ' 87' ' ' ALA . . . -73.78 131.34 41.46 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.338 -0.392 . . . . 0.0 112.02 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.639 ' CG2' ' HB ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -67.79 -41.36 85.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.808 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -141.14 40.79 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.791 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.439 ' CB ' ' HA2' ' D' ' 108' ' ' GLY . . . 66.4 -80.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.83 -24.94 43.2 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.663 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.07 64.03 1.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.957 0.408 . . . . 0.0 110.45 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.548 HG23 ' HB2' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -68.5 -16.84 64.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.576 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.693 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 18.0 p-10 -70.46 -20.21 62.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.317 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.639 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 14.7 t -106.86 130.76 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.117 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.782 HD22 ' HB1' ' A' ' 150' ' ' ALA . 0.5 OUTLIER -67.61 148.22 51.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.387 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 77' ' ' ALA . . . -89.63 -167.52 1.88 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.842 0.353 . . . . 0.0 111.743 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.658 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 1.5 mm? -78.3 157.27 29.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.04 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.66 -78.37 0.02 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.354 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.583 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 0.4 OUTLIER -167.13 0.54 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.032 0.444 . . . . 0.0 111.425 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.53 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 1.7 m -71.89 83.02 0.92 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.568 ' HB3' ' HB3' ' D' ' 34' ' ' LEU . . . -66.75 -13.9 61.94 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.827 0.346 . . . . 0.0 111.643 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.71 27.61 5.21 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.609 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.74 15.76 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.903 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.658 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . 3.0 m -100.86 -172.78 2.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.833 0.349 . . . . 0.0 110.613 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.9 167.63 9.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.514 ' H ' ' HB ' ' A' ' 144' ' ' THR . 2.3 m -121.59 128.41 51.93 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.314 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.456 ' HB3' ' H ' ' A' ' 141' ' ' GLY . 75.8 m-20 64.22 34.57 10.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.371 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.489 HG13 HD23 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -139.96 136.44 38.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.704 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.12 -156.83 8.33 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.546 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' A' ' 86' ' ' LEU . 3.2 p -137.82 116.72 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 122.942 0.497 . . . . 0.0 111.605 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 1.1 tt0 -91.91 150.39 21.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.841 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.689 HD12 ' HB3' ' A' ' 111' ' ' LEU . 0.5 OUTLIER -113.86 131.3 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.531 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -106.2 130.15 54.12 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.646 0.26 . . . . 0.0 111.041 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.736 ' HB3' HG22 ' A' ' 107' ' ' THR . 5.1 t0 -76.08 156.99 33.39 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.661 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.741 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 3.5 ttp180 -71.29 -17.51 62.46 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.731 0.3 . . . . 0.0 111.03 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.736 HG22 ' HB3' ' A' ' 105' ' ' ASP . 6.2 t -67.29 -17.91 64.97 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.028 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.68 -45.61 1.17 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.78 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.1 163.11 23.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.737 0.303 . . . . 0.0 111.114 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -84.16 127.38 33.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.104 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.689 ' HB3' HD12 ' A' ' 103' ' ' ILE . 12.1 tp -86.28 156.07 20.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.306 0.574 . . . . 0.0 110.6 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.88 HG23 HG21 ' A' ' 117' ' ' THR . 0.5 OUTLIER -106.17 139.09 41.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.179 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.604 HD13 ' HG ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -73.89 76.4 1.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.691 0.281 . . . . 0.0 110.789 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.42 -17.17 14.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.625 0.25 . . . . 0.0 111.561 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.31 -51.77 1.24 Allowed Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.615 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.01 18.88 21.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.832 0.349 . . . . 0.0 111.544 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.88 HG21 HG23 ' A' ' 112' ' ' THR . 0.2 OUTLIER -85.81 84.68 7.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.725 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 95.7 m-85 -101.42 98.74 9.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.785 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.7 m -130.82 62.35 1.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.825 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.27 145.88 30.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.687 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.631 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . 3.5 mm-40 -121.43 71.32 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.177 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.73 134.78 34.73 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.715 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.2 m -83.83 113.69 21.11 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.683 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.639 ' CD2' ' HB1' ' A' ' 20' ' ' ALA . 18.9 tp -73.99 142.97 45.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.651 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.656 ' HA ' HG23 ' A' ' 63' ' ' THR . 0.9 OUTLIER -138.67 162.13 35.42 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.557 179.489 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.66 113.1 12.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.717 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.51 -139.95 9.53 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.752 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 6.7 m -101.64 96.76 7.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.726 0.298 . . . . 0.0 110.804 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -83.58 148.58 27.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.92 0.391 . . . . 0.0 111.086 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.61 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -138.64 143.43 39.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.09 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.851 HG21 HG11 ' A' ' 71' ' ' VAL . 55.1 mt -104.63 112.39 65.33 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.741 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.6 Cg_endo -81.87 141.89 12.27 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.825 1.683 . . . . 0.0 112.522 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.58 141.09 22.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.847 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -104.46 152.64 22.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.079 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.644 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -153.54 100.99 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 111.567 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.547 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 17.4 ptt180 -107.15 177.27 4.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.385 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.498 ' HB3' HD21 ' A' ' 42' ' ' LEU . 4.7 m-85 -85.96 124.15 32.09 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.011 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.46 ' HB3' HG11 ' A' ' 85' ' ' VAL . 1.2 t80 -118.93 112.38 19.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.024 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.675 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -102.96 133.91 47.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.867 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -81.1 -28.82 35.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.531 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.456 ' H ' ' HB3' ' A' ' 98' ' ' ASN . . . -160.18 -111.04 0.28 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.961 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.87 110.56 21.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.607 0.203 . . . . 0.0 110.77 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.708 ' HB3' ' HA ' ' A' ' 39' ' ' THR . . . -65.63 134.21 52.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.763 0.316 . . . . 0.0 111.376 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.514 ' HB ' ' H ' ' A' ' 97' ' ' THR . 57.2 m -105.78 149.4 37.93 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.31 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.488 ' CD ' ' CG2' ' A' ' 144' ' ' THR . 1.4 Cg_endo -82.93 125.49 4.17 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.53 2.153 . . . . 0.0 112.057 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.8 -126.37 1.38 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.43 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -111.07 128.4 55.86 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.729 0.3 . . . . 0.0 111.348 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.44 52.18 1.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 110.441 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.82 151.98 20.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.564 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.782 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -158.32 169.54 24.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.942 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -131.03 128.65 40.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.212 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.496 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -122.22 144.09 49.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.229 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.34 145.32 31.83 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -96.89 134.72 39.86 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.009 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -124.26 148.13 47.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.902 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 131' ' ' ILE . 29.8 m -135.19 144.78 33.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 111.733 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.48 126.09 28.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.279 0.561 . . . . 0.0 110.389 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 21' ' ' CYS . 5.1 m-85 -106.0 128.75 54.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.498 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.567 ' HG3' ' C ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.877 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.246 0.07 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.63 77.07 0.19 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.037 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 10.7 m -117.33 119.23 34.49 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.439 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.677 HG23 ' HG3' ' C' ' 157' ' ' GLN . 4.0 m -98.32 127.17 44.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.548 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.88 HG21 HG12 ' C' ' 17' ' ' VAL . 1.6 m -146.12 171.08 4.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.58 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.14 114.72 23.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.548 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' C' ' 155' ' ' LYS . . . -69.84 -57.58 7.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.736 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.428 ' O ' HG23 ' B' ' 9' ' ' THR . . . -163.65 -144.63 4.09 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.989 -0.625 . . . . 0.0 111.854 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' THR . . . . . 1.041 HG22 HG23 ' C' ' 153' ' ' THR . 17.0 p -155.64 140.45 17.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.826 0.346 . . . . 0.0 111.364 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.552 HG13 HG23 ' C' ' 32' ' ' VAL . 29.2 t -130.35 117.53 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.241 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -91.51 116.97 29.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.409 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -89.88 107.08 18.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.916 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.81 113.28 26.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.435 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.436 ' HA3' ' OH ' ' C' ' 137' ' ' TYR . . . -144.42 167.01 27.11 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.898 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.689 ' CG ' ' O ' ' C' ' 146' ' ' GLY . 30.3 tt0 -155.64 135.21 12.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.926 0.393 . . . . 0.0 110.318 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' C' ' 148' ' ' ALA . 66.2 t -96.54 138.35 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.304 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.921 HG12 HG21 ' A' ' 5' ' ' VAL . 2.7 m -140.78 -173.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 111.056 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.12 173.48 12.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.074 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' C' ' 38' ' ' ARG . . . -85.82 39.71 0.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.639 ' HB1' ' CD2' ' B' ' 124' ' ' LEU . . . -114.28 -33.53 5.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.434 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.745 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.9 OUTLIER -161.13 150.03 16.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.965 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' C' ' 36' ' ' GLN . . . -149.68 112.02 4.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.079 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.675 ' HA ' ' HA ' ' B' ' 58' ' ' LEU . 3.1 p -59.94 153.37 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.029 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.73 152.8 28.18 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.628 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.42 81.03 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.296 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.84 15.68 62.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.03 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.94 -21.35 11.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.937 0.398 . . . . 0.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 89.3 t -44.65 -64.82 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.316 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.26 135.71 38.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.958 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.06 128.73 19.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.061 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.74 111.81 23.82 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.029 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.561 HG23 HG13 ' A' ' 10' ' ' VAL . 4.2 t -110.85 114.76 48.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.074 0.464 . . . . 0.0 110.489 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.78 124.42 46.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.681 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.4 -45.67 14.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.647 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.33 -161.88 12.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.572 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.615 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 1.1 mt-30 -99.87 129.68 45.99 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.619 0.247 . . . . 0.0 110.865 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.494 ' CG1' HG22 ' A' ' 16' ' ' VAL . 11.9 p -110.01 147.43 14.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.99 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.519 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -86.67 131.23 34.2 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.015 0.436 . . . . 0.0 111.786 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.698 ' HA ' ' HB3' ' B' ' 143' ' ' ALA . 4.8 t -54.18 -45.05 72.04 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.721 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.445 ' N ' HG23 ' B' ' 39' ' ' THR . . . -60.99 -39.36 89.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.146 0.498 . . . . 0.0 110.933 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' B' ' 38' ' ' ARG . 0.4 OUTLIER -70.52 -23.22 62.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.169 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.665 HD23 ' HB2' ' B' ' 139' ' ' ALA . 1.4 mp -124.55 51.63 1.59 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.639 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.6 29.92 7.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.356 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.85 128.41 48.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.348 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' B' ' 140' ' ' THR . 29.3 tt0 -52.95 103.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.815 0.34 . . . . 0.0 111.093 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.421 ' HA2' ' HE1' ' B' ' 138' ' ' PHE . . . 96.02 38.93 4.45 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.137 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' B' ' 139' ' ' ALA . . . -80.0 146.66 31.91 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.64 125.0 19.03 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.918 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 32.4 m -101.89 -166.28 1.28 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.604 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.99 133.02 55.7 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.871 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.553 ' HA ' ' HB3' ' B' ' 136' ' ' ARG . . . -92.67 120.21 32.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.264 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.641 HG22 ' O ' ' B' ' 135' ' ' ALA . 18.5 m -65.77 162.69 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.939 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.9 124.11 5.26 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.648 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -155.87 146.64 22.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.719 0.295 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.566 ' HB2' HG22 ' B' ' 130' ' ' THR . 3.3 p30 -136.91 160.25 39.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.515 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.564 HG23 ' O ' ' B' ' 56' ' ' ILE . 1.6 tp -100.71 117.0 45.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.516 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' GLN . . . . . 0.625 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -70.05 124.6 24.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.731 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.675 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 1.6 mp -133.82 87.5 2.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.184 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 4.9 p30 -73.63 174.57 8.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 57.72 79.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.811 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' CYS . . . . . 0.745 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 93.6 m -127.57 159.41 34.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.859 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ASP . . . . . 0.62 ' OD2' HG23 ' B' ' 65' ' ' VAL . 5.5 t70 -130.27 167.1 19.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.295 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.662 HG23 ' HA ' ' B' ' 125' ' ' ASN . 0.2 OUTLIER -114.31 -41.71 3.44 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.139 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.51 -22.63 65.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.086 0.469 . . . . 0.0 111.723 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' VAL . . . . . 0.62 HG23 ' OD2' ' B' ' 62' ' ' ASP . 82.4 t -70.44 -74.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.608 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' B' ' 124' ' ' LEU . . . -120.67 131.3 54.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.665 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.22 -48.59 6.12 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.936 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' LYS . . . . . 0.633 ' HE3' ' HB3' ' B' ' 121' ' ' GLU . 0.1 OUTLIER -96.23 161.48 13.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.595 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.05 124.72 6.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.584 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.698 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -100.44 155.02 18.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.069 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.827 HG11 HG21 ' B' ' 131' ' ' ILE . 2.3 t -132.73 148.34 31.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.673 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.442 ' HA ' HD21 ' B' ' 111' ' ' LEU . . . -145.63 150.1 35.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.698 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.569 ' HB2' HD13 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -119.98 137.05 54.3 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.549 0.214 . . . . 0.0 111.055 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.624 HD21 HG21 ' E' ' 130' ' ' THR . 0.9 OUTLIER -96.06 139.52 32.12 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.892 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 75' ' ' GLY . . . . . 0.423 ' CA ' ' HB3' ' B' ' 113' ' ' LEU . . . 178.45 179.82 48.44 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.807 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.3 OUTLIER -110.92 156.47 21.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.493 0.187 . . . . 0.0 110.848 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.676 ' O ' ' HB2' ' B' ' 87' ' ' ALA . . . -73.83 131.35 41.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.029 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.65 ' CG2' ' HB ' ' B' ' 85' ' ' VAL . 0.9 OUTLIER -67.74 -41.37 85.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.823 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.435 ' N ' HG23 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -141.15 40.65 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.81 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.435 ' HB3' ' HA2' ' E' ' 108' ' ' GLY . . . 66.49 -80.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.68 -24.99 42.19 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.725 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.06 64.03 1.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.451 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' THR . . . . . 0.556 HG23 ' HB2' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -68.43 -16.9 64.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.567 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ASN . . . . . 0.69 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 18.0 p-10 -70.44 -20.18 62.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.339 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.65 ' HB ' ' CG2' ' B' ' 78' ' ' ILE . 14.7 t -106.92 130.77 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.126 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.776 HD22 ' HB1' ' B' ' 150' ' ' ALA . 0.5 OUTLIER -67.68 148.19 51.67 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' B' ' 77' ' ' ALA . . . -89.6 -167.58 1.9 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.736 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.654 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 1.5 mm? -78.22 157.26 29.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -78.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.356 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' SER . . . . . 0.586 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 0.4 OUTLIER -167.08 0.51 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.972 0.415 . . . . 0.0 111.459 179.487 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 91' ' ' SER . . . . . 0.546 ' HA ' ' HB2' ' D' ' 25' ' ' ALA . 1.7 m -71.95 83.03 0.94 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.746 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' E' ' 34' ' ' LEU . . . -66.62 -13.98 61.83 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.921 0.391 . . . . 0.0 111.749 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.69 27.59 5.21 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.567 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.69 15.63 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.899 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' SER . . . . . 0.654 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . 3.0 m -100.88 -172.85 2.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.842 0.353 . . . . 0.0 110.604 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.88 167.6 9.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.849 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.522 ' H ' ' HB ' ' B' ' 144' ' ' THR . 2.3 m -121.51 128.38 52.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.341 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' ASN . . . . . 0.463 ' HB3' ' H ' ' B' ' 141' ' ' GLY . 75.9 m-20 64.24 34.5 10.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.415 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' VAL . . . . . 0.489 HG13 HD23 ' B' ' 42' ' ' LEU . 0.5 OUTLIER -139.92 136.46 38.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.744 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.08 -156.88 8.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.524 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' B' ' 86' ' ' LEU . 3.2 p -137.8 116.71 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 123.011 0.525 . . . . 0.0 111.665 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 1.2 tt0 -91.94 150.39 21.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.847 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.681 HD12 ' HB3' ' B' ' 111' ' ' LEU . 0.5 OUTLIER -113.81 131.31 66.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.505 179.487 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 104' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 0.3 OUTLIER -106.26 130.17 54.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.733 0.302 . . . . 0.0 111.025 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 105' ' ' ASP . . . . . 0.713 ' HB3' HG22 ' B' ' 107' ' ' THR . 5.1 t0 -76.12 156.97 33.33 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.703 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' ARG . . . . . 0.708 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 3.4 ttp180 -71.2 -17.55 62.52 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 111.085 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.713 HG22 ' HB3' ' B' ' 105' ' ' ASP . 6.2 t -67.19 -18.02 65.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.071 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.73 -45.6 1.17 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.784 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.11 163.07 23.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.691 0.281 . . . . 0.0 111.172 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -84.13 127.4 33.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.681 ' HB3' HD12 ' B' ' 103' ' ' ILE . 12.1 tp -86.28 156.12 20.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.323 0.582 . . . . 0.0 110.595 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.892 HG23 HG21 ' B' ' 117' ' ' THR . 0.5 OUTLIER -106.25 139.16 41.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.167 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.625 HD13 ' HG ' ' B' ' 86' ' ' LEU . 1.0 OUTLIER -73.92 76.49 1.66 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.707 0.289 . . . . 0.0 110.718 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.45 -17.2 14.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.519 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -51.79 1.24 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.642 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.95 18.83 21.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.933 0.397 . . . . 0.0 111.604 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' THR . . . . . 0.892 HG21 HG23 ' B' ' 112' ' ' THR . 0.2 OUTLIER -85.84 84.71 7.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.698 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . 95.7 m-85 -101.41 98.76 9.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.772 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 38.2 m -130.83 62.34 1.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.989 0.423 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.28 145.85 30.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.658 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.633 ' HB3' ' HE3' ' B' ' 68' ' ' LYS . 3.5 mm-40 -121.35 71.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.217 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.67 134.79 34.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.74 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 15.2 m -83.86 113.67 21.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.7 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.639 ' CD2' ' HB1' ' B' ' 20' ' ' ALA . 18.9 tp -73.98 142.92 45.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.649 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.662 ' HA ' HG23 ' B' ' 63' ' ' THR . 0.9 OUTLIER -138.55 162.13 35.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.53 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.8 113.13 12.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.65 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.59 -139.92 9.48 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.711 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 6.6 m -101.72 96.85 7.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.688 0.28 . . . . 0.0 110.8 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -83.67 148.61 27.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.898 0.38 . . . . 0.0 111.019 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.625 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -138.65 143.32 39.18 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.16 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 131' ' ' ILE . . . . . 0.827 HG21 HG11 ' B' ' 71' ' ' VAL . 54.9 mt -104.51 112.34 65.35 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' PRO . . . . . 0.708 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.95 142.05 12.25 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.697 1.598 . . . . 0.0 112.503 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.68 141.12 22.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.851 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -104.48 152.63 22.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.107 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.641 ' O ' HG22 ' B' ' 52' ' ' VAL . . . -153.57 101.09 2.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.949 0.404 . . . . 0.0 111.586 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 136' ' ' ARG . . . . . 0.553 ' HB3' ' HA ' ' B' ' 51' ' ' ALA . 17.5 ptt180 -107.19 177.28 4.9 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.436 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 137' ' ' TYR . . . . . 0.503 ' HB3' HD21 ' B' ' 42' ' ' LEU . 4.7 m-85 -85.96 124.08 32.02 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.019 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 138' ' ' PHE . . . . . 0.453 ' HB3' HG11 ' B' ' 85' ' ' VAL . 1.2 t80 -118.85 112.45 19.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.972 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.665 ' HB2' HD23 ' B' ' 42' ' ' LEU . . . -102.99 133.97 47.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.842 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 140' ' ' THR . . . . . 0.62 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 0.1 OUTLIER -81.11 -28.89 35.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.506 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 141' ' ' GLY . . . . . 0.463 ' H ' ' HB3' ' B' ' 98' ' ' ASN . . . -160.17 -111.07 0.28 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.894 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.91 110.54 21.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.502 0.191 . . . . 0.0 110.712 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 143' ' ' ALA . . . . . 0.698 ' HB3' ' HA ' ' B' ' 39' ' ' THR . . . -65.57 134.22 52.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.781 0.325 . . . . 0.0 111.45 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.601 ' O ' ' CG1' ' A' ' 16' ' ' VAL . 57.2 m -105.81 149.46 38.01 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.309 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 145' ' ' PRO . . . . . 0.493 ' CD ' ' CG2' ' B' ' 144' ' ' THR . 1.4 Cg_endo -82.95 125.47 4.16 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.592 2.195 . . . . 0.0 112.011 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 146' ' ' GLY . . . . . 0.675 ' O ' ' CG ' ' A' ' 15' ' ' GLU . . . 168.83 -126.3 1.37 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.423 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.448 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -111.12 128.45 55.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.817 0.342 . . . . 0.0 111.296 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 148' ' ' ALA . . . . . 0.698 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -125.45 52.12 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.188 0.518 . . . . 0.0 110.474 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -98.74 151.92 20.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.607 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.776 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -158.23 169.51 24.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.982 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.9 128.69 41.06 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.289 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 152' ' ' ALA . . . . . 0.483 ' HB2' HD11 ' B' ' 86' ' ' LEU . . . -122.25 144.07 49.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.153 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 153' ' ' THR . . . . . 1.04 HG23 HG22 ' A' ' 9' ' ' THR . 0.6 OUTLIER -106.36 145.32 31.83 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 154' ' ' PHE . . . . . 0.41 ' HB3' ' H ' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -96.88 134.63 39.96 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.095 0.474 . . . . 0.0 110.052 -179.004 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 155' ' ' LYS . . . . . 0.416 ' HA ' ' H ' ' A' ' 7' ' ' GLY . 9.9 mmtt -124.17 148.03 47.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.944 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 156' ' ' VAL . . . . . 0.521 HG23 HG23 ' A' ' 5' ' ' VAL . 30.0 m -135.04 144.85 33.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.81 0.338 . . . . 0.0 111.757 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.683 ' HG3' HG23 ' A' ' 4' ' ' THR . 0.0 OUTLIER -134.5 126.14 28.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.215 0.531 . . . . 0.0 110.386 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 158' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' B' ' 21' ' ' CYS . 5.2 m-85 -106.05 128.77 54.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.494 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 159' ' ' GLN . . . . . 0.565 ' HG3' ' C ' ' B' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.898 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.284 0.088 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.66 77.09 0.19 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.007 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 10.9 m -117.39 119.31 34.71 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.394 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 4' ' ' THR . . . . . 0.677 HG23 ' HG3' ' D' ' 157' ' ' GLN . 4.0 m -98.36 127.2 44.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.538 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.918 HG21 HG12 ' D' ' 17' ' ' VAL . 1.6 m -146.14 170.99 4.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.574 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.05 114.75 23.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.611 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 7' ' ' GLY . . . . . 0.414 ' H ' ' HA ' ' D' ' 155' ' ' LYS . . . -69.75 -57.64 7.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.801 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 8' ' ' GLY . . . . . 0.421 ' O ' HG23 ' C' ' 9' ' ' THR . . . -163.56 -144.59 4.08 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.892 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 9' ' ' THR . . . . . 0.986 HG22 HG23 ' D' ' 153' ' ' THR . 17.2 p -155.75 140.45 17.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.863 0.363 . . . . 0.0 111.396 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.559 HG13 HG23 ' D' ' 32' ' ' VAL . 29.5 t -130.28 117.49 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.212 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -91.59 117.09 29.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.392 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -89.88 107.02 18.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.911 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.71 113.29 26.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.454 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 14' ' ' GLY . . . . . 0.44 ' HA3' ' OH ' ' D' ' 137' ' ' TYR . . . -144.37 167.0 27.09 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.889 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 15' ' ' GLU . . . . . 0.676 ' CG ' ' O ' ' D' ' 146' ' ' GLY . 30.2 tt0 -155.73 135.18 12.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.975 0.417 . . . . 0.0 110.343 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' D' ' 148' ' ' ALA . 66.5 t -96.53 138.35 21.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.317 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.88 HG12 HG21 ' B' ' 5' ' ' VAL . 2.6 m -140.85 -173.37 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 0.0 110.996 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -80.09 173.46 12.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.967 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' ALA . . . . . 0.528 ' HA ' ' HB3' ' D' ' 38' ' ' ARG . . . -85.8 39.74 0.82 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.089 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 20' ' ' ALA . . . . . 0.631 ' HB1' ' CD2' ' C' ' 124' ' ' LEU . . . -114.24 -33.68 5.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.382 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 21' ' ' CYS . . . . . 0.675 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.9 OUTLIER -161.12 149.96 16.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.979 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 22' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' D' ' 36' ' ' GLN . . . -149.57 112.12 4.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.061 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 23' ' ' VAL . . . . . 0.665 ' HA ' ' HA ' ' C' ' 58' ' ' LEU . 3.1 p -59.97 153.4 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.04 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.76 152.83 28.12 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.624 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.53 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -57.58 -41.38 81.0 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.365 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.88 15.7 62.12 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.992 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.96 -21.39 11.14 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.927 0.394 . . . . 0.0 110.805 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 89.8 t -44.6 -64.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.334 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.26 135.61 38.94 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.913 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.0 128.8 19.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.043 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.71 111.71 23.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.111 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.552 HG23 HG13 ' B' ' 10' ' ' VAL . 4.2 t -110.74 114.79 48.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.103 0.478 . . . . 0.0 110.464 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.81 124.49 46.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.665 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.5 -45.7 14.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.603 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.32 -161.83 12.84 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.612 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' GLN . . . . . 0.623 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 1.1 mt-30 -99.85 129.7 45.97 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.557 0.218 . . . . 0.0 110.873 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.494 ' CG1' HG22 ' B' ' 16' ' ' VAL . 11.9 p -110.04 147.44 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.914 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 38' ' ' ARG . . . . . 0.513 ' HB3' ' HA ' ' B' ' 19' ' ' ALA . 0.7 OUTLIER -86.72 131.26 34.19 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.997 0.427 . . . . 0.0 111.804 179.204 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.697 ' HA ' ' HB3' ' C' ' 143' ' ' ALA . 4.8 t -54.12 -45.12 71.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.693 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.439 ' N ' HG23 ' C' ' 39' ' ' THR . . . -61.02 -39.36 89.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.114 0.483 . . . . 0.0 110.856 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 41' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' C' ' 38' ' ' ARG . 0.4 OUTLIER -70.63 -23.1 62.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.17 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.668 HD23 ' HB2' ' C' ' 139' ' ' ALA . 1.4 mp -124.61 51.58 1.6 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.583 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.66 29.95 7.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.326 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.84 128.45 48.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.32 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 45' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' C' ' 140' ' ' THR . 29.3 tt0 -53.0 102.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.114 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 46' ' ' GLY . . . . . 0.414 ' HA2' ' HE1' ' C' ' 138' ' ' PHE . . . 96.06 39.03 4.41 Favored Glycine 0 C--N 1.331 0.255 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.114 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' C' ' 139' ' ' ALA . . . -80.08 146.7 31.77 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.66 125.09 19.11 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.876 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 31.9 m -102.01 -166.27 1.27 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.625 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.96 133.03 55.71 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.836 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 51' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' C' ' 136' ' ' ARG . . . -92.74 120.21 32.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.299 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.623 HG22 ' O ' ' C' ' 135' ' ' ALA . 18.4 m -65.76 162.63 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.974 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.86 124.15 5.28 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.609 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -155.93 146.56 21.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.713 0.292 . . . . 0.0 110.932 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.578 ' HB2' HG22 ' C' ' 130' ' ' THR . 3.3 p30 -136.8 160.27 39.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.54 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.567 HG23 ' O ' ' C' ' 56' ' ' ILE . 1.6 tp -100.68 116.95 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.502 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.613 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.0 OUTLIER -70.09 124.56 24.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.763 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 58' ' ' LEU . . . . . 0.665 ' HA ' ' HA ' ' C' ' 23' ' ' VAL . 1.6 mp -133.68 87.42 2.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.231 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 59' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 4.9 p30 -73.67 174.54 8.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.918 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.8 79.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 61' ' ' CYS . . . . . 0.675 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 93.2 m -127.62 159.39 34.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.836 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 62' ' ' ASP . . . . . 0.607 ' OD2' HG23 ' C' ' 65' ' ' VAL . 5.5 t70 -130.22 167.07 19.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.354 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.667 HG23 ' HA ' ' C' ' 125' ' ' ASN . 0.2 OUTLIER -114.24 -41.75 3.44 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.167 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.5 -22.61 65.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.018 0.437 . . . . 0.0 111.714 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.607 HG23 ' OD2' ' C' ' 62' ' ' ASP . 81.4 t -70.4 -74.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.626 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 66' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' C' ' 124' ' ' LEU . . . -120.71 131.34 54.49 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.656 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.19 -48.63 6.11 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.81 0.338 . . . . 0.0 110.924 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 68' ' ' LYS . . . . . 0.634 ' HE3' ' HB3' ' C' ' 121' ' ' GLU . 0.1 OUTLIER -96.22 161.54 13.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.561 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.1 124.66 6.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.608 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.724 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -100.44 154.98 18.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.054 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 71' ' ' VAL . . . . . 0.829 HG11 HG21 ' C' ' 131' ' ' ILE . 2.3 t -132.72 148.3 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.713 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 72' ' ' ALA . . . . . 0.459 ' HA ' HD21 ' C' ' 111' ' ' LEU . . . -145.62 150.15 35.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.66 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 73' ' ' PHE . . . . . 0.568 ' HB2' HD13 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -119.95 137.0 54.31 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.077 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.624 HD21 HG21 ' F' ' 130' ' ' THR . 0.9 OUTLIER -96.08 139.52 32.14 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.874 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 75' ' ' GLY . . . . . 0.425 ' CA ' ' HB3' ' C' ' 113' ' ' LEU . . . 178.51 179.85 48.49 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.764 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.562 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.3 OUTLIER -110.94 156.42 21.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.545 0.212 . . . . 0.0 110.848 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 77' ' ' ALA . . . . . 0.668 ' O ' ' HB2' ' C' ' 87' ' ' ALA . . . -73.76 131.26 41.39 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.365 -0.38 . . . . 0.0 112.023 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 78' ' ' ILE . . . . . 0.649 ' CG2' ' HB ' ' C' ' 85' ' ' VAL . 0.9 OUTLIER -67.69 -41.37 85.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.865 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 79' ' ' ASP . . . . . 0.437 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.6 OUTLIER -141.18 40.84 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.8 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 80' ' ' ALA . . . . . 0.434 ' HB3' ' HA2' ' F' ' 108' ' ' GLY . . . 66.35 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.027 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.66 -24.95 41.86 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.723 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.12 64.04 1.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.953 0.406 . . . . 0.0 110.469 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 83' ' ' THR . . . . . 0.545 HG23 ' HB2' ' C' ' 77' ' ' ALA . 0.2 OUTLIER -68.44 -16.99 64.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.53 -179.512 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 84' ' ' ASN . . . . . 0.702 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 18.0 p-10 -70.35 -20.28 62.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.361 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.649 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 14.7 t -106.91 130.75 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.158 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.767 HD22 ' HB1' ' C' ' 150' ' ' ALA . 0.5 OUTLIER -67.56 148.19 51.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.431 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' C' ' 77' ' ' ALA . . . -89.64 -167.49 1.87 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.764 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.659 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 1.5 mm? -78.37 157.29 29.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.114 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -78.34 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.345 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 90' ' ' SER . . . . . 0.576 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 0.5 OUTLIER -167.1 0.53 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.018 0.437 . . . . 0.0 111.48 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 91' ' ' SER . . . . . 0.545 ' HA ' ' HB2' ' E' ' 25' ' ' ALA . 1.7 m -71.92 83.02 0.93 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 92' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' F' ' 34' ' ' LEU . . . -66.77 -13.88 61.95 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.879 0.371 . . . . 0.0 111.688 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.67 27.54 5.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.638 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.65 15.63 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.973 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 95' ' ' SER . . . . . 0.659 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 3.0 m -100.85 -172.84 2.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.766 0.317 . . . . 0.0 110.627 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.91 167.65 9.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 97' ' ' THR . . . . . 0.515 ' H ' ' HB ' ' C' ' 144' ' ' THR . 2.3 m -121.57 128.43 51.98 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.295 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 98' ' ' ASN . . . . . 0.457 ' HB3' ' H ' ' C' ' 141' ' ' GLY . 75.9 m-20 64.14 34.48 11.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.498 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 99' ' ' VAL . . . . . 0.478 HG13 HD23 ' C' ' 42' ' ' LEU . 0.5 OUTLIER -139.87 136.6 38.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.709 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.19 -156.91 8.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.498 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 101' ' ' VAL . . . . . 0.492 HG13 ' HB2' ' C' ' 86' ' ' LEU . 3.2 p -137.81 116.77 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 122.951 0.5 . . . . 0.0 111.644 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 102' ' ' GLN . . . . . 0.578 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 1.1 tt0 -91.91 150.36 21.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.873 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.67 HD12 ' HB3' ' C' ' 111' ' ' LEU . 0.5 OUTLIER -113.76 131.31 65.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.601 179.415 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 104' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 0.3 OUTLIER -106.24 130.19 54.15 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.664 0.269 . . . . 0.0 111.054 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 105' ' ' ASP . . . . . 0.743 ' HB3' HG22 ' C' ' 107' ' ' THR . 5.1 t0 -76.2 157.0 33.12 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.694 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 106' ' ' ARG . . . . . 0.71 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 3.5 ttp180 -71.24 -17.44 62.5 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.763 0.316 . . . . 0.0 111.101 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 107' ' ' THR . . . . . 0.743 HG22 ' HB3' ' C' ' 105' ' ' ASP . 6.2 t -67.27 -17.99 65.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.069 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.75 -45.62 1.17 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.766 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.14 163.11 23.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.727 0.298 . . . . 0.0 111.159 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -84.15 127.39 33.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 111' ' ' LEU . . . . . 0.67 ' HB3' HD12 ' C' ' 103' ' ' ILE . 12.1 tp -86.22 156.02 20.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.304 0.573 . . . . 0.0 110.638 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 112' ' ' THR . . . . . 0.892 HG23 HG21 ' C' ' 117' ' ' THR . 0.5 OUTLIER -106.14 139.17 41.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.151 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.624 HD13 ' HG ' ' C' ' 86' ' ' LEU . 1.0 OUTLIER -73.91 76.43 1.65 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.679 0.276 . . . . 0.0 110.706 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.41 -17.17 14.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.558 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.27 -51.75 1.25 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.648 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.03 18.84 21.66 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.941 0.4 . . . . 0.0 111.554 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 117' ' ' THR . . . . . 0.892 HG21 HG23 ' C' ' 112' ' ' THR . 0.2 OUTLIER -85.8 84.6 7.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.057 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 118' ' ' PHE . . . . . 0.724 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . 95.7 m-85 -101.38 98.77 9.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.795 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 38.7 m -130.79 62.28 1.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.25 145.86 30.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.715 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 121' ' ' GLU . . . . . 0.634 ' HB3' ' HE3' ' C' ' 68' ' ' LYS . 3.5 mm-40 -121.39 71.25 0.95 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.217 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.69 134.77 34.75 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.703 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 14.8 m -83.79 113.66 21.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.776 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 124' ' ' LEU . . . . . 0.631 ' CD2' ' HB1' ' C' ' 20' ' ' ALA . 18.9 tp -74.0 142.9 45.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.657 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 125' ' ' ASN . . . . . 0.667 ' HA ' HG23 ' C' ' 63' ' ' THR . 0.9 OUTLIER -138.57 162.1 35.41 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.573 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.73 113.2 12.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.7 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.48 -139.91 9.5 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.734 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 128' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 6.7 m -101.69 96.76 7.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.698 0.285 . . . . 0.0 110.773 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.59 148.48 27.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.895 0.379 . . . . 0.0 111.093 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 130' ' ' THR . . . . . 0.613 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -138.55 143.43 39.45 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.207 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 131' ' ' ILE . . . . . 0.829 HG21 HG11 ' C' ' 71' ' ' VAL . 55.1 mt -104.62 112.41 65.34 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 132' ' ' PRO . . . . . 0.71 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.5 Cg_endo -81.95 141.98 12.2 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.719 1.612 . . . . 0.0 112.526 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.401 ' HZ ' HD22 ' C' ' 111' ' ' LEU . 0.3 OUTLIER -150.63 141.06 22.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.85 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -104.49 152.53 22.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.131 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 135' ' ' ALA . . . . . 0.623 ' O ' HG22 ' C' ' 52' ' ' VAL . . . -153.52 101.08 2.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.98 0.419 . . . . 0.0 111.6 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.554 ' HB3' ' HA ' ' C' ' 51' ' ' ALA . 17.5 ptt180 -107.18 177.2 4.92 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.42 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 137' ' ' TYR . . . . . 0.497 ' HB3' HD21 ' C' ' 42' ' ' LEU . 4.7 m-85 -85.93 124.15 32.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.008 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 138' ' ' PHE . . . . . 0.466 ' HB3' HG11 ' C' ' 85' ' ' VAL . 1.2 t80 -118.9 112.38 19.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.959 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 139' ' ' ALA . . . . . 0.668 ' HB2' HD23 ' C' ' 42' ' ' LEU . . . -102.97 133.95 47.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.873 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 140' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 0.1 OUTLIER -81.1 -28.9 35.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.529 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 141' ' ' GLY . . . . . 0.457 ' H ' ' HB3' ' C' ' 98' ' ' ASN . . . -160.15 -111.06 0.28 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.926 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.85 110.56 21.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.537 0.208 . . . . 0.0 110.766 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 143' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' C' ' 39' ' ' THR . . . -65.65 134.29 52.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.83 0.348 . . . . 0.0 111.343 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 144' ' ' THR . . . . . 0.602 ' O ' ' CG1' ' B' ' 16' ' ' VAL . 56.4 m -105.82 149.39 37.93 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.346 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 145' ' ' PRO . . . . . 0.49 ' CD ' ' CG2' ' C' ' 144' ' ' THR . 1.4 Cg_endo -82.91 125.54 4.2 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.497 2.131 . . . . 0.0 112.023 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 146' ' ' GLY . . . . . 0.689 ' O ' ' CG ' ' B' ' 15' ' ' GLU . . . 168.78 -126.33 1.38 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.407 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 147' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -111.07 128.43 55.87 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.758 0.313 . . . . 0.0 111.317 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 148' ' ' ALA . . . . . 0.686 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -125.41 52.15 1.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.15 0.5 . . . . 0.0 110.492 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -98.78 151.93 20.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.597 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 150' ' ' ALA . . . . . 0.767 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -158.28 169.6 24.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.009 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -130.98 128.63 40.8 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.291 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 152' ' ' ALA . . . . . 0.479 ' HB2' HD11 ' C' ' 86' ' ' LEU . . . -122.21 144.06 49.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.228 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 153' ' ' THR . . . . . 1.041 HG23 HG22 ' B' ' 9' ' ' THR . 0.6 OUTLIER -106.37 145.34 31.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.185 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 154' ' ' PHE . . . . . 0.402 ' HB3' ' H ' ' B' ' 8' ' ' GLY . 0.5 OUTLIER -96.9 134.67 39.93 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.068 0.461 . . . . 0.0 110.019 -178.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 155' ' ' LYS . . . . . 0.416 ' HA ' ' H ' ' B' ' 7' ' ' GLY . 9.9 mmtt -124.15 148.14 47.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.895 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 156' ' ' VAL . . . . . 0.521 HG23 HG23 ' B' ' 5' ' ' VAL . 29.9 m -135.15 144.77 33.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.742 0.306 . . . . 0.0 111.791 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 157' ' ' GLN . . . . . 0.677 ' HG3' HG23 ' B' ' 4' ' ' THR . 0.0 OUTLIER -134.46 126.06 28.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.273 0.559 . . . . 0.0 110.399 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 158' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' C' ' 21' ' ' CYS . 5.2 m-85 -106.02 128.75 54.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.502 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 159' ' ' GLN . . . . . 0.56 ' HG3' ' C ' ' C' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 111.142 0.053 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.64 77.12 0.19 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.172 0.295 . . . . 0.0 110.983 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 3' ' ' THR . . . . . . . . . . . . . 10.9 m -117.41 119.32 34.75 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.387 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 4' ' ' THR . . . . . 0.682 HG23 ' HG3' ' E' ' 157' ' ' GLN . 4.0 m -98.37 127.21 44.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.535 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.92 HG21 HG12 ' E' ' 17' ' ' VAL . 1.6 m -146.1 171.03 4.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.601 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -86.02 114.61 23.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.599 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 7' ' ' GLY . . . . . 0.407 ' H ' ' HA ' ' E' ' 155' ' ' LYS . . . -69.61 -57.71 7.05 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.813 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 8' ' ' GLY . . . . . 0.43 ' O ' HG23 ' D' ' 9' ' ' THR . . . -163.59 -144.61 4.08 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.87 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 9' ' ' THR . . . . . 1.038 HG22 HG23 ' E' ' 153' ' ' THR . 17.1 p -155.7 140.46 17.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 111.371 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 10' ' ' VAL . . . . . 0.546 HG13 HG23 ' E' ' 32' ' ' VAL . 30.1 t -130.34 117.48 39.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.294 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -91.5 116.98 29.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.349 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -89.86 107.08 18.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.883 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.75 113.32 26.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.451 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 14' ' ' GLY . . . . . 0.441 ' HA3' ' OH ' ' E' ' 137' ' ' TYR . . . -144.42 166.98 27.12 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.919 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 15' ' ' GLU . . . . . 0.676 ' CG ' ' O ' ' E' ' 146' ' ' GLY . 30.2 tt0 -155.68 135.2 12.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.966 0.412 . . . . 0.0 110.32 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.699 HG23 ' HB2' ' E' ' 148' ' ' ALA . 65.8 t -96.53 138.36 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.275 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.918 HG12 HG21 ' C' ' 5' ' ' VAL . 2.7 m -140.85 -173.38 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.872 0.368 . . . . 0.0 111.002 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.08 173.41 12.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.075 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 19' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' E' ' 38' ' ' ARG . . . -85.82 39.76 0.82 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.041 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.639 ' HB1' ' CD2' ' D' ' 124' ' ' LEU . . . -114.31 -33.46 5.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.459 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 21' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.9 OUTLIER -161.18 149.98 16.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.935 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.64 112.09 4.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.102 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 23' ' ' VAL . . . . . 0.664 ' HA ' ' HA ' ' D' ' 58' ' ' LEU . 3.0 p -59.93 153.34 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.082 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.68 152.75 28.27 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.686 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.546 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -57.53 -41.46 80.93 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.357 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.81 15.7 62.06 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.968 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.95 -21.35 11.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.914 0.387 . . . . 0.0 110.814 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 90.1 t -44.58 -64.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.364 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.29 135.69 38.85 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.885 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.04 128.77 19.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.044 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.83 111.83 23.85 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.014 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.559 HG23 HG13 ' C' ' 10' ' ' VAL . 4.2 t -110.82 114.81 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.139 0.495 . . . . 0.0 110.519 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.75 124.45 46.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.649 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 0.9 OUTLIER -82.49 -45.74 14.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.574 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.37 -161.86 12.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.571 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' GLN . . . . . 0.608 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 1.1 mt-30 -99.83 129.69 45.95 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.648 0.261 . . . . 0.0 110.881 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.493 ' CG1' HG22 ' C' ' 16' ' ' VAL . 12.0 p -110.02 147.44 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.995 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 38' ' ' ARG . . . . . 0.528 ' HB3' ' HA ' ' C' ' 19' ' ' ALA . 0.7 OUTLIER -86.78 131.29 34.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.053 0.454 . . . . 0.0 111.69 179.301 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.693 ' HA ' ' HB3' ' D' ' 143' ' ' ALA . 4.8 t -54.09 -45.13 71.71 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.753 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.449 ' N ' HG23 ' D' ' 39' ' ' THR . . . -60.93 -39.37 89.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.137 0.494 . . . . 0.0 110.939 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 41' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' D' ' 38' ' ' ARG . 0.4 OUTLIER -70.62 -23.15 62.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.134 -179.661 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' D' ' 139' ' ' ALA . 1.4 mp -124.59 51.57 1.6 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.669 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.59 29.9 7.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.38 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.84 128.46 48.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.33 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 45' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' D' ' 140' ' ' THR . 29.5 tt0 -52.95 103.05 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.871 0.367 . . . . 0.0 111.117 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 46' ' ' GLY . . . . . 0.419 ' HA2' ' HE1' ' D' ' 138' ' ' PHE . . . 95.94 39.03 4.44 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.193 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' D' ' 139' ' ' ALA . . . -79.98 146.66 31.92 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.63 124.97 19.01 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.973 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 32.3 m -101.9 -166.31 1.28 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.626 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.04 132.99 55.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.848 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 51' ' ' ALA . . . . . 0.549 ' HA ' ' HB3' ' D' ' 136' ' ' ARG . . . -92.64 120.24 32.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.321 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 52' ' ' VAL . . . . . 0.631 HG22 ' O ' ' D' ' 135' ' ' ALA . 18.5 m -65.84 162.66 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.905 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.8 124.14 5.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.649 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.442 ' N ' HG21 ' A' ' 76' ' ' THR . 54.0 p90 -155.93 146.55 21.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.705 0.288 . . . . 0.0 110.942 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 55' ' ' ASN . . . . . 0.568 ' HB2' HG22 ' D' ' 130' ' ' THR . 0.6 OUTLIER -136.84 160.24 39.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.58 HG23 ' O ' ' D' ' 56' ' ' ILE . 1.6 tp -100.63 117.02 45.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.536 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 57' ' ' GLN . . . . . 0.611 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.0 OUTLIER -70.12 124.58 24.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.736 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 58' ' ' LEU . . . . . 0.664 ' HA ' ' HA ' ' D' ' 23' ' ' VAL . 1.6 mp -133.77 87.54 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.181 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 59' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 4.9 p30 -73.65 174.61 8.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.006 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.81 79.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.815 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 61' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 93.6 m -127.58 159.4 34.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.862 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 62' ' ' ASP . . . . . 0.612 ' OD2' HG23 ' D' ' 65' ' ' VAL . 5.5 t70 -130.24 167.11 18.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.28 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.661 HG23 ' HA ' ' D' ' 125' ' ' ASN . 0.2 OUTLIER -114.35 -41.66 3.44 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.47 -22.71 65.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.063 0.459 . . . . 0.0 111.723 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 65' ' ' VAL . . . . . 0.612 HG23 ' OD2' ' D' ' 62' ' ' ASP . 81.5 t -70.38 -74.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.635 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' D' ' 124' ' ' LEU . . . -120.76 131.33 54.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.634 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.21 -48.54 6.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.857 0.361 . . . . 0.0 110.981 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 68' ' ' LYS . . . . . 0.631 ' HE3' ' HB3' ' D' ' 121' ' ' GLU . 0.1 OUTLIER -96.25 161.54 13.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.555 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.09 124.63 6.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.642 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 70' ' ' ALA . . . . . 0.726 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -100.32 155.0 18.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.098 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 71' ' ' VAL . . . . . 0.849 HG11 HG21 ' D' ' 131' ' ' ILE . 2.3 t -132.75 148.22 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.745 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 72' ' ' ALA . . . . . 0.445 ' HA ' HD21 ' D' ' 111' ' ' LEU . . . -145.57 150.18 35.93 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.59 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 73' ' ' PHE . . . . . 0.557 ' HB2' HD13 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -119.99 136.96 54.35 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.053 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 74' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.9 OUTLIER -96.05 139.54 32.08 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.937 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 75' ' ' GLY . . . . . 0.429 ' CA ' ' HB3' ' D' ' 113' ' ' LEU . . . 178.53 179.83 48.5 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.745 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 76' ' ' THR . . . . . 0.548 ' H ' HD23 ' D' ' 86' ' ' LEU . 0.3 OUTLIER -111.0 156.39 21.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.534 0.207 . . . . 0.0 110.832 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.668 ' O ' ' HB2' ' D' ' 87' ' ' ALA . . . -73.78 131.3 41.41 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.04 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 78' ' ' ILE . . . . . 0.646 ' CG2' ' HB ' ' D' ' 85' ' ' VAL . 0.9 OUTLIER -67.72 -41.3 85.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.874 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.424 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.6 OUTLIER -141.17 40.75 1.78 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.808 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 66.44 -80.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.7 -24.96 42.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.688 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -99.1 64.04 1.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.448 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 83' ' ' THR . . . . . 0.542 HG23 ' HB2' ' D' ' 77' ' ' ALA . 0.2 OUTLIER -68.5 -16.86 64.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.584 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 84' ' ' ASN . . . . . 0.693 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 18.0 p-10 -70.36 -20.3 62.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.359 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.646 ' HB ' ' CG2' ' D' ' 78' ' ' ILE . 14.7 t -106.87 130.74 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.136 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.78 HD22 ' HB1' ' D' ' 150' ' ' ALA . 0.5 OUTLIER -67.66 148.18 51.69 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' D' ' 77' ' ' ALA . . . -89.62 -167.54 1.89 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 111.713 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.659 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 1.5 mm? -78.32 157.23 29.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.094 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -78.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.418 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.18 0.6 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.971 0.415 . . . . 0.0 111.483 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 91' ' ' SER . . . . . 0.537 ' HA ' ' HB2' ' F' ' 25' ' ' ALA . 1.7 m -71.91 82.94 0.93 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.65 -13.96 61.84 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.917 0.389 . . . . 0.0 111.749 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.61 27.61 5.23 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.581 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.67 15.6 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.946 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 95' ' ' SER . . . . . 0.659 ' HB3' ' HG ' ' D' ' 88' ' ' LEU . 3.0 m -100.9 -172.81 2.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.715 0.293 . . . . 0.0 110.635 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.86 167.62 9.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 97' ' ' THR . . . . . 0.517 ' H ' ' HB ' ' D' ' 144' ' ' THR . 2.3 m -121.51 128.36 51.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.34 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 98' ' ' ASN . . . . . 0.461 ' HB3' ' H ' ' D' ' 141' ' ' GLY . 76.0 m-20 64.28 34.44 10.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.468 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 99' ' ' VAL . . . . . 0.503 HG13 HD23 ' D' ' 42' ' ' LEU . 0.5 OUTLIER -139.92 136.46 38.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.738 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.08 -156.92 8.36 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.523 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 101' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' D' ' 86' ' ' LEU . 3.2 p -137.8 116.8 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.132 0.491 . . . . 0.0 111.647 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 102' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 1.2 tt0 -91.86 150.35 21.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.847 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 103' ' ' ILE . . . . . 0.688 HD12 ' HB3' ' D' ' 111' ' ' LEU . 0.5 OUTLIER -113.85 131.34 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.494 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 104' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 0.3 OUTLIER -106.29 130.16 54.19 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.68 0.276 . . . . 0.0 110.958 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 105' ' ' ASP . . . . . 0.738 ' HB3' HG22 ' D' ' 107' ' ' THR . 5.1 t0 -76.14 156.99 33.28 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.679 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 106' ' ' ARG . . . . . 0.741 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 3.5 ttp180 -71.19 -17.55 62.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.738 0.304 . . . . 0.0 111.078 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 107' ' ' THR . . . . . 0.738 HG22 ' HB3' ' D' ' 105' ' ' ASP . 6.2 t -67.17 -18.07 65.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.021 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 108' ' ' GLY . . . . . 0.439 ' HA2' ' CB ' ' A' ' 80' ' ' ALA . . . 123.7 -45.57 1.17 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.74 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.07 163.05 23.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.7 0.286 . . . . 0.0 111.154 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -84.13 127.41 33.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.08 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 111' ' ' LEU . . . . . 0.688 ' HB3' HD12 ' D' ' 103' ' ' ILE . 12.1 tp -86.24 156.11 20.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.258 0.551 . . . . 0.0 110.633 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 112' ' ' THR . . . . . 0.891 HG23 HG21 ' D' ' 117' ' ' THR . 0.5 OUTLIER -106.23 139.15 41.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.123 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 113' ' ' LEU . . . . . 0.602 HD13 ' HG ' ' D' ' 86' ' ' LEU . 1.0 OUTLIER -74.03 76.55 1.71 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.755 0.312 . . . . 0.0 110.742 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.54 -17.09 14.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.516 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.23 -51.86 1.25 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.664 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.99 18.86 21.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.858 0.361 . . . . 0.0 111.509 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 117' ' ' THR . . . . . 0.891 HG21 HG23 ' D' ' 112' ' ' THR . 0.2 OUTLIER -85.81 84.64 7.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.079 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.726 ' HB3' ' HB1' ' D' ' 70' ' ' ALA . 95.7 m-85 -101.37 98.77 9.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.759 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 38.1 m -130.77 62.33 1.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.28 145.74 30.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.735 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 121' ' ' GLU . . . . . 0.631 ' HB3' ' HE3' ' D' ' 68' ' ' LYS . 3.5 mm-40 -121.25 71.3 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.179 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 134.78 34.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.684 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 15.1 m -83.82 113.7 21.11 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.701 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 124' ' ' LEU . . . . . 0.639 ' CD2' ' HB1' ' D' ' 20' ' ' ALA . 19.0 tp -74.08 142.96 45.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.772 0.32 . . . . 0.0 110.61 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 125' ' ' ASN . . . . . 0.661 ' HA ' HG23 ' D' ' 63' ' ' THR . 0.9 OUTLIER -138.53 162.12 35.32 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.59 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.8 113.18 12.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.684 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.54 -140.02 9.57 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.688 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 128' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 6.6 m -101.66 96.87 7.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 110.773 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.65 148.54 27.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.843 0.354 . . . . 0.0 111.097 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 130' ' ' THR . . . . . 0.627 HG21 HD21 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -138.61 143.4 39.31 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.123 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 131' ' ' ILE . . . . . 0.849 HG21 HG11 ' D' ' 71' ' ' VAL . 55.1 mt -104.57 112.36 65.34 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 132' ' ' PRO . . . . . 0.741 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.4 Cg_endo -82.01 141.98 12.13 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.675 1.583 . . . . 0.0 112.458 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 133' ' ' PHE . . . . . 0.404 ' HZ ' HD22 ' D' ' 111' ' ' LEU . 0.3 OUTLIER -150.61 141.12 22.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.897 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -104.48 152.55 22.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.097 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.631 ' O ' HG22 ' D' ' 52' ' ' VAL . . . -153.53 101.08 2.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.954 0.407 . . . . 0.0 111.578 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 136' ' ' ARG . . . . . 0.549 ' HB3' ' HA ' ' D' ' 51' ' ' ALA . 17.5 ptt180 -107.18 177.19 4.92 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.379 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 137' ' ' TYR . . . . . 0.49 ' HB3' HD21 ' D' ' 42' ' ' LEU . 4.7 m-85 -85.92 124.04 31.94 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.089 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 138' ' ' PHE . . . . . 0.455 ' HB3' HG11 ' D' ' 85' ' ' VAL . 1.2 t80 -118.8 112.39 19.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.991 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 139' ' ' ALA . . . . . 0.685 ' HB2' HD23 ' D' ' 42' ' ' LEU . . . -102.97 134.0 47.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.828 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 140' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 0.1 OUTLIER -81.12 -28.86 34.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.507 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 141' ' ' GLY . . . . . 0.461 ' H ' ' HB3' ' D' ' 98' ' ' ASN . . . -160.19 -111.09 0.28 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.917 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.88 110.57 21.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.549 0.214 . . . . 0.0 110.744 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 143' ' ' ALA . . . . . 0.693 ' HB3' ' HA ' ' D' ' 39' ' ' THR . . . -65.69 134.27 52.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 111.341 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 144' ' ' THR . . . . . 0.602 ' O ' ' CG1' ' C' ' 16' ' ' VAL . 56.4 m -105.8 149.42 37.96 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.341 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 145' ' ' PRO . . . . . 0.487 ' CD ' ' CG2' ' D' ' 144' ' ' THR . 1.3 Cg_endo -82.96 125.52 4.17 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.519 2.146 . . . . 0.0 112.001 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 146' ' ' GLY . . . . . 0.676 ' O ' ' CG ' ' C' ' 15' ' ' GLU . . . 168.8 -126.37 1.38 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.412 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 147' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -111.1 128.45 55.89 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.813 0.339 . . . . 0.0 111.322 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 148' ' ' ALA . . . . . 0.688 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -125.46 52.14 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.15 0.5 . . . . 0.0 110.398 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -98.71 152.05 20.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.545 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 150' ' ' ALA . . . . . 0.78 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -158.38 169.46 24.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.959 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.96 128.67 40.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.256 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 152' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' D' ' 86' ' ' LEU . . . -122.19 144.06 49.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.251 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 153' ' ' THR . . . . . 0.986 HG23 HG22 ' C' ' 9' ' ' THR . 0.6 OUTLIER -106.34 145.34 31.8 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.209 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 154' ' ' PHE . . . . . 0.415 ' HB3' ' H ' ' C' ' 8' ' ' GLY . 0.5 OUTLIER -96.84 134.67 39.84 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.052 0.454 . . . . 0.0 110.121 -179.081 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 155' ' ' LYS . . . . . 0.414 ' HA ' ' H ' ' C' ' 7' ' ' GLY . 9.9 mmtt -124.24 148.07 47.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.854 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 156' ' ' VAL . . . . . 0.515 HG23 HG23 ' C' ' 5' ' ' VAL . 29.7 m -135.06 144.83 33.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.783 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 157' ' ' GLN . . . . . 0.677 ' HG3' HG23 ' C' ' 4' ' ' THR . 0.0 OUTLIER -134.51 126.06 28.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.283 0.563 . . . . 0.0 110.36 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 158' ' ' TYR . . . . . 0.563 ' CE1' ' HB2' ' D' ' 21' ' ' CYS . 5.2 m-85 -106.02 128.77 54.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.474 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 159' ' ' GLN . . . . . 0.563 ' HG3' ' C ' ' D' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 111.169 0.062 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.7 77.1 0.19 Allowed 'General case' 0 N--CA 1.462 0.146 0 O-C-N 123.1 0.25 . . . . 0.0 110.989 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 3' ' ' THR . . . . . . . . . . . . . 10.7 m -117.36 119.24 34.52 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.472 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 4' ' ' THR . . . . . 0.693 HG23 ' HG3' ' F' ' 157' ' ' GLN . 3.9 m -98.34 127.2 44.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.575 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.884 HG21 HG12 ' F' ' 17' ' ' VAL . 1.6 m -146.11 171.02 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.592 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -86.05 114.73 23.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.573 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 7' ' ' GLY . . . . . 0.411 ' H ' ' HA ' ' F' ' 155' ' ' LYS . . . -69.67 -57.75 6.98 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.923 -0.655 . . . . 0.0 112.829 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 8' ' ' GLY . . . . . 0.428 ' O ' HG23 ' E' ' 9' ' ' THR . . . -163.52 -144.6 4.08 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.901 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 9' ' ' THR . . . . . 1.025 HG22 HG23 ' F' ' 153' ' ' THR . 17.1 p -155.73 140.46 17.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.855 0.36 . . . . 0.0 111.385 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 10' ' ' VAL . . . . . 0.557 HG13 HG23 ' F' ' 32' ' ' VAL . 30.0 t -130.31 117.45 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.238 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -91.5 117.0 29.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.435 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -89.79 107.11 18.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.84 113.26 26.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.449 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 14' ' ' GLY . . . . . 0.426 ' HA3' ' OH ' ' F' ' 137' ' ' TYR . . . -144.41 166.98 27.11 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.933 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 15' ' ' GLU . . . . . 0.685 ' CG ' ' O ' ' F' ' 146' ' ' GLY . 30.2 tt0 -155.7 135.17 12.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.985 0.421 . . . . 0.0 110.294 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 16' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' F' ' 148' ' ' ALA . 66.1 t -96.48 138.31 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.264 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 17' ' ' VAL . . . . . 0.92 HG12 HG21 ' D' ' 5' ' ' VAL . 2.7 m -140.81 -173.34 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 111.06 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.13 173.41 12.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.052 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 19' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' F' ' 38' ' ' ARG . . . -85.73 39.73 0.81 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.641 ' HB1' ' CD2' ' E' ' 124' ' ' LEU . . . -114.34 -33.54 5.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.424 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 21' ' ' CYS . . . . . 0.667 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.9 OUTLIER -161.13 150.01 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.933 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.6 112.1 4.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.02 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 23' ' ' VAL . . . . . 0.667 ' HA ' ' HA ' ' E' ' 58' ' ' LEU . 3.1 p -60.02 153.41 4.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.989 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.76 152.81 28.12 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.665 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 25' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -57.5 -41.48 80.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.351 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.77 15.65 62.11 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.032 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -113.05 -21.2 11.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.902 0.382 . . . . 0.0 110.809 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -44.65 -64.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.298 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.23 135.69 38.8 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.957 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.02 128.78 19.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.059 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.78 111.79 23.82 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.058 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.546 HG23 HG13 ' D' ' 10' ' ' VAL . 4.2 t -110.81 114.74 47.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.479 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.68 124.55 46.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.703 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . 0.9 OUTLIER -82.54 -45.62 14.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.661 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.31 -161.86 12.83 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.583 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 36' ' ' GLN . . . . . 0.608 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 1.1 mt-30 -99.83 129.68 45.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.604 0.24 . . . . 0.0 110.862 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.49 ' CG1' HG22 ' D' ' 16' ' ' VAL . 11.8 p -110.11 147.5 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.924 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 38' ' ' ARG . . . . . 0.513 ' HB3' ' HA ' ' D' ' 19' ' ' ALA . 0.7 OUTLIER -86.77 131.24 34.18 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.974 0.416 . . . . 0.0 111.765 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 39' ' ' THR . . . . . 0.699 ' HA ' ' HB3' ' E' ' 143' ' ' ALA . 4.8 t -54.08 -45.09 71.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.772 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.45 ' N ' HG23 ' E' ' 39' ' ' THR . . . -61.01 -39.35 89.4 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.052 0.453 . . . . 0.0 110.854 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 41' ' ' SER . . . . . 0.401 ' HB2' ' HB2' ' E' ' 38' ' ' ARG . 0.4 OUTLIER -70.62 -23.16 62.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.178 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.678 HD23 ' HB2' ' E' ' 139' ' ' ALA . 1.4 mp -124.55 51.61 1.59 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.616 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.69 30.02 7.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.383 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.85 128.45 48.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.294 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 45' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' E' ' 140' ' ' THR . 29.5 tt0 -52.97 102.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.899 0.38 . . . . 0.0 111.139 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 46' ' ' GLY . . . . . 0.428 ' HA2' ' HE1' ' E' ' 138' ' ' PHE . . . 96.05 39.02 4.42 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.098 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 47' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' E' ' 139' ' ' ALA . . . -80.08 146.77 31.74 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.68 125.0 18.97 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.957 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 32.1 m -101.93 -166.31 1.28 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.589 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.99 133.04 55.72 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 51' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' E' ' 136' ' ' ARG . . . -92.7 120.21 32.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.237 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 52' ' ' VAL . . . . . 0.638 HG22 ' O ' ' E' ' 135' ' ' ALA . 18.5 m -65.78 162.69 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.86 124.08 5.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.688 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 54' ' ' PHE . . . . . 0.455 ' N ' HG21 ' B' ' 76' ' ' THR . 53.7 p90 -155.92 146.54 21.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.713 0.292 . . . . 0.0 110.951 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 55' ' ' ASN . . . . . 0.559 ' HB2' HG22 ' E' ' 130' ' ' THR . 0.6 OUTLIER -136.79 160.31 39.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.529 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 56' ' ' ILE . . . . . 0.57 HG23 ' O ' ' E' ' 56' ' ' ILE . 1.6 tp -100.69 116.94 45.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.563 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 57' ' ' GLN . . . . . 0.619 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.0 OUTLIER -70.0 124.64 24.57 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.766 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 58' ' ' LEU . . . . . 0.667 ' HA ' ' HA ' ' E' ' 23' ' ' VAL . 1.6 mp -133.79 87.49 2.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.204 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 59' ' ' ASN . . . . . 0.564 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 4.9 p30 -73.62 174.56 8.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.98 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.86 79.3 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.734 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 61' ' ' CYS . . . . . 0.667 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 93.4 m -127.62 159.44 34.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.88 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 62' ' ' ASP . . . . . 0.616 ' OD2' HG23 ' E' ' 65' ' ' VAL . 5.6 t70 -130.3 167.1 19.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.226 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 63' ' ' THR . . . . . 0.662 HG23 ' HA ' ' E' ' 125' ' ' ASN . 0.2 OUTLIER -114.26 -41.73 3.44 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.143 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.49 -22.64 65.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.013 0.435 . . . . 0.0 111.725 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 65' ' ' VAL . . . . . 0.616 HG23 ' OD2' ' E' ' 62' ' ' ASP . 83.1 t -70.43 -74.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.593 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 66' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' E' ' 124' ' ' LEU . . . -120.73 131.39 54.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.603 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.18 -48.6 6.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.956 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 68' ' ' LYS . . . . . 0.629 ' HE3' ' HB3' ' E' ' 121' ' ' GLU . 0.1 OUTLIER -96.23 161.51 13.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.09 124.67 6.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.633 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 70' ' ' ALA . . . . . 0.709 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -100.39 154.98 18.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.098 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 71' ' ' VAL . . . . . 0.834 HG11 HG21 ' E' ' 131' ' ' ILE . 2.3 t -132.72 148.28 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.715 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 72' ' ' ALA . . . . . 0.437 ' HA ' HD21 ' E' ' 111' ' ' LEU . . . -145.57 150.2 35.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.61 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 73' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -119.98 136.97 54.34 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 121.214 -0.195 . . . . 0.0 111.051 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 74' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.9 OUTLIER -95.95 139.48 32.08 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.956 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 75' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' E' ' 113' ' ' LEU . . . 178.5 179.84 48.48 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.797 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 76' ' ' THR . . . . . 0.549 ' H ' HD23 ' E' ' 86' ' ' LEU . 0.3 OUTLIER -110.98 156.37 21.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.449 0.166 . . . . 0.0 110.839 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 77' ' ' ALA . . . . . 0.671 ' O ' ' HB2' ' E' ' 87' ' ' ALA . . . -73.75 131.25 41.38 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.03 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 78' ' ' ILE . . . . . 0.649 ' CG2' ' HB ' ' E' ' 85' ' ' VAL . 0.9 OUTLIER -67.61 -41.48 85.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.831 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 79' ' ' ASP . . . . . 0.435 ' N ' HG23 ' E' ' 78' ' ' ILE . 0.6 OUTLIER -141.13 40.78 1.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 66.49 -80.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.003 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.73 -24.91 42.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.659 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -99.12 64.02 1.36 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 0.0 110.511 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 83' ' ' THR . . . . . 0.554 HG23 ' HB2' ' E' ' 77' ' ' ALA . 0.2 OUTLIER -68.48 -16.86 64.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.528 -179.473 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 84' ' ' ASN . . . . . 0.687 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 18.0 p-10 -70.41 -20.22 62.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.385 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.649 ' HB ' ' CG2' ' E' ' 78' ' ' ILE . 14.7 t -106.87 130.73 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.18 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 86' ' ' LEU . . . . . 0.786 HD22 ' HB1' ' E' ' 150' ' ' ALA . 0.5 OUTLIER -67.65 148.2 51.67 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 87' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' E' ' 77' ' ' ALA . . . -89.59 -167.52 1.88 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.846 0.355 . . . . 0.0 111.77 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.658 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 1.5 mm? -78.28 157.31 29.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -78.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.34 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.09 0.53 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.016 0.436 . . . . 0.0 111.462 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 91' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' E' ' 95' ' ' SER . 1.7 m -71.84 82.9 0.91 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.68 -13.92 61.85 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.872 0.368 . . . . 0.0 111.725 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.62 27.55 5.24 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.683 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.69 15.66 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.909 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 95' ' ' SER . . . . . 0.658 ' HB3' ' HG ' ' E' ' 88' ' ' LEU . 3.0 m -100.94 -172.8 2.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.782 0.325 . . . . 0.0 110.587 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.91 167.7 9.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.818 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 97' ' ' THR . . . . . 0.52 ' H ' ' HB ' ' E' ' 144' ' ' THR . 2.3 m -121.56 128.46 52.03 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.338 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 98' ' ' ASN . . . . . 0.446 ' HB3' ' H ' ' E' ' 141' ' ' GLY . 75.9 m-20 64.13 34.59 10.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.432 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 99' ' ' VAL . . . . . 0.491 HG13 HD23 ' E' ' 42' ' ' LEU . 0.5 OUTLIER -139.96 136.44 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.745 179.621 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.12 -156.94 8.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.536 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 101' ' ' VAL . . . . . 0.485 HG13 ' HB2' ' E' ' 86' ' ' LEU . 3.2 p -137.76 116.69 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 122.971 0.508 . . . . 0.0 111.653 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 102' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 1.2 tt0 -91.86 150.37 21.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.943 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 103' ' ' ILE . . . . . 0.683 HD12 ' HB3' ' E' ' 111' ' ' LEU . 0.5 OUTLIER -113.81 131.35 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.535 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 104' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 0.3 OUTLIER -106.22 130.14 54.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.673 0.273 . . . . 0.0 110.997 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 105' ' ' ASP . . . . . 0.713 ' HB3' HG22 ' E' ' 107' ' ' THR . 5.1 t0 -76.11 156.99 33.33 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.739 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 106' ' ' ARG . . . . . 0.712 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 3.5 ttp180 -71.22 -17.51 62.5 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.795 0.331 . . . . 0.0 111.087 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 107' ' ' THR . . . . . 0.713 HG22 ' HB3' ' E' ' 105' ' ' ASP . 6.2 t -67.3 -17.94 64.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.997 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 108' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' B' ' 80' ' ' ALA . . . 123.73 -45.59 1.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.804 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.1 163.09 23.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.76 0.314 . . . . 0.0 111.12 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 110' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -84.14 127.37 33.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.064 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 111' ' ' LEU . . . . . 0.683 ' HB3' HD12 ' E' ' 103' ' ' ILE . 12.1 tp -86.29 156.07 20.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.29 0.567 . . . . 0.0 110.596 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 112' ' ' THR . . . . . 0.898 HG23 HG21 ' E' ' 117' ' ' THR . 0.5 OUTLIER -106.21 139.14 41.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.157 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 113' ' ' LEU . . . . . 0.619 HD13 ' HG ' ' E' ' 86' ' ' LEU . 1.0 OUTLIER -73.93 76.48 1.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 110.765 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.48 -17.17 14.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.511 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -51.8 1.24 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.638 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.95 18.77 21.75 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.929 0.395 . . . . 0.0 111.599 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 117' ' ' THR . . . . . 0.898 HG21 HG23 ' E' ' 112' ' ' THR . 0.2 OUTLIER -85.73 84.61 7.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 118' ' ' PHE . . . . . 0.709 ' HB3' ' HB1' ' E' ' 70' ' ' ALA . 95.7 m-85 -101.39 98.77 9.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.795 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 39.2 m -130.84 62.46 1.61 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.3 145.82 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.704 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 121' ' ' GLU . . . . . 0.629 ' HB3' ' HE3' ' E' ' 68' ' ' LYS . 3.5 mm-40 -121.37 71.28 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.212 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.74 134.86 34.73 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.752 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 14.8 m -83.83 113.72 21.14 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.749 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 124' ' ' LEU . . . . . 0.641 ' CD2' ' HB1' ' E' ' 20' ' ' ALA . 18.9 tp -74.07 143.0 45.63 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.708 0.289 . . . . 0.0 110.619 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 125' ' ' ASN . . . . . 0.662 ' HA ' HG23 ' E' ' 63' ' ' THR . 0.9 OUTLIER -138.61 162.03 35.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.624 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.72 113.24 12.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.675 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.49 -139.94 9.52 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.73 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 128' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 6.6 m -101.69 96.8 7.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.677 0.275 . . . . 0.0 110.755 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.64 148.49 27.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.897 0.379 . . . . 0.0 111.185 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 130' ' ' THR . . . . . 0.624 HG21 HD21 ' B' ' 74' ' ' LEU . 0.2 OUTLIER -138.55 143.46 39.46 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.081 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 131' ' ' ILE . . . . . 0.834 HG21 HG11 ' E' ' 71' ' ' VAL . 54.9 mt -104.57 112.3 65.33 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 132' ' ' PRO . . . . . 0.712 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.5 Cg_endo -81.93 141.93 12.21 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.737 1.624 . . . . 0.0 112.502 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 133' ' ' PHE . . . . . 0.404 ' HZ ' HD22 ' E' ' 111' ' ' LEU . 0.3 OUTLIER -150.59 141.1 22.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.829 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -104.52 152.6 22.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.111 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 135' ' ' ALA . . . . . 0.638 ' O ' HG22 ' E' ' 52' ' ' VAL . . . -153.57 101.06 2.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 111.602 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 136' ' ' ARG . . . . . 0.552 ' HB3' ' HA ' ' E' ' 51' ' ' ALA . 17.4 ptt180 -107.18 177.24 4.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.408 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 137' ' ' TYR . . . . . 0.493 ' HB3' HD21 ' E' ' 42' ' ' LEU . 4.7 m-85 -85.98 124.12 32.08 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.027 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 138' ' ' PHE . . . . . 0.46 ' HB3' HG11 ' E' ' 85' ' ' VAL . 1.2 t80 -118.87 112.36 19.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.048 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 139' ' ' ALA . . . . . 0.678 ' HB2' HD23 ' E' ' 42' ' ' LEU . . . -102.93 133.94 47.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.882 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 140' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 0.1 OUTLIER -81.04 -28.92 35.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.553 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 141' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' E' ' 98' ' ' ASN . . . -160.21 -111.01 0.28 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.88 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.92 110.6 21.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.547 0.213 . . . . 0.0 110.703 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 143' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' E' ' 39' ' ' THR . . . -65.68 134.27 52.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 0.0 111.368 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 144' ' ' THR . . . . . 0.593 ' O ' ' CG1' ' D' ' 16' ' ' VAL . 56.9 m -105.87 149.43 38.01 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.304 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 145' ' ' PRO . . . . . 0.485 ' CD ' ' CG2' ' E' ' 144' ' ' THR . 1.4 Cg_endo -82.91 125.47 4.18 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.542 2.161 . . . . 0.0 112.028 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 146' ' ' GLY . . . . . 0.676 ' O ' ' CG ' ' D' ' 15' ' ' GLU . . . 168.79 -126.32 1.37 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.456 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 147' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -111.13 128.42 55.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.812 0.339 . . . . 0.0 111.294 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 148' ' ' ALA . . . . . 0.699 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -125.45 52.15 1.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.115 0.483 . . . . 0.0 110.412 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -98.75 152.0 20.16 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.611 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 150' ' ' ALA . . . . . 0.786 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -158.29 169.56 24.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.946 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.99 128.64 40.8 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.258 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 152' ' ' ALA . . . . . 0.49 ' HB2' HD11 ' E' ' 86' ' ' LEU . . . -122.17 144.08 49.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.269 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 153' ' ' THR . . . . . 1.038 HG23 HG22 ' D' ' 9' ' ' THR . 0.6 OUTLIER -106.34 145.34 31.81 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.182 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 154' ' ' PHE . . . . . 0.402 ' HB3' ' H ' ' D' ' 8' ' ' GLY . 0.5 OUTLIER -96.9 134.69 39.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.077 0.465 . . . . 0.0 110.069 -178.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 155' ' ' LYS . . . . . 0.407 ' HA ' ' H ' ' D' ' 7' ' ' GLY . 9.9 mmtt -124.22 148.08 47.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.863 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 156' ' ' VAL . . . . . 0.506 HG23 HG23 ' D' ' 5' ' ' VAL . 29.9 m -135.15 144.79 33.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.82 0.343 . . . . 0.0 111.685 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 157' ' ' GLN . . . . . 0.682 ' HG3' HG23 ' D' ' 4' ' ' THR . 0.0 OUTLIER -134.49 126.11 28.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.223 0.535 . . . . 0.0 110.362 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 158' ' ' TYR . . . . . 0.568 ' C ' ' HG3' ' E' ' 159' ' ' GLN . 5.2 m-85 -106.01 128.71 54.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.525 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 159' ' ' GLN . . . . . 0.568 ' HG3' ' C ' ' E' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.914 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 120.296 0.093 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.69 77.11 0.19 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.979 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 10.7 m -117.4 119.27 34.57 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.372 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 4.0 m -98.39 127.21 44.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.503 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.1 171.0 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.629 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.07 114.75 23.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.163 0.506 . . . . 0.0 110.602 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.79 -57.6 7.03 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.786 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 8' ' ' GLY . . . . . 0.425 ' O ' HG23 ' F' ' 9' ' ' THR . . . -163.62 -144.64 4.1 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.884 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 9' ' ' THR . . . . . 0.425 HG23 ' O ' ' F' ' 8' ' ' GLY . 17.1 p -155.7 140.41 17.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.872 0.367 . . . . 0.0 111.375 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 29.7 t -130.26 117.52 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.274 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.51 117.03 29.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.423 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -89.89 107.05 18.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.826 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.76 113.3 26.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.491 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -144.41 166.98 27.11 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.916 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -155.65 135.26 12.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.975 0.417 . . . . 0.0 110.341 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 66.0 t -96.63 138.3 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.248 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 17' ' ' VAL . . . . . 0.884 HG12 HG21 ' E' ' 5' ' ' VAL . 2.6 m -140.8 -173.3 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 0.0 111.008 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.15 173.42 12.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.094 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.76 39.74 0.81 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.064 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 20' ' ' ALA . . . . . 0.631 ' HB1' ' CD2' ' F' ' 124' ' ' LEU . . . -114.29 -33.57 5.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.445 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 21' ' ' CYS . . . . . 0.672 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.9 OUTLIER -161.18 150.04 16.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.971 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.69 112.08 4.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.105 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 23' ' ' VAL . . . . . 0.674 ' HA ' ' HA ' ' F' ' 58' ' ' LEU . 3.1 p -59.97 153.34 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.01 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.72 152.8 28.19 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.647 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 25' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -57.52 -41.55 81.11 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.292 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.72 15.72 61.91 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.984 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.98 -21.36 11.15 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.967 0.413 . . . . 0.0 110.848 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 90.1 t -44.55 -64.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.357 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.29 135.6 38.97 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.976 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.0 128.74 19.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.82 111.85 23.86 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.152 -0.477 . . . . 0.0 112.048 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.557 HG23 HG13 ' E' ' 10' ' ' VAL . 4.2 t -110.88 114.7 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.168 0.508 . . . . 0.0 110.506 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.67 124.51 46.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.643 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 34' ' ' LEU . . . . . 0.588 ' HB3' ' HB3' ' C' ' 92' ' ' ALA . 0.9 OUTLIER -82.54 -45.65 14.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.578 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.31 -161.95 12.8 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.618 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 36' ' ' GLN . . . . . 0.616 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 1.1 mt-30 -99.79 129.65 45.92 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.622 0.248 . . . . 0.0 110.922 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.498 ' CG1' HG22 ' E' ' 16' ' ' VAL . 11.8 p -109.98 147.5 14.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.954 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 38' ' ' ARG . . . . . 0.508 ' HB3' ' HA ' ' E' ' 19' ' ' ALA . 0.7 OUTLIER -86.79 131.19 34.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.0 0.429 . . . . 0.0 111.8 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 39' ' ' THR . . . . . 0.686 ' HA ' ' HB3' ' F' ' 143' ' ' ALA . 4.8 t -54.03 -45.16 71.5 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.758 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 40' ' ' ALA . . . . . 0.446 ' N ' HG23 ' F' ' 39' ' ' THR . . . -60.92 -39.39 89.2 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.078 0.466 . . . . 0.0 110.943 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 41' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' F' ' 38' ' ' ARG . 0.4 OUTLIER -70.54 -23.22 62.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.157 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 42' ' ' LEU . . . . . 0.67 HD23 ' HB2' ' F' ' 139' ' ' ALA . 1.4 mp -124.59 51.54 1.6 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.651 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.6 30.0 7.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.43 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.86 128.49 48.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.308 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 45' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' F' ' 140' ' ' THR . 29.2 tt0 -53.05 103.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 111.072 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 46' ' ' GLY . . . . . 0.413 ' HA2' ' HE1' ' F' ' 138' ' ' PHE . . . 96.01 39.05 4.42 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.101 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 47' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' F' ' 139' ' ' ALA . . . -80.14 146.68 31.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.64 125.1 19.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.897 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 49' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 32.5 m -101.98 -166.29 1.28 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.614 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.98 133.06 55.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.869 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 51' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' F' ' 136' ' ' ARG . . . -92.72 120.18 32.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.726 0.298 . . . . 0.0 111.246 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 52' ' ' VAL . . . . . 0.63 HG22 ' O ' ' F' ' 135' ' ' ALA . 18.6 m -65.85 162.67 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.888 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.83 124.07 5.26 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.635 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 54' ' ' PHE . . . . . 0.455 ' N ' HG21 ' C' ' 76' ' ' THR . 54.1 p90 -155.86 146.56 22.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.643 0.258 . . . . 0.0 111.027 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 55' ' ' ASN . . . . . 0.579 ' HB2' HG22 ' F' ' 130' ' ' THR . 0.6 OUTLIER -136.87 160.26 39.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.528 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 56' ' ' ILE . . . . . 0.574 HG23 ' O ' ' F' ' 56' ' ' ILE . 1.6 tp -100.65 116.91 45.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.555 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 57' ' ' GLN . . . . . 0.614 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.0 OUTLIER -70.04 124.61 24.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.76 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 58' ' ' LEU . . . . . 0.674 ' HA ' ' HA ' ' F' ' 23' ' ' VAL . 1.6 mp -133.77 87.48 2.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.216 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 59' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 4.9 p30 -73.69 174.57 8.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.931 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.82 79.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.763 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 61' ' ' CYS . . . . . 0.672 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 93.2 m -127.66 159.43 34.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.817 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 62' ' ' ASP . . . . . 0.604 ' OD2' HG23 ' F' ' 65' ' ' VAL . 5.5 t70 -130.27 167.07 19.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.288 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 63' ' ' THR . . . . . 0.662 HG23 ' HA ' ' F' ' 125' ' ' ASN . 0.2 OUTLIER -114.24 -41.7 3.45 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.197 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.57 -22.63 65.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.989 0.423 . . . . 0.0 111.694 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 65' ' ' VAL . . . . . 0.604 HG23 ' OD2' ' F' ' 62' ' ' ASP . 82.8 t -70.4 -74.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.657 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 66' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' F' ' 124' ' ' LEU . . . -120.75 131.34 54.45 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.629 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.24 -48.62 6.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.907 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 68' ' ' LYS . . . . . 0.632 ' HE3' ' HB3' ' F' ' 121' ' ' GLU . 0.1 OUTLIER -96.2 161.51 13.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.617 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.09 124.72 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.641 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 70' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -100.46 154.97 18.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.061 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 71' ' ' VAL . . . . . 0.825 HG11 HG21 ' F' ' 131' ' ' ILE . 2.3 t -132.73 148.33 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.69 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 72' ' ' ALA . . . . . 0.458 ' HA ' HD21 ' F' ' 111' ' ' LEU . . . -145.6 150.15 35.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.644 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 73' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -119.91 137.02 54.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.488 0.185 . . . . 0.0 111.059 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 74' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.9 OUTLIER -96.14 139.5 32.21 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.918 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 75' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' F' ' 113' ' ' LEU . . . 178.54 179.81 48.49 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.833 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 76' ' ' THR . . . . . 0.546 ' H ' HD23 ' F' ' 86' ' ' LEU . 0.3 OUTLIER -110.9 156.42 21.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.507 0.194 . . . . 0.0 110.856 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 77' ' ' ALA . . . . . 0.676 ' O ' ' HB2' ' F' ' 87' ' ' ALA . . . -73.81 131.26 41.35 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 78' ' ' ILE . . . . . 0.642 ' CG2' ' HB ' ' F' ' 85' ' ' VAL . 0.9 OUTLIER -67.69 -41.45 85.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.799 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 79' ' ' ASP . . . . . 0.427 ' N ' HG23 ' F' ' 78' ' ' ILE . 0.6 OUTLIER -141.12 40.77 1.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.773 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 66.45 -80.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.996 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.65 -24.99 41.92 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.696 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.01 63.93 1.37 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.851 0.358 . . . . 0.0 110.455 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 83' ' ' THR . . . . . 0.548 HG23 ' HB2' ' F' ' 77' ' ' ALA . 0.2 OUTLIER -68.5 -16.79 64.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.535 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 84' ' ' ASN . . . . . 0.703 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 18.0 p-10 -70.42 -20.25 62.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.329 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 85' ' ' VAL . . . . . 0.642 ' HB ' ' CG2' ' F' ' 78' ' ' ILE . 14.6 t -106.92 130.7 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.165 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 86' ' ' LEU . . . . . 0.788 HD22 ' HB1' ' F' ' 150' ' ' ALA . 0.5 OUTLIER -67.61 148.21 51.71 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 87' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' F' ' 77' ' ' ALA . . . -89.65 -167.47 1.87 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.87 0.367 . . . . 0.0 111.732 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 88' ' ' LEU . . . . . 0.657 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 1.5 mm? -78.34 157.22 29.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.054 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.61 -78.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.345 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 90' ' ' SER . . . . . 0.401 ' H ' ' H ' ' F' ' 91' ' ' SER . 0.5 OUTLIER -167.05 0.47 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.021 0.438 . . . . 0.0 111.469 179.476 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 91' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' F' ' 95' ' ' SER . 1.7 m -71.82 82.93 0.91 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.66 -13.95 61.87 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.863 0.364 . . . . 0.0 111.688 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.64 27.61 5.23 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.632 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.63 15.59 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.487 -0.864 . . . . 0.0 112.928 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 95' ' ' SER . . . . . 0.657 ' HB3' ' HG ' ' F' ' 88' ' ' LEU . 3.0 m -100.86 -172.82 2.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.713 0.292 . . . . 0.0 110.639 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.89 167.66 9.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.788 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 97' ' ' THR . . . . . 0.522 ' H ' ' HB ' ' F' ' 144' ' ' THR . 2.3 m -121.59 128.3 51.82 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.343 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 98' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' F' ' 141' ' ' GLY . 75.9 m-20 64.27 34.56 10.65 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.415 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 99' ' ' VAL . . . . . 0.485 HG13 HD23 ' F' ' 42' ' ' LEU . 0.5 OUTLIER -139.99 136.5 38.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.683 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.13 -156.87 8.34 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.577 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 101' ' ' VAL . . . . . 0.482 HG13 ' HB2' ' F' ' 86' ' ' LEU . 3.2 p -137.77 116.72 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 122.973 0.509 . . . . 0.0 111.616 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 102' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 1.2 tt0 -91.93 150.43 21.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 103' ' ' ILE . . . . . 0.666 HD12 ' HB3' ' F' ' 111' ' ' LEU . 0.5 OUTLIER -113.87 131.32 66.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.542 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 104' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 0.3 OUTLIER -106.29 130.1 54.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.645 0.259 . . . . 0.0 111.014 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 105' ' ' ASP . . . . . 0.737 ' HB3' HG22 ' F' ' 107' ' ' THR . 5.1 t0 -76.02 156.97 33.54 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.697 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 106' ' ' ARG . . . . . 0.721 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 3.5 ttp180 -71.31 -17.47 62.45 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.691 0.281 . . . . 0.0 111.061 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 107' ' ' THR . . . . . 0.737 HG22 ' HB3' ' F' ' 105' ' ' ASP . 6.2 t -67.19 -18.03 65.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 108' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' C' ' 80' ' ' ALA . . . 123.74 -45.63 1.17 Allowed Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.748 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.09 163.12 23.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.671 0.272 . . . . 0.0 111.181 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 110' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -84.16 127.45 33.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.067 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 111' ' ' LEU . . . . . 0.666 ' HB3' HD12 ' F' ' 103' ' ' ILE . 12.1 tp -86.28 156.18 20.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.317 0.58 . . . . 0.0 110.614 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 112' ' ' THR . . . . . 0.901 HG23 HG21 ' F' ' 117' ' ' THR . 0.5 OUTLIER -106.31 139.09 41.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.095 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 113' ' ' LEU . . . . . 0.626 HD13 ' HG ' ' F' ' 86' ' ' LEU . 1.0 OUTLIER -73.92 76.49 1.66 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.697 0.284 . . . . 0.0 110.746 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.45 -17.2 14.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.507 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.25 -51.8 1.25 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.647 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.05 18.89 21.57 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.918 0.39 . . . . 0.0 111.52 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 117' ' ' THR . . . . . 0.901 HG21 HG23 ' F' ' 112' ' ' THR . 0.2 OUTLIER -85.77 84.64 7.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 118' ' ' PHE . . . . . 0.722 ' HB3' ' HB1' ' F' ' 70' ' ' ALA . 95.7 m-85 -101.42 98.74 9.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.741 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 39.3 m -130.84 62.44 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.802 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.3 145.83 30.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.655 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 121' ' ' GLU . . . . . 0.632 ' HB3' ' HE3' ' F' ' 68' ' ' LYS . 3.5 mm-40 -121.34 71.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.223 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 134.7 34.72 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.738 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 15.2 m -83.81 113.68 21.09 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.739 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 124' ' ' LEU . . . . . 0.631 ' CD2' ' HB1' ' F' ' 20' ' ' ALA . 19.0 tp -74.01 142.96 45.75 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.751 0.31 . . . . 0.0 110.589 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 125' ' ' ASN . . . . . 0.662 ' HA ' HG23 ' F' ' 63' ' ' THR . 0.9 OUTLIER -138.59 162.02 35.63 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.615 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.66 113.12 12.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.718 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.55 -139.9 9.48 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.779 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 128' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 6.7 m -101.75 96.78 7.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.726 0.298 . . . . 0.0 110.795 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.61 148.56 27.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.925 0.393 . . . . 0.0 111.112 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 130' ' ' THR . . . . . 0.624 HG21 HD21 ' C' ' 74' ' ' LEU . 0.2 OUTLIER -138.57 143.4 39.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.158 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 131' ' ' ILE . . . . . 0.825 HG21 HG11 ' F' ' 71' ' ' VAL . 54.9 mt -104.66 112.45 65.33 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 132' ' ' PRO . . . . . 0.721 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.4 Cg_endo -81.93 141.94 12.22 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.758 1.639 . . . . 0.0 112.492 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.67 141.1 22.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.845 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -104.48 152.63 22.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.091 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 135' ' ' ALA . . . . . 0.63 ' O ' HG22 ' F' ' 52' ' ' VAL . . . -153.54 101.03 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.931 0.396 . . . . 0.0 111.615 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 136' ' ' ARG . . . . . 0.552 ' HB3' ' HA ' ' F' ' 51' ' ' ALA . 17.4 ptt180 -107.11 177.32 4.89 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.428 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 137' ' ' TYR . . . . . 0.49 ' HB3' HD21 ' F' ' 42' ' ' LEU . 4.6 m-85 -86.02 124.08 32.06 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.979 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 138' ' ' PHE . . . . . 0.46 ' HB3' HG11 ' F' ' 85' ' ' VAL . 1.2 t80 -118.81 112.38 19.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.016 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 139' ' ' ALA . . . . . 0.67 ' HB2' HD23 ' F' ' 42' ' ' LEU . . . -102.95 133.95 47.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.921 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 140' ' ' THR . . . . . 0.622 ' O ' ' HA ' ' F' ' 45' ' ' GLU . 0.1 OUTLIER -81.05 -28.89 35.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.547 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 141' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' F' ' 98' ' ' ASN . . . -160.18 -111.11 0.28 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.864 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.78 110.61 21.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.511 0.196 . . . . 0.0 110.784 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 143' ' ' ALA . . . . . 0.686 ' HB3' ' HA ' ' F' ' 39' ' ' THR . . . -65.69 134.31 52.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 111.336 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 144' ' ' THR . . . . . 0.604 ' O ' ' CG1' ' E' ' 16' ' ' VAL . 56.7 m -105.9 149.42 38.01 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.268 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 145' ' ' PRO . . . . . 0.483 ' CD ' ' CG2' ' F' ' 144' ' ' THR . 1.5 Cg_endo -82.84 125.45 4.22 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.541 2.161 . . . . 0.0 112.03 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 146' ' ' GLY . . . . . 0.685 ' O ' ' CG ' ' E' ' 15' ' ' GLU . . . 168.77 -126.32 1.37 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.418 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 147' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -111.05 128.46 55.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.772 0.32 . . . . 0.0 111.355 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 148' ' ' ALA . . . . . 0.688 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -125.48 52.09 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.162 0.506 . . . . 0.0 110.402 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -98.68 151.94 20.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.627 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 150' ' ' ALA . . . . . 0.788 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -158.27 169.51 24.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.986 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.93 128.67 40.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.249 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 152' ' ' ALA . . . . . 0.497 ' HB2' HD11 ' F' ' 86' ' ' LEU . . . -122.21 144.04 49.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.233 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 153' ' ' THR . . . . . 1.025 HG23 HG22 ' E' ' 9' ' ' THR . 0.6 OUTLIER -106.3 145.38 31.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 154' ' ' PHE . . . . . 0.419 ' HB3' ' H ' ' E' ' 8' ' ' GLY . 0.5 OUTLIER -96.98 134.69 40.0 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.107 0.48 . . . . 0.0 110.053 -179.024 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 155' ' ' LYS . . . . . 0.411 ' HA ' ' H ' ' E' ' 7' ' ' GLY . 9.9 mmtt -124.22 148.06 47.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.88 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 156' ' ' VAL . . . . . 0.523 HG23 HG23 ' E' ' 5' ' ' VAL . 29.8 m -135.12 144.85 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.818 0.342 . . . . 0.0 111.787 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 157' ' ' GLN . . . . . 0.693 ' HG3' HG23 ' E' ' 4' ' ' THR . 0.0 OUTLIER -134.54 126.04 28.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.304 0.573 . . . . 0.0 110.362 -179.596 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 158' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' F' ' 21' ' ' CYS . 5.2 m-85 -106.0 128.73 54.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.559 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 159' ' ' GLN . . . . . 0.556 ' HG3' ' C ' ' F' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.259 -0.876 . . . . 0.0 110.817 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.54 0.209 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' B' ' 157' ' ' GLN . 4.9 m -114.68 127.37 55.72 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.431 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.3 m -117.71 106.76 13.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.704 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.459 HG21 HG12 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -133.9 174.61 12.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.58 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.1 119.87 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.528 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.27 -49.49 15.47 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.827 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.3 -154.89 11.32 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.866 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.711 HG22 HG23 ' B' ' 153' ' ' THR . 2.6 p -142.39 140.01 31.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.949 0.404 . . . . 0.0 111.223 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.69 113.82 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.23 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.08 110.32 20.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.404 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.24 111.56 22.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.75 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HE3' HG11 ' A' ' 28' ' ' VAL . 3.6 tmtm? -102.98 110.59 22.56 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.438 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.26 168.33 22.63 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.952 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.684 ' O ' ' HA ' ' B' ' 36' ' ' GLN . 3.6 tt0 -158.98 133.08 7.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.898 0.38 . . . . 0.0 110.417 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.892 HG23 ' HB2' ' B' ' 148' ' ' ALA . 13.0 t -99.64 143.17 13.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.25 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.536 HG13 ' HG2' ' B' ' 36' ' ' GLN . 3.9 m -141.41 -172.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.912 0.387 . . . . 0.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.46 -176.97 5.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.083 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.87 46.94 1.36 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.055 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.75 -29.98 2.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.443 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.999 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -163.11 158.45 21.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.907 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' B' ' 36' ' ' GLN . . . -161.39 118.53 2.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.026 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -66.27 153.1 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.025 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.75 158.75 20.64 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.603 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.03 -34.4 74.79 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.347 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.1 12.99 63.72 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.91 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.77 -22.4 10.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.791 0.329 . . . . 0.0 110.77 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.482 HG11 ' HE3' ' A' ' 13' ' ' LYS . 19.6 t -43.93 -64.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.359 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.05 135.83 41.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.968 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.17 125.72 20.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.088 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.76 106.53 18.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.066 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.74 117.06 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.074 0.464 . . . . 0.0 110.418 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.7 131.03 45.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.584 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.77 -47.37 7.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.586 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.41 -163.53 12.16 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.562 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -101.07 126.62 47.77 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.684 0.278 . . . . 0.0 110.833 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 42' ' ' LEU . 14.9 p -110.42 146.84 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.923 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -82.85 139.18 33.62 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.74 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.494 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 5.4 t -62.79 -37.42 86.6 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.746 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.46 71.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.108 0.48 . . . . 0.0 110.829 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.03 -17.76 45.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.112 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.725 HD23 ' HB2' ' A' ' 139' ' ' ALA . 4.3 mp -125.65 33.1 5.17 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.668 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.74 18.87 18.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.312 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.87 130.3 52.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.431 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 140' ' ' THR . 22.5 tt0 -56.38 107.38 0.37 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.866 0.365 . . . . 0.0 111.016 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.53 30.57 5.84 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.214 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 138' ' ' PHE . . . -76.57 136.65 39.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 112.081 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 52.3 p -134.87 134.73 41.04 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.869 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 70.9 m -108.79 -168.22 1.32 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.637 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.0 t -63.89 128.45 35.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.795 0.331 . . . . 0.0 110.799 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' A' ' 134' ' ' GLN . . . -80.41 130.0 34.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.436 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.728 HG22 ' HB3' ' A' ' 135' ' ' ALA . 2.8 m -74.84 151.22 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.925 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.98 119.22 5.67 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.577 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -153.86 152.09 30.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.729 0.3 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -148.74 162.94 38.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.633 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 56' ' ' ILE . 1.2 tp -105.98 114.82 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.548 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.872 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -70.69 124.53 24.48 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.721 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -132.32 88.81 2.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.203 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.601 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -75.31 169.47 18.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.895 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' B' ' 38' ' ' ARG . 0.4 OUTLIER 66.39 68.23 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.773 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.999 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 56.3 m -117.11 155.03 30.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.763 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.622 ' HB2' HH22 ' B' ' 38' ' ' ARG . 20.0 t70 -135.76 155.69 49.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.214 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -111.15 -34.23 6.24 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.141 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.08 -22.13 66.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 0.0 111.755 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.6 -59.54 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.696 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB3' HD23 ' A' ' 124' ' ' LEU . . . -116.84 129.18 55.92 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.646 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -60.31 2.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.856 0.36 . . . . 0.0 110.964 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.28 -175.33 2.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.499 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.0 131.36 9.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.52 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.466 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -106.04 151.14 25.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.036 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.607 HG11 HG21 ' A' ' 131' ' ' ILE . 2.0 t -129.46 158.31 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.714 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.633 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -152.66 143.09 22.62 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.579 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.608 ' HB3' HD23 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -112.32 141.47 46.0 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.683 0.278 . . . . 0.0 111.019 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.026 HD21 HG21 ' D' ' 130' ' ' THR . 0.3 OUTLIER -107.64 139.47 42.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.012 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.75 -179.54 46.85 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.816 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.768 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.3 OUTLIER -103.85 156.35 17.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.634 0.254 . . . . 0.0 110.823 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.34 118.35 21.17 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.93 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.557 HG22 ' HB3' ' A' ' 82' ' ' HIS . 0.4 OUTLIER -59.03 -29.11 40.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.81 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.446 ' HB2' HG21 ' A' ' 140' ' ' THR . 0.1 OUTLIER -151.74 50.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.805 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.22 -89.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.079 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.07 -32.55 42.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.584 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.557 ' HB3' HG22 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -81.12 62.84 5.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.892 0.377 . . . . 0.0 110.384 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.63 -18.18 60.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.585 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.71 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 20.4 p-10 -75.91 -7.48 54.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.266 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.487 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 24.1 t -117.7 124.22 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.214 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.931 HD22 ' HB1' ' A' ' 150' ' ' ALA . 0.5 OUTLIER -66.19 139.33 58.11 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.278 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -84.85 -165.42 1.19 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.705 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.776 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 0.7 OUTLIER -71.91 168.67 17.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.963 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.86 -79.24 0.06 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.335 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.775 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 2.4 p -168.84 6.0 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.016 0.436 . . . . 0.0 111.545 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.612 ' O ' ' HB2' ' A' ' 95' ' ' SER . 69.8 m -77.57 83.27 3.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.906 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' D' ' 50' ' ' SER . . . -55.07 -34.65 63.78 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.882 0.373 . . . . 0.0 111.626 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.27 31.51 6.31 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.604 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.59 7.46 0.23 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.919 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.776 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -110.78 -174.32 2.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.921 0.391 . . . . 0.0 110.588 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.431 ' O ' HD21 ' A' ' 88' ' ' LEU . . . -97.75 179.07 4.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.968 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.785 ' H ' ' HB ' ' A' ' 144' ' ' THR . 1.1 m -132.31 125.97 32.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.331 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 97' ' ' THR . 66.2 m-20 66.61 25.88 9.87 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.45 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.66 130.4 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.657 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.14 -161.35 10.74 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.508 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.494 ' CG2' ' HB1' ' A' ' 135' ' ' ALA . 0.8 OUTLIER -130.84 131.94 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.096 0.559 . . . . 0.0 111.825 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.721 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 1.5 tt0 -98.48 151.44 20.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.923 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.525 ' N ' ' HG2' ' A' ' 102' ' ' GLN . 0.3 OUTLIER -117.34 128.62 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.542 179.485 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.801 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -103.01 133.51 48.01 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.713 0.292 . . . . 0.0 111.034 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.718 ' HB3' HG22 ' A' ' 107' ' ' THR . 7.1 t0 -87.71 158.39 18.82 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.659 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 106' ' ' ARG . 7.9 ttp85 -70.47 -27.67 64.41 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.78 0.324 . . . . 0.0 111.081 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.718 HG22 ' HB3' ' A' ' 105' ' ' ASP . 2.8 t -51.76 -25.67 8.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.047 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.08 -39.18 1.74 Allowed Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.603 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.33 157.97 17.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 111.032 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.801 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -70.33 137.12 50.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.079 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.633 HD21 ' HA ' ' A' ' 72' ' ' ALA . 13.5 tp -87.54 158.41 18.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.29 0.567 . . . . 0.0 110.555 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.998 HG23 HG21 ' A' ' 117' ' ' THR . 0.5 OUTLIER -101.74 142.0 33.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.116 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.608 HD23 ' HB3' ' A' ' 73' ' ' PHE . 1.9 mt -82.41 65.57 7.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.71 0.291 . . . . 0.0 110.702 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.09 -14.93 21.23 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.52 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.25 -54.16 0.7 Allowed Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.596 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.2 28.92 8.27 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.016 0.436 . . . . 0.0 111.651 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.998 HG21 HG23 ' A' ' 112' ' ' THR . 0.0 OUTLIER -88.72 76.54 8.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.169 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.597 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 91.6 m-85 -91.01 96.75 10.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.743 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 68.0 m -132.67 78.25 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.7 136.9 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.667 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.01 76.2 0.98 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.275 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.83 135.51 33.68 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.732 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.7 m -77.08 96.35 4.42 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.71 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.734 ' O ' HG23 ' A' ' 63' ' ' THR . 10.8 tp -68.21 132.95 48.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.567 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -128.46 166.86 17.95 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.582 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 6.3 t30 -79.45 105.75 10.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.656 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.03 -137.04 5.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.749 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 3.7 m -103.61 83.47 2.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.753 0.311 . . . . 0.0 110.825 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.694 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 1.7 t30 -71.03 139.88 50.6 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.911 0.386 . . . . 0.0 111.158 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.872 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -133.95 139.66 46.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.158 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.607 HG21 HG11 ' A' ' 71' ' ' VAL . 61.7 mt -98.07 110.53 56.29 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -81.8 135.15 8.79 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.777 1.651 . . . . 0.0 112.528 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.72 152.71 41.63 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.791 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.583 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 50.6 mt-30 -119.0 156.85 28.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.067 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.728 ' HB3' HG22 ' A' ' 52' ' ' VAL . . . -151.39 101.79 2.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.372 . . . . 0.0 111.65 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.6 168.37 9.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.364 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -80.11 123.26 27.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.194 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 1.3 t80 -126.16 119.13 26.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.026 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.725 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -112.02 125.2 53.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.888 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -68.93 -48.19 63.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.51 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.431 ' H ' ' HB3' ' A' ' 98' ' ' ASN . . . -133.1 -120.0 2.08 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.043 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.42 111.94 18.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.597 0.237 . . . . 0.0 110.68 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.707 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -61.89 113.82 3.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.781 0.324 . . . . 0.0 111.447 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.785 ' HB ' ' H ' ' A' ' 97' ' ' THR . 75.1 m -88.31 145.25 35.43 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.32 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 144' ' ' THR . 1.3 Cg_endo -82.83 134.26 7.2 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.458 2.106 . . . . 0.0 111.987 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.87 -135.59 4.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.553 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.691 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -96.21 134.21 39.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.889 0.376 . . . . 0.0 111.301 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.78 50.5 2.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.135 0.493 . . . . 0.0 110.499 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -99.01 146.17 26.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.503 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.931 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -154.99 174.12 15.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.932 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.495 ' C ' HD11 ' A' ' 86' ' ' LEU . 26.8 t70 -139.33 128.45 23.82 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.16 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -118.4 133.29 56.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.159 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.92 147.41 22.99 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.25 130.28 53.42 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.131 0.491 . . . . 0.0 110.07 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -126.69 143.99 51.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.871 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.523 HG12 ' CD1' ' A' ' 131' ' ' ILE . 27.3 m -127.4 151.9 34.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.645 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.36 121.12 13.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.263 0.554 . . . . 0.0 110.404 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' A' ' 21' ' ' CYS . 1.2 m-85 -98.28 121.65 40.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.548 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.822 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 111.188 0.07 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.62 71.07 0.5 Allowed 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.148 0.28 . . . . 0.0 110.93 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' C' ' 157' ' ' GLN . 4.9 m -114.67 127.43 55.76 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.464 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 20.5 m -117.75 106.85 13.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.623 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.454 HG21 HG12 ' C' ' 17' ' ' VAL . 0.0 OUTLIER -134.0 174.66 12.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.612 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.13 119.89 36.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.501 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.23 -49.55 15.42 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.835 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.28 -154.87 11.3 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.845 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.721 HG22 HG23 ' C' ' 153' ' ' THR . 2.7 p -142.41 140.04 31.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.974 0.416 . . . . 0.0 111.224 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.76 113.82 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.177 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.08 110.3 20.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.365 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -90.18 111.53 22.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.78 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.485 ' HE3' HG11 ' B' ' 28' ' ' VAL . 3.6 tmtm? -102.96 110.52 22.46 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.49 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.19 168.35 22.59 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.0 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.686 ' O ' ' HA ' ' C' ' 36' ' ' GLN . 3.6 tt0 -159.01 133.06 7.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.473 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.891 HG23 ' HB2' ' C' ' 148' ' ' ALA . 13.1 t -99.62 143.22 13.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.25 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.538 HG13 ' HG2' ' C' ' 36' ' ' GLN . 3.9 m -141.48 -172.15 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.838 0.352 . . . . 0.0 110.992 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.43 -177.02 5.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.083 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.77 46.91 1.36 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.77 -29.93 2.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.498 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER -163.18 158.41 21.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.94 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' C' ' 36' ' ' GLN . . . -161.39 118.54 2.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.041 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' B' ' 58' ' ' LEU . 0.8 OUTLIER -66.27 153.05 8.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.018 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.75 158.73 20.65 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.582 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.02 -34.39 74.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.345 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.14 13.07 63.6 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.914 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.81 -22.43 10.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.84 0.353 . . . . 0.0 110.782 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.485 HG11 ' HE3' ' B' ' 13' ' ' LYS . 19.8 t -44.08 -64.21 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.348 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.09 135.85 41.89 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.005 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.15 125.67 20.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.058 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.8 106.54 18.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.058 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.68 117.07 53.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.455 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.71 131.05 45.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.597 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.8 -47.32 7.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.658 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.34 -163.61 12.15 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.561 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 3.7 mt-30 -100.98 126.6 47.65 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.65 0.262 . . . . 0.0 110.817 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.451 HG21 HD13 ' B' ' 42' ' ' LEU . 14.9 p -110.4 146.89 15.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.9 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.622 HH22 ' HB2' ' A' ' 62' ' ' ASP . 2.9 mtp180 -82.92 139.17 33.53 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.655 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.489 ' HA ' ' HB3' ' B' ' 143' ' ' ALA . 5.4 t -62.77 -37.44 86.67 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.778 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.45 71.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.072 0.463 . . . . 0.0 110.818 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.05 -17.75 45.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.171 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.741 HD23 ' HB2' ' B' ' 139' ' ' ALA . 4.3 mp -125.66 33.11 5.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.662 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.74 18.89 18.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.341 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.92 130.26 52.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.387 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' B' ' 140' ' ' THR . 22.5 tt0 -56.27 107.29 0.35 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.832 0.349 . . . . 0.0 111.095 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.52 30.56 5.84 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.195 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' B' ' 138' ' ' PHE . . . -76.6 136.76 39.22 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.986 0.422 . . . . 0.0 112.093 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' B' ' 137' ' ' TYR . 51.6 p -134.99 134.69 40.74 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.822 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 70.8 m -108.74 -168.14 1.31 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.65 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 23.3 t -63.93 128.44 35.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.774 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.586 ' HB1' ' HB3' ' B' ' 134' ' ' GLN . . . -80.41 129.96 34.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.451 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.72 HG22 ' HB3' ' B' ' 135' ' ' ALA . 2.8 m -74.87 151.26 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.922 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.05 119.25 5.67 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.512 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.81 152.12 30.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.783 0.325 . . . . 0.0 110.951 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -148.75 162.96 38.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.661 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.609 HG23 ' O ' ' B' ' 56' ' ' ILE . 1.2 tp -105.94 114.87 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.573 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' GLN . . . . . 0.865 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -70.72 124.51 24.46 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.749 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 0.2 OUTLIER -132.32 88.78 2.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.242 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.587 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 0.1 OUTLIER -75.31 169.44 18.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' C' ' 38' ' ' ARG . 0.4 OUTLIER 66.38 68.25 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.788 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 61' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 56.3 m -117.11 155.0 30.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.816 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ASP . . . . . 0.621 ' HB2' HH22 ' C' ' 38' ' ' ARG . 19.9 t70 -135.74 155.65 50.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.311 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.733 HG23 ' O ' ' B' ' 124' ' ' LEU . 0.2 OUTLIER -111.11 -34.17 6.26 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.12 -22.17 66.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.008 0.433 . . . . 0.0 111.735 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.54 -59.54 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.767 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.548 ' HB3' HD23 ' B' ' 124' ' ' LEU . . . -116.76 129.16 55.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.706 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.16 -60.29 2.2 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.921 0.391 . . . . 0.0 111.019 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.26 -175.38 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.479 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.96 131.3 9.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.55 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -105.95 151.2 24.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.067 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.625 HG11 HG21 ' B' ' 131' ' ' ILE . 2.0 t -129.45 158.31 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.788 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.628 ' HA ' HD21 ' B' ' 111' ' ' LEU . . . -152.73 143.1 22.57 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.558 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.612 ' HB3' HD23 ' B' ' 113' ' ' LEU . 0.1 OUTLIER -112.3 141.49 45.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.648 0.261 . . . . 0.0 111.034 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.979 HD21 HG21 ' E' ' 130' ' ' THR . 0.3 OUTLIER -107.67 139.51 42.13 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.966 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.76 -179.46 46.91 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.851 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.767 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.3 OUTLIER -103.96 156.33 17.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.602 0.239 . . . . 0.0 110.782 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.4 ' HB2' HG23 ' B' ' 83' ' ' THR . . . -79.33 118.42 21.23 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.943 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.563 HG22 ' HB3' ' B' ' 82' ' ' HIS . 0.4 OUTLIER -59.05 -29.07 40.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.446 ' HB2' HG21 ' B' ' 140' ' ' THR . 0.1 OUTLIER -151.75 50.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.14 -89.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.118 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.06 -32.49 42.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.652 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.563 ' HB3' HG22 ' B' ' 78' ' ' ILE . 0.3 OUTLIER -81.15 62.83 5.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.938 0.399 . . . . 0.0 110.43 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 83' ' ' THR . . . . . 0.4 HG23 ' HB2' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -74.65 -18.13 60.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.557 -179.578 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ASN . . . . . 0.701 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 20.4 p-10 -76.01 -7.38 54.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.279 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.486 ' HB ' ' CG2' ' B' ' 78' ' ' ILE . 23.9 t -117.68 124.12 72.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.235 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.991 HD22 ' HB1' ' B' ' 150' ' ' ALA . 0.5 OUTLIER -66.21 139.34 58.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' B' ' 78' ' ' ILE . . . -84.87 -165.42 1.19 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.674 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.77 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 0.7 OUTLIER -71.86 168.67 17.41 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.086 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.94 -79.18 0.06 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.279 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' SER . . . . . 0.764 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 2.4 p -168.88 5.91 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.048 0.452 . . . . 0.0 111.572 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' SER . . . . . 0.61 ' O ' ' HB2' ' B' ' 95' ' ' SER . 69.9 m -77.56 83.22 3.96 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.952 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' E' ' 50' ' ' SER . . . -55.02 -34.68 63.69 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.88 0.372 . . . . 0.0 111.617 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.22 31.49 6.33 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.571 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.58 7.49 0.23 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.943 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' SER . . . . . 0.77 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . 0.6 OUTLIER -110.73 -174.33 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.943 0.401 . . . . 0.0 110.581 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 96' ' ' ALA . . . . . 0.432 ' O ' HD21 ' B' ' 88' ' ' LEU . . . -97.83 179.09 4.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.914 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.785 ' H ' ' HB ' ' B' ' 144' ' ' THR . 1.1 m -132.42 125.99 32.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.296 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' B' ' 97' ' ' THR . 66.1 m-20 66.66 25.84 9.79 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.422 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.69 130.44 70.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.686 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.08 -161.36 10.74 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.535 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.496 ' CG2' ' HB1' ' B' ' 135' ' ' ALA . 0.8 OUTLIER -130.87 131.97 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 123.056 0.542 . . . . 0.0 111.756 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.727 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 1.5 tt0 -98.52 151.49 20.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.901 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.524 ' N ' ' HG2' ' B' ' 102' ' ' GLN . 0.3 OUTLIER -117.36 128.67 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.513 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 104' ' ' LEU . . . . . 0.791 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 0.3 OUTLIER -103.03 133.55 47.97 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.707 0.289 . . . . 0.0 111.01 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 105' ' ' ASP . . . . . 0.719 ' HB3' HG22 ' B' ' 107' ' ' THR . 7.2 t0 -87.78 158.46 18.76 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.601 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' B' ' 106' ' ' ARG . 7.9 ttp85 -70.47 -27.75 64.46 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.733 0.301 . . . . 0.0 111.026 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.719 HG22 ' HB3' ' B' ' 105' ' ' ASP . 2.8 t -51.73 -25.74 8.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.036 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.26 -39.25 1.73 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.58 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.31 158.05 17.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 0.0 111.0 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.791 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -70.36 137.11 50.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.063 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.628 HD21 ' HA ' ' B' ' 72' ' ' ALA . 13.5 tp -87.55 158.29 18.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.333 0.587 . . . . 0.0 110.563 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.989 HG23 HG21 ' B' ' 117' ' ' THR . 0.5 OUTLIER -101.62 141.96 33.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.147 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' B' ' 73' ' ' PHE . 1.9 mt -82.32 65.54 7.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.734 0.302 . . . . 0.0 110.801 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.08 -14.94 21.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.542 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.28 -54.18 0.7 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.623 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.19 28.99 8.2 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.02 0.438 . . . . 0.0 111.69 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' THR . . . . . 0.989 HG21 HG23 ' B' ' 112' ' ' THR . 0.0 OUTLIER -88.8 76.6 7.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.124 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.601 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 91.4 m-85 -91.06 96.77 10.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.747 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 68.6 m -132.64 78.32 1.79 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.797 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.76 136.81 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.703 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -114.97 76.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.252 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.93 135.6 33.61 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.691 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 11.8 m -77.12 96.28 4.44 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.703 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.733 ' O ' HG23 ' B' ' 63' ' ' THR . 10.8 tp -68.12 132.94 48.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.589 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -128.47 166.74 18.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.601 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' B' ' 61' ' ' CYS . 6.2 t30 -79.38 105.78 10.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.697 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.03 -137.06 5.22 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.675 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 3.7 m -103.63 83.47 2.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.707 0.289 . . . . 0.0 110.773 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ASN . . . . . 0.692 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 1.7 t30 -71.09 139.84 50.48 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.979 0.418 . . . . 0.0 111.148 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.865 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -133.91 139.6 46.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.133 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 131' ' ' ILE . . . . . 0.625 HG21 HG11 ' B' ' 71' ' ' VAL . 61.8 mt -97.99 110.48 55.93 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 132' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -81.74 135.13 8.85 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.75 1.633 . . . . 0.0 112.574 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.76 152.65 41.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.756 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 134' ' ' GLN . . . . . 0.586 ' HB3' ' HB1' ' B' ' 51' ' ' ALA . 50.5 mt-30 -118.96 156.9 28.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.065 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' B' ' 102' ' ' GLN . . . -151.41 101.66 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.352 . . . . 0.0 111.659 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.58 168.33 9.17 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.35 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' B' ' 48' ' ' THR . 0.3 OUTLIER -80.06 123.32 27.75 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.173 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 138' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' B' ' 47' ' ' ALA . 1.3 t80 -126.2 119.12 26.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.948 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.741 ' HB2' HD23 ' B' ' 42' ' ' LEU . . . -111.99 125.16 53.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.919 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 140' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.22 63.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.507 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 141' ' ' GLY . . . . . 0.425 ' H ' ' HB3' ' B' ' 98' ' ' ASN . . . -133.1 -119.99 2.08 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.111 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.4 111.95 18.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.558 0.218 . . . . 0.0 110.738 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 143' ' ' ALA . . . . . 0.714 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -61.91 113.82 3.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.784 0.326 . . . . 0.0 111.409 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.785 ' HB ' ' H ' ' B' ' 97' ' ' THR . 74.1 m -88.25 145.23 35.47 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.302 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 145' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 144' ' ' THR . 1.3 Cg_endo -82.82 134.19 7.17 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.546 2.164 . . . . 0.0 112.019 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.88 -135.58 4.41 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.529 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.678 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -96.16 134.2 39.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.86 0.362 . . . . 0.0 111.361 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 148' ' ' ALA . . . . . 0.892 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -129.81 50.45 2.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.207 0.527 . . . . 0.0 110.506 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -98.93 146.15 26.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.551 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.991 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -154.91 174.08 15.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.883 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 151' ' ' ASP . . . . . 0.494 ' C ' HD11 ' B' ' 86' ' ' LEU . 26.6 t70 -139.31 128.49 23.93 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.171 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 152' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -118.45 133.27 56.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.169 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.711 HG23 HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -91.93 147.39 23.0 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.153 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.27 130.32 53.43 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.195 0.521 . . . . 0.0 110.037 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -126.64 143.89 51.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.931 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 156' ' ' VAL . . . . . 0.513 HG12 ' CD1' ' B' ' 131' ' ' ILE . 27.3 m -127.42 151.89 34.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.746 0.307 . . . . 0.0 111.709 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -141.39 121.1 13.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.32 0.581 . . . . 0.0 110.342 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 158' ' ' TYR . . . . . 0.578 ' CD2' ' HB ' ' A' ' 3' ' ' THR . 1.2 m-85 -98.21 121.64 40.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.577 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.86 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 111.176 0.065 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.59 71.06 0.5 Allowed 'General case' 0 C--O 1.232 0.132 0 O-C-N 123.122 0.264 . . . . 0.0 111.023 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.687 ' O ' ' HA ' ' D' ' 157' ' ' GLN . 4.9 m -114.71 127.42 55.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.447 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 20.8 m -117.84 106.77 13.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.609 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.456 HG21 HG12 ' D' ' 17' ' ' VAL . 0.0 OUTLIER -133.92 174.65 12.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.615 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.07 119.82 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.607 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.17 -49.5 15.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.835 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.32 -154.92 11.36 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.854 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 9' ' ' THR . . . . . 0.74 HG22 HG23 ' D' ' 153' ' ' THR . 2.7 p -142.4 139.98 31.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.927 0.394 . . . . 0.0 111.292 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.74 113.93 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.155 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -87.16 110.3 20.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.313 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.23 111.54 22.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.776 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' LYS . . . . . 0.487 ' HE3' HG11 ' C' ' 28' ' ' VAL . 3.7 tmtm? -102.94 110.61 22.59 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.435 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.32 168.38 22.64 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.058 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 15' ' ' GLU . . . . . 0.674 ' O ' ' HA ' ' D' ' 36' ' ' GLN . 3.6 tt0 -159.01 133.09 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 0.0 110.413 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.872 HG23 ' HB2' ' D' ' 148' ' ' ALA . 13.3 t -99.74 143.27 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.203 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.526 HG13 ' HG2' ' D' ' 36' ' ' GLN . 4.0 m -141.42 -172.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 111.074 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.56 -176.94 5.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.058 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.8 46.84 1.36 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.039 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.76 -29.96 2.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.924 0.392 . . . . 0.0 111.485 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 21' ' ' CYS . . . . . 0.988 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER -163.12 158.33 21.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.996 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 22' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' D' ' 36' ' ' GLN . . . -161.33 118.62 2.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.042 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 23' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' C' ' 58' ' ' LEU . 0.8 OUTLIER -66.28 153.07 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.086 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.78 158.73 20.62 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.613 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.562 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -61.01 -34.4 74.77 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.316 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.16 13.07 63.58 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.887 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.8 -22.44 10.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.801 0.334 . . . . 0.0 110.733 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.487 HG11 ' HE3' ' C' ' 13' ' ' LYS . 19.8 t -43.98 -64.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.336 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.04 135.83 41.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.949 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.21 125.72 20.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.066 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.74 106.53 18.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.15 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.75 117.05 53.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.067 0.461 . . . . 0.0 110.482 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.69 131.05 45.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.576 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.81 -47.31 7.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.607 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.33 -163.6 12.15 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.551 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' GLN . . . . . 0.686 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 3.7 mt-30 -100.98 126.59 47.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.634 0.255 . . . . 0.0 110.841 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.445 HG21 HD13 ' C' ' 42' ' ' LEU . 14.9 p -110.4 146.8 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.926 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 38' ' ' ARG . . . . . 0.621 HH22 ' HB2' ' B' ' 62' ' ' ASP . 2.8 mtp180 -82.8 139.08 33.74 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.757 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.5 ' HA ' ' HB3' ' C' ' 143' ' ' ALA . 5.5 t -62.74 -37.42 86.5 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.778 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.47 -31.49 71.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.125 0.488 . . . . 0.0 110.847 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.04 -17.73 45.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.102 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.743 HD23 ' HB2' ' C' ' 139' ' ' ALA . 4.3 mp -125.72 33.11 5.16 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.604 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.76 18.96 18.03 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.372 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.96 130.23 52.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.355 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' C' ' 140' ' ' THR . 22.5 tt0 -56.27 107.33 0.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.883 0.373 . . . . 0.0 111.088 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.6 30.51 5.83 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.133 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' C' ' 138' ' ' PHE . . . -76.58 136.62 39.25 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 48' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' C' ' 137' ' ' TYR . 52.2 p -134.91 134.73 40.95 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.848 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 71.1 m -108.76 -168.15 1.31 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.665 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 23.1 t -63.96 128.46 35.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.854 0.359 . . . . 0.0 110.756 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' C' ' 134' ' ' GLN . . . -80.4 129.98 34.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.43 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.715 HG22 ' HB3' ' C' ' 135' ' ' ALA . 2.8 m -74.86 151.21 6.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.993 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.01 119.26 5.68 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.547 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.91 152.08 30.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.731 0.301 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -148.72 162.95 38.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.694 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.609 HG23 ' O ' ' C' ' 56' ' ' ILE . 1.2 tp -105.96 114.82 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.534 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.886 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.0 OUTLIER -70.67 124.54 24.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.703 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 58' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' C' ' 23' ' ' VAL . 0.2 OUTLIER -132.34 88.79 2.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.235 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 59' ' ' ASN . . . . . 0.577 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 0.1 OUTLIER -75.28 169.44 18.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 60' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' D' ' 38' ' ' ARG . 0.4 OUTLIER 66.37 68.24 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.802 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 61' ' ' CYS . . . . . 0.988 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 56.3 m -117.13 155.04 30.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.809 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 62' ' ' ASP . . . . . 0.625 ' HB2' HH22 ' D' ' 38' ' ' ARG . 20.0 t70 -135.8 155.63 50.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.25 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.738 HG23 ' O ' ' C' ' 124' ' ' LEU . 0.2 OUTLIER -111.08 -34.22 6.25 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.121 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.13 -22.12 66.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.012 0.434 . . . . 0.0 111.705 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.57 -59.65 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.669 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' ALA . . . . . 0.56 ' HB3' HD23 ' C' ' 124' ' ' LEU . . . -116.69 129.1 55.93 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.72 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.13 -60.28 2.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.914 0.388 . . . . 0.0 111.033 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.23 -175.34 2.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.49 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.93 131.38 9.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.604 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -106.05 151.18 24.99 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.841 0.353 . . . . 0.0 111.056 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 71' ' ' VAL . . . . . 0.621 HG11 HG21 ' C' ' 131' ' ' ILE . 2.0 t -129.47 158.32 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.766 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 72' ' ' ALA . . . . . 0.657 ' HA ' HD21 ' C' ' 111' ' ' LEU . . . -152.66 143.06 22.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.61 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 73' ' ' PHE . . . . . 0.612 ' HB3' HD23 ' C' ' 113' ' ' LEU . 0.1 OUTLIER -112.29 141.5 45.92 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.643 0.259 . . . . 0.0 111.068 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.97 HD21 HG21 ' F' ' 130' ' ' THR . 0.3 OUTLIER -107.71 139.45 42.26 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.955 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.79 -179.48 46.92 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.837 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.765 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.3 OUTLIER -103.97 156.38 17.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.607 0.241 . . . . 0.0 110.811 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.37 118.38 21.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.981 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 78' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' C' ' 82' ' ' HIS . 0.4 OUTLIER -59.02 -29.09 40.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.887 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 79' ' ' ASP . . . . . 0.45 ' HB2' HG21 ' C' ' 140' ' ' THR . 0.1 OUTLIER -151.76 50.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.822 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.25 -89.9 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.069 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.06 -32.59 42.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.573 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 82' ' ' HIS . . . . . 0.564 ' HB3' HG22 ' C' ' 78' ' ' ILE . 0.3 OUTLIER -81.04 62.78 5.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.856 0.36 . . . . 0.0 110.438 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.58 -18.21 60.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.61 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 84' ' ' ASN . . . . . 0.706 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 20.4 p-10 -75.86 -7.49 54.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.329 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.492 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 23.9 t -117.68 124.16 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.217 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.986 HD22 ' HB1' ' C' ' 150' ' ' ALA . 0.5 OUTLIER -66.14 139.36 58.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.697 0.284 . . . . 0.0 110.244 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' C' ' 78' ' ' ILE . . . -84.9 -165.44 1.2 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.605 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.76 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 0.7 OUTLIER -71.88 168.65 17.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.012 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.93 -79.17 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.337 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 90' ' ' SER . . . . . 0.769 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 2.3 p -168.86 5.95 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 111.525 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 91' ' ' SER . . . . . 0.611 ' O ' ' HB2' ' C' ' 95' ' ' SER . 69.7 m -77.54 83.21 3.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.971 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 92' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' F' ' 50' ' ' SER . . . -54.99 -34.67 63.59 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.89 0.376 . . . . 0.0 111.63 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.29 31.48 6.32 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.586 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.59 7.48 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.94 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 95' ' ' SER . . . . . 0.76 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 0.6 OUTLIER -110.74 -174.32 2.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.888 0.375 . . . . 0.0 110.612 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 96' ' ' ALA . . . . . 0.432 ' O ' HD21 ' C' ' 88' ' ' LEU . . . -97.76 179.0 4.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 97' ' ' THR . . . . . 0.771 ' H ' ' HB ' ' C' ' 144' ' ' THR . 1.1 m -132.29 125.98 32.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.356 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 98' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' C' ' 97' ' ' THR . 66.0 m-20 66.57 25.92 9.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.396 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.7 130.37 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.705 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.07 -161.39 10.76 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.501 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 101' ' ' VAL . . . . . 0.486 ' CG2' ' HB1' ' C' ' 135' ' ' ALA . 0.8 OUTLIER -130.88 131.95 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 123.094 0.558 . . . . 0.0 111.866 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 102' ' ' GLN . . . . . 0.726 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 1.5 tt0 -98.49 151.46 20.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.897 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.525 ' N ' ' HG2' ' C' ' 102' ' ' GLN . 0.3 OUTLIER -117.33 128.64 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.58 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 104' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 0.3 OUTLIER -102.98 133.46 48.05 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.654 0.264 . . . . 0.0 111.033 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 105' ' ' ASP . . . . . 0.71 ' HB3' HG22 ' C' ' 107' ' ' THR . 7.2 t0 -87.74 158.44 18.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.636 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 106' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' C' ' 106' ' ' ARG . 7.9 ttp85 -70.5 -27.72 64.42 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.714 0.293 . . . . 0.0 111.02 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 107' ' ' THR . . . . . 0.71 HG22 ' HB3' ' C' ' 105' ' ' ASP . 2.8 t -51.68 -25.68 7.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.096 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.16 -39.29 1.73 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.617 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.26 157.99 17.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.351 . . . . 0.0 111.065 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -70.32 137.07 50.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.111 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 111' ' ' LEU . . . . . 0.657 HD21 ' HA ' ' C' ' 72' ' ' ALA . 13.5 tp -87.56 158.47 18.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.382 0.611 . . . . 0.0 110.499 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 112' ' ' THR . . . . . 0.998 HG23 HG21 ' C' ' 117' ' ' THR . 0.5 OUTLIER -101.76 141.97 33.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.123 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' C' ' 73' ' ' PHE . 1.9 mt -82.43 65.6 7.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 0.0 110.708 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.08 -14.93 21.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.528 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.19 -54.11 0.71 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.678 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.17 28.83 8.35 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.017 0.437 . . . . 0.0 111.721 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 117' ' ' THR . . . . . 0.998 HG21 HG23 ' C' ' 112' ' ' THR . 0.0 OUTLIER -88.72 76.6 8.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.24 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 118' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' C' ' 71' ' ' VAL . 91.3 m-85 -91.13 96.77 10.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.724 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 68.6 m -132.65 78.25 1.79 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.818 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.67 136.88 3.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.692 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.02 76.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.267 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.88 135.56 33.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.703 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 11.8 m -77.05 96.33 4.4 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.73 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 124' ' ' LEU . . . . . 0.738 ' O ' HG23 ' C' ' 63' ' ' THR . 10.8 tp -68.25 132.92 47.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.627 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -128.49 166.83 18.02 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.569 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 126' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' C' ' 61' ' ' CYS . 6.3 t30 -79.43 105.76 10.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.696 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.05 -137.06 5.22 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.655 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 128' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 3.7 m -103.62 83.49 2.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.688 0.28 . . . . 0.0 110.778 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 129' ' ' ASN . . . . . 0.686 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 1.7 t30 -71.12 139.92 50.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.959 0.409 . . . . 0.0 111.099 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 130' ' ' THR . . . . . 0.886 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -134.0 139.7 46.23 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.024 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 131' ' ' ILE . . . . . 0.621 HG21 HG11 ' C' ' 71' ' ' VAL . 61.9 mt -98.07 110.55 56.37 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 132' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -81.79 135.13 8.78 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.753 1.635 . . . . 0.0 112.596 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.71 152.67 41.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.773 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 134' ' ' GLN . . . . . 0.595 ' HB3' ' HB1' ' C' ' 51' ' ' ALA . 50.6 mt-30 -119.01 156.9 28.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.07 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 135' ' ' ALA . . . . . 0.726 ' HA ' ' O ' ' C' ' 102' ' ' GLN . . . -151.43 101.67 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 0.0 111.633 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.61 168.28 9.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.359 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 137' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' C' ' 48' ' ' THR . 0.3 OUTLIER -79.98 123.23 27.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.192 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 138' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' C' ' 47' ' ' ALA . 1.3 t80 -126.11 119.05 26.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.085 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 139' ' ' ALA . . . . . 0.743 ' HB2' HD23 ' C' ' 42' ' ' LEU . . . -111.95 125.21 53.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.954 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 140' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.17 64.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.543 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 141' ' ' GLY . . . . . 0.439 ' H ' ' HB3' ' C' ' 98' ' ' ASN . . . -133.15 -120.0 2.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.043 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.43 111.89 18.19 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.559 0.219 . . . . 0.0 110.708 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 143' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -61.88 113.78 2.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.794 0.331 . . . . 0.0 111.39 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 144' ' ' THR . . . . . 0.771 ' HB ' ' H ' ' C' ' 97' ' ' THR . 75.5 m -88.18 145.24 35.65 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.366 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.87 134.19 7.12 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.499 2.132 . . . . 0.0 112.005 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.93 -135.55 4.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.502 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 147' ' ' ALA . . . . . 0.703 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -96.24 134.23 39.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.881 0.372 . . . . 0.0 111.336 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 148' ' ' ALA . . . . . 0.891 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -129.85 50.49 2.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.161 0.505 . . . . 0.0 110.456 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -98.95 146.15 26.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.555 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 150' ' ' ALA . . . . . 0.986 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -154.9 174.11 15.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.986 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 151' ' ' ASP . . . . . 0.488 ' C ' HD11 ' C' ' 86' ' ' LEU . 26.9 t70 -139.28 128.48 23.95 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.186 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 152' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -118.43 133.35 55.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.11 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 153' ' ' THR . . . . . 0.721 HG23 HG22 ' B' ' 9' ' ' THR . 0.2 OUTLIER -91.97 147.41 22.98 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.26 130.25 53.44 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.125 0.488 . . . . 0.0 110.062 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -126.67 143.9 51.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.954 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 156' ' ' VAL . . . . . 0.524 HG12 ' CD1' ' C' ' 131' ' ' ILE . 27.3 m -127.35 151.92 34.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.69 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 157' ' ' GLN . . . . . 0.683 ' HA ' ' O ' ' B' ' 3' ' ' THR . 0.0 OUTLIER -141.34 121.15 13.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.298 0.57 . . . . 0.0 110.37 -179.668 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 158' ' ' TYR . . . . . 0.577 ' CD2' ' HB ' ' B' ' 3' ' ' THR . 1.2 m-85 -98.26 121.63 40.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.56 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.808 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 111.261 0.097 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.62 71.14 0.5 Allowed 'General case' 0 N--CA 1.462 0.157 0 O-C-N 123.107 0.254 . . . . 0.0 110.96 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 3' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' E' ' 157' ' ' GLN . 4.8 m -114.68 127.32 55.69 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.475 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 20.2 m -117.7 106.77 13.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.633 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.458 HG21 HG12 ' E' ' 17' ' ' VAL . 0.0 OUTLIER -133.91 174.64 12.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.567 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.13 119.83 36.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.586 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.2 -49.49 15.71 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.839 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.26 -154.82 11.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.848 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 9' ' ' THR . . . . . 0.709 HG22 HG23 ' E' ' 153' ' ' THR . 2.7 p -142.49 140.04 31.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.983 0.421 . . . . 0.0 111.176 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.73 113.89 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.151 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.14 110.39 20.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.363 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.3 111.48 22.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.74 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 13' ' ' LYS . . . . . 0.485 ' HE3' HG11 ' D' ' 28' ' ' VAL . 3.6 tmtm? -102.96 110.5 22.44 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.453 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.19 168.31 22.6 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.014 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 15' ' ' GLU . . . . . 0.687 ' O ' ' HA ' ' E' ' 36' ' ' GLN . 3.6 tt0 -158.99 133.07 7.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.93 0.395 . . . . 0.0 110.4 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.89 HG23 ' HB2' ' E' ' 148' ' ' ALA . 13.2 t -99.65 143.14 14.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.286 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.539 HG13 ' HG2' ' E' ' 36' ' ' GLN . 3.9 m -141.33 -172.11 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.862 0.363 . . . . 0.0 111.074 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.49 -176.91 5.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.034 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.87 46.95 1.36 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.106 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.77 -29.97 2.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 21' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER -163.14 158.38 21.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.915 -179.78 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 22' ' ' ALA . . . . . 0.565 ' HB1' ' O ' ' E' ' 36' ' ' GLN . . . -161.35 118.54 2.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.103 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 23' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' D' ' 58' ' ' LEU . 0.8 OUTLIER -66.25 152.99 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.065 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -84.68 158.77 20.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.611 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.559 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -61.03 -34.47 74.9 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.344 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.05 13.03 63.77 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.929 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.78 -22.43 10.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.776 0.322 . . . . 0.0 110.773 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 28' ' ' VAL . . . . . 0.485 HG11 ' HE3' ' D' ' 13' ' ' LYS . 19.8 t -44.04 -64.25 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.339 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.04 135.9 41.74 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.932 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -139.26 125.64 20.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.049 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.77 106.56 18.84 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.044 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.78 117.08 53.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.105 0.478 . . . . 0.0 110.431 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.74 131.09 45.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.527 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.8 -47.35 7.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.631 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.38 -163.56 12.16 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.564 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' GLN . . . . . 0.674 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 3.7 mt-30 -101.0 126.61 47.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.703 0.287 . . . . 0.0 110.83 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.455 HG21 HD13 ' D' ' 42' ' ' LEU . 14.9 p -110.42 146.83 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.934 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 38' ' ' ARG . . . . . 0.625 HH22 ' HB2' ' C' ' 62' ' ' ASP . 2.9 mtp180 -82.87 139.17 33.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.7 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.484 ' HA ' ' HB3' ' D' ' 143' ' ' ALA . 5.4 t -62.78 -37.53 87.03 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.745 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.4 -31.5 71.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.125 0.488 . . . . 0.0 110.896 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.99 -17.77 45.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.165 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.742 HD23 ' HB2' ' D' ' 139' ' ' ALA . 4.3 mp -125.66 33.11 5.17 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.609 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.76 18.9 18.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.298 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.94 130.26 52.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.34 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 45' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' D' ' 140' ' ' THR . 22.5 tt0 -56.29 107.32 0.36 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.884 0.373 . . . . 0.0 111.088 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.62 30.5 5.84 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.111 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' D' ' 138' ' ' PHE . . . -76.56 136.71 39.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.973 0.415 . . . . 0.0 112.109 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 48' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' D' ' 137' ' ' TYR . 52.3 p -134.94 134.71 40.88 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.879 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.527 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 70.7 m -108.76 -168.16 1.31 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.641 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 23.3 t -63.99 128.52 36.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.743 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 51' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' D' ' 134' ' ' GLN . . . -80.42 130.02 34.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.467 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 52' ' ' VAL . . . . . 0.775 ' HB ' ' HA ' ' A' ' 90' ' ' SER . 2.8 m -74.85 151.28 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.04 119.23 5.66 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.516 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -153.9 152.12 30.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.788 0.328 . . . . 0.0 110.837 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 55' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -148.77 162.94 38.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.693 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.606 HG23 ' O ' ' D' ' 56' ' ' ILE . 1.2 tp -105.91 114.76 46.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.563 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 57' ' ' GLN . . . . . 0.859 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.0 OUTLIER -70.65 124.51 24.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.744 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 58' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' D' ' 23' ' ' VAL . 0.2 OUTLIER -132.28 88.69 2.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.281 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 59' ' ' ASN . . . . . 0.598 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 0.1 OUTLIER -75.25 169.47 17.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 60' ' ' ASP . . . . . 0.401 ' CG ' ' HD2' ' E' ' 38' ' ' ARG . 0.4 OUTLIER 66.26 68.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.78 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 61' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 56.2 m -117.13 155.07 29.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 62' ' ' ASP . . . . . 0.624 ' HB2' HH22 ' E' ' 38' ' ' ARG . 19.9 t70 -135.75 155.66 50.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.277 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.729 HG23 ' O ' ' D' ' 124' ' ' LEU . 0.2 OUTLIER -111.11 -34.25 6.24 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.05 -22.14 66.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.952 0.406 . . . . 0.0 111.729 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.62 -59.49 2.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.74 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.575 ' HB3' HD23 ' D' ' 124' ' ' LEU . . . -116.82 129.16 55.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.623 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -60.23 2.22 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.878 0.371 . . . . 0.0 111.001 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.21 -175.34 2.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.456 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.96 131.36 9.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.59 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 70' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -105.96 151.18 24.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.104 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 71' ' ' VAL . . . . . 0.615 HG11 HG21 ' D' ' 131' ' ' ILE . 2.0 t -129.52 158.3 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.754 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 72' ' ' ALA . . . . . 0.627 ' HA ' HD21 ' D' ' 111' ' ' LEU . . . -152.68 143.08 22.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.584 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 73' ' ' PHE . . . . . 0.603 ' HB3' HD23 ' D' ' 113' ' ' LEU . 0.1 OUTLIER -112.33 141.46 46.02 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.691 0.281 . . . . 0.0 111.004 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 74' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.3 OUTLIER -107.69 139.52 42.13 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.018 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.79 -179.44 46.94 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.816 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.98 156.28 17.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.613 0.245 . . . . 0.0 110.767 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.3 118.38 21.17 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.969 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 78' ' ' ILE . . . . . 0.559 HG22 ' HB3' ' D' ' 82' ' ' HIS . 0.4 OUTLIER -59.01 -29.1 40.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.644 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.449 ' HB2' HG21 ' D' ' 140' ' ' THR . 0.1 OUTLIER -151.76 50.47 0.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.774 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.17 -89.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.09 -32.51 42.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.621 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 82' ' ' HIS . . . . . 0.559 ' HB3' HG22 ' D' ' 78' ' ' ILE . 0.3 OUTLIER -81.08 62.86 5.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 110.406 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.63 -18.18 60.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.558 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 84' ' ' ASN . . . . . 0.716 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 20.4 p-10 -76.04 -7.4 54.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.176 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.489 ' HB ' ' CG2' ' D' ' 78' ' ' ILE . 24.0 t -117.73 124.14 72.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.243 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.955 HD22 ' HB1' ' D' ' 150' ' ' ALA . 0.5 OUTLIER -66.15 139.35 58.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.713 0.292 . . . . 0.0 110.243 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' D' ' 78' ' ' ILE . . . -84.88 -165.44 1.2 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.693 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.774 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 0.7 OUTLIER -71.84 168.65 17.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.067 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.96 -79.23 0.06 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.263 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -168.81 5.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.986 0.422 . . . . 0.0 111.472 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 91' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' D' ' 95' ' ' SER . 70.3 m -77.47 83.22 3.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.11 -34.62 63.84 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.878 0.371 . . . . 0.0 111.633 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.24 31.5 6.32 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.687 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.57 7.39 0.23 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.881 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 95' ' ' SER . . . . . 0.774 ' HB3' ' HG ' ' D' ' 88' ' ' LEU . 0.6 OUTLIER -110.71 -174.33 2.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 110.651 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 96' ' ' ALA . . . . . 0.418 ' O ' HD21 ' D' ' 88' ' ' LEU . . . -97.78 179.01 4.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.931 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 97' ' ' THR . . . . . 0.788 ' H ' ' HB ' ' D' ' 144' ' ' THR . 1.1 m -132.24 125.92 32.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.369 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 98' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' D' ' 97' ' ' THR . 66.0 m-20 66.68 25.87 9.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.38 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.66 130.34 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.691 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.13 -161.38 10.76 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.485 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 101' ' ' VAL . . . . . 0.483 ' CG2' ' HB1' ' D' ' 135' ' ' ALA . 0.8 OUTLIER -130.84 131.94 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 123.12 0.568 . . . . 0.0 111.842 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 102' ' ' GLN . . . . . 0.724 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 1.5 tt0 -98.52 151.45 20.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.906 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 103' ' ' ILE . . . . . 0.525 ' N ' ' HG2' ' D' ' 102' ' ' GLN . 0.3 OUTLIER -117.3 128.65 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.499 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 104' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 0.3 OUTLIER -102.94 133.5 47.94 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.559 0.219 . . . . 0.0 111.051 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 105' ' ' ASP . . . . . 0.723 ' HB3' HG22 ' D' ' 107' ' ' THR . 7.1 t0 -87.73 158.47 18.79 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.685 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 106' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -70.56 -27.71 64.34 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.806 0.336 . . . . 0.0 111.047 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 107' ' ' THR . . . . . 0.723 HG22 ' HB3' ' D' ' 105' ' ' ASP . 2.8 t -51.69 -25.7 7.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.09 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.19 -39.27 1.73 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.557 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.27 158.0 17.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.352 . . . . 0.0 111.013 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -70.37 137.17 50.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.099 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 111' ' ' LEU . . . . . 0.627 HD21 ' HA ' ' D' ' 72' ' ' ALA . 13.5 tp -87.56 158.35 18.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.304 0.574 . . . . 0.0 110.529 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 112' ' ' THR . . . . . 1.035 HG23 HG21 ' D' ' 117' ' ' THR . 0.5 OUTLIER -101.72 142.01 33.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.095 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 113' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' D' ' 73' ' ' PHE . 1.9 mt -82.45 65.63 7.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 0.0 110.775 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.07 -15.01 21.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.485 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.23 -54.14 0.71 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.705 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.16 28.88 8.31 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.068 0.461 . . . . 0.0 111.756 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 117' ' ' THR . . . . . 1.035 HG21 HG23 ' D' ' 112' ' ' THR . 0.0 OUTLIER -88.81 76.62 7.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.186 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' D' ' 71' ' ' VAL . 91.5 m-85 -91.06 96.79 10.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.733 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 67.8 m -132.69 78.31 1.79 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.704 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.7 136.85 3.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.717 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -115.02 76.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.307 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.98 135.54 33.62 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.662 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 11.7 m -77.05 96.33 4.4 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.764 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 124' ' ' LEU . . . . . 0.729 ' O ' HG23 ' D' ' 63' ' ' THR . 10.8 tp -68.15 132.92 48.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.628 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -128.49 166.81 18.06 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.561 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 126' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' D' ' 61' ' ' CYS . 6.2 t30 -79.44 105.76 10.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.665 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.03 -136.99 5.19 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.734 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 128' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 3.7 m -103.72 83.44 2.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.716 0.293 . . . . 0.0 110.808 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 129' ' ' ASN . . . . . 0.694 ' HB2' ' SG ' ' D' ' 61' ' ' CYS . 1.7 t30 -71.04 139.85 50.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.899 0.38 . . . . 0.0 111.17 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 130' ' ' THR . . . . . 1.026 HG21 HD21 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -133.92 139.57 46.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.147 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 131' ' ' ILE . . . . . 0.615 HG21 HG11 ' D' ' 71' ' ' VAL . 61.8 mt -97.9 110.49 55.83 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 132' ' ' PRO . . . . . 0.768 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 7.6 Cg_endo -81.88 135.18 8.72 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.772 1.648 . . . . 0.0 112.562 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.74 152.65 41.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.802 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 134' ' ' GLN . . . . . 0.588 ' HB3' ' HB1' ' D' ' 51' ' ' ALA . 50.6 mt-30 -118.94 156.95 28.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.092 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.733 ' HB3' HG22 ' D' ' 52' ' ' VAL . . . -151.42 101.71 2.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 111.648 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.56 168.29 9.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.352 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 137' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' D' ' 48' ' ' THR . 0.3 OUTLIER -80.11 123.34 27.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.149 179.533 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 138' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' D' ' 47' ' ' ALA . 1.3 t80 -126.19 119.05 26.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.998 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 139' ' ' ALA . . . . . 0.742 ' HB2' HD23 ' D' ' 42' ' ' LEU . . . -111.98 125.17 53.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.904 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 140' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.23 63.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.494 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 141' ' ' GLY . . . . . 0.444 ' H ' ' HB3' ' D' ' 98' ' ' ASN . . . -133.06 -120.03 2.08 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.137 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.36 111.94 18.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.628 0.252 . . . . 0.0 110.718 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 143' ' ' ALA . . . . . 0.709 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -61.96 113.84 3.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.82 0.343 . . . . 0.0 111.377 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 144' ' ' THR . . . . . 0.788 ' HB ' ' H ' ' D' ' 97' ' ' THR . 75.4 m -88.27 145.28 35.56 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.323 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.86 134.17 7.12 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.533 2.156 . . . . 0.0 111.992 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.93 -135.63 4.42 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.499 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 147' ' ' ALA . . . . . 0.689 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -96.13 134.26 39.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.905 0.383 . . . . 0.0 111.362 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 148' ' ' ALA . . . . . 0.872 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -129.89 50.51 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.413 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -98.99 146.14 26.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.489 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 150' ' ' ALA . . . . . 0.955 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -154.95 174.17 15.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.92 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 151' ' ' ASP . . . . . 0.495 ' C ' HD11 ' D' ' 86' ' ' LEU . 26.8 t70 -139.34 128.4 23.74 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.184 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 152' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -118.37 133.34 55.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.126 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 153' ' ' THR . . . . . 0.74 HG23 HG22 ' C' ' 9' ' ' THR . 0.2 OUTLIER -91.97 147.42 22.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.27 130.33 53.43 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.169 0.509 . . . . 0.0 110.022 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -126.67 143.97 51.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.945 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 156' ' ' VAL . . . . . 0.523 HG12 ' CD1' ' D' ' 131' ' ' ILE . 27.4 m -127.45 151.87 34.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.85 0.357 . . . . 0.0 111.643 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 157' ' ' GLN . . . . . 0.687 ' HA ' ' O ' ' C' ' 3' ' ' THR . 0.0 OUTLIER -141.36 121.22 13.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.295 0.569 . . . . 0.0 110.372 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 158' ' ' TYR . . . . . 0.57 ' CD2' ' HB ' ' C' ' 3' ' ' THR . 1.2 m-85 -98.29 121.67 40.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.564 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.804 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 111.27 0.1 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.64 71.06 0.51 Allowed 'General case' 0 N--CA 1.462 0.149 0 O-C-N 123.109 0.256 . . . . 0.0 110.959 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 3' ' ' THR . . . . . 0.688 ' O ' ' HA ' ' F' ' 157' ' ' GLN . 4.9 m -114.7 127.36 55.71 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.499 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 20.8 m -117.74 106.86 13.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.577 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.453 HG21 HG12 ' F' ' 17' ' ' VAL . 0.0 OUTLIER -133.98 174.66 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.601 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.05 119.81 36.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.581 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.2 -49.49 15.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.822 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.32 -154.88 11.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.755 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 9' ' ' THR . . . . . 0.723 HG22 HG23 ' F' ' 153' ' ' THR . 2.7 p -142.43 139.95 31.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.904 0.383 . . . . 0.0 111.291 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.71 113.83 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.161 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.11 110.32 20.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.36 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.21 111.51 22.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.752 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 13' ' ' LYS . . . . . 0.492 ' HE3' HG11 ' E' ' 28' ' ' VAL . 3.6 tmtm? -102.98 110.56 22.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.488 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.22 168.36 22.59 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.053 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 15' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' F' ' 36' ' ' GLN . 3.6 tt0 -159.02 133.08 7.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.923 0.392 . . . . 0.0 110.438 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 16' ' ' VAL . . . . . 0.896 HG23 ' HB2' ' F' ' 148' ' ' ALA . 13.2 t -99.67 143.15 14.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.261 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 17' ' ' VAL . . . . . 0.524 HG13 ' HG2' ' F' ' 36' ' ' GLN . 3.9 m -141.34 -172.13 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.874 0.368 . . . . 0.0 111.057 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.48 -176.96 5.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.046 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.73 46.85 1.36 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.77 -30.0 2.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.9 0.381 . . . . 0.0 111.466 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 21' ' ' CYS . . . . . 1.014 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER -163.07 158.45 22.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.943 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 22' ' ' ALA . . . . . 0.568 ' HB1' ' O ' ' F' ' 36' ' ' GLN . . . -161.42 118.49 2.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.044 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 23' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' E' ' 58' ' ' LEU . 0.8 OUTLIER -66.23 153.02 8.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.05 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.7 158.74 20.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.59 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 25' ' ' ALA . . . . . 0.554 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -61.04 -34.34 74.72 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.388 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.18 13.07 63.54 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.936 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.76 -22.44 10.7 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.798 0.333 . . . . 0.0 110.746 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 28' ' ' VAL . . . . . 0.492 HG11 ' HE3' ' E' ' 13' ' ' LYS . 19.8 t -44.02 -64.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.319 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.0 135.72 42.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.02 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -139.11 125.72 20.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.78 106.53 18.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.108 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.78 117.06 53.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.147 0.499 . . . . 0.0 110.44 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.67 131.01 45.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.61 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.75 -47.29 7.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.682 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.3 -163.61 12.15 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.573 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 36' ' ' GLN . . . . . 0.687 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 3.7 mt-30 -100.97 126.61 47.64 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.717 0.294 . . . . 0.0 110.842 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.453 HG21 HD13 ' E' ' 42' ' ' LEU . 14.9 p -110.38 146.85 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.983 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 38' ' ' ARG . . . . . 0.624 HH22 ' HB2' ' D' ' 62' ' ' ASP . 2.9 mtp180 -82.96 139.23 33.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.632 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 39' ' ' THR . . . . . 0.501 ' HA ' ' HB3' ' E' ' 143' ' ' ALA . 5.4 t -62.78 -37.52 86.99 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.724 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.48 -31.47 71.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.12 0.486 . . . . 0.0 110.867 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.99 -17.74 45.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.196 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.741 HD23 ' HB2' ' E' ' 139' ' ' ALA . 4.3 mp -125.68 33.05 5.18 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.631 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.71 18.86 18.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.333 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.92 130.29 52.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.309 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 45' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' E' ' 140' ' ' THR . 22.4 tt0 -56.35 107.38 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.362 . . . . 0.0 111.059 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.52 30.53 5.85 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.183 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 47' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' E' ' 138' ' ' PHE . . . -76.61 136.75 39.21 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.976 0.417 . . . . 0.0 112.123 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 48' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' E' ' 137' ' ' TYR . 52.2 p -134.96 134.69 40.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.888 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.53 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 71.6 m -108.82 -168.21 1.32 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.565 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 50' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 23.1 t -63.9 128.43 35.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.783 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 51' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' E' ' 134' ' ' GLN . . . -80.38 129.99 34.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.447 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 52' ' ' VAL . . . . . 0.764 ' HB ' ' HA ' ' B' ' 90' ' ' SER . 2.8 m -74.87 151.22 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.9 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.01 119.22 5.67 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.578 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.85 152.1 30.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.728 0.299 . . . . 0.0 110.966 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -148.77 162.89 38.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.653 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 56' ' ' ILE . . . . . 0.603 HG23 ' O ' ' E' ' 56' ' ' ILE . 1.2 tp -105.87 114.86 46.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.567 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 57' ' ' GLN . . . . . 0.855 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.0 OUTLIER -70.72 124.58 24.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.695 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 58' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' E' ' 23' ' ' VAL . 0.2 OUTLIER -132.36 88.76 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.242 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 59' ' ' ASN . . . . . 0.592 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 0.1 OUTLIER -75.34 169.41 18.11 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 60' ' ' ASP . . . . . 0.409 ' CG ' ' HD2' ' F' ' 38' ' ' ARG . 0.4 OUTLIER 66.38 68.3 0.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.746 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 61' ' ' CYS . . . . . 1.014 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 56.1 m -117.15 155.03 30.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.797 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 62' ' ' ASP . . . . . 0.618 ' HB2' HH22 ' F' ' 38' ' ' ARG . 20.1 t70 -135.8 155.65 50.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.274 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 63' ' ' THR . . . . . 0.73 HG23 ' O ' ' E' ' 124' ' ' LEU . 0.2 OUTLIER -111.08 -34.22 6.25 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.12 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.05 -22.18 66.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.067 0.46 . . . . 0.0 111.718 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.63 -59.49 2.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.709 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 66' ' ' ALA . . . . . 0.559 ' HB3' HD23 ' E' ' 124' ' ' LEU . . . -116.86 129.18 55.91 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.628 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -60.35 2.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.896 0.379 . . . . 0.0 110.978 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.15 -175.37 2.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.537 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.96 131.32 9.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.588 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 70' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -105.97 151.19 24.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.073 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 71' ' ' VAL . . . . . 0.622 HG11 HG21 ' E' ' 131' ' ' ILE . 2.0 t -129.44 158.35 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.778 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 72' ' ' ALA . . . . . 0.628 ' HA ' HD21 ' E' ' 111' ' ' LEU . . . -152.71 143.06 22.56 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.599 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 73' ' ' PHE . . . . . 0.608 ' HB3' HD23 ' E' ' 113' ' ' LEU . 0.1 OUTLIER -112.29 141.43 46.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.542 0.21 . . . . 0.0 111.105 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 74' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.3 OUTLIER -107.7 139.49 42.18 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.992 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.76 -179.43 46.92 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.815 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -104.01 156.34 17.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.619 0.247 . . . . 0.0 110.79 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.35 118.37 21.19 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.934 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 78' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' E' ' 82' ' ' HIS . 0.4 OUTLIER -58.97 -29.14 40.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.895 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 79' ' ' ASP . . . . . 0.449 ' HB2' HG21 ' E' ' 140' ' ' THR . 0.1 OUTLIER -151.72 50.4 0.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.838 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.25 -89.9 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.103 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.03 -32.53 42.53 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.64 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 82' ' ' HIS . . . . . 0.564 ' HB3' HG22 ' E' ' 78' ' ' ILE . 0.3 OUTLIER -81.12 62.81 5.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.826 0.346 . . . . 0.0 110.376 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -18.09 60.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.599 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 84' ' ' ASN . . . . . 0.705 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 20.4 p-10 -76.1 -7.37 54.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.239 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.476 ' HB ' ' CG2' ' E' ' 78' ' ' ILE . 23.8 t -117.75 124.14 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.172 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 86' ' ' LEU . . . . . 0.982 HD22 ' HB1' ' E' ' 150' ' ' ALA . 0.5 OUTLIER -66.14 139.38 58.14 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.262 179.409 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 87' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' E' ' 78' ' ' ILE . . . -84.92 -165.41 1.19 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.667 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.771 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 0.7 OUTLIER -71.92 168.64 17.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.977 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.89 -79.23 0.06 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.308 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p -168.81 5.94 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.918 0.389 . . . . 0.0 111.506 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 91' ' ' SER . . . . . 0.612 ' O ' ' HB2' ' E' ' 95' ' ' SER . 70.2 m -77.57 83.22 3.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.07 -34.7 63.83 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.875 0.369 . . . . 0.0 111.57 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.23 31.5 6.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.635 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.58 7.44 0.23 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.965 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 95' ' ' SER . . . . . 0.771 ' HB3' ' HG ' ' E' ' 88' ' ' LEU . 0.6 OUTLIER -110.69 -174.32 2.45 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.911 0.386 . . . . 0.0 110.669 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 96' ' ' ALA . . . . . 0.432 ' O ' HD21 ' E' ' 88' ' ' LEU . . . -97.76 178.96 4.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 97' ' ' THR . . . . . 0.796 ' H ' ' HB ' ' E' ' 144' ' ' THR . 1.1 m -132.25 125.99 32.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.368 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 98' ' ' ASN . . . . . 0.438 ' HB3' ' H ' ' E' ' 141' ' ' GLY . 66.1 m-20 66.64 25.84 9.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.45 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.74 130.37 70.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.691 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.15 -161.38 10.77 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.463 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 101' ' ' VAL . . . . . 0.497 ' CG2' ' HB1' ' E' ' 135' ' ' ALA . 0.8 OUTLIER -130.89 131.97 64.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.025 0.53 . . . . 0.0 111.773 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 102' ' ' GLN . . . . . 0.724 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 1.5 tt0 -98.48 151.47 20.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.882 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 103' ' ' ILE . . . . . 0.527 ' N ' ' HG2' ' E' ' 102' ' ' GLN . 0.3 OUTLIER -117.36 128.73 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.498 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 104' ' ' LEU . . . . . 0.796 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 0.3 OUTLIER -103.03 133.5 48.05 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.62 0.248 . . . . 0.0 111.108 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 105' ' ' ASP . . . . . 0.716 ' HB3' HG22 ' E' ' 107' ' ' THR . 7.1 t0 -87.73 158.37 18.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.67 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 106' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' E' ' 106' ' ' ARG . 7.9 ttp85 -70.49 -27.68 64.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.778 0.323 . . . . 0.0 111.096 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 107' ' ' THR . . . . . 0.716 HG22 ' HB3' ' E' ' 105' ' ' ASP . 2.8 t -51.71 -25.72 7.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.058 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.21 -39.31 1.72 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.572 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.25 158.01 17.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 111.074 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 110' ' ' ALA . . . . . 0.796 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -70.36 137.17 50.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 111' ' ' LEU . . . . . 0.628 HD21 ' HA ' ' E' ' 72' ' ' ALA . 13.5 tp -87.52 158.31 18.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.347 0.594 . . . . 0.0 110.49 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 112' ' ' THR . . . . . 1.043 HG23 HG21 ' E' ' 117' ' ' THR . 0.5 OUTLIER -101.73 141.98 33.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.107 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 113' ' ' LEU . . . . . 0.608 HD23 ' HB3' ' E' ' 73' ' ' PHE . 1.9 mt -82.43 65.61 7.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 110.778 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.04 -15.05 21.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.478 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.29 -54.21 0.7 Allowed Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.668 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.06 28.79 8.39 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.028 0.442 . . . . 0.0 111.741 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 117' ' ' THR . . . . . 1.043 HG21 HG23 ' E' ' 112' ' ' THR . 0.0 OUTLIER -88.74 76.66 7.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.225 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 118' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' E' ' 71' ' ' VAL . 91.6 m-85 -91.11 96.75 10.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.781 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 68.6 m -132.62 78.24 1.79 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.828 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.67 136.91 3.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.662 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.06 76.21 0.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.294 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.88 135.59 33.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.674 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 11.8 m -77.09 96.36 4.43 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.738 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 124' ' ' LEU . . . . . 0.73 ' O ' HG23 ' E' ' 63' ' ' THR . 10.8 tp -68.24 132.97 48.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.591 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -128.5 166.78 18.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.603 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 126' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' E' ' 61' ' ' CYS . 6.3 t30 -79.4 105.66 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.683 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.08 -137.08 5.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.652 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 128' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 3.7 m -103.65 83.44 2.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.688 0.28 . . . . 0.0 110.832 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 129' ' ' ASN . . . . . 0.693 ' HB2' ' SG ' ' E' ' 61' ' ' CYS . 1.7 t30 -71.0 139.87 50.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.905 0.383 . . . . 0.0 111.163 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 130' ' ' THR . . . . . 0.979 HG21 HD21 ' B' ' 74' ' ' LEU . 0.2 OUTLIER -133.91 139.66 46.3 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.161 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 131' ' ' ILE . . . . . 0.622 HG21 HG11 ' E' ' 71' ' ' VAL . 61.8 mt -98.03 110.48 56.01 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 132' ' ' PRO . . . . . 0.767 ' HB3' ' HA ' ' B' ' 76' ' ' THR . 7.6 Cg_endo -81.86 135.16 8.73 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 121.792 1.661 . . . . 0.0 112.533 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.76 152.64 41.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.815 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 134' ' ' GLN . . . . . 0.587 ' HB3' ' HB1' ' E' ' 51' ' ' ALA . 50.5 mt-30 -118.97 156.86 28.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.099 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 135' ' ' ALA . . . . . 0.728 ' HB3' HG22 ' E' ' 52' ' ' VAL . . . -151.39 101.71 2.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 111.649 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.58 168.32 9.17 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.404 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 137' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' E' ' 48' ' ' THR . 0.3 OUTLIER -80.04 123.24 27.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.175 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 138' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' E' ' 47' ' ' ALA . 1.3 t80 -126.13 119.13 26.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.064 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 139' ' ' ALA . . . . . 0.741 ' HB2' HD23 ' E' ' 42' ' ' LEU . . . -111.98 125.22 53.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.867 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 140' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 0.2 OUTLIER -68.89 -48.24 63.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.546 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 141' ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' E' ' 98' ' ' ASN . . . -133.1 -119.96 2.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.085 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.42 111.96 18.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.612 0.244 . . . . 0.0 110.718 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 143' ' ' ALA . . . . . 0.719 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -61.95 113.89 3.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.803 0.335 . . . . 0.0 111.361 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 144' ' ' THR . . . . . 0.796 ' HB ' ' H ' ' E' ' 97' ' ' THR . 73.7 m -88.34 145.31 35.49 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.324 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 145' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' E' ' 144' ' ' THR . 1.3 Cg_endo -82.86 134.22 7.14 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.463 2.109 . . . . 0.0 112.019 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.87 -135.62 4.43 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.535 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 147' ' ' ALA . . . . . 0.679 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -96.12 134.19 39.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.392 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 148' ' ' ALA . . . . . 0.89 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -129.8 50.51 2.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.131 0.491 . . . . 0.0 110.474 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -98.97 146.13 26.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.501 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 150' ' ' ALA . . . . . 0.982 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -154.96 174.13 15.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.875 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 151' ' ' ASP . . . . . 0.483 ' C ' HD11 ' E' ' 86' ' ' LEU . 26.7 t70 -139.3 128.45 23.88 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.192 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 152' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -118.41 133.29 56.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.193 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 153' ' ' THR . . . . . 0.709 HG23 HG22 ' D' ' 9' ' ' THR . 0.2 OUTLIER -91.91 147.36 23.03 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.159 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.22 130.3 53.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.182 0.515 . . . . 0.0 110.054 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -126.63 143.91 51.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.911 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 156' ' ' VAL . . . . . 0.517 HG12 ' CD1' ' E' ' 131' ' ' ILE . 27.2 m -127.42 151.82 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.775 0.322 . . . . 0.0 111.729 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 157' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' D' ' 3' ' ' THR . 0.0 OUTLIER -141.34 121.19 13.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.326 0.584 . . . . 0.0 110.341 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 158' ' ' TYR . . . . . 0.573 ' CD2' ' HB ' ' D' ' 3' ' ' THR . 1.2 m-85 -98.31 121.66 40.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.532 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.82 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.251 0.072 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.72 71.03 0.51 Allowed 'General case' 0 CA--C 1.528 0.124 0 O-C-N 123.11 0.256 . . . . 0.0 110.972 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 4.9 m -114.69 127.38 55.73 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.433 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 20.7 m -117.82 106.74 13.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.587 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.86 174.71 12.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.577 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -97.11 119.89 36.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.553 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.34 -49.41 15.47 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.834 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.27 -154.87 11.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.862 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -142.46 140.07 31.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.985 0.421 . . . . 0.0 111.222 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.79 113.8 41.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.18 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -87.07 110.35 20.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.358 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -90.32 111.55 22.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.744 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 13' ' ' LYS . . . . . 0.485 ' HE3' HG11 ' F' ' 28' ' ' VAL . 3.7 tmtm? -102.97 110.6 22.58 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.39 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.25 168.38 22.6 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.962 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -159.09 133.02 7.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.893 0.378 . . . . 0.0 110.446 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 13.1 t -99.62 143.19 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.258 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 17' ' ' VAL . . . . . 0.453 HG12 HG21 ' E' ' 5' ' ' VAL . 3.9 m -141.41 -172.12 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.867 0.365 . . . . 0.0 110.987 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.51 -177.0 5.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.073 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.83 47.01 1.37 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.073 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.77 -29.98 2.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.434 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 21' ' ' CYS . . . . . 0.992 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER -163.19 158.33 21.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.906 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.34 118.61 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.045 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 23' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' F' ' 58' ' ' LEU . 0.8 OUTLIER -66.29 153.06 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.986 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -84.82 158.72 20.58 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.606 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 25' ' ' ALA . . . . . 0.562 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -60.99 -34.43 74.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.386 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.08 13.11 63.65 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.97 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.83 -22.43 10.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.796 0.332 . . . . 0.0 110.701 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 28' ' ' VAL . . . . . 0.485 HG11 ' HE3' ' F' ' 13' ' ' LYS . 19.8 t -44.05 -64.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.368 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.1 135.92 41.78 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.925 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.23 125.72 20.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.008 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.79 106.51 18.79 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.06 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.76 117.05 53.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.196 0.522 . . . . 0.0 110.445 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.66 131.06 45.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.607 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.79 -47.41 7.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.616 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.39 -163.62 12.15 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.581 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 36' ' ' GLN . . . . . 0.688 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 3.7 mt-30 -100.97 126.59 47.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.688 0.28 . . . . 0.0 110.863 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.444 HG21 HD13 ' F' ' 42' ' ' LEU . 14.9 p -110.36 146.84 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.912 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 38' ' ' ARG . . . . . 0.618 HH22 ' HB2' ' E' ' 62' ' ' ASP . 2.8 mtp180 -82.9 139.14 33.59 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.678 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 39' ' ' THR . . . . . 0.506 ' HA ' ' HB3' ' F' ' 143' ' ' ALA . 5.4 t -62.71 -37.51 86.78 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.762 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.46 -31.49 71.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.095 0.474 . . . . 0.0 110.837 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.03 -17.73 45.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.147 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 42' ' ' LEU . . . . . 0.739 HD23 ' HB2' ' F' ' 139' ' ' ALA . 4.3 mp -125.69 33.08 5.17 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.671 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.7 18.84 18.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.365 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.95 130.36 52.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.313 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 45' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' F' ' 140' ' ' THR . 22.5 tt0 -56.36 107.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.864 0.364 . . . . 0.0 111.027 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.64 30.42 5.86 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.179 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 47' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' F' ' 138' ' ' PHE . . . -76.57 136.7 39.26 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.95 0.405 . . . . 0.0 112.071 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 48' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' F' ' 137' ' ' TYR . 52.3 p -134.92 134.66 40.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.891 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 49' ' ' SER . . . . . 0.538 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 70.8 m -108.68 -168.23 1.32 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.657 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 50' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' C' ' 92' ' ' ALA . 23.1 t -63.89 128.47 35.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.807 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 51' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' F' ' 134' ' ' GLN . . . -80.44 130.02 34.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.406 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 52' ' ' VAL . . . . . 0.769 ' HB ' ' HA ' ' C' ' 90' ' ' SER . 2.8 m -74.84 151.25 6.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.97 119.21 5.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.622 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.86 152.1 30.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.711 0.291 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -148.77 162.99 38.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.643 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 56' ' ' ILE . . . . . 0.605 HG23 ' O ' ' F' ' 56' ' ' ILE . 1.2 tp -105.92 114.76 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.585 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 57' ' ' GLN . . . . . 0.889 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.0 OUTLIER -70.61 124.51 24.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.761 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 58' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' F' ' 23' ' ' VAL . 0.2 OUTLIER -132.35 88.81 2.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.192 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 59' ' ' ASN . . . . . 0.585 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 0.1 OUTLIER -75.35 169.52 17.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.34 68.26 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.787 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 61' ' ' CYS . . . . . 0.992 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 56.3 m -117.13 155.02 30.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.829 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -135.8 155.67 49.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.227 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 63' ' ' THR . . . . . 0.726 HG23 ' O ' ' F' ' 124' ' ' LEU . 0.2 OUTLIER -111.13 -34.23 6.24 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.085 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.09 -22.1 66.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.069 0.461 . . . . 0.0 111.759 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.61 -59.56 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.744 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 66' ' ' ALA . . . . . 0.569 ' HB3' HD23 ' F' ' 124' ' ' LEU . . . -116.74 129.12 55.93 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.617 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -60.27 2.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.959 0.409 . . . . 0.0 111.052 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.22 -175.41 2.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.47 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.93 131.34 9.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.607 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 70' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -106.02 151.19 24.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.025 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 71' ' ' VAL . . . . . 0.631 HG11 HG21 ' F' ' 131' ' ' ILE . 2.0 t -129.48 158.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.704 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 72' ' ' ALA . . . . . 0.657 ' HA ' HD21 ' F' ' 111' ' ' LEU . . . -152.66 143.02 22.57 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.626 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 73' ' ' PHE . . . . . 0.603 ' HB3' HD23 ' F' ' 113' ' ' LEU . 0.1 OUTLIER -112.23 141.44 45.94 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.663 0.268 . . . . 0.0 111.049 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 74' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.3 OUTLIER -107.63 139.54 42.01 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.981 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.76 -179.51 46.87 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.83 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.92 156.34 17.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.535 0.207 . . . . 0.0 110.819 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.34 118.44 21.25 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.877 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 78' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' F' ' 82' ' ' HIS . 0.4 OUTLIER -59.1 -29.08 40.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.834 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 79' ' ' ASP . . . . . 0.43 ' HB2' HG21 ' F' ' 140' ' ' THR . 0.1 OUTLIER -151.7 50.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.781 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.2 -89.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.095 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.09 -32.54 42.97 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.596 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 82' ' ' HIS . . . . . 0.564 ' HB3' HG22 ' F' ' 78' ' ' ILE . 0.3 OUTLIER -81.14 62.86 5.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.886 0.374 . . . . 0.0 110.414 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.53 -18.23 60.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.633 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 84' ' ' ASN . . . . . 0.705 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 20.4 p-10 -76.02 -7.4 54.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.258 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 85' ' ' VAL . . . . . 0.49 ' HB ' ' CG2' ' F' ' 78' ' ' ILE . 23.8 t -117.72 124.14 72.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.224 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 86' ' ' LEU . . . . . 0.959 HD22 ' HB1' ' F' ' 150' ' ' ALA . 0.5 OUTLIER -66.18 139.38 58.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.715 0.293 . . . . 0.0 110.266 179.454 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 87' ' ' ALA . . . . . 0.453 ' HB2' ' HA ' ' F' ' 78' ' ' ILE . . . -84.85 -165.37 1.17 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.741 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 88' ' ' LEU . . . . . 0.756 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 0.7 OUTLIER -71.87 168.65 17.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.056 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.91 -79.18 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.351 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p -168.87 6.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 111.549 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 91' ' ' SER . . . . . 0.609 ' O ' ' HB2' ' F' ' 95' ' ' SER . 69.4 m -77.62 83.24 4.01 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.04 -34.67 63.73 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.606 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.26 31.5 6.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.58 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.63 7.59 0.23 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.907 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 95' ' ' SER . . . . . 0.756 ' HB3' ' HG ' ' F' ' 88' ' ' LEU . 0.6 OUTLIER -110.87 -174.32 2.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.834 0.349 . . . . 0.0 110.553 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 96' ' ' ALA . . . . . 0.431 ' O ' HD21 ' F' ' 88' ' ' LEU . . . -97.76 179.0 4.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 97' ' ' THR . . . . . 0.784 ' H ' ' HB ' ' F' ' 144' ' ' THR . 1.1 m -132.32 125.98 32.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.316 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 98' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' F' ' 97' ' ' THR . 66.1 m-20 66.66 25.8 9.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.451 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.66 130.35 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.711 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.11 -161.37 10.75 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.492 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 101' ' ' VAL . . . . . 0.486 ' CG2' ' HB1' ' F' ' 135' ' ' ALA . 0.8 OUTLIER -130.89 131.88 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.122 0.569 . . . . 0.0 111.868 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 102' ' ' GLN . . . . . 0.721 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 1.5 tt0 -98.41 151.52 20.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.897 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 103' ' ' ILE . . . . . 0.518 ' N ' ' HG2' ' F' ' 102' ' ' GLN . 0.3 OUTLIER -117.36 128.65 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.503 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 104' ' ' LEU . . . . . 0.809 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 0.3 OUTLIER -103.04 133.52 48.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.647 0.261 . . . . 0.0 111.083 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 105' ' ' ASP . . . . . 0.702 ' HB3' HG22 ' F' ' 107' ' ' THR . 7.2 t0 -87.71 158.37 18.83 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.658 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 106' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' F' ' 106' ' ' ARG . 7.9 ttp85 -70.4 -27.75 64.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.778 0.323 . . . . 0.0 111.082 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 107' ' ' THR . . . . . 0.702 HG22 ' HB3' ' F' ' 105' ' ' ASP . 2.8 t -51.72 -25.72 7.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.056 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.26 -39.37 1.71 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.574 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.26 158.01 17.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 0.0 111.079 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 110' ' ' ALA . . . . . 0.809 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -70.3 137.11 50.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.034 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 111' ' ' LEU . . . . . 0.657 HD21 ' HA ' ' F' ' 72' ' ' ALA . 13.5 tp -87.53 158.38 18.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.338 0.589 . . . . 0.0 110.533 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 112' ' ' THR . . . . . 1.043 HG23 HG21 ' F' ' 117' ' ' THR . 0.5 OUTLIER -101.76 141.93 33.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.107 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 113' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' F' ' 73' ' ' PHE . 1.9 mt -82.33 65.58 7.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.7 0.286 . . . . 0.0 110.725 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.08 -14.97 21.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.521 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.21 -54.11 0.71 Allowed Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.661 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.19 28.97 8.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.066 0.46 . . . . 0.0 111.719 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 117' ' ' THR . . . . . 1.043 HG21 HG23 ' F' ' 112' ' ' THR . 0.0 OUTLIER -88.85 76.61 7.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.17 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 118' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' F' ' 71' ' ' VAL . 91.6 m-85 -91.07 96.77 10.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.746 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 67.8 m -132.6 78.22 1.79 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.764 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.7 136.97 3.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.688 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.09 76.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.276 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.9 135.59 33.62 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.635 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 12.0 m -77.09 96.25 4.41 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.763 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 124' ' ' LEU . . . . . 0.726 ' O ' HG23 ' F' ' 63' ' ' THR . 10.8 tp -68.19 132.97 48.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.582 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -128.47 166.77 18.12 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.552 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 126' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' F' ' 61' ' ' CYS . 6.3 t30 -79.41 105.74 10.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.743 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.02 -137.09 5.24 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.689 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 128' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 3.7 m -103.59 83.45 2.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.686 0.279 . . . . 0.0 110.847 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 129' ' ' ASN . . . . . 0.7 ' HB2' ' SG ' ' F' ' 61' ' ' CYS . 1.7 t30 -70.98 139.87 50.7 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.887 0.375 . . . . 0.0 111.165 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 130' ' ' THR . . . . . 0.97 HG21 HD21 ' C' ' 74' ' ' LEU . 0.2 OUTLIER -133.96 139.69 46.27 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.109 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 131' ' ' ILE . . . . . 0.631 HG21 HG11 ' F' ' 71' ' ' VAL . 61.8 mt -98.08 110.55 56.39 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 132' ' ' PRO . . . . . 0.765 ' HB3' ' HA ' ' C' ' 76' ' ' THR . 7.6 Cg_endo -81.82 135.13 8.76 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.796 1.664 . . . . 0.0 112.558 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.74 152.68 41.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.727 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 134' ' ' GLN . . . . . 0.589 ' HB3' ' HB1' ' F' ' 51' ' ' ALA . 50.5 mt-30 -119.0 156.9 28.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.096 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 135' ' ' ALA . . . . . 0.722 ' HB3' HG22 ' F' ' 52' ' ' VAL . . . -151.42 101.69 2.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.808 0.337 . . . . 0.0 111.641 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.59 168.33 9.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.373 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 137' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' F' ' 48' ' ' THR . 0.3 OUTLIER -80.09 123.3 27.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.113 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 138' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' F' ' 47' ' ' ALA . 1.3 t80 -126.18 119.05 26.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.051 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 139' ' ' ALA . . . . . 0.739 ' HB2' HD23 ' F' ' 42' ' ' LEU . . . -111.98 125.17 53.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.853 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 140' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' F' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.26 63.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.508 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 141' ' ' GLY . . . . . 0.434 ' H ' ' HB3' ' F' ' 98' ' ' ASN . . . -133.09 -120.05 2.08 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.058 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.27 111.91 18.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.548 0.213 . . . . 0.0 110.815 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 143' ' ' ALA . . . . . 0.709 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -61.91 113.86 3.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.815 0.341 . . . . 0.0 111.405 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 144' ' ' THR . . . . . 0.784 ' HB ' ' H ' ' F' ' 97' ' ' THR . 75.1 m -88.28 145.22 35.4 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.317 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.81 134.17 7.17 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.524 2.149 . . . . 0.0 111.978 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.94 -135.59 4.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.537 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 147' ' ' ALA . . . . . 0.71 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -96.21 134.2 39.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.966 0.412 . . . . 0.0 111.312 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 148' ' ' ALA . . . . . 0.896 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -129.82 50.48 2.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.184 0.516 . . . . 0.0 110.469 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -98.92 146.16 26.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.491 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 150' ' ' ALA . . . . . 0.959 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -154.91 174.12 15.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.876 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 151' ' ' ASP . . . . . 0.482 ' C ' HD11 ' F' ' 86' ' ' LEU . 26.8 t70 -139.34 128.49 23.87 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.225 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 152' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -118.41 133.38 55.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.159 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 153' ' ' THR . . . . . 0.723 HG23 HG22 ' E' ' 9' ' ' THR . 0.2 OUTLIER -92.02 147.42 22.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.24 130.28 53.42 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.143 0.497 . . . . 0.0 110.085 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -126.71 144.02 51.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.874 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 156' ' ' VAL . . . . . 0.526 HG12 ' CD1' ' F' ' 131' ' ' ILE . 27.3 m -127.42 151.9 34.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.677 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 157' ' ' GLN . . . . . 0.688 ' HA ' ' O ' ' E' ' 3' ' ' THR . 0.0 OUTLIER -141.35 121.18 13.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.237 0.542 . . . . 0.0 110.365 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 158' ' ' TYR . . . . . 0.575 ' CD2' ' HB ' ' E' ' 3' ' ' THR . 1.2 m-85 -98.25 121.65 40.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.539 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.802 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.533 0.206 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.589 ' OG1' ' HB2' ' B' ' 158' ' ' TYR . 6.2 p -117.73 97.5 5.88 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.499 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.607 HG22 ' HB2' ' B' ' 157' ' ' GLN . 68.4 p -87.86 108.7 19.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.576 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.63 172.77 13.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.592 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -77.2 110.77 12.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.587 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' B' ' 155' ' ' LYS . . . -65.69 -59.41 7.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.772 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.56 151.71 14.94 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.818 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.513 HG23 ' O ' ' B' ' 152' ' ' ALA . 24.2 m -103.54 143.13 33.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 111.279 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.441 HG12 ' HG3' ' B' ' 30' ' ' GLN . 1.2 m -130.94 115.61 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.208 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.62 105.77 14.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.398 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.448 ' HD2' HD21 ' B' ' 34' ' ' LEU . 52.1 m-85 -83.25 105.55 14.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.782 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.52 145.05 41.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.455 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.75 -179.72 42.55 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.958 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.15 134.23 22.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.0 110.376 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.635 HG11 ' O ' ' B' ' 144' ' ' THR . 3.3 t -90.85 127.14 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.286 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 20' ' ' ALA . 12.1 m -126.25 168.77 18.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -100.42 81.79 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.154 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' B' ' 40' ' ' ALA . . . 53.3 58.17 5.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.071 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB3' HG21 ' A' ' 17' ' ' VAL . . . -108.55 -62.86 1.4 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.36 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.781 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.9 OUTLIER -171.56 -159.94 0.16 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.915 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.634 ' HA ' ' HB2' ' B' ' 36' ' ' GLN . . . -156.88 74.01 0.78 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.456 ' N ' HD23 ' A' ' 58' ' ' LEU . 7.4 p -45.35 140.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.544 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -63.42 140.74 58.9 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.661 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.36 -51.15 69.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.311 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.11 -18.04 74.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.919 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.96 -6.39 58.04 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.832 0.349 . . . . 0.0 110.786 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 24' ' ' ASP . 50.9 t -72.63 -36.37 53.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.426 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.95 110.82 14.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.969 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.78 146.05 48.6 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.033 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.21 113.84 27.67 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.127 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.61 HG11 HG11 ' A' ' 52' ' ' VAL . 3.3 t -105.08 121.93 57.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.108 0.48 . . . . 0.0 110.448 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.86 106.41 17.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.683 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.79 -44.74 89.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.592 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.62 -156.9 15.99 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.568 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -91.07 107.01 18.91 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.596 0.236 . . . . 0.0 110.847 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.572 ' CG1' HD21 ' A' ' 42' ' ' LEU . 4.3 t -92.34 120.63 41.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.918 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 -85.71 132.49 34.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.746 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.0 p -71.45 -23.32 61.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.756 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.03 -19.19 64.88 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.965 0.412 . . . . 0.0 110.793 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.8 t -90.53 -36.55 14.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.183 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -121.52 70.52 0.94 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.58 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 142' ' ' ALA . . . -104.76 28.18 7.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.38 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.772 ' HG3' ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -150.58 142.01 23.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.384 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 2.7 tt0 -62.7 101.79 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.777 0.322 . . . . 0.0 111.136 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.3 4.27 8.41 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.062 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.772 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . . . -91.76 121.2 33.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.002 0.43 . . . . 0.0 111.985 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 5.8 t -110.3 151.2 27.68 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.806 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -95.7 -57.62 2.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.594 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.24 -174.88 4.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.853 0.359 . . . . 0.0 110.817 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.476 ' HB2' ' CD ' ' A' ' 136' ' ' ARG . . . -127.05 143.87 51.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.387 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.61 HG11 HG11 ' A' ' 32' ' ' VAL . 48.3 t -120.85 116.86 51.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.972 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.19 122.64 6.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.67 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -128.58 138.83 52.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.33 . . . . 0.0 110.978 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.472 HD22 ' CG2' ' A' ' 130' ' ' THR . 1.6 m120 -117.86 150.95 38.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.657 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.574 ' HB ' HG13 ' A' ' 131' ' ' ILE . 9.3 mm -106.78 103.67 15.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.57 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.21 132.23 52.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.783 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.757 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 1.0 OUTLIER -137.31 151.87 49.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.256 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -138.45 171.27 14.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.983 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 5.9 m-20 50.1 68.42 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.781 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -106.59 141.14 38.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.764 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.84 117.89 33.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.24 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.7 p -91.12 -13.18 33.52 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.62 -38.95 82.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.069 0.462 . . . . 0.0 111.765 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.65 -54.11 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.645 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.7 84.31 3.35 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.582 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.98 -41.21 10.13 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.805 0.336 . . . . 0.0 111.023 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.63 159.96 17.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.518 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.7 160.4 39.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.616 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.02 152.91 45.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.133 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.89 136.54 53.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.722 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.0 107.45 5.04 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.555 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.475 ' CD2' HD13 ' A' ' 103' ' ' ILE . 43.1 t80 -73.65 136.66 43.86 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.605 0.24 . . . . 0.0 111.025 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 153' ' ' THR . 6.6 tt -113.56 111.41 21.84 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.978 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.649 ' HA3' HD11 ' A' ' 113' ' ' LEU . . . -131.29 -178.49 15.5 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.864 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.659 ' H ' HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -104.32 137.58 42.0 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.461 0.172 . . . . 0.0 110.857 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.98 114.78 23.89 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.992 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.618 ' O ' ' HG2' ' D' ' 134' ' ' GLN . 1.2 tt -95.7 -36.73 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.867 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.897 ' CB ' HG21 ' A' ' 140' ' ' THR . 0.4 OUTLIER -143.38 130.23 20.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.746 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.92 -7.18 47.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.046 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.33 -29.19 68.39 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.587 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.34 -32.64 4.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.88 0.371 . . . . 0.0 110.459 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.435 ' O ' HG22 ' A' ' 83' ' ' THR . 3.5 m 60.49 19.42 9.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.589 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.631 ' HB3' ' HG2' ' A' ' 102' ' ' GLN . 0.6 OUTLIER -139.37 -16.99 1.03 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.296 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.709 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 0.9 OUTLIER -66.67 118.02 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.244 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.659 HD12 ' H ' ' A' ' 76' ' ' THR . 10.7 tp -69.72 144.17 52.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.264 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.452 ' HB3' ' OG1' ' A' ' 76' ' ' THR . . . -80.2 138.09 36.78 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.917 0.389 . . . . 0.0 111.721 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.686 ' HB3' ' HA ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -84.95 -146.62 0.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.068 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 149' ' ' ASN . 0.0 OUTLIER -48.53 155.02 0.58 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.268 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.566 ' O ' HG22 ' D' ' 52' ' ' VAL . 32.4 p -86.73 -11.92 49.75 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.923 0.392 . . . . 0.0 111.503 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.42 114.08 5.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.589 ' HA ' ' HB3' ' D' ' 50' ' ' SER . . . -83.38 22.19 1.06 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.951 0.405 . . . . 0.0 111.683 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.21 21.97 1.21 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.698 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.64 -32.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.017 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.654 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 15.9 t -65.14 166.73 9.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.866 0.365 . . . . 0.0 110.616 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.465 ' O ' HD13 ' A' ' 88' ' ' LEU . . . -89.65 163.44 15.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.851 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.42 169.66 17.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.34 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 57.4 29.34 16.78 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.383 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.573 ' HB ' ' HB1' ' A' ' 143' ' ' ALA . 7.2 p -156.38 150.6 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.825 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.709 ' HA3' ' HB ' ' A' ' 85' ' ' VAL . . . -164.2 176.93 40.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.609 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.617 HG22 ' CE1' ' A' ' 137' ' ' TYR . 3.0 t -107.63 111.29 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.018 0.527 . . . . 0.0 111.713 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.631 ' HG2' ' HB3' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -75.97 179.75 5.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.958 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.492 HD11 ' HA ' ' A' ' 113' ' ' LEU . 6.0 pt -150.36 116.54 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.457 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 12.9 tp -97.22 122.54 40.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.724 0.297 . . . . 0.0 111.068 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.91 150.08 42.92 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.739 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.506 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -71.43 -17.58 62.38 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.824 0.345 . . . . 0.0 111.121 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.43 HG21 ' HA ' ' A' ' 120' ' ' SER . 76.1 p -76.62 -37.22 56.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.11 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.52 -68.81 0.32 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.732 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.61 123.2 18.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.795 0.331 . . . . 0.0 111.129 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.74 117.99 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.184 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.514 HD11 ' O ' ' A' ' 117' ' ' THR . 2.1 tp -67.87 144.1 55.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.43 0.633 . . . . 0.0 110.491 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.428 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -75.11 140.45 43.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.071 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.649 HD11 ' HA3' ' A' ' 75' ' ' GLY . 1.3 tp -85.18 97.75 10.08 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.701 0.286 . . . . 0.0 110.668 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -152.78 -59.01 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.645 0.26 . . . . 0.0 111.582 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.556 ' HA3' ' OG1' ' D' ' 130' ' ' THR . . . 135.73 -26.63 3.14 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.615 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.731 ' HB2' ' HA ' ' D' ' 129' ' ' ASN . . . -101.27 28.78 5.15 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.994 0.426 . . . . 0.0 111.692 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.514 ' O ' HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -106.58 67.34 0.72 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.075 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.4 81.0 8.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.737 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.04 97.45 3.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.43 ' HA ' HG21 ' A' ' 107' ' ' THR . 2.0 t -165.54 144.79 6.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.587 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.28 50.22 0.9 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.204 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.8 94.18 5.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.715 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.69 110.38 12.47 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.679 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.602 ' HG ' ' ND2' ' A' ' 129' ' ' ASN . 0.3 OUTLIER -70.2 154.15 42.26 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.578 179.42 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.6 144.77 51.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.552 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.74 125.67 24.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.653 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.1 -102.01 1.1 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.725 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 86.9 m -106.23 128.45 53.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.655 0.264 . . . . 0.0 110.831 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.602 ' ND2' ' HG ' ' A' ' 124' ' ' LEU . 20.1 t-20 -121.15 158.13 28.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.874 0.368 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.472 ' CG2' HD22 ' A' ' 55' ' ' ASN . 0.2 OUTLIER -155.81 143.08 19.27 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.996 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.607 HD13 HG11 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -115.22 110.79 45.14 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.506 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.4 Cg_endo -82.21 151.85 15.95 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.618 1.546 . . . . 0.0 112.5 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.01 146.77 17.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.797 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.8 OUTLIER -114.38 145.83 41.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.108 179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.77 91.17 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 111.679 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.57 ' HE ' HG21 ' A' ' 48' ' ' THR . 28.0 mtm-85 -88.34 153.6 21.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.405 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.617 ' CE1' HG22 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -91.29 111.06 22.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.071 179.571 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.608 ' CD1' ' HB2' ' A' ' 102' ' ' GLN . 8.8 m-85 -108.08 172.19 6.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.962 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.574 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -123.42 143.65 50.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.851 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.897 HG21 ' CB ' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -98.73 44.39 1.03 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.565 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.48 89.07 1.07 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.978 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . . . 60.09 88.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.709 0.255 . . . . 0.0 110.689 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.573 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -70.61 161.73 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.405 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 158.73 60.65 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.226 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.76 149.18 12.55 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.54 2.16 . . . . 0.0 112.06 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.72 -119.73 0.86 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.479 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.654 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -123.94 127.71 48.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.861 0.362 . . . . 0.0 111.417 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.686 ' HA ' ' HB3' ' A' ' 88' ' ' LEU . . . -120.85 67.17 0.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.117 0.484 . . . . 0.0 110.389 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 47.5 t-20 -128.47 114.77 17.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.6 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.424 ' HB2' ' C ' ' A' ' 88' ' ' LEU . . . -158.83 146.97 18.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.984 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.39 140.3 32.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.171 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.19 169.28 17.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.176 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 74' ' ' LEU . 9.3 t -155.11 150.52 27.25 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.442 ' HE1' HG13 ' A' ' 56' ' ' ILE . 1.1 p90 -118.97 149.27 41.91 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.121 0.486 . . . . 0.0 110.083 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.436 ' HE3' HD13 ' A' ' 74' ' ' LEU . 4.7 mttt -113.53 156.68 23.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.869 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.607 HG11 HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -136.48 137.98 47.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.684 -179.058 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -107.5 128.03 54.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.318 0.58 . . . . 0.0 110.37 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -107.87 107.43 18.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.542 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.851 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.209 0.052 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' ALA . . . . . 0.727 ' H ' ' HA ' ' C' ' 159' ' ' GLN . . . 65.84 74.75 0.36 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.579 0.228 . . . . 0.0 110.98 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.6 ' OG1' ' HB2' ' C' ' 158' ' ' TYR . 6.2 p -117.74 97.56 5.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.46 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.606 HG22 ' HB2' ' C' ' 157' ' ' GLN . 67.9 p -87.91 108.61 19.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.527 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.51 172.75 13.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.59 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -77.24 110.86 12.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.494 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' GLY . . . . . 0.409 ' H ' ' HA ' ' C' ' 155' ' ' LYS . . . -65.76 -59.42 7.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.765 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.56 151.64 14.79 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.81 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.513 HG23 ' O ' ' C' ' 152' ' ' ALA . 24.2 m -103.44 143.09 33.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 111.357 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.438 HG12 ' HG3' ' C' ' 30' ' ' GLN . 1.2 m -130.98 115.63 30.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.186 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.65 105.71 14.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.349 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' PHE . . . . . 0.45 ' HD2' HD21 ' C' ' 34' ' ' LEU . 52.2 m-85 -83.17 105.47 14.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.783 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.46 145.07 41.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.446 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.74 -179.69 42.57 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.932 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.19 134.27 22.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.94 0.4 . . . . 0.0 110.306 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.635 HG11 ' O ' ' C' ' 144' ' ' THR . 3.3 t -90.9 127.16 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.264 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' B' ' 20' ' ' ALA . 12.1 m -126.25 168.75 18.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.86 0.362 . . . . 0.0 111.037 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.48 81.82 2.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.12 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' C' ' 40' ' ' ALA . . . 53.38 58.15 5.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.997 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.537 ' HB3' HG21 ' B' ' 17' ' ' VAL . . . -108.57 -62.82 1.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.442 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.9 OUTLIER -171.54 -159.86 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.914 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.64 ' HA ' ' HB2' ' C' ' 36' ' ' GLN . . . -156.84 74.07 0.79 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.463 ' N ' HD23 ' B' ' 58' ' ' LEU . 7.4 p -45.44 140.62 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.958 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.553 ' O ' HG23 ' B' ' 28' ' ' VAL . 0.5 OUTLIER -63.43 140.81 58.91 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.642 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.44 -51.15 69.5 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.307 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.08 -18.01 74.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.964 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -88.0 -6.32 58.05 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.827 0.346 . . . . 0.0 110.756 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.553 HG23 ' O ' ' B' ' 24' ' ' ASP . 50.5 t -72.78 -36.31 52.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.359 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.03 110.85 14.03 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.002 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' GLN . . . . . 0.441 ' HG3' HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -123.85 146.01 48.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.021 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.19 113.84 27.68 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.128 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.623 HG11 HG11 ' B' ' 52' ' ' VAL . 3.3 t -105.08 121.91 57.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.105 0.478 . . . . 0.0 110.475 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.84 106.37 17.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.721 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.448 HD21 ' HD2' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -64.69 -44.75 89.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.642 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.58 -156.91 16.0 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.558 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.634 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 3.7 mt-30 -91.1 106.98 18.9 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.629 0.252 . . . . 0.0 110.851 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.578 ' CG1' HD21 ' B' ' 42' ' ' LEU . 4.4 t -92.32 120.59 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.938 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' A' ' 19' ' ' ALA . 4.6 mtm105 -85.67 132.51 34.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.71 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 17' ' ' VAL . 29.4 p -71.54 -23.21 61.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.755 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . . . -68.08 -19.06 64.83 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.996 0.427 . . . . 0.0 110.844 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -90.6 -36.6 14.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.167 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' B' ' 139' ' ' ALA . 0.2 OUTLIER -121.48 70.54 0.94 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.61 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' B' ' 142' ' ' ALA . . . -104.7 28.11 7.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.423 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 0.77 ' HG3' ' HB2' ' B' ' 47' ' ' ALA . 0.0 OUTLIER -150.53 141.99 23.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.45 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' B' ' 140' ' ' THR . 2.7 tt0 -62.66 101.8 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.769 0.319 . . . . 0.0 111.104 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.26 4.26 8.44 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.099 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.77 ' HB2' ' HG3' ' B' ' 44' ' ' GLN . . . -91.74 121.32 33.27 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.982 0.42 . . . . 0.0 112.015 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' B' ' 137' ' ' TYR . 5.8 t -110.41 151.22 27.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.786 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -95.69 -57.67 2.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.596 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.23 -174.85 4.69 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.76 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.48 ' HB2' ' CD ' ' B' ' 136' ' ' ARG . . . -127.05 143.86 51.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.315 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.623 HG11 HG11 ' B' ' 32' ' ' VAL . 48.3 t -120.9 116.91 51.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.959 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.25 122.67 6.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.66 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -128.62 138.86 52.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.784 0.326 . . . . 0.0 111.0 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' B' ' 132' ' ' PRO . 1.0 OUTLIER -117.85 150.93 38.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.677 179.81 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.59 ' HB ' HG13 ' B' ' 131' ' ' ILE . 9.3 mm -106.77 103.66 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.607 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -61.15 132.27 53.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.798 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.762 ' HB3' ' SG ' ' B' ' 21' ' ' CYS . 1.0 OUTLIER -137.39 151.86 49.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.208 -179.677 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -138.38 171.34 14.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.972 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' B' ' 21' ' ' CYS . 5.9 m-20 49.98 68.48 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 0.0 OUTLIER -106.63 141.08 38.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.8 117.88 33.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.231 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.3 p -91.26 -13.02 33.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.69 -38.89 82.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.114 0.483 . . . . 0.0 111.79 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 76.4 t -107.75 -54.07 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.618 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.66 84.39 3.38 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.583 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -41.25 10.05 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.949 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.6 159.96 17.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.529 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.68 160.45 39.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.609 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.09 152.91 45.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.97 136.54 53.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.688 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.02 107.53 5.06 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.556 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.476 ' CD2' HD13 ' B' ' 103' ' ' ILE . 43.2 t80 -73.75 136.69 43.68 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.562 0.22 . . . . 0.0 111.02 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.457 ' HB3' ' O ' ' B' ' 153' ' ' THR . 6.6 tt -113.55 111.44 21.9 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.98 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' GLY . . . . . 0.628 ' HA3' HD11 ' B' ' 113' ' ' LEU . . . -131.38 -178.6 15.56 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.841 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.654 ' H ' HD12 ' B' ' 86' ' ' LEU . 0.2 OUTLIER -104.28 137.61 41.94 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.478 0.18 . . . . 0.0 110.844 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.98 114.77 23.87 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.895 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.614 ' O ' ' HG2' ' E' ' 134' ' ' GLN . 1.2 tt -95.76 -36.75 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.782 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.889 ' CB ' HG21 ' B' ' 140' ' ' THR . 0.4 OUTLIER -143.33 130.22 20.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.93 -7.26 47.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.21 -29.31 68.33 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.665 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.26 -32.67 4.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.945 0.402 . . . . 0.0 110.502 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' THR . . . . . 0.424 ' O ' HG22 ' B' ' 83' ' ' THR . 3.5 m 60.52 19.39 9.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.633 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ASN . . . . . 0.642 ' HB3' ' HG2' ' B' ' 102' ' ' GLN . 0.6 OUTLIER -139.35 -17.03 1.03 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.312 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.696 ' HB ' ' HA3' ' B' ' 100' ' ' GLY . 0.9 OUTLIER -66.65 118.08 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.2 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.654 HD12 ' H ' ' B' ' 76' ' ' THR . 10.7 tp -69.75 144.13 52.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.374 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.447 ' HB3' ' CB ' ' B' ' 76' ' ' THR . . . -80.05 137.98 36.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.868 0.366 . . . . 0.0 111.773 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.69 ' HB3' ' HA ' ' B' ' 148' ' ' ALA . 0.0 OUTLIER -84.99 -146.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.11 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 89' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' B' ' 149' ' ' ASN . 0.0 OUTLIER -48.59 155.09 0.58 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.256 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 90' ' ' SER . . . . . 0.576 ' O ' HG22 ' E' ' 52' ' ' VAL . 32.5 p -86.79 -11.91 49.58 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.971 0.415 . . . . 0.0 111.496 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.41 114.13 5.19 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.952 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.601 ' HA ' ' HB3' ' E' ' 50' ' ' SER . . . -83.45 22.24 1.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.907 0.384 . . . . 0.0 111.653 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.26 21.98 1.2 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.679 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.65 -32.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.024 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' SER . . . . . 0.663 ' HA ' ' HB3' ' B' ' 147' ' ' ALA . 15.9 t -65.08 166.68 9.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.791 0.329 . . . . 0.0 110.666 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 96' ' ' ALA . . . . . 0.465 ' O ' HD13 ' B' ' 88' ' ' LEU . . . -89.64 163.46 15.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.875 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.4 169.65 17.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.322 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 57.36 29.36 16.76 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.349 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' VAL . . . . . 0.575 ' HB ' ' HB1' ' B' ' 143' ' ' ALA . 7.2 p -156.42 150.54 10.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.794 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 100' ' ' GLY . . . . . 0.696 ' HA3' ' HB ' ' B' ' 85' ' ' VAL . . . -164.17 176.95 40.07 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.541 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.608 HG22 ' CE1' ' B' ' 137' ' ' TYR . 3.0 t -107.63 111.32 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 123.038 0.535 . . . . 0.0 111.666 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.642 ' HG2' ' HB3' ' B' ' 84' ' ' ASN . 0.0 OUTLIER -75.99 179.75 5.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.955 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' B' ' 113' ' ' LEU . 6.0 pt -150.34 116.59 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.474 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' B' ' 134' ' ' GLN . 12.8 tp -97.31 122.61 40.54 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.765 0.317 . . . . 0.0 110.967 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.88 150.13 42.68 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.639 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' ARG . . . . . 0.512 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -71.5 -17.55 62.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.763 0.316 . . . . 0.0 111.098 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.436 HG21 ' HA ' ' B' ' 120' ' ' SER . 75.8 p -76.64 -37.29 56.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.081 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.55 -68.72 0.32 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.689 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.67 123.26 18.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.831 0.348 . . . . 0.0 111.1 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.77 117.98 2.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.18 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.515 HD11 ' O ' ' B' ' 117' ' ' THR . 2.1 tp -67.82 144.1 55.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.417 0.627 . . . . 0.0 110.494 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.427 ' HA ' ' ND2' ' B' ' 84' ' ' ASN . 0.2 OUTLIER -75.14 140.51 43.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.079 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.628 HD11 ' HA3' ' B' ' 75' ' ' GLY . 1.3 tp -85.2 97.75 10.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.693 0.282 . . . . 0.0 110.619 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -152.83 -58.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.584 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 115' ' ' GLY . . . . . 0.555 ' HA3' ' OG1' ' E' ' 130' ' ' THR . . . 135.73 -26.58 3.15 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.632 -0.795 . . . . 0.0 112.67 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' ALA . . . . . 0.751 ' HB2' ' HA ' ' E' ' 129' ' ' ASN . . . -101.35 28.81 5.16 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.998 0.427 . . . . 0.0 111.641 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' THR . . . . . 0.515 ' O ' HD11 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -106.57 67.28 0.72 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.059 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.42 81.02 8.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.803 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.06 97.47 3.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.794 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.436 ' HA ' HG21 ' B' ' 107' ' ' THR . 1.9 t -165.61 144.79 6.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.546 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.34 50.36 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.139 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.79 94.18 5.73 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.676 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.73 110.31 12.46 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.723 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.604 ' HG ' ' ND2' ' B' ' 129' ' ' ASN . 0.3 OUTLIER -70.13 154.09 42.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.657 179.414 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -131.51 144.76 51.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.629 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.71 125.64 24.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.688 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.09 -102.06 1.11 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.734 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 86.9 m -106.16 128.48 53.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.633 0.254 . . . . 0.0 110.859 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ASN . . . . . 0.604 ' ND2' ' HG ' ' B' ' 124' ' ' LEU . 20.1 t-20 -121.14 158.18 28.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.896 0.379 . . . . 0.0 111.126 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.82 143.08 19.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.982 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' ILE . . . . . 0.598 HD13 HG11 ' B' ' 156' ' ' VAL . 0.1 OUTLIER -115.16 110.64 45.43 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 132' ' ' PRO . . . . . 0.512 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -82.14 151.83 16.1 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.609 1.539 . . . . 0.0 112.553 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.01 146.76 17.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.852 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 134' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' B' ' 104' ' ' LEU . 0.8 OUTLIER -114.28 145.9 41.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.088 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.89 91.13 1.9 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.913 0.387 . . . . 0.0 111.686 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' ARG . . . . . 0.566 ' HE ' HG21 ' B' ' 48' ' ' THR . 28.1 mtm-85 -88.33 153.59 21.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.374 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 137' ' ' TYR . . . . . 0.608 ' CE1' HG22 ' B' ' 101' ' ' VAL . 0.7 OUTLIER -91.24 111.01 22.31 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.129 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 138' ' ' PHE . . . . . 0.608 ' CD1' ' HB2' ' B' ' 102' ' ' GLN . 8.8 m-85 -108.08 172.17 6.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.029 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -123.43 143.68 49.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.862 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 140' ' ' THR . . . . . 0.889 HG21 ' CB ' ' B' ' 79' ' ' ASP . 0.2 OUTLIER -98.81 44.36 1.03 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.47 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.57 89.08 1.08 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.929 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 142' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' B' ' 43' ' ' ALA . . . 59.94 88.1 0.08 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.745 0.272 . . . . 0.0 110.777 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 143' ' ' ALA . . . . . 0.575 ' HB1' ' HB ' ' B' ' 99' ' ' VAL . . . -70.63 161.7 30.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.815 0.34 . . . . 0.0 111.379 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.635 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -124.48 158.73 60.64 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.213 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 145' ' ' PRO . . . . . 0.511 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 1.4 Cg_endo -83.81 149.22 12.49 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.502 2.135 . . . . 0.0 112.057 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.69 -119.78 0.86 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.483 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.663 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -123.95 127.67 48.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.874 0.369 . . . . 0.0 111.413 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 148' ' ' ALA . . . . . 0.69 ' HA ' ' HB3' ' B' ' 88' ' ' LEU . . . -120.8 67.16 0.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.428 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' B' ' 89' ' ' GLN . 47.5 t-20 -128.45 114.75 17.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.637 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.429 ' HB2' ' C ' ' B' ' 88' ' ' LEU . . . -158.77 147.05 18.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.034 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.45 140.3 32.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.121 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 152' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 9' ' ' THR . . . -136.19 169.31 17.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.208 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.457 ' O ' ' HB3' ' B' ' 74' ' ' LEU . 9.4 t -155.13 150.49 27.19 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 154' ' ' PHE . . . . . 0.439 ' HE1' HG13 ' B' ' 56' ' ' ILE . 1.1 p90 -119.03 149.21 42.05 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.024 0.44 . . . . 0.0 110.107 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 155' ' ' LYS . . . . . 0.447 ' HE3' HD13 ' B' ' 74' ' ' LEU . 4.7 mttt -113.42 156.56 23.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.914 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 156' ' ' VAL . . . . . 0.598 HG11 HD13 ' B' ' 131' ' ' ILE . 0.2 OUTLIER -136.43 138.02 47.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.699 -179.116 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.607 ' HB2' HG22 ' A' ' 4' ' ' THR . 64.1 tt0 -107.46 128.02 54.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.285 0.564 . . . . 0.0 110.369 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 158' ' ' TYR . . . . . 0.589 ' HB2' ' OG1' ' A' ' 3' ' ' THR . 60.9 m-85 -107.81 107.37 18.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.519 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.891 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.272 0.082 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 2' ' ' ALA . . . . . 0.71 ' H ' ' HA ' ' D' ' 159' ' ' GLN . . . 65.93 74.7 0.36 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.529 0.204 . . . . 0.0 110.929 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' D' ' 158' ' ' TYR . 6.0 p -117.74 97.5 5.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.479 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 4' ' ' THR . . . . . 0.629 HG22 ' HB2' ' D' ' 157' ' ' GLN . 67.8 p -87.92 108.74 19.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.529 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.61 172.71 13.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.571 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.15 110.76 12.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.567 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.73 -59.37 7.71 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.792 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.5 151.71 15.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.827 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 9' ' ' THR . . . . . 0.5 HG23 ' O ' ' D' ' 152' ' ' ALA . 24.1 m -103.48 143.11 33.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.855 0.36 . . . . 0.0 111.313 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.44 HG12 ' HG3' ' D' ' 30' ' ' GLN . 1.1 m -130.97 115.65 30.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.134 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -83.62 105.72 14.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.367 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' PHE . . . . . 0.456 ' HD2' HD21 ' D' ' 34' ' ' LEU . 52.2 m-85 -83.19 105.46 14.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.756 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.39 145.06 41.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.422 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.71 -179.68 42.56 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.974 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.23 134.27 22.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.971 0.415 . . . . 0.0 110.358 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.634 HG11 ' O ' ' D' ' 144' ' ' THR . 3.3 t -90.92 127.11 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.238 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' C' ' 20' ' ' ALA . 12.1 m -126.23 168.82 18.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.831 0.348 . . . . 0.0 111.022 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.53 81.88 2.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.046 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' ALA . . . . . 0.445 ' HA ' ' HG2' ' D' ' 38' ' ' ARG . . . 53.27 58.24 5.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.015 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 20' ' ' ALA . . . . . 0.525 ' HB3' HG21 ' C' ' 17' ' ' VAL . . . -108.61 -62.8 1.41 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.385 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 21' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.9 OUTLIER -171.57 -159.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.957 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 22' ' ' ALA . . . . . 0.625 ' HA ' ' HB2' ' D' ' 36' ' ' GLN . . . -156.88 74.0 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.059 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 23' ' ' VAL . . . . . 0.47 ' N ' HD23 ' C' ' 58' ' ' LEU . 7.4 p -45.3 140.56 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.061 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.554 ' O ' HG23 ' C' ' 28' ' ' VAL . 0.5 OUTLIER -63.45 140.79 58.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.615 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.43 -51.16 69.43 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.287 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.03 -18.04 74.23 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.966 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -88.0 -6.27 58.07 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.807 0.337 . . . . 0.0 110.794 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.554 HG23 ' O ' ' C' ' 24' ' ' ASP . 50.7 t -72.74 -36.43 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.332 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.94 110.92 14.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.95 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 30' ' ' GLN . . . . . 0.438 ' HG3' HG12 ' B' ' 10' ' ' VAL . 0.4 OUTLIER -123.86 146.05 48.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.987 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.18 113.84 27.68 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.113 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.625 HG11 HG11 ' C' ' 52' ' ' VAL . 3.3 t -105.13 121.92 57.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 110.404 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.85 106.42 17.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.641 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.45 HD21 ' HD2' ' B' ' 12' ' ' PHE . 0.6 OUTLIER -64.79 -44.73 89.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.555 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.61 -156.8 16.03 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.6 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' GLN . . . . . 0.64 ' HB2' ' HA ' ' B' ' 22' ' ' ALA . 3.7 mt-30 -91.09 106.93 18.86 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.663 0.268 . . . . 0.0 110.922 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.578 ' CG1' HD21 ' C' ' 42' ' ' LEU . 4.3 t -92.28 120.51 41.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.94 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 38' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' B' ' 19' ' ' ALA . 4.6 mtm105 -85.59 132.49 34.17 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.759 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.436 HG23 ' O ' ' B' ' 17' ' ' VAL . 29.1 p -71.48 -23.34 61.79 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.768 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' B' ' 19' ' ' ALA . . . -67.93 -19.2 64.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.935 0.397 . . . . 0.0 110.817 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 13.8 t -90.61 -36.56 14.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.159 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.591 ' HB2' ' HB2' ' C' ' 139' ' ' ALA . 0.2 OUTLIER -121.45 70.55 0.94 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.623 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 43' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' C' ' 142' ' ' ALA . . . -104.79 28.16 7.37 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.379 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' GLN . . . . . 0.752 ' HG3' ' HB2' ' C' ' 47' ' ' ALA . 0.0 OUTLIER -150.62 141.93 23.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.402 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 45' ' ' GLU . . . . . 0.449 ' HG3' ' HA ' ' C' ' 140' ' ' THR . 2.7 tt0 -62.62 101.78 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.764 0.316 . . . . 0.0 111.133 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.24 4.25 8.46 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.094 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.752 ' HB2' ' HG3' ' C' ' 44' ' ' GLN . . . -91.73 121.33 33.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.942 0.401 . . . . 0.0 112.016 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 48' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' C' ' 137' ' ' TYR . 5.8 t -110.41 151.16 27.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.815 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -95.66 -57.68 2.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.544 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.2 -174.88 4.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.87 0.367 . . . . 0.0 110.8 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 51' ' ' ALA . . . . . 0.475 ' HB2' ' CD ' ' C' ' 136' ' ' ARG . . . -127.06 143.82 51.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.395 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.625 HG11 HG11 ' C' ' 32' ' ' VAL . 48.3 t -120.85 116.85 51.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.006 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.16 122.61 6.19 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.685 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -128.58 138.82 52.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 111.022 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.503 ' ND2' ' HA ' ' C' ' 132' ' ' PRO . 1.0 OUTLIER -117.8 150.98 38.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.621 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.589 ' HB ' HG13 ' C' ' 131' ' ' ILE . 9.2 mm -106.83 103.64 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.617 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -61.07 132.25 53.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.751 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' LEU . . . . . 0.763 ' HB3' ' SG ' ' C' ' 21' ' ' CYS . 1.0 OUTLIER -137.44 151.81 48.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.244 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -138.35 171.39 14.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.962 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' C' ' 21' ' ' CYS . 5.9 m-20 49.97 68.51 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.791 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 61' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 0.0 OUTLIER -106.62 141.07 38.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.794 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.79 117.83 33.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.254 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 23.5 p -91.13 -13.1 33.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.58 -39.02 82.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.14 0.495 . . . . 0.0 111.76 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 75.8 t -107.63 -54.15 6.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.627 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.7 84.38 3.37 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.596 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.02 -41.27 10.08 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.911 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.69 159.98 17.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.459 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.71 160.38 39.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.612 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.01 153.01 44.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.18 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.95 136.46 54.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.73 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.95 107.4 5.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.618 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 73' ' ' PHE . . . . . 0.468 ' CD2' HD13 ' C' ' 103' ' ' ILE . 43.0 t80 -73.57 136.68 44.02 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.502 0.191 . . . . 0.0 111.082 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' C' ' 153' ' ' THR . 6.6 tt -113.6 111.4 21.81 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.003 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 75' ' ' GLY . . . . . 0.64 ' HA3' HD11 ' C' ' 113' ' ' LEU . . . -131.35 -178.54 15.53 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.765 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.665 ' H ' HD12 ' C' ' 86' ' ' LEU . 0.2 OUTLIER -104.28 137.55 42.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.5 0.191 . . . . 0.0 110.878 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.93 114.81 23.88 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.997 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 78' ' ' ILE . . . . . 0.613 ' O ' ' HG2' ' F' ' 134' ' ' GLN . 1.2 tt -95.75 -36.72 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 79' ' ' ASP . . . . . 0.902 ' CB ' HG21 ' C' ' 140' ' ' THR . 0.4 OUTLIER -143.39 130.28 20.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.722 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.95 -7.2 47.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.97 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.3 -29.18 68.28 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.637 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.31 -32.73 4.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.903 0.382 . . . . 0.0 110.432 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 83' ' ' THR . . . . . 0.421 ' O ' HG22 ' C' ' 83' ' ' THR . 3.5 m 60.59 19.41 9.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.574 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 84' ' ' ASN . . . . . 0.638 ' HB3' ' HG2' ' C' ' 102' ' ' GLN . 0.6 OUTLIER -139.39 -16.94 1.03 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.314 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.691 ' HB ' ' HA3' ' C' ' 100' ' ' GLY . 0.8 OUTLIER -66.71 118.08 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.172 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.665 HD12 ' H ' ' C' ' 76' ' ' THR . 10.7 tp -69.79 144.14 52.75 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.27 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.455 ' HB3' ' OG1' ' C' ' 76' ' ' THR . . . -80.07 138.0 36.89 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.777 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.691 ' HB3' ' HA ' ' C' ' 148' ' ' ALA . 0.0 OUTLIER -84.99 -146.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.068 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 89' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' C' ' 149' ' ' ASN . 0.0 OUTLIER -48.48 155.02 0.57 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.312 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 90' ' ' SER . . . . . 0.577 ' O ' HG22 ' F' ' 52' ' ' VAL . 33.1 p -86.79 -11.87 49.7 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.991 0.424 . . . . 0.0 111.489 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.42 114.08 5.16 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 92' ' ' ALA . . . . . 0.597 ' HA ' ' HB3' ' F' ' 50' ' ' SER . . . -83.38 22.25 1.05 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.919 0.39 . . . . 0.0 111.728 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.28 21.98 1.2 Allowed 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.699 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.75 -32.23 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.974 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 95' ' ' SER . . . . . 0.661 ' HA ' ' HB3' ' C' ' 147' ' ' ALA . 16.0 t -65.15 166.71 9.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.805 0.336 . . . . 0.0 110.682 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 96' ' ' ALA . . . . . 0.452 ' O ' HD13 ' C' ' 88' ' ' LEU . . . -89.64 163.46 15.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.892 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.37 169.63 17.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.347 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 57.35 29.36 16.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.378 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 99' ' ' VAL . . . . . 0.564 ' HB ' ' HB1' ' C' ' 143' ' ' ALA . 7.2 p -156.35 150.57 10.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.839 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 100' ' ' GLY . . . . . 0.691 ' HA3' ' HB ' ' C' ' 85' ' ' VAL . . . -164.19 176.93 40.08 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.584 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 101' ' ' VAL . . . . . 0.615 HG22 ' CE1' ' C' ' 137' ' ' TYR . 3.0 t -107.6 111.29 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.06 0.544 . . . . 0.0 111.74 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 102' ' ' GLN . . . . . 0.638 ' HG2' ' HB3' ' C' ' 84' ' ' ASN . 0.0 OUTLIER -75.98 179.73 5.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.979 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' C' ' 113' ' ' LEU . 6.0 pt -150.35 116.62 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.418 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 104' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' C' ' 134' ' ' GLN . 12.8 tp -97.23 122.55 40.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.676 0.274 . . . . 0.0 111.015 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.96 150.07 43.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.718 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 106' ' ' ARG . . . . . 0.529 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -71.47 -17.56 62.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.793 0.33 . . . . 0.0 111.087 179.559 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 107' ' ' THR . . . . . 0.44 HG21 ' HA ' ' C' ' 120' ' ' SER . 74.3 p -76.52 -37.29 56.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.152 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.55 -68.74 0.32 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.705 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.69 123.27 18.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.811 0.339 . . . . 0.0 111.14 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.66 117.98 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 111' ' ' LEU . . . . . 0.522 HD11 ' O ' ' C' ' 117' ' ' THR . 2.1 tp -67.83 144.06 55.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.473 0.654 . . . . 0.0 110.502 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 112' ' ' THR . . . . . 0.435 ' HA ' ' ND2' ' C' ' 84' ' ' ASN . 0.2 OUTLIER -75.08 140.43 43.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.127 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.64 HD11 ' HA3' ' C' ' 75' ' ' GLY . 1.3 tp -85.18 97.75 10.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 110.62 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -152.79 -59.03 0.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.68 0.276 . . . . 0.0 111.555 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 115' ' ' GLY . . . . . 0.57 ' HA3' ' OG1' ' F' ' 130' ' ' THR . . . 135.77 -26.63 3.14 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.577 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 116' ' ' ALA . . . . . 0.748 ' HB2' ' HA ' ' F' ' 129' ' ' ASN . . . -101.36 28.78 5.19 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.055 0.455 . . . . 0.0 111.656 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 117' ' ' THR . . . . . 0.522 ' O ' HD11 ' C' ' 111' ' ' LEU . 0.2 OUTLIER -106.56 67.31 0.72 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.05 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.38 80.96 8.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.77 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.96 97.46 3.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 120' ' ' SER . . . . . 0.44 ' HA ' HG21 ' C' ' 107' ' ' THR . 2.0 t -165.59 144.83 6.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.6 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.34 50.4 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.144 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.88 94.11 5.78 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.685 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.73 110.4 12.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.729 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 124' ' ' LEU . . . . . 0.607 ' HG ' ' ND2' ' C' ' 129' ' ' ASN . 0.3 OUTLIER -70.13 154.13 42.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.65 179.396 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -131.58 144.73 51.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.623 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.77 125.66 24.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.663 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.1 -102.02 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.715 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 86.4 m -106.23 128.55 54.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.652 0.263 . . . . 0.0 110.786 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 129' ' ' ASN . . . . . 0.607 ' ND2' ' HG ' ' C' ' 124' ' ' LEU . 20.1 t-20 -121.19 158.14 28.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.902 0.382 . . . . 0.0 111.116 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.79 143.09 19.3 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.986 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 131' ' ' ILE . . . . . 0.601 HD13 HG11 ' C' ' 156' ' ' VAL . 0.1 OUTLIER -115.22 110.73 45.2 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 132' ' ' PRO . . . . . 0.529 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.5 Cg_endo -82.1 151.77 16.18 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.632 1.554 . . . . 0.0 112.573 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.02 146.79 17.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 134' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' C' ' 104' ' ' LEU . 0.8 OUTLIER -114.4 145.8 41.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.088 179.428 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.76 91.22 1.92 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 111.674 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.58 ' HE ' HG21 ' C' ' 48' ' ' THR . 28.0 mtm-85 -88.33 153.55 21.11 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.345 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 137' ' ' TYR . . . . . 0.615 ' CE1' HG22 ' C' ' 101' ' ' VAL . 0.7 OUTLIER -91.22 111.04 22.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.103 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 138' ' ' PHE . . . . . 0.596 ' CD1' ' HB2' ' C' ' 102' ' ' GLN . 8.8 m-85 -108.13 172.21 6.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.939 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 139' ' ' ALA . . . . . 0.591 ' HB2' ' HB2' ' C' ' 42' ' ' LEU . . . -123.45 143.6 50.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.87 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 140' ' ' THR . . . . . 0.902 HG21 ' CB ' ' C' ' 79' ' ' ASP . 0.2 OUTLIER -98.71 44.47 1.03 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.529 179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.5 89.06 1.07 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.936 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 142' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' C' ' 43' ' ' ALA . . . 60.02 88.09 0.08 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.7 0.25 . . . . 0.0 110.693 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 143' ' ' ALA . . . . . 0.564 ' HB1' ' HB ' ' C' ' 99' ' ' VAL . . . -70.64 161.75 30.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.775 0.321 . . . . 0.0 111.444 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 144' ' ' THR . . . . . 0.635 ' O ' HG11 ' B' ' 16' ' ' VAL . 0.2 OUTLIER -124.49 158.71 60.73 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.191 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 145' ' ' PRO . . . . . 0.53 ' HA ' ' HB ' ' B' ' 16' ' ' VAL . 1.5 Cg_endo -83.72 149.25 12.63 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.501 2.134 . . . . 0.0 112.072 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.7 -119.76 0.86 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.52 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 147' ' ' ALA . . . . . 0.661 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -123.91 127.71 48.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.828 0.346 . . . . 0.0 111.418 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 148' ' ' ALA . . . . . 0.691 ' HA ' ' HB3' ' C' ' 88' ' ' LEU . . . -120.83 67.19 0.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.41 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 149' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' C' ' 89' ' ' GLN . 47.3 t-20 -128.49 114.78 17.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.599 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 150' ' ' ALA . . . . . 0.425 ' HB2' ' C ' ' C' ' 88' ' ' LEU . . . -158.87 146.93 18.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.0 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.33 140.31 32.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.148 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 152' ' ' ALA . . . . . 0.513 ' O ' HG23 ' B' ' 9' ' ' THR . . . -136.26 169.23 17.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.18 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 153' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' C' ' 74' ' ' LEU . 9.3 t -155.09 150.54 27.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 154' ' ' PHE . . . . . 0.427 ' HE1' HG13 ' C' ' 56' ' ' ILE . 1.1 p90 -119.05 149.21 42.05 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.077 0.465 . . . . 0.0 110.075 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 155' ' ' LYS . . . . . 0.42 ' HE3' HD13 ' C' ' 74' ' ' LEU . 4.7 mttt -113.48 156.64 23.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.908 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 156' ' ' VAL . . . . . 0.601 HG11 HD13 ' C' ' 131' ' ' ILE . 0.2 OUTLIER -136.45 138.03 47.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.663 -179.061 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 157' ' ' GLN . . . . . 0.606 ' HB2' HG22 ' B' ' 4' ' ' THR . 64.1 tt0 -107.5 128.05 54.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.363 0.601 . . . . 0.0 110.365 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 158' ' ' TYR . . . . . 0.6 ' HB2' ' OG1' ' B' ' 3' ' ' THR . 60.9 m-85 -107.85 107.46 18.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.541 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 159' ' ' GLN . . . . . 0.727 ' HA ' ' H ' ' B' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.884 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.312 0.101 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 2' ' ' ALA . . . . . 0.714 ' H ' ' HA ' ' E' ' 159' ' ' GLN . . . 65.87 74.72 0.36 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.937 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 3' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' E' ' 158' ' ' TYR . 6.2 p -117.71 97.48 5.88 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.489 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 4' ' ' THR . . . . . 0.62 HG22 ' HB2' ' E' ' 157' ' ' GLN . 68.1 p -87.87 108.72 19.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.559 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.401 HG11 HG12 ' E' ' 17' ' ' VAL . 15.3 m -126.63 172.74 13.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.612 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.13 110.81 12.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.566 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 7' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' E' ' 155' ' ' LYS . . . -65.67 -59.51 7.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.747 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.52 151.68 14.92 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.809 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 9' ' ' THR . . . . . 0.507 HG23 ' O ' ' E' ' 152' ' ' ALA . 24.2 m -103.45 143.08 33.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 111.319 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 10' ' ' VAL . . . . . 0.426 HG12 ' HG3' ' E' ' 30' ' ' GLN . 1.1 m -130.93 115.63 30.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.182 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.63 105.67 14.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.392 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 12' ' ' PHE . . . . . 0.445 ' HD2' HD21 ' E' ' 34' ' ' LEU . 52.0 m-85 -83.21 105.47 14.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.8 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.41 145.13 41.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.452 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.74 -179.67 42.58 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.98 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.26 134.2 22.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.937 0.399 . . . . 0.0 110.406 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.625 HG11 ' O ' ' E' ' 144' ' ' THR . 3.3 t -90.9 127.2 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.174 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' D' ' 20' ' ' ALA . 12.1 m -126.31 168.78 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.929 0.395 . . . . 0.0 111.025 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.49 81.85 2.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.092 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 19' ' ' ALA . . . . . 0.447 ' HA ' ' HG2' ' E' ' 38' ' ' ARG . . . 53.31 58.19 5.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.057 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.543 ' HB3' HG21 ' D' ' 17' ' ' VAL . . . -108.6 -62.83 1.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.36 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 21' ' ' CYS . . . . . 0.872 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.9 OUTLIER -171.53 -159.88 0.16 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 22' ' ' ALA . . . . . 0.635 ' HA ' ' HB2' ' E' ' 36' ' ' GLN . . . -156.86 74.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.098 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 23' ' ' VAL . . . . . 0.465 ' N ' HD23 ' D' ' 58' ' ' LEU . 7.4 p -45.36 140.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.081 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.555 ' O ' HG23 ' D' ' 28' ' ' VAL . 0.5 OUTLIER -63.49 140.79 58.91 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.656 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.4 -51.14 69.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.302 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.11 -17.98 74.33 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.937 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.96 -6.42 58.03 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.859 0.362 . . . . 0.0 110.818 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' VAL . . . . . 0.555 HG23 ' O ' ' D' ' 24' ' ' ASP . 50.5 t -72.7 -36.36 52.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.364 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.0 110.88 14.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.008 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 30' ' ' GLN . . . . . 0.44 ' HG3' HG12 ' C' ' 10' ' ' VAL . 0.4 OUTLIER -123.76 146.07 48.57 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.977 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.25 113.83 27.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.084 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.612 HG11 HG11 ' D' ' 52' ' ' VAL . 3.3 t -105.15 121.91 57.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.149 0.499 . . . . 0.0 110.433 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.84 106.37 17.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.669 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.456 HD21 ' HD2' ' C' ' 12' ' ' PHE . 0.6 OUTLIER -64.73 -44.74 89.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.595 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.6 -156.91 15.99 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.54 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' GLN . . . . . 0.625 ' HB2' ' HA ' ' C' ' 22' ' ' ALA . 3.7 mt-30 -91.06 106.95 18.88 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.656 0.265 . . . . 0.0 110.899 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.574 ' CG1' HD21 ' D' ' 42' ' ' LEU . 4.4 t -92.29 120.63 41.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.839 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 38' ' ' ARG . . . . . 0.445 ' HG2' ' HA ' ' C' ' 19' ' ' ALA . 4.6 mtm105 -85.68 132.46 34.14 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.742 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.425 HG23 ' O ' ' C' ' 17' ' ' VAL . 29.5 p -71.5 -23.23 61.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.753 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.443 ' CB ' ' HB2' ' C' ' 19' ' ' ALA . . . -68.13 -19.07 64.79 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.974 0.416 . . . . 0.0 110.823 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -90.59 -36.65 14.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.16 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' D' ' 139' ' ' ALA . 0.2 OUTLIER -121.44 70.62 0.94 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.555 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 43' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' D' ' 142' ' ' ALA . . . -104.79 28.18 7.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.392 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 44' ' ' GLN . . . . . 0.77 ' HG3' ' HB2' ' D' ' 47' ' ' ALA . 0.0 OUTLIER -150.59 141.92 23.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.437 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 45' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' D' ' 140' ' ' THR . 2.7 tt0 -62.69 101.78 0.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.819 0.342 . . . . 0.0 111.145 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.29 4.23 8.43 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.115 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.77 ' HB2' ' HG3' ' D' ' 44' ' ' GLN . . . -91.67 121.28 33.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.932 0.396 . . . . 0.0 112.03 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 48' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' D' ' 137' ' ' TYR . 5.9 t -110.42 151.18 27.8 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.826 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 5.1 t -95.62 -57.59 2.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.632 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.589 ' HB3' ' HA ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -148.23 -174.85 4.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.875 0.369 . . . . 0.0 110.756 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 51' ' ' ALA . . . . . 0.482 ' HB2' ' CD ' ' D' ' 136' ' ' ARG . . . -127.11 143.86 51.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.352 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 52' ' ' VAL . . . . . 0.612 HG11 HG11 ' D' ' 32' ' ' VAL . 48.2 t -120.84 116.86 51.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.974 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 53' ' ' GLY . . . . . 0.414 ' O ' HG21 ' A' ' 76' ' ' THR . . . -111.15 122.67 6.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.699 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -128.63 138.84 52.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.812 0.339 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 55' ' ' ASN . . . . . 0.479 HD22 ' CG2' ' D' ' 130' ' ' THR . 1.6 m120 -117.86 150.99 38.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.585 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.575 ' HB ' HG13 ' D' ' 131' ' ' ILE . 9.3 mm -106.86 103.77 15.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.547 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 57' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.11 132.28 53.23 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.788 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 58' ' ' LEU . . . . . 0.752 ' HB3' ' SG ' ' D' ' 21' ' ' CYS . 1.0 OUTLIER -137.49 151.81 48.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.205 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -138.32 171.36 14.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.977 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 60' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' D' ' 21' ' ' CYS . 5.9 m-20 50.0 68.55 0.73 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.743 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 61' ' ' CYS . . . . . 0.872 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 0.0 OUTLIER -106.67 141.11 38.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.792 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.78 117.83 33.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.254 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 23.4 p -91.21 -13.04 33.55 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -38.98 82.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.081 0.467 . . . . 0.0 111.707 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 75.8 t -107.67 -54.11 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.64 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.69 84.32 3.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.576 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.05 -41.23 10.08 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.955 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.57 159.99 17.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.517 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.7 160.4 39.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.586 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.07 152.94 45.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.157 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.9 136.55 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.699 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.04 107.46 5.03 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.565 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 73' ' ' PHE . . . . . 0.474 ' CD2' HD13 ' D' ' 103' ' ' ILE . 42.9 t80 -73.62 136.61 43.92 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.532 0.206 . . . . 0.0 111.06 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 74' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' D' ' 153' ' ' THR . 6.6 tt -113.55 111.39 21.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.006 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 75' ' ' GLY . . . . . 0.628 ' HA3' HD11 ' D' ' 113' ' ' LEU . . . -131.26 -178.5 15.5 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.883 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 76' ' ' THR . . . . . 0.664 ' H ' HD12 ' D' ' 86' ' ' LEU . 0.2 OUTLIER -104.37 137.54 42.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.493 0.187 . . . . 0.0 110.825 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.96 114.74 23.84 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.961 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.74 -36.78 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.842 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.9 ' CB ' HG21 ' D' ' 140' ' ' THR . 0.4 OUTLIER -143.32 130.19 20.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.8 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.83 -7.28 47.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.991 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.37 -29.14 68.38 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.557 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.33 -32.61 4.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.482 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 83' ' ' THR . . . . . 0.428 ' O ' HG22 ' D' ' 83' ' ' THR . 3.5 m 60.47 19.43 9.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.58 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 84' ' ' ASN . . . . . 0.614 ' HB3' ' HG2' ' D' ' 102' ' ' GLN . 0.6 OUTLIER -139.31 -16.94 1.04 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.409 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.699 ' HB ' ' HA3' ' D' ' 100' ' ' GLY . 0.9 OUTLIER -66.77 118.03 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.206 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.664 HD12 ' H ' ' D' ' 76' ' ' THR . 10.7 tp -69.7 144.13 52.91 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.275 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.454 ' HB3' ' OG1' ' D' ' 76' ' ' THR . . . -80.14 138.06 36.84 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.892 0.377 . . . . 0.0 111.71 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.698 ' HB3' ' HA ' ' D' ' 148' ' ' ALA . 0.0 OUTLIER -84.96 -146.62 0.1 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.079 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 89' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' D' ' 149' ' ' ASN . 0.0 OUTLIER -48.48 155.03 0.57 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.293 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 32.4 p -86.77 -11.91 49.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.533 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 8.2 t -66.43 114.15 5.22 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.34 22.09 1.07 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.932 0.396 . . . . 0.0 111.706 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.2 21.97 1.21 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.73 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.7 -32.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.957 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 95' ' ' SER . . . . . 0.659 ' HA ' ' HB3' ' D' ' 147' ' ' ALA . 15.8 t -65.16 166.64 9.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 110.654 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 96' ' ' ALA . . . . . 0.466 ' O ' HD13 ' D' ' 88' ' ' LEU . . . -89.59 163.53 15.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.827 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.45 169.7 17.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.276 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 98' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 57.26 29.42 16.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.38 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 99' ' ' VAL . . . . . 0.553 ' HB ' ' HB1' ' D' ' 143' ' ' ALA . 7.1 p -156.39 150.54 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 100' ' ' GLY . . . . . 0.699 ' HA3' ' HB ' ' D' ' 85' ' ' VAL . . . -164.14 176.95 40.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.587 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 101' ' ' VAL . . . . . 0.614 HG22 ' CE1' ' D' ' 137' ' ' TYR . 3.0 t -107.62 111.32 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 123.078 0.551 . . . . 0.0 111.663 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 102' ' ' GLN . . . . . 0.614 ' HG2' ' HB3' ' D' ' 84' ' ' ASN . 0.0 OUTLIER -76.0 179.72 5.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.942 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 103' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' D' ' 113' ' ' LEU . 6.0 pt -150.33 116.56 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.43 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 104' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' D' ' 134' ' ' GLN . 12.8 tp -97.21 122.55 40.36 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 111.068 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.91 150.11 42.86 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.65 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 106' ' ' ARG . . . . . 0.509 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -71.5 -17.54 62.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.846 0.355 . . . . 0.0 111.102 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 107' ' ' THR . . . . . 0.426 HG21 ' HA ' ' D' ' 120' ' ' SER . 76.1 p -76.62 -37.29 56.62 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.111 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.57 -68.74 0.32 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.677 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.55 123.17 18.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.772 0.32 . . . . 0.0 111.191 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.79 118.0 2.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.939 0.4 . . . . 0.0 111.15 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 111' ' ' LEU . . . . . 0.506 HD11 ' O ' ' D' ' 117' ' ' THR . 2.1 tp -67.88 144.09 55.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.43 0.633 . . . . 0.0 110.46 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 112' ' ' THR . . . . . 0.433 ' HA ' ' ND2' ' D' ' 84' ' ' ASN . 0.2 OUTLIER -75.15 140.46 43.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.095 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 113' ' ' LEU . . . . . 0.628 HD11 ' HA3' ' D' ' 75' ' ' GLY . 1.3 tp -85.15 97.78 10.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.748 0.308 . . . . 0.0 110.596 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -152.83 -59.07 0.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.65 0.262 . . . . 0.0 111.494 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.77 -26.61 3.14 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.552 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.34 28.82 5.15 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.045 0.45 . . . . 0.0 111.676 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 117' ' ' THR . . . . . 0.506 ' O ' HD11 ' D' ' 111' ' ' LEU . 0.2 OUTLIER -106.57 67.38 0.72 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.03 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.43 80.89 8.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.739 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.95 97.55 3.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.881 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 120' ' ' SER . . . . . 0.426 ' HA ' HG21 ' D' ' 107' ' ' THR . 2.0 t -165.66 144.79 6.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.531 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.32 50.34 0.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.204 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.81 94.11 5.73 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.714 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.69 110.26 12.38 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.69 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 124' ' ' LEU . . . . . 0.602 ' HG ' ' ND2' ' D' ' 129' ' ' ASN . 0.3 OUTLIER -70.1 154.1 42.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.558 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.58 144.77 51.32 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.584 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.75 125.63 24.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.645 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.1 -101.99 1.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.701 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 128' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 86.6 m -106.25 128.5 54.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.662 0.267 . . . . 0.0 110.773 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 129' ' ' ASN . . . . . 0.731 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 20.1 t-20 -121.15 158.25 28.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.874 0.368 . . . . 0.0 111.109 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 130' ' ' THR . . . . . 0.556 ' OG1' ' HA3' ' A' ' 115' ' ' GLY . 0.2 OUTLIER -155.87 143.08 19.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.057 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 131' ' ' ILE . . . . . 0.603 HD13 HG11 ' D' ' 156' ' ' VAL . 0.1 OUTLIER -115.28 110.75 45.05 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 132' ' ' PRO . . . . . 0.509 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.4 Cg_endo -82.16 151.83 16.06 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.666 1.577 . . . . 0.0 112.499 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.07 146.72 17.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 134' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 78' ' ' ILE . 0.8 OUTLIER -114.36 145.92 41.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.031 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.85 91.09 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.41 . . . . 0.0 111.735 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 136' ' ' ARG . . . . . 0.565 ' HE ' HG21 ' D' ' 48' ' ' THR . 28.1 mtm-85 -88.32 153.52 21.13 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.443 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 137' ' ' TYR . . . . . 0.614 ' CE1' HG22 ' D' ' 101' ' ' VAL . 0.7 OUTLIER -91.1 110.96 22.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.173 179.502 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 138' ' ' PHE . . . . . 0.607 ' CD1' ' HB2' ' D' ' 102' ' ' GLN . 8.8 m-85 -108.08 172.16 6.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.253 0.549 . . . . 0.0 111.971 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 139' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' D' ' 42' ' ' LEU . . . -123.39 143.64 49.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.89 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 140' ' ' THR . . . . . 0.9 HG21 ' CB ' ' D' ' 79' ' ' ASP . 0.2 OUTLIER -98.78 44.46 1.03 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.514 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.54 88.97 1.08 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.966 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 142' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' D' ' 43' ' ' ALA . . . 60.08 88.04 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.745 0.273 . . . . 0.0 110.73 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 143' ' ' ALA . . . . . 0.553 ' HB1' ' HB ' ' D' ' 99' ' ' VAL . . . -70.59 161.73 30.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.784 0.326 . . . . 0.0 111.479 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 144' ' ' THR . . . . . 0.634 ' O ' HG11 ' C' ' 16' ' ' VAL . 0.2 OUTLIER -124.54 158.77 60.69 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.203 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 145' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' C' ' 16' ' ' VAL . 1.4 Cg_endo -83.83 149.22 12.47 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.491 2.127 . . . . 0.0 111.995 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.71 -119.75 0.86 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.519 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 147' ' ' ALA . . . . . 0.659 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -123.95 127.65 48.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.799 0.333 . . . . 0.0 111.452 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 148' ' ' ALA . . . . . 0.698 ' HA ' ' HB3' ' D' ' 88' ' ' LEU . . . -120.86 67.2 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.124 0.488 . . . . 0.0 110.376 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 149' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' D' ' 89' ' ' GLN . 47.5 t-20 -128.54 114.77 17.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.607 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 150' ' ' ALA . . . . . 0.432 ' HB2' ' C ' ' D' ' 88' ' ' LEU . . . -158.8 147.01 18.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.994 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.4 140.31 32.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.173 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 152' ' ' ALA . . . . . 0.5 ' O ' HG23 ' C' ' 9' ' ' THR . . . -136.2 169.29 17.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.183 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 153' ' ' THR . . . . . 0.467 ' O ' ' HB3' ' D' ' 74' ' ' LEU . 9.3 t -155.15 150.52 27.2 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 154' ' ' PHE . . . . . 0.441 ' HE1' HG13 ' D' ' 56' ' ' ILE . 1.1 p90 -119.06 149.25 41.98 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.066 0.46 . . . . 0.0 110.059 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 155' ' ' LYS . . . . . 0.432 ' HE3' HD13 ' D' ' 74' ' ' LEU . 4.7 mttt -113.48 156.67 23.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.924 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 156' ' ' VAL . . . . . 0.603 HG11 HD13 ' D' ' 131' ' ' ILE . 0.2 OUTLIER -136.49 138.04 47.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.627 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 157' ' ' GLN . . . . . 0.629 ' HB2' HG22 ' C' ' 4' ' ' THR . 64.1 tt0 -107.41 128.01 54.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.27 0.557 . . . . 0.0 110.37 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 158' ' ' TYR . . . . . 0.594 ' HB2' ' OG1' ' C' ' 3' ' ' THR . 61.0 m-85 -107.85 107.45 18.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.49 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 159' ' ' GLN . . . . . 0.71 ' HA ' ' H ' ' C' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 120.281 0.086 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' E' E ' 2' ' ' ALA . . . . . 0.718 ' H ' ' HA ' ' F' ' 159' ' ' GLN . . . 65.96 74.63 0.36 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.978 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 3' ' ' THR . . . . . 0.592 ' OG1' ' HB2' ' F' ' 158' ' ' TYR . 6.1 p -117.74 97.53 5.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.482 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 4' ' ' THR . . . . . 0.61 HG22 ' HB2' ' F' ' 157' ' ' GLN . 68.3 p -87.89 108.67 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.562 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.59 172.75 13.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.627 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.16 110.86 12.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.567 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 7' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' F' ' 155' ' ' LYS . . . -65.85 -59.37 7.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.737 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.59 151.7 14.91 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.804 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 9' ' ' THR . . . . . 0.511 HG23 ' O ' ' F' ' 152' ' ' ALA . 24.2 m -103.46 143.1 33.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.799 0.333 . . . . 0.0 111.316 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 10' ' ' VAL . . . . . 0.427 HG12 ' HG3' ' F' ' 30' ' ' GLN . 1.1 m -130.97 115.67 31.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.171 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.65 105.78 14.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.347 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 12' ' ' PHE . . . . . 0.437 ' HD2' HD21 ' F' ' 34' ' ' LEU . 52.3 m-85 -83.15 105.5 14.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.804 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.45 145.04 41.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.4 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.75 -179.59 42.63 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.942 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.27 134.21 22.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.913 0.387 . . . . 0.0 110.35 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 16' ' ' VAL . . . . . 0.637 HG11 ' O ' ' F' ' 144' ' ' THR . 3.3 t -90.93 127.11 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.232 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 17' ' ' VAL . . . . . 0.533 HG21 ' HB3' ' E' ' 20' ' ' ALA . 11.9 m -126.22 168.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.811 0.339 . . . . 0.0 111.08 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.43 81.78 2.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.133 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 19' ' ' ALA . . . . . 0.436 ' HA ' ' HG2' ' F' ' 38' ' ' ARG . . . 53.35 58.15 5.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.078 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.533 ' HB3' HG21 ' E' ' 17' ' ' VAL . . . -108.58 -62.8 1.41 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.44 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 21' ' ' CYS . . . . . 0.821 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.9 OUTLIER -171.54 -159.87 0.16 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.946 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 22' ' ' ALA . . . . . 0.631 ' HA ' ' HB2' ' F' ' 36' ' ' GLN . . . -156.86 74.05 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 23' ' ' VAL . . . . . 0.466 ' N ' HD23 ' E' ' 58' ' ' LEU . 7.4 p -45.38 140.6 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.06 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 24' ' ' ASP . . . . . 0.539 ' O ' HG23 ' E' ' 28' ' ' VAL . 0.5 OUTLIER -63.45 140.82 58.91 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.614 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.08 69.83 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.288 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.13 -17.97 74.36 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.939 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.99 -6.37 58.03 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.843 0.354 . . . . 0.0 110.757 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 28' ' ' VAL . . . . . 0.539 HG23 ' O ' ' E' ' 24' ' ' ASP . 50.5 t -72.7 -36.34 52.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.365 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.02 110.81 13.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.984 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 30' ' ' GLN . . . . . 0.426 ' HG3' HG12 ' D' ' 10' ' ' VAL . 0.4 OUTLIER -123.79 146.01 48.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.994 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.15 113.77 27.56 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.132 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.621 HG11 HG11 ' E' ' 52' ' ' VAL . 3.3 t -105.03 121.98 57.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.175 0.512 . . . . 0.0 110.398 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.95 106.44 17.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.623 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.445 HD21 ' HD2' ' D' ' 12' ' ' PHE . 0.6 OUTLIER -64.75 -44.73 89.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.643 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.53 -156.86 16.05 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.587 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 36' ' ' GLN . . . . . 0.635 ' HB2' ' HA ' ' D' ' 22' ' ' ALA . 3.7 mt-30 -91.11 106.93 18.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.656 0.265 . . . . 0.0 110.828 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.575 ' CG1' HD21 ' E' ' 42' ' ' LEU . 4.4 t -92.33 120.61 41.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.874 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 38' ' ' ARG . . . . . 0.447 ' HG2' ' HA ' ' D' ' 19' ' ' ALA . 4.5 mtm105 -85.65 132.49 34.15 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.756 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 39' ' ' THR . . . . . 0.433 HG23 ' O ' ' D' ' 17' ' ' VAL . 29.5 p -71.49 -23.37 61.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.733 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' D' ' 19' ' ' ALA . . . -68.0 -19.1 64.89 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.987 0.422 . . . . 0.0 110.842 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -90.61 -36.53 14.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.181 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.581 ' HB2' ' HB2' ' E' ' 139' ' ' ALA . 0.2 OUTLIER -121.47 70.58 0.94 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.621 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 43' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' E' ' 142' ' ' ALA . . . -104.74 28.17 7.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.49 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 44' ' ' GLN . . . . . 0.778 ' HG3' ' HB2' ' E' ' 47' ' ' ALA . 0.0 OUTLIER -150.57 141.95 23.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.469 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 45' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' E' ' 140' ' ' THR . 2.7 tt0 -62.74 101.81 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 111.111 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.33 4.22 8.41 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.121 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 47' ' ' ALA . . . . . 0.778 ' HB2' ' HG3' ' E' ' 44' ' ' GLN . . . -91.78 121.24 33.23 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.008 0.433 . . . . 0.0 111.966 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 48' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' E' ' 137' ' ' TYR . 5.9 t -110.35 151.18 27.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.868 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 5.1 t -95.59 -57.66 2.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.62 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 50' ' ' SER . . . . . 0.601 ' HB3' ' HA ' ' B' ' 92' ' ' ALA . 0.2 OUTLIER -148.31 -174.82 4.69 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.918 0.389 . . . . 0.0 110.739 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 51' ' ' ALA . . . . . 0.476 ' HB2' ' CD ' ' E' ' 136' ' ' ARG . . . -127.09 143.83 51.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.359 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 52' ' ' VAL . . . . . 0.621 HG11 HG11 ' E' ' 32' ' ' VAL . 48.3 t -120.85 116.81 51.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 53' ' ' GLY . . . . . 0.402 ' O ' HG21 ' B' ' 76' ' ' THR . . . -111.18 122.69 6.22 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.653 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -128.63 138.79 52.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 111.001 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 55' ' ' ASN . . . . . 0.474 HD22 ' CG2' ' E' ' 130' ' ' THR . 1.5 m120 -117.82 150.9 38.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.654 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 56' ' ' ILE . . . . . 0.588 ' HB ' HG13 ' E' ' 131' ' ' ILE . 9.2 mm -106.77 103.72 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.549 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 57' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.13 132.26 53.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.774 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 58' ' ' LEU . . . . . 0.761 ' HB3' ' SG ' ' E' ' 21' ' ' CYS . 1.0 OUTLIER -137.47 151.8 48.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.223 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -138.33 171.35 14.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.98 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 60' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' E' ' 21' ' ' CYS . 6.0 m-20 50.01 68.47 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.83 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 61' ' ' CYS . . . . . 0.821 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 0.0 OUTLIER -106.63 141.09 38.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.95 0.405 . . . . 0.0 110.722 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.74 117.79 33.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.288 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 23.4 p -91.11 -13.18 33.55 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.6 -38.85 82.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.071 0.462 . . . . 0.0 111.849 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 76.4 t -107.71 -54.14 6.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.612 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.72 84.3 3.35 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.581 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.98 -41.26 10.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.97 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.65 159.99 17.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.457 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.76 160.38 39.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.582 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.05 152.93 45.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.102 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.9 136.53 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.714 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.0 107.5 5.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.61 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 73' ' ' PHE . . . . . 0.479 ' CD2' HD13 ' E' ' 103' ' ' ILE . 43.2 t80 -73.7 136.72 43.77 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.569 0.224 . . . . 0.0 110.995 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 74' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' E' ' 153' ' ' THR . 6.6 tt -113.61 111.39 21.78 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.947 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 75' ' ' GLY . . . . . 0.632 ' HA3' HD11 ' E' ' 113' ' ' LEU . . . -131.29 -178.55 15.53 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.843 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 76' ' ' THR . . . . . 0.658 ' H ' HD12 ' E' ' 86' ' ' LEU . 0.2 OUTLIER -104.28 137.54 42.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.479 0.18 . . . . 0.0 110.837 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.97 114.81 23.91 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.021 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.77 -36.73 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.825 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 79' ' ' ASP . . . . . 0.889 ' CB ' HG21 ' E' ' 140' ' ' THR . 0.4 OUTLIER -143.36 130.21 20.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.756 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.89 -7.23 47.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.04 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.28 -29.25 68.38 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.606 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.34 -32.62 4.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 110.442 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 83' ' ' THR . . . . . 0.429 ' O ' HG22 ' E' ' 83' ' ' THR . 3.5 m 60.53 19.46 9.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.574 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 84' ' ' ASN . . . . . 0.619 ' HB3' ' HG2' ' E' ' 102' ' ' GLN . 0.6 OUTLIER -139.43 -16.94 1.02 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.323 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.694 ' HB ' ' HA3' ' E' ' 100' ' ' GLY . 0.9 OUTLIER -66.69 117.99 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.243 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 86' ' ' LEU . . . . . 0.658 HD12 ' H ' ' E' ' 76' ' ' THR . 10.6 tp -69.71 144.15 52.89 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.291 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 87' ' ' ALA . . . . . 0.448 ' HB3' ' OG1' ' E' ' 76' ' ' THR . . . -80.1 138.06 36.87 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.892 0.377 . . . . 0.0 111.677 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.7 ' HB3' ' HA ' ' E' ' 148' ' ' ALA . 0.0 OUTLIER -85.0 -146.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.115 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 89' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' E' ' 149' ' ' ASN . 0.0 OUTLIER -48.54 155.04 0.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.807 0.337 . . . . 0.0 111.263 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 31.9 p -86.71 -11.9 49.84 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.549 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.43 114.05 5.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.975 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.35 22.17 1.06 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.007 0.432 . . . . 0.0 111.714 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.28 22.05 1.19 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.729 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.7 -32.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.537 -0.84 . . . . 0.0 113.001 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 95' ' ' SER . . . . . 0.646 ' HA ' ' HB3' ' E' ' 147' ' ' ALA . 15.8 t -65.12 166.7 9.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.652 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 96' ' ' ALA . . . . . 0.461 ' O ' HD13 ' E' ' 88' ' ' LEU . . . -89.67 163.43 15.13 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.35 169.68 17.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.378 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 98' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 57.32 29.37 16.72 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.415 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 99' ' ' VAL . . . . . 0.563 ' HB ' ' HB1' ' E' ' 143' ' ' ALA . 7.1 p -156.46 150.6 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.75 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 100' ' ' GLY . . . . . 0.694 ' HA3' ' HB ' ' E' ' 85' ' ' VAL . . . -164.18 176.85 40.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.583 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 101' ' ' VAL . . . . . 0.606 HG22 ' CE1' ' E' ' 137' ' ' TYR . 3.0 t -107.63 111.36 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.011 0.524 . . . . 0.0 111.709 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 102' ' ' GLN . . . . . 0.619 ' HG2' ' HB3' ' E' ' 84' ' ' ASN . 0.0 OUTLIER -76.02 179.75 5.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.943 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 103' ' ' ILE . . . . . 0.494 HD11 ' HA ' ' E' ' 113' ' ' LEU . 5.9 pt -150.39 116.56 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.387 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 104' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' E' ' 134' ' ' GLN . 12.9 tp -97.21 122.54 40.35 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.714 0.292 . . . . 0.0 111.095 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.91 150.16 42.74 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.724 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 106' ' ' ARG . . . . . 0.504 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -71.48 -17.6 62.35 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.792 0.33 . . . . 0.0 111.076 179.527 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 107' ' ' THR . . . . . 0.432 HG21 ' HA ' ' E' ' 120' ' ' SER . 75.4 p -76.62 -37.23 56.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.129 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.52 -68.76 0.32 Allowed Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.715 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.66 123.23 18.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.83 0.348 . . . . 0.0 111.106 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.7 118.01 2.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 111' ' ' LEU . . . . . 0.509 HD11 ' O ' ' E' ' 117' ' ' THR . 2.1 tp -67.91 144.12 55.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.39 0.614 . . . . 0.0 110.528 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 112' ' ' THR . . . . . 0.429 ' HA ' ' ND2' ' E' ' 84' ' ' ASN . 0.2 OUTLIER -75.13 140.48 43.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.133 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 113' ' ' LEU . . . . . 0.632 HD11 ' HA3' ' E' ' 75' ' ' GLY . 1.3 tp -85.25 97.79 10.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.732 0.301 . . . . 0.0 110.606 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -152.81 -58.94 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.579 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.75 -26.62 3.14 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.583 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.42 28.85 5.16 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.007 0.432 . . . . 0.0 111.626 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 117' ' ' THR . . . . . 0.509 ' O ' HD11 ' E' ' 111' ' ' LEU . 0.2 OUTLIER -106.59 67.31 0.72 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.087 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -82.44 81.07 8.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.709 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.13 97.47 3.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.872 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 120' ' ' SER . . . . . 0.432 ' HA ' HG21 ' E' ' 107' ' ' THR . 1.9 t -165.5 144.77 6.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.597 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.28 50.35 0.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.214 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.88 94.11 5.78 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.713 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.63 110.38 12.4 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.741 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 124' ' ' LEU . . . . . 0.605 ' HG ' ' ND2' ' E' ' 129' ' ' ASN . 0.3 OUTLIER -70.19 154.13 42.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.567 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.62 144.75 51.28 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.564 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.75 125.69 24.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.647 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 127' ' ' GLY . . . . . 0.528 ' HA3' HG21 ' A' ' 4' ' ' THR . . . 115.03 -102.0 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.737 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 128' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 87.1 m -106.21 128.46 53.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.604 0.24 . . . . 0.0 110.849 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 129' ' ' ASN . . . . . 0.751 ' HA ' ' HB2' ' B' ' 116' ' ' ALA . 20.1 t-20 -121.15 158.18 28.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.881 0.372 . . . . 0.0 111.147 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 130' ' ' THR . . . . . 0.555 ' OG1' ' HA3' ' B' ' 115' ' ' GLY . 0.2 OUTLIER -155.83 143.1 19.26 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.009 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 131' ' ' ILE . . . . . 0.609 HD13 HG11 ' E' ' 156' ' ' VAL . 0.1 OUTLIER -115.23 110.83 45.07 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 132' ' ' PRO . . . . . 0.504 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.3 Cg_endo -82.21 151.86 15.96 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.634 1.556 . . . . 0.0 112.548 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.08 146.79 17.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.795 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 134' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' B' ' 78' ' ' ILE . 0.8 OUTLIER -114.37 145.87 41.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.068 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.87 91.14 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.962 0.41 . . . . 0.0 111.713 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 136' ' ' ARG . . . . . 0.568 ' HE ' HG21 ' E' ' 48' ' ' THR . 28.2 mtm-85 -88.27 153.54 21.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.41 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 137' ' ' TYR . . . . . 0.606 ' CE1' HG22 ' E' ' 101' ' ' VAL . 0.7 OUTLIER -91.26 111.14 22.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.059 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 138' ' ' PHE . . . . . 0.607 ' CD1' ' HB2' ' E' ' 102' ' ' GLN . 8.7 m-85 -108.22 172.21 6.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.968 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 139' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' E' ' 42' ' ' LEU . . . -123.47 143.64 50.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.823 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 140' ' ' THR . . . . . 0.889 HG21 ' CB ' ' E' ' 79' ' ' ASP . 0.2 OUTLIER -98.72 44.43 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.567 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.51 89.07 1.07 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.963 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 142' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' E' ' 43' ' ' ALA . . . 60.03 88.04 0.08 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.696 0.248 . . . . 0.0 110.769 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 143' ' ' ALA . . . . . 0.563 ' HB1' ' HB ' ' E' ' 99' ' ' VAL . . . -70.62 161.73 30.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 111.458 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 144' ' ' THR . . . . . 0.625 ' O ' HG11 ' D' ' 16' ' ' VAL . 0.2 OUTLIER -124.48 158.73 60.65 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.23 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 145' ' ' PRO . . . . . 0.51 ' HA ' ' HB ' ' D' ' 16' ' ' VAL . 1.4 Cg_endo -83.76 149.23 12.57 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.569 2.179 . . . . 0.0 112.022 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.69 -119.72 0.86 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.582 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 147' ' ' ALA . . . . . 0.646 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -123.95 127.73 48.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.877 0.37 . . . . 0.0 111.384 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 148' ' ' ALA . . . . . 0.7 ' HA ' ' HB3' ' E' ' 88' ' ' LEU . . . -120.85 67.16 0.86 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.434 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 149' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' E' ' 89' ' ' GLN . 47.5 t-20 -128.51 114.82 17.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.594 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 150' ' ' ALA . . . . . 0.416 ' HB2' ' C ' ' E' ' 88' ' ' LEU . . . -158.85 147.0 18.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.03 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.48 140.28 32.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.218 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 152' ' ' ALA . . . . . 0.507 ' O ' HG23 ' D' ' 9' ' ' THR . . . -136.21 169.23 17.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.149 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 153' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' E' ' 74' ' ' LEU . 9.4 t -155.06 150.54 27.35 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 154' ' ' PHE . . . . . 0.442 ' HE1' HG13 ' E' ' 56' ' ' ILE . 1.1 p90 -119.05 149.3 41.9 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.1 0.476 . . . . 0.0 110.025 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 155' ' ' LYS . . . . . 0.447 ' HE3' HD13 ' E' ' 74' ' ' LEU . 4.7 mttt -113.53 156.74 23.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.85 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 156' ' ' VAL . . . . . 0.609 HG11 HD13 ' E' ' 131' ' ' ILE . 0.2 OUTLIER -136.51 138.01 47.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.653 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 157' ' ' GLN . . . . . 0.62 ' HB2' HG22 ' D' ' 4' ' ' THR . 64.1 tt0 -107.46 128.05 54.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.307 0.575 . . . . 0.0 110.328 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 158' ' ' TYR . . . . . 0.594 ' HB2' ' OG1' ' D' ' 3' ' ' THR . 61.0 m-85 -107.89 107.5 18.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.531 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 159' ' ' GLN . . . . . 0.714 ' HA ' ' H ' ' D' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.276 0.084 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.82 74.75 0.36 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.973 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 6.2 p -117.75 97.53 5.9 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.504 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 69.1 p -87.84 108.64 19.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.592 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.55 172.72 13.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.618 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -77.24 110.85 12.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.572 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.79 -59.37 7.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.75 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.56 151.71 14.96 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.763 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 24.2 m -103.53 143.09 33.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 111.253 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.92 115.62 30.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.241 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -83.59 105.79 14.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.397 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -83.21 105.5 14.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.76 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.49 145.09 41.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.43 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.75 -179.64 42.6 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.969 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.27 134.18 22.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.387 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 t -90.92 127.19 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.257 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 17' ' ' VAL . . . . . 0.531 HG21 ' HB3' ' F' ' 20' ' ' ALA . 12.0 m -126.25 168.74 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.887 0.375 . . . . 0.0 111.042 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -100.42 81.83 2.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.149 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.23 58.27 5.43 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.05 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 20' ' ' ALA . . . . . 0.531 ' HB3' HG21 ' F' ' 17' ' ' VAL . . . -108.61 -62.85 1.41 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.376 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 21' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.9 OUTLIER -171.57 -159.92 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.86 74.0 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.085 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 23' ' ' VAL . . . . . 0.468 ' N ' HD23 ' F' ' 58' ' ' LEU . 7.4 p -45.35 140.64 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.015 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 24' ' ' ASP . . . . . 0.547 ' O ' HG23 ' F' ' 28' ' ' VAL . 0.5 OUTLIER -63.45 140.79 58.91 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.679 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.41 -51.08 69.7 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.341 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.14 -18.06 74.45 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.871 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.94 -6.37 58.06 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.865 0.364 . . . . 0.0 110.835 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 28' ' ' VAL . . . . . 0.547 HG23 ' O ' ' F' ' 24' ' ' ASP . 50.6 t -72.66 -36.39 53.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.403 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.92 110.88 14.13 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 30' ' ' GLN . . . . . 0.427 ' HG3' HG12 ' E' ' 10' ' ' VAL . 0.4 OUTLIER -123.84 146.04 48.66 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.982 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.17 113.84 27.67 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.208 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.631 HG11 HG11 ' F' ' 52' ' ' VAL . 3.3 t -105.11 121.95 57.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.141 0.496 . . . . 0.0 110.457 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.83 106.39 17.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.633 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 34' ' ' LEU . . . . . 0.437 HD21 ' HD2' ' E' ' 12' ' ' PHE . 0.6 OUTLIER -64.77 -44.69 89.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.62 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.53 -156.97 16.01 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.561 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 36' ' ' GLN . . . . . 0.631 ' HB2' ' HA ' ' E' ' 22' ' ' ALA . 3.7 mt-30 -91.04 106.97 18.89 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.628 0.251 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.58 ' CG1' HD21 ' F' ' 42' ' ' LEU . 4.4 t -92.35 120.55 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.92 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 38' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' E' ' 19' ' ' ALA . 4.5 mtm105 -85.59 132.5 34.17 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.753 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 39' ' ' THR . . . . . 0.435 HG23 ' O ' ' E' ' 17' ' ' VAL . 29.4 p -71.56 -23.22 61.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.729 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 40' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' E' ' 19' ' ' ALA . . . -68.04 -19.19 64.87 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.007 0.432 . . . . 0.0 110.815 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 13.8 t -90.54 -36.6 14.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.16 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 42' ' ' LEU . . . . . 0.58 HD21 ' CG1' ' F' ' 37' ' ' VAL . 0.2 OUTLIER -121.43 70.56 0.94 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.648 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 43' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' F' ' 142' ' ' ALA . . . -104.82 28.11 7.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.331 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 44' ' ' GLN . . . . . 0.754 ' HG3' ' HB2' ' F' ' 47' ' ' ALA . 0.0 OUTLIER -150.54 142.01 23.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.392 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 45' ' ' GLU . . . . . 0.449 ' HG3' ' HA ' ' F' ' 140' ' ' THR . 2.7 tt0 -62.71 101.84 0.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.786 0.326 . . . . 0.0 111.084 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.21 4.27 8.47 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.197 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 47' ' ' ALA . . . . . 0.754 ' HB2' ' HG3' ' F' ' 44' ' ' GLN . . . -91.8 121.33 33.32 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.953 0.406 . . . . 0.0 111.981 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 48' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' F' ' 137' ' ' TYR . 5.9 t -110.41 151.13 27.86 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.836 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 49' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 5.2 t -95.63 -57.6 2.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.6 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 50' ' ' SER . . . . . 0.597 ' HB3' ' HA ' ' C' ' 92' ' ' ALA . 0.2 OUTLIER -148.24 -174.81 4.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.806 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 51' ' ' ALA . . . . . 0.474 ' HB2' ' CD ' ' F' ' 136' ' ' ARG . . . -127.13 143.84 51.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.284 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 52' ' ' VAL . . . . . 0.631 HG11 HG11 ' F' ' 32' ' ' VAL . 48.2 t -120.84 116.87 51.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.015 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 53' ' ' GLY . . . . . 0.41 ' O ' HG21 ' C' ' 76' ' ' THR . . . -111.18 122.69 6.21 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.648 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -128.63 138.85 52.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 0.0 110.934 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 55' ' ' ASN . . . . . 0.479 HD22 ' CG2' ' F' ' 130' ' ' THR . 1.6 m120 -117.88 150.97 38.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.607 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 56' ' ' ILE . . . . . 0.592 ' HB ' HG13 ' F' ' 131' ' ' ILE . 9.3 mm -106.82 103.7 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.585 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 57' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -61.13 132.22 53.04 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.769 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 58' ' ' LEU . . . . . 0.761 ' HB3' ' SG ' ' F' ' 21' ' ' CYS . 1.0 OUTLIER -137.4 151.74 48.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.253 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -138.3 171.43 14.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.026 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 60' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' F' ' 21' ' ' CYS . 5.9 m-20 49.95 68.52 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.812 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 61' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 0.0 OUTLIER -106.68 141.08 38.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.984 0.421 . . . . 0.0 110.736 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.74 117.83 33.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.266 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 23.4 p -91.15 -13.16 33.49 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.61 -38.95 82.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.033 0.444 . . . . 0.0 111.753 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 76.2 t -107.64 -54.1 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.65 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.76 84.33 3.34 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.604 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.97 -41.26 10.1 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.969 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.64 159.97 17.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.436 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.73 160.41 39.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.592 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.03 152.9 45.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.156 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.95 136.55 53.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.682 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.04 107.46 5.03 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.525 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 73' ' ' PHE . . . . . 0.467 ' CD2' HD13 ' F' ' 103' ' ' ILE . 43.0 t80 -73.63 136.7 43.91 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.58 0.228 . . . . 0.0 111.049 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 74' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' F' ' 153' ' ' THR . 6.6 tt -113.62 111.4 21.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.939 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 75' ' ' GLY . . . . . 0.635 ' HA3' HD11 ' F' ' 113' ' ' LEU . . . -131.31 -178.55 15.53 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.836 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 76' ' ' THR . . . . . 0.677 ' H ' HD12 ' F' ' 86' ' ' LEU . 0.2 OUTLIER -104.32 137.62 41.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.51 0.195 . . . . 0.0 110.79 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.02 114.73 23.88 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.935 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.69 -36.75 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.866 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 79' ' ' ASP . . . . . 0.9 ' CB ' HG21 ' F' ' 140' ' ' THR . 0.4 OUTLIER -143.38 130.26 20.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.752 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.94 -7.23 47.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.973 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.31 -29.2 68.34 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.636 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.28 -32.73 4.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.863 0.364 . . . . 0.0 110.455 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 83' ' ' THR . . . . . 0.427 ' O ' HG22 ' F' ' 83' ' ' THR . 3.4 m 60.55 19.37 9.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.632 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 84' ' ' ASN . . . . . 0.62 ' HB3' ' HG2' ' F' ' 102' ' ' GLN . 0.6 OUTLIER -139.36 -16.92 1.03 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.413 179.629 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 85' ' ' VAL . . . . . 0.686 ' HB ' ' HA3' ' F' ' 100' ' ' GLY . 0.8 OUTLIER -66.71 117.97 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.196 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 86' ' ' LEU . . . . . 0.677 HD12 ' H ' ' F' ' 76' ' ' THR . 10.7 tp -69.67 144.1 52.98 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.36 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 87' ' ' ALA . . . . . 0.454 ' HB3' ' OG1' ' F' ' 76' ' ' THR . . . -80.1 138.03 36.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.904 0.383 . . . . 0.0 111.762 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 88' ' ' LEU . . . . . 0.683 ' HB3' ' HA ' ' F' ' 148' ' ' ALA . 0.0 OUTLIER -84.94 -146.55 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.083 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 89' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' F' ' 149' ' ' ASN . 0.0 OUTLIER -48.66 155.1 0.59 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 32.8 p -86.78 -11.97 49.47 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.403 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.38 114.04 5.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.976 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.34 22.21 1.05 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.877 0.37 . . . . 0.0 111.667 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.28 22.06 1.19 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.692 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.69 -32.28 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.053 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 95' ' ' SER . . . . . 0.644 ' HA ' ' HB3' ' F' ' 147' ' ' ALA . 16.0 t -65.14 166.69 9.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.345 . . . . 0.0 110.616 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 96' ' ' ALA . . . . . 0.467 ' O ' HD13 ' F' ' 88' ' ' LEU . . . -89.61 163.49 15.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.87 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.41 169.61 17.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.329 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 98' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 57.36 29.36 16.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.414 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 99' ' ' VAL . . . . . 0.563 ' HB ' ' HB1' ' F' ' 143' ' ' ALA . 7.0 p -156.38 150.6 10.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.77 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 100' ' ' GLY . . . . . 0.686 ' HA3' ' HB ' ' F' ' 85' ' ' VAL . . . -164.22 176.96 40.11 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.604 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 101' ' ' VAL . . . . . 0.609 HG22 ' CE1' ' F' ' 137' ' ' TYR . 3.0 t -107.66 111.37 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 123.04 0.536 . . . . 0.0 111.706 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 102' ' ' GLN . . . . . 0.62 ' HG2' ' HB3' ' F' ' 84' ' ' ASN . 0.0 OUTLIER -76.04 179.68 5.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.922 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 103' ' ' ILE . . . . . 0.488 HD11 ' HA ' ' F' ' 113' ' ' LEU . 6.0 pt -150.34 116.57 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.464 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 104' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' F' ' 134' ' ' GLN . 12.8 tp -97.18 122.53 40.3 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.743 0.306 . . . . 0.0 111.075 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -62.89 150.12 42.72 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.696 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 106' ' ' ARG . . . . . 0.526 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -71.38 -17.69 62.4 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.772 0.32 . . . . 0.0 111.052 179.479 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 107' ' ' THR . . . . . 0.446 HG21 ' HA ' ' F' ' 120' ' ' SER . 75.7 p -76.61 -37.28 56.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.08 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.57 -68.77 0.32 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.685 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.68 123.27 18.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.875 0.369 . . . . 0.0 111.105 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.7 117.98 2.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 111' ' ' LEU . . . . . 0.514 HD11 ' O ' ' F' ' 117' ' ' THR . 2.1 tp -67.77 144.04 55.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.429 0.633 . . . . 0.0 110.532 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 112' ' ' THR . . . . . 0.432 ' HA ' ' ND2' ' F' ' 84' ' ' ASN . 0.2 OUTLIER -75.08 140.46 43.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.13 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 113' ' ' LEU . . . . . 0.635 HD11 ' HA3' ' F' ' 75' ' ' GLY . 1.3 tp -85.22 97.85 10.15 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.764 0.316 . . . . 0.0 110.582 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -152.8 -59.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.674 0.273 . . . . 0.0 111.595 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.79 -26.66 3.13 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.61 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.28 28.74 5.19 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.643 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 117' ' ' THR . . . . . 0.514 ' O ' HD11 ' F' ' 111' ' ' LEU . 0.2 OUTLIER -106.57 67.39 0.72 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.052 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.43 80.95 8.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.735 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.01 97.5 3.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.803 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 120' ' ' SER . . . . . 0.446 ' HA ' HG21 ' F' ' 107' ' ' THR . 1.9 t -165.53 144.8 6.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.576 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.29 50.36 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.232 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.87 94.12 5.78 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.659 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.73 110.35 12.5 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.643 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 124' ' ' LEU . . . . . 0.603 ' HG ' ' ND2' ' F' ' 129' ' ' ASN . 0.3 OUTLIER -70.13 154.15 42.27 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.579 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.62 144.77 51.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.552 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.76 125.64 24.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.667 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 127' ' ' GLY . . . . . 0.526 ' HA3' HG21 ' B' ' 4' ' ' THR . . . 115.03 -101.93 1.1 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.749 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 128' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' C' ' 116' ' ' ALA . 86.0 m -106.32 128.5 54.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.672 0.272 . . . . 0.0 110.782 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 129' ' ' ASN . . . . . 0.748 ' HA ' ' HB2' ' C' ' 116' ' ' ALA . 20.1 t-20 -121.08 158.21 28.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.129 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 130' ' ' THR . . . . . 0.57 ' OG1' ' HA3' ' C' ' 115' ' ' GLY . 0.2 OUTLIER -155.9 143.07 19.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.014 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 131' ' ' ILE . . . . . 0.613 HD13 HG11 ' F' ' 156' ' ' VAL . 0.1 OUTLIER -115.19 110.74 45.24 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 132' ' ' PRO . . . . . 0.526 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.4 Cg_endo -82.12 151.88 16.16 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.597 1.531 . . . . 0.0 112.514 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.0 146.76 17.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.84 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 134' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' C' ' 78' ' ' ILE . 0.8 OUTLIER -114.41 145.95 41.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.093 179.277 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.85 91.15 1.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 0.0 111.682 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 136' ' ' ARG . . . . . 0.572 ' HE ' HG21 ' F' ' 48' ' ' THR . 28.0 mtm-85 -88.33 153.56 21.1 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.403 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 137' ' ' TYR . . . . . 0.609 ' CE1' HG22 ' F' ' 101' ' ' VAL . 0.7 OUTLIER -91.19 111.03 22.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.101 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 138' ' ' PHE . . . . . 0.607 ' CD1' ' HB2' ' F' ' 102' ' ' GLN . 8.8 m-85 -108.11 172.17 6.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.978 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 139' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' F' ' 42' ' ' LEU . . . -123.41 143.71 49.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.807 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 140' ' ' THR . . . . . 0.9 HG21 ' CB ' ' F' ' 79' ' ' ASP . 0.2 OUTLIER -98.85 44.5 1.03 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.501 179.753 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.45 89.13 1.07 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.946 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 142' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' F' ' 43' ' ' ALA . . . 60.04 88.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.678 0.239 . . . . 0.0 110.694 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 143' ' ' ALA . . . . . 0.563 ' HB1' ' HB ' ' F' ' 99' ' ' VAL . . . -70.54 161.72 30.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.783 0.325 . . . . 0.0 111.431 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 144' ' ' THR . . . . . 0.637 ' O ' HG11 ' E' ' 16' ' ' VAL . 0.2 OUTLIER -124.46 158.65 60.88 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.292 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 145' ' ' PRO . . . . . 0.528 ' HA ' ' HB ' ' E' ' 16' ' ' VAL . 1.4 Cg_endo -83.75 149.19 12.58 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.499 2.132 . . . . 0.0 112.079 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.71 -119.73 0.86 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.563 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 147' ' ' ALA . . . . . 0.644 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -123.92 127.64 48.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 111.48 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 148' ' ' ALA . . . . . 0.683 ' HA ' ' HB3' ' F' ' 88' ' ' LEU . . . -120.77 67.1 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.139 0.495 . . . . 0.0 110.449 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 149' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' F' ' 89' ' ' GLN . 47.4 t-20 -128.47 114.73 17.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.667 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 150' ' ' ALA . . . . . 0.424 ' HB2' ' C ' ' F' ' 88' ' ' LEU . . . -158.77 146.92 18.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.056 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.37 140.29 32.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.181 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 152' ' ' ALA . . . . . 0.511 ' O ' HG23 ' E' ' 9' ' ' THR . . . -136.23 169.29 17.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.216 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 153' ' ' THR . . . . . 0.452 ' O ' ' HB3' ' F' ' 74' ' ' LEU . 9.4 t -155.09 150.56 27.33 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 154' ' ' PHE . . . . . 0.436 ' HE1' HG13 ' F' ' 56' ' ' ILE . 1.1 p90 -119.06 149.24 42.0 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.089 0.471 . . . . 0.0 110.103 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 155' ' ' LYS . . . . . 0.426 ' HE3' HD13 ' F' ' 74' ' ' LEU . 4.7 mttt -113.5 156.67 23.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.886 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 156' ' ' VAL . . . . . 0.613 HG11 HD13 ' F' ' 131' ' ' ILE . 0.2 OUTLIER -136.5 138.05 47.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.667 -179.067 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 157' ' ' GLN . . . . . 0.61 ' HB2' HG22 ' E' ' 4' ' ' THR . 64.1 tt0 -107.5 127.99 54.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.307 0.575 . . . . 0.0 110.344 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 158' ' ' TYR . . . . . 0.592 ' HB2' ' OG1' ' E' ' 3' ' ' THR . 60.9 m-85 -107.82 107.43 18.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.565 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 159' ' ' GLN . . . . . 0.718 ' HA ' ' H ' ' E' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.903 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.62 ' HB2' ' HG3' ' B' ' 159' ' ' GLN . . . . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.557 0.218 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' B' ' 157' ' ' GLN . 0.2 OUTLIER -103.08 110.35 22.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.419 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.37 136.14 38.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.55 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.64 HG23 HG23 ' B' ' 156' ' ' VAL . 0.0 OUTLIER -152.01 -175.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.61 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.51 130.04 38.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.677 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.77 -59.25 0.91 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.822 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.37 166.16 27.94 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.897 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.621 ' HA ' HG22 ' B' ' 153' ' ' THR . 26.8 m -94.36 121.11 35.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.904 0.383 . . . . 0.0 111.287 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.65 115.59 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.223 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -99.55 137.45 38.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.369 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.573 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 76.0 m-85 -127.49 97.73 4.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.22 175.8 6.56 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.428 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.91 149.49 5.78 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.923 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.33 108.63 13.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.776 0.322 . . . . 0.0 110.358 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' B' ' 37' ' ' VAL . 23.5 t -86.67 129.15 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.203 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 22' ' ' ALA . 18.8 m -127.38 163.5 30.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.041 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -86.0 61.52 6.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.07 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.484 ' HB3' HG21 ' A' ' 65' ' ' VAL . . . 44.93 52.63 8.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -127.29 -54.51 1.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.407 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.809 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER 177.7 111.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.866 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.502 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -105.63 126.08 51.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.073 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.86 145.64 7.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.055 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.623 ' O ' HG23 ' A' ' 28' ' ' VAL . 4.0 m-20 -74.83 147.23 41.34 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.696 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.67 -43.66 17.87 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.34 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.98 -20.0 60.16 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.84 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.2 t -79.54 -26.07 41.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.863 0.363 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 24' ' ' ASP . 57.5 t -49.19 -48.46 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.331 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.84 93.08 5.36 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.023 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.63 116.42 28.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.009 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 p -95.6 115.62 27.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.151 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.503 ' CG1' HG11 ' A' ' 52' ' ' VAL . 1.6 t -117.18 101.16 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.131 0.491 . . . . 0.0 110.402 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -105.62 126.96 52.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.655 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.26 -55.62 11.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.63 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.03 -111.6 3.91 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.519 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.11 115.28 16.76 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.514 0.197 . . . . 0.0 110.875 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.0 t -131.01 105.8 11.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.875 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -96.64 154.12 17.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.757 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.643 ' HA ' HD12 ' A' ' 42' ' ' LEU . 8.2 p -78.75 -19.84 51.35 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.759 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -19.52 65.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.066 0.46 . . . . 0.0 110.885 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.7 p -92.0 -21.27 20.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.207 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.715 ' CB ' ' HB2' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -139.14 62.36 1.54 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.58 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' A' ' 142' ' ' ALA . . . -101.13 9.12 42.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.321 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.19 136.0 24.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.37 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.593 ' N ' ' HA2' ' A' ' 141' ' ' GLY . 16.5 tt0 -58.48 121.37 10.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.915 0.388 . . . . 0.0 111.082 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.28 -25.46 8.23 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.149 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.75 137.29 58.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.939 0.4 . . . . 0.0 112.034 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.92 157.99 44.59 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.955 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.93 -166.21 1.09 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.621 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.8 m -65.23 156.19 32.68 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.767 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 134' ' ' GLN . . . -90.45 126.66 35.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.324 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.503 HG11 ' CG1' ' A' ' 32' ' ' VAL . 62.4 t -75.68 118.52 21.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.79 135.6 13.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.731 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HD2' HG12 ' A' ' 52' ' ' VAL . 46.2 p90 -170.74 142.1 1.92 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.915 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.676 ' HA ' ' O ' ' A' ' 131' ' ' ILE . 11.5 p30 -126.52 163.92 22.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.602 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 130' ' ' THR . 20.9 mm -105.13 120.03 55.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.525 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.7 ' HA ' HG22 ' A' ' 130' ' ' THR . 0.0 OUTLIER -82.15 115.66 21.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.712 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.639 HD11 HG13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -128.24 107.46 9.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.288 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.37 176.97 8.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.889 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.05 66.13 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.797 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.809 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 3.3 m -109.69 154.48 22.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.679 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.523 ' HA ' ' OD1' ' A' ' 126' ' ' ASN . 0.5 OUTLIER -154.71 138.3 16.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.263 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -97.54 -11.9 23.19 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -72.27 -48.69 40.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.003 0.43 . . . . 0.0 111.713 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 19' ' ' ALA . 10.8 t -69.1 -48.6 68.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.695 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 159' ' ' GLN . . . -138.02 153.26 49.39 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.599 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.19 18.66 4.48 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.95 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 10.6 tppt? -142.88 149.9 39.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.486 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.868 ' HB2' HD12 ' A' ' 124' ' ' LEU . . . -150.0 110.72 4.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.661 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 121' ' ' GLU . . . -108.05 169.99 8.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.1 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.414 HG21 HG21 ' A' ' 131' ' ' ILE . 0.5 OUTLIER -130.38 150.98 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.61 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.697 ' HB1' ' HA ' ' A' ' 116' ' ' ALA . . . -135.62 100.13 4.4 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.58 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.435 ' HB2' HD22 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -77.42 133.98 38.52 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.571 0.224 . . . . 0.0 111.107 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.746 HD11 ' HG2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -124.17 115.05 20.48 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.025 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.31 -173.23 26.45 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.729 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.6 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 7.0 m -112.59 149.03 33.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.583 0.23 . . . . 0.0 110.755 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 85' ' ' VAL . . . -98.97 133.81 42.72 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.942 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.786 ' HB ' ' HA ' ' A' ' 87' ' ' ALA . 16.1 tt -72.93 -37.98 55.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.17 167.64 12.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.834 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' D' ' 106' ' ' ARG . . . -70.17 -53.83 15.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.073 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.35 28.63 6.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.595 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.816 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 10.2 m170 -111.33 -45.62 3.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.369 . . . . 0.0 110.427 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.482 HG22 HH21 ' D' ' 106' ' ' ARG . 0.0 OUTLIER 46.42 -86.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.589 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -42.28 -42.4 3.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.239 179.674 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.816 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 21.3 t -61.29 126.57 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.093 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.062 HD22 ' HB1' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -81.25 164.41 22.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.455 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.786 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . . . -104.78 -177.49 3.38 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.672 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.09 -174.57 5.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.982 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.57 -170.71 3.24 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.372 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.869 ' HA ' HG13 ' D' ' 52' ' ' VAL . 27.4 p -74.77 7.81 2.84 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.914 0.387 . . . . 0.0 111.462 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.421 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 0.8 OUTLIER -96.96 80.39 2.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.632 ' HA ' ' HB2' ' D' ' 50' ' ' SER . . . -66.87 -41.13 87.76 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.624 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' D' ' 36' ' ' GLN . . . -103.73 25.96 9.16 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.675 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.8 -22.63 0.33 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.929 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 91' ' ' SER . 1.0 OUTLIER -107.68 175.18 5.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.906 0.384 . . . . 0.0 110.587 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.38 177.12 2.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.497 ' O ' HG12 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -138.58 167.86 21.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.21 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.584 ' HA ' ' HB ' ' A' ' 140' ' ' THR . 32.4 m-80 44.19 51.65 7.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.502 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 97' ' ' THR . 6.0 p -169.38 124.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.72 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.61 -164.74 11.5 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.634 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.8 91.16 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 122.97 0.508 . . . . 0.0 111.722 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.704 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 0.4 OUTLIER -71.4 116.65 11.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.885 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 113' ' ' LEU . 6.6 mt -89.64 120.59 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.492 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 1.0 OUTLIER -95.88 152.31 18.61 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.691 0.281 . . . . 0.0 111.092 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.16 159.99 14.68 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.613 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.537 ' CZ ' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -68.71 -13.73 62.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.92 0.39 . . . . 0.0 111.146 179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.6 p -74.41 -18.87 60.59 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.067 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.99 -40.11 2.23 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.664 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.41 164.67 13.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.781 0.324 . . . . 0.0 111.099 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -77.37 139.68 39.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.132 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.564 HD21 ' HB ' ' A' ' 117' ' ' THR . 5.9 tt -84.18 128.58 34.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.458 0.647 . . . . 0.0 110.506 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.413 ' O ' HD23 ' A' ' 111' ' ' LEU . 1.4 m -68.11 132.38 47.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.1 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.659 HD11 HD12 ' A' ' 103' ' ' ILE . 4.7 mp -88.04 99.83 12.46 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.621 0.248 . . . . 0.0 110.741 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' D' ' 130' ' ' THR . 0.8 OUTLIER -144.13 -32.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.502 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.498 ' CA ' HD23 ' A' ' 74' ' ' LEU . . . 146.46 -81.3 0.21 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.625 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.697 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . . . -97.22 64.1 1.9 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.959 0.409 . . . . 0.0 111.603 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.564 ' HB ' HD21 ' A' ' 111' ' ' LEU . 2.8 m -94.4 72.39 3.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.141 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -66.76 119.04 11.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.835 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.89 -49.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.852 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.57 84.69 6.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.547 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 70' ' ' ALA . 3.5 mt-10 -110.2 86.95 2.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.29 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.99 159.3 17.68 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.815 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -66.96 138.39 57.23 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.727 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.868 HD12 ' HB2' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -86.55 159.49 19.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.622 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.58 176.19 10.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.588 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 62' ' ' ASP . 0.9 OUTLIER -85.93 161.49 19.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.697 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.53 -121.0 5.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.775 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 74.4 m -119.54 140.31 50.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.682 0.277 . . . . 0.0 110.768 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.45 ' O ' HD12 ' A' ' 58' ' ' LEU . 5.1 t-20 -133.73 154.67 50.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.117 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.7 HG22 ' HA ' ' A' ' 57' ' ' GLN . 27.9 p -133.41 154.33 50.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.164 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.676 ' O ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -111.09 116.9 50.93 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.537 ' HG2' ' CZ ' ' A' ' 106' ' ' ARG . 7.5 Cg_endo -81.24 129.48 6.78 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.614 1.543 . . . . 0.0 112.581 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.459 ' HB3' ' CE1' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -140.89 146.9 38.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.794 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.526 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 8.4 mm100 -116.5 158.33 23.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.011 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . . . -159.42 105.53 1.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.914 0.388 . . . . 0.0 111.524 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.7 172.61 6.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.414 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.2 147.79 24.25 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.131 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.67 159.03 35.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.277 0.561 . . . . 0.0 111.923 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.715 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . . . -116.33 141.24 48.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.936 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.584 ' HB ' ' HA ' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -107.75 27.23 9.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.482 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.593 ' HA2' ' N ' ' A' ' 45' ' ' GLU . . . 97.55 83.6 1.71 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.971 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . . . 57.88 93.47 0.03 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.688 0.244 . . . . 0.0 110.746 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' A' ' 98' ' ' ASN . . . -80.0 165.37 22.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 111.403 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.7 p -108.34 168.87 7.22 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.153 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.61 133.54 6.14 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.569 2.179 . . . . 0.0 111.979 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.55 -119.24 0.81 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.471 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.81 121.7 13.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.894 0.378 . . . . 0.0 111.281 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.34 85.68 3.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.442 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -104.55 131.21 52.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.601 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 1.062 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -136.08 148.44 48.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.935 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.17 120.17 20.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.216 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.63 140.05 24.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.159 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.6 p -105.2 171.21 7.44 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.503 ' HZ ' HG21 ' A' ' 56' ' ' ILE . 13.7 p90 -138.2 147.39 43.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.038 0.447 . . . . 0.0 110.119 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.746 ' HG2' HD11 ' A' ' 74' ' ' LEU . 13.6 mmtt -100.89 172.01 7.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.901 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.49 ' HB ' ' CZ ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -135.51 111.4 12.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.82 0.343 . . . . 0.0 111.728 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -109.04 141.26 41.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.346 0.593 . . . . 0.0 110.414 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.49 ' CZ ' ' HB ' ' A' ' 156' ' ' VAL . 23.1 m-85 -135.36 105.58 6.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.583 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.617 ' HB3' ' HB3' ' A' ' 68' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.92 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' ALA . . . . . 0.695 ' H ' ' HA ' ' C' ' 159' ' ' GLN . . . 56.58 88.57 0.05 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.056 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' C' ' 157' ' ' GLN . 0.2 OUTLIER -103.08 110.38 22.29 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.393 179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 136.18 38.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.552 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.652 HG23 HG23 ' C' ' 156' ' ' VAL . 0.0 OUTLIER -152.05 -175.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.591 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.43 130.04 38.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.666 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.8 -59.33 0.91 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.756 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.4 166.2 28.04 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.894 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.624 ' HA ' HG22 ' C' ' 153' ' ' THR . 26.7 m -94.38 121.1 35.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.89 0.376 . . . . 0.0 111.269 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.69 115.64 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.24 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -99.54 137.55 37.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.351 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' C' ' 32' ' ' VAL . 76.0 m-85 -127.61 97.71 4.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.22 175.78 6.57 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.472 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.01 149.4 5.75 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.941 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.24 108.68 14.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.852 0.358 . . . . 0.0 110.414 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' C' ' 37' ' ' VAL . 23.6 t -86.71 129.19 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.175 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' B' ' 22' ' ' ALA . 18.7 m -127.45 163.51 30.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.033 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -85.95 61.35 6.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.027 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.483 ' HB3' HG21 ' B' ' 65' ' ' VAL . . . 45.02 52.64 8.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.053 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' B' ' 61' ' ' CYS . . . -127.24 -54.54 1.37 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.451 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.1 OUTLIER 177.73 111.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.893 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.499 ' HB2' HG22 ' B' ' 17' ' ' VAL . . . -105.67 126.05 51.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.083 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.81 145.61 7.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.035 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.608 ' O ' HG23 ' B' ' 28' ' ' VAL . 4.0 m-20 -74.82 147.27 41.32 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.68 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.8 -43.57 18.47 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.323 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.97 -20.07 60.06 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.809 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 45.3 t -79.58 -26.01 41.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.608 HG23 ' O ' ' B' ' 24' ' ' ASP . 57.4 t -49.21 -48.46 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.344 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.86 93.08 5.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.031 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.61 116.36 28.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.026 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.55 115.67 27.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.209 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 12' ' ' PHE . 1.7 t -117.23 101.07 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.182 0.515 . . . . 0.0 110.429 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -105.58 126.93 52.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.715 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.15 -55.66 11.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.62 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.02 -111.65 3.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.539 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.548 ' HG3' ' HA ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -77.05 115.29 16.71 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.501 0.191 . . . . 0.0 110.907 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 68.4 t -131.05 105.86 11.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.833 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.6 154.05 17.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.782 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.665 ' HA ' HD12 ' B' ' 42' ' ' LEU . 8.2 p -78.77 -19.79 51.4 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.702 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.51 -19.53 65.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.144 0.497 . . . . 0.0 110.899 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 96.5 p -92.01 -21.27 20.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.19 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.711 ' CB ' ' HB2' ' B' ' 139' ' ' ALA . 0.2 OUTLIER -139.0 62.27 1.54 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.707 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.727 ' HA ' ' HA ' ' B' ' 142' ' ' ALA . . . -101.09 9.14 42.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.363 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.19 136.03 24.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.335 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.579 ' N ' ' HA2' ' B' ' 141' ' ' GLY . 16.5 tt0 -58.59 121.33 10.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 111.154 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.4 -25.54 8.14 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.166 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.67 137.19 58.2 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.91 158.04 44.45 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.904 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -166.19 1.09 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.598 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 48.9 m -65.2 156.13 32.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.816 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.539 ' HB1' ' HB3' ' B' ' 134' ' ' GLN . . . -90.5 126.7 36.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.339 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.506 HG11 ' CG1' ' B' ' 32' ' ' VAL . 63.2 t -75.6 118.5 21.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.019 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.79 135.74 13.86 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.626 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' PHE . . . . . 0.5 ' HD2' HG12 ' B' ' 52' ' ' VAL . 46.3 p90 -170.85 142.08 1.86 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.815 0.341 . . . . 0.0 110.905 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.673 ' HA ' ' O ' ' B' ' 131' ' ' ILE . 11.5 p30 -126.52 163.93 22.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.54 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' B' ' 130' ' ' THR . 20.7 mm -105.17 119.97 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.503 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' GLN . . . . . 0.703 ' HA ' HG22 ' B' ' 130' ' ' THR . 0.0 OUTLIER -82.16 115.74 21.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.731 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.648 HD11 HG13 ' B' ' 131' ' ' ILE . 0.0 OUTLIER -128.33 107.47 9.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.252 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.37 176.99 8.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.86 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.03 66.21 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.714 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 3.3 m -109.73 154.46 22.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.711 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ASP . . . . . 0.531 ' HA ' ' OD1' ' B' ' 126' ' ' ASN . 0.5 OUTLIER -154.74 138.26 15.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.271 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' B' ' 66' ' ' ALA . 0.2 OUTLIER -97.55 -11.81 23.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.08 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.25 -48.68 40.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.115 0.483 . . . . 0.0 111.78 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' B' ' 19' ' ' ALA . 10.6 t -69.02 -48.7 68.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.764 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' B' ' 159' ' ' GLN . . . -137.93 153.36 49.5 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.637 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.29 18.67 4.43 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.868 0.366 . . . . 0.0 110.906 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' LYS . . . . . 0.61 ' HB3' ' HB3' ' B' ' 159' ' ' GLN . 10.6 tppt? -142.9 149.93 39.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.469 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.867 ' HB2' HD12 ' B' ' 124' ' ' LEU . . . -150.03 110.72 4.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.687 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' B' ' 121' ' ' GLU . . . -108.1 169.92 8.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.05 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.436 HG21 HG21 ' B' ' 131' ' ' ILE . 0.5 OUTLIER -130.35 150.93 35.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.63 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.698 ' HB1' ' HA ' ' B' ' 116' ' ' ALA . . . -135.62 100.16 4.41 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.518 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.438 ' HB2' HD22 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -77.35 133.84 38.63 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.572 0.225 . . . . 0.0 111.189 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.731 HD11 ' HG2' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -124.15 115.16 20.67 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.984 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.37 -173.24 26.53 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.777 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.606 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 7.0 m -112.6 149.04 33.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.565 0.221 . . . . 0.0 110.755 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' B' ' 85' ' ' VAL . . . -98.99 133.78 42.77 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.908 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.769 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 16.1 tt -72.91 -37.94 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.16 167.58 12.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.836 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' E' ' 106' ' ' ARG . . . -70.11 -53.85 15.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.42 28.74 6.08 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.564 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.808 ' HB3' ' HB ' ' B' ' 85' ' ' VAL . 10.2 m170 -111.38 -45.62 3.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.45 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' THR . . . . . 0.487 HG22 HH21 ' E' ' 106' ' ' ARG . 0.0 OUTLIER 46.41 -86.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.59 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' B' ' 82' ' ' HIS . 0.0 OUTLIER -42.3 -42.35 3.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.299 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.808 ' HB ' ' HB3' ' B' ' 82' ' ' HIS . 21.3 t -61.33 126.62 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.145 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 1.061 HD22 ' HB1' ' B' ' 150' ' ' ALA . 0.2 OUTLIER -81.31 164.33 22.27 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.281 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.769 ' HA ' ' HB ' ' B' ' 78' ' ' ILE . . . -104.74 -177.52 3.39 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.841 0.353 . . . . 0.0 111.67 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.03 -174.51 5.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.052 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.63 -170.68 3.22 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.394 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' SER . . . . . 0.898 ' HA ' HG13 ' E' ' 52' ' ' VAL . 27.4 p -74.85 7.95 2.8 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.92 0.39 . . . . 0.0 111.408 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' B' ' 95' ' ' SER . 0.8 OUTLIER -97.07 80.4 2.95 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.621 ' HA ' ' HB2' ' E' ' 50' ' ' SER . . . -66.83 -41.18 87.87 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.841 0.353 . . . . 0.0 111.664 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' E' ' 36' ' ' GLN . . . -103.76 26.07 9.05 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.698 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.81 -22.66 0.33 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.922 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' B' ' 91' ' ' SER . 1.0 OUTLIER -107.64 175.21 5.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.93 0.395 . . . . 0.0 110.606 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.53 177.18 3.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.848 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.498 ' O ' HG12 ' B' ' 99' ' ' VAL . 0.2 OUTLIER -138.59 167.89 20.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.27 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 98' ' ' ASN . . . . . 0.578 ' HA ' ' HB ' ' B' ' 140' ' ' THR . 32.2 m-80 44.12 51.63 7.2 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.53 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' VAL . . . . . 0.498 HG12 ' O ' ' B' ' 97' ' ' THR . 6.1 p -169.31 124.12 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.823 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.5 -164.68 11.5 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.619 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.86 91.12 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 122.925 0.49 . . . . 0.0 111.695 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.719 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 0.4 OUTLIER -71.42 116.58 11.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.919 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.656 HD12 HD11 ' B' ' 113' ' ' LEU . 6.6 mt -89.51 120.63 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.534 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' LEU . . . . . 0.499 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 1.0 OUTLIER -95.88 152.31 18.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.758 0.313 . . . . 0.0 111.041 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.23 160.12 14.58 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.573 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' ARG . . . . . 0.533 ' CZ ' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -68.83 -13.69 62.56 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.858 0.361 . . . . 0.0 111.032 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 44.8 p -74.45 -18.85 60.58 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.03 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.93 -40.15 2.22 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.659 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.34 164.69 13.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.774 0.321 . . . . 0.0 111.078 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -77.37 139.65 39.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.542 HD21 ' HB ' ' B' ' 117' ' ' THR . 5.9 tt -84.09 128.59 34.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.438 0.637 . . . . 0.0 110.462 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.4 m -68.13 132.38 47.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.111 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.656 HD11 HD12 ' B' ' 103' ' ' ILE . 4.7 mp -88.1 99.74 12.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.726 0.298 . . . . 0.0 110.748 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ASP . . . . . 0.504 ' O ' ' O ' ' E' ' 130' ' ' THR . 0.8 OUTLIER -144.1 -32.34 0.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.495 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 115' ' ' GLY . . . . . 0.495 ' CA ' HD23 ' B' ' 74' ' ' LEU . . . 146.44 -81.23 0.21 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.68 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' ALA . . . . . 0.698 ' HA ' ' HB1' ' B' ' 72' ' ' ALA . . . -97.24 64.02 1.88 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.986 0.422 . . . . 0.0 111.602 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' THR . . . . . 0.542 ' HB ' HD21 ' B' ' 111' ' ' LEU . 2.8 m -94.28 72.28 3.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.212 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.73 119.05 11.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.82 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.96 -48.97 0.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.57 84.68 6.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.559 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' B' ' 70' ' ' ALA . 3.5 mt-10 -110.19 87.0 2.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.227 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.09 159.32 17.6 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.802 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -67.0 138.35 57.18 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.666 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.867 HD12 ' HB2' ' B' ' 69' ' ' ALA . 0.4 OUTLIER -86.49 159.5 19.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.665 179.4 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.62 176.25 10.23 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.602 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' ASN . . . . . 0.531 ' OD1' ' HA ' ' B' ' 62' ' ' ASP . 0.9 OUTLIER -85.94 161.49 19.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.641 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.5 -121.03 5.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.756 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 73.2 m -119.5 140.32 50.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.661 0.267 . . . . 0.0 110.779 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ASN . . . . . 0.462 ' O ' HD12 ' B' ' 58' ' ' LEU . 5.1 t-20 -133.76 154.63 50.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.06 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.703 HG22 ' HA ' ' B' ' 57' ' ' GLN . 28.4 p -133.32 154.25 50.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.217 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' ILE . . . . . 0.673 ' O ' ' HA ' ' B' ' 55' ' ' ASN . 1.0 OUTLIER -110.95 116.89 51.22 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 132' ' ' PRO . . . . . 0.533 ' HG2' ' CZ ' ' B' ' 106' ' ' ARG . 7.6 Cg_endo -81.2 129.46 6.79 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 121.672 1.581 . . . . 0.0 112.594 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.463 ' HB3' ' CE1' ' B' ' 54' ' ' PHE . 0.1 OUTLIER -140.9 146.84 37.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.78 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 134' ' ' GLN . . . . . 0.539 ' HB3' ' HB1' ' B' ' 51' ' ' ALA . 8.4 mm100 -116.57 158.38 23.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.022 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' B' ' 103' ' ' ILE . . . -159.41 105.52 1.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 111.515 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.71 172.55 6.74 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.417 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.25 147.75 24.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.081 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.6 159.01 35.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.031 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.711 ' HB2' ' CB ' ' B' ' 42' ' ' LEU . . . -116.26 141.33 48.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.913 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 140' ' ' THR . . . . . 0.578 ' HB ' ' HA ' ' B' ' 98' ' ' ASN . 0.3 OUTLIER -107.86 27.27 9.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.467 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 141' ' ' GLY . . . . . 0.579 ' HA2' ' N ' ' B' ' 45' ' ' GLU . . . 97.49 83.6 1.7 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.015 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 142' ' ' ALA . . . . . 0.727 ' HA ' ' HA ' ' B' ' 43' ' ' ALA . . . 57.89 93.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.607 0.204 . . . . 0.0 110.821 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 143' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' B' ' 98' ' ' ASN . . . -80.05 165.51 22.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.709 0.29 . . . . 0.0 111.448 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 29.6 p -108.43 168.81 7.29 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.204 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.66 133.52 6.09 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.579 2.186 . . . . 0.0 111.987 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.61 -119.22 0.81 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.427 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.82 121.64 13.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.842 0.353 . . . . 0.0 111.306 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.32 85.7 3.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.5 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -104.6 131.23 52.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.56 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 1.061 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -136.1 148.47 48.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.949 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -133.19 120.21 20.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.197 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.61 140.01 24.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.199 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.621 HG22 ' HA ' ' A' ' 9' ' ' THR . 70.7 p -105.16 171.18 7.46 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 154' ' ' PHE . . . . . 0.511 ' HZ ' HG21 ' B' ' 56' ' ' ILE . 13.6 p90 -138.16 147.44 43.86 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.104 0.478 . . . . 0.0 110.124 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 155' ' ' LYS . . . . . 0.731 ' HG2' HD11 ' B' ' 74' ' ' LEU . 13.6 mmtt -100.94 172.02 7.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.892 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 156' ' ' VAL . . . . . 0.64 HG23 HG23 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -135.51 111.38 12.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.738 0.304 . . . . 0.0 111.681 -179.043 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 3' ' ' THR . 1.8 tt0 -109.06 141.28 41.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.369 0.604 . . . . 0.0 110.383 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 158' ' ' TYR . . . . . 0.485 ' CZ ' ' HB ' ' B' ' 156' ' ' VAL . 23.2 m-85 -135.39 105.55 6.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.553 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 159' ' ' GLN . . . . . 0.62 ' HG3' ' HB2' ' A' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.855 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 2' ' ' ALA . . . . . 0.672 ' H ' ' HA ' ' D' ' 159' ' ' GLN . . . 56.66 88.58 0.05 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.988 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' D' ' 157' ' ' GLN . 0.2 OUTLIER -103.05 110.38 22.28 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.428 179.708 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.4 136.24 38.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.523 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.646 HG23 HG23 ' D' ' 156' ' ' VAL . 0.0 OUTLIER -152.08 -175.28 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.63 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.54 130.08 38.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.595 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.81 -59.29 0.91 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.804 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.41 166.23 28.08 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.864 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 9' ' ' THR . . . . . 0.626 ' HA ' HG22 ' D' ' 153' ' ' THR . 27.0 m -94.46 121.16 35.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 111.219 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.6 115.61 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.258 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -99.56 137.51 37.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.311 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 12' ' ' PHE . . . . . 0.579 ' HA ' ' O ' ' D' ' 32' ' ' VAL . 75.8 m-85 -127.56 97.73 4.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.21 175.84 6.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.442 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.93 149.46 5.77 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.914 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.28 108.58 13.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.773 0.321 . . . . 0.0 110.432 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' D' ' 37' ' ' VAL . 23.1 t -86.6 129.07 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.283 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' C' ' 22' ' ' ALA . 18.7 m -127.39 163.55 30.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.826 0.346 . . . . 0.0 110.993 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -86.0 61.41 6.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.069 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' ALA . . . . . 0.49 ' HB3' HG21 ' C' ' 65' ' ' VAL . . . 44.95 52.64 8.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 20' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' C' ' 61' ' ' CYS . . . -127.29 -54.43 1.36 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.467 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 21' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.1 OUTLIER 177.73 111.65 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.92 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 22' ' ' ALA . . . . . 0.494 ' HB2' HG22 ' C' ' 17' ' ' VAL . . . -105.64 126.06 51.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.8 145.66 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.022 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.61 ' O ' HG23 ' C' ' 28' ' ' VAL . 4.0 m-20 -74.86 147.24 41.27 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.693 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.78 -43.64 18.43 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.337 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.88 -20.01 60.32 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.946 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 45.2 t -79.62 -26.04 41.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.857 0.36 . . . . 0.0 110.833 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.61 HG23 ' O ' ' C' ' 24' ' ' ASP . 57.5 t -49.08 -48.58 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.341 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.82 93.07 5.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.069 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.59 116.41 28.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.994 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 9.1 p -95.63 115.66 27.75 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.115 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' B' ' 12' ' ' PHE . 1.7 t -117.19 101.1 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.059 0.457 . . . . 0.0 110.438 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.55 126.9 52.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.688 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.19 -55.71 11.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.611 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.06 -111.71 3.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.471 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' GLN . . . . . 0.546 ' HG3' ' HA ' ' B' ' 24' ' ' ASP . 0.0 OUTLIER -77.02 115.32 16.72 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.516 0.198 . . . . 0.0 110.894 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' B' ' 16' ' ' VAL . 67.2 t -130.99 105.83 11.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.881 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.71 154.1 17.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.748 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.656 ' HA ' HD12 ' C' ' 42' ' ' LEU . 8.3 p -78.7 -19.86 51.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.779 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.53 -19.49 65.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 110.879 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 97.5 p -92.06 -21.26 20.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.143 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.716 ' CB ' ' HB2' ' C' ' 139' ' ' ALA . 0.2 OUTLIER -139.06 62.31 1.54 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.62 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 43' ' ' ALA . . . . . 0.726 ' HA ' ' HA ' ' C' ' 142' ' ' ALA . . . -101.26 9.2 42.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.23 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.25 136.07 24.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.306 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' GLU . . . . . 0.589 ' N ' ' HA2' ' C' ' 141' ' ' GLY . 16.5 tt0 -58.54 121.32 10.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 111.139 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.32 -25.43 8.22 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.189 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.8 137.27 58.22 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.937 0.398 . . . . 0.0 112.034 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.9 158.0 44.55 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.935 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.92 -166.23 1.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.627 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 48.8 m -65.18 156.25 32.35 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.782 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' ALA . . . . . 0.525 ' HB1' ' HB3' ' C' ' 134' ' ' GLN . . . -90.56 126.63 36.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.309 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.501 HG12 ' HD2' ' C' ' 54' ' ' PHE . 62.9 t -75.64 118.52 21.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.982 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.85 135.71 13.81 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.632 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' PHE . . . . . 0.501 ' HD2' HG12 ' C' ' 52' ' ' VAL . 46.3 p90 -170.76 142.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.755 0.312 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' C' ' 131' ' ' ILE . 11.5 p30 -126.56 163.91 22.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.569 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' C' ' 130' ' ' THR . 20.8 mm -105.1 119.89 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.519 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.694 ' HA ' HG22 ' C' ' 130' ' ' THR . 0.0 OUTLIER -82.09 115.69 21.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.761 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 58' ' ' LEU . . . . . 0.643 HD11 HG13 ' C' ' 131' ' ' ILE . 0.0 OUTLIER -128.23 107.45 9.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.295 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.36 176.99 8.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.954 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.03 66.24 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.734 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 61' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 3.3 m -109.75 154.4 22.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.668 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 62' ' ' ASP . . . . . 0.516 ' HA ' ' OD1' ' C' ' 126' ' ' ASN . 0.5 OUTLIER -154.65 138.33 16.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.295 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' C' ' 66' ' ' ALA . 0.2 OUTLIER -97.54 -11.9 23.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.07 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -72.26 -48.71 40.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.026 0.441 . . . . 0.0 111.732 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.49 HG21 ' HB3' ' C' ' 19' ' ' ALA . 10.6 t -69.0 -48.73 68.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.716 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 66' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' C' ' 159' ' ' GLN . . . -137.93 153.36 49.5 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.672 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.28 18.67 4.43 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.847 0.356 . . . . 0.0 110.878 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 68' ' ' LYS . . . . . 0.623 ' HB3' ' HB3' ' C' ' 159' ' ' GLN . 10.6 tppt? -142.9 149.95 39.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.41 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.864 ' HB2' HD12 ' C' ' 124' ' ' LEU . . . -150.02 110.71 4.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.671 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' C' ' 121' ' ' GLU . . . -108.07 169.97 8.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.083 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 71' ' ' VAL . . . . . 0.439 HG21 HG21 ' C' ' 131' ' ' ILE . 0.5 OUTLIER -130.38 150.96 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.632 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 72' ' ' ALA . . . . . 0.695 ' HB1' ' HA ' ' C' ' 116' ' ' ALA . . . -135.55 100.06 4.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.62 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 73' ' ' PHE . . . . . 0.436 ' HB2' HD22 ' C' ' 111' ' ' LEU . 0.2 OUTLIER -77.41 133.95 38.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.552 0.215 . . . . 0.0 111.117 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.748 HD11 ' HG2' ' C' ' 155' ' ' LYS . 0.0 OUTLIER -124.15 115.08 20.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.968 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.42 -173.24 26.57 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.761 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.609 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 7.1 m -112.61 149.0 33.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.618 0.247 . . . . 0.0 110.737 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 77' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' C' ' 85' ' ' VAL . . . -98.96 133.78 42.73 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.936 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 78' ' ' ILE . . . . . 0.758 ' HB ' ' HA ' ' C' ' 87' ' ' ALA . 16.1 tt -72.89 -38.01 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.13 167.61 12.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.802 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 80' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' F' ' 106' ' ' ARG . . . -70.21 -53.78 15.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.08 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.4 28.66 6.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.546 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 82' ' ' HIS . . . . . 0.822 ' HB3' ' HB ' ' C' ' 85' ' ' VAL . 10.2 m170 -111.3 -45.67 3.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.46 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 83' ' ' THR . . . . . 0.476 HG22 HH21 ' F' ' 106' ' ' ARG . 0.0 OUTLIER 46.48 -86.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.552 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 84' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' C' ' 82' ' ' HIS . 0.0 OUTLIER -42.19 -42.48 3.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.277 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.822 ' HB ' ' HB3' ' C' ' 82' ' ' HIS . 21.3 t -61.25 126.56 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.148 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 1.064 HD22 ' HB1' ' C' ' 150' ' ' ALA . 0.2 OUTLIER -81.22 164.39 22.32 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.413 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.758 ' HA ' ' HB ' ' C' ' 78' ' ' ILE . . . -104.79 -177.54 3.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.84 0.352 . . . . 0.0 111.661 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.03 -174.53 5.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.049 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.63 -170.66 3.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.317 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 90' ' ' SER . . . . . 0.909 ' HA ' HG13 ' F' ' 52' ' ' VAL . 26.9 p -74.85 7.85 2.86 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.989 0.423 . . . . 0.0 111.408 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 91' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' C' ' 95' ' ' SER . 0.8 OUTLIER -96.97 80.45 2.98 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.84 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 92' ' ' ALA . . . . . 0.613 ' HA ' ' HB2' ' F' ' 50' ' ' SER . . . -66.83 -41.24 87.78 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.853 0.359 . . . . 0.0 111.618 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 93' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' F' ' 36' ' ' GLN . . . -103.7 25.98 9.12 Favored 'General case' 0 N--CA 1.46 0.068 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.707 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.83 -22.69 0.33 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.947 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 95' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' C' ' 91' ' ' SER . 1.0 OUTLIER -107.66 175.18 5.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.913 0.387 . . . . 0.0 110.593 179.544 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.41 177.1 3.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 97' ' ' THR . . . . . 0.505 ' O ' HG12 ' C' ' 99' ' ' VAL . 0.2 OUTLIER -138.52 167.88 20.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.269 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 98' ' ' ASN . . . . . 0.58 ' HA ' ' HB ' ' C' ' 140' ' ' THR . 32.5 m-80 44.17 51.7 7.26 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.48 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 99' ' ' VAL . . . . . 0.505 HG12 ' O ' ' C' ' 97' ' ' THR . 6.0 p -169.39 124.12 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.767 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 100' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' C' ' 86' ' ' LEU . . . -129.55 -164.72 11.5 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.638 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 101' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.77 91.15 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 122.975 0.51 . . . . 0.0 111.7 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 102' ' ' GLN . . . . . 0.7 ' HA ' ' HA ' ' C' ' 85' ' ' VAL . 0.4 OUTLIER -71.45 116.63 12.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.858 -179.703 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.647 HD12 HD11 ' C' ' 113' ' ' LEU . 6.6 mt -89.68 120.61 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.445 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 104' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 1.0 OUTLIER -95.81 152.27 18.63 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.689 0.28 . . . . 0.0 111.164 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.16 160.07 14.62 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.601 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 106' ' ' ARG . . . . . 0.533 ' CZ ' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -68.8 -13.68 62.55 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.827 0.346 . . . . 0.0 111.066 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 45.0 p -74.37 -18.92 60.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.081 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.91 -40.01 2.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.71 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.41 164.71 13.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.816 0.341 . . . . 0.0 111.116 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -77.35 139.58 39.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.174 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 111' ' ' LEU . . . . . 0.553 HD21 ' HB ' ' C' ' 117' ' ' THR . 5.9 tt -84.08 128.48 34.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.435 0.636 . . . . 0.0 110.519 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 112' ' ' THR . . . . . . . . . . . . . 1.4 m -68.14 132.39 47.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.126 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.647 HD11 HD12 ' C' ' 103' ' ' ILE . 4.7 mp -87.99 99.69 12.35 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.791 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 114' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' F' ' 130' ' ' THR . 0.8 OUTLIER -144.03 -32.49 0.43 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.626 0.25 . . . . 0.0 111.568 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 115' ' ' GLY . . . . . 0.491 ' CA ' HD23 ' C' ' 74' ' ' LEU . . . 146.5 -81.25 0.21 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.669 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 116' ' ' ALA . . . . . 0.695 ' HA ' ' HB1' ' C' ' 72' ' ' ALA . . . -97.25 64.0 1.88 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.975 0.417 . . . . 0.0 111.659 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 117' ' ' THR . . . . . 0.553 ' HB ' HD21 ' C' ' 111' ' ' LEU . 2.8 m -94.26 72.28 3.88 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.18 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -66.69 119.04 11.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.9 t -143.95 -48.96 0.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.809 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 3.0 m -88.57 84.7 6.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.584 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 121' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' C' ' 70' ' ' ALA . 3.5 mt-10 -110.25 86.92 2.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.287 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.95 159.27 17.73 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -66.93 138.34 57.21 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.699 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 124' ' ' LEU . . . . . 0.864 HD12 ' HB2' ' C' ' 69' ' ' ALA . 0.4 OUTLIER -86.56 159.48 19.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.636 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.56 176.28 10.19 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.562 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 126' ' ' ASN . . . . . 0.516 ' OD1' ' HA ' ' C' ' 62' ' ' ASP . 0.9 OUTLIER -85.92 161.52 19.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.681 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.5 -121.0 5.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.756 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 72.4 m -119.47 140.36 50.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.675 0.274 . . . . 0.0 110.815 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 129' ' ' ASN . . . . . 0.46 ' O ' HD12 ' C' ' 58' ' ' LEU . 5.1 t-20 -133.8 154.64 50.86 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.876 0.37 . . . . 0.0 111.087 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 130' ' ' THR . . . . . 0.694 HG22 ' HA ' ' C' ' 57' ' ' GLN . 28.0 p -133.37 154.29 50.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.133 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 131' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' C' ' 55' ' ' ASN . 1.0 OUTLIER -111.0 116.84 51.19 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 132' ' ' PRO . . . . . 0.533 ' HG2' ' CZ ' ' C' ' 106' ' ' ARG . 7.7 Cg_endo -81.12 129.4 6.83 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.662 1.574 . . . . 0.0 112.675 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.464 ' HB3' ' CE1' ' C' ' 54' ' ' PHE . 0.1 OUTLIER -140.87 146.89 38.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.813 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 134' ' ' GLN . . . . . 0.525 ' HB3' ' HB1' ' C' ' 51' ' ' ALA . 8.4 mm100 -116.47 158.39 23.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.043 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 135' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' C' ' 103' ' ' ILE . . . -159.48 105.53 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.91 0.386 . . . . 0.0 111.545 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.72 172.5 6.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.399 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.16 147.72 24.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.128 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.58 158.99 35.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.057 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 139' ' ' ALA . . . . . 0.716 ' HB2' ' CB ' ' C' ' 42' ' ' LEU . . . -116.27 141.28 48.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.934 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 140' ' ' THR . . . . . 0.58 ' HB ' ' HA ' ' C' ' 98' ' ' ASN . 0.2 OUTLIER -107.83 27.23 9.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.471 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 141' ' ' GLY . . . . . 0.589 ' HA2' ' N ' ' C' ' 45' ' ' GLU . . . 97.63 83.59 1.71 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.97 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 142' ' ' ALA . . . . . 0.726 ' HA ' ' HA ' ' C' ' 43' ' ' ALA . . . 57.9 93.41 0.03 OUTLIER 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.666 0.233 . . . . 0.0 110.8 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 143' ' ' ALA . . . . . 0.547 ' HA ' ' HB2' ' C' ' 98' ' ' ASN . . . -80.02 165.38 22.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.764 0.316 . . . . 0.0 111.392 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 144' ' ' THR . . . . . . . . . . . . . 29.8 p -108.35 168.87 7.22 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.228 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.68 133.56 6.09 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.533 2.155 . . . . 0.0 112.015 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 146' ' ' GLY . . . . . 0.62 ' HA2' HG12 ' A' ' 5' ' ' VAL . . . 169.6 -119.25 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.477 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.8 121.73 13.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.887 0.375 . . . . 0.0 111.339 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.42 85.71 3.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.419 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -104.61 131.24 52.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.548 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 150' ' ' ALA . . . . . 1.064 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -136.06 148.51 48.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.971 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.24 120.19 20.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.205 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.64 140.0 24.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.207 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 153' ' ' THR . . . . . 0.624 HG22 ' HA ' ' B' ' 9' ' ' THR . 70.7 p -105.16 171.19 7.45 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 154' ' ' PHE . . . . . 0.51 ' HZ ' HG21 ' C' ' 56' ' ' ILE . 13.9 p90 -138.21 147.41 43.73 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.114 0.483 . . . . 0.0 110.074 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 155' ' ' LYS . . . . . 0.748 ' HG2' HD11 ' C' ' 74' ' ' LEU . 13.7 mmtt -100.89 171.94 7.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.936 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 156' ' ' VAL . . . . . 0.652 HG23 HG23 ' B' ' 5' ' ' VAL . 0.4 OUTLIER -135.47 111.41 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.84 0.352 . . . . 0.0 111.716 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 157' ' ' GLN . . . . . 0.556 ' HA ' ' O ' ' B' ' 3' ' ' THR . 1.8 tt0 -108.96 141.29 41.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.349 0.595 . . . . 0.0 110.409 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 158' ' ' TYR . . . . . 0.484 ' CZ ' ' HB ' ' C' ' 156' ' ' VAL . 23.0 m-85 -135.37 105.47 6.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.595 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 159' ' ' GLN . . . . . 0.695 ' HA ' ' H ' ' B' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 111.495 0.183 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 2' ' ' ALA . . . . . 0.68 ' H ' ' HA ' ' E' ' 159' ' ' GLN . . . 56.69 88.54 0.05 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.713 -0.222 . . . . 0.0 110.963 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 3' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' E' ' 157' ' ' GLN . 0.2 OUTLIER -103.08 110.38 22.29 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.383 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.36 136.2 38.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.592 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.646 HG23 HG23 ' E' ' 156' ' ' VAL . 0.0 OUTLIER -152.05 -175.35 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.562 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.44 130.05 38.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.685 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.81 -59.23 0.91 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.8 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.34 166.18 27.93 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.868 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 9' ' ' THR . . . . . 0.612 ' HA ' HG22 ' E' ' 153' ' ' THR . 27.0 m -94.38 121.15 35.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 0.0 111.197 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.73 115.61 36.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.208 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -99.54 137.51 37.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.374 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 12' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' E' ' 32' ' ' VAL . 76.0 m-85 -127.6 97.74 4.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.792 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.31 175.76 6.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.428 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.0 149.45 5.77 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.948 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.29 108.58 13.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.855 0.359 . . . . 0.0 110.35 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' E' ' 37' ' ' VAL . 23.5 t -86.59 129.1 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.243 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' D' ' 22' ' ' ALA . 18.8 m -127.35 163.54 30.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.815 0.34 . . . . 0.0 111.011 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -85.97 61.4 6.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.052 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' ALA . . . . . 0.487 ' HB3' HG21 ' D' ' 65' ' ' VAL . . . 44.88 52.64 7.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' D' ' 61' ' ' CYS . . . -127.22 -54.42 1.37 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.49 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 21' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.1 OUTLIER 177.64 111.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.879 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 22' ' ' ALA . . . . . 0.498 ' HB2' HG22 ' D' ' 17' ' ' VAL . . . -105.69 126.06 51.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.108 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.81 145.65 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.003 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.612 ' O ' HG23 ' D' ' 28' ' ' VAL . 4.0 m-20 -74.77 147.26 41.44 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.692 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.74 -43.62 18.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.396 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.96 -20.01 60.17 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.863 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 45.1 t -79.54 -26.12 41.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.899 0.381 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' VAL . . . . . 0.612 HG23 ' O ' ' D' ' 24' ' ' ASP . 57.3 t -49.1 -48.53 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.33 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.82 93.01 5.32 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.093 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.55 116.42 28.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.038 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.66 115.62 27.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.173 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' C' ' 12' ' ' PHE . 1.6 t -117.14 101.08 11.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.072 0.463 . . . . 0.0 110.469 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.58 126.97 52.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.698 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -68.2 -55.67 11.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.653 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.02 -111.69 3.94 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.498 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' GLN . . . . . 0.538 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -77.04 115.26 16.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.513 0.197 . . . . 0.0 110.947 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' C' ' 16' ' ' VAL . 67.6 t -131.0 105.83 11.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.888 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.67 154.1 17.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.722 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.637 ' HA ' HD12 ' D' ' 42' ' ' LEU . 8.3 p -78.7 -19.86 51.43 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.775 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -19.53 65.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.14 0.495 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 96.8 p -92.05 -21.2 20.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.184 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.718 ' CB ' ' HB2' ' D' ' 139' ' ' ALA . 0.2 OUTLIER -139.08 62.25 1.54 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.602 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 43' ' ' ALA . . . . . 0.728 ' HA ' ' HA ' ' D' ' 142' ' ' ALA . . . -101.15 9.17 42.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.36 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.17 136.06 24.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.359 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 45' ' ' GLU . . . . . 0.587 ' N ' ' HA2' ' D' ' 141' ' ' GLY . 16.4 tt0 -58.53 121.37 10.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 0.0 111.133 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.25 -25.44 8.25 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.209 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.75 137.22 58.21 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.83 158.07 44.32 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.95 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.05 -166.23 1.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.512 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.632 ' HB2' ' HA ' ' A' ' 92' ' ' ALA . 48.9 m -65.17 156.11 32.79 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.769 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 51' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' D' ' 134' ' ' GLN . . . -90.46 126.7 35.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.358 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 52' ' ' VAL . . . . . 0.869 HG13 ' HA ' ' A' ' 90' ' ' SER . 63.2 t -75.66 118.53 21.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.999 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.84 135.69 13.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.672 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.538 ' H ' HG21 ' A' ' 76' ' ' THR . 46.3 p90 -170.77 142.11 1.9 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 55' ' ' ASN . . . . . 0.68 ' HA ' ' O ' ' D' ' 131' ' ' ILE . 11.6 p30 -126.58 163.88 22.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.526 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' D' ' 130' ' ' THR . 20.7 mm -105.08 119.93 54.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.516 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 57' ' ' GLN . . . . . 0.698 ' HA ' HG22 ' D' ' 130' ' ' THR . 0.0 OUTLIER -82.15 115.65 21.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.761 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 58' ' ' LEU . . . . . 0.64 HD11 HG13 ' D' ' 131' ' ' ILE . 0.0 OUTLIER -128.21 107.42 9.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.298 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.35 177.0 8.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.951 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.11 66.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.756 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 61' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 3.3 m -109.66 154.39 22.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.742 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 62' ' ' ASP . . . . . 0.522 ' HA ' ' OD1' ' D' ' 126' ' ' ASN . 0.5 OUTLIER -154.66 138.37 16.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.214 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' D' ' 66' ' ' ALA . 0.2 OUTLIER -97.64 -11.82 23.14 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.19 -48.82 40.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.03 0.443 . . . . 0.0 111.746 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 65' ' ' VAL . . . . . 0.487 HG21 ' HB3' ' D' ' 19' ' ' ALA . 10.5 t -68.92 -48.71 68.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.742 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' D' ' 159' ' ' GLN . . . -137.97 153.32 49.46 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.637 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.27 18.68 4.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.926 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 68' ' ' LYS . . . . . 0.621 ' HB3' ' HB3' ' D' ' 159' ' ' GLN . 10.6 tppt? -142.84 149.9 39.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.573 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 69' ' ' ALA . . . . . 0.869 ' HB2' HD12 ' D' ' 124' ' ' LEU . . . -149.97 110.75 4.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.633 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 70' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' D' ' 121' ' ' GLU . . . -108.06 169.95 8.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.131 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 71' ' ' VAL . . . . . 0.431 HG21 HG21 ' D' ' 131' ' ' ILE . 0.5 OUTLIER -130.4 150.96 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.642 -179.507 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 72' ' ' ALA . . . . . 0.685 ' HB1' ' HA ' ' D' ' 116' ' ' ALA . . . -135.57 100.1 4.4 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.555 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 73' ' ' PHE . . . . . 0.435 ' HB2' HD22 ' D' ' 111' ' ' LEU . 0.2 OUTLIER -77.46 133.94 38.49 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.599 0.238 . . . . 0.0 111.128 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 74' ' ' LEU . . . . . 0.749 HD11 ' HG2' ' D' ' 155' ' ' LYS . 0.0 OUTLIER -124.15 115.08 20.53 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.932 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.35 -173.22 26.48 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.821 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -112.62 149.06 33.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.681 0.277 . . . . 0.0 110.739 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' D' ' 85' ' ' VAL . . . -98.95 133.79 42.72 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.939 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 78' ' ' ILE . . . . . 0.787 ' HB ' ' HA ' ' D' ' 87' ' ' ALA . 16.1 tt -72.96 -37.95 55.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.89 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.21 167.63 12.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.834 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.22 -53.83 15.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.08 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.36 28.71 6.07 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.536 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 82' ' ' HIS . . . . . 0.832 ' HB3' ' HB ' ' D' ' 85' ' ' VAL . 10.3 m170 -111.33 -45.7 3.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.928 0.394 . . . . 0.0 110.453 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.39 -86.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.603 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 84' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' D' ' 82' ' ' HIS . 0.0 OUTLIER -42.19 -42.46 3.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.268 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.832 ' HB ' ' HB3' ' D' ' 82' ' ' HIS . 21.3 t -61.3 126.53 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.135 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.997 HD22 ' HB1' ' D' ' 150' ' ' ALA . 0.2 OUTLIER -81.22 164.42 22.3 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.432 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.787 ' HA ' ' HB ' ' D' ' 78' ' ' ILE . . . -104.84 -177.53 3.39 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.852 0.358 . . . . 0.0 111.618 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.01 -174.53 5.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.009 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.64 -170.72 3.24 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.367 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 27.8 p -74.76 7.87 2.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.905 0.383 . . . . 0.0 111.46 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 91' ' ' SER . . . . . 0.421 ' HB2' ' HB3' ' D' ' 95' ' ' SER . 0.8 OUTLIER -97.06 80.41 2.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.84 -41.2 87.81 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.82 0.343 . . . . 0.0 111.636 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.72 26.01 9.1 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.682 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.77 -22.64 0.33 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.892 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 95' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' D' ' 91' ' ' SER . 1.0 OUTLIER -107.65 175.18 5.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 110.661 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.35 177.1 2.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 97' ' ' THR . . . . . 0.497 ' O ' HG12 ' D' ' 99' ' ' VAL . 0.2 OUTLIER -138.6 167.85 21.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.278 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 98' ' ' ASN . . . . . 0.585 ' HA ' ' HB ' ' D' ' 140' ' ' THR . 32.4 m-80 44.2 51.68 7.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.489 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 99' ' ' VAL . . . . . 0.497 HG12 ' O ' ' D' ' 97' ' ' THR . 6.0 p -169.34 124.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.702 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.61 -164.65 11.47 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.58 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 101' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.84 91.13 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.202 0.525 . . . . 0.0 111.73 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 102' ' ' GLN . . . . . 0.706 ' HA ' ' HA ' ' D' ' 85' ' ' VAL . 0.4 OUTLIER -71.43 116.65 12.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.857 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 103' ' ' ILE . . . . . 0.666 HD12 HD11 ' D' ' 113' ' ' LEU . 6.6 mt -89.61 120.64 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.457 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 104' ' ' LEU . . . . . 0.517 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 1.0 OUTLIER -95.84 152.32 18.6 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.691 0.281 . . . . 0.0 111.126 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.14 160.09 14.6 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.629 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 106' ' ' ARG . . . . . 0.536 ' CZ ' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -68.89 -13.6 62.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.835 0.35 . . . . 0.0 111.075 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 107' ' ' THR . . . . . . . . . . . . . 45.3 p -74.42 -18.9 60.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.144 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.0 -40.15 2.22 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.669 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.3 164.7 13.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.338 . . . . 0.0 111.119 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -77.4 139.66 39.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.148 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 111' ' ' LEU . . . . . 0.554 HD21 ' HB ' ' D' ' 117' ' ' THR . 5.9 tt -84.18 128.59 34.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.404 0.621 . . . . 0.0 110.503 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 112' ' ' THR . . . . . 0.408 ' O ' HD23 ' D' ' 111' ' ' LEU . 1.4 m -68.13 132.36 47.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.17 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 113' ' ' LEU . . . . . 0.666 HD11 HD12 ' D' ' 103' ' ' ILE . 4.7 mp -88.06 99.74 12.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.693 0.282 . . . . 0.0 110.737 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.06 -32.43 0.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.539 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 115' ' ' GLY . . . . . 0.497 ' CA ' HD23 ' D' ' 74' ' ' LEU . . . 146.45 -81.29 0.21 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.666 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 116' ' ' ALA . . . . . 0.685 ' HA ' ' HB1' ' D' ' 72' ' ' ALA . . . -97.23 64.12 1.89 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.0 0.429 . . . . 0.0 111.624 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 117' ' ' THR . . . . . 0.554 ' HB ' HD21 ' D' ' 111' ' ' LEU . 2.8 m -94.42 72.31 3.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.76 119.07 11.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.828 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.89 -49.03 0.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.57 84.75 6.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.575 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 121' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' D' ' 70' ' ' ALA . 3.6 mt-10 -110.16 86.94 2.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.268 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.0 159.32 17.66 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.83 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -67.07 138.33 57.07 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.68 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 124' ' ' LEU . . . . . 0.869 HD12 ' HB2' ' D' ' 69' ' ' ALA . 0.4 OUTLIER -86.47 159.46 19.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.68 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.55 176.28 10.19 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.635 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 126' ' ' ASN . . . . . 0.522 ' OD1' ' HA ' ' D' ' 62' ' ' ASP . 0.9 OUTLIER -85.98 161.52 18.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.639 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.53 -121.06 5.73 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.764 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 128' ' ' THR . . . . . 0.566 HG21 ' HE2' ' A' ' 155' ' ' LYS . 74.1 m -119.5 140.3 50.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.659 0.266 . . . . 0.0 110.765 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 129' ' ' ASN . . . . . 0.452 ' O ' HD12 ' D' ' 58' ' ' LEU . 5.1 t-20 -133.74 154.63 50.83 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.912 0.387 . . . . 0.0 111.087 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 130' ' ' THR . . . . . 0.698 HG22 ' HA ' ' D' ' 57' ' ' GLN . 28.2 p -133.36 154.32 50.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.167 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 131' ' ' ILE . . . . . 0.68 ' O ' ' HA ' ' D' ' 55' ' ' ASN . 1.0 OUTLIER -111.07 116.86 51.01 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 132' ' ' PRO . . . . . 0.6 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 7.7 Cg_endo -81.11 129.36 6.82 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.704 1.603 . . . . 0.0 112.667 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 133' ' ' PHE . . . . . 0.46 ' HB3' ' CE1' ' D' ' 54' ' ' PHE . 0.1 OUTLIER -140.87 146.87 38.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.81 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 134' ' ' GLN . . . . . 0.529 ' HB3' ' HB1' ' D' ' 51' ' ' ALA . 19.5 mm-40 -116.48 158.4 23.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.979 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' D' ' 103' ' ' ILE . . . -159.48 105.61 1.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.931 0.396 . . . . 0.0 111.539 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 136' ' ' ARG . . . . . 0.417 ' HG2' ' H ' ' D' ' 136' ' ' ARG . 1.2 ptt180 -103.68 172.57 6.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.405 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.23 147.72 24.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.086 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.58 159.05 35.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.005 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 139' ' ' ALA . . . . . 0.718 ' HB2' ' CB ' ' D' ' 42' ' ' LEU . . . -116.36 141.31 48.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.85 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 140' ' ' THR . . . . . 0.585 ' HB ' ' HA ' ' D' ' 98' ' ' ASN . 0.2 OUTLIER -107.78 27.2 9.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.496 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 141' ' ' GLY . . . . . 0.587 ' HA2' ' N ' ' D' ' 45' ' ' GLU . . . 97.55 83.6 1.71 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.014 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 142' ' ' ALA . . . . . 0.728 ' HA ' ' HA ' ' D' ' 43' ' ' ALA . . . 57.87 93.49 0.03 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.7 0.25 . . . . 0.0 110.759 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 143' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' D' ' 98' ' ' ASN . . . -79.97 165.44 22.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 111.375 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 144' ' ' THR . . . . . 0.405 ' HB ' ' CD ' ' D' ' 145' ' ' PRO . 29.4 p -108.37 168.85 7.25 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.234 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 145' ' ' PRO . . . . . 0.405 ' CD ' ' HB ' ' D' ' 144' ' ' THR . 1.3 Cg_endo -83.62 133.56 6.14 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.544 2.162 . . . . 0.0 112.002 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 146' ' ' GLY . . . . . 0.609 ' HA2' HG12 ' B' ' 5' ' ' VAL . . . 169.56 -119.25 0.81 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.477 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.84 121.69 13.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.787 0.327 . . . . 0.0 111.327 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.33 85.7 3.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.14 0.495 . . . . 0.0 110.506 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -104.57 131.21 52.25 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.597 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 150' ' ' ALA . . . . . 0.997 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -136.08 148.49 48.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.951 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.16 120.24 20.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.194 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.7 140.0 24.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.164 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 153' ' ' THR . . . . . 0.626 HG22 ' HA ' ' C' ' 9' ' ' THR . 70.7 p -105.2 171.18 7.46 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 154' ' ' PHE . . . . . 0.51 ' HZ ' HG21 ' D' ' 56' ' ' ILE . 13.5 p90 -138.18 147.4 43.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.138 0.494 . . . . 0.0 110.112 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 155' ' ' LYS . . . . . 0.749 ' HG2' HD11 ' D' ' 74' ' ' LEU . 13.7 mmtt -100.9 171.92 7.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.912 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 156' ' ' VAL . . . . . 0.646 HG23 HG23 ' C' ' 5' ' ' VAL . 0.4 OUTLIER -135.4 111.42 12.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.714 -179.104 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 157' ' ' GLN . . . . . 0.564 ' HA ' ' O ' ' C' ' 3' ' ' THR . 1.8 tt0 -109.03 141.32 41.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.273 0.559 . . . . 0.0 110.398 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 158' ' ' TYR . . . . . 0.48 ' CZ ' ' HB ' ' D' ' 156' ' ' VAL . 23.1 m-85 -135.43 105.43 6.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.555 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 159' ' ' GLN . . . . . 0.672 ' HA ' ' H ' ' C' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.899 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 111.48 0.178 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 2' ' ' ALA . . . . . 0.686 ' H ' ' HA ' ' F' ' 159' ' ' GLN . . . 56.56 88.6 0.05 OUTLIER 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.038 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 3' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' F' ' 157' ' ' GLN . 0.2 OUTLIER -103.14 110.34 22.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.411 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.31 136.26 38.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.57 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.66 HG23 HG23 ' F' ' 156' ' ' VAL . 0.0 OUTLIER -152.11 -175.28 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.616 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.54 130.06 38.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.646 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.73 -59.38 0.91 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.805 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.38 166.23 28.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.806 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 9' ' ' THR . . . . . 0.609 ' HA ' HG22 ' F' ' 153' ' ' THR . 27.0 m -94.47 121.18 35.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.939 0.4 . . . . 0.0 111.205 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.69 115.58 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.21 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -99.52 137.56 37.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.327 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 12' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' F' ' 32' ' ' VAL . 76.2 m-85 -127.61 97.78 4.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.815 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.3 175.8 6.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.378 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.97 149.46 5.77 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.91 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.29 108.61 13.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 110.345 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 16' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' F' ' 37' ' ' VAL . 23.4 t -86.62 129.16 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.213 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 17' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' E' ' 22' ' ' ALA . 18.7 m -127.43 163.53 30.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.787 0.327 . . . . 0.0 111.028 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -85.95 61.36 6.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.032 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 19' ' ' ALA . . . . . 0.491 ' HB3' HG21 ' E' ' 65' ' ' VAL . . . 45.0 52.64 8.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.051 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' E' ' 61' ' ' CYS . . . -127.27 -54.47 1.37 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.426 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 21' ' ' CYS . . . . . 0.818 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.1 OUTLIER 177.68 111.67 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.901 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 22' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' E' ' 17' ' ' VAL . . . -105.71 126.0 51.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.86 145.68 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.003 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 24' ' ' ASP . . . . . 0.607 ' O ' HG23 ' E' ' 28' ' ' VAL . 3.9 m-20 -74.9 147.28 41.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.652 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.73 -43.71 18.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.331 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.85 -20.06 60.27 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.865 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 45.1 t -79.58 -26.09 41.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.872 0.367 . . . . 0.0 110.851 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 28' ' ' VAL . . . . . 0.607 HG23 ' O ' ' E' ' 24' ' ' ASP . 57.8 t -49.13 -48.49 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.361 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.89 93.09 5.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.976 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.63 116.38 28.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.04 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.54 115.58 27.63 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.178 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' D' ' 12' ' ' PHE . 1.7 t -117.17 101.14 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.168 0.509 . . . . 0.0 110.463 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.58 126.91 52.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.711 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.613 HD21 ' HB3' ' B' ' 92' ' ' ALA . 0.3 OUTLIER -68.15 -55.71 11.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.619 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.03 -111.69 3.93 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.471 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 36' ' ' GLN . . . . . 0.545 ' HG3' ' HA ' ' D' ' 24' ' ' ASP . 0.0 OUTLIER -77.02 115.34 16.73 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.524 0.202 . . . . 0.0 110.902 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' D' ' 16' ' ' VAL . 67.5 t -131.11 105.85 11.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.819 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.6 154.11 17.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.77 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 39' ' ' THR . . . . . 0.665 ' HA ' HD12 ' E' ' 42' ' ' LEU . 8.4 p -78.71 -19.92 51.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.753 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.38 -19.58 65.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.125 0.488 . . . . 0.0 110.923 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 97.1 p -92.01 -21.24 20.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.156 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.701 ' CB ' ' HB2' ' E' ' 139' ' ' ALA . 0.2 OUTLIER -139.06 62.39 1.54 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.661 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 43' ' ' ALA . . . . . 0.727 ' HA ' ' HA ' ' E' ' 142' ' ' ALA . . . -101.23 9.12 42.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.246 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.15 136.02 24.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.32 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 45' ' ' GLU . . . . . 0.59 ' N ' ' HA2' ' E' ' 141' ' ' GLY . 16.5 tt0 -58.5 121.24 10.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 0.0 111.159 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.36 -25.47 8.19 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.196 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.66 137.24 58.22 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.93 157.93 44.75 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.919 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.97 -166.19 1.09 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.583 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 50' ' ' SER . . . . . 0.621 ' HB2' ' HA ' ' B' ' 92' ' ' ALA . 48.7 m -65.22 156.23 32.53 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.789 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 51' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' E' ' 134' ' ' GLN . . . -90.57 126.66 36.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.274 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 52' ' ' VAL . . . . . 0.898 HG13 ' HA ' ' B' ' 90' ' ' SER . 63.3 t -75.61 118.46 21.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.016 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.78 135.65 13.77 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.663 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 54' ' ' PHE . . . . . 0.531 ' H ' HG21 ' B' ' 76' ' ' THR . 46.2 p90 -170.77 142.04 1.89 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.831 0.348 . . . . 0.0 110.907 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 55' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' E' ' 131' ' ' ILE . 11.6 p30 -126.5 163.87 22.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.621 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 56' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' E' ' 130' ' ' THR . 21.0 mm -105.1 119.93 54.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.52 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 57' ' ' GLN . . . . . 0.675 ' HA ' HG22 ' E' ' 130' ' ' THR . 0.0 OUTLIER -82.18 115.74 21.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.744 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 58' ' ' LEU . . . . . 0.648 HD11 HG13 ' E' ' 131' ' ' ILE . 0.0 OUTLIER -128.28 107.45 9.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.267 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.34 177.09 8.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.924 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 62.95 66.13 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.818 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 61' ' ' CYS . . . . . 0.818 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 3.3 m -109.65 154.42 22.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.785 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 62' ' ' ASP . . . . . 0.512 ' HA ' ' OD1' ' E' ' 126' ' ' ASN . 0.5 OUTLIER -154.68 138.35 16.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.258 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 63' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' E' ' 66' ' ' ALA . 0.2 OUTLIER -97.63 -11.81 23.17 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.131 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.23 -48.72 40.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.993 0.425 . . . . 0.0 111.733 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 65' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' E' ' 19' ' ' ALA . 10.7 t -69.02 -48.67 68.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.712 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 66' ' ' ALA . . . . . 0.554 ' HB1' ' O ' ' E' ' 159' ' ' GLN . . . -137.94 153.39 49.49 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.616 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.3 18.62 4.43 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.802 0.334 . . . . 0.0 110.91 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 68' ' ' LYS . . . . . 0.611 ' HB3' ' HB3' ' E' ' 159' ' ' GLN . 10.6 tppt? -142.83 149.94 39.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.448 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 69' ' ' ALA . . . . . 0.863 ' HB2' HD12 ' E' ' 124' ' ' LEU . . . -150.01 110.65 4.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.729 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 70' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' E' ' 121' ' ' GLU . . . -108.01 169.92 8.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.067 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 71' ' ' VAL . . . . . 0.43 HG21 HG21 ' E' ' 131' ' ' ILE . 0.5 OUTLIER -130.34 150.95 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.681 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 72' ' ' ALA . . . . . 0.701 ' HB1' ' HA ' ' E' ' 116' ' ' ALA . . . -135.59 100.13 4.4 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.528 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 73' ' ' PHE . . . . . 0.437 ' HB2' HD22 ' E' ' 111' ' ' LEU . 0.2 OUTLIER -77.39 133.94 38.56 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.594 0.235 . . . . 0.0 111.136 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 74' ' ' LEU . . . . . 0.731 HD11 ' HG2' ' E' ' 155' ' ' LYS . 0.0 OUTLIER -124.17 115.06 20.49 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.971 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.35 -173.22 26.48 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.79 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -112.66 149.03 33.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.624 0.25 . . . . 0.0 110.715 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 77' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' E' ' 85' ' ' VAL . . . -98.95 133.8 42.71 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.852 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 78' ' ' ILE . . . . . 0.778 ' HB ' ' HA ' ' E' ' 87' ' ' ALA . 16.1 tt -72.95 -37.98 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.19 167.6 12.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.907 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.09 -53.86 15.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.4 28.67 6.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.597 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 82' ' ' HIS . . . . . 0.825 ' HB3' ' HB ' ' E' ' 85' ' ' VAL . 10.2 m170 -111.36 -45.57 3.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 0.0 110.446 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.4 -86.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.567 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 84' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' E' ' 82' ' ' HIS . 0.0 OUTLIER -42.17 -42.4 2.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.402 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.825 ' HB ' ' HB3' ' E' ' 82' ' ' HIS . 21.3 t -61.25 126.57 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.151 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 86' ' ' LEU . . . . . 1.029 HD22 ' HB1' ' E' ' 150' ' ' ALA . 0.2 OUTLIER -81.23 164.4 22.31 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 87' ' ' ALA . . . . . 0.778 ' HA ' ' HB ' ' E' ' 78' ' ' ILE . . . -104.77 -177.51 3.39 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.688 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.03 -174.56 5.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.974 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.59 -170.73 3.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.401 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 27.5 p -74.67 7.73 2.85 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.96 0.41 . . . . 0.0 111.464 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 91' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' E' ' 95' ' ' SER . 0.8 OUTLIER -96.93 80.42 2.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.86 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.87 -41.17 87.7 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.849 0.356 . . . . 0.0 111.623 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.7 25.94 9.17 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.664 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.8 -22.63 0.33 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.889 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 95' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' E' ' 91' ' ' SER . 1.0 OUTLIER -107.71 175.2 5.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.928 0.394 . . . . 0.0 110.597 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.37 177.08 3.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 97' ' ' THR . . . . . 0.496 ' O ' HG12 ' E' ' 99' ' ' VAL . 0.2 OUTLIER -138.56 167.87 21.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.305 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 98' ' ' ASN . . . . . 0.57 ' HA ' ' HB ' ' E' ' 140' ' ' THR . 32.4 m-80 44.15 51.68 7.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.526 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 99' ' ' VAL . . . . . 0.496 HG12 ' O ' ' E' ' 97' ' ' THR . 6.0 p -169.36 124.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.753 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.53 -164.65 11.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.594 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.9 91.07 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 122.997 0.519 . . . . 0.0 111.735 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 102' ' ' GLN . . . . . 0.708 ' HA ' ' HA ' ' E' ' 85' ' ' VAL . 0.4 OUTLIER -71.38 116.65 11.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.901 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 103' ' ' ILE . . . . . 0.666 HD12 HD11 ' E' ' 113' ' ' LEU . 6.5 mt -89.66 120.59 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.511 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 104' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 1.0 OUTLIER -95.85 152.32 18.6 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.738 0.304 . . . . 0.0 111.105 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.08 160.07 14.61 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.553 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 106' ' ' ARG . . . . . 0.535 ' CZ ' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -68.81 -13.7 62.56 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.83 0.348 . . . . 0.0 111.064 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 44.8 p -74.4 -18.95 60.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.097 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.0 -40.12 2.23 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.639 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.36 164.63 13.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.774 0.321 . . . . 0.0 111.116 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 110' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -77.38 139.66 39.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.128 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 111' ' ' LEU . . . . . 0.556 HD21 ' HB ' ' E' ' 117' ' ' THR . 5.9 tt -84.16 128.58 34.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.449 0.642 . . . . 0.0 110.477 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 112' ' ' THR . . . . . 0.406 ' O ' HD23 ' E' ' 111' ' ' LEU . 1.4 m -68.13 132.38 47.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.081 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 113' ' ' LEU . . . . . 0.666 HD11 HD12 ' E' ' 103' ' ' ILE . 4.7 mp -88.12 99.79 12.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.723 0.297 . . . . 0.0 110.699 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.09 -32.4 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.528 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 115' ' ' GLY . . . . . 0.497 ' CA ' HD23 ' E' ' 74' ' ' LEU . . . 146.42 -81.24 0.21 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.645 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 116' ' ' ALA . . . . . 0.701 ' HA ' ' HB1' ' E' ' 72' ' ' ALA . . . -97.24 64.03 1.88 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.038 0.447 . . . . 0.0 111.678 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 117' ' ' THR . . . . . 0.556 ' HB ' HD21 ' E' ' 111' ' ' LEU . 2.8 m -94.37 72.48 3.83 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.165 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.84 119.09 11.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.783 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.92 -49.03 0.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.83 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 3.0 m -88.55 84.73 6.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.573 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 121' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' E' ' 70' ' ' ALA . 3.5 mt-10 -110.26 86.95 2.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.263 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.06 159.32 17.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.801 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 2.5 t -67.04 138.38 57.14 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.734 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 124' ' ' LEU . . . . . 0.863 HD12 ' HB2' ' E' ' 69' ' ' ALA . 0.4 OUTLIER -86.53 159.54 19.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.636 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.66 176.22 10.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.595 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 126' ' ' ASN . . . . . 0.512 ' OD1' ' HA ' ' E' ' 62' ' ' ASP . 0.9 OUTLIER -85.89 161.47 19.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.703 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.51 -121.01 5.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.718 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 128' ' ' THR . . . . . 0.584 HG21 ' HE2' ' B' ' 155' ' ' LYS . 72.4 m -119.47 140.33 50.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.75 0.309 . . . . 0.0 110.788 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 129' ' ' ASN . . . . . 0.462 ' O ' HD12 ' E' ' 58' ' ' LEU . 5.1 t-20 -133.77 154.62 50.85 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.112 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 130' ' ' THR . . . . . 0.675 HG22 ' HA ' ' E' ' 57' ' ' GLN . 28.0 p -133.41 154.24 50.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.188 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 131' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' E' ' 55' ' ' ASN . 1.0 OUTLIER -110.88 116.79 51.49 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 132' ' ' PRO . . . . . 0.606 ' HB3' ' HA ' ' B' ' 76' ' ' THR . 7.6 Cg_endo -81.15 129.38 6.8 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.663 1.576 . . . . 0.0 112.667 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 133' ' ' PHE . . . . . 0.461 ' HB3' ' CE1' ' E' ' 54' ' ' PHE . 0.1 OUTLIER -140.81 146.89 38.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.796 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 134' ' ' GLN . . . . . 0.544 ' HB3' ' HB1' ' E' ' 51' ' ' ALA . 19.3 mm-40 -116.49 158.33 23.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.033 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 135' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' E' ' 103' ' ' ILE . . . -159.47 105.48 1.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.898 0.38 . . . . 0.0 111.589 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.67 172.53 6.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.457 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.18 147.77 24.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.051 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.65 159.0 36.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.994 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 139' ' ' ALA . . . . . 0.701 ' HB2' ' CB ' ' E' ' 42' ' ' LEU . . . -116.31 141.27 48.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.897 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 140' ' ' THR . . . . . 0.57 ' HB ' ' HA ' ' E' ' 98' ' ' ASN . 0.2 OUTLIER -107.81 27.22 9.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.499 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 141' ' ' GLY . . . . . 0.59 ' HA2' ' N ' ' E' ' 45' ' ' GLU . . . 97.5 83.57 1.7 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.031 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 142' ' ' ALA . . . . . 0.727 ' HA ' ' HA ' ' E' ' 43' ' ' ALA . . . 57.98 93.41 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.67 0.235 . . . . 0.0 110.765 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 143' ' ' ALA . . . . . 0.531 ' HA ' ' HB2' ' E' ' 98' ' ' ASN . . . -79.94 165.51 22.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.733 0.301 . . . . 0.0 111.453 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 144' ' ' THR . . . . . . . . . . . . . 29.6 p -108.49 168.86 7.22 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.202 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.59 133.54 6.16 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.572 2.181 . . . . 0.0 111.981 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 146' ' ' GLY . . . . . 0.626 ' HA2' HG12 ' C' ' 5' ' ' VAL . . . 169.55 -119.23 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.475 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.8 121.7 13.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.904 0.383 . . . . 0.0 111.382 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.34 85.68 3.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.541 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -104.58 131.25 52.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.58 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 150' ' ' ALA . . . . . 1.029 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -136.1 148.51 48.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.94 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.18 120.23 20.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.213 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.69 139.99 24.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.171 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 153' ' ' THR . . . . . 0.612 HG22 ' HA ' ' D' ' 9' ' ' THR . 71.0 p -105.21 171.17 7.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 154' ' ' PHE . . . . . 0.51 ' HZ ' HG21 ' E' ' 56' ' ' ILE . 13.6 p90 -138.18 147.39 43.78 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 110.143 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 155' ' ' LYS . . . . . 0.731 ' HG2' HD11 ' E' ' 74' ' ' LEU . 13.7 mmtt -100.92 171.94 7.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.919 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 156' ' ' VAL . . . . . 0.646 HG23 HG23 ' D' ' 5' ' ' VAL . 0.4 OUTLIER -135.44 111.37 12.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.754 0.311 . . . . 0.0 111.789 -179.133 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 157' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' D' ' 3' ' ' THR . 1.8 tt0 -108.97 141.28 41.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.312 0.577 . . . . 0.0 110.438 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 158' ' ' TYR . . . . . 0.487 ' CZ ' ' HB ' ' E' ' 156' ' ' VAL . 23.0 m-85 -135.36 105.52 6.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.613 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 159' ' ' GLN . . . . . 0.68 ' HA ' ' H ' ' D' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.903 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.57 88.66 0.05 OUTLIER 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.095 0.247 . . . . 0.0 110.995 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.11 110.45 22.4 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.397 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.49 136.11 38.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.534 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.99 -175.31 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.601 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.57 130.1 38.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.665 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.8 -59.26 0.91 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.794 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.4 166.22 28.06 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.899 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 26.9 m -94.44 121.15 35.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 111.196 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.68 115.66 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.229 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -99.55 137.5 37.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.361 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -127.62 97.8 4.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.748 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.26 175.74 6.58 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.458 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.04 149.48 5.78 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.897 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.32 108.6 13.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 110.407 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 23.4 t -86.61 129.15 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.183 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 17' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' F' ' 22' ' ' ALA . 18.7 m -127.39 163.54 30.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.06 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -85.93 61.37 6.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.041 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 19' ' ' ALA . . . . . 0.486 ' HB3' HG21 ' F' ' 65' ' ' VAL . . . 44.99 52.6 8.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 20' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' F' ' 61' ' ' CYS . . . -127.3 -54.42 1.36 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.44 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 21' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.1 OUTLIER 177.68 111.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.962 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 22' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' F' ' 17' ' ' VAL . . . -105.69 126.09 51.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.053 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.83 145.68 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.968 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 24' ' ' ASP . . . . . 0.623 ' O ' HG23 ' F' ' 28' ' ' VAL . 4.0 m-20 -74.86 147.24 41.27 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.66 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.77 -43.61 18.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.32 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.92 -20.01 60.25 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.896 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 45.6 t -79.6 -26.08 41.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 28' ' ' VAL . . . . . 0.623 HG23 ' O ' ' F' ' 24' ' ' ASP . 57.4 t -49.16 -48.52 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.279 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.84 93.04 5.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.965 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.54 116.42 28.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.035 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.62 115.63 27.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.155 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' E' ' 12' ' ' PHE . 1.7 t -117.21 101.1 11.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.133 0.492 . . . . 0.0 110.426 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.6 126.91 52.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.671 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 34' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' C' ' 92' ' ' ALA . 0.3 OUTLIER -68.15 -55.65 11.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.659 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.97 -111.67 3.93 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.555 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 36' ' ' GLN . . . . . 0.547 ' HG3' ' HA ' ' E' ' 24' ' ' ASP . 0.0 OUTLIER -77.0 115.28 16.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.52 0.2 . . . . 0.0 110.928 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' E' ' 16' ' ' VAL . 67.6 t -131.03 105.87 11.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.779 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.68 154.12 17.46 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.762 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 39' ' ' THR . . . . . 0.66 ' HA ' HD12 ' F' ' 42' ' ' LEU . 8.0 p -78.8 -19.81 51.25 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.724 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.42 -19.54 65.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.085 0.469 . . . . 0.0 110.913 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 96.6 p -92.08 -21.23 20.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.182 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 42' ' ' LEU . . . . . 0.702 ' CB ' ' HB2' ' F' ' 139' ' ' ALA . 0.2 OUTLIER -139.0 62.28 1.54 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.686 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 43' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' F' ' 142' ' ' ALA . . . -101.15 9.21 42.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.321 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.25 136.0 24.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.36 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 45' ' ' GLU . . . . . 0.586 ' N ' ' HA2' ' F' ' 141' ' ' GLY . 16.5 tt0 -58.6 121.36 10.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.942 0.401 . . . . 0.0 111.109 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.32 -25.4 8.23 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.139 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.86 137.25 58.22 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.909 0.385 . . . . 0.0 112.018 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.85 157.98 44.56 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.945 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.92 -166.16 1.09 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.642 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 50' ' ' SER . . . . . 0.613 ' HB2' ' HA ' ' C' ' 92' ' ' ALA . 48.9 m -65.2 156.15 32.73 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.818 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 51' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' F' ' 134' ' ' GLN . . . -90.47 126.73 36.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.32 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 52' ' ' VAL . . . . . 0.909 HG13 ' HA ' ' C' ' 90' ' ' SER . 63.1 t -75.66 118.55 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.981 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.78 135.68 13.8 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.687 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 54' ' ' PHE . . . . . 0.536 ' H ' HG21 ' C' ' 76' ' ' THR . 46.3 p90 -170.76 142.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.83 0.348 . . . . 0.0 110.948 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 55' ' ' ASN . . . . . 0.676 ' HA ' ' O ' ' F' ' 131' ' ' ILE . 11.5 p30 -126.59 163.95 22.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 56' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' F' ' 130' ' ' THR . 20.8 mm -105.16 119.91 54.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.516 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 57' ' ' GLN . . . . . 0.711 ' HA ' HG22 ' F' ' 130' ' ' THR . 0.0 OUTLIER -82.09 115.69 21.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.736 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 58' ' ' LEU . . . . . 0.645 HD11 HG13 ' F' ' 131' ' ' ILE . 0.0 OUTLIER -128.25 107.45 9.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.261 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.38 177.0 8.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.902 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 63.06 66.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.782 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 61' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 3.3 m -109.68 154.42 22.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.729 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 62' ' ' ASP . . . . . 0.531 ' HA ' ' OD1' ' F' ' 126' ' ' ASN . 0.5 OUTLIER -154.66 138.33 16.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.234 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 63' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' F' ' 66' ' ' ALA . 0.2 OUTLIER -97.57 -11.85 23.2 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.13 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.21 -48.78 40.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.095 0.474 . . . . 0.0 111.764 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 65' ' ' VAL . . . . . 0.486 HG21 ' HB3' ' F' ' 19' ' ' ALA . 10.6 t -69.02 -48.66 68.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.729 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 66' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' F' ' 159' ' ' GLN . . . -137.97 153.4 49.45 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.64 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.25 18.59 4.45 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.907 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 68' ' ' LYS . . . . . 0.612 ' HB3' ' HB3' ' F' ' 159' ' ' GLN . 10.6 tppt? -142.87 149.89 39.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.444 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 69' ' ' ALA . . . . . 0.865 ' HB2' HD12 ' F' ' 124' ' ' LEU . . . -150.01 110.71 4.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.714 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 70' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' F' ' 121' ' ' GLU . . . -108.05 169.95 8.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.034 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 71' ' ' VAL . . . . . 0.433 HG21 HG21 ' F' ' 131' ' ' ILE . 0.5 OUTLIER -130.37 150.95 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.647 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 72' ' ' ALA . . . . . 0.68 ' HB1' ' HA ' ' F' ' 116' ' ' ALA . . . -135.57 100.11 4.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.558 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 73' ' ' PHE . . . . . 0.438 ' HB2' HD22 ' F' ' 111' ' ' LEU . 0.2 OUTLIER -77.46 133.94 38.49 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.552 0.215 . . . . 0.0 111.154 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 74' ' ' LEU . . . . . 0.743 HD11 ' HG2' ' F' ' 155' ' ' LYS . 0.0 OUTLIER -124.16 115.11 20.58 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.975 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.34 -173.22 26.47 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.77 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 7.1 m -112.68 149.04 33.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.647 0.261 . . . . 0.0 110.726 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 77' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' F' ' 85' ' ' VAL . . . -98.91 133.72 42.79 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.002 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 78' ' ' ILE . . . . . 0.761 ' HB ' ' HA ' ' F' ' 87' ' ' ALA . 16.1 tt -72.89 -37.99 55.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.907 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.17 167.62 12.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.832 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.2 -53.86 15.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.027 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.34 28.73 6.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.6 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 82' ' ' HIS . . . . . 0.824 ' HB3' ' HB ' ' F' ' 85' ' ' VAL . 10.2 m170 -111.35 -45.62 3.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 0.0 110.434 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.43 -86.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.577 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 84' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' F' ' 82' ' ' HIS . 0.0 OUTLIER -42.19 -42.4 3.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.343 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 85' ' ' VAL . . . . . 0.824 ' HB ' ' HB3' ' F' ' 82' ' ' HIS . 21.3 t -61.35 126.54 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.165 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 86' ' ' LEU . . . . . 1.031 HD22 ' HB1' ' F' ' 150' ' ' ALA . 0.2 OUTLIER -81.19 164.41 22.34 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.247 179.493 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 87' ' ' ALA . . . . . 0.761 ' HA ' ' HB ' ' F' ' 78' ' ' ILE . . . -104.83 -177.58 3.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.903 0.383 . . . . 0.0 111.644 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -174.53 5.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.68 -170.69 3.23 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.356 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 27.9 p -74.74 7.76 2.86 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 111.42 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 91' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' F' ' 95' ' ' SER . 0.8 OUTLIER -96.91 80.37 3.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.86 -41.16 87.8 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.858 0.361 . . . . 0.0 111.606 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.74 26.0 9.12 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.687 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.78 -22.78 0.33 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.902 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 95' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' F' ' 91' ' ' SER . 1.0 OUTLIER -107.65 175.24 5.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.929 0.395 . . . . 0.0 110.646 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.51 177.11 3.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.849 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 97' ' ' THR . . . . . 0.506 ' O ' HG12 ' F' ' 99' ' ' VAL . 0.2 OUTLIER -138.53 167.78 21.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.277 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 98' ' ' ASN . . . . . 0.581 ' HA ' ' HB ' ' F' ' 140' ' ' THR . 32.5 m-80 44.15 51.69 7.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.515 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 99' ' ' VAL . . . . . 0.506 HG12 ' O ' ' F' ' 97' ' ' THR . 6.0 p -169.37 124.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.787 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.55 -164.72 11.5 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.616 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.85 91.12 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.192 0.52 . . . . 0.0 111.758 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 102' ' ' GLN . . . . . 0.704 ' HA ' ' HA ' ' F' ' 85' ' ' VAL . 0.4 OUTLIER -71.37 116.61 11.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.836 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 103' ' ' ILE . . . . . 0.654 HD12 HD11 ' F' ' 113' ' ' LEU . 6.6 mt -89.59 120.62 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.5 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 104' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 1.0 OUTLIER -95.81 152.3 18.61 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.679 0.276 . . . . 0.0 111.083 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.11 160.07 14.61 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.645 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 106' ' ' ARG . . . . . 0.533 ' CZ ' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -68.79 -13.71 62.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.873 0.368 . . . . 0.0 111.082 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 44.9 p -74.37 -18.96 60.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.075 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.0 -40.08 2.23 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.682 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.32 164.68 13.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 0.0 111.107 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 110' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -77.36 139.63 39.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.1 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 111' ' ' LEU . . . . . 0.556 HD21 ' HB ' ' F' ' 117' ' ' THR . 5.9 tt -84.13 128.55 34.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.469 0.652 . . . . 0.0 110.477 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 112' ' ' THR . . . . . 0.4 ' O ' HD23 ' F' ' 111' ' ' LEU . 1.4 m -68.14 132.41 47.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.133 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 113' ' ' LEU . . . . . 0.654 HD11 HD12 ' F' ' 103' ' ' ILE . 4.8 mp -88.06 99.69 12.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.684 0.278 . . . . 0.0 110.778 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.04 -32.48 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.628 0.252 . . . . 0.0 111.541 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 115' ' ' GLY . . . . . 0.491 ' CA ' HD23 ' F' ' 74' ' ' LEU . . . 146.53 -81.37 0.21 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.575 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 116' ' ' ALA . . . . . 0.68 ' HA ' ' HB1' ' F' ' 72' ' ' ALA . . . -97.1 63.99 1.92 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.986 0.422 . . . . 0.0 111.649 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 117' ' ' THR . . . . . 0.556 ' HB ' HD21 ' F' ' 111' ' ' LEU . 2.8 m -94.29 72.35 3.87 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.169 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.79 119.12 11.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.821 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.95 -49.05 0.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.778 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.55 84.69 6.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.606 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 121' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' F' ' 70' ' ' ALA . 3.6 mt-10 -110.23 87.06 2.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.236 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.04 159.27 17.66 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.802 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -67.01 138.34 57.15 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.654 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 124' ' ' LEU . . . . . 0.865 HD12 ' HB2' ' F' ' 69' ' ' ALA . 0.4 OUTLIER -86.47 159.44 19.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.692 179.389 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.53 176.28 10.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.64 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 126' ' ' ASN . . . . . 0.531 ' OD1' ' HA ' ' F' ' 62' ' ' ASP . 0.9 OUTLIER -85.91 161.5 19.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.667 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.46 -121.07 5.72 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.718 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 128' ' ' THR . . . . . 0.573 HG21 ' HE2' ' C' ' 155' ' ' LYS . 72.0 m -119.42 140.28 50.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.714 0.292 . . . . 0.0 110.821 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 129' ' ' ASN . . . . . 0.462 ' O ' HD12 ' F' ' 58' ' ' LEU . 5.1 t-20 -133.68 154.66 50.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.883 0.373 . . . . 0.0 111.122 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 130' ' ' THR . . . . . 0.711 HG22 ' HA ' ' F' ' 57' ' ' GLN . 28.0 p -133.4 154.3 50.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.091 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 131' ' ' ILE . . . . . 0.676 ' O ' ' HA ' ' F' ' 55' ' ' ASN . 1.0 OUTLIER -111.02 116.8 51.2 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 132' ' ' PRO . . . . . 0.609 ' HB3' ' HA ' ' C' ' 76' ' ' THR . 7.6 Cg_endo -81.14 129.43 6.83 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.665 1.576 . . . . 0.0 112.641 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 133' ' ' PHE . . . . . 0.463 ' HB3' ' CE1' ' F' ' 54' ' ' PHE . 0.1 OUTLIER -140.86 146.86 38.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.807 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 134' ' ' GLN . . . . . 0.533 ' HB3' ' HB1' ' F' ' 51' ' ' ALA . 19.2 mm-40 -116.52 158.34 23.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.008 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 135' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' F' ' 103' ' ' ILE . . . -159.37 105.45 1.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.847 0.356 . . . . 0.0 111.533 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.66 172.54 6.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.439 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.18 147.82 24.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.066 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.68 159.02 36.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.949 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 139' ' ' ALA . . . . . 0.702 ' HB2' ' CB ' ' F' ' 42' ' ' LEU . . . -116.3 141.21 48.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.9 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 140' ' ' THR . . . . . 0.581 ' HB ' ' HA ' ' F' ' 98' ' ' ASN . 0.2 OUTLIER -107.79 27.22 9.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.462 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 141' ' ' GLY . . . . . 0.586 ' HA2' ' N ' ' F' ' 45' ' ' GLU . . . 97.56 83.56 1.7 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.846 -0.693 . . . . 0.0 113.025 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 142' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' F' ' 43' ' ' ALA . . . 57.9 93.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.531 0.205 . . . . 0.0 110.813 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 143' ' ' ALA . . . . . 0.535 ' HA ' ' HB2' ' F' ' 98' ' ' ASN . . . -80.01 165.42 22.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.772 0.32 . . . . 0.0 111.37 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 144' ' ' THR . . . . . . . . . . . . . 29.8 p -108.42 168.86 7.23 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.196 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.58 133.56 6.18 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.56 2.174 . . . . 0.0 112.007 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 146' ' ' GLY . . . . . 0.616 ' HA2' HG12 ' D' ' 5' ' ' VAL . . . 169.53 -119.22 0.81 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.456 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.85 121.7 13.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.866 0.365 . . . . 0.0 111.27 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.35 85.65 3.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.485 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -104.5 131.29 52.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.581 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 150' ' ' ALA . . . . . 1.031 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -136.14 148.49 48.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.958 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.18 120.21 20.89 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.226 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.65 140.02 24.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.188 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 153' ' ' THR . . . . . 0.609 HG22 ' HA ' ' E' ' 9' ' ' THR . 70.5 p -105.24 171.13 7.48 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 154' ' ' PHE . . . . . 0.507 ' HZ ' HG21 ' F' ' 56' ' ' ILE . 13.7 p90 -138.13 147.42 43.92 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.152 0.501 . . . . 0.0 110.054 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 155' ' ' LYS . . . . . 0.743 ' HG2' HD11 ' F' ' 74' ' ' LEU . 13.6 mmtt -100.91 171.93 7.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.928 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 156' ' ' VAL . . . . . 0.66 HG23 HG23 ' E' ' 5' ' ' VAL . 0.4 OUTLIER -135.48 111.44 12.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.813 0.34 . . . . 0.0 111.717 -179.136 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 157' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' E' ' 3' ' ' THR . 1.8 tt0 -109.01 141.24 41.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.318 0.58 . . . . 0.0 110.431 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 158' ' ' TYR . . . . . 0.482 ' CZ ' ' HB ' ' F' ' 156' ' ' VAL . 23.0 m-85 -135.38 105.44 6.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.613 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 159' ' ' GLN . . . . . 0.686 ' HA ' ' H ' ' E' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.522 0.201 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' B' ' 158' ' ' TYR . 7.3 m -104.81 78.63 1.45 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.493 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.34 122.36 29.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.543 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.646 HG23 HG23 ' B' ' 156' ' ' VAL . 5.0 m -137.91 162.94 30.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.564 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.425 ' HB3' ' OE2' ' B' ' 15' ' ' GLU . 44.1 t-20 -84.29 114.57 21.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.626 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.481 ' HA3' ' CZ ' ' B' ' 154' ' ' PHE . . . -83.43 -41.48 8.39 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.719 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.446 ' N ' ' CE1' ' B' ' 154' ' ' PHE . . . -175.59 162.29 31.55 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.863 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' B' ' 153' ' ' THR . 99.0 m -90.75 137.84 32.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.929 0.395 . . . . 0.0 111.282 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.46 114.34 46.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.163 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -99.37 148.58 24.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.33 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.818 ' HB3' HD21 ' B' ' 34' ' ' LEU . 60.8 m-85 -133.8 113.09 11.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.76 ' HG2' ' HA ' ' B' ' 33' ' ' GLN . 0.0 OUTLIER -107.19 105.94 16.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.332 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.25 169.46 28.91 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.999 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.552 ' HB2' ' HG3' ' B' ' 36' ' ' GLN . 33.6 mt-10 -140.73 -171.02 3.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.839 0.352 . . . . 0.0 110.4 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.577 HG13 HG23 ' B' ' 37' ' ' VAL . 0.5 OUTLIER -139.24 152.86 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.209 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.735 ' O ' HG23 ' B' ' 39' ' ' THR . 0.0 OUTLIER -137.51 155.37 31.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.87 0.367 . . . . 0.0 111.061 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -85.23 53.1 2.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.041 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.679 ' HA ' ' HG2' ' B' ' 38' ' ' ARG . . . 61.46 92.67 0.05 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.066 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.575 ' H ' ' HG2' ' B' ' 38' ' ' ARG . . . -164.77 -47.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.476 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.654 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 1.6 m -159.8 176.83 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.009 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.611 ' HB2' ' HE ' ' B' ' 38' ' ' ARG . . . -147.27 111.93 5.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.137 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.618 HG13 ' HB3' ' A' ' 27' ' ' SER . 43.0 t -67.37 143.19 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.989 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.548 ' O ' HG23 ' A' ' 28' ' ' VAL . 17.0 m-20 -91.18 168.05 11.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.63 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.31 -50.0 74.31 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.468 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.42 -16.62 73.76 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.923 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.618 ' HB3' HG13 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -84.32 -24.36 29.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.907 0.384 . . . . 0.0 110.77 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.553 HG11 ' HG3' ' A' ' 13' ' ' LYS . 85.6 t -58.09 -37.24 60.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.33 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -140.38 106.02 5.12 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.03 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -109.07 106.97 17.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.125 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.8 95.63 9.03 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.019 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 52' ' ' VAL . 51.6 t -85.84 138.25 19.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.055 0.455 . . . . 0.0 110.358 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -113.15 132.6 55.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.701 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.545 ' N ' HD22 ' A' ' 34' ' ' LEU . 1.9 mm? -94.54 -71.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.594 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.87 -111.32 0.72 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.518 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -160.96 105.77 1.37 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.61 0.243 . . . . 0.0 110.879 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 m -91.1 142.35 13.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.978 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 38' ' ' ARG . 0.7 OUTLIER -81.05 162.53 23.73 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.771 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.442 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 82.5 p -80.35 -16.92 53.43 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.761 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.73 -31.26 63.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.073 0.463 . . . . 0.0 110.828 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.01 -28.48 39.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.145 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 1.7 mp -133.14 70.05 1.47 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.67 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . -103.67 11.21 36.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.448 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.04 146.83 27.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.341 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.48 121.25 13.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.369 . . . . 0.0 111.091 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.52 -10.39 12.77 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.179 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 138' ' ' PHE . . . -68.83 142.22 54.92 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.44 HG21 ' NH2' ' A' ' 136' ' ' ARG . 6.9 t -134.69 140.86 46.31 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.904 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.0 m -106.04 -152.77 0.48 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.569 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.9 178.57 1.05 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.908 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.05 168.9 15.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.733 0.301 . . . . 0.0 111.308 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.71 HG22 ' HB3' ' A' ' 135' ' ' ALA . 14.9 m -118.1 132.22 68.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.21 107.67 3.57 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.633 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.604 ' HD1' HG23 ' A' ' 52' ' ' VAL . 55.5 p90 -140.34 132.03 27.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.764 0.316 . . . . 0.0 110.914 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.522 ' HB2' HG22 ' A' ' 130' ' ' THR . 12.4 p30 -117.8 176.89 4.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.628 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.768 ' HB ' HD12 ' A' ' 131' ' ' ILE . 51.7 mm -119.05 121.74 67.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.478 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.37 122.59 30.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.829 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.584 ' HB2' ' HB3' ' A' ' 129' ' ' ASN . 0.9 OUTLIER -131.08 93.72 3.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.228 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.549 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.4 OUTLIER -77.1 160.85 28.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.899 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.2 87.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.756 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.654 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 69.8 m -120.52 131.87 54.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.75 97.87 9.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.255 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 1.5 m -77.41 -20.0 55.26 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.04 -27.53 68.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.023 0.439 . . . . 0.0 111.719 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.42 -35.71 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.626 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 63' ' ' THR . . . -131.03 131.29 44.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.642 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.45 -37.32 7.65 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.909 0.385 . . . . 0.0 110.932 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -121.72 171.37 8.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.553 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.55 136.15 15.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.587 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.706 ' HB3' ' HB3' ' A' ' 157' ' ' GLN . . . -94.57 157.97 15.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.028 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.38 106.24 20.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.713 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.83 ' HB3' ' HB3' ' A' ' 155' ' ' LYS . . . -109.58 164.26 12.69 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.619 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.661 ' HB2' HD11 ' A' ' 111' ' ' LEU . 6.6 t80 -142.2 141.1 32.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.497 0.189 . . . . 0.0 111.129 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.737 HD11 ' HG2' ' D' ' 57' ' ' GLN . 0.1 OUTLIER -122.7 103.35 8.61 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.008 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.503 ' HA3' HD23 ' A' ' 113' ' ' LEU . . . -153.44 -166.37 14.55 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.895 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.48 136.26 46.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.535 0.207 . . . . 0.0 110.726 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.677 ' H ' ' HB3' ' D' ' 132' ' ' PRO . . . -81.4 156.08 25.6 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.845 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.469 HG12 ' OG1' ' A' ' 140' ' ' THR . 3.1 tt -92.51 -20.69 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.773 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.557 ' HB2' HG21 ' A' ' 140' ' ' THR . 0.4 OUTLIER 176.15 179.76 0.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.829 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' D' ' 107' ' ' THR . . . -79.0 -33.81 44.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.974 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.42 -43.91 95.55 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.618 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.463 ' NE2' ' O ' ' A' ' 139' ' ' ALA . 43.7 m-70 -97.8 -64.41 1.04 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.827 0.346 . . . . 0.0 110.47 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.432 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.2 m 62.36 7.83 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.623 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.427 ' O ' HD12 ' A' ' 103' ' ' ILE . 86.9 m-20 -115.11 -25.47 8.09 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.238 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . 0.5 OUTLIER -79.56 143.74 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.189 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.631 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -76.68 148.6 36.73 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.251 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.9 178.22 4.4 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.85 0.357 . . . . 0.0 111.651 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -84.66 176.23 8.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.116 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 149' ' ' ASN . 22.8 pt20 -75.33 178.72 5.64 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.32 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.527 ' O ' HG12 ' D' ' 52' ' ' VAL . 1.0 OUTLIER -73.36 -11.46 60.49 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.989 0.423 . . . . 0.0 111.411 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 0.3 OUTLIER -64.68 87.26 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.931 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.89 -7.14 53.83 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.879 0.371 . . . . 0.0 111.667 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.477 ' HB1' ' HB1' ' C' ' 22' ' ' ALA . . . -133.11 19.91 4.07 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.644 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.62 -15.6 0.16 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.897 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 1.0 OUTLIER -97.35 174.98 6.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.906 0.384 . . . . 0.0 110.619 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.644 ' O ' HD22 ' A' ' 88' ' ' LEU . . . -114.12 157.87 22.03 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.823 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.53 HG23 HD11 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -112.96 162.73 15.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.319 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 69.26 41.66 1.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.415 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.3 p -177.67 130.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.827 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.06 179.45 28.6 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.623 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.497 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 1.6 t -98.98 95.34 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.026 0.531 . . . . 0.0 111.71 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 13.7 tt0 -69.87 159.83 32.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.881 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.433 HG12 ' CE2' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -121.72 98.38 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.513 179.441 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.679 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 1.1 tp -84.65 119.36 25.15 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.716 0.293 . . . . 0.0 111.122 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.24 158.12 31.92 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.642 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.553 ' HB2' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -61.2 -33.93 74.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.87 0.366 . . . . 0.0 111.043 179.549 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.554 HG23 ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -48.75 -38.17 20.96 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.013 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.69 -88.87 0.11 Allowed Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.591 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.19 -176.33 5.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.868 0.366 . . . . 0.0 111.104 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.679 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -79.9 143.93 33.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.126 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.661 HD11 ' HB2' ' A' ' 73' ' ' PHE . 0.6 OUTLIER -90.14 157.54 17.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.387 0.613 . . . . 0.0 110.522 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.448 ' HB ' HG21 ' A' ' 117' ' ' THR . 29.4 m -81.04 150.46 28.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.201 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 113' ' ' LEU . 3.0 mp -102.75 57.7 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.757 0.313 . . . . 0.0 110.72 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.43 19.65 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.532 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.26 -93.1 0.88 Allowed Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.631 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' D' ' 125' ' ' ASN . . . -102.71 69.67 1.08 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.028 0.442 . . . . 0.0 111.596 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 5.8 p -89.69 97.3 11.11 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.19 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.15 102.81 5.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.752 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.4 -82.69 0.65 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.554 ' HA ' HG23 ' A' ' 107' ' ' THR . 0.1 OUTLIER -63.26 100.87 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.611 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.9 79.11 7.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.228 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.428 HG21 ' CD ' ' A' ' 132' ' ' PRO . 4.7 p -82.55 159.18 22.85 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.769 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.2 m -85.28 139.74 31.38 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.764 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.46 136.18 33.43 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.69 0.281 . . . . 0.0 110.591 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -120.86 143.57 48.83 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.604 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.13 148.93 34.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.688 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.66 -106.17 2.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.704 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -85.15 153.24 22.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.731 0.3 . . . . 0.0 110.804 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.584 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 23.2 t-20 -148.45 120.7 8.37 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.942 0.401 . . . . 0.0 111.109 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -104.21 147.26 27.67 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.139 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.768 HD12 ' HB ' ' A' ' 56' ' ' ILE . 89.8 mt -116.61 119.25 36.08 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 106' ' ' ARG . 7.7 Cg_endo -80.83 119.06 3.54 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 121.704 1.602 . . . . 0.0 112.574 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.04 147.35 29.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.783 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.15 155.94 47.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.043 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.71 ' HB3' HG22 ' A' ' 52' ' ' VAL . . . -140.07 115.66 10.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.882 0.372 . . . . 0.0 111.639 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.44 ' NH2' HG21 ' A' ' 48' ' ' THR . 0.5 OUTLIER -111.27 148.98 31.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.477 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.6 151.29 45.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.158 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -144.52 164.56 30.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.002 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.635 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -124.43 145.76 49.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.783 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.557 HG21 ' HB2' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -117.84 13.0 14.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.48 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.79 79.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.919 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.64 92.15 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.598 0.199 . . . . 0.0 110.788 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.08 154.78 33.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.704 0.288 . . . . 0.0 111.38 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.9 p -116.68 166.17 13.42 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.29 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.27 151.49 12.16 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.474 2.116 . . . . 0.0 112.018 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.6 -106.33 0.46 Allowed Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.417 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -139.06 163.26 32.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.834 0.349 . . . . 0.0 111.411 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.98 79.93 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.504 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 89' ' ' GLN . 87.1 m-20 -99.98 142.51 31.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.51 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.521 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -127.81 168.98 14.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.073 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.53 110.04 0.86 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.2 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.631 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -146.99 145.4 29.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.118 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.67 164.17 13.26 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.627 ' CZ ' HG21 ' A' ' 56' ' ' ILE . 15.4 p90 -110.83 151.6 27.63 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.061 0.458 . . . . 0.0 110.162 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.83 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -109.7 160.84 15.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.961 -178.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.14 112.91 3.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.756 0.312 . . . . 0.0 111.699 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.706 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -91.87 124.41 35.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.295 0.569 . . . . 0.0 110.447 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -117.13 135.48 53.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.515 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.889 179.894 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.55 100.24 0.04 OUTLIER 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.0 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.551 ' HB ' ' HB2' ' C' ' 158' ' ' TYR . 7.4 m -104.81 78.6 1.44 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.416 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.33 122.39 29.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.533 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.644 HG23 HG23 ' C' ' 156' ' ' VAL . 5.0 m -137.93 162.86 30.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.539 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ASN . . . . . 0.434 ' HB3' ' OE2' ' C' ' 15' ' ' GLU . 44.0 t-20 -84.28 114.48 21.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.692 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' GLY . . . . . 0.496 ' HA3' ' CZ ' ' C' ' 154' ' ' PHE . . . -83.3 -41.54 8.43 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.703 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.444 ' N ' ' CE1' ' C' ' 154' ' ' PHE . . . -175.56 162.32 31.61 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.824 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' C' ' 153' ' ' THR . 99.2 m -90.81 137.91 31.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.925 0.393 . . . . 0.0 111.264 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.49 114.27 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.241 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -99.31 148.54 24.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.364 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' PHE . . . . . 0.834 ' HB3' HD21 ' C' ' 34' ' ' LEU . 60.6 m-85 -133.8 113.1 11.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.714 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.757 ' HG2' ' HA ' ' C' ' 33' ' ' GLN . 0.0 OUTLIER -107.19 105.86 16.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.392 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.18 169.45 28.87 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.99 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.541 ' HB2' ' HG3' ' C' ' 36' ' ' GLN . 33.8 mt-10 -140.73 -171.08 3.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.85 0.357 . . . . 0.0 110.425 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.569 HG13 HG23 ' C' ' 37' ' ' VAL . 0.5 OUTLIER -139.21 152.81 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.222 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.729 ' O ' HG23 ' C' ' 39' ' ' THR . 0.0 OUTLIER -137.42 155.43 31.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.834 0.35 . . . . 0.0 111.031 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -85.25 53.12 2.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.956 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.663 ' HA ' ' HG2' ' C' ' 38' ' ' ARG . . . 61.37 92.7 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.111 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.577 ' H ' ' HG2' ' C' ' 38' ' ' ARG . . . -164.74 -47.65 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.447 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.588 ' O ' HG21 ' B' ' 17' ' ' VAL . 1.6 m -159.83 176.82 11.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.009 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.609 ' HB2' ' HE ' ' C' ' 38' ' ' ARG . . . -147.24 111.89 5.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.15 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.618 HG13 ' HB3' ' B' ' 27' ' ' SER . 43.1 t -67.3 143.08 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.052 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.533 ' O ' HG23 ' B' ' 28' ' ' VAL . 16.9 m-20 -91.11 168.16 11.83 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.622 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.02 74.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.39 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.4 -16.62 73.72 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.92 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.618 ' HB3' HG13 ' B' ' 23' ' ' VAL . 0.4 OUTLIER -84.35 -24.38 29.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.921 0.391 . . . . 0.0 110.782 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.539 HG11 ' HG3' ' B' ' 13' ' ' LYS . 86.1 t -58.14 -37.13 60.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.339 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -140.35 106.08 5.14 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.997 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -109.03 106.92 17.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.12 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.74 95.55 8.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.069 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.554 HG11 HG21 ' B' ' 52' ' ' VAL . 51.2 t -85.76 138.21 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 110.451 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.76 ' HA ' ' HG2' ' A' ' 13' ' ' LYS . 3.2 mt-30 -113.18 132.54 55.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.64 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.818 HD21 ' HB3' ' A' ' 12' ' ' PHE . 1.8 mm? -94.45 -71.54 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.625 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.88 -111.3 0.71 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.524 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.552 ' HG3' ' HB2' ' A' ' 15' ' ' GLU . 3.6 tt0 -161.0 105.74 1.36 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.653 0.263 . . . . 0.0 110.919 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.577 HG23 HG13 ' A' ' 16' ' ' VAL . 5.7 m -91.06 142.35 13.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.966 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.679 ' HG2' ' HA ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -81.07 162.49 23.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.707 179.248 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.735 HG23 ' O ' ' A' ' 17' ' ' VAL . 82.5 p -80.35 -16.85 53.58 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.784 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.77 -31.17 63.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.175 0.512 . . . . 0.0 110.899 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.04 -28.49 39.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.12 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.65 ' HB3' ' HB2' ' B' ' 139' ' ' ALA . 1.7 mp -133.23 70.09 1.47 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.673 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' B' ' 39' ' ' THR . . . -103.65 11.17 36.39 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.432 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.06 146.82 27.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.371 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.49 121.25 13.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 0.0 111.099 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.55 -10.4 12.72 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.15 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' B' ' 138' ' ' PHE . . . -68.85 142.27 54.87 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.851 0.357 . . . . 0.0 111.951 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.441 HG21 ' NH2' ' B' ' 136' ' ' ARG . 6.8 t -134.77 140.82 46.2 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.846 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' SER . . . . . 0.403 ' OG ' HD11 ' B' ' 42' ' ' LEU . 17.2 m -106.06 -152.77 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.52 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.86 178.54 1.05 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.03 168.92 15.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.349 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.706 HG22 ' HB3' ' B' ' 135' ' ' ALA . 14.5 m -118.0 132.26 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.977 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.27 107.61 3.56 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.623 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' PHE . . . . . 0.591 ' HD1' HG23 ' B' ' 52' ' ' VAL . 55.6 p90 -140.34 132.06 27.35 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.812 0.339 . . . . 0.0 110.871 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.509 ' HB2' HG22 ' B' ' 130' ' ' THR . 12.5 p30 -117.78 176.81 5.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.636 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.791 ' HB ' HD12 ' B' ' 131' ' ' ILE . 51.8 mm -119.05 121.73 67.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.556 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.35 122.78 30.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.753 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' B' ' 129' ' ' ASN . 0.9 OUTLIER -131.27 93.71 3.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.246 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' B' ' 22' ' ' ALA . 0.4 OUTLIER -77.03 160.89 28.75 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 -179.733 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.17 87.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.745 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 69.9 m -120.44 131.88 54.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.71 97.9 9.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.269 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' B' ' 66' ' ' ALA . 1.5 m -77.47 -19.96 55.14 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.06 -27.48 68.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 111.768 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.39 -35.76 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.643 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' B' ' 63' ' ' THR . . . -131.05 131.28 44.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.64 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.46 -37.31 7.65 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.892 0.377 . . . . 0.0 110.948 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -121.69 171.39 8.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.56 136.1 15.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.552 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.702 ' HB3' ' HB3' ' B' ' 157' ' ' GLN . . . -94.5 158.04 15.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.062 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.41 106.28 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.679 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.83 ' HB3' ' HB3' ' B' ' 155' ' ' LYS . . . -109.6 164.29 12.67 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.65 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.674 ' HB2' HD11 ' B' ' 111' ' ' LEU . 6.5 t80 -142.27 141.03 32.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.502 0.191 . . . . 0.0 111.174 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.727 HD11 ' HG2' ' E' ' 57' ' ' GLN . 0.1 OUTLIER -122.71 103.38 8.62 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.993 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 75' ' ' GLY . . . . . 0.503 ' HA3' HD23 ' B' ' 113' ' ' LEU . . . -153.45 -166.37 14.56 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.875 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.54 136.3 46.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.585 0.231 . . . . 0.0 110.709 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.673 ' H ' ' HB3' ' E' ' 132' ' ' PRO . . . -81.52 156.13 25.42 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.879 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.47 HG12 ' OG1' ' B' ' 140' ' ' THR . 3.1 tt -92.51 -20.71 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.811 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.554 ' HB2' HG21 ' B' ' 140' ' ' THR . 0.4 OUTLIER 176.18 179.76 0.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.818 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' E' ' 107' ' ' THR . . . -78.91 -33.89 45.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.007 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.44 -43.84 95.64 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.6 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.452 ' NE2' ' O ' ' B' ' 139' ' ' ALA . 43.5 m-70 -97.86 -64.38 1.04 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.829 0.347 . . . . 0.0 110.435 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' THR . . . . . 0.43 ' HA ' ' HB1' ' B' ' 77' ' ' ALA . 1.2 m 62.33 7.83 2.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.647 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ASN . . . . . 0.422 ' O ' HD12 ' B' ' 103' ' ' ILE . 87.0 m-20 -115.15 -25.41 8.09 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.203 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.782 ' HA ' ' HA ' ' B' ' 102' ' ' GLN . 0.5 OUTLIER -79.62 143.75 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.152 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' B' ' 152' ' ' ALA . 0.3 OUTLIER -76.69 148.52 36.77 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.306 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.8 178.15 4.39 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.876 0.369 . . . . 0.0 111.734 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.658 HD22 ' O ' ' B' ' 96' ' ' ALA . 0.0 OUTLIER -84.6 176.13 8.8 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.071 179.386 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 89' ' ' GLN . . . . . 0.542 ' HB3' ' HB2' ' B' ' 149' ' ' ASN . 22.8 pt20 -75.19 178.62 5.62 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.355 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' SER . . . . . 0.535 ' O ' HG12 ' E' ' 52' ' ' VAL . 1.0 OUTLIER -73.34 -11.44 60.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.023 0.44 . . . . 0.0 111.409 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 91' ' ' SER . . . . . 0.514 ' HB3' ' HB3' ' B' ' 95' ' ' SER . 0.3 OUTLIER -64.72 87.27 0.06 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.909 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.86 -7.2 53.93 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.633 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' ALA . . . . . 0.465 ' HB1' ' HB1' ' D' ' 22' ' ' ALA . . . -133.09 19.87 4.07 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.641 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.66 -15.53 0.16 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.932 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' SER . . . . . 0.514 ' HB3' ' HB3' ' B' ' 91' ' ' SER . 1.0 OUTLIER -97.32 174.96 6.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.898 0.38 . . . . 0.0 110.583 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 96' ' ' ALA . . . . . 0.658 ' O ' HD22 ' B' ' 88' ' ' LEU . . . -114.13 157.88 22.02 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.83 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.544 HG23 HD11 ' B' ' 88' ' ' LEU . 0.2 OUTLIER -113.03 162.7 15.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.308 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 69.42 41.5 1.3 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.46 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 10.4 p -177.62 130.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.825 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.04 179.52 28.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.598 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' B' ' 86' ' ' LEU . 1.6 t -99.15 95.33 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.009 0.524 . . . . 0.0 111.672 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.782 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 13.7 tt0 -69.85 159.82 32.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.954 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.435 HG12 ' CE2' ' B' ' 73' ' ' PHE . 0.9 OUTLIER -121.69 98.41 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.56 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 104' ' ' LEU . . . . . 0.686 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 1.1 tp -84.8 119.38 25.23 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.792 0.33 . . . . 0.0 111.113 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.18 158.04 32.09 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.643 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' ARG . . . . . 0.555 ' HB2' ' HB2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -61.05 -33.93 74.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.913 0.387 . . . . 0.0 111.117 179.42 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.554 HG23 ' HA ' ' B' ' 120' ' ' SER . 0.0 OUTLIER -48.76 -38.25 21.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.972 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.73 -88.78 0.11 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.59 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.2 -176.35 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.892 0.377 . . . . 0.0 111.066 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.686 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -79.98 143.94 33.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' B' ' 73' ' ' PHE . 0.6 OUTLIER -90.09 157.56 17.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.363 0.601 . . . . 0.0 110.561 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.451 ' HB ' HG21 ' B' ' 117' ' ' THR . 29.7 m -81.12 150.43 28.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.111 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.606 HD12 ' N ' ' B' ' 113' ' ' LEU . 3.0 mp -102.7 57.66 0.78 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.691 0.281 . . . . 0.0 110.738 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.49 19.67 15.23 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.477 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.24 -93.05 0.88 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.634 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' E' ' 125' ' ' ASN . . . -102.71 69.66 1.08 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.03 0.443 . . . . 0.0 111.592 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' B' ' 72' ' ' ALA . 5.9 p -89.62 97.22 11.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.142 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.17 102.82 5.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.764 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.44 -82.74 0.65 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.554 ' HA ' HG23 ' B' ' 107' ' ' THR . 0.1 OUTLIER -63.22 100.93 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.614 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -88.87 79.02 7.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.143 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.436 HG21 ' CD ' ' B' ' 132' ' ' PRO . 4.6 p -82.52 159.17 22.9 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.737 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 16.0 m -85.33 139.71 31.37 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.746 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.36 136.15 33.44 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.609 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -120.8 143.56 48.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.644 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.2 148.95 34.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 110.63 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.67 -106.11 2.29 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.746 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -85.16 153.16 22.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.812 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ASN . . . . . 0.597 ' HB3' ' HB2' ' B' ' 58' ' ' LEU . 23.1 t-20 -148.4 120.76 8.43 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.93 0.395 . . . . 0.0 111.112 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.509 HG22 ' HB2' ' B' ' 55' ' ' ASN . 0.2 OUTLIER -104.24 147.26 27.68 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.151 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 131' ' ' ILE . . . . . 0.791 HD12 ' HB ' ' B' ' 56' ' ' ILE . 89.9 mt -116.58 119.19 36.23 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 132' ' ' PRO . . . . . 0.555 ' HB2' ' HB2' ' B' ' 106' ' ' ARG . 7.6 Cg_endo -80.79 119.14 3.57 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.632 1.555 . . . . 0.0 112.535 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.05 147.3 29.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.775 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.13 155.88 47.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.04 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.706 ' HB3' HG22 ' B' ' 52' ' ' VAL . . . -140.06 115.67 10.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.648 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 136' ' ' ARG . . . . . 0.441 ' NH2' HG21 ' B' ' 48' ' ' THR . 0.5 OUTLIER -111.26 148.93 31.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.535 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.48 151.27 45.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.119 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 138' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' B' ' 47' ' ' ALA . 0.2 OUTLIER -144.52 164.58 30.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.033 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.65 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -124.45 145.68 49.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.809 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 140' ' ' THR . . . . . 0.554 HG21 ' HB2' ' B' ' 79' ' ' ASP . 0.2 OUTLIER -117.77 13.01 14.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.545 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.83 79.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.97 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.73 92.14 0.02 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.619 0.21 . . . . 0.0 110.769 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.08 154.8 33.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.698 0.285 . . . . 0.0 111.393 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.527 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 39.3 p -116.76 166.22 13.34 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.223 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 145' ' ' PRO . . . . . 0.485 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 1.4 Cg_endo -84.27 151.5 12.16 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.467 2.112 . . . . 0.0 111.976 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.62 -106.29 0.46 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.401 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -139.06 163.32 32.72 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.839 0.352 . . . . 0.0 111.386 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -166.01 79.93 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.546 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.542 ' HB2' ' HB3' ' B' ' 89' ' ' GLN . 87.2 m-20 -99.92 142.47 31.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.557 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.512 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -127.76 169.02 14.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.01 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.6 109.94 0.85 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.261 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 152' ' ' ALA . . . . . 0.632 ' HB2' HD21 ' B' ' 86' ' ' LEU . . . -147.02 145.45 29.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.14 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -93.66 164.22 13.24 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.276 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 154' ' ' PHE . . . . . 0.622 ' CZ ' HG21 ' B' ' 56' ' ' ILE . 15.4 p90 -110.89 151.66 27.63 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.141 0.496 . . . . 0.0 110.137 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 155' ' ' LYS . . . . . 0.83 ' HB3' ' HB3' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -109.75 160.88 15.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.932 -178.891 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 156' ' ' VAL . . . . . 0.646 HG23 HG23 ' A' ' 5' ' ' VAL . 1.4 m -142.1 112.92 3.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.786 0.326 . . . . 0.0 111.706 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.702 ' HB3' ' HB3' ' B' ' 70' ' ' ALA . 0.3 OUTLIER -91.87 124.44 35.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.352 0.596 . . . . 0.0 110.426 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 158' ' ' TYR . . . . . 0.55 ' HB2' ' HB ' ' A' ' 3' ' ' THR . 57.3 m-85 -117.19 135.54 53.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.525 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.866 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.55 100.26 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.984 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' D' ' 158' ' ' TYR . 7.4 m -104.82 78.63 1.45 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.406 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 4' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' D' ' 156' ' ' VAL . 0.2 OUTLIER -85.31 122.39 29.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.599 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.646 HG23 HG23 ' D' ' 156' ' ' VAL . 5.0 m -137.94 162.94 30.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.472 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 6' ' ' ASN . . . . . 0.427 ' HB3' ' OE2' ' D' ' 15' ' ' GLU . 44.0 t-20 -84.37 114.55 21.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.615 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 7' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' D' ' 154' ' ' PHE . . . -83.47 -41.39 8.42 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.679 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 8' ' ' GLY . . . . . 0.443 ' N ' ' CE1' ' D' ' 154' ' ' PHE . . . -175.61 162.26 31.49 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.908 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 9' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' D' ' 153' ' ' THR . 99.2 m -90.79 137.92 31.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.981 0.42 . . . . 0.0 111.231 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.46 114.23 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.233 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -99.29 148.56 24.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.347 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 12' ' ' PHE . . . . . 0.814 ' HB3' HD21 ' D' ' 34' ' ' LEU . 60.8 m-85 -133.83 113.07 11.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.723 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 13' ' ' LYS . . . . . 0.738 ' HG2' ' HA ' ' D' ' 33' ' ' GLN . 0.0 OUTLIER -107.14 105.86 16.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.395 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.18 169.44 28.87 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.992 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' GLU . . . . . 0.551 ' HB2' ' HG3' ' D' ' 36' ' ' GLN . 33.8 mt-10 -140.73 -171.07 3.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.913 0.387 . . . . 0.0 110.391 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.583 HG13 HG23 ' D' ' 37' ' ' VAL . 0.5 OUTLIER -139.24 152.77 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.251 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.715 ' O ' HG23 ' D' ' 39' ' ' THR . 0.0 OUTLIER -137.42 155.35 31.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.888 0.375 . . . . 0.0 111.047 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -85.13 53.11 2.63 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' ALA . . . . . 0.671 ' HA ' ' HG2' ' D' ' 38' ' ' ARG . . . 61.33 92.74 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.098 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 20' ' ' ALA . . . . . 0.583 ' H ' ' HG2' ' D' ' 38' ' ' ARG . . . -164.8 -47.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.438 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 21' ' ' CYS . . . . . 0.754 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 1.6 m -159.81 176.83 11.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.951 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 22' ' ' ALA . . . . . 0.61 ' HB2' ' HE ' ' D' ' 38' ' ' ARG . . . -147.28 111.99 5.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.115 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 23' ' ' VAL . . . . . 0.604 HG13 ' HB3' ' C' ' 27' ' ' SER . 43.0 t -67.44 143.22 15.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.015 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.546 ' O ' HG23 ' C' ' 28' ' ' VAL . 17.0 m-20 -91.2 168.1 11.86 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.629 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.36 -50.0 74.35 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.42 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.38 -16.64 73.69 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.907 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' SER . . . . . 0.604 ' HB3' HG13 ' C' ' 23' ' ' VAL . 0.4 OUTLIER -84.31 -24.44 29.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.876 0.37 . . . . 0.0 110.742 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.546 HG23 ' O ' ' C' ' 24' ' ' ASP . 85.1 t -58.04 -37.23 60.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.359 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -140.37 105.91 5.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.043 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -108.95 106.95 17.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.155 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.79 95.6 9.02 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.047 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.546 HG11 HG21 ' C' ' 52' ' ' VAL . 51.7 t -85.82 138.24 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.099 0.476 . . . . 0.0 110.37 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.757 ' HA ' ' HG2' ' B' ' 13' ' ' LYS . 3.2 mt-30 -113.2 132.6 55.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.651 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' B' ' 12' ' ' PHE . 1.8 mm? -94.53 -71.43 0.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.627 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.83 -111.31 0.72 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.544 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' GLN . . . . . 0.541 ' HG3' ' HB2' ' B' ' 15' ' ' GLU . 3.6 tt0 -161.06 105.84 1.35 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.721 0.296 . . . . 0.0 110.874 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.569 HG23 HG13 ' B' ' 16' ' ' VAL . 5.6 m -91.15 142.37 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.937 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 38' ' ' ARG . . . . . 0.663 ' HG2' ' HA ' ' B' ' 19' ' ' ALA . 0.7 OUTLIER -81.18 162.55 23.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.694 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.729 HG23 ' O ' ' B' ' 17' ' ' VAL . 82.6 p -80.39 -16.79 53.66 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.765 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.81 -31.16 63.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.157 0.503 . . . . 0.0 110.839 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -28.5 39.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.11 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.636 ' HB3' ' HB2' ' C' ' 139' ' ' ALA . 1.7 mp -133.21 70.13 1.47 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.601 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 43' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' C' ' 39' ' ' THR . . . -103.67 11.18 36.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.5 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.01 146.83 27.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.466 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.5 121.28 13.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.871 0.367 . . . . 0.0 111.152 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.52 -10.47 12.75 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.114 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' C' ' 138' ' ' PHE . . . -68.78 142.21 54.98 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.874 0.369 . . . . 0.0 111.976 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 48' ' ' THR . . . . . 0.44 HG21 ' NH2' ' C' ' 136' ' ' ARG . 6.8 t -134.75 140.81 46.21 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.852 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 17.0 m -105.96 -152.79 0.48 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.56 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 1.4 t -65.94 178.6 1.06 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.859 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.11 168.82 15.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.805 0.336 . . . . 0.0 111.28 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' C' ' 135' ' ' ALA . 14.7 m -117.98 132.24 68.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.21 107.62 3.57 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.683 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' PHE . . . . . 0.591 ' HD1' HG23 ' C' ' 52' ' ' VAL . 55.6 p90 -140.31 132.09 27.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.741 0.305 . . . . 0.0 110.932 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.531 ' HB2' HG22 ' C' ' 130' ' ' THR . 12.5 p30 -117.83 176.83 5.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.565 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.794 ' HB ' HD12 ' C' ' 131' ' ' ILE . 51.7 mm -119.02 121.68 67.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.533 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.29 122.71 30.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.826 0.346 . . . . 0.0 110.831 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 58' ' ' LEU . . . . . 0.588 ' HB2' ' HB3' ' C' ' 129' ' ' ASN . 0.9 OUTLIER -131.23 93.75 3.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 59' ' ' ASN . . . . . 0.534 ' O ' ' HB3' ' C' ' 22' ' ' ALA . 0.4 OUTLIER -77.08 160.82 28.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.871 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.26 87.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.74 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 61' ' ' CYS . . . . . 0.754 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 70.2 m -120.52 131.8 54.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.813 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.61 97.91 9.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.343 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' C' ' 66' ' ' ALA . 1.5 m -77.44 -19.96 55.23 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.04 -27.56 68.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.978 0.418 . . . . 0.0 111.711 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 16.9 t -95.36 -35.76 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.613 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 66' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' C' ' 63' ' ' THR . . . -130.9 131.29 44.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.706 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.45 -37.27 7.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.912 0.387 . . . . 0.0 110.983 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -121.74 171.36 8.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.503 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.58 136.15 15.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.593 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.728 ' HB3' ' HB3' ' C' ' 157' ' ' GLN . . . -94.52 157.99 15.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.086 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.44 106.28 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.693 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 72' ' ' ALA . . . . . 0.839 ' HB3' ' HB3' ' C' ' 155' ' ' LYS . . . -109.6 164.31 12.65 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.597 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 73' ' ' PHE . . . . . 0.671 ' HB2' HD11 ' C' ' 111' ' ' LEU . 6.6 t80 -142.26 141.03 32.42 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.147 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.726 HD11 ' HG2' ' F' ' 57' ' ' GLN . 0.1 OUTLIER -122.66 103.37 8.63 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.981 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 75' ' ' GLY . . . . . 0.504 ' HA3' HD23 ' C' ' 113' ' ' LEU . . . -153.47 -166.38 14.58 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.909 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.5 136.27 46.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.574 0.226 . . . . 0.0 110.746 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 77' ' ' ALA . . . . . 0.685 ' H ' ' HB3' ' F' ' 132' ' ' PRO . . . -81.39 156.08 25.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.878 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 78' ' ' ILE . . . . . 0.472 HG12 ' OG1' ' C' ' 140' ' ' THR . 3.1 tt -92.56 -20.65 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.796 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 79' ' ' ASP . . . . . 0.563 ' HB2' HG21 ' C' ' 140' ' ' THR . 0.4 OUTLIER 176.15 179.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.821 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 80' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' F' ' 107' ' ' THR . . . -79.02 -33.76 44.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.988 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.39 -44.0 95.45 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.564 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' HIS . . . . . 0.447 ' HB3' HG23 ' C' ' 85' ' ' VAL . 43.3 m-70 -97.74 -64.42 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.787 0.327 . . . . 0.0 110.47 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 83' ' ' THR . . . . . 0.439 ' HA ' ' HB1' ' C' ' 77' ' ' ALA . 1.2 m 62.32 7.81 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.597 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 84' ' ' ASN . . . . . 0.419 ' O ' HD12 ' C' ' 103' ' ' ILE . 86.9 m-20 -115.02 -25.51 8.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.308 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' C' ' 102' ' ' GLN . 0.5 OUTLIER -79.53 143.63 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.214 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' C' ' 152' ' ' ALA . 0.3 OUTLIER -76.59 148.57 36.9 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.294 179.412 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.87 178.25 4.37 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.721 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.643 HD22 ' O ' ' C' ' 96' ' ' ALA . 0.0 OUTLIER -84.71 176.19 8.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.124 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 89' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' C' ' 149' ' ' ASN . 22.9 pt20 -75.18 178.69 5.56 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.352 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 90' ' ' SER . . . . . 0.53 ' O ' HG12 ' F' ' 52' ' ' VAL . 1.0 OUTLIER -73.36 -11.45 60.49 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.002 0.429 . . . . 0.0 111.461 179.408 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 91' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' C' ' 95' ' ' SER . 0.3 OUTLIER -64.72 87.27 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.92 -7.09 53.75 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.688 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 93' ' ' ALA . . . . . 0.47 ' HB1' ' HB1' ' E' ' 22' ' ' ALA . . . -133.15 19.92 4.06 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.614 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.64 -15.6 0.16 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.96 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 95' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' C' ' 91' ' ' SER . 1.0 OUTLIER -97.35 174.93 6.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 110.594 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 96' ' ' ALA . . . . . 0.643 ' O ' HD22 ' C' ' 88' ' ' LEU . . . -114.06 157.85 22.0 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 97' ' ' THR . . . . . 0.54 HG23 HD11 ' C' ' 88' ' ' LEU . 0.2 OUTLIER -112.9 162.78 15.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.325 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 69.33 41.52 1.32 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.366 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 10.3 p -177.58 130.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.06 179.45 28.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.604 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 101' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' C' ' 86' ' ' LEU . 1.6 t -99.07 95.27 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.072 0.549 . . . . 0.0 111.703 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 102' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' C' ' 85' ' ' VAL . 13.7 tt0 -69.88 159.8 33.0 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.9 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.432 HG12 ' CE2' ' C' ' 73' ' ' PHE . 0.9 OUTLIER -121.66 98.36 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.574 179.425 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 104' ' ' LEU . . . . . 0.678 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 1.1 tp -84.64 119.36 25.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.695 0.283 . . . . 0.0 111.148 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.13 158.08 32.12 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.677 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 106' ' ' ARG . . . . . 0.55 ' HB2' ' HB2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -61.13 -33.93 74.18 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.914 0.388 . . . . 0.0 111.085 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 107' ' ' THR . . . . . 0.553 HG23 ' HA ' ' C' ' 120' ' ' SER . 0.0 OUTLIER -48.8 -38.22 21.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.972 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.75 -88.82 0.11 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.544 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.17 -176.32 5.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.82 0.343 . . . . 0.0 111.143 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.678 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -79.98 143.89 33.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.136 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 111' ' ' LEU . . . . . 0.671 HD11 ' HB2' ' C' ' 73' ' ' PHE . 0.6 OUTLIER -90.07 157.51 17.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.389 0.614 . . . . 0.0 110.557 179.688 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 112' ' ' THR . . . . . 0.448 ' HB ' HG21 ' C' ' 117' ' ' THR . 29.9 m -81.13 150.45 28.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.154 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.603 HD12 ' N ' ' C' ' 113' ' ' LEU . 3.0 mp -102.68 57.64 0.78 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.675 0.274 . . . . 0.0 110.742 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.48 19.72 15.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.562 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.18 -93.08 0.88 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.647 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 116' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' F' ' 125' ' ' ASN . . . -102.73 69.58 1.08 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.097 0.475 . . . . 0.0 111.631 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 117' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' C' ' 72' ' ' ALA . 5.9 p -89.62 97.25 11.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.196 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.13 102.72 5.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.723 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.43 -82.69 0.65 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 120' ' ' SER . . . . . 0.553 ' HA ' HG23 ' C' ' 107' ' ' THR . 0.1 OUTLIER -63.16 100.87 0.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.715 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.82 79.01 7.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.208 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.43 HG21 ' CD ' ' C' ' 132' ' ' PRO . 4.5 p -82.56 159.1 22.85 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.729 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 16.3 m -85.17 139.71 31.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.825 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.42 136.15 33.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.811 0.338 . . . . 0.0 110.548 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -120.77 143.55 48.76 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.653 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.14 148.94 34.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.742 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.76 -106.21 2.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.692 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -85.2 153.25 22.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.734 0.302 . . . . 0.0 110.74 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 129' ' ' ASN . . . . . 0.588 ' HB3' ' HB2' ' C' ' 58' ' ' LEU . 23.2 t-20 -148.45 120.72 8.38 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.898 0.38 . . . . 0.0 111.112 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 130' ' ' THR . . . . . 0.531 HG22 ' HB2' ' C' ' 55' ' ' ASN . 0.2 OUTLIER -104.18 147.33 27.58 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.132 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 131' ' ' ILE . . . . . 0.794 HD12 ' HB ' ' C' ' 56' ' ' ILE . 89.8 mt -116.62 119.27 36.02 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 132' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' C' ' 106' ' ' ARG . 7.6 Cg_endo -80.92 119.17 3.53 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 121.652 1.568 . . . . 0.0 112.548 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.12 147.27 29.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.762 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.09 155.98 47.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.02 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 135' ' ' ALA . . . . . 0.713 ' HB3' HG22 ' C' ' 52' ' ' VAL . . . -140.09 115.7 10.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.93 0.395 . . . . 0.0 111.579 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.44 ' NH2' HG21 ' C' ' 48' ' ' THR . 0.5 OUTLIER -111.26 149.02 31.63 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.432 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.67 151.32 45.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.068 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 138' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' C' ' 47' ' ' ALA . 0.2 OUTLIER -144.55 164.56 30.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.924 -179.095 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 139' ' ' ALA . . . . . 0.636 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -124.41 145.74 49.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.923 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 140' ' ' THR . . . . . 0.563 HG21 ' HB2' ' C' ' 79' ' ' ASP . 0.2 OUTLIER -117.8 12.89 14.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.516 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.87 79.82 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.895 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.7 92.11 0.02 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.595 0.197 . . . . 0.0 110.796 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.11 154.83 33.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.75 0.31 . . . . 0.0 111.403 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 144' ' ' THR . . . . . 0.521 ' O ' ' HB ' ' B' ' 16' ' ' VAL . 39.8 p -116.75 166.22 13.34 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.181 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 145' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' B' ' 16' ' ' VAL . 1.3 Cg_endo -84.28 151.4 12.13 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.468 2.112 . . . . 0.0 111.993 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.7 -106.23 0.45 Allowed Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.403 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 147' ' ' ALA . . . . . 0.407 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -139.13 163.23 32.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.764 0.316 . . . . 0.0 111.411 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.89 79.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.502 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 149' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' C' ' 89' ' ' GLN . 87.1 m-20 -99.92 142.47 31.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.576 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 150' ' ' ALA . . . . . 0.526 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -127.77 168.96 14.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.052 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.54 109.99 0.86 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.267 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 152' ' ' ALA . . . . . 0.622 ' HB2' HD21 ' C' ' 86' ' ' LEU . . . -146.94 145.42 29.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.148 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 153' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' B' ' 9' ' ' THR . 0.9 OUTLIER -93.61 164.18 13.26 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 154' ' ' PHE . . . . . 0.631 ' CZ ' HG21 ' C' ' 56' ' ' ILE . 15.2 p90 -110.87 151.52 27.77 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.157 0.503 . . . . 0.0 110.187 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 155' ' ' LYS . . . . . 0.839 ' HB3' ' HB3' ' C' ' 72' ' ' ALA . 0.0 OUTLIER -109.6 160.95 15.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.943 -178.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 156' ' ' VAL . . . . . 0.644 HG23 HG23 ' B' ' 5' ' ' VAL . 1.5 m -142.17 112.9 3.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.761 0.315 . . . . 0.0 111.715 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 157' ' ' GLN . . . . . 0.728 ' HB3' ' HB3' ' C' ' 70' ' ' ALA . 0.3 OUTLIER -91.88 124.38 35.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.36 0.6 . . . . 0.0 110.46 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 158' ' ' TYR . . . . . 0.551 ' HB2' ' HB ' ' B' ' 3' ' ' THR . 57.6 m-85 -117.18 135.47 53.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.493 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.914 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.53 100.1 0.04 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.064 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 3' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' E' ' 158' ' ' TYR . 7.3 m -104.74 78.63 1.46 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.48 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.27 122.44 29.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.528 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.643 HG23 HG23 ' E' ' 156' ' ' VAL . 5.1 m -137.95 162.93 30.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.533 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 6' ' ' ASN . . . . . 0.43 ' HB3' ' OE2' ' E' ' 15' ' ' GLU . 44.0 t-20 -84.34 114.56 21.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.594 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 7' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' E' ' 154' ' ' PHE . . . -83.41 -41.48 8.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.683 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 8' ' ' GLY . . . . . 0.447 ' N ' ' CE1' ' E' ' 154' ' ' PHE . . . -175.64 162.28 31.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.847 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 9' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' E' ' 153' ' ' THR . 98.8 m -90.74 137.81 32.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.92 0.39 . . . . 0.0 111.28 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.43 114.28 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.254 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -99.38 148.49 24.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.312 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 12' ' ' PHE . . . . . 0.814 ' HB3' HD21 ' E' ' 34' ' ' LEU . 60.7 m-85 -133.74 113.08 11.92 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.824 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 13' ' ' LYS . . . . . 0.745 ' HG2' ' HA ' ' E' ' 33' ' ' GLN . 0.0 OUTLIER -107.12 105.82 16.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.39 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.17 169.48 28.86 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.958 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 15' ' ' GLU . . . . . 0.548 ' HB2' ' HG3' ' E' ' 36' ' ' GLN . 33.6 mt-10 -140.75 -171.05 3.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.849 0.357 . . . . 0.0 110.431 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.57 HG13 HG23 ' E' ' 37' ' ' VAL . 0.5 OUTLIER -139.23 152.88 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.144 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.723 ' O ' HG23 ' E' ' 39' ' ' THR . 0.0 OUTLIER -137.47 155.39 31.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.856 0.36 . . . . 0.0 111.069 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -85.19 53.06 2.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.011 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 19' ' ' ALA . . . . . 0.684 ' HA ' ' HG2' ' E' ' 38' ' ' ARG . . . 61.41 92.64 0.05 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.112 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.58 ' H ' ' HG2' ' E' ' 38' ' ' ARG . . . -164.72 -47.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.469 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 21' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 1.6 m -159.86 176.77 11.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.989 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 22' ' ' ALA . . . . . 0.623 ' HB2' ' HE ' ' E' ' 38' ' ' ARG . . . -147.22 111.91 5.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.157 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 23' ' ' VAL . . . . . 0.625 HG13 ' HB3' ' D' ' 27' ' ' SER . 43.2 t -67.29 143.08 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.004 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.547 ' O ' HG23 ' D' ' 28' ' ' VAL . 17.0 m-20 -91.16 168.15 11.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.619 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.37 -50.02 74.31 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.443 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.38 -16.61 73.67 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.967 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 27' ' ' SER . . . . . 0.625 ' HB3' HG13 ' D' ' 23' ' ' VAL . 0.4 OUTLIER -84.32 -24.44 29.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.892 0.377 . . . . 0.0 110.763 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 28' ' ' VAL . . . . . 0.547 HG23 ' O ' ' D' ' 24' ' ' ASP . 85.6 t -58.1 -37.19 60.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.346 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -140.41 105.98 5.1 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.033 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -109.08 106.95 17.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.106 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.74 95.56 8.98 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.096 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.54 HG11 HG21 ' D' ' 52' ' ' VAL . 51.9 t -85.76 138.17 19.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.11 0.481 . . . . 0.0 110.388 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 33' ' ' GLN . . . . . 0.738 ' HA ' ' HG2' ' C' ' 13' ' ' LYS . 3.1 mt-30 -113.11 132.59 55.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.688 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.814 HD21 ' HB3' ' C' ' 12' ' ' PHE . 1.8 mm? -94.47 -71.48 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.64 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.83 -111.33 0.72 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.526 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' GLN . . . . . 0.551 ' HG3' ' HB2' ' C' ' 15' ' ' GLU . 3.6 tt0 -160.96 105.83 1.37 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.648 0.261 . . . . 0.0 110.884 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.583 HG23 HG13 ' C' ' 16' ' ' VAL . 5.6 m -91.15 142.42 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.878 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 38' ' ' ARG . . . . . 0.671 ' HG2' ' HA ' ' C' ' 19' ' ' ALA . 0.7 OUTLIER -81.11 162.53 23.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.759 179.233 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.715 HG23 ' O ' ' C' ' 17' ' ' VAL . 82.4 p -80.34 -16.94 53.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.788 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.71 -31.23 63.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.166 0.508 . . . . 0.0 110.919 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.11 -28.42 39.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.116 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.618 ' HB3' ' HB2' ' D' ' 139' ' ' ALA . 1.7 mp -133.16 70.19 1.47 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.625 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 43' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' D' ' 39' ' ' THR . . . -103.71 11.21 36.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.424 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.06 146.85 27.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.38 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.48 121.22 13.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.56 -10.4 12.71 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.09 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' D' ' 138' ' ' PHE . . . -68.8 142.17 54.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.905 0.383 . . . . 0.0 111.97 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 48' ' ' THR . . . . . 0.433 HG21 ' NH2' ' D' ' 136' ' ' ARG . 6.9 t -134.72 140.84 46.26 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.816 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 16.8 m -106.02 -152.76 0.48 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.587 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 1.4 t -65.91 178.64 1.04 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.813 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.16 168.9 15.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.283 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 52' ' ' VAL . . . . . 0.681 HG22 ' HB3' ' D' ' 135' ' ' ALA . 14.7 m -118.02 132.25 68.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 53' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 88' ' ' LEU . . . -95.2 107.59 3.56 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.647 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.605 ' HD1' HG23 ' D' ' 52' ' ' VAL . 55.5 p90 -140.28 132.05 27.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.707 0.289 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 55' ' ' ASN . . . . . 0.53 ' HB2' HG22 ' D' ' 130' ' ' THR . 12.4 p30 -117.81 176.83 5.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.57 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.772 ' HB ' HD12 ' D' ' 131' ' ' ILE . 51.7 mm -118.98 121.7 67.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.532 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 57' ' ' GLN . . . . . 0.737 ' HG2' HD11 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -86.32 122.66 30.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.778 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 58' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' D' ' 129' ' ' ASN . 0.9 OUTLIER -131.2 93.71 3.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.234 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 59' ' ' ASN . . . . . 0.549 ' O ' ' HB3' ' D' ' 22' ' ' ALA . 0.4 OUTLIER -76.98 160.91 28.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.912 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.12 87.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.76 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 61' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 70.1 m -120.55 131.81 54.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.808 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.61 97.87 9.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.308 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' D' ' 66' ' ' ALA . 1.5 m -77.41 -19.98 55.31 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.06 -27.54 68.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.975 0.417 . . . . 0.0 111.701 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.4 -35.75 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.608 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' D' ' 63' ' ' THR . . . -130.94 131.24 44.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.716 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.41 -37.35 7.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.885 0.374 . . . . 0.0 110.954 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -121.69 171.4 8.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.577 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.55 136.13 15.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.555 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 70' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' D' ' 157' ' ' GLN . . . -94.49 157.95 15.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.087 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 38.1 t -110.42 106.31 20.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.655 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 72' ' ' ALA . . . . . 0.821 ' HB3' ' HB3' ' D' ' 155' ' ' LYS . . . -109.64 164.24 12.72 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.575 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 73' ' ' PHE . . . . . 0.659 ' HB2' HD11 ' D' ' 111' ' ' LEU . 6.5 t80 -142.21 141.11 32.51 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.564 0.221 . . . . 0.0 111.15 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 74' ' ' LEU . . . . . 0.429 HD22 ' NZ ' ' D' ' 155' ' ' LYS . 0.1 OUTLIER -122.72 103.37 8.61 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.991 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 75' ' ' GLY . . . . . 0.512 ' HA3' HD23 ' D' ' 113' ' ' LEU . . . -153.46 -166.43 14.62 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.889 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.46 136.37 46.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.611 0.243 . . . . 0.0 110.695 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.448 ' HB1' ' HA ' ' D' ' 83' ' ' THR . . . -81.54 156.12 25.4 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.88 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 78' ' ' ILE . . . . . 0.464 HG12 ' OG1' ' D' ' 140' ' ' THR . 3.0 tt -92.52 -20.67 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.83 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.565 ' HB2' HG21 ' D' ' 140' ' ' THR . 0.4 OUTLIER 176.15 179.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.825 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.95 -33.85 44.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.975 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.51 -43.82 95.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.595 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 82' ' ' HIS . . . . . 0.457 ' NE2' ' O ' ' D' ' 139' ' ' ALA . 43.6 m-70 -97.78 -64.48 1.04 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.862 0.363 . . . . 0.0 110.438 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 83' ' ' THR . . . . . 0.448 ' HA ' ' HB1' ' D' ' 77' ' ' ALA . 1.2 m 62.45 7.77 2.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.582 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 84' ' ' ASN . . . . . 0.417 ' O ' HD12 ' D' ' 103' ' ' ILE . 87.0 m-20 -115.08 -25.41 8.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.329 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' D' ' 102' ' ' GLN . 0.5 OUTLIER -79.58 143.68 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.171 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' D' ' 152' ' ' ALA . 0.3 OUTLIER -76.63 148.53 36.86 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.27 179.434 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.8 178.2 4.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.894 0.378 . . . . 0.0 111.716 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.652 HD22 ' O ' ' D' ' 96' ' ' ALA . 0.0 OUTLIER -84.67 176.16 8.75 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.096 179.395 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 89' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' D' ' 149' ' ' ASN . 22.8 pt20 -75.24 178.71 5.58 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.38 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.36 -11.5 60.5 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 111.428 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 91' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' D' ' 95' ' ' SER . 0.3 OUTLIER -64.62 87.24 0.05 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.891 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.88 -7.15 53.83 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.921 0.391 . . . . 0.0 111.697 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 93' ' ' ALA . . . . . 0.469 ' HB1' ' HB1' ' F' ' 22' ' ' ALA . . . -133.14 19.96 4.06 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.674 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.62 -15.58 0.16 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.942 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 95' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' D' ' 91' ' ' SER . 1.0 OUTLIER -97.33 174.89 6.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.9 0.381 . . . . 0.0 110.59 179.558 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 96' ' ' ALA . . . . . 0.652 ' O ' HD22 ' D' ' 88' ' ' LEU . . . -114.05 157.88 21.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.82 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 97' ' ' THR . . . . . 0.533 HG23 HD11 ' D' ' 88' ' ' LEU . 0.2 OUTLIER -112.9 162.72 15.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.305 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 98' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 69.29 41.62 1.32 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.387 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 99' ' ' VAL . . . . . . . . . . . . . 10.1 p -177.64 130.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.792 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.12 179.45 28.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.552 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 101' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' D' ' 86' ' ' LEU . 1.6 t -99.0 95.29 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 123.078 0.551 . . . . 0.0 111.681 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 102' ' ' GLN . . . . . 0.771 ' HA ' ' HA ' ' D' ' 85' ' ' VAL . 13.7 tt0 -69.84 159.79 32.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.892 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 103' ' ' ILE . . . . . 0.433 HG12 ' CE2' ' D' ' 73' ' ' PHE . 0.9 OUTLIER -121.7 98.45 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.522 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 104' ' ' LEU . . . . . 0.684 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 1.1 tp -84.75 119.38 25.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.755 0.312 . . . . 0.0 111.095 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.18 158.09 32.04 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.68 0.276 . . . . 0.0 111.646 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 106' ' ' ARG . . . . . 0.556 ' HB2' ' HB2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -61.19 -33.92 74.23 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.902 0.382 . . . . 0.0 111.048 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 107' ' ' THR . . . . . 0.561 HG23 ' HA ' ' D' ' 120' ' ' SER . 0.0 OUTLIER -48.72 -38.19 20.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.027 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.68 -88.81 0.11 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.603 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.16 -176.35 5.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.867 0.365 . . . . 0.0 111.139 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.684 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -79.96 143.93 33.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.098 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 111' ' ' LEU . . . . . 0.659 HD11 ' HB2' ' D' ' 73' ' ' PHE . 0.6 OUTLIER -90.08 157.58 17.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.386 0.612 . . . . 0.0 110.534 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 112' ' ' THR . . . . . 0.45 ' HB ' HG21 ' D' ' 117' ' ' THR . 30.0 m -81.22 150.47 28.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.099 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 113' ' ' LEU . . . . . 0.608 HD12 ' N ' ' D' ' 113' ' ' LEU . 2.9 mp -102.72 57.67 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.721 0.296 . . . . 0.0 110.742 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.42 19.57 15.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.552 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.23 -93.04 0.88 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.665 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.68 69.61 1.08 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.021 0.438 . . . . 0.0 111.564 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 117' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' D' ' 72' ' ' ALA . 5.8 p -89.69 97.34 11.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.2 102.83 5.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.786 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.45 -82.72 0.65 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 120' ' ' SER . . . . . 0.561 ' HA ' HG23 ' D' ' 107' ' ' THR . 0.1 OUTLIER -63.2 100.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.614 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.86 79.05 7.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.234 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.43 HG21 ' CD ' ' D' ' 132' ' ' PRO . 4.4 p -82.61 159.15 22.78 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.719 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 16.2 m -85.2 139.68 31.47 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.8 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.34 136.1 33.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.65 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 125' ' ' ASN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 116' ' ' ALA . 25.1 m120 -120.78 143.67 48.7 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.622 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.19 148.98 34.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.638 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.61 -106.12 2.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.75 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 128' ' ' THR . . . . . 0.648 HG21 ' NZ ' ' A' ' 155' ' ' LYS . 1.9 m -85.15 153.14 22.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.654 0.264 . . . . 0.0 110.817 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 129' ' ' ASN . . . . . 0.585 ' HB3' ' HB2' ' D' ' 58' ' ' LEU . 23.3 t-20 -148.39 120.68 8.39 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.874 0.368 . . . . 0.0 111.125 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 130' ' ' THR . . . . . 0.556 ' OG1' HD12 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -104.15 147.33 27.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.164 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 131' ' ' ILE . . . . . 0.772 HD12 ' HB ' ' D' ' 56' ' ' ILE . 89.4 mt -116.59 119.15 36.25 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 132' ' ' PRO . . . . . 0.677 ' HB3' ' H ' ' A' ' 77' ' ' ALA . 7.5 Cg_endo -80.95 119.11 3.5 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.645 1.563 . . . . 0.0 112.546 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.01 147.36 29.53 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.795 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.17 155.87 47.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.021 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.681 ' HB3' HG22 ' D' ' 52' ' ' VAL . . . -140.09 115.64 10.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.904 0.383 . . . . 0.0 111.575 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 136' ' ' ARG . . . . . 0.433 ' NH2' HG21 ' D' ' 48' ' ' THR . 0.5 OUTLIER -111.27 149.01 31.66 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.543 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.52 151.27 45.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.132 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 138' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' D' ' 47' ' ' ALA . 0.2 OUTLIER -144.49 164.61 30.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.225 0.536 . . . . 0.0 111.993 -179.154 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 139' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -124.5 145.71 49.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.901 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 140' ' ' THR . . . . . 0.565 HG21 ' HB2' ' D' ' 79' ' ' ASP . 0.2 OUTLIER -117.74 12.97 14.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.536 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.76 79.74 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.957 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.73 92.17 0.02 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.619 0.209 . . . . 0.0 110.716 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.13 154.86 33.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 111.357 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 144' ' ' THR . . . . . 0.524 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 39.2 p -116.76 166.16 13.49 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.237 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 145' ' ' PRO . . . . . 0.492 ' HA ' ' HB ' ' C' ' 16' ' ' VAL . 1.3 Cg_endo -84.24 151.49 12.21 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.45 2.1 . . . . 0.0 111.98 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.65 -106.34 0.46 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.453 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 147' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -139.05 163.26 32.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.823 0.344 . . . . 0.0 111.354 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.96 79.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.59 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 149' ' ' ASN . . . . . 0.531 ' HB2' ' HB3' ' D' ' 89' ' ' GLN . 87.1 m-20 -99.97 142.45 31.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.569 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 150' ' ' ALA . . . . . 0.508 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -127.72 168.99 14.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.969 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.55 109.99 0.86 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.214 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 152' ' ' ALA . . . . . 0.628 ' HB2' HD21 ' D' ' 86' ' ' LEU . . . -147.01 145.44 29.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.086 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 153' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' C' ' 9' ' ' THR . 1.0 OUTLIER -93.72 164.23 13.22 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.252 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 154' ' ' PHE . . . . . 0.63 ' CZ ' HG21 ' D' ' 56' ' ' ILE . 15.1 p90 -110.92 151.61 27.7 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.147 0.499 . . . . 0.0 110.108 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 155' ' ' LYS . . . . . 0.821 ' HB3' ' HB3' ' D' ' 72' ' ' ALA . 0.0 OUTLIER -109.64 160.84 15.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.951 -178.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 156' ' ' VAL . . . . . 0.646 HG23 HG23 ' C' ' 5' ' ' VAL . 1.4 m -142.15 112.93 3.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.803 0.335 . . . . 0.0 111.687 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 157' ' ' GLN . . . . . 0.713 ' HB3' ' HB3' ' D' ' 70' ' ' ALA . 0.3 OUTLIER -91.78 124.4 35.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.264 0.555 . . . . 0.0 110.398 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 158' ' ' TYR . . . . . 0.542 ' HB2' ' HB ' ' C' ' 3' ' ' THR . 57.6 m-85 -117.21 135.49 53.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.505 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.85 179.915 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.46 100.23 0.04 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.065 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 3' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' F' ' 158' ' ' TYR . 7.4 m -104.8 78.65 1.45 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.422 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.33 122.39 29.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.526 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.631 HG23 HG23 ' F' ' 156' ' ' VAL . 5.0 m -137.92 162.9 30.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.54 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 6' ' ' ASN . . . . . 0.433 ' HB3' ' OE2' ' F' ' 15' ' ' GLU . 44.0 t-20 -84.3 114.52 21.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.599 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 7' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' F' ' 154' ' ' PHE . . . -83.38 -41.52 8.4 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.684 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 8' ' ' GLY . . . . . 0.444 ' N ' ' CE1' ' F' ' 154' ' ' PHE . . . -175.56 162.29 31.57 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.889 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 9' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' F' ' 153' ' ' THR . 98.9 m -90.78 137.86 32.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.992 0.425 . . . . 0.0 111.269 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.44 114.27 46.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.184 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -99.34 148.44 24.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.343 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 12' ' ' PHE . . . . . 0.825 ' HB3' HD21 ' F' ' 34' ' ' LEU . 60.9 m-85 -133.75 113.12 11.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.794 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 13' ' ' LYS . . . . . 0.762 ' HG2' ' HA ' ' F' ' 33' ' ' GLN . 0.0 OUTLIER -107.23 105.89 16.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.351 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.23 169.44 28.9 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.023 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 15' ' ' GLU . . . . . 0.559 ' HB2' ' HG3' ' F' ' 36' ' ' GLN . 33.7 mt-10 -140.76 -171.13 3.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.853 0.359 . . . . 0.0 110.39 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 16' ' ' VAL . . . . . 0.585 HG13 HG23 ' F' ' 37' ' ' VAL . 0.5 OUTLIER -139.15 152.82 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.205 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 17' ' ' VAL . . . . . 0.732 ' O ' HG23 ' F' ' 39' ' ' THR . 0.0 OUTLIER -137.47 155.41 31.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.835 0.35 . . . . 0.0 111.038 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -85.23 53.02 2.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.005 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 19' ' ' ALA . . . . . 0.664 ' HA ' ' HG2' ' F' ' 38' ' ' ARG . . . 61.45 92.76 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.574 ' H ' ' HG2' ' F' ' 38' ' ' ARG . . . -164.84 -47.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.43 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 21' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 1.6 m -159.76 176.89 11.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.951 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 22' ' ' ALA . . . . . 0.602 ' HB2' ' HE ' ' F' ' 38' ' ' ARG . . . -147.29 111.9 5.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.13 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 23' ' ' VAL . . . . . 0.629 HG13 ' HB3' ' E' ' 27' ' ' SER . 43.1 t -67.31 143.14 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.998 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 24' ' ' ASP . . . . . 0.544 ' O ' HG23 ' E' ' 28' ' ' VAL . 17.1 m-20 -91.13 168.13 11.85 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.611 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.1 74.01 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.382 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.41 -16.64 73.74 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.929 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 27' ' ' SER . . . . . 0.629 ' HB3' HG13 ' E' ' 23' ' ' VAL . 0.4 OUTLIER -84.3 -24.35 29.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.944 0.402 . . . . 0.0 110.837 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 28' ' ' VAL . . . . . 0.544 HG23 ' O ' ' E' ' 24' ' ' ASP . 85.0 t -58.08 -37.25 60.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.345 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -140.34 105.97 5.12 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.007 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -109.0 106.95 17.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.12 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.77 95.53 8.99 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.071 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.552 HG11 HG21 ' E' ' 52' ' ' VAL . 51.4 t -85.74 138.27 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.074 0.464 . . . . 0.0 110.382 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 33' ' ' GLN . . . . . 0.745 ' HA ' ' HG2' ' D' ' 13' ' ' LYS . 3.2 mt-30 -113.23 132.53 55.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.641 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.814 HD21 ' HB3' ' D' ' 12' ' ' PHE . 1.8 mm? -94.47 -71.46 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.628 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.85 -111.3 0.71 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.578 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 36' ' ' GLN . . . . . 0.548 ' HG3' ' HB2' ' D' ' 15' ' ' GLU . 3.6 tt0 -161.03 105.81 1.36 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.625 0.25 . . . . 0.0 110.897 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.57 HG23 HG13 ' D' ' 16' ' ' VAL . 5.7 m -91.13 142.4 13.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.011 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 38' ' ' ARG . . . . . 0.684 ' HG2' ' HA ' ' D' ' 19' ' ' ALA . 0.7 OUTLIER -81.11 162.6 23.63 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.691 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 39' ' ' THR . . . . . 0.723 HG23 ' O ' ' D' ' 17' ' ' VAL . 82.6 p -80.47 -16.8 53.45 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.783 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.71 -31.22 63.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.197 0.522 . . . . 0.0 110.944 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.06 -28.47 39.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.113 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' E' ' 139' ' ' ALA . 1.7 mp -133.13 70.02 1.47 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.658 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 43' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' E' ' 39' ' ' THR . . . -103.61 11.19 36.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.451 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.01 146.84 27.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.394 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.47 121.24 13.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 111.146 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.55 -10.37 12.73 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.195 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 47' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' E' ' 138' ' ' PHE . . . -68.86 142.22 54.88 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 48' ' ' THR . . . . . 0.444 HG21 ' NH2' ' E' ' 136' ' ' ARG . 6.9 t -134.76 140.81 46.2 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.826 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.405 ' OG ' HD11 ' E' ' 42' ' ' LEU . 16.9 m -106.01 -152.74 0.48 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.615 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.92 178.62 1.05 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.909 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.1 168.81 15.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.784 0.326 . . . . 0.0 111.26 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 52' ' ' VAL . . . . . 0.714 HG22 ' HB3' ' E' ' 135' ' ' ALA . 14.7 m -117.97 132.2 68.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.955 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 53' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' B' ' 88' ' ' LEU . . . -95.18 107.61 3.57 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.627 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 54' ' ' PHE . . . . . 0.603 ' HD1' HG23 ' E' ' 52' ' ' VAL . 55.5 p90 -140.28 132.06 27.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 55' ' ' ASN . . . . . 0.519 ' HB2' HG22 ' E' ' 130' ' ' THR . 12.5 p30 -117.81 176.75 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.621 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 56' ' ' ILE . . . . . 0.793 ' HB ' HD12 ' E' ' 131' ' ' ILE . 51.6 mm -119.03 121.7 67.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.543 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 57' ' ' GLN . . . . . 0.727 ' HG2' HD11 ' B' ' 74' ' ' LEU . 0.0 OUTLIER -86.28 122.63 30.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.792 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 58' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' E' ' 129' ' ' ASN . 0.9 OUTLIER -131.13 93.74 3.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 59' ' ' ASN . . . . . 0.548 ' O ' ' HB3' ' E' ' 22' ' ' ALA . 0.4 OUTLIER -77.08 160.88 28.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.862 -179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.17 87.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.817 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 61' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 70.1 m -120.53 131.84 54.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.783 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.58 97.82 9.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.366 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 63' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' E' ' 66' ' ' ALA . 1.5 m -77.39 -19.95 55.4 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.1 -27.5 68.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.02 0.438 . . . . 0.0 111.715 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.44 -35.75 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.624 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 66' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' E' ' 63' ' ' THR . . . -131.05 131.32 44.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.648 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.49 -37.26 7.66 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.947 0.403 . . . . 0.0 110.94 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -121.74 171.39 8.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.558 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.55 136.1 15.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.532 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 70' ' ' ALA . . . . . 0.707 ' HB3' ' HB3' ' E' ' 157' ' ' GLN . . . -94.54 158.01 15.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.065 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 38.4 t -110.35 106.23 20.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.71 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 72' ' ' ALA . . . . . 0.821 ' HB3' ' HB3' ' E' ' 155' ' ' LYS . . . -109.58 164.36 12.6 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.594 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 73' ' ' PHE . . . . . 0.672 ' HB2' HD11 ' E' ' 111' ' ' LEU . 6.6 t80 -142.27 141.1 32.42 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.532 0.206 . . . . 0.0 111.131 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 74' ' ' LEU . . . . . 0.425 HD22 ' NZ ' ' E' ' 155' ' ' LYS . 0.1 OUTLIER -122.69 103.4 8.64 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.011 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 75' ' ' GLY . . . . . 0.506 ' HA3' HD23 ' E' ' 113' ' ' LEU . . . -153.5 -166.43 14.64 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.876 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.45 136.24 46.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.58 0.228 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 77' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' E' ' 83' ' ' THR . . . -81.35 156.15 25.62 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.935 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 78' ' ' ILE . . . . . 0.462 HG12 ' OG1' ' E' ' 140' ' ' THR . 3.1 tt -92.55 -20.67 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.881 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 79' ' ' ASP . . . . . 0.549 ' HB2' HG21 ' E' ' 140' ' ' THR . 0.4 OUTLIER 176.15 179.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.808 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.88 -33.87 45.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.009 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.48 -43.87 95.68 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.555 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 82' ' ' HIS . . . . . 0.462 ' NE2' ' O ' ' E' ' 139' ' ' ALA . 43.5 m-70 -97.8 -64.37 1.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.849 0.356 . . . . 0.0 110.492 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 83' ' ' THR . . . . . 0.436 ' HA ' ' HB1' ' E' ' 77' ' ' ALA . 1.2 m 62.31 7.85 2.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.609 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 84' ' ' ASN . . . . . 0.426 ' O ' HD12 ' E' ' 103' ' ' ILE . 86.8 m-20 -115.13 -25.46 8.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.255 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.787 ' HA ' ' HA ' ' E' ' 102' ' ' GLN . 0.5 OUTLIER -79.58 143.71 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.177 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 86' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' E' ' 152' ' ' ALA . 0.3 OUTLIER -76.68 148.54 36.78 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.294 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.83 178.23 4.36 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.909 0.385 . . . . 0.0 111.694 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.649 HD22 ' O ' ' E' ' 96' ' ' ALA . 0.0 OUTLIER -84.68 176.17 8.74 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.135 179.402 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 89' ' ' GLN . . . . . 0.537 ' HB3' ' HB2' ' E' ' 149' ' ' ASN . 22.9 pt20 -75.3 178.73 5.61 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.315 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.4 -11.42 60.47 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.999 0.428 . . . . 0.0 111.443 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 91' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' E' ' 95' ' ' SER . 0.3 OUTLIER -64.67 87.26 0.05 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.9 -7.13 53.8 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.909 0.385 . . . . 0.0 111.666 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.14 19.87 4.06 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.678 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.6 -15.6 0.16 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.924 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 95' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' E' ' 91' ' ' SER . 0.9 OUTLIER -97.28 174.95 6.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.886 0.374 . . . . 0.0 110.664 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 96' ' ' ALA . . . . . 0.649 ' O ' HD22 ' E' ' 88' ' ' LEU . . . -114.1 157.83 22.06 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.786 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 97' ' ' THR . . . . . 0.544 HG23 HD11 ' E' ' 88' ' ' LEU . 0.2 OUTLIER -112.92 162.68 15.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.359 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 98' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 69.4 41.53 1.3 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.368 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 99' ' ' VAL . . . . . . . . . . . . . 10.5 p -177.6 130.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.872 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.15 179.47 28.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.521 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 101' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' E' ' 86' ' ' LEU . 1.6 t -99.08 95.27 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.085 0.554 . . . . 0.0 111.65 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 102' ' ' GLN . . . . . 0.787 ' HA ' ' HA ' ' E' ' 85' ' ' VAL . 13.7 tt0 -69.84 159.83 32.91 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.959 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 103' ' ' ILE . . . . . 0.434 HG12 ' CE2' ' E' ' 73' ' ' PHE . 0.9 OUTLIER -121.7 98.49 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.516 179.436 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 104' ' ' LEU . . . . . 0.685 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 1.1 tp -84.79 119.39 25.24 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.701 0.286 . . . . 0.0 111.046 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.17 158.1 32.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.693 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 106' ' ' ARG . . . . . 0.555 ' HB2' ' HB2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -61.21 -33.83 74.11 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.958 0.409 . . . . 0.0 111.102 179.507 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 107' ' ' THR . . . . . 0.556 HG23 ' HA ' ' E' ' 120' ' ' SER . 0.0 OUTLIER -48.8 -38.23 21.45 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.037 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.76 -88.84 0.11 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.598 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.19 -176.39 5.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.863 0.363 . . . . 0.0 111.116 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 110' ' ' ALA . . . . . 0.685 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -79.86 143.88 33.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.221 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 111' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' E' ' 73' ' ' PHE . 0.6 OUTLIER -90.14 157.55 17.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.361 0.601 . . . . 0.0 110.545 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 112' ' ' THR . . . . . 0.451 ' HB ' HG21 ' E' ' 117' ' ' THR . 29.7 m -81.1 150.48 28.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.134 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 113' ' ' LEU . . . . . 0.604 HD12 ' N ' ' E' ' 113' ' ' LEU . 3.0 mp -102.74 57.72 0.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.695 0.283 . . . . 0.0 110.719 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.4 19.58 15.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.566 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.19 -93.04 0.88 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.677 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.77 69.72 1.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.077 0.465 . . . . 0.0 111.566 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 117' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' E' ' 72' ' ' ALA . 6.0 p -89.67 97.25 11.08 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.169 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.06 102.84 5.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.809 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.48 -82.83 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 120' ' ' SER . . . . . 0.556 ' HA ' HG23 ' E' ' 107' ' ' THR . 0.1 OUTLIER -63.09 100.86 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.62 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -88.9 79.04 7.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.196 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 122' ' ' THR . . . . . 0.435 HG21 ' CD ' ' E' ' 132' ' ' PRO . 4.6 p -82.54 159.2 22.86 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.667 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 16.1 m -85.27 139.72 31.4 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.731 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.45 136.14 33.46 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.746 0.308 . . . . 0.0 110.594 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 125' ' ' ASN . . . . . 0.532 ' HB3' ' HB3' ' B' ' 116' ' ' ALA . 25.0 m120 -120.77 143.59 48.73 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.613 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.16 148.91 34.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.639 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.71 -106.12 2.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.736 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 128' ' ' THR . . . . . 0.641 HG21 ' NZ ' ' B' ' 155' ' ' LYS . 1.9 m -85.22 153.2 22.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.715 0.293 . . . . 0.0 110.812 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 129' ' ' ASN . . . . . 0.6 ' HB3' ' HB2' ' E' ' 58' ' ' LEU . 23.2 t-20 -148.42 120.73 8.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.955 0.407 . . . . 0.0 111.09 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 130' ' ' THR . . . . . 0.568 ' OG1' HD12 ' B' ' 74' ' ' LEU . 0.2 OUTLIER -104.17 147.3 27.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.147 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 131' ' ' ILE . . . . . 0.793 HD12 ' HB ' ' E' ' 56' ' ' ILE . 89.8 mt -116.65 119.17 36.11 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 132' ' ' PRO . . . . . 0.673 ' HB3' ' H ' ' B' ' 77' ' ' ALA . 7.6 Cg_endo -80.92 119.09 3.51 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.594 1.53 . . . . 0.0 112.553 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.99 147.33 29.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.739 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.15 155.96 47.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.066 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 135' ' ' ALA . . . . . 0.714 ' HB3' HG22 ' E' ' 52' ' ' VAL . . . -140.09 115.71 10.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.912 0.387 . . . . 0.0 111.632 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 136' ' ' ARG . . . . . 0.444 ' NH2' HG21 ' E' ' 48' ' ' THR . 0.5 OUTLIER -111.34 148.99 31.78 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.479 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.53 151.31 45.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.113 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 138' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' E' ' 47' ' ' ALA . 0.2 OUTLIER -144.53 164.58 30.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.009 -179.13 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 139' ' ' ALA . . . . . 0.648 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -124.39 145.65 49.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.913 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 140' ' ' THR . . . . . 0.549 HG21 ' HB2' ' E' ' 79' ' ' ASP . 0.2 OUTLIER -117.78 12.95 14.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.513 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.85 79.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.914 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.74 92.14 0.02 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.608 0.204 . . . . 0.0 110.756 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.1 154.77 33.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.675 0.274 . . . . 0.0 111.4 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 144' ' ' THR . . . . . 0.523 ' O ' ' HB ' ' D' ' 16' ' ' VAL . 39.1 p -116.68 166.2 13.33 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.244 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 145' ' ' PRO . . . . . 0.484 ' HA ' ' HB ' ' D' ' 16' ' ' VAL . 1.3 Cg_endo -84.33 151.42 12.06 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.495 2.13 . . . . 0.0 111.988 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.73 -106.32 0.46 Allowed Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.414 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 147' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -139.05 163.27 32.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.794 0.331 . . . . 0.0 111.408 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.91 79.88 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.508 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 149' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' E' ' 89' ' ' GLN . 87.2 m-20 -99.9 142.48 31.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.557 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 150' ' ' ALA . . . . . 0.527 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -127.78 169.0 14.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.008 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.55 110.04 0.86 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.201 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 152' ' ' ALA . . . . . 0.628 ' HB2' HD21 ' E' ' 86' ' ' LEU . . . -147.06 145.39 29.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.13 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 153' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' D' ' 9' ' ' THR . 1.0 OUTLIER -93.62 164.23 13.24 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 154' ' ' PHE . . . . . 0.611 ' CZ ' HG21 ' E' ' 56' ' ' ILE . 15.1 p90 -110.98 151.59 27.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.193 0.521 . . . . 0.0 110.124 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 155' ' ' LYS . . . . . 0.821 ' HB3' ' HB3' ' E' ' 72' ' ' ALA . 0.0 OUTLIER -109.65 160.89 15.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.959 -178.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 156' ' ' VAL . . . . . 0.643 HG23 HG23 ' D' ' 5' ' ' VAL . 1.4 m -142.18 112.83 2.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.791 0.329 . . . . 0.0 111.678 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 157' ' ' GLN . . . . . 0.707 ' HB3' ' HB3' ' E' ' 70' ' ' ALA . 0.3 OUTLIER -91.83 124.39 35.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.338 0.59 . . . . 0.0 110.426 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 158' ' ' TYR . . . . . 0.539 ' HB2' ' HB ' ' D' ' 3' ' ' THR . 57.6 m-85 -117.17 135.52 53.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.456 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.859 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.55 100.22 0.04 OUTLIER 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.05 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -104.84 78.6 1.44 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.406 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.27 122.41 29.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.659 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 m -137.95 162.89 30.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.567 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -84.28 114.5 21.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.717 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.34 -41.52 8.42 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.678 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.57 162.24 31.49 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.936 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 98.8 m -90.71 137.79 32.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.92 0.39 . . . . 0.0 111.277 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.39 114.28 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.219 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -99.33 148.55 24.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.295 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -133.79 113.03 11.84 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.75 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 13' ' ' LYS . . . . . 0.536 ' HG3' HG11 ' F' ' 28' ' ' VAL . 0.0 OUTLIER -107.14 105.81 15.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.404 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.17 169.5 28.85 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.002 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 15' ' ' GLU . . . . . 0.433 ' OE2' ' HB3' ' E' ' 6' ' ' ASN . 33.5 mt-10 -140.78 -171.07 3.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.358 . . . . 0.0 110.429 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -139.21 152.82 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.197 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 17' ' ' VAL . . . . . 0.592 HG21 ' O ' ' F' ' 21' ' ' CYS . 0.0 OUTLIER -137.45 155.41 31.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.785 0.326 . . . . 0.0 111.037 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -85.16 52.98 2.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.08 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.43 92.69 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.11 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.75 -47.7 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.413 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 21' ' ' CYS . . . . . 0.708 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 1.6 m -159.74 176.86 11.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.983 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 22' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' F' ' 59' ' ' ASN . . . -147.3 112.0 5.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.155 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 23' ' ' VAL . . . . . 0.623 HG13 ' HB3' ' F' ' 27' ' ' SER . 42.8 t -67.39 143.17 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.946 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 24' ' ' ASP . . . . . 0.545 ' O ' HG23 ' F' ' 28' ' ' VAL . 17.0 m-20 -91.19 168.23 11.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.557 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.43 -50.0 74.44 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.455 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.35 -16.66 73.65 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.941 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 27' ' ' SER . . . . . 0.623 ' HB3' HG13 ' F' ' 23' ' ' VAL . 0.4 OUTLIER -84.32 -24.39 29.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.881 0.372 . . . . 0.0 110.767 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 28' ' ' VAL . . . . . 0.545 HG23 ' O ' ' F' ' 24' ' ' ASP . 85.4 t -58.12 -37.17 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.349 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -140.38 106.01 5.12 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.024 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -109.06 106.95 17.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.089 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.81 95.57 9.02 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.059 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.549 HG11 HG21 ' F' ' 52' ' ' VAL . 51.0 t -85.73 138.18 19.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.099 0.476 . . . . 0.0 110.378 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 33' ' ' GLN . . . . . 0.762 ' HA ' ' HG2' ' E' ' 13' ' ' LYS . 3.1 mt-30 -113.17 132.6 55.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.674 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 34' ' ' LEU . . . . . 0.825 HD21 ' HB3' ' E' ' 12' ' ' PHE . 1.8 mm? -94.51 -71.49 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.594 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.9 -111.31 0.71 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.512 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 36' ' ' GLN . . . . . 0.559 ' HG3' ' HB2' ' E' ' 15' ' ' GLU . 3.6 tt0 -160.96 105.75 1.37 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.573 0.225 . . . . 0.0 110.888 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.585 HG23 HG13 ' E' ' 16' ' ' VAL . 5.6 m -91.1 142.45 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.904 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 38' ' ' ARG . . . . . 0.664 ' HG2' ' HA ' ' E' ' 19' ' ' ALA . 0.7 OUTLIER -81.09 162.52 23.69 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.723 179.235 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 39' ' ' THR . . . . . 0.732 HG23 ' O ' ' E' ' 17' ' ' VAL . 82.5 p -80.4 -16.88 53.42 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.775 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.74 -31.27 63.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.115 0.483 . . . . 0.0 110.876 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.02 -28.51 39.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.121 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 42' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' F' ' 139' ' ' ALA . 1.7 mp -133.11 70.05 1.47 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.686 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 43' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' F' ' 39' ' ' THR . . . -103.65 11.2 36.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.445 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.07 146.84 27.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.394 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.43 121.24 13.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 111.158 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.57 -10.48 12.66 Favored Glycine 0 C--N 1.331 0.274 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.146 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 47' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' F' ' 138' ' ' PHE . . . -68.74 142.26 55.01 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 48' ' ' THR . . . . . 0.433 HG21 ' NH2' ' F' ' 136' ' ' ARG . 6.9 t -134.85 140.85 46.15 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.826 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -106.05 -152.75 0.48 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.519 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.91 178.52 1.07 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.881 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.02 168.86 15.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.281 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 52' ' ' VAL . . . . . 0.708 HG22 ' HB3' ' F' ' 135' ' ' ALA . 14.6 m -117.94 132.21 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.028 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 53' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' C' ' 88' ' ' LEU . . . -95.22 107.68 3.58 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.654 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 54' ' ' PHE . . . . . 0.583 ' HD1' HG23 ' F' ' 52' ' ' VAL . 55.5 p90 -140.35 132.12 27.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 55' ' ' ASN . . . . . 0.523 ' HB2' HG22 ' F' ' 130' ' ' THR . 12.5 p30 -117.85 176.84 5.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.61 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 56' ' ' ILE . . . . . 0.783 ' HB ' HD12 ' F' ' 131' ' ' ILE . 51.8 mm -119.0 121.7 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.549 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 57' ' ' GLN . . . . . 0.726 ' HG2' HD11 ' C' ' 74' ' ' LEU . 0.0 OUTLIER -86.26 122.61 30.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.855 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 58' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' F' ' 129' ' ' ASN . 0.9 OUTLIER -131.15 93.73 3.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.265 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 59' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' F' ' 22' ' ' ALA . 0.4 OUTLIER -77.17 160.92 28.6 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.21 87.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.798 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 61' ' ' CYS . . . . . 0.708 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 69.8 m -120.41 131.88 54.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.65 97.91 9.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.321 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 63' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' F' ' 66' ' ' ALA . 1.5 m -77.52 -19.89 55.08 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -27.45 68.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.985 0.422 . . . . 0.0 111.689 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.41 -35.76 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.597 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 66' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' F' ' 63' ' ' THR . . . -131.01 131.31 44.26 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.624 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.52 -37.3 7.63 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.964 0.412 . . . . 0.0 110.933 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -121.72 171.38 8.91 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.606 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.52 136.06 15.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.575 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 70' ' ' ALA . . . . . 0.725 ' HB3' ' HB3' ' F' ' 157' ' ' GLN . . . -94.47 157.92 15.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.101 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.36 106.25 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.682 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 72' ' ' ALA . . . . . 0.843 ' HB3' ' HB3' ' F' ' 155' ' ' LYS . . . -109.53 164.35 12.6 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.64 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 73' ' ' PHE . . . . . 0.67 ' HB2' HD11 ' F' ' 111' ' ' LEU . 6.5 t80 -142.25 141.05 32.44 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.52 0.2 . . . . 0.0 111.151 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 74' ' ' LEU . . . . . 0.434 HD22 ' NZ ' ' F' ' 155' ' ' LYS . 0.1 OUTLIER -122.68 103.32 8.59 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.038 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 75' ' ' GLY . . . . . 0.493 ' H ' ' HB3' ' F' ' 113' ' ' LEU . . . -153.42 -166.34 14.51 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.87 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.52 136.22 46.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.604 0.24 . . . . 0.0 110.714 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 77' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' F' ' 83' ' ' THR . . . -81.4 156.09 25.58 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.925 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 78' ' ' ILE . . . . . 0.47 HG12 ' OG1' ' F' ' 140' ' ' THR . 3.1 tt -92.51 -20.65 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.859 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 79' ' ' ASP . . . . . 0.553 ' HB2' HG21 ' F' ' 140' ' ' THR . 0.4 OUTLIER 176.18 179.75 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.757 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.04 -33.76 44.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.48 -43.88 95.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.583 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 82' ' ' HIS . . . . . 0.466 ' NE2' ' O ' ' F' ' 139' ' ' ALA . 43.5 m-70 -97.83 -64.38 1.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.812 0.339 . . . . 0.0 110.436 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 83' ' ' THR . . . . . 0.429 ' HA ' ' HB1' ' F' ' 77' ' ' ALA . 1.2 m 62.35 7.83 2.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.582 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 84' ' ' ASN . . . . . 0.415 ' O ' HD12 ' F' ' 103' ' ' ILE . 87.1 m-20 -115.09 -25.48 8.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.32 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 85' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' F' ' 102' ' ' GLN . 0.5 OUTLIER -79.53 143.75 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.199 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 86' ' ' LEU . . . . . 0.624 HD21 ' HB2' ' F' ' 152' ' ' ALA . 0.3 OUTLIER -76.62 148.57 36.87 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.392 179.359 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.87 178.22 4.39 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.799 0.333 . . . . 0.0 111.695 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 88' ' ' LEU . . . . . 0.657 HD22 ' O ' ' F' ' 96' ' ' ALA . 0.0 OUTLIER -84.72 176.2 8.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.069 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 89' ' ' GLN . . . . . 0.529 ' HB3' ' HB2' ' F' ' 149' ' ' ASN . 22.8 pt20 -75.29 178.71 5.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.36 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.34 -11.48 60.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.052 0.454 . . . . 0.0 111.447 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 91' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' F' ' 95' ' ' SER . 0.3 OUTLIER -64.69 87.28 0.05 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.884 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.95 -7.12 53.84 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.961 0.41 . . . . 0.0 111.666 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.08 19.86 4.08 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.699 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.58 -15.62 0.16 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.895 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 95' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' F' ' 91' ' ' SER . 1.0 OUTLIER -97.34 174.97 6.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.934 0.397 . . . . 0.0 110.572 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 96' ' ' ALA . . . . . 0.657 ' O ' HD22 ' F' ' 88' ' ' LEU . . . -114.14 157.83 22.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.85 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 97' ' ' THR . . . . . 0.54 HG23 HD11 ' F' ' 88' ' ' LEU . 0.2 OUTLIER -112.95 162.64 15.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.318 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 98' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 69.39 41.61 1.29 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.406 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 10.4 p -177.65 130.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.8 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.1 179.46 28.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.523 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 101' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' F' ' 86' ' ' LEU . 1.6 t -99.07 95.28 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.068 0.547 . . . . 0.0 111.716 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 102' ' ' GLN . . . . . 0.783 ' HA ' ' HA ' ' F' ' 85' ' ' VAL . 13.8 tt0 -69.88 159.82 32.96 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.898 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 103' ' ' ILE . . . . . 0.433 HG12 ' CE2' ' F' ' 73' ' ' PHE . 0.9 OUTLIER -121.65 98.39 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.538 179.456 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 104' ' ' LEU . . . . . 0.699 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 1.1 tp -84.76 119.39 25.23 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 111.082 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.15 158.08 32.1 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.701 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 106' ' ' ARG . . . . . 0.55 ' HB2' ' HB2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -61.16 -33.86 74.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.881 0.372 . . . . 0.0 111.093 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 107' ' ' THR . . . . . 0.534 HG23 ' HA ' ' F' ' 120' ' ' SER . 0.0 OUTLIER -48.77 -38.18 21.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.094 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.7 -88.77 0.11 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.597 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.23 -176.32 5.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.351 . . . . 0.0 111.111 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 110' ' ' ALA . . . . . 0.699 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -79.96 143.92 33.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 111' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' F' ' 73' ' ' PHE . 0.6 OUTLIER -90.1 157.53 17.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.359 0.6 . . . . 0.0 110.566 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 112' ' ' THR . . . . . 0.449 ' HB ' HG21 ' F' ' 117' ' ' THR . 29.5 m -81.13 150.4 28.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.127 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 113' ' ' LEU . . . . . 0.596 HD12 ' N ' ' F' ' 113' ' ' LEU . 3.0 mp -102.75 57.77 0.78 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.737 0.303 . . . . 0.0 110.696 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.47 19.63 15.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.56 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.26 -93.11 0.88 Allowed Glycine 0 C--N 1.328 0.13 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.628 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.7 69.57 1.08 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.083 0.468 . . . . 0.0 111.589 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 117' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' F' ' 72' ' ' ALA . 5.8 p -89.65 97.28 11.11 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.145 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.08 102.77 5.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.736 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.5 -82.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 120' ' ' SER . . . . . 0.534 ' HA ' HG23 ' F' ' 107' ' ' THR . 0.1 OUTLIER -63.25 100.89 0.26 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.609 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.91 79.07 7.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.186 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 122' ' ' THR . . . . . 0.435 HG21 ' CD ' ' F' ' 132' ' ' PRO . 4.6 p -82.56 159.18 22.84 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.701 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 16.1 m -85.29 139.73 31.37 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.708 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.42 136.13 33.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.617 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 125' ' ' ASN . . . . . 0.53 ' HB3' ' HB3' ' C' ' 116' ' ' ALA . 25.0 m120 -120.78 143.65 48.71 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.577 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.27 148.95 34.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.626 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.68 -106.22 2.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.745 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 128' ' ' THR . . . . . 0.647 HG21 ' NZ ' ' C' ' 155' ' ' LYS . 1.9 m -85.18 153.22 22.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.7 0.286 . . . . 0.0 110.757 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 129' ' ' ASN . . . . . 0.597 ' HB3' ' HB2' ' F' ' 58' ' ' LEU . 23.2 t-20 -148.43 120.71 8.39 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.909 0.385 . . . . 0.0 111.035 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 130' ' ' THR . . . . . 0.565 ' OG1' HD12 ' C' ' 74' ' ' LEU . 0.2 OUTLIER -104.19 147.33 27.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.14 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 131' ' ' ILE . . . . . 0.783 HD12 ' HB ' ' F' ' 56' ' ' ILE . 89.7 mt -116.64 119.18 36.12 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 132' ' ' PRO . . . . . 0.685 ' HB3' ' H ' ' C' ' 77' ' ' ALA . 7.6 Cg_endo -80.96 119.09 3.5 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 121.653 1.569 . . . . 0.0 112.531 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.98 147.29 29.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.756 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.09 155.92 47.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.041 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 135' ' ' ALA . . . . . 0.708 ' HB3' HG22 ' F' ' 52' ' ' VAL . . . -140.07 115.69 10.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.884 0.373 . . . . 0.0 111.598 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 136' ' ' ARG . . . . . 0.433 ' NH2' HG21 ' F' ' 48' ' ' THR . 0.5 OUTLIER -111.32 149.02 31.72 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.479 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.64 151.3 45.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.073 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 138' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' F' ' 47' ' ' ALA . 0.2 OUTLIER -144.5 164.6 30.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.97 -179.121 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 139' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -124.46 145.68 49.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.869 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 140' ' ' THR . . . . . 0.553 HG21 ' HB2' ' F' ' 79' ' ' ASP . 0.2 OUTLIER -117.75 12.99 14.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.512 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.81 79.83 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.874 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.59 92.19 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.62 0.21 . . . . 0.0 110.762 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.1 154.81 33.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.756 0.312 . . . . 0.0 111.377 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 144' ' ' THR . . . . . 0.516 ' O ' ' HB ' ' E' ' 16' ' ' VAL . 39.4 p -116.71 166.21 13.33 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.208 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 145' ' ' PRO . . . . . 0.49 ' HA ' ' HB ' ' E' ' 16' ' ' VAL . 1.3 Cg_endo -84.29 151.47 12.14 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.445 2.097 . . . . 0.0 111.975 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.64 -106.23 0.45 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.443 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 147' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -139.11 163.26 32.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.783 0.325 . . . . 0.0 111.357 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.98 79.9 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.498 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 149' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' F' ' 89' ' ' GLN . 87.2 m-20 -99.93 142.51 31.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.593 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 150' ' ' ALA . . . . . 0.528 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -127.83 169.06 14.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.042 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.59 109.91 0.85 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.186 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 152' ' ' ALA . . . . . 0.624 ' HB2' HD21 ' F' ' 86' ' ' LEU . . . -146.95 145.4 29.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.123 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 153' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' E' ' 9' ' ' THR . 1.0 OUTLIER -93.63 164.17 13.26 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 154' ' ' PHE . . . . . 0.629 ' CZ ' HG21 ' F' ' 56' ' ' ILE . 15.0 p90 -110.87 151.61 27.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.178 0.513 . . . . 0.0 110.125 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 155' ' ' LYS . . . . . 0.843 ' HB3' ' HB3' ' F' ' 72' ' ' ALA . 0.0 OUTLIER -109.69 160.95 15.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.893 -178.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 156' ' ' VAL . . . . . 0.631 HG23 HG23 ' E' ' 5' ' ' VAL . 1.5 m -142.19 112.84 2.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.846 0.355 . . . . 0.0 111.688 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 157' ' ' GLN . . . . . 0.725 ' HB3' ' HB3' ' F' ' 70' ' ' ALA . 0.3 OUTLIER -91.82 124.46 35.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.276 0.56 . . . . 0.0 110.429 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 158' ' ' TYR . . . . . 0.547 ' HB2' ' HB ' ' E' ' 3' ' ' THR . 57.5 m-85 -117.19 135.51 53.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.462 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.888 179.9 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.649 0.261 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.525 HG21 ' HB2' ' B' ' 18' ' ' ASN . 90.2 m -118.7 111.08 18.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.379 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.746 HG23 ' HG3' ' B' ' 157' ' ' GLN . 0.2 OUTLIER -97.77 127.36 43.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.554 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.649 HG23 HG23 ' B' ' 156' ' ' VAL . 0.0 OUTLIER -153.57 171.5 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.578 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.533 ' O ' ' NE2' ' C' ' 36' ' ' GLN . 1.2 t30 -94.42 122.1 36.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.608 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.0 -52.18 6.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.855 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.42 -145.43 5.81 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.886 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.535 HG23 HG23 ' B' ' 153' ' ' THR . 0.2 OUTLIER -146.81 139.81 25.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 111.28 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.4 121.6 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.136 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.59 106.61 18.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.324 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.437 ' HZ ' ' CZ ' ' B' ' 54' ' ' PHE . 8.9 m-85 -90.65 107.61 19.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.26 149.25 24.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.383 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.45 -179.07 47.54 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.902 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.67 ' HB3' ' HG3' ' B' ' 36' ' ' GLN . 0.1 OUTLIER -158.97 157.02 30.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.845 0.355 . . . . 0.0 110.394 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.8 t -113.71 132.23 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.245 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.558 HG13 ' HG2' ' B' ' 36' ' ' GLN . 5.5 m -136.88 176.58 7.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.887 0.375 . . . . 0.0 111.024 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.46 174.07 9.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.021 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 62' ' ' ASP . . . -83.37 35.35 0.49 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.066 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -116.89 -15.93 10.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.429 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.98 155.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.97 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.76 126.48 5.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.052 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.741 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -60.87 162.49 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.037 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 27' ' ' SER . 18.6 t70 -97.6 161.0 13.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.588 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.31 95.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.353 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.47 12.76 69.0 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.935 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.575 ' HB3' ' HB3' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -113.79 -25.6 8.57 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.92 0.39 . . . . 0.0 110.837 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' ' 28' ' ' VAL . 9.6 t -41.04 -62.02 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.373 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.57 119.96 39.59 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.033 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -126.09 119.13 26.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.033 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.71 103.32 15.48 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.115 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.88 115.12 43.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.168 0.509 . . . . 0.0 110.475 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.53 112.61 24.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.671 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.86 -30.36 58.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.622 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.02 -170.25 27.44 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.562 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.46 141.8 28.05 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.653 0.263 . . . . 0.0 110.871 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.562 HG11 HD22 ' A' ' 42' ' ' LEU . 5.8 p -125.34 157.14 34.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.88 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.53 122.46 29.04 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.704 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -40.39 87.01 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.774 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.51 -35.88 68.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.06 0.457 . . . . 0.0 110.773 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.13 -21.51 33.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.162 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.562 HD22 HG11 ' A' ' 37' ' ' VAL . 3.2 mp -110.51 29.49 7.67 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.579 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 141' ' ' GLY . . . -108.19 25.46 11.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.387 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.66 159.96 23.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.414 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 140' ' ' THR . 11.1 tt0 -82.87 108.66 16.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 0.0 111.166 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.93 10.84 51.54 Favored Glycine 0 C--N 1.33 0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.18 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -66.58 123.48 20.17 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.957 0.408 . . . . 0.0 112.014 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -120.64 140.28 51.79 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.828 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 4.6 m -101.65 -167.01 1.36 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.614 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.64 139.7 53.59 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.783 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.86 133.99 35.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.369 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 135' ' ' ALA . 18.8 m -87.0 166.49 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.927 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.7 128.83 7.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.63 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 133' ' ' PHE . 40.7 p90 -160.23 134.48 7.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.731 0.3 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.515 ' OD1' HG21 ' A' ' 130' ' ' THR . 16.0 p30 -132.87 147.73 52.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.494 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.637 HG22 ' HB ' ' A' ' 131' ' ' ILE . 1.0 OUTLIER -96.89 116.82 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.496 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.567 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -66.59 122.08 16.79 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.754 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.741 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -137.42 88.17 2.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.218 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.715 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 10.5 p30 -79.53 179.31 7.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.955 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.39 64.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 129' ' ' ASN . 4.4 m -110.53 163.23 13.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.839 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -140.14 155.02 47.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.287 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.24 -25.33 10.66 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -81.96 -16.38 50.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.156 0.503 . . . . 0.0 111.822 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.401 HG23 ' OD2' ' A' ' 62' ' ' ASP . 16.6 t -90.65 -48.41 14.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.662 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.11 142.9 36.03 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.637 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.8 -53.79 2.6 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.846 0.355 . . . . 0.0 110.995 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -94.86 158.16 15.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.514 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.934 ' HB2' HD13 ' A' ' 124' ' ' LEU . . . -137.21 120.46 16.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.588 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -97.57 129.17 44.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.096 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.593 HG11 HG21 ' A' ' 131' ' ' ILE . 15.9 t -113.05 152.23 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.672 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.98 146.58 27.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.606 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CD2' HG21 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -111.54 141.89 44.53 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.577 0.227 . . . . 0.0 111.067 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -105.7 103.31 12.8 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.934 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.87 -179.11 25.42 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.837 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.699 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.2 OUTLIER -105.16 157.79 17.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.57 0.224 . . . . 0.0 110.771 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.433 ' H ' ' HB2' ' D' ' 132' ' ' PRO . . . -77.85 132.82 38.17 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.876 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.453 ' CG2' ' HB ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER -66.61 -39.87 84.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.404 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.7 OUTLIER -146.21 53.55 1.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.788 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' D' ' 106' ' ' ARG . . . 61.42 -87.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.038 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.29 -36.55 53.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.594 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -81.34 59.93 4.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.865 0.364 . . . . 0.0 110.445 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.584 HG21 ' OD1' ' A' ' 114' ' ' ASP . 2.1 m -70.59 -20.41 62.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.483 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.891 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 26.5 p-10 -69.45 -13.73 62.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.29 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 102' ' ' GLN . 40.7 t -108.97 131.2 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.109 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -70.05 142.81 52.65 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.305 179.386 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.91 -170.52 3.05 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.946 0.403 . . . . 0.0 111.709 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 88' ' ' LEU . 1.2 mm? -80.04 161.4 25.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.02 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.73 -80.32 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.31 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.456 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 6.6 p -171.33 0.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.95 0.405 . . . . 0.0 111.446 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.687 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 73.4 m -76.81 85.65 3.4 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.902 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' D' ' 50' ' ' SER . . . -60.98 -32.34 71.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.86 0.362 . . . . 0.0 111.641 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.79 30.52 6.85 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.627 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.78 -3.14 0.11 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.92 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 0.1 OUTLIER -107.57 -176.72 3.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.882 0.372 . . . . 0.0 110.652 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.54 172.68 8.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.796 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.605 ' H ' ' HB ' ' A' ' 144' ' ' THR . 1.7 m -126.95 140.47 52.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.29 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.483 ' HB3' ' H ' ' A' ' 141' ' ' GLY . 27.4 m120 61.96 21.23 12.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.495 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 97' ' ' THR . 2.7 t -120.29 135.99 58.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.724 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.97 -160.62 10.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.531 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 86' ' ' LEU . 4.4 p -145.96 109.88 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.173 0.511 . . . . 0.0 111.677 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.681 ' HB2' HG22 ' A' ' 85' ' ' VAL . 0.5 OUTLIER -84.37 147.38 27.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.936 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.613 HG12 ' HG ' ' A' ' 113' ' ' LEU . 1.2 pp -110.72 127.84 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.501 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.93 HD12 ' HB2' ' A' ' 110' ' ' ALA . 1.4 tp -97.37 132.95 42.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.686 0.279 . . . . 0.0 111.045 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.67 ' HB3' HG22 ' A' ' 107' ' ' THR . 4.0 t0 -80.82 143.61 32.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.675 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -65.46 -17.5 64.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.838 0.351 . . . . 0.0 111.083 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.67 HG22 ' HB3' ' A' ' 105' ' ' ASP . 13.2 t -66.89 -20.61 65.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.001 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.08 -71.77 0.44 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.68 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.53 160.02 31.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.819 0.343 . . . . 0.0 111.044 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.93 ' HB2' HD12 ' A' ' 104' ' ' LEU . . . -75.66 131.46 39.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.692 HD21 ' O ' ' A' ' 117' ' ' THR . 12.2 tp -88.1 154.18 20.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.351 0.596 . . . . 0.0 110.6 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.891 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -96.37 142.7 28.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.145 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.613 ' HG ' HG12 ' A' ' 103' ' ' ILE . 0.8 OUTLIER -80.79 63.65 5.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.715 0.293 . . . . 0.0 110.747 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.584 ' OD1' HG21 ' A' ' 83' ' ' THR . 0.1 OUTLIER -90.63 -30.63 17.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.547 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.518 ' HA3' ' OG1' ' D' ' 130' ' ' THR . . . 115.75 -43.6 1.64 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.721 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.453 ' HB2' ' C ' ' D' ' 128' ' ' THR . . . -110.46 24.39 13.03 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.011 0.434 . . . . 0.0 111.717 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.692 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -82.22 68.35 8.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.554 ' CD1' ' HB2' ' A' ' 157' ' ' GLN . 40.8 m-85 -82.19 71.96 9.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.744 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.71 81.11 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.797 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.75 131.75 13.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.604 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.427 ' O ' ' HE2' ' A' ' 68' ' ' LYS . 1.5 mm-40 -100.72 52.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.232 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.664 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -72.14 132.02 43.59 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.734 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.81 107.71 15.63 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.638 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.934 HD13 ' HB2' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -88.27 126.53 35.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.563 179.427 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.515 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 1.1 m120 -120.62 -178.95 3.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.544 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.526 ' OD1' ' HA ' ' A' ' 62' ' ' ASP . 3.8 t30 -83.27 120.65 26.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.659 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.16 -121.79 2.53 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.686 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.715 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 75.6 m -122.14 103.41 8.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.7 0.286 . . . . 0.0 110.806 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.533 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 1.7 t30 -86.14 157.21 20.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.907 0.384 . . . . 0.0 111.144 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.567 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.3 OUTLIER -143.26 130.27 20.63 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.072 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.637 ' HB ' HG22 ' A' ' 56' ' ' ILE . 57.5 mt -84.21 104.24 4.04 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 7.6 Cg_endo -81.99 112.29 2.3 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.63 1.554 . . . . 0.0 112.629 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 54' ' ' PHE . 1.0 OUTLIER -126.67 158.32 36.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.856 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -126.01 156.04 40.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.083 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.536 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -148.22 105.18 3.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.96 0.409 . . . . 0.0 111.615 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.08 163.46 12.57 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.351 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.562 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 0.3 OUTLIER -81.71 119.73 24.22 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.099 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.468 ' HB3' HG11 ' A' ' 85' ' ' VAL . 2.1 t80 -108.84 142.62 39.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.213 0.53 . . . . 0.0 112.06 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -132.96 136.0 45.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.904 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 25.2 p -96.58 -56.16 2.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.519 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.483 ' H ' ' HB3' ' A' ' 98' ' ' ASN . . . -127.06 -129.88 3.31 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.044 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.91 107.12 12.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.647 0.224 . . . . 0.0 110.781 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -65.87 148.03 52.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.687 0.28 . . . . 0.0 111.466 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.605 ' HB ' ' H ' ' A' ' 97' ' ' THR . 48.5 m -114.82 144.68 32.42 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.284 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.402 ' HD2' HG23 ' A' ' 144' ' ' THR . 1.3 Cg_endo -81.9 130.98 6.84 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.521 2.147 . . . . 0.0 111.982 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 164.82 -116.28 0.69 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.492 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.62 150.39 29.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.826 0.346 . . . . 0.0 111.397 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.69 45.93 1.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.078 0.466 . . . . 0.0 110.402 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.96 141.07 30.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.505 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.401 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -153.72 162.6 41.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.959 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -133.99 135.37 43.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.252 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.751 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -134.1 152.51 51.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.174 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.458 ' H ' ' HB3' ' A' ' 74' ' ' LEU . 3.9 m -104.13 148.96 25.68 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.29 141.89 35.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.108 0.48 . . . . 0.0 110.106 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.59 152.36 40.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.896 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.586 HG12 HD11 ' A' ' 131' ' ' ILE . 20.1 m -135.7 133.19 51.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.808 0.337 . . . . 0.0 111.704 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.554 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . 1.8 tt0 -130.91 119.77 22.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.271 0.557 . . . . 0.0 110.407 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -101.95 113.31 26.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.57 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.835 179.974 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' C' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.24 0.066 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' ALA . . . . . 0.626 ' H ' ' HA ' ' C' ' 159' ' ' GLN . . . 59.14 55.8 4.21 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.081 0.238 . . . . 0.0 110.992 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.504 HG21 ' HB2' ' C' ' 18' ' ' ASN . 89.7 m -118.64 111.08 18.09 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.467 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.74 HG21 ' HA2' ' F' ' 127' ' ' GLY . 0.2 OUTLIER -97.78 127.33 43.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.572 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.632 HG23 HG23 ' C' ' 156' ' ' VAL . 0.0 OUTLIER -153.54 171.53 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.582 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ASN . . . . . 0.541 ' O ' ' NE2' ' D' ' 36' ' ' GLN . 1.2 t30 -94.48 122.09 36.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.562 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.84 -52.34 6.47 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.861 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.43 -145.44 5.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.846 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.526 HG23 HG23 ' C' ' 153' ' ' THR . 0.2 OUTLIER -146.76 139.86 25.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 111.254 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 45.3 t -122.4 121.61 64.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.148 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -99.69 106.6 18.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.369 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' PHE . . . . . 0.42 ' HZ ' ' CZ ' ' C' ' 54' ' ' PHE . 8.8 m-85 -90.6 107.59 19.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.26 149.21 24.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.376 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.42 -179.01 47.49 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.98 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.674 ' HB3' ' HG3' ' C' ' 36' ' ' GLN . 0.1 OUTLIER -158.97 157.04 30.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.915 0.388 . . . . 0.0 110.377 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.459 ' O ' HG11 ' A' ' 5' ' ' VAL . 18.0 t -113.77 132.25 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.199 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.619 HG12 HG21 ' A' ' 5' ' ' VAL . 5.5 m -136.9 176.56 7.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.11 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ASN . . . . . 0.525 ' HB2' HG21 ' A' ' 3' ' ' THR . 1.2 t30 -74.4 174.1 9.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.038 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' B' ' 62' ' ' ASP . . . -83.39 35.28 0.49 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.014 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' B' ' 61' ' ' CYS . . . -116.81 -15.93 10.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.466 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 180.0 155.23 0.59 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.915 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.4 ' HA ' HG21 ' B' ' 17' ' ' VAL . . . -157.69 126.42 5.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.074 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.735 ' HA ' ' HG ' ' B' ' 58' ' ' LEU . 0.7 OUTLIER -60.82 162.51 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.046 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' B' ' 27' ' ' SER . 18.5 t70 -97.56 161.0 13.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.634 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.45 96.27 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.346 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.39 12.75 69.08 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.953 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' B' ' 24' ' ' ASP . 0.6 OUTLIER -113.79 -25.54 8.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.438 HG23 ' H ' ' B' ' 28' ' ' VAL . 9.8 t -41.17 -62.01 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.28 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.56 119.97 39.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.055 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -126.1 119.11 26.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.058 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.71 103.31 15.46 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.158 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.81 115.11 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.11 0.481 . . . . 0.0 110.445 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.53 112.63 24.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.592 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.86 -30.39 58.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.6 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.07 -170.23 27.36 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.622 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.67 ' HG3' ' HB3' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -93.55 141.72 28.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.595 0.235 . . . . 0.0 110.88 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.548 HG11 HD22 ' B' ' 42' ' ' LEU . 5.8 p -125.22 157.18 34.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.899 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.56 122.39 28.96 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.735 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -40.52 86.96 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.756 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.44 -35.84 68.31 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.112 0.482 . . . . 0.0 110.842 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.1 -21.55 33.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.175 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.548 HD22 HG11 ' B' ' 37' ' ' VAL . 3.2 mp -110.5 29.49 7.66 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.666 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' B' ' 141' ' ' GLY . . . -108.26 25.55 11.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.364 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.81 159.99 23.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.299 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' B' ' 140' ' ' THR . 11.0 tt0 -82.88 108.65 16.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 111.19 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.95 10.83 51.5 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.202 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' B' ' 139' ' ' ALA . . . -66.62 123.51 20.29 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -120.69 140.24 51.89 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.928 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 4.6 m -101.56 -166.97 1.35 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.686 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.74 139.71 53.38 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.784 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.77 134.01 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.321 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.539 HG22 ' O ' ' B' ' 135' ' ' ALA . 18.8 m -87.07 166.44 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.911 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.69 128.83 7.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.634 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' PHE . . . . . 0.437 ' CZ ' ' HZ ' ' A' ' 12' ' ' PHE . 40.6 p90 -160.23 134.5 7.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.793 0.33 . . . . 0.0 110.932 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.512 ' OD1' HG21 ' B' ' 130' ' ' THR . 15.9 p30 -132.79 147.69 52.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.58 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.634 HG22 ' HB ' ' B' ' 131' ' ' ILE . 1.0 OUTLIER -96.75 116.78 39.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.589 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 57' ' ' GLN . . . . . 0.566 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -66.6 122.01 16.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.724 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.735 ' HG ' ' HA ' ' B' ' 23' ' ' VAL . 0.2 OUTLIER -137.45 88.23 2.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.247 -179.674 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.712 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 10.6 p30 -79.63 179.35 7.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.877 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.3 64.37 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.837 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' B' ' 129' ' ' ASN . 4.4 m -110.48 163.27 13.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.808 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' B' ' 19' ' ' ALA . 0.5 OUTLIER -140.18 155.04 47.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.275 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.23 -25.35 10.65 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -82.02 -16.33 50.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.067 0.46 . . . . 0.0 111.736 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' VAL . . . . . 0.402 HG23 ' OD2' ' B' ' 62' ' ' ASP . 16.7 t -90.66 -48.49 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.661 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.1 142.94 36.04 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.624 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.79 -53.89 2.59 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.842 0.353 . . . . 0.0 110.912 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' B' ' 121' ' ' GLU . 0.1 OUTLIER -94.77 158.16 15.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.519 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.905 ' HB2' HD13 ' B' ' 124' ' ' LEU . . . -137.17 120.44 16.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.637 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -97.57 129.13 44.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.124 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.608 HG11 HG21 ' B' ' 131' ' ' ILE . 15.9 t -113.04 152.28 14.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.73 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.99 146.57 27.09 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.554 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.476 ' CD2' HG21 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -111.58 141.92 44.55 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.591 0.234 . . . . 0.0 111.098 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' B' ' 152' ' ' ALA . 0.8 OUTLIER -105.62 103.33 12.82 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.96 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.91 -179.05 25.4 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.814 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.679 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.2 OUTLIER -105.25 157.78 17.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.533 0.206 . . . . 0.0 110.725 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.439 ' H ' ' HB2' ' E' ' 132' ' ' PRO . . . -77.86 132.75 38.12 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.898 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.446 ' CG2' ' HB ' ' B' ' 85' ' ' VAL . 0.6 OUTLIER -66.68 -39.76 84.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.2 53.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' E' ' 106' ' ' ARG . . . 61.32 -87.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.03 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.33 -36.5 53.17 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.602 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -81.39 59.98 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.36 . . . . 0.0 110.447 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' THR . . . . . 0.596 HG21 ' OD1' ' B' ' 114' ' ' ASP . 2.1 m -70.61 -20.49 62.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.512 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ASN . . . . . 0.879 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 26.6 p-10 -69.29 -13.74 62.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.352 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' B' ' 102' ' ' GLN . 40.8 t -108.97 131.15 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.127 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' B' ' 152' ' ' ALA . 0.6 OUTLIER -70.11 142.84 52.53 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.014 -0.275 . . . . 0.0 110.308 179.42 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.97 -170.53 3.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.891 0.377 . . . . 0.0 111.752 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' B' ' 88' ' ' LEU . 1.2 mm? -80.04 161.43 25.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.037 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.78 -80.24 0.01 OUTLIER 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.315 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' SER . . . . . 0.474 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 6.5 p -171.42 0.5 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.993 0.425 . . . . 0.0 111.504 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' SER . . . . . 0.675 ' HA ' ' HB2' ' D' ' 25' ' ' ALA . 73.5 m -76.86 85.55 3.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.921 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' E' ' 50' ' ' SER . . . -60.88 -32.33 71.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.968 0.413 . . . . 0.0 111.733 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.75 30.47 6.88 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.7 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.74 -3.22 0.11 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.945 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' SER . . . . . 0.603 ' HB2' ' HB2' ' B' ' 91' ' ' SER . 0.1 OUTLIER -107.5 -176.78 3.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 110.661 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.39 172.67 8.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.848 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.622 ' H ' ' HB ' ' B' ' 144' ' ' THR . 1.7 m -127.01 140.36 52.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.339 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 98' ' ' ASN . . . . . 0.5 ' HB3' ' H ' ' B' ' 141' ' ' GLY . 27.4 m120 62.05 21.3 12.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.441 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 97' ' ' THR . 2.7 t -120.38 135.98 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.723 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.0 -160.77 10.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.569 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.415 HG13 ' HB2' ' B' ' 86' ' ' LEU . 4.5 p -145.84 109.85 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 122.974 0.51 . . . . 0.0 111.767 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.679 ' HB2' HG22 ' B' ' 85' ' ' VAL . 0.5 OUTLIER -84.33 147.33 27.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.881 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.596 HG12 ' HG ' ' B' ' 113' ' ' LEU . 1.2 pp -110.69 127.88 67.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.515 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' LEU . . . . . 0.978 HD12 ' HB2' ' B' ' 110' ' ' ALA . 1.4 tp -97.46 132.95 42.67 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.637 0.256 . . . . 0.0 111.003 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' ASP . . . . . 0.652 ' HB3' HG22 ' B' ' 107' ' ' THR . 4.0 t0 -80.76 143.59 32.79 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.739 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -65.43 -17.55 64.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.817 0.341 . . . . 0.0 111.061 179.509 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.652 HG22 ' HB3' ' B' ' 105' ' ' ASP . 13.2 t -66.84 -20.65 65.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.011 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.05 -71.61 0.44 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.769 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.51 159.93 31.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.768 0.318 . . . . 0.0 111.139 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.978 ' HB2' HD12 ' B' ' 104' ' ' LEU . . . -75.54 131.49 40.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.162 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.685 HD21 ' O ' ' B' ' 117' ' ' THR . 12.2 tp -88.1 154.22 20.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.331 0.586 . . . . 0.0 110.553 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.879 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 0.4 OUTLIER -96.43 142.71 28.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.155 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.596 ' HG ' HG12 ' B' ' 103' ' ' ILE . 0.8 OUTLIER -80.82 63.68 5.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.771 0.32 . . . . 0.0 110.708 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ASP . . . . . 0.596 ' OD1' HG21 ' B' ' 83' ' ' THR . 0.1 OUTLIER -90.63 -30.6 17.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.573 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 115' ' ' GLY . . . . . 0.525 ' HA3' ' OG1' ' E' ' 130' ' ' THR . . . 115.76 -43.58 1.64 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.617 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 116' ' ' ALA . . . . . 0.456 ' HB2' ' C ' ' E' ' 128' ' ' THR . . . -110.58 24.43 12.97 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.006 0.431 . . . . 0.0 111.634 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' THR . . . . . 0.685 ' O ' HD21 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -82.12 68.28 8.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.13 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.54 ' CD1' ' HB2' ' B' ' 157' ' ' GLN . 41.2 m-85 -82.15 71.93 9.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.798 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.74 80.98 1.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.831 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.62 131.75 13.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.614 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 121' ' ' GLU . . . . . 0.434 ' O ' ' HE2' ' B' ' 68' ' ' LYS . 1.5 mm-40 -100.74 52.15 0.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.151 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.665 ' HB ' ' HB3' ' B' ' 69' ' ' ALA . 0.2 OUTLIER -72.14 131.92 43.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.738 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.62 107.59 15.37 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.774 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.905 HD13 ' HB2' ' B' ' 69' ' ' ALA . 1.0 OUTLIER -88.18 126.54 35.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.604 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' B' ' 61' ' ' CYS . 1.1 m120 -120.65 -178.92 3.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.577 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' ASN . . . . . 0.524 ' OD1' ' HA ' ' B' ' 62' ' ' ASP . 3.7 t30 -83.27 120.64 26.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.732 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.13 -121.78 2.53 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.683 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' THR . . . . . 0.712 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 75.5 m -122.14 103.38 8.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.734 0.302 . . . . 0.0 110.783 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ASN . . . . . 0.526 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 1.7 t30 -86.14 157.28 20.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.157 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.566 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.3 OUTLIER -143.32 130.22 20.51 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.064 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 131' ' ' ILE . . . . . 0.634 ' HB ' HG22 ' B' ' 56' ' ' ILE . 57.3 mt -84.09 104.22 3.96 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 132' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -82.09 112.48 2.3 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.611 1.541 . . . . 0.0 112.54 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.422 ' HB3' ' CZ ' ' B' ' 54' ' ' PHE . 1.0 OUTLIER -126.77 158.21 37.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.826 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -126.01 156.05 40.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.024 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.539 ' O ' HG22 ' B' ' 52' ' ' VAL . . . -148.17 105.12 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.922 0.391 . . . . 0.0 111.659 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -99.04 163.44 12.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.436 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 137' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 0.3 OUTLIER -81.67 119.75 24.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.085 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 138' ' ' PHE . . . . . 0.469 ' HB3' HG11 ' B' ' 85' ' ' VAL . 2.1 t80 -108.9 142.69 39.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.247 0.546 . . . . 0.0 112.012 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' B' ' 47' ' ' ALA . . . -132.97 136.0 45.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.918 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 140' ' ' THR . . . . . 0.655 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 25.3 p -96.53 -56.24 2.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.527 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 141' ' ' GLY . . . . . 0.5 ' H ' ' HB3' ' B' ' 98' ' ' ASN . . . -127.06 -129.83 3.3 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.03 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.01 107.15 12.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.682 0.241 . . . . 0.0 110.695 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 143' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' B' ' 97' ' ' THR . . . -65.94 148.12 52.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.765 0.317 . . . . 0.0 111.447 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.622 ' HB ' ' H ' ' B' ' 97' ' ' THR . 48.5 m -114.84 144.65 32.37 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.36 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -81.9 130.95 6.83 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.551 2.168 . . . . 0.0 111.967 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 146' ' ' GLY . . . . . 0.613 ' O ' ' HG3' ' A' ' 15' ' ' GLU . . . 164.86 -116.2 0.69 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.466 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.63 ' HA ' ' HG3' ' A' ' 15' ' ' GLU . . . -110.77 150.34 29.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.932 0.396 . . . . 0.0 111.279 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.6 45.87 1.6 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.108 0.48 . . . . 0.0 110.479 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.512 HD22 ' HB1' ' B' ' 147' ' ' ALA . 0.1 OUTLIER -96.86 141.02 30.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.609 -179.507 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.401 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -153.75 162.55 41.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.013 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.91 135.46 43.62 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.179 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 152' ' ' ALA . . . . . 0.747 ' HB2' HD11 ' B' ' 86' ' ' LEU . . . -134.18 152.51 51.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.157 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.535 HG23 HG23 ' A' ' 9' ' ' THR . 4.0 m -104.12 148.91 25.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.23 141.81 35.25 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.087 0.47 . . . . 0.0 110.141 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.53 152.34 40.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.905 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 156' ' ' VAL . . . . . 0.649 HG23 HG23 ' A' ' 5' ' ' VAL . 20.2 m -135.76 133.17 51.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 111.705 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.746 ' HG3' HG23 ' A' ' 4' ' ' THR . 1.8 tt0 -130.89 119.8 22.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.269 0.557 . . . . 0.0 110.405 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -101.97 113.19 26.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.564 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.852 -179.967 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 1' ' ' ALA . . . . . 0.59 ' HA ' ' HA ' ' D' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.232 0.063 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 2' ' ' ALA . . . . . 0.639 ' H ' ' HA ' ' D' ' 159' ' ' GLN . . . 59.07 55.84 4.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.592 0.234 . . . . 0.0 111.018 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.523 HG21 ' HB2' ' D' ' 18' ' ' ASN . 89.2 m -118.61 111.1 18.13 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.448 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 4' ' ' THR . . . . . 0.71 HG23 ' HG3' ' D' ' 157' ' ' GLN . 0.2 OUTLIER -97.78 127.3 43.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.609 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.639 HG23 HG23 ' D' ' 156' ' ' VAL . 0.0 OUTLIER -153.53 171.52 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.589 179.57 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 6' ' ' ASN . . . . . 0.537 ' O ' ' NE2' ' E' ' 36' ' ' GLN . 1.2 t30 -94.39 122.13 36.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.592 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.96 -52.3 6.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.817 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.4 -145.56 5.86 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.889 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 9' ' ' THR . . . . . 0.517 HG23 HG23 ' D' ' 153' ' ' THR . 0.2 OUTLIER -146.75 139.83 25.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.975 0.417 . . . . 0.0 111.277 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.38 121.65 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.152 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -99.71 106.6 18.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.309 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 12' ' ' PHE . . . . . 0.43 ' HZ ' ' CZ ' ' D' ' 54' ' ' PHE . 8.9 m-85 -90.59 107.62 19.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.783 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.34 149.23 24.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.337 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.39 -179.08 47.5 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.922 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 15' ' ' GLU . . . . . 0.664 ' HB3' ' HG3' ' D' ' 36' ' ' GLN . 0.1 OUTLIER -158.96 157.1 30.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.906 0.384 . . . . 0.0 110.311 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.46 ' O ' HG11 ' B' ' 5' ' ' VAL . 17.9 t -113.79 132.08 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.284 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.601 HG12 HG21 ' B' ' 5' ' ' VAL . 5.4 m -136.78 176.62 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.803 0.335 . . . . 0.0 111.058 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 18' ' ' ASN . . . . . 0.504 ' HB2' HG21 ' B' ' 3' ' ' THR . 1.2 t30 -74.42 174.15 9.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.058 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 19' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' C' ' 62' ' ' ASP . . . -83.47 35.43 0.5 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.075 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 20' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' C' ' 61' ' ' CYS . . . -116.92 -15.94 10.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.435 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.94 155.31 0.6 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.91 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.78 126.37 5.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' VAL . . . . . 0.737 ' HA ' ' HG ' ' C' ' 58' ' ' LEU . 0.7 OUTLIER -60.74 162.53 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.112 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' C' ' 27' ' ' SER . 18.7 t70 -97.66 161.0 13.97 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.577 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.687 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -64.07 -40.37 96.12 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.389 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.43 12.79 68.96 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.91 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' SER . . . . . 0.563 ' HB3' ' HB3' ' C' ' 24' ' ' ASP . 0.6 OUTLIER -113.87 -25.52 8.58 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.865 0.364 . . . . 0.0 110.808 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.407 HG23 ' H ' ' C' ' 28' ' ' VAL . 9.8 t -41.15 -61.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.35 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.55 119.95 39.56 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.085 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -126.14 119.15 26.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.984 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.69 103.32 15.48 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.078 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.86 115.13 43.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.145 0.498 . . . . 0.0 110.493 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.51 112.59 24.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.656 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.8 -30.4 59.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.692 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.03 -170.17 27.36 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.613 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' GLN . . . . . 0.674 ' HG3' ' HB3' ' B' ' 15' ' ' GLU . 0.1 OUTLIER -93.51 141.7 28.17 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.522 0.201 . . . . 0.0 110.887 -179.741 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.536 HG11 HD22 ' C' ' 42' ' ' LEU . 5.7 p -125.29 157.11 34.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.916 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.53 122.41 28.98 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.727 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -40.44 87.01 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.754 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.46 -35.87 68.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.05 0.452 . . . . 0.0 110.797 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.19 -21.39 33.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.16 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.536 HD22 HG11 ' C' ' 37' ' ' VAL . 3.2 mp -110.51 29.45 7.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.566 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 43' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' C' ' 141' ' ' GLY . . . -108.2 25.45 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.321 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.74 159.92 23.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.341 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 45' ' ' GLU . . . . . 0.654 ' HA ' ' O ' ' C' ' 140' ' ' THR . 11.0 tt0 -82.8 108.68 16.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.853 0.358 . . . . 0.0 111.168 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.9 10.91 51.52 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.163 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' C' ' 139' ' ' ALA . . . -66.76 123.49 20.27 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.933 0.396 . . . . 0.0 112.061 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -120.65 140.25 51.84 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.874 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 4.6 m -101.62 -167.02 1.36 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.611 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.68 139.65 53.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.786 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.82 133.95 35.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.309 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.541 HG22 ' O ' ' C' ' 135' ' ' ALA . 18.7 m -86.94 166.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.016 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.74 128.76 7.94 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.637 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' C' ' 133' ' ' PHE . 40.7 p90 -160.17 134.48 7.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.511 ' OD1' HG21 ' C' ' 130' ' ' THR . 15.8 p30 -132.75 147.73 52.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.583 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.631 HG22 ' HB ' ' C' ' 131' ' ' ILE . 1.0 OUTLIER -96.75 116.7 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.621 -179.749 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.557 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.0 OUTLIER -66.58 122.06 16.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.696 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 58' ' ' LEU . . . . . 0.737 ' HG ' ' HA ' ' C' ' 23' ' ' VAL . 0.2 OUTLIER -137.43 88.17 2.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.23 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 59' ' ' ASN . . . . . 0.714 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 10.5 p30 -79.6 179.4 7.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.88 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.3 64.46 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.783 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 61' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' C' ' 129' ' ' ASN . 4.4 m -110.53 163.26 13.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.786 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 62' ' ' ASP . . . . . 0.587 ' HB2' ' O ' ' C' ' 19' ' ' ALA . 0.5 OUTLIER -140.21 155.07 47.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.254 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.34 -25.31 10.63 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -82.08 -16.25 50.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.061 0.458 . . . . 0.0 111.745 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.403 HG23 ' OD2' ' C' ' 62' ' ' ASP . 16.6 t -90.66 -48.46 14.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.661 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.11 142.9 36.02 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.639 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.82 -53.81 2.6 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.847 0.356 . . . . 0.0 110.971 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 68' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' C' ' 121' ' ' GLU . 0.1 OUTLIER -94.79 158.16 15.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.491 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.899 ' HB2' HD13 ' C' ' 124' ' ' LEU . . . -137.22 120.47 16.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.611 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -97.54 129.03 44.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.137 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 71' ' ' VAL . . . . . 0.6 HG11 HG21 ' C' ' 131' ' ' ILE . 15.8 t -112.96 152.24 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.718 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.01 146.63 27.1 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.588 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 73' ' ' PHE . . . . . 0.474 ' CD2' HG21 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -111.53 141.88 44.54 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.5 0.191 . . . . 0.0 111.092 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' C' ' 152' ' ' ALA . 0.8 OUTLIER -105.72 103.24 12.7 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.974 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.88 -179.11 25.43 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.789 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.685 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.2 OUTLIER -105.15 157.85 16.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.595 0.236 . . . . 0.0 110.73 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 77' ' ' ALA . . . . . 0.422 ' H ' ' HB2' ' F' ' 132' ' ' PRO . . . -77.89 132.79 38.1 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.881 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 78' ' ' ILE . . . . . 0.449 ' CG2' ' HB ' ' C' ' 85' ' ' VAL . 0.6 OUTLIER -66.58 -39.88 84.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 79' ' ' ASP . . . . . 0.415 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.7 OUTLIER -146.19 53.58 1.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.824 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 80' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' F' ' 106' ' ' ARG . . . 61.42 -87.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.065 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.37 -36.51 53.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.576 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -81.37 59.97 4.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.883 0.373 . . . . 0.0 110.451 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 83' ' ' THR . . . . . 0.593 HG21 ' OD1' ' C' ' 114' ' ' ASP . 2.1 m -70.53 -20.53 62.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.49 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 84' ' ' ASN . . . . . 0.888 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 26.6 p-10 -69.34 -13.73 62.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.334 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.697 HG22 ' HB2' ' C' ' 102' ' ' GLN . 40.9 t -109.0 131.15 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.129 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.783 HD11 ' HB2' ' C' ' 152' ' ' ALA . 0.6 OUTLIER -70.07 142.85 52.61 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.324 179.42 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.0 -170.58 3.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.882 0.372 . . . . 0.0 111.71 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -79.89 161.44 25.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.102 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.75 -80.33 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.34 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 90' ' ' SER . . . . . 0.476 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 6.6 p -171.34 0.49 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.949 0.404 . . . . 0.0 111.481 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 91' ' ' SER . . . . . 0.677 ' HA ' ' HB2' ' E' ' 25' ' ' ALA . 73.5 m -76.84 85.66 3.42 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 92' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' F' ' 50' ' ' SER . . . -61.04 -32.23 71.86 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.876 0.369 . . . . 0.0 111.649 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.86 30.47 6.87 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.642 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.64 -3.26 0.11 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.947 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 95' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' C' ' 91' ' ' SER . 0.1 OUTLIER -107.54 -176.71 3.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.834 0.35 . . . . 0.0 110.656 179.642 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.49 172.58 8.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 97' ' ' THR . . . . . 0.613 ' H ' ' HB ' ' C' ' 144' ' ' THR . 1.6 m -126.93 140.4 52.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.351 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 98' ' ' ASN . . . . . 0.492 ' HB3' ' H ' ' C' ' 141' ' ' GLY . 27.4 m120 61.96 21.39 12.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.472 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 99' ' ' VAL . . . . . 0.543 HG23 ' O ' ' C' ' 97' ' ' THR . 2.7 t -120.44 136.0 58.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.727 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.94 -160.74 10.18 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.532 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 101' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' C' ' 86' ' ' LEU . 4.5 p -145.94 109.85 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.067 0.547 . . . . 0.0 111.758 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 102' ' ' GLN . . . . . 0.697 ' HB2' HG22 ' C' ' 85' ' ' VAL . 0.5 OUTLIER -84.27 147.38 27.26 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.93 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.598 HG12 ' HG ' ' C' ' 113' ' ' LEU . 1.2 pp -110.79 127.86 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.529 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 104' ' ' LEU . . . . . 0.976 HD12 ' HB2' ' C' ' 110' ' ' ALA . 1.4 tp -97.43 132.94 42.66 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.663 0.268 . . . . 0.0 111.02 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 105' ' ' ASP . . . . . 0.654 ' HB3' HG22 ' C' ' 107' ' ' THR . 4.0 t0 -80.78 143.58 32.77 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.688 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 106' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -65.42 -17.53 64.61 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.815 0.341 . . . . 0.0 111.043 179.488 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 107' ' ' THR . . . . . 0.654 HG22 ' HB3' ' C' ' 105' ' ' ASP . 13.2 t -66.83 -20.59 65.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.028 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.08 -71.85 0.44 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.682 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.5 159.97 31.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.825 0.345 . . . . 0.0 111.11 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.976 ' HB2' HD12 ' C' ' 104' ' ' LEU . . . -75.54 131.52 40.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 111' ' ' LEU . . . . . 0.696 HD21 ' O ' ' C' ' 117' ' ' THR . 12.2 tp -88.14 154.22 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.379 0.609 . . . . 0.0 110.514 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 112' ' ' THR . . . . . 0.888 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 0.4 OUTLIER -96.37 142.66 28.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.147 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.598 ' HG ' HG12 ' C' ' 103' ' ' ILE . 0.8 OUTLIER -80.76 63.61 5.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.783 0.325 . . . . 0.0 110.761 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 114' ' ' ASP . . . . . 0.593 ' OD1' HG21 ' C' ' 83' ' ' THR . 0.1 OUTLIER -90.7 -30.54 17.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.547 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 115' ' ' GLY . . . . . 0.527 ' HA3' ' OG1' ' F' ' 130' ' ' THR . . . 115.76 -43.57 1.65 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.595 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 116' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' F' ' 128' ' ' THR . . . -110.49 24.33 13.11 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.003 0.43 . . . . 0.0 111.679 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 117' ' ' THR . . . . . 0.696 ' O ' HD21 ' C' ' 111' ' ' LEU . 0.2 OUTLIER -82.15 68.37 8.52 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.118 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 118' ' ' PHE . . . . . 0.553 ' CD1' ' HB2' ' C' ' 157' ' ' GLN . 41.0 m-85 -82.2 72.0 9.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.801 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.76 80.99 1.86 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.65 131.75 13.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.606 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 121' ' ' GLU . . . . . 0.433 ' O ' ' HE2' ' C' ' 68' ' ' LYS . 1.5 mm-40 -100.76 52.2 0.86 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.212 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' C' ' 69' ' ' ALA . 0.2 OUTLIER -72.11 131.89 43.45 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.75 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.7 107.65 15.49 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.745 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 124' ' ' LEU . . . . . 0.899 HD13 ' HB2' ' C' ' 69' ' ' ALA . 1.0 OUTLIER -88.26 126.58 35.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.561 179.465 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 125' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' C' ' 61' ' ' CYS . 1.1 m120 -120.66 -178.93 3.84 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.525 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 126' ' ' ASN . . . . . 0.524 ' OD1' ' HA ' ' C' ' 62' ' ' ASP . 3.8 t30 -83.25 120.61 26.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.784 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.18 -121.67 2.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.659 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 128' ' ' THR . . . . . 0.714 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 76.5 m -122.21 103.37 8.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.746 0.308 . . . . 0.0 110.78 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 129' ' ' ASN . . . . . 0.529 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 1.8 t30 -86.21 157.26 20.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.896 0.379 . . . . 0.0 111.091 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 130' ' ' THR . . . . . 0.557 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.3 OUTLIER -143.29 130.17 20.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.104 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 131' ' ' ILE . . . . . 0.631 ' HB ' HG22 ' C' ' 56' ' ' ILE . 56.8 mt -83.97 104.14 3.79 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 132' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' C' ' 106' ' ' ARG . 7.6 Cg_endo -82.0 112.34 2.31 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.673 1.582 . . . . 0.0 112.582 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.43 ' HB3' ' CZ ' ' C' ' 54' ' ' PHE . 1.0 OUTLIER -126.7 158.29 36.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.828 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -126.0 156.1 40.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.059 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 135' ' ' ALA . . . . . 0.541 ' O ' HG22 ' C' ' 52' ' ' VAL . . . -148.15 105.14 3.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 0.0 111.609 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.05 163.36 12.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.416 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 137' ' ' TYR . . . . . 0.561 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 0.3 OUTLIER -81.64 119.71 24.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.116 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 138' ' ' PHE . . . . . 0.463 ' HB3' HG11 ' C' ' 85' ' ' VAL . 2.1 t80 -108.91 142.68 39.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.982 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 139' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' C' ' 47' ' ' ALA . . . -132.98 136.04 45.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.851 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 140' ' ' THR . . . . . 0.654 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 25.1 p -96.6 -56.21 2.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.476 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 141' ' ' GLY . . . . . 0.492 ' H ' ' HB3' ' C' ' 98' ' ' ASN . . . -127.06 -129.84 3.3 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.013 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.03 107.14 12.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.631 0.216 . . . . 0.0 110.702 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 143' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' C' ' 97' ' ' THR . . . -65.89 148.09 52.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.753 0.311 . . . . 0.0 111.434 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 144' ' ' THR . . . . . 0.613 ' HB ' ' H ' ' C' ' 97' ' ' THR . 47.8 m -114.87 144.67 32.42 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.307 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 145' ' ' PRO . . . . . 0.406 ' HD2' HG23 ' C' ' 144' ' ' THR . 1.3 Cg_endo -81.96 130.97 6.78 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.479 2.119 . . . . 0.0 112.009 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 146' ' ' GLY . . . . . 0.62 ' O ' ' HG3' ' B' ' 15' ' ' GLU . . . 164.89 -116.26 0.69 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.438 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 147' ' ' ALA . . . . . 0.611 ' HA ' ' HG3' ' B' ' 15' ' ' GLU . . . -110.67 150.37 29.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 111.351 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.67 45.89 1.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.46 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 149' ' ' ASN . . . . . 0.512 HD22 ' HB1' ' C' ' 147' ' ' ALA . 0.1 OUTLIER -96.83 141.0 30.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.618 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 150' ' ' ALA . . . . . 0.411 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -153.7 162.62 41.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.047 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.93 135.5 43.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.198 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 152' ' ' ALA . . . . . 0.783 ' HB2' HD11 ' C' ' 86' ' ' LEU . . . -134.16 152.51 51.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.23 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 153' ' ' THR . . . . . 0.526 HG23 HG23 ' B' ' 9' ' ' THR . 4.0 m -104.15 148.91 25.74 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.23 141.83 35.21 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.136 0.493 . . . . 0.0 110.165 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.54 152.41 40.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.916 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 156' ' ' VAL . . . . . 0.632 HG23 HG23 ' B' ' 5' ' ' VAL . 19.9 m -135.74 133.22 51.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.798 0.332 . . . . 0.0 111.684 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 157' ' ' GLN . . . . . 0.711 ' HG3' HG23 ' B' ' 4' ' ' THR . 1.8 tt0 -130.96 119.78 22.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.326 0.584 . . . . 0.0 110.397 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -101.93 113.24 26.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.577 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 159' ' ' GLN . . . . . 0.626 ' HA ' ' H ' ' B' ' 2' ' ' ALA . 3.6 mp0 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.836 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 1' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' E' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 111.105 0.039 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 2' ' ' ALA . . . . . 0.624 ' H ' ' HA ' ' E' ' 159' ' ' GLN . . . 59.11 55.8 4.22 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 123.104 0.253 . . . . 0.0 111.035 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 3' ' ' THR . . . . . 0.524 HG21 ' HB2' ' E' ' 18' ' ' ASN . 89.7 m -118.64 111.07 18.08 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.422 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 4' ' ' THR . . . . . 0.74 HG23 ' HG3' ' E' ' 157' ' ' GLN . 0.2 OUTLIER -97.76 127.33 43.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.524 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.657 HG23 HG23 ' E' ' 156' ' ' VAL . 0.0 OUTLIER -153.53 171.46 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.634 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 6' ' ' ASN . . . . . 0.531 ' O ' ' NE2' ' F' ' 36' ' ' GLN . 1.2 t30 -94.37 122.09 36.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.637 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.0 -52.23 6.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.802 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.46 -145.46 5.83 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.829 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 9' ' ' THR . . . . . 0.535 HG23 HG23 ' E' ' 153' ' ' THR . 0.2 OUTLIER -146.82 139.74 25.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.905 0.383 . . . . 0.0 111.299 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.33 121.63 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.125 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -99.65 106.66 18.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.361 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 12' ' ' PHE . . . . . 0.432 ' HZ ' ' CZ ' ' E' ' 54' ' ' PHE . 8.9 m-85 -90.65 107.59 19.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.797 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.29 149.18 24.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.404 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.42 -179.05 47.51 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.946 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 15' ' ' GLU . . . . . 0.673 ' HB3' ' HG3' ' E' ' 36' ' ' GLN . 0.1 OUTLIER -158.93 157.01 30.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.912 0.387 . . . . 0.0 110.358 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.461 ' O ' HG11 ' C' ' 5' ' ' VAL . 17.8 t -113.7 132.19 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.249 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.606 HG12 HG21 ' C' ' 5' ' ' VAL . 5.5 m -136.85 176.58 7.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.829 0.347 . . . . 0.0 111.008 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 18' ' ' ASN . . . . . 0.523 ' HB2' HG21 ' C' ' 3' ' ' THR . 1.2 t30 -74.36 174.11 9.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.068 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 19' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' D' ' 62' ' ' ASP . . . -83.4 35.32 0.49 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.059 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 20' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' D' ' 61' ' ' CYS . . . -116.92 -15.9 10.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.398 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.99 155.22 0.59 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.962 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.67 126.47 5.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.077 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 23' ' ' VAL . . . . . 0.74 ' HA ' ' HG ' ' D' ' 58' ' ' LEU . 0.7 OUTLIER -60.9 162.44 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.057 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' D' ' 27' ' ' SER . 18.7 t70 -97.58 160.97 14.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.623 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.675 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -64.11 -40.25 95.79 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.398 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.49 12.75 69.02 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.914 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 27' ' ' SER . . . . . 0.568 ' HB3' ' HB3' ' D' ' 24' ' ' ASP . 0.6 OUTLIER -113.84 -25.47 8.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.846 0.355 . . . . 0.0 110.787 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 28' ' ' VAL . . . . . 0.405 HG23 ' H ' ' D' ' 28' ' ' VAL . 10.0 t -41.15 -61.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.306 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.64 120.0 39.65 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.03 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -126.07 119.1 26.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.024 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.76 103.33 15.47 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.083 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.88 115.1 43.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.163 0.506 . . . . 0.0 110.424 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.5 112.56 24.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.646 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.83 -30.34 58.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.626 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.98 -170.23 27.49 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.571 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' GLN . . . . . 0.664 ' HG3' ' HB3' ' C' ' 15' ' ' GLU . 0.1 OUTLIER -93.48 141.79 28.07 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.526 0.203 . . . . 0.0 110.944 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.559 HG11 HD22 ' D' ' 42' ' ' LEU . 5.8 p -125.3 157.14 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.827 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.58 122.39 28.97 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.729 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -40.47 86.94 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.753 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.48 -35.82 68.39 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.053 0.454 . . . . 0.0 110.8 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -21.44 33.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.133 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.559 HD22 HG11 ' D' ' 37' ' ' VAL . 3.3 mp -110.5 29.51 7.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.623 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 43' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' D' ' 141' ' ' GLY . . . -108.24 25.44 11.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.34 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.71 159.97 23.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.38 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 45' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' D' ' 140' ' ' THR . 11.1 tt0 -82.94 108.73 16.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.916 0.388 . . . . 0.0 111.127 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.97 10.78 51.51 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.116 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' D' ' 139' ' ' ALA . . . -66.66 123.47 20.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.94 0.4 . . . . 0.0 111.974 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 77.5 p -120.64 140.3 51.77 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.879 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 4.6 m -101.68 -167.02 1.36 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.61 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 8.1 t -69.63 139.64 53.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.791 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.79 133.99 35.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.335 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 52' ' ' VAL . . . . . 0.532 HG22 ' O ' ' D' ' 135' ' ' ALA . 18.9 m -87.04 166.48 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.896 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.77 128.87 7.99 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.614 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.558 ' H ' HG21 ' A' ' 76' ' ' THR . 40.6 p90 -160.2 134.44 7.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.756 0.312 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 55' ' ' ASN . . . . . 0.516 ' OD1' HG21 ' D' ' 130' ' ' THR . 15.9 p30 -132.75 147.67 52.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.623 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.636 HG22 ' HB ' ' D' ' 131' ' ' ILE . 1.0 OUTLIER -96.74 116.75 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.567 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 57' ' ' GLN . . . . . 0.572 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.0 OUTLIER -66.61 122.04 16.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.744 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 58' ' ' LEU . . . . . 0.74 ' HG ' ' HA ' ' D' ' 23' ' ' VAL . 0.2 OUTLIER -137.4 88.17 2.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 59' ' ' ASN . . . . . 0.734 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 10.6 p30 -79.58 179.37 7.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.925 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.35 64.37 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.812 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 61' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' D' ' 129' ' ' ASN . 4.4 m -110.48 163.26 13.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.954 0.406 . . . . 0.0 110.761 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 62' ' ' ASP . . . . . 0.575 ' HB2' ' O ' ' D' ' 19' ' ' ALA . 0.5 OUTLIER -140.22 155.07 47.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.237 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.25 -25.36 10.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -81.99 -16.41 50.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.083 0.468 . . . . 0.0 111.703 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 t -90.61 -48.48 14.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.696 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.12 142.9 36.01 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.639 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.79 -53.82 2.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.848 0.356 . . . . 0.0 110.941 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 68' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' D' ' 121' ' ' GLU . 0.1 OUTLIER -94.86 158.1 15.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.482 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 69' ' ' ALA . . . . . 0.908 ' HB2' HD13 ' D' ' 124' ' ' LEU . . . -137.14 120.48 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.621 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 70' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -97.62 129.1 44.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.06 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 71' ' ' VAL . . . . . 0.594 HG11 HG21 ' D' ' 131' ' ' ILE . 15.9 t -112.99 152.28 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.671 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.05 146.61 27.06 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.522 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 73' ' ' PHE . . . . . 0.474 ' CD2' HG21 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -111.53 141.94 44.46 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.536 0.208 . . . . 0.0 111.092 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 74' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.8 OUTLIER -105.71 103.35 12.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.916 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.96 -179.11 25.5 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.806 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 157.84 17.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.558 0.218 . . . . 0.0 110.732 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.9 132.75 38.07 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.87 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 78' ' ' ILE . . . . . 0.452 ' CG2' ' HB ' ' D' ' 85' ' ' VAL . 0.6 OUTLIER -66.61 -39.79 84.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.42 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.7 OUTLIER -146.22 53.53 1.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.826 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.39 -87.54 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.33 -36.53 53.26 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.58 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -81.31 59.99 4.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.472 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 83' ' ' THR . . . . . 0.593 HG21 ' OD1' ' D' ' 114' ' ' ASP . 2.1 m -70.58 -20.53 62.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.575 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 84' ' ' ASN . . . . . 0.887 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 26.6 p-10 -69.35 -13.7 62.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.296 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' D' ' 102' ' ' GLN . 40.8 t -108.96 131.1 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.203 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.758 HD11 ' HB2' ' D' ' 152' ' ' ALA . 0.6 OUTLIER -70.02 142.89 52.69 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.323 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.02 -170.5 3.06 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.884 0.373 . . . . 0.0 111.688 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -80.02 161.44 25.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.022 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.76 -80.25 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.357 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 6.5 p -171.41 0.48 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 111.445 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 91' ' ' SER . . . . . 0.687 ' HA ' ' HB2' ' F' ' 25' ' ' ALA . 73.4 m -76.83 85.55 3.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.912 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.87 -32.32 71.76 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.655 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.83 30.45 6.88 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.641 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.71 -3.12 0.11 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.953 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 95' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' D' ' 91' ' ' SER . 0.1 OUTLIER -107.57 -176.79 3.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 110.638 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.56 172.58 8.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.811 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 97' ' ' THR . . . . . 0.611 ' H ' ' HB ' ' D' ' 144' ' ' THR . 1.7 m -126.86 140.43 52.36 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.288 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 98' ' ' ASN . . . . . 0.48 ' HB3' ' H ' ' D' ' 141' ' ' GLY . 27.3 m120 61.95 21.36 12.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.427 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 99' ' ' VAL . . . . . 0.55 HG23 ' O ' ' D' ' 97' ' ' THR . 2.7 t -120.35 136.02 58.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.742 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.0 -160.77 10.21 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.513 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 101' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' D' ' 86' ' ' LEU . 4.5 p -145.9 109.85 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.168 0.509 . . . . 0.0 111.762 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 102' ' ' GLN . . . . . 0.691 ' HB2' HG22 ' D' ' 85' ' ' VAL . 0.5 OUTLIER -84.31 147.36 27.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.93 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 103' ' ' ILE . . . . . 0.611 HG12 ' HG ' ' D' ' 113' ' ' LEU . 1.2 pp -110.73 127.81 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.49 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 104' ' ' LEU . . . . . 0.937 HD12 ' HB2' ' D' ' 110' ' ' ALA . 1.4 tp -97.37 132.92 42.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.676 0.274 . . . . 0.0 111.093 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 105' ' ' ASP . . . . . 0.673 ' HB3' HG22 ' D' ' 107' ' ' THR . 4.0 t0 -80.81 143.62 32.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.669 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 106' ' ' ARG . . . . . 0.543 ' HA ' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -65.47 -17.44 64.56 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.762 0.315 . . . . 0.0 111.101 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 107' ' ' THR . . . . . 0.673 HG22 ' HB3' ' D' ' 105' ' ' ASP . 13.3 t -66.87 -20.59 65.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.052 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.07 -71.78 0.44 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.674 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.48 159.93 31.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.829 0.347 . . . . 0.0 111.111 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.937 ' HB2' HD12 ' D' ' 104' ' ' LEU . . . -75.56 131.47 40.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.126 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 111' ' ' LEU . . . . . 0.682 HD21 ' O ' ' D' ' 117' ' ' THR . 12.2 tp -88.13 154.21 20.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.372 0.606 . . . . 0.0 110.63 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 112' ' ' THR . . . . . 0.887 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 0.4 OUTLIER -96.42 142.74 28.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.082 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 113' ' ' LEU . . . . . 0.611 ' HG ' HG12 ' D' ' 103' ' ' ILE . 0.8 OUTLIER -80.82 63.68 5.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.738 0.304 . . . . 0.0 110.704 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 114' ' ' ASP . . . . . 0.593 ' OD1' HG21 ' D' ' 83' ' ' THR . 0.1 OUTLIER -90.65 -30.66 17.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.648 0.261 . . . . 0.0 111.55 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.79 -43.6 1.64 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.593 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.56 24.38 13.04 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.996 0.427 . . . . 0.0 111.614 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 117' ' ' THR . . . . . 0.682 ' O ' HD21 ' D' ' 111' ' ' LEU . 0.2 OUTLIER -82.12 68.35 8.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.553 ' CD1' ' HB2' ' D' ' 157' ' ' GLN . 40.8 m-85 -82.21 71.98 9.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.754 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.71 80.99 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.58 131.75 13.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.576 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 121' ' ' GLU . . . . . 0.431 ' O ' ' HE2' ' D' ' 68' ' ' LYS . 1.5 mm-40 -100.77 52.11 0.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.222 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.666 ' HB ' ' HB3' ' D' ' 69' ' ' ALA . 0.2 OUTLIER -72.06 131.91 43.5 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.73 -179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.69 107.62 15.46 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.742 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 124' ' ' LEU . . . . . 0.908 HD13 ' HB2' ' D' ' 69' ' ' ALA . 1.0 OUTLIER -88.22 126.58 35.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.558 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 125' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' D' ' 61' ' ' CYS . 1.1 m120 -120.69 -178.94 3.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.575 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 126' ' ' ASN . . . . . 0.52 ' OD1' ' HA ' ' D' ' 62' ' ' ASP . 3.8 t30 -83.23 120.71 26.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.662 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.08 -121.72 2.52 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.709 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 128' ' ' THR . . . . . 0.734 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 75.8 m -122.21 103.42 8.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.711 0.291 . . . . 0.0 110.77 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 129' ' ' ASN . . . . . 0.534 ' HB2' ' SG ' ' D' ' 61' ' ' CYS . 1.7 t30 -86.14 157.23 20.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.172 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 130' ' ' THR . . . . . 0.572 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.3 OUTLIER -143.28 130.17 20.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.136 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 131' ' ' ILE . . . . . 0.636 ' HB ' HG22 ' D' ' 56' ' ' ILE . 57.0 mt -84.0 104.11 3.77 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 132' ' ' PRO . . . . . 0.699 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 7.6 Cg_endo -81.99 112.34 2.31 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.646 1.564 . . . . 0.0 112.568 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 133' ' ' PHE . . . . . 0.432 ' HB3' ' CZ ' ' D' ' 54' ' ' PHE . 1.0 OUTLIER -126.68 158.25 36.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.863 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -125.96 156.09 40.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.116 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.532 ' O ' HG22 ' D' ' 52' ' ' VAL . . . -148.22 105.12 3.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.947 0.404 . . . . 0.0 111.587 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -99.07 163.48 12.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.357 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 137' ' ' TYR . . . . . 0.573 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 0.3 OUTLIER -81.79 119.7 24.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.101 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 138' ' ' PHE . . . . . 0.461 ' HB3' HG11 ' D' ' 85' ' ' VAL . 2.1 t80 -108.84 142.68 39.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.056 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 139' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' D' ' 47' ' ' ALA . . . -132.92 136.05 45.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.904 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 140' ' ' THR . . . . . 0.656 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 25.1 p -96.66 -56.14 2.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.474 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 141' ' ' GLY . . . . . 0.48 ' H ' ' HB3' ' D' ' 98' ' ' ASN . . . -127.11 -129.87 3.3 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.988 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.98 107.05 12.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.652 0.226 . . . . 0.0 110.779 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 143' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' D' ' 97' ' ' THR . . . -65.85 148.09 52.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.714 0.292 . . . . 0.0 111.441 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 144' ' ' THR . . . . . 0.611 ' HB ' ' H ' ' D' ' 97' ' ' THR . 48.6 m -114.79 144.69 32.42 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.297 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 145' ' ' PRO . . . . . 0.411 ' HD2' HG23 ' D' ' 144' ' ' THR . 1.3 Cg_endo -81.97 130.91 6.75 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.573 2.182 . . . . 0.0 111.972 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 146' ' ' GLY . . . . . 0.621 ' O ' ' HG3' ' C' ' 15' ' ' GLU . . . 164.89 -116.25 0.69 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.439 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 147' ' ' ALA . . . . . 0.627 ' HA ' ' HG3' ' C' ' 15' ' ' GLU . . . -110.66 150.4 29.06 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.808 0.337 . . . . 0.0 111.339 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.65 45.88 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.45 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 149' ' ' ASN . . . . . 0.513 HD22 ' HB1' ' D' ' 147' ' ' ALA . 0.1 OUTLIER -96.85 141.06 30.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.578 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 150' ' ' ALA . . . . . 0.404 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -153.74 162.54 41.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.962 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.87 135.49 43.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.239 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 152' ' ' ALA . . . . . 0.758 ' HB2' HD11 ' D' ' 86' ' ' LEU . . . -134.19 152.49 51.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.217 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 153' ' ' THR . . . . . 0.517 HG23 HG23 ' C' ' 9' ' ' THR . 4.0 m -104.09 148.92 25.7 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.25 141.83 35.22 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.106 0.479 . . . . 0.0 110.113 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.57 152.39 40.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.921 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 156' ' ' VAL . . . . . 0.639 HG23 HG23 ' C' ' 5' ' ' VAL . 20.0 m -135.74 133.16 51.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.809 0.337 . . . . 0.0 111.635 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 157' ' ' GLN . . . . . 0.71 ' HG3' HG23 ' C' ' 4' ' ' THR . 1.8 tt0 -130.9 119.74 22.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.302 0.572 . . . . 0.0 110.417 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -101.94 113.31 26.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.587 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 159' ' ' GLN . . . . . 0.639 ' HA ' ' H ' ' C' ' 2' ' ' ALA . 3.6 mp0 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.839 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 1' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' F' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 111.108 0.04 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 2' ' ' ALA . . . . . 0.622 ' H ' ' HA ' ' F' ' 159' ' ' GLN . . . 59.16 55.73 4.23 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.106 0.254 . . . . 0.0 111.035 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 3' ' ' THR . . . . . 0.524 HG21 ' HB2' ' F' ' 18' ' ' ASN . 89.5 m -118.64 111.1 18.11 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.443 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 4' ' ' THR . . . . . 0.726 HG23 ' HG3' ' F' ' 157' ' ' GLN . 0.2 OUTLIER -97.79 127.38 43.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.575 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.638 HG23 HG23 ' F' ' 156' ' ' VAL . 0.0 OUTLIER -153.57 171.46 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.594 179.581 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.38 122.07 36.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.83 -52.37 6.46 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.859 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.41 -145.53 5.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.868 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 9' ' ' THR . . . . . 0.531 HG23 HG23 ' F' ' 153' ' ' THR . 0.2 OUTLIER -146.69 139.85 25.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 0.0 111.283 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.43 121.63 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.121 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.71 106.64 18.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.326 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 12' ' ' PHE . . . . . 0.434 ' HZ ' ' CZ ' ' F' ' 54' ' ' PHE . 8.9 m-85 -90.65 107.66 19.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.29 149.18 24.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.384 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.43 -179.03 47.51 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.971 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 15' ' ' GLU . . . . . 0.662 ' HB3' ' HG3' ' F' ' 36' ' ' GLN . 0.1 OUTLIER -158.96 157.01 30.49 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.849 0.357 . . . . 0.0 110.381 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 16' ' ' VAL . . . . . 0.457 ' O ' HG11 ' D' ' 5' ' ' VAL . 18.1 t -113.77 132.21 63.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.148 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 17' ' ' VAL . . . . . 0.615 HG12 HG21 ' D' ' 5' ' ' VAL . 5.6 m -136.84 176.55 7.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 111.107 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 18' ' ' ASN . . . . . 0.524 ' HB2' HG21 ' D' ' 3' ' ' THR . 1.2 t30 -74.36 174.11 9.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.012 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 19' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' E' ' 62' ' ' ASP . . . -83.45 35.38 0.5 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 20' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' E' ' 61' ' ' CYS . . . -116.93 -15.9 10.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.412 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.99 155.26 0.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.961 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.74 126.43 5.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 23' ' ' VAL . . . . . 0.728 ' HA ' ' HG ' ' E' ' 58' ' ' LEU . 0.7 OUTLIER -60.85 162.54 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.083 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 24' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' E' ' 27' ' ' SER . 18.6 t70 -97.66 160.99 13.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.595 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 25' ' ' ALA . . . . . 0.677 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -64.12 -40.33 95.97 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.365 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.41 12.73 69.09 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.9 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 27' ' ' SER . . . . . 0.573 ' HB3' ' HB3' ' E' ' 24' ' ' ASP . 0.6 OUTLIER -113.84 -25.51 8.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.836 0.35 . . . . 0.0 110.785 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 28' ' ' VAL . . . . . . . . . . . . . 9.7 t -41.14 -61.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.336 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.64 120.01 39.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.013 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -126.11 119.14 26.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.01 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.79 103.29 15.43 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.107 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.82 115.11 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.144 0.497 . . . . 0.0 110.534 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.45 112.6 24.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.601 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mp -75.87 -30.4 58.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.615 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.08 -170.2 27.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.581 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 36' ' ' GLN . . . . . 0.673 ' HG3' ' HB3' ' D' ' 15' ' ' GLU . 0.1 OUTLIER -93.47 141.71 28.15 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.608 0.242 . . . . 0.0 110.89 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.552 HG11 HD22 ' E' ' 42' ' ' LEU . 5.8 p -125.24 157.13 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.914 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.55 122.43 29.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.799 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -40.42 87.1 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.736 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.44 -35.86 68.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.125 0.488 . . . . 0.0 110.87 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -21.54 33.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.14 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.552 HD22 HG11 ' E' ' 37' ' ' VAL . 3.2 mp -110.49 29.38 7.76 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.621 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 43' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' E' ' 141' ' ' GLY . . . -108.16 25.53 11.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.357 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.72 160.0 23.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.342 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 45' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' E' ' 140' ' ' THR . 11.1 tt0 -82.92 108.64 16.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 111.131 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.94 10.9 51.39 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.145 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 47' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' E' ' 139' ' ' ALA . . . -66.75 123.47 20.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.943 0.401 . . . . 0.0 111.997 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -120.59 140.27 51.77 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.837 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 4.6 m -101.6 -167.01 1.36 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.625 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 50' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 8.1 t -69.66 139.7 53.55 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.774 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.87 134.03 35.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.348 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 52' ' ' VAL . . . . . 0.532 HG22 ' O ' ' E' ' 135' ' ' ALA . 18.8 m -87.01 166.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.962 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.75 128.89 8.01 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.628 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 54' ' ' PHE . . . . . 0.56 ' H ' HG21 ' B' ' 76' ' ' THR . 40.7 p90 -160.29 134.44 7.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.79 0.329 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 55' ' ' ASN . . . . . 0.514 ' OD1' HG21 ' E' ' 130' ' ' THR . 15.9 p30 -132.75 147.75 52.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.636 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 56' ' ' ILE . . . . . 0.636 HG22 ' HB ' ' E' ' 131' ' ' ILE . 1.0 OUTLIER -96.83 116.85 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.521 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 57' ' ' GLN . . . . . 0.576 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.0 OUTLIER -66.58 122.07 16.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.704 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 58' ' ' LEU . . . . . 0.728 ' HG ' ' HA ' ' E' ' 23' ' ' VAL . 0.2 OUTLIER -137.49 88.12 2.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.213 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 59' ' ' ASN . . . . . 0.717 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 10.6 p30 -79.6 179.29 7.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.89 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.42 64.42 0.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.779 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 61' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' E' ' 129' ' ' ASN . 4.4 m -110.56 163.2 13.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.755 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 62' ' ' ASP . . . . . 0.581 ' HB2' ' O ' ' E' ' 19' ' ' ALA . 0.5 OUTLIER -140.14 155.0 47.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.344 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.2 -25.42 10.63 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.95 -16.35 50.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.127 0.489 . . . . 0.0 111.754 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 65' ' ' VAL . . . . . 0.403 HG23 ' OD2' ' E' ' 62' ' ' ASP . 16.7 t -90.68 -48.41 14.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.68 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.16 142.92 35.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.575 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.82 -53.86 2.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.866 0.365 . . . . 0.0 110.918 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 68' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' E' ' 121' ' ' GLU . 0.1 OUTLIER -94.75 158.13 15.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.549 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 69' ' ' ALA . . . . . 0.933 ' HB2' HD13 ' E' ' 124' ' ' LEU . . . -137.19 120.42 16.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.649 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 70' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -97.54 129.13 44.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.111 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 71' ' ' VAL . . . . . 0.607 HG11 HG21 ' E' ' 131' ' ' ILE . 15.7 t -112.97 152.23 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.749 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.01 146.65 27.12 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.52 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 73' ' ' PHE . . . . . 0.475 ' CD2' HG21 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -111.58 141.86 44.63 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.525 0.202 . . . . 0.0 111.063 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 74' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.8 OUTLIER -105.67 103.38 12.88 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.962 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.95 -179.11 25.49 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.813 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.22 157.8 17.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.554 0.216 . . . . 0.0 110.761 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.91 132.75 38.06 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.849 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 78' ' ' ILE . . . . . 0.45 ' CG2' ' HB ' ' E' ' 85' ' ' VAL . 0.6 OUTLIER -66.55 -39.82 84.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.911 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 79' ' ' ASP . . . . . 0.419 ' N ' HG23 ' E' ' 78' ' ' ILE . 0.7 OUTLIER -146.23 53.59 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.844 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.36 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.013 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.28 -36.59 53.16 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.566 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -81.34 59.98 4.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 110.473 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 83' ' ' THR . . . . . 0.594 HG21 ' OD1' ' E' ' 114' ' ' ASP . 2.0 m -70.56 -20.5 62.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.533 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 84' ' ' ASN . . . . . 0.878 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 26.5 p-10 -69.34 -13.75 62.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.297 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' E' ' 102' ' ' GLN . 40.8 t -109.01 131.12 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.153 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 86' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' E' ' 152' ' ' ALA . 0.6 OUTLIER -69.99 142.87 52.74 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.05 -170.49 3.06 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.937 0.399 . . . . 0.0 111.668 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' E' ' 88' ' ' LEU . 1.2 mm? -80.01 161.4 25.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.985 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.67 -80.34 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.322 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 6.4 p -171.35 0.34 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.958 0.409 . . . . 0.0 111.449 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 91' ' ' SER . . . . . 0.598 ' HB2' ' HB2' ' E' ' 95' ' ' SER . 73.5 m -76.78 85.64 3.38 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.35 71.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.942 0.401 . . . . 0.0 111.653 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.82 30.45 6.89 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.611 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.72 -3.15 0.11 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.941 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 95' ' ' SER . . . . . 0.598 ' HB2' ' HB2' ' E' ' 91' ' ' SER . 0.1 OUTLIER -107.57 -176.76 3.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.838 0.351 . . . . 0.0 110.641 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.46 172.6 8.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 97' ' ' THR . . . . . 0.623 ' H ' ' HB ' ' E' ' 144' ' ' THR . 1.6 m -126.9 140.44 52.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.348 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 98' ' ' ASN . . . . . 0.495 ' HB3' ' H ' ' E' ' 141' ' ' GLY . 27.3 m120 61.96 21.33 12.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.45 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 99' ' ' VAL . . . . . 0.557 HG23 ' O ' ' E' ' 97' ' ' THR . 2.6 t -120.33 135.98 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.746 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.0 -160.73 10.19 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.583 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -145.88 109.89 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.181 0.515 . . . . 0.0 111.715 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 102' ' ' GLN . . . . . 0.66 ' HB2' HG22 ' E' ' 85' ' ' VAL . 0.5 OUTLIER -84.34 147.3 27.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.849 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 103' ' ' ILE . . . . . 0.598 HG12 ' HG ' ' E' ' 113' ' ' LEU . 1.2 pp -110.68 127.86 67.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.476 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 104' ' ' LEU . . . . . 0.972 HD12 ' HB2' ' E' ' 110' ' ' ALA . 1.4 tp -97.46 132.99 42.64 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.705 0.288 . . . . 0.0 111.021 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 105' ' ' ASP . . . . . 0.654 ' HB3' HG22 ' E' ' 107' ' ' THR . 4.0 t0 -80.84 143.62 32.64 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.662 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 106' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' B' ' 80' ' ' ALA . 0.0 OUTLIER -65.42 -17.52 64.61 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.813 0.34 . . . . 0.0 111.084 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 107' ' ' THR . . . . . 0.654 HG22 ' HB3' ' E' ' 105' ' ' ASP . 13.3 t -66.81 -20.63 65.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.03 -71.71 0.44 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.741 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.52 159.95 31.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.842 0.353 . . . . 0.0 111.061 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 110' ' ' ALA . . . . . 0.972 ' HB2' HD12 ' E' ' 104' ' ' LEU . . . -75.56 131.52 40.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.076 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 111' ' ' LEU . . . . . 0.684 HD21 ' O ' ' E' ' 117' ' ' THR . 12.2 tp -88.17 154.18 20.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.369 0.604 . . . . 0.0 110.549 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 112' ' ' THR . . . . . 0.878 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 0.4 OUTLIER -96.36 142.75 28.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.09 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 113' ' ' LEU . . . . . 0.598 ' HG ' HG12 ' E' ' 103' ' ' ILE . 0.8 OUTLIER -80.82 63.64 5.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.745 0.307 . . . . 0.0 110.716 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 114' ' ' ASP . . . . . 0.594 ' OD1' HG21 ' E' ' 83' ' ' THR . 0.1 OUTLIER -90.62 -30.65 17.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.541 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.76 -43.58 1.64 Allowed Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.627 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.56 24.38 13.04 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.011 0.434 . . . . 0.0 111.626 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 117' ' ' THR . . . . . 0.684 ' O ' HD21 ' E' ' 111' ' ' LEU . 0.2 OUTLIER -82.11 68.41 8.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.115 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 118' ' ' PHE . . . . . 0.538 ' CD1' ' HB2' ' E' ' 157' ' ' GLN . 41.0 m-85 -82.25 71.92 9.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.769 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.62 80.95 1.85 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.848 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.61 131.7 13.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.611 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 121' ' ' GLU . . . . . 0.432 ' O ' ' HE2' ' E' ' 68' ' ' LYS . 1.5 mm-40 -100.72 52.12 0.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.215 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 122' ' ' THR . . . . . 0.654 ' HB ' ' HB3' ' E' ' 69' ' ' ALA . 0.2 OUTLIER -72.07 131.93 43.53 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.713 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.75 107.69 15.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.675 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 124' ' ' LEU . . . . . 0.933 HD13 ' HB2' ' E' ' 69' ' ' ALA . 1.0 OUTLIER -88.31 126.53 35.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.537 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 125' ' ' ASN . . . . . 0.512 ' O ' ' HB3' ' E' ' 61' ' ' CYS . 1.1 m120 -120.58 -178.92 3.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.552 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 126' ' ' ASN . . . . . 0.524 ' OD1' ' HA ' ' E' ' 62' ' ' ASP . 3.7 t30 -83.29 120.66 26.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.735 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 127' ' ' GLY . . . . . 0.726 ' HA2' HG21 ' A' ' 4' ' ' THR . . . 136.16 -121.77 2.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.697 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 128' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 76.7 m -122.19 103.38 8.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.705 0.288 . . . . 0.0 110.764 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 129' ' ' ASN . . . . . 0.532 ' HB2' ' SG ' ' E' ' 61' ' ' CYS . 1.7 t30 -86.06 157.33 20.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.902 0.382 . . . . 0.0 111.127 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 130' ' ' THR . . . . . 0.576 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.3 OUTLIER -143.4 130.2 20.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.029 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 131' ' ' ILE . . . . . 0.636 ' HB ' HG22 ' E' ' 56' ' ' ILE . 57.4 mt -84.06 104.15 3.85 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 132' ' ' PRO . . . . . 0.679 ' HB3' ' HA ' ' B' ' 76' ' ' THR . 7.5 Cg_endo -82.05 112.41 2.3 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 121.609 1.539 . . . . 0.0 112.574 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 133' ' ' PHE . . . . . 0.425 ' HB3' ' CZ ' ' E' ' 54' ' ' PHE . 1.0 OUTLIER -126.64 158.26 36.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.88 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -126.02 156.08 40.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.095 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 135' ' ' ALA . . . . . 0.532 ' O ' HG22 ' E' ' 52' ' ' VAL . . . -148.23 105.08 3.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 111.613 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.04 163.47 12.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.415 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 137' ' ' TYR . . . . . 0.57 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 0.3 OUTLIER -81.79 119.75 24.28 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.064 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 138' ' ' PHE . . . . . 0.461 ' HB3' HG11 ' E' ' 85' ' ' VAL . 2.1 t80 -108.86 142.63 39.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.067 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 139' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' E' ' 47' ' ' ALA . . . -132.9 136.05 45.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.849 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 140' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 25.5 p -96.63 -56.16 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.534 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 141' ' ' GLY . . . . . 0.495 ' H ' ' HB3' ' E' ' 98' ' ' ASN . . . -127.14 -129.88 3.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.976 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.97 107.13 12.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.631 0.215 . . . . 0.0 110.782 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 143' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' E' ' 97' ' ' THR . . . -65.88 148.08 52.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.68 0.276 . . . . 0.0 111.447 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 144' ' ' THR . . . . . 0.623 ' HB ' ' H ' ' E' ' 97' ' ' THR . 48.0 m -114.85 144.74 32.55 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.275 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.0 131.0 6.76 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.499 2.133 . . . . 0.0 111.978 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 146' ' ' GLY . . . . . 0.603 ' O ' ' HG3' ' D' ' 15' ' ' GLU . . . 164.85 -116.25 0.69 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.435 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 147' ' ' ALA . . . . . 0.64 ' HA ' ' HG3' ' D' ' 15' ' ' GLU . . . -110.65 150.38 29.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.862 0.363 . . . . 0.0 111.304 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.63 45.92 1.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.449 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 149' ' ' ASN . . . . . 0.516 ' ND2' ' HB1' ' E' ' 147' ' ' ALA . 0.1 OUTLIER -96.97 141.0 30.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.54 -179.431 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 150' ' ' ALA . . . . . 0.404 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -153.67 162.59 41.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.006 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.95 135.43 43.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.271 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 152' ' ' ALA . . . . . 0.75 ' HB2' HD11 ' E' ' 86' ' ' LEU . . . -134.17 152.54 51.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.228 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 153' ' ' THR . . . . . 0.535 HG23 HG23 ' D' ' 9' ' ' THR . 4.0 m -104.19 148.92 25.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.21 141.88 35.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.088 0.47 . . . . 0.0 110.11 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.59 152.39 40.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.863 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 156' ' ' VAL . . . . . 0.657 HG23 HG23 ' D' ' 5' ' ' VAL . 20.2 m -135.75 133.17 51.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.789 0.328 . . . . 0.0 111.674 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 157' ' ' GLN . . . . . 0.74 ' HG3' HG23 ' D' ' 4' ' ' THR . 1.8 tt0 -130.92 119.82 22.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.318 0.58 . . . . 0.0 110.383 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -101.99 113.31 26.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.491 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 159' ' ' GLN . . . . . 0.624 ' HA ' ' H ' ' D' ' 2' ' ' ALA . 3.6 mp0 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.849 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.266 0.079 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.05 55.85 4.24 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.69 0.281 . . . . 0.0 111.075 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 89.7 m -118.7 111.11 18.09 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.445 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.79 127.26 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.588 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.48 171.5 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.551 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.42 122.08 36.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.62 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.95 -52.27 6.46 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.834 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.46 -145.52 5.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.888 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.72 139.8 25.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 0.0 111.296 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.37 121.6 64.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.149 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.72 106.56 18.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.392 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -90.52 107.69 19.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.842 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.28 149.15 25.0 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.457 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.47 -179.05 47.54 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.947 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.88 157.02 30.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.929 0.395 . . . . 0.0 110.368 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 16' ' ' VAL . . . . . 0.457 ' O ' HG11 ' E' ' 5' ' ' VAL . 18.0 t -113.73 132.19 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.225 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 17' ' ' VAL . . . . . 0.602 HG12 HG21 ' E' ' 5' ' ' VAL . 5.5 m -136.88 176.58 7.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.883 0.373 . . . . 0.0 110.991 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 18' ' ' ASN . . . . . 0.524 ' HB2' HG21 ' E' ' 3' ' ' THR . 1.2 t30 -74.45 174.13 9.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.036 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 19' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' F' ' 62' ' ' ASP . . . -83.43 35.37 0.5 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.036 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 20' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' F' ' 61' ' ' CYS . . . -116.95 -15.9 10.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.422 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.98 155.29 0.6 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.961 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.76 126.38 5.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.078 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 23' ' ' VAL . . . . . 0.741 ' HA ' ' HG ' ' F' ' 58' ' ' LEU . 0.7 OUTLIER -60.77 162.46 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.087 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 24' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' F' ' 27' ' ' SER . 18.6 t70 -97.61 161.02 13.97 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.615 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 25' ' ' ALA . . . . . 0.687 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -64.1 -40.39 96.1 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.348 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.37 12.74 69.09 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.927 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 27' ' ' SER . . . . . 0.558 ' HB3' ' HB3' ' F' ' 24' ' ' ASP . 0.6 OUTLIER -113.88 -25.46 8.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.825 0.345 . . . . 0.0 110.813 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 9.6 t -41.16 -61.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.37 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.59 119.9 39.49 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.061 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -126.02 119.07 26.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.057 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.7 103.3 15.46 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.118 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.89 115.13 43.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.147 0.499 . . . . 0.0 110.463 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.51 112.62 24.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.7 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.86 -30.37 58.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.646 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.03 -170.22 27.41 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.625 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 36' ' ' GLN . . . . . 0.662 ' HG3' ' HB3' ' E' ' 15' ' ' GLU . 0.1 OUTLIER -93.54 141.74 28.12 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.628 0.251 . . . . 0.0 110.909 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.544 HG11 HD22 ' F' ' 42' ' ' LEU . 5.7 p -125.29 157.1 34.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.97 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.49 122.44 28.99 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.732 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 39' ' ' THR . . . . . 0.436 HG22 ' H ' ' F' ' 39' ' ' THR . 0.0 OUTLIER -59.56 -40.36 87.06 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.784 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.81 68.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.053 0.454 . . . . 0.0 110.866 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.14 -21.5 33.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.125 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 42' ' ' LEU . . . . . 0.544 HD22 HG11 ' F' ' 37' ' ' VAL . 3.2 mp -110.52 29.47 7.68 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.59 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 43' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' F' ' 141' ' ' GLY . . . -108.24 25.52 11.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.322 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.74 159.96 23.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.386 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 45' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' F' ' 140' ' ' THR . 11.0 tt0 -82.86 108.69 16.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 0.0 111.155 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.9 10.86 51.59 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.157 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 47' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' F' ' 139' ' ' ALA . . . -66.67 123.42 20.03 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 77.5 p -120.59 140.29 51.73 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.922 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 49' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 4.6 m -101.63 -167.0 1.36 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.602 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 50' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 8.1 t -69.77 139.73 53.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.859 0.361 . . . . 0.0 110.751 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.78 134.03 35.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.362 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 52' ' ' VAL . . . . . 0.541 HG22 ' O ' ' F' ' 135' ' ' ALA . 18.7 m -87.06 166.5 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.972 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.78 128.92 8.01 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.585 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 54' ' ' PHE . . . . . 0.564 ' H ' HG21 ' C' ' 76' ' ' THR . 40.8 p90 -160.28 134.42 7.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.775 0.322 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 55' ' ' ASN . . . . . 0.512 ' OD1' HG21 ' F' ' 130' ' ' THR . 15.8 p30 -132.73 147.69 52.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.621 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 56' ' ' ILE . . . . . 0.631 HG22 ' HB ' ' F' ' 131' ' ' ILE . 1.0 OUTLIER -96.8 116.79 39.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.539 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 57' ' ' GLN . . . . . 0.565 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.0 OUTLIER -66.61 122.12 16.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.703 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 58' ' ' LEU . . . . . 0.741 ' HG ' ' HA ' ' F' ' 23' ' ' VAL . 0.2 OUTLIER -137.51 88.12 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 -179.567 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 59' ' ' ASN . . . . . 0.713 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 10.6 p30 -79.49 179.32 7.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.935 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.29 64.46 0.96 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.818 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 61' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' F' ' 129' ' ' ASN . 4.4 m -110.55 163.25 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.821 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 62' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' F' ' 19' ' ' ALA . 0.5 OUTLIER -140.19 155.01 47.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.235 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.23 -25.44 10.61 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.89 -16.42 50.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.126 0.489 . . . . 0.0 111.734 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 65' ' ' VAL . . . . . 0.403 HG23 ' OD2' ' F' ' 62' ' ' ASP . 16.8 t -90.68 -48.46 14.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.627 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.13 142.97 35.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.569 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.85 -53.81 2.6 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.882 0.372 . . . . 0.0 110.978 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 68' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' F' ' 121' ' ' GLU . 0.1 OUTLIER -94.85 158.09 15.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.492 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 69' ' ' ALA . . . . . 0.918 ' HB2' HD13 ' F' ' 124' ' ' LEU . . . -137.17 120.47 16.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.592 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 70' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -97.57 129.07 44.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.153 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 71' ' ' VAL . . . . . 0.605 HG11 HG21 ' F' ' 131' ' ' ILE . 15.9 t -112.92 152.24 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.708 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.02 146.62 27.1 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.56 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 73' ' ' PHE . . . . . 0.474 ' CD2' HG21 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -111.5 141.88 44.5 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.557 0.218 . . . . 0.0 111.078 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 74' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.8 OUTLIER -105.7 103.32 12.8 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.934 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.87 -179.08 25.4 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.83 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.2 157.83 17.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.501 0.191 . . . . 0.0 110.766 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.91 132.77 38.06 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.929 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 78' ' ' ILE . . . . . 0.445 ' CG2' ' HB ' ' F' ' 85' ' ' VAL . 0.6 OUTLIER -66.6 -39.83 84.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 79' ' ' ASP . . . . . 0.418 ' N ' HG23 ' F' ' 78' ' ' ILE . 0.7 OUTLIER -146.15 53.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.845 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.38 -87.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.048 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.34 -36.52 53.24 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.603 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -81.3 59.87 4.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.357 . . . . 0.0 110.484 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 83' ' ' THR . . . . . 0.594 HG21 ' OD1' ' F' ' 114' ' ' ASP . 2.1 m -70.58 -20.38 62.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.537 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 84' ' ' ASN . . . . . 0.897 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 26.5 p-10 -69.47 -13.67 62.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.284 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 85' ' ' VAL . . . . . 0.695 HG22 ' HB2' ' F' ' 102' ' ' GLN . 40.8 t -109.01 131.16 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.152 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 86' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' F' ' 152' ' ' ALA . 0.6 OUTLIER -70.09 142.85 52.58 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.03 -170.51 3.06 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.873 0.368 . . . . 0.0 111.666 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -79.98 161.39 25.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.963 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.75 -80.24 0.01 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.386 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 6.4 p -171.39 0.44 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.943 0.402 . . . . 0.0 111.391 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 91' ' ' SER . . . . . 0.608 ' HB2' ' HB2' ' F' ' 95' ' ' SER . 73.6 m -76.81 85.58 3.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.839 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.28 71.78 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.888 0.375 . . . . 0.0 111.67 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.89 30.49 6.85 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.61 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.76 -3.13 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.934 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 95' ' ' SER . . . . . 0.608 ' HB2' ' HB2' ' F' ' 91' ' ' SER . 0.1 OUTLIER -107.51 -176.67 3.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.366 . . . . 0.0 110.679 179.482 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.6 172.66 8.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.81 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 97' ' ' THR . . . . . 0.608 ' H ' ' HB ' ' F' ' 144' ' ' THR . 1.6 m -126.95 140.37 52.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.331 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 98' ' ' ASN . . . . . 0.502 ' HB3' ' H ' ' F' ' 141' ' ' GLY . 27.3 m120 62.0 21.31 12.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.454 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 99' ' ' VAL . . . . . 0.555 HG23 ' O ' ' F' ' 97' ' ' THR . 2.7 t -120.38 135.97 58.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.714 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.94 -160.67 10.14 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.552 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -145.93 109.86 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.171 0.51 . . . . 0.0 111.729 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 102' ' ' GLN . . . . . 0.695 ' HB2' HG22 ' F' ' 85' ' ' VAL . 0.5 OUTLIER -84.29 147.35 27.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.885 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 103' ' ' ILE . . . . . 0.599 HG12 ' HG ' ' F' ' 113' ' ' LEU . 1.2 pp -110.74 127.87 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.489 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 104' ' ' LEU . . . . . 0.977 HD12 ' HB2' ' F' ' 110' ' ' ALA . 1.4 tp -97.46 133.0 42.63 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.711 0.291 . . . . 0.0 111.017 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 105' ' ' ASP . . . . . 0.651 ' HB3' HG22 ' F' ' 107' ' ' THR . 4.0 t0 -80.81 143.57 32.73 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.706 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 106' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' C' ' 80' ' ' ALA . 0.0 OUTLIER -65.48 -17.48 64.59 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.802 0.334 . . . . 0.0 111.023 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 107' ' ' THR . . . . . 0.651 HG22 ' HB3' ' F' ' 105' ' ' ASP . 13.2 t -66.79 -20.73 66.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.973 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.07 -71.81 0.44 Allowed Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.669 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.39 160.01 31.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.826 0.346 . . . . 0.0 111.098 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 110' ' ' ALA . . . . . 0.977 ' HB2' HD12 ' F' ' 104' ' ' LEU . . . -75.59 131.38 39.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 111' ' ' LEU . . . . . 0.689 HD21 ' O ' ' F' ' 117' ' ' THR . 12.2 tp -88.06 154.17 20.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.359 0.6 . . . . 0.0 110.572 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 112' ' ' THR . . . . . 0.897 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 0.4 OUTLIER -96.41 142.69 28.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.062 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 113' ' ' LEU . . . . . 0.599 ' HG ' HG12 ' F' ' 103' ' ' ILE . 0.8 OUTLIER -80.76 63.61 5.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.723 0.297 . . . . 0.0 110.77 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 114' ' ' ASP . . . . . 0.594 ' OD1' HG21 ' F' ' 83' ' ' THR . 0.1 OUTLIER -90.58 -30.6 17.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.611 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.73 -43.59 1.64 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.686 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.61 24.43 12.97 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.988 0.423 . . . . 0.0 111.608 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 117' ' ' THR . . . . . 0.689 ' O ' HD21 ' F' ' 111' ' ' LEU . 0.2 OUTLIER -82.12 68.25 8.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.16 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 118' ' ' PHE . . . . . 0.554 ' CD1' ' HB2' ' F' ' 157' ' ' GLN . 40.9 m-85 -82.07 71.93 9.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.759 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.74 81.02 1.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.66 131.74 13.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.557 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 121' ' ' GLU . . . . . 0.435 ' O ' ' HE2' ' F' ' 68' ' ' LYS . 1.5 mm-40 -100.7 52.1 0.87 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.197 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 122' ' ' THR . . . . . 0.661 ' HB ' ' HB3' ' F' ' 69' ' ' ALA . 0.2 OUTLIER -72.14 131.98 43.54 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.78 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.63 107.54 15.35 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.771 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 124' ' ' LEU . . . . . 0.918 HD13 ' HB2' ' F' ' 69' ' ' ALA . 1.0 OUTLIER -88.23 126.58 35.23 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.59 179.455 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 125' ' ' ASN . . . . . 0.507 ' O ' ' HB3' ' F' ' 61' ' ' CYS . 1.1 m120 -120.65 -178.99 3.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.542 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 126' ' ' ASN . . . . . 0.512 ' OD1' ' HA ' ' F' ' 62' ' ' ASP . 3.8 t30 -83.25 120.68 26.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.695 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 127' ' ' GLY . . . . . 0.74 ' HA2' HG21 ' B' ' 4' ' ' THR . . . 136.12 -121.77 2.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.657 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 128' ' ' THR . . . . . 0.713 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 76.3 m -122.12 103.44 8.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.727 0.299 . . . . 0.0 110.807 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 129' ' ' ASN . . . . . 0.528 ' HB2' ' SG ' ' F' ' 61' ' ' CYS . 1.8 t30 -86.18 157.26 20.03 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.857 0.36 . . . . 0.0 111.086 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 130' ' ' THR . . . . . 0.565 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.3 OUTLIER -143.34 130.14 20.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.162 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 131' ' ' ILE . . . . . 0.631 ' HB ' HG22 ' F' ' 56' ' ' ILE . 57.3 mt -83.97 104.14 3.79 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 132' ' ' PRO . . . . . 0.685 ' HB3' ' HA ' ' C' ' 76' ' ' THR . 7.5 Cg_endo -82.08 112.45 2.3 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.535 1.49 . . . . 0.0 112.548 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 133' ' ' PHE . . . . . 0.429 ' HB3' ' CZ ' ' F' ' 54' ' ' PHE . 1.0 OUTLIER -126.69 158.27 36.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.856 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -125.97 156.01 40.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.119 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 135' ' ' ALA . . . . . 0.541 ' O ' HG22 ' F' ' 52' ' ' VAL . . . -148.14 105.15 3.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 111.609 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.11 163.46 12.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.375 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 137' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 0.3 OUTLIER -81.72 119.69 24.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.131 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 138' ' ' PHE . . . . . 0.467 ' HB3' HG11 ' F' ' 85' ' ' VAL . 2.1 t80 -108.82 142.69 39.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.275 0.56 . . . . 0.0 112.058 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 139' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' F' ' 47' ' ' ALA . . . -132.94 136.05 45.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.831 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 140' ' ' THR . . . . . 0.648 ' O ' ' HA ' ' F' ' 45' ' ' GLU . 24.9 p -96.65 -56.26 2.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.423 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 141' ' ' GLY . . . . . 0.502 ' H ' ' HB3' ' F' ' 98' ' ' ASN . . . -127.04 -129.91 3.31 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.973 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.94 107.15 12.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.521 0.201 . . . . 0.0 110.741 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 143' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' F' ' 97' ' ' THR . . . -65.89 148.07 52.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.686 0.279 . . . . 0.0 111.44 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 144' ' ' THR . . . . . 0.608 ' HB ' ' H ' ' F' ' 97' ' ' THR . 48.0 m -114.88 144.72 32.52 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.262 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 145' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' F' ' 144' ' ' THR . 1.4 Cg_endo -81.96 130.96 6.78 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.549 2.166 . . . . 0.0 111.953 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 146' ' ' GLY . . . . . 0.624 ' O ' ' HG3' ' E' ' 15' ' ' GLU . . . 164.82 -116.27 0.69 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.452 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 147' ' ' ALA . . . . . 0.634 ' HA ' ' HG3' ' E' ' 15' ' ' GLU . . . -110.65 150.4 29.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.866 0.365 . . . . 0.0 111.28 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.65 45.82 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.128 0.49 . . . . 0.0 110.513 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 149' ' ' ASN . . . . . 0.513 HD22 ' HB1' ' F' ' 147' ' ' ALA . 0.1 OUTLIER -96.85 141.02 30.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.535 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 150' ' ' ALA . . . . . 0.408 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -153.71 162.53 41.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.958 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.85 135.46 43.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.225 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 152' ' ' ALA . . . . . 0.78 ' HB2' HD11 ' F' ' 86' ' ' LEU . . . -134.16 152.51 51.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.17 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 153' ' ' THR . . . . . 0.531 HG23 HG23 ' E' ' 9' ' ' THR . 4.0 m -104.16 148.95 25.7 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.29 141.87 35.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.047 0.451 . . . . 0.0 110.155 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -122.57 152.41 40.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.89 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 156' ' ' VAL . . . . . 0.638 HG23 HG23 ' E' ' 5' ' ' VAL . 20.1 m -135.72 133.13 51.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.79 0.329 . . . . 0.0 111.683 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 157' ' ' GLN . . . . . 0.726 ' HG3' HG23 ' E' ' 4' ' ' THR . 1.8 tt0 -130.95 119.86 22.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.339 0.59 . . . . 0.0 110.342 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -102.0 113.28 26.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.523 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 159' ' ' GLN . . . . . 0.622 ' HA ' ' H ' ' E' ' 2' ' ' ALA . 3.6 mp0 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.569 0.223 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.38 87.58 6.08 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.475 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.619 ' HB ' ' HA3' ' E' ' 127' ' ' GLY . 3.5 m -90.46 115.43 27.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.602 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 m -127.21 166.97 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.604 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.633 ' HA ' ' HE2' ' B' ' 155' ' ' LYS . 19.9 t30 -83.06 115.15 21.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.517 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.33 -71.5 1.06 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.884 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.24 172.78 34.74 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.907 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 m -95.47 136.96 35.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.409 . . . . 0.0 111.305 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -120.84 130.68 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.218 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.53 ' O ' ' HB ' ' B' ' 32' ' ' VAL . 1.3 m80 -103.78 158.0 16.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.459 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 0.6 OUTLIER -145.81 89.57 1.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.633 ' HD3' HG22 ' B' ' 31' ' ' THR . 0.0 OUTLIER -79.97 135.19 36.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.41 179.706 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.57 178.39 42.07 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.958 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.634 ' HG2' ' HA ' ' B' ' 147' ' ' ALA . 2.6 mt-10 -156.8 -177.93 6.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.368 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.52 HG22 HG23 ' B' ' 37' ' ' VAL . 2.7 t -142.24 150.13 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.233 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.591 HG11 ' HE2' ' A' ' 158' ' ' TYR . 4.1 m -141.7 168.61 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.333 . . . . 0.0 111.066 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.02 74.73 4.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.058 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.88 91.86 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.027 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.46 -50.98 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.433 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER 179.82 -179.68 0.47 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.965 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.616 ' HA ' ' HB3' ' B' ' 36' ' ' GLN . . . -136.2 116.43 13.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.085 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.422 ' H ' ' CB ' ' B' ' 36' ' ' GLN . 69.2 t -67.08 120.15 13.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.026 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.441 ' O ' HG23 ' A' ' 28' ' ' VAL . 2.4 m-20 -64.39 150.49 46.25 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.585 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' B' ' 33' ' ' GLN . . . -48.37 -50.22 31.54 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.326 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.27 -31.8 81.71 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.895 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.04 -16.02 63.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.929 0.395 . . . . 0.0 110.847 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 24' ' ' ASP . 48.5 t -72.96 -43.59 58.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.41 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.39 106.04 10.32 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -116.65 134.03 55.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.074 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.49 96.04 6.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.058 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.445 HG11 HG21 ' A' ' 52' ' ' VAL . 69.3 t -89.46 131.25 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.131 0.491 . . . . 0.0 110.488 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.95 106.41 16.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.618 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.482 HD12 ' CE2' ' A' ' 137' ' ' TYR . 0.4 OUTLIER -73.8 -40.87 63.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.649 179.372 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.95 -122.46 6.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.595 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -144.52 153.95 42.38 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.699 0.285 . . . . 0.0 110.862 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.57 146.35 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.86 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.23 145.97 26.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.717 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.7 p -57.8 -23.02 50.47 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.719 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.93 -33.21 61.94 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.096 0.474 . . . . 0.0 110.844 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -31.15 69.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.124 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.621 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -130.76 86.42 2.37 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.649 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.7 36.2 4.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.37 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.64 150.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.337 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 1.7 tm-20 -64.78 134.83 54.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 111.136 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.79 -14.16 53.14 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.137 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 138' ' ' PHE . . . -57.2 129.86 43.64 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.938 0.399 . . . . 0.0 112.002 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.462 ' HB ' ' CE1' ' A' ' 138' ' ' PHE . 14.3 t -130.59 143.31 50.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.909 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.604 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 68.4 m -111.97 -157.16 0.61 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.552 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.9 t -74.62 150.15 39.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.784 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -103.2 146.64 28.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.322 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.445 HG21 HG11 ' A' ' 32' ' ' VAL . 22.4 m -83.38 148.34 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.4 121.21 6.21 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.6 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.41 ' CD1' HG23 ' A' ' 52' ' ' VAL . 16.2 p90 -153.83 125.56 7.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 0.0 110.928 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -109.28 156.17 20.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.609 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.6 mm -104.08 135.37 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.486 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.64 125.99 48.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.765 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 129' ' ' ASN . 4.3 mp -131.7 100.0 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.273 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.49 174.81 11.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.946 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.8 65.19 1.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.792 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 60.7 m -98.66 142.94 29.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.59 109.25 15.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.269 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.464 HG23 ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -92.44 29.54 1.69 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -90.03 -59.1 2.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.029 0.443 . . . . 0.0 111.819 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.28 -39.8 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.706 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.69 101.39 10.7 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.593 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.6 p -90.54 -28.82 18.25 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.902 0.382 . . . . 0.0 110.95 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.448 ' HZ1' ' HB2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -126.4 166.99 16.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.513 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.9 149.77 29.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.572 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 157' ' ' GLN . . . -112.85 159.79 18.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.092 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.2 t -108.04 123.25 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.689 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 155' ' ' LYS . . . -124.64 168.95 12.44 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.596 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.531 ' CB ' HD11 ' A' ' 111' ' ' LEU . 17.1 t80 -150.59 144.39 25.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.535 0.207 . . . . 0.0 111.168 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.652 HD12 ' OG1' ' D' ' 130' ' ' THR . 0.4 OUTLIER -121.56 88.64 2.97 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.989 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.514 ' C ' HD23 ' A' ' 113' ' ' LEU . . . -134.69 164.72 24.65 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.773 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -78.54 147.73 33.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.544 0.211 . . . . 0.0 110.779 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.564 ' H ' ' HB3' ' D' ' 132' ' ' PRO . . . -95.7 140.34 30.65 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.959 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.548 ' CG2' ' HB ' ' A' ' 85' ' ' VAL . 1.1 tt -78.71 -33.05 16.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.851 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.22 179.22 7.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.838 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.68 -27.87 36.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.059 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.25 -32.22 72.21 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.552 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.427 ' HB3' HG23 ' A' ' 85' ' ' VAL . 15.4 m-70 -97.33 -72.69 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 0.0 110.464 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.85 -7.24 1.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.586 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.754 ' HA ' HD13 ' A' ' 113' ' ' LEU . 3.0 m120 -108.7 -19.13 13.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.364 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . 50.2 t -80.65 132.03 32.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.124 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -76.52 134.95 39.31 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.355 179.381 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.28 165.18 6.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.828 0.347 . . . . 0.0 111.682 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.729 HD12 ' O ' ' D' ' 51' ' ' ALA . 0.1 OUTLIER -65.75 171.65 4.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.029 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.495 ' OE1' ' HB3' ' A' ' 91' ' ' SER . 8.0 pt20 -72.45 175.75 5.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.349 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.474 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 0.5 OUTLIER -76.06 -21.26 56.97 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.997 0.427 . . . . 0.0 111.492 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.495 ' HB3' ' OE1' ' A' ' 89' ' ' GLN . 32.0 t -80.92 67.56 6.87 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.45 ' HA ' ' OG ' ' A' ' 95' ' ' SER . . . -72.27 -9.74 58.87 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.901 0.381 . . . . 0.0 111.668 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.892 ' HB1' ' HB1' ' C' ' 22' ' ' ALA . . . -68.08 -22.91 64.9 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.632 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.39 6.76 2.5 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.932 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.699 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 30.7 p -93.73 150.75 20.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.637 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.69 167.21 18.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.834 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.65 165.15 14.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.366 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.527 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 85.0 m-20 63.29 45.43 5.0 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.494 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.461 ' HB ' ' CB ' ' A' ' 143' ' ' ALA . 3.5 p -170.63 131.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.787 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.08 -175.96 21.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.556 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.3 t -104.14 91.84 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 122.971 0.509 . . . . 0.0 111.745 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER -67.86 131.21 45.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 84' ' ' ASN . 0.7 OUTLIER -99.44 110.52 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.498 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 5.5 tp -91.23 149.94 21.55 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.709 0.29 . . . . 0.0 111.027 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.95 174.68 5.79 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.631 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 106' ' ' ARG . 1.5 ttt180 -72.49 -18.63 61.65 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.719 0.295 . . . . 0.0 110.989 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.0 p -69.25 -9.6 53.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.033 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.97 -48.44 0.95 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.625 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.94 163.54 15.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 0.0 111.062 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -70.39 125.51 27.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.174 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.531 HD11 ' CB ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -65.36 147.61 53.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.367 0.603 . . . . 0.0 110.564 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.679 ' HB ' HG21 ' A' ' 117' ' ' THR . 0.2 OUTLIER -74.03 144.58 45.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.131 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.754 HD13 ' HA ' ' A' ' 84' ' ' ASN . 10.2 mp -100.28 89.94 4.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.769 0.319 . . . . 0.0 110.663 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.432 ' HB2' ' CG2' ' A' ' 117' ' ' THR . 4.1 m-20 -142.42 11.37 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.657 0.265 . . . . 0.0 111.555 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.439 ' O ' ' HB1' ' A' ' 72' ' ' ALA . . . 96.91 -78.09 0.69 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.669 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' D' ' 125' ' ' ASN . . . -104.27 61.54 0.73 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.973 0.416 . . . . 0.0 111.662 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.679 HG21 ' HB ' ' A' ' 112' ' ' THR . 17.6 p -93.35 95.84 9.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.131 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.79 110.0 5.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.9 m -120.35 -72.92 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.773 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.4 113.03 25.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.602 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.448 ' HB2' ' HZ1' ' A' ' 68' ' ' LYS . 25.2 mt-10 -99.47 97.53 8.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.207 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.5 132.71 37.52 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.775 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -60.89 146.12 47.75 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.727 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.464 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.2 OUTLIER -85.48 156.56 20.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.562 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.78 142.75 40.88 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.54 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.94 113.63 6.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.74 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.59 -90.08 0.32 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.744 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.0 m -124.88 152.77 43.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.745 0.307 . . . . 0.0 110.798 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 17.1 t-20 -123.0 147.52 46.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.19 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.3 m -126.12 135.7 52.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.098 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.4 mt -114.03 115.65 45.47 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.4 ' HB2' ' HB2' ' A' ' 106' ' ' ARG . 7.5 Cg_endo -81.7 115.71 2.81 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.629 1.553 . . . . 0.0 112.567 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.58 150.81 46.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.825 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 4.5 mt-30 -142.48 166.67 24.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.029 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 102' ' ' GLN . . . -158.13 102.94 1.81 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 111.654 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -94.68 -173.4 3.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.396 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.604 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 3.8 m-85 -100.78 152.87 19.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.068 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.545 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -147.37 160.73 42.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.998 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -126.86 149.61 49.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.925 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -115.34 27.83 9.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.461 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.4 66.75 0.2 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.955 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.99 88.59 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.602 0.239 . . . . 0.0 110.744 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.461 ' CB ' ' HB ' ' A' ' 99' ' ' VAL . . . -60.19 156.88 14.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.709 0.29 . . . . 0.0 111.452 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.545 ' HB ' ' CD ' ' A' ' 145' ' ' PRO . 77.3 p -112.26 173.02 3.08 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.218 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.545 ' CD ' ' HB ' ' A' ' 144' ' ' THR . 1.3 Cg_endo -84.51 145.16 10.45 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.518 2.145 . . . . 0.0 111.995 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.44 -112.7 0.55 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.512 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -124.93 167.67 14.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.892 0.377 . . . . 0.0 111.275 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -157.19 57.54 0.52 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.411 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.85 132.73 36.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.539 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.47 163.13 28.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.937 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.45 125.58 1.83 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.231 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.794 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -154.57 165.79 35.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.244 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.9 163.18 12.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -119.01 134.6 55.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.102 0.477 . . . . 0.0 110.102 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -95.64 166.24 11.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.913 -178.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.24 112.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.793 0.33 . . . . 0.0 111.657 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.613 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -88.77 138.81 31.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.278 0.561 . . . . 0.0 110.403 -179.686 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.591 ' HE2' HG11 ' A' ' 17' ' ' VAL . 22.5 m-85 -127.65 113.16 15.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.568 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.976 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.241 0.067 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.94 68.26 0.88 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.645 0.26 . . . . 0.0 111.06 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.33 87.63 6.12 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.454 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.612 ' HB ' ' HA3' ' F' ' 127' ' ' GLY . 3.5 m -90.35 115.47 27.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.571 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -127.34 167.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.588 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ASN . . . . . 0.653 ' HA ' ' HE2' ' C' ' 155' ' ' LYS . 20.2 t30 -82.95 115.11 21.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.577 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.39 -71.48 1.06 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.827 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.31 172.78 34.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.909 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 33.3 m -95.52 137.01 35.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.941 0.4 . . . . 0.0 111.253 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 40.4 t -120.8 130.76 74.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.173 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' HIS . . . . . 0.54 ' O ' ' HB ' ' C' ' 32' ' ' VAL . 1.3 m80 -103.92 157.97 16.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.41 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' C' ' 32' ' ' VAL . 0.5 OUTLIER -145.82 89.67 1.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.823 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 13' ' ' LYS . . . . . 0.627 ' HD3' HG22 ' C' ' 31' ' ' THR . 0.0 OUTLIER -80.04 135.21 36.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.431 179.722 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.57 178.38 42.08 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.953 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.641 ' HG2' ' HA ' ' C' ' 147' ' ' ALA . 2.6 mt-10 -156.78 -177.86 6.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.385 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.512 HG22 HG23 ' C' ' 37' ' ' VAL . 2.7 t -142.35 150.1 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.235 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.572 HG11 ' HE2' ' B' ' 158' ' ' TYR . 4.1 m -141.73 168.57 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.856 0.36 . . . . 0.0 110.996 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -92.93 74.78 4.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.039 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.78 91.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.045 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.42 -51.07 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.421 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER 179.83 -179.8 0.48 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.996 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.603 ' HA ' ' HB3' ' C' ' 36' ' ' GLN . . . -136.14 116.5 13.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.138 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.423 ' H ' ' CB ' ' C' ' 36' ' ' GLN . 69.1 t -67.07 120.15 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.003 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.441 ' O ' HG23 ' B' ' 28' ' ' VAL . 2.4 m-20 -64.36 150.45 46.26 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.605 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.423 ' HB1' ' HB2' ' C' ' 33' ' ' GLN . . . -48.38 -50.1 32.1 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.388 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.36 -31.79 81.55 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.841 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.07 -15.98 63.58 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.879 0.371 . . . . 0.0 110.831 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 24' ' ' ASP . 48.6 t -72.96 -43.68 58.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.375 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.36 106.11 10.4 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.005 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -116.68 134.03 55.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' THR . . . . . 0.633 HG22 ' HD3' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -105.49 96.09 6.27 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.057 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.53 ' HB ' ' O ' ' A' ' 11' ' ' HIS . 69.3 t -89.53 131.27 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.15 0.5 . . . . 0.0 110.456 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.451 ' HA ' ' HG2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -108.97 106.48 16.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.637 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.493 HD12 ' CE2' ' B' ' 137' ' ' TYR . 0.4 OUTLIER -73.79 -40.89 63.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.66 179.371 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.89 -122.41 6.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.601 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.616 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 3.7 tt0 -144.6 153.85 42.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.586 0.231 . . . . 0.0 110.939 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.52 HG23 HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -128.5 146.32 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.909 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.529 ' HE ' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -98.25 146.0 26.07 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.7 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 17' ' ' VAL . 40.9 p -57.78 -22.99 50.12 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.713 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.01 -33.22 61.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.013 0.435 . . . . 0.0 110.809 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -31.1 69.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.174 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.617 ' HB3' ' HB2' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -130.83 86.34 2.36 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.604 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.64 36.19 4.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.357 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 177.56 150.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.392 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' B' ' 140' ' ' THR . 1.7 tm-20 -64.79 134.81 54.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.884 0.373 . . . . 0.0 111.103 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.79 -14.19 53.12 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.218 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' B' ' 138' ' ' PHE . . . -57.19 129.8 43.36 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' THR . . . . . 0.455 ' HB ' ' CE1' ' B' ' 138' ' ' PHE . 14.3 t -130.55 143.34 50.69 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.864 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' SER . . . . . 0.594 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 68.6 m -111.95 -157.2 0.61 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.579 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.416 ' H ' ' HB3' ' B' ' 49' ' ' SER . 27.5 t -74.46 150.13 40.05 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.863 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' B' ' 136' ' ' ARG . . . -103.28 146.61 28.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.328 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' B' ' 134' ' ' GLN . 22.0 m -83.31 148.31 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.981 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.35 121.21 6.22 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.638 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' PHE . . . . . 0.404 ' CD1' HG23 ' B' ' 52' ' ' VAL . 15.9 p90 -153.81 125.52 7.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.737 0.303 . . . . 0.0 110.955 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -109.23 156.22 20.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.626 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 22.5 mm -104.04 135.35 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.51 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.75 126.05 48.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.771 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.547 ' HB2' ' HB3' ' B' ' 129' ' ' ASN . 4.3 mp -131.62 99.91 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.275 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.43 174.79 11.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.71 65.24 1.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.809 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' B' ' 21' ' ' CYS . 60.6 m -98.64 142.86 29.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.822 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.58 109.22 15.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.329 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.473 HG23 ' HB3' ' B' ' 124' ' ' LEU . 0.2 OUTLIER -92.37 29.53 1.67 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.143 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -90.0 -59.16 2.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.039 0.447 . . . . 0.0 111.726 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.29 -39.82 13.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.71 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.58 101.3 10.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.614 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.1 p -90.58 -28.74 18.27 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.872 0.367 . . . . 0.0 110.971 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.49 166.94 16.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.523 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.82 149.8 29.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.646 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' B' ' 157' ' ' GLN . . . -112.88 159.77 18.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.097 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 51.1 t -108.06 123.25 63.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.693 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.685 ' HB3' ' HB3' ' B' ' 155' ' ' LYS . . . -124.6 168.96 12.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.563 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.534 ' CB ' HD11 ' B' ' 111' ' ' LEU . 17.2 t80 -150.59 144.37 25.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.533 0.206 . . . . 0.0 111.205 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.632 HD12 ' OG1' ' E' ' 130' ' ' THR . 0.4 OUTLIER -121.42 88.57 2.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.033 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 75' ' ' GLY . . . . . 0.514 ' C ' HD23 ' B' ' 113' ' ' LEU . . . -134.75 164.7 24.67 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.813 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.659 ' O ' ' HA ' ' B' ' 86' ' ' LEU . 0.6 OUTLIER -78.51 147.76 33.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.531 0.205 . . . . 0.0 110.775 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.564 ' H ' ' HB3' ' E' ' 132' ' ' PRO . . . -95.79 140.32 30.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.887 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.555 ' CG2' ' HB ' ' B' ' 85' ' ' VAL . 1.2 tt -78.7 -33.09 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.873 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.16 179.21 7.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.848 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.66 -27.84 37.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.26 -32.21 72.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.603 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.417 ' HB3' HG23 ' B' ' 85' ' ' VAL . 15.4 m-70 -97.38 -72.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 0.0 110.475 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.77 -7.13 1.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.599 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ASN . . . . . 0.764 ' HA ' HD13 ' B' ' 113' ' ' LEU . 3.1 m120 -108.8 -19.1 13.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.329 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' B' ' 102' ' ' GLN . 49.8 t -80.53 132.06 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.183 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.79 HD21 ' HB2' ' B' ' 152' ' ' ALA . 0.4 OUTLIER -76.61 134.91 39.2 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.283 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.21 165.16 6.09 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.939 0.399 . . . . 0.0 111.678 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' LEU . . . . . 0.723 HD12 ' O ' ' E' ' 51' ' ' ALA . 0.1 OUTLIER -65.72 171.7 4.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 89' ' ' GLN . . . . . 0.491 ' OE1' ' HB3' ' B' ' 91' ' ' SER . 8.0 pt20 -72.54 175.76 6.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.349 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 0.5 OUTLIER -76.04 -21.24 57.02 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.984 0.421 . . . . 0.0 111.492 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 91' ' ' SER . . . . . 0.491 ' HB3' ' OE1' ' B' ' 89' ' ' GLN . 32.1 t -80.94 67.53 6.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' ALA . . . . . 0.446 ' HA ' ' OG ' ' B' ' 95' ' ' SER . . . -72.29 -9.66 58.77 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.637 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' ALA . . . . . 0.88 ' HB1' ' HB1' ' D' ' 22' ' ' ALA . . . -68.05 -22.9 64.93 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.653 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.46 6.73 2.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.917 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' SER . . . . . 0.705 ' HA ' ' HB3' ' B' ' 147' ' ' ALA . 30.5 p -93.69 150.79 20.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.851 0.358 . . . . 0.0 110.632 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.79 167.19 18.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 165.18 14.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.366 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 98' ' ' ASN . . . . . 0.512 ' HA ' ' OG1' ' B' ' 140' ' ' THR . 85.0 m-20 63.17 45.54 5.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.465 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' VAL . . . . . 0.456 ' HB ' ' CB ' ' B' ' 143' ' ' ALA . 3.5 p -170.63 131.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.76 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.11 -176.02 21.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.529 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 75.8 t -104.06 91.85 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 122.946 0.498 . . . . 0.0 111.79 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 0.6 OUTLIER -67.83 131.18 45.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.919 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.518 HD12 ' O ' ' B' ' 84' ' ' ASN . 0.7 OUTLIER -99.4 110.53 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.526 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 104' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 5.5 tp -91.22 149.99 21.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.628 0.251 . . . . 0.0 111.053 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.95 174.62 5.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.652 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' B' ' 106' ' ' ARG . 1.5 ttt180 -72.44 -18.54 61.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.796 0.331 . . . . 0.0 111.079 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 46.0 p -69.36 -9.57 54.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.005 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.02 -48.43 0.95 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.671 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.91 163.57 15.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 0.0 111.154 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -70.45 125.52 27.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.534 HD11 ' CB ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -65.35 147.59 53.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.321 0.581 . . . . 0.0 110.607 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.678 ' HB ' HG21 ' B' ' 117' ' ' THR . 0.2 OUTLIER -73.99 144.56 45.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.136 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.764 HD13 ' HA ' ' B' ' 84' ' ' ASN . 10.2 mp -100.29 89.82 4.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.762 0.315 . . . . 0.0 110.682 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ASP . . . . . 0.441 ' HB2' ' CG2' ' B' ' 117' ' ' THR . 4.1 m-20 -142.36 11.47 1.92 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.668 0.27 . . . . 0.0 111.621 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' GLY . . . . . 0.449 ' O ' ' HB1' ' B' ' 72' ' ' ALA . . . 96.92 -78.14 0.69 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.576 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 116' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' E' ' 125' ' ' ASN . . . -104.26 61.56 0.73 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.976 0.417 . . . . 0.0 111.629 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' THR . . . . . 0.678 HG21 ' HB ' ' B' ' 112' ' ' THR . 17.7 p -93.38 95.82 9.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.123 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.77 109.97 5.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.781 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.32 -72.89 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.52 113.07 25.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.583 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.43 97.54 8.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.204 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.47 132.68 37.51 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.761 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 22.2 m -60.92 146.19 47.63 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.74 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' LEU . . . . . 0.473 ' HB3' HG23 ' B' ' 63' ' ' THR . 0.2 OUTLIER -85.48 156.5 20.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.595 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.77 142.8 40.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.515 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.01 113.61 6.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.732 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.59 -90.03 0.32 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.73 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 6.1 m -124.88 152.82 43.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.677 0.275 . . . . 0.0 110.815 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ASN . . . . . 0.547 ' HB3' ' HB2' ' B' ' 58' ' ' LEU . 17.0 t-20 -123.04 147.6 46.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.963 0.411 . . . . 0.0 111.096 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.3 m -126.19 135.61 51.84 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.085 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 131' ' ' ILE . . . . . . . . . . . . . 58.6 mt -113.95 115.72 45.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' PRO . . . . . 0.401 ' HB2' ' HB2' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.74 115.68 2.79 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.67 1.58 . . . . 0.0 112.598 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.58 150.84 46.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.806 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 134' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' B' ' 52' ' ' VAL . 4.5 mt-30 -142.46 166.75 23.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.034 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' B' ' 102' ' ' GLN . . . -158.22 102.88 1.79 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 0.0 111.626 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 136' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' B' ' 51' ' ' ALA . 0.2 OUTLIER -94.67 -173.41 3.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.439 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 137' ' ' TYR . . . . . 0.594 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 3.8 m-85 -100.83 152.83 20.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.074 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 138' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' B' ' 47' ' ' ALA . 0.2 OUTLIER -147.32 160.81 42.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.002 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.617 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -126.92 149.65 49.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.876 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 140' ' ' THR . . . . . 0.512 ' OG1' ' HA ' ' B' ' 98' ' ' ASN . 0.0 OUTLIER -115.41 27.86 9.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.453 179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.46 66.86 0.2 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.879 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.94 88.62 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.568 0.223 . . . . 0.0 110.69 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 143' ' ' ALA . . . . . 0.456 ' CB ' ' HB ' ' B' ' 99' ' ' VAL . . . -60.25 156.94 14.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.764 0.316 . . . . 0.0 111.407 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.543 ' HB ' ' CD ' ' B' ' 145' ' ' PRO . 76.5 p -112.23 173.04 3.07 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.236 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 145' ' ' PRO . . . . . 0.543 ' CD ' ' HB ' ' B' ' 144' ' ' THR . 1.3 Cg_endo -84.55 145.23 10.43 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.552 2.168 . . . . 0.0 111.979 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.37 -112.73 0.55 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.521 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.705 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -125.02 167.62 14.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.826 0.346 . . . . 0.0 111.308 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 148' ' ' ALA . . . . . 0.417 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -157.16 57.52 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.459 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -91.84 132.72 36.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.582 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.4 163.13 28.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.023 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.44 125.61 1.83 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.25 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 152' ' ' ALA . . . . . 0.79 ' HB2' HD21 ' B' ' 86' ' ' LEU . . . -154.51 165.82 35.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.211 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.92 163.11 12.77 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -119.01 134.6 55.09 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.181 0.515 . . . . 0.0 110.069 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 155' ' ' LYS . . . . . 0.685 ' HB3' ' HB3' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -95.57 166.26 11.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.923 -178.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.29 112.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.81 0.338 . . . . 0.0 111.663 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.625 ' HB3' ' HB3' ' B' ' 70' ' ' ALA . 0.2 OUTLIER -88.73 138.88 31.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.286 0.565 . . . . 0.0 110.423 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 158' ' ' TYR . . . . . 0.572 ' HE2' HG11 ' B' ' 17' ' ' VAL . 22.6 m-85 -127.73 113.11 15.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.554 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.937 179.992 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.304 0.097 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.96 68.25 0.88 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.62 0.248 . . . . 0.0 110.999 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.31 87.69 6.15 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.46 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 4' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' D' ' 157' ' ' GLN . 3.5 m -90.51 115.49 27.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.55 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 m -127.3 167.01 22.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.589 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 6' ' ' ASN . . . . . 0.649 ' HA ' ' HE2' ' D' ' 155' ' ' LYS . 19.9 t30 -83.06 115.16 21.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.507 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.34 -71.53 1.06 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.828 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.28 172.75 34.76 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.931 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 33.2 m -95.5 137.0 35.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.972 0.415 . . . . 0.0 111.219 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 40.1 t -120.78 130.75 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.225 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 11' ' ' HIS . . . . . 0.539 ' O ' ' HB ' ' D' ' 32' ' ' VAL . 1.3 m80 -103.86 157.99 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.392 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 12' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' D' ' 32' ' ' VAL . 0.6 OUTLIER -145.91 89.67 1.91 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.793 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 13' ' ' LYS . . . . . 0.634 ' HD3' HG22 ' D' ' 31' ' ' THR . 0.0 OUTLIER -80.04 135.15 36.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.437 179.718 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.5 178.43 42.02 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.898 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 15' ' ' GLU . . . . . 0.64 ' HG2' ' HA ' ' D' ' 147' ' ' ALA . 2.6 mt-10 -156.87 -177.98 7.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.382 . . . . 0.0 110.327 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.515 HG22 HG23 ' D' ' 37' ' ' VAL . 2.7 t -142.24 150.13 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.253 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.572 HG11 ' HE2' ' C' ' 158' ' ' TYR . 4.1 m -141.72 168.57 15.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 111.025 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.04 74.77 4.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.068 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.82 91.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.011 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.49 -50.97 0.08 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.475 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 21' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER 179.87 -179.77 0.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.019 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 22' ' ' ALA . . . . . 0.892 ' HB1' ' HB1' ' A' ' 93' ' ' ALA . . . -136.16 116.43 13.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.168 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 23' ' ' VAL . . . . . 0.41 ' H ' ' CB ' ' D' ' 36' ' ' GLN . 69.0 t -67.02 120.15 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.043 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.439 ' O ' HG23 ' C' ' 28' ' ' VAL . 2.4 m-20 -64.46 150.47 46.49 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.59 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' D' ' 33' ' ' GLN . . . -48.35 -50.16 31.58 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.343 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.34 -31.77 81.51 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.897 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.09 -15.93 63.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.439 HG23 ' O ' ' C' ' 24' ' ' ASP . 48.6 t -72.94 -43.67 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.36 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.44 106.08 10.34 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -116.67 133.98 55.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.026 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' THR . . . . . 0.627 HG22 ' HD3' ' B' ' 13' ' ' LYS . 1.0 OUTLIER -105.5 96.07 6.25 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.069 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' B' ' 11' ' ' HIS . 69.5 t -89.45 131.24 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.154 0.502 . . . . 0.0 110.434 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.457 ' HA ' ' HG2' ' B' ' 13' ' ' LYS . 0.3 OUTLIER -109.02 106.46 16.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.582 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.485 HD12 ' CE2' ' C' ' 137' ' ' TYR . 0.4 OUTLIER -73.82 -40.89 63.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.642 179.368 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.98 -122.45 6.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.556 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' GLN . . . . . 0.603 ' HB3' ' HA ' ' B' ' 22' ' ' ALA . 3.7 tt0 -144.55 153.9 42.31 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.621 0.248 . . . . 0.0 110.913 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.512 HG23 HG22 ' B' ' 16' ' ' VAL . 0.0 OUTLIER -128.51 146.3 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.848 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 38' ' ' ARG . . . . . 0.539 ' HE ' ' HB2' ' B' ' 22' ' ' ALA . 0.0 OUTLIER -98.22 145.96 26.1 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.772 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.56 HG23 ' O ' ' B' ' 17' ' ' VAL . 41.0 p -57.73 -23.03 49.87 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.777 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.94 -33.2 61.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.056 0.455 . . . . 0.0 110.833 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.0 -31.21 69.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.142 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.611 ' HB3' ' HB2' ' C' ' 139' ' ' ALA . 0.0 OUTLIER -130.77 86.41 2.37 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.65 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.68 36.14 4.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.371 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.6 150.89 0.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.343 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' C' ' 140' ' ' THR . 1.7 tm-20 -64.8 134.84 54.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.337 . . . . 0.0 111.135 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.74 -14.08 53.35 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.143 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' C' ' 138' ' ' PHE . . . -57.27 129.86 43.63 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 48' ' ' THR . . . . . 0.469 ' HB ' ' CE1' ' C' ' 138' ' ' PHE . 14.3 t -130.57 143.31 50.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.903 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 68.6 m -111.96 -157.23 0.61 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.565 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 50' ' ' SER . . . . . 0.404 ' H ' ' HB3' ' C' ' 49' ' ' SER . 27.7 t -74.59 150.13 39.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.816 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 51' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . . . -103.24 146.65 28.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.344 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' C' ' 134' ' ' GLN . 22.2 m -83.35 148.35 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.42 121.17 6.19 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.645 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' PHE . . . . . 0.414 ' CD1' HG23 ' C' ' 52' ' ' VAL . 16.3 p90 -153.79 125.59 7.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.777 0.322 . . . . 0.0 110.933 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -109.35 156.17 20.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.543 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 22.4 mm -103.9 135.28 42.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.635 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.7 126.04 48.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.755 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 58' ' ' LEU . . . . . 0.551 ' HB2' ' HB3' ' C' ' 129' ' ' ASN . 4.3 mp -131.57 100.0 4.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.298 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.41 174.82 11.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.943 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.68 65.28 1.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.804 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 61' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' C' ' 21' ' ' CYS . 60.7 m -98.73 142.98 29.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.796 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.66 109.25 15.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.303 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.457 HG23 ' HB3' ' C' ' 124' ' ' LEU . 0.2 OUTLIER -92.43 29.47 1.7 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -89.93 -59.19 2.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.015 0.436 . . . . 0.0 111.752 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.29 -39.87 13.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.654 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.61 101.34 10.67 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.629 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 31.1 p -90.54 -28.83 18.24 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 110.962 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.36 167.05 16.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.531 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.91 149.84 29.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.599 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' C' ' 157' ' ' GLN . . . -112.98 159.74 18.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.104 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.1 123.31 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.678 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' ALA . . . . . 0.687 ' HB3' ' HB3' ' C' ' 155' ' ' LYS . . . -124.65 169.0 12.38 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.55 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 73' ' ' PHE . . . . . 0.538 ' CB ' HD11 ' C' ' 111' ' ' LEU . 17.2 t80 -150.6 144.39 25.24 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.54 0.21 . . . . 0.0 111.104 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.657 HD12 ' OG1' ' F' ' 130' ' ' THR . 0.4 OUTLIER -121.46 88.62 2.97 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.976 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 75' ' ' GLY . . . . . 0.521 ' C ' HD23 ' C' ' 113' ' ' LEU . . . -134.78 164.7 24.68 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.779 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.656 ' O ' ' HA ' ' C' ' 86' ' ' LEU . 0.6 OUTLIER -78.55 147.77 33.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.571 0.224 . . . . 0.0 110.76 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 77' ' ' ALA . . . . . 0.558 ' H ' ' HB3' ' F' ' 132' ' ' PRO . . . -95.73 140.26 30.79 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.934 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 78' ' ' ILE . . . . . 0.56 ' CG2' ' HB ' ' C' ' 85' ' ' VAL . 1.1 tt -78.61 -33.18 16.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.86 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.17 179.28 6.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.69 -27.9 36.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.006 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.15 -32.24 72.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.671 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 82' ' ' HIS . . . . . 0.407 ' HB3' HG23 ' C' ' 85' ' ' VAL . 15.2 m-70 -97.32 -72.73 0.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 0.0 110.49 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 5.6 m 74.9 -7.25 1.78 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.563 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 84' ' ' ASN . . . . . 0.745 ' HA ' HD13 ' C' ' 113' ' ' LEU . 3.1 m120 -108.77 -19.13 13.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.329 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.56 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 49.9 t -80.58 132.01 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.162 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.766 HD21 ' HB2' ' C' ' 152' ' ' ALA . 0.4 OUTLIER -76.58 134.98 39.23 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.991 -0.283 . . . . 0.0 110.279 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.34 165.16 6.27 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.903 0.382 . . . . 0.0 111.676 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.738 HD12 ' O ' ' F' ' 51' ' ' ALA . 0.0 OUTLIER -65.72 171.74 4.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.069 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 89' ' ' GLN . . . . . 0.485 ' OE1' ' HB3' ' C' ' 91' ' ' SER . 8.1 pt20 -72.45 175.71 6.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.409 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 90' ' ' SER . . . . . 0.467 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 0.5 OUTLIER -75.98 -21.26 57.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.984 0.421 . . . . 0.0 111.518 179.414 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 91' ' ' SER . . . . . 0.485 ' HB3' ' OE1' ' C' ' 89' ' ' GLN . 32.1 t -80.95 67.6 6.92 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.811 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 92' ' ' ALA . . . . . 0.453 ' HA ' ' OG ' ' C' ' 95' ' ' SER . . . -72.28 -9.71 58.83 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.912 0.387 . . . . 0.0 111.681 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 93' ' ' ALA . . . . . 0.894 ' HB1' ' HB1' ' E' ' 22' ' ' ALA . . . -68.14 -22.77 64.85 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.615 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.54 6.75 2.46 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.895 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 95' ' ' SER . . . . . 0.689 ' HA ' ' HB3' ' C' ' 147' ' ' ALA . 31.5 p -93.72 150.82 20.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.851 0.358 . . . . 0.0 110.625 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.79 167.14 18.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.58 165.16 14.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.367 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 98' ' ' ASN . . . . . 0.527 ' HA ' ' OG1' ' C' ' 140' ' ' THR . 85.1 m-20 63.24 45.5 5.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.443 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 99' ' ' VAL . . . . . 0.472 ' HB ' ' CB ' ' C' ' 143' ' ' ALA . 3.5 p -170.65 131.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.762 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.03 -175.94 21.14 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.531 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 101' ' ' VAL . . . . . . . . . . . . . 76.0 t -104.14 91.88 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 122.981 0.512 . . . . 0.0 111.723 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 102' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' C' ' 85' ' ' VAL . 0.6 OUTLIER -67.95 131.16 44.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.916 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.52 HD12 ' O ' ' C' ' 84' ' ' ASN . 0.7 OUTLIER -99.34 110.56 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.535 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 104' ' ' LEU . . . . . 0.466 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 5.4 tp -91.22 149.94 21.55 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.625 0.25 . . . . 0.0 111.086 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.9 174.68 5.79 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.71 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 106' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' C' ' 106' ' ' ARG . 1.5 ttt180 -72.53 -18.45 61.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.79 0.329 . . . . 0.0 111.106 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 46.2 p -69.36 -9.67 54.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.996 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.99 -48.34 0.96 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.69 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.95 163.57 15.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 111.072 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -70.49 125.62 27.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.123 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 111' ' ' LEU . . . . . 0.538 HD11 ' CB ' ' C' ' 73' ' ' PHE . 0.0 OUTLIER -65.41 147.65 53.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.356 0.598 . . . . 0.0 110.557 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 112' ' ' THR . . . . . 0.702 ' HB ' HG21 ' C' ' 117' ' ' THR . 0.2 OUTLIER -74.11 144.63 44.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.113 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.745 HD13 ' HA ' ' C' ' 84' ' ' ASN . 10.2 mp -100.36 89.84 4.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.799 0.333 . . . . 0.0 110.718 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 114' ' ' ASP . . . . . 0.431 ' HB2' ' CG2' ' C' ' 117' ' ' THR . 4.0 m-20 -142.37 11.5 1.92 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.51 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 115' ' ' GLY . . . . . 0.438 ' O ' ' HB1' ' C' ' 72' ' ' ALA . . . 96.82 -78.08 0.7 Allowed Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.638 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 116' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' F' ' 125' ' ' ASN . . . -104.24 61.52 0.73 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.013 0.435 . . . . 0.0 111.686 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 117' ' ' THR . . . . . 0.702 HG21 ' HB ' ' C' ' 112' ' ' THR . 17.6 p -93.4 95.9 9.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.081 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.86 110.02 5.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.787 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 13.9 m -120.4 -72.85 0.67 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.42 113.04 25.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.666 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -99.39 97.52 8.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.186 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.45 132.71 37.46 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.752 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 22.0 m -60.89 146.15 47.65 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.708 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 124' ' ' LEU . . . . . 0.457 ' HB3' HG23 ' C' ' 63' ' ' THR . 0.2 OUTLIER -85.41 156.52 20.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.634 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.82 142.73 40.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.575 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.9 113.69 6.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.742 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.5 -90.01 0.32 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.702 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 6.1 m -124.91 152.82 43.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.692 0.282 . . . . 0.0 110.815 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 129' ' ' ASN . . . . . 0.551 ' HB3' ' HB2' ' C' ' 58' ' ' LEU . 17.1 t-20 -123.06 147.53 46.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 4.3 m -126.19 135.65 51.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.094 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 131' ' ' ILE . . . . . . . . . . . . . 58.2 mt -113.95 115.68 45.63 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 132' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -81.74 115.72 2.79 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 121.635 1.557 . . . . 0.0 112.54 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.57 150.8 46.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.828 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 134' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' C' ' 52' ' ' VAL . 4.5 mt-30 -142.4 166.74 23.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.032 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 135' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' C' ' 102' ' ' GLN . . . -158.22 102.92 1.79 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.927 0.394 . . . . 0.0 111.622 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 136' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' C' ' 51' ' ' ALA . 0.1 OUTLIER -94.69 -173.47 3.02 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.408 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 137' ' ' TYR . . . . . 0.59 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 3.8 m-85 -100.72 152.83 20.0 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.147 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 138' ' ' PHE . . . . . 0.553 ' HA ' ' O ' ' C' ' 47' ' ' ALA . 0.2 OUTLIER -147.3 160.73 42.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.026 -179.167 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 139' ' ' ALA . . . . . 0.611 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -126.85 149.63 49.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.915 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 140' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' C' ' 98' ' ' ASN . 0.0 OUTLIER -115.33 27.87 9.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.472 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.37 66.79 0.2 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.947 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.93 88.63 0.09 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.58 0.229 . . . . 0.0 110.769 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 143' ' ' ALA . . . . . 0.472 ' CB ' ' HB ' ' C' ' 99' ' ' VAL . . . -60.25 156.86 14.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.758 0.313 . . . . 0.0 111.4 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 144' ' ' THR . . . . . 0.552 ' HB ' ' CD ' ' C' ' 145' ' ' PRO . 77.3 p -112.2 173.05 3.07 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.254 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 145' ' ' PRO . . . . . 0.552 ' CD ' ' HB ' ' C' ' 144' ' ' THR . 1.3 Cg_endo -84.55 145.24 10.43 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.57 2.18 . . . . 0.0 111.923 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.31 -112.7 0.55 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.508 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 147' ' ' ALA . . . . . 0.689 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -124.92 167.68 14.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.913 0.387 . . . . 0.0 111.296 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 148' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -157.19 57.45 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.466 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -91.81 132.71 36.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.53 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.41 163.16 28.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.988 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.45 125.59 1.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.244 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 152' ' ' ALA . . . . . 0.766 ' HB2' HD21 ' C' ' 86' ' ' LEU . . . -154.57 165.78 35.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.264 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.88 163.17 12.72 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -119.02 134.57 55.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.061 0.458 . . . . 0.0 110.155 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 155' ' ' LYS . . . . . 0.687 ' HB3' ' HB3' ' C' ' 72' ' ' ALA . 0.0 OUTLIER -95.62 166.28 11.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.914 -178.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.22 112.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.754 0.312 . . . . 0.0 111.713 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 157' ' ' GLN . . . . . 0.634 ' HB3' ' HB3' ' C' ' 70' ' ' ALA . 0.2 OUTLIER -88.67 138.83 31.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.235 0.54 . . . . 0.0 110.385 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 158' ' ' TYR . . . . . 0.572 ' HE2' HG11 ' C' ' 17' ' ' VAL . 22.6 m-85 -127.76 113.21 15.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.523 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.913 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.248 0.07 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.96 68.35 0.87 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.935 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 3' ' ' THR . . . . . . . . . . . . . 7.5 m -92.39 87.63 6.09 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.439 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 4' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' E' ' 157' ' ' GLN . 3.5 m -90.39 115.48 27.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.542 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -127.3 167.02 22.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.565 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 6' ' ' ASN . . . . . 0.643 ' HA ' ' HE2' ' E' ' 155' ' ' LYS . 20.0 t30 -83.02 115.19 21.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.554 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.43 -71.49 1.06 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.806 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.3 172.75 34.77 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.897 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 33.1 m -95.45 136.94 35.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.918 0.39 . . . . 0.0 111.265 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.83 130.73 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.171 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 11' ' ' HIS . . . . . 0.539 ' O ' ' HB ' ' E' ' 32' ' ' VAL . 1.3 m80 -103.83 157.98 16.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.327 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 12' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' E' ' 32' ' ' VAL . 0.6 OUTLIER -145.87 89.68 1.92 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.76 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 13' ' ' LYS . . . . . 0.633 ' HD3' HG22 ' E' ' 31' ' ' THR . 0.0 OUTLIER -79.98 135.16 36.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.436 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.54 178.42 42.04 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.948 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 15' ' ' GLU . . . . . 0.652 ' HG2' ' HA ' ' E' ' 147' ' ' ALA . 2.5 mt-10 -156.79 -177.92 6.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.833 0.349 . . . . 0.0 110.414 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.514 HG22 HG23 ' E' ' 37' ' ' VAL . 2.7 t -142.24 150.16 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.27 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.585 HG11 ' HE2' ' D' ' 158' ' ' TYR . 4.2 m -141.76 168.53 14.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.86 0.362 . . . . 0.0 111.034 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -92.98 74.75 4.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.066 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.83 91.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.057 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.43 -51.06 0.09 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.402 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 21' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER 179.88 -179.78 0.48 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.005 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 22' ' ' ALA . . . . . 0.88 ' HB1' ' HB1' ' B' ' 93' ' ' ALA . . . -136.17 116.41 13.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.16 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 23' ' ' VAL . . . . . 0.423 ' H ' ' CB ' ' E' ' 36' ' ' GLN . 69.3 t -67.01 120.21 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.439 ' O ' HG23 ' D' ' 28' ' ' VAL . 2.4 m-20 -64.42 150.47 46.39 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.573 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' E' ' 33' ' ' GLN . . . -48.36 -50.16 31.66 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.42 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.26 -31.82 81.79 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.93 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.09 -15.95 63.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.868 0.366 . . . . 0.0 110.821 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 28' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 24' ' ' ASP . 48.8 t -73.04 -43.56 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.334 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.41 106.1 10.36 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.999 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -116.68 133.95 55.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.032 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 31' ' ' THR . . . . . 0.634 HG22 ' HD3' ' C' ' 13' ' ' LYS . 1.0 OUTLIER -105.48 96.05 6.24 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.042 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' C' ' 11' ' ' HIS . 68.9 t -89.39 131.28 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.161 0.505 . . . . 0.0 110.469 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 33' ' ' GLN . . . . . 0.465 ' HA ' ' HG2' ' C' ' 13' ' ' LYS . 0.3 OUTLIER -109.05 106.5 16.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.603 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.484 HD12 ' CE2' ' D' ' 137' ' ' TYR . 0.4 OUTLIER -73.85 -40.88 62.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.678 179.391 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.0 -122.47 6.75 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.522 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' GLN . . . . . 0.611 ' HB3' ' HA ' ' C' ' 22' ' ' ALA . 3.7 tt0 -144.55 153.83 42.23 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.566 0.222 . . . . 0.0 110.874 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.515 HG23 HG22 ' C' ' 16' ' ' VAL . 0.0 OUTLIER -128.46 146.32 34.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.911 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 38' ' ' ARG . . . . . 0.539 ' HE ' ' HB2' ' C' ' 22' ' ' ALA . 0.0 OUTLIER -98.2 145.99 26.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.768 179.196 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.556 HG23 ' O ' ' C' ' 17' ' ' VAL . 40.8 p -57.74 -23.06 50.09 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.743 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.97 -33.23 61.87 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.053 0.454 . . . . 0.0 110.8 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.02 -31.21 69.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.134 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' D' ' 139' ' ' ALA . 0.0 OUTLIER -130.72 86.37 2.37 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.69 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.71 36.27 4.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.346 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.56 150.82 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.38 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 45' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' D' ' 140' ' ' THR . 1.7 tm-20 -64.75 134.83 55.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.0 111.175 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.78 -14.22 53.16 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.213 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' D' ' 138' ' ' PHE . . . -57.14 129.86 43.61 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 48' ' ' THR . . . . . 0.46 ' HB ' ' CE1' ' D' ' 138' ' ' PHE . 14.4 t -130.61 143.35 50.69 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.878 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 68.8 m -111.96 -157.21 0.61 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.596 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.405 ' HB3' ' HB1' ' A' ' 92' ' ' ALA . 27.7 t -74.55 150.06 39.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.834 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 51' ' ' ALA . . . . . 0.729 ' O ' HD12 ' A' ' 88' ' ' LEU . . . -103.19 146.64 28.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.326 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 52' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' A' ' 90' ' ' SER . 22.3 m -83.37 148.33 5.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.909 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.38 121.21 6.21 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.633 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.412 ' CD1' HG23 ' D' ' 52' ' ' VAL . 16.3 p90 -153.88 125.54 7.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.855 0.36 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -109.28 156.24 20.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.492 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 56' ' ' ILE . . . . . . . . . . . . . 22.6 mm -104.05 135.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.534 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.66 126.01 48.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.753 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 58' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' D' ' 129' ' ' ASN . 4.3 mp -131.62 99.97 4.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.275 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.46 174.73 11.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.902 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.8 65.26 1.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.782 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 61' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' D' ' 21' ' ' CYS . 60.7 m -98.71 142.92 29.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.746 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.6 109.2 15.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.301 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.461 HG23 ' HB3' ' D' ' 124' ' ' LEU . 0.2 OUTLIER -92.43 29.65 1.66 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -90.06 -59.27 2.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.069 0.462 . . . . 0.0 111.752 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.18 -39.8 13.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.732 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.64 101.39 10.71 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.586 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 31.3 p -90.58 -28.76 18.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.885 0.374 . . . . 0.0 110.999 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 68' ' ' LYS . . . . . 0.449 ' HZ1' ' HB2' ' D' ' 121' ' ' GLU . 0.0 OUTLIER -126.49 166.91 16.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.482 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.8 149.82 29.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.664 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 70' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' D' ' 157' ' ' GLN . . . -112.91 159.77 18.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.101 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 52.4 t -108.08 123.31 63.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.662 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 72' ' ' ALA . . . . . 0.679 ' HB3' ' HB3' ' D' ' 155' ' ' LYS . . . -124.61 168.92 12.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.622 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 73' ' ' PHE . . . . . 0.532 ' CB ' HD11 ' D' ' 111' ' ' LEU . 17.2 t80 -150.62 144.41 25.23 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.585 0.231 . . . . 0.0 111.133 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 74' ' ' LEU . . . . . 0.444 HD23 ' O ' ' D' ' 74' ' ' LEU . 0.4 OUTLIER -121.5 88.6 2.97 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.999 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 75' ' ' GLY . . . . . 0.521 ' C ' HD23 ' D' ' 113' ' ' LEU . . . -134.74 164.72 24.67 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.759 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 76' ' ' THR . . . . . 0.665 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.6 OUTLIER -78.56 147.76 33.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.565 0.222 . . . . 0.0 110.774 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.82 140.32 30.77 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.912 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 78' ' ' ILE . . . . . 0.555 ' CG2' ' HB ' ' D' ' 85' ' ' VAL . 1.1 tt -78.65 -33.11 16.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.921 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.16 179.27 7.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.859 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.69 -27.91 36.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.059 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.17 -32.29 72.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.619 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 82' ' ' HIS . . . . . 0.416 ' HB3' HG23 ' D' ' 85' ' ' VAL . 15.3 m-70 -97.28 -72.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.482 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.86 -7.22 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.592 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 84' ' ' ASN . . . . . 0.758 ' HA ' HD13 ' D' ' 113' ' ' LEU . 3.1 m120 -108.79 -19.1 13.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.287 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' D' ' 102' ' ' GLN . 50.3 t -80.65 131.98 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.134 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' D' ' 152' ' ' ALA . 0.4 OUTLIER -76.52 134.96 39.31 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.32 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.31 165.19 6.2 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.889 0.376 . . . . 0.0 111.669 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 88' ' ' LEU . . . . . 0.423 ' H ' ' HG ' ' D' ' 88' ' ' LEU . 0.1 OUTLIER -65.75 171.69 4.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.056 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 89' ' ' GLN . . . . . 0.492 ' OE1' ' HB3' ' D' ' 91' ' ' SER . 8.1 pt20 -72.48 175.67 6.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.412 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.98 -21.19 57.22 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.071 0.462 . . . . 0.0 111.521 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 91' ' ' SER . . . . . 0.492 ' HB3' ' OE1' ' D' ' 89' ' ' GLN . 32.1 t -81.02 67.64 7.01 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.825 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 92' ' ' ALA . . . . . 0.449 ' HA ' ' OG ' ' D' ' 95' ' ' SER . . . -72.33 -9.7 58.84 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.943 0.401 . . . . 0.0 111.682 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 93' ' ' ALA . . . . . 0.896 ' HB1' ' HB1' ' F' ' 22' ' ' ALA . . . -68.06 -22.88 64.92 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.615 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.51 6.78 2.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.911 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 95' ' ' SER . . . . . 0.699 ' HA ' ' HB3' ' D' ' 147' ' ' ALA . 31.6 p -93.77 150.86 20.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.846 0.355 . . . . 0.0 110.599 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.82 167.24 18.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.834 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.68 165.16 14.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.295 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 98' ' ' ASN . . . . . 0.525 ' HA ' ' OG1' ' D' ' 140' ' ' THR . 85.0 m-20 63.3 45.46 4.98 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.434 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 99' ' ' VAL . . . . . 0.465 ' HB ' ' CB ' ' D' ' 143' ' ' ALA . 3.4 p -170.67 131.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.784 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.05 -175.92 21.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.54 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 101' ' ' VAL . . . . . . . . . . . . . 76.4 t -104.2 91.91 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.187 0.518 . . . . 0.0 111.669 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 102' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' D' ' 85' ' ' VAL . 0.6 OUTLIER -67.9 131.25 45.16 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.877 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 103' ' ' ILE . . . . . 0.512 HD12 ' O ' ' D' ' 84' ' ' ASN . 0.7 OUTLIER -99.47 110.64 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.468 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 104' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 5.5 tp -91.33 149.96 21.51 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.633 0.254 . . . . 0.0 111.056 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.87 174.65 5.8 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.714 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 106' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' D' ' 106' ' ' ARG . 1.5 ttt180 -72.47 -18.55 61.67 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.714 0.293 . . . . 0.0 111.033 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 107' ' ' THR . . . . . . . . . . . . . 46.3 p -69.33 -9.58 53.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.06 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.98 -48.41 0.96 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.643 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.92 163.56 15.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.063 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -70.47 125.57 27.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.155 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 111' ' ' LEU . . . . . 0.532 HD11 ' CB ' ' D' ' 73' ' ' PHE . 0.0 OUTLIER -65.33 147.64 53.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.328 0.585 . . . . 0.0 110.593 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 112' ' ' THR . . . . . 0.67 ' HB ' HG21 ' D' ' 117' ' ' THR . 0.2 OUTLIER -74.1 144.61 44.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.085 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 113' ' ' LEU . . . . . 0.758 HD13 ' HA ' ' D' ' 84' ' ' ASN . 10.2 mp -100.34 89.89 4.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.727 0.298 . . . . 0.0 110.686 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 114' ' ' ASP . . . . . 0.433 ' HB2' ' CG2' ' D' ' 117' ' ' THR . 4.0 m-20 -142.37 11.44 1.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.569 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 115' ' ' GLY . . . . . 0.443 ' O ' ' HB1' ' D' ' 72' ' ' ALA . . . 96.88 -78.06 0.69 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.624 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 116' ' ' ALA . . . . . 0.463 ' CB ' HG21 ' C' ' 4' ' ' THR . . . -104.26 61.49 0.73 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.999 0.428 . . . . 0.0 111.706 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 117' ' ' THR . . . . . 0.67 HG21 ' HB ' ' D' ' 112' ' ' THR . 17.5 p -93.41 95.86 9.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.131 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.81 110.05 5.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.746 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.39 -72.9 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.878 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.45 113.05 25.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.622 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 121' ' ' GLU . . . . . 0.449 ' HB2' ' HZ1' ' D' ' 68' ' ' LYS . 25.2 mt-10 -99.44 97.56 8.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.191 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.5 132.74 37.49 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.752 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -60.94 146.11 47.96 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.709 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 124' ' ' LEU . . . . . 0.461 ' HB3' HG23 ' D' ' 63' ' ' THR . 0.2 OUTLIER -85.34 156.49 20.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.632 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 125' ' ' ASN . . . . . 0.534 ' HB3' ' HB3' ' A' ' 116' ' ' ALA . 32.6 m120 -137.81 142.74 40.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.577 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.97 113.7 6.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.689 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.51 -90.05 0.32 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.701 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 128' ' ' THR . . . . . 0.433 ' HB ' ' HD3' ' A' ' 155' ' ' LYS . 6.2 m -124.94 152.86 43.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.734 0.302 . . . . 0.0 110.82 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 129' ' ' ASN . . . . . 0.542 ' HB3' ' HB2' ' D' ' 58' ' ' LEU . 17.1 t-20 -123.06 147.56 46.57 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.866 0.365 . . . . 0.0 111.158 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 130' ' ' THR . . . . . 0.652 ' OG1' HD12 ' A' ' 74' ' ' LEU . 4.3 m -126.22 135.71 51.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.05 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 131' ' ' ILE . . . . . . . . . . . . . 58.5 mt -114.01 115.7 45.48 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 132' ' ' PRO . . . . . 0.564 ' HB3' ' H ' ' A' ' 77' ' ' ALA . 7.5 Cg_endo -81.67 115.71 2.82 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 121.703 1.602 . . . . 0.0 112.545 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.59 150.79 46.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.802 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 134' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' D' ' 52' ' ' VAL . 1.3 mt-30 -142.5 166.61 24.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.081 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' D' ' 102' ' ' GLN . . . -158.14 102.9 1.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.922 0.392 . . . . 0.0 111.638 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 136' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' D' ' 51' ' ' ALA . 0.2 OUTLIER -94.67 -173.41 3.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.415 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 137' ' ' TYR . . . . . 0.605 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 3.8 m-85 -100.82 152.86 20.0 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.09 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 138' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' D' ' 47' ' ' ALA . 0.2 OUTLIER -147.33 160.73 42.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.083 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 139' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -126.82 149.71 49.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.895 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 140' ' ' THR . . . . . 0.525 ' OG1' ' HA ' ' D' ' 98' ' ' ASN . 0.0 OUTLIER -115.4 27.79 9.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.402 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.38 66.86 0.2 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.888 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.92 88.61 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.576 0.188 . . . . 0.0 110.759 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 143' ' ' ALA . . . . . 0.465 ' CB ' ' HB ' ' D' ' 99' ' ' VAL . . . -60.2 156.9 14.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.709 0.29 . . . . 0.0 111.438 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 144' ' ' THR . . . . . 0.548 ' HB ' ' CD ' ' D' ' 145' ' ' PRO . 76.9 p -112.21 173.08 3.05 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.213 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 145' ' ' PRO . . . . . 0.548 ' CD ' ' HB ' ' D' ' 144' ' ' THR . 1.3 Cg_endo -84.58 145.2 10.38 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.565 2.177 . . . . 0.0 111.937 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.38 -112.72 0.55 Allowed Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.555 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 147' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -124.92 167.69 14.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.812 0.339 . . . . 0.0 111.394 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 148' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -157.22 57.54 0.51 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.103 0.478 . . . . 0.0 110.468 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.87 132.74 36.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.534 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.48 163.12 28.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.027 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.39 125.6 1.85 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.282 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 152' ' ' ALA . . . . . 0.792 ' HB2' HD21 ' D' ' 86' ' ' LEU . . . -154.59 165.78 35.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.173 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.84 163.16 12.72 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -119.0 134.48 55.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.023 0.439 . . . . 0.0 110.2 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 155' ' ' LYS . . . . . 0.679 ' HB3' ' HB3' ' D' ' 72' ' ' ALA . 0.0 OUTLIER -95.61 166.3 11.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.91 -178.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.25 112.83 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.832 0.348 . . . . 0.0 111.638 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 157' ' ' GLN . . . . . 0.615 ' HB3' ' HB3' ' D' ' 70' ' ' ALA . 0.2 OUTLIER -88.82 138.84 31.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.331 0.586 . . . . 0.0 110.393 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 158' ' ' TYR . . . . . 0.585 ' HE2' HG11 ' D' ' 17' ' ' VAL . 22.5 m-85 -127.65 113.16 15.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.519 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.962 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.261 0.076 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.0 68.24 0.88 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.587 0.232 . . . . 0.0 111.022 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -92.31 87.66 6.13 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.473 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 4' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' F' ' 157' ' ' GLN . 3.5 m -90.5 115.48 27.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.545 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 m -127.22 167.0 22.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.583 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 6' ' ' ASN . . . . . 0.653 ' HA ' ' HE2' ' F' ' 155' ' ' LYS . 20.0 t30 -83.04 115.14 21.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.497 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.41 -71.45 1.07 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.853 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.29 172.78 34.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.049 -0.595 . . . . 0.0 111.931 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 9' ' ' THR . . . . . . . . . . . . . 33.4 m -95.49 137.03 35.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.916 0.389 . . . . 0.0 111.284 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -120.85 130.68 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.185 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 11' ' ' HIS . . . . . 0.535 ' O ' ' HB ' ' F' ' 32' ' ' VAL . 1.3 m80 -103.82 157.99 16.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.397 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 12' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' F' ' 32' ' ' VAL . 0.6 OUTLIER -145.84 89.66 1.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 13' ' ' LYS . . . . . 0.631 ' HD3' HG22 ' F' ' 31' ' ' THR . 0.0 OUTLIER -79.95 135.21 36.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.477 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.56 178.38 42.07 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.898 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 15' ' ' GLU . . . . . 0.654 ' HG2' ' HA ' ' F' ' 147' ' ' ALA . 2.6 mt-10 -156.81 -177.9 6.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.938 0.399 . . . . 0.0 110.357 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 16' ' ' VAL . . . . . 0.525 HG22 HG23 ' F' ' 37' ' ' VAL . 2.7 t -142.29 150.13 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.239 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 17' ' ' VAL . . . . . 0.589 HG11 ' HE2' ' E' ' 158' ' ' TYR . 4.1 m -141.71 168.61 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.832 0.349 . . . . 0.0 111.083 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.06 74.74 4.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.087 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.89 91.89 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.5 -51.01 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.432 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 21' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER 179.82 -179.79 0.47 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.986 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 22' ' ' ALA . . . . . 0.894 ' HB1' ' HB1' ' C' ' 93' ' ' ALA . . . -136.16 116.43 13.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.146 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 23' ' ' VAL . . . . . 0.421 ' H ' ' CB ' ' F' ' 36' ' ' GLN . 67.7 t -67.01 120.14 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 24' ' ' ASP . . . . . 0.445 ' O ' HG23 ' E' ' 28' ' ' VAL . 2.4 m-20 -64.38 150.49 46.21 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.602 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.38 -50.18 31.7 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.355 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.3 -31.77 81.58 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.918 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.02 -16.05 63.62 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.902 0.382 . . . . 0.0 110.859 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 28' ' ' VAL . . . . . 0.445 HG23 ' O ' ' E' ' 24' ' ' ASP . 48.4 t -72.93 -43.61 59.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.401 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.44 106.09 10.35 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -116.62 133.99 55.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 31' ' ' THR . . . . . 0.633 HG22 ' HD3' ' D' ' 13' ' ' LYS . 0.9 OUTLIER -105.5 96.03 6.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.095 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' D' ' 11' ' ' HIS . 69.6 t -89.45 131.27 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.215 0.531 . . . . 0.0 110.437 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 33' ' ' GLN . . . . . 0.456 ' HA ' ' HG2' ' D' ' 13' ' ' LYS . 0.3 OUTLIER -108.99 106.48 16.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.599 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.494 HD12 ' CE2' ' E' ' 137' ' ' TYR . 0.4 OUTLIER -73.89 -40.93 62.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.552 179.419 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.04 -122.48 6.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.564 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 36' ' ' GLN . . . . . 0.612 ' HB3' ' HA ' ' D' ' 22' ' ' ALA . 3.7 tt0 -144.51 153.98 42.43 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.633 0.254 . . . . 0.0 110.881 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.514 HG23 HG22 ' D' ' 16' ' ' VAL . 0.0 OUTLIER -128.57 146.33 34.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.873 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 38' ' ' ARG . . . . . 0.547 ' HE ' ' HB2' ' D' ' 22' ' ' ALA . 0.0 OUTLIER -98.19 146.0 26.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.731 179.178 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 39' ' ' THR . . . . . 0.55 HG23 ' O ' ' D' ' 17' ' ' VAL . 40.9 p -57.79 -23.07 50.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.709 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.98 -33.21 61.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.013 0.435 . . . . 0.0 110.791 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.03 -31.15 69.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.222 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' E' ' 139' ' ' ALA . 0.0 OUTLIER -130.76 86.44 2.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.598 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.66 36.16 4.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.337 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.59 150.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.365 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 45' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' E' ' 140' ' ' THR . 1.7 tm-20 -64.78 134.88 55.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 0.0 111.118 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.8 -14.28 53.07 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.146 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 47' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' E' ' 138' ' ' PHE . . . -57.22 129.92 43.9 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.938 0.399 . . . . 0.0 112.043 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 48' ' ' THR . . . . . 0.465 ' HB ' ' CE1' ' E' ' 138' ' ' PHE . 14.3 t -130.67 143.29 50.65 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.874 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 68.9 m -111.87 -157.14 0.61 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.625 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 50' ' ' SER . . . . . 0.408 ' HB3' ' HB1' ' B' ' 92' ' ' ALA . 27.5 t -74.58 150.05 39.86 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.865 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 51' ' ' ALA . . . . . 0.723 ' O ' HD12 ' B' ' 88' ' ' LEU . . . -103.22 146.63 28.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.334 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 52' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' B' ' 90' ' ' SER . 22.1 m -83.41 148.37 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.44 121.27 6.22 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.601 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 54' ' ' PHE . . . . . 0.406 ' CD1' HG23 ' E' ' 52' ' ' VAL . 16.5 p90 -153.87 125.57 7.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.797 0.332 . . . . 0.0 110.949 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -109.33 156.19 20.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.59 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 56' ' ' ILE . . . . . . . . . . . . . 22.4 mm -103.95 135.29 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.565 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.72 125.99 48.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.75 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 58' ' ' LEU . . . . . 0.541 ' HB2' ' HB3' ' E' ' 129' ' ' ASN . 4.3 mp -131.6 99.9 4.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.326 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.32 174.72 11.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.966 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.74 65.3 1.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.79 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 61' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' E' ' 21' ' ' CYS . 60.7 m -98.71 142.94 29.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.792 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.64 109.25 15.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.266 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 63' ' ' THR . . . . . 0.473 HG23 ' HB3' ' E' ' 124' ' ' LEU . 0.2 OUTLIER -92.47 29.59 1.68 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.144 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -89.99 -59.26 2.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.085 0.469 . . . . 0.0 111.727 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.25 -39.84 13.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.666 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.6 101.34 10.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.597 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 30.8 p -90.56 -28.79 18.25 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.38 167.08 16.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.509 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.95 149.75 29.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.617 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 70' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' E' ' 157' ' ' GLN . . . -112.88 159.75 18.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.1 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 52.2 t -108.09 123.29 63.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.665 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 72' ' ' ALA . . . . . 0.677 ' HB3' ' HB3' ' E' ' 155' ' ' LYS . . . -124.63 168.92 12.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.615 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 73' ' ' PHE . . . . . 0.539 ' CB ' HD11 ' E' ' 111' ' ' LEU . 17.2 t80 -150.63 144.4 25.21 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.601 0.239 . . . . 0.0 111.1 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 74' ' ' LEU . . . . . 0.441 HD23 ' O ' ' E' ' 74' ' ' LEU . 0.4 OUTLIER -121.46 88.64 2.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.989 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 75' ' ' GLY . . . . . 0.52 ' C ' HD23 ' E' ' 113' ' ' LEU . . . -134.76 164.7 24.67 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.816 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 76' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.6 OUTLIER -78.57 147.72 33.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.595 0.236 . . . . 0.0 110.708 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.68 140.29 30.71 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.961 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 78' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' E' ' 85' ' ' VAL . 1.1 tt -78.58 -33.16 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.914 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.18 179.18 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.904 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.58 -27.96 37.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.059 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.21 -32.22 72.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.633 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 82' ' ' HIS . . . . . 0.41 ' HB3' HG23 ' E' ' 85' ' ' VAL . 15.3 m-70 -97.29 -72.81 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.931 0.396 . . . . 0.0 110.461 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.88 -7.15 1.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.593 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 84' ' ' ASN . . . . . 0.76 ' HA ' HD13 ' E' ' 113' ' ' LEU . 3.1 m120 -108.83 -19.1 13.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.325 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' E' ' 102' ' ' GLN . 49.6 t -80.55 132.07 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.152 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 86' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' E' ' 152' ' ' ALA . 0.4 OUTLIER -76.63 134.96 39.16 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.304 179.398 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.25 165.21 6.1 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.867 0.365 . . . . 0.0 111.645 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 88' ' ' LEU . . . . . 0.424 ' HG ' ' H ' ' E' ' 88' ' ' LEU . 0.1 OUTLIER -65.86 171.79 4.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.998 179.444 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 89' ' ' GLN . . . . . 0.491 ' OE1' ' HB3' ' E' ' 91' ' ' SER . 8.0 pt20 -72.56 175.71 6.09 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.425 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.04 -21.18 57.1 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.009 0.433 . . . . 0.0 111.498 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 91' ' ' SER . . . . . 0.491 ' HB3' ' OE1' ' E' ' 89' ' ' GLN . 32.0 t -80.91 67.49 6.82 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 92' ' ' ALA . . . . . 0.453 ' HA ' ' OG ' ' E' ' 95' ' ' SER . . . -72.18 -9.77 58.88 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.969 0.414 . . . . 0.0 111.723 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.04 -22.88 64.93 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.669 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.46 6.75 2.48 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.946 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 95' ' ' SER . . . . . 0.692 ' HA ' ' HB3' ' E' ' 147' ' ' ALA . 31.0 p -93.73 150.78 20.11 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.821 0.343 . . . . 0.0 110.688 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.77 167.22 18.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.876 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.66 165.09 14.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.365 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 98' ' ' ASN . . . . . 0.514 ' HA ' ' OG1' ' E' ' 140' ' ' THR . 85.0 m-20 63.36 45.42 4.93 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.443 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 99' ' ' VAL . . . . . 0.454 ' HB ' ' CB ' ' E' ' 143' ' ' ALA . 3.4 p -170.64 131.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.692 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.04 -175.99 21.18 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.54 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 101' ' ' VAL . . . . . . . . . . . . . 76.3 t -104.07 91.83 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 122.994 0.517 . . . . 0.0 111.708 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 102' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' E' ' 85' ' ' VAL . 0.6 OUTLIER -67.9 131.21 45.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 103' ' ' ILE . . . . . 0.516 HD12 ' O ' ' E' ' 84' ' ' ASN . 0.7 OUTLIER -99.42 110.62 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.475 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 104' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 5.5 tp -91.3 149.93 21.53 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.699 0.285 . . . . 0.0 111.029 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.9 174.65 5.8 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.701 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 106' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' E' ' 106' ' ' ARG . 1.5 ttt180 -72.53 -18.4 61.65 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.759 0.314 . . . . 0.0 111.067 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 46.2 p -69.41 -9.63 54.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.99 -48.38 0.96 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.636 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.88 163.58 15.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 111.11 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 110' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -70.53 125.59 27.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 111' ' ' LEU . . . . . 0.539 HD11 ' CB ' ' E' ' 73' ' ' PHE . 0.0 OUTLIER -65.38 147.57 53.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.353 0.596 . . . . 0.0 110.557 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 112' ' ' THR . . . . . 0.671 ' HB ' HG21 ' E' ' 117' ' ' THR . 0.2 OUTLIER -74.03 144.57 45.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.157 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 113' ' ' LEU . . . . . 0.76 HD13 ' HA ' ' E' ' 84' ' ' ASN . 10.2 mp -100.26 89.82 4.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.776 0.322 . . . . 0.0 110.753 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 114' ' ' ASP . . . . . 0.433 ' HB2' ' CG2' ' E' ' 117' ' ' THR . 4.1 m-20 -142.34 11.43 1.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.685 0.279 . . . . 0.0 111.623 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 115' ' ' GLY . . . . . 0.45 ' O ' ' HB1' ' E' ' 72' ' ' ALA . . . 96.87 -78.1 0.7 Allowed Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.619 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 116' ' ' ALA . . . . . 0.456 ' CB ' HG21 ' D' ' 4' ' ' THR . . . -104.29 61.63 0.73 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.976 0.417 . . . . 0.0 111.666 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 117' ' ' THR . . . . . 0.671 HG21 ' HB ' ' E' ' 112' ' ' THR . 17.6 p -93.5 95.87 9.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.114 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.74 109.92 5.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.819 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.26 -72.96 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.43 113.09 25.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.638 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -99.47 97.51 8.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.184 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.45 132.74 37.42 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.724 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 22.3 m -61.01 146.13 48.2 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.691 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 124' ' ' LEU . . . . . 0.473 ' HB3' HG23 ' E' ' 63' ' ' THR . 0.2 OUTLIER -85.41 156.49 20.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.645 179.419 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 125' ' ' ASN . . . . . 0.534 ' HB3' ' HB3' ' B' ' 116' ' ' ALA . 32.6 m120 -137.83 142.78 40.78 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.542 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.91 113.69 6.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.717 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 127' ' ' GLY . . . . . 0.619 ' HA3' ' HB ' ' A' ' 4' ' ' THR . . . 128.45 -89.97 0.32 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.731 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 128' ' ' THR . . . . . 0.429 ' HB ' ' HD3' ' B' ' 155' ' ' LYS . 6.2 m -124.92 152.83 43.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.73 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 129' ' ' ASN . . . . . 0.541 ' HB3' ' HB2' ' E' ' 58' ' ' LEU . 17.0 t-20 -123.08 147.54 46.61 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.122 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 130' ' ' THR . . . . . 0.632 ' OG1' HD12 ' B' ' 74' ' ' LEU . 4.3 m -126.13 135.76 52.07 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.043 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 131' ' ' ILE . . . . . . . . . . . . . 58.4 mt -114.04 115.61 45.46 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 132' ' ' PRO . . . . . 0.564 ' HB3' ' H ' ' B' ' 77' ' ' ALA . 7.5 Cg_endo -81.69 115.69 2.81 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.698 1.599 . . . . 0.0 112.566 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.6 150.79 46.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.807 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 134' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' E' ' 52' ' ' VAL . 1.2 mt-30 -142.44 166.71 23.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.034 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 135' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' E' ' 102' ' ' GLN . . . -158.17 102.93 1.8 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.382 . . . . 0.0 111.636 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 136' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' E' ' 51' ' ' ALA . 0.1 OUTLIER -94.72 -173.42 3.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.352 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 137' ' ' TYR . . . . . 0.591 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 3.7 m-85 -100.86 152.87 20.0 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.082 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 138' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' E' ' 47' ' ' ALA . 0.2 OUTLIER -147.35 160.73 42.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.072 -179.183 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 139' ' ' ALA . . . . . 0.615 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -126.82 149.67 49.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.885 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 140' ' ' THR . . . . . 0.514 ' OG1' ' HA ' ' E' ' 98' ' ' ASN . 0.0 OUTLIER -115.35 27.84 9.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.484 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.4 66.79 0.2 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.951 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.91 88.61 0.09 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.604 0.24 . . . . 0.0 110.742 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 143' ' ' ALA . . . . . 0.454 ' CB ' ' HB ' ' E' ' 99' ' ' VAL . . . -60.21 156.89 14.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.751 0.31 . . . . 0.0 111.424 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 144' ' ' THR . . . . . 0.555 ' HB ' ' CD ' ' E' ' 145' ' ' PRO . 77.0 p -112.18 173.05 3.07 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.305 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 145' ' ' PRO . . . . . 0.555 ' CD ' ' HB ' ' E' ' 144' ' ' THR . 1.4 Cg_endo -84.6 145.25 10.37 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.477 2.118 . . . . 0.0 112.029 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.37 -112.73 0.55 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.56 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 147' ' ' ALA . . . . . 0.692 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -124.98 167.66 14.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.88 0.371 . . . . 0.0 111.337 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 148' ' ' ALA . . . . . 0.413 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -157.13 57.46 0.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.497 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.86 132.74 36.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.559 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.42 163.13 28.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.037 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.48 125.65 1.82 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.184 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 152' ' ' ALA . . . . . 0.794 ' HB2' HD21 ' E' ' 86' ' ' LEU . . . -154.61 165.71 35.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.204 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.83 163.13 12.74 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -119.04 134.56 55.12 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.094 0.473 . . . . 0.0 110.108 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 155' ' ' LYS . . . . . 0.677 ' HB3' ' HB3' ' E' ' 72' ' ' ALA . 0.0 OUTLIER -95.48 166.25 11.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.928 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.33 112.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.888 0.375 . . . . 0.0 111.641 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 157' ' ' GLN . . . . . 0.613 ' HB3' ' HB3' ' E' ' 70' ' ' ALA . 0.2 OUTLIER -88.76 138.85 31.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.242 0.544 . . . . 0.0 110.404 -179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 158' ' ' TYR . . . . . 0.589 ' HE2' HG11 ' E' ' 17' ' ' VAL . 22.5 m-85 -127.71 113.15 15.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.512 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.909 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.226 0.06 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.0 68.24 0.88 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.552 0.215 . . . . 0.0 111.049 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.36 87.66 6.11 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.469 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m -90.49 115.46 27.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.591 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -127.28 166.93 23.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.588 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -82.99 115.23 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.524 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.48 -71.45 1.07 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.801 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.3 172.78 34.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.918 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 33.2 m -95.49 136.96 35.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.399 . . . . 0.0 111.265 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 40.3 t -120.82 130.72 74.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.194 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -103.84 157.96 16.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.432 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -145.84 89.63 1.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 13' ' ' LYS . . . . . 0.428 ' HG2' ' H ' ' F' ' 13' ' ' LYS . 0.0 OUTLIER -79.97 135.19 36.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.431 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.56 178.38 42.08 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.853 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -156.84 -177.93 6.98 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.862 0.363 . . . . 0.0 110.345 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.25 150.15 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.222 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 17' ' ' VAL . . . . . 0.581 HG11 ' HE2' ' F' ' 158' ' ' TYR . 4.1 m -141.7 168.6 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.876 0.37 . . . . 0.0 111.025 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.02 74.66 4.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.05 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.95 91.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.035 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.46 -51.0 0.09 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.423 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 21' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER 179.88 -179.72 0.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.974 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 22' ' ' ALA . . . . . 0.896 ' HB1' ' HB1' ' D' ' 93' ' ' ALA . . . -136.18 116.51 13.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.161 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 23' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.1 120.23 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.995 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 24' ' ' ASP . . . . . 0.43 ' O ' HG23 ' F' ' 28' ' ' VAL . 2.4 m-20 -64.47 150.45 46.54 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.564 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.39 -50.07 32.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.343 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.37 -31.73 81.33 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.936 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.1 -15.99 63.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.923 0.392 . . . . 0.0 110.851 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 28' ' ' VAL . . . . . 0.43 HG23 ' O ' ' F' ' 24' ' ' ASP . 48.7 t -72.99 -43.63 58.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.379 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.41 106.15 10.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.994 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -116.78 134.05 55.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.03 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 31' ' ' THR . . . . . 0.631 HG22 ' HD3' ' E' ' 13' ' ' LYS . 0.9 OUTLIER -105.47 96.12 6.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.083 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' E' ' 11' ' ' HIS . 69.3 t -89.53 131.24 37.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 33' ' ' GLN . . . . . 0.449 ' HA ' ' HG2' ' E' ' 13' ' ' LYS . 0.3 OUTLIER -108.95 106.49 16.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.616 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 34' ' ' LEU . . . . . 0.481 HD12 ' CE2' ' F' ' 137' ' ' TYR . 0.4 OUTLIER -73.86 -40.91 62.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.637 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.01 -122.45 6.74 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.559 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 36' ' ' GLN . . . . . 0.613 ' HB3' ' HA ' ' E' ' 22' ' ' ALA . 3.7 tt0 -144.55 153.87 42.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.658 0.265 . . . . 0.0 110.936 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.525 HG23 HG22 ' E' ' 16' ' ' VAL . 0.0 OUTLIER -128.46 146.29 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.963 -179.598 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 38' ' ' ARG . . . . . 0.528 ' HE ' ' HB2' ' E' ' 22' ' ' ALA . 0.0 OUTLIER -98.2 145.94 26.11 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.764 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 39' ' ' THR . . . . . 0.554 HG23 ' O ' ' E' ' 17' ' ' VAL . 40.8 p -57.7 -23.06 49.75 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.721 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.07 -33.09 61.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.022 0.439 . . . . 0.0 110.805 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -31.11 69.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.208 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 42' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' F' ' 139' ' ' ALA . 0.0 OUTLIER -130.78 86.44 2.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.622 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.7 36.23 4.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.411 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 177.6 150.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.324 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 45' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' F' ' 140' ' ' THR . 1.7 tm-20 -64.72 134.85 55.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.34 . . . . 0.0 111.116 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.74 -14.21 53.3 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.215 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 47' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' F' ' 138' ' ' PHE . . . -57.22 129.91 43.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.927 0.394 . . . . 0.0 112.052 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 48' ' ' THR . . . . . 0.465 ' HB ' ' CE1' ' F' ' 138' ' ' PHE . 14.3 t -130.66 143.35 50.69 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.861 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 49' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 68.8 m -111.98 -157.21 0.61 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.604 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 50' ' ' SER . . . . . 0.416 ' HB3' ' HB1' ' C' ' 92' ' ' ALA . 27.7 t -74.59 150.12 39.81 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.856 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 51' ' ' ALA . . . . . 0.738 ' O ' HD12 ' C' ' 88' ' ' LEU . . . -103.19 146.7 28.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.301 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 52' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' C' ' 90' ' ' SER . 22.2 m -83.45 148.35 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.915 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.4 121.2 6.2 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.628 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 54' ' ' PHE . . . . . 0.412 ' CD1' HG23 ' F' ' 52' ' ' VAL . 16.2 p90 -153.88 125.55 7.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.852 0.358 . . . . 0.0 110.889 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -109.26 156.17 20.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.533 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 56' ' ' ILE . . . . . . . . . . . . . 22.4 mm -103.96 135.38 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.583 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.75 126.07 48.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.713 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 58' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' F' ' 129' ' ' ASN . 4.3 mp -131.65 99.96 4.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.286 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.4 174.82 11.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.982 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.71 65.21 1.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.83 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 61' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' F' ' 21' ' ' CYS . 60.6 m -98.68 142.98 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.813 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.68 109.21 15.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.261 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 63' ' ' THR . . . . . 0.463 HG23 ' HB3' ' F' ' 124' ' ' LEU . 0.2 OUTLIER -92.42 29.57 1.68 Allowed 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -90.05 -59.21 2.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.028 0.442 . . . . 0.0 111.679 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.2 -39.93 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.662 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.58 101.36 10.69 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.543 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 30.9 p -90.59 -28.71 18.27 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.857 0.36 . . . . 0.0 110.963 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.52 166.94 16.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.491 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.79 149.88 29.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.583 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 70' ' ' ALA . . . . . 0.627 ' HB3' ' HB3' ' F' ' 157' ' ' GLN . . . -112.98 159.74 18.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.164 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 51.4 t -108.02 123.28 63.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.689 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 72' ' ' ALA . . . . . 0.693 ' HB3' ' HB3' ' F' ' 155' ' ' LYS . . . -124.71 168.99 12.42 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.484 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 73' ' ' PHE . . . . . 0.54 ' CB ' HD11 ' F' ' 111' ' ' LEU . 17.2 t80 -150.58 144.47 25.3 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.562 0.22 . . . . 0.0 111.147 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 74' ' ' LEU . . . . . 0.429 HD23 ' O ' ' F' ' 74' ' ' LEU . 0.4 OUTLIER -121.58 88.61 2.97 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.989 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 75' ' ' GLY . . . . . 0.524 ' C ' HD23 ' F' ' 113' ' ' LEU . . . -134.74 164.65 24.67 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.777 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 76' ' ' THR . . . . . 0.67 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.6 OUTLIER -78.51 147.8 33.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.547 0.213 . . . . 0.0 110.786 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.78 140.38 30.66 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.838 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 78' ' ' ILE . . . . . 0.562 ' CG2' ' HB ' ' F' ' 85' ' ' VAL . 1.1 tt -78.7 -33.15 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.16 179.23 7.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.833 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.71 -27.78 36.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.036 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.3 -32.18 72.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.586 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 82' ' ' HIS . . . . . 0.412 ' HB3' HG23 ' F' ' 85' ' ' VAL . 15.3 m-70 -97.33 -72.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.877 0.37 . . . . 0.0 110.446 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.87 -7.21 1.79 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.582 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 84' ' ' ASN . . . . . 0.748 ' HA ' HD13 ' F' ' 113' ' ' LEU . 3.0 m120 -108.81 -19.08 13.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.311 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 85' ' ' VAL . . . . . 0.562 ' HB ' ' CG2' ' F' ' 78' ' ' ILE . 50.4 t -80.71 132.02 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.206 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 86' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' F' ' 152' ' ' ALA . 0.4 OUTLIER -76.55 135.0 39.26 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.255 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.27 165.15 6.18 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.923 0.392 . . . . 0.0 111.691 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 88' ' ' LEU . . . . . 0.439 ' H ' ' HG ' ' F' ' 88' ' ' LEU . 0.1 OUTLIER -65.76 171.78 4.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.018 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 89' ' ' GLN . . . . . 0.493 ' OE1' ' HB3' ' F' ' 91' ' ' SER . 8.0 pt20 -72.56 175.74 6.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.427 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.02 -21.22 57.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.002 0.43 . . . . 0.0 111.474 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 91' ' ' SER . . . . . 0.493 ' HB3' ' OE1' ' F' ' 89' ' ' GLN . 32.1 t -81.02 67.6 6.99 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 92' ' ' ALA . . . . . 0.446 ' HA ' ' OG ' ' F' ' 95' ' ' SER . . . -72.35 -9.67 58.81 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.576 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.04 -22.86 64.94 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.683 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.47 6.71 2.47 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.86 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 95' ' ' SER . . . . . 0.69 ' HA ' ' HB3' ' F' ' 147' ' ' ALA . 30.8 p -93.71 150.78 20.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.854 0.359 . . . . 0.0 110.674 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.71 167.18 18.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.64 165.19 14.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.314 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 98' ' ' ASN . . . . . 0.527 ' HA ' ' OG1' ' F' ' 140' ' ' THR . 85.1 m-20 63.2 45.5 5.06 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.489 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 99' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' F' ' 143' ' ' ALA . 3.4 p -170.65 131.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.72 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.02 -175.94 21.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.511 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 101' ' ' VAL . . . . . . . . . . . . . 76.4 t -104.19 91.9 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 122.979 0.512 . . . . 0.0 111.656 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 102' ' ' GLN . . . . . 0.552 ' HA ' ' HA ' ' F' ' 85' ' ' VAL . 0.6 OUTLIER -67.88 131.18 45.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.898 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 103' ' ' ILE . . . . . 0.52 HD12 ' O ' ' F' ' 84' ' ' ASN . 0.7 OUTLIER -99.45 110.52 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.497 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 104' ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 5.5 tp -91.15 149.98 21.57 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.656 0.265 . . . . 0.0 111.078 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.94 174.55 5.84 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.631 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 106' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' F' ' 106' ' ' ARG . 1.5 ttt180 -72.45 -18.46 61.69 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.75 0.309 . . . . 0.0 111.075 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 46.2 p -69.35 -9.66 54.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.999 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.0 -48.33 0.96 Allowed Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.671 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.96 163.57 15.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.779 0.323 . . . . 0.0 111.089 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 110' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -70.52 125.59 27.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 111' ' ' LEU . . . . . 0.54 HD11 ' CB ' ' F' ' 73' ' ' PHE . 0.0 OUTLIER -65.43 147.7 52.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.419 0.628 . . . . 0.0 110.558 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 112' ' ' THR . . . . . 0.705 ' HB ' HG21 ' F' ' 117' ' ' THR . 0.2 OUTLIER -74.16 144.67 44.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.12 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 113' ' ' LEU . . . . . 0.748 HD13 ' HA ' ' F' ' 84' ' ' ASN . 10.2 mp -100.35 89.97 4.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 110.644 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 114' ' ' ASP . . . . . 0.436 ' HB2' ' CG2' ' F' ' 117' ' ' THR . 4.1 m-20 -142.41 11.41 1.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.691 0.281 . . . . 0.0 111.6 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 115' ' ' GLY . . . . . 0.448 ' O ' ' HB1' ' F' ' 72' ' ' ALA . . . 96.91 -78.16 0.69 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.611 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 116' ' ' ALA . . . . . 0.465 ' CB ' HG21 ' E' ' 4' ' ' THR . . . -104.29 61.61 0.73 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.966 0.412 . . . . 0.0 111.62 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 117' ' ' THR . . . . . 0.705 HG21 ' HB ' ' F' ' 112' ' ' THR . 17.6 p -93.42 95.84 9.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.126 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.77 110.0 5.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.794 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.4 -72.91 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.833 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.49 113.04 25.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.665 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.36 97.42 8.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.25 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.47 132.66 37.52 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.787 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 21.8 m -60.81 146.15 47.26 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.762 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 124' ' ' LEU . . . . . 0.463 ' HB3' HG23 ' F' ' 63' ' ' THR . 0.2 OUTLIER -85.51 156.6 20.71 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.547 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 125' ' ' ASN . . . . . 0.535 ' HB3' ' HB3' ' C' ' 116' ' ' ALA . 32.6 m120 -137.91 142.71 40.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.474 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.9 113.73 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.704 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 127' ' ' GLY . . . . . 0.612 ' HA3' ' HB ' ' B' ' 4' ' ' THR . . . 128.44 -90.01 0.32 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.693 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 128' ' ' THR . . . . . 0.439 ' HB ' ' HD3' ' C' ' 155' ' ' LYS . 6.2 m -124.92 152.86 43.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.704 0.287 . . . . 0.0 110.751 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 129' ' ' ASN . . . . . 0.545 ' HB3' ' HB2' ' F' ' 58' ' ' LEU . 17.0 t-20 -123.09 147.58 46.59 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.926 0.394 . . . . 0.0 111.113 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 130' ' ' THR . . . . . 0.657 ' OG1' HD12 ' C' ' 74' ' ' LEU . 4.3 m -126.16 135.69 51.96 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.03 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 131' ' ' ILE . . . . . . . . . . . . . 58.6 mt -114.05 115.68 45.38 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 132' ' ' PRO . . . . . 0.558 ' HB3' ' H ' ' C' ' 77' ' ' ALA . 7.5 Cg_endo -81.7 115.71 2.81 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.604 1.536 . . . . 0.0 112.572 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.57 150.79 46.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.823 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 134' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' F' ' 52' ' ' VAL . 1.2 mt-30 -142.39 166.72 23.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.086 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 135' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' F' ' 102' ' ' GLN . . . -158.21 102.9 1.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.972 0.415 . . . . 0.0 111.587 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 136' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' F' ' 51' ' ' ALA . 0.2 OUTLIER -94.67 -173.46 3.02 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.397 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 137' ' ' TYR . . . . . 0.601 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 3.8 m-85 -100.76 152.82 20.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.115 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 138' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' F' ' 47' ' ' ALA . 0.2 OUTLIER -147.28 160.8 42.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.046 -179.227 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 139' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -126.88 149.63 49.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.86 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 140' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' F' ' 98' ' ' ASN . 0.0 OUTLIER -115.33 27.83 9.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.491 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.39 66.76 0.2 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.948 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . 63.0 88.57 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.615 0.207 . . . . 0.0 110.747 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 143' ' ' ALA . . . . . 0.469 ' CB ' ' HB ' ' F' ' 99' ' ' VAL . . . -60.22 156.88 14.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.728 0.299 . . . . 0.0 111.431 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 144' ' ' THR . . . . . 0.548 ' HB ' ' CD ' ' F' ' 145' ' ' PRO . 77.4 p -112.17 173.07 3.06 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.243 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 145' ' ' PRO . . . . . 0.548 ' CD ' ' HB ' ' F' ' 144' ' ' THR . 1.4 Cg_endo -84.6 145.22 10.36 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.543 2.162 . . . . 0.0 111.922 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.42 -112.77 0.55 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.495 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 147' ' ' ALA . . . . . 0.69 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -124.98 167.68 14.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.903 0.382 . . . . 0.0 111.337 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 148' ' ' ALA . . . . . 0.426 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -157.16 57.49 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.403 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.89 132.71 36.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.514 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.41 163.12 28.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.008 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.44 125.63 1.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.205 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 152' ' ' ALA . . . . . 0.767 ' HB2' HD21 ' F' ' 86' ' ' LEU . . . -154.57 165.79 35.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.215 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.83 163.17 12.71 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -119.03 134.53 55.14 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.116 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 155' ' ' LYS . . . . . 0.693 ' HB3' ' HB3' ' F' ' 72' ' ' ALA . 0.0 OUTLIER -95.51 166.21 11.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.951 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.23 112.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.771 0.32 . . . . 0.0 111.684 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 157' ' ' GLN . . . . . 0.627 ' HB3' ' HB3' ' F' ' 70' ' ' ALA . 0.2 OUTLIER -88.74 138.79 31.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.264 0.554 . . . . 0.0 110.404 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 158' ' ' TYR . . . . . 0.581 ' HE2' HG11 ' F' ' 17' ' ' VAL . 22.5 m-85 -127.63 113.2 15.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.503 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.924 179.981 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.552 0.215 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.514 HG21 ' HB2' ' B' ' 18' ' ' ASN . 57.4 m -111.23 101.02 9.55 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.46 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.651 HG21 ' HA2' ' E' ' 127' ' ' GLY . 60.6 m -86.71 131.93 34.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.56 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.788 HG23 HG23 ' B' ' 156' ' ' VAL . 0.0 OUTLIER -161.18 168.04 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.525 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -100.1 118.78 37.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.539 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.4 -56.31 6.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.748 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.94 -145.38 4.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.873 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.831 HG23 HG23 ' B' ' 153' ' ' THR . 0.0 OUTLIER -145.0 142.05 29.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.933 0.397 . . . . 0.0 111.284 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.2 t -121.65 107.32 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.176 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.75 111.0 21.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.386 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.508 ' CD1' HD11 ' B' ' 34' ' ' LEU . 32.0 m-85 -87.61 113.52 23.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.775 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.12 118.61 36.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.412 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.56 175.53 39.77 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.909 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.598 ' HG3' ' HA ' ' B' ' 147' ' ' ALA . 0.1 OUTLIER -151.27 162.14 41.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.946 0.403 . . . . 0.0 110.31 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.75 HG23 ' HB2' ' B' ' 148' ' ' ALA . 2.2 t -114.94 119.43 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.29 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.508 HG21 ' HA ' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -121.33 168.14 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.818 0.342 . . . . 0.0 111.064 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.459 ' HA ' HG22 ' B' ' 39' ' ' THR . 1.3 t-20 -68.46 -175.27 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.004 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.593 ' O ' HG21 ' A' ' 65' ' ' VAL . . . -91.14 52.66 2.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.93 -15.74 1.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.335 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -176.88 147.6 0.6 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.975 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.508 ' HA ' HG21 ' A' ' 17' ' ' VAL . . . -152.62 110.08 3.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.046 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -52.97 159.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.032 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.37 164.48 14.31 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.578 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.07 -52.29 65.89 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.397 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.43 11.92 66.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.858 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.5 t -96.23 -30.79 13.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.989 0.423 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.421 HG23 ' H ' ' A' ' 28' ' ' VAL . 11.4 t -49.88 -71.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.311 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.54 104.4 15.27 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.02 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -112.23 140.41 46.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.104 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.79 110.16 21.47 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.067 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.18 108.35 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.167 0.508 . . . . 0.0 110.42 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.59 112.5 22.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.638 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.549 HD21 ' CG2' ' A' ' 101' ' ' VAL . 5.2 mp -81.15 -41.82 21.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.572 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.67 -171.08 21.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.649 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -93.6 145.95 24.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.565 0.222 . . . . 0.0 110.912 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.515 HG22 ' H ' ' A' ' 38' ' ' ARG . 5.0 p -124.86 169.88 15.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.95 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.515 ' H ' HG22 ' A' ' 37' ' ' VAL . 5.2 mtt-85 -98.95 121.42 40.88 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.717 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -61.87 -31.06 71.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.738 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.56 -39.3 84.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.999 0.428 . . . . 0.0 110.81 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.3 m -81.32 -10.35 59.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.204 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.741 ' O ' ' HB2' ' A' ' 143' ' ' ALA . 0.6 OUTLIER -129.36 40.51 3.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.556 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.605 ' HA ' ' H ' ' A' ' 143' ' ' ALA . . . -111.86 10.88 20.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.366 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.53 145.55 48.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.329 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 140' ' ' THR . 18.2 tt0 -63.34 121.17 13.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 111.159 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.02 14.54 33.51 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.15 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.699 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -72.26 121.2 19.0 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 p -129.97 133.84 47.06 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.893 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 57.8 m -112.52 -166.75 1.11 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.625 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.2 t -59.08 149.48 27.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.818 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.82 153.57 17.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.347 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.649 HG22 ' HB3' ' A' ' 135' ' ' ALA . 3.7 m -103.37 130.31 53.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.98 121.53 6.57 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.619 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.496 ' HD1' HG23 ' A' ' 52' ' ' VAL . 52.3 p90 -153.7 136.41 15.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.779 0.323 . . . . 0.0 110.955 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ILE . 24.7 p30 -133.59 141.3 47.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.679 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.639 HG21 HD12 ' A' ' 131' ' ' ILE . 1.2 tt -85.13 126.49 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.622 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.609 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.1 OUTLIER -75.77 119.39 19.72 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.773 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -130.69 87.31 2.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.316 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.721 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 6.8 p-10 -77.18 173.72 11.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.981 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.519 ' HB3' ' HE ' ' B' ' 38' ' ' ARG . 41.5 m-20 62.82 66.38 0.76 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 34.4 m -115.64 161.96 17.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.732 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.51 ' HA ' ' OD1' ' A' ' 126' ' ' ASN . 0.2 OUTLIER -145.94 157.82 43.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.289 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.481 HG23 ' HA ' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -107.5 -16.74 14.29 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.13 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.39 -33.63 32.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.062 0.458 . . . . 0.0 111.763 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.593 HG21 ' O ' ' A' ' 19' ' ' ALA . 20.1 t -75.21 -41.56 44.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.665 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.91 146.75 29.15 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.558 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.83 -39.37 3.73 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.895 0.378 . . . . 0.0 110.92 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.31 159.53 15.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.477 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.601 ' HB3' ' HB ' ' A' ' 122' ' ' THR . . . -147.2 118.88 8.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.616 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -96.84 140.72 30.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.096 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 131' ' ' ILE . 3.1 t -118.43 139.71 44.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.798 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.4 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -140.54 133.92 29.86 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.523 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.792 ' HD2' HD13 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -101.26 138.04 38.8 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.575 0.226 . . . . 0.0 111.15 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.734 HD21 HG21 ' D' ' 130' ' ' THR . 6.6 tt -100.99 91.02 4.38 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.001 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.37 -167.37 11.32 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.87 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -116.75 159.52 22.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.64 0.257 . . . . 0.0 110.752 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB2' HG23 ' A' ' 83' ' ' THR . . . -83.96 137.96 33.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.996 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 82' ' ' HIS . 9.0 tt -77.17 -40.52 29.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.88 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.603 ' HB2' HG21 ' A' ' 140' ' ' THR . 0.1 OUTLIER -141.18 55.24 1.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.852 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' D' ' 106' ' ' ARG . . . 52.85 -84.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.081 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -60.1 -16.12 39.58 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.577 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.46 ' O ' HG22 ' A' ' 78' ' ' ILE . 24.5 m80 -100.6 56.74 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.597 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.526 HG23 ' HB2' ' A' ' 77' ' ' ALA . 1.1 m -71.36 -22.46 61.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.537 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 2.9 p30 -57.23 -18.68 17.12 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.338 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 138' ' ' PHE . 11.6 t -115.19 133.31 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.213 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.912 HD12 HD22 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -72.93 154.12 40.69 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.347 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.601 ' N ' HD23 ' A' ' 86' ' ' LEU . . . -90.72 -161.37 0.8 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.846 0.355 . . . . 0.0 111.793 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.31 6.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.974 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.65 -83.92 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.312 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.26 20.53 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.415 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.754 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 1.5 m -86.59 79.34 8.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.75 -31.51 38.42 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.916 0.389 . . . . 0.0 111.672 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' D' ' 36' ' ' GLN . . . -128.09 54.53 1.72 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.615 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.89 -17.27 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.975 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.754 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 0.9 OUTLIER -89.47 177.19 6.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.797 0.332 . . . . 0.0 110.622 179.608 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.69 175.24 8.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.777 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -137.51 137.98 39.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.269 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 97' ' ' THR . 74.0 m-80 71.69 17.64 5.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.434 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.99 148.93 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.728 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.28 -176.74 35.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.46 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.549 ' CG2' HD21 ' A' ' 34' ' ' LEU . 7.7 p -125.58 111.02 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 122.993 0.517 . . . . 0.0 111.718 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.612 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 0.9 OUTLIER -81.53 147.74 29.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.873 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.792 HD13 ' HD2' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -123.76 115.94 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.489 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -88.7 140.55 29.34 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.621 0.248 . . . . 0.0 111.031 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . 2.1 t70 -89.37 152.0 21.75 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.68 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.645 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -71.74 -21.08 61.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.816 0.341 . . . . 0.0 111.101 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.61 ' HB ' ' HA ' ' A' ' 120' ' ' SER . 5.8 t -62.89 -21.94 66.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.064 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.69 -83.09 0.19 Allowed Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.611 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.69 170.67 15.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.776 0.322 . . . . 0.0 111.098 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.739 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -74.82 138.64 42.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.224 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.617 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 5.1 tp -94.53 153.38 17.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.343 0.592 . . . . 0.0 110.568 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.782 HG22 HG21 ' A' ' 117' ' ' THR . 6.2 t -93.68 148.24 22.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.171 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.912 HD22 HD12 ' A' ' 86' ' ' LEU . 1.4 mp -89.51 64.78 6.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.77 0.319 . . . . 0.0 110.771 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.557 ' HB2' ' OG1' ' A' ' 117' ' ' THR . 0.5 OUTLIER -95.04 -16.1 22.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.606 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.604 ' HA3' ' HG1' ' D' ' 130' ' ' THR . . . 104.44 -56.28 0.56 Allowed Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.66 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' D' ' 125' ' ' ASN . . . -103.56 29.08 5.95 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.994 0.426 . . . . 0.0 111.667 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.782 HG21 HG22 ' A' ' 112' ' ' THR . 3.4 m -87.19 65.85 9.01 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.105 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.519 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 48.3 m-85 -77.69 73.45 4.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.5 70.78 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.61 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 0.7 OUTLIER -148.63 126.09 11.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.681 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.05 53.21 2.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.25 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -74.06 128.34 35.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.75 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.36 117.89 25.45 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.703 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.51 134.76 33.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.719 0.295 . . . . 0.0 110.538 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.481 ' HA ' HG23 ' A' ' 63' ' ' THR . 0.3 OUTLIER -129.21 163.1 26.33 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.672 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' A' ' 62' ' ' ASP . 1.5 t30 -67.61 125.33 25.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.669 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.61 -141.04 12.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.687 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 6.3 m -101.73 92.47 4.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.647 0.26 . . . . 0.0 110.729 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . 0.541 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 1.2 t30 -76.54 145.03 39.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.926 0.393 . . . . 0.0 111.13 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.609 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -134.63 131.81 38.24 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.049 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.687 HD11 HG12 ' A' ' 156' ' ' VAL . 28.4 mt -87.43 109.82 29.03 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.645 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.4 Cg_endo -81.65 112.12 2.38 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.578 1.518 . . . . 0.0 112.608 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.28 138.22 51.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 28.2 mt-30 -110.1 157.5 19.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.062 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.649 ' HB3' HG22 ' A' ' 52' ' ' VAL . . . -152.68 107.91 3.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.97 0.414 . . . . 0.0 111.585 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -102.51 174.4 5.92 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.36 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 0.6 OUTLIER -85.96 120.88 27.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.083 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.526 ' HB3' HG11 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -117.67 139.6 50.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.076 -179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.699 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -129.88 145.66 51.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.914 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' THR . . . . . 0.603 HG21 ' HB2' ' A' ' 79' ' ' ASP . 16.5 p -104.43 -53.4 2.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.483 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.76 -121.48 3.26 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.989 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.12 112.83 24.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.517 0.199 . . . . 0.0 110.719 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 42' ' ' LEU . . . -61.68 150.85 35.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.805 0.336 . . . . 0.0 111.519 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.558 HG23 ' HD2' ' A' ' 145' ' ' PRO . 60.0 m -126.79 151.49 73.67 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.26 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.558 ' HD2' HG23 ' A' ' 144' ' ' THR . 1.4 Cg_endo -83.03 140.23 9.92 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.573 2.182 . . . . 0.0 111.963 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.9 -138.1 6.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.539 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -87.21 144.99 26.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.898 0.38 . . . . 0.0 111.367 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.73 38.87 1.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.527 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.05 153.48 22.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.505 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.588 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -161.87 171.28 17.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.04 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.42 126.8 7.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.239 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' A' ' 86' ' ' LEU . . . -125.35 142.85 51.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.249 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.86 133.17 34.89 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.482 ' HD1' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -86.45 127.87 34.89 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.119 0.485 . . . . 0.0 110.079 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.49 150.51 29.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.962 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.687 HG12 HD11 ' A' ' 131' ' ' ILE . 14.2 m -136.23 144.48 32.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.863 0.363 . . . . 0.0 111.571 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -136.19 132.76 36.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.32 0.581 . . . . 0.0 110.386 -179.683 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.494 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 5.5 m-85 -117.41 119.77 36.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.516 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 1' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' C' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.23 0.062 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.19 64.9 1.55 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.086 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' THR . . . . . 0.532 HG21 ' HB2' ' C' ' 18' ' ' ASN . 59.0 m -111.21 100.99 9.53 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.05 0.452 . . . . 0.0 111.536 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.661 HG21 ' HA2' ' F' ' 127' ' ' GLY . 60.1 m -86.72 131.91 34.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.545 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.809 HG23 HG23 ' C' ' 156' ' ' VAL . 0.0 OUTLIER -161.09 168.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.532 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.17 118.75 37.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.571 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.32 -56.32 6.97 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.759 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.97 -145.36 4.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.923 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' THR . . . . . 0.82 HG23 HG23 ' C' ' 153' ' ' THR . 0.0 OUTLIER -144.99 142.1 29.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.927 0.394 . . . . 0.0 111.302 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.66 107.37 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.198 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.81 110.95 21.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.365 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' PHE . . . . . 0.506 ' CD1' HD11 ' C' ' 34' ' ' LEU . 31.8 m-85 -87.58 113.58 23.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.794 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 118.55 36.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.338 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.51 175.6 39.73 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.973 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.615 ' HG3' ' HA ' ' C' ' 147' ' ' ALA . 0.1 OUTLIER -151.36 162.08 41.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.967 0.413 . . . . 0.0 110.302 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.732 HG23 ' HB2' ' C' ' 148' ' ' ALA . 2.2 t -114.95 119.38 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.268 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' B' ' 22' ' ' ALA . 0.3 OUTLIER -121.28 168.1 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.887 0.375 . . . . 0.0 111.017 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ASN . . . . . 0.514 ' HB2' HG21 ' A' ' 3' ' ' THR . 1.3 t-20 -68.54 -175.25 0.63 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.91 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.606 ' O ' HG21 ' B' ' 65' ' ' VAL . . . -91.1 52.61 2.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.233 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.95 -15.64 1.32 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.39 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.798 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER -176.95 147.63 0.59 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.965 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.494 ' HA ' HG21 ' B' ' 17' ' ' VAL . . . -152.63 110.04 3.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.084 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' B' ' 58' ' ' LEU . 0.3 OUTLIER -53.0 159.07 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.39 164.47 14.3 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.563 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.99 -52.39 65.44 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.369 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.33 11.91 66.35 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.916 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 18.4 t -96.25 -30.78 13.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.894 0.378 . . . . 0.0 110.908 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.408 ' H ' HG23 ' B' ' 28' ' ' VAL . 11.3 t -49.89 -71.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.341 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.55 104.36 15.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.012 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -112.21 140.34 46.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.082 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.82 110.13 21.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.054 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.13 108.42 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.157 0.503 . . . . 0.0 110.44 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.66 112.43 22.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.63 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.544 HD21 ' CG2' ' B' ' 101' ' ' VAL . 5.2 mp -81.12 -41.82 21.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.625 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.76 -171.05 21.51 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.603 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' GLN . . . . . 0.549 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 1.7 mt-30 -93.69 145.88 24.25 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.602 0.239 . . . . 0.0 110.908 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.516 HG22 ' H ' ' B' ' 38' ' ' ARG . 5.0 p -124.8 169.89 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.94 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.519 ' HE ' ' HB3' ' A' ' 60' ' ' ASP . 5.1 mtt-85 -98.95 121.5 40.99 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.68 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' THR . . . . . 0.541 ' O ' ' HB2' ' B' ' 43' ' ' ALA . 0.6 OUTLIER -62.01 -31.0 71.34 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.705 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.28 84.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.91 0.386 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 70.9 m -81.31 -10.39 59.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.149 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.755 ' O ' ' HB2' ' B' ' 143' ' ' ALA . 0.6 OUTLIER -129.27 40.48 3.61 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.59 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ALA . . . . . 0.617 ' HA ' ' H ' ' B' ' 143' ' ' ALA . . . -111.86 10.94 20.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.333 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.56 145.52 48.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.326 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' B' ' 140' ' ' THR . 18.2 tt0 -63.3 121.15 13.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.81 0.338 . . . . 0.0 111.133 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.05 14.49 33.56 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.163 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' B' ' 139' ' ' ALA . . . -72.36 121.19 19.08 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 15.1 p -130.01 133.8 47.0 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.86 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 57.8 m -112.47 -166.68 1.1 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.592 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 36.2 t -59.07 149.52 27.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.76 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.84 153.59 17.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.397 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' VAL . . . . . 0.655 HG22 ' HB3' ' B' ' 135' ' ' ALA . 3.7 m -103.42 130.31 53.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.92 121.45 6.53 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.64 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' PHE . . . . . 0.492 ' HD1' HG23 ' B' ' 52' ' ' VAL . 52.1 p90 -153.64 136.41 15.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.816 0.341 . . . . 0.0 110.962 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' B' ' 131' ' ' ILE . 24.8 p30 -133.58 141.31 47.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.707 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.649 HG21 HD12 ' B' ' 131' ' ' ILE . 1.2 tt -85.19 126.45 40.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.59 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' GLN . . . . . 0.609 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.1 OUTLIER -75.79 119.38 19.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.711 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 0.2 OUTLIER -130.64 87.34 2.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.299 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ASN . . . . . 0.721 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 6.7 p-10 -77.29 173.71 11.59 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.955 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ASP . . . . . 0.53 ' HB3' ' HE ' ' C' ' 38' ' ' ARG . 41.6 m-20 62.85 66.43 0.75 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.878 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' CYS . . . . . 0.798 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 34.4 m -115.71 161.96 17.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.736 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ASP . . . . . 0.504 ' HA ' ' OD1' ' B' ' 126' ' ' ASN . 0.2 OUTLIER -145.91 157.86 43.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.35 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.476 HG23 ' HA ' ' B' ' 125' ' ' ASN . 0.0 OUTLIER -107.54 -16.71 14.29 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.13 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.4 -33.7 32.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.057 0.456 . . . . 0.0 111.737 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' VAL . . . . . 0.606 HG21 ' O ' ' B' ' 19' ' ' ALA . 20.0 t -75.12 -41.62 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.675 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.94 146.75 29.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.55 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.75 -39.43 3.74 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.893 0.378 . . . . 0.0 110.951 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.31 159.55 15.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.456 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' ALA . . . . . 0.603 ' HB3' ' HB ' ' B' ' 122' ' ' THR . . . -147.18 118.88 8.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.608 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.524 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -96.84 140.79 30.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.025 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.473 HG11 HG21 ' B' ' 131' ' ' ILE . 3.1 t -118.52 139.69 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.762 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.52 133.93 29.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.595 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' PHE . . . . . 0.771 ' HD2' HD13 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -101.28 138.06 38.8 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.623 0.249 . . . . 0.0 111.116 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.714 HD21 HG21 ' E' ' 130' ' ' THR . 6.6 tt -101.05 91.12 4.41 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.003 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.38 -167.4 11.32 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.886 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' THR . . . . . 0.659 ' O ' ' HA ' ' B' ' 86' ' ' LEU . 0.3 OUTLIER -116.7 159.45 22.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.58 0.229 . . . . 0.0 110.761 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.517 ' HB2' HG23 ' B' ' 83' ' ' THR . . . -83.84 137.92 33.46 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.013 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ILE . . . . . 0.452 HG22 ' O ' ' B' ' 82' ' ' HIS . 9.0 tt -77.16 -40.47 29.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.894 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ASP . . . . . 0.603 ' HB2' HG21 ' B' ' 140' ' ' THR . 0.1 OUTLIER -141.26 55.26 1.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.786 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 80' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' E' ' 106' ' ' ARG . . . 52.93 -84.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.008 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' B' ' 79' ' ' ASP . . . -60.07 -16.11 39.27 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.62 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' HIS . . . . . 0.452 ' O ' HG22 ' B' ' 78' ' ' ILE . 24.2 m80 -100.54 56.68 0.9 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.925 0.393 . . . . 0.0 110.619 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' THR . . . . . 0.517 HG23 ' HB2' ' B' ' 77' ' ' ALA . 1.1 m -71.33 -22.42 61.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.587 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ASN . . . . . 0.738 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 2.9 p30 -57.23 -18.71 17.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.305 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' B' ' 138' ' ' PHE . 11.5 t -115.18 133.45 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.211 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' LEU . . . . . 0.923 HD12 HD22 ' B' ' 113' ' ' LEU . 0.8 OUTLIER -73.01 154.03 40.66 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.352 179.362 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.601 ' N ' HD23 ' B' ' 86' ' ' LEU . . . -90.69 -161.34 0.79 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.823 0.344 . . . . 0.0 111.793 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.23 6.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.016 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.65 -83.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.31 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.26 20.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.453 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' SER . . . . . 0.77 ' HB2' ' HB2' ' B' ' 95' ' ' SER . 1.5 m -86.53 79.35 8.97 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.71 -31.56 38.36 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.808 0.337 . . . . 0.0 111.642 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' E' ' 36' ' ' GLN . . . -128.02 54.4 1.72 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.663 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.87 -17.3 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.934 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' SER . . . . . 0.77 ' HB2' ' HB2' ' B' ' 91' ' ' SER . 0.9 OUTLIER -89.35 177.21 6.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.768 0.318 . . . . 0.0 110.703 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.71 175.31 8.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.785 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' B' ' 98' ' ' ASN . 0.2 OUTLIER -137.61 137.94 39.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.25 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 98' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' B' ' 97' ' ' THR . 74.0 m-80 71.78 17.6 5.38 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.444 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.95 149.0 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.672 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.44 -176.76 35.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.441 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.544 ' CG2' HD21 ' B' ' 34' ' ' LEU . 7.7 p -125.56 111.1 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 122.974 0.51 . . . . 0.0 111.678 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 102' ' ' GLN . . . . . 0.609 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 0.9 OUTLIER -81.67 147.68 29.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.789 -179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 103' ' ' ILE . . . . . 0.771 HD13 ' HD2' ' B' ' 73' ' ' PHE . 0.9 OUTLIER -123.64 115.91 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.54 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 104' ' ' LEU . . . . . 0.709 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 0.4 OUTLIER -88.68 140.5 29.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.614 0.245 . . . . 0.0 111.036 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 105' ' ' ASP . . . . . 0.601 ' HB2' ' HB2' ' B' ' 111' ' ' LEU . 2.1 t70 -89.31 152.01 21.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.708 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' ARG . . . . . 0.627 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -71.8 -21.03 61.76 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.752 0.31 . . . . 0.0 111.027 179.48 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 107' ' ' THR . . . . . 0.614 ' HB ' ' HA ' ' B' ' 120' ' ' SER . 5.8 t -62.91 -21.94 66.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.007 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.64 -83.02 0.19 Allowed Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.662 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.69 170.72 15.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.767 0.318 . . . . 0.0 111.05 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.709 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -74.94 138.68 42.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.186 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' B' ' 105' ' ' ASP . 5.1 tp -94.53 153.47 17.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.385 0.612 . . . . 0.0 110.571 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' THR . . . . . 0.805 HG22 HG21 ' B' ' 117' ' ' THR . 6.2 t -93.68 148.28 22.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.105 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.923 HD22 HD12 ' B' ' 86' ' ' LEU . 1.4 mp -89.64 64.9 6.74 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.783 0.325 . . . . 0.0 110.722 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ASP . . . . . 0.556 ' HB2' ' OG1' ' B' ' 117' ' ' THR . 0.5 OUTLIER -95.07 -16.07 22.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.62 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 115' ' ' GLY . . . . . 0.607 ' HA3' ' HG1' ' E' ' 130' ' ' THR . . . 104.43 -56.24 0.57 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.637 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' E' ' 125' ' ' ASN . . . -103.61 29.0 6.03 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.029 0.442 . . . . 0.0 111.714 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' THR . . . . . 0.805 HG21 HG22 ' B' ' 112' ' ' THR . 3.4 m -87.08 65.85 9.1 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.142 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' PHE . . . . . 0.524 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . 48.3 m-85 -77.65 73.4 4.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.772 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.53 70.86 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' SER . . . . . 0.614 ' HA ' ' HB ' ' B' ' 107' ' ' THR . 0.7 OUTLIER -148.69 126.11 11.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.673 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.07 53.18 2.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.232 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' B' ' 69' ' ' ALA . 0.2 OUTLIER -73.97 128.28 35.1 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.732 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.33 117.97 25.47 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.675 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.51 134.8 33.76 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.548 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 125' ' ' ASN . . . . . 0.476 ' HA ' HG23 ' B' ' 63' ' ' THR . 0.3 OUTLIER -129.28 163.06 26.49 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.637 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 126' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' B' ' 62' ' ' ASP . 1.5 t30 -67.58 125.43 26.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.66 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.58 -141.06 12.22 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.664 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 6.3 m -101.74 92.34 4.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.673 0.273 . . . . 0.0 110.788 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ASN . . . . . 0.544 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 1.2 t30 -76.44 145.01 39.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.164 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.609 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.0 OUTLIER -134.62 131.81 38.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.073 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 131' ' ' ILE . . . . . 0.677 HD11 HG12 ' B' ' 156' ' ' VAL . 28.4 mt -87.41 109.8 28.86 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 132' ' ' PRO . . . . . 0.627 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.6 Cg_endo -81.52 112.06 2.4 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 121.645 1.563 . . . . 0.0 112.608 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.3 138.24 51.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.875 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 134' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' B' ' 52' ' ' VAL . 28.1 mt-30 -110.13 157.48 19.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.035 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 135' ' ' ALA . . . . . 0.655 ' HB3' HG22 ' B' ' 52' ' ' VAL . . . -152.66 107.84 3.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.905 0.383 . . . . 0.0 111.602 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -102.5 174.38 5.93 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.376 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' TYR . . . . . 0.475 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 0.6 OUTLIER -85.97 120.87 27.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.105 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 138' ' ' PHE . . . . . 0.516 ' HB3' HG11 ' B' ' 85' ' ' VAL . 0.2 OUTLIER -117.66 139.57 50.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.062 -179.181 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 139' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' B' ' 47' ' ' ALA . . . -129.86 145.57 51.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.913 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 140' ' ' THR . . . . . 0.603 HG21 ' HB2' ' B' ' 79' ' ' ASP . 16.7 p -104.32 -53.41 2.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.513 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.75 -121.54 3.27 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.027 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.04 112.88 24.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.573 0.225 . . . . 0.0 110.729 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 143' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' B' ' 42' ' ' LEU . . . -61.69 150.86 35.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.783 0.325 . . . . 0.0 111.481 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.554 HG23 ' HD2' ' B' ' 145' ' ' PRO . 59.6 m -126.79 151.51 73.72 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.274 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 145' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' B' ' 144' ' ' THR . 1.3 Cg_endo -83.06 140.24 9.9 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.626 2.218 . . . . 0.0 111.945 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.91 -138.09 6.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.518 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' ALA . . . . . 0.598 ' HA ' ' HG3' ' A' ' 15' ' ' GLU . . . -87.2 144.99 26.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.925 0.393 . . . . 0.0 111.351 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 148' ' ' ALA . . . . . 0.75 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -140.7 38.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.566 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -86.09 153.59 21.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.546 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 150' ' ' ALA . . . . . 0.607 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -161.88 171.24 18.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.041 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.45 126.79 7.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.251 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 152' ' ' ALA . . . . . 0.541 ' HB2' ' CD1' ' B' ' 86' ' ' LEU . . . -125.32 142.78 51.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.259 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.831 HG23 HG23 ' A' ' 9' ' ' THR . 0.5 OUTLIER -89.83 133.18 34.87 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 154' ' ' PHE . . . . . 0.403 ' HD1' ' HA ' ' B' ' 154' ' ' PHE . 0.0 OUTLIER -86.41 127.85 34.88 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.118 0.485 . . . . 0.0 110.137 -179.024 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 155' ' ' LYS . . . . . 0.4 ' HE3' HD12 ' B' ' 74' ' ' LEU . 29.1 mmtt -111.54 150.53 29.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.882 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 156' ' ' VAL . . . . . 0.788 HG23 HG23 ' A' ' 5' ' ' VAL . 14.3 m -136.19 144.47 33.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.614 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 157' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -136.17 132.75 36.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.253 0.549 . . . . 0.0 110.442 -179.686 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 158' ' ' TYR . . . . . 0.495 ' OH ' ' HB3' ' B' ' 21' ' ' CYS . 5.5 m-85 -117.45 119.7 35.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.514 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.881 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 1' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' D' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 111.123 0.045 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.26 65.02 1.5 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.598 0.237 . . . . 0.0 110.96 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 3' ' ' THR . . . . . 0.525 HG21 ' HB2' ' D' ' 18' ' ' ASN . 57.2 m -111.23 101.0 9.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.471 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 4' ' ' THR . . . . . 0.512 ' HA ' ' HG2' ' D' ' 157' ' ' GLN . 61.6 m -86.63 131.85 34.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.67 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.792 HG23 HG23 ' D' ' 156' ' ' VAL . 0.0 OUTLIER -161.11 168.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.607 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.09 118.68 36.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.616 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.26 -56.38 6.96 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.752 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.97 -145.38 4.66 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.909 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 9' ' ' THR . . . . . 0.812 HG23 HG23 ' D' ' 153' ' ' THR . 0.0 OUTLIER -145.02 142.06 29.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.399 . . . . 0.0 111.292 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 10' ' ' VAL . . . . . 0.4 HG21 ' HZ ' ' D' ' 73' ' ' PHE . 44.0 t -121.59 107.33 19.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.211 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.73 110.97 21.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.424 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 12' ' ' PHE . . . . . 0.51 ' CD1' HD11 ' D' ' 34' ' ' LEU . 32.0 m-85 -87.59 113.59 23.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.713 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.19 118.53 36.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.379 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.54 175.58 39.76 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.974 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' GLU . . . . . 0.608 ' HG3' ' HA ' ' D' ' 147' ' ' ALA . 0.1 OUTLIER -151.36 162.16 41.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.967 0.413 . . . . 0.0 110.263 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 16' ' ' VAL . . . . . 0.743 HG23 ' HB2' ' D' ' 148' ' ' ALA . 2.2 t -115.08 119.48 61.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.153 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 17' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' C' ' 22' ' ' ALA . 0.3 OUTLIER -121.31 168.1 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.808 0.337 . . . . 0.0 111.063 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 18' ' ' ASN . . . . . 0.532 ' HB2' HG21 ' B' ' 3' ' ' THR . 1.3 t-20 -68.5 -175.24 0.63 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.976 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 19' ' ' ALA . . . . . 0.602 ' O ' HG21 ' C' ' 65' ' ' VAL . . . -91.11 52.63 2.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.93 -15.76 1.32 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.361 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER -176.91 147.64 0.6 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.926 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 22' ' ' ALA . . . . . 0.507 ' HA ' HG21 ' C' ' 17' ' ' VAL . . . -152.59 110.04 3.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.097 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 23' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' C' ' 58' ' ' LEU . 0.3 OUTLIER -53.08 159.07 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.01 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -90.32 164.46 14.34 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.614 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -57.01 -52.39 65.47 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.357 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.38 11.97 66.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.912 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 18.3 t -96.29 -30.78 13.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.889 0.376 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 11.2 t -49.76 -71.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.341 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.52 104.31 15.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.086 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -112.19 140.36 46.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.113 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.8 110.07 21.35 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.142 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -108.04 108.4 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.118 0.485 . . . . 0.0 110.386 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.67 112.42 22.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.687 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 34' ' ' LEU . . . . . 0.538 HD21 ' CG2' ' C' ' 101' ' ' VAL . 5.3 mp -81.03 -41.8 22.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.699 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.72 -171.12 21.61 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.604 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 1.7 mt-30 -93.67 145.91 24.21 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.62 0.247 . . . . 0.0 110.913 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.51 HG22 ' H ' ' C' ' 38' ' ' ARG . 5.0 p -124.84 169.94 15.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.94 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 38' ' ' ARG . . . . . 0.53 ' HE ' ' HB3' ' B' ' 60' ' ' ASP . 5.2 mtt-85 -98.93 121.37 40.79 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.71 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 39' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' C' ' 43' ' ' ALA . 0.6 OUTLIER -61.96 -30.94 71.27 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.717 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.61 -39.3 84.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.909 0.385 . . . . 0.0 110.764 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 71.3 m -81.29 -10.4 59.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.163 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.757 ' O ' ' HB2' ' C' ' 143' ' ' ALA . 0.6 OUTLIER -129.34 40.45 3.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.577 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 43' ' ' ALA . . . . . 0.618 ' HA ' ' H ' ' C' ' 143' ' ' ALA . . . -111.89 10.91 20.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.355 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.51 145.52 48.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.372 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' C' ' 140' ' ' THR . 18.1 tt0 -63.26 121.12 12.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.814 0.34 . . . . 0.0 111.204 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.07 14.4 33.77 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.14 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' C' ' 139' ' ' ALA . . . -72.21 121.19 18.93 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 14.9 p -129.98 133.77 47.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.908 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 57.8 m -112.44 -166.73 1.1 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.59 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 36.1 t -59.06 149.46 27.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.801 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.82 153.64 17.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.369 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 52' ' ' VAL . . . . . 0.65 HG22 ' HB3' ' C' ' 135' ' ' ALA . 3.7 m -103.44 130.4 53.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.97 121.43 6.53 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.662 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' PHE . . . . . 0.497 ' HD1' HG23 ' C' ' 52' ' ' VAL . 52.2 p90 -153.65 136.39 15.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.776 0.322 . . . . 0.0 110.986 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 55' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' C' ' 131' ' ' ILE . 24.7 p30 -133.54 141.33 47.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.637 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.634 HG21 HD12 ' C' ' 131' ' ' ILE . 1.2 tt -85.17 126.52 40.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.62 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.603 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.1 OUTLIER -75.88 119.4 19.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.713 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 58' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' C' ' 23' ' ' VAL . 0.2 OUTLIER -130.63 87.29 2.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.254 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 59' ' ' ASN . . . . . 0.719 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 6.7 p-10 -77.15 173.7 11.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.998 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 60' ' ' ASP . . . . . 0.523 ' HB3' ' HE ' ' D' ' 38' ' ' ARG . 41.3 m-20 62.83 66.4 0.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 61' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 34.5 m -115.68 161.98 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.742 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 62' ' ' ASP . . . . . 0.51 ' HA ' ' OD1' ' C' ' 126' ' ' ASN . 0.2 OUTLIER -145.94 157.85 43.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.3 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.491 HG23 ' HA ' ' C' ' 125' ' ' ASN . 0.0 OUTLIER -107.54 -16.65 14.31 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.138 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -81.35 -33.67 32.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.124 0.488 . . . . 0.0 111.817 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 65' ' ' VAL . . . . . 0.602 HG21 ' O ' ' C' ' 19' ' ' ALA . 20.0 t -75.14 -41.68 44.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.661 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.84 146.79 29.24 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.595 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.84 -39.35 3.73 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.897 0.379 . . . . 0.0 110.95 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.22 159.54 15.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.467 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 69' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' C' ' 122' ' ' THR . . . -147.24 118.87 7.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.578 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 70' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -96.81 140.79 30.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.847 0.356 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 71' ' ' VAL . . . . . 0.479 HG11 HG21 ' C' ' 131' ' ' ILE . 3.1 t -118.51 139.74 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.732 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 72' ' ' ALA . . . . . 0.407 ' HA ' HD21 ' C' ' 111' ' ' LEU . . . -140.54 133.91 29.84 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.521 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 73' ' ' PHE . . . . . 0.781 ' HD2' HD13 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -101.25 138.08 38.74 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.538 0.209 . . . . 0.0 111.185 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 74' ' ' LEU . . . . . 0.717 HD21 HG21 ' F' ' 130' ' ' THR . 6.6 tt -101.06 91.09 4.4 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.982 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.37 -167.37 11.32 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.871 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 76' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' C' ' 86' ' ' LEU . 0.3 OUTLIER -116.67 159.53 22.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.557 0.218 . . . . 0.0 110.796 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 77' ' ' ALA . . . . . 0.525 ' HB2' HG23 ' C' ' 83' ' ' THR . . . -83.95 137.95 33.38 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.942 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 78' ' ' ILE . . . . . 0.457 HG22 ' O ' ' C' ' 82' ' ' HIS . 8.9 tt -77.18 -40.5 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.905 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 79' ' ' ASP . . . . . 0.62 ' HB2' HG21 ' C' ' 140' ' ' THR . 0.1 OUTLIER -141.18 55.31 1.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.796 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 80' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' F' ' 106' ' ' ARG . . . 52.86 -84.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.051 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' C' ' 79' ' ' ASP . . . -60.09 -16.09 39.36 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.621 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 82' ' ' HIS . . . . . 0.457 ' O ' HG22 ' C' ' 78' ' ' ILE . 24.2 m80 -100.64 56.76 0.9 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.931 0.396 . . . . 0.0 110.584 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 83' ' ' THR . . . . . 0.525 HG23 ' HB2' ' C' ' 77' ' ' ALA . 1.1 m -71.33 -22.44 61.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.584 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 84' ' ' ASN . . . . . 0.735 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 2.8 p30 -57.18 -18.72 16.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.341 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.505 HG11 ' HB3' ' C' ' 138' ' ' PHE . 11.6 t -115.19 133.34 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.219 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 86' ' ' LEU . . . . . 0.927 HD12 HD22 ' C' ' 113' ' ' LEU . 0.8 OUTLIER -72.96 154.12 40.67 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.606 ' N ' HD23 ' C' ' 86' ' ' LEU . . . -90.76 -161.4 0.8 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.777 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.27 6.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.966 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.72 -83.84 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.317 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.27 20.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.985 0.421 . . . . 0.0 111.468 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 91' ' ' SER . . . . . 0.774 ' HB2' ' HB2' ' C' ' 95' ' ' SER . 1.5 m -86.58 79.25 8.98 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.67 -31.56 37.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.831 0.348 . . . . 0.0 111.611 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 93' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' F' ' 36' ' ' GLN . . . -128.1 54.49 1.72 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.661 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.9 -17.23 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.067 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 95' ' ' SER . . . . . 0.774 ' HB2' ' HB2' ' C' ' 91' ' ' SER . 0.9 OUTLIER -89.43 177.22 6.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.707 0.289 . . . . 0.0 110.65 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.77 175.3 8.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.759 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 97' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' C' ' 98' ' ' ASN . 0.2 OUTLIER -137.55 137.98 39.14 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.215 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 98' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' C' ' 97' ' ' THR . 74.0 m-80 71.69 17.63 5.46 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.465 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.9 148.96 26.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.741 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.39 -176.77 35.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.464 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 101' ' ' VAL . . . . . 0.538 ' CG2' HD21 ' C' ' 34' ' ' LEU . 7.7 p -125.58 111.03 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.01 0.524 . . . . 0.0 111.711 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 102' ' ' GLN . . . . . 0.614 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 0.9 OUTLIER -81.54 147.75 29.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 -179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 103' ' ' ILE . . . . . 0.781 HD13 ' HD2' ' C' ' 73' ' ' PHE . 0.9 OUTLIER -123.77 115.94 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.489 179.45 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 104' ' ' LEU . . . . . 0.721 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 0.4 OUTLIER -88.73 140.53 29.35 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.634 0.254 . . . . 0.0 111.052 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 105' ' ' ASP . . . . . 0.59 ' HB2' ' HB2' ' C' ' 111' ' ' LEU . 2.1 t70 -89.36 152.06 21.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.711 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 106' ' ' ARG . . . . . 0.621 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -71.76 -21.05 61.79 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.785 0.326 . . . . 0.0 111.075 179.456 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 107' ' ' THR . . . . . 0.615 ' HB ' ' HA ' ' C' ' 120' ' ' SER . 5.8 t -62.99 -21.84 66.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.959 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.72 -83.08 0.19 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.669 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.73 170.66 15.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.833 0.349 . . . . 0.0 111.033 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.721 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -74.77 138.57 42.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 111' ' ' LEU . . . . . 0.59 ' HB2' ' HB2' ' C' ' 105' ' ' ASP . 5.1 tp -94.45 153.41 17.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.363 0.601 . . . . 0.0 110.557 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 112' ' ' THR . . . . . 0.779 HG22 HG21 ' C' ' 117' ' ' THR . 6.2 t -93.7 148.22 22.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.084 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 113' ' ' LEU . . . . . 0.927 HD22 HD12 ' C' ' 86' ' ' LEU . 1.4 mp -89.51 64.82 6.82 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.729 0.3 . . . . 0.0 110.715 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 114' ' ' ASP . . . . . 0.544 ' HB2' ' OG1' ' C' ' 117' ' ' THR . 0.5 OUTLIER -95.11 -16.05 22.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.588 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 115' ' ' GLY . . . . . 0.617 ' HA3' ' HG1' ' F' ' 130' ' ' THR . . . 104.41 -56.27 0.57 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.64 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 116' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' F' ' 125' ' ' ASN . . . -103.57 29.01 6.0 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.049 0.452 . . . . 0.0 111.709 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 117' ' ' THR . . . . . 0.779 HG21 HG22 ' C' ' 112' ' ' THR . 3.4 m -87.27 65.87 8.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.145 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 118' ' ' PHE . . . . . 0.527 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . 48.5 m-85 -77.66 73.47 4.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.792 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.57 70.83 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.837 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 120' ' ' SER . . . . . 0.615 ' HA ' ' HB ' ' C' ' 107' ' ' THR . 0.7 OUTLIER -148.68 126.15 11.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.15 53.25 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.202 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' C' ' 69' ' ' ALA . 0.2 OUTLIER -73.93 128.31 35.18 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.698 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.44 117.94 25.55 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.719 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.51 134.78 33.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.781 0.324 . . . . 0.0 110.489 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 125' ' ' ASN . . . . . 0.491 ' HA ' HG23 ' C' ' 63' ' ' THR . 0.3 OUTLIER -129.26 163.07 26.45 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.674 179.494 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 126' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' C' ' 62' ' ' ASP . 1.5 t30 -67.54 125.37 25.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.82 0.343 . . . . 0.0 110.687 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.62 -141.01 12.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.659 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 128' ' ' THR . . . . . 0.719 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 6.3 m -101.73 92.41 4.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.673 0.273 . . . . 0.0 110.778 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 129' ' ' ASN . . . . . 0.528 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 1.2 t30 -76.52 145.02 39.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.946 0.403 . . . . 0.0 111.119 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 130' ' ' THR . . . . . 0.603 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.0 OUTLIER -134.62 131.78 38.22 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.042 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 131' ' ' ILE . . . . . 0.69 HD11 HG12 ' C' ' 156' ' ' VAL . 28.3 mt -87.33 109.79 28.49 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 132' ' ' PRO . . . . . 0.621 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.4 Cg_endo -81.67 112.17 2.38 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.585 1.524 . . . . 0.0 112.53 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.36 138.28 51.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.804 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 134' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' C' ' 52' ' ' VAL . 28.2 mt-30 -110.11 157.53 19.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.986 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 135' ' ' ALA . . . . . 0.65 ' HB3' HG22 ' C' ' 52' ' ' VAL . . . -152.67 107.93 3.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.975 0.417 . . . . 0.0 111.608 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -102.54 174.41 5.91 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.338 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 137' ' ' TYR . . . . . 0.485 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 0.6 OUTLIER -86.08 120.9 27.96 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.069 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 138' ' ' PHE . . . . . 0.505 ' HB3' HG11 ' C' ' 85' ' ' VAL . 0.2 OUTLIER -117.66 139.61 50.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.006 -179.134 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 139' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' C' ' 47' ' ' ALA . . . -129.93 145.66 51.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.875 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 140' ' ' THR . . . . . 0.62 HG21 ' HB2' ' C' ' 79' ' ' ASP . 16.5 p -104.38 -53.43 2.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.478 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.7 -121.56 3.27 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.024 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.1 112.97 24.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.59 0.233 . . . . 0.0 110.693 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 143' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' C' ' 42' ' ' LEU . . . -61.82 150.95 35.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.772 0.32 . . . . 0.0 111.42 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 144' ' ' THR . . . . . 0.551 HG23 ' HD2' ' C' ' 145' ' ' PRO . 58.2 m -126.89 151.51 73.96 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.199 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 145' ' ' PRO . . . . . 0.551 ' HD2' HG23 ' C' ' 144' ' ' THR . 1.3 Cg_endo -83.07 140.2 9.87 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.528 2.152 . . . . 0.0 111.936 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.94 -137.98 6.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.574 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 147' ' ' ALA . . . . . 0.615 ' HA ' ' HG3' ' B' ' 15' ' ' GLU . . . -87.23 145.07 26.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.984 0.421 . . . . 0.0 111.307 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 148' ' ' ALA . . . . . 0.732 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -140.76 38.83 1.83 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -86.0 153.52 22.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.486 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 150' ' ' ALA . . . . . 0.604 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -161.87 171.23 18.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.019 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.4 126.79 7.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.328 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 152' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' C' ' 86' ' ' LEU . . . -125.31 142.8 51.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.328 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 153' ' ' THR . . . . . 0.82 HG23 HG23 ' B' ' 9' ' ' THR . 0.5 OUTLIER -89.85 133.17 34.88 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 154' ' ' PHE . . . . . 0.501 ' HD1' ' HA ' ' C' ' 154' ' ' PHE . 0.0 OUTLIER -86.44 127.85 34.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.104 0.478 . . . . 0.0 110.113 -178.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 155' ' ' LYS . . . . . 0.401 ' HE3' HD12 ' C' ' 74' ' ' LEU . 29.0 mmtt -111.43 150.52 29.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.921 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 156' ' ' VAL . . . . . 0.809 HG23 HG23 ' B' ' 5' ' ' VAL . 14.3 m -136.23 144.46 33.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.859 0.361 . . . . 0.0 111.582 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 157' ' ' GLN . . . . . 0.583 ' O ' ' HA ' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -136.16 132.73 36.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.34 0.59 . . . . 0.0 110.391 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 158' ' ' TYR . . . . . 0.494 ' OH ' ' HB3' ' C' ' 21' ' ' CYS . 5.6 m-85 -117.45 119.8 36.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.51 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 159' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' B' ' 1' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.33 -0.843 . . . . 0.0 110.799 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 1' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' E' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.235 0.064 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.26 64.86 1.57 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.627 0.251 . . . . 0.0 111.065 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 3' ' ' THR . . . . . 0.518 HG21 ' HB2' ' E' ' 18' ' ' ASN . 57.9 m -111.17 100.96 9.52 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.524 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 4' ' ' THR . . . . . 0.51 ' HA ' ' HG2' ' E' ' 157' ' ' GLN . 61.6 m -86.59 131.91 34.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.609 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.774 HG23 HG23 ' E' ' 156' ' ' VAL . 0.0 OUTLIER -161.16 168.06 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.523 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.19 118.71 37.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.584 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.31 -56.3 7.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.76 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.94 -145.34 4.65 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.919 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 9' ' ' THR . . . . . 0.81 HG23 HG23 ' E' ' 153' ' ' THR . 0.0 OUTLIER -145.02 142.09 29.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 0.0 111.282 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 10' ' ' VAL . . . . . 0.4 HG21 ' HZ ' ' E' ' 73' ' ' PHE . 43.8 t -121.66 107.27 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.168 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.7 111.03 21.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.366 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 12' ' ' PHE . . . . . 0.511 ' CD1' HD11 ' E' ' 34' ' ' LEU . 32.1 m-85 -87.63 113.53 23.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.777 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.13 118.54 36.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.405 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.48 175.61 39.71 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.887 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 15' ' ' GLU . . . . . 0.594 ' HG3' ' HA ' ' E' ' 147' ' ' ALA . 0.1 OUTLIER -151.38 162.12 41.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.946 0.403 . . . . 0.0 110.313 179.562 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 16' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' E' ' 148' ' ' ALA . 2.2 t -114.99 119.45 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.214 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 17' ' ' VAL . . . . . 0.518 HG21 ' HA ' ' D' ' 22' ' ' ALA . 0.3 OUTLIER -121.32 168.05 14.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.815 0.341 . . . . 0.0 111.07 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 18' ' ' ASN . . . . . 0.525 ' HB2' HG21 ' C' ' 3' ' ' THR . 1.3 t-20 -68.44 -175.21 0.62 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.984 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 19' ' ' ALA . . . . . 0.589 ' O ' HG21 ' D' ' 65' ' ' VAL . . . -91.24 52.67 2.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.89 -15.71 1.33 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.374 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 21' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER -176.91 147.59 0.6 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.928 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 22' ' ' ALA . . . . . 0.518 ' HA ' HG21 ' D' ' 17' ' ' VAL . . . -152.64 110.04 3.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.114 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 23' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' D' ' 58' ' ' LEU . 0.3 OUTLIER -52.97 159.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.023 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -90.38 164.5 14.29 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.6 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -57.0 -52.38 65.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.365 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.36 11.87 66.56 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.872 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 18.7 t -96.14 -30.86 13.28 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.904 0.383 . . . . 0.0 110.929 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 t -49.83 -71.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.355 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.59 104.34 15.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.044 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -112.14 140.3 46.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.071 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.77 110.18 21.5 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.028 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.13 108.36 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.155 0.503 . . . . 0.0 110.453 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.56 112.46 22.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.685 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 34' ' ' LEU . . . . . 0.543 HD21 ' CG2' ' D' ' 101' ' ' VAL . 5.2 mp -81.19 -41.72 21.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.673 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.64 -171.05 21.62 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.626 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 1.7 mt-30 -93.57 145.93 24.17 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.524 0.202 . . . . 0.0 110.979 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.51 HG22 ' H ' ' D' ' 38' ' ' ARG . 4.9 p -124.84 169.89 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.991 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 38' ' ' ARG . . . . . 0.523 ' HE ' ' HB3' ' C' ' 60' ' ' ASP . 5.2 mtt-85 -98.88 121.42 40.8 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.714 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 39' ' ' THR . . . . . 0.543 ' O ' ' HB2' ' D' ' 43' ' ' ALA . 0.6 OUTLIER -62.01 -31.01 71.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.672 179.482 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.25 84.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.992 0.425 . . . . 0.0 110.852 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 71.1 m -81.31 -10.45 59.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.139 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.736 ' O ' ' HB2' ' D' ' 143' ' ' ALA . 0.6 OUTLIER -129.25 40.42 3.62 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.607 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 43' ' ' ALA . . . . . 0.617 ' HA ' ' H ' ' D' ' 143' ' ' ALA . . . -111.83 10.91 20.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.363 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.51 145.49 48.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.369 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 45' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' D' ' 140' ' ' THR . 18.2 tt0 -63.34 121.26 13.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.11 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.05 14.38 33.9 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.155 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' D' ' 139' ' ' ALA . . . -72.17 121.22 18.93 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 14.9 p -130.04 133.79 46.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.919 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 57.8 m -112.46 -166.73 1.1 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.607 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 36.3 t -59.11 149.47 27.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.897 0.379 . . . . 0.0 110.768 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.76 153.64 17.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.404 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 52' ' ' VAL . . . . . 0.668 HG22 ' HB3' ' D' ' 135' ' ' ALA . 3.7 m -103.41 130.33 53.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.96 121.5 6.56 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.576 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.492 ' HD1' HG23 ' D' ' 52' ' ' VAL . 52.3 p90 -153.71 136.44 15.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.816 0.341 . . . . 0.0 110.94 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 55' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' D' ' 131' ' ' ILE . 24.7 p30 -133.57 141.33 47.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.628 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 56' ' ' ILE . . . . . 0.642 HG21 HD12 ' D' ' 131' ' ' ILE . 1.2 tt -85.06 126.42 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.645 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 57' ' ' GLN . . . . . 0.601 ' HG3' HD11 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -75.73 119.41 19.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.742 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 58' ' ' LEU . . . . . 0.531 ' HA ' ' HA ' ' D' ' 23' ' ' VAL . 0.2 OUTLIER -130.68 87.36 2.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.258 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 59' ' ' ASN . . . . . 0.719 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 6.7 p-10 -77.3 173.64 11.68 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.956 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 60' ' ' ASP . . . . . 0.524 ' HB3' ' HE ' ' E' ' 38' ' ' ARG . 41.3 m-20 62.91 66.4 0.75 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.844 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 61' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 34.6 m -115.69 161.98 17.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.714 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 62' ' ' ASP . . . . . 0.514 ' HA ' ' OD1' ' D' ' 126' ' ' ASN . 0.2 OUTLIER -145.88 157.92 43.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.323 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.491 HG23 ' HA ' ' D' ' 125' ' ' ASN . 0.0 OUTLIER -107.59 -16.67 14.3 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -81.42 -33.65 32.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.028 0.442 . . . . 0.0 111.708 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 65' ' ' VAL . . . . . 0.589 HG21 ' O ' ' D' ' 19' ' ' ALA . 20.0 t -75.19 -41.6 44.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.629 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.93 146.7 29.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.553 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.77 -39.3 3.76 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.972 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.3 159.58 15.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.477 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 69' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' D' ' 122' ' ' THR . . . -147.19 118.82 7.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.649 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 70' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -96.83 140.74 30.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.093 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 71' ' ' VAL . . . . . 0.457 HG11 HG21 ' D' ' 131' ' ' ILE . 3.1 t -118.5 139.71 44.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.784 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 72' ' ' ALA . . . . . 0.403 ' HA ' HD21 ' D' ' 111' ' ' LEU . . . -140.56 133.94 29.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.522 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 73' ' ' PHE . . . . . 0.788 ' HD2' HD13 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -101.21 137.97 38.86 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.509 0.195 . . . . 0.0 111.243 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 74' ' ' LEU . . . . . . . . . . . . . 6.6 tt -100.97 91.08 4.41 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.011 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.43 -167.38 11.31 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.891 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 76' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.3 OUTLIER -116.68 159.56 22.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.585 0.231 . . . . 0.0 110.761 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.52 ' HB2' HG23 ' D' ' 83' ' ' THR . . . -83.96 137.85 33.42 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.018 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 78' ' ' ILE . . . . . 0.45 HG22 ' O ' ' D' ' 82' ' ' HIS . 9.0 tt -77.13 -40.48 30.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.882 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 79' ' ' ASP . . . . . 0.606 ' HB2' HG21 ' D' ' 140' ' ' THR . 0.1 OUTLIER -141.22 55.21 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.848 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 52.87 -84.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.075 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' D' ' 79' ' ' ASP . . . -60.09 -16.05 39.19 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.663 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 82' ' ' HIS . . . . . 0.45 ' O ' HG22 ' D' ' 78' ' ' ILE . 24.2 m80 -100.64 56.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 110.568 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 83' ' ' THR . . . . . 0.52 HG23 ' HB2' ' D' ' 77' ' ' ALA . 1.1 m -71.41 -22.42 61.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.563 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 84' ' ' ASN . . . . . 0.739 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 2.8 p30 -57.17 -18.67 16.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.359 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.518 HG11 ' HB3' ' D' ' 138' ' ' PHE . 11.6 t -115.24 133.34 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.227 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 86' ' ' LEU . . . . . 0.908 HD12 HD22 ' D' ' 113' ' ' LEU . 0.8 OUTLIER -72.93 154.06 40.71 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.341 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.601 ' N ' HD23 ' D' ' 86' ' ' LEU . . . -90.66 -161.41 0.8 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.837 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.69 -178.27 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.01 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -83.88 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.339 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.33 20.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.998 0.427 . . . . 0.0 111.49 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 91' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' D' ' 95' ' ' SER . 1.5 m -86.6 79.35 8.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.73 -31.49 38.2 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.913 0.387 . . . . 0.0 111.71 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.08 54.43 1.72 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.646 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.9 -17.29 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.931 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 95' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' D' ' 91' ' ' SER . 0.9 OUTLIER -89.39 177.16 6.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.75 0.309 . . . . 0.0 110.661 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.76 175.3 8.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.812 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 97' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' D' ' 98' ' ' ASN . 0.2 OUTLIER -137.52 138.03 39.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.263 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 98' ' ' ASN . . . . . 0.529 ' HB2' ' O ' ' D' ' 97' ' ' THR . 74.0 m-80 71.63 17.6 5.53 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.52 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.86 148.94 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.733 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.35 -176.74 35.65 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.436 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 101' ' ' VAL . . . . . 0.543 ' CG2' HD21 ' D' ' 34' ' ' LEU . 7.7 p -125.59 111.01 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 122.968 0.507 . . . . 0.0 111.759 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 102' ' ' GLN . . . . . 0.616 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 0.9 OUTLIER -81.53 147.71 29.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 103' ' ' ILE . . . . . 0.788 HD13 ' HD2' ' D' ' 73' ' ' PHE . 0.9 OUTLIER -123.74 115.92 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.478 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 104' ' ' LEU . . . . . 0.74 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 0.4 OUTLIER -88.69 140.52 29.37 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.693 0.283 . . . . 0.0 111.051 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 105' ' ' ASP . . . . . 0.605 ' HB2' ' HB2' ' D' ' 111' ' ' LEU . 2.1 t70 -89.26 151.98 21.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.693 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 106' ' ' ARG . . . . . 0.646 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -71.78 -21.07 61.77 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.805 0.336 . . . . 0.0 111.07 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 107' ' ' THR . . . . . 0.616 ' HB ' ' HA ' ' D' ' 120' ' ' SER . 5.8 t -62.9 -21.91 66.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.97 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.68 -83.02 0.19 Allowed Glycine 0 CA--C 1.517 0.219 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.722 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.74 170.7 15.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.834 0.349 . . . . 0.0 111.106 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.74 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -74.84 138.61 42.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.183 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 111' ' ' LEU . . . . . 0.605 ' HB2' ' HB2' ' D' ' 105' ' ' ASP . 5.1 tp -94.37 153.41 17.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.276 0.56 . . . . 0.0 110.604 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 112' ' ' THR . . . . . 0.776 HG22 HG21 ' D' ' 117' ' ' THR . 6.2 t -93.72 148.33 22.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.046 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 113' ' ' LEU . . . . . 0.908 HD22 HD12 ' D' ' 86' ' ' LEU . 1.4 mp -89.7 64.87 6.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.894 0.378 . . . . 0.0 110.758 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 114' ' ' ASP . . . . . 0.541 ' HB2' ' OG1' ' D' ' 117' ' ' THR . 0.5 OUTLIER -94.98 -16.15 22.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.648 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.49 -56.26 0.56 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.693 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.53 29.05 5.96 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.949 0.404 . . . . 0.0 111.719 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 117' ' ' THR . . . . . 0.776 HG21 HG22 ' D' ' 112' ' ' THR . 3.4 m -87.26 65.92 8.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.041 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 118' ' ' PHE . . . . . 0.52 ' HB3' ' HB1' ' D' ' 70' ' ' ALA . 48.5 m-85 -77.69 73.42 4.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.808 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.49 70.79 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 120' ' ' SER . . . . . 0.616 ' HA ' ' HB ' ' D' ' 107' ' ' THR . 0.7 OUTLIER -148.64 126.07 11.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.67 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.08 53.27 2.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.198 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' D' ' 69' ' ' ALA . 0.2 OUTLIER -74.04 128.32 35.22 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.715 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.36 117.9 25.45 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.765 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.52 134.8 33.76 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.831 0.348 . . . . 0.0 110.524 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 125' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -129.24 163.09 26.37 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.654 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 126' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' D' ' 62' ' ' ASP . 1.5 t30 -67.6 125.37 25.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.7 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 127' ' ' GLY . . . . . 0.451 ' HA3' ' HE2' ' A' ' 118' ' ' PHE . . . 128.62 -140.97 12.14 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.718 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 128' ' ' THR . . . . . 0.719 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 6.3 m -101.8 92.45 4.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.672 0.272 . . . . 0.0 110.772 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 129' ' ' ASN . . . . . 0.54 ' HB2' ' SG ' ' D' ' 61' ' ' CYS . 1.2 t30 -76.5 145.04 39.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.92 0.391 . . . . 0.0 111.147 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 130' ' ' THR . . . . . 0.734 HG21 HD21 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -134.68 131.79 38.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.063 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 131' ' ' ILE . . . . . 0.686 HD11 HG12 ' D' ' 156' ' ' VAL . 28.2 mt -87.32 109.73 28.01 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 132' ' ' PRO . . . . . 0.646 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.5 Cg_endo -81.57 112.13 2.4 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.599 1.533 . . . . 0.0 112.576 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.35 138.2 51.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.844 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 134' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' D' ' 52' ' ' VAL . 28.3 mt-30 -110.1 157.55 19.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.99 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 135' ' ' ALA . . . . . 0.668 ' HB3' HG22 ' D' ' 52' ' ' VAL . . . -152.68 107.92 3.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 111.568 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -102.53 174.34 5.94 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.381 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 137' ' ' TYR . . . . . 0.462 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 0.6 OUTLIER -85.99 120.81 27.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.097 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 138' ' ' PHE . . . . . 0.518 ' HB3' HG11 ' D' ' 85' ' ' VAL . 0.2 OUTLIER -117.62 139.56 50.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.079 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 139' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' D' ' 47' ' ' ALA . . . -129.88 145.64 51.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.851 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 140' ' ' THR . . . . . 0.606 HG21 ' HB2' ' D' ' 79' ' ' ASP . 16.3 p -104.46 -53.43 2.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.407 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.67 -121.52 3.27 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.014 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.08 112.92 24.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.568 0.223 . . . . 0.0 110.676 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 143' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' D' ' 42' ' ' LEU . . . -61.78 150.86 35.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.755 0.312 . . . . 0.0 111.453 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 144' ' ' THR . . . . . 0.553 HG23 ' HD2' ' D' ' 145' ' ' PRO . 60.4 m -126.81 151.52 73.77 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.274 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 145' ' ' PRO . . . . . 0.553 ' HD2' HG23 ' D' ' 144' ' ' THR . 1.3 Cg_endo -83.08 140.2 9.85 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.613 2.208 . . . . 0.0 111.941 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.94 -138.14 6.59 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.485 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 147' ' ' ALA . . . . . 0.608 ' HA ' ' HG3' ' C' ' 15' ' ' GLU . . . -87.14 145.02 26.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.912 0.387 . . . . 0.0 111.378 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 148' ' ' ALA . . . . . 0.743 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -140.73 38.79 1.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.545 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -86.1 153.53 22.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.48 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 150' ' ' ALA . . . . . 0.589 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -161.86 171.25 18.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.048 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.42 126.8 7.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.242 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 152' ' ' ALA . . . . . 0.528 ' HB2' ' CD1' ' D' ' 86' ' ' LEU . . . -125.31 142.85 51.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.257 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 153' ' ' THR . . . . . 0.812 HG23 HG23 ' C' ' 9' ' ' THR . 0.5 OUTLIER -89.84 133.17 34.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 154' ' ' PHE . . . . . 0.501 ' HD1' ' HA ' ' D' ' 154' ' ' PHE . 0.0 OUTLIER -86.46 127.88 34.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.042 0.449 . . . . 0.0 110.096 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.48 150.57 29.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.958 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 156' ' ' VAL . . . . . 0.792 HG23 HG23 ' C' ' 5' ' ' VAL . 14.4 m -136.24 144.39 33.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.826 0.346 . . . . 0.0 111.594 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 157' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' D' ' 69' ' ' ALA . 0.0 OUTLIER -136.16 132.74 36.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.268 0.556 . . . . 0.0 110.415 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 158' ' ' TYR . . . . . 0.489 ' OH ' ' HB3' ' D' ' 21' ' ' CYS . 5.5 m-85 -117.42 119.78 36.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.505 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 159' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' C' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.844 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 1' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' F' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 120.209 0.052 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.21 64.86 1.57 Allowed 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.126 0.266 . . . . 0.0 111.079 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 3' ' ' THR . . . . . 0.538 HG21 ' HB2' ' F' ' 18' ' ' ASN . 57.8 m -111.17 101.03 9.58 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.42 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 4' ' ' THR . . . . . 0.502 ' O ' HG13 ' E' ' 5' ' ' VAL . 60.0 m -86.72 131.91 34.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.539 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.802 HG23 HG23 ' F' ' 156' ' ' VAL . 0.0 OUTLIER -161.15 168.05 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.513 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.15 118.76 37.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.58 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.36 -56.26 7.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.759 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.01 -145.36 4.66 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.883 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 9' ' ' THR . . . . . 0.811 HG23 HG23 ' F' ' 153' ' ' THR . 0.0 OUTLIER -145.01 142.07 29.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.288 -179.587 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 44.0 t -121.64 107.31 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.17 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.72 110.93 21.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.431 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 12' ' ' PHE . . . . . 0.501 ' CD1' HD11 ' F' ' 34' ' ' LEU . 32.2 m-85 -87.54 113.48 23.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.15 118.54 36.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.443 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.49 175.49 39.72 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.946 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 15' ' ' GLU . . . . . 0.594 ' HG3' ' HA ' ' F' ' 147' ' ' ALA . 0.1 OUTLIER -151.29 162.13 41.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.994 0.426 . . . . 0.0 110.303 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 16' ' ' VAL . . . . . 0.736 HG23 ' HB2' ' F' ' 148' ' ' ALA . 2.2 t -114.97 119.33 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.265 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 17' ' ' VAL . . . . . 0.492 HG21 ' HA ' ' E' ' 22' ' ' ALA . 0.3 OUTLIER -121.26 168.06 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.843 0.354 . . . . 0.0 111.039 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 18' ' ' ASN . . . . . 0.518 ' HB2' HG21 ' D' ' 3' ' ' THR . 1.3 t-20 -68.38 -175.26 0.61 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.01 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 19' ' ' ALA . . . . . 0.605 ' O ' HG21 ' E' ' 65' ' ' VAL . . . -91.12 52.59 2.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.95 -15.66 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.357 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 21' ' ' CYS . . . . . 0.726 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER -176.96 147.55 0.58 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.981 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 22' ' ' ALA . . . . . 0.492 ' HA ' HG21 ' E' ' 17' ' ' VAL . . . -152.57 110.05 3.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 23' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' E' ' 58' ' ' LEU . 0.3 OUTLIER -53.0 159.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.011 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -90.37 164.46 14.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.592 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 25' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -56.91 -52.42 65.24 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.402 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.35 11.9 66.43 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.881 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 18.3 t -96.21 -30.77 13.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.895 0.379 . . . . 0.0 110.917 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 28' ' ' VAL . . . . . 0.426 ' H ' HG23 ' E' ' 28' ' ' VAL . 11.2 t -49.84 -71.71 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.38 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.47 104.29 15.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -112.17 140.4 46.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.07 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.83 110.16 21.46 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.301 -0.409 . . . . 0.0 112.045 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.17 108.46 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.136 0.493 . . . . 0.0 110.434 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.65 112.47 22.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 34' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' E' ' 101' ' ' VAL . 5.3 mp -81.17 -41.8 21.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.67 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.72 -171.02 21.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.632 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 36' ' ' GLN . . . . . 0.55 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 1.7 mt-30 -93.62 145.9 24.21 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.502 0.192 . . . . 0.0 110.969 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.515 HG22 ' H ' ' E' ' 38' ' ' ARG . 5.0 p -124.82 169.88 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.942 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 38' ' ' ARG . . . . . 0.524 ' HE ' ' HB3' ' D' ' 60' ' ' ASP . 5.2 mtt-85 -98.94 121.45 40.91 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.701 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 39' ' ' THR . . . . . 0.545 ' O ' ' HB2' ' E' ' 43' ' ' ALA . 0.6 OUTLIER -61.99 -31.03 71.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.675 179.521 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.3 85.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.987 0.422 . . . . 0.0 110.85 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 70.5 m -81.36 -10.3 59.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.128 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 42' ' ' LEU . . . . . 0.739 ' O ' ' HB2' ' E' ' 143' ' ' ALA . 0.6 OUTLIER -129.33 40.34 3.62 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.571 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 43' ' ' ALA . . . . . 0.607 ' HA ' ' H ' ' E' ' 143' ' ' ALA . . . -111.87 10.98 20.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.392 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.6 145.47 48.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.35 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 45' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' E' ' 140' ' ' THR . 18.2 tt0 -63.28 121.17 13.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.367 . . . . 0.0 111.109 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.03 14.48 33.67 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.113 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 47' ' ' ALA . . . . . 0.692 ' HB3' ' HB3' ' E' ' 139' ' ' ALA . . . -72.14 121.19 18.86 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 14.9 p -130.03 133.72 46.93 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.906 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 49' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 57.9 m -112.43 -166.69 1.1 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.623 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 36.3 t -59.03 149.5 27.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.774 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.84 153.6 17.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.386 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 52' ' ' VAL . . . . . 0.669 HG22 ' HB3' ' E' ' 135' ' ' ALA . 3.7 m -103.45 130.34 53.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.877 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.94 121.4 6.52 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.612 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 54' ' ' PHE . . . . . 0.49 ' HD1' HG23 ' E' ' 52' ' ' VAL . 52.2 p90 -153.6 136.44 15.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 110.97 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 55' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' E' ' 131' ' ' ILE . 24.7 p30 -133.55 141.39 47.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.682 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 56' ' ' ILE . . . . . 0.645 HG21 HD12 ' E' ' 131' ' ' ILE . 1.2 tt -85.18 126.43 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.627 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 57' ' ' GLN . . . . . 0.599 ' HG3' HD11 ' B' ' 74' ' ' LEU . 0.1 OUTLIER -75.8 119.45 19.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.732 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 58' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' E' ' 23' ' ' VAL . 0.2 OUTLIER -130.75 87.34 2.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.214 -179.609 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 59' ' ' ASN . . . . . 0.728 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 6.7 p-10 -77.2 173.71 11.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.991 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 60' ' ' ASP . . . . . 0.527 ' HB3' ' HE ' ' F' ' 38' ' ' ARG . 41.6 m-20 62.89 66.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 61' ' ' CYS . . . . . 0.726 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 34.5 m -115.66 161.98 17.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.74 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 62' ' ' ASP . . . . . 0.514 ' HA ' ' OD1' ' E' ' 126' ' ' ASN . 0.2 OUTLIER -145.91 157.82 43.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.333 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 63' ' ' THR . . . . . 0.482 HG23 ' HA ' ' E' ' 125' ' ' ASN . 0.0 OUTLIER -107.51 -16.65 14.31 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.186 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.4 -33.63 32.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.055 0.455 . . . . 0.0 111.755 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 65' ' ' VAL . . . . . 0.605 HG21 ' O ' ' E' ' 19' ' ' ALA . 20.0 t -75.19 -41.55 44.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.668 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.94 146.76 29.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.528 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -39.25 3.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.008 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.32 159.61 15.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.431 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 69' ' ' ALA . . . . . 0.601 ' HB3' ' HB ' ' E' ' 122' ' ' THR . . . -147.26 118.87 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.612 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 70' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -96.9 140.81 30.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.063 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 71' ' ' VAL . . . . . 0.471 HG11 HG21 ' E' ' 131' ' ' ILE . 3.1 t -118.57 139.74 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.714 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.56 133.9 29.78 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.533 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 73' ' ' PHE . . . . . 0.792 ' HD2' HD13 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -101.16 138.01 38.76 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 122.388 -0.195 . . . . 0.0 111.185 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 74' ' ' LEU . . . . . 0.41 HD12 ' HE3' ' E' ' 155' ' ' LYS . 6.6 tt -100.98 91.02 4.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.028 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.37 -167.37 11.32 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.872 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 76' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.3 OUTLIER -116.71 159.48 22.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.631 0.253 . . . . 0.0 110.729 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 77' ' ' ALA . . . . . 0.52 ' HB2' HG23 ' E' ' 83' ' ' THR . . . -83.94 137.94 33.39 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.024 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 78' ' ' ILE . . . . . 0.456 HG22 ' O ' ' E' ' 82' ' ' HIS . 8.9 tt -77.18 -40.48 29.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.911 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 79' ' ' ASP . . . . . 0.601 ' HB2' HG21 ' E' ' 140' ' ' THR . 0.1 OUTLIER -141.22 55.26 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.882 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 52.88 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 81' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' E' ' 79' ' ' ASP . . . -60.09 -15.99 38.89 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.652 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 82' ' ' HIS . . . . . 0.456 ' O ' HG22 ' E' ' 78' ' ' ILE . 24.2 m80 -100.68 56.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.929 0.395 . . . . 0.0 110.557 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 83' ' ' THR . . . . . 0.52 HG23 ' HB2' ' E' ' 77' ' ' ALA . 1.1 m -71.32 -22.53 61.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.574 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 84' ' ' ASN . . . . . 0.737 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 2.9 p30 -57.2 -18.62 16.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.347 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 85' ' ' VAL . . . . . 0.505 HG11 ' HB3' ' E' ' 138' ' ' PHE . 11.6 t -115.23 133.36 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.205 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 86' ' ' LEU . . . . . 0.928 HD12 HD22 ' E' ' 113' ' ' LEU . 0.8 OUTLIER -72.95 154.01 40.72 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.368 179.332 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 87' ' ' ALA . . . . . 0.602 ' N ' HD23 ' E' ' 86' ' ' LEU . . . -90.67 -161.35 0.79 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.872 0.367 . . . . 0.0 111.781 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.74 -178.24 6.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.925 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.72 -83.82 0.04 OUTLIER 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.364 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.35 20.49 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.989 0.423 . . . . 0.0 111.464 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 91' ' ' SER . . . . . 0.766 ' HB2' ' HB2' ' E' ' 95' ' ' SER . 1.5 m -86.56 79.3 8.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.7 -31.54 38.14 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.867 0.365 . . . . 0.0 111.624 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.05 54.43 1.72 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.671 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.86 -17.34 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.02 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 95' ' ' SER . . . . . 0.766 ' HB2' ' HB2' ' E' ' 91' ' ' SER . 0.9 OUTLIER -89.41 177.2 6.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.804 0.335 . . . . 0.0 110.67 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.68 175.19 8.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.795 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 97' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' E' ' 98' ' ' ASN . 0.2 OUTLIER -137.5 138.01 39.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.275 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 98' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' E' ' 97' ' ' THR . 74.0 m-80 71.71 17.52 5.46 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.532 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.87 149.0 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.719 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.34 -176.75 35.65 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.447 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 101' ' ' VAL . . . . . 0.541 ' CG2' HD21 ' E' ' 34' ' ' LEU . 7.7 p -125.63 111.04 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.003 0.521 . . . . 0.0 111.736 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 102' ' ' GLN . . . . . 0.611 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 0.9 OUTLIER -81.58 147.67 29.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.878 -179.67 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 103' ' ' ILE . . . . . 0.792 HD13 ' HD2' ' E' ' 73' ' ' PHE . 0.9 OUTLIER -123.64 115.95 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.55 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 104' ' ' LEU . . . . . 0.714 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 0.4 OUTLIER -88.77 140.51 29.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.688 0.28 . . . . 0.0 111.02 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 105' ' ' ASP . . . . . 0.597 ' HB3' HG22 ' E' ' 107' ' ' THR . 2.1 t70 -89.28 152.02 21.79 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.661 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 106' ' ' ARG . . . . . 0.63 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -71.79 -21.02 61.77 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.819 0.343 . . . . 0.0 111.119 179.392 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 107' ' ' THR . . . . . 0.615 ' HB ' ' HA ' ' E' ' 120' ' ' SER . 5.8 t -62.89 -21.98 66.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.981 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.69 -83.05 0.19 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.626 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.66 170.68 15.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 111.105 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 110' ' ' ALA . . . . . 0.714 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -74.85 138.63 42.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.227 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 111' ' ' LEU . . . . . 0.594 ' HB2' ' HB2' ' E' ' 105' ' ' ASP . 5.0 tp -94.45 153.45 17.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.366 0.603 . . . . 0.0 110.577 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 112' ' ' THR . . . . . 0.804 HG22 HG21 ' E' ' 117' ' ' THR . 6.2 t -93.78 148.29 22.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.049 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 113' ' ' LEU . . . . . 0.928 HD22 HD12 ' E' ' 86' ' ' LEU . 1.4 mp -89.53 64.82 6.81 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.773 0.32 . . . . 0.0 110.742 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 114' ' ' ASP . . . . . 0.559 ' HB2' ' OG1' ' E' ' 117' ' ' THR . 0.5 OUTLIER -95.1 -15.95 23.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.662 0.268 . . . . 0.0 111.665 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.34 -56.25 0.57 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.682 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.58 29.05 5.98 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.983 0.42 . . . . 0.0 111.679 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 117' ' ' THR . . . . . 0.804 HG21 HG22 ' E' ' 112' ' ' THR . 3.4 m -87.11 65.82 9.06 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.153 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 118' ' ' PHE . . . . . 0.52 ' HB3' ' HB1' ' E' ' 70' ' ' ALA . 48.3 m-85 -77.67 73.39 4.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.814 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.54 70.85 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 120' ' ' SER . . . . . 0.615 ' HA ' ' HB ' ' E' ' 107' ' ' THR . 0.7 OUTLIER -148.66 126.08 11.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.679 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.06 53.23 2.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.203 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 122' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' E' ' 69' ' ' ALA . 0.2 OUTLIER -74.04 128.31 35.2 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.67 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 4.5 m -86.29 118.0 25.46 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.759 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.61 134.82 33.77 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.779 0.323 . . . . 0.0 110.482 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 125' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' B' ' 116' ' ' ALA . 0.3 OUTLIER -129.3 163.08 26.47 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.662 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 126' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' E' ' 62' ' ' ASP . 1.5 t30 -67.56 125.34 25.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.653 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 127' ' ' GLY . . . . . 0.651 ' HA2' HG21 ' A' ' 4' ' ' THR . . . 128.59 -140.97 12.14 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.686 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 128' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 6.3 m -101.76 92.5 4.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.666 0.27 . . . . 0.0 110.752 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 129' ' ' ASN . . . . . 0.542 ' HB2' ' SG ' ' E' ' 61' ' ' CYS . 1.2 t30 -76.58 144.98 39.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.89 0.376 . . . . 0.0 111.099 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 130' ' ' THR . . . . . 0.714 HG21 HD21 ' B' ' 74' ' ' LEU . 0.0 OUTLIER -134.63 131.81 38.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.05 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 131' ' ' ILE . . . . . 0.685 HD11 HG12 ' E' ' 156' ' ' VAL . 28.3 mt -87.34 109.74 28.16 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 132' ' ' PRO . . . . . 0.63 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.4 Cg_endo -81.61 112.15 2.39 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 121.604 1.536 . . . . 0.0 112.544 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.32 138.21 51.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 134' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' E' ' 52' ' ' VAL . 44.1 mt-30 -110.03 157.49 19.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.075 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 135' ' ' ALA . . . . . 0.669 ' HB3' HG22 ' E' ' 52' ' ' VAL . . . -152.65 107.85 3.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 111.636 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -102.58 174.34 5.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.338 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 137' ' ' TYR . . . . . 0.468 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 0.6 OUTLIER -85.9 120.86 27.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.036 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 138' ' ' PHE . . . . . 0.505 ' HB3' HG11 ' E' ' 85' ' ' VAL . 0.2 OUTLIER -117.68 139.64 50.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.001 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 139' ' ' ALA . . . . . 0.692 ' HB3' ' HB3' ' E' ' 47' ' ' ALA . . . -129.95 145.62 51.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.915 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 140' ' ' THR . . . . . 0.601 HG21 ' HB2' ' E' ' 79' ' ' ASP . 16.5 p -104.45 -53.33 2.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.464 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.8 -121.49 3.25 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.983 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.07 112.91 24.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.572 0.225 . . . . 0.0 110.723 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 143' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' E' ' 42' ' ' LEU . . . -61.79 150.89 35.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.794 0.33 . . . . 0.0 111.406 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 144' ' ' THR . . . . . 0.55 HG23 ' HD2' ' E' ' 145' ' ' PRO . 59.8 m -126.81 151.59 73.89 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.261 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 145' ' ' PRO . . . . . 0.55 ' HD2' HG23 ' E' ' 144' ' ' THR . 1.3 Cg_endo -83.09 140.15 9.82 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.59 2.193 . . . . 0.0 111.956 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.98 -138.01 6.52 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.521 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 147' ' ' ALA . . . . . 0.594 ' HA ' ' HG3' ' D' ' 15' ' ' GLU . . . -87.22 145.01 26.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.941 0.4 . . . . 0.0 111.329 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 148' ' ' ALA . . . . . 0.749 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -140.74 38.84 1.83 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.589 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -86.09 153.5 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.47 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 150' ' ' ALA . . . . . 0.598 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -161.88 171.21 18.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.966 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.42 126.84 7.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.232 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 152' ' ' ALA . . . . . 0.537 ' HB2' ' CD1' ' E' ' 86' ' ' LEU . . . -125.36 142.81 51.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.252 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 153' ' ' THR . . . . . 0.81 HG23 HG23 ' D' ' 9' ' ' THR . 0.4 OUTLIER -89.88 133.2 34.89 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 154' ' ' PHE . . . . . 0.448 ' HD1' ' HA ' ' E' ' 154' ' ' PHE . 0.0 OUTLIER -86.41 127.84 34.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.016 0.436 . . . . 0.0 110.148 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 155' ' ' LYS . . . . . 0.41 ' HE3' HD12 ' E' ' 74' ' ' LEU . 29.1 mmtt -111.41 150.55 29.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.96 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 156' ' ' VAL . . . . . 0.774 HG23 HG23 ' D' ' 5' ' ' VAL . 14.2 m -136.23 144.44 33.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.863 0.363 . . . . 0.0 111.551 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 157' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' E' ' 69' ' ' ALA . 0.0 OUTLIER -136.17 132.76 36.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.24 0.543 . . . . 0.0 110.459 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 158' ' ' TYR . . . . . 0.495 ' OH ' ' HB3' ' E' ' 21' ' ' CYS . 5.5 m-85 -117.48 119.79 36.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.537 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 159' ' ' GLN . . . . . 0.555 ' HA ' ' HA ' ' D' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.223 0.059 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.22 64.84 1.57 Allowed 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.118 0.261 . . . . 0.0 111.033 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 58.2 m -111.12 101.06 9.61 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.487 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 4' ' ' THR . . . . . 0.497 ' O ' HG13 ' F' ' 5' ' ' VAL . 60.3 m -86.73 131.92 34.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.586 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 5' ' ' VAL . . . . . 0.497 HG13 ' O ' ' F' ' 4' ' ' THR . 0.0 OUTLIER -161.16 168.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.48 179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.13 118.82 37.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.548 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.38 -56.39 6.87 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.704 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.97 -145.36 4.66 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.877 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.02 142.0 29.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 111.311 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 44.0 t -121.58 107.36 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.18 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -88.78 110.95 21.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.421 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -87.55 113.5 23.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.759 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.16 118.63 36.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.354 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.56 175.48 39.78 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.958 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.26 162.15 41.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.957 0.408 . . . . 0.0 110.289 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.01 119.35 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.259 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 17' ' ' VAL . . . . . 0.498 HG21 ' HA ' ' F' ' 22' ' ' ALA . 0.3 OUTLIER -121.26 168.1 14.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 111.039 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 18' ' ' ASN . . . . . 0.538 ' HB2' HG21 ' E' ' 3' ' ' THR . 1.3 t-20 -68.45 -175.2 0.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.953 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 19' ' ' ALA . . . . . 0.604 ' O ' HG21 ' F' ' 65' ' ' VAL . . . -91.23 52.64 2.15 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.9 -15.72 1.33 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.351 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 21' ' ' CYS . . . . . 0.781 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER -176.87 147.61 0.61 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.987 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 22' ' ' ALA . . . . . 0.498 ' HA ' HG21 ' F' ' 17' ' ' VAL . . . -152.58 110.02 3.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 23' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' F' ' 58' ' ' LEU . 0.3 OUTLIER -52.98 159.07 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -90.36 164.49 14.31 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.613 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 25' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -57.0 -52.36 65.59 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.402 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.41 11.95 66.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.888 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 18.4 t -96.25 -30.71 13.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.911 0.386 . . . . 0.0 110.95 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 t -49.87 -71.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.299 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.54 104.31 15.19 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -112.12 140.3 46.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.122 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.72 110.12 21.44 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.123 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.12 108.44 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.165 0.507 . . . . 0.0 110.429 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.61 112.39 22.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.634 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 34' ' ' LEU . . . . . 0.542 HD21 ' CG2' ' F' ' 101' ' ' VAL . 5.3 mp -81.11 -41.83 21.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.611 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.69 -171.06 21.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.638 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 36' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 1.7 mt-30 -93.63 145.87 24.23 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.536 0.207 . . . . 0.0 110.919 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.517 HG22 ' H ' ' F' ' 38' ' ' ARG . 5.0 p -124.87 169.87 15.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.929 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 38' ' ' ARG . . . . . 0.527 ' HE ' ' HB3' ' E' ' 60' ' ' ASP . 5.2 mtt-85 -98.88 121.4 40.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.703 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 39' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' F' ' 43' ' ' ALA . 0.6 OUTLIER -61.94 -30.99 71.28 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.75 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.57 -39.33 84.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.008 0.432 . . . . 0.0 110.774 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 71.5 m -81.31 -10.32 59.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.2 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 42' ' ' LEU . . . . . 0.751 ' O ' ' HB2' ' F' ' 143' ' ' ALA . 0.6 OUTLIER -129.4 40.42 3.6 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.588 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 43' ' ' ALA . . . . . 0.612 ' HA ' ' H ' ' F' ' 143' ' ' ALA . . . -111.89 10.96 20.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.428 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.52 145.44 48.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.399 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 45' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' F' ' 140' ' ' THR . 18.1 tt0 -63.25 121.25 13.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.852 0.358 . . . . 0.0 111.095 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.97 14.44 33.91 Favored Glycine 0 C--N 1.33 0.249 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.176 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 47' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' F' ' 139' ' ' ALA . . . -72.16 121.21 18.91 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 15.1 p -130.04 133.8 46.97 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.848 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 49' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 57.9 m -112.47 -166.71 1.1 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.628 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 36.1 t -59.07 149.45 27.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.793 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.72 153.63 17.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.39 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 52' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' F' ' 135' ' ' ALA . 3.7 m -103.44 130.4 53.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.0 121.48 6.56 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.621 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 54' ' ' PHE . . . . . 0.498 ' HD1' HG23 ' F' ' 52' ' ' VAL . 52.3 p90 -153.64 136.45 15.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 110.955 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 55' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' F' ' 131' ' ' ILE . 24.8 p30 -133.56 141.33 47.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.685 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 56' ' ' ILE . . . . . 0.642 HG21 HD12 ' F' ' 131' ' ' ILE . 1.2 tt -85.15 126.49 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.634 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 57' ' ' GLN . . . . . 0.607 ' HG3' HD11 ' C' ' 74' ' ' LEU . 0.1 OUTLIER -75.83 119.38 19.74 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.752 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 58' ' ' LEU . . . . . 0.536 ' HA ' ' HA ' ' F' ' 23' ' ' VAL . 0.2 OUTLIER -130.68 87.4 2.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.29 -179.698 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 59' ' ' ASN . . . . . 0.727 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 6.8 p-10 -77.28 173.8 11.49 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.988 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 60' ' ' ASP . . . . . 0.43 ' HB2' ' HB3' ' F' ' 22' ' ' ALA . 41.6 m-20 62.78 66.47 0.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 61' ' ' CYS . . . . . 0.781 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 34.6 m -115.8 161.91 18.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.659 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 62' ' ' ASP . . . . . 0.514 ' HA ' ' OD1' ' F' ' 126' ' ' ASN . 0.2 OUTLIER -145.87 157.86 43.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.322 -179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 63' ' ' THR . . . . . 0.491 HG23 ' HA ' ' F' ' 125' ' ' ASN . 0.0 OUTLIER -107.49 -16.73 14.29 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.3 -33.75 32.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.012 0.434 . . . . 0.0 111.689 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 65' ' ' VAL . . . . . 0.604 HG21 ' O ' ' F' ' 19' ' ' ALA . 20.1 t -75.14 -41.64 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.619 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.95 146.74 29.1 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.567 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -39.3 3.73 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.863 0.363 . . . . 0.0 110.945 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.28 159.56 15.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.446 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 69' ' ' ALA . . . . . 0.603 ' HB3' ' HB ' ' F' ' 122' ' ' THR . . . -147.22 118.81 7.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.6 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 70' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -96.81 140.75 30.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.066 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 71' ' ' VAL . . . . . 0.482 HG11 HG21 ' F' ' 131' ' ' ILE . 3.1 t -118.55 139.79 44.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.713 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 72' ' ' ALA . . . . . 0.405 ' HA ' HD21 ' F' ' 111' ' ' LEU . . . -140.58 133.91 29.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.562 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 73' ' ' PHE . . . . . 0.773 ' HD2' HD13 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -101.19 138.07 38.71 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 122.338 -0.226 . . . . 0.0 111.172 179.603 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 74' ' ' LEU . . . . . 0.402 ' HB3' ' H ' ' F' ' 153' ' ' THR . 6.6 tt -101.07 91.08 4.39 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.003 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.4 -167.41 11.32 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.869 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 76' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.3 OUTLIER -116.74 159.51 22.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.611 0.243 . . . . 0.0 110.701 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 77' ' ' ALA . . . . . 0.519 ' HB2' HG23 ' F' ' 83' ' ' THR . . . -83.93 137.93 33.41 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.984 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 78' ' ' ILE . . . . . 0.459 HG22 ' O ' ' F' ' 82' ' ' HIS . 9.0 tt -77.14 -40.51 30.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.913 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 79' ' ' ASP . . . . . 0.613 ' HB2' HG21 ' F' ' 140' ' ' THR . 0.1 OUTLIER -141.22 55.24 1.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.82 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 52.94 -84.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.086 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 81' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' F' ' 79' ' ' ASP . . . -60.12 -16.02 39.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.611 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 82' ' ' HIS . . . . . 0.459 ' O ' HG22 ' F' ' 78' ' ' ILE . 24.2 m80 -100.64 56.69 0.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.912 0.386 . . . . 0.0 110.566 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 83' ' ' THR . . . . . 0.519 HG23 ' HB2' ' F' ' 77' ' ' ALA . 1.1 m -71.35 -22.47 61.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.567 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 84' ' ' ASN . . . . . 0.735 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 2.9 p30 -57.12 -18.75 16.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.409 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 85' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' F' ' 138' ' ' PHE . 11.5 t -115.15 133.42 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.25 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 86' ' ' LEU . . . . . 0.925 HD12 HD22 ' F' ' 113' ' ' LEU . 0.8 OUTLIER -73.0 154.05 40.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 87' ' ' ALA . . . . . 0.601 ' N ' HD23 ' F' ' 86' ' ' LEU . . . -90.66 -161.41 0.8 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.823 0.344 . . . . 0.0 111.778 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.24 6.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.988 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.67 -83.95 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.282 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.26 20.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.443 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 91' ' ' SER . . . . . 0.775 ' HB2' ' HB2' ' F' ' 95' ' ' SER . 1.5 m -86.65 79.37 8.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.76 -31.45 38.29 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.832 0.349 . . . . 0.0 111.665 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.09 54.41 1.73 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.621 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.89 -17.2 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.946 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 95' ' ' SER . . . . . 0.775 ' HB2' ' HB2' ' F' ' 91' ' ' SER . 0.9 OUTLIER -89.39 177.25 6.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.777 0.323 . . . . 0.0 110.672 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.83 175.18 8.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.735 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 97' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' F' ' 98' ' ' ASN . 0.2 OUTLIER -137.46 137.97 39.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.289 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 98' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' F' ' 97' ' ' THR . 74.0 m-80 71.75 17.6 5.4 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.433 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.97 149.01 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.701 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.32 -176.74 35.62 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.433 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 101' ' ' VAL . . . . . 0.542 ' CG2' HD21 ' F' ' 34' ' ' LEU . 7.7 p -125.64 111.02 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 122.976 0.51 . . . . 0.0 111.735 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 102' ' ' GLN . . . . . 0.616 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 0.9 OUTLIER -81.59 147.68 29.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.883 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 103' ' ' ILE . . . . . 0.773 HD13 ' HD2' ' F' ' 73' ' ' PHE . 0.9 OUTLIER -123.64 115.86 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.566 179.502 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 104' ' ' LEU . . . . . 0.719 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 0.4 OUTLIER -88.63 140.5 29.39 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.661 0.267 . . . . 0.0 111.076 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 105' ' ' ASP . . . . . 0.607 ' HB2' ' HB2' ' F' ' 111' ' ' LEU . 2.1 t70 -89.29 151.99 21.8 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.68 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 106' ' ' ARG . . . . . 0.62 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -71.77 -21.11 61.78 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.73 0.3 . . . . 0.0 111.054 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 107' ' ' THR . . . . . 0.6 ' HB ' ' HA ' ' F' ' 120' ' ' SER . 5.9 t -62.88 -21.87 66.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.063 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.65 -83.03 0.19 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.695 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.69 170.67 15.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.751 0.31 . . . . 0.0 111.063 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 110' ' ' ALA . . . . . 0.719 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -74.85 138.61 42.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.225 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 111' ' ' LEU . . . . . 0.607 ' HB2' ' HB2' ' F' ' 105' ' ' ASP . 5.1 tp -94.47 153.4 17.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.329 0.585 . . . . 0.0 110.531 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 112' ' ' THR . . . . . 0.785 HG22 HG21 ' F' ' 117' ' ' THR . 6.2 t -93.71 148.27 22.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.094 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 113' ' ' LEU . . . . . 0.925 HD22 HD12 ' F' ' 86' ' ' LEU . 1.4 mp -89.51 64.73 6.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.784 0.326 . . . . 0.0 110.777 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 114' ' ' ASP . . . . . 0.555 ' HB2' ' OG1' ' F' ' 117' ' ' THR . 0.5 OUTLIER -95.05 -15.96 23.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.723 0.297 . . . . 0.0 111.685 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.36 -56.21 0.57 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.691 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.59 29.07 5.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.961 0.41 . . . . 0.0 111.626 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 117' ' ' THR . . . . . 0.785 HG21 HG22 ' F' ' 112' ' ' THR . 3.4 m -87.23 65.89 9.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.069 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 118' ' ' PHE . . . . . 0.527 ' HB3' ' HB1' ' F' ' 70' ' ' ALA . 48.5 m-85 -77.68 73.39 4.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.806 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.49 70.91 0.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 120' ' ' SER . . . . . 0.6 ' HA ' ' HB ' ' F' ' 107' ' ' THR . 0.7 OUTLIER -148.68 126.06 11.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.696 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.04 53.17 2.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.205 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 122' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' F' ' 69' ' ' ALA . 0.2 OUTLIER -73.97 128.32 35.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.765 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.35 117.86 25.42 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.772 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tp -88.45 134.79 33.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.761 0.315 . . . . 0.0 110.498 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 125' ' ' ASN . . . . . 0.53 ' HB3' ' O ' ' C' ' 116' ' ' ALA . 0.3 OUTLIER -129.3 163.09 26.43 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.63 179.505 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 126' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' F' ' 62' ' ' ASP . 1.5 t30 -67.61 125.43 26.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.699 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 127' ' ' GLY . . . . . 0.661 ' HA2' HG21 ' B' ' 4' ' ' THR . . . 128.55 -141.0 12.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.707 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 128' ' ' THR . . . . . 0.727 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 6.3 m -101.74 92.44 4.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.716 0.293 . . . . 0.0 110.809 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 129' ' ' ASN . . . . . 0.529 ' HB2' ' SG ' ' F' ' 61' ' ' CYS . 1.2 t30 -76.55 144.99 39.33 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.881 0.372 . . . . 0.0 111.14 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 130' ' ' THR . . . . . 0.717 HG21 HD21 ' C' ' 74' ' ' LEU . 0.0 OUTLIER -134.61 131.76 38.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.073 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 131' ' ' ILE . . . . . 0.688 HD11 HG12 ' F' ' 156' ' ' VAL . 28.1 mt -87.31 109.81 28.66 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 132' ' ' PRO . . . . . 0.62 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.4 Cg_endo -81.67 112.16 2.38 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.617 1.544 . . . . 0.0 112.558 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.36 138.21 51.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.842 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 134' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' F' ' 52' ' ' VAL . 28.2 mt-30 -110.08 157.5 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.007 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 135' ' ' ALA . . . . . 0.672 ' HB3' HG22 ' F' ' 52' ' ' VAL . . . -152.69 107.87 3.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 111.606 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -102.47 174.37 5.93 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.378 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 137' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 0.6 OUTLIER -86.04 120.83 27.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.08 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 138' ' ' PHE . . . . . 0.516 ' HB3' HG11 ' F' ' 85' ' ' VAL . 0.2 OUTLIER -117.64 139.67 50.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.056 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 139' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' F' ' 47' ' ' ALA . . . -129.96 145.57 51.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.902 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 140' ' ' THR . . . . . 0.613 HG21 ' HB2' ' F' ' 79' ' ' ASP . 16.5 p -104.36 -53.38 2.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.511 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.73 -121.47 3.26 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.995 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.12 112.93 24.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.549 0.214 . . . . 0.0 110.649 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 143' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' F' ' 42' ' ' LEU . . . -61.73 150.88 35.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.76 0.314 . . . . 0.0 111.479 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 144' ' ' THR . . . . . 0.544 HG23 ' HD2' ' F' ' 145' ' ' PRO . 60.1 m -126.85 151.52 73.88 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.27 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 145' ' ' PRO . . . . . 0.544 ' HD2' HG23 ' F' ' 144' ' ' THR . 1.4 Cg_endo -82.96 140.14 9.96 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.573 2.182 . . . . 0.0 112.024 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.98 -138.07 6.55 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.529 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 147' ' ' ALA . . . . . 0.594 ' HA ' ' HG3' ' E' ' 15' ' ' GLU . . . -87.22 145.04 26.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.881 0.372 . . . . 0.0 111.344 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 148' ' ' ALA . . . . . 0.736 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -140.77 38.79 1.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.558 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -86.04 153.57 22.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.549 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 150' ' ' ALA . . . . . 0.599 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -161.92 171.2 18.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.997 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.41 126.79 7.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.193 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 152' ' ' ALA . . . . . 0.528 ' HB2' ' CD1' ' F' ' 86' ' ' LEU . . . -125.34 142.81 51.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.341 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 153' ' ' THR . . . . . 0.811 HG23 HG23 ' E' ' 9' ' ' THR . 0.4 OUTLIER -89.88 133.19 34.89 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 154' ' ' PHE . . . . . 0.517 ' HD1' ' HA ' ' F' ' 154' ' ' PHE . 0.0 OUTLIER -86.34 127.83 34.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.025 0.441 . . . . 0.0 110.131 -179.004 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.47 150.5 29.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.941 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 156' ' ' VAL . . . . . 0.802 HG23 HG23 ' E' ' 5' ' ' VAL . 14.5 m -136.19 144.42 33.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 111.597 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 157' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' F' ' 69' ' ' ALA . 0.0 OUTLIER -136.23 132.79 36.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.364 0.602 . . . . 0.0 110.382 -179.743 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 158' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' F' ' 21' ' ' CYS . 5.5 m-85 -117.41 119.78 36.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.563 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 159' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' E' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.867 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.327 0.108 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.37 88.97 0.04 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.034 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.17 114.5 18.43 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.414 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -97.3 119.2 35.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.664 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.654 HG23 HG22 ' B' ' 156' ' ' VAL . 19.5 m -136.58 158.25 37.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.584 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.12 115.94 22.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.607 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.63 -79.61 0.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.851 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.511 ' H ' ' HB3' ' B' ' 154' ' ' PHE . . . -148.55 -145.94 4.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.903 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.556 HG22 HG23 ' B' ' 153' ' ' THR . 15.0 p -142.05 145.14 34.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.0 0.428 . . . . 0.0 111.24 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.5 t -127.83 119.5 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.245 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.46 113.16 25.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.386 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.75 90.68 5.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.799 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.11 120.72 32.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.367 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.05 170.5 32.64 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.91 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.653 ' HG3' ' O ' ' B' ' 146' ' ' GLY . 21.4 tt0 -160.61 129.19 4.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.402 . . . . 0.0 110.364 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.792 HG13 HG13 ' B' ' 37' ' ' VAL . 2.2 t -89.66 136.95 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.191 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.771 ' O ' HG22 ' B' ' 39' ' ' THR . 34.3 m -136.37 -160.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.781 0.324 . . . . 0.0 111.134 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.95 177.08 6.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.013 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' B' ' 40' ' ' ALA . . . -90.25 49.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.064 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -122.17 -39.66 2.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.394 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.675 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -162.15 146.38 12.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.943 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.02 121.65 14.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.637 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 2.5 p -63.71 143.5 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.054 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.562 ' HB3' ' HB2' ' A' ' 27' ' ' SER . 13.5 t70 -72.9 154.62 40.5 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.581 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.446 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -54.31 -53.89 47.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.354 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.54 1.03 88.67 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.88 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.562 ' HB2' ' HB3' ' A' ' 24' ' ' ASP . 7.9 t -99.28 -16.66 18.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.879 0.371 . . . . 0.0 110.836 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 25' ' ' ALA . 10.9 t -53.18 -50.84 44.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.355 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -114.06 126.16 54.79 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.973 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.423 HE22 ' HA ' ' A' ' 56' ' ' ILE . 3.7 mt-30 -125.61 135.6 52.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.051 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.92 109.11 21.91 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.128 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.51 115.14 48.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.086 0.47 . . . . 0.0 110.475 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.17 124.72 50.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.662 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.24 -42.31 23.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.602 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.1 -165.42 12.15 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.574 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -93.57 119.21 32.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.62 0.248 . . . . 0.0 110.854 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 137' ' ' TYR . 8.2 p -104.88 133.95 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.871 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -79.93 137.65 36.93 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.667 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -49.42 75.45 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.767 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.55 -33.48 54.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.026 0.441 . . . . 0.0 110.872 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.38 61.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.114 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.622 ' O ' ' HB2' ' A' ' 143' ' ' ALA . 0.6 OUTLIER -114.04 39.82 2.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.619 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.24 33.94 3.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.396 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.664 ' HB2' ' HB2' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -124.48 142.87 50.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.346 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.22 95.69 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 0.0 111.146 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.4 33.69 5.84 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.152 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 44' ' ' GLN . . . -78.83 143.55 35.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.981 0.42 . . . . 0.0 111.958 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.507 ' HB ' ' HD2' ' A' ' 136' ' ' ARG . 18.1 p -131.67 131.93 43.55 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.902 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 1.3 m -103.78 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.548 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -57.78 141.9 47.29 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -99.07 125.51 44.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.393 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 135' ' ' ALA . 24.8 m -76.51 150.99 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.956 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.34 143.29 16.43 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.4 ' HE2' ' HB3' ' A' ' 135' ' ' ALA . 37.5 p90 -171.48 140.44 1.39 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.844 0.354 . . . . 0.0 110.925 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -136.32 138.56 41.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.582 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.534 HG23 ' O ' ' A' ' 56' ' ' ILE . 0.7 OUTLIER -88.42 116.79 30.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.554 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.85 ' HA ' HG23 ' A' ' 130' ' ' THR . 5.0 mp0 -69.36 138.31 53.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.643 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -145.6 91.66 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.287 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.529 ' HA ' HG23 ' A' ' 128' ' ' THR . 4.1 p-10 -78.43 176.89 8.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.938 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.793 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.675 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 10.5 m -133.87 147.78 51.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.76 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.71 161.93 20.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.321 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.63 HG23 ' HA ' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -111.79 -34.18 6.1 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.067 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -72.54 -28.18 62.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.037 0.446 . . . . 0.0 111.718 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.18 -58.54 4.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.703 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.2 126.07 32.67 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.575 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -42.15 7.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.954 0.407 . . . . 0.0 110.943 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.24 156.83 18.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.517 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' A' ' 122' ' ' THR . . . -146.63 133.23 19.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.57 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -113.38 155.11 25.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.104 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.791 HG11 HG21 ' A' ' 131' ' ' ILE . 2.0 t -136.4 148.57 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.684 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -152.9 163.48 39.7 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.6 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.441 ' CD1' ' HB1' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -130.23 142.28 50.57 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 122.409 -0.182 . . . . 0.0 111.16 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 152' ' ' ALA . 1.4 tt -109.16 119.05 38.35 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.066 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.825 ' HA3' HD22 ' A' ' 113' ' ' LEU . . . -162.74 -161.92 12.93 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.769 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.633 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.3 OUTLIER -120.92 162.92 19.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.578 0.228 . . . . 0.0 110.779 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' A' ' 87' ' ' ALA . . . -83.57 139.08 33.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.934 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.531 HG23 ' N ' ' A' ' 79' ' ' ASP . 11.1 tt -66.09 -47.61 84.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.987 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.531 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -134.46 46.69 2.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.849 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.608 ' HB1' ' O ' ' D' ' 105' ' ' ASP . . . 64.49 -84.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.078 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.77 -36.4 40.9 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.603 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.43 69.2 10.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.888 0.375 . . . . 0.0 110.523 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -74.1 -7.51 52.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.487 -179.447 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.625 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 30.0 p-10 -74.74 -25.39 59.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.334 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 138' ' ' PHE . 6.4 t -104.92 143.84 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.169 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.611 ' HG ' HD13 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -74.8 160.86 30.17 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.338 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.688 ' HB2' ' O ' ' A' ' 77' ' ' ALA . . . -103.64 179.85 4.15 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.874 0.369 . . . . 0.0 111.712 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.717 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 1.3 mm? -66.58 171.29 5.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.045 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.562 ' HG3' ' HB2' ' A' ' 149' ' ' ASN . 1.3 mm-40 -68.61 -83.7 0.03 OUTLIER 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.265 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.412 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 6.0 p -169.12 19.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.959 0.409 . . . . 0.0 111.451 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.542 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 3.2 m -90.16 86.28 6.5 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' D' ' 50' ' ' SER . . . -61.16 -24.99 66.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.631 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.4 41.25 3.52 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.66 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.96 0.69 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.858 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.85 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 1.9 m -89.26 -173.59 4.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.773 0.321 . . . . 0.0 110.71 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.425 ' HB3' HD11 ' A' ' 88' ' ' LEU . . . -100.99 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 99' ' ' VAL . 3.0 m -131.06 123.92 29.72 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.299 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.21 29.43 18.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.459 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 97' ' ' THR . 1.7 t -125.31 129.33 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.835 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.85 -171.06 21.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.522 ' CG2' ' HB1' ' A' ' 135' ' ' ALA . 1.9 p -122.97 116.71 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.204 0.526 . . . . 0.0 111.69 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.55 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 3.9 tt0 -81.74 151.45 27.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.915 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.82 123.84 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.531 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.506 HD13 ' OE1' ' A' ' 134' ' ' GLN . 0.5 OUTLIER -104.72 125.18 50.55 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.658 0.266 . . . . 0.0 111.013 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.805 ' HB3' HG22 ' A' ' 107' ' ' THR . 13.6 t0 -77.57 143.07 38.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.672 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.697 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -62.73 -14.86 49.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.742 0.306 . . . . 0.0 111.043 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.805 HG22 ' HB3' ' A' ' 105' ' ' ASP . 8.8 t -63.04 -20.94 65.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.012 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.28 -43.57 1.36 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.735 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.69 160.71 14.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.767 0.318 . . . . 0.0 111.082 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.36 133.16 40.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.125 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.659 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 12.3 tp -95.54 160.94 14.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.373 0.606 . . . . 0.0 110.531 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 2.9 t -110.21 136.81 48.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.076 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.825 HD22 ' HA3' ' A' ' 75' ' ' GLY . 1.4 mt -70.25 89.64 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.76 0.314 . . . . 0.0 110.689 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -18.43 6.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.487 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -62.25 0.88 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.664 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.566 ' HB3' ' OD1' ' D' ' 129' ' ' ASN . . . -92.95 18.23 9.43 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.993 0.425 . . . . 0.0 111.659 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.548 HG21 HG23 ' A' ' 112' ' ' THR . 0.0 OUTLIER -83.97 72.58 10.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.065 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.604 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 78.4 m-85 -92.32 89.77 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.799 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 54.6 m -130.56 73.11 1.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.91 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.21 142.32 21.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.682 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.98 68.56 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.208 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.642 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -81.51 133.14 35.35 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.684 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.7 m -87.6 124.13 33.19 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.681 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.3 119.32 35.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.648 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.63 ' HA ' HG23 ' A' ' 63' ' ' THR . 2.9 m120 -113.71 171.91 7.29 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.587 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.48 109.75 16.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.647 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.82 -133.8 4.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.714 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.529 HG23 ' HA ' ' A' ' 59' ' ' ASN . 46.1 m -110.5 86.75 2.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.742 0.306 . . . . 0.0 110.794 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -69.34 155.07 41.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.829 0.347 . . . . 0.0 111.162 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.85 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -142.79 137.07 29.44 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.089 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.791 HG21 HG11 ' A' ' 71' ' ' VAL . 6.9 mt -100.25 109.12 55.66 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.697 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.5 Cg_endo -81.76 148.25 15.67 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.721 1.614 . . . . 0.0 112.536 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.413 ' CZ ' ' HA ' ' A' ' 105' ' ' ASP . 0.5 OUTLIER -158.82 145.31 17.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.908 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.506 ' OE1' HD13 ' A' ' 104' ' ' LEU . 4.1 mt-30 -111.24 160.4 17.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.024 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.766 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -155.98 97.82 1.84 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.951 0.405 . . . . 0.0 111.613 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.507 ' HD2' ' HB ' ' A' ' 48' ' ' THR . 14.4 ptt180 -101.57 173.61 6.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.41 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 1.8 m-85 -83.64 135.04 34.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.134 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.602 ' HB3' HG11 ' A' ' 85' ' ' VAL . 1.7 t80 -128.86 128.18 43.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.022 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.454 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -108.52 138.0 45.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.817 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.529 HG21 ' HB2' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -89.94 -9.56 48.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.494 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.31 -95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.963 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.71 101.49 11.33 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.513 0.197 . . . . 0.0 110.737 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 42' ' ' LEU . . . -61.36 144.35 54.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.749 0.309 . . . . 0.0 111.378 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.602 ' CG2' ' CD ' ' A' ' 145' ' ' PRO . 99.2 m -123.94 153.15 67.42 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.22 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.602 ' CD ' ' CG2' ' A' ' 144' ' ' THR . 1.3 Cg_endo -83.01 144.78 12.14 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.523 2.149 . . . . 0.0 111.989 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.3 -116.09 0.7 Allowed Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.503 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.85 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -119.73 132.37 55.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.892 0.377 . . . . 0.0 111.361 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.37 43.36 3.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.13 0.491 . . . . 0.0 110.414 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.562 ' HB2' ' HG3' ' A' ' 89' ' ' GLN . 1.1 m120 -95.68 150.88 19.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.586 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.507 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -168.5 -178.63 3.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.017 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.78 153.0 39.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.238 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -141.22 151.12 43.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.239 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.66 133.73 54.55 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.71 148.72 28.82 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.093 0.473 . . . . 0.0 110.112 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 118' ' ' PHE . 11.2 mmtt -135.02 139.43 44.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.949 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.403 HG12 ' CD1' ' A' ' 131' ' ' ILE . 3.1 m -134.52 141.3 43.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.778 0.323 . . . . 0.0 111.685 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.547 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 3.8 tt0 -128.78 128.97 45.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.318 0.58 . . . . 0.0 110.358 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.71 128.59 51.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.565 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.33 0.109 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.37 88.99 0.04 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.588 0.232 . . . . 0.0 111.022 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.18 114.49 18.41 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.402 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -97.31 119.19 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.65 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.654 HG23 HG22 ' C' ' 156' ' ' VAL . 19.4 m -136.58 158.24 37.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.525 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.16 115.99 22.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.552 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.64 -79.61 0.13 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.873 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.514 ' H ' ' HB3' ' C' ' 154' ' ' PHE . . . -148.56 -145.9 4.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.879 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.561 HG22 HG23 ' C' ' 153' ' ' THR . 14.9 p -142.11 145.12 33.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.052 0.453 . . . . 0.0 111.225 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 32.5 t -127.8 119.51 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.267 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.44 113.14 25.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.377 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.7 90.72 5.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.814 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.15 120.71 32.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.337 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.02 170.48 32.62 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.908 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.642 ' HG3' ' O ' ' C' ' 146' ' ' GLY . 21.4 tt0 -160.59 129.19 4.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.975 0.417 . . . . 0.0 110.395 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.809 HG13 HG13 ' C' ' 37' ' ' VAL . 2.2 t -89.66 136.93 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.226 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.753 ' O ' HG22 ' C' ' 39' ' ' THR . 34.3 m -136.35 -160.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.785 0.326 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.93 177.02 6.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.977 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' C' ' 40' ' ' ALA . . . -90.21 49.67 1.73 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.053 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' B' ' 61' ' ' CYS . . . -122.19 -39.67 2.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.437 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.701 ' HG ' ' HG ' ' B' ' 61' ' ' CYS . 0.5 OUTLIER -162.13 146.38 12.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.959 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.04 121.62 14.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.623 ' HA ' ' HG ' ' B' ' 58' ' ' LEU . 2.4 p -63.71 143.54 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.037 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.561 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 13.6 t70 -72.94 154.65 40.46 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.582 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.439 ' O ' HG23 ' B' ' 28' ' ' VAL . . . -54.33 -53.88 47.86 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.341 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.55 1.05 88.65 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.868 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.561 ' HB2' ' HB3' ' B' ' 24' ' ' ASP . 7.9 t -99.29 -16.68 18.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.872 0.367 . . . . 0.0 110.826 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 25' ' ' ALA . 10.7 t -53.14 -50.85 43.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.377 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -114.08 126.19 54.82 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.972 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLN . . . . . 0.43 HE22 ' HA ' ' B' ' 56' ' ' ILE . 3.7 mt-30 -125.61 135.57 52.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.064 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.92 109.17 21.95 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.117 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.57 115.16 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 0.0 110.463 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.2 124.74 50.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.631 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.26 -42.34 23.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.596 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.13 -165.34 12.14 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.557 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 4.0 mt-30 -93.65 119.24 32.42 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.64 0.257 . . . . 0.0 110.834 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.792 HG13 HG13 ' A' ' 16' ' ' VAL . 8.2 p -104.91 133.94 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.87 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' B' ' 41' ' ' SER . 0.1 OUTLIER -79.92 137.62 36.93 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.668 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -62.53 -49.38 75.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.762 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . . . -53.52 -33.5 54.74 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.01 0.433 . . . . 0.0 110.865 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' B' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.33 61.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.112 -179.742 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' B' ' 143' ' ' ALA . 0.6 OUTLIER -114.07 39.81 2.64 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.613 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.2 33.96 3.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.448 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 0.667 ' HB2' ' HB2' ' B' ' 47' ' ' ALA . 0.3 OUTLIER -124.48 142.88 50.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.344 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.25 95.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.371 . . . . 0.0 111.148 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.43 33.63 5.85 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.139 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' B' ' 44' ' ' GLN . . . -78.87 143.5 35.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.418 . . . . 0.0 111.949 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.494 ' HB ' ' HD2' ' B' ' 136' ' ' ARG . 18.1 p -131.61 131.9 43.62 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.895 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 1.3 m -103.75 -167.22 1.34 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.572 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -57.82 141.91 47.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.863 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.465 ' HB2' ' HB3' ' B' ' 136' ' ' ARG . . . -99.05 125.52 44.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.377 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.773 HG22 ' O ' ' B' ' 135' ' ' ALA . 24.8 m -76.53 151.0 6.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.961 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.36 143.28 16.44 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.527 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -171.47 140.44 1.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.801 0.334 . . . . 0.0 110.936 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -136.33 138.6 41.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.571 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.542 HG23 ' O ' ' B' ' 56' ' ' ILE . 0.7 OUTLIER -88.45 116.79 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.542 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLN . . . . . 0.842 ' HA ' HG23 ' B' ' 130' ' ' THR . 5.0 mp0 -69.38 138.31 53.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.802 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.643 ' HB3' ' SG ' ' B' ' 21' ' ' CYS . 0.3 OUTLIER -145.58 91.67 2.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.276 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.525 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 4.1 p-10 -78.43 176.86 8.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.912 0.387 . . . . 0.0 110.915 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.92 81.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' CYS . . . . . 0.701 ' HG ' ' HG ' ' B' ' 21' ' ' CYS . 10.4 m -133.85 147.8 51.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.78 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.7 161.91 20.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.349 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.644 HG23 ' HA ' ' B' ' 125' ' ' ASN . 0.0 OUTLIER -111.75 -34.19 6.1 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.08 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -72.52 -28.2 62.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.072 0.463 . . . . 0.0 111.735 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.18 -58.56 4.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.658 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.22 126.06 32.62 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.592 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.39 -42.09 7.13 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.956 0.407 . . . . 0.0 110.954 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LYS . . . . . 0.441 ' HD2' ' HA ' ' B' ' 68' ' ' LYS . 1.2 tptp -89.28 156.8 18.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.465 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.651 ' HB3' ' HB ' ' B' ' 122' ' ' THR . . . -146.61 133.21 19.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.609 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -113.35 155.11 25.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.137 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.763 HG11 HG21 ' B' ' 131' ' ' ILE . 2.0 t -136.39 148.53 27.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.725 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' B' ' 155' ' ' LYS . . . -152.9 163.51 39.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.553 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.441 ' CD1' ' HB1' ' B' ' 152' ' ' ALA . 0.2 OUTLIER -130.23 142.25 50.58 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 122.411 -0.181 . . . . 0.0 111.207 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' B' ' 152' ' ' ALA . 1.4 tt -109.12 119.05 38.36 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.053 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.793 ' HA3' HD22 ' B' ' 113' ' ' LEU . . . -162.74 -161.9 12.89 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.757 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.64 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.3 OUTLIER -120.97 162.92 19.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.59 0.233 . . . . 0.0 110.788 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.694 ' O ' ' HB2' ' B' ' 87' ' ' ALA . . . -83.54 139.08 33.1 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.936 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.538 HG23 ' N ' ' B' ' 79' ' ' ASP . 11.1 tt -66.09 -47.64 84.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.973 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.542 ' HB2' HG21 ' B' ' 140' ' ' THR . 0.2 OUTLIER -134.42 46.69 2.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.891 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' E' ' 105' ' ' ASP . . . 64.48 -83.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.096 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.79 -36.42 41.17 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.576 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.4 69.19 10.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.541 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' THR . . . . . 0.477 HG23 ' HB2' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -74.08 -7.53 52.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.549 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ASN . . . . . 0.603 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 30.1 p-10 -74.69 -25.4 59.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.383 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.6 HG11 ' HB3' ' B' ' 138' ' ' PHE . 6.4 t -104.92 143.88 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.17 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.6 ' HG ' HD13 ' B' ' 113' ' ' LEU . 0.3 OUTLIER -74.84 160.89 30.11 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.265 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' B' ' 77' ' ' ALA . . . -103.66 179.88 4.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.861 0.363 . . . . 0.0 111.702 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.699 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 1.3 mm? -66.59 171.3 5.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.038 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' GLN . . . . . 0.563 ' HG3' ' HB2' ' B' ' 149' ' ' ASN . 1.3 mm-40 -68.57 -83.75 0.03 OUTLIER 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.275 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' SER . . . . . 0.409 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 5.9 p -169.11 19.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.907 0.384 . . . . 0.0 111.426 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' SER . . . . . 0.535 ' HA ' ' HB2' ' D' ' 25' ' ' ALA . 3.2 m -90.13 86.26 6.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.505 ' HB2' HG13 ' E' ' 52' ' ' VAL . . . -61.1 -25.03 66.68 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.652 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.42 41.31 3.5 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.638 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.03 0.72 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.828 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' SER . . . . . 0.846 ' HA ' ' HB3' ' B' ' 147' ' ' ALA . 1.9 m -89.28 -173.58 4.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.784 0.326 . . . . 0.0 110.71 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.418 ' HB3' HD11 ' B' ' 88' ' ' LEU . . . -100.97 -177.3 3.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.409 ' O ' HG23 ' B' ' 99' ' ' VAL . 3.0 m -131.03 123.94 29.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.301 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 61.18 29.46 18.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.462 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 97' ' ' THR . 1.7 t -125.31 129.33 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.86 -171.15 21.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.515 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' B' ' 86' ' ' LEU . 1.9 p -122.89 116.72 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.208 0.528 . . . . 0.0 111.682 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 3.9 tt0 -81.77 151.46 27.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.923 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.83 123.82 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.511 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' LEU . . . . . 0.512 HD13 ' OE1' ' B' ' 134' ' ' GLN . 0.5 OUTLIER -104.68 125.17 50.52 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.645 0.26 . . . . 0.0 111.041 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ASP . . . . . 0.8 ' HB3' HG22 ' B' ' 107' ' ' THR . 13.6 t0 -77.61 143.12 38.5 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.659 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' ARG . . . . . 0.719 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -62.75 -14.88 49.93 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.722 0.296 . . . . 0.0 111.048 179.45 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.8 HG22 ' HB3' ' B' ' 105' ' ' ASP . 8.8 t -62.97 -20.96 65.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.024 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.3 -43.57 1.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.729 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.7 160.71 14.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.327 . . . . 0.0 111.088 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.35 133.18 40.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.122 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.66 ' HB2' ' HB2' ' B' ' 105' ' ' ASP . 12.3 tp -95.56 160.9 14.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.401 0.619 . . . . 0.0 110.469 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 2.9 t -110.19 136.8 48.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.075 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.793 HD22 ' HA3' ' B' ' 75' ' ' GLY . 1.4 mt -70.22 89.59 0.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.764 0.316 . . . . 0.0 110.655 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.34 -18.46 6.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.509 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.3 -62.27 0.87 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.645 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' ALA . . . . . 0.568 ' HB3' ' OD1' ' E' ' 129' ' ' ASN . . . -92.95 18.23 9.44 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.023 0.44 . . . . 0.0 111.668 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.546 HG21 HG23 ' B' ' 112' ' ' THR . 0.0 OUTLIER -83.91 72.53 10.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.039 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.588 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . 78.3 m-85 -92.35 89.8 6.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.775 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 55.1 m -130.58 73.15 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.23 142.29 21.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.691 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -103.96 68.55 0.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.194 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.651 ' HB ' ' HB3' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -81.43 133.16 35.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.72 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 8.7 m -87.61 124.14 33.21 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.687 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.33 119.34 35.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.633 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.644 ' HA ' HG23 ' B' ' 63' ' ' THR . 2.9 m120 -113.74 171.94 7.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.573 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.5 109.76 16.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.646 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.8 -133.79 4.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.712 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 46.4 m -110.53 86.75 2.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.759 0.314 . . . . 0.0 110.807 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.32 155.05 41.06 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.222 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.842 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -142.76 137.1 29.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.092 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 131' ' ' ILE . . . . . 0.763 HG21 HG11 ' B' ' 71' ' ' VAL . 6.9 mt -100.26 109.07 55.53 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' PRO . . . . . 0.719 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.73 148.26 15.73 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 121.666 1.577 . . . . 0.0 112.543 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' B' ' 105' ' ' ASP . 0.5 OUTLIER -158.8 145.32 17.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.921 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 134' ' ' GLN . . . . . 0.512 ' OE1' HD13 ' B' ' 104' ' ' LEU . 4.1 mt-30 -111.24 160.4 17.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.034 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.773 ' O ' HG22 ' B' ' 52' ' ' VAL . . . -156.0 97.79 1.84 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.956 0.408 . . . . 0.0 111.589 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 136' ' ' ARG . . . . . 0.494 ' HD2' ' HB ' ' B' ' 48' ' ' THR . 14.4 ptt180 -101.54 173.59 6.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.405 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 1.8 m-85 -83.62 135.04 34.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.181 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' PHE . . . . . 0.6 ' HB3' HG11 ' B' ' 85' ' ' VAL . 1.8 t80 -128.88 128.18 43.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.988 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.462 ' HB2' HD23 ' B' ' 42' ' ' LEU . . . -108.53 138.0 45.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.86 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 140' ' ' THR . . . . . 0.542 HG21 ' HB2' ' B' ' 79' ' ' ASP . 0.3 OUTLIER -89.96 -9.55 48.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.478 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.3 -95.23 0.1 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.951 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.74 101.52 11.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.514 0.197 . . . . 0.0 110.744 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 42' ' ' LEU . . . -61.39 144.35 54.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.73 0.3 . . . . 0.0 111.379 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.598 ' CG2' ' CD ' ' B' ' 145' ' ' PRO . 99.2 m -123.95 153.17 67.47 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.196 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.598 ' CD ' ' CG2' ' B' ' 144' ' ' THR . 1.3 Cg_endo -83.04 144.78 12.11 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.519 2.146 . . . . 0.0 112.006 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 146' ' ' GLY . . . . . 0.653 ' O ' ' HG3' ' A' ' 15' ' ' GLU . . . 157.3 -116.09 0.7 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.494 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.846 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -119.75 132.4 55.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.903 0.382 . . . . 0.0 111.316 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' ALA . . . . . 0.606 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -125.39 43.33 3.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.16 0.505 . . . . 0.0 110.417 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.563 ' HB2' ' HG3' ' B' ' 89' ' ' GLN . 1.1 m120 -95.65 150.88 19.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.573 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.512 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -168.49 -178.63 3.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.03 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.77 152.98 39.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.261 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -141.2 151.11 43.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.264 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.556 HG23 HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -112.69 133.75 54.56 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.511 ' HB3' ' H ' ' A' ' 8' ' ' GLY . 0.1 OUTLIER -81.65 148.68 28.91 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.053 0.454 . . . . 0.0 110.158 -179.062 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.555 ' HB3' ' CZ ' ' B' ' 118' ' ' PHE . 11.2 mmtt -135.03 139.49 44.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.928 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 156' ' ' VAL . . . . . 0.654 HG22 HG23 ' A' ' 5' ' ' VAL . 3.1 m -134.55 141.27 43.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.776 0.322 . . . . 0.0 111.698 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.537 ' HB3' ' HB3' ' B' ' 70' ' ' ALA . 3.9 tt0 -128.79 128.96 45.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.346 0.593 . . . . 0.0 110.353 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.72 128.62 51.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.583 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.841 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.261 0.077 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.4 88.97 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.004 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.19 114.48 18.39 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.436 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -97.26 119.19 35.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.644 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.635 HG23 HG22 ' D' ' 156' ' ' VAL . 19.5 m -136.56 158.26 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.63 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.15 115.99 22.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.578 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.66 -79.58 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.876 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' GLY . . . . . 0.512 ' H ' ' HB3' ' D' ' 154' ' ' PHE . . . -148.55 -145.97 4.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.898 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 9' ' ' THR . . . . . 0.564 HG22 HG23 ' D' ' 153' ' ' THR . 15.2 p -142.03 145.12 34.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.956 0.408 . . . . 0.0 111.32 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 32.0 t -127.82 119.53 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.26 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.43 113.17 25.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.391 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -95.75 90.66 5.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.792 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.1 120.73 32.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.357 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.04 170.48 32.63 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.918 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' GLU . . . . . 0.653 ' HG3' ' O ' ' D' ' 146' ' ' GLY . 21.4 tt0 -160.6 129.19 4.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.987 0.423 . . . . 0.0 110.368 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.778 HG13 HG13 ' D' ' 37' ' ' VAL . 2.2 t -89.66 136.91 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.246 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.767 ' O ' HG22 ' D' ' 39' ' ' THR . 34.3 m -136.35 -160.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.767 0.318 . . . . 0.0 111.147 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.98 177.01 6.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.998 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' D' ' 40' ' ' ALA . . . -90.16 49.59 1.73 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.038 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 20' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' C' ' 61' ' ' CYS . . . -122.16 -39.69 2.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.398 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 21' ' ' CYS . . . . . 0.707 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.5 OUTLIER -162.13 146.39 12.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.943 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.05 121.61 14.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.141 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' VAL . . . . . 0.616 ' HA ' ' HG ' ' C' ' 58' ' ' LEU . 2.4 p -63.67 143.5 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.049 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' C' ' 27' ' ' SER . 13.5 t70 -72.88 154.6 40.52 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.597 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -54.3 -53.88 47.84 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.345 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.56 1.03 88.71 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.874 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' SER . . . . . 0.572 ' HB2' ' HB3' ' C' ' 24' ' ' ASP . 7.9 t -99.3 -16.63 18.41 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.879 0.371 . . . . 0.0 110.842 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.445 HG23 ' O ' ' C' ' 25' ' ' ALA . 10.8 t -53.18 -50.83 44.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.35 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -114.07 126.19 54.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.98 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' GLN . . . . . 0.43 HE22 ' HA ' ' C' ' 56' ' ' ILE . 3.7 mt-30 -125.64 135.58 52.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.063 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.91 109.11 21.9 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.13 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.5 115.15 48.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.132 0.491 . . . . 0.0 110.464 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.17 124.73 50.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.667 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.26 -42.28 23.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.584 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.08 -165.39 12.15 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.583 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' GLN . . . . . 0.588 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 4.1 mt-30 -93.62 119.2 32.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.626 0.25 . . . . 0.0 110.841 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.809 HG13 HG13 ' B' ' 16' ' ' VAL . 8.2 p -104.86 133.95 47.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.897 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 38' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' C' ' 41' ' ' SER . 0.1 OUTLIER -79.9 137.65 36.95 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.689 179.271 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.753 HG22 ' O ' ' B' ' 17' ' ' VAL . 0.2 OUTLIER -62.51 -49.43 75.37 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.75 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' B' ' 19' ' ' ALA . . . -53.56 -33.48 54.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.994 0.426 . . . . 0.0 110.837 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' C' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.31 61.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.11 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.622 ' O ' ' HB2' ' C' ' 143' ' ' ALA . 0.6 OUTLIER -114.12 39.84 2.64 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.642 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.24 33.95 3.28 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.386 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 44' ' ' GLN . . . . . 0.672 ' HB2' ' HB2' ' C' ' 47' ' ' ALA . 0.3 OUTLIER -124.51 142.92 50.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.289 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.26 95.7 0.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.145 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.41 33.72 5.83 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.126 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' C' ' 44' ' ' GLN . . . -78.93 143.52 35.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.976 0.417 . . . . 0.0 111.928 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 48' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' C' ' 136' ' ' ARG . 18.1 p -131.63 131.94 43.62 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.884 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.532 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 1.3 m -103.82 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.524 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -57.76 141.86 47.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' ALA . . . . . 0.489 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . . . -99.03 125.48 44.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.379 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.77 HG22 ' O ' ' C' ' 135' ' ' ALA . 24.7 m -76.51 150.98 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.956 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.3 143.27 16.41 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.572 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' PHE . . . . . 0.408 ' HE2' ' HB3' ' C' ' 135' ' ' ALA . 37.5 p90 -171.49 140.45 1.39 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.771 0.319 . . . . 0.0 110.895 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -136.33 138.62 41.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.541 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.541 HG23 ' O ' ' C' ' 56' ' ' ILE . 0.7 OUTLIER -88.47 116.77 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.554 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.846 ' HA ' HG23 ' C' ' 130' ' ' THR . 5.0 mp0 -69.33 138.29 53.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.794 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 58' ' ' LEU . . . . . 0.635 ' HB3' ' SG ' ' C' ' 21' ' ' CYS . 0.3 OUTLIER -145.62 91.65 2.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.281 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 59' ' ' ASN . . . . . 0.521 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 4.1 p-10 -78.46 176.86 8.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.946 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.81 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 61' ' ' CYS . . . . . 0.707 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 10.4 m -133.87 147.74 51.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.798 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.67 161.92 20.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.341 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.633 HG23 ' HA ' ' C' ' 125' ' ' ASN . 0.0 OUTLIER -111.77 -34.19 6.1 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -72.59 -28.14 62.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.045 0.45 . . . . 0.0 111.725 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -73.15 -58.55 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.733 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.21 126.07 32.64 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.58 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.33 -42.19 7.1 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.964 0.411 . . . . 0.0 110.938 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 68' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' C' ' 68' ' ' LYS . 1.2 tptp -89.22 156.85 18.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.502 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.64 ' HB3' ' HB ' ' C' ' 122' ' ' THR . . . -146.65 133.18 19.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.596 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.602 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -113.31 155.11 25.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.165 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 71' ' ' VAL . . . . . 0.752 HG11 HG21 ' C' ' 131' ' ' ILE . 2.0 t -136.4 148.54 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.7 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 72' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' C' ' 155' ' ' LYS . . . -152.88 163.49 39.68 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.579 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 73' ' ' PHE . . . . . 0.438 ' CD1' ' HB1' ' C' ' 152' ' ' ALA . 0.2 OUTLIER -130.24 142.28 50.57 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.468 0.175 . . . . 0.0 111.197 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' C' ' 152' ' ' ALA . 1.4 tt -109.17 119.04 38.33 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.052 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 75' ' ' GLY . . . . . 0.83 ' HA3' HD22 ' C' ' 113' ' ' LEU . . . -162.74 -161.82 12.79 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.736 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.631 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.3 OUTLIER -121.04 162.91 19.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.624 0.25 . . . . 0.0 110.762 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 77' ' ' ALA . . . . . 0.7 ' O ' ' HB2' ' C' ' 87' ' ' ALA . . . -83.54 139.08 33.1 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.933 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 78' ' ' ILE . . . . . 0.542 HG23 ' N ' ' C' ' 79' ' ' ASP . 11.1 tt -66.08 -47.59 84.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.94 0.4 . . . . 0.0 111.007 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 79' ' ' ASP . . . . . 0.542 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.2 OUTLIER -134.45 46.62 2.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.862 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 80' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' F' ' 105' ' ' ASP . . . 64.49 -84.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.075 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.75 -36.39 40.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.61 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.5 69.24 10.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.924 0.393 . . . . 0.0 110.51 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 83' ' ' THR . . . . . 0.484 HG23 ' HB2' ' C' ' 77' ' ' ALA . 0.2 OUTLIER -74.13 -7.49 52.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.51 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 84' ' ' ASN . . . . . 0.621 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 30.0 p-10 -74.7 -25.4 59.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.36 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.612 HG11 ' HB3' ' C' ' 138' ' ' PHE . 6.4 t -104.92 143.81 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.148 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.596 ' HG ' HD13 ' C' ' 113' ' ' LEU . 0.3 OUTLIER -74.78 160.88 30.16 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.308 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' C' ' 77' ' ' ALA . . . -103.67 179.87 4.15 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.897 0.379 . . . . 0.0 111.685 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.708 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 1.3 mm? -66.58 171.29 5.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 89' ' ' GLN . . . . . 0.536 ' HG3' ' HB2' ' C' ' 149' ' ' ASN . 1.3 mm-40 -68.61 -83.74 0.03 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.279 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 90' ' ' SER . . . . . 0.413 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 5.9 p -169.08 19.14 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.941 0.4 . . . . 0.0 111.426 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 91' ' ' SER . . . . . 0.537 ' HA ' ' HB2' ' E' ' 25' ' ' ALA . 3.3 m -90.15 86.26 6.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.897 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 92' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' F' ' 50' ' ' SER . . . -61.13 -25.01 66.69 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.637 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.39 41.22 3.53 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.669 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.0 0.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.87 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 95' ' ' SER . . . . . 0.834 ' HA ' ' HB3' ' C' ' 147' ' ' ALA . 1.9 m -89.24 -173.58 4.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.813 0.34 . . . . 0.0 110.691 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 96' ' ' ALA . . . . . 0.409 ' HB3' HD11 ' C' ' 88' ' ' LEU . . . -100.98 -177.25 3.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 3.0 m -131.11 123.96 29.73 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.303 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.17 29.46 18.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.467 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 1.7 t -125.32 129.35 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.818 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.84 -171.04 21.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.508 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 101' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' C' ' 86' ' ' LEU . 1.9 p -122.97 116.73 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.213 0.53 . . . . 0.0 111.679 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 102' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 3.9 tt0 -81.75 151.42 27.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.936 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.8 123.81 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.563 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 104' ' ' LEU . . . . . 0.508 HD13 ' OE1' ' C' ' 134' ' ' GLN . 0.5 OUTLIER -104.69 125.17 50.53 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.638 0.256 . . . . 0.0 111.002 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 105' ' ' ASP . . . . . 0.799 ' HB3' HG22 ' C' ' 107' ' ' THR . 13.6 t0 -77.58 143.05 38.62 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.695 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 106' ' ' ARG . . . . . 0.712 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -62.64 -14.94 49.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.757 0.313 . . . . 0.0 111.063 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 107' ' ' THR . . . . . 0.799 HG22 ' HB3' ' C' ' 105' ' ' ASP . 8.8 t -62.96 -20.97 65.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.27 -43.58 1.36 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.727 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.71 160.71 14.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.789 0.328 . . . . 0.0 111.08 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.37 133.16 40.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.085 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 111' ' ' LEU . . . . . 0.667 ' HB2' ' HB2' ' C' ' 105' ' ' ASP . 12.3 tp -95.5 160.94 14.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.378 0.608 . . . . 0.0 110.554 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 112' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 2.9 t -110.22 136.79 48.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.068 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.83 HD22 ' HA3' ' C' ' 75' ' ' GLY . 1.4 mt -70.22 89.61 0.65 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.751 0.31 . . . . 0.0 110.685 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.34 -18.44 6.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.472 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.32 -62.24 0.87 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.683 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 116' ' ' ALA . . . . . 0.564 ' HB3' ' OD1' ' F' ' 129' ' ' ASN . . . -92.94 18.21 9.45 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 121.042 0.448 . . . . 0.0 111.696 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 117' ' ' THR . . . . . 0.545 HG21 HG23 ' C' ' 112' ' ' THR . 0.0 OUTLIER -83.98 72.59 10.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.049 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 118' ' ' PHE . . . . . 0.602 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . 78.1 m-85 -92.37 89.75 6.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.765 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 55.1 m -130.54 73.12 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.938 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.22 142.28 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.651 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -103.98 68.51 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.199 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -81.43 133.13 35.36 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.71 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 8.6 m -87.6 124.12 33.18 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.697 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.3 119.29 35.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.655 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 125' ' ' ASN . . . . . 0.633 ' HA ' HG23 ' C' ' 63' ' ' THR . 2.9 m120 -113.69 171.9 7.3 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.586 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.48 109.72 16.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.618 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.85 -133.79 4.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.714 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 128' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 46.4 m -110.52 86.78 2.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.722 0.296 . . . . 0.0 110.779 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 129' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.38 155.06 41.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.866 0.365 . . . . 0.0 111.143 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 130' ' ' THR . . . . . 0.846 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -142.79 137.09 29.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.086 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 131' ' ' ILE . . . . . 0.752 HG21 HG11 ' C' ' 71' ' ' VAL . 6.9 mt -100.3 109.13 55.81 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 132' ' ' PRO . . . . . 0.712 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.5 Cg_endo -81.76 148.25 15.68 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.668 1.579 . . . . 0.0 112.546 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' C' ' 105' ' ' ASP . 0.5 OUTLIER -158.81 145.27 17.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.933 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 134' ' ' GLN . . . . . 0.508 ' OE1' HD13 ' C' ' 104' ' ' LEU . 4.1 mt-30 -111.23 160.41 17.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.052 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.77 ' O ' HG22 ' C' ' 52' ' ' VAL . . . -155.97 97.81 1.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.945 0.402 . . . . 0.0 111.609 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.495 ' HD2' ' HB ' ' C' ' 48' ' ' THR . 14.4 ptt180 -101.57 173.59 6.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.4 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 137' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 1.8 m-85 -83.66 135.04 34.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.121 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 138' ' ' PHE . . . . . 0.612 ' HB3' HG11 ' C' ' 85' ' ' VAL . 1.8 t80 -128.86 128.16 43.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.235 0.541 . . . . 0.0 112.01 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 139' ' ' ALA . . . . . 0.473 ' HB2' HD23 ' C' ' 42' ' ' LEU . . . -108.5 138.01 45.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.83 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 140' ' ' THR . . . . . 0.542 HG21 ' HB2' ' C' ' 79' ' ' ASP . 0.3 OUTLIER -90.0 -9.54 48.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.458 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.3 -95.25 0.1 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.0 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.74 101.49 11.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.51 0.195 . . . . 0.0 110.704 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 143' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' C' ' 42' ' ' LEU . . . -61.36 144.36 54.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.758 0.313 . . . . 0.0 111.368 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 144' ' ' THR . . . . . 0.597 ' CG2' ' CD ' ' C' ' 145' ' ' PRO . 99.2 m -123.96 153.14 67.5 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.211 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 145' ' ' PRO . . . . . 0.597 ' CD ' ' CG2' ' C' ' 144' ' ' THR . 1.3 Cg_endo -82.99 144.78 12.17 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.49 2.127 . . . . 0.0 111.999 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 146' ' ' GLY . . . . . 0.642 ' O ' ' HG3' ' B' ' 15' ' ' GLU . . . 157.3 -116.09 0.7 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.468 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 147' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -119.72 132.37 55.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 111.387 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 148' ' ' ALA . . . . . 0.634 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -125.38 43.36 3.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.136 0.493 . . . . 0.0 110.383 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 149' ' ' ASN . . . . . 0.536 ' HB2' ' HG3' ' C' ' 89' ' ' GLN . 1.1 m120 -95.68 150.86 19.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.635 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 150' ' ' ALA . . . . . 0.506 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -168.45 -178.65 3.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.012 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.76 153.0 39.71 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.274 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 152' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -141.21 151.12 43.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.243 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 153' ' ' THR . . . . . 0.561 HG23 HG22 ' B' ' 9' ' ' THR . 0.2 OUTLIER -112.69 133.76 54.55 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 154' ' ' PHE . . . . . 0.514 ' HB3' ' H ' ' B' ' 8' ' ' GLY . 0.1 OUTLIER -81.71 148.68 28.84 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.036 0.446 . . . . 0.0 110.136 -179.05 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 155' ' ' LYS . . . . . 0.556 ' HB3' ' CZ ' ' C' ' 118' ' ' PHE . 11.2 mmtt -135.01 139.43 44.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.945 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 156' ' ' VAL . . . . . 0.654 HG22 HG23 ' B' ' 5' ' ' VAL . 3.1 m -134.52 141.3 43.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.82 0.343 . . . . 0.0 111.685 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 157' ' ' GLN . . . . . 0.559 ' HB3' ' HB3' ' C' ' 70' ' ' ALA . 3.9 tt0 -128.78 129.0 45.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.326 0.584 . . . . 0.0 110.34 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.7 128.6 51.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.563 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.834 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.331 0.11 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.41 88.94 0.04 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.567 0.222 . . . . 0.0 111.024 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.16 114.54 18.49 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.378 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -97.35 119.2 35.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.638 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.632 HG23 HG22 ' E' ' 156' ' ' VAL . 19.5 m -136.6 158.24 37.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.582 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.12 115.95 22.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.626 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.66 -79.57 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.876 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 8' ' ' GLY . . . . . 0.507 ' H ' ' HB3' ' E' ' 154' ' ' PHE . . . -148.55 -145.94 4.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.892 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 9' ' ' THR . . . . . 0.569 HG22 HG23 ' E' ' 153' ' ' THR . 15.0 p -142.05 145.11 33.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.028 0.442 . . . . 0.0 111.238 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 32.6 t -127.8 119.49 51.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.259 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -92.42 113.19 25.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.387 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.76 90.65 5.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.08 120.74 32.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.297 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.07 170.46 32.64 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.901 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' GLU . . . . . 0.656 ' HG3' ' O ' ' E' ' 146' ' ' GLY . 21.4 tt0 -160.59 129.23 4.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.98 0.419 . . . . 0.0 110.382 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.818 HG13 HG13 ' E' ' 37' ' ' VAL . 2.2 t -89.67 136.92 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.233 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.763 ' O ' HG22 ' E' ' 39' ' ' THR . 34.3 m -136.35 -160.77 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.77 0.319 . . . . 0.0 111.162 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.93 176.98 6.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.009 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' E' ' 40' ' ' ALA . . . -90.18 49.63 1.73 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.085 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' D' ' 61' ' ' CYS . . . -122.18 -39.65 2.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.403 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 21' ' ' CYS . . . . . 0.641 ' SG ' ' HB3' ' D' ' 58' ' ' LEU . 0.5 OUTLIER -162.17 146.35 12.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.946 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.97 121.68 14.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' VAL . . . . . 0.636 ' HA ' ' HG ' ' D' ' 58' ' ' LEU . 2.5 p -63.75 143.51 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' D' ' 27' ' ' SER . 13.6 t70 -72.97 154.64 40.44 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.549 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -54.3 -53.89 47.65 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.336 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.54 1.03 88.67 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.911 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' SER . . . . . 0.557 ' HB2' ' HB3' ' D' ' 24' ' ' ASP . 7.9 t -99.28 -16.66 18.41 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.873 0.368 . . . . 0.0 110.829 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 28' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 25' ' ' ALA . 10.9 t -53.19 -50.81 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.338 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -114.12 126.15 54.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.987 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' GLN . . . . . 0.415 HE22 ' HA ' ' D' ' 56' ' ' ILE . 3.7 mt-30 -125.58 135.58 52.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.063 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.93 109.17 21.95 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.132 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.57 115.13 48.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.144 0.497 . . . . 0.0 110.458 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.17 124.73 50.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.671 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.24 -42.29 23.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.62 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.08 -165.38 12.15 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.574 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 4.1 mt-30 -93.62 119.23 32.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.635 0.255 . . . . 0.0 110.83 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.778 HG13 HG13 ' C' ' 16' ' ' VAL . 8.2 p -104.92 133.95 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.884 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 38' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' D' ' 38' ' ' ARG . 0.1 OUTLIER -79.96 137.66 36.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.628 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.767 HG22 ' O ' ' C' ' 17' ' ' VAL . 0.2 OUTLIER -62.52 -49.39 75.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.764 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' C' ' 19' ' ' ALA . . . -53.53 -33.5 54.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.051 0.453 . . . . 0.0 110.85 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' D' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.38 61.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.116 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' D' ' 143' ' ' ALA . 0.6 OUTLIER -114.01 39.79 2.63 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.662 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.22 33.94 3.28 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.391 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 44' ' ' GLN . . . . . 0.67 ' HB2' ' HB2' ' D' ' 47' ' ' ALA . 0.3 OUTLIER -124.46 142.88 50.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.323 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.2 95.67 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.0 111.138 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.37 33.72 5.84 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.152 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.67 ' HB2' ' HB2' ' D' ' 44' ' ' GLN . . . -78.94 143.56 35.68 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.991 0.424 . . . . 0.0 111.955 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 48' ' ' THR . . . . . 0.507 ' HB ' ' HD2' ' D' ' 136' ' ' ARG . 18.2 p -131.64 131.96 43.62 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.869 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 1.3 m -103.82 -167.2 1.34 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.541 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.502 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 3.9 t -57.77 141.92 47.19 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.872 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 51' ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' D' ' 136' ' ' ARG . . . -99.06 125.5 44.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.369 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 52' ' ' VAL . . . . . 0.762 HG22 ' O ' ' D' ' 135' ' ' ALA . 24.8 m -76.53 150.96 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.953 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.26 143.26 16.39 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.598 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.402 ' HE2' ' HB3' ' D' ' 135' ' ' ALA . 37.5 p90 -171.48 140.42 1.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.796 0.331 . . . . 0.0 110.972 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 55' ' ' ASN . . . . . 0.46 ' HB3' HG23 ' A' ' 76' ' ' THR . 17.0 p30 -136.3 138.58 41.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.603 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.535 HG23 ' O ' ' D' ' 56' ' ' ILE . 0.7 OUTLIER -88.38 116.76 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.588 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 57' ' ' GLN . . . . . 0.841 ' HA ' HG23 ' D' ' 130' ' ' THR . 5.0 mp0 -69.35 138.32 53.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.78 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 58' ' ' LEU . . . . . 0.641 ' HB3' ' SG ' ' D' ' 21' ' ' CYS . 0.3 OUTLIER -145.62 91.69 2.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.292 -179.667 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 59' ' ' ASN . . . . . 0.527 ' HA ' HG23 ' D' ' 128' ' ' THR . 4.1 p-10 -78.39 176.86 8.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.906 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.9 81.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.798 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 61' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 10.4 m -133.82 147.77 51.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.798 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.67 161.92 20.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.328 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.632 HG23 ' HA ' ' D' ' 125' ' ' ASN . 0.0 OUTLIER -111.76 -34.2 6.1 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.088 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -72.57 -28.14 62.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.017 0.437 . . . . 0.0 111.72 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 59.4 t -73.25 -58.47 4.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.696 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.17 126.06 32.7 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.571 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.4 -42.08 7.13 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.955 0.407 . . . . 0.0 110.964 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.29 156.85 18.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.457 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 69' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' D' ' 122' ' ' THR . . . -146.66 133.21 19.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.556 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 70' ' ' ALA . . . . . 0.605 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -113.34 155.12 25.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.144 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 71' ' ' VAL . . . . . 0.775 HG11 HG21 ' D' ' 131' ' ' ILE . 2.0 t -136.41 148.56 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.641 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 72' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' D' ' 155' ' ' LYS . . . -152.87 163.5 39.64 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.573 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 73' ' ' PHE . . . . . 0.428 ' CD1' ' HB1' ' D' ' 152' ' ' ALA . 0.2 OUTLIER -130.26 142.31 50.56 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 122.4 -0.187 . . . . 0.0 111.161 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 74' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 1.4 tt -109.21 119.04 38.3 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.071 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 75' ' ' GLY . . . . . 0.828 ' HA3' HD22 ' D' ' 113' ' ' LEU . . . -162.72 -161.88 12.86 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.786 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 76' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.3 OUTLIER -120.97 162.91 19.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.545 0.212 . . . . 0.0 110.78 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' D' ' 87' ' ' ALA . . . -83.55 139.06 33.11 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.967 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 78' ' ' ILE . . . . . 0.54 HG23 ' N ' ' D' ' 79' ' ' ASP . 11.1 tt -66.05 -47.63 84.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.948 0.404 . . . . 0.0 111.003 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.54 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.2 OUTLIER -134.44 46.68 2.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.813 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.47 -83.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.072 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.78 -36.39 41.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.62 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.42 69.25 10.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.375 . . . . 0.0 110.546 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 83' ' ' THR . . . . . 0.488 HG23 ' HB2' ' D' ' 77' ' ' ALA . 0.2 OUTLIER -74.12 -7.52 52.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.544 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 84' ' ' ASN . . . . . 0.626 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 30.1 p-10 -74.71 -25.4 59.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.332 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.605 HG11 ' HB3' ' D' ' 138' ' ' PHE . 6.4 t -104.91 143.85 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.161 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.61 ' HG ' HD13 ' D' ' 113' ' ' LEU . 0.3 OUTLIER -74.8 160.88 30.14 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.31 179.433 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' D' ' 77' ' ' ALA . . . -103.62 179.85 4.15 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.857 0.36 . . . . 0.0 111.739 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.724 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 1.3 mm? -66.59 171.3 5.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.071 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 89' ' ' GLN . . . . . 0.561 ' HG3' ' HB2' ' D' ' 149' ' ' ASN . 1.3 mm-40 -68.57 -83.76 0.03 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.25 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.14 19.17 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.937 0.399 . . . . 0.0 111.447 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 91' ' ' SER . . . . . 0.541 ' HA ' ' HB2' ' F' ' 25' ' ' ALA . 3.3 m -90.16 86.24 6.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.927 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.16 -24.98 66.7 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.598 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.37 41.25 3.52 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.686 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.01 0.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.866 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 95' ' ' SER . . . . . 0.851 ' HA ' ' HB3' ' D' ' 147' ' ' ALA . 1.9 m -89.24 -173.57 4.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.751 0.31 . . . . 0.0 110.724 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 96' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' D' ' 88' ' ' LEU . . . -101.0 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.849 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 97' ' ' THR . . . . . 0.411 ' O ' HG23 ' D' ' 99' ' ' VAL . 3.0 m -131.1 123.87 29.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.319 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.26 29.44 18.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.444 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 99' ' ' VAL . . . . . 0.411 HG23 ' O ' ' D' ' 97' ' ' THR . 1.7 t -125.34 129.32 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.822 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.87 -171.11 21.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.522 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 101' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' D' ' 86' ' ' LEU . 1.9 p -122.96 116.74 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.256 0.55 . . . . 0.0 111.694 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 102' ' ' GLN . . . . . 0.557 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 3.9 tt0 -81.76 151.43 27.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.915 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.79 123.82 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.575 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 104' ' ' LEU . . . . . 0.536 HD22 ' HB2' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -104.73 125.19 50.57 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.661 0.267 . . . . 0.0 110.986 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 105' ' ' ASP . . . . . 0.81 ' HB3' HG22 ' D' ' 107' ' ' THR . 13.6 t0 -77.61 143.12 38.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.693 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 106' ' ' ARG . . . . . 0.694 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -62.72 -14.93 50.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.748 0.308 . . . . 0.0 111.029 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 107' ' ' THR . . . . . 0.81 HG22 ' HB3' ' D' ' 105' ' ' ASP . 8.8 t -62.98 -20.95 65.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.013 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.25 -43.54 1.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.735 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.72 160.7 14.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.83 0.348 . . . . 0.0 111.093 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.33 133.18 40.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 111' ' ' LEU . . . . . 0.667 ' HB2' ' HB2' ' D' ' 105' ' ' ASP . 12.3 tp -95.53 160.91 14.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.397 0.618 . . . . 0.0 110.477 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 112' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 2.9 t -110.23 136.79 48.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.046 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 113' ' ' LEU . . . . . 0.828 HD22 ' HA3' ' D' ' 75' ' ' GLY . 1.4 mt -70.2 89.55 0.65 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.702 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.29 -18.44 6.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.515 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.31 -62.28 0.87 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.619 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.93 18.26 9.37 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.958 0.408 . . . . 0.0 111.638 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 117' ' ' THR . . . . . 0.546 HG21 HG23 ' D' ' 112' ' ' THR . 0.0 OUTLIER -83.98 72.57 10.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.605 ' HB3' ' HB1' ' D' ' 70' ' ' ALA . 78.1 m-85 -92.35 89.75 6.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.792 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 55.5 m -130.55 73.19 1.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.86 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.24 142.3 21.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.695 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.95 68.51 0.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.208 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.639 ' HB ' ' HB3' ' D' ' 69' ' ' ALA . 0.0 OUTLIER -81.45 133.11 35.36 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.722 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 8.5 m -87.51 124.1 33.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.77 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.3 119.27 35.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.677 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 125' ' ' ASN . . . . . 0.632 ' HA ' HG23 ' D' ' 63' ' ' THR . 2.9 m120 -113.66 171.91 7.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.599 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.47 109.75 16.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.648 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.8 -133.78 4.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.705 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 128' ' ' THR . . . . . 0.533 ' HB ' ' HE3' ' A' ' 155' ' ' LYS . 46.5 m -110.54 86.77 2.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.731 0.3 . . . . 0.0 110.757 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 129' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' A' ' 116' ' ' ALA . 1.1 t30 -69.36 155.07 41.04 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.825 0.345 . . . . 0.0 111.199 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 130' ' ' THR . . . . . 0.841 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.2 OUTLIER -142.8 137.08 29.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.066 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 131' ' ' ILE . . . . . 0.775 HG21 HG11 ' D' ' 71' ' ' VAL . 6.9 mt -100.26 109.13 55.7 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 132' ' ' PRO . . . . . 0.694 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.5 Cg_endo -81.78 148.29 15.66 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.673 1.582 . . . . 0.0 112.526 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.411 ' CZ ' ' HA ' ' D' ' 105' ' ' ASP . 0.5 OUTLIER -158.85 145.28 16.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.913 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 134' ' ' GLN . . . . . 0.511 ' OE1' HD13 ' D' ' 104' ' ' LEU . 4.1 mt-30 -111.23 160.4 17.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.041 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.762 ' O ' HG22 ' D' ' 52' ' ' VAL . . . -155.99 97.82 1.84 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.96 0.41 . . . . 0.0 111.629 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 136' ' ' ARG . . . . . 0.507 ' HD2' ' HB ' ' D' ' 48' ' ' THR . 14.4 ptt180 -101.57 173.64 6.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.417 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 137' ' ' TYR . . . . . 0.55 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 1.8 m-85 -83.64 135.01 34.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.142 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 138' ' ' PHE . . . . . 0.605 ' HB3' HG11 ' D' ' 85' ' ' VAL . 1.8 t80 -128.85 128.21 43.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.283 0.563 . . . . 0.0 112.013 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 139' ' ' ALA . . . . . 0.458 ' HB2' HD23 ' D' ' 42' ' ' LEU . . . -108.54 137.99 45.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.874 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 140' ' ' THR . . . . . 0.538 HG21 ' HB2' ' D' ' 79' ' ' ASP . 0.3 OUTLIER -89.93 -9.57 48.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.48 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.31 -95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.999 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.74 101.5 11.33 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.526 0.203 . . . . 0.0 110.708 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 143' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' D' ' 42' ' ' LEU . . . -61.35 144.35 54.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.752 0.311 . . . . 0.0 111.395 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 144' ' ' THR . . . . . 0.594 ' CG2' ' CD ' ' D' ' 145' ' ' PRO . 99.2 m -123.96 153.15 67.5 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.217 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 145' ' ' PRO . . . . . 0.594 ' CD ' ' CG2' ' D' ' 144' ' ' THR . 1.3 Cg_endo -82.97 144.71 12.17 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.56 2.173 . . . . 0.0 111.987 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 146' ' ' GLY . . . . . 0.653 ' O ' ' HG3' ' C' ' 15' ' ' GLU . . . 157.32 -116.1 0.7 Allowed Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.479 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 147' ' ' ALA . . . . . 0.851 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -119.71 132.38 55.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.376 . . . . 0.0 111.37 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 148' ' ' ALA . . . . . 0.627 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -125.37 43.37 3.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.397 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 149' ' ' ASN . . . . . 0.561 ' HB2' ' HG3' ' D' ' 89' ' ' GLN . 1.1 m120 -95.68 150.86 19.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.593 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 150' ' ' ALA . . . . . 0.507 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -168.45 -178.64 3.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.987 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.77 152.98 39.68 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.251 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 152' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -141.2 151.1 43.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.257 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 153' ' ' THR . . . . . 0.564 HG23 HG22 ' C' ' 9' ' ' THR . 0.2 OUTLIER -112.63 133.7 54.53 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 154' ' ' PHE . . . . . 0.512 ' HB3' ' H ' ' C' ' 8' ' ' GLY . 0.1 OUTLIER -81.68 148.73 28.85 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.07 0.462 . . . . 0.0 110.137 -179.043 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 155' ' ' LYS . . . . . 0.55 ' HB3' ' CZ ' ' D' ' 118' ' ' PHE . 11.2 mmtt -135.06 139.45 44.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.924 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 156' ' ' VAL . . . . . 0.635 HG22 HG23 ' C' ' 5' ' ' VAL . 3.1 m -134.53 141.3 43.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.783 0.325 . . . . 0.0 111.687 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 157' ' ' GLN . . . . . 0.531 ' HB3' ' HB3' ' D' ' 70' ' ' ALA . 3.8 tt0 -128.78 128.97 45.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.31 0.576 . . . . 0.0 110.363 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.73 128.58 51.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.552 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.85 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.281 0.086 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.37 88.93 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.028 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.14 114.5 18.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.446 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -97.29 119.17 35.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.685 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.647 HG23 HG22 ' F' ' 156' ' ' VAL . 19.6 m -136.56 158.25 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.605 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.13 116.01 22.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.59 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.74 -79.55 0.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.846 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 8' ' ' GLY . . . . . 0.501 ' H ' ' HB3' ' F' ' 154' ' ' PHE . . . -148.56 -145.96 4.24 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.882 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 9' ' ' THR . . . . . 0.565 HG22 HG23 ' F' ' 153' ' ' THR . 15.2 p -141.99 145.15 34.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.963 0.411 . . . . 0.0 111.302 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 32.5 t -127.83 119.49 51.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.262 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.4 113.16 25.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.374 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.76 90.66 5.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.814 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.08 120.74 32.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.342 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.06 170.53 32.65 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.933 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 15' ' ' GLU . . . . . 0.652 ' HG3' ' O ' ' F' ' 146' ' ' GLY . 21.4 tt0 -160.62 129.19 4.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 110.333 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 16' ' ' VAL . . . . . 0.784 HG13 HG13 ' F' ' 37' ' ' VAL . 2.2 t -89.66 136.92 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.25 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 17' ' ' VAL . . . . . 0.758 ' O ' HG22 ' F' ' 39' ' ' THR . 34.3 m -136.35 -160.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.774 0.321 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.95 177.01 6.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.03 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 19' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' F' ' 40' ' ' ALA . . . -90.15 49.64 1.73 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' E' ' 61' ' ' CYS . . . -122.16 -39.73 2.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.384 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 21' ' ' CYS . . . . . 0.644 ' SG ' ' HB3' ' E' ' 58' ' ' LEU . 0.5 OUTLIER -162.09 146.41 12.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.905 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.05 121.6 14.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.104 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 23' ' ' VAL . . . . . 0.621 ' HA ' ' HG ' ' E' ' 58' ' ' LEU . 2.5 p -63.68 143.52 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 24' ' ' ASP . . . . . 0.563 ' HB3' ' HB2' ' E' ' 27' ' ' SER . 13.5 t70 -72.92 154.61 40.49 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.595 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 25' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -54.32 -53.83 48.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.358 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.59 1.03 88.75 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.875 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 27' ' ' SER . . . . . 0.563 ' HB2' ' HB3' ' E' ' 24' ' ' ASP . 7.9 t -99.28 -16.67 18.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.891 0.376 . . . . 0.0 110.849 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 28' ' ' VAL . . . . . 0.446 HG23 ' O ' ' E' ' 25' ' ' ALA . 10.9 t -53.18 -50.82 44.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.329 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -114.13 126.17 54.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.987 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 30' ' ' GLN . . . . . 0.433 HE22 ' HA ' ' E' ' 56' ' ' ILE . 3.7 mt-30 -125.6 135.56 52.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.062 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.92 109.14 21.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.1 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.55 115.11 48.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.11 0.481 . . . . 0.0 110.435 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.15 124.75 50.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.66 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.21 -42.33 23.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.624 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.1 -165.39 12.15 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.592 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 36' ' ' GLN . . . . . 0.602 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 4.0 mt-30 -93.61 119.2 32.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.642 0.258 . . . . 0.0 110.837 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.818 HG13 HG13 ' D' ' 16' ' ' VAL . 8.2 p -104.89 133.94 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.856 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 38' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' E' ' 38' ' ' ARG . 0.1 OUTLIER -79.9 137.65 36.95 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.694 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 39' ' ' THR . . . . . 0.763 HG22 ' O ' ' D' ' 17' ' ' VAL . 0.2 OUTLIER -62.55 -49.39 75.49 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.747 179.465 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' D' ' 19' ' ' ALA . . . -53.55 -33.47 54.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.0 0.428 . . . . 0.0 110.857 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 41' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' E' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.33 61.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.113 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.606 ' O ' ' HB2' ' E' ' 143' ' ' ALA . 0.6 OUTLIER -114.09 39.83 2.64 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.617 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.28 33.96 3.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.385 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 44' ' ' GLN . . . . . 0.664 ' HB2' ' HB2' ' E' ' 47' ' ' ALA . 0.3 OUTLIER -124.47 142.85 51.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.346 179.541 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.24 95.73 0.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.896 0.379 . . . . 0.0 111.156 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.35 33.71 5.84 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.191 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 47' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' E' ' 44' ' ' GLN . . . -78.9 143.51 35.81 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 111.968 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.492 ' HB ' ' HD2' ' E' ' 136' ' ' ARG . 18.1 p -131.62 131.97 43.65 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.882 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 1.3 m -103.8 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.556 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 50' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 3.9 t -57.83 141.9 47.51 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.853 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 51' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' E' ' 136' ' ' ARG . . . -99.05 125.53 44.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.426 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 52' ' ' VAL . . . . . 0.764 HG22 ' O ' ' E' ' 135' ' ' ALA . 24.7 m -76.51 150.95 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.27 143.26 16.39 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.588 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -171.49 140.46 1.39 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.821 0.343 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 55' ' ' ASN . . . . . 0.458 ' HB3' HG23 ' B' ' 76' ' ' THR . 17.0 p30 -136.32 138.59 41.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.598 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 56' ' ' ILE . . . . . 0.538 HG23 ' O ' ' E' ' 56' ' ' ILE . 0.7 OUTLIER -88.43 116.76 30.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.568 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 57' ' ' GLN . . . . . 0.839 ' HA ' HG23 ' E' ' 130' ' ' THR . 5.0 mp0 -69.35 138.3 53.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.787 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 58' ' ' LEU . . . . . 0.644 ' HB3' ' SG ' ' E' ' 21' ' ' CYS . 0.3 OUTLIER -145.57 91.62 2.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.284 -179.602 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 59' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 4.1 p-10 -78.4 176.83 8.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.943 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 61' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' E' ' 20' ' ' ALA . 10.4 m -133.84 147.78 51.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.796 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.68 161.94 20.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.328 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 63' ' ' THR . . . . . 0.639 HG23 ' HA ' ' E' ' 125' ' ' ASN . 0.0 OUTLIER -111.79 -34.2 6.09 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.082 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -72.56 -28.15 62.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.008 0.433 . . . . 0.0 111.704 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.19 -58.55 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.667 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.21 126.05 32.61 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.567 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.38 -42.08 7.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.972 0.415 . . . . 0.0 110.968 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.31 156.83 18.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.456 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 69' ' ' ALA . . . . . 0.654 ' HB3' ' HB ' ' E' ' 122' ' ' THR . . . -146.61 133.21 19.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.572 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 70' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -113.33 155.11 25.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.156 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 71' ' ' VAL . . . . . 0.793 HG11 HG21 ' E' ' 131' ' ' ILE . 2.0 t -136.39 148.6 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.655 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 72' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' E' ' 155' ' ' LYS . . . -152.93 163.51 39.66 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.563 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 73' ' ' PHE . . . . . 0.442 ' CD1' ' HB1' ' E' ' 152' ' ' ALA . 0.2 OUTLIER -130.25 142.24 50.57 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 122.408 -0.183 . . . . 0.0 111.179 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 74' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 1.4 tt -109.21 119.08 38.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.053 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 75' ' ' GLY . . . . . 0.819 ' HA3' HD22 ' E' ' 113' ' ' LEU . . . -162.72 -161.89 12.87 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.777 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 76' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.3 OUTLIER -120.95 162.94 19.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.605 0.241 . . . . 0.0 110.773 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 77' ' ' ALA . . . . . 0.694 ' O ' ' HB2' ' E' ' 87' ' ' ALA . . . -83.55 139.07 33.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.955 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 78' ' ' ILE . . . . . 0.539 HG23 ' N ' ' E' ' 79' ' ' ASP . 11.1 tt -66.09 -47.6 84.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.979 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 79' ' ' ASP . . . . . 0.544 ' HB2' HG21 ' E' ' 140' ' ' THR . 0.2 OUTLIER -134.5 46.68 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.847 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.54 -84.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.74 -36.43 40.75 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.609 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.44 69.26 10.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.891 0.377 . . . . 0.0 110.547 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 83' ' ' THR . . . . . 0.476 HG23 ' HB2' ' E' ' 77' ' ' ALA . 0.2 OUTLIER -74.15 -7.44 52.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.528 -179.45 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 84' ' ' ASN . . . . . 0.605 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 30.0 p-10 -74.77 -25.4 59.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.336 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.613 HG11 ' HB3' ' E' ' 138' ' ' PHE . 6.4 t -104.88 143.86 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.188 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 86' ' ' LEU . . . . . 0.593 ' HG ' HD13 ' E' ' 113' ' ' LEU . 0.3 OUTLIER -74.82 160.86 30.15 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.292 179.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 87' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' E' ' 77' ' ' ALA . . . -103.61 179.87 4.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.907 0.384 . . . . 0.0 111.725 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.712 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 1.3 mm? -66.6 171.28 5.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 89' ' ' GLN . . . . . 0.555 ' HG3' ' HB2' ' E' ' 149' ' ' ASN . 1.3 mm-40 -68.55 -83.78 0.03 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.253 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.09 19.13 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.935 0.398 . . . . 0.0 111.44 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 91' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' E' ' 95' ' ' SER . 3.2 m -90.15 86.23 6.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.09 -25.02 66.66 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.66 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.39 41.26 3.52 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.66 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.99 0.72 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.872 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 95' ' ' SER . . . . . 0.853 ' HA ' ' HB3' ' E' ' 147' ' ' ALA . 1.9 m -89.3 -173.57 4.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 110.722 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 96' ' ' ALA . . . . . 0.419 ' HB3' HD11 ' E' ' 88' ' ' LEU . . . -100.96 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 97' ' ' THR . . . . . 0.413 ' O ' HG23 ' E' ' 99' ' ' VAL . 3.0 m -131.09 123.91 29.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.315 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.17 29.48 18.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.46 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 99' ' ' VAL . . . . . 0.413 HG23 ' O ' ' E' ' 97' ' ' THR . 1.7 t -125.29 129.33 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.809 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.85 -171.09 21.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.504 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 101' ' ' VAL . . . . . 0.521 ' CG2' ' HB1' ' E' ' 135' ' ' ALA . 1.9 p -122.93 116.73 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.195 0.522 . . . . 0.0 111.679 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 102' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 3.9 tt0 -81.77 151.45 27.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.931 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.79 123.83 70.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.515 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 104' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' B' ' 80' ' ' ALA . 0.5 OUTLIER -104.71 125.18 50.55 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.704 0.288 . . . . 0.0 111.003 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 105' ' ' ASP . . . . . 0.795 ' HB3' HG22 ' E' ' 107' ' ' THR . 13.6 t0 -77.58 143.04 38.62 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.715 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 106' ' ' ARG . . . . . 0.716 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -62.67 -14.91 49.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.705 0.288 . . . . 0.0 111.025 179.47 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 107' ' ' THR . . . . . 0.795 HG22 ' HB3' ' E' ' 105' ' ' ASP . 8.8 t -63.01 -20.96 65.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.011 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.28 -43.51 1.37 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.745 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.75 160.67 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.083 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.36 133.14 40.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.088 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.645 ' HB2' ' HB2' ' E' ' 105' ' ' ASP . 12.3 tp -95.5 160.97 14.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.389 0.614 . . . . 0.0 110.511 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 112' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 2.8 t -110.26 136.79 48.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.043 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 113' ' ' LEU . . . . . 0.819 HD22 ' HA3' ' E' ' 75' ' ' GLY . 1.4 mt -70.22 89.6 0.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.745 0.307 . . . . 0.0 110.663 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -18.45 6.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.463 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -62.26 0.88 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.67 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.96 18.22 9.45 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.99 0.424 . . . . 0.0 111.651 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 117' ' ' THR . . . . . 0.545 HG21 HG23 ' E' ' 112' ' ' THR . 0.0 OUTLIER -83.92 72.55 10.41 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.058 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 118' ' ' PHE . . . . . 0.587 ' HB3' ' HB1' ' E' ' 70' ' ' ALA . 78.1 m-85 -92.34 89.78 6.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 55.2 m -130.6 73.2 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.25 142.28 21.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.691 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.98 68.57 0.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.144 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 122' ' ' THR . . . . . 0.654 ' HB ' ' HB3' ' E' ' 69' ' ' ALA . 0.0 OUTLIER -81.5 133.12 35.35 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.688 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 8.6 m -87.55 124.13 33.17 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.713 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tp -97.33 119.33 35.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.632 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 125' ' ' ASN . . . . . 0.639 ' HA ' HG23 ' E' ' 63' ' ' THR . 2.9 m120 -113.68 171.89 7.31 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.609 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.49 109.8 16.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.637 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.77 -133.81 4.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.71 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 128' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 46.2 m -110.52 86.76 2.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.767 0.317 . . . . 0.0 110.79 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 129' ' ' ASN . . . . . 0.568 ' OD1' ' HB3' ' B' ' 116' ' ' ALA . 1.2 t30 -69.37 155.05 41.07 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.822 0.344 . . . . 0.0 111.16 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 130' ' ' THR . . . . . 0.839 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.2 OUTLIER -142.78 137.07 29.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.1 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 131' ' ' ILE . . . . . 0.793 HG21 HG11 ' E' ' 71' ' ' VAL . 6.9 mt -100.23 109.05 55.39 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 132' ' ' PRO . . . . . 0.716 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.5 Cg_endo -81.7 148.24 15.77 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.718 1.612 . . . . 0.0 112.525 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 133' ' ' PHE . . . . . 0.414 ' CZ ' ' HA ' ' E' ' 105' ' ' ASP . 0.5 OUTLIER -158.8 145.3 17.06 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.924 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 134' ' ' GLN . . . . . 0.507 ' OE1' HD13 ' E' ' 104' ' ' LEU . 4.1 mt-30 -111.23 160.43 16.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.041 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 135' ' ' ALA . . . . . 0.764 ' O ' HG22 ' E' ' 52' ' ' VAL . . . -155.98 97.8 1.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.9 0.381 . . . . 0.0 111.621 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 136' ' ' ARG . . . . . 0.492 ' HD2' ' HB ' ' E' ' 48' ' ' THR . 14.4 ptt180 -101.57 173.6 6.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.412 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 137' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 1.8 m-85 -83.66 135.03 34.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.144 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 138' ' ' PHE . . . . . 0.613 ' HB3' HG11 ' E' ' 85' ' ' VAL . 1.7 t80 -128.84 128.16 43.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.055 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 139' ' ' ALA . . . . . 0.458 ' HB2' HD23 ' E' ' 42' ' ' LEU . . . -108.51 137.96 45.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.836 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 140' ' ' THR . . . . . 0.544 HG21 ' HB2' ' E' ' 79' ' ' ASP . 0.3 OUTLIER -89.92 -9.54 48.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.49 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.28 -95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.947 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.71 101.52 11.36 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.529 0.204 . . . . 0.0 110.735 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 143' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' E' ' 42' ' ' LEU . . . -61.39 144.38 54.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.788 0.328 . . . . 0.0 111.336 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 144' ' ' THR . . . . . 0.607 ' CG2' ' CD ' ' E' ' 145' ' ' PRO . 99.2 m -123.95 153.15 67.46 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.236 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 145' ' ' PRO . . . . . 0.607 ' CD ' ' CG2' ' E' ' 144' ' ' THR . 1.4 Cg_endo -82.97 144.76 12.18 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.561 2.174 . . . . 0.0 111.979 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 146' ' ' GLY . . . . . 0.656 ' O ' ' HG3' ' D' ' 15' ' ' GLU . . . 157.3 -116.09 0.7 Allowed Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.49 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 147' ' ' ALA . . . . . 0.853 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -119.72 132.38 55.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.871 0.367 . . . . 0.0 111.403 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 148' ' ' ALA . . . . . 0.606 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -125.39 43.36 3.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.112 0.482 . . . . 0.0 110.379 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 149' ' ' ASN . . . . . 0.555 ' HB2' ' HG3' ' E' ' 89' ' ' GLN . 1.1 m120 -95.67 150.86 19.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.609 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 150' ' ' ALA . . . . . 0.51 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -168.47 -178.63 3.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.009 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.76 152.99 39.7 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.228 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 152' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -141.2 151.12 43.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.206 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 153' ' ' THR . . . . . 0.569 HG23 HG22 ' D' ' 9' ' ' THR . 0.2 OUTLIER -112.66 133.74 54.54 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 154' ' ' PHE . . . . . 0.507 ' HB3' ' H ' ' D' ' 8' ' ' GLY . 0.1 OUTLIER -81.72 148.72 28.82 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.103 0.478 . . . . 0.0 110.114 -179.05 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 155' ' ' LYS . . . . . 0.558 ' HB3' ' CZ ' ' E' ' 118' ' ' PHE . 11.3 mmtt -135.02 139.49 44.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.931 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 156' ' ' VAL . . . . . 0.632 HG22 HG23 ' D' ' 5' ' ' VAL . 3.1 m -134.51 141.3 43.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.687 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 157' ' ' GLN . . . . . 0.547 ' HB3' ' HB3' ' E' ' 70' ' ' ALA . 3.8 tt0 -128.8 128.97 45.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.29 0.567 . . . . 0.0 110.373 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.69 128.58 51.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.536 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.331 0.11 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.4 88.96 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.568 0.223 . . . . 0.0 111.008 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.17 114.47 18.39 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.396 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -97.26 119.23 35.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.664 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 m -136.61 158.25 37.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.562 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.18 115.99 22.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.581 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.59 -79.63 0.13 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.878 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.56 -145.95 4.24 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.904 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 15.2 p -142.02 145.12 34.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.944 0.402 . . . . 0.0 111.314 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 32.0 t -127.84 119.47 51.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.226 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -92.4 113.18 25.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.407 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -95.8 90.65 5.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.794 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.09 120.76 32.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.343 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.09 170.48 32.66 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.934 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -160.59 129.18 4.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.957 0.408 . . . . 0.0 110.36 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.67 136.91 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.254 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.34 -160.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.786 0.327 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.93 177.02 6.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.967 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.22 49.62 1.73 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.064 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 20' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' F' ' 61' ' ' CYS . . . -122.15 -39.71 2.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.437 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 21' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' F' ' 58' ' ' LEU . 0.5 OUTLIER -162.12 146.39 12.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.943 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.02 121.61 14.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 23' ' ' VAL . . . . . 0.617 ' HA ' ' HG ' ' F' ' 58' ' ' LEU . 2.5 p -63.7 143.49 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 24' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' F' ' 27' ' ' SER . 13.5 t70 -72.87 154.61 40.52 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.59 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 25' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -54.32 -53.87 48.01 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.335 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.56 1.03 88.7 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.863 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 27' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' F' ' 24' ' ' ASP . 7.9 t -99.32 -16.59 18.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.842 0.354 . . . . 0.0 110.814 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 28' ' ' VAL . . . . . 0.441 HG23 ' O ' ' F' ' 25' ' ' ALA . 10.9 t -53.24 -50.78 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.324 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -114.12 126.1 54.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.995 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 30' ' ' GLN . . . . . 0.426 HE22 ' HA ' ' F' ' 56' ' ' ILE . 3.7 mt-30 -125.57 135.65 52.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.059 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.93 109.18 21.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.091 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -115.59 115.12 48.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.148 0.499 . . . . 0.0 110.416 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -105.19 124.67 49.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.665 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.2 -42.29 23.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.603 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.08 -165.35 12.14 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.579 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 36' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 4.0 mt-30 -93.67 119.16 32.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.657 0.265 . . . . 0.0 110.851 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.784 HG13 HG13 ' E' ' 16' ' ' VAL . 8.2 p -104.84 133.97 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 38' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' F' ' 41' ' ' SER . 0.1 OUTLIER -79.93 137.62 36.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.687 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 39' ' ' THR . . . . . 0.758 HG22 ' O ' ' E' ' 17' ' ' VAL . 0.2 OUTLIER -62.45 -49.46 75.34 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.775 179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 40' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' E' ' 19' ' ' ALA . . . -53.53 -33.48 54.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.983 0.42 . . . . 0.0 110.829 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 41' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' F' ' 38' ' ' ARG . 0.1 OUTLIER -74.98 -31.37 61.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.113 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 42' ' ' LEU . . . . . 0.617 ' O ' ' HB2' ' F' ' 143' ' ' ALA . 0.6 OUTLIER -114.02 39.82 2.63 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.611 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.25 33.93 3.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.388 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 44' ' ' GLN . . . . . 0.674 ' HB2' ' HB2' ' F' ' 47' ' ' ALA . 0.3 OUTLIER -124.46 142.84 51.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.366 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.22 95.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.867 0.365 . . . . 0.0 111.161 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.41 33.67 5.85 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.149 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 47' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' F' ' 44' ' ' GLN . . . -78.79 143.51 36.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.979 0.418 . . . . 0.0 111.973 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 48' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' F' ' 136' ' ' ARG . 18.1 p -131.63 132.0 43.66 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.899 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 49' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 1.3 m -103.81 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.504 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 50' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 3.9 t -57.81 141.91 47.42 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 51' ' ' ALA . . . . . 0.472 ' HB2' ' HB3' ' F' ' 136' ' ' ARG . . . -99.03 125.5 44.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.376 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 52' ' ' VAL . . . . . 0.764 HG22 ' O ' ' F' ' 135' ' ' ALA . 24.9 m -76.53 150.97 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.959 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.3 143.25 16.41 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.583 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 54' ' ' PHE . . . . . 0.406 ' HE2' ' HB3' ' F' ' 135' ' ' ALA . 37.4 p90 -171.47 140.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.839 0.352 . . . . 0.0 110.902 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 55' ' ' ASN . . . . . 0.465 ' HB3' HG23 ' C' ' 76' ' ' THR . 17.0 p30 -136.35 138.61 41.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.535 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 56' ' ' ILE . . . . . 0.54 HG23 ' O ' ' F' ' 56' ' ' ILE . 0.7 OUTLIER -88.42 116.76 30.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.57 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 57' ' ' GLN . . . . . 0.829 ' HA ' HG23 ' F' ' 130' ' ' THR . 5.0 mp0 -69.39 138.31 53.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.803 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 58' ' ' LEU . . . . . 0.636 ' HB3' ' SG ' ' F' ' 21' ' ' CYS . 0.3 OUTLIER -145.58 91.67 2.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.284 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 59' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 4.1 p-10 -78.43 176.87 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.925 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.86 0.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.792 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 61' ' ' CYS . . . . . 0.616 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 10.4 m -133.83 147.8 51.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.779 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.71 161.93 20.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.318 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 63' ' ' THR . . . . . 0.626 HG23 ' HA ' ' F' ' 125' ' ' ASN . 0.0 OUTLIER -111.73 -34.25 6.09 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -72.53 -28.2 62.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.04 0.448 . . . . 0.0 111.728 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -73.13 -58.58 4.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.703 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.19 126.09 32.74 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.569 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.32 -42.17 7.12 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.95 0.405 . . . . 0.0 110.954 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 68' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' F' ' 68' ' ' LYS . 1.2 tptp -89.3 156.82 18.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.478 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 69' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' F' ' 122' ' ' THR . . . -146.63 133.19 19.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.588 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 70' ' ' ALA . . . . . 0.6 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -113.31 155.12 25.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.156 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 71' ' ' VAL . . . . . 0.769 HG11 HG21 ' F' ' 131' ' ' ILE . 2.0 t -136.4 148.56 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.69 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 72' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' F' ' 155' ' ' LYS . . . -152.9 163.49 39.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.55 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 73' ' ' PHE . . . . . 0.444 ' CD1' ' HB1' ' F' ' 152' ' ' ALA . 0.2 OUTLIER -130.25 142.3 50.57 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 121.247 -0.181 . . . . 0.0 111.186 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 74' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 1.4 tt -109.18 119.04 38.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.055 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 75' ' ' GLY . . . . . 0.823 ' HA3' HD22 ' F' ' 113' ' ' LEU . . . -162.72 -161.87 12.84 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.759 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 76' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.3 OUTLIER -120.99 162.89 19.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.585 0.231 . . . . 0.0 110.775 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 77' ' ' ALA . . . . . 0.699 ' O ' ' HB2' ' F' ' 87' ' ' ALA . . . -83.53 139.08 33.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.937 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 78' ' ' ILE . . . . . 0.535 HG23 ' N ' ' F' ' 79' ' ' ASP . 11.1 tt -66.06 -47.66 84.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.981 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 79' ' ' ASP . . . . . 0.55 ' HB2' HG21 ' F' ' 140' ' ' THR . 0.2 OUTLIER -134.44 46.68 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.857 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.48 -84.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.76 -36.42 40.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.58 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.49 69.27 10.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.918 0.39 . . . . 0.0 110.52 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 83' ' ' THR . . . . . 0.48 HG23 ' HB2' ' F' ' 77' ' ' ALA . 0.2 OUTLIER -74.11 -7.51 52.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.527 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 84' ' ' ASN . . . . . 0.621 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 30.1 p-10 -74.7 -25.44 59.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.338 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 85' ' ' VAL . . . . . 0.598 HG11 ' HB3' ' F' ' 138' ' ' PHE . 6.4 t -104.89 143.86 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.152 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 86' ' ' LEU . . . . . 0.599 ' HG ' HD13 ' F' ' 113' ' ' LEU . 0.3 OUTLIER -74.83 160.88 30.13 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.263 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 87' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' F' ' 77' ' ' ALA . . . -103.66 179.86 4.15 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.902 0.382 . . . . 0.0 111.698 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 88' ' ' LEU . . . . . 0.712 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 1.3 mm? -66.56 171.27 5.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.019 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 89' ' ' GLN . . . . . 0.544 ' HG3' ' HB2' ' F' ' 149' ' ' ASN . 1.3 mm-40 -68.58 -83.74 0.03 OUTLIER 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.262 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.13 19.15 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.975 0.416 . . . . 0.0 111.459 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 91' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' F' ' 95' ' ' SER . 3.3 m -90.17 86.21 6.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.936 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.06 -25.03 66.65 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.663 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.37 41.23 3.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.647 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.02 0.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.852 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 95' ' ' SER . . . . . 0.835 ' HA ' ' HB3' ' F' ' 147' ' ' ALA . 1.9 m -89.28 -173.6 4.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 110.667 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 96' ' ' ALA . . . . . 0.423 ' HB3' HD11 ' F' ' 88' ' ' LEU . . . -101.01 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.846 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 3.0 m -131.04 123.92 29.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.322 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.18 29.46 18.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.479 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 1.7 t -125.29 129.29 73.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.824 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.8 -171.07 21.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.516 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 101' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' F' ' 86' ' ' LEU . 1.9 p -122.98 116.72 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.238 0.542 . . . . 0.0 111.703 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 102' ' ' GLN . . . . . 0.548 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 3.9 tt0 -81.75 151.45 27.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.942 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.81 123.85 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.525 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 104' ' ' LEU . . . . . 0.532 HD22 ' HB2' ' C' ' 80' ' ' ALA . 0.5 OUTLIER -104.72 125.16 50.53 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.647 0.261 . . . . 0.0 111.011 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 105' ' ' ASP . . . . . 0.806 ' HB3' HG22 ' F' ' 107' ' ' THR . 13.5 t0 -77.54 143.07 38.68 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.683 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 106' ' ' ARG . . . . . 0.709 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -62.76 -14.82 49.43 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.756 0.312 . . . . 0.0 111.053 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 107' ' ' THR . . . . . 0.806 HG22 ' HB3' ' F' ' 105' ' ' ASP . 8.8 t -63.03 -20.93 65.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.038 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.25 -43.53 1.36 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.748 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.7 160.69 14.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.753 0.311 . . . . 0.0 111.109 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.32 133.17 40.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 111' ' ' LEU . . . . . 0.671 ' HB2' ' HB2' ' F' ' 105' ' ' ASP . 12.3 tp -95.52 160.89 14.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.381 0.61 . . . . 0.0 110.52 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 112' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 2.9 t -110.19 136.79 48.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.093 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 113' ' ' LEU . . . . . 0.823 HD22 ' HA3' ' F' ' 75' ' ' GLY . 1.4 mt -70.2 89.59 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.299 . . . . 0.0 110.65 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -18.46 6.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.482 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.29 -62.26 0.88 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.647 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.97 18.25 9.43 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-O 121.008 0.432 . . . . 0.0 111.661 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 117' ' ' THR . . . . . 0.546 HG21 HG23 ' F' ' 112' ' ' THR . 0.0 OUTLIER -83.92 72.54 10.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.015 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 118' ' ' PHE . . . . . 0.6 ' HB3' ' HB1' ' F' ' 70' ' ' ALA . 78.2 m-85 -92.31 89.74 6.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.775 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 54.8 m -130.51 73.13 1.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.914 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.23 142.34 21.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.676 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -104.02 68.54 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.165 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 122' ' ' THR . . . . . 0.641 ' HB ' ' HB3' ' F' ' 69' ' ' ALA . 0.0 OUTLIER -81.45 133.12 35.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.721 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 8.5 m -87.55 124.12 33.16 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.738 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.31 119.29 35.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.672 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 125' ' ' ASN . . . . . 0.626 ' HA ' HG23 ' F' ' 63' ' ' THR . 2.9 m120 -113.71 171.93 7.29 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.581 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.5 109.74 16.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.656 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.84 -133.84 4.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.733 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 128' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 46.4 m -110.49 86.71 2.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.743 0.306 . . . . 0.0 110.811 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 129' ' ' ASN . . . . . 0.564 ' OD1' ' HB3' ' C' ' 116' ' ' ALA . 1.1 t30 -69.3 155.07 41.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.179 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 130' ' ' THR . . . . . 0.829 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.2 OUTLIER -142.79 137.08 29.45 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.099 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 131' ' ' ILE . . . . . 0.769 HG21 HG11 ' F' ' 71' ' ' VAL . 6.9 mt -100.25 109.09 55.57 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 132' ' ' PRO . . . . . 0.709 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.5 Cg_endo -81.72 148.26 15.74 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.721 1.614 . . . . 0.0 112.543 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 133' ' ' PHE . . . . . 0.419 ' CZ ' ' HA ' ' F' ' 105' ' ' ASP . 0.5 OUTLIER -158.86 145.29 16.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.903 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 134' ' ' GLN . . . . . 0.515 ' OE1' HD13 ' F' ' 104' ' ' LEU . 4.1 mt-30 -111.23 160.43 16.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.042 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 135' ' ' ALA . . . . . 0.764 ' O ' HG22 ' F' ' 52' ' ' VAL . . . -156.03 97.82 1.83 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.995 0.426 . . . . 0.0 111.597 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 136' ' ' ARG . . . . . 0.498 ' HD2' ' HB ' ' F' ' 48' ' ' THR . 14.4 ptt180 -101.5 173.6 6.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.407 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 137' ' ' TYR . . . . . 0.539 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 1.8 m-85 -83.65 135.03 34.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.168 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 138' ' ' PHE . . . . . 0.598 ' HB3' HG11 ' F' ' 85' ' ' VAL . 1.8 t80 -128.87 128.23 43.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.282 0.563 . . . . 0.0 111.972 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 139' ' ' ALA . . . . . 0.472 ' HB2' HD23 ' F' ' 42' ' ' LEU . . . -108.58 137.97 45.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.854 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 140' ' ' THR . . . . . 0.55 HG21 ' HB2' ' F' ' 79' ' ' ASP . 0.3 OUTLIER -89.93 -9.56 48.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.477 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.32 -95.22 0.1 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.996 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.75 101.47 11.3 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.529 0.204 . . . . 0.0 110.741 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 143' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' F' ' 42' ' ' LEU . . . -61.35 144.33 54.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.715 0.293 . . . . 0.0 111.409 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 144' ' ' THR . . . . . 0.607 ' CG2' ' CD ' ' F' ' 145' ' ' PRO . 99.1 m -123.92 153.17 67.35 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.216 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 145' ' ' PRO . . . . . 0.607 ' CD ' ' CG2' ' F' ' 144' ' ' THR . 1.3 Cg_endo -83.03 144.79 12.13 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.567 2.178 . . . . 0.0 111.98 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 146' ' ' GLY . . . . . 0.652 ' O ' ' HG3' ' E' ' 15' ' ' GLU . . . 157.27 -116.08 0.7 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.473 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 147' ' ' ALA . . . . . 0.835 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -119.73 132.44 55.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.899 0.38 . . . . 0.0 111.335 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 148' ' ' ALA . . . . . 0.631 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -125.44 43.36 3.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.12 0.486 . . . . 0.0 110.387 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 149' ' ' ASN . . . . . 0.544 ' HB2' ' HG3' ' F' ' 89' ' ' GLN . 1.1 m120 -95.69 150.86 19.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.623 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 150' ' ' ALA . . . . . 0.508 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -168.44 -178.63 3.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.992 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.77 153.01 39.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.253 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 152' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -141.22 151.11 43.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.258 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 153' ' ' THR . . . . . 0.565 HG23 HG22 ' E' ' 9' ' ' THR . 0.2 OUTLIER -112.68 133.74 54.56 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.252 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 154' ' ' PHE . . . . . 0.501 ' HB3' ' H ' ' E' ' 8' ' ' GLY . 0.1 OUTLIER -81.73 148.72 28.8 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.103 0.478 . . . . 0.0 110.11 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 155' ' ' LYS . . . . . 0.553 ' HB3' ' CZ ' ' F' ' 118' ' ' PHE . 11.2 mmtt -135.01 139.47 44.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.945 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 156' ' ' VAL . . . . . 0.647 HG22 HG23 ' E' ' 5' ' ' VAL . 3.1 m -134.53 141.27 43.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.702 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 157' ' ' GLN . . . . . 0.555 ' HB3' ' HB3' ' F' ' 70' ' ' ALA . 3.8 tt0 -128.77 129.0 45.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.328 0.585 . . . . 0.0 110.37 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.71 128.61 51.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.546 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 111.103 0.038 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' B' ' 158' ' ' TYR . . . 52.73 88.35 0.03 OUTLIER 'General case' 0 C--O 1.232 0.146 0 O-C-N 123.196 0.31 . . . . 0.0 111.026 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' B' ' 157' ' ' GLN . 5.5 m -122.99 116.19 23.14 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.406 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.488 HG21 ' CA ' ' E' ' 127' ' ' GLY . 1.8 m -99.6 117.26 33.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.573 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.633 HG23 HG23 ' B' ' 156' ' ' VAL . 1.7 m -144.49 158.02 14.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.557 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' B' ' 154' ' ' PHE . 13.0 t30 -78.68 123.76 27.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.73 -71.18 1.0 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.822 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.543 ' H ' ' HB3' ' B' ' 154' ' ' PHE . . . -152.72 -147.04 4.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.759 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.965 HG22 HG23 ' B' ' 153' ' ' THR . 24.5 p -148.72 134.43 18.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.022 0.439 . . . . 0.0 111.249 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.33 124.39 72.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.186 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.624 ' HA ' ' OD1' ' B' ' 151' ' ' ASP . 57.5 t-80 -91.58 116.17 28.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.323 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -96.83 105.48 17.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -104.61 118.71 37.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.507 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.32 172.92 30.82 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.952 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.729 ' O ' ' HA ' ' B' ' 36' ' ' GLN . 25.8 tt0 -160.39 135.93 8.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.965 0.412 . . . . 0.0 110.425 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.778 HG23 ' HB2' ' B' ' 148' ' ' ALA . 43.4 t -96.78 132.73 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.272 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.564 HG11 ' OE1' ' B' ' 36' ' ' GLN . 18.5 m -133.82 -177.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.805 0.336 . . . . 0.0 111.068 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.567 ' HA ' HG22 ' B' ' 39' ' ' THR . 0.3 OUTLIER -75.7 -170.26 1.25 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.017 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.79 45.37 0.98 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.125 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.568 ' O ' HD21 ' A' ' 124' ' ' LEU . . . -121.26 -24.8 5.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.415 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -168.91 140.68 2.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.792 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 60' ' ' ASP . . . -132.87 116.95 17.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.741 HG12 ' HB2' ' B' ' 36' ' ' GLN . 0.5 OUTLIER -67.03 146.23 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.011 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.473 ' O ' HG23 ' A' ' 28' ' ' VAL . 12.9 t0 -80.34 152.03 29.16 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.55 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.06 96.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.39 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.88 2.72 85.9 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.891 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -106.23 -19.94 13.55 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.813 0.339 . . . . 0.0 110.793 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 24' ' ' ASP . 39.8 t -47.43 -52.09 5.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.336 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.19 136.48 48.61 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.035 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.71 136.85 39.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.02 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.52 102.83 12.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.127 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.66 128.34 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.121 0.486 . . . . 0.0 110.51 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -114.75 123.06 48.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.615 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.45 -42.72 15.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.608 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.45 -167.44 13.2 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.603 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -96.75 124.51 40.75 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.654 0.264 . . . . 0.0 110.852 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.71 147.54 11.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.986 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.71 134.94 34.33 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.418 0.449 . . . . 0.0 111.725 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -60.07 -44.48 94.73 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.75 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.26 -36.88 61.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.095 0.474 . . . . 0.0 110.893 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.9 -35.8 62.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.168 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.747 HD23 HG13 ' A' ' 99' ' ' VAL . 2.9 mp -106.66 34.58 3.34 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.657 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.9 15.85 27.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.391 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.98 132.04 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.34 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 140' ' ' THR . 6.8 tt0 -56.56 108.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.827 0.346 . . . . 0.0 111.106 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.93 25.93 10.11 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.121 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -71.49 137.75 48.42 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 p -136.94 122.73 19.96 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.913 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 136' ' ' ARG . 53.9 m -100.07 -175.18 2.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.649 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 t -55.65 137.29 49.56 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.808 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.476 ' CA ' ' HB3' ' A' ' 136' ' ' ARG . . . -92.32 133.57 35.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.342 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 135' ' ' ALA . 26.2 m -76.76 162.48 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.52 141.14 16.76 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.643 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -173.76 137.75 0.61 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.79 0.329 . . . . 0.0 110.933 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -136.49 145.85 45.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.682 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 56' ' ' ILE . 1.2 tp -91.04 116.79 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.663 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.73 ' HA ' HG23 ' A' ' 130' ' ' THR . 1.3 mp0 -72.93 128.65 36.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.813 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.459 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -137.35 89.13 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.225 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.731 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 9.8 p30 -74.79 176.47 7.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.039 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.515 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 0.9 OUTLIER 58.97 74.78 0.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.889 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 36.5 m -126.31 148.83 49.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.412 ' OD2' HG23 ' A' ' 65' ' ' VAL . 1.6 t70 -121.58 169.75 10.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.318 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.25 -32.66 4.91 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.48 -28.0 56.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.261 0.553 . . . . 0.0 111.753 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.412 HG23 ' OD2' ' A' ' 62' ' ' ASP . 25.5 t -73.63 -56.69 8.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.68 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.459 ' HB3' ' HB1' ' A' ' 20' ' ' ALA . . . -134.99 122.76 22.31 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.652 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.54 -50.11 5.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.894 0.378 . . . . 0.0 110.936 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.401 ' NZ ' ' HA ' ' A' ' 68' ' ' LYS . 1.8 tptp -89.75 152.15 21.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.529 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 122' ' ' THR . . . -144.24 137.87 27.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.582 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -113.41 157.28 22.11 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.092 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.739 HG11 HG21 ' A' ' 131' ' ' ILE . 1.8 t -138.75 149.97 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.668 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.86 155.13 37.52 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.565 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.543 ' CB ' HD13 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -125.05 136.69 53.93 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.644 0.259 . . . . 0.0 111.004 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.576 HD21 HG21 ' D' ' 130' ' ' THR . 0.9 OUTLIER -97.2 136.13 38.15 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.017 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.446 ' CA ' ' HB3' ' A' ' 113' ' ' LEU . . . -174.0 -172.91 39.69 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.762 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.667 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.2 OUTLIER -118.66 144.6 46.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.485 0.183 . . . . 0.0 110.835 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.639 ' HB2' HG23 ' A' ' 83' ' ' THR . . . -62.52 138.62 58.51 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.925 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.504 HG23 ' N ' ' A' ' 79' ' ' ASP . 5.7 tt -71.63 -45.56 66.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.932 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.504 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -133.13 42.47 3.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.857 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 79' ' ' ASP . . . 70.12 -80.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.977 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.06 -29.78 68.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.552 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.445 ' HB3' HG22 ' A' ' 78' ' ' ILE . 1.7 m80 -89.77 69.41 7.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 110.445 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.639 HG23 ' HB2' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -74.52 -16.17 60.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.576 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 20.7 p-10 -66.26 -19.05 65.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.267 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 138' ' ' PHE . 13.4 t -113.65 133.81 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.198 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.766 ' HG ' HD13 ' A' ' 113' ' ' LEU . 0.4 OUTLIER -67.89 161.48 26.27 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.529 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 77' ' ' ALA . . . -103.54 -174.65 2.6 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.869 0.366 . . . . 0.0 111.787 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.71 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 0.3 OUTLIER -67.38 165.22 16.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.084 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.518 ' CG ' ' HB2' ' A' ' 149' ' ' ASN . 3.6 mm100 -63.43 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.815 0.34 . . . . 0.0 111.3 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.454 ' O ' HG12 ' D' ' 52' ' ' VAL . 2.3 p -165.45 3.66 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 111.492 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.528 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 0.7 OUTLIER -80.03 79.74 6.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.525 ' HB2' HG13 ' D' ' 52' ' ' VAL . . . -57.08 -24.72 56.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.885 0.374 . . . . 0.0 111.658 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.18 33.94 5.25 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.682 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.8 0.44 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.943 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.71 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . 38.4 m -96.8 177.94 5.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.877 0.37 . . . . 0.0 110.64 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.47 -178.71 7.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.804 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.494 ' HB ' ' OG1' ' A' ' 144' ' ' THR . 2.0 m -134.53 119.01 17.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.338 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 97' ' ' THR . 32.6 m-20 68.85 34.41 3.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.388 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.747 HG13 HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -138.03 130.79 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.808 179.684 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.11 -170.55 18.84 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.568 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -119.72 114.48 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.014 0.526 . . . . 0.0 111.719 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 1.8 tt0 -87.33 150.21 24.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.912 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.551 HG12 ' HG ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -114.98 135.96 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.53 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.28 133.57 55.04 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.675 0.274 . . . . 0.0 111.03 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.858 ' HB3' HG22 ' A' ' 107' ' ' THR . 6.1 t0 -82.36 149.75 27.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.664 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.751 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.4 OUTLIER -67.85 -16.25 64.0 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.8 0.333 . . . . 0.0 111.053 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.858 HG22 ' HB3' ' A' ' 105' ' ' ASP . 8.8 t -63.67 -28.35 69.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.033 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.0 -40.48 1.58 Allowed Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.661 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.422 ' H ' HG23 ' A' ' 107' ' ' THR . . . -91.51 163.09 14.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.815 0.34 . . . . 0.0 111.049 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.17 133.36 35.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.563 HD21 ' O ' ' A' ' 117' ' ' THR . 4.8 tp -96.74 150.02 21.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.407 0.622 . . . . 0.0 110.526 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.855 HG23 HG21 ' A' ' 117' ' ' THR . 1.9 t -98.37 141.78 30.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.156 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.766 HD13 ' HG ' ' A' ' 86' ' ' LEU . 1.6 mt -76.43 89.48 3.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.783 0.325 . . . . 0.0 110.704 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.08 -18.19 5.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.554 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.79 -60.58 0.46 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.616 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.504 ' HB2' ' N ' ' D' ' 129' ' ' ASN . . . -96.46 26.98 4.03 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.04 0.448 . . . . 0.0 111.69 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.855 HG21 HG23 ' A' ' 112' ' ' THR . 0.0 OUTLIER -87.04 74.86 9.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.148 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.582 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 62.7 m-85 -94.88 92.86 7.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.819 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.8 m -136.32 68.92 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.81 150.19 28.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.622 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.25 67.66 0.7 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.171 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.6 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -79.15 114.71 18.31 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.747 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -73.94 127.96 34.24 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.724 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.568 HD21 ' O ' ' A' ' 20' ' ' ALA . 4.0 tp -92.08 132.14 36.81 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.64 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.12 151.12 49.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.58 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 3.1 t30 -69.12 111.99 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.636 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.61 -138.83 8.65 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.672 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.731 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 87.8 m -98.84 82.5 2.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.633 0.254 . . . . 0.0 110.724 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.456 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 2.3 t30 -71.82 148.19 46.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.949 0.404 . . . . 0.0 111.062 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.73 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -138.67 148.57 44.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.119 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.739 HG21 HG11 ' A' ' 71' ' ' VAL . 15.6 mt -110.0 112.23 57.93 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.751 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.4 Cg_endo -81.82 136.98 9.7 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.629 1.553 . . . . 0.0 112.564 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.0 136.09 19.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.718 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -111.43 158.4 19.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.04 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.675 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -154.19 111.35 3.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.951 0.405 . . . . 0.0 111.63 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.476 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . 19.8 ptt180 -108.93 174.09 6.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.344 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.695 ' HB3' HD21 ' A' ' 42' ' ' LEU . 1.7 m-85 -81.37 137.67 35.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.14 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.518 ' HB3' HG21 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -131.61 124.15 29.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.2 0.524 . . . . 0.0 112.072 -179.256 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -108.47 130.17 55.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.839 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -77.46 -27.95 52.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.495 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.49 -96.51 0.11 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.981 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.93 98.46 8.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.623 0.211 . . . . 0.0 110.722 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.548 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -56.6 148.89 18.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.746 0.308 . . . . 0.0 111.413 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.723 ' CG2' ' CD ' ' A' ' 145' ' ' PRO . 90.1 m -125.41 156.96 69.48 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.219 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.723 ' CD ' ' CG2' ' A' ' 144' ' ' THR . 1.4 Cg_endo -83.45 136.3 7.51 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.517 2.145 . . . . 0.0 111.925 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 163.56 -127.56 1.7 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.474 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.652 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -110.92 132.88 53.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.863 0.364 . . . . 0.0 111.363 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.24 43.69 2.93 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.133 0.492 . . . . 0.0 110.451 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.518 ' HB2' ' CG ' ' A' ' 89' ' ' GLN . 9.3 m120 -92.27 144.28 25.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.529 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.684 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -160.64 178.81 9.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.0 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -146.94 145.01 29.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.255 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -133.74 139.74 46.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.169 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.1 135.29 42.8 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.58 152.18 27.34 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.005 0.431 . . . . 0.0 110.188 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.413 ' HE3' ' HB ' ' D' ' 128' ' ' THR . 15.2 mmtm -134.18 146.84 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.916 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.09 140.71 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.857 0.36 . . . . 0.0 111.626 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.432 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -134.54 132.73 39.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.281 0.562 . . . . 0.0 110.45 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 21' ' ' CYS . 11.1 m-85 -107.3 128.05 54.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.49 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.873 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 111.147 0.054 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' C' ' 158' ' ' TYR . . . 52.78 88.29 0.03 OUTLIER 'General case' 0 C--O 1.232 0.15 0 O-C-N 123.154 0.284 . . . . 0.0 111.039 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' C' ' 157' ' ' GLN . 5.5 m -122.92 116.22 23.24 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.379 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.492 HG21 ' CA ' ' F' ' 127' ' ' GLY . 1.8 m -99.68 117.18 33.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.563 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.616 HG23 HG23 ' C' ' 156' ' ' VAL . 1.8 m -144.41 158.09 15.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.577 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' C' ' 154' ' ' PHE . 13.1 t30 -78.74 123.81 27.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.54 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.77 -71.24 1.0 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.836 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.531 ' H ' ' HB3' ' C' ' 154' ' ' PHE . . . -152.66 -147.05 4.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.84 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.954 HG22 HG23 ' C' ' 153' ' ' THR . 24.5 p -148.69 134.44 18.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.969 0.414 . . . . 0.0 111.318 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.39 124.34 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.147 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' HIS . . . . . 0.636 ' HA ' ' OD1' ' C' ' 151' ' ' ASP . 57.4 t-80 -91.47 116.2 28.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.337 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -96.88 105.53 17.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.738 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -104.62 118.72 37.28 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.474 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.3 172.9 30.81 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.936 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.738 ' O ' ' HA ' ' C' ' 36' ' ' GLN . 25.8 tt0 -160.38 135.95 8.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.911 0.386 . . . . 0.0 110.398 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.761 HG23 ' HB2' ' C' ' 148' ' ' ALA . 43.7 t -96.87 132.79 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.204 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.565 HG11 ' OE1' ' C' ' 36' ' ' GLN . 18.1 m -133.88 -177.12 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.934 0.397 . . . . 0.0 110.98 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ASN . . . . . 0.563 ' HA ' HG22 ' C' ' 39' ' ' THR . 0.3 OUTLIER -75.85 -170.34 1.32 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.931 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.76 45.51 0.97 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.084 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.577 ' O ' HD21 ' B' ' 124' ' ' LEU . . . -121.34 -24.85 5.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.386 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.716 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER -168.81 140.64 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.864 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' B' ' 60' ' ' ASP . . . -132.79 116.97 17.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.082 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.744 HG12 ' HB2' ' C' ' 36' ' ' GLN . 0.5 OUTLIER -67.05 146.22 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.034 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.473 ' O ' HG23 ' B' ' 28' ' ' VAL . 12.8 t0 -80.33 152.09 29.15 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.562 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.84 -39.95 95.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.417 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.9 2.65 85.83 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.844 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -106.26 -19.89 13.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.826 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 24' ' ' ASP . 39.8 t -47.36 -52.22 5.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.336 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.15 136.43 48.66 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.036 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.63 136.86 39.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.066 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.53 102.87 12.77 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.062 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 26.0 t -107.69 128.25 63.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.527 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -114.7 123.07 48.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.652 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.43 -42.71 15.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.61 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.44 -167.44 13.2 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.581 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.741 ' HB2' HG12 ' A' ' 23' ' ' VAL . 2.9 mt-30 -96.7 124.47 40.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.613 0.244 . . . . 0.0 110.892 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.78 147.53 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.93 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.67 134.95 34.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.026 0.441 . . . . 0.0 111.669 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -60.07 -44.49 94.7 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.739 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.29 -36.84 61.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.184 0.516 . . . . 0.0 110.919 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.83 -35.86 62.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.223 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.755 HD23 HG13 ' B' ' 99' ' ' VAL . 2.9 mp -106.69 34.58 3.34 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.626 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.95 15.88 27.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.329 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.0 132.08 56.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.299 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' B' ' 140' ' ' THR . 6.7 tt0 -56.58 108.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.846 0.355 . . . . 0.0 111.076 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.95 25.9 10.12 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.144 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' B' ' 139' ' ' ALA . . . -71.42 137.77 48.57 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 7.3 p -136.98 122.75 19.93 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.927 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' B' ' 136' ' ' ARG . 53.4 m -100.09 -175.21 2.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.644 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.9 t -55.67 137.33 49.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.799 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.481 ' CA ' ' HB3' ' B' ' 136' ' ' ARG . . . -92.29 133.46 35.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.327 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.683 HG22 ' O ' ' B' ' 135' ' ' ALA . 26.1 m -76.71 162.54 4.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.49 141.16 16.78 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.592 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -173.76 137.77 0.62 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.804 0.335 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -136.56 145.83 45.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.603 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.527 HG23 ' O ' ' B' ' 56' ' ' ILE . 1.2 tp -91.03 116.77 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.607 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLN . . . . . 0.722 ' HA ' HG23 ' B' ' 130' ' ' THR . 1.3 mp0 -72.93 128.58 35.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.79 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.457 ' HG ' ' HA ' ' B' ' 23' ' ' VAL . 0.3 OUTLIER -137.31 89.17 2.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.242 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.723 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 9.8 p30 -74.81 176.53 6.98 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.012 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ASP . . . . . 0.512 ' HB2' ' HB3' ' B' ' 22' ' ' ALA . 0.9 OUTLIER 58.93 74.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 61' ' ' CYS . . . . . 0.716 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 36.8 m -126.32 148.86 49.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.804 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ASP . . . . . 0.404 ' OD2' HG23 ' B' ' 65' ' ' VAL . 1.6 t70 -121.58 169.77 10.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.281 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.27 -32.69 4.89 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -76.52 -27.94 56.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.169 0.509 . . . . 0.0 111.72 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.404 HG23 ' OD2' ' B' ' 62' ' ' ASP . 25.6 t -73.66 -56.69 8.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.677 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.466 ' HB3' ' HB1' ' B' ' 20' ' ' ALA . . . -135.02 122.74 22.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.674 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -50.04 5.13 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.89 0.376 . . . . 0.0 110.923 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -89.76 152.12 21.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.574 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' B' ' 122' ' ' THR . . . -144.25 137.8 27.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.604 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.603 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -113.35 157.25 22.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.11 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.754 HG11 HG21 ' B' ' 131' ' ' ILE . 1.8 t -138.78 149.96 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.656 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.82 155.11 37.52 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.596 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.545 ' CB ' HD13 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -125.04 136.68 53.92 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.634 0.254 . . . . 0.0 110.969 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.581 HD11 ' HG3' ' E' ' 57' ' ' GLN . 0.9 OUTLIER -97.15 136.1 38.15 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.032 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.459 ' CA ' ' HB3' ' B' ' 113' ' ' LEU . . . -174.02 -172.95 39.74 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.731 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.677 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.2 OUTLIER -118.63 144.55 46.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.537 0.208 . . . . 0.0 110.831 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.652 ' HB2' HG23 ' B' ' 83' ' ' THR . . . -62.48 138.53 58.48 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.958 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.501 HG23 ' N ' ' B' ' 79' ' ' ASP . 5.7 tt -71.55 -45.59 67.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.884 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.501 ' N ' HG23 ' B' ' 78' ' ' ILE . 0.3 OUTLIER -133.19 42.54 3.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.818 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' B' ' 79' ' ' ASP . . . 70.04 -80.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.056 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.08 -29.71 68.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.56 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.422 ' HB3' HG22 ' B' ' 78' ' ' ILE . 1.6 m80 -89.87 69.39 7.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.418 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' THR . . . . . 0.652 HG23 ' HB2' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -74.47 -16.2 60.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.604 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ASN . . . . . 0.726 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 20.8 p-10 -66.11 -19.16 65.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.334 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' B' ' 138' ' ' PHE . 13.5 t -113.6 133.83 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.173 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.774 ' HG ' HD13 ' B' ' 113' ' ' LEU . 0.4 OUTLIER -67.83 161.53 26.04 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.458 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' B' ' 77' ' ' ALA . . . -103.61 -174.72 2.61 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.866 0.365 . . . . 0.0 111.772 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.703 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 0.3 OUTLIER -67.36 165.21 16.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.049 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 89' ' ' GLN . . . . . 0.519 ' CG ' ' HB2' ' B' ' 149' ' ' ASN . 3.6 mm100 -63.42 -79.73 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.33 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' SER . . . . . 0.45 ' O ' HG12 ' E' ' 52' ' ' VAL . 2.3 p -165.48 3.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 111.549 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' SER . . . . . 0.536 ' HA ' ' HB2' ' D' ' 25' ' ' ALA . 0.7 OUTLIER -80.16 79.73 6.68 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.501 ' HB2' HG13 ' E' ' 52' ' ' VAL . . . -57.05 -24.76 56.15 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.868 0.366 . . . . 0.0 111.617 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.2 33.99 5.24 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.692 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.77 0.42 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.911 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' SER . . . . . 0.703 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . 38.4 m -96.8 177.93 5.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.873 0.368 . . . . 0.0 110.622 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.54 -178.65 7.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.806 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' B' ' 98' ' ' ASN . 2.0 m -134.42 119.05 18.09 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.379 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 98' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' B' ' 97' ' ' THR . 32.5 m-20 68.68 34.53 3.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.441 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' VAL . . . . . 0.755 HG13 HD23 ' B' ' 42' ' ' LEU . 0.4 OUTLIER -138.13 130.85 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.784 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.14 -170.63 18.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.539 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' B' ' 86' ' ' LEU . 0.2 OUTLIER -119.61 114.48 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.017 0.527 . . . . 0.0 111.766 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 1.8 tt0 -87.4 150.24 23.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.92 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.55 HG12 ' HG ' ' B' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 135.99 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.471 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.31 133.59 55.05 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.654 0.264 . . . . 0.0 110.988 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ASP . . . . . 0.864 ' HB3' HG22 ' B' ' 107' ' ' THR . 6.1 t0 -82.29 149.75 27.63 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.725 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' ARG . . . . . 0.736 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.4 OUTLIER -67.82 -16.26 64.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.811 0.339 . . . . 0.0 111.103 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.864 HG22 ' HB3' ' B' ' 105' ' ' ASP . 8.8 t -63.69 -28.39 69.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.006 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.08 -40.55 1.57 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.662 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ALA . . . . . 0.419 ' H ' HG23 ' B' ' 107' ' ' THR . . . -91.48 163.12 14.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.819 0.342 . . . . 0.0 111.052 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.12 133.35 35.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.204 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.564 HD21 ' O ' ' B' ' 117' ' ' THR . 4.8 tp -96.69 150.0 21.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.413 0.625 . . . . 0.0 110.539 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.864 HG23 HG21 ' B' ' 117' ' ' THR . 1.9 t -98.48 141.76 30.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.177 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.774 HD13 ' HG ' ' B' ' 86' ' ' LEU . 1.6 mt -76.36 89.4 3.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.741 0.305 . . . . 0.0 110.746 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.07 -18.14 5.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.503 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.8 -60.65 0.46 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.588 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' ALA . . . . . 0.501 ' HB2' ' N ' ' E' ' 129' ' ' ASN . . . -96.5 27.03 4.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.035 0.445 . . . . 0.0 111.632 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.864 HG21 HG23 ' B' ' 112' ' ' THR . 0.0 OUTLIER -87.07 74.89 9.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.164 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.603 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . 62.6 m-85 -94.92 92.89 7.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 25.5 m -136.33 68.93 1.43 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.86 150.29 28.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.557 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -107.34 67.63 0.7 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.206 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.614 ' O ' ' HB3' ' B' ' 69' ' ' ALA . 0.2 OUTLIER -79.15 114.71 18.31 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.757 -179.549 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 12.0 m -73.98 128.02 34.41 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.713 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.577 HD21 ' O ' ' B' ' 20' ' ' ALA . 4.0 tp -92.11 132.17 36.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.614 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.17 151.09 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.583 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' B' ' 61' ' ' CYS . 3.1 t30 -69.03 111.97 5.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.627 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.55 -138.96 8.75 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.643 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' THR . . . . . 0.723 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 87.7 m -98.71 82.55 2.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.637 0.256 . . . . 0.0 110.792 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ASN . . . . . 0.462 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 2.3 t30 -71.76 148.14 46.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.805 0.336 . . . . 0.0 111.188 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.722 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -138.64 148.61 44.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 131' ' ' ILE . . . . . 0.754 HG21 HG11 ' B' ' 71' ' ' VAL . 15.6 mt -110.01 112.22 57.91 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 132' ' ' PRO . . . . . 0.736 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.83 137.03 9.72 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.574 1.516 . . . . 0.0 112.578 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.03 136.02 19.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.739 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -111.45 158.41 19.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.033 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.683 ' O ' HG22 ' B' ' 52' ' ' VAL . . . -154.15 111.33 3.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.924 0.392 . . . . 0.0 111.633 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 136' ' ' ARG . . . . . 0.481 ' HB3' ' CA ' ' B' ' 51' ' ' ALA . 19.8 ptt180 -108.94 174.11 6.02 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.375 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 137' ' ' TYR . . . . . 0.686 ' HB3' HD21 ' B' ' 42' ' ' LEU . 1.7 m-85 -81.4 137.64 35.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.047 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 138' ' ' PHE . . . . . 0.517 ' HB3' HG21 ' B' ' 85' ' ' VAL . 0.9 OUTLIER -131.53 124.14 29.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.104 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' B' ' 47' ' ' ALA . . . -108.51 130.16 55.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.834 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 140' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' B' ' 45' ' ' GLU . 0.2 OUTLIER -77.44 -27.9 52.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.571 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.48 -96.52 0.11 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.006 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.99 98.49 8.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.572 0.225 . . . . 0.0 110.666 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -56.64 148.93 18.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.742 0.306 . . . . 0.0 111.418 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.724 ' CG2' ' CD ' ' B' ' 145' ' ' PRO . 90.5 m -125.44 156.95 69.57 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.208 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.724 ' CD ' ' CG2' ' B' ' 144' ' ' THR . 1.4 Cg_endo -83.42 136.28 7.53 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.52 2.147 . . . . 0.0 111.974 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 146' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' A' ' 15' ' ' GLU . . . 163.64 -127.57 1.69 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.51 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.66 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -110.93 132.92 53.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.829 0.347 . . . . 0.0 111.328 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 148' ' ' ALA . . . . . 0.778 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -124.28 43.75 2.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.422 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.519 ' HB2' ' CG ' ' B' ' 89' ' ' GLN . 14.0 m-80 -92.34 144.32 25.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.506 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.692 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -160.68 178.85 9.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.968 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' ASP . . . . . 0.624 ' OD1' ' HA ' ' A' ' 11' ' ' HIS . 15.7 t70 -146.97 145.03 29.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.218 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -133.79 139.73 46.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.18 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.965 HG23 HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -101.04 135.25 42.79 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.131 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.543 ' HB3' ' H ' ' A' ' 8' ' ' GLY . 0.2 OUTLIER -81.52 152.16 27.42 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.118 0.485 . . . . 0.0 110.125 -179.082 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.424 ' HE3' ' HB ' ' E' ' 128' ' ' THR . 15.2 mmtm -134.22 146.84 50.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.877 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 156' ' ' VAL . . . . . 0.633 HG23 HG23 ' A' ' 5' ' ' VAL . 33.1 m -139.07 140.77 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.8 0.333 . . . . 0.0 111.617 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 3' ' ' THR . 0.1 OUTLIER -134.52 132.67 39.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.272 0.558 . . . . 0.0 110.485 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 158' ' ' TYR . . . . . 0.56 ' CE1' ' HB2' ' B' ' 21' ' ' CYS . 10.9 m-85 -107.22 128.01 54.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.557 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.907 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 120.222 0.058 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' D' ' 158' ' ' TYR . . . 52.76 88.35 0.03 OUTLIER 'General case' 0 C--O 1.232 0.163 0 O-C-N 123.141 0.275 . . . . 0.0 111.015 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' D' ' 157' ' ' GLN . 5.5 m -123.0 116.28 23.27 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.381 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -99.66 117.16 33.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.6 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.629 HG23 HG23 ' D' ' 156' ' ' VAL . 1.8 m -144.45 157.96 14.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.626 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 6' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' D' ' 154' ' ' PHE . 13.2 t30 -78.66 123.75 27.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.582 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.7 -71.24 1.0 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.819 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' GLY . . . . . 0.541 ' H ' ' HB3' ' D' ' 154' ' ' PHE . . . -152.7 -147.01 4.49 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.773 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' THR . . . . . 0.93 HG22 HG23 ' D' ' 153' ' ' THR . 24.1 p -148.75 134.51 18.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.053 0.454 . . . . 0.0 111.243 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.35 124.33 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.201 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' HIS . . . . . 0.632 ' HA ' ' OD1' ' D' ' 151' ' ' ASP . 57.4 t-80 -91.51 116.13 28.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.308 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -96.8 105.49 17.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.824 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -104.66 118.67 37.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.484 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.22 172.94 30.76 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.98 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' GLU . . . . . 0.738 ' O ' ' HA ' ' D' ' 36' ' ' GLN . 25.7 tt0 -160.39 135.93 8.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.913 0.387 . . . . 0.0 110.459 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.77 HG23 ' HB2' ' D' ' 148' ' ' ALA . 43.8 t -96.86 132.85 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.168 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.553 HG11 ' OE1' ' D' ' 36' ' ' GLN . 18.2 m -133.97 -177.21 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.93 0.395 . . . . 0.0 110.965 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 18' ' ' ASN . . . . . 0.569 ' HA ' HG22 ' D' ' 39' ' ' THR . 0.3 OUTLIER -75.75 -170.28 1.27 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.977 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.82 45.5 0.97 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.073 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' ALA . . . . . 0.559 ' O ' HD21 ' C' ' 124' ' ' LEU . . . -121.31 -24.85 5.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.383 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 21' ' ' CYS . . . . . 0.698 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER -168.87 140.69 2.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.864 -179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' HB2' ' C' ' 60' ' ' ASP . . . -132.82 117.02 17.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.041 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 23' ' ' VAL . . . . . 0.733 HG12 ' HB2' ' D' ' 36' ' ' GLN . 0.5 OUTLIER -67.11 146.26 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.113 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.466 ' O ' HG23 ' C' ' 28' ' ' VAL . 12.9 t0 -80.4 152.11 29.02 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.545 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.528 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -62.77 -40.02 95.97 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.483 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.91 2.67 85.83 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.886 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -106.14 -20.05 13.53 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.872 0.368 . . . . 0.0 110.817 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.466 HG23 ' O ' ' C' ' 24' ' ' ASP . 39.7 t -47.31 -52.15 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.324 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.21 136.42 48.71 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.995 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.72 136.91 39.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.017 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.56 102.86 12.76 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.074 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 26.1 t -107.66 128.34 62.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.051 0.453 . . . . 0.0 110.485 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -114.78 123.16 48.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.603 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.49 -42.74 15.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.593 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.5 -167.42 13.17 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.613 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' GLN . . . . . 0.744 ' HB2' HG12 ' B' ' 23' ' ' VAL . 2.9 mt-30 -96.77 124.42 40.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.586 0.231 . . . . 0.0 110.882 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.73 147.59 11.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.946 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.76 134.97 34.31 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.67 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.563 HG22 ' HA ' ' B' ' 18' ' ' ASN . 0.0 OUTLIER -60.1 -44.37 94.88 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.798 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.41 -36.74 61.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.063 0.458 . . . . 0.0 110.835 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.97 -35.73 62.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.191 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.751 HD23 HG13 ' C' ' 99' ' ' VAL . 2.9 mp -106.71 34.56 3.36 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.646 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.97 15.82 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.334 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.96 132.05 56.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.359 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 45' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' C' ' 140' ' ' THR . 6.8 tt0 -56.54 108.8 0.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.806 0.336 . . . . 0.0 111.107 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.89 25.96 10.12 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.152 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' C' ' 139' ' ' ALA . . . -71.49 137.8 48.45 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 7.4 p -137.01 122.77 19.93 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.864 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' C' ' 136' ' ' ARG . 54.0 m -100.09 -175.16 2.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.655 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 2.8 t -55.63 137.3 49.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.811 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' ALA . . . . . 0.481 ' CA ' ' HB3' ' C' ' 136' ' ' ARG . . . -92.4 133.48 35.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.34 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.68 HG22 ' O ' ' C' ' 135' ' ' ALA . 26.4 m -76.7 162.51 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.56 141.2 16.79 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.519 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -173.74 137.73 0.62 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.721 0.296 . . . . 0.0 111.015 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -136.5 145.74 45.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.647 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.532 HG23 ' O ' ' C' ' 56' ' ' ILE . 1.2 tp -90.92 116.76 32.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.68 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.704 ' HA ' HG23 ' C' ' 130' ' ' THR . 1.3 mp0 -72.9 128.55 35.83 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 58' ' ' LEU . . . . . 0.453 ' HG ' ' HA ' ' C' ' 23' ' ' VAL . 0.3 OUTLIER -137.28 89.18 2.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.284 -179.648 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 59' ' ' ASN . . . . . 0.709 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 9.8 p30 -74.82 176.46 7.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.013 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 60' ' ' ASP . . . . . 0.498 ' HB2' ' HB3' ' C' ' 22' ' ' ALA . 0.8 OUTLIER 58.92 74.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.818 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 61' ' ' CYS . . . . . 0.698 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 36.3 m -126.34 148.91 49.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 62' ' ' ASP . . . . . 0.403 ' OD2' HG23 ' C' ' 65' ' ' VAL . 1.6 t70 -121.63 169.72 10.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.35 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.26 -32.7 4.89 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.52 -27.88 56.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 111.765 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.403 HG23 ' OD2' ' C' ' 62' ' ' ASP . 25.6 t -73.6 -56.81 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.64 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 66' ' ' ALA . . . . . 0.466 ' HB3' ' HB1' ' C' ' 20' ' ' ALA . . . -134.98 122.7 22.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.65 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.45 -50.1 5.14 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.861 0.362 . . . . 0.0 110.997 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 68' ' ' LYS . . . . . 0.429 ' HA ' ' HZ3' ' C' ' 68' ' ' LYS . 1.8 tptp -89.78 152.14 21.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.558 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' C' ' 122' ' ' THR . . . -144.26 137.84 27.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.575 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -113.41 157.24 22.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.073 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 71' ' ' VAL . . . . . 0.736 HG11 HG21 ' C' ' 131' ' ' ILE . 1.8 t -138.74 149.94 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.665 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.82 155.1 37.51 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.59 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' PHE . . . . . 0.552 ' CB ' HD13 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -124.99 136.66 53.93 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.012 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.568 HD11 ' HG3' ' F' ' 57' ' ' GLN . 0.9 OUTLIER -97.16 136.17 38.07 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.994 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 75' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' C' ' 113' ' ' LEU . . . -174.01 -172.95 39.74 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.817 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.666 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.2 OUTLIER -118.67 144.54 46.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.551 0.215 . . . . 0.0 110.796 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 77' ' ' ALA . . . . . 0.637 ' HB2' HG23 ' C' ' 83' ' ' THR . . . -62.5 138.6 58.5 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.913 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 78' ' ' ILE . . . . . 0.508 HG23 ' N ' ' C' ' 79' ' ' ASP . 5.7 tt -71.66 -45.54 66.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.85 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 79' ' ' ASP . . . . . 0.508 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.3 OUTLIER -133.15 42.47 3.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 80' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' C' ' 79' ' ' ASP . . . 70.19 -80.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.032 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.11 -29.68 68.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.609 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 82' ' ' HIS . . . . . 0.432 ' HB3' HG22 ' C' ' 78' ' ' ILE . 1.7 m80 -89.84 69.39 7.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.832 0.349 . . . . 0.0 110.424 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 83' ' ' THR . . . . . 0.637 HG23 ' HB2' ' C' ' 77' ' ' ALA . 0.2 OUTLIER -74.55 -16.13 60.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.604 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 84' ' ' ASN . . . . . 0.746 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 20.8 p-10 -66.18 -19.04 65.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.336 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.523 HG21 ' HB3' ' C' ' 138' ' ' PHE . 13.5 t -113.66 133.86 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.128 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.773 ' HG ' HD13 ' C' ' 113' ' ' LEU . 0.4 OUTLIER -67.91 161.53 26.22 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.267 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' C' ' 77' ' ' ALA . . . -103.58 -174.66 2.6 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.862 0.363 . . . . 0.0 111.764 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.702 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 0.3 OUTLIER -67.4 165.17 17.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.116 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 89' ' ' GLN . . . . . 0.525 ' CG ' ' HB2' ' C' ' 149' ' ' ASN . 3.6 mm100 -63.36 -79.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.365 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 90' ' ' SER . . . . . 0.449 ' O ' HG12 ' F' ' 52' ' ' VAL . 2.3 p -165.52 3.61 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.01 0.433 . . . . 0.0 111.579 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 91' ' ' SER . . . . . 0.533 ' HA ' ' HB2' ' E' ' 25' ' ' ALA . 0.7 OUTLIER -80.09 79.83 6.59 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 92' ' ' ALA . . . . . 0.522 ' HB2' HG13 ' F' ' 52' ' ' VAL . . . -57.09 -24.79 56.49 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.891 0.377 . . . . 0.0 111.634 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.17 33.94 5.25 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.69 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.85 0.46 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.937 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 95' ' ' SER . . . . . 0.702 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 38.6 m -96.78 177.94 5.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 110.607 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.52 -178.73 7.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.784 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 97' ' ' THR . . . . . 0.495 ' HB ' ' OG1' ' C' ' 144' ' ' THR . 2.0 m -134.44 119.02 18.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.369 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 98' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' C' ' 97' ' ' THR . 32.8 m-20 68.78 34.48 3.33 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.457 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 99' ' ' VAL . . . . . 0.751 HG13 HD23 ' C' ' 42' ' ' LEU . 0.4 OUTLIER -138.12 130.85 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.727 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.21 -170.63 19.01 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.566 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 101' ' ' VAL . . . . . 0.59 HG13 ' HB2' ' C' ' 86' ' ' LEU . 0.2 OUTLIER -119.62 114.51 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 123.028 0.531 . . . . 0.0 111.717 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 102' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 1.8 tt0 -87.39 150.2 23.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.923 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.563 HG12 ' HG ' ' C' ' 113' ' ' LEU . 0.8 OUTLIER -114.94 136.07 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.481 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.37 133.52 55.11 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.711 0.291 . . . . 0.0 111.032 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 105' ' ' ASP . . . . . 0.838 ' HB3' HG22 ' C' ' 107' ' ' THR . 6.1 t0 -82.24 149.74 27.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.674 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 106' ' ' ARG . . . . . 0.757 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.4 OUTLIER -67.87 -16.23 63.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.795 0.331 . . . . 0.0 111.058 179.537 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 107' ' ' THR . . . . . 0.838 HG22 ' HB3' ' C' ' 105' ' ' ASP . 8.8 t -63.62 -28.39 69.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.043 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.97 -40.46 1.58 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.717 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 109' ' ' ALA . . . . . 0.416 ' H ' HG23 ' C' ' 107' ' ' THR . . . -91.54 163.08 14.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.822 0.344 . . . . 0.0 110.999 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.14 133.36 35.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.198 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 111' ' ' LEU . . . . . 0.563 HD21 ' O ' ' C' ' 117' ' ' THR . 4.8 tp -96.72 149.98 21.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.368 0.604 . . . . 0.0 110.603 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 112' ' ' THR . . . . . 0.848 HG23 HG21 ' C' ' 117' ' ' THR . 1.9 t -98.43 141.73 30.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.773 HD13 ' HG ' ' C' ' 86' ' ' LEU . 1.6 mt -76.39 89.48 3.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.808 0.337 . . . . 0.0 110.727 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.15 -18.06 5.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.697 0.284 . . . . 0.0 111.525 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.78 -60.63 0.46 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.559 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 116' ' ' ALA . . . . . 0.504 ' HB2' ' C ' ' F' ' 128' ' ' THR . . . -96.46 26.96 4.04 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.996 0.427 . . . . 0.0 111.636 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 117' ' ' THR . . . . . 0.848 HG21 HG23 ' C' ' 112' ' ' THR . 0.0 OUTLIER -87.04 74.81 9.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.157 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 118' ' ' PHE . . . . . 0.595 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . 62.8 m-85 -94.93 92.93 7.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.812 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 25.6 m -136.35 68.94 1.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.831 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.83 150.27 28.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.646 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.34 67.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.178 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' C' ' 69' ' ' ALA . 0.2 OUTLIER -79.19 114.71 18.35 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.7 -179.509 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -74.02 128.04 34.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.729 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 124' ' ' LEU . . . . . 0.559 HD21 ' O ' ' C' ' 20' ' ' ALA . 4.0 tp -92.14 132.19 36.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.594 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.13 151.01 49.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.641 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 126' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' C' ' 61' ' ' CYS . 3.1 t30 -69.05 112.11 5.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.632 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.43 -138.93 8.77 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.756 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 128' ' ' THR . . . . . 0.709 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 87.0 m -98.72 82.54 2.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.642 0.258 . . . . 0.0 110.827 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 129' ' ' ASN . . . . . 0.454 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 2.3 t30 -71.84 148.13 46.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.89 0.376 . . . . 0.0 111.145 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 130' ' ' THR . . . . . 0.704 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -138.57 148.57 44.33 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.209 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 131' ' ' ILE . . . . . 0.736 HG21 HG11 ' C' ' 71' ' ' VAL . 15.7 mt -110.03 112.27 57.83 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 132' ' ' PRO . . . . . 0.757 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.6 Cg_endo -81.8 137.02 9.75 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.599 1.532 . . . . 0.0 112.566 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.01 136.09 19.94 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.727 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -111.5 158.38 19.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.081 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.68 ' O ' HG22 ' C' ' 52' ' ' VAL . . . -154.18 111.36 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.969 0.414 . . . . 0.0 111.64 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.481 ' HB3' ' CA ' ' C' ' 51' ' ' ALA . 19.8 ptt180 -108.89 174.06 6.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.385 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 137' ' ' TYR . . . . . 0.706 ' HB3' HD21 ' C' ' 42' ' ' LEU . 1.7 m-85 -81.41 137.73 35.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.103 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 138' ' ' PHE . . . . . 0.523 ' HB3' HG21 ' C' ' 85' ' ' VAL . 0.9 OUTLIER -131.58 124.13 29.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.092 -179.25 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 139' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' C' ' 47' ' ' ALA . . . -108.48 130.19 55.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.824 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 140' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' C' ' 45' ' ' GLU . 0.2 OUTLIER -77.46 -27.93 52.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.518 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.5 -96.54 0.11 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.955 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.95 98.49 8.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.578 0.227 . . . . 0.0 110.714 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 143' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -56.56 148.92 18.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.757 0.313 . . . . 0.0 111.364 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 144' ' ' THR . . . . . 0.715 ' CG2' ' CD ' ' C' ' 145' ' ' PRO . 91.0 m -125.43 156.99 69.5 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.247 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 145' ' ' PRO . . . . . 0.715 ' CD ' ' CG2' ' C' ' 144' ' ' THR . 1.5 Cg_endo -83.38 136.17 7.51 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.631 2.22 . . . . 0.0 111.987 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 146' ' ' GLY . . . . . 0.577 ' O ' ' HG3' ' B' ' 15' ' ' GLU . . . 163.62 -127.57 1.69 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.429 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 147' ' ' ALA . . . . . 0.659 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -110.88 132.9 53.81 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.763 0.316 . . . . 0.0 111.369 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 148' ' ' ALA . . . . . 0.761 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -124.28 43.78 2.91 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.107 0.479 . . . . 0.0 110.438 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 149' ' ' ASN . . . . . 0.525 ' HB2' ' CG ' ' C' ' 89' ' ' GLN . 13.8 m-80 -92.33 144.27 25.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.511 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 150' ' ' ALA . . . . . 0.695 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -160.66 178.88 9.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.989 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 151' ' ' ASP . . . . . 0.636 ' OD1' ' HA ' ' B' ' 11' ' ' HIS . 15.6 t70 -146.98 145.02 29.6 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.298 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 152' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -133.75 139.78 46.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.273 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 153' ' ' THR . . . . . 0.954 HG23 HG22 ' B' ' 9' ' ' THR . 0.2 OUTLIER -101.11 135.28 42.83 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.202 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 154' ' ' PHE . . . . . 0.531 ' HB3' ' H ' ' B' ' 8' ' ' GLY . 0.2 OUTLIER -81.54 152.17 27.4 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.06 0.457 . . . . 0.0 110.136 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 155' ' ' LYS . . . . . 0.419 ' HE3' ' HB ' ' F' ' 128' ' ' THR . 15.2 mmtm -134.24 146.87 50.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.934 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 156' ' ' VAL . . . . . 0.616 HG23 HG23 ' B' ' 5' ' ' VAL . 33.1 m -139.18 140.79 37.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.859 0.362 . . . . 0.0 111.622 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 157' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' B' ' 3' ' ' THR . 0.1 OUTLIER -134.53 132.68 39.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.335 0.588 . . . . 0.0 110.406 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 158' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' C' ' 21' ' ' CYS . 11.0 m-85 -107.35 128.04 54.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.541 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.823 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.267 0.079 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' E' ' 158' ' ' TYR . . . 52.85 88.35 0.03 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.976 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 3' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' E' ' 157' ' ' GLN . 5.4 m -123.0 116.2 23.16 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.413 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -99.6 117.22 33.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.582 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.629 HG23 HG23 ' E' ' 156' ' ' VAL . 1.8 m -144.44 158.03 15.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.655 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 6' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' E' ' 154' ' ' PHE . 13.2 t30 -78.71 123.75 27.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.597 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.83 -71.1 1.02 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.792 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 8' ' ' GLY . . . . . 0.522 ' H ' ' HB3' ' E' ' 154' ' ' PHE . . . -152.75 -146.98 4.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.806 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 9' ' ' THR . . . . . 0.932 HG22 HG23 ' E' ' 153' ' ' THR . 24.1 p -148.76 134.49 18.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.011 0.434 . . . . 0.0 111.258 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.4 124.37 72.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.159 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' HIS . . . . . 0.619 ' HA ' ' OD1' ' E' ' 151' ' ' ASP . 57.3 t-80 -91.52 116.17 28.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.292 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -96.84 105.49 17.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.814 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -104.64 118.73 37.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.422 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.31 172.93 30.82 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.945 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 15' ' ' GLU . . . . . 0.744 ' O ' ' HA ' ' E' ' 36' ' ' GLN . 25.8 tt0 -160.36 135.96 8.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.943 0.401 . . . . 0.0 110.339 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.777 HG23 ' HB2' ' E' ' 148' ' ' ALA . 43.2 t -96.79 132.81 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.25 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.563 HG11 ' OE1' ' E' ' 36' ' ' GLN . 18.2 m -133.91 -177.16 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.897 0.38 . . . . 0.0 111.008 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 18' ' ' ASN . . . . . 0.565 ' HA ' HG22 ' E' ' 39' ' ' THR . 0.3 OUTLIER -75.74 -170.37 1.3 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.932 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.74 45.41 0.98 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.029 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.576 ' O ' HD21 ' D' ' 124' ' ' LEU . . . -121.36 -24.78 5.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.369 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 21' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER -168.82 140.65 2.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.881 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 22' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' D' ' 60' ' ' ASP . . . -132.8 116.99 17.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.068 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 23' ' ' VAL . . . . . 0.738 HG12 ' HB2' ' E' ' 36' ' ' GLN . 0.5 OUTLIER -67.05 146.18 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.044 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.467 ' O ' HG23 ' D' ' 28' ' ' VAL . 12.9 t0 -80.33 152.04 29.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.58 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -62.69 -40.07 95.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.464 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.91 2.64 85.81 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.867 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -106.17 -19.94 13.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.845 0.355 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 28' ' ' VAL . . . . . 0.467 HG23 ' O ' ' D' ' 24' ' ' ASP . 39.8 t -47.42 -52.1 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.344 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.19 136.41 48.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.032 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.72 136.92 39.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.035 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.48 102.77 12.69 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.057 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 25.7 t -107.64 128.29 62.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.058 0.456 . . . . 0.0 110.56 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -114.75 123.03 48.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.614 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.4 -42.71 15.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.684 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.55 -167.43 13.16 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.618 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 36' ' ' GLN . . . . . 0.738 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 2.9 mt-30 -96.79 124.58 40.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.618 0.247 . . . . 0.0 110.845 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.86 147.52 11.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.822 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.77 134.98 34.3 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.661 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.569 HG22 ' HA ' ' C' ' 18' ' ' ASN . 0.0 OUTLIER -60.04 -44.42 94.66 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.828 179.321 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.35 -36.78 61.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.135 0.493 . . . . 0.0 110.92 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.94 -35.86 62.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.135 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.746 HD23 HG13 ' D' ' 99' ' ' VAL . 2.9 mp -106.6 34.55 3.35 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.614 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.9 15.8 27.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.32 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.94 132.09 56.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.323 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 45' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' D' ' 140' ' ' THR . 6.8 tt0 -56.55 108.78 0.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.744 0.307 . . . . 0.0 111.117 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.95 25.88 10.14 Favored Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.136 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' D' ' 139' ' ' ALA . . . -71.48 137.76 48.45 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.963 0.411 . . . . 0.0 112.058 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 7.3 p -137.01 122.77 19.93 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.92 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' D' ' 136' ' ' ARG . 53.4 m -100.12 -175.19 2.88 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.606 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 2.9 t -55.59 137.31 49.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.808 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 51' ' ' ALA . . . . . 0.48 ' CA ' ' HB3' ' D' ' 136' ' ' ARG . . . -92.41 133.51 35.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.348 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 52' ' ' VAL . . . . . 0.675 HG22 ' O ' ' D' ' 135' ' ' ALA . 26.6 m -76.76 162.47 4.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.49 141.16 16.78 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.552 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.569 ' H ' HG21 ' A' ' 76' ' ' THR . 39.4 p90 -173.74 137.79 0.62 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.783 0.325 . . . . 0.0 110.965 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 55' ' ' ASN . . . . . 0.501 ' OD1' HD21 ' A' ' 74' ' ' LEU . 17.9 p30 -136.5 145.81 45.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.681 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.532 HG23 ' O ' ' D' ' 56' ' ' ILE . 1.2 tp -90.95 116.76 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.627 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 57' ' ' GLN . . . . . 0.729 ' HA ' HG23 ' D' ' 130' ' ' THR . 1.3 mp0 -72.87 128.59 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.803 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 58' ' ' LEU . . . . . 0.46 ' HG ' ' HA ' ' D' ' 23' ' ' VAL . 0.3 OUTLIER -137.31 89.11 2.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.264 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 59' ' ' ASN . . . . . 0.722 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 9.8 p30 -74.76 176.54 6.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.951 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 60' ' ' ASP . . . . . 0.505 ' HB2' ' HB3' ' D' ' 22' ' ' ALA . 0.9 OUTLIER 58.9 74.79 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.888 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 61' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 36.6 m -126.33 148.89 49.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.808 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 62' ' ' ASP . . . . . 0.412 ' OD2' HG23 ' D' ' 65' ' ' VAL . 1.5 t70 -121.61 169.78 10.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.317 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.32 -32.63 4.9 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -76.57 -27.89 56.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.197 0.522 . . . . 0.0 111.742 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 65' ' ' VAL . . . . . 0.412 HG23 ' OD2' ' D' ' 62' ' ' ASP . 25.6 t -73.57 -56.83 8.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.677 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.458 ' HB3' ' HB1' ' D' ' 20' ' ' ALA . . . -134.93 122.77 22.39 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.647 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.57 -50.02 5.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.921 0.391 . . . . 0.0 110.977 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -89.84 152.12 21.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.517 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 69' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' D' ' 122' ' ' THR . . . -144.22 137.86 27.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.586 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 70' ' ' ALA . . . . . 0.596 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -113.41 157.23 22.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.078 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 71' ' ' VAL . . . . . 0.739 HG11 HG21 ' D' ' 131' ' ' ILE . 1.8 t -138.7 150.0 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.638 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.8 155.11 37.54 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.624 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 73' ' ' PHE . . . . . 0.546 ' CB ' HD13 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -125.08 136.69 53.9 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.651 0.262 . . . . 0.0 111.012 179.764 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 74' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.9 OUTLIER -97.19 136.12 38.16 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.978 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 75' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' D' ' 113' ' ' LEU . . . -174.03 -172.96 39.76 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.744 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 76' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.2 OUTLIER -118.72 144.57 46.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.552 0.215 . . . . 0.0 110.801 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.632 ' HB2' HG23 ' D' ' 83' ' ' THR . . . -62.47 138.53 58.48 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.91 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 78' ' ' ILE . . . . . 0.507 HG23 ' N ' ' D' ' 79' ' ' ASP . 5.7 tt -71.52 -45.65 67.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.893 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.507 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.3 OUTLIER -133.15 42.55 3.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.771 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 80' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' D' ' 79' ' ' ASP . . . 70.16 -80.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.11 -29.7 68.89 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.529 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 82' ' ' HIS . . . . . 0.445 ' HB3' HG22 ' D' ' 78' ' ' ILE . 1.7 m80 -89.82 69.39 7.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.754 0.311 . . . . 0.0 110.436 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 83' ' ' THR . . . . . 0.632 HG23 ' HB2' ' D' ' 77' ' ' ALA . 0.2 OUTLIER -74.56 -16.15 60.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.6 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 84' ' ' ASN . . . . . 0.746 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 20.8 p-10 -66.24 -19.08 65.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.261 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' D' ' 138' ' ' PHE . 13.4 t -113.57 133.84 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.179 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.765 ' HG ' HD13 ' D' ' 113' ' ' LEU . 0.4 OUTLIER -67.87 161.47 26.27 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' D' ' 77' ' ' ALA . . . -103.59 -174.72 2.61 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.837 0.351 . . . . 0.0 111.79 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.709 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 0.3 OUTLIER -67.33 165.23 16.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.104 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 89' ' ' GLN . . . . . 0.529 ' CG ' ' HB2' ' D' ' 149' ' ' ASN . 3.6 mm100 -63.43 -79.76 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.323 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -165.46 3.78 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.051 0.453 . . . . 0.0 111.6 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 91' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' F' ' 25' ' ' ALA . 0.7 OUTLIER -80.09 79.72 6.6 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.06 -24.77 56.27 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.815 0.341 . . . . 0.0 111.606 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.13 33.89 5.27 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.731 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.75 0.43 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.935 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 95' ' ' SER . . . . . 0.709 ' HB3' ' HG ' ' D' ' 88' ' ' LEU . 38.7 m -96.7 177.94 5.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 110.679 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.52 -178.7 7.06 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.796 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 97' ' ' THR . . . . . 0.493 ' HB ' ' OG1' ' D' ' 144' ' ' THR . 2.0 m -134.41 119.08 18.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.354 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 98' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' D' ' 97' ' ' THR . 32.4 m-20 68.67 34.56 3.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.439 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 99' ' ' VAL . . . . . 0.746 HG13 HD23 ' D' ' 42' ' ' LEU . 0.4 OUTLIER -138.16 130.81 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.755 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.15 -170.62 18.95 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.539 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 101' ' ' VAL . . . . . 0.589 HG13 ' HB2' ' D' ' 86' ' ' LEU . 0.2 OUTLIER -119.66 114.49 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.036 0.534 . . . . 0.0 111.654 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 102' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 1.8 tt0 -87.36 150.22 23.98 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.887 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 103' ' ' ILE . . . . . 0.554 HG12 ' HG ' ' D' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 136.07 52.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.461 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.34 133.47 55.12 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.636 0.255 . . . . 0.0 111.053 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 105' ' ' ASP . . . . . 0.854 ' HB3' HG22 ' D' ' 107' ' ' THR . 6.1 t0 -82.21 149.77 27.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.725 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 106' ' ' ARG . . . . . 0.754 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.4 OUTLIER -67.89 -16.23 63.98 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.729 0.3 . . . . 0.0 111.046 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 107' ' ' THR . . . . . 0.854 HG22 ' HB3' ' D' ' 105' ' ' ASP . 8.8 t -63.65 -28.42 69.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.039 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.01 -40.41 1.59 Allowed Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.64 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 109' ' ' ALA . . . . . 0.411 ' H ' HG23 ' D' ' 107' ' ' THR . . . -91.46 163.06 14.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.777 0.322 . . . . 0.0 111.054 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.08 133.3 35.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.207 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 111' ' ' LEU . . . . . 0.567 HD21 ' O ' ' D' ' 117' ' ' THR . 4.8 tp -96.73 150.06 21.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.356 0.598 . . . . 0.0 110.516 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 112' ' ' THR . . . . . 0.863 HG23 HG21 ' D' ' 117' ' ' THR . 1.9 t -98.53 141.72 31.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.098 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 113' ' ' LEU . . . . . 0.765 HD13 ' HG ' ' D' ' 86' ' ' LEU . 1.6 mt -76.34 89.51 3.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.735 0.302 . . . . 0.0 110.765 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.15 -18.19 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.652 0.263 . . . . 0.0 111.497 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.82 -60.65 0.46 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.618 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 116' ' ' ALA . . . . . 0.461 ' HA ' ' CE2' ' D' ' 118' ' ' PHE . . . -96.43 26.94 4.04 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.948 0.404 . . . . 0.0 111.631 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 117' ' ' THR . . . . . 0.863 HG21 HG23 ' D' ' 112' ' ' THR . 0.0 OUTLIER -87.02 74.89 9.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.199 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.596 ' HB3' ' HB1' ' D' ' 70' ' ' ALA . 63.1 m-85 -94.94 92.86 7.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.834 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 25.5 m -136.27 68.9 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.81 150.23 28.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.616 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -107.3 67.71 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.135 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.611 ' O ' ' HB3' ' D' ' 69' ' ' ALA . 0.2 OUTLIER -79.23 114.67 18.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.735 -179.576 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -73.97 127.94 34.2 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.756 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 124' ' ' LEU . . . . . 0.576 HD21 ' O ' ' D' ' 20' ' ' ALA . 4.0 tp -92.01 132.14 36.77 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.649 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.09 151.14 49.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.6 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 126' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' D' ' 61' ' ' CYS . 3.1 t30 -69.1 112.08 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.613 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.55 -138.91 8.72 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.659 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 128' ' ' THR . . . . . 0.722 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 87.7 m -98.81 82.58 2.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.642 0.258 . . . . 0.0 110.729 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 129' ' ' ASN . . . . . 0.504 ' N ' ' HB2' ' A' ' 116' ' ' ALA . 2.3 t30 -71.88 148.16 46.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.937 0.398 . . . . 0.0 111.06 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 130' ' ' THR . . . . . 0.729 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.2 OUTLIER -138.57 148.64 44.41 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.161 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 131' ' ' ILE . . . . . 0.739 HG21 HG11 ' D' ' 71' ' ' VAL . 15.8 mt -110.09 112.28 57.7 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 132' ' ' PRO . . . . . 0.754 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.5 Cg_endo -81.77 136.97 9.76 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.677 1.585 . . . . 0.0 112.597 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.04 136.06 19.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.676 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -111.42 158.34 19.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.055 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.675 ' O ' HG22 ' D' ' 52' ' ' VAL . . . -154.18 111.29 3.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.935 0.397 . . . . 0.0 111.637 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 136' ' ' ARG . . . . . 0.48 ' HB3' ' CA ' ' D' ' 51' ' ' ALA . 19.8 ptt180 -108.85 174.21 5.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.346 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 137' ' ' TYR . . . . . 0.696 ' HB3' HD21 ' D' ' 42' ' ' LEU . 1.7 m-85 -81.53 137.68 35.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.03 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 138' ' ' PHE . . . . . 0.529 ' HB3' HG21 ' D' ' 85' ' ' VAL . 0.9 OUTLIER -131.55 124.11 29.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.136 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 139' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' D' ' 47' ' ' ALA . . . -108.42 130.28 55.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.855 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 140' ' ' THR . . . . . 0.499 ' O ' ' HG3' ' D' ' 45' ' ' GLU . 0.2 OUTLIER -77.49 -28.02 52.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.535 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.41 -96.47 0.11 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.879 -0.676 . . . . 0.0 113.057 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.03 98.49 8.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.551 0.215 . . . . 0.0 110.697 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 143' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -56.59 148.91 18.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.758 0.313 . . . . 0.0 111.404 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 144' ' ' THR . . . . . 0.716 ' CG2' ' CD ' ' D' ' 145' ' ' PRO . 91.6 m -125.38 156.93 69.45 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.288 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 145' ' ' PRO . . . . . 0.716 ' CD ' ' CG2' ' D' ' 144' ' ' THR . 1.5 Cg_endo -83.28 136.18 7.63 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.584 2.189 . . . . 0.0 111.989 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 146' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' C' ' 15' ' ' GLU . . . 163.58 -127.53 1.69 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.472 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 147' ' ' ALA . . . . . 0.649 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -110.98 132.88 53.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.842 0.354 . . . . 0.0 111.354 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 148' ' ' ALA . . . . . 0.77 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -124.25 43.74 2.92 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.148 0.499 . . . . 0.0 110.43 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 149' ' ' ASN . . . . . 0.529 ' HB2' ' CG ' ' D' ' 89' ' ' GLN . 13.9 m-80 -92.34 144.25 25.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.499 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 150' ' ' ALA . . . . . 0.699 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -160.6 178.93 9.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.975 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 151' ' ' ASP . . . . . 0.632 ' OD1' ' HA ' ' C' ' 11' ' ' HIS . 15.6 t70 -147.03 145.02 29.55 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.226 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 152' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -133.76 139.71 46.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.198 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 153' ' ' THR . . . . . 0.93 HG23 HG22 ' C' ' 9' ' ' THR . 0.2 OUTLIER -100.99 135.26 42.73 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 154' ' ' PHE . . . . . 0.541 ' HB3' ' H ' ' C' ' 8' ' ' GLY . 0.2 OUTLIER -81.56 152.16 27.37 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.054 0.454 . . . . 0.0 110.136 -179.123 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 155' ' ' LYS . . . . . 0.407 ' O ' HG13 ' D' ' 71' ' ' VAL . 15.2 mmtm -134.25 146.88 50.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.908 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 156' ' ' VAL . . . . . 0.629 HG23 HG23 ' C' ' 5' ' ' VAL . 33.1 m -139.09 140.78 37.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.786 0.326 . . . . 0.0 111.626 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 157' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' C' ' 3' ' ' THR . 0.9 OUTLIER -134.54 132.65 39.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.297 0.57 . . . . 0.0 110.425 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 158' ' ' TYR . . . . . 0.567 ' CE1' ' HB2' ' D' ' 21' ' ' CYS . 11.0 m-85 -107.25 128.05 54.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.514 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.849 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.249 0.071 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 2' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' F' ' 158' ' ' TYR . . . 52.85 88.26 0.03 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.994 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 3' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' F' ' 157' ' ' GLN . 5.5 m -122.92 116.29 23.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.385 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -99.69 117.17 33.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.521 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.626 HG23 HG23 ' F' ' 156' ' ' VAL . 1.8 m -144.42 157.99 15.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.618 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 6' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' F' ' 154' ' ' PHE . 13.2 t30 -78.62 123.81 27.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.58 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.83 -71.15 1.01 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.827 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 8' ' ' GLY . . . . . 0.543 ' H ' ' HB3' ' F' ' 154' ' ' PHE . . . -152.7 -146.96 4.48 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.816 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 9' ' ' THR . . . . . 0.951 HG22 HG23 ' F' ' 153' ' ' THR . 24.4 p -148.75 134.42 18.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.005 0.431 . . . . 0.0 111.268 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.33 124.38 72.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.169 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 11' ' ' HIS . . . . . 0.627 ' HA ' ' OD1' ' F' ' 151' ' ' ASP . 57.4 t-80 -91.56 116.2 28.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.306 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -96.78 105.47 17.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.753 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -104.58 118.69 37.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.512 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.27 172.89 30.79 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.924 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 15' ' ' GLU . . . . . 0.735 ' O ' ' HA ' ' F' ' 36' ' ' GLN . 25.8 tt0 -160.3 135.95 8.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.896 0.379 . . . . 0.0 110.384 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 16' ' ' VAL . . . . . 0.764 HG23 ' HB2' ' F' ' 148' ' ' ALA . 43.2 t -96.83 132.78 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.243 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 17' ' ' VAL . . . . . 0.565 HG11 ' OE1' ' F' ' 36' ' ' GLN . 18.2 m -133.91 -177.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.878 0.371 . . . . 0.0 111.007 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 18' ' ' ASN . . . . . 0.563 ' HA ' HG22 ' F' ' 39' ' ' THR . 0.3 OUTLIER -75.76 -170.28 1.28 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.894 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.73 45.35 0.98 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.078 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.562 ' O ' HD21 ' E' ' 124' ' ' LEU . . . -121.24 -24.9 5.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.424 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 21' ' ' CYS . . . . . 0.857 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER -168.8 140.69 2.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.888 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 22' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' E' ' 60' ' ' ASP . . . -132.86 116.95 17.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.066 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 23' ' ' VAL . . . . . 0.745 HG12 ' HB2' ' F' ' 36' ' ' GLN . 0.5 OUTLIER -67.03 146.26 13.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.101 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 24' ' ' ASP . . . . . 0.474 ' O ' HG23 ' E' ' 28' ' ' VAL . 12.9 t0 -80.37 152.08 29.08 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.547 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 25' ' ' ALA . . . . . 0.533 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -62.77 -40.06 96.12 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.419 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.93 2.72 85.83 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.891 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -106.23 -19.86 13.57 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.823 0.344 . . . . 0.0 110.825 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 28' ' ' VAL . . . . . 0.474 HG23 ' O ' ' E' ' 24' ' ' ASP . 39.7 t -47.4 -52.16 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.35 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.21 136.45 48.66 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.029 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.73 136.84 39.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.014 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.44 102.89 12.82 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.042 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.69 128.25 63.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.068 0.461 . . . . 0.0 110.547 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -114.64 123.02 48.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.693 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.45 -42.72 15.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.581 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.51 -167.45 13.18 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.587 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 36' ' ' GLN . . . . . 0.744 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 2.9 mt-30 -96.77 124.45 40.75 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.589 0.233 . . . . 0.0 110.927 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.77 147.52 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.848 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.68 134.93 34.34 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.698 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 39' ' ' THR . . . . . 0.565 HG22 ' HA ' ' D' ' 18' ' ' ASN . 0.0 OUTLIER -59.99 -44.48 94.49 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.815 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.25 -36.96 61.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.081 0.467 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.85 -35.83 62.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.165 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.739 HD23 HG13 ' E' ' 99' ' ' VAL . 3.0 mp -106.59 34.51 3.37 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.667 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.92 15.84 27.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.375 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.99 132.07 56.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.283 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 45' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' E' ' 140' ' ' THR . 6.8 tt0 -56.5 108.69 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.766 0.317 . . . . 0.0 111.124 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.96 25.97 10.05 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.09 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 47' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' E' ' 139' ' ' ALA . . . -71.49 137.75 48.43 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 7.4 p -137.0 122.71 19.86 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.898 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' E' ' 136' ' ' ARG . 54.2 m -100.02 -175.25 2.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.659 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 50' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 2.8 t -55.63 137.28 49.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.787 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 51' ' ' ALA . . . . . 0.478 ' CA ' ' HB3' ' E' ' 136' ' ' ARG . . . -92.28 133.56 35.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.344 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 52' ' ' VAL . . . . . 0.686 HG22 ' O ' ' E' ' 135' ' ' ALA . 26.2 m -76.78 162.48 4.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.52 141.17 16.78 Favored Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.538 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 54' ' ' PHE . . . . . 0.556 ' H ' HG21 ' B' ' 76' ' ' THR . 39.3 p90 -173.74 137.8 0.62 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.758 0.313 . . . . 0.0 110.941 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 55' ' ' ASN . . . . . 0.496 ' OD1' HD21 ' B' ' 74' ' ' LEU . 18.0 p30 -136.44 145.83 45.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.692 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 56' ' ' ILE . . . . . 0.528 HG23 ' O ' ' E' ' 56' ' ' ILE . 1.2 tp -91.04 116.8 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.617 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 57' ' ' GLN . . . . . 0.726 ' HA ' HG23 ' E' ' 130' ' ' THR . 1.3 mp0 -72.87 128.65 36.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.78 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 58' ' ' LEU . . . . . 0.458 ' HG ' ' HA ' ' E' ' 23' ' ' VAL . 0.3 OUTLIER -137.39 89.2 2.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.236 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 59' ' ' ASN . . . . . 0.694 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 9.8 p30 -74.9 176.51 7.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.985 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 60' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' E' ' 22' ' ' ALA . 0.9 OUTLIER 58.98 74.85 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.775 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 61' ' ' CYS . . . . . 0.857 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 36.8 m -126.37 148.87 49.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 62' ' ' ASP . . . . . 0.407 ' OD2' HG23 ' E' ' 65' ' ' VAL . 1.6 t70 -121.58 169.77 10.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.317 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.27 -32.69 4.89 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.55 -27.95 56.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.155 0.502 . . . . 0.0 111.685 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 65' ' ' VAL . . . . . 0.407 HG23 ' OD2' ' E' ' 62' ' ' ASP . 25.6 t -73.58 -56.76 8.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.702 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 66' ' ' ALA . . . . . 0.465 ' HB3' ' HB1' ' E' ' 20' ' ' ALA . . . -134.94 122.75 22.35 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.672 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.62 -50.02 5.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.927 0.394 . . . . 0.0 110.932 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 68' ' ' LYS . . . . . 0.4 ' HA ' ' NZ ' ' E' ' 68' ' ' LYS . 1.8 tptp -89.75 152.09 21.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.567 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 69' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' E' ' 122' ' ' THR . . . -144.25 137.9 27.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.521 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 70' ' ' ALA . . . . . 0.599 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -113.41 157.22 22.19 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.094 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 71' ' ' VAL . . . . . 0.757 HG11 HG21 ' E' ' 131' ' ' ILE . 1.8 t -138.75 150.06 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.649 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.87 155.03 37.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.57 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 73' ' ' PHE . . . . . 0.557 ' CB ' HD13 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -124.98 136.66 53.94 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.592 0.234 . . . . 0.0 111.071 179.764 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 74' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.9 OUTLIER -97.21 136.13 38.16 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.011 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 75' ' ' GLY . . . . . 0.449 ' CA ' ' HB3' ' E' ' 113' ' ' LEU . . . -174.01 -172.94 39.72 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.735 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 76' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.2 OUTLIER -118.71 144.53 46.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.497 0.189 . . . . 0.0 110.826 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 77' ' ' ALA . . . . . 0.652 ' HB2' HG23 ' E' ' 83' ' ' THR . . . -62.42 138.51 58.47 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.963 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 78' ' ' ILE . . . . . 0.51 HG23 ' N ' ' E' ' 79' ' ' ASP . 5.7 tt -71.6 -45.59 66.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.843 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 79' ' ' ASP . . . . . 0.51 ' N ' HG23 ' E' ' 78' ' ' ILE . 0.3 OUTLIER -133.11 42.49 3.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.833 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 80' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' E' ' 79' ' ' ASP . . . 70.09 -80.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.002 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.15 -29.64 68.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.584 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 82' ' ' HIS . . . . . 0.425 ' HB3' HG22 ' E' ' 78' ' ' ILE . 1.7 m80 -89.9 69.45 7.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.874 0.369 . . . . 0.0 110.414 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 83' ' ' THR . . . . . 0.652 HG23 ' HB2' ' E' ' 77' ' ' ALA . 0.2 OUTLIER -74.55 -16.16 60.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.585 -179.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 84' ' ' ASN . . . . . 0.729 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 20.7 p-10 -66.2 -19.09 65.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.292 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' E' ' 138' ' ' PHE . 13.4 t -113.56 133.81 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.188 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 86' ' ' LEU . . . . . 0.775 ' HG ' HD13 ' E' ' 113' ' ' LEU . 0.4 OUTLIER -67.81 161.6 25.85 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 87' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' E' ' 77' ' ' ALA . . . -103.63 -174.75 2.62 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.936 0.398 . . . . 0.0 111.727 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.704 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 0.3 OUTLIER -67.37 165.18 16.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.082 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 89' ' ' GLN . . . . . 0.515 ' CG ' ' HB2' ' E' ' 149' ' ' ASN . 3.6 mm100 -63.41 -79.7 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.376 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -165.49 3.7 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.019 0.437 . . . . 0.0 111.538 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.04 79.77 6.54 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.923 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.14 -24.69 55.98 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.853 0.359 . . . . 0.0 111.573 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.22 34.0 5.23 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.689 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.88 0.47 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.952 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 95' ' ' SER . . . . . 0.704 ' HB3' ' HG ' ' E' ' 88' ' ' LEU . 38.4 m -96.84 177.94 5.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.915 0.388 . . . . 0.0 110.598 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.46 -178.72 7.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.797 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 97' ' ' THR . . . . . 0.497 ' HB ' ' OG1' ' E' ' 144' ' ' THR . 2.0 m -134.44 119.06 18.09 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.373 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 98' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' E' ' 97' ' ' THR . 32.8 m-20 68.76 34.4 3.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.471 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 99' ' ' VAL . . . . . 0.739 HG13 HD23 ' E' ' 42' ' ' LEU . 0.4 OUTLIER -138.06 130.85 40.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.796 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.08 -170.57 18.85 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.538 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 101' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' E' ' 86' ' ' LEU . 0.2 OUTLIER -119.7 114.47 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.028 0.531 . . . . 0.0 111.749 -179.713 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 102' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 1.8 tt0 -87.37 150.24 23.95 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.877 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 103' ' ' ILE . . . . . 0.557 HD13 ' CB ' ' E' ' 73' ' ' PHE . 0.8 OUTLIER -115.0 136.01 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.417 179.496 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.31 133.52 55.08 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.7 0.286 . . . . 0.0 111.073 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 105' ' ' ASP . . . . . 0.866 ' HB3' HG22 ' E' ' 107' ' ' THR . 6.1 t0 -82.27 149.76 27.65 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.655 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 106' ' ' ARG . . . . . 0.735 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.4 OUTLIER -67.88 -16.2 63.97 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.762 0.315 . . . . 0.0 111.065 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 107' ' ' THR . . . . . 0.866 HG22 ' HB3' ' E' ' 105' ' ' ASP . 8.9 t -63.72 -28.35 69.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.003 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.0 -40.54 1.57 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.684 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 109' ' ' ALA . . . . . 0.42 ' H ' HG23 ' E' ' 107' ' ' THR . . . -91.42 163.04 14.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 0.0 111.039 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.09 133.36 35.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.229 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.571 HD21 ' O ' ' E' ' 117' ' ' THR . 4.8 tp -96.72 150.03 21.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.383 0.611 . . . . 0.0 110.5 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 112' ' ' THR . . . . . 0.866 HG23 HG21 ' E' ' 117' ' ' THR . 1.9 t -98.42 141.7 30.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.183 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 113' ' ' LEU . . . . . 0.775 HD13 ' HG ' ' E' ' 86' ' ' LEU . 1.6 mt -76.33 89.36 3.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.758 0.313 . . . . 0.0 110.758 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.0 -18.21 5.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.652 0.263 . . . . 0.0 111.52 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.78 -60.65 0.46 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.681 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 116' ' ' ALA . . . . . 0.463 ' HA ' ' CE2' ' E' ' 118' ' ' PHE . . . -96.48 27.04 4.01 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.028 0.442 . . . . 0.0 111.641 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 117' ' ' THR . . . . . 0.866 HG21 HG23 ' E' ' 112' ' ' THR . 0.0 OUTLIER -87.11 74.86 9.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.13 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 118' ' ' PHE . . . . . 0.599 ' HB3' ' HB1' ' E' ' 70' ' ' ALA . 62.8 m-85 -94.87 92.89 7.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.823 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 25.7 m -136.32 68.85 1.43 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.829 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.84 150.31 28.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.579 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.39 67.73 0.7 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.083 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 122' ' ' THR . . . . . 0.613 ' O ' ' HB3' ' E' ' 69' ' ' ALA . 0.2 OUTLIER -79.19 114.74 18.37 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.704 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -74.02 127.98 34.31 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.676 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 124' ' ' LEU . . . . . 0.562 HD21 ' O ' ' E' ' 20' ' ' ALA . 4.0 tp -92.04 132.17 36.76 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.651 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.13 151.1 49.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.608 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 126' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' E' ' 61' ' ' CYS . 3.1 t30 -69.1 112.08 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.668 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 127' ' ' GLY . . . . . 0.488 ' CA ' HG21 ' A' ' 4' ' ' THR . . . 142.56 -138.85 8.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.724 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 128' ' ' THR . . . . . 0.694 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 87.4 m -98.85 82.49 2.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.676 0.274 . . . . 0.0 110.84 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 129' ' ' ASN . . . . . 0.501 ' N ' ' HB2' ' B' ' 116' ' ' ALA . 2.3 t30 -71.82 148.18 46.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.938 0.399 . . . . 0.0 111.07 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 130' ' ' THR . . . . . 0.726 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.2 OUTLIER -138.63 148.6 44.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.138 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 131' ' ' ILE . . . . . 0.757 HG21 HG11 ' E' ' 71' ' ' VAL . 15.6 mt -109.96 112.2 58.04 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 132' ' ' PRO . . . . . 0.735 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.5 Cg_endo -81.77 137.01 9.78 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.671 1.581 . . . . 0.0 112.585 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.06 135.98 19.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.782 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -111.44 158.36 19.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.076 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 135' ' ' ALA . . . . . 0.686 ' O ' HG22 ' E' ' 52' ' ' VAL . . . -154.16 111.36 3.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.979 0.419 . . . . 0.0 111.616 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 136' ' ' ARG . . . . . 0.478 ' HB3' ' CA ' ' E' ' 51' ' ' ALA . 19.8 ptt180 -108.91 174.1 6.02 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.375 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 137' ' ' TYR . . . . . 0.701 ' HB3' HD21 ' E' ' 42' ' ' LEU . 1.7 m-85 -81.41 137.68 35.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.067 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 138' ' ' PHE . . . . . 0.514 ' HB3' HG21 ' E' ' 85' ' ' VAL . 0.9 OUTLIER -131.52 124.14 29.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.14 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 139' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' E' ' 47' ' ' ALA . . . -108.49 130.23 55.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.815 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 140' ' ' THR . . . . . 0.5 ' O ' ' HG3' ' E' ' 45' ' ' GLU . 0.2 OUTLIER -77.47 -27.96 52.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.537 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.46 -96.46 0.11 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.971 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.02 98.46 8.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.606 0.203 . . . . 0.0 110.623 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 143' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -56.59 148.86 18.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 111.373 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 144' ' ' THR . . . . . 0.728 ' CG2' ' CD ' ' E' ' 145' ' ' PRO . 93.2 m -125.35 156.93 69.4 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.316 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 145' ' ' PRO . . . . . 0.728 ' CD ' ' CG2' ' E' ' 144' ' ' THR . 1.4 Cg_endo -83.34 136.27 7.61 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.507 2.138 . . . . 0.0 111.993 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 146' ' ' GLY . . . . . 0.58 ' O ' ' HG3' ' D' ' 15' ' ' GLU . . . 163.56 -127.57 1.7 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.434 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 147' ' ' ALA . . . . . 0.645 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -110.94 132.94 53.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.921 0.391 . . . . 0.0 111.291 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 148' ' ' ALA . . . . . 0.777 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -124.29 43.71 2.93 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.421 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 149' ' ' ASN . . . . . 0.515 ' HB2' ' CG ' ' E' ' 89' ' ' GLN . 13.8 m-80 -92.32 144.25 25.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.535 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 150' ' ' ALA . . . . . 0.683 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -160.58 178.94 9.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.939 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 151' ' ' ASP . . . . . 0.619 ' OD1' ' HA ' ' D' ' 11' ' ' HIS . 15.7 t70 -147.05 145.01 29.52 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.201 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 152' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -133.76 139.8 46.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.196 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 153' ' ' THR . . . . . 0.932 HG23 HG22 ' D' ' 9' ' ' THR . 0.2 OUTLIER -101.14 135.25 42.91 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.144 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 154' ' ' PHE . . . . . 0.522 ' HB3' ' H ' ' D' ' 8' ' ' GLY . 0.2 OUTLIER -81.51 152.1 27.47 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.094 0.473 . . . . 0.0 110.148 -179.086 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 155' ' ' LYS . . . . . 0.407 ' O ' HG13 ' E' ' 71' ' ' VAL . 15.2 mmtm -134.2 146.84 50.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.947 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 156' ' ' VAL . . . . . 0.629 HG23 HG23 ' D' ' 5' ' ' VAL . 33.1 m -139.11 140.8 37.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.765 0.317 . . . . 0.0 111.64 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 157' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' D' ' 3' ' ' THR . 0.1 OUTLIER -134.55 132.63 39.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.291 0.567 . . . . 0.0 110.434 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 158' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' E' ' 21' ' ' CYS . 11.0 m-85 -107.23 128.05 54.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.58 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.839 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.26 0.076 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.67 88.39 0.03 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.051 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 5.5 m -122.95 116.28 23.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.358 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -99.69 117.29 33.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.51 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -144.49 158.03 14.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.596 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -78.73 123.71 27.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.586 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.67 -71.21 1.0 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.855 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.68 -146.93 4.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.825 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 24.5 p -148.77 134.4 18.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.998 0.428 . . . . 0.0 111.278 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.36 124.37 72.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.185 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -91.55 116.27 28.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.282 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -96.92 105.54 17.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.726 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -104.65 118.74 37.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.437 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.29 172.88 30.8 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.975 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -160.32 135.98 8.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.961 0.41 . . . . 0.0 110.405 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 43.4 t -96.86 132.79 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.281 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 17' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.89 -177.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.802 0.334 . . . . 0.0 111.019 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -75.72 -170.31 1.27 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.017 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.76 45.43 0.98 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.065 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 20' ' ' ALA . . . . . 0.571 ' O ' HD21 ' F' ' 124' ' ' LEU . . . -121.29 -24.84 5.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.401 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 21' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER -168.86 140.7 2.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.816 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 22' ' ' ALA . . . . . 0.493 ' HB3' ' HB2' ' F' ' 60' ' ' ASP . . . -132.9 116.91 17.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.05 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 23' ' ' VAL . . . . . 0.453 ' HA ' ' HG ' ' F' ' 58' ' ' LEU . 0.5 OUTLIER -67.06 146.24 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.108 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 24' ' ' ASP . . . . . 0.472 ' O ' HG23 ' F' ' 28' ' ' VAL . 12.9 t0 -80.45 152.06 28.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.542 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 25' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -62.71 -40.05 95.94 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.445 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.87 2.64 85.87 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.872 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 23.0 t -106.19 -19.95 13.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.849 0.357 . . . . 0.0 110.867 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 28' ' ' VAL . . . . . 0.472 HG23 ' O ' ' F' ' 24' ' ' ASP . 39.9 t -47.31 -52.2 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.354 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.15 136.42 48.67 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.045 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.69 136.86 39.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.004 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.56 102.85 12.74 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.07 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.64 128.27 62.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.052 0.453 . . . . 0.0 110.51 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -114.75 123.09 48.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.677 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.47 -42.68 15.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.604 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.42 -167.44 13.21 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.604 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 36' ' ' GLN . . . . . 0.745 ' HB2' HG12 ' E' ' 23' ' ' VAL . 2.9 mt-30 -96.77 124.41 40.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.615 0.245 . . . . 0.0 110.885 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.72 147.54 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.895 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.64 134.94 34.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.682 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 39' ' ' THR . . . . . 0.563 HG22 ' HA ' ' E' ' 18' ' ' ASN . 0.0 OUTLIER -60.06 -44.45 94.71 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.797 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.23 -36.94 61.58 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.101 0.477 . . . . 0.0 110.91 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.79 -35.91 62.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.185 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 42' ' ' LEU . . . . . 0.755 HD23 HG13 ' F' ' 99' ' ' VAL . 2.9 mp -106.63 34.53 3.36 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.602 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.87 15.8 27.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.307 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.94 132.05 56.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.337 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 45' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' F' ' 140' ' ' THR . 6.8 tt0 -56.53 108.74 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 111.172 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.93 25.93 10.11 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.16 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' F' ' 139' ' ' ALA . . . -71.5 137.73 48.39 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 7.3 p -136.96 122.76 19.97 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.881 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 49' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' F' ' 136' ' ' ARG . 53.4 m -100.05 -175.23 2.89 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.61 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 50' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' C' ' 92' ' ' ALA . 2.8 t -55.62 137.3 49.38 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.819 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 51' ' ' ALA . . . . . 0.482 ' CA ' ' HB3' ' F' ' 136' ' ' ARG . . . -92.35 133.45 35.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.331 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 52' ' ' VAL . . . . . 0.676 HG22 ' O ' ' F' ' 135' ' ' ALA . 26.2 m -76.68 162.51 4.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.54 141.17 16.77 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.605 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 54' ' ' PHE . . . . . 0.573 ' H ' HG21 ' C' ' 76' ' ' THR . 39.3 p90 -173.76 137.81 0.62 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.796 0.331 . . . . 0.0 110.985 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 55' ' ' ASN . . . . . 0.501 ' OD1' HD21 ' C' ' 74' ' ' LEU . 17.9 p30 -136.56 145.88 45.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.604 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 56' ' ' ILE . . . . . 0.529 HG23 ' O ' ' F' ' 56' ' ' ILE . 1.2 tp -91.1 116.79 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.643 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 57' ' ' GLN . . . . . 0.704 ' HA ' HG23 ' F' ' 130' ' ' THR . 1.3 mp0 -72.86 128.55 35.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.812 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 58' ' ' LEU . . . . . 0.453 ' HG ' ' HA ' ' F' ' 23' ' ' VAL . 0.3 OUTLIER -137.34 89.14 2.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.275 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 59' ' ' ASN . . . . . 0.727 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 9.8 p30 -74.75 176.46 7.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.956 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 60' ' ' ASP . . . . . 0.493 ' HB2' ' HB3' ' F' ' 22' ' ' ALA . 0.8 OUTLIER 58.98 74.77 0.43 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.834 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 61' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 36.8 m -126.34 148.91 49.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.8 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 62' ' ' ASP . . . . . 0.404 ' OD2' HG23 ' F' ' 65' ' ' VAL . 1.6 t70 -121.62 169.74 10.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.285 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.32 -32.6 4.91 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.58 -27.92 56.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.266 0.555 . . . . 0.0 111.752 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 65' ' ' VAL . . . . . 0.404 HG23 ' OD2' ' F' ' 62' ' ' ASP . 25.3 t -73.54 -56.81 8.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.715 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 66' ' ' ALA . . . . . 0.465 ' HB3' ' HB1' ' F' ' 20' ' ' ALA . . . -134.93 122.77 22.39 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.693 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.55 -50.11 5.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.932 0.396 . . . . 0.0 110.931 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 68' ' ' LYS . . . . . 0.401 ' NZ ' ' HA ' ' F' ' 68' ' ' LYS . 1.8 tptp -89.76 152.12 21.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.556 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 69' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' F' ' 122' ' ' THR . . . -144.25 137.8 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.559 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 70' ' ' ALA . . . . . 0.6 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -113.38 157.26 22.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.087 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 71' ' ' VAL . . . . . 0.74 HG11 HG21 ' F' ' 131' ' ' ILE . 1.8 t -138.75 150.06 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.638 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.87 155.05 37.35 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.593 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 73' ' ' PHE . . . . . 0.552 ' CB ' HD13 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -125.02 136.62 53.88 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.549 0.214 . . . . 0.0 111.056 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 74' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.9 OUTLIER -97.17 136.11 38.16 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.019 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 75' ' ' GLY . . . . . 0.454 ' CA ' ' HB3' ' F' ' 113' ' ' LEU . . . -174.0 -172.94 39.72 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.761 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 76' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.2 OUTLIER -118.73 144.53 46.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.553 0.216 . . . . 0.0 110.785 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 77' ' ' ALA . . . . . 0.634 ' HB2' HG23 ' F' ' 83' ' ' THR . . . -62.46 138.59 58.49 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.94 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 78' ' ' ILE . . . . . 0.496 HG23 ' N ' ' F' ' 79' ' ' ASP . 5.7 tt -71.66 -45.56 66.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.85 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 79' ' ' ASP . . . . . 0.496 ' N ' HG23 ' F' ' 78' ' ' ILE . 0.3 OUTLIER -133.11 42.45 3.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.793 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 80' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' F' ' 79' ' ' ASP . . . 70.16 -80.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.06 -29.68 68.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.64 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 82' ' ' HIS . . . . . 0.427 ' HB3' HG22 ' F' ' 78' ' ' ILE . 1.7 m80 -89.87 69.38 7.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.813 0.34 . . . . 0.0 110.426 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 83' ' ' THR . . . . . 0.634 HG23 ' HB2' ' F' ' 77' ' ' ALA . 0.2 OUTLIER -74.53 -16.12 60.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.631 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 84' ' ' ASN . . . . . 0.745 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 20.7 p-10 -66.25 -19.05 65.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.285 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 85' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' F' ' 138' ' ' PHE . 13.4 t -113.6 133.8 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.202 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 86' ' ' LEU . . . . . 0.773 ' HG ' HD13 ' F' ' 113' ' ' LEU . 0.4 OUTLIER -67.73 161.54 25.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 87' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' F' ' 77' ' ' ALA . . . -103.66 -174.71 2.61 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.84 0.352 . . . . 0.0 111.756 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 88' ' ' LEU . . . . . 0.7 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 0.3 OUTLIER -67.36 165.22 16.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.069 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 89' ' ' GLN . . . . . 0.523 ' CG ' ' HB2' ' F' ' 149' ' ' ASN . 3.6 mm100 -63.54 -79.67 0.03 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.302 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -165.48 3.73 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.003 0.43 . . . . 0.0 111.487 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.08 79.75 6.59 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.17 -24.63 55.69 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.849 0.357 . . . . 0.0 111.608 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.2 33.99 5.24 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.653 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.85 0.44 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.958 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 95' ' ' SER . . . . . 0.7 ' HB3' ' HG ' ' F' ' 88' ' ' LEU . 38.4 m -96.73 177.95 5.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.86 0.362 . . . . 0.0 110.612 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.46 -178.65 7.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 97' ' ' THR . . . . . 0.497 ' HB ' ' OG1' ' F' ' 144' ' ' THR . 2.0 m -134.55 119.04 17.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.341 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 98' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' F' ' 97' ' ' THR . 32.6 m-20 68.75 34.48 3.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.433 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 99' ' ' VAL . . . . . 0.755 HG13 HD23 ' F' ' 42' ' ' LEU . 0.4 OUTLIER -138.08 130.88 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.765 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.21 -170.6 18.97 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.537 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 101' ' ' VAL . . . . . 0.574 HG13 ' HB2' ' F' ' 86' ' ' LEU . 0.2 OUTLIER -119.64 114.44 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.008 0.523 . . . . 0.0 111.737 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 102' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 1.8 tt0 -87.35 150.24 23.97 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 103' ' ' ILE . . . . . 0.565 HG12 ' HG ' ' F' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 136.01 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.474 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.39 133.56 55.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.705 0.288 . . . . 0.0 111.028 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 105' ' ' ASP . . . . . 0.837 ' HB3' HG22 ' F' ' 107' ' ' THR . 6.1 t0 -82.23 149.72 27.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.749 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 106' ' ' ARG . . . . . 0.753 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.4 OUTLIER -67.87 -16.24 64.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.798 0.332 . . . . 0.0 111.098 179.558 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 107' ' ' THR . . . . . 0.837 HG22 ' HB3' ' F' ' 105' ' ' ASP . 8.8 t -63.59 -28.46 69.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.979 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.04 -40.55 1.57 Allowed Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.616 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 109' ' ' ALA . . . . . 0.416 ' H ' HG23 ' F' ' 107' ' ' THR . . . -91.43 163.04 14.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.811 0.339 . . . . 0.0 111.038 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.18 133.4 35.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 111' ' ' LEU . . . . . 0.571 HD21 ' O ' ' F' ' 117' ' ' THR . 4.8 tp -96.66 149.94 21.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.386 0.612 . . . . 0.0 110.558 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 112' ' ' THR . . . . . 0.842 HG23 HG21 ' F' ' 117' ' ' THR . 1.9 t -98.48 141.7 31.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.085 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 113' ' ' LEU . . . . . 0.773 HD13 ' HG ' ' F' ' 86' ' ' LEU . 1.6 mt -76.33 89.47 3.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.744 0.307 . . . . 0.0 110.761 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.09 -18.22 5.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.67 0.271 . . . . 0.0 111.52 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.86 -60.68 0.45 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.529 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 116' ' ' ALA . . . . . 0.463 ' HA ' ' CE2' ' F' ' 118' ' ' PHE . . . -96.44 26.97 4.03 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.041 0.448 . . . . 0.0 111.683 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 117' ' ' THR . . . . . 0.842 HG21 HG23 ' F' ' 112' ' ' THR . 0.0 OUTLIER -87.01 74.85 9.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.155 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 118' ' ' PHE . . . . . 0.6 ' HB3' ' HB1' ' F' ' 70' ' ' ALA . 63.3 m-85 -94.97 92.96 7.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.768 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 25.6 m -136.35 68.9 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.796 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.81 150.29 28.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.629 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.34 67.6 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.136 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 122' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' F' ' 69' ' ' ALA . 0.2 OUTLIER -79.15 114.66 18.27 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.69 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 12.1 m -73.95 127.97 34.29 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.742 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 124' ' ' LEU . . . . . 0.571 HD21 ' O ' ' F' ' 20' ' ' ALA . 4.0 tp -92.11 132.21 36.77 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.602 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.1 151.07 49.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.63 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 126' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' F' ' 61' ' ' CYS . 3.1 t30 -69.1 112.05 5.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 110.646 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 127' ' ' GLY . . . . . 0.492 ' CA ' HG21 ' B' ' 4' ' ' THR . . . 142.51 -138.9 8.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.687 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 128' ' ' THR . . . . . 0.727 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 87.7 m -98.76 82.59 2.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.664 0.269 . . . . 0.0 110.792 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 129' ' ' ASN . . . . . 0.495 ' N ' ' HB2' ' C' ' 116' ' ' ALA . 2.3 t30 -71.85 148.19 46.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.893 0.377 . . . . 0.0 111.094 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 130' ' ' THR . . . . . 0.704 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.2 OUTLIER -138.63 148.66 44.34 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.154 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 131' ' ' ILE . . . . . 0.74 HG21 HG11 ' F' ' 71' ' ' VAL . 15.6 mt -110.05 112.17 57.86 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 132' ' ' PRO . . . . . 0.753 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.6 Cg_endo -81.78 136.98 9.75 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.612 1.541 . . . . 0.0 112.587 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.0 136.1 19.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.773 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -111.42 158.45 19.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.037 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 135' ' ' ALA . . . . . 0.676 ' O ' HG22 ' F' ' 52' ' ' VAL . . . -154.2 111.35 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.924 0.392 . . . . 0.0 111.674 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 136' ' ' ARG . . . . . 0.482 ' HB3' ' CA ' ' F' ' 51' ' ' ALA . 19.8 ptt180 -108.86 174.0 6.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.382 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 137' ' ' TYR . . . . . 0.705 ' HB3' HD21 ' F' ' 42' ' ' LEU . 1.7 m-85 -81.37 137.62 35.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.122 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 138' ' ' PHE . . . . . 0.517 ' HB3' HG21 ' F' ' 85' ' ' VAL . 0.9 OUTLIER -131.51 124.16 29.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.096 -179.241 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 139' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' F' ' 47' ' ' ALA . . . -108.52 130.15 55.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.868 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 140' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' F' ' 45' ' ' GLU . 0.2 OUTLIER -77.37 -28.01 52.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.557 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.46 -96.41 0.11 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.005 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.01 98.51 8.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.583 0.23 . . . . 0.0 110.648 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 143' ' ' ALA . . . . . 0.567 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -56.66 148.92 18.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.674 0.274 . . . . 0.0 111.377 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 144' ' ' THR . . . . . 0.728 ' CG2' ' CD ' ' F' ' 145' ' ' PRO . 90.3 m -125.48 157.0 69.61 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.213 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 145' ' ' PRO . . . . . 0.728 ' CD ' ' CG2' ' F' ' 144' ' ' THR . 1.4 Cg_endo -83.36 136.22 7.56 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.552 2.168 . . . . 0.0 111.978 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 146' ' ' GLY . . . . . 0.585 ' O ' ' HG3' ' E' ' 15' ' ' GLU . . . 163.61 -127.56 1.69 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.457 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 147' ' ' ALA . . . . . 0.656 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -110.85 132.92 53.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.864 0.364 . . . . 0.0 111.414 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 148' ' ' ALA . . . . . 0.764 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -124.25 43.65 2.94 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.126 0.489 . . . . 0.0 110.459 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 149' ' ' ASN . . . . . 0.523 ' HB2' ' CG ' ' F' ' 89' ' ' GLN . 13.9 m-80 -92.34 144.28 25.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.54 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 150' ' ' ALA . . . . . 0.684 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -160.6 178.9 9.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.995 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 151' ' ' ASP . . . . . 0.627 ' OD1' ' HA ' ' E' ' 11' ' ' HIS . 15.7 t70 -147.02 144.97 29.54 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.215 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 152' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -133.73 139.76 46.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.114 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 153' ' ' THR . . . . . 0.951 HG23 HG22 ' E' ' 9' ' ' THR . 0.2 OUTLIER -101.07 135.26 42.81 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.078 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 154' ' ' PHE . . . . . 0.543 ' HB3' ' H ' ' E' ' 8' ' ' GLY . 0.2 OUTLIER -81.58 152.13 27.36 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.013 0.435 . . . . 0.0 110.152 -179.052 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 155' ' ' LYS . . . . . 0.413 ' O ' HG13 ' F' ' 71' ' ' VAL . 15.2 mmtm -134.22 146.86 50.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.897 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 156' ' ' VAL . . . . . 0.626 HG23 HG23 ' E' ' 5' ' ' VAL . 33.0 m -139.14 140.76 37.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.853 0.359 . . . . 0.0 111.632 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 157' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' E' ' 3' ' ' THR . 0.1 OUTLIER -134.5 132.74 39.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.266 0.555 . . . . 0.0 110.42 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 158' ' ' TYR . . . . . 0.567 ' CE1' ' HB2' ' F' ' 21' ' ' CYS . 10.9 m-85 -107.31 128.1 54.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.493 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.886 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 120.168 0.032 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.65 77.1 0.19 Allowed 'General case' 0 N--CA 1.462 0.17 0 O-C-N 123.132 0.27 . . . . 0.0 110.976 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.8 m -117.36 119.27 34.6 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.397 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.683 HG23 ' HG3' ' B' ' 157' ' ' GLN . 4.0 m -98.41 127.22 44.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.515 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.921 HG21 HG12 ' B' ' 17' ' ' VAL . 1.6 m -146.14 171.02 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.6 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.04 114.69 23.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.601 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' B' ' 155' ' ' LYS . . . -69.65 -57.77 6.98 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.791 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 9' ' ' THR . . . -163.52 -144.6 4.08 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.9 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 1.04 HG22 HG23 ' B' ' 153' ' ' THR . 17.1 p -155.69 140.51 17.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.818 0.342 . . . . 0.0 111.4 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.561 HG13 HG23 ' B' ' 32' ' ' VAL . 29.9 t -130.38 117.55 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.26 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -91.55 117.05 29.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.336 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -89.96 107.12 18.92 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.8 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.76 113.28 26.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.45 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.44 ' HA3' ' OH ' ' B' ' 137' ' ' TYR . . . -144.43 166.99 27.12 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.889 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.675 ' CG ' ' O ' ' B' ' 146' ' ' GLY . 30.2 tt0 -155.66 135.23 12.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.053 0.454 . . . . 0.0 110.286 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.698 HG23 ' HB2' ' B' ' 148' ' ' ALA . 66.4 t -96.59 138.38 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.293 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.85 -173.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.832 0.349 . . . . 0.0 110.977 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.15 173.46 12.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.034 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' B' ' 38' ' ' ARG . . . -85.86 39.83 0.82 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.042 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.639 ' HB1' ' CD2' ' A' ' 124' ' ' LEU . . . -114.36 -33.57 5.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.349 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.739 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.9 OUTLIER -161.16 149.97 16.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.953 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.64 112.08 4.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.07 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.669 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 3.1 p -59.9 153.42 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.065 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.76 152.76 28.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.674 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.52 80.83 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.349 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.81 15.75 61.93 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.939 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -113.06 -21.32 11.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.909 0.385 . . . . 0.0 110.815 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -44.61 -64.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.364 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.28 135.61 38.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.925 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.02 128.73 19.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.79 111.8 23.83 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.012 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.2 t -110.82 114.77 48.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.141 0.496 . . . . 0.0 110.494 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.68 124.51 46.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.649 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.49 -45.73 14.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.619 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.37 -161.91 12.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.534 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -99.77 129.7 45.91 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.649 0.261 . . . . 0.0 110.828 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p -110.05 147.47 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.948 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.42 ' HB2' ' HB2' ' A' ' 41' ' ' SER . 0.7 OUTLIER -86.76 131.24 34.19 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.94 0.4 . . . . 0.0 111.766 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.708 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 4.8 t -54.1 -45.1 71.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.757 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.443 ' N ' HG23 ' A' ' 39' ' ' THR . . . -61.01 -39.31 89.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.069 0.461 . . . . 0.0 110.875 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 38' ' ' ARG . 0.4 OUTLIER -70.55 -23.19 62.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.19 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.675 HD23 ' HB2' ' A' ' 139' ' ' ALA . 1.4 mp -124.63 51.62 1.6 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.586 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.59 29.95 7.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.418 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.84 128.36 48.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.41 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 140' ' ' THR . 29.4 tt0 -52.88 102.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 111.097 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.415 ' HA2' ' HE1' ' A' ' 138' ' ' PHE . . . 96.05 39.01 4.42 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.126 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -80.1 146.72 31.74 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.62 125.01 19.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.95 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 32.4 m -101.91 -166.35 1.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.644 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.01 133.02 55.7 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.845 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 136' ' ' ARG . . . -92.66 120.13 32.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.26 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 135' ' ' ALA . 18.3 m -65.71 162.59 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.946 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.85 124.11 5.27 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.592 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -155.9 146.56 21.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.684 0.278 . . . . 0.0 110.948 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.564 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.4 p30 -136.83 160.19 39.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.576 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 56' ' ' ILE . 1.6 tp -100.56 116.93 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.562 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.61 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -70.07 124.56 24.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.766 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.669 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 1.6 mp -133.72 87.44 2.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.23 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 4.9 p30 -73.61 174.54 8.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.949 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.82 79.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.818 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.739 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 93.6 m -127.59 159.37 34.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.61 ' OD2' HG23 ' A' ' 65' ' ' VAL . 5.6 t70 -130.23 167.12 18.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.238 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.656 HG23 ' HA ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -114.32 -41.7 3.44 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.154 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.51 -22.61 65.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.047 0.451 . . . . 0.0 111.735 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.61 HG23 ' OD2' ' A' ' 62' ' ' ASP . 81.3 t -70.43 -74.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.601 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 124' ' ' LEU . . . -120.75 131.36 54.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.571 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -48.58 6.13 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.863 0.363 . . . . 0.0 110.997 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.631 ' HE3' ' HB3' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -96.18 161.58 13.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.556 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.17 124.58 6.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.606 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.725 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -100.35 154.98 18.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.094 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.851 HG11 HG21 ' A' ' 131' ' ' ILE . 2.3 t -132.76 148.31 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.696 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.442 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -145.64 150.12 35.76 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.599 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.558 ' HB2' HD13 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -119.92 137.02 54.29 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.568 0.223 . . . . 0.0 111.022 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.627 HD21 HG21 ' D' ' 130' ' ' THR . 0.9 OUTLIER -96.0 139.46 32.16 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.966 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' A' ' 113' ' ' LEU . . . 178.5 179.84 48.48 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.733 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.546 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.3 OUTLIER -111.0 156.38 21.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.559 0.218 . . . . 0.0 110.807 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.674 ' O ' ' HB2' ' A' ' 87' ' ' ALA . . . -73.78 131.34 41.46 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.338 -0.392 . . . . 0.0 112.02 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.639 ' CG2' ' HB ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -67.79 -41.36 85.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.808 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -141.14 40.79 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.791 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.439 ' CB ' ' HA2' ' D' ' 108' ' ' GLY . . . 66.4 -80.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.83 -24.94 43.2 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.663 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.07 64.03 1.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.957 0.408 . . . . 0.0 110.45 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.548 HG23 ' HB2' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -68.5 -16.84 64.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.576 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.693 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 18.0 p-10 -70.46 -20.21 62.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.317 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.639 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 14.7 t -106.86 130.76 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.117 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.782 HD22 ' HB1' ' A' ' 150' ' ' ALA . 0.5 OUTLIER -67.61 148.22 51.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.387 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 77' ' ' ALA . . . -89.63 -167.52 1.88 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.842 0.353 . . . . 0.0 111.743 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.658 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 1.5 mm? -78.3 157.27 29.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.04 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.66 -78.37 0.02 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.354 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.583 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 0.4 OUTLIER -167.13 0.54 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.032 0.444 . . . . 0.0 111.425 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.53 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 1.7 m -71.89 83.02 0.92 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.568 ' HB3' ' HB3' ' D' ' 34' ' ' LEU . . . -66.75 -13.9 61.94 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.827 0.346 . . . . 0.0 111.643 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.71 27.61 5.21 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.609 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.74 15.76 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.903 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.658 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . 3.0 m -100.86 -172.78 2.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.833 0.349 . . . . 0.0 110.613 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.9 167.63 9.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.514 ' H ' ' HB ' ' A' ' 144' ' ' THR . 2.3 m -121.59 128.41 51.93 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.314 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.456 ' HB3' ' H ' ' A' ' 141' ' ' GLY . 75.8 m-20 64.22 34.57 10.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.371 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.489 HG13 HD23 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -139.96 136.44 38.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.704 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.12 -156.83 8.33 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.546 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' A' ' 86' ' ' LEU . 3.2 p -137.82 116.72 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 122.942 0.497 . . . . 0.0 111.605 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 1.1 tt0 -91.91 150.39 21.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.841 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.689 HD12 ' HB3' ' A' ' 111' ' ' LEU . 0.5 OUTLIER -113.86 131.3 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.531 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -106.2 130.15 54.12 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.646 0.26 . . . . 0.0 111.041 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.736 ' HB3' HG22 ' A' ' 107' ' ' THR . 5.1 t0 -76.08 156.99 33.39 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.661 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.741 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 3.5 ttp180 -71.29 -17.51 62.46 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.731 0.3 . . . . 0.0 111.03 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.736 HG22 ' HB3' ' A' ' 105' ' ' ASP . 6.2 t -67.29 -17.91 64.97 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.028 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.68 -45.61 1.17 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.78 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.1 163.11 23.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.737 0.303 . . . . 0.0 111.114 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -84.16 127.38 33.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.104 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.689 ' HB3' HD12 ' A' ' 103' ' ' ILE . 12.1 tp -86.28 156.07 20.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.306 0.574 . . . . 0.0 110.6 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.88 HG23 HG21 ' A' ' 117' ' ' THR . 0.5 OUTLIER -106.17 139.09 41.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.179 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.604 HD13 ' HG ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -73.89 76.4 1.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.691 0.281 . . . . 0.0 110.789 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.42 -17.17 14.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.625 0.25 . . . . 0.0 111.561 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.31 -51.77 1.24 Allowed Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.615 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.01 18.88 21.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.832 0.349 . . . . 0.0 111.544 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.88 HG21 HG23 ' A' ' 112' ' ' THR . 0.2 OUTLIER -85.81 84.68 7.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.725 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 95.7 m-85 -101.42 98.74 9.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.785 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.7 m -130.82 62.35 1.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.825 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.27 145.88 30.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.687 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.631 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . 3.5 mm-40 -121.43 71.32 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.177 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.73 134.78 34.73 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.715 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.2 m -83.83 113.69 21.11 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.683 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.639 ' CD2' ' HB1' ' A' ' 20' ' ' ALA . 18.9 tp -73.99 142.97 45.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.651 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.656 ' HA ' HG23 ' A' ' 63' ' ' THR . 0.9 OUTLIER -138.67 162.13 35.42 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.557 179.489 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.66 113.1 12.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.717 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.51 -139.95 9.53 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.752 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 6.7 m -101.64 96.76 7.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.726 0.298 . . . . 0.0 110.804 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -83.58 148.58 27.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.92 0.391 . . . . 0.0 111.086 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.61 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -138.64 143.43 39.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.09 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.851 HG21 HG11 ' A' ' 71' ' ' VAL . 55.1 mt -104.63 112.39 65.33 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.741 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.6 Cg_endo -81.87 141.89 12.27 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.825 1.683 . . . . 0.0 112.522 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.58 141.09 22.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.847 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -104.46 152.64 22.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.079 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.644 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -153.54 100.99 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 111.567 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.547 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 17.4 ptt180 -107.15 177.27 4.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.385 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.498 ' HB3' HD21 ' A' ' 42' ' ' LEU . 4.7 m-85 -85.96 124.15 32.09 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.011 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.46 ' HB3' HG11 ' A' ' 85' ' ' VAL . 1.2 t80 -118.93 112.38 19.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.024 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.675 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -102.96 133.91 47.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.867 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -81.1 -28.82 35.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.531 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.456 ' H ' ' HB3' ' A' ' 98' ' ' ASN . . . -160.18 -111.04 0.28 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.961 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.87 110.56 21.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.607 0.203 . . . . 0.0 110.77 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.708 ' HB3' ' HA ' ' A' ' 39' ' ' THR . . . -65.63 134.21 52.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.763 0.316 . . . . 0.0 111.376 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.514 ' HB ' ' H ' ' A' ' 97' ' ' THR . 57.2 m -105.78 149.4 37.93 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.31 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.488 ' CD ' ' CG2' ' A' ' 144' ' ' THR . 1.4 Cg_endo -82.93 125.49 4.17 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.53 2.153 . . . . 0.0 112.057 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.8 -126.37 1.38 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.43 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -111.07 128.4 55.86 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.729 0.3 . . . . 0.0 111.348 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.44 52.18 1.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 110.441 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.82 151.98 20.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.564 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.782 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -158.32 169.54 24.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.942 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -131.03 128.65 40.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.212 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.496 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -122.22 144.09 49.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.229 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.34 145.32 31.83 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -96.89 134.72 39.86 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.009 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -124.26 148.13 47.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.902 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 131' ' ' ILE . 29.8 m -135.19 144.78 33.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 111.733 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.48 126.09 28.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.279 0.561 . . . . 0.0 110.389 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 21' ' ' CYS . 5.1 m-85 -106.0 128.75 54.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.498 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.567 ' HG3' ' C ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.877 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.246 0.07 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.63 77.07 0.19 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.037 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 10.7 m -117.33 119.23 34.49 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.439 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.677 HG23 ' HG3' ' C' ' 157' ' ' GLN . 4.0 m -98.32 127.17 44.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.548 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.88 HG21 HG12 ' C' ' 17' ' ' VAL . 1.6 m -146.12 171.08 4.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.58 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.14 114.72 23.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.548 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' C' ' 155' ' ' LYS . . . -69.84 -57.58 7.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.736 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.428 ' O ' HG23 ' B' ' 9' ' ' THR . . . -163.65 -144.63 4.09 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.989 -0.625 . . . . 0.0 111.854 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' THR . . . . . 1.041 HG22 HG23 ' C' ' 153' ' ' THR . 17.0 p -155.64 140.45 17.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.826 0.346 . . . . 0.0 111.364 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.552 HG13 HG23 ' C' ' 32' ' ' VAL . 29.2 t -130.35 117.53 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.241 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -91.51 116.97 29.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.409 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -89.88 107.08 18.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.916 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.81 113.28 26.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.435 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.436 ' HA3' ' OH ' ' C' ' 137' ' ' TYR . . . -144.42 167.01 27.11 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.898 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.689 ' CG ' ' O ' ' C' ' 146' ' ' GLY . 30.3 tt0 -155.64 135.21 12.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.926 0.393 . . . . 0.0 110.318 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' C' ' 148' ' ' ALA . 66.2 t -96.54 138.35 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.304 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.921 HG12 HG21 ' A' ' 5' ' ' VAL . 2.7 m -140.78 -173.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 111.056 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.12 173.48 12.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.074 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' C' ' 38' ' ' ARG . . . -85.82 39.71 0.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.639 ' HB1' ' CD2' ' B' ' 124' ' ' LEU . . . -114.28 -33.53 5.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.434 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.745 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.9 OUTLIER -161.13 150.03 16.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.965 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' C' ' 36' ' ' GLN . . . -149.68 112.02 4.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.079 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.675 ' HA ' ' HA ' ' B' ' 58' ' ' LEU . 3.1 p -59.94 153.37 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.029 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.73 152.8 28.18 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.628 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.42 81.03 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.296 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.84 15.68 62.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.03 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.94 -21.35 11.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.937 0.398 . . . . 0.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 89.3 t -44.65 -64.82 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.316 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.26 135.71 38.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.958 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.06 128.73 19.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.061 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.74 111.81 23.82 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.029 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.561 HG23 HG13 ' A' ' 10' ' ' VAL . 4.2 t -110.85 114.76 48.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.074 0.464 . . . . 0.0 110.489 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.78 124.42 46.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.681 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.4 -45.67 14.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.647 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.33 -161.88 12.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.572 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.615 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 1.1 mt-30 -99.87 129.68 45.99 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.619 0.247 . . . . 0.0 110.865 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.494 ' CG1' HG22 ' A' ' 16' ' ' VAL . 11.9 p -110.01 147.43 14.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.99 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.519 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -86.67 131.23 34.2 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.015 0.436 . . . . 0.0 111.786 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.698 ' HA ' ' HB3' ' B' ' 143' ' ' ALA . 4.8 t -54.18 -45.05 72.04 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.721 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.445 ' N ' HG23 ' B' ' 39' ' ' THR . . . -60.99 -39.36 89.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.146 0.498 . . . . 0.0 110.933 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' B' ' 38' ' ' ARG . 0.4 OUTLIER -70.52 -23.22 62.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.169 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.665 HD23 ' HB2' ' B' ' 139' ' ' ALA . 1.4 mp -124.55 51.63 1.59 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.639 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.6 29.92 7.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.356 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.85 128.41 48.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.348 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' B' ' 140' ' ' THR . 29.3 tt0 -52.95 103.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.815 0.34 . . . . 0.0 111.093 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.421 ' HA2' ' HE1' ' B' ' 138' ' ' PHE . . . 96.02 38.93 4.45 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.137 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' B' ' 139' ' ' ALA . . . -80.0 146.66 31.91 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.64 125.0 19.03 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.918 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 32.4 m -101.89 -166.28 1.28 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.604 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.99 133.02 55.7 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.871 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.553 ' HA ' ' HB3' ' B' ' 136' ' ' ARG . . . -92.67 120.21 32.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.264 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.641 HG22 ' O ' ' B' ' 135' ' ' ALA . 18.5 m -65.77 162.69 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.939 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.9 124.11 5.26 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.648 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -155.87 146.64 22.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.719 0.295 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.566 ' HB2' HG22 ' B' ' 130' ' ' THR . 3.3 p30 -136.91 160.25 39.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.515 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.564 HG23 ' O ' ' B' ' 56' ' ' ILE . 1.6 tp -100.71 117.0 45.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.516 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLN . . . . . 0.625 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -70.05 124.6 24.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.731 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.675 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 1.6 mp -133.82 87.5 2.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.184 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 4.9 p30 -73.63 174.57 8.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 57.72 79.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.811 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' CYS . . . . . 0.745 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 93.6 m -127.57 159.41 34.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.859 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ASP . . . . . 0.62 ' OD2' HG23 ' B' ' 65' ' ' VAL . 5.5 t70 -130.27 167.1 19.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.295 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.662 HG23 ' HA ' ' B' ' 125' ' ' ASN . 0.2 OUTLIER -114.31 -41.71 3.44 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.139 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.51 -22.63 65.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.086 0.469 . . . . 0.0 111.723 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.62 HG23 ' OD2' ' B' ' 62' ' ' ASP . 82.4 t -70.44 -74.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.608 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' B' ' 124' ' ' LEU . . . -120.67 131.3 54.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.665 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.22 -48.59 6.12 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.936 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' LYS . . . . . 0.633 ' HE3' ' HB3' ' B' ' 121' ' ' GLU . 0.1 OUTLIER -96.23 161.48 13.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.595 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.05 124.72 6.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.584 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.698 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -100.44 155.02 18.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.069 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.827 HG11 HG21 ' B' ' 131' ' ' ILE . 2.3 t -132.73 148.34 31.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.673 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.442 ' HA ' HD21 ' B' ' 111' ' ' LEU . . . -145.63 150.1 35.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.698 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.569 ' HB2' HD13 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -119.98 137.05 54.3 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.549 0.214 . . . . 0.0 111.055 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.624 HD21 HG21 ' E' ' 130' ' ' THR . 0.9 OUTLIER -96.06 139.52 32.12 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.892 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.423 ' CA ' ' HB3' ' B' ' 113' ' ' LEU . . . 178.45 179.82 48.44 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.807 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.3 OUTLIER -110.92 156.47 21.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.493 0.187 . . . . 0.0 110.848 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.676 ' O ' ' HB2' ' B' ' 87' ' ' ALA . . . -73.83 131.35 41.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.029 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.65 ' CG2' ' HB ' ' B' ' 85' ' ' VAL . 0.9 OUTLIER -67.74 -41.37 85.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.823 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.435 ' N ' HG23 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -141.15 40.65 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.81 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.435 ' HB3' ' HA2' ' E' ' 108' ' ' GLY . . . 66.49 -80.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.68 -24.99 42.19 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.725 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.06 64.03 1.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.451 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' THR . . . . . 0.556 HG23 ' HB2' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -68.43 -16.9 64.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.567 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ASN . . . . . 0.69 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 18.0 p-10 -70.44 -20.18 62.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.339 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.65 ' HB ' ' CG2' ' B' ' 78' ' ' ILE . 14.7 t -106.92 130.77 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.126 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.776 HD22 ' HB1' ' B' ' 150' ' ' ALA . 0.5 OUTLIER -67.68 148.19 51.67 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' B' ' 77' ' ' ALA . . . -89.6 -167.58 1.9 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.736 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.654 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 1.5 mm? -78.22 157.26 29.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -78.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.356 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' SER . . . . . 0.586 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 0.4 OUTLIER -167.08 0.51 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.972 0.415 . . . . 0.0 111.459 179.487 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 91' ' ' SER . . . . . 0.546 ' HA ' ' HB2' ' D' ' 25' ' ' ALA . 1.7 m -71.95 83.03 0.94 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.746 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' E' ' 34' ' ' LEU . . . -66.62 -13.98 61.83 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.921 0.391 . . . . 0.0 111.749 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.69 27.59 5.21 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.567 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.69 15.63 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.899 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' SER . . . . . 0.654 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . 3.0 m -100.88 -172.85 2.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.842 0.353 . . . . 0.0 110.604 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.88 167.6 9.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.849 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.522 ' H ' ' HB ' ' B' ' 144' ' ' THR . 2.3 m -121.51 128.38 52.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.341 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' ASN . . . . . 0.463 ' HB3' ' H ' ' B' ' 141' ' ' GLY . 75.9 m-20 64.24 34.5 10.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.415 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' VAL . . . . . 0.489 HG13 HD23 ' B' ' 42' ' ' LEU . 0.5 OUTLIER -139.92 136.46 38.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.744 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.08 -156.88 8.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.524 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' B' ' 86' ' ' LEU . 3.2 p -137.8 116.71 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 123.011 0.525 . . . . 0.0 111.665 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 1.2 tt0 -91.94 150.39 21.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.847 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.681 HD12 ' HB3' ' B' ' 111' ' ' LEU . 0.5 OUTLIER -113.81 131.31 66.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.505 179.487 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 104' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 0.3 OUTLIER -106.26 130.17 54.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.733 0.302 . . . . 0.0 111.025 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ASP . . . . . 0.713 ' HB3' HG22 ' B' ' 107' ' ' THR . 5.1 t0 -76.12 156.97 33.33 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.703 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' ARG . . . . . 0.708 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 3.4 ttp180 -71.2 -17.55 62.52 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 111.085 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.713 HG22 ' HB3' ' B' ' 105' ' ' ASP . 6.2 t -67.19 -18.02 65.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.071 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.73 -45.6 1.17 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.784 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.11 163.07 23.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.691 0.281 . . . . 0.0 111.172 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -84.13 127.4 33.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.681 ' HB3' HD12 ' B' ' 103' ' ' ILE . 12.1 tp -86.28 156.12 20.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.323 0.582 . . . . 0.0 110.595 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.892 HG23 HG21 ' B' ' 117' ' ' THR . 0.5 OUTLIER -106.25 139.16 41.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.167 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.625 HD13 ' HG ' ' B' ' 86' ' ' LEU . 1.0 OUTLIER -73.92 76.49 1.66 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.707 0.289 . . . . 0.0 110.718 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.45 -17.2 14.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.519 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -51.79 1.24 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.642 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.95 18.83 21.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.933 0.397 . . . . 0.0 111.604 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.892 HG21 HG23 ' B' ' 112' ' ' THR . 0.2 OUTLIER -85.84 84.71 7.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.698 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . 95.7 m-85 -101.41 98.76 9.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.772 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 38.2 m -130.83 62.34 1.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.989 0.423 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.28 145.85 30.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.658 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.633 ' HB3' ' HE3' ' B' ' 68' ' ' LYS . 3.5 mm-40 -121.35 71.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.217 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.67 134.79 34.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.74 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 15.2 m -83.86 113.67 21.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.7 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.639 ' CD2' ' HB1' ' B' ' 20' ' ' ALA . 18.9 tp -73.98 142.92 45.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.649 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.662 ' HA ' HG23 ' B' ' 63' ' ' THR . 0.9 OUTLIER -138.55 162.13 35.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.53 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.8 113.13 12.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.65 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.59 -139.92 9.48 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.711 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 6.6 m -101.72 96.85 7.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.688 0.28 . . . . 0.0 110.8 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -83.67 148.61 27.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.898 0.38 . . . . 0.0 111.019 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.625 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -138.65 143.32 39.18 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.16 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 131' ' ' ILE . . . . . 0.827 HG21 HG11 ' B' ' 71' ' ' VAL . 54.9 mt -104.51 112.34 65.35 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' PRO . . . . . 0.708 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.95 142.05 12.25 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.697 1.598 . . . . 0.0 112.503 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.68 141.12 22.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.851 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -104.48 152.63 22.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.107 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.641 ' O ' HG22 ' B' ' 52' ' ' VAL . . . -153.57 101.09 2.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.949 0.404 . . . . 0.0 111.586 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 136' ' ' ARG . . . . . 0.553 ' HB3' ' HA ' ' B' ' 51' ' ' ALA . 17.5 ptt180 -107.19 177.28 4.9 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.436 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' TYR . . . . . 0.503 ' HB3' HD21 ' B' ' 42' ' ' LEU . 4.7 m-85 -85.96 124.08 32.02 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.019 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 138' ' ' PHE . . . . . 0.453 ' HB3' HG11 ' B' ' 85' ' ' VAL . 1.2 t80 -118.85 112.45 19.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.972 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.665 ' HB2' HD23 ' B' ' 42' ' ' LEU . . . -102.99 133.97 47.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.842 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 140' ' ' THR . . . . . 0.62 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 0.1 OUTLIER -81.11 -28.89 35.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.506 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 141' ' ' GLY . . . . . 0.463 ' H ' ' HB3' ' B' ' 98' ' ' ASN . . . -160.17 -111.07 0.28 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.894 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.91 110.54 21.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.502 0.191 . . . . 0.0 110.712 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 143' ' ' ALA . . . . . 0.698 ' HB3' ' HA ' ' B' ' 39' ' ' THR . . . -65.57 134.22 52.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.781 0.325 . . . . 0.0 111.45 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.601 ' O ' ' CG1' ' A' ' 16' ' ' VAL . 57.2 m -105.81 149.46 38.01 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.309 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.493 ' CD ' ' CG2' ' B' ' 144' ' ' THR . 1.4 Cg_endo -82.95 125.47 4.16 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.592 2.195 . . . . 0.0 112.011 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 146' ' ' GLY . . . . . 0.675 ' O ' ' CG ' ' A' ' 15' ' ' GLU . . . 168.83 -126.3 1.37 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.423 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.448 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -111.12 128.45 55.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.817 0.342 . . . . 0.0 111.296 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 148' ' ' ALA . . . . . 0.698 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -125.45 52.12 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.188 0.518 . . . . 0.0 110.474 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -98.74 151.92 20.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.607 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.776 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -158.23 169.51 24.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.982 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.9 128.69 41.06 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.289 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' ALA . . . . . 0.483 ' HB2' HD11 ' B' ' 86' ' ' LEU . . . -122.25 144.07 49.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.153 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 153' ' ' THR . . . . . 1.04 HG23 HG22 ' A' ' 9' ' ' THR . 0.6 OUTLIER -106.36 145.32 31.83 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.41 ' HB3' ' H ' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -96.88 134.63 39.96 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.095 0.474 . . . . 0.0 110.052 -179.004 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.416 ' HA ' ' H ' ' A' ' 7' ' ' GLY . 9.9 mmtt -124.17 148.03 47.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.944 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 156' ' ' VAL . . . . . 0.521 HG23 HG23 ' A' ' 5' ' ' VAL . 30.0 m -135.04 144.85 33.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.81 0.338 . . . . 0.0 111.757 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.683 ' HG3' HG23 ' A' ' 4' ' ' THR . 0.0 OUTLIER -134.5 126.14 28.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.215 0.531 . . . . 0.0 110.386 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 158' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' B' ' 21' ' ' CYS . 5.2 m-85 -106.05 128.77 54.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.494 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 159' ' ' GLN . . . . . 0.565 ' HG3' ' C ' ' B' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.898 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.284 0.088 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.66 77.09 0.19 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.007 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 10.9 m -117.39 119.31 34.71 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.394 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' THR . . . . . 0.677 HG23 ' HG3' ' D' ' 157' ' ' GLN . 4.0 m -98.36 127.2 44.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.538 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.918 HG21 HG12 ' D' ' 17' ' ' VAL . 1.6 m -146.14 170.99 4.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.574 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.05 114.75 23.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.611 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' GLY . . . . . 0.414 ' H ' ' HA ' ' D' ' 155' ' ' LYS . . . -69.75 -57.64 7.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.801 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 8' ' ' GLY . . . . . 0.421 ' O ' HG23 ' C' ' 9' ' ' THR . . . -163.56 -144.59 4.08 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.892 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 9' ' ' THR . . . . . 0.986 HG22 HG23 ' D' ' 153' ' ' THR . 17.2 p -155.75 140.45 17.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.863 0.363 . . . . 0.0 111.396 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.559 HG13 HG23 ' D' ' 32' ' ' VAL . 29.5 t -130.28 117.49 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.212 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -91.59 117.09 29.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.392 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -89.88 107.02 18.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.911 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.71 113.29 26.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.454 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' GLY . . . . . 0.44 ' HA3' ' OH ' ' D' ' 137' ' ' TYR . . . -144.37 167.0 27.09 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.889 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 15' ' ' GLU . . . . . 0.676 ' CG ' ' O ' ' D' ' 146' ' ' GLY . 30.2 tt0 -155.73 135.18 12.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.975 0.417 . . . . 0.0 110.343 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' D' ' 148' ' ' ALA . 66.5 t -96.53 138.35 21.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.317 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.88 HG12 HG21 ' B' ' 5' ' ' VAL . 2.6 m -140.85 -173.37 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 0.0 110.996 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -80.09 173.46 12.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.967 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' ALA . . . . . 0.528 ' HA ' ' HB3' ' D' ' 38' ' ' ARG . . . -85.8 39.74 0.82 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.089 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 20' ' ' ALA . . . . . 0.631 ' HB1' ' CD2' ' C' ' 124' ' ' LEU . . . -114.24 -33.68 5.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.382 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 21' ' ' CYS . . . . . 0.675 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.9 OUTLIER -161.12 149.96 16.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.979 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 22' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' D' ' 36' ' ' GLN . . . -149.57 112.12 4.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.061 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 23' ' ' VAL . . . . . 0.665 ' HA ' ' HA ' ' C' ' 58' ' ' LEU . 3.1 p -59.97 153.4 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.04 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.76 152.83 28.12 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.624 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.53 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -57.58 -41.38 81.0 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.365 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.88 15.7 62.12 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.992 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.96 -21.39 11.14 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.927 0.394 . . . . 0.0 110.805 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 89.8 t -44.6 -64.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.334 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.26 135.61 38.94 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.913 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.0 128.8 19.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.043 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.71 111.71 23.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.111 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.552 HG23 HG13 ' B' ' 10' ' ' VAL . 4.2 t -110.74 114.79 48.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.103 0.478 . . . . 0.0 110.464 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.81 124.49 46.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.665 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.5 -45.7 14.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.603 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.32 -161.83 12.84 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.612 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' GLN . . . . . 0.623 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 1.1 mt-30 -99.85 129.7 45.97 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.557 0.218 . . . . 0.0 110.873 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.494 ' CG1' HG22 ' B' ' 16' ' ' VAL . 11.9 p -110.04 147.44 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.914 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 38' ' ' ARG . . . . . 0.513 ' HB3' ' HA ' ' B' ' 19' ' ' ALA . 0.7 OUTLIER -86.72 131.26 34.19 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.997 0.427 . . . . 0.0 111.804 179.204 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.697 ' HA ' ' HB3' ' C' ' 143' ' ' ALA . 4.8 t -54.12 -45.12 71.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.693 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.439 ' N ' HG23 ' C' ' 39' ' ' THR . . . -61.02 -39.36 89.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.114 0.483 . . . . 0.0 110.856 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 41' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' C' ' 38' ' ' ARG . 0.4 OUTLIER -70.63 -23.1 62.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.17 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.668 HD23 ' HB2' ' C' ' 139' ' ' ALA . 1.4 mp -124.61 51.58 1.6 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.583 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.66 29.95 7.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.326 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.84 128.45 48.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.32 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 45' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' C' ' 140' ' ' THR . 29.3 tt0 -53.0 102.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.114 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 46' ' ' GLY . . . . . 0.414 ' HA2' ' HE1' ' C' ' 138' ' ' PHE . . . 96.06 39.03 4.41 Favored Glycine 0 C--N 1.331 0.255 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.114 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' C' ' 139' ' ' ALA . . . -80.08 146.7 31.77 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.66 125.09 19.11 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.876 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 31.9 m -102.01 -166.27 1.27 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.625 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.96 133.03 55.71 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.836 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 51' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' C' ' 136' ' ' ARG . . . -92.74 120.21 32.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.299 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.623 HG22 ' O ' ' C' ' 135' ' ' ALA . 18.4 m -65.76 162.63 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.974 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.86 124.15 5.28 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.609 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -155.93 146.56 21.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.713 0.292 . . . . 0.0 110.932 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.578 ' HB2' HG22 ' C' ' 130' ' ' THR . 3.3 p30 -136.8 160.27 39.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.54 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.567 HG23 ' O ' ' C' ' 56' ' ' ILE . 1.6 tp -100.68 116.95 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.502 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.613 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.0 OUTLIER -70.09 124.56 24.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.763 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 58' ' ' LEU . . . . . 0.665 ' HA ' ' HA ' ' C' ' 23' ' ' VAL . 1.6 mp -133.68 87.42 2.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.231 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 59' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 4.9 p30 -73.67 174.54 8.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.918 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.8 79.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' CYS . . . . . 0.675 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 93.2 m -127.62 159.39 34.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.836 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 62' ' ' ASP . . . . . 0.607 ' OD2' HG23 ' C' ' 65' ' ' VAL . 5.5 t70 -130.22 167.07 19.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.354 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.667 HG23 ' HA ' ' C' ' 125' ' ' ASN . 0.2 OUTLIER -114.24 -41.75 3.44 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.167 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.5 -22.61 65.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.018 0.437 . . . . 0.0 111.714 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.607 HG23 ' OD2' ' C' ' 62' ' ' ASP . 81.4 t -70.4 -74.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.626 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 66' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' C' ' 124' ' ' LEU . . . -120.71 131.34 54.49 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.656 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.19 -48.63 6.11 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.81 0.338 . . . . 0.0 110.924 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 68' ' ' LYS . . . . . 0.634 ' HE3' ' HB3' ' C' ' 121' ' ' GLU . 0.1 OUTLIER -96.22 161.54 13.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.561 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.1 124.66 6.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.608 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.724 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -100.44 154.98 18.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.054 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 71' ' ' VAL . . . . . 0.829 HG11 HG21 ' C' ' 131' ' ' ILE . 2.3 t -132.72 148.3 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.713 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 72' ' ' ALA . . . . . 0.459 ' HA ' HD21 ' C' ' 111' ' ' LEU . . . -145.62 150.15 35.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.66 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 73' ' ' PHE . . . . . 0.568 ' HB2' HD13 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -119.95 137.0 54.31 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.077 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.624 HD21 HG21 ' F' ' 130' ' ' THR . 0.9 OUTLIER -96.08 139.52 32.14 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.874 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 75' ' ' GLY . . . . . 0.425 ' CA ' ' HB3' ' C' ' 113' ' ' LEU . . . 178.51 179.85 48.49 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.764 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.562 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.3 OUTLIER -110.94 156.42 21.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.545 0.212 . . . . 0.0 110.848 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 77' ' ' ALA . . . . . 0.668 ' O ' ' HB2' ' C' ' 87' ' ' ALA . . . -73.76 131.26 41.39 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.365 -0.38 . . . . 0.0 112.023 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 78' ' ' ILE . . . . . 0.649 ' CG2' ' HB ' ' C' ' 85' ' ' VAL . 0.9 OUTLIER -67.69 -41.37 85.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.865 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 79' ' ' ASP . . . . . 0.437 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.6 OUTLIER -141.18 40.84 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.8 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 80' ' ' ALA . . . . . 0.434 ' HB3' ' HA2' ' F' ' 108' ' ' GLY . . . 66.35 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.027 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.66 -24.95 41.86 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.723 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.12 64.04 1.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.953 0.406 . . . . 0.0 110.469 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 83' ' ' THR . . . . . 0.545 HG23 ' HB2' ' C' ' 77' ' ' ALA . 0.2 OUTLIER -68.44 -16.99 64.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.53 -179.512 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 84' ' ' ASN . . . . . 0.702 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 18.0 p-10 -70.35 -20.28 62.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.361 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.649 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 14.7 t -106.91 130.75 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.158 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.767 HD22 ' HB1' ' C' ' 150' ' ' ALA . 0.5 OUTLIER -67.56 148.19 51.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.431 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' C' ' 77' ' ' ALA . . . -89.64 -167.49 1.87 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.764 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.659 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 1.5 mm? -78.37 157.29 29.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.114 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -78.34 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.345 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 90' ' ' SER . . . . . 0.576 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 0.5 OUTLIER -167.1 0.53 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.018 0.437 . . . . 0.0 111.48 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 91' ' ' SER . . . . . 0.545 ' HA ' ' HB2' ' E' ' 25' ' ' ALA . 1.7 m -71.92 83.02 0.93 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 92' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' F' ' 34' ' ' LEU . . . -66.77 -13.88 61.95 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.879 0.371 . . . . 0.0 111.688 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.67 27.54 5.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.638 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.65 15.63 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.973 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 95' ' ' SER . . . . . 0.659 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 3.0 m -100.85 -172.84 2.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.766 0.317 . . . . 0.0 110.627 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.91 167.65 9.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 97' ' ' THR . . . . . 0.515 ' H ' ' HB ' ' C' ' 144' ' ' THR . 2.3 m -121.57 128.43 51.98 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.295 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 98' ' ' ASN . . . . . 0.457 ' HB3' ' H ' ' C' ' 141' ' ' GLY . 75.9 m-20 64.14 34.48 11.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.498 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 99' ' ' VAL . . . . . 0.478 HG13 HD23 ' C' ' 42' ' ' LEU . 0.5 OUTLIER -139.87 136.6 38.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.709 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.19 -156.91 8.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.498 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 101' ' ' VAL . . . . . 0.492 HG13 ' HB2' ' C' ' 86' ' ' LEU . 3.2 p -137.81 116.77 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 122.951 0.5 . . . . 0.0 111.644 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 102' ' ' GLN . . . . . 0.578 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 1.1 tt0 -91.91 150.36 21.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.873 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.67 HD12 ' HB3' ' C' ' 111' ' ' LEU . 0.5 OUTLIER -113.76 131.31 65.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.601 179.415 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 104' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 0.3 OUTLIER -106.24 130.19 54.15 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.664 0.269 . . . . 0.0 111.054 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 105' ' ' ASP . . . . . 0.743 ' HB3' HG22 ' C' ' 107' ' ' THR . 5.1 t0 -76.2 157.0 33.12 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.694 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 106' ' ' ARG . . . . . 0.71 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 3.5 ttp180 -71.24 -17.44 62.5 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.763 0.316 . . . . 0.0 111.101 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 107' ' ' THR . . . . . 0.743 HG22 ' HB3' ' C' ' 105' ' ' ASP . 6.2 t -67.27 -17.99 65.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.069 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.75 -45.62 1.17 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.766 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.14 163.11 23.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.727 0.298 . . . . 0.0 111.159 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -84.15 127.39 33.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 111' ' ' LEU . . . . . 0.67 ' HB3' HD12 ' C' ' 103' ' ' ILE . 12.1 tp -86.22 156.02 20.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.304 0.573 . . . . 0.0 110.638 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 112' ' ' THR . . . . . 0.892 HG23 HG21 ' C' ' 117' ' ' THR . 0.5 OUTLIER -106.14 139.17 41.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.151 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.624 HD13 ' HG ' ' C' ' 86' ' ' LEU . 1.0 OUTLIER -73.91 76.43 1.65 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.679 0.276 . . . . 0.0 110.706 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.41 -17.17 14.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.558 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.27 -51.75 1.25 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.648 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.03 18.84 21.66 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.941 0.4 . . . . 0.0 111.554 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 117' ' ' THR . . . . . 0.892 HG21 HG23 ' C' ' 112' ' ' THR . 0.2 OUTLIER -85.8 84.6 7.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.057 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 118' ' ' PHE . . . . . 0.724 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . 95.7 m-85 -101.38 98.77 9.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.795 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 38.7 m -130.79 62.28 1.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.25 145.86 30.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.715 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 121' ' ' GLU . . . . . 0.634 ' HB3' ' HE3' ' C' ' 68' ' ' LYS . 3.5 mm-40 -121.39 71.25 0.95 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.217 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.69 134.77 34.75 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.703 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 14.8 m -83.79 113.66 21.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.776 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 124' ' ' LEU . . . . . 0.631 ' CD2' ' HB1' ' C' ' 20' ' ' ALA . 18.9 tp -74.0 142.9 45.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.657 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 125' ' ' ASN . . . . . 0.667 ' HA ' HG23 ' C' ' 63' ' ' THR . 0.9 OUTLIER -138.57 162.1 35.41 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.573 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.73 113.2 12.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.7 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.48 -139.91 9.5 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.734 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 128' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 6.7 m -101.69 96.76 7.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.698 0.285 . . . . 0.0 110.773 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.59 148.48 27.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.895 0.379 . . . . 0.0 111.093 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 130' ' ' THR . . . . . 0.613 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -138.55 143.43 39.45 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.207 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 131' ' ' ILE . . . . . 0.829 HG21 HG11 ' C' ' 71' ' ' VAL . 55.1 mt -104.62 112.41 65.34 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 132' ' ' PRO . . . . . 0.71 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.5 Cg_endo -81.95 141.98 12.2 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.719 1.612 . . . . 0.0 112.526 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.401 ' HZ ' HD22 ' C' ' 111' ' ' LEU . 0.3 OUTLIER -150.63 141.06 22.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.85 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -104.49 152.53 22.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.131 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.623 ' O ' HG22 ' C' ' 52' ' ' VAL . . . -153.52 101.08 2.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.98 0.419 . . . . 0.0 111.6 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.554 ' HB3' ' HA ' ' C' ' 51' ' ' ALA . 17.5 ptt180 -107.18 177.2 4.92 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.42 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 137' ' ' TYR . . . . . 0.497 ' HB3' HD21 ' C' ' 42' ' ' LEU . 4.7 m-85 -85.93 124.15 32.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.008 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 138' ' ' PHE . . . . . 0.466 ' HB3' HG11 ' C' ' 85' ' ' VAL . 1.2 t80 -118.9 112.38 19.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.959 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 139' ' ' ALA . . . . . 0.668 ' HB2' HD23 ' C' ' 42' ' ' LEU . . . -102.97 133.95 47.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.873 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 140' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 0.1 OUTLIER -81.1 -28.9 35.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.529 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 141' ' ' GLY . . . . . 0.457 ' H ' ' HB3' ' C' ' 98' ' ' ASN . . . -160.15 -111.06 0.28 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.926 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.85 110.56 21.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.537 0.208 . . . . 0.0 110.766 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 143' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' C' ' 39' ' ' THR . . . -65.65 134.29 52.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.83 0.348 . . . . 0.0 111.343 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 144' ' ' THR . . . . . 0.602 ' O ' ' CG1' ' B' ' 16' ' ' VAL . 56.4 m -105.82 149.39 37.93 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.346 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 145' ' ' PRO . . . . . 0.49 ' CD ' ' CG2' ' C' ' 144' ' ' THR . 1.4 Cg_endo -82.91 125.54 4.2 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.497 2.131 . . . . 0.0 112.023 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 146' ' ' GLY . . . . . 0.689 ' O ' ' CG ' ' B' ' 15' ' ' GLU . . . 168.78 -126.33 1.38 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.407 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 147' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -111.07 128.43 55.87 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.758 0.313 . . . . 0.0 111.317 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 148' ' ' ALA . . . . . 0.686 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -125.41 52.15 1.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.15 0.5 . . . . 0.0 110.492 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -98.78 151.93 20.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.597 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 150' ' ' ALA . . . . . 0.767 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -158.28 169.6 24.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.009 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -130.98 128.63 40.8 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.291 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 152' ' ' ALA . . . . . 0.479 ' HB2' HD11 ' C' ' 86' ' ' LEU . . . -122.21 144.06 49.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.228 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 153' ' ' THR . . . . . 1.041 HG23 HG22 ' B' ' 9' ' ' THR . 0.6 OUTLIER -106.37 145.34 31.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.185 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 154' ' ' PHE . . . . . 0.402 ' HB3' ' H ' ' B' ' 8' ' ' GLY . 0.5 OUTLIER -96.9 134.67 39.93 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.068 0.461 . . . . 0.0 110.019 -178.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 155' ' ' LYS . . . . . 0.416 ' HA ' ' H ' ' B' ' 7' ' ' GLY . 9.9 mmtt -124.15 148.14 47.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.895 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 156' ' ' VAL . . . . . 0.521 HG23 HG23 ' B' ' 5' ' ' VAL . 29.9 m -135.15 144.77 33.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.742 0.306 . . . . 0.0 111.791 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 157' ' ' GLN . . . . . 0.677 ' HG3' HG23 ' B' ' 4' ' ' THR . 0.0 OUTLIER -134.46 126.06 28.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.273 0.559 . . . . 0.0 110.399 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 158' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' C' ' 21' ' ' CYS . 5.2 m-85 -106.02 128.75 54.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.502 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 159' ' ' GLN . . . . . 0.56 ' HG3' ' C ' ' C' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 111.142 0.053 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.64 77.12 0.19 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.172 0.295 . . . . 0.0 110.983 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 3' ' ' THR . . . . . . . . . . . . . 10.9 m -117.41 119.32 34.75 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.387 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 4' ' ' THR . . . . . 0.682 HG23 ' HG3' ' E' ' 157' ' ' GLN . 4.0 m -98.37 127.21 44.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.535 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.92 HG21 HG12 ' E' ' 17' ' ' VAL . 1.6 m -146.1 171.03 4.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.601 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -86.02 114.61 23.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.599 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' GLY . . . . . 0.407 ' H ' ' HA ' ' E' ' 155' ' ' LYS . . . -69.61 -57.71 7.05 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.813 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 8' ' ' GLY . . . . . 0.43 ' O ' HG23 ' D' ' 9' ' ' THR . . . -163.59 -144.61 4.08 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.87 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 9' ' ' THR . . . . . 1.038 HG22 HG23 ' E' ' 153' ' ' THR . 17.1 p -155.7 140.46 17.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 111.371 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 10' ' ' VAL . . . . . 0.546 HG13 HG23 ' E' ' 32' ' ' VAL . 30.1 t -130.34 117.48 39.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.294 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -91.5 116.98 29.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.349 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -89.86 107.08 18.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.883 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.75 113.32 26.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.451 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 14' ' ' GLY . . . . . 0.441 ' HA3' ' OH ' ' E' ' 137' ' ' TYR . . . -144.42 166.98 27.12 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.919 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 15' ' ' GLU . . . . . 0.676 ' CG ' ' O ' ' E' ' 146' ' ' GLY . 30.2 tt0 -155.68 135.2 12.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.966 0.412 . . . . 0.0 110.32 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.699 HG23 ' HB2' ' E' ' 148' ' ' ALA . 65.8 t -96.53 138.36 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.275 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.918 HG12 HG21 ' C' ' 5' ' ' VAL . 2.7 m -140.85 -173.38 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.872 0.368 . . . . 0.0 111.002 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.08 173.41 12.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.075 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 19' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' E' ' 38' ' ' ARG . . . -85.82 39.76 0.82 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.041 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.639 ' HB1' ' CD2' ' D' ' 124' ' ' LEU . . . -114.31 -33.46 5.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.459 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 21' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.9 OUTLIER -161.18 149.98 16.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.935 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.64 112.09 4.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.102 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 23' ' ' VAL . . . . . 0.664 ' HA ' ' HA ' ' D' ' 58' ' ' LEU . 3.0 p -59.93 153.34 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.082 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.68 152.75 28.27 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.686 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.546 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -57.53 -41.46 80.93 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.357 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.81 15.7 62.06 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.968 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.95 -21.35 11.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.914 0.387 . . . . 0.0 110.814 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 90.1 t -44.58 -64.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.364 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.29 135.69 38.85 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.885 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.04 128.77 19.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.044 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.83 111.83 23.85 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.014 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.559 HG23 HG13 ' C' ' 10' ' ' VAL . 4.2 t -110.82 114.81 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.139 0.495 . . . . 0.0 110.519 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.75 124.45 46.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.649 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 0.9 OUTLIER -82.49 -45.74 14.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.574 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.37 -161.86 12.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.571 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' GLN . . . . . 0.608 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 1.1 mt-30 -99.83 129.69 45.95 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.648 0.261 . . . . 0.0 110.881 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.493 ' CG1' HG22 ' C' ' 16' ' ' VAL . 12.0 p -110.02 147.44 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.995 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 38' ' ' ARG . . . . . 0.528 ' HB3' ' HA ' ' C' ' 19' ' ' ALA . 0.7 OUTLIER -86.78 131.29 34.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.053 0.454 . . . . 0.0 111.69 179.301 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.693 ' HA ' ' HB3' ' D' ' 143' ' ' ALA . 4.8 t -54.09 -45.13 71.71 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.753 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.449 ' N ' HG23 ' D' ' 39' ' ' THR . . . -60.93 -39.37 89.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.137 0.494 . . . . 0.0 110.939 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 41' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' D' ' 38' ' ' ARG . 0.4 OUTLIER -70.62 -23.15 62.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.134 -179.661 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' D' ' 139' ' ' ALA . 1.4 mp -124.59 51.57 1.6 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.669 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.59 29.9 7.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.38 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.84 128.46 48.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.33 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 45' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' D' ' 140' ' ' THR . 29.5 tt0 -52.95 103.05 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.871 0.367 . . . . 0.0 111.117 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 46' ' ' GLY . . . . . 0.419 ' HA2' ' HE1' ' D' ' 138' ' ' PHE . . . 95.94 39.03 4.44 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.193 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' D' ' 139' ' ' ALA . . . -79.98 146.66 31.92 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.63 124.97 19.01 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.973 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 32.3 m -101.9 -166.31 1.28 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.626 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.04 132.99 55.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.848 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 51' ' ' ALA . . . . . 0.549 ' HA ' ' HB3' ' D' ' 136' ' ' ARG . . . -92.64 120.24 32.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.321 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 52' ' ' VAL . . . . . 0.631 HG22 ' O ' ' D' ' 135' ' ' ALA . 18.5 m -65.84 162.66 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.905 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.8 124.14 5.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.649 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.442 ' N ' HG21 ' A' ' 76' ' ' THR . 54.0 p90 -155.93 146.55 21.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.705 0.288 . . . . 0.0 110.942 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 55' ' ' ASN . . . . . 0.568 ' HB2' HG22 ' D' ' 130' ' ' THR . 0.6 OUTLIER -136.84 160.24 39.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.58 HG23 ' O ' ' D' ' 56' ' ' ILE . 1.6 tp -100.63 117.02 45.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.536 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 57' ' ' GLN . . . . . 0.611 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.0 OUTLIER -70.12 124.58 24.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.736 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 58' ' ' LEU . . . . . 0.664 ' HA ' ' HA ' ' D' ' 23' ' ' VAL . 1.6 mp -133.77 87.54 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.181 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 59' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 4.9 p30 -73.65 174.61 8.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.006 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.81 79.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.815 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 61' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 93.6 m -127.58 159.4 34.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.862 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 62' ' ' ASP . . . . . 0.612 ' OD2' HG23 ' D' ' 65' ' ' VAL . 5.5 t70 -130.24 167.11 18.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.28 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.661 HG23 ' HA ' ' D' ' 125' ' ' ASN . 0.2 OUTLIER -114.35 -41.66 3.44 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.47 -22.71 65.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.063 0.459 . . . . 0.0 111.723 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 65' ' ' VAL . . . . . 0.612 HG23 ' OD2' ' D' ' 62' ' ' ASP . 81.5 t -70.38 -74.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.635 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' D' ' 124' ' ' LEU . . . -120.76 131.33 54.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.634 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.21 -48.54 6.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.857 0.361 . . . . 0.0 110.981 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 68' ' ' LYS . . . . . 0.631 ' HE3' ' HB3' ' D' ' 121' ' ' GLU . 0.1 OUTLIER -96.25 161.54 13.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.555 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.09 124.63 6.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.642 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 70' ' ' ALA . . . . . 0.726 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -100.32 155.0 18.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.098 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 71' ' ' VAL . . . . . 0.849 HG11 HG21 ' D' ' 131' ' ' ILE . 2.3 t -132.75 148.22 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.745 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 72' ' ' ALA . . . . . 0.445 ' HA ' HD21 ' D' ' 111' ' ' LEU . . . -145.57 150.18 35.93 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.59 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 73' ' ' PHE . . . . . 0.557 ' HB2' HD13 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -119.99 136.96 54.35 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.053 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 74' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.9 OUTLIER -96.05 139.54 32.08 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.937 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 75' ' ' GLY . . . . . 0.429 ' CA ' ' HB3' ' D' ' 113' ' ' LEU . . . 178.53 179.83 48.5 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.745 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 76' ' ' THR . . . . . 0.548 ' H ' HD23 ' D' ' 86' ' ' LEU . 0.3 OUTLIER -111.0 156.39 21.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.534 0.207 . . . . 0.0 110.832 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.668 ' O ' ' HB2' ' D' ' 87' ' ' ALA . . . -73.78 131.3 41.41 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.04 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 78' ' ' ILE . . . . . 0.646 ' CG2' ' HB ' ' D' ' 85' ' ' VAL . 0.9 OUTLIER -67.72 -41.3 85.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.874 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.424 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.6 OUTLIER -141.17 40.75 1.78 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.808 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 66.44 -80.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.7 -24.96 42.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.688 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -99.1 64.04 1.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.448 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 83' ' ' THR . . . . . 0.542 HG23 ' HB2' ' D' ' 77' ' ' ALA . 0.2 OUTLIER -68.5 -16.86 64.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.584 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 84' ' ' ASN . . . . . 0.693 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 18.0 p-10 -70.36 -20.3 62.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.359 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.646 ' HB ' ' CG2' ' D' ' 78' ' ' ILE . 14.7 t -106.87 130.74 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.136 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.78 HD22 ' HB1' ' D' ' 150' ' ' ALA . 0.5 OUTLIER -67.66 148.18 51.69 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' D' ' 77' ' ' ALA . . . -89.62 -167.54 1.89 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 111.713 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.659 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 1.5 mm? -78.32 157.23 29.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.094 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -78.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.418 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.18 0.6 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.971 0.415 . . . . 0.0 111.483 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 91' ' ' SER . . . . . 0.537 ' HA ' ' HB2' ' F' ' 25' ' ' ALA . 1.7 m -71.91 82.94 0.93 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.65 -13.96 61.84 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.917 0.389 . . . . 0.0 111.749 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.61 27.61 5.23 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.581 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.67 15.6 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.946 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 95' ' ' SER . . . . . 0.659 ' HB3' ' HG ' ' D' ' 88' ' ' LEU . 3.0 m -100.9 -172.81 2.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.715 0.293 . . . . 0.0 110.635 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.86 167.62 9.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 97' ' ' THR . . . . . 0.517 ' H ' ' HB ' ' D' ' 144' ' ' THR . 2.3 m -121.51 128.36 51.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.34 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 98' ' ' ASN . . . . . 0.461 ' HB3' ' H ' ' D' ' 141' ' ' GLY . 76.0 m-20 64.28 34.44 10.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.468 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 99' ' ' VAL . . . . . 0.503 HG13 HD23 ' D' ' 42' ' ' LEU . 0.5 OUTLIER -139.92 136.46 38.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.738 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.08 -156.92 8.36 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.523 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 101' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' D' ' 86' ' ' LEU . 3.2 p -137.8 116.8 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.132 0.491 . . . . 0.0 111.647 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 102' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 1.2 tt0 -91.86 150.35 21.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.847 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 103' ' ' ILE . . . . . 0.688 HD12 ' HB3' ' D' ' 111' ' ' LEU . 0.5 OUTLIER -113.85 131.34 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.494 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 104' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 0.3 OUTLIER -106.29 130.16 54.19 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.68 0.276 . . . . 0.0 110.958 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 105' ' ' ASP . . . . . 0.738 ' HB3' HG22 ' D' ' 107' ' ' THR . 5.1 t0 -76.14 156.99 33.28 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.679 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 106' ' ' ARG . . . . . 0.741 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 3.5 ttp180 -71.19 -17.55 62.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.738 0.304 . . . . 0.0 111.078 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 107' ' ' THR . . . . . 0.738 HG22 ' HB3' ' D' ' 105' ' ' ASP . 6.2 t -67.17 -18.07 65.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.021 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 108' ' ' GLY . . . . . 0.439 ' HA2' ' CB ' ' A' ' 80' ' ' ALA . . . 123.7 -45.57 1.17 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.74 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.07 163.05 23.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.7 0.286 . . . . 0.0 111.154 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -84.13 127.41 33.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.08 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 111' ' ' LEU . . . . . 0.688 ' HB3' HD12 ' D' ' 103' ' ' ILE . 12.1 tp -86.24 156.11 20.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.258 0.551 . . . . 0.0 110.633 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 112' ' ' THR . . . . . 0.891 HG23 HG21 ' D' ' 117' ' ' THR . 0.5 OUTLIER -106.23 139.15 41.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.123 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 113' ' ' LEU . . . . . 0.602 HD13 ' HG ' ' D' ' 86' ' ' LEU . 1.0 OUTLIER -74.03 76.55 1.71 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.755 0.312 . . . . 0.0 110.742 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.54 -17.09 14.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.516 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.23 -51.86 1.25 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.664 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.99 18.86 21.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.858 0.361 . . . . 0.0 111.509 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 117' ' ' THR . . . . . 0.891 HG21 HG23 ' D' ' 112' ' ' THR . 0.2 OUTLIER -85.81 84.64 7.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.079 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.726 ' HB3' ' HB1' ' D' ' 70' ' ' ALA . 95.7 m-85 -101.37 98.77 9.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.759 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 38.1 m -130.77 62.33 1.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.28 145.74 30.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.735 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 121' ' ' GLU . . . . . 0.631 ' HB3' ' HE3' ' D' ' 68' ' ' LYS . 3.5 mm-40 -121.25 71.3 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.179 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 134.78 34.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.684 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 15.1 m -83.82 113.7 21.11 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.701 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 124' ' ' LEU . . . . . 0.639 ' CD2' ' HB1' ' D' ' 20' ' ' ALA . 19.0 tp -74.08 142.96 45.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.772 0.32 . . . . 0.0 110.61 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 125' ' ' ASN . . . . . 0.661 ' HA ' HG23 ' D' ' 63' ' ' THR . 0.9 OUTLIER -138.53 162.12 35.32 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.59 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.8 113.18 12.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.684 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.54 -140.02 9.57 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.688 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 128' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 6.6 m -101.66 96.87 7.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 110.773 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.65 148.54 27.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.843 0.354 . . . . 0.0 111.097 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 130' ' ' THR . . . . . 0.627 HG21 HD21 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -138.61 143.4 39.31 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.123 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 131' ' ' ILE . . . . . 0.849 HG21 HG11 ' D' ' 71' ' ' VAL . 55.1 mt -104.57 112.36 65.34 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 132' ' ' PRO . . . . . 0.741 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.4 Cg_endo -82.01 141.98 12.13 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.675 1.583 . . . . 0.0 112.458 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.404 ' HZ ' HD22 ' D' ' 111' ' ' LEU . 0.3 OUTLIER -150.61 141.12 22.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.897 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -104.48 152.55 22.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.097 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.631 ' O ' HG22 ' D' ' 52' ' ' VAL . . . -153.53 101.08 2.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.954 0.407 . . . . 0.0 111.578 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 136' ' ' ARG . . . . . 0.549 ' HB3' ' HA ' ' D' ' 51' ' ' ALA . 17.5 ptt180 -107.18 177.19 4.92 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.379 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 137' ' ' TYR . . . . . 0.49 ' HB3' HD21 ' D' ' 42' ' ' LEU . 4.7 m-85 -85.92 124.04 31.94 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.089 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 138' ' ' PHE . . . . . 0.455 ' HB3' HG11 ' D' ' 85' ' ' VAL . 1.2 t80 -118.8 112.39 19.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.991 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 139' ' ' ALA . . . . . 0.685 ' HB2' HD23 ' D' ' 42' ' ' LEU . . . -102.97 134.0 47.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.828 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 140' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 0.1 OUTLIER -81.12 -28.86 34.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.507 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 141' ' ' GLY . . . . . 0.461 ' H ' ' HB3' ' D' ' 98' ' ' ASN . . . -160.19 -111.09 0.28 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.917 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.88 110.57 21.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.549 0.214 . . . . 0.0 110.744 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 143' ' ' ALA . . . . . 0.693 ' HB3' ' HA ' ' D' ' 39' ' ' THR . . . -65.69 134.27 52.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 111.341 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 144' ' ' THR . . . . . 0.602 ' O ' ' CG1' ' C' ' 16' ' ' VAL . 56.4 m -105.8 149.42 37.96 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.341 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 145' ' ' PRO . . . . . 0.487 ' CD ' ' CG2' ' D' ' 144' ' ' THR . 1.3 Cg_endo -82.96 125.52 4.17 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.519 2.146 . . . . 0.0 112.001 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 146' ' ' GLY . . . . . 0.676 ' O ' ' CG ' ' C' ' 15' ' ' GLU . . . 168.8 -126.37 1.38 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.412 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 147' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -111.1 128.45 55.89 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.813 0.339 . . . . 0.0 111.322 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 148' ' ' ALA . . . . . 0.688 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -125.46 52.14 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.15 0.5 . . . . 0.0 110.398 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -98.71 152.05 20.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.545 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 150' ' ' ALA . . . . . 0.78 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -158.38 169.46 24.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.959 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.96 128.67 40.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.256 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 152' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' D' ' 86' ' ' LEU . . . -122.19 144.06 49.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.251 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 153' ' ' THR . . . . . 0.986 HG23 HG22 ' C' ' 9' ' ' THR . 0.6 OUTLIER -106.34 145.34 31.8 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.209 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 154' ' ' PHE . . . . . 0.415 ' HB3' ' H ' ' C' ' 8' ' ' GLY . 0.5 OUTLIER -96.84 134.67 39.84 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.052 0.454 . . . . 0.0 110.121 -179.081 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 155' ' ' LYS . . . . . 0.414 ' HA ' ' H ' ' C' ' 7' ' ' GLY . 9.9 mmtt -124.24 148.07 47.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.854 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 156' ' ' VAL . . . . . 0.515 HG23 HG23 ' C' ' 5' ' ' VAL . 29.7 m -135.06 144.83 33.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.783 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 157' ' ' GLN . . . . . 0.677 ' HG3' HG23 ' C' ' 4' ' ' THR . 0.0 OUTLIER -134.51 126.06 28.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.283 0.563 . . . . 0.0 110.36 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 158' ' ' TYR . . . . . 0.563 ' CE1' ' HB2' ' D' ' 21' ' ' CYS . 5.2 m-85 -106.02 128.77 54.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.474 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 159' ' ' GLN . . . . . 0.563 ' HG3' ' C ' ' D' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 111.169 0.062 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.7 77.1 0.19 Allowed 'General case' 0 N--CA 1.462 0.146 0 O-C-N 123.1 0.25 . . . . 0.0 110.989 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 3' ' ' THR . . . . . . . . . . . . . 10.7 m -117.36 119.24 34.52 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.472 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 4' ' ' THR . . . . . 0.693 HG23 ' HG3' ' F' ' 157' ' ' GLN . 3.9 m -98.34 127.2 44.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.575 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.884 HG21 HG12 ' F' ' 17' ' ' VAL . 1.6 m -146.11 171.02 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.592 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -86.05 114.73 23.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.573 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 7' ' ' GLY . . . . . 0.411 ' H ' ' HA ' ' F' ' 155' ' ' LYS . . . -69.67 -57.75 6.98 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.923 -0.655 . . . . 0.0 112.829 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 8' ' ' GLY . . . . . 0.428 ' O ' HG23 ' E' ' 9' ' ' THR . . . -163.52 -144.6 4.08 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.901 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 9' ' ' THR . . . . . 1.025 HG22 HG23 ' F' ' 153' ' ' THR . 17.1 p -155.73 140.46 17.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.855 0.36 . . . . 0.0 111.385 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 10' ' ' VAL . . . . . 0.557 HG13 HG23 ' F' ' 32' ' ' VAL . 30.0 t -130.31 117.45 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.238 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 76.8 t60 -91.5 117.0 29.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.435 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -89.79 107.11 18.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.84 113.26 26.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.449 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 14' ' ' GLY . . . . . 0.426 ' HA3' ' OH ' ' F' ' 137' ' ' TYR . . . -144.41 166.98 27.11 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.933 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 15' ' ' GLU . . . . . 0.685 ' CG ' ' O ' ' F' ' 146' ' ' GLY . 30.2 tt0 -155.7 135.17 12.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.985 0.421 . . . . 0.0 110.294 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 16' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' F' ' 148' ' ' ALA . 66.1 t -96.48 138.31 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.264 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 17' ' ' VAL . . . . . 0.92 HG12 HG21 ' D' ' 5' ' ' VAL . 2.7 m -140.81 -173.34 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 111.06 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.13 173.41 12.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.052 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 19' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' F' ' 38' ' ' ARG . . . -85.73 39.73 0.81 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.641 ' HB1' ' CD2' ' E' ' 124' ' ' LEU . . . -114.34 -33.54 5.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.424 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 21' ' ' CYS . . . . . 0.667 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.9 OUTLIER -161.13 150.01 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.933 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.6 112.1 4.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.02 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 23' ' ' VAL . . . . . 0.667 ' HA ' ' HA ' ' E' ' 58' ' ' LEU . 3.1 p -60.02 153.41 4.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.989 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.76 152.81 28.12 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.665 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 25' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -57.5 -41.48 80.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.351 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.77 15.65 62.11 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.032 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -113.05 -21.2 11.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.902 0.382 . . . . 0.0 110.809 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -44.65 -64.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.298 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.23 135.69 38.8 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.957 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.02 128.78 19.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.059 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.78 111.79 23.82 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.058 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.546 HG23 HG13 ' D' ' 10' ' ' VAL . 4.2 t -110.81 114.74 47.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.479 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.68 124.55 46.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.703 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . 0.9 OUTLIER -82.54 -45.62 14.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.661 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.31 -161.86 12.83 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.583 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 36' ' ' GLN . . . . . 0.608 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 1.1 mt-30 -99.83 129.68 45.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.604 0.24 . . . . 0.0 110.862 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.49 ' CG1' HG22 ' D' ' 16' ' ' VAL . 11.8 p -110.11 147.5 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.924 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 38' ' ' ARG . . . . . 0.513 ' HB3' ' HA ' ' D' ' 19' ' ' ALA . 0.7 OUTLIER -86.77 131.24 34.18 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.974 0.416 . . . . 0.0 111.765 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 39' ' ' THR . . . . . 0.699 ' HA ' ' HB3' ' E' ' 143' ' ' ALA . 4.8 t -54.08 -45.09 71.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.772 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.45 ' N ' HG23 ' E' ' 39' ' ' THR . . . -61.01 -39.35 89.4 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.052 0.453 . . . . 0.0 110.854 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 41' ' ' SER . . . . . 0.401 ' HB2' ' HB2' ' E' ' 38' ' ' ARG . 0.4 OUTLIER -70.62 -23.16 62.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.178 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.678 HD23 ' HB2' ' E' ' 139' ' ' ALA . 1.4 mp -124.55 51.61 1.59 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.616 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.69 30.02 7.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.383 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.85 128.45 48.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.294 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 45' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' E' ' 140' ' ' THR . 29.5 tt0 -52.97 102.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.899 0.38 . . . . 0.0 111.139 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 46' ' ' GLY . . . . . 0.428 ' HA2' ' HE1' ' E' ' 138' ' ' PHE . . . 96.05 39.02 4.42 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.098 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 47' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' E' ' 139' ' ' ALA . . . -80.08 146.77 31.74 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.68 125.0 18.97 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.957 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 32.1 m -101.93 -166.31 1.28 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.589 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.99 133.04 55.72 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 51' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' E' ' 136' ' ' ARG . . . -92.7 120.21 32.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.237 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 52' ' ' VAL . . . . . 0.638 HG22 ' O ' ' E' ' 135' ' ' ALA . 18.5 m -65.78 162.69 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.86 124.08 5.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.688 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 54' ' ' PHE . . . . . 0.455 ' N ' HG21 ' B' ' 76' ' ' THR . 53.7 p90 -155.92 146.54 21.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.713 0.292 . . . . 0.0 110.951 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 55' ' ' ASN . . . . . 0.559 ' HB2' HG22 ' E' ' 130' ' ' THR . 0.6 OUTLIER -136.79 160.31 39.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.529 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 56' ' ' ILE . . . . . 0.57 HG23 ' O ' ' E' ' 56' ' ' ILE . 1.6 tp -100.69 116.94 45.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.563 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 57' ' ' GLN . . . . . 0.619 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.0 OUTLIER -70.0 124.64 24.57 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.766 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 58' ' ' LEU . . . . . 0.667 ' HA ' ' HA ' ' E' ' 23' ' ' VAL . 1.6 mp -133.79 87.49 2.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.204 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 59' ' ' ASN . . . . . 0.564 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 4.9 p30 -73.62 174.56 8.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.98 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.86 79.3 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.734 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 61' ' ' CYS . . . . . 0.667 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 93.4 m -127.62 159.44 34.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.88 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 62' ' ' ASP . . . . . 0.616 ' OD2' HG23 ' E' ' 65' ' ' VAL . 5.6 t70 -130.3 167.1 19.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.226 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 63' ' ' THR . . . . . 0.662 HG23 ' HA ' ' E' ' 125' ' ' ASN . 0.2 OUTLIER -114.26 -41.73 3.44 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.143 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.49 -22.64 65.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.013 0.435 . . . . 0.0 111.725 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 65' ' ' VAL . . . . . 0.616 HG23 ' OD2' ' E' ' 62' ' ' ASP . 83.1 t -70.43 -74.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.593 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 66' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' E' ' 124' ' ' LEU . . . -120.73 131.39 54.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.603 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.18 -48.6 6.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.956 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 68' ' ' LYS . . . . . 0.629 ' HE3' ' HB3' ' E' ' 121' ' ' GLU . 0.1 OUTLIER -96.23 161.51 13.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.09 124.67 6.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.633 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 70' ' ' ALA . . . . . 0.709 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -100.39 154.98 18.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.098 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 71' ' ' VAL . . . . . 0.834 HG11 HG21 ' E' ' 131' ' ' ILE . 2.3 t -132.72 148.28 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.715 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 72' ' ' ALA . . . . . 0.437 ' HA ' HD21 ' E' ' 111' ' ' LEU . . . -145.57 150.2 35.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.61 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 73' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -119.98 136.97 54.34 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 121.214 -0.195 . . . . 0.0 111.051 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 74' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.9 OUTLIER -95.95 139.48 32.08 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.956 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 75' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' E' ' 113' ' ' LEU . . . 178.5 179.84 48.48 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.797 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 76' ' ' THR . . . . . 0.549 ' H ' HD23 ' E' ' 86' ' ' LEU . 0.3 OUTLIER -110.98 156.37 21.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.449 0.166 . . . . 0.0 110.839 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 77' ' ' ALA . . . . . 0.671 ' O ' ' HB2' ' E' ' 87' ' ' ALA . . . -73.75 131.25 41.38 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.03 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 78' ' ' ILE . . . . . 0.649 ' CG2' ' HB ' ' E' ' 85' ' ' VAL . 0.9 OUTLIER -67.61 -41.48 85.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.831 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 79' ' ' ASP . . . . . 0.435 ' N ' HG23 ' E' ' 78' ' ' ILE . 0.6 OUTLIER -141.13 40.78 1.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 66.49 -80.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.003 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.73 -24.91 42.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.659 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -99.12 64.02 1.36 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 0.0 110.511 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 83' ' ' THR . . . . . 0.554 HG23 ' HB2' ' E' ' 77' ' ' ALA . 0.2 OUTLIER -68.48 -16.86 64.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.528 -179.473 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 84' ' ' ASN . . . . . 0.687 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 18.0 p-10 -70.41 -20.22 62.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.385 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.649 ' HB ' ' CG2' ' E' ' 78' ' ' ILE . 14.7 t -106.87 130.73 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.18 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 86' ' ' LEU . . . . . 0.786 HD22 ' HB1' ' E' ' 150' ' ' ALA . 0.5 OUTLIER -67.65 148.2 51.67 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 87' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' E' ' 77' ' ' ALA . . . -89.59 -167.52 1.88 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.846 0.355 . . . . 0.0 111.77 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.658 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 1.5 mm? -78.28 157.31 29.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -78.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.34 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.09 0.53 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.016 0.436 . . . . 0.0 111.462 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 91' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' E' ' 95' ' ' SER . 1.7 m -71.84 82.9 0.91 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.68 -13.92 61.85 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.872 0.368 . . . . 0.0 111.725 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.62 27.55 5.24 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.683 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.69 15.66 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.909 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 95' ' ' SER . . . . . 0.658 ' HB3' ' HG ' ' E' ' 88' ' ' LEU . 3.0 m -100.94 -172.8 2.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.782 0.325 . . . . 0.0 110.587 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.91 167.7 9.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.818 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 97' ' ' THR . . . . . 0.52 ' H ' ' HB ' ' E' ' 144' ' ' THR . 2.3 m -121.56 128.46 52.03 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.338 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 98' ' ' ASN . . . . . 0.446 ' HB3' ' H ' ' E' ' 141' ' ' GLY . 75.9 m-20 64.13 34.59 10.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.432 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 99' ' ' VAL . . . . . 0.491 HG13 HD23 ' E' ' 42' ' ' LEU . 0.5 OUTLIER -139.96 136.44 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.745 179.621 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.12 -156.94 8.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.536 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 101' ' ' VAL . . . . . 0.485 HG13 ' HB2' ' E' ' 86' ' ' LEU . 3.2 p -137.76 116.69 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 122.971 0.508 . . . . 0.0 111.653 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 102' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 1.2 tt0 -91.86 150.37 21.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.943 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 103' ' ' ILE . . . . . 0.683 HD12 ' HB3' ' E' ' 111' ' ' LEU . 0.5 OUTLIER -113.81 131.35 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.535 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 104' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 0.3 OUTLIER -106.22 130.14 54.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.673 0.273 . . . . 0.0 110.997 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 105' ' ' ASP . . . . . 0.713 ' HB3' HG22 ' E' ' 107' ' ' THR . 5.1 t0 -76.11 156.99 33.33 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.739 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 106' ' ' ARG . . . . . 0.712 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 3.5 ttp180 -71.22 -17.51 62.5 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.795 0.331 . . . . 0.0 111.087 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 107' ' ' THR . . . . . 0.713 HG22 ' HB3' ' E' ' 105' ' ' ASP . 6.2 t -67.3 -17.94 64.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.997 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 108' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' B' ' 80' ' ' ALA . . . 123.73 -45.59 1.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.804 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.1 163.09 23.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.76 0.314 . . . . 0.0 111.12 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 110' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -84.14 127.37 33.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.064 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.683 ' HB3' HD12 ' E' ' 103' ' ' ILE . 12.1 tp -86.29 156.07 20.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.29 0.567 . . . . 0.0 110.596 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 112' ' ' THR . . . . . 0.898 HG23 HG21 ' E' ' 117' ' ' THR . 0.5 OUTLIER -106.21 139.14 41.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.157 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 113' ' ' LEU . . . . . 0.619 HD13 ' HG ' ' E' ' 86' ' ' LEU . 1.0 OUTLIER -73.93 76.48 1.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 110.765 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.48 -17.17 14.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.511 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -51.8 1.24 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.638 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.95 18.77 21.75 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.929 0.395 . . . . 0.0 111.599 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 117' ' ' THR . . . . . 0.898 HG21 HG23 ' E' ' 112' ' ' THR . 0.2 OUTLIER -85.73 84.61 7.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 118' ' ' PHE . . . . . 0.709 ' HB3' ' HB1' ' E' ' 70' ' ' ALA . 95.7 m-85 -101.39 98.77 9.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.795 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 39.2 m -130.84 62.46 1.61 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.3 145.82 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.704 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 121' ' ' GLU . . . . . 0.629 ' HB3' ' HE3' ' E' ' 68' ' ' LYS . 3.5 mm-40 -121.37 71.28 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.212 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.74 134.86 34.73 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.752 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 14.8 m -83.83 113.72 21.14 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.749 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 124' ' ' LEU . . . . . 0.641 ' CD2' ' HB1' ' E' ' 20' ' ' ALA . 18.9 tp -74.07 143.0 45.63 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.708 0.289 . . . . 0.0 110.619 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 125' ' ' ASN . . . . . 0.662 ' HA ' HG23 ' E' ' 63' ' ' THR . 0.9 OUTLIER -138.61 162.03 35.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.624 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.72 113.24 12.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.675 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.49 -139.94 9.52 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.73 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 128' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 6.6 m -101.69 96.8 7.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.677 0.275 . . . . 0.0 110.755 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.64 148.49 27.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.897 0.379 . . . . 0.0 111.185 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 130' ' ' THR . . . . . 0.624 HG21 HD21 ' B' ' 74' ' ' LEU . 0.2 OUTLIER -138.55 143.46 39.46 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.081 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 131' ' ' ILE . . . . . 0.834 HG21 HG11 ' E' ' 71' ' ' VAL . 54.9 mt -104.57 112.3 65.33 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 132' ' ' PRO . . . . . 0.712 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.5 Cg_endo -81.93 141.93 12.21 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.737 1.624 . . . . 0.0 112.502 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 133' ' ' PHE . . . . . 0.404 ' HZ ' HD22 ' E' ' 111' ' ' LEU . 0.3 OUTLIER -150.59 141.1 22.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.829 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -104.52 152.6 22.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.111 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 135' ' ' ALA . . . . . 0.638 ' O ' HG22 ' E' ' 52' ' ' VAL . . . -153.57 101.06 2.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 111.602 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 136' ' ' ARG . . . . . 0.552 ' HB3' ' HA ' ' E' ' 51' ' ' ALA . 17.4 ptt180 -107.18 177.24 4.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.408 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 137' ' ' TYR . . . . . 0.493 ' HB3' HD21 ' E' ' 42' ' ' LEU . 4.7 m-85 -85.98 124.12 32.08 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.027 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 138' ' ' PHE . . . . . 0.46 ' HB3' HG11 ' E' ' 85' ' ' VAL . 1.2 t80 -118.87 112.36 19.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.048 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 139' ' ' ALA . . . . . 0.678 ' HB2' HD23 ' E' ' 42' ' ' LEU . . . -102.93 133.94 47.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.882 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 140' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 0.1 OUTLIER -81.04 -28.92 35.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.553 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 141' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' E' ' 98' ' ' ASN . . . -160.21 -111.01 0.28 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.88 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.92 110.6 21.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.547 0.213 . . . . 0.0 110.703 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 143' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' E' ' 39' ' ' THR . . . -65.68 134.27 52.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 0.0 111.368 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 144' ' ' THR . . . . . 0.593 ' O ' ' CG1' ' D' ' 16' ' ' VAL . 56.9 m -105.87 149.43 38.01 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.304 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 145' ' ' PRO . . . . . 0.485 ' CD ' ' CG2' ' E' ' 144' ' ' THR . 1.4 Cg_endo -82.91 125.47 4.18 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.542 2.161 . . . . 0.0 112.028 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 146' ' ' GLY . . . . . 0.676 ' O ' ' CG ' ' D' ' 15' ' ' GLU . . . 168.79 -126.32 1.37 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.456 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 147' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -111.13 128.42 55.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.812 0.339 . . . . 0.0 111.294 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 148' ' ' ALA . . . . . 0.699 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -125.45 52.15 1.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.115 0.483 . . . . 0.0 110.412 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -98.75 152.0 20.16 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.611 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 150' ' ' ALA . . . . . 0.786 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -158.29 169.56 24.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.946 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.99 128.64 40.8 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.258 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 152' ' ' ALA . . . . . 0.49 ' HB2' HD11 ' E' ' 86' ' ' LEU . . . -122.17 144.08 49.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.269 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 153' ' ' THR . . . . . 1.038 HG23 HG22 ' D' ' 9' ' ' THR . 0.6 OUTLIER -106.34 145.34 31.81 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.182 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 154' ' ' PHE . . . . . 0.402 ' HB3' ' H ' ' D' ' 8' ' ' GLY . 0.5 OUTLIER -96.9 134.69 39.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.077 0.465 . . . . 0.0 110.069 -178.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 155' ' ' LYS . . . . . 0.407 ' HA ' ' H ' ' D' ' 7' ' ' GLY . 9.9 mmtt -124.22 148.08 47.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.863 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 156' ' ' VAL . . . . . 0.506 HG23 HG23 ' D' ' 5' ' ' VAL . 29.9 m -135.15 144.79 33.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.82 0.343 . . . . 0.0 111.685 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 157' ' ' GLN . . . . . 0.682 ' HG3' HG23 ' D' ' 4' ' ' THR . 0.0 OUTLIER -134.49 126.11 28.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.223 0.535 . . . . 0.0 110.362 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 158' ' ' TYR . . . . . 0.568 ' C ' ' HG3' ' E' ' 159' ' ' GLN . 5.2 m-85 -106.01 128.71 54.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.525 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 159' ' ' GLN . . . . . 0.568 ' HG3' ' C ' ' E' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.914 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 120.296 0.093 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.69 77.11 0.19 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.979 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 10.7 m -117.4 119.27 34.57 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.372 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 4.0 m -98.39 127.21 44.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.503 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.1 171.0 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.629 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.07 114.75 23.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.163 0.506 . . . . 0.0 110.602 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.79 -57.6 7.03 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.786 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 8' ' ' GLY . . . . . 0.425 ' O ' HG23 ' F' ' 9' ' ' THR . . . -163.62 -144.64 4.1 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.884 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 9' ' ' THR . . . . . 0.425 HG23 ' O ' ' F' ' 8' ' ' GLY . 17.1 p -155.7 140.41 17.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.872 0.367 . . . . 0.0 111.375 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 29.7 t -130.26 117.52 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.274 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.51 117.03 29.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.423 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -89.89 107.05 18.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.826 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.76 113.3 26.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.491 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -144.41 166.98 27.11 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.916 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -155.65 135.26 12.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.975 0.417 . . . . 0.0 110.341 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 66.0 t -96.63 138.3 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.248 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 17' ' ' VAL . . . . . 0.884 HG12 HG21 ' E' ' 5' ' ' VAL . 2.6 m -140.8 -173.3 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 0.0 111.008 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.15 173.42 12.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.094 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.76 39.74 0.81 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.064 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 20' ' ' ALA . . . . . 0.631 ' HB1' ' CD2' ' F' ' 124' ' ' LEU . . . -114.29 -33.57 5.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.445 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 21' ' ' CYS . . . . . 0.672 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.9 OUTLIER -161.18 150.04 16.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.971 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.69 112.08 4.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.105 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 23' ' ' VAL . . . . . 0.674 ' HA ' ' HA ' ' F' ' 58' ' ' LEU . 3.1 p -59.97 153.34 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.01 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.72 152.8 28.19 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.647 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 25' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -57.52 -41.55 81.11 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.292 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.72 15.72 61.91 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.984 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.98 -21.36 11.15 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.967 0.413 . . . . 0.0 110.848 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 90.1 t -44.55 -64.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.357 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.29 135.6 38.97 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.976 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.0 128.74 19.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.82 111.85 23.86 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.152 -0.477 . . . . 0.0 112.048 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.557 HG23 HG13 ' E' ' 10' ' ' VAL . 4.2 t -110.88 114.7 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.168 0.508 . . . . 0.0 110.506 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.67 124.51 46.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.643 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 34' ' ' LEU . . . . . 0.588 ' HB3' ' HB3' ' C' ' 92' ' ' ALA . 0.9 OUTLIER -82.54 -45.65 14.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.578 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.31 -161.95 12.8 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.618 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 36' ' ' GLN . . . . . 0.616 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 1.1 mt-30 -99.79 129.65 45.92 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.622 0.248 . . . . 0.0 110.922 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.498 ' CG1' HG22 ' E' ' 16' ' ' VAL . 11.8 p -109.98 147.5 14.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.954 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 38' ' ' ARG . . . . . 0.508 ' HB3' ' HA ' ' E' ' 19' ' ' ALA . 0.7 OUTLIER -86.79 131.19 34.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.0 0.429 . . . . 0.0 111.8 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 39' ' ' THR . . . . . 0.686 ' HA ' ' HB3' ' F' ' 143' ' ' ALA . 4.8 t -54.03 -45.16 71.5 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.758 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 40' ' ' ALA . . . . . 0.446 ' N ' HG23 ' F' ' 39' ' ' THR . . . -60.92 -39.39 89.2 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.078 0.466 . . . . 0.0 110.943 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 41' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' F' ' 38' ' ' ARG . 0.4 OUTLIER -70.54 -23.22 62.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.157 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 42' ' ' LEU . . . . . 0.67 HD23 ' HB2' ' F' ' 139' ' ' ALA . 1.4 mp -124.59 51.54 1.6 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.651 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.6 30.0 7.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.43 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.86 128.49 48.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.308 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 45' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' F' ' 140' ' ' THR . 29.2 tt0 -53.05 103.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 111.072 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 46' ' ' GLY . . . . . 0.413 ' HA2' ' HE1' ' F' ' 138' ' ' PHE . . . 96.01 39.05 4.42 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.101 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 47' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' F' ' 139' ' ' ALA . . . -80.14 146.68 31.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.64 125.1 19.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.897 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 49' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 32.5 m -101.98 -166.29 1.28 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.614 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.98 133.06 55.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.869 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 51' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' F' ' 136' ' ' ARG . . . -92.72 120.18 32.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.726 0.298 . . . . 0.0 111.246 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 52' ' ' VAL . . . . . 0.63 HG22 ' O ' ' F' ' 135' ' ' ALA . 18.6 m -65.85 162.67 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.888 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.83 124.07 5.26 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.635 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 54' ' ' PHE . . . . . 0.455 ' N ' HG21 ' C' ' 76' ' ' THR . 54.1 p90 -155.86 146.56 22.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.643 0.258 . . . . 0.0 111.027 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 55' ' ' ASN . . . . . 0.579 ' HB2' HG22 ' F' ' 130' ' ' THR . 0.6 OUTLIER -136.87 160.26 39.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.528 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 56' ' ' ILE . . . . . 0.574 HG23 ' O ' ' F' ' 56' ' ' ILE . 1.6 tp -100.65 116.91 45.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.555 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 57' ' ' GLN . . . . . 0.614 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.0 OUTLIER -70.04 124.61 24.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.76 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 58' ' ' LEU . . . . . 0.674 ' HA ' ' HA ' ' F' ' 23' ' ' VAL . 1.6 mp -133.77 87.48 2.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.216 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 59' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 4.9 p30 -73.69 174.57 8.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.931 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.82 79.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.763 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 61' ' ' CYS . . . . . 0.672 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 93.2 m -127.66 159.43 34.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.817 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 62' ' ' ASP . . . . . 0.604 ' OD2' HG23 ' F' ' 65' ' ' VAL . 5.5 t70 -130.27 167.07 19.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.288 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 63' ' ' THR . . . . . 0.662 HG23 ' HA ' ' F' ' 125' ' ' ASN . 0.2 OUTLIER -114.24 -41.7 3.45 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.197 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.57 -22.63 65.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.989 0.423 . . . . 0.0 111.694 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 65' ' ' VAL . . . . . 0.604 HG23 ' OD2' ' F' ' 62' ' ' ASP . 82.8 t -70.4 -74.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.657 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 66' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' F' ' 124' ' ' LEU . . . -120.75 131.34 54.45 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.629 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.24 -48.62 6.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.907 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 68' ' ' LYS . . . . . 0.632 ' HE3' ' HB3' ' F' ' 121' ' ' GLU . 0.1 OUTLIER -96.2 161.51 13.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.617 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.09 124.72 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.641 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 70' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -100.46 154.97 18.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.061 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 71' ' ' VAL . . . . . 0.825 HG11 HG21 ' F' ' 131' ' ' ILE . 2.3 t -132.73 148.33 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.69 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 72' ' ' ALA . . . . . 0.458 ' HA ' HD21 ' F' ' 111' ' ' LEU . . . -145.6 150.15 35.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.644 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 73' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -119.91 137.02 54.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.488 0.185 . . . . 0.0 111.059 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 74' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.9 OUTLIER -96.14 139.5 32.21 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.918 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 75' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' F' ' 113' ' ' LEU . . . 178.54 179.81 48.49 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.833 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 76' ' ' THR . . . . . 0.546 ' H ' HD23 ' F' ' 86' ' ' LEU . 0.3 OUTLIER -110.9 156.42 21.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.507 0.194 . . . . 0.0 110.856 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 77' ' ' ALA . . . . . 0.676 ' O ' ' HB2' ' F' ' 87' ' ' ALA . . . -73.81 131.26 41.35 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 78' ' ' ILE . . . . . 0.642 ' CG2' ' HB ' ' F' ' 85' ' ' VAL . 0.9 OUTLIER -67.69 -41.45 85.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.799 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 79' ' ' ASP . . . . . 0.427 ' N ' HG23 ' F' ' 78' ' ' ILE . 0.6 OUTLIER -141.12 40.77 1.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.773 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 66.45 -80.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.996 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.65 -24.99 41.92 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.696 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.01 63.93 1.37 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.851 0.358 . . . . 0.0 110.455 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 83' ' ' THR . . . . . 0.548 HG23 ' HB2' ' F' ' 77' ' ' ALA . 0.2 OUTLIER -68.5 -16.79 64.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.535 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 84' ' ' ASN . . . . . 0.703 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 18.0 p-10 -70.42 -20.25 62.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.329 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 85' ' ' VAL . . . . . 0.642 ' HB ' ' CG2' ' F' ' 78' ' ' ILE . 14.6 t -106.92 130.7 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.165 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 86' ' ' LEU . . . . . 0.788 HD22 ' HB1' ' F' ' 150' ' ' ALA . 0.5 OUTLIER -67.61 148.21 51.71 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 87' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' F' ' 77' ' ' ALA . . . -89.65 -167.47 1.87 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.87 0.367 . . . . 0.0 111.732 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 88' ' ' LEU . . . . . 0.657 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 1.5 mm? -78.34 157.22 29.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.054 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.61 -78.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.345 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 90' ' ' SER . . . . . 0.401 ' H ' ' H ' ' F' ' 91' ' ' SER . 0.5 OUTLIER -167.05 0.47 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.021 0.438 . . . . 0.0 111.469 179.476 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 91' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' F' ' 95' ' ' SER . 1.7 m -71.82 82.93 0.91 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.66 -13.95 61.87 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.863 0.364 . . . . 0.0 111.688 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.64 27.61 5.23 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.632 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.63 15.59 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.487 -0.864 . . . . 0.0 112.928 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 95' ' ' SER . . . . . 0.657 ' HB3' ' HG ' ' F' ' 88' ' ' LEU . 3.0 m -100.86 -172.82 2.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.713 0.292 . . . . 0.0 110.639 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.89 167.66 9.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.788 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 97' ' ' THR . . . . . 0.522 ' H ' ' HB ' ' F' ' 144' ' ' THR . 2.3 m -121.59 128.3 51.82 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.343 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 98' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' F' ' 141' ' ' GLY . 75.9 m-20 64.27 34.56 10.65 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.415 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 99' ' ' VAL . . . . . 0.485 HG13 HD23 ' F' ' 42' ' ' LEU . 0.5 OUTLIER -139.99 136.5 38.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.683 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.13 -156.87 8.34 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.577 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 101' ' ' VAL . . . . . 0.482 HG13 ' HB2' ' F' ' 86' ' ' LEU . 3.2 p -137.77 116.72 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 122.973 0.509 . . . . 0.0 111.616 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 102' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 1.2 tt0 -91.93 150.43 21.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 103' ' ' ILE . . . . . 0.666 HD12 ' HB3' ' F' ' 111' ' ' LEU . 0.5 OUTLIER -113.87 131.32 66.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.542 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 104' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 0.3 OUTLIER -106.29 130.1 54.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.645 0.259 . . . . 0.0 111.014 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 105' ' ' ASP . . . . . 0.737 ' HB3' HG22 ' F' ' 107' ' ' THR . 5.1 t0 -76.02 156.97 33.54 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.697 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 106' ' ' ARG . . . . . 0.721 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 3.5 ttp180 -71.31 -17.47 62.45 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.691 0.281 . . . . 0.0 111.061 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 107' ' ' THR . . . . . 0.737 HG22 ' HB3' ' F' ' 105' ' ' ASP . 6.2 t -67.19 -18.03 65.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 108' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' C' ' 80' ' ' ALA . . . 123.74 -45.63 1.17 Allowed Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.748 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.09 163.12 23.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.671 0.272 . . . . 0.0 111.181 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 110' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -84.16 127.45 33.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.067 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 111' ' ' LEU . . . . . 0.666 ' HB3' HD12 ' F' ' 103' ' ' ILE . 12.1 tp -86.28 156.18 20.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.317 0.58 . . . . 0.0 110.614 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 112' ' ' THR . . . . . 0.901 HG23 HG21 ' F' ' 117' ' ' THR . 0.5 OUTLIER -106.31 139.09 41.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.095 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 113' ' ' LEU . . . . . 0.626 HD13 ' HG ' ' F' ' 86' ' ' LEU . 1.0 OUTLIER -73.92 76.49 1.66 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.697 0.284 . . . . 0.0 110.746 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.45 -17.2 14.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.507 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.25 -51.8 1.25 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.647 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.05 18.89 21.57 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.918 0.39 . . . . 0.0 111.52 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 117' ' ' THR . . . . . 0.901 HG21 HG23 ' F' ' 112' ' ' THR . 0.2 OUTLIER -85.77 84.64 7.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 118' ' ' PHE . . . . . 0.722 ' HB3' ' HB1' ' F' ' 70' ' ' ALA . 95.7 m-85 -101.42 98.74 9.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.741 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 39.3 m -130.84 62.44 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.802 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.3 145.83 30.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.655 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 121' ' ' GLU . . . . . 0.632 ' HB3' ' HE3' ' F' ' 68' ' ' LYS . 3.5 mm-40 -121.34 71.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.223 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 134.7 34.72 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.738 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 15.2 m -83.81 113.68 21.09 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.739 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 124' ' ' LEU . . . . . 0.631 ' CD2' ' HB1' ' F' ' 20' ' ' ALA . 19.0 tp -74.01 142.96 45.75 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.751 0.31 . . . . 0.0 110.589 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 125' ' ' ASN . . . . . 0.662 ' HA ' HG23 ' F' ' 63' ' ' THR . 0.9 OUTLIER -138.59 162.02 35.63 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.615 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.66 113.12 12.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.718 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.55 -139.9 9.48 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.779 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 128' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 6.7 m -101.75 96.78 7.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.726 0.298 . . . . 0.0 110.795 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.61 148.56 27.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.925 0.393 . . . . 0.0 111.112 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 130' ' ' THR . . . . . 0.624 HG21 HD21 ' C' ' 74' ' ' LEU . 0.2 OUTLIER -138.57 143.4 39.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.158 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 131' ' ' ILE . . . . . 0.825 HG21 HG11 ' F' ' 71' ' ' VAL . 54.9 mt -104.66 112.45 65.33 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 132' ' ' PRO . . . . . 0.721 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.4 Cg_endo -81.93 141.94 12.22 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.758 1.639 . . . . 0.0 112.492 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.67 141.1 22.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.845 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -104.48 152.63 22.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.091 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 135' ' ' ALA . . . . . 0.63 ' O ' HG22 ' F' ' 52' ' ' VAL . . . -153.54 101.03 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.931 0.396 . . . . 0.0 111.615 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 136' ' ' ARG . . . . . 0.552 ' HB3' ' HA ' ' F' ' 51' ' ' ALA . 17.4 ptt180 -107.11 177.32 4.89 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.428 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 137' ' ' TYR . . . . . 0.49 ' HB3' HD21 ' F' ' 42' ' ' LEU . 4.6 m-85 -86.02 124.08 32.06 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.979 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 138' ' ' PHE . . . . . 0.46 ' HB3' HG11 ' F' ' 85' ' ' VAL . 1.2 t80 -118.81 112.38 19.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.016 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 139' ' ' ALA . . . . . 0.67 ' HB2' HD23 ' F' ' 42' ' ' LEU . . . -102.95 133.95 47.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.921 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 140' ' ' THR . . . . . 0.622 ' O ' ' HA ' ' F' ' 45' ' ' GLU . 0.1 OUTLIER -81.05 -28.89 35.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.547 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 141' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' F' ' 98' ' ' ASN . . . -160.18 -111.11 0.28 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.864 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.78 110.61 21.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.511 0.196 . . . . 0.0 110.784 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 143' ' ' ALA . . . . . 0.686 ' HB3' ' HA ' ' F' ' 39' ' ' THR . . . -65.69 134.31 52.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 111.336 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 144' ' ' THR . . . . . 0.604 ' O ' ' CG1' ' E' ' 16' ' ' VAL . 56.7 m -105.9 149.42 38.01 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.268 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 145' ' ' PRO . . . . . 0.483 ' CD ' ' CG2' ' F' ' 144' ' ' THR . 1.5 Cg_endo -82.84 125.45 4.22 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.541 2.161 . . . . 0.0 112.03 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 146' ' ' GLY . . . . . 0.685 ' O ' ' CG ' ' E' ' 15' ' ' GLU . . . 168.77 -126.32 1.37 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.418 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 147' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -111.05 128.46 55.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.772 0.32 . . . . 0.0 111.355 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 148' ' ' ALA . . . . . 0.688 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -125.48 52.09 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.162 0.506 . . . . 0.0 110.402 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -98.68 151.94 20.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.627 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 150' ' ' ALA . . . . . 0.788 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -158.27 169.51 24.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.986 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.93 128.67 40.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.249 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 152' ' ' ALA . . . . . 0.497 ' HB2' HD11 ' F' ' 86' ' ' LEU . . . -122.21 144.04 49.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.233 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 153' ' ' THR . . . . . 1.025 HG23 HG22 ' E' ' 9' ' ' THR . 0.6 OUTLIER -106.3 145.38 31.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 154' ' ' PHE . . . . . 0.419 ' HB3' ' H ' ' E' ' 8' ' ' GLY . 0.5 OUTLIER -96.98 134.69 40.0 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.107 0.48 . . . . 0.0 110.053 -179.024 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 155' ' ' LYS . . . . . 0.411 ' HA ' ' H ' ' E' ' 7' ' ' GLY . 9.9 mmtt -124.22 148.06 47.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.88 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 156' ' ' VAL . . . . . 0.523 HG23 HG23 ' E' ' 5' ' ' VAL . 29.8 m -135.12 144.85 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.818 0.342 . . . . 0.0 111.787 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 157' ' ' GLN . . . . . 0.693 ' HG3' HG23 ' E' ' 4' ' ' THR . 0.0 OUTLIER -134.54 126.04 28.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.304 0.573 . . . . 0.0 110.362 -179.596 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 158' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' F' ' 21' ' ' CYS . 5.2 m-85 -106.0 128.73 54.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.559 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 159' ' ' GLN . . . . . 0.556 ' HG3' ' C ' ' F' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.259 -0.876 . . . . 0.0 110.817 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.258 0.075 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.61 71.05 0.5 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.992 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' B' ' 157' ' ' GLN . 4.9 m -114.68 127.37 55.72 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.431 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.3 m -117.71 106.76 13.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.704 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.459 HG21 HG12 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -133.9 174.61 12.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.58 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.1 119.87 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.528 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.27 -49.49 15.47 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.827 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.3 -154.89 11.32 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.866 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.711 HG22 HG23 ' B' ' 153' ' ' THR . 2.6 p -142.39 140.01 31.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.949 0.404 . . . . 0.0 111.223 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.69 113.82 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.23 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.08 110.32 20.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.404 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.24 111.56 22.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.75 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HE3' HG11 ' A' ' 28' ' ' VAL . 3.6 tmtm? -102.98 110.59 22.56 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.438 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.26 168.33 22.63 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.952 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.684 ' O ' ' HA ' ' B' ' 36' ' ' GLN . 3.6 tt0 -158.98 133.08 7.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.898 0.38 . . . . 0.0 110.417 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.892 HG23 ' HB2' ' B' ' 148' ' ' ALA . 13.0 t -99.64 143.17 13.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.25 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.536 HG13 ' HG2' ' B' ' 36' ' ' GLN . 3.9 m -141.41 -172.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.912 0.387 . . . . 0.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.46 -176.97 5.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.083 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.87 46.94 1.36 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.055 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.75 -29.98 2.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.443 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.999 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -163.11 158.45 21.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.907 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' B' ' 36' ' ' GLN . . . -161.39 118.53 2.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.026 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -66.27 153.1 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.025 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.75 158.75 20.64 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.603 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.03 -34.4 74.79 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.347 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.1 12.99 63.72 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.91 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.77 -22.4 10.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.791 0.329 . . . . 0.0 110.77 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.482 HG11 ' HE3' ' A' ' 13' ' ' LYS . 19.6 t -43.93 -64.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.359 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.05 135.83 41.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.968 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.17 125.72 20.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.088 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.76 106.53 18.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.066 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.74 117.06 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.074 0.464 . . . . 0.0 110.418 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.7 131.03 45.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.584 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.77 -47.37 7.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.586 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.41 -163.53 12.16 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.562 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -101.07 126.62 47.77 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.684 0.278 . . . . 0.0 110.833 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 42' ' ' LEU . 14.9 p -110.42 146.84 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.923 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -82.85 139.18 33.62 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.74 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.494 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 5.4 t -62.79 -37.42 86.6 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.746 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.46 71.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.108 0.48 . . . . 0.0 110.829 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.03 -17.76 45.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.112 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.725 HD23 ' HB2' ' A' ' 139' ' ' ALA . 4.3 mp -125.65 33.1 5.17 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.668 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.74 18.87 18.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.312 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.87 130.3 52.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.431 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 140' ' ' THR . 22.5 tt0 -56.38 107.38 0.37 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.866 0.365 . . . . 0.0 111.016 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.53 30.57 5.84 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.214 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 138' ' ' PHE . . . -76.57 136.65 39.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 112.081 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 52.3 p -134.87 134.73 41.04 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.869 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 70.9 m -108.79 -168.22 1.32 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.637 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.0 t -63.89 128.45 35.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.795 0.331 . . . . 0.0 110.799 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' A' ' 134' ' ' GLN . . . -80.41 130.0 34.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.436 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.728 HG22 ' HB3' ' A' ' 135' ' ' ALA . 2.8 m -74.84 151.22 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.925 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.98 119.22 5.67 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.577 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -153.86 152.09 30.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.729 0.3 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -148.74 162.94 38.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.633 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 56' ' ' ILE . 1.2 tp -105.98 114.82 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.548 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.872 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -70.69 124.53 24.48 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.721 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -132.32 88.81 2.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.203 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.601 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -75.31 169.47 18.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.895 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' B' ' 38' ' ' ARG . 0.4 OUTLIER 66.39 68.23 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.773 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.999 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 56.3 m -117.11 155.03 30.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.763 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.622 ' HB2' HH22 ' B' ' 38' ' ' ARG . 20.0 t70 -135.76 155.69 49.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.214 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -111.15 -34.23 6.24 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.141 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.08 -22.13 66.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 0.0 111.755 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.6 -59.54 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.696 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB3' HD23 ' A' ' 124' ' ' LEU . . . -116.84 129.18 55.92 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.646 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -60.31 2.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.856 0.36 . . . . 0.0 110.964 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.28 -175.33 2.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.499 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.0 131.36 9.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.52 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.466 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -106.04 151.14 25.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.036 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.607 HG11 HG21 ' A' ' 131' ' ' ILE . 2.0 t -129.46 158.31 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.714 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.633 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -152.66 143.09 22.62 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.579 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.608 ' HB3' HD23 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -112.32 141.47 46.0 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.683 0.278 . . . . 0.0 111.019 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.026 HD21 HG21 ' D' ' 130' ' ' THR . 0.3 OUTLIER -107.64 139.47 42.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.012 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.75 -179.54 46.85 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.816 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.768 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.3 OUTLIER -103.85 156.35 17.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.634 0.254 . . . . 0.0 110.823 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.34 118.35 21.17 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.93 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.557 HG22 ' HB3' ' A' ' 82' ' ' HIS . 0.4 OUTLIER -59.03 -29.11 40.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.81 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.446 ' HB2' HG21 ' A' ' 140' ' ' THR . 0.1 OUTLIER -151.74 50.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.805 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.22 -89.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.079 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.07 -32.55 42.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.584 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.557 ' HB3' HG22 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -81.12 62.84 5.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.892 0.377 . . . . 0.0 110.384 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.63 -18.18 60.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.585 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.71 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 20.4 p-10 -75.91 -7.48 54.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.266 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.487 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 24.1 t -117.7 124.22 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.214 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.931 HD22 ' HB1' ' A' ' 150' ' ' ALA . 0.5 OUTLIER -66.19 139.33 58.11 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.278 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -84.85 -165.42 1.19 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.705 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.776 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 0.7 OUTLIER -71.91 168.67 17.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.963 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.86 -79.24 0.06 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.335 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.775 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 2.4 p -168.84 6.0 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.016 0.436 . . . . 0.0 111.545 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.612 ' O ' ' HB2' ' A' ' 95' ' ' SER . 69.8 m -77.57 83.27 3.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.906 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' D' ' 50' ' ' SER . . . -55.07 -34.65 63.78 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.882 0.373 . . . . 0.0 111.626 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.27 31.51 6.31 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.604 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.59 7.46 0.23 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.919 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.776 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -110.78 -174.32 2.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.921 0.391 . . . . 0.0 110.588 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.431 ' O ' HD21 ' A' ' 88' ' ' LEU . . . -97.75 179.07 4.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.968 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.785 ' H ' ' HB ' ' A' ' 144' ' ' THR . 1.1 m -132.31 125.97 32.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.331 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 97' ' ' THR . 66.2 m-20 66.61 25.88 9.87 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.45 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.66 130.4 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.657 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.14 -161.35 10.74 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.508 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.494 ' CG2' ' HB1' ' A' ' 135' ' ' ALA . 0.8 OUTLIER -130.84 131.94 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.096 0.559 . . . . 0.0 111.825 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.721 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 1.5 tt0 -98.48 151.44 20.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.923 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.525 ' N ' ' HG2' ' A' ' 102' ' ' GLN . 0.3 OUTLIER -117.34 128.62 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.542 179.485 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.801 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -103.01 133.51 48.01 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.713 0.292 . . . . 0.0 111.034 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.718 ' HB3' HG22 ' A' ' 107' ' ' THR . 7.1 t0 -87.71 158.39 18.82 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.659 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 106' ' ' ARG . 7.9 ttp85 -70.47 -27.67 64.41 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.78 0.324 . . . . 0.0 111.081 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.718 HG22 ' HB3' ' A' ' 105' ' ' ASP . 2.8 t -51.76 -25.67 8.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.047 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.08 -39.18 1.74 Allowed Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.603 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.33 157.97 17.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 111.032 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.801 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -70.33 137.12 50.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.079 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.633 HD21 ' HA ' ' A' ' 72' ' ' ALA . 13.5 tp -87.54 158.41 18.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.29 0.567 . . . . 0.0 110.555 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.998 HG23 HG21 ' A' ' 117' ' ' THR . 0.5 OUTLIER -101.74 142.0 33.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.116 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.608 HD23 ' HB3' ' A' ' 73' ' ' PHE . 1.9 mt -82.41 65.57 7.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.71 0.291 . . . . 0.0 110.702 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.09 -14.93 21.23 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.52 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.25 -54.16 0.7 Allowed Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.596 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.2 28.92 8.27 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.016 0.436 . . . . 0.0 111.651 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.998 HG21 HG23 ' A' ' 112' ' ' THR . 0.0 OUTLIER -88.72 76.54 8.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.169 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.597 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 91.6 m-85 -91.01 96.75 10.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.743 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 68.0 m -132.67 78.25 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.7 136.9 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.667 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.01 76.2 0.98 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.275 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.83 135.51 33.68 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.732 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.7 m -77.08 96.35 4.42 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.71 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.734 ' O ' HG23 ' A' ' 63' ' ' THR . 10.8 tp -68.21 132.95 48.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.567 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -128.46 166.86 17.95 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.582 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 6.3 t30 -79.45 105.75 10.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.656 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.03 -137.04 5.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.749 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 3.7 m -103.61 83.47 2.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.753 0.311 . . . . 0.0 110.825 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.694 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 1.7 t30 -71.03 139.88 50.6 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.911 0.386 . . . . 0.0 111.158 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.872 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -133.95 139.66 46.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.158 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.607 HG21 HG11 ' A' ' 71' ' ' VAL . 61.7 mt -98.07 110.53 56.29 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -81.8 135.15 8.79 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.777 1.651 . . . . 0.0 112.528 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.72 152.71 41.63 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.791 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.583 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 50.6 mt-30 -119.0 156.85 28.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.067 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.728 ' HB3' HG22 ' A' ' 52' ' ' VAL . . . -151.39 101.79 2.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.372 . . . . 0.0 111.65 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.6 168.37 9.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.364 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -80.11 123.26 27.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.194 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 1.3 t80 -126.16 119.13 26.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.026 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.725 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -112.02 125.2 53.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.888 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -68.93 -48.19 63.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.51 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.431 ' H ' ' HB3' ' A' ' 98' ' ' ASN . . . -133.1 -120.0 2.08 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.043 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.42 111.94 18.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.597 0.237 . . . . 0.0 110.68 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.707 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -61.89 113.82 3.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.781 0.324 . . . . 0.0 111.447 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.785 ' HB ' ' H ' ' A' ' 97' ' ' THR . 75.1 m -88.31 145.25 35.43 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.32 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 144' ' ' THR . 1.3 Cg_endo -82.83 134.26 7.2 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.458 2.106 . . . . 0.0 111.987 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.87 -135.59 4.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.553 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.691 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -96.21 134.21 39.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.889 0.376 . . . . 0.0 111.301 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.78 50.5 2.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.135 0.493 . . . . 0.0 110.499 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -99.01 146.17 26.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.503 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.931 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -154.99 174.12 15.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.932 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.495 ' C ' HD11 ' A' ' 86' ' ' LEU . 26.8 t70 -139.33 128.45 23.82 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.16 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -118.4 133.29 56.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.159 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.92 147.41 22.99 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.25 130.28 53.42 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.131 0.491 . . . . 0.0 110.07 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -126.69 143.99 51.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.871 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.523 HG12 ' CD1' ' A' ' 131' ' ' ILE . 27.3 m -127.4 151.9 34.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.645 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.36 121.12 13.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.263 0.554 . . . . 0.0 110.404 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' A' ' 21' ' ' CYS . 1.2 m-85 -98.28 121.65 40.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.548 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.822 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 111.188 0.07 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.62 71.07 0.5 Allowed 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.148 0.28 . . . . 0.0 110.93 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' C' ' 157' ' ' GLN . 4.9 m -114.67 127.43 55.76 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.464 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 20.5 m -117.75 106.85 13.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.623 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.454 HG21 HG12 ' C' ' 17' ' ' VAL . 0.0 OUTLIER -134.0 174.66 12.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.612 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.13 119.89 36.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.501 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.23 -49.55 15.42 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.835 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.28 -154.87 11.3 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.845 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.721 HG22 HG23 ' C' ' 153' ' ' THR . 2.7 p -142.41 140.04 31.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.974 0.416 . . . . 0.0 111.224 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.76 113.82 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.177 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.08 110.3 20.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.365 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -90.18 111.53 22.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.78 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.485 ' HE3' HG11 ' B' ' 28' ' ' VAL . 3.6 tmtm? -102.96 110.52 22.46 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.49 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.19 168.35 22.59 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.0 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.686 ' O ' ' HA ' ' C' ' 36' ' ' GLN . 3.6 tt0 -159.01 133.06 7.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.473 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.891 HG23 ' HB2' ' C' ' 148' ' ' ALA . 13.1 t -99.62 143.22 13.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.25 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.538 HG13 ' HG2' ' C' ' 36' ' ' GLN . 3.9 m -141.48 -172.15 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.838 0.352 . . . . 0.0 110.992 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.43 -177.02 5.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.083 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.77 46.91 1.36 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.77 -29.93 2.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.498 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER -163.18 158.41 21.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.94 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' C' ' 36' ' ' GLN . . . -161.39 118.54 2.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.041 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' B' ' 58' ' ' LEU . 0.8 OUTLIER -66.27 153.05 8.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.018 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.75 158.73 20.65 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.582 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.02 -34.39 74.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.345 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.14 13.07 63.6 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.914 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.81 -22.43 10.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.84 0.353 . . . . 0.0 110.782 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.485 HG11 ' HE3' ' B' ' 13' ' ' LYS . 19.8 t -44.08 -64.21 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.348 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.09 135.85 41.89 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.005 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.15 125.67 20.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.058 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.8 106.54 18.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.058 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.68 117.07 53.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.455 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.71 131.05 45.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.597 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.8 -47.32 7.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.658 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.34 -163.61 12.15 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.561 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 3.7 mt-30 -100.98 126.6 47.65 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.65 0.262 . . . . 0.0 110.817 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.451 HG21 HD13 ' B' ' 42' ' ' LEU . 14.9 p -110.4 146.89 15.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.9 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.622 HH22 ' HB2' ' A' ' 62' ' ' ASP . 2.9 mtp180 -82.92 139.17 33.53 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.655 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.489 ' HA ' ' HB3' ' B' ' 143' ' ' ALA . 5.4 t -62.77 -37.44 86.67 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.778 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.45 71.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.072 0.463 . . . . 0.0 110.818 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.05 -17.75 45.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.171 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.741 HD23 ' HB2' ' B' ' 139' ' ' ALA . 4.3 mp -125.66 33.11 5.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.662 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.74 18.89 18.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.341 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.92 130.26 52.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.387 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' B' ' 140' ' ' THR . 22.5 tt0 -56.27 107.29 0.35 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.832 0.349 . . . . 0.0 111.095 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.52 30.56 5.84 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.195 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' B' ' 138' ' ' PHE . . . -76.6 136.76 39.22 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.986 0.422 . . . . 0.0 112.093 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' B' ' 137' ' ' TYR . 51.6 p -134.99 134.69 40.74 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.822 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 70.8 m -108.74 -168.14 1.31 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.65 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 23.3 t -63.93 128.44 35.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.774 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.586 ' HB1' ' HB3' ' B' ' 134' ' ' GLN . . . -80.41 129.96 34.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.451 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.72 HG22 ' HB3' ' B' ' 135' ' ' ALA . 2.8 m -74.87 151.26 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.922 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.05 119.25 5.67 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.512 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.81 152.12 30.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.783 0.325 . . . . 0.0 110.951 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -148.75 162.96 38.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.661 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.609 HG23 ' O ' ' B' ' 56' ' ' ILE . 1.2 tp -105.94 114.87 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.573 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLN . . . . . 0.865 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -70.72 124.51 24.46 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.749 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 0.2 OUTLIER -132.32 88.78 2.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.242 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.587 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 0.1 OUTLIER -75.31 169.44 18.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' C' ' 38' ' ' ARG . 0.4 OUTLIER 66.38 68.25 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.788 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 61' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 56.3 m -117.11 155.0 30.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.816 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ASP . . . . . 0.621 ' HB2' HH22 ' C' ' 38' ' ' ARG . 19.9 t70 -135.74 155.65 50.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.311 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.733 HG23 ' O ' ' B' ' 124' ' ' LEU . 0.2 OUTLIER -111.11 -34.17 6.26 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.12 -22.17 66.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.008 0.433 . . . . 0.0 111.735 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.54 -59.54 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.767 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.548 ' HB3' HD23 ' B' ' 124' ' ' LEU . . . -116.76 129.16 55.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.706 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.16 -60.29 2.2 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.921 0.391 . . . . 0.0 111.019 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.26 -175.38 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.479 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.96 131.3 9.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.55 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -105.95 151.2 24.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.067 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.625 HG11 HG21 ' B' ' 131' ' ' ILE . 2.0 t -129.45 158.31 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.788 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.628 ' HA ' HD21 ' B' ' 111' ' ' LEU . . . -152.73 143.1 22.57 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.558 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.612 ' HB3' HD23 ' B' ' 113' ' ' LEU . 0.1 OUTLIER -112.3 141.49 45.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.648 0.261 . . . . 0.0 111.034 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.979 HD21 HG21 ' E' ' 130' ' ' THR . 0.3 OUTLIER -107.67 139.51 42.13 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.966 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.76 -179.46 46.91 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.851 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.767 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.3 OUTLIER -103.96 156.33 17.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.602 0.239 . . . . 0.0 110.782 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.4 ' HB2' HG23 ' B' ' 83' ' ' THR . . . -79.33 118.42 21.23 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.943 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.563 HG22 ' HB3' ' B' ' 82' ' ' HIS . 0.4 OUTLIER -59.05 -29.07 40.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.446 ' HB2' HG21 ' B' ' 140' ' ' THR . 0.1 OUTLIER -151.75 50.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.14 -89.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.118 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.06 -32.49 42.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.652 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.563 ' HB3' HG22 ' B' ' 78' ' ' ILE . 0.3 OUTLIER -81.15 62.83 5.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.938 0.399 . . . . 0.0 110.43 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 83' ' ' THR . . . . . 0.4 HG23 ' HB2' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -74.65 -18.13 60.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.557 -179.578 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ASN . . . . . 0.701 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 20.4 p-10 -76.01 -7.38 54.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.279 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.486 ' HB ' ' CG2' ' B' ' 78' ' ' ILE . 23.9 t -117.68 124.12 72.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.235 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.991 HD22 ' HB1' ' B' ' 150' ' ' ALA . 0.5 OUTLIER -66.21 139.34 58.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' B' ' 78' ' ' ILE . . . -84.87 -165.42 1.19 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.674 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.77 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 0.7 OUTLIER -71.86 168.67 17.41 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.086 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.94 -79.18 0.06 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.279 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' SER . . . . . 0.764 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 2.4 p -168.88 5.91 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.048 0.452 . . . . 0.0 111.572 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' SER . . . . . 0.61 ' O ' ' HB2' ' B' ' 95' ' ' SER . 69.9 m -77.56 83.22 3.96 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.952 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' E' ' 50' ' ' SER . . . -55.02 -34.68 63.69 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.88 0.372 . . . . 0.0 111.617 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.22 31.49 6.33 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.571 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.58 7.49 0.23 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.943 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' SER . . . . . 0.77 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . 0.6 OUTLIER -110.73 -174.33 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.943 0.401 . . . . 0.0 110.581 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.432 ' O ' HD21 ' B' ' 88' ' ' LEU . . . -97.83 179.09 4.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.914 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.785 ' H ' ' HB ' ' B' ' 144' ' ' THR . 1.1 m -132.42 125.99 32.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.296 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' B' ' 97' ' ' THR . 66.1 m-20 66.66 25.84 9.79 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.422 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.69 130.44 70.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.686 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.08 -161.36 10.74 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.535 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.496 ' CG2' ' HB1' ' B' ' 135' ' ' ALA . 0.8 OUTLIER -130.87 131.97 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 123.056 0.542 . . . . 0.0 111.756 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.727 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 1.5 tt0 -98.52 151.49 20.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.901 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.524 ' N ' ' HG2' ' B' ' 102' ' ' GLN . 0.3 OUTLIER -117.36 128.67 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.513 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 104' ' ' LEU . . . . . 0.791 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 0.3 OUTLIER -103.03 133.55 47.97 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.707 0.289 . . . . 0.0 111.01 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ASP . . . . . 0.719 ' HB3' HG22 ' B' ' 107' ' ' THR . 7.2 t0 -87.78 158.46 18.76 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.601 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' B' ' 106' ' ' ARG . 7.9 ttp85 -70.47 -27.75 64.46 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.733 0.301 . . . . 0.0 111.026 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.719 HG22 ' HB3' ' B' ' 105' ' ' ASP . 2.8 t -51.73 -25.74 8.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.036 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.26 -39.25 1.73 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.58 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.31 158.05 17.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 0.0 111.0 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.791 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -70.36 137.11 50.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.063 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.628 HD21 ' HA ' ' B' ' 72' ' ' ALA . 13.5 tp -87.55 158.29 18.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.333 0.587 . . . . 0.0 110.563 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.989 HG23 HG21 ' B' ' 117' ' ' THR . 0.5 OUTLIER -101.62 141.96 33.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.147 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' B' ' 73' ' ' PHE . 1.9 mt -82.32 65.54 7.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.734 0.302 . . . . 0.0 110.801 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.08 -14.94 21.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.542 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.28 -54.18 0.7 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.623 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.19 28.99 8.2 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.02 0.438 . . . . 0.0 111.69 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.989 HG21 HG23 ' B' ' 112' ' ' THR . 0.0 OUTLIER -88.8 76.6 7.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.124 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.601 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 91.4 m-85 -91.06 96.77 10.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.747 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 68.6 m -132.64 78.32 1.79 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.797 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.76 136.81 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.703 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -114.97 76.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.252 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.93 135.6 33.61 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.691 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 11.8 m -77.12 96.28 4.44 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.703 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.733 ' O ' HG23 ' B' ' 63' ' ' THR . 10.8 tp -68.12 132.94 48.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.589 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -128.47 166.74 18.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.601 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' B' ' 61' ' ' CYS . 6.2 t30 -79.38 105.78 10.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.697 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.03 -137.06 5.22 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.675 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 3.7 m -103.63 83.47 2.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.707 0.289 . . . . 0.0 110.773 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ASN . . . . . 0.692 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 1.7 t30 -71.09 139.84 50.48 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.979 0.418 . . . . 0.0 111.148 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.865 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -133.91 139.6 46.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.133 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 131' ' ' ILE . . . . . 0.625 HG21 HG11 ' B' ' 71' ' ' VAL . 61.8 mt -97.99 110.48 55.93 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -81.74 135.13 8.85 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.75 1.633 . . . . 0.0 112.574 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.76 152.65 41.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.756 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 134' ' ' GLN . . . . . 0.586 ' HB3' ' HB1' ' B' ' 51' ' ' ALA . 50.5 mt-30 -118.96 156.9 28.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.065 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' B' ' 102' ' ' GLN . . . -151.41 101.66 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.352 . . . . 0.0 111.659 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.58 168.33 9.17 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.35 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' B' ' 48' ' ' THR . 0.3 OUTLIER -80.06 123.32 27.75 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.173 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 138' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' B' ' 47' ' ' ALA . 1.3 t80 -126.2 119.12 26.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.948 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.741 ' HB2' HD23 ' B' ' 42' ' ' LEU . . . -111.99 125.16 53.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.919 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 140' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.22 63.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.507 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 141' ' ' GLY . . . . . 0.425 ' H ' ' HB3' ' B' ' 98' ' ' ASN . . . -133.1 -119.99 2.08 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.111 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.4 111.95 18.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.558 0.218 . . . . 0.0 110.738 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' ALA . . . . . 0.714 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -61.91 113.82 3.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.784 0.326 . . . . 0.0 111.409 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.785 ' HB ' ' H ' ' B' ' 97' ' ' THR . 74.1 m -88.25 145.23 35.47 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.302 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 144' ' ' THR . 1.3 Cg_endo -82.82 134.19 7.17 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.546 2.164 . . . . 0.0 112.019 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.88 -135.58 4.41 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.529 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.678 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -96.16 134.2 39.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.86 0.362 . . . . 0.0 111.361 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 148' ' ' ALA . . . . . 0.892 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -129.81 50.45 2.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.207 0.527 . . . . 0.0 110.506 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -98.93 146.15 26.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.551 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.991 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -154.91 174.08 15.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.883 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' ASP . . . . . 0.494 ' C ' HD11 ' B' ' 86' ' ' LEU . 26.6 t70 -139.31 128.49 23.93 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.171 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -118.45 133.27 56.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.169 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.711 HG23 HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -91.93 147.39 23.0 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.153 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.27 130.32 53.43 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.195 0.521 . . . . 0.0 110.037 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -126.64 143.89 51.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.931 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' VAL . . . . . 0.513 HG12 ' CD1' ' B' ' 131' ' ' ILE . 27.3 m -127.42 151.89 34.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.746 0.307 . . . . 0.0 111.709 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -141.39 121.1 13.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.32 0.581 . . . . 0.0 110.342 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 158' ' ' TYR . . . . . 0.578 ' CD2' ' HB ' ' A' ' 3' ' ' THR . 1.2 m-85 -98.21 121.64 40.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.577 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.86 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 111.176 0.065 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.59 71.06 0.5 Allowed 'General case' 0 C--O 1.232 0.132 0 O-C-N 123.122 0.264 . . . . 0.0 111.023 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.687 ' O ' ' HA ' ' D' ' 157' ' ' GLN . 4.9 m -114.71 127.42 55.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.447 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 20.8 m -117.84 106.77 13.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.609 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.456 HG21 HG12 ' D' ' 17' ' ' VAL . 0.0 OUTLIER -133.92 174.65 12.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.615 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.07 119.82 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.607 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.17 -49.5 15.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.835 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.32 -154.92 11.36 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.854 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' THR . . . . . 0.74 HG22 HG23 ' D' ' 153' ' ' THR . 2.7 p -142.4 139.98 31.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.927 0.394 . . . . 0.0 111.292 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.74 113.93 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.155 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -87.16 110.3 20.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.313 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.23 111.54 22.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.776 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.487 ' HE3' HG11 ' C' ' 28' ' ' VAL . 3.7 tmtm? -102.94 110.61 22.59 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.435 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.32 168.38 22.64 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.058 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' GLU . . . . . 0.674 ' O ' ' HA ' ' D' ' 36' ' ' GLN . 3.6 tt0 -159.01 133.09 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 0.0 110.413 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.872 HG23 ' HB2' ' D' ' 148' ' ' ALA . 13.3 t -99.74 143.27 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.203 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.526 HG13 ' HG2' ' D' ' 36' ' ' GLN . 4.0 m -141.42 -172.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 111.074 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.56 -176.94 5.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.058 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.8 46.84 1.36 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.039 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.76 -29.96 2.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.924 0.392 . . . . 0.0 111.485 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 21' ' ' CYS . . . . . 0.988 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER -163.12 158.33 21.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.996 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 22' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' D' ' 36' ' ' GLN . . . -161.33 118.62 2.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.042 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 23' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' C' ' 58' ' ' LEU . 0.8 OUTLIER -66.28 153.07 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.086 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.78 158.73 20.62 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.613 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.562 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -61.01 -34.4 74.77 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.316 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.16 13.07 63.58 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.887 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.8 -22.44 10.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.801 0.334 . . . . 0.0 110.733 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.487 HG11 ' HE3' ' C' ' 13' ' ' LYS . 19.8 t -43.98 -64.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.336 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.04 135.83 41.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.949 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.21 125.72 20.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.066 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.74 106.53 18.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.15 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.75 117.05 53.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.067 0.461 . . . . 0.0 110.482 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.69 131.05 45.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.576 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.81 -47.31 7.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.607 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.33 -163.6 12.15 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.551 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' GLN . . . . . 0.686 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 3.7 mt-30 -100.98 126.59 47.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.634 0.255 . . . . 0.0 110.841 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.445 HG21 HD13 ' C' ' 42' ' ' LEU . 14.9 p -110.4 146.8 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.926 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 38' ' ' ARG . . . . . 0.621 HH22 ' HB2' ' B' ' 62' ' ' ASP . 2.8 mtp180 -82.8 139.08 33.74 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.757 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.5 ' HA ' ' HB3' ' C' ' 143' ' ' ALA . 5.5 t -62.74 -37.42 86.5 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.778 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.47 -31.49 71.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.125 0.488 . . . . 0.0 110.847 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.04 -17.73 45.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.102 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.743 HD23 ' HB2' ' C' ' 139' ' ' ALA . 4.3 mp -125.72 33.11 5.16 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.604 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.76 18.96 18.03 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.372 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.96 130.23 52.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.355 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' C' ' 140' ' ' THR . 22.5 tt0 -56.27 107.33 0.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.883 0.373 . . . . 0.0 111.088 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.6 30.51 5.83 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.133 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' C' ' 138' ' ' PHE . . . -76.58 136.62 39.25 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 48' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' C' ' 137' ' ' TYR . 52.2 p -134.91 134.73 40.95 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.848 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 71.1 m -108.76 -168.15 1.31 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.665 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 23.1 t -63.96 128.46 35.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.854 0.359 . . . . 0.0 110.756 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' C' ' 134' ' ' GLN . . . -80.4 129.98 34.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.43 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.715 HG22 ' HB3' ' C' ' 135' ' ' ALA . 2.8 m -74.86 151.21 6.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.993 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.01 119.26 5.68 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.547 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.91 152.08 30.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.731 0.301 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -148.72 162.95 38.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.694 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.609 HG23 ' O ' ' C' ' 56' ' ' ILE . 1.2 tp -105.96 114.82 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.534 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.886 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.0 OUTLIER -70.67 124.54 24.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.703 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 58' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' C' ' 23' ' ' VAL . 0.2 OUTLIER -132.34 88.79 2.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.235 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 59' ' ' ASN . . . . . 0.577 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 0.1 OUTLIER -75.28 169.44 18.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 60' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' D' ' 38' ' ' ARG . 0.4 OUTLIER 66.37 68.24 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.802 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 61' ' ' CYS . . . . . 0.988 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 56.3 m -117.13 155.04 30.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.809 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 62' ' ' ASP . . . . . 0.625 ' HB2' HH22 ' D' ' 38' ' ' ARG . 20.0 t70 -135.8 155.63 50.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.25 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.738 HG23 ' O ' ' C' ' 124' ' ' LEU . 0.2 OUTLIER -111.08 -34.22 6.25 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.121 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.13 -22.12 66.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.012 0.434 . . . . 0.0 111.705 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.57 -59.65 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.669 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' ALA . . . . . 0.56 ' HB3' HD23 ' C' ' 124' ' ' LEU . . . -116.69 129.1 55.93 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.72 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.13 -60.28 2.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.914 0.388 . . . . 0.0 111.033 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.23 -175.34 2.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.49 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.93 131.38 9.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.604 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -106.05 151.18 24.99 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.841 0.353 . . . . 0.0 111.056 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 71' ' ' VAL . . . . . 0.621 HG11 HG21 ' C' ' 131' ' ' ILE . 2.0 t -129.47 158.32 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.766 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 72' ' ' ALA . . . . . 0.657 ' HA ' HD21 ' C' ' 111' ' ' LEU . . . -152.66 143.06 22.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.61 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 73' ' ' PHE . . . . . 0.612 ' HB3' HD23 ' C' ' 113' ' ' LEU . 0.1 OUTLIER -112.29 141.5 45.92 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.643 0.259 . . . . 0.0 111.068 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.97 HD21 HG21 ' F' ' 130' ' ' THR . 0.3 OUTLIER -107.71 139.45 42.26 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.955 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.79 -179.48 46.92 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.837 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.765 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.3 OUTLIER -103.97 156.38 17.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.607 0.241 . . . . 0.0 110.811 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.37 118.38 21.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.981 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 78' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' C' ' 82' ' ' HIS . 0.4 OUTLIER -59.02 -29.09 40.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.887 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 79' ' ' ASP . . . . . 0.45 ' HB2' HG21 ' C' ' 140' ' ' THR . 0.1 OUTLIER -151.76 50.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.822 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.25 -89.9 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.069 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.06 -32.59 42.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.573 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 82' ' ' HIS . . . . . 0.564 ' HB3' HG22 ' C' ' 78' ' ' ILE . 0.3 OUTLIER -81.04 62.78 5.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.856 0.36 . . . . 0.0 110.438 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.58 -18.21 60.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.61 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 84' ' ' ASN . . . . . 0.706 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 20.4 p-10 -75.86 -7.49 54.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.329 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.492 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 23.9 t -117.68 124.16 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.217 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.986 HD22 ' HB1' ' C' ' 150' ' ' ALA . 0.5 OUTLIER -66.14 139.36 58.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.697 0.284 . . . . 0.0 110.244 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' C' ' 78' ' ' ILE . . . -84.9 -165.44 1.2 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.605 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.76 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 0.7 OUTLIER -71.88 168.65 17.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.012 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.93 -79.17 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.337 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 90' ' ' SER . . . . . 0.769 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 2.3 p -168.86 5.95 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 111.525 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 91' ' ' SER . . . . . 0.611 ' O ' ' HB2' ' C' ' 95' ' ' SER . 69.7 m -77.54 83.21 3.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.971 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 92' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' F' ' 50' ' ' SER . . . -54.99 -34.67 63.59 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.89 0.376 . . . . 0.0 111.63 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.29 31.48 6.32 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.586 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.59 7.48 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.94 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 95' ' ' SER . . . . . 0.76 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 0.6 OUTLIER -110.74 -174.32 2.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.888 0.375 . . . . 0.0 110.612 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 96' ' ' ALA . . . . . 0.432 ' O ' HD21 ' C' ' 88' ' ' LEU . . . -97.76 179.0 4.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 97' ' ' THR . . . . . 0.771 ' H ' ' HB ' ' C' ' 144' ' ' THR . 1.1 m -132.29 125.98 32.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.356 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 98' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' C' ' 97' ' ' THR . 66.0 m-20 66.57 25.92 9.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.396 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.7 130.37 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.705 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.07 -161.39 10.76 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.501 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 101' ' ' VAL . . . . . 0.486 ' CG2' ' HB1' ' C' ' 135' ' ' ALA . 0.8 OUTLIER -130.88 131.95 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 123.094 0.558 . . . . 0.0 111.866 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 102' ' ' GLN . . . . . 0.726 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 1.5 tt0 -98.49 151.46 20.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.897 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.525 ' N ' ' HG2' ' C' ' 102' ' ' GLN . 0.3 OUTLIER -117.33 128.64 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.58 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 104' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 0.3 OUTLIER -102.98 133.46 48.05 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.654 0.264 . . . . 0.0 111.033 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 105' ' ' ASP . . . . . 0.71 ' HB3' HG22 ' C' ' 107' ' ' THR . 7.2 t0 -87.74 158.44 18.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.636 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 106' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' C' ' 106' ' ' ARG . 7.9 ttp85 -70.5 -27.72 64.42 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.714 0.293 . . . . 0.0 111.02 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 107' ' ' THR . . . . . 0.71 HG22 ' HB3' ' C' ' 105' ' ' ASP . 2.8 t -51.68 -25.68 7.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.096 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.16 -39.29 1.73 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.617 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.26 157.99 17.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.351 . . . . 0.0 111.065 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -70.32 137.07 50.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.111 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 111' ' ' LEU . . . . . 0.657 HD21 ' HA ' ' C' ' 72' ' ' ALA . 13.5 tp -87.56 158.47 18.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.382 0.611 . . . . 0.0 110.499 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 112' ' ' THR . . . . . 0.998 HG23 HG21 ' C' ' 117' ' ' THR . 0.5 OUTLIER -101.76 141.97 33.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.123 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' C' ' 73' ' ' PHE . 1.9 mt -82.43 65.6 7.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 0.0 110.708 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.08 -14.93 21.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.528 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.19 -54.11 0.71 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.678 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.17 28.83 8.35 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.017 0.437 . . . . 0.0 111.721 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 117' ' ' THR . . . . . 0.998 HG21 HG23 ' C' ' 112' ' ' THR . 0.0 OUTLIER -88.72 76.6 8.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.24 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 118' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' C' ' 71' ' ' VAL . 91.3 m-85 -91.13 96.77 10.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.724 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 68.6 m -132.65 78.25 1.79 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.818 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.67 136.88 3.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.692 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.02 76.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.267 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.88 135.56 33.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.703 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 11.8 m -77.05 96.33 4.4 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.73 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 124' ' ' LEU . . . . . 0.738 ' O ' HG23 ' C' ' 63' ' ' THR . 10.8 tp -68.25 132.92 47.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.627 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -128.49 166.83 18.02 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.569 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 126' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' C' ' 61' ' ' CYS . 6.3 t30 -79.43 105.76 10.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.696 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.05 -137.06 5.22 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.655 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 128' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 3.7 m -103.62 83.49 2.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.688 0.28 . . . . 0.0 110.778 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 129' ' ' ASN . . . . . 0.686 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 1.7 t30 -71.12 139.92 50.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.959 0.409 . . . . 0.0 111.099 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 130' ' ' THR . . . . . 0.886 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -134.0 139.7 46.23 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.024 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 131' ' ' ILE . . . . . 0.621 HG21 HG11 ' C' ' 71' ' ' VAL . 61.9 mt -98.07 110.55 56.37 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 132' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -81.79 135.13 8.78 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.753 1.635 . . . . 0.0 112.596 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.71 152.67 41.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.773 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 134' ' ' GLN . . . . . 0.595 ' HB3' ' HB1' ' C' ' 51' ' ' ALA . 50.6 mt-30 -119.01 156.9 28.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.07 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.726 ' HA ' ' O ' ' C' ' 102' ' ' GLN . . . -151.43 101.67 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 0.0 111.633 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.61 168.28 9.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.359 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 137' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' C' ' 48' ' ' THR . 0.3 OUTLIER -79.98 123.23 27.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.192 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 138' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' C' ' 47' ' ' ALA . 1.3 t80 -126.11 119.05 26.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.085 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 139' ' ' ALA . . . . . 0.743 ' HB2' HD23 ' C' ' 42' ' ' LEU . . . -111.95 125.21 53.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.954 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 140' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.17 64.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.543 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 141' ' ' GLY . . . . . 0.439 ' H ' ' HB3' ' C' ' 98' ' ' ASN . . . -133.15 -120.0 2.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.043 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.43 111.89 18.19 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.559 0.219 . . . . 0.0 110.708 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 143' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -61.88 113.78 2.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.794 0.331 . . . . 0.0 111.39 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 144' ' ' THR . . . . . 0.771 ' HB ' ' H ' ' C' ' 97' ' ' THR . 75.5 m -88.18 145.24 35.65 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.366 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.87 134.19 7.12 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.499 2.132 . . . . 0.0 112.005 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.93 -135.55 4.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.502 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 147' ' ' ALA . . . . . 0.703 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -96.24 134.23 39.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.881 0.372 . . . . 0.0 111.336 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 148' ' ' ALA . . . . . 0.891 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -129.85 50.49 2.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.161 0.505 . . . . 0.0 110.456 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -98.95 146.15 26.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.555 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 150' ' ' ALA . . . . . 0.986 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -154.9 174.11 15.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.986 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 151' ' ' ASP . . . . . 0.488 ' C ' HD11 ' C' ' 86' ' ' LEU . 26.9 t70 -139.28 128.48 23.95 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.186 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 152' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -118.43 133.35 55.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.11 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 153' ' ' THR . . . . . 0.721 HG23 HG22 ' B' ' 9' ' ' THR . 0.2 OUTLIER -91.97 147.41 22.98 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.26 130.25 53.44 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.125 0.488 . . . . 0.0 110.062 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -126.67 143.9 51.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.954 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 156' ' ' VAL . . . . . 0.524 HG12 ' CD1' ' C' ' 131' ' ' ILE . 27.3 m -127.35 151.92 34.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.69 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 157' ' ' GLN . . . . . 0.683 ' HA ' ' O ' ' B' ' 3' ' ' THR . 0.0 OUTLIER -141.34 121.15 13.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.298 0.57 . . . . 0.0 110.37 -179.668 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 158' ' ' TYR . . . . . 0.577 ' CD2' ' HB ' ' B' ' 3' ' ' THR . 1.2 m-85 -98.26 121.63 40.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.56 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.808 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 111.261 0.097 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.62 71.14 0.5 Allowed 'General case' 0 N--CA 1.462 0.157 0 O-C-N 123.107 0.254 . . . . 0.0 110.96 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 3' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' E' ' 157' ' ' GLN . 4.8 m -114.68 127.32 55.69 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.475 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 20.2 m -117.7 106.77 13.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.633 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.458 HG21 HG12 ' E' ' 17' ' ' VAL . 0.0 OUTLIER -133.91 174.64 12.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.567 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.13 119.83 36.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.586 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.2 -49.49 15.71 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.839 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.26 -154.82 11.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.848 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 9' ' ' THR . . . . . 0.709 HG22 HG23 ' E' ' 153' ' ' THR . 2.7 p -142.49 140.04 31.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.983 0.421 . . . . 0.0 111.176 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.73 113.89 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.151 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.14 110.39 20.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.363 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.3 111.48 22.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.74 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 13' ' ' LYS . . . . . 0.485 ' HE3' HG11 ' D' ' 28' ' ' VAL . 3.6 tmtm? -102.96 110.5 22.44 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.453 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.19 168.31 22.6 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.014 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 15' ' ' GLU . . . . . 0.687 ' O ' ' HA ' ' E' ' 36' ' ' GLN . 3.6 tt0 -158.99 133.07 7.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.93 0.395 . . . . 0.0 110.4 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.89 HG23 ' HB2' ' E' ' 148' ' ' ALA . 13.2 t -99.65 143.14 14.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.286 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.539 HG13 ' HG2' ' E' ' 36' ' ' GLN . 3.9 m -141.33 -172.11 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.862 0.363 . . . . 0.0 111.074 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.49 -176.91 5.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.034 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.87 46.95 1.36 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.106 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.77 -29.97 2.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 21' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER -163.14 158.38 21.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.915 -179.78 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 22' ' ' ALA . . . . . 0.565 ' HB1' ' O ' ' E' ' 36' ' ' GLN . . . -161.35 118.54 2.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.103 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 23' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' D' ' 58' ' ' LEU . 0.8 OUTLIER -66.25 152.99 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.065 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -84.68 158.77 20.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.611 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.559 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -61.03 -34.47 74.9 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.344 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.05 13.03 63.77 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.929 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.78 -22.43 10.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.776 0.322 . . . . 0.0 110.773 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 28' ' ' VAL . . . . . 0.485 HG11 ' HE3' ' D' ' 13' ' ' LYS . 19.8 t -44.04 -64.25 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.339 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.04 135.9 41.74 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.932 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -139.26 125.64 20.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.049 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.77 106.56 18.84 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.044 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.78 117.08 53.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.105 0.478 . . . . 0.0 110.431 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.74 131.09 45.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.527 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.8 -47.35 7.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.631 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.38 -163.56 12.16 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.564 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' GLN . . . . . 0.674 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 3.7 mt-30 -101.0 126.61 47.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.703 0.287 . . . . 0.0 110.83 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.455 HG21 HD13 ' D' ' 42' ' ' LEU . 14.9 p -110.42 146.83 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.934 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 38' ' ' ARG . . . . . 0.625 HH22 ' HB2' ' C' ' 62' ' ' ASP . 2.9 mtp180 -82.87 139.17 33.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.7 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.484 ' HA ' ' HB3' ' D' ' 143' ' ' ALA . 5.4 t -62.78 -37.53 87.03 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.745 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.4 -31.5 71.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.125 0.488 . . . . 0.0 110.896 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.99 -17.77 45.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.165 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.742 HD23 ' HB2' ' D' ' 139' ' ' ALA . 4.3 mp -125.66 33.11 5.17 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.609 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.76 18.9 18.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.298 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.94 130.26 52.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.34 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 45' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' D' ' 140' ' ' THR . 22.5 tt0 -56.29 107.32 0.36 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.884 0.373 . . . . 0.0 111.088 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.62 30.5 5.84 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.111 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' D' ' 138' ' ' PHE . . . -76.56 136.71 39.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.973 0.415 . . . . 0.0 112.109 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 48' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' D' ' 137' ' ' TYR . 52.3 p -134.94 134.71 40.88 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.879 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.527 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 70.7 m -108.76 -168.16 1.31 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.641 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 23.3 t -63.99 128.52 36.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.743 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 51' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' D' ' 134' ' ' GLN . . . -80.42 130.02 34.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.467 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 52' ' ' VAL . . . . . 0.775 ' HB ' ' HA ' ' A' ' 90' ' ' SER . 2.8 m -74.85 151.28 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.04 119.23 5.66 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.516 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -153.9 152.12 30.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.788 0.328 . . . . 0.0 110.837 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 55' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -148.77 162.94 38.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.693 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.606 HG23 ' O ' ' D' ' 56' ' ' ILE . 1.2 tp -105.91 114.76 46.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.563 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 57' ' ' GLN . . . . . 0.859 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.0 OUTLIER -70.65 124.51 24.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.744 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 58' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' D' ' 23' ' ' VAL . 0.2 OUTLIER -132.28 88.69 2.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.281 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 59' ' ' ASN . . . . . 0.598 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 0.1 OUTLIER -75.25 169.47 17.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 60' ' ' ASP . . . . . 0.401 ' CG ' ' HD2' ' E' ' 38' ' ' ARG . 0.4 OUTLIER 66.26 68.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.78 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 61' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 56.2 m -117.13 155.07 29.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 62' ' ' ASP . . . . . 0.624 ' HB2' HH22 ' E' ' 38' ' ' ARG . 19.9 t70 -135.75 155.66 50.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.277 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.729 HG23 ' O ' ' D' ' 124' ' ' LEU . 0.2 OUTLIER -111.11 -34.25 6.24 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.05 -22.14 66.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.952 0.406 . . . . 0.0 111.729 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.62 -59.49 2.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.74 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.575 ' HB3' HD23 ' D' ' 124' ' ' LEU . . . -116.82 129.16 55.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.623 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -60.23 2.22 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.878 0.371 . . . . 0.0 111.001 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.21 -175.34 2.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.456 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.96 131.36 9.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.59 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 70' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -105.96 151.18 24.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.104 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 71' ' ' VAL . . . . . 0.615 HG11 HG21 ' D' ' 131' ' ' ILE . 2.0 t -129.52 158.3 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.754 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 72' ' ' ALA . . . . . 0.627 ' HA ' HD21 ' D' ' 111' ' ' LEU . . . -152.68 143.08 22.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.584 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 73' ' ' PHE . . . . . 0.603 ' HB3' HD23 ' D' ' 113' ' ' LEU . 0.1 OUTLIER -112.33 141.46 46.02 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.691 0.281 . . . . 0.0 111.004 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 74' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.3 OUTLIER -107.69 139.52 42.13 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.018 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.79 -179.44 46.94 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.816 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.98 156.28 17.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.613 0.245 . . . . 0.0 110.767 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.3 118.38 21.17 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.969 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 78' ' ' ILE . . . . . 0.559 HG22 ' HB3' ' D' ' 82' ' ' HIS . 0.4 OUTLIER -59.01 -29.1 40.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.644 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.449 ' HB2' HG21 ' D' ' 140' ' ' THR . 0.1 OUTLIER -151.76 50.47 0.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.774 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.17 -89.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.09 -32.51 42.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.621 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 82' ' ' HIS . . . . . 0.559 ' HB3' HG22 ' D' ' 78' ' ' ILE . 0.3 OUTLIER -81.08 62.86 5.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 110.406 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.63 -18.18 60.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.558 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 84' ' ' ASN . . . . . 0.716 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 20.4 p-10 -76.04 -7.4 54.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.176 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.489 ' HB ' ' CG2' ' D' ' 78' ' ' ILE . 24.0 t -117.73 124.14 72.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.243 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.955 HD22 ' HB1' ' D' ' 150' ' ' ALA . 0.5 OUTLIER -66.15 139.35 58.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.713 0.292 . . . . 0.0 110.243 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' D' ' 78' ' ' ILE . . . -84.88 -165.44 1.2 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.693 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.774 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 0.7 OUTLIER -71.84 168.65 17.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.067 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.96 -79.23 0.06 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.263 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -168.81 5.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.986 0.422 . . . . 0.0 111.472 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 91' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' D' ' 95' ' ' SER . 70.3 m -77.47 83.22 3.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.11 -34.62 63.84 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.878 0.371 . . . . 0.0 111.633 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.24 31.5 6.32 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.687 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.57 7.39 0.23 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.881 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 95' ' ' SER . . . . . 0.774 ' HB3' ' HG ' ' D' ' 88' ' ' LEU . 0.6 OUTLIER -110.71 -174.33 2.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 110.651 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 96' ' ' ALA . . . . . 0.418 ' O ' HD21 ' D' ' 88' ' ' LEU . . . -97.78 179.01 4.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.931 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 97' ' ' THR . . . . . 0.788 ' H ' ' HB ' ' D' ' 144' ' ' THR . 1.1 m -132.24 125.92 32.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.369 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 98' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' D' ' 97' ' ' THR . 66.0 m-20 66.68 25.87 9.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.38 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.66 130.34 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.691 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.13 -161.38 10.76 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.485 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 101' ' ' VAL . . . . . 0.483 ' CG2' ' HB1' ' D' ' 135' ' ' ALA . 0.8 OUTLIER -130.84 131.94 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 123.12 0.568 . . . . 0.0 111.842 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 102' ' ' GLN . . . . . 0.724 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 1.5 tt0 -98.52 151.45 20.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.906 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 103' ' ' ILE . . . . . 0.525 ' N ' ' HG2' ' D' ' 102' ' ' GLN . 0.3 OUTLIER -117.3 128.65 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.499 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 104' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 0.3 OUTLIER -102.94 133.5 47.94 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.559 0.219 . . . . 0.0 111.051 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 105' ' ' ASP . . . . . 0.723 ' HB3' HG22 ' D' ' 107' ' ' THR . 7.1 t0 -87.73 158.47 18.79 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.685 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 106' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -70.56 -27.71 64.34 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.806 0.336 . . . . 0.0 111.047 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 107' ' ' THR . . . . . 0.723 HG22 ' HB3' ' D' ' 105' ' ' ASP . 2.8 t -51.69 -25.7 7.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.09 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.19 -39.27 1.73 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.557 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.27 158.0 17.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.352 . . . . 0.0 111.013 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -70.37 137.17 50.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.099 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 111' ' ' LEU . . . . . 0.627 HD21 ' HA ' ' D' ' 72' ' ' ALA . 13.5 tp -87.56 158.35 18.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.304 0.574 . . . . 0.0 110.529 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 112' ' ' THR . . . . . 1.035 HG23 HG21 ' D' ' 117' ' ' THR . 0.5 OUTLIER -101.72 142.01 33.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.095 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 113' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' D' ' 73' ' ' PHE . 1.9 mt -82.45 65.63 7.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 0.0 110.775 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.07 -15.01 21.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.485 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.23 -54.14 0.71 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.705 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.16 28.88 8.31 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.068 0.461 . . . . 0.0 111.756 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 117' ' ' THR . . . . . 1.035 HG21 HG23 ' D' ' 112' ' ' THR . 0.0 OUTLIER -88.81 76.62 7.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.186 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' D' ' 71' ' ' VAL . 91.5 m-85 -91.06 96.79 10.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.733 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 67.8 m -132.69 78.31 1.79 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.704 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.7 136.85 3.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.717 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -115.02 76.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.307 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.98 135.54 33.62 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.662 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 11.7 m -77.05 96.33 4.4 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.764 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 124' ' ' LEU . . . . . 0.729 ' O ' HG23 ' D' ' 63' ' ' THR . 10.8 tp -68.15 132.92 48.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.628 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -128.49 166.81 18.06 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.561 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 126' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' D' ' 61' ' ' CYS . 6.2 t30 -79.44 105.76 10.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.665 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.03 -136.99 5.19 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.734 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 128' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 3.7 m -103.72 83.44 2.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.716 0.293 . . . . 0.0 110.808 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 129' ' ' ASN . . . . . 0.694 ' HB2' ' SG ' ' D' ' 61' ' ' CYS . 1.7 t30 -71.04 139.85 50.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.899 0.38 . . . . 0.0 111.17 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 130' ' ' THR . . . . . 1.026 HG21 HD21 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -133.92 139.57 46.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.147 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 131' ' ' ILE . . . . . 0.615 HG21 HG11 ' D' ' 71' ' ' VAL . 61.8 mt -97.9 110.49 55.83 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 132' ' ' PRO . . . . . 0.768 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 7.6 Cg_endo -81.88 135.18 8.72 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.772 1.648 . . . . 0.0 112.562 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.74 152.65 41.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.802 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 134' ' ' GLN . . . . . 0.588 ' HB3' ' HB1' ' D' ' 51' ' ' ALA . 50.6 mt-30 -118.94 156.95 28.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.092 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.733 ' HB3' HG22 ' D' ' 52' ' ' VAL . . . -151.42 101.71 2.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 111.648 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.56 168.29 9.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.352 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 137' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' D' ' 48' ' ' THR . 0.3 OUTLIER -80.11 123.34 27.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.149 179.533 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 138' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' D' ' 47' ' ' ALA . 1.3 t80 -126.19 119.05 26.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.998 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 139' ' ' ALA . . . . . 0.742 ' HB2' HD23 ' D' ' 42' ' ' LEU . . . -111.98 125.17 53.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.904 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 140' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.23 63.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.494 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 141' ' ' GLY . . . . . 0.444 ' H ' ' HB3' ' D' ' 98' ' ' ASN . . . -133.06 -120.03 2.08 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.137 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.36 111.94 18.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.628 0.252 . . . . 0.0 110.718 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 143' ' ' ALA . . . . . 0.709 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -61.96 113.84 3.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.82 0.343 . . . . 0.0 111.377 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 144' ' ' THR . . . . . 0.788 ' HB ' ' H ' ' D' ' 97' ' ' THR . 75.4 m -88.27 145.28 35.56 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.323 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.86 134.17 7.12 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.533 2.156 . . . . 0.0 111.992 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.93 -135.63 4.42 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.499 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 147' ' ' ALA . . . . . 0.689 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -96.13 134.26 39.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.905 0.383 . . . . 0.0 111.362 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 148' ' ' ALA . . . . . 0.872 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -129.89 50.51 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.413 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -98.99 146.14 26.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.489 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 150' ' ' ALA . . . . . 0.955 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -154.95 174.17 15.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.92 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 151' ' ' ASP . . . . . 0.495 ' C ' HD11 ' D' ' 86' ' ' LEU . 26.8 t70 -139.34 128.4 23.74 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.184 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 152' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -118.37 133.34 55.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.126 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 153' ' ' THR . . . . . 0.74 HG23 HG22 ' C' ' 9' ' ' THR . 0.2 OUTLIER -91.97 147.42 22.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.27 130.33 53.43 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.169 0.509 . . . . 0.0 110.022 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -126.67 143.97 51.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.945 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 156' ' ' VAL . . . . . 0.523 HG12 ' CD1' ' D' ' 131' ' ' ILE . 27.4 m -127.45 151.87 34.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.85 0.357 . . . . 0.0 111.643 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 157' ' ' GLN . . . . . 0.687 ' HA ' ' O ' ' C' ' 3' ' ' THR . 0.0 OUTLIER -141.36 121.22 13.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.295 0.569 . . . . 0.0 110.372 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 158' ' ' TYR . . . . . 0.57 ' CD2' ' HB ' ' C' ' 3' ' ' THR . 1.2 m-85 -98.29 121.67 40.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.564 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.804 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 111.27 0.1 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.64 71.06 0.51 Allowed 'General case' 0 N--CA 1.462 0.149 0 O-C-N 123.109 0.256 . . . . 0.0 110.959 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 3' ' ' THR . . . . . 0.688 ' O ' ' HA ' ' F' ' 157' ' ' GLN . 4.9 m -114.7 127.36 55.71 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.499 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 20.8 m -117.74 106.86 13.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.577 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.453 HG21 HG12 ' F' ' 17' ' ' VAL . 0.0 OUTLIER -133.98 174.66 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.601 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.05 119.81 36.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.581 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.2 -49.49 15.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.822 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.32 -154.88 11.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.755 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 9' ' ' THR . . . . . 0.723 HG22 HG23 ' F' ' 153' ' ' THR . 2.7 p -142.43 139.95 31.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.904 0.383 . . . . 0.0 111.291 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.71 113.83 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.161 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.11 110.32 20.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.36 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.21 111.51 22.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.752 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 13' ' ' LYS . . . . . 0.492 ' HE3' HG11 ' E' ' 28' ' ' VAL . 3.6 tmtm? -102.98 110.56 22.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.488 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.22 168.36 22.59 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.053 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 15' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' F' ' 36' ' ' GLN . 3.6 tt0 -159.02 133.08 7.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.923 0.392 . . . . 0.0 110.438 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 16' ' ' VAL . . . . . 0.896 HG23 ' HB2' ' F' ' 148' ' ' ALA . 13.2 t -99.67 143.15 14.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.261 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 17' ' ' VAL . . . . . 0.524 HG13 ' HG2' ' F' ' 36' ' ' GLN . 3.9 m -141.34 -172.13 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.874 0.368 . . . . 0.0 111.057 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.48 -176.96 5.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.046 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.73 46.85 1.36 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.77 -30.0 2.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.9 0.381 . . . . 0.0 111.466 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 21' ' ' CYS . . . . . 1.014 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER -163.07 158.45 22.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.943 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 22' ' ' ALA . . . . . 0.568 ' HB1' ' O ' ' F' ' 36' ' ' GLN . . . -161.42 118.49 2.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.044 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 23' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' E' ' 58' ' ' LEU . 0.8 OUTLIER -66.23 153.02 8.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.05 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.7 158.74 20.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.59 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 25' ' ' ALA . . . . . 0.554 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -61.04 -34.34 74.72 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.388 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.18 13.07 63.54 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.936 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.76 -22.44 10.7 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.798 0.333 . . . . 0.0 110.746 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 28' ' ' VAL . . . . . 0.492 HG11 ' HE3' ' E' ' 13' ' ' LYS . 19.8 t -44.02 -64.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.319 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.0 135.72 42.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.02 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -139.11 125.72 20.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.78 106.53 18.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.108 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.78 117.06 53.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.147 0.499 . . . . 0.0 110.44 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.67 131.01 45.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.61 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.75 -47.29 7.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.682 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.3 -163.61 12.15 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.573 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 36' ' ' GLN . . . . . 0.687 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 3.7 mt-30 -100.97 126.61 47.64 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.717 0.294 . . . . 0.0 110.842 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.453 HG21 HD13 ' E' ' 42' ' ' LEU . 14.9 p -110.38 146.85 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.983 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 38' ' ' ARG . . . . . 0.624 HH22 ' HB2' ' D' ' 62' ' ' ASP . 2.9 mtp180 -82.96 139.23 33.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.632 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 39' ' ' THR . . . . . 0.501 ' HA ' ' HB3' ' E' ' 143' ' ' ALA . 5.4 t -62.78 -37.52 86.99 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.724 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.48 -31.47 71.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.12 0.486 . . . . 0.0 110.867 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.99 -17.74 45.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.196 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.741 HD23 ' HB2' ' E' ' 139' ' ' ALA . 4.3 mp -125.68 33.05 5.18 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.631 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.71 18.86 18.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.333 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.92 130.29 52.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.309 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 45' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' E' ' 140' ' ' THR . 22.4 tt0 -56.35 107.38 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.362 . . . . 0.0 111.059 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.52 30.53 5.85 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.183 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 47' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' E' ' 138' ' ' PHE . . . -76.61 136.75 39.21 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.976 0.417 . . . . 0.0 112.123 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' E' ' 137' ' ' TYR . 52.2 p -134.96 134.69 40.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.888 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.53 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 71.6 m -108.82 -168.21 1.32 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.565 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 50' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 23.1 t -63.9 128.43 35.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.783 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 51' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' E' ' 134' ' ' GLN . . . -80.38 129.99 34.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.447 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 52' ' ' VAL . . . . . 0.764 ' HB ' ' HA ' ' B' ' 90' ' ' SER . 2.8 m -74.87 151.22 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.9 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.01 119.22 5.67 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.578 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.85 152.1 30.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.728 0.299 . . . . 0.0 110.966 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -148.77 162.89 38.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.653 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 56' ' ' ILE . . . . . 0.603 HG23 ' O ' ' E' ' 56' ' ' ILE . 1.2 tp -105.87 114.86 46.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.567 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 57' ' ' GLN . . . . . 0.855 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.0 OUTLIER -70.72 124.58 24.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.695 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 58' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' E' ' 23' ' ' VAL . 0.2 OUTLIER -132.36 88.76 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.242 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 59' ' ' ASN . . . . . 0.592 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 0.1 OUTLIER -75.34 169.41 18.11 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 60' ' ' ASP . . . . . 0.409 ' CG ' ' HD2' ' F' ' 38' ' ' ARG . 0.4 OUTLIER 66.38 68.3 0.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.746 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 61' ' ' CYS . . . . . 1.014 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 56.1 m -117.15 155.03 30.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.797 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 62' ' ' ASP . . . . . 0.618 ' HB2' HH22 ' F' ' 38' ' ' ARG . 20.1 t70 -135.8 155.65 50.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.274 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 63' ' ' THR . . . . . 0.73 HG23 ' O ' ' E' ' 124' ' ' LEU . 0.2 OUTLIER -111.08 -34.22 6.25 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.12 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.05 -22.18 66.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.067 0.46 . . . . 0.0 111.718 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.63 -59.49 2.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.709 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 66' ' ' ALA . . . . . 0.559 ' HB3' HD23 ' E' ' 124' ' ' LEU . . . -116.86 129.18 55.91 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.628 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -60.35 2.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.896 0.379 . . . . 0.0 110.978 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.15 -175.37 2.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.537 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.96 131.32 9.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.588 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 70' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -105.97 151.19 24.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.073 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 71' ' ' VAL . . . . . 0.622 HG11 HG21 ' E' ' 131' ' ' ILE . 2.0 t -129.44 158.35 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.778 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 72' ' ' ALA . . . . . 0.628 ' HA ' HD21 ' E' ' 111' ' ' LEU . . . -152.71 143.06 22.56 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.599 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 73' ' ' PHE . . . . . 0.608 ' HB3' HD23 ' E' ' 113' ' ' LEU . 0.1 OUTLIER -112.29 141.43 46.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.542 0.21 . . . . 0.0 111.105 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 74' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.3 OUTLIER -107.7 139.49 42.18 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.992 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.76 -179.43 46.92 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.815 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -104.01 156.34 17.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.619 0.247 . . . . 0.0 110.79 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.35 118.37 21.19 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.934 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 78' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' E' ' 82' ' ' HIS . 0.4 OUTLIER -58.97 -29.14 40.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.895 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 79' ' ' ASP . . . . . 0.449 ' HB2' HG21 ' E' ' 140' ' ' THR . 0.1 OUTLIER -151.72 50.4 0.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.838 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.25 -89.9 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.103 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.03 -32.53 42.53 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.64 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 82' ' ' HIS . . . . . 0.564 ' HB3' HG22 ' E' ' 78' ' ' ILE . 0.3 OUTLIER -81.12 62.81 5.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.826 0.346 . . . . 0.0 110.376 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -18.09 60.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.599 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 84' ' ' ASN . . . . . 0.705 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 20.4 p-10 -76.1 -7.37 54.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.239 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.476 ' HB ' ' CG2' ' E' ' 78' ' ' ILE . 23.8 t -117.75 124.14 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.172 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 86' ' ' LEU . . . . . 0.982 HD22 ' HB1' ' E' ' 150' ' ' ALA . 0.5 OUTLIER -66.14 139.38 58.14 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.262 179.409 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 87' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' E' ' 78' ' ' ILE . . . -84.92 -165.41 1.19 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.667 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.771 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 0.7 OUTLIER -71.92 168.64 17.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.977 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.89 -79.23 0.06 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.308 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p -168.81 5.94 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.918 0.389 . . . . 0.0 111.506 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 91' ' ' SER . . . . . 0.612 ' O ' ' HB2' ' E' ' 95' ' ' SER . 70.2 m -77.57 83.22 3.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.07 -34.7 63.83 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.875 0.369 . . . . 0.0 111.57 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.23 31.5 6.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.635 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.58 7.44 0.23 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.965 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 95' ' ' SER . . . . . 0.771 ' HB3' ' HG ' ' E' ' 88' ' ' LEU . 0.6 OUTLIER -110.69 -174.32 2.45 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.911 0.386 . . . . 0.0 110.669 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 96' ' ' ALA . . . . . 0.432 ' O ' HD21 ' E' ' 88' ' ' LEU . . . -97.76 178.96 4.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 97' ' ' THR . . . . . 0.796 ' H ' ' HB ' ' E' ' 144' ' ' THR . 1.1 m -132.25 125.99 32.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.368 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 98' ' ' ASN . . . . . 0.438 ' HB3' ' H ' ' E' ' 141' ' ' GLY . 66.1 m-20 66.64 25.84 9.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.45 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.74 130.37 70.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.691 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.15 -161.38 10.77 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.463 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 101' ' ' VAL . . . . . 0.497 ' CG2' ' HB1' ' E' ' 135' ' ' ALA . 0.8 OUTLIER -130.89 131.97 64.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.025 0.53 . . . . 0.0 111.773 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 102' ' ' GLN . . . . . 0.724 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 1.5 tt0 -98.48 151.47 20.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.882 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 103' ' ' ILE . . . . . 0.527 ' N ' ' HG2' ' E' ' 102' ' ' GLN . 0.3 OUTLIER -117.36 128.73 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.498 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 104' ' ' LEU . . . . . 0.796 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 0.3 OUTLIER -103.03 133.5 48.05 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.62 0.248 . . . . 0.0 111.108 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 105' ' ' ASP . . . . . 0.716 ' HB3' HG22 ' E' ' 107' ' ' THR . 7.1 t0 -87.73 158.37 18.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.67 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 106' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' E' ' 106' ' ' ARG . 7.9 ttp85 -70.49 -27.68 64.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.778 0.323 . . . . 0.0 111.096 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 107' ' ' THR . . . . . 0.716 HG22 ' HB3' ' E' ' 105' ' ' ASP . 2.8 t -51.71 -25.72 7.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.058 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.21 -39.31 1.72 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.572 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.25 158.01 17.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 111.074 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 110' ' ' ALA . . . . . 0.796 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -70.36 137.17 50.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.628 HD21 ' HA ' ' E' ' 72' ' ' ALA . 13.5 tp -87.52 158.31 18.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.347 0.594 . . . . 0.0 110.49 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 112' ' ' THR . . . . . 1.043 HG23 HG21 ' E' ' 117' ' ' THR . 0.5 OUTLIER -101.73 141.98 33.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.107 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 113' ' ' LEU . . . . . 0.608 HD23 ' HB3' ' E' ' 73' ' ' PHE . 1.9 mt -82.43 65.61 7.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 110.778 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.04 -15.05 21.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.478 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.29 -54.21 0.7 Allowed Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.668 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.06 28.79 8.39 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.028 0.442 . . . . 0.0 111.741 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 117' ' ' THR . . . . . 1.043 HG21 HG23 ' E' ' 112' ' ' THR . 0.0 OUTLIER -88.74 76.66 7.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.225 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 118' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' E' ' 71' ' ' VAL . 91.6 m-85 -91.11 96.75 10.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.781 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 68.6 m -132.62 78.24 1.79 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.828 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.67 136.91 3.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.662 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.06 76.21 0.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.294 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.88 135.59 33.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.674 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 11.8 m -77.09 96.36 4.43 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.738 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 124' ' ' LEU . . . . . 0.73 ' O ' HG23 ' E' ' 63' ' ' THR . 10.8 tp -68.24 132.97 48.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.591 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -128.5 166.78 18.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.603 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 126' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' E' ' 61' ' ' CYS . 6.3 t30 -79.4 105.66 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.683 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.08 -137.08 5.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.652 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 128' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 3.7 m -103.65 83.44 2.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.688 0.28 . . . . 0.0 110.832 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 129' ' ' ASN . . . . . 0.693 ' HB2' ' SG ' ' E' ' 61' ' ' CYS . 1.7 t30 -71.0 139.87 50.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.905 0.383 . . . . 0.0 111.163 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 130' ' ' THR . . . . . 0.979 HG21 HD21 ' B' ' 74' ' ' LEU . 0.2 OUTLIER -133.91 139.66 46.3 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.161 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 131' ' ' ILE . . . . . 0.622 HG21 HG11 ' E' ' 71' ' ' VAL . 61.8 mt -98.03 110.48 56.01 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 132' ' ' PRO . . . . . 0.767 ' HB3' ' HA ' ' B' ' 76' ' ' THR . 7.6 Cg_endo -81.86 135.16 8.73 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 121.792 1.661 . . . . 0.0 112.533 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.76 152.64 41.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.815 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 134' ' ' GLN . . . . . 0.587 ' HB3' ' HB1' ' E' ' 51' ' ' ALA . 50.5 mt-30 -118.97 156.86 28.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.099 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 135' ' ' ALA . . . . . 0.728 ' HB3' HG22 ' E' ' 52' ' ' VAL . . . -151.39 101.71 2.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 111.649 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.58 168.32 9.17 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.404 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 137' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' E' ' 48' ' ' THR . 0.3 OUTLIER -80.04 123.24 27.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.175 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 138' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' E' ' 47' ' ' ALA . 1.3 t80 -126.13 119.13 26.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.064 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 139' ' ' ALA . . . . . 0.741 ' HB2' HD23 ' E' ' 42' ' ' LEU . . . -111.98 125.22 53.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.867 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 140' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 0.2 OUTLIER -68.89 -48.24 63.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.546 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 141' ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' E' ' 98' ' ' ASN . . . -133.1 -119.96 2.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.085 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.42 111.96 18.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.612 0.244 . . . . 0.0 110.718 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 143' ' ' ALA . . . . . 0.719 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -61.95 113.89 3.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.803 0.335 . . . . 0.0 111.361 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 144' ' ' THR . . . . . 0.796 ' HB ' ' H ' ' E' ' 97' ' ' THR . 73.7 m -88.34 145.31 35.49 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.324 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 145' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' E' ' 144' ' ' THR . 1.3 Cg_endo -82.86 134.22 7.14 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.463 2.109 . . . . 0.0 112.019 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.87 -135.62 4.43 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.535 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 147' ' ' ALA . . . . . 0.679 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -96.12 134.19 39.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.392 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 148' ' ' ALA . . . . . 0.89 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -129.8 50.51 2.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.131 0.491 . . . . 0.0 110.474 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -98.97 146.13 26.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.501 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 150' ' ' ALA . . . . . 0.982 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -154.96 174.13 15.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.875 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 151' ' ' ASP . . . . . 0.483 ' C ' HD11 ' E' ' 86' ' ' LEU . 26.7 t70 -139.3 128.45 23.88 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.192 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 152' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -118.41 133.29 56.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.193 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 153' ' ' THR . . . . . 0.709 HG23 HG22 ' D' ' 9' ' ' THR . 0.2 OUTLIER -91.91 147.36 23.03 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.159 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.22 130.3 53.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.182 0.515 . . . . 0.0 110.054 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -126.63 143.91 51.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.911 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 156' ' ' VAL . . . . . 0.517 HG12 ' CD1' ' E' ' 131' ' ' ILE . 27.2 m -127.42 151.82 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.775 0.322 . . . . 0.0 111.729 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 157' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' D' ' 3' ' ' THR . 0.0 OUTLIER -141.34 121.19 13.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.326 0.584 . . . . 0.0 110.341 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 158' ' ' TYR . . . . . 0.573 ' CD2' ' HB ' ' D' ' 3' ' ' THR . 1.2 m-85 -98.31 121.66 40.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.532 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.82 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.251 0.072 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.72 71.03 0.51 Allowed 'General case' 0 CA--C 1.528 0.124 0 O-C-N 123.11 0.256 . . . . 0.0 110.972 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 4.9 m -114.69 127.38 55.73 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.433 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 20.7 m -117.82 106.74 13.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.587 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.86 174.71 12.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.577 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -97.11 119.89 36.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.553 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.34 -49.41 15.47 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.834 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.27 -154.87 11.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.862 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -142.46 140.07 31.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.985 0.421 . . . . 0.0 111.222 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.79 113.8 41.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.18 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -87.07 110.35 20.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.358 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -90.32 111.55 22.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.744 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 13' ' ' LYS . . . . . 0.485 ' HE3' HG11 ' F' ' 28' ' ' VAL . 3.7 tmtm? -102.97 110.6 22.58 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.39 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.25 168.38 22.6 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.962 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -159.09 133.02 7.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.893 0.378 . . . . 0.0 110.446 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 13.1 t -99.62 143.19 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.258 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 17' ' ' VAL . . . . . 0.453 HG12 HG21 ' E' ' 5' ' ' VAL . 3.9 m -141.41 -172.12 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.867 0.365 . . . . 0.0 110.987 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.51 -177.0 5.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.073 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.83 47.01 1.37 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.073 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.77 -29.98 2.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.434 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 21' ' ' CYS . . . . . 0.992 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER -163.19 158.33 21.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.906 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.34 118.61 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.045 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 23' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' F' ' 58' ' ' LEU . 0.8 OUTLIER -66.29 153.06 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.986 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -84.82 158.72 20.58 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.606 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 25' ' ' ALA . . . . . 0.562 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -60.99 -34.43 74.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.386 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.08 13.11 63.65 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.97 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.83 -22.43 10.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.796 0.332 . . . . 0.0 110.701 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 28' ' ' VAL . . . . . 0.485 HG11 ' HE3' ' F' ' 13' ' ' LYS . 19.8 t -44.05 -64.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.368 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.1 135.92 41.78 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.925 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.23 125.72 20.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.008 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.79 106.51 18.79 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.06 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.76 117.05 53.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.196 0.522 . . . . 0.0 110.445 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.66 131.06 45.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.607 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.79 -47.41 7.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.616 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.39 -163.62 12.15 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.581 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 36' ' ' GLN . . . . . 0.688 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 3.7 mt-30 -100.97 126.59 47.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.688 0.28 . . . . 0.0 110.863 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.444 HG21 HD13 ' F' ' 42' ' ' LEU . 14.9 p -110.36 146.84 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.912 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 38' ' ' ARG . . . . . 0.618 HH22 ' HB2' ' E' ' 62' ' ' ASP . 2.8 mtp180 -82.9 139.14 33.59 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.678 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 39' ' ' THR . . . . . 0.506 ' HA ' ' HB3' ' F' ' 143' ' ' ALA . 5.4 t -62.71 -37.51 86.78 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.762 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.46 -31.49 71.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.095 0.474 . . . . 0.0 110.837 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.03 -17.73 45.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.147 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 42' ' ' LEU . . . . . 0.739 HD23 ' HB2' ' F' ' 139' ' ' ALA . 4.3 mp -125.69 33.08 5.17 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.671 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.7 18.84 18.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.365 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.95 130.36 52.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.313 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 45' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' F' ' 140' ' ' THR . 22.5 tt0 -56.36 107.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.864 0.364 . . . . 0.0 111.027 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.64 30.42 5.86 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.179 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 47' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' F' ' 138' ' ' PHE . . . -76.57 136.7 39.26 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.95 0.405 . . . . 0.0 112.071 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 48' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' F' ' 137' ' ' TYR . 52.3 p -134.92 134.66 40.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.891 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 49' ' ' SER . . . . . 0.538 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 70.8 m -108.68 -168.23 1.32 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.657 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 50' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' C' ' 92' ' ' ALA . 23.1 t -63.89 128.47 35.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.807 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 51' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' F' ' 134' ' ' GLN . . . -80.44 130.02 34.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.406 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 52' ' ' VAL . . . . . 0.769 ' HB ' ' HA ' ' C' ' 90' ' ' SER . 2.8 m -74.84 151.25 6.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.97 119.21 5.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.622 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.86 152.1 30.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.711 0.291 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -148.77 162.99 38.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.643 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 56' ' ' ILE . . . . . 0.605 HG23 ' O ' ' F' ' 56' ' ' ILE . 1.2 tp -105.92 114.76 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.585 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 57' ' ' GLN . . . . . 0.889 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.0 OUTLIER -70.61 124.51 24.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.761 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 58' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' F' ' 23' ' ' VAL . 0.2 OUTLIER -132.35 88.81 2.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.192 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 59' ' ' ASN . . . . . 0.585 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 0.1 OUTLIER -75.35 169.52 17.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.34 68.26 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.787 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 61' ' ' CYS . . . . . 0.992 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 56.3 m -117.13 155.02 30.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.829 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -135.8 155.67 49.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.227 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 63' ' ' THR . . . . . 0.726 HG23 ' O ' ' F' ' 124' ' ' LEU . 0.2 OUTLIER -111.13 -34.23 6.24 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.085 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.09 -22.1 66.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.069 0.461 . . . . 0.0 111.759 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.61 -59.56 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.744 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 66' ' ' ALA . . . . . 0.569 ' HB3' HD23 ' F' ' 124' ' ' LEU . . . -116.74 129.12 55.93 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.617 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -60.27 2.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.959 0.409 . . . . 0.0 111.052 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.22 -175.41 2.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.47 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.93 131.34 9.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.607 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 70' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -106.02 151.19 24.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.025 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 71' ' ' VAL . . . . . 0.631 HG11 HG21 ' F' ' 131' ' ' ILE . 2.0 t -129.48 158.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.704 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 72' ' ' ALA . . . . . 0.657 ' HA ' HD21 ' F' ' 111' ' ' LEU . . . -152.66 143.02 22.57 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.626 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 73' ' ' PHE . . . . . 0.603 ' HB3' HD23 ' F' ' 113' ' ' LEU . 0.1 OUTLIER -112.23 141.44 45.94 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.663 0.268 . . . . 0.0 111.049 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 74' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.3 OUTLIER -107.63 139.54 42.01 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.981 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.76 -179.51 46.87 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.83 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.92 156.34 17.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.535 0.207 . . . . 0.0 110.819 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.34 118.44 21.25 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.877 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 78' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' F' ' 82' ' ' HIS . 0.4 OUTLIER -59.1 -29.08 40.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.834 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 79' ' ' ASP . . . . . 0.43 ' HB2' HG21 ' F' ' 140' ' ' THR . 0.1 OUTLIER -151.7 50.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.781 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.2 -89.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.095 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.09 -32.54 42.97 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.596 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 82' ' ' HIS . . . . . 0.564 ' HB3' HG22 ' F' ' 78' ' ' ILE . 0.3 OUTLIER -81.14 62.86 5.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.886 0.374 . . . . 0.0 110.414 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.53 -18.23 60.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.633 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 84' ' ' ASN . . . . . 0.705 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 20.4 p-10 -76.02 -7.4 54.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.258 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 85' ' ' VAL . . . . . 0.49 ' HB ' ' CG2' ' F' ' 78' ' ' ILE . 23.8 t -117.72 124.14 72.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.224 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 86' ' ' LEU . . . . . 0.959 HD22 ' HB1' ' F' ' 150' ' ' ALA . 0.5 OUTLIER -66.18 139.38 58.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.715 0.293 . . . . 0.0 110.266 179.454 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 87' ' ' ALA . . . . . 0.453 ' HB2' ' HA ' ' F' ' 78' ' ' ILE . . . -84.85 -165.37 1.17 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.741 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 88' ' ' LEU . . . . . 0.756 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 0.7 OUTLIER -71.87 168.65 17.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.056 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.91 -79.18 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.351 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p -168.87 6.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 111.549 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 91' ' ' SER . . . . . 0.609 ' O ' ' HB2' ' F' ' 95' ' ' SER . 69.4 m -77.62 83.24 4.01 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.04 -34.67 63.73 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.606 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.26 31.5 6.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.58 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.63 7.59 0.23 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.907 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 95' ' ' SER . . . . . 0.756 ' HB3' ' HG ' ' F' ' 88' ' ' LEU . 0.6 OUTLIER -110.87 -174.32 2.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.834 0.349 . . . . 0.0 110.553 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 96' ' ' ALA . . . . . 0.431 ' O ' HD21 ' F' ' 88' ' ' LEU . . . -97.76 179.0 4.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 97' ' ' THR . . . . . 0.784 ' H ' ' HB ' ' F' ' 144' ' ' THR . 1.1 m -132.32 125.98 32.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.316 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 98' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' F' ' 97' ' ' THR . 66.1 m-20 66.66 25.8 9.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.451 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.66 130.35 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.711 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.11 -161.37 10.75 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.492 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 101' ' ' VAL . . . . . 0.486 ' CG2' ' HB1' ' F' ' 135' ' ' ALA . 0.8 OUTLIER -130.89 131.88 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.122 0.569 . . . . 0.0 111.868 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 102' ' ' GLN . . . . . 0.721 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 1.5 tt0 -98.41 151.52 20.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.897 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 103' ' ' ILE . . . . . 0.518 ' N ' ' HG2' ' F' ' 102' ' ' GLN . 0.3 OUTLIER -117.36 128.65 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.503 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 104' ' ' LEU . . . . . 0.809 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 0.3 OUTLIER -103.04 133.52 48.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.647 0.261 . . . . 0.0 111.083 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 105' ' ' ASP . . . . . 0.702 ' HB3' HG22 ' F' ' 107' ' ' THR . 7.2 t0 -87.71 158.37 18.83 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.658 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 106' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' F' ' 106' ' ' ARG . 7.9 ttp85 -70.4 -27.75 64.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.778 0.323 . . . . 0.0 111.082 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 107' ' ' THR . . . . . 0.702 HG22 ' HB3' ' F' ' 105' ' ' ASP . 2.8 t -51.72 -25.72 7.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.056 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.26 -39.37 1.71 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.574 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.26 158.01 17.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 0.0 111.079 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 110' ' ' ALA . . . . . 0.809 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -70.3 137.11 50.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.034 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 111' ' ' LEU . . . . . 0.657 HD21 ' HA ' ' F' ' 72' ' ' ALA . 13.5 tp -87.53 158.38 18.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.338 0.589 . . . . 0.0 110.533 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 112' ' ' THR . . . . . 1.043 HG23 HG21 ' F' ' 117' ' ' THR . 0.5 OUTLIER -101.76 141.93 33.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.107 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 113' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' F' ' 73' ' ' PHE . 1.9 mt -82.33 65.58 7.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.7 0.286 . . . . 0.0 110.725 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.08 -14.97 21.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.521 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.21 -54.11 0.71 Allowed Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.661 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.19 28.97 8.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.066 0.46 . . . . 0.0 111.719 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 117' ' ' THR . . . . . 1.043 HG21 HG23 ' F' ' 112' ' ' THR . 0.0 OUTLIER -88.85 76.61 7.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.17 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 118' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' F' ' 71' ' ' VAL . 91.6 m-85 -91.07 96.77 10.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.746 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 67.8 m -132.6 78.22 1.79 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.764 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.7 136.97 3.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.688 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.09 76.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.276 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.9 135.59 33.62 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.635 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 12.0 m -77.09 96.25 4.41 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.763 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 124' ' ' LEU . . . . . 0.726 ' O ' HG23 ' F' ' 63' ' ' THR . 10.8 tp -68.19 132.97 48.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.582 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -128.47 166.77 18.12 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.552 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 126' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' F' ' 61' ' ' CYS . 6.3 t30 -79.41 105.74 10.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.743 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.02 -137.09 5.24 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.689 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 128' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 3.7 m -103.59 83.45 2.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.686 0.279 . . . . 0.0 110.847 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 129' ' ' ASN . . . . . 0.7 ' HB2' ' SG ' ' F' ' 61' ' ' CYS . 1.7 t30 -70.98 139.87 50.7 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.887 0.375 . . . . 0.0 111.165 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 130' ' ' THR . . . . . 0.97 HG21 HD21 ' C' ' 74' ' ' LEU . 0.2 OUTLIER -133.96 139.69 46.27 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.109 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 131' ' ' ILE . . . . . 0.631 HG21 HG11 ' F' ' 71' ' ' VAL . 61.8 mt -98.08 110.55 56.39 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 132' ' ' PRO . . . . . 0.765 ' HB3' ' HA ' ' C' ' 76' ' ' THR . 7.6 Cg_endo -81.82 135.13 8.76 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.796 1.664 . . . . 0.0 112.558 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.74 152.68 41.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.727 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 134' ' ' GLN . . . . . 0.589 ' HB3' ' HB1' ' F' ' 51' ' ' ALA . 50.5 mt-30 -119.0 156.9 28.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.096 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 135' ' ' ALA . . . . . 0.722 ' HB3' HG22 ' F' ' 52' ' ' VAL . . . -151.42 101.69 2.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.808 0.337 . . . . 0.0 111.641 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.59 168.33 9.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.373 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 137' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' F' ' 48' ' ' THR . 0.3 OUTLIER -80.09 123.3 27.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.113 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 138' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' F' ' 47' ' ' ALA . 1.3 t80 -126.18 119.05 26.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.051 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 139' ' ' ALA . . . . . 0.739 ' HB2' HD23 ' F' ' 42' ' ' LEU . . . -111.98 125.17 53.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.853 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 140' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' F' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.26 63.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.508 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 141' ' ' GLY . . . . . 0.434 ' H ' ' HB3' ' F' ' 98' ' ' ASN . . . -133.09 -120.05 2.08 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.058 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.27 111.91 18.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.548 0.213 . . . . 0.0 110.815 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 143' ' ' ALA . . . . . 0.709 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -61.91 113.86 3.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.815 0.341 . . . . 0.0 111.405 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 144' ' ' THR . . . . . 0.784 ' HB ' ' H ' ' F' ' 97' ' ' THR . 75.1 m -88.28 145.22 35.4 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.317 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.81 134.17 7.17 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.524 2.149 . . . . 0.0 111.978 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.94 -135.59 4.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.537 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 147' ' ' ALA . . . . . 0.71 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -96.21 134.2 39.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.966 0.412 . . . . 0.0 111.312 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 148' ' ' ALA . . . . . 0.896 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -129.82 50.48 2.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.184 0.516 . . . . 0.0 110.469 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -98.92 146.16 26.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.491 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 150' ' ' ALA . . . . . 0.959 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -154.91 174.12 15.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.876 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 151' ' ' ASP . . . . . 0.482 ' C ' HD11 ' F' ' 86' ' ' LEU . 26.8 t70 -139.34 128.49 23.87 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.225 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 152' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -118.41 133.38 55.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.159 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 153' ' ' THR . . . . . 0.723 HG23 HG22 ' E' ' 9' ' ' THR . 0.2 OUTLIER -92.02 147.42 22.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.24 130.28 53.42 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.143 0.497 . . . . 0.0 110.085 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -126.71 144.02 51.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.874 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 156' ' ' VAL . . . . . 0.526 HG12 ' CD1' ' F' ' 131' ' ' ILE . 27.3 m -127.42 151.9 34.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.677 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 157' ' ' GLN . . . . . 0.688 ' HA ' ' O ' ' E' ' 3' ' ' THR . 0.0 OUTLIER -141.35 121.18 13.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.237 0.542 . . . . 0.0 110.365 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 158' ' ' TYR . . . . . 0.575 ' CD2' ' HB ' ' E' ' 3' ' ' THR . 1.2 m-85 -98.25 121.65 40.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.539 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.802 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.213 0.054 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.7 ' H ' ' HA ' ' B' ' 159' ' ' GLN . . . 65.93 74.71 0.36 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.533 0.206 . . . . 0.0 110.94 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.589 ' OG1' ' HB2' ' B' ' 158' ' ' TYR . 6.2 p -117.73 97.5 5.88 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.499 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.607 HG22 ' HB2' ' B' ' 157' ' ' GLN . 68.4 p -87.86 108.7 19.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.576 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.63 172.77 13.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.592 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -77.2 110.77 12.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.587 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' B' ' 155' ' ' LYS . . . -65.69 -59.41 7.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.772 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.56 151.71 14.94 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.818 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.513 HG23 ' O ' ' B' ' 152' ' ' ALA . 24.2 m -103.54 143.13 33.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 111.279 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.441 HG12 ' HG3' ' B' ' 30' ' ' GLN . 1.2 m -130.94 115.61 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.208 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.62 105.77 14.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.398 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.448 ' HD2' HD21 ' B' ' 34' ' ' LEU . 52.1 m-85 -83.25 105.55 14.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.782 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.52 145.05 41.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.455 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.75 -179.72 42.55 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.958 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.15 134.23 22.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.0 110.376 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.635 HG11 ' O ' ' B' ' 144' ' ' THR . 3.3 t -90.85 127.14 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.286 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 20' ' ' ALA . 12.1 m -126.25 168.77 18.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -100.42 81.79 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.154 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' B' ' 40' ' ' ALA . . . 53.3 58.17 5.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.071 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB3' HG21 ' A' ' 17' ' ' VAL . . . -108.55 -62.86 1.4 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.36 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.781 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.9 OUTLIER -171.56 -159.94 0.16 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.915 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.634 ' HA ' ' HB2' ' B' ' 36' ' ' GLN . . . -156.88 74.01 0.78 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.456 ' N ' HD23 ' A' ' 58' ' ' LEU . 7.4 p -45.35 140.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.544 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -63.42 140.74 58.9 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.661 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.36 -51.15 69.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.311 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.11 -18.04 74.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.919 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.96 -6.39 58.04 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.832 0.349 . . . . 0.0 110.786 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 24' ' ' ASP . 50.9 t -72.63 -36.37 53.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.426 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.95 110.82 14.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.969 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.78 146.05 48.6 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.033 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.21 113.84 27.67 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.127 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.61 HG11 HG11 ' A' ' 52' ' ' VAL . 3.3 t -105.08 121.93 57.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.108 0.48 . . . . 0.0 110.448 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.86 106.41 17.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.683 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.79 -44.74 89.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.592 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.62 -156.9 15.99 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.568 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -91.07 107.01 18.91 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.596 0.236 . . . . 0.0 110.847 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.572 ' CG1' HD21 ' A' ' 42' ' ' LEU . 4.3 t -92.34 120.63 41.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.918 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 -85.71 132.49 34.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.746 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.0 p -71.45 -23.32 61.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.756 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.03 -19.19 64.88 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.965 0.412 . . . . 0.0 110.793 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.8 t -90.53 -36.55 14.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.183 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -121.52 70.52 0.94 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.58 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 142' ' ' ALA . . . -104.76 28.18 7.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.38 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.772 ' HG3' ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -150.58 142.01 23.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.384 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 2.7 tt0 -62.7 101.79 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.777 0.322 . . . . 0.0 111.136 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.3 4.27 8.41 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.062 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.772 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . . . -91.76 121.2 33.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.002 0.43 . . . . 0.0 111.985 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 5.8 t -110.3 151.2 27.68 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.806 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -95.7 -57.62 2.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.594 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.24 -174.88 4.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.853 0.359 . . . . 0.0 110.817 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.476 ' HB2' ' CD ' ' A' ' 136' ' ' ARG . . . -127.05 143.87 51.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.387 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.61 HG11 HG11 ' A' ' 32' ' ' VAL . 48.3 t -120.85 116.86 51.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.972 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.19 122.64 6.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.67 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -128.58 138.83 52.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.33 . . . . 0.0 110.978 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.472 HD22 ' CG2' ' A' ' 130' ' ' THR . 1.6 m120 -117.86 150.95 38.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.657 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.574 ' HB ' HG13 ' A' ' 131' ' ' ILE . 9.3 mm -106.78 103.67 15.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.57 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.21 132.23 52.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.783 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.757 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 1.0 OUTLIER -137.31 151.87 49.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.256 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -138.45 171.27 14.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.983 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 5.9 m-20 50.1 68.42 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.781 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -106.59 141.14 38.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.764 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.84 117.89 33.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.24 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.7 p -91.12 -13.18 33.52 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.62 -38.95 82.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.069 0.462 . . . . 0.0 111.765 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.65 -54.11 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.645 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.7 84.31 3.35 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.582 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.98 -41.21 10.13 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.805 0.336 . . . . 0.0 111.023 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.63 159.96 17.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.518 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.7 160.4 39.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.616 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.02 152.91 45.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.133 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.89 136.54 53.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.722 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.0 107.45 5.04 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.555 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.475 ' CD2' HD13 ' A' ' 103' ' ' ILE . 43.1 t80 -73.65 136.66 43.86 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.605 0.24 . . . . 0.0 111.025 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 153' ' ' THR . 6.6 tt -113.56 111.41 21.84 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.978 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.649 ' HA3' HD11 ' A' ' 113' ' ' LEU . . . -131.29 -178.49 15.5 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.864 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.659 ' H ' HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -104.32 137.58 42.0 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.461 0.172 . . . . 0.0 110.857 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.98 114.78 23.89 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.992 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.618 ' O ' ' HG2' ' D' ' 134' ' ' GLN . 1.2 tt -95.7 -36.73 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.867 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.897 ' CB ' HG21 ' A' ' 140' ' ' THR . 0.4 OUTLIER -143.38 130.23 20.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.746 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.92 -7.18 47.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.046 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.33 -29.19 68.39 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.587 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.34 -32.64 4.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.88 0.371 . . . . 0.0 110.459 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.435 ' O ' HG22 ' A' ' 83' ' ' THR . 3.5 m 60.49 19.42 9.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.589 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.631 ' HB3' ' HG2' ' A' ' 102' ' ' GLN . 0.6 OUTLIER -139.37 -16.99 1.03 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.296 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.709 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 0.9 OUTLIER -66.67 118.02 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.244 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.659 HD12 ' H ' ' A' ' 76' ' ' THR . 10.7 tp -69.72 144.17 52.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.264 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.452 ' HB3' ' OG1' ' A' ' 76' ' ' THR . . . -80.2 138.09 36.78 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.917 0.389 . . . . 0.0 111.721 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.686 ' HB3' ' HA ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -84.95 -146.62 0.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.068 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 149' ' ' ASN . 0.0 OUTLIER -48.53 155.02 0.58 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.268 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.566 ' O ' HG22 ' D' ' 52' ' ' VAL . 32.4 p -86.73 -11.92 49.75 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.923 0.392 . . . . 0.0 111.503 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.42 114.08 5.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.589 ' HA ' ' HB3' ' D' ' 50' ' ' SER . . . -83.38 22.19 1.06 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.951 0.405 . . . . 0.0 111.683 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.21 21.97 1.21 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.698 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.64 -32.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.017 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.654 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 15.9 t -65.14 166.73 9.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.866 0.365 . . . . 0.0 110.616 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.465 ' O ' HD13 ' A' ' 88' ' ' LEU . . . -89.65 163.44 15.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.851 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.42 169.66 17.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.34 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 57.4 29.34 16.78 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.383 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.573 ' HB ' ' HB1' ' A' ' 143' ' ' ALA . 7.2 p -156.38 150.6 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.825 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.709 ' HA3' ' HB ' ' A' ' 85' ' ' VAL . . . -164.2 176.93 40.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.609 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.617 HG22 ' CE1' ' A' ' 137' ' ' TYR . 3.0 t -107.63 111.29 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.018 0.527 . . . . 0.0 111.713 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.631 ' HG2' ' HB3' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -75.97 179.75 5.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.958 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.492 HD11 ' HA ' ' A' ' 113' ' ' LEU . 6.0 pt -150.36 116.54 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.457 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 12.9 tp -97.22 122.54 40.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.724 0.297 . . . . 0.0 111.068 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.91 150.08 42.92 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.739 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.506 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -71.43 -17.58 62.38 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.824 0.345 . . . . 0.0 111.121 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.43 HG21 ' HA ' ' A' ' 120' ' ' SER . 76.1 p -76.62 -37.22 56.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.11 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.52 -68.81 0.32 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.732 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.61 123.2 18.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.795 0.331 . . . . 0.0 111.129 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.74 117.99 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.184 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.514 HD11 ' O ' ' A' ' 117' ' ' THR . 2.1 tp -67.87 144.1 55.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.43 0.633 . . . . 0.0 110.491 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.428 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -75.11 140.45 43.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.071 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.649 HD11 ' HA3' ' A' ' 75' ' ' GLY . 1.3 tp -85.18 97.75 10.08 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.701 0.286 . . . . 0.0 110.668 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -152.78 -59.01 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.645 0.26 . . . . 0.0 111.582 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.556 ' HA3' ' OG1' ' D' ' 130' ' ' THR . . . 135.73 -26.63 3.14 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.615 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.731 ' HB2' ' HA ' ' D' ' 129' ' ' ASN . . . -101.27 28.78 5.15 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.994 0.426 . . . . 0.0 111.692 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.514 ' O ' HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -106.58 67.34 0.72 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.075 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.4 81.0 8.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.737 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.04 97.45 3.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.43 ' HA ' HG21 ' A' ' 107' ' ' THR . 2.0 t -165.54 144.79 6.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.587 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.28 50.22 0.9 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.204 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.8 94.18 5.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.715 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.69 110.38 12.47 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.679 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.602 ' HG ' ' ND2' ' A' ' 129' ' ' ASN . 0.3 OUTLIER -70.2 154.15 42.26 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.578 179.42 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.6 144.77 51.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.552 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.74 125.67 24.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.653 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.1 -102.01 1.1 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.725 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 86.9 m -106.23 128.45 53.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.655 0.264 . . . . 0.0 110.831 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.602 ' ND2' ' HG ' ' A' ' 124' ' ' LEU . 20.1 t-20 -121.15 158.13 28.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.874 0.368 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.472 ' CG2' HD22 ' A' ' 55' ' ' ASN . 0.2 OUTLIER -155.81 143.08 19.27 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.996 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.607 HD13 HG11 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -115.22 110.79 45.14 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.506 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.4 Cg_endo -82.21 151.85 15.95 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.618 1.546 . . . . 0.0 112.5 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.01 146.77 17.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.797 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.8 OUTLIER -114.38 145.83 41.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.108 179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.77 91.17 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 111.679 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.57 ' HE ' HG21 ' A' ' 48' ' ' THR . 28.0 mtm-85 -88.34 153.6 21.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.405 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.617 ' CE1' HG22 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -91.29 111.06 22.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.071 179.571 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.608 ' CD1' ' HB2' ' A' ' 102' ' ' GLN . 8.8 m-85 -108.08 172.19 6.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.962 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.574 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -123.42 143.65 50.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.851 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.897 HG21 ' CB ' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -98.73 44.39 1.03 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.565 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.48 89.07 1.07 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.978 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . . . 60.09 88.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.709 0.255 . . . . 0.0 110.689 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.573 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -70.61 161.73 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.405 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 158.73 60.65 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.226 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.76 149.18 12.55 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.54 2.16 . . . . 0.0 112.06 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.72 -119.73 0.86 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.479 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.654 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -123.94 127.71 48.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.861 0.362 . . . . 0.0 111.417 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.686 ' HA ' ' HB3' ' A' ' 88' ' ' LEU . . . -120.85 67.17 0.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.117 0.484 . . . . 0.0 110.389 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 47.5 t-20 -128.47 114.77 17.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.6 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.424 ' HB2' ' C ' ' A' ' 88' ' ' LEU . . . -158.83 146.97 18.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.984 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.39 140.3 32.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.171 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.19 169.28 17.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.176 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 74' ' ' LEU . 9.3 t -155.11 150.52 27.25 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.442 ' HE1' HG13 ' A' ' 56' ' ' ILE . 1.1 p90 -118.97 149.27 41.91 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.121 0.486 . . . . 0.0 110.083 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.436 ' HE3' HD13 ' A' ' 74' ' ' LEU . 4.7 mttt -113.53 156.68 23.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.869 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.607 HG11 HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -136.48 137.98 47.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.684 -179.058 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -107.5 128.03 54.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.318 0.58 . . . . 0.0 110.37 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -107.87 107.43 18.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.542 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.851 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.209 0.052 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.727 ' H ' ' HA ' ' C' ' 159' ' ' GLN . . . 65.84 74.75 0.36 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.579 0.228 . . . . 0.0 110.98 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.6 ' OG1' ' HB2' ' C' ' 158' ' ' TYR . 6.2 p -117.74 97.56 5.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.46 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.606 HG22 ' HB2' ' C' ' 157' ' ' GLN . 67.9 p -87.91 108.61 19.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.527 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.51 172.75 13.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.59 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -77.24 110.86 12.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.494 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLY . . . . . 0.409 ' H ' ' HA ' ' C' ' 155' ' ' LYS . . . -65.76 -59.42 7.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.765 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.56 151.64 14.79 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.81 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.513 HG23 ' O ' ' C' ' 152' ' ' ALA . 24.2 m -103.44 143.09 33.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 111.357 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.438 HG12 ' HG3' ' C' ' 30' ' ' GLN . 1.2 m -130.98 115.63 30.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.186 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.65 105.71 14.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.349 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' PHE . . . . . 0.45 ' HD2' HD21 ' C' ' 34' ' ' LEU . 52.2 m-85 -83.17 105.47 14.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.783 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.46 145.07 41.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.446 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.74 -179.69 42.57 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.932 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.19 134.27 22.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.94 0.4 . . . . 0.0 110.306 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.635 HG11 ' O ' ' C' ' 144' ' ' THR . 3.3 t -90.9 127.16 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.264 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' B' ' 20' ' ' ALA . 12.1 m -126.25 168.75 18.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.86 0.362 . . . . 0.0 111.037 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.48 81.82 2.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.12 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' C' ' 40' ' ' ALA . . . 53.38 58.15 5.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.997 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.537 ' HB3' HG21 ' B' ' 17' ' ' VAL . . . -108.57 -62.82 1.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.442 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.9 OUTLIER -171.54 -159.86 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.914 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.64 ' HA ' ' HB2' ' C' ' 36' ' ' GLN . . . -156.84 74.07 0.79 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.463 ' N ' HD23 ' B' ' 58' ' ' LEU . 7.4 p -45.44 140.62 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.958 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.553 ' O ' HG23 ' B' ' 28' ' ' VAL . 0.5 OUTLIER -63.43 140.81 58.91 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.642 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.44 -51.15 69.5 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.307 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.08 -18.01 74.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.964 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -88.0 -6.32 58.05 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.827 0.346 . . . . 0.0 110.756 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.553 HG23 ' O ' ' B' ' 24' ' ' ASP . 50.5 t -72.78 -36.31 52.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.359 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.03 110.85 14.03 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.002 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' GLN . . . . . 0.441 ' HG3' HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -123.85 146.01 48.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.021 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.19 113.84 27.68 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.128 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.623 HG11 HG11 ' B' ' 52' ' ' VAL . 3.3 t -105.08 121.91 57.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.105 0.478 . . . . 0.0 110.475 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.84 106.37 17.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.721 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.448 HD21 ' HD2' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -64.69 -44.75 89.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.642 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.58 -156.91 16.0 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.558 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.634 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 3.7 mt-30 -91.1 106.98 18.9 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.629 0.252 . . . . 0.0 110.851 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.578 ' CG1' HD21 ' B' ' 42' ' ' LEU . 4.4 t -92.32 120.59 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.938 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' A' ' 19' ' ' ALA . 4.6 mtm105 -85.67 132.51 34.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.71 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 17' ' ' VAL . 29.4 p -71.54 -23.21 61.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.755 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . . . -68.08 -19.06 64.83 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.996 0.427 . . . . 0.0 110.844 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -90.6 -36.6 14.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.167 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' B' ' 139' ' ' ALA . 0.2 OUTLIER -121.48 70.54 0.94 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.61 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' B' ' 142' ' ' ALA . . . -104.7 28.11 7.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.423 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 0.77 ' HG3' ' HB2' ' B' ' 47' ' ' ALA . 0.0 OUTLIER -150.53 141.99 23.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.45 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' B' ' 140' ' ' THR . 2.7 tt0 -62.66 101.8 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.769 0.319 . . . . 0.0 111.104 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.26 4.26 8.44 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.099 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.77 ' HB2' ' HG3' ' B' ' 44' ' ' GLN . . . -91.74 121.32 33.27 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.982 0.42 . . . . 0.0 112.015 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' B' ' 137' ' ' TYR . 5.8 t -110.41 151.22 27.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.786 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -95.69 -57.67 2.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.596 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.23 -174.85 4.69 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.76 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.48 ' HB2' ' CD ' ' B' ' 136' ' ' ARG . . . -127.05 143.86 51.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.315 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.623 HG11 HG11 ' B' ' 32' ' ' VAL . 48.3 t -120.9 116.91 51.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.959 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.25 122.67 6.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.66 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -128.62 138.86 52.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.784 0.326 . . . . 0.0 111.0 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' B' ' 132' ' ' PRO . 1.0 OUTLIER -117.85 150.93 38.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.677 179.81 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.59 ' HB ' HG13 ' B' ' 131' ' ' ILE . 9.3 mm -106.77 103.66 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.607 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -61.15 132.27 53.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.798 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.762 ' HB3' ' SG ' ' B' ' 21' ' ' CYS . 1.0 OUTLIER -137.39 151.86 49.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.208 -179.677 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -138.38 171.34 14.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.972 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' B' ' 21' ' ' CYS . 5.9 m-20 49.98 68.48 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 0.0 OUTLIER -106.63 141.08 38.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.8 117.88 33.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.231 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.3 p -91.26 -13.02 33.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.69 -38.89 82.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.114 0.483 . . . . 0.0 111.79 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 76.4 t -107.75 -54.07 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.618 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.66 84.39 3.38 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.583 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -41.25 10.05 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.949 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.6 159.96 17.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.529 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.68 160.45 39.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.609 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.09 152.91 45.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.97 136.54 53.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.688 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.02 107.53 5.06 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.556 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.476 ' CD2' HD13 ' B' ' 103' ' ' ILE . 43.2 t80 -73.75 136.69 43.68 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.562 0.22 . . . . 0.0 111.02 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.457 ' HB3' ' O ' ' B' ' 153' ' ' THR . 6.6 tt -113.55 111.44 21.9 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.98 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.628 ' HA3' HD11 ' B' ' 113' ' ' LEU . . . -131.38 -178.6 15.56 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.841 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.654 ' H ' HD12 ' B' ' 86' ' ' LEU . 0.2 OUTLIER -104.28 137.61 41.94 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.478 0.18 . . . . 0.0 110.844 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.98 114.77 23.87 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.895 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.614 ' O ' ' HG2' ' E' ' 134' ' ' GLN . 1.2 tt -95.76 -36.75 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.782 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.889 ' CB ' HG21 ' B' ' 140' ' ' THR . 0.4 OUTLIER -143.33 130.22 20.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.93 -7.26 47.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.21 -29.31 68.33 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.665 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.26 -32.67 4.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.945 0.402 . . . . 0.0 110.502 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' THR . . . . . 0.424 ' O ' HG22 ' B' ' 83' ' ' THR . 3.5 m 60.52 19.39 9.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.633 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ASN . . . . . 0.642 ' HB3' ' HG2' ' B' ' 102' ' ' GLN . 0.6 OUTLIER -139.35 -17.03 1.03 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.312 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.696 ' HB ' ' HA3' ' B' ' 100' ' ' GLY . 0.9 OUTLIER -66.65 118.08 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.2 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.654 HD12 ' H ' ' B' ' 76' ' ' THR . 10.7 tp -69.75 144.13 52.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.374 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.447 ' HB3' ' CB ' ' B' ' 76' ' ' THR . . . -80.05 137.98 36.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.868 0.366 . . . . 0.0 111.773 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.69 ' HB3' ' HA ' ' B' ' 148' ' ' ALA . 0.0 OUTLIER -84.99 -146.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.11 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 89' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' B' ' 149' ' ' ASN . 0.0 OUTLIER -48.59 155.09 0.58 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.256 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 90' ' ' SER . . . . . 0.576 ' O ' HG22 ' E' ' 52' ' ' VAL . 32.5 p -86.79 -11.91 49.58 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.971 0.415 . . . . 0.0 111.496 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.41 114.13 5.19 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.952 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.601 ' HA ' ' HB3' ' E' ' 50' ' ' SER . . . -83.45 22.24 1.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.907 0.384 . . . . 0.0 111.653 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.26 21.98 1.2 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.679 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.65 -32.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.024 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' SER . . . . . 0.663 ' HA ' ' HB3' ' B' ' 147' ' ' ALA . 15.9 t -65.08 166.68 9.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.791 0.329 . . . . 0.0 110.666 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.465 ' O ' HD13 ' B' ' 88' ' ' LEU . . . -89.64 163.46 15.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.875 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.4 169.65 17.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.322 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 57.36 29.36 16.76 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.349 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' VAL . . . . . 0.575 ' HB ' ' HB1' ' B' ' 143' ' ' ALA . 7.2 p -156.42 150.54 10.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.794 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 100' ' ' GLY . . . . . 0.696 ' HA3' ' HB ' ' B' ' 85' ' ' VAL . . . -164.17 176.95 40.07 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.541 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.608 HG22 ' CE1' ' B' ' 137' ' ' TYR . 3.0 t -107.63 111.32 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 123.038 0.535 . . . . 0.0 111.666 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.642 ' HG2' ' HB3' ' B' ' 84' ' ' ASN . 0.0 OUTLIER -75.99 179.75 5.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.955 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' B' ' 113' ' ' LEU . 6.0 pt -150.34 116.59 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.474 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' B' ' 134' ' ' GLN . 12.8 tp -97.31 122.61 40.54 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.765 0.317 . . . . 0.0 110.967 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.88 150.13 42.68 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.639 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' ARG . . . . . 0.512 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -71.5 -17.55 62.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.763 0.316 . . . . 0.0 111.098 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.436 HG21 ' HA ' ' B' ' 120' ' ' SER . 75.8 p -76.64 -37.29 56.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.081 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.55 -68.72 0.32 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.689 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.67 123.26 18.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.831 0.348 . . . . 0.0 111.1 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.77 117.98 2.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.18 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.515 HD11 ' O ' ' B' ' 117' ' ' THR . 2.1 tp -67.82 144.1 55.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.417 0.627 . . . . 0.0 110.494 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.427 ' HA ' ' ND2' ' B' ' 84' ' ' ASN . 0.2 OUTLIER -75.14 140.51 43.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.079 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.628 HD11 ' HA3' ' B' ' 75' ' ' GLY . 1.3 tp -85.2 97.75 10.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.693 0.282 . . . . 0.0 110.619 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -152.83 -58.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.584 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' GLY . . . . . 0.555 ' HA3' ' OG1' ' E' ' 130' ' ' THR . . . 135.73 -26.58 3.15 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.632 -0.795 . . . . 0.0 112.67 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' ALA . . . . . 0.751 ' HB2' ' HA ' ' E' ' 129' ' ' ASN . . . -101.35 28.81 5.16 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.998 0.427 . . . . 0.0 111.641 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.515 ' O ' HD11 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -106.57 67.28 0.72 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.059 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.42 81.02 8.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.803 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.06 97.47 3.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.794 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.436 ' HA ' HG21 ' B' ' 107' ' ' THR . 1.9 t -165.61 144.79 6.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.546 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.34 50.36 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.139 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.79 94.18 5.73 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.676 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.73 110.31 12.46 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.723 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.604 ' HG ' ' ND2' ' B' ' 129' ' ' ASN . 0.3 OUTLIER -70.13 154.09 42.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.657 179.414 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -131.51 144.76 51.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.629 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.71 125.64 24.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.688 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.09 -102.06 1.11 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.734 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 86.9 m -106.16 128.48 53.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.633 0.254 . . . . 0.0 110.859 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ASN . . . . . 0.604 ' ND2' ' HG ' ' B' ' 124' ' ' LEU . 20.1 t-20 -121.14 158.18 28.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.896 0.379 . . . . 0.0 111.126 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.82 143.08 19.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.982 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' ILE . . . . . 0.598 HD13 HG11 ' B' ' 156' ' ' VAL . 0.1 OUTLIER -115.16 110.64 45.43 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 132' ' ' PRO . . . . . 0.512 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -82.14 151.83 16.1 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.609 1.539 . . . . 0.0 112.553 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.01 146.76 17.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.852 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' B' ' 104' ' ' LEU . 0.8 OUTLIER -114.28 145.9 41.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.088 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.89 91.13 1.9 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.913 0.387 . . . . 0.0 111.686 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' ARG . . . . . 0.566 ' HE ' HG21 ' B' ' 48' ' ' THR . 28.1 mtm-85 -88.33 153.59 21.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.374 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 137' ' ' TYR . . . . . 0.608 ' CE1' HG22 ' B' ' 101' ' ' VAL . 0.7 OUTLIER -91.24 111.01 22.31 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.129 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 138' ' ' PHE . . . . . 0.608 ' CD1' ' HB2' ' B' ' 102' ' ' GLN . 8.8 m-85 -108.08 172.17 6.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.029 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -123.43 143.68 49.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.862 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 140' ' ' THR . . . . . 0.889 HG21 ' CB ' ' B' ' 79' ' ' ASP . 0.2 OUTLIER -98.81 44.36 1.03 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.47 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.57 89.08 1.08 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.929 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 142' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' B' ' 43' ' ' ALA . . . 59.94 88.1 0.08 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.745 0.272 . . . . 0.0 110.777 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 143' ' ' ALA . . . . . 0.575 ' HB1' ' HB ' ' B' ' 99' ' ' VAL . . . -70.63 161.7 30.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.815 0.34 . . . . 0.0 111.379 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.635 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -124.48 158.73 60.64 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.213 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.511 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 1.4 Cg_endo -83.81 149.22 12.49 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.502 2.135 . . . . 0.0 112.057 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.69 -119.78 0.86 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.483 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.663 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -123.95 127.67 48.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.874 0.369 . . . . 0.0 111.413 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' ALA . . . . . 0.69 ' HA ' ' HB3' ' B' ' 88' ' ' LEU . . . -120.8 67.16 0.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.428 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' B' ' 89' ' ' GLN . 47.5 t-20 -128.45 114.75 17.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.637 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.429 ' HB2' ' C ' ' B' ' 88' ' ' LEU . . . -158.77 147.05 18.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.034 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.45 140.3 32.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.121 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 9' ' ' THR . . . -136.19 169.31 17.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.208 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.457 ' O ' ' HB3' ' B' ' 74' ' ' LEU . 9.4 t -155.13 150.49 27.19 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.439 ' HE1' HG13 ' B' ' 56' ' ' ILE . 1.1 p90 -119.03 149.21 42.05 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.024 0.44 . . . . 0.0 110.107 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.447 ' HE3' HD13 ' B' ' 74' ' ' LEU . 4.7 mttt -113.42 156.56 23.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.914 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 156' ' ' VAL . . . . . 0.598 HG11 HD13 ' B' ' 131' ' ' ILE . 0.2 OUTLIER -136.43 138.02 47.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.699 -179.116 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.607 ' HB2' HG22 ' A' ' 4' ' ' THR . 64.1 tt0 -107.46 128.02 54.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.285 0.564 . . . . 0.0 110.369 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 158' ' ' TYR . . . . . 0.589 ' HB2' ' OG1' ' A' ' 3' ' ' THR . 60.9 m-85 -107.81 107.37 18.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.519 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 159' ' ' GLN . . . . . 0.7 ' HA ' ' H ' ' A' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.272 0.082 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.71 ' H ' ' HA ' ' D' ' 159' ' ' GLN . . . 65.93 74.7 0.36 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.529 0.204 . . . . 0.0 110.929 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' D' ' 158' ' ' TYR . 6.0 p -117.74 97.5 5.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.479 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 4' ' ' THR . . . . . 0.629 HG22 ' HB2' ' D' ' 157' ' ' GLN . 67.8 p -87.92 108.74 19.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.529 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.61 172.71 13.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.571 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.15 110.76 12.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.567 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.73 -59.37 7.71 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.792 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.5 151.71 15.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.827 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' THR . . . . . 0.5 HG23 ' O ' ' D' ' 152' ' ' ALA . 24.1 m -103.48 143.11 33.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.855 0.36 . . . . 0.0 111.313 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.44 HG12 ' HG3' ' D' ' 30' ' ' GLN . 1.1 m -130.97 115.65 30.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.134 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -83.62 105.72 14.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.367 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' PHE . . . . . 0.456 ' HD2' HD21 ' D' ' 34' ' ' LEU . 52.2 m-85 -83.19 105.46 14.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.756 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.39 145.06 41.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.422 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.71 -179.68 42.56 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.974 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.23 134.27 22.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.971 0.415 . . . . 0.0 110.358 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.634 HG11 ' O ' ' D' ' 144' ' ' THR . 3.3 t -90.92 127.11 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.238 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' C' ' 20' ' ' ALA . 12.1 m -126.23 168.82 18.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.831 0.348 . . . . 0.0 111.022 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.53 81.88 2.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.046 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' ALA . . . . . 0.445 ' HA ' ' HG2' ' D' ' 38' ' ' ARG . . . 53.27 58.24 5.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.015 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 20' ' ' ALA . . . . . 0.525 ' HB3' HG21 ' C' ' 17' ' ' VAL . . . -108.61 -62.8 1.41 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.385 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 21' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.9 OUTLIER -171.57 -159.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.957 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 22' ' ' ALA . . . . . 0.625 ' HA ' ' HB2' ' D' ' 36' ' ' GLN . . . -156.88 74.0 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.059 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 23' ' ' VAL . . . . . 0.47 ' N ' HD23 ' C' ' 58' ' ' LEU . 7.4 p -45.3 140.56 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.061 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.554 ' O ' HG23 ' C' ' 28' ' ' VAL . 0.5 OUTLIER -63.45 140.79 58.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.615 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.43 -51.16 69.43 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.287 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.03 -18.04 74.23 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.966 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -88.0 -6.27 58.07 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.807 0.337 . . . . 0.0 110.794 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.554 HG23 ' O ' ' C' ' 24' ' ' ASP . 50.7 t -72.74 -36.43 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.332 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.94 110.92 14.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.95 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 30' ' ' GLN . . . . . 0.438 ' HG3' HG12 ' B' ' 10' ' ' VAL . 0.4 OUTLIER -123.86 146.05 48.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.987 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.18 113.84 27.68 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.113 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.625 HG11 HG11 ' C' ' 52' ' ' VAL . 3.3 t -105.13 121.92 57.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 110.404 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.85 106.42 17.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.641 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.45 HD21 ' HD2' ' B' ' 12' ' ' PHE . 0.6 OUTLIER -64.79 -44.73 89.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.555 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.61 -156.8 16.03 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.6 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' GLN . . . . . 0.64 ' HB2' ' HA ' ' B' ' 22' ' ' ALA . 3.7 mt-30 -91.09 106.93 18.86 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.663 0.268 . . . . 0.0 110.922 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.578 ' CG1' HD21 ' C' ' 42' ' ' LEU . 4.3 t -92.28 120.51 41.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.94 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 38' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' B' ' 19' ' ' ALA . 4.6 mtm105 -85.59 132.49 34.17 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.759 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.436 HG23 ' O ' ' B' ' 17' ' ' VAL . 29.1 p -71.48 -23.34 61.79 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.768 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' B' ' 19' ' ' ALA . . . -67.93 -19.2 64.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.935 0.397 . . . . 0.0 110.817 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 13.8 t -90.61 -36.56 14.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.159 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.591 ' HB2' ' HB2' ' C' ' 139' ' ' ALA . 0.2 OUTLIER -121.45 70.55 0.94 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.623 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 43' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' C' ' 142' ' ' ALA . . . -104.79 28.16 7.37 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.379 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' GLN . . . . . 0.752 ' HG3' ' HB2' ' C' ' 47' ' ' ALA . 0.0 OUTLIER -150.62 141.93 23.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.402 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 45' ' ' GLU . . . . . 0.449 ' HG3' ' HA ' ' C' ' 140' ' ' THR . 2.7 tt0 -62.62 101.78 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.764 0.316 . . . . 0.0 111.133 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.24 4.25 8.46 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.094 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.752 ' HB2' ' HG3' ' C' ' 44' ' ' GLN . . . -91.73 121.33 33.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.942 0.401 . . . . 0.0 112.016 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 48' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' C' ' 137' ' ' TYR . 5.8 t -110.41 151.16 27.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.815 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -95.66 -57.68 2.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.544 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.2 -174.88 4.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.87 0.367 . . . . 0.0 110.8 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 51' ' ' ALA . . . . . 0.475 ' HB2' ' CD ' ' C' ' 136' ' ' ARG . . . -127.06 143.82 51.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.395 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.625 HG11 HG11 ' C' ' 32' ' ' VAL . 48.3 t -120.85 116.85 51.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.006 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.16 122.61 6.19 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.685 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -128.58 138.82 52.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 111.022 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.503 ' ND2' ' HA ' ' C' ' 132' ' ' PRO . 1.0 OUTLIER -117.8 150.98 38.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.621 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.589 ' HB ' HG13 ' C' ' 131' ' ' ILE . 9.2 mm -106.83 103.64 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.617 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -61.07 132.25 53.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.751 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' LEU . . . . . 0.763 ' HB3' ' SG ' ' C' ' 21' ' ' CYS . 1.0 OUTLIER -137.44 151.81 48.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.244 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -138.35 171.39 14.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.962 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' C' ' 21' ' ' CYS . 5.9 m-20 49.97 68.51 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.791 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 61' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 0.0 OUTLIER -106.62 141.07 38.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.794 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.79 117.83 33.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.254 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 23.5 p -91.13 -13.1 33.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.58 -39.02 82.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.14 0.495 . . . . 0.0 111.76 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 75.8 t -107.63 -54.15 6.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.627 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.7 84.38 3.37 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.596 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.02 -41.27 10.08 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.911 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.69 159.98 17.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.459 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.71 160.38 39.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.612 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.01 153.01 44.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.18 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.95 136.46 54.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.73 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.95 107.4 5.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.618 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 73' ' ' PHE . . . . . 0.468 ' CD2' HD13 ' C' ' 103' ' ' ILE . 43.0 t80 -73.57 136.68 44.02 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.502 0.191 . . . . 0.0 111.082 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' C' ' 153' ' ' THR . 6.6 tt -113.6 111.4 21.81 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.003 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 75' ' ' GLY . . . . . 0.64 ' HA3' HD11 ' C' ' 113' ' ' LEU . . . -131.35 -178.54 15.53 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.765 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.665 ' H ' HD12 ' C' ' 86' ' ' LEU . 0.2 OUTLIER -104.28 137.55 42.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.5 0.191 . . . . 0.0 110.878 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.93 114.81 23.88 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.997 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 78' ' ' ILE . . . . . 0.613 ' O ' ' HG2' ' F' ' 134' ' ' GLN . 1.2 tt -95.75 -36.72 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 79' ' ' ASP . . . . . 0.902 ' CB ' HG21 ' C' ' 140' ' ' THR . 0.4 OUTLIER -143.39 130.28 20.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.722 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.95 -7.2 47.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.97 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.3 -29.18 68.28 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.637 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.31 -32.73 4.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.903 0.382 . . . . 0.0 110.432 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 83' ' ' THR . . . . . 0.421 ' O ' HG22 ' C' ' 83' ' ' THR . 3.5 m 60.59 19.41 9.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.574 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 84' ' ' ASN . . . . . 0.638 ' HB3' ' HG2' ' C' ' 102' ' ' GLN . 0.6 OUTLIER -139.39 -16.94 1.03 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.314 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.691 ' HB ' ' HA3' ' C' ' 100' ' ' GLY . 0.8 OUTLIER -66.71 118.08 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.172 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.665 HD12 ' H ' ' C' ' 76' ' ' THR . 10.7 tp -69.79 144.14 52.75 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.27 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.455 ' HB3' ' OG1' ' C' ' 76' ' ' THR . . . -80.07 138.0 36.89 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.777 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.691 ' HB3' ' HA ' ' C' ' 148' ' ' ALA . 0.0 OUTLIER -84.99 -146.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.068 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 89' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' C' ' 149' ' ' ASN . 0.0 OUTLIER -48.48 155.02 0.57 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.312 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 90' ' ' SER . . . . . 0.577 ' O ' HG22 ' F' ' 52' ' ' VAL . 33.1 p -86.79 -11.87 49.7 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.991 0.424 . . . . 0.0 111.489 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.42 114.08 5.16 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 92' ' ' ALA . . . . . 0.597 ' HA ' ' HB3' ' F' ' 50' ' ' SER . . . -83.38 22.25 1.05 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.919 0.39 . . . . 0.0 111.728 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.28 21.98 1.2 Allowed 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.699 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.75 -32.23 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.974 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 95' ' ' SER . . . . . 0.661 ' HA ' ' HB3' ' C' ' 147' ' ' ALA . 16.0 t -65.15 166.71 9.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.805 0.336 . . . . 0.0 110.682 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 96' ' ' ALA . . . . . 0.452 ' O ' HD13 ' C' ' 88' ' ' LEU . . . -89.64 163.46 15.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.892 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.37 169.63 17.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.347 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 57.35 29.36 16.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.378 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 99' ' ' VAL . . . . . 0.564 ' HB ' ' HB1' ' C' ' 143' ' ' ALA . 7.2 p -156.35 150.57 10.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.839 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 100' ' ' GLY . . . . . 0.691 ' HA3' ' HB ' ' C' ' 85' ' ' VAL . . . -164.19 176.93 40.08 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.584 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 101' ' ' VAL . . . . . 0.615 HG22 ' CE1' ' C' ' 137' ' ' TYR . 3.0 t -107.6 111.29 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.06 0.544 . . . . 0.0 111.74 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 102' ' ' GLN . . . . . 0.638 ' HG2' ' HB3' ' C' ' 84' ' ' ASN . 0.0 OUTLIER -75.98 179.73 5.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.979 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' C' ' 113' ' ' LEU . 6.0 pt -150.35 116.62 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.418 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 104' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' C' ' 134' ' ' GLN . 12.8 tp -97.23 122.55 40.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.676 0.274 . . . . 0.0 111.015 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.96 150.07 43.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.718 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 106' ' ' ARG . . . . . 0.529 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -71.47 -17.56 62.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.793 0.33 . . . . 0.0 111.087 179.559 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 107' ' ' THR . . . . . 0.44 HG21 ' HA ' ' C' ' 120' ' ' SER . 74.3 p -76.52 -37.29 56.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.152 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.55 -68.74 0.32 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.705 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.69 123.27 18.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.811 0.339 . . . . 0.0 111.14 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.66 117.98 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 111' ' ' LEU . . . . . 0.522 HD11 ' O ' ' C' ' 117' ' ' THR . 2.1 tp -67.83 144.06 55.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.473 0.654 . . . . 0.0 110.502 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 112' ' ' THR . . . . . 0.435 ' HA ' ' ND2' ' C' ' 84' ' ' ASN . 0.2 OUTLIER -75.08 140.43 43.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.127 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.64 HD11 ' HA3' ' C' ' 75' ' ' GLY . 1.3 tp -85.18 97.75 10.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 110.62 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -152.79 -59.03 0.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.68 0.276 . . . . 0.0 111.555 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 115' ' ' GLY . . . . . 0.57 ' HA3' ' OG1' ' F' ' 130' ' ' THR . . . 135.77 -26.63 3.14 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.577 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 116' ' ' ALA . . . . . 0.748 ' HB2' ' HA ' ' F' ' 129' ' ' ASN . . . -101.36 28.78 5.19 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.055 0.455 . . . . 0.0 111.656 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 117' ' ' THR . . . . . 0.522 ' O ' HD11 ' C' ' 111' ' ' LEU . 0.2 OUTLIER -106.56 67.31 0.72 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.05 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.38 80.96 8.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.77 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.96 97.46 3.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 120' ' ' SER . . . . . 0.44 ' HA ' HG21 ' C' ' 107' ' ' THR . 2.0 t -165.59 144.83 6.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.6 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.34 50.4 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.144 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.88 94.11 5.78 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.685 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.73 110.4 12.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.729 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 124' ' ' LEU . . . . . 0.607 ' HG ' ' ND2' ' C' ' 129' ' ' ASN . 0.3 OUTLIER -70.13 154.13 42.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.65 179.396 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -131.58 144.73 51.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.623 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.77 125.66 24.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.663 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.1 -102.02 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.715 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 86.4 m -106.23 128.55 54.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.652 0.263 . . . . 0.0 110.786 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 129' ' ' ASN . . . . . 0.607 ' ND2' ' HG ' ' C' ' 124' ' ' LEU . 20.1 t-20 -121.19 158.14 28.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.902 0.382 . . . . 0.0 111.116 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.79 143.09 19.3 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.986 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 131' ' ' ILE . . . . . 0.601 HD13 HG11 ' C' ' 156' ' ' VAL . 0.1 OUTLIER -115.22 110.73 45.2 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 132' ' ' PRO . . . . . 0.529 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.5 Cg_endo -82.1 151.77 16.18 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.632 1.554 . . . . 0.0 112.573 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.02 146.79 17.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 134' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' C' ' 104' ' ' LEU . 0.8 OUTLIER -114.4 145.8 41.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.088 179.428 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.76 91.22 1.92 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 111.674 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.58 ' HE ' HG21 ' C' ' 48' ' ' THR . 28.0 mtm-85 -88.33 153.55 21.11 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.345 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 137' ' ' TYR . . . . . 0.615 ' CE1' HG22 ' C' ' 101' ' ' VAL . 0.7 OUTLIER -91.22 111.04 22.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.103 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 138' ' ' PHE . . . . . 0.596 ' CD1' ' HB2' ' C' ' 102' ' ' GLN . 8.8 m-85 -108.13 172.21 6.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.939 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 139' ' ' ALA . . . . . 0.591 ' HB2' ' HB2' ' C' ' 42' ' ' LEU . . . -123.45 143.6 50.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.87 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 140' ' ' THR . . . . . 0.902 HG21 ' CB ' ' C' ' 79' ' ' ASP . 0.2 OUTLIER -98.71 44.47 1.03 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.529 179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.5 89.06 1.07 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.936 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 142' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' C' ' 43' ' ' ALA . . . 60.02 88.09 0.08 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.7 0.25 . . . . 0.0 110.693 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 143' ' ' ALA . . . . . 0.564 ' HB1' ' HB ' ' C' ' 99' ' ' VAL . . . -70.64 161.75 30.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.775 0.321 . . . . 0.0 111.444 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 144' ' ' THR . . . . . 0.635 ' O ' HG11 ' B' ' 16' ' ' VAL . 0.2 OUTLIER -124.49 158.71 60.73 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.191 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 145' ' ' PRO . . . . . 0.53 ' HA ' ' HB ' ' B' ' 16' ' ' VAL . 1.5 Cg_endo -83.72 149.25 12.63 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.501 2.134 . . . . 0.0 112.072 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.7 -119.76 0.86 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.52 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 147' ' ' ALA . . . . . 0.661 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -123.91 127.71 48.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.828 0.346 . . . . 0.0 111.418 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 148' ' ' ALA . . . . . 0.691 ' HA ' ' HB3' ' C' ' 88' ' ' LEU . . . -120.83 67.19 0.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.41 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 149' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' C' ' 89' ' ' GLN . 47.3 t-20 -128.49 114.78 17.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.599 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 150' ' ' ALA . . . . . 0.425 ' HB2' ' C ' ' C' ' 88' ' ' LEU . . . -158.87 146.93 18.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.0 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.33 140.31 32.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.148 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 152' ' ' ALA . . . . . 0.513 ' O ' HG23 ' B' ' 9' ' ' THR . . . -136.26 169.23 17.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.18 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 153' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' C' ' 74' ' ' LEU . 9.3 t -155.09 150.54 27.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 154' ' ' PHE . . . . . 0.427 ' HE1' HG13 ' C' ' 56' ' ' ILE . 1.1 p90 -119.05 149.21 42.05 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.077 0.465 . . . . 0.0 110.075 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 155' ' ' LYS . . . . . 0.42 ' HE3' HD13 ' C' ' 74' ' ' LEU . 4.7 mttt -113.48 156.64 23.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.908 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 156' ' ' VAL . . . . . 0.601 HG11 HD13 ' C' ' 131' ' ' ILE . 0.2 OUTLIER -136.45 138.03 47.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.663 -179.061 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 157' ' ' GLN . . . . . 0.606 ' HB2' HG22 ' B' ' 4' ' ' THR . 64.1 tt0 -107.5 128.05 54.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.363 0.601 . . . . 0.0 110.365 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 158' ' ' TYR . . . . . 0.6 ' HB2' ' OG1' ' B' ' 3' ' ' THR . 60.9 m-85 -107.85 107.46 18.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.541 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 159' ' ' GLN . . . . . 0.727 ' HA ' ' H ' ' B' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.884 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.312 0.101 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.714 ' H ' ' HA ' ' E' ' 159' ' ' GLN . . . 65.87 74.72 0.36 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.937 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 3' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' E' ' 158' ' ' TYR . 6.2 p -117.71 97.48 5.88 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.489 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 4' ' ' THR . . . . . 0.62 HG22 ' HB2' ' E' ' 157' ' ' GLN . 68.1 p -87.87 108.72 19.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.559 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.401 HG11 HG12 ' E' ' 17' ' ' VAL . 15.3 m -126.63 172.74 13.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.612 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.13 110.81 12.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.566 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 7' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' E' ' 155' ' ' LYS . . . -65.67 -59.51 7.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.747 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.52 151.68 14.92 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.809 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 9' ' ' THR . . . . . 0.507 HG23 ' O ' ' E' ' 152' ' ' ALA . 24.2 m -103.45 143.08 33.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 111.319 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 10' ' ' VAL . . . . . 0.426 HG12 ' HG3' ' E' ' 30' ' ' GLN . 1.1 m -130.93 115.63 30.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.182 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.63 105.67 14.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.392 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 12' ' ' PHE . . . . . 0.445 ' HD2' HD21 ' E' ' 34' ' ' LEU . 52.0 m-85 -83.21 105.47 14.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.8 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.41 145.13 41.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.452 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.74 -179.67 42.58 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.98 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.26 134.2 22.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.937 0.399 . . . . 0.0 110.406 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.625 HG11 ' O ' ' E' ' 144' ' ' THR . 3.3 t -90.9 127.2 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.174 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' D' ' 20' ' ' ALA . 12.1 m -126.31 168.78 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.929 0.395 . . . . 0.0 111.025 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.49 81.85 2.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.092 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' ALA . . . . . 0.447 ' HA ' ' HG2' ' E' ' 38' ' ' ARG . . . 53.31 58.19 5.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.057 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.543 ' HB3' HG21 ' D' ' 17' ' ' VAL . . . -108.6 -62.83 1.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.36 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 21' ' ' CYS . . . . . 0.872 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.9 OUTLIER -171.53 -159.88 0.16 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 22' ' ' ALA . . . . . 0.635 ' HA ' ' HB2' ' E' ' 36' ' ' GLN . . . -156.86 74.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.098 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 23' ' ' VAL . . . . . 0.465 ' N ' HD23 ' D' ' 58' ' ' LEU . 7.4 p -45.36 140.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.081 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.555 ' O ' HG23 ' D' ' 28' ' ' VAL . 0.5 OUTLIER -63.49 140.79 58.91 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.656 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.4 -51.14 69.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.302 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.11 -17.98 74.33 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.937 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.96 -6.42 58.03 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.859 0.362 . . . . 0.0 110.818 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' VAL . . . . . 0.555 HG23 ' O ' ' D' ' 24' ' ' ASP . 50.5 t -72.7 -36.36 52.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.364 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.0 110.88 14.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.008 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 30' ' ' GLN . . . . . 0.44 ' HG3' HG12 ' C' ' 10' ' ' VAL . 0.4 OUTLIER -123.76 146.07 48.57 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.977 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.25 113.83 27.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.084 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.612 HG11 HG11 ' D' ' 52' ' ' VAL . 3.3 t -105.15 121.91 57.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.149 0.499 . . . . 0.0 110.433 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.84 106.37 17.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.669 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.456 HD21 ' HD2' ' C' ' 12' ' ' PHE . 0.6 OUTLIER -64.73 -44.74 89.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.595 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.6 -156.91 15.99 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.54 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' GLN . . . . . 0.625 ' HB2' ' HA ' ' C' ' 22' ' ' ALA . 3.7 mt-30 -91.06 106.95 18.88 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.656 0.265 . . . . 0.0 110.899 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.574 ' CG1' HD21 ' D' ' 42' ' ' LEU . 4.4 t -92.29 120.63 41.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.839 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 38' ' ' ARG . . . . . 0.445 ' HG2' ' HA ' ' C' ' 19' ' ' ALA . 4.6 mtm105 -85.68 132.46 34.14 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.742 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.425 HG23 ' O ' ' C' ' 17' ' ' VAL . 29.5 p -71.5 -23.23 61.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.753 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.443 ' CB ' ' HB2' ' C' ' 19' ' ' ALA . . . -68.13 -19.07 64.79 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.974 0.416 . . . . 0.0 110.823 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -90.59 -36.65 14.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.16 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' D' ' 139' ' ' ALA . 0.2 OUTLIER -121.44 70.62 0.94 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.555 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 43' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' D' ' 142' ' ' ALA . . . -104.79 28.18 7.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.392 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 44' ' ' GLN . . . . . 0.77 ' HG3' ' HB2' ' D' ' 47' ' ' ALA . 0.0 OUTLIER -150.59 141.92 23.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.437 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 45' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' D' ' 140' ' ' THR . 2.7 tt0 -62.69 101.78 0.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.819 0.342 . . . . 0.0 111.145 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.29 4.23 8.43 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.115 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.77 ' HB2' ' HG3' ' D' ' 44' ' ' GLN . . . -91.67 121.28 33.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.932 0.396 . . . . 0.0 112.03 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 48' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' D' ' 137' ' ' TYR . 5.9 t -110.42 151.18 27.8 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.826 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 5.1 t -95.62 -57.59 2.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.632 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.589 ' HB3' ' HA ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -148.23 -174.85 4.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.875 0.369 . . . . 0.0 110.756 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 51' ' ' ALA . . . . . 0.482 ' HB2' ' CD ' ' D' ' 136' ' ' ARG . . . -127.11 143.86 51.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.352 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 52' ' ' VAL . . . . . 0.612 HG11 HG11 ' D' ' 32' ' ' VAL . 48.2 t -120.84 116.86 51.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.974 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 53' ' ' GLY . . . . . 0.414 ' O ' HG21 ' A' ' 76' ' ' THR . . . -111.15 122.67 6.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.699 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -128.63 138.84 52.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.812 0.339 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 55' ' ' ASN . . . . . 0.479 HD22 ' CG2' ' D' ' 130' ' ' THR . 1.6 m120 -117.86 150.99 38.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.585 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.575 ' HB ' HG13 ' D' ' 131' ' ' ILE . 9.3 mm -106.86 103.77 15.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.547 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 57' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.11 132.28 53.23 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.788 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 58' ' ' LEU . . . . . 0.752 ' HB3' ' SG ' ' D' ' 21' ' ' CYS . 1.0 OUTLIER -137.49 151.81 48.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.205 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -138.32 171.36 14.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.977 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 60' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' D' ' 21' ' ' CYS . 5.9 m-20 50.0 68.55 0.73 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.743 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 61' ' ' CYS . . . . . 0.872 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 0.0 OUTLIER -106.67 141.11 38.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.792 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.78 117.83 33.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.254 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 23.4 p -91.21 -13.04 33.55 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -38.98 82.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.081 0.467 . . . . 0.0 111.707 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 75.8 t -107.67 -54.11 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.64 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.69 84.32 3.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.576 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.05 -41.23 10.08 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.955 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.57 159.99 17.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.517 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.7 160.4 39.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.586 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.07 152.94 45.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.157 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.9 136.55 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.699 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.04 107.46 5.03 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.565 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 73' ' ' PHE . . . . . 0.474 ' CD2' HD13 ' D' ' 103' ' ' ILE . 42.9 t80 -73.62 136.61 43.92 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.532 0.206 . . . . 0.0 111.06 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 74' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' D' ' 153' ' ' THR . 6.6 tt -113.55 111.39 21.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.006 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 75' ' ' GLY . . . . . 0.628 ' HA3' HD11 ' D' ' 113' ' ' LEU . . . -131.26 -178.5 15.5 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.883 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 76' ' ' THR . . . . . 0.664 ' H ' HD12 ' D' ' 86' ' ' LEU . 0.2 OUTLIER -104.37 137.54 42.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.493 0.187 . . . . 0.0 110.825 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.96 114.74 23.84 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.961 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.74 -36.78 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.842 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.9 ' CB ' HG21 ' D' ' 140' ' ' THR . 0.4 OUTLIER -143.32 130.19 20.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.8 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.83 -7.28 47.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.991 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.37 -29.14 68.38 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.557 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.33 -32.61 4.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.482 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 83' ' ' THR . . . . . 0.428 ' O ' HG22 ' D' ' 83' ' ' THR . 3.5 m 60.47 19.43 9.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.58 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 84' ' ' ASN . . . . . 0.614 ' HB3' ' HG2' ' D' ' 102' ' ' GLN . 0.6 OUTLIER -139.31 -16.94 1.04 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.409 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.699 ' HB ' ' HA3' ' D' ' 100' ' ' GLY . 0.9 OUTLIER -66.77 118.03 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.206 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.664 HD12 ' H ' ' D' ' 76' ' ' THR . 10.7 tp -69.7 144.13 52.91 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.275 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.454 ' HB3' ' OG1' ' D' ' 76' ' ' THR . . . -80.14 138.06 36.84 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.892 0.377 . . . . 0.0 111.71 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.698 ' HB3' ' HA ' ' D' ' 148' ' ' ALA . 0.0 OUTLIER -84.96 -146.62 0.1 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.079 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 89' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' D' ' 149' ' ' ASN . 0.0 OUTLIER -48.48 155.03 0.57 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.293 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 32.4 p -86.77 -11.91 49.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.533 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 8.2 t -66.43 114.15 5.22 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.34 22.09 1.07 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.932 0.396 . . . . 0.0 111.706 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.2 21.97 1.21 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.73 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.7 -32.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.957 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 95' ' ' SER . . . . . 0.659 ' HA ' ' HB3' ' D' ' 147' ' ' ALA . 15.8 t -65.16 166.64 9.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 110.654 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 96' ' ' ALA . . . . . 0.466 ' O ' HD13 ' D' ' 88' ' ' LEU . . . -89.59 163.53 15.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.827 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.45 169.7 17.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.276 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 98' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 57.26 29.42 16.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.38 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 99' ' ' VAL . . . . . 0.553 ' HB ' ' HB1' ' D' ' 143' ' ' ALA . 7.1 p -156.39 150.54 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 100' ' ' GLY . . . . . 0.699 ' HA3' ' HB ' ' D' ' 85' ' ' VAL . . . -164.14 176.95 40.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.587 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 101' ' ' VAL . . . . . 0.614 HG22 ' CE1' ' D' ' 137' ' ' TYR . 3.0 t -107.62 111.32 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 123.078 0.551 . . . . 0.0 111.663 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 102' ' ' GLN . . . . . 0.614 ' HG2' ' HB3' ' D' ' 84' ' ' ASN . 0.0 OUTLIER -76.0 179.72 5.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.942 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 103' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' D' ' 113' ' ' LEU . 6.0 pt -150.33 116.56 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.43 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 104' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' D' ' 134' ' ' GLN . 12.8 tp -97.21 122.55 40.36 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 111.068 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.91 150.11 42.86 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.65 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 106' ' ' ARG . . . . . 0.509 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -71.5 -17.54 62.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.846 0.355 . . . . 0.0 111.102 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 107' ' ' THR . . . . . 0.426 HG21 ' HA ' ' D' ' 120' ' ' SER . 76.1 p -76.62 -37.29 56.62 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.111 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.57 -68.74 0.32 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.677 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.55 123.17 18.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.772 0.32 . . . . 0.0 111.191 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.79 118.0 2.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.939 0.4 . . . . 0.0 111.15 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 111' ' ' LEU . . . . . 0.506 HD11 ' O ' ' D' ' 117' ' ' THR . 2.1 tp -67.88 144.09 55.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.43 0.633 . . . . 0.0 110.46 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 112' ' ' THR . . . . . 0.433 ' HA ' ' ND2' ' D' ' 84' ' ' ASN . 0.2 OUTLIER -75.15 140.46 43.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.095 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 113' ' ' LEU . . . . . 0.628 HD11 ' HA3' ' D' ' 75' ' ' GLY . 1.3 tp -85.15 97.78 10.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.748 0.308 . . . . 0.0 110.596 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -152.83 -59.07 0.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.65 0.262 . . . . 0.0 111.494 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.77 -26.61 3.14 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.552 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.34 28.82 5.15 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.045 0.45 . . . . 0.0 111.676 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 117' ' ' THR . . . . . 0.506 ' O ' HD11 ' D' ' 111' ' ' LEU . 0.2 OUTLIER -106.57 67.38 0.72 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.03 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.43 80.89 8.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.739 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.95 97.55 3.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.881 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 120' ' ' SER . . . . . 0.426 ' HA ' HG21 ' D' ' 107' ' ' THR . 2.0 t -165.66 144.79 6.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.531 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.32 50.34 0.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.204 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.81 94.11 5.73 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.714 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.69 110.26 12.38 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.69 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 124' ' ' LEU . . . . . 0.602 ' HG ' ' ND2' ' D' ' 129' ' ' ASN . 0.3 OUTLIER -70.1 154.1 42.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.558 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.58 144.77 51.32 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.584 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.75 125.63 24.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.645 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.1 -101.99 1.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.701 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 128' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 86.6 m -106.25 128.5 54.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.662 0.267 . . . . 0.0 110.773 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 129' ' ' ASN . . . . . 0.731 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 20.1 t-20 -121.15 158.25 28.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.874 0.368 . . . . 0.0 111.109 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 130' ' ' THR . . . . . 0.556 ' OG1' ' HA3' ' A' ' 115' ' ' GLY . 0.2 OUTLIER -155.87 143.08 19.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.057 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 131' ' ' ILE . . . . . 0.603 HD13 HG11 ' D' ' 156' ' ' VAL . 0.1 OUTLIER -115.28 110.75 45.05 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 132' ' ' PRO . . . . . 0.509 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.4 Cg_endo -82.16 151.83 16.06 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.666 1.577 . . . . 0.0 112.499 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.07 146.72 17.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 134' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 78' ' ' ILE . 0.8 OUTLIER -114.36 145.92 41.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.031 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.85 91.09 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.41 . . . . 0.0 111.735 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 136' ' ' ARG . . . . . 0.565 ' HE ' HG21 ' D' ' 48' ' ' THR . 28.1 mtm-85 -88.32 153.52 21.13 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.443 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 137' ' ' TYR . . . . . 0.614 ' CE1' HG22 ' D' ' 101' ' ' VAL . 0.7 OUTLIER -91.1 110.96 22.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.173 179.502 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 138' ' ' PHE . . . . . 0.607 ' CD1' ' HB2' ' D' ' 102' ' ' GLN . 8.8 m-85 -108.08 172.16 6.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.253 0.549 . . . . 0.0 111.971 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 139' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' D' ' 42' ' ' LEU . . . -123.39 143.64 49.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.89 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 140' ' ' THR . . . . . 0.9 HG21 ' CB ' ' D' ' 79' ' ' ASP . 0.2 OUTLIER -98.78 44.46 1.03 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.514 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.54 88.97 1.08 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.966 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 142' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' D' ' 43' ' ' ALA . . . 60.08 88.04 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.745 0.273 . . . . 0.0 110.73 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 143' ' ' ALA . . . . . 0.553 ' HB1' ' HB ' ' D' ' 99' ' ' VAL . . . -70.59 161.73 30.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.784 0.326 . . . . 0.0 111.479 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 144' ' ' THR . . . . . 0.634 ' O ' HG11 ' C' ' 16' ' ' VAL . 0.2 OUTLIER -124.54 158.77 60.69 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.203 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 145' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' C' ' 16' ' ' VAL . 1.4 Cg_endo -83.83 149.22 12.47 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.491 2.127 . . . . 0.0 111.995 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.71 -119.75 0.86 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.519 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 147' ' ' ALA . . . . . 0.659 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -123.95 127.65 48.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.799 0.333 . . . . 0.0 111.452 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 148' ' ' ALA . . . . . 0.698 ' HA ' ' HB3' ' D' ' 88' ' ' LEU . . . -120.86 67.2 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.124 0.488 . . . . 0.0 110.376 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 149' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' D' ' 89' ' ' GLN . 47.5 t-20 -128.54 114.77 17.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.607 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 150' ' ' ALA . . . . . 0.432 ' HB2' ' C ' ' D' ' 88' ' ' LEU . . . -158.8 147.01 18.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.994 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.4 140.31 32.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.173 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 152' ' ' ALA . . . . . 0.5 ' O ' HG23 ' C' ' 9' ' ' THR . . . -136.2 169.29 17.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.183 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 153' ' ' THR . . . . . 0.467 ' O ' ' HB3' ' D' ' 74' ' ' LEU . 9.3 t -155.15 150.52 27.2 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 154' ' ' PHE . . . . . 0.441 ' HE1' HG13 ' D' ' 56' ' ' ILE . 1.1 p90 -119.06 149.25 41.98 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.066 0.46 . . . . 0.0 110.059 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 155' ' ' LYS . . . . . 0.432 ' HE3' HD13 ' D' ' 74' ' ' LEU . 4.7 mttt -113.48 156.67 23.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.924 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 156' ' ' VAL . . . . . 0.603 HG11 HD13 ' D' ' 131' ' ' ILE . 0.2 OUTLIER -136.49 138.04 47.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.627 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 157' ' ' GLN . . . . . 0.629 ' HB2' HG22 ' C' ' 4' ' ' THR . 64.1 tt0 -107.41 128.01 54.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.27 0.557 . . . . 0.0 110.37 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 158' ' ' TYR . . . . . 0.594 ' HB2' ' OG1' ' C' ' 3' ' ' THR . 61.0 m-85 -107.85 107.45 18.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.49 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 159' ' ' GLN . . . . . 0.71 ' HA ' ' H ' ' C' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 120.281 0.086 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 2' ' ' ALA . . . . . 0.718 ' H ' ' HA ' ' F' ' 159' ' ' GLN . . . 65.96 74.63 0.36 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.978 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 3' ' ' THR . . . . . 0.592 ' OG1' ' HB2' ' F' ' 158' ' ' TYR . 6.1 p -117.74 97.53 5.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.482 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 4' ' ' THR . . . . . 0.61 HG22 ' HB2' ' F' ' 157' ' ' GLN . 68.3 p -87.89 108.67 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.562 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.59 172.75 13.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.627 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.16 110.86 12.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.567 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 7' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' F' ' 155' ' ' LYS . . . -65.85 -59.37 7.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.737 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.59 151.7 14.91 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.804 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 9' ' ' THR . . . . . 0.511 HG23 ' O ' ' F' ' 152' ' ' ALA . 24.2 m -103.46 143.1 33.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.799 0.333 . . . . 0.0 111.316 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 10' ' ' VAL . . . . . 0.427 HG12 ' HG3' ' F' ' 30' ' ' GLN . 1.1 m -130.97 115.67 31.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.171 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.65 105.78 14.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.347 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 12' ' ' PHE . . . . . 0.437 ' HD2' HD21 ' F' ' 34' ' ' LEU . 52.3 m-85 -83.15 105.5 14.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.804 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.45 145.04 41.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.4 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.75 -179.59 42.63 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.942 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.27 134.21 22.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.913 0.387 . . . . 0.0 110.35 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 16' ' ' VAL . . . . . 0.637 HG11 ' O ' ' F' ' 144' ' ' THR . 3.3 t -90.93 127.11 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.232 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 17' ' ' VAL . . . . . 0.533 HG21 ' HB3' ' E' ' 20' ' ' ALA . 11.9 m -126.22 168.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.811 0.339 . . . . 0.0 111.08 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.43 81.78 2.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.133 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 19' ' ' ALA . . . . . 0.436 ' HA ' ' HG2' ' F' ' 38' ' ' ARG . . . 53.35 58.15 5.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.078 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.533 ' HB3' HG21 ' E' ' 17' ' ' VAL . . . -108.58 -62.8 1.41 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.44 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 21' ' ' CYS . . . . . 0.821 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.9 OUTLIER -171.54 -159.87 0.16 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.946 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 22' ' ' ALA . . . . . 0.631 ' HA ' ' HB2' ' F' ' 36' ' ' GLN . . . -156.86 74.05 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 23' ' ' VAL . . . . . 0.466 ' N ' HD23 ' E' ' 58' ' ' LEU . 7.4 p -45.38 140.6 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.06 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 24' ' ' ASP . . . . . 0.539 ' O ' HG23 ' E' ' 28' ' ' VAL . 0.5 OUTLIER -63.45 140.82 58.91 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.614 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.08 69.83 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.288 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.13 -17.97 74.36 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.939 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.99 -6.37 58.03 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.843 0.354 . . . . 0.0 110.757 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 28' ' ' VAL . . . . . 0.539 HG23 ' O ' ' E' ' 24' ' ' ASP . 50.5 t -72.7 -36.34 52.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.365 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.02 110.81 13.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.984 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 30' ' ' GLN . . . . . 0.426 ' HG3' HG12 ' D' ' 10' ' ' VAL . 0.4 OUTLIER -123.79 146.01 48.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.994 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.15 113.77 27.56 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.132 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.621 HG11 HG11 ' E' ' 52' ' ' VAL . 3.3 t -105.03 121.98 57.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.175 0.512 . . . . 0.0 110.398 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.95 106.44 17.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.623 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.445 HD21 ' HD2' ' D' ' 12' ' ' PHE . 0.6 OUTLIER -64.75 -44.73 89.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.643 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.53 -156.86 16.05 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.587 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 36' ' ' GLN . . . . . 0.635 ' HB2' ' HA ' ' D' ' 22' ' ' ALA . 3.7 mt-30 -91.11 106.93 18.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.656 0.265 . . . . 0.0 110.828 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.575 ' CG1' HD21 ' E' ' 42' ' ' LEU . 4.4 t -92.33 120.61 41.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.874 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 38' ' ' ARG . . . . . 0.447 ' HG2' ' HA ' ' D' ' 19' ' ' ALA . 4.5 mtm105 -85.65 132.49 34.15 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.756 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 39' ' ' THR . . . . . 0.433 HG23 ' O ' ' D' ' 17' ' ' VAL . 29.5 p -71.49 -23.37 61.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.733 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' D' ' 19' ' ' ALA . . . -68.0 -19.1 64.89 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.987 0.422 . . . . 0.0 110.842 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -90.61 -36.53 14.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.181 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.581 ' HB2' ' HB2' ' E' ' 139' ' ' ALA . 0.2 OUTLIER -121.47 70.58 0.94 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.621 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 43' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' E' ' 142' ' ' ALA . . . -104.74 28.17 7.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.49 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 44' ' ' GLN . . . . . 0.778 ' HG3' ' HB2' ' E' ' 47' ' ' ALA . 0.0 OUTLIER -150.57 141.95 23.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.469 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 45' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' E' ' 140' ' ' THR . 2.7 tt0 -62.74 101.81 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 111.111 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.33 4.22 8.41 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.121 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 47' ' ' ALA . . . . . 0.778 ' HB2' ' HG3' ' E' ' 44' ' ' GLN . . . -91.78 121.24 33.23 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.008 0.433 . . . . 0.0 111.966 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' E' ' 137' ' ' TYR . 5.9 t -110.35 151.18 27.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.868 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 5.1 t -95.59 -57.66 2.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.62 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 50' ' ' SER . . . . . 0.601 ' HB3' ' HA ' ' B' ' 92' ' ' ALA . 0.2 OUTLIER -148.31 -174.82 4.69 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.918 0.389 . . . . 0.0 110.739 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 51' ' ' ALA . . . . . 0.476 ' HB2' ' CD ' ' E' ' 136' ' ' ARG . . . -127.09 143.83 51.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.359 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 52' ' ' VAL . . . . . 0.621 HG11 HG11 ' E' ' 32' ' ' VAL . 48.3 t -120.85 116.81 51.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 53' ' ' GLY . . . . . 0.402 ' O ' HG21 ' B' ' 76' ' ' THR . . . -111.18 122.69 6.22 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.653 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -128.63 138.79 52.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 111.001 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 55' ' ' ASN . . . . . 0.474 HD22 ' CG2' ' E' ' 130' ' ' THR . 1.5 m120 -117.82 150.9 38.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.654 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 56' ' ' ILE . . . . . 0.588 ' HB ' HG13 ' E' ' 131' ' ' ILE . 9.2 mm -106.77 103.72 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.549 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 57' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.13 132.26 53.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.774 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 58' ' ' LEU . . . . . 0.761 ' HB3' ' SG ' ' E' ' 21' ' ' CYS . 1.0 OUTLIER -137.47 151.8 48.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.223 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -138.33 171.35 14.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.98 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 60' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' E' ' 21' ' ' CYS . 6.0 m-20 50.01 68.47 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.83 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 61' ' ' CYS . . . . . 0.821 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 0.0 OUTLIER -106.63 141.09 38.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.95 0.405 . . . . 0.0 110.722 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.74 117.79 33.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.288 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 23.4 p -91.11 -13.18 33.55 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.6 -38.85 82.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.071 0.462 . . . . 0.0 111.849 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 76.4 t -107.71 -54.14 6.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.612 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.72 84.3 3.35 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.581 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.98 -41.26 10.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.97 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.65 159.99 17.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.457 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.76 160.38 39.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.582 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.05 152.93 45.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.102 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.9 136.53 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.714 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.0 107.5 5.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.61 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 73' ' ' PHE . . . . . 0.479 ' CD2' HD13 ' E' ' 103' ' ' ILE . 43.2 t80 -73.7 136.72 43.77 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.569 0.224 . . . . 0.0 110.995 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 74' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' E' ' 153' ' ' THR . 6.6 tt -113.61 111.39 21.78 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.947 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 75' ' ' GLY . . . . . 0.632 ' HA3' HD11 ' E' ' 113' ' ' LEU . . . -131.29 -178.55 15.53 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.843 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 76' ' ' THR . . . . . 0.658 ' H ' HD12 ' E' ' 86' ' ' LEU . 0.2 OUTLIER -104.28 137.54 42.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.479 0.18 . . . . 0.0 110.837 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.97 114.81 23.91 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.021 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.77 -36.73 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.825 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 79' ' ' ASP . . . . . 0.889 ' CB ' HG21 ' E' ' 140' ' ' THR . 0.4 OUTLIER -143.36 130.21 20.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.756 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.89 -7.23 47.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.04 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.28 -29.25 68.38 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.606 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.34 -32.62 4.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 110.442 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 83' ' ' THR . . . . . 0.429 ' O ' HG22 ' E' ' 83' ' ' THR . 3.5 m 60.53 19.46 9.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.574 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 84' ' ' ASN . . . . . 0.619 ' HB3' ' HG2' ' E' ' 102' ' ' GLN . 0.6 OUTLIER -139.43 -16.94 1.02 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.323 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.694 ' HB ' ' HA3' ' E' ' 100' ' ' GLY . 0.9 OUTLIER -66.69 117.99 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.243 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 86' ' ' LEU . . . . . 0.658 HD12 ' H ' ' E' ' 76' ' ' THR . 10.6 tp -69.71 144.15 52.89 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.291 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 87' ' ' ALA . . . . . 0.448 ' HB3' ' OG1' ' E' ' 76' ' ' THR . . . -80.1 138.06 36.87 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.892 0.377 . . . . 0.0 111.677 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.7 ' HB3' ' HA ' ' E' ' 148' ' ' ALA . 0.0 OUTLIER -85.0 -146.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.115 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 89' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' E' ' 149' ' ' ASN . 0.0 OUTLIER -48.54 155.04 0.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.807 0.337 . . . . 0.0 111.263 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 31.9 p -86.71 -11.9 49.84 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.549 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.43 114.05 5.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.975 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.35 22.17 1.06 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.007 0.432 . . . . 0.0 111.714 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.28 22.05 1.19 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.729 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.7 -32.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.537 -0.84 . . . . 0.0 113.001 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 95' ' ' SER . . . . . 0.646 ' HA ' ' HB3' ' E' ' 147' ' ' ALA . 15.8 t -65.12 166.7 9.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.652 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 96' ' ' ALA . . . . . 0.461 ' O ' HD13 ' E' ' 88' ' ' LEU . . . -89.67 163.43 15.13 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.35 169.68 17.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.378 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 98' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 57.32 29.37 16.72 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.415 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 99' ' ' VAL . . . . . 0.563 ' HB ' ' HB1' ' E' ' 143' ' ' ALA . 7.1 p -156.46 150.6 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.75 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 100' ' ' GLY . . . . . 0.694 ' HA3' ' HB ' ' E' ' 85' ' ' VAL . . . -164.18 176.85 40.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.583 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 101' ' ' VAL . . . . . 0.606 HG22 ' CE1' ' E' ' 137' ' ' TYR . 3.0 t -107.63 111.36 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.011 0.524 . . . . 0.0 111.709 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 102' ' ' GLN . . . . . 0.619 ' HG2' ' HB3' ' E' ' 84' ' ' ASN . 0.0 OUTLIER -76.02 179.75 5.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.943 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 103' ' ' ILE . . . . . 0.494 HD11 ' HA ' ' E' ' 113' ' ' LEU . 5.9 pt -150.39 116.56 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.387 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 104' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' E' ' 134' ' ' GLN . 12.9 tp -97.21 122.54 40.35 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.714 0.292 . . . . 0.0 111.095 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.91 150.16 42.74 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.724 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 106' ' ' ARG . . . . . 0.504 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -71.48 -17.6 62.35 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.792 0.33 . . . . 0.0 111.076 179.527 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 107' ' ' THR . . . . . 0.432 HG21 ' HA ' ' E' ' 120' ' ' SER . 75.4 p -76.62 -37.23 56.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.129 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.52 -68.76 0.32 Allowed Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.715 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.66 123.23 18.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.83 0.348 . . . . 0.0 111.106 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.7 118.01 2.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.509 HD11 ' O ' ' E' ' 117' ' ' THR . 2.1 tp -67.91 144.12 55.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.39 0.614 . . . . 0.0 110.528 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 112' ' ' THR . . . . . 0.429 ' HA ' ' ND2' ' E' ' 84' ' ' ASN . 0.2 OUTLIER -75.13 140.48 43.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.133 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 113' ' ' LEU . . . . . 0.632 HD11 ' HA3' ' E' ' 75' ' ' GLY . 1.3 tp -85.25 97.79 10.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.732 0.301 . . . . 0.0 110.606 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -152.81 -58.94 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.579 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.75 -26.62 3.14 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.583 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.42 28.85 5.16 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.007 0.432 . . . . 0.0 111.626 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 117' ' ' THR . . . . . 0.509 ' O ' HD11 ' E' ' 111' ' ' LEU . 0.2 OUTLIER -106.59 67.31 0.72 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.087 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -82.44 81.07 8.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.709 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.13 97.47 3.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.872 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 120' ' ' SER . . . . . 0.432 ' HA ' HG21 ' E' ' 107' ' ' THR . 1.9 t -165.5 144.77 6.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.597 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.28 50.35 0.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.214 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.88 94.11 5.78 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.713 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.63 110.38 12.4 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.741 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 124' ' ' LEU . . . . . 0.605 ' HG ' ' ND2' ' E' ' 129' ' ' ASN . 0.3 OUTLIER -70.19 154.13 42.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.567 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.62 144.75 51.28 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.564 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.75 125.69 24.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.647 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 127' ' ' GLY . . . . . 0.528 ' HA3' HG21 ' A' ' 4' ' ' THR . . . 115.03 -102.0 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.737 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 128' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 87.1 m -106.21 128.46 53.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.604 0.24 . . . . 0.0 110.849 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 129' ' ' ASN . . . . . 0.751 ' HA ' ' HB2' ' B' ' 116' ' ' ALA . 20.1 t-20 -121.15 158.18 28.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.881 0.372 . . . . 0.0 111.147 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 130' ' ' THR . . . . . 0.555 ' OG1' ' HA3' ' B' ' 115' ' ' GLY . 0.2 OUTLIER -155.83 143.1 19.26 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.009 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 131' ' ' ILE . . . . . 0.609 HD13 HG11 ' E' ' 156' ' ' VAL . 0.1 OUTLIER -115.23 110.83 45.07 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 132' ' ' PRO . . . . . 0.504 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.3 Cg_endo -82.21 151.86 15.96 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.634 1.556 . . . . 0.0 112.548 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.08 146.79 17.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.795 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 134' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' B' ' 78' ' ' ILE . 0.8 OUTLIER -114.37 145.87 41.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.068 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.87 91.14 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.962 0.41 . . . . 0.0 111.713 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 136' ' ' ARG . . . . . 0.568 ' HE ' HG21 ' E' ' 48' ' ' THR . 28.2 mtm-85 -88.27 153.54 21.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.41 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 137' ' ' TYR . . . . . 0.606 ' CE1' HG22 ' E' ' 101' ' ' VAL . 0.7 OUTLIER -91.26 111.14 22.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.059 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 138' ' ' PHE . . . . . 0.607 ' CD1' ' HB2' ' E' ' 102' ' ' GLN . 8.7 m-85 -108.22 172.21 6.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.968 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 139' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' E' ' 42' ' ' LEU . . . -123.47 143.64 50.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.823 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 140' ' ' THR . . . . . 0.889 HG21 ' CB ' ' E' ' 79' ' ' ASP . 0.2 OUTLIER -98.72 44.43 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.567 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.51 89.07 1.07 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.963 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 142' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' E' ' 43' ' ' ALA . . . 60.03 88.04 0.08 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.696 0.248 . . . . 0.0 110.769 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 143' ' ' ALA . . . . . 0.563 ' HB1' ' HB ' ' E' ' 99' ' ' VAL . . . -70.62 161.73 30.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 111.458 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 144' ' ' THR . . . . . 0.625 ' O ' HG11 ' D' ' 16' ' ' VAL . 0.2 OUTLIER -124.48 158.73 60.65 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.23 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 145' ' ' PRO . . . . . 0.51 ' HA ' ' HB ' ' D' ' 16' ' ' VAL . 1.4 Cg_endo -83.76 149.23 12.57 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.569 2.179 . . . . 0.0 112.022 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.69 -119.72 0.86 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.582 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 147' ' ' ALA . . . . . 0.646 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -123.95 127.73 48.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.877 0.37 . . . . 0.0 111.384 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 148' ' ' ALA . . . . . 0.7 ' HA ' ' HB3' ' E' ' 88' ' ' LEU . . . -120.85 67.16 0.86 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.434 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 149' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' E' ' 89' ' ' GLN . 47.5 t-20 -128.51 114.82 17.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.594 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 150' ' ' ALA . . . . . 0.416 ' HB2' ' C ' ' E' ' 88' ' ' LEU . . . -158.85 147.0 18.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.03 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.48 140.28 32.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.218 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 152' ' ' ALA . . . . . 0.507 ' O ' HG23 ' D' ' 9' ' ' THR . . . -136.21 169.23 17.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.149 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 153' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' E' ' 74' ' ' LEU . 9.4 t -155.06 150.54 27.35 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 154' ' ' PHE . . . . . 0.442 ' HE1' HG13 ' E' ' 56' ' ' ILE . 1.1 p90 -119.05 149.3 41.9 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.1 0.476 . . . . 0.0 110.025 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 155' ' ' LYS . . . . . 0.447 ' HE3' HD13 ' E' ' 74' ' ' LEU . 4.7 mttt -113.53 156.74 23.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.85 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 156' ' ' VAL . . . . . 0.609 HG11 HD13 ' E' ' 131' ' ' ILE . 0.2 OUTLIER -136.51 138.01 47.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.653 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 157' ' ' GLN . . . . . 0.62 ' HB2' HG22 ' D' ' 4' ' ' THR . 64.1 tt0 -107.46 128.05 54.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.307 0.575 . . . . 0.0 110.328 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 158' ' ' TYR . . . . . 0.594 ' HB2' ' OG1' ' D' ' 3' ' ' THR . 61.0 m-85 -107.89 107.5 18.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.531 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 159' ' ' GLN . . . . . 0.714 ' HA ' ' H ' ' D' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.276 0.084 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.82 74.75 0.36 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.973 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 6.2 p -117.75 97.53 5.9 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.504 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 69.1 p -87.84 108.64 19.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.592 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.55 172.72 13.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.618 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -77.24 110.85 12.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.572 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.79 -59.37 7.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.75 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.56 151.71 14.96 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.763 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 24.2 m -103.53 143.09 33.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 111.253 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.92 115.62 30.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.241 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -83.59 105.79 14.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.397 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -83.21 105.5 14.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.76 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.49 145.09 41.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.43 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.75 -179.64 42.6 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.969 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.27 134.18 22.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.387 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 t -90.92 127.19 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.257 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 17' ' ' VAL . . . . . 0.531 HG21 ' HB3' ' F' ' 20' ' ' ALA . 12.0 m -126.25 168.74 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.887 0.375 . . . . 0.0 111.042 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -100.42 81.83 2.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.149 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.23 58.27 5.43 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.05 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 20' ' ' ALA . . . . . 0.531 ' HB3' HG21 ' F' ' 17' ' ' VAL . . . -108.61 -62.85 1.41 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.376 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 21' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.9 OUTLIER -171.57 -159.92 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.86 74.0 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.085 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 23' ' ' VAL . . . . . 0.468 ' N ' HD23 ' F' ' 58' ' ' LEU . 7.4 p -45.35 140.64 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.015 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 24' ' ' ASP . . . . . 0.547 ' O ' HG23 ' F' ' 28' ' ' VAL . 0.5 OUTLIER -63.45 140.79 58.91 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.679 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.41 -51.08 69.7 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.341 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.14 -18.06 74.45 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.871 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.94 -6.37 58.06 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.865 0.364 . . . . 0.0 110.835 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 28' ' ' VAL . . . . . 0.547 HG23 ' O ' ' F' ' 24' ' ' ASP . 50.6 t -72.66 -36.39 53.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.403 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.92 110.88 14.13 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 30' ' ' GLN . . . . . 0.427 ' HG3' HG12 ' E' ' 10' ' ' VAL . 0.4 OUTLIER -123.84 146.04 48.66 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.982 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.17 113.84 27.67 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.208 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.631 HG11 HG11 ' F' ' 52' ' ' VAL . 3.3 t -105.11 121.95 57.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.141 0.496 . . . . 0.0 110.457 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.83 106.39 17.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.633 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 34' ' ' LEU . . . . . 0.437 HD21 ' HD2' ' E' ' 12' ' ' PHE . 0.6 OUTLIER -64.77 -44.69 89.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.62 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.53 -156.97 16.01 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.561 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 36' ' ' GLN . . . . . 0.631 ' HB2' ' HA ' ' E' ' 22' ' ' ALA . 3.7 mt-30 -91.04 106.97 18.89 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.628 0.251 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.58 ' CG1' HD21 ' F' ' 42' ' ' LEU . 4.4 t -92.35 120.55 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.92 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 38' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' E' ' 19' ' ' ALA . 4.5 mtm105 -85.59 132.5 34.17 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.753 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 39' ' ' THR . . . . . 0.435 HG23 ' O ' ' E' ' 17' ' ' VAL . 29.4 p -71.56 -23.22 61.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.729 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 40' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' E' ' 19' ' ' ALA . . . -68.04 -19.19 64.87 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.007 0.432 . . . . 0.0 110.815 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 13.8 t -90.54 -36.6 14.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.16 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 42' ' ' LEU . . . . . 0.58 HD21 ' CG1' ' F' ' 37' ' ' VAL . 0.2 OUTLIER -121.43 70.56 0.94 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.648 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 43' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' F' ' 142' ' ' ALA . . . -104.82 28.11 7.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.331 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 44' ' ' GLN . . . . . 0.754 ' HG3' ' HB2' ' F' ' 47' ' ' ALA . 0.0 OUTLIER -150.54 142.01 23.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.392 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 45' ' ' GLU . . . . . 0.449 ' HG3' ' HA ' ' F' ' 140' ' ' THR . 2.7 tt0 -62.71 101.84 0.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.786 0.326 . . . . 0.0 111.084 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.21 4.27 8.47 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.197 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 47' ' ' ALA . . . . . 0.754 ' HB2' ' HG3' ' F' ' 44' ' ' GLN . . . -91.8 121.33 33.32 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.953 0.406 . . . . 0.0 111.981 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 48' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' F' ' 137' ' ' TYR . 5.9 t -110.41 151.13 27.86 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.836 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 49' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 5.2 t -95.63 -57.6 2.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.6 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 50' ' ' SER . . . . . 0.597 ' HB3' ' HA ' ' C' ' 92' ' ' ALA . 0.2 OUTLIER -148.24 -174.81 4.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.806 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 51' ' ' ALA . . . . . 0.474 ' HB2' ' CD ' ' F' ' 136' ' ' ARG . . . -127.13 143.84 51.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.284 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 52' ' ' VAL . . . . . 0.631 HG11 HG11 ' F' ' 32' ' ' VAL . 48.2 t -120.84 116.87 51.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.015 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 53' ' ' GLY . . . . . 0.41 ' O ' HG21 ' C' ' 76' ' ' THR . . . -111.18 122.69 6.21 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.648 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -128.63 138.85 52.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 0.0 110.934 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 55' ' ' ASN . . . . . 0.479 HD22 ' CG2' ' F' ' 130' ' ' THR . 1.6 m120 -117.88 150.97 38.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.607 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 56' ' ' ILE . . . . . 0.592 ' HB ' HG13 ' F' ' 131' ' ' ILE . 9.3 mm -106.82 103.7 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.585 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 57' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -61.13 132.22 53.04 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.769 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 58' ' ' LEU . . . . . 0.761 ' HB3' ' SG ' ' F' ' 21' ' ' CYS . 1.0 OUTLIER -137.4 151.74 48.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.253 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -138.3 171.43 14.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.026 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 60' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' F' ' 21' ' ' CYS . 5.9 m-20 49.95 68.52 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.812 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 61' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 0.0 OUTLIER -106.68 141.08 38.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.984 0.421 . . . . 0.0 110.736 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.74 117.83 33.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.266 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 23.4 p -91.15 -13.16 33.49 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.61 -38.95 82.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.033 0.444 . . . . 0.0 111.753 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 76.2 t -107.64 -54.1 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.65 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.76 84.33 3.34 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.604 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.97 -41.26 10.1 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.969 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.64 159.97 17.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.436 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.73 160.41 39.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.592 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.03 152.9 45.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.156 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.95 136.55 53.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.682 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.04 107.46 5.03 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.525 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 73' ' ' PHE . . . . . 0.467 ' CD2' HD13 ' F' ' 103' ' ' ILE . 43.0 t80 -73.63 136.7 43.91 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.58 0.228 . . . . 0.0 111.049 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 74' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' F' ' 153' ' ' THR . 6.6 tt -113.62 111.4 21.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.939 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 75' ' ' GLY . . . . . 0.635 ' HA3' HD11 ' F' ' 113' ' ' LEU . . . -131.31 -178.55 15.53 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.836 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 76' ' ' THR . . . . . 0.677 ' H ' HD12 ' F' ' 86' ' ' LEU . 0.2 OUTLIER -104.32 137.62 41.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.51 0.195 . . . . 0.0 110.79 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.02 114.73 23.88 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.935 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.69 -36.75 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.866 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 79' ' ' ASP . . . . . 0.9 ' CB ' HG21 ' F' ' 140' ' ' THR . 0.4 OUTLIER -143.38 130.26 20.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.752 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.94 -7.23 47.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.973 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.31 -29.2 68.34 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.636 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.28 -32.73 4.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.863 0.364 . . . . 0.0 110.455 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 83' ' ' THR . . . . . 0.427 ' O ' HG22 ' F' ' 83' ' ' THR . 3.4 m 60.55 19.37 9.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.632 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 84' ' ' ASN . . . . . 0.62 ' HB3' ' HG2' ' F' ' 102' ' ' GLN . 0.6 OUTLIER -139.36 -16.92 1.03 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.413 179.629 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 85' ' ' VAL . . . . . 0.686 ' HB ' ' HA3' ' F' ' 100' ' ' GLY . 0.8 OUTLIER -66.71 117.97 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.196 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 86' ' ' LEU . . . . . 0.677 HD12 ' H ' ' F' ' 76' ' ' THR . 10.7 tp -69.67 144.1 52.98 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.36 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 87' ' ' ALA . . . . . 0.454 ' HB3' ' OG1' ' F' ' 76' ' ' THR . . . -80.1 138.03 36.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.904 0.383 . . . . 0.0 111.762 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 88' ' ' LEU . . . . . 0.683 ' HB3' ' HA ' ' F' ' 148' ' ' ALA . 0.0 OUTLIER -84.94 -146.55 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.083 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 89' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' F' ' 149' ' ' ASN . 0.0 OUTLIER -48.66 155.1 0.59 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 32.8 p -86.78 -11.97 49.47 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.403 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.38 114.04 5.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.976 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.34 22.21 1.05 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.877 0.37 . . . . 0.0 111.667 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.28 22.06 1.19 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.692 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.69 -32.28 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.053 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 95' ' ' SER . . . . . 0.644 ' HA ' ' HB3' ' F' ' 147' ' ' ALA . 16.0 t -65.14 166.69 9.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.345 . . . . 0.0 110.616 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 96' ' ' ALA . . . . . 0.467 ' O ' HD13 ' F' ' 88' ' ' LEU . . . -89.61 163.49 15.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.87 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.41 169.61 17.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.329 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 98' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 57.36 29.36 16.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.414 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 99' ' ' VAL . . . . . 0.563 ' HB ' ' HB1' ' F' ' 143' ' ' ALA . 7.0 p -156.38 150.6 10.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.77 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 100' ' ' GLY . . . . . 0.686 ' HA3' ' HB ' ' F' ' 85' ' ' VAL . . . -164.22 176.96 40.11 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.604 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 101' ' ' VAL . . . . . 0.609 HG22 ' CE1' ' F' ' 137' ' ' TYR . 3.0 t -107.66 111.37 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 123.04 0.536 . . . . 0.0 111.706 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 102' ' ' GLN . . . . . 0.62 ' HG2' ' HB3' ' F' ' 84' ' ' ASN . 0.0 OUTLIER -76.04 179.68 5.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.922 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 103' ' ' ILE . . . . . 0.488 HD11 ' HA ' ' F' ' 113' ' ' LEU . 6.0 pt -150.34 116.57 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.464 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 104' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' F' ' 134' ' ' GLN . 12.8 tp -97.18 122.53 40.3 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.743 0.306 . . . . 0.0 111.075 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -62.89 150.12 42.72 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.696 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 106' ' ' ARG . . . . . 0.526 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -71.38 -17.69 62.4 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.772 0.32 . . . . 0.0 111.052 179.479 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 107' ' ' THR . . . . . 0.446 HG21 ' HA ' ' F' ' 120' ' ' SER . 75.7 p -76.61 -37.28 56.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.08 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.57 -68.77 0.32 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.685 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.68 123.27 18.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.875 0.369 . . . . 0.0 111.105 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.7 117.98 2.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 111' ' ' LEU . . . . . 0.514 HD11 ' O ' ' F' ' 117' ' ' THR . 2.1 tp -67.77 144.04 55.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.429 0.633 . . . . 0.0 110.532 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 112' ' ' THR . . . . . 0.432 ' HA ' ' ND2' ' F' ' 84' ' ' ASN . 0.2 OUTLIER -75.08 140.46 43.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.13 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 113' ' ' LEU . . . . . 0.635 HD11 ' HA3' ' F' ' 75' ' ' GLY . 1.3 tp -85.22 97.85 10.15 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.764 0.316 . . . . 0.0 110.582 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -152.8 -59.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.674 0.273 . . . . 0.0 111.595 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.79 -26.66 3.13 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.61 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.28 28.74 5.19 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.643 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 117' ' ' THR . . . . . 0.514 ' O ' HD11 ' F' ' 111' ' ' LEU . 0.2 OUTLIER -106.57 67.39 0.72 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.052 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.43 80.95 8.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.735 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.01 97.5 3.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.803 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 120' ' ' SER . . . . . 0.446 ' HA ' HG21 ' F' ' 107' ' ' THR . 1.9 t -165.53 144.8 6.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.576 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.29 50.36 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.232 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.87 94.12 5.78 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.659 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.73 110.35 12.5 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.643 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 124' ' ' LEU . . . . . 0.603 ' HG ' ' ND2' ' F' ' 129' ' ' ASN . 0.3 OUTLIER -70.13 154.15 42.27 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.579 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.62 144.77 51.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.552 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.76 125.64 24.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.667 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 127' ' ' GLY . . . . . 0.526 ' HA3' HG21 ' B' ' 4' ' ' THR . . . 115.03 -101.93 1.1 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.749 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 128' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' C' ' 116' ' ' ALA . 86.0 m -106.32 128.5 54.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.672 0.272 . . . . 0.0 110.782 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 129' ' ' ASN . . . . . 0.748 ' HA ' ' HB2' ' C' ' 116' ' ' ALA . 20.1 t-20 -121.08 158.21 28.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.129 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 130' ' ' THR . . . . . 0.57 ' OG1' ' HA3' ' C' ' 115' ' ' GLY . 0.2 OUTLIER -155.9 143.07 19.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.014 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 131' ' ' ILE . . . . . 0.613 HD13 HG11 ' F' ' 156' ' ' VAL . 0.1 OUTLIER -115.19 110.74 45.24 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 132' ' ' PRO . . . . . 0.526 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.4 Cg_endo -82.12 151.88 16.16 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.597 1.531 . . . . 0.0 112.514 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.0 146.76 17.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.84 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 134' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' C' ' 78' ' ' ILE . 0.8 OUTLIER -114.41 145.95 41.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.093 179.277 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.85 91.15 1.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 0.0 111.682 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 136' ' ' ARG . . . . . 0.572 ' HE ' HG21 ' F' ' 48' ' ' THR . 28.0 mtm-85 -88.33 153.56 21.1 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.403 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 137' ' ' TYR . . . . . 0.609 ' CE1' HG22 ' F' ' 101' ' ' VAL . 0.7 OUTLIER -91.19 111.03 22.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.101 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 138' ' ' PHE . . . . . 0.607 ' CD1' ' HB2' ' F' ' 102' ' ' GLN . 8.8 m-85 -108.11 172.17 6.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.978 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 139' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' F' ' 42' ' ' LEU . . . -123.41 143.71 49.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.807 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 140' ' ' THR . . . . . 0.9 HG21 ' CB ' ' F' ' 79' ' ' ASP . 0.2 OUTLIER -98.85 44.5 1.03 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.501 179.753 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.45 89.13 1.07 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.946 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 142' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' F' ' 43' ' ' ALA . . . 60.04 88.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.678 0.239 . . . . 0.0 110.694 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 143' ' ' ALA . . . . . 0.563 ' HB1' ' HB ' ' F' ' 99' ' ' VAL . . . -70.54 161.72 30.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.783 0.325 . . . . 0.0 111.431 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 144' ' ' THR . . . . . 0.637 ' O ' HG11 ' E' ' 16' ' ' VAL . 0.2 OUTLIER -124.46 158.65 60.88 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.292 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 145' ' ' PRO . . . . . 0.528 ' HA ' ' HB ' ' E' ' 16' ' ' VAL . 1.4 Cg_endo -83.75 149.19 12.58 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.499 2.132 . . . . 0.0 112.079 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.71 -119.73 0.86 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.563 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 147' ' ' ALA . . . . . 0.644 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -123.92 127.64 48.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 111.48 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 148' ' ' ALA . . . . . 0.683 ' HA ' ' HB3' ' F' ' 88' ' ' LEU . . . -120.77 67.1 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.139 0.495 . . . . 0.0 110.449 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 149' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' F' ' 89' ' ' GLN . 47.4 t-20 -128.47 114.73 17.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.667 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 150' ' ' ALA . . . . . 0.424 ' HB2' ' C ' ' F' ' 88' ' ' LEU . . . -158.77 146.92 18.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.056 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.37 140.29 32.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.181 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 152' ' ' ALA . . . . . 0.511 ' O ' HG23 ' E' ' 9' ' ' THR . . . -136.23 169.29 17.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.216 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 153' ' ' THR . . . . . 0.452 ' O ' ' HB3' ' F' ' 74' ' ' LEU . 9.4 t -155.09 150.56 27.33 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 154' ' ' PHE . . . . . 0.436 ' HE1' HG13 ' F' ' 56' ' ' ILE . 1.1 p90 -119.06 149.24 42.0 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.089 0.471 . . . . 0.0 110.103 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 155' ' ' LYS . . . . . 0.426 ' HE3' HD13 ' F' ' 74' ' ' LEU . 4.7 mttt -113.5 156.67 23.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.886 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 156' ' ' VAL . . . . . 0.613 HG11 HD13 ' F' ' 131' ' ' ILE . 0.2 OUTLIER -136.5 138.05 47.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.667 -179.067 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 157' ' ' GLN . . . . . 0.61 ' HB2' HG22 ' E' ' 4' ' ' THR . 64.1 tt0 -107.5 127.99 54.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.307 0.575 . . . . 0.0 110.344 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 158' ' ' TYR . . . . . 0.592 ' HB2' ' OG1' ' E' ' 3' ' ' THR . 60.9 m-85 -107.82 107.43 18.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.565 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 159' ' ' GLN . . . . . 0.718 ' HA ' ' H ' ' E' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.903 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.686 ' H ' ' HA ' ' B' ' 159' ' ' GLN . . . 56.66 88.54 0.05 OUTLIER 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.052 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' B' ' 157' ' ' GLN . 0.2 OUTLIER -103.08 110.35 22.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.419 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.37 136.14 38.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.55 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.64 HG23 HG23 ' B' ' 156' ' ' VAL . 0.0 OUTLIER -152.01 -175.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.61 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.51 130.04 38.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.677 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.77 -59.25 0.91 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.822 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.37 166.16 27.94 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.897 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.621 ' HA ' HG22 ' B' ' 153' ' ' THR . 26.8 m -94.36 121.11 35.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.904 0.383 . . . . 0.0 111.287 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.65 115.59 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.223 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -99.55 137.45 38.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.369 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.573 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 76.0 m-85 -127.49 97.73 4.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.22 175.8 6.56 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.428 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.91 149.49 5.78 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.923 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.33 108.63 13.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.776 0.322 . . . . 0.0 110.358 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' B' ' 37' ' ' VAL . 23.5 t -86.67 129.15 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.203 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 22' ' ' ALA . 18.8 m -127.38 163.5 30.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.041 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -86.0 61.52 6.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.07 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.484 ' HB3' HG21 ' A' ' 65' ' ' VAL . . . 44.93 52.63 8.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -127.29 -54.51 1.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.407 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.809 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER 177.7 111.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.866 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.502 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -105.63 126.08 51.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.073 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.86 145.64 7.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.055 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.623 ' O ' HG23 ' A' ' 28' ' ' VAL . 4.0 m-20 -74.83 147.23 41.34 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.696 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.67 -43.66 17.87 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.34 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.98 -20.0 60.16 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.84 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.2 t -79.54 -26.07 41.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.863 0.363 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 24' ' ' ASP . 57.5 t -49.19 -48.46 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.331 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.84 93.08 5.36 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.023 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.63 116.42 28.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.009 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 p -95.6 115.62 27.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.151 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.503 ' CG1' HG11 ' A' ' 52' ' ' VAL . 1.6 t -117.18 101.16 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.131 0.491 . . . . 0.0 110.402 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -105.62 126.96 52.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.655 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.26 -55.62 11.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.63 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.03 -111.6 3.91 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.519 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.11 115.28 16.76 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.514 0.197 . . . . 0.0 110.875 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.0 t -131.01 105.8 11.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.875 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -96.64 154.12 17.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.757 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.643 ' HA ' HD12 ' A' ' 42' ' ' LEU . 8.2 p -78.75 -19.84 51.35 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.759 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -19.52 65.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.066 0.46 . . . . 0.0 110.885 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.7 p -92.0 -21.27 20.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.207 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.715 ' CB ' ' HB2' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -139.14 62.36 1.54 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.58 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' A' ' 142' ' ' ALA . . . -101.13 9.12 42.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.321 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.19 136.0 24.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.37 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.593 ' N ' ' HA2' ' A' ' 141' ' ' GLY . 16.5 tt0 -58.48 121.37 10.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.915 0.388 . . . . 0.0 111.082 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.28 -25.46 8.23 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.149 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.75 137.29 58.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.939 0.4 . . . . 0.0 112.034 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.92 157.99 44.59 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.955 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.93 -166.21 1.09 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.621 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.8 m -65.23 156.19 32.68 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.767 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 134' ' ' GLN . . . -90.45 126.66 35.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.324 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.503 HG11 ' CG1' ' A' ' 32' ' ' VAL . 62.4 t -75.68 118.52 21.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.79 135.6 13.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.731 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HD2' HG12 ' A' ' 52' ' ' VAL . 46.2 p90 -170.74 142.1 1.92 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.915 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.676 ' HA ' ' O ' ' A' ' 131' ' ' ILE . 11.5 p30 -126.52 163.92 22.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.602 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 130' ' ' THR . 20.9 mm -105.13 120.03 55.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.525 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.7 ' HA ' HG22 ' A' ' 130' ' ' THR . 0.0 OUTLIER -82.15 115.66 21.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.712 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.639 HD11 HG13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -128.24 107.46 9.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.288 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.37 176.97 8.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.889 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.05 66.13 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.797 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.809 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 3.3 m -109.69 154.48 22.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.679 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.523 ' HA ' ' OD1' ' A' ' 126' ' ' ASN . 0.5 OUTLIER -154.71 138.3 16.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.263 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -97.54 -11.9 23.19 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -72.27 -48.69 40.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.003 0.43 . . . . 0.0 111.713 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 19' ' ' ALA . 10.8 t -69.1 -48.6 68.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.695 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 159' ' ' GLN . . . -138.02 153.26 49.39 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.599 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.19 18.66 4.48 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.95 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 10.6 tppt? -142.88 149.9 39.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.486 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.868 ' HB2' HD12 ' A' ' 124' ' ' LEU . . . -150.0 110.72 4.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.661 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 121' ' ' GLU . . . -108.05 169.99 8.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.1 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.414 HG21 HG21 ' A' ' 131' ' ' ILE . 0.5 OUTLIER -130.38 150.98 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.61 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.697 ' HB1' ' HA ' ' A' ' 116' ' ' ALA . . . -135.62 100.13 4.4 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.58 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.435 ' HB2' HD22 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -77.42 133.98 38.52 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.571 0.224 . . . . 0.0 111.107 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.746 HD11 ' HG2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -124.17 115.05 20.48 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.025 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.31 -173.23 26.45 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.729 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.6 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 7.0 m -112.59 149.03 33.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.583 0.23 . . . . 0.0 110.755 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 85' ' ' VAL . . . -98.97 133.81 42.72 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.942 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.786 ' HB ' ' HA ' ' A' ' 87' ' ' ALA . 16.1 tt -72.93 -37.98 55.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.17 167.64 12.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.834 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' D' ' 106' ' ' ARG . . . -70.17 -53.83 15.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.073 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.35 28.63 6.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.595 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.816 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 10.2 m170 -111.33 -45.62 3.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.369 . . . . 0.0 110.427 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.482 HG22 HH21 ' D' ' 106' ' ' ARG . 0.0 OUTLIER 46.42 -86.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.589 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -42.28 -42.4 3.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.239 179.674 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.816 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 21.3 t -61.29 126.57 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.093 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.062 HD22 ' HB1' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -81.25 164.41 22.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.455 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.786 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . . . -104.78 -177.49 3.38 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.672 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.09 -174.57 5.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.982 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.57 -170.71 3.24 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.372 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.869 ' HA ' HG13 ' D' ' 52' ' ' VAL . 27.4 p -74.77 7.81 2.84 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.914 0.387 . . . . 0.0 111.462 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.421 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 0.8 OUTLIER -96.96 80.39 2.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.632 ' HA ' ' HB2' ' D' ' 50' ' ' SER . . . -66.87 -41.13 87.76 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.624 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' D' ' 36' ' ' GLN . . . -103.73 25.96 9.16 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.675 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.8 -22.63 0.33 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.929 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 91' ' ' SER . 1.0 OUTLIER -107.68 175.18 5.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.906 0.384 . . . . 0.0 110.587 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.38 177.12 2.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.497 ' O ' HG12 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -138.58 167.86 21.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.21 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.584 ' HA ' ' HB ' ' A' ' 140' ' ' THR . 32.4 m-80 44.19 51.65 7.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.502 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 97' ' ' THR . 6.0 p -169.38 124.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.72 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.61 -164.74 11.5 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.634 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.8 91.16 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 122.97 0.508 . . . . 0.0 111.722 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.704 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 0.4 OUTLIER -71.4 116.65 11.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.885 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 113' ' ' LEU . 6.6 mt -89.64 120.59 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.492 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 1.0 OUTLIER -95.88 152.31 18.61 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.691 0.281 . . . . 0.0 111.092 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.16 159.99 14.68 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.613 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.537 ' CZ ' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -68.71 -13.73 62.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.92 0.39 . . . . 0.0 111.146 179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.6 p -74.41 -18.87 60.59 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.067 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.99 -40.11 2.23 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.664 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.41 164.67 13.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.781 0.324 . . . . 0.0 111.099 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -77.37 139.68 39.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.132 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.564 HD21 ' HB ' ' A' ' 117' ' ' THR . 5.9 tt -84.18 128.58 34.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.458 0.647 . . . . 0.0 110.506 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.413 ' O ' HD23 ' A' ' 111' ' ' LEU . 1.4 m -68.11 132.38 47.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.1 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.659 HD11 HD12 ' A' ' 103' ' ' ILE . 4.7 mp -88.04 99.83 12.46 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.621 0.248 . . . . 0.0 110.741 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' D' ' 130' ' ' THR . 0.8 OUTLIER -144.13 -32.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.502 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.498 ' CA ' HD23 ' A' ' 74' ' ' LEU . . . 146.46 -81.3 0.21 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.625 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.697 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . . . -97.22 64.1 1.9 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.959 0.409 . . . . 0.0 111.603 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.564 ' HB ' HD21 ' A' ' 111' ' ' LEU . 2.8 m -94.4 72.39 3.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.141 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -66.76 119.04 11.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.835 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.89 -49.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.852 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.57 84.69 6.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.547 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 70' ' ' ALA . 3.5 mt-10 -110.2 86.95 2.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.29 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.99 159.3 17.68 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.815 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -66.96 138.39 57.23 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.727 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.868 HD12 ' HB2' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -86.55 159.49 19.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.622 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.58 176.19 10.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.588 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 62' ' ' ASP . 0.9 OUTLIER -85.93 161.49 19.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.697 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.53 -121.0 5.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.775 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 74.4 m -119.54 140.31 50.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.682 0.277 . . . . 0.0 110.768 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.45 ' O ' HD12 ' A' ' 58' ' ' LEU . 5.1 t-20 -133.73 154.67 50.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.117 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.7 HG22 ' HA ' ' A' ' 57' ' ' GLN . 27.9 p -133.41 154.33 50.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.164 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.676 ' O ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -111.09 116.9 50.93 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.537 ' HG2' ' CZ ' ' A' ' 106' ' ' ARG . 7.5 Cg_endo -81.24 129.48 6.78 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.614 1.543 . . . . 0.0 112.581 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.459 ' HB3' ' CE1' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -140.89 146.9 38.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.794 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.526 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 8.4 mm100 -116.5 158.33 23.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.011 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . . . -159.42 105.53 1.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.914 0.388 . . . . 0.0 111.524 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.7 172.61 6.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.414 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.2 147.79 24.25 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.131 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.67 159.03 35.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.277 0.561 . . . . 0.0 111.923 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.715 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . . . -116.33 141.24 48.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.936 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.584 ' HB ' ' HA ' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -107.75 27.23 9.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.482 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.593 ' HA2' ' N ' ' A' ' 45' ' ' GLU . . . 97.55 83.6 1.71 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.971 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . . . 57.88 93.47 0.03 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.688 0.244 . . . . 0.0 110.746 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' A' ' 98' ' ' ASN . . . -80.0 165.37 22.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 111.403 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.7 p -108.34 168.87 7.22 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.153 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.61 133.54 6.14 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.569 2.179 . . . . 0.0 111.979 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.55 -119.24 0.81 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.471 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.81 121.7 13.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.894 0.378 . . . . 0.0 111.281 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.34 85.68 3.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.442 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -104.55 131.21 52.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.601 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 1.062 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -136.08 148.44 48.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.935 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.17 120.17 20.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.216 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.63 140.05 24.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.159 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.6 p -105.2 171.21 7.44 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.503 ' HZ ' HG21 ' A' ' 56' ' ' ILE . 13.7 p90 -138.2 147.39 43.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.038 0.447 . . . . 0.0 110.119 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.746 ' HG2' HD11 ' A' ' 74' ' ' LEU . 13.6 mmtt -100.89 172.01 7.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.901 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.49 ' HB ' ' CZ ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -135.51 111.4 12.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.82 0.343 . . . . 0.0 111.728 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -109.04 141.26 41.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.346 0.593 . . . . 0.0 110.414 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.49 ' CZ ' ' HB ' ' A' ' 156' ' ' VAL . 23.1 m-85 -135.36 105.58 6.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.583 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.617 ' HB3' ' HB3' ' A' ' 68' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.92 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.695 ' H ' ' HA ' ' C' ' 159' ' ' GLN . . . 56.58 88.57 0.05 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.056 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' C' ' 157' ' ' GLN . 0.2 OUTLIER -103.08 110.38 22.29 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.393 179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 136.18 38.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.552 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.652 HG23 HG23 ' C' ' 156' ' ' VAL . 0.0 OUTLIER -152.05 -175.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.591 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.43 130.04 38.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.666 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.8 -59.33 0.91 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.756 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.4 166.2 28.04 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.894 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.624 ' HA ' HG22 ' C' ' 153' ' ' THR . 26.7 m -94.38 121.1 35.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.89 0.376 . . . . 0.0 111.269 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.69 115.64 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.24 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -99.54 137.55 37.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.351 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' C' ' 32' ' ' VAL . 76.0 m-85 -127.61 97.71 4.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.22 175.78 6.57 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.472 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.01 149.4 5.75 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.941 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.24 108.68 14.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.852 0.358 . . . . 0.0 110.414 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' C' ' 37' ' ' VAL . 23.6 t -86.71 129.19 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.175 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' B' ' 22' ' ' ALA . 18.7 m -127.45 163.51 30.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.033 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -85.95 61.35 6.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.027 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.483 ' HB3' HG21 ' B' ' 65' ' ' VAL . . . 45.02 52.64 8.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.053 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' B' ' 61' ' ' CYS . . . -127.24 -54.54 1.37 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.451 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.1 OUTLIER 177.73 111.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.893 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.499 ' HB2' HG22 ' B' ' 17' ' ' VAL . . . -105.67 126.05 51.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.083 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.81 145.61 7.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.035 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.608 ' O ' HG23 ' B' ' 28' ' ' VAL . 4.0 m-20 -74.82 147.27 41.32 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.68 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.8 -43.57 18.47 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.323 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.97 -20.07 60.06 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.809 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 45.3 t -79.58 -26.01 41.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.608 HG23 ' O ' ' B' ' 24' ' ' ASP . 57.4 t -49.21 -48.46 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.344 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.86 93.08 5.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.031 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.61 116.36 28.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.026 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.55 115.67 27.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.209 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 12' ' ' PHE . 1.7 t -117.23 101.07 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.182 0.515 . . . . 0.0 110.429 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -105.58 126.93 52.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.715 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.15 -55.66 11.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.62 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.02 -111.65 3.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.539 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.548 ' HG3' ' HA ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -77.05 115.29 16.71 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.501 0.191 . . . . 0.0 110.907 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 68.4 t -131.05 105.86 11.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.833 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.6 154.05 17.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.782 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.665 ' HA ' HD12 ' B' ' 42' ' ' LEU . 8.2 p -78.77 -19.79 51.4 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.702 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.51 -19.53 65.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.144 0.497 . . . . 0.0 110.899 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 96.5 p -92.01 -21.27 20.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.19 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.711 ' CB ' ' HB2' ' B' ' 139' ' ' ALA . 0.2 OUTLIER -139.0 62.27 1.54 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.707 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.727 ' HA ' ' HA ' ' B' ' 142' ' ' ALA . . . -101.09 9.14 42.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.363 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.19 136.03 24.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.335 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.579 ' N ' ' HA2' ' B' ' 141' ' ' GLY . 16.5 tt0 -58.59 121.33 10.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 111.154 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.4 -25.54 8.14 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.166 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.67 137.19 58.2 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.91 158.04 44.45 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.904 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -166.19 1.09 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.598 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 48.9 m -65.2 156.13 32.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.816 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.539 ' HB1' ' HB3' ' B' ' 134' ' ' GLN . . . -90.5 126.7 36.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.339 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.506 HG11 ' CG1' ' B' ' 32' ' ' VAL . 63.2 t -75.6 118.5 21.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.019 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.79 135.74 13.86 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.626 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' PHE . . . . . 0.5 ' HD2' HG12 ' B' ' 52' ' ' VAL . 46.3 p90 -170.85 142.08 1.86 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.815 0.341 . . . . 0.0 110.905 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.673 ' HA ' ' O ' ' B' ' 131' ' ' ILE . 11.5 p30 -126.52 163.93 22.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.54 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' B' ' 130' ' ' THR . 20.7 mm -105.17 119.97 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.503 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLN . . . . . 0.703 ' HA ' HG22 ' B' ' 130' ' ' THR . 0.0 OUTLIER -82.16 115.74 21.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.731 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.648 HD11 HG13 ' B' ' 131' ' ' ILE . 0.0 OUTLIER -128.33 107.47 9.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.252 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.37 176.99 8.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.86 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.03 66.21 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.714 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 3.3 m -109.73 154.46 22.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.711 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ASP . . . . . 0.531 ' HA ' ' OD1' ' B' ' 126' ' ' ASN . 0.5 OUTLIER -154.74 138.26 15.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.271 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' B' ' 66' ' ' ALA . 0.2 OUTLIER -97.55 -11.81 23.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.08 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.25 -48.68 40.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.115 0.483 . . . . 0.0 111.78 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' B' ' 19' ' ' ALA . 10.6 t -69.02 -48.7 68.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.764 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' B' ' 159' ' ' GLN . . . -137.93 153.36 49.5 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.637 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.29 18.67 4.43 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.868 0.366 . . . . 0.0 110.906 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' LYS . . . . . 0.61 ' HB3' ' HB3' ' B' ' 159' ' ' GLN . 10.6 tppt? -142.9 149.93 39.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.469 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.867 ' HB2' HD12 ' B' ' 124' ' ' LEU . . . -150.03 110.72 4.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.687 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' B' ' 121' ' ' GLU . . . -108.1 169.92 8.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.05 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.436 HG21 HG21 ' B' ' 131' ' ' ILE . 0.5 OUTLIER -130.35 150.93 35.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.63 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.698 ' HB1' ' HA ' ' B' ' 116' ' ' ALA . . . -135.62 100.16 4.41 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.518 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.438 ' HB2' HD22 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -77.35 133.84 38.63 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.572 0.225 . . . . 0.0 111.189 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.731 HD11 ' HG2' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -124.15 115.16 20.67 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.984 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.37 -173.24 26.53 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.777 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.606 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 7.0 m -112.6 149.04 33.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.565 0.221 . . . . 0.0 110.755 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' B' ' 85' ' ' VAL . . . -98.99 133.78 42.77 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.908 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.769 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 16.1 tt -72.91 -37.94 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.16 167.58 12.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.836 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' E' ' 106' ' ' ARG . . . -70.11 -53.85 15.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.42 28.74 6.08 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.564 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.808 ' HB3' ' HB ' ' B' ' 85' ' ' VAL . 10.2 m170 -111.38 -45.62 3.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.45 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' THR . . . . . 0.487 HG22 HH21 ' E' ' 106' ' ' ARG . 0.0 OUTLIER 46.41 -86.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.59 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' B' ' 82' ' ' HIS . 0.0 OUTLIER -42.3 -42.35 3.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.299 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.808 ' HB ' ' HB3' ' B' ' 82' ' ' HIS . 21.3 t -61.33 126.62 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.145 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 1.061 HD22 ' HB1' ' B' ' 150' ' ' ALA . 0.2 OUTLIER -81.31 164.33 22.27 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.281 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.769 ' HA ' ' HB ' ' B' ' 78' ' ' ILE . . . -104.74 -177.52 3.39 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.841 0.353 . . . . 0.0 111.67 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.03 -174.51 5.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.052 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.63 -170.68 3.22 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.394 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' SER . . . . . 0.898 ' HA ' HG13 ' E' ' 52' ' ' VAL . 27.4 p -74.85 7.95 2.8 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.92 0.39 . . . . 0.0 111.408 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' B' ' 95' ' ' SER . 0.8 OUTLIER -97.07 80.4 2.95 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.621 ' HA ' ' HB2' ' E' ' 50' ' ' SER . . . -66.83 -41.18 87.87 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.841 0.353 . . . . 0.0 111.664 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' E' ' 36' ' ' GLN . . . -103.76 26.07 9.05 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.698 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.81 -22.66 0.33 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.922 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' B' ' 91' ' ' SER . 1.0 OUTLIER -107.64 175.21 5.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.93 0.395 . . . . 0.0 110.606 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.53 177.18 3.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.848 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.498 ' O ' HG12 ' B' ' 99' ' ' VAL . 0.2 OUTLIER -138.59 167.89 20.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.27 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 98' ' ' ASN . . . . . 0.578 ' HA ' ' HB ' ' B' ' 140' ' ' THR . 32.2 m-80 44.12 51.63 7.2 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.53 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' VAL . . . . . 0.498 HG12 ' O ' ' B' ' 97' ' ' THR . 6.1 p -169.31 124.12 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.823 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.5 -164.68 11.5 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.619 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.86 91.12 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 122.925 0.49 . . . . 0.0 111.695 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.719 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 0.4 OUTLIER -71.42 116.58 11.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.919 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.656 HD12 HD11 ' B' ' 113' ' ' LEU . 6.6 mt -89.51 120.63 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.534 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' LEU . . . . . 0.499 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 1.0 OUTLIER -95.88 152.31 18.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.758 0.313 . . . . 0.0 111.041 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.23 160.12 14.58 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.573 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' ARG . . . . . 0.533 ' CZ ' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -68.83 -13.69 62.56 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.858 0.361 . . . . 0.0 111.032 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 44.8 p -74.45 -18.85 60.58 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.03 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.93 -40.15 2.22 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.659 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.34 164.69 13.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.774 0.321 . . . . 0.0 111.078 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -77.37 139.65 39.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.542 HD21 ' HB ' ' B' ' 117' ' ' THR . 5.9 tt -84.09 128.59 34.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.438 0.637 . . . . 0.0 110.462 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.4 m -68.13 132.38 47.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.111 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.656 HD11 HD12 ' B' ' 103' ' ' ILE . 4.7 mp -88.1 99.74 12.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.726 0.298 . . . . 0.0 110.748 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ASP . . . . . 0.504 ' O ' ' O ' ' E' ' 130' ' ' THR . 0.8 OUTLIER -144.1 -32.34 0.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.495 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 115' ' ' GLY . . . . . 0.495 ' CA ' HD23 ' B' ' 74' ' ' LEU . . . 146.44 -81.23 0.21 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.68 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' ALA . . . . . 0.698 ' HA ' ' HB1' ' B' ' 72' ' ' ALA . . . -97.24 64.02 1.88 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.986 0.422 . . . . 0.0 111.602 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.542 ' HB ' HD21 ' B' ' 111' ' ' LEU . 2.8 m -94.28 72.28 3.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.212 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.73 119.05 11.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.82 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.96 -48.97 0.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.57 84.68 6.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.559 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' B' ' 70' ' ' ALA . 3.5 mt-10 -110.19 87.0 2.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.227 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.09 159.32 17.6 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.802 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -67.0 138.35 57.18 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.666 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.867 HD12 ' HB2' ' B' ' 69' ' ' ALA . 0.4 OUTLIER -86.49 159.5 19.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.665 179.4 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.62 176.25 10.23 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.602 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' ASN . . . . . 0.531 ' OD1' ' HA ' ' B' ' 62' ' ' ASP . 0.9 OUTLIER -85.94 161.49 19.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.641 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.5 -121.03 5.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.756 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 73.2 m -119.5 140.32 50.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.661 0.267 . . . . 0.0 110.779 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ASN . . . . . 0.462 ' O ' HD12 ' B' ' 58' ' ' LEU . 5.1 t-20 -133.76 154.63 50.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.06 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.703 HG22 ' HA ' ' B' ' 57' ' ' GLN . 28.4 p -133.32 154.25 50.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.217 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' ILE . . . . . 0.673 ' O ' ' HA ' ' B' ' 55' ' ' ASN . 1.0 OUTLIER -110.95 116.89 51.22 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 132' ' ' PRO . . . . . 0.533 ' HG2' ' CZ ' ' B' ' 106' ' ' ARG . 7.6 Cg_endo -81.2 129.46 6.79 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 121.672 1.581 . . . . 0.0 112.594 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.463 ' HB3' ' CE1' ' B' ' 54' ' ' PHE . 0.1 OUTLIER -140.9 146.84 37.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.78 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 134' ' ' GLN . . . . . 0.539 ' HB3' ' HB1' ' B' ' 51' ' ' ALA . 8.4 mm100 -116.57 158.38 23.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.022 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' B' ' 103' ' ' ILE . . . -159.41 105.52 1.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 111.515 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.71 172.55 6.74 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.417 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.25 147.75 24.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.081 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.6 159.01 35.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.031 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.711 ' HB2' ' CB ' ' B' ' 42' ' ' LEU . . . -116.26 141.33 48.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.913 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 140' ' ' THR . . . . . 0.578 ' HB ' ' HA ' ' B' ' 98' ' ' ASN . 0.3 OUTLIER -107.86 27.27 9.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.467 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 141' ' ' GLY . . . . . 0.579 ' HA2' ' N ' ' B' ' 45' ' ' GLU . . . 97.49 83.6 1.7 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.015 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 142' ' ' ALA . . . . . 0.727 ' HA ' ' HA ' ' B' ' 43' ' ' ALA . . . 57.89 93.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.607 0.204 . . . . 0.0 110.821 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 143' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' B' ' 98' ' ' ASN . . . -80.05 165.51 22.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.709 0.29 . . . . 0.0 111.448 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 29.6 p -108.43 168.81 7.29 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.204 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.66 133.52 6.09 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.579 2.186 . . . . 0.0 111.987 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.61 -119.22 0.81 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.427 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.82 121.64 13.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.842 0.353 . . . . 0.0 111.306 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.32 85.7 3.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.5 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -104.6 131.23 52.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.56 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 1.061 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -136.1 148.47 48.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.949 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -133.19 120.21 20.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.197 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.61 140.01 24.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.199 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.621 HG22 ' HA ' ' A' ' 9' ' ' THR . 70.7 p -105.16 171.18 7.46 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.511 ' HZ ' HG21 ' B' ' 56' ' ' ILE . 13.6 p90 -138.16 147.44 43.86 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.104 0.478 . . . . 0.0 110.124 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.731 ' HG2' HD11 ' B' ' 74' ' ' LEU . 13.6 mmtt -100.94 172.02 7.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.892 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 156' ' ' VAL . . . . . 0.64 HG23 HG23 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -135.51 111.38 12.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.738 0.304 . . . . 0.0 111.681 -179.043 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 3' ' ' THR . 1.8 tt0 -109.06 141.28 41.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.369 0.604 . . . . 0.0 110.383 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 158' ' ' TYR . . . . . 0.485 ' CZ ' ' HB ' ' B' ' 156' ' ' VAL . 23.2 m-85 -135.39 105.55 6.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.553 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 159' ' ' GLN . . . . . 0.686 ' HA ' ' H ' ' A' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.855 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.672 ' H ' ' HA ' ' D' ' 159' ' ' GLN . . . 56.66 88.58 0.05 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.988 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' D' ' 157' ' ' GLN . 0.2 OUTLIER -103.05 110.38 22.28 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.428 179.708 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.4 136.24 38.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.523 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.646 HG23 HG23 ' D' ' 156' ' ' VAL . 0.0 OUTLIER -152.08 -175.28 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.63 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.54 130.08 38.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.595 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.81 -59.29 0.91 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.804 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.41 166.23 28.08 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.864 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 9' ' ' THR . . . . . 0.626 ' HA ' HG22 ' D' ' 153' ' ' THR . 27.0 m -94.46 121.16 35.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 111.219 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.6 115.61 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.258 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -99.56 137.51 37.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.311 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 12' ' ' PHE . . . . . 0.579 ' HA ' ' O ' ' D' ' 32' ' ' VAL . 75.8 m-85 -127.56 97.73 4.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.21 175.84 6.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.442 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.93 149.46 5.77 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.914 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.28 108.58 13.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.773 0.321 . . . . 0.0 110.432 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' D' ' 37' ' ' VAL . 23.1 t -86.6 129.07 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.283 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' C' ' 22' ' ' ALA . 18.7 m -127.39 163.55 30.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.826 0.346 . . . . 0.0 110.993 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -86.0 61.41 6.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.069 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' ALA . . . . . 0.49 ' HB3' HG21 ' C' ' 65' ' ' VAL . . . 44.95 52.64 8.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 20' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' C' ' 61' ' ' CYS . . . -127.29 -54.43 1.36 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.467 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 21' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.1 OUTLIER 177.73 111.65 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.92 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 22' ' ' ALA . . . . . 0.494 ' HB2' HG22 ' C' ' 17' ' ' VAL . . . -105.64 126.06 51.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.8 145.66 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.022 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.61 ' O ' HG23 ' C' ' 28' ' ' VAL . 4.0 m-20 -74.86 147.24 41.27 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.693 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.78 -43.64 18.43 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.337 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.88 -20.01 60.32 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.946 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 45.2 t -79.62 -26.04 41.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.857 0.36 . . . . 0.0 110.833 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.61 HG23 ' O ' ' C' ' 24' ' ' ASP . 57.5 t -49.08 -48.58 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.341 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.82 93.07 5.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.069 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.59 116.41 28.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.994 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 9.1 p -95.63 115.66 27.75 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.115 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' B' ' 12' ' ' PHE . 1.7 t -117.19 101.1 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.059 0.457 . . . . 0.0 110.438 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.55 126.9 52.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.688 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.19 -55.71 11.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.611 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.06 -111.71 3.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.471 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' GLN . . . . . 0.546 ' HG3' ' HA ' ' B' ' 24' ' ' ASP . 0.0 OUTLIER -77.02 115.32 16.72 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.516 0.198 . . . . 0.0 110.894 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' B' ' 16' ' ' VAL . 67.2 t -130.99 105.83 11.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.881 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.71 154.1 17.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.748 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.656 ' HA ' HD12 ' C' ' 42' ' ' LEU . 8.3 p -78.7 -19.86 51.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.779 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.53 -19.49 65.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 110.879 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 97.5 p -92.06 -21.26 20.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.143 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.716 ' CB ' ' HB2' ' C' ' 139' ' ' ALA . 0.2 OUTLIER -139.06 62.31 1.54 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.62 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 43' ' ' ALA . . . . . 0.726 ' HA ' ' HA ' ' C' ' 142' ' ' ALA . . . -101.26 9.2 42.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.23 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.25 136.07 24.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.306 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' GLU . . . . . 0.589 ' N ' ' HA2' ' C' ' 141' ' ' GLY . 16.5 tt0 -58.54 121.32 10.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 111.139 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.32 -25.43 8.22 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.189 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.8 137.27 58.22 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.937 0.398 . . . . 0.0 112.034 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.9 158.0 44.55 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.935 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.92 -166.23 1.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.627 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 48.8 m -65.18 156.25 32.35 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.782 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' ALA . . . . . 0.525 ' HB1' ' HB3' ' C' ' 134' ' ' GLN . . . -90.56 126.63 36.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.309 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.501 HG12 ' HD2' ' C' ' 54' ' ' PHE . 62.9 t -75.64 118.52 21.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.982 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.85 135.71 13.81 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.632 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' PHE . . . . . 0.501 ' HD2' HG12 ' C' ' 52' ' ' VAL . 46.3 p90 -170.76 142.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.755 0.312 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' C' ' 131' ' ' ILE . 11.5 p30 -126.56 163.91 22.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.569 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' C' ' 130' ' ' THR . 20.8 mm -105.1 119.89 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.519 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.694 ' HA ' HG22 ' C' ' 130' ' ' THR . 0.0 OUTLIER -82.09 115.69 21.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.761 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 58' ' ' LEU . . . . . 0.643 HD11 HG13 ' C' ' 131' ' ' ILE . 0.0 OUTLIER -128.23 107.45 9.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.295 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.36 176.99 8.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.954 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.03 66.24 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.734 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 61' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 3.3 m -109.75 154.4 22.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.668 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 62' ' ' ASP . . . . . 0.516 ' HA ' ' OD1' ' C' ' 126' ' ' ASN . 0.5 OUTLIER -154.65 138.33 16.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.295 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' C' ' 66' ' ' ALA . 0.2 OUTLIER -97.54 -11.9 23.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.07 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -72.26 -48.71 40.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.026 0.441 . . . . 0.0 111.732 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.49 HG21 ' HB3' ' C' ' 19' ' ' ALA . 10.6 t -69.0 -48.73 68.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.716 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 66' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' C' ' 159' ' ' GLN . . . -137.93 153.36 49.5 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.672 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.28 18.67 4.43 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.847 0.356 . . . . 0.0 110.878 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' LYS . . . . . 0.623 ' HB3' ' HB3' ' C' ' 159' ' ' GLN . 10.6 tppt? -142.9 149.95 39.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.41 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.864 ' HB2' HD12 ' C' ' 124' ' ' LEU . . . -150.02 110.71 4.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.671 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' C' ' 121' ' ' GLU . . . -108.07 169.97 8.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.083 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 71' ' ' VAL . . . . . 0.439 HG21 HG21 ' C' ' 131' ' ' ILE . 0.5 OUTLIER -130.38 150.96 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.632 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 72' ' ' ALA . . . . . 0.695 ' HB1' ' HA ' ' C' ' 116' ' ' ALA . . . -135.55 100.06 4.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.62 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 73' ' ' PHE . . . . . 0.436 ' HB2' HD22 ' C' ' 111' ' ' LEU . 0.2 OUTLIER -77.41 133.95 38.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.552 0.215 . . . . 0.0 111.117 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.748 HD11 ' HG2' ' C' ' 155' ' ' LYS . 0.0 OUTLIER -124.15 115.08 20.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.968 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.42 -173.24 26.57 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.761 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.609 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 7.1 m -112.61 149.0 33.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.618 0.247 . . . . 0.0 110.737 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 77' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' C' ' 85' ' ' VAL . . . -98.96 133.78 42.73 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.936 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 78' ' ' ILE . . . . . 0.758 ' HB ' ' HA ' ' C' ' 87' ' ' ALA . 16.1 tt -72.89 -38.01 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.13 167.61 12.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.802 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 80' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' F' ' 106' ' ' ARG . . . -70.21 -53.78 15.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.08 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.4 28.66 6.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.546 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 82' ' ' HIS . . . . . 0.822 ' HB3' ' HB ' ' C' ' 85' ' ' VAL . 10.2 m170 -111.3 -45.67 3.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.46 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 83' ' ' THR . . . . . 0.476 HG22 HH21 ' F' ' 106' ' ' ARG . 0.0 OUTLIER 46.48 -86.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.552 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 84' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' C' ' 82' ' ' HIS . 0.0 OUTLIER -42.19 -42.48 3.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.277 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.822 ' HB ' ' HB3' ' C' ' 82' ' ' HIS . 21.3 t -61.25 126.56 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.148 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 1.064 HD22 ' HB1' ' C' ' 150' ' ' ALA . 0.2 OUTLIER -81.22 164.39 22.32 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.413 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.758 ' HA ' ' HB ' ' C' ' 78' ' ' ILE . . . -104.79 -177.54 3.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.84 0.352 . . . . 0.0 111.661 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.03 -174.53 5.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.049 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.63 -170.66 3.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.317 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 90' ' ' SER . . . . . 0.909 ' HA ' HG13 ' F' ' 52' ' ' VAL . 26.9 p -74.85 7.85 2.86 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.989 0.423 . . . . 0.0 111.408 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 91' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' C' ' 95' ' ' SER . 0.8 OUTLIER -96.97 80.45 2.98 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.84 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 92' ' ' ALA . . . . . 0.613 ' HA ' ' HB2' ' F' ' 50' ' ' SER . . . -66.83 -41.24 87.78 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.853 0.359 . . . . 0.0 111.618 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 93' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' F' ' 36' ' ' GLN . . . -103.7 25.98 9.12 Favored 'General case' 0 N--CA 1.46 0.068 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.707 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.83 -22.69 0.33 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.947 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 95' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' C' ' 91' ' ' SER . 1.0 OUTLIER -107.66 175.18 5.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.913 0.387 . . . . 0.0 110.593 179.544 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.41 177.1 3.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 97' ' ' THR . . . . . 0.505 ' O ' HG12 ' C' ' 99' ' ' VAL . 0.2 OUTLIER -138.52 167.88 20.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.269 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 98' ' ' ASN . . . . . 0.58 ' HA ' ' HB ' ' C' ' 140' ' ' THR . 32.5 m-80 44.17 51.7 7.26 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.48 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 99' ' ' VAL . . . . . 0.505 HG12 ' O ' ' C' ' 97' ' ' THR . 6.0 p -169.39 124.12 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.767 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 100' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' C' ' 86' ' ' LEU . . . -129.55 -164.72 11.5 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.638 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 101' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.77 91.15 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 122.975 0.51 . . . . 0.0 111.7 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 102' ' ' GLN . . . . . 0.7 ' HA ' ' HA ' ' C' ' 85' ' ' VAL . 0.4 OUTLIER -71.45 116.63 12.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.858 -179.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.647 HD12 HD11 ' C' ' 113' ' ' LEU . 6.6 mt -89.68 120.61 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.445 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 104' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 1.0 OUTLIER -95.81 152.27 18.63 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.689 0.28 . . . . 0.0 111.164 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.16 160.07 14.62 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.601 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 106' ' ' ARG . . . . . 0.533 ' CZ ' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -68.8 -13.68 62.55 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.827 0.346 . . . . 0.0 111.066 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 45.0 p -74.37 -18.92 60.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.081 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.91 -40.01 2.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.71 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.41 164.71 13.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.816 0.341 . . . . 0.0 111.116 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -77.35 139.58 39.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.174 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 111' ' ' LEU . . . . . 0.553 HD21 ' HB ' ' C' ' 117' ' ' THR . 5.9 tt -84.08 128.48 34.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.435 0.636 . . . . 0.0 110.519 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 112' ' ' THR . . . . . . . . . . . . . 1.4 m -68.14 132.39 47.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.126 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.647 HD11 HD12 ' C' ' 103' ' ' ILE . 4.7 mp -87.99 99.69 12.35 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.791 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 114' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' F' ' 130' ' ' THR . 0.8 OUTLIER -144.03 -32.49 0.43 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.626 0.25 . . . . 0.0 111.568 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 115' ' ' GLY . . . . . 0.491 ' CA ' HD23 ' C' ' 74' ' ' LEU . . . 146.5 -81.25 0.21 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.669 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 116' ' ' ALA . . . . . 0.695 ' HA ' ' HB1' ' C' ' 72' ' ' ALA . . . -97.25 64.0 1.88 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.975 0.417 . . . . 0.0 111.659 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 117' ' ' THR . . . . . 0.553 ' HB ' HD21 ' C' ' 111' ' ' LEU . 2.8 m -94.26 72.28 3.88 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.18 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -66.69 119.04 11.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.9 t -143.95 -48.96 0.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.809 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 3.0 m -88.57 84.7 6.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.584 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 121' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' C' ' 70' ' ' ALA . 3.5 mt-10 -110.25 86.92 2.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.287 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.95 159.27 17.73 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -66.93 138.34 57.21 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.699 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 124' ' ' LEU . . . . . 0.864 HD12 ' HB2' ' C' ' 69' ' ' ALA . 0.4 OUTLIER -86.56 159.48 19.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.636 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.56 176.28 10.19 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.562 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 126' ' ' ASN . . . . . 0.516 ' OD1' ' HA ' ' C' ' 62' ' ' ASP . 0.9 OUTLIER -85.92 161.52 19.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.681 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.5 -121.0 5.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.756 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 72.4 m -119.47 140.36 50.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.675 0.274 . . . . 0.0 110.815 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 129' ' ' ASN . . . . . 0.46 ' O ' HD12 ' C' ' 58' ' ' LEU . 5.1 t-20 -133.8 154.64 50.86 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.876 0.37 . . . . 0.0 111.087 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 130' ' ' THR . . . . . 0.694 HG22 ' HA ' ' C' ' 57' ' ' GLN . 28.0 p -133.37 154.29 50.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.133 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 131' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' C' ' 55' ' ' ASN . 1.0 OUTLIER -111.0 116.84 51.19 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 132' ' ' PRO . . . . . 0.533 ' HG2' ' CZ ' ' C' ' 106' ' ' ARG . 7.7 Cg_endo -81.12 129.4 6.83 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.662 1.574 . . . . 0.0 112.675 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.464 ' HB3' ' CE1' ' C' ' 54' ' ' PHE . 0.1 OUTLIER -140.87 146.89 38.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.813 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 134' ' ' GLN . . . . . 0.525 ' HB3' ' HB1' ' C' ' 51' ' ' ALA . 8.4 mm100 -116.47 158.39 23.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.043 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' C' ' 103' ' ' ILE . . . -159.48 105.53 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.91 0.386 . . . . 0.0 111.545 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.72 172.5 6.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.399 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.16 147.72 24.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.128 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.58 158.99 35.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.057 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 139' ' ' ALA . . . . . 0.716 ' HB2' ' CB ' ' C' ' 42' ' ' LEU . . . -116.27 141.28 48.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.934 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 140' ' ' THR . . . . . 0.58 ' HB ' ' HA ' ' C' ' 98' ' ' ASN . 0.2 OUTLIER -107.83 27.23 9.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.471 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 141' ' ' GLY . . . . . 0.589 ' HA2' ' N ' ' C' ' 45' ' ' GLU . . . 97.63 83.59 1.71 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.97 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 142' ' ' ALA . . . . . 0.726 ' HA ' ' HA ' ' C' ' 43' ' ' ALA . . . 57.9 93.41 0.03 OUTLIER 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.666 0.233 . . . . 0.0 110.8 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 143' ' ' ALA . . . . . 0.547 ' HA ' ' HB2' ' C' ' 98' ' ' ASN . . . -80.02 165.38 22.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.764 0.316 . . . . 0.0 111.392 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 144' ' ' THR . . . . . . . . . . . . . 29.8 p -108.35 168.87 7.22 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.228 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.68 133.56 6.09 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.533 2.155 . . . . 0.0 112.015 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 146' ' ' GLY . . . . . 0.62 ' HA2' HG12 ' A' ' 5' ' ' VAL . . . 169.6 -119.25 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.477 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.8 121.73 13.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.887 0.375 . . . . 0.0 111.339 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.42 85.71 3.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.419 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -104.61 131.24 52.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.548 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 150' ' ' ALA . . . . . 1.064 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -136.06 148.51 48.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.971 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.24 120.19 20.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.205 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.64 140.0 24.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.207 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 153' ' ' THR . . . . . 0.624 HG22 ' HA ' ' B' ' 9' ' ' THR . 70.7 p -105.16 171.19 7.45 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 154' ' ' PHE . . . . . 0.51 ' HZ ' HG21 ' C' ' 56' ' ' ILE . 13.9 p90 -138.21 147.41 43.73 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.114 0.483 . . . . 0.0 110.074 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 155' ' ' LYS . . . . . 0.748 ' HG2' HD11 ' C' ' 74' ' ' LEU . 13.7 mmtt -100.89 171.94 7.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.936 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 156' ' ' VAL . . . . . 0.652 HG23 HG23 ' B' ' 5' ' ' VAL . 0.4 OUTLIER -135.47 111.41 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.84 0.352 . . . . 0.0 111.716 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 157' ' ' GLN . . . . . 0.556 ' HA ' ' O ' ' B' ' 3' ' ' THR . 1.8 tt0 -108.96 141.29 41.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.349 0.595 . . . . 0.0 110.409 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 158' ' ' TYR . . . . . 0.484 ' CZ ' ' HB ' ' C' ' 156' ' ' VAL . 23.0 m-85 -135.37 105.47 6.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.595 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 159' ' ' GLN . . . . . 0.695 ' HA ' ' H ' ' B' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 111.495 0.183 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.68 ' H ' ' HA ' ' E' ' 159' ' ' GLN . . . 56.69 88.54 0.05 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.713 -0.222 . . . . 0.0 110.963 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 3' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' E' ' 157' ' ' GLN . 0.2 OUTLIER -103.08 110.38 22.29 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.383 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.36 136.2 38.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.592 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.646 HG23 HG23 ' E' ' 156' ' ' VAL . 0.0 OUTLIER -152.05 -175.35 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.562 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.44 130.05 38.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.685 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.81 -59.23 0.91 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.8 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.34 166.18 27.93 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.868 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 9' ' ' THR . . . . . 0.612 ' HA ' HG22 ' E' ' 153' ' ' THR . 27.0 m -94.38 121.15 35.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 0.0 111.197 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.73 115.61 36.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.208 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -99.54 137.51 37.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.374 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 12' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' E' ' 32' ' ' VAL . 76.0 m-85 -127.6 97.74 4.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.792 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.31 175.76 6.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.428 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.0 149.45 5.77 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.948 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.29 108.58 13.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.855 0.359 . . . . 0.0 110.35 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' E' ' 37' ' ' VAL . 23.5 t -86.59 129.1 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.243 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' D' ' 22' ' ' ALA . 18.8 m -127.35 163.54 30.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.815 0.34 . . . . 0.0 111.011 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -85.97 61.4 6.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.052 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' ALA . . . . . 0.487 ' HB3' HG21 ' D' ' 65' ' ' VAL . . . 44.88 52.64 7.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' D' ' 61' ' ' CYS . . . -127.22 -54.42 1.37 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.49 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 21' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.1 OUTLIER 177.64 111.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.879 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 22' ' ' ALA . . . . . 0.498 ' HB2' HG22 ' D' ' 17' ' ' VAL . . . -105.69 126.06 51.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.108 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.81 145.65 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.003 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.612 ' O ' HG23 ' D' ' 28' ' ' VAL . 4.0 m-20 -74.77 147.26 41.44 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.692 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.74 -43.62 18.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.396 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.96 -20.01 60.17 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.863 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 45.1 t -79.54 -26.12 41.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.899 0.381 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' VAL . . . . . 0.612 HG23 ' O ' ' D' ' 24' ' ' ASP . 57.3 t -49.1 -48.53 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.33 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.82 93.01 5.32 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.093 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.55 116.42 28.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.038 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.66 115.62 27.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.173 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' C' ' 12' ' ' PHE . 1.6 t -117.14 101.08 11.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.072 0.463 . . . . 0.0 110.469 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.58 126.97 52.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.698 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -68.2 -55.67 11.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.653 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.02 -111.69 3.94 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.498 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' GLN . . . . . 0.538 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -77.04 115.26 16.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.513 0.197 . . . . 0.0 110.947 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' C' ' 16' ' ' VAL . 67.6 t -131.0 105.83 11.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.888 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.67 154.1 17.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.722 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.637 ' HA ' HD12 ' D' ' 42' ' ' LEU . 8.3 p -78.7 -19.86 51.43 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.775 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -19.53 65.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.14 0.495 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 96.8 p -92.05 -21.2 20.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.184 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.718 ' CB ' ' HB2' ' D' ' 139' ' ' ALA . 0.2 OUTLIER -139.08 62.25 1.54 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.602 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 43' ' ' ALA . . . . . 0.728 ' HA ' ' HA ' ' D' ' 142' ' ' ALA . . . -101.15 9.17 42.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.36 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.17 136.06 24.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.359 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 45' ' ' GLU . . . . . 0.587 ' N ' ' HA2' ' D' ' 141' ' ' GLY . 16.4 tt0 -58.53 121.37 10.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 0.0 111.133 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.25 -25.44 8.25 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.209 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.75 137.22 58.21 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.83 158.07 44.32 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.95 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.05 -166.23 1.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.512 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.632 ' HB2' ' HA ' ' A' ' 92' ' ' ALA . 48.9 m -65.17 156.11 32.79 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.769 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 51' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' D' ' 134' ' ' GLN . . . -90.46 126.7 35.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.358 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 52' ' ' VAL . . . . . 0.869 HG13 ' HA ' ' A' ' 90' ' ' SER . 63.2 t -75.66 118.53 21.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.999 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.84 135.69 13.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.672 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.538 ' H ' HG21 ' A' ' 76' ' ' THR . 46.3 p90 -170.77 142.11 1.9 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 55' ' ' ASN . . . . . 0.68 ' HA ' ' O ' ' D' ' 131' ' ' ILE . 11.6 p30 -126.58 163.88 22.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.526 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' D' ' 130' ' ' THR . 20.7 mm -105.08 119.93 54.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.516 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 57' ' ' GLN . . . . . 0.698 ' HA ' HG22 ' D' ' 130' ' ' THR . 0.0 OUTLIER -82.15 115.65 21.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.761 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 58' ' ' LEU . . . . . 0.64 HD11 HG13 ' D' ' 131' ' ' ILE . 0.0 OUTLIER -128.21 107.42 9.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.298 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.35 177.0 8.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.951 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.11 66.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.756 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 61' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 3.3 m -109.66 154.39 22.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.742 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 62' ' ' ASP . . . . . 0.522 ' HA ' ' OD1' ' D' ' 126' ' ' ASN . 0.5 OUTLIER -154.66 138.37 16.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.214 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' D' ' 66' ' ' ALA . 0.2 OUTLIER -97.64 -11.82 23.14 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.19 -48.82 40.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.03 0.443 . . . . 0.0 111.746 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 65' ' ' VAL . . . . . 0.487 HG21 ' HB3' ' D' ' 19' ' ' ALA . 10.5 t -68.92 -48.71 68.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.742 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' D' ' 159' ' ' GLN . . . -137.97 153.32 49.46 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.637 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.27 18.68 4.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.926 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 68' ' ' LYS . . . . . 0.621 ' HB3' ' HB3' ' D' ' 159' ' ' GLN . 10.6 tppt? -142.84 149.9 39.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.573 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 69' ' ' ALA . . . . . 0.869 ' HB2' HD12 ' D' ' 124' ' ' LEU . . . -149.97 110.75 4.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.633 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 70' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' D' ' 121' ' ' GLU . . . -108.06 169.95 8.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.131 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 71' ' ' VAL . . . . . 0.431 HG21 HG21 ' D' ' 131' ' ' ILE . 0.5 OUTLIER -130.4 150.96 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.642 -179.507 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 72' ' ' ALA . . . . . 0.685 ' HB1' ' HA ' ' D' ' 116' ' ' ALA . . . -135.57 100.1 4.4 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.555 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 73' ' ' PHE . . . . . 0.435 ' HB2' HD22 ' D' ' 111' ' ' LEU . 0.2 OUTLIER -77.46 133.94 38.49 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.599 0.238 . . . . 0.0 111.128 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 74' ' ' LEU . . . . . 0.749 HD11 ' HG2' ' D' ' 155' ' ' LYS . 0.0 OUTLIER -124.15 115.08 20.53 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.932 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.35 -173.22 26.48 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.821 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -112.62 149.06 33.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.681 0.277 . . . . 0.0 110.739 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' D' ' 85' ' ' VAL . . . -98.95 133.79 42.72 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.939 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 78' ' ' ILE . . . . . 0.787 ' HB ' ' HA ' ' D' ' 87' ' ' ALA . 16.1 tt -72.96 -37.95 55.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.89 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.21 167.63 12.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.834 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.22 -53.83 15.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.08 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.36 28.71 6.07 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.536 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 82' ' ' HIS . . . . . 0.832 ' HB3' ' HB ' ' D' ' 85' ' ' VAL . 10.3 m170 -111.33 -45.7 3.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.928 0.394 . . . . 0.0 110.453 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.39 -86.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.603 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 84' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' D' ' 82' ' ' HIS . 0.0 OUTLIER -42.19 -42.46 3.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.268 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.832 ' HB ' ' HB3' ' D' ' 82' ' ' HIS . 21.3 t -61.3 126.53 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.135 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.997 HD22 ' HB1' ' D' ' 150' ' ' ALA . 0.2 OUTLIER -81.22 164.42 22.3 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.432 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.787 ' HA ' ' HB ' ' D' ' 78' ' ' ILE . . . -104.84 -177.53 3.39 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.852 0.358 . . . . 0.0 111.618 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.01 -174.53 5.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.009 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.64 -170.72 3.24 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.367 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 27.8 p -74.76 7.87 2.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.905 0.383 . . . . 0.0 111.46 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 91' ' ' SER . . . . . 0.421 ' HB2' ' HB3' ' D' ' 95' ' ' SER . 0.8 OUTLIER -97.06 80.41 2.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.84 -41.2 87.81 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.82 0.343 . . . . 0.0 111.636 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.72 26.01 9.1 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.682 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.77 -22.64 0.33 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.892 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 95' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' D' ' 91' ' ' SER . 1.0 OUTLIER -107.65 175.18 5.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 110.661 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.35 177.1 2.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 97' ' ' THR . . . . . 0.497 ' O ' HG12 ' D' ' 99' ' ' VAL . 0.2 OUTLIER -138.6 167.85 21.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.278 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 98' ' ' ASN . . . . . 0.585 ' HA ' ' HB ' ' D' ' 140' ' ' THR . 32.4 m-80 44.2 51.68 7.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.489 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 99' ' ' VAL . . . . . 0.497 HG12 ' O ' ' D' ' 97' ' ' THR . 6.0 p -169.34 124.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.702 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.61 -164.65 11.47 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.58 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 101' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.84 91.13 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.202 0.525 . . . . 0.0 111.73 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 102' ' ' GLN . . . . . 0.706 ' HA ' ' HA ' ' D' ' 85' ' ' VAL . 0.4 OUTLIER -71.43 116.65 12.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.857 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 103' ' ' ILE . . . . . 0.666 HD12 HD11 ' D' ' 113' ' ' LEU . 6.6 mt -89.61 120.64 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.457 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 104' ' ' LEU . . . . . 0.517 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 1.0 OUTLIER -95.84 152.32 18.6 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.691 0.281 . . . . 0.0 111.126 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.14 160.09 14.6 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.629 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 106' ' ' ARG . . . . . 0.536 ' CZ ' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -68.89 -13.6 62.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.835 0.35 . . . . 0.0 111.075 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 107' ' ' THR . . . . . . . . . . . . . 45.3 p -74.42 -18.9 60.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.144 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.0 -40.15 2.22 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.669 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.3 164.7 13.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.338 . . . . 0.0 111.119 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -77.4 139.66 39.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.148 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 111' ' ' LEU . . . . . 0.554 HD21 ' HB ' ' D' ' 117' ' ' THR . 5.9 tt -84.18 128.59 34.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.404 0.621 . . . . 0.0 110.503 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 112' ' ' THR . . . . . 0.408 ' O ' HD23 ' D' ' 111' ' ' LEU . 1.4 m -68.13 132.36 47.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.17 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 113' ' ' LEU . . . . . 0.666 HD11 HD12 ' D' ' 103' ' ' ILE . 4.7 mp -88.06 99.74 12.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.693 0.282 . . . . 0.0 110.737 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.06 -32.43 0.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.539 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 115' ' ' GLY . . . . . 0.497 ' CA ' HD23 ' D' ' 74' ' ' LEU . . . 146.45 -81.29 0.21 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.666 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 116' ' ' ALA . . . . . 0.685 ' HA ' ' HB1' ' D' ' 72' ' ' ALA . . . -97.23 64.12 1.89 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.0 0.429 . . . . 0.0 111.624 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 117' ' ' THR . . . . . 0.554 ' HB ' HD21 ' D' ' 111' ' ' LEU . 2.8 m -94.42 72.31 3.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.76 119.07 11.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.828 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.89 -49.03 0.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.57 84.75 6.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.575 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 121' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' D' ' 70' ' ' ALA . 3.6 mt-10 -110.16 86.94 2.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.268 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.0 159.32 17.66 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.83 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -67.07 138.33 57.07 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.68 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 124' ' ' LEU . . . . . 0.869 HD12 ' HB2' ' D' ' 69' ' ' ALA . 0.4 OUTLIER -86.47 159.46 19.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.68 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.55 176.28 10.19 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.635 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 126' ' ' ASN . . . . . 0.522 ' OD1' ' HA ' ' D' ' 62' ' ' ASP . 0.9 OUTLIER -85.98 161.52 18.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.639 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.53 -121.06 5.73 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.764 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 128' ' ' THR . . . . . 0.566 HG21 ' HE2' ' A' ' 155' ' ' LYS . 74.1 m -119.5 140.3 50.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.659 0.266 . . . . 0.0 110.765 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 129' ' ' ASN . . . . . 0.452 ' O ' HD12 ' D' ' 58' ' ' LEU . 5.1 t-20 -133.74 154.63 50.83 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.912 0.387 . . . . 0.0 111.087 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 130' ' ' THR . . . . . 0.698 HG22 ' HA ' ' D' ' 57' ' ' GLN . 28.2 p -133.36 154.32 50.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.167 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 131' ' ' ILE . . . . . 0.68 ' O ' ' HA ' ' D' ' 55' ' ' ASN . 1.0 OUTLIER -111.07 116.86 51.01 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 132' ' ' PRO . . . . . 0.6 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 7.7 Cg_endo -81.11 129.36 6.82 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.704 1.603 . . . . 0.0 112.667 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.46 ' HB3' ' CE1' ' D' ' 54' ' ' PHE . 0.1 OUTLIER -140.87 146.87 38.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.81 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 134' ' ' GLN . . . . . 0.529 ' HB3' ' HB1' ' D' ' 51' ' ' ALA . 19.5 mm-40 -116.48 158.4 23.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.979 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' D' ' 103' ' ' ILE . . . -159.48 105.61 1.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.931 0.396 . . . . 0.0 111.539 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 136' ' ' ARG . . . . . 0.417 ' HG2' ' H ' ' D' ' 136' ' ' ARG . 1.2 ptt180 -103.68 172.57 6.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.405 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.23 147.72 24.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.086 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.58 159.05 35.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.005 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 139' ' ' ALA . . . . . 0.718 ' HB2' ' CB ' ' D' ' 42' ' ' LEU . . . -116.36 141.31 48.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.85 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 140' ' ' THR . . . . . 0.585 ' HB ' ' HA ' ' D' ' 98' ' ' ASN . 0.2 OUTLIER -107.78 27.2 9.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.496 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 141' ' ' GLY . . . . . 0.587 ' HA2' ' N ' ' D' ' 45' ' ' GLU . . . 97.55 83.6 1.71 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.014 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 142' ' ' ALA . . . . . 0.728 ' HA ' ' HA ' ' D' ' 43' ' ' ALA . . . 57.87 93.49 0.03 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.7 0.25 . . . . 0.0 110.759 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 143' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' D' ' 98' ' ' ASN . . . -79.97 165.44 22.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 111.375 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 144' ' ' THR . . . . . 0.405 ' HB ' ' CD ' ' D' ' 145' ' ' PRO . 29.4 p -108.37 168.85 7.25 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.234 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 145' ' ' PRO . . . . . 0.405 ' CD ' ' HB ' ' D' ' 144' ' ' THR . 1.3 Cg_endo -83.62 133.56 6.14 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.544 2.162 . . . . 0.0 112.002 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 146' ' ' GLY . . . . . 0.609 ' HA2' HG12 ' B' ' 5' ' ' VAL . . . 169.56 -119.25 0.81 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.477 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.84 121.69 13.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.787 0.327 . . . . 0.0 111.327 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.33 85.7 3.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.14 0.495 . . . . 0.0 110.506 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -104.57 131.21 52.25 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.597 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 150' ' ' ALA . . . . . 0.997 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -136.08 148.49 48.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.951 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.16 120.24 20.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.194 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.7 140.0 24.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.164 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 153' ' ' THR . . . . . 0.626 HG22 ' HA ' ' C' ' 9' ' ' THR . 70.7 p -105.2 171.18 7.46 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 154' ' ' PHE . . . . . 0.51 ' HZ ' HG21 ' D' ' 56' ' ' ILE . 13.5 p90 -138.18 147.4 43.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.138 0.494 . . . . 0.0 110.112 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 155' ' ' LYS . . . . . 0.749 ' HG2' HD11 ' D' ' 74' ' ' LEU . 13.7 mmtt -100.9 171.92 7.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.912 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 156' ' ' VAL . . . . . 0.646 HG23 HG23 ' C' ' 5' ' ' VAL . 0.4 OUTLIER -135.4 111.42 12.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.714 -179.104 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 157' ' ' GLN . . . . . 0.564 ' HA ' ' O ' ' C' ' 3' ' ' THR . 1.8 tt0 -109.03 141.32 41.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.273 0.559 . . . . 0.0 110.398 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 158' ' ' TYR . . . . . 0.48 ' CZ ' ' HB ' ' D' ' 156' ' ' VAL . 23.1 m-85 -135.43 105.43 6.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.555 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 159' ' ' GLN . . . . . 0.672 ' HA ' ' H ' ' C' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.899 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 111.48 0.178 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 2' ' ' ALA . . . . . 0.686 ' H ' ' HA ' ' F' ' 159' ' ' GLN . . . 56.56 88.6 0.05 OUTLIER 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.038 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 3' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' F' ' 157' ' ' GLN . 0.2 OUTLIER -103.14 110.34 22.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.411 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.31 136.26 38.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.57 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.66 HG23 HG23 ' F' ' 156' ' ' VAL . 0.0 OUTLIER -152.11 -175.28 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.616 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.54 130.06 38.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.646 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.73 -59.38 0.91 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.805 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.38 166.23 28.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.806 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 9' ' ' THR . . . . . 0.609 ' HA ' HG22 ' F' ' 153' ' ' THR . 27.0 m -94.47 121.18 35.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.939 0.4 . . . . 0.0 111.205 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.69 115.58 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.21 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -99.52 137.56 37.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.327 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 12' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' F' ' 32' ' ' VAL . 76.2 m-85 -127.61 97.78 4.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.815 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.3 175.8 6.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.378 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.97 149.46 5.77 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.91 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.29 108.61 13.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 110.345 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 16' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' F' ' 37' ' ' VAL . 23.4 t -86.62 129.16 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.213 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 17' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' E' ' 22' ' ' ALA . 18.7 m -127.43 163.53 30.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.787 0.327 . . . . 0.0 111.028 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -85.95 61.36 6.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.032 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 19' ' ' ALA . . . . . 0.491 ' HB3' HG21 ' E' ' 65' ' ' VAL . . . 45.0 52.64 8.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.051 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' E' ' 61' ' ' CYS . . . -127.27 -54.47 1.37 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.426 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 21' ' ' CYS . . . . . 0.818 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.1 OUTLIER 177.68 111.67 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.901 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 22' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' E' ' 17' ' ' VAL . . . -105.71 126.0 51.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.86 145.68 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.003 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 24' ' ' ASP . . . . . 0.607 ' O ' HG23 ' E' ' 28' ' ' VAL . 3.9 m-20 -74.9 147.28 41.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.652 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.73 -43.71 18.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.331 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.85 -20.06 60.27 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.865 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 45.1 t -79.58 -26.09 41.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.872 0.367 . . . . 0.0 110.851 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 28' ' ' VAL . . . . . 0.607 HG23 ' O ' ' E' ' 24' ' ' ASP . 57.8 t -49.13 -48.49 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.361 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.89 93.09 5.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.976 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.63 116.38 28.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.04 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.54 115.58 27.63 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.178 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' D' ' 12' ' ' PHE . 1.7 t -117.17 101.14 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.168 0.509 . . . . 0.0 110.463 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.58 126.91 52.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.711 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.613 HD21 ' HB3' ' B' ' 92' ' ' ALA . 0.3 OUTLIER -68.15 -55.71 11.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.619 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.03 -111.69 3.93 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.471 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 36' ' ' GLN . . . . . 0.545 ' HG3' ' HA ' ' D' ' 24' ' ' ASP . 0.0 OUTLIER -77.02 115.34 16.73 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.524 0.202 . . . . 0.0 110.902 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' D' ' 16' ' ' VAL . 67.5 t -131.11 105.85 11.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.819 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.6 154.11 17.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.77 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 39' ' ' THR . . . . . 0.665 ' HA ' HD12 ' E' ' 42' ' ' LEU . 8.4 p -78.71 -19.92 51.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.753 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.38 -19.58 65.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.125 0.488 . . . . 0.0 110.923 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 97.1 p -92.01 -21.24 20.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.156 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.701 ' CB ' ' HB2' ' E' ' 139' ' ' ALA . 0.2 OUTLIER -139.06 62.39 1.54 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.661 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 43' ' ' ALA . . . . . 0.727 ' HA ' ' HA ' ' E' ' 142' ' ' ALA . . . -101.23 9.12 42.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.246 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.15 136.02 24.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.32 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 45' ' ' GLU . . . . . 0.59 ' N ' ' HA2' ' E' ' 141' ' ' GLY . 16.5 tt0 -58.5 121.24 10.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 0.0 111.159 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.36 -25.47 8.19 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.196 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.66 137.24 58.22 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.93 157.93 44.75 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.919 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.97 -166.19 1.09 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.583 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 50' ' ' SER . . . . . 0.621 ' HB2' ' HA ' ' B' ' 92' ' ' ALA . 48.7 m -65.22 156.23 32.53 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.789 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 51' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' E' ' 134' ' ' GLN . . . -90.57 126.66 36.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.274 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 52' ' ' VAL . . . . . 0.898 HG13 ' HA ' ' B' ' 90' ' ' SER . 63.3 t -75.61 118.46 21.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.016 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.78 135.65 13.77 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.663 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 54' ' ' PHE . . . . . 0.531 ' H ' HG21 ' B' ' 76' ' ' THR . 46.2 p90 -170.77 142.04 1.89 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.831 0.348 . . . . 0.0 110.907 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 55' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' E' ' 131' ' ' ILE . 11.6 p30 -126.5 163.87 22.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.621 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 56' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' E' ' 130' ' ' THR . 21.0 mm -105.1 119.93 54.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.52 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 57' ' ' GLN . . . . . 0.675 ' HA ' HG22 ' E' ' 130' ' ' THR . 0.0 OUTLIER -82.18 115.74 21.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.744 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 58' ' ' LEU . . . . . 0.648 HD11 HG13 ' E' ' 131' ' ' ILE . 0.0 OUTLIER -128.28 107.45 9.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.267 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.34 177.09 8.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.924 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 62.95 66.13 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.818 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 61' ' ' CYS . . . . . 0.818 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 3.3 m -109.65 154.42 22.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.785 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 62' ' ' ASP . . . . . 0.512 ' HA ' ' OD1' ' E' ' 126' ' ' ASN . 0.5 OUTLIER -154.68 138.35 16.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.258 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 63' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' E' ' 66' ' ' ALA . 0.2 OUTLIER -97.63 -11.81 23.17 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.131 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.23 -48.72 40.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.993 0.425 . . . . 0.0 111.733 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 65' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' E' ' 19' ' ' ALA . 10.7 t -69.02 -48.67 68.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.712 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 66' ' ' ALA . . . . . 0.554 ' HB1' ' O ' ' E' ' 159' ' ' GLN . . . -137.94 153.39 49.49 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.616 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.3 18.62 4.43 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.802 0.334 . . . . 0.0 110.91 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 68' ' ' LYS . . . . . 0.611 ' HB3' ' HB3' ' E' ' 159' ' ' GLN . 10.6 tppt? -142.83 149.94 39.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.448 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 69' ' ' ALA . . . . . 0.863 ' HB2' HD12 ' E' ' 124' ' ' LEU . . . -150.01 110.65 4.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.729 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 70' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' E' ' 121' ' ' GLU . . . -108.01 169.92 8.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.067 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 71' ' ' VAL . . . . . 0.43 HG21 HG21 ' E' ' 131' ' ' ILE . 0.5 OUTLIER -130.34 150.95 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.681 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 72' ' ' ALA . . . . . 0.701 ' HB1' ' HA ' ' E' ' 116' ' ' ALA . . . -135.59 100.13 4.4 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.528 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 73' ' ' PHE . . . . . 0.437 ' HB2' HD22 ' E' ' 111' ' ' LEU . 0.2 OUTLIER -77.39 133.94 38.56 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.594 0.235 . . . . 0.0 111.136 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 74' ' ' LEU . . . . . 0.731 HD11 ' HG2' ' E' ' 155' ' ' LYS . 0.0 OUTLIER -124.17 115.06 20.49 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.971 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.35 -173.22 26.48 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.79 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -112.66 149.03 33.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.624 0.25 . . . . 0.0 110.715 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 77' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' E' ' 85' ' ' VAL . . . -98.95 133.8 42.71 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.852 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 78' ' ' ILE . . . . . 0.778 ' HB ' ' HA ' ' E' ' 87' ' ' ALA . 16.1 tt -72.95 -37.98 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.19 167.6 12.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.907 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.09 -53.86 15.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.4 28.67 6.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.597 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 82' ' ' HIS . . . . . 0.825 ' HB3' ' HB ' ' E' ' 85' ' ' VAL . 10.2 m170 -111.36 -45.57 3.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 0.0 110.446 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.4 -86.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.567 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 84' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' E' ' 82' ' ' HIS . 0.0 OUTLIER -42.17 -42.4 2.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.402 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.825 ' HB ' ' HB3' ' E' ' 82' ' ' HIS . 21.3 t -61.25 126.57 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.151 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 86' ' ' LEU . . . . . 1.029 HD22 ' HB1' ' E' ' 150' ' ' ALA . 0.2 OUTLIER -81.23 164.4 22.31 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 87' ' ' ALA . . . . . 0.778 ' HA ' ' HB ' ' E' ' 78' ' ' ILE . . . -104.77 -177.51 3.39 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.688 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.03 -174.56 5.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.974 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.59 -170.73 3.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.401 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 27.5 p -74.67 7.73 2.85 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.96 0.41 . . . . 0.0 111.464 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 91' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' E' ' 95' ' ' SER . 0.8 OUTLIER -96.93 80.42 2.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.86 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.87 -41.17 87.7 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.849 0.356 . . . . 0.0 111.623 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.7 25.94 9.17 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.664 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.8 -22.63 0.33 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.889 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 95' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' E' ' 91' ' ' SER . 1.0 OUTLIER -107.71 175.2 5.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.928 0.394 . . . . 0.0 110.597 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.37 177.08 3.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 97' ' ' THR . . . . . 0.496 ' O ' HG12 ' E' ' 99' ' ' VAL . 0.2 OUTLIER -138.56 167.87 21.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.305 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 98' ' ' ASN . . . . . 0.57 ' HA ' ' HB ' ' E' ' 140' ' ' THR . 32.4 m-80 44.15 51.68 7.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.526 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 99' ' ' VAL . . . . . 0.496 HG12 ' O ' ' E' ' 97' ' ' THR . 6.0 p -169.36 124.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.753 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.53 -164.65 11.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.594 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.9 91.07 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 122.997 0.519 . . . . 0.0 111.735 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 102' ' ' GLN . . . . . 0.708 ' HA ' ' HA ' ' E' ' 85' ' ' VAL . 0.4 OUTLIER -71.38 116.65 11.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.901 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 103' ' ' ILE . . . . . 0.666 HD12 HD11 ' E' ' 113' ' ' LEU . 6.5 mt -89.66 120.59 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.511 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 104' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 1.0 OUTLIER -95.85 152.32 18.6 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.738 0.304 . . . . 0.0 111.105 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.08 160.07 14.61 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.553 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 106' ' ' ARG . . . . . 0.535 ' CZ ' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -68.81 -13.7 62.56 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.83 0.348 . . . . 0.0 111.064 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 44.8 p -74.4 -18.95 60.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.097 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.0 -40.12 2.23 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.639 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.36 164.63 13.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.774 0.321 . . . . 0.0 111.116 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 110' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -77.38 139.66 39.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.128 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.556 HD21 ' HB ' ' E' ' 117' ' ' THR . 5.9 tt -84.16 128.58 34.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.449 0.642 . . . . 0.0 110.477 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 112' ' ' THR . . . . . 0.406 ' O ' HD23 ' E' ' 111' ' ' LEU . 1.4 m -68.13 132.38 47.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.081 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 113' ' ' LEU . . . . . 0.666 HD11 HD12 ' E' ' 103' ' ' ILE . 4.7 mp -88.12 99.79 12.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.723 0.297 . . . . 0.0 110.699 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.09 -32.4 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.528 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 115' ' ' GLY . . . . . 0.497 ' CA ' HD23 ' E' ' 74' ' ' LEU . . . 146.42 -81.24 0.21 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.645 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 116' ' ' ALA . . . . . 0.701 ' HA ' ' HB1' ' E' ' 72' ' ' ALA . . . -97.24 64.03 1.88 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.038 0.447 . . . . 0.0 111.678 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 117' ' ' THR . . . . . 0.556 ' HB ' HD21 ' E' ' 111' ' ' LEU . 2.8 m -94.37 72.48 3.83 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.165 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.84 119.09 11.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.783 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.92 -49.03 0.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.83 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 3.0 m -88.55 84.73 6.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.573 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 121' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' E' ' 70' ' ' ALA . 3.5 mt-10 -110.26 86.95 2.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.263 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.06 159.32 17.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.801 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 2.5 t -67.04 138.38 57.14 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.734 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 124' ' ' LEU . . . . . 0.863 HD12 ' HB2' ' E' ' 69' ' ' ALA . 0.4 OUTLIER -86.53 159.54 19.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.636 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.66 176.22 10.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.595 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 126' ' ' ASN . . . . . 0.512 ' OD1' ' HA ' ' E' ' 62' ' ' ASP . 0.9 OUTLIER -85.89 161.47 19.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.703 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.51 -121.01 5.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.718 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 128' ' ' THR . . . . . 0.584 HG21 ' HE2' ' B' ' 155' ' ' LYS . 72.4 m -119.47 140.33 50.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.75 0.309 . . . . 0.0 110.788 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 129' ' ' ASN . . . . . 0.462 ' O ' HD12 ' E' ' 58' ' ' LEU . 5.1 t-20 -133.77 154.62 50.85 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.112 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 130' ' ' THR . . . . . 0.675 HG22 ' HA ' ' E' ' 57' ' ' GLN . 28.0 p -133.41 154.24 50.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.188 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 131' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' E' ' 55' ' ' ASN . 1.0 OUTLIER -110.88 116.79 51.49 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 132' ' ' PRO . . . . . 0.606 ' HB3' ' HA ' ' B' ' 76' ' ' THR . 7.6 Cg_endo -81.15 129.38 6.8 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.663 1.576 . . . . 0.0 112.667 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 133' ' ' PHE . . . . . 0.461 ' HB3' ' CE1' ' E' ' 54' ' ' PHE . 0.1 OUTLIER -140.81 146.89 38.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.796 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 134' ' ' GLN . . . . . 0.544 ' HB3' ' HB1' ' E' ' 51' ' ' ALA . 19.3 mm-40 -116.49 158.33 23.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.033 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 135' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' E' ' 103' ' ' ILE . . . -159.47 105.48 1.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.898 0.38 . . . . 0.0 111.589 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.67 172.53 6.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.457 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.18 147.77 24.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.051 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.65 159.0 36.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.994 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 139' ' ' ALA . . . . . 0.701 ' HB2' ' CB ' ' E' ' 42' ' ' LEU . . . -116.31 141.27 48.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.897 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 140' ' ' THR . . . . . 0.57 ' HB ' ' HA ' ' E' ' 98' ' ' ASN . 0.2 OUTLIER -107.81 27.22 9.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.499 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 141' ' ' GLY . . . . . 0.59 ' HA2' ' N ' ' E' ' 45' ' ' GLU . . . 97.5 83.57 1.7 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.031 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 142' ' ' ALA . . . . . 0.727 ' HA ' ' HA ' ' E' ' 43' ' ' ALA . . . 57.98 93.41 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.67 0.235 . . . . 0.0 110.765 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 143' ' ' ALA . . . . . 0.531 ' HA ' ' HB2' ' E' ' 98' ' ' ASN . . . -79.94 165.51 22.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.733 0.301 . . . . 0.0 111.453 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 144' ' ' THR . . . . . . . . . . . . . 29.6 p -108.49 168.86 7.22 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.202 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.59 133.54 6.16 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.572 2.181 . . . . 0.0 111.981 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 146' ' ' GLY . . . . . 0.626 ' HA2' HG12 ' C' ' 5' ' ' VAL . . . 169.55 -119.23 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.475 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.8 121.7 13.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.904 0.383 . . . . 0.0 111.382 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.34 85.68 3.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.541 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -104.58 131.25 52.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.58 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 150' ' ' ALA . . . . . 1.029 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -136.1 148.51 48.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.94 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.18 120.23 20.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.213 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.69 139.99 24.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.171 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 153' ' ' THR . . . . . 0.612 HG22 ' HA ' ' D' ' 9' ' ' THR . 71.0 p -105.21 171.17 7.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 154' ' ' PHE . . . . . 0.51 ' HZ ' HG21 ' E' ' 56' ' ' ILE . 13.6 p90 -138.18 147.39 43.78 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 110.143 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 155' ' ' LYS . . . . . 0.731 ' HG2' HD11 ' E' ' 74' ' ' LEU . 13.7 mmtt -100.92 171.94 7.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.919 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 156' ' ' VAL . . . . . 0.646 HG23 HG23 ' D' ' 5' ' ' VAL . 0.4 OUTLIER -135.44 111.37 12.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.754 0.311 . . . . 0.0 111.789 -179.133 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 157' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' D' ' 3' ' ' THR . 1.8 tt0 -108.97 141.28 41.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.312 0.577 . . . . 0.0 110.438 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 158' ' ' TYR . . . . . 0.487 ' CZ ' ' HB ' ' E' ' 156' ' ' VAL . 23.0 m-85 -135.36 105.52 6.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.613 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 159' ' ' GLN . . . . . 0.68 ' HA ' ' H ' ' D' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.903 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.57 88.66 0.05 OUTLIER 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.095 0.247 . . . . 0.0 110.995 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.11 110.45 22.4 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.397 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.49 136.11 38.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.534 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.99 -175.31 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.601 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.57 130.1 38.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.665 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.8 -59.26 0.91 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.794 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.4 166.22 28.06 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.899 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 26.9 m -94.44 121.15 35.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 111.196 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.68 115.66 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.229 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -99.55 137.5 37.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.361 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -127.62 97.8 4.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.748 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.26 175.74 6.58 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.458 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.04 149.48 5.78 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.897 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.32 108.6 13.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 110.407 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 23.4 t -86.61 129.15 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.183 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 17' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' F' ' 22' ' ' ALA . 18.7 m -127.39 163.54 30.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.06 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -85.93 61.37 6.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.041 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 19' ' ' ALA . . . . . 0.486 ' HB3' HG21 ' F' ' 65' ' ' VAL . . . 44.99 52.6 8.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 20' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' F' ' 61' ' ' CYS . . . -127.3 -54.42 1.36 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.44 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 21' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.1 OUTLIER 177.68 111.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.962 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 22' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' F' ' 17' ' ' VAL . . . -105.69 126.09 51.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.053 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.83 145.68 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.968 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 24' ' ' ASP . . . . . 0.623 ' O ' HG23 ' F' ' 28' ' ' VAL . 4.0 m-20 -74.86 147.24 41.27 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.66 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.77 -43.61 18.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.32 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.92 -20.01 60.25 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.896 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 45.6 t -79.6 -26.08 41.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 28' ' ' VAL . . . . . 0.623 HG23 ' O ' ' F' ' 24' ' ' ASP . 57.4 t -49.16 -48.52 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.279 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.84 93.04 5.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.965 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.54 116.42 28.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.035 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.62 115.63 27.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.155 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' E' ' 12' ' ' PHE . 1.7 t -117.21 101.1 11.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.133 0.492 . . . . 0.0 110.426 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.6 126.91 52.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.671 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 34' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' C' ' 92' ' ' ALA . 0.3 OUTLIER -68.15 -55.65 11.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.659 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.97 -111.67 3.93 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.555 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 36' ' ' GLN . . . . . 0.547 ' HG3' ' HA ' ' E' ' 24' ' ' ASP . 0.0 OUTLIER -77.0 115.28 16.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.52 0.2 . . . . 0.0 110.928 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' E' ' 16' ' ' VAL . 67.6 t -131.03 105.87 11.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.779 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.68 154.12 17.46 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.762 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 39' ' ' THR . . . . . 0.66 ' HA ' HD12 ' F' ' 42' ' ' LEU . 8.0 p -78.8 -19.81 51.25 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.724 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.42 -19.54 65.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.085 0.469 . . . . 0.0 110.913 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 96.6 p -92.08 -21.23 20.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.182 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 42' ' ' LEU . . . . . 0.702 ' CB ' ' HB2' ' F' ' 139' ' ' ALA . 0.2 OUTLIER -139.0 62.28 1.54 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.686 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 43' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' F' ' 142' ' ' ALA . . . -101.15 9.21 42.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.321 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.25 136.0 24.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.36 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 45' ' ' GLU . . . . . 0.586 ' N ' ' HA2' ' F' ' 141' ' ' GLY . 16.5 tt0 -58.6 121.36 10.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.942 0.401 . . . . 0.0 111.109 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.32 -25.4 8.23 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.139 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.86 137.25 58.22 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.909 0.385 . . . . 0.0 112.018 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.85 157.98 44.56 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.945 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.92 -166.16 1.09 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.642 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 50' ' ' SER . . . . . 0.613 ' HB2' ' HA ' ' C' ' 92' ' ' ALA . 48.9 m -65.2 156.15 32.73 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.818 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 51' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' F' ' 134' ' ' GLN . . . -90.47 126.73 36.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.32 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 52' ' ' VAL . . . . . 0.909 HG13 ' HA ' ' C' ' 90' ' ' SER . 63.1 t -75.66 118.55 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.981 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.78 135.68 13.8 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.687 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 54' ' ' PHE . . . . . 0.536 ' H ' HG21 ' C' ' 76' ' ' THR . 46.3 p90 -170.76 142.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.83 0.348 . . . . 0.0 110.948 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 55' ' ' ASN . . . . . 0.676 ' HA ' ' O ' ' F' ' 131' ' ' ILE . 11.5 p30 -126.59 163.95 22.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 56' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' F' ' 130' ' ' THR . 20.8 mm -105.16 119.91 54.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.516 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 57' ' ' GLN . . . . . 0.711 ' HA ' HG22 ' F' ' 130' ' ' THR . 0.0 OUTLIER -82.09 115.69 21.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.736 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 58' ' ' LEU . . . . . 0.645 HD11 HG13 ' F' ' 131' ' ' ILE . 0.0 OUTLIER -128.25 107.45 9.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.261 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.38 177.0 8.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.902 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 63.06 66.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.782 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 61' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 3.3 m -109.68 154.42 22.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.729 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 62' ' ' ASP . . . . . 0.531 ' HA ' ' OD1' ' F' ' 126' ' ' ASN . 0.5 OUTLIER -154.66 138.33 16.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.234 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 63' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' F' ' 66' ' ' ALA . 0.2 OUTLIER -97.57 -11.85 23.2 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.13 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.21 -48.78 40.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.095 0.474 . . . . 0.0 111.764 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 65' ' ' VAL . . . . . 0.486 HG21 ' HB3' ' F' ' 19' ' ' ALA . 10.6 t -69.02 -48.66 68.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.729 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 66' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' F' ' 159' ' ' GLN . . . -137.97 153.4 49.45 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.64 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.25 18.59 4.45 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.907 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 68' ' ' LYS . . . . . 0.612 ' HB3' ' HB3' ' F' ' 159' ' ' GLN . 10.6 tppt? -142.87 149.89 39.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.444 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 69' ' ' ALA . . . . . 0.865 ' HB2' HD12 ' F' ' 124' ' ' LEU . . . -150.01 110.71 4.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.714 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 70' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' F' ' 121' ' ' GLU . . . -108.05 169.95 8.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.034 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 71' ' ' VAL . . . . . 0.433 HG21 HG21 ' F' ' 131' ' ' ILE . 0.5 OUTLIER -130.37 150.95 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.647 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 72' ' ' ALA . . . . . 0.68 ' HB1' ' HA ' ' F' ' 116' ' ' ALA . . . -135.57 100.11 4.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.558 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 73' ' ' PHE . . . . . 0.438 ' HB2' HD22 ' F' ' 111' ' ' LEU . 0.2 OUTLIER -77.46 133.94 38.49 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.552 0.215 . . . . 0.0 111.154 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 74' ' ' LEU . . . . . 0.743 HD11 ' HG2' ' F' ' 155' ' ' LYS . 0.0 OUTLIER -124.16 115.11 20.58 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.975 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.34 -173.22 26.47 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.77 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 7.1 m -112.68 149.04 33.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.647 0.261 . . . . 0.0 110.726 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 77' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' F' ' 85' ' ' VAL . . . -98.91 133.72 42.79 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.002 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 78' ' ' ILE . . . . . 0.761 ' HB ' ' HA ' ' F' ' 87' ' ' ALA . 16.1 tt -72.89 -37.99 55.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.907 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.17 167.62 12.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.832 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.2 -53.86 15.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.027 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.34 28.73 6.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.6 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 82' ' ' HIS . . . . . 0.824 ' HB3' ' HB ' ' F' ' 85' ' ' VAL . 10.2 m170 -111.35 -45.62 3.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 0.0 110.434 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.43 -86.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.577 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 84' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' F' ' 82' ' ' HIS . 0.0 OUTLIER -42.19 -42.4 3.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.343 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 85' ' ' VAL . . . . . 0.824 ' HB ' ' HB3' ' F' ' 82' ' ' HIS . 21.3 t -61.35 126.54 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.165 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 86' ' ' LEU . . . . . 1.031 HD22 ' HB1' ' F' ' 150' ' ' ALA . 0.2 OUTLIER -81.19 164.41 22.34 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.247 179.493 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 87' ' ' ALA . . . . . 0.761 ' HA ' ' HB ' ' F' ' 78' ' ' ILE . . . -104.83 -177.58 3.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.903 0.383 . . . . 0.0 111.644 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -174.53 5.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.68 -170.69 3.23 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.356 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 27.9 p -74.74 7.76 2.86 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 111.42 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 91' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' F' ' 95' ' ' SER . 0.8 OUTLIER -96.91 80.37 3.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.86 -41.16 87.8 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.858 0.361 . . . . 0.0 111.606 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.74 26.0 9.12 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.687 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.78 -22.78 0.33 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.902 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 95' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' F' ' 91' ' ' SER . 1.0 OUTLIER -107.65 175.24 5.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.929 0.395 . . . . 0.0 110.646 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.51 177.11 3.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.849 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 97' ' ' THR . . . . . 0.506 ' O ' HG12 ' F' ' 99' ' ' VAL . 0.2 OUTLIER -138.53 167.78 21.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.277 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 98' ' ' ASN . . . . . 0.581 ' HA ' ' HB ' ' F' ' 140' ' ' THR . 32.5 m-80 44.15 51.69 7.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.515 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 99' ' ' VAL . . . . . 0.506 HG12 ' O ' ' F' ' 97' ' ' THR . 6.0 p -169.37 124.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.787 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.55 -164.72 11.5 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.616 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.85 91.12 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.192 0.52 . . . . 0.0 111.758 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 102' ' ' GLN . . . . . 0.704 ' HA ' ' HA ' ' F' ' 85' ' ' VAL . 0.4 OUTLIER -71.37 116.61 11.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.836 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 103' ' ' ILE . . . . . 0.654 HD12 HD11 ' F' ' 113' ' ' LEU . 6.6 mt -89.59 120.62 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.5 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 104' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 1.0 OUTLIER -95.81 152.3 18.61 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.679 0.276 . . . . 0.0 111.083 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.11 160.07 14.61 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.645 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 106' ' ' ARG . . . . . 0.533 ' CZ ' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -68.79 -13.71 62.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.873 0.368 . . . . 0.0 111.082 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 44.9 p -74.37 -18.96 60.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.075 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.0 -40.08 2.23 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.682 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.32 164.68 13.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 0.0 111.107 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 110' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -77.36 139.63 39.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.1 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 111' ' ' LEU . . . . . 0.556 HD21 ' HB ' ' F' ' 117' ' ' THR . 5.9 tt -84.13 128.55 34.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.469 0.652 . . . . 0.0 110.477 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 112' ' ' THR . . . . . 0.4 ' O ' HD23 ' F' ' 111' ' ' LEU . 1.4 m -68.14 132.41 47.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.133 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 113' ' ' LEU . . . . . 0.654 HD11 HD12 ' F' ' 103' ' ' ILE . 4.8 mp -88.06 99.69 12.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.684 0.278 . . . . 0.0 110.778 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.04 -32.48 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.628 0.252 . . . . 0.0 111.541 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 115' ' ' GLY . . . . . 0.491 ' CA ' HD23 ' F' ' 74' ' ' LEU . . . 146.53 -81.37 0.21 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.575 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 116' ' ' ALA . . . . . 0.68 ' HA ' ' HB1' ' F' ' 72' ' ' ALA . . . -97.1 63.99 1.92 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.986 0.422 . . . . 0.0 111.649 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 117' ' ' THR . . . . . 0.556 ' HB ' HD21 ' F' ' 111' ' ' LEU . 2.8 m -94.29 72.35 3.87 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.169 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.79 119.12 11.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.821 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.95 -49.05 0.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.778 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.55 84.69 6.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.606 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 121' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' F' ' 70' ' ' ALA . 3.6 mt-10 -110.23 87.06 2.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.236 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.04 159.27 17.66 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.802 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -67.01 138.34 57.15 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.654 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 124' ' ' LEU . . . . . 0.865 HD12 ' HB2' ' F' ' 69' ' ' ALA . 0.4 OUTLIER -86.47 159.44 19.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.692 179.389 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.53 176.28 10.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.64 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 126' ' ' ASN . . . . . 0.531 ' OD1' ' HA ' ' F' ' 62' ' ' ASP . 0.9 OUTLIER -85.91 161.5 19.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.667 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.46 -121.07 5.72 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.718 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 128' ' ' THR . . . . . 0.573 HG21 ' HE2' ' C' ' 155' ' ' LYS . 72.0 m -119.42 140.28 50.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.714 0.292 . . . . 0.0 110.821 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 129' ' ' ASN . . . . . 0.462 ' O ' HD12 ' F' ' 58' ' ' LEU . 5.1 t-20 -133.68 154.66 50.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.883 0.373 . . . . 0.0 111.122 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 130' ' ' THR . . . . . 0.711 HG22 ' HA ' ' F' ' 57' ' ' GLN . 28.0 p -133.4 154.3 50.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.091 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 131' ' ' ILE . . . . . 0.676 ' O ' ' HA ' ' F' ' 55' ' ' ASN . 1.0 OUTLIER -111.02 116.8 51.2 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 132' ' ' PRO . . . . . 0.609 ' HB3' ' HA ' ' C' ' 76' ' ' THR . 7.6 Cg_endo -81.14 129.43 6.83 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.665 1.576 . . . . 0.0 112.641 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 133' ' ' PHE . . . . . 0.463 ' HB3' ' CE1' ' F' ' 54' ' ' PHE . 0.1 OUTLIER -140.86 146.86 38.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.807 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 134' ' ' GLN . . . . . 0.533 ' HB3' ' HB1' ' F' ' 51' ' ' ALA . 19.2 mm-40 -116.52 158.34 23.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.008 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 135' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' F' ' 103' ' ' ILE . . . -159.37 105.45 1.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.847 0.356 . . . . 0.0 111.533 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.66 172.54 6.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.439 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.18 147.82 24.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.066 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.68 159.02 36.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.949 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 139' ' ' ALA . . . . . 0.702 ' HB2' ' CB ' ' F' ' 42' ' ' LEU . . . -116.3 141.21 48.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.9 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 140' ' ' THR . . . . . 0.581 ' HB ' ' HA ' ' F' ' 98' ' ' ASN . 0.2 OUTLIER -107.79 27.22 9.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.462 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 141' ' ' GLY . . . . . 0.586 ' HA2' ' N ' ' F' ' 45' ' ' GLU . . . 97.56 83.56 1.7 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.846 -0.693 . . . . 0.0 113.025 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 142' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' F' ' 43' ' ' ALA . . . 57.9 93.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.531 0.205 . . . . 0.0 110.813 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 143' ' ' ALA . . . . . 0.535 ' HA ' ' HB2' ' F' ' 98' ' ' ASN . . . -80.01 165.42 22.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.772 0.32 . . . . 0.0 111.37 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 144' ' ' THR . . . . . . . . . . . . . 29.8 p -108.42 168.86 7.23 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.196 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.58 133.56 6.18 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.56 2.174 . . . . 0.0 112.007 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 146' ' ' GLY . . . . . 0.616 ' HA2' HG12 ' D' ' 5' ' ' VAL . . . 169.53 -119.22 0.81 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.456 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.85 121.7 13.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.866 0.365 . . . . 0.0 111.27 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.35 85.65 3.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.485 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -104.5 131.29 52.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.581 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 150' ' ' ALA . . . . . 1.031 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -136.14 148.49 48.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.958 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.18 120.21 20.89 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.226 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.65 140.02 24.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.188 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 153' ' ' THR . . . . . 0.609 HG22 ' HA ' ' E' ' 9' ' ' THR . 70.5 p -105.24 171.13 7.48 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 154' ' ' PHE . . . . . 0.507 ' HZ ' HG21 ' F' ' 56' ' ' ILE . 13.7 p90 -138.13 147.42 43.92 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.152 0.501 . . . . 0.0 110.054 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 155' ' ' LYS . . . . . 0.743 ' HG2' HD11 ' F' ' 74' ' ' LEU . 13.6 mmtt -100.91 171.93 7.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.928 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 156' ' ' VAL . . . . . 0.66 HG23 HG23 ' E' ' 5' ' ' VAL . 0.4 OUTLIER -135.48 111.44 12.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.813 0.34 . . . . 0.0 111.717 -179.136 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 157' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' E' ' 3' ' ' THR . 1.8 tt0 -109.01 141.24 41.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.318 0.58 . . . . 0.0 110.431 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 158' ' ' TYR . . . . . 0.482 ' CZ ' ' HB ' ' F' ' 156' ' ' VAL . 23.0 m-85 -135.38 105.44 6.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.613 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 159' ' ' GLN . . . . . 0.686 ' HA ' ' H ' ' E' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.58 100.21 0.04 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.02 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' B' ' 158' ' ' TYR . 7.3 m -104.81 78.63 1.45 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.493 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.34 122.36 29.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.543 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.646 HG23 HG23 ' B' ' 156' ' ' VAL . 5.0 m -137.91 162.94 30.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.564 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.425 ' HB3' ' OE2' ' B' ' 15' ' ' GLU . 44.1 t-20 -84.29 114.57 21.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.626 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.481 ' HA3' ' CZ ' ' B' ' 154' ' ' PHE . . . -83.43 -41.48 8.39 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.719 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.446 ' N ' ' CE1' ' B' ' 154' ' ' PHE . . . -175.59 162.29 31.55 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.863 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' B' ' 153' ' ' THR . 99.0 m -90.75 137.84 32.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.929 0.395 . . . . 0.0 111.282 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.46 114.34 46.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.163 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -99.37 148.58 24.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.33 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.818 ' HB3' HD21 ' B' ' 34' ' ' LEU . 60.8 m-85 -133.8 113.09 11.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.76 ' HG2' ' HA ' ' B' ' 33' ' ' GLN . 0.0 OUTLIER -107.19 105.94 16.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.332 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.25 169.46 28.91 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.999 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.552 ' HB2' ' HG3' ' B' ' 36' ' ' GLN . 33.6 mt-10 -140.73 -171.02 3.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.839 0.352 . . . . 0.0 110.4 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.577 HG13 HG23 ' B' ' 37' ' ' VAL . 0.5 OUTLIER -139.24 152.86 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.209 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.735 ' O ' HG23 ' B' ' 39' ' ' THR . 0.0 OUTLIER -137.51 155.37 31.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.87 0.367 . . . . 0.0 111.061 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -85.23 53.1 2.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.041 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.679 ' HA ' ' HG2' ' B' ' 38' ' ' ARG . . . 61.46 92.67 0.05 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.066 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.575 ' H ' ' HG2' ' B' ' 38' ' ' ARG . . . -164.77 -47.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.476 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.654 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 1.6 m -159.8 176.83 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.009 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.611 ' HB2' ' HE ' ' B' ' 38' ' ' ARG . . . -147.27 111.93 5.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.137 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.618 HG13 ' HB3' ' A' ' 27' ' ' SER . 43.0 t -67.37 143.19 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.989 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.548 ' O ' HG23 ' A' ' 28' ' ' VAL . 17.0 m-20 -91.18 168.05 11.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.63 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.31 -50.0 74.31 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.468 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.42 -16.62 73.76 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.923 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.618 ' HB3' HG13 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -84.32 -24.36 29.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.907 0.384 . . . . 0.0 110.77 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.553 HG11 ' HG3' ' A' ' 13' ' ' LYS . 85.6 t -58.09 -37.24 60.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.33 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -140.38 106.02 5.12 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.03 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -109.07 106.97 17.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.125 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.8 95.63 9.03 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.019 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 52' ' ' VAL . 51.6 t -85.84 138.25 19.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.055 0.455 . . . . 0.0 110.358 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -113.15 132.6 55.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.701 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.545 ' N ' HD22 ' A' ' 34' ' ' LEU . 1.9 mm? -94.54 -71.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.594 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.87 -111.32 0.72 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.518 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -160.96 105.77 1.37 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.61 0.243 . . . . 0.0 110.879 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 m -91.1 142.35 13.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.978 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 38' ' ' ARG . 0.7 OUTLIER -81.05 162.53 23.73 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.771 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.442 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 82.5 p -80.35 -16.92 53.43 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.761 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.73 -31.26 63.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.073 0.463 . . . . 0.0 110.828 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.01 -28.48 39.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.145 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 1.7 mp -133.14 70.05 1.47 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.67 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . -103.67 11.21 36.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.448 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.04 146.83 27.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.341 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.48 121.25 13.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.369 . . . . 0.0 111.091 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.52 -10.39 12.77 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.179 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 138' ' ' PHE . . . -68.83 142.22 54.92 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.44 HG21 ' NH2' ' A' ' 136' ' ' ARG . 6.9 t -134.69 140.86 46.31 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.904 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.0 m -106.04 -152.77 0.48 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.569 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.9 178.57 1.05 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.908 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.05 168.9 15.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.733 0.301 . . . . 0.0 111.308 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.71 HG22 ' HB3' ' A' ' 135' ' ' ALA . 14.9 m -118.1 132.22 68.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.21 107.67 3.57 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.633 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.604 ' HD1' HG23 ' A' ' 52' ' ' VAL . 55.5 p90 -140.34 132.03 27.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.764 0.316 . . . . 0.0 110.914 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.522 ' HB2' HG22 ' A' ' 130' ' ' THR . 12.4 p30 -117.8 176.89 4.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.628 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.768 ' HB ' HD12 ' A' ' 131' ' ' ILE . 51.7 mm -119.05 121.74 67.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.478 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.37 122.59 30.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.829 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.584 ' HB2' ' HB3' ' A' ' 129' ' ' ASN . 0.9 OUTLIER -131.08 93.72 3.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.228 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.549 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.4 OUTLIER -77.1 160.85 28.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.899 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.2 87.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.756 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.654 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 69.8 m -120.52 131.87 54.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.75 97.87 9.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.255 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 1.5 m -77.41 -20.0 55.26 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.04 -27.53 68.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.023 0.439 . . . . 0.0 111.719 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.42 -35.71 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.626 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 63' ' ' THR . . . -131.03 131.29 44.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.642 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.45 -37.32 7.65 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.909 0.385 . . . . 0.0 110.932 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -121.72 171.37 8.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.553 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.55 136.15 15.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.587 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.706 ' HB3' ' HB3' ' A' ' 157' ' ' GLN . . . -94.57 157.97 15.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.028 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.38 106.24 20.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.713 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.83 ' HB3' ' HB3' ' A' ' 155' ' ' LYS . . . -109.58 164.26 12.69 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.619 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.661 ' HB2' HD11 ' A' ' 111' ' ' LEU . 6.6 t80 -142.2 141.1 32.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.497 0.189 . . . . 0.0 111.129 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.737 HD11 ' HG2' ' D' ' 57' ' ' GLN . 0.1 OUTLIER -122.7 103.35 8.61 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.008 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.503 ' HA3' HD23 ' A' ' 113' ' ' LEU . . . -153.44 -166.37 14.55 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.895 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.48 136.26 46.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.535 0.207 . . . . 0.0 110.726 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.677 ' H ' ' HB3' ' D' ' 132' ' ' PRO . . . -81.4 156.08 25.6 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.845 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.469 HG12 ' OG1' ' A' ' 140' ' ' THR . 3.1 tt -92.51 -20.69 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.773 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.557 ' HB2' HG21 ' A' ' 140' ' ' THR . 0.4 OUTLIER 176.15 179.76 0.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.829 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' D' ' 107' ' ' THR . . . -79.0 -33.81 44.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.974 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.42 -43.91 95.55 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.618 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.463 ' NE2' ' O ' ' A' ' 139' ' ' ALA . 43.7 m-70 -97.8 -64.41 1.04 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.827 0.346 . . . . 0.0 110.47 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.432 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.2 m 62.36 7.83 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.623 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.427 ' O ' HD12 ' A' ' 103' ' ' ILE . 86.9 m-20 -115.11 -25.47 8.09 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.238 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . 0.5 OUTLIER -79.56 143.74 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.189 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.631 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -76.68 148.6 36.73 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.251 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.9 178.22 4.4 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.85 0.357 . . . . 0.0 111.651 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -84.66 176.23 8.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.116 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 149' ' ' ASN . 22.8 pt20 -75.33 178.72 5.64 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.32 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.527 ' O ' HG12 ' D' ' 52' ' ' VAL . 1.0 OUTLIER -73.36 -11.46 60.49 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.989 0.423 . . . . 0.0 111.411 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 0.3 OUTLIER -64.68 87.26 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.931 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.89 -7.14 53.83 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.879 0.371 . . . . 0.0 111.667 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.477 ' HB1' ' HB1' ' C' ' 22' ' ' ALA . . . -133.11 19.91 4.07 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.644 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.62 -15.6 0.16 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.897 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 1.0 OUTLIER -97.35 174.98 6.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.906 0.384 . . . . 0.0 110.619 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.644 ' O ' HD22 ' A' ' 88' ' ' LEU . . . -114.12 157.87 22.03 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.823 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.53 HG23 HD11 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -112.96 162.73 15.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.319 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 69.26 41.66 1.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.415 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.3 p -177.67 130.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.827 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.06 179.45 28.6 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.623 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.497 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 1.6 t -98.98 95.34 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.026 0.531 . . . . 0.0 111.71 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 13.7 tt0 -69.87 159.83 32.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.881 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.433 HG12 ' CE2' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -121.72 98.38 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.513 179.441 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.679 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 1.1 tp -84.65 119.36 25.15 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.716 0.293 . . . . 0.0 111.122 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.24 158.12 31.92 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.642 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.553 ' HB2' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -61.2 -33.93 74.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.87 0.366 . . . . 0.0 111.043 179.549 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.554 HG23 ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -48.75 -38.17 20.96 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.013 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.69 -88.87 0.11 Allowed Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.591 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.19 -176.33 5.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.868 0.366 . . . . 0.0 111.104 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.679 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -79.9 143.93 33.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.126 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.661 HD11 ' HB2' ' A' ' 73' ' ' PHE . 0.6 OUTLIER -90.14 157.54 17.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.387 0.613 . . . . 0.0 110.522 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.448 ' HB ' HG21 ' A' ' 117' ' ' THR . 29.4 m -81.04 150.46 28.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.201 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 113' ' ' LEU . 3.0 mp -102.75 57.7 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.757 0.313 . . . . 0.0 110.72 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.43 19.65 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.532 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.26 -93.1 0.88 Allowed Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.631 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' D' ' 125' ' ' ASN . . . -102.71 69.67 1.08 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.028 0.442 . . . . 0.0 111.596 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 5.8 p -89.69 97.3 11.11 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.19 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.15 102.81 5.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.752 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.4 -82.69 0.65 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.554 ' HA ' HG23 ' A' ' 107' ' ' THR . 0.1 OUTLIER -63.26 100.87 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.611 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.9 79.11 7.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.228 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.428 HG21 ' CD ' ' A' ' 132' ' ' PRO . 4.7 p -82.55 159.18 22.85 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.769 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.2 m -85.28 139.74 31.38 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.764 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.46 136.18 33.43 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.69 0.281 . . . . 0.0 110.591 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -120.86 143.57 48.83 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.604 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.13 148.93 34.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.688 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.66 -106.17 2.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.704 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -85.15 153.24 22.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.731 0.3 . . . . 0.0 110.804 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.584 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 23.2 t-20 -148.45 120.7 8.37 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.942 0.401 . . . . 0.0 111.109 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -104.21 147.26 27.67 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.139 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.768 HD12 ' HB ' ' A' ' 56' ' ' ILE . 89.8 mt -116.61 119.25 36.08 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 106' ' ' ARG . 7.7 Cg_endo -80.83 119.06 3.54 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 121.704 1.602 . . . . 0.0 112.574 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.04 147.35 29.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.783 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.15 155.94 47.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.043 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.71 ' HB3' HG22 ' A' ' 52' ' ' VAL . . . -140.07 115.66 10.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.882 0.372 . . . . 0.0 111.639 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.44 ' NH2' HG21 ' A' ' 48' ' ' THR . 0.5 OUTLIER -111.27 148.98 31.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.477 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.6 151.29 45.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.158 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -144.52 164.56 30.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.002 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.635 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -124.43 145.76 49.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.783 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.557 HG21 ' HB2' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -117.84 13.0 14.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.48 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.79 79.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.919 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.64 92.15 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.598 0.199 . . . . 0.0 110.788 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.08 154.78 33.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.704 0.288 . . . . 0.0 111.38 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.9 p -116.68 166.17 13.42 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.29 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.27 151.49 12.16 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.474 2.116 . . . . 0.0 112.018 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.6 -106.33 0.46 Allowed Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.417 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -139.06 163.26 32.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.834 0.349 . . . . 0.0 111.411 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.98 79.93 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.504 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 89' ' ' GLN . 87.1 m-20 -99.98 142.51 31.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.51 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.521 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -127.81 168.98 14.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.073 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.53 110.04 0.86 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.2 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.631 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -146.99 145.4 29.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.118 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.67 164.17 13.26 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.627 ' CZ ' HG21 ' A' ' 56' ' ' ILE . 15.4 p90 -110.83 151.6 27.63 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.061 0.458 . . . . 0.0 110.162 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.83 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -109.7 160.84 15.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.961 -178.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.14 112.91 3.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.756 0.312 . . . . 0.0 111.699 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.706 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -91.87 124.41 35.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.295 0.569 . . . . 0.0 110.447 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -117.13 135.48 53.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.515 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.889 179.894 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.55 100.24 0.04 OUTLIER 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.0 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.551 ' HB ' ' HB2' ' C' ' 158' ' ' TYR . 7.4 m -104.81 78.6 1.44 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.416 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.33 122.39 29.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.533 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.644 HG23 HG23 ' C' ' 156' ' ' VAL . 5.0 m -137.93 162.86 30.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.539 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.434 ' HB3' ' OE2' ' C' ' 15' ' ' GLU . 44.0 t-20 -84.28 114.48 21.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.692 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLY . . . . . 0.496 ' HA3' ' CZ ' ' C' ' 154' ' ' PHE . . . -83.3 -41.54 8.43 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.703 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.444 ' N ' ' CE1' ' C' ' 154' ' ' PHE . . . -175.56 162.32 31.61 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.824 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' C' ' 153' ' ' THR . 99.2 m -90.81 137.91 31.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.925 0.393 . . . . 0.0 111.264 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.49 114.27 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.241 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -99.31 148.54 24.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.364 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' PHE . . . . . 0.834 ' HB3' HD21 ' C' ' 34' ' ' LEU . 60.6 m-85 -133.8 113.1 11.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.714 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.757 ' HG2' ' HA ' ' C' ' 33' ' ' GLN . 0.0 OUTLIER -107.19 105.86 16.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.392 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.18 169.45 28.87 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.99 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.541 ' HB2' ' HG3' ' C' ' 36' ' ' GLN . 33.8 mt-10 -140.73 -171.08 3.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.85 0.357 . . . . 0.0 110.425 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.569 HG13 HG23 ' C' ' 37' ' ' VAL . 0.5 OUTLIER -139.21 152.81 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.222 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.729 ' O ' HG23 ' C' ' 39' ' ' THR . 0.0 OUTLIER -137.42 155.43 31.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.834 0.35 . . . . 0.0 111.031 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -85.25 53.12 2.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.956 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.663 ' HA ' ' HG2' ' C' ' 38' ' ' ARG . . . 61.37 92.7 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.111 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.577 ' H ' ' HG2' ' C' ' 38' ' ' ARG . . . -164.74 -47.65 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.447 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.588 ' O ' HG21 ' B' ' 17' ' ' VAL . 1.6 m -159.83 176.82 11.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.009 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.609 ' HB2' ' HE ' ' C' ' 38' ' ' ARG . . . -147.24 111.89 5.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.15 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.618 HG13 ' HB3' ' B' ' 27' ' ' SER . 43.1 t -67.3 143.08 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.052 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.533 ' O ' HG23 ' B' ' 28' ' ' VAL . 16.9 m-20 -91.11 168.16 11.83 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.622 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.02 74.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.39 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.4 -16.62 73.72 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.92 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.618 ' HB3' HG13 ' B' ' 23' ' ' VAL . 0.4 OUTLIER -84.35 -24.38 29.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.921 0.391 . . . . 0.0 110.782 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.539 HG11 ' HG3' ' B' ' 13' ' ' LYS . 86.1 t -58.14 -37.13 60.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.339 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -140.35 106.08 5.14 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.997 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -109.03 106.92 17.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.12 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.74 95.55 8.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.069 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.554 HG11 HG21 ' B' ' 52' ' ' VAL . 51.2 t -85.76 138.21 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 110.451 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.76 ' HA ' ' HG2' ' A' ' 13' ' ' LYS . 3.2 mt-30 -113.18 132.54 55.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.64 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.818 HD21 ' HB3' ' A' ' 12' ' ' PHE . 1.8 mm? -94.45 -71.54 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.625 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.88 -111.3 0.71 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.524 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.552 ' HG3' ' HB2' ' A' ' 15' ' ' GLU . 3.6 tt0 -161.0 105.74 1.36 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.653 0.263 . . . . 0.0 110.919 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.577 HG23 HG13 ' A' ' 16' ' ' VAL . 5.7 m -91.06 142.35 13.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.966 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.679 ' HG2' ' HA ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -81.07 162.49 23.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.707 179.248 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.735 HG23 ' O ' ' A' ' 17' ' ' VAL . 82.5 p -80.35 -16.85 53.58 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.784 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.77 -31.17 63.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.175 0.512 . . . . 0.0 110.899 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.04 -28.49 39.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.12 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.65 ' HB3' ' HB2' ' B' ' 139' ' ' ALA . 1.7 mp -133.23 70.09 1.47 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.673 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' B' ' 39' ' ' THR . . . -103.65 11.17 36.39 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.432 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.06 146.82 27.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.371 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.49 121.25 13.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 0.0 111.099 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.55 -10.4 12.72 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.15 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' B' ' 138' ' ' PHE . . . -68.85 142.27 54.87 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.851 0.357 . . . . 0.0 111.951 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.441 HG21 ' NH2' ' B' ' 136' ' ' ARG . 6.8 t -134.77 140.82 46.2 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.846 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' SER . . . . . 0.403 ' OG ' HD11 ' B' ' 42' ' ' LEU . 17.2 m -106.06 -152.77 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.52 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.86 178.54 1.05 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.03 168.92 15.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.349 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.706 HG22 ' HB3' ' B' ' 135' ' ' ALA . 14.5 m -118.0 132.26 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.977 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.27 107.61 3.56 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.623 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' PHE . . . . . 0.591 ' HD1' HG23 ' B' ' 52' ' ' VAL . 55.6 p90 -140.34 132.06 27.35 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.812 0.339 . . . . 0.0 110.871 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.509 ' HB2' HG22 ' B' ' 130' ' ' THR . 12.5 p30 -117.78 176.81 5.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.636 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.791 ' HB ' HD12 ' B' ' 131' ' ' ILE . 51.8 mm -119.05 121.73 67.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.556 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.35 122.78 30.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.753 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' B' ' 129' ' ' ASN . 0.9 OUTLIER -131.27 93.71 3.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.246 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' B' ' 22' ' ' ALA . 0.4 OUTLIER -77.03 160.89 28.75 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 -179.733 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.17 87.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.745 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 69.9 m -120.44 131.88 54.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.71 97.9 9.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.269 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' B' ' 66' ' ' ALA . 1.5 m -77.47 -19.96 55.14 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.06 -27.48 68.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 111.768 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.39 -35.76 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.643 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' B' ' 63' ' ' THR . . . -131.05 131.28 44.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.64 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.46 -37.31 7.65 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.892 0.377 . . . . 0.0 110.948 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -121.69 171.39 8.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.56 136.1 15.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.552 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.702 ' HB3' ' HB3' ' B' ' 157' ' ' GLN . . . -94.5 158.04 15.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.062 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.41 106.28 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.679 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.83 ' HB3' ' HB3' ' B' ' 155' ' ' LYS . . . -109.6 164.29 12.67 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.65 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.674 ' HB2' HD11 ' B' ' 111' ' ' LEU . 6.5 t80 -142.27 141.03 32.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.502 0.191 . . . . 0.0 111.174 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.727 HD11 ' HG2' ' E' ' 57' ' ' GLN . 0.1 OUTLIER -122.71 103.38 8.62 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.993 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.503 ' HA3' HD23 ' B' ' 113' ' ' LEU . . . -153.45 -166.37 14.56 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.875 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.54 136.3 46.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.585 0.231 . . . . 0.0 110.709 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.673 ' H ' ' HB3' ' E' ' 132' ' ' PRO . . . -81.52 156.13 25.42 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.879 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.47 HG12 ' OG1' ' B' ' 140' ' ' THR . 3.1 tt -92.51 -20.71 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.811 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.554 ' HB2' HG21 ' B' ' 140' ' ' THR . 0.4 OUTLIER 176.18 179.76 0.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.818 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' E' ' 107' ' ' THR . . . -78.91 -33.89 45.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.007 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.44 -43.84 95.64 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.6 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.452 ' NE2' ' O ' ' B' ' 139' ' ' ALA . 43.5 m-70 -97.86 -64.38 1.04 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.829 0.347 . . . . 0.0 110.435 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' THR . . . . . 0.43 ' HA ' ' HB1' ' B' ' 77' ' ' ALA . 1.2 m 62.33 7.83 2.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.647 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ASN . . . . . 0.422 ' O ' HD12 ' B' ' 103' ' ' ILE . 87.0 m-20 -115.15 -25.41 8.09 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.203 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.782 ' HA ' ' HA ' ' B' ' 102' ' ' GLN . 0.5 OUTLIER -79.62 143.75 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.152 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' B' ' 152' ' ' ALA . 0.3 OUTLIER -76.69 148.52 36.77 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.306 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.8 178.15 4.39 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.876 0.369 . . . . 0.0 111.734 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.658 HD22 ' O ' ' B' ' 96' ' ' ALA . 0.0 OUTLIER -84.6 176.13 8.8 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.071 179.386 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 89' ' ' GLN . . . . . 0.542 ' HB3' ' HB2' ' B' ' 149' ' ' ASN . 22.8 pt20 -75.19 178.62 5.62 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.355 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' SER . . . . . 0.535 ' O ' HG12 ' E' ' 52' ' ' VAL . 1.0 OUTLIER -73.34 -11.44 60.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.023 0.44 . . . . 0.0 111.409 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 91' ' ' SER . . . . . 0.514 ' HB3' ' HB3' ' B' ' 95' ' ' SER . 0.3 OUTLIER -64.72 87.27 0.06 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.909 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.86 -7.2 53.93 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.633 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' ALA . . . . . 0.465 ' HB1' ' HB1' ' D' ' 22' ' ' ALA . . . -133.09 19.87 4.07 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.641 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.66 -15.53 0.16 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.932 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' SER . . . . . 0.514 ' HB3' ' HB3' ' B' ' 91' ' ' SER . 1.0 OUTLIER -97.32 174.96 6.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.898 0.38 . . . . 0.0 110.583 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.658 ' O ' HD22 ' B' ' 88' ' ' LEU . . . -114.13 157.88 22.02 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.83 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.544 HG23 HD11 ' B' ' 88' ' ' LEU . 0.2 OUTLIER -113.03 162.7 15.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.308 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 69.42 41.5 1.3 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.46 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 10.4 p -177.62 130.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.825 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.04 179.52 28.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.598 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' B' ' 86' ' ' LEU . 1.6 t -99.15 95.33 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.009 0.524 . . . . 0.0 111.672 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.782 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 13.7 tt0 -69.85 159.82 32.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.954 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.435 HG12 ' CE2' ' B' ' 73' ' ' PHE . 0.9 OUTLIER -121.69 98.41 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.56 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 104' ' ' LEU . . . . . 0.686 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 1.1 tp -84.8 119.38 25.23 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.792 0.33 . . . . 0.0 111.113 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.18 158.04 32.09 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.643 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' ARG . . . . . 0.555 ' HB2' ' HB2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -61.05 -33.93 74.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.913 0.387 . . . . 0.0 111.117 179.42 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.554 HG23 ' HA ' ' B' ' 120' ' ' SER . 0.0 OUTLIER -48.76 -38.25 21.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.972 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.73 -88.78 0.11 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.59 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.2 -176.35 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.892 0.377 . . . . 0.0 111.066 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.686 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -79.98 143.94 33.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' B' ' 73' ' ' PHE . 0.6 OUTLIER -90.09 157.56 17.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.363 0.601 . . . . 0.0 110.561 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.451 ' HB ' HG21 ' B' ' 117' ' ' THR . 29.7 m -81.12 150.43 28.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.111 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.606 HD12 ' N ' ' B' ' 113' ' ' LEU . 3.0 mp -102.7 57.66 0.78 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.691 0.281 . . . . 0.0 110.738 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.49 19.67 15.23 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.477 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.24 -93.05 0.88 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.634 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' E' ' 125' ' ' ASN . . . -102.71 69.66 1.08 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.03 0.443 . . . . 0.0 111.592 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' B' ' 72' ' ' ALA . 5.9 p -89.62 97.22 11.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.142 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.17 102.82 5.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.764 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.44 -82.74 0.65 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.554 ' HA ' HG23 ' B' ' 107' ' ' THR . 0.1 OUTLIER -63.22 100.93 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.614 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -88.87 79.02 7.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.143 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.436 HG21 ' CD ' ' B' ' 132' ' ' PRO . 4.6 p -82.52 159.17 22.9 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.737 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 16.0 m -85.33 139.71 31.37 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.746 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.36 136.15 33.44 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.609 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -120.8 143.56 48.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.644 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.2 148.95 34.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 110.63 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.67 -106.11 2.29 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.746 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -85.16 153.16 22.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.812 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ASN . . . . . 0.597 ' HB3' ' HB2' ' B' ' 58' ' ' LEU . 23.1 t-20 -148.4 120.76 8.43 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.93 0.395 . . . . 0.0 111.112 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.509 HG22 ' HB2' ' B' ' 55' ' ' ASN . 0.2 OUTLIER -104.24 147.26 27.68 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.151 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 131' ' ' ILE . . . . . 0.791 HD12 ' HB ' ' B' ' 56' ' ' ILE . 89.9 mt -116.58 119.19 36.23 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' PRO . . . . . 0.555 ' HB2' ' HB2' ' B' ' 106' ' ' ARG . 7.6 Cg_endo -80.79 119.14 3.57 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.632 1.555 . . . . 0.0 112.535 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.05 147.3 29.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.775 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.13 155.88 47.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.04 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.706 ' HB3' HG22 ' B' ' 52' ' ' VAL . . . -140.06 115.67 10.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.648 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 136' ' ' ARG . . . . . 0.441 ' NH2' HG21 ' B' ' 48' ' ' THR . 0.5 OUTLIER -111.26 148.93 31.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.535 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.48 151.27 45.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.119 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 138' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' B' ' 47' ' ' ALA . 0.2 OUTLIER -144.52 164.58 30.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.033 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.65 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -124.45 145.68 49.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.809 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 140' ' ' THR . . . . . 0.554 HG21 ' HB2' ' B' ' 79' ' ' ASP . 0.2 OUTLIER -117.77 13.01 14.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.545 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.83 79.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.97 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.73 92.14 0.02 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.619 0.21 . . . . 0.0 110.769 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.08 154.8 33.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.698 0.285 . . . . 0.0 111.393 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.527 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 39.3 p -116.76 166.22 13.34 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.223 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.485 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 1.4 Cg_endo -84.27 151.5 12.16 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.467 2.112 . . . . 0.0 111.976 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.62 -106.29 0.46 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.401 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -139.06 163.32 32.72 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.839 0.352 . . . . 0.0 111.386 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -166.01 79.93 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.546 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.542 ' HB2' ' HB3' ' B' ' 89' ' ' GLN . 87.2 m-20 -99.92 142.47 31.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.557 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.512 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -127.76 169.02 14.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.01 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.6 109.94 0.85 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.261 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' ALA . . . . . 0.632 ' HB2' HD21 ' B' ' 86' ' ' LEU . . . -147.02 145.45 29.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.14 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -93.66 164.22 13.24 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.276 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.622 ' CZ ' HG21 ' B' ' 56' ' ' ILE . 15.4 p90 -110.89 151.66 27.63 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.141 0.496 . . . . 0.0 110.137 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.83 ' HB3' ' HB3' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -109.75 160.88 15.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.932 -178.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 156' ' ' VAL . . . . . 0.646 HG23 HG23 ' A' ' 5' ' ' VAL . 1.4 m -142.1 112.92 3.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.786 0.326 . . . . 0.0 111.706 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.702 ' HB3' ' HB3' ' B' ' 70' ' ' ALA . 0.3 OUTLIER -91.87 124.44 35.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.352 0.596 . . . . 0.0 110.426 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 158' ' ' TYR . . . . . 0.55 ' HB2' ' HB ' ' A' ' 3' ' ' THR . 57.3 m-85 -117.19 135.54 53.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.525 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.866 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.55 100.26 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.984 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' D' ' 158' ' ' TYR . 7.4 m -104.82 78.63 1.45 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.406 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 4' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' D' ' 156' ' ' VAL . 0.2 OUTLIER -85.31 122.39 29.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.599 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.646 HG23 HG23 ' D' ' 156' ' ' VAL . 5.0 m -137.94 162.94 30.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.472 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 6' ' ' ASN . . . . . 0.427 ' HB3' ' OE2' ' D' ' 15' ' ' GLU . 44.0 t-20 -84.37 114.55 21.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.615 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 7' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' D' ' 154' ' ' PHE . . . -83.47 -41.39 8.42 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.679 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 8' ' ' GLY . . . . . 0.443 ' N ' ' CE1' ' D' ' 154' ' ' PHE . . . -175.61 162.26 31.49 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.908 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 9' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' D' ' 153' ' ' THR . 99.2 m -90.79 137.92 31.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.981 0.42 . . . . 0.0 111.231 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.46 114.23 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.233 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -99.29 148.56 24.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.347 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' PHE . . . . . 0.814 ' HB3' HD21 ' D' ' 34' ' ' LEU . 60.8 m-85 -133.83 113.07 11.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.723 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.738 ' HG2' ' HA ' ' D' ' 33' ' ' GLN . 0.0 OUTLIER -107.14 105.86 16.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.395 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.18 169.44 28.87 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.992 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' GLU . . . . . 0.551 ' HB2' ' HG3' ' D' ' 36' ' ' GLN . 33.8 mt-10 -140.73 -171.07 3.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.913 0.387 . . . . 0.0 110.391 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.583 HG13 HG23 ' D' ' 37' ' ' VAL . 0.5 OUTLIER -139.24 152.77 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.251 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.715 ' O ' HG23 ' D' ' 39' ' ' THR . 0.0 OUTLIER -137.42 155.35 31.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.888 0.375 . . . . 0.0 111.047 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -85.13 53.11 2.63 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' ALA . . . . . 0.671 ' HA ' ' HG2' ' D' ' 38' ' ' ARG . . . 61.33 92.74 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.098 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 20' ' ' ALA . . . . . 0.583 ' H ' ' HG2' ' D' ' 38' ' ' ARG . . . -164.8 -47.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.438 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 21' ' ' CYS . . . . . 0.754 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 1.6 m -159.81 176.83 11.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.951 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 22' ' ' ALA . . . . . 0.61 ' HB2' ' HE ' ' D' ' 38' ' ' ARG . . . -147.28 111.99 5.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.115 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 23' ' ' VAL . . . . . 0.604 HG13 ' HB3' ' C' ' 27' ' ' SER . 43.0 t -67.44 143.22 15.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.015 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.546 ' O ' HG23 ' C' ' 28' ' ' VAL . 17.0 m-20 -91.2 168.1 11.86 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.629 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.36 -50.0 74.35 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.42 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.38 -16.64 73.69 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.907 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' SER . . . . . 0.604 ' HB3' HG13 ' C' ' 23' ' ' VAL . 0.4 OUTLIER -84.31 -24.44 29.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.876 0.37 . . . . 0.0 110.742 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.546 HG23 ' O ' ' C' ' 24' ' ' ASP . 85.1 t -58.04 -37.23 60.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.359 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -140.37 105.91 5.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.043 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -108.95 106.95 17.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.155 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.79 95.6 9.02 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.047 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.546 HG11 HG21 ' C' ' 52' ' ' VAL . 51.7 t -85.82 138.24 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.099 0.476 . . . . 0.0 110.37 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.757 ' HA ' ' HG2' ' B' ' 13' ' ' LYS . 3.2 mt-30 -113.2 132.6 55.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.651 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' B' ' 12' ' ' PHE . 1.8 mm? -94.53 -71.43 0.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.627 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.83 -111.31 0.72 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.544 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' GLN . . . . . 0.541 ' HG3' ' HB2' ' B' ' 15' ' ' GLU . 3.6 tt0 -161.06 105.84 1.35 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.721 0.296 . . . . 0.0 110.874 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.569 HG23 HG13 ' B' ' 16' ' ' VAL . 5.6 m -91.15 142.37 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.937 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 38' ' ' ARG . . . . . 0.663 ' HG2' ' HA ' ' B' ' 19' ' ' ALA . 0.7 OUTLIER -81.18 162.55 23.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.694 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.729 HG23 ' O ' ' B' ' 17' ' ' VAL . 82.6 p -80.39 -16.79 53.66 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.765 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.81 -31.16 63.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.157 0.503 . . . . 0.0 110.839 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -28.5 39.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.11 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.636 ' HB3' ' HB2' ' C' ' 139' ' ' ALA . 1.7 mp -133.21 70.13 1.47 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.601 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 43' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' C' ' 39' ' ' THR . . . -103.67 11.18 36.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.5 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.01 146.83 27.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.466 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.5 121.28 13.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.871 0.367 . . . . 0.0 111.152 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.52 -10.47 12.75 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.114 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' C' ' 138' ' ' PHE . . . -68.78 142.21 54.98 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.874 0.369 . . . . 0.0 111.976 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 48' ' ' THR . . . . . 0.44 HG21 ' NH2' ' C' ' 136' ' ' ARG . 6.8 t -134.75 140.81 46.21 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.852 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 17.0 m -105.96 -152.79 0.48 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.56 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 1.4 t -65.94 178.6 1.06 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.859 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.11 168.82 15.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.805 0.336 . . . . 0.0 111.28 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' C' ' 135' ' ' ALA . 14.7 m -117.98 132.24 68.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.21 107.62 3.57 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.683 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' PHE . . . . . 0.591 ' HD1' HG23 ' C' ' 52' ' ' VAL . 55.6 p90 -140.31 132.09 27.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.741 0.305 . . . . 0.0 110.932 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.531 ' HB2' HG22 ' C' ' 130' ' ' THR . 12.5 p30 -117.83 176.83 5.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.565 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.794 ' HB ' HD12 ' C' ' 131' ' ' ILE . 51.7 mm -119.02 121.68 67.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.533 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.29 122.71 30.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.826 0.346 . . . . 0.0 110.831 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 58' ' ' LEU . . . . . 0.588 ' HB2' ' HB3' ' C' ' 129' ' ' ASN . 0.9 OUTLIER -131.23 93.75 3.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 59' ' ' ASN . . . . . 0.534 ' O ' ' HB3' ' C' ' 22' ' ' ALA . 0.4 OUTLIER -77.08 160.82 28.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.871 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.26 87.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.74 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 61' ' ' CYS . . . . . 0.754 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 70.2 m -120.52 131.8 54.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.813 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.61 97.91 9.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.343 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' C' ' 66' ' ' ALA . 1.5 m -77.44 -19.96 55.23 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.04 -27.56 68.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.978 0.418 . . . . 0.0 111.711 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 16.9 t -95.36 -35.76 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.613 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 66' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' C' ' 63' ' ' THR . . . -130.9 131.29 44.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.706 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.45 -37.27 7.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.912 0.387 . . . . 0.0 110.983 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -121.74 171.36 8.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.503 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.58 136.15 15.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.593 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.728 ' HB3' ' HB3' ' C' ' 157' ' ' GLN . . . -94.52 157.99 15.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.086 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.44 106.28 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.693 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 72' ' ' ALA . . . . . 0.839 ' HB3' ' HB3' ' C' ' 155' ' ' LYS . . . -109.6 164.31 12.65 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.597 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 73' ' ' PHE . . . . . 0.671 ' HB2' HD11 ' C' ' 111' ' ' LEU . 6.6 t80 -142.26 141.03 32.42 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.147 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.726 HD11 ' HG2' ' F' ' 57' ' ' GLN . 0.1 OUTLIER -122.66 103.37 8.63 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.981 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 75' ' ' GLY . . . . . 0.504 ' HA3' HD23 ' C' ' 113' ' ' LEU . . . -153.47 -166.38 14.58 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.909 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.5 136.27 46.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.574 0.226 . . . . 0.0 110.746 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 77' ' ' ALA . . . . . 0.685 ' H ' ' HB3' ' F' ' 132' ' ' PRO . . . -81.39 156.08 25.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.878 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 78' ' ' ILE . . . . . 0.472 HG12 ' OG1' ' C' ' 140' ' ' THR . 3.1 tt -92.56 -20.65 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.796 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 79' ' ' ASP . . . . . 0.563 ' HB2' HG21 ' C' ' 140' ' ' THR . 0.4 OUTLIER 176.15 179.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.821 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 80' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' F' ' 107' ' ' THR . . . -79.02 -33.76 44.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.988 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.39 -44.0 95.45 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.564 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' HIS . . . . . 0.447 ' HB3' HG23 ' C' ' 85' ' ' VAL . 43.3 m-70 -97.74 -64.42 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.787 0.327 . . . . 0.0 110.47 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 83' ' ' THR . . . . . 0.439 ' HA ' ' HB1' ' C' ' 77' ' ' ALA . 1.2 m 62.32 7.81 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.597 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 84' ' ' ASN . . . . . 0.419 ' O ' HD12 ' C' ' 103' ' ' ILE . 86.9 m-20 -115.02 -25.51 8.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.308 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' C' ' 102' ' ' GLN . 0.5 OUTLIER -79.53 143.63 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.214 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' C' ' 152' ' ' ALA . 0.3 OUTLIER -76.59 148.57 36.9 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.294 179.412 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.87 178.25 4.37 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.721 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.643 HD22 ' O ' ' C' ' 96' ' ' ALA . 0.0 OUTLIER -84.71 176.19 8.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.124 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 89' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' C' ' 149' ' ' ASN . 22.9 pt20 -75.18 178.69 5.56 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.352 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 90' ' ' SER . . . . . 0.53 ' O ' HG12 ' F' ' 52' ' ' VAL . 1.0 OUTLIER -73.36 -11.45 60.49 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.002 0.429 . . . . 0.0 111.461 179.408 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 91' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' C' ' 95' ' ' SER . 0.3 OUTLIER -64.72 87.27 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.92 -7.09 53.75 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.688 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' ALA . . . . . 0.47 ' HB1' ' HB1' ' E' ' 22' ' ' ALA . . . -133.15 19.92 4.06 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.614 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.64 -15.6 0.16 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.96 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 95' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' C' ' 91' ' ' SER . 1.0 OUTLIER -97.35 174.93 6.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 110.594 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 96' ' ' ALA . . . . . 0.643 ' O ' HD22 ' C' ' 88' ' ' LEU . . . -114.06 157.85 22.0 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 97' ' ' THR . . . . . 0.54 HG23 HD11 ' C' ' 88' ' ' LEU . 0.2 OUTLIER -112.9 162.78 15.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.325 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 69.33 41.52 1.32 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.366 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 10.3 p -177.58 130.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.06 179.45 28.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.604 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' C' ' 86' ' ' LEU . 1.6 t -99.07 95.27 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.072 0.549 . . . . 0.0 111.703 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 102' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' C' ' 85' ' ' VAL . 13.7 tt0 -69.88 159.8 33.0 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.9 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.432 HG12 ' CE2' ' C' ' 73' ' ' PHE . 0.9 OUTLIER -121.66 98.36 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.574 179.425 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 104' ' ' LEU . . . . . 0.678 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 1.1 tp -84.64 119.36 25.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.695 0.283 . . . . 0.0 111.148 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.13 158.08 32.12 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.677 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 106' ' ' ARG . . . . . 0.55 ' HB2' ' HB2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -61.13 -33.93 74.18 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.914 0.388 . . . . 0.0 111.085 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 107' ' ' THR . . . . . 0.553 HG23 ' HA ' ' C' ' 120' ' ' SER . 0.0 OUTLIER -48.8 -38.22 21.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.972 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.75 -88.82 0.11 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.544 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.17 -176.32 5.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.82 0.343 . . . . 0.0 111.143 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.678 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -79.98 143.89 33.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.136 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 111' ' ' LEU . . . . . 0.671 HD11 ' HB2' ' C' ' 73' ' ' PHE . 0.6 OUTLIER -90.07 157.51 17.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.389 0.614 . . . . 0.0 110.557 179.688 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 112' ' ' THR . . . . . 0.448 ' HB ' HG21 ' C' ' 117' ' ' THR . 29.9 m -81.13 150.45 28.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.154 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.603 HD12 ' N ' ' C' ' 113' ' ' LEU . 3.0 mp -102.68 57.64 0.78 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.675 0.274 . . . . 0.0 110.742 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.48 19.72 15.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.562 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.18 -93.08 0.88 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.647 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 116' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' F' ' 125' ' ' ASN . . . -102.73 69.58 1.08 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.097 0.475 . . . . 0.0 111.631 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 117' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' C' ' 72' ' ' ALA . 5.9 p -89.62 97.25 11.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.196 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.13 102.72 5.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.723 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.43 -82.69 0.65 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 120' ' ' SER . . . . . 0.553 ' HA ' HG23 ' C' ' 107' ' ' THR . 0.1 OUTLIER -63.16 100.87 0.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.715 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.82 79.01 7.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.208 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.43 HG21 ' CD ' ' C' ' 132' ' ' PRO . 4.5 p -82.56 159.1 22.85 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.729 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 16.3 m -85.17 139.71 31.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.825 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.42 136.15 33.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.811 0.338 . . . . 0.0 110.548 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -120.77 143.55 48.76 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.653 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.14 148.94 34.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.742 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.76 -106.21 2.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.692 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -85.2 153.25 22.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.734 0.302 . . . . 0.0 110.74 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 129' ' ' ASN . . . . . 0.588 ' HB3' ' HB2' ' C' ' 58' ' ' LEU . 23.2 t-20 -148.45 120.72 8.38 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.898 0.38 . . . . 0.0 111.112 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 130' ' ' THR . . . . . 0.531 HG22 ' HB2' ' C' ' 55' ' ' ASN . 0.2 OUTLIER -104.18 147.33 27.58 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.132 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 131' ' ' ILE . . . . . 0.794 HD12 ' HB ' ' C' ' 56' ' ' ILE . 89.8 mt -116.62 119.27 36.02 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 132' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' C' ' 106' ' ' ARG . 7.6 Cg_endo -80.92 119.17 3.53 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 121.652 1.568 . . . . 0.0 112.548 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.12 147.27 29.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.762 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.09 155.98 47.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.02 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.713 ' HB3' HG22 ' C' ' 52' ' ' VAL . . . -140.09 115.7 10.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.93 0.395 . . . . 0.0 111.579 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.44 ' NH2' HG21 ' C' ' 48' ' ' THR . 0.5 OUTLIER -111.26 149.02 31.63 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.432 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.67 151.32 45.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.068 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 138' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' C' ' 47' ' ' ALA . 0.2 OUTLIER -144.55 164.56 30.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.924 -179.095 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 139' ' ' ALA . . . . . 0.636 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -124.41 145.74 49.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.923 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 140' ' ' THR . . . . . 0.563 HG21 ' HB2' ' C' ' 79' ' ' ASP . 0.2 OUTLIER -117.8 12.89 14.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.516 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.87 79.82 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.895 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.7 92.11 0.02 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.595 0.197 . . . . 0.0 110.796 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.11 154.83 33.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.75 0.31 . . . . 0.0 111.403 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 144' ' ' THR . . . . . 0.521 ' O ' ' HB ' ' B' ' 16' ' ' VAL . 39.8 p -116.75 166.22 13.34 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.181 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 145' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' B' ' 16' ' ' VAL . 1.3 Cg_endo -84.28 151.4 12.13 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.468 2.112 . . . . 0.0 111.993 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.7 -106.23 0.45 Allowed Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.403 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 147' ' ' ALA . . . . . 0.407 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -139.13 163.23 32.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.764 0.316 . . . . 0.0 111.411 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.89 79.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.502 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 149' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' C' ' 89' ' ' GLN . 87.1 m-20 -99.92 142.47 31.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.576 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 150' ' ' ALA . . . . . 0.526 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -127.77 168.96 14.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.052 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.54 109.99 0.86 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.267 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 152' ' ' ALA . . . . . 0.622 ' HB2' HD21 ' C' ' 86' ' ' LEU . . . -146.94 145.42 29.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.148 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 153' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' B' ' 9' ' ' THR . 0.9 OUTLIER -93.61 164.18 13.26 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 154' ' ' PHE . . . . . 0.631 ' CZ ' HG21 ' C' ' 56' ' ' ILE . 15.2 p90 -110.87 151.52 27.77 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.157 0.503 . . . . 0.0 110.187 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 155' ' ' LYS . . . . . 0.839 ' HB3' ' HB3' ' C' ' 72' ' ' ALA . 0.0 OUTLIER -109.6 160.95 15.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.943 -178.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 156' ' ' VAL . . . . . 0.644 HG23 HG23 ' B' ' 5' ' ' VAL . 1.5 m -142.17 112.9 3.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.761 0.315 . . . . 0.0 111.715 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 157' ' ' GLN . . . . . 0.728 ' HB3' ' HB3' ' C' ' 70' ' ' ALA . 0.3 OUTLIER -91.88 124.38 35.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.36 0.6 . . . . 0.0 110.46 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 158' ' ' TYR . . . . . 0.551 ' HB2' ' HB ' ' B' ' 3' ' ' THR . 57.6 m-85 -117.18 135.47 53.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.493 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.914 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.53 100.1 0.04 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.064 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' E' ' 158' ' ' TYR . 7.3 m -104.74 78.63 1.46 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.48 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.27 122.44 29.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.528 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.643 HG23 HG23 ' E' ' 156' ' ' VAL . 5.1 m -137.95 162.93 30.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.533 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 6' ' ' ASN . . . . . 0.43 ' HB3' ' OE2' ' E' ' 15' ' ' GLU . 44.0 t-20 -84.34 114.56 21.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.594 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 7' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' E' ' 154' ' ' PHE . . . -83.41 -41.48 8.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.683 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 8' ' ' GLY . . . . . 0.447 ' N ' ' CE1' ' E' ' 154' ' ' PHE . . . -175.64 162.28 31.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.847 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 9' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' E' ' 153' ' ' THR . 98.8 m -90.74 137.81 32.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.92 0.39 . . . . 0.0 111.28 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.43 114.28 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.254 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -99.38 148.49 24.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.312 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 12' ' ' PHE . . . . . 0.814 ' HB3' HD21 ' E' ' 34' ' ' LEU . 60.7 m-85 -133.74 113.08 11.92 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.824 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 13' ' ' LYS . . . . . 0.745 ' HG2' ' HA ' ' E' ' 33' ' ' GLN . 0.0 OUTLIER -107.12 105.82 16.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.39 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.17 169.48 28.86 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.958 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 15' ' ' GLU . . . . . 0.548 ' HB2' ' HG3' ' E' ' 36' ' ' GLN . 33.6 mt-10 -140.75 -171.05 3.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.849 0.357 . . . . 0.0 110.431 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.57 HG13 HG23 ' E' ' 37' ' ' VAL . 0.5 OUTLIER -139.23 152.88 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.144 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.723 ' O ' HG23 ' E' ' 39' ' ' THR . 0.0 OUTLIER -137.47 155.39 31.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.856 0.36 . . . . 0.0 111.069 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -85.19 53.06 2.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.011 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 19' ' ' ALA . . . . . 0.684 ' HA ' ' HG2' ' E' ' 38' ' ' ARG . . . 61.41 92.64 0.05 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.112 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.58 ' H ' ' HG2' ' E' ' 38' ' ' ARG . . . -164.72 -47.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.469 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 21' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 1.6 m -159.86 176.77 11.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.989 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 22' ' ' ALA . . . . . 0.623 ' HB2' ' HE ' ' E' ' 38' ' ' ARG . . . -147.22 111.91 5.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.157 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 23' ' ' VAL . . . . . 0.625 HG13 ' HB3' ' D' ' 27' ' ' SER . 43.2 t -67.29 143.08 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.004 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.547 ' O ' HG23 ' D' ' 28' ' ' VAL . 17.0 m-20 -91.16 168.15 11.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.619 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.37 -50.02 74.31 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.443 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.38 -16.61 73.67 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.967 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' SER . . . . . 0.625 ' HB3' HG13 ' D' ' 23' ' ' VAL . 0.4 OUTLIER -84.32 -24.44 29.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.892 0.377 . . . . 0.0 110.763 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 28' ' ' VAL . . . . . 0.547 HG23 ' O ' ' D' ' 24' ' ' ASP . 85.6 t -58.1 -37.19 60.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.346 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -140.41 105.98 5.1 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.033 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -109.08 106.95 17.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.106 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.74 95.56 8.98 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.096 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.54 HG11 HG21 ' D' ' 52' ' ' VAL . 51.9 t -85.76 138.17 19.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.11 0.481 . . . . 0.0 110.388 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 33' ' ' GLN . . . . . 0.738 ' HA ' ' HG2' ' C' ' 13' ' ' LYS . 3.1 mt-30 -113.11 132.59 55.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.688 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.814 HD21 ' HB3' ' C' ' 12' ' ' PHE . 1.8 mm? -94.47 -71.48 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.64 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.83 -111.33 0.72 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.526 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' GLN . . . . . 0.551 ' HG3' ' HB2' ' C' ' 15' ' ' GLU . 3.6 tt0 -160.96 105.83 1.37 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.648 0.261 . . . . 0.0 110.884 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.583 HG23 HG13 ' C' ' 16' ' ' VAL . 5.6 m -91.15 142.42 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.878 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 38' ' ' ARG . . . . . 0.671 ' HG2' ' HA ' ' C' ' 19' ' ' ALA . 0.7 OUTLIER -81.11 162.53 23.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.759 179.233 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.715 HG23 ' O ' ' C' ' 17' ' ' VAL . 82.4 p -80.34 -16.94 53.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.788 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.71 -31.23 63.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.166 0.508 . . . . 0.0 110.919 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.11 -28.42 39.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.116 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.618 ' HB3' ' HB2' ' D' ' 139' ' ' ALA . 1.7 mp -133.16 70.19 1.47 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.625 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 43' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' D' ' 39' ' ' THR . . . -103.71 11.21 36.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.424 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.06 146.85 27.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.38 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.48 121.22 13.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.56 -10.4 12.71 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.09 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' D' ' 138' ' ' PHE . . . -68.8 142.17 54.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.905 0.383 . . . . 0.0 111.97 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 48' ' ' THR . . . . . 0.433 HG21 ' NH2' ' D' ' 136' ' ' ARG . 6.9 t -134.72 140.84 46.26 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.816 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 16.8 m -106.02 -152.76 0.48 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.587 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 1.4 t -65.91 178.64 1.04 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.813 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.16 168.9 15.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.283 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 52' ' ' VAL . . . . . 0.681 HG22 ' HB3' ' D' ' 135' ' ' ALA . 14.7 m -118.02 132.25 68.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 53' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 88' ' ' LEU . . . -95.2 107.59 3.56 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.647 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.605 ' HD1' HG23 ' D' ' 52' ' ' VAL . 55.5 p90 -140.28 132.05 27.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.707 0.289 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 55' ' ' ASN . . . . . 0.53 ' HB2' HG22 ' D' ' 130' ' ' THR . 12.4 p30 -117.81 176.83 5.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.57 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.772 ' HB ' HD12 ' D' ' 131' ' ' ILE . 51.7 mm -118.98 121.7 67.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.532 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 57' ' ' GLN . . . . . 0.737 ' HG2' HD11 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -86.32 122.66 30.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.778 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 58' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' D' ' 129' ' ' ASN . 0.9 OUTLIER -131.2 93.71 3.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.234 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 59' ' ' ASN . . . . . 0.549 ' O ' ' HB3' ' D' ' 22' ' ' ALA . 0.4 OUTLIER -76.98 160.91 28.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.912 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.12 87.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.76 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 61' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 70.1 m -120.55 131.81 54.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.808 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.61 97.87 9.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.308 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' D' ' 66' ' ' ALA . 1.5 m -77.41 -19.98 55.31 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.06 -27.54 68.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.975 0.417 . . . . 0.0 111.701 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.4 -35.75 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.608 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' D' ' 63' ' ' THR . . . -130.94 131.24 44.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.716 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.41 -37.35 7.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.885 0.374 . . . . 0.0 110.954 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -121.69 171.4 8.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.577 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.55 136.13 15.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.555 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 70' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' D' ' 157' ' ' GLN . . . -94.49 157.95 15.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.087 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 38.1 t -110.42 106.31 20.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.655 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 72' ' ' ALA . . . . . 0.821 ' HB3' ' HB3' ' D' ' 155' ' ' LYS . . . -109.64 164.24 12.72 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.575 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 73' ' ' PHE . . . . . 0.659 ' HB2' HD11 ' D' ' 111' ' ' LEU . 6.5 t80 -142.21 141.11 32.51 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.564 0.221 . . . . 0.0 111.15 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 74' ' ' LEU . . . . . 0.429 HD22 ' NZ ' ' D' ' 155' ' ' LYS . 0.1 OUTLIER -122.72 103.37 8.61 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.991 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 75' ' ' GLY . . . . . 0.512 ' HA3' HD23 ' D' ' 113' ' ' LEU . . . -153.46 -166.43 14.62 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.889 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.46 136.37 46.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.611 0.243 . . . . 0.0 110.695 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.448 ' HB1' ' HA ' ' D' ' 83' ' ' THR . . . -81.54 156.12 25.4 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.88 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 78' ' ' ILE . . . . . 0.464 HG12 ' OG1' ' D' ' 140' ' ' THR . 3.0 tt -92.52 -20.67 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.83 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.565 ' HB2' HG21 ' D' ' 140' ' ' THR . 0.4 OUTLIER 176.15 179.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.825 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.95 -33.85 44.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.975 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.51 -43.82 95.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.595 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 82' ' ' HIS . . . . . 0.457 ' NE2' ' O ' ' D' ' 139' ' ' ALA . 43.6 m-70 -97.78 -64.48 1.04 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.862 0.363 . . . . 0.0 110.438 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 83' ' ' THR . . . . . 0.448 ' HA ' ' HB1' ' D' ' 77' ' ' ALA . 1.2 m 62.45 7.77 2.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.582 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 84' ' ' ASN . . . . . 0.417 ' O ' HD12 ' D' ' 103' ' ' ILE . 87.0 m-20 -115.08 -25.41 8.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.329 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' D' ' 102' ' ' GLN . 0.5 OUTLIER -79.58 143.68 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.171 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' D' ' 152' ' ' ALA . 0.3 OUTLIER -76.63 148.53 36.86 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.27 179.434 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.8 178.2 4.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.894 0.378 . . . . 0.0 111.716 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.652 HD22 ' O ' ' D' ' 96' ' ' ALA . 0.0 OUTLIER -84.67 176.16 8.75 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.096 179.395 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 89' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' D' ' 149' ' ' ASN . 22.8 pt20 -75.24 178.71 5.58 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.38 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.36 -11.5 60.5 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 111.428 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 91' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' D' ' 95' ' ' SER . 0.3 OUTLIER -64.62 87.24 0.05 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.891 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.88 -7.15 53.83 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.921 0.391 . . . . 0.0 111.697 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 93' ' ' ALA . . . . . 0.469 ' HB1' ' HB1' ' F' ' 22' ' ' ALA . . . -133.14 19.96 4.06 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.674 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.62 -15.58 0.16 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.942 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 95' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' D' ' 91' ' ' SER . 1.0 OUTLIER -97.33 174.89 6.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.9 0.381 . . . . 0.0 110.59 179.558 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 96' ' ' ALA . . . . . 0.652 ' O ' HD22 ' D' ' 88' ' ' LEU . . . -114.05 157.88 21.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.82 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 97' ' ' THR . . . . . 0.533 HG23 HD11 ' D' ' 88' ' ' LEU . 0.2 OUTLIER -112.9 162.72 15.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.305 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 98' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 69.29 41.62 1.32 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.387 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 99' ' ' VAL . . . . . . . . . . . . . 10.1 p -177.64 130.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.792 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.12 179.45 28.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.552 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 101' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' D' ' 86' ' ' LEU . 1.6 t -99.0 95.29 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 123.078 0.551 . . . . 0.0 111.681 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 102' ' ' GLN . . . . . 0.771 ' HA ' ' HA ' ' D' ' 85' ' ' VAL . 13.7 tt0 -69.84 159.79 32.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.892 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 103' ' ' ILE . . . . . 0.433 HG12 ' CE2' ' D' ' 73' ' ' PHE . 0.9 OUTLIER -121.7 98.45 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.522 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 104' ' ' LEU . . . . . 0.684 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 1.1 tp -84.75 119.38 25.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.755 0.312 . . . . 0.0 111.095 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.18 158.09 32.04 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.68 0.276 . . . . 0.0 111.646 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 106' ' ' ARG . . . . . 0.556 ' HB2' ' HB2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -61.19 -33.92 74.23 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.902 0.382 . . . . 0.0 111.048 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 107' ' ' THR . . . . . 0.561 HG23 ' HA ' ' D' ' 120' ' ' SER . 0.0 OUTLIER -48.72 -38.19 20.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.027 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.68 -88.81 0.11 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.603 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.16 -176.35 5.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.867 0.365 . . . . 0.0 111.139 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.684 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -79.96 143.93 33.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.098 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 111' ' ' LEU . . . . . 0.659 HD11 ' HB2' ' D' ' 73' ' ' PHE . 0.6 OUTLIER -90.08 157.58 17.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.386 0.612 . . . . 0.0 110.534 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 112' ' ' THR . . . . . 0.45 ' HB ' HG21 ' D' ' 117' ' ' THR . 30.0 m -81.22 150.47 28.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.099 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 113' ' ' LEU . . . . . 0.608 HD12 ' N ' ' D' ' 113' ' ' LEU . 2.9 mp -102.72 57.67 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.721 0.296 . . . . 0.0 110.742 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.42 19.57 15.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.552 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.23 -93.04 0.88 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.665 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.68 69.61 1.08 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.021 0.438 . . . . 0.0 111.564 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 117' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' D' ' 72' ' ' ALA . 5.8 p -89.69 97.34 11.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.2 102.83 5.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.786 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.45 -82.72 0.65 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 120' ' ' SER . . . . . 0.561 ' HA ' HG23 ' D' ' 107' ' ' THR . 0.1 OUTLIER -63.2 100.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.614 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.86 79.05 7.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.234 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.43 HG21 ' CD ' ' D' ' 132' ' ' PRO . 4.4 p -82.61 159.15 22.78 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.719 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 16.2 m -85.2 139.68 31.47 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.8 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.34 136.1 33.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.65 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 125' ' ' ASN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 116' ' ' ALA . 25.1 m120 -120.78 143.67 48.7 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.622 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.19 148.98 34.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.638 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.61 -106.12 2.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.75 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 128' ' ' THR . . . . . 0.648 HG21 ' NZ ' ' A' ' 155' ' ' LYS . 1.9 m -85.15 153.14 22.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.654 0.264 . . . . 0.0 110.817 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 129' ' ' ASN . . . . . 0.585 ' HB3' ' HB2' ' D' ' 58' ' ' LEU . 23.3 t-20 -148.39 120.68 8.39 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.874 0.368 . . . . 0.0 111.125 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 130' ' ' THR . . . . . 0.556 ' OG1' HD12 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -104.15 147.33 27.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.164 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 131' ' ' ILE . . . . . 0.772 HD12 ' HB ' ' D' ' 56' ' ' ILE . 89.4 mt -116.59 119.15 36.25 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 132' ' ' PRO . . . . . 0.677 ' HB3' ' H ' ' A' ' 77' ' ' ALA . 7.5 Cg_endo -80.95 119.11 3.5 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.645 1.563 . . . . 0.0 112.546 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.01 147.36 29.53 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.795 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.17 155.87 47.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.021 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.681 ' HB3' HG22 ' D' ' 52' ' ' VAL . . . -140.09 115.64 10.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.904 0.383 . . . . 0.0 111.575 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 136' ' ' ARG . . . . . 0.433 ' NH2' HG21 ' D' ' 48' ' ' THR . 0.5 OUTLIER -111.27 149.01 31.66 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.543 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.52 151.27 45.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.132 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 138' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' D' ' 47' ' ' ALA . 0.2 OUTLIER -144.49 164.61 30.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.225 0.536 . . . . 0.0 111.993 -179.154 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 139' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -124.5 145.71 49.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.901 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 140' ' ' THR . . . . . 0.565 HG21 ' HB2' ' D' ' 79' ' ' ASP . 0.2 OUTLIER -117.74 12.97 14.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.536 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.76 79.74 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.957 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.73 92.17 0.02 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.619 0.209 . . . . 0.0 110.716 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.13 154.86 33.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 111.357 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 144' ' ' THR . . . . . 0.524 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 39.2 p -116.76 166.16 13.49 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.237 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 145' ' ' PRO . . . . . 0.492 ' HA ' ' HB ' ' C' ' 16' ' ' VAL . 1.3 Cg_endo -84.24 151.49 12.21 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.45 2.1 . . . . 0.0 111.98 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.65 -106.34 0.46 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.453 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 147' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -139.05 163.26 32.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.823 0.344 . . . . 0.0 111.354 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.96 79.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.59 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 149' ' ' ASN . . . . . 0.531 ' HB2' ' HB3' ' D' ' 89' ' ' GLN . 87.1 m-20 -99.97 142.45 31.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.569 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 150' ' ' ALA . . . . . 0.508 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -127.72 168.99 14.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.969 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.55 109.99 0.86 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.214 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 152' ' ' ALA . . . . . 0.628 ' HB2' HD21 ' D' ' 86' ' ' LEU . . . -147.01 145.44 29.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.086 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 153' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' C' ' 9' ' ' THR . 1.0 OUTLIER -93.72 164.23 13.22 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.252 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 154' ' ' PHE . . . . . 0.63 ' CZ ' HG21 ' D' ' 56' ' ' ILE . 15.1 p90 -110.92 151.61 27.7 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.147 0.499 . . . . 0.0 110.108 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 155' ' ' LYS . . . . . 0.821 ' HB3' ' HB3' ' D' ' 72' ' ' ALA . 0.0 OUTLIER -109.64 160.84 15.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.951 -178.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 156' ' ' VAL . . . . . 0.646 HG23 HG23 ' C' ' 5' ' ' VAL . 1.4 m -142.15 112.93 3.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.803 0.335 . . . . 0.0 111.687 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 157' ' ' GLN . . . . . 0.713 ' HB3' ' HB3' ' D' ' 70' ' ' ALA . 0.3 OUTLIER -91.78 124.4 35.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.264 0.555 . . . . 0.0 110.398 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 158' ' ' TYR . . . . . 0.542 ' HB2' ' HB ' ' C' ' 3' ' ' THR . 57.6 m-85 -117.21 135.49 53.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.505 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.85 179.915 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.46 100.23 0.04 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.065 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 3' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' F' ' 158' ' ' TYR . 7.4 m -104.8 78.65 1.45 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.422 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.33 122.39 29.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.526 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.631 HG23 HG23 ' F' ' 156' ' ' VAL . 5.0 m -137.92 162.9 30.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.54 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 6' ' ' ASN . . . . . 0.433 ' HB3' ' OE2' ' F' ' 15' ' ' GLU . 44.0 t-20 -84.3 114.52 21.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.599 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 7' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' F' ' 154' ' ' PHE . . . -83.38 -41.52 8.4 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.684 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 8' ' ' GLY . . . . . 0.444 ' N ' ' CE1' ' F' ' 154' ' ' PHE . . . -175.56 162.29 31.57 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.889 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 9' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' F' ' 153' ' ' THR . 98.9 m -90.78 137.86 32.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.992 0.425 . . . . 0.0 111.269 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.44 114.27 46.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.184 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -99.34 148.44 24.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.343 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 12' ' ' PHE . . . . . 0.825 ' HB3' HD21 ' F' ' 34' ' ' LEU . 60.9 m-85 -133.75 113.12 11.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.794 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 13' ' ' LYS . . . . . 0.762 ' HG2' ' HA ' ' F' ' 33' ' ' GLN . 0.0 OUTLIER -107.23 105.89 16.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.351 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.23 169.44 28.9 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.023 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 15' ' ' GLU . . . . . 0.559 ' HB2' ' HG3' ' F' ' 36' ' ' GLN . 33.7 mt-10 -140.76 -171.13 3.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.853 0.359 . . . . 0.0 110.39 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 16' ' ' VAL . . . . . 0.585 HG13 HG23 ' F' ' 37' ' ' VAL . 0.5 OUTLIER -139.15 152.82 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.205 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 17' ' ' VAL . . . . . 0.732 ' O ' HG23 ' F' ' 39' ' ' THR . 0.0 OUTLIER -137.47 155.41 31.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.835 0.35 . . . . 0.0 111.038 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -85.23 53.02 2.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.005 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 19' ' ' ALA . . . . . 0.664 ' HA ' ' HG2' ' F' ' 38' ' ' ARG . . . 61.45 92.76 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.574 ' H ' ' HG2' ' F' ' 38' ' ' ARG . . . -164.84 -47.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.43 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 21' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 1.6 m -159.76 176.89 11.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.951 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 22' ' ' ALA . . . . . 0.602 ' HB2' ' HE ' ' F' ' 38' ' ' ARG . . . -147.29 111.9 5.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.13 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 23' ' ' VAL . . . . . 0.629 HG13 ' HB3' ' E' ' 27' ' ' SER . 43.1 t -67.31 143.14 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.998 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 24' ' ' ASP . . . . . 0.544 ' O ' HG23 ' E' ' 28' ' ' VAL . 17.1 m-20 -91.13 168.13 11.85 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.611 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.1 74.01 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.382 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.41 -16.64 73.74 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.929 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 27' ' ' SER . . . . . 0.629 ' HB3' HG13 ' E' ' 23' ' ' VAL . 0.4 OUTLIER -84.3 -24.35 29.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.944 0.402 . . . . 0.0 110.837 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 28' ' ' VAL . . . . . 0.544 HG23 ' O ' ' E' ' 24' ' ' ASP . 85.0 t -58.08 -37.25 60.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.345 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -140.34 105.97 5.12 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.007 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -109.0 106.95 17.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.12 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.77 95.53 8.99 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.071 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.552 HG11 HG21 ' E' ' 52' ' ' VAL . 51.4 t -85.74 138.27 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.074 0.464 . . . . 0.0 110.382 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 33' ' ' GLN . . . . . 0.745 ' HA ' ' HG2' ' D' ' 13' ' ' LYS . 3.2 mt-30 -113.23 132.53 55.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.641 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.814 HD21 ' HB3' ' D' ' 12' ' ' PHE . 1.8 mm? -94.47 -71.46 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.628 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.85 -111.3 0.71 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.578 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 36' ' ' GLN . . . . . 0.548 ' HG3' ' HB2' ' D' ' 15' ' ' GLU . 3.6 tt0 -161.03 105.81 1.36 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.625 0.25 . . . . 0.0 110.897 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.57 HG23 HG13 ' D' ' 16' ' ' VAL . 5.7 m -91.13 142.4 13.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.011 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 38' ' ' ARG . . . . . 0.684 ' HG2' ' HA ' ' D' ' 19' ' ' ALA . 0.7 OUTLIER -81.11 162.6 23.63 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.691 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 39' ' ' THR . . . . . 0.723 HG23 ' O ' ' D' ' 17' ' ' VAL . 82.6 p -80.47 -16.8 53.45 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.783 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.71 -31.22 63.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.197 0.522 . . . . 0.0 110.944 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.06 -28.47 39.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.113 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' E' ' 139' ' ' ALA . 1.7 mp -133.13 70.02 1.47 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.658 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 43' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' E' ' 39' ' ' THR . . . -103.61 11.19 36.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.451 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.01 146.84 27.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.394 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.47 121.24 13.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 111.146 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.55 -10.37 12.73 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.195 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 47' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' E' ' 138' ' ' PHE . . . -68.86 142.22 54.88 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.444 HG21 ' NH2' ' E' ' 136' ' ' ARG . 6.9 t -134.76 140.81 46.2 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.826 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.405 ' OG ' HD11 ' E' ' 42' ' ' LEU . 16.9 m -106.01 -152.74 0.48 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.615 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.92 178.62 1.05 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.909 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.1 168.81 15.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.784 0.326 . . . . 0.0 111.26 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 52' ' ' VAL . . . . . 0.714 HG22 ' HB3' ' E' ' 135' ' ' ALA . 14.7 m -117.97 132.2 68.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.955 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 53' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' B' ' 88' ' ' LEU . . . -95.18 107.61 3.57 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.627 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 54' ' ' PHE . . . . . 0.603 ' HD1' HG23 ' E' ' 52' ' ' VAL . 55.5 p90 -140.28 132.06 27.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 55' ' ' ASN . . . . . 0.519 ' HB2' HG22 ' E' ' 130' ' ' THR . 12.5 p30 -117.81 176.75 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.621 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 56' ' ' ILE . . . . . 0.793 ' HB ' HD12 ' E' ' 131' ' ' ILE . 51.6 mm -119.03 121.7 67.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.543 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 57' ' ' GLN . . . . . 0.727 ' HG2' HD11 ' B' ' 74' ' ' LEU . 0.0 OUTLIER -86.28 122.63 30.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.792 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 58' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' E' ' 129' ' ' ASN . 0.9 OUTLIER -131.13 93.74 3.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 59' ' ' ASN . . . . . 0.548 ' O ' ' HB3' ' E' ' 22' ' ' ALA . 0.4 OUTLIER -77.08 160.88 28.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.862 -179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.17 87.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.817 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 61' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 70.1 m -120.53 131.84 54.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.783 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.58 97.82 9.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.366 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 63' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' E' ' 66' ' ' ALA . 1.5 m -77.39 -19.95 55.4 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.1 -27.5 68.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.02 0.438 . . . . 0.0 111.715 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.44 -35.75 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.624 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 66' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' E' ' 63' ' ' THR . . . -131.05 131.32 44.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.648 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.49 -37.26 7.66 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.947 0.403 . . . . 0.0 110.94 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -121.74 171.39 8.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.558 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.55 136.1 15.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.532 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 70' ' ' ALA . . . . . 0.707 ' HB3' ' HB3' ' E' ' 157' ' ' GLN . . . -94.54 158.01 15.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.065 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 38.4 t -110.35 106.23 20.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.71 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 72' ' ' ALA . . . . . 0.821 ' HB3' ' HB3' ' E' ' 155' ' ' LYS . . . -109.58 164.36 12.6 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.594 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 73' ' ' PHE . . . . . 0.672 ' HB2' HD11 ' E' ' 111' ' ' LEU . 6.6 t80 -142.27 141.1 32.42 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.532 0.206 . . . . 0.0 111.131 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 74' ' ' LEU . . . . . 0.425 HD22 ' NZ ' ' E' ' 155' ' ' LYS . 0.1 OUTLIER -122.69 103.4 8.64 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.011 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 75' ' ' GLY . . . . . 0.506 ' HA3' HD23 ' E' ' 113' ' ' LEU . . . -153.5 -166.43 14.64 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.876 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.45 136.24 46.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.58 0.228 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 77' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' E' ' 83' ' ' THR . . . -81.35 156.15 25.62 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.935 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 78' ' ' ILE . . . . . 0.462 HG12 ' OG1' ' E' ' 140' ' ' THR . 3.1 tt -92.55 -20.67 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.881 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 79' ' ' ASP . . . . . 0.549 ' HB2' HG21 ' E' ' 140' ' ' THR . 0.4 OUTLIER 176.15 179.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.808 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.88 -33.87 45.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.009 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.48 -43.87 95.68 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.555 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 82' ' ' HIS . . . . . 0.462 ' NE2' ' O ' ' E' ' 139' ' ' ALA . 43.5 m-70 -97.8 -64.37 1.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.849 0.356 . . . . 0.0 110.492 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 83' ' ' THR . . . . . 0.436 ' HA ' ' HB1' ' E' ' 77' ' ' ALA . 1.2 m 62.31 7.85 2.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.609 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 84' ' ' ASN . . . . . 0.426 ' O ' HD12 ' E' ' 103' ' ' ILE . 86.8 m-20 -115.13 -25.46 8.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.255 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.787 ' HA ' ' HA ' ' E' ' 102' ' ' GLN . 0.5 OUTLIER -79.58 143.71 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.177 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 86' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' E' ' 152' ' ' ALA . 0.3 OUTLIER -76.68 148.54 36.78 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.294 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.83 178.23 4.36 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.909 0.385 . . . . 0.0 111.694 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.649 HD22 ' O ' ' E' ' 96' ' ' ALA . 0.0 OUTLIER -84.68 176.17 8.74 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.135 179.402 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 89' ' ' GLN . . . . . 0.537 ' HB3' ' HB2' ' E' ' 149' ' ' ASN . 22.9 pt20 -75.3 178.73 5.61 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.315 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.4 -11.42 60.47 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.999 0.428 . . . . 0.0 111.443 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 91' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' E' ' 95' ' ' SER . 0.3 OUTLIER -64.67 87.26 0.05 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.9 -7.13 53.8 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.909 0.385 . . . . 0.0 111.666 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.14 19.87 4.06 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.678 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.6 -15.6 0.16 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.924 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 95' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' E' ' 91' ' ' SER . 0.9 OUTLIER -97.28 174.95 6.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.886 0.374 . . . . 0.0 110.664 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 96' ' ' ALA . . . . . 0.649 ' O ' HD22 ' E' ' 88' ' ' LEU . . . -114.1 157.83 22.06 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.786 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 97' ' ' THR . . . . . 0.544 HG23 HD11 ' E' ' 88' ' ' LEU . 0.2 OUTLIER -112.92 162.68 15.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.359 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 98' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 69.4 41.53 1.3 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.368 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 99' ' ' VAL . . . . . . . . . . . . . 10.5 p -177.6 130.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.872 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.15 179.47 28.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.521 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 101' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' E' ' 86' ' ' LEU . 1.6 t -99.08 95.27 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.085 0.554 . . . . 0.0 111.65 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 102' ' ' GLN . . . . . 0.787 ' HA ' ' HA ' ' E' ' 85' ' ' VAL . 13.7 tt0 -69.84 159.83 32.91 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.959 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 103' ' ' ILE . . . . . 0.434 HG12 ' CE2' ' E' ' 73' ' ' PHE . 0.9 OUTLIER -121.7 98.49 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.516 179.436 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 104' ' ' LEU . . . . . 0.685 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 1.1 tp -84.79 119.39 25.24 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.701 0.286 . . . . 0.0 111.046 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.17 158.1 32.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.693 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 106' ' ' ARG . . . . . 0.555 ' HB2' ' HB2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -61.21 -33.83 74.11 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.958 0.409 . . . . 0.0 111.102 179.507 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 107' ' ' THR . . . . . 0.556 HG23 ' HA ' ' E' ' 120' ' ' SER . 0.0 OUTLIER -48.8 -38.23 21.45 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.037 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.76 -88.84 0.11 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.598 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.19 -176.39 5.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.863 0.363 . . . . 0.0 111.116 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 110' ' ' ALA . . . . . 0.685 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -79.86 143.88 33.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.221 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' E' ' 73' ' ' PHE . 0.6 OUTLIER -90.14 157.55 17.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.361 0.601 . . . . 0.0 110.545 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 112' ' ' THR . . . . . 0.451 ' HB ' HG21 ' E' ' 117' ' ' THR . 29.7 m -81.1 150.48 28.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.134 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 113' ' ' LEU . . . . . 0.604 HD12 ' N ' ' E' ' 113' ' ' LEU . 3.0 mp -102.74 57.72 0.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.695 0.283 . . . . 0.0 110.719 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.4 19.58 15.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.566 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.19 -93.04 0.88 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.677 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.77 69.72 1.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.077 0.465 . . . . 0.0 111.566 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 117' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' E' ' 72' ' ' ALA . 6.0 p -89.67 97.25 11.08 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.169 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.06 102.84 5.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.809 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.48 -82.83 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 120' ' ' SER . . . . . 0.556 ' HA ' HG23 ' E' ' 107' ' ' THR . 0.1 OUTLIER -63.09 100.86 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.62 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -88.9 79.04 7.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.196 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 122' ' ' THR . . . . . 0.435 HG21 ' CD ' ' E' ' 132' ' ' PRO . 4.6 p -82.54 159.2 22.86 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.667 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 16.1 m -85.27 139.72 31.4 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.731 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.45 136.14 33.46 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.746 0.308 . . . . 0.0 110.594 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 125' ' ' ASN . . . . . 0.532 ' HB3' ' HB3' ' B' ' 116' ' ' ALA . 25.0 m120 -120.77 143.59 48.73 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.613 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.16 148.91 34.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.639 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.71 -106.12 2.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.736 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 128' ' ' THR . . . . . 0.641 HG21 ' NZ ' ' B' ' 155' ' ' LYS . 1.9 m -85.22 153.2 22.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.715 0.293 . . . . 0.0 110.812 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 129' ' ' ASN . . . . . 0.6 ' HB3' ' HB2' ' E' ' 58' ' ' LEU . 23.2 t-20 -148.42 120.73 8.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.955 0.407 . . . . 0.0 111.09 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 130' ' ' THR . . . . . 0.568 ' OG1' HD12 ' B' ' 74' ' ' LEU . 0.2 OUTLIER -104.17 147.3 27.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.147 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 131' ' ' ILE . . . . . 0.793 HD12 ' HB ' ' E' ' 56' ' ' ILE . 89.8 mt -116.65 119.17 36.11 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 132' ' ' PRO . . . . . 0.673 ' HB3' ' H ' ' B' ' 77' ' ' ALA . 7.6 Cg_endo -80.92 119.09 3.51 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.594 1.53 . . . . 0.0 112.553 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.99 147.33 29.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.739 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.15 155.96 47.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.066 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 135' ' ' ALA . . . . . 0.714 ' HB3' HG22 ' E' ' 52' ' ' VAL . . . -140.09 115.71 10.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.912 0.387 . . . . 0.0 111.632 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 136' ' ' ARG . . . . . 0.444 ' NH2' HG21 ' E' ' 48' ' ' THR . 0.5 OUTLIER -111.34 148.99 31.78 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.479 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.53 151.31 45.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.113 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 138' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' E' ' 47' ' ' ALA . 0.2 OUTLIER -144.53 164.58 30.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.009 -179.13 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 139' ' ' ALA . . . . . 0.648 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -124.39 145.65 49.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.913 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 140' ' ' THR . . . . . 0.549 HG21 ' HB2' ' E' ' 79' ' ' ASP . 0.2 OUTLIER -117.78 12.95 14.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.513 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.85 79.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.914 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.74 92.14 0.02 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.608 0.204 . . . . 0.0 110.756 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.1 154.77 33.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.675 0.274 . . . . 0.0 111.4 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 144' ' ' THR . . . . . 0.523 ' O ' ' HB ' ' D' ' 16' ' ' VAL . 39.1 p -116.68 166.2 13.33 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.244 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 145' ' ' PRO . . . . . 0.484 ' HA ' ' HB ' ' D' ' 16' ' ' VAL . 1.3 Cg_endo -84.33 151.42 12.06 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.495 2.13 . . . . 0.0 111.988 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.73 -106.32 0.46 Allowed Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.414 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 147' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -139.05 163.27 32.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.794 0.331 . . . . 0.0 111.408 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.91 79.88 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.508 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 149' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' E' ' 89' ' ' GLN . 87.2 m-20 -99.9 142.48 31.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.557 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 150' ' ' ALA . . . . . 0.527 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -127.78 169.0 14.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.008 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.55 110.04 0.86 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.201 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 152' ' ' ALA . . . . . 0.628 ' HB2' HD21 ' E' ' 86' ' ' LEU . . . -147.06 145.39 29.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.13 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 153' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' D' ' 9' ' ' THR . 1.0 OUTLIER -93.62 164.23 13.24 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 154' ' ' PHE . . . . . 0.611 ' CZ ' HG21 ' E' ' 56' ' ' ILE . 15.1 p90 -110.98 151.59 27.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.193 0.521 . . . . 0.0 110.124 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 155' ' ' LYS . . . . . 0.821 ' HB3' ' HB3' ' E' ' 72' ' ' ALA . 0.0 OUTLIER -109.65 160.89 15.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.959 -178.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 156' ' ' VAL . . . . . 0.643 HG23 HG23 ' D' ' 5' ' ' VAL . 1.4 m -142.18 112.83 2.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.791 0.329 . . . . 0.0 111.678 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 157' ' ' GLN . . . . . 0.707 ' HB3' ' HB3' ' E' ' 70' ' ' ALA . 0.3 OUTLIER -91.83 124.39 35.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.338 0.59 . . . . 0.0 110.426 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 158' ' ' TYR . . . . . 0.539 ' HB2' ' HB ' ' D' ' 3' ' ' THR . 57.6 m-85 -117.17 135.52 53.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.456 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.859 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.55 100.22 0.04 OUTLIER 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.05 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -104.84 78.6 1.44 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.406 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.27 122.41 29.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.659 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 m -137.95 162.89 30.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.567 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -84.28 114.5 21.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.717 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.34 -41.52 8.42 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.678 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.57 162.24 31.49 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.936 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 98.8 m -90.71 137.79 32.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.92 0.39 . . . . 0.0 111.277 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.39 114.28 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.219 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -99.33 148.55 24.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.295 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -133.79 113.03 11.84 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.75 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 13' ' ' LYS . . . . . 0.536 ' HG3' HG11 ' F' ' 28' ' ' VAL . 0.0 OUTLIER -107.14 105.81 15.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.404 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.17 169.5 28.85 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.002 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 15' ' ' GLU . . . . . 0.433 ' OE2' ' HB3' ' E' ' 6' ' ' ASN . 33.5 mt-10 -140.78 -171.07 3.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.358 . . . . 0.0 110.429 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -139.21 152.82 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.197 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 17' ' ' VAL . . . . . 0.592 HG21 ' O ' ' F' ' 21' ' ' CYS . 0.0 OUTLIER -137.45 155.41 31.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.785 0.326 . . . . 0.0 111.037 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -85.16 52.98 2.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.08 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.43 92.69 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.11 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.75 -47.7 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.413 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 21' ' ' CYS . . . . . 0.708 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 1.6 m -159.74 176.86 11.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.983 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 22' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' F' ' 59' ' ' ASN . . . -147.3 112.0 5.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.155 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 23' ' ' VAL . . . . . 0.623 HG13 ' HB3' ' F' ' 27' ' ' SER . 42.8 t -67.39 143.17 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.946 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 24' ' ' ASP . . . . . 0.545 ' O ' HG23 ' F' ' 28' ' ' VAL . 17.0 m-20 -91.19 168.23 11.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.557 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.43 -50.0 74.44 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.455 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.35 -16.66 73.65 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.941 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 27' ' ' SER . . . . . 0.623 ' HB3' HG13 ' F' ' 23' ' ' VAL . 0.4 OUTLIER -84.32 -24.39 29.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.881 0.372 . . . . 0.0 110.767 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 28' ' ' VAL . . . . . 0.545 HG23 ' O ' ' F' ' 24' ' ' ASP . 85.4 t -58.12 -37.17 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.349 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -140.38 106.01 5.12 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.024 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -109.06 106.95 17.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.089 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.81 95.57 9.02 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.059 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.549 HG11 HG21 ' F' ' 52' ' ' VAL . 51.0 t -85.73 138.18 19.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.099 0.476 . . . . 0.0 110.378 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 33' ' ' GLN . . . . . 0.762 ' HA ' ' HG2' ' E' ' 13' ' ' LYS . 3.1 mt-30 -113.17 132.6 55.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.674 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 34' ' ' LEU . . . . . 0.825 HD21 ' HB3' ' E' ' 12' ' ' PHE . 1.8 mm? -94.51 -71.49 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.594 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.9 -111.31 0.71 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.512 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 36' ' ' GLN . . . . . 0.559 ' HG3' ' HB2' ' E' ' 15' ' ' GLU . 3.6 tt0 -160.96 105.75 1.37 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.573 0.225 . . . . 0.0 110.888 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.585 HG23 HG13 ' E' ' 16' ' ' VAL . 5.6 m -91.1 142.45 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.904 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 38' ' ' ARG . . . . . 0.664 ' HG2' ' HA ' ' E' ' 19' ' ' ALA . 0.7 OUTLIER -81.09 162.52 23.69 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.723 179.235 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 39' ' ' THR . . . . . 0.732 HG23 ' O ' ' E' ' 17' ' ' VAL . 82.5 p -80.4 -16.88 53.42 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.775 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.74 -31.27 63.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.115 0.483 . . . . 0.0 110.876 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.02 -28.51 39.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.121 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 42' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' F' ' 139' ' ' ALA . 1.7 mp -133.11 70.05 1.47 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.686 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 43' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' F' ' 39' ' ' THR . . . -103.65 11.2 36.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.445 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.07 146.84 27.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.394 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.43 121.24 13.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 111.158 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.57 -10.48 12.66 Favored Glycine 0 C--N 1.331 0.274 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.146 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 47' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' F' ' 138' ' ' PHE . . . -68.74 142.26 55.01 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 48' ' ' THR . . . . . 0.433 HG21 ' NH2' ' F' ' 136' ' ' ARG . 6.9 t -134.85 140.85 46.15 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.826 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -106.05 -152.75 0.48 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.519 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.91 178.52 1.07 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.881 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.02 168.86 15.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.281 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 52' ' ' VAL . . . . . 0.708 HG22 ' HB3' ' F' ' 135' ' ' ALA . 14.6 m -117.94 132.21 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.028 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 53' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' C' ' 88' ' ' LEU . . . -95.22 107.68 3.58 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.654 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 54' ' ' PHE . . . . . 0.583 ' HD1' HG23 ' F' ' 52' ' ' VAL . 55.5 p90 -140.35 132.12 27.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 55' ' ' ASN . . . . . 0.523 ' HB2' HG22 ' F' ' 130' ' ' THR . 12.5 p30 -117.85 176.84 5.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.61 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 56' ' ' ILE . . . . . 0.783 ' HB ' HD12 ' F' ' 131' ' ' ILE . 51.8 mm -119.0 121.7 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.549 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 57' ' ' GLN . . . . . 0.726 ' HG2' HD11 ' C' ' 74' ' ' LEU . 0.0 OUTLIER -86.26 122.61 30.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.855 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 58' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' F' ' 129' ' ' ASN . 0.9 OUTLIER -131.15 93.73 3.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.265 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 59' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' F' ' 22' ' ' ALA . 0.4 OUTLIER -77.17 160.92 28.6 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.21 87.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.798 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 61' ' ' CYS . . . . . 0.708 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 69.8 m -120.41 131.88 54.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.65 97.91 9.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.321 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 63' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' F' ' 66' ' ' ALA . 1.5 m -77.52 -19.89 55.08 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -27.45 68.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.985 0.422 . . . . 0.0 111.689 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.41 -35.76 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.597 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 66' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' F' ' 63' ' ' THR . . . -131.01 131.31 44.26 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.624 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.52 -37.3 7.63 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.964 0.412 . . . . 0.0 110.933 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -121.72 171.38 8.91 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.606 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.52 136.06 15.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.575 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 70' ' ' ALA . . . . . 0.725 ' HB3' ' HB3' ' F' ' 157' ' ' GLN . . . -94.47 157.92 15.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.101 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.36 106.25 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.682 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 72' ' ' ALA . . . . . 0.843 ' HB3' ' HB3' ' F' ' 155' ' ' LYS . . . -109.53 164.35 12.6 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.64 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 73' ' ' PHE . . . . . 0.67 ' HB2' HD11 ' F' ' 111' ' ' LEU . 6.5 t80 -142.25 141.05 32.44 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.52 0.2 . . . . 0.0 111.151 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 74' ' ' LEU . . . . . 0.434 HD22 ' NZ ' ' F' ' 155' ' ' LYS . 0.1 OUTLIER -122.68 103.32 8.59 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.038 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 75' ' ' GLY . . . . . 0.493 ' H ' ' HB3' ' F' ' 113' ' ' LEU . . . -153.42 -166.34 14.51 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.87 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.52 136.22 46.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.604 0.24 . . . . 0.0 110.714 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 77' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' F' ' 83' ' ' THR . . . -81.4 156.09 25.58 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.925 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 78' ' ' ILE . . . . . 0.47 HG12 ' OG1' ' F' ' 140' ' ' THR . 3.1 tt -92.51 -20.65 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.859 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 79' ' ' ASP . . . . . 0.553 ' HB2' HG21 ' F' ' 140' ' ' THR . 0.4 OUTLIER 176.18 179.75 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.757 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.04 -33.76 44.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.48 -43.88 95.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.583 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 82' ' ' HIS . . . . . 0.466 ' NE2' ' O ' ' F' ' 139' ' ' ALA . 43.5 m-70 -97.83 -64.38 1.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.812 0.339 . . . . 0.0 110.436 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 83' ' ' THR . . . . . 0.429 ' HA ' ' HB1' ' F' ' 77' ' ' ALA . 1.2 m 62.35 7.83 2.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.582 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 84' ' ' ASN . . . . . 0.415 ' O ' HD12 ' F' ' 103' ' ' ILE . 87.1 m-20 -115.09 -25.48 8.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.32 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 85' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' F' ' 102' ' ' GLN . 0.5 OUTLIER -79.53 143.75 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.199 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 86' ' ' LEU . . . . . 0.624 HD21 ' HB2' ' F' ' 152' ' ' ALA . 0.3 OUTLIER -76.62 148.57 36.87 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.392 179.359 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.87 178.22 4.39 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.799 0.333 . . . . 0.0 111.695 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 88' ' ' LEU . . . . . 0.657 HD22 ' O ' ' F' ' 96' ' ' ALA . 0.0 OUTLIER -84.72 176.2 8.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.069 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 89' ' ' GLN . . . . . 0.529 ' HB3' ' HB2' ' F' ' 149' ' ' ASN . 22.8 pt20 -75.29 178.71 5.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.36 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.34 -11.48 60.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.052 0.454 . . . . 0.0 111.447 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 91' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' F' ' 95' ' ' SER . 0.3 OUTLIER -64.69 87.28 0.05 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.884 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.95 -7.12 53.84 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.961 0.41 . . . . 0.0 111.666 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.08 19.86 4.08 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.699 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.58 -15.62 0.16 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.895 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 95' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' F' ' 91' ' ' SER . 1.0 OUTLIER -97.34 174.97 6.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.934 0.397 . . . . 0.0 110.572 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 96' ' ' ALA . . . . . 0.657 ' O ' HD22 ' F' ' 88' ' ' LEU . . . -114.14 157.83 22.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.85 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 97' ' ' THR . . . . . 0.54 HG23 HD11 ' F' ' 88' ' ' LEU . 0.2 OUTLIER -112.95 162.64 15.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.318 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 98' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 69.39 41.61 1.29 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.406 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 10.4 p -177.65 130.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.8 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.1 179.46 28.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.523 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 101' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' F' ' 86' ' ' LEU . 1.6 t -99.07 95.28 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.068 0.547 . . . . 0.0 111.716 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 102' ' ' GLN . . . . . 0.783 ' HA ' ' HA ' ' F' ' 85' ' ' VAL . 13.8 tt0 -69.88 159.82 32.96 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.898 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 103' ' ' ILE . . . . . 0.433 HG12 ' CE2' ' F' ' 73' ' ' PHE . 0.9 OUTLIER -121.65 98.39 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.538 179.456 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 104' ' ' LEU . . . . . 0.699 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 1.1 tp -84.76 119.39 25.23 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 111.082 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.15 158.08 32.1 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.701 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 106' ' ' ARG . . . . . 0.55 ' HB2' ' HB2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -61.16 -33.86 74.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.881 0.372 . . . . 0.0 111.093 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 107' ' ' THR . . . . . 0.534 HG23 ' HA ' ' F' ' 120' ' ' SER . 0.0 OUTLIER -48.77 -38.18 21.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.094 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.7 -88.77 0.11 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.597 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.23 -176.32 5.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.351 . . . . 0.0 111.111 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 110' ' ' ALA . . . . . 0.699 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -79.96 143.92 33.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 111' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' F' ' 73' ' ' PHE . 0.6 OUTLIER -90.1 157.53 17.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.359 0.6 . . . . 0.0 110.566 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 112' ' ' THR . . . . . 0.449 ' HB ' HG21 ' F' ' 117' ' ' THR . 29.5 m -81.13 150.4 28.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.127 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 113' ' ' LEU . . . . . 0.596 HD12 ' N ' ' F' ' 113' ' ' LEU . 3.0 mp -102.75 57.77 0.78 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.737 0.303 . . . . 0.0 110.696 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.47 19.63 15.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.56 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.26 -93.11 0.88 Allowed Glycine 0 C--N 1.328 0.13 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.628 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.7 69.57 1.08 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.083 0.468 . . . . 0.0 111.589 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 117' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' F' ' 72' ' ' ALA . 5.8 p -89.65 97.28 11.11 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.145 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.08 102.77 5.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.736 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.5 -82.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 120' ' ' SER . . . . . 0.534 ' HA ' HG23 ' F' ' 107' ' ' THR . 0.1 OUTLIER -63.25 100.89 0.26 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.609 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.91 79.07 7.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.186 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 122' ' ' THR . . . . . 0.435 HG21 ' CD ' ' F' ' 132' ' ' PRO . 4.6 p -82.56 159.18 22.84 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.701 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 16.1 m -85.29 139.73 31.37 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.708 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.42 136.13 33.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.617 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 125' ' ' ASN . . . . . 0.53 ' HB3' ' HB3' ' C' ' 116' ' ' ALA . 25.0 m120 -120.78 143.65 48.71 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.577 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.27 148.95 34.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.626 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.68 -106.22 2.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.745 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 128' ' ' THR . . . . . 0.647 HG21 ' NZ ' ' C' ' 155' ' ' LYS . 1.9 m -85.18 153.22 22.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.7 0.286 . . . . 0.0 110.757 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 129' ' ' ASN . . . . . 0.597 ' HB3' ' HB2' ' F' ' 58' ' ' LEU . 23.2 t-20 -148.43 120.71 8.39 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.909 0.385 . . . . 0.0 111.035 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 130' ' ' THR . . . . . 0.565 ' OG1' HD12 ' C' ' 74' ' ' LEU . 0.2 OUTLIER -104.19 147.33 27.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.14 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 131' ' ' ILE . . . . . 0.783 HD12 ' HB ' ' F' ' 56' ' ' ILE . 89.7 mt -116.64 119.18 36.12 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 132' ' ' PRO . . . . . 0.685 ' HB3' ' H ' ' C' ' 77' ' ' ALA . 7.6 Cg_endo -80.96 119.09 3.5 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 121.653 1.569 . . . . 0.0 112.531 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.98 147.29 29.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.756 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.09 155.92 47.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.041 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 135' ' ' ALA . . . . . 0.708 ' HB3' HG22 ' F' ' 52' ' ' VAL . . . -140.07 115.69 10.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.884 0.373 . . . . 0.0 111.598 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 136' ' ' ARG . . . . . 0.433 ' NH2' HG21 ' F' ' 48' ' ' THR . 0.5 OUTLIER -111.32 149.02 31.72 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.479 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.64 151.3 45.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.073 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 138' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' F' ' 47' ' ' ALA . 0.2 OUTLIER -144.5 164.6 30.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.97 -179.121 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 139' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -124.46 145.68 49.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.869 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 140' ' ' THR . . . . . 0.553 HG21 ' HB2' ' F' ' 79' ' ' ASP . 0.2 OUTLIER -117.75 12.99 14.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.512 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.81 79.83 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.874 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.59 92.19 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.62 0.21 . . . . 0.0 110.762 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.1 154.81 33.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.756 0.312 . . . . 0.0 111.377 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 144' ' ' THR . . . . . 0.516 ' O ' ' HB ' ' E' ' 16' ' ' VAL . 39.4 p -116.71 166.21 13.33 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.208 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 145' ' ' PRO . . . . . 0.49 ' HA ' ' HB ' ' E' ' 16' ' ' VAL . 1.3 Cg_endo -84.29 151.47 12.14 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.445 2.097 . . . . 0.0 111.975 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.64 -106.23 0.45 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.443 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 147' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -139.11 163.26 32.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.783 0.325 . . . . 0.0 111.357 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.98 79.9 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.498 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 149' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' F' ' 89' ' ' GLN . 87.2 m-20 -99.93 142.51 31.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.593 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 150' ' ' ALA . . . . . 0.528 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -127.83 169.06 14.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.042 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.59 109.91 0.85 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.186 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 152' ' ' ALA . . . . . 0.624 ' HB2' HD21 ' F' ' 86' ' ' LEU . . . -146.95 145.4 29.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.123 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 153' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' E' ' 9' ' ' THR . 1.0 OUTLIER -93.63 164.17 13.26 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 154' ' ' PHE . . . . . 0.629 ' CZ ' HG21 ' F' ' 56' ' ' ILE . 15.0 p90 -110.87 151.61 27.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.178 0.513 . . . . 0.0 110.125 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 155' ' ' LYS . . . . . 0.843 ' HB3' ' HB3' ' F' ' 72' ' ' ALA . 0.0 OUTLIER -109.69 160.95 15.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.893 -178.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 156' ' ' VAL . . . . . 0.631 HG23 HG23 ' E' ' 5' ' ' VAL . 1.5 m -142.19 112.84 2.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.846 0.355 . . . . 0.0 111.688 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 157' ' ' GLN . . . . . 0.725 ' HB3' ' HB3' ' F' ' 70' ' ' ALA . 0.3 OUTLIER -91.82 124.46 35.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.276 0.56 . . . . 0.0 110.429 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 158' ' ' TYR . . . . . 0.547 ' HB2' ' HB ' ' E' ' 3' ' ' THR . 57.5 m-85 -117.19 135.51 53.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.462 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.888 179.9 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' B' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.254 0.073 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.629 ' H ' ' HA ' ' B' ' 159' ' ' GLN . . . 59.07 55.86 4.22 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.649 0.261 . . . . 0.0 111.027 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.525 HG21 ' HB2' ' B' ' 18' ' ' ASN . 90.2 m -118.7 111.08 18.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.379 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.746 HG23 ' HG3' ' B' ' 157' ' ' GLN . 0.2 OUTLIER -97.77 127.36 43.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.554 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.649 HG23 HG23 ' B' ' 156' ' ' VAL . 0.0 OUTLIER -153.57 171.5 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.578 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.533 ' O ' ' NE2' ' C' ' 36' ' ' GLN . 1.2 t30 -94.42 122.1 36.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.608 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.0 -52.18 6.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.855 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.42 -145.43 5.81 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.886 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.535 HG23 HG23 ' B' ' 153' ' ' THR . 0.2 OUTLIER -146.81 139.81 25.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 111.28 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.4 121.6 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.136 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.59 106.61 18.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.324 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.437 ' HZ ' ' CZ ' ' B' ' 54' ' ' PHE . 8.9 m-85 -90.65 107.61 19.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.26 149.25 24.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.383 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.45 -179.07 47.54 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.902 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.67 ' HB3' ' HG3' ' B' ' 36' ' ' GLN . 0.1 OUTLIER -158.97 157.02 30.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.845 0.355 . . . . 0.0 110.394 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.8 t -113.71 132.23 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.245 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.558 HG13 ' HG2' ' B' ' 36' ' ' GLN . 5.5 m -136.88 176.58 7.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.887 0.375 . . . . 0.0 111.024 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.46 174.07 9.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.021 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 62' ' ' ASP . . . -83.37 35.35 0.49 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.066 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -116.89 -15.93 10.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.429 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.98 155.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.97 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.76 126.48 5.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.052 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.741 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -60.87 162.49 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.037 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 27' ' ' SER . 18.6 t70 -97.6 161.0 13.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.588 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.31 95.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.353 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.47 12.76 69.0 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.935 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.575 ' HB3' ' HB3' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -113.79 -25.6 8.57 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.92 0.39 . . . . 0.0 110.837 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' ' 28' ' ' VAL . 9.6 t -41.04 -62.02 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.373 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.57 119.96 39.59 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.033 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -126.09 119.13 26.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.033 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.71 103.32 15.48 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.115 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.88 115.12 43.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.168 0.509 . . . . 0.0 110.475 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.53 112.61 24.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.671 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.86 -30.36 58.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.622 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.02 -170.25 27.44 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.562 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.46 141.8 28.05 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.653 0.263 . . . . 0.0 110.871 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.562 HG11 HD22 ' A' ' 42' ' ' LEU . 5.8 p -125.34 157.14 34.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.88 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.53 122.46 29.04 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.704 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -40.39 87.01 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.774 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.51 -35.88 68.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.06 0.457 . . . . 0.0 110.773 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.13 -21.51 33.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.162 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.562 HD22 HG11 ' A' ' 37' ' ' VAL . 3.2 mp -110.51 29.49 7.67 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.579 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 141' ' ' GLY . . . -108.19 25.46 11.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.387 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.66 159.96 23.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.414 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 140' ' ' THR . 11.1 tt0 -82.87 108.66 16.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 0.0 111.166 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.93 10.84 51.54 Favored Glycine 0 C--N 1.33 0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.18 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -66.58 123.48 20.17 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.957 0.408 . . . . 0.0 112.014 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -120.64 140.28 51.79 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.828 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 4.6 m -101.65 -167.01 1.36 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.614 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.64 139.7 53.59 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.783 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.86 133.99 35.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.369 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 135' ' ' ALA . 18.8 m -87.0 166.49 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.927 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.7 128.83 7.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.63 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 133' ' ' PHE . 40.7 p90 -160.23 134.48 7.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.731 0.3 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.515 ' OD1' HG21 ' A' ' 130' ' ' THR . 16.0 p30 -132.87 147.73 52.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.494 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.637 HG22 ' HB ' ' A' ' 131' ' ' ILE . 1.0 OUTLIER -96.89 116.82 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.496 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.567 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -66.59 122.08 16.79 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.754 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.741 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -137.42 88.17 2.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.218 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.715 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 10.5 p30 -79.53 179.31 7.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.955 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.39 64.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 129' ' ' ASN . 4.4 m -110.53 163.23 13.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.839 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -140.14 155.02 47.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.287 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.24 -25.33 10.66 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -81.96 -16.38 50.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.156 0.503 . . . . 0.0 111.822 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.401 HG23 ' OD2' ' A' ' 62' ' ' ASP . 16.6 t -90.65 -48.41 14.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.662 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.11 142.9 36.03 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.637 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.8 -53.79 2.6 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.846 0.355 . . . . 0.0 110.995 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -94.86 158.16 15.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.514 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.934 ' HB2' HD13 ' A' ' 124' ' ' LEU . . . -137.21 120.46 16.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.588 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -97.57 129.17 44.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.096 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.593 HG11 HG21 ' A' ' 131' ' ' ILE . 15.9 t -113.05 152.23 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.672 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.98 146.58 27.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.606 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CD2' HG21 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -111.54 141.89 44.53 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.577 0.227 . . . . 0.0 111.067 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -105.7 103.31 12.8 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.934 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.87 -179.11 25.42 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.837 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.699 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.2 OUTLIER -105.16 157.79 17.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.57 0.224 . . . . 0.0 110.771 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.433 ' H ' ' HB2' ' D' ' 132' ' ' PRO . . . -77.85 132.82 38.17 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.876 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.453 ' CG2' ' HB ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER -66.61 -39.87 84.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.404 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.7 OUTLIER -146.21 53.55 1.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.788 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' D' ' 106' ' ' ARG . . . 61.42 -87.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.038 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.29 -36.55 53.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.594 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -81.34 59.93 4.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.865 0.364 . . . . 0.0 110.445 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.584 HG21 ' OD1' ' A' ' 114' ' ' ASP . 2.1 m -70.59 -20.41 62.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.483 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.891 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 26.5 p-10 -69.45 -13.73 62.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.29 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 102' ' ' GLN . 40.7 t -108.97 131.2 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.109 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -70.05 142.81 52.65 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.305 179.386 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.91 -170.52 3.05 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.946 0.403 . . . . 0.0 111.709 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 88' ' ' LEU . 1.2 mm? -80.04 161.4 25.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.02 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.73 -80.32 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.31 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.456 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 6.6 p -171.33 0.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.95 0.405 . . . . 0.0 111.446 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.687 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 73.4 m -76.81 85.65 3.4 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.902 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' D' ' 50' ' ' SER . . . -60.98 -32.34 71.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.86 0.362 . . . . 0.0 111.641 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.79 30.52 6.85 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.627 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.78 -3.14 0.11 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.92 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 0.1 OUTLIER -107.57 -176.72 3.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.882 0.372 . . . . 0.0 110.652 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.54 172.68 8.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.796 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.605 ' H ' ' HB ' ' A' ' 144' ' ' THR . 1.7 m -126.95 140.47 52.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.29 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.483 ' HB3' ' H ' ' A' ' 141' ' ' GLY . 27.4 m120 61.96 21.23 12.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.495 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 97' ' ' THR . 2.7 t -120.29 135.99 58.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.724 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.97 -160.62 10.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.531 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 86' ' ' LEU . 4.4 p -145.96 109.88 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.173 0.511 . . . . 0.0 111.677 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.681 ' HB2' HG22 ' A' ' 85' ' ' VAL . 0.5 OUTLIER -84.37 147.38 27.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.936 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.613 HG12 ' HG ' ' A' ' 113' ' ' LEU . 1.2 pp -110.72 127.84 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.501 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.93 HD12 ' HB2' ' A' ' 110' ' ' ALA . 1.4 tp -97.37 132.95 42.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.686 0.279 . . . . 0.0 111.045 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.67 ' HB3' HG22 ' A' ' 107' ' ' THR . 4.0 t0 -80.82 143.61 32.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.675 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -65.46 -17.5 64.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.838 0.351 . . . . 0.0 111.083 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.67 HG22 ' HB3' ' A' ' 105' ' ' ASP . 13.2 t -66.89 -20.61 65.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.001 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.08 -71.77 0.44 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.68 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.53 160.02 31.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.819 0.343 . . . . 0.0 111.044 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.93 ' HB2' HD12 ' A' ' 104' ' ' LEU . . . -75.66 131.46 39.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.692 HD21 ' O ' ' A' ' 117' ' ' THR . 12.2 tp -88.1 154.18 20.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.351 0.596 . . . . 0.0 110.6 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.891 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -96.37 142.7 28.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.145 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.613 ' HG ' HG12 ' A' ' 103' ' ' ILE . 0.8 OUTLIER -80.79 63.65 5.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.715 0.293 . . . . 0.0 110.747 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.584 ' OD1' HG21 ' A' ' 83' ' ' THR . 0.1 OUTLIER -90.63 -30.63 17.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.547 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.518 ' HA3' ' OG1' ' D' ' 130' ' ' THR . . . 115.75 -43.6 1.64 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.721 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.453 ' HB2' ' C ' ' D' ' 128' ' ' THR . . . -110.46 24.39 13.03 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.011 0.434 . . . . 0.0 111.717 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.692 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -82.22 68.35 8.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.554 ' CD1' ' HB2' ' A' ' 157' ' ' GLN . 40.8 m-85 -82.19 71.96 9.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.744 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.71 81.11 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.797 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.75 131.75 13.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.604 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.427 ' O ' ' HE2' ' A' ' 68' ' ' LYS . 1.5 mm-40 -100.72 52.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.232 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.664 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -72.14 132.02 43.59 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.734 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.81 107.71 15.63 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.638 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.934 HD13 ' HB2' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -88.27 126.53 35.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.563 179.427 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.515 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 1.1 m120 -120.62 -178.95 3.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.544 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.526 ' OD1' ' HA ' ' A' ' 62' ' ' ASP . 3.8 t30 -83.27 120.65 26.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.659 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.16 -121.79 2.53 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.686 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.715 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 75.6 m -122.14 103.41 8.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.7 0.286 . . . . 0.0 110.806 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.533 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 1.7 t30 -86.14 157.21 20.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.907 0.384 . . . . 0.0 111.144 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.567 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.3 OUTLIER -143.26 130.27 20.63 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.072 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.637 ' HB ' HG22 ' A' ' 56' ' ' ILE . 57.5 mt -84.21 104.24 4.04 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 7.6 Cg_endo -81.99 112.29 2.3 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.63 1.554 . . . . 0.0 112.629 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 54' ' ' PHE . 1.0 OUTLIER -126.67 158.32 36.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.856 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -126.01 156.04 40.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.083 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.536 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -148.22 105.18 3.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.96 0.409 . . . . 0.0 111.615 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.08 163.46 12.57 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.351 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.562 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 0.3 OUTLIER -81.71 119.73 24.22 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.099 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.468 ' HB3' HG11 ' A' ' 85' ' ' VAL . 2.1 t80 -108.84 142.62 39.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.213 0.53 . . . . 0.0 112.06 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -132.96 136.0 45.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.904 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 25.2 p -96.58 -56.16 2.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.519 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.483 ' H ' ' HB3' ' A' ' 98' ' ' ASN . . . -127.06 -129.88 3.31 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.044 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.91 107.12 12.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.647 0.224 . . . . 0.0 110.781 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -65.87 148.03 52.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.687 0.28 . . . . 0.0 111.466 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.605 ' HB ' ' H ' ' A' ' 97' ' ' THR . 48.5 m -114.82 144.68 32.42 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.284 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.402 ' HD2' HG23 ' A' ' 144' ' ' THR . 1.3 Cg_endo -81.9 130.98 6.84 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.521 2.147 . . . . 0.0 111.982 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 164.82 -116.28 0.69 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.492 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.62 150.39 29.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.826 0.346 . . . . 0.0 111.397 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.69 45.93 1.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.078 0.466 . . . . 0.0 110.402 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.96 141.07 30.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.505 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.401 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -153.72 162.6 41.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.959 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -133.99 135.37 43.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.252 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.751 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -134.1 152.51 51.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.174 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.458 ' H ' ' HB3' ' A' ' 74' ' ' LEU . 3.9 m -104.13 148.96 25.68 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.29 141.89 35.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.108 0.48 . . . . 0.0 110.106 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.59 152.36 40.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.896 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.586 HG12 HD11 ' A' ' 131' ' ' ILE . 20.1 m -135.7 133.19 51.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.808 0.337 . . . . 0.0 111.704 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.554 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . 1.8 tt0 -130.91 119.77 22.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.271 0.557 . . . . 0.0 110.407 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -101.95 113.31 26.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.57 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.835 179.974 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' C' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.24 0.066 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.626 ' H ' ' HA ' ' C' ' 159' ' ' GLN . . . 59.14 55.8 4.21 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.081 0.238 . . . . 0.0 110.992 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.504 HG21 ' HB2' ' C' ' 18' ' ' ASN . 89.7 m -118.64 111.08 18.09 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.467 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.74 HG21 ' HA2' ' F' ' 127' ' ' GLY . 0.2 OUTLIER -97.78 127.33 43.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.572 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.632 HG23 HG23 ' C' ' 156' ' ' VAL . 0.0 OUTLIER -153.54 171.53 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.582 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.541 ' O ' ' NE2' ' D' ' 36' ' ' GLN . 1.2 t30 -94.48 122.09 36.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.562 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.84 -52.34 6.47 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.861 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.43 -145.44 5.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.846 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.526 HG23 HG23 ' C' ' 153' ' ' THR . 0.2 OUTLIER -146.76 139.86 25.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 111.254 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 45.3 t -122.4 121.61 64.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.148 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -99.69 106.6 18.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.369 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' PHE . . . . . 0.42 ' HZ ' ' CZ ' ' C' ' 54' ' ' PHE . 8.8 m-85 -90.6 107.59 19.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.26 149.21 24.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.376 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.42 -179.01 47.49 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.98 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.674 ' HB3' ' HG3' ' C' ' 36' ' ' GLN . 0.1 OUTLIER -158.97 157.04 30.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.915 0.388 . . . . 0.0 110.377 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.459 ' O ' HG11 ' A' ' 5' ' ' VAL . 18.0 t -113.77 132.25 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.199 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.619 HG12 HG21 ' A' ' 5' ' ' VAL . 5.5 m -136.9 176.56 7.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.11 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ASN . . . . . 0.525 ' HB2' HG21 ' A' ' 3' ' ' THR . 1.2 t30 -74.4 174.1 9.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.038 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' B' ' 62' ' ' ASP . . . -83.39 35.28 0.49 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.014 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' B' ' 61' ' ' CYS . . . -116.81 -15.93 10.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.466 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 180.0 155.23 0.59 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.915 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.4 ' HA ' HG21 ' B' ' 17' ' ' VAL . . . -157.69 126.42 5.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.074 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.735 ' HA ' ' HG ' ' B' ' 58' ' ' LEU . 0.7 OUTLIER -60.82 162.51 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.046 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' B' ' 27' ' ' SER . 18.5 t70 -97.56 161.0 13.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.634 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.45 96.27 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.346 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.39 12.75 69.08 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.953 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' B' ' 24' ' ' ASP . 0.6 OUTLIER -113.79 -25.54 8.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.438 HG23 ' H ' ' B' ' 28' ' ' VAL . 9.8 t -41.17 -62.01 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.28 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.56 119.97 39.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.055 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -126.1 119.11 26.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.058 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.71 103.31 15.46 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.158 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.81 115.11 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.11 0.481 . . . . 0.0 110.445 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.53 112.63 24.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.592 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.86 -30.39 58.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.6 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.07 -170.23 27.36 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.622 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.67 ' HG3' ' HB3' ' A' ' 15' ' ' GLU . 0.1 OUTLIER -93.55 141.72 28.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.595 0.235 . . . . 0.0 110.88 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.548 HG11 HD22 ' B' ' 42' ' ' LEU . 5.8 p -125.22 157.18 34.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.899 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.56 122.39 28.96 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.735 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -40.52 86.96 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.756 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.44 -35.84 68.31 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.112 0.482 . . . . 0.0 110.842 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.1 -21.55 33.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.175 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.548 HD22 HG11 ' B' ' 37' ' ' VAL . 3.2 mp -110.5 29.49 7.66 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.666 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' B' ' 141' ' ' GLY . . . -108.26 25.55 11.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.364 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.81 159.99 23.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.299 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' B' ' 140' ' ' THR . 11.0 tt0 -82.88 108.65 16.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 111.19 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.95 10.83 51.5 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.202 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' B' ' 139' ' ' ALA . . . -66.62 123.51 20.29 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -120.69 140.24 51.89 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.928 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 4.6 m -101.56 -166.97 1.35 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.686 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.74 139.71 53.38 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.784 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.77 134.01 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.321 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.539 HG22 ' O ' ' B' ' 135' ' ' ALA . 18.8 m -87.07 166.44 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.911 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.69 128.83 7.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.634 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' PHE . . . . . 0.437 ' CZ ' ' HZ ' ' A' ' 12' ' ' PHE . 40.6 p90 -160.23 134.5 7.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.793 0.33 . . . . 0.0 110.932 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.512 ' OD1' HG21 ' B' ' 130' ' ' THR . 15.9 p30 -132.79 147.69 52.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.58 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.634 HG22 ' HB ' ' B' ' 131' ' ' ILE . 1.0 OUTLIER -96.75 116.78 39.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.589 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLN . . . . . 0.566 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -66.6 122.01 16.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.724 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.735 ' HG ' ' HA ' ' B' ' 23' ' ' VAL . 0.2 OUTLIER -137.45 88.23 2.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.247 -179.674 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.712 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 10.6 p30 -79.63 179.35 7.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.877 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.3 64.37 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.837 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' B' ' 129' ' ' ASN . 4.4 m -110.48 163.27 13.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.808 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' B' ' 19' ' ' ALA . 0.5 OUTLIER -140.18 155.04 47.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.275 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.23 -25.35 10.65 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -82.02 -16.33 50.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.067 0.46 . . . . 0.0 111.736 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.402 HG23 ' OD2' ' B' ' 62' ' ' ASP . 16.7 t -90.66 -48.49 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.661 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.1 142.94 36.04 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.624 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.79 -53.89 2.59 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.842 0.353 . . . . 0.0 110.912 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' B' ' 121' ' ' GLU . 0.1 OUTLIER -94.77 158.16 15.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.519 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.905 ' HB2' HD13 ' B' ' 124' ' ' LEU . . . -137.17 120.44 16.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.637 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -97.57 129.13 44.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.124 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.608 HG11 HG21 ' B' ' 131' ' ' ILE . 15.9 t -113.04 152.28 14.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.73 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.99 146.57 27.09 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.554 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.476 ' CD2' HG21 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -111.58 141.92 44.55 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.591 0.234 . . . . 0.0 111.098 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' B' ' 152' ' ' ALA . 0.8 OUTLIER -105.62 103.33 12.82 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.96 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.91 -179.05 25.4 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.814 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.679 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.2 OUTLIER -105.25 157.78 17.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.533 0.206 . . . . 0.0 110.725 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.439 ' H ' ' HB2' ' E' ' 132' ' ' PRO . . . -77.86 132.75 38.12 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.898 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.446 ' CG2' ' HB ' ' B' ' 85' ' ' VAL . 0.6 OUTLIER -66.68 -39.76 84.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.2 53.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' E' ' 106' ' ' ARG . . . 61.32 -87.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.03 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.33 -36.5 53.17 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.602 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -81.39 59.98 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.36 . . . . 0.0 110.447 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' THR . . . . . 0.596 HG21 ' OD1' ' B' ' 114' ' ' ASP . 2.1 m -70.61 -20.49 62.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.512 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ASN . . . . . 0.879 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 26.6 p-10 -69.29 -13.74 62.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.352 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' B' ' 102' ' ' GLN . 40.8 t -108.97 131.15 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.127 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' B' ' 152' ' ' ALA . 0.6 OUTLIER -70.11 142.84 52.53 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.014 -0.275 . . . . 0.0 110.308 179.42 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.97 -170.53 3.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.891 0.377 . . . . 0.0 111.752 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' B' ' 88' ' ' LEU . 1.2 mm? -80.04 161.43 25.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.037 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.78 -80.24 0.01 OUTLIER 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.315 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' SER . . . . . 0.474 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 6.5 p -171.42 0.5 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.993 0.425 . . . . 0.0 111.504 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' SER . . . . . 0.675 ' HA ' ' HB2' ' D' ' 25' ' ' ALA . 73.5 m -76.86 85.55 3.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.921 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' E' ' 50' ' ' SER . . . -60.88 -32.33 71.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.968 0.413 . . . . 0.0 111.733 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.75 30.47 6.88 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.7 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.74 -3.22 0.11 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.945 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' SER . . . . . 0.603 ' HB2' ' HB2' ' B' ' 91' ' ' SER . 0.1 OUTLIER -107.5 -176.78 3.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 110.661 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.39 172.67 8.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.848 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.622 ' H ' ' HB ' ' B' ' 144' ' ' THR . 1.7 m -127.01 140.36 52.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.339 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' ASN . . . . . 0.5 ' HB3' ' H ' ' B' ' 141' ' ' GLY . 27.4 m120 62.05 21.3 12.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.441 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 97' ' ' THR . 2.7 t -120.38 135.98 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.723 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.0 -160.77 10.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.569 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.415 HG13 ' HB2' ' B' ' 86' ' ' LEU . 4.5 p -145.84 109.85 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 122.974 0.51 . . . . 0.0 111.767 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.679 ' HB2' HG22 ' B' ' 85' ' ' VAL . 0.5 OUTLIER -84.33 147.33 27.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.881 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.596 HG12 ' HG ' ' B' ' 113' ' ' LEU . 1.2 pp -110.69 127.88 67.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.515 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' LEU . . . . . 0.978 HD12 ' HB2' ' B' ' 110' ' ' ALA . 1.4 tp -97.46 132.95 42.67 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.637 0.256 . . . . 0.0 111.003 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ASP . . . . . 0.652 ' HB3' HG22 ' B' ' 107' ' ' THR . 4.0 t0 -80.76 143.59 32.79 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.739 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -65.43 -17.55 64.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.817 0.341 . . . . 0.0 111.061 179.509 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.652 HG22 ' HB3' ' B' ' 105' ' ' ASP . 13.2 t -66.84 -20.65 65.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.011 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.05 -71.61 0.44 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.769 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.51 159.93 31.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.768 0.318 . . . . 0.0 111.139 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.978 ' HB2' HD12 ' B' ' 104' ' ' LEU . . . -75.54 131.49 40.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.162 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.685 HD21 ' O ' ' B' ' 117' ' ' THR . 12.2 tp -88.1 154.22 20.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.331 0.586 . . . . 0.0 110.553 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.879 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 0.4 OUTLIER -96.43 142.71 28.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.155 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.596 ' HG ' HG12 ' B' ' 103' ' ' ILE . 0.8 OUTLIER -80.82 63.68 5.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.771 0.32 . . . . 0.0 110.708 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ASP . . . . . 0.596 ' OD1' HG21 ' B' ' 83' ' ' THR . 0.1 OUTLIER -90.63 -30.6 17.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.573 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 115' ' ' GLY . . . . . 0.525 ' HA3' ' OG1' ' E' ' 130' ' ' THR . . . 115.76 -43.58 1.64 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.617 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' ALA . . . . . 0.456 ' HB2' ' C ' ' E' ' 128' ' ' THR . . . -110.58 24.43 12.97 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.006 0.431 . . . . 0.0 111.634 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.685 ' O ' HD21 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -82.12 68.28 8.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.13 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.54 ' CD1' ' HB2' ' B' ' 157' ' ' GLN . 41.2 m-85 -82.15 71.93 9.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.798 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.74 80.98 1.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.831 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.62 131.75 13.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.614 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLU . . . . . 0.434 ' O ' ' HE2' ' B' ' 68' ' ' LYS . 1.5 mm-40 -100.74 52.15 0.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.151 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.665 ' HB ' ' HB3' ' B' ' 69' ' ' ALA . 0.2 OUTLIER -72.14 131.92 43.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.738 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.62 107.59 15.37 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.774 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.905 HD13 ' HB2' ' B' ' 69' ' ' ALA . 1.0 OUTLIER -88.18 126.54 35.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.604 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' B' ' 61' ' ' CYS . 1.1 m120 -120.65 -178.92 3.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.577 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' ASN . . . . . 0.524 ' OD1' ' HA ' ' B' ' 62' ' ' ASP . 3.7 t30 -83.27 120.64 26.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.732 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.13 -121.78 2.53 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.683 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' THR . . . . . 0.712 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 75.5 m -122.14 103.38 8.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.734 0.302 . . . . 0.0 110.783 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ASN . . . . . 0.526 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 1.7 t30 -86.14 157.28 20.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.157 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.566 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.3 OUTLIER -143.32 130.22 20.51 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.064 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 131' ' ' ILE . . . . . 0.634 ' HB ' HG22 ' B' ' 56' ' ' ILE . 57.3 mt -84.09 104.22 3.96 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -82.09 112.48 2.3 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.611 1.541 . . . . 0.0 112.54 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.422 ' HB3' ' CZ ' ' B' ' 54' ' ' PHE . 1.0 OUTLIER -126.77 158.21 37.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.826 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -126.01 156.05 40.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.024 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.539 ' O ' HG22 ' B' ' 52' ' ' VAL . . . -148.17 105.12 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.922 0.391 . . . . 0.0 111.659 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -99.04 163.44 12.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.436 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 0.3 OUTLIER -81.67 119.75 24.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.085 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 138' ' ' PHE . . . . . 0.469 ' HB3' HG11 ' B' ' 85' ' ' VAL . 2.1 t80 -108.9 142.69 39.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.247 0.546 . . . . 0.0 112.012 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' B' ' 47' ' ' ALA . . . -132.97 136.0 45.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.918 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 140' ' ' THR . . . . . 0.655 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 25.3 p -96.53 -56.24 2.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.527 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 141' ' ' GLY . . . . . 0.5 ' H ' ' HB3' ' B' ' 98' ' ' ASN . . . -127.06 -129.83 3.3 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.03 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.01 107.15 12.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.682 0.241 . . . . 0.0 110.695 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' B' ' 97' ' ' THR . . . -65.94 148.12 52.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.765 0.317 . . . . 0.0 111.447 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.622 ' HB ' ' H ' ' B' ' 97' ' ' THR . 48.5 m -114.84 144.65 32.37 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.36 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -81.9 130.95 6.83 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.551 2.168 . . . . 0.0 111.967 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' GLY . . . . . 0.613 ' O ' ' HG3' ' A' ' 15' ' ' GLU . . . 164.86 -116.2 0.69 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.466 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.63 ' HA ' ' HG3' ' A' ' 15' ' ' GLU . . . -110.77 150.34 29.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.932 0.396 . . . . 0.0 111.279 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.6 45.87 1.6 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.108 0.48 . . . . 0.0 110.479 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.512 HD22 ' HB1' ' B' ' 147' ' ' ALA . 0.1 OUTLIER -96.86 141.02 30.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.609 -179.507 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.401 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -153.75 162.55 41.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.013 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.91 135.46 43.62 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.179 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' ALA . . . . . 0.747 ' HB2' HD11 ' B' ' 86' ' ' LEU . . . -134.18 152.51 51.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.157 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.535 HG23 HG23 ' A' ' 9' ' ' THR . 4.0 m -104.12 148.91 25.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.23 141.81 35.25 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.087 0.47 . . . . 0.0 110.141 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.53 152.34 40.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.905 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' VAL . . . . . 0.649 HG23 HG23 ' A' ' 5' ' ' VAL . 20.2 m -135.76 133.17 51.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 111.705 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.746 ' HG3' HG23 ' A' ' 4' ' ' THR . 1.8 tt0 -130.89 119.8 22.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.269 0.557 . . . . 0.0 110.405 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -101.97 113.19 26.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.564 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' GLN . . . . . 0.629 ' HA ' ' H ' ' A' ' 2' ' ' ALA . 3.6 mp0 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.852 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 1' ' ' ALA . . . . . 0.59 ' HA ' ' HA ' ' D' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.232 0.063 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.639 ' H ' ' HA ' ' D' ' 159' ' ' GLN . . . 59.07 55.84 4.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.592 0.234 . . . . 0.0 111.018 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.523 HG21 ' HB2' ' D' ' 18' ' ' ASN . 89.2 m -118.61 111.1 18.13 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.448 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 4' ' ' THR . . . . . 0.71 HG23 ' HG3' ' D' ' 157' ' ' GLN . 0.2 OUTLIER -97.78 127.3 43.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.609 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.639 HG23 HG23 ' D' ' 156' ' ' VAL . 0.0 OUTLIER -153.53 171.52 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.589 179.57 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 6' ' ' ASN . . . . . 0.537 ' O ' ' NE2' ' E' ' 36' ' ' GLN . 1.2 t30 -94.39 122.13 36.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.592 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.96 -52.3 6.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.817 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.4 -145.56 5.86 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.889 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' THR . . . . . 0.517 HG23 HG23 ' D' ' 153' ' ' THR . 0.2 OUTLIER -146.75 139.83 25.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.975 0.417 . . . . 0.0 111.277 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.38 121.65 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.152 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -99.71 106.6 18.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.309 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' PHE . . . . . 0.43 ' HZ ' ' CZ ' ' D' ' 54' ' ' PHE . 8.9 m-85 -90.59 107.62 19.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.783 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.34 149.23 24.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.337 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.39 -179.08 47.5 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.922 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 15' ' ' GLU . . . . . 0.664 ' HB3' ' HG3' ' D' ' 36' ' ' GLN . 0.1 OUTLIER -158.96 157.1 30.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.906 0.384 . . . . 0.0 110.311 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.46 ' O ' HG11 ' B' ' 5' ' ' VAL . 17.9 t -113.79 132.08 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.284 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.601 HG12 HG21 ' B' ' 5' ' ' VAL . 5.4 m -136.78 176.62 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.803 0.335 . . . . 0.0 111.058 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 18' ' ' ASN . . . . . 0.504 ' HB2' HG21 ' B' ' 3' ' ' THR . 1.2 t30 -74.42 174.15 9.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.058 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 19' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' C' ' 62' ' ' ASP . . . -83.47 35.43 0.5 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.075 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 20' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' C' ' 61' ' ' CYS . . . -116.92 -15.94 10.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.435 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.94 155.31 0.6 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.91 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.78 126.37 5.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' VAL . . . . . 0.737 ' HA ' ' HG ' ' C' ' 58' ' ' LEU . 0.7 OUTLIER -60.74 162.53 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.112 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' C' ' 27' ' ' SER . 18.7 t70 -97.66 161.0 13.97 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.577 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.687 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -64.07 -40.37 96.12 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.389 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.43 12.79 68.96 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.91 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' SER . . . . . 0.563 ' HB3' ' HB3' ' C' ' 24' ' ' ASP . 0.6 OUTLIER -113.87 -25.52 8.58 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.865 0.364 . . . . 0.0 110.808 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.407 HG23 ' H ' ' C' ' 28' ' ' VAL . 9.8 t -41.15 -61.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.35 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.55 119.95 39.56 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.085 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -126.14 119.15 26.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.984 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.69 103.32 15.48 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.078 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.86 115.13 43.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.145 0.498 . . . . 0.0 110.493 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.51 112.59 24.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.656 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.8 -30.4 59.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.692 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.03 -170.17 27.36 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.613 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' GLN . . . . . 0.674 ' HG3' ' HB3' ' B' ' 15' ' ' GLU . 0.1 OUTLIER -93.51 141.7 28.17 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.522 0.201 . . . . 0.0 110.887 -179.741 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.536 HG11 HD22 ' C' ' 42' ' ' LEU . 5.7 p -125.29 157.11 34.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.916 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.53 122.41 28.98 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.727 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -40.44 87.01 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.754 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.46 -35.87 68.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.05 0.452 . . . . 0.0 110.797 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.19 -21.39 33.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.16 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.536 HD22 HG11 ' C' ' 37' ' ' VAL . 3.2 mp -110.51 29.45 7.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.566 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 43' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' C' ' 141' ' ' GLY . . . -108.2 25.45 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.321 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.74 159.92 23.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.341 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 45' ' ' GLU . . . . . 0.654 ' HA ' ' O ' ' C' ' 140' ' ' THR . 11.0 tt0 -82.8 108.68 16.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.853 0.358 . . . . 0.0 111.168 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.9 10.91 51.52 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.163 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' C' ' 139' ' ' ALA . . . -66.76 123.49 20.27 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.933 0.396 . . . . 0.0 112.061 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -120.65 140.25 51.84 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.874 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 4.6 m -101.62 -167.02 1.36 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.611 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.68 139.65 53.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.786 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.82 133.95 35.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.309 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.541 HG22 ' O ' ' C' ' 135' ' ' ALA . 18.7 m -86.94 166.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.016 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.74 128.76 7.94 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.637 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 54' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' C' ' 133' ' ' PHE . 40.7 p90 -160.17 134.48 7.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.511 ' OD1' HG21 ' C' ' 130' ' ' THR . 15.8 p30 -132.75 147.73 52.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.583 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.631 HG22 ' HB ' ' C' ' 131' ' ' ILE . 1.0 OUTLIER -96.75 116.7 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.621 -179.749 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.557 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.0 OUTLIER -66.58 122.06 16.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.696 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 58' ' ' LEU . . . . . 0.737 ' HG ' ' HA ' ' C' ' 23' ' ' VAL . 0.2 OUTLIER -137.43 88.17 2.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.23 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 59' ' ' ASN . . . . . 0.714 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 10.5 p30 -79.6 179.4 7.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.88 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.3 64.46 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.783 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' C' ' 129' ' ' ASN . 4.4 m -110.53 163.26 13.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.786 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 62' ' ' ASP . . . . . 0.587 ' HB2' ' O ' ' C' ' 19' ' ' ALA . 0.5 OUTLIER -140.21 155.07 47.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.254 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.34 -25.31 10.63 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -82.08 -16.25 50.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.061 0.458 . . . . 0.0 111.745 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.403 HG23 ' OD2' ' C' ' 62' ' ' ASP . 16.6 t -90.66 -48.46 14.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.661 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.11 142.9 36.02 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.639 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.82 -53.81 2.6 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.847 0.356 . . . . 0.0 110.971 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 68' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' C' ' 121' ' ' GLU . 0.1 OUTLIER -94.79 158.16 15.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.491 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.899 ' HB2' HD13 ' C' ' 124' ' ' LEU . . . -137.22 120.47 16.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.611 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -97.54 129.03 44.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.137 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 71' ' ' VAL . . . . . 0.6 HG11 HG21 ' C' ' 131' ' ' ILE . 15.8 t -112.96 152.24 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.718 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.01 146.63 27.1 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.588 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 73' ' ' PHE . . . . . 0.474 ' CD2' HG21 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -111.53 141.88 44.54 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.5 0.191 . . . . 0.0 111.092 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' C' ' 152' ' ' ALA . 0.8 OUTLIER -105.72 103.24 12.7 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.974 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.88 -179.11 25.43 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.789 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.685 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.2 OUTLIER -105.15 157.85 16.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.595 0.236 . . . . 0.0 110.73 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 77' ' ' ALA . . . . . 0.422 ' H ' ' HB2' ' F' ' 132' ' ' PRO . . . -77.89 132.79 38.1 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.881 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 78' ' ' ILE . . . . . 0.449 ' CG2' ' HB ' ' C' ' 85' ' ' VAL . 0.6 OUTLIER -66.58 -39.88 84.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 79' ' ' ASP . . . . . 0.415 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.7 OUTLIER -146.19 53.58 1.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.824 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 80' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' F' ' 106' ' ' ARG . . . 61.42 -87.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.065 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.37 -36.51 53.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.576 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -81.37 59.97 4.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.883 0.373 . . . . 0.0 110.451 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 83' ' ' THR . . . . . 0.593 HG21 ' OD1' ' C' ' 114' ' ' ASP . 2.1 m -70.53 -20.53 62.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.49 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 84' ' ' ASN . . . . . 0.888 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 26.6 p-10 -69.34 -13.73 62.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.334 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.697 HG22 ' HB2' ' C' ' 102' ' ' GLN . 40.9 t -109.0 131.15 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.129 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.783 HD11 ' HB2' ' C' ' 152' ' ' ALA . 0.6 OUTLIER -70.07 142.85 52.61 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.324 179.42 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.0 -170.58 3.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.882 0.372 . . . . 0.0 111.71 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -79.89 161.44 25.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.102 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.75 -80.33 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.34 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 90' ' ' SER . . . . . 0.476 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 6.6 p -171.34 0.49 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.949 0.404 . . . . 0.0 111.481 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 91' ' ' SER . . . . . 0.677 ' HA ' ' HB2' ' E' ' 25' ' ' ALA . 73.5 m -76.84 85.66 3.42 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 92' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' F' ' 50' ' ' SER . . . -61.04 -32.23 71.86 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.876 0.369 . . . . 0.0 111.649 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.86 30.47 6.87 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.642 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.64 -3.26 0.11 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.947 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 95' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' C' ' 91' ' ' SER . 0.1 OUTLIER -107.54 -176.71 3.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.834 0.35 . . . . 0.0 110.656 179.642 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.49 172.58 8.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 97' ' ' THR . . . . . 0.613 ' H ' ' HB ' ' C' ' 144' ' ' THR . 1.6 m -126.93 140.4 52.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.351 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 98' ' ' ASN . . . . . 0.492 ' HB3' ' H ' ' C' ' 141' ' ' GLY . 27.4 m120 61.96 21.39 12.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.472 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 99' ' ' VAL . . . . . 0.543 HG23 ' O ' ' C' ' 97' ' ' THR . 2.7 t -120.44 136.0 58.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.727 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.94 -160.74 10.18 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.532 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 101' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' C' ' 86' ' ' LEU . 4.5 p -145.94 109.85 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.067 0.547 . . . . 0.0 111.758 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 102' ' ' GLN . . . . . 0.697 ' HB2' HG22 ' C' ' 85' ' ' VAL . 0.5 OUTLIER -84.27 147.38 27.26 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.93 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.598 HG12 ' HG ' ' C' ' 113' ' ' LEU . 1.2 pp -110.79 127.86 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.529 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 104' ' ' LEU . . . . . 0.976 HD12 ' HB2' ' C' ' 110' ' ' ALA . 1.4 tp -97.43 132.94 42.66 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.663 0.268 . . . . 0.0 111.02 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 105' ' ' ASP . . . . . 0.654 ' HB3' HG22 ' C' ' 107' ' ' THR . 4.0 t0 -80.78 143.58 32.77 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.688 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 106' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -65.42 -17.53 64.61 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.815 0.341 . . . . 0.0 111.043 179.488 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 107' ' ' THR . . . . . 0.654 HG22 ' HB3' ' C' ' 105' ' ' ASP . 13.2 t -66.83 -20.59 65.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.028 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.08 -71.85 0.44 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.682 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.5 159.97 31.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.825 0.345 . . . . 0.0 111.11 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.976 ' HB2' HD12 ' C' ' 104' ' ' LEU . . . -75.54 131.52 40.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 111' ' ' LEU . . . . . 0.696 HD21 ' O ' ' C' ' 117' ' ' THR . 12.2 tp -88.14 154.22 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.379 0.609 . . . . 0.0 110.514 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 112' ' ' THR . . . . . 0.888 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 0.4 OUTLIER -96.37 142.66 28.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.147 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.598 ' HG ' HG12 ' C' ' 103' ' ' ILE . 0.8 OUTLIER -80.76 63.61 5.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.783 0.325 . . . . 0.0 110.761 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 114' ' ' ASP . . . . . 0.593 ' OD1' HG21 ' C' ' 83' ' ' THR . 0.1 OUTLIER -90.7 -30.54 17.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.547 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 115' ' ' GLY . . . . . 0.527 ' HA3' ' OG1' ' F' ' 130' ' ' THR . . . 115.76 -43.57 1.65 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.595 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 116' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' F' ' 128' ' ' THR . . . -110.49 24.33 13.11 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.003 0.43 . . . . 0.0 111.679 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 117' ' ' THR . . . . . 0.696 ' O ' HD21 ' C' ' 111' ' ' LEU . 0.2 OUTLIER -82.15 68.37 8.52 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.118 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 118' ' ' PHE . . . . . 0.553 ' CD1' ' HB2' ' C' ' 157' ' ' GLN . 41.0 m-85 -82.2 72.0 9.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.801 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.76 80.99 1.86 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.65 131.75 13.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.606 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 121' ' ' GLU . . . . . 0.433 ' O ' ' HE2' ' C' ' 68' ' ' LYS . 1.5 mm-40 -100.76 52.2 0.86 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.212 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' C' ' 69' ' ' ALA . 0.2 OUTLIER -72.11 131.89 43.45 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.75 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.7 107.65 15.49 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.745 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 124' ' ' LEU . . . . . 0.899 HD13 ' HB2' ' C' ' 69' ' ' ALA . 1.0 OUTLIER -88.26 126.58 35.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.561 179.465 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 125' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' C' ' 61' ' ' CYS . 1.1 m120 -120.66 -178.93 3.84 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.525 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 126' ' ' ASN . . . . . 0.524 ' OD1' ' HA ' ' C' ' 62' ' ' ASP . 3.8 t30 -83.25 120.61 26.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.784 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.18 -121.67 2.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.659 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 128' ' ' THR . . . . . 0.714 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 76.5 m -122.21 103.37 8.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.746 0.308 . . . . 0.0 110.78 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 129' ' ' ASN . . . . . 0.529 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 1.8 t30 -86.21 157.26 20.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.896 0.379 . . . . 0.0 111.091 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 130' ' ' THR . . . . . 0.557 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.3 OUTLIER -143.29 130.17 20.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.104 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 131' ' ' ILE . . . . . 0.631 ' HB ' HG22 ' C' ' 56' ' ' ILE . 56.8 mt -83.97 104.14 3.79 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 132' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' C' ' 106' ' ' ARG . 7.6 Cg_endo -82.0 112.34 2.31 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.673 1.582 . . . . 0.0 112.582 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.43 ' HB3' ' CZ ' ' C' ' 54' ' ' PHE . 1.0 OUTLIER -126.7 158.29 36.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.828 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -126.0 156.1 40.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.059 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.541 ' O ' HG22 ' C' ' 52' ' ' VAL . . . -148.15 105.14 3.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 0.0 111.609 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.05 163.36 12.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.416 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 137' ' ' TYR . . . . . 0.561 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 0.3 OUTLIER -81.64 119.71 24.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.116 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 138' ' ' PHE . . . . . 0.463 ' HB3' HG11 ' C' ' 85' ' ' VAL . 2.1 t80 -108.91 142.68 39.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.982 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 139' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' C' ' 47' ' ' ALA . . . -132.98 136.04 45.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.851 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 140' ' ' THR . . . . . 0.654 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 25.1 p -96.6 -56.21 2.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.476 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 141' ' ' GLY . . . . . 0.492 ' H ' ' HB3' ' C' ' 98' ' ' ASN . . . -127.06 -129.84 3.3 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.013 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.03 107.14 12.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.631 0.216 . . . . 0.0 110.702 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 143' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' C' ' 97' ' ' THR . . . -65.89 148.09 52.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.753 0.311 . . . . 0.0 111.434 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 144' ' ' THR . . . . . 0.613 ' HB ' ' H ' ' C' ' 97' ' ' THR . 47.8 m -114.87 144.67 32.42 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.307 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 145' ' ' PRO . . . . . 0.406 ' HD2' HG23 ' C' ' 144' ' ' THR . 1.3 Cg_endo -81.96 130.97 6.78 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.479 2.119 . . . . 0.0 112.009 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 146' ' ' GLY . . . . . 0.62 ' O ' ' HG3' ' B' ' 15' ' ' GLU . . . 164.89 -116.26 0.69 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.438 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 147' ' ' ALA . . . . . 0.611 ' HA ' ' HG3' ' B' ' 15' ' ' GLU . . . -110.67 150.37 29.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 111.351 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.67 45.89 1.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.46 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 149' ' ' ASN . . . . . 0.512 HD22 ' HB1' ' C' ' 147' ' ' ALA . 0.1 OUTLIER -96.83 141.0 30.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.618 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 150' ' ' ALA . . . . . 0.411 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -153.7 162.62 41.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.047 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.93 135.5 43.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.198 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 152' ' ' ALA . . . . . 0.783 ' HB2' HD11 ' C' ' 86' ' ' LEU . . . -134.16 152.51 51.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.23 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 153' ' ' THR . . . . . 0.526 HG23 HG23 ' B' ' 9' ' ' THR . 4.0 m -104.15 148.91 25.74 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.23 141.83 35.21 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.136 0.493 . . . . 0.0 110.165 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.54 152.41 40.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.916 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 156' ' ' VAL . . . . . 0.632 HG23 HG23 ' B' ' 5' ' ' VAL . 19.9 m -135.74 133.22 51.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.798 0.332 . . . . 0.0 111.684 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 157' ' ' GLN . . . . . 0.711 ' HG3' HG23 ' B' ' 4' ' ' THR . 1.8 tt0 -130.96 119.78 22.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.326 0.584 . . . . 0.0 110.397 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -101.93 113.24 26.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.577 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 159' ' ' GLN . . . . . 0.626 ' HA ' ' H ' ' B' ' 2' ' ' ALA . 3.6 mp0 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.836 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 1' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' E' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 111.105 0.039 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.624 ' H ' ' HA ' ' E' ' 159' ' ' GLN . . . 59.11 55.8 4.22 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 123.104 0.253 . . . . 0.0 111.035 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 3' ' ' THR . . . . . 0.524 HG21 ' HB2' ' E' ' 18' ' ' ASN . 89.7 m -118.64 111.07 18.08 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.422 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 4' ' ' THR . . . . . 0.74 HG23 ' HG3' ' E' ' 157' ' ' GLN . 0.2 OUTLIER -97.76 127.33 43.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.524 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.657 HG23 HG23 ' E' ' 156' ' ' VAL . 0.0 OUTLIER -153.53 171.46 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.634 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 6' ' ' ASN . . . . . 0.531 ' O ' ' NE2' ' F' ' 36' ' ' GLN . 1.2 t30 -94.37 122.09 36.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.637 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.0 -52.23 6.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.802 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.46 -145.46 5.83 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.829 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 9' ' ' THR . . . . . 0.535 HG23 HG23 ' E' ' 153' ' ' THR . 0.2 OUTLIER -146.82 139.74 25.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.905 0.383 . . . . 0.0 111.299 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.33 121.63 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.125 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -99.65 106.66 18.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.361 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 12' ' ' PHE . . . . . 0.432 ' HZ ' ' CZ ' ' E' ' 54' ' ' PHE . 8.9 m-85 -90.65 107.59 19.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.797 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.29 149.18 24.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.404 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.42 -179.05 47.51 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.946 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 15' ' ' GLU . . . . . 0.673 ' HB3' ' HG3' ' E' ' 36' ' ' GLN . 0.1 OUTLIER -158.93 157.01 30.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.912 0.387 . . . . 0.0 110.358 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.461 ' O ' HG11 ' C' ' 5' ' ' VAL . 17.8 t -113.7 132.19 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.249 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.606 HG12 HG21 ' C' ' 5' ' ' VAL . 5.5 m -136.85 176.58 7.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.829 0.347 . . . . 0.0 111.008 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 18' ' ' ASN . . . . . 0.523 ' HB2' HG21 ' C' ' 3' ' ' THR . 1.2 t30 -74.36 174.11 9.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.068 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 19' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' D' ' 62' ' ' ASP . . . -83.4 35.32 0.49 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.059 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 20' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' D' ' 61' ' ' CYS . . . -116.92 -15.9 10.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.398 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.99 155.22 0.59 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.962 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.67 126.47 5.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.077 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 23' ' ' VAL . . . . . 0.74 ' HA ' ' HG ' ' D' ' 58' ' ' LEU . 0.7 OUTLIER -60.9 162.44 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.057 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' D' ' 27' ' ' SER . 18.7 t70 -97.58 160.97 14.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.623 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.675 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -64.11 -40.25 95.79 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.398 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.49 12.75 69.02 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.914 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' SER . . . . . 0.568 ' HB3' ' HB3' ' D' ' 24' ' ' ASP . 0.6 OUTLIER -113.84 -25.47 8.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.846 0.355 . . . . 0.0 110.787 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 28' ' ' VAL . . . . . 0.405 HG23 ' H ' ' D' ' 28' ' ' VAL . 10.0 t -41.15 -61.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.306 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.64 120.0 39.65 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.03 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -126.07 119.1 26.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.024 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.76 103.33 15.47 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.083 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.88 115.1 43.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.163 0.506 . . . . 0.0 110.424 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.5 112.56 24.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.646 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.83 -30.34 58.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.626 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.98 -170.23 27.49 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.571 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' GLN . . . . . 0.664 ' HG3' ' HB3' ' C' ' 15' ' ' GLU . 0.1 OUTLIER -93.48 141.79 28.07 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.526 0.203 . . . . 0.0 110.944 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.559 HG11 HD22 ' D' ' 42' ' ' LEU . 5.8 p -125.3 157.14 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.827 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.58 122.39 28.97 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.729 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -40.47 86.94 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.753 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.48 -35.82 68.39 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.053 0.454 . . . . 0.0 110.8 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -21.44 33.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.133 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.559 HD22 HG11 ' D' ' 37' ' ' VAL . 3.3 mp -110.5 29.51 7.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.623 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 43' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' D' ' 141' ' ' GLY . . . -108.24 25.44 11.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.34 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.71 159.97 23.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.38 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 45' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' D' ' 140' ' ' THR . 11.1 tt0 -82.94 108.73 16.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.916 0.388 . . . . 0.0 111.127 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.97 10.78 51.51 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.116 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' D' ' 139' ' ' ALA . . . -66.66 123.47 20.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.94 0.4 . . . . 0.0 111.974 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 77.5 p -120.64 140.3 51.77 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.879 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 4.6 m -101.68 -167.02 1.36 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.61 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 8.1 t -69.63 139.64 53.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.791 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.79 133.99 35.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.335 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 52' ' ' VAL . . . . . 0.532 HG22 ' O ' ' D' ' 135' ' ' ALA . 18.9 m -87.04 166.48 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.896 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.77 128.87 7.99 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.614 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.558 ' H ' HG21 ' A' ' 76' ' ' THR . 40.6 p90 -160.2 134.44 7.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.756 0.312 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 55' ' ' ASN . . . . . 0.516 ' OD1' HG21 ' D' ' 130' ' ' THR . 15.9 p30 -132.75 147.67 52.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.623 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.636 HG22 ' HB ' ' D' ' 131' ' ' ILE . 1.0 OUTLIER -96.74 116.75 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.567 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 57' ' ' GLN . . . . . 0.572 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.0 OUTLIER -66.61 122.04 16.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.744 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 58' ' ' LEU . . . . . 0.74 ' HG ' ' HA ' ' D' ' 23' ' ' VAL . 0.2 OUTLIER -137.4 88.17 2.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 59' ' ' ASN . . . . . 0.734 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 10.6 p30 -79.58 179.37 7.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.925 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.35 64.37 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.812 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 61' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' D' ' 129' ' ' ASN . 4.4 m -110.48 163.26 13.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.954 0.406 . . . . 0.0 110.761 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 62' ' ' ASP . . . . . 0.575 ' HB2' ' O ' ' D' ' 19' ' ' ALA . 0.5 OUTLIER -140.22 155.07 47.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.237 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.25 -25.36 10.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -81.99 -16.41 50.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.083 0.468 . . . . 0.0 111.703 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 t -90.61 -48.48 14.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.696 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.12 142.9 36.01 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.639 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.79 -53.82 2.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.848 0.356 . . . . 0.0 110.941 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 68' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' D' ' 121' ' ' GLU . 0.1 OUTLIER -94.86 158.1 15.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.482 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 69' ' ' ALA . . . . . 0.908 ' HB2' HD13 ' D' ' 124' ' ' LEU . . . -137.14 120.48 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.621 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 70' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -97.62 129.1 44.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.06 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 71' ' ' VAL . . . . . 0.594 HG11 HG21 ' D' ' 131' ' ' ILE . 15.9 t -112.99 152.28 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.671 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.05 146.61 27.06 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.522 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 73' ' ' PHE . . . . . 0.474 ' CD2' HG21 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -111.53 141.94 44.46 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.536 0.208 . . . . 0.0 111.092 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 74' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.8 OUTLIER -105.71 103.35 12.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.916 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.96 -179.11 25.5 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.806 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 157.84 17.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.558 0.218 . . . . 0.0 110.732 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.9 132.75 38.07 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.87 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 78' ' ' ILE . . . . . 0.452 ' CG2' ' HB ' ' D' ' 85' ' ' VAL . 0.6 OUTLIER -66.61 -39.79 84.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.42 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.7 OUTLIER -146.22 53.53 1.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.826 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.39 -87.54 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.33 -36.53 53.26 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.58 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -81.31 59.99 4.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.472 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 83' ' ' THR . . . . . 0.593 HG21 ' OD1' ' D' ' 114' ' ' ASP . 2.1 m -70.58 -20.53 62.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.575 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 84' ' ' ASN . . . . . 0.887 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 26.6 p-10 -69.35 -13.7 62.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.296 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' D' ' 102' ' ' GLN . 40.8 t -108.96 131.1 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.203 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.758 HD11 ' HB2' ' D' ' 152' ' ' ALA . 0.6 OUTLIER -70.02 142.89 52.69 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.323 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.02 -170.5 3.06 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.884 0.373 . . . . 0.0 111.688 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -80.02 161.44 25.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.022 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.76 -80.25 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.357 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 6.5 p -171.41 0.48 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 111.445 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 91' ' ' SER . . . . . 0.687 ' HA ' ' HB2' ' F' ' 25' ' ' ALA . 73.4 m -76.83 85.55 3.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.912 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.87 -32.32 71.76 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.655 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.83 30.45 6.88 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.641 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.71 -3.12 0.11 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.953 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 95' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' D' ' 91' ' ' SER . 0.1 OUTLIER -107.57 -176.79 3.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 110.638 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.56 172.58 8.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.811 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 97' ' ' THR . . . . . 0.611 ' H ' ' HB ' ' D' ' 144' ' ' THR . 1.7 m -126.86 140.43 52.36 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.288 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 98' ' ' ASN . . . . . 0.48 ' HB3' ' H ' ' D' ' 141' ' ' GLY . 27.3 m120 61.95 21.36 12.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.427 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 99' ' ' VAL . . . . . 0.55 HG23 ' O ' ' D' ' 97' ' ' THR . 2.7 t -120.35 136.02 58.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.742 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.0 -160.77 10.21 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.513 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 101' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' D' ' 86' ' ' LEU . 4.5 p -145.9 109.85 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.168 0.509 . . . . 0.0 111.762 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 102' ' ' GLN . . . . . 0.691 ' HB2' HG22 ' D' ' 85' ' ' VAL . 0.5 OUTLIER -84.31 147.36 27.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.93 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 103' ' ' ILE . . . . . 0.611 HG12 ' HG ' ' D' ' 113' ' ' LEU . 1.2 pp -110.73 127.81 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.49 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 104' ' ' LEU . . . . . 0.937 HD12 ' HB2' ' D' ' 110' ' ' ALA . 1.4 tp -97.37 132.92 42.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.676 0.274 . . . . 0.0 111.093 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 105' ' ' ASP . . . . . 0.673 ' HB3' HG22 ' D' ' 107' ' ' THR . 4.0 t0 -80.81 143.62 32.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.669 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 106' ' ' ARG . . . . . 0.543 ' HA ' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -65.47 -17.44 64.56 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.762 0.315 . . . . 0.0 111.101 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 107' ' ' THR . . . . . 0.673 HG22 ' HB3' ' D' ' 105' ' ' ASP . 13.3 t -66.87 -20.59 65.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.052 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.07 -71.78 0.44 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.674 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.48 159.93 31.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.829 0.347 . . . . 0.0 111.111 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.937 ' HB2' HD12 ' D' ' 104' ' ' LEU . . . -75.56 131.47 40.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.126 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 111' ' ' LEU . . . . . 0.682 HD21 ' O ' ' D' ' 117' ' ' THR . 12.2 tp -88.13 154.21 20.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.372 0.606 . . . . 0.0 110.63 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 112' ' ' THR . . . . . 0.887 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 0.4 OUTLIER -96.42 142.74 28.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.082 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 113' ' ' LEU . . . . . 0.611 ' HG ' HG12 ' D' ' 103' ' ' ILE . 0.8 OUTLIER -80.82 63.68 5.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.738 0.304 . . . . 0.0 110.704 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 114' ' ' ASP . . . . . 0.593 ' OD1' HG21 ' D' ' 83' ' ' THR . 0.1 OUTLIER -90.65 -30.66 17.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.648 0.261 . . . . 0.0 111.55 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.79 -43.6 1.64 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.593 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.56 24.38 13.04 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.996 0.427 . . . . 0.0 111.614 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 117' ' ' THR . . . . . 0.682 ' O ' HD21 ' D' ' 111' ' ' LEU . 0.2 OUTLIER -82.12 68.35 8.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.553 ' CD1' ' HB2' ' D' ' 157' ' ' GLN . 40.8 m-85 -82.21 71.98 9.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.754 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.71 80.99 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.58 131.75 13.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.576 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 121' ' ' GLU . . . . . 0.431 ' O ' ' HE2' ' D' ' 68' ' ' LYS . 1.5 mm-40 -100.77 52.11 0.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.222 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.666 ' HB ' ' HB3' ' D' ' 69' ' ' ALA . 0.2 OUTLIER -72.06 131.91 43.5 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.73 -179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.69 107.62 15.46 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.742 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 124' ' ' LEU . . . . . 0.908 HD13 ' HB2' ' D' ' 69' ' ' ALA . 1.0 OUTLIER -88.22 126.58 35.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.558 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 125' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' D' ' 61' ' ' CYS . 1.1 m120 -120.69 -178.94 3.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.575 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 126' ' ' ASN . . . . . 0.52 ' OD1' ' HA ' ' D' ' 62' ' ' ASP . 3.8 t30 -83.23 120.71 26.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.662 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.08 -121.72 2.52 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.709 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 128' ' ' THR . . . . . 0.734 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 75.8 m -122.21 103.42 8.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.711 0.291 . . . . 0.0 110.77 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 129' ' ' ASN . . . . . 0.534 ' HB2' ' SG ' ' D' ' 61' ' ' CYS . 1.7 t30 -86.14 157.23 20.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.172 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 130' ' ' THR . . . . . 0.572 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.3 OUTLIER -143.28 130.17 20.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.136 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 131' ' ' ILE . . . . . 0.636 ' HB ' HG22 ' D' ' 56' ' ' ILE . 57.0 mt -84.0 104.11 3.77 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 132' ' ' PRO . . . . . 0.699 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 7.6 Cg_endo -81.99 112.34 2.31 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.646 1.564 . . . . 0.0 112.568 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.432 ' HB3' ' CZ ' ' D' ' 54' ' ' PHE . 1.0 OUTLIER -126.68 158.25 36.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.863 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -125.96 156.09 40.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.116 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.532 ' O ' HG22 ' D' ' 52' ' ' VAL . . . -148.22 105.12 3.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.947 0.404 . . . . 0.0 111.587 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -99.07 163.48 12.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.357 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 137' ' ' TYR . . . . . 0.573 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 0.3 OUTLIER -81.79 119.7 24.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.101 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 138' ' ' PHE . . . . . 0.461 ' HB3' HG11 ' D' ' 85' ' ' VAL . 2.1 t80 -108.84 142.68 39.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.056 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 139' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' D' ' 47' ' ' ALA . . . -132.92 136.05 45.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.904 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 140' ' ' THR . . . . . 0.656 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 25.1 p -96.66 -56.14 2.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.474 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 141' ' ' GLY . . . . . 0.48 ' H ' ' HB3' ' D' ' 98' ' ' ASN . . . -127.11 -129.87 3.3 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.988 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.98 107.05 12.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.652 0.226 . . . . 0.0 110.779 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 143' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' D' ' 97' ' ' THR . . . -65.85 148.09 52.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.714 0.292 . . . . 0.0 111.441 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 144' ' ' THR . . . . . 0.611 ' HB ' ' H ' ' D' ' 97' ' ' THR . 48.6 m -114.79 144.69 32.42 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.297 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 145' ' ' PRO . . . . . 0.411 ' HD2' HG23 ' D' ' 144' ' ' THR . 1.3 Cg_endo -81.97 130.91 6.75 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.573 2.182 . . . . 0.0 111.972 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 146' ' ' GLY . . . . . 0.621 ' O ' ' HG3' ' C' ' 15' ' ' GLU . . . 164.89 -116.25 0.69 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.439 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 147' ' ' ALA . . . . . 0.627 ' HA ' ' HG3' ' C' ' 15' ' ' GLU . . . -110.66 150.4 29.06 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.808 0.337 . . . . 0.0 111.339 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.65 45.88 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.45 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 149' ' ' ASN . . . . . 0.513 HD22 ' HB1' ' D' ' 147' ' ' ALA . 0.1 OUTLIER -96.85 141.06 30.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.578 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 150' ' ' ALA . . . . . 0.404 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -153.74 162.54 41.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.962 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.87 135.49 43.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.239 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 152' ' ' ALA . . . . . 0.758 ' HB2' HD11 ' D' ' 86' ' ' LEU . . . -134.19 152.49 51.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.217 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 153' ' ' THR . . . . . 0.517 HG23 HG23 ' C' ' 9' ' ' THR . 4.0 m -104.09 148.92 25.7 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.25 141.83 35.22 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.106 0.479 . . . . 0.0 110.113 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.57 152.39 40.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.921 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 156' ' ' VAL . . . . . 0.639 HG23 HG23 ' C' ' 5' ' ' VAL . 20.0 m -135.74 133.16 51.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.809 0.337 . . . . 0.0 111.635 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 157' ' ' GLN . . . . . 0.71 ' HG3' HG23 ' C' ' 4' ' ' THR . 1.8 tt0 -130.9 119.74 22.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.302 0.572 . . . . 0.0 110.417 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -101.94 113.31 26.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.587 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 159' ' ' GLN . . . . . 0.639 ' HA ' ' H ' ' C' ' 2' ' ' ALA . 3.6 mp0 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.839 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 1' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' F' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 111.108 0.04 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 2' ' ' ALA . . . . . 0.622 ' H ' ' HA ' ' F' ' 159' ' ' GLN . . . 59.16 55.73 4.23 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.106 0.254 . . . . 0.0 111.035 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 3' ' ' THR . . . . . 0.524 HG21 ' HB2' ' F' ' 18' ' ' ASN . 89.5 m -118.64 111.1 18.11 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.443 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 4' ' ' THR . . . . . 0.726 HG23 ' HG3' ' F' ' 157' ' ' GLN . 0.2 OUTLIER -97.79 127.38 43.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.575 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.638 HG23 HG23 ' F' ' 156' ' ' VAL . 0.0 OUTLIER -153.57 171.46 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.594 179.581 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.38 122.07 36.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.83 -52.37 6.46 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.859 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.41 -145.53 5.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.868 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 9' ' ' THR . . . . . 0.531 HG23 HG23 ' F' ' 153' ' ' THR . 0.2 OUTLIER -146.69 139.85 25.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 0.0 111.283 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.43 121.63 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.121 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.71 106.64 18.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.326 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 12' ' ' PHE . . . . . 0.434 ' HZ ' ' CZ ' ' F' ' 54' ' ' PHE . 8.9 m-85 -90.65 107.66 19.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.29 149.18 24.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.384 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.43 -179.03 47.51 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.971 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 15' ' ' GLU . . . . . 0.662 ' HB3' ' HG3' ' F' ' 36' ' ' GLN . 0.1 OUTLIER -158.96 157.01 30.49 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.849 0.357 . . . . 0.0 110.381 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 16' ' ' VAL . . . . . 0.457 ' O ' HG11 ' D' ' 5' ' ' VAL . 18.1 t -113.77 132.21 63.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.148 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 17' ' ' VAL . . . . . 0.615 HG12 HG21 ' D' ' 5' ' ' VAL . 5.6 m -136.84 176.55 7.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 111.107 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 18' ' ' ASN . . . . . 0.524 ' HB2' HG21 ' D' ' 3' ' ' THR . 1.2 t30 -74.36 174.11 9.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.012 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 19' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' E' ' 62' ' ' ASP . . . -83.45 35.38 0.5 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 20' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' E' ' 61' ' ' CYS . . . -116.93 -15.9 10.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.412 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.99 155.26 0.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.961 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.74 126.43 5.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 23' ' ' VAL . . . . . 0.728 ' HA ' ' HG ' ' E' ' 58' ' ' LEU . 0.7 OUTLIER -60.85 162.54 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.083 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 24' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' E' ' 27' ' ' SER . 18.6 t70 -97.66 160.99 13.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.595 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 25' ' ' ALA . . . . . 0.677 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -64.12 -40.33 95.97 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.365 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.41 12.73 69.09 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.9 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 27' ' ' SER . . . . . 0.573 ' HB3' ' HB3' ' E' ' 24' ' ' ASP . 0.6 OUTLIER -113.84 -25.51 8.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.836 0.35 . . . . 0.0 110.785 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 28' ' ' VAL . . . . . . . . . . . . . 9.7 t -41.14 -61.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.336 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.64 120.01 39.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.013 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -126.11 119.14 26.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.01 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.79 103.29 15.43 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.107 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.82 115.11 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.144 0.497 . . . . 0.0 110.534 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.45 112.6 24.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.601 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mp -75.87 -30.4 58.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.615 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.08 -170.2 27.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.581 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 36' ' ' GLN . . . . . 0.673 ' HG3' ' HB3' ' D' ' 15' ' ' GLU . 0.1 OUTLIER -93.47 141.71 28.15 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.608 0.242 . . . . 0.0 110.89 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.552 HG11 HD22 ' E' ' 42' ' ' LEU . 5.8 p -125.24 157.13 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.914 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.55 122.43 29.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.799 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -40.42 87.1 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.736 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.44 -35.86 68.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.125 0.488 . . . . 0.0 110.87 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -21.54 33.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.14 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.552 HD22 HG11 ' E' ' 37' ' ' VAL . 3.2 mp -110.49 29.38 7.76 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.621 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 43' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' E' ' 141' ' ' GLY . . . -108.16 25.53 11.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.357 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.72 160.0 23.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.342 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 45' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' E' ' 140' ' ' THR . 11.1 tt0 -82.92 108.64 16.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 111.131 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.94 10.9 51.39 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.145 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 47' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' E' ' 139' ' ' ALA . . . -66.75 123.47 20.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.943 0.401 . . . . 0.0 111.997 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -120.59 140.27 51.77 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.837 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 4.6 m -101.6 -167.01 1.36 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.625 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 50' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 8.1 t -69.66 139.7 53.55 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.774 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.87 134.03 35.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.348 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 52' ' ' VAL . . . . . 0.532 HG22 ' O ' ' E' ' 135' ' ' ALA . 18.8 m -87.01 166.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.962 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.75 128.89 8.01 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.628 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 54' ' ' PHE . . . . . 0.56 ' H ' HG21 ' B' ' 76' ' ' THR . 40.7 p90 -160.29 134.44 7.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.79 0.329 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 55' ' ' ASN . . . . . 0.514 ' OD1' HG21 ' E' ' 130' ' ' THR . 15.9 p30 -132.75 147.75 52.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.636 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 56' ' ' ILE . . . . . 0.636 HG22 ' HB ' ' E' ' 131' ' ' ILE . 1.0 OUTLIER -96.83 116.85 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.521 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 57' ' ' GLN . . . . . 0.576 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.0 OUTLIER -66.58 122.07 16.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.704 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 58' ' ' LEU . . . . . 0.728 ' HG ' ' HA ' ' E' ' 23' ' ' VAL . 0.2 OUTLIER -137.49 88.12 2.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.213 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 59' ' ' ASN . . . . . 0.717 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 10.6 p30 -79.6 179.29 7.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.89 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.42 64.42 0.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.779 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 61' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' E' ' 129' ' ' ASN . 4.4 m -110.56 163.2 13.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.755 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 62' ' ' ASP . . . . . 0.581 ' HB2' ' O ' ' E' ' 19' ' ' ALA . 0.5 OUTLIER -140.14 155.0 47.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.344 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.2 -25.42 10.63 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.95 -16.35 50.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.127 0.489 . . . . 0.0 111.754 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 65' ' ' VAL . . . . . 0.403 HG23 ' OD2' ' E' ' 62' ' ' ASP . 16.7 t -90.68 -48.41 14.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.68 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.16 142.92 35.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.575 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.82 -53.86 2.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.866 0.365 . . . . 0.0 110.918 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 68' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' E' ' 121' ' ' GLU . 0.1 OUTLIER -94.75 158.13 15.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.549 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 69' ' ' ALA . . . . . 0.933 ' HB2' HD13 ' E' ' 124' ' ' LEU . . . -137.19 120.42 16.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.649 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 70' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -97.54 129.13 44.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.111 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 71' ' ' VAL . . . . . 0.607 HG11 HG21 ' E' ' 131' ' ' ILE . 15.7 t -112.97 152.23 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.749 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.01 146.65 27.12 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.52 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 73' ' ' PHE . . . . . 0.475 ' CD2' HG21 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -111.58 141.86 44.63 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.525 0.202 . . . . 0.0 111.063 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 74' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.8 OUTLIER -105.67 103.38 12.88 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.962 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.95 -179.11 25.49 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.813 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.22 157.8 17.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.554 0.216 . . . . 0.0 110.761 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.91 132.75 38.06 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.849 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 78' ' ' ILE . . . . . 0.45 ' CG2' ' HB ' ' E' ' 85' ' ' VAL . 0.6 OUTLIER -66.55 -39.82 84.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.911 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 79' ' ' ASP . . . . . 0.419 ' N ' HG23 ' E' ' 78' ' ' ILE . 0.7 OUTLIER -146.23 53.59 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.844 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.36 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.013 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.28 -36.59 53.16 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.566 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -81.34 59.98 4.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 110.473 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 83' ' ' THR . . . . . 0.594 HG21 ' OD1' ' E' ' 114' ' ' ASP . 2.0 m -70.56 -20.5 62.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.533 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 84' ' ' ASN . . . . . 0.878 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 26.5 p-10 -69.34 -13.75 62.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.297 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' E' ' 102' ' ' GLN . 40.8 t -109.01 131.12 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.153 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 86' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' E' ' 152' ' ' ALA . 0.6 OUTLIER -69.99 142.87 52.74 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.05 -170.49 3.06 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.937 0.399 . . . . 0.0 111.668 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' E' ' 88' ' ' LEU . 1.2 mm? -80.01 161.4 25.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.985 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.67 -80.34 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.322 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 6.4 p -171.35 0.34 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.958 0.409 . . . . 0.0 111.449 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 91' ' ' SER . . . . . 0.598 ' HB2' ' HB2' ' E' ' 95' ' ' SER . 73.5 m -76.78 85.64 3.38 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.35 71.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.942 0.401 . . . . 0.0 111.653 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.82 30.45 6.89 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.611 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.72 -3.15 0.11 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.941 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 95' ' ' SER . . . . . 0.598 ' HB2' ' HB2' ' E' ' 91' ' ' SER . 0.1 OUTLIER -107.57 -176.76 3.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.838 0.351 . . . . 0.0 110.641 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.46 172.6 8.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 97' ' ' THR . . . . . 0.623 ' H ' ' HB ' ' E' ' 144' ' ' THR . 1.6 m -126.9 140.44 52.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.348 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 98' ' ' ASN . . . . . 0.495 ' HB3' ' H ' ' E' ' 141' ' ' GLY . 27.3 m120 61.96 21.33 12.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.45 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 99' ' ' VAL . . . . . 0.557 HG23 ' O ' ' E' ' 97' ' ' THR . 2.6 t -120.33 135.98 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.746 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.0 -160.73 10.19 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.583 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -145.88 109.89 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.181 0.515 . . . . 0.0 111.715 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 102' ' ' GLN . . . . . 0.66 ' HB2' HG22 ' E' ' 85' ' ' VAL . 0.5 OUTLIER -84.34 147.3 27.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.849 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 103' ' ' ILE . . . . . 0.598 HG12 ' HG ' ' E' ' 113' ' ' LEU . 1.2 pp -110.68 127.86 67.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.476 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 104' ' ' LEU . . . . . 0.972 HD12 ' HB2' ' E' ' 110' ' ' ALA . 1.4 tp -97.46 132.99 42.64 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.705 0.288 . . . . 0.0 111.021 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 105' ' ' ASP . . . . . 0.654 ' HB3' HG22 ' E' ' 107' ' ' THR . 4.0 t0 -80.84 143.62 32.64 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.662 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 106' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' B' ' 80' ' ' ALA . 0.0 OUTLIER -65.42 -17.52 64.61 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.813 0.34 . . . . 0.0 111.084 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 107' ' ' THR . . . . . 0.654 HG22 ' HB3' ' E' ' 105' ' ' ASP . 13.3 t -66.81 -20.63 65.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.03 -71.71 0.44 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.741 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.52 159.95 31.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.842 0.353 . . . . 0.0 111.061 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 110' ' ' ALA . . . . . 0.972 ' HB2' HD12 ' E' ' 104' ' ' LEU . . . -75.56 131.52 40.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.076 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.684 HD21 ' O ' ' E' ' 117' ' ' THR . 12.2 tp -88.17 154.18 20.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.369 0.604 . . . . 0.0 110.549 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 112' ' ' THR . . . . . 0.878 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 0.4 OUTLIER -96.36 142.75 28.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.09 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 113' ' ' LEU . . . . . 0.598 ' HG ' HG12 ' E' ' 103' ' ' ILE . 0.8 OUTLIER -80.82 63.64 5.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.745 0.307 . . . . 0.0 110.716 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 114' ' ' ASP . . . . . 0.594 ' OD1' HG21 ' E' ' 83' ' ' THR . 0.1 OUTLIER -90.62 -30.65 17.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.541 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.76 -43.58 1.64 Allowed Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.627 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.56 24.38 13.04 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.011 0.434 . . . . 0.0 111.626 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 117' ' ' THR . . . . . 0.684 ' O ' HD21 ' E' ' 111' ' ' LEU . 0.2 OUTLIER -82.11 68.41 8.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.115 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 118' ' ' PHE . . . . . 0.538 ' CD1' ' HB2' ' E' ' 157' ' ' GLN . 41.0 m-85 -82.25 71.92 9.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.769 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.62 80.95 1.85 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.848 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.61 131.7 13.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.611 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 121' ' ' GLU . . . . . 0.432 ' O ' ' HE2' ' E' ' 68' ' ' LYS . 1.5 mm-40 -100.72 52.12 0.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.215 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 122' ' ' THR . . . . . 0.654 ' HB ' ' HB3' ' E' ' 69' ' ' ALA . 0.2 OUTLIER -72.07 131.93 43.53 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.713 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.75 107.69 15.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.675 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 124' ' ' LEU . . . . . 0.933 HD13 ' HB2' ' E' ' 69' ' ' ALA . 1.0 OUTLIER -88.31 126.53 35.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.537 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 125' ' ' ASN . . . . . 0.512 ' O ' ' HB3' ' E' ' 61' ' ' CYS . 1.1 m120 -120.58 -178.92 3.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.552 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 126' ' ' ASN . . . . . 0.524 ' OD1' ' HA ' ' E' ' 62' ' ' ASP . 3.7 t30 -83.29 120.66 26.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.735 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 127' ' ' GLY . . . . . 0.726 ' HA2' HG21 ' A' ' 4' ' ' THR . . . 136.16 -121.77 2.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.697 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 128' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 76.7 m -122.19 103.38 8.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.705 0.288 . . . . 0.0 110.764 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 129' ' ' ASN . . . . . 0.532 ' HB2' ' SG ' ' E' ' 61' ' ' CYS . 1.7 t30 -86.06 157.33 20.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.902 0.382 . . . . 0.0 111.127 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 130' ' ' THR . . . . . 0.576 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.3 OUTLIER -143.4 130.2 20.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.029 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 131' ' ' ILE . . . . . 0.636 ' HB ' HG22 ' E' ' 56' ' ' ILE . 57.4 mt -84.06 104.15 3.85 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 132' ' ' PRO . . . . . 0.679 ' HB3' ' HA ' ' B' ' 76' ' ' THR . 7.5 Cg_endo -82.05 112.41 2.3 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 121.609 1.539 . . . . 0.0 112.574 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 133' ' ' PHE . . . . . 0.425 ' HB3' ' CZ ' ' E' ' 54' ' ' PHE . 1.0 OUTLIER -126.64 158.26 36.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.88 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -126.02 156.08 40.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.095 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 135' ' ' ALA . . . . . 0.532 ' O ' HG22 ' E' ' 52' ' ' VAL . . . -148.23 105.08 3.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 111.613 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.04 163.47 12.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.415 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 137' ' ' TYR . . . . . 0.57 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 0.3 OUTLIER -81.79 119.75 24.28 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.064 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 138' ' ' PHE . . . . . 0.461 ' HB3' HG11 ' E' ' 85' ' ' VAL . 2.1 t80 -108.86 142.63 39.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.067 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 139' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' E' ' 47' ' ' ALA . . . -132.9 136.05 45.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.849 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 140' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 25.5 p -96.63 -56.16 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.534 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 141' ' ' GLY . . . . . 0.495 ' H ' ' HB3' ' E' ' 98' ' ' ASN . . . -127.14 -129.88 3.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.976 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.97 107.13 12.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.631 0.215 . . . . 0.0 110.782 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 143' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' E' ' 97' ' ' THR . . . -65.88 148.08 52.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.68 0.276 . . . . 0.0 111.447 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 144' ' ' THR . . . . . 0.623 ' HB ' ' H ' ' E' ' 97' ' ' THR . 48.0 m -114.85 144.74 32.55 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.275 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.0 131.0 6.76 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.499 2.133 . . . . 0.0 111.978 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 146' ' ' GLY . . . . . 0.603 ' O ' ' HG3' ' D' ' 15' ' ' GLU . . . 164.85 -116.25 0.69 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.435 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 147' ' ' ALA . . . . . 0.64 ' HA ' ' HG3' ' D' ' 15' ' ' GLU . . . -110.65 150.38 29.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.862 0.363 . . . . 0.0 111.304 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.63 45.92 1.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.449 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 149' ' ' ASN . . . . . 0.516 ' ND2' ' HB1' ' E' ' 147' ' ' ALA . 0.1 OUTLIER -96.97 141.0 30.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.54 -179.431 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 150' ' ' ALA . . . . . 0.404 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -153.67 162.59 41.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.006 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.95 135.43 43.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.271 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 152' ' ' ALA . . . . . 0.75 ' HB2' HD11 ' E' ' 86' ' ' LEU . . . -134.17 152.54 51.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.228 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 153' ' ' THR . . . . . 0.535 HG23 HG23 ' D' ' 9' ' ' THR . 4.0 m -104.19 148.92 25.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.21 141.88 35.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.088 0.47 . . . . 0.0 110.11 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.59 152.39 40.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.863 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 156' ' ' VAL . . . . . 0.657 HG23 HG23 ' D' ' 5' ' ' VAL . 20.2 m -135.75 133.17 51.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.789 0.328 . . . . 0.0 111.674 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 157' ' ' GLN . . . . . 0.74 ' HG3' HG23 ' D' ' 4' ' ' THR . 1.8 tt0 -130.92 119.82 22.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.318 0.58 . . . . 0.0 110.383 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -101.99 113.31 26.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.491 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 159' ' ' GLN . . . . . 0.624 ' HA ' ' H ' ' D' ' 2' ' ' ALA . 3.6 mp0 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.849 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.266 0.079 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.05 55.85 4.24 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.69 0.281 . . . . 0.0 111.075 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 89.7 m -118.7 111.11 18.09 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.445 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.79 127.26 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.588 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.48 171.5 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.551 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.42 122.08 36.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.62 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.95 -52.27 6.46 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.834 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.46 -145.52 5.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.888 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.72 139.8 25.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 0.0 111.296 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.37 121.6 64.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.149 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.72 106.56 18.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.392 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -90.52 107.69 19.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.842 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.28 149.15 25.0 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.457 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.47 -179.05 47.54 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.947 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.88 157.02 30.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.929 0.395 . . . . 0.0 110.368 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 16' ' ' VAL . . . . . 0.457 ' O ' HG11 ' E' ' 5' ' ' VAL . 18.0 t -113.73 132.19 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.225 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 17' ' ' VAL . . . . . 0.602 HG12 HG21 ' E' ' 5' ' ' VAL . 5.5 m -136.88 176.58 7.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.883 0.373 . . . . 0.0 110.991 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 18' ' ' ASN . . . . . 0.524 ' HB2' HG21 ' E' ' 3' ' ' THR . 1.2 t30 -74.45 174.13 9.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.036 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 19' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' F' ' 62' ' ' ASP . . . -83.43 35.37 0.5 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.036 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 20' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' F' ' 61' ' ' CYS . . . -116.95 -15.9 10.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.422 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.98 155.29 0.6 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.961 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.76 126.38 5.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.078 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 23' ' ' VAL . . . . . 0.741 ' HA ' ' HG ' ' F' ' 58' ' ' LEU . 0.7 OUTLIER -60.77 162.46 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.087 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 24' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' F' ' 27' ' ' SER . 18.6 t70 -97.61 161.02 13.97 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.615 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 25' ' ' ALA . . . . . 0.687 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -64.1 -40.39 96.1 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.348 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.37 12.74 69.09 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.927 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 27' ' ' SER . . . . . 0.558 ' HB3' ' HB3' ' F' ' 24' ' ' ASP . 0.6 OUTLIER -113.88 -25.46 8.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.825 0.345 . . . . 0.0 110.813 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 9.6 t -41.16 -61.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.37 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.59 119.9 39.49 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.061 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -126.02 119.07 26.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.057 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.7 103.3 15.46 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.118 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.89 115.13 43.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.147 0.499 . . . . 0.0 110.463 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.51 112.62 24.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.7 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.86 -30.37 58.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.646 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.03 -170.22 27.41 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.625 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 36' ' ' GLN . . . . . 0.662 ' HG3' ' HB3' ' E' ' 15' ' ' GLU . 0.1 OUTLIER -93.54 141.74 28.12 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.628 0.251 . . . . 0.0 110.909 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.544 HG11 HD22 ' F' ' 42' ' ' LEU . 5.7 p -125.29 157.1 34.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.97 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.49 122.44 28.99 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.732 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 39' ' ' THR . . . . . 0.436 HG22 ' H ' ' F' ' 39' ' ' THR . 0.0 OUTLIER -59.56 -40.36 87.06 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.784 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.81 68.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.053 0.454 . . . . 0.0 110.866 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.14 -21.5 33.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.125 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 42' ' ' LEU . . . . . 0.544 HD22 HG11 ' F' ' 37' ' ' VAL . 3.2 mp -110.52 29.47 7.68 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.59 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 43' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' F' ' 141' ' ' GLY . . . -108.24 25.52 11.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.322 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.74 159.96 23.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.386 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 45' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' F' ' 140' ' ' THR . 11.0 tt0 -82.86 108.69 16.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 0.0 111.155 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.9 10.86 51.59 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.157 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 47' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' F' ' 139' ' ' ALA . . . -66.67 123.42 20.03 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 77.5 p -120.59 140.29 51.73 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.922 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 49' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 4.6 m -101.63 -167.0 1.36 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.602 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 50' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 8.1 t -69.77 139.73 53.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.859 0.361 . . . . 0.0 110.751 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.78 134.03 35.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.362 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 52' ' ' VAL . . . . . 0.541 HG22 ' O ' ' F' ' 135' ' ' ALA . 18.7 m -87.06 166.5 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.972 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.78 128.92 8.01 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.585 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 54' ' ' PHE . . . . . 0.564 ' H ' HG21 ' C' ' 76' ' ' THR . 40.8 p90 -160.28 134.42 7.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.775 0.322 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 55' ' ' ASN . . . . . 0.512 ' OD1' HG21 ' F' ' 130' ' ' THR . 15.8 p30 -132.73 147.69 52.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.621 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 56' ' ' ILE . . . . . 0.631 HG22 ' HB ' ' F' ' 131' ' ' ILE . 1.0 OUTLIER -96.8 116.79 39.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.539 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 57' ' ' GLN . . . . . 0.565 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.0 OUTLIER -66.61 122.12 16.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.703 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 58' ' ' LEU . . . . . 0.741 ' HG ' ' HA ' ' F' ' 23' ' ' VAL . 0.2 OUTLIER -137.51 88.12 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 -179.567 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 59' ' ' ASN . . . . . 0.713 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 10.6 p30 -79.49 179.32 7.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.935 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.29 64.46 0.96 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.818 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 61' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' F' ' 129' ' ' ASN . 4.4 m -110.55 163.25 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.821 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 62' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' F' ' 19' ' ' ALA . 0.5 OUTLIER -140.19 155.01 47.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.235 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.23 -25.44 10.61 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.89 -16.42 50.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.126 0.489 . . . . 0.0 111.734 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 65' ' ' VAL . . . . . 0.403 HG23 ' OD2' ' F' ' 62' ' ' ASP . 16.8 t -90.68 -48.46 14.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.627 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.13 142.97 35.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.569 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.85 -53.81 2.6 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.882 0.372 . . . . 0.0 110.978 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 68' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' F' ' 121' ' ' GLU . 0.1 OUTLIER -94.85 158.09 15.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.492 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 69' ' ' ALA . . . . . 0.918 ' HB2' HD13 ' F' ' 124' ' ' LEU . . . -137.17 120.47 16.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.592 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 70' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -97.57 129.07 44.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.153 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 71' ' ' VAL . . . . . 0.605 HG11 HG21 ' F' ' 131' ' ' ILE . 15.9 t -112.92 152.24 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.708 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.02 146.62 27.1 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.56 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 73' ' ' PHE . . . . . 0.474 ' CD2' HG21 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -111.5 141.88 44.5 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.557 0.218 . . . . 0.0 111.078 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 74' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.8 OUTLIER -105.7 103.32 12.8 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.934 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.87 -179.08 25.4 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.83 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.2 157.83 17.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.501 0.191 . . . . 0.0 110.766 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.91 132.77 38.06 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.929 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 78' ' ' ILE . . . . . 0.445 ' CG2' ' HB ' ' F' ' 85' ' ' VAL . 0.6 OUTLIER -66.6 -39.83 84.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 79' ' ' ASP . . . . . 0.418 ' N ' HG23 ' F' ' 78' ' ' ILE . 0.7 OUTLIER -146.15 53.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.845 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.38 -87.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.048 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.34 -36.52 53.24 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.603 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -81.3 59.87 4.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.357 . . . . 0.0 110.484 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 83' ' ' THR . . . . . 0.594 HG21 ' OD1' ' F' ' 114' ' ' ASP . 2.1 m -70.58 -20.38 62.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.537 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 84' ' ' ASN . . . . . 0.897 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 26.5 p-10 -69.47 -13.67 62.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.284 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 85' ' ' VAL . . . . . 0.695 HG22 ' HB2' ' F' ' 102' ' ' GLN . 40.8 t -109.01 131.16 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.152 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 86' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' F' ' 152' ' ' ALA . 0.6 OUTLIER -70.09 142.85 52.58 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.03 -170.51 3.06 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.873 0.368 . . . . 0.0 111.666 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -79.98 161.39 25.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.963 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.75 -80.24 0.01 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.386 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 6.4 p -171.39 0.44 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.943 0.402 . . . . 0.0 111.391 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 91' ' ' SER . . . . . 0.608 ' HB2' ' HB2' ' F' ' 95' ' ' SER . 73.6 m -76.81 85.58 3.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.839 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.28 71.78 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.888 0.375 . . . . 0.0 111.67 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.89 30.49 6.85 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.61 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.76 -3.13 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.934 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 95' ' ' SER . . . . . 0.608 ' HB2' ' HB2' ' F' ' 91' ' ' SER . 0.1 OUTLIER -107.51 -176.67 3.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.366 . . . . 0.0 110.679 179.482 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.6 172.66 8.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.81 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 97' ' ' THR . . . . . 0.608 ' H ' ' HB ' ' F' ' 144' ' ' THR . 1.6 m -126.95 140.37 52.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.331 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 98' ' ' ASN . . . . . 0.502 ' HB3' ' H ' ' F' ' 141' ' ' GLY . 27.3 m120 62.0 21.31 12.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.454 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 99' ' ' VAL . . . . . 0.555 HG23 ' O ' ' F' ' 97' ' ' THR . 2.7 t -120.38 135.97 58.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.714 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.94 -160.67 10.14 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.552 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -145.93 109.86 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.171 0.51 . . . . 0.0 111.729 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 102' ' ' GLN . . . . . 0.695 ' HB2' HG22 ' F' ' 85' ' ' VAL . 0.5 OUTLIER -84.29 147.35 27.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.885 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 103' ' ' ILE . . . . . 0.599 HG12 ' HG ' ' F' ' 113' ' ' LEU . 1.2 pp -110.74 127.87 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.489 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 104' ' ' LEU . . . . . 0.977 HD12 ' HB2' ' F' ' 110' ' ' ALA . 1.4 tp -97.46 133.0 42.63 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.711 0.291 . . . . 0.0 111.017 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 105' ' ' ASP . . . . . 0.651 ' HB3' HG22 ' F' ' 107' ' ' THR . 4.0 t0 -80.81 143.57 32.73 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.706 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 106' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' C' ' 80' ' ' ALA . 0.0 OUTLIER -65.48 -17.48 64.59 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.802 0.334 . . . . 0.0 111.023 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 107' ' ' THR . . . . . 0.651 HG22 ' HB3' ' F' ' 105' ' ' ASP . 13.2 t -66.79 -20.73 66.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.973 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.07 -71.81 0.44 Allowed Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.669 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.39 160.01 31.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.826 0.346 . . . . 0.0 111.098 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 110' ' ' ALA . . . . . 0.977 ' HB2' HD12 ' F' ' 104' ' ' LEU . . . -75.59 131.38 39.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 111' ' ' LEU . . . . . 0.689 HD21 ' O ' ' F' ' 117' ' ' THR . 12.2 tp -88.06 154.17 20.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.359 0.6 . . . . 0.0 110.572 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 112' ' ' THR . . . . . 0.897 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 0.4 OUTLIER -96.41 142.69 28.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.062 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 113' ' ' LEU . . . . . 0.599 ' HG ' HG12 ' F' ' 103' ' ' ILE . 0.8 OUTLIER -80.76 63.61 5.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.723 0.297 . . . . 0.0 110.77 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 114' ' ' ASP . . . . . 0.594 ' OD1' HG21 ' F' ' 83' ' ' THR . 0.1 OUTLIER -90.58 -30.6 17.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.611 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.73 -43.59 1.64 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.686 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.61 24.43 12.97 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.988 0.423 . . . . 0.0 111.608 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 117' ' ' THR . . . . . 0.689 ' O ' HD21 ' F' ' 111' ' ' LEU . 0.2 OUTLIER -82.12 68.25 8.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.16 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 118' ' ' PHE . . . . . 0.554 ' CD1' ' HB2' ' F' ' 157' ' ' GLN . 40.9 m-85 -82.07 71.93 9.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.759 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.74 81.02 1.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.66 131.74 13.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.557 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 121' ' ' GLU . . . . . 0.435 ' O ' ' HE2' ' F' ' 68' ' ' LYS . 1.5 mm-40 -100.7 52.1 0.87 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.197 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 122' ' ' THR . . . . . 0.661 ' HB ' ' HB3' ' F' ' 69' ' ' ALA . 0.2 OUTLIER -72.14 131.98 43.54 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.78 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.63 107.54 15.35 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.771 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 124' ' ' LEU . . . . . 0.918 HD13 ' HB2' ' F' ' 69' ' ' ALA . 1.0 OUTLIER -88.23 126.58 35.23 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.59 179.455 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 125' ' ' ASN . . . . . 0.507 ' O ' ' HB3' ' F' ' 61' ' ' CYS . 1.1 m120 -120.65 -178.99 3.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.542 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 126' ' ' ASN . . . . . 0.512 ' OD1' ' HA ' ' F' ' 62' ' ' ASP . 3.8 t30 -83.25 120.68 26.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.695 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 127' ' ' GLY . . . . . 0.74 ' HA2' HG21 ' B' ' 4' ' ' THR . . . 136.12 -121.77 2.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.657 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 128' ' ' THR . . . . . 0.713 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 76.3 m -122.12 103.44 8.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.727 0.299 . . . . 0.0 110.807 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 129' ' ' ASN . . . . . 0.528 ' HB2' ' SG ' ' F' ' 61' ' ' CYS . 1.8 t30 -86.18 157.26 20.03 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.857 0.36 . . . . 0.0 111.086 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 130' ' ' THR . . . . . 0.565 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.3 OUTLIER -143.34 130.14 20.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.162 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 131' ' ' ILE . . . . . 0.631 ' HB ' HG22 ' F' ' 56' ' ' ILE . 57.3 mt -83.97 104.14 3.79 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 132' ' ' PRO . . . . . 0.685 ' HB3' ' HA ' ' C' ' 76' ' ' THR . 7.5 Cg_endo -82.08 112.45 2.3 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.535 1.49 . . . . 0.0 112.548 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 133' ' ' PHE . . . . . 0.429 ' HB3' ' CZ ' ' F' ' 54' ' ' PHE . 1.0 OUTLIER -126.69 158.27 36.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.856 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -125.97 156.01 40.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.119 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 135' ' ' ALA . . . . . 0.541 ' O ' HG22 ' F' ' 52' ' ' VAL . . . -148.14 105.15 3.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 111.609 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.11 163.46 12.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.375 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 137' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 0.3 OUTLIER -81.72 119.69 24.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.131 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 138' ' ' PHE . . . . . 0.467 ' HB3' HG11 ' F' ' 85' ' ' VAL . 2.1 t80 -108.82 142.69 39.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.275 0.56 . . . . 0.0 112.058 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 139' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' F' ' 47' ' ' ALA . . . -132.94 136.05 45.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.831 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 140' ' ' THR . . . . . 0.648 ' O ' ' HA ' ' F' ' 45' ' ' GLU . 24.9 p -96.65 -56.26 2.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.423 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 141' ' ' GLY . . . . . 0.502 ' H ' ' HB3' ' F' ' 98' ' ' ASN . . . -127.04 -129.91 3.31 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.973 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.94 107.15 12.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.521 0.201 . . . . 0.0 110.741 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 143' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' F' ' 97' ' ' THR . . . -65.89 148.07 52.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.686 0.279 . . . . 0.0 111.44 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 144' ' ' THR . . . . . 0.608 ' HB ' ' H ' ' F' ' 97' ' ' THR . 48.0 m -114.88 144.72 32.52 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.262 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 145' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' F' ' 144' ' ' THR . 1.4 Cg_endo -81.96 130.96 6.78 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.549 2.166 . . . . 0.0 111.953 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 146' ' ' GLY . . . . . 0.624 ' O ' ' HG3' ' E' ' 15' ' ' GLU . . . 164.82 -116.27 0.69 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.452 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 147' ' ' ALA . . . . . 0.634 ' HA ' ' HG3' ' E' ' 15' ' ' GLU . . . -110.65 150.4 29.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.866 0.365 . . . . 0.0 111.28 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.65 45.82 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.128 0.49 . . . . 0.0 110.513 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 149' ' ' ASN . . . . . 0.513 HD22 ' HB1' ' F' ' 147' ' ' ALA . 0.1 OUTLIER -96.85 141.02 30.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.535 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 150' ' ' ALA . . . . . 0.408 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -153.71 162.53 41.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.958 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.85 135.46 43.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.225 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 152' ' ' ALA . . . . . 0.78 ' HB2' HD11 ' F' ' 86' ' ' LEU . . . -134.16 152.51 51.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.17 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 153' ' ' THR . . . . . 0.531 HG23 HG23 ' E' ' 9' ' ' THR . 4.0 m -104.16 148.95 25.7 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.29 141.87 35.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.047 0.451 . . . . 0.0 110.155 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -122.57 152.41 40.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.89 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 156' ' ' VAL . . . . . 0.638 HG23 HG23 ' E' ' 5' ' ' VAL . 20.1 m -135.72 133.13 51.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.79 0.329 . . . . 0.0 111.683 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 157' ' ' GLN . . . . . 0.726 ' HG3' HG23 ' E' ' 4' ' ' THR . 1.8 tt0 -130.95 119.86 22.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.339 0.59 . . . . 0.0 110.342 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -102.0 113.28 26.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.523 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 159' ' ' GLN . . . . . 0.622 ' HA ' ' H ' ' E' ' 2' ' ' ALA . 3.6 mp0 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 120.245 0.069 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.93 68.38 0.87 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.569 0.223 . . . . 0.0 111.021 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.38 87.58 6.08 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.475 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.619 ' HB ' ' HA3' ' E' ' 127' ' ' GLY . 3.5 m -90.46 115.43 27.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.602 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 m -127.21 166.97 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.604 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.633 ' HA ' ' HE2' ' B' ' 155' ' ' LYS . 19.9 t30 -83.06 115.15 21.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.517 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.33 -71.5 1.06 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.884 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.24 172.78 34.74 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.907 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 m -95.47 136.96 35.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.409 . . . . 0.0 111.305 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -120.84 130.68 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.218 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.53 ' O ' ' HB ' ' B' ' 32' ' ' VAL . 1.3 m80 -103.78 158.0 16.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.459 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 0.6 OUTLIER -145.81 89.57 1.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.633 ' HD3' HG22 ' B' ' 31' ' ' THR . 0.0 OUTLIER -79.97 135.19 36.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.41 179.706 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.57 178.39 42.07 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.958 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.634 ' HG2' ' HA ' ' B' ' 147' ' ' ALA . 2.6 mt-10 -156.8 -177.93 6.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.368 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.52 HG22 HG23 ' B' ' 37' ' ' VAL . 2.7 t -142.24 150.13 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.233 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.591 HG11 ' HE2' ' A' ' 158' ' ' TYR . 4.1 m -141.7 168.61 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.333 . . . . 0.0 111.066 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.02 74.73 4.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.058 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.88 91.86 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.027 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.46 -50.98 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.433 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER 179.82 -179.68 0.47 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.965 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.616 ' HA ' ' HB3' ' B' ' 36' ' ' GLN . . . -136.2 116.43 13.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.085 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.422 ' H ' ' CB ' ' B' ' 36' ' ' GLN . 69.2 t -67.08 120.15 13.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.026 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.441 ' O ' HG23 ' A' ' 28' ' ' VAL . 2.4 m-20 -64.39 150.49 46.25 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.585 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' B' ' 33' ' ' GLN . . . -48.37 -50.22 31.54 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.326 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.27 -31.8 81.71 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.895 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.04 -16.02 63.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.929 0.395 . . . . 0.0 110.847 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 24' ' ' ASP . 48.5 t -72.96 -43.59 58.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.41 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.39 106.04 10.32 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -116.65 134.03 55.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.074 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.49 96.04 6.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.058 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.445 HG11 HG21 ' A' ' 52' ' ' VAL . 69.3 t -89.46 131.25 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.131 0.491 . . . . 0.0 110.488 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.95 106.41 16.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.618 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.482 HD12 ' CE2' ' A' ' 137' ' ' TYR . 0.4 OUTLIER -73.8 -40.87 63.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.649 179.372 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.95 -122.46 6.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.595 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -144.52 153.95 42.38 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.699 0.285 . . . . 0.0 110.862 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.57 146.35 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.86 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.23 145.97 26.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.717 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.7 p -57.8 -23.02 50.47 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.719 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.93 -33.21 61.94 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.096 0.474 . . . . 0.0 110.844 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -31.15 69.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.124 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.621 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -130.76 86.42 2.37 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.649 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.7 36.2 4.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.37 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.64 150.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.337 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 1.7 tm-20 -64.78 134.83 54.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 111.136 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.79 -14.16 53.14 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.137 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 138' ' ' PHE . . . -57.2 129.86 43.64 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.938 0.399 . . . . 0.0 112.002 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.462 ' HB ' ' CE1' ' A' ' 138' ' ' PHE . 14.3 t -130.59 143.31 50.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.909 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.604 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 68.4 m -111.97 -157.16 0.61 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.552 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.9 t -74.62 150.15 39.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.784 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -103.2 146.64 28.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.322 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.445 HG21 HG11 ' A' ' 32' ' ' VAL . 22.4 m -83.38 148.34 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.4 121.21 6.21 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.6 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.41 ' CD1' HG23 ' A' ' 52' ' ' VAL . 16.2 p90 -153.83 125.56 7.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 0.0 110.928 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -109.28 156.17 20.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.609 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.6 mm -104.08 135.37 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.486 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.64 125.99 48.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.765 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 129' ' ' ASN . 4.3 mp -131.7 100.0 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.273 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.49 174.81 11.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.946 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.8 65.19 1.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.792 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 60.7 m -98.66 142.94 29.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.59 109.25 15.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.269 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.464 HG23 ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -92.44 29.54 1.69 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -90.03 -59.1 2.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.029 0.443 . . . . 0.0 111.819 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.28 -39.8 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.706 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.69 101.39 10.7 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.593 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.6 p -90.54 -28.82 18.25 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.902 0.382 . . . . 0.0 110.95 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.448 ' HZ1' ' HB2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -126.4 166.99 16.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.513 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.9 149.77 29.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.572 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 157' ' ' GLN . . . -112.85 159.79 18.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.092 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.2 t -108.04 123.25 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.689 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 155' ' ' LYS . . . -124.64 168.95 12.44 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.596 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.531 ' CB ' HD11 ' A' ' 111' ' ' LEU . 17.1 t80 -150.59 144.39 25.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.535 0.207 . . . . 0.0 111.168 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.652 HD12 ' OG1' ' D' ' 130' ' ' THR . 0.4 OUTLIER -121.56 88.64 2.97 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.989 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.514 ' C ' HD23 ' A' ' 113' ' ' LEU . . . -134.69 164.72 24.65 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.773 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -78.54 147.73 33.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.544 0.211 . . . . 0.0 110.779 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.564 ' H ' ' HB3' ' D' ' 132' ' ' PRO . . . -95.7 140.34 30.65 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.959 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.548 ' CG2' ' HB ' ' A' ' 85' ' ' VAL . 1.1 tt -78.71 -33.05 16.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.851 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.22 179.22 7.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.838 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.68 -27.87 36.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.059 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.25 -32.22 72.21 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.552 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.427 ' HB3' HG23 ' A' ' 85' ' ' VAL . 15.4 m-70 -97.33 -72.69 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 0.0 110.464 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.85 -7.24 1.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.586 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.754 ' HA ' HD13 ' A' ' 113' ' ' LEU . 3.0 m120 -108.7 -19.13 13.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.364 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . 50.2 t -80.65 132.03 32.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.124 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -76.52 134.95 39.31 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.355 179.381 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.28 165.18 6.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.828 0.347 . . . . 0.0 111.682 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.729 HD12 ' O ' ' D' ' 51' ' ' ALA . 0.1 OUTLIER -65.75 171.65 4.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.029 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.495 ' OE1' ' HB3' ' A' ' 91' ' ' SER . 8.0 pt20 -72.45 175.75 5.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.349 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.474 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 0.5 OUTLIER -76.06 -21.26 56.97 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.997 0.427 . . . . 0.0 111.492 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.495 ' HB3' ' OE1' ' A' ' 89' ' ' GLN . 32.0 t -80.92 67.56 6.87 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.45 ' HA ' ' OG ' ' A' ' 95' ' ' SER . . . -72.27 -9.74 58.87 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.901 0.381 . . . . 0.0 111.668 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.892 ' HB1' ' HB1' ' C' ' 22' ' ' ALA . . . -68.08 -22.91 64.9 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.632 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.39 6.76 2.5 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.932 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.699 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 30.7 p -93.73 150.75 20.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.637 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.69 167.21 18.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.834 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.65 165.15 14.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.366 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.527 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 85.0 m-20 63.29 45.43 5.0 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.494 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.461 ' HB ' ' CB ' ' A' ' 143' ' ' ALA . 3.5 p -170.63 131.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.787 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.08 -175.96 21.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.556 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.3 t -104.14 91.84 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 122.971 0.509 . . . . 0.0 111.745 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER -67.86 131.21 45.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 84' ' ' ASN . 0.7 OUTLIER -99.44 110.52 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.498 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 5.5 tp -91.23 149.94 21.55 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.709 0.29 . . . . 0.0 111.027 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.95 174.68 5.79 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.631 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 106' ' ' ARG . 1.5 ttt180 -72.49 -18.63 61.65 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.719 0.295 . . . . 0.0 110.989 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.0 p -69.25 -9.6 53.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.033 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.97 -48.44 0.95 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.625 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.94 163.54 15.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 0.0 111.062 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -70.39 125.51 27.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.174 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.531 HD11 ' CB ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -65.36 147.61 53.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.367 0.603 . . . . 0.0 110.564 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.679 ' HB ' HG21 ' A' ' 117' ' ' THR . 0.2 OUTLIER -74.03 144.58 45.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.131 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.754 HD13 ' HA ' ' A' ' 84' ' ' ASN . 10.2 mp -100.28 89.94 4.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.769 0.319 . . . . 0.0 110.663 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.432 ' HB2' ' CG2' ' A' ' 117' ' ' THR . 4.1 m-20 -142.42 11.37 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.657 0.265 . . . . 0.0 111.555 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.439 ' O ' ' HB1' ' A' ' 72' ' ' ALA . . . 96.91 -78.09 0.69 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.669 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' D' ' 125' ' ' ASN . . . -104.27 61.54 0.73 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.973 0.416 . . . . 0.0 111.662 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.679 HG21 ' HB ' ' A' ' 112' ' ' THR . 17.6 p -93.35 95.84 9.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.131 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.79 110.0 5.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.9 m -120.35 -72.92 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.773 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.4 113.03 25.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.602 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.448 ' HB2' ' HZ1' ' A' ' 68' ' ' LYS . 25.2 mt-10 -99.47 97.53 8.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.207 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.5 132.71 37.52 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.775 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -60.89 146.12 47.75 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.727 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.464 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.2 OUTLIER -85.48 156.56 20.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.562 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.78 142.75 40.88 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.54 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.94 113.63 6.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.74 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.59 -90.08 0.32 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.744 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.0 m -124.88 152.77 43.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.745 0.307 . . . . 0.0 110.798 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 17.1 t-20 -123.0 147.52 46.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.19 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.3 m -126.12 135.7 52.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.098 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.4 mt -114.03 115.65 45.47 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.4 ' HB2' ' HB2' ' A' ' 106' ' ' ARG . 7.5 Cg_endo -81.7 115.71 2.81 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.629 1.553 . . . . 0.0 112.567 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.58 150.81 46.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.825 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 4.5 mt-30 -142.48 166.67 24.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.029 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 102' ' ' GLN . . . -158.13 102.94 1.81 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 111.654 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -94.68 -173.4 3.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.396 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.604 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 3.8 m-85 -100.78 152.87 19.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.068 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.545 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -147.37 160.73 42.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.998 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -126.86 149.61 49.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.925 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -115.34 27.83 9.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.461 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.4 66.75 0.2 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.955 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.99 88.59 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.602 0.239 . . . . 0.0 110.744 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.461 ' CB ' ' HB ' ' A' ' 99' ' ' VAL . . . -60.19 156.88 14.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.709 0.29 . . . . 0.0 111.452 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.545 ' HB ' ' CD ' ' A' ' 145' ' ' PRO . 77.3 p -112.26 173.02 3.08 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.218 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.545 ' CD ' ' HB ' ' A' ' 144' ' ' THR . 1.3 Cg_endo -84.51 145.16 10.45 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.518 2.145 . . . . 0.0 111.995 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.44 -112.7 0.55 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.512 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -124.93 167.67 14.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.892 0.377 . . . . 0.0 111.275 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -157.19 57.54 0.52 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.411 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.85 132.73 36.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.539 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.47 163.13 28.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.937 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.45 125.58 1.83 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.231 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.794 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -154.57 165.79 35.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.244 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.9 163.18 12.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -119.01 134.6 55.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.102 0.477 . . . . 0.0 110.102 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -95.64 166.24 11.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.913 -178.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.24 112.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.793 0.33 . . . . 0.0 111.657 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.613 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -88.77 138.81 31.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.278 0.561 . . . . 0.0 110.403 -179.686 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.591 ' HE2' HG11 ' A' ' 17' ' ' VAL . 22.5 m-85 -127.65 113.16 15.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.568 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.976 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.241 0.067 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.94 68.26 0.88 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.645 0.26 . . . . 0.0 111.06 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.33 87.63 6.12 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.454 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.612 ' HB ' ' HA3' ' F' ' 127' ' ' GLY . 3.5 m -90.35 115.47 27.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.571 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -127.34 167.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.588 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.653 ' HA ' ' HE2' ' C' ' 155' ' ' LYS . 20.2 t30 -82.95 115.11 21.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.577 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.39 -71.48 1.06 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.827 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.31 172.78 34.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.909 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 33.3 m -95.52 137.01 35.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.941 0.4 . . . . 0.0 111.253 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 40.4 t -120.8 130.76 74.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.173 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' HIS . . . . . 0.54 ' O ' ' HB ' ' C' ' 32' ' ' VAL . 1.3 m80 -103.92 157.97 16.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.41 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' C' ' 32' ' ' VAL . 0.5 OUTLIER -145.82 89.67 1.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.823 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 13' ' ' LYS . . . . . 0.627 ' HD3' HG22 ' C' ' 31' ' ' THR . 0.0 OUTLIER -80.04 135.21 36.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.431 179.722 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.57 178.38 42.08 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.953 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.641 ' HG2' ' HA ' ' C' ' 147' ' ' ALA . 2.6 mt-10 -156.78 -177.86 6.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.385 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.512 HG22 HG23 ' C' ' 37' ' ' VAL . 2.7 t -142.35 150.1 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.235 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.572 HG11 ' HE2' ' B' ' 158' ' ' TYR . 4.1 m -141.73 168.57 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.856 0.36 . . . . 0.0 110.996 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -92.93 74.78 4.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.039 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.78 91.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.045 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.42 -51.07 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.421 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER 179.83 -179.8 0.48 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.996 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.603 ' HA ' ' HB3' ' C' ' 36' ' ' GLN . . . -136.14 116.5 13.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.138 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.423 ' H ' ' CB ' ' C' ' 36' ' ' GLN . 69.1 t -67.07 120.15 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.003 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.441 ' O ' HG23 ' B' ' 28' ' ' VAL . 2.4 m-20 -64.36 150.45 46.26 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.605 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.423 ' HB1' ' HB2' ' C' ' 33' ' ' GLN . . . -48.38 -50.1 32.1 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.388 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.36 -31.79 81.55 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.841 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.07 -15.98 63.58 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.879 0.371 . . . . 0.0 110.831 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 24' ' ' ASP . 48.6 t -72.96 -43.68 58.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.375 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.36 106.11 10.4 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.005 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -116.68 134.03 55.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.999 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' THR . . . . . 0.633 HG22 ' HD3' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -105.49 96.09 6.27 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.057 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.53 ' HB ' ' O ' ' A' ' 11' ' ' HIS . 69.3 t -89.53 131.27 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.15 0.5 . . . . 0.0 110.456 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.451 ' HA ' ' HG2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -108.97 106.48 16.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.637 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.493 HD12 ' CE2' ' B' ' 137' ' ' TYR . 0.4 OUTLIER -73.79 -40.89 63.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.66 179.371 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.89 -122.41 6.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.601 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.616 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 3.7 tt0 -144.6 153.85 42.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.586 0.231 . . . . 0.0 110.939 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.52 HG23 HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -128.5 146.32 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.909 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.529 ' HE ' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -98.25 146.0 26.07 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.7 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 17' ' ' VAL . 40.9 p -57.78 -22.99 50.12 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.713 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.01 -33.22 61.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.013 0.435 . . . . 0.0 110.809 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -31.1 69.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.174 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.617 ' HB3' ' HB2' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -130.83 86.34 2.36 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.604 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.64 36.19 4.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.357 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 177.56 150.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.392 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' B' ' 140' ' ' THR . 1.7 tm-20 -64.79 134.81 54.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.884 0.373 . . . . 0.0 111.103 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.79 -14.19 53.12 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.218 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' B' ' 138' ' ' PHE . . . -57.19 129.8 43.36 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' THR . . . . . 0.455 ' HB ' ' CE1' ' B' ' 138' ' ' PHE . 14.3 t -130.55 143.34 50.69 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.864 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' SER . . . . . 0.594 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 68.6 m -111.95 -157.2 0.61 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.579 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.416 ' H ' ' HB3' ' B' ' 49' ' ' SER . 27.5 t -74.46 150.13 40.05 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.863 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' B' ' 136' ' ' ARG . . . -103.28 146.61 28.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.328 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' B' ' 134' ' ' GLN . 22.0 m -83.31 148.31 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.981 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.35 121.21 6.22 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.638 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' PHE . . . . . 0.404 ' CD1' HG23 ' B' ' 52' ' ' VAL . 15.9 p90 -153.81 125.52 7.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.737 0.303 . . . . 0.0 110.955 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -109.23 156.22 20.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.626 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 22.5 mm -104.04 135.35 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.51 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.75 126.05 48.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.771 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.547 ' HB2' ' HB3' ' B' ' 129' ' ' ASN . 4.3 mp -131.62 99.91 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.275 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.43 174.79 11.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.71 65.24 1.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.809 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' B' ' 21' ' ' CYS . 60.6 m -98.64 142.86 29.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.822 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.58 109.22 15.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.329 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.473 HG23 ' HB3' ' B' ' 124' ' ' LEU . 0.2 OUTLIER -92.37 29.53 1.67 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.143 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -90.0 -59.16 2.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.039 0.447 . . . . 0.0 111.726 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.29 -39.82 13.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.71 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.58 101.3 10.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.614 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.1 p -90.58 -28.74 18.27 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.872 0.367 . . . . 0.0 110.971 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.49 166.94 16.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.523 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.82 149.8 29.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.646 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' B' ' 157' ' ' GLN . . . -112.88 159.77 18.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.097 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 51.1 t -108.06 123.25 63.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.693 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.685 ' HB3' ' HB3' ' B' ' 155' ' ' LYS . . . -124.6 168.96 12.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.563 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.534 ' CB ' HD11 ' B' ' 111' ' ' LEU . 17.2 t80 -150.59 144.37 25.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.533 0.206 . . . . 0.0 111.205 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.632 HD12 ' OG1' ' E' ' 130' ' ' THR . 0.4 OUTLIER -121.42 88.57 2.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.033 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 75' ' ' GLY . . . . . 0.514 ' C ' HD23 ' B' ' 113' ' ' LEU . . . -134.75 164.7 24.67 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.813 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.659 ' O ' ' HA ' ' B' ' 86' ' ' LEU . 0.6 OUTLIER -78.51 147.76 33.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.531 0.205 . . . . 0.0 110.775 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.564 ' H ' ' HB3' ' E' ' 132' ' ' PRO . . . -95.79 140.32 30.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.887 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.555 ' CG2' ' HB ' ' B' ' 85' ' ' VAL . 1.2 tt -78.7 -33.09 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.873 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.16 179.21 7.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.848 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.66 -27.84 37.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.26 -32.21 72.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.603 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.417 ' HB3' HG23 ' B' ' 85' ' ' VAL . 15.4 m-70 -97.38 -72.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 0.0 110.475 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.77 -7.13 1.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.599 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ASN . . . . . 0.764 ' HA ' HD13 ' B' ' 113' ' ' LEU . 3.1 m120 -108.8 -19.1 13.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.329 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' B' ' 102' ' ' GLN . 49.8 t -80.53 132.06 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.183 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.79 HD21 ' HB2' ' B' ' 152' ' ' ALA . 0.4 OUTLIER -76.61 134.91 39.2 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.283 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.21 165.16 6.09 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.939 0.399 . . . . 0.0 111.678 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' LEU . . . . . 0.723 HD12 ' O ' ' E' ' 51' ' ' ALA . 0.1 OUTLIER -65.72 171.7 4.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 89' ' ' GLN . . . . . 0.491 ' OE1' ' HB3' ' B' ' 91' ' ' SER . 8.0 pt20 -72.54 175.76 6.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.349 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 0.5 OUTLIER -76.04 -21.24 57.02 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.984 0.421 . . . . 0.0 111.492 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 91' ' ' SER . . . . . 0.491 ' HB3' ' OE1' ' B' ' 89' ' ' GLN . 32.1 t -80.94 67.53 6.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.446 ' HA ' ' OG ' ' B' ' 95' ' ' SER . . . -72.29 -9.66 58.77 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.637 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' ALA . . . . . 0.88 ' HB1' ' HB1' ' D' ' 22' ' ' ALA . . . -68.05 -22.9 64.93 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.653 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.46 6.73 2.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.917 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' SER . . . . . 0.705 ' HA ' ' HB3' ' B' ' 147' ' ' ALA . 30.5 p -93.69 150.79 20.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.851 0.358 . . . . 0.0 110.632 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.79 167.19 18.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 165.18 14.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.366 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 98' ' ' ASN . . . . . 0.512 ' HA ' ' OG1' ' B' ' 140' ' ' THR . 85.0 m-20 63.17 45.54 5.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.465 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' VAL . . . . . 0.456 ' HB ' ' CB ' ' B' ' 143' ' ' ALA . 3.5 p -170.63 131.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.76 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.11 -176.02 21.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.529 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 75.8 t -104.06 91.85 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 122.946 0.498 . . . . 0.0 111.79 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 0.6 OUTLIER -67.83 131.18 45.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.919 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.518 HD12 ' O ' ' B' ' 84' ' ' ASN . 0.7 OUTLIER -99.4 110.53 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.526 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 104' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 5.5 tp -91.22 149.99 21.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.628 0.251 . . . . 0.0 111.053 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.95 174.62 5.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.652 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' B' ' 106' ' ' ARG . 1.5 ttt180 -72.44 -18.54 61.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.796 0.331 . . . . 0.0 111.079 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 46.0 p -69.36 -9.57 54.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.005 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.02 -48.43 0.95 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.671 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.91 163.57 15.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 0.0 111.154 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -70.45 125.52 27.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.534 HD11 ' CB ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -65.35 147.59 53.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.321 0.581 . . . . 0.0 110.607 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.678 ' HB ' HG21 ' B' ' 117' ' ' THR . 0.2 OUTLIER -73.99 144.56 45.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.136 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.764 HD13 ' HA ' ' B' ' 84' ' ' ASN . 10.2 mp -100.29 89.82 4.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.762 0.315 . . . . 0.0 110.682 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ASP . . . . . 0.441 ' HB2' ' CG2' ' B' ' 117' ' ' THR . 4.1 m-20 -142.36 11.47 1.92 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.668 0.27 . . . . 0.0 111.621 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' GLY . . . . . 0.449 ' O ' ' HB1' ' B' ' 72' ' ' ALA . . . 96.92 -78.14 0.69 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.576 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 116' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' E' ' 125' ' ' ASN . . . -104.26 61.56 0.73 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.976 0.417 . . . . 0.0 111.629 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.678 HG21 ' HB ' ' B' ' 112' ' ' THR . 17.7 p -93.38 95.82 9.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.123 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.77 109.97 5.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.781 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.32 -72.89 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.52 113.07 25.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.583 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.43 97.54 8.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.204 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.47 132.68 37.51 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.761 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 22.2 m -60.92 146.19 47.63 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.74 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.473 ' HB3' HG23 ' B' ' 63' ' ' THR . 0.2 OUTLIER -85.48 156.5 20.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.595 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.77 142.8 40.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.515 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.01 113.61 6.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.732 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.59 -90.03 0.32 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.73 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 6.1 m -124.88 152.82 43.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.677 0.275 . . . . 0.0 110.815 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ASN . . . . . 0.547 ' HB3' ' HB2' ' B' ' 58' ' ' LEU . 17.0 t-20 -123.04 147.6 46.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.963 0.411 . . . . 0.0 111.096 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.3 m -126.19 135.61 51.84 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.085 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' ILE . . . . . . . . . . . . . 58.6 mt -113.95 115.72 45.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' PRO . . . . . 0.401 ' HB2' ' HB2' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.74 115.68 2.79 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.67 1.58 . . . . 0.0 112.598 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.58 150.84 46.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.806 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 134' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' B' ' 52' ' ' VAL . 4.5 mt-30 -142.46 166.75 23.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.034 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' B' ' 102' ' ' GLN . . . -158.22 102.88 1.79 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 0.0 111.626 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 136' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' B' ' 51' ' ' ALA . 0.2 OUTLIER -94.67 -173.41 3.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.439 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 137' ' ' TYR . . . . . 0.594 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 3.8 m-85 -100.83 152.83 20.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.074 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 138' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' B' ' 47' ' ' ALA . 0.2 OUTLIER -147.32 160.81 42.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.002 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.617 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -126.92 149.65 49.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.876 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 140' ' ' THR . . . . . 0.512 ' OG1' ' HA ' ' B' ' 98' ' ' ASN . 0.0 OUTLIER -115.41 27.86 9.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.453 179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.46 66.86 0.2 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.879 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.94 88.62 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.568 0.223 . . . . 0.0 110.69 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' ALA . . . . . 0.456 ' CB ' ' HB ' ' B' ' 99' ' ' VAL . . . -60.25 156.94 14.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.764 0.316 . . . . 0.0 111.407 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.543 ' HB ' ' CD ' ' B' ' 145' ' ' PRO . 76.5 p -112.23 173.04 3.07 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.236 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.543 ' CD ' ' HB ' ' B' ' 144' ' ' THR . 1.3 Cg_endo -84.55 145.23 10.43 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.552 2.168 . . . . 0.0 111.979 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.37 -112.73 0.55 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.521 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.705 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -125.02 167.62 14.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.826 0.346 . . . . 0.0 111.308 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 148' ' ' ALA . . . . . 0.417 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -157.16 57.52 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.459 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -91.84 132.72 36.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.582 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.4 163.13 28.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.023 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.44 125.61 1.83 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.25 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' ALA . . . . . 0.79 ' HB2' HD21 ' B' ' 86' ' ' LEU . . . -154.51 165.82 35.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.211 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.92 163.11 12.77 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -119.01 134.6 55.09 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.181 0.515 . . . . 0.0 110.069 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.685 ' HB3' ' HB3' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -95.57 166.26 11.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.923 -178.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.29 112.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.81 0.338 . . . . 0.0 111.663 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.625 ' HB3' ' HB3' ' B' ' 70' ' ' ALA . 0.2 OUTLIER -88.73 138.88 31.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.286 0.565 . . . . 0.0 110.423 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 158' ' ' TYR . . . . . 0.572 ' HE2' HG11 ' B' ' 17' ' ' VAL . 22.6 m-85 -127.73 113.11 15.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.554 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.937 179.992 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.304 0.097 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.96 68.25 0.88 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.62 0.248 . . . . 0.0 110.999 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.31 87.69 6.15 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.46 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' D' ' 157' ' ' GLN . 3.5 m -90.51 115.49 27.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.55 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 m -127.3 167.01 22.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.589 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' ASN . . . . . 0.649 ' HA ' ' HE2' ' D' ' 155' ' ' LYS . 19.9 t30 -83.06 115.16 21.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.507 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.34 -71.53 1.06 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.828 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.28 172.75 34.76 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.931 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 33.2 m -95.5 137.0 35.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.972 0.415 . . . . 0.0 111.219 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 40.1 t -120.78 130.75 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.225 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' HIS . . . . . 0.539 ' O ' ' HB ' ' D' ' 32' ' ' VAL . 1.3 m80 -103.86 157.99 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.392 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 12' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' D' ' 32' ' ' VAL . 0.6 OUTLIER -145.91 89.67 1.91 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.793 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.634 ' HD3' HG22 ' D' ' 31' ' ' THR . 0.0 OUTLIER -80.04 135.15 36.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.437 179.718 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.5 178.43 42.02 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.898 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' GLU . . . . . 0.64 ' HG2' ' HA ' ' D' ' 147' ' ' ALA . 2.6 mt-10 -156.87 -177.98 7.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.382 . . . . 0.0 110.327 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.515 HG22 HG23 ' D' ' 37' ' ' VAL . 2.7 t -142.24 150.13 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.253 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.572 HG11 ' HE2' ' C' ' 158' ' ' TYR . 4.1 m -141.72 168.57 15.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 111.025 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.04 74.77 4.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.068 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.82 91.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.011 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.49 -50.97 0.08 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.475 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 21' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER 179.87 -179.77 0.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.019 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 22' ' ' ALA . . . . . 0.892 ' HB1' ' HB1' ' A' ' 93' ' ' ALA . . . -136.16 116.43 13.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.168 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 23' ' ' VAL . . . . . 0.41 ' H ' ' CB ' ' D' ' 36' ' ' GLN . 69.0 t -67.02 120.15 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.043 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.439 ' O ' HG23 ' C' ' 28' ' ' VAL . 2.4 m-20 -64.46 150.47 46.49 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.59 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' D' ' 33' ' ' GLN . . . -48.35 -50.16 31.58 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.343 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.34 -31.77 81.51 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.897 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.09 -15.93 63.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.439 HG23 ' O ' ' C' ' 24' ' ' ASP . 48.6 t -72.94 -43.67 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.36 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.44 106.08 10.34 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -116.67 133.98 55.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.026 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' THR . . . . . 0.627 HG22 ' HD3' ' B' ' 13' ' ' LYS . 1.0 OUTLIER -105.5 96.07 6.25 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.069 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' B' ' 11' ' ' HIS . 69.5 t -89.45 131.24 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.154 0.502 . . . . 0.0 110.434 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.457 ' HA ' ' HG2' ' B' ' 13' ' ' LYS . 0.3 OUTLIER -109.02 106.46 16.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.582 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.485 HD12 ' CE2' ' C' ' 137' ' ' TYR . 0.4 OUTLIER -73.82 -40.89 63.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.642 179.368 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.98 -122.45 6.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.556 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' GLN . . . . . 0.603 ' HB3' ' HA ' ' B' ' 22' ' ' ALA . 3.7 tt0 -144.55 153.9 42.31 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.621 0.248 . . . . 0.0 110.913 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.512 HG23 HG22 ' B' ' 16' ' ' VAL . 0.0 OUTLIER -128.51 146.3 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.848 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 38' ' ' ARG . . . . . 0.539 ' HE ' ' HB2' ' B' ' 22' ' ' ALA . 0.0 OUTLIER -98.22 145.96 26.1 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.772 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.56 HG23 ' O ' ' B' ' 17' ' ' VAL . 41.0 p -57.73 -23.03 49.87 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.777 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.94 -33.2 61.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.056 0.455 . . . . 0.0 110.833 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.0 -31.21 69.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.142 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.611 ' HB3' ' HB2' ' C' ' 139' ' ' ALA . 0.0 OUTLIER -130.77 86.41 2.37 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.65 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.68 36.14 4.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.371 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.6 150.89 0.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.343 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' C' ' 140' ' ' THR . 1.7 tm-20 -64.8 134.84 54.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.337 . . . . 0.0 111.135 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.74 -14.08 53.35 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.143 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' C' ' 138' ' ' PHE . . . -57.27 129.86 43.63 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 48' ' ' THR . . . . . 0.469 ' HB ' ' CE1' ' C' ' 138' ' ' PHE . 14.3 t -130.57 143.31 50.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.903 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 68.6 m -111.96 -157.23 0.61 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.565 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 50' ' ' SER . . . . . 0.404 ' H ' ' HB3' ' C' ' 49' ' ' SER . 27.7 t -74.59 150.13 39.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.816 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 51' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . . . -103.24 146.65 28.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.344 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' C' ' 134' ' ' GLN . 22.2 m -83.35 148.35 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.42 121.17 6.19 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.645 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' PHE . . . . . 0.414 ' CD1' HG23 ' C' ' 52' ' ' VAL . 16.3 p90 -153.79 125.59 7.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.777 0.322 . . . . 0.0 110.933 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -109.35 156.17 20.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.543 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 22.4 mm -103.9 135.28 42.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.635 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.7 126.04 48.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.755 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 58' ' ' LEU . . . . . 0.551 ' HB2' ' HB3' ' C' ' 129' ' ' ASN . 4.3 mp -131.57 100.0 4.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.298 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.41 174.82 11.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.943 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.68 65.28 1.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.804 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 61' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' C' ' 21' ' ' CYS . 60.7 m -98.73 142.98 29.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.796 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.66 109.25 15.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.303 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.457 HG23 ' HB3' ' C' ' 124' ' ' LEU . 0.2 OUTLIER -92.43 29.47 1.7 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -89.93 -59.19 2.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.015 0.436 . . . . 0.0 111.752 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.29 -39.87 13.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.654 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.61 101.34 10.67 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.629 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 31.1 p -90.54 -28.83 18.24 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 110.962 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.36 167.05 16.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.531 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.91 149.84 29.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.599 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' C' ' 157' ' ' GLN . . . -112.98 159.74 18.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.104 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.1 123.31 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.678 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' ALA . . . . . 0.687 ' HB3' ' HB3' ' C' ' 155' ' ' LYS . . . -124.65 169.0 12.38 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.55 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 73' ' ' PHE . . . . . 0.538 ' CB ' HD11 ' C' ' 111' ' ' LEU . 17.2 t80 -150.6 144.39 25.24 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.54 0.21 . . . . 0.0 111.104 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.657 HD12 ' OG1' ' F' ' 130' ' ' THR . 0.4 OUTLIER -121.46 88.62 2.97 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.976 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 75' ' ' GLY . . . . . 0.521 ' C ' HD23 ' C' ' 113' ' ' LEU . . . -134.78 164.7 24.68 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.779 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.656 ' O ' ' HA ' ' C' ' 86' ' ' LEU . 0.6 OUTLIER -78.55 147.77 33.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.571 0.224 . . . . 0.0 110.76 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 77' ' ' ALA . . . . . 0.558 ' H ' ' HB3' ' F' ' 132' ' ' PRO . . . -95.73 140.26 30.79 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.934 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 78' ' ' ILE . . . . . 0.56 ' CG2' ' HB ' ' C' ' 85' ' ' VAL . 1.1 tt -78.61 -33.18 16.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.86 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.17 179.28 6.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.69 -27.9 36.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.006 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.15 -32.24 72.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.671 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 82' ' ' HIS . . . . . 0.407 ' HB3' HG23 ' C' ' 85' ' ' VAL . 15.2 m-70 -97.32 -72.73 0.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 0.0 110.49 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 5.6 m 74.9 -7.25 1.78 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.563 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 84' ' ' ASN . . . . . 0.745 ' HA ' HD13 ' C' ' 113' ' ' LEU . 3.1 m120 -108.77 -19.13 13.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.329 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.56 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 49.9 t -80.58 132.01 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.162 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.766 HD21 ' HB2' ' C' ' 152' ' ' ALA . 0.4 OUTLIER -76.58 134.98 39.23 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.991 -0.283 . . . . 0.0 110.279 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.34 165.16 6.27 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.903 0.382 . . . . 0.0 111.676 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.738 HD12 ' O ' ' F' ' 51' ' ' ALA . 0.0 OUTLIER -65.72 171.74 4.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.069 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 89' ' ' GLN . . . . . 0.485 ' OE1' ' HB3' ' C' ' 91' ' ' SER . 8.1 pt20 -72.45 175.71 6.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.409 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 90' ' ' SER . . . . . 0.467 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 0.5 OUTLIER -75.98 -21.26 57.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.984 0.421 . . . . 0.0 111.518 179.414 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 91' ' ' SER . . . . . 0.485 ' HB3' ' OE1' ' C' ' 89' ' ' GLN . 32.1 t -80.95 67.6 6.92 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.811 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 92' ' ' ALA . . . . . 0.453 ' HA ' ' OG ' ' C' ' 95' ' ' SER . . . -72.28 -9.71 58.83 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.912 0.387 . . . . 0.0 111.681 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 93' ' ' ALA . . . . . 0.894 ' HB1' ' HB1' ' E' ' 22' ' ' ALA . . . -68.14 -22.77 64.85 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.615 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.54 6.75 2.46 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.895 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 95' ' ' SER . . . . . 0.689 ' HA ' ' HB3' ' C' ' 147' ' ' ALA . 31.5 p -93.72 150.82 20.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.851 0.358 . . . . 0.0 110.625 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.79 167.14 18.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.58 165.16 14.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.367 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 98' ' ' ASN . . . . . 0.527 ' HA ' ' OG1' ' C' ' 140' ' ' THR . 85.1 m-20 63.24 45.5 5.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.443 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 99' ' ' VAL . . . . . 0.472 ' HB ' ' CB ' ' C' ' 143' ' ' ALA . 3.5 p -170.65 131.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.762 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.03 -175.94 21.14 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.531 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 101' ' ' VAL . . . . . . . . . . . . . 76.0 t -104.14 91.88 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 122.981 0.512 . . . . 0.0 111.723 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 102' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' C' ' 85' ' ' VAL . 0.6 OUTLIER -67.95 131.16 44.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.916 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.52 HD12 ' O ' ' C' ' 84' ' ' ASN . 0.7 OUTLIER -99.34 110.56 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.535 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 104' ' ' LEU . . . . . 0.466 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 5.4 tp -91.22 149.94 21.55 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.625 0.25 . . . . 0.0 111.086 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.9 174.68 5.79 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.71 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 106' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' C' ' 106' ' ' ARG . 1.5 ttt180 -72.53 -18.45 61.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.79 0.329 . . . . 0.0 111.106 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 46.2 p -69.36 -9.67 54.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.996 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.99 -48.34 0.96 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.69 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.95 163.57 15.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 111.072 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -70.49 125.62 27.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.123 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 111' ' ' LEU . . . . . 0.538 HD11 ' CB ' ' C' ' 73' ' ' PHE . 0.0 OUTLIER -65.41 147.65 53.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.356 0.598 . . . . 0.0 110.557 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 112' ' ' THR . . . . . 0.702 ' HB ' HG21 ' C' ' 117' ' ' THR . 0.2 OUTLIER -74.11 144.63 44.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.113 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.745 HD13 ' HA ' ' C' ' 84' ' ' ASN . 10.2 mp -100.36 89.84 4.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.799 0.333 . . . . 0.0 110.718 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 114' ' ' ASP . . . . . 0.431 ' HB2' ' CG2' ' C' ' 117' ' ' THR . 4.0 m-20 -142.37 11.5 1.92 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.51 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 115' ' ' GLY . . . . . 0.438 ' O ' ' HB1' ' C' ' 72' ' ' ALA . . . 96.82 -78.08 0.7 Allowed Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.638 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 116' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' F' ' 125' ' ' ASN . . . -104.24 61.52 0.73 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.013 0.435 . . . . 0.0 111.686 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 117' ' ' THR . . . . . 0.702 HG21 ' HB ' ' C' ' 112' ' ' THR . 17.6 p -93.4 95.9 9.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.081 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.86 110.02 5.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.787 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 13.9 m -120.4 -72.85 0.67 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.42 113.04 25.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.666 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -99.39 97.52 8.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.186 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.45 132.71 37.46 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.752 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 22.0 m -60.89 146.15 47.65 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.708 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 124' ' ' LEU . . . . . 0.457 ' HB3' HG23 ' C' ' 63' ' ' THR . 0.2 OUTLIER -85.41 156.52 20.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.634 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.82 142.73 40.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.575 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.9 113.69 6.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.742 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.5 -90.01 0.32 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.702 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 6.1 m -124.91 152.82 43.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.692 0.282 . . . . 0.0 110.815 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 129' ' ' ASN . . . . . 0.551 ' HB3' ' HB2' ' C' ' 58' ' ' LEU . 17.1 t-20 -123.06 147.53 46.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 4.3 m -126.19 135.65 51.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.094 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 131' ' ' ILE . . . . . . . . . . . . . 58.2 mt -113.95 115.68 45.63 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 132' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -81.74 115.72 2.79 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 121.635 1.557 . . . . 0.0 112.54 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.57 150.8 46.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.828 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 134' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' C' ' 52' ' ' VAL . 4.5 mt-30 -142.4 166.74 23.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.032 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' C' ' 102' ' ' GLN . . . -158.22 102.92 1.79 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.927 0.394 . . . . 0.0 111.622 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 136' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' C' ' 51' ' ' ALA . 0.1 OUTLIER -94.69 -173.47 3.02 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.408 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 137' ' ' TYR . . . . . 0.59 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 3.8 m-85 -100.72 152.83 20.0 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.147 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 138' ' ' PHE . . . . . 0.553 ' HA ' ' O ' ' C' ' 47' ' ' ALA . 0.2 OUTLIER -147.3 160.73 42.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.026 -179.167 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 139' ' ' ALA . . . . . 0.611 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -126.85 149.63 49.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.915 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 140' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' C' ' 98' ' ' ASN . 0.0 OUTLIER -115.33 27.87 9.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.472 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.37 66.79 0.2 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.947 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.93 88.63 0.09 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.58 0.229 . . . . 0.0 110.769 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 143' ' ' ALA . . . . . 0.472 ' CB ' ' HB ' ' C' ' 99' ' ' VAL . . . -60.25 156.86 14.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.758 0.313 . . . . 0.0 111.4 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 144' ' ' THR . . . . . 0.552 ' HB ' ' CD ' ' C' ' 145' ' ' PRO . 77.3 p -112.2 173.05 3.07 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.254 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 145' ' ' PRO . . . . . 0.552 ' CD ' ' HB ' ' C' ' 144' ' ' THR . 1.3 Cg_endo -84.55 145.24 10.43 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.57 2.18 . . . . 0.0 111.923 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.31 -112.7 0.55 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.508 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 147' ' ' ALA . . . . . 0.689 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -124.92 167.68 14.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.913 0.387 . . . . 0.0 111.296 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 148' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -157.19 57.45 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.466 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -91.81 132.71 36.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.53 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.41 163.16 28.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.988 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.45 125.59 1.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.244 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 152' ' ' ALA . . . . . 0.766 ' HB2' HD21 ' C' ' 86' ' ' LEU . . . -154.57 165.78 35.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.264 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.88 163.17 12.72 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -119.02 134.57 55.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.061 0.458 . . . . 0.0 110.155 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 155' ' ' LYS . . . . . 0.687 ' HB3' ' HB3' ' C' ' 72' ' ' ALA . 0.0 OUTLIER -95.62 166.28 11.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.914 -178.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.22 112.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.754 0.312 . . . . 0.0 111.713 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 157' ' ' GLN . . . . . 0.634 ' HB3' ' HB3' ' C' ' 70' ' ' ALA . 0.2 OUTLIER -88.67 138.83 31.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.235 0.54 . . . . 0.0 110.385 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 158' ' ' TYR . . . . . 0.572 ' HE2' HG11 ' C' ' 17' ' ' VAL . 22.6 m-85 -127.76 113.21 15.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.523 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.913 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.248 0.07 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.96 68.35 0.87 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.935 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 3' ' ' THR . . . . . . . . . . . . . 7.5 m -92.39 87.63 6.09 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.439 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 4' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' E' ' 157' ' ' GLN . 3.5 m -90.39 115.48 27.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.542 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -127.3 167.02 22.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.565 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 6' ' ' ASN . . . . . 0.643 ' HA ' ' HE2' ' E' ' 155' ' ' LYS . 20.0 t30 -83.02 115.19 21.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.554 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.43 -71.49 1.06 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.806 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.3 172.75 34.77 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.897 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 33.1 m -95.45 136.94 35.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.918 0.39 . . . . 0.0 111.265 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.83 130.73 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.171 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 11' ' ' HIS . . . . . 0.539 ' O ' ' HB ' ' E' ' 32' ' ' VAL . 1.3 m80 -103.83 157.98 16.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.327 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 12' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' E' ' 32' ' ' VAL . 0.6 OUTLIER -145.87 89.68 1.92 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.76 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 13' ' ' LYS . . . . . 0.633 ' HD3' HG22 ' E' ' 31' ' ' THR . 0.0 OUTLIER -79.98 135.16 36.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.436 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.54 178.42 42.04 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.948 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 15' ' ' GLU . . . . . 0.652 ' HG2' ' HA ' ' E' ' 147' ' ' ALA . 2.5 mt-10 -156.79 -177.92 6.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.833 0.349 . . . . 0.0 110.414 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.514 HG22 HG23 ' E' ' 37' ' ' VAL . 2.7 t -142.24 150.16 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.27 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.585 HG11 ' HE2' ' D' ' 158' ' ' TYR . 4.2 m -141.76 168.53 14.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.86 0.362 . . . . 0.0 111.034 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -92.98 74.75 4.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.066 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.83 91.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.057 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.43 -51.06 0.09 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.402 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 21' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER 179.88 -179.78 0.48 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.005 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 22' ' ' ALA . . . . . 0.88 ' HB1' ' HB1' ' B' ' 93' ' ' ALA . . . -136.17 116.41 13.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.16 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 23' ' ' VAL . . . . . 0.423 ' H ' ' CB ' ' E' ' 36' ' ' GLN . 69.3 t -67.01 120.21 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.439 ' O ' HG23 ' D' ' 28' ' ' VAL . 2.4 m-20 -64.42 150.47 46.39 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.573 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' E' ' 33' ' ' GLN . . . -48.36 -50.16 31.66 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.42 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.26 -31.82 81.79 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.93 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.09 -15.95 63.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.868 0.366 . . . . 0.0 110.821 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 28' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 24' ' ' ASP . 48.8 t -73.04 -43.56 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.334 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.41 106.1 10.36 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.999 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -116.68 133.95 55.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.032 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 31' ' ' THR . . . . . 0.634 HG22 ' HD3' ' C' ' 13' ' ' LYS . 1.0 OUTLIER -105.48 96.05 6.24 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.042 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' C' ' 11' ' ' HIS . 68.9 t -89.39 131.28 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.161 0.505 . . . . 0.0 110.469 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 33' ' ' GLN . . . . . 0.465 ' HA ' ' HG2' ' C' ' 13' ' ' LYS . 0.3 OUTLIER -109.05 106.5 16.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.603 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.484 HD12 ' CE2' ' D' ' 137' ' ' TYR . 0.4 OUTLIER -73.85 -40.88 62.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.678 179.391 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.0 -122.47 6.75 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.522 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 36' ' ' GLN . . . . . 0.611 ' HB3' ' HA ' ' C' ' 22' ' ' ALA . 3.7 tt0 -144.55 153.83 42.23 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.566 0.222 . . . . 0.0 110.874 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.515 HG23 HG22 ' C' ' 16' ' ' VAL . 0.0 OUTLIER -128.46 146.32 34.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.911 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 38' ' ' ARG . . . . . 0.539 ' HE ' ' HB2' ' C' ' 22' ' ' ALA . 0.0 OUTLIER -98.2 145.99 26.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.768 179.196 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.556 HG23 ' O ' ' C' ' 17' ' ' VAL . 40.8 p -57.74 -23.06 50.09 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.743 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.97 -33.23 61.87 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.053 0.454 . . . . 0.0 110.8 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.02 -31.21 69.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.134 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' D' ' 139' ' ' ALA . 0.0 OUTLIER -130.72 86.37 2.37 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.69 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.71 36.27 4.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.346 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.56 150.82 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.38 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 45' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' D' ' 140' ' ' THR . 1.7 tm-20 -64.75 134.83 55.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.0 111.175 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.78 -14.22 53.16 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.213 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' D' ' 138' ' ' PHE . . . -57.14 129.86 43.61 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 48' ' ' THR . . . . . 0.46 ' HB ' ' CE1' ' D' ' 138' ' ' PHE . 14.4 t -130.61 143.35 50.69 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.878 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 68.8 m -111.96 -157.21 0.61 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.596 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.405 ' HB3' ' HB1' ' A' ' 92' ' ' ALA . 27.7 t -74.55 150.06 39.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.834 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 51' ' ' ALA . . . . . 0.729 ' O ' HD12 ' A' ' 88' ' ' LEU . . . -103.19 146.64 28.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.326 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 52' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' A' ' 90' ' ' SER . 22.3 m -83.37 148.33 5.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.909 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.38 121.21 6.21 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.633 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.412 ' CD1' HG23 ' D' ' 52' ' ' VAL . 16.3 p90 -153.88 125.54 7.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.855 0.36 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -109.28 156.24 20.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.492 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 56' ' ' ILE . . . . . . . . . . . . . 22.6 mm -104.05 135.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.534 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.66 126.01 48.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.753 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 58' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' D' ' 129' ' ' ASN . 4.3 mp -131.62 99.97 4.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.275 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.46 174.73 11.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.902 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.8 65.26 1.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.782 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 61' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' D' ' 21' ' ' CYS . 60.7 m -98.71 142.92 29.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.746 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.6 109.2 15.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.301 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.461 HG23 ' HB3' ' D' ' 124' ' ' LEU . 0.2 OUTLIER -92.43 29.65 1.66 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -90.06 -59.27 2.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.069 0.462 . . . . 0.0 111.752 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.18 -39.8 13.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.732 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.64 101.39 10.71 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.586 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 31.3 p -90.58 -28.76 18.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.885 0.374 . . . . 0.0 110.999 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 68' ' ' LYS . . . . . 0.449 ' HZ1' ' HB2' ' D' ' 121' ' ' GLU . 0.0 OUTLIER -126.49 166.91 16.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.482 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.8 149.82 29.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.664 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 70' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' D' ' 157' ' ' GLN . . . -112.91 159.77 18.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.101 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 52.4 t -108.08 123.31 63.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.662 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 72' ' ' ALA . . . . . 0.679 ' HB3' ' HB3' ' D' ' 155' ' ' LYS . . . -124.61 168.92 12.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.622 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 73' ' ' PHE . . . . . 0.532 ' CB ' HD11 ' D' ' 111' ' ' LEU . 17.2 t80 -150.62 144.41 25.23 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.585 0.231 . . . . 0.0 111.133 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 74' ' ' LEU . . . . . 0.444 HD23 ' O ' ' D' ' 74' ' ' LEU . 0.4 OUTLIER -121.5 88.6 2.97 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.999 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 75' ' ' GLY . . . . . 0.521 ' C ' HD23 ' D' ' 113' ' ' LEU . . . -134.74 164.72 24.67 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.759 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 76' ' ' THR . . . . . 0.665 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.6 OUTLIER -78.56 147.76 33.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.565 0.222 . . . . 0.0 110.774 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.82 140.32 30.77 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.912 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 78' ' ' ILE . . . . . 0.555 ' CG2' ' HB ' ' D' ' 85' ' ' VAL . 1.1 tt -78.65 -33.11 16.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.921 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.16 179.27 7.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.859 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.69 -27.91 36.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.059 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.17 -32.29 72.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.619 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 82' ' ' HIS . . . . . 0.416 ' HB3' HG23 ' D' ' 85' ' ' VAL . 15.3 m-70 -97.28 -72.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.482 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.86 -7.22 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.592 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 84' ' ' ASN . . . . . 0.758 ' HA ' HD13 ' D' ' 113' ' ' LEU . 3.1 m120 -108.79 -19.1 13.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.287 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' D' ' 102' ' ' GLN . 50.3 t -80.65 131.98 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.134 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' D' ' 152' ' ' ALA . 0.4 OUTLIER -76.52 134.96 39.31 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.32 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.31 165.19 6.2 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.889 0.376 . . . . 0.0 111.669 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 88' ' ' LEU . . . . . 0.423 ' H ' ' HG ' ' D' ' 88' ' ' LEU . 0.1 OUTLIER -65.75 171.69 4.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.056 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 89' ' ' GLN . . . . . 0.492 ' OE1' ' HB3' ' D' ' 91' ' ' SER . 8.1 pt20 -72.48 175.67 6.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.412 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.98 -21.19 57.22 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.071 0.462 . . . . 0.0 111.521 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 91' ' ' SER . . . . . 0.492 ' HB3' ' OE1' ' D' ' 89' ' ' GLN . 32.1 t -81.02 67.64 7.01 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.825 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 92' ' ' ALA . . . . . 0.449 ' HA ' ' OG ' ' D' ' 95' ' ' SER . . . -72.33 -9.7 58.84 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.943 0.401 . . . . 0.0 111.682 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 93' ' ' ALA . . . . . 0.896 ' HB1' ' HB1' ' F' ' 22' ' ' ALA . . . -68.06 -22.88 64.92 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.615 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.51 6.78 2.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.911 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 95' ' ' SER . . . . . 0.699 ' HA ' ' HB3' ' D' ' 147' ' ' ALA . 31.6 p -93.77 150.86 20.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.846 0.355 . . . . 0.0 110.599 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.82 167.24 18.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.834 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.68 165.16 14.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.295 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 98' ' ' ASN . . . . . 0.525 ' HA ' ' OG1' ' D' ' 140' ' ' THR . 85.0 m-20 63.3 45.46 4.98 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.434 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 99' ' ' VAL . . . . . 0.465 ' HB ' ' CB ' ' D' ' 143' ' ' ALA . 3.4 p -170.67 131.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.784 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.05 -175.92 21.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.54 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 101' ' ' VAL . . . . . . . . . . . . . 76.4 t -104.2 91.91 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.187 0.518 . . . . 0.0 111.669 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 102' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' D' ' 85' ' ' VAL . 0.6 OUTLIER -67.9 131.25 45.16 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.877 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 103' ' ' ILE . . . . . 0.512 HD12 ' O ' ' D' ' 84' ' ' ASN . 0.7 OUTLIER -99.47 110.64 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.468 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 104' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 5.5 tp -91.33 149.96 21.51 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.633 0.254 . . . . 0.0 111.056 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.87 174.65 5.8 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.714 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 106' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' D' ' 106' ' ' ARG . 1.5 ttt180 -72.47 -18.55 61.67 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.714 0.293 . . . . 0.0 111.033 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 107' ' ' THR . . . . . . . . . . . . . 46.3 p -69.33 -9.58 53.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.06 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.98 -48.41 0.96 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.643 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.92 163.56 15.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.063 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -70.47 125.57 27.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.155 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 111' ' ' LEU . . . . . 0.532 HD11 ' CB ' ' D' ' 73' ' ' PHE . 0.0 OUTLIER -65.33 147.64 53.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.328 0.585 . . . . 0.0 110.593 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 112' ' ' THR . . . . . 0.67 ' HB ' HG21 ' D' ' 117' ' ' THR . 0.2 OUTLIER -74.1 144.61 44.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.085 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 113' ' ' LEU . . . . . 0.758 HD13 ' HA ' ' D' ' 84' ' ' ASN . 10.2 mp -100.34 89.89 4.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.727 0.298 . . . . 0.0 110.686 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 114' ' ' ASP . . . . . 0.433 ' HB2' ' CG2' ' D' ' 117' ' ' THR . 4.0 m-20 -142.37 11.44 1.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.569 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 115' ' ' GLY . . . . . 0.443 ' O ' ' HB1' ' D' ' 72' ' ' ALA . . . 96.88 -78.06 0.69 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.624 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 116' ' ' ALA . . . . . 0.463 ' CB ' HG21 ' C' ' 4' ' ' THR . . . -104.26 61.49 0.73 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.999 0.428 . . . . 0.0 111.706 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 117' ' ' THR . . . . . 0.67 HG21 ' HB ' ' D' ' 112' ' ' THR . 17.5 p -93.41 95.86 9.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.131 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.81 110.05 5.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.746 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.39 -72.9 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.878 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.45 113.05 25.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.622 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 121' ' ' GLU . . . . . 0.449 ' HB2' ' HZ1' ' D' ' 68' ' ' LYS . 25.2 mt-10 -99.44 97.56 8.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.191 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.5 132.74 37.49 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.752 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -60.94 146.11 47.96 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.709 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 124' ' ' LEU . . . . . 0.461 ' HB3' HG23 ' D' ' 63' ' ' THR . 0.2 OUTLIER -85.34 156.49 20.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.632 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 125' ' ' ASN . . . . . 0.534 ' HB3' ' HB3' ' A' ' 116' ' ' ALA . 32.6 m120 -137.81 142.74 40.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.577 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.97 113.7 6.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.689 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.51 -90.05 0.32 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.701 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 128' ' ' THR . . . . . 0.433 ' HB ' ' HD3' ' A' ' 155' ' ' LYS . 6.2 m -124.94 152.86 43.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.734 0.302 . . . . 0.0 110.82 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 129' ' ' ASN . . . . . 0.542 ' HB3' ' HB2' ' D' ' 58' ' ' LEU . 17.1 t-20 -123.06 147.56 46.57 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.866 0.365 . . . . 0.0 111.158 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 130' ' ' THR . . . . . 0.652 ' OG1' HD12 ' A' ' 74' ' ' LEU . 4.3 m -126.22 135.71 51.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.05 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 131' ' ' ILE . . . . . . . . . . . . . 58.5 mt -114.01 115.7 45.48 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 132' ' ' PRO . . . . . 0.564 ' HB3' ' H ' ' A' ' 77' ' ' ALA . 7.5 Cg_endo -81.67 115.71 2.82 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 121.703 1.602 . . . . 0.0 112.545 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.59 150.79 46.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.802 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 134' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' D' ' 52' ' ' VAL . 1.3 mt-30 -142.5 166.61 24.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.081 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' D' ' 102' ' ' GLN . . . -158.14 102.9 1.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.922 0.392 . . . . 0.0 111.638 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 136' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' D' ' 51' ' ' ALA . 0.2 OUTLIER -94.67 -173.41 3.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.415 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 137' ' ' TYR . . . . . 0.605 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 3.8 m-85 -100.82 152.86 20.0 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.09 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 138' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' D' ' 47' ' ' ALA . 0.2 OUTLIER -147.33 160.73 42.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.083 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 139' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -126.82 149.71 49.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.895 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 140' ' ' THR . . . . . 0.525 ' OG1' ' HA ' ' D' ' 98' ' ' ASN . 0.0 OUTLIER -115.4 27.79 9.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.402 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.38 66.86 0.2 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.888 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.92 88.61 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.576 0.188 . . . . 0.0 110.759 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 143' ' ' ALA . . . . . 0.465 ' CB ' ' HB ' ' D' ' 99' ' ' VAL . . . -60.2 156.9 14.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.709 0.29 . . . . 0.0 111.438 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 144' ' ' THR . . . . . 0.548 ' HB ' ' CD ' ' D' ' 145' ' ' PRO . 76.9 p -112.21 173.08 3.05 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.213 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 145' ' ' PRO . . . . . 0.548 ' CD ' ' HB ' ' D' ' 144' ' ' THR . 1.3 Cg_endo -84.58 145.2 10.38 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.565 2.177 . . . . 0.0 111.937 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.38 -112.72 0.55 Allowed Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.555 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 147' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -124.92 167.69 14.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.812 0.339 . . . . 0.0 111.394 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 148' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -157.22 57.54 0.51 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.103 0.478 . . . . 0.0 110.468 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.87 132.74 36.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.534 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.48 163.12 28.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.027 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.39 125.6 1.85 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.282 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 152' ' ' ALA . . . . . 0.792 ' HB2' HD21 ' D' ' 86' ' ' LEU . . . -154.59 165.78 35.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.173 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.84 163.16 12.72 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -119.0 134.48 55.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.023 0.439 . . . . 0.0 110.2 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 155' ' ' LYS . . . . . 0.679 ' HB3' ' HB3' ' D' ' 72' ' ' ALA . 0.0 OUTLIER -95.61 166.3 11.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.91 -178.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.25 112.83 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.832 0.348 . . . . 0.0 111.638 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 157' ' ' GLN . . . . . 0.615 ' HB3' ' HB3' ' D' ' 70' ' ' ALA . 0.2 OUTLIER -88.82 138.84 31.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.331 0.586 . . . . 0.0 110.393 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 158' ' ' TYR . . . . . 0.585 ' HE2' HG11 ' D' ' 17' ' ' VAL . 22.5 m-85 -127.65 113.16 15.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.519 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.962 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.261 0.076 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.0 68.24 0.88 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.587 0.232 . . . . 0.0 111.022 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -92.31 87.66 6.13 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.473 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 4' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' F' ' 157' ' ' GLN . 3.5 m -90.5 115.48 27.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.545 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 m -127.22 167.0 22.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.583 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 6' ' ' ASN . . . . . 0.653 ' HA ' ' HE2' ' F' ' 155' ' ' LYS . 20.0 t30 -83.04 115.14 21.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.497 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.41 -71.45 1.07 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.853 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.29 172.78 34.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.049 -0.595 . . . . 0.0 111.931 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 9' ' ' THR . . . . . . . . . . . . . 33.4 m -95.49 137.03 35.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.916 0.389 . . . . 0.0 111.284 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -120.85 130.68 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.185 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 11' ' ' HIS . . . . . 0.535 ' O ' ' HB ' ' F' ' 32' ' ' VAL . 1.3 m80 -103.82 157.99 16.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.397 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 12' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' F' ' 32' ' ' VAL . 0.6 OUTLIER -145.84 89.66 1.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 13' ' ' LYS . . . . . 0.631 ' HD3' HG22 ' F' ' 31' ' ' THR . 0.0 OUTLIER -79.95 135.21 36.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.477 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.56 178.38 42.07 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.898 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 15' ' ' GLU . . . . . 0.654 ' HG2' ' HA ' ' F' ' 147' ' ' ALA . 2.6 mt-10 -156.81 -177.9 6.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.938 0.399 . . . . 0.0 110.357 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 16' ' ' VAL . . . . . 0.525 HG22 HG23 ' F' ' 37' ' ' VAL . 2.7 t -142.29 150.13 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.239 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 17' ' ' VAL . . . . . 0.589 HG11 ' HE2' ' E' ' 158' ' ' TYR . 4.1 m -141.71 168.61 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.832 0.349 . . . . 0.0 111.083 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.06 74.74 4.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.087 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.89 91.89 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.5 -51.01 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.432 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 21' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER 179.82 -179.79 0.47 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.986 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 22' ' ' ALA . . . . . 0.894 ' HB1' ' HB1' ' C' ' 93' ' ' ALA . . . -136.16 116.43 13.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.146 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 23' ' ' VAL . . . . . 0.421 ' H ' ' CB ' ' F' ' 36' ' ' GLN . 67.7 t -67.01 120.14 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 24' ' ' ASP . . . . . 0.445 ' O ' HG23 ' E' ' 28' ' ' VAL . 2.4 m-20 -64.38 150.49 46.21 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.602 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.38 -50.18 31.7 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.355 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.3 -31.77 81.58 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.918 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.02 -16.05 63.62 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.902 0.382 . . . . 0.0 110.859 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 28' ' ' VAL . . . . . 0.445 HG23 ' O ' ' E' ' 24' ' ' ASP . 48.4 t -72.93 -43.61 59.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.401 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.44 106.09 10.35 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -116.62 133.99 55.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.079 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 31' ' ' THR . . . . . 0.633 HG22 ' HD3' ' D' ' 13' ' ' LYS . 0.9 OUTLIER -105.5 96.03 6.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.095 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' D' ' 11' ' ' HIS . 69.6 t -89.45 131.27 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.215 0.531 . . . . 0.0 110.437 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 33' ' ' GLN . . . . . 0.456 ' HA ' ' HG2' ' D' ' 13' ' ' LYS . 0.3 OUTLIER -108.99 106.48 16.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.599 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.494 HD12 ' CE2' ' E' ' 137' ' ' TYR . 0.4 OUTLIER -73.89 -40.93 62.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.552 179.419 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.04 -122.48 6.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.564 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 36' ' ' GLN . . . . . 0.612 ' HB3' ' HA ' ' D' ' 22' ' ' ALA . 3.7 tt0 -144.51 153.98 42.43 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.633 0.254 . . . . 0.0 110.881 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.514 HG23 HG22 ' D' ' 16' ' ' VAL . 0.0 OUTLIER -128.57 146.33 34.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.873 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 38' ' ' ARG . . . . . 0.547 ' HE ' ' HB2' ' D' ' 22' ' ' ALA . 0.0 OUTLIER -98.19 146.0 26.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.731 179.178 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 39' ' ' THR . . . . . 0.55 HG23 ' O ' ' D' ' 17' ' ' VAL . 40.9 p -57.79 -23.07 50.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.709 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.98 -33.21 61.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.013 0.435 . . . . 0.0 110.791 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.03 -31.15 69.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.222 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' E' ' 139' ' ' ALA . 0.0 OUTLIER -130.76 86.44 2.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.598 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.66 36.16 4.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.337 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.59 150.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.365 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 45' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' E' ' 140' ' ' THR . 1.7 tm-20 -64.78 134.88 55.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 0.0 111.118 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.8 -14.28 53.07 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.146 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 47' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' E' ' 138' ' ' PHE . . . -57.22 129.92 43.9 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.938 0.399 . . . . 0.0 112.043 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 48' ' ' THR . . . . . 0.465 ' HB ' ' CE1' ' E' ' 138' ' ' PHE . 14.3 t -130.67 143.29 50.65 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.874 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 68.9 m -111.87 -157.14 0.61 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.625 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 50' ' ' SER . . . . . 0.408 ' HB3' ' HB1' ' B' ' 92' ' ' ALA . 27.5 t -74.58 150.05 39.86 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.865 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 51' ' ' ALA . . . . . 0.723 ' O ' HD12 ' B' ' 88' ' ' LEU . . . -103.22 146.63 28.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.334 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 52' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' B' ' 90' ' ' SER . 22.1 m -83.41 148.37 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.44 121.27 6.22 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.601 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 54' ' ' PHE . . . . . 0.406 ' CD1' HG23 ' E' ' 52' ' ' VAL . 16.5 p90 -153.87 125.57 7.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.797 0.332 . . . . 0.0 110.949 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -109.33 156.19 20.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.59 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 56' ' ' ILE . . . . . . . . . . . . . 22.4 mm -103.95 135.29 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.565 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.72 125.99 48.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.75 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 58' ' ' LEU . . . . . 0.541 ' HB2' ' HB3' ' E' ' 129' ' ' ASN . 4.3 mp -131.6 99.9 4.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.326 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.32 174.72 11.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.966 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.74 65.3 1.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.79 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 61' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' E' ' 21' ' ' CYS . 60.7 m -98.71 142.94 29.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.792 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.64 109.25 15.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.266 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 63' ' ' THR . . . . . 0.473 HG23 ' HB3' ' E' ' 124' ' ' LEU . 0.2 OUTLIER -92.47 29.59 1.68 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.144 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -89.99 -59.26 2.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.085 0.469 . . . . 0.0 111.727 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.25 -39.84 13.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.666 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.6 101.34 10.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.597 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 30.8 p -90.56 -28.79 18.25 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.38 167.08 16.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.509 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.95 149.75 29.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.617 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 70' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' E' ' 157' ' ' GLN . . . -112.88 159.75 18.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.1 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 52.2 t -108.09 123.29 63.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.665 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 72' ' ' ALA . . . . . 0.677 ' HB3' ' HB3' ' E' ' 155' ' ' LYS . . . -124.63 168.92 12.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.615 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 73' ' ' PHE . . . . . 0.539 ' CB ' HD11 ' E' ' 111' ' ' LEU . 17.2 t80 -150.63 144.4 25.21 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.601 0.239 . . . . 0.0 111.1 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 74' ' ' LEU . . . . . 0.441 HD23 ' O ' ' E' ' 74' ' ' LEU . 0.4 OUTLIER -121.46 88.64 2.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.989 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 75' ' ' GLY . . . . . 0.52 ' C ' HD23 ' E' ' 113' ' ' LEU . . . -134.76 164.7 24.67 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.816 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 76' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.6 OUTLIER -78.57 147.72 33.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.595 0.236 . . . . 0.0 110.708 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.68 140.29 30.71 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.961 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 78' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' E' ' 85' ' ' VAL . 1.1 tt -78.58 -33.16 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.914 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.18 179.18 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.904 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.58 -27.96 37.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.059 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.21 -32.22 72.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.633 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 82' ' ' HIS . . . . . 0.41 ' HB3' HG23 ' E' ' 85' ' ' VAL . 15.3 m-70 -97.29 -72.81 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.931 0.396 . . . . 0.0 110.461 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.88 -7.15 1.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.593 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 84' ' ' ASN . . . . . 0.76 ' HA ' HD13 ' E' ' 113' ' ' LEU . 3.1 m120 -108.83 -19.1 13.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.325 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' E' ' 102' ' ' GLN . 49.6 t -80.55 132.07 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.152 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 86' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' E' ' 152' ' ' ALA . 0.4 OUTLIER -76.63 134.96 39.16 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.304 179.398 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.25 165.21 6.1 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.867 0.365 . . . . 0.0 111.645 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 88' ' ' LEU . . . . . 0.424 ' HG ' ' H ' ' E' ' 88' ' ' LEU . 0.1 OUTLIER -65.86 171.79 4.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.998 179.444 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 89' ' ' GLN . . . . . 0.491 ' OE1' ' HB3' ' E' ' 91' ' ' SER . 8.0 pt20 -72.56 175.71 6.09 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.425 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.04 -21.18 57.1 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.009 0.433 . . . . 0.0 111.498 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 91' ' ' SER . . . . . 0.491 ' HB3' ' OE1' ' E' ' 89' ' ' GLN . 32.0 t -80.91 67.49 6.82 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 92' ' ' ALA . . . . . 0.453 ' HA ' ' OG ' ' E' ' 95' ' ' SER . . . -72.18 -9.77 58.88 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.969 0.414 . . . . 0.0 111.723 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.04 -22.88 64.93 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.669 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.46 6.75 2.48 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.946 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 95' ' ' SER . . . . . 0.692 ' HA ' ' HB3' ' E' ' 147' ' ' ALA . 31.0 p -93.73 150.78 20.11 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.821 0.343 . . . . 0.0 110.688 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.77 167.22 18.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.876 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.66 165.09 14.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.365 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 98' ' ' ASN . . . . . 0.514 ' HA ' ' OG1' ' E' ' 140' ' ' THR . 85.0 m-20 63.36 45.42 4.93 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.443 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 99' ' ' VAL . . . . . 0.454 ' HB ' ' CB ' ' E' ' 143' ' ' ALA . 3.4 p -170.64 131.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.692 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.04 -175.99 21.18 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.54 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 101' ' ' VAL . . . . . . . . . . . . . 76.3 t -104.07 91.83 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 122.994 0.517 . . . . 0.0 111.708 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 102' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' E' ' 85' ' ' VAL . 0.6 OUTLIER -67.9 131.21 45.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 103' ' ' ILE . . . . . 0.516 HD12 ' O ' ' E' ' 84' ' ' ASN . 0.7 OUTLIER -99.42 110.62 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.475 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 104' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 5.5 tp -91.3 149.93 21.53 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.699 0.285 . . . . 0.0 111.029 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.9 174.65 5.8 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.701 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 106' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' E' ' 106' ' ' ARG . 1.5 ttt180 -72.53 -18.4 61.65 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.759 0.314 . . . . 0.0 111.067 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 46.2 p -69.41 -9.63 54.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.99 -48.38 0.96 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.636 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.88 163.58 15.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 111.11 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 110' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -70.53 125.59 27.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.539 HD11 ' CB ' ' E' ' 73' ' ' PHE . 0.0 OUTLIER -65.38 147.57 53.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.353 0.596 . . . . 0.0 110.557 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 112' ' ' THR . . . . . 0.671 ' HB ' HG21 ' E' ' 117' ' ' THR . 0.2 OUTLIER -74.03 144.57 45.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.157 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 113' ' ' LEU . . . . . 0.76 HD13 ' HA ' ' E' ' 84' ' ' ASN . 10.2 mp -100.26 89.82 4.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.776 0.322 . . . . 0.0 110.753 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 114' ' ' ASP . . . . . 0.433 ' HB2' ' CG2' ' E' ' 117' ' ' THR . 4.1 m-20 -142.34 11.43 1.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.685 0.279 . . . . 0.0 111.623 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 115' ' ' GLY . . . . . 0.45 ' O ' ' HB1' ' E' ' 72' ' ' ALA . . . 96.87 -78.1 0.7 Allowed Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.619 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 116' ' ' ALA . . . . . 0.456 ' CB ' HG21 ' D' ' 4' ' ' THR . . . -104.29 61.63 0.73 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.976 0.417 . . . . 0.0 111.666 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 117' ' ' THR . . . . . 0.671 HG21 ' HB ' ' E' ' 112' ' ' THR . 17.6 p -93.5 95.87 9.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.114 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.74 109.92 5.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.819 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.26 -72.96 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.43 113.09 25.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.638 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -99.47 97.51 8.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.184 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.45 132.74 37.42 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.724 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 22.3 m -61.01 146.13 48.2 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.691 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 124' ' ' LEU . . . . . 0.473 ' HB3' HG23 ' E' ' 63' ' ' THR . 0.2 OUTLIER -85.41 156.49 20.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.645 179.419 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 125' ' ' ASN . . . . . 0.534 ' HB3' ' HB3' ' B' ' 116' ' ' ALA . 32.6 m120 -137.83 142.78 40.78 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.542 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.91 113.69 6.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.717 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 127' ' ' GLY . . . . . 0.619 ' HA3' ' HB ' ' A' ' 4' ' ' THR . . . 128.45 -89.97 0.32 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.731 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 128' ' ' THR . . . . . 0.429 ' HB ' ' HD3' ' B' ' 155' ' ' LYS . 6.2 m -124.92 152.83 43.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.73 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 129' ' ' ASN . . . . . 0.541 ' HB3' ' HB2' ' E' ' 58' ' ' LEU . 17.0 t-20 -123.08 147.54 46.61 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.122 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 130' ' ' THR . . . . . 0.632 ' OG1' HD12 ' B' ' 74' ' ' LEU . 4.3 m -126.13 135.76 52.07 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.043 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 131' ' ' ILE . . . . . . . . . . . . . 58.4 mt -114.04 115.61 45.46 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 132' ' ' PRO . . . . . 0.564 ' HB3' ' H ' ' B' ' 77' ' ' ALA . 7.5 Cg_endo -81.69 115.69 2.81 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.698 1.599 . . . . 0.0 112.566 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.6 150.79 46.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.807 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 134' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' E' ' 52' ' ' VAL . 1.2 mt-30 -142.44 166.71 23.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.034 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 135' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' E' ' 102' ' ' GLN . . . -158.17 102.93 1.8 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.382 . . . . 0.0 111.636 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 136' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' E' ' 51' ' ' ALA . 0.1 OUTLIER -94.72 -173.42 3.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.352 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 137' ' ' TYR . . . . . 0.591 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 3.7 m-85 -100.86 152.87 20.0 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.082 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 138' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' E' ' 47' ' ' ALA . 0.2 OUTLIER -147.35 160.73 42.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.072 -179.183 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 139' ' ' ALA . . . . . 0.615 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -126.82 149.67 49.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.885 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 140' ' ' THR . . . . . 0.514 ' OG1' ' HA ' ' E' ' 98' ' ' ASN . 0.0 OUTLIER -115.35 27.84 9.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.484 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.4 66.79 0.2 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.951 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.91 88.61 0.09 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.604 0.24 . . . . 0.0 110.742 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 143' ' ' ALA . . . . . 0.454 ' CB ' ' HB ' ' E' ' 99' ' ' VAL . . . -60.21 156.89 14.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.751 0.31 . . . . 0.0 111.424 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 144' ' ' THR . . . . . 0.555 ' HB ' ' CD ' ' E' ' 145' ' ' PRO . 77.0 p -112.18 173.05 3.07 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.305 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 145' ' ' PRO . . . . . 0.555 ' CD ' ' HB ' ' E' ' 144' ' ' THR . 1.4 Cg_endo -84.6 145.25 10.37 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.477 2.118 . . . . 0.0 112.029 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.37 -112.73 0.55 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.56 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 147' ' ' ALA . . . . . 0.692 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -124.98 167.66 14.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.88 0.371 . . . . 0.0 111.337 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 148' ' ' ALA . . . . . 0.413 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -157.13 57.46 0.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.497 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.86 132.74 36.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.559 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.42 163.13 28.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.037 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.48 125.65 1.82 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.184 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 152' ' ' ALA . . . . . 0.794 ' HB2' HD21 ' E' ' 86' ' ' LEU . . . -154.61 165.71 35.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.204 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.83 163.13 12.74 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -119.04 134.56 55.12 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.094 0.473 . . . . 0.0 110.108 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 155' ' ' LYS . . . . . 0.677 ' HB3' ' HB3' ' E' ' 72' ' ' ALA . 0.0 OUTLIER -95.48 166.25 11.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.928 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.33 112.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.888 0.375 . . . . 0.0 111.641 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 157' ' ' GLN . . . . . 0.613 ' HB3' ' HB3' ' E' ' 70' ' ' ALA . 0.2 OUTLIER -88.76 138.85 31.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.242 0.544 . . . . 0.0 110.404 -179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 158' ' ' TYR . . . . . 0.589 ' HE2' HG11 ' E' ' 17' ' ' VAL . 22.5 m-85 -127.71 113.15 15.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.512 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.909 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.226 0.06 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.0 68.24 0.88 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.552 0.215 . . . . 0.0 111.049 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.36 87.66 6.11 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.469 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m -90.49 115.46 27.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.591 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -127.28 166.93 23.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.588 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -82.99 115.23 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.524 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.48 -71.45 1.07 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.801 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.3 172.78 34.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.918 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 33.2 m -95.49 136.96 35.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.399 . . . . 0.0 111.265 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 40.3 t -120.82 130.72 74.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.194 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -103.84 157.96 16.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.432 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -145.84 89.63 1.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 13' ' ' LYS . . . . . 0.428 ' HG2' ' H ' ' F' ' 13' ' ' LYS . 0.0 OUTLIER -79.97 135.19 36.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.431 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.56 178.38 42.08 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.853 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -156.84 -177.93 6.98 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.862 0.363 . . . . 0.0 110.345 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.25 150.15 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.222 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 17' ' ' VAL . . . . . 0.581 HG11 ' HE2' ' F' ' 158' ' ' TYR . 4.1 m -141.7 168.6 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.876 0.37 . . . . 0.0 111.025 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.02 74.66 4.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.05 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.95 91.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.035 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.46 -51.0 0.09 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.423 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 21' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER 179.88 -179.72 0.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.974 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 22' ' ' ALA . . . . . 0.896 ' HB1' ' HB1' ' D' ' 93' ' ' ALA . . . -136.18 116.51 13.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.161 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 23' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.1 120.23 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.995 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 24' ' ' ASP . . . . . 0.43 ' O ' HG23 ' F' ' 28' ' ' VAL . 2.4 m-20 -64.47 150.45 46.54 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.564 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.39 -50.07 32.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.343 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.37 -31.73 81.33 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.936 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.1 -15.99 63.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.923 0.392 . . . . 0.0 110.851 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 28' ' ' VAL . . . . . 0.43 HG23 ' O ' ' F' ' 24' ' ' ASP . 48.7 t -72.99 -43.63 58.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.379 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.41 106.15 10.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.994 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -116.78 134.05 55.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.03 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 31' ' ' THR . . . . . 0.631 HG22 ' HD3' ' E' ' 13' ' ' LYS . 0.9 OUTLIER -105.47 96.12 6.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.083 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' E' ' 11' ' ' HIS . 69.3 t -89.53 131.24 37.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 33' ' ' GLN . . . . . 0.449 ' HA ' ' HG2' ' E' ' 13' ' ' LYS . 0.3 OUTLIER -108.95 106.49 16.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.616 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 34' ' ' LEU . . . . . 0.481 HD12 ' CE2' ' F' ' 137' ' ' TYR . 0.4 OUTLIER -73.86 -40.91 62.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.637 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.01 -122.45 6.74 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.559 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 36' ' ' GLN . . . . . 0.613 ' HB3' ' HA ' ' E' ' 22' ' ' ALA . 3.7 tt0 -144.55 153.87 42.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.658 0.265 . . . . 0.0 110.936 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.525 HG23 HG22 ' E' ' 16' ' ' VAL . 0.0 OUTLIER -128.46 146.29 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.963 -179.598 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 38' ' ' ARG . . . . . 0.528 ' HE ' ' HB2' ' E' ' 22' ' ' ALA . 0.0 OUTLIER -98.2 145.94 26.11 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.764 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 39' ' ' THR . . . . . 0.554 HG23 ' O ' ' E' ' 17' ' ' VAL . 40.8 p -57.7 -23.06 49.75 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.721 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.07 -33.09 61.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.022 0.439 . . . . 0.0 110.805 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -31.11 69.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.208 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 42' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' F' ' 139' ' ' ALA . 0.0 OUTLIER -130.78 86.44 2.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.622 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.7 36.23 4.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.411 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 177.6 150.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.324 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 45' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' F' ' 140' ' ' THR . 1.7 tm-20 -64.72 134.85 55.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.34 . . . . 0.0 111.116 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.74 -14.21 53.3 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.215 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 47' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' F' ' 138' ' ' PHE . . . -57.22 129.91 43.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.927 0.394 . . . . 0.0 112.052 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 48' ' ' THR . . . . . 0.465 ' HB ' ' CE1' ' F' ' 138' ' ' PHE . 14.3 t -130.66 143.35 50.69 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.861 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 49' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 68.8 m -111.98 -157.21 0.61 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.604 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 50' ' ' SER . . . . . 0.416 ' HB3' ' HB1' ' C' ' 92' ' ' ALA . 27.7 t -74.59 150.12 39.81 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.856 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 51' ' ' ALA . . . . . 0.738 ' O ' HD12 ' C' ' 88' ' ' LEU . . . -103.19 146.7 28.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.301 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 52' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' C' ' 90' ' ' SER . 22.2 m -83.45 148.35 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.915 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.4 121.2 6.2 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.628 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 54' ' ' PHE . . . . . 0.412 ' CD1' HG23 ' F' ' 52' ' ' VAL . 16.2 p90 -153.88 125.55 7.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.852 0.358 . . . . 0.0 110.889 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -109.26 156.17 20.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.533 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 56' ' ' ILE . . . . . . . . . . . . . 22.4 mm -103.96 135.38 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.583 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.75 126.07 48.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.713 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 58' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' F' ' 129' ' ' ASN . 4.3 mp -131.65 99.96 4.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.286 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.4 174.82 11.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.982 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.71 65.21 1.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.83 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 61' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' F' ' 21' ' ' CYS . 60.6 m -98.68 142.98 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.813 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.68 109.21 15.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.261 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 63' ' ' THR . . . . . 0.463 HG23 ' HB3' ' F' ' 124' ' ' LEU . 0.2 OUTLIER -92.42 29.57 1.68 Allowed 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -90.05 -59.21 2.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.028 0.442 . . . . 0.0 111.679 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.2 -39.93 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.662 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.58 101.36 10.69 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.543 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 30.9 p -90.59 -28.71 18.27 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.857 0.36 . . . . 0.0 110.963 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.52 166.94 16.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.491 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.79 149.88 29.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.583 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 70' ' ' ALA . . . . . 0.627 ' HB3' ' HB3' ' F' ' 157' ' ' GLN . . . -112.98 159.74 18.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.164 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 51.4 t -108.02 123.28 63.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.689 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 72' ' ' ALA . . . . . 0.693 ' HB3' ' HB3' ' F' ' 155' ' ' LYS . . . -124.71 168.99 12.42 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.484 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 73' ' ' PHE . . . . . 0.54 ' CB ' HD11 ' F' ' 111' ' ' LEU . 17.2 t80 -150.58 144.47 25.3 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.562 0.22 . . . . 0.0 111.147 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 74' ' ' LEU . . . . . 0.429 HD23 ' O ' ' F' ' 74' ' ' LEU . 0.4 OUTLIER -121.58 88.61 2.97 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.989 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 75' ' ' GLY . . . . . 0.524 ' C ' HD23 ' F' ' 113' ' ' LEU . . . -134.74 164.65 24.67 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.777 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 76' ' ' THR . . . . . 0.67 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.6 OUTLIER -78.51 147.8 33.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.547 0.213 . . . . 0.0 110.786 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.78 140.38 30.66 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.838 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 78' ' ' ILE . . . . . 0.562 ' CG2' ' HB ' ' F' ' 85' ' ' VAL . 1.1 tt -78.7 -33.15 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.16 179.23 7.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.833 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.71 -27.78 36.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.036 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.3 -32.18 72.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.586 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 82' ' ' HIS . . . . . 0.412 ' HB3' HG23 ' F' ' 85' ' ' VAL . 15.3 m-70 -97.33 -72.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.877 0.37 . . . . 0.0 110.446 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.87 -7.21 1.79 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.582 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 84' ' ' ASN . . . . . 0.748 ' HA ' HD13 ' F' ' 113' ' ' LEU . 3.0 m120 -108.81 -19.08 13.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.311 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 85' ' ' VAL . . . . . 0.562 ' HB ' ' CG2' ' F' ' 78' ' ' ILE . 50.4 t -80.71 132.02 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.206 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 86' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' F' ' 152' ' ' ALA . 0.4 OUTLIER -76.55 135.0 39.26 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.255 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.27 165.15 6.18 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.923 0.392 . . . . 0.0 111.691 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 88' ' ' LEU . . . . . 0.439 ' H ' ' HG ' ' F' ' 88' ' ' LEU . 0.1 OUTLIER -65.76 171.78 4.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.018 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 89' ' ' GLN . . . . . 0.493 ' OE1' ' HB3' ' F' ' 91' ' ' SER . 8.0 pt20 -72.56 175.74 6.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.427 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.02 -21.22 57.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.002 0.43 . . . . 0.0 111.474 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 91' ' ' SER . . . . . 0.493 ' HB3' ' OE1' ' F' ' 89' ' ' GLN . 32.1 t -81.02 67.6 6.99 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 92' ' ' ALA . . . . . 0.446 ' HA ' ' OG ' ' F' ' 95' ' ' SER . . . -72.35 -9.67 58.81 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.576 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.04 -22.86 64.94 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.683 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.47 6.71 2.47 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.86 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 95' ' ' SER . . . . . 0.69 ' HA ' ' HB3' ' F' ' 147' ' ' ALA . 30.8 p -93.71 150.78 20.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.854 0.359 . . . . 0.0 110.674 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.71 167.18 18.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.64 165.19 14.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.314 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 98' ' ' ASN . . . . . 0.527 ' HA ' ' OG1' ' F' ' 140' ' ' THR . 85.1 m-20 63.2 45.5 5.06 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.489 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 99' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' F' ' 143' ' ' ALA . 3.4 p -170.65 131.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.72 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.02 -175.94 21.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.511 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 101' ' ' VAL . . . . . . . . . . . . . 76.4 t -104.19 91.9 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 122.979 0.512 . . . . 0.0 111.656 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 102' ' ' GLN . . . . . 0.552 ' HA ' ' HA ' ' F' ' 85' ' ' VAL . 0.6 OUTLIER -67.88 131.18 45.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.898 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 103' ' ' ILE . . . . . 0.52 HD12 ' O ' ' F' ' 84' ' ' ASN . 0.7 OUTLIER -99.45 110.52 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.497 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 104' ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 5.5 tp -91.15 149.98 21.57 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.656 0.265 . . . . 0.0 111.078 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.94 174.55 5.84 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.631 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 106' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' F' ' 106' ' ' ARG . 1.5 ttt180 -72.45 -18.46 61.69 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.75 0.309 . . . . 0.0 111.075 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 46.2 p -69.35 -9.66 54.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.999 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.0 -48.33 0.96 Allowed Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.671 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.96 163.57 15.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.779 0.323 . . . . 0.0 111.089 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 110' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -70.52 125.59 27.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 111' ' ' LEU . . . . . 0.54 HD11 ' CB ' ' F' ' 73' ' ' PHE . 0.0 OUTLIER -65.43 147.7 52.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.419 0.628 . . . . 0.0 110.558 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 112' ' ' THR . . . . . 0.705 ' HB ' HG21 ' F' ' 117' ' ' THR . 0.2 OUTLIER -74.16 144.67 44.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.12 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 113' ' ' LEU . . . . . 0.748 HD13 ' HA ' ' F' ' 84' ' ' ASN . 10.2 mp -100.35 89.97 4.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 110.644 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 114' ' ' ASP . . . . . 0.436 ' HB2' ' CG2' ' F' ' 117' ' ' THR . 4.1 m-20 -142.41 11.41 1.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.691 0.281 . . . . 0.0 111.6 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 115' ' ' GLY . . . . . 0.448 ' O ' ' HB1' ' F' ' 72' ' ' ALA . . . 96.91 -78.16 0.69 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.611 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 116' ' ' ALA . . . . . 0.465 ' CB ' HG21 ' E' ' 4' ' ' THR . . . -104.29 61.61 0.73 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.966 0.412 . . . . 0.0 111.62 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 117' ' ' THR . . . . . 0.705 HG21 ' HB ' ' F' ' 112' ' ' THR . 17.6 p -93.42 95.84 9.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.126 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.77 110.0 5.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.794 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.4 -72.91 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.833 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.49 113.04 25.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.665 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.36 97.42 8.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.25 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.47 132.66 37.52 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.787 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 21.8 m -60.81 146.15 47.26 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.762 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 124' ' ' LEU . . . . . 0.463 ' HB3' HG23 ' F' ' 63' ' ' THR . 0.2 OUTLIER -85.51 156.6 20.71 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.547 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 125' ' ' ASN . . . . . 0.535 ' HB3' ' HB3' ' C' ' 116' ' ' ALA . 32.6 m120 -137.91 142.71 40.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.474 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.9 113.73 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.704 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 127' ' ' GLY . . . . . 0.612 ' HA3' ' HB ' ' B' ' 4' ' ' THR . . . 128.44 -90.01 0.32 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.693 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 128' ' ' THR . . . . . 0.439 ' HB ' ' HD3' ' C' ' 155' ' ' LYS . 6.2 m -124.92 152.86 43.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.704 0.287 . . . . 0.0 110.751 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 129' ' ' ASN . . . . . 0.545 ' HB3' ' HB2' ' F' ' 58' ' ' LEU . 17.0 t-20 -123.09 147.58 46.59 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.926 0.394 . . . . 0.0 111.113 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 130' ' ' THR . . . . . 0.657 ' OG1' HD12 ' C' ' 74' ' ' LEU . 4.3 m -126.16 135.69 51.96 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.03 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 131' ' ' ILE . . . . . . . . . . . . . 58.6 mt -114.05 115.68 45.38 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 132' ' ' PRO . . . . . 0.558 ' HB3' ' H ' ' C' ' 77' ' ' ALA . 7.5 Cg_endo -81.7 115.71 2.81 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.604 1.536 . . . . 0.0 112.572 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.57 150.79 46.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.823 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 134' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' F' ' 52' ' ' VAL . 1.2 mt-30 -142.39 166.72 23.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.086 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 135' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' F' ' 102' ' ' GLN . . . -158.21 102.9 1.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.972 0.415 . . . . 0.0 111.587 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 136' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' F' ' 51' ' ' ALA . 0.2 OUTLIER -94.67 -173.46 3.02 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.397 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 137' ' ' TYR . . . . . 0.601 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 3.8 m-85 -100.76 152.82 20.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.115 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 138' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' F' ' 47' ' ' ALA . 0.2 OUTLIER -147.28 160.8 42.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.046 -179.227 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 139' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -126.88 149.63 49.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.86 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 140' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' F' ' 98' ' ' ASN . 0.0 OUTLIER -115.33 27.83 9.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.491 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.39 66.76 0.2 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.948 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . 63.0 88.57 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.615 0.207 . . . . 0.0 110.747 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 143' ' ' ALA . . . . . 0.469 ' CB ' ' HB ' ' F' ' 99' ' ' VAL . . . -60.22 156.88 14.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.728 0.299 . . . . 0.0 111.431 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 144' ' ' THR . . . . . 0.548 ' HB ' ' CD ' ' F' ' 145' ' ' PRO . 77.4 p -112.17 173.07 3.06 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.243 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 145' ' ' PRO . . . . . 0.548 ' CD ' ' HB ' ' F' ' 144' ' ' THR . 1.4 Cg_endo -84.6 145.22 10.36 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.543 2.162 . . . . 0.0 111.922 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.42 -112.77 0.55 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.495 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 147' ' ' ALA . . . . . 0.69 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -124.98 167.68 14.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.903 0.382 . . . . 0.0 111.337 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 148' ' ' ALA . . . . . 0.426 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -157.16 57.49 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.403 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.89 132.71 36.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.514 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.41 163.12 28.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.008 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.44 125.63 1.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.205 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 152' ' ' ALA . . . . . 0.767 ' HB2' HD21 ' F' ' 86' ' ' LEU . . . -154.57 165.79 35.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.215 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.83 163.17 12.71 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -119.03 134.53 55.14 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.116 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 155' ' ' LYS . . . . . 0.693 ' HB3' ' HB3' ' F' ' 72' ' ' ALA . 0.0 OUTLIER -95.51 166.21 11.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.951 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.23 112.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.771 0.32 . . . . 0.0 111.684 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 157' ' ' GLN . . . . . 0.627 ' HB3' ' HB3' ' F' ' 70' ' ' ALA . 0.2 OUTLIER -88.74 138.79 31.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.264 0.554 . . . . 0.0 110.404 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 158' ' ' TYR . . . . . 0.581 ' HE2' HG11 ' F' ' 17' ' ' VAL . 22.5 m-85 -127.63 113.2 15.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.503 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.924 179.981 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' B' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 120.27 0.081 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.22 64.95 1.53 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.002 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.514 HG21 ' HB2' ' B' ' 18' ' ' ASN . 57.4 m -111.23 101.02 9.55 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.46 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.651 HG21 ' HA2' ' E' ' 127' ' ' GLY . 60.6 m -86.71 131.93 34.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.56 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.788 HG23 HG23 ' B' ' 156' ' ' VAL . 0.0 OUTLIER -161.18 168.04 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.525 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -100.1 118.78 37.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.539 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.4 -56.31 6.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.748 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.94 -145.38 4.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.873 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.831 HG23 HG23 ' B' ' 153' ' ' THR . 0.0 OUTLIER -145.0 142.05 29.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.933 0.397 . . . . 0.0 111.284 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.2 t -121.65 107.32 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.176 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.75 111.0 21.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.386 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.508 ' CD1' HD11 ' B' ' 34' ' ' LEU . 32.0 m-85 -87.61 113.52 23.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.775 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.12 118.61 36.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.412 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.56 175.53 39.77 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.909 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.598 ' HG3' ' HA ' ' B' ' 147' ' ' ALA . 0.1 OUTLIER -151.27 162.14 41.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.946 0.403 . . . . 0.0 110.31 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.75 HG23 ' HB2' ' B' ' 148' ' ' ALA . 2.2 t -114.94 119.43 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.29 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.508 HG21 ' HA ' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -121.33 168.14 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.818 0.342 . . . . 0.0 111.064 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.459 ' HA ' HG22 ' B' ' 39' ' ' THR . 1.3 t-20 -68.46 -175.27 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.004 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.593 ' O ' HG21 ' A' ' 65' ' ' VAL . . . -91.14 52.66 2.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.93 -15.74 1.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.335 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -176.88 147.6 0.6 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.975 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.508 ' HA ' HG21 ' A' ' 17' ' ' VAL . . . -152.62 110.08 3.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.046 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -52.97 159.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.032 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.37 164.48 14.31 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.578 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.07 -52.29 65.89 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.397 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.43 11.92 66.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.858 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.5 t -96.23 -30.79 13.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.989 0.423 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.421 HG23 ' H ' ' A' ' 28' ' ' VAL . 11.4 t -49.88 -71.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.311 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.54 104.4 15.27 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.02 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -112.23 140.41 46.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.104 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.79 110.16 21.47 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.067 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.18 108.35 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.167 0.508 . . . . 0.0 110.42 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.59 112.5 22.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.638 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.549 HD21 ' CG2' ' A' ' 101' ' ' VAL . 5.2 mp -81.15 -41.82 21.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.572 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.67 -171.08 21.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.649 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -93.6 145.95 24.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.565 0.222 . . . . 0.0 110.912 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.515 HG22 ' H ' ' A' ' 38' ' ' ARG . 5.0 p -124.86 169.88 15.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.95 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.515 ' H ' HG22 ' A' ' 37' ' ' VAL . 5.2 mtt-85 -98.95 121.42 40.88 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.717 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -61.87 -31.06 71.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.738 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.56 -39.3 84.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.999 0.428 . . . . 0.0 110.81 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.3 m -81.32 -10.35 59.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.204 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.741 ' O ' ' HB2' ' A' ' 143' ' ' ALA . 0.6 OUTLIER -129.36 40.51 3.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.556 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.605 ' HA ' ' H ' ' A' ' 143' ' ' ALA . . . -111.86 10.88 20.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.366 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.53 145.55 48.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.329 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 140' ' ' THR . 18.2 tt0 -63.34 121.17 13.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 111.159 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.02 14.54 33.51 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.15 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.699 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -72.26 121.2 19.0 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 p -129.97 133.84 47.06 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.893 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 57.8 m -112.52 -166.75 1.11 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.625 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.2 t -59.08 149.48 27.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.818 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.82 153.57 17.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.347 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.649 HG22 ' HB3' ' A' ' 135' ' ' ALA . 3.7 m -103.37 130.31 53.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.98 121.53 6.57 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.619 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.496 ' HD1' HG23 ' A' ' 52' ' ' VAL . 52.3 p90 -153.7 136.41 15.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.779 0.323 . . . . 0.0 110.955 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ILE . 24.7 p30 -133.59 141.3 47.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.679 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.639 HG21 HD12 ' A' ' 131' ' ' ILE . 1.2 tt -85.13 126.49 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.622 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.609 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.1 OUTLIER -75.77 119.39 19.72 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.773 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -130.69 87.31 2.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.316 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.721 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 6.8 p-10 -77.18 173.72 11.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.981 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.519 ' HB3' ' HE ' ' B' ' 38' ' ' ARG . 41.5 m-20 62.82 66.38 0.76 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 34.4 m -115.64 161.96 17.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.732 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.51 ' HA ' ' OD1' ' A' ' 126' ' ' ASN . 0.2 OUTLIER -145.94 157.82 43.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.289 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.481 HG23 ' HA ' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -107.5 -16.74 14.29 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.13 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.39 -33.63 32.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.062 0.458 . . . . 0.0 111.763 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.593 HG21 ' O ' ' A' ' 19' ' ' ALA . 20.1 t -75.21 -41.56 44.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.665 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.91 146.75 29.15 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.558 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.83 -39.37 3.73 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.895 0.378 . . . . 0.0 110.92 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.31 159.53 15.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.477 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.601 ' HB3' ' HB ' ' A' ' 122' ' ' THR . . . -147.2 118.88 8.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.616 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -96.84 140.72 30.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.096 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 131' ' ' ILE . 3.1 t -118.43 139.71 44.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.798 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.4 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -140.54 133.92 29.86 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.523 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.792 ' HD2' HD13 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -101.26 138.04 38.8 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.575 0.226 . . . . 0.0 111.15 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.734 HD21 HG21 ' D' ' 130' ' ' THR . 6.6 tt -100.99 91.02 4.38 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.001 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.37 -167.37 11.32 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.87 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -116.75 159.52 22.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.64 0.257 . . . . 0.0 110.752 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB2' HG23 ' A' ' 83' ' ' THR . . . -83.96 137.96 33.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.996 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 82' ' ' HIS . 9.0 tt -77.17 -40.52 29.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.88 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.603 ' HB2' HG21 ' A' ' 140' ' ' THR . 0.1 OUTLIER -141.18 55.24 1.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.852 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' D' ' 106' ' ' ARG . . . 52.85 -84.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.081 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -60.1 -16.12 39.58 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.577 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.46 ' O ' HG22 ' A' ' 78' ' ' ILE . 24.5 m80 -100.6 56.74 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.597 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.526 HG23 ' HB2' ' A' ' 77' ' ' ALA . 1.1 m -71.36 -22.46 61.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.537 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 2.9 p30 -57.23 -18.68 17.12 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.338 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 138' ' ' PHE . 11.6 t -115.19 133.31 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.213 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.912 HD12 HD22 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -72.93 154.12 40.69 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.347 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.601 ' N ' HD23 ' A' ' 86' ' ' LEU . . . -90.72 -161.37 0.8 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.846 0.355 . . . . 0.0 111.793 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.31 6.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.974 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.65 -83.92 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.312 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.26 20.53 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.415 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.754 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 1.5 m -86.59 79.34 8.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.75 -31.51 38.42 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.916 0.389 . . . . 0.0 111.672 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' D' ' 36' ' ' GLN . . . -128.09 54.53 1.72 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.615 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.89 -17.27 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.975 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.754 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 0.9 OUTLIER -89.47 177.19 6.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.797 0.332 . . . . 0.0 110.622 179.608 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.69 175.24 8.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.777 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -137.51 137.98 39.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.269 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 97' ' ' THR . 74.0 m-80 71.69 17.64 5.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.434 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.99 148.93 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.728 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.28 -176.74 35.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.46 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.549 ' CG2' HD21 ' A' ' 34' ' ' LEU . 7.7 p -125.58 111.02 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 122.993 0.517 . . . . 0.0 111.718 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.612 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 0.9 OUTLIER -81.53 147.74 29.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.873 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.792 HD13 ' HD2' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -123.76 115.94 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.489 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -88.7 140.55 29.34 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.621 0.248 . . . . 0.0 111.031 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . 2.1 t70 -89.37 152.0 21.75 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.68 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.645 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -71.74 -21.08 61.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.816 0.341 . . . . 0.0 111.101 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.61 ' HB ' ' HA ' ' A' ' 120' ' ' SER . 5.8 t -62.89 -21.94 66.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.064 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.69 -83.09 0.19 Allowed Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.611 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.69 170.67 15.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.776 0.322 . . . . 0.0 111.098 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.739 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -74.82 138.64 42.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.224 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.617 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 5.1 tp -94.53 153.38 17.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.343 0.592 . . . . 0.0 110.568 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.782 HG22 HG21 ' A' ' 117' ' ' THR . 6.2 t -93.68 148.24 22.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.171 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.912 HD22 HD12 ' A' ' 86' ' ' LEU . 1.4 mp -89.51 64.78 6.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.77 0.319 . . . . 0.0 110.771 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.557 ' HB2' ' OG1' ' A' ' 117' ' ' THR . 0.5 OUTLIER -95.04 -16.1 22.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.606 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.604 ' HA3' ' HG1' ' D' ' 130' ' ' THR . . . 104.44 -56.28 0.56 Allowed Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.66 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' D' ' 125' ' ' ASN . . . -103.56 29.08 5.95 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.994 0.426 . . . . 0.0 111.667 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.782 HG21 HG22 ' A' ' 112' ' ' THR . 3.4 m -87.19 65.85 9.01 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.105 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.519 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 48.3 m-85 -77.69 73.45 4.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.5 70.78 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.61 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 0.7 OUTLIER -148.63 126.09 11.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.681 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.05 53.21 2.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.25 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -74.06 128.34 35.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.75 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.36 117.89 25.45 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.703 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.51 134.76 33.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.719 0.295 . . . . 0.0 110.538 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.481 ' HA ' HG23 ' A' ' 63' ' ' THR . 0.3 OUTLIER -129.21 163.1 26.33 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.672 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' A' ' 62' ' ' ASP . 1.5 t30 -67.61 125.33 25.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.669 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.61 -141.04 12.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.687 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 6.3 m -101.73 92.47 4.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.647 0.26 . . . . 0.0 110.729 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.541 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 1.2 t30 -76.54 145.03 39.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.926 0.393 . . . . 0.0 111.13 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.609 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -134.63 131.81 38.24 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.049 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.687 HD11 HG12 ' A' ' 156' ' ' VAL . 28.4 mt -87.43 109.82 29.03 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.645 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.4 Cg_endo -81.65 112.12 2.38 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.578 1.518 . . . . 0.0 112.608 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.28 138.22 51.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 28.2 mt-30 -110.1 157.5 19.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.062 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.649 ' HB3' HG22 ' A' ' 52' ' ' VAL . . . -152.68 107.91 3.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.97 0.414 . . . . 0.0 111.585 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -102.51 174.4 5.92 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.36 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 0.6 OUTLIER -85.96 120.88 27.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.083 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.526 ' HB3' HG11 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -117.67 139.6 50.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.076 -179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.699 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -129.88 145.66 51.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.914 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' THR . . . . . 0.603 HG21 ' HB2' ' A' ' 79' ' ' ASP . 16.5 p -104.43 -53.4 2.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.483 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.76 -121.48 3.26 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.989 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.12 112.83 24.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.517 0.199 . . . . 0.0 110.719 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 42' ' ' LEU . . . -61.68 150.85 35.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.805 0.336 . . . . 0.0 111.519 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.558 HG23 ' HD2' ' A' ' 145' ' ' PRO . 60.0 m -126.79 151.49 73.67 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.26 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.558 ' HD2' HG23 ' A' ' 144' ' ' THR . 1.4 Cg_endo -83.03 140.23 9.92 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.573 2.182 . . . . 0.0 111.963 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.9 -138.1 6.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.539 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -87.21 144.99 26.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.898 0.38 . . . . 0.0 111.367 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.73 38.87 1.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.527 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.05 153.48 22.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.505 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.588 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -161.87 171.28 17.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.04 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.42 126.8 7.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.239 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' A' ' 86' ' ' LEU . . . -125.35 142.85 51.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.249 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.86 133.17 34.89 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.482 ' HD1' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -86.45 127.87 34.89 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.119 0.485 . . . . 0.0 110.079 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.49 150.51 29.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.962 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.687 HG12 HD11 ' A' ' 131' ' ' ILE . 14.2 m -136.23 144.48 32.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.863 0.363 . . . . 0.0 111.571 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -136.19 132.76 36.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.32 0.581 . . . . 0.0 110.386 -179.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.494 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 5.5 m-85 -117.41 119.77 36.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.516 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' C' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.23 0.062 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.19 64.9 1.55 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.086 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' THR . . . . . 0.532 HG21 ' HB2' ' C' ' 18' ' ' ASN . 59.0 m -111.21 100.99 9.53 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.05 0.452 . . . . 0.0 111.536 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.661 HG21 ' HA2' ' F' ' 127' ' ' GLY . 60.1 m -86.72 131.91 34.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.545 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.809 HG23 HG23 ' C' ' 156' ' ' VAL . 0.0 OUTLIER -161.09 168.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.532 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.17 118.75 37.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.571 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.32 -56.32 6.97 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.759 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.97 -145.36 4.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.923 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.82 HG23 HG23 ' C' ' 153' ' ' THR . 0.0 OUTLIER -144.99 142.1 29.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.927 0.394 . . . . 0.0 111.302 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.66 107.37 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.198 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.81 110.95 21.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.365 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' PHE . . . . . 0.506 ' CD1' HD11 ' C' ' 34' ' ' LEU . 31.8 m-85 -87.58 113.58 23.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.794 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 118.55 36.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.338 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.51 175.6 39.73 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.973 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.615 ' HG3' ' HA ' ' C' ' 147' ' ' ALA . 0.1 OUTLIER -151.36 162.08 41.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.967 0.413 . . . . 0.0 110.302 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.732 HG23 ' HB2' ' C' ' 148' ' ' ALA . 2.2 t -114.95 119.38 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.268 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' B' ' 22' ' ' ALA . 0.3 OUTLIER -121.28 168.1 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.887 0.375 . . . . 0.0 111.017 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ASN . . . . . 0.514 ' HB2' HG21 ' A' ' 3' ' ' THR . 1.3 t-20 -68.54 -175.25 0.63 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.91 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.606 ' O ' HG21 ' B' ' 65' ' ' VAL . . . -91.1 52.61 2.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.233 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.95 -15.64 1.32 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.39 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.798 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER -176.95 147.63 0.59 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.965 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.494 ' HA ' HG21 ' B' ' 17' ' ' VAL . . . -152.63 110.04 3.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.084 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' B' ' 58' ' ' LEU . 0.3 OUTLIER -53.0 159.07 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.39 164.47 14.3 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.563 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.99 -52.39 65.44 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.369 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.33 11.91 66.35 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.916 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 18.4 t -96.25 -30.78 13.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.894 0.378 . . . . 0.0 110.908 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.408 ' H ' HG23 ' B' ' 28' ' ' VAL . 11.3 t -49.89 -71.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.341 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.55 104.36 15.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.012 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -112.21 140.34 46.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.082 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.82 110.13 21.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.054 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.13 108.42 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.157 0.503 . . . . 0.0 110.44 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.66 112.43 22.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.63 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.544 HD21 ' CG2' ' B' ' 101' ' ' VAL . 5.2 mp -81.12 -41.82 21.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.625 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.76 -171.05 21.51 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.603 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' GLN . . . . . 0.549 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 1.7 mt-30 -93.69 145.88 24.25 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.602 0.239 . . . . 0.0 110.908 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.516 HG22 ' H ' ' B' ' 38' ' ' ARG . 5.0 p -124.8 169.89 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.94 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.519 ' HE ' ' HB3' ' A' ' 60' ' ' ASP . 5.1 mtt-85 -98.95 121.5 40.99 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.68 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' THR . . . . . 0.541 ' O ' ' HB2' ' B' ' 43' ' ' ALA . 0.6 OUTLIER -62.01 -31.0 71.34 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.705 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.28 84.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.91 0.386 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 70.9 m -81.31 -10.39 59.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.149 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.755 ' O ' ' HB2' ' B' ' 143' ' ' ALA . 0.6 OUTLIER -129.27 40.48 3.61 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.59 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ALA . . . . . 0.617 ' HA ' ' H ' ' B' ' 143' ' ' ALA . . . -111.86 10.94 20.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.333 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.56 145.52 48.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.326 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' B' ' 140' ' ' THR . 18.2 tt0 -63.3 121.15 13.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.81 0.338 . . . . 0.0 111.133 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.05 14.49 33.56 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.163 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' B' ' 139' ' ' ALA . . . -72.36 121.19 19.08 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 15.1 p -130.01 133.8 47.0 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.86 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 57.8 m -112.47 -166.68 1.1 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.592 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 36.2 t -59.07 149.52 27.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.76 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.84 153.59 17.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.397 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.655 HG22 ' HB3' ' B' ' 135' ' ' ALA . 3.7 m -103.42 130.31 53.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.92 121.45 6.53 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.64 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' PHE . . . . . 0.492 ' HD1' HG23 ' B' ' 52' ' ' VAL . 52.1 p90 -153.64 136.41 15.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.816 0.341 . . . . 0.0 110.962 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' B' ' 131' ' ' ILE . 24.8 p30 -133.58 141.31 47.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.707 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.649 HG21 HD12 ' B' ' 131' ' ' ILE . 1.2 tt -85.19 126.45 40.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.59 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLN . . . . . 0.609 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.1 OUTLIER -75.79 119.38 19.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.711 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 0.2 OUTLIER -130.64 87.34 2.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.299 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ASN . . . . . 0.721 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 6.7 p-10 -77.29 173.71 11.59 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.955 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ASP . . . . . 0.53 ' HB3' ' HE ' ' C' ' 38' ' ' ARG . 41.6 m-20 62.85 66.43 0.75 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.878 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' CYS . . . . . 0.798 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 34.4 m -115.71 161.96 17.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.736 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ASP . . . . . 0.504 ' HA ' ' OD1' ' B' ' 126' ' ' ASN . 0.2 OUTLIER -145.91 157.86 43.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.35 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.476 HG23 ' HA ' ' B' ' 125' ' ' ASN . 0.0 OUTLIER -107.54 -16.71 14.29 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.13 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.4 -33.7 32.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.057 0.456 . . . . 0.0 111.737 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.606 HG21 ' O ' ' B' ' 19' ' ' ALA . 20.0 t -75.12 -41.62 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.675 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.94 146.75 29.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.55 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.75 -39.43 3.74 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.893 0.378 . . . . 0.0 110.951 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.31 159.55 15.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.456 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' ALA . . . . . 0.603 ' HB3' ' HB ' ' B' ' 122' ' ' THR . . . -147.18 118.88 8.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.608 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.524 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -96.84 140.79 30.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.025 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.473 HG11 HG21 ' B' ' 131' ' ' ILE . 3.1 t -118.52 139.69 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.762 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.52 133.93 29.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.595 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' PHE . . . . . 0.771 ' HD2' HD13 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -101.28 138.06 38.8 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.623 0.249 . . . . 0.0 111.116 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.714 HD21 HG21 ' E' ' 130' ' ' THR . 6.6 tt -101.05 91.12 4.41 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.003 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.38 -167.4 11.32 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.886 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' THR . . . . . 0.659 ' O ' ' HA ' ' B' ' 86' ' ' LEU . 0.3 OUTLIER -116.7 159.45 22.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.58 0.229 . . . . 0.0 110.761 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.517 ' HB2' HG23 ' B' ' 83' ' ' THR . . . -83.84 137.92 33.46 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.013 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ILE . . . . . 0.452 HG22 ' O ' ' B' ' 82' ' ' HIS . 9.0 tt -77.16 -40.47 29.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.894 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ASP . . . . . 0.603 ' HB2' HG21 ' B' ' 140' ' ' THR . 0.1 OUTLIER -141.26 55.26 1.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.786 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' E' ' 106' ' ' ARG . . . 52.93 -84.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.008 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' B' ' 79' ' ' ASP . . . -60.07 -16.11 39.27 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.62 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' HIS . . . . . 0.452 ' O ' HG22 ' B' ' 78' ' ' ILE . 24.2 m80 -100.54 56.68 0.9 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.925 0.393 . . . . 0.0 110.619 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' THR . . . . . 0.517 HG23 ' HB2' ' B' ' 77' ' ' ALA . 1.1 m -71.33 -22.42 61.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.587 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ASN . . . . . 0.738 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 2.9 p30 -57.23 -18.71 17.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.305 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' B' ' 138' ' ' PHE . 11.5 t -115.18 133.45 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.211 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' LEU . . . . . 0.923 HD12 HD22 ' B' ' 113' ' ' LEU . 0.8 OUTLIER -73.01 154.03 40.66 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.352 179.362 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.601 ' N ' HD23 ' B' ' 86' ' ' LEU . . . -90.69 -161.34 0.79 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.823 0.344 . . . . 0.0 111.793 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.23 6.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.016 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.65 -83.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.31 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.26 20.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.453 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' SER . . . . . 0.77 ' HB2' ' HB2' ' B' ' 95' ' ' SER . 1.5 m -86.53 79.35 8.97 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.71 -31.56 38.36 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.808 0.337 . . . . 0.0 111.642 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' E' ' 36' ' ' GLN . . . -128.02 54.4 1.72 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.663 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.87 -17.3 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.934 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' SER . . . . . 0.77 ' HB2' ' HB2' ' B' ' 91' ' ' SER . 0.9 OUTLIER -89.35 177.21 6.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.768 0.318 . . . . 0.0 110.703 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.71 175.31 8.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.785 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' B' ' 98' ' ' ASN . 0.2 OUTLIER -137.61 137.94 39.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.25 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 98' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' B' ' 97' ' ' THR . 74.0 m-80 71.78 17.6 5.38 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.444 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.95 149.0 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.672 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.44 -176.76 35.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.441 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.544 ' CG2' HD21 ' B' ' 34' ' ' LEU . 7.7 p -125.56 111.1 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 122.974 0.51 . . . . 0.0 111.678 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' GLN . . . . . 0.609 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 0.9 OUTLIER -81.67 147.68 29.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.789 -179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.771 HD13 ' HD2' ' B' ' 73' ' ' PHE . 0.9 OUTLIER -123.64 115.91 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.54 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 104' ' ' LEU . . . . . 0.709 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 0.4 OUTLIER -88.68 140.5 29.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.614 0.245 . . . . 0.0 111.036 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ASP . . . . . 0.601 ' HB2' ' HB2' ' B' ' 111' ' ' LEU . 2.1 t70 -89.31 152.01 21.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.708 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' ARG . . . . . 0.627 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -71.8 -21.03 61.76 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.752 0.31 . . . . 0.0 111.027 179.48 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 107' ' ' THR . . . . . 0.614 ' HB ' ' HA ' ' B' ' 120' ' ' SER . 5.8 t -62.91 -21.94 66.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.007 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.64 -83.02 0.19 Allowed Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.662 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.69 170.72 15.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.767 0.318 . . . . 0.0 111.05 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.709 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -74.94 138.68 42.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.186 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' B' ' 105' ' ' ASP . 5.1 tp -94.53 153.47 17.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.385 0.612 . . . . 0.0 110.571 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' THR . . . . . 0.805 HG22 HG21 ' B' ' 117' ' ' THR . 6.2 t -93.68 148.28 22.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.105 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.923 HD22 HD12 ' B' ' 86' ' ' LEU . 1.4 mp -89.64 64.9 6.74 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.783 0.325 . . . . 0.0 110.722 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ASP . . . . . 0.556 ' HB2' ' OG1' ' B' ' 117' ' ' THR . 0.5 OUTLIER -95.07 -16.07 22.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.62 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 115' ' ' GLY . . . . . 0.607 ' HA3' ' HG1' ' E' ' 130' ' ' THR . . . 104.43 -56.24 0.57 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.637 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' E' ' 125' ' ' ASN . . . -103.61 29.0 6.03 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.029 0.442 . . . . 0.0 111.714 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.805 HG21 HG22 ' B' ' 112' ' ' THR . 3.4 m -87.08 65.85 9.1 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.142 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' PHE . . . . . 0.524 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . 48.3 m-85 -77.65 73.4 4.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.772 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.53 70.86 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' SER . . . . . 0.614 ' HA ' ' HB ' ' B' ' 107' ' ' THR . 0.7 OUTLIER -148.69 126.11 11.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.673 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.07 53.18 2.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.232 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' B' ' 69' ' ' ALA . 0.2 OUTLIER -73.97 128.28 35.1 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.732 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.33 117.97 25.47 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.675 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.51 134.8 33.76 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.548 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' ASN . . . . . 0.476 ' HA ' HG23 ' B' ' 63' ' ' THR . 0.3 OUTLIER -129.28 163.06 26.49 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.637 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 126' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' B' ' 62' ' ' ASP . 1.5 t30 -67.58 125.43 26.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.66 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.58 -141.06 12.22 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.664 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 6.3 m -101.74 92.34 4.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.673 0.273 . . . . 0.0 110.788 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ASN . . . . . 0.544 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 1.2 t30 -76.44 145.01 39.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.164 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.609 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.0 OUTLIER -134.62 131.81 38.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.073 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 131' ' ' ILE . . . . . 0.677 HD11 HG12 ' B' ' 156' ' ' VAL . 28.4 mt -87.41 109.8 28.86 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' PRO . . . . . 0.627 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.6 Cg_endo -81.52 112.06 2.4 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 121.645 1.563 . . . . 0.0 112.608 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.3 138.24 51.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.875 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 134' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' B' ' 52' ' ' VAL . 28.1 mt-30 -110.13 157.48 19.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.035 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.655 ' HB3' HG22 ' B' ' 52' ' ' VAL . . . -152.66 107.84 3.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.905 0.383 . . . . 0.0 111.602 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -102.5 174.38 5.93 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.376 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' TYR . . . . . 0.475 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 0.6 OUTLIER -85.97 120.87 27.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.105 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 138' ' ' PHE . . . . . 0.516 ' HB3' HG11 ' B' ' 85' ' ' VAL . 0.2 OUTLIER -117.66 139.57 50.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.062 -179.181 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' B' ' 47' ' ' ALA . . . -129.86 145.57 51.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.913 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 140' ' ' THR . . . . . 0.603 HG21 ' HB2' ' B' ' 79' ' ' ASP . 16.7 p -104.32 -53.41 2.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.513 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.75 -121.54 3.27 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.027 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.04 112.88 24.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.573 0.225 . . . . 0.0 110.729 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' B' ' 42' ' ' LEU . . . -61.69 150.86 35.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.783 0.325 . . . . 0.0 111.481 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.554 HG23 ' HD2' ' B' ' 145' ' ' PRO . 59.6 m -126.79 151.51 73.72 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.274 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' B' ' 144' ' ' THR . 1.3 Cg_endo -83.06 140.24 9.9 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.626 2.218 . . . . 0.0 111.945 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.91 -138.09 6.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.518 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' ALA . . . . . 0.598 ' HA ' ' HG3' ' A' ' 15' ' ' GLU . . . -87.2 144.99 26.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.925 0.393 . . . . 0.0 111.351 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 148' ' ' ALA . . . . . 0.75 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -140.7 38.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.566 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -86.09 153.59 21.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.546 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' ALA . . . . . 0.607 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -161.88 171.24 18.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.041 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.45 126.79 7.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.251 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' ALA . . . . . 0.541 ' HB2' ' CD1' ' B' ' 86' ' ' LEU . . . -125.32 142.78 51.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.259 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.831 HG23 HG23 ' A' ' 9' ' ' THR . 0.5 OUTLIER -89.83 133.18 34.87 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 154' ' ' PHE . . . . . 0.403 ' HD1' ' HA ' ' B' ' 154' ' ' PHE . 0.0 OUTLIER -86.41 127.85 34.88 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.118 0.485 . . . . 0.0 110.137 -179.024 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 155' ' ' LYS . . . . . 0.4 ' HE3' HD12 ' B' ' 74' ' ' LEU . 29.1 mmtt -111.54 150.53 29.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.882 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 156' ' ' VAL . . . . . 0.788 HG23 HG23 ' A' ' 5' ' ' VAL . 14.3 m -136.19 144.47 33.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.614 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -136.17 132.75 36.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.253 0.549 . . . . 0.0 110.442 -179.686 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 158' ' ' TYR . . . . . 0.495 ' OH ' ' HB3' ' B' ' 21' ' ' CYS . 5.5 m-85 -117.45 119.7 35.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.514 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 159' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.881 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 1' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' D' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 111.123 0.045 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.26 65.02 1.5 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.598 0.237 . . . . 0.0 110.96 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' THR . . . . . 0.525 HG21 ' HB2' ' D' ' 18' ' ' ASN . 57.2 m -111.23 101.0 9.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.471 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 4' ' ' THR . . . . . 0.512 ' HA ' ' HG2' ' D' ' 157' ' ' GLN . 61.6 m -86.63 131.85 34.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.67 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.792 HG23 HG23 ' D' ' 156' ' ' VAL . 0.0 OUTLIER -161.11 168.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.607 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.09 118.68 36.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.616 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.26 -56.38 6.96 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.752 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.97 -145.38 4.66 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.909 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 9' ' ' THR . . . . . 0.812 HG23 HG23 ' D' ' 153' ' ' THR . 0.0 OUTLIER -145.02 142.06 29.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.399 . . . . 0.0 111.292 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 10' ' ' VAL . . . . . 0.4 HG21 ' HZ ' ' D' ' 73' ' ' PHE . 44.0 t -121.59 107.33 19.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.211 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.73 110.97 21.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.424 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 12' ' ' PHE . . . . . 0.51 ' CD1' HD11 ' D' ' 34' ' ' LEU . 32.0 m-85 -87.59 113.59 23.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.713 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.19 118.53 36.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.379 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.54 175.58 39.76 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.974 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' GLU . . . . . 0.608 ' HG3' ' HA ' ' D' ' 147' ' ' ALA . 0.1 OUTLIER -151.36 162.16 41.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.967 0.413 . . . . 0.0 110.263 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 16' ' ' VAL . . . . . 0.743 HG23 ' HB2' ' D' ' 148' ' ' ALA . 2.2 t -115.08 119.48 61.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.153 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 17' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' C' ' 22' ' ' ALA . 0.3 OUTLIER -121.31 168.1 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.808 0.337 . . . . 0.0 111.063 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 18' ' ' ASN . . . . . 0.532 ' HB2' HG21 ' B' ' 3' ' ' THR . 1.3 t-20 -68.5 -175.24 0.63 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.976 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 19' ' ' ALA . . . . . 0.602 ' O ' HG21 ' C' ' 65' ' ' VAL . . . -91.11 52.63 2.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.93 -15.76 1.32 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.361 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER -176.91 147.64 0.6 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.926 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 22' ' ' ALA . . . . . 0.507 ' HA ' HG21 ' C' ' 17' ' ' VAL . . . -152.59 110.04 3.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.097 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 23' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' C' ' 58' ' ' LEU . 0.3 OUTLIER -53.08 159.07 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.01 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -90.32 164.46 14.34 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.614 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -57.01 -52.39 65.47 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.357 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.38 11.97 66.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.912 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 18.3 t -96.29 -30.78 13.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.889 0.376 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 11.2 t -49.76 -71.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.341 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.52 104.31 15.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.086 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -112.19 140.36 46.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.113 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.8 110.07 21.35 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.142 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -108.04 108.4 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.118 0.485 . . . . 0.0 110.386 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.67 112.42 22.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.687 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 34' ' ' LEU . . . . . 0.538 HD21 ' CG2' ' C' ' 101' ' ' VAL . 5.3 mp -81.03 -41.8 22.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.699 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.72 -171.12 21.61 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.604 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 1.7 mt-30 -93.67 145.91 24.21 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.62 0.247 . . . . 0.0 110.913 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.51 HG22 ' H ' ' C' ' 38' ' ' ARG . 5.0 p -124.84 169.94 15.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.94 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 38' ' ' ARG . . . . . 0.53 ' HE ' ' HB3' ' B' ' 60' ' ' ASP . 5.2 mtt-85 -98.93 121.37 40.79 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.71 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 39' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' C' ' 43' ' ' ALA . 0.6 OUTLIER -61.96 -30.94 71.27 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.717 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.61 -39.3 84.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.909 0.385 . . . . 0.0 110.764 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 71.3 m -81.29 -10.4 59.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.163 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.757 ' O ' ' HB2' ' C' ' 143' ' ' ALA . 0.6 OUTLIER -129.34 40.45 3.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.577 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 43' ' ' ALA . . . . . 0.618 ' HA ' ' H ' ' C' ' 143' ' ' ALA . . . -111.89 10.91 20.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.355 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.51 145.52 48.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.372 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' C' ' 140' ' ' THR . 18.1 tt0 -63.26 121.12 12.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.814 0.34 . . . . 0.0 111.204 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.07 14.4 33.77 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.14 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' C' ' 139' ' ' ALA . . . -72.21 121.19 18.93 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 14.9 p -129.98 133.77 47.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.908 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 57.8 m -112.44 -166.73 1.1 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.59 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 36.1 t -59.06 149.46 27.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.801 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.82 153.64 17.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.369 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 52' ' ' VAL . . . . . 0.65 HG22 ' HB3' ' C' ' 135' ' ' ALA . 3.7 m -103.44 130.4 53.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.97 121.43 6.53 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.662 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' PHE . . . . . 0.497 ' HD1' HG23 ' C' ' 52' ' ' VAL . 52.2 p90 -153.65 136.39 15.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.776 0.322 . . . . 0.0 110.986 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 55' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' C' ' 131' ' ' ILE . 24.7 p30 -133.54 141.33 47.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.637 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.634 HG21 HD12 ' C' ' 131' ' ' ILE . 1.2 tt -85.17 126.52 40.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.62 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.603 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.1 OUTLIER -75.88 119.4 19.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.713 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 58' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' C' ' 23' ' ' VAL . 0.2 OUTLIER -130.63 87.29 2.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.254 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 59' ' ' ASN . . . . . 0.719 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 6.7 p-10 -77.15 173.7 11.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.998 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 60' ' ' ASP . . . . . 0.523 ' HB3' ' HE ' ' D' ' 38' ' ' ARG . 41.3 m-20 62.83 66.4 0.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 61' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 34.5 m -115.68 161.98 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.742 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 62' ' ' ASP . . . . . 0.51 ' HA ' ' OD1' ' C' ' 126' ' ' ASN . 0.2 OUTLIER -145.94 157.85 43.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.3 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.491 HG23 ' HA ' ' C' ' 125' ' ' ASN . 0.0 OUTLIER -107.54 -16.65 14.31 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.138 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -81.35 -33.67 32.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.124 0.488 . . . . 0.0 111.817 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 65' ' ' VAL . . . . . 0.602 HG21 ' O ' ' C' ' 19' ' ' ALA . 20.0 t -75.14 -41.68 44.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.661 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.84 146.79 29.24 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.595 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.84 -39.35 3.73 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.897 0.379 . . . . 0.0 110.95 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.22 159.54 15.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.467 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 69' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' C' ' 122' ' ' THR . . . -147.24 118.87 7.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.578 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 70' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -96.81 140.79 30.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.847 0.356 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 71' ' ' VAL . . . . . 0.479 HG11 HG21 ' C' ' 131' ' ' ILE . 3.1 t -118.51 139.74 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.732 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 72' ' ' ALA . . . . . 0.407 ' HA ' HD21 ' C' ' 111' ' ' LEU . . . -140.54 133.91 29.84 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.521 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 73' ' ' PHE . . . . . 0.781 ' HD2' HD13 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -101.25 138.08 38.74 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.538 0.209 . . . . 0.0 111.185 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.717 HD21 HG21 ' F' ' 130' ' ' THR . 6.6 tt -101.06 91.09 4.4 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.982 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.37 -167.37 11.32 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.871 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 76' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' C' ' 86' ' ' LEU . 0.3 OUTLIER -116.67 159.53 22.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.557 0.218 . . . . 0.0 110.796 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 77' ' ' ALA . . . . . 0.525 ' HB2' HG23 ' C' ' 83' ' ' THR . . . -83.95 137.95 33.38 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.942 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 78' ' ' ILE . . . . . 0.457 HG22 ' O ' ' C' ' 82' ' ' HIS . 8.9 tt -77.18 -40.5 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.905 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 79' ' ' ASP . . . . . 0.62 ' HB2' HG21 ' C' ' 140' ' ' THR . 0.1 OUTLIER -141.18 55.31 1.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.796 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 80' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' F' ' 106' ' ' ARG . . . 52.86 -84.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.051 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' C' ' 79' ' ' ASP . . . -60.09 -16.09 39.36 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.621 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 82' ' ' HIS . . . . . 0.457 ' O ' HG22 ' C' ' 78' ' ' ILE . 24.2 m80 -100.64 56.76 0.9 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.931 0.396 . . . . 0.0 110.584 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 83' ' ' THR . . . . . 0.525 HG23 ' HB2' ' C' ' 77' ' ' ALA . 1.1 m -71.33 -22.44 61.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.584 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 84' ' ' ASN . . . . . 0.735 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 2.8 p30 -57.18 -18.72 16.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.341 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.505 HG11 ' HB3' ' C' ' 138' ' ' PHE . 11.6 t -115.19 133.34 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.219 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 86' ' ' LEU . . . . . 0.927 HD12 HD22 ' C' ' 113' ' ' LEU . 0.8 OUTLIER -72.96 154.12 40.67 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.606 ' N ' HD23 ' C' ' 86' ' ' LEU . . . -90.76 -161.4 0.8 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.777 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.27 6.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.966 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.72 -83.84 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.317 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.27 20.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.985 0.421 . . . . 0.0 111.468 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 91' ' ' SER . . . . . 0.774 ' HB2' ' HB2' ' C' ' 95' ' ' SER . 1.5 m -86.58 79.25 8.98 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.67 -31.56 37.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.831 0.348 . . . . 0.0 111.611 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 93' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' F' ' 36' ' ' GLN . . . -128.1 54.49 1.72 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.661 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.9 -17.23 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.067 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 95' ' ' SER . . . . . 0.774 ' HB2' ' HB2' ' C' ' 91' ' ' SER . 0.9 OUTLIER -89.43 177.22 6.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.707 0.289 . . . . 0.0 110.65 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.77 175.3 8.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.759 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 97' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' C' ' 98' ' ' ASN . 0.2 OUTLIER -137.55 137.98 39.14 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.215 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 98' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' C' ' 97' ' ' THR . 74.0 m-80 71.69 17.63 5.46 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.465 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.9 148.96 26.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.741 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.39 -176.77 35.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.464 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 101' ' ' VAL . . . . . 0.538 ' CG2' HD21 ' C' ' 34' ' ' LEU . 7.7 p -125.58 111.03 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.01 0.524 . . . . 0.0 111.711 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 102' ' ' GLN . . . . . 0.614 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 0.9 OUTLIER -81.54 147.75 29.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 -179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 103' ' ' ILE . . . . . 0.781 HD13 ' HD2' ' C' ' 73' ' ' PHE . 0.9 OUTLIER -123.77 115.94 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.489 179.45 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 104' ' ' LEU . . . . . 0.721 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 0.4 OUTLIER -88.73 140.53 29.35 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.634 0.254 . . . . 0.0 111.052 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 105' ' ' ASP . . . . . 0.59 ' HB2' ' HB2' ' C' ' 111' ' ' LEU . 2.1 t70 -89.36 152.06 21.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.711 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 106' ' ' ARG . . . . . 0.621 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -71.76 -21.05 61.79 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.785 0.326 . . . . 0.0 111.075 179.456 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 107' ' ' THR . . . . . 0.615 ' HB ' ' HA ' ' C' ' 120' ' ' SER . 5.8 t -62.99 -21.84 66.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.959 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.72 -83.08 0.19 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.669 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.73 170.66 15.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.833 0.349 . . . . 0.0 111.033 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.721 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -74.77 138.57 42.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 111' ' ' LEU . . . . . 0.59 ' HB2' ' HB2' ' C' ' 105' ' ' ASP . 5.1 tp -94.45 153.41 17.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.363 0.601 . . . . 0.0 110.557 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 112' ' ' THR . . . . . 0.779 HG22 HG21 ' C' ' 117' ' ' THR . 6.2 t -93.7 148.22 22.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.084 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 113' ' ' LEU . . . . . 0.927 HD22 HD12 ' C' ' 86' ' ' LEU . 1.4 mp -89.51 64.82 6.82 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.729 0.3 . . . . 0.0 110.715 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 114' ' ' ASP . . . . . 0.544 ' HB2' ' OG1' ' C' ' 117' ' ' THR . 0.5 OUTLIER -95.11 -16.05 22.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.588 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 115' ' ' GLY . . . . . 0.617 ' HA3' ' HG1' ' F' ' 130' ' ' THR . . . 104.41 -56.27 0.57 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.64 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 116' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' F' ' 125' ' ' ASN . . . -103.57 29.01 6.0 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.049 0.452 . . . . 0.0 111.709 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 117' ' ' THR . . . . . 0.779 HG21 HG22 ' C' ' 112' ' ' THR . 3.4 m -87.27 65.87 8.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.145 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 118' ' ' PHE . . . . . 0.527 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . 48.5 m-85 -77.66 73.47 4.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.792 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.57 70.83 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.837 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 120' ' ' SER . . . . . 0.615 ' HA ' ' HB ' ' C' ' 107' ' ' THR . 0.7 OUTLIER -148.68 126.15 11.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.15 53.25 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.202 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' C' ' 69' ' ' ALA . 0.2 OUTLIER -73.93 128.31 35.18 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.698 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.44 117.94 25.55 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.719 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.51 134.78 33.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.781 0.324 . . . . 0.0 110.489 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 125' ' ' ASN . . . . . 0.491 ' HA ' HG23 ' C' ' 63' ' ' THR . 0.3 OUTLIER -129.26 163.07 26.45 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.674 179.494 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 126' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' C' ' 62' ' ' ASP . 1.5 t30 -67.54 125.37 25.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.82 0.343 . . . . 0.0 110.687 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.62 -141.01 12.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.659 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 128' ' ' THR . . . . . 0.719 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 6.3 m -101.73 92.41 4.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.673 0.273 . . . . 0.0 110.778 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 129' ' ' ASN . . . . . 0.528 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 1.2 t30 -76.52 145.02 39.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.946 0.403 . . . . 0.0 111.119 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 130' ' ' THR . . . . . 0.603 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.0 OUTLIER -134.62 131.78 38.22 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.042 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 131' ' ' ILE . . . . . 0.69 HD11 HG12 ' C' ' 156' ' ' VAL . 28.3 mt -87.33 109.79 28.49 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 132' ' ' PRO . . . . . 0.621 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.4 Cg_endo -81.67 112.17 2.38 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.585 1.524 . . . . 0.0 112.53 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.36 138.28 51.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.804 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 134' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' C' ' 52' ' ' VAL . 28.2 mt-30 -110.11 157.53 19.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.986 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.65 ' HB3' HG22 ' C' ' 52' ' ' VAL . . . -152.67 107.93 3.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.975 0.417 . . . . 0.0 111.608 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -102.54 174.41 5.91 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.338 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 137' ' ' TYR . . . . . 0.485 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 0.6 OUTLIER -86.08 120.9 27.96 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.069 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 138' ' ' PHE . . . . . 0.505 ' HB3' HG11 ' C' ' 85' ' ' VAL . 0.2 OUTLIER -117.66 139.61 50.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.006 -179.134 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 139' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' C' ' 47' ' ' ALA . . . -129.93 145.66 51.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.875 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 140' ' ' THR . . . . . 0.62 HG21 ' HB2' ' C' ' 79' ' ' ASP . 16.5 p -104.38 -53.43 2.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.478 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.7 -121.56 3.27 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.024 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.1 112.97 24.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.59 0.233 . . . . 0.0 110.693 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 143' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' C' ' 42' ' ' LEU . . . -61.82 150.95 35.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.772 0.32 . . . . 0.0 111.42 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 144' ' ' THR . . . . . 0.551 HG23 ' HD2' ' C' ' 145' ' ' PRO . 58.2 m -126.89 151.51 73.96 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.199 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 145' ' ' PRO . . . . . 0.551 ' HD2' HG23 ' C' ' 144' ' ' THR . 1.3 Cg_endo -83.07 140.2 9.87 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.528 2.152 . . . . 0.0 111.936 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.94 -137.98 6.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.574 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 147' ' ' ALA . . . . . 0.615 ' HA ' ' HG3' ' B' ' 15' ' ' GLU . . . -87.23 145.07 26.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.984 0.421 . . . . 0.0 111.307 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 148' ' ' ALA . . . . . 0.732 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -140.76 38.83 1.83 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -86.0 153.52 22.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.486 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 150' ' ' ALA . . . . . 0.604 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -161.87 171.23 18.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.019 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.4 126.79 7.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.328 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 152' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' C' ' 86' ' ' LEU . . . -125.31 142.8 51.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.328 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 153' ' ' THR . . . . . 0.82 HG23 HG23 ' B' ' 9' ' ' THR . 0.5 OUTLIER -89.85 133.17 34.88 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 154' ' ' PHE . . . . . 0.501 ' HD1' ' HA ' ' C' ' 154' ' ' PHE . 0.0 OUTLIER -86.44 127.85 34.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.104 0.478 . . . . 0.0 110.113 -178.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 155' ' ' LYS . . . . . 0.401 ' HE3' HD12 ' C' ' 74' ' ' LEU . 29.0 mmtt -111.43 150.52 29.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.921 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 156' ' ' VAL . . . . . 0.809 HG23 HG23 ' B' ' 5' ' ' VAL . 14.3 m -136.23 144.46 33.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.859 0.361 . . . . 0.0 111.582 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 157' ' ' GLN . . . . . 0.583 ' O ' ' HA ' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -136.16 132.73 36.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.34 0.59 . . . . 0.0 110.391 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 158' ' ' TYR . . . . . 0.494 ' OH ' ' HB3' ' C' ' 21' ' ' CYS . 5.6 m-85 -117.45 119.8 36.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.51 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 159' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' B' ' 1' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.33 -0.843 . . . . 0.0 110.799 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 1' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' E' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.235 0.064 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.26 64.86 1.57 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.627 0.251 . . . . 0.0 111.065 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 3' ' ' THR . . . . . 0.518 HG21 ' HB2' ' E' ' 18' ' ' ASN . 57.9 m -111.17 100.96 9.52 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.524 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 4' ' ' THR . . . . . 0.51 ' HA ' ' HG2' ' E' ' 157' ' ' GLN . 61.6 m -86.59 131.91 34.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.609 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.774 HG23 HG23 ' E' ' 156' ' ' VAL . 0.0 OUTLIER -161.16 168.06 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.523 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.19 118.71 37.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.584 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.31 -56.3 7.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.76 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.94 -145.34 4.65 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.919 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 9' ' ' THR . . . . . 0.81 HG23 HG23 ' E' ' 153' ' ' THR . 0.0 OUTLIER -145.02 142.09 29.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 0.0 111.282 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 10' ' ' VAL . . . . . 0.4 HG21 ' HZ ' ' E' ' 73' ' ' PHE . 43.8 t -121.66 107.27 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.168 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.7 111.03 21.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.366 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 12' ' ' PHE . . . . . 0.511 ' CD1' HD11 ' E' ' 34' ' ' LEU . 32.1 m-85 -87.63 113.53 23.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.777 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.13 118.54 36.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.405 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.48 175.61 39.71 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.887 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 15' ' ' GLU . . . . . 0.594 ' HG3' ' HA ' ' E' ' 147' ' ' ALA . 0.1 OUTLIER -151.38 162.12 41.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.946 0.403 . . . . 0.0 110.313 179.562 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 16' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' E' ' 148' ' ' ALA . 2.2 t -114.99 119.45 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.214 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 17' ' ' VAL . . . . . 0.518 HG21 ' HA ' ' D' ' 22' ' ' ALA . 0.3 OUTLIER -121.32 168.05 14.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.815 0.341 . . . . 0.0 111.07 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 18' ' ' ASN . . . . . 0.525 ' HB2' HG21 ' C' ' 3' ' ' THR . 1.3 t-20 -68.44 -175.21 0.62 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.984 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 19' ' ' ALA . . . . . 0.589 ' O ' HG21 ' D' ' 65' ' ' VAL . . . -91.24 52.67 2.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.89 -15.71 1.33 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.374 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 21' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER -176.91 147.59 0.6 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.928 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 22' ' ' ALA . . . . . 0.518 ' HA ' HG21 ' D' ' 17' ' ' VAL . . . -152.64 110.04 3.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.114 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 23' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' D' ' 58' ' ' LEU . 0.3 OUTLIER -52.97 159.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.023 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -90.38 164.5 14.29 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.6 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -57.0 -52.38 65.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.365 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.36 11.87 66.56 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.872 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 18.7 t -96.14 -30.86 13.28 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.904 0.383 . . . . 0.0 110.929 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 t -49.83 -71.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.355 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.59 104.34 15.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.044 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -112.14 140.3 46.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.071 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.77 110.18 21.5 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.028 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.13 108.36 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.155 0.503 . . . . 0.0 110.453 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.56 112.46 22.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.685 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 34' ' ' LEU . . . . . 0.543 HD21 ' CG2' ' D' ' 101' ' ' VAL . 5.2 mp -81.19 -41.72 21.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.673 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.64 -171.05 21.62 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.626 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 1.7 mt-30 -93.57 145.93 24.17 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.524 0.202 . . . . 0.0 110.979 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.51 HG22 ' H ' ' D' ' 38' ' ' ARG . 4.9 p -124.84 169.89 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.991 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 38' ' ' ARG . . . . . 0.523 ' HE ' ' HB3' ' C' ' 60' ' ' ASP . 5.2 mtt-85 -98.88 121.42 40.8 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.714 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 39' ' ' THR . . . . . 0.543 ' O ' ' HB2' ' D' ' 43' ' ' ALA . 0.6 OUTLIER -62.01 -31.01 71.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.672 179.482 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.25 84.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.992 0.425 . . . . 0.0 110.852 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 71.1 m -81.31 -10.45 59.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.139 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.736 ' O ' ' HB2' ' D' ' 143' ' ' ALA . 0.6 OUTLIER -129.25 40.42 3.62 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.607 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 43' ' ' ALA . . . . . 0.617 ' HA ' ' H ' ' D' ' 143' ' ' ALA . . . -111.83 10.91 20.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.363 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.51 145.49 48.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.369 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 45' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' D' ' 140' ' ' THR . 18.2 tt0 -63.34 121.26 13.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.11 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.05 14.38 33.9 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.155 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' D' ' 139' ' ' ALA . . . -72.17 121.22 18.93 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 14.9 p -130.04 133.79 46.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.919 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 57.8 m -112.46 -166.73 1.1 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.607 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 36.3 t -59.11 149.47 27.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.897 0.379 . . . . 0.0 110.768 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.76 153.64 17.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.404 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 52' ' ' VAL . . . . . 0.668 HG22 ' HB3' ' D' ' 135' ' ' ALA . 3.7 m -103.41 130.33 53.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.96 121.5 6.56 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.576 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.492 ' HD1' HG23 ' D' ' 52' ' ' VAL . 52.3 p90 -153.71 136.44 15.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.816 0.341 . . . . 0.0 110.94 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 55' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' D' ' 131' ' ' ILE . 24.7 p30 -133.57 141.33 47.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.628 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 56' ' ' ILE . . . . . 0.642 HG21 HD12 ' D' ' 131' ' ' ILE . 1.2 tt -85.06 126.42 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.645 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 57' ' ' GLN . . . . . 0.601 ' HG3' HD11 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -75.73 119.41 19.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.742 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 58' ' ' LEU . . . . . 0.531 ' HA ' ' HA ' ' D' ' 23' ' ' VAL . 0.2 OUTLIER -130.68 87.36 2.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.258 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 59' ' ' ASN . . . . . 0.719 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 6.7 p-10 -77.3 173.64 11.68 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.956 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 60' ' ' ASP . . . . . 0.524 ' HB3' ' HE ' ' E' ' 38' ' ' ARG . 41.3 m-20 62.91 66.4 0.75 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.844 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 61' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 34.6 m -115.69 161.98 17.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.714 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 62' ' ' ASP . . . . . 0.514 ' HA ' ' OD1' ' D' ' 126' ' ' ASN . 0.2 OUTLIER -145.88 157.92 43.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.323 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.491 HG23 ' HA ' ' D' ' 125' ' ' ASN . 0.0 OUTLIER -107.59 -16.67 14.3 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -81.42 -33.65 32.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.028 0.442 . . . . 0.0 111.708 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 65' ' ' VAL . . . . . 0.589 HG21 ' O ' ' D' ' 19' ' ' ALA . 20.0 t -75.19 -41.6 44.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.629 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.93 146.7 29.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.553 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.77 -39.3 3.76 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.972 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.3 159.58 15.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.477 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 69' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' D' ' 122' ' ' THR . . . -147.19 118.82 7.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.649 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 70' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -96.83 140.74 30.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.093 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 71' ' ' VAL . . . . . 0.457 HG11 HG21 ' D' ' 131' ' ' ILE . 3.1 t -118.5 139.71 44.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.784 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 72' ' ' ALA . . . . . 0.403 ' HA ' HD21 ' D' ' 111' ' ' LEU . . . -140.56 133.94 29.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.522 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 73' ' ' PHE . . . . . 0.788 ' HD2' HD13 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -101.21 137.97 38.86 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.509 0.195 . . . . 0.0 111.243 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 74' ' ' LEU . . . . . . . . . . . . . 6.6 tt -100.97 91.08 4.41 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.011 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.43 -167.38 11.31 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.891 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 76' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.3 OUTLIER -116.68 159.56 22.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.585 0.231 . . . . 0.0 110.761 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.52 ' HB2' HG23 ' D' ' 83' ' ' THR . . . -83.96 137.85 33.42 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.018 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 78' ' ' ILE . . . . . 0.45 HG22 ' O ' ' D' ' 82' ' ' HIS . 9.0 tt -77.13 -40.48 30.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.882 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 79' ' ' ASP . . . . . 0.606 ' HB2' HG21 ' D' ' 140' ' ' THR . 0.1 OUTLIER -141.22 55.21 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.848 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 52.87 -84.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.075 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' D' ' 79' ' ' ASP . . . -60.09 -16.05 39.19 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.663 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 82' ' ' HIS . . . . . 0.45 ' O ' HG22 ' D' ' 78' ' ' ILE . 24.2 m80 -100.64 56.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 110.568 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 83' ' ' THR . . . . . 0.52 HG23 ' HB2' ' D' ' 77' ' ' ALA . 1.1 m -71.41 -22.42 61.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.563 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 84' ' ' ASN . . . . . 0.739 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 2.8 p30 -57.17 -18.67 16.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.359 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.518 HG11 ' HB3' ' D' ' 138' ' ' PHE . 11.6 t -115.24 133.34 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.227 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 86' ' ' LEU . . . . . 0.908 HD12 HD22 ' D' ' 113' ' ' LEU . 0.8 OUTLIER -72.93 154.06 40.71 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.341 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.601 ' N ' HD23 ' D' ' 86' ' ' LEU . . . -90.66 -161.41 0.8 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.837 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.69 -178.27 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.01 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -83.88 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.339 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.33 20.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.998 0.427 . . . . 0.0 111.49 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 91' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' D' ' 95' ' ' SER . 1.5 m -86.6 79.35 8.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.73 -31.49 38.2 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.913 0.387 . . . . 0.0 111.71 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.08 54.43 1.72 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.646 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.9 -17.29 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.931 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 95' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' D' ' 91' ' ' SER . 0.9 OUTLIER -89.39 177.16 6.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.75 0.309 . . . . 0.0 110.661 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.76 175.3 8.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.812 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 97' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' D' ' 98' ' ' ASN . 0.2 OUTLIER -137.52 138.03 39.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.263 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 98' ' ' ASN . . . . . 0.529 ' HB2' ' O ' ' D' ' 97' ' ' THR . 74.0 m-80 71.63 17.6 5.53 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.52 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.86 148.94 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.733 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.35 -176.74 35.65 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.436 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 101' ' ' VAL . . . . . 0.543 ' CG2' HD21 ' D' ' 34' ' ' LEU . 7.7 p -125.59 111.01 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 122.968 0.507 . . . . 0.0 111.759 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 102' ' ' GLN . . . . . 0.616 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 0.9 OUTLIER -81.53 147.71 29.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 103' ' ' ILE . . . . . 0.788 HD13 ' HD2' ' D' ' 73' ' ' PHE . 0.9 OUTLIER -123.74 115.92 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.478 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 104' ' ' LEU . . . . . 0.74 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 0.4 OUTLIER -88.69 140.52 29.37 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.693 0.283 . . . . 0.0 111.051 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 105' ' ' ASP . . . . . 0.605 ' HB2' ' HB2' ' D' ' 111' ' ' LEU . 2.1 t70 -89.26 151.98 21.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.693 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 106' ' ' ARG . . . . . 0.646 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -71.78 -21.07 61.77 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.805 0.336 . . . . 0.0 111.07 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 107' ' ' THR . . . . . 0.616 ' HB ' ' HA ' ' D' ' 120' ' ' SER . 5.8 t -62.9 -21.91 66.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.97 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.68 -83.02 0.19 Allowed Glycine 0 CA--C 1.517 0.219 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.722 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.74 170.7 15.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.834 0.349 . . . . 0.0 111.106 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.74 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -74.84 138.61 42.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.183 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 111' ' ' LEU . . . . . 0.605 ' HB2' ' HB2' ' D' ' 105' ' ' ASP . 5.1 tp -94.37 153.41 17.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.276 0.56 . . . . 0.0 110.604 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 112' ' ' THR . . . . . 0.776 HG22 HG21 ' D' ' 117' ' ' THR . 6.2 t -93.72 148.33 22.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.046 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 113' ' ' LEU . . . . . 0.908 HD22 HD12 ' D' ' 86' ' ' LEU . 1.4 mp -89.7 64.87 6.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.894 0.378 . . . . 0.0 110.758 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 114' ' ' ASP . . . . . 0.541 ' HB2' ' OG1' ' D' ' 117' ' ' THR . 0.5 OUTLIER -94.98 -16.15 22.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.648 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.49 -56.26 0.56 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.693 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.53 29.05 5.96 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.949 0.404 . . . . 0.0 111.719 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 117' ' ' THR . . . . . 0.776 HG21 HG22 ' D' ' 112' ' ' THR . 3.4 m -87.26 65.92 8.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.041 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 118' ' ' PHE . . . . . 0.52 ' HB3' ' HB1' ' D' ' 70' ' ' ALA . 48.5 m-85 -77.69 73.42 4.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.808 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.49 70.79 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 120' ' ' SER . . . . . 0.616 ' HA ' ' HB ' ' D' ' 107' ' ' THR . 0.7 OUTLIER -148.64 126.07 11.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.67 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.08 53.27 2.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.198 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' D' ' 69' ' ' ALA . 0.2 OUTLIER -74.04 128.32 35.22 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.715 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.36 117.9 25.45 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.765 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.52 134.8 33.76 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.831 0.348 . . . . 0.0 110.524 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 125' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -129.24 163.09 26.37 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.654 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 126' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' D' ' 62' ' ' ASP . 1.5 t30 -67.6 125.37 25.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.7 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 127' ' ' GLY . . . . . 0.451 ' HA3' ' HE2' ' A' ' 118' ' ' PHE . . . 128.62 -140.97 12.14 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.718 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 128' ' ' THR . . . . . 0.719 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 6.3 m -101.8 92.45 4.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.672 0.272 . . . . 0.0 110.772 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 129' ' ' ASN . . . . . 0.54 ' HB2' ' SG ' ' D' ' 61' ' ' CYS . 1.2 t30 -76.5 145.04 39.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.92 0.391 . . . . 0.0 111.147 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 130' ' ' THR . . . . . 0.734 HG21 HD21 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -134.68 131.79 38.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.063 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 131' ' ' ILE . . . . . 0.686 HD11 HG12 ' D' ' 156' ' ' VAL . 28.2 mt -87.32 109.73 28.01 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 132' ' ' PRO . . . . . 0.646 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.5 Cg_endo -81.57 112.13 2.4 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.599 1.533 . . . . 0.0 112.576 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.35 138.2 51.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.844 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 134' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' D' ' 52' ' ' VAL . 28.3 mt-30 -110.1 157.55 19.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.99 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.668 ' HB3' HG22 ' D' ' 52' ' ' VAL . . . -152.68 107.92 3.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 111.568 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -102.53 174.34 5.94 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.381 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 137' ' ' TYR . . . . . 0.462 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 0.6 OUTLIER -85.99 120.81 27.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.097 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 138' ' ' PHE . . . . . 0.518 ' HB3' HG11 ' D' ' 85' ' ' VAL . 0.2 OUTLIER -117.62 139.56 50.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.079 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 139' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' D' ' 47' ' ' ALA . . . -129.88 145.64 51.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.851 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 140' ' ' THR . . . . . 0.606 HG21 ' HB2' ' D' ' 79' ' ' ASP . 16.3 p -104.46 -53.43 2.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.407 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.67 -121.52 3.27 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.014 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.08 112.92 24.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.568 0.223 . . . . 0.0 110.676 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 143' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' D' ' 42' ' ' LEU . . . -61.78 150.86 35.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.755 0.312 . . . . 0.0 111.453 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 144' ' ' THR . . . . . 0.553 HG23 ' HD2' ' D' ' 145' ' ' PRO . 60.4 m -126.81 151.52 73.77 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.274 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 145' ' ' PRO . . . . . 0.553 ' HD2' HG23 ' D' ' 144' ' ' THR . 1.3 Cg_endo -83.08 140.2 9.85 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.613 2.208 . . . . 0.0 111.941 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.94 -138.14 6.59 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.485 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 147' ' ' ALA . . . . . 0.608 ' HA ' ' HG3' ' C' ' 15' ' ' GLU . . . -87.14 145.02 26.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.912 0.387 . . . . 0.0 111.378 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 148' ' ' ALA . . . . . 0.743 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -140.73 38.79 1.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.545 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -86.1 153.53 22.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.48 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 150' ' ' ALA . . . . . 0.589 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -161.86 171.25 18.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.048 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.42 126.8 7.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.242 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 152' ' ' ALA . . . . . 0.528 ' HB2' ' CD1' ' D' ' 86' ' ' LEU . . . -125.31 142.85 51.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.257 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 153' ' ' THR . . . . . 0.812 HG23 HG23 ' C' ' 9' ' ' THR . 0.5 OUTLIER -89.84 133.17 34.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 154' ' ' PHE . . . . . 0.501 ' HD1' ' HA ' ' D' ' 154' ' ' PHE . 0.0 OUTLIER -86.46 127.88 34.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.042 0.449 . . . . 0.0 110.096 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.48 150.57 29.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.958 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 156' ' ' VAL . . . . . 0.792 HG23 HG23 ' C' ' 5' ' ' VAL . 14.4 m -136.24 144.39 33.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.826 0.346 . . . . 0.0 111.594 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 157' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' D' ' 69' ' ' ALA . 0.0 OUTLIER -136.16 132.74 36.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.268 0.556 . . . . 0.0 110.415 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 158' ' ' TYR . . . . . 0.489 ' OH ' ' HB3' ' D' ' 21' ' ' CYS . 5.5 m-85 -117.42 119.78 36.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.505 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 159' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' C' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.844 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 1' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' F' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 120.209 0.052 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.21 64.86 1.57 Allowed 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.126 0.266 . . . . 0.0 111.079 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 3' ' ' THR . . . . . 0.538 HG21 ' HB2' ' F' ' 18' ' ' ASN . 57.8 m -111.17 101.03 9.58 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.42 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 4' ' ' THR . . . . . 0.502 ' O ' HG13 ' E' ' 5' ' ' VAL . 60.0 m -86.72 131.91 34.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.539 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.802 HG23 HG23 ' F' ' 156' ' ' VAL . 0.0 OUTLIER -161.15 168.05 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.513 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.15 118.76 37.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.58 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.36 -56.26 7.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.759 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.01 -145.36 4.66 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.883 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 9' ' ' THR . . . . . 0.811 HG23 HG23 ' F' ' 153' ' ' THR . 0.0 OUTLIER -145.01 142.07 29.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.288 -179.587 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 44.0 t -121.64 107.31 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.17 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.72 110.93 21.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.431 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 12' ' ' PHE . . . . . 0.501 ' CD1' HD11 ' F' ' 34' ' ' LEU . 32.2 m-85 -87.54 113.48 23.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.15 118.54 36.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.443 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.49 175.49 39.72 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.946 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 15' ' ' GLU . . . . . 0.594 ' HG3' ' HA ' ' F' ' 147' ' ' ALA . 0.1 OUTLIER -151.29 162.13 41.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.994 0.426 . . . . 0.0 110.303 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 16' ' ' VAL . . . . . 0.736 HG23 ' HB2' ' F' ' 148' ' ' ALA . 2.2 t -114.97 119.33 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.265 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 17' ' ' VAL . . . . . 0.492 HG21 ' HA ' ' E' ' 22' ' ' ALA . 0.3 OUTLIER -121.26 168.06 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.843 0.354 . . . . 0.0 111.039 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 18' ' ' ASN . . . . . 0.518 ' HB2' HG21 ' D' ' 3' ' ' THR . 1.3 t-20 -68.38 -175.26 0.61 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.01 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 19' ' ' ALA . . . . . 0.605 ' O ' HG21 ' E' ' 65' ' ' VAL . . . -91.12 52.59 2.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.95 -15.66 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.357 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 21' ' ' CYS . . . . . 0.726 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER -176.96 147.55 0.58 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.981 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 22' ' ' ALA . . . . . 0.492 ' HA ' HG21 ' E' ' 17' ' ' VAL . . . -152.57 110.05 3.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 23' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' E' ' 58' ' ' LEU . 0.3 OUTLIER -53.0 159.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.011 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -90.37 164.46 14.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.592 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 25' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -56.91 -52.42 65.24 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.402 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.35 11.9 66.43 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.881 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 18.3 t -96.21 -30.77 13.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.895 0.379 . . . . 0.0 110.917 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 28' ' ' VAL . . . . . 0.426 ' H ' HG23 ' E' ' 28' ' ' VAL . 11.2 t -49.84 -71.71 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.38 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.47 104.29 15.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -112.17 140.4 46.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.07 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.83 110.16 21.46 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.301 -0.409 . . . . 0.0 112.045 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.17 108.46 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.136 0.493 . . . . 0.0 110.434 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.65 112.47 22.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 34' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' E' ' 101' ' ' VAL . 5.3 mp -81.17 -41.8 21.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.67 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.72 -171.02 21.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.632 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 36' ' ' GLN . . . . . 0.55 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 1.7 mt-30 -93.62 145.9 24.21 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.502 0.192 . . . . 0.0 110.969 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.515 HG22 ' H ' ' E' ' 38' ' ' ARG . 5.0 p -124.82 169.88 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.942 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 38' ' ' ARG . . . . . 0.524 ' HE ' ' HB3' ' D' ' 60' ' ' ASP . 5.2 mtt-85 -98.94 121.45 40.91 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.701 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 39' ' ' THR . . . . . 0.545 ' O ' ' HB2' ' E' ' 43' ' ' ALA . 0.6 OUTLIER -61.99 -31.03 71.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.675 179.521 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.3 85.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.987 0.422 . . . . 0.0 110.85 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 70.5 m -81.36 -10.3 59.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.128 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 42' ' ' LEU . . . . . 0.739 ' O ' ' HB2' ' E' ' 143' ' ' ALA . 0.6 OUTLIER -129.33 40.34 3.62 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.571 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 43' ' ' ALA . . . . . 0.607 ' HA ' ' H ' ' E' ' 143' ' ' ALA . . . -111.87 10.98 20.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.392 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.6 145.47 48.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.35 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 45' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' E' ' 140' ' ' THR . 18.2 tt0 -63.28 121.17 13.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.367 . . . . 0.0 111.109 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.03 14.48 33.67 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.113 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 47' ' ' ALA . . . . . 0.692 ' HB3' ' HB3' ' E' ' 139' ' ' ALA . . . -72.14 121.19 18.86 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 14.9 p -130.03 133.72 46.93 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.906 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 49' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 57.9 m -112.43 -166.69 1.1 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.623 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 36.3 t -59.03 149.5 27.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.774 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.84 153.6 17.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.386 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 52' ' ' VAL . . . . . 0.669 HG22 ' HB3' ' E' ' 135' ' ' ALA . 3.7 m -103.45 130.34 53.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.877 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.94 121.4 6.52 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.612 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 54' ' ' PHE . . . . . 0.49 ' HD1' HG23 ' E' ' 52' ' ' VAL . 52.2 p90 -153.6 136.44 15.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 110.97 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 55' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' E' ' 131' ' ' ILE . 24.7 p30 -133.55 141.39 47.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.682 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 56' ' ' ILE . . . . . 0.645 HG21 HD12 ' E' ' 131' ' ' ILE . 1.2 tt -85.18 126.43 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.627 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 57' ' ' GLN . . . . . 0.599 ' HG3' HD11 ' B' ' 74' ' ' LEU . 0.1 OUTLIER -75.8 119.45 19.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.732 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 58' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' E' ' 23' ' ' VAL . 0.2 OUTLIER -130.75 87.34 2.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.214 -179.609 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 59' ' ' ASN . . . . . 0.728 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 6.7 p-10 -77.2 173.71 11.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.991 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 60' ' ' ASP . . . . . 0.527 ' HB3' ' HE ' ' F' ' 38' ' ' ARG . 41.6 m-20 62.89 66.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 61' ' ' CYS . . . . . 0.726 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 34.5 m -115.66 161.98 17.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.74 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 62' ' ' ASP . . . . . 0.514 ' HA ' ' OD1' ' E' ' 126' ' ' ASN . 0.2 OUTLIER -145.91 157.82 43.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.333 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 63' ' ' THR . . . . . 0.482 HG23 ' HA ' ' E' ' 125' ' ' ASN . 0.0 OUTLIER -107.51 -16.65 14.31 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.186 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.4 -33.63 32.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.055 0.455 . . . . 0.0 111.755 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 65' ' ' VAL . . . . . 0.605 HG21 ' O ' ' E' ' 19' ' ' ALA . 20.0 t -75.19 -41.55 44.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.668 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.94 146.76 29.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.528 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -39.25 3.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.008 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.32 159.61 15.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.431 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 69' ' ' ALA . . . . . 0.601 ' HB3' ' HB ' ' E' ' 122' ' ' THR . . . -147.26 118.87 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.612 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 70' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -96.9 140.81 30.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.063 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 71' ' ' VAL . . . . . 0.471 HG11 HG21 ' E' ' 131' ' ' ILE . 3.1 t -118.57 139.74 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.714 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.56 133.9 29.78 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.533 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 73' ' ' PHE . . . . . 0.792 ' HD2' HD13 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -101.16 138.01 38.76 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 122.388 -0.195 . . . . 0.0 111.185 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 74' ' ' LEU . . . . . 0.41 HD12 ' HE3' ' E' ' 155' ' ' LYS . 6.6 tt -100.98 91.02 4.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.028 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.37 -167.37 11.32 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.872 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 76' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.3 OUTLIER -116.71 159.48 22.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.631 0.253 . . . . 0.0 110.729 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 77' ' ' ALA . . . . . 0.52 ' HB2' HG23 ' E' ' 83' ' ' THR . . . -83.94 137.94 33.39 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.024 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 78' ' ' ILE . . . . . 0.456 HG22 ' O ' ' E' ' 82' ' ' HIS . 8.9 tt -77.18 -40.48 29.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.911 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 79' ' ' ASP . . . . . 0.601 ' HB2' HG21 ' E' ' 140' ' ' THR . 0.1 OUTLIER -141.22 55.26 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.882 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 52.88 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 81' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' E' ' 79' ' ' ASP . . . -60.09 -15.99 38.89 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.652 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 82' ' ' HIS . . . . . 0.456 ' O ' HG22 ' E' ' 78' ' ' ILE . 24.2 m80 -100.68 56.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.929 0.395 . . . . 0.0 110.557 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 83' ' ' THR . . . . . 0.52 HG23 ' HB2' ' E' ' 77' ' ' ALA . 1.1 m -71.32 -22.53 61.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.574 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 84' ' ' ASN . . . . . 0.737 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 2.9 p30 -57.2 -18.62 16.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.347 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 85' ' ' VAL . . . . . 0.505 HG11 ' HB3' ' E' ' 138' ' ' PHE . 11.6 t -115.23 133.36 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.205 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 86' ' ' LEU . . . . . 0.928 HD12 HD22 ' E' ' 113' ' ' LEU . 0.8 OUTLIER -72.95 154.01 40.72 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.368 179.332 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 87' ' ' ALA . . . . . 0.602 ' N ' HD23 ' E' ' 86' ' ' LEU . . . -90.67 -161.35 0.79 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.872 0.367 . . . . 0.0 111.781 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.74 -178.24 6.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.925 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.72 -83.82 0.04 OUTLIER 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.364 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.35 20.49 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.989 0.423 . . . . 0.0 111.464 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 91' ' ' SER . . . . . 0.766 ' HB2' ' HB2' ' E' ' 95' ' ' SER . 1.5 m -86.56 79.3 8.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.7 -31.54 38.14 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.867 0.365 . . . . 0.0 111.624 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.05 54.43 1.72 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.671 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.86 -17.34 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.02 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 95' ' ' SER . . . . . 0.766 ' HB2' ' HB2' ' E' ' 91' ' ' SER . 0.9 OUTLIER -89.41 177.2 6.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.804 0.335 . . . . 0.0 110.67 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.68 175.19 8.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.795 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 97' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' E' ' 98' ' ' ASN . 0.2 OUTLIER -137.5 138.01 39.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.275 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 98' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' E' ' 97' ' ' THR . 74.0 m-80 71.71 17.52 5.46 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.532 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.87 149.0 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.719 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.34 -176.75 35.65 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.447 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 101' ' ' VAL . . . . . 0.541 ' CG2' HD21 ' E' ' 34' ' ' LEU . 7.7 p -125.63 111.04 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.003 0.521 . . . . 0.0 111.736 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 102' ' ' GLN . . . . . 0.611 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 0.9 OUTLIER -81.58 147.67 29.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.878 -179.67 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 103' ' ' ILE . . . . . 0.792 HD13 ' HD2' ' E' ' 73' ' ' PHE . 0.9 OUTLIER -123.64 115.95 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.55 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 104' ' ' LEU . . . . . 0.714 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 0.4 OUTLIER -88.77 140.51 29.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.688 0.28 . . . . 0.0 111.02 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 105' ' ' ASP . . . . . 0.597 ' HB3' HG22 ' E' ' 107' ' ' THR . 2.1 t70 -89.28 152.02 21.79 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.661 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 106' ' ' ARG . . . . . 0.63 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -71.79 -21.02 61.77 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.819 0.343 . . . . 0.0 111.119 179.392 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 107' ' ' THR . . . . . 0.615 ' HB ' ' HA ' ' E' ' 120' ' ' SER . 5.8 t -62.89 -21.98 66.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.981 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.69 -83.05 0.19 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.626 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.66 170.68 15.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 111.105 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 110' ' ' ALA . . . . . 0.714 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -74.85 138.63 42.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.227 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 111' ' ' LEU . . . . . 0.594 ' HB2' ' HB2' ' E' ' 105' ' ' ASP . 5.0 tp -94.45 153.45 17.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.366 0.603 . . . . 0.0 110.577 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 112' ' ' THR . . . . . 0.804 HG22 HG21 ' E' ' 117' ' ' THR . 6.2 t -93.78 148.29 22.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.049 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 113' ' ' LEU . . . . . 0.928 HD22 HD12 ' E' ' 86' ' ' LEU . 1.4 mp -89.53 64.82 6.81 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.773 0.32 . . . . 0.0 110.742 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 114' ' ' ASP . . . . . 0.559 ' HB2' ' OG1' ' E' ' 117' ' ' THR . 0.5 OUTLIER -95.1 -15.95 23.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.662 0.268 . . . . 0.0 111.665 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.34 -56.25 0.57 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.682 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.58 29.05 5.98 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.983 0.42 . . . . 0.0 111.679 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 117' ' ' THR . . . . . 0.804 HG21 HG22 ' E' ' 112' ' ' THR . 3.4 m -87.11 65.82 9.06 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.153 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 118' ' ' PHE . . . . . 0.52 ' HB3' ' HB1' ' E' ' 70' ' ' ALA . 48.3 m-85 -77.67 73.39 4.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.814 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.54 70.85 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 120' ' ' SER . . . . . 0.615 ' HA ' ' HB ' ' E' ' 107' ' ' THR . 0.7 OUTLIER -148.66 126.08 11.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.679 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.06 53.23 2.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.203 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 122' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' E' ' 69' ' ' ALA . 0.2 OUTLIER -74.04 128.31 35.2 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.67 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 4.5 m -86.29 118.0 25.46 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.759 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.61 134.82 33.77 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.779 0.323 . . . . 0.0 110.482 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 125' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' B' ' 116' ' ' ALA . 0.3 OUTLIER -129.3 163.08 26.47 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.662 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 126' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' E' ' 62' ' ' ASP . 1.5 t30 -67.56 125.34 25.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.653 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 127' ' ' GLY . . . . . 0.651 ' HA2' HG21 ' A' ' 4' ' ' THR . . . 128.59 -140.97 12.14 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.686 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 128' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 6.3 m -101.76 92.5 4.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.666 0.27 . . . . 0.0 110.752 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 129' ' ' ASN . . . . . 0.542 ' HB2' ' SG ' ' E' ' 61' ' ' CYS . 1.2 t30 -76.58 144.98 39.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.89 0.376 . . . . 0.0 111.099 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 130' ' ' THR . . . . . 0.714 HG21 HD21 ' B' ' 74' ' ' LEU . 0.0 OUTLIER -134.63 131.81 38.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.05 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 131' ' ' ILE . . . . . 0.685 HD11 HG12 ' E' ' 156' ' ' VAL . 28.3 mt -87.34 109.74 28.16 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 132' ' ' PRO . . . . . 0.63 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.4 Cg_endo -81.61 112.15 2.39 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 121.604 1.536 . . . . 0.0 112.544 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.32 138.21 51.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 134' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' E' ' 52' ' ' VAL . 44.1 mt-30 -110.03 157.49 19.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.075 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 135' ' ' ALA . . . . . 0.669 ' HB3' HG22 ' E' ' 52' ' ' VAL . . . -152.65 107.85 3.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 111.636 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -102.58 174.34 5.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.338 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 137' ' ' TYR . . . . . 0.468 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 0.6 OUTLIER -85.9 120.86 27.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.036 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 138' ' ' PHE . . . . . 0.505 ' HB3' HG11 ' E' ' 85' ' ' VAL . 0.2 OUTLIER -117.68 139.64 50.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.001 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 139' ' ' ALA . . . . . 0.692 ' HB3' ' HB3' ' E' ' 47' ' ' ALA . . . -129.95 145.62 51.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.915 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 140' ' ' THR . . . . . 0.601 HG21 ' HB2' ' E' ' 79' ' ' ASP . 16.5 p -104.45 -53.33 2.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.464 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.8 -121.49 3.25 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.983 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.07 112.91 24.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.572 0.225 . . . . 0.0 110.723 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 143' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' E' ' 42' ' ' LEU . . . -61.79 150.89 35.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.794 0.33 . . . . 0.0 111.406 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 144' ' ' THR . . . . . 0.55 HG23 ' HD2' ' E' ' 145' ' ' PRO . 59.8 m -126.81 151.59 73.89 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.261 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 145' ' ' PRO . . . . . 0.55 ' HD2' HG23 ' E' ' 144' ' ' THR . 1.3 Cg_endo -83.09 140.15 9.82 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.59 2.193 . . . . 0.0 111.956 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.98 -138.01 6.52 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.521 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 147' ' ' ALA . . . . . 0.594 ' HA ' ' HG3' ' D' ' 15' ' ' GLU . . . -87.22 145.01 26.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.941 0.4 . . . . 0.0 111.329 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 148' ' ' ALA . . . . . 0.749 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -140.74 38.84 1.83 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.589 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -86.09 153.5 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.47 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 150' ' ' ALA . . . . . 0.598 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -161.88 171.21 18.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.966 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.42 126.84 7.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.232 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 152' ' ' ALA . . . . . 0.537 ' HB2' ' CD1' ' E' ' 86' ' ' LEU . . . -125.36 142.81 51.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.252 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 153' ' ' THR . . . . . 0.81 HG23 HG23 ' D' ' 9' ' ' THR . 0.4 OUTLIER -89.88 133.2 34.89 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 154' ' ' PHE . . . . . 0.448 ' HD1' ' HA ' ' E' ' 154' ' ' PHE . 0.0 OUTLIER -86.41 127.84 34.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.016 0.436 . . . . 0.0 110.148 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 155' ' ' LYS . . . . . 0.41 ' HE3' HD12 ' E' ' 74' ' ' LEU . 29.1 mmtt -111.41 150.55 29.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.96 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 156' ' ' VAL . . . . . 0.774 HG23 HG23 ' D' ' 5' ' ' VAL . 14.2 m -136.23 144.44 33.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.863 0.363 . . . . 0.0 111.551 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 157' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' E' ' 69' ' ' ALA . 0.0 OUTLIER -136.17 132.76 36.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.24 0.543 . . . . 0.0 110.459 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 158' ' ' TYR . . . . . 0.495 ' OH ' ' HB3' ' E' ' 21' ' ' CYS . 5.5 m-85 -117.48 119.79 36.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.537 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 159' ' ' GLN . . . . . 0.555 ' HA ' ' HA ' ' D' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.223 0.059 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.22 64.84 1.57 Allowed 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.118 0.261 . . . . 0.0 111.033 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 58.2 m -111.12 101.06 9.61 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.487 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 4' ' ' THR . . . . . 0.497 ' O ' HG13 ' F' ' 5' ' ' VAL . 60.3 m -86.73 131.92 34.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.586 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 5' ' ' VAL . . . . . 0.497 HG13 ' O ' ' F' ' 4' ' ' THR . 0.0 OUTLIER -161.16 168.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.48 179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.13 118.82 37.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.548 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.38 -56.39 6.87 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.704 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.97 -145.36 4.66 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.877 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.02 142.0 29.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 111.311 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 44.0 t -121.58 107.36 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.18 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -88.78 110.95 21.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.421 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -87.55 113.5 23.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.759 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.16 118.63 36.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.354 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.56 175.48 39.78 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.958 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.26 162.15 41.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.957 0.408 . . . . 0.0 110.289 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.01 119.35 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.259 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 17' ' ' VAL . . . . . 0.498 HG21 ' HA ' ' F' ' 22' ' ' ALA . 0.3 OUTLIER -121.26 168.1 14.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 111.039 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 18' ' ' ASN . . . . . 0.538 ' HB2' HG21 ' E' ' 3' ' ' THR . 1.3 t-20 -68.45 -175.2 0.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.953 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 19' ' ' ALA . . . . . 0.604 ' O ' HG21 ' F' ' 65' ' ' VAL . . . -91.23 52.64 2.15 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.9 -15.72 1.33 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.351 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 21' ' ' CYS . . . . . 0.781 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER -176.87 147.61 0.61 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.987 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 22' ' ' ALA . . . . . 0.498 ' HA ' HG21 ' F' ' 17' ' ' VAL . . . -152.58 110.02 3.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 23' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' F' ' 58' ' ' LEU . 0.3 OUTLIER -52.98 159.07 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -90.36 164.49 14.31 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.613 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 25' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -57.0 -52.36 65.59 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.402 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.41 11.95 66.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.888 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 18.4 t -96.25 -30.71 13.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.911 0.386 . . . . 0.0 110.95 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 t -49.87 -71.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.299 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.54 104.31 15.19 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -112.12 140.3 46.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.122 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.72 110.12 21.44 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.123 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.12 108.44 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.165 0.507 . . . . 0.0 110.429 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.61 112.39 22.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.634 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 34' ' ' LEU . . . . . 0.542 HD21 ' CG2' ' F' ' 101' ' ' VAL . 5.3 mp -81.11 -41.83 21.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.611 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.69 -171.06 21.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.638 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 36' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 1.7 mt-30 -93.63 145.87 24.23 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.536 0.207 . . . . 0.0 110.919 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.517 HG22 ' H ' ' F' ' 38' ' ' ARG . 5.0 p -124.87 169.87 15.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.929 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 38' ' ' ARG . . . . . 0.527 ' HE ' ' HB3' ' E' ' 60' ' ' ASP . 5.2 mtt-85 -98.88 121.4 40.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.703 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 39' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' F' ' 43' ' ' ALA . 0.6 OUTLIER -61.94 -30.99 71.28 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.75 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.57 -39.33 84.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.008 0.432 . . . . 0.0 110.774 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 71.5 m -81.31 -10.32 59.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.2 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 42' ' ' LEU . . . . . 0.751 ' O ' ' HB2' ' F' ' 143' ' ' ALA . 0.6 OUTLIER -129.4 40.42 3.6 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.588 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 43' ' ' ALA . . . . . 0.612 ' HA ' ' H ' ' F' ' 143' ' ' ALA . . . -111.89 10.96 20.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.428 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.52 145.44 48.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.399 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 45' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' F' ' 140' ' ' THR . 18.1 tt0 -63.25 121.25 13.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.852 0.358 . . . . 0.0 111.095 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.97 14.44 33.91 Favored Glycine 0 C--N 1.33 0.249 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.176 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 47' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' F' ' 139' ' ' ALA . . . -72.16 121.21 18.91 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 15.1 p -130.04 133.8 46.97 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.848 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 49' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 57.9 m -112.47 -166.71 1.1 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.628 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 36.1 t -59.07 149.45 27.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.793 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.72 153.63 17.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.39 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 52' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' F' ' 135' ' ' ALA . 3.7 m -103.44 130.4 53.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.0 121.48 6.56 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.621 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 54' ' ' PHE . . . . . 0.498 ' HD1' HG23 ' F' ' 52' ' ' VAL . 52.3 p90 -153.64 136.45 15.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 110.955 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 55' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' F' ' 131' ' ' ILE . 24.8 p30 -133.56 141.33 47.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.685 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 56' ' ' ILE . . . . . 0.642 HG21 HD12 ' F' ' 131' ' ' ILE . 1.2 tt -85.15 126.49 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.634 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 57' ' ' GLN . . . . . 0.607 ' HG3' HD11 ' C' ' 74' ' ' LEU . 0.1 OUTLIER -75.83 119.38 19.74 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.752 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 58' ' ' LEU . . . . . 0.536 ' HA ' ' HA ' ' F' ' 23' ' ' VAL . 0.2 OUTLIER -130.68 87.4 2.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.29 -179.698 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 59' ' ' ASN . . . . . 0.727 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 6.8 p-10 -77.28 173.8 11.49 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.988 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 60' ' ' ASP . . . . . 0.43 ' HB2' ' HB3' ' F' ' 22' ' ' ALA . 41.6 m-20 62.78 66.47 0.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 61' ' ' CYS . . . . . 0.781 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 34.6 m -115.8 161.91 18.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.659 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 62' ' ' ASP . . . . . 0.514 ' HA ' ' OD1' ' F' ' 126' ' ' ASN . 0.2 OUTLIER -145.87 157.86 43.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.322 -179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 63' ' ' THR . . . . . 0.491 HG23 ' HA ' ' F' ' 125' ' ' ASN . 0.0 OUTLIER -107.49 -16.73 14.29 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.3 -33.75 32.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.012 0.434 . . . . 0.0 111.689 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 65' ' ' VAL . . . . . 0.604 HG21 ' O ' ' F' ' 19' ' ' ALA . 20.1 t -75.14 -41.64 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.619 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.95 146.74 29.1 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.567 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -39.3 3.73 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.863 0.363 . . . . 0.0 110.945 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.28 159.56 15.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.446 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 69' ' ' ALA . . . . . 0.603 ' HB3' ' HB ' ' F' ' 122' ' ' THR . . . -147.22 118.81 7.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.6 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 70' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -96.81 140.75 30.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.066 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 71' ' ' VAL . . . . . 0.482 HG11 HG21 ' F' ' 131' ' ' ILE . 3.1 t -118.55 139.79 44.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.713 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 72' ' ' ALA . . . . . 0.405 ' HA ' HD21 ' F' ' 111' ' ' LEU . . . -140.58 133.91 29.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.562 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 73' ' ' PHE . . . . . 0.773 ' HD2' HD13 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -101.19 138.07 38.71 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 122.338 -0.226 . . . . 0.0 111.172 179.603 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 74' ' ' LEU . . . . . 0.402 ' HB3' ' H ' ' F' ' 153' ' ' THR . 6.6 tt -101.07 91.08 4.39 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.003 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.4 -167.41 11.32 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.869 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 76' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.3 OUTLIER -116.74 159.51 22.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.611 0.243 . . . . 0.0 110.701 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 77' ' ' ALA . . . . . 0.519 ' HB2' HG23 ' F' ' 83' ' ' THR . . . -83.93 137.93 33.41 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.984 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 78' ' ' ILE . . . . . 0.459 HG22 ' O ' ' F' ' 82' ' ' HIS . 9.0 tt -77.14 -40.51 30.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.913 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 79' ' ' ASP . . . . . 0.613 ' HB2' HG21 ' F' ' 140' ' ' THR . 0.1 OUTLIER -141.22 55.24 1.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.82 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 52.94 -84.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.086 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 81' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' F' ' 79' ' ' ASP . . . -60.12 -16.02 39.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.611 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 82' ' ' HIS . . . . . 0.459 ' O ' HG22 ' F' ' 78' ' ' ILE . 24.2 m80 -100.64 56.69 0.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.912 0.386 . . . . 0.0 110.566 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 83' ' ' THR . . . . . 0.519 HG23 ' HB2' ' F' ' 77' ' ' ALA . 1.1 m -71.35 -22.47 61.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.567 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 84' ' ' ASN . . . . . 0.735 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 2.9 p30 -57.12 -18.75 16.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.409 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 85' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' F' ' 138' ' ' PHE . 11.5 t -115.15 133.42 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.25 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 86' ' ' LEU . . . . . 0.925 HD12 HD22 ' F' ' 113' ' ' LEU . 0.8 OUTLIER -73.0 154.05 40.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 87' ' ' ALA . . . . . 0.601 ' N ' HD23 ' F' ' 86' ' ' LEU . . . -90.66 -161.41 0.8 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.823 0.344 . . . . 0.0 111.778 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.24 6.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.988 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.67 -83.95 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.282 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.26 20.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.443 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 91' ' ' SER . . . . . 0.775 ' HB2' ' HB2' ' F' ' 95' ' ' SER . 1.5 m -86.65 79.37 8.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.76 -31.45 38.29 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.832 0.349 . . . . 0.0 111.665 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.09 54.41 1.73 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.621 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.89 -17.2 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.946 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 95' ' ' SER . . . . . 0.775 ' HB2' ' HB2' ' F' ' 91' ' ' SER . 0.9 OUTLIER -89.39 177.25 6.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.777 0.323 . . . . 0.0 110.672 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.83 175.18 8.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.735 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 97' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' F' ' 98' ' ' ASN . 0.2 OUTLIER -137.46 137.97 39.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.289 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 98' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' F' ' 97' ' ' THR . 74.0 m-80 71.75 17.6 5.4 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.433 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.97 149.01 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.701 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.32 -176.74 35.62 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.433 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 101' ' ' VAL . . . . . 0.542 ' CG2' HD21 ' F' ' 34' ' ' LEU . 7.7 p -125.64 111.02 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 122.976 0.51 . . . . 0.0 111.735 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 102' ' ' GLN . . . . . 0.616 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 0.9 OUTLIER -81.59 147.68 29.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.883 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 103' ' ' ILE . . . . . 0.773 HD13 ' HD2' ' F' ' 73' ' ' PHE . 0.9 OUTLIER -123.64 115.86 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.566 179.502 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 104' ' ' LEU . . . . . 0.719 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 0.4 OUTLIER -88.63 140.5 29.39 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.661 0.267 . . . . 0.0 111.076 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 105' ' ' ASP . . . . . 0.607 ' HB2' ' HB2' ' F' ' 111' ' ' LEU . 2.1 t70 -89.29 151.99 21.8 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.68 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 106' ' ' ARG . . . . . 0.62 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -71.77 -21.11 61.78 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.73 0.3 . . . . 0.0 111.054 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 107' ' ' THR . . . . . 0.6 ' HB ' ' HA ' ' F' ' 120' ' ' SER . 5.9 t -62.88 -21.87 66.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.063 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.65 -83.03 0.19 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.695 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.69 170.67 15.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.751 0.31 . . . . 0.0 111.063 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 110' ' ' ALA . . . . . 0.719 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -74.85 138.61 42.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.225 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 111' ' ' LEU . . . . . 0.607 ' HB2' ' HB2' ' F' ' 105' ' ' ASP . 5.1 tp -94.47 153.4 17.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.329 0.585 . . . . 0.0 110.531 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 112' ' ' THR . . . . . 0.785 HG22 HG21 ' F' ' 117' ' ' THR . 6.2 t -93.71 148.27 22.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.094 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 113' ' ' LEU . . . . . 0.925 HD22 HD12 ' F' ' 86' ' ' LEU . 1.4 mp -89.51 64.73 6.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.784 0.326 . . . . 0.0 110.777 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 114' ' ' ASP . . . . . 0.555 ' HB2' ' OG1' ' F' ' 117' ' ' THR . 0.5 OUTLIER -95.05 -15.96 23.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.723 0.297 . . . . 0.0 111.685 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.36 -56.21 0.57 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.691 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.59 29.07 5.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.961 0.41 . . . . 0.0 111.626 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 117' ' ' THR . . . . . 0.785 HG21 HG22 ' F' ' 112' ' ' THR . 3.4 m -87.23 65.89 9.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.069 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 118' ' ' PHE . . . . . 0.527 ' HB3' ' HB1' ' F' ' 70' ' ' ALA . 48.5 m-85 -77.68 73.39 4.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.806 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.49 70.91 0.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 120' ' ' SER . . . . . 0.6 ' HA ' ' HB ' ' F' ' 107' ' ' THR . 0.7 OUTLIER -148.68 126.06 11.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.696 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.04 53.17 2.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.205 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 122' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' F' ' 69' ' ' ALA . 0.2 OUTLIER -73.97 128.32 35.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.765 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.35 117.86 25.42 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.772 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tp -88.45 134.79 33.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.761 0.315 . . . . 0.0 110.498 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 125' ' ' ASN . . . . . 0.53 ' HB3' ' O ' ' C' ' 116' ' ' ALA . 0.3 OUTLIER -129.3 163.09 26.43 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.63 179.505 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 126' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' F' ' 62' ' ' ASP . 1.5 t30 -67.61 125.43 26.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.699 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 127' ' ' GLY . . . . . 0.661 ' HA2' HG21 ' B' ' 4' ' ' THR . . . 128.55 -141.0 12.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.707 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 128' ' ' THR . . . . . 0.727 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 6.3 m -101.74 92.44 4.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.716 0.293 . . . . 0.0 110.809 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 129' ' ' ASN . . . . . 0.529 ' HB2' ' SG ' ' F' ' 61' ' ' CYS . 1.2 t30 -76.55 144.99 39.33 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.881 0.372 . . . . 0.0 111.14 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 130' ' ' THR . . . . . 0.717 HG21 HD21 ' C' ' 74' ' ' LEU . 0.0 OUTLIER -134.61 131.76 38.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.073 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 131' ' ' ILE . . . . . 0.688 HD11 HG12 ' F' ' 156' ' ' VAL . 28.1 mt -87.31 109.81 28.66 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 132' ' ' PRO . . . . . 0.62 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.4 Cg_endo -81.67 112.16 2.38 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.617 1.544 . . . . 0.0 112.558 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.36 138.21 51.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.842 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 134' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' F' ' 52' ' ' VAL . 28.2 mt-30 -110.08 157.5 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.007 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 135' ' ' ALA . . . . . 0.672 ' HB3' HG22 ' F' ' 52' ' ' VAL . . . -152.69 107.87 3.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 111.606 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -102.47 174.37 5.93 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.378 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 137' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 0.6 OUTLIER -86.04 120.83 27.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.08 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 138' ' ' PHE . . . . . 0.516 ' HB3' HG11 ' F' ' 85' ' ' VAL . 0.2 OUTLIER -117.64 139.67 50.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.056 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 139' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' F' ' 47' ' ' ALA . . . -129.96 145.57 51.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.902 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 140' ' ' THR . . . . . 0.613 HG21 ' HB2' ' F' ' 79' ' ' ASP . 16.5 p -104.36 -53.38 2.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.511 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.73 -121.47 3.26 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.995 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.12 112.93 24.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.549 0.214 . . . . 0.0 110.649 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 143' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' F' ' 42' ' ' LEU . . . -61.73 150.88 35.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.76 0.314 . . . . 0.0 111.479 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 144' ' ' THR . . . . . 0.544 HG23 ' HD2' ' F' ' 145' ' ' PRO . 60.1 m -126.85 151.52 73.88 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.27 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 145' ' ' PRO . . . . . 0.544 ' HD2' HG23 ' F' ' 144' ' ' THR . 1.4 Cg_endo -82.96 140.14 9.96 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.573 2.182 . . . . 0.0 112.024 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.98 -138.07 6.55 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.529 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 147' ' ' ALA . . . . . 0.594 ' HA ' ' HG3' ' E' ' 15' ' ' GLU . . . -87.22 145.04 26.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.881 0.372 . . . . 0.0 111.344 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 148' ' ' ALA . . . . . 0.736 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -140.77 38.79 1.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.558 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -86.04 153.57 22.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.549 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 150' ' ' ALA . . . . . 0.599 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -161.92 171.2 18.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.997 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.41 126.79 7.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.193 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 152' ' ' ALA . . . . . 0.528 ' HB2' ' CD1' ' F' ' 86' ' ' LEU . . . -125.34 142.81 51.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.341 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 153' ' ' THR . . . . . 0.811 HG23 HG23 ' E' ' 9' ' ' THR . 0.4 OUTLIER -89.88 133.19 34.89 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 154' ' ' PHE . . . . . 0.517 ' HD1' ' HA ' ' F' ' 154' ' ' PHE . 0.0 OUTLIER -86.34 127.83 34.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.025 0.441 . . . . 0.0 110.131 -179.004 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.47 150.5 29.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.941 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 156' ' ' VAL . . . . . 0.802 HG23 HG23 ' E' ' 5' ' ' VAL . 14.5 m -136.19 144.42 33.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 111.597 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 157' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' F' ' 69' ' ' ALA . 0.0 OUTLIER -136.23 132.79 36.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.364 0.602 . . . . 0.0 110.382 -179.743 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 158' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' F' ' 21' ' ' CYS . 5.5 m-85 -117.41 119.78 36.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.563 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 159' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' E' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.867 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.516 0.198 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.17 114.5 18.43 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.414 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -97.3 119.2 35.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.664 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.654 HG23 HG22 ' B' ' 156' ' ' VAL . 19.5 m -136.58 158.25 37.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.584 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.12 115.94 22.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.607 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.63 -79.61 0.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.851 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.511 ' H ' ' HB3' ' B' ' 154' ' ' PHE . . . -148.55 -145.94 4.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.903 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.556 HG22 HG23 ' B' ' 153' ' ' THR . 15.0 p -142.05 145.14 34.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.0 0.428 . . . . 0.0 111.24 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.5 t -127.83 119.5 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.245 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.46 113.16 25.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.386 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.75 90.68 5.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.799 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.11 120.72 32.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.367 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.05 170.5 32.64 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.91 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.653 ' HG3' ' O ' ' B' ' 146' ' ' GLY . 21.4 tt0 -160.61 129.19 4.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.402 . . . . 0.0 110.364 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.792 HG13 HG13 ' B' ' 37' ' ' VAL . 2.2 t -89.66 136.95 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.191 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.771 ' O ' HG22 ' B' ' 39' ' ' THR . 34.3 m -136.37 -160.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.781 0.324 . . . . 0.0 111.134 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.95 177.08 6.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.013 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' B' ' 40' ' ' ALA . . . -90.25 49.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.064 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -122.17 -39.66 2.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.394 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.675 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -162.15 146.38 12.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.943 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.02 121.65 14.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.637 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 2.5 p -63.71 143.5 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.054 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.562 ' HB3' ' HB2' ' A' ' 27' ' ' SER . 13.5 t70 -72.9 154.62 40.5 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.581 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.446 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -54.31 -53.89 47.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.354 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.54 1.03 88.67 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.88 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.562 ' HB2' ' HB3' ' A' ' 24' ' ' ASP . 7.9 t -99.28 -16.66 18.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.879 0.371 . . . . 0.0 110.836 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 25' ' ' ALA . 10.9 t -53.18 -50.84 44.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.355 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -114.06 126.16 54.79 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.973 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.423 HE22 ' HA ' ' A' ' 56' ' ' ILE . 3.7 mt-30 -125.61 135.6 52.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.051 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.92 109.11 21.91 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.128 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.51 115.14 48.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.086 0.47 . . . . 0.0 110.475 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.17 124.72 50.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.662 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.24 -42.31 23.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.602 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.1 -165.42 12.15 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.574 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -93.57 119.21 32.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.62 0.248 . . . . 0.0 110.854 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 137' ' ' TYR . 8.2 p -104.88 133.95 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.871 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -79.93 137.65 36.93 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.667 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -49.42 75.45 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.767 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.55 -33.48 54.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.026 0.441 . . . . 0.0 110.872 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.38 61.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.114 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.622 ' O ' ' HB2' ' A' ' 143' ' ' ALA . 0.6 OUTLIER -114.04 39.82 2.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.619 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.24 33.94 3.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.396 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.664 ' HB2' ' HB2' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -124.48 142.87 50.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.346 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.22 95.69 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 0.0 111.146 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.4 33.69 5.84 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.152 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 44' ' ' GLN . . . -78.83 143.55 35.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.981 0.42 . . . . 0.0 111.958 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.507 ' HB ' ' HD2' ' A' ' 136' ' ' ARG . 18.1 p -131.67 131.93 43.55 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.902 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 1.3 m -103.78 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.548 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -57.78 141.9 47.29 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -99.07 125.51 44.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.393 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 135' ' ' ALA . 24.8 m -76.51 150.99 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.956 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.34 143.29 16.43 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.4 ' HE2' ' HB3' ' A' ' 135' ' ' ALA . 37.5 p90 -171.48 140.44 1.39 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.844 0.354 . . . . 0.0 110.925 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -136.32 138.56 41.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.582 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.534 HG23 ' O ' ' A' ' 56' ' ' ILE . 0.7 OUTLIER -88.42 116.79 30.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.554 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.85 ' HA ' HG23 ' A' ' 130' ' ' THR . 5.0 mp0 -69.36 138.31 53.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.643 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -145.6 91.66 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.287 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.529 ' HA ' HG23 ' A' ' 128' ' ' THR . 8.2 p30 -78.43 176.89 8.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.938 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.793 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.675 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 10.5 m -133.87 147.78 51.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.76 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.71 161.93 20.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.321 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.63 HG23 ' HA ' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -111.79 -34.18 6.1 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -72.54 -28.18 62.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.037 0.446 . . . . 0.0 111.718 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.18 -58.54 4.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.703 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.2 126.07 32.67 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.575 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -42.15 7.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.954 0.407 . . . . 0.0 110.943 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.24 156.83 18.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.517 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' A' ' 122' ' ' THR . . . -146.63 133.23 19.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.57 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -113.38 155.11 25.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.104 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.791 HG11 HG21 ' A' ' 131' ' ' ILE . 2.0 t -136.4 148.57 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.684 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -152.9 163.48 39.7 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.6 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.441 ' CD1' ' HB1' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -130.23 142.28 50.57 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 122.409 -0.182 . . . . 0.0 111.16 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 152' ' ' ALA . 1.4 tt -109.16 119.05 38.35 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.066 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.825 ' HA3' HD22 ' A' ' 113' ' ' LEU . . . -162.74 -161.92 12.93 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.769 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.633 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.3 OUTLIER -120.92 162.92 19.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.578 0.228 . . . . 0.0 110.779 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' A' ' 87' ' ' ALA . . . -83.57 139.08 33.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.934 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.531 HG23 ' N ' ' A' ' 79' ' ' ASP . 11.1 tt -66.09 -47.61 84.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.987 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.531 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -134.46 46.69 2.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.849 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.608 ' HB1' ' O ' ' D' ' 105' ' ' ASP . . . 64.49 -84.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.078 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.77 -36.4 40.9 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.603 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.43 69.2 10.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.888 0.375 . . . . 0.0 110.523 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -74.1 -7.51 52.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.487 -179.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.625 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 30.0 p-10 -74.74 -25.39 59.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.334 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 138' ' ' PHE . 6.4 t -104.92 143.84 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.169 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.611 ' HG ' HD13 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -74.8 160.86 30.17 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.338 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.688 ' HB2' ' O ' ' A' ' 77' ' ' ALA . . . -103.64 179.85 4.15 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.874 0.369 . . . . 0.0 111.712 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.717 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 1.3 mm? -66.58 171.29 5.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.045 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.562 ' HG3' ' HB2' ' A' ' 149' ' ' ASN . 1.3 mm-40 -68.61 -83.7 0.03 OUTLIER 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.265 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.412 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 6.0 p -169.12 19.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.959 0.409 . . . . 0.0 111.451 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.542 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 3.2 m -90.16 86.28 6.5 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' D' ' 50' ' ' SER . . . -61.16 -24.99 66.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.631 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.4 41.25 3.52 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.66 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.96 0.69 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.858 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.85 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 1.9 m -89.26 -173.59 4.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.773 0.321 . . . . 0.0 110.71 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.425 ' HB3' HD11 ' A' ' 88' ' ' LEU . . . -100.99 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 99' ' ' VAL . 3.0 m -131.06 123.92 29.72 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.299 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.21 29.43 18.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.459 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 97' ' ' THR . 1.7 t -125.31 129.33 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.835 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.85 -171.06 21.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.522 ' CG2' ' HB1' ' A' ' 135' ' ' ALA . 1.9 p -122.97 116.71 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.204 0.526 . . . . 0.0 111.69 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.55 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 2.8 tt0 -81.74 151.45 27.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.915 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.82 123.84 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.531 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.655 HD13 ' NE2' ' A' ' 134' ' ' GLN . 0.5 OUTLIER -104.72 125.18 50.55 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.658 0.266 . . . . 0.0 111.013 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.805 ' HB3' HG22 ' A' ' 107' ' ' THR . 13.6 t0 -77.57 143.07 38.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.672 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.697 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -62.73 -14.86 49.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.742 0.306 . . . . 0.0 111.043 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.805 HG22 ' HB3' ' A' ' 105' ' ' ASP . 8.8 t -63.04 -20.94 65.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.012 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.28 -43.57 1.36 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.735 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.69 160.71 14.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.767 0.318 . . . . 0.0 111.082 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.36 133.16 40.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.125 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.659 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 12.3 tp -95.54 160.94 14.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.373 0.606 . . . . 0.0 110.531 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 2.9 t -110.21 136.81 48.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.076 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.825 HD22 ' HA3' ' A' ' 75' ' ' GLY . 1.4 mt -70.25 89.64 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.76 0.314 . . . . 0.0 110.689 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -18.43 6.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.487 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -62.25 0.88 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.664 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.566 ' HB3' ' OD1' ' D' ' 129' ' ' ASN . . . -92.95 18.23 9.43 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.993 0.425 . . . . 0.0 111.659 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.548 HG21 HG23 ' A' ' 112' ' ' THR . 0.0 OUTLIER -83.97 72.58 10.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.065 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.604 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 78.4 m-85 -92.32 89.77 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.799 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 54.6 m -130.56 73.11 1.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.91 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.21 142.32 21.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.682 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.98 68.56 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.208 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.642 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -81.51 133.14 35.35 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.684 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.7 m -87.6 124.13 33.19 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.681 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.3 119.32 35.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.648 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.63 ' HA ' HG23 ' A' ' 63' ' ' THR . 2.9 m120 -113.71 171.91 7.29 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.587 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.48 109.75 16.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.647 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.82 -133.8 4.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.714 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.529 HG23 ' HA ' ' A' ' 59' ' ' ASN . 46.1 m -110.5 86.75 2.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.742 0.306 . . . . 0.0 110.794 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -69.34 155.07 41.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.829 0.347 . . . . 0.0 111.162 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.85 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -142.79 137.07 29.44 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.089 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.791 HG21 HG11 ' A' ' 71' ' ' VAL . 6.9 mt -100.25 109.12 55.66 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.697 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.5 Cg_endo -81.76 148.25 15.67 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.721 1.614 . . . . 0.0 112.536 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.413 ' CZ ' ' HA ' ' A' ' 105' ' ' ASP . 0.5 OUTLIER -158.82 145.31 17.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.908 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.655 ' NE2' HD13 ' A' ' 104' ' ' LEU . 5.2 mt-30 -111.24 160.4 17.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.024 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.766 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -155.98 97.82 1.84 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.951 0.405 . . . . 0.0 111.613 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.507 ' HD2' ' HB ' ' A' ' 48' ' ' THR . 14.4 ptt180 -101.57 173.61 6.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.41 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 1.8 m-85 -83.64 135.04 34.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.134 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.602 ' HB3' HG11 ' A' ' 85' ' ' VAL . 1.7 t80 -128.86 128.18 43.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.022 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.454 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -108.52 138.0 45.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.817 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.529 HG21 ' HB2' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -89.94 -9.56 48.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.494 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.31 -95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.963 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.71 101.49 11.33 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.513 0.197 . . . . 0.0 110.737 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 42' ' ' LEU . . . -61.36 144.35 54.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.749 0.309 . . . . 0.0 111.378 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.602 ' CG2' ' CD ' ' A' ' 145' ' ' PRO . 99.2 m -123.94 153.15 67.42 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.22 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.602 ' CD ' ' CG2' ' A' ' 144' ' ' THR . 1.3 Cg_endo -83.01 144.78 12.14 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.523 2.149 . . . . 0.0 111.989 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.3 -116.09 0.7 Allowed Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.503 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.85 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -119.73 132.37 55.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.892 0.377 . . . . 0.0 111.361 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.37 43.36 3.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.13 0.491 . . . . 0.0 110.414 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.562 ' HB2' ' HG3' ' A' ' 89' ' ' GLN . 1.1 m120 -95.68 150.88 19.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.586 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.507 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -168.5 -178.63 3.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.017 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.78 153.0 39.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.238 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -141.22 151.12 43.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.239 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.66 133.73 54.55 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.71 148.72 28.82 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.093 0.473 . . . . 0.0 110.112 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 118' ' ' PHE . 11.2 mmtt -135.02 139.43 44.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.949 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.403 HG12 ' CD1' ' A' ' 131' ' ' ILE . 3.1 m -134.52 141.3 43.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.778 0.323 . . . . 0.0 111.685 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.547 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 3.8 tt0 -128.78 128.97 45.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.318 0.58 . . . . 0.0 110.358 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.71 128.59 51.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.565 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.33 0.109 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.37 88.99 0.04 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.588 0.232 . . . . 0.0 111.022 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.18 114.49 18.41 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.402 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -97.31 119.19 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.65 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.654 HG23 HG22 ' C' ' 156' ' ' VAL . 19.4 m -136.58 158.24 37.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.525 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.16 115.99 22.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.552 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.64 -79.61 0.13 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.873 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.514 ' H ' ' HB3' ' C' ' 154' ' ' PHE . . . -148.56 -145.9 4.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.879 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.561 HG22 HG23 ' C' ' 153' ' ' THR . 14.9 p -142.11 145.12 33.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.052 0.453 . . . . 0.0 111.225 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 32.5 t -127.8 119.51 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.267 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.44 113.14 25.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.377 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.7 90.72 5.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.814 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.15 120.71 32.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.337 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.02 170.48 32.62 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.908 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.642 ' HG3' ' O ' ' C' ' 146' ' ' GLY . 21.4 tt0 -160.59 129.19 4.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.975 0.417 . . . . 0.0 110.395 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.809 HG13 HG13 ' C' ' 37' ' ' VAL . 2.2 t -89.66 136.93 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.226 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.753 ' O ' HG22 ' C' ' 39' ' ' THR . 34.3 m -136.35 -160.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.785 0.326 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.93 177.02 6.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.977 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' C' ' 40' ' ' ALA . . . -90.21 49.67 1.73 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.053 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' B' ' 61' ' ' CYS . . . -122.19 -39.67 2.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.437 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.701 ' HG ' ' HG ' ' B' ' 61' ' ' CYS . 0.5 OUTLIER -162.13 146.38 12.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.959 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.04 121.62 14.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.623 ' HA ' ' HG ' ' B' ' 58' ' ' LEU . 2.4 p -63.71 143.54 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.037 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.561 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 13.6 t70 -72.94 154.65 40.46 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.582 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.439 ' O ' HG23 ' B' ' 28' ' ' VAL . . . -54.33 -53.88 47.86 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.341 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.55 1.05 88.65 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.868 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.561 ' HB2' ' HB3' ' B' ' 24' ' ' ASP . 7.9 t -99.29 -16.68 18.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.872 0.367 . . . . 0.0 110.826 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 25' ' ' ALA . 10.7 t -53.14 -50.85 43.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.377 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -114.08 126.19 54.82 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.972 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' GLN . . . . . 0.43 HE22 ' HA ' ' B' ' 56' ' ' ILE . 3.7 mt-30 -125.61 135.57 52.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.064 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.92 109.17 21.95 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.117 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.57 115.16 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 0.0 110.463 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.2 124.74 50.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.631 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.26 -42.34 23.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.596 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.13 -165.34 12.14 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.557 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 3.7 mt-30 -93.65 119.24 32.42 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.64 0.257 . . . . 0.0 110.834 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.792 HG13 HG13 ' A' ' 16' ' ' VAL . 8.2 p -104.91 133.94 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.87 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' B' ' 41' ' ' SER . 0.1 OUTLIER -79.92 137.62 36.93 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.668 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -62.53 -49.38 75.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.762 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . . . -53.52 -33.5 54.74 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.01 0.433 . . . . 0.0 110.865 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' B' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.33 61.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.112 -179.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' B' ' 143' ' ' ALA . 0.6 OUTLIER -114.07 39.81 2.64 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.613 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.2 33.96 3.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.448 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 0.667 ' HB2' ' HB2' ' B' ' 47' ' ' ALA . 0.3 OUTLIER -124.48 142.88 50.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.344 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.25 95.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.371 . . . . 0.0 111.148 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.43 33.63 5.85 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.139 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' B' ' 44' ' ' GLN . . . -78.87 143.5 35.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.418 . . . . 0.0 111.949 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.494 ' HB ' ' HD2' ' B' ' 136' ' ' ARG . 18.1 p -131.61 131.9 43.62 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.895 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 1.3 m -103.75 -167.22 1.34 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.572 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -57.82 141.91 47.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.863 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.465 ' HB2' ' HB3' ' B' ' 136' ' ' ARG . . . -99.05 125.52 44.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.377 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.773 HG22 ' O ' ' B' ' 135' ' ' ALA . 24.8 m -76.53 151.0 6.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.961 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.36 143.28 16.44 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.527 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -171.47 140.44 1.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.801 0.334 . . . . 0.0 110.936 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -136.33 138.6 41.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.571 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.542 HG23 ' O ' ' B' ' 56' ' ' ILE . 0.7 OUTLIER -88.45 116.79 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.542 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . 0.842 ' HA ' HG23 ' B' ' 130' ' ' THR . 5.0 mp0 -69.38 138.31 53.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.802 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.643 ' HB3' ' SG ' ' B' ' 21' ' ' CYS . 0.3 OUTLIER -145.58 91.67 2.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.276 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.525 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 8.2 p30 -78.43 176.86 8.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.912 0.387 . . . . 0.0 110.915 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.92 81.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' CYS . . . . . 0.701 ' HG ' ' HG ' ' B' ' 21' ' ' CYS . 10.4 m -133.85 147.8 51.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.78 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.7 161.91 20.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.349 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.644 HG23 ' HA ' ' B' ' 125' ' ' ASN . 0.0 OUTLIER -111.75 -34.19 6.1 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -72.52 -28.2 62.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.072 0.463 . . . . 0.0 111.735 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.18 -58.56 4.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.658 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.22 126.06 32.62 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.592 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.39 -42.09 7.13 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.956 0.407 . . . . 0.0 110.954 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . 0.441 ' HD2' ' HA ' ' B' ' 68' ' ' LYS . 1.2 tptp -89.28 156.8 18.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.465 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.651 ' HB3' ' HB ' ' B' ' 122' ' ' THR . . . -146.61 133.21 19.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.609 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -113.35 155.11 25.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.137 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.763 HG11 HG21 ' B' ' 131' ' ' ILE . 2.0 t -136.39 148.53 27.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.725 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' B' ' 155' ' ' LYS . . . -152.9 163.51 39.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.553 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.441 ' CD1' ' HB1' ' B' ' 152' ' ' ALA . 0.2 OUTLIER -130.23 142.25 50.58 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 122.411 -0.181 . . . . 0.0 111.207 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' B' ' 152' ' ' ALA . 1.4 tt -109.12 119.05 38.36 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.053 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . 0.793 ' HA3' HD22 ' B' ' 113' ' ' LEU . . . -162.74 -161.9 12.89 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.757 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.64 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.3 OUTLIER -120.97 162.92 19.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.59 0.233 . . . . 0.0 110.788 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.694 ' O ' ' HB2' ' B' ' 87' ' ' ALA . . . -83.54 139.08 33.1 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.936 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.538 HG23 ' N ' ' B' ' 79' ' ' ASP . 11.1 tt -66.09 -47.64 84.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.973 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.542 ' HB2' HG21 ' B' ' 140' ' ' THR . 0.2 OUTLIER -134.42 46.69 2.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.891 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' E' ' 105' ' ' ASP . . . 64.48 -83.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.096 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.79 -36.42 41.17 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.576 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.4 69.19 10.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.541 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' THR . . . . . 0.477 HG23 ' HB2' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -74.08 -7.53 52.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.549 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . 0.603 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 30.1 p-10 -74.69 -25.4 59.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.383 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.6 HG11 ' HB3' ' B' ' 138' ' ' PHE . 6.4 t -104.92 143.88 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.17 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.6 ' HG ' HD13 ' B' ' 113' ' ' LEU . 0.3 OUTLIER -74.84 160.89 30.11 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.265 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' B' ' 77' ' ' ALA . . . -103.66 179.88 4.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.861 0.363 . . . . 0.0 111.702 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.699 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 1.3 mm? -66.59 171.3 5.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.038 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . 0.563 ' HG3' ' HB2' ' B' ' 149' ' ' ASN . 1.3 mm-40 -68.57 -83.75 0.03 OUTLIER 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.275 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . 0.409 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 5.9 p -169.11 19.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.907 0.384 . . . . 0.0 111.426 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' SER . . . . . 0.535 ' HA ' ' HB2' ' D' ' 25' ' ' ALA . 3.2 m -90.13 86.26 6.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.505 ' HB2' HG13 ' E' ' 52' ' ' VAL . . . -61.1 -25.03 66.68 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.652 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.42 41.31 3.5 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.638 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.03 0.72 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.828 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' SER . . . . . 0.846 ' HA ' ' HB3' ' B' ' 147' ' ' ALA . 1.9 m -89.28 -173.58 4.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.784 0.326 . . . . 0.0 110.71 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . 0.418 ' HB3' HD11 ' B' ' 88' ' ' LEU . . . -100.97 -177.3 3.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.409 ' O ' HG23 ' B' ' 99' ' ' VAL . 3.0 m -131.03 123.94 29.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.301 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 61.18 29.46 18.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.462 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 97' ' ' THR . 1.7 t -125.31 129.33 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.86 -171.15 21.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.515 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' B' ' 86' ' ' LEU . 1.9 p -122.89 116.72 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.208 0.528 . . . . 0.0 111.682 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 2.8 tt0 -81.77 151.46 27.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.923 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.83 123.82 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.511 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . 0.659 HD13 ' NE2' ' B' ' 134' ' ' GLN . 0.5 OUTLIER -104.68 125.17 50.52 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.645 0.26 . . . . 0.0 111.041 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . 0.8 ' HB3' HG22 ' B' ' 107' ' ' THR . 13.6 t0 -77.61 143.12 38.5 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.659 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . 0.719 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -62.75 -14.88 49.93 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.722 0.296 . . . . 0.0 111.048 179.45 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.8 HG22 ' HB3' ' B' ' 105' ' ' ASP . 8.8 t -62.97 -20.96 65.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.024 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.3 -43.57 1.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.729 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.7 160.71 14.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.327 . . . . 0.0 111.088 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.35 133.18 40.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.122 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.66 ' HB2' ' HB2' ' B' ' 105' ' ' ASP . 12.3 tp -95.56 160.9 14.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.401 0.619 . . . . 0.0 110.469 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 2.9 t -110.19 136.8 48.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.075 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.793 HD22 ' HA3' ' B' ' 75' ' ' GLY . 1.4 mt -70.22 89.59 0.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.764 0.316 . . . . 0.0 110.655 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.34 -18.46 6.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.509 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.3 -62.27 0.87 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.645 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . 0.568 ' HB3' ' OD1' ' E' ' 129' ' ' ASN . . . -92.95 18.23 9.44 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.023 0.44 . . . . 0.0 111.668 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . 0.546 HG21 HG23 ' B' ' 112' ' ' THR . 0.0 OUTLIER -83.91 72.53 10.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.039 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.588 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . 78.3 m-85 -92.35 89.8 6.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.775 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 55.1 m -130.58 73.15 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.23 142.29 21.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.691 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -103.96 68.55 0.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.194 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.651 ' HB ' ' HB3' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -81.43 133.16 35.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.72 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 8.7 m -87.61 124.14 33.21 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.687 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.33 119.34 35.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.633 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.644 ' HA ' HG23 ' B' ' 63' ' ' THR . 2.9 m120 -113.74 171.94 7.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.573 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.5 109.76 16.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.646 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.8 -133.79 4.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.712 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 46.4 m -110.53 86.75 2.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.759 0.314 . . . . 0.0 110.807 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.32 155.05 41.06 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.222 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.842 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -142.76 137.1 29.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.092 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' ILE . . . . . 0.763 HG21 HG11 ' B' ' 71' ' ' VAL . 6.9 mt -100.26 109.07 55.53 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' PRO . . . . . 0.719 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.73 148.26 15.73 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 121.666 1.577 . . . . 0.0 112.543 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' B' ' 105' ' ' ASP . 0.5 OUTLIER -158.8 145.32 17.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.921 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' GLN . . . . . 0.659 ' NE2' HD13 ' B' ' 104' ' ' LEU . 5.2 mt-30 -111.24 160.4 17.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.034 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.773 ' O ' HG22 ' B' ' 52' ' ' VAL . . . -156.0 97.79 1.84 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.956 0.408 . . . . 0.0 111.589 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . 0.494 ' HD2' ' HB ' ' B' ' 48' ' ' THR . 14.4 ptt180 -101.54 173.59 6.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.405 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 1.8 m-85 -83.62 135.04 34.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.181 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . 0.6 ' HB3' HG11 ' B' ' 85' ' ' VAL . 1.8 t80 -128.88 128.18 43.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.988 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.462 ' HB2' HD23 ' B' ' 42' ' ' LEU . . . -108.53 138.0 45.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.86 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' THR . . . . . 0.542 HG21 ' HB2' ' B' ' 79' ' ' ASP . 0.3 OUTLIER -89.96 -9.55 48.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.478 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.3 -95.23 0.1 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.951 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.74 101.52 11.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.514 0.197 . . . . 0.0 110.744 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 42' ' ' LEU . . . -61.39 144.35 54.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.73 0.3 . . . . 0.0 111.379 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.598 ' CG2' ' CD ' ' B' ' 145' ' ' PRO . 99.2 m -123.95 153.17 67.47 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.196 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . 0.598 ' CD ' ' CG2' ' B' ' 144' ' ' THR . 1.3 Cg_endo -83.04 144.78 12.11 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.519 2.146 . . . . 0.0 112.006 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . 0.653 ' O ' ' HG3' ' A' ' 15' ' ' GLU . . . 157.3 -116.09 0.7 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.494 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.846 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -119.75 132.4 55.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.903 0.382 . . . . 0.0 111.316 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' ALA . . . . . 0.606 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -125.39 43.33 3.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.16 0.505 . . . . 0.0 110.417 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.563 ' HB2' ' HG3' ' B' ' 89' ' ' GLN . 1.1 m120 -95.65 150.88 19.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.573 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.512 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -168.49 -178.63 3.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.03 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.77 152.98 39.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.261 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -141.2 151.11 43.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.264 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.556 HG23 HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -112.69 133.75 54.56 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' PHE . . . . . 0.511 ' HB3' ' H ' ' A' ' 8' ' ' GLY . 0.1 OUTLIER -81.65 148.68 28.91 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.053 0.454 . . . . 0.0 110.158 -179.062 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . 0.555 ' HB3' ' CZ ' ' B' ' 118' ' ' PHE . 11.2 mmtt -135.03 139.49 44.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.928 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' VAL . . . . . 0.654 HG22 HG23 ' A' ' 5' ' ' VAL . 3.1 m -134.55 141.27 43.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.776 0.322 . . . . 0.0 111.698 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.537 ' HB3' ' HB3' ' B' ' 70' ' ' ALA . 3.9 tt0 -128.79 128.96 45.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.346 0.593 . . . . 0.0 110.353 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.72 128.62 51.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.583 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.841 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.261 0.077 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.4 88.97 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.004 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.19 114.48 18.39 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.436 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -97.26 119.19 35.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.644 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.635 HG23 HG22 ' D' ' 156' ' ' VAL . 19.5 m -136.56 158.26 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.63 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.15 115.99 22.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.578 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.66 -79.58 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.876 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . 0.512 ' H ' ' HB3' ' D' ' 154' ' ' PHE . . . -148.55 -145.97 4.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.898 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . 0.564 HG22 HG23 ' D' ' 153' ' ' THR . 15.2 p -142.03 145.12 34.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.956 0.408 . . . . 0.0 111.32 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 32.0 t -127.82 119.53 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.26 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.43 113.17 25.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.391 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -95.75 90.66 5.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.792 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.1 120.73 32.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.357 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.04 170.48 32.63 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.918 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' GLU . . . . . 0.653 ' HG3' ' O ' ' D' ' 146' ' ' GLY . 21.4 tt0 -160.6 129.19 4.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.987 0.423 . . . . 0.0 110.368 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.778 HG13 HG13 ' D' ' 37' ' ' VAL . 2.2 t -89.66 136.91 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.246 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.767 ' O ' HG22 ' D' ' 39' ' ' THR . 34.3 m -136.35 -160.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.767 0.318 . . . . 0.0 111.147 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.98 177.01 6.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.998 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' D' ' 40' ' ' ALA . . . -90.16 49.59 1.73 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.038 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' C' ' 61' ' ' CYS . . . -122.16 -39.69 2.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.398 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' CYS . . . . . 0.707 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.5 OUTLIER -162.13 146.39 12.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.943 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.05 121.61 14.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.141 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . 0.616 ' HA ' ' HG ' ' C' ' 58' ' ' LEU . 2.4 p -63.67 143.5 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.049 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' C' ' 27' ' ' SER . 13.5 t70 -72.88 154.6 40.52 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.597 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -54.3 -53.88 47.84 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.345 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.56 1.03 88.71 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.874 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . 0.572 ' HB2' ' HB3' ' C' ' 24' ' ' ASP . 7.9 t -99.3 -16.63 18.41 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.879 0.371 . . . . 0.0 110.842 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.445 HG23 ' O ' ' C' ' 25' ' ' ALA . 10.8 t -53.18 -50.83 44.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.35 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -114.07 126.19 54.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.98 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' GLN . . . . . 0.43 HE22 ' HA ' ' C' ' 56' ' ' ILE . 3.7 mt-30 -125.64 135.58 52.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.063 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.91 109.11 21.9 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.13 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.5 115.15 48.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.132 0.491 . . . . 0.0 110.464 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.17 124.73 50.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.667 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.26 -42.28 23.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.584 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.08 -165.39 12.15 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.583 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . 0.588 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 3.7 mt-30 -93.62 119.2 32.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.626 0.25 . . . . 0.0 110.841 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.809 HG13 HG13 ' B' ' 16' ' ' VAL . 8.2 p -104.86 133.95 47.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.897 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' C' ' 41' ' ' SER . 0.1 OUTLIER -79.9 137.65 36.95 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.689 179.271 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.753 HG22 ' O ' ' B' ' 17' ' ' VAL . 0.2 OUTLIER -62.51 -49.43 75.37 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.75 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' B' ' 19' ' ' ALA . . . -53.56 -33.48 54.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.994 0.426 . . . . 0.0 110.837 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' C' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.31 61.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.11 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.622 ' O ' ' HB2' ' C' ' 143' ' ' ALA . 0.6 OUTLIER -114.12 39.84 2.64 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.642 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.24 33.95 3.28 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.386 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . 0.672 ' HB2' ' HB2' ' C' ' 47' ' ' ALA . 0.3 OUTLIER -124.51 142.92 50.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.289 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.26 95.7 0.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.145 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.41 33.72 5.83 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.126 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' C' ' 44' ' ' GLN . . . -78.93 143.52 35.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.976 0.417 . . . . 0.0 111.928 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' C' ' 136' ' ' ARG . 18.1 p -131.63 131.94 43.62 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.884 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.532 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 1.3 m -103.82 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.524 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -57.76 141.86 47.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . 0.489 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . . . -99.03 125.48 44.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.379 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.77 HG22 ' O ' ' C' ' 135' ' ' ALA . 24.7 m -76.51 150.98 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.956 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.3 143.27 16.41 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.572 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . 0.408 ' HE2' ' HB3' ' C' ' 135' ' ' ALA . 37.5 p90 -171.49 140.45 1.39 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.771 0.319 . . . . 0.0 110.895 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -136.33 138.62 41.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.541 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.541 HG23 ' O ' ' C' ' 56' ' ' ILE . 0.7 OUTLIER -88.47 116.77 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.554 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.846 ' HA ' HG23 ' C' ' 130' ' ' THR . 5.0 mp0 -69.33 138.29 53.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.794 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . 0.635 ' HB3' ' SG ' ' C' ' 21' ' ' CYS . 0.3 OUTLIER -145.62 91.65 2.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.281 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . 0.521 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 8.2 p30 -78.46 176.86 8.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.946 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.81 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' CYS . . . . . 0.707 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 10.4 m -133.87 147.74 51.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.798 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.67 161.92 20.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.341 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.633 HG23 ' HA ' ' C' ' 125' ' ' ASN . 0.0 OUTLIER -111.77 -34.19 6.1 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -72.59 -28.14 62.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.045 0.45 . . . . 0.0 111.725 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -73.15 -58.55 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.733 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.21 126.07 32.64 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.58 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.33 -42.19 7.1 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.964 0.411 . . . . 0.0 110.938 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' C' ' 68' ' ' LYS . 1.2 tptp -89.22 156.85 18.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.502 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.64 ' HB3' ' HB ' ' C' ' 122' ' ' THR . . . -146.65 133.18 19.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.596 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.602 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -113.31 155.11 25.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.165 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . 0.752 HG11 HG21 ' C' ' 131' ' ' ILE . 2.0 t -136.4 148.54 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.7 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' C' ' 155' ' ' LYS . . . -152.88 163.49 39.68 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.579 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' PHE . . . . . 0.438 ' CD1' ' HB1' ' C' ' 152' ' ' ALA . 0.2 OUTLIER -130.24 142.28 50.57 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.468 0.175 . . . . 0.0 111.197 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' C' ' 152' ' ' ALA . 1.4 tt -109.17 119.04 38.33 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.052 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . 0.83 ' HA3' HD22 ' C' ' 113' ' ' LEU . . . -162.74 -161.82 12.79 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.736 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.631 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.3 OUTLIER -121.04 162.91 19.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.624 0.25 . . . . 0.0 110.762 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . 0.7 ' O ' ' HB2' ' C' ' 87' ' ' ALA . . . -83.54 139.08 33.1 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.933 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . 0.542 HG23 ' N ' ' C' ' 79' ' ' ASP . 11.1 tt -66.08 -47.59 84.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.94 0.4 . . . . 0.0 111.007 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' ASP . . . . . 0.542 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.2 OUTLIER -134.45 46.62 2.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.862 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' F' ' 105' ' ' ASP . . . 64.49 -84.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.075 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.75 -36.39 40.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.61 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.5 69.24 10.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.924 0.393 . . . . 0.0 110.51 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . 0.484 HG23 ' HB2' ' C' ' 77' ' ' ALA . 0.2 OUTLIER -74.13 -7.49 52.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.51 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' ASN . . . . . 0.621 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 30.0 p-10 -74.7 -25.4 59.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.36 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.612 HG11 ' HB3' ' C' ' 138' ' ' PHE . 6.4 t -104.92 143.81 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.148 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.596 ' HG ' HD13 ' C' ' 113' ' ' LEU . 0.3 OUTLIER -74.78 160.88 30.16 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.308 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' C' ' 77' ' ' ALA . . . -103.67 179.87 4.15 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.897 0.379 . . . . 0.0 111.685 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.708 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 1.3 mm? -66.58 171.29 5.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' GLN . . . . . 0.536 ' HG3' ' HB2' ' C' ' 149' ' ' ASN . 1.3 mm-40 -68.61 -83.74 0.03 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.279 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' SER . . . . . 0.413 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 5.9 p -169.08 19.14 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.941 0.4 . . . . 0.0 111.426 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' SER . . . . . 0.537 ' HA ' ' HB2' ' E' ' 25' ' ' ALA . 3.3 m -90.15 86.26 6.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.897 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' F' ' 50' ' ' SER . . . -61.13 -25.01 66.69 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.637 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.39 41.22 3.53 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.669 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.0 0.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.87 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' SER . . . . . 0.834 ' HA ' ' HB3' ' C' ' 147' ' ' ALA . 1.9 m -89.24 -173.58 4.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.813 0.34 . . . . 0.0 110.691 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' ALA . . . . . 0.409 ' HB3' HD11 ' C' ' 88' ' ' LEU . . . -100.98 -177.25 3.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 3.0 m -131.11 123.96 29.73 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.303 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.17 29.46 18.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.467 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 1.7 t -125.32 129.35 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.818 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.84 -171.04 21.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.508 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' C' ' 86' ' ' LEU . 1.9 p -122.97 116.73 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.213 0.53 . . . . 0.0 111.679 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 102' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 2.8 tt0 -81.75 151.42 27.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.936 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.8 123.81 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.563 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' LEU . . . . . 0.658 HD13 ' NE2' ' C' ' 134' ' ' GLN . 0.5 OUTLIER -104.69 125.17 50.53 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.638 0.256 . . . . 0.0 111.002 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . 0.799 ' HB3' HG22 ' C' ' 107' ' ' THR . 13.6 t0 -77.58 143.05 38.62 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.695 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 106' ' ' ARG . . . . . 0.712 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -62.64 -14.94 49.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.757 0.313 . . . . 0.0 111.063 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 107' ' ' THR . . . . . 0.799 HG22 ' HB3' ' C' ' 105' ' ' ASP . 8.8 t -62.96 -20.97 65.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.27 -43.58 1.36 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.727 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.71 160.71 14.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.789 0.328 . . . . 0.0 111.08 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.37 133.16 40.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.085 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 111' ' ' LEU . . . . . 0.667 ' HB2' ' HB2' ' C' ' 105' ' ' ASP . 12.3 tp -95.5 160.94 14.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.378 0.608 . . . . 0.0 110.554 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 112' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 2.9 t -110.22 136.79 48.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.068 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.83 HD22 ' HA3' ' C' ' 75' ' ' GLY . 1.4 mt -70.22 89.61 0.65 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.751 0.31 . . . . 0.0 110.685 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.34 -18.44 6.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.472 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.32 -62.24 0.87 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.683 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 116' ' ' ALA . . . . . 0.564 ' HB3' ' OD1' ' F' ' 129' ' ' ASN . . . -92.94 18.21 9.45 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 121.042 0.448 . . . . 0.0 111.696 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . 0.545 HG21 HG23 ' C' ' 112' ' ' THR . 0.0 OUTLIER -83.98 72.59 10.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.049 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 118' ' ' PHE . . . . . 0.602 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . 78.1 m-85 -92.37 89.75 6.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.765 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 55.1 m -130.54 73.12 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.938 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.22 142.28 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.651 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -103.98 68.51 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.199 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -81.43 133.13 35.36 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.71 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 8.6 m -87.6 124.12 33.18 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.697 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.3 119.29 35.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.655 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 125' ' ' ASN . . . . . 0.633 ' HA ' HG23 ' C' ' 63' ' ' THR . 2.9 m120 -113.69 171.9 7.3 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.586 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.48 109.72 16.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.618 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.85 -133.79 4.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.714 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 128' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 46.4 m -110.52 86.78 2.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.722 0.296 . . . . 0.0 110.779 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 129' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.38 155.06 41.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.866 0.365 . . . . 0.0 111.143 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 130' ' ' THR . . . . . 0.846 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -142.79 137.09 29.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.086 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 131' ' ' ILE . . . . . 0.752 HG21 HG11 ' C' ' 71' ' ' VAL . 6.9 mt -100.3 109.13 55.81 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 132' ' ' PRO . . . . . 0.712 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.5 Cg_endo -81.76 148.25 15.68 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.668 1.579 . . . . 0.0 112.546 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' C' ' 105' ' ' ASP . 0.5 OUTLIER -158.81 145.27 17.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.933 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 134' ' ' GLN . . . . . 0.658 ' NE2' HD13 ' C' ' 104' ' ' LEU . 5.2 mt-30 -111.23 160.41 17.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.052 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . 0.77 ' O ' HG22 ' C' ' 52' ' ' VAL . . . -155.97 97.81 1.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.945 0.402 . . . . 0.0 111.609 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.495 ' HD2' ' HB ' ' C' ' 48' ' ' THR . 14.4 ptt180 -101.57 173.59 6.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.4 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 137' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 1.8 m-85 -83.66 135.04 34.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.121 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 138' ' ' PHE . . . . . 0.612 ' HB3' HG11 ' C' ' 85' ' ' VAL . 1.8 t80 -128.86 128.16 43.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.235 0.541 . . . . 0.0 112.01 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 139' ' ' ALA . . . . . 0.473 ' HB2' HD23 ' C' ' 42' ' ' LEU . . . -108.5 138.01 45.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.83 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 140' ' ' THR . . . . . 0.542 HG21 ' HB2' ' C' ' 79' ' ' ASP . 0.3 OUTLIER -90.0 -9.54 48.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.458 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.3 -95.25 0.1 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.0 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.74 101.49 11.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.51 0.195 . . . . 0.0 110.704 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 143' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' C' ' 42' ' ' LEU . . . -61.36 144.36 54.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.758 0.313 . . . . 0.0 111.368 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 144' ' ' THR . . . . . 0.597 ' CG2' ' CD ' ' C' ' 145' ' ' PRO . 99.2 m -123.96 153.14 67.5 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.211 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 145' ' ' PRO . . . . . 0.597 ' CD ' ' CG2' ' C' ' 144' ' ' THR . 1.3 Cg_endo -82.99 144.78 12.17 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.49 2.127 . . . . 0.0 111.999 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 146' ' ' GLY . . . . . 0.642 ' O ' ' HG3' ' B' ' 15' ' ' GLU . . . 157.3 -116.09 0.7 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.468 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 147' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -119.72 132.37 55.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 111.387 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 148' ' ' ALA . . . . . 0.634 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -125.38 43.36 3.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.136 0.493 . . . . 0.0 110.383 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 149' ' ' ASN . . . . . 0.536 ' HB2' ' HG3' ' C' ' 89' ' ' GLN . 1.1 m120 -95.68 150.86 19.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.635 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 150' ' ' ALA . . . . . 0.506 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -168.45 -178.65 3.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.012 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.76 153.0 39.71 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.274 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 152' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -141.21 151.12 43.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.243 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . 0.561 HG23 HG22 ' B' ' 9' ' ' THR . 0.2 OUTLIER -112.69 133.76 54.55 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 154' ' ' PHE . . . . . 0.514 ' HB3' ' H ' ' B' ' 8' ' ' GLY . 0.1 OUTLIER -81.71 148.68 28.84 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.036 0.446 . . . . 0.0 110.136 -179.05 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 155' ' ' LYS . . . . . 0.556 ' HB3' ' CZ ' ' C' ' 118' ' ' PHE . 11.2 mmtt -135.01 139.43 44.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.945 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 156' ' ' VAL . . . . . 0.654 HG22 HG23 ' B' ' 5' ' ' VAL . 3.1 m -134.52 141.3 43.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.82 0.343 . . . . 0.0 111.685 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 157' ' ' GLN . . . . . 0.559 ' HB3' ' HB3' ' C' ' 70' ' ' ALA . 3.9 tt0 -128.78 129.0 45.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.326 0.584 . . . . 0.0 110.34 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.7 128.6 51.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.563 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.834 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.331 0.11 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.41 88.94 0.04 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.567 0.222 . . . . 0.0 111.024 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.16 114.54 18.49 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.378 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -97.35 119.2 35.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.638 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.632 HG23 HG22 ' E' ' 156' ' ' VAL . 19.5 m -136.6 158.24 37.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.582 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.12 115.95 22.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.626 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.66 -79.57 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.876 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . 0.507 ' H ' ' HB3' ' E' ' 154' ' ' PHE . . . -148.55 -145.94 4.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.892 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . 0.569 HG22 HG23 ' E' ' 153' ' ' THR . 15.0 p -142.05 145.11 33.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.028 0.442 . . . . 0.0 111.238 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 32.6 t -127.8 119.49 51.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.259 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -92.42 113.19 25.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.387 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.76 90.65 5.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.08 120.74 32.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.297 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.07 170.46 32.64 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.901 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' GLU . . . . . 0.656 ' HG3' ' O ' ' E' ' 146' ' ' GLY . 21.4 tt0 -160.59 129.23 4.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.98 0.419 . . . . 0.0 110.382 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.818 HG13 HG13 ' E' ' 37' ' ' VAL . 2.2 t -89.67 136.92 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.233 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.763 ' O ' HG22 ' E' ' 39' ' ' THR . 34.3 m -136.35 -160.77 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.77 0.319 . . . . 0.0 111.162 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.93 176.98 6.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.009 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' E' ' 40' ' ' ALA . . . -90.18 49.63 1.73 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.085 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' D' ' 61' ' ' CYS . . . -122.18 -39.65 2.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.403 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' CYS . . . . . 0.641 ' SG ' ' HB3' ' D' ' 58' ' ' LEU . 0.5 OUTLIER -162.17 146.35 12.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.946 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.97 121.68 14.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . 0.636 ' HA ' ' HG ' ' D' ' 58' ' ' LEU . 2.5 p -63.75 143.51 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' D' ' 27' ' ' SER . 13.6 t70 -72.97 154.64 40.44 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.549 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -54.3 -53.89 47.65 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.336 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.54 1.03 88.67 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.911 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . 0.557 ' HB2' ' HB3' ' D' ' 24' ' ' ASP . 7.9 t -99.28 -16.66 18.41 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.873 0.368 . . . . 0.0 110.829 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 25' ' ' ALA . 10.9 t -53.19 -50.81 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.338 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -114.12 126.15 54.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.987 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' GLN . . . . . 0.415 HE22 ' HA ' ' D' ' 56' ' ' ILE . 3.7 mt-30 -125.58 135.58 52.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.063 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.93 109.17 21.95 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.132 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.57 115.13 48.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.144 0.497 . . . . 0.0 110.458 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.17 124.73 50.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.671 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.24 -42.29 23.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.62 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.08 -165.38 12.15 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.574 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 3.7 mt-30 -93.62 119.23 32.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.635 0.255 . . . . 0.0 110.83 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.778 HG13 HG13 ' C' ' 16' ' ' VAL . 8.2 p -104.92 133.95 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.884 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' D' ' 38' ' ' ARG . 0.1 OUTLIER -79.96 137.66 36.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.628 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.767 HG22 ' O ' ' C' ' 17' ' ' VAL . 0.2 OUTLIER -62.52 -49.39 75.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.764 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' C' ' 19' ' ' ALA . . . -53.53 -33.5 54.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.051 0.453 . . . . 0.0 110.85 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' D' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.38 61.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.116 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' D' ' 143' ' ' ALA . 0.6 OUTLIER -114.01 39.79 2.63 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.662 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.22 33.94 3.28 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.391 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' GLN . . . . . 0.67 ' HB2' ' HB2' ' D' ' 47' ' ' ALA . 0.3 OUTLIER -124.46 142.88 50.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.323 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.2 95.67 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.0 111.138 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.37 33.72 5.84 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.152 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.67 ' HB2' ' HB2' ' D' ' 44' ' ' GLN . . . -78.94 143.56 35.68 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.991 0.424 . . . . 0.0 111.955 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' THR . . . . . 0.507 ' HB ' ' HD2' ' D' ' 136' ' ' ARG . 18.2 p -131.64 131.96 43.62 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.869 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 1.3 m -103.82 -167.2 1.34 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.541 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.502 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 3.9 t -57.77 141.92 47.19 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.872 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' D' ' 136' ' ' ARG . . . -99.06 125.5 44.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.369 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' VAL . . . . . 0.762 HG22 ' O ' ' D' ' 135' ' ' ALA . 24.8 m -76.53 150.96 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.953 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.26 143.26 16.39 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.598 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.402 ' HE2' ' HB3' ' D' ' 135' ' ' ALA . 37.5 p90 -171.48 140.42 1.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.796 0.331 . . . . 0.0 110.972 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' ASN . . . . . 0.46 ' HB3' HG23 ' A' ' 76' ' ' THR . 17.0 p30 -136.3 138.58 41.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.603 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.535 HG23 ' O ' ' D' ' 56' ' ' ILE . 0.7 OUTLIER -88.38 116.76 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.588 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' GLN . . . . . 0.841 ' HA ' HG23 ' D' ' 130' ' ' THR . 5.0 mp0 -69.35 138.32 53.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.78 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . 0.641 ' HB3' ' SG ' ' D' ' 21' ' ' CYS . 0.3 OUTLIER -145.62 91.69 2.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.292 -179.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . 0.527 ' HA ' HG23 ' D' ' 128' ' ' THR . 8.2 p30 -78.39 176.86 8.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.906 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.9 81.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.798 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 10.4 m -133.82 147.77 51.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.798 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.67 161.92 20.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.328 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.632 HG23 ' HA ' ' D' ' 125' ' ' ASN . 0.0 OUTLIER -111.76 -34.2 6.1 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.088 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -72.57 -28.14 62.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.017 0.437 . . . . 0.0 111.72 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 59.4 t -73.25 -58.47 4.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.696 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.17 126.06 32.7 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.571 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.4 -42.08 7.13 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.955 0.407 . . . . 0.0 110.964 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.29 156.85 18.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.457 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' D' ' 122' ' ' THR . . . -146.66 133.21 19.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.556 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . 0.605 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -113.34 155.12 25.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.144 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . 0.775 HG11 HG21 ' D' ' 131' ' ' ILE . 2.0 t -136.41 148.56 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.641 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 72' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' D' ' 155' ' ' LYS . . . -152.87 163.5 39.64 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.573 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 73' ' ' PHE . . . . . 0.428 ' CD1' ' HB1' ' D' ' 152' ' ' ALA . 0.2 OUTLIER -130.26 142.31 50.56 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 122.4 -0.187 . . . . 0.0 111.161 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 74' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 1.4 tt -109.21 119.04 38.3 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.071 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . 0.828 ' HA3' HD22 ' D' ' 113' ' ' LEU . . . -162.72 -161.88 12.86 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.786 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.3 OUTLIER -120.97 162.91 19.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.545 0.212 . . . . 0.0 110.78 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' D' ' 87' ' ' ALA . . . -83.55 139.06 33.11 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.967 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 78' ' ' ILE . . . . . 0.54 HG23 ' N ' ' D' ' 79' ' ' ASP . 11.1 tt -66.05 -47.63 84.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.948 0.404 . . . . 0.0 111.003 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.54 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.2 OUTLIER -134.44 46.68 2.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.813 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.47 -83.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.072 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.78 -36.39 41.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.62 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.42 69.25 10.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.375 . . . . 0.0 110.546 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 83' ' ' THR . . . . . 0.488 HG23 ' HB2' ' D' ' 77' ' ' ALA . 0.2 OUTLIER -74.12 -7.52 52.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.544 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . 0.626 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 30.1 p-10 -74.71 -25.4 59.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.332 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.605 HG11 ' HB3' ' D' ' 138' ' ' PHE . 6.4 t -104.91 143.85 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.161 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.61 ' HG ' HD13 ' D' ' 113' ' ' LEU . 0.3 OUTLIER -74.8 160.88 30.14 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.31 179.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' D' ' 77' ' ' ALA . . . -103.62 179.85 4.15 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.857 0.36 . . . . 0.0 111.739 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.724 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 1.3 mm? -66.59 171.3 5.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.071 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 89' ' ' GLN . . . . . 0.561 ' HG3' ' HB2' ' D' ' 149' ' ' ASN . 1.3 mm-40 -68.57 -83.76 0.03 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.25 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.14 19.17 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.937 0.399 . . . . 0.0 111.447 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . 0.541 ' HA ' ' HB2' ' F' ' 25' ' ' ALA . 3.3 m -90.16 86.24 6.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.927 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.16 -24.98 66.7 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.598 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.37 41.25 3.52 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.686 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.01 0.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.866 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 95' ' ' SER . . . . . 0.851 ' HA ' ' HB3' ' D' ' 147' ' ' ALA . 1.9 m -89.24 -173.57 4.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.751 0.31 . . . . 0.0 110.724 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 96' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' D' ' 88' ' ' LEU . . . -101.0 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.849 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . 0.411 ' O ' HG23 ' D' ' 99' ' ' VAL . 3.0 m -131.1 123.87 29.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.319 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.26 29.44 18.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.444 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 99' ' ' VAL . . . . . 0.411 HG23 ' O ' ' D' ' 97' ' ' THR . 1.7 t -125.34 129.32 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.822 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.87 -171.11 21.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.522 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 101' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' D' ' 86' ' ' LEU . 1.9 p -122.96 116.74 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.256 0.55 . . . . 0.0 111.694 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 102' ' ' GLN . . . . . 0.557 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 2.8 tt0 -81.76 151.43 27.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.915 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.79 123.82 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.575 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 104' ' ' LEU . . . . . 0.659 HD13 ' NE2' ' D' ' 134' ' ' GLN . 0.5 OUTLIER -104.73 125.19 50.57 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.661 0.267 . . . . 0.0 110.986 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . 0.81 ' HB3' HG22 ' D' ' 107' ' ' THR . 13.6 t0 -77.61 143.12 38.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.693 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 106' ' ' ARG . . . . . 0.694 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -62.72 -14.93 50.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.748 0.308 . . . . 0.0 111.029 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 107' ' ' THR . . . . . 0.81 HG22 ' HB3' ' D' ' 105' ' ' ASP . 8.8 t -62.98 -20.95 65.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.013 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.25 -43.54 1.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.735 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.72 160.7 14.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.83 0.348 . . . . 0.0 111.093 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.33 133.18 40.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 111' ' ' LEU . . . . . 0.667 ' HB2' ' HB2' ' D' ' 105' ' ' ASP . 12.3 tp -95.53 160.91 14.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.397 0.618 . . . . 0.0 110.477 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 112' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 2.9 t -110.23 136.79 48.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.046 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 113' ' ' LEU . . . . . 0.828 HD22 ' HA3' ' D' ' 75' ' ' GLY . 1.4 mt -70.2 89.55 0.65 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.702 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.29 -18.44 6.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.515 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.31 -62.28 0.87 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.619 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.93 18.26 9.37 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.958 0.408 . . . . 0.0 111.638 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 117' ' ' THR . . . . . 0.546 HG21 HG23 ' D' ' 112' ' ' THR . 0.0 OUTLIER -83.98 72.57 10.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.605 ' HB3' ' HB1' ' D' ' 70' ' ' ALA . 78.1 m-85 -92.35 89.75 6.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.792 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 55.5 m -130.55 73.19 1.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.86 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.24 142.3 21.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.695 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.95 68.51 0.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.208 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.639 ' HB ' ' HB3' ' D' ' 69' ' ' ALA . 0.0 OUTLIER -81.45 133.11 35.36 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.722 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 8.5 m -87.51 124.1 33.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.77 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.3 119.27 35.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.677 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 125' ' ' ASN . . . . . 0.632 ' HA ' HG23 ' D' ' 63' ' ' THR . 2.9 m120 -113.66 171.91 7.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.599 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.47 109.75 16.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.648 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.8 -133.78 4.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.705 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 128' ' ' THR . . . . . 0.533 ' HB ' ' HE3' ' A' ' 155' ' ' LYS . 46.5 m -110.54 86.77 2.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.731 0.3 . . . . 0.0 110.757 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 129' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' A' ' 116' ' ' ALA . 1.1 t30 -69.36 155.07 41.04 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.825 0.345 . . . . 0.0 111.199 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 130' ' ' THR . . . . . 0.841 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.2 OUTLIER -142.8 137.08 29.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.066 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 131' ' ' ILE . . . . . 0.775 HG21 HG11 ' D' ' 71' ' ' VAL . 6.9 mt -100.26 109.13 55.7 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 132' ' ' PRO . . . . . 0.694 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.5 Cg_endo -81.78 148.29 15.66 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.673 1.582 . . . . 0.0 112.526 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . 0.411 ' CZ ' ' HA ' ' D' ' 105' ' ' ASP . 0.5 OUTLIER -158.85 145.28 16.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.913 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 134' ' ' GLN . . . . . 0.659 ' NE2' HD13 ' D' ' 104' ' ' LEU . 5.2 mt-30 -111.23 160.4 17.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.041 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.762 ' O ' HG22 ' D' ' 52' ' ' VAL . . . -155.99 97.82 1.84 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.96 0.41 . . . . 0.0 111.629 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 136' ' ' ARG . . . . . 0.507 ' HD2' ' HB ' ' D' ' 48' ' ' THR . 14.4 ptt180 -101.57 173.64 6.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.417 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 137' ' ' TYR . . . . . 0.55 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 1.8 m-85 -83.64 135.01 34.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.142 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 138' ' ' PHE . . . . . 0.605 ' HB3' HG11 ' D' ' 85' ' ' VAL . 1.8 t80 -128.85 128.21 43.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.283 0.563 . . . . 0.0 112.013 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 139' ' ' ALA . . . . . 0.458 ' HB2' HD23 ' D' ' 42' ' ' LEU . . . -108.54 137.99 45.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.874 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 140' ' ' THR . . . . . 0.538 HG21 ' HB2' ' D' ' 79' ' ' ASP . 0.3 OUTLIER -89.93 -9.57 48.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.48 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.31 -95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.999 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.74 101.5 11.33 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.526 0.203 . . . . 0.0 110.708 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 143' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' D' ' 42' ' ' LEU . . . -61.35 144.35 54.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.752 0.311 . . . . 0.0 111.395 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 144' ' ' THR . . . . . 0.594 ' CG2' ' CD ' ' D' ' 145' ' ' PRO . 99.2 m -123.96 153.15 67.5 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.217 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 145' ' ' PRO . . . . . 0.594 ' CD ' ' CG2' ' D' ' 144' ' ' THR . 1.3 Cg_endo -82.97 144.71 12.17 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.56 2.173 . . . . 0.0 111.987 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 146' ' ' GLY . . . . . 0.653 ' O ' ' HG3' ' C' ' 15' ' ' GLU . . . 157.32 -116.1 0.7 Allowed Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.479 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 147' ' ' ALA . . . . . 0.851 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -119.71 132.38 55.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.376 . . . . 0.0 111.37 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 148' ' ' ALA . . . . . 0.627 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -125.37 43.37 3.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.397 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 149' ' ' ASN . . . . . 0.561 ' HB2' ' HG3' ' D' ' 89' ' ' GLN . 1.1 m120 -95.68 150.86 19.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.593 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 150' ' ' ALA . . . . . 0.507 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -168.45 -178.64 3.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.987 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.77 152.98 39.68 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.251 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 152' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -141.2 151.1 43.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.257 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 153' ' ' THR . . . . . 0.564 HG23 HG22 ' C' ' 9' ' ' THR . 0.2 OUTLIER -112.63 133.7 54.53 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 154' ' ' PHE . . . . . 0.512 ' HB3' ' H ' ' C' ' 8' ' ' GLY . 0.1 OUTLIER -81.68 148.73 28.85 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.07 0.462 . . . . 0.0 110.137 -179.043 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 155' ' ' LYS . . . . . 0.55 ' HB3' ' CZ ' ' D' ' 118' ' ' PHE . 11.2 mmtt -135.06 139.45 44.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.924 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 156' ' ' VAL . . . . . 0.635 HG22 HG23 ' C' ' 5' ' ' VAL . 3.1 m -134.53 141.3 43.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.783 0.325 . . . . 0.0 111.687 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 157' ' ' GLN . . . . . 0.531 ' HB3' ' HB3' ' D' ' 70' ' ' ALA . 3.8 tt0 -128.78 128.97 45.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.31 0.576 . . . . 0.0 110.363 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.73 128.58 51.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.552 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.85 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.281 0.086 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.37 88.93 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.028 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.14 114.5 18.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.446 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -97.29 119.17 35.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.685 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.647 HG23 HG22 ' F' ' 156' ' ' VAL . 19.6 m -136.56 158.25 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.605 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.13 116.01 22.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.59 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.74 -79.55 0.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.846 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . 0.501 ' H ' ' HB3' ' F' ' 154' ' ' PHE . . . -148.56 -145.96 4.24 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.882 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 9' ' ' THR . . . . . 0.565 HG22 HG23 ' F' ' 153' ' ' THR . 15.2 p -141.99 145.15 34.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.963 0.411 . . . . 0.0 111.302 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 32.5 t -127.83 119.49 51.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.262 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.4 113.16 25.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.374 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.76 90.66 5.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.814 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.08 120.74 32.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.342 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.06 170.53 32.65 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.933 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 15' ' ' GLU . . . . . 0.652 ' HG3' ' O ' ' F' ' 146' ' ' GLY . 21.4 tt0 -160.62 129.19 4.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 110.333 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 16' ' ' VAL . . . . . 0.784 HG13 HG13 ' F' ' 37' ' ' VAL . 2.2 t -89.66 136.92 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.25 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . 0.758 ' O ' HG22 ' F' ' 39' ' ' THR . 34.3 m -136.35 -160.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.774 0.321 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.95 177.01 6.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.03 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 19' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' F' ' 40' ' ' ALA . . . -90.15 49.64 1.73 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' E' ' 61' ' ' CYS . . . -122.16 -39.73 2.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.384 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 21' ' ' CYS . . . . . 0.644 ' SG ' ' HB3' ' E' ' 58' ' ' LEU . 0.5 OUTLIER -162.09 146.41 12.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.905 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.05 121.6 14.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.104 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 23' ' ' VAL . . . . . 0.621 ' HA ' ' HG ' ' E' ' 58' ' ' LEU . 2.5 p -63.68 143.52 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 24' ' ' ASP . . . . . 0.563 ' HB3' ' HB2' ' E' ' 27' ' ' SER . 13.5 t70 -72.92 154.61 40.49 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.595 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -54.32 -53.83 48.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.358 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.59 1.03 88.75 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.875 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . 0.563 ' HB2' ' HB3' ' E' ' 24' ' ' ASP . 7.9 t -99.28 -16.67 18.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.891 0.376 . . . . 0.0 110.849 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 28' ' ' VAL . . . . . 0.446 HG23 ' O ' ' E' ' 25' ' ' ALA . 10.9 t -53.18 -50.82 44.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.329 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -114.13 126.17 54.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.987 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 30' ' ' GLN . . . . . 0.433 HE22 ' HA ' ' E' ' 56' ' ' ILE . 3.7 mt-30 -125.6 135.56 52.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.062 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.92 109.14 21.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.1 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.55 115.11 48.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.11 0.481 . . . . 0.0 110.435 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.15 124.75 50.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.66 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.21 -42.33 23.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.624 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.1 -165.39 12.15 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.592 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 36' ' ' GLN . . . . . 0.602 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 3.7 mt-30 -93.61 119.2 32.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.642 0.258 . . . . 0.0 110.837 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.818 HG13 HG13 ' D' ' 16' ' ' VAL . 8.2 p -104.89 133.94 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.856 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' E' ' 38' ' ' ARG . 0.1 OUTLIER -79.9 137.65 36.95 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.694 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 39' ' ' THR . . . . . 0.763 HG22 ' O ' ' D' ' 17' ' ' VAL . 0.2 OUTLIER -62.55 -49.39 75.49 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.747 179.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' D' ' 19' ' ' ALA . . . -53.55 -33.47 54.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.0 0.428 . . . . 0.0 110.857 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 41' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' E' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.33 61.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.113 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.606 ' O ' ' HB2' ' E' ' 143' ' ' ALA . 0.6 OUTLIER -114.09 39.83 2.64 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.617 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.28 33.96 3.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.385 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 44' ' ' GLN . . . . . 0.664 ' HB2' ' HB2' ' E' ' 47' ' ' ALA . 0.3 OUTLIER -124.47 142.85 51.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.346 179.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.24 95.73 0.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.896 0.379 . . . . 0.0 111.156 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.35 33.71 5.84 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.191 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 47' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' E' ' 44' ' ' GLN . . . -78.9 143.51 35.81 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 111.968 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . 0.492 ' HB ' ' HD2' ' E' ' 136' ' ' ARG . 18.1 p -131.62 131.97 43.65 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.882 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 1.3 m -103.8 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.556 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 50' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 3.9 t -57.83 141.9 47.51 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.853 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 51' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' E' ' 136' ' ' ARG . . . -99.05 125.53 44.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.426 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 52' ' ' VAL . . . . . 0.764 HG22 ' O ' ' E' ' 135' ' ' ALA . 24.7 m -76.51 150.95 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.27 143.26 16.39 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.588 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -171.49 140.46 1.39 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.821 0.343 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 55' ' ' ASN . . . . . 0.458 ' HB3' HG23 ' B' ' 76' ' ' THR . 17.0 p30 -136.32 138.59 41.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.598 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 56' ' ' ILE . . . . . 0.538 HG23 ' O ' ' E' ' 56' ' ' ILE . 0.7 OUTLIER -88.43 116.76 30.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.568 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 57' ' ' GLN . . . . . 0.839 ' HA ' HG23 ' E' ' 130' ' ' THR . 5.0 mp0 -69.35 138.3 53.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.787 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . 0.644 ' HB3' ' SG ' ' E' ' 21' ' ' CYS . 0.3 OUTLIER -145.57 91.62 2.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.284 -179.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 8.1 p30 -78.4 176.83 8.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.943 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 61' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' E' ' 20' ' ' ALA . 10.4 m -133.84 147.78 51.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.796 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.68 161.94 20.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.328 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 63' ' ' THR . . . . . 0.639 HG23 ' HA ' ' E' ' 125' ' ' ASN . 0.0 OUTLIER -111.79 -34.2 6.09 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.082 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -72.56 -28.15 62.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.008 0.433 . . . . 0.0 111.704 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.19 -58.55 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.667 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.21 126.05 32.61 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.567 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.38 -42.08 7.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.972 0.415 . . . . 0.0 110.968 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.31 156.83 18.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.456 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 69' ' ' ALA . . . . . 0.654 ' HB3' ' HB ' ' E' ' 122' ' ' THR . . . -146.61 133.21 19.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.572 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -113.33 155.11 25.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.156 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . 0.793 HG11 HG21 ' E' ' 131' ' ' ILE . 2.0 t -136.39 148.6 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.655 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' E' ' 155' ' ' LYS . . . -152.93 163.51 39.66 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.563 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 73' ' ' PHE . . . . . 0.442 ' CD1' ' HB1' ' E' ' 152' ' ' ALA . 0.2 OUTLIER -130.25 142.24 50.57 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 122.408 -0.183 . . . . 0.0 111.179 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 74' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 1.4 tt -109.21 119.08 38.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.053 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . 0.819 ' HA3' HD22 ' E' ' 113' ' ' LEU . . . -162.72 -161.89 12.87 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.777 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 76' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.3 OUTLIER -120.95 162.94 19.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.605 0.241 . . . . 0.0 110.773 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 77' ' ' ALA . . . . . 0.694 ' O ' ' HB2' ' E' ' 87' ' ' ALA . . . -83.55 139.07 33.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.955 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 78' ' ' ILE . . . . . 0.539 HG23 ' N ' ' E' ' 79' ' ' ASP . 11.1 tt -66.09 -47.6 84.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.979 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 79' ' ' ASP . . . . . 0.544 ' HB2' HG21 ' E' ' 140' ' ' THR . 0.2 OUTLIER -134.5 46.68 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.847 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.54 -84.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.74 -36.43 40.75 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.609 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.44 69.26 10.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.891 0.377 . . . . 0.0 110.547 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 83' ' ' THR . . . . . 0.476 HG23 ' HB2' ' E' ' 77' ' ' ALA . 0.2 OUTLIER -74.15 -7.44 52.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.528 -179.45 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 84' ' ' ASN . . . . . 0.605 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 30.0 p-10 -74.77 -25.4 59.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.336 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.613 HG11 ' HB3' ' E' ' 138' ' ' PHE . 6.4 t -104.88 143.86 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.188 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 86' ' ' LEU . . . . . 0.593 ' HG ' HD13 ' E' ' 113' ' ' LEU . 0.3 OUTLIER -74.82 160.86 30.15 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.292 179.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 87' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' E' ' 77' ' ' ALA . . . -103.61 179.87 4.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.907 0.384 . . . . 0.0 111.725 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.712 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 1.3 mm? -66.6 171.28 5.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 89' ' ' GLN . . . . . 0.555 ' HG3' ' HB2' ' E' ' 149' ' ' ASN . 1.3 mm-40 -68.55 -83.78 0.03 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.253 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.09 19.13 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.935 0.398 . . . . 0.0 111.44 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 91' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' E' ' 95' ' ' SER . 3.2 m -90.15 86.23 6.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.09 -25.02 66.66 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.66 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.39 41.26 3.52 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.66 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.99 0.72 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.872 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 95' ' ' SER . . . . . 0.853 ' HA ' ' HB3' ' E' ' 147' ' ' ALA . 1.9 m -89.3 -173.57 4.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 110.722 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 96' ' ' ALA . . . . . 0.419 ' HB3' HD11 ' E' ' 88' ' ' LEU . . . -100.96 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . 0.413 ' O ' HG23 ' E' ' 99' ' ' VAL . 3.0 m -131.09 123.91 29.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.315 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.17 29.48 18.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.46 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 99' ' ' VAL . . . . . 0.413 HG23 ' O ' ' E' ' 97' ' ' THR . 1.7 t -125.29 129.33 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.809 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.85 -171.09 21.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.504 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 101' ' ' VAL . . . . . 0.521 ' CG2' ' HB1' ' E' ' 135' ' ' ALA . 1.9 p -122.93 116.73 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.195 0.522 . . . . 0.0 111.679 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 102' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 2.8 tt0 -81.77 151.45 27.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.931 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.79 123.83 70.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.515 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 104' ' ' LEU . . . . . 0.652 HD13 ' NE2' ' E' ' 134' ' ' GLN . 0.5 OUTLIER -104.71 125.18 50.55 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.704 0.288 . . . . 0.0 111.003 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . 0.795 ' HB3' HG22 ' E' ' 107' ' ' THR . 13.6 t0 -77.58 143.04 38.62 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.715 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 106' ' ' ARG . . . . . 0.716 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -62.67 -14.91 49.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.705 0.288 . . . . 0.0 111.025 179.47 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 107' ' ' THR . . . . . 0.795 HG22 ' HB3' ' E' ' 105' ' ' ASP . 8.8 t -63.01 -20.96 65.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.011 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.28 -43.51 1.37 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.745 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.75 160.67 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.083 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.36 133.14 40.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.088 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 111' ' ' LEU . . . . . 0.645 ' HB2' ' HB2' ' E' ' 105' ' ' ASP . 12.3 tp -95.5 160.97 14.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.389 0.614 . . . . 0.0 110.511 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 112' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 2.8 t -110.26 136.79 48.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.043 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 113' ' ' LEU . . . . . 0.819 HD22 ' HA3' ' E' ' 75' ' ' GLY . 1.4 mt -70.22 89.6 0.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.745 0.307 . . . . 0.0 110.663 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -18.45 6.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.463 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -62.26 0.88 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.67 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.96 18.22 9.45 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.99 0.424 . . . . 0.0 111.651 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 117' ' ' THR . . . . . 0.545 HG21 HG23 ' E' ' 112' ' ' THR . 0.0 OUTLIER -83.92 72.55 10.41 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.058 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 118' ' ' PHE . . . . . 0.587 ' HB3' ' HB1' ' E' ' 70' ' ' ALA . 78.1 m-85 -92.34 89.78 6.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 55.2 m -130.6 73.2 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.25 142.28 21.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.691 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.98 68.57 0.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.144 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 122' ' ' THR . . . . . 0.654 ' HB ' ' HB3' ' E' ' 69' ' ' ALA . 0.0 OUTLIER -81.5 133.12 35.35 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.688 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 8.6 m -87.55 124.13 33.17 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.713 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tp -97.33 119.33 35.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.632 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 125' ' ' ASN . . . . . 0.639 ' HA ' HG23 ' E' ' 63' ' ' THR . 2.9 m120 -113.68 171.89 7.31 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.609 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.49 109.8 16.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.637 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.77 -133.81 4.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.71 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 128' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 46.2 m -110.52 86.76 2.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.767 0.317 . . . . 0.0 110.79 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 129' ' ' ASN . . . . . 0.568 ' OD1' ' HB3' ' B' ' 116' ' ' ALA . 1.2 t30 -69.37 155.05 41.07 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.822 0.344 . . . . 0.0 111.16 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 130' ' ' THR . . . . . 0.839 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.2 OUTLIER -142.78 137.07 29.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.1 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 131' ' ' ILE . . . . . 0.793 HG21 HG11 ' E' ' 71' ' ' VAL . 6.9 mt -100.23 109.05 55.39 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 132' ' ' PRO . . . . . 0.716 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.5 Cg_endo -81.7 148.24 15.77 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.718 1.612 . . . . 0.0 112.525 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 133' ' ' PHE . . . . . 0.414 ' CZ ' ' HA ' ' E' ' 105' ' ' ASP . 0.5 OUTLIER -158.8 145.3 17.06 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.924 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 134' ' ' GLN . . . . . 0.652 ' NE2' HD13 ' E' ' 104' ' ' LEU . 5.2 mt-30 -111.23 160.43 16.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.041 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 135' ' ' ALA . . . . . 0.764 ' O ' HG22 ' E' ' 52' ' ' VAL . . . -155.98 97.8 1.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.9 0.381 . . . . 0.0 111.621 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 136' ' ' ARG . . . . . 0.492 ' HD2' ' HB ' ' E' ' 48' ' ' THR . 14.4 ptt180 -101.57 173.6 6.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.412 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 137' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 1.8 m-85 -83.66 135.03 34.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.144 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 138' ' ' PHE . . . . . 0.613 ' HB3' HG11 ' E' ' 85' ' ' VAL . 1.7 t80 -128.84 128.16 43.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.055 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 139' ' ' ALA . . . . . 0.458 ' HB2' HD23 ' E' ' 42' ' ' LEU . . . -108.51 137.96 45.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.836 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 140' ' ' THR . . . . . 0.544 HG21 ' HB2' ' E' ' 79' ' ' ASP . 0.3 OUTLIER -89.92 -9.54 48.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.49 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.28 -95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.947 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.71 101.52 11.36 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.529 0.204 . . . . 0.0 110.735 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 143' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' E' ' 42' ' ' LEU . . . -61.39 144.38 54.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.788 0.328 . . . . 0.0 111.336 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 144' ' ' THR . . . . . 0.607 ' CG2' ' CD ' ' E' ' 145' ' ' PRO . 99.2 m -123.95 153.15 67.46 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.236 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 145' ' ' PRO . . . . . 0.607 ' CD ' ' CG2' ' E' ' 144' ' ' THR . 1.4 Cg_endo -82.97 144.76 12.18 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.561 2.174 . . . . 0.0 111.979 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 146' ' ' GLY . . . . . 0.656 ' O ' ' HG3' ' D' ' 15' ' ' GLU . . . 157.3 -116.09 0.7 Allowed Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.49 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 147' ' ' ALA . . . . . 0.853 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -119.72 132.38 55.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.871 0.367 . . . . 0.0 111.403 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 148' ' ' ALA . . . . . 0.606 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -125.39 43.36 3.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.112 0.482 . . . . 0.0 110.379 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 149' ' ' ASN . . . . . 0.555 ' HB2' ' HG3' ' E' ' 89' ' ' GLN . 1.1 m120 -95.67 150.86 19.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.609 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 150' ' ' ALA . . . . . 0.51 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -168.47 -178.63 3.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.009 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.76 152.99 39.7 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.228 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 152' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -141.2 151.12 43.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.206 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 153' ' ' THR . . . . . 0.569 HG23 HG22 ' D' ' 9' ' ' THR . 0.2 OUTLIER -112.66 133.74 54.54 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 154' ' ' PHE . . . . . 0.507 ' HB3' ' H ' ' D' ' 8' ' ' GLY . 0.1 OUTLIER -81.72 148.72 28.82 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.103 0.478 . . . . 0.0 110.114 -179.05 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 155' ' ' LYS . . . . . 0.558 ' HB3' ' CZ ' ' E' ' 118' ' ' PHE . 11.3 mmtt -135.02 139.49 44.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.931 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 156' ' ' VAL . . . . . 0.632 HG22 HG23 ' D' ' 5' ' ' VAL . 3.1 m -134.51 141.3 43.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.687 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 157' ' ' GLN . . . . . 0.547 ' HB3' ' HB3' ' E' ' 70' ' ' ALA . 3.8 tt0 -128.8 128.97 45.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.29 0.567 . . . . 0.0 110.373 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.69 128.58 51.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.536 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.331 0.11 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.4 88.96 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.568 0.223 . . . . 0.0 111.008 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.17 114.47 18.39 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.396 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -97.26 119.23 35.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.664 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 m -136.61 158.25 37.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.562 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.18 115.99 22.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.581 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.59 -79.63 0.13 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.878 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.56 -145.95 4.24 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.904 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 15.2 p -142.02 145.12 34.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.944 0.402 . . . . 0.0 111.314 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 32.0 t -127.84 119.47 51.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.226 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -92.4 113.18 25.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.407 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -95.8 90.65 5.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.794 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.09 120.76 32.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.343 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.09 170.48 32.66 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.934 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -160.59 129.18 4.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.957 0.408 . . . . 0.0 110.36 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.67 136.91 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.254 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.34 -160.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.786 0.327 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.93 177.02 6.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.967 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.22 49.62 1.73 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.064 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' F' ' 61' ' ' CYS . . . -122.15 -39.71 2.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.437 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 21' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' F' ' 58' ' ' LEU . 0.5 OUTLIER -162.12 146.39 12.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.943 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.02 121.61 14.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 23' ' ' VAL . . . . . 0.617 ' HA ' ' HG ' ' F' ' 58' ' ' LEU . 2.5 p -63.7 143.49 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 24' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' F' ' 27' ' ' SER . 13.5 t70 -72.87 154.61 40.52 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.59 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -54.32 -53.87 48.01 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.335 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.56 1.03 88.7 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.863 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 27' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' F' ' 24' ' ' ASP . 7.9 t -99.32 -16.59 18.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.842 0.354 . . . . 0.0 110.814 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 28' ' ' VAL . . . . . 0.441 HG23 ' O ' ' F' ' 25' ' ' ALA . 10.9 t -53.24 -50.78 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.324 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -114.12 126.1 54.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.995 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 30' ' ' GLN . . . . . 0.426 HE22 ' HA ' ' F' ' 56' ' ' ILE . 3.7 mt-30 -125.57 135.65 52.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.059 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.93 109.18 21.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.091 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -115.59 115.12 48.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.148 0.499 . . . . 0.0 110.416 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -105.19 124.67 49.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.665 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.2 -42.29 23.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.603 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.08 -165.35 12.14 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.579 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 36' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 3.7 mt-30 -93.67 119.16 32.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.657 0.265 . . . . 0.0 110.851 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.784 HG13 HG13 ' E' ' 16' ' ' VAL . 8.2 p -104.84 133.97 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 38' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' F' ' 41' ' ' SER . 0.1 OUTLIER -79.93 137.62 36.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.687 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 39' ' ' THR . . . . . 0.758 HG22 ' O ' ' E' ' 17' ' ' VAL . 0.2 OUTLIER -62.45 -49.46 75.34 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.775 179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' E' ' 19' ' ' ALA . . . -53.53 -33.48 54.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.983 0.42 . . . . 0.0 110.829 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 41' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' F' ' 38' ' ' ARG . 0.1 OUTLIER -74.98 -31.37 61.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.113 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . 0.617 ' O ' ' HB2' ' F' ' 143' ' ' ALA . 0.6 OUTLIER -114.02 39.82 2.63 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.611 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.25 33.93 3.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.388 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 44' ' ' GLN . . . . . 0.674 ' HB2' ' HB2' ' F' ' 47' ' ' ALA . 0.3 OUTLIER -124.46 142.84 51.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.366 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.22 95.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.867 0.365 . . . . 0.0 111.161 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.41 33.67 5.85 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.149 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 47' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' F' ' 44' ' ' GLN . . . -78.79 143.51 36.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.979 0.418 . . . . 0.0 111.973 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 48' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' F' ' 136' ' ' ARG . 18.1 p -131.63 132.0 43.66 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.899 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 49' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 1.3 m -103.81 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.504 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 50' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 3.9 t -57.81 141.91 47.42 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 51' ' ' ALA . . . . . 0.472 ' HB2' ' HB3' ' F' ' 136' ' ' ARG . . . -99.03 125.5 44.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.376 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 52' ' ' VAL . . . . . 0.764 HG22 ' O ' ' F' ' 135' ' ' ALA . 24.9 m -76.53 150.97 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.959 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.3 143.25 16.41 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.583 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 54' ' ' PHE . . . . . 0.406 ' HE2' ' HB3' ' F' ' 135' ' ' ALA . 37.4 p90 -171.47 140.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.839 0.352 . . . . 0.0 110.902 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 55' ' ' ASN . . . . . 0.465 ' HB3' HG23 ' C' ' 76' ' ' THR . 17.0 p30 -136.35 138.61 41.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.535 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 56' ' ' ILE . . . . . 0.54 HG23 ' O ' ' F' ' 56' ' ' ILE . 0.7 OUTLIER -88.42 116.76 30.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.57 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 57' ' ' GLN . . . . . 0.829 ' HA ' HG23 ' F' ' 130' ' ' THR . 5.0 mp0 -69.39 138.31 53.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.803 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . 0.636 ' HB3' ' SG ' ' F' ' 21' ' ' CYS . 0.3 OUTLIER -145.58 91.67 2.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.284 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 59' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 8.2 p30 -78.43 176.87 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.925 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.86 0.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.792 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 61' ' ' CYS . . . . . 0.616 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 10.4 m -133.83 147.8 51.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.779 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.71 161.93 20.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.318 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 63' ' ' THR . . . . . 0.626 HG23 ' HA ' ' F' ' 125' ' ' ASN . 0.0 OUTLIER -111.73 -34.25 6.09 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -72.53 -28.2 62.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.04 0.448 . . . . 0.0 111.728 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -73.13 -58.58 4.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.703 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.19 126.09 32.74 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.569 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.32 -42.17 7.12 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.95 0.405 . . . . 0.0 110.954 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 68' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' F' ' 68' ' ' LYS . 1.2 tptp -89.3 156.82 18.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.478 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 69' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' F' ' 122' ' ' THR . . . -146.63 133.19 19.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.588 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 70' ' ' ALA . . . . . 0.6 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -113.31 155.12 25.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.156 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 71' ' ' VAL . . . . . 0.769 HG11 HG21 ' F' ' 131' ' ' ILE . 2.0 t -136.4 148.56 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.69 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 72' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' F' ' 155' ' ' LYS . . . -152.9 163.49 39.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.55 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 73' ' ' PHE . . . . . 0.444 ' CD1' ' HB1' ' F' ' 152' ' ' ALA . 0.2 OUTLIER -130.25 142.3 50.57 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 121.247 -0.181 . . . . 0.0 111.186 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 74' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 1.4 tt -109.18 119.04 38.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.055 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . 0.823 ' HA3' HD22 ' F' ' 113' ' ' LEU . . . -162.72 -161.87 12.84 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.759 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 76' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.3 OUTLIER -120.99 162.89 19.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.585 0.231 . . . . 0.0 110.775 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 77' ' ' ALA . . . . . 0.699 ' O ' ' HB2' ' F' ' 87' ' ' ALA . . . -83.53 139.08 33.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.937 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 78' ' ' ILE . . . . . 0.535 HG23 ' N ' ' F' ' 79' ' ' ASP . 11.1 tt -66.06 -47.66 84.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.981 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 79' ' ' ASP . . . . . 0.55 ' HB2' HG21 ' F' ' 140' ' ' THR . 0.2 OUTLIER -134.44 46.68 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.857 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.48 -84.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.76 -36.42 40.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.58 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.49 69.27 10.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.918 0.39 . . . . 0.0 110.52 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 83' ' ' THR . . . . . 0.48 HG23 ' HB2' ' F' ' 77' ' ' ALA . 0.2 OUTLIER -74.11 -7.51 52.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.527 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 84' ' ' ASN . . . . . 0.621 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 30.1 p-10 -74.7 -25.44 59.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.338 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 85' ' ' VAL . . . . . 0.598 HG11 ' HB3' ' F' ' 138' ' ' PHE . 6.4 t -104.89 143.86 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.152 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 86' ' ' LEU . . . . . 0.599 ' HG ' HD13 ' F' ' 113' ' ' LEU . 0.3 OUTLIER -74.83 160.88 30.13 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.263 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 87' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' F' ' 77' ' ' ALA . . . -103.66 179.86 4.15 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.902 0.382 . . . . 0.0 111.698 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . 0.712 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 1.3 mm? -66.56 171.27 5.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.019 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 89' ' ' GLN . . . . . 0.544 ' HG3' ' HB2' ' F' ' 149' ' ' ASN . 1.3 mm-40 -68.58 -83.74 0.03 OUTLIER 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.262 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.13 19.15 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.975 0.416 . . . . 0.0 111.459 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 91' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' F' ' 95' ' ' SER . 3.3 m -90.17 86.21 6.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.936 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.06 -25.03 66.65 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.663 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.37 41.23 3.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.647 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.02 0.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.852 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 95' ' ' SER . . . . . 0.835 ' HA ' ' HB3' ' F' ' 147' ' ' ALA . 1.9 m -89.28 -173.6 4.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 110.667 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 96' ' ' ALA . . . . . 0.423 ' HB3' HD11 ' F' ' 88' ' ' LEU . . . -101.01 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.846 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 3.0 m -131.04 123.92 29.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.322 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.18 29.46 18.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.479 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 1.7 t -125.29 129.29 73.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.824 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.8 -171.07 21.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.516 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 101' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' F' ' 86' ' ' LEU . 1.9 p -122.98 116.72 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.238 0.542 . . . . 0.0 111.703 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 102' ' ' GLN . . . . . 0.548 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 2.8 tt0 -81.75 151.45 27.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.942 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.81 123.85 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.525 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 104' ' ' LEU . . . . . 0.665 HD13 ' NE2' ' F' ' 134' ' ' GLN . 0.5 OUTLIER -104.72 125.16 50.53 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.647 0.261 . . . . 0.0 111.011 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . 0.806 ' HB3' HG22 ' F' ' 107' ' ' THR . 13.5 t0 -77.54 143.07 38.68 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.683 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 106' ' ' ARG . . . . . 0.709 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -62.76 -14.82 49.43 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.756 0.312 . . . . 0.0 111.053 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 107' ' ' THR . . . . . 0.806 HG22 ' HB3' ' F' ' 105' ' ' ASP . 8.8 t -63.03 -20.93 65.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.038 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.25 -43.53 1.36 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.748 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.7 160.69 14.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.753 0.311 . . . . 0.0 111.109 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.32 133.17 40.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 111' ' ' LEU . . . . . 0.671 ' HB2' ' HB2' ' F' ' 105' ' ' ASP . 12.3 tp -95.52 160.89 14.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.381 0.61 . . . . 0.0 110.52 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 112' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 2.9 t -110.19 136.79 48.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.093 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 113' ' ' LEU . . . . . 0.823 HD22 ' HA3' ' F' ' 75' ' ' GLY . 1.4 mt -70.2 89.59 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.299 . . . . 0.0 110.65 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -18.46 6.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.482 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.29 -62.26 0.88 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.647 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.97 18.25 9.43 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-O 121.008 0.432 . . . . 0.0 111.661 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 117' ' ' THR . . . . . 0.546 HG21 HG23 ' F' ' 112' ' ' THR . 0.0 OUTLIER -83.92 72.54 10.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.015 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 118' ' ' PHE . . . . . 0.6 ' HB3' ' HB1' ' F' ' 70' ' ' ALA . 78.2 m-85 -92.31 89.74 6.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.775 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 54.8 m -130.51 73.13 1.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.914 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.23 142.34 21.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.676 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -104.02 68.54 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.165 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 122' ' ' THR . . . . . 0.641 ' HB ' ' HB3' ' F' ' 69' ' ' ALA . 0.0 OUTLIER -81.45 133.12 35.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.721 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 8.5 m -87.55 124.12 33.16 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.738 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.31 119.29 35.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.672 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 125' ' ' ASN . . . . . 0.626 ' HA ' HG23 ' F' ' 63' ' ' THR . 2.9 m120 -113.71 171.93 7.29 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.581 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.5 109.74 16.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.656 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.84 -133.84 4.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.733 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 128' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 46.4 m -110.49 86.71 2.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.743 0.306 . . . . 0.0 110.811 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 129' ' ' ASN . . . . . 0.564 ' OD1' ' HB3' ' C' ' 116' ' ' ALA . 1.1 t30 -69.3 155.07 41.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.179 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 130' ' ' THR . . . . . 0.829 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.2 OUTLIER -142.79 137.08 29.45 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.099 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 131' ' ' ILE . . . . . 0.769 HG21 HG11 ' F' ' 71' ' ' VAL . 6.9 mt -100.25 109.09 55.57 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 132' ' ' PRO . . . . . 0.709 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.5 Cg_endo -81.72 148.26 15.74 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.721 1.614 . . . . 0.0 112.543 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 133' ' ' PHE . . . . . 0.419 ' CZ ' ' HA ' ' F' ' 105' ' ' ASP . 0.5 OUTLIER -158.86 145.29 16.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.903 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 134' ' ' GLN . . . . . 0.665 ' NE2' HD13 ' F' ' 104' ' ' LEU . 5.2 mt-30 -111.23 160.43 16.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.042 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 135' ' ' ALA . . . . . 0.764 ' O ' HG22 ' F' ' 52' ' ' VAL . . . -156.03 97.82 1.83 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.995 0.426 . . . . 0.0 111.597 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 136' ' ' ARG . . . . . 0.498 ' HD2' ' HB ' ' F' ' 48' ' ' THR . 14.4 ptt180 -101.5 173.6 6.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.407 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 137' ' ' TYR . . . . . 0.539 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 1.8 m-85 -83.65 135.03 34.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.168 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 138' ' ' PHE . . . . . 0.598 ' HB3' HG11 ' F' ' 85' ' ' VAL . 1.8 t80 -128.87 128.23 43.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.282 0.563 . . . . 0.0 111.972 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 139' ' ' ALA . . . . . 0.472 ' HB2' HD23 ' F' ' 42' ' ' LEU . . . -108.58 137.97 45.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.854 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 140' ' ' THR . . . . . 0.55 HG21 ' HB2' ' F' ' 79' ' ' ASP . 0.3 OUTLIER -89.93 -9.56 48.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.477 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.32 -95.22 0.1 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.996 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.75 101.47 11.3 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.529 0.204 . . . . 0.0 110.741 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 143' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' F' ' 42' ' ' LEU . . . -61.35 144.33 54.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.715 0.293 . . . . 0.0 111.409 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 144' ' ' THR . . . . . 0.607 ' CG2' ' CD ' ' F' ' 145' ' ' PRO . 99.1 m -123.92 153.17 67.35 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.216 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 145' ' ' PRO . . . . . 0.607 ' CD ' ' CG2' ' F' ' 144' ' ' THR . 1.3 Cg_endo -83.03 144.79 12.13 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.567 2.178 . . . . 0.0 111.98 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 146' ' ' GLY . . . . . 0.652 ' O ' ' HG3' ' E' ' 15' ' ' GLU . . . 157.27 -116.08 0.7 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.473 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 147' ' ' ALA . . . . . 0.835 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -119.73 132.44 55.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.899 0.38 . . . . 0.0 111.335 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 148' ' ' ALA . . . . . 0.631 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -125.44 43.36 3.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.12 0.486 . . . . 0.0 110.387 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 149' ' ' ASN . . . . . 0.544 ' HB2' ' HG3' ' F' ' 89' ' ' GLN . 1.1 m120 -95.69 150.86 19.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.623 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 150' ' ' ALA . . . . . 0.508 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -168.44 -178.63 3.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.992 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.77 153.01 39.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.253 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 152' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -141.22 151.11 43.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.258 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 153' ' ' THR . . . . . 0.565 HG23 HG22 ' E' ' 9' ' ' THR . 0.2 OUTLIER -112.68 133.74 54.56 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 154' ' ' PHE . . . . . 0.501 ' HB3' ' H ' ' E' ' 8' ' ' GLY . 0.1 OUTLIER -81.73 148.72 28.8 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.103 0.478 . . . . 0.0 110.11 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 155' ' ' LYS . . . . . 0.553 ' HB3' ' CZ ' ' F' ' 118' ' ' PHE . 11.2 mmtt -135.01 139.47 44.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.945 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 156' ' ' VAL . . . . . 0.647 HG22 HG23 ' E' ' 5' ' ' VAL . 3.1 m -134.53 141.27 43.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.702 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 157' ' ' GLN . . . . . 0.555 ' HB3' ' HB3' ' F' ' 70' ' ' ALA . 3.8 tt0 -128.77 129.0 45.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.328 0.585 . . . . 0.0 110.37 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.71 128.61 51.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.546 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' B' ' 158' ' ' TYR . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.591 0.234 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' B' ' 157' ' ' GLN . 5.5 m -122.99 116.19 23.14 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.406 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.488 HG21 ' CA ' ' E' ' 127' ' ' GLY . 1.8 m -99.6 117.26 33.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.573 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.633 HG23 HG23 ' B' ' 156' ' ' VAL . 1.7 m -144.49 158.02 14.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.557 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' B' ' 154' ' ' PHE . 13.0 t30 -78.68 123.76 27.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.73 -71.18 1.0 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.822 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.543 ' H ' ' HB3' ' B' ' 154' ' ' PHE . . . -152.72 -147.04 4.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.759 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.965 HG22 HG23 ' B' ' 153' ' ' THR . 24.5 p -148.72 134.43 18.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.022 0.439 . . . . 0.0 111.249 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.33 124.39 72.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.186 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.624 ' HA ' ' OD1' ' B' ' 151' ' ' ASP . 57.5 t-80 -91.58 116.17 28.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.323 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -96.83 105.48 17.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HG2' ' ND2' ' B' ' 149' ' ' ASN . 5.1 tttm -104.61 118.71 37.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.507 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.32 172.92 30.82 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.952 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.729 ' O ' ' HA ' ' B' ' 36' ' ' GLN . 25.8 tt0 -160.39 135.93 8.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.965 0.412 . . . . 0.0 110.425 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.778 HG23 ' HB2' ' B' ' 148' ' ' ALA . 43.4 t -96.78 132.73 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.272 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.719 HG11 ' NE2' ' B' ' 36' ' ' GLN . 18.5 m -133.82 -177.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.805 0.336 . . . . 0.0 111.068 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.567 ' HA ' HG22 ' B' ' 39' ' ' THR . 0.3 OUTLIER -75.7 -170.26 1.25 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.017 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.79 45.37 0.98 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.125 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.568 ' O ' HD21 ' A' ' 124' ' ' LEU . . . -121.26 -24.8 5.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.415 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -168.91 140.68 2.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.792 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 60' ' ' ASP . . . -132.87 116.95 17.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.741 HG12 ' HB2' ' B' ' 36' ' ' GLN . 0.5 OUTLIER -67.03 146.23 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.011 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.473 ' O ' HG23 ' A' ' 28' ' ' VAL . 12.9 t0 -80.34 152.03 29.16 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.55 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.06 96.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.39 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.88 2.72 85.9 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.891 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -106.23 -19.94 13.55 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.813 0.339 . . . . 0.0 110.793 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 24' ' ' ASP . 39.8 t -47.43 -52.09 5.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.336 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.19 136.48 48.61 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.035 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.71 136.85 39.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.02 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.52 102.83 12.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.127 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.66 128.34 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.121 0.486 . . . . 0.0 110.51 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -114.75 123.06 48.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.615 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.45 -42.72 15.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.608 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.45 -167.44 13.2 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.603 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -96.75 124.51 40.75 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.654 0.264 . . . . 0.0 110.852 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.71 147.54 11.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.986 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.71 134.94 34.33 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.418 0.449 . . . . 0.0 111.725 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -60.07 -44.48 94.73 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.75 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.26 -36.88 61.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.095 0.474 . . . . 0.0 110.893 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.9 -35.8 62.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.168 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.747 HD23 HG13 ' A' ' 99' ' ' VAL . 2.9 mp -106.66 34.58 3.34 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.657 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.9 15.85 27.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.391 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.98 132.04 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.34 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 140' ' ' THR . 6.8 tt0 -56.56 108.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.827 0.346 . . . . 0.0 111.106 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.93 25.93 10.11 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.121 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -71.49 137.75 48.42 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 p -136.94 122.73 19.96 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.913 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 136' ' ' ARG . 53.9 m -100.07 -175.18 2.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.649 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 t -55.65 137.29 49.56 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.808 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.476 ' CA ' ' HB3' ' A' ' 136' ' ' ARG . . . -92.32 133.57 35.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.342 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 135' ' ' ALA . 26.2 m -76.76 162.48 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.52 141.14 16.76 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.643 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -173.76 137.75 0.61 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.79 0.329 . . . . 0.0 110.933 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -136.49 145.85 45.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.682 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 56' ' ' ILE . 1.2 tp -91.04 116.79 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.663 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.73 ' HA ' HG23 ' A' ' 130' ' ' THR . 1.3 mp0 -72.93 128.65 36.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.813 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.459 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -137.35 89.13 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.225 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.731 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 9.8 p30 -74.79 176.47 7.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.039 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.515 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 0.9 OUTLIER 58.97 74.78 0.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.889 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 36.5 m -126.31 148.83 49.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.412 ' OD2' HG23 ' A' ' 65' ' ' VAL . 1.6 t70 -121.58 169.75 10.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.318 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.25 -32.66 4.91 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.48 -28.0 56.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.261 0.553 . . . . 0.0 111.753 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.412 HG23 ' OD2' ' A' ' 62' ' ' ASP . 25.5 t -73.63 -56.69 8.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.68 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.459 ' HB3' ' HB1' ' A' ' 20' ' ' ALA . . . -134.99 122.76 22.31 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.652 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.54 -50.11 5.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.894 0.378 . . . . 0.0 110.936 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.401 ' NZ ' ' HA ' ' A' ' 68' ' ' LYS . 1.8 tptp -89.75 152.15 21.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.529 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 122' ' ' THR . . . -144.24 137.87 27.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.582 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -113.41 157.28 22.11 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.092 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.739 HG11 HG21 ' A' ' 131' ' ' ILE . 1.8 t -138.75 149.97 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.668 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.86 155.13 37.52 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.565 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.543 ' CB ' HD13 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -125.05 136.69 53.93 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.644 0.259 . . . . 0.0 111.004 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.576 HD21 HG21 ' D' ' 130' ' ' THR . 0.9 OUTLIER -97.2 136.13 38.15 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.017 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.446 ' CA ' ' HB3' ' A' ' 113' ' ' LEU . . . -174.0 -172.91 39.69 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.762 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.667 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.2 OUTLIER -118.66 144.6 46.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.485 0.183 . . . . 0.0 110.835 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.639 ' HB2' HG23 ' A' ' 83' ' ' THR . . . -62.52 138.62 58.51 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.925 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.504 HG23 ' N ' ' A' ' 79' ' ' ASP . 5.7 tt -71.63 -45.56 66.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.932 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.504 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -133.13 42.47 3.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.857 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 79' ' ' ASP . . . 70.12 -80.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.977 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.06 -29.78 68.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.552 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.445 ' HB3' HG22 ' A' ' 78' ' ' ILE . 1.7 m80 -89.77 69.41 7.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 110.445 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.639 HG23 ' HB2' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -74.52 -16.17 60.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.576 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 20.7 p-10 -66.26 -19.05 65.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.267 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 138' ' ' PHE . 13.4 t -113.65 133.81 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.198 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.766 ' HG ' HD13 ' A' ' 113' ' ' LEU . 0.4 OUTLIER -67.89 161.48 26.27 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 77' ' ' ALA . . . -103.54 -174.65 2.6 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.869 0.366 . . . . 0.0 111.787 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.71 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 0.3 OUTLIER -67.38 165.22 16.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.084 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.518 ' CG ' ' HB2' ' A' ' 149' ' ' ASN . 5.7 mm-40 -63.43 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.815 0.34 . . . . 0.0 111.3 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.454 ' O ' HG12 ' D' ' 52' ' ' VAL . 2.3 p -165.45 3.66 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 111.492 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.528 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 0.7 OUTLIER -80.03 79.74 6.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.525 ' HB2' HG13 ' D' ' 52' ' ' VAL . . . -57.08 -24.72 56.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.885 0.374 . . . . 0.0 111.658 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.18 33.94 5.25 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.682 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.8 0.44 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.943 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.71 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . 38.4 m -96.8 177.94 5.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.877 0.37 . . . . 0.0 110.64 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.47 -178.71 7.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.804 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.494 ' HB ' ' OG1' ' A' ' 144' ' ' THR . 2.0 m -134.53 119.01 17.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.338 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 97' ' ' THR . 32.6 m-20 68.85 34.41 3.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.388 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.747 HG13 HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -138.03 130.79 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.808 179.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.11 -170.55 18.84 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.568 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -119.72 114.48 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.014 0.526 . . . . 0.0 111.719 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 0.8 OUTLIER -87.33 150.21 24.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.912 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.551 HG12 ' HG ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -114.98 135.96 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.53 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.28 133.57 55.04 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.675 0.274 . . . . 0.0 111.03 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.858 ' HB3' HG22 ' A' ' 107' ' ' THR . 6.1 t0 -82.36 149.75 27.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.664 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.751 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.4 OUTLIER -67.85 -16.25 64.0 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.8 0.333 . . . . 0.0 111.053 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.858 HG22 ' HB3' ' A' ' 105' ' ' ASP . 8.8 t -63.67 -28.35 69.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.033 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.0 -40.48 1.58 Allowed Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.661 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.422 ' H ' HG23 ' A' ' 107' ' ' THR . . . -91.51 163.09 14.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.815 0.34 . . . . 0.0 111.049 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.17 133.36 35.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.563 HD21 ' O ' ' A' ' 117' ' ' THR . 4.8 tp -96.74 150.02 21.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.407 0.622 . . . . 0.0 110.526 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.855 HG23 HG21 ' A' ' 117' ' ' THR . 1.9 t -98.37 141.78 30.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.156 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.766 HD13 ' HG ' ' A' ' 86' ' ' LEU . 1.6 mt -76.43 89.48 3.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.783 0.325 . . . . 0.0 110.704 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.08 -18.19 5.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.554 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.79 -60.58 0.46 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.616 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.504 ' HB2' ' N ' ' D' ' 129' ' ' ASN . . . -96.46 26.98 4.03 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.04 0.448 . . . . 0.0 111.69 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.855 HG21 HG23 ' A' ' 112' ' ' THR . 0.0 OUTLIER -87.04 74.86 9.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.148 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.582 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 62.7 m-85 -94.88 92.86 7.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.819 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.8 m -136.32 68.92 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.81 150.19 28.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.622 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.25 67.66 0.7 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.171 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.6 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -79.15 114.71 18.31 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.747 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -73.94 127.96 34.24 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.724 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.568 HD21 ' O ' ' A' ' 20' ' ' ALA . 4.0 tp -92.08 132.14 36.81 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.64 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.12 151.12 49.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.58 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 3.1 t30 -69.12 111.99 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.636 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.61 -138.83 8.65 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.672 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.731 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 87.8 m -98.84 82.5 2.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.633 0.254 . . . . 0.0 110.724 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.456 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 2.3 t30 -71.82 148.19 46.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.949 0.404 . . . . 0.0 111.062 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.73 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -138.67 148.57 44.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.119 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.739 HG21 HG11 ' A' ' 71' ' ' VAL . 15.6 mt -110.0 112.23 57.93 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.751 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.4 Cg_endo -81.82 136.98 9.7 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.629 1.553 . . . . 0.0 112.564 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.0 136.09 19.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.718 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -111.43 158.4 19.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.04 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.675 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -154.19 111.35 3.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.951 0.405 . . . . 0.0 111.63 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.476 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . 19.8 ptt180 -108.93 174.09 6.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.344 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.695 ' HB3' HD21 ' A' ' 42' ' ' LEU . 1.7 m-85 -81.37 137.67 35.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.14 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.518 ' HB3' HG21 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -131.61 124.15 29.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.2 0.524 . . . . 0.0 112.072 -179.256 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -108.47 130.17 55.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.839 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -77.46 -27.95 52.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.495 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.49 -96.51 0.11 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.981 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.93 98.46 8.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.623 0.211 . . . . 0.0 110.722 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.548 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -56.6 148.89 18.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.746 0.308 . . . . 0.0 111.413 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.723 ' CG2' ' CD ' ' A' ' 145' ' ' PRO . 90.1 m -125.41 156.96 69.48 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.219 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.723 ' CD ' ' CG2' ' A' ' 144' ' ' THR . 1.4 Cg_endo -83.45 136.3 7.51 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.517 2.145 . . . . 0.0 111.925 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 163.56 -127.56 1.7 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.474 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.652 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -110.92 132.88 53.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.863 0.364 . . . . 0.0 111.363 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.24 43.69 2.93 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.133 0.492 . . . . 0.0 110.451 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.518 ' HB2' ' CG ' ' A' ' 89' ' ' GLN . 9.3 m120 -92.27 144.28 25.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.529 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.684 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -160.64 178.81 9.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.0 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -146.94 145.01 29.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.255 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -133.74 139.74 46.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.169 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.1 135.29 42.8 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.58 152.18 27.34 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.005 0.431 . . . . 0.0 110.188 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.413 ' HE3' ' HB ' ' D' ' 128' ' ' THR . 15.2 mmtm -134.18 146.84 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.916 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.09 140.71 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.857 0.36 . . . . 0.0 111.626 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.432 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -134.54 132.73 39.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.281 0.562 . . . . 0.0 110.45 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 21' ' ' CYS . 11.1 m-85 -107.3 128.05 54.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.49 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.873 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 111.147 0.054 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' C' ' 158' ' ' TYR . . . 52.78 88.29 0.03 OUTLIER 'General case' 0 C--O 1.232 0.15 0 O-C-N 123.154 0.284 . . . . 0.0 111.039 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' C' ' 157' ' ' GLN . 5.5 m -122.92 116.22 23.24 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.379 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.492 HG21 ' CA ' ' F' ' 127' ' ' GLY . 1.8 m -99.68 117.18 33.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.563 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.616 HG23 HG23 ' C' ' 156' ' ' VAL . 1.8 m -144.41 158.09 15.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.577 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' C' ' 154' ' ' PHE . 13.1 t30 -78.74 123.81 27.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.54 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.77 -71.24 1.0 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.836 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.531 ' H ' ' HB3' ' C' ' 154' ' ' PHE . . . -152.66 -147.05 4.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.84 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.954 HG22 HG23 ' C' ' 153' ' ' THR . 24.5 p -148.69 134.44 18.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.969 0.414 . . . . 0.0 111.318 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.39 124.34 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.147 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' HIS . . . . . 0.636 ' HA ' ' OD1' ' C' ' 151' ' ' ASP . 57.4 t-80 -91.47 116.2 28.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.337 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -96.88 105.53 17.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.738 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.407 ' HG2' ' ND2' ' C' ' 149' ' ' ASN . 5.1 tttm -104.62 118.72 37.28 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.474 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.3 172.9 30.81 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.936 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.738 ' O ' ' HA ' ' C' ' 36' ' ' GLN . 25.8 tt0 -160.38 135.95 8.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.911 0.386 . . . . 0.0 110.398 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.761 HG23 ' HB2' ' C' ' 148' ' ' ALA . 43.7 t -96.87 132.79 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.204 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.706 HG11 ' NE2' ' C' ' 36' ' ' GLN . 18.1 m -133.88 -177.12 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.934 0.397 . . . . 0.0 110.98 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . 0.563 ' HA ' HG22 ' C' ' 39' ' ' THR . 0.3 OUTLIER -75.85 -170.34 1.32 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.931 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.76 45.51 0.97 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.084 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.577 ' O ' HD21 ' B' ' 124' ' ' LEU . . . -121.34 -24.85 5.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.386 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.716 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER -168.81 140.64 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.864 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' B' ' 60' ' ' ASP . . . -132.79 116.97 17.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.082 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.744 HG12 ' HB2' ' C' ' 36' ' ' GLN . 0.5 OUTLIER -67.05 146.22 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.034 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.473 ' O ' HG23 ' B' ' 28' ' ' VAL . 12.8 t0 -80.33 152.09 29.15 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.562 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.84 -39.95 95.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.417 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.9 2.65 85.83 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.844 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -106.26 -19.89 13.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.826 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 24' ' ' ASP . 39.8 t -47.36 -52.22 5.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.336 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.15 136.43 48.66 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.036 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.63 136.86 39.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.066 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.53 102.87 12.77 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.062 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 26.0 t -107.69 128.25 63.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.527 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -114.7 123.07 48.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.652 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.43 -42.71 15.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.61 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.44 -167.44 13.2 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.581 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.741 ' HB2' HG12 ' A' ' 23' ' ' VAL . 3.7 mt-30 -96.7 124.47 40.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.613 0.244 . . . . 0.0 110.892 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.78 147.53 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.93 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.67 134.95 34.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.026 0.441 . . . . 0.0 111.669 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -60.07 -44.49 94.7 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.739 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.29 -36.84 61.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.184 0.516 . . . . 0.0 110.919 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.83 -35.86 62.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.223 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.755 HD23 HG13 ' B' ' 99' ' ' VAL . 2.9 mp -106.69 34.58 3.34 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.626 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.95 15.88 27.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.329 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.0 132.08 56.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.299 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' B' ' 140' ' ' THR . 6.7 tt0 -56.58 108.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.846 0.355 . . . . 0.0 111.076 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.95 25.9 10.12 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.144 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' B' ' 139' ' ' ALA . . . -71.42 137.77 48.57 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 7.3 p -136.98 122.75 19.93 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.927 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' B' ' 136' ' ' ARG . 53.4 m -100.09 -175.21 2.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.644 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.9 t -55.67 137.33 49.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.799 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.481 ' CA ' ' HB3' ' B' ' 136' ' ' ARG . . . -92.29 133.46 35.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.327 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.683 HG22 ' O ' ' B' ' 135' ' ' ALA . 26.1 m -76.71 162.54 4.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.49 141.16 16.78 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.592 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -173.76 137.77 0.62 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.804 0.335 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -136.56 145.83 45.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.603 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.527 HG23 ' O ' ' B' ' 56' ' ' ILE . 1.2 tp -91.03 116.77 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.607 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . 0.722 ' HA ' HG23 ' B' ' 130' ' ' THR . 1.3 mp0 -72.93 128.58 35.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.79 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.457 ' HG ' ' HA ' ' B' ' 23' ' ' VAL . 0.3 OUTLIER -137.31 89.17 2.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.242 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.723 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 9.8 p30 -74.81 176.53 6.98 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.012 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . 0.512 ' HB2' ' HB3' ' B' ' 22' ' ' ALA . 0.9 OUTLIER 58.93 74.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' CYS . . . . . 0.716 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 36.8 m -126.32 148.86 49.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.804 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . 0.404 ' OD2' HG23 ' B' ' 65' ' ' VAL . 1.6 t70 -121.58 169.77 10.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.281 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.27 -32.69 4.89 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -76.52 -27.94 56.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.169 0.509 . . . . 0.0 111.72 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . 0.404 HG23 ' OD2' ' B' ' 62' ' ' ASP . 25.6 t -73.66 -56.69 8.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.677 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.466 ' HB3' ' HB1' ' B' ' 20' ' ' ALA . . . -135.02 122.74 22.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.674 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -50.04 5.13 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.89 0.376 . . . . 0.0 110.923 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -89.76 152.12 21.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.574 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' B' ' 122' ' ' THR . . . -144.25 137.8 27.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.604 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.603 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -113.35 157.25 22.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.11 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.754 HG11 HG21 ' B' ' 131' ' ' ILE . 1.8 t -138.78 149.96 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.656 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.82 155.11 37.52 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.596 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.545 ' CB ' HD13 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -125.04 136.68 53.92 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.634 0.254 . . . . 0.0 110.969 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.581 HD11 ' HG3' ' E' ' 57' ' ' GLN . 0.9 OUTLIER -97.15 136.1 38.15 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.032 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . 0.459 ' CA ' ' HB3' ' B' ' 113' ' ' LEU . . . -174.02 -172.95 39.74 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.731 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.677 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.2 OUTLIER -118.63 144.55 46.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.537 0.208 . . . . 0.0 110.831 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.652 ' HB2' HG23 ' B' ' 83' ' ' THR . . . -62.48 138.53 58.48 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.958 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.501 HG23 ' N ' ' B' ' 79' ' ' ASP . 5.7 tt -71.55 -45.59 67.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.884 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.501 ' N ' HG23 ' B' ' 78' ' ' ILE . 0.3 OUTLIER -133.19 42.54 3.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.818 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' B' ' 79' ' ' ASP . . . 70.04 -80.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.056 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.08 -29.71 68.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.56 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.422 ' HB3' HG22 ' B' ' 78' ' ' ILE . 1.6 m80 -89.87 69.39 7.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.418 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' THR . . . . . 0.652 HG23 ' HB2' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -74.47 -16.2 60.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.604 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . 0.726 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 20.8 p-10 -66.11 -19.16 65.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.334 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' B' ' 138' ' ' PHE . 13.5 t -113.6 133.83 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.173 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.774 ' HG ' HD13 ' B' ' 113' ' ' LEU . 0.4 OUTLIER -67.83 161.53 26.04 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' B' ' 77' ' ' ALA . . . -103.61 -174.72 2.61 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.866 0.365 . . . . 0.0 111.772 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.703 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 0.3 OUTLIER -67.36 165.21 16.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.049 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . 0.519 ' CG ' ' HB2' ' B' ' 149' ' ' ASN . 5.7 mm-40 -63.42 -79.73 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.33 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . 0.45 ' O ' HG12 ' E' ' 52' ' ' VAL . 2.3 p -165.48 3.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 111.549 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' SER . . . . . 0.536 ' HA ' ' HB2' ' D' ' 25' ' ' ALA . 0.7 OUTLIER -80.16 79.73 6.68 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.501 ' HB2' HG13 ' E' ' 52' ' ' VAL . . . -57.05 -24.76 56.15 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.868 0.366 . . . . 0.0 111.617 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.2 33.99 5.24 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.692 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.77 0.42 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.911 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' SER . . . . . 0.703 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . 38.4 m -96.8 177.93 5.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.873 0.368 . . . . 0.0 110.622 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.54 -178.65 7.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.806 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' B' ' 98' ' ' ASN . 2.0 m -134.42 119.05 18.09 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.379 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' B' ' 97' ' ' THR . 32.5 m-20 68.68 34.53 3.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.441 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . 0.755 HG13 HD23 ' B' ' 42' ' ' LEU . 0.4 OUTLIER -138.13 130.85 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.784 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.14 -170.63 18.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.539 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' B' ' 86' ' ' LEU . 0.2 OUTLIER -119.61 114.48 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.017 0.527 . . . . 0.0 111.766 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 0.8 OUTLIER -87.4 150.24 23.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.92 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.55 HG12 ' HG ' ' B' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 135.99 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.471 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.31 133.59 55.05 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.654 0.264 . . . . 0.0 110.988 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . 0.864 ' HB3' HG22 ' B' ' 107' ' ' THR . 6.1 t0 -82.29 149.75 27.63 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.725 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . 0.736 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.4 OUTLIER -67.82 -16.26 64.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.811 0.339 . . . . 0.0 111.103 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.864 HG22 ' HB3' ' B' ' 105' ' ' ASP . 8.8 t -63.69 -28.39 69.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.006 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.08 -40.55 1.57 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.662 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . 0.419 ' H ' HG23 ' B' ' 107' ' ' THR . . . -91.48 163.12 14.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.819 0.342 . . . . 0.0 111.052 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.12 133.35 35.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.204 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.564 HD21 ' O ' ' B' ' 117' ' ' THR . 4.8 tp -96.69 150.0 21.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.413 0.625 . . . . 0.0 110.539 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.864 HG23 HG21 ' B' ' 117' ' ' THR . 1.9 t -98.48 141.76 30.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.177 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.774 HD13 ' HG ' ' B' ' 86' ' ' LEU . 1.6 mt -76.36 89.4 3.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.741 0.305 . . . . 0.0 110.746 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.07 -18.14 5.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.503 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.8 -60.65 0.46 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.588 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . 0.501 ' HB2' ' N ' ' E' ' 129' ' ' ASN . . . -96.5 27.03 4.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.035 0.445 . . . . 0.0 111.632 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . 0.864 HG21 HG23 ' B' ' 112' ' ' THR . 0.0 OUTLIER -87.07 74.89 9.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.164 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.603 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . 62.6 m-85 -94.92 92.89 7.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 25.5 m -136.33 68.93 1.43 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.86 150.29 28.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.557 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -107.34 67.63 0.7 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.206 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.614 ' O ' ' HB3' ' B' ' 69' ' ' ALA . 0.2 OUTLIER -79.15 114.71 18.31 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.757 -179.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 12.0 m -73.98 128.02 34.41 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.713 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.577 HD21 ' O ' ' B' ' 20' ' ' ALA . 4.0 tp -92.11 132.17 36.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.614 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.17 151.09 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.583 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' B' ' 61' ' ' CYS . 3.1 t30 -69.03 111.97 5.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.627 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.55 -138.96 8.75 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.643 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . 0.723 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 87.7 m -98.71 82.55 2.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.637 0.256 . . . . 0.0 110.792 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . 0.462 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 2.3 t30 -71.76 148.14 46.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.805 0.336 . . . . 0.0 111.188 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.722 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -138.64 148.61 44.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' ILE . . . . . 0.754 HG21 HG11 ' B' ' 71' ' ' VAL . 15.6 mt -110.01 112.22 57.91 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' PRO . . . . . 0.736 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.83 137.03 9.72 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.574 1.516 . . . . 0.0 112.578 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.03 136.02 19.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.739 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -111.45 158.41 19.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.033 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.683 ' O ' HG22 ' B' ' 52' ' ' VAL . . . -154.15 111.33 3.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.924 0.392 . . . . 0.0 111.633 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . 0.481 ' HB3' ' CA ' ' B' ' 51' ' ' ALA . 19.8 ptt180 -108.94 174.11 6.02 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.375 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . 0.686 ' HB3' HD21 ' B' ' 42' ' ' LEU . 1.7 m-85 -81.4 137.64 35.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.047 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . 0.517 ' HB3' HG21 ' B' ' 85' ' ' VAL . 0.9 OUTLIER -131.53 124.14 29.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.104 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' B' ' 47' ' ' ALA . . . -108.51 130.16 55.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.834 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' B' ' 45' ' ' GLU . 0.2 OUTLIER -77.44 -27.9 52.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.571 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.48 -96.52 0.11 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.006 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.99 98.49 8.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.572 0.225 . . . . 0.0 110.666 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -56.64 148.93 18.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.742 0.306 . . . . 0.0 111.418 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.724 ' CG2' ' CD ' ' B' ' 145' ' ' PRO . 90.5 m -125.44 156.95 69.57 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.208 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . 0.724 ' CD ' ' CG2' ' B' ' 144' ' ' THR . 1.4 Cg_endo -83.42 136.28 7.53 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.52 2.147 . . . . 0.0 111.974 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' A' ' 15' ' ' GLU . . . 163.64 -127.57 1.69 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.51 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.66 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -110.93 132.92 53.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.829 0.347 . . . . 0.0 111.328 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' ALA . . . . . 0.778 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -124.28 43.75 2.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.422 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.519 ' HB2' ' CG ' ' B' ' 89' ' ' GLN . 9.3 m120 -92.34 144.32 25.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.506 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.692 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -160.68 178.85 9.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.968 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . 0.624 ' OD1' ' HA ' ' A' ' 11' ' ' HIS . 15.7 t70 -146.97 145.03 29.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.218 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -133.79 139.73 46.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.18 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.965 HG23 HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -101.04 135.25 42.79 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.131 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' PHE . . . . . 0.543 ' HB3' ' H ' ' A' ' 8' ' ' GLY . 0.2 OUTLIER -81.52 152.16 27.42 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.118 0.485 . . . . 0.0 110.125 -179.082 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . 0.424 ' HE3' ' HB ' ' E' ' 128' ' ' THR . 15.2 mmtm -134.22 146.84 50.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.877 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' VAL . . . . . 0.633 HG23 HG23 ' A' ' 5' ' ' VAL . 33.1 m -139.07 140.77 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.8 0.333 . . . . 0.0 111.617 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 3' ' ' THR . 0.9 OUTLIER -134.52 132.67 39.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.272 0.558 . . . . 0.0 110.485 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' TYR . . . . . 0.56 ' CE1' ' HB2' ' B' ' 21' ' ' CYS . 10.9 m-85 -107.22 128.01 54.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.557 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.907 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 120.222 0.058 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' D' ' 158' ' ' TYR . . . 52.76 88.35 0.03 OUTLIER 'General case' 0 C--O 1.232 0.163 0 O-C-N 123.141 0.275 . . . . 0.0 111.015 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' D' ' 157' ' ' GLN . 5.5 m -123.0 116.28 23.27 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.381 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -99.66 117.16 33.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.6 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.629 HG23 HG23 ' D' ' 156' ' ' VAL . 1.8 m -144.45 157.96 14.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.626 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' D' ' 154' ' ' PHE . 13.2 t30 -78.66 123.75 27.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.582 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.7 -71.24 1.0 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.819 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . 0.541 ' H ' ' HB3' ' D' ' 154' ' ' PHE . . . -152.7 -147.01 4.49 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.773 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . 0.93 HG22 HG23 ' D' ' 153' ' ' THR . 24.1 p -148.75 134.51 18.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.053 0.454 . . . . 0.0 111.243 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.35 124.33 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.201 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' HIS . . . . . 0.632 ' HA ' ' OD1' ' D' ' 151' ' ' ASP . 57.4 t-80 -91.51 116.13 28.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.308 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -96.8 105.49 17.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.824 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . 0.409 ' HG2' ' ND2' ' D' ' 149' ' ' ASN . 5.1 tttm -104.66 118.67 37.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.484 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.22 172.94 30.76 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.98 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' GLU . . . . . 0.738 ' O ' ' HA ' ' D' ' 36' ' ' GLN . 25.7 tt0 -160.39 135.93 8.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.913 0.387 . . . . 0.0 110.459 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.77 HG23 ' HB2' ' D' ' 148' ' ' ALA . 43.8 t -96.86 132.85 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.168 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.723 HG11 ' NE2' ' D' ' 36' ' ' GLN . 18.2 m -133.97 -177.21 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.93 0.395 . . . . 0.0 110.965 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . 0.569 ' HA ' HG22 ' D' ' 39' ' ' THR . 0.3 OUTLIER -75.75 -170.28 1.27 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.977 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.82 45.5 0.97 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.073 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . 0.559 ' O ' HD21 ' C' ' 124' ' ' LEU . . . -121.31 -24.85 5.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.383 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' CYS . . . . . 0.698 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER -168.87 140.69 2.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.864 -179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' HB2' ' C' ' 60' ' ' ASP . . . -132.82 117.02 17.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.041 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . 0.733 HG12 ' HB2' ' D' ' 36' ' ' GLN . 0.5 OUTLIER -67.11 146.26 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.113 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.466 ' O ' HG23 ' C' ' 28' ' ' VAL . 12.9 t0 -80.4 152.11 29.02 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.545 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.528 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -62.77 -40.02 95.97 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.483 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.91 2.67 85.83 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.886 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -106.14 -20.05 13.53 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.872 0.368 . . . . 0.0 110.817 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.466 HG23 ' O ' ' C' ' 24' ' ' ASP . 39.7 t -47.31 -52.15 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.324 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.21 136.42 48.71 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.995 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.72 136.91 39.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.017 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.56 102.86 12.76 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.074 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 26.1 t -107.66 128.34 62.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.051 0.453 . . . . 0.0 110.485 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -114.78 123.16 48.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.603 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.49 -42.74 15.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.593 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.5 -167.42 13.17 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.613 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . 0.744 ' HB2' HG12 ' B' ' 23' ' ' VAL . 3.7 mt-30 -96.77 124.42 40.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.586 0.231 . . . . 0.0 110.882 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.73 147.59 11.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.946 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.76 134.97 34.31 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.67 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.563 HG22 ' HA ' ' B' ' 18' ' ' ASN . 0.0 OUTLIER -60.1 -44.37 94.88 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.798 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.41 -36.74 61.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.063 0.458 . . . . 0.0 110.835 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.97 -35.73 62.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.191 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.751 HD23 HG13 ' C' ' 99' ' ' VAL . 2.9 mp -106.71 34.56 3.36 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.646 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.97 15.82 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.334 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.96 132.05 56.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.359 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' C' ' 140' ' ' THR . 6.8 tt0 -56.54 108.8 0.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.806 0.336 . . . . 0.0 111.107 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.89 25.96 10.12 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.152 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' C' ' 139' ' ' ALA . . . -71.49 137.8 48.45 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 7.4 p -137.01 122.77 19.93 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.864 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' C' ' 136' ' ' ARG . 54.0 m -100.09 -175.16 2.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.655 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 2.8 t -55.63 137.3 49.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.811 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . 0.481 ' CA ' ' HB3' ' C' ' 136' ' ' ARG . . . -92.4 133.48 35.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.34 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.68 HG22 ' O ' ' C' ' 135' ' ' ALA . 26.4 m -76.7 162.51 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.56 141.2 16.79 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.519 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -173.74 137.73 0.62 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.721 0.296 . . . . 0.0 111.015 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -136.5 145.74 45.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.647 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.532 HG23 ' O ' ' C' ' 56' ' ' ILE . 1.2 tp -90.92 116.76 32.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.68 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.704 ' HA ' HG23 ' C' ' 130' ' ' THR . 1.3 mp0 -72.9 128.55 35.83 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . 0.453 ' HG ' ' HA ' ' C' ' 23' ' ' VAL . 0.3 OUTLIER -137.28 89.18 2.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.284 -179.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . 0.709 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 9.8 p30 -74.82 176.46 7.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.013 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' ASP . . . . . 0.498 ' HB2' ' HB3' ' C' ' 22' ' ' ALA . 0.8 OUTLIER 58.92 74.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.818 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' CYS . . . . . 0.698 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 36.3 m -126.34 148.91 49.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . 0.403 ' OD2' HG23 ' C' ' 65' ' ' VAL . 1.6 t70 -121.63 169.72 10.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.35 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.26 -32.7 4.89 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.52 -27.88 56.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 111.765 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.403 HG23 ' OD2' ' C' ' 62' ' ' ASP . 25.6 t -73.6 -56.81 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.64 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . 0.466 ' HB3' ' HB1' ' C' ' 20' ' ' ALA . . . -134.98 122.7 22.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.65 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.45 -50.1 5.14 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.861 0.362 . . . . 0.0 110.997 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' LYS . . . . . 0.429 ' HA ' ' HZ3' ' C' ' 68' ' ' LYS . 1.8 tptp -89.78 152.14 21.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.558 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' C' ' 122' ' ' THR . . . -144.26 137.84 27.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.575 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -113.41 157.24 22.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.073 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . 0.736 HG11 HG21 ' C' ' 131' ' ' ILE . 1.8 t -138.74 149.94 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.665 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.82 155.1 37.51 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.59 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' PHE . . . . . 0.552 ' CB ' HD13 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -124.99 136.66 53.93 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.012 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.568 HD11 ' HG3' ' F' ' 57' ' ' GLN . 0.9 OUTLIER -97.16 136.17 38.07 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.994 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' C' ' 113' ' ' LEU . . . -174.01 -172.95 39.74 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.817 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.666 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.2 OUTLIER -118.67 144.54 46.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.551 0.215 . . . . 0.0 110.796 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . 0.637 ' HB2' HG23 ' C' ' 83' ' ' THR . . . -62.5 138.6 58.5 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.913 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . 0.508 HG23 ' N ' ' C' ' 79' ' ' ASP . 5.7 tt -71.66 -45.54 66.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.85 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' ASP . . . . . 0.508 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.3 OUTLIER -133.15 42.47 3.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' C' ' 79' ' ' ASP . . . 70.19 -80.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.032 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.11 -29.68 68.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.609 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . 0.432 ' HB3' HG22 ' C' ' 78' ' ' ILE . 1.7 m80 -89.84 69.39 7.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.832 0.349 . . . . 0.0 110.424 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . 0.637 HG23 ' HB2' ' C' ' 77' ' ' ALA . 0.2 OUTLIER -74.55 -16.13 60.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.604 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' ASN . . . . . 0.746 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 20.8 p-10 -66.18 -19.04 65.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.336 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.523 HG21 ' HB3' ' C' ' 138' ' ' PHE . 13.5 t -113.66 133.86 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.128 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.773 ' HG ' HD13 ' C' ' 113' ' ' LEU . 0.4 OUTLIER -67.91 161.53 26.22 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.267 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' C' ' 77' ' ' ALA . . . -103.58 -174.66 2.6 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.862 0.363 . . . . 0.0 111.764 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.702 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 0.3 OUTLIER -67.4 165.17 17.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.116 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' GLN . . . . . 0.525 ' CG ' ' HB2' ' C' ' 149' ' ' ASN . 5.7 mm-40 -63.36 -79.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.365 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' SER . . . . . 0.449 ' O ' HG12 ' F' ' 52' ' ' VAL . 2.3 p -165.52 3.61 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.01 0.433 . . . . 0.0 111.579 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' SER . . . . . 0.533 ' HA ' ' HB2' ' E' ' 25' ' ' ALA . 0.7 OUTLIER -80.09 79.83 6.59 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' ALA . . . . . 0.522 ' HB2' HG13 ' F' ' 52' ' ' VAL . . . -57.09 -24.79 56.49 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.891 0.377 . . . . 0.0 111.634 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.17 33.94 5.25 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.69 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.85 0.46 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.937 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' SER . . . . . 0.702 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 38.6 m -96.78 177.94 5.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 110.607 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.52 -178.73 7.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.784 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . 0.495 ' HB ' ' OG1' ' C' ' 144' ' ' THR . 2.0 m -134.44 119.02 18.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.369 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' C' ' 97' ' ' THR . 32.8 m-20 68.78 34.48 3.33 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.457 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 99' ' ' VAL . . . . . 0.751 HG13 HD23 ' C' ' 42' ' ' LEU . 0.4 OUTLIER -138.12 130.85 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.727 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.21 -170.63 19.01 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.566 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' VAL . . . . . 0.59 HG13 ' HB2' ' C' ' 86' ' ' LEU . 0.2 OUTLIER -119.62 114.51 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 123.028 0.531 . . . . 0.0 111.717 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 102' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 0.8 OUTLIER -87.39 150.2 23.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.923 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.563 HG12 ' HG ' ' C' ' 113' ' ' LEU . 0.8 OUTLIER -114.94 136.07 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.481 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.37 133.52 55.11 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.711 0.291 . . . . 0.0 111.032 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . 0.838 ' HB3' HG22 ' C' ' 107' ' ' THR . 6.1 t0 -82.24 149.74 27.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.674 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 106' ' ' ARG . . . . . 0.757 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.4 OUTLIER -67.87 -16.23 63.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.795 0.331 . . . . 0.0 111.058 179.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 107' ' ' THR . . . . . 0.838 HG22 ' HB3' ' C' ' 105' ' ' ASP . 8.8 t -63.62 -28.39 69.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.043 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.97 -40.46 1.58 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.717 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 109' ' ' ALA . . . . . 0.416 ' H ' HG23 ' C' ' 107' ' ' THR . . . -91.54 163.08 14.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.822 0.344 . . . . 0.0 110.999 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.14 133.36 35.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.198 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 111' ' ' LEU . . . . . 0.563 HD21 ' O ' ' C' ' 117' ' ' THR . 4.8 tp -96.72 149.98 21.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.368 0.604 . . . . 0.0 110.603 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 112' ' ' THR . . . . . 0.848 HG23 HG21 ' C' ' 117' ' ' THR . 1.9 t -98.43 141.73 30.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.773 HD13 ' HG ' ' C' ' 86' ' ' LEU . 1.6 mt -76.39 89.48 3.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.808 0.337 . . . . 0.0 110.727 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.15 -18.06 5.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.697 0.284 . . . . 0.0 111.525 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.78 -60.63 0.46 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.559 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 116' ' ' ALA . . . . . 0.504 ' HB2' ' C ' ' F' ' 128' ' ' THR . . . -96.46 26.96 4.04 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.996 0.427 . . . . 0.0 111.636 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . 0.848 HG21 HG23 ' C' ' 112' ' ' THR . 0.0 OUTLIER -87.04 74.81 9.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.157 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 118' ' ' PHE . . . . . 0.595 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . 62.8 m-85 -94.93 92.93 7.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.812 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 25.6 m -136.35 68.94 1.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.831 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.83 150.27 28.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.646 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.34 67.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.178 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' C' ' 69' ' ' ALA . 0.2 OUTLIER -79.19 114.71 18.35 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.7 -179.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -74.02 128.04 34.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.729 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . 0.559 HD21 ' O ' ' C' ' 20' ' ' ALA . 4.0 tp -92.14 132.19 36.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.594 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.13 151.01 49.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.641 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 126' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' C' ' 61' ' ' CYS . 3.1 t30 -69.05 112.11 5.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.632 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.43 -138.93 8.77 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.756 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 128' ' ' THR . . . . . 0.709 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 87.0 m -98.72 82.54 2.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.642 0.258 . . . . 0.0 110.827 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 129' ' ' ASN . . . . . 0.454 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 2.3 t30 -71.84 148.13 46.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.89 0.376 . . . . 0.0 111.145 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 130' ' ' THR . . . . . 0.704 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -138.57 148.57 44.33 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.209 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 131' ' ' ILE . . . . . 0.736 HG21 HG11 ' C' ' 71' ' ' VAL . 15.7 mt -110.03 112.27 57.83 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 132' ' ' PRO . . . . . 0.757 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.6 Cg_endo -81.8 137.02 9.75 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.599 1.532 . . . . 0.0 112.566 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.01 136.09 19.94 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.727 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -111.5 158.38 19.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.081 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . 0.68 ' O ' HG22 ' C' ' 52' ' ' VAL . . . -154.18 111.36 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.969 0.414 . . . . 0.0 111.64 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.481 ' HB3' ' CA ' ' C' ' 51' ' ' ALA . 19.8 ptt180 -108.89 174.06 6.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.385 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 137' ' ' TYR . . . . . 0.706 ' HB3' HD21 ' C' ' 42' ' ' LEU . 1.7 m-85 -81.41 137.73 35.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.103 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 138' ' ' PHE . . . . . 0.523 ' HB3' HG21 ' C' ' 85' ' ' VAL . 0.9 OUTLIER -131.58 124.13 29.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.092 -179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 139' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' C' ' 47' ' ' ALA . . . -108.48 130.19 55.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.824 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 140' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' C' ' 45' ' ' GLU . 0.2 OUTLIER -77.46 -27.93 52.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.518 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.5 -96.54 0.11 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.955 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.95 98.49 8.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.578 0.227 . . . . 0.0 110.714 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 143' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -56.56 148.92 18.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.757 0.313 . . . . 0.0 111.364 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 144' ' ' THR . . . . . 0.715 ' CG2' ' CD ' ' C' ' 145' ' ' PRO . 91.0 m -125.43 156.99 69.5 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.247 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 145' ' ' PRO . . . . . 0.715 ' CD ' ' CG2' ' C' ' 144' ' ' THR . 1.5 Cg_endo -83.38 136.17 7.51 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.631 2.22 . . . . 0.0 111.987 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 146' ' ' GLY . . . . . 0.577 ' O ' ' HG3' ' B' ' 15' ' ' GLU . . . 163.62 -127.57 1.69 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.429 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 147' ' ' ALA . . . . . 0.659 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -110.88 132.9 53.81 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.763 0.316 . . . . 0.0 111.369 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 148' ' ' ALA . . . . . 0.761 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -124.28 43.78 2.91 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.107 0.479 . . . . 0.0 110.438 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 149' ' ' ASN . . . . . 0.525 ' HB2' ' CG ' ' C' ' 89' ' ' GLN . 9.2 m120 -92.33 144.27 25.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.511 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 150' ' ' ALA . . . . . 0.695 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -160.66 178.88 9.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.989 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 151' ' ' ASP . . . . . 0.636 ' OD1' ' HA ' ' B' ' 11' ' ' HIS . 15.6 t70 -146.98 145.02 29.6 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.298 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 152' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -133.75 139.78 46.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.273 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . 0.954 HG23 HG22 ' B' ' 9' ' ' THR . 0.2 OUTLIER -101.11 135.28 42.83 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.202 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 154' ' ' PHE . . . . . 0.531 ' HB3' ' H ' ' B' ' 8' ' ' GLY . 0.2 OUTLIER -81.54 152.17 27.4 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.06 0.457 . . . . 0.0 110.136 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 155' ' ' LYS . . . . . 0.419 ' HE3' ' HB ' ' F' ' 128' ' ' THR . 15.2 mmtm -134.24 146.87 50.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.934 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 156' ' ' VAL . . . . . 0.616 HG23 HG23 ' B' ' 5' ' ' VAL . 33.1 m -139.18 140.79 37.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.859 0.362 . . . . 0.0 111.622 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 157' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' B' ' 3' ' ' THR . 0.9 OUTLIER -134.53 132.68 39.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.335 0.588 . . . . 0.0 110.406 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 158' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' C' ' 21' ' ' CYS . 11.0 m-85 -107.35 128.04 54.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.541 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.823 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.267 0.079 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' E' ' 158' ' ' TYR . . . 52.85 88.35 0.03 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.976 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 3' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' E' ' 157' ' ' GLN . 5.4 m -123.0 116.2 23.16 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.413 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -99.6 117.22 33.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.582 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.629 HG23 HG23 ' E' ' 156' ' ' VAL . 1.8 m -144.44 158.03 15.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.655 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 6' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' E' ' 154' ' ' PHE . 13.2 t30 -78.71 123.75 27.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.597 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.83 -71.1 1.02 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.792 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . 0.522 ' H ' ' HB3' ' E' ' 154' ' ' PHE . . . -152.75 -146.98 4.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.806 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . 0.932 HG22 HG23 ' E' ' 153' ' ' THR . 24.1 p -148.76 134.49 18.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.011 0.434 . . . . 0.0 111.258 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.4 124.37 72.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.159 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' HIS . . . . . 0.619 ' HA ' ' OD1' ' E' ' 151' ' ' ASP . 57.3 t-80 -91.52 116.17 28.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.292 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -96.84 105.49 17.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.814 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' LYS . . . . . 0.416 ' HG2' ' ND2' ' E' ' 149' ' ' ASN . 5.1 tttm -104.64 118.73 37.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.422 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.31 172.93 30.82 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.945 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' GLU . . . . . 0.744 ' O ' ' HA ' ' E' ' 36' ' ' GLN . 25.8 tt0 -160.36 135.96 8.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.943 0.401 . . . . 0.0 110.339 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.777 HG23 ' HB2' ' E' ' 148' ' ' ALA . 43.2 t -96.79 132.81 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.25 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.723 HG11 ' NE2' ' E' ' 36' ' ' GLN . 18.2 m -133.91 -177.16 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.897 0.38 . . . . 0.0 111.008 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' ASN . . . . . 0.565 ' HA ' HG22 ' E' ' 39' ' ' THR . 0.3 OUTLIER -75.74 -170.37 1.3 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.932 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.74 45.41 0.98 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.029 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.576 ' O ' HD21 ' D' ' 124' ' ' LEU . . . -121.36 -24.78 5.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.369 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER -168.82 140.65 2.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.881 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' D' ' 60' ' ' ASP . . . -132.8 116.99 17.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.068 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . 0.738 HG12 ' HB2' ' E' ' 36' ' ' GLN . 0.5 OUTLIER -67.05 146.18 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.044 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.467 ' O ' HG23 ' D' ' 28' ' ' VAL . 12.9 t0 -80.33 152.04 29.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.58 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -62.69 -40.07 95.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.464 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.91 2.64 85.81 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.867 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -106.17 -19.94 13.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.845 0.355 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . 0.467 HG23 ' O ' ' D' ' 24' ' ' ASP . 39.8 t -47.42 -52.1 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.344 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.19 136.41 48.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.032 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.72 136.92 39.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.035 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.48 102.77 12.69 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.057 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 25.7 t -107.64 128.29 62.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.058 0.456 . . . . 0.0 110.56 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -114.75 123.03 48.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.614 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.4 -42.71 15.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.684 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.55 -167.43 13.16 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.618 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' GLN . . . . . 0.738 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 3.7 mt-30 -96.79 124.58 40.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.618 0.247 . . . . 0.0 110.845 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.86 147.52 11.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.822 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.77 134.98 34.3 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.661 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.569 HG22 ' HA ' ' C' ' 18' ' ' ASN . 0.0 OUTLIER -60.04 -44.42 94.66 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.828 179.321 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.35 -36.78 61.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.135 0.493 . . . . 0.0 110.92 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.94 -35.86 62.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.135 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.746 HD23 HG13 ' D' ' 99' ' ' VAL . 2.9 mp -106.6 34.55 3.35 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.614 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.9 15.8 27.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.32 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.94 132.09 56.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.323 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' D' ' 140' ' ' THR . 6.8 tt0 -56.55 108.78 0.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.744 0.307 . . . . 0.0 111.117 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.95 25.88 10.14 Favored Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.136 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' D' ' 139' ' ' ALA . . . -71.48 137.76 48.45 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.963 0.411 . . . . 0.0 112.058 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 7.3 p -137.01 122.77 19.93 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.92 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' D' ' 136' ' ' ARG . 53.4 m -100.12 -175.19 2.88 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.606 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 2.9 t -55.59 137.31 49.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.808 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' ALA . . . . . 0.48 ' CA ' ' HB3' ' D' ' 136' ' ' ARG . . . -92.41 133.51 35.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.348 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' VAL . . . . . 0.675 HG22 ' O ' ' D' ' 135' ' ' ALA . 26.6 m -76.76 162.47 4.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.49 141.16 16.78 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.552 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.569 ' H ' HG21 ' A' ' 76' ' ' THR . 39.4 p90 -173.74 137.79 0.62 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.783 0.325 . . . . 0.0 110.965 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' ASN . . . . . 0.501 ' OD1' HD21 ' A' ' 74' ' ' LEU . 17.9 p30 -136.5 145.81 45.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.681 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.532 HG23 ' O ' ' D' ' 56' ' ' ILE . 1.2 tp -90.95 116.76 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.627 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' GLN . . . . . 0.729 ' HA ' HG23 ' D' ' 130' ' ' THR . 1.3 mp0 -72.87 128.59 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.803 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . 0.46 ' HG ' ' HA ' ' D' ' 23' ' ' VAL . 0.3 OUTLIER -137.31 89.11 2.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.264 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . 0.722 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 9.8 p30 -74.76 176.54 6.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.951 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' ASP . . . . . 0.505 ' HB2' ' HB3' ' D' ' 22' ' ' ALA . 0.9 OUTLIER 58.9 74.79 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.888 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 36.6 m -126.33 148.89 49.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.808 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . 0.412 ' OD2' HG23 ' D' ' 65' ' ' VAL . 1.5 t70 -121.61 169.78 10.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.317 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.32 -32.63 4.9 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -76.57 -27.89 56.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.197 0.522 . . . . 0.0 111.742 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . 0.412 HG23 ' OD2' ' D' ' 62' ' ' ASP . 25.6 t -73.57 -56.83 8.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.677 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.458 ' HB3' ' HB1' ' D' ' 20' ' ' ALA . . . -134.93 122.77 22.39 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.647 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.57 -50.02 5.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.921 0.391 . . . . 0.0 110.977 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -89.84 152.12 21.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.517 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' D' ' 122' ' ' THR . . . -144.22 137.86 27.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.586 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . 0.596 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -113.41 157.23 22.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.078 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . 0.739 HG11 HG21 ' D' ' 131' ' ' ILE . 1.8 t -138.7 150.0 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.638 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.8 155.11 37.54 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.624 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 73' ' ' PHE . . . . . 0.546 ' CB ' HD13 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -125.08 136.69 53.9 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.651 0.262 . . . . 0.0 111.012 179.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 74' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.9 OUTLIER -97.19 136.12 38.16 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.978 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' D' ' 113' ' ' LEU . . . -174.03 -172.96 39.76 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.744 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.2 OUTLIER -118.72 144.57 46.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.552 0.215 . . . . 0.0 110.801 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.632 ' HB2' HG23 ' D' ' 83' ' ' THR . . . -62.47 138.53 58.48 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.91 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 78' ' ' ILE . . . . . 0.507 HG23 ' N ' ' D' ' 79' ' ' ASP . 5.7 tt -71.52 -45.65 67.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.893 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.507 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.3 OUTLIER -133.15 42.55 3.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.771 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' D' ' 79' ' ' ASP . . . 70.16 -80.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.11 -29.7 68.89 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.529 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . 0.445 ' HB3' HG22 ' D' ' 78' ' ' ILE . 1.7 m80 -89.82 69.39 7.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.754 0.311 . . . . 0.0 110.436 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 83' ' ' THR . . . . . 0.632 HG23 ' HB2' ' D' ' 77' ' ' ALA . 0.2 OUTLIER -74.56 -16.15 60.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.6 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . 0.746 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 20.8 p-10 -66.24 -19.08 65.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.261 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' D' ' 138' ' ' PHE . 13.4 t -113.57 133.84 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.179 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.765 ' HG ' HD13 ' D' ' 113' ' ' LEU . 0.4 OUTLIER -67.87 161.47 26.27 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' D' ' 77' ' ' ALA . . . -103.59 -174.72 2.61 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.837 0.351 . . . . 0.0 111.79 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.709 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 0.3 OUTLIER -67.33 165.23 16.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.104 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 89' ' ' GLN . . . . . 0.529 ' CG ' ' HB2' ' D' ' 149' ' ' ASN . 5.7 mm-40 -63.43 -79.76 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.323 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -165.46 3.78 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.051 0.453 . . . . 0.0 111.6 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' F' ' 25' ' ' ALA . 0.7 OUTLIER -80.09 79.72 6.6 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.06 -24.77 56.27 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.815 0.341 . . . . 0.0 111.606 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.13 33.89 5.27 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.731 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.75 0.43 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.935 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 95' ' ' SER . . . . . 0.709 ' HB3' ' HG ' ' D' ' 88' ' ' LEU . 38.7 m -96.7 177.94 5.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 110.679 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.52 -178.7 7.06 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.796 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . 0.493 ' HB ' ' OG1' ' D' ' 144' ' ' THR . 2.0 m -134.41 119.08 18.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.354 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 98' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' D' ' 97' ' ' THR . 32.4 m-20 68.67 34.56 3.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.439 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 99' ' ' VAL . . . . . 0.746 HG13 HD23 ' D' ' 42' ' ' LEU . 0.4 OUTLIER -138.16 130.81 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.755 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.15 -170.62 18.95 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.539 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 101' ' ' VAL . . . . . 0.589 HG13 ' HB2' ' D' ' 86' ' ' LEU . 0.2 OUTLIER -119.66 114.49 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.036 0.534 . . . . 0.0 111.654 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 102' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 0.8 OUTLIER -87.36 150.22 23.98 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.887 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 103' ' ' ILE . . . . . 0.554 HG12 ' HG ' ' D' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 136.07 52.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.461 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.34 133.47 55.12 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.636 0.255 . . . . 0.0 111.053 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . 0.854 ' HB3' HG22 ' D' ' 107' ' ' THR . 6.1 t0 -82.21 149.77 27.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.725 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 106' ' ' ARG . . . . . 0.754 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.4 OUTLIER -67.89 -16.23 63.98 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.729 0.3 . . . . 0.0 111.046 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 107' ' ' THR . . . . . 0.854 HG22 ' HB3' ' D' ' 105' ' ' ASP . 8.8 t -63.65 -28.42 69.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.039 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.01 -40.41 1.59 Allowed Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.64 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 109' ' ' ALA . . . . . 0.411 ' H ' HG23 ' D' ' 107' ' ' THR . . . -91.46 163.06 14.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.777 0.322 . . . . 0.0 111.054 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.08 133.3 35.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.207 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 111' ' ' LEU . . . . . 0.567 HD21 ' O ' ' D' ' 117' ' ' THR . 4.8 tp -96.73 150.06 21.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.356 0.598 . . . . 0.0 110.516 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 112' ' ' THR . . . . . 0.863 HG23 HG21 ' D' ' 117' ' ' THR . 1.9 t -98.53 141.72 31.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.098 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 113' ' ' LEU . . . . . 0.765 HD13 ' HG ' ' D' ' 86' ' ' LEU . 1.6 mt -76.34 89.51 3.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.735 0.302 . . . . 0.0 110.765 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.15 -18.19 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.652 0.263 . . . . 0.0 111.497 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.82 -60.65 0.46 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.618 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 116' ' ' ALA . . . . . 0.461 ' HA ' ' CE2' ' D' ' 118' ' ' PHE . . . -96.43 26.94 4.04 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.948 0.404 . . . . 0.0 111.631 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 117' ' ' THR . . . . . 0.863 HG21 HG23 ' D' ' 112' ' ' THR . 0.0 OUTLIER -87.02 74.89 9.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.199 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.596 ' HB3' ' HB1' ' D' ' 70' ' ' ALA . 63.1 m-85 -94.94 92.86 7.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.834 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 25.5 m -136.27 68.9 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.81 150.23 28.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.616 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -107.3 67.71 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.135 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.611 ' O ' ' HB3' ' D' ' 69' ' ' ALA . 0.2 OUTLIER -79.23 114.67 18.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.735 -179.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -73.97 127.94 34.2 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.756 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . 0.576 HD21 ' O ' ' D' ' 20' ' ' ALA . 4.0 tp -92.01 132.14 36.77 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.649 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.09 151.14 49.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.6 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 126' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' D' ' 61' ' ' CYS . 3.1 t30 -69.1 112.08 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.613 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.55 -138.91 8.72 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.659 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 128' ' ' THR . . . . . 0.722 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 87.7 m -98.81 82.58 2.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.642 0.258 . . . . 0.0 110.729 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 129' ' ' ASN . . . . . 0.504 ' N ' ' HB2' ' A' ' 116' ' ' ALA . 2.3 t30 -71.88 148.16 46.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.937 0.398 . . . . 0.0 111.06 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 130' ' ' THR . . . . . 0.729 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.2 OUTLIER -138.57 148.64 44.41 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.161 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 131' ' ' ILE . . . . . 0.739 HG21 HG11 ' D' ' 71' ' ' VAL . 15.8 mt -110.09 112.28 57.7 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 132' ' ' PRO . . . . . 0.754 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.5 Cg_endo -81.77 136.97 9.76 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.677 1.585 . . . . 0.0 112.597 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.04 136.06 19.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.676 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -111.42 158.34 19.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.055 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.675 ' O ' HG22 ' D' ' 52' ' ' VAL . . . -154.18 111.29 3.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.935 0.397 . . . . 0.0 111.637 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 136' ' ' ARG . . . . . 0.48 ' HB3' ' CA ' ' D' ' 51' ' ' ALA . 19.8 ptt180 -108.85 174.21 5.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.346 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 137' ' ' TYR . . . . . 0.696 ' HB3' HD21 ' D' ' 42' ' ' LEU . 1.7 m-85 -81.53 137.68 35.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.03 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 138' ' ' PHE . . . . . 0.529 ' HB3' HG21 ' D' ' 85' ' ' VAL . 0.9 OUTLIER -131.55 124.11 29.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.136 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 139' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' D' ' 47' ' ' ALA . . . -108.42 130.28 55.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.855 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 140' ' ' THR . . . . . 0.499 ' O ' ' HG3' ' D' ' 45' ' ' GLU . 0.2 OUTLIER -77.49 -28.02 52.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.535 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.41 -96.47 0.11 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.879 -0.676 . . . . 0.0 113.057 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.03 98.49 8.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.551 0.215 . . . . 0.0 110.697 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 143' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -56.59 148.91 18.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.758 0.313 . . . . 0.0 111.404 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 144' ' ' THR . . . . . 0.716 ' CG2' ' CD ' ' D' ' 145' ' ' PRO . 91.6 m -125.38 156.93 69.45 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.288 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 145' ' ' PRO . . . . . 0.716 ' CD ' ' CG2' ' D' ' 144' ' ' THR . 1.5 Cg_endo -83.28 136.18 7.63 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.584 2.189 . . . . 0.0 111.989 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 146' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' C' ' 15' ' ' GLU . . . 163.58 -127.53 1.69 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.472 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 147' ' ' ALA . . . . . 0.649 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -110.98 132.88 53.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.842 0.354 . . . . 0.0 111.354 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 148' ' ' ALA . . . . . 0.77 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -124.25 43.74 2.92 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.148 0.499 . . . . 0.0 110.43 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 149' ' ' ASN . . . . . 0.529 ' HB2' ' CG ' ' D' ' 89' ' ' GLN . 9.2 m120 -92.34 144.25 25.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.499 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 150' ' ' ALA . . . . . 0.699 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -160.6 178.93 9.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.975 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 151' ' ' ASP . . . . . 0.632 ' OD1' ' HA ' ' C' ' 11' ' ' HIS . 15.6 t70 -147.03 145.02 29.55 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.226 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 152' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -133.76 139.71 46.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.198 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 153' ' ' THR . . . . . 0.93 HG23 HG22 ' C' ' 9' ' ' THR . 0.2 OUTLIER -100.99 135.26 42.73 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 154' ' ' PHE . . . . . 0.541 ' HB3' ' H ' ' C' ' 8' ' ' GLY . 0.2 OUTLIER -81.56 152.16 27.37 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.054 0.454 . . . . 0.0 110.136 -179.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 155' ' ' LYS . . . . . 0.407 ' O ' HG13 ' D' ' 71' ' ' VAL . 15.2 mmtm -134.25 146.88 50.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.908 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 156' ' ' VAL . . . . . 0.629 HG23 HG23 ' C' ' 5' ' ' VAL . 33.1 m -139.09 140.78 37.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.786 0.326 . . . . 0.0 111.626 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 157' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' C' ' 3' ' ' THR . 0.9 OUTLIER -134.54 132.65 39.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.297 0.57 . . . . 0.0 110.425 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 158' ' ' TYR . . . . . 0.567 ' CE1' ' HB2' ' D' ' 21' ' ' CYS . 11.0 m-85 -107.25 128.05 54.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.514 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.849 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.249 0.071 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 2' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' F' ' 158' ' ' TYR . . . 52.85 88.26 0.03 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.994 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 3' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' F' ' 157' ' ' GLN . 5.5 m -122.92 116.29 23.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.385 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -99.69 117.17 33.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.521 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.626 HG23 HG23 ' F' ' 156' ' ' VAL . 1.8 m -144.42 157.99 15.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.618 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 6' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' F' ' 154' ' ' PHE . 13.2 t30 -78.62 123.81 27.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.58 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.83 -71.15 1.01 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.827 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . 0.543 ' H ' ' HB3' ' F' ' 154' ' ' PHE . . . -152.7 -146.96 4.48 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.816 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 9' ' ' THR . . . . . 0.951 HG22 HG23 ' F' ' 153' ' ' THR . 24.4 p -148.75 134.42 18.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.005 0.431 . . . . 0.0 111.268 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.33 124.38 72.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.169 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 11' ' ' HIS . . . . . 0.627 ' HA ' ' OD1' ' F' ' 151' ' ' ASP . 57.4 t-80 -91.56 116.2 28.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.306 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -96.78 105.47 17.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.753 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 13' ' ' LYS . . . . . 0.4 ' HG2' ' ND2' ' F' ' 149' ' ' ASN . 5.1 tttm -104.58 118.69 37.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.512 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.27 172.89 30.79 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.924 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 15' ' ' GLU . . . . . 0.735 ' O ' ' HA ' ' F' ' 36' ' ' GLN . 25.8 tt0 -160.3 135.95 8.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.896 0.379 . . . . 0.0 110.384 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 16' ' ' VAL . . . . . 0.764 HG23 ' HB2' ' F' ' 148' ' ' ALA . 43.2 t -96.83 132.78 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.243 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . 0.711 HG11 ' NE2' ' F' ' 36' ' ' GLN . 18.2 m -133.91 -177.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.878 0.371 . . . . 0.0 111.007 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . 0.563 ' HA ' HG22 ' F' ' 39' ' ' THR . 0.3 OUTLIER -75.76 -170.28 1.28 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.894 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.73 45.35 0.98 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.078 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.562 ' O ' HD21 ' E' ' 124' ' ' LEU . . . -121.24 -24.9 5.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.424 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 21' ' ' CYS . . . . . 0.857 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER -168.8 140.69 2.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.888 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 22' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' E' ' 60' ' ' ASP . . . -132.86 116.95 17.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.066 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 23' ' ' VAL . . . . . 0.745 HG12 ' HB2' ' F' ' 36' ' ' GLN . 0.5 OUTLIER -67.03 146.26 13.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.101 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 24' ' ' ASP . . . . . 0.474 ' O ' HG23 ' E' ' 28' ' ' VAL . 12.9 t0 -80.37 152.08 29.08 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.547 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . 0.533 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -62.77 -40.06 96.12 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.419 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.93 2.72 85.83 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.891 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -106.23 -19.86 13.57 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.823 0.344 . . . . 0.0 110.825 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 28' ' ' VAL . . . . . 0.474 HG23 ' O ' ' E' ' 24' ' ' ASP . 39.7 t -47.4 -52.16 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.35 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.21 136.45 48.66 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.029 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.73 136.84 39.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.014 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.44 102.89 12.82 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.042 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.69 128.25 63.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.068 0.461 . . . . 0.0 110.547 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -114.64 123.02 48.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.693 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.45 -42.72 15.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.581 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.51 -167.45 13.18 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.587 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 36' ' ' GLN . . . . . 0.744 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 3.7 mt-30 -96.77 124.45 40.75 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.589 0.233 . . . . 0.0 110.927 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.77 147.52 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.848 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.68 134.93 34.34 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.698 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 39' ' ' THR . . . . . 0.565 HG22 ' HA ' ' D' ' 18' ' ' ASN . 0.0 OUTLIER -59.99 -44.48 94.49 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.815 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.25 -36.96 61.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.081 0.467 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.85 -35.83 62.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.165 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.739 HD23 HG13 ' E' ' 99' ' ' VAL . 3.0 mp -106.59 34.51 3.37 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.667 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.92 15.84 27.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.375 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.99 132.07 56.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.283 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' E' ' 140' ' ' THR . 6.8 tt0 -56.5 108.69 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.766 0.317 . . . . 0.0 111.124 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.96 25.97 10.05 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.09 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 47' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' E' ' 139' ' ' ALA . . . -71.49 137.75 48.43 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 7.4 p -137.0 122.71 19.86 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.898 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' E' ' 136' ' ' ARG . 54.2 m -100.02 -175.25 2.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.659 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 50' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 2.8 t -55.63 137.28 49.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.787 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 51' ' ' ALA . . . . . 0.478 ' CA ' ' HB3' ' E' ' 136' ' ' ARG . . . -92.28 133.56 35.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.344 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 52' ' ' VAL . . . . . 0.686 HG22 ' O ' ' E' ' 135' ' ' ALA . 26.2 m -76.78 162.48 4.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.52 141.17 16.78 Favored Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.538 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 54' ' ' PHE . . . . . 0.556 ' H ' HG21 ' B' ' 76' ' ' THR . 39.3 p90 -173.74 137.8 0.62 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.758 0.313 . . . . 0.0 110.941 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 55' ' ' ASN . . . . . 0.496 ' OD1' HD21 ' B' ' 74' ' ' LEU . 18.0 p30 -136.44 145.83 45.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.692 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 56' ' ' ILE . . . . . 0.528 HG23 ' O ' ' E' ' 56' ' ' ILE . 1.2 tp -91.04 116.8 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.617 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 57' ' ' GLN . . . . . 0.726 ' HA ' HG23 ' E' ' 130' ' ' THR . 1.3 mp0 -72.87 128.65 36.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.78 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . 0.458 ' HG ' ' HA ' ' E' ' 23' ' ' VAL . 0.3 OUTLIER -137.39 89.2 2.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.236 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . 0.694 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 9.8 p30 -74.9 176.51 7.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.985 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 60' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' E' ' 22' ' ' ALA . 0.9 OUTLIER 58.98 74.85 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.775 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 61' ' ' CYS . . . . . 0.857 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 36.8 m -126.37 148.87 49.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . 0.407 ' OD2' HG23 ' E' ' 65' ' ' VAL . 1.6 t70 -121.58 169.77 10.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.317 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.27 -32.69 4.89 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.55 -27.95 56.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.155 0.502 . . . . 0.0 111.685 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . 0.407 HG23 ' OD2' ' E' ' 62' ' ' ASP . 25.6 t -73.58 -56.76 8.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.702 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 66' ' ' ALA . . . . . 0.465 ' HB3' ' HB1' ' E' ' 20' ' ' ALA . . . -134.94 122.75 22.35 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.672 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.62 -50.02 5.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.927 0.394 . . . . 0.0 110.932 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 68' ' ' LYS . . . . . 0.4 ' HA ' ' NZ ' ' E' ' 68' ' ' LYS . 1.8 tptp -89.75 152.09 21.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.567 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 69' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' E' ' 122' ' ' THR . . . -144.25 137.9 27.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.521 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . 0.599 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -113.41 157.22 22.19 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.094 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . 0.757 HG11 HG21 ' E' ' 131' ' ' ILE . 1.8 t -138.75 150.06 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.649 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.87 155.03 37.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.57 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 73' ' ' PHE . . . . . 0.557 ' CB ' HD13 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -124.98 136.66 53.94 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.592 0.234 . . . . 0.0 111.071 179.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 74' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.9 OUTLIER -97.21 136.13 38.16 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.011 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . 0.449 ' CA ' ' HB3' ' E' ' 113' ' ' LEU . . . -174.01 -172.94 39.72 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.735 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 76' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.2 OUTLIER -118.71 144.53 46.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.497 0.189 . . . . 0.0 110.826 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 77' ' ' ALA . . . . . 0.652 ' HB2' HG23 ' E' ' 83' ' ' THR . . . -62.42 138.51 58.47 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.963 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 78' ' ' ILE . . . . . 0.51 HG23 ' N ' ' E' ' 79' ' ' ASP . 5.7 tt -71.6 -45.59 66.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.843 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 79' ' ' ASP . . . . . 0.51 ' N ' HG23 ' E' ' 78' ' ' ILE . 0.3 OUTLIER -133.11 42.49 3.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.833 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' E' ' 79' ' ' ASP . . . 70.09 -80.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.002 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.15 -29.64 68.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.584 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 82' ' ' HIS . . . . . 0.425 ' HB3' HG22 ' E' ' 78' ' ' ILE . 1.7 m80 -89.9 69.45 7.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.874 0.369 . . . . 0.0 110.414 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 83' ' ' THR . . . . . 0.652 HG23 ' HB2' ' E' ' 77' ' ' ALA . 0.2 OUTLIER -74.55 -16.16 60.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.585 -179.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 84' ' ' ASN . . . . . 0.729 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 20.7 p-10 -66.2 -19.09 65.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.292 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' E' ' 138' ' ' PHE . 13.4 t -113.56 133.81 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.188 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 86' ' ' LEU . . . . . 0.775 ' HG ' HD13 ' E' ' 113' ' ' LEU . 0.4 OUTLIER -67.81 161.6 25.85 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 87' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' E' ' 77' ' ' ALA . . . -103.63 -174.75 2.62 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.936 0.398 . . . . 0.0 111.727 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.704 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 0.3 OUTLIER -67.37 165.18 16.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.082 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 89' ' ' GLN . . . . . 0.515 ' CG ' ' HB2' ' E' ' 149' ' ' ASN . 5.7 mm-40 -63.41 -79.7 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.376 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -165.49 3.7 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.019 0.437 . . . . 0.0 111.538 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.04 79.77 6.54 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.923 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.14 -24.69 55.98 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.853 0.359 . . . . 0.0 111.573 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.22 34.0 5.23 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.689 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.88 0.47 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.952 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 95' ' ' SER . . . . . 0.704 ' HB3' ' HG ' ' E' ' 88' ' ' LEU . 38.4 m -96.84 177.94 5.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.915 0.388 . . . . 0.0 110.598 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.46 -178.72 7.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.797 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . 0.497 ' HB ' ' OG1' ' E' ' 144' ' ' THR . 2.0 m -134.44 119.06 18.09 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.373 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 98' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' E' ' 97' ' ' THR . 32.8 m-20 68.76 34.4 3.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.471 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 99' ' ' VAL . . . . . 0.739 HG13 HD23 ' E' ' 42' ' ' LEU . 0.4 OUTLIER -138.06 130.85 40.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.796 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.08 -170.57 18.85 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.538 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 101' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' E' ' 86' ' ' LEU . 0.2 OUTLIER -119.7 114.47 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.028 0.531 . . . . 0.0 111.749 -179.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 102' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 0.8 OUTLIER -87.37 150.24 23.95 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.877 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 103' ' ' ILE . . . . . 0.557 HD13 ' CB ' ' E' ' 73' ' ' PHE . 0.8 OUTLIER -115.0 136.01 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.417 179.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.31 133.52 55.08 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.7 0.286 . . . . 0.0 111.073 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . 0.866 ' HB3' HG22 ' E' ' 107' ' ' THR . 6.1 t0 -82.27 149.76 27.65 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.655 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 106' ' ' ARG . . . . . 0.735 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.4 OUTLIER -67.88 -16.2 63.97 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.762 0.315 . . . . 0.0 111.065 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 107' ' ' THR . . . . . 0.866 HG22 ' HB3' ' E' ' 105' ' ' ASP . 8.9 t -63.72 -28.35 69.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.003 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.0 -40.54 1.57 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.684 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 109' ' ' ALA . . . . . 0.42 ' H ' HG23 ' E' ' 107' ' ' THR . . . -91.42 163.04 14.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 0.0 111.039 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.09 133.36 35.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.229 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 111' ' ' LEU . . . . . 0.571 HD21 ' O ' ' E' ' 117' ' ' THR . 4.8 tp -96.72 150.03 21.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.383 0.611 . . . . 0.0 110.5 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 112' ' ' THR . . . . . 0.866 HG23 HG21 ' E' ' 117' ' ' THR . 1.9 t -98.42 141.7 30.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.183 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 113' ' ' LEU . . . . . 0.775 HD13 ' HG ' ' E' ' 86' ' ' LEU . 1.6 mt -76.33 89.36 3.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.758 0.313 . . . . 0.0 110.758 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.0 -18.21 5.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.652 0.263 . . . . 0.0 111.52 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.78 -60.65 0.46 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.681 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 116' ' ' ALA . . . . . 0.463 ' HA ' ' CE2' ' E' ' 118' ' ' PHE . . . -96.48 27.04 4.01 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.028 0.442 . . . . 0.0 111.641 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 117' ' ' THR . . . . . 0.866 HG21 HG23 ' E' ' 112' ' ' THR . 0.0 OUTLIER -87.11 74.86 9.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.13 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 118' ' ' PHE . . . . . 0.599 ' HB3' ' HB1' ' E' ' 70' ' ' ALA . 62.8 m-85 -94.87 92.89 7.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.823 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 25.7 m -136.32 68.85 1.43 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.829 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.84 150.31 28.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.579 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.39 67.73 0.7 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.083 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 122' ' ' THR . . . . . 0.613 ' O ' ' HB3' ' E' ' 69' ' ' ALA . 0.2 OUTLIER -79.19 114.74 18.37 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.704 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -74.02 127.98 34.31 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.676 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . 0.562 HD21 ' O ' ' E' ' 20' ' ' ALA . 4.0 tp -92.04 132.17 36.76 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.651 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.13 151.1 49.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.608 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 126' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' E' ' 61' ' ' CYS . 3.1 t30 -69.1 112.08 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.668 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 127' ' ' GLY . . . . . 0.488 ' CA ' HG21 ' A' ' 4' ' ' THR . . . 142.56 -138.85 8.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.724 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 128' ' ' THR . . . . . 0.694 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 87.4 m -98.85 82.49 2.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.676 0.274 . . . . 0.0 110.84 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 129' ' ' ASN . . . . . 0.501 ' N ' ' HB2' ' B' ' 116' ' ' ALA . 2.3 t30 -71.82 148.18 46.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.938 0.399 . . . . 0.0 111.07 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 130' ' ' THR . . . . . 0.726 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.2 OUTLIER -138.63 148.6 44.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.138 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 131' ' ' ILE . . . . . 0.757 HG21 HG11 ' E' ' 71' ' ' VAL . 15.6 mt -109.96 112.2 58.04 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 132' ' ' PRO . . . . . 0.735 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.5 Cg_endo -81.77 137.01 9.78 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.671 1.581 . . . . 0.0 112.585 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.06 135.98 19.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.782 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -111.44 158.36 19.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.076 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 135' ' ' ALA . . . . . 0.686 ' O ' HG22 ' E' ' 52' ' ' VAL . . . -154.16 111.36 3.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.979 0.419 . . . . 0.0 111.616 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 136' ' ' ARG . . . . . 0.478 ' HB3' ' CA ' ' E' ' 51' ' ' ALA . 19.8 ptt180 -108.91 174.1 6.02 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.375 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 137' ' ' TYR . . . . . 0.701 ' HB3' HD21 ' E' ' 42' ' ' LEU . 1.7 m-85 -81.41 137.68 35.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.067 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 138' ' ' PHE . . . . . 0.514 ' HB3' HG21 ' E' ' 85' ' ' VAL . 0.9 OUTLIER -131.52 124.14 29.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.14 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 139' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' E' ' 47' ' ' ALA . . . -108.49 130.23 55.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.815 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 140' ' ' THR . . . . . 0.5 ' O ' ' HG3' ' E' ' 45' ' ' GLU . 0.2 OUTLIER -77.47 -27.96 52.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.537 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.46 -96.46 0.11 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.971 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.02 98.46 8.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.606 0.203 . . . . 0.0 110.623 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 143' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -56.59 148.86 18.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 111.373 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 144' ' ' THR . . . . . 0.728 ' CG2' ' CD ' ' E' ' 145' ' ' PRO . 93.2 m -125.35 156.93 69.4 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.316 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 145' ' ' PRO . . . . . 0.728 ' CD ' ' CG2' ' E' ' 144' ' ' THR . 1.4 Cg_endo -83.34 136.27 7.61 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.507 2.138 . . . . 0.0 111.993 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 146' ' ' GLY . . . . . 0.58 ' O ' ' HG3' ' D' ' 15' ' ' GLU . . . 163.56 -127.57 1.7 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.434 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 147' ' ' ALA . . . . . 0.645 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -110.94 132.94 53.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.921 0.391 . . . . 0.0 111.291 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 148' ' ' ALA . . . . . 0.777 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -124.29 43.71 2.93 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.421 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 149' ' ' ASN . . . . . 0.515 ' HB2' ' CG ' ' E' ' 89' ' ' GLN . 9.2 m120 -92.32 144.25 25.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.535 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 150' ' ' ALA . . . . . 0.683 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -160.58 178.94 9.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.939 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 151' ' ' ASP . . . . . 0.619 ' OD1' ' HA ' ' D' ' 11' ' ' HIS . 15.7 t70 -147.05 145.01 29.52 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.201 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 152' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -133.76 139.8 46.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.196 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 153' ' ' THR . . . . . 0.932 HG23 HG22 ' D' ' 9' ' ' THR . 0.2 OUTLIER -101.14 135.25 42.91 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 154' ' ' PHE . . . . . 0.522 ' HB3' ' H ' ' D' ' 8' ' ' GLY . 0.2 OUTLIER -81.51 152.1 27.47 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.094 0.473 . . . . 0.0 110.148 -179.086 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 155' ' ' LYS . . . . . 0.407 ' O ' HG13 ' E' ' 71' ' ' VAL . 15.2 mmtm -134.2 146.84 50.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.947 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 156' ' ' VAL . . . . . 0.629 HG23 HG23 ' D' ' 5' ' ' VAL . 33.1 m -139.11 140.8 37.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.765 0.317 . . . . 0.0 111.64 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 157' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' D' ' 3' ' ' THR . 0.9 OUTLIER -134.55 132.63 39.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.291 0.567 . . . . 0.0 110.434 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 158' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' E' ' 21' ' ' CYS . 11.0 m-85 -107.23 128.05 54.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.58 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.839 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.26 0.076 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.67 88.39 0.03 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.051 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 5.5 m -122.95 116.28 23.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.358 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -99.69 117.29 33.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.51 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -144.49 158.03 14.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.596 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -78.73 123.71 27.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.586 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.67 -71.21 1.0 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.855 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.68 -146.93 4.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.825 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 24.5 p -148.77 134.4 18.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.998 0.428 . . . . 0.0 111.278 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.36 124.37 72.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.185 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -91.55 116.27 28.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.282 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -96.92 105.54 17.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.726 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -104.65 118.74 37.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.437 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.29 172.88 30.8 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.975 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -160.32 135.98 8.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.961 0.41 . . . . 0.0 110.405 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 43.4 t -96.86 132.79 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.281 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 17' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.89 -177.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.802 0.334 . . . . 0.0 111.019 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -75.72 -170.31 1.27 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.017 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.76 45.43 0.98 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.065 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . 0.571 ' O ' HD21 ' F' ' 124' ' ' LEU . . . -121.29 -24.84 5.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.401 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 21' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER -168.86 140.7 2.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.816 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 22' ' ' ALA . . . . . 0.493 ' HB3' ' HB2' ' F' ' 60' ' ' ASP . . . -132.9 116.91 17.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.05 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 23' ' ' VAL . . . . . 0.453 ' HA ' ' HG ' ' F' ' 58' ' ' LEU . 0.5 OUTLIER -67.06 146.24 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.108 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 24' ' ' ASP . . . . . 0.472 ' O ' HG23 ' F' ' 28' ' ' VAL . 12.9 t0 -80.45 152.06 28.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.542 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -62.71 -40.05 95.94 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.445 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.87 2.64 85.87 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.872 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 23.0 t -106.19 -19.95 13.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.849 0.357 . . . . 0.0 110.867 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 28' ' ' VAL . . . . . 0.472 HG23 ' O ' ' F' ' 24' ' ' ASP . 39.9 t -47.31 -52.2 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.354 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.15 136.42 48.67 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.045 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.69 136.86 39.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.004 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.56 102.85 12.74 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.07 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.64 128.27 62.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.052 0.453 . . . . 0.0 110.51 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -114.75 123.09 48.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.677 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.47 -42.68 15.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.604 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.42 -167.44 13.21 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.604 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 36' ' ' GLN . . . . . 0.745 ' HB2' HG12 ' E' ' 23' ' ' VAL . 3.7 mt-30 -96.77 124.41 40.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.615 0.245 . . . . 0.0 110.885 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.72 147.54 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.895 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.64 134.94 34.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.682 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 39' ' ' THR . . . . . 0.563 HG22 ' HA ' ' E' ' 18' ' ' ASN . 0.0 OUTLIER -60.06 -44.45 94.71 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.797 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.23 -36.94 61.58 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.101 0.477 . . . . 0.0 110.91 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.79 -35.91 62.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.185 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . 0.755 HD23 HG13 ' F' ' 99' ' ' VAL . 2.9 mp -106.63 34.53 3.36 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.602 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.87 15.8 27.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.307 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.94 132.05 56.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.337 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' F' ' 140' ' ' THR . 6.8 tt0 -56.53 108.74 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 111.172 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.93 25.93 10.11 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.16 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' F' ' 139' ' ' ALA . . . -71.5 137.73 48.39 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 7.3 p -136.96 122.76 19.97 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.881 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 49' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' F' ' 136' ' ' ARG . 53.4 m -100.05 -175.23 2.89 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.61 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 50' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' C' ' 92' ' ' ALA . 2.8 t -55.62 137.3 49.38 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.819 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 51' ' ' ALA . . . . . 0.482 ' CA ' ' HB3' ' F' ' 136' ' ' ARG . . . -92.35 133.45 35.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.331 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 52' ' ' VAL . . . . . 0.676 HG22 ' O ' ' F' ' 135' ' ' ALA . 26.2 m -76.68 162.51 4.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.54 141.17 16.77 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.605 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 54' ' ' PHE . . . . . 0.573 ' H ' HG21 ' C' ' 76' ' ' THR . 39.3 p90 -173.76 137.81 0.62 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.796 0.331 . . . . 0.0 110.985 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 55' ' ' ASN . . . . . 0.501 ' OD1' HD21 ' C' ' 74' ' ' LEU . 17.9 p30 -136.56 145.88 45.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.604 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 56' ' ' ILE . . . . . 0.529 HG23 ' O ' ' F' ' 56' ' ' ILE . 1.2 tp -91.1 116.79 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.643 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 57' ' ' GLN . . . . . 0.704 ' HA ' HG23 ' F' ' 130' ' ' THR . 1.3 mp0 -72.86 128.55 35.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.812 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . 0.453 ' HG ' ' HA ' ' F' ' 23' ' ' VAL . 0.3 OUTLIER -137.34 89.14 2.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.275 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 59' ' ' ASN . . . . . 0.727 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 9.8 p30 -74.75 176.46 7.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.956 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 60' ' ' ASP . . . . . 0.493 ' HB2' ' HB3' ' F' ' 22' ' ' ALA . 0.8 OUTLIER 58.98 74.77 0.43 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.834 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 61' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 36.8 m -126.34 148.91 49.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.8 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . 0.404 ' OD2' HG23 ' F' ' 65' ' ' VAL . 1.6 t70 -121.62 169.74 10.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.285 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.32 -32.6 4.91 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.58 -27.92 56.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.266 0.555 . . . . 0.0 111.752 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . 0.404 HG23 ' OD2' ' F' ' 62' ' ' ASP . 25.3 t -73.54 -56.81 8.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.715 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 66' ' ' ALA . . . . . 0.465 ' HB3' ' HB1' ' F' ' 20' ' ' ALA . . . -134.93 122.77 22.39 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.693 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.55 -50.11 5.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.932 0.396 . . . . 0.0 110.931 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 68' ' ' LYS . . . . . 0.401 ' NZ ' ' HA ' ' F' ' 68' ' ' LYS . 1.8 tptp -89.76 152.12 21.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.556 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 69' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' F' ' 122' ' ' THR . . . -144.25 137.8 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.559 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 70' ' ' ALA . . . . . 0.6 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -113.38 157.26 22.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.087 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 71' ' ' VAL . . . . . 0.74 HG11 HG21 ' F' ' 131' ' ' ILE . 1.8 t -138.75 150.06 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.638 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.87 155.05 37.35 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.593 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 73' ' ' PHE . . . . . 0.552 ' CB ' HD13 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -125.02 136.62 53.88 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.549 0.214 . . . . 0.0 111.056 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 74' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.9 OUTLIER -97.17 136.11 38.16 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.019 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . 0.454 ' CA ' ' HB3' ' F' ' 113' ' ' LEU . . . -174.0 -172.94 39.72 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.761 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 76' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.2 OUTLIER -118.73 144.53 46.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.553 0.216 . . . . 0.0 110.785 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 77' ' ' ALA . . . . . 0.634 ' HB2' HG23 ' F' ' 83' ' ' THR . . . -62.46 138.59 58.49 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.94 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 78' ' ' ILE . . . . . 0.496 HG23 ' N ' ' F' ' 79' ' ' ASP . 5.7 tt -71.66 -45.56 66.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.85 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 79' ' ' ASP . . . . . 0.496 ' N ' HG23 ' F' ' 78' ' ' ILE . 0.3 OUTLIER -133.11 42.45 3.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.793 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 80' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' F' ' 79' ' ' ASP . . . 70.16 -80.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.06 -29.68 68.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.64 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 82' ' ' HIS . . . . . 0.427 ' HB3' HG22 ' F' ' 78' ' ' ILE . 1.7 m80 -89.87 69.38 7.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.813 0.34 . . . . 0.0 110.426 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 83' ' ' THR . . . . . 0.634 HG23 ' HB2' ' F' ' 77' ' ' ALA . 0.2 OUTLIER -74.53 -16.12 60.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.631 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 84' ' ' ASN . . . . . 0.745 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 20.7 p-10 -66.25 -19.05 65.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.285 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 85' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' F' ' 138' ' ' PHE . 13.4 t -113.6 133.8 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.202 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 86' ' ' LEU . . . . . 0.773 ' HG ' HD13 ' F' ' 113' ' ' LEU . 0.4 OUTLIER -67.73 161.54 25.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 87' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' F' ' 77' ' ' ALA . . . -103.66 -174.71 2.61 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.84 0.352 . . . . 0.0 111.756 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . 0.7 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 0.3 OUTLIER -67.36 165.22 16.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.069 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 89' ' ' GLN . . . . . 0.523 ' CG ' ' HB2' ' F' ' 149' ' ' ASN . 5.6 mm-40 -63.54 -79.67 0.03 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.302 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -165.48 3.73 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.003 0.43 . . . . 0.0 111.487 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.08 79.75 6.59 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.17 -24.63 55.69 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.849 0.357 . . . . 0.0 111.608 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.2 33.99 5.24 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.653 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.85 0.44 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.958 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 95' ' ' SER . . . . . 0.7 ' HB3' ' HG ' ' F' ' 88' ' ' LEU . 38.4 m -96.73 177.95 5.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.86 0.362 . . . . 0.0 110.612 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.46 -178.65 7.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . 0.497 ' HB ' ' OG1' ' F' ' 144' ' ' THR . 2.0 m -134.55 119.04 17.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.341 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 98' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' F' ' 97' ' ' THR . 32.6 m-20 68.75 34.48 3.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.433 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 99' ' ' VAL . . . . . 0.755 HG13 HD23 ' F' ' 42' ' ' LEU . 0.4 OUTLIER -138.08 130.88 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.765 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.21 -170.6 18.97 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.537 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 101' ' ' VAL . . . . . 0.574 HG13 ' HB2' ' F' ' 86' ' ' LEU . 0.2 OUTLIER -119.64 114.44 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.008 0.523 . . . . 0.0 111.737 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 102' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 0.8 OUTLIER -87.35 150.24 23.97 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 103' ' ' ILE . . . . . 0.565 HG12 ' HG ' ' F' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 136.01 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.474 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.39 133.56 55.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.705 0.288 . . . . 0.0 111.028 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . 0.837 ' HB3' HG22 ' F' ' 107' ' ' THR . 6.1 t0 -82.23 149.72 27.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.749 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 106' ' ' ARG . . . . . 0.753 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.4 OUTLIER -67.87 -16.24 64.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.798 0.332 . . . . 0.0 111.098 179.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 107' ' ' THR . . . . . 0.837 HG22 ' HB3' ' F' ' 105' ' ' ASP . 8.8 t -63.59 -28.46 69.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.979 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.04 -40.55 1.57 Allowed Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.616 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 109' ' ' ALA . . . . . 0.416 ' H ' HG23 ' F' ' 107' ' ' THR . . . -91.43 163.04 14.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.811 0.339 . . . . 0.0 111.038 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.18 133.4 35.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 111' ' ' LEU . . . . . 0.571 HD21 ' O ' ' F' ' 117' ' ' THR . 4.8 tp -96.66 149.94 21.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.386 0.612 . . . . 0.0 110.558 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 112' ' ' THR . . . . . 0.842 HG23 HG21 ' F' ' 117' ' ' THR . 1.9 t -98.48 141.7 31.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.085 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 113' ' ' LEU . . . . . 0.773 HD13 ' HG ' ' F' ' 86' ' ' LEU . 1.6 mt -76.33 89.47 3.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.744 0.307 . . . . 0.0 110.761 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.09 -18.22 5.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.67 0.271 . . . . 0.0 111.52 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.86 -60.68 0.45 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.529 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 116' ' ' ALA . . . . . 0.463 ' HA ' ' CE2' ' F' ' 118' ' ' PHE . . . -96.44 26.97 4.03 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.041 0.448 . . . . 0.0 111.683 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 117' ' ' THR . . . . . 0.842 HG21 HG23 ' F' ' 112' ' ' THR . 0.0 OUTLIER -87.01 74.85 9.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.155 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 118' ' ' PHE . . . . . 0.6 ' HB3' ' HB1' ' F' ' 70' ' ' ALA . 63.3 m-85 -94.97 92.96 7.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.768 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 25.6 m -136.35 68.9 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.796 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.81 150.29 28.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.629 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.34 67.6 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.136 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 122' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' F' ' 69' ' ' ALA . 0.2 OUTLIER -79.15 114.66 18.27 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.69 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 12.1 m -73.95 127.97 34.29 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.742 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . 0.571 HD21 ' O ' ' F' ' 20' ' ' ALA . 4.0 tp -92.11 132.21 36.77 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.602 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.1 151.07 49.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.63 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 126' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' F' ' 61' ' ' CYS . 3.1 t30 -69.1 112.05 5.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 110.646 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 127' ' ' GLY . . . . . 0.492 ' CA ' HG21 ' B' ' 4' ' ' THR . . . 142.51 -138.9 8.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.687 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 128' ' ' THR . . . . . 0.727 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 87.7 m -98.76 82.59 2.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.664 0.269 . . . . 0.0 110.792 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 129' ' ' ASN . . . . . 0.495 ' N ' ' HB2' ' C' ' 116' ' ' ALA . 2.3 t30 -71.85 148.19 46.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.893 0.377 . . . . 0.0 111.094 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 130' ' ' THR . . . . . 0.704 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.2 OUTLIER -138.63 148.66 44.34 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.154 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 131' ' ' ILE . . . . . 0.74 HG21 HG11 ' F' ' 71' ' ' VAL . 15.6 mt -110.05 112.17 57.86 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 132' ' ' PRO . . . . . 0.753 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.6 Cg_endo -81.78 136.98 9.75 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.612 1.541 . . . . 0.0 112.587 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.0 136.1 19.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.773 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -111.42 158.45 19.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.037 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 135' ' ' ALA . . . . . 0.676 ' O ' HG22 ' F' ' 52' ' ' VAL . . . -154.2 111.35 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.924 0.392 . . . . 0.0 111.674 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 136' ' ' ARG . . . . . 0.482 ' HB3' ' CA ' ' F' ' 51' ' ' ALA . 19.8 ptt180 -108.86 174.0 6.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.382 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 137' ' ' TYR . . . . . 0.705 ' HB3' HD21 ' F' ' 42' ' ' LEU . 1.7 m-85 -81.37 137.62 35.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.122 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 138' ' ' PHE . . . . . 0.517 ' HB3' HG21 ' F' ' 85' ' ' VAL . 0.9 OUTLIER -131.51 124.16 29.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.096 -179.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 139' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' F' ' 47' ' ' ALA . . . -108.52 130.15 55.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.868 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 140' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' F' ' 45' ' ' GLU . 0.2 OUTLIER -77.37 -28.01 52.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.557 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.46 -96.41 0.11 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.005 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.01 98.51 8.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.583 0.23 . . . . 0.0 110.648 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 143' ' ' ALA . . . . . 0.567 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -56.66 148.92 18.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.674 0.274 . . . . 0.0 111.377 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 144' ' ' THR . . . . . 0.728 ' CG2' ' CD ' ' F' ' 145' ' ' PRO . 90.3 m -125.48 157.0 69.61 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.213 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 145' ' ' PRO . . . . . 0.728 ' CD ' ' CG2' ' F' ' 144' ' ' THR . 1.4 Cg_endo -83.36 136.22 7.56 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.552 2.168 . . . . 0.0 111.978 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 146' ' ' GLY . . . . . 0.585 ' O ' ' HG3' ' E' ' 15' ' ' GLU . . . 163.61 -127.56 1.69 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.457 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 147' ' ' ALA . . . . . 0.656 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -110.85 132.92 53.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.864 0.364 . . . . 0.0 111.414 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 148' ' ' ALA . . . . . 0.764 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -124.25 43.65 2.94 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.126 0.489 . . . . 0.0 110.459 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 149' ' ' ASN . . . . . 0.523 ' HB2' ' CG ' ' F' ' 89' ' ' GLN . 9.3 m120 -92.34 144.28 25.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.54 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 150' ' ' ALA . . . . . 0.684 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -160.6 178.9 9.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.995 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 151' ' ' ASP . . . . . 0.627 ' OD1' ' HA ' ' E' ' 11' ' ' HIS . 15.7 t70 -147.02 144.97 29.54 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.215 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 152' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -133.73 139.76 46.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.114 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 153' ' ' THR . . . . . 0.951 HG23 HG22 ' E' ' 9' ' ' THR . 0.2 OUTLIER -101.07 135.26 42.81 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.078 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 154' ' ' PHE . . . . . 0.543 ' HB3' ' H ' ' E' ' 8' ' ' GLY . 0.2 OUTLIER -81.58 152.13 27.36 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.013 0.435 . . . . 0.0 110.152 -179.052 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 155' ' ' LYS . . . . . 0.413 ' O ' HG13 ' F' ' 71' ' ' VAL . 15.2 mmtm -134.22 146.86 50.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.897 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 156' ' ' VAL . . . . . 0.626 HG23 HG23 ' E' ' 5' ' ' VAL . 33.0 m -139.14 140.76 37.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.853 0.359 . . . . 0.0 111.632 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 157' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' E' ' 3' ' ' THR . 0.9 OUTLIER -134.5 132.74 39.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.266 0.555 . . . . 0.0 110.42 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 158' ' ' TYR . . . . . 0.567 ' CE1' ' HB2' ' F' ' 21' ' ' CYS . 10.9 m-85 -107.31 128.1 54.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.493 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.886 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.17 0 CA-C-O 120.546 0.213 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.8 m -117.36 119.27 34.6 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.397 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.683 HG23 ' HG3' ' B' ' 157' ' ' GLN . 4.0 m -98.41 127.22 44.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.515 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.921 HG21 HG12 ' B' ' 17' ' ' VAL . 1.6 m -146.14 171.02 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.6 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.04 114.69 23.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.601 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' B' ' 155' ' ' LYS . . . -69.65 -57.77 6.98 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.791 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 9' ' ' THR . . . -163.52 -144.6 4.08 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.9 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 1.04 HG22 HG23 ' B' ' 153' ' ' THR . 17.1 p -155.69 140.51 17.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.818 0.342 . . . . 0.0 111.4 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.561 HG13 HG23 ' B' ' 32' ' ' VAL . 29.9 t -130.38 117.55 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.26 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.55 117.05 29.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.336 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -89.96 107.12 18.92 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.8 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.76 113.28 26.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.45 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.44 ' HA3' ' OH ' ' B' ' 137' ' ' TYR . . . -144.43 166.99 27.12 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.889 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.675 ' CG ' ' O ' ' B' ' 146' ' ' GLY . 30.2 tt0 -155.66 135.23 12.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.053 0.454 . . . . 0.0 110.286 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.698 HG23 ' HB2' ' B' ' 148' ' ' ALA . 66.4 t -96.59 138.38 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.293 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.657 HG21 HE21 ' B' ' 36' ' ' GLN . 2.6 m -140.85 -173.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.832 0.349 . . . . 0.0 110.977 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.15 173.46 12.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.034 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' B' ' 38' ' ' ARG . . . -85.86 39.83 0.82 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.042 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.639 ' HB1' ' CD2' ' A' ' 124' ' ' LEU . . . -114.36 -33.57 5.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.349 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.739 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.9 OUTLIER -161.16 149.97 16.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.953 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.64 112.08 4.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.07 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.669 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 3.1 p -59.9 153.42 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.065 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.76 152.76 28.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.674 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.52 80.83 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.349 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.81 15.75 61.93 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.939 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -113.06 -21.32 11.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.909 0.385 . . . . 0.0 110.815 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -44.61 -64.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.364 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.28 135.61 38.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.925 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.02 128.73 19.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.79 111.8 23.83 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.012 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.2 t -110.82 114.77 48.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.141 0.496 . . . . 0.0 110.494 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.68 124.51 46.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.649 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.49 -45.73 14.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.619 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.37 -161.91 12.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.534 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -99.77 129.7 45.91 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.649 0.261 . . . . 0.0 110.828 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p -110.05 147.47 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.948 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.42 ' HB2' ' HB2' ' A' ' 41' ' ' SER . 0.7 OUTLIER -86.76 131.24 34.19 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.94 0.4 . . . . 0.0 111.766 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.708 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 4.8 t -54.1 -45.1 71.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.757 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.443 ' N ' HG23 ' A' ' 39' ' ' THR . . . -61.01 -39.31 89.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.069 0.461 . . . . 0.0 110.875 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 38' ' ' ARG . 0.4 OUTLIER -70.55 -23.19 62.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.19 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.675 HD23 ' HB2' ' A' ' 139' ' ' ALA . 1.4 mp -124.63 51.62 1.6 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.586 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.59 29.95 7.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.418 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.84 128.36 48.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.41 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 140' ' ' THR . 29.4 tt0 -52.88 102.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 111.097 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.415 ' HA2' ' HE1' ' A' ' 138' ' ' PHE . . . 96.05 39.01 4.42 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.126 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -80.1 146.72 31.74 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.62 125.01 19.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.95 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 32.4 m -101.91 -166.35 1.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.644 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.01 133.02 55.7 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.845 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 136' ' ' ARG . . . -92.66 120.13 32.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.26 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 135' ' ' ALA . 18.3 m -65.71 162.59 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.946 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.85 124.11 5.27 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.592 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -155.9 146.56 21.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.684 0.278 . . . . 0.0 110.948 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.564 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.4 p30 -136.83 160.19 39.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.576 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 56' ' ' ILE . 1.6 tp -100.56 116.93 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.562 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.61 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -70.07 124.56 24.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.766 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.669 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 1.6 mp -133.72 87.44 2.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.23 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 4.9 p30 -73.61 174.54 8.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.949 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.82 79.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.818 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.739 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 93.6 m -127.59 159.37 34.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.61 ' OD2' HG23 ' A' ' 65' ' ' VAL . 5.6 t70 -130.23 167.12 18.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.238 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.656 HG23 ' HA ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -114.32 -41.7 3.44 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.154 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.51 -22.61 65.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.047 0.451 . . . . 0.0 111.735 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.61 HG23 ' OD2' ' A' ' 62' ' ' ASP . 81.3 t -70.43 -74.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.601 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 124' ' ' LEU . . . -120.75 131.36 54.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.571 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -48.58 6.13 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.863 0.363 . . . . 0.0 110.997 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.631 ' HE3' ' HB3' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -96.18 161.58 13.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.556 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.17 124.58 6.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.606 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.725 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -100.35 154.98 18.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.094 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.851 HG11 HG21 ' A' ' 131' ' ' ILE . 2.3 t -132.76 148.31 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.696 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.442 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -145.64 150.12 35.76 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.599 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.558 ' HB2' HD13 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -119.92 137.02 54.29 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.568 0.223 . . . . 0.0 111.022 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.627 HD21 HG21 ' D' ' 130' ' ' THR . 0.9 OUTLIER -96.0 139.46 32.16 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.966 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' A' ' 113' ' ' LEU . . . 178.5 179.84 48.48 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.733 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.546 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.3 OUTLIER -111.0 156.38 21.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.559 0.218 . . . . 0.0 110.807 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.674 ' O ' ' HB2' ' A' ' 87' ' ' ALA . . . -73.78 131.34 41.46 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.338 -0.392 . . . . 0.0 112.02 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.639 ' CG2' ' HB ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -67.79 -41.36 85.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.808 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.439 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -141.14 40.79 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.791 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.439 ' CB ' ' HA2' ' D' ' 108' ' ' GLY . . . 66.4 -80.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.83 -24.94 43.2 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.663 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.07 64.03 1.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.957 0.408 . . . . 0.0 110.45 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.548 HG23 ' HB2' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -68.5 -16.84 64.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.576 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.693 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 18.0 p-10 -70.46 -20.21 62.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.317 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.639 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 14.7 t -106.86 130.76 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.117 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.782 HD22 ' HB1' ' A' ' 150' ' ' ALA . 0.5 OUTLIER -67.61 148.22 51.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.387 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 77' ' ' ALA . . . -89.63 -167.52 1.88 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.842 0.353 . . . . 0.0 111.743 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.658 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 1.5 mm? -78.3 157.27 29.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.04 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.66 -78.37 0.02 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.354 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.583 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 0.4 OUTLIER -167.13 0.54 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.032 0.444 . . . . 0.0 111.425 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.53 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 1.7 m -71.89 83.02 0.92 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.568 ' HB3' ' HB3' ' D' ' 34' ' ' LEU . . . -66.75 -13.9 61.94 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.827 0.346 . . . . 0.0 111.643 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.71 27.61 5.21 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.609 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.74 15.76 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.903 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.658 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . 3.0 m -100.86 -172.78 2.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.833 0.349 . . . . 0.0 110.613 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.9 167.63 9.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.514 ' H ' ' HB ' ' A' ' 144' ' ' THR . 2.3 m -121.59 128.41 51.93 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.314 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.456 ' HB3' ' H ' ' A' ' 141' ' ' GLY . 75.8 m-20 64.22 34.57 10.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.371 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.489 HG13 HD23 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -139.96 136.44 38.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.704 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.12 -156.83 8.33 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.546 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' A' ' 86' ' ' LEU . 3.2 p -137.82 116.72 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 122.942 0.497 . . . . 0.0 111.605 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 1.1 tt0 -91.91 150.39 21.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.841 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.689 HD12 ' HB3' ' A' ' 111' ' ' LEU . 0.5 OUTLIER -113.86 131.3 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.531 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -106.2 130.15 54.12 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.646 0.26 . . . . 0.0 111.041 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.736 ' HB3' HG22 ' A' ' 107' ' ' THR . 5.1 t0 -76.08 156.99 33.39 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.661 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.741 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 3.5 ttp180 -71.29 -17.51 62.46 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.731 0.3 . . . . 0.0 111.03 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.736 HG22 ' HB3' ' A' ' 105' ' ' ASP . 6.2 t -67.29 -17.91 64.97 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.028 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.68 -45.61 1.17 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.78 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.1 163.11 23.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.737 0.303 . . . . 0.0 111.114 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -84.16 127.38 33.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.104 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.689 ' HB3' HD12 ' A' ' 103' ' ' ILE . 12.1 tp -86.28 156.07 20.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.306 0.574 . . . . 0.0 110.6 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.88 HG23 HG21 ' A' ' 117' ' ' THR . 0.5 OUTLIER -106.17 139.09 41.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.179 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.604 HD13 ' HG ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -73.89 76.4 1.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.691 0.281 . . . . 0.0 110.789 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.42 -17.17 14.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.625 0.25 . . . . 0.0 111.561 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.31 -51.77 1.24 Allowed Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.615 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.01 18.88 21.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.832 0.349 . . . . 0.0 111.544 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.88 HG21 HG23 ' A' ' 112' ' ' THR . 0.2 OUTLIER -85.81 84.68 7.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.725 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 95.7 m-85 -101.42 98.74 9.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.785 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.7 m -130.82 62.35 1.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.825 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.27 145.88 30.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.687 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.631 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . 3.5 mm-40 -121.43 71.32 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.177 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.73 134.78 34.73 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.715 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.2 m -83.83 113.69 21.11 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.683 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.639 ' CD2' ' HB1' ' A' ' 20' ' ' ALA . 18.9 tp -73.99 142.97 45.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.651 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.656 ' HA ' HG23 ' A' ' 63' ' ' THR . 0.9 OUTLIER -138.67 162.13 35.42 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.557 179.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.66 113.1 12.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.717 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.51 -139.95 9.53 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.752 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 6.7 m -101.64 96.76 7.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.726 0.298 . . . . 0.0 110.804 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -83.58 148.58 27.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.92 0.391 . . . . 0.0 111.086 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.61 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -138.64 143.43 39.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.09 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.851 HG21 HG11 ' A' ' 71' ' ' VAL . 55.1 mt -104.63 112.39 65.33 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.741 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.6 Cg_endo -81.87 141.89 12.27 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.825 1.683 . . . . 0.0 112.522 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.58 141.09 22.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.847 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.46 152.64 22.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.079 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.644 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -153.54 100.99 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 111.567 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.547 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 17.4 ptt180 -107.15 177.27 4.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.385 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.498 ' HB3' HD21 ' A' ' 42' ' ' LEU . 4.7 m-85 -85.96 124.15 32.09 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.011 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.46 ' HB3' HG11 ' A' ' 85' ' ' VAL . 1.2 t80 -118.93 112.38 19.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.024 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.675 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -102.96 133.91 47.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.867 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -81.1 -28.82 35.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.531 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.456 ' H ' ' HB3' ' A' ' 98' ' ' ASN . . . -160.18 -111.04 0.28 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.961 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.87 110.56 21.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.607 0.203 . . . . 0.0 110.77 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.708 ' HB3' ' HA ' ' A' ' 39' ' ' THR . . . -65.63 134.21 52.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.763 0.316 . . . . 0.0 111.376 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.514 ' HB ' ' H ' ' A' ' 97' ' ' THR . 57.2 m -105.78 149.4 37.93 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.31 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.488 ' CD ' ' CG2' ' A' ' 144' ' ' THR . 1.4 Cg_endo -82.93 125.49 4.17 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.53 2.153 . . . . 0.0 112.057 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.8 -126.37 1.38 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.43 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -111.07 128.4 55.86 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.729 0.3 . . . . 0.0 111.348 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.44 52.18 1.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 110.441 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.82 151.98 20.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.564 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.782 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -158.32 169.54 24.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.942 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -131.03 128.65 40.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.212 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.496 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -122.22 144.09 49.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.229 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.34 145.32 31.83 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -96.89 134.72 39.86 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.009 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -124.26 148.13 47.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.902 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 131' ' ' ILE . 29.8 m -135.19 144.78 33.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 111.733 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.48 126.09 28.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.279 0.561 . . . . 0.0 110.389 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 21' ' ' CYS . 5.1 m-85 -106.0 128.75 54.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.498 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.567 ' HG3' ' C ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.877 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.246 0.07 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.63 77.07 0.19 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.037 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 10.7 m -117.33 119.23 34.49 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.439 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.677 HG23 ' HG3' ' C' ' 157' ' ' GLN . 4.0 m -98.32 127.17 44.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.548 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.88 HG21 HG12 ' C' ' 17' ' ' VAL . 1.6 m -146.12 171.08 4.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.58 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.14 114.72 23.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.548 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' C' ' 155' ' ' LYS . . . -69.84 -57.58 7.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.736 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.428 ' O ' HG23 ' B' ' 9' ' ' THR . . . -163.65 -144.63 4.09 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.989 -0.625 . . . . 0.0 111.854 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 1.041 HG22 HG23 ' C' ' 153' ' ' THR . 17.0 p -155.64 140.45 17.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.826 0.346 . . . . 0.0 111.364 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.552 HG13 HG23 ' C' ' 32' ' ' VAL . 29.2 t -130.35 117.53 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.241 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -91.51 116.97 29.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.409 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -89.88 107.08 18.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.916 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.81 113.28 26.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.435 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.436 ' HA3' ' OH ' ' C' ' 137' ' ' TYR . . . -144.42 167.01 27.11 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.898 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.689 ' CG ' ' O ' ' C' ' 146' ' ' GLY . 30.3 tt0 -155.64 135.21 12.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.926 0.393 . . . . 0.0 110.318 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' C' ' 148' ' ' ALA . 66.2 t -96.54 138.35 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.304 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.921 HG12 HG21 ' A' ' 5' ' ' VAL . 2.7 m -140.78 -173.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 111.056 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.12 173.48 12.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.074 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' C' ' 38' ' ' ARG . . . -85.82 39.71 0.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.639 ' HB1' ' CD2' ' B' ' 124' ' ' LEU . . . -114.28 -33.53 5.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.434 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.745 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.9 OUTLIER -161.13 150.03 16.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.965 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' C' ' 36' ' ' GLN . . . -149.68 112.02 4.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.079 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.675 ' HA ' ' HA ' ' B' ' 58' ' ' LEU . 3.1 p -59.94 153.37 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.029 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.73 152.8 28.18 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.628 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.42 81.03 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.296 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.84 15.68 62.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.03 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.94 -21.35 11.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.937 0.398 . . . . 0.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 89.3 t -44.65 -64.82 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.316 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.26 135.71 38.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.958 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.06 128.73 19.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.061 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.74 111.81 23.82 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.029 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.561 HG23 HG13 ' A' ' 10' ' ' VAL . 4.2 t -110.85 114.76 48.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.074 0.464 . . . . 0.0 110.489 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.78 124.42 46.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.681 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.4 -45.67 14.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.647 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.33 -161.88 12.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.572 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.657 HE21 HG21 ' A' ' 17' ' ' VAL . 1.8 mt-30 -99.87 129.68 45.99 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.619 0.247 . . . . 0.0 110.865 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.494 ' CG1' HG22 ' A' ' 16' ' ' VAL . 11.9 p -110.01 147.43 14.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.99 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.519 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -86.67 131.23 34.2 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.015 0.436 . . . . 0.0 111.786 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.698 ' HA ' ' HB3' ' B' ' 143' ' ' ALA . 4.8 t -54.18 -45.05 72.04 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.721 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.445 ' N ' HG23 ' B' ' 39' ' ' THR . . . -60.99 -39.36 89.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.146 0.498 . . . . 0.0 110.933 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' B' ' 38' ' ' ARG . 0.4 OUTLIER -70.52 -23.22 62.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.169 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.665 HD23 ' HB2' ' B' ' 139' ' ' ALA . 1.4 mp -124.55 51.63 1.59 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.639 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.6 29.92 7.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.356 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.85 128.41 48.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.348 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' B' ' 140' ' ' THR . 29.3 tt0 -52.95 103.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.815 0.34 . . . . 0.0 111.093 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.421 ' HA2' ' HE1' ' B' ' 138' ' ' PHE . . . 96.02 38.93 4.45 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.137 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' B' ' 139' ' ' ALA . . . -80.0 146.66 31.91 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.64 125.0 19.03 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.918 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 32.4 m -101.89 -166.28 1.28 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.604 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.99 133.02 55.7 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.871 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.553 ' HA ' ' HB3' ' B' ' 136' ' ' ARG . . . -92.67 120.21 32.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.264 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.641 HG22 ' O ' ' B' ' 135' ' ' ALA . 18.5 m -65.77 162.69 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.939 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.9 124.11 5.26 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.648 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -155.87 146.64 22.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.719 0.295 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.566 ' HB2' HG22 ' B' ' 130' ' ' THR . 3.3 p30 -136.91 160.25 39.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.515 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.564 HG23 ' O ' ' B' ' 56' ' ' ILE . 1.6 tp -100.71 117.0 45.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.516 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . 0.625 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -70.05 124.6 24.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.731 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.675 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 1.6 mp -133.82 87.5 2.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.184 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 4.9 p30 -73.63 174.57 8.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 57.72 79.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.811 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' CYS . . . . . 0.745 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 93.6 m -127.57 159.41 34.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.859 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . 0.62 ' OD2' HG23 ' B' ' 65' ' ' VAL . 5.5 t70 -130.27 167.1 19.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.295 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.662 HG23 ' HA ' ' B' ' 125' ' ' ASN . 0.2 OUTLIER -114.31 -41.71 3.44 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.139 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.51 -22.63 65.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.086 0.469 . . . . 0.0 111.723 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . 0.62 HG23 ' OD2' ' B' ' 62' ' ' ASP . 82.4 t -70.44 -74.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.608 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' B' ' 124' ' ' LEU . . . -120.67 131.3 54.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.665 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.22 -48.59 6.12 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.936 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . 0.633 ' HE3' ' HB3' ' B' ' 121' ' ' GLU . 0.1 OUTLIER -96.23 161.48 13.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.595 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.05 124.72 6.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.584 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.698 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -100.44 155.02 18.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.069 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.827 HG11 HG21 ' B' ' 131' ' ' ILE . 2.3 t -132.73 148.34 31.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.673 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.442 ' HA ' HD21 ' B' ' 111' ' ' LEU . . . -145.63 150.1 35.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.698 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.569 ' HB2' HD13 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -119.98 137.05 54.3 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.549 0.214 . . . . 0.0 111.055 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.624 HD21 HG21 ' E' ' 130' ' ' THR . 0.9 OUTLIER -96.06 139.52 32.12 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.892 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . 0.423 ' CA ' ' HB3' ' B' ' 113' ' ' LEU . . . 178.45 179.82 48.44 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.807 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.3 OUTLIER -110.92 156.47 21.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.493 0.187 . . . . 0.0 110.848 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.676 ' O ' ' HB2' ' B' ' 87' ' ' ALA . . . -73.83 131.35 41.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.029 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.65 ' CG2' ' HB ' ' B' ' 85' ' ' VAL . 0.9 OUTLIER -67.74 -41.37 85.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.823 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.435 ' N ' HG23 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -141.15 40.65 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.81 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.435 ' HB3' ' HA2' ' E' ' 108' ' ' GLY . . . 66.49 -80.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.68 -24.99 42.19 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.725 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.06 64.03 1.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.451 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' THR . . . . . 0.556 HG23 ' HB2' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -68.43 -16.9 64.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.567 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . 0.69 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 18.0 p-10 -70.44 -20.18 62.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.339 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.65 ' HB ' ' CG2' ' B' ' 78' ' ' ILE . 14.7 t -106.92 130.77 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.126 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.776 HD22 ' HB1' ' B' ' 150' ' ' ALA . 0.5 OUTLIER -67.68 148.19 51.67 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' B' ' 77' ' ' ALA . . . -89.6 -167.58 1.9 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.736 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.654 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 1.5 mm? -78.22 157.26 29.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -78.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.356 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . 0.586 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 0.4 OUTLIER -167.08 0.51 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.972 0.415 . . . . 0.0 111.459 179.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' SER . . . . . 0.546 ' HA ' ' HB2' ' D' ' 25' ' ' ALA . 1.7 m -71.95 83.03 0.94 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.746 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' E' ' 34' ' ' LEU . . . -66.62 -13.98 61.83 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.921 0.391 . . . . 0.0 111.749 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.69 27.59 5.21 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.567 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.69 15.63 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.899 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' SER . . . . . 0.654 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . 3.0 m -100.88 -172.85 2.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.842 0.353 . . . . 0.0 110.604 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.88 167.6 9.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.849 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.522 ' H ' ' HB ' ' B' ' 144' ' ' THR . 2.3 m -121.51 128.38 52.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.341 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . 0.463 ' HB3' ' H ' ' B' ' 141' ' ' GLY . 75.9 m-20 64.24 34.5 10.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.415 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . 0.489 HG13 HD23 ' B' ' 42' ' ' LEU . 0.5 OUTLIER -139.92 136.46 38.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.744 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.08 -156.88 8.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.524 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' B' ' 86' ' ' LEU . 3.2 p -137.8 116.71 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 123.011 0.525 . . . . 0.0 111.665 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 1.2 tt0 -91.94 150.39 21.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.847 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.681 HD12 ' HB3' ' B' ' 111' ' ' LEU . 0.5 OUTLIER -113.81 131.31 66.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.505 179.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 0.3 OUTLIER -106.26 130.17 54.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.733 0.302 . . . . 0.0 111.025 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . 0.713 ' HB3' HG22 ' B' ' 107' ' ' THR . 5.1 t0 -76.12 156.97 33.33 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.703 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . 0.708 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 3.4 ttp180 -71.2 -17.55 62.52 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 111.085 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.713 HG22 ' HB3' ' B' ' 105' ' ' ASP . 6.2 t -67.19 -18.02 65.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.071 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.73 -45.6 1.17 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.784 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.11 163.07 23.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.691 0.281 . . . . 0.0 111.172 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -84.13 127.4 33.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.681 ' HB3' HD12 ' B' ' 103' ' ' ILE . 12.1 tp -86.28 156.12 20.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.323 0.582 . . . . 0.0 110.595 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.892 HG23 HG21 ' B' ' 117' ' ' THR . 0.5 OUTLIER -106.25 139.16 41.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.167 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.625 HD13 ' HG ' ' B' ' 86' ' ' LEU . 1.0 OUTLIER -73.92 76.49 1.66 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.707 0.289 . . . . 0.0 110.718 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.45 -17.2 14.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.519 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -51.79 1.24 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.642 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.95 18.83 21.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.933 0.397 . . . . 0.0 111.604 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . 0.892 HG21 HG23 ' B' ' 112' ' ' THR . 0.2 OUTLIER -85.84 84.71 7.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.698 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . 95.7 m-85 -101.41 98.76 9.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.772 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 38.2 m -130.83 62.34 1.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.989 0.423 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.28 145.85 30.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.658 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.633 ' HB3' ' HE3' ' B' ' 68' ' ' LYS . 3.5 mm-40 -121.35 71.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.217 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.67 134.79 34.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.74 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 15.2 m -83.86 113.67 21.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.7 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.639 ' CD2' ' HB1' ' B' ' 20' ' ' ALA . 18.9 tp -73.98 142.92 45.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.649 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.662 ' HA ' HG23 ' B' ' 63' ' ' THR . 0.9 OUTLIER -138.55 162.13 35.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.53 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.8 113.13 12.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.65 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.59 -139.92 9.48 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.711 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 6.6 m -101.72 96.85 7.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.688 0.28 . . . . 0.0 110.8 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -83.67 148.61 27.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.898 0.38 . . . . 0.0 111.019 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.625 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -138.65 143.32 39.18 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.16 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' ILE . . . . . 0.827 HG21 HG11 ' B' ' 71' ' ' VAL . 54.9 mt -104.51 112.34 65.35 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' PRO . . . . . 0.708 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.95 142.05 12.25 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.697 1.598 . . . . 0.0 112.503 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.68 141.12 22.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.851 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -104.48 152.63 22.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.107 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.641 ' O ' HG22 ' B' ' 52' ' ' VAL . . . -153.57 101.09 2.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.949 0.404 . . . . 0.0 111.586 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . 0.553 ' HB3' ' HA ' ' B' ' 51' ' ' ALA . 17.5 ptt180 -107.19 177.28 4.9 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.436 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . 0.503 ' HB3' HD21 ' B' ' 42' ' ' LEU . 4.7 m-85 -85.96 124.08 32.02 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.019 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . 0.453 ' HB3' HG11 ' B' ' 85' ' ' VAL . 1.2 t80 -118.85 112.45 19.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.972 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.665 ' HB2' HD23 ' B' ' 42' ' ' LEU . . . -102.99 133.97 47.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.842 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' THR . . . . . 0.62 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 0.1 OUTLIER -81.11 -28.89 35.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.506 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . 0.463 ' H ' ' HB3' ' B' ' 98' ' ' ASN . . . -160.17 -111.07 0.28 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.894 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.91 110.54 21.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.502 0.191 . . . . 0.0 110.712 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' ALA . . . . . 0.698 ' HB3' ' HA ' ' B' ' 39' ' ' THR . . . -65.57 134.22 52.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.781 0.325 . . . . 0.0 111.45 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.601 ' O ' ' CG1' ' A' ' 16' ' ' VAL . 57.2 m -105.81 149.46 38.01 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.309 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . 0.493 ' CD ' ' CG2' ' B' ' 144' ' ' THR . 1.4 Cg_endo -82.95 125.47 4.16 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.592 2.195 . . . . 0.0 112.011 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . 0.675 ' O ' ' CG ' ' A' ' 15' ' ' GLU . . . 168.83 -126.3 1.37 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.423 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.448 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -111.12 128.45 55.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.817 0.342 . . . . 0.0 111.296 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' ALA . . . . . 0.698 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -125.45 52.12 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.188 0.518 . . . . 0.0 110.474 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.74 151.92 20.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.607 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.776 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -158.23 169.51 24.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.982 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.9 128.69 41.06 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.289 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . 0.483 ' HB2' HD11 ' B' ' 86' ' ' LEU . . . -122.25 144.07 49.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.153 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 1.04 HG23 HG22 ' A' ' 9' ' ' THR . 0.6 OUTLIER -106.36 145.32 31.83 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' PHE . . . . . 0.41 ' HB3' ' H ' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -96.88 134.63 39.96 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.095 0.474 . . . . 0.0 110.052 -179.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . 0.416 ' HA ' ' H ' ' A' ' 7' ' ' GLY . 9.9 mmtt -124.17 148.03 47.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.944 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' VAL . . . . . 0.521 HG23 HG23 ' A' ' 5' ' ' VAL . 30.0 m -135.04 144.85 33.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.81 0.338 . . . . 0.0 111.757 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.683 ' HG3' HG23 ' A' ' 4' ' ' THR . 0.0 OUTLIER -134.5 126.14 28.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.215 0.531 . . . . 0.0 110.386 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' B' ' 21' ' ' CYS . 5.2 m-85 -106.05 128.77 54.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.494 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . 0.565 ' HG3' ' C ' ' B' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.898 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.284 0.088 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.66 77.09 0.19 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.007 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 10.9 m -117.39 119.31 34.71 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.394 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 4' ' ' THR . . . . . 0.677 HG23 ' HG3' ' D' ' 157' ' ' GLN . 4.0 m -98.36 127.2 44.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.538 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.918 HG21 HG12 ' D' ' 17' ' ' VAL . 1.6 m -146.14 170.99 4.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.574 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.05 114.75 23.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.611 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' GLY . . . . . 0.414 ' H ' ' HA ' ' D' ' 155' ' ' LYS . . . -69.75 -57.64 7.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.801 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . 0.421 ' O ' HG23 ' C' ' 9' ' ' THR . . . -163.56 -144.59 4.08 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.892 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . 0.986 HG22 HG23 ' D' ' 153' ' ' THR . 17.2 p -155.75 140.45 17.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.863 0.363 . . . . 0.0 111.396 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.559 HG13 HG23 ' D' ' 32' ' ' VAL . 29.5 t -130.28 117.49 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.212 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.59 117.09 29.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.392 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -89.88 107.02 18.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.911 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.71 113.29 26.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.454 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . 0.44 ' HA3' ' OH ' ' D' ' 137' ' ' TYR . . . -144.37 167.0 27.09 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.889 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' GLU . . . . . 0.676 ' CG ' ' O ' ' D' ' 146' ' ' GLY . 30.2 tt0 -155.73 135.18 12.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.975 0.417 . . . . 0.0 110.343 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' D' ' 148' ' ' ALA . 66.5 t -96.53 138.35 21.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.317 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.88 HG12 HG21 ' B' ' 5' ' ' VAL . 2.6 m -140.85 -173.37 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 0.0 110.996 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.09 173.46 12.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.967 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . 0.528 ' HA ' ' HB3' ' D' ' 38' ' ' ARG . . . -85.8 39.74 0.82 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.089 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . 0.631 ' HB1' ' CD2' ' C' ' 124' ' ' LEU . . . -114.24 -33.68 5.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.382 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' CYS . . . . . 0.675 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.9 OUTLIER -161.12 149.96 16.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.979 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' D' ' 36' ' ' GLN . . . -149.57 112.12 4.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.061 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . 0.665 ' HA ' ' HA ' ' C' ' 58' ' ' LEU . 3.1 p -59.97 153.4 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.04 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.76 152.83 28.12 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.624 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.53 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -57.58 -41.38 81.0 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.365 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.88 15.7 62.12 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.992 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.96 -21.39 11.14 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.927 0.394 . . . . 0.0 110.805 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 89.8 t -44.6 -64.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.334 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.26 135.61 38.94 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.913 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.0 128.8 19.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.043 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.71 111.71 23.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.111 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.552 HG23 HG13 ' B' ' 10' ' ' VAL . 4.2 t -110.74 114.79 48.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.103 0.478 . . . . 0.0 110.464 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.81 124.49 46.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.665 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.5 -45.7 14.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.603 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.32 -161.83 12.84 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.612 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . 0.666 HE21 HG21 ' B' ' 17' ' ' VAL . 1.8 mt-30 -99.85 129.7 45.97 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.557 0.218 . . . . 0.0 110.873 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.494 ' CG1' HG22 ' B' ' 16' ' ' VAL . 11.9 p -110.04 147.44 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.914 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' ARG . . . . . 0.513 ' HB3' ' HA ' ' B' ' 19' ' ' ALA . 0.7 OUTLIER -86.72 131.26 34.19 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.997 0.427 . . . . 0.0 111.804 179.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.697 ' HA ' ' HB3' ' C' ' 143' ' ' ALA . 4.8 t -54.12 -45.12 71.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.693 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.439 ' N ' HG23 ' C' ' 39' ' ' THR . . . -61.02 -39.36 89.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.114 0.483 . . . . 0.0 110.856 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' C' ' 38' ' ' ARG . 0.4 OUTLIER -70.63 -23.1 62.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.17 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.668 HD23 ' HB2' ' C' ' 139' ' ' ALA . 1.4 mp -124.61 51.58 1.6 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.583 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.66 29.95 7.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.326 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.84 128.45 48.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.32 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' C' ' 140' ' ' THR . 29.3 tt0 -53.0 102.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.114 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . 0.414 ' HA2' ' HE1' ' C' ' 138' ' ' PHE . . . 96.06 39.03 4.41 Favored Glycine 0 C--N 1.331 0.255 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.114 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' C' ' 139' ' ' ALA . . . -80.08 146.7 31.77 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.66 125.09 19.11 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.876 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 31.9 m -102.01 -166.27 1.27 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.625 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.96 133.03 55.71 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.836 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' C' ' 136' ' ' ARG . . . -92.74 120.21 32.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.299 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.623 HG22 ' O ' ' C' ' 135' ' ' ALA . 18.4 m -65.76 162.63 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.974 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.86 124.15 5.28 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.609 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -155.93 146.56 21.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.713 0.292 . . . . 0.0 110.932 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.578 ' HB2' HG22 ' C' ' 130' ' ' THR . 3.3 p30 -136.8 160.27 39.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.54 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.567 HG23 ' O ' ' C' ' 56' ' ' ILE . 1.6 tp -100.68 116.95 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.502 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.613 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.0 OUTLIER -70.09 124.56 24.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.763 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . 0.665 ' HA ' ' HA ' ' C' ' 23' ' ' VAL . 1.6 mp -133.68 87.42 2.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.231 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 4.9 p30 -73.67 174.54 8.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.918 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.8 79.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' CYS . . . . . 0.675 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 93.2 m -127.62 159.39 34.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.836 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . 0.607 ' OD2' HG23 ' C' ' 65' ' ' VAL . 5.5 t70 -130.22 167.07 19.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.354 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.667 HG23 ' HA ' ' C' ' 125' ' ' ASN . 0.2 OUTLIER -114.24 -41.75 3.44 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.5 -22.61 65.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.018 0.437 . . . . 0.0 111.714 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.607 HG23 ' OD2' ' C' ' 62' ' ' ASP . 81.4 t -70.4 -74.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.626 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' C' ' 124' ' ' LEU . . . -120.71 131.34 54.49 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.656 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.19 -48.63 6.11 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.81 0.338 . . . . 0.0 110.924 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' LYS . . . . . 0.634 ' HE3' ' HB3' ' C' ' 121' ' ' GLU . 0.1 OUTLIER -96.22 161.54 13.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.561 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.1 124.66 6.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.608 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.724 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -100.44 154.98 18.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.054 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . 0.829 HG11 HG21 ' C' ' 131' ' ' ILE . 2.3 t -132.72 148.3 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.713 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . 0.459 ' HA ' HD21 ' C' ' 111' ' ' LEU . . . -145.62 150.15 35.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.66 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' PHE . . . . . 0.568 ' HB2' HD13 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -119.95 137.0 54.31 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.077 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.624 HD21 HG21 ' F' ' 130' ' ' THR . 0.9 OUTLIER -96.08 139.52 32.14 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.874 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . 0.425 ' CA ' ' HB3' ' C' ' 113' ' ' LEU . . . 178.51 179.85 48.49 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.764 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.562 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.3 OUTLIER -110.94 156.42 21.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.545 0.212 . . . . 0.0 110.848 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . 0.668 ' O ' ' HB2' ' C' ' 87' ' ' ALA . . . -73.76 131.26 41.39 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.365 -0.38 . . . . 0.0 112.023 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . 0.649 ' CG2' ' HB ' ' C' ' 85' ' ' VAL . 0.9 OUTLIER -67.69 -41.37 85.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.865 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' ASP . . . . . 0.437 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.6 OUTLIER -141.18 40.84 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.8 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . 0.434 ' HB3' ' HA2' ' F' ' 108' ' ' GLY . . . 66.35 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.027 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.66 -24.95 41.86 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.723 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.12 64.04 1.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.953 0.406 . . . . 0.0 110.469 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . 0.545 HG23 ' HB2' ' C' ' 77' ' ' ALA . 0.2 OUTLIER -68.44 -16.99 64.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.53 -179.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' ASN . . . . . 0.702 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 18.0 p-10 -70.35 -20.28 62.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.361 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.649 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 14.7 t -106.91 130.75 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.158 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.767 HD22 ' HB1' ' C' ' 150' ' ' ALA . 0.5 OUTLIER -67.56 148.19 51.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' C' ' 77' ' ' ALA . . . -89.64 -167.49 1.87 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.764 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.659 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 1.5 mm? -78.37 157.29 29.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.114 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -78.34 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.345 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' SER . . . . . 0.576 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 0.5 OUTLIER -167.1 0.53 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.018 0.437 . . . . 0.0 111.48 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' SER . . . . . 0.545 ' HA ' ' HB2' ' E' ' 25' ' ' ALA . 1.7 m -71.92 83.02 0.93 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' F' ' 34' ' ' LEU . . . -66.77 -13.88 61.95 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.879 0.371 . . . . 0.0 111.688 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.67 27.54 5.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.638 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.65 15.63 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.973 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' SER . . . . . 0.659 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 3.0 m -100.85 -172.84 2.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.766 0.317 . . . . 0.0 110.627 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.91 167.65 9.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . 0.515 ' H ' ' HB ' ' C' ' 144' ' ' THR . 2.3 m -121.57 128.43 51.98 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.295 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . 0.457 ' HB3' ' H ' ' C' ' 141' ' ' GLY . 75.9 m-20 64.14 34.48 11.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.498 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 99' ' ' VAL . . . . . 0.478 HG13 HD23 ' C' ' 42' ' ' LEU . 0.5 OUTLIER -139.87 136.6 38.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.709 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.19 -156.91 8.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.498 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' VAL . . . . . 0.492 HG13 ' HB2' ' C' ' 86' ' ' LEU . 3.2 p -137.81 116.77 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 122.951 0.5 . . . . 0.0 111.644 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 102' ' ' GLN . . . . . 0.578 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 1.1 tt0 -91.91 150.36 21.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.873 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.67 HD12 ' HB3' ' C' ' 111' ' ' LEU . 0.5 OUTLIER -113.76 131.31 65.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.601 179.415 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 0.3 OUTLIER -106.24 130.19 54.15 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.664 0.269 . . . . 0.0 111.054 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . 0.743 ' HB3' HG22 ' C' ' 107' ' ' THR . 5.1 t0 -76.2 157.0 33.12 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.694 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 106' ' ' ARG . . . . . 0.71 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 3.5 ttp180 -71.24 -17.44 62.5 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.763 0.316 . . . . 0.0 111.101 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 107' ' ' THR . . . . . 0.743 HG22 ' HB3' ' C' ' 105' ' ' ASP . 6.2 t -67.27 -17.99 65.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.069 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.75 -45.62 1.17 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.766 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.14 163.11 23.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.727 0.298 . . . . 0.0 111.159 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -84.15 127.39 33.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 111' ' ' LEU . . . . . 0.67 ' HB3' HD12 ' C' ' 103' ' ' ILE . 12.1 tp -86.22 156.02 20.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.304 0.573 . . . . 0.0 110.638 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 112' ' ' THR . . . . . 0.892 HG23 HG21 ' C' ' 117' ' ' THR . 0.5 OUTLIER -106.14 139.17 41.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.151 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.624 HD13 ' HG ' ' C' ' 86' ' ' LEU . 1.0 OUTLIER -73.91 76.43 1.65 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.679 0.276 . . . . 0.0 110.706 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.41 -17.17 14.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.558 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.27 -51.75 1.25 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.648 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.03 18.84 21.66 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.941 0.4 . . . . 0.0 111.554 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . 0.892 HG21 HG23 ' C' ' 112' ' ' THR . 0.2 OUTLIER -85.8 84.6 7.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.057 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 118' ' ' PHE . . . . . 0.724 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . 95.7 m-85 -101.38 98.77 9.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.795 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 38.7 m -130.79 62.28 1.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.25 145.86 30.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.715 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . 0.634 ' HB3' ' HE3' ' C' ' 68' ' ' LYS . 3.5 mm-40 -121.39 71.25 0.95 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.217 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.69 134.77 34.75 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.703 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 14.8 m -83.79 113.66 21.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.776 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . 0.631 ' CD2' ' HB1' ' C' ' 20' ' ' ALA . 18.9 tp -74.0 142.9 45.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.657 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 125' ' ' ASN . . . . . 0.667 ' HA ' HG23 ' C' ' 63' ' ' THR . 0.9 OUTLIER -138.57 162.1 35.41 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.573 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.73 113.2 12.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.7 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.48 -139.91 9.5 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.734 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 128' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 6.7 m -101.69 96.76 7.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.698 0.285 . . . . 0.0 110.773 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.59 148.48 27.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.895 0.379 . . . . 0.0 111.093 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 130' ' ' THR . . . . . 0.613 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -138.55 143.43 39.45 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.207 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 131' ' ' ILE . . . . . 0.829 HG21 HG11 ' C' ' 71' ' ' VAL . 55.1 mt -104.62 112.41 65.34 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 132' ' ' PRO . . . . . 0.71 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.5 Cg_endo -81.95 141.98 12.2 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.719 1.612 . . . . 0.0 112.526 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.401 ' HZ ' HD22 ' C' ' 111' ' ' LEU . 0.3 OUTLIER -150.63 141.06 22.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.85 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.49 152.53 22.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.131 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . 0.623 ' O ' HG22 ' C' ' 52' ' ' VAL . . . -153.52 101.08 2.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.98 0.419 . . . . 0.0 111.6 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.554 ' HB3' ' HA ' ' C' ' 51' ' ' ALA . 17.5 ptt180 -107.18 177.2 4.92 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.42 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 137' ' ' TYR . . . . . 0.497 ' HB3' HD21 ' C' ' 42' ' ' LEU . 4.7 m-85 -85.93 124.15 32.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.008 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 138' ' ' PHE . . . . . 0.466 ' HB3' HG11 ' C' ' 85' ' ' VAL . 1.2 t80 -118.9 112.38 19.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.959 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 139' ' ' ALA . . . . . 0.668 ' HB2' HD23 ' C' ' 42' ' ' LEU . . . -102.97 133.95 47.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.873 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 140' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 0.1 OUTLIER -81.1 -28.9 35.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.529 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . 0.457 ' H ' ' HB3' ' C' ' 98' ' ' ASN . . . -160.15 -111.06 0.28 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.926 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.85 110.56 21.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.537 0.208 . . . . 0.0 110.766 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 143' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' C' ' 39' ' ' THR . . . -65.65 134.29 52.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.83 0.348 . . . . 0.0 111.343 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 144' ' ' THR . . . . . 0.602 ' O ' ' CG1' ' B' ' 16' ' ' VAL . 56.4 m -105.82 149.39 37.93 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.346 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 145' ' ' PRO . . . . . 0.49 ' CD ' ' CG2' ' C' ' 144' ' ' THR . 1.4 Cg_endo -82.91 125.54 4.2 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.497 2.131 . . . . 0.0 112.023 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 146' ' ' GLY . . . . . 0.689 ' O ' ' CG ' ' B' ' 15' ' ' GLU . . . 168.78 -126.33 1.38 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.407 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 147' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -111.07 128.43 55.87 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.758 0.313 . . . . 0.0 111.317 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 148' ' ' ALA . . . . . 0.686 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -125.41 52.15 1.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.15 0.5 . . . . 0.0 110.492 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -98.78 151.93 20.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.597 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 150' ' ' ALA . . . . . 0.767 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -158.28 169.6 24.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.009 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -130.98 128.63 40.8 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.291 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 152' ' ' ALA . . . . . 0.479 ' HB2' HD11 ' C' ' 86' ' ' LEU . . . -122.21 144.06 49.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.228 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . 1.041 HG23 HG22 ' B' ' 9' ' ' THR . 0.6 OUTLIER -106.37 145.34 31.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 154' ' ' PHE . . . . . 0.402 ' HB3' ' H ' ' B' ' 8' ' ' GLY . 0.5 OUTLIER -96.9 134.67 39.93 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.068 0.461 . . . . 0.0 110.019 -178.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 155' ' ' LYS . . . . . 0.416 ' HA ' ' H ' ' B' ' 7' ' ' GLY . 9.9 mmtt -124.15 148.14 47.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.895 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 156' ' ' VAL . . . . . 0.521 HG23 HG23 ' B' ' 5' ' ' VAL . 29.9 m -135.15 144.77 33.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.742 0.306 . . . . 0.0 111.791 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 157' ' ' GLN . . . . . 0.677 ' HG3' HG23 ' B' ' 4' ' ' THR . 0.0 OUTLIER -134.46 126.06 28.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.273 0.559 . . . . 0.0 110.399 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 158' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' C' ' 21' ' ' CYS . 5.2 m-85 -106.02 128.75 54.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.502 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . 0.56 ' HG3' ' C ' ' C' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 111.142 0.053 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.64 77.12 0.19 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.172 0.295 . . . . 0.0 110.983 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 3' ' ' THR . . . . . . . . . . . . . 10.9 m -117.41 119.32 34.75 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.387 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . 0.682 HG23 ' HG3' ' E' ' 157' ' ' GLN . 4.0 m -98.37 127.21 44.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.535 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.92 HG21 HG12 ' E' ' 17' ' ' VAL . 1.6 m -146.1 171.03 4.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.601 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -86.02 114.61 23.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.599 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 7' ' ' GLY . . . . . 0.407 ' H ' ' HA ' ' E' ' 155' ' ' LYS . . . -69.61 -57.71 7.05 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.813 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . 0.43 ' O ' HG23 ' D' ' 9' ' ' THR . . . -163.59 -144.61 4.08 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.87 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . 1.038 HG22 HG23 ' E' ' 153' ' ' THR . 17.1 p -155.7 140.46 17.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 111.371 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' VAL . . . . . 0.546 HG13 HG23 ' E' ' 32' ' ' VAL . 30.1 t -130.34 117.48 39.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.294 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.5 116.98 29.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.349 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -89.86 107.08 18.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.883 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.75 113.32 26.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.451 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' GLY . . . . . 0.441 ' HA3' ' OH ' ' E' ' 137' ' ' TYR . . . -144.42 166.98 27.12 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.919 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' GLU . . . . . 0.676 ' CG ' ' O ' ' E' ' 146' ' ' GLY . 30.2 tt0 -155.68 135.2 12.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.966 0.412 . . . . 0.0 110.32 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.699 HG23 ' HB2' ' E' ' 148' ' ' ALA . 65.8 t -96.53 138.36 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.275 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.918 HG12 HG21 ' C' ' 5' ' ' VAL . 2.7 m -140.85 -173.38 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.872 0.368 . . . . 0.0 111.002 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.08 173.41 12.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.075 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' E' ' 38' ' ' ARG . . . -85.82 39.76 0.82 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.041 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.639 ' HB1' ' CD2' ' D' ' 124' ' ' LEU . . . -114.31 -33.46 5.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.459 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.9 OUTLIER -161.18 149.98 16.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.935 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.64 112.09 4.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.102 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . 0.664 ' HA ' ' HA ' ' D' ' 58' ' ' LEU . 3.0 p -59.93 153.34 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.082 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.68 152.75 28.27 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.686 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.546 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -57.53 -41.46 80.93 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.357 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.81 15.7 62.06 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.968 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.95 -21.35 11.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.914 0.387 . . . . 0.0 110.814 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 90.1 t -44.58 -64.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.364 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.29 135.69 38.85 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.885 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.04 128.77 19.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.044 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.83 111.83 23.85 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.014 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.559 HG23 HG13 ' C' ' 10' ' ' VAL . 4.2 t -110.82 114.81 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.139 0.495 . . . . 0.0 110.519 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.75 124.45 46.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.649 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 0.9 OUTLIER -82.49 -45.74 14.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.574 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.37 -161.86 12.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.571 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' GLN . . . . . 0.645 HE21 HG21 ' C' ' 17' ' ' VAL . 1.8 mt-30 -99.83 129.69 45.95 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.648 0.261 . . . . 0.0 110.881 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.493 ' CG1' HG22 ' C' ' 16' ' ' VAL . 12.0 p -110.02 147.44 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.995 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . 0.528 ' HB3' ' HA ' ' C' ' 19' ' ' ALA . 0.7 OUTLIER -86.78 131.29 34.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.053 0.454 . . . . 0.0 111.69 179.301 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.693 ' HA ' ' HB3' ' D' ' 143' ' ' ALA . 4.8 t -54.09 -45.13 71.71 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.753 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.449 ' N ' HG23 ' D' ' 39' ' ' THR . . . -60.93 -39.37 89.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.137 0.494 . . . . 0.0 110.939 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' D' ' 38' ' ' ARG . 0.4 OUTLIER -70.62 -23.15 62.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.134 -179.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' D' ' 139' ' ' ALA . 1.4 mp -124.59 51.57 1.6 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.669 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.59 29.9 7.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.38 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.84 128.46 48.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.33 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' D' ' 140' ' ' THR . 29.5 tt0 -52.95 103.05 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.871 0.367 . . . . 0.0 111.117 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . 0.419 ' HA2' ' HE1' ' D' ' 138' ' ' PHE . . . 95.94 39.03 4.44 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.193 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' D' ' 139' ' ' ALA . . . -79.98 146.66 31.92 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.63 124.97 19.01 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.973 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 32.3 m -101.9 -166.31 1.28 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.626 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.04 132.99 55.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.848 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' ALA . . . . . 0.549 ' HA ' ' HB3' ' D' ' 136' ' ' ARG . . . -92.64 120.24 32.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.321 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' VAL . . . . . 0.631 HG22 ' O ' ' D' ' 135' ' ' ALA . 18.5 m -65.84 162.66 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.905 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.8 124.14 5.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.649 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.442 ' N ' HG21 ' A' ' 76' ' ' THR . 54.0 p90 -155.93 146.55 21.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.705 0.288 . . . . 0.0 110.942 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' ASN . . . . . 0.568 ' HB2' HG22 ' D' ' 130' ' ' THR . 3.4 p30 -136.84 160.24 39.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.58 HG23 ' O ' ' D' ' 56' ' ' ILE . 1.6 tp -100.63 117.02 45.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.536 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' GLN . . . . . 0.611 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.0 OUTLIER -70.12 124.58 24.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.736 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . 0.664 ' HA ' ' HA ' ' D' ' 23' ' ' VAL . 1.6 mp -133.77 87.54 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.181 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 4.9 p30 -73.65 174.61 8.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.006 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.81 79.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.815 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 93.6 m -127.58 159.4 34.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.862 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . 0.612 ' OD2' HG23 ' D' ' 65' ' ' VAL . 5.5 t70 -130.24 167.11 18.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.28 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.661 HG23 ' HA ' ' D' ' 125' ' ' ASN . 0.2 OUTLIER -114.35 -41.66 3.44 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.47 -22.71 65.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.063 0.459 . . . . 0.0 111.723 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . 0.612 HG23 ' OD2' ' D' ' 62' ' ' ASP . 81.5 t -70.38 -74.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.635 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' D' ' 124' ' ' LEU . . . -120.76 131.33 54.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.634 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.21 -48.54 6.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.857 0.361 . . . . 0.0 110.981 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' LYS . . . . . 0.631 ' HE3' ' HB3' ' D' ' 121' ' ' GLU . 0.1 OUTLIER -96.25 161.54 13.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.555 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.09 124.63 6.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.642 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . 0.726 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -100.32 155.0 18.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.098 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . 0.849 HG11 HG21 ' D' ' 131' ' ' ILE . 2.3 t -132.75 148.22 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.745 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 72' ' ' ALA . . . . . 0.445 ' HA ' HD21 ' D' ' 111' ' ' LEU . . . -145.57 150.18 35.93 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.59 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 73' ' ' PHE . . . . . 0.557 ' HB2' HD13 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -119.99 136.96 54.35 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.053 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 74' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.9 OUTLIER -96.05 139.54 32.08 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.937 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . 0.429 ' CA ' ' HB3' ' D' ' 113' ' ' LEU . . . 178.53 179.83 48.5 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.745 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . 0.548 ' H ' HD23 ' D' ' 86' ' ' LEU . 0.3 OUTLIER -111.0 156.39 21.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.534 0.207 . . . . 0.0 110.832 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.668 ' O ' ' HB2' ' D' ' 87' ' ' ALA . . . -73.78 131.3 41.41 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.04 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 78' ' ' ILE . . . . . 0.646 ' CG2' ' HB ' ' D' ' 85' ' ' VAL . 0.9 OUTLIER -67.72 -41.3 85.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.874 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.424 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.6 OUTLIER -141.17 40.75 1.78 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.808 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 66.44 -80.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.7 -24.96 42.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.688 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -99.1 64.04 1.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.448 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 83' ' ' THR . . . . . 0.542 HG23 ' HB2' ' D' ' 77' ' ' ALA . 0.2 OUTLIER -68.5 -16.86 64.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.584 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . 0.693 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 18.0 p-10 -70.36 -20.3 62.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.359 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.646 ' HB ' ' CG2' ' D' ' 78' ' ' ILE . 14.7 t -106.87 130.74 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.136 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.78 HD22 ' HB1' ' D' ' 150' ' ' ALA . 0.5 OUTLIER -67.66 148.18 51.69 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' D' ' 77' ' ' ALA . . . -89.62 -167.54 1.89 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 111.713 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.659 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 1.5 mm? -78.32 157.23 29.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.094 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -78.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.418 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.18 0.6 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.971 0.415 . . . . 0.0 111.483 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . 0.537 ' HA ' ' HB2' ' F' ' 25' ' ' ALA . 1.7 m -71.91 82.94 0.93 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.65 -13.96 61.84 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.917 0.389 . . . . 0.0 111.749 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.61 27.61 5.23 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.581 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.67 15.6 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.946 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 95' ' ' SER . . . . . 0.659 ' HB3' ' HG ' ' D' ' 88' ' ' LEU . 3.0 m -100.9 -172.81 2.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.715 0.293 . . . . 0.0 110.635 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.86 167.62 9.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . 0.517 ' H ' ' HB ' ' D' ' 144' ' ' THR . 2.3 m -121.51 128.36 51.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.34 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 98' ' ' ASN . . . . . 0.461 ' HB3' ' H ' ' D' ' 141' ' ' GLY . 76.0 m-20 64.28 34.44 10.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.468 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 99' ' ' VAL . . . . . 0.503 HG13 HD23 ' D' ' 42' ' ' LEU . 0.5 OUTLIER -139.92 136.46 38.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.738 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.08 -156.92 8.36 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.523 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 101' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' D' ' 86' ' ' LEU . 3.2 p -137.8 116.8 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.132 0.491 . . . . 0.0 111.647 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 102' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 1.2 tt0 -91.86 150.35 21.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.847 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 103' ' ' ILE . . . . . 0.688 HD12 ' HB3' ' D' ' 111' ' ' LEU . 0.5 OUTLIER -113.85 131.34 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.494 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 104' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 0.3 OUTLIER -106.29 130.16 54.19 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.68 0.276 . . . . 0.0 110.958 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . 0.738 ' HB3' HG22 ' D' ' 107' ' ' THR . 5.1 t0 -76.14 156.99 33.28 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.679 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 106' ' ' ARG . . . . . 0.741 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 3.5 ttp180 -71.19 -17.55 62.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.738 0.304 . . . . 0.0 111.078 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 107' ' ' THR . . . . . 0.738 HG22 ' HB3' ' D' ' 105' ' ' ASP . 6.2 t -67.17 -18.07 65.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.021 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 108' ' ' GLY . . . . . 0.439 ' HA2' ' CB ' ' A' ' 80' ' ' ALA . . . 123.7 -45.57 1.17 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.74 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.07 163.05 23.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.7 0.286 . . . . 0.0 111.154 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -84.13 127.41 33.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.08 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 111' ' ' LEU . . . . . 0.688 ' HB3' HD12 ' D' ' 103' ' ' ILE . 12.1 tp -86.24 156.11 20.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.258 0.551 . . . . 0.0 110.633 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 112' ' ' THR . . . . . 0.891 HG23 HG21 ' D' ' 117' ' ' THR . 0.5 OUTLIER -106.23 139.15 41.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.123 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 113' ' ' LEU . . . . . 0.602 HD13 ' HG ' ' D' ' 86' ' ' LEU . 1.0 OUTLIER -74.03 76.55 1.71 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.755 0.312 . . . . 0.0 110.742 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.54 -17.09 14.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.516 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.23 -51.86 1.25 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.664 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.99 18.86 21.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.858 0.361 . . . . 0.0 111.509 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 117' ' ' THR . . . . . 0.891 HG21 HG23 ' D' ' 112' ' ' THR . 0.2 OUTLIER -85.81 84.64 7.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.079 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.726 ' HB3' ' HB1' ' D' ' 70' ' ' ALA . 95.7 m-85 -101.37 98.77 9.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.759 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 38.1 m -130.77 62.33 1.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.28 145.74 30.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.735 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . 0.631 ' HB3' ' HE3' ' D' ' 68' ' ' LYS . 3.5 mm-40 -121.25 71.3 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.179 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 134.78 34.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.684 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 15.1 m -83.82 113.7 21.11 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.701 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . 0.639 ' CD2' ' HB1' ' D' ' 20' ' ' ALA . 19.0 tp -74.08 142.96 45.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.772 0.32 . . . . 0.0 110.61 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 125' ' ' ASN . . . . . 0.661 ' HA ' HG23 ' D' ' 63' ' ' THR . 0.9 OUTLIER -138.53 162.12 35.32 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.59 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.8 113.18 12.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.684 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.54 -140.02 9.57 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.688 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 128' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 6.6 m -101.66 96.87 7.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 110.773 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.65 148.54 27.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.843 0.354 . . . . 0.0 111.097 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 130' ' ' THR . . . . . 0.627 HG21 HD21 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -138.61 143.4 39.31 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.123 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 131' ' ' ILE . . . . . 0.849 HG21 HG11 ' D' ' 71' ' ' VAL . 55.1 mt -104.57 112.36 65.34 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 132' ' ' PRO . . . . . 0.741 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.4 Cg_endo -82.01 141.98 12.13 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.675 1.583 . . . . 0.0 112.458 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . 0.404 ' HZ ' HD22 ' D' ' 111' ' ' LEU . 0.3 OUTLIER -150.61 141.12 22.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.897 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.48 152.55 22.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.097 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.631 ' O ' HG22 ' D' ' 52' ' ' VAL . . . -153.53 101.08 2.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.954 0.407 . . . . 0.0 111.578 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 136' ' ' ARG . . . . . 0.549 ' HB3' ' HA ' ' D' ' 51' ' ' ALA . 17.5 ptt180 -107.18 177.19 4.92 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.379 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 137' ' ' TYR . . . . . 0.49 ' HB3' HD21 ' D' ' 42' ' ' LEU . 4.7 m-85 -85.92 124.04 31.94 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.089 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 138' ' ' PHE . . . . . 0.455 ' HB3' HG11 ' D' ' 85' ' ' VAL . 1.2 t80 -118.8 112.39 19.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.991 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 139' ' ' ALA . . . . . 0.685 ' HB2' HD23 ' D' ' 42' ' ' LEU . . . -102.97 134.0 47.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.828 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 140' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 0.1 OUTLIER -81.12 -28.86 34.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.507 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . 0.461 ' H ' ' HB3' ' D' ' 98' ' ' ASN . . . -160.19 -111.09 0.28 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.917 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.88 110.57 21.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.549 0.214 . . . . 0.0 110.744 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 143' ' ' ALA . . . . . 0.693 ' HB3' ' HA ' ' D' ' 39' ' ' THR . . . -65.69 134.27 52.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 111.341 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 144' ' ' THR . . . . . 0.602 ' O ' ' CG1' ' C' ' 16' ' ' VAL . 56.4 m -105.8 149.42 37.96 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.341 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 145' ' ' PRO . . . . . 0.487 ' CD ' ' CG2' ' D' ' 144' ' ' THR . 1.3 Cg_endo -82.96 125.52 4.17 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.519 2.146 . . . . 0.0 112.001 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 146' ' ' GLY . . . . . 0.676 ' O ' ' CG ' ' C' ' 15' ' ' GLU . . . 168.8 -126.37 1.38 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.412 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 147' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -111.1 128.45 55.89 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.813 0.339 . . . . 0.0 111.322 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 148' ' ' ALA . . . . . 0.688 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -125.46 52.14 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.15 0.5 . . . . 0.0 110.398 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -98.71 152.05 20.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.545 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 150' ' ' ALA . . . . . 0.78 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -158.38 169.46 24.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.959 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.96 128.67 40.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.256 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 152' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' D' ' 86' ' ' LEU . . . -122.19 144.06 49.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.251 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 153' ' ' THR . . . . . 0.986 HG23 HG22 ' C' ' 9' ' ' THR . 0.6 OUTLIER -106.34 145.34 31.8 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.209 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 154' ' ' PHE . . . . . 0.415 ' HB3' ' H ' ' C' ' 8' ' ' GLY . 0.5 OUTLIER -96.84 134.67 39.84 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.052 0.454 . . . . 0.0 110.121 -179.081 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 155' ' ' LYS . . . . . 0.414 ' HA ' ' H ' ' C' ' 7' ' ' GLY . 9.9 mmtt -124.24 148.07 47.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.854 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 156' ' ' VAL . . . . . 0.515 HG23 HG23 ' C' ' 5' ' ' VAL . 29.7 m -135.06 144.83 33.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.783 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 157' ' ' GLN . . . . . 0.677 ' HG3' HG23 ' C' ' 4' ' ' THR . 0.0 OUTLIER -134.51 126.06 28.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.283 0.563 . . . . 0.0 110.36 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 158' ' ' TYR . . . . . 0.563 ' CE1' ' HB2' ' D' ' 21' ' ' CYS . 5.2 m-85 -106.02 128.77 54.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.474 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 159' ' ' GLN . . . . . 0.563 ' HG3' ' C ' ' D' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 111.169 0.062 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.7 77.1 0.19 Allowed 'General case' 0 N--CA 1.462 0.146 0 O-C-N 123.1 0.25 . . . . 0.0 110.989 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 3' ' ' THR . . . . . . . . . . . . . 10.7 m -117.36 119.24 34.52 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.472 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 4' ' ' THR . . . . . 0.693 HG23 ' HG3' ' F' ' 157' ' ' GLN . 3.9 m -98.34 127.2 44.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.575 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.884 HG21 HG12 ' F' ' 17' ' ' VAL . 1.6 m -146.11 171.02 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.592 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -86.05 114.73 23.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.573 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 7' ' ' GLY . . . . . 0.411 ' H ' ' HA ' ' F' ' 155' ' ' LYS . . . -69.67 -57.75 6.98 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.923 -0.655 . . . . 0.0 112.829 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . 0.428 ' O ' HG23 ' E' ' 9' ' ' THR . . . -163.52 -144.6 4.08 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.901 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 9' ' ' THR . . . . . 1.025 HG22 HG23 ' F' ' 153' ' ' THR . 17.1 p -155.73 140.46 17.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.855 0.36 . . . . 0.0 111.385 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 10' ' ' VAL . . . . . 0.557 HG13 HG23 ' F' ' 32' ' ' VAL . 30.0 t -130.31 117.45 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.238 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.5 117.0 29.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.435 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -89.79 107.11 18.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.84 113.26 26.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.449 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 14' ' ' GLY . . . . . 0.426 ' HA3' ' OH ' ' F' ' 137' ' ' TYR . . . -144.41 166.98 27.11 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.933 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 15' ' ' GLU . . . . . 0.685 ' CG ' ' O ' ' F' ' 146' ' ' GLY . 30.2 tt0 -155.7 135.17 12.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.985 0.421 . . . . 0.0 110.294 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 16' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' F' ' 148' ' ' ALA . 66.1 t -96.48 138.31 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.264 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . 0.92 HG12 HG21 ' D' ' 5' ' ' VAL . 2.7 m -140.81 -173.34 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 111.06 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.13 173.41 12.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.052 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 19' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' F' ' 38' ' ' ARG . . . -85.73 39.73 0.81 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.641 ' HB1' ' CD2' ' E' ' 124' ' ' LEU . . . -114.34 -33.54 5.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.424 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 21' ' ' CYS . . . . . 0.667 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.9 OUTLIER -161.13 150.01 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.933 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.6 112.1 4.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.02 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 23' ' ' VAL . . . . . 0.667 ' HA ' ' HA ' ' E' ' 58' ' ' LEU . 3.1 p -60.02 153.41 4.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.989 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.76 152.81 28.12 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.665 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -57.5 -41.48 80.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.351 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.77 15.65 62.11 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.032 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -113.05 -21.2 11.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.902 0.382 . . . . 0.0 110.809 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -44.65 -64.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.298 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.23 135.69 38.8 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.957 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.02 128.78 19.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.059 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.78 111.79 23.82 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.058 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.546 HG23 HG13 ' D' ' 10' ' ' VAL . 4.2 t -110.81 114.74 47.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.479 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.68 124.55 46.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.703 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . 0.9 OUTLIER -82.54 -45.62 14.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.661 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.31 -161.86 12.83 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.583 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 36' ' ' GLN . . . . . 0.647 HE21 HG21 ' D' ' 17' ' ' VAL . 1.8 mt-30 -99.83 129.68 45.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.604 0.24 . . . . 0.0 110.862 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.49 ' CG1' HG22 ' D' ' 16' ' ' VAL . 11.8 p -110.11 147.5 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.924 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . 0.513 ' HB3' ' HA ' ' D' ' 19' ' ' ALA . 0.7 OUTLIER -86.77 131.24 34.18 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.974 0.416 . . . . 0.0 111.765 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 39' ' ' THR . . . . . 0.699 ' HA ' ' HB3' ' E' ' 143' ' ' ALA . 4.8 t -54.08 -45.09 71.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.772 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.45 ' N ' HG23 ' E' ' 39' ' ' THR . . . -61.01 -39.35 89.4 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.052 0.453 . . . . 0.0 110.854 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 41' ' ' SER . . . . . 0.401 ' HB2' ' HB2' ' E' ' 38' ' ' ARG . 0.4 OUTLIER -70.62 -23.16 62.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.178 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.678 HD23 ' HB2' ' E' ' 139' ' ' ALA . 1.4 mp -124.55 51.61 1.59 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.616 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.69 30.02 7.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.383 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.85 128.45 48.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.294 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' E' ' 140' ' ' THR . 29.5 tt0 -52.97 102.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.899 0.38 . . . . 0.0 111.139 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . 0.428 ' HA2' ' HE1' ' E' ' 138' ' ' PHE . . . 96.05 39.02 4.42 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.098 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 47' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' E' ' 139' ' ' ALA . . . -80.08 146.77 31.74 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.68 125.0 18.97 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.957 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 32.1 m -101.93 -166.31 1.28 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.589 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.99 133.04 55.72 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 51' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' E' ' 136' ' ' ARG . . . -92.7 120.21 32.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.237 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 52' ' ' VAL . . . . . 0.638 HG22 ' O ' ' E' ' 135' ' ' ALA . 18.5 m -65.78 162.69 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.86 124.08 5.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.688 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 54' ' ' PHE . . . . . 0.455 ' N ' HG21 ' B' ' 76' ' ' THR . 53.7 p90 -155.92 146.54 21.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.713 0.292 . . . . 0.0 110.951 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 55' ' ' ASN . . . . . 0.559 ' HB2' HG22 ' E' ' 130' ' ' THR . 3.4 p30 -136.79 160.31 39.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.529 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 56' ' ' ILE . . . . . 0.57 HG23 ' O ' ' E' ' 56' ' ' ILE . 1.6 tp -100.69 116.94 45.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.563 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 57' ' ' GLN . . . . . 0.619 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.0 OUTLIER -70.0 124.64 24.57 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.766 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . 0.667 ' HA ' ' HA ' ' E' ' 23' ' ' VAL . 1.6 mp -133.79 87.49 2.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.204 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . 0.564 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 4.9 p30 -73.62 174.56 8.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.98 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.86 79.3 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.734 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 61' ' ' CYS . . . . . 0.667 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 93.4 m -127.62 159.44 34.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.88 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . 0.616 ' OD2' HG23 ' E' ' 65' ' ' VAL . 5.6 t70 -130.3 167.1 19.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.226 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 63' ' ' THR . . . . . 0.662 HG23 ' HA ' ' E' ' 125' ' ' ASN . 0.2 OUTLIER -114.26 -41.73 3.44 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.143 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.49 -22.64 65.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.013 0.435 . . . . 0.0 111.725 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . 0.616 HG23 ' OD2' ' E' ' 62' ' ' ASP . 83.1 t -70.43 -74.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.593 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 66' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' E' ' 124' ' ' LEU . . . -120.73 131.39 54.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.603 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.18 -48.6 6.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.956 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 68' ' ' LYS . . . . . 0.629 ' HE3' ' HB3' ' E' ' 121' ' ' GLU . 0.1 OUTLIER -96.23 161.51 13.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.09 124.67 6.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.633 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . 0.709 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -100.39 154.98 18.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.098 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . 0.834 HG11 HG21 ' E' ' 131' ' ' ILE . 2.3 t -132.72 148.28 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.715 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . 0.437 ' HA ' HD21 ' E' ' 111' ' ' LEU . . . -145.57 150.2 35.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.61 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 73' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -119.98 136.97 54.34 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 121.214 -0.195 . . . . 0.0 111.051 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 74' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.9 OUTLIER -95.95 139.48 32.08 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.956 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' E' ' 113' ' ' LEU . . . 178.5 179.84 48.48 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.797 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 76' ' ' THR . . . . . 0.549 ' H ' HD23 ' E' ' 86' ' ' LEU . 0.3 OUTLIER -110.98 156.37 21.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.449 0.166 . . . . 0.0 110.839 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 77' ' ' ALA . . . . . 0.671 ' O ' ' HB2' ' E' ' 87' ' ' ALA . . . -73.75 131.25 41.38 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.03 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 78' ' ' ILE . . . . . 0.649 ' CG2' ' HB ' ' E' ' 85' ' ' VAL . 0.9 OUTLIER -67.61 -41.48 85.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.831 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 79' ' ' ASP . . . . . 0.435 ' N ' HG23 ' E' ' 78' ' ' ILE . 0.6 OUTLIER -141.13 40.78 1.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 66.49 -80.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.003 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.73 -24.91 42.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.659 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -99.12 64.02 1.36 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 0.0 110.511 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 83' ' ' THR . . . . . 0.554 HG23 ' HB2' ' E' ' 77' ' ' ALA . 0.2 OUTLIER -68.48 -16.86 64.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.528 -179.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 84' ' ' ASN . . . . . 0.687 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 18.0 p-10 -70.41 -20.22 62.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.385 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.649 ' HB ' ' CG2' ' E' ' 78' ' ' ILE . 14.7 t -106.87 130.73 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.18 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 86' ' ' LEU . . . . . 0.786 HD22 ' HB1' ' E' ' 150' ' ' ALA . 0.5 OUTLIER -67.65 148.2 51.67 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 87' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' E' ' 77' ' ' ALA . . . -89.59 -167.52 1.88 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.846 0.355 . . . . 0.0 111.77 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.658 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 1.5 mm? -78.28 157.31 29.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -78.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.34 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.09 0.53 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.016 0.436 . . . . 0.0 111.462 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 91' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' E' ' 95' ' ' SER . 1.7 m -71.84 82.9 0.91 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.68 -13.92 61.85 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.872 0.368 . . . . 0.0 111.725 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.62 27.55 5.24 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.683 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.69 15.66 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.909 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 95' ' ' SER . . . . . 0.658 ' HB3' ' HG ' ' E' ' 88' ' ' LEU . 3.0 m -100.94 -172.8 2.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.782 0.325 . . . . 0.0 110.587 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.91 167.7 9.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.818 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . 0.52 ' H ' ' HB ' ' E' ' 144' ' ' THR . 2.3 m -121.56 128.46 52.03 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.338 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 98' ' ' ASN . . . . . 0.446 ' HB3' ' H ' ' E' ' 141' ' ' GLY . 75.9 m-20 64.13 34.59 10.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.432 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 99' ' ' VAL . . . . . 0.491 HG13 HD23 ' E' ' 42' ' ' LEU . 0.5 OUTLIER -139.96 136.44 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.745 179.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.12 -156.94 8.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.536 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 101' ' ' VAL . . . . . 0.485 HG13 ' HB2' ' E' ' 86' ' ' LEU . 3.2 p -137.76 116.69 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 122.971 0.508 . . . . 0.0 111.653 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 102' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 1.2 tt0 -91.86 150.37 21.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.943 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 103' ' ' ILE . . . . . 0.683 HD12 ' HB3' ' E' ' 111' ' ' LEU . 0.5 OUTLIER -113.81 131.35 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.535 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 104' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 0.3 OUTLIER -106.22 130.14 54.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.673 0.273 . . . . 0.0 110.997 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . 0.713 ' HB3' HG22 ' E' ' 107' ' ' THR . 5.1 t0 -76.11 156.99 33.33 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.739 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 106' ' ' ARG . . . . . 0.712 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 3.5 ttp180 -71.22 -17.51 62.5 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.795 0.331 . . . . 0.0 111.087 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 107' ' ' THR . . . . . 0.713 HG22 ' HB3' ' E' ' 105' ' ' ASP . 6.2 t -67.3 -17.94 64.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.997 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 108' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' B' ' 80' ' ' ALA . . . 123.73 -45.59 1.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.804 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.1 163.09 23.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.76 0.314 . . . . 0.0 111.12 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 110' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -84.14 127.37 33.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.064 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 111' ' ' LEU . . . . . 0.683 ' HB3' HD12 ' E' ' 103' ' ' ILE . 12.1 tp -86.29 156.07 20.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.29 0.567 . . . . 0.0 110.596 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 112' ' ' THR . . . . . 0.898 HG23 HG21 ' E' ' 117' ' ' THR . 0.5 OUTLIER -106.21 139.14 41.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.157 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 113' ' ' LEU . . . . . 0.619 HD13 ' HG ' ' E' ' 86' ' ' LEU . 1.0 OUTLIER -73.93 76.48 1.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 110.765 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.48 -17.17 14.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.511 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -51.8 1.24 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.638 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.95 18.77 21.75 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.929 0.395 . . . . 0.0 111.599 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 117' ' ' THR . . . . . 0.898 HG21 HG23 ' E' ' 112' ' ' THR . 0.2 OUTLIER -85.73 84.61 7.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 118' ' ' PHE . . . . . 0.709 ' HB3' ' HB1' ' E' ' 70' ' ' ALA . 95.7 m-85 -101.39 98.77 9.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.795 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 39.2 m -130.84 62.46 1.61 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.3 145.82 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.704 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 121' ' ' GLU . . . . . 0.629 ' HB3' ' HE3' ' E' ' 68' ' ' LYS . 3.5 mm-40 -121.37 71.28 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.212 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.74 134.86 34.73 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.752 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 14.8 m -83.83 113.72 21.14 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.749 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . 0.641 ' CD2' ' HB1' ' E' ' 20' ' ' ALA . 18.9 tp -74.07 143.0 45.63 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.708 0.289 . . . . 0.0 110.619 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 125' ' ' ASN . . . . . 0.662 ' HA ' HG23 ' E' ' 63' ' ' THR . 0.9 OUTLIER -138.61 162.03 35.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.624 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.72 113.24 12.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.675 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.49 -139.94 9.52 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.73 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 128' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 6.6 m -101.69 96.8 7.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.677 0.275 . . . . 0.0 110.755 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.64 148.49 27.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.897 0.379 . . . . 0.0 111.185 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 130' ' ' THR . . . . . 0.624 HG21 HD21 ' B' ' 74' ' ' LEU . 0.2 OUTLIER -138.55 143.46 39.46 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.081 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 131' ' ' ILE . . . . . 0.834 HG21 HG11 ' E' ' 71' ' ' VAL . 54.9 mt -104.57 112.3 65.33 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 132' ' ' PRO . . . . . 0.712 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.5 Cg_endo -81.93 141.93 12.21 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.737 1.624 . . . . 0.0 112.502 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 133' ' ' PHE . . . . . 0.404 ' HZ ' HD22 ' E' ' 111' ' ' LEU . 0.3 OUTLIER -150.59 141.1 22.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.829 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.52 152.6 22.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.111 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 135' ' ' ALA . . . . . 0.638 ' O ' HG22 ' E' ' 52' ' ' VAL . . . -153.57 101.06 2.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 111.602 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 136' ' ' ARG . . . . . 0.552 ' HB3' ' HA ' ' E' ' 51' ' ' ALA . 17.4 ptt180 -107.18 177.24 4.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.408 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 137' ' ' TYR . . . . . 0.493 ' HB3' HD21 ' E' ' 42' ' ' LEU . 4.7 m-85 -85.98 124.12 32.08 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.027 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 138' ' ' PHE . . . . . 0.46 ' HB3' HG11 ' E' ' 85' ' ' VAL . 1.2 t80 -118.87 112.36 19.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.048 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 139' ' ' ALA . . . . . 0.678 ' HB2' HD23 ' E' ' 42' ' ' LEU . . . -102.93 133.94 47.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.882 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 140' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 0.1 OUTLIER -81.04 -28.92 35.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.553 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' E' ' 98' ' ' ASN . . . -160.21 -111.01 0.28 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.88 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.92 110.6 21.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.547 0.213 . . . . 0.0 110.703 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 143' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' E' ' 39' ' ' THR . . . -65.68 134.27 52.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 0.0 111.368 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 144' ' ' THR . . . . . 0.593 ' O ' ' CG1' ' D' ' 16' ' ' VAL . 56.9 m -105.87 149.43 38.01 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.304 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 145' ' ' PRO . . . . . 0.485 ' CD ' ' CG2' ' E' ' 144' ' ' THR . 1.4 Cg_endo -82.91 125.47 4.18 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.542 2.161 . . . . 0.0 112.028 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 146' ' ' GLY . . . . . 0.676 ' O ' ' CG ' ' D' ' 15' ' ' GLU . . . 168.79 -126.32 1.37 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.456 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 147' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -111.13 128.42 55.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.812 0.339 . . . . 0.0 111.294 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 148' ' ' ALA . . . . . 0.699 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -125.45 52.15 1.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.115 0.483 . . . . 0.0 110.412 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.75 152.0 20.16 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.611 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 150' ' ' ALA . . . . . 0.786 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -158.29 169.56 24.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.946 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.99 128.64 40.8 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.258 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 152' ' ' ALA . . . . . 0.49 ' HB2' HD11 ' E' ' 86' ' ' LEU . . . -122.17 144.08 49.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.269 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 153' ' ' THR . . . . . 1.038 HG23 HG22 ' D' ' 9' ' ' THR . 0.6 OUTLIER -106.34 145.34 31.81 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.182 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 154' ' ' PHE . . . . . 0.402 ' HB3' ' H ' ' D' ' 8' ' ' GLY . 0.5 OUTLIER -96.9 134.69 39.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.077 0.465 . . . . 0.0 110.069 -178.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 155' ' ' LYS . . . . . 0.407 ' HA ' ' H ' ' D' ' 7' ' ' GLY . 9.9 mmtt -124.22 148.08 47.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.863 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 156' ' ' VAL . . . . . 0.506 HG23 HG23 ' D' ' 5' ' ' VAL . 29.9 m -135.15 144.79 33.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.82 0.343 . . . . 0.0 111.685 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 157' ' ' GLN . . . . . 0.682 ' HG3' HG23 ' D' ' 4' ' ' THR . 0.0 OUTLIER -134.49 126.11 28.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.223 0.535 . . . . 0.0 110.362 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 158' ' ' TYR . . . . . 0.568 ' C ' ' HG3' ' E' ' 159' ' ' GLN . 5.2 m-85 -106.01 128.71 54.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.525 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 159' ' ' GLN . . . . . 0.568 ' HG3' ' C ' ' E' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.914 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 120.296 0.093 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.69 77.11 0.19 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.979 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 10.7 m -117.4 119.27 34.57 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.372 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 4.0 m -98.39 127.21 44.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.503 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.1 171.0 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.629 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.07 114.75 23.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.163 0.506 . . . . 0.0 110.602 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.79 -57.6 7.03 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.786 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . 0.425 ' O ' HG23 ' F' ' 9' ' ' THR . . . -163.62 -144.64 4.1 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.884 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 9' ' ' THR . . . . . 0.425 HG23 ' O ' ' F' ' 8' ' ' GLY . 17.1 p -155.7 140.41 17.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.872 0.367 . . . . 0.0 111.375 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 29.7 t -130.26 117.52 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.274 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.51 117.03 29.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.423 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -89.89 107.05 18.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.826 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.76 113.3 26.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.491 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -144.41 166.98 27.11 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.916 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -155.65 135.26 12.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.975 0.417 . . . . 0.0 110.341 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 66.0 t -96.63 138.3 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.248 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 17' ' ' VAL . . . . . 0.884 HG12 HG21 ' E' ' 5' ' ' VAL . 2.6 m -140.8 -173.3 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 0.0 111.008 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.15 173.42 12.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.094 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.76 39.74 0.81 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.064 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . 0.631 ' HB1' ' CD2' ' F' ' 124' ' ' LEU . . . -114.29 -33.57 5.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.445 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 21' ' ' CYS . . . . . 0.672 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.9 OUTLIER -161.18 150.04 16.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.971 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.69 112.08 4.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.105 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 23' ' ' VAL . . . . . 0.674 ' HA ' ' HA ' ' F' ' 58' ' ' LEU . 3.1 p -59.97 153.34 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.01 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.72 152.8 28.19 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.647 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -57.52 -41.55 81.11 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.292 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.72 15.72 61.91 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.984 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.98 -21.36 11.15 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.967 0.413 . . . . 0.0 110.848 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 90.1 t -44.55 -64.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.357 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.29 135.6 38.97 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.976 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.0 128.74 19.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.82 111.85 23.86 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.152 -0.477 . . . . 0.0 112.048 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.557 HG23 HG13 ' E' ' 10' ' ' VAL . 4.2 t -110.88 114.7 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.168 0.508 . . . . 0.0 110.506 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.67 124.51 46.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.643 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 34' ' ' LEU . . . . . 0.588 ' HB3' ' HB3' ' C' ' 92' ' ' ALA . 0.9 OUTLIER -82.54 -45.65 14.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.578 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.31 -161.95 12.8 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.618 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 36' ' ' GLN . . . . . 0.668 HE21 HG21 ' E' ' 17' ' ' VAL . 1.8 mt-30 -99.79 129.65 45.92 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.622 0.248 . . . . 0.0 110.922 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.498 ' CG1' HG22 ' E' ' 16' ' ' VAL . 11.8 p -109.98 147.5 14.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.954 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 38' ' ' ARG . . . . . 0.508 ' HB3' ' HA ' ' E' ' 19' ' ' ALA . 0.7 OUTLIER -86.79 131.19 34.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.0 0.429 . . . . 0.0 111.8 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 39' ' ' THR . . . . . 0.686 ' HA ' ' HB3' ' F' ' 143' ' ' ALA . 4.8 t -54.03 -45.16 71.5 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.758 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . 0.446 ' N ' HG23 ' F' ' 39' ' ' THR . . . -60.92 -39.39 89.2 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.078 0.466 . . . . 0.0 110.943 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 41' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' F' ' 38' ' ' ARG . 0.4 OUTLIER -70.54 -23.22 62.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.157 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . 0.67 HD23 ' HB2' ' F' ' 139' ' ' ALA . 1.4 mp -124.59 51.54 1.6 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.651 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.6 30.0 7.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.43 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.86 128.49 48.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.308 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' F' ' 140' ' ' THR . 29.2 tt0 -53.05 103.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 111.072 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . 0.413 ' HA2' ' HE1' ' F' ' 138' ' ' PHE . . . 96.01 39.05 4.42 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.101 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 47' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' F' ' 139' ' ' ALA . . . -80.14 146.68 31.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.64 125.1 19.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.897 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 49' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 32.5 m -101.98 -166.29 1.28 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.614 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.98 133.06 55.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.869 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 51' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' F' ' 136' ' ' ARG . . . -92.72 120.18 32.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.726 0.298 . . . . 0.0 111.246 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 52' ' ' VAL . . . . . 0.63 HG22 ' O ' ' F' ' 135' ' ' ALA . 18.6 m -65.85 162.67 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.888 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.83 124.07 5.26 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.635 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 54' ' ' PHE . . . . . 0.455 ' N ' HG21 ' C' ' 76' ' ' THR . 54.1 p90 -155.86 146.56 22.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.643 0.258 . . . . 0.0 111.027 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 55' ' ' ASN . . . . . 0.579 ' HB2' HG22 ' F' ' 130' ' ' THR . 3.3 p30 -136.87 160.26 39.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.528 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 56' ' ' ILE . . . . . 0.574 HG23 ' O ' ' F' ' 56' ' ' ILE . 1.6 tp -100.65 116.91 45.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.555 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 57' ' ' GLN . . . . . 0.614 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.0 OUTLIER -70.04 124.61 24.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.76 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . 0.674 ' HA ' ' HA ' ' F' ' 23' ' ' VAL . 1.6 mp -133.77 87.48 2.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.216 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 59' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 4.9 p30 -73.69 174.57 8.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.931 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.82 79.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.763 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 61' ' ' CYS . . . . . 0.672 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 93.2 m -127.66 159.43 34.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.817 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . 0.604 ' OD2' HG23 ' F' ' 65' ' ' VAL . 5.5 t70 -130.27 167.07 19.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.288 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 63' ' ' THR . . . . . 0.662 HG23 ' HA ' ' F' ' 125' ' ' ASN . 0.2 OUTLIER -114.24 -41.7 3.45 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.57 -22.63 65.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.989 0.423 . . . . 0.0 111.694 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . 0.604 HG23 ' OD2' ' F' ' 62' ' ' ASP . 82.8 t -70.4 -74.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.657 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 66' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' F' ' 124' ' ' LEU . . . -120.75 131.34 54.45 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.629 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.24 -48.62 6.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.907 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 68' ' ' LYS . . . . . 0.632 ' HE3' ' HB3' ' F' ' 121' ' ' GLU . 0.1 OUTLIER -96.2 161.51 13.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.617 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.09 124.72 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.641 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 70' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -100.46 154.97 18.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.061 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 71' ' ' VAL . . . . . 0.825 HG11 HG21 ' F' ' 131' ' ' ILE . 2.3 t -132.73 148.33 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.69 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 72' ' ' ALA . . . . . 0.458 ' HA ' HD21 ' F' ' 111' ' ' LEU . . . -145.6 150.15 35.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.644 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 73' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -119.91 137.02 54.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.488 0.185 . . . . 0.0 111.059 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 74' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.9 OUTLIER -96.14 139.5 32.21 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.918 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' F' ' 113' ' ' LEU . . . 178.54 179.81 48.49 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.833 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 76' ' ' THR . . . . . 0.546 ' H ' HD23 ' F' ' 86' ' ' LEU . 0.3 OUTLIER -110.9 156.42 21.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.507 0.194 . . . . 0.0 110.856 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 77' ' ' ALA . . . . . 0.676 ' O ' ' HB2' ' F' ' 87' ' ' ALA . . . -73.81 131.26 41.35 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 78' ' ' ILE . . . . . 0.642 ' CG2' ' HB ' ' F' ' 85' ' ' VAL . 0.9 OUTLIER -67.69 -41.45 85.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.799 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 79' ' ' ASP . . . . . 0.427 ' N ' HG23 ' F' ' 78' ' ' ILE . 0.6 OUTLIER -141.12 40.77 1.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.773 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 66.45 -80.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.996 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.65 -24.99 41.92 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.696 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.01 63.93 1.37 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.851 0.358 . . . . 0.0 110.455 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 83' ' ' THR . . . . . 0.548 HG23 ' HB2' ' F' ' 77' ' ' ALA . 0.2 OUTLIER -68.5 -16.79 64.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.535 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 84' ' ' ASN . . . . . 0.703 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 18.0 p-10 -70.42 -20.25 62.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.329 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 85' ' ' VAL . . . . . 0.642 ' HB ' ' CG2' ' F' ' 78' ' ' ILE . 14.6 t -106.92 130.7 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.165 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 86' ' ' LEU . . . . . 0.788 HD22 ' HB1' ' F' ' 150' ' ' ALA . 0.5 OUTLIER -67.61 148.21 51.71 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 87' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' F' ' 77' ' ' ALA . . . -89.65 -167.47 1.87 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.87 0.367 . . . . 0.0 111.732 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . 0.657 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 1.5 mm? -78.34 157.22 29.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.054 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.61 -78.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.345 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 90' ' ' SER . . . . . 0.401 ' H ' ' H ' ' F' ' 91' ' ' SER . 0.5 OUTLIER -167.05 0.47 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.021 0.438 . . . . 0.0 111.469 179.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 91' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' F' ' 95' ' ' SER . 1.7 m -71.82 82.93 0.91 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.66 -13.95 61.87 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.863 0.364 . . . . 0.0 111.688 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.64 27.61 5.23 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.632 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.63 15.59 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.487 -0.864 . . . . 0.0 112.928 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 95' ' ' SER . . . . . 0.657 ' HB3' ' HG ' ' F' ' 88' ' ' LEU . 3.0 m -100.86 -172.82 2.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.713 0.292 . . . . 0.0 110.639 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.89 167.66 9.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.788 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . 0.522 ' H ' ' HB ' ' F' ' 144' ' ' THR . 2.3 m -121.59 128.3 51.82 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.343 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 98' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' F' ' 141' ' ' GLY . 75.9 m-20 64.27 34.56 10.65 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.415 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 99' ' ' VAL . . . . . 0.485 HG13 HD23 ' F' ' 42' ' ' LEU . 0.5 OUTLIER -139.99 136.5 38.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.683 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.13 -156.87 8.34 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.577 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 101' ' ' VAL . . . . . 0.482 HG13 ' HB2' ' F' ' 86' ' ' LEU . 3.2 p -137.77 116.72 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 122.973 0.509 . . . . 0.0 111.616 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 102' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 1.2 tt0 -91.93 150.43 21.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 103' ' ' ILE . . . . . 0.666 HD12 ' HB3' ' F' ' 111' ' ' LEU . 0.5 OUTLIER -113.87 131.32 66.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.542 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 104' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 0.3 OUTLIER -106.29 130.1 54.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.645 0.259 . . . . 0.0 111.014 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . 0.737 ' HB3' HG22 ' F' ' 107' ' ' THR . 5.1 t0 -76.02 156.97 33.54 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.697 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 106' ' ' ARG . . . . . 0.721 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 3.5 ttp180 -71.31 -17.47 62.45 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.691 0.281 . . . . 0.0 111.061 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 107' ' ' THR . . . . . 0.737 HG22 ' HB3' ' F' ' 105' ' ' ASP . 6.2 t -67.19 -18.03 65.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 108' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' C' ' 80' ' ' ALA . . . 123.74 -45.63 1.17 Allowed Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.748 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.09 163.12 23.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.671 0.272 . . . . 0.0 111.181 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 110' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -84.16 127.45 33.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.067 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 111' ' ' LEU . . . . . 0.666 ' HB3' HD12 ' F' ' 103' ' ' ILE . 12.1 tp -86.28 156.18 20.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.317 0.58 . . . . 0.0 110.614 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 112' ' ' THR . . . . . 0.901 HG23 HG21 ' F' ' 117' ' ' THR . 0.5 OUTLIER -106.31 139.09 41.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.095 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 113' ' ' LEU . . . . . 0.626 HD13 ' HG ' ' F' ' 86' ' ' LEU . 1.0 OUTLIER -73.92 76.49 1.66 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.697 0.284 . . . . 0.0 110.746 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.45 -17.2 14.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.507 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.25 -51.8 1.25 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.647 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.05 18.89 21.57 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.918 0.39 . . . . 0.0 111.52 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 117' ' ' THR . . . . . 0.901 HG21 HG23 ' F' ' 112' ' ' THR . 0.2 OUTLIER -85.77 84.64 7.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 118' ' ' PHE . . . . . 0.722 ' HB3' ' HB1' ' F' ' 70' ' ' ALA . 95.7 m-85 -101.42 98.74 9.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.741 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 39.3 m -130.84 62.44 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.802 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.3 145.83 30.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.655 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 121' ' ' GLU . . . . . 0.632 ' HB3' ' HE3' ' F' ' 68' ' ' LYS . 3.5 mm-40 -121.34 71.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.223 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 134.7 34.72 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.738 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 15.2 m -83.81 113.68 21.09 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.739 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . 0.631 ' CD2' ' HB1' ' F' ' 20' ' ' ALA . 19.0 tp -74.01 142.96 45.75 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.751 0.31 . . . . 0.0 110.589 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 125' ' ' ASN . . . . . 0.662 ' HA ' HG23 ' F' ' 63' ' ' THR . 0.9 OUTLIER -138.59 162.02 35.63 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.615 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.66 113.12 12.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.718 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.55 -139.9 9.48 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.779 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 128' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 6.7 m -101.75 96.78 7.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.726 0.298 . . . . 0.0 110.795 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.61 148.56 27.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.925 0.393 . . . . 0.0 111.112 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 130' ' ' THR . . . . . 0.624 HG21 HD21 ' C' ' 74' ' ' LEU . 0.2 OUTLIER -138.57 143.4 39.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.158 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 131' ' ' ILE . . . . . 0.825 HG21 HG11 ' F' ' 71' ' ' VAL . 54.9 mt -104.66 112.45 65.33 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 132' ' ' PRO . . . . . 0.721 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.4 Cg_endo -81.93 141.94 12.22 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.758 1.639 . . . . 0.0 112.492 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.67 141.1 22.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.845 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -104.48 152.63 22.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.091 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 135' ' ' ALA . . . . . 0.63 ' O ' HG22 ' F' ' 52' ' ' VAL . . . -153.54 101.03 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.931 0.396 . . . . 0.0 111.615 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 136' ' ' ARG . . . . . 0.552 ' HB3' ' HA ' ' F' ' 51' ' ' ALA . 17.4 ptt180 -107.11 177.32 4.89 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.428 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 137' ' ' TYR . . . . . 0.49 ' HB3' HD21 ' F' ' 42' ' ' LEU . 4.6 m-85 -86.02 124.08 32.06 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.979 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 138' ' ' PHE . . . . . 0.46 ' HB3' HG11 ' F' ' 85' ' ' VAL . 1.2 t80 -118.81 112.38 19.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.016 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 139' ' ' ALA . . . . . 0.67 ' HB2' HD23 ' F' ' 42' ' ' LEU . . . -102.95 133.95 47.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.921 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 140' ' ' THR . . . . . 0.622 ' O ' ' HA ' ' F' ' 45' ' ' GLU . 0.1 OUTLIER -81.05 -28.89 35.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.547 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' F' ' 98' ' ' ASN . . . -160.18 -111.11 0.28 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.864 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.78 110.61 21.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.511 0.196 . . . . 0.0 110.784 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 143' ' ' ALA . . . . . 0.686 ' HB3' ' HA ' ' F' ' 39' ' ' THR . . . -65.69 134.31 52.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 111.336 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 144' ' ' THR . . . . . 0.604 ' O ' ' CG1' ' E' ' 16' ' ' VAL . 56.7 m -105.9 149.42 38.01 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.268 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 145' ' ' PRO . . . . . 0.483 ' CD ' ' CG2' ' F' ' 144' ' ' THR . 1.5 Cg_endo -82.84 125.45 4.22 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.541 2.161 . . . . 0.0 112.03 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 146' ' ' GLY . . . . . 0.685 ' O ' ' CG ' ' E' ' 15' ' ' GLU . . . 168.77 -126.32 1.37 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.418 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 147' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -111.05 128.46 55.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.772 0.32 . . . . 0.0 111.355 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 148' ' ' ALA . . . . . 0.688 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -125.48 52.09 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.162 0.506 . . . . 0.0 110.402 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -98.68 151.94 20.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.627 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 150' ' ' ALA . . . . . 0.788 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -158.27 169.51 24.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.986 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.93 128.67 40.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.249 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 152' ' ' ALA . . . . . 0.497 ' HB2' HD11 ' F' ' 86' ' ' LEU . . . -122.21 144.04 49.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.233 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 153' ' ' THR . . . . . 1.025 HG23 HG22 ' E' ' 9' ' ' THR . 0.6 OUTLIER -106.3 145.38 31.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 154' ' ' PHE . . . . . 0.419 ' HB3' ' H ' ' E' ' 8' ' ' GLY . 0.5 OUTLIER -96.98 134.69 40.0 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.107 0.48 . . . . 0.0 110.053 -179.024 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 155' ' ' LYS . . . . . 0.411 ' HA ' ' H ' ' E' ' 7' ' ' GLY . 9.9 mmtt -124.22 148.06 47.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.88 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 156' ' ' VAL . . . . . 0.523 HG23 HG23 ' E' ' 5' ' ' VAL . 29.8 m -135.12 144.85 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.818 0.342 . . . . 0.0 111.787 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 157' ' ' GLN . . . . . 0.693 ' HG3' HG23 ' E' ' 4' ' ' THR . 0.0 OUTLIER -134.54 126.04 28.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.304 0.573 . . . . 0.0 110.362 -179.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 158' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' F' ' 21' ' ' CYS . 5.2 m-85 -106.0 128.73 54.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.559 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 159' ' ' GLN . . . . . 0.556 ' HG3' ' C ' ' F' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.259 -0.876 . . . . 0.0 110.817 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.54 0.209 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' B' ' 157' ' ' GLN . 4.9 m -114.68 127.37 55.72 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.431 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.3 m -117.71 106.76 13.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.704 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.459 HG21 HG12 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -133.9 174.61 12.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.58 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.1 119.87 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.528 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.27 -49.49 15.47 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.827 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.3 -154.89 11.32 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.866 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.711 HG22 HG23 ' B' ' 153' ' ' THR . 2.6 p -142.39 140.01 31.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.949 0.404 . . . . 0.0 111.223 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.69 113.82 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.23 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.08 110.32 20.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.404 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.24 111.56 22.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.75 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HG2' HD22 ' B' ' 149' ' ' ASN . 3.6 tmtm? -102.98 110.59 22.56 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.438 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.26 168.33 22.63 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.952 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.684 ' O ' ' HA ' ' B' ' 36' ' ' GLN . 3.6 tt0 -158.98 133.08 7.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.898 0.38 . . . . 0.0 110.417 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.892 HG23 ' HB2' ' B' ' 148' ' ' ALA . 13.0 t -99.64 143.17 13.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.25 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.536 HG13 ' HG2' ' B' ' 36' ' ' GLN . 3.9 m -141.41 -172.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.912 0.387 . . . . 0.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.46 -176.97 5.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.083 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.87 46.94 1.36 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.055 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.75 -29.98 2.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.443 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.999 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -163.11 158.45 21.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.907 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' B' ' 36' ' ' GLN . . . -161.39 118.53 2.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.026 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -66.27 153.1 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.025 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.75 158.75 20.64 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.603 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.03 -34.4 74.79 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.347 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.1 12.99 63.72 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.91 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.77 -22.4 10.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.791 0.329 . . . . 0.0 110.77 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.482 HG11 ' HE3' ' A' ' 13' ' ' LYS . 19.6 t -43.93 -64.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.359 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.05 135.83 41.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.968 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.17 125.72 20.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.088 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.76 106.53 18.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.066 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.74 117.06 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.074 0.464 . . . . 0.0 110.418 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.7 131.03 45.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.584 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.77 -47.37 7.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.586 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.41 -163.53 12.16 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.562 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -101.07 126.62 47.77 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.684 0.278 . . . . 0.0 110.833 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 42' ' ' LEU . 14.9 p -110.42 146.84 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.923 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -82.85 139.18 33.62 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.74 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.494 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 5.4 t -62.79 -37.42 86.6 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.746 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.46 71.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.108 0.48 . . . . 0.0 110.829 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.03 -17.76 45.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.112 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.725 HD23 ' HB2' ' A' ' 139' ' ' ALA . 4.3 mp -125.65 33.1 5.17 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.668 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.74 18.87 18.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.312 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.87 130.3 52.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.431 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 140' ' ' THR . 22.5 tt0 -56.38 107.38 0.37 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.866 0.365 . . . . 0.0 111.016 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.53 30.57 5.84 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.214 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 138' ' ' PHE . . . -76.57 136.65 39.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 112.081 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 52.3 p -134.87 134.73 41.04 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.869 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 70.9 m -108.79 -168.22 1.32 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.637 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.0 t -63.89 128.45 35.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.795 0.331 . . . . 0.0 110.799 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' A' ' 134' ' ' GLN . . . -80.41 130.0 34.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.436 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.728 HG22 ' HB3' ' A' ' 135' ' ' ALA . 2.8 m -74.84 151.22 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.925 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.98 119.22 5.67 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.577 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -153.86 152.09 30.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.729 0.3 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -148.74 162.94 38.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.633 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 56' ' ' ILE . 1.2 tp -105.98 114.82 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.548 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.872 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -70.69 124.53 24.48 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.721 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -132.32 88.81 2.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.203 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.601 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -75.31 169.47 18.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.895 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' B' ' 38' ' ' ARG . 0.4 OUTLIER 66.39 68.23 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.773 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.999 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 56.3 m -117.11 155.03 30.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.763 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.622 ' HB2' HH22 ' B' ' 38' ' ' ARG . 20.0 t70 -135.76 155.69 49.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.214 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -111.15 -34.23 6.24 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.141 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.08 -22.13 66.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 0.0 111.755 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.6 -59.54 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.696 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB3' HD23 ' A' ' 124' ' ' LEU . . . -116.84 129.18 55.92 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.646 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -60.31 2.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.856 0.36 . . . . 0.0 110.964 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.28 -175.33 2.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.499 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.0 131.36 9.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.52 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.466 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -106.04 151.14 25.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.036 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.607 HG11 HG21 ' A' ' 131' ' ' ILE . 2.0 t -129.46 158.31 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.714 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.633 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -152.66 143.09 22.62 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.579 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.608 ' HB3' HD23 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -112.32 141.47 46.0 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.683 0.278 . . . . 0.0 111.019 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.026 HD21 HG21 ' D' ' 130' ' ' THR . 0.3 OUTLIER -107.64 139.47 42.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.012 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.75 -179.54 46.85 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.816 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.768 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.3 OUTLIER -103.85 156.35 17.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.634 0.254 . . . . 0.0 110.823 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.34 118.35 21.17 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.93 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.557 HG22 ' HB3' ' A' ' 82' ' ' HIS . 0.4 OUTLIER -59.03 -29.11 40.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.81 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.446 ' HB2' HG21 ' A' ' 140' ' ' THR . 0.1 OUTLIER -151.74 50.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.805 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.22 -89.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.079 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.07 -32.55 42.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.584 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.557 ' HB3' HG22 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -81.12 62.84 5.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.892 0.377 . . . . 0.0 110.384 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.63 -18.18 60.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.585 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.71 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 20.4 p-10 -75.91 -7.48 54.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.266 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.487 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 24.1 t -117.7 124.22 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.214 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.931 HD22 ' HB1' ' A' ' 150' ' ' ALA . 0.5 OUTLIER -66.19 139.33 58.11 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.278 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -84.85 -165.42 1.19 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.705 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.776 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 0.7 OUTLIER -71.91 168.67 17.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.963 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.86 -79.24 0.06 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.335 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.775 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 2.4 p -168.84 6.0 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.016 0.436 . . . . 0.0 111.545 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.612 ' O ' ' HB2' ' A' ' 95' ' ' SER . 69.8 m -77.57 83.27 3.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.906 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' D' ' 50' ' ' SER . . . -55.07 -34.65 63.78 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.882 0.373 . . . . 0.0 111.626 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.27 31.51 6.31 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.604 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.59 7.46 0.23 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.919 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.776 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -110.78 -174.32 2.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.921 0.391 . . . . 0.0 110.588 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.431 ' O ' HD21 ' A' ' 88' ' ' LEU . . . -97.75 179.07 4.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.968 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.785 ' H ' ' HB ' ' A' ' 144' ' ' THR . 1.1 m -132.31 125.97 32.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.331 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 97' ' ' THR . 66.2 m-20 66.61 25.88 9.87 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.45 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.66 130.4 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.657 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.14 -161.35 10.74 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.508 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.494 ' CG2' ' HB1' ' A' ' 135' ' ' ALA . 0.8 OUTLIER -130.84 131.94 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.096 0.559 . . . . 0.0 111.825 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.721 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 1.5 tt0 -98.48 151.44 20.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.923 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.525 ' N ' ' HG2' ' A' ' 102' ' ' GLN . 0.3 OUTLIER -117.34 128.62 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.542 179.485 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.801 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -103.01 133.51 48.01 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.713 0.292 . . . . 0.0 111.034 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.718 ' HB3' HG22 ' A' ' 107' ' ' THR . 7.1 t0 -87.71 158.39 18.82 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.659 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 106' ' ' ARG . 7.9 ttp85 -70.47 -27.67 64.41 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.78 0.324 . . . . 0.0 111.081 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.718 HG22 ' HB3' ' A' ' 105' ' ' ASP . 2.8 t -51.76 -25.67 8.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.047 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.08 -39.18 1.74 Allowed Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.603 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.33 157.97 17.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 111.032 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.801 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -70.33 137.12 50.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.079 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.633 HD21 ' HA ' ' A' ' 72' ' ' ALA . 13.5 tp -87.54 158.41 18.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.29 0.567 . . . . 0.0 110.555 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.998 HG23 HG21 ' A' ' 117' ' ' THR . 0.5 OUTLIER -101.74 142.0 33.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.116 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.608 HD23 ' HB3' ' A' ' 73' ' ' PHE . 1.9 mt -82.41 65.57 7.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.71 0.291 . . . . 0.0 110.702 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.09 -14.93 21.23 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.52 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.25 -54.16 0.7 Allowed Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.596 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.2 28.92 8.27 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.016 0.436 . . . . 0.0 111.651 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.998 HG21 HG23 ' A' ' 112' ' ' THR . 0.0 OUTLIER -88.72 76.54 8.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.169 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.597 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 91.6 m-85 -91.01 96.75 10.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.743 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 68.0 m -132.67 78.25 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.7 136.9 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.667 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.01 76.2 0.98 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.275 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.83 135.51 33.68 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.732 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.7 m -77.08 96.35 4.42 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.71 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.734 ' O ' HG23 ' A' ' 63' ' ' THR . 10.8 tp -68.21 132.95 48.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.567 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -128.46 166.86 17.95 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.582 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 6.3 t30 -79.45 105.75 10.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.656 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.03 -137.04 5.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.749 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 3.7 m -103.61 83.47 2.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.753 0.311 . . . . 0.0 110.825 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.694 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 1.7 t30 -71.03 139.88 50.6 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.911 0.386 . . . . 0.0 111.158 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.872 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -133.95 139.66 46.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.158 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.607 HG21 HG11 ' A' ' 71' ' ' VAL . 61.7 mt -98.07 110.53 56.29 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -81.8 135.15 8.79 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.777 1.651 . . . . 0.0 112.528 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.72 152.71 41.63 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.791 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.583 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 50.6 mt-30 -119.0 156.85 28.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.067 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.728 ' HB3' HG22 ' A' ' 52' ' ' VAL . . . -151.39 101.79 2.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.372 . . . . 0.0 111.65 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.6 168.37 9.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.364 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -80.11 123.26 27.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.194 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 1.3 t80 -126.16 119.13 26.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.026 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.725 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -112.02 125.2 53.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.888 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -68.93 -48.19 63.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.51 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.431 ' H ' ' HB3' ' A' ' 98' ' ' ASN . . . -133.1 -120.0 2.08 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.043 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.42 111.94 18.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.597 0.237 . . . . 0.0 110.68 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.707 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -61.89 113.82 3.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.781 0.324 . . . . 0.0 111.447 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.785 ' HB ' ' H ' ' A' ' 97' ' ' THR . 75.1 m -88.31 145.25 35.43 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.32 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 144' ' ' THR . 1.3 Cg_endo -82.83 134.26 7.2 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.458 2.106 . . . . 0.0 111.987 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.87 -135.59 4.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.553 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.691 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -96.21 134.21 39.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.889 0.376 . . . . 0.0 111.301 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.78 50.5 2.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.135 0.493 . . . . 0.0 110.499 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -99.01 146.17 26.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.503 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.931 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -154.99 174.12 15.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.932 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.495 ' C ' HD11 ' A' ' 86' ' ' LEU . 26.8 t70 -139.33 128.45 23.82 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.16 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -118.4 133.29 56.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.159 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.92 147.41 22.99 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.25 130.28 53.42 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.131 0.491 . . . . 0.0 110.07 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -126.69 143.99 51.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.871 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.523 HG12 ' CD1' ' A' ' 131' ' ' ILE . 27.3 m -127.4 151.9 34.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.645 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.36 121.12 13.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.263 0.554 . . . . 0.0 110.404 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' A' ' 21' ' ' CYS . 1.2 m-85 -98.28 121.65 40.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.548 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.822 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 111.188 0.07 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.62 71.07 0.5 Allowed 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.148 0.28 . . . . 0.0 110.93 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' C' ' 157' ' ' GLN . 4.9 m -114.67 127.43 55.76 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.464 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 20.5 m -117.75 106.85 13.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.623 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.454 HG21 HG12 ' C' ' 17' ' ' VAL . 0.0 OUTLIER -134.0 174.66 12.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.612 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.13 119.89 36.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.501 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.23 -49.55 15.42 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.835 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.28 -154.87 11.3 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.845 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.721 HG22 HG23 ' C' ' 153' ' ' THR . 2.7 p -142.41 140.04 31.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.974 0.416 . . . . 0.0 111.224 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.76 113.82 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.177 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.08 110.3 20.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.365 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -90.18 111.53 22.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.78 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.498 ' HG2' HD22 ' C' ' 149' ' ' ASN . 3.6 tmtm? -102.96 110.52 22.46 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.49 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.19 168.35 22.59 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.0 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.686 ' O ' ' HA ' ' C' ' 36' ' ' GLN . 3.6 tt0 -159.01 133.06 7.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.473 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.891 HG23 ' HB2' ' C' ' 148' ' ' ALA . 13.1 t -99.62 143.22 13.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.25 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.538 HG13 ' HG2' ' C' ' 36' ' ' GLN . 3.9 m -141.48 -172.15 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.838 0.352 . . . . 0.0 110.992 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.43 -177.02 5.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.083 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.77 46.91 1.36 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.77 -29.93 2.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.498 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER -163.18 158.41 21.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.94 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' C' ' 36' ' ' GLN . . . -161.39 118.54 2.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.041 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' B' ' 58' ' ' LEU . 0.8 OUTLIER -66.27 153.05 8.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.018 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.75 158.73 20.65 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.582 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.02 -34.39 74.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.345 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.14 13.07 63.6 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.914 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.81 -22.43 10.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.84 0.353 . . . . 0.0 110.782 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.485 HG11 ' HE3' ' B' ' 13' ' ' LYS . 19.8 t -44.08 -64.21 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.348 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.09 135.85 41.89 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.005 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.15 125.67 20.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.058 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.8 106.54 18.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.058 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.68 117.07 53.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.455 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.71 131.05 45.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.597 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.8 -47.32 7.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.658 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.34 -163.61 12.15 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.561 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 3.7 mt-30 -100.98 126.6 47.65 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.65 0.262 . . . . 0.0 110.817 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.451 HG21 HD13 ' B' ' 42' ' ' LEU . 14.9 p -110.4 146.89 15.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.9 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.622 HH22 ' HB2' ' A' ' 62' ' ' ASP . 2.9 mtp180 -82.92 139.17 33.53 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.655 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.489 ' HA ' ' HB3' ' B' ' 143' ' ' ALA . 5.4 t -62.77 -37.44 86.67 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.778 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.45 71.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.072 0.463 . . . . 0.0 110.818 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.05 -17.75 45.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.171 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.741 HD23 ' HB2' ' B' ' 139' ' ' ALA . 4.3 mp -125.66 33.11 5.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.662 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.74 18.89 18.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.341 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.92 130.26 52.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.387 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' B' ' 140' ' ' THR . 22.5 tt0 -56.27 107.29 0.35 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.832 0.349 . . . . 0.0 111.095 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.52 30.56 5.84 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.195 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' B' ' 138' ' ' PHE . . . -76.6 136.76 39.22 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.986 0.422 . . . . 0.0 112.093 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' B' ' 137' ' ' TYR . 51.6 p -134.99 134.69 40.74 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.822 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 70.8 m -108.74 -168.14 1.31 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.65 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 23.3 t -63.93 128.44 35.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.774 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.586 ' HB1' ' HB3' ' B' ' 134' ' ' GLN . . . -80.41 129.96 34.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.451 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.72 HG22 ' HB3' ' B' ' 135' ' ' ALA . 2.8 m -74.87 151.26 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.922 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.05 119.25 5.67 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.512 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.81 152.12 30.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.783 0.325 . . . . 0.0 110.951 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -148.75 162.96 38.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.661 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.609 HG23 ' O ' ' B' ' 56' ' ' ILE . 1.2 tp -105.94 114.87 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.573 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . 0.865 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -70.72 124.51 24.46 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.749 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 0.2 OUTLIER -132.32 88.78 2.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.242 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.587 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 0.1 OUTLIER -75.31 169.44 18.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' C' ' 38' ' ' ARG . 0.4 OUTLIER 66.38 68.25 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.788 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 56.3 m -117.11 155.0 30.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.816 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . 0.621 ' HB2' HH22 ' C' ' 38' ' ' ARG . 19.9 t70 -135.74 155.65 50.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.311 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.733 HG23 ' O ' ' B' ' 124' ' ' LEU . 0.2 OUTLIER -111.11 -34.17 6.26 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.12 -22.17 66.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.008 0.433 . . . . 0.0 111.735 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.54 -59.54 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.767 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.548 ' HB3' HD23 ' B' ' 124' ' ' LEU . . . -116.76 129.16 55.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.706 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.16 -60.29 2.2 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.921 0.391 . . . . 0.0 111.019 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.26 -175.38 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.479 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.96 131.3 9.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.55 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -105.95 151.2 24.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.067 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.625 HG11 HG21 ' B' ' 131' ' ' ILE . 2.0 t -129.45 158.31 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.788 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.628 ' HA ' HD21 ' B' ' 111' ' ' LEU . . . -152.73 143.1 22.57 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.558 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.612 ' HB3' HD23 ' B' ' 113' ' ' LEU . 0.1 OUTLIER -112.3 141.49 45.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.648 0.261 . . . . 0.0 111.034 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.979 HD21 HG21 ' E' ' 130' ' ' THR . 0.3 OUTLIER -107.67 139.51 42.13 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.966 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.76 -179.46 46.91 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.851 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.767 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.3 OUTLIER -103.96 156.33 17.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.602 0.239 . . . . 0.0 110.782 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.4 ' HB2' HG23 ' B' ' 83' ' ' THR . . . -79.33 118.42 21.23 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.943 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.563 HG22 ' HB3' ' B' ' 82' ' ' HIS . 0.4 OUTLIER -59.05 -29.07 40.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.446 ' HB2' HG21 ' B' ' 140' ' ' THR . 0.1 OUTLIER -151.75 50.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.14 -89.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.118 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.06 -32.49 42.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.652 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.563 ' HB3' HG22 ' B' ' 78' ' ' ILE . 0.3 OUTLIER -81.15 62.83 5.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.938 0.399 . . . . 0.0 110.43 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' THR . . . . . 0.4 HG23 ' HB2' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -74.65 -18.13 60.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.557 -179.578 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . 0.701 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 20.4 p-10 -76.01 -7.38 54.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.279 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.486 ' HB ' ' CG2' ' B' ' 78' ' ' ILE . 23.9 t -117.68 124.12 72.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.235 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.991 HD22 ' HB1' ' B' ' 150' ' ' ALA . 0.5 OUTLIER -66.21 139.34 58.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' B' ' 78' ' ' ILE . . . -84.87 -165.42 1.19 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.674 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.77 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 0.7 OUTLIER -71.86 168.67 17.41 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.086 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.94 -79.18 0.06 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.279 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . 0.764 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 2.4 p -168.88 5.91 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.048 0.452 . . . . 0.0 111.572 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' SER . . . . . 0.61 ' O ' ' HB2' ' B' ' 95' ' ' SER . 69.9 m -77.56 83.22 3.96 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.952 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' E' ' 50' ' ' SER . . . -55.02 -34.68 63.69 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.88 0.372 . . . . 0.0 111.617 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.22 31.49 6.33 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.571 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.58 7.49 0.23 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.943 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' SER . . . . . 0.77 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . 0.6 OUTLIER -110.73 -174.33 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.943 0.401 . . . . 0.0 110.581 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . 0.432 ' O ' HD21 ' B' ' 88' ' ' LEU . . . -97.83 179.09 4.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.914 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.785 ' H ' ' HB ' ' B' ' 144' ' ' THR . 1.1 m -132.42 125.99 32.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.296 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' B' ' 97' ' ' THR . 66.1 m-20 66.66 25.84 9.79 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.422 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.69 130.44 70.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.686 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.08 -161.36 10.74 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.535 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.496 ' CG2' ' HB1' ' B' ' 135' ' ' ALA . 0.8 OUTLIER -130.87 131.97 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 123.056 0.542 . . . . 0.0 111.756 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.727 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 1.5 tt0 -98.52 151.49 20.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.901 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.524 ' N ' ' HG2' ' B' ' 102' ' ' GLN . 0.3 OUTLIER -117.36 128.67 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.513 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . 0.791 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 0.3 OUTLIER -103.03 133.55 47.97 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.707 0.289 . . . . 0.0 111.01 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . 0.719 ' HB3' HG22 ' B' ' 107' ' ' THR . 7.2 t0 -87.78 158.46 18.76 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.601 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' B' ' 106' ' ' ARG . 7.9 ttp85 -70.47 -27.75 64.46 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.733 0.301 . . . . 0.0 111.026 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.719 HG22 ' HB3' ' B' ' 105' ' ' ASP . 2.8 t -51.73 -25.74 8.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.036 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.26 -39.25 1.73 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.58 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.31 158.05 17.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 0.0 111.0 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.791 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -70.36 137.11 50.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.063 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.628 HD21 ' HA ' ' B' ' 72' ' ' ALA . 13.5 tp -87.55 158.29 18.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.333 0.587 . . . . 0.0 110.563 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.989 HG23 HG21 ' B' ' 117' ' ' THR . 0.5 OUTLIER -101.62 141.96 33.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.147 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' B' ' 73' ' ' PHE . 1.9 mt -82.32 65.54 7.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.734 0.302 . . . . 0.0 110.801 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.08 -14.94 21.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.542 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.28 -54.18 0.7 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.623 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.19 28.99 8.2 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.02 0.438 . . . . 0.0 111.69 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . 0.989 HG21 HG23 ' B' ' 112' ' ' THR . 0.0 OUTLIER -88.8 76.6 7.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.124 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.601 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 91.4 m-85 -91.06 96.77 10.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.747 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 68.6 m -132.64 78.32 1.79 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.797 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.76 136.81 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.703 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -114.97 76.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.252 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.93 135.6 33.61 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.691 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 11.8 m -77.12 96.28 4.44 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.703 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.733 ' O ' HG23 ' B' ' 63' ' ' THR . 10.8 tp -68.12 132.94 48.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.589 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -128.47 166.74 18.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.601 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' B' ' 61' ' ' CYS . 6.2 t30 -79.38 105.78 10.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.697 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.03 -137.06 5.22 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.675 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 3.7 m -103.63 83.47 2.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.707 0.289 . . . . 0.0 110.773 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . 0.692 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 1.7 t30 -71.09 139.84 50.48 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.979 0.418 . . . . 0.0 111.148 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.865 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -133.91 139.6 46.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.133 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' ILE . . . . . 0.625 HG21 HG11 ' B' ' 71' ' ' VAL . 61.8 mt -97.99 110.48 55.93 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -81.74 135.13 8.85 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.75 1.633 . . . . 0.0 112.574 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.76 152.65 41.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.756 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' GLN . . . . . 0.586 ' HB3' ' HB1' ' B' ' 51' ' ' ALA . 50.5 mt-30 -118.96 156.9 28.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.065 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' B' ' 102' ' ' GLN . . . -151.41 101.66 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.352 . . . . 0.0 111.659 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.58 168.33 9.17 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.35 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' B' ' 48' ' ' THR . 0.3 OUTLIER -80.06 123.32 27.75 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.173 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' B' ' 47' ' ' ALA . 1.3 t80 -126.2 119.12 26.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.948 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.741 ' HB2' HD23 ' B' ' 42' ' ' LEU . . . -111.99 125.16 53.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.919 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.22 63.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.507 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . 0.425 ' H ' ' HB3' ' B' ' 98' ' ' ASN . . . -133.1 -119.99 2.08 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.111 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.4 111.95 18.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.558 0.218 . . . . 0.0 110.738 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' ALA . . . . . 0.714 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -61.91 113.82 3.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.784 0.326 . . . . 0.0 111.409 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.785 ' HB ' ' H ' ' B' ' 97' ' ' THR . 74.1 m -88.25 145.23 35.47 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.302 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 144' ' ' THR . 1.3 Cg_endo -82.82 134.19 7.17 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.546 2.164 . . . . 0.0 112.019 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.88 -135.58 4.41 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.529 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.678 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -96.16 134.2 39.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.86 0.362 . . . . 0.0 111.361 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' ALA . . . . . 0.892 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -129.81 50.45 2.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.207 0.527 . . . . 0.0 110.506 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.495 HD22 ' HG2' ' A' ' 13' ' ' LYS . 3.4 m120 -98.93 146.15 26.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.551 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.991 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -154.91 174.08 15.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.883 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . 0.494 ' C ' HD11 ' B' ' 86' ' ' LEU . 26.6 t70 -139.31 128.49 23.93 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.171 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -118.45 133.27 56.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.169 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.711 HG23 HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -91.93 147.39 23.0 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.153 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.27 130.32 53.43 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.195 0.521 . . . . 0.0 110.037 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -126.64 143.89 51.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.931 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' VAL . . . . . 0.513 HG12 ' CD1' ' B' ' 131' ' ' ILE . 27.3 m -127.42 151.89 34.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.746 0.307 . . . . 0.0 111.709 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -141.39 121.1 13.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.32 0.581 . . . . 0.0 110.342 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' TYR . . . . . 0.578 ' CD2' ' HB ' ' A' ' 3' ' ' THR . 1.2 m-85 -98.21 121.64 40.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.577 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.86 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 111.176 0.065 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.59 71.06 0.5 Allowed 'General case' 0 C--O 1.232 0.132 0 O-C-N 123.122 0.264 . . . . 0.0 111.023 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.687 ' O ' ' HA ' ' D' ' 157' ' ' GLN . 4.9 m -114.71 127.42 55.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.447 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 20.8 m -117.84 106.77 13.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.609 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.456 HG21 HG12 ' D' ' 17' ' ' VAL . 0.0 OUTLIER -133.92 174.65 12.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.615 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.07 119.82 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.607 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.17 -49.5 15.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.835 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.32 -154.92 11.36 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.854 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . 0.74 HG22 HG23 ' D' ' 153' ' ' THR . 2.7 p -142.4 139.98 31.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.927 0.394 . . . . 0.0 111.292 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.74 113.93 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.155 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -87.16 110.3 20.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.313 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.23 111.54 22.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.776 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . 0.494 ' HG2' HD22 ' D' ' 149' ' ' ASN . 3.7 tmtm? -102.94 110.61 22.59 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.435 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.32 168.38 22.64 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.058 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' GLU . . . . . 0.674 ' O ' ' HA ' ' D' ' 36' ' ' GLN . 3.6 tt0 -159.01 133.09 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 0.0 110.413 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.872 HG23 ' HB2' ' D' ' 148' ' ' ALA . 13.3 t -99.74 143.27 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.203 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.526 HG13 ' HG2' ' D' ' 36' ' ' GLN . 4.0 m -141.42 -172.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 111.074 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.56 -176.94 5.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.058 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.8 46.84 1.36 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.039 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.76 -29.96 2.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.924 0.392 . . . . 0.0 111.485 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' CYS . . . . . 0.988 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER -163.12 158.33 21.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.996 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' D' ' 36' ' ' GLN . . . -161.33 118.62 2.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.042 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' C' ' 58' ' ' LEU . 0.8 OUTLIER -66.28 153.07 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.086 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.78 158.73 20.62 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.613 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.562 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -61.01 -34.4 74.77 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.316 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.16 13.07 63.58 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.887 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.8 -22.44 10.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.801 0.334 . . . . 0.0 110.733 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.487 HG11 ' HE3' ' C' ' 13' ' ' LYS . 19.8 t -43.98 -64.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.336 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.04 135.83 41.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.949 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.21 125.72 20.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.066 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.74 106.53 18.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.15 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.75 117.05 53.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.067 0.461 . . . . 0.0 110.482 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.69 131.05 45.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.576 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.81 -47.31 7.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.607 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.33 -163.6 12.15 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.551 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . 0.686 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 3.7 mt-30 -100.98 126.59 47.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.634 0.255 . . . . 0.0 110.841 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.445 HG21 HD13 ' C' ' 42' ' ' LEU . 14.9 p -110.4 146.8 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.926 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' ARG . . . . . 0.621 HH22 ' HB2' ' B' ' 62' ' ' ASP . 2.8 mtp180 -82.8 139.08 33.74 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.757 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.5 ' HA ' ' HB3' ' C' ' 143' ' ' ALA . 5.5 t -62.74 -37.42 86.5 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.778 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.47 -31.49 71.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.125 0.488 . . . . 0.0 110.847 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.04 -17.73 45.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.102 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.743 HD23 ' HB2' ' C' ' 139' ' ' ALA . 4.3 mp -125.72 33.11 5.16 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.604 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.76 18.96 18.03 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.372 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.96 130.23 52.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.355 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' C' ' 140' ' ' THR . 22.5 tt0 -56.27 107.33 0.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.883 0.373 . . . . 0.0 111.088 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.6 30.51 5.83 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.133 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' C' ' 138' ' ' PHE . . . -76.58 136.62 39.25 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' C' ' 137' ' ' TYR . 52.2 p -134.91 134.73 40.95 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.848 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 71.1 m -108.76 -168.15 1.31 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.665 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 23.1 t -63.96 128.46 35.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.854 0.359 . . . . 0.0 110.756 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' C' ' 134' ' ' GLN . . . -80.4 129.98 34.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.43 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.715 HG22 ' HB3' ' C' ' 135' ' ' ALA . 2.8 m -74.86 151.21 6.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.993 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.01 119.26 5.68 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.547 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.91 152.08 30.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.731 0.301 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -148.72 162.95 38.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.694 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.609 HG23 ' O ' ' C' ' 56' ' ' ILE . 1.2 tp -105.96 114.82 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.534 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.886 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.0 OUTLIER -70.67 124.54 24.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.703 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' C' ' 23' ' ' VAL . 0.2 OUTLIER -132.34 88.79 2.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.235 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . 0.577 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 0.1 OUTLIER -75.28 169.44 18.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' D' ' 38' ' ' ARG . 0.4 OUTLIER 66.37 68.24 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.802 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' CYS . . . . . 0.988 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 56.3 m -117.13 155.04 30.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.809 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . 0.625 ' HB2' HH22 ' D' ' 38' ' ' ARG . 20.0 t70 -135.8 155.63 50.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.25 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.738 HG23 ' O ' ' C' ' 124' ' ' LEU . 0.2 OUTLIER -111.08 -34.22 6.25 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.121 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.13 -22.12 66.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.012 0.434 . . . . 0.0 111.705 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.57 -59.65 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.669 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . 0.56 ' HB3' HD23 ' C' ' 124' ' ' LEU . . . -116.69 129.1 55.93 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.72 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.13 -60.28 2.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.914 0.388 . . . . 0.0 111.033 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.23 -175.34 2.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.49 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.93 131.38 9.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.604 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -106.05 151.18 24.99 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.841 0.353 . . . . 0.0 111.056 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . 0.621 HG11 HG21 ' C' ' 131' ' ' ILE . 2.0 t -129.47 158.32 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.766 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . 0.657 ' HA ' HD21 ' C' ' 111' ' ' LEU . . . -152.66 143.06 22.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.61 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' PHE . . . . . 0.612 ' HB3' HD23 ' C' ' 113' ' ' LEU . 0.1 OUTLIER -112.29 141.5 45.92 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.643 0.259 . . . . 0.0 111.068 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.97 HD21 HG21 ' F' ' 130' ' ' THR . 0.3 OUTLIER -107.71 139.45 42.26 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.955 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.79 -179.48 46.92 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.837 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.765 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.3 OUTLIER -103.97 156.38 17.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.607 0.241 . . . . 0.0 110.811 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.37 118.38 21.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.981 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' C' ' 82' ' ' HIS . 0.4 OUTLIER -59.02 -29.09 40.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.887 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' ASP . . . . . 0.45 ' HB2' HG21 ' C' ' 140' ' ' THR . 0.1 OUTLIER -151.76 50.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.822 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.25 -89.9 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.069 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.06 -32.59 42.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.573 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . 0.564 ' HB3' HG22 ' C' ' 78' ' ' ILE . 0.3 OUTLIER -81.04 62.78 5.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.856 0.36 . . . . 0.0 110.438 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.58 -18.21 60.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.61 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' ASN . . . . . 0.706 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 20.4 p-10 -75.86 -7.49 54.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.329 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.492 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 23.9 t -117.68 124.16 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.217 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.986 HD22 ' HB1' ' C' ' 150' ' ' ALA . 0.5 OUTLIER -66.14 139.36 58.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.697 0.284 . . . . 0.0 110.244 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' C' ' 78' ' ' ILE . . . -84.9 -165.44 1.2 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.605 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.76 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 0.7 OUTLIER -71.88 168.65 17.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.012 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.93 -79.17 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.337 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' SER . . . . . 0.769 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 2.3 p -168.86 5.95 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 111.525 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' SER . . . . . 0.611 ' O ' ' HB2' ' C' ' 95' ' ' SER . 69.7 m -77.54 83.21 3.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.971 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' F' ' 50' ' ' SER . . . -54.99 -34.67 63.59 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.89 0.376 . . . . 0.0 111.63 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.29 31.48 6.32 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.586 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.59 7.48 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.94 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' SER . . . . . 0.76 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 0.6 OUTLIER -110.74 -174.32 2.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.888 0.375 . . . . 0.0 110.612 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' ALA . . . . . 0.432 ' O ' HD21 ' C' ' 88' ' ' LEU . . . -97.76 179.0 4.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . 0.771 ' H ' ' HB ' ' C' ' 144' ' ' THR . 1.1 m -132.29 125.98 32.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.356 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' C' ' 97' ' ' THR . 66.0 m-20 66.57 25.92 9.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.396 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.7 130.37 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.705 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.07 -161.39 10.76 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.501 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' VAL . . . . . 0.486 ' CG2' ' HB1' ' C' ' 135' ' ' ALA . 0.8 OUTLIER -130.88 131.95 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 123.094 0.558 . . . . 0.0 111.866 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 102' ' ' GLN . . . . . 0.726 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 1.5 tt0 -98.49 151.46 20.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.897 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.525 ' N ' ' HG2' ' C' ' 102' ' ' GLN . 0.3 OUTLIER -117.33 128.64 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.58 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 0.3 OUTLIER -102.98 133.46 48.05 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.654 0.264 . . . . 0.0 111.033 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . 0.71 ' HB3' HG22 ' C' ' 107' ' ' THR . 7.2 t0 -87.74 158.44 18.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.636 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 106' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' C' ' 106' ' ' ARG . 7.9 ttp85 -70.5 -27.72 64.42 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.714 0.293 . . . . 0.0 111.02 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 107' ' ' THR . . . . . 0.71 HG22 ' HB3' ' C' ' 105' ' ' ASP . 2.8 t -51.68 -25.68 7.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.096 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.16 -39.29 1.73 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.617 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.26 157.99 17.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.351 . . . . 0.0 111.065 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -70.32 137.07 50.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.111 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 111' ' ' LEU . . . . . 0.657 HD21 ' HA ' ' C' ' 72' ' ' ALA . 13.5 tp -87.56 158.47 18.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.382 0.611 . . . . 0.0 110.499 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 112' ' ' THR . . . . . 0.998 HG23 HG21 ' C' ' 117' ' ' THR . 0.5 OUTLIER -101.76 141.97 33.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.123 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' C' ' 73' ' ' PHE . 1.9 mt -82.43 65.6 7.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 0.0 110.708 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.08 -14.93 21.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.528 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.19 -54.11 0.71 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.678 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.17 28.83 8.35 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.017 0.437 . . . . 0.0 111.721 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . 0.998 HG21 HG23 ' C' ' 112' ' ' THR . 0.0 OUTLIER -88.72 76.6 8.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.24 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 118' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' C' ' 71' ' ' VAL . 91.3 m-85 -91.13 96.77 10.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.724 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 68.6 m -132.65 78.25 1.79 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.818 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.67 136.88 3.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.692 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.02 76.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.267 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.88 135.56 33.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.703 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 11.8 m -77.05 96.33 4.4 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.73 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . 0.738 ' O ' HG23 ' C' ' 63' ' ' THR . 10.8 tp -68.25 132.92 47.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.627 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -128.49 166.83 18.02 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.569 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 126' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' C' ' 61' ' ' CYS . 6.3 t30 -79.43 105.76 10.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.696 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.05 -137.06 5.22 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.655 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 128' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 3.7 m -103.62 83.49 2.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.688 0.28 . . . . 0.0 110.778 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 129' ' ' ASN . . . . . 0.686 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 1.7 t30 -71.12 139.92 50.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.959 0.409 . . . . 0.0 111.099 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 130' ' ' THR . . . . . 0.886 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -134.0 139.7 46.23 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.024 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 131' ' ' ILE . . . . . 0.621 HG21 HG11 ' C' ' 71' ' ' VAL . 61.9 mt -98.07 110.55 56.37 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 132' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -81.79 135.13 8.78 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.753 1.635 . . . . 0.0 112.596 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.71 152.67 41.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.773 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 134' ' ' GLN . . . . . 0.595 ' HB3' ' HB1' ' C' ' 51' ' ' ALA . 50.6 mt-30 -119.01 156.9 28.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.07 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . 0.726 ' HA ' ' O ' ' C' ' 102' ' ' GLN . . . -151.43 101.67 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 0.0 111.633 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.61 168.28 9.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.359 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 137' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' C' ' 48' ' ' THR . 0.3 OUTLIER -79.98 123.23 27.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.192 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 138' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' C' ' 47' ' ' ALA . 1.3 t80 -126.11 119.05 26.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.085 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 139' ' ' ALA . . . . . 0.743 ' HB2' HD23 ' C' ' 42' ' ' LEU . . . -111.95 125.21 53.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.954 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 140' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.17 64.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.543 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . 0.439 ' H ' ' HB3' ' C' ' 98' ' ' ASN . . . -133.15 -120.0 2.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.043 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.43 111.89 18.19 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.559 0.219 . . . . 0.0 110.708 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 143' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -61.88 113.78 2.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.794 0.331 . . . . 0.0 111.39 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 144' ' ' THR . . . . . 0.771 ' HB ' ' H ' ' C' ' 97' ' ' THR . 75.5 m -88.18 145.24 35.65 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.366 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.87 134.19 7.12 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.499 2.132 . . . . 0.0 112.005 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.93 -135.55 4.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.502 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 147' ' ' ALA . . . . . 0.703 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -96.24 134.23 39.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.881 0.372 . . . . 0.0 111.336 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 148' ' ' ALA . . . . . 0.891 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -129.85 50.49 2.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.161 0.505 . . . . 0.0 110.456 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 149' ' ' ASN . . . . . 0.498 HD22 ' HG2' ' B' ' 13' ' ' LYS . 3.5 m120 -98.95 146.15 26.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.555 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 150' ' ' ALA . . . . . 0.986 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -154.9 174.11 15.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.986 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 151' ' ' ASP . . . . . 0.488 ' C ' HD11 ' C' ' 86' ' ' LEU . 26.9 t70 -139.28 128.48 23.95 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.186 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 152' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -118.43 133.35 55.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.11 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . 0.721 HG23 HG22 ' B' ' 9' ' ' THR . 0.2 OUTLIER -91.97 147.41 22.98 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.26 130.25 53.44 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.125 0.488 . . . . 0.0 110.062 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -126.67 143.9 51.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.954 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 156' ' ' VAL . . . . . 0.524 HG12 ' CD1' ' C' ' 131' ' ' ILE . 27.3 m -127.35 151.92 34.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.69 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 157' ' ' GLN . . . . . 0.683 ' HA ' ' O ' ' B' ' 3' ' ' THR . 0.0 OUTLIER -141.34 121.15 13.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.298 0.57 . . . . 0.0 110.37 -179.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 158' ' ' TYR . . . . . 0.577 ' CD2' ' HB ' ' B' ' 3' ' ' THR . 1.2 m-85 -98.26 121.63 40.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.56 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.808 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 111.261 0.097 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.62 71.14 0.5 Allowed 'General case' 0 N--CA 1.462 0.157 0 O-C-N 123.107 0.254 . . . . 0.0 110.96 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 3' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' E' ' 157' ' ' GLN . 4.8 m -114.68 127.32 55.69 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.475 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 20.2 m -117.7 106.77 13.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.633 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.458 HG21 HG12 ' E' ' 17' ' ' VAL . 0.0 OUTLIER -133.91 174.64 12.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.567 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.13 119.83 36.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.586 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.2 -49.49 15.71 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.839 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.26 -154.82 11.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.848 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . 0.709 HG22 HG23 ' E' ' 153' ' ' THR . 2.7 p -142.49 140.04 31.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.983 0.421 . . . . 0.0 111.176 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.73 113.89 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.151 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.14 110.39 20.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.363 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.3 111.48 22.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.74 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' LYS . . . . . 0.492 ' HG2' HD22 ' E' ' 149' ' ' ASN . 3.6 tmtm? -102.96 110.5 22.44 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.453 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.19 168.31 22.6 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.014 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' GLU . . . . . 0.687 ' O ' ' HA ' ' E' ' 36' ' ' GLN . 3.6 tt0 -158.99 133.07 7.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.93 0.395 . . . . 0.0 110.4 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.89 HG23 ' HB2' ' E' ' 148' ' ' ALA . 13.2 t -99.65 143.14 14.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.286 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.539 HG13 ' HG2' ' E' ' 36' ' ' GLN . 3.9 m -141.33 -172.11 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.862 0.363 . . . . 0.0 111.074 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.49 -176.91 5.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.034 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.87 46.95 1.36 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.106 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.77 -29.97 2.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER -163.14 158.38 21.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.915 -179.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . 0.565 ' HB1' ' O ' ' E' ' 36' ' ' GLN . . . -161.35 118.54 2.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.103 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' D' ' 58' ' ' LEU . 0.8 OUTLIER -66.25 152.99 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.065 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -84.68 158.77 20.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.611 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.559 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -61.03 -34.47 74.9 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.344 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.05 13.03 63.77 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.929 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.78 -22.43 10.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.776 0.322 . . . . 0.0 110.773 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . 0.485 HG11 ' HE3' ' D' ' 13' ' ' LYS . 19.8 t -44.04 -64.25 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.339 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.04 135.9 41.74 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.932 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -139.26 125.64 20.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.049 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.77 106.56 18.84 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.044 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.78 117.08 53.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.105 0.478 . . . . 0.0 110.431 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.74 131.09 45.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.527 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.8 -47.35 7.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.631 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.38 -163.56 12.16 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.564 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' GLN . . . . . 0.674 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 3.7 mt-30 -101.0 126.61 47.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.703 0.287 . . . . 0.0 110.83 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.455 HG21 HD13 ' D' ' 42' ' ' LEU . 14.9 p -110.42 146.83 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.934 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . 0.625 HH22 ' HB2' ' C' ' 62' ' ' ASP . 2.9 mtp180 -82.87 139.17 33.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.7 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.484 ' HA ' ' HB3' ' D' ' 143' ' ' ALA . 5.4 t -62.78 -37.53 87.03 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.745 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.4 -31.5 71.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.125 0.488 . . . . 0.0 110.896 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.99 -17.77 45.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.165 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.742 HD23 ' HB2' ' D' ' 139' ' ' ALA . 4.3 mp -125.66 33.11 5.17 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.609 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.76 18.9 18.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.298 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.94 130.26 52.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.34 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' D' ' 140' ' ' THR . 22.5 tt0 -56.29 107.32 0.36 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.884 0.373 . . . . 0.0 111.088 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.62 30.5 5.84 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.111 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' D' ' 138' ' ' PHE . . . -76.56 136.71 39.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.973 0.415 . . . . 0.0 112.109 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' D' ' 137' ' ' TYR . 52.3 p -134.94 134.71 40.88 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.879 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.527 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 70.7 m -108.76 -168.16 1.31 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.641 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 23.3 t -63.99 128.52 36.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.743 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' D' ' 134' ' ' GLN . . . -80.42 130.02 34.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.467 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' VAL . . . . . 0.775 ' HB ' ' HA ' ' A' ' 90' ' ' SER . 2.8 m -74.85 151.28 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.04 119.23 5.66 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.516 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -153.9 152.12 30.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.788 0.328 . . . . 0.0 110.837 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -148.77 162.94 38.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.693 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.606 HG23 ' O ' ' D' ' 56' ' ' ILE . 1.2 tp -105.91 114.76 46.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.563 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' GLN . . . . . 0.859 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.0 OUTLIER -70.65 124.51 24.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.744 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' D' ' 23' ' ' VAL . 0.2 OUTLIER -132.28 88.69 2.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.281 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . 0.598 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 0.1 OUTLIER -75.25 169.47 17.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' ASP . . . . . 0.401 ' CG ' ' HD2' ' E' ' 38' ' ' ARG . 0.4 OUTLIER 66.26 68.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.78 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 56.2 m -117.13 155.07 29.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . 0.624 ' HB2' HH22 ' E' ' 38' ' ' ARG . 19.9 t70 -135.75 155.66 50.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.277 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.729 HG23 ' O ' ' D' ' 124' ' ' LEU . 0.2 OUTLIER -111.11 -34.25 6.24 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.05 -22.14 66.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.952 0.406 . . . . 0.0 111.729 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.62 -59.49 2.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.74 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.575 ' HB3' HD23 ' D' ' 124' ' ' LEU . . . -116.82 129.16 55.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.623 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -60.23 2.22 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.878 0.371 . . . . 0.0 111.001 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.21 -175.34 2.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.456 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.96 131.36 9.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.59 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -105.96 151.18 24.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.104 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . 0.615 HG11 HG21 ' D' ' 131' ' ' ILE . 2.0 t -129.52 158.3 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.754 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 72' ' ' ALA . . . . . 0.627 ' HA ' HD21 ' D' ' 111' ' ' LEU . . . -152.68 143.08 22.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.584 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 73' ' ' PHE . . . . . 0.603 ' HB3' HD23 ' D' ' 113' ' ' LEU . 0.1 OUTLIER -112.33 141.46 46.02 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.691 0.281 . . . . 0.0 111.004 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 74' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.3 OUTLIER -107.69 139.52 42.13 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.018 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.79 -179.44 46.94 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.816 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.98 156.28 17.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.613 0.245 . . . . 0.0 110.767 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.3 118.38 21.17 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.969 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 78' ' ' ILE . . . . . 0.559 HG22 ' HB3' ' D' ' 82' ' ' HIS . 0.4 OUTLIER -59.01 -29.1 40.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.449 ' HB2' HG21 ' D' ' 140' ' ' THR . 0.1 OUTLIER -151.76 50.47 0.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.774 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.17 -89.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.09 -32.51 42.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.621 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . 0.559 ' HB3' HG22 ' D' ' 78' ' ' ILE . 0.3 OUTLIER -81.08 62.86 5.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 110.406 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.63 -18.18 60.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.558 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . 0.716 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 20.4 p-10 -76.04 -7.4 54.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.176 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.489 ' HB ' ' CG2' ' D' ' 78' ' ' ILE . 24.0 t -117.73 124.14 72.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.243 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.955 HD22 ' HB1' ' D' ' 150' ' ' ALA . 0.5 OUTLIER -66.15 139.35 58.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.713 0.292 . . . . 0.0 110.243 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' D' ' 78' ' ' ILE . . . -84.88 -165.44 1.2 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.693 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.774 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 0.7 OUTLIER -71.84 168.65 17.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.067 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.96 -79.23 0.06 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.263 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -168.81 5.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.986 0.422 . . . . 0.0 111.472 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' D' ' 95' ' ' SER . 70.3 m -77.47 83.22 3.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.11 -34.62 63.84 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.878 0.371 . . . . 0.0 111.633 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.24 31.5 6.32 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.687 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.57 7.39 0.23 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.881 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 95' ' ' SER . . . . . 0.774 ' HB3' ' HG ' ' D' ' 88' ' ' LEU . 0.6 OUTLIER -110.71 -174.33 2.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 110.651 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 96' ' ' ALA . . . . . 0.418 ' O ' HD21 ' D' ' 88' ' ' LEU . . . -97.78 179.01 4.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.931 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . 0.788 ' H ' ' HB ' ' D' ' 144' ' ' THR . 1.1 m -132.24 125.92 32.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.369 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 98' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' D' ' 97' ' ' THR . 66.0 m-20 66.68 25.87 9.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.38 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.66 130.34 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.691 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.13 -161.38 10.76 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.485 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 101' ' ' VAL . . . . . 0.483 ' CG2' ' HB1' ' D' ' 135' ' ' ALA . 0.8 OUTLIER -130.84 131.94 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 123.12 0.568 . . . . 0.0 111.842 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 102' ' ' GLN . . . . . 0.724 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 1.5 tt0 -98.52 151.45 20.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.906 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 103' ' ' ILE . . . . . 0.525 ' N ' ' HG2' ' D' ' 102' ' ' GLN . 0.3 OUTLIER -117.3 128.65 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.499 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 104' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 0.3 OUTLIER -102.94 133.5 47.94 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.559 0.219 . . . . 0.0 111.051 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . 0.723 ' HB3' HG22 ' D' ' 107' ' ' THR . 7.1 t0 -87.73 158.47 18.79 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.685 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 106' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -70.56 -27.71 64.34 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.806 0.336 . . . . 0.0 111.047 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 107' ' ' THR . . . . . 0.723 HG22 ' HB3' ' D' ' 105' ' ' ASP . 2.8 t -51.69 -25.7 7.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.09 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.19 -39.27 1.73 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.557 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.27 158.0 17.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.352 . . . . 0.0 111.013 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -70.37 137.17 50.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.099 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 111' ' ' LEU . . . . . 0.627 HD21 ' HA ' ' D' ' 72' ' ' ALA . 13.5 tp -87.56 158.35 18.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.304 0.574 . . . . 0.0 110.529 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 112' ' ' THR . . . . . 1.035 HG23 HG21 ' D' ' 117' ' ' THR . 0.5 OUTLIER -101.72 142.01 33.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.095 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 113' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' D' ' 73' ' ' PHE . 1.9 mt -82.45 65.63 7.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 0.0 110.775 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.07 -15.01 21.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.485 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.23 -54.14 0.71 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.705 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.16 28.88 8.31 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.068 0.461 . . . . 0.0 111.756 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 117' ' ' THR . . . . . 1.035 HG21 HG23 ' D' ' 112' ' ' THR . 0.0 OUTLIER -88.81 76.62 7.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.186 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' D' ' 71' ' ' VAL . 91.5 m-85 -91.06 96.79 10.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.733 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 67.8 m -132.69 78.31 1.79 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.704 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.7 136.85 3.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.717 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -115.02 76.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.307 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.98 135.54 33.62 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.662 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 11.7 m -77.05 96.33 4.4 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.764 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . 0.729 ' O ' HG23 ' D' ' 63' ' ' THR . 10.8 tp -68.15 132.92 48.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.628 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -128.49 166.81 18.06 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.561 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 126' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' D' ' 61' ' ' CYS . 6.2 t30 -79.44 105.76 10.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.665 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.03 -136.99 5.19 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.734 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 128' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 3.7 m -103.72 83.44 2.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.716 0.293 . . . . 0.0 110.808 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 129' ' ' ASN . . . . . 0.694 ' HB2' ' SG ' ' D' ' 61' ' ' CYS . 1.7 t30 -71.04 139.85 50.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.899 0.38 . . . . 0.0 111.17 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 130' ' ' THR . . . . . 1.026 HG21 HD21 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -133.92 139.57 46.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.147 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 131' ' ' ILE . . . . . 0.615 HG21 HG11 ' D' ' 71' ' ' VAL . 61.8 mt -97.9 110.49 55.83 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 132' ' ' PRO . . . . . 0.768 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 7.6 Cg_endo -81.88 135.18 8.72 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.772 1.648 . . . . 0.0 112.562 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.74 152.65 41.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.802 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 134' ' ' GLN . . . . . 0.588 ' HB3' ' HB1' ' D' ' 51' ' ' ALA . 50.6 mt-30 -118.94 156.95 28.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.092 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.733 ' HB3' HG22 ' D' ' 52' ' ' VAL . . . -151.42 101.71 2.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 111.648 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.56 168.29 9.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.352 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 137' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' D' ' 48' ' ' THR . 0.3 OUTLIER -80.11 123.34 27.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.149 179.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 138' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' D' ' 47' ' ' ALA . 1.3 t80 -126.19 119.05 26.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.998 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 139' ' ' ALA . . . . . 0.742 ' HB2' HD23 ' D' ' 42' ' ' LEU . . . -111.98 125.17 53.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.904 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 140' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.23 63.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.494 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . 0.444 ' H ' ' HB3' ' D' ' 98' ' ' ASN . . . -133.06 -120.03 2.08 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.137 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.36 111.94 18.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.628 0.252 . . . . 0.0 110.718 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 143' ' ' ALA . . . . . 0.709 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -61.96 113.84 3.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.82 0.343 . . . . 0.0 111.377 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 144' ' ' THR . . . . . 0.788 ' HB ' ' H ' ' D' ' 97' ' ' THR . 75.4 m -88.27 145.28 35.56 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.323 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.86 134.17 7.12 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.533 2.156 . . . . 0.0 111.992 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.93 -135.63 4.42 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.499 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 147' ' ' ALA . . . . . 0.689 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -96.13 134.26 39.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.905 0.383 . . . . 0.0 111.362 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 148' ' ' ALA . . . . . 0.872 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -129.89 50.51 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.413 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 149' ' ' ASN . . . . . 0.494 HD22 ' HG2' ' C' ' 13' ' ' LYS . 3.5 m120 -98.99 146.14 26.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.489 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 150' ' ' ALA . . . . . 0.955 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -154.95 174.17 15.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.92 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 151' ' ' ASP . . . . . 0.495 ' C ' HD11 ' D' ' 86' ' ' LEU . 26.8 t70 -139.34 128.4 23.74 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.184 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 152' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -118.37 133.34 55.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.126 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 153' ' ' THR . . . . . 0.74 HG23 HG22 ' C' ' 9' ' ' THR . 0.2 OUTLIER -91.97 147.42 22.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.27 130.33 53.43 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.169 0.509 . . . . 0.0 110.022 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -126.67 143.97 51.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.945 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 156' ' ' VAL . . . . . 0.523 HG12 ' CD1' ' D' ' 131' ' ' ILE . 27.4 m -127.45 151.87 34.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.85 0.357 . . . . 0.0 111.643 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 157' ' ' GLN . . . . . 0.687 ' HA ' ' O ' ' C' ' 3' ' ' THR . 0.0 OUTLIER -141.36 121.22 13.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.295 0.569 . . . . 0.0 110.372 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 158' ' ' TYR . . . . . 0.57 ' CD2' ' HB ' ' C' ' 3' ' ' THR . 1.2 m-85 -98.29 121.67 40.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.564 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.804 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 111.27 0.1 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.64 71.06 0.51 Allowed 'General case' 0 N--CA 1.462 0.149 0 O-C-N 123.109 0.256 . . . . 0.0 110.959 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 3' ' ' THR . . . . . 0.688 ' O ' ' HA ' ' F' ' 157' ' ' GLN . 4.9 m -114.7 127.36 55.71 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.499 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 20.8 m -117.74 106.86 13.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.577 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.453 HG21 HG12 ' F' ' 17' ' ' VAL . 0.0 OUTLIER -133.98 174.66 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.601 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.05 119.81 36.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.581 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.2 -49.49 15.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.822 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.32 -154.88 11.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.755 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 9' ' ' THR . . . . . 0.723 HG22 HG23 ' F' ' 153' ' ' THR . 2.7 p -142.43 139.95 31.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.904 0.383 . . . . 0.0 111.291 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.71 113.83 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.161 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.11 110.32 20.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.36 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.21 111.51 22.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.752 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 13' ' ' LYS . . . . . 0.497 ' HG2' HD22 ' F' ' 149' ' ' ASN . 3.6 tmtm? -102.98 110.56 22.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.488 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.22 168.36 22.59 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.053 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 15' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' F' ' 36' ' ' GLN . 3.6 tt0 -159.02 133.08 7.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.923 0.392 . . . . 0.0 110.438 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 16' ' ' VAL . . . . . 0.896 HG23 ' HB2' ' F' ' 148' ' ' ALA . 13.2 t -99.67 143.15 14.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.261 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . 0.524 HG13 ' HG2' ' F' ' 36' ' ' GLN . 3.9 m -141.34 -172.13 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.874 0.368 . . . . 0.0 111.057 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.48 -176.96 5.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.046 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.73 46.85 1.36 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.77 -30.0 2.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.9 0.381 . . . . 0.0 111.466 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 21' ' ' CYS . . . . . 1.014 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER -163.07 158.45 22.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.943 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 22' ' ' ALA . . . . . 0.568 ' HB1' ' O ' ' F' ' 36' ' ' GLN . . . -161.42 118.49 2.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.044 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 23' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' E' ' 58' ' ' LEU . 0.8 OUTLIER -66.23 153.02 8.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.05 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.7 158.74 20.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.59 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . 0.554 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -61.04 -34.34 74.72 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.388 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.18 13.07 63.54 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.936 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.76 -22.44 10.7 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.798 0.333 . . . . 0.0 110.746 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 28' ' ' VAL . . . . . 0.492 HG11 ' HE3' ' E' ' 13' ' ' LYS . 19.8 t -44.02 -64.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.319 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.0 135.72 42.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.02 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -139.11 125.72 20.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.78 106.53 18.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.108 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.78 117.06 53.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.147 0.499 . . . . 0.0 110.44 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.67 131.01 45.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.61 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.75 -47.29 7.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.682 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.3 -163.61 12.15 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.573 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 36' ' ' GLN . . . . . 0.687 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 3.7 mt-30 -100.97 126.61 47.64 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.717 0.294 . . . . 0.0 110.842 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.453 HG21 HD13 ' E' ' 42' ' ' LEU . 14.9 p -110.38 146.85 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.983 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . 0.624 HH22 ' HB2' ' D' ' 62' ' ' ASP . 2.9 mtp180 -82.96 139.23 33.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.632 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 39' ' ' THR . . . . . 0.501 ' HA ' ' HB3' ' E' ' 143' ' ' ALA . 5.4 t -62.78 -37.52 86.99 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.724 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.48 -31.47 71.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.12 0.486 . . . . 0.0 110.867 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.99 -17.74 45.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.196 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.741 HD23 ' HB2' ' E' ' 139' ' ' ALA . 4.3 mp -125.68 33.05 5.18 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.631 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.71 18.86 18.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.333 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.92 130.29 52.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.309 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' E' ' 140' ' ' THR . 22.4 tt0 -56.35 107.38 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.362 . . . . 0.0 111.059 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.52 30.53 5.85 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.183 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 47' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' E' ' 138' ' ' PHE . . . -76.61 136.75 39.21 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.976 0.417 . . . . 0.0 112.123 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' E' ' 137' ' ' TYR . 52.2 p -134.96 134.69 40.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.888 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.53 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 71.6 m -108.82 -168.21 1.32 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.565 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 50' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 23.1 t -63.9 128.43 35.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.783 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 51' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' E' ' 134' ' ' GLN . . . -80.38 129.99 34.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.447 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 52' ' ' VAL . . . . . 0.764 ' HB ' ' HA ' ' B' ' 90' ' ' SER . 2.8 m -74.87 151.22 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.9 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.01 119.22 5.67 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.578 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.85 152.1 30.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.728 0.299 . . . . 0.0 110.966 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -148.77 162.89 38.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.653 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 56' ' ' ILE . . . . . 0.603 HG23 ' O ' ' E' ' 56' ' ' ILE . 1.2 tp -105.87 114.86 46.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.567 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 57' ' ' GLN . . . . . 0.855 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.0 OUTLIER -70.72 124.58 24.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.695 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' E' ' 23' ' ' VAL . 0.2 OUTLIER -132.36 88.76 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.242 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . 0.592 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 0.1 OUTLIER -75.34 169.41 18.11 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 60' ' ' ASP . . . . . 0.409 ' CG ' ' HD2' ' F' ' 38' ' ' ARG . 0.4 OUTLIER 66.38 68.3 0.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.746 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 61' ' ' CYS . . . . . 1.014 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 56.1 m -117.15 155.03 30.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.797 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . 0.618 ' HB2' HH22 ' F' ' 38' ' ' ARG . 20.1 t70 -135.8 155.65 50.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.274 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 63' ' ' THR . . . . . 0.73 HG23 ' O ' ' E' ' 124' ' ' LEU . 0.2 OUTLIER -111.08 -34.22 6.25 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.12 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.05 -22.18 66.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.067 0.46 . . . . 0.0 111.718 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.63 -59.49 2.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.709 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 66' ' ' ALA . . . . . 0.559 ' HB3' HD23 ' E' ' 124' ' ' LEU . . . -116.86 129.18 55.91 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.628 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -60.35 2.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.896 0.379 . . . . 0.0 110.978 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.15 -175.37 2.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.537 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.96 131.32 9.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.588 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -105.97 151.19 24.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.073 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . 0.622 HG11 HG21 ' E' ' 131' ' ' ILE . 2.0 t -129.44 158.35 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.778 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . 0.628 ' HA ' HD21 ' E' ' 111' ' ' LEU . . . -152.71 143.06 22.56 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.599 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 73' ' ' PHE . . . . . 0.608 ' HB3' HD23 ' E' ' 113' ' ' LEU . 0.1 OUTLIER -112.29 141.43 46.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.542 0.21 . . . . 0.0 111.105 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 74' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.3 OUTLIER -107.7 139.49 42.18 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.992 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.76 -179.43 46.92 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.815 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -104.01 156.34 17.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.619 0.247 . . . . 0.0 110.79 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.35 118.37 21.19 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.934 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 78' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' E' ' 82' ' ' HIS . 0.4 OUTLIER -58.97 -29.14 40.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.895 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 79' ' ' ASP . . . . . 0.449 ' HB2' HG21 ' E' ' 140' ' ' THR . 0.1 OUTLIER -151.72 50.4 0.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.838 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.25 -89.9 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.103 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.03 -32.53 42.53 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.64 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 82' ' ' HIS . . . . . 0.564 ' HB3' HG22 ' E' ' 78' ' ' ILE . 0.3 OUTLIER -81.12 62.81 5.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.826 0.346 . . . . 0.0 110.376 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -18.09 60.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.599 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 84' ' ' ASN . . . . . 0.705 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 20.4 p-10 -76.1 -7.37 54.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.239 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.476 ' HB ' ' CG2' ' E' ' 78' ' ' ILE . 23.8 t -117.75 124.14 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.172 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 86' ' ' LEU . . . . . 0.982 HD22 ' HB1' ' E' ' 150' ' ' ALA . 0.5 OUTLIER -66.14 139.38 58.14 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.262 179.409 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 87' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' E' ' 78' ' ' ILE . . . -84.92 -165.41 1.19 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.667 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.771 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 0.7 OUTLIER -71.92 168.64 17.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.977 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.89 -79.23 0.06 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.308 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p -168.81 5.94 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.918 0.389 . . . . 0.0 111.506 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 91' ' ' SER . . . . . 0.612 ' O ' ' HB2' ' E' ' 95' ' ' SER . 70.2 m -77.57 83.22 3.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.07 -34.7 63.83 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.875 0.369 . . . . 0.0 111.57 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.23 31.5 6.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.635 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.58 7.44 0.23 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.965 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 95' ' ' SER . . . . . 0.771 ' HB3' ' HG ' ' E' ' 88' ' ' LEU . 0.6 OUTLIER -110.69 -174.32 2.45 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.911 0.386 . . . . 0.0 110.669 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 96' ' ' ALA . . . . . 0.432 ' O ' HD21 ' E' ' 88' ' ' LEU . . . -97.76 178.96 4.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . 0.796 ' H ' ' HB ' ' E' ' 144' ' ' THR . 1.1 m -132.25 125.99 32.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.368 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 98' ' ' ASN . . . . . 0.438 ' HB3' ' H ' ' E' ' 141' ' ' GLY . 66.1 m-20 66.64 25.84 9.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.45 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.74 130.37 70.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.691 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.15 -161.38 10.77 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.463 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 101' ' ' VAL . . . . . 0.497 ' CG2' ' HB1' ' E' ' 135' ' ' ALA . 0.8 OUTLIER -130.89 131.97 64.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.025 0.53 . . . . 0.0 111.773 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 102' ' ' GLN . . . . . 0.724 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 1.5 tt0 -98.48 151.47 20.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.882 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 103' ' ' ILE . . . . . 0.527 ' N ' ' HG2' ' E' ' 102' ' ' GLN . 0.3 OUTLIER -117.36 128.73 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.498 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 104' ' ' LEU . . . . . 0.796 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 0.3 OUTLIER -103.03 133.5 48.05 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.62 0.248 . . . . 0.0 111.108 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . 0.716 ' HB3' HG22 ' E' ' 107' ' ' THR . 7.1 t0 -87.73 158.37 18.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.67 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 106' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' E' ' 106' ' ' ARG . 7.9 ttp85 -70.49 -27.68 64.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.778 0.323 . . . . 0.0 111.096 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 107' ' ' THR . . . . . 0.716 HG22 ' HB3' ' E' ' 105' ' ' ASP . 2.8 t -51.71 -25.72 7.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.058 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.21 -39.31 1.72 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.572 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.25 158.01 17.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 111.074 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 110' ' ' ALA . . . . . 0.796 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -70.36 137.17 50.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 111' ' ' LEU . . . . . 0.628 HD21 ' HA ' ' E' ' 72' ' ' ALA . 13.5 tp -87.52 158.31 18.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.347 0.594 . . . . 0.0 110.49 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 112' ' ' THR . . . . . 1.043 HG23 HG21 ' E' ' 117' ' ' THR . 0.5 OUTLIER -101.73 141.98 33.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.107 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 113' ' ' LEU . . . . . 0.608 HD23 ' HB3' ' E' ' 73' ' ' PHE . 1.9 mt -82.43 65.61 7.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 110.778 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.04 -15.05 21.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.478 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.29 -54.21 0.7 Allowed Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.668 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.06 28.79 8.39 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.028 0.442 . . . . 0.0 111.741 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 117' ' ' THR . . . . . 1.043 HG21 HG23 ' E' ' 112' ' ' THR . 0.0 OUTLIER -88.74 76.66 7.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.225 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 118' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' E' ' 71' ' ' VAL . 91.6 m-85 -91.11 96.75 10.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.781 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 68.6 m -132.62 78.24 1.79 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.828 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.67 136.91 3.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.662 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.06 76.21 0.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.294 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.88 135.59 33.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.674 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 11.8 m -77.09 96.36 4.43 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.738 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . 0.73 ' O ' HG23 ' E' ' 63' ' ' THR . 10.8 tp -68.24 132.97 48.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.591 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -128.5 166.78 18.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.603 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 126' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' E' ' 61' ' ' CYS . 6.3 t30 -79.4 105.66 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.683 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.08 -137.08 5.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.652 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 128' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 3.7 m -103.65 83.44 2.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.688 0.28 . . . . 0.0 110.832 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 129' ' ' ASN . . . . . 0.693 ' HB2' ' SG ' ' E' ' 61' ' ' CYS . 1.7 t30 -71.0 139.87 50.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.905 0.383 . . . . 0.0 111.163 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 130' ' ' THR . . . . . 0.979 HG21 HD21 ' B' ' 74' ' ' LEU . 0.2 OUTLIER -133.91 139.66 46.3 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.161 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 131' ' ' ILE . . . . . 0.622 HG21 HG11 ' E' ' 71' ' ' VAL . 61.8 mt -98.03 110.48 56.01 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 132' ' ' PRO . . . . . 0.767 ' HB3' ' HA ' ' B' ' 76' ' ' THR . 7.6 Cg_endo -81.86 135.16 8.73 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 121.792 1.661 . . . . 0.0 112.533 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.76 152.64 41.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.815 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 134' ' ' GLN . . . . . 0.587 ' HB3' ' HB1' ' E' ' 51' ' ' ALA . 50.5 mt-30 -118.97 156.86 28.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.099 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 135' ' ' ALA . . . . . 0.728 ' HB3' HG22 ' E' ' 52' ' ' VAL . . . -151.39 101.71 2.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 111.649 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.58 168.32 9.17 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.404 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 137' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' E' ' 48' ' ' THR . 0.3 OUTLIER -80.04 123.24 27.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.175 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 138' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' E' ' 47' ' ' ALA . 1.3 t80 -126.13 119.13 26.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.064 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 139' ' ' ALA . . . . . 0.741 ' HB2' HD23 ' E' ' 42' ' ' LEU . . . -111.98 125.22 53.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.867 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 140' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 0.2 OUTLIER -68.89 -48.24 63.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.546 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' E' ' 98' ' ' ASN . . . -133.1 -119.96 2.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.085 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.42 111.96 18.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.612 0.244 . . . . 0.0 110.718 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 143' ' ' ALA . . . . . 0.719 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -61.95 113.89 3.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.803 0.335 . . . . 0.0 111.361 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 144' ' ' THR . . . . . 0.796 ' HB ' ' H ' ' E' ' 97' ' ' THR . 73.7 m -88.34 145.31 35.49 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.324 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 145' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' E' ' 144' ' ' THR . 1.3 Cg_endo -82.86 134.22 7.14 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.463 2.109 . . . . 0.0 112.019 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.87 -135.62 4.43 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.535 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 147' ' ' ALA . . . . . 0.679 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -96.12 134.19 39.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.392 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 148' ' ' ALA . . . . . 0.89 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -129.8 50.51 2.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.131 0.491 . . . . 0.0 110.474 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 149' ' ' ASN . . . . . 0.492 HD22 ' HG2' ' D' ' 13' ' ' LYS . 3.5 m120 -98.97 146.13 26.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.501 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 150' ' ' ALA . . . . . 0.982 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -154.96 174.13 15.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.875 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 151' ' ' ASP . . . . . 0.483 ' C ' HD11 ' E' ' 86' ' ' LEU . 26.7 t70 -139.3 128.45 23.88 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.192 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 152' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -118.41 133.29 56.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.193 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 153' ' ' THR . . . . . 0.709 HG23 HG22 ' D' ' 9' ' ' THR . 0.2 OUTLIER -91.91 147.36 23.03 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.22 130.3 53.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.182 0.515 . . . . 0.0 110.054 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -126.63 143.91 51.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.911 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 156' ' ' VAL . . . . . 0.517 HG12 ' CD1' ' E' ' 131' ' ' ILE . 27.2 m -127.42 151.82 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.775 0.322 . . . . 0.0 111.729 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 157' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' D' ' 3' ' ' THR . 0.0 OUTLIER -141.34 121.19 13.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.326 0.584 . . . . 0.0 110.341 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 158' ' ' TYR . . . . . 0.573 ' CD2' ' HB ' ' D' ' 3' ' ' THR . 1.2 m-85 -98.31 121.66 40.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.532 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.82 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.251 0.072 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.72 71.03 0.51 Allowed 'General case' 0 CA--C 1.528 0.124 0 O-C-N 123.11 0.256 . . . . 0.0 110.972 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 4.9 m -114.69 127.38 55.73 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.433 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 20.7 m -117.82 106.74 13.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.587 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.86 174.71 12.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.577 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -97.11 119.89 36.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.553 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.34 -49.41 15.47 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.834 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.27 -154.87 11.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.862 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -142.46 140.07 31.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.985 0.421 . . . . 0.0 111.222 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.79 113.8 41.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.18 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -87.07 110.35 20.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.358 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -90.32 111.55 22.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.744 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 13' ' ' LYS . . . . . 0.485 ' HE3' HG11 ' F' ' 28' ' ' VAL . 3.7 tmtm? -102.97 110.6 22.58 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.39 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.25 168.38 22.6 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.962 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -159.09 133.02 7.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.893 0.378 . . . . 0.0 110.446 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 13.1 t -99.62 143.19 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.258 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 17' ' ' VAL . . . . . 0.453 HG12 HG21 ' E' ' 5' ' ' VAL . 3.9 m -141.41 -172.12 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.867 0.365 . . . . 0.0 110.987 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.51 -177.0 5.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.073 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.83 47.01 1.37 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.073 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.77 -29.98 2.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.434 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 21' ' ' CYS . . . . . 0.992 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER -163.19 158.33 21.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.906 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.34 118.61 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.045 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 23' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' F' ' 58' ' ' LEU . 0.8 OUTLIER -66.29 153.06 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.986 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -84.82 158.72 20.58 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.606 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . 0.562 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -60.99 -34.43 74.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.386 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.08 13.11 63.65 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.97 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.83 -22.43 10.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.796 0.332 . . . . 0.0 110.701 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 28' ' ' VAL . . . . . 0.485 HG11 ' HE3' ' F' ' 13' ' ' LYS . 19.8 t -44.05 -64.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.368 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.1 135.92 41.78 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.925 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.23 125.72 20.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.008 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.79 106.51 18.79 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.06 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.76 117.05 53.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.196 0.522 . . . . 0.0 110.445 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.66 131.06 45.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.607 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.79 -47.41 7.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.616 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.39 -163.62 12.15 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.581 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 36' ' ' GLN . . . . . 0.688 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 3.7 mt-30 -100.97 126.59 47.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.688 0.28 . . . . 0.0 110.863 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.444 HG21 HD13 ' F' ' 42' ' ' LEU . 14.9 p -110.36 146.84 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.912 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 38' ' ' ARG . . . . . 0.618 HH22 ' HB2' ' E' ' 62' ' ' ASP . 2.8 mtp180 -82.9 139.14 33.59 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.678 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 39' ' ' THR . . . . . 0.506 ' HA ' ' HB3' ' F' ' 143' ' ' ALA . 5.4 t -62.71 -37.51 86.78 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.762 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.46 -31.49 71.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.095 0.474 . . . . 0.0 110.837 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.03 -17.73 45.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.147 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . 0.739 HD23 ' HB2' ' F' ' 139' ' ' ALA . 4.3 mp -125.69 33.08 5.17 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.671 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.7 18.84 18.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.365 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.95 130.36 52.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.313 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' F' ' 140' ' ' THR . 22.5 tt0 -56.36 107.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.864 0.364 . . . . 0.0 111.027 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.64 30.42 5.86 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.179 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 47' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' F' ' 138' ' ' PHE . . . -76.57 136.7 39.26 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.95 0.405 . . . . 0.0 112.071 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 48' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' F' ' 137' ' ' TYR . 52.3 p -134.92 134.66 40.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.891 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 49' ' ' SER . . . . . 0.538 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 70.8 m -108.68 -168.23 1.32 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.657 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 50' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' C' ' 92' ' ' ALA . 23.1 t -63.89 128.47 35.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.807 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 51' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' F' ' 134' ' ' GLN . . . -80.44 130.02 34.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.406 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 52' ' ' VAL . . . . . 0.769 ' HB ' ' HA ' ' C' ' 90' ' ' SER . 2.8 m -74.84 151.25 6.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.97 119.21 5.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.622 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.86 152.1 30.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.711 0.291 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -148.77 162.99 38.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.643 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 56' ' ' ILE . . . . . 0.605 HG23 ' O ' ' F' ' 56' ' ' ILE . 1.2 tp -105.92 114.76 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.585 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 57' ' ' GLN . . . . . 0.889 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.0 OUTLIER -70.61 124.51 24.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.761 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' F' ' 23' ' ' VAL . 0.2 OUTLIER -132.35 88.81 2.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.192 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 59' ' ' ASN . . . . . 0.585 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 0.1 OUTLIER -75.35 169.52 17.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.34 68.26 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.787 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 61' ' ' CYS . . . . . 0.992 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 56.3 m -117.13 155.02 30.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.829 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -135.8 155.67 49.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.227 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 63' ' ' THR . . . . . 0.726 HG23 ' O ' ' F' ' 124' ' ' LEU . 0.2 OUTLIER -111.13 -34.23 6.24 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.09 -22.1 66.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.069 0.461 . . . . 0.0 111.759 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.61 -59.56 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.744 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 66' ' ' ALA . . . . . 0.569 ' HB3' HD23 ' F' ' 124' ' ' LEU . . . -116.74 129.12 55.93 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.617 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -60.27 2.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.959 0.409 . . . . 0.0 111.052 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.22 -175.41 2.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.47 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.93 131.34 9.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.607 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 70' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -106.02 151.19 24.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.025 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 71' ' ' VAL . . . . . 0.631 HG11 HG21 ' F' ' 131' ' ' ILE . 2.0 t -129.48 158.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.704 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 72' ' ' ALA . . . . . 0.657 ' HA ' HD21 ' F' ' 111' ' ' LEU . . . -152.66 143.02 22.57 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.626 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 73' ' ' PHE . . . . . 0.603 ' HB3' HD23 ' F' ' 113' ' ' LEU . 0.1 OUTLIER -112.23 141.44 45.94 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.663 0.268 . . . . 0.0 111.049 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 74' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.3 OUTLIER -107.63 139.54 42.01 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.981 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.76 -179.51 46.87 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.83 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.92 156.34 17.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.535 0.207 . . . . 0.0 110.819 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.34 118.44 21.25 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.877 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 78' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' F' ' 82' ' ' HIS . 0.4 OUTLIER -59.1 -29.08 40.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.834 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 79' ' ' ASP . . . . . 0.43 ' HB2' HG21 ' F' ' 140' ' ' THR . 0.1 OUTLIER -151.7 50.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.781 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.2 -89.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.095 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.09 -32.54 42.97 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.596 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 82' ' ' HIS . . . . . 0.564 ' HB3' HG22 ' F' ' 78' ' ' ILE . 0.3 OUTLIER -81.14 62.86 5.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.886 0.374 . . . . 0.0 110.414 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.53 -18.23 60.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.633 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 84' ' ' ASN . . . . . 0.705 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 20.4 p-10 -76.02 -7.4 54.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.258 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 85' ' ' VAL . . . . . 0.49 ' HB ' ' CG2' ' F' ' 78' ' ' ILE . 23.8 t -117.72 124.14 72.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.224 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 86' ' ' LEU . . . . . 0.959 HD22 ' HB1' ' F' ' 150' ' ' ALA . 0.5 OUTLIER -66.18 139.38 58.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.715 0.293 . . . . 0.0 110.266 179.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 87' ' ' ALA . . . . . 0.453 ' HB2' ' HA ' ' F' ' 78' ' ' ILE . . . -84.85 -165.37 1.17 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.741 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . 0.756 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 0.7 OUTLIER -71.87 168.65 17.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.056 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.91 -79.18 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.351 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p -168.87 6.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 111.549 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 91' ' ' SER . . . . . 0.609 ' O ' ' HB2' ' F' ' 95' ' ' SER . 69.4 m -77.62 83.24 4.01 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.04 -34.67 63.73 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.606 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.26 31.5 6.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.58 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.63 7.59 0.23 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.907 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 95' ' ' SER . . . . . 0.756 ' HB3' ' HG ' ' F' ' 88' ' ' LEU . 0.6 OUTLIER -110.87 -174.32 2.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.834 0.349 . . . . 0.0 110.553 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 96' ' ' ALA . . . . . 0.431 ' O ' HD21 ' F' ' 88' ' ' LEU . . . -97.76 179.0 4.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . 0.784 ' H ' ' HB ' ' F' ' 144' ' ' THR . 1.1 m -132.32 125.98 32.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.316 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 98' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' F' ' 97' ' ' THR . 66.1 m-20 66.66 25.8 9.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.451 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.66 130.35 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.711 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.11 -161.37 10.75 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.492 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 101' ' ' VAL . . . . . 0.486 ' CG2' ' HB1' ' F' ' 135' ' ' ALA . 0.8 OUTLIER -130.89 131.88 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.122 0.569 . . . . 0.0 111.868 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 102' ' ' GLN . . . . . 0.721 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 1.5 tt0 -98.41 151.52 20.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.897 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 103' ' ' ILE . . . . . 0.518 ' N ' ' HG2' ' F' ' 102' ' ' GLN . 0.3 OUTLIER -117.36 128.65 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.503 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 104' ' ' LEU . . . . . 0.809 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 0.3 OUTLIER -103.04 133.52 48.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.647 0.261 . . . . 0.0 111.083 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . 0.702 ' HB3' HG22 ' F' ' 107' ' ' THR . 7.2 t0 -87.71 158.37 18.83 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.658 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 106' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' F' ' 106' ' ' ARG . 7.9 ttp85 -70.4 -27.75 64.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.778 0.323 . . . . 0.0 111.082 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 107' ' ' THR . . . . . 0.702 HG22 ' HB3' ' F' ' 105' ' ' ASP . 2.8 t -51.72 -25.72 7.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.056 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.26 -39.37 1.71 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.574 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.26 158.01 17.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 0.0 111.079 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 110' ' ' ALA . . . . . 0.809 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -70.3 137.11 50.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.034 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 111' ' ' LEU . . . . . 0.657 HD21 ' HA ' ' F' ' 72' ' ' ALA . 13.5 tp -87.53 158.38 18.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.338 0.589 . . . . 0.0 110.533 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 112' ' ' THR . . . . . 1.043 HG23 HG21 ' F' ' 117' ' ' THR . 0.5 OUTLIER -101.76 141.93 33.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.107 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 113' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' F' ' 73' ' ' PHE . 1.9 mt -82.33 65.58 7.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.7 0.286 . . . . 0.0 110.725 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.08 -14.97 21.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.521 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.21 -54.11 0.71 Allowed Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.661 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.19 28.97 8.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.066 0.46 . . . . 0.0 111.719 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 117' ' ' THR . . . . . 1.043 HG21 HG23 ' F' ' 112' ' ' THR . 0.0 OUTLIER -88.85 76.61 7.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.17 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 118' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' F' ' 71' ' ' VAL . 91.6 m-85 -91.07 96.77 10.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.746 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 67.8 m -132.6 78.22 1.79 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.764 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.7 136.97 3.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.688 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.09 76.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.276 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.9 135.59 33.62 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.635 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 12.0 m -77.09 96.25 4.41 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.763 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . 0.726 ' O ' HG23 ' F' ' 63' ' ' THR . 10.8 tp -68.19 132.97 48.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.582 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -128.47 166.77 18.12 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.552 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 126' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' F' ' 61' ' ' CYS . 6.3 t30 -79.41 105.74 10.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.743 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.02 -137.09 5.24 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.689 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 128' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 3.7 m -103.59 83.45 2.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.686 0.279 . . . . 0.0 110.847 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 129' ' ' ASN . . . . . 0.7 ' HB2' ' SG ' ' F' ' 61' ' ' CYS . 1.7 t30 -70.98 139.87 50.7 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.887 0.375 . . . . 0.0 111.165 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 130' ' ' THR . . . . . 0.97 HG21 HD21 ' C' ' 74' ' ' LEU . 0.2 OUTLIER -133.96 139.69 46.27 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.109 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 131' ' ' ILE . . . . . 0.631 HG21 HG11 ' F' ' 71' ' ' VAL . 61.8 mt -98.08 110.55 56.39 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 132' ' ' PRO . . . . . 0.765 ' HB3' ' HA ' ' C' ' 76' ' ' THR . 7.6 Cg_endo -81.82 135.13 8.76 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.796 1.664 . . . . 0.0 112.558 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.74 152.68 41.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.727 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 134' ' ' GLN . . . . . 0.589 ' HB3' ' HB1' ' F' ' 51' ' ' ALA . 50.5 mt-30 -119.0 156.9 28.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.096 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 135' ' ' ALA . . . . . 0.722 ' HB3' HG22 ' F' ' 52' ' ' VAL . . . -151.42 101.69 2.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.808 0.337 . . . . 0.0 111.641 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.59 168.33 9.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.373 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 137' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' F' ' 48' ' ' THR . 0.3 OUTLIER -80.09 123.3 27.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.113 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 138' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' F' ' 47' ' ' ALA . 1.3 t80 -126.18 119.05 26.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.051 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 139' ' ' ALA . . . . . 0.739 ' HB2' HD23 ' F' ' 42' ' ' LEU . . . -111.98 125.17 53.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.853 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 140' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' F' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.26 63.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.508 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . 0.434 ' H ' ' HB3' ' F' ' 98' ' ' ASN . . . -133.09 -120.05 2.08 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.058 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.27 111.91 18.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.548 0.213 . . . . 0.0 110.815 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 143' ' ' ALA . . . . . 0.709 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -61.91 113.86 3.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.815 0.341 . . . . 0.0 111.405 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 144' ' ' THR . . . . . 0.784 ' HB ' ' H ' ' F' ' 97' ' ' THR . 75.1 m -88.28 145.22 35.4 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.317 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.81 134.17 7.17 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.524 2.149 . . . . 0.0 111.978 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.94 -135.59 4.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.537 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 147' ' ' ALA . . . . . 0.71 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -96.21 134.2 39.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.966 0.412 . . . . 0.0 111.312 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 148' ' ' ALA . . . . . 0.896 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -129.82 50.48 2.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.184 0.516 . . . . 0.0 110.469 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 149' ' ' ASN . . . . . 0.497 HD22 ' HG2' ' E' ' 13' ' ' LYS . 3.5 m120 -98.92 146.16 26.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.491 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 150' ' ' ALA . . . . . 0.959 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -154.91 174.12 15.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.876 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 151' ' ' ASP . . . . . 0.482 ' C ' HD11 ' F' ' 86' ' ' LEU . 26.8 t70 -139.34 128.49 23.87 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.225 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 152' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -118.41 133.38 55.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.159 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 153' ' ' THR . . . . . 0.723 HG23 HG22 ' E' ' 9' ' ' THR . 0.2 OUTLIER -92.02 147.42 22.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.24 130.28 53.42 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.143 0.497 . . . . 0.0 110.085 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -126.71 144.02 51.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.874 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 156' ' ' VAL . . . . . 0.526 HG12 ' CD1' ' F' ' 131' ' ' ILE . 27.3 m -127.42 151.9 34.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.677 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 157' ' ' GLN . . . . . 0.688 ' HA ' ' O ' ' E' ' 3' ' ' THR . 0.0 OUTLIER -141.35 121.18 13.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.237 0.542 . . . . 0.0 110.365 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 158' ' ' TYR . . . . . 0.575 ' CD2' ' HB ' ' E' ' 3' ' ' THR . 1.2 m-85 -98.25 121.65 40.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.539 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.802 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.533 0.206 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.589 ' OG1' ' HB2' ' B' ' 158' ' ' TYR . 6.2 p -117.73 97.5 5.88 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.499 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.607 HG22 ' HB2' ' B' ' 157' ' ' GLN . 68.4 p -87.86 108.7 19.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.576 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.63 172.77 13.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.592 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -77.2 110.77 12.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.587 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' B' ' 155' ' ' LYS . . . -65.69 -59.41 7.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.772 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.56 151.71 14.94 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.818 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.513 HG23 ' O ' ' B' ' 152' ' ' ALA . 24.2 m -103.54 143.13 33.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 111.279 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.441 HG12 ' HG3' ' B' ' 30' ' ' GLN . 1.2 m -130.94 115.61 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.208 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.62 105.77 14.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.398 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.448 ' HD2' HD21 ' B' ' 34' ' ' LEU . 52.1 m-85 -83.25 105.55 14.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.782 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.52 145.05 41.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.455 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.75 -179.72 42.55 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.958 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.15 134.23 22.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.0 110.376 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.635 HG11 ' O ' ' B' ' 144' ' ' THR . 3.3 t -90.85 127.14 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.286 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 20' ' ' ALA . 12.1 m -126.25 168.77 18.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -100.42 81.79 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.154 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' B' ' 40' ' ' ALA . . . 53.3 58.17 5.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.071 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB3' HG21 ' A' ' 17' ' ' VAL . . . -108.55 -62.86 1.4 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.36 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.781 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.9 OUTLIER -171.56 -159.94 0.16 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.915 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.634 ' HA ' ' HB2' ' B' ' 36' ' ' GLN . . . -156.88 74.01 0.78 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.456 ' N ' HD23 ' A' ' 58' ' ' LEU . 7.4 p -45.35 140.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.544 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -63.42 140.74 58.9 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.661 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.36 -51.15 69.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.311 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.11 -18.04 74.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.919 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.96 -6.39 58.04 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.832 0.349 . . . . 0.0 110.786 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 24' ' ' ASP . 50.9 t -72.63 -36.37 53.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.426 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.95 110.82 14.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.969 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.78 146.05 48.6 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.033 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.21 113.84 27.67 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.127 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.61 HG11 HG11 ' A' ' 52' ' ' VAL . 3.3 t -105.08 121.93 57.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.108 0.48 . . . . 0.0 110.448 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.86 106.41 17.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.683 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.79 -44.74 89.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.592 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.62 -156.9 15.99 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.568 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -91.07 107.01 18.91 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.596 0.236 . . . . 0.0 110.847 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.572 ' CG1' HD21 ' A' ' 42' ' ' LEU . 4.3 t -92.34 120.63 41.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.918 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 -85.71 132.49 34.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.746 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.0 p -71.45 -23.32 61.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.756 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.03 -19.19 64.88 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.965 0.412 . . . . 0.0 110.793 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.8 t -90.53 -36.55 14.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.183 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -121.52 70.52 0.94 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.58 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 142' ' ' ALA . . . -104.76 28.18 7.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.38 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.772 ' HG3' ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -150.58 142.01 23.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.384 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 2.7 tt0 -62.7 101.79 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.777 0.322 . . . . 0.0 111.136 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.3 4.27 8.41 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.062 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.772 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . . . -91.76 121.2 33.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.002 0.43 . . . . 0.0 111.985 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 5.8 t -110.3 151.2 27.68 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.806 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -95.7 -57.62 2.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.594 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.24 -174.88 4.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.853 0.359 . . . . 0.0 110.817 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.476 ' HB2' ' CD ' ' A' ' 136' ' ' ARG . . . -127.05 143.87 51.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.387 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.61 HG11 HG11 ' A' ' 32' ' ' VAL . 48.3 t -120.85 116.86 51.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.972 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.19 122.64 6.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.67 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -128.58 138.83 52.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.33 . . . . 0.0 110.978 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.472 HD22 ' CG2' ' A' ' 130' ' ' THR . 1.6 m120 -117.86 150.95 38.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.657 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.574 ' HB ' HG13 ' A' ' 131' ' ' ILE . 9.3 mm -106.78 103.67 15.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.57 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.21 132.23 52.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.783 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.757 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 1.0 OUTLIER -137.31 151.87 49.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.256 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -138.45 171.27 14.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.983 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 5.9 m-20 50.1 68.42 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.781 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -106.59 141.14 38.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.764 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.84 117.89 33.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.24 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.7 p -91.12 -13.18 33.52 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.62 -38.95 82.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.069 0.462 . . . . 0.0 111.765 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.65 -54.11 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.645 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.7 84.31 3.35 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.582 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.98 -41.21 10.13 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.805 0.336 . . . . 0.0 111.023 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.63 159.96 17.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.518 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.7 160.4 39.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.616 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.02 152.91 45.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.133 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.89 136.54 53.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.722 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.0 107.45 5.04 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.555 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.475 ' CD2' HD13 ' A' ' 103' ' ' ILE . 43.1 t80 -73.65 136.66 43.86 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.605 0.24 . . . . 0.0 111.025 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 153' ' ' THR . 6.6 tt -113.56 111.41 21.84 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.978 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.649 ' HA3' HD11 ' A' ' 113' ' ' LEU . . . -131.29 -178.49 15.5 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.864 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.659 ' H ' HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -104.32 137.58 42.0 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.461 0.172 . . . . 0.0 110.857 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.98 114.78 23.89 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.992 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.618 ' O ' ' HG2' ' D' ' 134' ' ' GLN . 1.2 tt -95.7 -36.73 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.867 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.897 ' CB ' HG21 ' A' ' 140' ' ' THR . 0.4 OUTLIER -143.38 130.23 20.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.746 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.92 -7.18 47.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.046 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.33 -29.19 68.39 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.587 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.34 -32.64 4.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.88 0.371 . . . . 0.0 110.459 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.435 ' O ' HG22 ' A' ' 83' ' ' THR . 3.5 m 60.49 19.42 9.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.589 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.631 ' HB3' ' HG2' ' A' ' 102' ' ' GLN . 0.6 OUTLIER -139.37 -16.99 1.03 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.296 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.709 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 0.9 OUTLIER -66.67 118.02 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.244 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.659 HD12 ' H ' ' A' ' 76' ' ' THR . 10.7 tp -69.72 144.17 52.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.264 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.452 ' HB3' ' OG1' ' A' ' 76' ' ' THR . . . -80.2 138.09 36.78 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.917 0.389 . . . . 0.0 111.721 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.686 ' HB3' ' HA ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -84.95 -146.62 0.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.068 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 149' ' ' ASN . 0.0 OUTLIER -48.53 155.02 0.58 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.268 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.566 ' O ' HG22 ' D' ' 52' ' ' VAL . 32.4 p -86.73 -11.92 49.75 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.923 0.392 . . . . 0.0 111.503 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.42 114.08 5.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.589 ' HA ' ' HB3' ' D' ' 50' ' ' SER . . . -83.38 22.19 1.06 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.951 0.405 . . . . 0.0 111.683 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.21 21.97 1.21 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.698 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.64 -32.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.017 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.654 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 15.9 t -65.14 166.73 9.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.866 0.365 . . . . 0.0 110.616 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.465 ' O ' HD13 ' A' ' 88' ' ' LEU . . . -89.65 163.44 15.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.851 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.42 169.66 17.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.34 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 57.4 29.34 16.78 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.383 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.573 ' HB ' ' HB1' ' A' ' 143' ' ' ALA . 7.2 p -156.38 150.6 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.825 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.709 ' HA3' ' HB ' ' A' ' 85' ' ' VAL . . . -164.2 176.93 40.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.609 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.617 HG22 ' CE1' ' A' ' 137' ' ' TYR . 3.0 t -107.63 111.29 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.018 0.527 . . . . 0.0 111.713 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.631 ' HG2' ' HB3' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -75.97 179.75 5.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.958 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.492 HD11 ' HA ' ' A' ' 113' ' ' LEU . 6.0 pt -150.36 116.54 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.457 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 12.9 tp -97.22 122.54 40.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.724 0.297 . . . . 0.0 111.068 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.91 150.08 42.92 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.739 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.506 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -71.43 -17.58 62.38 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.824 0.345 . . . . 0.0 111.121 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.43 HG21 ' HA ' ' A' ' 120' ' ' SER . 76.1 p -76.62 -37.22 56.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.11 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.52 -68.81 0.32 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.732 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.61 123.2 18.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.795 0.331 . . . . 0.0 111.129 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.74 117.99 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.184 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.514 HD11 ' O ' ' A' ' 117' ' ' THR . 2.1 tp -67.87 144.1 55.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.43 0.633 . . . . 0.0 110.491 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.428 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -75.11 140.45 43.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.071 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.649 HD11 ' HA3' ' A' ' 75' ' ' GLY . 1.3 tp -85.18 97.75 10.08 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.701 0.286 . . . . 0.0 110.668 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -152.78 -59.01 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.645 0.26 . . . . 0.0 111.582 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.556 ' HA3' ' OG1' ' D' ' 130' ' ' THR . . . 135.73 -26.63 3.14 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.615 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.731 ' HB2' ' HA ' ' D' ' 129' ' ' ASN . . . -101.27 28.78 5.15 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.994 0.426 . . . . 0.0 111.692 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.514 ' O ' HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -106.58 67.34 0.72 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.075 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.4 81.0 8.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.737 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.04 97.45 3.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.43 ' HA ' HG21 ' A' ' 107' ' ' THR . 2.0 t -165.54 144.79 6.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.587 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.28 50.22 0.9 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.204 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.8 94.18 5.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.715 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.69 110.38 12.47 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.679 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.602 ' HG ' ' ND2' ' A' ' 129' ' ' ASN . 0.3 OUTLIER -70.2 154.15 42.26 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.578 179.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.6 144.77 51.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.552 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.74 125.67 24.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.653 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.1 -102.01 1.1 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.725 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 86.9 m -106.23 128.45 53.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.655 0.264 . . . . 0.0 110.831 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.602 ' ND2' ' HG ' ' A' ' 124' ' ' LEU . 20.1 t-20 -121.15 158.13 28.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.874 0.368 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.472 ' CG2' HD22 ' A' ' 55' ' ' ASN . 0.2 OUTLIER -155.81 143.08 19.27 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.996 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.607 HD13 HG11 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -115.22 110.79 45.14 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.506 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.4 Cg_endo -82.21 151.85 15.95 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.618 1.546 . . . . 0.0 112.5 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.01 146.77 17.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.797 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.8 OUTLIER -114.38 145.83 41.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.108 179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.77 91.17 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 111.679 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.57 ' HE ' HG21 ' A' ' 48' ' ' THR . 28.0 mtm-85 -88.34 153.6 21.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.405 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.617 ' CE1' HG22 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -91.29 111.06 22.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.071 179.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.608 ' CD1' ' HB2' ' A' ' 102' ' ' GLN . 8.8 m-85 -108.08 172.19 6.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.962 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.574 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -123.42 143.65 50.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.851 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.897 HG21 ' CB ' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -98.73 44.39 1.03 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.565 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.48 89.07 1.07 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.978 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . . . 60.09 88.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.709 0.255 . . . . 0.0 110.689 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.573 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -70.61 161.73 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.405 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 158.73 60.65 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.226 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.76 149.18 12.55 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.54 2.16 . . . . 0.0 112.06 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.72 -119.73 0.86 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.479 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.654 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -123.94 127.71 48.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.861 0.362 . . . . 0.0 111.417 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.686 ' HA ' ' HB3' ' A' ' 88' ' ' LEU . . . -120.85 67.17 0.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.117 0.484 . . . . 0.0 110.389 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 47.5 t-20 -128.47 114.77 17.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.6 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.424 ' HB2' ' C ' ' A' ' 88' ' ' LEU . . . -158.83 146.97 18.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.984 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.39 140.3 32.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.171 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.19 169.28 17.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.176 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 74' ' ' LEU . 9.3 t -155.11 150.52 27.25 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.442 ' HE1' HG13 ' A' ' 56' ' ' ILE . 1.1 p90 -118.97 149.27 41.91 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.121 0.486 . . . . 0.0 110.083 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.436 ' HE3' HD13 ' A' ' 74' ' ' LEU . 4.7 mttt -113.53 156.68 23.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.869 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.607 HG11 HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -136.48 137.98 47.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.684 -179.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -107.5 128.03 54.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.318 0.58 . . . . 0.0 110.37 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -107.87 107.43 18.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.542 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.851 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.209 0.052 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . 0.727 ' H ' ' HA ' ' C' ' 159' ' ' GLN . . . 65.84 74.75 0.36 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.579 0.228 . . . . 0.0 110.98 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.6 ' OG1' ' HB2' ' C' ' 158' ' ' TYR . 6.2 p -117.74 97.56 5.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.46 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.606 HG22 ' HB2' ' C' ' 157' ' ' GLN . 67.9 p -87.91 108.61 19.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.527 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.51 172.75 13.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.59 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -77.24 110.86 12.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.494 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . 0.409 ' H ' ' HA ' ' C' ' 155' ' ' LYS . . . -65.76 -59.42 7.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.765 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.56 151.64 14.79 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.81 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.513 HG23 ' O ' ' C' ' 152' ' ' ALA . 24.2 m -103.44 143.09 33.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 111.357 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.438 HG12 ' HG3' ' C' ' 30' ' ' GLN . 1.2 m -130.98 115.63 30.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.186 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.65 105.71 14.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.349 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . 0.45 ' HD2' HD21 ' C' ' 34' ' ' LEU . 52.2 m-85 -83.17 105.47 14.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.783 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.46 145.07 41.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.446 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.74 -179.69 42.57 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.932 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.19 134.27 22.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.94 0.4 . . . . 0.0 110.306 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.635 HG11 ' O ' ' C' ' 144' ' ' THR . 3.3 t -90.9 127.16 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.264 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' B' ' 20' ' ' ALA . 12.1 m -126.25 168.75 18.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.86 0.362 . . . . 0.0 111.037 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.48 81.82 2.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.12 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' C' ' 40' ' ' ALA . . . 53.38 58.15 5.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.997 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.537 ' HB3' HG21 ' B' ' 17' ' ' VAL . . . -108.57 -62.82 1.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.442 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.9 OUTLIER -171.54 -159.86 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.914 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.64 ' HA ' ' HB2' ' C' ' 36' ' ' GLN . . . -156.84 74.07 0.79 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.463 ' N ' HD23 ' B' ' 58' ' ' LEU . 7.4 p -45.44 140.62 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.958 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.553 ' O ' HG23 ' B' ' 28' ' ' VAL . 0.5 OUTLIER -63.43 140.81 58.91 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.642 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.44 -51.15 69.5 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.307 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.08 -18.01 74.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.964 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -88.0 -6.32 58.05 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.827 0.346 . . . . 0.0 110.756 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.553 HG23 ' O ' ' B' ' 24' ' ' ASP . 50.5 t -72.78 -36.31 52.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.359 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.03 110.85 14.03 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.002 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' GLN . . . . . 0.441 ' HG3' HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -123.85 146.01 48.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.021 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.19 113.84 27.68 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.128 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.623 HG11 HG11 ' B' ' 52' ' ' VAL . 3.3 t -105.08 121.91 57.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.105 0.478 . . . . 0.0 110.475 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.84 106.37 17.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.721 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.448 HD21 ' HD2' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -64.69 -44.75 89.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.642 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.58 -156.91 16.0 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.558 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.634 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 3.7 mt-30 -91.1 106.98 18.9 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.629 0.252 . . . . 0.0 110.851 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.578 ' CG1' HD21 ' B' ' 42' ' ' LEU . 4.4 t -92.32 120.59 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.938 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' A' ' 19' ' ' ALA . 4.6 mtm105 -85.67 132.51 34.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.71 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 17' ' ' VAL . 29.4 p -71.54 -23.21 61.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.755 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . . . -68.08 -19.06 64.83 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.996 0.427 . . . . 0.0 110.844 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -90.6 -36.6 14.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.167 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' B' ' 139' ' ' ALA . 0.2 OUTLIER -121.48 70.54 0.94 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.61 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' B' ' 142' ' ' ALA . . . -104.7 28.11 7.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.423 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 0.77 ' HG3' ' HB2' ' B' ' 47' ' ' ALA . 0.0 OUTLIER -150.53 141.99 23.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.45 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' B' ' 140' ' ' THR . 2.7 tt0 -62.66 101.8 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.769 0.319 . . . . 0.0 111.104 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.26 4.26 8.44 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.099 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.77 ' HB2' ' HG3' ' B' ' 44' ' ' GLN . . . -91.74 121.32 33.27 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.982 0.42 . . . . 0.0 112.015 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' B' ' 137' ' ' TYR . 5.8 t -110.41 151.22 27.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.786 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -95.69 -57.67 2.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.596 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.23 -174.85 4.69 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.76 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.48 ' HB2' ' CD ' ' B' ' 136' ' ' ARG . . . -127.05 143.86 51.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.315 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.623 HG11 HG11 ' B' ' 32' ' ' VAL . 48.3 t -120.9 116.91 51.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.959 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.25 122.67 6.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.66 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -128.62 138.86 52.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.784 0.326 . . . . 0.0 111.0 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.472 HD22 ' CG2' ' B' ' 130' ' ' THR . 1.6 m120 -117.85 150.93 38.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.677 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.59 ' HB ' HG13 ' B' ' 131' ' ' ILE . 9.3 mm -106.77 103.66 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.607 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -61.15 132.27 53.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.798 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.762 ' HB3' ' SG ' ' B' ' 21' ' ' CYS . 1.0 OUTLIER -137.39 151.86 49.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.208 -179.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -138.38 171.34 14.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.972 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' B' ' 21' ' ' CYS . 5.9 m-20 49.98 68.48 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 0.0 OUTLIER -106.63 141.08 38.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.8 117.88 33.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.231 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.3 p -91.26 -13.02 33.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.69 -38.89 82.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.114 0.483 . . . . 0.0 111.79 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 76.4 t -107.75 -54.07 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.618 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.66 84.39 3.38 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.583 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -41.25 10.05 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.949 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.6 159.96 17.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.529 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.68 160.45 39.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.609 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.09 152.91 45.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.97 136.54 53.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.688 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.02 107.53 5.06 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.556 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.476 ' CD2' HD13 ' B' ' 103' ' ' ILE . 43.2 t80 -73.75 136.69 43.68 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.562 0.22 . . . . 0.0 111.02 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.457 ' HB3' ' O ' ' B' ' 153' ' ' THR . 6.6 tt -113.55 111.44 21.9 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.98 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . 0.628 ' HA3' HD11 ' B' ' 113' ' ' LEU . . . -131.38 -178.6 15.56 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.841 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.654 ' H ' HD12 ' B' ' 86' ' ' LEU . 0.2 OUTLIER -104.28 137.61 41.94 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.478 0.18 . . . . 0.0 110.844 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.98 114.77 23.87 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.895 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.614 ' O ' ' HG2' ' E' ' 134' ' ' GLN . 1.2 tt -95.76 -36.75 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.782 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.889 ' CB ' HG21 ' B' ' 140' ' ' THR . 0.4 OUTLIER -143.33 130.22 20.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.93 -7.26 47.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.21 -29.31 68.33 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.665 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 -32.67 4.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.945 0.402 . . . . 0.0 110.502 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' THR . . . . . 0.424 ' O ' HG22 ' B' ' 83' ' ' THR . 3.5 m 60.52 19.39 9.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.633 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . 0.642 ' HB3' ' HG2' ' B' ' 102' ' ' GLN . 0.6 OUTLIER -139.35 -17.03 1.03 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.312 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.696 ' HB ' ' HA3' ' B' ' 100' ' ' GLY . 0.9 OUTLIER -66.65 118.08 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.2 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.654 HD12 ' H ' ' B' ' 76' ' ' THR . 10.7 tp -69.75 144.13 52.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.374 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.447 ' HB3' ' CB ' ' B' ' 76' ' ' THR . . . -80.05 137.98 36.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.868 0.366 . . . . 0.0 111.773 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.69 ' HB3' ' HA ' ' B' ' 148' ' ' ALA . 0.0 OUTLIER -84.99 -146.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.11 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' B' ' 149' ' ' ASN . 0.0 OUTLIER -48.59 155.09 0.58 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.256 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . 0.576 ' O ' HG22 ' E' ' 52' ' ' VAL . 32.5 p -86.79 -11.91 49.58 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.971 0.415 . . . . 0.0 111.496 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.41 114.13 5.19 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.952 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.601 ' HA ' ' HB3' ' E' ' 50' ' ' SER . . . -83.45 22.24 1.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.907 0.384 . . . . 0.0 111.653 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.26 21.98 1.2 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.679 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.65 -32.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.024 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' SER . . . . . 0.663 ' HA ' ' HB3' ' B' ' 147' ' ' ALA . 15.9 t -65.08 166.68 9.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.791 0.329 . . . . 0.0 110.666 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . 0.465 ' O ' HD13 ' B' ' 88' ' ' LEU . . . -89.64 163.46 15.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.875 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.4 169.65 17.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.322 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 57.36 29.36 16.76 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.349 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . 0.575 ' HB ' ' HB1' ' B' ' 143' ' ' ALA . 7.2 p -156.42 150.54 10.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.794 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . 0.696 ' HA3' ' HB ' ' B' ' 85' ' ' VAL . . . -164.17 176.95 40.07 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.541 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.608 HG22 ' CE1' ' B' ' 137' ' ' TYR . 3.0 t -107.63 111.32 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 123.038 0.535 . . . . 0.0 111.666 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.642 ' HG2' ' HB3' ' B' ' 84' ' ' ASN . 0.0 OUTLIER -75.99 179.75 5.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.955 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' B' ' 113' ' ' LEU . 6.0 pt -150.34 116.59 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.474 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' B' ' 134' ' ' GLN . 12.8 tp -97.31 122.61 40.54 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.765 0.317 . . . . 0.0 110.967 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.88 150.13 42.68 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.639 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . 0.512 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -71.5 -17.55 62.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.763 0.316 . . . . 0.0 111.098 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.436 HG21 ' HA ' ' B' ' 120' ' ' SER . 75.8 p -76.64 -37.29 56.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.081 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.55 -68.72 0.32 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.689 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.67 123.26 18.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.831 0.348 . . . . 0.0 111.1 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.77 117.98 2.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.18 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.515 HD11 ' O ' ' B' ' 117' ' ' THR . 2.1 tp -67.82 144.1 55.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.417 0.627 . . . . 0.0 110.494 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.427 ' HA ' ' ND2' ' B' ' 84' ' ' ASN . 0.2 OUTLIER -75.14 140.51 43.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.079 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.628 HD11 ' HA3' ' B' ' 75' ' ' GLY . 1.3 tp -85.2 97.75 10.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.693 0.282 . . . . 0.0 110.619 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -152.83 -58.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.584 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . 0.555 ' HA3' ' OG1' ' E' ' 130' ' ' THR . . . 135.73 -26.58 3.15 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.632 -0.795 . . . . 0.0 112.67 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . 0.751 ' HB2' ' HA ' ' E' ' 129' ' ' ASN . . . -101.35 28.81 5.16 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.998 0.427 . . . . 0.0 111.641 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . 0.515 ' O ' HD11 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -106.57 67.28 0.72 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.059 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.42 81.02 8.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.803 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.06 97.47 3.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.794 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.436 ' HA ' HG21 ' B' ' 107' ' ' THR . 1.9 t -165.61 144.79 6.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.546 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.34 50.36 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.139 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.79 94.18 5.73 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.676 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.73 110.31 12.46 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.723 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.604 ' HG ' ' ND2' ' B' ' 129' ' ' ASN . 0.3 OUTLIER -70.13 154.09 42.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.657 179.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -131.51 144.76 51.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.629 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.71 125.64 24.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.688 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.09 -102.06 1.11 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.734 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 86.9 m -106.16 128.48 53.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.633 0.254 . . . . 0.0 110.859 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . 0.604 ' ND2' ' HG ' ' B' ' 124' ' ' LEU . 20.1 t-20 -121.14 158.18 28.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.896 0.379 . . . . 0.0 111.126 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.472 ' CG2' HD22 ' B' ' 55' ' ' ASN . 0.2 OUTLIER -155.82 143.08 19.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.982 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' ILE . . . . . 0.598 HD13 HG11 ' B' ' 156' ' ' VAL . 0.1 OUTLIER -115.16 110.64 45.43 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' PRO . . . . . 0.512 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -82.14 151.83 16.1 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.609 1.539 . . . . 0.0 112.553 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.01 146.76 17.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.852 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' B' ' 104' ' ' LEU . 0.8 OUTLIER -114.28 145.9 41.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.088 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.89 91.13 1.9 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.913 0.387 . . . . 0.0 111.686 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . 0.566 ' HE ' HG21 ' B' ' 48' ' ' THR . 28.1 mtm-85 -88.33 153.59 21.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.374 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . 0.608 ' CE1' HG22 ' B' ' 101' ' ' VAL . 0.7 OUTLIER -91.24 111.01 22.31 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.129 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . 0.608 ' CD1' ' HB2' ' B' ' 102' ' ' GLN . 8.8 m-85 -108.08 172.17 6.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.029 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -123.43 143.68 49.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.862 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' THR . . . . . 0.889 HG21 ' CB ' ' B' ' 79' ' ' ASP . 0.2 OUTLIER -98.81 44.36 1.03 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.47 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.57 89.08 1.08 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.929 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' B' ' 43' ' ' ALA . . . 59.94 88.1 0.08 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.745 0.272 . . . . 0.0 110.777 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' ALA . . . . . 0.575 ' HB1' ' HB ' ' B' ' 99' ' ' VAL . . . -70.63 161.7 30.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.815 0.34 . . . . 0.0 111.379 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.635 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -124.48 158.73 60.64 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.213 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . 0.511 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 1.4 Cg_endo -83.81 149.22 12.49 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.502 2.135 . . . . 0.0 112.057 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.69 -119.78 0.86 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.483 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.663 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -123.95 127.67 48.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.874 0.369 . . . . 0.0 111.413 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' ALA . . . . . 0.69 ' HA ' ' HB3' ' B' ' 88' ' ' LEU . . . -120.8 67.16 0.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.428 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' B' ' 89' ' ' GLN . 47.5 t-20 -128.45 114.75 17.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.637 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.429 ' HB2' ' C ' ' B' ' 88' ' ' LEU . . . -158.77 147.05 18.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.034 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.45 140.3 32.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.121 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 9' ' ' THR . . . -136.19 169.31 17.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.208 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.457 ' O ' ' HB3' ' B' ' 74' ' ' LEU . 9.4 t -155.13 150.49 27.19 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' PHE . . . . . 0.439 ' HE1' HG13 ' B' ' 56' ' ' ILE . 1.1 p90 -119.03 149.21 42.05 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.024 0.44 . . . . 0.0 110.107 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . 0.447 ' HE3' HD13 ' B' ' 74' ' ' LEU . 4.7 mttt -113.42 156.56 23.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.914 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' VAL . . . . . 0.598 HG11 HD13 ' B' ' 131' ' ' ILE . 0.2 OUTLIER -136.43 138.02 47.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.699 -179.116 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.607 ' HB2' HG22 ' A' ' 4' ' ' THR . 64.1 tt0 -107.46 128.02 54.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.285 0.564 . . . . 0.0 110.369 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' TYR . . . . . 0.589 ' HB2' ' OG1' ' A' ' 3' ' ' THR . 60.9 m-85 -107.81 107.37 18.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.519 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.891 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.272 0.082 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . 0.71 ' H ' ' HA ' ' D' ' 159' ' ' GLN . . . 65.93 74.7 0.36 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.529 0.204 . . . . 0.0 110.929 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' D' ' 158' ' ' TYR . 6.0 p -117.74 97.5 5.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.479 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 4' ' ' THR . . . . . 0.629 HG22 ' HB2' ' D' ' 157' ' ' GLN . 67.8 p -87.92 108.74 19.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.529 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.61 172.71 13.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.571 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.15 110.76 12.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.567 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.73 -59.37 7.71 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.792 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.5 151.71 15.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.827 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . 0.5 HG23 ' O ' ' D' ' 152' ' ' ALA . 24.1 m -103.48 143.11 33.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.855 0.36 . . . . 0.0 111.313 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.44 HG12 ' HG3' ' D' ' 30' ' ' GLN . 1.1 m -130.97 115.65 30.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.134 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -83.62 105.72 14.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.367 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' PHE . . . . . 0.456 ' HD2' HD21 ' D' ' 34' ' ' LEU . 52.2 m-85 -83.19 105.46 14.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.756 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.39 145.06 41.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.422 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.71 -179.68 42.56 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.974 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.23 134.27 22.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.971 0.415 . . . . 0.0 110.358 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.634 HG11 ' O ' ' D' ' 144' ' ' THR . 3.3 t -90.92 127.11 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.238 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' C' ' 20' ' ' ALA . 12.1 m -126.23 168.82 18.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.831 0.348 . . . . 0.0 111.022 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.53 81.88 2.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.046 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . 0.445 ' HA ' ' HG2' ' D' ' 38' ' ' ARG . . . 53.27 58.24 5.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.015 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . 0.525 ' HB3' HG21 ' C' ' 17' ' ' VAL . . . -108.61 -62.8 1.41 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.385 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.9 OUTLIER -171.57 -159.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.957 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . 0.625 ' HA ' ' HB2' ' D' ' 36' ' ' GLN . . . -156.88 74.0 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.059 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . 0.47 ' N ' HD23 ' C' ' 58' ' ' LEU . 7.4 p -45.3 140.56 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.061 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.554 ' O ' HG23 ' C' ' 28' ' ' VAL . 0.5 OUTLIER -63.45 140.79 58.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.615 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.43 -51.16 69.43 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.287 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.03 -18.04 74.23 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.966 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -88.0 -6.27 58.07 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.807 0.337 . . . . 0.0 110.794 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.554 HG23 ' O ' ' C' ' 24' ' ' ASP . 50.7 t -72.74 -36.43 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.332 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.94 110.92 14.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.95 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' GLN . . . . . 0.438 ' HG3' HG12 ' B' ' 10' ' ' VAL . 0.4 OUTLIER -123.86 146.05 48.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.987 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.18 113.84 27.68 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.113 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.625 HG11 HG11 ' C' ' 52' ' ' VAL . 3.3 t -105.13 121.92 57.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 110.404 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.85 106.42 17.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.641 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.45 HD21 ' HD2' ' B' ' 12' ' ' PHE . 0.6 OUTLIER -64.79 -44.73 89.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.555 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.61 -156.8 16.03 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.6 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . 0.64 ' HB2' ' HA ' ' B' ' 22' ' ' ALA . 3.7 mt-30 -91.09 106.93 18.86 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.663 0.268 . . . . 0.0 110.922 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.578 ' CG1' HD21 ' C' ' 42' ' ' LEU . 4.3 t -92.28 120.51 41.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.94 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' B' ' 19' ' ' ALA . 4.6 mtm105 -85.59 132.49 34.17 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.759 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.436 HG23 ' O ' ' B' ' 17' ' ' VAL . 29.1 p -71.48 -23.34 61.79 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.768 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' B' ' 19' ' ' ALA . . . -67.93 -19.2 64.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.935 0.397 . . . . 0.0 110.817 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 13.8 t -90.61 -36.56 14.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.159 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.591 ' HB2' ' HB2' ' C' ' 139' ' ' ALA . 0.2 OUTLIER -121.45 70.55 0.94 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.623 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' C' ' 142' ' ' ALA . . . -104.79 28.16 7.37 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.379 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . 0.752 ' HG3' ' HB2' ' C' ' 47' ' ' ALA . 0.0 OUTLIER -150.62 141.93 23.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.402 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . 0.449 ' HG3' ' HA ' ' C' ' 140' ' ' THR . 2.7 tt0 -62.62 101.78 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.764 0.316 . . . . 0.0 111.133 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.24 4.25 8.46 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.094 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.752 ' HB2' ' HG3' ' C' ' 44' ' ' GLN . . . -91.73 121.33 33.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.942 0.401 . . . . 0.0 112.016 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' C' ' 137' ' ' TYR . 5.8 t -110.41 151.16 27.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.815 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -95.66 -57.68 2.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.544 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.2 -174.88 4.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.87 0.367 . . . . 0.0 110.8 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . 0.475 ' HB2' ' CD ' ' C' ' 136' ' ' ARG . . . -127.06 143.82 51.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.395 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.625 HG11 HG11 ' C' ' 32' ' ' VAL . 48.3 t -120.85 116.85 51.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.006 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.16 122.61 6.19 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.685 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -128.58 138.82 52.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 111.022 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.483 HD22 ' CG2' ' C' ' 130' ' ' THR . 1.6 m120 -117.8 150.98 38.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.621 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.589 ' HB ' HG13 ' C' ' 131' ' ' ILE . 9.2 mm -106.83 103.64 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.617 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -61.07 132.25 53.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.751 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . 0.763 ' HB3' ' SG ' ' C' ' 21' ' ' CYS . 1.0 OUTLIER -137.44 151.81 48.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.244 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -138.35 171.39 14.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.962 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' C' ' 21' ' ' CYS . 5.9 m-20 49.97 68.51 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.791 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 0.0 OUTLIER -106.62 141.07 38.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.794 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.79 117.83 33.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.254 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 23.5 p -91.13 -13.1 33.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.58 -39.02 82.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.14 0.495 . . . . 0.0 111.76 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 75.8 t -107.63 -54.15 6.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.627 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.7 84.38 3.37 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.596 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.02 -41.27 10.08 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.911 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.69 159.98 17.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.459 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.71 160.38 39.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.612 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.01 153.01 44.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.18 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.95 136.46 54.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.73 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.95 107.4 5.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.618 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' PHE . . . . . 0.468 ' CD2' HD13 ' C' ' 103' ' ' ILE . 43.0 t80 -73.57 136.68 44.02 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.502 0.191 . . . . 0.0 111.082 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' C' ' 153' ' ' THR . 6.6 tt -113.6 111.4 21.81 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.003 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . 0.64 ' HA3' HD11 ' C' ' 113' ' ' LEU . . . -131.35 -178.54 15.53 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.765 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.665 ' H ' HD12 ' C' ' 86' ' ' LEU . 0.2 OUTLIER -104.28 137.55 42.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.5 0.191 . . . . 0.0 110.878 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.93 114.81 23.88 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.997 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . 0.613 ' O ' ' HG2' ' F' ' 134' ' ' GLN . 1.2 tt -95.75 -36.72 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' ASP . . . . . 0.902 ' CB ' HG21 ' C' ' 140' ' ' THR . 0.4 OUTLIER -143.39 130.28 20.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.722 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.95 -7.2 47.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.97 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.3 -29.18 68.28 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.637 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.31 -32.73 4.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.903 0.382 . . . . 0.0 110.432 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . 0.421 ' O ' HG22 ' C' ' 83' ' ' THR . 3.5 m 60.59 19.41 9.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.574 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' ASN . . . . . 0.638 ' HB3' ' HG2' ' C' ' 102' ' ' GLN . 0.6 OUTLIER -139.39 -16.94 1.03 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.314 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.691 ' HB ' ' HA3' ' C' ' 100' ' ' GLY . 0.8 OUTLIER -66.71 118.08 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.172 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.665 HD12 ' H ' ' C' ' 76' ' ' THR . 10.7 tp -69.79 144.14 52.75 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.27 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.455 ' HB3' ' OG1' ' C' ' 76' ' ' THR . . . -80.07 138.0 36.89 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.777 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.691 ' HB3' ' HA ' ' C' ' 148' ' ' ALA . 0.0 OUTLIER -84.99 -146.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.068 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' C' ' 149' ' ' ASN . 0.0 OUTLIER -48.48 155.02 0.57 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.312 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' SER . . . . . 0.577 ' O ' HG22 ' F' ' 52' ' ' VAL . 33.1 p -86.79 -11.87 49.7 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.991 0.424 . . . . 0.0 111.489 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.42 114.08 5.16 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' ALA . . . . . 0.597 ' HA ' ' HB3' ' F' ' 50' ' ' SER . . . -83.38 22.25 1.05 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.919 0.39 . . . . 0.0 111.728 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.28 21.98 1.2 Allowed 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.699 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.75 -32.23 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.974 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' SER . . . . . 0.661 ' HA ' ' HB3' ' C' ' 147' ' ' ALA . 16.0 t -65.15 166.71 9.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.805 0.336 . . . . 0.0 110.682 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' ALA . . . . . 0.452 ' O ' HD13 ' C' ' 88' ' ' LEU . . . -89.64 163.46 15.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.892 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.37 169.63 17.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.347 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 57.35 29.36 16.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.378 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 99' ' ' VAL . . . . . 0.564 ' HB ' ' HB1' ' C' ' 143' ' ' ALA . 7.2 p -156.35 150.57 10.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.839 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . 0.691 ' HA3' ' HB ' ' C' ' 85' ' ' VAL . . . -164.19 176.93 40.08 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.584 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' VAL . . . . . 0.615 HG22 ' CE1' ' C' ' 137' ' ' TYR . 3.0 t -107.6 111.29 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.06 0.544 . . . . 0.0 111.74 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 102' ' ' GLN . . . . . 0.638 ' HG2' ' HB3' ' C' ' 84' ' ' ASN . 0.0 OUTLIER -75.98 179.73 5.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.979 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' C' ' 113' ' ' LEU . 6.0 pt -150.35 116.62 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.418 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' C' ' 134' ' ' GLN . 12.8 tp -97.23 122.55 40.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.676 0.274 . . . . 0.0 111.015 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.96 150.07 43.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.718 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 106' ' ' ARG . . . . . 0.529 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -71.47 -17.56 62.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.793 0.33 . . . . 0.0 111.087 179.559 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 107' ' ' THR . . . . . 0.44 HG21 ' HA ' ' C' ' 120' ' ' SER . 74.3 p -76.52 -37.29 56.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.152 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.55 -68.74 0.32 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.705 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.69 123.27 18.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.811 0.339 . . . . 0.0 111.14 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.66 117.98 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 111' ' ' LEU . . . . . 0.522 HD11 ' O ' ' C' ' 117' ' ' THR . 2.1 tp -67.83 144.06 55.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.473 0.654 . . . . 0.0 110.502 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 112' ' ' THR . . . . . 0.435 ' HA ' ' ND2' ' C' ' 84' ' ' ASN . 0.2 OUTLIER -75.08 140.43 43.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.127 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.64 HD11 ' HA3' ' C' ' 75' ' ' GLY . 1.3 tp -85.18 97.75 10.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 110.62 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -152.79 -59.03 0.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.68 0.276 . . . . 0.0 111.555 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . 0.57 ' HA3' ' OG1' ' F' ' 130' ' ' THR . . . 135.77 -26.63 3.14 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.577 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 116' ' ' ALA . . . . . 0.748 ' HB2' ' HA ' ' F' ' 129' ' ' ASN . . . -101.36 28.78 5.19 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.055 0.455 . . . . 0.0 111.656 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . 0.522 ' O ' HD11 ' C' ' 111' ' ' LEU . 0.2 OUTLIER -106.56 67.31 0.72 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.05 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.38 80.96 8.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.77 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.96 97.46 3.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 120' ' ' SER . . . . . 0.44 ' HA ' HG21 ' C' ' 107' ' ' THR . 2.0 t -165.59 144.83 6.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.6 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.34 50.4 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.144 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.88 94.11 5.78 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.685 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.73 110.4 12.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.729 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . 0.607 ' HG ' ' ND2' ' C' ' 129' ' ' ASN . 0.3 OUTLIER -70.13 154.13 42.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.65 179.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -131.58 144.73 51.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.623 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.77 125.66 24.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.663 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.1 -102.02 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.715 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 86.4 m -106.23 128.55 54.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.652 0.263 . . . . 0.0 110.786 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 129' ' ' ASN . . . . . 0.607 ' ND2' ' HG ' ' C' ' 124' ' ' LEU . 20.1 t-20 -121.19 158.14 28.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.902 0.382 . . . . 0.0 111.116 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 130' ' ' THR . . . . . 0.483 ' CG2' HD22 ' C' ' 55' ' ' ASN . 0.2 OUTLIER -155.79 143.09 19.3 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.986 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 131' ' ' ILE . . . . . 0.601 HD13 HG11 ' C' ' 156' ' ' VAL . 0.1 OUTLIER -115.22 110.73 45.2 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 132' ' ' PRO . . . . . 0.529 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.5 Cg_endo -82.1 151.77 16.18 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.632 1.554 . . . . 0.0 112.573 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.02 146.79 17.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 134' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' C' ' 104' ' ' LEU . 0.8 OUTLIER -114.4 145.8 41.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.088 179.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.76 91.22 1.92 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 111.674 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.58 ' HE ' HG21 ' C' ' 48' ' ' THR . 28.0 mtm-85 -88.33 153.55 21.11 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.345 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 137' ' ' TYR . . . . . 0.615 ' CE1' HG22 ' C' ' 101' ' ' VAL . 0.7 OUTLIER -91.22 111.04 22.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.103 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 138' ' ' PHE . . . . . 0.596 ' CD1' ' HB2' ' C' ' 102' ' ' GLN . 8.8 m-85 -108.13 172.21 6.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.939 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 139' ' ' ALA . . . . . 0.591 ' HB2' ' HB2' ' C' ' 42' ' ' LEU . . . -123.45 143.6 50.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.87 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 140' ' ' THR . . . . . 0.902 HG21 ' CB ' ' C' ' 79' ' ' ASP . 0.2 OUTLIER -98.71 44.47 1.03 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.529 179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.5 89.06 1.07 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.936 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 142' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' C' ' 43' ' ' ALA . . . 60.02 88.09 0.08 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.7 0.25 . . . . 0.0 110.693 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 143' ' ' ALA . . . . . 0.564 ' HB1' ' HB ' ' C' ' 99' ' ' VAL . . . -70.64 161.75 30.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.775 0.321 . . . . 0.0 111.444 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 144' ' ' THR . . . . . 0.635 ' O ' HG11 ' B' ' 16' ' ' VAL . 0.2 OUTLIER -124.49 158.71 60.73 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.191 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 145' ' ' PRO . . . . . 0.53 ' HA ' ' HB ' ' B' ' 16' ' ' VAL . 1.5 Cg_endo -83.72 149.25 12.63 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.501 2.134 . . . . 0.0 112.072 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.7 -119.76 0.86 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.52 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 147' ' ' ALA . . . . . 0.661 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -123.91 127.71 48.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.828 0.346 . . . . 0.0 111.418 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 148' ' ' ALA . . . . . 0.691 ' HA ' ' HB3' ' C' ' 88' ' ' LEU . . . -120.83 67.19 0.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.41 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 149' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' C' ' 89' ' ' GLN . 47.3 t-20 -128.49 114.78 17.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.599 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 150' ' ' ALA . . . . . 0.425 ' HB2' ' C ' ' C' ' 88' ' ' LEU . . . -158.87 146.93 18.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.0 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.33 140.31 32.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.148 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 152' ' ' ALA . . . . . 0.513 ' O ' HG23 ' B' ' 9' ' ' THR . . . -136.26 169.23 17.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.18 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' C' ' 74' ' ' LEU . 9.3 t -155.09 150.54 27.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 154' ' ' PHE . . . . . 0.427 ' HE1' HG13 ' C' ' 56' ' ' ILE . 1.1 p90 -119.05 149.21 42.05 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.077 0.465 . . . . 0.0 110.075 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 155' ' ' LYS . . . . . 0.42 ' HE3' HD13 ' C' ' 74' ' ' LEU . 4.7 mttt -113.48 156.64 23.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.908 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 156' ' ' VAL . . . . . 0.601 HG11 HD13 ' C' ' 131' ' ' ILE . 0.2 OUTLIER -136.45 138.03 47.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.663 -179.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 157' ' ' GLN . . . . . 0.606 ' HB2' HG22 ' B' ' 4' ' ' THR . 64.1 tt0 -107.5 128.05 54.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.363 0.601 . . . . 0.0 110.365 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 158' ' ' TYR . . . . . 0.6 ' HB2' ' OG1' ' B' ' 3' ' ' THR . 60.9 m-85 -107.85 107.46 18.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.541 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . 0.727 ' HA ' ' H ' ' B' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.884 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.312 0.101 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . 0.714 ' H ' ' HA ' ' E' ' 159' ' ' GLN . . . 65.87 74.72 0.36 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.937 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 3' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' E' ' 158' ' ' TYR . 6.2 p -117.71 97.48 5.88 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.489 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . 0.62 HG22 ' HB2' ' E' ' 157' ' ' GLN . 68.1 p -87.87 108.72 19.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.559 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.401 HG11 HG12 ' E' ' 17' ' ' VAL . 15.3 m -126.63 172.74 13.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.612 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.13 110.81 12.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.566 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 7' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' E' ' 155' ' ' LYS . . . -65.67 -59.51 7.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.747 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.52 151.68 14.92 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.809 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . 0.507 HG23 ' O ' ' E' ' 152' ' ' ALA . 24.2 m -103.45 143.08 33.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 111.319 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' VAL . . . . . 0.426 HG12 ' HG3' ' E' ' 30' ' ' GLN . 1.1 m -130.93 115.63 30.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.182 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.63 105.67 14.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.392 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' PHE . . . . . 0.445 ' HD2' HD21 ' E' ' 34' ' ' LEU . 52.0 m-85 -83.21 105.47 14.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.8 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.41 145.13 41.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.452 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.74 -179.67 42.58 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.98 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.26 134.2 22.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.937 0.399 . . . . 0.0 110.406 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.625 HG11 ' O ' ' E' ' 144' ' ' THR . 3.3 t -90.9 127.2 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.174 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' D' ' 20' ' ' ALA . 12.1 m -126.31 168.78 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.929 0.395 . . . . 0.0 111.025 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.49 81.85 2.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.092 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' ALA . . . . . 0.447 ' HA ' ' HG2' ' E' ' 38' ' ' ARG . . . 53.31 58.19 5.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.057 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.543 ' HB3' HG21 ' D' ' 17' ' ' VAL . . . -108.6 -62.83 1.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.36 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' CYS . . . . . 0.872 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.9 OUTLIER -171.53 -159.88 0.16 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . 0.635 ' HA ' ' HB2' ' E' ' 36' ' ' GLN . . . -156.86 74.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.098 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . 0.465 ' N ' HD23 ' D' ' 58' ' ' LEU . 7.4 p -45.36 140.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.081 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.555 ' O ' HG23 ' D' ' 28' ' ' VAL . 0.5 OUTLIER -63.49 140.79 58.91 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.656 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.4 -51.14 69.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.302 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.11 -17.98 74.33 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.937 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.96 -6.42 58.03 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.859 0.362 . . . . 0.0 110.818 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . 0.555 HG23 ' O ' ' D' ' 24' ' ' ASP . 50.5 t -72.7 -36.36 52.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.364 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.0 110.88 14.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.008 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' GLN . . . . . 0.44 ' HG3' HG12 ' C' ' 10' ' ' VAL . 0.4 OUTLIER -123.76 146.07 48.57 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.977 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.25 113.83 27.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.084 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.612 HG11 HG11 ' D' ' 52' ' ' VAL . 3.3 t -105.15 121.91 57.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.149 0.499 . . . . 0.0 110.433 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.84 106.37 17.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.669 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.456 HD21 ' HD2' ' C' ' 12' ' ' PHE . 0.6 OUTLIER -64.73 -44.74 89.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.595 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.6 -156.91 15.99 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.54 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' GLN . . . . . 0.625 ' HB2' ' HA ' ' C' ' 22' ' ' ALA . 3.7 mt-30 -91.06 106.95 18.88 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.656 0.265 . . . . 0.0 110.899 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.574 ' CG1' HD21 ' D' ' 42' ' ' LEU . 4.4 t -92.29 120.63 41.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.839 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . 0.445 ' HG2' ' HA ' ' C' ' 19' ' ' ALA . 4.6 mtm105 -85.68 132.46 34.14 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.742 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.425 HG23 ' O ' ' C' ' 17' ' ' VAL . 29.5 p -71.5 -23.23 61.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.753 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.443 ' CB ' ' HB2' ' C' ' 19' ' ' ALA . . . -68.13 -19.07 64.79 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.974 0.416 . . . . 0.0 110.823 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -90.59 -36.65 14.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.16 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' D' ' 139' ' ' ALA . 0.2 OUTLIER -121.44 70.62 0.94 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.555 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' D' ' 142' ' ' ALA . . . -104.79 28.18 7.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.392 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' GLN . . . . . 0.77 ' HG3' ' HB2' ' D' ' 47' ' ' ALA . 0.0 OUTLIER -150.59 141.92 23.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.437 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' D' ' 140' ' ' THR . 2.7 tt0 -62.69 101.78 0.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.819 0.342 . . . . 0.0 111.145 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.29 4.23 8.43 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.115 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.77 ' HB2' ' HG3' ' D' ' 44' ' ' GLN . . . -91.67 121.28 33.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.932 0.396 . . . . 0.0 112.03 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' D' ' 137' ' ' TYR . 5.9 t -110.42 151.18 27.8 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.826 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 5.1 t -95.62 -57.59 2.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.632 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.589 ' HB3' ' HA ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -148.23 -174.85 4.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.875 0.369 . . . . 0.0 110.756 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' ALA . . . . . 0.482 ' HB2' ' CD ' ' D' ' 136' ' ' ARG . . . -127.11 143.86 51.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.352 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' VAL . . . . . 0.612 HG11 HG11 ' D' ' 32' ' ' VAL . 48.2 t -120.84 116.86 51.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.974 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . 0.414 ' O ' HG21 ' A' ' 76' ' ' THR . . . -111.15 122.67 6.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.699 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -128.63 138.84 52.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.812 0.339 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' ASN . . . . . 0.479 HD22 ' CG2' ' D' ' 130' ' ' THR . 1.6 m120 -117.86 150.99 38.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.585 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.575 ' HB ' HG13 ' D' ' 131' ' ' ILE . 9.3 mm -106.86 103.77 15.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.547 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.11 132.28 53.23 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.788 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . 0.752 ' HB3' ' SG ' ' D' ' 21' ' ' CYS . 1.0 OUTLIER -137.49 151.81 48.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.205 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -138.32 171.36 14.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.977 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' D' ' 21' ' ' CYS . 5.9 m-20 50.0 68.55 0.73 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.743 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' CYS . . . . . 0.872 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 0.0 OUTLIER -106.67 141.11 38.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.792 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.78 117.83 33.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.254 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 23.4 p -91.21 -13.04 33.55 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -38.98 82.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.081 0.467 . . . . 0.0 111.707 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 75.8 t -107.67 -54.11 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.64 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.69 84.32 3.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.576 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.05 -41.23 10.08 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.955 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.57 159.99 17.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.517 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.7 160.4 39.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.586 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.07 152.94 45.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.157 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.9 136.55 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.699 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.04 107.46 5.03 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.565 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 73' ' ' PHE . . . . . 0.474 ' CD2' HD13 ' D' ' 103' ' ' ILE . 42.9 t80 -73.62 136.61 43.92 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.532 0.206 . . . . 0.0 111.06 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 74' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' D' ' 153' ' ' THR . 6.6 tt -113.55 111.39 21.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.006 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . 0.628 ' HA3' HD11 ' D' ' 113' ' ' LEU . . . -131.26 -178.5 15.5 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.883 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . 0.664 ' H ' HD12 ' D' ' 86' ' ' LEU . 0.2 OUTLIER -104.37 137.54 42.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.493 0.187 . . . . 0.0 110.825 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.96 114.74 23.84 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.961 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.74 -36.78 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.842 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.9 ' CB ' HG21 ' D' ' 140' ' ' THR . 0.4 OUTLIER -143.32 130.19 20.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.8 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.83 -7.28 47.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.991 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.37 -29.14 68.38 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.557 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.33 -32.61 4.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.482 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 83' ' ' THR . . . . . 0.428 ' O ' HG22 ' D' ' 83' ' ' THR . 3.5 m 60.47 19.43 9.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.58 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . 0.614 ' HB3' ' HG2' ' D' ' 102' ' ' GLN . 0.6 OUTLIER -139.31 -16.94 1.04 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.409 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.699 ' HB ' ' HA3' ' D' ' 100' ' ' GLY . 0.9 OUTLIER -66.77 118.03 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.206 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.664 HD12 ' H ' ' D' ' 76' ' ' THR . 10.7 tp -69.7 144.13 52.91 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.275 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.454 ' HB3' ' OG1' ' D' ' 76' ' ' THR . . . -80.14 138.06 36.84 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.892 0.377 . . . . 0.0 111.71 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.698 ' HB3' ' HA ' ' D' ' 148' ' ' ALA . 0.0 OUTLIER -84.96 -146.62 0.1 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.079 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 89' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' D' ' 149' ' ' ASN . 0.0 OUTLIER -48.48 155.03 0.57 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.293 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 32.4 p -86.77 -11.91 49.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.533 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 8.2 t -66.43 114.15 5.22 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.34 22.09 1.07 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.932 0.396 . . . . 0.0 111.706 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.2 21.97 1.21 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.73 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.7 -32.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.957 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 95' ' ' SER . . . . . 0.659 ' HA ' ' HB3' ' D' ' 147' ' ' ALA . 15.8 t -65.16 166.64 9.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 110.654 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 96' ' ' ALA . . . . . 0.466 ' O ' HD13 ' D' ' 88' ' ' LEU . . . -89.59 163.53 15.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.827 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.45 169.7 17.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.276 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 98' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 57.26 29.42 16.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.38 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 99' ' ' VAL . . . . . 0.553 ' HB ' ' HB1' ' D' ' 143' ' ' ALA . 7.1 p -156.39 150.54 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 100' ' ' GLY . . . . . 0.699 ' HA3' ' HB ' ' D' ' 85' ' ' VAL . . . -164.14 176.95 40.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.587 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 101' ' ' VAL . . . . . 0.614 HG22 ' CE1' ' D' ' 137' ' ' TYR . 3.0 t -107.62 111.32 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 123.078 0.551 . . . . 0.0 111.663 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 102' ' ' GLN . . . . . 0.614 ' HG2' ' HB3' ' D' ' 84' ' ' ASN . 0.0 OUTLIER -76.0 179.72 5.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.942 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 103' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' D' ' 113' ' ' LEU . 6.0 pt -150.33 116.56 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.43 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 104' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' D' ' 134' ' ' GLN . 12.8 tp -97.21 122.55 40.36 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 111.068 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.91 150.11 42.86 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.65 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 106' ' ' ARG . . . . . 0.509 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -71.5 -17.54 62.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.846 0.355 . . . . 0.0 111.102 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 107' ' ' THR . . . . . 0.426 HG21 ' HA ' ' D' ' 120' ' ' SER . 76.1 p -76.62 -37.29 56.62 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.111 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.57 -68.74 0.32 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.677 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.55 123.17 18.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.772 0.32 . . . . 0.0 111.191 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.79 118.0 2.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.939 0.4 . . . . 0.0 111.15 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 111' ' ' LEU . . . . . 0.506 HD11 ' O ' ' D' ' 117' ' ' THR . 2.1 tp -67.88 144.09 55.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.43 0.633 . . . . 0.0 110.46 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 112' ' ' THR . . . . . 0.433 ' HA ' ' ND2' ' D' ' 84' ' ' ASN . 0.2 OUTLIER -75.15 140.46 43.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.095 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 113' ' ' LEU . . . . . 0.628 HD11 ' HA3' ' D' ' 75' ' ' GLY . 1.3 tp -85.15 97.78 10.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.748 0.308 . . . . 0.0 110.596 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -152.83 -59.07 0.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.65 0.262 . . . . 0.0 111.494 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.77 -26.61 3.14 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.552 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.34 28.82 5.15 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.045 0.45 . . . . 0.0 111.676 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 117' ' ' THR . . . . . 0.506 ' O ' HD11 ' D' ' 111' ' ' LEU . 0.2 OUTLIER -106.57 67.38 0.72 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.03 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.43 80.89 8.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.739 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.95 97.55 3.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.881 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 120' ' ' SER . . . . . 0.426 ' HA ' HG21 ' D' ' 107' ' ' THR . 2.0 t -165.66 144.79 6.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.531 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.32 50.34 0.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.204 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.81 94.11 5.73 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.714 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.69 110.26 12.38 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.69 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . 0.602 ' HG ' ' ND2' ' D' ' 129' ' ' ASN . 0.3 OUTLIER -70.1 154.1 42.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.558 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.58 144.77 51.32 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.584 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.75 125.63 24.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.645 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.1 -101.99 1.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.701 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 128' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 86.6 m -106.25 128.5 54.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.662 0.267 . . . . 0.0 110.773 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 129' ' ' ASN . . . . . 0.731 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 20.1 t-20 -121.15 158.25 28.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.874 0.368 . . . . 0.0 111.109 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 130' ' ' THR . . . . . 0.556 ' OG1' ' HA3' ' A' ' 115' ' ' GLY . 0.2 OUTLIER -155.87 143.08 19.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.057 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 131' ' ' ILE . . . . . 0.603 HD13 HG11 ' D' ' 156' ' ' VAL . 0.1 OUTLIER -115.28 110.75 45.05 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 132' ' ' PRO . . . . . 0.509 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.4 Cg_endo -82.16 151.83 16.06 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.666 1.577 . . . . 0.0 112.499 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.07 146.72 17.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 134' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 78' ' ' ILE . 0.8 OUTLIER -114.36 145.92 41.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.031 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.85 91.09 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.41 . . . . 0.0 111.735 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 136' ' ' ARG . . . . . 0.565 ' HE ' HG21 ' D' ' 48' ' ' THR . 28.1 mtm-85 -88.32 153.52 21.13 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.443 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 137' ' ' TYR . . . . . 0.614 ' CE1' HG22 ' D' ' 101' ' ' VAL . 0.7 OUTLIER -91.1 110.96 22.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.173 179.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 138' ' ' PHE . . . . . 0.607 ' CD1' ' HB2' ' D' ' 102' ' ' GLN . 8.8 m-85 -108.08 172.16 6.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.253 0.549 . . . . 0.0 111.971 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 139' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' D' ' 42' ' ' LEU . . . -123.39 143.64 49.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.89 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 140' ' ' THR . . . . . 0.9 HG21 ' CB ' ' D' ' 79' ' ' ASP . 0.2 OUTLIER -98.78 44.46 1.03 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.514 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.54 88.97 1.08 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.966 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' D' ' 43' ' ' ALA . . . 60.08 88.04 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.745 0.273 . . . . 0.0 110.73 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 143' ' ' ALA . . . . . 0.553 ' HB1' ' HB ' ' D' ' 99' ' ' VAL . . . -70.59 161.73 30.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.784 0.326 . . . . 0.0 111.479 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 144' ' ' THR . . . . . 0.634 ' O ' HG11 ' C' ' 16' ' ' VAL . 0.2 OUTLIER -124.54 158.77 60.69 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.203 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 145' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' C' ' 16' ' ' VAL . 1.4 Cg_endo -83.83 149.22 12.47 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.491 2.127 . . . . 0.0 111.995 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.71 -119.75 0.86 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.519 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 147' ' ' ALA . . . . . 0.659 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -123.95 127.65 48.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.799 0.333 . . . . 0.0 111.452 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 148' ' ' ALA . . . . . 0.698 ' HA ' ' HB3' ' D' ' 88' ' ' LEU . . . -120.86 67.2 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.124 0.488 . . . . 0.0 110.376 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 149' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' D' ' 89' ' ' GLN . 47.5 t-20 -128.54 114.77 17.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.607 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 150' ' ' ALA . . . . . 0.432 ' HB2' ' C ' ' D' ' 88' ' ' LEU . . . -158.8 147.01 18.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.994 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.4 140.31 32.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.173 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 152' ' ' ALA . . . . . 0.5 ' O ' HG23 ' C' ' 9' ' ' THR . . . -136.2 169.29 17.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.183 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 153' ' ' THR . . . . . 0.467 ' O ' ' HB3' ' D' ' 74' ' ' LEU . 9.3 t -155.15 150.52 27.2 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 154' ' ' PHE . . . . . 0.441 ' HE1' HG13 ' D' ' 56' ' ' ILE . 1.1 p90 -119.06 149.25 41.98 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.066 0.46 . . . . 0.0 110.059 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 155' ' ' LYS . . . . . 0.432 ' HE3' HD13 ' D' ' 74' ' ' LEU . 4.7 mttt -113.48 156.67 23.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.924 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 156' ' ' VAL . . . . . 0.603 HG11 HD13 ' D' ' 131' ' ' ILE . 0.2 OUTLIER -136.49 138.04 47.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.627 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 157' ' ' GLN . . . . . 0.629 ' HB2' HG22 ' C' ' 4' ' ' THR . 64.1 tt0 -107.41 128.01 54.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.27 0.557 . . . . 0.0 110.37 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 158' ' ' TYR . . . . . 0.594 ' HB2' ' OG1' ' C' ' 3' ' ' THR . 61.0 m-85 -107.85 107.45 18.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.49 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 159' ' ' GLN . . . . . 0.71 ' HA ' ' H ' ' C' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 120.281 0.086 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' E' E ' 2' ' ' ALA . . . . . 0.718 ' H ' ' HA ' ' F' ' 159' ' ' GLN . . . 65.96 74.63 0.36 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.978 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 3' ' ' THR . . . . . 0.592 ' OG1' ' HB2' ' F' ' 158' ' ' TYR . 6.1 p -117.74 97.53 5.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.482 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 4' ' ' THR . . . . . 0.61 HG22 ' HB2' ' F' ' 157' ' ' GLN . 68.3 p -87.89 108.67 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.562 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.59 172.75 13.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.627 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.16 110.86 12.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.567 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 7' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' F' ' 155' ' ' LYS . . . -65.85 -59.37 7.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.737 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.59 151.7 14.91 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.804 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 9' ' ' THR . . . . . 0.511 HG23 ' O ' ' F' ' 152' ' ' ALA . 24.2 m -103.46 143.1 33.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.799 0.333 . . . . 0.0 111.316 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 10' ' ' VAL . . . . . 0.427 HG12 ' HG3' ' F' ' 30' ' ' GLN . 1.1 m -130.97 115.67 31.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.171 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.65 105.78 14.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.347 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 12' ' ' PHE . . . . . 0.437 ' HD2' HD21 ' F' ' 34' ' ' LEU . 52.3 m-85 -83.15 105.5 14.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.804 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.45 145.04 41.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.4 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.75 -179.59 42.63 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.942 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.27 134.21 22.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.913 0.387 . . . . 0.0 110.35 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 16' ' ' VAL . . . . . 0.637 HG11 ' O ' ' F' ' 144' ' ' THR . 3.3 t -90.93 127.11 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.232 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . 0.533 HG21 ' HB3' ' E' ' 20' ' ' ALA . 11.9 m -126.22 168.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.811 0.339 . . . . 0.0 111.08 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.43 81.78 2.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.133 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 19' ' ' ALA . . . . . 0.436 ' HA ' ' HG2' ' F' ' 38' ' ' ARG . . . 53.35 58.15 5.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.078 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.533 ' HB3' HG21 ' E' ' 17' ' ' VAL . . . -108.58 -62.8 1.41 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.44 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 21' ' ' CYS . . . . . 0.821 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.9 OUTLIER -171.54 -159.87 0.16 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.946 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 22' ' ' ALA . . . . . 0.631 ' HA ' ' HB2' ' F' ' 36' ' ' GLN . . . -156.86 74.05 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 23' ' ' VAL . . . . . 0.466 ' N ' HD23 ' E' ' 58' ' ' LEU . 7.4 p -45.38 140.6 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.06 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 24' ' ' ASP . . . . . 0.539 ' O ' HG23 ' E' ' 28' ' ' VAL . 0.5 OUTLIER -63.45 140.82 58.91 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.614 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.08 69.83 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.288 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.13 -17.97 74.36 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.939 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.99 -6.37 58.03 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.843 0.354 . . . . 0.0 110.757 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 28' ' ' VAL . . . . . 0.539 HG23 ' O ' ' E' ' 24' ' ' ASP . 50.5 t -72.7 -36.34 52.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.365 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.02 110.81 13.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.984 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 30' ' ' GLN . . . . . 0.426 ' HG3' HG12 ' D' ' 10' ' ' VAL . 0.4 OUTLIER -123.79 146.01 48.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.994 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.15 113.77 27.56 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.132 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.621 HG11 HG11 ' E' ' 52' ' ' VAL . 3.3 t -105.03 121.98 57.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.175 0.512 . . . . 0.0 110.398 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.95 106.44 17.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.623 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.445 HD21 ' HD2' ' D' ' 12' ' ' PHE . 0.6 OUTLIER -64.75 -44.73 89.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.643 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.53 -156.86 16.05 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.587 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 36' ' ' GLN . . . . . 0.635 ' HB2' ' HA ' ' D' ' 22' ' ' ALA . 3.7 mt-30 -91.11 106.93 18.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.656 0.265 . . . . 0.0 110.828 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.575 ' CG1' HD21 ' E' ' 42' ' ' LEU . 4.4 t -92.33 120.61 41.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.874 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . 0.447 ' HG2' ' HA ' ' D' ' 19' ' ' ALA . 4.5 mtm105 -85.65 132.49 34.15 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.756 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 39' ' ' THR . . . . . 0.433 HG23 ' O ' ' D' ' 17' ' ' VAL . 29.5 p -71.49 -23.37 61.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.733 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' D' ' 19' ' ' ALA . . . -68.0 -19.1 64.89 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.987 0.422 . . . . 0.0 110.842 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -90.61 -36.53 14.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.181 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.581 ' HB2' ' HB2' ' E' ' 139' ' ' ALA . 0.2 OUTLIER -121.47 70.58 0.94 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.621 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 43' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' E' ' 142' ' ' ALA . . . -104.74 28.17 7.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.49 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 44' ' ' GLN . . . . . 0.778 ' HG3' ' HB2' ' E' ' 47' ' ' ALA . 0.0 OUTLIER -150.57 141.95 23.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.469 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' E' ' 140' ' ' THR . 2.7 tt0 -62.74 101.81 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 111.111 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.33 4.22 8.41 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.121 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 47' ' ' ALA . . . . . 0.778 ' HB2' ' HG3' ' E' ' 44' ' ' GLN . . . -91.78 121.24 33.23 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.008 0.433 . . . . 0.0 111.966 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' E' ' 137' ' ' TYR . 5.9 t -110.35 151.18 27.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.868 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 5.1 t -95.59 -57.66 2.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.62 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 50' ' ' SER . . . . . 0.601 ' HB3' ' HA ' ' B' ' 92' ' ' ALA . 0.2 OUTLIER -148.31 -174.82 4.69 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.918 0.389 . . . . 0.0 110.739 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 51' ' ' ALA . . . . . 0.476 ' HB2' ' CD ' ' E' ' 136' ' ' ARG . . . -127.09 143.83 51.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.359 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 52' ' ' VAL . . . . . 0.621 HG11 HG11 ' E' ' 32' ' ' VAL . 48.3 t -120.85 116.81 51.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 53' ' ' GLY . . . . . 0.402 ' O ' HG21 ' B' ' 76' ' ' THR . . . -111.18 122.69 6.22 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.653 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -128.63 138.79 52.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 111.001 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 55' ' ' ASN . . . . . 0.474 HD22 ' CG2' ' E' ' 130' ' ' THR . 1.5 m120 -117.82 150.9 38.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.654 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 56' ' ' ILE . . . . . 0.588 ' HB ' HG13 ' E' ' 131' ' ' ILE . 9.2 mm -106.77 103.72 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.549 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 57' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.13 132.26 53.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.774 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . 0.761 ' HB3' ' SG ' ' E' ' 21' ' ' CYS . 1.0 OUTLIER -137.47 151.8 48.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.223 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -138.33 171.35 14.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.98 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 60' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' E' ' 21' ' ' CYS . 6.0 m-20 50.01 68.47 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.83 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 61' ' ' CYS . . . . . 0.821 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 0.0 OUTLIER -106.63 141.09 38.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.95 0.405 . . . . 0.0 110.722 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.74 117.79 33.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.288 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 23.4 p -91.11 -13.18 33.55 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.6 -38.85 82.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.071 0.462 . . . . 0.0 111.849 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 76.4 t -107.71 -54.14 6.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.612 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.72 84.3 3.35 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.581 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.98 -41.26 10.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.97 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.65 159.99 17.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.457 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.76 160.38 39.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.582 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.05 152.93 45.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.102 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.9 136.53 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.714 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.0 107.5 5.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.61 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 73' ' ' PHE . . . . . 0.479 ' CD2' HD13 ' E' ' 103' ' ' ILE . 43.2 t80 -73.7 136.72 43.77 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.569 0.224 . . . . 0.0 110.995 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 74' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' E' ' 153' ' ' THR . 6.6 tt -113.61 111.39 21.78 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.947 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . 0.632 ' HA3' HD11 ' E' ' 113' ' ' LEU . . . -131.29 -178.55 15.53 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.843 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 76' ' ' THR . . . . . 0.658 ' H ' HD12 ' E' ' 86' ' ' LEU . 0.2 OUTLIER -104.28 137.54 42.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.479 0.18 . . . . 0.0 110.837 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.97 114.81 23.91 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.021 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.77 -36.73 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.825 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 79' ' ' ASP . . . . . 0.889 ' CB ' HG21 ' E' ' 140' ' ' THR . 0.4 OUTLIER -143.36 130.21 20.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.756 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.89 -7.23 47.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.04 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.28 -29.25 68.38 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.606 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.34 -32.62 4.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 110.442 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 83' ' ' THR . . . . . 0.429 ' O ' HG22 ' E' ' 83' ' ' THR . 3.5 m 60.53 19.46 9.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.574 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 84' ' ' ASN . . . . . 0.619 ' HB3' ' HG2' ' E' ' 102' ' ' GLN . 0.6 OUTLIER -139.43 -16.94 1.02 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.323 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.694 ' HB ' ' HA3' ' E' ' 100' ' ' GLY . 0.9 OUTLIER -66.69 117.99 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.243 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 86' ' ' LEU . . . . . 0.658 HD12 ' H ' ' E' ' 76' ' ' THR . 10.6 tp -69.71 144.15 52.89 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.291 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 87' ' ' ALA . . . . . 0.448 ' HB3' ' OG1' ' E' ' 76' ' ' THR . . . -80.1 138.06 36.87 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.892 0.377 . . . . 0.0 111.677 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.7 ' HB3' ' HA ' ' E' ' 148' ' ' ALA . 0.0 OUTLIER -85.0 -146.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.115 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 89' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' E' ' 149' ' ' ASN . 0.0 OUTLIER -48.54 155.04 0.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.807 0.337 . . . . 0.0 111.263 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 31.9 p -86.71 -11.9 49.84 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.549 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.43 114.05 5.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.975 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.35 22.17 1.06 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.007 0.432 . . . . 0.0 111.714 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.28 22.05 1.19 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.729 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.7 -32.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.537 -0.84 . . . . 0.0 113.001 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 95' ' ' SER . . . . . 0.646 ' HA ' ' HB3' ' E' ' 147' ' ' ALA . 15.8 t -65.12 166.7 9.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.652 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 96' ' ' ALA . . . . . 0.461 ' O ' HD13 ' E' ' 88' ' ' LEU . . . -89.67 163.43 15.13 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.35 169.68 17.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.378 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 98' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 57.32 29.37 16.72 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.415 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 99' ' ' VAL . . . . . 0.563 ' HB ' ' HB1' ' E' ' 143' ' ' ALA . 7.1 p -156.46 150.6 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.75 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 100' ' ' GLY . . . . . 0.694 ' HA3' ' HB ' ' E' ' 85' ' ' VAL . . . -164.18 176.85 40.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.583 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 101' ' ' VAL . . . . . 0.606 HG22 ' CE1' ' E' ' 137' ' ' TYR . 3.0 t -107.63 111.36 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.011 0.524 . . . . 0.0 111.709 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 102' ' ' GLN . . . . . 0.619 ' HG2' ' HB3' ' E' ' 84' ' ' ASN . 0.0 OUTLIER -76.02 179.75 5.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.943 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 103' ' ' ILE . . . . . 0.494 HD11 ' HA ' ' E' ' 113' ' ' LEU . 5.9 pt -150.39 116.56 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.387 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 104' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' E' ' 134' ' ' GLN . 12.9 tp -97.21 122.54 40.35 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.714 0.292 . . . . 0.0 111.095 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.91 150.16 42.74 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.724 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 106' ' ' ARG . . . . . 0.504 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -71.48 -17.6 62.35 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.792 0.33 . . . . 0.0 111.076 179.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 107' ' ' THR . . . . . 0.432 HG21 ' HA ' ' E' ' 120' ' ' SER . 75.4 p -76.62 -37.23 56.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.129 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.52 -68.76 0.32 Allowed Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.715 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.66 123.23 18.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.83 0.348 . . . . 0.0 111.106 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.7 118.01 2.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 111' ' ' LEU . . . . . 0.509 HD11 ' O ' ' E' ' 117' ' ' THR . 2.1 tp -67.91 144.12 55.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.39 0.614 . . . . 0.0 110.528 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 112' ' ' THR . . . . . 0.429 ' HA ' ' ND2' ' E' ' 84' ' ' ASN . 0.2 OUTLIER -75.13 140.48 43.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.133 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 113' ' ' LEU . . . . . 0.632 HD11 ' HA3' ' E' ' 75' ' ' GLY . 1.3 tp -85.25 97.79 10.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.732 0.301 . . . . 0.0 110.606 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -152.81 -58.94 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.579 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.75 -26.62 3.14 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.583 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.42 28.85 5.16 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.007 0.432 . . . . 0.0 111.626 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 117' ' ' THR . . . . . 0.509 ' O ' HD11 ' E' ' 111' ' ' LEU . 0.2 OUTLIER -106.59 67.31 0.72 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.087 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -82.44 81.07 8.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.709 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.13 97.47 3.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.872 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 120' ' ' SER . . . . . 0.432 ' HA ' HG21 ' E' ' 107' ' ' THR . 1.9 t -165.5 144.77 6.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.597 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.28 50.35 0.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.214 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.88 94.11 5.78 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.713 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.63 110.38 12.4 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.741 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . 0.605 ' HG ' ' ND2' ' E' ' 129' ' ' ASN . 0.3 OUTLIER -70.19 154.13 42.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.567 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.62 144.75 51.28 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.564 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.75 125.69 24.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.647 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 127' ' ' GLY . . . . . 0.528 ' HA3' HG21 ' A' ' 4' ' ' THR . . . 115.03 -102.0 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.737 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 128' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 87.1 m -106.21 128.46 53.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.604 0.24 . . . . 0.0 110.849 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 129' ' ' ASN . . . . . 0.751 ' HA ' ' HB2' ' B' ' 116' ' ' ALA . 20.1 t-20 -121.15 158.18 28.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.881 0.372 . . . . 0.0 111.147 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 130' ' ' THR . . . . . 0.555 ' OG1' ' HA3' ' B' ' 115' ' ' GLY . 0.2 OUTLIER -155.83 143.1 19.26 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.009 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 131' ' ' ILE . . . . . 0.609 HD13 HG11 ' E' ' 156' ' ' VAL . 0.1 OUTLIER -115.23 110.83 45.07 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 132' ' ' PRO . . . . . 0.504 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.3 Cg_endo -82.21 151.86 15.96 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.634 1.556 . . . . 0.0 112.548 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.08 146.79 17.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.795 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 134' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' B' ' 78' ' ' ILE . 0.8 OUTLIER -114.37 145.87 41.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.068 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.87 91.14 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.962 0.41 . . . . 0.0 111.713 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 136' ' ' ARG . . . . . 0.568 ' HE ' HG21 ' E' ' 48' ' ' THR . 28.2 mtm-85 -88.27 153.54 21.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.41 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 137' ' ' TYR . . . . . 0.606 ' CE1' HG22 ' E' ' 101' ' ' VAL . 0.7 OUTLIER -91.26 111.14 22.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.059 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 138' ' ' PHE . . . . . 0.607 ' CD1' ' HB2' ' E' ' 102' ' ' GLN . 8.7 m-85 -108.22 172.21 6.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.968 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 139' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' E' ' 42' ' ' LEU . . . -123.47 143.64 50.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.823 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 140' ' ' THR . . . . . 0.889 HG21 ' CB ' ' E' ' 79' ' ' ASP . 0.2 OUTLIER -98.72 44.43 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.567 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.51 89.07 1.07 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.963 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 142' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' E' ' 43' ' ' ALA . . . 60.03 88.04 0.08 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.696 0.248 . . . . 0.0 110.769 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 143' ' ' ALA . . . . . 0.563 ' HB1' ' HB ' ' E' ' 99' ' ' VAL . . . -70.62 161.73 30.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 111.458 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 144' ' ' THR . . . . . 0.625 ' O ' HG11 ' D' ' 16' ' ' VAL . 0.2 OUTLIER -124.48 158.73 60.65 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.23 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 145' ' ' PRO . . . . . 0.51 ' HA ' ' HB ' ' D' ' 16' ' ' VAL . 1.4 Cg_endo -83.76 149.23 12.57 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.569 2.179 . . . . 0.0 112.022 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.69 -119.72 0.86 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.582 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 147' ' ' ALA . . . . . 0.646 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -123.95 127.73 48.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.877 0.37 . . . . 0.0 111.384 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 148' ' ' ALA . . . . . 0.7 ' HA ' ' HB3' ' E' ' 88' ' ' LEU . . . -120.85 67.16 0.86 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.434 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 149' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' E' ' 89' ' ' GLN . 47.5 t-20 -128.51 114.82 17.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.594 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 150' ' ' ALA . . . . . 0.416 ' HB2' ' C ' ' E' ' 88' ' ' LEU . . . -158.85 147.0 18.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.03 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.48 140.28 32.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.218 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 152' ' ' ALA . . . . . 0.507 ' O ' HG23 ' D' ' 9' ' ' THR . . . -136.21 169.23 17.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.149 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 153' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' E' ' 74' ' ' LEU . 9.4 t -155.06 150.54 27.35 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 154' ' ' PHE . . . . . 0.442 ' HE1' HG13 ' E' ' 56' ' ' ILE . 1.1 p90 -119.05 149.3 41.9 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.1 0.476 . . . . 0.0 110.025 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 155' ' ' LYS . . . . . 0.447 ' HE3' HD13 ' E' ' 74' ' ' LEU . 4.7 mttt -113.53 156.74 23.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.85 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 156' ' ' VAL . . . . . 0.609 HG11 HD13 ' E' ' 131' ' ' ILE . 0.2 OUTLIER -136.51 138.01 47.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.653 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 157' ' ' GLN . . . . . 0.62 ' HB2' HG22 ' D' ' 4' ' ' THR . 64.1 tt0 -107.46 128.05 54.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.307 0.575 . . . . 0.0 110.328 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 158' ' ' TYR . . . . . 0.594 ' HB2' ' OG1' ' D' ' 3' ' ' THR . 61.0 m-85 -107.89 107.5 18.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.531 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 159' ' ' GLN . . . . . 0.714 ' HA ' ' H ' ' D' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.276 0.084 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.82 74.75 0.36 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.973 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 6.2 p -117.75 97.53 5.9 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.504 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 69.1 p -87.84 108.64 19.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.592 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.55 172.72 13.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.618 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -77.24 110.85 12.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.572 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.79 -59.37 7.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.75 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.56 151.71 14.96 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.763 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 24.2 m -103.53 143.09 33.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 111.253 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.92 115.62 30.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.241 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -83.59 105.79 14.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.397 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -83.21 105.5 14.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.76 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.49 145.09 41.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.43 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.75 -179.64 42.6 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.969 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.27 134.18 22.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.387 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 t -90.92 127.19 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.257 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 17' ' ' VAL . . . . . 0.531 HG21 ' HB3' ' F' ' 20' ' ' ALA . 12.0 m -126.25 168.74 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.887 0.375 . . . . 0.0 111.042 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -100.42 81.83 2.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.149 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.23 58.27 5.43 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.05 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . 0.531 ' HB3' HG21 ' F' ' 17' ' ' VAL . . . -108.61 -62.85 1.41 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.376 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 21' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.9 OUTLIER -171.57 -159.92 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.86 74.0 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.085 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 23' ' ' VAL . . . . . 0.468 ' N ' HD23 ' F' ' 58' ' ' LEU . 7.4 p -45.35 140.64 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.015 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 24' ' ' ASP . . . . . 0.547 ' O ' HG23 ' F' ' 28' ' ' VAL . 0.5 OUTLIER -63.45 140.79 58.91 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.679 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.41 -51.08 69.7 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.341 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.14 -18.06 74.45 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.871 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.94 -6.37 58.06 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.865 0.364 . . . . 0.0 110.835 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 28' ' ' VAL . . . . . 0.547 HG23 ' O ' ' F' ' 24' ' ' ASP . 50.6 t -72.66 -36.39 53.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.403 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.92 110.88 14.13 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 30' ' ' GLN . . . . . 0.427 ' HG3' HG12 ' E' ' 10' ' ' VAL . 0.4 OUTLIER -123.84 146.04 48.66 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.982 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.17 113.84 27.67 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.208 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.631 HG11 HG11 ' F' ' 52' ' ' VAL . 3.3 t -105.11 121.95 57.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.141 0.496 . . . . 0.0 110.457 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.83 106.39 17.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.633 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 34' ' ' LEU . . . . . 0.437 HD21 ' HD2' ' E' ' 12' ' ' PHE . 0.6 OUTLIER -64.77 -44.69 89.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.62 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.53 -156.97 16.01 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.561 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 36' ' ' GLN . . . . . 0.631 ' HB2' ' HA ' ' E' ' 22' ' ' ALA . 3.7 mt-30 -91.04 106.97 18.89 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.628 0.251 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.58 ' CG1' HD21 ' F' ' 42' ' ' LEU . 4.4 t -92.35 120.55 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.92 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 38' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' E' ' 19' ' ' ALA . 4.5 mtm105 -85.59 132.5 34.17 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.753 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 39' ' ' THR . . . . . 0.435 HG23 ' O ' ' E' ' 17' ' ' VAL . 29.4 p -71.56 -23.22 61.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.729 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' E' ' 19' ' ' ALA . . . -68.04 -19.19 64.87 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.007 0.432 . . . . 0.0 110.815 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 13.8 t -90.54 -36.6 14.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.16 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . 0.58 HD21 ' CG1' ' F' ' 37' ' ' VAL . 0.2 OUTLIER -121.43 70.56 0.94 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.648 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 43' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' F' ' 142' ' ' ALA . . . -104.82 28.11 7.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.331 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 44' ' ' GLN . . . . . 0.754 ' HG3' ' HB2' ' F' ' 47' ' ' ALA . 0.0 OUTLIER -150.54 142.01 23.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.392 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . 0.449 ' HG3' ' HA ' ' F' ' 140' ' ' THR . 2.7 tt0 -62.71 101.84 0.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.786 0.326 . . . . 0.0 111.084 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.21 4.27 8.47 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.197 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 47' ' ' ALA . . . . . 0.754 ' HB2' ' HG3' ' F' ' 44' ' ' GLN . . . -91.8 121.33 33.32 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.953 0.406 . . . . 0.0 111.981 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 48' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' F' ' 137' ' ' TYR . 5.9 t -110.41 151.13 27.86 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.836 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 49' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 5.2 t -95.63 -57.6 2.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.6 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 50' ' ' SER . . . . . 0.597 ' HB3' ' HA ' ' C' ' 92' ' ' ALA . 0.2 OUTLIER -148.24 -174.81 4.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.806 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 51' ' ' ALA . . . . . 0.474 ' HB2' ' CD ' ' F' ' 136' ' ' ARG . . . -127.13 143.84 51.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.284 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 52' ' ' VAL . . . . . 0.631 HG11 HG11 ' F' ' 32' ' ' VAL . 48.2 t -120.84 116.87 51.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.015 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 53' ' ' GLY . . . . . 0.41 ' O ' HG21 ' C' ' 76' ' ' THR . . . -111.18 122.69 6.21 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.648 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -128.63 138.85 52.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 0.0 110.934 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 55' ' ' ASN . . . . . 0.479 HD22 ' CG2' ' F' ' 130' ' ' THR . 1.6 m120 -117.88 150.97 38.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.607 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 56' ' ' ILE . . . . . 0.592 ' HB ' HG13 ' F' ' 131' ' ' ILE . 9.3 mm -106.82 103.7 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.585 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 57' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -61.13 132.22 53.04 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.769 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . 0.761 ' HB3' ' SG ' ' F' ' 21' ' ' CYS . 1.0 OUTLIER -137.4 151.74 48.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.253 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -138.3 171.43 14.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.026 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 60' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' F' ' 21' ' ' CYS . 5.9 m-20 49.95 68.52 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.812 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 61' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 0.0 OUTLIER -106.68 141.08 38.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.984 0.421 . . . . 0.0 110.736 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.74 117.83 33.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.266 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 23.4 p -91.15 -13.16 33.49 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.61 -38.95 82.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.033 0.444 . . . . 0.0 111.753 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 76.2 t -107.64 -54.1 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.65 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.76 84.33 3.34 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.604 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.97 -41.26 10.1 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.969 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.64 159.97 17.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.436 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.73 160.41 39.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.592 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.03 152.9 45.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.156 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.95 136.55 53.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.682 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.04 107.46 5.03 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.525 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 73' ' ' PHE . . . . . 0.467 ' CD2' HD13 ' F' ' 103' ' ' ILE . 43.0 t80 -73.63 136.7 43.91 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.58 0.228 . . . . 0.0 111.049 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 74' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' F' ' 153' ' ' THR . 6.6 tt -113.62 111.4 21.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.939 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . 0.635 ' HA3' HD11 ' F' ' 113' ' ' LEU . . . -131.31 -178.55 15.53 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.836 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 76' ' ' THR . . . . . 0.677 ' H ' HD12 ' F' ' 86' ' ' LEU . 0.2 OUTLIER -104.32 137.62 41.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.51 0.195 . . . . 0.0 110.79 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.02 114.73 23.88 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.935 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.69 -36.75 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.866 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 79' ' ' ASP . . . . . 0.9 ' CB ' HG21 ' F' ' 140' ' ' THR . 0.4 OUTLIER -143.38 130.26 20.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.752 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.94 -7.23 47.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.973 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.31 -29.2 68.34 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.636 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 -32.73 4.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.863 0.364 . . . . 0.0 110.455 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 83' ' ' THR . . . . . 0.427 ' O ' HG22 ' F' ' 83' ' ' THR . 3.4 m 60.55 19.37 9.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.632 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 84' ' ' ASN . . . . . 0.62 ' HB3' ' HG2' ' F' ' 102' ' ' GLN . 0.6 OUTLIER -139.36 -16.92 1.03 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.413 179.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 85' ' ' VAL . . . . . 0.686 ' HB ' ' HA3' ' F' ' 100' ' ' GLY . 0.8 OUTLIER -66.71 117.97 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.196 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 86' ' ' LEU . . . . . 0.677 HD12 ' H ' ' F' ' 76' ' ' THR . 10.7 tp -69.67 144.1 52.98 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.36 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 87' ' ' ALA . . . . . 0.454 ' HB3' ' OG1' ' F' ' 76' ' ' THR . . . -80.1 138.03 36.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.904 0.383 . . . . 0.0 111.762 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . 0.683 ' HB3' ' HA ' ' F' ' 148' ' ' ALA . 0.0 OUTLIER -84.94 -146.55 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.083 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 89' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' F' ' 149' ' ' ASN . 0.0 OUTLIER -48.66 155.1 0.59 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 32.8 p -86.78 -11.97 49.47 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.403 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.38 114.04 5.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.976 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.34 22.21 1.05 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.877 0.37 . . . . 0.0 111.667 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.28 22.06 1.19 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.692 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.69 -32.28 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.053 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 95' ' ' SER . . . . . 0.644 ' HA ' ' HB3' ' F' ' 147' ' ' ALA . 16.0 t -65.14 166.69 9.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.345 . . . . 0.0 110.616 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 96' ' ' ALA . . . . . 0.467 ' O ' HD13 ' F' ' 88' ' ' LEU . . . -89.61 163.49 15.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.87 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.41 169.61 17.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.329 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 98' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 57.36 29.36 16.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.414 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 99' ' ' VAL . . . . . 0.563 ' HB ' ' HB1' ' F' ' 143' ' ' ALA . 7.0 p -156.38 150.6 10.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.77 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 100' ' ' GLY . . . . . 0.686 ' HA3' ' HB ' ' F' ' 85' ' ' VAL . . . -164.22 176.96 40.11 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.604 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 101' ' ' VAL . . . . . 0.609 HG22 ' CE1' ' F' ' 137' ' ' TYR . 3.0 t -107.66 111.37 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 123.04 0.536 . . . . 0.0 111.706 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 102' ' ' GLN . . . . . 0.62 ' HG2' ' HB3' ' F' ' 84' ' ' ASN . 0.0 OUTLIER -76.04 179.68 5.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.922 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 103' ' ' ILE . . . . . 0.488 HD11 ' HA ' ' F' ' 113' ' ' LEU . 6.0 pt -150.34 116.57 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.464 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 104' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' F' ' 134' ' ' GLN . 12.8 tp -97.18 122.53 40.3 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.743 0.306 . . . . 0.0 111.075 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -62.89 150.12 42.72 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.696 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 106' ' ' ARG . . . . . 0.526 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -71.38 -17.69 62.4 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.772 0.32 . . . . 0.0 111.052 179.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 107' ' ' THR . . . . . 0.446 HG21 ' HA ' ' F' ' 120' ' ' SER . 75.7 p -76.61 -37.28 56.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.08 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.57 -68.77 0.32 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.685 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.68 123.27 18.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.875 0.369 . . . . 0.0 111.105 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.7 117.98 2.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 111' ' ' LEU . . . . . 0.514 HD11 ' O ' ' F' ' 117' ' ' THR . 2.1 tp -67.77 144.04 55.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.429 0.633 . . . . 0.0 110.532 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 112' ' ' THR . . . . . 0.432 ' HA ' ' ND2' ' F' ' 84' ' ' ASN . 0.2 OUTLIER -75.08 140.46 43.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.13 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 113' ' ' LEU . . . . . 0.635 HD11 ' HA3' ' F' ' 75' ' ' GLY . 1.3 tp -85.22 97.85 10.15 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.764 0.316 . . . . 0.0 110.582 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -152.8 -59.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.674 0.273 . . . . 0.0 111.595 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.79 -26.66 3.13 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.61 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.28 28.74 5.19 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.643 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 117' ' ' THR . . . . . 0.514 ' O ' HD11 ' F' ' 111' ' ' LEU . 0.2 OUTLIER -106.57 67.39 0.72 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.052 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.43 80.95 8.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.735 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.01 97.5 3.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.803 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 120' ' ' SER . . . . . 0.446 ' HA ' HG21 ' F' ' 107' ' ' THR . 1.9 t -165.53 144.8 6.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.576 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.29 50.36 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.232 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.87 94.12 5.78 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.659 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.73 110.35 12.5 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.643 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . 0.603 ' HG ' ' ND2' ' F' ' 129' ' ' ASN . 0.3 OUTLIER -70.13 154.15 42.27 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.579 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.62 144.77 51.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.552 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.76 125.64 24.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.667 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 127' ' ' GLY . . . . . 0.526 ' HA3' HG21 ' B' ' 4' ' ' THR . . . 115.03 -101.93 1.1 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.749 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 128' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' C' ' 116' ' ' ALA . 86.0 m -106.32 128.5 54.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.672 0.272 . . . . 0.0 110.782 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 129' ' ' ASN . . . . . 0.748 ' HA ' ' HB2' ' C' ' 116' ' ' ALA . 20.1 t-20 -121.08 158.21 28.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.129 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 130' ' ' THR . . . . . 0.57 ' OG1' ' HA3' ' C' ' 115' ' ' GLY . 0.2 OUTLIER -155.9 143.07 19.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.014 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 131' ' ' ILE . . . . . 0.613 HD13 HG11 ' F' ' 156' ' ' VAL . 0.1 OUTLIER -115.19 110.74 45.24 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 132' ' ' PRO . . . . . 0.526 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.4 Cg_endo -82.12 151.88 16.16 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.597 1.531 . . . . 0.0 112.514 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.0 146.76 17.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.84 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 134' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' C' ' 78' ' ' ILE . 0.8 OUTLIER -114.41 145.95 41.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.093 179.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.85 91.15 1.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 0.0 111.682 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 136' ' ' ARG . . . . . 0.572 ' HE ' HG21 ' F' ' 48' ' ' THR . 28.0 mtm-85 -88.33 153.56 21.1 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.403 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 137' ' ' TYR . . . . . 0.609 ' CE1' HG22 ' F' ' 101' ' ' VAL . 0.7 OUTLIER -91.19 111.03 22.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.101 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 138' ' ' PHE . . . . . 0.607 ' CD1' ' HB2' ' F' ' 102' ' ' GLN . 8.8 m-85 -108.11 172.17 6.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.978 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 139' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' F' ' 42' ' ' LEU . . . -123.41 143.71 49.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.807 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 140' ' ' THR . . . . . 0.9 HG21 ' CB ' ' F' ' 79' ' ' ASP . 0.2 OUTLIER -98.85 44.5 1.03 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.501 179.753 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.45 89.13 1.07 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.946 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 142' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' F' ' 43' ' ' ALA . . . 60.04 88.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.678 0.239 . . . . 0.0 110.694 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 143' ' ' ALA . . . . . 0.563 ' HB1' ' HB ' ' F' ' 99' ' ' VAL . . . -70.54 161.72 30.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.783 0.325 . . . . 0.0 111.431 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 144' ' ' THR . . . . . 0.637 ' O ' HG11 ' E' ' 16' ' ' VAL . 0.2 OUTLIER -124.46 158.65 60.88 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.292 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 145' ' ' PRO . . . . . 0.528 ' HA ' ' HB ' ' E' ' 16' ' ' VAL . 1.4 Cg_endo -83.75 149.19 12.58 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.499 2.132 . . . . 0.0 112.079 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.71 -119.73 0.86 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.563 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 147' ' ' ALA . . . . . 0.644 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -123.92 127.64 48.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 111.48 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 148' ' ' ALA . . . . . 0.683 ' HA ' ' HB3' ' F' ' 88' ' ' LEU . . . -120.77 67.1 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.139 0.495 . . . . 0.0 110.449 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 149' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' F' ' 89' ' ' GLN . 47.4 t-20 -128.47 114.73 17.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.667 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 150' ' ' ALA . . . . . 0.424 ' HB2' ' C ' ' F' ' 88' ' ' LEU . . . -158.77 146.92 18.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.056 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.37 140.29 32.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.181 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 152' ' ' ALA . . . . . 0.511 ' O ' HG23 ' E' ' 9' ' ' THR . . . -136.23 169.29 17.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.216 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 153' ' ' THR . . . . . 0.452 ' O ' ' HB3' ' F' ' 74' ' ' LEU . 9.4 t -155.09 150.56 27.33 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 154' ' ' PHE . . . . . 0.436 ' HE1' HG13 ' F' ' 56' ' ' ILE . 1.1 p90 -119.06 149.24 42.0 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.089 0.471 . . . . 0.0 110.103 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 155' ' ' LYS . . . . . 0.426 ' HE3' HD13 ' F' ' 74' ' ' LEU . 4.7 mttt -113.5 156.67 23.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.886 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 156' ' ' VAL . . . . . 0.613 HG11 HD13 ' F' ' 131' ' ' ILE . 0.2 OUTLIER -136.5 138.05 47.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.667 -179.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 157' ' ' GLN . . . . . 0.61 ' HB2' HG22 ' E' ' 4' ' ' THR . 64.1 tt0 -107.5 127.99 54.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.307 0.575 . . . . 0.0 110.344 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 158' ' ' TYR . . . . . 0.592 ' HB2' ' OG1' ' E' ' 3' ' ' THR . 60.9 m-85 -107.82 107.43 18.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.565 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 159' ' ' GLN . . . . . 0.718 ' HA ' ' H ' ' E' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.903 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.62 ' HB2' ' HG3' ' B' ' 159' ' ' GLN . . . . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.557 0.218 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' B' ' 157' ' ' GLN . 0.2 OUTLIER -103.08 110.35 22.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.419 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.37 136.14 38.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.55 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.64 HG23 HG23 ' B' ' 156' ' ' VAL . 0.0 OUTLIER -152.01 -175.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.61 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.51 130.04 38.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.677 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.77 -59.25 0.91 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.822 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.37 166.16 27.94 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.897 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.621 ' HA ' HG22 ' B' ' 153' ' ' THR . 26.8 m -94.36 121.11 35.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.904 0.383 . . . . 0.0 111.287 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.65 115.59 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.223 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -99.55 137.45 38.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.369 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.573 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 76.0 m-85 -127.49 97.73 4.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.22 175.8 6.56 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.428 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.91 149.49 5.78 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.923 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.33 108.63 13.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.776 0.322 . . . . 0.0 110.358 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' B' ' 37' ' ' VAL . 23.5 t -86.67 129.15 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.203 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 22' ' ' ALA . 18.8 m -127.38 163.5 30.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.041 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -86.0 61.52 6.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.07 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.484 ' HB3' HG21 ' A' ' 65' ' ' VAL . . . 44.93 52.63 8.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -127.29 -54.51 1.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.407 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.809 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER 177.7 111.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.866 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.502 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -105.63 126.08 51.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.073 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.86 145.64 7.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.055 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.623 ' O ' HG23 ' A' ' 28' ' ' VAL . 4.0 m-20 -74.83 147.23 41.34 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.696 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.67 -43.66 17.87 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.34 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.98 -20.0 60.16 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.84 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.2 t -79.54 -26.07 41.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.863 0.363 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 24' ' ' ASP . 57.5 t -49.19 -48.46 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.331 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.84 93.08 5.36 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.023 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.63 116.42 28.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.009 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 p -95.6 115.62 27.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.151 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.503 ' CG1' HG11 ' A' ' 52' ' ' VAL . 1.6 t -117.18 101.16 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.131 0.491 . . . . 0.0 110.402 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -105.62 126.96 52.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.655 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.26 -55.62 11.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.63 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.03 -111.6 3.91 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.519 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.11 115.28 16.76 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.514 0.197 . . . . 0.0 110.875 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.0 t -131.01 105.8 11.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.875 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -96.64 154.12 17.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.757 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.643 ' HA ' HD12 ' A' ' 42' ' ' LEU . 8.2 p -78.75 -19.84 51.35 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.759 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -19.52 65.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.066 0.46 . . . . 0.0 110.885 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.7 p -92.0 -21.27 20.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.207 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.715 ' CB ' ' HB2' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -139.14 62.36 1.54 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.58 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' A' ' 142' ' ' ALA . . . -101.13 9.12 42.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.321 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.19 136.0 24.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.37 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.593 ' N ' ' HA2' ' A' ' 141' ' ' GLY . 16.5 tt0 -58.48 121.37 10.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.915 0.388 . . . . 0.0 111.082 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.28 -25.46 8.23 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.149 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.75 137.29 58.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.939 0.4 . . . . 0.0 112.034 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.92 157.99 44.59 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.955 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.93 -166.21 1.09 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.621 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.8 m -65.23 156.19 32.68 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.767 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 134' ' ' GLN . . . -90.45 126.66 35.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.324 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.503 HG11 ' CG1' ' A' ' 32' ' ' VAL . 62.4 t -75.68 118.52 21.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.79 135.6 13.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.731 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HD2' HG12 ' A' ' 52' ' ' VAL . 46.2 p90 -170.74 142.1 1.92 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.915 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.676 ' HA ' ' O ' ' A' ' 131' ' ' ILE . 11.5 p30 -126.52 163.92 22.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.602 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 130' ' ' THR . 20.9 mm -105.13 120.03 55.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.525 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.7 ' HA ' HG22 ' A' ' 130' ' ' THR . 0.0 OUTLIER -82.15 115.66 21.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.712 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.639 HD11 HG13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -128.24 107.46 9.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.288 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.37 176.97 8.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.889 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.05 66.13 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.797 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.809 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 3.3 m -109.69 154.48 22.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.679 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.523 ' HA ' ' OD1' ' A' ' 126' ' ' ASN . 0.5 OUTLIER -154.71 138.3 16.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.263 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -97.54 -11.9 23.19 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -72.27 -48.69 40.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.003 0.43 . . . . 0.0 111.713 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 19' ' ' ALA . 10.8 t -69.1 -48.6 68.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.695 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 159' ' ' GLN . . . -138.02 153.26 49.39 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.599 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.19 18.66 4.48 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.95 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 10.6 tppt? -142.88 149.9 39.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.486 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.868 ' HB2' HD12 ' A' ' 124' ' ' LEU . . . -150.0 110.72 4.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.661 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 121' ' ' GLU . . . -108.05 169.99 8.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.1 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.414 HG21 HG21 ' A' ' 131' ' ' ILE . 0.5 OUTLIER -130.38 150.98 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.61 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.697 ' HB1' ' HA ' ' A' ' 116' ' ' ALA . . . -135.62 100.13 4.4 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.58 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.435 ' HB2' HD22 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -77.42 133.98 38.52 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.571 0.224 . . . . 0.0 111.107 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.746 HD11 ' HG2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -124.17 115.05 20.48 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.025 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.31 -173.23 26.45 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.729 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.6 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 7.0 m -112.59 149.03 33.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.583 0.23 . . . . 0.0 110.755 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 85' ' ' VAL . . . -98.97 133.81 42.72 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.942 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.786 ' HB ' ' HA ' ' A' ' 87' ' ' ALA . 16.1 tt -72.93 -37.98 55.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.17 167.64 12.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.834 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' D' ' 106' ' ' ARG . . . -70.17 -53.83 15.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.073 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.35 28.63 6.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.595 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.816 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 10.2 m170 -111.33 -45.62 3.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.369 . . . . 0.0 110.427 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.482 HG22 HH21 ' D' ' 106' ' ' ARG . 0.0 OUTLIER 46.42 -86.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.589 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -42.28 -42.4 3.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.239 179.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.816 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 21.3 t -61.29 126.57 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.093 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.062 HD22 ' HB1' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -81.25 164.41 22.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.786 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . . . -104.78 -177.49 3.38 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.672 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.09 -174.57 5.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.982 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.57 -170.71 3.24 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.372 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.869 ' HA ' HG13 ' D' ' 52' ' ' VAL . 27.4 p -74.77 7.81 2.84 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.914 0.387 . . . . 0.0 111.462 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.421 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 0.8 OUTLIER -96.96 80.39 2.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.632 ' HA ' ' HB2' ' D' ' 50' ' ' SER . . . -66.87 -41.13 87.76 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.624 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' D' ' 36' ' ' GLN . . . -103.73 25.96 9.16 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.675 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.8 -22.63 0.33 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.929 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 91' ' ' SER . 1.0 OUTLIER -107.68 175.18 5.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.906 0.384 . . . . 0.0 110.587 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.38 177.12 2.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.497 ' O ' HG12 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -138.58 167.86 21.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.21 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.584 ' HA ' ' HB ' ' A' ' 140' ' ' THR . 32.4 m-80 44.19 51.65 7.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.502 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 97' ' ' THR . 6.0 p -169.38 124.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.72 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.61 -164.74 11.5 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.634 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.8 91.16 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 122.97 0.508 . . . . 0.0 111.722 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.704 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER -71.4 116.65 11.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.885 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 113' ' ' LEU . 6.6 mt -89.64 120.59 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.492 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 1.0 OUTLIER -95.88 152.31 18.61 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.691 0.281 . . . . 0.0 111.092 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.16 159.99 14.68 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.613 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.537 ' CZ ' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -68.71 -13.73 62.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.92 0.39 . . . . 0.0 111.146 179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.6 p -74.41 -18.87 60.59 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.067 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.99 -40.11 2.23 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.664 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.41 164.67 13.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.781 0.324 . . . . 0.0 111.099 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -77.37 139.68 39.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.132 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.564 HD21 ' HB ' ' A' ' 117' ' ' THR . 5.9 tt -84.18 128.58 34.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.458 0.647 . . . . 0.0 110.506 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.435 ' HA ' HD22 ' A' ' 84' ' ' ASN . 1.4 m -68.11 132.38 47.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.1 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.659 HD11 HD12 ' A' ' 103' ' ' ILE . 4.7 mp -88.04 99.83 12.46 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.621 0.248 . . . . 0.0 110.741 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' D' ' 130' ' ' THR . 0.8 OUTLIER -144.13 -32.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.502 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.498 ' CA ' HD23 ' A' ' 74' ' ' LEU . . . 146.46 -81.3 0.21 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.625 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.697 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . . . -97.22 64.1 1.9 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.959 0.409 . . . . 0.0 111.603 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.564 ' HB ' HD21 ' A' ' 111' ' ' LEU . 2.8 m -94.4 72.39 3.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.141 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -66.76 119.04 11.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.835 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.89 -49.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.852 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.57 84.69 6.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.547 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 70' ' ' ALA . 3.5 mt-10 -110.2 86.95 2.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.29 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.99 159.3 17.68 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.815 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -66.96 138.39 57.23 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.727 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.868 HD12 ' HB2' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -86.55 159.49 19.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.622 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.58 176.19 10.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.588 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 62' ' ' ASP . 0.9 OUTLIER -85.93 161.49 19.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.697 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.53 -121.0 5.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.775 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 74.4 m -119.54 140.31 50.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.682 0.277 . . . . 0.0 110.768 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.45 ' O ' HD12 ' A' ' 58' ' ' LEU . 5.1 t-20 -133.73 154.67 50.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.117 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.7 HG22 ' HA ' ' A' ' 57' ' ' GLN . 27.9 p -133.41 154.33 50.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.164 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.676 ' O ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -111.09 116.9 50.93 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.537 ' HG2' ' CZ ' ' A' ' 106' ' ' ARG . 7.5 Cg_endo -81.24 129.48 6.78 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.614 1.543 . . . . 0.0 112.581 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.459 ' HB3' ' CE1' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -140.89 146.9 38.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.794 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.526 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 19.3 mm-40 -116.5 158.33 23.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.011 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . . . -159.42 105.53 1.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.914 0.388 . . . . 0.0 111.524 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.7 172.61 6.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.414 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.2 147.79 24.25 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.131 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.67 159.03 35.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.277 0.561 . . . . 0.0 111.923 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.715 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . . . -116.33 141.24 48.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.936 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.584 ' HB ' ' HA ' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -107.75 27.23 9.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.482 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.593 ' HA2' ' N ' ' A' ' 45' ' ' GLU . . . 97.55 83.6 1.71 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.971 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . . . 57.88 93.47 0.03 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.688 0.244 . . . . 0.0 110.746 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' A' ' 98' ' ' ASN . . . -80.0 165.37 22.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 111.403 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.7 p -108.34 168.87 7.22 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.153 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.61 133.54 6.14 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.569 2.179 . . . . 0.0 111.979 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.55 -119.24 0.81 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.471 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.81 121.7 13.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.894 0.378 . . . . 0.0 111.281 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.34 85.68 3.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.442 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -104.55 131.21 52.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.601 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 1.062 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -136.08 148.44 48.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.935 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.17 120.17 20.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.216 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.63 140.05 24.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.159 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.6 p -105.2 171.21 7.44 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.503 ' HZ ' HG21 ' A' ' 56' ' ' ILE . 13.7 p90 -138.2 147.39 43.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.038 0.447 . . . . 0.0 110.119 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.746 ' HG2' HD11 ' A' ' 74' ' ' LEU . 13.6 mmtt -100.89 172.01 7.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.901 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.49 ' HB ' ' CZ ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -135.51 111.4 12.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.82 0.343 . . . . 0.0 111.728 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -109.04 141.26 41.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.346 0.593 . . . . 0.0 110.414 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.49 ' CZ ' ' HB ' ' A' ' 156' ' ' VAL . 23.1 m-85 -135.36 105.58 6.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.583 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.617 ' HB3' ' HB3' ' A' ' 68' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.92 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . 0.695 ' H ' ' HA ' ' C' ' 159' ' ' GLN . . . 56.58 88.57 0.05 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.056 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' C' ' 157' ' ' GLN . 0.2 OUTLIER -103.08 110.38 22.29 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.393 179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 136.18 38.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.552 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.652 HG23 HG23 ' C' ' 156' ' ' VAL . 0.0 OUTLIER -152.05 -175.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.591 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.43 130.04 38.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.666 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.8 -59.33 0.91 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.756 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.4 166.2 28.04 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.894 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.624 ' HA ' HG22 ' C' ' 153' ' ' THR . 26.7 m -94.38 121.1 35.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.89 0.376 . . . . 0.0 111.269 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.69 115.64 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.24 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -99.54 137.55 37.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.351 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' C' ' 32' ' ' VAL . 76.0 m-85 -127.61 97.71 4.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.22 175.78 6.57 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.472 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.01 149.4 5.75 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.941 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.24 108.68 14.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.852 0.358 . . . . 0.0 110.414 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' C' ' 37' ' ' VAL . 23.6 t -86.71 129.19 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.175 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' B' ' 22' ' ' ALA . 18.7 m -127.45 163.51 30.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.033 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -85.95 61.35 6.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.027 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.483 ' HB3' HG21 ' B' ' 65' ' ' VAL . . . 45.02 52.64 8.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.053 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' B' ' 61' ' ' CYS . . . -127.24 -54.54 1.37 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.451 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.1 OUTLIER 177.73 111.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.893 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.499 ' HB2' HG22 ' B' ' 17' ' ' VAL . . . -105.67 126.05 51.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.083 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.81 145.61 7.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.035 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.608 ' O ' HG23 ' B' ' 28' ' ' VAL . 4.0 m-20 -74.82 147.27 41.32 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.68 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.8 -43.57 18.47 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.323 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.97 -20.07 60.06 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.809 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 45.3 t -79.58 -26.01 41.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.608 HG23 ' O ' ' B' ' 24' ' ' ASP . 57.4 t -49.21 -48.46 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.344 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.86 93.08 5.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.031 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.61 116.36 28.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.026 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.55 115.67 27.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.209 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 12' ' ' PHE . 1.7 t -117.23 101.07 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.182 0.515 . . . . 0.0 110.429 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -105.58 126.93 52.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.715 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.15 -55.66 11.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.62 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.02 -111.65 3.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.539 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.548 ' HG3' ' HA ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -77.05 115.29 16.71 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.501 0.191 . . . . 0.0 110.907 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 68.4 t -131.05 105.86 11.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.833 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.6 154.05 17.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.782 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.665 ' HA ' HD12 ' B' ' 42' ' ' LEU . 8.2 p -78.77 -19.79 51.4 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.702 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.51 -19.53 65.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.144 0.497 . . . . 0.0 110.899 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 96.5 p -92.01 -21.27 20.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.19 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.711 ' CB ' ' HB2' ' B' ' 139' ' ' ALA . 0.2 OUTLIER -139.0 62.27 1.54 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.707 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.727 ' HA ' ' HA ' ' B' ' 142' ' ' ALA . . . -101.09 9.14 42.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.363 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.19 136.03 24.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.335 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.579 ' N ' ' HA2' ' B' ' 141' ' ' GLY . 16.5 tt0 -58.59 121.33 10.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 111.154 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.4 -25.54 8.14 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.166 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.67 137.19 58.2 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.91 158.04 44.45 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.904 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -166.19 1.09 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.598 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 48.9 m -65.2 156.13 32.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.816 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.539 ' HB1' ' HB3' ' B' ' 134' ' ' GLN . . . -90.5 126.7 36.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.339 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.506 HG11 ' CG1' ' B' ' 32' ' ' VAL . 63.2 t -75.6 118.5 21.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.019 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.79 135.74 13.86 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.626 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . 0.5 ' HD2' HG12 ' B' ' 52' ' ' VAL . 46.3 p90 -170.85 142.08 1.86 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.815 0.341 . . . . 0.0 110.905 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.673 ' HA ' ' O ' ' B' ' 131' ' ' ILE . 11.5 p30 -126.52 163.93 22.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.54 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' B' ' 130' ' ' THR . 20.7 mm -105.17 119.97 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.503 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . 0.703 ' HA ' HG22 ' B' ' 130' ' ' THR . 0.0 OUTLIER -82.16 115.74 21.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.731 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.648 HD11 HG13 ' B' ' 131' ' ' ILE . 0.0 OUTLIER -128.33 107.47 9.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.252 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.37 176.99 8.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.86 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.03 66.21 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.714 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 3.3 m -109.73 154.46 22.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.711 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . 0.531 ' HA ' ' OD1' ' B' ' 126' ' ' ASN . 0.5 OUTLIER -154.74 138.26 15.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.271 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' B' ' 66' ' ' ALA . 0.2 OUTLIER -97.55 -11.81 23.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.08 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.25 -48.68 40.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.115 0.483 . . . . 0.0 111.78 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' B' ' 19' ' ' ALA . 10.6 t -69.02 -48.7 68.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.764 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' B' ' 159' ' ' GLN . . . -137.93 153.36 49.5 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.637 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.29 18.67 4.43 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.868 0.366 . . . . 0.0 110.906 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . 0.61 ' HB3' ' HB3' ' B' ' 159' ' ' GLN . 10.6 tppt? -142.9 149.93 39.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.469 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.867 ' HB2' HD12 ' B' ' 124' ' ' LEU . . . -150.03 110.72 4.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.687 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' B' ' 121' ' ' GLU . . . -108.1 169.92 8.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.05 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.436 HG21 HG21 ' B' ' 131' ' ' ILE . 0.5 OUTLIER -130.35 150.93 35.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.63 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.698 ' HB1' ' HA ' ' B' ' 116' ' ' ALA . . . -135.62 100.16 4.41 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.518 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.438 ' HB2' HD22 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -77.35 133.84 38.63 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.572 0.225 . . . . 0.0 111.189 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.731 HD11 ' HG2' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -124.15 115.16 20.67 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.984 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.37 -173.24 26.53 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.777 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.606 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 7.0 m -112.6 149.04 33.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.565 0.221 . . . . 0.0 110.755 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' B' ' 85' ' ' VAL . . . -98.99 133.78 42.77 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.908 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.769 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 16.1 tt -72.91 -37.94 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.16 167.58 12.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.836 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' E' ' 106' ' ' ARG . . . -70.11 -53.85 15.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.42 28.74 6.08 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.564 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.808 ' HB3' ' HB ' ' B' ' 85' ' ' VAL . 10.2 m170 -111.38 -45.62 3.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.45 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' THR . . . . . 0.487 HG22 HH21 ' E' ' 106' ' ' ARG . 0.0 OUTLIER 46.41 -86.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.59 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' B' ' 82' ' ' HIS . 0.0 OUTLIER -42.3 -42.35 3.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.299 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.808 ' HB ' ' HB3' ' B' ' 82' ' ' HIS . 21.3 t -61.33 126.62 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.145 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 1.061 HD22 ' HB1' ' B' ' 150' ' ' ALA . 0.2 OUTLIER -81.31 164.33 22.27 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.281 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.769 ' HA ' ' HB ' ' B' ' 78' ' ' ILE . . . -104.74 -177.52 3.39 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.841 0.353 . . . . 0.0 111.67 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.03 -174.51 5.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.052 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.63 -170.68 3.22 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.394 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . 0.898 ' HA ' HG13 ' E' ' 52' ' ' VAL . 27.4 p -74.85 7.95 2.8 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.92 0.39 . . . . 0.0 111.408 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' B' ' 95' ' ' SER . 0.8 OUTLIER -97.07 80.4 2.95 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.621 ' HA ' ' HB2' ' E' ' 50' ' ' SER . . . -66.83 -41.18 87.87 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.841 0.353 . . . . 0.0 111.664 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' E' ' 36' ' ' GLN . . . -103.76 26.07 9.05 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.698 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.81 -22.66 0.33 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.922 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' B' ' 91' ' ' SER . 1.0 OUTLIER -107.64 175.21 5.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.93 0.395 . . . . 0.0 110.606 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.53 177.18 3.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.848 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.498 ' O ' HG12 ' B' ' 99' ' ' VAL . 0.2 OUTLIER -138.59 167.89 20.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.27 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . 0.578 ' HA ' ' HB ' ' B' ' 140' ' ' THR . 32.2 m-80 44.12 51.63 7.2 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.53 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . 0.498 HG12 ' O ' ' B' ' 97' ' ' THR . 6.1 p -169.31 124.12 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.823 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.5 -164.68 11.5 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.619 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.86 91.12 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 122.925 0.49 . . . . 0.0 111.695 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.719 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 0.6 OUTLIER -71.42 116.58 11.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.919 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.656 HD12 HD11 ' B' ' 113' ' ' LEU . 6.6 mt -89.51 120.63 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.534 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . 0.499 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 1.0 OUTLIER -95.88 152.31 18.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.758 0.313 . . . . 0.0 111.041 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.23 160.12 14.58 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.573 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . 0.533 ' CZ ' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -68.83 -13.69 62.56 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.858 0.361 . . . . 0.0 111.032 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 44.8 p -74.45 -18.85 60.58 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.03 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.93 -40.15 2.22 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.659 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.34 164.69 13.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.774 0.321 . . . . 0.0 111.078 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -77.37 139.65 39.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.542 HD21 ' HB ' ' B' ' 117' ' ' THR . 5.9 tt -84.09 128.59 34.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.438 0.637 . . . . 0.0 110.462 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.439 ' HA ' HD22 ' B' ' 84' ' ' ASN . 1.4 m -68.13 132.38 47.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.111 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.656 HD11 HD12 ' B' ' 103' ' ' ILE . 4.7 mp -88.1 99.74 12.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.726 0.298 . . . . 0.0 110.748 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . 0.504 ' O ' ' O ' ' E' ' 130' ' ' THR . 0.8 OUTLIER -144.1 -32.34 0.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.495 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . 0.495 ' CA ' HD23 ' B' ' 74' ' ' LEU . . . 146.44 -81.23 0.21 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.68 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . 0.698 ' HA ' ' HB1' ' B' ' 72' ' ' ALA . . . -97.24 64.02 1.88 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.986 0.422 . . . . 0.0 111.602 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . 0.542 ' HB ' HD21 ' B' ' 111' ' ' LEU . 2.8 m -94.28 72.28 3.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.212 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.73 119.05 11.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.82 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.96 -48.97 0.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.57 84.68 6.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.559 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' B' ' 70' ' ' ALA . 3.5 mt-10 -110.19 87.0 2.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.227 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.09 159.32 17.6 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.802 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -67.0 138.35 57.18 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.666 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.867 HD12 ' HB2' ' B' ' 69' ' ' ALA . 0.4 OUTLIER -86.49 159.5 19.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.665 179.4 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.62 176.25 10.23 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.602 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' ASN . . . . . 0.531 ' OD1' ' HA ' ' B' ' 62' ' ' ASP . 0.9 OUTLIER -85.94 161.49 19.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.641 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.5 -121.03 5.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.756 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 73.2 m -119.5 140.32 50.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.661 0.267 . . . . 0.0 110.779 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . 0.462 ' O ' HD12 ' B' ' 58' ' ' LEU . 5.1 t-20 -133.76 154.63 50.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.06 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.703 HG22 ' HA ' ' B' ' 57' ' ' GLN . 28.4 p -133.32 154.25 50.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.217 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' ILE . . . . . 0.673 ' O ' ' HA ' ' B' ' 55' ' ' ASN . 1.0 OUTLIER -110.95 116.89 51.22 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' PRO . . . . . 0.533 ' HG2' ' CZ ' ' B' ' 106' ' ' ARG . 7.6 Cg_endo -81.2 129.46 6.79 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 121.672 1.581 . . . . 0.0 112.594 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.463 ' HB3' ' CE1' ' B' ' 54' ' ' PHE . 0.1 OUTLIER -140.9 146.84 37.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.78 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' GLN . . . . . 0.539 ' HB3' ' HB1' ' B' ' 51' ' ' ALA . 19.5 mm-40 -116.57 158.38 23.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.022 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' B' ' 103' ' ' ILE . . . -159.41 105.52 1.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 111.515 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.71 172.55 6.74 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.417 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.25 147.75 24.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.081 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.6 159.01 35.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.031 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.711 ' HB2' ' CB ' ' B' ' 42' ' ' LEU . . . -116.26 141.33 48.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.913 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' THR . . . . . 0.578 ' HB ' ' HA ' ' B' ' 98' ' ' ASN . 0.3 OUTLIER -107.86 27.27 9.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.467 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . 0.579 ' HA2' ' N ' ' B' ' 45' ' ' GLU . . . 97.49 83.6 1.7 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.015 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . 0.727 ' HA ' ' HA ' ' B' ' 43' ' ' ALA . . . 57.89 93.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.607 0.204 . . . . 0.0 110.821 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' B' ' 98' ' ' ASN . . . -80.05 165.51 22.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.709 0.29 . . . . 0.0 111.448 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 29.6 p -108.43 168.81 7.29 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.204 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.66 133.52 6.09 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.579 2.186 . . . . 0.0 111.987 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.61 -119.22 0.81 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.427 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.82 121.64 13.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.842 0.353 . . . . 0.0 111.306 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.32 85.7 3.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.5 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -104.6 131.23 52.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.56 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 1.061 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -136.1 148.47 48.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.949 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -133.19 120.21 20.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.197 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.61 140.01 24.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.199 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.621 HG22 ' HA ' ' A' ' 9' ' ' THR . 70.7 p -105.16 171.18 7.46 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' PHE . . . . . 0.511 ' HZ ' HG21 ' B' ' 56' ' ' ILE . 13.6 p90 -138.16 147.44 43.86 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.104 0.478 . . . . 0.0 110.124 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . 0.731 ' HG2' HD11 ' B' ' 74' ' ' LEU . 13.6 mmtt -100.94 172.02 7.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.892 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' VAL . . . . . 0.64 HG23 HG23 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -135.51 111.38 12.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.738 0.304 . . . . 0.0 111.681 -179.043 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 3' ' ' THR . 1.8 tt0 -109.06 141.28 41.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.369 0.604 . . . . 0.0 110.383 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' TYR . . . . . 0.485 ' CZ ' ' HB ' ' B' ' 156' ' ' VAL . 23.2 m-85 -135.39 105.55 6.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.553 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . 0.62 ' HG3' ' HB2' ' A' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.855 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . 0.672 ' H ' ' HA ' ' D' ' 159' ' ' GLN . . . 56.66 88.58 0.05 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.988 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' D' ' 157' ' ' GLN . 0.2 OUTLIER -103.05 110.38 22.28 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.428 179.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.4 136.24 38.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.523 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.646 HG23 HG23 ' D' ' 156' ' ' VAL . 0.0 OUTLIER -152.08 -175.28 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.63 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.54 130.08 38.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.595 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.81 -59.29 0.91 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.804 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.41 166.23 28.08 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.864 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . 0.626 ' HA ' HG22 ' D' ' 153' ' ' THR . 27.0 m -94.46 121.16 35.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 111.219 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.6 115.61 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.258 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -99.56 137.51 37.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.311 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' PHE . . . . . 0.579 ' HA ' ' O ' ' D' ' 32' ' ' VAL . 75.8 m-85 -127.56 97.73 4.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.21 175.84 6.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.442 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.93 149.46 5.77 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.914 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.28 108.58 13.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.773 0.321 . . . . 0.0 110.432 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' D' ' 37' ' ' VAL . 23.1 t -86.6 129.07 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.283 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' C' ' 22' ' ' ALA . 18.7 m -127.39 163.55 30.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.826 0.346 . . . . 0.0 110.993 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -86.0 61.41 6.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.069 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . 0.49 ' HB3' HG21 ' C' ' 65' ' ' VAL . . . 44.95 52.64 8.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' C' ' 61' ' ' CYS . . . -127.29 -54.43 1.36 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.467 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.1 OUTLIER 177.73 111.65 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.92 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . 0.494 ' HB2' HG22 ' C' ' 17' ' ' VAL . . . -105.64 126.06 51.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.8 145.66 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.022 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.61 ' O ' HG23 ' C' ' 28' ' ' VAL . 4.0 m-20 -74.86 147.24 41.27 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.693 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.78 -43.64 18.43 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.337 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.88 -20.01 60.32 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.946 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 45.2 t -79.62 -26.04 41.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.857 0.36 . . . . 0.0 110.833 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.61 HG23 ' O ' ' C' ' 24' ' ' ASP . 57.5 t -49.08 -48.58 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.341 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.82 93.07 5.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.069 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.59 116.41 28.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.994 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 9.1 p -95.63 115.66 27.75 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.115 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' B' ' 12' ' ' PHE . 1.7 t -117.19 101.1 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.059 0.457 . . . . 0.0 110.438 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.55 126.9 52.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.688 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.19 -55.71 11.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.611 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.06 -111.71 3.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.471 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . 0.546 ' HG3' ' HA ' ' B' ' 24' ' ' ASP . 0.0 OUTLIER -77.02 115.32 16.72 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.516 0.198 . . . . 0.0 110.894 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' B' ' 16' ' ' VAL . 67.2 t -130.99 105.83 11.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.881 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.71 154.1 17.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.748 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.656 ' HA ' HD12 ' C' ' 42' ' ' LEU . 8.3 p -78.7 -19.86 51.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.779 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.53 -19.49 65.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 110.879 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 97.5 p -92.06 -21.26 20.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.143 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.716 ' CB ' ' HB2' ' C' ' 139' ' ' ALA . 0.2 OUTLIER -139.06 62.31 1.54 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.62 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . 0.726 ' HA ' ' HA ' ' C' ' 142' ' ' ALA . . . -101.26 9.2 42.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.23 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.25 136.07 24.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.306 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . 0.589 ' N ' ' HA2' ' C' ' 141' ' ' GLY . 16.5 tt0 -58.54 121.32 10.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 111.139 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.32 -25.43 8.22 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.189 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.8 137.27 58.22 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.937 0.398 . . . . 0.0 112.034 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.9 158.0 44.55 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.935 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.92 -166.23 1.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.627 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 48.8 m -65.18 156.25 32.35 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.782 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . 0.525 ' HB1' ' HB3' ' C' ' 134' ' ' GLN . . . -90.56 126.63 36.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.309 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.501 HG12 ' HD2' ' C' ' 54' ' ' PHE . 62.9 t -75.64 118.52 21.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.982 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.85 135.71 13.81 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.632 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . 0.501 ' HD2' HG12 ' C' ' 52' ' ' VAL . 46.3 p90 -170.76 142.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.755 0.312 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' C' ' 131' ' ' ILE . 11.5 p30 -126.56 163.91 22.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.569 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' C' ' 130' ' ' THR . 20.8 mm -105.1 119.89 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.519 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.694 ' HA ' HG22 ' C' ' 130' ' ' THR . 0.0 OUTLIER -82.09 115.69 21.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.761 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . 0.643 HD11 HG13 ' C' ' 131' ' ' ILE . 0.0 OUTLIER -128.23 107.45 9.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.295 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.36 176.99 8.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.954 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.03 66.24 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.734 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 3.3 m -109.75 154.4 22.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.668 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . 0.516 ' HA ' ' OD1' ' C' ' 126' ' ' ASN . 0.5 OUTLIER -154.65 138.33 16.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.295 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' C' ' 66' ' ' ALA . 0.2 OUTLIER -97.54 -11.9 23.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.07 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -72.26 -48.71 40.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.026 0.441 . . . . 0.0 111.732 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.49 HG21 ' HB3' ' C' ' 19' ' ' ALA . 10.6 t -69.0 -48.73 68.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.716 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' C' ' 159' ' ' GLN . . . -137.93 153.36 49.5 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.672 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.28 18.67 4.43 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.847 0.356 . . . . 0.0 110.878 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' LYS . . . . . 0.623 ' HB3' ' HB3' ' C' ' 159' ' ' GLN . 10.6 tppt? -142.9 149.95 39.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.41 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.864 ' HB2' HD12 ' C' ' 124' ' ' LEU . . . -150.02 110.71 4.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.671 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' C' ' 121' ' ' GLU . . . -108.07 169.97 8.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.083 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . 0.439 HG21 HG21 ' C' ' 131' ' ' ILE . 0.5 OUTLIER -130.38 150.96 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.632 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . 0.695 ' HB1' ' HA ' ' C' ' 116' ' ' ALA . . . -135.55 100.06 4.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.62 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' PHE . . . . . 0.436 ' HB2' HD22 ' C' ' 111' ' ' LEU . 0.2 OUTLIER -77.41 133.95 38.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.552 0.215 . . . . 0.0 111.117 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.748 HD11 ' HG2' ' C' ' 155' ' ' LYS . 0.0 OUTLIER -124.15 115.08 20.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.968 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.42 -173.24 26.57 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.761 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.609 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 7.1 m -112.61 149.0 33.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.618 0.247 . . . . 0.0 110.737 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' C' ' 85' ' ' VAL . . . -98.96 133.78 42.73 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.936 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . 0.758 ' HB ' ' HA ' ' C' ' 87' ' ' ALA . 16.1 tt -72.89 -38.01 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.13 167.61 12.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.802 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' F' ' 106' ' ' ARG . . . -70.21 -53.78 15.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.08 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.4 28.66 6.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.546 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . 0.822 ' HB3' ' HB ' ' C' ' 85' ' ' VAL . 10.2 m170 -111.3 -45.67 3.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.46 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . 0.476 HG22 HH21 ' F' ' 106' ' ' ARG . 0.0 OUTLIER 46.48 -86.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.552 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' C' ' 82' ' ' HIS . 0.0 OUTLIER -42.19 -42.48 3.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.277 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.822 ' HB ' ' HB3' ' C' ' 82' ' ' HIS . 21.3 t -61.25 126.56 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.148 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 1.064 HD22 ' HB1' ' C' ' 150' ' ' ALA . 0.2 OUTLIER -81.22 164.39 22.32 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.413 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.758 ' HA ' ' HB ' ' C' ' 78' ' ' ILE . . . -104.79 -177.54 3.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.84 0.352 . . . . 0.0 111.661 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.03 -174.53 5.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.049 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.63 -170.66 3.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.317 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' SER . . . . . 0.909 ' HA ' HG13 ' F' ' 52' ' ' VAL . 26.9 p -74.85 7.85 2.86 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.989 0.423 . . . . 0.0 111.408 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' C' ' 95' ' ' SER . 0.8 OUTLIER -96.97 80.45 2.98 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.84 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' ALA . . . . . 0.613 ' HA ' ' HB2' ' F' ' 50' ' ' SER . . . -66.83 -41.24 87.78 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.853 0.359 . . . . 0.0 111.618 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' F' ' 36' ' ' GLN . . . -103.7 25.98 9.12 Favored 'General case' 0 N--CA 1.46 0.068 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.707 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.83 -22.69 0.33 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.947 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' C' ' 91' ' ' SER . 1.0 OUTLIER -107.66 175.18 5.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.913 0.387 . . . . 0.0 110.593 179.544 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.41 177.1 3.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . 0.505 ' O ' HG12 ' C' ' 99' ' ' VAL . 0.2 OUTLIER -138.52 167.88 20.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.269 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . 0.58 ' HA ' ' HB ' ' C' ' 140' ' ' THR . 32.5 m-80 44.17 51.7 7.26 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.48 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 99' ' ' VAL . . . . . 0.505 HG12 ' O ' ' C' ' 97' ' ' THR . 6.0 p -169.39 124.12 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.767 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' C' ' 86' ' ' LEU . . . -129.55 -164.72 11.5 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.638 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.77 91.15 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 122.975 0.51 . . . . 0.0 111.7 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 102' ' ' GLN . . . . . 0.7 ' HA ' ' HA ' ' C' ' 85' ' ' VAL . 0.6 OUTLIER -71.45 116.63 12.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.858 -179.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.647 HD12 HD11 ' C' ' 113' ' ' LEU . 6.6 mt -89.68 120.61 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.445 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 1.0 OUTLIER -95.81 152.27 18.63 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.689 0.28 . . . . 0.0 111.164 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.16 160.07 14.62 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.601 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 106' ' ' ARG . . . . . 0.533 ' CZ ' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -68.8 -13.68 62.55 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.827 0.346 . . . . 0.0 111.066 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 45.0 p -74.37 -18.92 60.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.081 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.91 -40.01 2.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.71 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.41 164.71 13.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.816 0.341 . . . . 0.0 111.116 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -77.35 139.58 39.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.174 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 111' ' ' LEU . . . . . 0.553 HD21 ' HB ' ' C' ' 117' ' ' THR . 5.9 tt -84.08 128.48 34.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.435 0.636 . . . . 0.0 110.519 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 112' ' ' THR . . . . . 0.442 ' HA ' HD22 ' C' ' 84' ' ' ASN . 1.4 m -68.14 132.39 47.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.126 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.647 HD11 HD12 ' C' ' 103' ' ' ILE . 4.7 mp -87.99 99.69 12.35 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.791 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 114' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' F' ' 130' ' ' THR . 0.8 OUTLIER -144.03 -32.49 0.43 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.626 0.25 . . . . 0.0 111.568 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . 0.491 ' CA ' HD23 ' C' ' 74' ' ' LEU . . . 146.5 -81.25 0.21 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.669 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 116' ' ' ALA . . . . . 0.695 ' HA ' ' HB1' ' C' ' 72' ' ' ALA . . . -97.25 64.0 1.88 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.975 0.417 . . . . 0.0 111.659 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . 0.553 ' HB ' HD21 ' C' ' 111' ' ' LEU . 2.8 m -94.26 72.28 3.88 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.18 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -66.69 119.04 11.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.9 t -143.95 -48.96 0.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.809 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 3.0 m -88.57 84.7 6.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.584 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' C' ' 70' ' ' ALA . 3.5 mt-10 -110.25 86.92 2.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.287 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.95 159.27 17.73 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -66.93 138.34 57.21 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.699 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . 0.864 HD12 ' HB2' ' C' ' 69' ' ' ALA . 0.4 OUTLIER -86.56 159.48 19.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.636 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.56 176.28 10.19 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.562 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 126' ' ' ASN . . . . . 0.516 ' OD1' ' HA ' ' C' ' 62' ' ' ASP . 0.9 OUTLIER -85.92 161.52 19.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.681 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.5 -121.0 5.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.756 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 72.4 m -119.47 140.36 50.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.675 0.274 . . . . 0.0 110.815 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 129' ' ' ASN . . . . . 0.46 ' O ' HD12 ' C' ' 58' ' ' LEU . 5.1 t-20 -133.8 154.64 50.86 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.876 0.37 . . . . 0.0 111.087 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 130' ' ' THR . . . . . 0.694 HG22 ' HA ' ' C' ' 57' ' ' GLN . 28.0 p -133.37 154.29 50.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.133 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 131' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' C' ' 55' ' ' ASN . 1.0 OUTLIER -111.0 116.84 51.19 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 132' ' ' PRO . . . . . 0.533 ' HG2' ' CZ ' ' C' ' 106' ' ' ARG . 7.7 Cg_endo -81.12 129.4 6.83 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.662 1.574 . . . . 0.0 112.675 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.464 ' HB3' ' CE1' ' C' ' 54' ' ' PHE . 0.1 OUTLIER -140.87 146.89 38.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.813 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 134' ' ' GLN . . . . . 0.525 ' HB3' ' HB1' ' C' ' 51' ' ' ALA . 19.4 mm-40 -116.47 158.39 23.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.043 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' C' ' 103' ' ' ILE . . . -159.48 105.53 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.91 0.386 . . . . 0.0 111.545 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.72 172.5 6.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.399 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.16 147.72 24.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.128 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.58 158.99 35.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.057 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 139' ' ' ALA . . . . . 0.716 ' HB2' ' CB ' ' C' ' 42' ' ' LEU . . . -116.27 141.28 48.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.934 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 140' ' ' THR . . . . . 0.58 ' HB ' ' HA ' ' C' ' 98' ' ' ASN . 0.2 OUTLIER -107.83 27.23 9.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.471 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . 0.589 ' HA2' ' N ' ' C' ' 45' ' ' GLU . . . 97.63 83.59 1.71 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.97 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 142' ' ' ALA . . . . . 0.726 ' HA ' ' HA ' ' C' ' 43' ' ' ALA . . . 57.9 93.41 0.03 OUTLIER 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.666 0.233 . . . . 0.0 110.8 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 143' ' ' ALA . . . . . 0.547 ' HA ' ' HB2' ' C' ' 98' ' ' ASN . . . -80.02 165.38 22.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.764 0.316 . . . . 0.0 111.392 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 144' ' ' THR . . . . . . . . . . . . . 29.8 p -108.35 168.87 7.22 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.228 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.68 133.56 6.09 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.533 2.155 . . . . 0.0 112.015 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 146' ' ' GLY . . . . . 0.62 ' HA2' HG12 ' A' ' 5' ' ' VAL . . . 169.6 -119.25 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.477 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.8 121.73 13.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.887 0.375 . . . . 0.0 111.339 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.42 85.71 3.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.419 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -104.61 131.24 52.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.548 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 150' ' ' ALA . . . . . 1.064 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -136.06 148.51 48.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.971 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.24 120.19 20.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.205 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.64 140.0 24.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.207 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . 0.624 HG22 ' HA ' ' B' ' 9' ' ' THR . 70.7 p -105.16 171.19 7.45 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 154' ' ' PHE . . . . . 0.51 ' HZ ' HG21 ' C' ' 56' ' ' ILE . 13.9 p90 -138.21 147.41 43.73 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.114 0.483 . . . . 0.0 110.074 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 155' ' ' LYS . . . . . 0.748 ' HG2' HD11 ' C' ' 74' ' ' LEU . 13.7 mmtt -100.89 171.94 7.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.936 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 156' ' ' VAL . . . . . 0.652 HG23 HG23 ' B' ' 5' ' ' VAL . 0.4 OUTLIER -135.47 111.41 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.84 0.352 . . . . 0.0 111.716 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 157' ' ' GLN . . . . . 0.556 ' HA ' ' O ' ' B' ' 3' ' ' THR . 1.8 tt0 -108.96 141.29 41.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.349 0.595 . . . . 0.0 110.409 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 158' ' ' TYR . . . . . 0.484 ' CZ ' ' HB ' ' C' ' 156' ' ' VAL . 23.0 m-85 -135.37 105.47 6.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.595 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . 0.695 ' HA ' ' H ' ' B' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 111.495 0.183 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . 0.68 ' H ' ' HA ' ' E' ' 159' ' ' GLN . . . 56.69 88.54 0.05 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.713 -0.222 . . . . 0.0 110.963 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 3' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' E' ' 157' ' ' GLN . 0.2 OUTLIER -103.08 110.38 22.29 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.383 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.36 136.2 38.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.592 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.646 HG23 HG23 ' E' ' 156' ' ' VAL . 0.0 OUTLIER -152.05 -175.35 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.562 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.44 130.05 38.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.685 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.81 -59.23 0.91 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.8 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.34 166.18 27.93 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.868 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . 0.612 ' HA ' HG22 ' E' ' 153' ' ' THR . 27.0 m -94.38 121.15 35.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 0.0 111.197 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.73 115.61 36.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.208 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -99.54 137.51 37.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.374 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' E' ' 32' ' ' VAL . 76.0 m-85 -127.6 97.74 4.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.792 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.31 175.76 6.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.428 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.0 149.45 5.77 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.948 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.29 108.58 13.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.855 0.359 . . . . 0.0 110.35 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' E' ' 37' ' ' VAL . 23.5 t -86.59 129.1 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.243 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' D' ' 22' ' ' ALA . 18.8 m -127.35 163.54 30.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.815 0.34 . . . . 0.0 111.011 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -85.97 61.4 6.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.052 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' ALA . . . . . 0.487 ' HB3' HG21 ' D' ' 65' ' ' VAL . . . 44.88 52.64 7.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' D' ' 61' ' ' CYS . . . -127.22 -54.42 1.37 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.49 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.1 OUTLIER 177.64 111.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.879 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . 0.498 ' HB2' HG22 ' D' ' 17' ' ' VAL . . . -105.69 126.06 51.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.108 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.81 145.65 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.003 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.612 ' O ' HG23 ' D' ' 28' ' ' VAL . 4.0 m-20 -74.77 147.26 41.44 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.692 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.74 -43.62 18.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.396 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.96 -20.01 60.17 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.863 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 45.1 t -79.54 -26.12 41.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.899 0.381 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . 0.612 HG23 ' O ' ' D' ' 24' ' ' ASP . 57.3 t -49.1 -48.53 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.33 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.82 93.01 5.32 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.093 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.55 116.42 28.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.038 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.66 115.62 27.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.173 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' C' ' 12' ' ' PHE . 1.6 t -117.14 101.08 11.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.072 0.463 . . . . 0.0 110.469 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.58 126.97 52.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.698 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -68.2 -55.67 11.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.653 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.02 -111.69 3.94 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.498 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' GLN . . . . . 0.538 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -77.04 115.26 16.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.513 0.197 . . . . 0.0 110.947 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' C' ' 16' ' ' VAL . 67.6 t -131.0 105.83 11.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.888 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.67 154.1 17.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.722 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.637 ' HA ' HD12 ' D' ' 42' ' ' LEU . 8.3 p -78.7 -19.86 51.43 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.775 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -19.53 65.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.14 0.495 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 96.8 p -92.05 -21.2 20.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.184 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.718 ' CB ' ' HB2' ' D' ' 139' ' ' ALA . 0.2 OUTLIER -139.08 62.25 1.54 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.602 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . 0.728 ' HA ' ' HA ' ' D' ' 142' ' ' ALA . . . -101.15 9.17 42.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.36 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.17 136.06 24.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.359 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . 0.587 ' N ' ' HA2' ' D' ' 141' ' ' GLY . 16.4 tt0 -58.53 121.37 10.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 0.0 111.133 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.25 -25.44 8.25 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.209 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.75 137.22 58.21 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.83 158.07 44.32 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.95 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.05 -166.23 1.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.512 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.632 ' HB2' ' HA ' ' A' ' 92' ' ' ALA . 48.9 m -65.17 156.11 32.79 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.769 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' D' ' 134' ' ' GLN . . . -90.46 126.7 35.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.358 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' VAL . . . . . 0.869 HG13 ' HA ' ' A' ' 90' ' ' SER . 63.2 t -75.66 118.53 21.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.999 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.84 135.69 13.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.672 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.538 ' H ' HG21 ' A' ' 76' ' ' THR . 46.3 p90 -170.77 142.11 1.9 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' ASN . . . . . 0.68 ' HA ' ' O ' ' D' ' 131' ' ' ILE . 11.6 p30 -126.58 163.88 22.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.526 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' D' ' 130' ' ' THR . 20.7 mm -105.08 119.93 54.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.516 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' GLN . . . . . 0.698 ' HA ' HG22 ' D' ' 130' ' ' THR . 0.0 OUTLIER -82.15 115.65 21.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.761 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . 0.64 HD11 HG13 ' D' ' 131' ' ' ILE . 0.0 OUTLIER -128.21 107.42 9.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.298 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.35 177.0 8.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.951 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.11 66.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.756 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 3.3 m -109.66 154.39 22.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.742 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . 0.522 ' HA ' ' OD1' ' D' ' 126' ' ' ASN . 0.5 OUTLIER -154.66 138.37 16.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.214 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' D' ' 66' ' ' ALA . 0.2 OUTLIER -97.64 -11.82 23.14 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.19 -48.82 40.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.03 0.443 . . . . 0.0 111.746 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . 0.487 HG21 ' HB3' ' D' ' 19' ' ' ALA . 10.5 t -68.92 -48.71 68.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.742 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' D' ' 159' ' ' GLN . . . -137.97 153.32 49.46 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.637 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.27 18.68 4.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.926 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' LYS . . . . . 0.621 ' HB3' ' HB3' ' D' ' 159' ' ' GLN . 10.6 tppt? -142.84 149.9 39.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.573 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' ALA . . . . . 0.869 ' HB2' HD12 ' D' ' 124' ' ' LEU . . . -149.97 110.75 4.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.633 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' D' ' 121' ' ' GLU . . . -108.06 169.95 8.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.131 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . 0.431 HG21 HG21 ' D' ' 131' ' ' ILE . 0.5 OUTLIER -130.4 150.96 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.642 -179.507 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 72' ' ' ALA . . . . . 0.685 ' HB1' ' HA ' ' D' ' 116' ' ' ALA . . . -135.57 100.1 4.4 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.555 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 73' ' ' PHE . . . . . 0.435 ' HB2' HD22 ' D' ' 111' ' ' LEU . 0.2 OUTLIER -77.46 133.94 38.49 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.599 0.238 . . . . 0.0 111.128 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 74' ' ' LEU . . . . . 0.749 HD11 ' HG2' ' D' ' 155' ' ' LYS . 0.0 OUTLIER -124.15 115.08 20.53 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.932 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.35 -173.22 26.48 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.821 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -112.62 149.06 33.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.681 0.277 . . . . 0.0 110.739 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' D' ' 85' ' ' VAL . . . -98.95 133.79 42.72 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.939 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 78' ' ' ILE . . . . . 0.787 ' HB ' ' HA ' ' D' ' 87' ' ' ALA . 16.1 tt -72.96 -37.95 55.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.89 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.21 167.63 12.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.834 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.22 -53.83 15.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.08 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.36 28.71 6.07 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.536 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . 0.832 ' HB3' ' HB ' ' D' ' 85' ' ' VAL . 10.3 m170 -111.33 -45.7 3.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.928 0.394 . . . . 0.0 110.453 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.39 -86.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.603 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' D' ' 82' ' ' HIS . 0.0 OUTLIER -42.19 -42.46 3.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.268 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.832 ' HB ' ' HB3' ' D' ' 82' ' ' HIS . 21.3 t -61.3 126.53 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.135 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.997 HD22 ' HB1' ' D' ' 150' ' ' ALA . 0.2 OUTLIER -81.22 164.42 22.3 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.432 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.787 ' HA ' ' HB ' ' D' ' 78' ' ' ILE . . . -104.84 -177.53 3.39 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.852 0.358 . . . . 0.0 111.618 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.01 -174.53 5.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.009 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.64 -170.72 3.24 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.367 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 27.8 p -74.76 7.87 2.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.905 0.383 . . . . 0.0 111.46 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . 0.421 ' HB2' ' HB3' ' D' ' 95' ' ' SER . 0.8 OUTLIER -97.06 80.41 2.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.84 -41.2 87.81 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.82 0.343 . . . . 0.0 111.636 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.72 26.01 9.1 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.682 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.77 -22.64 0.33 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.892 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 95' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' D' ' 91' ' ' SER . 1.0 OUTLIER -107.65 175.18 5.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 110.661 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.35 177.1 2.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . 0.497 ' O ' HG12 ' D' ' 99' ' ' VAL . 0.2 OUTLIER -138.6 167.85 21.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.278 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 98' ' ' ASN . . . . . 0.585 ' HA ' ' HB ' ' D' ' 140' ' ' THR . 32.4 m-80 44.2 51.68 7.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.489 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 99' ' ' VAL . . . . . 0.497 HG12 ' O ' ' D' ' 97' ' ' THR . 6.0 p -169.34 124.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.702 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.61 -164.65 11.47 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.58 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 101' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.84 91.13 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.202 0.525 . . . . 0.0 111.73 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 102' ' ' GLN . . . . . 0.706 ' HA ' ' HA ' ' D' ' 85' ' ' VAL . 0.6 OUTLIER -71.43 116.65 12.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.857 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 103' ' ' ILE . . . . . 0.666 HD12 HD11 ' D' ' 113' ' ' LEU . 6.6 mt -89.61 120.64 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.457 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 104' ' ' LEU . . . . . 0.517 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 1.0 OUTLIER -95.84 152.32 18.6 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.691 0.281 . . . . 0.0 111.126 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.14 160.09 14.6 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.629 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 106' ' ' ARG . . . . . 0.536 ' CZ ' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -68.89 -13.6 62.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.835 0.35 . . . . 0.0 111.075 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 107' ' ' THR . . . . . . . . . . . . . 45.3 p -74.42 -18.9 60.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.144 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.0 -40.15 2.22 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.669 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.3 164.7 13.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.338 . . . . 0.0 111.119 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -77.4 139.66 39.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.148 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 111' ' ' LEU . . . . . 0.554 HD21 ' HB ' ' D' ' 117' ' ' THR . 5.9 tt -84.18 128.59 34.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.404 0.621 . . . . 0.0 110.503 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 112' ' ' THR . . . . . 0.437 ' HA ' HD22 ' D' ' 84' ' ' ASN . 1.4 m -68.13 132.36 47.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.17 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 113' ' ' LEU . . . . . 0.666 HD11 HD12 ' D' ' 103' ' ' ILE . 4.7 mp -88.06 99.74 12.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.693 0.282 . . . . 0.0 110.737 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.06 -32.43 0.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.539 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . 0.497 ' CA ' HD23 ' D' ' 74' ' ' LEU . . . 146.45 -81.29 0.21 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.666 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 116' ' ' ALA . . . . . 0.685 ' HA ' ' HB1' ' D' ' 72' ' ' ALA . . . -97.23 64.12 1.89 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.0 0.429 . . . . 0.0 111.624 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 117' ' ' THR . . . . . 0.554 ' HB ' HD21 ' D' ' 111' ' ' LEU . 2.8 m -94.42 72.31 3.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.76 119.07 11.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.828 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.89 -49.03 0.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.57 84.75 6.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.575 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' D' ' 70' ' ' ALA . 3.6 mt-10 -110.16 86.94 2.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.268 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.0 159.32 17.66 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.83 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -67.07 138.33 57.07 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.68 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . 0.869 HD12 ' HB2' ' D' ' 69' ' ' ALA . 0.4 OUTLIER -86.47 159.46 19.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.68 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.55 176.28 10.19 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.635 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 126' ' ' ASN . . . . . 0.522 ' OD1' ' HA ' ' D' ' 62' ' ' ASP . 0.9 OUTLIER -85.98 161.52 18.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.639 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.53 -121.06 5.73 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.764 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 128' ' ' THR . . . . . 0.566 HG21 ' HE2' ' A' ' 155' ' ' LYS . 74.1 m -119.5 140.3 50.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.659 0.266 . . . . 0.0 110.765 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 129' ' ' ASN . . . . . 0.452 ' O ' HD12 ' D' ' 58' ' ' LEU . 5.1 t-20 -133.74 154.63 50.83 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.912 0.387 . . . . 0.0 111.087 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 130' ' ' THR . . . . . 0.698 HG22 ' HA ' ' D' ' 57' ' ' GLN . 28.2 p -133.36 154.32 50.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.167 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 131' ' ' ILE . . . . . 0.68 ' O ' ' HA ' ' D' ' 55' ' ' ASN . 1.0 OUTLIER -111.07 116.86 51.01 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 132' ' ' PRO . . . . . 0.6 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 7.7 Cg_endo -81.11 129.36 6.82 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.704 1.603 . . . . 0.0 112.667 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . 0.46 ' HB3' ' CE1' ' D' ' 54' ' ' PHE . 0.1 OUTLIER -140.87 146.87 38.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.81 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 134' ' ' GLN . . . . . 0.529 ' HB3' ' HB1' ' D' ' 51' ' ' ALA . 19.5 mm-40 -116.48 158.4 23.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.979 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' D' ' 103' ' ' ILE . . . -159.48 105.61 1.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.931 0.396 . . . . 0.0 111.539 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 136' ' ' ARG . . . . . 0.417 ' HG2' ' H ' ' D' ' 136' ' ' ARG . 1.2 ptt180 -103.68 172.57 6.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.405 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.23 147.72 24.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.086 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.58 159.05 35.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.005 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 139' ' ' ALA . . . . . 0.718 ' HB2' ' CB ' ' D' ' 42' ' ' LEU . . . -116.36 141.31 48.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.85 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 140' ' ' THR . . . . . 0.585 ' HB ' ' HA ' ' D' ' 98' ' ' ASN . 0.2 OUTLIER -107.78 27.2 9.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.496 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . 0.587 ' HA2' ' N ' ' D' ' 45' ' ' GLU . . . 97.55 83.6 1.71 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.014 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . 0.728 ' HA ' ' HA ' ' D' ' 43' ' ' ALA . . . 57.87 93.49 0.03 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.7 0.25 . . . . 0.0 110.759 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 143' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' D' ' 98' ' ' ASN . . . -79.97 165.44 22.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 111.375 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 144' ' ' THR . . . . . 0.405 ' HB ' ' CD ' ' D' ' 145' ' ' PRO . 29.4 p -108.37 168.85 7.25 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.234 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 145' ' ' PRO . . . . . 0.405 ' CD ' ' HB ' ' D' ' 144' ' ' THR . 1.3 Cg_endo -83.62 133.56 6.14 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.544 2.162 . . . . 0.0 112.002 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 146' ' ' GLY . . . . . 0.609 ' HA2' HG12 ' B' ' 5' ' ' VAL . . . 169.56 -119.25 0.81 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.477 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.84 121.69 13.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.787 0.327 . . . . 0.0 111.327 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.33 85.7 3.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.14 0.495 . . . . 0.0 110.506 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -104.57 131.21 52.25 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.597 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 150' ' ' ALA . . . . . 0.997 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -136.08 148.49 48.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.951 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.16 120.24 20.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.194 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.7 140.0 24.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.164 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 153' ' ' THR . . . . . 0.626 HG22 ' HA ' ' C' ' 9' ' ' THR . 70.7 p -105.2 171.18 7.46 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 154' ' ' PHE . . . . . 0.51 ' HZ ' HG21 ' D' ' 56' ' ' ILE . 13.5 p90 -138.18 147.4 43.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.138 0.494 . . . . 0.0 110.112 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 155' ' ' LYS . . . . . 0.749 ' HG2' HD11 ' D' ' 74' ' ' LEU . 13.7 mmtt -100.9 171.92 7.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.912 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 156' ' ' VAL . . . . . 0.646 HG23 HG23 ' C' ' 5' ' ' VAL . 0.4 OUTLIER -135.4 111.42 12.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.714 -179.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 157' ' ' GLN . . . . . 0.564 ' HA ' ' O ' ' C' ' 3' ' ' THR . 1.8 tt0 -109.03 141.32 41.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.273 0.559 . . . . 0.0 110.398 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 158' ' ' TYR . . . . . 0.48 ' CZ ' ' HB ' ' D' ' 156' ' ' VAL . 23.1 m-85 -135.43 105.43 6.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.555 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 159' ' ' GLN . . . . . 0.672 ' HA ' ' H ' ' C' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.899 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 111.48 0.178 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 2' ' ' ALA . . . . . 0.686 ' H ' ' HA ' ' F' ' 159' ' ' GLN . . . 56.56 88.6 0.05 OUTLIER 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.038 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 3' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' F' ' 157' ' ' GLN . 0.2 OUTLIER -103.14 110.34 22.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.411 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.31 136.26 38.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.57 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.66 HG23 HG23 ' F' ' 156' ' ' VAL . 0.0 OUTLIER -152.11 -175.28 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.616 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.54 130.06 38.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.646 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.73 -59.38 0.91 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.805 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.38 166.23 28.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.806 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 9' ' ' THR . . . . . 0.609 ' HA ' HG22 ' F' ' 153' ' ' THR . 27.0 m -94.47 121.18 35.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.939 0.4 . . . . 0.0 111.205 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.69 115.58 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.21 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -99.52 137.56 37.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.327 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 12' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' F' ' 32' ' ' VAL . 76.2 m-85 -127.61 97.78 4.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.815 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.3 175.8 6.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.378 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.97 149.46 5.77 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.91 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.29 108.61 13.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 110.345 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 16' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' F' ' 37' ' ' VAL . 23.4 t -86.62 129.16 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.213 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' E' ' 22' ' ' ALA . 18.7 m -127.43 163.53 30.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.787 0.327 . . . . 0.0 111.028 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -85.95 61.36 6.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.032 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 19' ' ' ALA . . . . . 0.491 ' HB3' HG21 ' E' ' 65' ' ' VAL . . . 45.0 52.64 8.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.051 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' E' ' 61' ' ' CYS . . . -127.27 -54.47 1.37 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.426 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 21' ' ' CYS . . . . . 0.818 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.1 OUTLIER 177.68 111.67 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.901 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 22' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' E' ' 17' ' ' VAL . . . -105.71 126.0 51.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.86 145.68 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.003 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 24' ' ' ASP . . . . . 0.607 ' O ' HG23 ' E' ' 28' ' ' VAL . 3.9 m-20 -74.9 147.28 41.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.652 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.73 -43.71 18.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.331 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.85 -20.06 60.27 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.865 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 45.1 t -79.58 -26.09 41.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.872 0.367 . . . . 0.0 110.851 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 28' ' ' VAL . . . . . 0.607 HG23 ' O ' ' E' ' 24' ' ' ASP . 57.8 t -49.13 -48.49 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.361 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.89 93.09 5.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.976 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.63 116.38 28.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.04 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.54 115.58 27.63 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.178 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' D' ' 12' ' ' PHE . 1.7 t -117.17 101.14 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.168 0.509 . . . . 0.0 110.463 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.58 126.91 52.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.711 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.613 HD21 ' HB3' ' B' ' 92' ' ' ALA . 0.3 OUTLIER -68.15 -55.71 11.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.619 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.03 -111.69 3.93 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.471 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 36' ' ' GLN . . . . . 0.545 ' HG3' ' HA ' ' D' ' 24' ' ' ASP . 0.0 OUTLIER -77.02 115.34 16.73 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.524 0.202 . . . . 0.0 110.902 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' D' ' 16' ' ' VAL . 67.5 t -131.11 105.85 11.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.819 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.6 154.11 17.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.77 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 39' ' ' THR . . . . . 0.665 ' HA ' HD12 ' E' ' 42' ' ' LEU . 8.4 p -78.71 -19.92 51.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.753 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.38 -19.58 65.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.125 0.488 . . . . 0.0 110.923 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 97.1 p -92.01 -21.24 20.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.156 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.701 ' CB ' ' HB2' ' E' ' 139' ' ' ALA . 0.2 OUTLIER -139.06 62.39 1.54 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.661 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 43' ' ' ALA . . . . . 0.727 ' HA ' ' HA ' ' E' ' 142' ' ' ALA . . . -101.23 9.12 42.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.246 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.15 136.02 24.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.32 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . 0.59 ' N ' ' HA2' ' E' ' 141' ' ' GLY . 16.5 tt0 -58.5 121.24 10.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 0.0 111.159 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.36 -25.47 8.19 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.196 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.66 137.24 58.22 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.93 157.93 44.75 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.919 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.97 -166.19 1.09 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.583 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 50' ' ' SER . . . . . 0.621 ' HB2' ' HA ' ' B' ' 92' ' ' ALA . 48.7 m -65.22 156.23 32.53 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.789 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 51' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' E' ' 134' ' ' GLN . . . -90.57 126.66 36.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.274 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 52' ' ' VAL . . . . . 0.898 HG13 ' HA ' ' B' ' 90' ' ' SER . 63.3 t -75.61 118.46 21.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.016 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.78 135.65 13.77 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.663 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 54' ' ' PHE . . . . . 0.531 ' H ' HG21 ' B' ' 76' ' ' THR . 46.2 p90 -170.77 142.04 1.89 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.831 0.348 . . . . 0.0 110.907 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 55' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' E' ' 131' ' ' ILE . 11.6 p30 -126.5 163.87 22.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.621 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 56' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' E' ' 130' ' ' THR . 21.0 mm -105.1 119.93 54.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.52 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 57' ' ' GLN . . . . . 0.675 ' HA ' HG22 ' E' ' 130' ' ' THR . 0.0 OUTLIER -82.18 115.74 21.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.744 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . 0.648 HD11 HG13 ' E' ' 131' ' ' ILE . 0.0 OUTLIER -128.28 107.45 9.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.267 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.34 177.09 8.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.924 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 62.95 66.13 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.818 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 61' ' ' CYS . . . . . 0.818 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 3.3 m -109.65 154.42 22.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.785 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . 0.512 ' HA ' ' OD1' ' E' ' 126' ' ' ASN . 0.5 OUTLIER -154.68 138.35 16.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.258 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 63' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' E' ' 66' ' ' ALA . 0.2 OUTLIER -97.63 -11.81 23.17 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.131 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.23 -48.72 40.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.993 0.425 . . . . 0.0 111.733 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' E' ' 19' ' ' ALA . 10.7 t -69.02 -48.67 68.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.712 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 66' ' ' ALA . . . . . 0.554 ' HB1' ' O ' ' E' ' 159' ' ' GLN . . . -137.94 153.39 49.49 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.616 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.3 18.62 4.43 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.802 0.334 . . . . 0.0 110.91 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 68' ' ' LYS . . . . . 0.611 ' HB3' ' HB3' ' E' ' 159' ' ' GLN . 10.6 tppt? -142.83 149.94 39.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.448 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 69' ' ' ALA . . . . . 0.863 ' HB2' HD12 ' E' ' 124' ' ' LEU . . . -150.01 110.65 4.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.729 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' E' ' 121' ' ' GLU . . . -108.01 169.92 8.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.067 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . 0.43 HG21 HG21 ' E' ' 131' ' ' ILE . 0.5 OUTLIER -130.34 150.95 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.681 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . 0.701 ' HB1' ' HA ' ' E' ' 116' ' ' ALA . . . -135.59 100.13 4.4 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.528 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 73' ' ' PHE . . . . . 0.437 ' HB2' HD22 ' E' ' 111' ' ' LEU . 0.2 OUTLIER -77.39 133.94 38.56 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.594 0.235 . . . . 0.0 111.136 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 74' ' ' LEU . . . . . 0.731 HD11 ' HG2' ' E' ' 155' ' ' LYS . 0.0 OUTLIER -124.17 115.06 20.49 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.971 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.35 -173.22 26.48 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.79 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -112.66 149.03 33.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.624 0.25 . . . . 0.0 110.715 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 77' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' E' ' 85' ' ' VAL . . . -98.95 133.8 42.71 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.852 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 78' ' ' ILE . . . . . 0.778 ' HB ' ' HA ' ' E' ' 87' ' ' ALA . 16.1 tt -72.95 -37.98 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.19 167.6 12.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.907 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.09 -53.86 15.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.4 28.67 6.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.597 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 82' ' ' HIS . . . . . 0.825 ' HB3' ' HB ' ' E' ' 85' ' ' VAL . 10.2 m170 -111.36 -45.57 3.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 0.0 110.446 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.4 -86.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.567 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 84' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' E' ' 82' ' ' HIS . 0.0 OUTLIER -42.17 -42.4 2.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.402 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.825 ' HB ' ' HB3' ' E' ' 82' ' ' HIS . 21.3 t -61.25 126.57 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.151 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 86' ' ' LEU . . . . . 1.029 HD22 ' HB1' ' E' ' 150' ' ' ALA . 0.2 OUTLIER -81.23 164.4 22.31 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 87' ' ' ALA . . . . . 0.778 ' HA ' ' HB ' ' E' ' 78' ' ' ILE . . . -104.77 -177.51 3.39 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.688 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.03 -174.56 5.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.974 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.59 -170.73 3.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.401 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 27.5 p -74.67 7.73 2.85 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.96 0.41 . . . . 0.0 111.464 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 91' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' E' ' 95' ' ' SER . 0.8 OUTLIER -96.93 80.42 2.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.86 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.87 -41.17 87.7 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.849 0.356 . . . . 0.0 111.623 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.7 25.94 9.17 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.664 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.8 -22.63 0.33 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.889 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 95' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' E' ' 91' ' ' SER . 1.0 OUTLIER -107.71 175.2 5.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.928 0.394 . . . . 0.0 110.597 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.37 177.08 3.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . 0.496 ' O ' HG12 ' E' ' 99' ' ' VAL . 0.2 OUTLIER -138.56 167.87 21.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.305 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 98' ' ' ASN . . . . . 0.57 ' HA ' ' HB ' ' E' ' 140' ' ' THR . 32.4 m-80 44.15 51.68 7.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.526 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 99' ' ' VAL . . . . . 0.496 HG12 ' O ' ' E' ' 97' ' ' THR . 6.0 p -169.36 124.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.753 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.53 -164.65 11.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.594 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.9 91.07 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 122.997 0.519 . . . . 0.0 111.735 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 102' ' ' GLN . . . . . 0.708 ' HA ' ' HA ' ' E' ' 85' ' ' VAL . 0.6 OUTLIER -71.38 116.65 11.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.901 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 103' ' ' ILE . . . . . 0.666 HD12 HD11 ' E' ' 113' ' ' LEU . 6.5 mt -89.66 120.59 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.511 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 104' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 1.0 OUTLIER -95.85 152.32 18.6 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.738 0.304 . . . . 0.0 111.105 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.08 160.07 14.61 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.553 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 106' ' ' ARG . . . . . 0.535 ' CZ ' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -68.81 -13.7 62.56 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.83 0.348 . . . . 0.0 111.064 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 44.8 p -74.4 -18.95 60.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.097 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.0 -40.12 2.23 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.639 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.36 164.63 13.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.774 0.321 . . . . 0.0 111.116 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 110' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -77.38 139.66 39.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.128 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 111' ' ' LEU . . . . . 0.556 HD21 ' HB ' ' E' ' 117' ' ' THR . 5.9 tt -84.16 128.58 34.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.449 0.642 . . . . 0.0 110.477 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 112' ' ' THR . . . . . 0.431 ' HA ' HD22 ' E' ' 84' ' ' ASN . 1.4 m -68.13 132.38 47.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.081 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 113' ' ' LEU . . . . . 0.666 HD11 HD12 ' E' ' 103' ' ' ILE . 4.7 mp -88.12 99.79 12.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.723 0.297 . . . . 0.0 110.699 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.09 -32.4 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.528 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . 0.497 ' CA ' HD23 ' E' ' 74' ' ' LEU . . . 146.42 -81.24 0.21 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.645 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 116' ' ' ALA . . . . . 0.701 ' HA ' ' HB1' ' E' ' 72' ' ' ALA . . . -97.24 64.03 1.88 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.038 0.447 . . . . 0.0 111.678 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 117' ' ' THR . . . . . 0.556 ' HB ' HD21 ' E' ' 111' ' ' LEU . 2.8 m -94.37 72.48 3.83 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.165 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.84 119.09 11.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.783 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.92 -49.03 0.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.83 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 3.0 m -88.55 84.73 6.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.573 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 121' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' E' ' 70' ' ' ALA . 3.5 mt-10 -110.26 86.95 2.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.263 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.06 159.32 17.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.801 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 2.5 t -67.04 138.38 57.14 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.734 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . 0.863 HD12 ' HB2' ' E' ' 69' ' ' ALA . 0.4 OUTLIER -86.53 159.54 19.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.636 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.66 176.22 10.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.595 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 126' ' ' ASN . . . . . 0.512 ' OD1' ' HA ' ' E' ' 62' ' ' ASP . 0.9 OUTLIER -85.89 161.47 19.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.703 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.51 -121.01 5.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.718 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 128' ' ' THR . . . . . 0.584 HG21 ' HE2' ' B' ' 155' ' ' LYS . 72.4 m -119.47 140.33 50.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.75 0.309 . . . . 0.0 110.788 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 129' ' ' ASN . . . . . 0.462 ' O ' HD12 ' E' ' 58' ' ' LEU . 5.1 t-20 -133.77 154.62 50.85 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.112 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 130' ' ' THR . . . . . 0.675 HG22 ' HA ' ' E' ' 57' ' ' GLN . 28.0 p -133.41 154.24 50.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.188 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 131' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' E' ' 55' ' ' ASN . 1.0 OUTLIER -110.88 116.79 51.49 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 132' ' ' PRO . . . . . 0.606 ' HB3' ' HA ' ' B' ' 76' ' ' THR . 7.6 Cg_endo -81.15 129.38 6.8 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.663 1.576 . . . . 0.0 112.667 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 133' ' ' PHE . . . . . 0.461 ' HB3' ' CE1' ' E' ' 54' ' ' PHE . 0.1 OUTLIER -140.81 146.89 38.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.796 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 134' ' ' GLN . . . . . 0.544 ' HB3' ' HB1' ' E' ' 51' ' ' ALA . 19.3 mm-40 -116.49 158.33 23.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.033 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 135' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' E' ' 103' ' ' ILE . . . -159.47 105.48 1.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.898 0.38 . . . . 0.0 111.589 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.67 172.53 6.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.457 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.18 147.77 24.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.051 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.65 159.0 36.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.994 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 139' ' ' ALA . . . . . 0.701 ' HB2' ' CB ' ' E' ' 42' ' ' LEU . . . -116.31 141.27 48.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.897 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 140' ' ' THR . . . . . 0.57 ' HB ' ' HA ' ' E' ' 98' ' ' ASN . 0.2 OUTLIER -107.81 27.22 9.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.499 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . 0.59 ' HA2' ' N ' ' E' ' 45' ' ' GLU . . . 97.5 83.57 1.7 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.031 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 142' ' ' ALA . . . . . 0.727 ' HA ' ' HA ' ' E' ' 43' ' ' ALA . . . 57.98 93.41 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.67 0.235 . . . . 0.0 110.765 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 143' ' ' ALA . . . . . 0.531 ' HA ' ' HB2' ' E' ' 98' ' ' ASN . . . -79.94 165.51 22.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.733 0.301 . . . . 0.0 111.453 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 144' ' ' THR . . . . . . . . . . . . . 29.6 p -108.49 168.86 7.22 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.202 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.59 133.54 6.16 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.572 2.181 . . . . 0.0 111.981 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 146' ' ' GLY . . . . . 0.626 ' HA2' HG12 ' C' ' 5' ' ' VAL . . . 169.55 -119.23 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.475 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.8 121.7 13.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.904 0.383 . . . . 0.0 111.382 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.34 85.68 3.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.541 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -104.58 131.25 52.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.58 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 150' ' ' ALA . . . . . 1.029 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -136.1 148.51 48.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.94 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.18 120.23 20.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.213 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.69 139.99 24.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.171 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 153' ' ' THR . . . . . 0.612 HG22 ' HA ' ' D' ' 9' ' ' THR . 71.0 p -105.21 171.17 7.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 154' ' ' PHE . . . . . 0.51 ' HZ ' HG21 ' E' ' 56' ' ' ILE . 13.6 p90 -138.18 147.39 43.78 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 110.143 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 155' ' ' LYS . . . . . 0.731 ' HG2' HD11 ' E' ' 74' ' ' LEU . 13.7 mmtt -100.92 171.94 7.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.919 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 156' ' ' VAL . . . . . 0.646 HG23 HG23 ' D' ' 5' ' ' VAL . 0.4 OUTLIER -135.44 111.37 12.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.754 0.311 . . . . 0.0 111.789 -179.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 157' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' D' ' 3' ' ' THR . 1.8 tt0 -108.97 141.28 41.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.312 0.577 . . . . 0.0 110.438 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 158' ' ' TYR . . . . . 0.487 ' CZ ' ' HB ' ' E' ' 156' ' ' VAL . 23.0 m-85 -135.36 105.52 6.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.613 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 159' ' ' GLN . . . . . 0.68 ' HA ' ' H ' ' D' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.903 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.57 88.66 0.05 OUTLIER 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.095 0.247 . . . . 0.0 110.995 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.11 110.45 22.4 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.397 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.49 136.11 38.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.534 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.99 -175.31 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.601 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.57 130.1 38.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.665 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.8 -59.26 0.91 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.794 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.4 166.22 28.06 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.899 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 26.9 m -94.44 121.15 35.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 111.196 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.68 115.66 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.229 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -99.55 137.5 37.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.361 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -127.62 97.8 4.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.748 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.26 175.74 6.58 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.458 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.04 149.48 5.78 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.897 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.32 108.6 13.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 110.407 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 23.4 t -86.61 129.15 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.183 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 17' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' F' ' 22' ' ' ALA . 18.7 m -127.39 163.54 30.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.06 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -85.93 61.37 6.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.041 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 19' ' ' ALA . . . . . 0.486 ' HB3' HG21 ' F' ' 65' ' ' VAL . . . 44.99 52.6 8.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' F' ' 61' ' ' CYS . . . -127.3 -54.42 1.36 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.44 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 21' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.1 OUTLIER 177.68 111.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.962 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 22' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' F' ' 17' ' ' VAL . . . -105.69 126.09 51.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.053 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.83 145.68 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.968 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 24' ' ' ASP . . . . . 0.623 ' O ' HG23 ' F' ' 28' ' ' VAL . 4.0 m-20 -74.86 147.24 41.27 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.66 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.77 -43.61 18.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.32 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.92 -20.01 60.25 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.896 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 45.6 t -79.6 -26.08 41.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 28' ' ' VAL . . . . . 0.623 HG23 ' O ' ' F' ' 24' ' ' ASP . 57.4 t -49.16 -48.52 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.279 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.84 93.04 5.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.965 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.54 116.42 28.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.035 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.62 115.63 27.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.155 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' E' ' 12' ' ' PHE . 1.7 t -117.21 101.1 11.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.133 0.492 . . . . 0.0 110.426 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.6 126.91 52.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.671 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 34' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' C' ' 92' ' ' ALA . 0.3 OUTLIER -68.15 -55.65 11.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.659 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.97 -111.67 3.93 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.555 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 36' ' ' GLN . . . . . 0.547 ' HG3' ' HA ' ' E' ' 24' ' ' ASP . 0.0 OUTLIER -77.0 115.28 16.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.52 0.2 . . . . 0.0 110.928 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' E' ' 16' ' ' VAL . 67.6 t -131.03 105.87 11.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.779 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.68 154.12 17.46 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.762 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 39' ' ' THR . . . . . 0.66 ' HA ' HD12 ' F' ' 42' ' ' LEU . 8.0 p -78.8 -19.81 51.25 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.724 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.42 -19.54 65.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.085 0.469 . . . . 0.0 110.913 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 96.6 p -92.08 -21.23 20.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.182 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . 0.702 ' CB ' ' HB2' ' F' ' 139' ' ' ALA . 0.2 OUTLIER -139.0 62.28 1.54 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.686 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 43' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' F' ' 142' ' ' ALA . . . -101.15 9.21 42.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.321 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.25 136.0 24.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.36 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . 0.586 ' N ' ' HA2' ' F' ' 141' ' ' GLY . 16.5 tt0 -58.6 121.36 10.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.942 0.401 . . . . 0.0 111.109 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.32 -25.4 8.23 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.139 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.86 137.25 58.22 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.909 0.385 . . . . 0.0 112.018 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.85 157.98 44.56 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.945 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.92 -166.16 1.09 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.642 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 50' ' ' SER . . . . . 0.613 ' HB2' ' HA ' ' C' ' 92' ' ' ALA . 48.9 m -65.2 156.15 32.73 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.818 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 51' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' F' ' 134' ' ' GLN . . . -90.47 126.73 36.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.32 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 52' ' ' VAL . . . . . 0.909 HG13 ' HA ' ' C' ' 90' ' ' SER . 63.1 t -75.66 118.55 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.981 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.78 135.68 13.8 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.687 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 54' ' ' PHE . . . . . 0.536 ' H ' HG21 ' C' ' 76' ' ' THR . 46.3 p90 -170.76 142.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.83 0.348 . . . . 0.0 110.948 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 55' ' ' ASN . . . . . 0.676 ' HA ' ' O ' ' F' ' 131' ' ' ILE . 11.5 p30 -126.59 163.95 22.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 56' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' F' ' 130' ' ' THR . 20.8 mm -105.16 119.91 54.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.516 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 57' ' ' GLN . . . . . 0.711 ' HA ' HG22 ' F' ' 130' ' ' THR . 0.0 OUTLIER -82.09 115.69 21.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.736 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . 0.645 HD11 HG13 ' F' ' 131' ' ' ILE . 0.0 OUTLIER -128.25 107.45 9.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.261 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.38 177.0 8.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.902 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 63.06 66.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.782 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 61' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 3.3 m -109.68 154.42 22.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.729 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . 0.531 ' HA ' ' OD1' ' F' ' 126' ' ' ASN . 0.5 OUTLIER -154.66 138.33 16.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.234 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 63' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' F' ' 66' ' ' ALA . 0.2 OUTLIER -97.57 -11.85 23.2 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.13 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.21 -48.78 40.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.095 0.474 . . . . 0.0 111.764 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . 0.486 HG21 ' HB3' ' F' ' 19' ' ' ALA . 10.6 t -69.02 -48.66 68.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.729 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 66' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' F' ' 159' ' ' GLN . . . -137.97 153.4 49.45 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.64 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.25 18.59 4.45 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.907 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 68' ' ' LYS . . . . . 0.612 ' HB3' ' HB3' ' F' ' 159' ' ' GLN . 10.6 tppt? -142.87 149.89 39.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.444 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 69' ' ' ALA . . . . . 0.865 ' HB2' HD12 ' F' ' 124' ' ' LEU . . . -150.01 110.71 4.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.714 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 70' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' F' ' 121' ' ' GLU . . . -108.05 169.95 8.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.034 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 71' ' ' VAL . . . . . 0.433 HG21 HG21 ' F' ' 131' ' ' ILE . 0.5 OUTLIER -130.37 150.95 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.647 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 72' ' ' ALA . . . . . 0.68 ' HB1' ' HA ' ' F' ' 116' ' ' ALA . . . -135.57 100.11 4.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.558 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 73' ' ' PHE . . . . . 0.438 ' HB2' HD22 ' F' ' 111' ' ' LEU . 0.2 OUTLIER -77.46 133.94 38.49 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.552 0.215 . . . . 0.0 111.154 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 74' ' ' LEU . . . . . 0.743 HD11 ' HG2' ' F' ' 155' ' ' LYS . 0.0 OUTLIER -124.16 115.11 20.58 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.975 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.34 -173.22 26.47 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.77 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 7.1 m -112.68 149.04 33.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.647 0.261 . . . . 0.0 110.726 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 77' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' F' ' 85' ' ' VAL . . . -98.91 133.72 42.79 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.002 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 78' ' ' ILE . . . . . 0.761 ' HB ' ' HA ' ' F' ' 87' ' ' ALA . 16.1 tt -72.89 -37.99 55.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.907 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.17 167.62 12.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.832 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.2 -53.86 15.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.027 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.34 28.73 6.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.6 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 82' ' ' HIS . . . . . 0.824 ' HB3' ' HB ' ' F' ' 85' ' ' VAL . 10.2 m170 -111.35 -45.62 3.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 0.0 110.434 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.43 -86.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.577 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 84' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' F' ' 82' ' ' HIS . 0.0 OUTLIER -42.19 -42.4 3.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.343 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 85' ' ' VAL . . . . . 0.824 ' HB ' ' HB3' ' F' ' 82' ' ' HIS . 21.3 t -61.35 126.54 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.165 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 86' ' ' LEU . . . . . 1.031 HD22 ' HB1' ' F' ' 150' ' ' ALA . 0.2 OUTLIER -81.19 164.41 22.34 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.247 179.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 87' ' ' ALA . . . . . 0.761 ' HA ' ' HB ' ' F' ' 78' ' ' ILE . . . -104.83 -177.58 3.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.903 0.383 . . . . 0.0 111.644 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -174.53 5.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.68 -170.69 3.23 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.356 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 27.9 p -74.74 7.76 2.86 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 111.42 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 91' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' F' ' 95' ' ' SER . 0.8 OUTLIER -96.91 80.37 3.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.86 -41.16 87.8 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.858 0.361 . . . . 0.0 111.606 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.74 26.0 9.12 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.687 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.78 -22.78 0.33 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.902 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 95' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' F' ' 91' ' ' SER . 1.0 OUTLIER -107.65 175.24 5.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.929 0.395 . . . . 0.0 110.646 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.51 177.11 3.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.849 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . 0.506 ' O ' HG12 ' F' ' 99' ' ' VAL . 0.2 OUTLIER -138.53 167.78 21.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.277 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 98' ' ' ASN . . . . . 0.581 ' HA ' ' HB ' ' F' ' 140' ' ' THR . 32.5 m-80 44.15 51.69 7.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.515 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 99' ' ' VAL . . . . . 0.506 HG12 ' O ' ' F' ' 97' ' ' THR . 6.0 p -169.37 124.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.787 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.55 -164.72 11.5 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.616 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.85 91.12 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.192 0.52 . . . . 0.0 111.758 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 102' ' ' GLN . . . . . 0.704 ' HA ' ' HA ' ' F' ' 85' ' ' VAL . 0.6 OUTLIER -71.37 116.61 11.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.836 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 103' ' ' ILE . . . . . 0.654 HD12 HD11 ' F' ' 113' ' ' LEU . 6.6 mt -89.59 120.62 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.5 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 104' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 1.0 OUTLIER -95.81 152.3 18.61 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.679 0.276 . . . . 0.0 111.083 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.11 160.07 14.61 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.645 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 106' ' ' ARG . . . . . 0.533 ' CZ ' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -68.79 -13.71 62.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.873 0.368 . . . . 0.0 111.082 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 44.9 p -74.37 -18.96 60.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.075 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.0 -40.08 2.23 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.682 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.32 164.68 13.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 0.0 111.107 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 110' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -77.36 139.63 39.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.1 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 111' ' ' LEU . . . . . 0.556 HD21 ' HB ' ' F' ' 117' ' ' THR . 5.9 tt -84.13 128.55 34.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.469 0.652 . . . . 0.0 110.477 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 112' ' ' THR . . . . . 0.44 ' HA ' HD22 ' F' ' 84' ' ' ASN . 1.4 m -68.14 132.41 47.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.133 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 113' ' ' LEU . . . . . 0.654 HD11 HD12 ' F' ' 103' ' ' ILE . 4.8 mp -88.06 99.69 12.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.684 0.278 . . . . 0.0 110.778 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.04 -32.48 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.628 0.252 . . . . 0.0 111.541 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . 0.491 ' CA ' HD23 ' F' ' 74' ' ' LEU . . . 146.53 -81.37 0.21 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.575 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 116' ' ' ALA . . . . . 0.68 ' HA ' ' HB1' ' F' ' 72' ' ' ALA . . . -97.1 63.99 1.92 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.986 0.422 . . . . 0.0 111.649 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 117' ' ' THR . . . . . 0.556 ' HB ' HD21 ' F' ' 111' ' ' LEU . 2.8 m -94.29 72.35 3.87 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.169 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.79 119.12 11.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.821 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.95 -49.05 0.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.778 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.55 84.69 6.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.606 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 121' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' F' ' 70' ' ' ALA . 3.6 mt-10 -110.23 87.06 2.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.236 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.04 159.27 17.66 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.802 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -67.01 138.34 57.15 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.654 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . 0.865 HD12 ' HB2' ' F' ' 69' ' ' ALA . 0.4 OUTLIER -86.47 159.44 19.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.692 179.389 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.53 176.28 10.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.64 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 126' ' ' ASN . . . . . 0.531 ' OD1' ' HA ' ' F' ' 62' ' ' ASP . 0.9 OUTLIER -85.91 161.5 19.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.667 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.46 -121.07 5.72 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.718 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 128' ' ' THR . . . . . 0.573 HG21 ' HE2' ' C' ' 155' ' ' LYS . 72.0 m -119.42 140.28 50.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.714 0.292 . . . . 0.0 110.821 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 129' ' ' ASN . . . . . 0.462 ' O ' HD12 ' F' ' 58' ' ' LEU . 5.1 t-20 -133.68 154.66 50.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.883 0.373 . . . . 0.0 111.122 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 130' ' ' THR . . . . . 0.711 HG22 ' HA ' ' F' ' 57' ' ' GLN . 28.0 p -133.4 154.3 50.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.091 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 131' ' ' ILE . . . . . 0.676 ' O ' ' HA ' ' F' ' 55' ' ' ASN . 1.0 OUTLIER -111.02 116.8 51.2 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 132' ' ' PRO . . . . . 0.609 ' HB3' ' HA ' ' C' ' 76' ' ' THR . 7.6 Cg_endo -81.14 129.43 6.83 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.665 1.576 . . . . 0.0 112.641 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 133' ' ' PHE . . . . . 0.463 ' HB3' ' CE1' ' F' ' 54' ' ' PHE . 0.1 OUTLIER -140.86 146.86 38.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.807 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 134' ' ' GLN . . . . . 0.533 ' HB3' ' HB1' ' F' ' 51' ' ' ALA . 19.2 mm-40 -116.52 158.34 23.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.008 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 135' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' F' ' 103' ' ' ILE . . . -159.37 105.45 1.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.847 0.356 . . . . 0.0 111.533 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.66 172.54 6.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.439 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.18 147.82 24.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.066 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.68 159.02 36.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.949 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 139' ' ' ALA . . . . . 0.702 ' HB2' ' CB ' ' F' ' 42' ' ' LEU . . . -116.3 141.21 48.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.9 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 140' ' ' THR . . . . . 0.581 ' HB ' ' HA ' ' F' ' 98' ' ' ASN . 0.2 OUTLIER -107.79 27.22 9.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.462 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . 0.586 ' HA2' ' N ' ' F' ' 45' ' ' GLU . . . 97.56 83.56 1.7 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.846 -0.693 . . . . 0.0 113.025 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 142' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' F' ' 43' ' ' ALA . . . 57.9 93.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.531 0.205 . . . . 0.0 110.813 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 143' ' ' ALA . . . . . 0.535 ' HA ' ' HB2' ' F' ' 98' ' ' ASN . . . -80.01 165.42 22.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.772 0.32 . . . . 0.0 111.37 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 144' ' ' THR . . . . . . . . . . . . . 29.8 p -108.42 168.86 7.23 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.196 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.58 133.56 6.18 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.56 2.174 . . . . 0.0 112.007 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 146' ' ' GLY . . . . . 0.616 ' HA2' HG12 ' D' ' 5' ' ' VAL . . . 169.53 -119.22 0.81 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.456 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.85 121.7 13.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.866 0.365 . . . . 0.0 111.27 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.35 85.65 3.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.485 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -104.5 131.29 52.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.581 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 150' ' ' ALA . . . . . 1.031 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -136.14 148.49 48.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.958 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.18 120.21 20.89 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.226 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.65 140.02 24.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.188 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 153' ' ' THR . . . . . 0.609 HG22 ' HA ' ' E' ' 9' ' ' THR . 70.5 p -105.24 171.13 7.48 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 154' ' ' PHE . . . . . 0.507 ' HZ ' HG21 ' F' ' 56' ' ' ILE . 13.7 p90 -138.13 147.42 43.92 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.152 0.501 . . . . 0.0 110.054 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 155' ' ' LYS . . . . . 0.743 ' HG2' HD11 ' F' ' 74' ' ' LEU . 13.6 mmtt -100.91 171.93 7.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.928 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 156' ' ' VAL . . . . . 0.66 HG23 HG23 ' E' ' 5' ' ' VAL . 0.4 OUTLIER -135.48 111.44 12.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.813 0.34 . . . . 0.0 111.717 -179.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 157' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' E' ' 3' ' ' THR . 1.8 tt0 -109.01 141.24 41.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.318 0.58 . . . . 0.0 110.431 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 158' ' ' TYR . . . . . 0.482 ' CZ ' ' HB ' ' F' ' 156' ' ' VAL . 23.0 m-85 -135.38 105.44 6.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.613 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 159' ' ' GLN . . . . . 0.686 ' HA ' ' H ' ' E' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.522 0.201 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' B' ' 158' ' ' TYR . 7.3 m -104.81 78.63 1.45 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.493 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.34 122.36 29.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.543 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.646 HG23 HG23 ' B' ' 156' ' ' VAL . 5.0 m -137.91 162.94 30.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.564 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.425 ' HB3' ' OE2' ' B' ' 15' ' ' GLU . 44.1 t-20 -84.29 114.57 21.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.626 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.481 ' HA3' ' CZ ' ' B' ' 154' ' ' PHE . . . -83.43 -41.48 8.39 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.719 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.446 ' N ' ' CE1' ' B' ' 154' ' ' PHE . . . -175.59 162.29 31.55 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.863 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' B' ' 153' ' ' THR . 99.0 m -90.75 137.84 32.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.929 0.395 . . . . 0.0 111.282 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.46 114.34 46.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.163 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.409 ' HD2' ' OD2' ' B' ' 151' ' ' ASP . 4.6 m80 -99.37 148.58 24.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.33 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.818 ' HB3' HD21 ' B' ' 34' ' ' LEU . 60.8 m-85 -133.8 113.09 11.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.76 ' HG2' ' HA ' ' B' ' 33' ' ' GLN . 0.0 OUTLIER -107.19 105.94 16.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.332 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.25 169.46 28.91 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.999 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.552 ' HB2' ' HG3' ' B' ' 36' ' ' GLN . 33.6 mt-10 -140.73 -171.02 3.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.839 0.352 . . . . 0.0 110.4 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.577 HG13 HG23 ' B' ' 37' ' ' VAL . 0.5 OUTLIER -139.24 152.86 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.209 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.735 ' O ' HG23 ' B' ' 39' ' ' THR . 0.0 OUTLIER -137.51 155.37 31.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.87 0.367 . . . . 0.0 111.061 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -85.23 53.1 2.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.041 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.679 ' HA ' ' HG2' ' B' ' 38' ' ' ARG . . . 61.46 92.67 0.05 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.066 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.575 ' H ' ' HG2' ' B' ' 38' ' ' ARG . . . -164.77 -47.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.476 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.654 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 1.6 m -159.8 176.83 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.009 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.611 ' HB2' ' HE ' ' B' ' 38' ' ' ARG . . . -147.27 111.93 5.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.137 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.618 HG13 ' HB3' ' A' ' 27' ' ' SER . 43.0 t -67.37 143.19 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.989 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.548 ' O ' HG23 ' A' ' 28' ' ' VAL . 17.0 m-20 -91.18 168.05 11.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.63 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.31 -50.0 74.31 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.468 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.42 -16.62 73.76 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.923 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.618 ' HB3' HG13 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -84.32 -24.36 29.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.907 0.384 . . . . 0.0 110.77 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.553 HG11 ' HG3' ' A' ' 13' ' ' LYS . 85.6 t -58.09 -37.24 60.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.33 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -140.38 106.02 5.12 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.03 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.433 HE21 ' HA ' ' A' ' 27' ' ' SER . 5.4 mt-30 -109.07 106.97 17.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.125 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.8 95.63 9.03 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.019 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 52' ' ' VAL . 51.6 t -85.84 138.25 19.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.055 0.455 . . . . 0.0 110.358 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -113.15 132.6 55.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.701 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.545 ' N ' HD22 ' A' ' 34' ' ' LEU . 1.9 mm? -94.54 -71.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.594 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.87 -111.32 0.72 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.518 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -160.96 105.77 1.37 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.61 0.243 . . . . 0.0 110.879 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 m -91.1 142.35 13.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.978 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 38' ' ' ARG . 0.7 OUTLIER -81.05 162.53 23.73 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.771 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.442 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 82.5 p -80.35 -16.92 53.43 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.761 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.73 -31.26 63.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.073 0.463 . . . . 0.0 110.828 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.01 -28.48 39.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.145 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 1.7 mp -133.14 70.05 1.47 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.67 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . -103.67 11.21 36.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.448 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.04 146.83 27.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.341 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.48 121.25 13.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.369 . . . . 0.0 111.091 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.52 -10.39 12.77 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.179 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 138' ' ' PHE . . . -68.83 142.22 54.92 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.44 HG21 ' NH2' ' A' ' 136' ' ' ARG . 6.9 t -134.69 140.86 46.31 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.904 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.0 m -106.04 -152.77 0.48 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.569 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.9 178.57 1.05 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.908 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.05 168.9 15.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.733 0.301 . . . . 0.0 111.308 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.71 HG22 ' HB3' ' A' ' 135' ' ' ALA . 14.9 m -118.1 132.22 68.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.21 107.67 3.57 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.633 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.604 ' HD1' HG23 ' A' ' 52' ' ' VAL . 55.5 p90 -140.34 132.03 27.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.764 0.316 . . . . 0.0 110.914 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.522 ' HB2' HG22 ' A' ' 130' ' ' THR . 1.6 p-10 -117.8 176.89 4.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.628 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.768 ' HB ' HD12 ' A' ' 131' ' ' ILE . 51.7 mm -119.05 121.74 67.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.478 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.37 122.59 30.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.829 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.584 ' HB2' ' HB3' ' A' ' 129' ' ' ASN . 0.9 OUTLIER -131.08 93.72 3.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.228 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.549 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.4 OUTLIER -77.1 160.85 28.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.899 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.2 87.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.756 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.654 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 69.8 m -120.52 131.87 54.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.75 97.87 9.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.255 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 1.5 m -77.41 -20.0 55.26 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.04 -27.53 68.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.023 0.439 . . . . 0.0 111.719 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.42 -35.71 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.626 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 63' ' ' THR . . . -131.03 131.29 44.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.642 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.45 -37.32 7.65 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.909 0.385 . . . . 0.0 110.932 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -121.72 171.37 8.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.553 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.55 136.15 15.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.587 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.706 ' HB3' ' HB3' ' A' ' 157' ' ' GLN . . . -94.57 157.97 15.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.028 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.38 106.24 20.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.713 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.83 ' HB3' ' HB3' ' A' ' 155' ' ' LYS . . . -109.58 164.26 12.69 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.619 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.661 ' HB2' HD11 ' A' ' 111' ' ' LEU . 6.6 t80 -142.2 141.1 32.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.497 0.189 . . . . 0.0 111.129 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.737 HD11 ' HG2' ' D' ' 57' ' ' GLN . 0.1 OUTLIER -122.7 103.35 8.61 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.008 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.503 ' HA3' HD23 ' A' ' 113' ' ' LEU . . . -153.44 -166.37 14.55 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.895 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.48 136.26 46.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.535 0.207 . . . . 0.0 110.726 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.677 ' H ' ' HB3' ' D' ' 132' ' ' PRO . . . -81.4 156.08 25.6 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.845 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.469 HG12 ' OG1' ' A' ' 140' ' ' THR . 3.1 tt -92.51 -20.69 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.773 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.557 ' HB2' HG21 ' A' ' 140' ' ' THR . 0.4 OUTLIER 176.15 179.76 0.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.829 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' D' ' 107' ' ' THR . . . -79.0 -33.81 44.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.974 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.42 -43.91 95.55 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.618 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.463 ' NE2' ' O ' ' A' ' 139' ' ' ALA . 43.7 m-70 -97.8 -64.41 1.04 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.827 0.346 . . . . 0.0 110.47 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.432 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.2 m 62.36 7.83 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.623 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.427 ' O ' HD12 ' A' ' 103' ' ' ILE . 6.5 m120 -115.11 -25.47 8.09 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.238 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . 0.5 OUTLIER -79.56 143.74 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.189 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.631 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -76.68 148.6 36.73 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.251 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.9 178.22 4.4 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.85 0.357 . . . . 0.0 111.651 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -84.66 176.23 8.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.116 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 149' ' ' ASN . 22.8 pt20 -75.33 178.72 5.64 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.32 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.527 ' O ' HG12 ' D' ' 52' ' ' VAL . 1.0 OUTLIER -73.36 -11.46 60.49 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.989 0.423 . . . . 0.0 111.411 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 0.3 OUTLIER -64.68 87.26 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.931 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.89 -7.14 53.83 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.879 0.371 . . . . 0.0 111.667 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.477 ' HB1' ' HB1' ' C' ' 22' ' ' ALA . . . -133.11 19.91 4.07 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.644 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.62 -15.6 0.16 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.897 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 1.0 OUTLIER -97.35 174.98 6.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.906 0.384 . . . . 0.0 110.619 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.644 ' O ' HD22 ' A' ' 88' ' ' LEU . . . -114.12 157.87 22.03 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.823 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.53 HG23 HD11 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -112.96 162.73 15.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.319 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 69.26 41.66 1.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.415 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.3 p -177.67 130.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.827 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.06 179.45 28.6 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.623 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.497 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 1.6 t -98.98 95.34 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.026 0.531 . . . . 0.0 111.71 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 1.9 tt0 -69.87 159.83 32.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.881 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.433 HG12 ' CE2' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -121.72 98.38 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.513 179.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.679 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 1.1 tp -84.65 119.36 25.15 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.716 0.293 . . . . 0.0 111.122 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.24 158.12 31.92 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.642 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.553 ' HB2' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -61.2 -33.93 74.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.87 0.366 . . . . 0.0 111.043 179.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.554 HG23 ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -48.75 -38.17 20.96 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.013 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.69 -88.87 0.11 Allowed Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.591 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.19 -176.33 5.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.868 0.366 . . . . 0.0 111.104 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.679 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -79.9 143.93 33.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.126 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.661 HD11 ' HB2' ' A' ' 73' ' ' PHE . 0.6 OUTLIER -90.14 157.54 17.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.387 0.613 . . . . 0.0 110.522 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.448 ' HB ' HG21 ' A' ' 117' ' ' THR . 29.4 m -81.04 150.46 28.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.201 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 113' ' ' LEU . 3.0 mp -102.75 57.7 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.757 0.313 . . . . 0.0 110.72 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.43 19.65 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.532 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.26 -93.1 0.88 Allowed Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.631 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' D' ' 125' ' ' ASN . . . -102.71 69.67 1.08 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.028 0.442 . . . . 0.0 111.596 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 5.8 p -89.69 97.3 11.11 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.19 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.15 102.81 5.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.752 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.4 -82.69 0.65 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.554 ' HA ' HG23 ' A' ' 107' ' ' THR . 0.1 OUTLIER -63.26 100.87 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.611 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.9 79.11 7.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.228 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.428 HG21 ' CD ' ' A' ' 132' ' ' PRO . 4.7 p -82.55 159.18 22.85 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.769 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.2 m -85.28 139.74 31.38 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.764 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.46 136.18 33.43 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.69 0.281 . . . . 0.0 110.591 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -120.86 143.57 48.83 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.604 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.13 148.93 34.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.688 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.66 -106.17 2.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.704 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -85.15 153.24 22.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.731 0.3 . . . . 0.0 110.804 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.584 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 23.2 t-20 -148.45 120.7 8.37 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.942 0.401 . . . . 0.0 111.109 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -104.21 147.26 27.67 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.139 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.768 HD12 ' HB ' ' A' ' 56' ' ' ILE . 89.8 mt -116.61 119.25 36.08 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 106' ' ' ARG . 7.7 Cg_endo -80.83 119.06 3.54 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 121.704 1.602 . . . . 0.0 112.574 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.04 147.35 29.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.783 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.15 155.94 47.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.043 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.71 ' HB3' HG22 ' A' ' 52' ' ' VAL . . . -140.07 115.66 10.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.882 0.372 . . . . 0.0 111.639 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.44 ' NH2' HG21 ' A' ' 48' ' ' THR . 0.5 OUTLIER -111.27 148.98 31.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.477 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.6 151.29 45.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.158 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -144.52 164.56 30.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.002 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.635 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -124.43 145.76 49.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.783 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.557 HG21 ' HB2' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -117.84 13.0 14.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.48 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.79 79.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.919 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.64 92.15 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.598 0.199 . . . . 0.0 110.788 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.08 154.78 33.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.704 0.288 . . . . 0.0 111.38 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.9 p -116.68 166.17 13.42 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.29 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.27 151.49 12.16 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.474 2.116 . . . . 0.0 112.018 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.6 -106.33 0.46 Allowed Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.417 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -139.06 163.26 32.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.834 0.349 . . . . 0.0 111.411 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.98 79.93 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.504 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 89' ' ' GLN . 87.1 m-20 -99.98 142.51 31.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.51 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.521 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -127.81 168.98 14.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.073 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.53 110.04 0.86 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.2 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.631 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -146.99 145.4 29.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.118 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.67 164.17 13.26 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.627 ' CZ ' HG21 ' A' ' 56' ' ' ILE . 15.4 p90 -110.83 151.6 27.63 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.061 0.458 . . . . 0.0 110.162 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.83 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -109.7 160.84 15.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.961 -178.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.14 112.91 3.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.756 0.312 . . . . 0.0 111.699 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.706 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -91.87 124.41 35.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.295 0.569 . . . . 0.0 110.447 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -117.13 135.48 53.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.515 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.889 179.894 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.55 100.24 0.04 OUTLIER 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.0 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.551 ' HB ' ' HB2' ' C' ' 158' ' ' TYR . 7.4 m -104.81 78.6 1.44 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.416 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.33 122.39 29.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.533 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.644 HG23 HG23 ' C' ' 156' ' ' VAL . 5.0 m -137.93 162.86 30.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.539 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . 0.434 ' HB3' ' OE2' ' C' ' 15' ' ' GLU . 44.0 t-20 -84.28 114.48 21.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.692 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . 0.496 ' HA3' ' CZ ' ' C' ' 154' ' ' PHE . . . -83.3 -41.54 8.43 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.703 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.444 ' N ' ' CE1' ' C' ' 154' ' ' PHE . . . -175.56 162.32 31.61 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.824 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' C' ' 153' ' ' THR . 99.2 m -90.81 137.91 31.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.925 0.393 . . . . 0.0 111.264 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.49 114.27 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.241 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' HIS . . . . . 0.409 ' HD2' ' OD2' ' C' ' 151' ' ' ASP . 4.5 m80 -99.31 148.54 24.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.364 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . 0.834 ' HB3' HD21 ' C' ' 34' ' ' LEU . 60.6 m-85 -133.8 113.1 11.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.714 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.757 ' HG2' ' HA ' ' C' ' 33' ' ' GLN . 0.0 OUTLIER -107.19 105.86 16.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.392 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.18 169.45 28.87 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.99 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.541 ' HB2' ' HG3' ' C' ' 36' ' ' GLN . 33.8 mt-10 -140.73 -171.08 3.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.85 0.357 . . . . 0.0 110.425 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.569 HG13 HG23 ' C' ' 37' ' ' VAL . 0.5 OUTLIER -139.21 152.81 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.222 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.729 ' O ' HG23 ' C' ' 39' ' ' THR . 0.0 OUTLIER -137.42 155.43 31.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.834 0.35 . . . . 0.0 111.031 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -85.25 53.12 2.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.956 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.663 ' HA ' ' HG2' ' C' ' 38' ' ' ARG . . . 61.37 92.7 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.111 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.577 ' H ' ' HG2' ' C' ' 38' ' ' ARG . . . -164.74 -47.65 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.447 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.588 ' O ' HG21 ' B' ' 17' ' ' VAL . 1.6 m -159.83 176.82 11.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.009 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.609 ' HB2' ' HE ' ' C' ' 38' ' ' ARG . . . -147.24 111.89 5.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.15 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.618 HG13 ' HB3' ' B' ' 27' ' ' SER . 43.1 t -67.3 143.08 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.052 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.533 ' O ' HG23 ' B' ' 28' ' ' VAL . 16.9 m-20 -91.11 168.16 11.83 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.622 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.02 74.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.39 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.4 -16.62 73.72 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.92 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.618 ' HB3' HG13 ' B' ' 23' ' ' VAL . 0.4 OUTLIER -84.35 -24.38 29.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.921 0.391 . . . . 0.0 110.782 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.539 HG11 ' HG3' ' B' ' 13' ' ' LYS . 86.1 t -58.14 -37.13 60.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.339 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -140.35 106.08 5.14 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.997 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' GLN . . . . . 0.435 HE21 ' HA ' ' B' ' 27' ' ' SER . 5.4 mt-30 -109.03 106.92 17.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.12 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.74 95.55 8.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.069 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.554 HG11 HG21 ' B' ' 52' ' ' VAL . 51.2 t -85.76 138.21 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 110.451 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.76 ' HA ' ' HG2' ' A' ' 13' ' ' LYS . 3.2 mt-30 -113.18 132.54 55.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.64 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.818 HD21 ' HB3' ' A' ' 12' ' ' PHE . 1.8 mm? -94.45 -71.54 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.625 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.88 -111.3 0.71 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.524 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.552 ' HG3' ' HB2' ' A' ' 15' ' ' GLU . 3.6 tt0 -161.0 105.74 1.36 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.653 0.263 . . . . 0.0 110.919 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.577 HG23 HG13 ' A' ' 16' ' ' VAL . 5.7 m -91.06 142.35 13.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.966 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.679 ' HG2' ' HA ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -81.07 162.49 23.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.707 179.248 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.735 HG23 ' O ' ' A' ' 17' ' ' VAL . 82.5 p -80.35 -16.85 53.58 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.784 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.77 -31.17 63.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.175 0.512 . . . . 0.0 110.899 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.04 -28.49 39.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.12 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.65 ' HB3' ' HB2' ' B' ' 139' ' ' ALA . 1.7 mp -133.23 70.09 1.47 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.673 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' B' ' 39' ' ' THR . . . -103.65 11.17 36.39 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.432 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.06 146.82 27.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.371 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.49 121.25 13.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 0.0 111.099 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.55 -10.4 12.72 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.15 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' B' ' 138' ' ' PHE . . . -68.85 142.27 54.87 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.851 0.357 . . . . 0.0 111.951 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.441 HG21 ' NH2' ' B' ' 136' ' ' ARG . 6.8 t -134.77 140.82 46.2 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.846 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . 0.403 ' OG ' HD11 ' B' ' 42' ' ' LEU . 17.2 m -106.06 -152.77 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.52 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.86 178.54 1.05 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.03 168.92 15.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.349 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.706 HG22 ' HB3' ' B' ' 135' ' ' ALA . 14.5 m -118.0 132.26 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.977 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.27 107.61 3.56 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.623 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . 0.591 ' HD1' HG23 ' B' ' 52' ' ' VAL . 55.6 p90 -140.34 132.06 27.35 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.812 0.339 . . . . 0.0 110.871 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.509 ' HB2' HG22 ' B' ' 130' ' ' THR . 1.6 p-10 -117.78 176.81 5.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.636 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.791 ' HB ' HD12 ' B' ' 131' ' ' ILE . 51.8 mm -119.05 121.73 67.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.556 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.35 122.78 30.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.753 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' B' ' 129' ' ' ASN . 0.9 OUTLIER -131.27 93.71 3.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.246 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' B' ' 22' ' ' ALA . 0.4 OUTLIER -77.03 160.89 28.75 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 -179.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.17 87.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.745 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 69.9 m -120.44 131.88 54.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.71 97.9 9.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.269 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' B' ' 66' ' ' ALA . 1.5 m -77.47 -19.96 55.14 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.06 -27.48 68.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 111.768 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.39 -35.76 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.643 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' B' ' 63' ' ' THR . . . -131.05 131.28 44.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.64 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.46 -37.31 7.65 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.892 0.377 . . . . 0.0 110.948 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -121.69 171.39 8.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.56 136.1 15.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.552 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.702 ' HB3' ' HB3' ' B' ' 157' ' ' GLN . . . -94.5 158.04 15.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.062 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.41 106.28 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.679 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.83 ' HB3' ' HB3' ' B' ' 155' ' ' LYS . . . -109.6 164.29 12.67 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.65 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.674 ' HB2' HD11 ' B' ' 111' ' ' LEU . 6.5 t80 -142.27 141.03 32.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.502 0.191 . . . . 0.0 111.174 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.727 HD11 ' HG2' ' E' ' 57' ' ' GLN . 0.1 OUTLIER -122.71 103.38 8.62 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.993 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . 0.503 ' HA3' HD23 ' B' ' 113' ' ' LEU . . . -153.45 -166.37 14.56 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.875 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.54 136.3 46.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.585 0.231 . . . . 0.0 110.709 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.673 ' H ' ' HB3' ' E' ' 132' ' ' PRO . . . -81.52 156.13 25.42 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.879 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.47 HG12 ' OG1' ' B' ' 140' ' ' THR . 3.1 tt -92.51 -20.71 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.811 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.554 ' HB2' HG21 ' B' ' 140' ' ' THR . 0.4 OUTLIER 176.18 179.76 0.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.818 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' E' ' 107' ' ' THR . . . -78.91 -33.89 45.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.007 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.44 -43.84 95.64 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.6 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.452 ' NE2' ' O ' ' B' ' 139' ' ' ALA . 43.5 m-70 -97.86 -64.38 1.04 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.829 0.347 . . . . 0.0 110.435 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' THR . . . . . 0.43 ' HA ' ' HB1' ' B' ' 77' ' ' ALA . 1.2 m 62.33 7.83 2.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.647 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . 0.422 ' O ' HD12 ' B' ' 103' ' ' ILE . 6.5 m120 -115.15 -25.41 8.09 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.203 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.782 ' HA ' ' HA ' ' B' ' 102' ' ' GLN . 0.5 OUTLIER -79.62 143.75 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.152 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' B' ' 152' ' ' ALA . 0.3 OUTLIER -76.69 148.52 36.77 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.306 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.8 178.15 4.39 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.876 0.369 . . . . 0.0 111.734 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.658 HD22 ' O ' ' B' ' 96' ' ' ALA . 0.0 OUTLIER -84.6 176.13 8.8 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.071 179.386 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . 0.542 ' HB3' ' HB2' ' B' ' 149' ' ' ASN . 22.8 pt20 -75.19 178.62 5.62 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.355 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . 0.535 ' O ' HG12 ' E' ' 52' ' ' VAL . 1.0 OUTLIER -73.34 -11.44 60.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.023 0.44 . . . . 0.0 111.409 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' SER . . . . . 0.514 ' HB3' ' HB3' ' B' ' 95' ' ' SER . 0.3 OUTLIER -64.72 87.27 0.06 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.909 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.86 -7.2 53.93 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.633 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . 0.465 ' HB1' ' HB1' ' D' ' 22' ' ' ALA . . . -133.09 19.87 4.07 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.641 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.66 -15.53 0.16 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.932 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' SER . . . . . 0.514 ' HB3' ' HB3' ' B' ' 91' ' ' SER . 1.0 OUTLIER -97.32 174.96 6.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.898 0.38 . . . . 0.0 110.583 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . 0.658 ' O ' HD22 ' B' ' 88' ' ' LEU . . . -114.13 157.88 22.02 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.83 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.544 HG23 HD11 ' B' ' 88' ' ' LEU . 0.2 OUTLIER -113.03 162.7 15.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.308 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 69.42 41.5 1.3 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.46 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 10.4 p -177.62 130.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.825 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.04 179.52 28.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.598 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' B' ' 86' ' ' LEU . 1.6 t -99.15 95.33 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.009 0.524 . . . . 0.0 111.672 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.782 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 1.9 tt0 -69.85 159.82 32.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.954 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.435 HG12 ' CE2' ' B' ' 73' ' ' PHE . 0.9 OUTLIER -121.69 98.41 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.56 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . 0.686 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 1.1 tp -84.8 119.38 25.23 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.792 0.33 . . . . 0.0 111.113 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.18 158.04 32.09 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.643 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . 0.555 ' HB2' ' HB2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -61.05 -33.93 74.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.913 0.387 . . . . 0.0 111.117 179.42 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.554 HG23 ' HA ' ' B' ' 120' ' ' SER . 0.0 OUTLIER -48.76 -38.25 21.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.972 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.73 -88.78 0.11 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.59 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.2 -176.35 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.892 0.377 . . . . 0.0 111.066 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.686 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -79.98 143.94 33.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' B' ' 73' ' ' PHE . 0.6 OUTLIER -90.09 157.56 17.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.363 0.601 . . . . 0.0 110.561 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.451 ' HB ' HG21 ' B' ' 117' ' ' THR . 29.7 m -81.12 150.43 28.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.111 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.606 HD12 ' N ' ' B' ' 113' ' ' LEU . 3.0 mp -102.7 57.66 0.78 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.691 0.281 . . . . 0.0 110.738 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.49 19.67 15.23 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.477 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.24 -93.05 0.88 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.634 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' E' ' 125' ' ' ASN . . . -102.71 69.66 1.08 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.03 0.443 . . . . 0.0 111.592 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' B' ' 72' ' ' ALA . 5.9 p -89.62 97.22 11.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.142 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.17 102.82 5.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.764 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.44 -82.74 0.65 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.554 ' HA ' HG23 ' B' ' 107' ' ' THR . 0.1 OUTLIER -63.22 100.93 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.614 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -88.87 79.02 7.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.143 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.436 HG21 ' CD ' ' B' ' 132' ' ' PRO . 4.6 p -82.52 159.17 22.9 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.737 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 16.0 m -85.33 139.71 31.37 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.746 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.36 136.15 33.44 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.609 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -120.8 143.56 48.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.644 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.2 148.95 34.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 110.63 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.67 -106.11 2.29 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.746 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -85.16 153.16 22.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.812 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . 0.597 ' HB3' ' HB2' ' B' ' 58' ' ' LEU . 23.1 t-20 -148.4 120.76 8.43 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.93 0.395 . . . . 0.0 111.112 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.509 HG22 ' HB2' ' B' ' 55' ' ' ASN . 0.2 OUTLIER -104.24 147.26 27.68 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.151 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' ILE . . . . . 0.791 HD12 ' HB ' ' B' ' 56' ' ' ILE . 89.9 mt -116.58 119.19 36.23 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' PRO . . . . . 0.555 ' HB2' ' HB2' ' B' ' 106' ' ' ARG . 7.6 Cg_endo -80.79 119.14 3.57 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.632 1.555 . . . . 0.0 112.535 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.05 147.3 29.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.775 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.13 155.88 47.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.04 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.706 ' HB3' HG22 ' B' ' 52' ' ' VAL . . . -140.06 115.67 10.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.648 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . 0.441 ' NH2' HG21 ' B' ' 48' ' ' THR . 0.5 OUTLIER -111.26 148.93 31.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.535 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.48 151.27 45.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.119 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' B' ' 47' ' ' ALA . 0.2 OUTLIER -144.52 164.58 30.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.033 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.65 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -124.45 145.68 49.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.809 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' THR . . . . . 0.554 HG21 ' HB2' ' B' ' 79' ' ' ASP . 0.2 OUTLIER -117.77 13.01 14.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.545 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.83 79.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.97 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.73 92.14 0.02 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.619 0.21 . . . . 0.0 110.769 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.08 154.8 33.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.698 0.285 . . . . 0.0 111.393 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.527 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 39.3 p -116.76 166.22 13.34 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.223 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . 0.485 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 1.4 Cg_endo -84.27 151.5 12.16 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.467 2.112 . . . . 0.0 111.976 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.62 -106.29 0.46 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.401 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -139.06 163.32 32.72 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.839 0.352 . . . . 0.0 111.386 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -166.01 79.93 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.546 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.542 ' HB2' ' HB3' ' B' ' 89' ' ' GLN . 87.2 m-20 -99.92 142.47 31.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.557 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.512 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -127.76 169.02 14.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.01 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . 0.409 ' OD2' ' HD2' ' A' ' 11' ' ' HIS . 4.2 t70 -165.6 109.94 0.85 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.261 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . 0.632 ' HB2' HD21 ' B' ' 86' ' ' LEU . . . -147.02 145.45 29.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.14 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -93.66 164.22 13.24 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.276 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' PHE . . . . . 0.622 ' CZ ' HG21 ' B' ' 56' ' ' ILE . 15.4 p90 -110.89 151.66 27.63 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.141 0.496 . . . . 0.0 110.137 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . 0.83 ' HB3' ' HB3' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -109.75 160.88 15.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.932 -178.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' VAL . . . . . 0.646 HG23 HG23 ' A' ' 5' ' ' VAL . 1.4 m -142.1 112.92 3.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.786 0.326 . . . . 0.0 111.706 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.702 ' HB3' ' HB3' ' B' ' 70' ' ' ALA . 0.3 OUTLIER -91.87 124.44 35.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.352 0.596 . . . . 0.0 110.426 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' TYR . . . . . 0.55 ' HB2' ' HB ' ' A' ' 3' ' ' THR . 57.3 m-85 -117.19 135.54 53.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.525 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.866 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.55 100.26 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.984 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' D' ' 158' ' ' TYR . 7.4 m -104.82 78.63 1.45 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.406 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 4' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' D' ' 156' ' ' VAL . 0.2 OUTLIER -85.31 122.39 29.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.599 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.646 HG23 HG23 ' D' ' 156' ' ' VAL . 5.0 m -137.94 162.94 30.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.472 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' ASN . . . . . 0.427 ' HB3' ' OE2' ' D' ' 15' ' ' GLU . 44.0 t-20 -84.37 114.55 21.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.615 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' D' ' 154' ' ' PHE . . . -83.47 -41.39 8.42 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.679 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . 0.443 ' N ' ' CE1' ' D' ' 154' ' ' PHE . . . -175.61 162.26 31.49 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.908 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' D' ' 153' ' ' THR . 99.2 m -90.79 137.92 31.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.981 0.42 . . . . 0.0 111.231 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.46 114.23 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.233 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' HIS . . . . . 0.412 ' HD2' ' OD2' ' D' ' 151' ' ' ASP . 4.5 m80 -99.29 148.56 24.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.347 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' PHE . . . . . 0.814 ' HB3' HD21 ' D' ' 34' ' ' LEU . 60.8 m-85 -133.83 113.07 11.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.723 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . 0.738 ' HG2' ' HA ' ' D' ' 33' ' ' GLN . 0.0 OUTLIER -107.14 105.86 16.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.395 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.18 169.44 28.87 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.992 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' GLU . . . . . 0.551 ' HB2' ' HG3' ' D' ' 36' ' ' GLN . 33.8 mt-10 -140.73 -171.07 3.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.913 0.387 . . . . 0.0 110.391 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.583 HG13 HG23 ' D' ' 37' ' ' VAL . 0.5 OUTLIER -139.24 152.77 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.251 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.715 ' O ' HG23 ' D' ' 39' ' ' THR . 0.0 OUTLIER -137.42 155.35 31.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.888 0.375 . . . . 0.0 111.047 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -85.13 53.11 2.63 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . 0.671 ' HA ' ' HG2' ' D' ' 38' ' ' ARG . . . 61.33 92.74 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.098 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . 0.583 ' H ' ' HG2' ' D' ' 38' ' ' ARG . . . -164.8 -47.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.438 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' CYS . . . . . 0.754 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 1.6 m -159.81 176.83 11.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.951 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . 0.61 ' HB2' ' HE ' ' D' ' 38' ' ' ARG . . . -147.28 111.99 5.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.115 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . 0.604 HG13 ' HB3' ' C' ' 27' ' ' SER . 43.0 t -67.44 143.22 15.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.015 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.546 ' O ' HG23 ' C' ' 28' ' ' VAL . 17.0 m-20 -91.2 168.1 11.86 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.629 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.36 -50.0 74.35 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.42 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.38 -16.64 73.69 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.907 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . 0.604 ' HB3' HG13 ' C' ' 23' ' ' VAL . 0.4 OUTLIER -84.31 -24.44 29.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.876 0.37 . . . . 0.0 110.742 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.546 HG23 ' O ' ' C' ' 24' ' ' ASP . 85.1 t -58.04 -37.23 60.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.359 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -140.37 105.91 5.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.043 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' GLN . . . . . 0.447 HE21 ' HA ' ' C' ' 27' ' ' SER . 5.4 mt-30 -108.95 106.95 17.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.155 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.79 95.6 9.02 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.047 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.546 HG11 HG21 ' C' ' 52' ' ' VAL . 51.7 t -85.82 138.24 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.099 0.476 . . . . 0.0 110.37 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.757 ' HA ' ' HG2' ' B' ' 13' ' ' LYS . 3.2 mt-30 -113.2 132.6 55.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.651 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' B' ' 12' ' ' PHE . 1.8 mm? -94.53 -71.43 0.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.627 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.83 -111.31 0.72 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.544 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . 0.541 ' HG3' ' HB2' ' B' ' 15' ' ' GLU . 3.6 tt0 -161.06 105.84 1.35 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.721 0.296 . . . . 0.0 110.874 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.569 HG23 HG13 ' B' ' 16' ' ' VAL . 5.6 m -91.15 142.37 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.937 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' ARG . . . . . 0.663 ' HG2' ' HA ' ' B' ' 19' ' ' ALA . 0.7 OUTLIER -81.18 162.55 23.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.694 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.729 HG23 ' O ' ' B' ' 17' ' ' VAL . 82.6 p -80.39 -16.79 53.66 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.765 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.81 -31.16 63.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.157 0.503 . . . . 0.0 110.839 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -28.5 39.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.11 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.636 ' HB3' ' HB2' ' C' ' 139' ' ' ALA . 1.7 mp -133.21 70.13 1.47 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.601 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' C' ' 39' ' ' THR . . . -103.67 11.18 36.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.5 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.01 146.83 27.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.466 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.5 121.28 13.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.871 0.367 . . . . 0.0 111.152 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.52 -10.47 12.75 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.114 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' C' ' 138' ' ' PHE . . . -68.78 142.21 54.98 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.874 0.369 . . . . 0.0 111.976 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' THR . . . . . 0.44 HG21 ' NH2' ' C' ' 136' ' ' ARG . 6.8 t -134.75 140.81 46.21 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.852 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 17.0 m -105.96 -152.79 0.48 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.56 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 1.4 t -65.94 178.6 1.06 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.859 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.11 168.82 15.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.805 0.336 . . . . 0.0 111.28 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' C' ' 135' ' ' ALA . 14.7 m -117.98 132.24 68.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.21 107.62 3.57 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.683 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . 0.591 ' HD1' HG23 ' C' ' 52' ' ' VAL . 55.6 p90 -140.31 132.09 27.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.741 0.305 . . . . 0.0 110.932 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.531 ' HB2' HG22 ' C' ' 130' ' ' THR . 1.5 p-10 -117.83 176.83 5.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.565 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.794 ' HB ' HD12 ' C' ' 131' ' ' ILE . 51.7 mm -119.02 121.68 67.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.533 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.29 122.71 30.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.826 0.346 . . . . 0.0 110.831 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . 0.588 ' HB2' ' HB3' ' C' ' 129' ' ' ASN . 0.9 OUTLIER -131.23 93.75 3.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . 0.534 ' O ' ' HB3' ' C' ' 22' ' ' ALA . 0.4 OUTLIER -77.08 160.82 28.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.871 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.26 87.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.74 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' CYS . . . . . 0.754 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 70.2 m -120.52 131.8 54.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.813 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.61 97.91 9.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.343 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' C' ' 66' ' ' ALA . 1.5 m -77.44 -19.96 55.23 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.04 -27.56 68.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.978 0.418 . . . . 0.0 111.711 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 16.9 t -95.36 -35.76 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.613 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' C' ' 63' ' ' THR . . . -130.9 131.29 44.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.706 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.45 -37.27 7.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.912 0.387 . . . . 0.0 110.983 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -121.74 171.36 8.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.503 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.58 136.15 15.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.593 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.728 ' HB3' ' HB3' ' C' ' 157' ' ' GLN . . . -94.52 157.99 15.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.086 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.44 106.28 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.693 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . 0.839 ' HB3' ' HB3' ' C' ' 155' ' ' LYS . . . -109.6 164.31 12.65 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.597 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' PHE . . . . . 0.671 ' HB2' HD11 ' C' ' 111' ' ' LEU . 6.6 t80 -142.26 141.03 32.42 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.147 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.726 HD11 ' HG2' ' F' ' 57' ' ' GLN . 0.1 OUTLIER -122.66 103.37 8.63 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.981 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . 0.504 ' HA3' HD23 ' C' ' 113' ' ' LEU . . . -153.47 -166.38 14.58 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.909 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.5 136.27 46.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.574 0.226 . . . . 0.0 110.746 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . 0.685 ' H ' ' HB3' ' F' ' 132' ' ' PRO . . . -81.39 156.08 25.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.878 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . 0.472 HG12 ' OG1' ' C' ' 140' ' ' THR . 3.1 tt -92.56 -20.65 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.796 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' ASP . . . . . 0.563 ' HB2' HG21 ' C' ' 140' ' ' THR . 0.4 OUTLIER 176.15 179.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.821 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' F' ' 107' ' ' THR . . . -79.02 -33.76 44.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.988 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.39 -44.0 95.45 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.564 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . 0.447 ' HB3' HG23 ' C' ' 85' ' ' VAL . 43.3 m-70 -97.74 -64.42 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.787 0.327 . . . . 0.0 110.47 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . 0.439 ' HA ' ' HB1' ' C' ' 77' ' ' ALA . 1.2 m 62.32 7.81 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.597 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' ASN . . . . . 0.419 ' O ' HD12 ' C' ' 103' ' ' ILE . 6.6 m120 -115.02 -25.51 8.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.308 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' C' ' 102' ' ' GLN . 0.5 OUTLIER -79.53 143.63 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.214 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' C' ' 152' ' ' ALA . 0.3 OUTLIER -76.59 148.57 36.9 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.294 179.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.87 178.25 4.37 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.721 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.643 HD22 ' O ' ' C' ' 96' ' ' ALA . 0.0 OUTLIER -84.71 176.19 8.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.124 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' C' ' 149' ' ' ASN . 22.9 pt20 -75.18 178.69 5.56 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.352 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' SER . . . . . 0.53 ' O ' HG12 ' F' ' 52' ' ' VAL . 1.0 OUTLIER -73.36 -11.45 60.49 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.002 0.429 . . . . 0.0 111.461 179.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' C' ' 95' ' ' SER . 0.3 OUTLIER -64.72 87.27 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.92 -7.09 53.75 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.688 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' ALA . . . . . 0.47 ' HB1' ' HB1' ' E' ' 22' ' ' ALA . . . -133.15 19.92 4.06 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.614 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.64 -15.6 0.16 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.96 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' C' ' 91' ' ' SER . 1.0 OUTLIER -97.35 174.93 6.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 110.594 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' ALA . . . . . 0.643 ' O ' HD22 ' C' ' 88' ' ' LEU . . . -114.06 157.85 22.0 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . 0.54 HG23 HD11 ' C' ' 88' ' ' LEU . 0.2 OUTLIER -112.9 162.78 15.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.325 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 69.33 41.52 1.32 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.366 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 10.3 p -177.58 130.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.06 179.45 28.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.604 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' C' ' 86' ' ' LEU . 1.6 t -99.07 95.27 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.072 0.549 . . . . 0.0 111.703 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 102' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' C' ' 85' ' ' VAL . 1.9 tt0 -69.88 159.8 33.0 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.9 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.432 HG12 ' CE2' ' C' ' 73' ' ' PHE . 0.9 OUTLIER -121.66 98.36 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.574 179.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' LEU . . . . . 0.678 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 1.1 tp -84.64 119.36 25.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.695 0.283 . . . . 0.0 111.148 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.13 158.08 32.12 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.677 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 106' ' ' ARG . . . . . 0.55 ' HB2' ' HB2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -61.13 -33.93 74.18 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.914 0.388 . . . . 0.0 111.085 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 107' ' ' THR . . . . . 0.553 HG23 ' HA ' ' C' ' 120' ' ' SER . 0.0 OUTLIER -48.8 -38.22 21.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.972 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.75 -88.82 0.11 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.544 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.17 -176.32 5.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.82 0.343 . . . . 0.0 111.143 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.678 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -79.98 143.89 33.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.136 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 111' ' ' LEU . . . . . 0.671 HD11 ' HB2' ' C' ' 73' ' ' PHE . 0.6 OUTLIER -90.07 157.51 17.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.389 0.614 . . . . 0.0 110.557 179.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 112' ' ' THR . . . . . 0.448 ' HB ' HG21 ' C' ' 117' ' ' THR . 29.9 m -81.13 150.45 28.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.154 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.603 HD12 ' N ' ' C' ' 113' ' ' LEU . 3.0 mp -102.68 57.64 0.78 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.675 0.274 . . . . 0.0 110.742 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.48 19.72 15.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.562 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.18 -93.08 0.88 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.647 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 116' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' F' ' 125' ' ' ASN . . . -102.73 69.58 1.08 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.097 0.475 . . . . 0.0 111.631 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' C' ' 72' ' ' ALA . 5.9 p -89.62 97.25 11.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.196 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.13 102.72 5.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.723 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.43 -82.69 0.65 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 120' ' ' SER . . . . . 0.553 ' HA ' HG23 ' C' ' 107' ' ' THR . 0.1 OUTLIER -63.16 100.87 0.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.715 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.82 79.01 7.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.208 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.43 HG21 ' CD ' ' C' ' 132' ' ' PRO . 4.5 p -82.56 159.1 22.85 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.729 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 16.3 m -85.17 139.71 31.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.825 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.42 136.15 33.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.811 0.338 . . . . 0.0 110.548 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -120.77 143.55 48.76 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.653 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.14 148.94 34.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.742 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.76 -106.21 2.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.692 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -85.2 153.25 22.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.734 0.302 . . . . 0.0 110.74 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 129' ' ' ASN . . . . . 0.588 ' HB3' ' HB2' ' C' ' 58' ' ' LEU . 23.2 t-20 -148.45 120.72 8.38 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.898 0.38 . . . . 0.0 111.112 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 130' ' ' THR . . . . . 0.531 HG22 ' HB2' ' C' ' 55' ' ' ASN . 0.2 OUTLIER -104.18 147.33 27.58 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.132 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 131' ' ' ILE . . . . . 0.794 HD12 ' HB ' ' C' ' 56' ' ' ILE . 89.8 mt -116.62 119.27 36.02 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 132' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' C' ' 106' ' ' ARG . 7.6 Cg_endo -80.92 119.17 3.53 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 121.652 1.568 . . . . 0.0 112.548 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.12 147.27 29.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.762 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.09 155.98 47.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.02 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . 0.713 ' HB3' HG22 ' C' ' 52' ' ' VAL . . . -140.09 115.7 10.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.93 0.395 . . . . 0.0 111.579 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.44 ' NH2' HG21 ' C' ' 48' ' ' THR . 0.5 OUTLIER -111.26 149.02 31.63 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.432 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.67 151.32 45.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.068 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 138' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' C' ' 47' ' ' ALA . 0.2 OUTLIER -144.55 164.56 30.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.924 -179.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 139' ' ' ALA . . . . . 0.636 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -124.41 145.74 49.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.923 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 140' ' ' THR . . . . . 0.563 HG21 ' HB2' ' C' ' 79' ' ' ASP . 0.2 OUTLIER -117.8 12.89 14.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.516 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.87 79.82 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.895 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.7 92.11 0.02 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.595 0.197 . . . . 0.0 110.796 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.11 154.83 33.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.75 0.31 . . . . 0.0 111.403 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 144' ' ' THR . . . . . 0.521 ' O ' ' HB ' ' B' ' 16' ' ' VAL . 39.8 p -116.75 166.22 13.34 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.181 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 145' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' B' ' 16' ' ' VAL . 1.3 Cg_endo -84.28 151.4 12.13 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.468 2.112 . . . . 0.0 111.993 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.7 -106.23 0.45 Allowed Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.403 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 147' ' ' ALA . . . . . 0.407 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -139.13 163.23 32.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.764 0.316 . . . . 0.0 111.411 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.89 79.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.502 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 149' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' C' ' 89' ' ' GLN . 87.1 m-20 -99.92 142.47 31.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.576 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 150' ' ' ALA . . . . . 0.526 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -127.77 168.96 14.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.052 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 151' ' ' ASP . . . . . 0.409 ' OD2' ' HD2' ' B' ' 11' ' ' HIS . 4.2 t70 -165.54 109.99 0.86 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.267 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 152' ' ' ALA . . . . . 0.622 ' HB2' HD21 ' C' ' 86' ' ' LEU . . . -146.94 145.42 29.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.148 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' B' ' 9' ' ' THR . 0.9 OUTLIER -93.61 164.18 13.26 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 154' ' ' PHE . . . . . 0.631 ' CZ ' HG21 ' C' ' 56' ' ' ILE . 15.2 p90 -110.87 151.52 27.77 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.157 0.503 . . . . 0.0 110.187 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 155' ' ' LYS . . . . . 0.839 ' HB3' ' HB3' ' C' ' 72' ' ' ALA . 0.0 OUTLIER -109.6 160.95 15.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.943 -178.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 156' ' ' VAL . . . . . 0.644 HG23 HG23 ' B' ' 5' ' ' VAL . 1.5 m -142.17 112.9 3.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.761 0.315 . . . . 0.0 111.715 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 157' ' ' GLN . . . . . 0.728 ' HB3' ' HB3' ' C' ' 70' ' ' ALA . 0.3 OUTLIER -91.88 124.38 35.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.36 0.6 . . . . 0.0 110.46 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 158' ' ' TYR . . . . . 0.551 ' HB2' ' HB ' ' B' ' 3' ' ' THR . 57.6 m-85 -117.18 135.47 53.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.493 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.914 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.53 100.1 0.04 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.064 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 3' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' E' ' 158' ' ' TYR . 7.3 m -104.74 78.63 1.46 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.48 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.27 122.44 29.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.528 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.643 HG23 HG23 ' E' ' 156' ' ' VAL . 5.1 m -137.95 162.93 30.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.533 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 6' ' ' ASN . . . . . 0.43 ' HB3' ' OE2' ' E' ' 15' ' ' GLU . 44.0 t-20 -84.34 114.56 21.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.594 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 7' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' E' ' 154' ' ' PHE . . . -83.41 -41.48 8.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.683 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . 0.447 ' N ' ' CE1' ' E' ' 154' ' ' PHE . . . -175.64 162.28 31.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.847 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' E' ' 153' ' ' THR . 98.8 m -90.74 137.81 32.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.92 0.39 . . . . 0.0 111.28 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.43 114.28 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.254 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' HIS . . . . . 0.411 ' HD2' ' OD2' ' E' ' 151' ' ' ASP . 4.6 m80 -99.38 148.49 24.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.312 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' PHE . . . . . 0.814 ' HB3' HD21 ' E' ' 34' ' ' LEU . 60.7 m-85 -133.74 113.08 11.92 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.824 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' LYS . . . . . 0.745 ' HG2' ' HA ' ' E' ' 33' ' ' GLN . 0.0 OUTLIER -107.12 105.82 16.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.39 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.17 169.48 28.86 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.958 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' GLU . . . . . 0.548 ' HB2' ' HG3' ' E' ' 36' ' ' GLN . 33.6 mt-10 -140.75 -171.05 3.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.849 0.357 . . . . 0.0 110.431 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.57 HG13 HG23 ' E' ' 37' ' ' VAL . 0.5 OUTLIER -139.23 152.88 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.144 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.723 ' O ' HG23 ' E' ' 39' ' ' THR . 0.0 OUTLIER -137.47 155.39 31.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.856 0.36 . . . . 0.0 111.069 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -85.19 53.06 2.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.011 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' ALA . . . . . 0.684 ' HA ' ' HG2' ' E' ' 38' ' ' ARG . . . 61.41 92.64 0.05 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.112 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.58 ' H ' ' HG2' ' E' ' 38' ' ' ARG . . . -164.72 -47.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.469 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 1.6 m -159.86 176.77 11.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.989 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . 0.623 ' HB2' ' HE ' ' E' ' 38' ' ' ARG . . . -147.22 111.91 5.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.157 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . 0.625 HG13 ' HB3' ' D' ' 27' ' ' SER . 43.2 t -67.29 143.08 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.004 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.547 ' O ' HG23 ' D' ' 28' ' ' VAL . 17.0 m-20 -91.16 168.15 11.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.619 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.37 -50.02 74.31 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.443 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.38 -16.61 73.67 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.967 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . 0.625 ' HB3' HG13 ' D' ' 23' ' ' VAL . 0.4 OUTLIER -84.32 -24.44 29.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.892 0.377 . . . . 0.0 110.763 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . 0.547 HG23 ' O ' ' D' ' 24' ' ' ASP . 85.6 t -58.1 -37.19 60.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.346 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -140.41 105.98 5.1 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.033 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' GLN . . . . . 0.435 HE21 ' HA ' ' D' ' 27' ' ' SER . 5.4 mt-30 -109.08 106.95 17.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.106 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.74 95.56 8.98 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.096 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.54 HG11 HG21 ' D' ' 52' ' ' VAL . 51.9 t -85.76 138.17 19.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.11 0.481 . . . . 0.0 110.388 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.738 ' HA ' ' HG2' ' C' ' 13' ' ' LYS . 3.1 mt-30 -113.11 132.59 55.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.688 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.814 HD21 ' HB3' ' C' ' 12' ' ' PHE . 1.8 mm? -94.47 -71.48 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.64 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.83 -111.33 0.72 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.526 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' GLN . . . . . 0.551 ' HG3' ' HB2' ' C' ' 15' ' ' GLU . 3.6 tt0 -160.96 105.83 1.37 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.648 0.261 . . . . 0.0 110.884 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.583 HG23 HG13 ' C' ' 16' ' ' VAL . 5.6 m -91.15 142.42 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.878 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . 0.671 ' HG2' ' HA ' ' C' ' 19' ' ' ALA . 0.7 OUTLIER -81.11 162.53 23.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.759 179.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.715 HG23 ' O ' ' C' ' 17' ' ' VAL . 82.4 p -80.34 -16.94 53.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.788 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.71 -31.23 63.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.166 0.508 . . . . 0.0 110.919 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.11 -28.42 39.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.116 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.618 ' HB3' ' HB2' ' D' ' 139' ' ' ALA . 1.7 mp -133.16 70.19 1.47 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.625 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' D' ' 39' ' ' THR . . . -103.71 11.21 36.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.424 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.06 146.85 27.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.38 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.48 121.22 13.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.56 -10.4 12.71 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.09 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' D' ' 138' ' ' PHE . . . -68.8 142.17 54.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.905 0.383 . . . . 0.0 111.97 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' THR . . . . . 0.433 HG21 ' NH2' ' D' ' 136' ' ' ARG . 6.9 t -134.72 140.84 46.26 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.816 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 16.8 m -106.02 -152.76 0.48 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.587 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 1.4 t -65.91 178.64 1.04 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.813 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.16 168.9 15.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.283 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' VAL . . . . . 0.681 HG22 ' HB3' ' D' ' 135' ' ' ALA . 14.7 m -118.02 132.25 68.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 88' ' ' LEU . . . -95.2 107.59 3.56 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.647 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.605 ' HD1' HG23 ' D' ' 52' ' ' VAL . 55.5 p90 -140.28 132.05 27.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.707 0.289 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' ASN . . . . . 0.53 ' HB2' HG22 ' D' ' 130' ' ' THR . 1.6 p-10 -117.81 176.83 5.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.57 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.772 ' HB ' HD12 ' D' ' 131' ' ' ILE . 51.7 mm -118.98 121.7 67.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.532 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' GLN . . . . . 0.737 ' HG2' HD11 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -86.32 122.66 30.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.778 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' D' ' 129' ' ' ASN . 0.9 OUTLIER -131.2 93.71 3.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.234 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . 0.549 ' O ' ' HB3' ' D' ' 22' ' ' ALA . 0.4 OUTLIER -76.98 160.91 28.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.912 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.12 87.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.76 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 70.1 m -120.55 131.81 54.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.808 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.61 97.87 9.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.308 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' D' ' 66' ' ' ALA . 1.5 m -77.41 -19.98 55.31 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.06 -27.54 68.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.975 0.417 . . . . 0.0 111.701 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.4 -35.75 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.608 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' D' ' 63' ' ' THR . . . -130.94 131.24 44.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.716 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.41 -37.35 7.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.885 0.374 . . . . 0.0 110.954 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -121.69 171.4 8.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.577 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.55 136.13 15.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.555 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' D' ' 157' ' ' GLN . . . -94.49 157.95 15.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.087 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 38.1 t -110.42 106.31 20.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.655 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 72' ' ' ALA . . . . . 0.821 ' HB3' ' HB3' ' D' ' 155' ' ' LYS . . . -109.64 164.24 12.72 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.575 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 73' ' ' PHE . . . . . 0.659 ' HB2' HD11 ' D' ' 111' ' ' LEU . 6.5 t80 -142.21 141.11 32.51 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.564 0.221 . . . . 0.0 111.15 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 74' ' ' LEU . . . . . 0.429 HD22 ' NZ ' ' D' ' 155' ' ' LYS . 0.1 OUTLIER -122.72 103.37 8.61 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.991 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . 0.512 ' HA3' HD23 ' D' ' 113' ' ' LEU . . . -153.46 -166.43 14.62 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.889 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.46 136.37 46.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.611 0.243 . . . . 0.0 110.695 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.448 ' HB1' ' HA ' ' D' ' 83' ' ' THR . . . -81.54 156.12 25.4 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.88 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 78' ' ' ILE . . . . . 0.464 HG12 ' OG1' ' D' ' 140' ' ' THR . 3.0 tt -92.52 -20.67 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.83 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.565 ' HB2' HG21 ' D' ' 140' ' ' THR . 0.4 OUTLIER 176.15 179.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.825 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.95 -33.85 44.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.975 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.51 -43.82 95.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.595 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . 0.457 ' NE2' ' O ' ' D' ' 139' ' ' ALA . 43.6 m-70 -97.78 -64.48 1.04 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.862 0.363 . . . . 0.0 110.438 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 83' ' ' THR . . . . . 0.448 ' HA ' ' HB1' ' D' ' 77' ' ' ALA . 1.2 m 62.45 7.77 2.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.582 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . 0.417 ' O ' HD12 ' D' ' 103' ' ' ILE . 6.5 m120 -115.08 -25.41 8.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.329 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' D' ' 102' ' ' GLN . 0.5 OUTLIER -79.58 143.68 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.171 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' D' ' 152' ' ' ALA . 0.3 OUTLIER -76.63 148.53 36.86 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.27 179.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.8 178.2 4.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.894 0.378 . . . . 0.0 111.716 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.652 HD22 ' O ' ' D' ' 96' ' ' ALA . 0.0 OUTLIER -84.67 176.16 8.75 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.096 179.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 89' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' D' ' 149' ' ' ASN . 22.8 pt20 -75.24 178.71 5.58 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.38 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.36 -11.5 60.5 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 111.428 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' D' ' 95' ' ' SER . 0.3 OUTLIER -64.62 87.24 0.05 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.891 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.88 -7.15 53.83 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.921 0.391 . . . . 0.0 111.697 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 93' ' ' ALA . . . . . 0.469 ' HB1' ' HB1' ' F' ' 22' ' ' ALA . . . -133.14 19.96 4.06 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.674 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.62 -15.58 0.16 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.942 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 95' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' D' ' 91' ' ' SER . 1.0 OUTLIER -97.33 174.89 6.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.9 0.381 . . . . 0.0 110.59 179.558 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 96' ' ' ALA . . . . . 0.652 ' O ' HD22 ' D' ' 88' ' ' LEU . . . -114.05 157.88 21.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.82 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . 0.533 HG23 HD11 ' D' ' 88' ' ' LEU . 0.2 OUTLIER -112.9 162.72 15.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.305 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 98' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 69.29 41.62 1.32 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.387 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 99' ' ' VAL . . . . . . . . . . . . . 10.1 p -177.64 130.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.792 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.12 179.45 28.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.552 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 101' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' D' ' 86' ' ' LEU . 1.6 t -99.0 95.29 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 123.078 0.551 . . . . 0.0 111.681 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 102' ' ' GLN . . . . . 0.771 ' HA ' ' HA ' ' D' ' 85' ' ' VAL . 1.9 tt0 -69.84 159.79 32.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.892 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 103' ' ' ILE . . . . . 0.433 HG12 ' CE2' ' D' ' 73' ' ' PHE . 0.9 OUTLIER -121.7 98.45 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.522 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 104' ' ' LEU . . . . . 0.684 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 1.1 tp -84.75 119.38 25.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.755 0.312 . . . . 0.0 111.095 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.18 158.09 32.04 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.68 0.276 . . . . 0.0 111.646 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 106' ' ' ARG . . . . . 0.556 ' HB2' ' HB2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -61.19 -33.92 74.23 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.902 0.382 . . . . 0.0 111.048 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 107' ' ' THR . . . . . 0.561 HG23 ' HA ' ' D' ' 120' ' ' SER . 0.0 OUTLIER -48.72 -38.19 20.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.027 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.68 -88.81 0.11 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.603 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.16 -176.35 5.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.867 0.365 . . . . 0.0 111.139 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.684 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -79.96 143.93 33.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.098 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 111' ' ' LEU . . . . . 0.659 HD11 ' HB2' ' D' ' 73' ' ' PHE . 0.6 OUTLIER -90.08 157.58 17.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.386 0.612 . . . . 0.0 110.534 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 112' ' ' THR . . . . . 0.45 ' HB ' HG21 ' D' ' 117' ' ' THR . 30.0 m -81.22 150.47 28.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.099 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 113' ' ' LEU . . . . . 0.608 HD12 ' N ' ' D' ' 113' ' ' LEU . 2.9 mp -102.72 57.67 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.721 0.296 . . . . 0.0 110.742 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.42 19.57 15.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.552 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.23 -93.04 0.88 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.665 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.68 69.61 1.08 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.021 0.438 . . . . 0.0 111.564 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 117' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' D' ' 72' ' ' ALA . 5.8 p -89.69 97.34 11.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.2 102.83 5.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.786 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.45 -82.72 0.65 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 120' ' ' SER . . . . . 0.561 ' HA ' HG23 ' D' ' 107' ' ' THR . 0.1 OUTLIER -63.2 100.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.614 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.86 79.05 7.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.234 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.43 HG21 ' CD ' ' D' ' 132' ' ' PRO . 4.4 p -82.61 159.15 22.78 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.719 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 16.2 m -85.2 139.68 31.47 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.8 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.34 136.1 33.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.65 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 125' ' ' ASN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 116' ' ' ALA . 25.1 m120 -120.78 143.67 48.7 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.622 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.19 148.98 34.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.638 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.61 -106.12 2.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.75 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 128' ' ' THR . . . . . 0.648 HG21 ' NZ ' ' A' ' 155' ' ' LYS . 1.9 m -85.15 153.14 22.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.654 0.264 . . . . 0.0 110.817 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 129' ' ' ASN . . . . . 0.585 ' HB3' ' HB2' ' D' ' 58' ' ' LEU . 23.3 t-20 -148.39 120.68 8.39 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.874 0.368 . . . . 0.0 111.125 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 130' ' ' THR . . . . . 0.556 ' OG1' HD12 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -104.15 147.33 27.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.164 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 131' ' ' ILE . . . . . 0.772 HD12 ' HB ' ' D' ' 56' ' ' ILE . 89.4 mt -116.59 119.15 36.25 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 132' ' ' PRO . . . . . 0.677 ' HB3' ' H ' ' A' ' 77' ' ' ALA . 7.5 Cg_endo -80.95 119.11 3.5 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.645 1.563 . . . . 0.0 112.546 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.01 147.36 29.53 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.795 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.17 155.87 47.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.021 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.681 ' HB3' HG22 ' D' ' 52' ' ' VAL . . . -140.09 115.64 10.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.904 0.383 . . . . 0.0 111.575 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 136' ' ' ARG . . . . . 0.433 ' NH2' HG21 ' D' ' 48' ' ' THR . 0.5 OUTLIER -111.27 149.01 31.66 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.543 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.52 151.27 45.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.132 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 138' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' D' ' 47' ' ' ALA . 0.2 OUTLIER -144.49 164.61 30.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.225 0.536 . . . . 0.0 111.993 -179.154 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 139' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -124.5 145.71 49.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.901 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 140' ' ' THR . . . . . 0.565 HG21 ' HB2' ' D' ' 79' ' ' ASP . 0.2 OUTLIER -117.74 12.97 14.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.536 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.76 79.74 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.957 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.73 92.17 0.02 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.619 0.209 . . . . 0.0 110.716 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.13 154.86 33.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 111.357 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 144' ' ' THR . . . . . 0.524 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 39.2 p -116.76 166.16 13.49 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.237 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 145' ' ' PRO . . . . . 0.492 ' HA ' ' HB ' ' C' ' 16' ' ' VAL . 1.3 Cg_endo -84.24 151.49 12.21 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.45 2.1 . . . . 0.0 111.98 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.65 -106.34 0.46 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.453 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 147' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -139.05 163.26 32.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.823 0.344 . . . . 0.0 111.354 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.96 79.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.59 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 149' ' ' ASN . . . . . 0.531 ' HB2' ' HB3' ' D' ' 89' ' ' GLN . 87.1 m-20 -99.97 142.45 31.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.569 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 150' ' ' ALA . . . . . 0.508 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -127.72 168.99 14.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.969 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 151' ' ' ASP . . . . . 0.412 ' OD2' ' HD2' ' C' ' 11' ' ' HIS . 4.2 t70 -165.55 109.99 0.86 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.214 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 152' ' ' ALA . . . . . 0.628 ' HB2' HD21 ' D' ' 86' ' ' LEU . . . -147.01 145.44 29.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.086 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 153' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' C' ' 9' ' ' THR . 1.0 OUTLIER -93.72 164.23 13.22 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.252 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 154' ' ' PHE . . . . . 0.63 ' CZ ' HG21 ' D' ' 56' ' ' ILE . 15.1 p90 -110.92 151.61 27.7 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.147 0.499 . . . . 0.0 110.108 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 155' ' ' LYS . . . . . 0.821 ' HB3' ' HB3' ' D' ' 72' ' ' ALA . 0.0 OUTLIER -109.64 160.84 15.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.951 -178.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 156' ' ' VAL . . . . . 0.646 HG23 HG23 ' C' ' 5' ' ' VAL . 1.4 m -142.15 112.93 3.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.803 0.335 . . . . 0.0 111.687 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 157' ' ' GLN . . . . . 0.713 ' HB3' ' HB3' ' D' ' 70' ' ' ALA . 0.3 OUTLIER -91.78 124.4 35.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.264 0.555 . . . . 0.0 110.398 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 158' ' ' TYR . . . . . 0.542 ' HB2' ' HB ' ' C' ' 3' ' ' THR . 57.6 m-85 -117.21 135.49 53.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.505 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.85 179.915 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.46 100.23 0.04 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.065 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 3' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' F' ' 158' ' ' TYR . 7.4 m -104.8 78.65 1.45 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.422 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.33 122.39 29.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.526 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.631 HG23 HG23 ' F' ' 156' ' ' VAL . 5.0 m -137.92 162.9 30.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.54 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 6' ' ' ASN . . . . . 0.433 ' HB3' ' OE2' ' F' ' 15' ' ' GLU . 44.0 t-20 -84.3 114.52 21.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.599 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 7' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' F' ' 154' ' ' PHE . . . -83.38 -41.52 8.4 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.684 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . 0.444 ' N ' ' CE1' ' F' ' 154' ' ' PHE . . . -175.56 162.29 31.57 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.889 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 9' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' F' ' 153' ' ' THR . 98.9 m -90.78 137.86 32.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.992 0.425 . . . . 0.0 111.269 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.44 114.27 46.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.184 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 11' ' ' HIS . . . . . 0.408 ' HD2' ' OD2' ' F' ' 151' ' ' ASP . 4.6 m80 -99.34 148.44 24.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.343 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 12' ' ' PHE . . . . . 0.825 ' HB3' HD21 ' F' ' 34' ' ' LEU . 60.9 m-85 -133.75 113.12 11.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.794 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 13' ' ' LYS . . . . . 0.762 ' HG2' ' HA ' ' F' ' 33' ' ' GLN . 0.0 OUTLIER -107.23 105.89 16.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.351 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.23 169.44 28.9 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.023 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 15' ' ' GLU . . . . . 0.559 ' HB2' ' HG3' ' F' ' 36' ' ' GLN . 33.7 mt-10 -140.76 -171.13 3.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.853 0.359 . . . . 0.0 110.39 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 16' ' ' VAL . . . . . 0.585 HG13 HG23 ' F' ' 37' ' ' VAL . 0.5 OUTLIER -139.15 152.82 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.205 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . 0.732 ' O ' HG23 ' F' ' 39' ' ' THR . 0.0 OUTLIER -137.47 155.41 31.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.835 0.35 . . . . 0.0 111.038 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -85.23 53.02 2.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.005 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 19' ' ' ALA . . . . . 0.664 ' HA ' ' HG2' ' F' ' 38' ' ' ARG . . . 61.45 92.76 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.574 ' H ' ' HG2' ' F' ' 38' ' ' ARG . . . -164.84 -47.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.43 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 21' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 1.6 m -159.76 176.89 11.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.951 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 22' ' ' ALA . . . . . 0.602 ' HB2' ' HE ' ' F' ' 38' ' ' ARG . . . -147.29 111.9 5.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.13 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 23' ' ' VAL . . . . . 0.629 HG13 ' HB3' ' E' ' 27' ' ' SER . 43.1 t -67.31 143.14 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.998 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 24' ' ' ASP . . . . . 0.544 ' O ' HG23 ' E' ' 28' ' ' VAL . 17.1 m-20 -91.13 168.13 11.85 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.611 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.1 74.01 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.382 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.41 -16.64 73.74 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.929 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . 0.629 ' HB3' HG13 ' E' ' 23' ' ' VAL . 0.4 OUTLIER -84.3 -24.35 29.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.944 0.402 . . . . 0.0 110.837 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 28' ' ' VAL . . . . . 0.544 HG23 ' O ' ' E' ' 24' ' ' ASP . 85.0 t -58.08 -37.25 60.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.345 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -140.34 105.97 5.12 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.007 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 30' ' ' GLN . . . . . 0.436 HE21 ' HA ' ' E' ' 27' ' ' SER . 5.4 mt-30 -109.0 106.95 17.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.12 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.77 95.53 8.99 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.071 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.552 HG11 HG21 ' E' ' 52' ' ' VAL . 51.4 t -85.74 138.27 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.074 0.464 . . . . 0.0 110.382 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 33' ' ' GLN . . . . . 0.745 ' HA ' ' HG2' ' D' ' 13' ' ' LYS . 3.2 mt-30 -113.23 132.53 55.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.641 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.814 HD21 ' HB3' ' D' ' 12' ' ' PHE . 1.8 mm? -94.47 -71.46 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.628 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.85 -111.3 0.71 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.578 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 36' ' ' GLN . . . . . 0.548 ' HG3' ' HB2' ' D' ' 15' ' ' GLU . 3.6 tt0 -161.03 105.81 1.36 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.625 0.25 . . . . 0.0 110.897 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.57 HG23 HG13 ' D' ' 16' ' ' VAL . 5.7 m -91.13 142.4 13.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.011 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . 0.684 ' HG2' ' HA ' ' D' ' 19' ' ' ALA . 0.7 OUTLIER -81.11 162.6 23.63 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.691 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 39' ' ' THR . . . . . 0.723 HG23 ' O ' ' D' ' 17' ' ' VAL . 82.6 p -80.47 -16.8 53.45 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.783 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.71 -31.22 63.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.197 0.522 . . . . 0.0 110.944 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.06 -28.47 39.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.113 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' E' ' 139' ' ' ALA . 1.7 mp -133.13 70.02 1.47 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.658 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 43' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' E' ' 39' ' ' THR . . . -103.61 11.19 36.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.451 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.01 146.84 27.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.394 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.47 121.24 13.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 111.146 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.55 -10.37 12.73 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.195 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 47' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' E' ' 138' ' ' PHE . . . -68.86 142.22 54.88 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . 0.444 HG21 ' NH2' ' E' ' 136' ' ' ARG . 6.9 t -134.76 140.81 46.2 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.826 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.405 ' OG ' HD11 ' E' ' 42' ' ' LEU . 16.9 m -106.01 -152.74 0.48 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.615 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.92 178.62 1.05 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.909 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.1 168.81 15.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.784 0.326 . . . . 0.0 111.26 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 52' ' ' VAL . . . . . 0.714 HG22 ' HB3' ' E' ' 135' ' ' ALA . 14.7 m -117.97 132.2 68.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.955 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 53' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' B' ' 88' ' ' LEU . . . -95.18 107.61 3.57 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.627 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 54' ' ' PHE . . . . . 0.603 ' HD1' HG23 ' E' ' 52' ' ' VAL . 55.5 p90 -140.28 132.06 27.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 55' ' ' ASN . . . . . 0.519 ' HB2' HG22 ' E' ' 130' ' ' THR . 1.5 p-10 -117.81 176.75 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.621 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 56' ' ' ILE . . . . . 0.793 ' HB ' HD12 ' E' ' 131' ' ' ILE . 51.6 mm -119.03 121.7 67.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.543 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 57' ' ' GLN . . . . . 0.727 ' HG2' HD11 ' B' ' 74' ' ' LEU . 0.0 OUTLIER -86.28 122.63 30.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.792 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' E' ' 129' ' ' ASN . 0.9 OUTLIER -131.13 93.74 3.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . 0.548 ' O ' ' HB3' ' E' ' 22' ' ' ALA . 0.4 OUTLIER -77.08 160.88 28.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.862 -179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.17 87.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.817 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 61' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 70.1 m -120.53 131.84 54.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.783 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.58 97.82 9.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.366 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 63' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' E' ' 66' ' ' ALA . 1.5 m -77.39 -19.95 55.4 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.1 -27.5 68.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.02 0.438 . . . . 0.0 111.715 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.44 -35.75 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.624 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 66' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' E' ' 63' ' ' THR . . . -131.05 131.32 44.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.648 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.49 -37.26 7.66 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.947 0.403 . . . . 0.0 110.94 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -121.74 171.39 8.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.558 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.55 136.1 15.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.532 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . 0.707 ' HB3' ' HB3' ' E' ' 157' ' ' GLN . . . -94.54 158.01 15.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.065 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 38.4 t -110.35 106.23 20.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.71 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . 0.821 ' HB3' ' HB3' ' E' ' 155' ' ' LYS . . . -109.58 164.36 12.6 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.594 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 73' ' ' PHE . . . . . 0.672 ' HB2' HD11 ' E' ' 111' ' ' LEU . 6.6 t80 -142.27 141.1 32.42 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.532 0.206 . . . . 0.0 111.131 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 74' ' ' LEU . . . . . 0.425 HD22 ' NZ ' ' E' ' 155' ' ' LYS . 0.1 OUTLIER -122.69 103.4 8.64 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.011 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . 0.506 ' HA3' HD23 ' E' ' 113' ' ' LEU . . . -153.5 -166.43 14.64 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.876 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.45 136.24 46.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.58 0.228 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 77' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' E' ' 83' ' ' THR . . . -81.35 156.15 25.62 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.935 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 78' ' ' ILE . . . . . 0.462 HG12 ' OG1' ' E' ' 140' ' ' THR . 3.1 tt -92.55 -20.67 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.881 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 79' ' ' ASP . . . . . 0.549 ' HB2' HG21 ' E' ' 140' ' ' THR . 0.4 OUTLIER 176.15 179.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.808 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.88 -33.87 45.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.009 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.48 -43.87 95.68 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.555 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 82' ' ' HIS . . . . . 0.462 ' NE2' ' O ' ' E' ' 139' ' ' ALA . 43.5 m-70 -97.8 -64.37 1.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.849 0.356 . . . . 0.0 110.492 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 83' ' ' THR . . . . . 0.436 ' HA ' ' HB1' ' E' ' 77' ' ' ALA . 1.2 m 62.31 7.85 2.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.609 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 84' ' ' ASN . . . . . 0.426 ' O ' HD12 ' E' ' 103' ' ' ILE . 6.5 m120 -115.13 -25.46 8.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.255 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.787 ' HA ' ' HA ' ' E' ' 102' ' ' GLN . 0.5 OUTLIER -79.58 143.71 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.177 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 86' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' E' ' 152' ' ' ALA . 0.3 OUTLIER -76.68 148.54 36.78 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.294 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.83 178.23 4.36 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.909 0.385 . . . . 0.0 111.694 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.649 HD22 ' O ' ' E' ' 96' ' ' ALA . 0.0 OUTLIER -84.68 176.17 8.74 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.135 179.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 89' ' ' GLN . . . . . 0.537 ' HB3' ' HB2' ' E' ' 149' ' ' ASN . 22.9 pt20 -75.3 178.73 5.61 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.315 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.4 -11.42 60.47 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.999 0.428 . . . . 0.0 111.443 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 91' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' E' ' 95' ' ' SER . 0.3 OUTLIER -64.67 87.26 0.05 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.9 -7.13 53.8 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.909 0.385 . . . . 0.0 111.666 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.14 19.87 4.06 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.678 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.6 -15.6 0.16 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.924 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 95' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' E' ' 91' ' ' SER . 0.9 OUTLIER -97.28 174.95 6.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.886 0.374 . . . . 0.0 110.664 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 96' ' ' ALA . . . . . 0.649 ' O ' HD22 ' E' ' 88' ' ' LEU . . . -114.1 157.83 22.06 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.786 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . 0.544 HG23 HD11 ' E' ' 88' ' ' LEU . 0.2 OUTLIER -112.92 162.68 15.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.359 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 98' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 69.4 41.53 1.3 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.368 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 99' ' ' VAL . . . . . . . . . . . . . 10.5 p -177.6 130.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.872 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.15 179.47 28.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.521 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 101' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' E' ' 86' ' ' LEU . 1.6 t -99.08 95.27 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.085 0.554 . . . . 0.0 111.65 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 102' ' ' GLN . . . . . 0.787 ' HA ' ' HA ' ' E' ' 85' ' ' VAL . 1.9 tt0 -69.84 159.83 32.91 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.959 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 103' ' ' ILE . . . . . 0.434 HG12 ' CE2' ' E' ' 73' ' ' PHE . 0.9 OUTLIER -121.7 98.49 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.516 179.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 104' ' ' LEU . . . . . 0.685 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 1.1 tp -84.79 119.39 25.24 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.701 0.286 . . . . 0.0 111.046 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.17 158.1 32.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.693 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 106' ' ' ARG . . . . . 0.555 ' HB2' ' HB2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -61.21 -33.83 74.11 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.958 0.409 . . . . 0.0 111.102 179.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 107' ' ' THR . . . . . 0.556 HG23 ' HA ' ' E' ' 120' ' ' SER . 0.0 OUTLIER -48.8 -38.23 21.45 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.037 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.76 -88.84 0.11 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.598 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.19 -176.39 5.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.863 0.363 . . . . 0.0 111.116 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 110' ' ' ALA . . . . . 0.685 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -79.86 143.88 33.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.221 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 111' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' E' ' 73' ' ' PHE . 0.6 OUTLIER -90.14 157.55 17.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.361 0.601 . . . . 0.0 110.545 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 112' ' ' THR . . . . . 0.451 ' HB ' HG21 ' E' ' 117' ' ' THR . 29.7 m -81.1 150.48 28.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.134 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 113' ' ' LEU . . . . . 0.604 HD12 ' N ' ' E' ' 113' ' ' LEU . 3.0 mp -102.74 57.72 0.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.695 0.283 . . . . 0.0 110.719 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.4 19.58 15.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.566 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.19 -93.04 0.88 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.677 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.77 69.72 1.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.077 0.465 . . . . 0.0 111.566 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 117' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' E' ' 72' ' ' ALA . 6.0 p -89.67 97.25 11.08 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.169 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.06 102.84 5.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.809 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.48 -82.83 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 120' ' ' SER . . . . . 0.556 ' HA ' HG23 ' E' ' 107' ' ' THR . 0.1 OUTLIER -63.09 100.86 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.62 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -88.9 79.04 7.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.196 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 122' ' ' THR . . . . . 0.435 HG21 ' CD ' ' E' ' 132' ' ' PRO . 4.6 p -82.54 159.2 22.86 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.667 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 16.1 m -85.27 139.72 31.4 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.731 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.45 136.14 33.46 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.746 0.308 . . . . 0.0 110.594 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 125' ' ' ASN . . . . . 0.532 ' HB3' ' HB3' ' B' ' 116' ' ' ALA . 25.0 m120 -120.77 143.59 48.73 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.613 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.16 148.91 34.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.639 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.71 -106.12 2.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.736 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 128' ' ' THR . . . . . 0.641 HG21 ' NZ ' ' B' ' 155' ' ' LYS . 1.9 m -85.22 153.2 22.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.715 0.293 . . . . 0.0 110.812 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 129' ' ' ASN . . . . . 0.6 ' HB3' ' HB2' ' E' ' 58' ' ' LEU . 23.2 t-20 -148.42 120.73 8.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.955 0.407 . . . . 0.0 111.09 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 130' ' ' THR . . . . . 0.568 ' OG1' HD12 ' B' ' 74' ' ' LEU . 0.2 OUTLIER -104.17 147.3 27.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.147 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 131' ' ' ILE . . . . . 0.793 HD12 ' HB ' ' E' ' 56' ' ' ILE . 89.8 mt -116.65 119.17 36.11 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 132' ' ' PRO . . . . . 0.673 ' HB3' ' H ' ' B' ' 77' ' ' ALA . 7.6 Cg_endo -80.92 119.09 3.51 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.594 1.53 . . . . 0.0 112.553 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.99 147.33 29.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.739 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.15 155.96 47.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.066 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 135' ' ' ALA . . . . . 0.714 ' HB3' HG22 ' E' ' 52' ' ' VAL . . . -140.09 115.71 10.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.912 0.387 . . . . 0.0 111.632 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 136' ' ' ARG . . . . . 0.444 ' NH2' HG21 ' E' ' 48' ' ' THR . 0.5 OUTLIER -111.34 148.99 31.78 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.479 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.53 151.31 45.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.113 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 138' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' E' ' 47' ' ' ALA . 0.2 OUTLIER -144.53 164.58 30.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.009 -179.13 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 139' ' ' ALA . . . . . 0.648 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -124.39 145.65 49.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.913 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 140' ' ' THR . . . . . 0.549 HG21 ' HB2' ' E' ' 79' ' ' ASP . 0.2 OUTLIER -117.78 12.95 14.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.513 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.85 79.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.914 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.74 92.14 0.02 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.608 0.204 . . . . 0.0 110.756 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.1 154.77 33.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.675 0.274 . . . . 0.0 111.4 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 144' ' ' THR . . . . . 0.523 ' O ' ' HB ' ' D' ' 16' ' ' VAL . 39.1 p -116.68 166.2 13.33 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.244 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 145' ' ' PRO . . . . . 0.484 ' HA ' ' HB ' ' D' ' 16' ' ' VAL . 1.3 Cg_endo -84.33 151.42 12.06 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.495 2.13 . . . . 0.0 111.988 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.73 -106.32 0.46 Allowed Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.414 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 147' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -139.05 163.27 32.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.794 0.331 . . . . 0.0 111.408 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.91 79.88 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.508 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 149' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' E' ' 89' ' ' GLN . 87.2 m-20 -99.9 142.48 31.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.557 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 150' ' ' ALA . . . . . 0.527 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -127.78 169.0 14.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.008 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 151' ' ' ASP . . . . . 0.411 ' OD2' ' HD2' ' D' ' 11' ' ' HIS . 4.2 t70 -165.55 110.04 0.86 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.201 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 152' ' ' ALA . . . . . 0.628 ' HB2' HD21 ' E' ' 86' ' ' LEU . . . -147.06 145.39 29.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.13 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 153' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' D' ' 9' ' ' THR . 1.0 OUTLIER -93.62 164.23 13.24 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 154' ' ' PHE . . . . . 0.611 ' CZ ' HG21 ' E' ' 56' ' ' ILE . 15.1 p90 -110.98 151.59 27.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.193 0.521 . . . . 0.0 110.124 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 155' ' ' LYS . . . . . 0.821 ' HB3' ' HB3' ' E' ' 72' ' ' ALA . 0.0 OUTLIER -109.65 160.89 15.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.959 -178.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 156' ' ' VAL . . . . . 0.643 HG23 HG23 ' D' ' 5' ' ' VAL . 1.4 m -142.18 112.83 2.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.791 0.329 . . . . 0.0 111.678 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 157' ' ' GLN . . . . . 0.707 ' HB3' ' HB3' ' E' ' 70' ' ' ALA . 0.3 OUTLIER -91.83 124.39 35.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.338 0.59 . . . . 0.0 110.426 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 158' ' ' TYR . . . . . 0.539 ' HB2' ' HB ' ' D' ' 3' ' ' THR . 57.6 m-85 -117.17 135.52 53.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.456 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.859 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.55 100.22 0.04 OUTLIER 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.05 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -104.84 78.6 1.44 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.406 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.27 122.41 29.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.659 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 m -137.95 162.89 30.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.567 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -84.28 114.5 21.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.717 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.34 -41.52 8.42 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.678 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.57 162.24 31.49 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.936 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 98.8 m -90.71 137.79 32.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.92 0.39 . . . . 0.0 111.277 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.39 114.28 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.219 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -99.33 148.55 24.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.295 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -133.79 113.03 11.84 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.75 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 13' ' ' LYS . . . . . 0.536 ' HG3' HG11 ' F' ' 28' ' ' VAL . 0.0 OUTLIER -107.14 105.81 15.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.404 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.17 169.5 28.85 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.002 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 15' ' ' GLU . . . . . 0.433 ' OE2' ' HB3' ' E' ' 6' ' ' ASN . 33.5 mt-10 -140.78 -171.07 3.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.358 . . . . 0.0 110.429 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -139.21 152.82 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.197 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 17' ' ' VAL . . . . . 0.592 HG21 ' O ' ' F' ' 21' ' ' CYS . 0.0 OUTLIER -137.45 155.41 31.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.785 0.326 . . . . 0.0 111.037 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -85.16 52.98 2.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.08 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.43 92.69 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.11 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.75 -47.7 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.413 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 21' ' ' CYS . . . . . 0.708 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 1.6 m -159.74 176.86 11.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.983 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 22' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' F' ' 59' ' ' ASN . . . -147.3 112.0 5.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.155 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 23' ' ' VAL . . . . . 0.623 HG13 ' HB3' ' F' ' 27' ' ' SER . 42.8 t -67.39 143.17 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.946 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 24' ' ' ASP . . . . . 0.545 ' O ' HG23 ' F' ' 28' ' ' VAL . 17.0 m-20 -91.19 168.23 11.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.557 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.43 -50.0 74.44 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.455 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.35 -16.66 73.65 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.941 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 27' ' ' SER . . . . . 0.623 ' HB3' HG13 ' F' ' 23' ' ' VAL . 0.4 OUTLIER -84.32 -24.39 29.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.881 0.372 . . . . 0.0 110.767 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 28' ' ' VAL . . . . . 0.545 HG23 ' O ' ' F' ' 24' ' ' ASP . 85.4 t -58.12 -37.17 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.349 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -140.38 106.01 5.12 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.024 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 30' ' ' GLN . . . . . 0.44 HE21 ' HA ' ' F' ' 27' ' ' SER . 5.4 mt-30 -109.06 106.95 17.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.089 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.81 95.57 9.02 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.059 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.549 HG11 HG21 ' F' ' 52' ' ' VAL . 51.0 t -85.73 138.18 19.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.099 0.476 . . . . 0.0 110.378 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 33' ' ' GLN . . . . . 0.762 ' HA ' ' HG2' ' E' ' 13' ' ' LYS . 3.1 mt-30 -113.17 132.6 55.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.674 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 34' ' ' LEU . . . . . 0.825 HD21 ' HB3' ' E' ' 12' ' ' PHE . 1.8 mm? -94.51 -71.49 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.594 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.9 -111.31 0.71 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.512 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 36' ' ' GLN . . . . . 0.559 ' HG3' ' HB2' ' E' ' 15' ' ' GLU . 3.6 tt0 -160.96 105.75 1.37 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.573 0.225 . . . . 0.0 110.888 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.585 HG23 HG13 ' E' ' 16' ' ' VAL . 5.6 m -91.1 142.45 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.904 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 38' ' ' ARG . . . . . 0.664 ' HG2' ' HA ' ' E' ' 19' ' ' ALA . 0.7 OUTLIER -81.09 162.52 23.69 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.723 179.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 39' ' ' THR . . . . . 0.732 HG23 ' O ' ' E' ' 17' ' ' VAL . 82.5 p -80.4 -16.88 53.42 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.775 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.74 -31.27 63.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.115 0.483 . . . . 0.0 110.876 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.02 -28.51 39.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.121 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' F' ' 139' ' ' ALA . 1.7 mp -133.11 70.05 1.47 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.686 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 43' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' F' ' 39' ' ' THR . . . -103.65 11.2 36.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.445 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.07 146.84 27.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.394 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.43 121.24 13.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 111.158 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.57 -10.48 12.66 Favored Glycine 0 C--N 1.331 0.274 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.146 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 47' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' F' ' 138' ' ' PHE . . . -68.74 142.26 55.01 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 48' ' ' THR . . . . . 0.433 HG21 ' NH2' ' F' ' 136' ' ' ARG . 6.9 t -134.85 140.85 46.15 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.826 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -106.05 -152.75 0.48 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.519 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.91 178.52 1.07 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.881 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.02 168.86 15.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.281 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 52' ' ' VAL . . . . . 0.708 HG22 ' HB3' ' F' ' 135' ' ' ALA . 14.6 m -117.94 132.21 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.028 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 53' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' C' ' 88' ' ' LEU . . . -95.22 107.68 3.58 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.654 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 54' ' ' PHE . . . . . 0.583 ' HD1' HG23 ' F' ' 52' ' ' VAL . 55.5 p90 -140.35 132.12 27.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 55' ' ' ASN . . . . . 0.523 ' HB2' HG22 ' F' ' 130' ' ' THR . 1.6 p-10 -117.85 176.84 5.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.61 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 56' ' ' ILE . . . . . 0.783 ' HB ' HD12 ' F' ' 131' ' ' ILE . 51.8 mm -119.0 121.7 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.549 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 57' ' ' GLN . . . . . 0.726 ' HG2' HD11 ' C' ' 74' ' ' LEU . 0.0 OUTLIER -86.26 122.61 30.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.855 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' F' ' 129' ' ' ASN . 0.9 OUTLIER -131.15 93.73 3.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.265 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 59' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' F' ' 22' ' ' ALA . 0.4 OUTLIER -77.17 160.92 28.6 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.21 87.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.798 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 61' ' ' CYS . . . . . 0.708 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 69.8 m -120.41 131.88 54.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.65 97.91 9.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.321 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 63' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' F' ' 66' ' ' ALA . 1.5 m -77.52 -19.89 55.08 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -27.45 68.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.985 0.422 . . . . 0.0 111.689 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.41 -35.76 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.597 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 66' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' F' ' 63' ' ' THR . . . -131.01 131.31 44.26 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.624 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.52 -37.3 7.63 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.964 0.412 . . . . 0.0 110.933 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -121.72 171.38 8.91 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.606 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.52 136.06 15.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.575 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 70' ' ' ALA . . . . . 0.725 ' HB3' ' HB3' ' F' ' 157' ' ' GLN . . . -94.47 157.92 15.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.101 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.36 106.25 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.682 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 72' ' ' ALA . . . . . 0.843 ' HB3' ' HB3' ' F' ' 155' ' ' LYS . . . -109.53 164.35 12.6 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.64 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 73' ' ' PHE . . . . . 0.67 ' HB2' HD11 ' F' ' 111' ' ' LEU . 6.5 t80 -142.25 141.05 32.44 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.52 0.2 . . . . 0.0 111.151 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 74' ' ' LEU . . . . . 0.434 HD22 ' NZ ' ' F' ' 155' ' ' LYS . 0.1 OUTLIER -122.68 103.32 8.59 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.038 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . 0.493 ' H ' ' HB3' ' F' ' 113' ' ' LEU . . . -153.42 -166.34 14.51 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.87 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.52 136.22 46.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.604 0.24 . . . . 0.0 110.714 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 77' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' F' ' 83' ' ' THR . . . -81.4 156.09 25.58 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.925 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 78' ' ' ILE . . . . . 0.47 HG12 ' OG1' ' F' ' 140' ' ' THR . 3.1 tt -92.51 -20.65 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.859 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 79' ' ' ASP . . . . . 0.553 ' HB2' HG21 ' F' ' 140' ' ' THR . 0.4 OUTLIER 176.18 179.75 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.757 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.04 -33.76 44.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.48 -43.88 95.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.583 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 82' ' ' HIS . . . . . 0.466 ' NE2' ' O ' ' F' ' 139' ' ' ALA . 43.5 m-70 -97.83 -64.38 1.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.812 0.339 . . . . 0.0 110.436 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 83' ' ' THR . . . . . 0.429 ' HA ' ' HB1' ' F' ' 77' ' ' ALA . 1.2 m 62.35 7.83 2.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.582 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 84' ' ' ASN . . . . . 0.415 ' O ' HD12 ' F' ' 103' ' ' ILE . 6.5 m120 -115.09 -25.48 8.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.32 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 85' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' F' ' 102' ' ' GLN . 0.5 OUTLIER -79.53 143.75 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.199 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 86' ' ' LEU . . . . . 0.624 HD21 ' HB2' ' F' ' 152' ' ' ALA . 0.3 OUTLIER -76.62 148.57 36.87 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.392 179.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.87 178.22 4.39 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.799 0.333 . . . . 0.0 111.695 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . 0.657 HD22 ' O ' ' F' ' 96' ' ' ALA . 0.0 OUTLIER -84.72 176.2 8.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.069 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 89' ' ' GLN . . . . . 0.529 ' HB3' ' HB2' ' F' ' 149' ' ' ASN . 22.8 pt20 -75.29 178.71 5.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.36 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.34 -11.48 60.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.052 0.454 . . . . 0.0 111.447 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 91' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' F' ' 95' ' ' SER . 0.3 OUTLIER -64.69 87.28 0.05 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.884 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.95 -7.12 53.84 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.961 0.41 . . . . 0.0 111.666 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.08 19.86 4.08 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.699 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.58 -15.62 0.16 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.895 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 95' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' F' ' 91' ' ' SER . 1.0 OUTLIER -97.34 174.97 6.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.934 0.397 . . . . 0.0 110.572 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 96' ' ' ALA . . . . . 0.657 ' O ' HD22 ' F' ' 88' ' ' LEU . . . -114.14 157.83 22.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.85 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . 0.54 HG23 HD11 ' F' ' 88' ' ' LEU . 0.2 OUTLIER -112.95 162.64 15.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.318 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 98' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 69.39 41.61 1.29 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.406 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 10.4 p -177.65 130.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.8 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.1 179.46 28.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.523 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 101' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' F' ' 86' ' ' LEU . 1.6 t -99.07 95.28 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.068 0.547 . . . . 0.0 111.716 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 102' ' ' GLN . . . . . 0.783 ' HA ' ' HA ' ' F' ' 85' ' ' VAL . 1.9 tt0 -69.88 159.82 32.96 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.898 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 103' ' ' ILE . . . . . 0.433 HG12 ' CE2' ' F' ' 73' ' ' PHE . 0.9 OUTLIER -121.65 98.39 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.538 179.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 104' ' ' LEU . . . . . 0.699 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 1.1 tp -84.76 119.39 25.23 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 111.082 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.15 158.08 32.1 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.701 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 106' ' ' ARG . . . . . 0.55 ' HB2' ' HB2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -61.16 -33.86 74.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.881 0.372 . . . . 0.0 111.093 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 107' ' ' THR . . . . . 0.534 HG23 ' HA ' ' F' ' 120' ' ' SER . 0.0 OUTLIER -48.77 -38.18 21.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.094 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.7 -88.77 0.11 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.597 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.23 -176.32 5.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.351 . . . . 0.0 111.111 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 110' ' ' ALA . . . . . 0.699 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -79.96 143.92 33.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 111' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' F' ' 73' ' ' PHE . 0.6 OUTLIER -90.1 157.53 17.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.359 0.6 . . . . 0.0 110.566 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 112' ' ' THR . . . . . 0.449 ' HB ' HG21 ' F' ' 117' ' ' THR . 29.5 m -81.13 150.4 28.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.127 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 113' ' ' LEU . . . . . 0.596 HD12 ' N ' ' F' ' 113' ' ' LEU . 3.0 mp -102.75 57.77 0.78 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.737 0.303 . . . . 0.0 110.696 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.47 19.63 15.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.56 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.26 -93.11 0.88 Allowed Glycine 0 C--N 1.328 0.13 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.628 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.7 69.57 1.08 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.083 0.468 . . . . 0.0 111.589 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 117' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' F' ' 72' ' ' ALA . 5.8 p -89.65 97.28 11.11 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.145 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.08 102.77 5.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.736 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.5 -82.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 120' ' ' SER . . . . . 0.534 ' HA ' HG23 ' F' ' 107' ' ' THR . 0.1 OUTLIER -63.25 100.89 0.26 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.609 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.91 79.07 7.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.186 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 122' ' ' THR . . . . . 0.435 HG21 ' CD ' ' F' ' 132' ' ' PRO . 4.6 p -82.56 159.18 22.84 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.701 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 16.1 m -85.29 139.73 31.37 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.708 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.42 136.13 33.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.617 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 125' ' ' ASN . . . . . 0.53 ' HB3' ' HB3' ' C' ' 116' ' ' ALA . 25.0 m120 -120.78 143.65 48.71 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.577 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.27 148.95 34.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.626 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.68 -106.22 2.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.745 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 128' ' ' THR . . . . . 0.647 HG21 ' NZ ' ' C' ' 155' ' ' LYS . 1.9 m -85.18 153.22 22.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.7 0.286 . . . . 0.0 110.757 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 129' ' ' ASN . . . . . 0.597 ' HB3' ' HB2' ' F' ' 58' ' ' LEU . 23.2 t-20 -148.43 120.71 8.39 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.909 0.385 . . . . 0.0 111.035 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 130' ' ' THR . . . . . 0.565 ' OG1' HD12 ' C' ' 74' ' ' LEU . 0.2 OUTLIER -104.19 147.33 27.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.14 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 131' ' ' ILE . . . . . 0.783 HD12 ' HB ' ' F' ' 56' ' ' ILE . 89.7 mt -116.64 119.18 36.12 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 132' ' ' PRO . . . . . 0.685 ' HB3' ' H ' ' C' ' 77' ' ' ALA . 7.6 Cg_endo -80.96 119.09 3.5 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 121.653 1.569 . . . . 0.0 112.531 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.98 147.29 29.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.756 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.09 155.92 47.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.041 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 135' ' ' ALA . . . . . 0.708 ' HB3' HG22 ' F' ' 52' ' ' VAL . . . -140.07 115.69 10.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.884 0.373 . . . . 0.0 111.598 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 136' ' ' ARG . . . . . 0.433 ' NH2' HG21 ' F' ' 48' ' ' THR . 0.5 OUTLIER -111.32 149.02 31.72 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.479 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.64 151.3 45.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.073 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 138' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' F' ' 47' ' ' ALA . 0.2 OUTLIER -144.5 164.6 30.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.97 -179.121 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 139' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -124.46 145.68 49.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.869 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 140' ' ' THR . . . . . 0.553 HG21 ' HB2' ' F' ' 79' ' ' ASP . 0.2 OUTLIER -117.75 12.99 14.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.512 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.81 79.83 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.874 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.59 92.19 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.62 0.21 . . . . 0.0 110.762 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.1 154.81 33.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.756 0.312 . . . . 0.0 111.377 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 144' ' ' THR . . . . . 0.516 ' O ' ' HB ' ' E' ' 16' ' ' VAL . 39.4 p -116.71 166.21 13.33 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.208 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 145' ' ' PRO . . . . . 0.49 ' HA ' ' HB ' ' E' ' 16' ' ' VAL . 1.3 Cg_endo -84.29 151.47 12.14 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.445 2.097 . . . . 0.0 111.975 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.64 -106.23 0.45 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.443 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 147' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -139.11 163.26 32.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.783 0.325 . . . . 0.0 111.357 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.98 79.9 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.498 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 149' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' F' ' 89' ' ' GLN . 87.2 m-20 -99.93 142.51 31.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.593 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 150' ' ' ALA . . . . . 0.528 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -127.83 169.06 14.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.042 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 151' ' ' ASP . . . . . 0.408 ' OD2' ' HD2' ' E' ' 11' ' ' HIS . 4.2 t70 -165.59 109.91 0.85 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.186 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 152' ' ' ALA . . . . . 0.624 ' HB2' HD21 ' F' ' 86' ' ' LEU . . . -146.95 145.4 29.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.123 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 153' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' E' ' 9' ' ' THR . 1.0 OUTLIER -93.63 164.17 13.26 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 154' ' ' PHE . . . . . 0.629 ' CZ ' HG21 ' F' ' 56' ' ' ILE . 15.0 p90 -110.87 151.61 27.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.178 0.513 . . . . 0.0 110.125 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 155' ' ' LYS . . . . . 0.843 ' HB3' ' HB3' ' F' ' 72' ' ' ALA . 0.0 OUTLIER -109.69 160.95 15.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.893 -178.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 156' ' ' VAL . . . . . 0.631 HG23 HG23 ' E' ' 5' ' ' VAL . 1.5 m -142.19 112.84 2.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.846 0.355 . . . . 0.0 111.688 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 157' ' ' GLN . . . . . 0.725 ' HB3' ' HB3' ' F' ' 70' ' ' ALA . 0.3 OUTLIER -91.82 124.46 35.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.276 0.56 . . . . 0.0 110.429 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 158' ' ' TYR . . . . . 0.547 ' HB2' ' HB ' ' E' ' 3' ' ' THR . 57.5 m-85 -117.19 135.51 53.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.462 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.888 179.9 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.649 0.261 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.525 HG21 ' HB2' ' B' ' 18' ' ' ASN . 90.2 m -118.7 111.08 18.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.379 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.746 HG23 ' HG3' ' B' ' 157' ' ' GLN . 0.2 OUTLIER -97.77 127.36 43.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.554 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.649 HG23 HG23 ' B' ' 156' ' ' VAL . 0.0 OUTLIER -153.57 171.5 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.578 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.42 122.1 36.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.608 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.424 ' HA2' HE22 ' C' ' 36' ' ' GLN . . . -76.0 -52.18 6.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.855 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.42 -145.43 5.81 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.886 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.535 HG23 HG23 ' B' ' 153' ' ' THR . 0.2 OUTLIER -146.81 139.81 25.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 111.28 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.4 121.6 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.136 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.59 106.61 18.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.324 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.437 ' HZ ' ' CZ ' ' B' ' 54' ' ' PHE . 8.9 m-85 -90.65 107.61 19.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.627 ' HG2' HD22 ' B' ' 149' ' ' ASN . 0.1 OUTLIER -103.26 149.25 24.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.383 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.45 -179.07 47.54 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.902 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.67 ' HB3' ' HG3' ' B' ' 36' ' ' GLN . 0.1 OUTLIER -158.97 157.02 30.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.845 0.355 . . . . 0.0 110.394 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.8 t -113.71 132.23 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.245 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.558 HG13 ' HG2' ' B' ' 36' ' ' GLN . 5.5 m -136.88 176.58 7.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.887 0.375 . . . . 0.0 111.024 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.46 174.07 9.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.021 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 62' ' ' ASP . . . -83.37 35.35 0.49 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.066 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -116.89 -15.93 10.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.429 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.98 155.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.97 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.76 126.48 5.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.052 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.741 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -60.87 162.49 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.037 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 27' ' ' SER . 18.6 t70 -97.6 161.0 13.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.588 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.31 95.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.353 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.47 12.76 69.0 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.935 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.575 ' HB3' ' HB3' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -113.79 -25.6 8.57 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.92 0.39 . . . . 0.0 110.837 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' ' 28' ' ' VAL . 9.6 t -41.04 -62.02 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.373 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.57 119.96 39.59 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.033 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -126.09 119.13 26.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.033 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.71 103.32 15.48 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.115 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.88 115.12 43.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.168 0.509 . . . . 0.0 110.475 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.53 112.61 24.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.671 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.86 -30.36 58.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.622 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.02 -170.25 27.44 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.562 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.46 141.8 28.05 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.653 0.263 . . . . 0.0 110.871 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.562 HG11 HD22 ' A' ' 42' ' ' LEU . 5.8 p -125.34 157.14 34.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.88 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.53 122.46 29.04 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.704 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -40.39 87.01 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.774 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.51 -35.88 68.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.06 0.457 . . . . 0.0 110.773 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.13 -21.51 33.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.162 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.562 HD22 HG11 ' A' ' 37' ' ' VAL . 3.2 mp -110.51 29.49 7.67 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.579 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 141' ' ' GLY . . . -108.19 25.46 11.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.387 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.66 159.96 23.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.414 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 140' ' ' THR . 11.1 tt0 -82.87 108.66 16.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 0.0 111.166 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.93 10.84 51.54 Favored Glycine 0 C--N 1.33 0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.18 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -66.58 123.48 20.17 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.957 0.408 . . . . 0.0 112.014 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -120.64 140.28 51.79 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.828 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 4.6 m -101.65 -167.01 1.36 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.614 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.64 139.7 53.59 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.783 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.86 133.99 35.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.369 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 135' ' ' ALA . 18.8 m -87.0 166.49 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.927 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.7 128.83 7.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.63 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 133' ' ' PHE . 40.7 p90 -160.23 134.48 7.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.731 0.3 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.515 ' OD1' HG21 ' A' ' 130' ' ' THR . 16.0 p30 -132.87 147.73 52.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.494 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.637 HG22 ' HB ' ' A' ' 131' ' ' ILE . 1.0 OUTLIER -96.89 116.82 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.496 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.567 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -66.59 122.08 16.79 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.754 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.741 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -137.42 88.17 2.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.218 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.715 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 10.5 p30 -79.53 179.31 7.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.955 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.39 64.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 129' ' ' ASN . 4.4 m -110.53 163.23 13.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.839 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -140.14 155.02 47.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.287 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.24 -25.33 10.66 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -81.96 -16.38 50.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.156 0.503 . . . . 0.0 111.822 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.401 HG23 ' OD2' ' A' ' 62' ' ' ASP . 16.6 t -90.65 -48.41 14.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.662 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.11 142.9 36.03 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.637 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.8 -53.79 2.6 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.846 0.355 . . . . 0.0 110.995 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -94.86 158.16 15.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.514 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.934 ' HB2' HD13 ' A' ' 124' ' ' LEU . . . -137.21 120.46 16.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.588 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -97.57 129.17 44.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.096 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.593 HG11 HG21 ' A' ' 131' ' ' ILE . 15.9 t -113.05 152.23 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.672 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.98 146.58 27.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.606 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CD2' HG21 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -111.54 141.89 44.53 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.577 0.227 . . . . 0.0 111.067 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -105.7 103.31 12.8 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.934 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.87 -179.11 25.42 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.837 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.699 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.2 OUTLIER -105.16 157.79 17.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.57 0.224 . . . . 0.0 110.771 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.433 ' H ' ' HB2' ' D' ' 132' ' ' PRO . . . -77.85 132.82 38.17 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.876 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.453 ' CG2' ' HB ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER -66.61 -39.87 84.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.404 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.7 OUTLIER -146.21 53.55 1.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.788 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' D' ' 106' ' ' ARG . . . 61.42 -87.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.038 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.29 -36.55 53.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.594 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -81.34 59.93 4.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.865 0.364 . . . . 0.0 110.445 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.584 HG21 ' OD1' ' A' ' 114' ' ' ASP . 2.1 m -70.59 -20.41 62.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.483 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.891 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 26.5 p-10 -69.45 -13.73 62.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.29 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 102' ' ' GLN . 40.7 t -108.97 131.2 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.109 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -70.05 142.81 52.65 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.305 179.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.91 -170.52 3.05 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.946 0.403 . . . . 0.0 111.709 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 88' ' ' LEU . 1.2 mm? -80.04 161.4 25.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.02 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.73 -80.32 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.31 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.456 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 6.6 p -171.33 0.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.95 0.405 . . . . 0.0 111.446 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.687 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 73.4 m -76.81 85.65 3.4 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.902 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' D' ' 50' ' ' SER . . . -60.98 -32.34 71.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.86 0.362 . . . . 0.0 111.641 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.79 30.52 6.85 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.627 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.78 -3.14 0.11 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.92 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 0.1 OUTLIER -107.57 -176.72 3.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.882 0.372 . . . . 0.0 110.652 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.54 172.68 8.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.796 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.605 ' H ' ' HB ' ' A' ' 144' ' ' THR . 1.7 m -126.95 140.47 52.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.29 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.483 ' HB3' ' H ' ' A' ' 141' ' ' GLY . 68.4 m-80 61.96 21.23 12.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.495 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 97' ' ' THR . 2.7 t -120.29 135.99 58.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.724 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.97 -160.62 10.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.531 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 86' ' ' LEU . 4.4 p -145.96 109.88 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.173 0.511 . . . . 0.0 111.677 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.681 ' HB2' HG22 ' A' ' 85' ' ' VAL . 0.5 OUTLIER -84.37 147.38 27.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.936 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.613 HG12 ' HG ' ' A' ' 113' ' ' LEU . 1.2 pp -110.72 127.84 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.501 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.93 HD12 ' HB2' ' A' ' 110' ' ' ALA . 1.4 tp -97.37 132.95 42.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.686 0.279 . . . . 0.0 111.045 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.67 ' HB3' HG22 ' A' ' 107' ' ' THR . 4.0 t0 -80.82 143.61 32.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.675 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -65.46 -17.5 64.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.838 0.351 . . . . 0.0 111.083 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.67 HG22 ' HB3' ' A' ' 105' ' ' ASP . 13.2 t -66.89 -20.61 65.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.001 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.08 -71.77 0.44 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.68 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.53 160.02 31.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.819 0.343 . . . . 0.0 111.044 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.93 ' HB2' HD12 ' A' ' 104' ' ' LEU . . . -75.66 131.46 39.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.692 HD21 ' O ' ' A' ' 117' ' ' THR . 12.2 tp -88.1 154.18 20.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.351 0.596 . . . . 0.0 110.6 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.891 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -96.37 142.7 28.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.145 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.613 ' HG ' HG12 ' A' ' 103' ' ' ILE . 0.8 OUTLIER -80.79 63.65 5.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.715 0.293 . . . . 0.0 110.747 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.584 ' OD1' HG21 ' A' ' 83' ' ' THR . 0.1 OUTLIER -90.63 -30.63 17.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.547 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.518 ' HA3' ' OG1' ' D' ' 130' ' ' THR . . . 115.75 -43.6 1.64 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.721 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.453 ' HB2' ' C ' ' D' ' 128' ' ' THR . . . -110.46 24.39 13.03 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.011 0.434 . . . . 0.0 111.717 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.692 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -82.22 68.35 8.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.554 ' CD1' ' HB2' ' A' ' 157' ' ' GLN . 40.8 m-85 -82.19 71.96 9.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.744 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.71 81.11 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.797 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.75 131.75 13.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.604 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.427 ' O ' ' HE2' ' A' ' 68' ' ' LYS . 1.5 mm-40 -100.72 52.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.232 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.664 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -72.14 132.02 43.59 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.734 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.81 107.71 15.63 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.638 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.934 HD13 ' HB2' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -88.27 126.53 35.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.563 179.427 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.515 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 1.1 m120 -120.62 -178.95 3.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.544 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.526 ' OD1' ' HA ' ' A' ' 62' ' ' ASP . 3.8 t30 -83.27 120.65 26.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.659 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.16 -121.79 2.53 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.686 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.715 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 75.6 m -122.14 103.41 8.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.7 0.286 . . . . 0.0 110.806 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.533 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 1.7 t30 -86.14 157.21 20.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.907 0.384 . . . . 0.0 111.144 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.567 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.3 OUTLIER -143.26 130.27 20.63 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.072 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.637 ' HB ' HG22 ' A' ' 56' ' ' ILE . 57.5 mt -84.21 104.24 4.04 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 7.6 Cg_endo -81.99 112.29 2.3 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.63 1.554 . . . . 0.0 112.629 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 54' ' ' PHE . 1.0 OUTLIER -126.67 158.32 36.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.856 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -126.01 156.04 40.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.083 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.536 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -148.22 105.18 3.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.96 0.409 . . . . 0.0 111.615 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.08 163.46 12.57 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.351 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.562 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 0.3 OUTLIER -81.71 119.73 24.22 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.099 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.468 ' HB3' HG11 ' A' ' 85' ' ' VAL . 2.1 t80 -108.84 142.62 39.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.213 0.53 . . . . 0.0 112.06 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -132.96 136.0 45.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.904 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 25.2 p -96.58 -56.16 2.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.519 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.483 ' H ' ' HB3' ' A' ' 98' ' ' ASN . . . -127.06 -129.88 3.31 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.044 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.91 107.12 12.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.647 0.224 . . . . 0.0 110.781 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -65.87 148.03 52.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.687 0.28 . . . . 0.0 111.466 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.605 ' HB ' ' H ' ' A' ' 97' ' ' THR . 48.5 m -114.82 144.68 32.42 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.284 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.402 ' HD2' HG23 ' A' ' 144' ' ' THR . 1.3 Cg_endo -81.9 130.98 6.84 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.521 2.147 . . . . 0.0 111.982 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 164.82 -116.28 0.69 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.492 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.62 150.39 29.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.826 0.346 . . . . 0.0 111.397 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.69 45.93 1.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.078 0.466 . . . . 0.0 110.402 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.96 141.07 30.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.505 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.401 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -153.72 162.6 41.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.959 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -133.99 135.37 43.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.252 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.751 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -134.1 152.51 51.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.174 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.458 ' H ' ' HB3' ' A' ' 74' ' ' LEU . 3.9 m -104.13 148.96 25.68 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.29 141.89 35.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.108 0.48 . . . . 0.0 110.106 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.59 152.36 40.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.896 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.586 HG12 HD11 ' A' ' 131' ' ' ILE . 20.1 m -135.7 133.19 51.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.808 0.337 . . . . 0.0 111.704 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.554 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . 1.8 tt0 -130.91 119.77 22.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.271 0.557 . . . . 0.0 110.407 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -101.95 113.31 26.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.57 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.418 ' NE2' ' HB3' ' A' ' 157' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.835 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' C' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.24 0.066 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . 0.626 ' H ' ' HA ' ' C' ' 159' ' ' GLN . . . 59.14 55.8 4.21 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.081 0.238 . . . . 0.0 110.992 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.504 HG21 ' HB2' ' C' ' 18' ' ' ASN . 89.7 m -118.64 111.08 18.09 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.467 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.74 HG21 ' HA2' ' F' ' 127' ' ' GLY . 0.2 OUTLIER -97.78 127.33 43.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.572 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.632 HG23 HG23 ' C' ' 156' ' ' VAL . 0.0 OUTLIER -153.54 171.53 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.582 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.48 122.09 36.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.562 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . 0.423 ' HA2' HE22 ' D' ' 36' ' ' GLN . . . -75.84 -52.34 6.47 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.861 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.43 -145.44 5.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.846 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.526 HG23 HG23 ' C' ' 153' ' ' THR . 0.2 OUTLIER -146.76 139.86 25.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 111.254 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 45.3 t -122.4 121.61 64.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.148 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -99.69 106.6 18.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.369 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . 0.42 ' HZ ' ' CZ ' ' C' ' 54' ' ' PHE . 8.8 m-85 -90.6 107.59 19.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.625 ' HG2' HD22 ' C' ' 149' ' ' ASN . 0.1 OUTLIER -103.26 149.21 24.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.376 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.42 -179.01 47.49 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.98 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.674 ' HB3' ' HG3' ' C' ' 36' ' ' GLN . 0.1 OUTLIER -158.97 157.04 30.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.915 0.388 . . . . 0.0 110.377 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.459 ' O ' HG11 ' A' ' 5' ' ' VAL . 18.0 t -113.77 132.25 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.199 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.619 HG12 HG21 ' A' ' 5' ' ' VAL . 5.5 m -136.9 176.56 7.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.11 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . 0.525 ' HB2' HG21 ' A' ' 3' ' ' THR . 0.4 OUTLIER -74.4 174.1 9.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.038 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' B' ' 62' ' ' ASP . . . -83.39 35.28 0.49 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.014 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' B' ' 61' ' ' CYS . . . -116.81 -15.93 10.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.466 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 180.0 155.23 0.59 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.915 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.4 ' HA ' HG21 ' B' ' 17' ' ' VAL . . . -157.69 126.42 5.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.074 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.735 ' HA ' ' HG ' ' B' ' 58' ' ' LEU . 0.7 OUTLIER -60.82 162.51 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.046 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' B' ' 27' ' ' SER . 18.5 t70 -97.56 161.0 13.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.634 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.45 96.27 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.346 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.39 12.75 69.08 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.953 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' B' ' 24' ' ' ASP . 0.6 OUTLIER -113.79 -25.54 8.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.438 HG23 ' H ' ' B' ' 28' ' ' VAL . 9.8 t -41.17 -62.01 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.28 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.56 119.97 39.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.055 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -126.1 119.11 26.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.058 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.71 103.31 15.46 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.158 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.81 115.11 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.11 0.481 . . . . 0.0 110.445 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.53 112.63 24.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.592 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.86 -30.39 58.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.6 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.07 -170.23 27.36 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.622 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.67 ' HG3' ' HB3' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -93.55 141.72 28.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.595 0.235 . . . . 0.0 110.88 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.548 HG11 HD22 ' B' ' 42' ' ' LEU . 5.8 p -125.22 157.18 34.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.899 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.56 122.39 28.96 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.735 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -40.52 86.96 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.756 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.44 -35.84 68.31 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.112 0.482 . . . . 0.0 110.842 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.1 -21.55 33.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.175 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.548 HD22 HG11 ' B' ' 37' ' ' VAL . 3.2 mp -110.5 29.49 7.66 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.666 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' B' ' 141' ' ' GLY . . . -108.26 25.55 11.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.364 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.81 159.99 23.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.299 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' B' ' 140' ' ' THR . 11.0 tt0 -82.88 108.65 16.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 111.19 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.95 10.83 51.5 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.202 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' B' ' 139' ' ' ALA . . . -66.62 123.51 20.29 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -120.69 140.24 51.89 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.928 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 4.6 m -101.56 -166.97 1.35 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.686 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.74 139.71 53.38 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.784 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.77 134.01 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.321 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.539 HG22 ' O ' ' B' ' 135' ' ' ALA . 18.8 m -87.07 166.44 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.911 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.69 128.83 7.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.634 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . 0.437 ' CZ ' ' HZ ' ' A' ' 12' ' ' PHE . 40.6 p90 -160.23 134.5 7.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.793 0.33 . . . . 0.0 110.932 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.512 ' OD1' HG21 ' B' ' 130' ' ' THR . 15.9 p30 -132.79 147.69 52.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.58 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.634 HG22 ' HB ' ' B' ' 131' ' ' ILE . 1.0 OUTLIER -96.75 116.78 39.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.589 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . 0.566 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -66.6 122.01 16.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.724 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.735 ' HG ' ' HA ' ' B' ' 23' ' ' VAL . 0.2 OUTLIER -137.45 88.23 2.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.247 -179.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.712 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 10.6 p30 -79.63 179.35 7.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.877 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.3 64.37 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.837 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' B' ' 129' ' ' ASN . 4.4 m -110.48 163.27 13.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.808 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' B' ' 19' ' ' ALA . 0.5 OUTLIER -140.18 155.04 47.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.275 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.23 -25.35 10.65 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -82.02 -16.33 50.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.067 0.46 . . . . 0.0 111.736 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . 0.402 HG23 ' OD2' ' B' ' 62' ' ' ASP . 16.7 t -90.66 -48.49 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.661 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.1 142.94 36.04 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.624 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.79 -53.89 2.59 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.842 0.353 . . . . 0.0 110.912 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' B' ' 121' ' ' GLU . 0.1 OUTLIER -94.77 158.16 15.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.519 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.905 ' HB2' HD13 ' B' ' 124' ' ' LEU . . . -137.17 120.44 16.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.637 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -97.57 129.13 44.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.124 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.608 HG11 HG21 ' B' ' 131' ' ' ILE . 15.9 t -113.04 152.28 14.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.73 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.99 146.57 27.09 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.554 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.476 ' CD2' HG21 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -111.58 141.92 44.55 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.591 0.234 . . . . 0.0 111.098 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' B' ' 152' ' ' ALA . 0.8 OUTLIER -105.62 103.33 12.82 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.96 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.91 -179.05 25.4 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.814 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.679 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.2 OUTLIER -105.25 157.78 17.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.533 0.206 . . . . 0.0 110.725 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.439 ' H ' ' HB2' ' E' ' 132' ' ' PRO . . . -77.86 132.75 38.12 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.898 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.446 ' CG2' ' HB ' ' B' ' 85' ' ' VAL . 0.6 OUTLIER -66.68 -39.76 84.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.2 53.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' E' ' 106' ' ' ARG . . . 61.32 -87.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.03 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.33 -36.5 53.17 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.602 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -81.39 59.98 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.36 . . . . 0.0 110.447 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' THR . . . . . 0.596 HG21 ' OD1' ' B' ' 114' ' ' ASP . 2.1 m -70.61 -20.49 62.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.512 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . 0.879 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 26.6 p-10 -69.29 -13.74 62.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.352 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' B' ' 102' ' ' GLN . 40.8 t -108.97 131.15 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.127 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' B' ' 152' ' ' ALA . 0.6 OUTLIER -70.11 142.84 52.53 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.014 -0.275 . . . . 0.0 110.308 179.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.97 -170.53 3.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.891 0.377 . . . . 0.0 111.752 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' B' ' 88' ' ' LEU . 1.2 mm? -80.04 161.43 25.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.037 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.78 -80.24 0.01 OUTLIER 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.315 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . 0.474 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 6.5 p -171.42 0.5 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.993 0.425 . . . . 0.0 111.504 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' SER . . . . . 0.675 ' HA ' ' HB2' ' D' ' 25' ' ' ALA . 73.5 m -76.86 85.55 3.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.921 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' E' ' 50' ' ' SER . . . -60.88 -32.33 71.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.968 0.413 . . . . 0.0 111.733 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.75 30.47 6.88 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.7 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.74 -3.22 0.11 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.945 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' SER . . . . . 0.603 ' HB2' ' HB2' ' B' ' 91' ' ' SER . 0.1 OUTLIER -107.5 -176.78 3.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 110.661 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.39 172.67 8.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.848 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.622 ' H ' ' HB ' ' B' ' 144' ' ' THR . 1.7 m -127.01 140.36 52.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.339 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . 0.5 ' HB3' ' H ' ' B' ' 141' ' ' GLY . 68.4 m-80 62.05 21.3 12.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.441 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 97' ' ' THR . 2.7 t -120.38 135.98 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.723 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.0 -160.77 10.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.569 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.415 HG13 ' HB2' ' B' ' 86' ' ' LEU . 4.5 p -145.84 109.85 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 122.974 0.51 . . . . 0.0 111.767 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.679 ' HB2' HG22 ' B' ' 85' ' ' VAL . 0.5 OUTLIER -84.33 147.33 27.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.881 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.596 HG12 ' HG ' ' B' ' 113' ' ' LEU . 1.2 pp -110.69 127.88 67.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.515 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . 0.978 HD12 ' HB2' ' B' ' 110' ' ' ALA . 1.4 tp -97.46 132.95 42.67 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.637 0.256 . . . . 0.0 111.003 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . 0.652 ' HB3' HG22 ' B' ' 107' ' ' THR . 4.0 t0 -80.76 143.59 32.79 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.739 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -65.43 -17.55 64.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.817 0.341 . . . . 0.0 111.061 179.509 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.652 HG22 ' HB3' ' B' ' 105' ' ' ASP . 13.2 t -66.84 -20.65 65.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.011 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.05 -71.61 0.44 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.769 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.51 159.93 31.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.768 0.318 . . . . 0.0 111.139 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.978 ' HB2' HD12 ' B' ' 104' ' ' LEU . . . -75.54 131.49 40.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.162 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.685 HD21 ' O ' ' B' ' 117' ' ' THR . 12.2 tp -88.1 154.22 20.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.331 0.586 . . . . 0.0 110.553 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.879 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 0.4 OUTLIER -96.43 142.71 28.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.155 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.596 ' HG ' HG12 ' B' ' 103' ' ' ILE . 0.8 OUTLIER -80.82 63.68 5.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.771 0.32 . . . . 0.0 110.708 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . 0.596 ' OD1' HG21 ' B' ' 83' ' ' THR . 0.1 OUTLIER -90.63 -30.6 17.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.573 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . 0.525 ' HA3' ' OG1' ' E' ' 130' ' ' THR . . . 115.76 -43.58 1.64 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.617 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . 0.456 ' HB2' ' C ' ' E' ' 128' ' ' THR . . . -110.58 24.43 12.97 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.006 0.431 . . . . 0.0 111.634 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . 0.685 ' O ' HD21 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -82.12 68.28 8.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.13 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.54 ' CD1' ' HB2' ' B' ' 157' ' ' GLN . 41.2 m-85 -82.15 71.93 9.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.798 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.74 80.98 1.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.831 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.62 131.75 13.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.614 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . 0.434 ' O ' ' HE2' ' B' ' 68' ' ' LYS . 1.5 mm-40 -100.74 52.15 0.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.151 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.665 ' HB ' ' HB3' ' B' ' 69' ' ' ALA . 0.2 OUTLIER -72.14 131.92 43.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.738 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.62 107.59 15.37 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.774 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.905 HD13 ' HB2' ' B' ' 69' ' ' ALA . 1.0 OUTLIER -88.18 126.54 35.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.604 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' B' ' 61' ' ' CYS . 1.1 m120 -120.65 -178.92 3.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.577 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' ASN . . . . . 0.524 ' OD1' ' HA ' ' B' ' 62' ' ' ASP . 3.7 t30 -83.27 120.64 26.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.732 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.13 -121.78 2.53 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.683 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . 0.712 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 75.5 m -122.14 103.38 8.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.734 0.302 . . . . 0.0 110.783 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . 0.526 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 1.7 t30 -86.14 157.28 20.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.157 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.566 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.3 OUTLIER -143.32 130.22 20.51 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.064 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' ILE . . . . . 0.634 ' HB ' HG22 ' B' ' 56' ' ' ILE . 57.3 mt -84.09 104.22 3.96 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -82.09 112.48 2.3 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.611 1.541 . . . . 0.0 112.54 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.422 ' HB3' ' CZ ' ' B' ' 54' ' ' PHE . 1.0 OUTLIER -126.77 158.21 37.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.826 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -126.01 156.05 40.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.024 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.539 ' O ' HG22 ' B' ' 52' ' ' VAL . . . -148.17 105.12 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.922 0.391 . . . . 0.0 111.659 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -99.04 163.44 12.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.436 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 0.3 OUTLIER -81.67 119.75 24.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.085 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . 0.469 ' HB3' HG11 ' B' ' 85' ' ' VAL . 2.1 t80 -108.9 142.69 39.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.247 0.546 . . . . 0.0 112.012 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' B' ' 47' ' ' ALA . . . -132.97 136.0 45.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.918 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' THR . . . . . 0.655 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 25.3 p -96.53 -56.24 2.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.527 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . 0.5 ' H ' ' HB3' ' B' ' 98' ' ' ASN . . . -127.06 -129.83 3.3 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.03 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.01 107.15 12.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.682 0.241 . . . . 0.0 110.695 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' B' ' 97' ' ' THR . . . -65.94 148.12 52.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.765 0.317 . . . . 0.0 111.447 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.622 ' HB ' ' H ' ' B' ' 97' ' ' THR . 48.5 m -114.84 144.65 32.37 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.36 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -81.9 130.95 6.83 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.551 2.168 . . . . 0.0 111.967 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . 0.613 ' O ' ' HG3' ' A' ' 15' ' ' GLU . . . 164.86 -116.2 0.69 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.466 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.63 ' HA ' ' HG3' ' A' ' 15' ' ' GLU . . . -110.77 150.34 29.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.932 0.396 . . . . 0.0 111.279 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.6 45.87 1.6 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.108 0.48 . . . . 0.0 110.479 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.627 HD22 ' HG2' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -96.86 141.02 30.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.609 -179.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.401 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -153.75 162.55 41.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.013 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.91 135.46 43.62 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.179 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . 0.747 ' HB2' HD11 ' B' ' 86' ' ' LEU . . . -134.18 152.51 51.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.157 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.535 HG23 HG23 ' A' ' 9' ' ' THR . 4.0 m -104.12 148.91 25.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.23 141.81 35.25 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.087 0.47 . . . . 0.0 110.141 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.53 152.34 40.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.905 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' VAL . . . . . 0.649 HG23 HG23 ' A' ' 5' ' ' VAL . 20.2 m -135.76 133.17 51.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 111.705 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.746 ' HG3' HG23 ' A' ' 4' ' ' THR . 1.8 tt0 -130.89 119.8 22.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.269 0.557 . . . . 0.0 110.405 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -101.97 113.19 26.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.564 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . 0.423 ' NE2' ' HB3' ' B' ' 157' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.852 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 1' ' ' ALA . . . . . 0.59 ' HA ' ' HA ' ' D' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.232 0.063 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . 0.639 ' H ' ' HA ' ' D' ' 159' ' ' GLN . . . 59.07 55.84 4.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.592 0.234 . . . . 0.0 111.018 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.523 HG21 ' HB2' ' D' ' 18' ' ' ASN . 89.2 m -118.61 111.1 18.13 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.448 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 4' ' ' THR . . . . . 0.71 HG23 ' HG3' ' D' ' 157' ' ' GLN . 0.2 OUTLIER -97.78 127.3 43.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.609 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.639 HG23 HG23 ' D' ' 156' ' ' VAL . 0.0 OUTLIER -153.53 171.52 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.589 179.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.39 122.13 36.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.592 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' GLY . . . . . 0.421 ' HA2' HE22 ' E' ' 36' ' ' GLN . . . -75.96 -52.3 6.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.817 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.4 -145.56 5.86 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.889 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . 0.517 HG23 HG23 ' D' ' 153' ' ' THR . 0.2 OUTLIER -146.75 139.83 25.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.975 0.417 . . . . 0.0 111.277 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.38 121.65 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.152 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -99.71 106.6 18.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.309 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' PHE . . . . . 0.43 ' HZ ' ' CZ ' ' D' ' 54' ' ' PHE . 8.9 m-85 -90.59 107.62 19.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.783 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . 0.624 ' HG2' HD22 ' D' ' 149' ' ' ASN . 0.1 OUTLIER -103.34 149.23 24.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.337 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.39 -179.08 47.5 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.922 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' GLU . . . . . 0.664 ' HB3' ' HG3' ' D' ' 36' ' ' GLN . 0.1 OUTLIER -158.96 157.1 30.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.906 0.384 . . . . 0.0 110.311 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.46 ' O ' HG11 ' B' ' 5' ' ' VAL . 17.9 t -113.79 132.08 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.284 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.601 HG12 HG21 ' B' ' 5' ' ' VAL . 5.4 m -136.78 176.62 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.803 0.335 . . . . 0.0 111.058 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . 0.504 ' HB2' HG21 ' B' ' 3' ' ' THR . 0.4 OUTLIER -74.42 174.15 9.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.058 -179.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' C' ' 62' ' ' ASP . . . -83.47 35.43 0.5 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.075 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' C' ' 61' ' ' CYS . . . -116.92 -15.94 10.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.435 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.94 155.31 0.6 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.91 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.78 126.37 5.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . 0.737 ' HA ' ' HG ' ' C' ' 58' ' ' LEU . 0.7 OUTLIER -60.74 162.53 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.112 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' C' ' 27' ' ' SER . 18.7 t70 -97.66 161.0 13.97 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.577 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.687 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -64.07 -40.37 96.12 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.389 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.43 12.79 68.96 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.91 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . 0.563 ' HB3' ' HB3' ' C' ' 24' ' ' ASP . 0.6 OUTLIER -113.87 -25.52 8.58 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.865 0.364 . . . . 0.0 110.808 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.407 HG23 ' H ' ' C' ' 28' ' ' VAL . 9.8 t -41.15 -61.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.35 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.55 119.95 39.56 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.085 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -126.14 119.15 26.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.984 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.69 103.32 15.48 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.078 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.86 115.13 43.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.145 0.498 . . . . 0.0 110.493 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.51 112.59 24.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.656 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.8 -30.4 59.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.692 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.03 -170.17 27.36 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.613 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . 0.674 ' HG3' ' HB3' ' B' ' 15' ' ' GLU . 0.4 OUTLIER -93.51 141.7 28.17 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.522 0.201 . . . . 0.0 110.887 -179.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.536 HG11 HD22 ' C' ' 42' ' ' LEU . 5.7 p -125.29 157.11 34.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.916 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.53 122.41 28.98 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.727 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -40.44 87.01 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.754 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.46 -35.87 68.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.05 0.452 . . . . 0.0 110.797 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.19 -21.39 33.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.16 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.536 HD22 HG11 ' C' ' 37' ' ' VAL . 3.2 mp -110.51 29.45 7.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.566 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' C' ' 141' ' ' GLY . . . -108.2 25.45 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.321 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.74 159.92 23.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.341 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . 0.654 ' HA ' ' O ' ' C' ' 140' ' ' THR . 11.0 tt0 -82.8 108.68 16.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.853 0.358 . . . . 0.0 111.168 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.9 10.91 51.52 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.163 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' C' ' 139' ' ' ALA . . . -66.76 123.49 20.27 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.933 0.396 . . . . 0.0 112.061 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -120.65 140.25 51.84 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.874 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 4.6 m -101.62 -167.02 1.36 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.611 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.68 139.65 53.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.786 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.82 133.95 35.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.309 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.541 HG22 ' O ' ' C' ' 135' ' ' ALA . 18.7 m -86.94 166.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.016 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.74 128.76 7.94 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.637 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' C' ' 133' ' ' PHE . 40.7 p90 -160.17 134.48 7.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.511 ' OD1' HG21 ' C' ' 130' ' ' THR . 15.8 p30 -132.75 147.73 52.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.583 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.631 HG22 ' HB ' ' C' ' 131' ' ' ILE . 1.0 OUTLIER -96.75 116.7 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.621 -179.749 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.557 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.0 OUTLIER -66.58 122.06 16.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.696 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . 0.737 ' HG ' ' HA ' ' C' ' 23' ' ' VAL . 0.2 OUTLIER -137.43 88.17 2.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.23 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . 0.714 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 10.5 p30 -79.6 179.4 7.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.88 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.3 64.46 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.783 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' C' ' 129' ' ' ASN . 4.4 m -110.53 163.26 13.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.786 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . 0.587 ' HB2' ' O ' ' C' ' 19' ' ' ALA . 0.5 OUTLIER -140.21 155.07 47.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.254 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.34 -25.31 10.63 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -82.08 -16.25 50.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.061 0.458 . . . . 0.0 111.745 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.403 HG23 ' OD2' ' C' ' 62' ' ' ASP . 16.6 t -90.66 -48.46 14.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.661 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.11 142.9 36.02 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.639 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.82 -53.81 2.6 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.847 0.356 . . . . 0.0 110.971 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' C' ' 121' ' ' GLU . 0.1 OUTLIER -94.79 158.16 15.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.491 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.899 ' HB2' HD13 ' C' ' 124' ' ' LEU . . . -137.22 120.47 16.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.611 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -97.54 129.03 44.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.137 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . 0.6 HG11 HG21 ' C' ' 131' ' ' ILE . 15.8 t -112.96 152.24 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.718 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.01 146.63 27.1 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.588 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' PHE . . . . . 0.474 ' CD2' HG21 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -111.53 141.88 44.54 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.5 0.191 . . . . 0.0 111.092 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' C' ' 152' ' ' ALA . 0.8 OUTLIER -105.72 103.24 12.7 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.974 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.88 -179.11 25.43 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.789 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.685 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.2 OUTLIER -105.15 157.85 16.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.595 0.236 . . . . 0.0 110.73 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . 0.422 ' H ' ' HB2' ' F' ' 132' ' ' PRO . . . -77.89 132.79 38.1 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.881 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . 0.449 ' CG2' ' HB ' ' C' ' 85' ' ' VAL . 0.6 OUTLIER -66.58 -39.88 84.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' ASP . . . . . 0.415 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.7 OUTLIER -146.19 53.58 1.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.824 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' F' ' 106' ' ' ARG . . . 61.42 -87.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.065 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.37 -36.51 53.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.576 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -81.37 59.97 4.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.883 0.373 . . . . 0.0 110.451 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . 0.593 HG21 ' OD1' ' C' ' 114' ' ' ASP . 2.1 m -70.53 -20.53 62.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.49 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' ASN . . . . . 0.888 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 26.6 p-10 -69.34 -13.73 62.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.334 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.697 HG22 ' HB2' ' C' ' 102' ' ' GLN . 40.9 t -109.0 131.15 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.129 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.783 HD11 ' HB2' ' C' ' 152' ' ' ALA . 0.6 OUTLIER -70.07 142.85 52.61 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.324 179.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.0 -170.58 3.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.882 0.372 . . . . 0.0 111.71 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -79.89 161.44 25.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.102 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.75 -80.33 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.34 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' SER . . . . . 0.476 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 6.6 p -171.34 0.49 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.949 0.404 . . . . 0.0 111.481 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' SER . . . . . 0.677 ' HA ' ' HB2' ' E' ' 25' ' ' ALA . 73.5 m -76.84 85.66 3.42 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' F' ' 50' ' ' SER . . . -61.04 -32.23 71.86 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.876 0.369 . . . . 0.0 111.649 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.86 30.47 6.87 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.642 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.64 -3.26 0.11 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.947 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' C' ' 91' ' ' SER . 0.1 OUTLIER -107.54 -176.71 3.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.834 0.35 . . . . 0.0 110.656 179.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.49 172.58 8.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . 0.613 ' H ' ' HB ' ' C' ' 144' ' ' THR . 1.6 m -126.93 140.4 52.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.351 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . 0.492 ' HB3' ' H ' ' C' ' 141' ' ' GLY . 68.4 m-80 61.96 21.39 12.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.472 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 99' ' ' VAL . . . . . 0.543 HG23 ' O ' ' C' ' 97' ' ' THR . 2.7 t -120.44 136.0 58.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.727 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.94 -160.74 10.18 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.532 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' C' ' 86' ' ' LEU . 4.5 p -145.94 109.85 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.067 0.547 . . . . 0.0 111.758 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 102' ' ' GLN . . . . . 0.697 ' HB2' HG22 ' C' ' 85' ' ' VAL . 0.5 OUTLIER -84.27 147.38 27.26 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.93 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.598 HG12 ' HG ' ' C' ' 113' ' ' LEU . 1.2 pp -110.79 127.86 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.529 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' LEU . . . . . 0.976 HD12 ' HB2' ' C' ' 110' ' ' ALA . 1.4 tp -97.43 132.94 42.66 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.663 0.268 . . . . 0.0 111.02 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . 0.654 ' HB3' HG22 ' C' ' 107' ' ' THR . 4.0 t0 -80.78 143.58 32.77 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.688 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 106' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -65.42 -17.53 64.61 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.815 0.341 . . . . 0.0 111.043 179.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 107' ' ' THR . . . . . 0.654 HG22 ' HB3' ' C' ' 105' ' ' ASP . 13.2 t -66.83 -20.59 65.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.028 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.08 -71.85 0.44 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.682 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.5 159.97 31.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.825 0.345 . . . . 0.0 111.11 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.976 ' HB2' HD12 ' C' ' 104' ' ' LEU . . . -75.54 131.52 40.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 111' ' ' LEU . . . . . 0.696 HD21 ' O ' ' C' ' 117' ' ' THR . 12.2 tp -88.14 154.22 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.379 0.609 . . . . 0.0 110.514 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 112' ' ' THR . . . . . 0.888 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 0.4 OUTLIER -96.37 142.66 28.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.147 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.598 ' HG ' HG12 ' C' ' 103' ' ' ILE . 0.8 OUTLIER -80.76 63.61 5.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.783 0.325 . . . . 0.0 110.761 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 114' ' ' ASP . . . . . 0.593 ' OD1' HG21 ' C' ' 83' ' ' THR . 0.1 OUTLIER -90.7 -30.54 17.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.547 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . 0.527 ' HA3' ' OG1' ' F' ' 130' ' ' THR . . . 115.76 -43.57 1.65 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.595 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 116' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' F' ' 128' ' ' THR . . . -110.49 24.33 13.11 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.003 0.43 . . . . 0.0 111.679 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . 0.696 ' O ' HD21 ' C' ' 111' ' ' LEU . 0.2 OUTLIER -82.15 68.37 8.52 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.118 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 118' ' ' PHE . . . . . 0.553 ' CD1' ' HB2' ' C' ' 157' ' ' GLN . 41.0 m-85 -82.2 72.0 9.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.801 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.76 80.99 1.86 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.65 131.75 13.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.606 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . 0.433 ' O ' ' HE2' ' C' ' 68' ' ' LYS . 1.5 mm-40 -100.76 52.2 0.86 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.212 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' C' ' 69' ' ' ALA . 0.2 OUTLIER -72.11 131.89 43.45 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.75 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.7 107.65 15.49 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.745 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . 0.899 HD13 ' HB2' ' C' ' 69' ' ' ALA . 1.0 OUTLIER -88.26 126.58 35.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.561 179.465 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 125' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' C' ' 61' ' ' CYS . 1.1 m120 -120.66 -178.93 3.84 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.525 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 126' ' ' ASN . . . . . 0.524 ' OD1' ' HA ' ' C' ' 62' ' ' ASP . 3.8 t30 -83.25 120.61 26.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.784 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.18 -121.67 2.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.659 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 128' ' ' THR . . . . . 0.714 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 76.5 m -122.21 103.37 8.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.746 0.308 . . . . 0.0 110.78 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 129' ' ' ASN . . . . . 0.529 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 1.8 t30 -86.21 157.26 20.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.896 0.379 . . . . 0.0 111.091 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 130' ' ' THR . . . . . 0.557 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.3 OUTLIER -143.29 130.17 20.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.104 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 131' ' ' ILE . . . . . 0.631 ' HB ' HG22 ' C' ' 56' ' ' ILE . 56.8 mt -83.97 104.14 3.79 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 132' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' C' ' 106' ' ' ARG . 7.6 Cg_endo -82.0 112.34 2.31 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.673 1.582 . . . . 0.0 112.582 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.43 ' HB3' ' CZ ' ' C' ' 54' ' ' PHE . 1.0 OUTLIER -126.7 158.29 36.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.828 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -126.0 156.1 40.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.059 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . 0.541 ' O ' HG22 ' C' ' 52' ' ' VAL . . . -148.15 105.14 3.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 0.0 111.609 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.05 163.36 12.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.416 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 137' ' ' TYR . . . . . 0.561 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 0.3 OUTLIER -81.64 119.71 24.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.116 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 138' ' ' PHE . . . . . 0.463 ' HB3' HG11 ' C' ' 85' ' ' VAL . 2.1 t80 -108.91 142.68 39.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.982 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 139' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' C' ' 47' ' ' ALA . . . -132.98 136.04 45.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.851 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 140' ' ' THR . . . . . 0.654 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 25.1 p -96.6 -56.21 2.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.476 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . 0.492 ' H ' ' HB3' ' C' ' 98' ' ' ASN . . . -127.06 -129.84 3.3 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.013 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.03 107.14 12.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.631 0.216 . . . . 0.0 110.702 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 143' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' C' ' 97' ' ' THR . . . -65.89 148.09 52.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.753 0.311 . . . . 0.0 111.434 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 144' ' ' THR . . . . . 0.613 ' HB ' ' H ' ' C' ' 97' ' ' THR . 47.8 m -114.87 144.67 32.42 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.307 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 145' ' ' PRO . . . . . 0.406 ' HD2' HG23 ' C' ' 144' ' ' THR . 1.3 Cg_endo -81.96 130.97 6.78 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.479 2.119 . . . . 0.0 112.009 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 146' ' ' GLY . . . . . 0.62 ' O ' ' HG3' ' B' ' 15' ' ' GLU . . . 164.89 -116.26 0.69 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.438 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 147' ' ' ALA . . . . . 0.611 ' HA ' ' HG3' ' B' ' 15' ' ' GLU . . . -110.67 150.37 29.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 111.351 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.67 45.89 1.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.46 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 149' ' ' ASN . . . . . 0.625 HD22 ' HG2' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -96.83 141.0 30.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.618 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 150' ' ' ALA . . . . . 0.411 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -153.7 162.62 41.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.047 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.93 135.5 43.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.198 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 152' ' ' ALA . . . . . 0.783 ' HB2' HD11 ' C' ' 86' ' ' LEU . . . -134.16 152.51 51.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.23 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . 0.526 HG23 HG23 ' B' ' 9' ' ' THR . 4.0 m -104.15 148.91 25.74 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.23 141.83 35.21 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.136 0.493 . . . . 0.0 110.165 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.54 152.41 40.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.916 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 156' ' ' VAL . . . . . 0.632 HG23 HG23 ' B' ' 5' ' ' VAL . 19.9 m -135.74 133.22 51.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.798 0.332 . . . . 0.0 111.684 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 157' ' ' GLN . . . . . 0.711 ' HG3' HG23 ' B' ' 4' ' ' THR . 1.8 tt0 -130.96 119.78 22.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.326 0.584 . . . . 0.0 110.397 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -101.93 113.24 26.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.577 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . 0.626 ' HA ' ' H ' ' B' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.836 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 1' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' E' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 111.105 0.039 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . 0.624 ' H ' ' HA ' ' E' ' 159' ' ' GLN . . . 59.11 55.8 4.22 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 123.104 0.253 . . . . 0.0 111.035 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 3' ' ' THR . . . . . 0.524 HG21 ' HB2' ' E' ' 18' ' ' ASN . 89.7 m -118.64 111.07 18.08 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.422 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . 0.74 HG23 ' HG3' ' E' ' 157' ' ' GLN . 0.2 OUTLIER -97.76 127.33 43.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.524 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.657 HG23 HG23 ' E' ' 156' ' ' VAL . 0.0 OUTLIER -153.53 171.46 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.634 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.37 122.09 36.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.637 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 7' ' ' GLY . . . . . 0.425 ' HA2' HE22 ' F' ' 36' ' ' GLN . . . -76.0 -52.23 6.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.802 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.46 -145.46 5.83 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.829 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . 0.535 HG23 HG23 ' E' ' 153' ' ' THR . 0.2 OUTLIER -146.82 139.74 25.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.905 0.383 . . . . 0.0 111.299 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.33 121.63 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.125 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -99.65 106.66 18.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.361 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' PHE . . . . . 0.432 ' HZ ' ' CZ ' ' E' ' 54' ' ' PHE . 8.9 m-85 -90.65 107.59 19.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.797 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' LYS . . . . . 0.605 ' HG2' HD22 ' E' ' 149' ' ' ASN . 0.1 OUTLIER -103.29 149.18 24.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.404 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.42 -179.05 47.51 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.946 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' GLU . . . . . 0.673 ' HB3' ' HG3' ' E' ' 36' ' ' GLN . 0.1 OUTLIER -158.93 157.01 30.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.912 0.387 . . . . 0.0 110.358 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.461 ' O ' HG11 ' C' ' 5' ' ' VAL . 17.8 t -113.7 132.19 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.249 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.606 HG12 HG21 ' C' ' 5' ' ' VAL . 5.5 m -136.85 176.58 7.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.829 0.347 . . . . 0.0 111.008 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' ASN . . . . . 0.523 ' HB2' HG21 ' C' ' 3' ' ' THR . 0.4 OUTLIER -74.36 174.11 9.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.068 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' D' ' 62' ' ' ASP . . . -83.4 35.32 0.49 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.059 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' D' ' 61' ' ' CYS . . . -116.92 -15.9 10.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.398 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.99 155.22 0.59 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.962 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.67 126.47 5.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.077 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . 0.74 ' HA ' ' HG ' ' D' ' 58' ' ' LEU . 0.7 OUTLIER -60.9 162.44 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.057 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' D' ' 27' ' ' SER . 18.7 t70 -97.58 160.97 14.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.623 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.675 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -64.11 -40.25 95.79 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.398 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.49 12.75 69.02 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.914 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . 0.568 ' HB3' ' HB3' ' D' ' 24' ' ' ASP . 0.6 OUTLIER -113.84 -25.47 8.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.846 0.355 . . . . 0.0 110.787 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . 0.405 HG23 ' H ' ' D' ' 28' ' ' VAL . 10.0 t -41.15 -61.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.306 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.64 120.0 39.65 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.03 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -126.07 119.1 26.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.024 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.76 103.33 15.47 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.083 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.88 115.1 43.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.163 0.506 . . . . 0.0 110.424 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.5 112.56 24.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.646 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.83 -30.34 58.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.626 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.98 -170.23 27.49 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.571 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' GLN . . . . . 0.664 ' HG3' ' HB3' ' C' ' 15' ' ' GLU . 0.4 OUTLIER -93.48 141.79 28.07 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.526 0.203 . . . . 0.0 110.944 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.559 HG11 HD22 ' D' ' 42' ' ' LEU . 5.8 p -125.3 157.14 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.827 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.58 122.39 28.97 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.729 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -40.47 86.94 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.753 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.48 -35.82 68.39 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.053 0.454 . . . . 0.0 110.8 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -21.44 33.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.133 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.559 HD22 HG11 ' D' ' 37' ' ' VAL . 3.3 mp -110.5 29.51 7.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.623 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' D' ' 141' ' ' GLY . . . -108.24 25.44 11.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.34 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.71 159.97 23.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.38 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' D' ' 140' ' ' THR . 11.1 tt0 -82.94 108.73 16.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.916 0.388 . . . . 0.0 111.127 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.97 10.78 51.51 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.116 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' D' ' 139' ' ' ALA . . . -66.66 123.47 20.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.94 0.4 . . . . 0.0 111.974 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 77.5 p -120.64 140.3 51.77 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.879 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 4.6 m -101.68 -167.02 1.36 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.61 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 8.1 t -69.63 139.64 53.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.791 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.79 133.99 35.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.335 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' VAL . . . . . 0.532 HG22 ' O ' ' D' ' 135' ' ' ALA . 18.9 m -87.04 166.48 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.896 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.77 128.87 7.99 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.614 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.558 ' H ' HG21 ' A' ' 76' ' ' THR . 40.6 p90 -160.2 134.44 7.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.756 0.312 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' ASN . . . . . 0.516 ' OD1' HG21 ' D' ' 130' ' ' THR . 15.9 p30 -132.75 147.67 52.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.623 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.636 HG22 ' HB ' ' D' ' 131' ' ' ILE . 1.0 OUTLIER -96.74 116.75 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.567 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' GLN . . . . . 0.572 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.0 OUTLIER -66.61 122.04 16.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.744 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . 0.74 ' HG ' ' HA ' ' D' ' 23' ' ' VAL . 0.2 OUTLIER -137.4 88.17 2.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . 0.734 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 10.6 p30 -79.58 179.37 7.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.925 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.35 64.37 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.812 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' D' ' 129' ' ' ASN . 4.4 m -110.48 163.26 13.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.954 0.406 . . . . 0.0 110.761 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . 0.575 ' HB2' ' O ' ' D' ' 19' ' ' ALA . 0.5 OUTLIER -140.22 155.07 47.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.237 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.25 -25.36 10.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -81.99 -16.41 50.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.083 0.468 . . . . 0.0 111.703 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 t -90.61 -48.48 14.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.696 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.12 142.9 36.01 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.639 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.79 -53.82 2.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.848 0.356 . . . . 0.0 110.941 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' D' ' 121' ' ' GLU . 0.1 OUTLIER -94.86 158.1 15.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.482 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' ALA . . . . . 0.908 ' HB2' HD13 ' D' ' 124' ' ' LEU . . . -137.14 120.48 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.621 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -97.62 129.1 44.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.06 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . 0.594 HG11 HG21 ' D' ' 131' ' ' ILE . 15.9 t -112.99 152.28 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.671 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.05 146.61 27.06 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.522 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 73' ' ' PHE . . . . . 0.474 ' CD2' HG21 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -111.53 141.94 44.46 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.536 0.208 . . . . 0.0 111.092 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 74' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.8 OUTLIER -105.71 103.35 12.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.916 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.96 -179.11 25.5 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.806 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 157.84 17.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.558 0.218 . . . . 0.0 110.732 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.9 132.75 38.07 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.87 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 78' ' ' ILE . . . . . 0.452 ' CG2' ' HB ' ' D' ' 85' ' ' VAL . 0.6 OUTLIER -66.61 -39.79 84.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.42 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.7 OUTLIER -146.22 53.53 1.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.826 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.39 -87.54 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.33 -36.53 53.26 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.58 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -81.31 59.99 4.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.472 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 83' ' ' THR . . . . . 0.593 HG21 ' OD1' ' D' ' 114' ' ' ASP . 2.1 m -70.58 -20.53 62.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.575 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . 0.887 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 26.6 p-10 -69.35 -13.7 62.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.296 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' D' ' 102' ' ' GLN . 40.8 t -108.96 131.1 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.203 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.758 HD11 ' HB2' ' D' ' 152' ' ' ALA . 0.6 OUTLIER -70.02 142.89 52.69 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.323 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.02 -170.5 3.06 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.884 0.373 . . . . 0.0 111.688 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -80.02 161.44 25.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.022 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.76 -80.25 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.357 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 6.5 p -171.41 0.48 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 111.445 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . 0.687 ' HA ' ' HB2' ' F' ' 25' ' ' ALA . 73.4 m -76.83 85.55 3.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.912 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.87 -32.32 71.76 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.655 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.83 30.45 6.88 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.641 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.71 -3.12 0.11 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.953 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 95' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' D' ' 91' ' ' SER . 0.1 OUTLIER -107.57 -176.79 3.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 110.638 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.56 172.58 8.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.811 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . 0.611 ' H ' ' HB ' ' D' ' 144' ' ' THR . 1.7 m -126.86 140.43 52.36 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.288 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 98' ' ' ASN . . . . . 0.48 ' HB3' ' H ' ' D' ' 141' ' ' GLY . 68.3 m-80 61.95 21.36 12.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.427 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 99' ' ' VAL . . . . . 0.55 HG23 ' O ' ' D' ' 97' ' ' THR . 2.7 t -120.35 136.02 58.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.742 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.0 -160.77 10.21 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.513 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 101' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' D' ' 86' ' ' LEU . 4.5 p -145.9 109.85 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.168 0.509 . . . . 0.0 111.762 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 102' ' ' GLN . . . . . 0.691 ' HB2' HG22 ' D' ' 85' ' ' VAL . 0.5 OUTLIER -84.31 147.36 27.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.93 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 103' ' ' ILE . . . . . 0.611 HG12 ' HG ' ' D' ' 113' ' ' LEU . 1.2 pp -110.73 127.81 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.49 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 104' ' ' LEU . . . . . 0.937 HD12 ' HB2' ' D' ' 110' ' ' ALA . 1.4 tp -97.37 132.92 42.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.676 0.274 . . . . 0.0 111.093 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . 0.673 ' HB3' HG22 ' D' ' 107' ' ' THR . 4.0 t0 -80.81 143.62 32.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.669 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 106' ' ' ARG . . . . . 0.543 ' HA ' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -65.47 -17.44 64.56 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.762 0.315 . . . . 0.0 111.101 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 107' ' ' THR . . . . . 0.673 HG22 ' HB3' ' D' ' 105' ' ' ASP . 13.3 t -66.87 -20.59 65.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.052 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.07 -71.78 0.44 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.674 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.48 159.93 31.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.829 0.347 . . . . 0.0 111.111 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.937 ' HB2' HD12 ' D' ' 104' ' ' LEU . . . -75.56 131.47 40.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.126 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 111' ' ' LEU . . . . . 0.682 HD21 ' O ' ' D' ' 117' ' ' THR . 12.2 tp -88.13 154.21 20.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.372 0.606 . . . . 0.0 110.63 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 112' ' ' THR . . . . . 0.887 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 0.4 OUTLIER -96.42 142.74 28.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.082 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 113' ' ' LEU . . . . . 0.611 ' HG ' HG12 ' D' ' 103' ' ' ILE . 0.8 OUTLIER -80.82 63.68 5.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.738 0.304 . . . . 0.0 110.704 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 114' ' ' ASP . . . . . 0.593 ' OD1' HG21 ' D' ' 83' ' ' THR . 0.1 OUTLIER -90.65 -30.66 17.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.648 0.261 . . . . 0.0 111.55 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.79 -43.6 1.64 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.593 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.56 24.38 13.04 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.996 0.427 . . . . 0.0 111.614 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 117' ' ' THR . . . . . 0.682 ' O ' HD21 ' D' ' 111' ' ' LEU . 0.2 OUTLIER -82.12 68.35 8.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.553 ' CD1' ' HB2' ' D' ' 157' ' ' GLN . 40.8 m-85 -82.21 71.98 9.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.754 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.71 80.99 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.58 131.75 13.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.576 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . 0.431 ' O ' ' HE2' ' D' ' 68' ' ' LYS . 1.5 mm-40 -100.77 52.11 0.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.222 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.666 ' HB ' ' HB3' ' D' ' 69' ' ' ALA . 0.2 OUTLIER -72.06 131.91 43.5 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.73 -179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.69 107.62 15.46 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.742 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . 0.908 HD13 ' HB2' ' D' ' 69' ' ' ALA . 1.0 OUTLIER -88.22 126.58 35.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.558 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 125' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' D' ' 61' ' ' CYS . 1.1 m120 -120.69 -178.94 3.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.575 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 126' ' ' ASN . . . . . 0.52 ' OD1' ' HA ' ' D' ' 62' ' ' ASP . 3.8 t30 -83.23 120.71 26.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.662 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.08 -121.72 2.52 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.709 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 128' ' ' THR . . . . . 0.734 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 75.8 m -122.21 103.42 8.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.711 0.291 . . . . 0.0 110.77 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 129' ' ' ASN . . . . . 0.534 ' HB2' ' SG ' ' D' ' 61' ' ' CYS . 1.7 t30 -86.14 157.23 20.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.172 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 130' ' ' THR . . . . . 0.572 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.3 OUTLIER -143.28 130.17 20.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.136 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 131' ' ' ILE . . . . . 0.636 ' HB ' HG22 ' D' ' 56' ' ' ILE . 57.0 mt -84.0 104.11 3.77 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 132' ' ' PRO . . . . . 0.699 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 7.6 Cg_endo -81.99 112.34 2.31 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.646 1.564 . . . . 0.0 112.568 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . 0.432 ' HB3' ' CZ ' ' D' ' 54' ' ' PHE . 1.0 OUTLIER -126.68 158.25 36.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.863 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -125.96 156.09 40.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.116 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.532 ' O ' HG22 ' D' ' 52' ' ' VAL . . . -148.22 105.12 3.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.947 0.404 . . . . 0.0 111.587 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -99.07 163.48 12.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.357 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 137' ' ' TYR . . . . . 0.573 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 0.3 OUTLIER -81.79 119.7 24.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.101 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 138' ' ' PHE . . . . . 0.461 ' HB3' HG11 ' D' ' 85' ' ' VAL . 2.1 t80 -108.84 142.68 39.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.056 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 139' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' D' ' 47' ' ' ALA . . . -132.92 136.05 45.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.904 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 140' ' ' THR . . . . . 0.656 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 25.1 p -96.66 -56.14 2.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.474 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . 0.48 ' H ' ' HB3' ' D' ' 98' ' ' ASN . . . -127.11 -129.87 3.3 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.988 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.98 107.05 12.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.652 0.226 . . . . 0.0 110.779 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 143' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' D' ' 97' ' ' THR . . . -65.85 148.09 52.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.714 0.292 . . . . 0.0 111.441 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 144' ' ' THR . . . . . 0.611 ' HB ' ' H ' ' D' ' 97' ' ' THR . 48.6 m -114.79 144.69 32.42 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.297 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 145' ' ' PRO . . . . . 0.411 ' HD2' HG23 ' D' ' 144' ' ' THR . 1.3 Cg_endo -81.97 130.91 6.75 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.573 2.182 . . . . 0.0 111.972 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 146' ' ' GLY . . . . . 0.621 ' O ' ' HG3' ' C' ' 15' ' ' GLU . . . 164.89 -116.25 0.69 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.439 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 147' ' ' ALA . . . . . 0.627 ' HA ' ' HG3' ' C' ' 15' ' ' GLU . . . -110.66 150.4 29.06 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.808 0.337 . . . . 0.0 111.339 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.65 45.88 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.45 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 149' ' ' ASN . . . . . 0.624 HD22 ' HG2' ' C' ' 13' ' ' LYS . 0.2 OUTLIER -96.85 141.06 30.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.578 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 150' ' ' ALA . . . . . 0.404 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -153.74 162.54 41.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.962 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.87 135.49 43.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.239 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 152' ' ' ALA . . . . . 0.758 ' HB2' HD11 ' D' ' 86' ' ' LEU . . . -134.19 152.49 51.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.217 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 153' ' ' THR . . . . . 0.517 HG23 HG23 ' C' ' 9' ' ' THR . 4.0 m -104.09 148.92 25.7 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.25 141.83 35.22 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.106 0.479 . . . . 0.0 110.113 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.57 152.39 40.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.921 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 156' ' ' VAL . . . . . 0.639 HG23 HG23 ' C' ' 5' ' ' VAL . 20.0 m -135.74 133.16 51.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.809 0.337 . . . . 0.0 111.635 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 157' ' ' GLN . . . . . 0.71 ' HG3' HG23 ' C' ' 4' ' ' THR . 1.8 tt0 -130.9 119.74 22.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.302 0.572 . . . . 0.0 110.417 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -101.94 113.31 26.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.587 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 159' ' ' GLN . . . . . 0.639 ' HA ' ' H ' ' C' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.839 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 1' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' F' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 111.108 0.04 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 2' ' ' ALA . . . . . 0.622 ' H ' ' HA ' ' F' ' 159' ' ' GLN . . . 59.16 55.73 4.23 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.106 0.254 . . . . 0.0 111.035 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 3' ' ' THR . . . . . 0.524 HG21 ' HB2' ' F' ' 18' ' ' ASN . 89.5 m -118.64 111.1 18.11 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.443 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 4' ' ' THR . . . . . 0.726 HG23 ' HG3' ' F' ' 157' ' ' GLN . 0.2 OUTLIER -97.79 127.38 43.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.575 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.638 HG23 HG23 ' F' ' 156' ' ' VAL . 0.0 OUTLIER -153.57 171.46 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.594 179.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.38 122.07 36.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.83 -52.37 6.46 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.859 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.41 -145.53 5.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.868 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 9' ' ' THR . . . . . 0.531 HG23 HG23 ' F' ' 153' ' ' THR . 0.2 OUTLIER -146.69 139.85 25.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 0.0 111.283 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.43 121.63 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.121 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.71 106.64 18.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.326 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 12' ' ' PHE . . . . . 0.434 ' HZ ' ' CZ ' ' F' ' 54' ' ' PHE . 8.9 m-85 -90.65 107.66 19.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 13' ' ' LYS . . . . . 0.623 ' HG2' HD22 ' F' ' 149' ' ' ASN . 0.1 OUTLIER -103.29 149.18 24.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.384 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.43 -179.03 47.51 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.971 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 15' ' ' GLU . . . . . 0.662 ' HB3' ' HG3' ' F' ' 36' ' ' GLN . 0.1 OUTLIER -158.96 157.01 30.49 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.849 0.357 . . . . 0.0 110.381 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 16' ' ' VAL . . . . . 0.457 ' O ' HG11 ' D' ' 5' ' ' VAL . 18.1 t -113.77 132.21 63.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.148 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . 0.615 HG12 HG21 ' D' ' 5' ' ' VAL . 5.6 m -136.84 176.55 7.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 111.107 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . 0.524 ' HB2' HG21 ' D' ' 3' ' ' THR . 0.4 OUTLIER -74.36 174.11 9.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.012 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 19' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' E' ' 62' ' ' ASP . . . -83.45 35.38 0.5 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' E' ' 61' ' ' CYS . . . -116.93 -15.9 10.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.412 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.99 155.26 0.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.961 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.74 126.43 5.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 23' ' ' VAL . . . . . 0.728 ' HA ' ' HG ' ' E' ' 58' ' ' LEU . 0.7 OUTLIER -60.85 162.54 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.083 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 24' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' E' ' 27' ' ' SER . 18.6 t70 -97.66 160.99 13.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.595 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . 0.677 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -64.12 -40.33 95.97 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.365 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.41 12.73 69.09 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.9 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . 0.573 ' HB3' ' HB3' ' E' ' 24' ' ' ASP . 0.6 OUTLIER -113.84 -25.51 8.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.836 0.35 . . . . 0.0 110.785 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 28' ' ' VAL . . . . . . . . . . . . . 9.7 t -41.14 -61.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.336 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.64 120.01 39.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.013 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -126.11 119.14 26.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.01 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.79 103.29 15.43 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.107 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.82 115.11 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.144 0.497 . . . . 0.0 110.534 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.45 112.6 24.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.601 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mp -75.87 -30.4 58.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.615 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.08 -170.2 27.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.581 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 36' ' ' GLN . . . . . 0.673 ' HG3' ' HB3' ' D' ' 15' ' ' GLU . 0.4 OUTLIER -93.47 141.71 28.15 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.608 0.242 . . . . 0.0 110.89 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.552 HG11 HD22 ' E' ' 42' ' ' LEU . 5.8 p -125.24 157.13 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.914 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.55 122.43 29.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.799 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -40.42 87.1 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.736 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.44 -35.86 68.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.125 0.488 . . . . 0.0 110.87 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -21.54 33.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.14 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.552 HD22 HG11 ' E' ' 37' ' ' VAL . 3.2 mp -110.49 29.38 7.76 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.621 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 43' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' E' ' 141' ' ' GLY . . . -108.16 25.53 11.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.357 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.72 160.0 23.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.342 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' E' ' 140' ' ' THR . 11.1 tt0 -82.92 108.64 16.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 111.131 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.94 10.9 51.39 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.145 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 47' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' E' ' 139' ' ' ALA . . . -66.75 123.47 20.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.943 0.401 . . . . 0.0 111.997 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -120.59 140.27 51.77 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.837 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 4.6 m -101.6 -167.01 1.36 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.625 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 50' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 8.1 t -69.66 139.7 53.55 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.774 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.87 134.03 35.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.348 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 52' ' ' VAL . . . . . 0.532 HG22 ' O ' ' E' ' 135' ' ' ALA . 18.8 m -87.01 166.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.962 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.75 128.89 8.01 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.628 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 54' ' ' PHE . . . . . 0.56 ' H ' HG21 ' B' ' 76' ' ' THR . 40.7 p90 -160.29 134.44 7.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.79 0.329 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 55' ' ' ASN . . . . . 0.514 ' OD1' HG21 ' E' ' 130' ' ' THR . 15.9 p30 -132.75 147.75 52.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.636 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 56' ' ' ILE . . . . . 0.636 HG22 ' HB ' ' E' ' 131' ' ' ILE . 1.0 OUTLIER -96.83 116.85 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.521 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 57' ' ' GLN . . . . . 0.576 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.0 OUTLIER -66.58 122.07 16.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.704 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . 0.728 ' HG ' ' HA ' ' E' ' 23' ' ' VAL . 0.2 OUTLIER -137.49 88.12 2.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.213 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . 0.717 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 10.6 p30 -79.6 179.29 7.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.89 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.42 64.42 0.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.779 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 61' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' E' ' 129' ' ' ASN . 4.4 m -110.56 163.2 13.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.755 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . 0.581 ' HB2' ' O ' ' E' ' 19' ' ' ALA . 0.5 OUTLIER -140.14 155.0 47.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.344 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.2 -25.42 10.63 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.95 -16.35 50.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.127 0.489 . . . . 0.0 111.754 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . 0.403 HG23 ' OD2' ' E' ' 62' ' ' ASP . 16.7 t -90.68 -48.41 14.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.68 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.16 142.92 35.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.575 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.82 -53.86 2.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.866 0.365 . . . . 0.0 110.918 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 68' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' E' ' 121' ' ' GLU . 0.1 OUTLIER -94.75 158.13 15.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.549 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 69' ' ' ALA . . . . . 0.933 ' HB2' HD13 ' E' ' 124' ' ' LEU . . . -137.19 120.42 16.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.649 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -97.54 129.13 44.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.111 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . 0.607 HG11 HG21 ' E' ' 131' ' ' ILE . 15.7 t -112.97 152.23 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.749 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.01 146.65 27.12 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.52 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 73' ' ' PHE . . . . . 0.475 ' CD2' HG21 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -111.58 141.86 44.63 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.525 0.202 . . . . 0.0 111.063 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 74' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.8 OUTLIER -105.67 103.38 12.88 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.962 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.95 -179.11 25.49 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.813 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.22 157.8 17.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.554 0.216 . . . . 0.0 110.761 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.91 132.75 38.06 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.849 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 78' ' ' ILE . . . . . 0.45 ' CG2' ' HB ' ' E' ' 85' ' ' VAL . 0.6 OUTLIER -66.55 -39.82 84.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.911 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 79' ' ' ASP . . . . . 0.419 ' N ' HG23 ' E' ' 78' ' ' ILE . 0.7 OUTLIER -146.23 53.59 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.844 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.36 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.013 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.28 -36.59 53.16 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.566 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -81.34 59.98 4.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 110.473 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 83' ' ' THR . . . . . 0.594 HG21 ' OD1' ' E' ' 114' ' ' ASP . 2.0 m -70.56 -20.5 62.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.533 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 84' ' ' ASN . . . . . 0.878 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 26.5 p-10 -69.34 -13.75 62.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.297 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' E' ' 102' ' ' GLN . 40.8 t -109.01 131.12 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.153 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 86' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' E' ' 152' ' ' ALA . 0.6 OUTLIER -69.99 142.87 52.74 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.05 -170.49 3.06 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.937 0.399 . . . . 0.0 111.668 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' E' ' 88' ' ' LEU . 1.2 mm? -80.01 161.4 25.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.985 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.67 -80.34 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.322 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 6.4 p -171.35 0.34 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.958 0.409 . . . . 0.0 111.449 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 91' ' ' SER . . . . . 0.598 ' HB2' ' HB2' ' E' ' 95' ' ' SER . 73.5 m -76.78 85.64 3.38 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.35 71.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.942 0.401 . . . . 0.0 111.653 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.82 30.45 6.89 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.611 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.72 -3.15 0.11 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.941 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 95' ' ' SER . . . . . 0.598 ' HB2' ' HB2' ' E' ' 91' ' ' SER . 0.1 OUTLIER -107.57 -176.76 3.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.838 0.351 . . . . 0.0 110.641 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.46 172.6 8.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . 0.623 ' H ' ' HB ' ' E' ' 144' ' ' THR . 1.6 m -126.9 140.44 52.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.348 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 98' ' ' ASN . . . . . 0.495 ' HB3' ' H ' ' E' ' 141' ' ' GLY . 68.3 m-80 61.96 21.33 12.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.45 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 99' ' ' VAL . . . . . 0.557 HG23 ' O ' ' E' ' 97' ' ' THR . 2.6 t -120.33 135.98 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.746 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.0 -160.73 10.19 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.583 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -145.88 109.89 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.181 0.515 . . . . 0.0 111.715 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 102' ' ' GLN . . . . . 0.66 ' HB2' HG22 ' E' ' 85' ' ' VAL . 0.5 OUTLIER -84.34 147.3 27.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.849 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 103' ' ' ILE . . . . . 0.598 HG12 ' HG ' ' E' ' 113' ' ' LEU . 1.2 pp -110.68 127.86 67.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.476 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 104' ' ' LEU . . . . . 0.972 HD12 ' HB2' ' E' ' 110' ' ' ALA . 1.4 tp -97.46 132.99 42.64 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.705 0.288 . . . . 0.0 111.021 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . 0.654 ' HB3' HG22 ' E' ' 107' ' ' THR . 4.0 t0 -80.84 143.62 32.64 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.662 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 106' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' B' ' 80' ' ' ALA . 0.0 OUTLIER -65.42 -17.52 64.61 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.813 0.34 . . . . 0.0 111.084 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 107' ' ' THR . . . . . 0.654 HG22 ' HB3' ' E' ' 105' ' ' ASP . 13.3 t -66.81 -20.63 65.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.03 -71.71 0.44 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.741 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.52 159.95 31.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.842 0.353 . . . . 0.0 111.061 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 110' ' ' ALA . . . . . 0.972 ' HB2' HD12 ' E' ' 104' ' ' LEU . . . -75.56 131.52 40.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.076 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 111' ' ' LEU . . . . . 0.684 HD21 ' O ' ' E' ' 117' ' ' THR . 12.2 tp -88.17 154.18 20.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.369 0.604 . . . . 0.0 110.549 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 112' ' ' THR . . . . . 0.878 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 0.4 OUTLIER -96.36 142.75 28.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.09 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 113' ' ' LEU . . . . . 0.598 ' HG ' HG12 ' E' ' 103' ' ' ILE . 0.8 OUTLIER -80.82 63.64 5.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.745 0.307 . . . . 0.0 110.716 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 114' ' ' ASP . . . . . 0.594 ' OD1' HG21 ' E' ' 83' ' ' THR . 0.1 OUTLIER -90.62 -30.65 17.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.541 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.76 -43.58 1.64 Allowed Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.627 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.56 24.38 13.04 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.011 0.434 . . . . 0.0 111.626 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 117' ' ' THR . . . . . 0.684 ' O ' HD21 ' E' ' 111' ' ' LEU . 0.2 OUTLIER -82.11 68.41 8.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.115 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 118' ' ' PHE . . . . . 0.538 ' CD1' ' HB2' ' E' ' 157' ' ' GLN . 41.0 m-85 -82.25 71.92 9.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.769 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.62 80.95 1.85 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.848 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.61 131.7 13.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.611 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 121' ' ' GLU . . . . . 0.432 ' O ' ' HE2' ' E' ' 68' ' ' LYS . 1.5 mm-40 -100.72 52.12 0.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.215 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 122' ' ' THR . . . . . 0.654 ' HB ' ' HB3' ' E' ' 69' ' ' ALA . 0.2 OUTLIER -72.07 131.93 43.53 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.713 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.75 107.69 15.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.675 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . 0.933 HD13 ' HB2' ' E' ' 69' ' ' ALA . 1.0 OUTLIER -88.31 126.53 35.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.537 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 125' ' ' ASN . . . . . 0.512 ' O ' ' HB3' ' E' ' 61' ' ' CYS . 1.1 m120 -120.58 -178.92 3.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.552 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 126' ' ' ASN . . . . . 0.524 ' OD1' ' HA ' ' E' ' 62' ' ' ASP . 3.7 t30 -83.29 120.66 26.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.735 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 127' ' ' GLY . . . . . 0.726 ' HA2' HG21 ' A' ' 4' ' ' THR . . . 136.16 -121.77 2.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.697 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 128' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 76.7 m -122.19 103.38 8.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.705 0.288 . . . . 0.0 110.764 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 129' ' ' ASN . . . . . 0.532 ' HB2' ' SG ' ' E' ' 61' ' ' CYS . 1.7 t30 -86.06 157.33 20.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.902 0.382 . . . . 0.0 111.127 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 130' ' ' THR . . . . . 0.576 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.3 OUTLIER -143.4 130.2 20.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.029 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 131' ' ' ILE . . . . . 0.636 ' HB ' HG22 ' E' ' 56' ' ' ILE . 57.4 mt -84.06 104.15 3.85 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 132' ' ' PRO . . . . . 0.679 ' HB3' ' HA ' ' B' ' 76' ' ' THR . 7.5 Cg_endo -82.05 112.41 2.3 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 121.609 1.539 . . . . 0.0 112.574 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 133' ' ' PHE . . . . . 0.425 ' HB3' ' CZ ' ' E' ' 54' ' ' PHE . 1.0 OUTLIER -126.64 158.26 36.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.88 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -126.02 156.08 40.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.095 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 135' ' ' ALA . . . . . 0.532 ' O ' HG22 ' E' ' 52' ' ' VAL . . . -148.23 105.08 3.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 111.613 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.04 163.47 12.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.415 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 137' ' ' TYR . . . . . 0.57 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 0.3 OUTLIER -81.79 119.75 24.28 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.064 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 138' ' ' PHE . . . . . 0.461 ' HB3' HG11 ' E' ' 85' ' ' VAL . 2.1 t80 -108.86 142.63 39.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.067 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 139' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' E' ' 47' ' ' ALA . . . -132.9 136.05 45.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.849 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 140' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 25.5 p -96.63 -56.16 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.534 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . 0.495 ' H ' ' HB3' ' E' ' 98' ' ' ASN . . . -127.14 -129.88 3.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.976 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.97 107.13 12.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.631 0.215 . . . . 0.0 110.782 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 143' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' E' ' 97' ' ' THR . . . -65.88 148.08 52.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.68 0.276 . . . . 0.0 111.447 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 144' ' ' THR . . . . . 0.623 ' HB ' ' H ' ' E' ' 97' ' ' THR . 48.0 m -114.85 144.74 32.55 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.275 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.0 131.0 6.76 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.499 2.133 . . . . 0.0 111.978 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 146' ' ' GLY . . . . . 0.603 ' O ' ' HG3' ' D' ' 15' ' ' GLU . . . 164.85 -116.25 0.69 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.435 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 147' ' ' ALA . . . . . 0.64 ' HA ' ' HG3' ' D' ' 15' ' ' GLU . . . -110.65 150.38 29.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.862 0.363 . . . . 0.0 111.304 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.63 45.92 1.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.449 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 149' ' ' ASN . . . . . 0.605 HD22 ' HG2' ' D' ' 13' ' ' LYS . 0.2 OUTLIER -96.97 141.0 30.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.54 -179.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 150' ' ' ALA . . . . . 0.404 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -153.67 162.59 41.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.006 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.95 135.43 43.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.271 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 152' ' ' ALA . . . . . 0.75 ' HB2' HD11 ' E' ' 86' ' ' LEU . . . -134.17 152.54 51.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.228 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 153' ' ' THR . . . . . 0.535 HG23 HG23 ' D' ' 9' ' ' THR . 4.0 m -104.19 148.92 25.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.21 141.88 35.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.088 0.47 . . . . 0.0 110.11 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.59 152.39 40.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.863 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 156' ' ' VAL . . . . . 0.657 HG23 HG23 ' D' ' 5' ' ' VAL . 20.2 m -135.75 133.17 51.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.789 0.328 . . . . 0.0 111.674 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 157' ' ' GLN . . . . . 0.74 ' HG3' HG23 ' D' ' 4' ' ' THR . 1.8 tt0 -130.92 119.82 22.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.318 0.58 . . . . 0.0 110.383 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -101.99 113.31 26.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.491 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 159' ' ' GLN . . . . . 0.624 ' HA ' ' H ' ' D' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.849 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.266 0.079 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.05 55.85 4.24 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.69 0.281 . . . . 0.0 111.075 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 89.7 m -118.7 111.11 18.09 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.445 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.79 127.26 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.588 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.48 171.5 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.551 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.42 122.08 36.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.62 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.95 -52.27 6.46 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.834 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.46 -145.52 5.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.888 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.72 139.8 25.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 0.0 111.296 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.37 121.6 64.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.149 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.72 106.56 18.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.392 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -90.52 107.69 19.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.842 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.28 149.15 25.0 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.457 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.47 -179.05 47.54 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.947 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.88 157.02 30.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.929 0.395 . . . . 0.0 110.368 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 16' ' ' VAL . . . . . 0.457 ' O ' HG11 ' E' ' 5' ' ' VAL . 18.0 t -113.73 132.19 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.225 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 17' ' ' VAL . . . . . 0.602 HG12 HG21 ' E' ' 5' ' ' VAL . 5.5 m -136.88 176.58 7.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.883 0.373 . . . . 0.0 110.991 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 18' ' ' ASN . . . . . 0.524 ' HB2' HG21 ' E' ' 3' ' ' THR . 0.4 OUTLIER -74.45 174.13 9.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.036 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 19' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' F' ' 62' ' ' ASP . . . -83.43 35.37 0.5 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.036 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' F' ' 61' ' ' CYS . . . -116.95 -15.9 10.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.422 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.98 155.29 0.6 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.961 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.76 126.38 5.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.078 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 23' ' ' VAL . . . . . 0.741 ' HA ' ' HG ' ' F' ' 58' ' ' LEU . 0.7 OUTLIER -60.77 162.46 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.087 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 24' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' F' ' 27' ' ' SER . 18.6 t70 -97.61 161.02 13.97 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.615 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . 0.687 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -64.1 -40.39 96.1 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.348 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.37 12.74 69.09 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.927 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 27' ' ' SER . . . . . 0.558 ' HB3' ' HB3' ' F' ' 24' ' ' ASP . 0.6 OUTLIER -113.88 -25.46 8.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.825 0.345 . . . . 0.0 110.813 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 9.6 t -41.16 -61.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.37 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.59 119.9 39.49 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.061 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -126.02 119.07 26.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.057 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.7 103.3 15.46 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.118 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.89 115.13 43.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.147 0.499 . . . . 0.0 110.463 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.51 112.62 24.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.7 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.86 -30.37 58.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.646 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.03 -170.22 27.41 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.625 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 36' ' ' GLN . . . . . 0.662 ' HG3' ' HB3' ' E' ' 15' ' ' GLU . 0.4 OUTLIER -93.54 141.74 28.12 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.628 0.251 . . . . 0.0 110.909 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.544 HG11 HD22 ' F' ' 42' ' ' LEU . 5.7 p -125.29 157.1 34.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.97 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.49 122.44 28.99 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.732 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 39' ' ' THR . . . . . 0.436 HG22 ' H ' ' F' ' 39' ' ' THR . 0.0 OUTLIER -59.56 -40.36 87.06 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.784 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.81 68.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.053 0.454 . . . . 0.0 110.866 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.14 -21.5 33.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.125 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . 0.544 HD22 HG11 ' F' ' 37' ' ' VAL . 3.2 mp -110.52 29.47 7.68 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.59 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 43' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' F' ' 141' ' ' GLY . . . -108.24 25.52 11.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.322 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.74 159.96 23.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.386 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' F' ' 140' ' ' THR . 11.0 tt0 -82.86 108.69 16.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 0.0 111.155 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.9 10.86 51.59 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.157 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 47' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' F' ' 139' ' ' ALA . . . -66.67 123.42 20.03 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 77.5 p -120.59 140.29 51.73 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.922 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 49' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 4.6 m -101.63 -167.0 1.36 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.602 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 50' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 8.1 t -69.77 139.73 53.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.859 0.361 . . . . 0.0 110.751 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.78 134.03 35.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.362 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 52' ' ' VAL . . . . . 0.541 HG22 ' O ' ' F' ' 135' ' ' ALA . 18.7 m -87.06 166.5 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.972 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.78 128.92 8.01 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.585 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 54' ' ' PHE . . . . . 0.564 ' H ' HG21 ' C' ' 76' ' ' THR . 40.8 p90 -160.28 134.42 7.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.775 0.322 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 55' ' ' ASN . . . . . 0.512 ' OD1' HG21 ' F' ' 130' ' ' THR . 15.8 p30 -132.73 147.69 52.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.621 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 56' ' ' ILE . . . . . 0.631 HG22 ' HB ' ' F' ' 131' ' ' ILE . 1.0 OUTLIER -96.8 116.79 39.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.539 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 57' ' ' GLN . . . . . 0.565 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.0 OUTLIER -66.61 122.12 16.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.703 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . 0.741 ' HG ' ' HA ' ' F' ' 23' ' ' VAL . 0.2 OUTLIER -137.51 88.12 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 -179.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 59' ' ' ASN . . . . . 0.713 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 10.6 p30 -79.49 179.32 7.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.935 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.29 64.46 0.96 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.818 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 61' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' F' ' 129' ' ' ASN . 4.4 m -110.55 163.25 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.821 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' F' ' 19' ' ' ALA . 0.5 OUTLIER -140.19 155.01 47.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.235 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.23 -25.44 10.61 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.89 -16.42 50.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.126 0.489 . . . . 0.0 111.734 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . 0.403 HG23 ' OD2' ' F' ' 62' ' ' ASP . 16.8 t -90.68 -48.46 14.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.627 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.13 142.97 35.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.569 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.85 -53.81 2.6 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.882 0.372 . . . . 0.0 110.978 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 68' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' F' ' 121' ' ' GLU . 0.1 OUTLIER -94.85 158.09 15.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.492 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 69' ' ' ALA . . . . . 0.918 ' HB2' HD13 ' F' ' 124' ' ' LEU . . . -137.17 120.47 16.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.592 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 70' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -97.57 129.07 44.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.153 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 71' ' ' VAL . . . . . 0.605 HG11 HG21 ' F' ' 131' ' ' ILE . 15.9 t -112.92 152.24 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.708 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.02 146.62 27.1 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.56 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 73' ' ' PHE . . . . . 0.474 ' CD2' HG21 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -111.5 141.88 44.5 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.557 0.218 . . . . 0.0 111.078 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 74' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.8 OUTLIER -105.7 103.32 12.8 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.934 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.87 -179.08 25.4 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.83 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.2 157.83 17.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.501 0.191 . . . . 0.0 110.766 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.91 132.77 38.06 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.929 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 78' ' ' ILE . . . . . 0.445 ' CG2' ' HB ' ' F' ' 85' ' ' VAL . 0.6 OUTLIER -66.6 -39.83 84.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 79' ' ' ASP . . . . . 0.418 ' N ' HG23 ' F' ' 78' ' ' ILE . 0.7 OUTLIER -146.15 53.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.845 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.38 -87.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.048 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.34 -36.52 53.24 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.603 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -81.3 59.87 4.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.357 . . . . 0.0 110.484 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 83' ' ' THR . . . . . 0.594 HG21 ' OD1' ' F' ' 114' ' ' ASP . 2.1 m -70.58 -20.38 62.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.537 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 84' ' ' ASN . . . . . 0.897 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 26.5 p-10 -69.47 -13.67 62.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.284 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 85' ' ' VAL . . . . . 0.695 HG22 ' HB2' ' F' ' 102' ' ' GLN . 40.8 t -109.01 131.16 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.152 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 86' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' F' ' 152' ' ' ALA . 0.6 OUTLIER -70.09 142.85 52.58 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.03 -170.51 3.06 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.873 0.368 . . . . 0.0 111.666 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -79.98 161.39 25.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.963 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.75 -80.24 0.01 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.386 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 6.4 p -171.39 0.44 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.943 0.402 . . . . 0.0 111.391 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 91' ' ' SER . . . . . 0.608 ' HB2' ' HB2' ' F' ' 95' ' ' SER . 73.6 m -76.81 85.58 3.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.839 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.28 71.78 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.888 0.375 . . . . 0.0 111.67 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.89 30.49 6.85 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.61 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.76 -3.13 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.934 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 95' ' ' SER . . . . . 0.608 ' HB2' ' HB2' ' F' ' 91' ' ' SER . 0.1 OUTLIER -107.51 -176.67 3.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.366 . . . . 0.0 110.679 179.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.6 172.66 8.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.81 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . 0.608 ' H ' ' HB ' ' F' ' 144' ' ' THR . 1.6 m -126.95 140.37 52.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.331 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 98' ' ' ASN . . . . . 0.502 ' HB3' ' H ' ' F' ' 141' ' ' GLY . 68.3 m-80 62.0 21.31 12.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.454 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 99' ' ' VAL . . . . . 0.555 HG23 ' O ' ' F' ' 97' ' ' THR . 2.7 t -120.38 135.97 58.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.714 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.94 -160.67 10.14 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.552 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -145.93 109.86 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.171 0.51 . . . . 0.0 111.729 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 102' ' ' GLN . . . . . 0.695 ' HB2' HG22 ' F' ' 85' ' ' VAL . 0.5 OUTLIER -84.29 147.35 27.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.885 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 103' ' ' ILE . . . . . 0.599 HG12 ' HG ' ' F' ' 113' ' ' LEU . 1.2 pp -110.74 127.87 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.489 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 104' ' ' LEU . . . . . 0.977 HD12 ' HB2' ' F' ' 110' ' ' ALA . 1.4 tp -97.46 133.0 42.63 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.711 0.291 . . . . 0.0 111.017 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . 0.651 ' HB3' HG22 ' F' ' 107' ' ' THR . 4.0 t0 -80.81 143.57 32.73 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.706 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 106' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' C' ' 80' ' ' ALA . 0.0 OUTLIER -65.48 -17.48 64.59 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.802 0.334 . . . . 0.0 111.023 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 107' ' ' THR . . . . . 0.651 HG22 ' HB3' ' F' ' 105' ' ' ASP . 13.2 t -66.79 -20.73 66.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.973 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.07 -71.81 0.44 Allowed Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.669 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.39 160.01 31.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.826 0.346 . . . . 0.0 111.098 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 110' ' ' ALA . . . . . 0.977 ' HB2' HD12 ' F' ' 104' ' ' LEU . . . -75.59 131.38 39.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 111' ' ' LEU . . . . . 0.689 HD21 ' O ' ' F' ' 117' ' ' THR . 12.2 tp -88.06 154.17 20.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.359 0.6 . . . . 0.0 110.572 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 112' ' ' THR . . . . . 0.897 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 0.4 OUTLIER -96.41 142.69 28.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.062 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 113' ' ' LEU . . . . . 0.599 ' HG ' HG12 ' F' ' 103' ' ' ILE . 0.8 OUTLIER -80.76 63.61 5.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.723 0.297 . . . . 0.0 110.77 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 114' ' ' ASP . . . . . 0.594 ' OD1' HG21 ' F' ' 83' ' ' THR . 0.1 OUTLIER -90.58 -30.6 17.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.611 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.73 -43.59 1.64 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.686 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.61 24.43 12.97 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.988 0.423 . . . . 0.0 111.608 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 117' ' ' THR . . . . . 0.689 ' O ' HD21 ' F' ' 111' ' ' LEU . 0.2 OUTLIER -82.12 68.25 8.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.16 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 118' ' ' PHE . . . . . 0.554 ' CD1' ' HB2' ' F' ' 157' ' ' GLN . 40.9 m-85 -82.07 71.93 9.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.759 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.74 81.02 1.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.66 131.74 13.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.557 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 121' ' ' GLU . . . . . 0.435 ' O ' ' HE2' ' F' ' 68' ' ' LYS . 1.5 mm-40 -100.7 52.1 0.87 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.197 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 122' ' ' THR . . . . . 0.661 ' HB ' ' HB3' ' F' ' 69' ' ' ALA . 0.2 OUTLIER -72.14 131.98 43.54 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.78 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.63 107.54 15.35 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.771 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . 0.918 HD13 ' HB2' ' F' ' 69' ' ' ALA . 1.0 OUTLIER -88.23 126.58 35.23 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.59 179.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 125' ' ' ASN . . . . . 0.507 ' O ' ' HB3' ' F' ' 61' ' ' CYS . 1.1 m120 -120.65 -178.99 3.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.542 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 126' ' ' ASN . . . . . 0.512 ' OD1' ' HA ' ' F' ' 62' ' ' ASP . 3.8 t30 -83.25 120.68 26.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.695 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 127' ' ' GLY . . . . . 0.74 ' HA2' HG21 ' B' ' 4' ' ' THR . . . 136.12 -121.77 2.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.657 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 128' ' ' THR . . . . . 0.713 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 76.3 m -122.12 103.44 8.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.727 0.299 . . . . 0.0 110.807 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 129' ' ' ASN . . . . . 0.528 ' HB2' ' SG ' ' F' ' 61' ' ' CYS . 1.8 t30 -86.18 157.26 20.03 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.857 0.36 . . . . 0.0 111.086 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 130' ' ' THR . . . . . 0.565 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.3 OUTLIER -143.34 130.14 20.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.162 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 131' ' ' ILE . . . . . 0.631 ' HB ' HG22 ' F' ' 56' ' ' ILE . 57.3 mt -83.97 104.14 3.79 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 132' ' ' PRO . . . . . 0.685 ' HB3' ' HA ' ' C' ' 76' ' ' THR . 7.5 Cg_endo -82.08 112.45 2.3 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.535 1.49 . . . . 0.0 112.548 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 133' ' ' PHE . . . . . 0.429 ' HB3' ' CZ ' ' F' ' 54' ' ' PHE . 1.0 OUTLIER -126.69 158.27 36.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.856 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -125.97 156.01 40.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.119 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 135' ' ' ALA . . . . . 0.541 ' O ' HG22 ' F' ' 52' ' ' VAL . . . -148.14 105.15 3.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 111.609 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.11 163.46 12.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.375 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 137' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 0.3 OUTLIER -81.72 119.69 24.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.131 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 138' ' ' PHE . . . . . 0.467 ' HB3' HG11 ' F' ' 85' ' ' VAL . 2.1 t80 -108.82 142.69 39.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.275 0.56 . . . . 0.0 112.058 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 139' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' F' ' 47' ' ' ALA . . . -132.94 136.05 45.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.831 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 140' ' ' THR . . . . . 0.648 ' O ' ' HA ' ' F' ' 45' ' ' GLU . 24.9 p -96.65 -56.26 2.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.423 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . 0.502 ' H ' ' HB3' ' F' ' 98' ' ' ASN . . . -127.04 -129.91 3.31 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.973 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.94 107.15 12.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.521 0.201 . . . . 0.0 110.741 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 143' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' F' ' 97' ' ' THR . . . -65.89 148.07 52.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.686 0.279 . . . . 0.0 111.44 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 144' ' ' THR . . . . . 0.608 ' HB ' ' H ' ' F' ' 97' ' ' THR . 48.0 m -114.88 144.72 32.52 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.262 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 145' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' F' ' 144' ' ' THR . 1.4 Cg_endo -81.96 130.96 6.78 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.549 2.166 . . . . 0.0 111.953 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 146' ' ' GLY . . . . . 0.624 ' O ' ' HG3' ' E' ' 15' ' ' GLU . . . 164.82 -116.27 0.69 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.452 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 147' ' ' ALA . . . . . 0.634 ' HA ' ' HG3' ' E' ' 15' ' ' GLU . . . -110.65 150.4 29.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.866 0.365 . . . . 0.0 111.28 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.65 45.82 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.128 0.49 . . . . 0.0 110.513 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 149' ' ' ASN . . . . . 0.623 HD22 ' HG2' ' E' ' 13' ' ' LYS . 0.2 OUTLIER -96.85 141.02 30.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.535 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 150' ' ' ALA . . . . . 0.408 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -153.71 162.53 41.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.958 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.85 135.46 43.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.225 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 152' ' ' ALA . . . . . 0.78 ' HB2' HD11 ' F' ' 86' ' ' LEU . . . -134.16 152.51 51.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.17 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 153' ' ' THR . . . . . 0.531 HG23 HG23 ' E' ' 9' ' ' THR . 4.0 m -104.16 148.95 25.7 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.29 141.87 35.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.047 0.451 . . . . 0.0 110.155 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -122.57 152.41 40.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.89 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 156' ' ' VAL . . . . . 0.638 HG23 HG23 ' E' ' 5' ' ' VAL . 20.1 m -135.72 133.13 51.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.79 0.329 . . . . 0.0 111.683 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 157' ' ' GLN . . . . . 0.726 ' HG3' HG23 ' E' ' 4' ' ' THR . 1.8 tt0 -130.95 119.86 22.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.339 0.59 . . . . 0.0 110.342 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -102.0 113.28 26.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.523 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 159' ' ' GLN . . . . . 0.622 ' HA ' ' H ' ' E' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.85 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.569 0.223 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.38 87.58 6.08 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.475 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.619 ' HB ' ' HA3' ' E' ' 127' ' ' GLY . 3.5 m -90.46 115.43 27.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.602 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 m -127.21 166.97 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.604 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.633 ' HA ' ' HE2' ' B' ' 155' ' ' LYS . 19.9 t30 -83.06 115.15 21.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.517 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.33 -71.5 1.06 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.884 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.24 172.78 34.74 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.907 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 m -95.47 136.96 35.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.409 . . . . 0.0 111.305 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -120.84 130.68 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.218 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.53 ' O ' ' HB ' ' B' ' 32' ' ' VAL . 1.3 m80 -103.78 158.0 16.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.459 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 0.6 OUTLIER -145.81 89.57 1.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.633 ' HD3' HG22 ' B' ' 31' ' ' THR . 0.0 OUTLIER -79.97 135.19 36.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.41 179.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.57 178.39 42.07 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.958 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.634 ' HG2' ' HA ' ' B' ' 147' ' ' ALA . 2.6 mt-10 -156.8 -177.93 6.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.368 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.52 HG22 HG23 ' B' ' 37' ' ' VAL . 2.7 t -142.24 150.13 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.233 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.591 HG11 ' HE2' ' A' ' 158' ' ' TYR . 4.1 m -141.7 168.61 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.333 . . . . 0.0 111.066 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.02 74.73 4.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.058 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.88 91.86 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.027 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.46 -50.98 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.433 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER 179.82 -179.68 0.47 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.965 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.616 ' HA ' ' HB3' ' B' ' 36' ' ' GLN . . . -136.2 116.43 13.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.085 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.422 ' H ' ' CB ' ' B' ' 36' ' ' GLN . 69.2 t -67.08 120.15 13.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.026 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.441 ' O ' HG23 ' A' ' 28' ' ' VAL . 2.4 m-20 -64.39 150.49 46.25 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.585 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' B' ' 33' ' ' GLN . . . -48.37 -50.22 31.54 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.326 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.27 -31.8 81.71 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.895 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.406 ' HA ' HE21 ' A' ' 30' ' ' GLN . 0.4 OUTLIER -69.04 -16.02 63.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.929 0.395 . . . . 0.0 110.847 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 24' ' ' ASP . 48.5 t -72.96 -43.59 58.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.41 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.39 106.04 10.32 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.406 HE21 ' HA ' ' A' ' 27' ' ' SER . 17.0 mt-30 -116.65 134.03 55.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.074 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.49 96.04 6.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.058 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.445 HG11 HG21 ' A' ' 52' ' ' VAL . 69.3 t -89.46 131.25 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.131 0.491 . . . . 0.0 110.488 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.95 106.41 16.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.618 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.482 HD12 ' CE2' ' A' ' 137' ' ' TYR . 0.4 OUTLIER -73.8 -40.87 63.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.649 179.372 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.95 -122.46 6.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.595 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -144.52 153.95 42.38 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.699 0.285 . . . . 0.0 110.862 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.57 146.35 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.86 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.23 145.97 26.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.717 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.7 p -57.8 -23.02 50.47 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.719 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.93 -33.21 61.94 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.096 0.474 . . . . 0.0 110.844 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -31.15 69.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.124 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.621 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -130.76 86.42 2.37 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.649 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.7 36.2 4.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.37 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.64 150.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.337 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 1.7 tm-20 -64.78 134.83 54.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 111.136 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.79 -14.16 53.14 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.137 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 138' ' ' PHE . . . -57.2 129.86 43.64 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.938 0.399 . . . . 0.0 112.002 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.462 ' HB ' ' CE1' ' A' ' 138' ' ' PHE . 14.3 t -130.59 143.31 50.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.909 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.604 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 68.4 m -111.97 -157.16 0.61 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.552 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.9 t -74.62 150.15 39.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.784 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -103.2 146.64 28.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.322 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.445 HG21 HG11 ' A' ' 32' ' ' VAL . 22.4 m -83.38 148.34 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.4 121.21 6.21 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.6 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.41 ' CD1' HG23 ' A' ' 52' ' ' VAL . 16.2 p90 -153.83 125.56 7.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 0.0 110.928 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.28 156.17 20.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.609 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.6 mm -104.08 135.37 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.486 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.64 125.99 48.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.765 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 129' ' ' ASN . 4.3 mp -131.7 100.0 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.273 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.49 174.81 11.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.946 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.8 65.19 1.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.792 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 60.7 m -98.66 142.94 29.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.59 109.25 15.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.269 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.464 HG23 ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -92.44 29.54 1.69 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.03 -59.1 2.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.029 0.443 . . . . 0.0 111.819 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.28 -39.8 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.706 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.69 101.39 10.7 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.593 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.6 p -90.54 -28.82 18.25 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.902 0.382 . . . . 0.0 110.95 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.448 ' HZ1' ' HB2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -126.4 166.99 16.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.513 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.9 149.77 29.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.572 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 157' ' ' GLN . . . -112.85 159.79 18.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.092 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.2 t -108.04 123.25 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.689 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 155' ' ' LYS . . . -124.64 168.95 12.44 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.596 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.531 ' CB ' HD11 ' A' ' 111' ' ' LEU . 17.1 t80 -150.59 144.39 25.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.535 0.207 . . . . 0.0 111.168 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.652 HD12 ' OG1' ' D' ' 130' ' ' THR . 0.4 OUTLIER -121.56 88.64 2.97 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.989 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.514 ' C ' HD23 ' A' ' 113' ' ' LEU . . . -134.69 164.72 24.65 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.773 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -78.54 147.73 33.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.544 0.211 . . . . 0.0 110.779 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.564 ' H ' ' HB3' ' D' ' 132' ' ' PRO . . . -95.7 140.34 30.65 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.959 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.548 ' CG2' ' HB ' ' A' ' 85' ' ' VAL . 1.1 tt -78.71 -33.05 16.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.851 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.22 179.22 7.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.838 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.68 -27.87 36.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.059 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.25 -32.22 72.21 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.552 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.427 ' HB3' HG23 ' A' ' 85' ' ' VAL . 15.4 m-70 -97.33 -72.69 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 0.0 110.464 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.85 -7.24 1.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.586 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.754 ' HA ' HD13 ' A' ' 113' ' ' LEU . 3.0 m120 -108.7 -19.13 13.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.364 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . 50.2 t -80.65 132.03 32.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.124 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -76.52 134.95 39.31 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.355 179.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.28 165.18 6.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.828 0.347 . . . . 0.0 111.682 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.729 HD12 ' O ' ' D' ' 51' ' ' ALA . 0.1 OUTLIER -65.75 171.65 4.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.029 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.495 ' OE1' ' HB3' ' A' ' 91' ' ' SER . 8.0 pt20 -72.45 175.75 5.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.349 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.474 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 0.5 OUTLIER -76.06 -21.26 56.97 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.997 0.427 . . . . 0.0 111.492 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.495 ' HB3' ' OE1' ' A' ' 89' ' ' GLN . 32.0 t -80.92 67.56 6.87 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.45 ' HA ' ' OG ' ' A' ' 95' ' ' SER . . . -72.27 -9.74 58.87 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.901 0.381 . . . . 0.0 111.668 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.892 ' HB1' ' HB1' ' C' ' 22' ' ' ALA . . . -68.08 -22.91 64.9 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.632 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.39 6.76 2.5 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.932 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.699 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 30.7 p -93.73 150.75 20.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.637 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.69 167.21 18.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.834 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.65 165.15 14.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.366 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.527 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 85.0 m-20 63.29 45.43 5.0 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.494 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.461 ' HB ' ' CB ' ' A' ' 143' ' ' ALA . 3.5 p -170.63 131.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.787 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.08 -175.96 21.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.556 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.3 t -104.14 91.84 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 122.971 0.509 . . . . 0.0 111.745 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -67.86 131.21 45.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 84' ' ' ASN . 0.7 OUTLIER -99.44 110.52 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.498 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 5.5 tp -91.23 149.94 21.55 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.709 0.29 . . . . 0.0 111.027 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.95 174.68 5.79 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.631 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 106' ' ' ARG . 1.5 ttt180 -72.49 -18.63 61.65 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.719 0.295 . . . . 0.0 110.989 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.0 p -69.25 -9.6 53.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.033 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.97 -48.44 0.95 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.625 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.94 163.54 15.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 0.0 111.062 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -70.39 125.51 27.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.174 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.531 HD11 ' CB ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -65.36 147.61 53.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.367 0.603 . . . . 0.0 110.564 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.679 ' HB ' HG21 ' A' ' 117' ' ' THR . 0.2 OUTLIER -74.03 144.58 45.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.131 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.754 HD13 ' HA ' ' A' ' 84' ' ' ASN . 10.2 mp -100.28 89.94 4.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.769 0.319 . . . . 0.0 110.663 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.432 ' HB2' ' CG2' ' A' ' 117' ' ' THR . 4.1 m-20 -142.42 11.37 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.657 0.265 . . . . 0.0 111.555 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.439 ' O ' ' HB1' ' A' ' 72' ' ' ALA . . . 96.91 -78.09 0.69 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.669 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' D' ' 125' ' ' ASN . . . -104.27 61.54 0.73 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.973 0.416 . . . . 0.0 111.662 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.679 HG21 ' HB ' ' A' ' 112' ' ' THR . 17.6 p -93.35 95.84 9.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.131 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.79 110.0 5.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.9 m -120.35 -72.92 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.773 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.4 113.03 25.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.602 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.448 ' HB2' ' HZ1' ' A' ' 68' ' ' LYS . 25.2 mt-10 -99.47 97.53 8.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.207 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.5 132.71 37.52 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.775 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -60.89 146.12 47.75 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.727 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.464 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.2 OUTLIER -85.48 156.56 20.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.562 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.78 142.75 40.88 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.54 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.94 113.63 6.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.74 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.59 -90.08 0.32 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.744 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.0 m -124.88 152.77 43.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.745 0.307 . . . . 0.0 110.798 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 17.1 t-20 -123.0 147.52 46.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.19 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.3 m -126.12 135.7 52.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.098 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.4 mt -114.03 115.65 45.47 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.4 ' HB2' ' HB2' ' A' ' 106' ' ' ARG . 7.5 Cg_endo -81.7 115.71 2.81 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.629 1.553 . . . . 0.0 112.567 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.58 150.81 46.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.825 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 1.2 mt-30 -142.48 166.67 24.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.029 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 102' ' ' GLN . . . -158.13 102.94 1.81 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 111.654 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -94.68 -173.4 3.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.396 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.604 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 3.8 m-85 -100.78 152.87 19.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.068 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.545 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -147.37 160.73 42.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.998 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -126.86 149.61 49.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.925 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -115.34 27.83 9.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.461 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.4 66.75 0.2 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.955 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.99 88.59 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.602 0.239 . . . . 0.0 110.744 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.461 ' CB ' ' HB ' ' A' ' 99' ' ' VAL . . . -60.19 156.88 14.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.709 0.29 . . . . 0.0 111.452 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.545 ' HB ' ' CD ' ' A' ' 145' ' ' PRO . 77.3 p -112.26 173.02 3.08 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.218 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.545 ' CD ' ' HB ' ' A' ' 144' ' ' THR . 1.3 Cg_endo -84.51 145.16 10.45 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.518 2.145 . . . . 0.0 111.995 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.44 -112.7 0.55 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.512 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -124.93 167.67 14.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.892 0.377 . . . . 0.0 111.275 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -157.19 57.54 0.52 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.411 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.85 132.73 36.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.539 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.47 163.13 28.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.937 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.45 125.58 1.83 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.231 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.794 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -154.57 165.79 35.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.244 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.9 163.18 12.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -119.01 134.6 55.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.102 0.477 . . . . 0.0 110.102 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -95.64 166.24 11.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.913 -178.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.24 112.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.793 0.33 . . . . 0.0 111.657 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.613 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -88.77 138.81 31.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.278 0.561 . . . . 0.0 110.403 -179.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.591 ' HE2' HG11 ' A' ' 17' ' ' VAL . 22.5 m-85 -127.65 113.16 15.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.568 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.976 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.241 0.067 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.94 68.26 0.88 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.645 0.26 . . . . 0.0 111.06 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.33 87.63 6.12 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.454 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.612 ' HB ' ' HA3' ' F' ' 127' ' ' GLY . 3.5 m -90.35 115.47 27.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.571 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -127.34 167.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.588 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . 0.653 ' HA ' ' HE2' ' C' ' 155' ' ' LYS . 20.2 t30 -82.95 115.11 21.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.577 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.39 -71.48 1.06 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.827 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.31 172.78 34.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.909 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 33.3 m -95.52 137.01 35.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.941 0.4 . . . . 0.0 111.253 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 40.4 t -120.8 130.76 74.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.173 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' HIS . . . . . 0.54 ' O ' ' HB ' ' C' ' 32' ' ' VAL . 1.3 m80 -103.92 157.97 16.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.41 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' C' ' 32' ' ' VAL . 0.5 OUTLIER -145.82 89.67 1.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.823 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . 0.627 ' HD3' HG22 ' C' ' 31' ' ' THR . 0.0 OUTLIER -80.04 135.21 36.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.431 179.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.57 178.38 42.08 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.953 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.641 ' HG2' ' HA ' ' C' ' 147' ' ' ALA . 2.6 mt-10 -156.78 -177.86 6.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.385 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.512 HG22 HG23 ' C' ' 37' ' ' VAL . 2.7 t -142.35 150.1 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.235 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.572 HG11 ' HE2' ' B' ' 158' ' ' TYR . 4.1 m -141.73 168.57 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.856 0.36 . . . . 0.0 110.996 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -92.93 74.78 4.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.039 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.78 91.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.045 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.42 -51.07 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.421 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER 179.83 -179.8 0.48 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.996 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.603 ' HA ' ' HB3' ' C' ' 36' ' ' GLN . . . -136.14 116.5 13.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.138 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.423 ' H ' ' CB ' ' C' ' 36' ' ' GLN . 69.1 t -67.07 120.15 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.003 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.441 ' O ' HG23 ' B' ' 28' ' ' VAL . 2.4 m-20 -64.36 150.45 46.26 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.605 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.423 ' HB1' ' HB2' ' C' ' 33' ' ' GLN . . . -48.38 -50.1 32.1 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.388 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.36 -31.79 81.55 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.841 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . 0.407 ' HA ' HE21 ' B' ' 30' ' ' GLN . 0.4 OUTLIER -69.07 -15.98 63.58 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.879 0.371 . . . . 0.0 110.831 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 24' ' ' ASP . 48.6 t -72.96 -43.68 58.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.375 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.36 106.11 10.4 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.005 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' GLN . . . . . 0.407 HE21 ' HA ' ' B' ' 27' ' ' SER . 17.0 mt-30 -116.68 134.03 55.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . 0.633 HG22 ' HD3' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -105.49 96.09 6.27 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.057 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.53 ' HB ' ' O ' ' A' ' 11' ' ' HIS . 69.3 t -89.53 131.27 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.15 0.5 . . . . 0.0 110.456 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.451 ' HA ' ' HG2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -108.97 106.48 16.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.637 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.493 HD12 ' CE2' ' B' ' 137' ' ' TYR . 0.4 OUTLIER -73.79 -40.89 63.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.66 179.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.89 -122.41 6.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.601 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.616 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 16.3 tt0 -144.6 153.85 42.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.586 0.231 . . . . 0.0 110.939 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.52 HG23 HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -128.5 146.32 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.909 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.529 ' HE ' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -98.25 146.0 26.07 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.7 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 17' ' ' VAL . 40.9 p -57.78 -22.99 50.12 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.713 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.01 -33.22 61.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.013 0.435 . . . . 0.0 110.809 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -31.1 69.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.174 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.617 ' HB3' ' HB2' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -130.83 86.34 2.36 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.604 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.64 36.19 4.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.357 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 177.56 150.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.392 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' B' ' 140' ' ' THR . 1.7 tm-20 -64.79 134.81 54.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.884 0.373 . . . . 0.0 111.103 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.79 -14.19 53.12 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.218 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' B' ' 138' ' ' PHE . . . -57.19 129.8 43.36 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . 0.455 ' HB ' ' CE1' ' B' ' 138' ' ' PHE . 14.3 t -130.55 143.34 50.69 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.864 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . 0.594 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 68.6 m -111.95 -157.2 0.61 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.579 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.416 ' H ' ' HB3' ' B' ' 49' ' ' SER . 27.5 t -74.46 150.13 40.05 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.863 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' B' ' 136' ' ' ARG . . . -103.28 146.61 28.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.328 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' B' ' 134' ' ' GLN . 22.0 m -83.31 148.31 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.981 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.35 121.21 6.22 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.638 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . 0.404 ' CD1' HG23 ' B' ' 52' ' ' VAL . 15.9 p90 -153.81 125.52 7.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.737 0.303 . . . . 0.0 110.955 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.23 156.22 20.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.626 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 22.5 mm -104.04 135.35 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.51 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.75 126.05 48.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.771 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.547 ' HB2' ' HB3' ' B' ' 129' ' ' ASN . 4.3 mp -131.62 99.91 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.275 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.43 174.79 11.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.71 65.24 1.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.809 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' B' ' 21' ' ' CYS . 60.6 m -98.64 142.86 29.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.822 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.58 109.22 15.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.329 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.473 HG23 ' HB3' ' B' ' 124' ' ' LEU . 0.2 OUTLIER -92.37 29.53 1.67 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.143 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . 0.425 HD22 ' HA ' ' B' ' 64' ' ' ASN . 0.1 OUTLIER -90.0 -59.16 2.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.039 0.447 . . . . 0.0 111.726 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.29 -39.82 13.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.71 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.58 101.3 10.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.614 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.1 p -90.58 -28.74 18.27 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.872 0.367 . . . . 0.0 110.971 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.49 166.94 16.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.523 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.82 149.8 29.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.646 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' B' ' 157' ' ' GLN . . . -112.88 159.77 18.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.097 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 51.1 t -108.06 123.25 63.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.693 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.685 ' HB3' ' HB3' ' B' ' 155' ' ' LYS . . . -124.6 168.96 12.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.563 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.534 ' CB ' HD11 ' B' ' 111' ' ' LEU . 17.2 t80 -150.59 144.37 25.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.533 0.206 . . . . 0.0 111.205 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.632 HD12 ' OG1' ' E' ' 130' ' ' THR . 0.4 OUTLIER -121.42 88.57 2.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.033 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . 0.514 ' C ' HD23 ' B' ' 113' ' ' LEU . . . -134.75 164.7 24.67 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.813 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.659 ' O ' ' HA ' ' B' ' 86' ' ' LEU . 0.6 OUTLIER -78.51 147.76 33.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.531 0.205 . . . . 0.0 110.775 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.564 ' H ' ' HB3' ' E' ' 132' ' ' PRO . . . -95.79 140.32 30.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.887 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.555 ' CG2' ' HB ' ' B' ' 85' ' ' VAL . 1.2 tt -78.7 -33.09 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.873 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.16 179.21 7.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.848 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.66 -27.84 37.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.26 -32.21 72.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.603 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.417 ' HB3' HG23 ' B' ' 85' ' ' VAL . 15.4 m-70 -97.38 -72.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 0.0 110.475 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.77 -7.13 1.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.599 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . 0.764 ' HA ' HD13 ' B' ' 113' ' ' LEU . 3.1 m120 -108.8 -19.1 13.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.329 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' B' ' 102' ' ' GLN . 49.8 t -80.53 132.06 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.183 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.79 HD21 ' HB2' ' B' ' 152' ' ' ALA . 0.4 OUTLIER -76.61 134.91 39.2 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.283 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.21 165.16 6.09 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.939 0.399 . . . . 0.0 111.678 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . 0.723 HD12 ' O ' ' E' ' 51' ' ' ALA . 0.1 OUTLIER -65.72 171.7 4.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . 0.491 ' OE1' ' HB3' ' B' ' 91' ' ' SER . 8.0 pt20 -72.54 175.76 6.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.349 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 0.5 OUTLIER -76.04 -21.24 57.02 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.984 0.421 . . . . 0.0 111.492 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' SER . . . . . 0.491 ' HB3' ' OE1' ' B' ' 89' ' ' GLN . 32.1 t -80.94 67.53 6.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . 0.446 ' HA ' ' OG ' ' B' ' 95' ' ' SER . . . -72.29 -9.66 58.77 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.637 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . 0.88 ' HB1' ' HB1' ' D' ' 22' ' ' ALA . . . -68.05 -22.9 64.93 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.653 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.46 6.73 2.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.917 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' SER . . . . . 0.705 ' HA ' ' HB3' ' B' ' 147' ' ' ALA . 30.5 p -93.69 150.79 20.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.851 0.358 . . . . 0.0 110.632 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.79 167.19 18.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 165.18 14.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.366 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . 0.512 ' HA ' ' OG1' ' B' ' 140' ' ' THR . 85.0 m-20 63.17 45.54 5.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.465 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . 0.456 ' HB ' ' CB ' ' B' ' 143' ' ' ALA . 3.5 p -170.63 131.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.76 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.11 -176.02 21.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.529 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 75.8 t -104.06 91.85 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 122.946 0.498 . . . . 0.0 111.79 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 0.0 OUTLIER -67.83 131.18 45.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.919 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.518 HD12 ' O ' ' B' ' 84' ' ' ASN . 0.7 OUTLIER -99.4 110.53 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.526 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 5.5 tp -91.22 149.99 21.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.628 0.251 . . . . 0.0 111.053 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.95 174.62 5.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.652 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' B' ' 106' ' ' ARG . 1.5 ttt180 -72.44 -18.54 61.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.796 0.331 . . . . 0.0 111.079 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 46.0 p -69.36 -9.57 54.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.005 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.02 -48.43 0.95 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.671 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.91 163.57 15.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 0.0 111.154 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -70.45 125.52 27.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.534 HD11 ' CB ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -65.35 147.59 53.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.321 0.581 . . . . 0.0 110.607 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.678 ' HB ' HG21 ' B' ' 117' ' ' THR . 0.2 OUTLIER -73.99 144.56 45.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.136 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.764 HD13 ' HA ' ' B' ' 84' ' ' ASN . 10.2 mp -100.29 89.82 4.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.762 0.315 . . . . 0.0 110.682 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . 0.441 ' HB2' ' CG2' ' B' ' 117' ' ' THR . 4.1 m-20 -142.36 11.47 1.92 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.668 0.27 . . . . 0.0 111.621 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . 0.449 ' O ' ' HB1' ' B' ' 72' ' ' ALA . . . 96.92 -78.14 0.69 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.576 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' E' ' 125' ' ' ASN . . . -104.26 61.56 0.73 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.976 0.417 . . . . 0.0 111.629 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . 0.678 HG21 ' HB ' ' B' ' 112' ' ' THR . 17.7 p -93.38 95.82 9.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.123 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.77 109.97 5.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.781 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.32 -72.89 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.52 113.07 25.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.583 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.43 97.54 8.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.204 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.47 132.68 37.51 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.761 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 22.2 m -60.92 146.19 47.63 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.74 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . 0.473 ' HB3' HG23 ' B' ' 63' ' ' THR . 0.2 OUTLIER -85.48 156.5 20.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.595 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.77 142.8 40.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.515 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.01 113.61 6.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.732 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.59 -90.03 0.32 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.73 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 6.1 m -124.88 152.82 43.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.677 0.275 . . . . 0.0 110.815 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . 0.547 ' HB3' ' HB2' ' B' ' 58' ' ' LEU . 17.0 t-20 -123.04 147.6 46.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.963 0.411 . . . . 0.0 111.096 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.3 m -126.19 135.61 51.84 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.085 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' ILE . . . . . . . . . . . . . 58.6 mt -113.95 115.72 45.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' PRO . . . . . 0.401 ' HB2' ' HB2' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.74 115.68 2.79 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.67 1.58 . . . . 0.0 112.598 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.58 150.84 46.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.806 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' B' ' 52' ' ' VAL . 1.2 mt-30 -142.46 166.75 23.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.034 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' B' ' 102' ' ' GLN . . . -158.22 102.88 1.79 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 0.0 111.626 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' B' ' 51' ' ' ALA . 0.2 OUTLIER -94.67 -173.41 3.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.439 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . 0.594 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 3.8 m-85 -100.83 152.83 20.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.074 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' B' ' 47' ' ' ALA . 0.2 OUTLIER -147.32 160.81 42.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.002 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.617 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -126.92 149.65 49.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.876 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' THR . . . . . 0.512 ' OG1' ' HA ' ' B' ' 98' ' ' ASN . 0.0 OUTLIER -115.41 27.86 9.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.453 179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.46 66.86 0.2 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.879 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.94 88.62 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.568 0.223 . . . . 0.0 110.69 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' ALA . . . . . 0.456 ' CB ' ' HB ' ' B' ' 99' ' ' VAL . . . -60.25 156.94 14.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.764 0.316 . . . . 0.0 111.407 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.543 ' HB ' ' CD ' ' B' ' 145' ' ' PRO . 76.5 p -112.23 173.04 3.07 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.236 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . 0.543 ' CD ' ' HB ' ' B' ' 144' ' ' THR . 1.3 Cg_endo -84.55 145.23 10.43 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.552 2.168 . . . . 0.0 111.979 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.37 -112.73 0.55 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.521 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.705 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -125.02 167.62 14.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.826 0.346 . . . . 0.0 111.308 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' ALA . . . . . 0.417 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -157.16 57.52 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.459 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -91.84 132.72 36.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.582 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.4 163.13 28.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.023 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.44 125.61 1.83 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.25 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . 0.79 ' HB2' HD21 ' B' ' 86' ' ' LEU . . . -154.51 165.82 35.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.211 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.92 163.11 12.77 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -119.01 134.6 55.09 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.181 0.515 . . . . 0.0 110.069 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . 0.685 ' HB3' ' HB3' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -95.57 166.26 11.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.923 -178.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.29 112.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.81 0.338 . . . . 0.0 111.663 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.625 ' HB3' ' HB3' ' B' ' 70' ' ' ALA . 0.2 OUTLIER -88.73 138.88 31.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.286 0.565 . . . . 0.0 110.423 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' TYR . . . . . 0.572 ' HE2' HG11 ' B' ' 17' ' ' VAL . 22.6 m-85 -127.73 113.11 15.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.554 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.937 179.992 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.304 0.097 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.96 68.25 0.88 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.62 0.248 . . . . 0.0 110.999 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.31 87.69 6.15 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.46 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 4' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' D' ' 157' ' ' GLN . 3.5 m -90.51 115.49 27.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.55 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 m -127.3 167.01 22.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.589 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' ASN . . . . . 0.649 ' HA ' ' HE2' ' D' ' 155' ' ' LYS . 19.9 t30 -83.06 115.16 21.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.507 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.34 -71.53 1.06 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.828 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.28 172.75 34.76 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.931 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 33.2 m -95.5 137.0 35.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.972 0.415 . . . . 0.0 111.219 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 40.1 t -120.78 130.75 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.225 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' HIS . . . . . 0.539 ' O ' ' HB ' ' D' ' 32' ' ' VAL . 1.3 m80 -103.86 157.99 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.392 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' D' ' 32' ' ' VAL . 0.6 OUTLIER -145.91 89.67 1.91 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.793 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . 0.634 ' HD3' HG22 ' D' ' 31' ' ' THR . 0.0 OUTLIER -80.04 135.15 36.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.437 179.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.5 178.43 42.02 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.898 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' GLU . . . . . 0.64 ' HG2' ' HA ' ' D' ' 147' ' ' ALA . 2.6 mt-10 -156.87 -177.98 7.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.382 . . . . 0.0 110.327 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.515 HG22 HG23 ' D' ' 37' ' ' VAL . 2.7 t -142.24 150.13 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.253 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.572 HG11 ' HE2' ' C' ' 158' ' ' TYR . 4.1 m -141.72 168.57 15.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 111.025 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.04 74.77 4.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.068 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.82 91.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.011 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.49 -50.97 0.08 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.475 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER 179.87 -179.77 0.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.019 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . 0.892 ' HB1' ' HB1' ' A' ' 93' ' ' ALA . . . -136.16 116.43 13.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.168 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . 0.41 ' H ' ' CB ' ' D' ' 36' ' ' GLN . 69.0 t -67.02 120.15 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.043 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.439 ' O ' HG23 ' C' ' 28' ' ' VAL . 2.4 m-20 -64.46 150.47 46.49 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.59 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' D' ' 33' ' ' GLN . . . -48.35 -50.16 31.58 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.343 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.34 -31.77 81.51 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.897 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . 0.408 ' HA ' HE21 ' C' ' 30' ' ' GLN . 0.4 OUTLIER -69.09 -15.93 63.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.439 HG23 ' O ' ' C' ' 24' ' ' ASP . 48.6 t -72.94 -43.67 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.36 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.44 106.08 10.34 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' GLN . . . . . 0.408 HE21 ' HA ' ' C' ' 27' ' ' SER . 16.9 mt-30 -116.67 133.98 55.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.026 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' THR . . . . . 0.627 HG22 ' HD3' ' B' ' 13' ' ' LYS . 1.0 OUTLIER -105.5 96.07 6.25 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.069 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' B' ' 11' ' ' HIS . 69.5 t -89.45 131.24 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.154 0.502 . . . . 0.0 110.434 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.457 ' HA ' ' HG2' ' B' ' 13' ' ' LYS . 0.3 OUTLIER -109.02 106.46 16.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.582 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.485 HD12 ' CE2' ' C' ' 137' ' ' TYR . 0.4 OUTLIER -73.82 -40.89 63.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.642 179.368 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.98 -122.45 6.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.556 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . 0.603 ' HB3' ' HA ' ' B' ' 22' ' ' ALA . 16.2 tt0 -144.55 153.9 42.31 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.621 0.248 . . . . 0.0 110.913 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.512 HG23 HG22 ' B' ' 16' ' ' VAL . 0.0 OUTLIER -128.51 146.3 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.848 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' ARG . . . . . 0.539 ' HE ' ' HB2' ' B' ' 22' ' ' ALA . 0.0 OUTLIER -98.22 145.96 26.1 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.772 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.56 HG23 ' O ' ' B' ' 17' ' ' VAL . 41.0 p -57.73 -23.03 49.87 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.777 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.94 -33.2 61.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.056 0.455 . . . . 0.0 110.833 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.0 -31.21 69.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.142 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.611 ' HB3' ' HB2' ' C' ' 139' ' ' ALA . 0.0 OUTLIER -130.77 86.41 2.37 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.65 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.68 36.14 4.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.371 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.6 150.89 0.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.343 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' C' ' 140' ' ' THR . 1.7 tm-20 -64.8 134.84 54.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.337 . . . . 0.0 111.135 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.74 -14.08 53.35 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.143 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' C' ' 138' ' ' PHE . . . -57.27 129.86 43.63 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' THR . . . . . 0.469 ' HB ' ' CE1' ' C' ' 138' ' ' PHE . 14.3 t -130.57 143.31 50.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.903 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 68.6 m -111.96 -157.23 0.61 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.565 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . 0.404 ' H ' ' HB3' ' C' ' 49' ' ' SER . 27.7 t -74.59 150.13 39.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.816 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . . . -103.24 146.65 28.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.344 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' C' ' 134' ' ' GLN . 22.2 m -83.35 148.35 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.42 121.17 6.19 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.645 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . 0.414 ' CD1' HG23 ' C' ' 52' ' ' VAL . 16.3 p90 -153.79 125.59 7.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.777 0.322 . . . . 0.0 110.933 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.35 156.17 20.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.543 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 22.4 mm -103.9 135.28 42.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.635 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.7 126.04 48.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.755 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . 0.551 ' HB2' ' HB3' ' C' ' 129' ' ' ASN . 4.3 mp -131.57 100.0 4.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.298 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.41 174.82 11.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.943 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.68 65.28 1.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.804 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' C' ' 21' ' ' CYS . 60.7 m -98.73 142.98 29.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.796 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.66 109.25 15.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.303 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.457 HG23 ' HB3' ' C' ' 124' ' ' LEU . 0.2 OUTLIER -92.43 29.47 1.7 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' ASN . . . . . 0.477 HD22 ' HA ' ' C' ' 64' ' ' ASN . 0.1 OUTLIER -89.93 -59.19 2.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.015 0.436 . . . . 0.0 111.752 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.29 -39.87 13.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.654 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.61 101.34 10.67 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.629 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 31.1 p -90.54 -28.83 18.24 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 110.962 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.36 167.05 16.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.531 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.91 149.84 29.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.599 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' C' ' 157' ' ' GLN . . . -112.98 159.74 18.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.104 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.1 123.31 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.678 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . 0.687 ' HB3' ' HB3' ' C' ' 155' ' ' LYS . . . -124.65 169.0 12.38 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.55 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' PHE . . . . . 0.538 ' CB ' HD11 ' C' ' 111' ' ' LEU . 17.2 t80 -150.6 144.39 25.24 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.54 0.21 . . . . 0.0 111.104 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.657 HD12 ' OG1' ' F' ' 130' ' ' THR . 0.4 OUTLIER -121.46 88.62 2.97 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.976 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . 0.521 ' C ' HD23 ' C' ' 113' ' ' LEU . . . -134.78 164.7 24.68 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.779 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.656 ' O ' ' HA ' ' C' ' 86' ' ' LEU . 0.6 OUTLIER -78.55 147.77 33.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.571 0.224 . . . . 0.0 110.76 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . 0.558 ' H ' ' HB3' ' F' ' 132' ' ' PRO . . . -95.73 140.26 30.79 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.934 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . 0.56 ' CG2' ' HB ' ' C' ' 85' ' ' VAL . 1.1 tt -78.61 -33.18 16.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.86 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.17 179.28 6.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.69 -27.9 36.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.006 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.15 -32.24 72.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.671 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . 0.407 ' HB3' HG23 ' C' ' 85' ' ' VAL . 15.2 m-70 -97.32 -72.73 0.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 0.0 110.49 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 5.6 m 74.9 -7.25 1.78 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.563 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' ASN . . . . . 0.745 ' HA ' HD13 ' C' ' 113' ' ' LEU . 3.1 m120 -108.77 -19.13 13.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.329 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.56 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 49.9 t -80.58 132.01 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.162 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.766 HD21 ' HB2' ' C' ' 152' ' ' ALA . 0.4 OUTLIER -76.58 134.98 39.23 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.991 -0.283 . . . . 0.0 110.279 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.34 165.16 6.27 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.903 0.382 . . . . 0.0 111.676 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.738 HD12 ' O ' ' F' ' 51' ' ' ALA . 0.0 OUTLIER -65.72 171.74 4.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.069 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' GLN . . . . . 0.485 ' OE1' ' HB3' ' C' ' 91' ' ' SER . 8.1 pt20 -72.45 175.71 6.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.409 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' SER . . . . . 0.467 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 0.5 OUTLIER -75.98 -21.26 57.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.984 0.421 . . . . 0.0 111.518 179.414 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' SER . . . . . 0.485 ' HB3' ' OE1' ' C' ' 89' ' ' GLN . 32.1 t -80.95 67.6 6.92 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.811 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' ALA . . . . . 0.453 ' HA ' ' OG ' ' C' ' 95' ' ' SER . . . -72.28 -9.71 58.83 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.912 0.387 . . . . 0.0 111.681 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' ALA . . . . . 0.894 ' HB1' ' HB1' ' E' ' 22' ' ' ALA . . . -68.14 -22.77 64.85 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.615 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.54 6.75 2.46 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.895 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' SER . . . . . 0.689 ' HA ' ' HB3' ' C' ' 147' ' ' ALA . 31.5 p -93.72 150.82 20.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.851 0.358 . . . . 0.0 110.625 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.79 167.14 18.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.58 165.16 14.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.367 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . 0.527 ' HA ' ' OG1' ' C' ' 140' ' ' THR . 85.1 m-20 63.24 45.5 5.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.443 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 99' ' ' VAL . . . . . 0.472 ' HB ' ' CB ' ' C' ' 143' ' ' ALA . 3.5 p -170.65 131.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.762 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.03 -175.94 21.14 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.531 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' VAL . . . . . . . . . . . . . 76.0 t -104.14 91.88 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 122.981 0.512 . . . . 0.0 111.723 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 102' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' C' ' 85' ' ' VAL . 0.0 OUTLIER -67.95 131.16 44.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.916 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.52 HD12 ' O ' ' C' ' 84' ' ' ASN . 0.7 OUTLIER -99.34 110.56 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.535 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' LEU . . . . . 0.466 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 5.4 tp -91.22 149.94 21.55 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.625 0.25 . . . . 0.0 111.086 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.9 174.68 5.79 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.71 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 106' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' C' ' 106' ' ' ARG . 1.5 ttt180 -72.53 -18.45 61.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.79 0.329 . . . . 0.0 111.106 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 46.2 p -69.36 -9.67 54.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.996 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.99 -48.34 0.96 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.69 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.95 163.57 15.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 111.072 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -70.49 125.62 27.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.123 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 111' ' ' LEU . . . . . 0.538 HD11 ' CB ' ' C' ' 73' ' ' PHE . 0.0 OUTLIER -65.41 147.65 53.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.356 0.598 . . . . 0.0 110.557 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 112' ' ' THR . . . . . 0.702 ' HB ' HG21 ' C' ' 117' ' ' THR . 0.2 OUTLIER -74.11 144.63 44.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.113 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.745 HD13 ' HA ' ' C' ' 84' ' ' ASN . 10.2 mp -100.36 89.84 4.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.799 0.333 . . . . 0.0 110.718 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 114' ' ' ASP . . . . . 0.431 ' HB2' ' CG2' ' C' ' 117' ' ' THR . 4.0 m-20 -142.37 11.5 1.92 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.51 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . 0.438 ' O ' ' HB1' ' C' ' 72' ' ' ALA . . . 96.82 -78.08 0.7 Allowed Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.638 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 116' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' F' ' 125' ' ' ASN . . . -104.24 61.52 0.73 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.013 0.435 . . . . 0.0 111.686 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . 0.702 HG21 ' HB ' ' C' ' 112' ' ' THR . 17.6 p -93.4 95.9 9.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.081 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.86 110.02 5.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.787 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 13.9 m -120.4 -72.85 0.67 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.42 113.04 25.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.666 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -99.39 97.52 8.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.186 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.45 132.71 37.46 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.752 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 22.0 m -60.89 146.15 47.65 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.708 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . 0.457 ' HB3' HG23 ' C' ' 63' ' ' THR . 0.2 OUTLIER -85.41 156.52 20.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.634 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.82 142.73 40.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.575 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.9 113.69 6.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.742 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.5 -90.01 0.32 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.702 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 6.1 m -124.91 152.82 43.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.692 0.282 . . . . 0.0 110.815 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 129' ' ' ASN . . . . . 0.551 ' HB3' ' HB2' ' C' ' 58' ' ' LEU . 17.1 t-20 -123.06 147.53 46.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 4.3 m -126.19 135.65 51.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.094 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 131' ' ' ILE . . . . . . . . . . . . . 58.2 mt -113.95 115.68 45.63 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 132' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -81.74 115.72 2.79 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 121.635 1.557 . . . . 0.0 112.54 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.57 150.8 46.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.828 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 134' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' C' ' 52' ' ' VAL . 1.2 mt-30 -142.4 166.74 23.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.032 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' C' ' 102' ' ' GLN . . . -158.22 102.92 1.79 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.927 0.394 . . . . 0.0 111.622 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' C' ' 51' ' ' ALA . 0.1 OUTLIER -94.69 -173.47 3.02 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.408 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 137' ' ' TYR . . . . . 0.59 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 3.8 m-85 -100.72 152.83 20.0 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.147 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 138' ' ' PHE . . . . . 0.553 ' HA ' ' O ' ' C' ' 47' ' ' ALA . 0.2 OUTLIER -147.3 160.73 42.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.026 -179.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 139' ' ' ALA . . . . . 0.611 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -126.85 149.63 49.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.915 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 140' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' C' ' 98' ' ' ASN . 0.0 OUTLIER -115.33 27.87 9.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.472 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.37 66.79 0.2 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.947 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.93 88.63 0.09 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.58 0.229 . . . . 0.0 110.769 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 143' ' ' ALA . . . . . 0.472 ' CB ' ' HB ' ' C' ' 99' ' ' VAL . . . -60.25 156.86 14.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.758 0.313 . . . . 0.0 111.4 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 144' ' ' THR . . . . . 0.552 ' HB ' ' CD ' ' C' ' 145' ' ' PRO . 77.3 p -112.2 173.05 3.07 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.254 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 145' ' ' PRO . . . . . 0.552 ' CD ' ' HB ' ' C' ' 144' ' ' THR . 1.3 Cg_endo -84.55 145.24 10.43 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.57 2.18 . . . . 0.0 111.923 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.31 -112.7 0.55 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.508 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 147' ' ' ALA . . . . . 0.689 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -124.92 167.68 14.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.913 0.387 . . . . 0.0 111.296 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 148' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -157.19 57.45 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.466 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -91.81 132.71 36.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.53 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.41 163.16 28.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.988 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.45 125.59 1.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.244 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 152' ' ' ALA . . . . . 0.766 ' HB2' HD21 ' C' ' 86' ' ' LEU . . . -154.57 165.78 35.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.264 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.88 163.17 12.72 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -119.02 134.57 55.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.061 0.458 . . . . 0.0 110.155 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 155' ' ' LYS . . . . . 0.687 ' HB3' ' HB3' ' C' ' 72' ' ' ALA . 0.0 OUTLIER -95.62 166.28 11.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.914 -178.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.22 112.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.754 0.312 . . . . 0.0 111.713 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 157' ' ' GLN . . . . . 0.634 ' HB3' ' HB3' ' C' ' 70' ' ' ALA . 0.2 OUTLIER -88.67 138.83 31.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.235 0.54 . . . . 0.0 110.385 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 158' ' ' TYR . . . . . 0.572 ' HE2' HG11 ' C' ' 17' ' ' VAL . 22.6 m-85 -127.76 113.21 15.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.523 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.913 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.248 0.07 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.96 68.35 0.87 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.935 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 3' ' ' THR . . . . . . . . . . . . . 7.5 m -92.39 87.63 6.09 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.439 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' E' ' 157' ' ' GLN . 3.5 m -90.39 115.48 27.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.542 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -127.3 167.02 22.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.565 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 6' ' ' ASN . . . . . 0.643 ' HA ' ' HE2' ' E' ' 155' ' ' LYS . 20.0 t30 -83.02 115.19 21.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.554 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.43 -71.49 1.06 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.806 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.3 172.75 34.77 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.897 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 33.1 m -95.45 136.94 35.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.918 0.39 . . . . 0.0 111.265 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.83 130.73 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.171 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' HIS . . . . . 0.539 ' O ' ' HB ' ' E' ' 32' ' ' VAL . 1.3 m80 -103.83 157.98 16.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.327 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' E' ' 32' ' ' VAL . 0.6 OUTLIER -145.87 89.68 1.92 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.76 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' LYS . . . . . 0.633 ' HD3' HG22 ' E' ' 31' ' ' THR . 0.0 OUTLIER -79.98 135.16 36.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.436 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.54 178.42 42.04 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.948 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' GLU . . . . . 0.652 ' HG2' ' HA ' ' E' ' 147' ' ' ALA . 2.5 mt-10 -156.79 -177.92 6.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.833 0.349 . . . . 0.0 110.414 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.514 HG22 HG23 ' E' ' 37' ' ' VAL . 2.7 t -142.24 150.16 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.27 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.585 HG11 ' HE2' ' D' ' 158' ' ' TYR . 4.2 m -141.76 168.53 14.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.86 0.362 . . . . 0.0 111.034 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -92.98 74.75 4.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.066 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.83 91.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.057 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.43 -51.06 0.09 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.402 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER 179.88 -179.78 0.48 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.005 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . 0.88 ' HB1' ' HB1' ' B' ' 93' ' ' ALA . . . -136.17 116.41 13.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.16 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . 0.423 ' H ' ' CB ' ' E' ' 36' ' ' GLN . 69.3 t -67.01 120.21 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.439 ' O ' HG23 ' D' ' 28' ' ' VAL . 2.4 m-20 -64.42 150.47 46.39 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.573 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' E' ' 33' ' ' GLN . . . -48.36 -50.16 31.66 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.42 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.26 -31.82 81.79 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.93 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . 0.413 ' HA ' HE21 ' D' ' 30' ' ' GLN . 0.4 OUTLIER -69.09 -15.95 63.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.868 0.366 . . . . 0.0 110.821 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 24' ' ' ASP . 48.8 t -73.04 -43.56 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.334 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.41 106.1 10.36 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.999 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' GLN . . . . . 0.413 HE21 ' HA ' ' D' ' 27' ' ' SER . 16.9 mt-30 -116.68 133.95 55.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.032 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' THR . . . . . 0.634 HG22 ' HD3' ' C' ' 13' ' ' LYS . 1.0 OUTLIER -105.48 96.05 6.24 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.042 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' C' ' 11' ' ' HIS . 68.9 t -89.39 131.28 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.161 0.505 . . . . 0.0 110.469 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.465 ' HA ' ' HG2' ' C' ' 13' ' ' LYS . 0.3 OUTLIER -109.05 106.5 16.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.603 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.484 HD12 ' CE2' ' D' ' 137' ' ' TYR . 0.4 OUTLIER -73.85 -40.88 62.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.678 179.391 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.0 -122.47 6.75 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.522 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' GLN . . . . . 0.611 ' HB3' ' HA ' ' C' ' 22' ' ' ALA . 16.3 tt0 -144.55 153.83 42.23 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.566 0.222 . . . . 0.0 110.874 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.515 HG23 HG22 ' C' ' 16' ' ' VAL . 0.0 OUTLIER -128.46 146.32 34.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.911 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . 0.539 ' HE ' ' HB2' ' C' ' 22' ' ' ALA . 0.0 OUTLIER -98.2 145.99 26.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.768 179.196 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.556 HG23 ' O ' ' C' ' 17' ' ' VAL . 40.8 p -57.74 -23.06 50.09 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.743 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.97 -33.23 61.87 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.053 0.454 . . . . 0.0 110.8 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.02 -31.21 69.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.134 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' D' ' 139' ' ' ALA . 0.0 OUTLIER -130.72 86.37 2.37 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.69 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.71 36.27 4.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.346 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.56 150.82 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.38 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' D' ' 140' ' ' THR . 1.7 tm-20 -64.75 134.83 55.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.0 111.175 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.78 -14.22 53.16 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.213 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' D' ' 138' ' ' PHE . . . -57.14 129.86 43.61 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' THR . . . . . 0.46 ' HB ' ' CE1' ' D' ' 138' ' ' PHE . 14.4 t -130.61 143.35 50.69 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.878 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 68.8 m -111.96 -157.21 0.61 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.596 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.405 ' HB3' ' HB1' ' A' ' 92' ' ' ALA . 27.7 t -74.55 150.06 39.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.834 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' ALA . . . . . 0.729 ' O ' HD12 ' A' ' 88' ' ' LEU . . . -103.19 146.64 28.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.326 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' A' ' 90' ' ' SER . 22.3 m -83.37 148.33 5.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.909 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.38 121.21 6.21 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.633 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.412 ' CD1' HG23 ' D' ' 52' ' ' VAL . 16.3 p90 -153.88 125.54 7.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.855 0.36 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.28 156.24 20.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.492 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . . . . . . . . . 22.6 mm -104.05 135.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.534 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.66 126.01 48.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.753 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' D' ' 129' ' ' ASN . 4.3 mp -131.62 99.97 4.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.275 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.46 174.73 11.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.902 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.8 65.26 1.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.782 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' D' ' 21' ' ' CYS . 60.7 m -98.71 142.92 29.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.746 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.6 109.2 15.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.301 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.461 HG23 ' HB3' ' D' ' 124' ' ' LEU . 0.2 OUTLIER -92.43 29.65 1.66 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 64' ' ' ASN . . . . . 0.456 HD22 ' HA ' ' D' ' 64' ' ' ASN . 0.1 OUTLIER -90.06 -59.27 2.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.069 0.462 . . . . 0.0 111.752 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.18 -39.8 13.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.732 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.64 101.39 10.71 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.586 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 31.3 p -90.58 -28.76 18.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.885 0.374 . . . . 0.0 110.999 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' LYS . . . . . 0.449 ' HZ1' ' HB2' ' D' ' 121' ' ' GLU . 0.0 OUTLIER -126.49 166.91 16.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.482 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.8 149.82 29.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.664 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' D' ' 157' ' ' GLN . . . -112.91 159.77 18.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.101 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 52.4 t -108.08 123.31 63.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.662 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 72' ' ' ALA . . . . . 0.679 ' HB3' ' HB3' ' D' ' 155' ' ' LYS . . . -124.61 168.92 12.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.622 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 73' ' ' PHE . . . . . 0.532 ' CB ' HD11 ' D' ' 111' ' ' LEU . 17.2 t80 -150.62 144.41 25.23 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.585 0.231 . . . . 0.0 111.133 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 74' ' ' LEU . . . . . 0.444 HD23 ' O ' ' D' ' 74' ' ' LEU . 0.4 OUTLIER -121.5 88.6 2.97 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.999 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . 0.521 ' C ' HD23 ' D' ' 113' ' ' LEU . . . -134.74 164.72 24.67 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.759 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . 0.665 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.6 OUTLIER -78.56 147.76 33.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.565 0.222 . . . . 0.0 110.774 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.82 140.32 30.77 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.912 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 78' ' ' ILE . . . . . 0.555 ' CG2' ' HB ' ' D' ' 85' ' ' VAL . 1.1 tt -78.65 -33.11 16.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.921 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.16 179.27 7.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.859 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.69 -27.91 36.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.059 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.17 -32.29 72.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.619 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . 0.416 ' HB3' HG23 ' D' ' 85' ' ' VAL . 15.3 m-70 -97.28 -72.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.482 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.86 -7.22 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.592 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . 0.758 ' HA ' HD13 ' D' ' 113' ' ' LEU . 3.1 m120 -108.79 -19.1 13.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.287 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' D' ' 102' ' ' GLN . 50.3 t -80.65 131.98 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.134 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' D' ' 152' ' ' ALA . 0.4 OUTLIER -76.52 134.96 39.31 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.32 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.31 165.19 6.2 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.889 0.376 . . . . 0.0 111.669 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . 0.423 ' H ' ' HG ' ' D' ' 88' ' ' LEU . 0.1 OUTLIER -65.75 171.69 4.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.056 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 89' ' ' GLN . . . . . 0.492 ' OE1' ' HB3' ' D' ' 91' ' ' SER . 8.1 pt20 -72.48 175.67 6.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.412 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.98 -21.19 57.22 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.071 0.462 . . . . 0.0 111.521 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . 0.492 ' HB3' ' OE1' ' D' ' 89' ' ' GLN . 32.1 t -81.02 67.64 7.01 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.825 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 92' ' ' ALA . . . . . 0.449 ' HA ' ' OG ' ' D' ' 95' ' ' SER . . . -72.33 -9.7 58.84 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.943 0.401 . . . . 0.0 111.682 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 93' ' ' ALA . . . . . 0.896 ' HB1' ' HB1' ' F' ' 22' ' ' ALA . . . -68.06 -22.88 64.92 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.615 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.51 6.78 2.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.911 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 95' ' ' SER . . . . . 0.699 ' HA ' ' HB3' ' D' ' 147' ' ' ALA . 31.6 p -93.77 150.86 20.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.846 0.355 . . . . 0.0 110.599 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.82 167.24 18.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.834 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.68 165.16 14.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.295 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 98' ' ' ASN . . . . . 0.525 ' HA ' ' OG1' ' D' ' 140' ' ' THR . 85.0 m-20 63.3 45.46 4.98 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.434 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 99' ' ' VAL . . . . . 0.465 ' HB ' ' CB ' ' D' ' 143' ' ' ALA . 3.4 p -170.67 131.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.784 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.05 -175.92 21.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.54 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 101' ' ' VAL . . . . . . . . . . . . . 76.4 t -104.2 91.91 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.187 0.518 . . . . 0.0 111.669 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 102' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' D' ' 85' ' ' VAL . 0.0 OUTLIER -67.9 131.25 45.16 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.877 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 103' ' ' ILE . . . . . 0.512 HD12 ' O ' ' D' ' 84' ' ' ASN . 0.7 OUTLIER -99.47 110.64 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.468 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 104' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 5.5 tp -91.33 149.96 21.51 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.633 0.254 . . . . 0.0 111.056 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.87 174.65 5.8 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.714 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 106' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' D' ' 106' ' ' ARG . 1.5 ttt180 -72.47 -18.55 61.67 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.714 0.293 . . . . 0.0 111.033 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 107' ' ' THR . . . . . . . . . . . . . 46.3 p -69.33 -9.58 53.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.06 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.98 -48.41 0.96 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.643 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.92 163.56 15.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.063 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -70.47 125.57 27.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.155 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 111' ' ' LEU . . . . . 0.532 HD11 ' CB ' ' D' ' 73' ' ' PHE . 0.0 OUTLIER -65.33 147.64 53.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.328 0.585 . . . . 0.0 110.593 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 112' ' ' THR . . . . . 0.67 ' HB ' HG21 ' D' ' 117' ' ' THR . 0.2 OUTLIER -74.1 144.61 44.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.085 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 113' ' ' LEU . . . . . 0.758 HD13 ' HA ' ' D' ' 84' ' ' ASN . 10.2 mp -100.34 89.89 4.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.727 0.298 . . . . 0.0 110.686 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 114' ' ' ASP . . . . . 0.433 ' HB2' ' CG2' ' D' ' 117' ' ' THR . 4.0 m-20 -142.37 11.44 1.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.569 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . 0.443 ' O ' ' HB1' ' D' ' 72' ' ' ALA . . . 96.88 -78.06 0.69 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.624 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 116' ' ' ALA . . . . . 0.463 ' CB ' HG21 ' C' ' 4' ' ' THR . . . -104.26 61.49 0.73 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.999 0.428 . . . . 0.0 111.706 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 117' ' ' THR . . . . . 0.67 HG21 ' HB ' ' D' ' 112' ' ' THR . 17.5 p -93.41 95.86 9.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.131 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.81 110.05 5.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.746 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.39 -72.9 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.878 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.45 113.05 25.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.622 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . 0.449 ' HB2' ' HZ1' ' D' ' 68' ' ' LYS . 25.2 mt-10 -99.44 97.56 8.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.191 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.5 132.74 37.49 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.752 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -60.94 146.11 47.96 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.709 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . 0.461 ' HB3' HG23 ' D' ' 63' ' ' THR . 0.2 OUTLIER -85.34 156.49 20.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.632 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 125' ' ' ASN . . . . . 0.534 ' HB3' ' HB3' ' A' ' 116' ' ' ALA . 32.6 m120 -137.81 142.74 40.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.577 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.97 113.7 6.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.689 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.51 -90.05 0.32 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.701 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 128' ' ' THR . . . . . 0.433 ' HB ' ' HD3' ' A' ' 155' ' ' LYS . 6.2 m -124.94 152.86 43.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.734 0.302 . . . . 0.0 110.82 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 129' ' ' ASN . . . . . 0.542 ' HB3' ' HB2' ' D' ' 58' ' ' LEU . 17.1 t-20 -123.06 147.56 46.57 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.866 0.365 . . . . 0.0 111.158 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 130' ' ' THR . . . . . 0.652 ' OG1' HD12 ' A' ' 74' ' ' LEU . 4.3 m -126.22 135.71 51.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.05 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 131' ' ' ILE . . . . . . . . . . . . . 58.5 mt -114.01 115.7 45.48 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 132' ' ' PRO . . . . . 0.564 ' HB3' ' H ' ' A' ' 77' ' ' ALA . 7.5 Cg_endo -81.67 115.71 2.82 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 121.703 1.602 . . . . 0.0 112.545 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.59 150.79 46.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.802 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 134' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' D' ' 52' ' ' VAL . 1.3 mt-30 -142.5 166.61 24.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.081 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' D' ' 102' ' ' GLN . . . -158.14 102.9 1.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.922 0.392 . . . . 0.0 111.638 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 136' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' D' ' 51' ' ' ALA . 0.2 OUTLIER -94.67 -173.41 3.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.415 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 137' ' ' TYR . . . . . 0.605 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 3.8 m-85 -100.82 152.86 20.0 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.09 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 138' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' D' ' 47' ' ' ALA . 0.2 OUTLIER -147.33 160.73 42.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.083 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 139' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -126.82 149.71 49.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.895 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 140' ' ' THR . . . . . 0.525 ' OG1' ' HA ' ' D' ' 98' ' ' ASN . 0.0 OUTLIER -115.4 27.79 9.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.402 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.38 66.86 0.2 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.888 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.92 88.61 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.576 0.188 . . . . 0.0 110.759 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 143' ' ' ALA . . . . . 0.465 ' CB ' ' HB ' ' D' ' 99' ' ' VAL . . . -60.2 156.9 14.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.709 0.29 . . . . 0.0 111.438 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 144' ' ' THR . . . . . 0.548 ' HB ' ' CD ' ' D' ' 145' ' ' PRO . 76.9 p -112.21 173.08 3.05 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.213 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 145' ' ' PRO . . . . . 0.548 ' CD ' ' HB ' ' D' ' 144' ' ' THR . 1.3 Cg_endo -84.58 145.2 10.38 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.565 2.177 . . . . 0.0 111.937 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.38 -112.72 0.55 Allowed Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.555 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 147' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -124.92 167.69 14.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.812 0.339 . . . . 0.0 111.394 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 148' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -157.22 57.54 0.51 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.103 0.478 . . . . 0.0 110.468 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.87 132.74 36.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.534 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.48 163.12 28.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.027 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.39 125.6 1.85 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.282 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 152' ' ' ALA . . . . . 0.792 ' HB2' HD21 ' D' ' 86' ' ' LEU . . . -154.59 165.78 35.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.173 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.84 163.16 12.72 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -119.0 134.48 55.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.023 0.439 . . . . 0.0 110.2 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 155' ' ' LYS . . . . . 0.679 ' HB3' ' HB3' ' D' ' 72' ' ' ALA . 0.0 OUTLIER -95.61 166.3 11.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.91 -178.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.25 112.83 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.832 0.348 . . . . 0.0 111.638 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 157' ' ' GLN . . . . . 0.615 ' HB3' ' HB3' ' D' ' 70' ' ' ALA . 0.2 OUTLIER -88.82 138.84 31.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.331 0.586 . . . . 0.0 110.393 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 158' ' ' TYR . . . . . 0.585 ' HE2' HG11 ' D' ' 17' ' ' VAL . 22.5 m-85 -127.65 113.16 15.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.519 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.962 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.261 0.076 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.0 68.24 0.88 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.587 0.232 . . . . 0.0 111.022 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -92.31 87.66 6.13 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.473 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 4' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' F' ' 157' ' ' GLN . 3.5 m -90.5 115.48 27.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.545 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 m -127.22 167.0 22.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.583 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 6' ' ' ASN . . . . . 0.653 ' HA ' ' HE2' ' F' ' 155' ' ' LYS . 20.0 t30 -83.04 115.14 21.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.497 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.41 -71.45 1.07 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.853 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.29 172.78 34.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.049 -0.595 . . . . 0.0 111.931 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 9' ' ' THR . . . . . . . . . . . . . 33.4 m -95.49 137.03 35.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.916 0.389 . . . . 0.0 111.284 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -120.85 130.68 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.185 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 11' ' ' HIS . . . . . 0.535 ' O ' ' HB ' ' F' ' 32' ' ' VAL . 1.3 m80 -103.82 157.99 16.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.397 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 12' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' F' ' 32' ' ' VAL . 0.6 OUTLIER -145.84 89.66 1.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 13' ' ' LYS . . . . . 0.631 ' HD3' HG22 ' F' ' 31' ' ' THR . 0.0 OUTLIER -79.95 135.21 36.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.477 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.56 178.38 42.07 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.898 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 15' ' ' GLU . . . . . 0.654 ' HG2' ' HA ' ' F' ' 147' ' ' ALA . 2.6 mt-10 -156.81 -177.9 6.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.938 0.399 . . . . 0.0 110.357 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 16' ' ' VAL . . . . . 0.525 HG22 HG23 ' F' ' 37' ' ' VAL . 2.7 t -142.29 150.13 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.239 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . 0.589 HG11 ' HE2' ' E' ' 158' ' ' TYR . 4.1 m -141.71 168.61 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.832 0.349 . . . . 0.0 111.083 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.06 74.74 4.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.087 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.89 91.89 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.5 -51.01 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.432 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 21' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER 179.82 -179.79 0.47 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.986 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 22' ' ' ALA . . . . . 0.894 ' HB1' ' HB1' ' C' ' 93' ' ' ALA . . . -136.16 116.43 13.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.146 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 23' ' ' VAL . . . . . 0.421 ' H ' ' CB ' ' F' ' 36' ' ' GLN . 67.7 t -67.01 120.14 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 24' ' ' ASP . . . . . 0.445 ' O ' HG23 ' E' ' 28' ' ' VAL . 2.4 m-20 -64.38 150.49 46.21 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.602 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.38 -50.18 31.7 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.355 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.3 -31.77 81.58 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.918 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . 0.418 ' HA ' HE21 ' E' ' 30' ' ' GLN . 0.4 OUTLIER -69.02 -16.05 63.62 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.902 0.382 . . . . 0.0 110.859 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 28' ' ' VAL . . . . . 0.445 HG23 ' O ' ' E' ' 24' ' ' ASP . 48.4 t -72.93 -43.61 59.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.401 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.44 106.09 10.35 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 30' ' ' GLN . . . . . 0.418 HE21 ' HA ' ' E' ' 27' ' ' SER . 16.9 mt-30 -116.62 133.99 55.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.079 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 31' ' ' THR . . . . . 0.633 HG22 ' HD3' ' D' ' 13' ' ' LYS . 0.9 OUTLIER -105.5 96.03 6.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.095 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' D' ' 11' ' ' HIS . 69.6 t -89.45 131.27 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.215 0.531 . . . . 0.0 110.437 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 33' ' ' GLN . . . . . 0.456 ' HA ' ' HG2' ' D' ' 13' ' ' LYS . 0.3 OUTLIER -108.99 106.48 16.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.599 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.494 HD12 ' CE2' ' E' ' 137' ' ' TYR . 0.4 OUTLIER -73.89 -40.93 62.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.552 179.419 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.04 -122.48 6.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.564 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 36' ' ' GLN . . . . . 0.612 ' HB3' ' HA ' ' D' ' 22' ' ' ALA . 16.3 tt0 -144.51 153.98 42.43 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.633 0.254 . . . . 0.0 110.881 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.514 HG23 HG22 ' D' ' 16' ' ' VAL . 0.0 OUTLIER -128.57 146.33 34.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.873 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . 0.547 ' HE ' ' HB2' ' D' ' 22' ' ' ALA . 0.0 OUTLIER -98.19 146.0 26.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.731 179.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 39' ' ' THR . . . . . 0.55 HG23 ' O ' ' D' ' 17' ' ' VAL . 40.9 p -57.79 -23.07 50.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.709 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.98 -33.21 61.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.013 0.435 . . . . 0.0 110.791 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.03 -31.15 69.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.222 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' E' ' 139' ' ' ALA . 0.0 OUTLIER -130.76 86.44 2.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.598 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.66 36.16 4.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.337 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.59 150.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.365 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' E' ' 140' ' ' THR . 1.7 tm-20 -64.78 134.88 55.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 0.0 111.118 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.8 -14.28 53.07 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.146 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 47' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' E' ' 138' ' ' PHE . . . -57.22 129.92 43.9 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.938 0.399 . . . . 0.0 112.043 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . 0.465 ' HB ' ' CE1' ' E' ' 138' ' ' PHE . 14.3 t -130.67 143.29 50.65 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.874 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 68.9 m -111.87 -157.14 0.61 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.625 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 50' ' ' SER . . . . . 0.408 ' HB3' ' HB1' ' B' ' 92' ' ' ALA . 27.5 t -74.58 150.05 39.86 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.865 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 51' ' ' ALA . . . . . 0.723 ' O ' HD12 ' B' ' 88' ' ' LEU . . . -103.22 146.63 28.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.334 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 52' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' B' ' 90' ' ' SER . 22.1 m -83.41 148.37 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.44 121.27 6.22 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.601 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 54' ' ' PHE . . . . . 0.406 ' CD1' HG23 ' E' ' 52' ' ' VAL . 16.5 p90 -153.87 125.57 7.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.797 0.332 . . . . 0.0 110.949 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.33 156.19 20.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.59 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 56' ' ' ILE . . . . . . . . . . . . . 22.4 mm -103.95 135.29 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.565 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.72 125.99 48.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.75 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . 0.541 ' HB2' ' HB3' ' E' ' 129' ' ' ASN . 4.3 mp -131.6 99.9 4.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.326 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.32 174.72 11.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.966 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.74 65.3 1.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.79 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 61' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' E' ' 21' ' ' CYS . 60.7 m -98.71 142.94 29.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.792 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.64 109.25 15.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.266 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 63' ' ' THR . . . . . 0.473 HG23 ' HB3' ' E' ' 124' ' ' LEU . 0.2 OUTLIER -92.47 29.59 1.68 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.144 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.99 -59.26 2.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.085 0.469 . . . . 0.0 111.727 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.25 -39.84 13.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.666 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.6 101.34 10.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.597 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 30.8 p -90.56 -28.79 18.25 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.38 167.08 16.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.509 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.95 149.75 29.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.617 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' E' ' 157' ' ' GLN . . . -112.88 159.75 18.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.1 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 52.2 t -108.09 123.29 63.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.665 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . 0.677 ' HB3' ' HB3' ' E' ' 155' ' ' LYS . . . -124.63 168.92 12.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.615 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 73' ' ' PHE . . . . . 0.539 ' CB ' HD11 ' E' ' 111' ' ' LEU . 17.2 t80 -150.63 144.4 25.21 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.601 0.239 . . . . 0.0 111.1 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 74' ' ' LEU . . . . . 0.441 HD23 ' O ' ' E' ' 74' ' ' LEU . 0.4 OUTLIER -121.46 88.64 2.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.989 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . 0.52 ' C ' HD23 ' E' ' 113' ' ' LEU . . . -134.76 164.7 24.67 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.816 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 76' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.6 OUTLIER -78.57 147.72 33.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.595 0.236 . . . . 0.0 110.708 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.68 140.29 30.71 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.961 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 78' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' E' ' 85' ' ' VAL . 1.1 tt -78.58 -33.16 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.914 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.18 179.18 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.904 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.58 -27.96 37.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.059 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.21 -32.22 72.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.633 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 82' ' ' HIS . . . . . 0.41 ' HB3' HG23 ' E' ' 85' ' ' VAL . 15.3 m-70 -97.29 -72.81 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.931 0.396 . . . . 0.0 110.461 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.88 -7.15 1.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.593 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 84' ' ' ASN . . . . . 0.76 ' HA ' HD13 ' E' ' 113' ' ' LEU . 3.1 m120 -108.83 -19.1 13.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.325 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' E' ' 102' ' ' GLN . 49.6 t -80.55 132.07 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.152 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 86' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' E' ' 152' ' ' ALA . 0.4 OUTLIER -76.63 134.96 39.16 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.304 179.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.25 165.21 6.1 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.867 0.365 . . . . 0.0 111.645 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . 0.424 ' HG ' ' H ' ' E' ' 88' ' ' LEU . 0.1 OUTLIER -65.86 171.79 4.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.998 179.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 89' ' ' GLN . . . . . 0.491 ' OE1' ' HB3' ' E' ' 91' ' ' SER . 8.0 pt20 -72.56 175.71 6.09 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.425 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.04 -21.18 57.1 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.009 0.433 . . . . 0.0 111.498 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 91' ' ' SER . . . . . 0.491 ' HB3' ' OE1' ' E' ' 89' ' ' GLN . 32.0 t -80.91 67.49 6.82 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 92' ' ' ALA . . . . . 0.453 ' HA ' ' OG ' ' E' ' 95' ' ' SER . . . -72.18 -9.77 58.88 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.969 0.414 . . . . 0.0 111.723 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.04 -22.88 64.93 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.669 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.46 6.75 2.48 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.946 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 95' ' ' SER . . . . . 0.692 ' HA ' ' HB3' ' E' ' 147' ' ' ALA . 31.0 p -93.73 150.78 20.11 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.821 0.343 . . . . 0.0 110.688 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.77 167.22 18.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.876 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.66 165.09 14.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.365 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 98' ' ' ASN . . . . . 0.514 ' HA ' ' OG1' ' E' ' 140' ' ' THR . 85.0 m-20 63.36 45.42 4.93 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.443 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 99' ' ' VAL . . . . . 0.454 ' HB ' ' CB ' ' E' ' 143' ' ' ALA . 3.4 p -170.64 131.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.692 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.04 -175.99 21.18 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.54 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 101' ' ' VAL . . . . . . . . . . . . . 76.3 t -104.07 91.83 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 122.994 0.517 . . . . 0.0 111.708 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 102' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' E' ' 85' ' ' VAL . 0.0 OUTLIER -67.9 131.21 45.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 103' ' ' ILE . . . . . 0.516 HD12 ' O ' ' E' ' 84' ' ' ASN . 0.7 OUTLIER -99.42 110.62 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.475 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 104' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 5.5 tp -91.3 149.93 21.53 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.699 0.285 . . . . 0.0 111.029 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.9 174.65 5.8 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.701 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 106' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' E' ' 106' ' ' ARG . 1.5 ttt180 -72.53 -18.4 61.65 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.759 0.314 . . . . 0.0 111.067 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 46.2 p -69.41 -9.63 54.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.99 -48.38 0.96 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.636 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.88 163.58 15.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 111.11 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 110' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -70.53 125.59 27.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 111' ' ' LEU . . . . . 0.539 HD11 ' CB ' ' E' ' 73' ' ' PHE . 0.0 OUTLIER -65.38 147.57 53.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.353 0.596 . . . . 0.0 110.557 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 112' ' ' THR . . . . . 0.671 ' HB ' HG21 ' E' ' 117' ' ' THR . 0.2 OUTLIER -74.03 144.57 45.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.157 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 113' ' ' LEU . . . . . 0.76 HD13 ' HA ' ' E' ' 84' ' ' ASN . 10.2 mp -100.26 89.82 4.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.776 0.322 . . . . 0.0 110.753 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 114' ' ' ASP . . . . . 0.433 ' HB2' ' CG2' ' E' ' 117' ' ' THR . 4.1 m-20 -142.34 11.43 1.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.685 0.279 . . . . 0.0 111.623 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . 0.45 ' O ' ' HB1' ' E' ' 72' ' ' ALA . . . 96.87 -78.1 0.7 Allowed Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.619 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 116' ' ' ALA . . . . . 0.456 ' CB ' HG21 ' D' ' 4' ' ' THR . . . -104.29 61.63 0.73 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.976 0.417 . . . . 0.0 111.666 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 117' ' ' THR . . . . . 0.671 HG21 ' HB ' ' E' ' 112' ' ' THR . 17.6 p -93.5 95.87 9.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.114 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.74 109.92 5.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.819 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.26 -72.96 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.43 113.09 25.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.638 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -99.47 97.51 8.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.184 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.45 132.74 37.42 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.724 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 22.3 m -61.01 146.13 48.2 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.691 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . 0.473 ' HB3' HG23 ' E' ' 63' ' ' THR . 0.2 OUTLIER -85.41 156.49 20.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.645 179.419 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 125' ' ' ASN . . . . . 0.534 ' HB3' ' HB3' ' B' ' 116' ' ' ALA . 32.6 m120 -137.83 142.78 40.78 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.542 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.91 113.69 6.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.717 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 127' ' ' GLY . . . . . 0.619 ' HA3' ' HB ' ' A' ' 4' ' ' THR . . . 128.45 -89.97 0.32 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.731 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 128' ' ' THR . . . . . 0.429 ' HB ' ' HD3' ' B' ' 155' ' ' LYS . 6.2 m -124.92 152.83 43.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.73 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 129' ' ' ASN . . . . . 0.541 ' HB3' ' HB2' ' E' ' 58' ' ' LEU . 17.0 t-20 -123.08 147.54 46.61 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.122 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 130' ' ' THR . . . . . 0.632 ' OG1' HD12 ' B' ' 74' ' ' LEU . 4.3 m -126.13 135.76 52.07 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.043 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 131' ' ' ILE . . . . . . . . . . . . . 58.4 mt -114.04 115.61 45.46 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 132' ' ' PRO . . . . . 0.564 ' HB3' ' H ' ' B' ' 77' ' ' ALA . 7.5 Cg_endo -81.69 115.69 2.81 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.698 1.599 . . . . 0.0 112.566 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.6 150.79 46.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.807 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 134' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' E' ' 52' ' ' VAL . 1.2 mt-30 -142.44 166.71 23.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.034 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 135' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' E' ' 102' ' ' GLN . . . -158.17 102.93 1.8 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.382 . . . . 0.0 111.636 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 136' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' E' ' 51' ' ' ALA . 0.1 OUTLIER -94.72 -173.42 3.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.352 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 137' ' ' TYR . . . . . 0.591 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 3.7 m-85 -100.86 152.87 20.0 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.082 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 138' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' E' ' 47' ' ' ALA . 0.2 OUTLIER -147.35 160.73 42.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.072 -179.183 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 139' ' ' ALA . . . . . 0.615 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -126.82 149.67 49.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.885 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 140' ' ' THR . . . . . 0.514 ' OG1' ' HA ' ' E' ' 98' ' ' ASN . 0.0 OUTLIER -115.35 27.84 9.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.484 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.4 66.79 0.2 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.951 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.91 88.61 0.09 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.604 0.24 . . . . 0.0 110.742 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 143' ' ' ALA . . . . . 0.454 ' CB ' ' HB ' ' E' ' 99' ' ' VAL . . . -60.21 156.89 14.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.751 0.31 . . . . 0.0 111.424 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 144' ' ' THR . . . . . 0.555 ' HB ' ' CD ' ' E' ' 145' ' ' PRO . 77.0 p -112.18 173.05 3.07 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.305 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 145' ' ' PRO . . . . . 0.555 ' CD ' ' HB ' ' E' ' 144' ' ' THR . 1.4 Cg_endo -84.6 145.25 10.37 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.477 2.118 . . . . 0.0 112.029 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.37 -112.73 0.55 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.56 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 147' ' ' ALA . . . . . 0.692 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -124.98 167.66 14.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.88 0.371 . . . . 0.0 111.337 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 148' ' ' ALA . . . . . 0.413 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -157.13 57.46 0.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.497 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.86 132.74 36.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.559 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.42 163.13 28.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.037 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.48 125.65 1.82 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.184 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 152' ' ' ALA . . . . . 0.794 ' HB2' HD21 ' E' ' 86' ' ' LEU . . . -154.61 165.71 35.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.204 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.83 163.13 12.74 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -119.04 134.56 55.12 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.094 0.473 . . . . 0.0 110.108 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 155' ' ' LYS . . . . . 0.677 ' HB3' ' HB3' ' E' ' 72' ' ' ALA . 0.0 OUTLIER -95.48 166.25 11.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.928 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.33 112.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.888 0.375 . . . . 0.0 111.641 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 157' ' ' GLN . . . . . 0.613 ' HB3' ' HB3' ' E' ' 70' ' ' ALA . 0.2 OUTLIER -88.76 138.85 31.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.242 0.544 . . . . 0.0 110.404 -179.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 158' ' ' TYR . . . . . 0.589 ' HE2' HG11 ' E' ' 17' ' ' VAL . 22.5 m-85 -127.71 113.15 15.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.512 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.909 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.226 0.06 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.0 68.24 0.88 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.552 0.215 . . . . 0.0 111.049 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.36 87.66 6.11 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.469 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m -90.49 115.46 27.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.591 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -127.28 166.93 23.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.588 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -82.99 115.23 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.524 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.48 -71.45 1.07 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.801 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.3 172.78 34.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.918 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 33.2 m -95.49 136.96 35.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.399 . . . . 0.0 111.265 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 40.3 t -120.82 130.72 74.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.194 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -103.84 157.96 16.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.432 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -145.84 89.63 1.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 13' ' ' LYS . . . . . 0.428 ' HG2' ' H ' ' F' ' 13' ' ' LYS . 0.0 OUTLIER -79.97 135.19 36.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.431 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.56 178.38 42.08 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.853 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -156.84 -177.93 6.98 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.862 0.363 . . . . 0.0 110.345 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.25 150.15 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.222 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 17' ' ' VAL . . . . . 0.581 HG11 ' HE2' ' F' ' 158' ' ' TYR . 4.1 m -141.7 168.6 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.876 0.37 . . . . 0.0 111.025 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.02 74.66 4.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.05 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.95 91.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.035 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.46 -51.0 0.09 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.423 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 21' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER 179.88 -179.72 0.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.974 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 22' ' ' ALA . . . . . 0.896 ' HB1' ' HB1' ' D' ' 93' ' ' ALA . . . -136.18 116.51 13.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.161 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 23' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.1 120.23 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.995 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 24' ' ' ASP . . . . . 0.43 ' O ' HG23 ' F' ' 28' ' ' VAL . 2.4 m-20 -64.47 150.45 46.54 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.564 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.39 -50.07 32.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.343 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.37 -31.73 81.33 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.936 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 27' ' ' SER . . . . . 0.41 ' HA ' HE21 ' F' ' 30' ' ' GLN . 0.4 OUTLIER -69.1 -15.99 63.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.923 0.392 . . . . 0.0 110.851 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 28' ' ' VAL . . . . . 0.43 HG23 ' O ' ' F' ' 24' ' ' ASP . 48.7 t -72.99 -43.63 58.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.379 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.41 106.15 10.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.994 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 30' ' ' GLN . . . . . 0.41 HE21 ' HA ' ' F' ' 27' ' ' SER . 17.0 mt-30 -116.78 134.05 55.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.03 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 31' ' ' THR . . . . . 0.631 HG22 ' HD3' ' E' ' 13' ' ' LYS . 0.9 OUTLIER -105.47 96.12 6.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.083 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' E' ' 11' ' ' HIS . 69.3 t -89.53 131.24 37.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 33' ' ' GLN . . . . . 0.449 ' HA ' ' HG2' ' E' ' 13' ' ' LYS . 0.3 OUTLIER -108.95 106.49 16.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.616 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 34' ' ' LEU . . . . . 0.481 HD12 ' CE2' ' F' ' 137' ' ' TYR . 0.4 OUTLIER -73.86 -40.91 62.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.637 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.01 -122.45 6.74 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.559 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 36' ' ' GLN . . . . . 0.613 ' HB3' ' HA ' ' E' ' 22' ' ' ALA . 16.1 tt0 -144.55 153.87 42.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.658 0.265 . . . . 0.0 110.936 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.525 HG23 HG22 ' E' ' 16' ' ' VAL . 0.0 OUTLIER -128.46 146.29 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.963 -179.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 38' ' ' ARG . . . . . 0.528 ' HE ' ' HB2' ' E' ' 22' ' ' ALA . 0.0 OUTLIER -98.2 145.94 26.11 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.764 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 39' ' ' THR . . . . . 0.554 HG23 ' O ' ' E' ' 17' ' ' VAL . 40.8 p -57.7 -23.06 49.75 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.721 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.07 -33.09 61.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.022 0.439 . . . . 0.0 110.805 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -31.11 69.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.208 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' F' ' 139' ' ' ALA . 0.0 OUTLIER -130.78 86.44 2.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.622 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.7 36.23 4.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.411 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 177.6 150.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.324 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' F' ' 140' ' ' THR . 1.7 tm-20 -64.72 134.85 55.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.34 . . . . 0.0 111.116 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.74 -14.21 53.3 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.215 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 47' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' F' ' 138' ' ' PHE . . . -57.22 129.91 43.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.927 0.394 . . . . 0.0 112.052 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 48' ' ' THR . . . . . 0.465 ' HB ' ' CE1' ' F' ' 138' ' ' PHE . 14.3 t -130.66 143.35 50.69 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.861 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 49' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 68.8 m -111.98 -157.21 0.61 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.604 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 50' ' ' SER . . . . . 0.416 ' HB3' ' HB1' ' C' ' 92' ' ' ALA . 27.7 t -74.59 150.12 39.81 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.856 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 51' ' ' ALA . . . . . 0.738 ' O ' HD12 ' C' ' 88' ' ' LEU . . . -103.19 146.7 28.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.301 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 52' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' C' ' 90' ' ' SER . 22.2 m -83.45 148.35 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.915 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.4 121.2 6.2 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.628 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 54' ' ' PHE . . . . . 0.412 ' CD1' HG23 ' F' ' 52' ' ' VAL . 16.2 p90 -153.88 125.55 7.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.852 0.358 . . . . 0.0 110.889 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.26 156.17 20.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.533 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 56' ' ' ILE . . . . . . . . . . . . . 22.4 mm -103.96 135.38 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.583 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.75 126.07 48.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.713 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' F' ' 129' ' ' ASN . 4.3 mp -131.65 99.96 4.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.286 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.4 174.82 11.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.982 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.71 65.21 1.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.83 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 61' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' F' ' 21' ' ' CYS . 60.6 m -98.68 142.98 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.813 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.68 109.21 15.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.261 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 63' ' ' THR . . . . . 0.463 HG23 ' HB3' ' F' ' 124' ' ' LEU . 0.2 OUTLIER -92.42 29.57 1.68 Allowed 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 64' ' ' ASN . . . . . 0.418 HD22 ' HA ' ' F' ' 64' ' ' ASN . 0.1 OUTLIER -90.05 -59.21 2.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.028 0.442 . . . . 0.0 111.679 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.2 -39.93 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.662 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.58 101.36 10.69 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.543 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 30.9 p -90.59 -28.71 18.27 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.857 0.36 . . . . 0.0 110.963 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.52 166.94 16.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.491 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.79 149.88 29.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.583 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 70' ' ' ALA . . . . . 0.627 ' HB3' ' HB3' ' F' ' 157' ' ' GLN . . . -112.98 159.74 18.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.164 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 51.4 t -108.02 123.28 63.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.689 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 72' ' ' ALA . . . . . 0.693 ' HB3' ' HB3' ' F' ' 155' ' ' LYS . . . -124.71 168.99 12.42 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.484 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 73' ' ' PHE . . . . . 0.54 ' CB ' HD11 ' F' ' 111' ' ' LEU . 17.2 t80 -150.58 144.47 25.3 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.562 0.22 . . . . 0.0 111.147 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 74' ' ' LEU . . . . . 0.429 HD23 ' O ' ' F' ' 74' ' ' LEU . 0.4 OUTLIER -121.58 88.61 2.97 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.989 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . 0.524 ' C ' HD23 ' F' ' 113' ' ' LEU . . . -134.74 164.65 24.67 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.777 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 76' ' ' THR . . . . . 0.67 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.6 OUTLIER -78.51 147.8 33.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.547 0.213 . . . . 0.0 110.786 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.78 140.38 30.66 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.838 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 78' ' ' ILE . . . . . 0.562 ' CG2' ' HB ' ' F' ' 85' ' ' VAL . 1.1 tt -78.7 -33.15 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.16 179.23 7.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.833 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.71 -27.78 36.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.036 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.3 -32.18 72.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.586 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 82' ' ' HIS . . . . . 0.412 ' HB3' HG23 ' F' ' 85' ' ' VAL . 15.3 m-70 -97.33 -72.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.877 0.37 . . . . 0.0 110.446 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.87 -7.21 1.79 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.582 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 84' ' ' ASN . . . . . 0.748 ' HA ' HD13 ' F' ' 113' ' ' LEU . 3.0 m120 -108.81 -19.08 13.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.311 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 85' ' ' VAL . . . . . 0.562 ' HB ' ' CG2' ' F' ' 78' ' ' ILE . 50.4 t -80.71 132.02 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.206 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 86' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' F' ' 152' ' ' ALA . 0.4 OUTLIER -76.55 135.0 39.26 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.255 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.27 165.15 6.18 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.923 0.392 . . . . 0.0 111.691 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . 0.439 ' H ' ' HG ' ' F' ' 88' ' ' LEU . 0.1 OUTLIER -65.76 171.78 4.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.018 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 89' ' ' GLN . . . . . 0.493 ' OE1' ' HB3' ' F' ' 91' ' ' SER . 8.0 pt20 -72.56 175.74 6.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.427 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.02 -21.22 57.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.002 0.43 . . . . 0.0 111.474 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 91' ' ' SER . . . . . 0.493 ' HB3' ' OE1' ' F' ' 89' ' ' GLN . 32.1 t -81.02 67.6 6.99 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 92' ' ' ALA . . . . . 0.446 ' HA ' ' OG ' ' F' ' 95' ' ' SER . . . -72.35 -9.67 58.81 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.576 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.04 -22.86 64.94 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.683 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.47 6.71 2.47 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.86 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 95' ' ' SER . . . . . 0.69 ' HA ' ' HB3' ' F' ' 147' ' ' ALA . 30.8 p -93.71 150.78 20.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.854 0.359 . . . . 0.0 110.674 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.71 167.18 18.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.64 165.19 14.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.314 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 98' ' ' ASN . . . . . 0.527 ' HA ' ' OG1' ' F' ' 140' ' ' THR . 85.1 m-20 63.2 45.5 5.06 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.489 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 99' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' F' ' 143' ' ' ALA . 3.4 p -170.65 131.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.72 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.02 -175.94 21.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.511 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 101' ' ' VAL . . . . . . . . . . . . . 76.4 t -104.19 91.9 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 122.979 0.512 . . . . 0.0 111.656 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 102' ' ' GLN . . . . . 0.552 ' HA ' ' HA ' ' F' ' 85' ' ' VAL . 0.0 OUTLIER -67.88 131.18 45.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.898 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 103' ' ' ILE . . . . . 0.52 HD12 ' O ' ' F' ' 84' ' ' ASN . 0.7 OUTLIER -99.45 110.52 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.497 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 104' ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 5.5 tp -91.15 149.98 21.57 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.656 0.265 . . . . 0.0 111.078 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.94 174.55 5.84 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.631 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 106' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' F' ' 106' ' ' ARG . 1.5 ttt180 -72.45 -18.46 61.69 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.75 0.309 . . . . 0.0 111.075 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 46.2 p -69.35 -9.66 54.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.999 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.0 -48.33 0.96 Allowed Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.671 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.96 163.57 15.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.779 0.323 . . . . 0.0 111.089 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 110' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -70.52 125.59 27.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 111' ' ' LEU . . . . . 0.54 HD11 ' CB ' ' F' ' 73' ' ' PHE . 0.0 OUTLIER -65.43 147.7 52.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.419 0.628 . . . . 0.0 110.558 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 112' ' ' THR . . . . . 0.705 ' HB ' HG21 ' F' ' 117' ' ' THR . 0.2 OUTLIER -74.16 144.67 44.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.12 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 113' ' ' LEU . . . . . 0.748 HD13 ' HA ' ' F' ' 84' ' ' ASN . 10.2 mp -100.35 89.97 4.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 110.644 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 114' ' ' ASP . . . . . 0.436 ' HB2' ' CG2' ' F' ' 117' ' ' THR . 4.1 m-20 -142.41 11.41 1.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.691 0.281 . . . . 0.0 111.6 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . 0.448 ' O ' ' HB1' ' F' ' 72' ' ' ALA . . . 96.91 -78.16 0.69 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.611 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 116' ' ' ALA . . . . . 0.465 ' CB ' HG21 ' E' ' 4' ' ' THR . . . -104.29 61.61 0.73 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.966 0.412 . . . . 0.0 111.62 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 117' ' ' THR . . . . . 0.705 HG21 ' HB ' ' F' ' 112' ' ' THR . 17.6 p -93.42 95.84 9.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.126 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.77 110.0 5.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.794 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.4 -72.91 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.833 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.49 113.04 25.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.665 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.36 97.42 8.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.25 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.47 132.66 37.52 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.787 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 21.8 m -60.81 146.15 47.26 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.762 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . 0.463 ' HB3' HG23 ' F' ' 63' ' ' THR . 0.2 OUTLIER -85.51 156.6 20.71 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.547 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 125' ' ' ASN . . . . . 0.535 ' HB3' ' HB3' ' C' ' 116' ' ' ALA . 32.6 m120 -137.91 142.71 40.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.474 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.9 113.73 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.704 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 127' ' ' GLY . . . . . 0.612 ' HA3' ' HB ' ' B' ' 4' ' ' THR . . . 128.44 -90.01 0.32 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.693 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 128' ' ' THR . . . . . 0.439 ' HB ' ' HD3' ' C' ' 155' ' ' LYS . 6.2 m -124.92 152.86 43.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.704 0.287 . . . . 0.0 110.751 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 129' ' ' ASN . . . . . 0.545 ' HB3' ' HB2' ' F' ' 58' ' ' LEU . 17.0 t-20 -123.09 147.58 46.59 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.926 0.394 . . . . 0.0 111.113 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 130' ' ' THR . . . . . 0.657 ' OG1' HD12 ' C' ' 74' ' ' LEU . 4.3 m -126.16 135.69 51.96 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.03 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 131' ' ' ILE . . . . . . . . . . . . . 58.6 mt -114.05 115.68 45.38 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 132' ' ' PRO . . . . . 0.558 ' HB3' ' H ' ' C' ' 77' ' ' ALA . 7.5 Cg_endo -81.7 115.71 2.81 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.604 1.536 . . . . 0.0 112.572 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.57 150.79 46.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.823 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 134' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' F' ' 52' ' ' VAL . 1.2 mt-30 -142.39 166.72 23.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.086 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 135' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' F' ' 102' ' ' GLN . . . -158.21 102.9 1.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.972 0.415 . . . . 0.0 111.587 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 136' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' F' ' 51' ' ' ALA . 0.2 OUTLIER -94.67 -173.46 3.02 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.397 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 137' ' ' TYR . . . . . 0.601 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 3.8 m-85 -100.76 152.82 20.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.115 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 138' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' F' ' 47' ' ' ALA . 0.2 OUTLIER -147.28 160.8 42.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.046 -179.227 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 139' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -126.88 149.63 49.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.86 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 140' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' F' ' 98' ' ' ASN . 0.0 OUTLIER -115.33 27.83 9.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.491 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.39 66.76 0.2 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.948 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . 63.0 88.57 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.615 0.207 . . . . 0.0 110.747 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 143' ' ' ALA . . . . . 0.469 ' CB ' ' HB ' ' F' ' 99' ' ' VAL . . . -60.22 156.88 14.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.728 0.299 . . . . 0.0 111.431 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 144' ' ' THR . . . . . 0.548 ' HB ' ' CD ' ' F' ' 145' ' ' PRO . 77.4 p -112.17 173.07 3.06 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.243 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 145' ' ' PRO . . . . . 0.548 ' CD ' ' HB ' ' F' ' 144' ' ' THR . 1.4 Cg_endo -84.6 145.22 10.36 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.543 2.162 . . . . 0.0 111.922 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.42 -112.77 0.55 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.495 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 147' ' ' ALA . . . . . 0.69 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -124.98 167.68 14.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.903 0.382 . . . . 0.0 111.337 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 148' ' ' ALA . . . . . 0.426 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -157.16 57.49 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.403 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.89 132.71 36.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.514 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.41 163.12 28.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.008 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.44 125.63 1.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.205 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 152' ' ' ALA . . . . . 0.767 ' HB2' HD21 ' F' ' 86' ' ' LEU . . . -154.57 165.79 35.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.215 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.83 163.17 12.71 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -119.03 134.53 55.14 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.116 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 155' ' ' LYS . . . . . 0.693 ' HB3' ' HB3' ' F' ' 72' ' ' ALA . 0.0 OUTLIER -95.51 166.21 11.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.951 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.23 112.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.771 0.32 . . . . 0.0 111.684 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 157' ' ' GLN . . . . . 0.627 ' HB3' ' HB3' ' F' ' 70' ' ' ALA . 0.2 OUTLIER -88.74 138.79 31.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.264 0.554 . . . . 0.0 110.404 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 158' ' ' TYR . . . . . 0.581 ' HE2' HG11 ' F' ' 17' ' ' VAL . 22.5 m-85 -127.63 113.2 15.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.503 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.924 179.981 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.552 0.215 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.514 HG21 ' HB2' ' B' ' 18' ' ' ASN . 57.4 m -111.23 101.02 9.55 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.46 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.651 HG21 ' HA2' ' E' ' 127' ' ' GLY . 60.6 m -86.71 131.93 34.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.56 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.788 HG23 HG23 ' B' ' 156' ' ' VAL . 0.0 OUTLIER -161.18 168.04 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.525 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -100.1 118.78 37.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.539 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.4 -56.31 6.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.748 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.94 -145.38 4.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.873 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.831 HG23 HG23 ' B' ' 153' ' ' THR . 0.0 OUTLIER -145.0 142.05 29.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.933 0.397 . . . . 0.0 111.284 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.2 t -121.65 107.32 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.176 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.75 111.0 21.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.386 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.508 ' CD1' HD11 ' B' ' 34' ' ' LEU . 32.0 m-85 -87.61 113.52 23.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.775 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.12 118.61 36.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.412 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.56 175.53 39.77 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.909 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.598 ' HG3' ' HA ' ' B' ' 147' ' ' ALA . 0.1 OUTLIER -151.27 162.14 41.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.946 0.403 . . . . 0.0 110.31 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.75 HG23 ' HB2' ' B' ' 148' ' ' ALA . 2.2 t -114.94 119.43 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.29 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.539 HG11 ' NE2' ' B' ' 36' ' ' GLN . 0.3 OUTLIER -121.33 168.14 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.818 0.342 . . . . 0.0 111.064 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.459 ' HA ' HG22 ' B' ' 39' ' ' THR . 1.3 t-20 -68.46 -175.27 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.004 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.593 ' O ' HG21 ' A' ' 65' ' ' VAL . . . -91.14 52.66 2.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.93 -15.74 1.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.335 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -176.88 147.6 0.6 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.975 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.508 ' HA ' HG21 ' A' ' 17' ' ' VAL . . . -152.62 110.08 3.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.046 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -52.97 159.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.032 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.37 164.48 14.31 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.578 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.07 -52.29 65.89 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.397 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.43 11.92 66.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.858 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.5 t -96.23 -30.79 13.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.989 0.423 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.421 HG23 ' H ' ' A' ' 28' ' ' VAL . 11.4 t -49.88 -71.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.311 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.54 104.4 15.27 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.02 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.534 HE22 ' HA ' ' A' ' 56' ' ' ILE . 41.6 mt-30 -112.23 140.41 46.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.104 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.79 110.16 21.47 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.067 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.18 108.35 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.167 0.508 . . . . 0.0 110.42 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.59 112.5 22.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.638 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.549 HD21 ' CG2' ' A' ' 101' ' ' VAL . 5.2 mp -81.15 -41.82 21.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.572 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.67 -171.08 21.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.649 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -93.6 145.95 24.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.565 0.222 . . . . 0.0 110.912 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.515 HG22 ' H ' ' A' ' 38' ' ' ARG . 5.0 p -124.86 169.88 15.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.95 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.515 ' H ' HG22 ' A' ' 37' ' ' VAL . 5.2 mtt-85 -98.95 121.42 40.88 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.717 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -61.87 -31.06 71.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.738 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.56 -39.3 84.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.999 0.428 . . . . 0.0 110.81 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.3 m -81.32 -10.35 59.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.204 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.741 ' O ' ' HB2' ' A' ' 143' ' ' ALA . 0.6 OUTLIER -129.36 40.51 3.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.556 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.605 ' HA ' ' H ' ' A' ' 143' ' ' ALA . . . -111.86 10.88 20.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.366 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.53 145.55 48.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.329 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 140' ' ' THR . 18.2 tt0 -63.34 121.17 13.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 111.159 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.02 14.54 33.51 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.15 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.699 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -72.26 121.2 19.0 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 p -129.97 133.84 47.06 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.893 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 57.8 m -112.52 -166.75 1.11 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.625 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.2 t -59.08 149.48 27.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.818 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.82 153.57 17.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.347 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.649 HG22 ' HB3' ' A' ' 135' ' ' ALA . 3.7 m -103.37 130.31 53.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.98 121.53 6.57 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.619 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.496 ' HD1' HG23 ' A' ' 52' ' ' VAL . 52.3 p90 -153.7 136.41 15.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.779 0.323 . . . . 0.0 110.955 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ILE . 24.7 p30 -133.59 141.3 47.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.679 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.639 HG21 HD12 ' A' ' 131' ' ' ILE . 1.2 tt -85.13 126.49 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.622 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.609 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.1 OUTLIER -75.77 119.39 19.72 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.773 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -130.69 87.31 2.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.316 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.721 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 5.0 p30 -77.18 173.72 11.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.981 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.519 ' HB3' ' HE ' ' B' ' 38' ' ' ARG . 41.5 m-20 62.82 66.38 0.76 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 34.4 m -115.64 161.96 17.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.732 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.51 ' HA ' ' OD1' ' A' ' 126' ' ' ASN . 0.2 OUTLIER -145.94 157.82 43.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.289 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.481 HG23 ' HA ' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -107.5 -16.74 14.29 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.13 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.39 -33.63 32.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.062 0.458 . . . . 0.0 111.763 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.593 HG21 ' O ' ' A' ' 19' ' ' ALA . 20.1 t -75.21 -41.56 44.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.665 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.91 146.75 29.15 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.558 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.83 -39.37 3.73 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.895 0.378 . . . . 0.0 110.92 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.31 159.53 15.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.477 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.601 ' HB3' ' HB ' ' A' ' 122' ' ' THR . . . -147.2 118.88 8.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.616 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -96.84 140.72 30.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.096 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 131' ' ' ILE . 3.1 t -118.43 139.71 44.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.798 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.4 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -140.54 133.92 29.86 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.523 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.792 ' HD2' HD13 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -101.26 138.04 38.8 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.575 0.226 . . . . 0.0 111.15 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.734 HD21 HG21 ' D' ' 130' ' ' THR . 6.6 tt -100.99 91.02 4.38 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.001 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.37 -167.37 11.32 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.87 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -116.75 159.52 22.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.64 0.257 . . . . 0.0 110.752 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB2' HG23 ' A' ' 83' ' ' THR . . . -83.96 137.96 33.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.996 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 82' ' ' HIS . 9.0 tt -77.17 -40.52 29.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.88 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.603 ' HB2' HG21 ' A' ' 140' ' ' THR . 0.1 OUTLIER -141.18 55.24 1.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.852 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' D' ' 106' ' ' ARG . . . 52.85 -84.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.081 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -60.1 -16.12 39.58 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.577 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.46 ' O ' HG22 ' A' ' 78' ' ' ILE . 24.5 m80 -100.6 56.74 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.597 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.526 HG23 ' HB2' ' A' ' 77' ' ' ALA . 1.1 m -71.36 -22.46 61.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.537 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 8.6 p-10 -57.23 -18.68 17.12 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.338 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 138' ' ' PHE . 11.6 t -115.19 133.31 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.213 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.912 HD12 HD22 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -72.93 154.12 40.69 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.347 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.601 ' N ' HD23 ' A' ' 86' ' ' LEU . . . -90.72 -161.37 0.8 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.846 0.355 . . . . 0.0 111.793 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.31 6.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.974 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.65 -83.92 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.312 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.26 20.53 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.415 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.754 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 1.5 m -86.59 79.34 8.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.75 -31.51 38.42 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.916 0.389 . . . . 0.0 111.672 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' D' ' 36' ' ' GLN . . . -128.09 54.53 1.72 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.615 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.89 -17.27 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.975 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.754 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 0.9 OUTLIER -89.47 177.19 6.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.797 0.332 . . . . 0.0 110.622 179.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.69 175.24 8.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.777 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -137.51 137.98 39.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.269 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 97' ' ' THR . 74.0 m-80 71.69 17.64 5.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.434 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.99 148.93 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.728 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.28 -176.74 35.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.46 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.549 ' CG2' HD21 ' A' ' 34' ' ' LEU . 7.7 p -125.58 111.02 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 122.993 0.517 . . . . 0.0 111.718 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.612 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 0.9 OUTLIER -81.53 147.74 29.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.873 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.792 HD13 ' HD2' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -123.76 115.94 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.489 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -88.7 140.55 29.34 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.621 0.248 . . . . 0.0 111.031 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . 2.1 t70 -89.37 152.0 21.75 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.68 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.645 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -71.74 -21.08 61.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.816 0.341 . . . . 0.0 111.101 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.61 ' HB ' ' HA ' ' A' ' 120' ' ' SER . 5.8 t -62.89 -21.94 66.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.064 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.69 -83.09 0.19 Allowed Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.611 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.69 170.67 15.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.776 0.322 . . . . 0.0 111.098 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.739 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -74.82 138.64 42.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.224 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.617 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 5.1 tp -94.53 153.38 17.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.343 0.592 . . . . 0.0 110.568 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.782 HG22 HG21 ' A' ' 117' ' ' THR . 6.2 t -93.68 148.24 22.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.171 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.912 HD22 HD12 ' A' ' 86' ' ' LEU . 1.4 mp -89.51 64.78 6.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.77 0.319 . . . . 0.0 110.771 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.557 ' HB2' ' OG1' ' A' ' 117' ' ' THR . 0.5 OUTLIER -95.04 -16.1 22.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.606 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.604 ' HA3' ' HG1' ' D' ' 130' ' ' THR . . . 104.44 -56.28 0.56 Allowed Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.66 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' D' ' 125' ' ' ASN . . . -103.56 29.08 5.95 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.994 0.426 . . . . 0.0 111.667 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.782 HG21 HG22 ' A' ' 112' ' ' THR . 3.4 m -87.19 65.85 9.01 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.105 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.519 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 48.3 m-85 -77.69 73.45 4.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.5 70.78 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.61 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 0.7 OUTLIER -148.63 126.09 11.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.681 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.05 53.21 2.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.25 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -74.06 128.34 35.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.75 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.36 117.89 25.45 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.703 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.51 134.76 33.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.719 0.295 . . . . 0.0 110.538 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.481 ' HA ' HG23 ' A' ' 63' ' ' THR . 0.3 OUTLIER -129.21 163.1 26.33 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.672 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' A' ' 62' ' ' ASP . 1.5 t30 -67.61 125.33 25.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.669 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.61 -141.04 12.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.687 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 6.3 m -101.73 92.47 4.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.647 0.26 . . . . 0.0 110.729 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . 0.541 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 1.2 t30 -76.54 145.03 39.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.926 0.393 . . . . 0.0 111.13 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.609 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -134.63 131.81 38.24 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.049 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.687 HD11 HG12 ' A' ' 156' ' ' VAL . 28.4 mt -87.43 109.82 29.03 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.645 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.4 Cg_endo -81.65 112.12 2.38 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.578 1.518 . . . . 0.0 112.608 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.28 138.22 51.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 28.2 mt-30 -110.1 157.5 19.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.062 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.649 ' HB3' HG22 ' A' ' 52' ' ' VAL . . . -152.68 107.91 3.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.97 0.414 . . . . 0.0 111.585 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -102.51 174.4 5.92 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.36 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 0.6 OUTLIER -85.96 120.88 27.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.083 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.526 ' HB3' HG11 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -117.67 139.6 50.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.076 -179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.699 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -129.88 145.66 51.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.914 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' THR . . . . . 0.603 HG21 ' HB2' ' A' ' 79' ' ' ASP . 16.5 p -104.43 -53.4 2.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.483 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.76 -121.48 3.26 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.989 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.12 112.83 24.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.517 0.199 . . . . 0.0 110.719 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 42' ' ' LEU . . . -61.68 150.85 35.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.805 0.336 . . . . 0.0 111.519 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.558 HG23 ' HD2' ' A' ' 145' ' ' PRO . 60.0 m -126.79 151.49 73.67 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.26 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.558 ' HD2' HG23 ' A' ' 144' ' ' THR . 1.4 Cg_endo -83.03 140.23 9.92 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.573 2.182 . . . . 0.0 111.963 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.9 -138.1 6.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.539 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -87.21 144.99 26.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.898 0.38 . . . . 0.0 111.367 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.73 38.87 1.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.527 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.05 153.48 22.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.505 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.588 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -161.87 171.28 17.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.04 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.42 126.8 7.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.239 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' A' ' 86' ' ' LEU . . . -125.35 142.85 51.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.249 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.86 133.17 34.89 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.482 ' HD1' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -86.45 127.87 34.89 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.119 0.485 . . . . 0.0 110.079 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.49 150.51 29.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.962 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.687 HG12 HD11 ' A' ' 131' ' ' ILE . 14.2 m -136.23 144.48 32.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.863 0.363 . . . . 0.0 111.571 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -136.19 132.76 36.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.32 0.581 . . . . 0.0 110.386 -179.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.494 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 5.5 m-85 -117.41 119.77 36.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.516 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' C' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.23 0.062 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.19 64.9 1.55 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.086 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' THR . . . . . 0.532 HG21 ' HB2' ' C' ' 18' ' ' ASN . 59.0 m -111.21 100.99 9.53 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.05 0.452 . . . . 0.0 111.536 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.661 HG21 ' HA2' ' F' ' 127' ' ' GLY . 60.1 m -86.72 131.91 34.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.545 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.809 HG23 HG23 ' C' ' 156' ' ' VAL . 0.0 OUTLIER -161.09 168.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.532 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.17 118.75 37.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.571 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.32 -56.32 6.97 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.759 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.97 -145.36 4.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.923 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' THR . . . . . 0.82 HG23 HG23 ' C' ' 153' ' ' THR . 0.0 OUTLIER -144.99 142.1 29.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.927 0.394 . . . . 0.0 111.302 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.66 107.37 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.198 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.81 110.95 21.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.365 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . 0.506 ' CD1' HD11 ' C' ' 34' ' ' LEU . 31.8 m-85 -87.58 113.58 23.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.794 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 118.55 36.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.338 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.51 175.6 39.73 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.973 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.615 ' HG3' ' HA ' ' C' ' 147' ' ' ALA . 0.1 OUTLIER -151.36 162.08 41.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.967 0.413 . . . . 0.0 110.302 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.732 HG23 ' HB2' ' C' ' 148' ' ' ALA . 2.2 t -114.95 119.38 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.268 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.533 HG11 ' NE2' ' C' ' 36' ' ' GLN . 0.3 OUTLIER -121.28 168.1 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.887 0.375 . . . . 0.0 111.017 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . 0.514 ' HB2' HG21 ' A' ' 3' ' ' THR . 1.3 t-20 -68.54 -175.25 0.63 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.91 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.606 ' O ' HG21 ' B' ' 65' ' ' VAL . . . -91.1 52.61 2.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.233 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.95 -15.64 1.32 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.39 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.798 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER -176.95 147.63 0.59 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.965 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.494 ' HA ' HG21 ' B' ' 17' ' ' VAL . . . -152.63 110.04 3.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.084 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' B' ' 58' ' ' LEU . 0.3 OUTLIER -53.0 159.07 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.39 164.47 14.3 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.563 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.99 -52.39 65.44 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.369 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.33 11.91 66.35 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.916 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 18.4 t -96.25 -30.78 13.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.894 0.378 . . . . 0.0 110.908 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.408 ' H ' HG23 ' B' ' 28' ' ' VAL . 11.3 t -49.89 -71.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.341 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.55 104.36 15.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.012 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' GLN . . . . . 0.541 HE22 ' HA ' ' B' ' 56' ' ' ILE . 41.8 mt-30 -112.21 140.34 46.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.082 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.82 110.13 21.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.054 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.13 108.42 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.157 0.503 . . . . 0.0 110.44 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.66 112.43 22.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.63 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.544 HD21 ' CG2' ' B' ' 101' ' ' VAL . 5.2 mp -81.12 -41.82 21.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.625 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.76 -171.05 21.51 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.603 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' GLN . . . . . 0.549 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 2.4 mt-30 -93.69 145.88 24.25 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.602 0.239 . . . . 0.0 110.908 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.516 HG22 ' H ' ' B' ' 38' ' ' ARG . 5.0 p -124.8 169.89 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.94 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.519 ' HE ' ' HB3' ' A' ' 60' ' ' ASP . 5.1 mtt-85 -98.95 121.5 40.99 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.68 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' THR . . . . . 0.541 ' O ' ' HB2' ' B' ' 43' ' ' ALA . 0.6 OUTLIER -62.01 -31.0 71.34 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.705 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.28 84.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.91 0.386 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 70.9 m -81.31 -10.39 59.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.149 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.755 ' O ' ' HB2' ' B' ' 143' ' ' ALA . 0.6 OUTLIER -129.27 40.48 3.61 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.59 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ALA . . . . . 0.617 ' HA ' ' H ' ' B' ' 143' ' ' ALA . . . -111.86 10.94 20.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.333 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.56 145.52 48.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.326 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' B' ' 140' ' ' THR . 18.2 tt0 -63.3 121.15 13.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.81 0.338 . . . . 0.0 111.133 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.05 14.49 33.56 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.163 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' B' ' 139' ' ' ALA . . . -72.36 121.19 19.08 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 15.1 p -130.01 133.8 47.0 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.86 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 57.8 m -112.47 -166.68 1.1 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.592 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 36.2 t -59.07 149.52 27.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.76 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.84 153.59 17.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.397 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' VAL . . . . . 0.655 HG22 ' HB3' ' B' ' 135' ' ' ALA . 3.7 m -103.42 130.31 53.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.92 121.45 6.53 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.64 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . 0.492 ' HD1' HG23 ' B' ' 52' ' ' VAL . 52.1 p90 -153.64 136.41 15.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.816 0.341 . . . . 0.0 110.962 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' B' ' 131' ' ' ILE . 24.8 p30 -133.58 141.31 47.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.707 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.649 HG21 HD12 ' B' ' 131' ' ' ILE . 1.2 tt -85.19 126.45 40.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.59 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . 0.609 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.1 OUTLIER -75.79 119.38 19.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.711 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 0.2 OUTLIER -130.64 87.34 2.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.299 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ASN . . . . . 0.721 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 5.1 p30 -77.29 173.71 11.59 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.955 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ASP . . . . . 0.53 ' HB3' ' HE ' ' C' ' 38' ' ' ARG . 41.6 m-20 62.85 66.43 0.75 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.878 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' CYS . . . . . 0.798 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 34.4 m -115.71 161.96 17.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.736 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ASP . . . . . 0.504 ' HA ' ' OD1' ' B' ' 126' ' ' ASN . 0.2 OUTLIER -145.91 157.86 43.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.35 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.476 HG23 ' HA ' ' B' ' 125' ' ' ASN . 0.0 OUTLIER -107.54 -16.71 14.29 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.13 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.4 -33.7 32.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.057 0.456 . . . . 0.0 111.737 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' VAL . . . . . 0.606 HG21 ' O ' ' B' ' 19' ' ' ALA . 20.0 t -75.12 -41.62 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.675 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.94 146.75 29.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.55 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.75 -39.43 3.74 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.893 0.378 . . . . 0.0 110.951 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.31 159.55 15.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.456 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' ALA . . . . . 0.603 ' HB3' ' HB ' ' B' ' 122' ' ' THR . . . -147.18 118.88 8.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.608 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.524 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -96.84 140.79 30.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.025 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.473 HG11 HG21 ' B' ' 131' ' ' ILE . 3.1 t -118.52 139.69 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.762 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.52 133.93 29.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.595 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' PHE . . . . . 0.771 ' HD2' HD13 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -101.28 138.06 38.8 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.623 0.249 . . . . 0.0 111.116 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.714 HD21 HG21 ' E' ' 130' ' ' THR . 6.6 tt -101.05 91.12 4.41 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.003 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.38 -167.4 11.32 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.886 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' THR . . . . . 0.659 ' O ' ' HA ' ' B' ' 86' ' ' LEU . 0.3 OUTLIER -116.7 159.45 22.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.58 0.229 . . . . 0.0 110.761 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.517 ' HB2' HG23 ' B' ' 83' ' ' THR . . . -83.84 137.92 33.46 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.013 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . 0.452 HG22 ' O ' ' B' ' 82' ' ' HIS . 9.0 tt -77.16 -40.47 29.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.894 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ASP . . . . . 0.603 ' HB2' HG21 ' B' ' 140' ' ' THR . 0.1 OUTLIER -141.26 55.26 1.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.786 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' E' ' 106' ' ' ARG . . . 52.93 -84.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.008 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' B' ' 79' ' ' ASP . . . -60.07 -16.11 39.27 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.62 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' HIS . . . . . 0.452 ' O ' HG22 ' B' ' 78' ' ' ILE . 24.2 m80 -100.54 56.68 0.9 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.925 0.393 . . . . 0.0 110.619 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' THR . . . . . 0.517 HG23 ' HB2' ' B' ' 77' ' ' ALA . 1.1 m -71.33 -22.42 61.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.587 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . 0.738 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 8.6 p-10 -57.23 -18.71 17.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.305 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' B' ' 138' ' ' PHE . 11.5 t -115.18 133.45 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.211 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' LEU . . . . . 0.923 HD12 HD22 ' B' ' 113' ' ' LEU . 0.8 OUTLIER -73.01 154.03 40.66 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.352 179.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.601 ' N ' HD23 ' B' ' 86' ' ' LEU . . . -90.69 -161.34 0.79 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.823 0.344 . . . . 0.0 111.793 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.23 6.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.016 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.65 -83.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.31 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.26 20.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.453 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' SER . . . . . 0.77 ' HB2' ' HB2' ' B' ' 95' ' ' SER . 1.5 m -86.53 79.35 8.97 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.71 -31.56 38.36 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.808 0.337 . . . . 0.0 111.642 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' E' ' 36' ' ' GLN . . . -128.02 54.4 1.72 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.663 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.87 -17.3 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.934 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' SER . . . . . 0.77 ' HB2' ' HB2' ' B' ' 91' ' ' SER . 0.9 OUTLIER -89.35 177.21 6.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.768 0.318 . . . . 0.0 110.703 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.71 175.31 8.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.785 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' B' ' 98' ' ' ASN . 0.2 OUTLIER -137.61 137.94 39.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.25 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' B' ' 97' ' ' THR . 74.0 m-80 71.78 17.6 5.38 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.444 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.95 149.0 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.672 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.44 -176.76 35.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.441 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.544 ' CG2' HD21 ' B' ' 34' ' ' LEU . 7.7 p -125.56 111.1 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 122.974 0.51 . . . . 0.0 111.678 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' GLN . . . . . 0.609 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 0.9 OUTLIER -81.67 147.68 29.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.789 -179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' ILE . . . . . 0.771 HD13 ' HD2' ' B' ' 73' ' ' PHE . 0.9 OUTLIER -123.64 115.91 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.54 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' LEU . . . . . 0.709 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 0.4 OUTLIER -88.68 140.5 29.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.614 0.245 . . . . 0.0 111.036 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' ASP . . . . . 0.601 ' HB2' ' HB2' ' B' ' 111' ' ' LEU . 2.1 t70 -89.31 152.01 21.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.708 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' ARG . . . . . 0.627 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -71.8 -21.03 61.76 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.752 0.31 . . . . 0.0 111.027 179.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' THR . . . . . 0.614 ' HB ' ' HA ' ' B' ' 120' ' ' SER . 5.8 t -62.91 -21.94 66.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.007 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.64 -83.02 0.19 Allowed Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.662 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.69 170.72 15.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.767 0.318 . . . . 0.0 111.05 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.709 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -74.94 138.68 42.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.186 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' B' ' 105' ' ' ASP . 5.1 tp -94.53 153.47 17.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.385 0.612 . . . . 0.0 110.571 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . 0.805 HG22 HG21 ' B' ' 117' ' ' THR . 6.2 t -93.68 148.28 22.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.105 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.923 HD22 HD12 ' B' ' 86' ' ' LEU . 1.4 mp -89.64 64.9 6.74 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.783 0.325 . . . . 0.0 110.722 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ASP . . . . . 0.556 ' HB2' ' OG1' ' B' ' 117' ' ' THR . 0.5 OUTLIER -95.07 -16.07 22.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.62 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' GLY . . . . . 0.607 ' HA3' ' HG1' ' E' ' 130' ' ' THR . . . 104.43 -56.24 0.57 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.637 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' E' ' 125' ' ' ASN . . . -103.61 29.0 6.03 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.029 0.442 . . . . 0.0 111.714 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . 0.805 HG21 HG22 ' B' ' 112' ' ' THR . 3.4 m -87.08 65.85 9.1 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.142 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' PHE . . . . . 0.524 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . 48.3 m-85 -77.65 73.4 4.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.772 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.53 70.86 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' SER . . . . . 0.614 ' HA ' ' HB ' ' B' ' 107' ' ' THR . 0.7 OUTLIER -148.69 126.11 11.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.673 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.07 53.18 2.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.232 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' B' ' 69' ' ' ALA . 0.2 OUTLIER -73.97 128.28 35.1 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.732 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.33 117.97 25.47 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.675 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.51 134.8 33.76 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.548 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' ASN . . . . . 0.476 ' HA ' HG23 ' B' ' 63' ' ' THR . 0.3 OUTLIER -129.28 163.06 26.49 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.637 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' B' ' 62' ' ' ASP . 1.5 t30 -67.58 125.43 26.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.66 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.58 -141.06 12.22 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.664 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 6.3 m -101.74 92.34 4.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.673 0.273 . . . . 0.0 110.788 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ASN . . . . . 0.544 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 1.2 t30 -76.44 145.01 39.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.164 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.609 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.0 OUTLIER -134.62 131.81 38.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.073 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' ILE . . . . . 0.677 HD11 HG12 ' B' ' 156' ' ' VAL . 28.4 mt -87.41 109.8 28.86 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' PRO . . . . . 0.627 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.6 Cg_endo -81.52 112.06 2.4 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 121.645 1.563 . . . . 0.0 112.608 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.3 138.24 51.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.875 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' B' ' 52' ' ' VAL . 28.1 mt-30 -110.13 157.48 19.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.035 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . 0.655 ' HB3' HG22 ' B' ' 52' ' ' VAL . . . -152.66 107.84 3.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.905 0.383 . . . . 0.0 111.602 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -102.5 174.38 5.93 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.376 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . 0.475 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 0.6 OUTLIER -85.97 120.87 27.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.105 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . 0.516 ' HB3' HG11 ' B' ' 85' ' ' VAL . 0.2 OUTLIER -117.66 139.57 50.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.062 -179.181 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' B' ' 47' ' ' ALA . . . -129.86 145.57 51.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.913 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' THR . . . . . 0.603 HG21 ' HB2' ' B' ' 79' ' ' ASP . 16.7 p -104.32 -53.41 2.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.513 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.75 -121.54 3.27 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.027 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.04 112.88 24.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.573 0.225 . . . . 0.0 110.729 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' B' ' 42' ' ' LEU . . . -61.69 150.86 35.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.783 0.325 . . . . 0.0 111.481 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.554 HG23 ' HD2' ' B' ' 145' ' ' PRO . 59.6 m -126.79 151.51 73.72 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.274 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' B' ' 144' ' ' THR . 1.3 Cg_endo -83.06 140.24 9.9 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.626 2.218 . . . . 0.0 111.945 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.91 -138.09 6.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.518 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' ALA . . . . . 0.598 ' HA ' ' HG3' ' A' ' 15' ' ' GLU . . . -87.2 144.99 26.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.925 0.393 . . . . 0.0 111.351 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' ALA . . . . . 0.75 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -140.7 38.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.566 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.09 153.59 21.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.546 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' ALA . . . . . 0.607 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -161.88 171.24 18.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.041 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.45 126.79 7.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.251 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' ALA . . . . . 0.541 ' HB2' ' CD1' ' B' ' 86' ' ' LEU . . . -125.32 142.78 51.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.259 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.831 HG23 HG23 ' A' ' 9' ' ' THR . 0.5 OUTLIER -89.83 133.18 34.87 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' PHE . . . . . 0.403 ' HD1' ' HA ' ' B' ' 154' ' ' PHE . 0.0 OUTLIER -86.41 127.85 34.88 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.118 0.485 . . . . 0.0 110.137 -179.024 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' LYS . . . . . 0.4 ' HE3' HD12 ' B' ' 74' ' ' LEU . 29.1 mmtt -111.54 150.53 29.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.882 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' VAL . . . . . 0.788 HG23 HG23 ' A' ' 5' ' ' VAL . 14.3 m -136.19 144.47 33.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.614 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -136.17 132.75 36.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.253 0.549 . . . . 0.0 110.442 -179.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' TYR . . . . . 0.495 ' OH ' ' HB3' ' B' ' 21' ' ' CYS . 5.5 m-85 -117.45 119.7 35.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.514 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.881 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 1' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' D' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 111.123 0.045 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.26 65.02 1.5 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.598 0.237 . . . . 0.0 110.96 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 3' ' ' THR . . . . . 0.525 HG21 ' HB2' ' D' ' 18' ' ' ASN . 57.2 m -111.23 101.0 9.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.471 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 4' ' ' THR . . . . . 0.512 ' HA ' ' HG2' ' D' ' 157' ' ' GLN . 61.6 m -86.63 131.85 34.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.67 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.792 HG23 HG23 ' D' ' 156' ' ' VAL . 0.0 OUTLIER -161.11 168.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.607 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.09 118.68 36.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.616 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.26 -56.38 6.96 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.752 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.97 -145.38 4.66 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.909 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' THR . . . . . 0.812 HG23 HG23 ' D' ' 153' ' ' THR . 0.0 OUTLIER -145.02 142.06 29.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.399 . . . . 0.0 111.292 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' VAL . . . . . 0.4 HG21 ' HZ ' ' D' ' 73' ' ' PHE . 44.0 t -121.59 107.33 19.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.211 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.73 110.97 21.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.424 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' PHE . . . . . 0.51 ' CD1' HD11 ' D' ' 34' ' ' LEU . 32.0 m-85 -87.59 113.59 23.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.713 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.19 118.53 36.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.379 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.54 175.58 39.76 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.974 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' GLU . . . . . 0.608 ' HG3' ' HA ' ' D' ' 147' ' ' ALA . 0.1 OUTLIER -151.36 162.16 41.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.967 0.413 . . . . 0.0 110.263 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' VAL . . . . . 0.743 HG23 ' HB2' ' D' ' 148' ' ' ALA . 2.2 t -115.08 119.48 61.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.153 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' VAL . . . . . 0.531 HG11 ' NE2' ' D' ' 36' ' ' GLN . 0.3 OUTLIER -121.31 168.1 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.808 0.337 . . . . 0.0 111.063 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' ASN . . . . . 0.532 ' HB2' HG21 ' B' ' 3' ' ' THR . 1.3 t-20 -68.5 -175.24 0.63 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.976 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . 0.602 ' O ' HG21 ' C' ' 65' ' ' VAL . . . -91.11 52.63 2.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.93 -15.76 1.32 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.361 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER -176.91 147.64 0.6 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.926 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . 0.507 ' HA ' HG21 ' C' ' 17' ' ' VAL . . . -152.59 110.04 3.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.097 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' C' ' 58' ' ' LEU . 0.3 OUTLIER -53.08 159.07 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.01 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -90.32 164.46 14.34 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.614 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -57.01 -52.39 65.47 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.357 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.38 11.97 66.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.912 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 18.3 t -96.29 -30.78 13.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.889 0.376 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 11.2 t -49.76 -71.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.341 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.52 104.31 15.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.086 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' GLN . . . . . 0.532 HE22 ' HA ' ' C' ' 56' ' ' ILE . 41.7 mt-30 -112.19 140.36 46.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.113 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.8 110.07 21.35 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.142 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -108.04 108.4 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.118 0.485 . . . . 0.0 110.386 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.67 112.42 22.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.687 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' LEU . . . . . 0.538 HD21 ' CG2' ' C' ' 101' ' ' VAL . 5.3 mp -81.03 -41.8 22.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.699 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.72 -171.12 21.61 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.604 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 2.4 mt-30 -93.67 145.91 24.21 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.62 0.247 . . . . 0.0 110.913 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.51 HG22 ' H ' ' C' ' 38' ' ' ARG . 5.0 p -124.84 169.94 15.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.94 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' ARG . . . . . 0.53 ' HE ' ' HB3' ' B' ' 60' ' ' ASP . 5.2 mtt-85 -98.93 121.37 40.79 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.71 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' C' ' 43' ' ' ALA . 0.6 OUTLIER -61.96 -30.94 71.27 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.717 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.61 -39.3 84.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.909 0.385 . . . . 0.0 110.764 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 71.3 m -81.29 -10.4 59.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.163 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.757 ' O ' ' HB2' ' C' ' 143' ' ' ALA . 0.6 OUTLIER -129.34 40.45 3.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.577 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' ALA . . . . . 0.618 ' HA ' ' H ' ' C' ' 143' ' ' ALA . . . -111.89 10.91 20.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.355 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.51 145.52 48.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.372 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' C' ' 140' ' ' THR . 18.1 tt0 -63.26 121.12 12.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.814 0.34 . . . . 0.0 111.204 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.07 14.4 33.77 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.14 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' C' ' 139' ' ' ALA . . . -72.21 121.19 18.93 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 14.9 p -129.98 133.77 47.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.908 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 57.8 m -112.44 -166.73 1.1 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.59 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 36.1 t -59.06 149.46 27.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.801 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.82 153.64 17.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.369 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' VAL . . . . . 0.65 HG22 ' HB3' ' C' ' 135' ' ' ALA . 3.7 m -103.44 130.4 53.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.97 121.43 6.53 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.662 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . 0.497 ' HD1' HG23 ' C' ' 52' ' ' VAL . 52.2 p90 -153.65 136.39 15.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.776 0.322 . . . . 0.0 110.986 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' C' ' 131' ' ' ILE . 24.7 p30 -133.54 141.33 47.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.637 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.634 HG21 HD12 ' C' ' 131' ' ' ILE . 1.2 tt -85.17 126.52 40.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.62 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.603 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.1 OUTLIER -75.88 119.4 19.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.713 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' C' ' 23' ' ' VAL . 0.2 OUTLIER -130.63 87.29 2.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.254 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' ASN . . . . . 0.719 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 5.1 p30 -77.15 173.7 11.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.998 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' ASP . . . . . 0.523 ' HB3' ' HE ' ' D' ' 38' ' ' ARG . 41.3 m-20 62.83 66.4 0.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 34.5 m -115.68 161.98 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.742 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' ASP . . . . . 0.51 ' HA ' ' OD1' ' C' ' 126' ' ' ASN . 0.2 OUTLIER -145.94 157.85 43.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.3 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.491 HG23 ' HA ' ' C' ' 125' ' ' ASN . 0.0 OUTLIER -107.54 -16.65 14.31 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.138 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -81.35 -33.67 32.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.124 0.488 . . . . 0.0 111.817 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' VAL . . . . . 0.602 HG21 ' O ' ' C' ' 19' ' ' ALA . 20.0 t -75.14 -41.68 44.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.661 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.84 146.79 29.24 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.595 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.84 -39.35 3.73 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.897 0.379 . . . . 0.0 110.95 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.22 159.54 15.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.467 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' C' ' 122' ' ' THR . . . -147.24 118.87 7.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.578 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -96.81 140.79 30.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.847 0.356 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' VAL . . . . . 0.479 HG11 HG21 ' C' ' 131' ' ' ILE . 3.1 t -118.51 139.74 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.732 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' ALA . . . . . 0.407 ' HA ' HD21 ' C' ' 111' ' ' LEU . . . -140.54 133.91 29.84 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.521 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' PHE . . . . . 0.781 ' HD2' HD13 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -101.25 138.08 38.74 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.538 0.209 . . . . 0.0 111.185 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' LEU . . . . . 0.717 HD21 HG21 ' F' ' 130' ' ' THR . 6.6 tt -101.06 91.09 4.4 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.982 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.37 -167.37 11.32 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.871 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' C' ' 86' ' ' LEU . 0.3 OUTLIER -116.67 159.53 22.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.557 0.218 . . . . 0.0 110.796 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . 0.525 ' HB2' HG23 ' C' ' 83' ' ' THR . . . -83.95 137.95 33.38 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.942 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' ILE . . . . . 0.457 HG22 ' O ' ' C' ' 82' ' ' HIS . 8.9 tt -77.18 -40.5 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.905 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' ASP . . . . . 0.62 ' HB2' HG21 ' C' ' 140' ' ' THR . 0.1 OUTLIER -141.18 55.31 1.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.796 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' F' ' 106' ' ' ARG . . . 52.86 -84.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.051 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' C' ' 79' ' ' ASP . . . -60.09 -16.09 39.36 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.621 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' HIS . . . . . 0.457 ' O ' HG22 ' C' ' 78' ' ' ILE . 24.2 m80 -100.64 56.76 0.9 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.931 0.396 . . . . 0.0 110.584 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . 0.525 HG23 ' HB2' ' C' ' 77' ' ' ALA . 1.1 m -71.33 -22.44 61.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.584 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' ASN . . . . . 0.735 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 8.6 p-10 -57.18 -18.72 16.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.341 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.505 HG11 ' HB3' ' C' ' 138' ' ' PHE . 11.6 t -115.19 133.34 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.219 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' LEU . . . . . 0.927 HD12 HD22 ' C' ' 113' ' ' LEU . 0.8 OUTLIER -72.96 154.12 40.67 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.606 ' N ' HD23 ' C' ' 86' ' ' LEU . . . -90.76 -161.4 0.8 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.777 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.27 6.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.966 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.72 -83.84 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.317 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.27 20.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.985 0.421 . . . . 0.0 111.468 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' SER . . . . . 0.774 ' HB2' ' HB2' ' C' ' 95' ' ' SER . 1.5 m -86.58 79.25 8.98 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.67 -31.56 37.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.831 0.348 . . . . 0.0 111.611 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' F' ' 36' ' ' GLN . . . -128.1 54.49 1.72 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.661 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.9 -17.23 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.067 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' SER . . . . . 0.774 ' HB2' ' HB2' ' C' ' 91' ' ' SER . 0.9 OUTLIER -89.43 177.22 6.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.707 0.289 . . . . 0.0 110.65 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.77 175.3 8.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.759 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' C' ' 98' ' ' ASN . 0.2 OUTLIER -137.55 137.98 39.14 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.215 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 98' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' C' ' 97' ' ' THR . 74.0 m-80 71.69 17.63 5.46 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.465 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.9 148.96 26.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.741 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.39 -176.77 35.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.464 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' VAL . . . . . 0.538 ' CG2' HD21 ' C' ' 34' ' ' LEU . 7.7 p -125.58 111.03 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.01 0.524 . . . . 0.0 111.711 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 102' ' ' GLN . . . . . 0.614 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 0.9 OUTLIER -81.54 147.75 29.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 -179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' ILE . . . . . 0.781 HD13 ' HD2' ' C' ' 73' ' ' PHE . 0.9 OUTLIER -123.77 115.94 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.489 179.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' LEU . . . . . 0.721 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 0.4 OUTLIER -88.73 140.53 29.35 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.634 0.254 . . . . 0.0 111.052 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 105' ' ' ASP . . . . . 0.59 ' HB2' ' HB2' ' C' ' 111' ' ' LEU . 2.1 t70 -89.36 152.06 21.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.711 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 106' ' ' ARG . . . . . 0.621 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -71.76 -21.05 61.79 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.785 0.326 . . . . 0.0 111.075 179.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 107' ' ' THR . . . . . 0.615 ' HB ' ' HA ' ' C' ' 120' ' ' SER . 5.8 t -62.99 -21.84 66.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.959 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.72 -83.08 0.19 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.669 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.73 170.66 15.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.833 0.349 . . . . 0.0 111.033 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.721 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -74.77 138.57 42.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 111' ' ' LEU . . . . . 0.59 ' HB2' ' HB2' ' C' ' 105' ' ' ASP . 5.1 tp -94.45 153.41 17.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.363 0.601 . . . . 0.0 110.557 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 112' ' ' THR . . . . . 0.779 HG22 HG21 ' C' ' 117' ' ' THR . 6.2 t -93.7 148.22 22.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.084 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 113' ' ' LEU . . . . . 0.927 HD22 HD12 ' C' ' 86' ' ' LEU . 1.4 mp -89.51 64.82 6.82 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.729 0.3 . . . . 0.0 110.715 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 114' ' ' ASP . . . . . 0.544 ' HB2' ' OG1' ' C' ' 117' ' ' THR . 0.5 OUTLIER -95.11 -16.05 22.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.588 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 115' ' ' GLY . . . . . 0.617 ' HA3' ' HG1' ' F' ' 130' ' ' THR . . . 104.41 -56.27 0.57 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.64 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 116' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' F' ' 125' ' ' ASN . . . -103.57 29.01 6.0 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.049 0.452 . . . . 0.0 111.709 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 117' ' ' THR . . . . . 0.779 HG21 HG22 ' C' ' 112' ' ' THR . 3.4 m -87.27 65.87 8.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.145 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 118' ' ' PHE . . . . . 0.527 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . 48.5 m-85 -77.66 73.47 4.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.792 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.57 70.83 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.837 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 120' ' ' SER . . . . . 0.615 ' HA ' ' HB ' ' C' ' 107' ' ' THR . 0.7 OUTLIER -148.68 126.15 11.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.15 53.25 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.202 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' C' ' 69' ' ' ALA . 0.2 OUTLIER -73.93 128.31 35.18 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.698 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.44 117.94 25.55 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.719 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.51 134.78 33.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.781 0.324 . . . . 0.0 110.489 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 125' ' ' ASN . . . . . 0.491 ' HA ' HG23 ' C' ' 63' ' ' THR . 0.3 OUTLIER -129.26 163.07 26.45 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.674 179.494 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 126' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' C' ' 62' ' ' ASP . 1.5 t30 -67.54 125.37 25.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.82 0.343 . . . . 0.0 110.687 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.62 -141.01 12.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.659 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 128' ' ' THR . . . . . 0.719 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 6.3 m -101.73 92.41 4.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.673 0.273 . . . . 0.0 110.778 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 129' ' ' ASN . . . . . 0.528 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 1.2 t30 -76.52 145.02 39.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.946 0.403 . . . . 0.0 111.119 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 130' ' ' THR . . . . . 0.603 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.0 OUTLIER -134.62 131.78 38.22 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.042 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 131' ' ' ILE . . . . . 0.69 HD11 HG12 ' C' ' 156' ' ' VAL . 28.3 mt -87.33 109.79 28.49 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 132' ' ' PRO . . . . . 0.621 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.4 Cg_endo -81.67 112.17 2.38 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.585 1.524 . . . . 0.0 112.53 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.36 138.28 51.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.804 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 134' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' C' ' 52' ' ' VAL . 28.2 mt-30 -110.11 157.53 19.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.986 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 135' ' ' ALA . . . . . 0.65 ' HB3' HG22 ' C' ' 52' ' ' VAL . . . -152.67 107.93 3.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.975 0.417 . . . . 0.0 111.608 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -102.54 174.41 5.91 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.338 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 137' ' ' TYR . . . . . 0.485 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 0.6 OUTLIER -86.08 120.9 27.96 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.069 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 138' ' ' PHE . . . . . 0.505 ' HB3' HG11 ' C' ' 85' ' ' VAL . 0.2 OUTLIER -117.66 139.61 50.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.006 -179.134 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 139' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' C' ' 47' ' ' ALA . . . -129.93 145.66 51.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.875 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 140' ' ' THR . . . . . 0.62 HG21 ' HB2' ' C' ' 79' ' ' ASP . 16.5 p -104.38 -53.43 2.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.478 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.7 -121.56 3.27 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.024 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.1 112.97 24.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.59 0.233 . . . . 0.0 110.693 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 143' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' C' ' 42' ' ' LEU . . . -61.82 150.95 35.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.772 0.32 . . . . 0.0 111.42 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 144' ' ' THR . . . . . 0.551 HG23 ' HD2' ' C' ' 145' ' ' PRO . 58.2 m -126.89 151.51 73.96 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.199 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 145' ' ' PRO . . . . . 0.551 ' HD2' HG23 ' C' ' 144' ' ' THR . 1.3 Cg_endo -83.07 140.2 9.87 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.528 2.152 . . . . 0.0 111.936 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.94 -137.98 6.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.574 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 147' ' ' ALA . . . . . 0.615 ' HA ' ' HG3' ' B' ' 15' ' ' GLU . . . -87.23 145.07 26.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.984 0.421 . . . . 0.0 111.307 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 148' ' ' ALA . . . . . 0.732 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -140.76 38.83 1.83 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.0 153.52 22.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.486 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 150' ' ' ALA . . . . . 0.604 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -161.87 171.23 18.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.019 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.4 126.79 7.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.328 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 152' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' C' ' 86' ' ' LEU . . . -125.31 142.8 51.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.328 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 153' ' ' THR . . . . . 0.82 HG23 HG23 ' B' ' 9' ' ' THR . 0.5 OUTLIER -89.85 133.17 34.88 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 154' ' ' PHE . . . . . 0.501 ' HD1' ' HA ' ' C' ' 154' ' ' PHE . 0.0 OUTLIER -86.44 127.85 34.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.104 0.478 . . . . 0.0 110.113 -178.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 155' ' ' LYS . . . . . 0.401 ' HE3' HD12 ' C' ' 74' ' ' LEU . 29.0 mmtt -111.43 150.52 29.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.921 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 156' ' ' VAL . . . . . 0.809 HG23 HG23 ' B' ' 5' ' ' VAL . 14.3 m -136.23 144.46 33.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.859 0.361 . . . . 0.0 111.582 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 157' ' ' GLN . . . . . 0.583 ' O ' ' HA ' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -136.16 132.73 36.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.34 0.59 . . . . 0.0 110.391 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 158' ' ' TYR . . . . . 0.494 ' OH ' ' HB3' ' C' ' 21' ' ' CYS . 5.6 m-85 -117.45 119.8 36.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.51 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 159' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' B' ' 1' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.33 -0.843 . . . . 0.0 110.799 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 1' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' E' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.235 0.064 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.26 64.86 1.57 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.627 0.251 . . . . 0.0 111.065 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 3' ' ' THR . . . . . 0.518 HG21 ' HB2' ' E' ' 18' ' ' ASN . 57.9 m -111.17 100.96 9.52 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.524 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 4' ' ' THR . . . . . 0.51 ' HA ' ' HG2' ' E' ' 157' ' ' GLN . 61.6 m -86.59 131.91 34.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.609 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.774 HG23 HG23 ' E' ' 156' ' ' VAL . 0.0 OUTLIER -161.16 168.06 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.523 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.19 118.71 37.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.584 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.31 -56.3 7.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.76 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.94 -145.34 4.65 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.919 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 9' ' ' THR . . . . . 0.81 HG23 HG23 ' E' ' 153' ' ' THR . 0.0 OUTLIER -145.02 142.09 29.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 0.0 111.282 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' VAL . . . . . 0.4 HG21 ' HZ ' ' E' ' 73' ' ' PHE . 43.8 t -121.66 107.27 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.168 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.7 111.03 21.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.366 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' PHE . . . . . 0.511 ' CD1' HD11 ' E' ' 34' ' ' LEU . 32.1 m-85 -87.63 113.53 23.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.777 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.13 118.54 36.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.405 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.48 175.61 39.71 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.887 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' GLU . . . . . 0.594 ' HG3' ' HA ' ' E' ' 147' ' ' ALA . 0.1 OUTLIER -151.38 162.12 41.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.946 0.403 . . . . 0.0 110.313 179.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' E' ' 148' ' ' ALA . 2.2 t -114.99 119.45 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.214 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' VAL . . . . . 0.539 HG11 ' NE2' ' E' ' 36' ' ' GLN . 0.3 OUTLIER -121.32 168.05 14.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.815 0.341 . . . . 0.0 111.07 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' ASN . . . . . 0.525 ' HB2' HG21 ' C' ' 3' ' ' THR . 1.3 t-20 -68.44 -175.21 0.62 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.984 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' ALA . . . . . 0.589 ' O ' HG21 ' D' ' 65' ' ' VAL . . . -91.24 52.67 2.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.89 -15.71 1.33 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.374 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER -176.91 147.59 0.6 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.928 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . 0.518 ' HA ' HG21 ' D' ' 17' ' ' VAL . . . -152.64 110.04 3.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.114 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' D' ' 58' ' ' LEU . 0.3 OUTLIER -52.97 159.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.023 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -90.38 164.5 14.29 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.6 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -57.0 -52.38 65.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.365 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.36 11.87 66.56 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.872 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 18.7 t -96.14 -30.86 13.28 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.904 0.383 . . . . 0.0 110.929 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 t -49.83 -71.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.355 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.59 104.34 15.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.044 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' GLN . . . . . 0.533 HE22 ' HA ' ' D' ' 56' ' ' ILE . 41.7 mt-30 -112.14 140.3 46.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.071 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.77 110.18 21.5 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.028 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.13 108.36 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.155 0.503 . . . . 0.0 110.453 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.56 112.46 22.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.685 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' LEU . . . . . 0.543 HD21 ' CG2' ' D' ' 101' ' ' VAL . 5.2 mp -81.19 -41.72 21.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.673 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.64 -171.05 21.62 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.626 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 2.4 mt-30 -93.57 145.93 24.17 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.524 0.202 . . . . 0.0 110.979 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.51 HG22 ' H ' ' D' ' 38' ' ' ARG . 4.9 p -124.84 169.89 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.991 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' ARG . . . . . 0.523 ' HE ' ' HB3' ' C' ' 60' ' ' ASP . 5.2 mtt-85 -98.88 121.42 40.8 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.714 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' THR . . . . . 0.543 ' O ' ' HB2' ' D' ' 43' ' ' ALA . 0.6 OUTLIER -62.01 -31.01 71.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.672 179.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.25 84.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.992 0.425 . . . . 0.0 110.852 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 71.1 m -81.31 -10.45 59.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.139 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.736 ' O ' ' HB2' ' D' ' 143' ' ' ALA . 0.6 OUTLIER -129.25 40.42 3.62 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.607 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' ALA . . . . . 0.617 ' HA ' ' H ' ' D' ' 143' ' ' ALA . . . -111.83 10.91 20.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.363 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.51 145.49 48.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.369 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' D' ' 140' ' ' THR . 18.2 tt0 -63.34 121.26 13.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.11 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.05 14.38 33.9 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.155 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' D' ' 139' ' ' ALA . . . -72.17 121.22 18.93 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 14.9 p -130.04 133.79 46.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.919 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 57.8 m -112.46 -166.73 1.1 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.607 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 36.3 t -59.11 149.47 27.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.897 0.379 . . . . 0.0 110.768 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.76 153.64 17.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.404 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' VAL . . . . . 0.668 HG22 ' HB3' ' D' ' 135' ' ' ALA . 3.7 m -103.41 130.33 53.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.96 121.5 6.56 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.576 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.492 ' HD1' HG23 ' D' ' 52' ' ' VAL . 52.3 p90 -153.71 136.44 15.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.816 0.341 . . . . 0.0 110.94 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' D' ' 131' ' ' ILE . 24.7 p30 -133.57 141.33 47.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.628 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' ILE . . . . . 0.642 HG21 HD12 ' D' ' 131' ' ' ILE . 1.2 tt -85.06 126.42 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.645 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' GLN . . . . . 0.601 ' HG3' HD11 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -75.73 119.41 19.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.742 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' LEU . . . . . 0.531 ' HA ' ' HA ' ' D' ' 23' ' ' VAL . 0.2 OUTLIER -130.68 87.36 2.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.258 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' ASN . . . . . 0.719 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 5.0 p30 -77.3 173.64 11.68 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.956 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' ASP . . . . . 0.524 ' HB3' ' HE ' ' E' ' 38' ' ' ARG . 41.3 m-20 62.91 66.4 0.75 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.844 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 34.6 m -115.69 161.98 17.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.714 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' ASP . . . . . 0.514 ' HA ' ' OD1' ' D' ' 126' ' ' ASN . 0.2 OUTLIER -145.88 157.92 43.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.323 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.491 HG23 ' HA ' ' D' ' 125' ' ' ASN . 0.0 OUTLIER -107.59 -16.67 14.3 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -81.42 -33.65 32.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.028 0.442 . . . . 0.0 111.708 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 65' ' ' VAL . . . . . 0.589 HG21 ' O ' ' D' ' 19' ' ' ALA . 20.0 t -75.19 -41.6 44.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.629 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.93 146.7 29.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.553 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.77 -39.3 3.76 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.972 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.3 159.58 15.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.477 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' D' ' 122' ' ' THR . . . -147.19 118.82 7.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.649 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -96.83 140.74 30.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.093 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' VAL . . . . . 0.457 HG11 HG21 ' D' ' 131' ' ' ILE . 3.1 t -118.5 139.71 44.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.784 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 72' ' ' ALA . . . . . 0.403 ' HA ' HD21 ' D' ' 111' ' ' LEU . . . -140.56 133.94 29.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.522 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 73' ' ' PHE . . . . . 0.788 ' HD2' HD13 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -101.21 137.97 38.86 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.509 0.195 . . . . 0.0 111.243 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 74' ' ' LEU . . . . . . . . . . . . . 6.6 tt -100.97 91.08 4.41 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.011 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.43 -167.38 11.31 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.891 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 76' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.3 OUTLIER -116.68 159.56 22.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.585 0.231 . . . . 0.0 110.761 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.52 ' HB2' HG23 ' D' ' 83' ' ' THR . . . -83.96 137.85 33.42 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.018 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 78' ' ' ILE . . . . . 0.45 HG22 ' O ' ' D' ' 82' ' ' HIS . 9.0 tt -77.13 -40.48 30.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.882 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 79' ' ' ASP . . . . . 0.606 ' HB2' HG21 ' D' ' 140' ' ' THR . 0.1 OUTLIER -141.22 55.21 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.848 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 52.87 -84.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.075 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' D' ' 79' ' ' ASP . . . -60.09 -16.05 39.19 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.663 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 82' ' ' HIS . . . . . 0.45 ' O ' HG22 ' D' ' 78' ' ' ILE . 24.2 m80 -100.64 56.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 110.568 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 83' ' ' THR . . . . . 0.52 HG23 ' HB2' ' D' ' 77' ' ' ALA . 1.1 m -71.41 -22.42 61.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.563 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 84' ' ' ASN . . . . . 0.739 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 8.6 p-10 -57.17 -18.67 16.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.359 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.518 HG11 ' HB3' ' D' ' 138' ' ' PHE . 11.6 t -115.24 133.34 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.227 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 86' ' ' LEU . . . . . 0.908 HD12 HD22 ' D' ' 113' ' ' LEU . 0.8 OUTLIER -72.93 154.06 40.71 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.341 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.601 ' N ' HD23 ' D' ' 86' ' ' LEU . . . -90.66 -161.41 0.8 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.837 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.69 -178.27 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.01 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -83.88 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.339 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.33 20.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.998 0.427 . . . . 0.0 111.49 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 91' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' D' ' 95' ' ' SER . 1.5 m -86.6 79.35 8.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.73 -31.49 38.2 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.913 0.387 . . . . 0.0 111.71 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.08 54.43 1.72 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.646 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.9 -17.29 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.931 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 95' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' D' ' 91' ' ' SER . 0.9 OUTLIER -89.39 177.16 6.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.75 0.309 . . . . 0.0 110.661 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.76 175.3 8.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.812 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 97' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' D' ' 98' ' ' ASN . 0.2 OUTLIER -137.52 138.03 39.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.263 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 98' ' ' ASN . . . . . 0.529 ' HB2' ' O ' ' D' ' 97' ' ' THR . 74.0 m-80 71.63 17.6 5.53 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.52 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.86 148.94 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.733 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.35 -176.74 35.65 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.436 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 101' ' ' VAL . . . . . 0.543 ' CG2' HD21 ' D' ' 34' ' ' LEU . 7.7 p -125.59 111.01 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 122.968 0.507 . . . . 0.0 111.759 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 102' ' ' GLN . . . . . 0.616 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 0.9 OUTLIER -81.53 147.71 29.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 103' ' ' ILE . . . . . 0.788 HD13 ' HD2' ' D' ' 73' ' ' PHE . 0.9 OUTLIER -123.74 115.92 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.478 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 104' ' ' LEU . . . . . 0.74 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 0.4 OUTLIER -88.69 140.52 29.37 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.693 0.283 . . . . 0.0 111.051 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 105' ' ' ASP . . . . . 0.605 ' HB2' ' HB2' ' D' ' 111' ' ' LEU . 2.1 t70 -89.26 151.98 21.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.693 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 106' ' ' ARG . . . . . 0.646 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -71.78 -21.07 61.77 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.805 0.336 . . . . 0.0 111.07 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 107' ' ' THR . . . . . 0.616 ' HB ' ' HA ' ' D' ' 120' ' ' SER . 5.8 t -62.9 -21.91 66.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.97 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.68 -83.02 0.19 Allowed Glycine 0 CA--C 1.517 0.219 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.722 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.74 170.7 15.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.834 0.349 . . . . 0.0 111.106 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.74 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -74.84 138.61 42.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.183 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 111' ' ' LEU . . . . . 0.605 ' HB2' ' HB2' ' D' ' 105' ' ' ASP . 5.1 tp -94.37 153.41 17.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.276 0.56 . . . . 0.0 110.604 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 112' ' ' THR . . . . . 0.776 HG22 HG21 ' D' ' 117' ' ' THR . 6.2 t -93.72 148.33 22.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.046 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 113' ' ' LEU . . . . . 0.908 HD22 HD12 ' D' ' 86' ' ' LEU . 1.4 mp -89.7 64.87 6.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.894 0.378 . . . . 0.0 110.758 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 114' ' ' ASP . . . . . 0.541 ' HB2' ' OG1' ' D' ' 117' ' ' THR . 0.5 OUTLIER -94.98 -16.15 22.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.648 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.49 -56.26 0.56 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.693 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.53 29.05 5.96 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.949 0.404 . . . . 0.0 111.719 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 117' ' ' THR . . . . . 0.776 HG21 HG22 ' D' ' 112' ' ' THR . 3.4 m -87.26 65.92 8.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.041 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 118' ' ' PHE . . . . . 0.52 ' HB3' ' HB1' ' D' ' 70' ' ' ALA . 48.5 m-85 -77.69 73.42 4.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.808 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.49 70.79 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 120' ' ' SER . . . . . 0.616 ' HA ' ' HB ' ' D' ' 107' ' ' THR . 0.7 OUTLIER -148.64 126.07 11.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.67 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.08 53.27 2.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.198 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' D' ' 69' ' ' ALA . 0.2 OUTLIER -74.04 128.32 35.22 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.715 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.36 117.9 25.45 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.765 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.52 134.8 33.76 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.831 0.348 . . . . 0.0 110.524 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 125' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -129.24 163.09 26.37 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.654 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 126' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' D' ' 62' ' ' ASP . 1.5 t30 -67.6 125.37 25.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.7 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 127' ' ' GLY . . . . . 0.451 ' HA3' ' HE2' ' A' ' 118' ' ' PHE . . . 128.62 -140.97 12.14 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.718 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 128' ' ' THR . . . . . 0.719 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 6.3 m -101.8 92.45 4.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.672 0.272 . . . . 0.0 110.772 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 129' ' ' ASN . . . . . 0.54 ' HB2' ' SG ' ' D' ' 61' ' ' CYS . 1.2 t30 -76.5 145.04 39.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.92 0.391 . . . . 0.0 111.147 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 130' ' ' THR . . . . . 0.734 HG21 HD21 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -134.68 131.79 38.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.063 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 131' ' ' ILE . . . . . 0.686 HD11 HG12 ' D' ' 156' ' ' VAL . 28.2 mt -87.32 109.73 28.01 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 132' ' ' PRO . . . . . 0.646 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.5 Cg_endo -81.57 112.13 2.4 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.599 1.533 . . . . 0.0 112.576 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.35 138.2 51.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.844 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 134' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' D' ' 52' ' ' VAL . 28.3 mt-30 -110.1 157.55 19.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.99 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 135' ' ' ALA . . . . . 0.668 ' HB3' HG22 ' D' ' 52' ' ' VAL . . . -152.68 107.92 3.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 111.568 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -102.53 174.34 5.94 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.381 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 137' ' ' TYR . . . . . 0.462 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 0.6 OUTLIER -85.99 120.81 27.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.097 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 138' ' ' PHE . . . . . 0.518 ' HB3' HG11 ' D' ' 85' ' ' VAL . 0.2 OUTLIER -117.62 139.56 50.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.079 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 139' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' D' ' 47' ' ' ALA . . . -129.88 145.64 51.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.851 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 140' ' ' THR . . . . . 0.606 HG21 ' HB2' ' D' ' 79' ' ' ASP . 16.3 p -104.46 -53.43 2.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.407 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.67 -121.52 3.27 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.014 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.08 112.92 24.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.568 0.223 . . . . 0.0 110.676 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 143' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' D' ' 42' ' ' LEU . . . -61.78 150.86 35.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.755 0.312 . . . . 0.0 111.453 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 144' ' ' THR . . . . . 0.553 HG23 ' HD2' ' D' ' 145' ' ' PRO . 60.4 m -126.81 151.52 73.77 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.274 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 145' ' ' PRO . . . . . 0.553 ' HD2' HG23 ' D' ' 144' ' ' THR . 1.3 Cg_endo -83.08 140.2 9.85 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.613 2.208 . . . . 0.0 111.941 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.94 -138.14 6.59 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.485 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 147' ' ' ALA . . . . . 0.608 ' HA ' ' HG3' ' C' ' 15' ' ' GLU . . . -87.14 145.02 26.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.912 0.387 . . . . 0.0 111.378 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 148' ' ' ALA . . . . . 0.743 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -140.73 38.79 1.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.545 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.1 153.53 22.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.48 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 150' ' ' ALA . . . . . 0.589 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -161.86 171.25 18.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.048 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.42 126.8 7.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.242 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 152' ' ' ALA . . . . . 0.528 ' HB2' ' CD1' ' D' ' 86' ' ' LEU . . . -125.31 142.85 51.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.257 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 153' ' ' THR . . . . . 0.812 HG23 HG23 ' C' ' 9' ' ' THR . 0.5 OUTLIER -89.84 133.17 34.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 154' ' ' PHE . . . . . 0.501 ' HD1' ' HA ' ' D' ' 154' ' ' PHE . 0.0 OUTLIER -86.46 127.88 34.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.042 0.449 . . . . 0.0 110.096 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.48 150.57 29.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.958 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 156' ' ' VAL . . . . . 0.792 HG23 HG23 ' C' ' 5' ' ' VAL . 14.4 m -136.24 144.39 33.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.826 0.346 . . . . 0.0 111.594 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 157' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' D' ' 69' ' ' ALA . 0.0 OUTLIER -136.16 132.74 36.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.268 0.556 . . . . 0.0 110.415 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 158' ' ' TYR . . . . . 0.489 ' OH ' ' HB3' ' D' ' 21' ' ' CYS . 5.5 m-85 -117.42 119.78 36.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.505 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 159' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' C' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.844 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 1' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' F' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 120.209 0.052 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.21 64.86 1.57 Allowed 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.126 0.266 . . . . 0.0 111.079 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 3' ' ' THR . . . . . 0.538 HG21 ' HB2' ' F' ' 18' ' ' ASN . 57.8 m -111.17 101.03 9.58 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.42 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 4' ' ' THR . . . . . 0.502 ' O ' HG13 ' E' ' 5' ' ' VAL . 60.0 m -86.72 131.91 34.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.539 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.802 HG23 HG23 ' F' ' 156' ' ' VAL . 0.0 OUTLIER -161.15 168.05 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.513 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.15 118.76 37.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.58 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.36 -56.26 7.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.759 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.01 -145.36 4.66 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.883 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 9' ' ' THR . . . . . 0.811 HG23 HG23 ' F' ' 153' ' ' THR . 0.0 OUTLIER -145.01 142.07 29.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.288 -179.587 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 44.0 t -121.64 107.31 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.17 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.72 110.93 21.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.431 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 12' ' ' PHE . . . . . 0.501 ' CD1' HD11 ' F' ' 34' ' ' LEU . 32.2 m-85 -87.54 113.48 23.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.15 118.54 36.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.443 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.49 175.49 39.72 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.946 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 15' ' ' GLU . . . . . 0.594 ' HG3' ' HA ' ' F' ' 147' ' ' ALA . 0.1 OUTLIER -151.29 162.13 41.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.994 0.426 . . . . 0.0 110.303 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 16' ' ' VAL . . . . . 0.736 HG23 ' HB2' ' F' ' 148' ' ' ALA . 2.2 t -114.97 119.33 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.265 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 17' ' ' VAL . . . . . 0.531 HG11 ' NE2' ' F' ' 36' ' ' GLN . 0.3 OUTLIER -121.26 168.06 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.843 0.354 . . . . 0.0 111.039 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 18' ' ' ASN . . . . . 0.518 ' HB2' HG21 ' D' ' 3' ' ' THR . 1.3 t-20 -68.38 -175.26 0.61 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.01 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 19' ' ' ALA . . . . . 0.605 ' O ' HG21 ' E' ' 65' ' ' VAL . . . -91.12 52.59 2.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.95 -15.66 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.357 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 21' ' ' CYS . . . . . 0.726 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER -176.96 147.55 0.58 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.981 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 22' ' ' ALA . . . . . 0.492 ' HA ' HG21 ' E' ' 17' ' ' VAL . . . -152.57 110.05 3.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 23' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' E' ' 58' ' ' LEU . 0.3 OUTLIER -53.0 159.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.011 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -90.37 164.46 14.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.592 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 25' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -56.91 -52.42 65.24 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.402 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.35 11.9 66.43 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.881 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 18.3 t -96.21 -30.77 13.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.895 0.379 . . . . 0.0 110.917 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 28' ' ' VAL . . . . . 0.426 ' H ' HG23 ' E' ' 28' ' ' VAL . 11.2 t -49.84 -71.71 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.38 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.47 104.29 15.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 30' ' ' GLN . . . . . 0.536 HE22 ' HA ' ' E' ' 56' ' ' ILE . 41.8 mt-30 -112.17 140.4 46.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.07 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.83 110.16 21.46 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.301 -0.409 . . . . 0.0 112.045 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.17 108.46 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.136 0.493 . . . . 0.0 110.434 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.65 112.47 22.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 34' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' E' ' 101' ' ' VAL . 5.3 mp -81.17 -41.8 21.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.67 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.72 -171.02 21.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.632 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 36' ' ' GLN . . . . . 0.55 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 2.4 mt-30 -93.62 145.9 24.21 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.502 0.192 . . . . 0.0 110.969 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.515 HG22 ' H ' ' E' ' 38' ' ' ARG . 5.0 p -124.82 169.88 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.942 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 38' ' ' ARG . . . . . 0.524 ' HE ' ' HB3' ' D' ' 60' ' ' ASP . 5.2 mtt-85 -98.94 121.45 40.91 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.701 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 39' ' ' THR . . . . . 0.545 ' O ' ' HB2' ' E' ' 43' ' ' ALA . 0.6 OUTLIER -61.99 -31.03 71.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.675 179.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.3 85.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.987 0.422 . . . . 0.0 110.85 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 70.5 m -81.36 -10.3 59.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.128 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 42' ' ' LEU . . . . . 0.739 ' O ' ' HB2' ' E' ' 143' ' ' ALA . 0.6 OUTLIER -129.33 40.34 3.62 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.571 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 43' ' ' ALA . . . . . 0.607 ' HA ' ' H ' ' E' ' 143' ' ' ALA . . . -111.87 10.98 20.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.392 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.6 145.47 48.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.35 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 45' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' E' ' 140' ' ' THR . 18.2 tt0 -63.28 121.17 13.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.367 . . . . 0.0 111.109 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.03 14.48 33.67 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.113 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 47' ' ' ALA . . . . . 0.692 ' HB3' ' HB3' ' E' ' 139' ' ' ALA . . . -72.14 121.19 18.86 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 14.9 p -130.03 133.72 46.93 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.906 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 49' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 57.9 m -112.43 -166.69 1.1 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.623 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 36.3 t -59.03 149.5 27.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.774 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.84 153.6 17.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.386 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 52' ' ' VAL . . . . . 0.669 HG22 ' HB3' ' E' ' 135' ' ' ALA . 3.7 m -103.45 130.34 53.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.877 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.94 121.4 6.52 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.612 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 54' ' ' PHE . . . . . 0.49 ' HD1' HG23 ' E' ' 52' ' ' VAL . 52.2 p90 -153.6 136.44 15.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 110.97 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 55' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' E' ' 131' ' ' ILE . 24.7 p30 -133.55 141.39 47.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.682 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 56' ' ' ILE . . . . . 0.645 HG21 HD12 ' E' ' 131' ' ' ILE . 1.2 tt -85.18 126.43 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.627 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 57' ' ' GLN . . . . . 0.599 ' HG3' HD11 ' B' ' 74' ' ' LEU . 0.1 OUTLIER -75.8 119.45 19.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.732 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 58' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' E' ' 23' ' ' VAL . 0.2 OUTLIER -130.75 87.34 2.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.214 -179.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 59' ' ' ASN . . . . . 0.728 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 5.1 p30 -77.2 173.71 11.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.991 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 60' ' ' ASP . . . . . 0.527 ' HB3' ' HE ' ' F' ' 38' ' ' ARG . 41.6 m-20 62.89 66.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 61' ' ' CYS . . . . . 0.726 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 34.5 m -115.66 161.98 17.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.74 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 62' ' ' ASP . . . . . 0.514 ' HA ' ' OD1' ' E' ' 126' ' ' ASN . 0.2 OUTLIER -145.91 157.82 43.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.333 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 63' ' ' THR . . . . . 0.482 HG23 ' HA ' ' E' ' 125' ' ' ASN . 0.0 OUTLIER -107.51 -16.65 14.31 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.186 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.4 -33.63 32.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.055 0.455 . . . . 0.0 111.755 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 65' ' ' VAL . . . . . 0.605 HG21 ' O ' ' E' ' 19' ' ' ALA . 20.0 t -75.19 -41.55 44.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.668 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.94 146.76 29.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.528 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -39.25 3.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.008 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.32 159.61 15.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.431 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 69' ' ' ALA . . . . . 0.601 ' HB3' ' HB ' ' E' ' 122' ' ' THR . . . -147.26 118.87 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.612 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 70' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -96.9 140.81 30.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.063 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 71' ' ' VAL . . . . . 0.471 HG11 HG21 ' E' ' 131' ' ' ILE . 3.1 t -118.57 139.74 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.714 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.56 133.9 29.78 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.533 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 73' ' ' PHE . . . . . 0.792 ' HD2' HD13 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -101.16 138.01 38.76 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 122.388 -0.195 . . . . 0.0 111.185 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 74' ' ' LEU . . . . . 0.41 HD12 ' HE3' ' E' ' 155' ' ' LYS . 6.6 tt -100.98 91.02 4.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.028 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.37 -167.37 11.32 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.872 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 76' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.3 OUTLIER -116.71 159.48 22.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.631 0.253 . . . . 0.0 110.729 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 77' ' ' ALA . . . . . 0.52 ' HB2' HG23 ' E' ' 83' ' ' THR . . . -83.94 137.94 33.39 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.024 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 78' ' ' ILE . . . . . 0.456 HG22 ' O ' ' E' ' 82' ' ' HIS . 8.9 tt -77.18 -40.48 29.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.911 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 79' ' ' ASP . . . . . 0.601 ' HB2' HG21 ' E' ' 140' ' ' THR . 0.1 OUTLIER -141.22 55.26 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.882 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 52.88 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 81' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' E' ' 79' ' ' ASP . . . -60.09 -15.99 38.89 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.652 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 82' ' ' HIS . . . . . 0.456 ' O ' HG22 ' E' ' 78' ' ' ILE . 24.2 m80 -100.68 56.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.929 0.395 . . . . 0.0 110.557 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 83' ' ' THR . . . . . 0.52 HG23 ' HB2' ' E' ' 77' ' ' ALA . 1.1 m -71.32 -22.53 61.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.574 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 84' ' ' ASN . . . . . 0.737 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 8.6 p-10 -57.2 -18.62 16.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.347 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 85' ' ' VAL . . . . . 0.505 HG11 ' HB3' ' E' ' 138' ' ' PHE . 11.6 t -115.23 133.36 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.205 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 86' ' ' LEU . . . . . 0.928 HD12 HD22 ' E' ' 113' ' ' LEU . 0.8 OUTLIER -72.95 154.01 40.72 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.368 179.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 87' ' ' ALA . . . . . 0.602 ' N ' HD23 ' E' ' 86' ' ' LEU . . . -90.67 -161.35 0.79 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.872 0.367 . . . . 0.0 111.781 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.74 -178.24 6.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.925 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.72 -83.82 0.04 OUTLIER 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.364 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.35 20.49 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.989 0.423 . . . . 0.0 111.464 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 91' ' ' SER . . . . . 0.766 ' HB2' ' HB2' ' E' ' 95' ' ' SER . 1.5 m -86.56 79.3 8.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.7 -31.54 38.14 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.867 0.365 . . . . 0.0 111.624 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.05 54.43 1.72 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.671 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.86 -17.34 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.02 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 95' ' ' SER . . . . . 0.766 ' HB2' ' HB2' ' E' ' 91' ' ' SER . 0.9 OUTLIER -89.41 177.2 6.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.804 0.335 . . . . 0.0 110.67 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.68 175.19 8.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.795 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 97' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' E' ' 98' ' ' ASN . 0.2 OUTLIER -137.5 138.01 39.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.275 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 98' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' E' ' 97' ' ' THR . 74.0 m-80 71.71 17.52 5.46 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.532 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.87 149.0 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.719 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.34 -176.75 35.65 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.447 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 101' ' ' VAL . . . . . 0.541 ' CG2' HD21 ' E' ' 34' ' ' LEU . 7.7 p -125.63 111.04 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.003 0.521 . . . . 0.0 111.736 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 102' ' ' GLN . . . . . 0.611 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 0.9 OUTLIER -81.58 147.67 29.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.878 -179.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 103' ' ' ILE . . . . . 0.792 HD13 ' HD2' ' E' ' 73' ' ' PHE . 0.9 OUTLIER -123.64 115.95 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.55 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 104' ' ' LEU . . . . . 0.714 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 0.4 OUTLIER -88.77 140.51 29.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.688 0.28 . . . . 0.0 111.02 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 105' ' ' ASP . . . . . 0.597 ' HB3' HG22 ' E' ' 107' ' ' THR . 2.1 t70 -89.28 152.02 21.79 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.661 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 106' ' ' ARG . . . . . 0.63 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -71.79 -21.02 61.77 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.819 0.343 . . . . 0.0 111.119 179.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 107' ' ' THR . . . . . 0.615 ' HB ' ' HA ' ' E' ' 120' ' ' SER . 5.8 t -62.89 -21.98 66.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.981 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.69 -83.05 0.19 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.626 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.66 170.68 15.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 111.105 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 110' ' ' ALA . . . . . 0.714 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -74.85 138.63 42.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.227 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 111' ' ' LEU . . . . . 0.594 ' HB2' ' HB2' ' E' ' 105' ' ' ASP . 5.0 tp -94.45 153.45 17.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.366 0.603 . . . . 0.0 110.577 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 112' ' ' THR . . . . . 0.804 HG22 HG21 ' E' ' 117' ' ' THR . 6.2 t -93.78 148.29 22.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.049 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 113' ' ' LEU . . . . . 0.928 HD22 HD12 ' E' ' 86' ' ' LEU . 1.4 mp -89.53 64.82 6.81 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.773 0.32 . . . . 0.0 110.742 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 114' ' ' ASP . . . . . 0.559 ' HB2' ' OG1' ' E' ' 117' ' ' THR . 0.5 OUTLIER -95.1 -15.95 23.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.662 0.268 . . . . 0.0 111.665 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.34 -56.25 0.57 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.682 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.58 29.05 5.98 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.983 0.42 . . . . 0.0 111.679 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 117' ' ' THR . . . . . 0.804 HG21 HG22 ' E' ' 112' ' ' THR . 3.4 m -87.11 65.82 9.06 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.153 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 118' ' ' PHE . . . . . 0.52 ' HB3' ' HB1' ' E' ' 70' ' ' ALA . 48.3 m-85 -77.67 73.39 4.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.814 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.54 70.85 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 120' ' ' SER . . . . . 0.615 ' HA ' ' HB ' ' E' ' 107' ' ' THR . 0.7 OUTLIER -148.66 126.08 11.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.679 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.06 53.23 2.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.203 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 122' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' E' ' 69' ' ' ALA . 0.2 OUTLIER -74.04 128.31 35.2 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.67 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 4.5 m -86.29 118.0 25.46 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.759 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.61 134.82 33.77 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.779 0.323 . . . . 0.0 110.482 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 125' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' B' ' 116' ' ' ALA . 0.3 OUTLIER -129.3 163.08 26.47 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.662 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 126' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' E' ' 62' ' ' ASP . 1.5 t30 -67.56 125.34 25.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.653 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 127' ' ' GLY . . . . . 0.651 ' HA2' HG21 ' A' ' 4' ' ' THR . . . 128.59 -140.97 12.14 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.686 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 128' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 6.3 m -101.76 92.5 4.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.666 0.27 . . . . 0.0 110.752 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 129' ' ' ASN . . . . . 0.542 ' HB2' ' SG ' ' E' ' 61' ' ' CYS . 1.2 t30 -76.58 144.98 39.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.89 0.376 . . . . 0.0 111.099 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 130' ' ' THR . . . . . 0.714 HG21 HD21 ' B' ' 74' ' ' LEU . 0.0 OUTLIER -134.63 131.81 38.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.05 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 131' ' ' ILE . . . . . 0.685 HD11 HG12 ' E' ' 156' ' ' VAL . 28.3 mt -87.34 109.74 28.16 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 132' ' ' PRO . . . . . 0.63 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.4 Cg_endo -81.61 112.15 2.39 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 121.604 1.536 . . . . 0.0 112.544 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.32 138.21 51.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 134' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' E' ' 52' ' ' VAL . 28.1 mt-30 -110.03 157.49 19.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.075 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 135' ' ' ALA . . . . . 0.669 ' HB3' HG22 ' E' ' 52' ' ' VAL . . . -152.65 107.85 3.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 111.636 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -102.58 174.34 5.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.338 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 137' ' ' TYR . . . . . 0.468 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 0.6 OUTLIER -85.9 120.86 27.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.036 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 138' ' ' PHE . . . . . 0.505 ' HB3' HG11 ' E' ' 85' ' ' VAL . 0.2 OUTLIER -117.68 139.64 50.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.001 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 139' ' ' ALA . . . . . 0.692 ' HB3' ' HB3' ' E' ' 47' ' ' ALA . . . -129.95 145.62 51.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.915 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 140' ' ' THR . . . . . 0.601 HG21 ' HB2' ' E' ' 79' ' ' ASP . 16.5 p -104.45 -53.33 2.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.464 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.8 -121.49 3.25 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.983 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.07 112.91 24.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.572 0.225 . . . . 0.0 110.723 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 143' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' E' ' 42' ' ' LEU . . . -61.79 150.89 35.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.794 0.33 . . . . 0.0 111.406 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 144' ' ' THR . . . . . 0.55 HG23 ' HD2' ' E' ' 145' ' ' PRO . 59.8 m -126.81 151.59 73.89 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.261 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 145' ' ' PRO . . . . . 0.55 ' HD2' HG23 ' E' ' 144' ' ' THR . 1.3 Cg_endo -83.09 140.15 9.82 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.59 2.193 . . . . 0.0 111.956 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.98 -138.01 6.52 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.521 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 147' ' ' ALA . . . . . 0.594 ' HA ' ' HG3' ' D' ' 15' ' ' GLU . . . -87.22 145.01 26.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.941 0.4 . . . . 0.0 111.329 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 148' ' ' ALA . . . . . 0.749 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -140.74 38.84 1.83 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.589 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.09 153.5 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.47 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 150' ' ' ALA . . . . . 0.598 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -161.88 171.21 18.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.966 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.42 126.84 7.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.232 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 152' ' ' ALA . . . . . 0.537 ' HB2' ' CD1' ' E' ' 86' ' ' LEU . . . -125.36 142.81 51.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.252 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 153' ' ' THR . . . . . 0.81 HG23 HG23 ' D' ' 9' ' ' THR . 0.4 OUTLIER -89.88 133.2 34.89 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 154' ' ' PHE . . . . . 0.448 ' HD1' ' HA ' ' E' ' 154' ' ' PHE . 0.0 OUTLIER -86.41 127.84 34.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.016 0.436 . . . . 0.0 110.148 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 155' ' ' LYS . . . . . 0.41 ' HE3' HD12 ' E' ' 74' ' ' LEU . 29.1 mmtt -111.41 150.55 29.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.96 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 156' ' ' VAL . . . . . 0.774 HG23 HG23 ' D' ' 5' ' ' VAL . 14.2 m -136.23 144.44 33.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.863 0.363 . . . . 0.0 111.551 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 157' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' E' ' 69' ' ' ALA . 0.0 OUTLIER -136.17 132.76 36.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.24 0.543 . . . . 0.0 110.459 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 158' ' ' TYR . . . . . 0.495 ' OH ' ' HB3' ' E' ' 21' ' ' CYS . 5.5 m-85 -117.48 119.79 36.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.537 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 159' ' ' GLN . . . . . 0.555 ' HA ' ' HA ' ' D' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.223 0.059 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.22 64.84 1.57 Allowed 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.118 0.261 . . . . 0.0 111.033 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 58.2 m -111.12 101.06 9.61 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.487 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 4' ' ' THR . . . . . 0.497 ' O ' HG13 ' F' ' 5' ' ' VAL . 60.3 m -86.73 131.92 34.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.586 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . 0.497 HG13 ' O ' ' F' ' 4' ' ' THR . 0.0 OUTLIER -161.16 168.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.48 179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.13 118.82 37.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.548 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.38 -56.39 6.87 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.704 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.97 -145.36 4.66 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.877 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.02 142.0 29.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 111.311 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 44.0 t -121.58 107.36 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.18 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -88.78 110.95 21.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.421 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -87.55 113.5 23.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.759 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.16 118.63 36.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.354 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.56 175.48 39.78 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.958 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.26 162.15 41.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.957 0.408 . . . . 0.0 110.289 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.01 119.35 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.259 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 17' ' ' VAL . . . . . 0.498 HG21 ' HA ' ' F' ' 22' ' ' ALA . 0.3 OUTLIER -121.26 168.1 14.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 111.039 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 18' ' ' ASN . . . . . 0.538 ' HB2' HG21 ' E' ' 3' ' ' THR . 1.3 t-20 -68.45 -175.2 0.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.953 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 19' ' ' ALA . . . . . 0.604 ' O ' HG21 ' F' ' 65' ' ' VAL . . . -91.23 52.64 2.15 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.9 -15.72 1.33 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.351 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 21' ' ' CYS . . . . . 0.781 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER -176.87 147.61 0.61 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.987 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 22' ' ' ALA . . . . . 0.498 ' HA ' HG21 ' F' ' 17' ' ' VAL . . . -152.58 110.02 3.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 23' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' F' ' 58' ' ' LEU . 0.3 OUTLIER -52.98 159.07 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -90.36 164.49 14.31 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.613 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 25' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -57.0 -52.36 65.59 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.402 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.41 11.95 66.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.888 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 18.4 t -96.25 -30.71 13.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.911 0.386 . . . . 0.0 110.95 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 t -49.87 -71.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.299 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.54 104.31 15.19 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 30' ' ' GLN . . . . . 0.541 HE22 ' HA ' ' F' ' 56' ' ' ILE . 41.8 mt-30 -112.12 140.3 46.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.122 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.72 110.12 21.44 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.123 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.12 108.44 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.165 0.507 . . . . 0.0 110.429 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.61 112.39 22.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.634 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 34' ' ' LEU . . . . . 0.542 HD21 ' CG2' ' F' ' 101' ' ' VAL . 5.3 mp -81.11 -41.83 21.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.611 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.69 -171.06 21.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.638 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 36' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 2.4 mt-30 -93.63 145.87 24.23 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.536 0.207 . . . . 0.0 110.919 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.517 HG22 ' H ' ' F' ' 38' ' ' ARG . 5.0 p -124.87 169.87 15.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.929 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 38' ' ' ARG . . . . . 0.527 ' HE ' ' HB3' ' E' ' 60' ' ' ASP . 5.2 mtt-85 -98.88 121.4 40.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.703 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 39' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' F' ' 43' ' ' ALA . 0.6 OUTLIER -61.94 -30.99 71.28 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.75 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.57 -39.33 84.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.008 0.432 . . . . 0.0 110.774 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 71.5 m -81.31 -10.32 59.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.2 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 42' ' ' LEU . . . . . 0.751 ' O ' ' HB2' ' F' ' 143' ' ' ALA . 0.6 OUTLIER -129.4 40.42 3.6 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.588 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 43' ' ' ALA . . . . . 0.612 ' HA ' ' H ' ' F' ' 143' ' ' ALA . . . -111.89 10.96 20.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.428 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.52 145.44 48.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.399 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 45' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' F' ' 140' ' ' THR . 18.1 tt0 -63.25 121.25 13.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.852 0.358 . . . . 0.0 111.095 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.97 14.44 33.91 Favored Glycine 0 C--N 1.33 0.249 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.176 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 47' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' F' ' 139' ' ' ALA . . . -72.16 121.21 18.91 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 15.1 p -130.04 133.8 46.97 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.848 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 49' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 57.9 m -112.47 -166.71 1.1 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.628 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 36.1 t -59.07 149.45 27.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.793 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.72 153.63 17.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.39 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 52' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' F' ' 135' ' ' ALA . 3.7 m -103.44 130.4 53.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.0 121.48 6.56 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.621 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 54' ' ' PHE . . . . . 0.498 ' HD1' HG23 ' F' ' 52' ' ' VAL . 52.3 p90 -153.64 136.45 15.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 110.955 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 55' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' F' ' 131' ' ' ILE . 24.8 p30 -133.56 141.33 47.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.685 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 56' ' ' ILE . . . . . 0.642 HG21 HD12 ' F' ' 131' ' ' ILE . 1.2 tt -85.15 126.49 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.634 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 57' ' ' GLN . . . . . 0.607 ' HG3' HD11 ' C' ' 74' ' ' LEU . 0.1 OUTLIER -75.83 119.38 19.74 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.752 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 58' ' ' LEU . . . . . 0.536 ' HA ' ' HA ' ' F' ' 23' ' ' VAL . 0.2 OUTLIER -130.68 87.4 2.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.29 -179.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 59' ' ' ASN . . . . . 0.727 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 5.1 p30 -77.28 173.8 11.49 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.988 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 60' ' ' ASP . . . . . 0.43 ' HB2' ' HB3' ' F' ' 22' ' ' ALA . 41.6 m-20 62.78 66.47 0.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 61' ' ' CYS . . . . . 0.781 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 34.6 m -115.8 161.91 18.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.659 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 62' ' ' ASP . . . . . 0.514 ' HA ' ' OD1' ' F' ' 126' ' ' ASN . 0.2 OUTLIER -145.87 157.86 43.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.322 -179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 63' ' ' THR . . . . . 0.491 HG23 ' HA ' ' F' ' 125' ' ' ASN . 0.0 OUTLIER -107.49 -16.73 14.29 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.3 -33.75 32.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.012 0.434 . . . . 0.0 111.689 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 65' ' ' VAL . . . . . 0.604 HG21 ' O ' ' F' ' 19' ' ' ALA . 20.1 t -75.14 -41.64 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.619 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.95 146.74 29.1 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.567 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -39.3 3.73 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.863 0.363 . . . . 0.0 110.945 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.28 159.56 15.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.446 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 69' ' ' ALA . . . . . 0.603 ' HB3' ' HB ' ' F' ' 122' ' ' THR . . . -147.22 118.81 7.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.6 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 70' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -96.81 140.75 30.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.066 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 71' ' ' VAL . . . . . 0.482 HG11 HG21 ' F' ' 131' ' ' ILE . 3.1 t -118.55 139.79 44.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.713 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 72' ' ' ALA . . . . . 0.405 ' HA ' HD21 ' F' ' 111' ' ' LEU . . . -140.58 133.91 29.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.562 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 73' ' ' PHE . . . . . 0.773 ' HD2' HD13 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -101.19 138.07 38.71 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 122.338 -0.226 . . . . 0.0 111.172 179.603 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 74' ' ' LEU . . . . . 0.402 ' HB3' ' H ' ' F' ' 153' ' ' THR . 6.6 tt -101.07 91.08 4.39 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.003 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.4 -167.41 11.32 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.869 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 76' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.3 OUTLIER -116.74 159.51 22.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.611 0.243 . . . . 0.0 110.701 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 77' ' ' ALA . . . . . 0.519 ' HB2' HG23 ' F' ' 83' ' ' THR . . . -83.93 137.93 33.41 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.984 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 78' ' ' ILE . . . . . 0.459 HG22 ' O ' ' F' ' 82' ' ' HIS . 9.0 tt -77.14 -40.51 30.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.913 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 79' ' ' ASP . . . . . 0.613 ' HB2' HG21 ' F' ' 140' ' ' THR . 0.1 OUTLIER -141.22 55.24 1.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.82 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 52.94 -84.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.086 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 81' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' F' ' 79' ' ' ASP . . . -60.12 -16.02 39.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.611 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 82' ' ' HIS . . . . . 0.459 ' O ' HG22 ' F' ' 78' ' ' ILE . 24.2 m80 -100.64 56.69 0.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.912 0.386 . . . . 0.0 110.566 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 83' ' ' THR . . . . . 0.519 HG23 ' HB2' ' F' ' 77' ' ' ALA . 1.1 m -71.35 -22.47 61.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.567 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 84' ' ' ASN . . . . . 0.735 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 8.6 p-10 -57.12 -18.75 16.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.409 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 85' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' F' ' 138' ' ' PHE . 11.5 t -115.15 133.42 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.25 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 86' ' ' LEU . . . . . 0.925 HD12 HD22 ' F' ' 113' ' ' LEU . 0.8 OUTLIER -73.0 154.05 40.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 87' ' ' ALA . . . . . 0.601 ' N ' HD23 ' F' ' 86' ' ' LEU . . . -90.66 -161.41 0.8 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.823 0.344 . . . . 0.0 111.778 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.24 6.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.988 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.67 -83.95 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.282 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.26 20.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.443 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 91' ' ' SER . . . . . 0.775 ' HB2' ' HB2' ' F' ' 95' ' ' SER . 1.5 m -86.65 79.37 8.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.76 -31.45 38.29 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.832 0.349 . . . . 0.0 111.665 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.09 54.41 1.73 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.621 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.89 -17.2 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.946 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 95' ' ' SER . . . . . 0.775 ' HB2' ' HB2' ' F' ' 91' ' ' SER . 0.9 OUTLIER -89.39 177.25 6.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.777 0.323 . . . . 0.0 110.672 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.83 175.18 8.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.735 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 97' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' F' ' 98' ' ' ASN . 0.2 OUTLIER -137.46 137.97 39.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.289 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 98' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' F' ' 97' ' ' THR . 74.0 m-80 71.75 17.6 5.4 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.433 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.97 149.01 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.701 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.32 -176.74 35.62 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.433 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 101' ' ' VAL . . . . . 0.542 ' CG2' HD21 ' F' ' 34' ' ' LEU . 7.7 p -125.64 111.02 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 122.976 0.51 . . . . 0.0 111.735 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 102' ' ' GLN . . . . . 0.616 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 0.9 OUTLIER -81.59 147.68 29.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.883 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 103' ' ' ILE . . . . . 0.773 HD13 ' HD2' ' F' ' 73' ' ' PHE . 0.9 OUTLIER -123.64 115.86 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.566 179.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 104' ' ' LEU . . . . . 0.719 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 0.4 OUTLIER -88.63 140.5 29.39 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.661 0.267 . . . . 0.0 111.076 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 105' ' ' ASP . . . . . 0.607 ' HB2' ' HB2' ' F' ' 111' ' ' LEU . 2.1 t70 -89.29 151.99 21.8 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.68 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 106' ' ' ARG . . . . . 0.62 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -71.77 -21.11 61.78 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.73 0.3 . . . . 0.0 111.054 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 107' ' ' THR . . . . . 0.6 ' HB ' ' HA ' ' F' ' 120' ' ' SER . 5.9 t -62.88 -21.87 66.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.063 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.65 -83.03 0.19 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.695 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.69 170.67 15.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.751 0.31 . . . . 0.0 111.063 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 110' ' ' ALA . . . . . 0.719 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -74.85 138.61 42.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.225 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 111' ' ' LEU . . . . . 0.607 ' HB2' ' HB2' ' F' ' 105' ' ' ASP . 5.1 tp -94.47 153.4 17.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.329 0.585 . . . . 0.0 110.531 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 112' ' ' THR . . . . . 0.785 HG22 HG21 ' F' ' 117' ' ' THR . 6.2 t -93.71 148.27 22.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.094 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 113' ' ' LEU . . . . . 0.925 HD22 HD12 ' F' ' 86' ' ' LEU . 1.4 mp -89.51 64.73 6.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.784 0.326 . . . . 0.0 110.777 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 114' ' ' ASP . . . . . 0.555 ' HB2' ' OG1' ' F' ' 117' ' ' THR . 0.5 OUTLIER -95.05 -15.96 23.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.723 0.297 . . . . 0.0 111.685 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.36 -56.21 0.57 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.691 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.59 29.07 5.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.961 0.41 . . . . 0.0 111.626 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 117' ' ' THR . . . . . 0.785 HG21 HG22 ' F' ' 112' ' ' THR . 3.4 m -87.23 65.89 9.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.069 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 118' ' ' PHE . . . . . 0.527 ' HB3' ' HB1' ' F' ' 70' ' ' ALA . 48.5 m-85 -77.68 73.39 4.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.806 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.49 70.91 0.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 120' ' ' SER . . . . . 0.6 ' HA ' ' HB ' ' F' ' 107' ' ' THR . 0.7 OUTLIER -148.68 126.06 11.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.696 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.04 53.17 2.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.205 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 122' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' F' ' 69' ' ' ALA . 0.2 OUTLIER -73.97 128.32 35.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.765 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.35 117.86 25.42 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.772 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tp -88.45 134.79 33.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.761 0.315 . . . . 0.0 110.498 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 125' ' ' ASN . . . . . 0.53 ' HB3' ' O ' ' C' ' 116' ' ' ALA . 0.3 OUTLIER -129.3 163.09 26.43 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.63 179.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 126' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' F' ' 62' ' ' ASP . 1.5 t30 -67.61 125.43 26.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.699 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 127' ' ' GLY . . . . . 0.661 ' HA2' HG21 ' B' ' 4' ' ' THR . . . 128.55 -141.0 12.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.707 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 128' ' ' THR . . . . . 0.727 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 6.3 m -101.74 92.44 4.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.716 0.293 . . . . 0.0 110.809 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 129' ' ' ASN . . . . . 0.529 ' HB2' ' SG ' ' F' ' 61' ' ' CYS . 1.2 t30 -76.55 144.99 39.33 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.881 0.372 . . . . 0.0 111.14 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 130' ' ' THR . . . . . 0.717 HG21 HD21 ' C' ' 74' ' ' LEU . 0.0 OUTLIER -134.61 131.76 38.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.073 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 131' ' ' ILE . . . . . 0.688 HD11 HG12 ' F' ' 156' ' ' VAL . 28.1 mt -87.31 109.81 28.66 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 132' ' ' PRO . . . . . 0.62 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.4 Cg_endo -81.67 112.16 2.38 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.617 1.544 . . . . 0.0 112.558 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.36 138.21 51.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.842 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 134' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' F' ' 52' ' ' VAL . 28.2 mt-30 -110.08 157.5 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.007 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 135' ' ' ALA . . . . . 0.672 ' HB3' HG22 ' F' ' 52' ' ' VAL . . . -152.69 107.87 3.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 111.606 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -102.47 174.37 5.93 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.378 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 137' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 0.6 OUTLIER -86.04 120.83 27.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.08 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 138' ' ' PHE . . . . . 0.516 ' HB3' HG11 ' F' ' 85' ' ' VAL . 0.2 OUTLIER -117.64 139.67 50.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.056 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 139' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' F' ' 47' ' ' ALA . . . -129.96 145.57 51.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.902 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 140' ' ' THR . . . . . 0.613 HG21 ' HB2' ' F' ' 79' ' ' ASP . 16.5 p -104.36 -53.38 2.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.511 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.73 -121.47 3.26 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.995 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.12 112.93 24.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.549 0.214 . . . . 0.0 110.649 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 143' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' F' ' 42' ' ' LEU . . . -61.73 150.88 35.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.76 0.314 . . . . 0.0 111.479 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 144' ' ' THR . . . . . 0.544 HG23 ' HD2' ' F' ' 145' ' ' PRO . 60.1 m -126.85 151.52 73.88 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.27 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 145' ' ' PRO . . . . . 0.544 ' HD2' HG23 ' F' ' 144' ' ' THR . 1.4 Cg_endo -82.96 140.14 9.96 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.573 2.182 . . . . 0.0 112.024 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.98 -138.07 6.55 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.529 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 147' ' ' ALA . . . . . 0.594 ' HA ' ' HG3' ' E' ' 15' ' ' GLU . . . -87.22 145.04 26.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.881 0.372 . . . . 0.0 111.344 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 148' ' ' ALA . . . . . 0.736 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -140.77 38.79 1.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.558 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.04 153.57 22.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.549 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 150' ' ' ALA . . . . . 0.599 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -161.92 171.2 18.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.997 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.41 126.79 7.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.193 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 152' ' ' ALA . . . . . 0.528 ' HB2' ' CD1' ' F' ' 86' ' ' LEU . . . -125.34 142.81 51.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.341 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 153' ' ' THR . . . . . 0.811 HG23 HG23 ' E' ' 9' ' ' THR . 0.4 OUTLIER -89.88 133.19 34.89 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 154' ' ' PHE . . . . . 0.517 ' HD1' ' HA ' ' F' ' 154' ' ' PHE . 0.0 OUTLIER -86.34 127.83 34.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.025 0.441 . . . . 0.0 110.131 -179.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.47 150.5 29.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.941 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 156' ' ' VAL . . . . . 0.802 HG23 HG23 ' E' ' 5' ' ' VAL . 14.5 m -136.19 144.42 33.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 111.597 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 157' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' F' ' 69' ' ' ALA . 0.0 OUTLIER -136.23 132.79 36.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.364 0.602 . . . . 0.0 110.382 -179.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 158' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' F' ' 21' ' ' CYS . 5.5 m-85 -117.41 119.78 36.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.563 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 159' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' E' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.867 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.327 0.108 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.37 88.97 0.04 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.034 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.17 114.5 18.43 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.414 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -97.3 119.2 35.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.664 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.654 HG23 HG22 ' B' ' 156' ' ' VAL . 19.5 m -136.58 158.25 37.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.584 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.12 115.94 22.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.607 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.63 -79.61 0.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.851 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.511 ' H ' ' HB3' ' B' ' 154' ' ' PHE . . . -148.55 -145.94 4.24 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.05 -0.595 . . . . 0.0 111.903 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.556 HG22 HG23 ' B' ' 153' ' ' THR . 15.0 p -142.05 145.14 34.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.0 0.428 . . . . 0.0 111.24 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.5 t -127.83 119.5 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.245 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.46 113.16 25.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.386 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.75 90.68 5.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.799 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.11 120.72 32.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.367 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.05 170.5 32.64 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.91 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.653 ' HG3' ' O ' ' B' ' 146' ' ' GLY . 21.4 tt0 -160.61 129.19 4.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.943 0.402 . . . . 0.0 110.364 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.792 HG13 HG13 ' B' ' 37' ' ' VAL . 2.2 t -89.66 136.95 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.191 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.771 ' O ' HG22 ' B' ' 39' ' ' THR . 34.3 m -136.37 -160.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.781 0.324 . . . . 0.0 111.134 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.95 177.08 6.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.013 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' B' ' 40' ' ' ALA . . . -90.25 49.61 1.72 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.064 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -122.17 -39.66 2.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.394 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.675 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.5 OUTLIER -162.15 146.38 12.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.943 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.02 121.65 14.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.637 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 2.5 p -63.71 143.5 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.054 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.562 ' HB3' ' HB2' ' A' ' 27' ' ' SER . 13.5 t70 -72.9 154.62 40.5 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.581 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.446 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -54.31 -53.89 47.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.354 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.54 1.03 88.67 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.88 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.562 ' HB2' ' HB3' ' A' ' 24' ' ' ASP . 7.9 t -99.28 -16.66 18.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.879 0.371 . . . . 0.0 110.836 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 25' ' ' ALA . 10.9 t -53.18 -50.84 44.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.355 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -114.06 126.16 54.79 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.973 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.423 HE22 ' HA ' ' A' ' 56' ' ' ILE . 3.7 mt-30 -125.61 135.6 52.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.051 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.92 109.11 21.91 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.099 -0.5 . . . . 0.0 112.128 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.51 115.14 48.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.086 0.47 . . . . 0.0 110.475 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.17 124.72 50.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.662 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.24 -42.31 23.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.602 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.1 -165.42 12.15 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.574 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -93.57 119.21 32.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.62 0.248 . . . . 0.0 110.854 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.426 ' HB ' ' CE2' ' A' ' 137' ' ' TYR . 8.2 p -104.88 133.95 47.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.871 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -79.93 137.65 36.93 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.667 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.5 -49.42 75.45 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.767 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.55 -33.48 54.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.026 0.441 . . . . 0.0 110.872 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.38 61.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.114 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.622 ' O ' ' HB2' ' A' ' 143' ' ' ALA . 0.6 OUTLIER -114.04 39.82 2.63 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.619 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.24 33.94 3.29 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.396 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.664 ' HB2' ' HB2' ' A' ' 47' ' ' ALA . 0.3 OUTLIER -124.48 142.87 50.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.346 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.22 95.69 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 0.0 111.146 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.4 33.69 5.84 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.152 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 44' ' ' GLN . . . -78.83 143.55 35.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.981 0.42 . . . . 0.0 111.958 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.507 ' HB ' ' HD2' ' A' ' 136' ' ' ARG . 18.1 p -131.67 131.93 43.55 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.902 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 1.3 m -103.78 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.548 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -57.78 141.9 47.29 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.866 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -99.07 125.51 44.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.393 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 135' ' ' ALA . 24.8 m -76.51 150.99 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.956 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.34 143.29 16.43 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.516 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.4 ' HE2' ' HB3' ' A' ' 135' ' ' ALA . 37.5 p90 -171.48 140.44 1.39 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.844 0.354 . . . . 0.0 110.925 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -136.32 138.56 41.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.582 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.534 HG23 ' O ' ' A' ' 56' ' ' ILE . 0.7 OUTLIER -88.42 116.79 30.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.554 -179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.85 ' HA ' HG23 ' A' ' 130' ' ' THR . 5.0 mp0 -69.36 138.31 53.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.783 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.643 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -145.6 91.66 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.287 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.529 ' HA ' HG23 ' A' ' 128' ' ' THR . 8.2 p30 -78.43 176.89 8.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.938 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.793 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.675 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 10.5 m -133.87 147.78 51.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.76 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.71 161.93 20.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.321 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.63 HG23 ' HA ' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -111.79 -34.18 6.1 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -72.54 -28.18 62.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.037 0.446 . . . . 0.0 111.718 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.18 -58.54 4.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.703 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.2 126.07 32.67 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.575 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -42.15 7.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.954 0.407 . . . . 0.0 110.943 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.24 156.83 18.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.517 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.642 ' HB3' ' HB ' ' A' ' 122' ' ' THR . . . -146.63 133.23 19.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.57 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -113.38 155.11 25.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.104 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.791 HG11 HG21 ' A' ' 131' ' ' ILE . 2.0 t -136.4 148.57 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.684 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 155' ' ' LYS . . . -152.9 163.48 39.7 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.659 -0.246 . . . . 0.0 110.6 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.441 ' CD1' ' HB1' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -130.23 142.28 50.57 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 122.409 -0.182 . . . . 0.0 111.16 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 152' ' ' ALA . 1.4 tt -109.16 119.05 38.35 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.066 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.825 ' HA3' HD22 ' A' ' 113' ' ' LEU . . . -162.74 -161.92 12.93 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.769 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.633 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.3 OUTLIER -120.92 162.92 19.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.578 0.228 . . . . 0.0 110.779 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' A' ' 87' ' ' ALA . . . -83.57 139.08 33.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.934 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.531 HG23 ' N ' ' A' ' 79' ' ' ASP . 11.1 tt -66.09 -47.61 84.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.987 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.531 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -134.46 46.69 2.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.849 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.608 ' HB1' ' O ' ' D' ' 105' ' ' ASP . . . 64.49 -84.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.078 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.77 -36.4 40.9 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.603 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.43 69.2 10.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.888 0.375 . . . . 0.0 110.523 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -74.1 -7.51 52.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.487 -179.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.625 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 30.0 p-10 -74.74 -25.39 59.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.334 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.602 HG11 ' HB3' ' A' ' 138' ' ' PHE . 6.4 t -104.92 143.84 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.169 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.611 ' HG ' HD13 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -74.8 160.86 30.17 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.338 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.688 ' HB2' ' O ' ' A' ' 77' ' ' ALA . . . -103.64 179.85 4.15 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.874 0.369 . . . . 0.0 111.712 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.717 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 1.3 mm? -66.58 171.29 5.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.045 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.562 ' HG3' ' HB2' ' A' ' 149' ' ' ASN . 1.3 mm-40 -68.61 -83.7 0.03 OUTLIER 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.265 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.412 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 6.0 p -169.12 19.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.959 0.409 . . . . 0.0 111.451 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.542 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 3.2 m -90.16 86.28 6.5 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' D' ' 50' ' ' SER . . . -61.16 -24.99 66.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.631 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.4 41.25 3.52 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.66 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.96 0.69 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.858 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.85 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 1.9 m -89.26 -173.59 4.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.773 0.321 . . . . 0.0 110.71 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.425 ' HB3' HD11 ' A' ' 88' ' ' LEU . . . -100.99 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 99' ' ' VAL . 3.0 m -131.06 123.92 29.72 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.299 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.21 29.43 18.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.459 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 97' ' ' THR . 1.7 t -125.31 129.33 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.835 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.85 -171.06 21.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.522 ' CG2' ' HB1' ' A' ' 135' ' ' ALA . 1.9 p -122.97 116.71 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.204 0.526 . . . . 0.0 111.69 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.55 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 2.8 tt0 -81.74 151.45 27.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.915 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.82 123.84 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.531 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.655 HD13 ' NE2' ' A' ' 134' ' ' GLN . 0.5 OUTLIER -104.72 125.18 50.55 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.658 0.266 . . . . 0.0 111.013 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.805 ' HB3' HG22 ' A' ' 107' ' ' THR . 13.6 t0 -77.57 143.07 38.62 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.672 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.697 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -62.73 -14.86 49.49 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.742 0.306 . . . . 0.0 111.043 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.805 HG22 ' HB3' ' A' ' 105' ' ' ASP . 8.8 t -63.04 -20.94 65.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.012 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.28 -43.57 1.36 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.735 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.69 160.71 14.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.767 0.318 . . . . 0.0 111.082 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.36 133.16 40.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.125 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.659 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 12.3 tp -95.54 160.94 14.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.373 0.606 . . . . 0.0 110.531 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 2.9 t -110.21 136.81 48.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.076 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.825 HD22 ' HA3' ' A' ' 75' ' ' GLY . 1.4 mt -70.25 89.64 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.76 0.314 . . . . 0.0 110.689 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -18.43 6.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.487 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -62.25 0.88 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.664 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.566 ' HB3' ' OD1' ' D' ' 129' ' ' ASN . . . -92.95 18.23 9.43 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.993 0.425 . . . . 0.0 111.659 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.548 HG21 HG23 ' A' ' 112' ' ' THR . 0.0 OUTLIER -83.97 72.58 10.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.065 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.604 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 78.4 m-85 -92.32 89.77 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.799 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 54.6 m -130.56 73.11 1.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.91 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.21 142.32 21.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.682 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.98 68.56 0.91 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.208 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.642 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -81.51 133.14 35.35 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.684 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 8.7 m -87.6 124.13 33.19 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.681 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.3 119.32 35.59 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.648 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.63 ' HA ' HG23 ' A' ' 63' ' ' THR . 2.9 m120 -113.71 171.91 7.29 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.587 179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.48 109.75 16.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.647 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.82 -133.8 4.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.714 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.529 HG23 ' HA ' ' A' ' 59' ' ' ASN . 46.1 m -110.5 86.75 2.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.742 0.306 . . . . 0.0 110.794 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -69.34 155.07 41.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.829 0.347 . . . . 0.0 111.162 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.85 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -142.79 137.07 29.44 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.089 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.791 HG21 HG11 ' A' ' 71' ' ' VAL . 6.9 mt -100.25 109.12 55.66 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.697 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.5 Cg_endo -81.76 148.25 15.67 Favored 'Trans proline' 0 C--N 1.356 0.933 0 C-N-CA 121.721 1.614 . . . . 0.0 112.536 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.413 ' CZ ' ' HA ' ' A' ' 105' ' ' ASP . 0.5 OUTLIER -158.82 145.31 17.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.908 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.655 ' NE2' HD13 ' A' ' 104' ' ' LEU . 5.2 mt-30 -111.24 160.4 17.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.024 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.766 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -155.98 97.82 1.84 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.951 0.405 . . . . 0.0 111.613 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.507 ' HD2' ' HB ' ' A' ' 48' ' ' THR . 14.4 ptt180 -101.57 173.61 6.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.41 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 1.8 m-85 -83.64 135.04 34.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.134 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.602 ' HB3' HG11 ' A' ' 85' ' ' VAL . 1.7 t80 -128.86 128.18 43.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.022 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.454 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -108.52 138.0 45.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.817 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.529 HG21 ' HB2' ' A' ' 79' ' ' ASP . 0.3 OUTLIER -89.94 -9.56 48.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.494 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.31 -95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.963 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.71 101.49 11.33 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.513 0.197 . . . . 0.0 110.737 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 42' ' ' LEU . . . -61.36 144.35 54.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.749 0.309 . . . . 0.0 111.378 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.602 ' CG2' ' CD ' ' A' ' 145' ' ' PRO . 99.2 m -123.94 153.15 67.42 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.22 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.602 ' CD ' ' CG2' ' A' ' 144' ' ' THR . 1.3 Cg_endo -83.01 144.78 12.14 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.523 2.149 . . . . 0.0 111.989 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.3 -116.09 0.7 Allowed Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.503 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.85 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -119.73 132.37 55.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.892 0.377 . . . . 0.0 111.361 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.37 43.36 3.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.13 0.491 . . . . 0.0 110.414 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.562 ' HB2' ' HG3' ' A' ' 89' ' ' GLN . 1.1 m120 -95.68 150.88 19.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.586 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.507 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -168.5 -178.63 3.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.017 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.78 153.0 39.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.238 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -141.22 151.12 43.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.239 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.66 133.73 54.55 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.71 148.72 28.82 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.093 0.473 . . . . 0.0 110.112 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 118' ' ' PHE . 11.2 mmtt -135.02 139.43 44.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.949 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.403 HG12 ' CD1' ' A' ' 131' ' ' ILE . 3.1 m -134.52 141.3 43.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.778 0.323 . . . . 0.0 111.685 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.547 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 3.8 tt0 -128.78 128.97 45.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.318 0.58 . . . . 0.0 110.358 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.71 128.59 51.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.565 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.33 0.109 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.37 88.99 0.04 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.588 0.232 . . . . 0.0 111.022 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.18 114.49 18.41 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.402 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -97.31 119.19 35.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.65 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.654 HG23 HG22 ' C' ' 156' ' ' VAL . 19.4 m -136.58 158.24 37.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.525 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.16 115.99 22.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.552 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.64 -79.61 0.13 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.873 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.514 ' H ' ' HB3' ' C' ' 154' ' ' PHE . . . -148.56 -145.9 4.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.879 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.561 HG22 HG23 ' C' ' 153' ' ' THR . 14.9 p -142.11 145.12 33.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.052 0.453 . . . . 0.0 111.225 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 32.5 t -127.8 119.51 51.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.267 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.44 113.14 25.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.377 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.7 90.72 5.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.814 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.15 120.71 32.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.337 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.02 170.48 32.62 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.908 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.642 ' HG3' ' O ' ' C' ' 146' ' ' GLY . 21.4 tt0 -160.59 129.19 4.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.975 0.417 . . . . 0.0 110.395 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.809 HG13 HG13 ' C' ' 37' ' ' VAL . 2.2 t -89.66 136.93 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.226 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.753 ' O ' HG22 ' C' ' 39' ' ' THR . 34.3 m -136.35 -160.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.785 0.326 . . . . 0.0 111.157 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.93 177.02 6.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.977 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' C' ' 40' ' ' ALA . . . -90.21 49.67 1.73 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.053 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' B' ' 61' ' ' CYS . . . -122.19 -39.67 2.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.437 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.701 ' HG ' ' HG ' ' B' ' 61' ' ' CYS . 0.5 OUTLIER -162.13 146.38 12.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.959 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.04 121.62 14.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.623 ' HA ' ' HG ' ' B' ' 58' ' ' LEU . 2.4 p -63.71 143.54 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.037 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.561 ' HB3' ' HB2' ' B' ' 27' ' ' SER . 13.6 t70 -72.94 154.65 40.46 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.582 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.439 ' O ' HG23 ' B' ' 28' ' ' VAL . . . -54.33 -53.88 47.86 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.341 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.55 1.05 88.65 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.868 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.561 ' HB2' ' HB3' ' B' ' 24' ' ' ASP . 7.9 t -99.29 -16.68 18.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.872 0.367 . . . . 0.0 110.826 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 25' ' ' ALA . 10.7 t -53.14 -50.85 43.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.377 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -114.08 126.19 54.82 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.972 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLN . . . . . 0.43 HE22 ' HA ' ' B' ' 56' ' ' ILE . 3.7 mt-30 -125.61 135.57 52.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.064 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.92 109.17 21.95 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.117 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.57 115.16 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.123 0.487 . . . . 0.0 110.463 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.2 124.74 50.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.631 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.26 -42.34 23.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.596 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.13 -165.34 12.14 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.557 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 3.7 mt-30 -93.65 119.24 32.42 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.64 0.257 . . . . 0.0 110.834 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.792 HG13 HG13 ' A' ' 16' ' ' VAL . 8.2 p -104.91 133.94 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.87 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' B' ' 41' ' ' SER . 0.1 OUTLIER -79.92 137.62 36.93 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.668 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -62.53 -49.38 75.56 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.762 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 19' ' ' ALA . . . -53.52 -33.5 54.74 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.01 0.433 . . . . 0.0 110.865 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' B' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.33 61.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.112 -179.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' B' ' 143' ' ' ALA . 0.6 OUTLIER -114.07 39.81 2.64 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.613 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.2 33.96 3.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.448 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 0.667 ' HB2' ' HB2' ' B' ' 47' ' ' ALA . 0.3 OUTLIER -124.48 142.88 50.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.344 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.25 95.7 0.31 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.88 0.371 . . . . 0.0 111.148 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.43 33.63 5.85 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.139 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.667 ' HB2' ' HB2' ' B' ' 44' ' ' GLN . . . -78.87 143.5 35.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.977 0.418 . . . . 0.0 111.949 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.494 ' HB ' ' HD2' ' B' ' 136' ' ' ARG . 18.1 p -131.61 131.9 43.62 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.895 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 1.3 m -103.75 -167.22 1.34 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.572 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -57.82 141.91 47.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.863 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.465 ' HB2' ' HB3' ' B' ' 136' ' ' ARG . . . -99.05 125.52 44.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.377 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.773 HG22 ' O ' ' B' ' 135' ' ' ALA . 24.8 m -76.53 151.0 6.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.961 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.36 143.28 16.44 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.527 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -171.47 140.44 1.4 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.801 0.334 . . . . 0.0 110.936 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -136.33 138.6 41.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.571 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.542 HG23 ' O ' ' B' ' 56' ' ' ILE . 0.7 OUTLIER -88.45 116.79 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.542 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . 0.842 ' HA ' HG23 ' B' ' 130' ' ' THR . 5.0 mp0 -69.38 138.31 53.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.802 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.643 ' HB3' ' SG ' ' B' ' 21' ' ' CYS . 0.3 OUTLIER -145.58 91.67 2.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.276 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.525 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 8.2 p30 -78.43 176.86 8.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.912 0.387 . . . . 0.0 110.915 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.92 81.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.783 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' CYS . . . . . 0.701 ' HG ' ' HG ' ' B' ' 21' ' ' CYS . 10.4 m -133.85 147.8 51.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.78 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.7 161.91 20.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.349 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.644 HG23 ' HA ' ' B' ' 125' ' ' ASN . 0.0 OUTLIER -111.75 -34.19 6.1 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 -72.52 -28.2 62.72 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.072 0.463 . . . . 0.0 111.735 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.18 -58.56 4.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.658 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.22 126.06 32.62 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.592 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.39 -42.09 7.13 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.956 0.407 . . . . 0.0 110.954 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . 0.441 ' HD2' ' HA ' ' B' ' 68' ' ' LYS . 1.2 tptp -89.28 156.8 18.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.465 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.651 ' HB3' ' HB ' ' B' ' 122' ' ' THR . . . -146.61 133.21 19.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.609 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -113.35 155.11 25.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.137 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.763 HG11 HG21 ' B' ' 131' ' ' ILE . 2.0 t -136.39 148.53 27.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.725 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' B' ' 155' ' ' LYS . . . -152.9 163.51 39.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.553 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.441 ' CD1' ' HB1' ' B' ' 152' ' ' ALA . 0.2 OUTLIER -130.23 142.25 50.58 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 122.411 -0.181 . . . . 0.0 111.207 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' B' ' 152' ' ' ALA . 1.4 tt -109.12 119.05 38.36 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.053 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.793 ' HA3' HD22 ' B' ' 113' ' ' LEU . . . -162.74 -161.9 12.89 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.757 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.64 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.3 OUTLIER -120.97 162.92 19.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.59 0.233 . . . . 0.0 110.788 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.694 ' O ' ' HB2' ' B' ' 87' ' ' ALA . . . -83.54 139.08 33.1 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.936 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.538 HG23 ' N ' ' B' ' 79' ' ' ASP . 11.1 tt -66.09 -47.64 84.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.973 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.542 ' HB2' HG21 ' B' ' 140' ' ' THR . 0.2 OUTLIER -134.42 46.69 2.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.891 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' E' ' 105' ' ' ASP . . . 64.48 -83.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.096 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.79 -36.42 41.17 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.576 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.4 69.19 10.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.875 0.369 . . . . 0.0 110.541 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' THR . . . . . 0.477 HG23 ' HB2' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -74.08 -7.53 52.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.549 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . 0.603 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 30.1 p-10 -74.69 -25.4 59.13 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.383 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.6 HG11 ' HB3' ' B' ' 138' ' ' PHE . 6.4 t -104.92 143.88 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.17 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.6 ' HG ' HD13 ' B' ' 113' ' ' LEU . 0.3 OUTLIER -74.84 160.89 30.11 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.265 179.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' B' ' 77' ' ' ALA . . . -103.66 179.88 4.15 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.861 0.363 . . . . 0.0 111.702 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.699 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 1.3 mm? -66.59 171.3 5.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.038 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . 0.563 ' HG3' ' HB2' ' B' ' 149' ' ' ASN . 1.3 mm-40 -68.57 -83.75 0.03 OUTLIER 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.275 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . 0.409 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 5.9 p -169.11 19.16 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.907 0.384 . . . . 0.0 111.426 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . 0.535 ' HA ' ' HB2' ' D' ' 25' ' ' ALA . 3.2 m -90.13 86.26 6.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.905 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.505 ' HB2' HG13 ' E' ' 52' ' ' VAL . . . -61.1 -25.03 66.68 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.652 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.42 41.31 3.5 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.638 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.03 0.72 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.828 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' SER . . . . . 0.846 ' HA ' ' HB3' ' B' ' 147' ' ' ALA . 1.9 m -89.28 -173.58 4.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.784 0.326 . . . . 0.0 110.71 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.418 ' HB3' HD11 ' B' ' 88' ' ' LEU . . . -100.97 -177.3 3.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.409 ' O ' HG23 ' B' ' 99' ' ' VAL . 3.0 m -131.03 123.94 29.82 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.301 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 61.18 29.46 18.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.462 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 97' ' ' THR . 1.7 t -125.31 129.33 73.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.86 -171.15 21.99 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.515 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.533 HG13 ' HB2' ' B' ' 86' ' ' LEU . 1.9 p -122.89 116.72 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.208 0.528 . . . . 0.0 111.682 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.54 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 2.8 tt0 -81.77 151.46 27.42 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.923 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.83 123.82 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.511 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . 0.659 HD13 ' NE2' ' B' ' 134' ' ' GLN . 0.5 OUTLIER -104.68 125.17 50.52 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.645 0.26 . . . . 0.0 111.041 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . 0.8 ' HB3' HG22 ' B' ' 107' ' ' THR . 13.6 t0 -77.61 143.12 38.5 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.659 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . 0.719 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -62.75 -14.88 49.93 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.722 0.296 . . . . 0.0 111.048 179.45 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.8 HG22 ' HB3' ' B' ' 105' ' ' ASP . 8.8 t -62.97 -20.96 65.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.024 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.3 -43.57 1.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.729 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.7 160.71 14.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.327 . . . . 0.0 111.088 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.35 133.18 40.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.122 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.66 ' HB2' ' HB2' ' B' ' 105' ' ' ASP . 12.3 tp -95.56 160.9 14.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.401 0.619 . . . . 0.0 110.469 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 2.9 t -110.19 136.8 48.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.075 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.793 HD22 ' HA3' ' B' ' 75' ' ' GLY . 1.4 mt -70.22 89.59 0.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.764 0.316 . . . . 0.0 110.655 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.34 -18.46 6.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.509 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.3 -62.27 0.87 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.645 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . 0.568 ' HB3' ' OD1' ' E' ' 129' ' ' ASN . . . -92.95 18.23 9.44 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 121.023 0.44 . . . . 0.0 111.668 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.546 HG21 HG23 ' B' ' 112' ' ' THR . 0.0 OUTLIER -83.91 72.53 10.41 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.039 -179.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.588 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . 78.3 m-85 -92.35 89.8 6.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.775 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 55.1 m -130.58 73.15 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.92 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.23 142.29 21.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.691 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -103.96 68.55 0.91 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.194 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.651 ' HB ' ' HB3' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -81.43 133.16 35.37 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.72 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 8.7 m -87.61 124.14 33.21 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.687 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.33 119.34 35.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.633 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.644 ' HA ' HG23 ' B' ' 63' ' ' THR . 2.9 m120 -113.74 171.94 7.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.573 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.5 109.76 16.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.646 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.8 -133.79 4.69 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.712 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 46.4 m -110.53 86.75 2.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.759 0.314 . . . . 0.0 110.807 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.32 155.05 41.06 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.222 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.842 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -142.76 137.1 29.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.092 -179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' ILE . . . . . 0.763 HG21 HG11 ' B' ' 71' ' ' VAL . 6.9 mt -100.26 109.07 55.53 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' PRO . . . . . 0.719 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.73 148.26 15.73 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 121.666 1.577 . . . . 0.0 112.543 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.408 ' CZ ' ' HA ' ' B' ' 105' ' ' ASP . 0.5 OUTLIER -158.8 145.32 17.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.921 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' GLN . . . . . 0.659 ' NE2' HD13 ' B' ' 104' ' ' LEU . 5.2 mt-30 -111.24 160.4 17.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.034 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.773 ' O ' HG22 ' B' ' 52' ' ' VAL . . . -156.0 97.79 1.84 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.956 0.408 . . . . 0.0 111.589 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . 0.494 ' HD2' ' HB ' ' B' ' 48' ' ' THR . 14.4 ptt180 -101.54 173.59 6.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.405 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 1.8 m-85 -83.62 135.04 34.76 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.181 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . 0.6 ' HB3' HG11 ' B' ' 85' ' ' VAL . 1.8 t80 -128.88 128.18 43.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.988 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.462 ' HB2' HD23 ' B' ' 42' ' ' LEU . . . -108.53 138.0 45.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.86 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' THR . . . . . 0.542 HG21 ' HB2' ' B' ' 79' ' ' ASP . 0.3 OUTLIER -89.96 -9.55 48.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.478 179.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.3 -95.23 0.1 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.951 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.74 101.52 11.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.514 0.197 . . . . 0.0 110.744 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' B' ' 42' ' ' LEU . . . -61.39 144.35 54.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.73 0.3 . . . . 0.0 111.379 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.598 ' CG2' ' CD ' ' B' ' 145' ' ' PRO . 99.2 m -123.95 153.17 67.47 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.196 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.598 ' CD ' ' CG2' ' B' ' 144' ' ' THR . 1.3 Cg_endo -83.04 144.78 12.11 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 122.519 2.146 . . . . 0.0 112.006 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . 0.653 ' O ' ' HG3' ' A' ' 15' ' ' GLU . . . 157.3 -116.09 0.7 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.494 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.846 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -119.75 132.4 55.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.903 0.382 . . . . 0.0 111.316 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . 0.606 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -125.39 43.33 3.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.16 0.505 . . . . 0.0 110.417 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.563 ' HB2' ' HG3' ' B' ' 89' ' ' GLN . 1.1 m120 -95.65 150.88 19.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.573 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.512 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -168.49 -178.63 3.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.03 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.77 152.98 39.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.261 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -141.2 151.11 43.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.264 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.556 HG23 HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -112.69 133.75 54.56 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.263 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.511 ' HB3' ' H ' ' A' ' 8' ' ' GLY . 0.1 OUTLIER -81.65 148.68 28.91 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.053 0.454 . . . . 0.0 110.158 -179.062 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.555 ' HB3' ' CZ ' ' B' ' 118' ' ' PHE . 11.2 mmtt -135.03 139.49 44.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.928 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' VAL . . . . . 0.654 HG22 HG23 ' A' ' 5' ' ' VAL . 3.1 m -134.55 141.27 43.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.776 0.322 . . . . 0.0 111.698 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.537 ' HB3' ' HB3' ' B' ' 70' ' ' ALA . 3.9 tt0 -128.79 128.96 45.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.346 0.593 . . . . 0.0 110.353 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.72 128.62 51.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.583 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.841 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.261 0.077 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.4 88.97 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.724 -0.217 . . . . 0.0 111.004 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.19 114.48 18.39 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.436 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -97.26 119.19 35.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.644 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.635 HG23 HG22 ' D' ' 156' ' ' VAL . 19.5 m -136.56 158.26 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.63 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.15 115.99 22.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.578 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.66 -79.58 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.876 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . 0.512 ' H ' ' HB3' ' D' ' 154' ' ' PHE . . . -148.55 -145.97 4.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.898 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . 0.564 HG22 HG23 ' D' ' 153' ' ' THR . 15.2 p -142.03 145.12 34.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.956 0.408 . . . . 0.0 111.32 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 32.0 t -127.82 119.53 51.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.26 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.43 113.17 25.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.391 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -95.75 90.66 5.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.792 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.1 120.73 32.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.357 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.04 170.48 32.63 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.918 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' GLU . . . . . 0.653 ' HG3' ' O ' ' D' ' 146' ' ' GLY . 21.4 tt0 -160.6 129.19 4.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.987 0.423 . . . . 0.0 110.368 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.778 HG13 HG13 ' D' ' 37' ' ' VAL . 2.2 t -89.66 136.91 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.246 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.767 ' O ' HG22 ' D' ' 39' ' ' THR . 34.3 m -136.35 -160.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.767 0.318 . . . . 0.0 111.147 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.98 177.01 6.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.998 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' D' ' 40' ' ' ALA . . . -90.16 49.59 1.73 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.038 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' C' ' 61' ' ' CYS . . . -122.16 -39.69 2.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.398 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' CYS . . . . . 0.707 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.5 OUTLIER -162.13 146.39 12.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.943 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.05 121.61 14.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.141 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . 0.616 ' HA ' ' HG ' ' C' ' 58' ' ' LEU . 2.4 p -63.67 143.5 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.049 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.572 ' HB3' ' HB2' ' C' ' 27' ' ' SER . 13.5 t70 -72.88 154.6 40.52 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.597 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -54.3 -53.88 47.84 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.345 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.56 1.03 88.71 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.874 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . 0.572 ' HB2' ' HB3' ' C' ' 24' ' ' ASP . 7.9 t -99.3 -16.63 18.41 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.879 0.371 . . . . 0.0 110.842 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.445 HG23 ' O ' ' C' ' 25' ' ' ALA . 10.8 t -53.18 -50.83 44.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.35 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -114.07 126.19 54.83 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.98 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' GLN . . . . . 0.43 HE22 ' HA ' ' C' ' 56' ' ' ILE . 3.7 mt-30 -125.64 135.58 52.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.063 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.91 109.11 21.9 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.13 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.5 115.15 48.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.132 0.491 . . . . 0.0 110.464 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.17 124.73 50.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.667 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.26 -42.28 23.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.584 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.08 -165.39 12.15 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.583 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . 0.588 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 3.7 mt-30 -93.62 119.2 32.35 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.626 0.25 . . . . 0.0 110.841 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.809 HG13 HG13 ' B' ' 16' ' ' VAL . 8.2 p -104.86 133.95 47.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.897 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' ARG . . . . . 0.416 ' HB2' ' HB2' ' C' ' 41' ' ' SER . 0.1 OUTLIER -79.9 137.65 36.95 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.689 179.271 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.753 HG22 ' O ' ' B' ' 17' ' ' VAL . 0.2 OUTLIER -62.51 -49.43 75.37 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.75 179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' B' ' 19' ' ' ALA . . . -53.56 -33.48 54.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.994 0.426 . . . . 0.0 110.837 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' C' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.31 61.42 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.11 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.622 ' O ' ' HB2' ' C' ' 143' ' ' ALA . 0.6 OUTLIER -114.12 39.84 2.64 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.642 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.24 33.95 3.28 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.386 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . 0.672 ' HB2' ' HB2' ' C' ' 47' ' ' ALA . 0.3 OUTLIER -124.51 142.92 50.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.289 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.26 95.7 0.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.145 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.41 33.72 5.83 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.126 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' C' ' 44' ' ' GLN . . . -78.93 143.52 35.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.976 0.417 . . . . 0.0 111.928 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' C' ' 136' ' ' ARG . 18.1 p -131.63 131.94 43.62 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.884 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.532 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 1.3 m -103.82 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.524 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 3.9 t -57.76 141.86 47.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.861 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . 0.489 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . . . -99.03 125.48 44.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.379 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.77 HG22 ' O ' ' C' ' 135' ' ' ALA . 24.7 m -76.51 150.98 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.956 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.3 143.27 16.41 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.572 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . 0.408 ' HE2' ' HB3' ' C' ' 135' ' ' ALA . 37.5 p90 -171.49 140.45 1.39 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.771 0.319 . . . . 0.0 110.895 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -136.33 138.62 41.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.541 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.541 HG23 ' O ' ' C' ' 56' ' ' ILE . 0.7 OUTLIER -88.47 116.77 30.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.554 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.846 ' HA ' HG23 ' C' ' 130' ' ' THR . 5.0 mp0 -69.33 138.29 53.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.794 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . 0.635 ' HB3' ' SG ' ' C' ' 21' ' ' CYS . 0.3 OUTLIER -145.62 91.65 2.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.281 -179.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . 0.521 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 8.2 p30 -78.46 176.86 8.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.946 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.81 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' CYS . . . . . 0.707 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 10.4 m -133.87 147.74 51.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.798 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.67 161.92 20.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.341 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.633 HG23 ' HA ' ' C' ' 125' ' ' ASN . 0.0 OUTLIER -111.77 -34.19 6.1 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -179.069 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -72.59 -28.14 62.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.045 0.45 . . . . 0.0 111.725 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 58.6 t -73.15 -58.55 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.733 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.21 126.07 32.64 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.58 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.33 -42.19 7.1 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.964 0.411 . . . . 0.0 110.938 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' C' ' 68' ' ' LYS . 1.2 tptp -89.22 156.85 18.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.502 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.64 ' HB3' ' HB ' ' C' ' 122' ' ' THR . . . -146.65 133.18 19.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.596 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.602 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -113.31 155.11 25.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.165 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . 0.752 HG11 HG21 ' C' ' 131' ' ' ILE . 2.0 t -136.4 148.54 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.7 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' C' ' 155' ' ' LYS . . . -152.88 163.49 39.68 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.579 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' PHE . . . . . 0.438 ' CD1' ' HB1' ' C' ' 152' ' ' ALA . 0.2 OUTLIER -130.24 142.28 50.57 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.468 0.175 . . . . 0.0 111.197 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' C' ' 152' ' ' ALA . 1.4 tt -109.17 119.04 38.33 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.052 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . 0.83 ' HA3' HD22 ' C' ' 113' ' ' LEU . . . -162.74 -161.82 12.79 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.736 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.631 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.3 OUTLIER -121.04 162.91 19.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.624 0.25 . . . . 0.0 110.762 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . 0.7 ' O ' ' HB2' ' C' ' 87' ' ' ALA . . . -83.54 139.08 33.1 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.933 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . 0.542 HG23 ' N ' ' C' ' 79' ' ' ASP . 11.1 tt -66.08 -47.59 84.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.94 0.4 . . . . 0.0 111.007 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' ASP . . . . . 0.542 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.2 OUTLIER -134.45 46.62 2.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.862 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' F' ' 105' ' ' ASP . . . 64.49 -84.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.075 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.75 -36.39 40.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.61 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.5 69.24 10.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.924 0.393 . . . . 0.0 110.51 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . 0.484 HG23 ' HB2' ' C' ' 77' ' ' ALA . 0.2 OUTLIER -74.13 -7.49 52.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.51 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' ASN . . . . . 0.621 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 30.0 p-10 -74.7 -25.4 59.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.36 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.612 HG11 ' HB3' ' C' ' 138' ' ' PHE . 6.4 t -104.92 143.81 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.148 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.596 ' HG ' HD13 ' C' ' 113' ' ' LEU . 0.3 OUTLIER -74.78 160.88 30.16 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.308 179.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' C' ' 77' ' ' ALA . . . -103.67 179.87 4.15 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.897 0.379 . . . . 0.0 111.685 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.708 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 1.3 mm? -66.58 171.29 5.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.035 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' GLN . . . . . 0.536 ' HG3' ' HB2' ' C' ' 149' ' ' ASN . 1.3 mm-40 -68.61 -83.74 0.03 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.279 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . 0.413 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 5.9 p -169.08 19.14 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.941 0.4 . . . . 0.0 111.426 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' SER . . . . . 0.537 ' HA ' ' HB2' ' E' ' 25' ' ' ALA . 3.3 m -90.15 86.26 6.49 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.897 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' F' ' 50' ' ' SER . . . -61.13 -25.01 66.69 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.637 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.39 41.22 3.53 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.669 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.0 0.78 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.87 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' SER . . . . . 0.834 ' HA ' ' HB3' ' C' ' 147' ' ' ALA . 1.9 m -89.24 -173.58 4.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.813 0.34 . . . . 0.0 110.691 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . 0.409 ' HB3' HD11 ' C' ' 88' ' ' LEU . . . -100.98 -177.25 3.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.874 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 3.0 m -131.11 123.96 29.73 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.303 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.17 29.46 18.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.467 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 1.7 t -125.32 129.35 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.818 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.84 -171.04 21.86 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.508 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' C' ' 86' ' ' LEU . 1.9 p -122.97 116.73 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 121.213 0.53 . . . . 0.0 111.679 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' GLN . . . . . 0.543 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 2.8 tt0 -81.75 151.42 27.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.936 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.8 123.81 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.563 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' LEU . . . . . 0.658 HD13 ' NE2' ' C' ' 134' ' ' GLN . 0.5 OUTLIER -104.69 125.17 50.53 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.638 0.256 . . . . 0.0 111.002 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . 0.799 ' HB3' HG22 ' C' ' 107' ' ' THR . 13.6 t0 -77.58 143.05 38.62 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.695 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . 0.712 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -62.64 -14.94 49.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.757 0.313 . . . . 0.0 111.063 179.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . 0.799 HG22 ' HB3' ' C' ' 105' ' ' ASP . 8.8 t -62.96 -20.97 65.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.27 -43.58 1.36 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.727 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.71 160.71 14.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.789 0.328 . . . . 0.0 111.08 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.37 133.16 40.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.085 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' LEU . . . . . 0.667 ' HB2' ' HB2' ' C' ' 105' ' ' ASP . 12.3 tp -95.5 160.94 14.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.378 0.608 . . . . 0.0 110.554 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 2.9 t -110.22 136.79 48.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.068 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.83 HD22 ' HA3' ' C' ' 75' ' ' GLY . 1.4 mt -70.22 89.61 0.65 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.751 0.31 . . . . 0.0 110.685 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.34 -18.44 6.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.472 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.32 -62.24 0.87 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.683 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' ALA . . . . . 0.564 ' HB3' ' OD1' ' F' ' 129' ' ' ASN . . . -92.94 18.21 9.45 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-O 121.042 0.448 . . . . 0.0 111.696 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . 0.545 HG21 HG23 ' C' ' 112' ' ' THR . 0.0 OUTLIER -83.98 72.59 10.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.049 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' PHE . . . . . 0.602 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . 78.1 m-85 -92.37 89.75 6.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.765 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 55.1 m -130.54 73.12 1.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.938 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.22 142.28 21.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.651 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -103.98 68.51 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.199 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -81.43 133.13 35.36 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.71 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 8.6 m -87.6 124.12 33.18 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.697 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.3 119.29 35.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.655 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . 0.633 ' HA ' HG23 ' C' ' 63' ' ' THR . 2.9 m120 -113.69 171.9 7.3 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.586 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.48 109.72 16.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.618 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.85 -133.79 4.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.714 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 46.4 m -110.52 86.78 2.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.722 0.296 . . . . 0.0 110.779 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.38 155.06 41.06 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.866 0.365 . . . . 0.0 111.143 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . 0.846 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -142.79 137.09 29.47 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.086 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 131' ' ' ILE . . . . . 0.752 HG21 HG11 ' C' ' 71' ' ' VAL . 6.9 mt -100.3 109.13 55.81 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 132' ' ' PRO . . . . . 0.712 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.5 Cg_endo -81.76 148.25 15.68 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.668 1.579 . . . . 0.0 112.546 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' C' ' 105' ' ' ASP . 0.5 OUTLIER -158.81 145.27 17.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.933 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 134' ' ' GLN . . . . . 0.658 ' NE2' HD13 ' C' ' 104' ' ' LEU . 5.2 mt-30 -111.23 160.41 17.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.052 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.77 ' O ' HG22 ' C' ' 52' ' ' VAL . . . -155.97 97.81 1.84 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.945 0.402 . . . . 0.0 111.609 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.495 ' HD2' ' HB ' ' C' ' 48' ' ' THR . 14.4 ptt180 -101.57 173.59 6.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.4 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 137' ' ' TYR . . . . . 0.532 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 1.8 m-85 -83.66 135.04 34.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.121 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 138' ' ' PHE . . . . . 0.612 ' HB3' HG11 ' C' ' 85' ' ' VAL . 1.8 t80 -128.86 128.16 43.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.235 0.541 . . . . 0.0 112.01 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 139' ' ' ALA . . . . . 0.473 ' HB2' HD23 ' C' ' 42' ' ' LEU . . . -108.5 138.01 45.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.83 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 140' ' ' THR . . . . . 0.542 HG21 ' HB2' ' C' ' 79' ' ' ASP . 0.3 OUTLIER -90.0 -9.54 48.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.458 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.3 -95.25 0.1 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.0 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.74 101.49 11.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.51 0.195 . . . . 0.0 110.704 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 143' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' C' ' 42' ' ' LEU . . . -61.36 144.36 54.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.758 0.313 . . . . 0.0 111.368 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 144' ' ' THR . . . . . 0.597 ' CG2' ' CD ' ' C' ' 145' ' ' PRO . 99.2 m -123.96 153.14 67.5 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.211 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 145' ' ' PRO . . . . . 0.597 ' CD ' ' CG2' ' C' ' 144' ' ' THR . 1.3 Cg_endo -82.99 144.78 12.17 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.49 2.127 . . . . 0.0 111.999 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . 0.642 ' O ' ' HG3' ' B' ' 15' ' ' GLU . . . 157.3 -116.09 0.7 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.468 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 147' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -119.72 132.37 55.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.887 0.375 . . . . 0.0 111.387 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 148' ' ' ALA . . . . . 0.634 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -125.38 43.36 3.07 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.136 0.493 . . . . 0.0 110.383 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 149' ' ' ASN . . . . . 0.536 ' HB2' ' HG3' ' C' ' 89' ' ' GLN . 1.1 m120 -95.68 150.86 19.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.635 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 150' ' ' ALA . . . . . 0.506 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -168.45 -178.65 3.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.012 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.76 153.0 39.71 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.274 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -141.21 151.12 43.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.243 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . 0.561 HG23 HG22 ' B' ' 9' ' ' THR . 0.2 OUTLIER -112.69 133.76 54.55 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 154' ' ' PHE . . . . . 0.514 ' HB3' ' H ' ' B' ' 8' ' ' GLY . 0.1 OUTLIER -81.71 148.68 28.84 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.036 0.446 . . . . 0.0 110.136 -179.05 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . 0.556 ' HB3' ' CZ ' ' C' ' 118' ' ' PHE . 11.2 mmtt -135.01 139.43 44.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.945 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 156' ' ' VAL . . . . . 0.654 HG22 HG23 ' B' ' 5' ' ' VAL . 3.1 m -134.52 141.3 43.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.82 0.343 . . . . 0.0 111.685 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . 0.559 ' HB3' ' HB3' ' C' ' 70' ' ' ALA . 3.9 tt0 -128.78 129.0 45.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.326 0.584 . . . . 0.0 110.34 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.7 128.6 51.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.563 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.834 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.331 0.11 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.41 88.94 0.04 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.567 0.222 . . . . 0.0 111.024 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.16 114.54 18.49 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.378 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 3.7 m -97.35 119.2 35.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.638 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.632 HG23 HG22 ' E' ' 156' ' ' VAL . 19.5 m -136.6 158.24 37.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.582 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -83.12 115.95 22.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.626 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.66 -79.57 0.13 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.876 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . 0.507 ' H ' ' HB3' ' E' ' 154' ' ' PHE . . . -148.55 -145.94 4.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.892 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . 0.569 HG22 HG23 ' E' ' 153' ' ' THR . 15.0 p -142.05 145.11 33.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.028 0.442 . . . . 0.0 111.238 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 32.6 t -127.8 119.49 51.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.259 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -92.42 113.19 25.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.387 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.76 90.65 5.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.08 120.74 32.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.297 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.07 170.46 32.64 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.901 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' GLU . . . . . 0.656 ' HG3' ' O ' ' E' ' 146' ' ' GLY . 21.4 tt0 -160.59 129.23 4.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.98 0.419 . . . . 0.0 110.382 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.818 HG13 HG13 ' E' ' 37' ' ' VAL . 2.2 t -89.67 136.92 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.233 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.763 ' O ' HG22 ' E' ' 39' ' ' THR . 34.3 m -136.35 -160.77 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-O 120.77 0.319 . . . . 0.0 111.162 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.93 176.98 6.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.009 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' E' ' 40' ' ' ALA . . . -90.18 49.63 1.73 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.085 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' D' ' 61' ' ' CYS . . . -122.18 -39.65 2.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.403 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' CYS . . . . . 0.641 ' SG ' ' HB3' ' D' ' 58' ' ' LEU . 0.5 OUTLIER -162.17 146.35 12.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.946 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.97 121.68 14.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . 0.636 ' HA ' ' HG ' ' D' ' 58' ' ' LEU . 2.5 p -63.75 143.51 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.082 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' D' ' 27' ' ' SER . 13.6 t70 -72.97 154.64 40.44 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.549 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -54.3 -53.89 47.65 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.336 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.54 1.03 88.67 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.911 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . 0.557 ' HB2' ' HB3' ' D' ' 24' ' ' ASP . 7.9 t -99.28 -16.66 18.41 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.873 0.368 . . . . 0.0 110.829 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 25' ' ' ALA . 10.9 t -53.19 -50.81 44.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.338 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -114.12 126.15 54.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.987 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' GLN . . . . . 0.415 HE22 ' HA ' ' D' ' 56' ' ' ILE . 3.7 mt-30 -125.58 135.58 52.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.063 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.93 109.17 21.95 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.132 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.57 115.13 48.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.144 0.497 . . . . 0.0 110.458 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.17 124.73 50.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.671 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.24 -42.29 23.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.62 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.08 -165.38 12.15 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.574 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' GLN . . . . . 0.606 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 3.7 mt-30 -93.62 119.23 32.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.635 0.255 . . . . 0.0 110.83 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.778 HG13 HG13 ' C' ' 16' ' ' VAL . 8.2 p -104.92 133.95 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.884 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' D' ' 38' ' ' ARG . 0.1 OUTLIER -79.96 137.66 36.91 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.628 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.767 HG22 ' O ' ' C' ' 17' ' ' VAL . 0.2 OUTLIER -62.52 -49.39 75.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.764 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.502 ' HB3' ' HB2' ' C' ' 19' ' ' ALA . . . -53.53 -33.5 54.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.051 0.453 . . . . 0.0 110.85 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' D' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.38 61.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.116 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' D' ' 143' ' ' ALA . 0.6 OUTLIER -114.01 39.79 2.63 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.662 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.22 33.94 3.28 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.391 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' GLN . . . . . 0.67 ' HB2' ' HB2' ' D' ' 47' ' ' ALA . 0.3 OUTLIER -124.46 142.88 50.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.323 179.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -66.2 95.67 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.0 111.138 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.37 33.72 5.84 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.152 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.67 ' HB2' ' HB2' ' D' ' 44' ' ' GLN . . . -78.94 143.56 35.68 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.991 0.424 . . . . 0.0 111.955 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . 0.507 ' HB ' ' HD2' ' D' ' 136' ' ' ARG . 18.2 p -131.64 131.96 43.62 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.869 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 1.3 m -103.82 -167.2 1.34 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.541 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.502 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 3.9 t -57.77 141.92 47.19 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.872 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' D' ' 136' ' ' ARG . . . -99.06 125.5 44.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.369 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' VAL . . . . . 0.762 HG22 ' O ' ' D' ' 135' ' ' ALA . 24.8 m -76.53 150.96 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.953 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.26 143.26 16.39 Favored Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.598 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.402 ' HE2' ' HB3' ' D' ' 135' ' ' ALA . 37.5 p90 -171.48 140.42 1.39 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.796 0.331 . . . . 0.0 110.972 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' ASN . . . . . 0.46 ' HB3' HG23 ' A' ' 76' ' ' THR . 17.0 p30 -136.3 138.58 41.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.603 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.535 HG23 ' O ' ' D' ' 56' ' ' ILE . 0.7 OUTLIER -88.38 116.76 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.588 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' GLN . . . . . 0.841 ' HA ' HG23 ' D' ' 130' ' ' THR . 5.0 mp0 -69.35 138.32 53.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.78 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . 0.641 ' HB3' ' SG ' ' D' ' 21' ' ' CYS . 0.3 OUTLIER -145.62 91.69 2.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.292 -179.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . 0.527 ' HA ' HG23 ' D' ' 128' ' ' THR . 8.2 p30 -78.39 176.86 8.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.906 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.9 81.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.798 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 10.4 m -133.82 147.77 51.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.798 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.67 161.92 20.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.328 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.632 HG23 ' HA ' ' D' ' 125' ' ' ASN . 0.0 OUTLIER -111.76 -34.2 6.1 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.088 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -72.57 -28.14 62.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.017 0.437 . . . . 0.0 111.72 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 59.4 t -73.25 -58.47 4.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.696 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.17 126.06 32.7 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.571 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.4 -42.08 7.13 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.955 0.407 . . . . 0.0 110.964 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.29 156.85 18.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.457 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' ALA . . . . . 0.639 ' HB3' ' HB ' ' D' ' 122' ' ' THR . . . -146.66 133.21 19.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.556 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . 0.605 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -113.34 155.12 25.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.144 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . 0.775 HG11 HG21 ' D' ' 131' ' ' ILE . 2.0 t -136.41 148.56 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.641 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' D' ' 155' ' ' LYS . . . -152.87 163.5 39.64 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.573 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' PHE . . . . . 0.428 ' CD1' ' HB1' ' D' ' 152' ' ' ALA . 0.2 OUTLIER -130.26 142.31 50.56 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 122.4 -0.187 . . . . 0.0 111.161 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 1.4 tt -109.21 119.04 38.3 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.071 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . 0.828 ' HA3' HD22 ' D' ' 113' ' ' LEU . . . -162.72 -161.88 12.86 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.786 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.3 OUTLIER -120.97 162.91 19.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.545 0.212 . . . . 0.0 110.78 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.687 ' O ' ' HB2' ' D' ' 87' ' ' ALA . . . -83.55 139.06 33.11 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.967 179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' ILE . . . . . 0.54 HG23 ' N ' ' D' ' 79' ' ' ASP . 11.1 tt -66.05 -47.63 84.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.948 0.404 . . . . 0.0 111.003 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.54 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.2 OUTLIER -134.44 46.68 2.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.813 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.47 -83.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.072 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.78 -36.39 41.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.62 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.42 69.25 10.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.886 0.375 . . . . 0.0 110.546 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' THR . . . . . 0.488 HG23 ' HB2' ' D' ' 77' ' ' ALA . 0.2 OUTLIER -74.12 -7.52 52.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.544 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . 0.626 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 30.1 p-10 -74.71 -25.4 59.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.332 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.605 HG11 ' HB3' ' D' ' 138' ' ' PHE . 6.4 t -104.91 143.85 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.161 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.61 ' HG ' HD13 ' D' ' 113' ' ' LEU . 0.3 OUTLIER -74.8 160.88 30.14 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.31 179.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' D' ' 77' ' ' ALA . . . -103.62 179.85 4.15 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.857 0.36 . . . . 0.0 111.739 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.724 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 1.3 mm? -66.59 171.3 5.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.071 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' GLN . . . . . 0.561 ' HG3' ' HB2' ' D' ' 149' ' ' ASN . 1.3 mm-40 -68.57 -83.76 0.03 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.25 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.14 19.17 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.937 0.399 . . . . 0.0 111.447 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . 0.541 ' HA ' ' HB2' ' F' ' 25' ' ' ALA . 3.3 m -90.16 86.24 6.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.927 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.16 -24.98 66.7 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.598 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.37 41.25 3.52 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.686 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.01 0.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.866 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 95' ' ' SER . . . . . 0.851 ' HA ' ' HB3' ' D' ' 147' ' ' ALA . 1.9 m -89.24 -173.57 4.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.751 0.31 . . . . 0.0 110.724 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 96' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' D' ' 88' ' ' LEU . . . -101.0 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.849 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . 0.411 ' O ' HG23 ' D' ' 99' ' ' VAL . 3.0 m -131.1 123.87 29.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.319 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.26 29.44 18.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.444 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 99' ' ' VAL . . . . . 0.411 HG23 ' O ' ' D' ' 97' ' ' THR . 1.7 t -125.34 129.32 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.822 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.87 -171.11 21.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.522 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 101' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' D' ' 86' ' ' LEU . 1.9 p -122.96 116.74 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.256 0.55 . . . . 0.0 111.694 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 102' ' ' GLN . . . . . 0.557 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 2.8 tt0 -81.76 151.43 27.46 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.915 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.79 123.82 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.575 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 104' ' ' LEU . . . . . 0.659 HD13 ' NE2' ' D' ' 134' ' ' GLN . 0.5 OUTLIER -104.73 125.19 50.57 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.661 0.267 . . . . 0.0 110.986 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . 0.81 ' HB3' HG22 ' D' ' 107' ' ' THR . 13.6 t0 -77.61 143.12 38.5 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.693 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 106' ' ' ARG . . . . . 0.694 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -62.72 -14.93 50.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.748 0.308 . . . . 0.0 111.029 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 107' ' ' THR . . . . . 0.81 HG22 ' HB3' ' D' ' 105' ' ' ASP . 8.8 t -62.98 -20.95 65.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.013 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.25 -43.54 1.36 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.735 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.72 160.7 14.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.83 0.348 . . . . 0.0 111.093 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.33 133.18 40.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.132 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 111' ' ' LEU . . . . . 0.667 ' HB2' ' HB2' ' D' ' 105' ' ' ASP . 12.3 tp -95.53 160.91 14.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.397 0.618 . . . . 0.0 110.477 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 112' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 2.9 t -110.23 136.79 48.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.046 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 113' ' ' LEU . . . . . 0.828 HD22 ' HA3' ' D' ' 75' ' ' GLY . 1.4 mt -70.2 89.55 0.65 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.702 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.29 -18.44 6.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.515 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.31 -62.28 0.87 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.619 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.93 18.26 9.37 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.958 0.408 . . . . 0.0 111.638 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 117' ' ' THR . . . . . 0.546 HG21 HG23 ' D' ' 112' ' ' THR . 0.0 OUTLIER -83.98 72.57 10.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.605 ' HB3' ' HB1' ' D' ' 70' ' ' ALA . 78.1 m-85 -92.35 89.75 6.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.792 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 55.5 m -130.55 73.19 1.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.86 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.24 142.3 21.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.695 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.95 68.51 0.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.208 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.639 ' HB ' ' HB3' ' D' ' 69' ' ' ALA . 0.0 OUTLIER -81.45 133.11 35.36 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.722 -179.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 8.5 m -87.51 124.1 33.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.77 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.3 119.27 35.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.677 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 125' ' ' ASN . . . . . 0.632 ' HA ' HG23 ' D' ' 63' ' ' THR . 2.9 m120 -113.66 171.91 7.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.599 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.47 109.75 16.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.648 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.8 -133.78 4.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.705 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 128' ' ' THR . . . . . 0.533 ' HB ' ' HE3' ' A' ' 155' ' ' LYS . 46.5 m -110.54 86.77 2.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.731 0.3 . . . . 0.0 110.757 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 129' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' A' ' 116' ' ' ALA . 1.1 t30 -69.36 155.07 41.04 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.825 0.345 . . . . 0.0 111.199 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 130' ' ' THR . . . . . 0.841 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.2 OUTLIER -142.8 137.08 29.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.066 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 131' ' ' ILE . . . . . 0.775 HG21 HG11 ' D' ' 71' ' ' VAL . 6.9 mt -100.26 109.13 55.7 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 132' ' ' PRO . . . . . 0.694 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.5 Cg_endo -81.78 148.29 15.66 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.673 1.582 . . . . 0.0 112.526 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.411 ' CZ ' ' HA ' ' D' ' 105' ' ' ASP . 0.5 OUTLIER -158.85 145.28 16.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.913 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 134' ' ' GLN . . . . . 0.659 ' NE2' HD13 ' D' ' 104' ' ' LEU . 5.2 mt-30 -111.23 160.4 17.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.041 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.762 ' O ' HG22 ' D' ' 52' ' ' VAL . . . -155.99 97.82 1.84 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.96 0.41 . . . . 0.0 111.629 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 136' ' ' ARG . . . . . 0.507 ' HD2' ' HB ' ' D' ' 48' ' ' THR . 14.4 ptt180 -101.57 173.64 6.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.417 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 137' ' ' TYR . . . . . 0.55 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 1.8 m-85 -83.64 135.01 34.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.142 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 138' ' ' PHE . . . . . 0.605 ' HB3' HG11 ' D' ' 85' ' ' VAL . 1.8 t80 -128.85 128.21 43.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.283 0.563 . . . . 0.0 112.013 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 139' ' ' ALA . . . . . 0.458 ' HB2' HD23 ' D' ' 42' ' ' LEU . . . -108.54 137.99 45.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.874 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 140' ' ' THR . . . . . 0.538 HG21 ' HB2' ' D' ' 79' ' ' ASP . 0.3 OUTLIER -89.93 -9.57 48.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.48 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.31 -95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.999 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.74 101.5 11.33 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.526 0.203 . . . . 0.0 110.708 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 143' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' D' ' 42' ' ' LEU . . . -61.35 144.35 54.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.752 0.311 . . . . 0.0 111.395 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 144' ' ' THR . . . . . 0.594 ' CG2' ' CD ' ' D' ' 145' ' ' PRO . 99.2 m -123.96 153.15 67.5 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.217 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 145' ' ' PRO . . . . . 0.594 ' CD ' ' CG2' ' D' ' 144' ' ' THR . 1.3 Cg_endo -82.97 144.71 12.17 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.56 2.173 . . . . 0.0 111.987 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . 0.653 ' O ' ' HG3' ' C' ' 15' ' ' GLU . . . 157.32 -116.1 0.7 Allowed Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.479 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 147' ' ' ALA . . . . . 0.851 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -119.71 132.38 55.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.376 . . . . 0.0 111.37 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 148' ' ' ALA . . . . . 0.627 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -125.37 43.37 3.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.397 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 149' ' ' ASN . . . . . 0.561 ' HB2' ' HG3' ' D' ' 89' ' ' GLN . 1.1 m120 -95.68 150.86 19.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.593 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 150' ' ' ALA . . . . . 0.507 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -168.45 -178.64 3.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.987 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.77 152.98 39.68 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.251 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 152' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -141.2 151.1 43.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.257 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 153' ' ' THR . . . . . 0.564 HG23 HG22 ' C' ' 9' ' ' THR . 0.2 OUTLIER -112.63 133.7 54.53 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.221 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 154' ' ' PHE . . . . . 0.512 ' HB3' ' H ' ' C' ' 8' ' ' GLY . 0.1 OUTLIER -81.68 148.73 28.85 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.07 0.462 . . . . 0.0 110.137 -179.043 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . 0.55 ' HB3' ' CZ ' ' D' ' 118' ' ' PHE . 11.2 mmtt -135.06 139.45 44.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.924 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 156' ' ' VAL . . . . . 0.635 HG22 HG23 ' C' ' 5' ' ' VAL . 3.1 m -134.53 141.3 43.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.783 0.325 . . . . 0.0 111.687 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 157' ' ' GLN . . . . . 0.531 ' HB3' ' HB3' ' D' ' 70' ' ' ALA . 3.8 tt0 -128.78 128.97 45.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.31 0.576 . . . . 0.0 110.363 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.73 128.58 51.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.552 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.85 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.281 0.086 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.37 88.93 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.028 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.14 114.5 18.45 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.446 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -97.29 119.17 35.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.685 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.647 HG23 HG22 ' F' ' 156' ' ' VAL . 19.6 m -136.56 158.25 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.605 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.13 116.01 22.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.59 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.74 -79.55 0.13 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.846 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . 0.501 ' H ' ' HB3' ' F' ' 154' ' ' PHE . . . -148.56 -145.96 4.24 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.882 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 9' ' ' THR . . . . . 0.565 HG22 HG23 ' F' ' 153' ' ' THR . 15.2 p -141.99 145.15 34.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.963 0.411 . . . . 0.0 111.302 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 32.5 t -127.83 119.49 51.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.262 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -92.4 113.16 25.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.374 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -95.76 90.66 5.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.814 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.08 120.74 32.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.342 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.06 170.53 32.65 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.933 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 15' ' ' GLU . . . . . 0.652 ' HG3' ' O ' ' F' ' 146' ' ' GLY . 21.4 tt0 -160.62 129.19 4.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 110.333 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 16' ' ' VAL . . . . . 0.784 HG13 HG13 ' F' ' 37' ' ' VAL . 2.2 t -89.66 136.92 22.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.25 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . 0.758 ' O ' HG22 ' F' ' 39' ' ' THR . 34.3 m -136.35 -160.78 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.774 0.321 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.95 177.01 6.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.03 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 19' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' F' ' 40' ' ' ALA . . . -90.15 49.64 1.73 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.105 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' E' ' 61' ' ' CYS . . . -122.16 -39.73 2.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.384 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 21' ' ' CYS . . . . . 0.644 ' SG ' ' HB3' ' E' ' 58' ' ' LEU . 0.5 OUTLIER -162.09 146.41 12.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.905 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.05 121.6 14.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.104 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 23' ' ' VAL . . . . . 0.621 ' HA ' ' HG ' ' E' ' 58' ' ' LEU . 2.5 p -63.68 143.52 15.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 24' ' ' ASP . . . . . 0.563 ' HB3' ' HB2' ' E' ' 27' ' ' SER . 13.5 t70 -72.92 154.61 40.49 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.595 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -54.32 -53.83 48.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.358 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.59 1.03 88.75 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.875 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . 0.563 ' HB2' ' HB3' ' E' ' 24' ' ' ASP . 7.9 t -99.28 -16.67 18.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.891 0.376 . . . . 0.0 110.849 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 28' ' ' VAL . . . . . 0.446 HG23 ' O ' ' E' ' 25' ' ' ALA . 10.9 t -53.18 -50.82 44.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.329 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -114.13 126.17 54.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.987 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 30' ' ' GLN . . . . . 0.433 HE22 ' HA ' ' E' ' 56' ' ' ILE . 3.7 mt-30 -125.6 135.56 52.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.062 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.92 109.14 21.92 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.1 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -115.55 115.11 48.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.11 0.481 . . . . 0.0 110.435 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -105.15 124.75 50.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.66 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.21 -42.33 23.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.624 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.1 -165.39 12.15 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.592 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 36' ' ' GLN . . . . . 0.602 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 3.7 mt-30 -93.61 119.2 32.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.642 0.258 . . . . 0.0 110.837 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.818 HG13 HG13 ' D' ' 16' ' ' VAL . 8.2 p -104.89 133.94 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.856 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' E' ' 38' ' ' ARG . 0.1 OUTLIER -79.9 137.65 36.95 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.694 179.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 39' ' ' THR . . . . . 0.763 HG22 ' O ' ' D' ' 17' ' ' VAL . 0.2 OUTLIER -62.55 -49.39 75.49 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.747 179.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' D' ' 19' ' ' ALA . . . -53.55 -33.47 54.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.0 0.428 . . . . 0.0 110.857 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 41' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' E' ' 38' ' ' ARG . 0.1 OUTLIER -74.97 -31.33 61.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.113 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.606 ' O ' ' HB2' ' E' ' 143' ' ' ALA . 0.6 OUTLIER -114.09 39.83 2.64 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.617 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.28 33.96 3.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.385 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 44' ' ' GLN . . . . . 0.664 ' HB2' ' HB2' ' E' ' 47' ' ' ALA . 0.3 OUTLIER -124.47 142.85 51.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.346 179.541 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -66.24 95.73 0.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.896 0.379 . . . . 0.0 111.156 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.35 33.71 5.84 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.191 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 47' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' E' ' 44' ' ' GLN . . . -78.9 143.51 35.81 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 111.968 179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.492 ' HB ' ' HD2' ' E' ' 136' ' ' ARG . 18.1 p -131.62 131.97 43.65 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.882 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 1.3 m -103.8 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.556 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 50' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 3.9 t -57.83 141.9 47.51 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.853 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 51' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' E' ' 136' ' ' ARG . . . -99.05 125.53 44.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.426 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 52' ' ' VAL . . . . . 0.764 HG22 ' O ' ' E' ' 135' ' ' ALA . 24.7 m -76.51 150.95 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.956 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.27 143.26 16.39 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.588 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -171.49 140.46 1.39 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.821 0.343 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 55' ' ' ASN . . . . . 0.458 ' HB3' HG23 ' B' ' 76' ' ' THR . 17.0 p30 -136.32 138.59 41.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.598 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 56' ' ' ILE . . . . . 0.538 HG23 ' O ' ' E' ' 56' ' ' ILE . 0.7 OUTLIER -88.43 116.76 30.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.568 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 57' ' ' GLN . . . . . 0.839 ' HA ' HG23 ' E' ' 130' ' ' THR . 5.0 mp0 -69.35 138.3 53.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.787 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . 0.644 ' HB3' ' SG ' ' E' ' 21' ' ' CYS . 0.3 OUTLIER -145.57 91.62 2.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.284 -179.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 8.1 p30 -78.4 176.83 8.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.943 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.797 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 61' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' E' ' 20' ' ' ALA . 10.4 m -133.84 147.78 51.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.796 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.68 161.94 20.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.328 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 63' ' ' THR . . . . . 0.639 HG23 ' HA ' ' E' ' 125' ' ' ASN . 0.0 OUTLIER -111.79 -34.2 6.09 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.082 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 m-20 -72.56 -28.15 62.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.008 0.433 . . . . 0.0 111.704 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.19 -58.55 4.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.667 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.21 126.05 32.61 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.567 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.38 -42.08 7.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.972 0.415 . . . . 0.0 110.968 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -89.31 156.83 18.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.456 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 69' ' ' ALA . . . . . 0.654 ' HB3' ' HB ' ' E' ' 122' ' ' THR . . . -146.61 133.21 19.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.572 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -113.33 155.11 25.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.156 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . 0.793 HG11 HG21 ' E' ' 131' ' ' ILE . 2.0 t -136.39 148.6 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.655 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' E' ' 155' ' ' LYS . . . -152.93 163.51 39.66 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.563 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 73' ' ' PHE . . . . . 0.442 ' CD1' ' HB1' ' E' ' 152' ' ' ALA . 0.2 OUTLIER -130.25 142.24 50.57 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 122.408 -0.183 . . . . 0.0 111.179 179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 74' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 1.4 tt -109.21 119.08 38.43 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.053 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . 0.819 ' HA3' HD22 ' E' ' 113' ' ' LEU . . . -162.72 -161.89 12.87 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.777 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 76' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.3 OUTLIER -120.95 162.94 19.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.605 0.241 . . . . 0.0 110.773 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 77' ' ' ALA . . . . . 0.694 ' O ' ' HB2' ' E' ' 87' ' ' ALA . . . -83.55 139.07 33.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.955 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 78' ' ' ILE . . . . . 0.539 HG23 ' N ' ' E' ' 79' ' ' ASP . 11.1 tt -66.09 -47.6 84.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.979 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 79' ' ' ASP . . . . . 0.544 ' HB2' HG21 ' E' ' 140' ' ' THR . 0.2 OUTLIER -134.5 46.68 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.847 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.54 -84.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.74 -36.43 40.75 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.609 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.44 69.26 10.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.891 0.377 . . . . 0.0 110.547 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 83' ' ' THR . . . . . 0.476 HG23 ' HB2' ' E' ' 77' ' ' ALA . 0.2 OUTLIER -74.15 -7.44 52.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.528 -179.45 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 84' ' ' ASN . . . . . 0.605 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 30.0 p-10 -74.77 -25.4 59.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.336 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.613 HG11 ' HB3' ' E' ' 138' ' ' PHE . 6.4 t -104.88 143.86 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.188 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 86' ' ' LEU . . . . . 0.593 ' HG ' HD13 ' E' ' 113' ' ' LEU . 0.3 OUTLIER -74.82 160.86 30.15 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.292 179.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 87' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' E' ' 77' ' ' ALA . . . -103.61 179.87 4.15 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.907 0.384 . . . . 0.0 111.725 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.712 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 1.3 mm? -66.6 171.28 5.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.049 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 89' ' ' GLN . . . . . 0.555 ' HG3' ' HB2' ' E' ' 149' ' ' ASN . 1.3 mm-40 -68.55 -83.78 0.03 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.253 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.09 19.13 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.935 0.398 . . . . 0.0 111.44 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 91' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' E' ' 95' ' ' SER . 3.2 m -90.15 86.23 6.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.09 -25.02 66.66 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.66 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.39 41.26 3.52 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.66 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.99 0.72 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.872 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 95' ' ' SER . . . . . 0.853 ' HA ' ' HB3' ' E' ' 147' ' ' ALA . 1.9 m -89.3 -173.57 4.07 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.736 0.303 . . . . 0.0 110.722 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 96' ' ' ALA . . . . . 0.419 ' HB3' HD11 ' E' ' 88' ' ' LEU . . . -100.96 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.859 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . 0.413 ' O ' HG23 ' E' ' 99' ' ' VAL . 3.0 m -131.09 123.91 29.65 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.315 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.17 29.48 18.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.46 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 99' ' ' VAL . . . . . 0.413 HG23 ' O ' ' E' ' 97' ' ' THR . 1.7 t -125.29 129.33 73.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.809 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.85 -171.09 21.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.504 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 101' ' ' VAL . . . . . 0.521 ' CG2' ' HB1' ' E' ' 135' ' ' ALA . 1.9 p -122.93 116.73 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 121.195 0.522 . . . . 0.0 111.679 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 102' ' ' GLN . . . . . 0.549 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 2.8 tt0 -81.77 151.45 27.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.931 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.79 123.83 70.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.515 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 104' ' ' LEU . . . . . 0.652 HD13 ' NE2' ' E' ' 134' ' ' GLN . 0.5 OUTLIER -104.71 125.18 50.55 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.704 0.288 . . . . 0.0 111.003 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . 0.795 ' HB3' HG22 ' E' ' 107' ' ' THR . 13.6 t0 -77.58 143.04 38.62 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.715 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 106' ' ' ARG . . . . . 0.716 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -62.67 -14.91 49.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.705 0.288 . . . . 0.0 111.025 179.47 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . 0.795 HG22 ' HB3' ' E' ' 105' ' ' ASP . 8.8 t -63.01 -20.96 65.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.011 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.28 -43.51 1.37 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.745 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.75 160.67 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 111.083 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.36 133.14 40.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.088 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.645 ' HB2' ' HB2' ' E' ' 105' ' ' ASP . 12.3 tp -95.5 160.97 14.26 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.389 0.614 . . . . 0.0 110.511 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 112' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 2.8 t -110.26 136.79 48.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.043 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 113' ' ' LEU . . . . . 0.819 HD22 ' HA3' ' E' ' 75' ' ' GLY . 1.4 mt -70.22 89.6 0.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.745 0.307 . . . . 0.0 110.663 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -18.45 6.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.463 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -62.26 0.88 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.67 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.96 18.22 9.45 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.99 0.424 . . . . 0.0 111.651 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 117' ' ' THR . . . . . 0.545 HG21 HG23 ' E' ' 112' ' ' THR . 0.0 OUTLIER -83.92 72.55 10.41 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.058 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . 0.587 ' HB3' ' HB1' ' E' ' 70' ' ' ALA . 78.1 m-85 -92.34 89.78 6.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.74 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 55.2 m -130.6 73.2 1.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.25 142.28 21.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.691 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -103.98 68.57 0.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.144 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . 0.654 ' HB ' ' HB3' ' E' ' 69' ' ' ALA . 0.0 OUTLIER -81.5 133.12 35.35 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.688 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 8.6 m -87.55 124.13 33.17 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.713 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tp -97.33 119.33 35.65 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.632 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 125' ' ' ASN . . . . . 0.639 ' HA ' HG23 ' E' ' 63' ' ' THR . 2.9 m120 -113.68 171.89 7.31 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.609 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.49 109.8 16.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.637 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.77 -133.81 4.71 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.71 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 128' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 46.2 m -110.52 86.76 2.37 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.767 0.317 . . . . 0.0 110.79 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 129' ' ' ASN . . . . . 0.568 ' OD1' ' HB3' ' B' ' 116' ' ' ALA . 1.2 t30 -69.37 155.05 41.07 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.822 0.344 . . . . 0.0 111.16 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 130' ' ' THR . . . . . 0.839 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.2 OUTLIER -142.78 137.07 29.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.1 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 131' ' ' ILE . . . . . 0.793 HG21 HG11 ' E' ' 71' ' ' VAL . 6.9 mt -100.23 109.05 55.39 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 132' ' ' PRO . . . . . 0.716 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.5 Cg_endo -81.7 148.24 15.77 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.718 1.612 . . . . 0.0 112.525 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 133' ' ' PHE . . . . . 0.414 ' CZ ' ' HA ' ' E' ' 105' ' ' ASP . 0.5 OUTLIER -158.8 145.3 17.06 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.924 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 134' ' ' GLN . . . . . 0.652 ' NE2' HD13 ' E' ' 104' ' ' LEU . 5.2 mt-30 -111.23 160.43 16.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.041 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . 0.764 ' O ' HG22 ' E' ' 52' ' ' VAL . . . -155.98 97.8 1.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.9 0.381 . . . . 0.0 111.621 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 136' ' ' ARG . . . . . 0.492 ' HD2' ' HB ' ' E' ' 48' ' ' THR . 14.4 ptt180 -101.57 173.6 6.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.412 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 137' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 1.8 m-85 -83.66 135.03 34.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.144 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 138' ' ' PHE . . . . . 0.613 ' HB3' HG11 ' E' ' 85' ' ' VAL . 1.7 t80 -128.84 128.16 43.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.055 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 139' ' ' ALA . . . . . 0.458 ' HB2' HD23 ' E' ' 42' ' ' LEU . . . -108.51 137.96 45.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.836 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 140' ' ' THR . . . . . 0.544 HG21 ' HB2' ' E' ' 79' ' ' ASP . 0.3 OUTLIER -89.92 -9.54 48.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.49 179.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.28 -95.26 0.1 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.947 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.71 101.52 11.36 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.529 0.204 . . . . 0.0 110.735 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 143' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' E' ' 42' ' ' LEU . . . -61.39 144.38 54.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.788 0.328 . . . . 0.0 111.336 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 144' ' ' THR . . . . . 0.607 ' CG2' ' CD ' ' E' ' 145' ' ' PRO . 99.2 m -123.95 153.15 67.46 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.236 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 145' ' ' PRO . . . . . 0.607 ' CD ' ' CG2' ' E' ' 144' ' ' THR . 1.4 Cg_endo -82.97 144.76 12.18 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.561 2.174 . . . . 0.0 111.979 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 146' ' ' GLY . . . . . 0.656 ' O ' ' HG3' ' D' ' 15' ' ' GLU . . . 157.3 -116.09 0.7 Allowed Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.49 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 147' ' ' ALA . . . . . 0.853 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -119.72 132.38 55.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.871 0.367 . . . . 0.0 111.403 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 148' ' ' ALA . . . . . 0.606 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -125.39 43.36 3.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.112 0.482 . . . . 0.0 110.379 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 149' ' ' ASN . . . . . 0.555 ' HB2' ' HG3' ' E' ' 89' ' ' GLN . 1.1 m120 -95.67 150.86 19.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.609 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 150' ' ' ALA . . . . . 0.51 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -168.47 -178.63 3.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.009 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.76 152.99 39.7 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.228 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 152' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -141.2 151.12 43.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.206 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 153' ' ' THR . . . . . 0.569 HG23 HG22 ' D' ' 9' ' ' THR . 0.2 OUTLIER -112.66 133.74 54.54 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 154' ' ' PHE . . . . . 0.507 ' HB3' ' H ' ' D' ' 8' ' ' GLY . 0.1 OUTLIER -81.72 148.72 28.82 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.103 0.478 . . . . 0.0 110.114 -179.05 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . 0.558 ' HB3' ' CZ ' ' E' ' 118' ' ' PHE . 11.3 mmtt -135.02 139.49 44.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.931 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 156' ' ' VAL . . . . . 0.632 HG22 HG23 ' D' ' 5' ' ' VAL . 3.1 m -134.51 141.3 43.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.687 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 157' ' ' GLN . . . . . 0.547 ' HB3' ' HB3' ' E' ' 70' ' ' ALA . 3.8 tt0 -128.8 128.97 45.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.29 0.567 . . . . 0.0 110.373 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.69 128.58 51.01 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.536 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.331 0.11 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.4 88.96 0.04 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.568 0.223 . . . . 0.0 111.008 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.17 114.47 18.39 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.396 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m -97.26 119.23 35.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.664 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 m -136.61 158.25 37.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.562 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -83.18 115.99 22.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.581 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.59 -79.63 0.13 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.878 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.56 -145.95 4.24 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.904 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 15.2 p -142.02 145.12 34.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.944 0.402 . . . . 0.0 111.314 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 32.0 t -127.84 119.47 51.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.226 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -92.4 113.18 25.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.407 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -95.8 90.65 5.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.794 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -91.09 120.76 32.32 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.343 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -154.09 170.48 32.66 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.934 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -160.59 129.18 4.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.957 0.408 . . . . 0.0 110.36 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 t -89.67 136.91 22.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.254 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.34 -160.77 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.786 0.327 . . . . 0.0 111.132 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.93 177.02 6.3 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.967 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.22 49.62 1.73 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.064 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' F' ' 61' ' ' CYS . . . -122.15 -39.71 2.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.437 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 21' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' F' ' 58' ' ' LEU . 0.5 OUTLIER -162.12 146.39 12.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.943 -179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.02 121.61 14.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.11 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 23' ' ' VAL . . . . . 0.617 ' HA ' ' HG ' ' F' ' 58' ' ' LEU . 2.5 p -63.7 143.49 15.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.074 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 24' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' F' ' 27' ' ' SER . 13.5 t70 -72.87 154.61 40.52 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.59 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -54.32 -53.87 48.01 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.335 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.56 1.03 88.7 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.863 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 27' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' F' ' 24' ' ' ASP . 7.9 t -99.32 -16.59 18.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.842 0.354 . . . . 0.0 110.814 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 28' ' ' VAL . . . . . 0.441 HG23 ' O ' ' F' ' 25' ' ' ALA . 10.9 t -53.24 -50.78 45.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.324 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -114.12 126.1 54.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.995 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 30' ' ' GLN . . . . . 0.426 HE22 ' HA ' ' F' ' 56' ' ' ILE . 3.7 mt-30 -125.57 135.65 52.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.059 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.93 109.18 21.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.091 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -115.59 115.12 48.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.148 0.499 . . . . 0.0 110.416 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -105.19 124.67 49.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.665 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 mp -80.2 -42.29 23.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.603 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.08 -165.35 12.14 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.579 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 36' ' ' GLN . . . . . 0.604 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 3.7 mt-30 -93.67 119.16 32.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.657 0.265 . . . . 0.0 110.851 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.784 HG13 HG13 ' E' ' 16' ' ' VAL . 8.2 p -104.84 133.97 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 38' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' F' ' 41' ' ' SER . 0.1 OUTLIER -79.93 137.62 36.92 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.687 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 39' ' ' THR . . . . . 0.758 HG22 ' O ' ' E' ' 17' ' ' VAL . 0.2 OUTLIER -62.45 -49.46 75.34 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.775 179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' E' ' 19' ' ' ALA . . . -53.53 -33.48 54.7 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.983 0.42 . . . . 0.0 110.829 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 41' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' F' ' 38' ' ' ARG . 0.1 OUTLIER -74.98 -31.37 61.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.113 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . 0.617 ' O ' ' HB2' ' F' ' 143' ' ' ALA . 0.6 OUTLIER -114.02 39.82 2.63 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.611 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -104.25 33.93 3.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.388 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 44' ' ' GLN . . . . . 0.674 ' HB2' ' HB2' ' F' ' 47' ' ' ALA . 0.3 OUTLIER -124.46 142.84 51.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.366 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.22 95.67 0.31 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.867 0.365 . . . . 0.0 111.161 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.41 33.67 5.85 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.149 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 47' ' ' ALA . . . . . 0.674 ' HB2' ' HB2' ' F' ' 44' ' ' GLN . . . -78.79 143.51 36.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.979 0.418 . . . . 0.0 111.973 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . 0.498 ' HB ' ' HD2' ' F' ' 136' ' ' ARG . 18.1 p -131.63 132.0 43.66 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.899 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 49' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 1.3 m -103.81 -167.23 1.34 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.504 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 50' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 3.9 t -57.81 141.91 47.42 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 51' ' ' ALA . . . . . 0.472 ' HB2' ' HB3' ' F' ' 136' ' ' ARG . . . -99.03 125.5 44.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.376 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 52' ' ' VAL . . . . . 0.764 HG22 ' O ' ' F' ' 135' ' ' ALA . 24.9 m -76.53 150.97 6.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.959 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.3 143.25 16.41 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.583 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 54' ' ' PHE . . . . . 0.406 ' HE2' ' HB3' ' F' ' 135' ' ' ALA . 37.4 p90 -171.47 140.47 1.4 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.839 0.352 . . . . 0.0 110.902 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 55' ' ' ASN . . . . . 0.465 ' HB3' HG23 ' C' ' 76' ' ' THR . 17.0 p30 -136.35 138.61 41.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.535 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 56' ' ' ILE . . . . . 0.54 HG23 ' O ' ' F' ' 56' ' ' ILE . 0.7 OUTLIER -88.42 116.76 30.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.57 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 57' ' ' GLN . . . . . 0.829 ' HA ' HG23 ' F' ' 130' ' ' THR . 5.0 mp0 -69.39 138.31 53.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.803 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . 0.636 ' HB3' ' SG ' ' F' ' 21' ' ' CYS . 0.3 OUTLIER -145.58 91.67 2.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.284 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 59' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 8.2 p30 -78.43 176.87 8.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.925 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 57.94 81.86 0.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.792 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 61' ' ' CYS . . . . . 0.616 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 10.4 m -133.83 147.8 51.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.779 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.71 161.93 20.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.318 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 63' ' ' THR . . . . . 0.626 HG23 ' HA ' ' F' ' 125' ' ' ASN . 0.0 OUTLIER -111.73 -34.25 6.09 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -72.53 -28.2 62.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.04 0.448 . . . . 0.0 111.728 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 59.2 t -73.13 -58.58 4.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.703 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.19 126.09 32.74 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.569 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.32 -42.17 7.12 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.95 0.405 . . . . 0.0 110.954 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 68' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' F' ' 68' ' ' LYS . 1.2 tptp -89.3 156.82 18.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.478 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 69' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' F' ' 122' ' ' THR . . . -146.63 133.19 19.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.588 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 70' ' ' ALA . . . . . 0.6 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -113.31 155.12 25.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.156 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 71' ' ' VAL . . . . . 0.769 HG11 HG21 ' F' ' 131' ' ' ILE . 2.0 t -136.4 148.56 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.69 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 72' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' F' ' 155' ' ' LYS . . . -152.9 163.49 39.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.55 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 73' ' ' PHE . . . . . 0.444 ' CD1' ' HB1' ' F' ' 152' ' ' ALA . 0.2 OUTLIER -130.25 142.3 50.57 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 121.247 -0.181 . . . . 0.0 111.186 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 74' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 1.4 tt -109.18 119.04 38.31 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.055 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . 0.823 ' HA3' HD22 ' F' ' 113' ' ' LEU . . . -162.72 -161.87 12.84 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.759 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 76' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.3 OUTLIER -120.99 162.89 19.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.585 0.231 . . . . 0.0 110.775 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 77' ' ' ALA . . . . . 0.699 ' O ' ' HB2' ' F' ' 87' ' ' ALA . . . -83.53 139.08 33.11 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.937 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 78' ' ' ILE . . . . . 0.535 HG23 ' N ' ' F' ' 79' ' ' ASP . 11.1 tt -66.06 -47.66 84.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.981 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 79' ' ' ASP . . . . . 0.55 ' HB2' HG21 ' F' ' 140' ' ' THR . 0.2 OUTLIER -134.44 46.68 2.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.857 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 64.48 -84.0 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -51.76 -36.42 40.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.58 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -84.49 69.27 10.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.918 0.39 . . . . 0.0 110.52 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 83' ' ' THR . . . . . 0.48 HG23 ' HB2' ' F' ' 77' ' ' ALA . 0.2 OUTLIER -74.11 -7.51 52.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.527 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 84' ' ' ASN . . . . . 0.621 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 30.1 p-10 -74.7 -25.44 59.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.338 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 85' ' ' VAL . . . . . 0.598 HG11 ' HB3' ' F' ' 138' ' ' PHE . 6.4 t -104.89 143.86 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.152 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 86' ' ' LEU . . . . . 0.599 ' HG ' HD13 ' F' ' 113' ' ' LEU . 0.3 OUTLIER -74.83 160.88 30.13 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.263 179.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 87' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' F' ' 77' ' ' ALA . . . -103.66 179.86 4.15 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.902 0.382 . . . . 0.0 111.698 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . 0.712 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 1.3 mm? -66.56 171.27 5.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.019 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 89' ' ' GLN . . . . . 0.544 ' HG3' ' HB2' ' F' ' 149' ' ' ASN . 1.3 mm-40 -68.58 -83.74 0.03 OUTLIER 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.262 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 6.0 p -169.13 19.15 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.975 0.416 . . . . 0.0 111.459 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 91' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' F' ' 95' ' ' SER . 3.3 m -90.17 86.21 6.47 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.936 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.06 -25.03 66.65 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.663 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.37 41.23 3.52 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.647 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.02 0.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.852 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 95' ' ' SER . . . . . 0.835 ' HA ' ' HB3' ' F' ' 147' ' ' ALA . 1.9 m -89.28 -173.6 4.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 110.667 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 96' ' ' ALA . . . . . 0.423 ' HB3' HD11 ' F' ' 88' ' ' LEU . . . -101.01 -177.28 3.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.846 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 3.0 m -131.04 123.92 29.77 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.322 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 98' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 61.18 29.46 18.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.479 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 1.7 t -125.29 129.29 73.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.824 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.8 -171.07 21.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.516 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 101' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' F' ' 86' ' ' LEU . 1.9 p -122.98 116.72 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.238 0.542 . . . . 0.0 111.703 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 102' ' ' GLN . . . . . 0.548 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 2.8 tt0 -81.75 151.45 27.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.942 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 103' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -114.81 123.85 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.525 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 104' ' ' LEU . . . . . 0.665 HD13 ' NE2' ' F' ' 134' ' ' GLN . 0.5 OUTLIER -104.72 125.16 50.53 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.647 0.261 . . . . 0.0 111.011 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . 0.806 ' HB3' HG22 ' F' ' 107' ' ' THR . 13.5 t0 -77.54 143.07 38.68 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.683 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 106' ' ' ARG . . . . . 0.709 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -62.76 -14.82 49.43 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.756 0.312 . . . . 0.0 111.053 179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . 0.806 HG22 ' HB3' ' F' ' 105' ' ' ASP . 8.8 t -63.03 -20.93 65.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.038 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.25 -43.53 1.36 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.748 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.7 160.69 14.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.753 0.311 . . . . 0.0 111.109 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.32 133.17 40.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . 0.671 ' HB2' ' HB2' ' F' ' 105' ' ' ASP . 12.3 tp -95.52 160.89 14.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.381 0.61 . . . . 0.0 110.52 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 112' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 2.9 t -110.19 136.79 48.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.093 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 113' ' ' LEU . . . . . 0.823 HD22 ' HA3' ' F' ' 75' ' ' GLY . 1.4 mt -70.2 89.59 0.65 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.299 . . . . 0.0 110.65 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -18.46 6.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.482 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.29 -62.26 0.88 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.647 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.97 18.25 9.43 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-O 121.008 0.432 . . . . 0.0 111.661 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 117' ' ' THR . . . . . 0.546 HG21 HG23 ' F' ' 112' ' ' THR . 0.0 OUTLIER -83.92 72.54 10.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.015 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . 0.6 ' HB3' ' HB1' ' F' ' 70' ' ' ALA . 78.2 m-85 -92.31 89.74 6.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.775 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 54.8 m -130.51 73.13 1.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.914 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.23 142.34 21.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.676 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -104.02 68.54 0.91 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.165 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . 0.641 ' HB ' ' HB3' ' F' ' 69' ' ' ALA . 0.0 OUTLIER -81.45 133.12 35.36 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.721 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 8.5 m -87.55 124.12 33.16 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.738 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -97.31 119.29 35.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.672 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 125' ' ' ASN . . . . . 0.626 ' HA ' HG23 ' F' ' 63' ' ' THR . 2.9 m120 -113.71 171.93 7.29 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.581 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.5 109.74 16.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.656 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 148.84 -133.84 4.71 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.733 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 128' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 46.4 m -110.49 86.71 2.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.743 0.306 . . . . 0.0 110.811 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 129' ' ' ASN . . . . . 0.564 ' OD1' ' HB3' ' C' ' 116' ' ' ALA . 1.1 t30 -69.3 155.07 41.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.179 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 130' ' ' THR . . . . . 0.829 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.2 OUTLIER -142.79 137.08 29.45 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.099 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 131' ' ' ILE . . . . . 0.769 HG21 HG11 ' F' ' 71' ' ' VAL . 6.9 mt -100.25 109.09 55.57 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 132' ' ' PRO . . . . . 0.709 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.5 Cg_endo -81.72 148.26 15.74 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.721 1.614 . . . . 0.0 112.543 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 133' ' ' PHE . . . . . 0.419 ' CZ ' ' HA ' ' F' ' 105' ' ' ASP . 0.5 OUTLIER -158.86 145.29 16.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.903 179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 134' ' ' GLN . . . . . 0.665 ' NE2' HD13 ' F' ' 104' ' ' LEU . 5.2 mt-30 -111.23 160.43 16.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.042 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . 0.764 ' O ' HG22 ' F' ' 52' ' ' VAL . . . -156.03 97.82 1.83 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.995 0.426 . . . . 0.0 111.597 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 136' ' ' ARG . . . . . 0.498 ' HD2' ' HB ' ' F' ' 48' ' ' THR . 14.4 ptt180 -101.5 173.6 6.36 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.407 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 137' ' ' TYR . . . . . 0.539 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 1.8 m-85 -83.65 135.03 34.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.168 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 138' ' ' PHE . . . . . 0.598 ' HB3' HG11 ' F' ' 85' ' ' VAL . 1.8 t80 -128.87 128.23 43.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.282 0.563 . . . . 0.0 111.972 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 139' ' ' ALA . . . . . 0.472 ' HB2' HD23 ' F' ' 42' ' ' LEU . . . -108.58 137.97 45.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.854 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 140' ' ' THR . . . . . 0.55 HG21 ' HB2' ' F' ' 79' ' ' ASP . 0.3 OUTLIER -89.93 -9.56 48.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.477 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 174.32 -95.22 0.1 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.996 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.75 101.47 11.3 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.529 0.204 . . . . 0.0 110.741 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 143' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' F' ' 42' ' ' LEU . . . -61.35 144.33 54.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.715 0.293 . . . . 0.0 111.409 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 144' ' ' THR . . . . . 0.607 ' CG2' ' CD ' ' F' ' 145' ' ' PRO . 99.1 m -123.92 153.17 67.35 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.216 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 145' ' ' PRO . . . . . 0.607 ' CD ' ' CG2' ' F' ' 144' ' ' THR . 1.3 Cg_endo -83.03 144.79 12.13 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.567 2.178 . . . . 0.0 111.98 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 146' ' ' GLY . . . . . 0.652 ' O ' ' HG3' ' E' ' 15' ' ' GLU . . . 157.27 -116.08 0.7 Allowed Glycine 0 C--N 1.33 0.208 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.473 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 147' ' ' ALA . . . . . 0.835 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -119.73 132.44 55.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.899 0.38 . . . . 0.0 111.335 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 148' ' ' ALA . . . . . 0.631 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -125.44 43.36 3.07 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.12 0.486 . . . . 0.0 110.387 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 149' ' ' ASN . . . . . 0.544 ' HB2' ' HG3' ' F' ' 89' ' ' GLN . 1.1 m120 -95.69 150.86 19.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.623 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 150' ' ' ALA . . . . . 0.508 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -168.44 -178.63 3.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.992 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -146.77 153.01 39.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.253 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 152' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -141.22 151.11 43.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.258 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 153' ' ' THR . . . . . 0.565 HG23 HG22 ' E' ' 9' ' ' THR . 0.2 OUTLIER -112.68 133.74 54.56 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 154' ' ' PHE . . . . . 0.501 ' HB3' ' H ' ' E' ' 8' ' ' GLY . 0.1 OUTLIER -81.73 148.72 28.8 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.103 0.478 . . . . 0.0 110.11 -179.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . 0.553 ' HB3' ' CZ ' ' F' ' 118' ' ' PHE . 11.2 mmtt -135.01 139.47 44.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.945 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 156' ' ' VAL . . . . . 0.647 HG22 HG23 ' E' ' 5' ' ' VAL . 3.1 m -134.53 141.27 43.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.702 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 157' ' ' GLN . . . . . 0.555 ' HB3' ' HB3' ' F' ' 70' ' ' ALA . 3.8 tt0 -128.77 129.0 45.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.328 0.585 . . . . 0.0 110.37 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.71 128.61 51.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.546 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.866 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 111.103 0.038 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' B' ' 158' ' ' TYR . . . 52.73 88.35 0.03 OUTLIER 'General case' 0 C--O 1.232 0.146 0 O-C-N 123.196 0.31 . . . . 0.0 111.026 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' B' ' 157' ' ' GLN . 5.5 m -122.99 116.19 23.14 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.406 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.488 HG21 ' CA ' ' E' ' 127' ' ' GLY . 1.8 m -99.6 117.26 33.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.573 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.633 HG23 HG23 ' B' ' 156' ' ' VAL . 1.7 m -144.49 158.02 14.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.557 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' B' ' 154' ' ' PHE . 13.0 t30 -78.68 123.76 27.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.54 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.73 -71.18 1.0 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.822 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.543 ' H ' ' HB3' ' B' ' 154' ' ' PHE . . . -152.72 -147.04 4.5 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.759 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.965 HG22 HG23 ' B' ' 153' ' ' THR . 24.5 p -148.72 134.43 18.83 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.022 0.439 . . . . 0.0 111.249 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.33 124.39 72.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.186 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.624 ' HA ' ' OD1' ' B' ' 151' ' ' ASP . 57.5 t-80 -91.58 116.17 28.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.323 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -96.83 105.48 17.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HG2' ' ND2' ' B' ' 149' ' ' ASN . 5.1 tttm -104.61 118.71 37.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.507 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.32 172.92 30.82 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.952 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.729 ' O ' ' HA ' ' B' ' 36' ' ' GLN . 25.8 tt0 -160.39 135.93 8.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.965 0.412 . . . . 0.0 110.425 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.778 HG23 ' HB2' ' B' ' 148' ' ' ALA . 43.4 t -96.78 132.73 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.272 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.719 HG11 ' NE2' ' B' ' 36' ' ' GLN . 18.5 m -133.82 -177.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.805 0.336 . . . . 0.0 111.068 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.567 ' HA ' HG22 ' B' ' 39' ' ' THR . 0.3 OUTLIER -75.7 -170.26 1.25 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.017 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.79 45.37 0.98 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.125 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.568 ' O ' HD21 ' A' ' 124' ' ' LEU . . . -121.26 -24.8 5.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.415 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -168.91 140.68 2.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.792 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 60' ' ' ASP . . . -132.87 116.95 17.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.069 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.741 HG12 ' HB2' ' B' ' 36' ' ' GLN . 0.5 OUTLIER -67.03 146.23 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.011 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.473 ' O ' HG23 ' A' ' 28' ' ' VAL . 12.9 t0 -80.34 152.03 29.16 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.55 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.06 96.1 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.39 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.88 2.72 85.9 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.891 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -106.23 -19.94 13.55 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.813 0.339 . . . . 0.0 110.793 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 24' ' ' ASP . 39.8 t -47.43 -52.09 5.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.336 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.19 136.48 48.61 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.035 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.71 136.85 39.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.02 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.52 102.83 12.73 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.127 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.66 128.34 62.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.121 0.486 . . . . 0.0 110.51 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -114.75 123.06 48.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.615 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.45 -42.72 15.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.608 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.45 -167.44 13.2 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.603 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -96.75 124.51 40.75 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.654 0.264 . . . . 0.0 110.852 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.71 147.54 11.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.986 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.71 134.94 34.33 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.418 0.449 . . . . 0.0 111.725 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.431 HG22 ' H ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -60.07 -44.48 94.73 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.75 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.26 -36.88 61.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.095 0.474 . . . . 0.0 110.893 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.9 -35.8 62.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.168 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.747 HD23 HG13 ' A' ' 99' ' ' VAL . 2.9 mp -106.66 34.58 3.34 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.657 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.9 15.85 27.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.391 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.98 132.04 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.34 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 140' ' ' THR . 6.8 tt0 -56.56 108.79 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.827 0.346 . . . . 0.0 111.106 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.93 25.93 10.11 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.121 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -71.49 137.75 48.42 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 p -136.94 122.73 19.96 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.913 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 136' ' ' ARG . 53.9 m -100.07 -175.18 2.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.649 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 t -55.65 137.29 49.56 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.808 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.476 ' CA ' ' HB3' ' A' ' 136' ' ' ARG . . . -92.32 133.57 35.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.342 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 135' ' ' ALA . 26.2 m -76.76 162.48 4.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.52 141.14 16.76 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.643 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -173.76 137.75 0.61 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.79 0.329 . . . . 0.0 110.933 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -136.49 145.85 45.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.682 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 56' ' ' ILE . 1.2 tp -91.04 116.79 32.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.663 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.73 ' HA ' HG23 ' A' ' 130' ' ' THR . 1.3 mp0 -72.93 128.65 36.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.813 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.459 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -137.35 89.13 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.225 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.731 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 9.8 p30 -74.79 176.47 7.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.039 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.515 ' HB2' ' HB3' ' A' ' 22' ' ' ALA . 0.9 OUTLIER 58.97 74.78 0.43 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.889 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 36.5 m -126.31 148.83 49.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.86 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.412 ' OD2' HG23 ' A' ' 65' ' ' VAL . 1.6 t70 -121.58 169.75 10.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.318 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.25 -32.66 4.91 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.48 -28.0 56.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.261 0.553 . . . . 0.0 111.753 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.412 HG23 ' OD2' ' A' ' 62' ' ' ASP . 25.5 t -73.63 -56.69 8.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.68 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.459 ' HB3' ' HB1' ' A' ' 20' ' ' ALA . . . -134.99 122.76 22.31 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.652 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.54 -50.11 5.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.894 0.378 . . . . 0.0 110.936 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.401 ' NZ ' ' HA ' ' A' ' 68' ' ' LYS . 1.8 tptp -89.75 152.15 21.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.529 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 122' ' ' THR . . . -144.24 137.87 27.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.582 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -113.41 157.28 22.11 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.092 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.739 HG11 HG21 ' A' ' 131' ' ' ILE . 1.8 t -138.75 149.97 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.668 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.86 155.13 37.52 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.565 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.543 ' CB ' HD13 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -125.05 136.69 53.93 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.644 0.259 . . . . 0.0 111.004 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.576 HD21 HG21 ' D' ' 130' ' ' THR . 0.9 OUTLIER -97.2 136.13 38.15 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.017 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.446 ' CA ' ' HB3' ' A' ' 113' ' ' LEU . . . -174.0 -172.91 39.69 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.762 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.667 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.2 OUTLIER -118.66 144.6 46.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.485 0.183 . . . . 0.0 110.835 179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.639 ' HB2' HG23 ' A' ' 83' ' ' THR . . . -62.52 138.62 58.51 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.925 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.504 HG23 ' N ' ' A' ' 79' ' ' ASP . 5.7 tt -71.63 -45.56 66.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.932 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.504 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -133.13 42.47 3.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.857 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 79' ' ' ASP . . . 70.12 -80.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.977 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.06 -29.78 68.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.552 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.445 ' HB3' HG22 ' A' ' 78' ' ' ILE . 1.7 m80 -89.77 69.41 7.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 110.445 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.639 HG23 ' HB2' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -74.52 -16.17 60.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.576 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 20.7 p-10 -66.26 -19.05 65.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.267 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 138' ' ' PHE . 13.4 t -113.65 133.81 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.198 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.766 ' HG ' HD13 ' A' ' 113' ' ' LEU . 0.4 OUTLIER -67.89 161.48 26.27 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 77' ' ' ALA . . . -103.54 -174.65 2.6 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.869 0.366 . . . . 0.0 111.787 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.71 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 0.3 OUTLIER -67.38 165.22 16.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.084 179.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.518 ' CG ' ' HB2' ' A' ' 149' ' ' ASN . 5.7 mm-40 -63.43 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.815 0.34 . . . . 0.0 111.3 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.454 ' O ' HG12 ' D' ' 52' ' ' VAL . 2.3 p -165.45 3.66 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 111.492 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.528 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 0.7 OUTLIER -80.03 79.74 6.54 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.525 ' HB2' HG13 ' D' ' 52' ' ' VAL . . . -57.08 -24.72 56.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.885 0.374 . . . . 0.0 111.658 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.18 33.94 5.25 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.682 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.8 0.44 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.943 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.71 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . 38.4 m -96.8 177.94 5.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.877 0.37 . . . . 0.0 110.64 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.47 -178.71 7.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.804 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.494 ' HB ' ' OG1' ' A' ' 144' ' ' THR . 2.0 m -134.53 119.01 17.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.338 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 97' ' ' THR . 32.6 m-20 68.85 34.41 3.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.388 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.747 HG13 HD23 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -138.03 130.79 40.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.808 179.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.11 -170.55 18.84 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.568 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -119.72 114.48 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.014 0.526 . . . . 0.0 111.719 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 0.8 OUTLIER -87.33 150.21 24.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.912 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.551 HG12 ' HG ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -114.98 135.96 53.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.53 179.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.28 133.57 55.04 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.675 0.274 . . . . 0.0 111.03 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.858 ' HB3' HG22 ' A' ' 107' ' ' THR . 6.1 t0 -82.36 149.75 27.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.664 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.751 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.4 OUTLIER -67.85 -16.25 64.0 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.8 0.333 . . . . 0.0 111.053 179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.858 HG22 ' HB3' ' A' ' 105' ' ' ASP . 8.8 t -63.67 -28.35 69.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.033 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.0 -40.48 1.58 Allowed Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.661 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.422 ' H ' HG23 ' A' ' 107' ' ' THR . . . -91.51 163.09 14.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.815 0.34 . . . . 0.0 111.049 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.17 133.36 35.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.134 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.563 HD21 ' O ' ' A' ' 117' ' ' THR . 4.8 tp -96.74 150.02 21.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.407 0.622 . . . . 0.0 110.526 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.855 HG23 HG21 ' A' ' 117' ' ' THR . 1.9 t -98.37 141.78 30.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.156 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.766 HD13 ' HG ' ' A' ' 86' ' ' LEU . 1.6 mt -76.43 89.48 3.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.783 0.325 . . . . 0.0 110.704 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.08 -18.19 5.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.554 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.79 -60.58 0.46 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.616 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.504 ' HB2' ' N ' ' D' ' 129' ' ' ASN . . . -96.46 26.98 4.03 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.04 0.448 . . . . 0.0 111.69 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.855 HG21 HG23 ' A' ' 112' ' ' THR . 0.0 OUTLIER -87.04 74.86 9.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.148 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.582 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 62.7 m-85 -94.88 92.86 7.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.819 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.8 m -136.32 68.92 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.81 150.19 28.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.622 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.25 67.66 0.7 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.171 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.6 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -79.15 114.71 18.31 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.747 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -73.94 127.96 34.24 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.724 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.568 HD21 ' O ' ' A' ' 20' ' ' ALA . 4.0 tp -92.08 132.14 36.81 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.64 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.12 151.12 49.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.58 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 3.1 t30 -69.12 111.99 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.636 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.61 -138.83 8.65 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.672 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.731 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 87.8 m -98.84 82.5 2.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.633 0.254 . . . . 0.0 110.724 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.456 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 2.3 t30 -71.82 148.19 46.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.949 0.404 . . . . 0.0 111.062 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.73 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -138.67 148.57 44.17 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.119 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.739 HG21 HG11 ' A' ' 71' ' ' VAL . 15.6 mt -110.0 112.23 57.93 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.751 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.4 Cg_endo -81.82 136.98 9.7 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.629 1.553 . . . . 0.0 112.564 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.0 136.09 19.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.718 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -111.43 158.4 19.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.04 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.675 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -154.19 111.35 3.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.951 0.405 . . . . 0.0 111.63 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.476 ' HB3' ' CA ' ' A' ' 51' ' ' ALA . 19.8 ptt180 -108.93 174.09 6.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.344 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.695 ' HB3' HD21 ' A' ' 42' ' ' LEU . 1.7 m-85 -81.37 137.67 35.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.14 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.518 ' HB3' HG21 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -131.61 124.15 29.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.2 0.524 . . . . 0.0 112.072 -179.256 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -108.47 130.17 55.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.839 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -77.46 -27.95 52.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.495 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.49 -96.51 0.11 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.981 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.93 98.46 8.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.623 0.211 . . . . 0.0 110.722 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.548 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -56.6 148.89 18.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.746 0.308 . . . . 0.0 111.413 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.723 ' CG2' ' CD ' ' A' ' 145' ' ' PRO . 90.1 m -125.41 156.96 69.48 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.219 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.723 ' CD ' ' CG2' ' A' ' 144' ' ' THR . 1.4 Cg_endo -83.45 136.3 7.51 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 122.517 2.145 . . . . 0.0 111.925 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 163.56 -127.56 1.7 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.474 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.652 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -110.92 132.88 53.83 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.863 0.364 . . . . 0.0 111.363 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -124.24 43.69 2.93 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.133 0.492 . . . . 0.0 110.451 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.518 ' HB2' ' CG ' ' A' ' 89' ' ' GLN . 9.3 m120 -92.27 144.28 25.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.529 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.684 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -160.64 178.81 9.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.0 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -146.94 145.01 29.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.255 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -133.74 139.74 46.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.169 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.1 135.29 42.8 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.58 152.18 27.34 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.005 0.431 . . . . 0.0 110.188 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.413 ' HE3' ' HB ' ' D' ' 128' ' ' THR . 15.2 mmtm -134.18 146.84 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.916 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.1 m -139.09 140.71 37.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.857 0.36 . . . . 0.0 111.626 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.432 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -134.54 132.73 39.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.281 0.562 . . . . 0.0 110.45 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 21' ' ' CYS . 11.1 m-85 -107.3 128.05 54.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.49 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.873 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 111.147 0.054 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' C' ' 158' ' ' TYR . . . 52.78 88.29 0.03 OUTLIER 'General case' 0 C--O 1.232 0.15 0 O-C-N 123.154 0.284 . . . . 0.0 111.039 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' C' ' 157' ' ' GLN . 5.5 m -122.92 116.22 23.24 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.379 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.492 HG21 ' CA ' ' F' ' 127' ' ' GLY . 1.8 m -99.68 117.18 33.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.563 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.616 HG23 HG23 ' C' ' 156' ' ' VAL . 1.8 m -144.41 158.09 15.07 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.577 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' C' ' 154' ' ' PHE . 13.1 t30 -78.74 123.81 27.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.54 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.77 -71.24 1.0 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.836 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.531 ' H ' ' HB3' ' C' ' 154' ' ' PHE . . . -152.66 -147.05 4.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.84 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.954 HG22 HG23 ' C' ' 153' ' ' THR . 24.5 p -148.69 134.44 18.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.969 0.414 . . . . 0.0 111.318 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.39 124.34 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.147 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' HIS . . . . . 0.636 ' HA ' ' OD1' ' C' ' 151' ' ' ASP . 57.4 t-80 -91.47 116.2 28.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.337 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -96.88 105.53 17.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.738 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.407 ' HG2' ' ND2' ' C' ' 149' ' ' ASN . 5.1 tttm -104.62 118.72 37.28 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.474 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.3 172.9 30.81 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.936 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.738 ' O ' ' HA ' ' C' ' 36' ' ' GLN . 25.8 tt0 -160.38 135.95 8.18 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.911 0.386 . . . . 0.0 110.398 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.761 HG23 ' HB2' ' C' ' 148' ' ' ALA . 43.7 t -96.87 132.79 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.204 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.706 HG11 ' NE2' ' C' ' 36' ' ' GLN . 18.1 m -133.88 -177.12 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.934 0.397 . . . . 0.0 110.98 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . 0.563 ' HA ' HG22 ' C' ' 39' ' ' THR . 0.3 OUTLIER -75.85 -170.34 1.32 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.931 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.76 45.51 0.97 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.084 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.577 ' O ' HD21 ' B' ' 124' ' ' LEU . . . -121.34 -24.85 5.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.386 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.716 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER -168.81 140.64 2.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.864 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' B' ' 60' ' ' ASP . . . -132.79 116.97 17.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.082 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.744 HG12 ' HB2' ' C' ' 36' ' ' GLN . 0.5 OUTLIER -67.05 146.22 13.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.034 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.473 ' O ' HG23 ' B' ' 28' ' ' VAL . 12.8 t0 -80.33 152.09 29.15 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.562 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.84 -39.95 95.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.417 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.9 2.65 85.83 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.844 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -106.26 -19.89 13.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.807 0.337 . . . . 0.0 110.826 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 24' ' ' ASP . 39.8 t -47.36 -52.22 5.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.336 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.15 136.43 48.66 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.036 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.63 136.86 39.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.066 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.53 102.87 12.77 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.062 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 26.0 t -107.69 128.25 63.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.527 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -114.7 123.07 48.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.652 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.43 -42.71 15.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.61 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.44 -167.44 13.2 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.581 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.741 ' HB2' HG12 ' A' ' 23' ' ' VAL . 3.7 mt-30 -96.7 124.47 40.69 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.613 0.244 . . . . 0.0 110.892 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.78 147.53 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.93 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.67 134.95 34.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.026 0.441 . . . . 0.0 111.669 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.567 HG22 ' HA ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -60.07 -44.49 94.7 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.739 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.29 -36.84 61.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.184 0.516 . . . . 0.0 110.919 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.83 -35.86 62.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.223 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.755 HD23 HG13 ' B' ' 99' ' ' VAL . 2.9 mp -106.69 34.58 3.34 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.626 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.95 15.88 27.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.329 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.0 132.08 56.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.299 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' B' ' 140' ' ' THR . 6.7 tt0 -56.58 108.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.846 0.355 . . . . 0.0 111.076 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.95 25.9 10.12 Favored Glycine 0 C--N 1.331 0.278 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.144 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' B' ' 139' ' ' ALA . . . -71.42 137.77 48.57 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 7.3 p -136.98 122.75 19.93 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.927 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' B' ' 136' ' ' ARG . 53.4 m -100.09 -175.21 2.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.644 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.9 t -55.67 137.33 49.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.799 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.481 ' CA ' ' HB3' ' B' ' 136' ' ' ARG . . . -92.29 133.46 35.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.327 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.683 HG22 ' O ' ' B' ' 135' ' ' ALA . 26.1 m -76.71 162.54 4.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.49 141.16 16.78 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.592 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -173.76 137.77 0.62 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.804 0.335 . . . . 0.0 110.934 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -136.56 145.83 45.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.603 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.527 HG23 ' O ' ' B' ' 56' ' ' ILE . 1.2 tp -91.03 116.77 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.607 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . 0.722 ' HA ' HG23 ' B' ' 130' ' ' THR . 1.3 mp0 -72.93 128.58 35.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.79 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.457 ' HG ' ' HA ' ' B' ' 23' ' ' VAL . 0.3 OUTLIER -137.31 89.17 2.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.242 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.723 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 9.8 p30 -74.81 176.53 6.98 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.012 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . 0.512 ' HB2' ' HB3' ' B' ' 22' ' ' ALA . 0.9 OUTLIER 58.93 74.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.825 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' CYS . . . . . 0.716 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 36.8 m -126.32 148.86 49.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.804 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . 0.404 ' OD2' HG23 ' B' ' 65' ' ' VAL . 1.6 t70 -121.58 169.77 10.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.281 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.27 -32.69 4.89 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -76.52 -27.94 56.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.169 0.509 . . . . 0.0 111.72 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.404 HG23 ' OD2' ' B' ' 62' ' ' ASP . 25.6 t -73.66 -56.69 8.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.677 179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.466 ' HB3' ' HB1' ' B' ' 20' ' ' ALA . . . -135.02 122.74 22.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.674 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.56 -50.04 5.13 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.89 0.376 . . . . 0.0 110.923 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -89.76 152.12 21.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.574 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' B' ' 122' ' ' THR . . . -144.25 137.8 27.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.604 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.603 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -113.35 157.25 22.09 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.11 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.754 HG11 HG21 ' B' ' 131' ' ' ILE . 1.8 t -138.78 149.96 23.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.656 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.82 155.11 37.52 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.596 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.545 ' CB ' HD13 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -125.04 136.68 53.92 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.634 0.254 . . . . 0.0 110.969 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.581 HD11 ' HG3' ' E' ' 57' ' ' GLN . 0.9 OUTLIER -97.15 136.1 38.15 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.032 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.459 ' CA ' ' HB3' ' B' ' 113' ' ' LEU . . . -174.02 -172.95 39.74 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.731 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.677 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.2 OUTLIER -118.63 144.55 46.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.537 0.208 . . . . 0.0 110.831 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.652 ' HB2' HG23 ' B' ' 83' ' ' THR . . . -62.48 138.53 58.48 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.958 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.501 HG23 ' N ' ' B' ' 79' ' ' ASP . 5.7 tt -71.55 -45.59 67.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.884 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.501 ' N ' HG23 ' B' ' 78' ' ' ILE . 0.3 OUTLIER -133.19 42.54 3.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.818 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' B' ' 79' ' ' ASP . . . 70.04 -80.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.056 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.08 -29.71 68.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.56 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.422 ' HB3' HG22 ' B' ' 78' ' ' ILE . 1.6 m80 -89.87 69.39 7.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.418 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' THR . . . . . 0.652 HG23 ' HB2' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -74.47 -16.2 60.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.604 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . 0.726 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 20.8 p-10 -66.11 -19.16 65.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.334 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' B' ' 138' ' ' PHE . 13.5 t -113.6 133.83 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.173 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.774 ' HG ' HD13 ' B' ' 113' ' ' LEU . 0.4 OUTLIER -67.83 161.53 26.04 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 179.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' B' ' 77' ' ' ALA . . . -103.61 -174.72 2.61 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.866 0.365 . . . . 0.0 111.772 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.703 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 0.3 OUTLIER -67.36 165.21 16.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.049 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . 0.519 ' CG ' ' HB2' ' B' ' 149' ' ' ASN . 5.7 mm-40 -63.42 -79.73 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.33 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . 0.45 ' O ' HG12 ' E' ' 52' ' ' VAL . 2.3 p -165.48 3.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.018 0.437 . . . . 0.0 111.549 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . 0.536 ' HA ' ' HB2' ' D' ' 25' ' ' ALA . 0.7 OUTLIER -80.16 79.73 6.68 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.869 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.501 ' HB2' HG13 ' E' ' 52' ' ' VAL . . . -57.05 -24.76 56.15 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.868 0.366 . . . . 0.0 111.617 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.2 33.99 5.24 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.692 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.77 0.42 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.911 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' SER . . . . . 0.703 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . 38.4 m -96.8 177.93 5.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.873 0.368 . . . . 0.0 110.622 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.54 -178.65 7.04 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.806 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' B' ' 98' ' ' ASN . 2.0 m -134.42 119.05 18.09 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.379 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' B' ' 97' ' ' THR . 32.5 m-20 68.68 34.53 3.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.441 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . 0.755 HG13 HD23 ' B' ' 42' ' ' LEU . 0.4 OUTLIER -138.13 130.85 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.784 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.14 -170.63 18.96 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.539 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.586 HG13 ' HB2' ' B' ' 86' ' ' LEU . 0.2 OUTLIER -119.61 114.48 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.017 0.527 . . . . 0.0 111.766 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 0.8 OUTLIER -87.4 150.24 23.94 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.92 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.55 HG12 ' HG ' ' B' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 135.99 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.471 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.31 133.59 55.05 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.654 0.264 . . . . 0.0 110.988 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . 0.864 ' HB3' HG22 ' B' ' 107' ' ' THR . 6.1 t0 -82.29 149.75 27.63 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.725 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . 0.736 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.4 OUTLIER -67.82 -16.26 64.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.811 0.339 . . . . 0.0 111.103 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.864 HG22 ' HB3' ' B' ' 105' ' ' ASP . 8.8 t -63.69 -28.39 69.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.006 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.08 -40.55 1.57 Allowed Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.662 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . 0.419 ' H ' HG23 ' B' ' 107' ' ' THR . . . -91.48 163.12 14.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.819 0.342 . . . . 0.0 111.052 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.12 133.35 35.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.204 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.564 HD21 ' O ' ' B' ' 117' ' ' THR . 4.8 tp -96.69 150.0 21.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.413 0.625 . . . . 0.0 110.539 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.864 HG23 HG21 ' B' ' 117' ' ' THR . 1.9 t -98.48 141.76 30.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.177 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.774 HD13 ' HG ' ' B' ' 86' ' ' LEU . 1.6 mt -76.36 89.4 3.18 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.741 0.305 . . . . 0.0 110.746 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.07 -18.14 5.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.503 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.8 -60.65 0.46 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.588 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . 0.501 ' HB2' ' N ' ' E' ' 129' ' ' ASN . . . -96.5 27.03 4.02 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.035 0.445 . . . . 0.0 111.632 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.864 HG21 HG23 ' B' ' 112' ' ' THR . 0.0 OUTLIER -87.07 74.89 9.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.164 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.603 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . 62.6 m-85 -94.92 92.89 7.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 25.5 m -136.33 68.93 1.43 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.84 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.86 150.29 28.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.557 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -107.34 67.63 0.7 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.206 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.614 ' O ' ' HB3' ' B' ' 69' ' ' ALA . 0.2 OUTLIER -79.15 114.71 18.31 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.757 -179.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 12.0 m -73.98 128.02 34.41 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.713 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.577 HD21 ' O ' ' B' ' 20' ' ' ALA . 4.0 tp -92.11 132.17 36.8 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.614 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.17 151.09 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.583 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' B' ' 61' ' ' CYS . 3.1 t30 -69.03 111.97 5.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.627 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.55 -138.96 8.75 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.643 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . 0.723 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 87.7 m -98.71 82.55 2.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.637 0.256 . . . . 0.0 110.792 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . 0.462 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 2.3 t30 -71.76 148.14 46.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.805 0.336 . . . . 0.0 111.188 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.722 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -138.64 148.61 44.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 -179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' ILE . . . . . 0.754 HG21 HG11 ' B' ' 71' ' ' VAL . 15.6 mt -110.01 112.22 57.91 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' PRO . . . . . 0.736 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.83 137.03 9.72 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.574 1.516 . . . . 0.0 112.578 -179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.03 136.02 19.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.739 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -111.45 158.41 19.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.033 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.683 ' O ' HG22 ' B' ' 52' ' ' VAL . . . -154.15 111.33 3.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.924 0.392 . . . . 0.0 111.633 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . 0.481 ' HB3' ' CA ' ' B' ' 51' ' ' ALA . 19.8 ptt180 -108.94 174.11 6.02 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.375 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . 0.686 ' HB3' HD21 ' B' ' 42' ' ' LEU . 1.7 m-85 -81.4 137.64 35.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.047 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . 0.517 ' HB3' HG21 ' B' ' 85' ' ' VAL . 0.9 OUTLIER -131.53 124.14 29.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.104 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' B' ' 47' ' ' ALA . . . -108.51 130.16 55.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.834 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' B' ' 45' ' ' GLU . 0.2 OUTLIER -77.44 -27.9 52.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.571 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.48 -96.52 0.11 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.006 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.99 98.49 8.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.572 0.225 . . . . 0.0 110.666 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' ALA . . . . . 0.575 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -56.64 148.93 18.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.742 0.306 . . . . 0.0 111.418 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.724 ' CG2' ' CD ' ' B' ' 145' ' ' PRO . 90.5 m -125.44 156.95 69.57 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.208 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.724 ' CD ' ' CG2' ' B' ' 144' ' ' THR . 1.4 Cg_endo -83.42 136.28 7.53 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.52 2.147 . . . . 0.0 111.974 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' A' ' 15' ' ' GLU . . . 163.64 -127.57 1.69 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.51 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.66 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -110.93 132.92 53.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.829 0.347 . . . . 0.0 111.328 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . 0.778 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -124.28 43.75 2.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.422 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.519 ' HB2' ' CG ' ' B' ' 89' ' ' GLN . 9.3 m120 -92.34 144.32 25.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.506 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.692 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -160.68 178.85 9.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.968 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . 0.624 ' OD1' ' HA ' ' A' ' 11' ' ' HIS . 15.7 t70 -146.97 145.03 29.62 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.218 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -133.79 139.73 46.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.18 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.965 HG23 HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -101.04 135.25 42.79 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.131 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.543 ' HB3' ' H ' ' A' ' 8' ' ' GLY . 0.2 OUTLIER -81.52 152.16 27.42 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.118 0.485 . . . . 0.0 110.125 -179.082 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.424 ' HE3' ' HB ' ' E' ' 128' ' ' THR . 15.2 mmtm -134.22 146.84 50.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.877 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' VAL . . . . . 0.633 HG23 HG23 ' A' ' 5' ' ' VAL . 33.1 m -139.07 140.77 37.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.8 0.333 . . . . 0.0 111.617 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 3' ' ' THR . 0.9 OUTLIER -134.52 132.67 39.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.272 0.558 . . . . 0.0 110.485 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . 0.56 ' CE1' ' HB2' ' B' ' 21' ' ' CYS . 10.9 m-85 -107.22 128.01 54.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.557 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.907 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 120.222 0.058 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' D' ' 158' ' ' TYR . . . 52.76 88.35 0.03 OUTLIER 'General case' 0 C--O 1.232 0.163 0 O-C-N 123.141 0.275 . . . . 0.0 111.015 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' D' ' 157' ' ' GLN . 5.5 m -123.0 116.28 23.27 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.381 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -99.66 117.16 33.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.6 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.629 HG23 HG23 ' D' ' 156' ' ' VAL . 1.8 m -144.45 157.96 14.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.626 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' D' ' 154' ' ' PHE . 13.2 t30 -78.66 123.75 27.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.582 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.7 -71.24 1.0 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.819 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . 0.541 ' H ' ' HB3' ' D' ' 154' ' ' PHE . . . -152.7 -147.01 4.49 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.773 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . 0.93 HG22 HG23 ' D' ' 153' ' ' THR . 24.1 p -148.75 134.51 18.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.053 0.454 . . . . 0.0 111.243 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.35 124.33 72.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.201 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' HIS . . . . . 0.632 ' HA ' ' OD1' ' D' ' 151' ' ' ASP . 57.4 t-80 -91.51 116.13 28.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.308 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -96.8 105.49 17.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.824 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.409 ' HG2' ' ND2' ' D' ' 149' ' ' ASN . 5.1 tttm -104.66 118.67 37.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.484 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.22 172.94 30.76 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.98 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' GLU . . . . . 0.738 ' O ' ' HA ' ' D' ' 36' ' ' GLN . 25.7 tt0 -160.39 135.93 8.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.913 0.387 . . . . 0.0 110.459 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.77 HG23 ' HB2' ' D' ' 148' ' ' ALA . 43.8 t -96.86 132.85 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.168 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.723 HG11 ' NE2' ' D' ' 36' ' ' GLN . 18.2 m -133.97 -177.21 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.93 0.395 . . . . 0.0 110.965 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . 0.569 ' HA ' HG22 ' D' ' 39' ' ' THR . 0.3 OUTLIER -75.75 -170.28 1.27 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.977 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.82 45.5 0.97 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.073 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . 0.559 ' O ' HD21 ' C' ' 124' ' ' LEU . . . -121.31 -24.85 5.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.383 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' CYS . . . . . 0.698 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER -168.87 140.69 2.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.864 -179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' HB2' ' C' ' 60' ' ' ASP . . . -132.82 117.02 17.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.041 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . 0.733 HG12 ' HB2' ' D' ' 36' ' ' GLN . 0.5 OUTLIER -67.11 146.26 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.113 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.466 ' O ' HG23 ' C' ' 28' ' ' VAL . 12.9 t0 -80.4 152.11 29.02 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.545 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.528 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -62.77 -40.02 95.97 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.483 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.91 2.67 85.83 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.886 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -106.14 -20.05 13.53 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.872 0.368 . . . . 0.0 110.817 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.466 HG23 ' O ' ' C' ' 24' ' ' ASP . 39.7 t -47.31 -52.15 5.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.324 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.21 136.42 48.71 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.995 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.72 136.91 39.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.017 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.56 102.86 12.76 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.074 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 26.1 t -107.66 128.34 62.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.051 0.453 . . . . 0.0 110.485 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -114.78 123.16 48.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.603 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.49 -42.74 15.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.593 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.5 -167.42 13.17 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.613 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . 0.744 ' HB2' HG12 ' B' ' 23' ' ' VAL . 3.7 mt-30 -96.77 124.42 40.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.586 0.231 . . . . 0.0 110.882 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.73 147.59 11.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.946 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.76 134.97 34.31 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.67 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.563 HG22 ' HA ' ' B' ' 18' ' ' ASN . 0.0 OUTLIER -60.1 -44.37 94.88 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.798 179.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.41 -36.74 61.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.063 0.458 . . . . 0.0 110.835 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.97 -35.73 62.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.191 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.751 HD23 HG13 ' C' ' 99' ' ' VAL . 2.9 mp -106.71 34.56 3.36 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.646 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.97 15.82 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.334 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.96 132.05 56.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.359 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' C' ' 140' ' ' THR . 6.8 tt0 -56.54 108.8 0.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.806 0.336 . . . . 0.0 111.107 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.89 25.96 10.12 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.152 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' C' ' 139' ' ' ALA . . . -71.49 137.8 48.45 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 7.4 p -137.01 122.77 19.93 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.864 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' C' ' 136' ' ' ARG . 54.0 m -100.09 -175.16 2.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.655 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 2.8 t -55.63 137.3 49.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.811 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . 0.481 ' CA ' ' HB3' ' C' ' 136' ' ' ARG . . . -92.4 133.48 35.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.34 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.68 HG22 ' O ' ' C' ' 135' ' ' ALA . 26.4 m -76.7 162.51 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.56 141.2 16.79 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.519 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -173.74 137.73 0.62 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.721 0.296 . . . . 0.0 111.015 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -136.5 145.74 45.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.647 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.532 HG23 ' O ' ' C' ' 56' ' ' ILE . 1.2 tp -90.92 116.76 32.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.68 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.704 ' HA ' HG23 ' C' ' 130' ' ' THR . 1.3 mp0 -72.9 128.55 35.83 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.824 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . 0.453 ' HG ' ' HA ' ' C' ' 23' ' ' VAL . 0.3 OUTLIER -137.28 89.18 2.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.284 -179.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . 0.709 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 9.8 p30 -74.82 176.46 7.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.013 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' ASP . . . . . 0.498 ' HB2' ' HB3' ' C' ' 22' ' ' ALA . 0.8 OUTLIER 58.92 74.87 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.818 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' CYS . . . . . 0.698 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 36.3 m -126.34 148.91 49.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . 0.403 ' OD2' HG23 ' C' ' 65' ' ' VAL . 1.6 t70 -121.63 169.72 10.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.35 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.26 -32.7 4.89 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.52 -27.88 56.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.238 0.542 . . . . 0.0 111.765 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.403 HG23 ' OD2' ' C' ' 62' ' ' ASP . 25.6 t -73.6 -56.81 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.64 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . 0.466 ' HB3' ' HB1' ' C' ' 20' ' ' ALA . . . -134.98 122.7 22.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.65 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.45 -50.1 5.14 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.861 0.362 . . . . 0.0 110.997 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' LYS . . . . . 0.429 ' HA ' ' HZ3' ' C' ' 68' ' ' LYS . 1.8 tptp -89.78 152.14 21.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.558 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' C' ' 122' ' ' THR . . . -144.26 137.84 27.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.575 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -113.41 157.24 22.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.073 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . 0.736 HG11 HG21 ' C' ' 131' ' ' ILE . 1.8 t -138.74 149.94 23.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.665 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.82 155.1 37.51 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.59 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' PHE . . . . . 0.552 ' CB ' HD13 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -124.99 136.66 53.93 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.012 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.568 HD11 ' HG3' ' F' ' 57' ' ' GLN . 0.9 OUTLIER -97.16 136.17 38.07 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.994 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' C' ' 113' ' ' LEU . . . -174.01 -172.95 39.74 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.817 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.666 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.2 OUTLIER -118.67 144.54 46.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.551 0.215 . . . . 0.0 110.796 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . 0.637 ' HB2' HG23 ' C' ' 83' ' ' THR . . . -62.5 138.6 58.5 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.913 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . 0.508 HG23 ' N ' ' C' ' 79' ' ' ASP . 5.7 tt -71.66 -45.54 66.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.85 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' ASP . . . . . 0.508 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.3 OUTLIER -133.15 42.47 3.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' C' ' 79' ' ' ASP . . . 70.19 -80.73 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.032 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.11 -29.68 68.84 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.609 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . 0.432 ' HB3' HG22 ' C' ' 78' ' ' ILE . 1.7 m80 -89.84 69.39 7.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.832 0.349 . . . . 0.0 110.424 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . 0.637 HG23 ' HB2' ' C' ' 77' ' ' ALA . 0.2 OUTLIER -74.55 -16.13 60.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.604 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' ASN . . . . . 0.746 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 20.8 p-10 -66.18 -19.04 65.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.336 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.523 HG21 ' HB3' ' C' ' 138' ' ' PHE . 13.5 t -113.66 133.86 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.128 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.773 ' HG ' HD13 ' C' ' 113' ' ' LEU . 0.4 OUTLIER -67.91 161.53 26.22 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.267 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.614 ' HB2' ' O ' ' C' ' 77' ' ' ALA . . . -103.58 -174.66 2.6 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.862 0.363 . . . . 0.0 111.764 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.702 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 0.3 OUTLIER -67.4 165.17 17.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.116 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' GLN . . . . . 0.525 ' CG ' ' HB2' ' C' ' 149' ' ' ASN . 5.7 mm-40 -63.36 -79.69 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.365 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . 0.449 ' O ' HG12 ' F' ' 52' ' ' VAL . 2.3 p -165.52 3.61 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 121.01 0.433 . . . . 0.0 111.579 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' SER . . . . . 0.533 ' HA ' ' HB2' ' E' ' 25' ' ' ALA . 0.7 OUTLIER -80.09 79.83 6.59 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' ALA . . . . . 0.522 ' HB2' HG13 ' F' ' 52' ' ' VAL . . . -57.09 -24.79 56.49 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.891 0.377 . . . . 0.0 111.634 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.17 33.94 5.25 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.69 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.85 0.46 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.937 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' SER . . . . . 0.702 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 38.6 m -96.78 177.94 5.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.892 0.377 . . . . 0.0 110.607 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.52 -178.73 7.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.784 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . 0.495 ' HB ' ' OG1' ' C' ' 144' ' ' THR . 2.0 m -134.44 119.02 18.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.369 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' C' ' 97' ' ' THR . 32.8 m-20 68.78 34.48 3.33 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.457 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' VAL . . . . . 0.751 HG13 HD23 ' C' ' 42' ' ' LEU . 0.4 OUTLIER -138.12 130.85 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.727 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.21 -170.63 19.01 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.566 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' VAL . . . . . 0.59 HG13 ' HB2' ' C' ' 86' ' ' LEU . 0.2 OUTLIER -119.62 114.51 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 123.028 0.531 . . . . 0.0 111.717 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 0.8 OUTLIER -87.39 150.2 23.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.923 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.563 HG12 ' HG ' ' C' ' 113' ' ' LEU . 0.8 OUTLIER -114.94 136.07 52.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.481 179.455 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.37 133.52 55.11 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.711 0.291 . . . . 0.0 111.032 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . 0.838 ' HB3' HG22 ' C' ' 107' ' ' THR . 6.1 t0 -82.24 149.74 27.69 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.674 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . 0.757 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.4 OUTLIER -67.87 -16.23 63.99 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.795 0.331 . . . . 0.0 111.058 179.537 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . 0.838 HG22 ' HB3' ' C' ' 105' ' ' ASP . 8.8 t -63.62 -28.39 69.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.043 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 133.97 -40.46 1.58 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.717 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' ALA . . . . . 0.416 ' H ' HG23 ' C' ' 107' ' ' THR . . . -91.54 163.08 14.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.822 0.344 . . . . 0.0 110.999 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.14 133.36 35.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.198 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' LEU . . . . . 0.563 HD21 ' O ' ' C' ' 117' ' ' THR . 4.8 tp -96.72 149.98 21.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.368 0.604 . . . . 0.0 110.603 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' THR . . . . . 0.848 HG23 HG21 ' C' ' 117' ' ' THR . 1.9 t -98.43 141.73 30.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.773 HD13 ' HG ' ' C' ' 86' ' ' LEU . 1.6 mt -76.39 89.48 3.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.808 0.337 . . . . 0.0 110.727 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.15 -18.06 5.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.697 0.284 . . . . 0.0 111.525 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.78 -60.63 0.46 Allowed Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.559 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' ALA . . . . . 0.504 ' HB2' ' C ' ' F' ' 128' ' ' THR . . . -96.46 26.96 4.04 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.996 0.427 . . . . 0.0 111.636 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . 0.848 HG21 HG23 ' C' ' 112' ' ' THR . 0.0 OUTLIER -87.04 74.81 9.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.157 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' PHE . . . . . 0.595 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . 62.8 m-85 -94.93 92.93 7.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.812 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 25.6 m -136.35 68.94 1.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.831 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.83 150.27 28.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.646 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.34 67.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.178 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' C' ' 69' ' ' ALA . 0.2 OUTLIER -79.19 114.71 18.35 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.7 -179.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -74.02 128.04 34.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.729 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . 0.559 HD21 ' O ' ' C' ' 20' ' ' ALA . 4.0 tp -92.14 132.19 36.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.594 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.13 151.01 49.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.641 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' C' ' 61' ' ' CYS . 3.1 t30 -69.05 112.11 5.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.892 0.377 . . . . 0.0 110.632 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.43 -138.93 8.77 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.756 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' THR . . . . . 0.709 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 87.0 m -98.72 82.54 2.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.642 0.258 . . . . 0.0 110.827 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 129' ' ' ASN . . . . . 0.454 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 2.3 t30 -71.84 148.13 46.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.89 0.376 . . . . 0.0 111.145 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . 0.704 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -138.57 148.57 44.33 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.209 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 131' ' ' ILE . . . . . 0.736 HG21 HG11 ' C' ' 71' ' ' VAL . 15.7 mt -110.03 112.27 57.83 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 132' ' ' PRO . . . . . 0.757 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.6 Cg_endo -81.8 137.02 9.75 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.599 1.532 . . . . 0.0 112.566 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.01 136.09 19.94 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.727 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -111.5 158.38 19.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.081 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.68 ' O ' HG22 ' C' ' 52' ' ' VAL . . . -154.18 111.36 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.969 0.414 . . . . 0.0 111.64 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.481 ' HB3' ' CA ' ' C' ' 51' ' ' ALA . 19.8 ptt180 -108.89 174.06 6.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.385 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 137' ' ' TYR . . . . . 0.706 ' HB3' HD21 ' C' ' 42' ' ' LEU . 1.7 m-85 -81.41 137.73 35.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.103 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 138' ' ' PHE . . . . . 0.523 ' HB3' HG21 ' C' ' 85' ' ' VAL . 0.9 OUTLIER -131.58 124.13 29.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.092 -179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 139' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' C' ' 47' ' ' ALA . . . -108.48 130.19 55.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.824 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 140' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' C' ' 45' ' ' GLU . 0.2 OUTLIER -77.46 -27.93 52.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.518 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.5 -96.54 0.11 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.955 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -103.95 98.49 8.32 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.578 0.227 . . . . 0.0 110.714 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 143' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -56.56 148.92 18.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.757 0.313 . . . . 0.0 111.364 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 144' ' ' THR . . . . . 0.715 ' CG2' ' CD ' ' C' ' 145' ' ' PRO . 91.0 m -125.43 156.99 69.5 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.247 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 145' ' ' PRO . . . . . 0.715 ' CD ' ' CG2' ' C' ' 144' ' ' THR . 1.5 Cg_endo -83.38 136.17 7.51 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.631 2.22 . . . . 0.0 111.987 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . 0.577 ' O ' ' HG3' ' B' ' 15' ' ' GLU . . . 163.62 -127.57 1.69 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.429 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 147' ' ' ALA . . . . . 0.659 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -110.88 132.9 53.81 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.763 0.316 . . . . 0.0 111.369 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 148' ' ' ALA . . . . . 0.761 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -124.28 43.78 2.91 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.107 0.479 . . . . 0.0 110.438 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 149' ' ' ASN . . . . . 0.525 ' HB2' ' CG ' ' C' ' 89' ' ' GLN . 9.2 m120 -92.33 144.27 25.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.511 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 150' ' ' ALA . . . . . 0.695 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -160.66 178.88 9.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.989 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 151' ' ' ASP . . . . . 0.636 ' OD1' ' HA ' ' B' ' 11' ' ' HIS . 15.6 t70 -146.98 145.02 29.6 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.298 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -133.75 139.78 46.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.273 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . 0.954 HG23 HG22 ' B' ' 9' ' ' THR . 0.2 OUTLIER -101.11 135.28 42.83 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.202 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 154' ' ' PHE . . . . . 0.531 ' HB3' ' H ' ' B' ' 8' ' ' GLY . 0.2 OUTLIER -81.54 152.17 27.4 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.06 0.457 . . . . 0.0 110.136 -179.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . 0.419 ' HE3' ' HB ' ' F' ' 128' ' ' THR . 15.2 mmtm -134.24 146.87 50.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.934 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 156' ' ' VAL . . . . . 0.616 HG23 HG23 ' B' ' 5' ' ' VAL . 33.1 m -139.18 140.79 37.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.859 0.362 . . . . 0.0 111.622 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' B' ' 3' ' ' THR . 0.9 OUTLIER -134.53 132.68 39.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.335 0.588 . . . . 0.0 110.406 -179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' C' ' 21' ' ' CYS . 11.0 m-85 -107.35 128.04 54.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.541 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.823 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.267 0.079 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' E' ' 158' ' ' TYR . . . 52.85 88.35 0.03 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.976 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' E' ' 157' ' ' GLN . 5.4 m -123.0 116.2 23.16 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.413 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -99.6 117.22 33.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.582 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.629 HG23 HG23 ' E' ' 156' ' ' VAL . 1.8 m -144.44 158.03 15.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.655 179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' E' ' 154' ' ' PHE . 13.2 t30 -78.71 123.75 27.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.597 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.83 -71.1 1.02 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.792 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . 0.522 ' H ' ' HB3' ' E' ' 154' ' ' PHE . . . -152.75 -146.98 4.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.806 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . 0.932 HG22 HG23 ' E' ' 153' ' ' THR . 24.1 p -148.76 134.49 18.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.011 0.434 . . . . 0.0 111.258 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.4 124.37 72.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.159 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' HIS . . . . . 0.619 ' HA ' ' OD1' ' E' ' 151' ' ' ASP . 57.3 t-80 -91.52 116.17 28.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.292 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -96.84 105.49 17.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.814 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' LYS . . . . . 0.416 ' HG2' ' ND2' ' E' ' 149' ' ' ASN . 5.1 tttm -104.64 118.73 37.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.422 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.31 172.93 30.82 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.945 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' GLU . . . . . 0.744 ' O ' ' HA ' ' E' ' 36' ' ' GLN . 25.8 tt0 -160.36 135.96 8.21 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.943 0.401 . . . . 0.0 110.339 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.777 HG23 ' HB2' ' E' ' 148' ' ' ALA . 43.2 t -96.79 132.81 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.25 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.723 HG11 ' NE2' ' E' ' 36' ' ' GLN . 18.2 m -133.91 -177.16 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.897 0.38 . . . . 0.0 111.008 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' ASN . . . . . 0.565 ' HA ' HG22 ' E' ' 39' ' ' THR . 0.3 OUTLIER -75.74 -170.37 1.3 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.932 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.74 45.41 0.98 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.029 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.576 ' O ' HD21 ' D' ' 124' ' ' LEU . . . -121.36 -24.78 5.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.369 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER -168.82 140.65 2.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.881 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' D' ' 60' ' ' ASP . . . -132.8 116.99 17.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.068 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . 0.738 HG12 ' HB2' ' E' ' 36' ' ' GLN . 0.5 OUTLIER -67.05 146.18 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.044 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.467 ' O ' HG23 ' D' ' 28' ' ' VAL . 12.9 t0 -80.33 152.04 29.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.58 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -62.69 -40.07 95.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.464 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.91 2.64 85.81 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.867 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -106.17 -19.94 13.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.845 0.355 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . 0.467 HG23 ' O ' ' D' ' 24' ' ' ASP . 39.8 t -47.42 -52.1 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.344 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.19 136.41 48.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.032 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.72 136.92 39.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.035 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.48 102.77 12.69 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.057 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 25.7 t -107.64 128.29 62.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.058 0.456 . . . . 0.0 110.56 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -114.75 123.03 48.21 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.614 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.4 -42.71 15.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.684 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.55 -167.43 13.16 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.618 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' GLN . . . . . 0.738 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 3.7 mt-30 -96.79 124.58 40.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.618 0.247 . . . . 0.0 110.845 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.86 147.52 11.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.822 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.77 134.98 34.3 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.661 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.569 HG22 ' HA ' ' C' ' 18' ' ' ASN . 0.0 OUTLIER -60.04 -44.42 94.66 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.828 179.321 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.35 -36.78 61.71 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.135 0.493 . . . . 0.0 110.92 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.94 -35.86 62.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.135 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.746 HD23 HG13 ' D' ' 99' ' ' VAL . 2.9 mp -106.6 34.55 3.35 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.614 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.9 15.8 27.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.32 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.94 132.09 56.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.323 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' D' ' 140' ' ' THR . 6.8 tt0 -56.55 108.78 0.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.744 0.307 . . . . 0.0 111.117 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.95 25.88 10.14 Favored Glycine 0 C--N 1.33 0.244 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.136 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' D' ' 139' ' ' ALA . . . -71.48 137.76 48.45 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.963 0.411 . . . . 0.0 112.058 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 7.3 p -137.01 122.77 19.93 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.92 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' D' ' 136' ' ' ARG . 53.4 m -100.12 -175.19 2.88 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.606 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 2.9 t -55.59 137.31 49.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.808 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' ALA . . . . . 0.48 ' CA ' ' HB3' ' D' ' 136' ' ' ARG . . . -92.41 133.51 35.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.348 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' VAL . . . . . 0.675 HG22 ' O ' ' D' ' 135' ' ' ALA . 26.6 m -76.76 162.47 4.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.49 141.16 16.78 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.552 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.569 ' H ' HG21 ' A' ' 76' ' ' THR . 39.4 p90 -173.74 137.79 0.62 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.783 0.325 . . . . 0.0 110.965 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' ASN . . . . . 0.501 ' OD1' HD21 ' A' ' 74' ' ' LEU . 17.9 p30 -136.5 145.81 45.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.681 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.532 HG23 ' O ' ' D' ' 56' ' ' ILE . 1.2 tp -90.95 116.76 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.627 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' GLN . . . . . 0.729 ' HA ' HG23 ' D' ' 130' ' ' THR . 1.3 mp0 -72.87 128.59 35.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.803 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . 0.46 ' HG ' ' HA ' ' D' ' 23' ' ' VAL . 0.3 OUTLIER -137.31 89.11 2.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.264 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . 0.722 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 9.8 p30 -74.76 176.54 6.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.951 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' ASP . . . . . 0.505 ' HB2' ' HB3' ' D' ' 22' ' ' ALA . 0.9 OUTLIER 58.9 74.79 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.888 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' CYS . . . . . 0.713 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 36.6 m -126.33 148.89 49.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.808 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . 0.412 ' OD2' HG23 ' D' ' 65' ' ' VAL . 1.5 t70 -121.61 169.78 10.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.317 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.32 -32.63 4.9 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -76.57 -27.89 56.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.197 0.522 . . . . 0.0 111.742 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . 0.412 HG23 ' OD2' ' D' ' 62' ' ' ASP . 25.6 t -73.57 -56.83 8.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.677 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.458 ' HB3' ' HB1' ' D' ' 20' ' ' ALA . . . -134.93 122.77 22.39 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.647 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.57 -50.02 5.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.921 0.391 . . . . 0.0 110.977 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 1.8 tptp -89.84 152.12 21.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.517 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' D' ' 122' ' ' THR . . . -144.22 137.86 27.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.586 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . 0.596 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -113.41 157.23 22.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.078 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . 0.739 HG11 HG21 ' D' ' 131' ' ' ILE . 1.8 t -138.7 150.0 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.638 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.8 155.11 37.54 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.624 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' PHE . . . . . 0.546 ' CB ' HD13 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -125.08 136.69 53.9 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.651 0.262 . . . . 0.0 111.012 179.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.9 OUTLIER -97.19 136.12 38.16 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.978 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . 0.455 ' CA ' ' HB3' ' D' ' 113' ' ' LEU . . . -174.03 -172.96 39.76 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.744 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.2 OUTLIER -118.72 144.57 46.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.552 0.215 . . . . 0.0 110.801 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.632 ' HB2' HG23 ' D' ' 83' ' ' THR . . . -62.47 138.53 58.48 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.91 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 78' ' ' ILE . . . . . 0.507 HG23 ' N ' ' D' ' 79' ' ' ASP . 5.7 tt -71.52 -45.65 67.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.893 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.507 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.3 OUTLIER -133.15 42.55 3.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.771 -179.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' D' ' 79' ' ' ASP . . . 70.16 -80.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.11 -29.7 68.89 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.529 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . 0.445 ' HB3' HG22 ' D' ' 78' ' ' ILE . 1.7 m80 -89.82 69.39 7.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.754 0.311 . . . . 0.0 110.436 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 83' ' ' THR . . . . . 0.632 HG23 ' HB2' ' D' ' 77' ' ' ALA . 0.2 OUTLIER -74.56 -16.15 60.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.6 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . 0.746 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 20.8 p-10 -66.24 -19.08 65.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.261 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' D' ' 138' ' ' PHE . 13.4 t -113.57 133.84 58.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.179 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.765 ' HG ' HD13 ' D' ' 113' ' ' LEU . 0.4 OUTLIER -67.87 161.47 26.27 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' D' ' 77' ' ' ALA . . . -103.59 -174.72 2.61 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.837 0.351 . . . . 0.0 111.79 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.709 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 0.3 OUTLIER -67.33 165.23 16.8 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.104 179.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 89' ' ' GLN . . . . . 0.529 ' CG ' ' HB2' ' D' ' 149' ' ' ASN . 5.7 mm-40 -63.43 -79.76 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.323 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -165.46 3.78 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.051 0.453 . . . . 0.0 111.6 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' F' ' 25' ' ' ALA . 0.7 OUTLIER -80.09 79.72 6.6 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.06 -24.77 56.27 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.815 0.341 . . . . 0.0 111.606 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.13 33.89 5.27 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.731 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.75 0.43 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.935 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 95' ' ' SER . . . . . 0.709 ' HB3' ' HG ' ' D' ' 88' ' ' LEU . 38.7 m -96.7 177.94 5.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.856 0.36 . . . . 0.0 110.679 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.52 -178.7 7.06 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.796 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . 0.493 ' HB ' ' OG1' ' D' ' 144' ' ' THR . 2.0 m -134.41 119.08 18.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.354 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 98' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' D' ' 97' ' ' THR . 32.4 m-20 68.67 34.56 3.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.439 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 99' ' ' VAL . . . . . 0.746 HG13 HD23 ' D' ' 42' ' ' LEU . 0.4 OUTLIER -138.16 130.81 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.755 179.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.15 -170.62 18.95 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.539 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 101' ' ' VAL . . . . . 0.589 HG13 ' HB2' ' D' ' 86' ' ' LEU . 0.2 OUTLIER -119.66 114.49 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.036 0.534 . . . . 0.0 111.654 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 102' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 0.8 OUTLIER -87.36 150.22 23.98 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.887 -179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 103' ' ' ILE . . . . . 0.554 HG12 ' HG ' ' D' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 136.07 52.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.461 179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.34 133.47 55.12 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.636 0.255 . . . . 0.0 111.053 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . 0.854 ' HB3' HG22 ' D' ' 107' ' ' THR . 6.1 t0 -82.21 149.77 27.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.725 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 106' ' ' ARG . . . . . 0.754 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.4 OUTLIER -67.89 -16.23 63.98 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.729 0.3 . . . . 0.0 111.046 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 107' ' ' THR . . . . . 0.854 HG22 ' HB3' ' D' ' 105' ' ' ASP . 8.8 t -63.65 -28.42 69.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.039 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.01 -40.41 1.59 Allowed Glycine 0 CA--C 1.518 0.242 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.64 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 109' ' ' ALA . . . . . 0.411 ' H ' HG23 ' D' ' 107' ' ' THR . . . -91.46 163.06 14.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.777 0.322 . . . . 0.0 111.054 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.08 133.3 35.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.207 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 111' ' ' LEU . . . . . 0.567 HD21 ' O ' ' D' ' 117' ' ' THR . 4.8 tp -96.73 150.06 21.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.356 0.598 . . . . 0.0 110.516 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 112' ' ' THR . . . . . 0.863 HG23 HG21 ' D' ' 117' ' ' THR . 1.9 t -98.53 141.72 31.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.098 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 113' ' ' LEU . . . . . 0.765 HD13 ' HG ' ' D' ' 86' ' ' LEU . 1.6 mt -76.34 89.51 3.18 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.735 0.302 . . . . 0.0 110.765 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.15 -18.19 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.652 0.263 . . . . 0.0 111.497 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.82 -60.65 0.46 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.618 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 116' ' ' ALA . . . . . 0.461 ' HA ' ' CE2' ' D' ' 118' ' ' PHE . . . -96.43 26.94 4.04 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.948 0.404 . . . . 0.0 111.631 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 117' ' ' THR . . . . . 0.863 HG21 HG23 ' D' ' 112' ' ' THR . 0.0 OUTLIER -87.02 74.89 9.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.199 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.596 ' HB3' ' HB1' ' D' ' 70' ' ' ALA . 63.1 m-85 -94.94 92.86 7.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.834 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 25.5 m -136.27 68.9 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.81 150.23 28.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.616 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -107.3 67.71 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.135 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.611 ' O ' ' HB3' ' D' ' 69' ' ' ALA . 0.2 OUTLIER -79.23 114.67 18.35 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.735 -179.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -73.97 127.94 34.2 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.756 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . 0.576 HD21 ' O ' ' D' ' 20' ' ' ALA . 4.0 tp -92.01 132.14 36.77 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.649 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.09 151.14 49.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.6 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 126' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' D' ' 61' ' ' CYS . 3.1 t30 -69.1 112.08 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.905 0.383 . . . . 0.0 110.613 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.55 -138.91 8.72 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.659 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 128' ' ' THR . . . . . 0.722 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 87.7 m -98.81 82.58 2.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.642 0.258 . . . . 0.0 110.729 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 129' ' ' ASN . . . . . 0.504 ' N ' ' HB2' ' A' ' 116' ' ' ALA . 2.3 t30 -71.88 148.16 46.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.937 0.398 . . . . 0.0 111.06 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 130' ' ' THR . . . . . 0.729 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.2 OUTLIER -138.57 148.64 44.41 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.161 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 131' ' ' ILE . . . . . 0.739 HG21 HG11 ' D' ' 71' ' ' VAL . 15.8 mt -110.09 112.28 57.7 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 132' ' ' PRO . . . . . 0.754 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.5 Cg_endo -81.77 136.97 9.76 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.677 1.585 . . . . 0.0 112.597 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.04 136.06 19.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.676 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -111.42 158.34 19.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.055 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.675 ' O ' HG22 ' D' ' 52' ' ' VAL . . . -154.18 111.29 3.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.935 0.397 . . . . 0.0 111.637 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 136' ' ' ARG . . . . . 0.48 ' HB3' ' CA ' ' D' ' 51' ' ' ALA . 19.8 ptt180 -108.85 174.21 5.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.346 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 137' ' ' TYR . . . . . 0.696 ' HB3' HD21 ' D' ' 42' ' ' LEU . 1.7 m-85 -81.53 137.68 35.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.03 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 138' ' ' PHE . . . . . 0.529 ' HB3' HG21 ' D' ' 85' ' ' VAL . 0.9 OUTLIER -131.55 124.11 29.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.136 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 139' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' D' ' 47' ' ' ALA . . . -108.42 130.28 55.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.855 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 140' ' ' THR . . . . . 0.499 ' O ' ' HG3' ' D' ' 45' ' ' GLU . 0.2 OUTLIER -77.49 -28.02 52.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.535 179.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.41 -96.47 0.11 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.879 -0.676 . . . . 0.0 113.057 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.03 98.49 8.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.551 0.215 . . . . 0.0 110.697 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 143' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -56.59 148.91 18.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.758 0.313 . . . . 0.0 111.404 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 144' ' ' THR . . . . . 0.716 ' CG2' ' CD ' ' D' ' 145' ' ' PRO . 91.6 m -125.38 156.93 69.45 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.288 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 145' ' ' PRO . . . . . 0.716 ' CD ' ' CG2' ' D' ' 144' ' ' THR . 1.5 Cg_endo -83.28 136.18 7.63 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.584 2.189 . . . . 0.0 111.989 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' C' ' 15' ' ' GLU . . . 163.58 -127.53 1.69 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.472 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 147' ' ' ALA . . . . . 0.649 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -110.98 132.88 53.84 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.842 0.354 . . . . 0.0 111.354 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 148' ' ' ALA . . . . . 0.77 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -124.25 43.74 2.92 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.148 0.499 . . . . 0.0 110.43 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 149' ' ' ASN . . . . . 0.529 ' HB2' ' CG ' ' D' ' 89' ' ' GLN . 9.2 m120 -92.34 144.25 25.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.499 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 150' ' ' ALA . . . . . 0.699 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -160.6 178.93 9.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.975 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 151' ' ' ASP . . . . . 0.632 ' OD1' ' HA ' ' C' ' 11' ' ' HIS . 15.6 t70 -147.03 145.02 29.55 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.226 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 152' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -133.76 139.71 46.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.198 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 153' ' ' THR . . . . . 0.93 HG23 HG22 ' C' ' 9' ' ' THR . 0.2 OUTLIER -100.99 135.26 42.73 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.145 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 154' ' ' PHE . . . . . 0.541 ' HB3' ' H ' ' C' ' 8' ' ' GLY . 0.2 OUTLIER -81.56 152.16 27.37 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.054 0.454 . . . . 0.0 110.136 -179.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . 0.407 ' O ' HG13 ' D' ' 71' ' ' VAL . 15.2 mmtm -134.25 146.88 50.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.908 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 156' ' ' VAL . . . . . 0.629 HG23 HG23 ' C' ' 5' ' ' VAL . 33.1 m -139.09 140.78 37.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.786 0.326 . . . . 0.0 111.626 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 157' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' C' ' 3' ' ' THR . 0.9 OUTLIER -134.54 132.65 39.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.297 0.57 . . . . 0.0 110.425 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . 0.567 ' CE1' ' HB2' ' D' ' 21' ' ' CYS . 11.0 m-85 -107.25 128.05 54.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.514 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.849 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.249 0.071 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' F' ' 158' ' ' TYR . . . 52.85 88.26 0.03 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.994 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 3' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' F' ' 157' ' ' GLN . 5.5 m -122.92 116.29 23.36 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.385 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -99.69 117.17 33.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.521 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.626 HG23 HG23 ' F' ' 156' ' ' VAL . 1.8 m -144.42 157.99 15.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.618 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 6' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' F' ' 154' ' ' PHE . 13.2 t30 -78.62 123.81 27.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.58 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.83 -71.15 1.01 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.827 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . 0.543 ' H ' ' HB3' ' F' ' 154' ' ' PHE . . . -152.7 -146.96 4.48 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.816 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 9' ' ' THR . . . . . 0.951 HG22 HG23 ' F' ' 153' ' ' THR . 24.4 p -148.75 134.42 18.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.005 0.431 . . . . 0.0 111.268 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.33 124.38 72.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.169 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 11' ' ' HIS . . . . . 0.627 ' HA ' ' OD1' ' F' ' 151' ' ' ASP . 57.4 t-80 -91.56 116.2 28.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.306 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -96.78 105.47 17.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.753 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 13' ' ' LYS . . . . . 0.4 ' HG2' ' ND2' ' F' ' 149' ' ' ASN . 5.1 tttm -104.58 118.69 37.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.512 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.27 172.89 30.79 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.924 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 15' ' ' GLU . . . . . 0.735 ' O ' ' HA ' ' F' ' 36' ' ' GLN . 25.8 tt0 -160.3 135.95 8.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.896 0.379 . . . . 0.0 110.384 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 16' ' ' VAL . . . . . 0.764 HG23 ' HB2' ' F' ' 148' ' ' ALA . 43.2 t -96.83 132.78 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.243 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . 0.711 HG11 ' NE2' ' F' ' 36' ' ' GLN . 18.2 m -133.91 -177.17 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.878 0.371 . . . . 0.0 111.007 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . 0.563 ' HA ' HG22 ' F' ' 39' ' ' THR . 0.3 OUTLIER -75.76 -170.28 1.28 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.894 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.73 45.35 0.98 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.078 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.562 ' O ' HD21 ' E' ' 124' ' ' LEU . . . -121.24 -24.9 5.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.424 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 21' ' ' CYS . . . . . 0.857 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER -168.8 140.69 2.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.888 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 22' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' E' ' 60' ' ' ASP . . . -132.86 116.95 17.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.066 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 23' ' ' VAL . . . . . 0.745 HG12 ' HB2' ' F' ' 36' ' ' GLN . 0.5 OUTLIER -67.03 146.26 13.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.101 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 24' ' ' ASP . . . . . 0.474 ' O ' HG23 ' E' ' 28' ' ' VAL . 12.9 t0 -80.37 152.08 29.08 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.547 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . 0.533 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -62.77 -40.06 96.12 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.419 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.93 2.72 85.83 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.891 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -106.23 -19.86 13.57 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.823 0.344 . . . . 0.0 110.825 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 28' ' ' VAL . . . . . 0.474 HG23 ' O ' ' E' ' 24' ' ' ASP . 39.7 t -47.4 -52.16 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.35 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.21 136.45 48.66 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.029 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.73 136.84 39.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.014 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.44 102.89 12.82 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.042 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.69 128.25 63.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.068 0.461 . . . . 0.0 110.547 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -114.64 123.02 48.25 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.693 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.45 -42.72 15.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.581 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.51 -167.45 13.18 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.587 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 36' ' ' GLN . . . . . 0.744 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 3.7 mt-30 -96.77 124.45 40.75 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.589 0.233 . . . . 0.0 110.927 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.77 147.52 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.848 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.68 134.93 34.34 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.698 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 39' ' ' THR . . . . . 0.565 HG22 ' HA ' ' D' ' 18' ' ' ASN . 0.0 OUTLIER -59.99 -44.48 94.49 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.815 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.25 -36.96 61.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.081 0.467 . . . . 0.0 110.843 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.85 -35.83 62.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.165 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.739 HD23 HG13 ' E' ' 99' ' ' VAL . 3.0 mp -106.59 34.51 3.37 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.667 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.92 15.84 27.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.375 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.99 132.07 56.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.283 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' E' ' 140' ' ' THR . 6.8 tt0 -56.5 108.69 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.766 0.317 . . . . 0.0 111.124 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.96 25.97 10.05 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.09 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 47' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' E' ' 139' ' ' ALA . . . -71.49 137.75 48.43 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 7.4 p -137.0 122.71 19.86 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.898 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' E' ' 136' ' ' ARG . 54.2 m -100.02 -175.25 2.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.659 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 50' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 2.8 t -55.63 137.28 49.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.787 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 51' ' ' ALA . . . . . 0.478 ' CA ' ' HB3' ' E' ' 136' ' ' ARG . . . -92.28 133.56 35.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.344 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 52' ' ' VAL . . . . . 0.686 HG22 ' O ' ' E' ' 135' ' ' ALA . 26.2 m -76.78 162.48 4.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.52 141.17 16.78 Favored Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.538 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 54' ' ' PHE . . . . . 0.556 ' H ' HG21 ' B' ' 76' ' ' THR . 39.3 p90 -173.74 137.8 0.62 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.758 0.313 . . . . 0.0 110.941 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 55' ' ' ASN . . . . . 0.496 ' OD1' HD21 ' B' ' 74' ' ' LEU . 18.0 p30 -136.44 145.83 45.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.692 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 56' ' ' ILE . . . . . 0.528 HG23 ' O ' ' E' ' 56' ' ' ILE . 1.2 tp -91.04 116.8 33.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.617 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 57' ' ' GLN . . . . . 0.726 ' HA ' HG23 ' E' ' 130' ' ' THR . 1.3 mp0 -72.87 128.65 36.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.78 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . 0.458 ' HG ' ' HA ' ' E' ' 23' ' ' VAL . 0.3 OUTLIER -137.39 89.2 2.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.236 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . 0.694 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 9.8 p30 -74.9 176.51 7.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.985 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 60' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' E' ' 22' ' ' ALA . 0.9 OUTLIER 58.98 74.85 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.775 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 61' ' ' CYS . . . . . 0.857 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 36.8 m -126.37 148.87 49.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . 0.407 ' OD2' HG23 ' E' ' 65' ' ' VAL . 1.6 t70 -121.58 169.77 10.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.317 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.27 -32.69 4.89 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.55 -27.95 56.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.155 0.502 . . . . 0.0 111.685 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . 0.407 HG23 ' OD2' ' E' ' 62' ' ' ASP . 25.6 t -73.58 -56.76 8.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.702 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . 0.465 ' HB3' ' HB1' ' E' ' 20' ' ' ALA . . . -134.94 122.75 22.35 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.672 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.62 -50.02 5.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.927 0.394 . . . . 0.0 110.932 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 68' ' ' LYS . . . . . 0.4 ' HA ' ' NZ ' ' E' ' 68' ' ' LYS . 1.8 tptp -89.75 152.09 21.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.567 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 69' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' E' ' 122' ' ' THR . . . -144.25 137.9 27.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.521 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . 0.599 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -113.41 157.22 22.19 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.094 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . 0.757 HG11 HG21 ' E' ' 131' ' ' ILE . 1.8 t -138.75 150.06 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.649 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.87 155.03 37.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.57 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 73' ' ' PHE . . . . . 0.557 ' CB ' HD13 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -124.98 136.66 53.94 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.592 0.234 . . . . 0.0 111.071 179.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 74' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.9 OUTLIER -97.21 136.13 38.16 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.011 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . 0.449 ' CA ' ' HB3' ' E' ' 113' ' ' LEU . . . -174.01 -172.94 39.72 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.735 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 76' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.2 OUTLIER -118.71 144.53 46.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.497 0.189 . . . . 0.0 110.826 179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 77' ' ' ALA . . . . . 0.652 ' HB2' HG23 ' E' ' 83' ' ' THR . . . -62.42 138.51 58.47 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.963 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 78' ' ' ILE . . . . . 0.51 HG23 ' N ' ' E' ' 79' ' ' ASP . 5.7 tt -71.6 -45.59 66.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.843 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 79' ' ' ASP . . . . . 0.51 ' N ' HG23 ' E' ' 78' ' ' ILE . 0.3 OUTLIER -133.11 42.49 3.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.833 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' E' ' 79' ' ' ASP . . . 70.09 -80.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.002 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.15 -29.64 68.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.584 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 82' ' ' HIS . . . . . 0.425 ' HB3' HG22 ' E' ' 78' ' ' ILE . 1.7 m80 -89.9 69.45 7.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.874 0.369 . . . . 0.0 110.414 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 83' ' ' THR . . . . . 0.652 HG23 ' HB2' ' E' ' 77' ' ' ALA . 0.2 OUTLIER -74.55 -16.16 60.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.585 -179.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 84' ' ' ASN . . . . . 0.729 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 20.7 p-10 -66.2 -19.09 65.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.292 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' E' ' 138' ' ' PHE . 13.4 t -113.56 133.81 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.188 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 86' ' ' LEU . . . . . 0.775 ' HG ' HD13 ' E' ' 113' ' ' LEU . 0.4 OUTLIER -67.81 161.6 25.85 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.456 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 87' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' E' ' 77' ' ' ALA . . . -103.63 -174.75 2.62 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.936 0.398 . . . . 0.0 111.727 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.704 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 0.3 OUTLIER -67.37 165.18 16.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.082 179.374 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 89' ' ' GLN . . . . . 0.515 ' CG ' ' HB2' ' E' ' 149' ' ' ASN . 5.7 mm-40 -63.41 -79.7 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.376 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -165.49 3.7 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.019 0.437 . . . . 0.0 111.538 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.04 79.77 6.54 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.923 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.14 -24.69 55.98 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.853 0.359 . . . . 0.0 111.573 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.22 34.0 5.23 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.689 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.88 0.47 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.952 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 95' ' ' SER . . . . . 0.704 ' HB3' ' HG ' ' E' ' 88' ' ' LEU . 38.4 m -96.84 177.94 5.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.915 0.388 . . . . 0.0 110.598 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.46 -178.72 7.06 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.797 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . 0.497 ' HB ' ' OG1' ' E' ' 144' ' ' THR . 2.0 m -134.44 119.06 18.09 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.373 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 98' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' E' ' 97' ' ' THR . 32.8 m-20 68.76 34.4 3.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.471 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 99' ' ' VAL . . . . . 0.739 HG13 HD23 ' E' ' 42' ' ' LEU . 0.4 OUTLIER -138.06 130.85 40.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.796 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.08 -170.57 18.85 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.538 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 101' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' E' ' 86' ' ' LEU . 0.2 OUTLIER -119.7 114.47 44.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.028 0.531 . . . . 0.0 111.749 -179.713 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 102' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 0.8 OUTLIER -87.37 150.24 23.95 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.877 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 103' ' ' ILE . . . . . 0.557 HD13 ' CB ' ' E' ' 73' ' ' PHE . 0.8 OUTLIER -115.0 136.01 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.417 179.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.31 133.52 55.08 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.7 0.286 . . . . 0.0 111.073 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . 0.866 ' HB3' HG22 ' E' ' 107' ' ' THR . 6.1 t0 -82.27 149.76 27.65 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.655 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 106' ' ' ARG . . . . . 0.735 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.4 OUTLIER -67.88 -16.2 63.97 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.762 0.315 . . . . 0.0 111.065 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . 0.866 HG22 ' HB3' ' E' ' 105' ' ' ASP . 8.9 t -63.72 -28.35 69.83 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.003 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.0 -40.54 1.57 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.684 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 109' ' ' ALA . . . . . 0.42 ' H ' HG23 ' E' ' 107' ' ' THR . . . -91.42 163.04 14.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.827 0.346 . . . . 0.0 111.039 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.09 133.36 35.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.229 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.571 HD21 ' O ' ' E' ' 117' ' ' THR . 4.8 tp -96.72 150.03 21.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.383 0.611 . . . . 0.0 110.5 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 112' ' ' THR . . . . . 0.866 HG23 HG21 ' E' ' 117' ' ' THR . 1.9 t -98.42 141.7 30.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.183 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 113' ' ' LEU . . . . . 0.775 HD13 ' HG ' ' E' ' 86' ' ' LEU . 1.6 mt -76.33 89.36 3.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.758 0.313 . . . . 0.0 110.758 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.0 -18.21 5.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.652 0.263 . . . . 0.0 111.52 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.78 -60.65 0.46 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.681 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 116' ' ' ALA . . . . . 0.463 ' HA ' ' CE2' ' E' ' 118' ' ' PHE . . . -96.48 27.04 4.01 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.028 0.442 . . . . 0.0 111.641 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 117' ' ' THR . . . . . 0.866 HG21 HG23 ' E' ' 112' ' ' THR . 0.0 OUTLIER -87.11 74.86 9.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.13 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . 0.599 ' HB3' ' HB1' ' E' ' 70' ' ' ALA . 62.8 m-85 -94.87 92.89 7.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.823 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 25.7 m -136.32 68.85 1.43 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.829 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.84 150.31 28.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.579 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.39 67.73 0.7 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.083 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . 0.613 ' O ' ' HB3' ' E' ' 69' ' ' ALA . 0.2 OUTLIER -79.19 114.74 18.37 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.704 -179.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 11.9 m -74.02 127.98 34.31 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.676 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . 0.562 HD21 ' O ' ' E' ' 20' ' ' ALA . 4.0 tp -92.04 132.17 36.76 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.651 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.13 151.1 49.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.608 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' E' ' 61' ' ' CYS . 3.1 t30 -69.1 112.08 5.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.668 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . 0.488 ' CA ' HG21 ' A' ' 4' ' ' THR . . . 142.56 -138.85 8.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.724 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 128' ' ' THR . . . . . 0.694 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 87.4 m -98.85 82.49 2.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.676 0.274 . . . . 0.0 110.84 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 129' ' ' ASN . . . . . 0.501 ' N ' ' HB2' ' B' ' 116' ' ' ALA . 2.3 t30 -71.82 148.18 46.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.938 0.399 . . . . 0.0 111.07 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 130' ' ' THR . . . . . 0.726 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.2 OUTLIER -138.63 148.6 44.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.138 -179.789 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 131' ' ' ILE . . . . . 0.757 HG21 HG11 ' E' ' 71' ' ' VAL . 15.6 mt -109.96 112.2 58.04 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 132' ' ' PRO . . . . . 0.735 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.5 Cg_endo -81.77 137.01 9.78 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.671 1.581 . . . . 0.0 112.585 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.06 135.98 19.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.782 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -111.44 158.36 19.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.076 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . 0.686 ' O ' HG22 ' E' ' 52' ' ' VAL . . . -154.16 111.36 3.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.979 0.419 . . . . 0.0 111.616 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 136' ' ' ARG . . . . . 0.478 ' HB3' ' CA ' ' E' ' 51' ' ' ALA . 19.8 ptt180 -108.91 174.1 6.02 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.375 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 137' ' ' TYR . . . . . 0.701 ' HB3' HD21 ' E' ' 42' ' ' LEU . 1.7 m-85 -81.41 137.68 35.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.067 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 138' ' ' PHE . . . . . 0.514 ' HB3' HG21 ' E' ' 85' ' ' VAL . 0.9 OUTLIER -131.52 124.14 29.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.14 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 139' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' E' ' 47' ' ' ALA . . . -108.49 130.23 55.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.815 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 140' ' ' THR . . . . . 0.5 ' O ' ' HG3' ' E' ' 45' ' ' GLU . 0.2 OUTLIER -77.47 -27.96 52.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.537 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.46 -96.46 0.11 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.971 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.02 98.46 8.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.606 0.203 . . . . 0.0 110.623 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 143' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -56.59 148.86 18.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.784 0.326 . . . . 0.0 111.373 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 144' ' ' THR . . . . . 0.728 ' CG2' ' CD ' ' E' ' 145' ' ' PRO . 93.2 m -125.35 156.93 69.4 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.316 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 145' ' ' PRO . . . . . 0.728 ' CD ' ' CG2' ' E' ' 144' ' ' THR . 1.4 Cg_endo -83.34 136.27 7.61 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.507 2.138 . . . . 0.0 111.993 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 146' ' ' GLY . . . . . 0.58 ' O ' ' HG3' ' D' ' 15' ' ' GLU . . . 163.56 -127.57 1.7 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.434 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 147' ' ' ALA . . . . . 0.645 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -110.94 132.94 53.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.921 0.391 . . . . 0.0 111.291 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 148' ' ' ALA . . . . . 0.777 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -124.29 43.71 2.93 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.421 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 149' ' ' ASN . . . . . 0.515 ' HB2' ' CG ' ' E' ' 89' ' ' GLN . 9.2 m120 -92.32 144.25 25.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.535 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 150' ' ' ALA . . . . . 0.683 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -160.58 178.94 9.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.939 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 151' ' ' ASP . . . . . 0.619 ' OD1' ' HA ' ' D' ' 11' ' ' HIS . 15.7 t70 -147.05 145.01 29.52 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.201 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 152' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -133.76 139.8 46.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.196 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 153' ' ' THR . . . . . 0.932 HG23 HG22 ' D' ' 9' ' ' THR . 0.2 OUTLIER -101.14 135.25 42.91 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 154' ' ' PHE . . . . . 0.522 ' HB3' ' H ' ' D' ' 8' ' ' GLY . 0.2 OUTLIER -81.51 152.1 27.47 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.094 0.473 . . . . 0.0 110.148 -179.086 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . 0.407 ' O ' HG13 ' E' ' 71' ' ' VAL . 15.2 mmtm -134.2 146.84 50.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.947 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 156' ' ' VAL . . . . . 0.629 HG23 HG23 ' D' ' 5' ' ' VAL . 33.1 m -139.11 140.8 37.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.765 0.317 . . . . 0.0 111.64 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 157' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' D' ' 3' ' ' THR . 0.9 OUTLIER -134.55 132.63 39.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.291 0.567 . . . . 0.0 110.434 -179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' E' ' 21' ' ' CYS . 11.0 m-85 -107.23 128.05 54.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.58 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.839 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.26 0.076 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.67 88.39 0.03 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.051 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 5.5 m -122.95 116.28 23.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.358 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -99.69 117.29 33.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.51 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 m -144.49 158.03 14.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.596 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -78.73 123.71 27.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.586 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.67 -71.21 1.0 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.855 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.68 -146.93 4.47 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.825 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 24.5 p -148.77 134.4 18.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.998 0.428 . . . . 0.0 111.278 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.36 124.37 72.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.185 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -91.55 116.27 28.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.282 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -96.92 105.54 17.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.726 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -104.65 118.74 37.32 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.437 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.29 172.88 30.8 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.975 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -160.32 135.98 8.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.961 0.41 . . . . 0.0 110.405 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 43.4 t -96.86 132.79 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.281 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 17' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.89 -177.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.802 0.334 . . . . 0.0 111.019 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -75.72 -170.31 1.27 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.017 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.76 45.43 0.98 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.065 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . 0.571 ' O ' HD21 ' F' ' 124' ' ' LEU . . . -121.29 -24.84 5.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.401 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 21' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER -168.86 140.7 2.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.816 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 22' ' ' ALA . . . . . 0.493 ' HB3' ' HB2' ' F' ' 60' ' ' ASP . . . -132.9 116.91 17.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.05 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 23' ' ' VAL . . . . . 0.453 ' HA ' ' HG ' ' F' ' 58' ' ' LEU . 0.5 OUTLIER -67.06 146.24 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.108 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 24' ' ' ASP . . . . . 0.472 ' O ' HG23 ' F' ' 28' ' ' VAL . 12.9 t0 -80.45 152.06 28.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.542 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -62.71 -40.05 95.94 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.445 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.87 2.64 85.87 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.872 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 23.0 t -106.19 -19.95 13.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.849 0.357 . . . . 0.0 110.867 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 28' ' ' VAL . . . . . 0.472 HG23 ' O ' ' F' ' 24' ' ' ASP . 39.9 t -47.31 -52.2 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.354 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -109.15 136.42 48.67 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.045 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -136.69 136.86 39.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.004 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 2.7 m -103.56 102.85 12.74 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.07 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.64 128.27 62.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.052 0.453 . . . . 0.0 110.51 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -114.75 123.09 48.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.677 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.47 -42.68 15.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.604 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.42 -167.44 13.21 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.604 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 36' ' ' GLN . . . . . 0.745 ' HB2' HG12 ' E' ' 23' ' ' VAL . 3.7 mt-30 -96.77 124.41 40.74 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.615 0.245 . . . . 0.0 110.885 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.72 147.54 11.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.895 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -84.64 134.94 34.36 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.682 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 39' ' ' THR . . . . . 0.563 HG22 ' HA ' ' E' ' 18' ' ' ASN . 0.0 OUTLIER -60.06 -44.45 94.71 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.797 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.23 -36.94 61.58 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.101 0.477 . . . . 0.0 110.91 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.79 -35.91 62.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.185 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . 0.755 HD23 HG13 ' F' ' 99' ' ' VAL . 2.9 mp -106.63 34.53 3.36 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.602 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -103.87 15.8 27.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.307 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.94 132.05 56.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.337 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' F' ' 140' ' ' THR . 6.8 tt0 -56.53 108.74 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 111.172 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.93 25.93 10.11 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.784 -0.643 . . . . 0.0 112.16 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 47' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' F' ' 139' ' ' ALA . . . -71.5 137.73 48.39 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 7.3 p -136.96 122.76 19.97 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.881 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 49' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' F' ' 136' ' ' ARG . 53.4 m -100.05 -175.23 2.89 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.61 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 50' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' C' ' 92' ' ' ALA . 2.8 t -55.62 137.3 49.38 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.819 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 51' ' ' ALA . . . . . 0.482 ' CA ' ' HB3' ' F' ' 136' ' ' ARG . . . -92.35 133.45 35.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.331 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 52' ' ' VAL . . . . . 0.676 HG22 ' O ' ' F' ' 135' ' ' ALA . 26.2 m -76.68 162.51 4.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.54 141.17 16.77 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.605 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 54' ' ' PHE . . . . . 0.573 ' H ' HG21 ' C' ' 76' ' ' THR . 39.3 p90 -173.76 137.81 0.62 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.796 0.331 . . . . 0.0 110.985 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 55' ' ' ASN . . . . . 0.501 ' OD1' HD21 ' C' ' 74' ' ' LEU . 17.9 p30 -136.56 145.88 45.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.604 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 56' ' ' ILE . . . . . 0.529 HG23 ' O ' ' F' ' 56' ' ' ILE . 1.2 tp -91.1 116.79 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.643 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 57' ' ' GLN . . . . . 0.704 ' HA ' HG23 ' F' ' 130' ' ' THR . 1.3 mp0 -72.86 128.55 35.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.812 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . 0.453 ' HG ' ' HA ' ' F' ' 23' ' ' VAL . 0.3 OUTLIER -137.34 89.14 2.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.275 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 59' ' ' ASN . . . . . 0.727 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 9.8 p30 -74.75 176.46 7.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.956 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 60' ' ' ASP . . . . . 0.493 ' HB2' ' HB3' ' F' ' 22' ' ' ALA . 0.8 OUTLIER 58.98 74.77 0.43 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.834 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 61' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 36.8 m -126.34 148.91 49.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.8 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . 0.404 ' OD2' HG23 ' F' ' 65' ' ' VAL . 1.6 t70 -121.62 169.74 10.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.285 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -117.32 -32.6 4.91 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -76.58 -27.92 56.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.266 0.555 . . . . 0.0 111.752 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . 0.404 HG23 ' OD2' ' F' ' 62' ' ' ASP . 25.3 t -73.54 -56.81 8.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.715 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 66' ' ' ALA . . . . . 0.465 ' HB3' ' HB1' ' F' ' 20' ' ' ALA . . . -134.93 122.77 22.39 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.693 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.55 -50.11 5.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.932 0.396 . . . . 0.0 110.931 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 68' ' ' LYS . . . . . 0.401 ' NZ ' ' HA ' ' F' ' 68' ' ' LYS . 1.8 tptp -89.76 152.12 21.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.556 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 69' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' F' ' 122' ' ' THR . . . -144.25 137.8 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.559 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 70' ' ' ALA . . . . . 0.6 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -113.38 157.26 22.11 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.087 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 71' ' ' VAL . . . . . 0.74 HG11 HG21 ' F' ' 131' ' ' ILE . 1.8 t -138.75 150.06 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.638 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -151.87 155.05 37.35 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.593 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 73' ' ' PHE . . . . . 0.552 ' CB ' HD13 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -125.02 136.62 53.88 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.549 0.214 . . . . 0.0 111.056 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 74' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.9 OUTLIER -97.17 136.11 38.16 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.019 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . 0.454 ' CA ' ' HB3' ' F' ' 113' ' ' LEU . . . -174.0 -172.94 39.72 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.761 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 76' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.2 OUTLIER -118.73 144.53 46.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.553 0.216 . . . . 0.0 110.785 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 77' ' ' ALA . . . . . 0.634 ' HB2' HG23 ' F' ' 83' ' ' THR . . . -62.46 138.59 58.49 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.94 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 78' ' ' ILE . . . . . 0.496 HG23 ' N ' ' F' ' 79' ' ' ASP . 5.7 tt -71.66 -45.56 66.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.85 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 79' ' ' ASP . . . . . 0.496 ' N ' HG23 ' F' ' 78' ' ' ILE . 0.3 OUTLIER -133.11 42.45 3.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.793 -179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 80' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' F' ' 79' ' ' ASP . . . 70.16 -80.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.06 -29.68 68.7 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.64 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 82' ' ' HIS . . . . . 0.427 ' HB3' HG22 ' F' ' 78' ' ' ILE . 1.7 m80 -89.87 69.38 7.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.813 0.34 . . . . 0.0 110.426 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 83' ' ' THR . . . . . 0.634 HG23 ' HB2' ' F' ' 77' ' ' ALA . 0.2 OUTLIER -74.53 -16.12 60.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.631 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 84' ' ' ASN . . . . . 0.745 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 20.7 p-10 -66.25 -19.05 65.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.285 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 85' ' ' VAL . . . . . 0.517 HG21 ' HB3' ' F' ' 138' ' ' PHE . 13.4 t -113.6 133.8 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.202 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 86' ' ' LEU . . . . . 0.773 ' HG ' HD13 ' F' ' 113' ' ' LEU . 0.4 OUTLIER -67.73 161.54 25.78 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 87' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' F' ' 77' ' ' ALA . . . -103.66 -174.71 2.61 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.84 0.352 . . . . 0.0 111.756 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . 0.7 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 0.3 OUTLIER -67.36 165.22 16.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.069 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 89' ' ' GLN . . . . . 0.523 ' CG ' ' HB2' ' F' ' 149' ' ' ASN . 5.6 mm-40 -63.54 -79.67 0.03 OUTLIER 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.302 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -165.48 3.73 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.003 0.43 . . . . 0.0 111.487 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.08 79.75 6.59 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.906 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.17 -24.63 55.69 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.849 0.357 . . . . 0.0 111.608 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -123.2 33.99 5.24 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.653 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.85 0.44 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.958 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 95' ' ' SER . . . . . 0.7 ' HB3' ' HG ' ' F' ' 88' ' ' LEU . 38.4 m -96.73 177.95 5.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.86 0.362 . . . . 0.0 110.612 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.46 -178.65 7.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . 0.497 ' HB ' ' OG1' ' F' ' 144' ' ' THR . 2.0 m -134.55 119.04 17.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.341 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 98' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' F' ' 97' ' ' THR . 32.6 m-20 68.75 34.48 3.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.433 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 99' ' ' VAL . . . . . 0.755 HG13 HD23 ' F' ' 42' ' ' LEU . 0.4 OUTLIER -138.08 130.88 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.765 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.21 -170.6 18.97 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.537 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 101' ' ' VAL . . . . . 0.574 HG13 ' HB2' ' F' ' 86' ' ' LEU . 0.2 OUTLIER -119.64 114.44 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 123.008 0.523 . . . . 0.0 111.737 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 102' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 0.8 OUTLIER -87.35 150.24 23.97 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.895 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 103' ' ' ILE . . . . . 0.565 HG12 ' HG ' ' F' ' 113' ' ' LEU . 0.8 OUTLIER -115.0 136.01 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.474 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.39 133.56 55.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.705 0.288 . . . . 0.0 111.028 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . 0.837 ' HB3' HG22 ' F' ' 107' ' ' THR . 6.1 t0 -82.23 149.72 27.71 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.749 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 106' ' ' ARG . . . . . 0.753 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.4 OUTLIER -67.87 -16.24 64.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.798 0.332 . . . . 0.0 111.098 179.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . 0.837 HG22 ' HB3' ' F' ' 105' ' ' ASP . 8.8 t -63.59 -28.46 69.94 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.979 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.04 -40.55 1.57 Allowed Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.616 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 109' ' ' ALA . . . . . 0.416 ' H ' HG23 ' F' ' 107' ' ' THR . . . -91.43 163.04 14.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.811 0.339 . . . . 0.0 111.038 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.18 133.4 35.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . 0.571 HD21 ' O ' ' F' ' 117' ' ' THR . 4.8 tp -96.66 149.94 21.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.386 0.612 . . . . 0.0 110.558 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 112' ' ' THR . . . . . 0.842 HG23 HG21 ' F' ' 117' ' ' THR . 1.9 t -98.48 141.7 31.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.085 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 113' ' ' LEU . . . . . 0.773 HD13 ' HG ' ' F' ' 86' ' ' LEU . 1.6 mt -76.33 89.47 3.17 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.744 0.307 . . . . 0.0 110.761 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.09 -18.22 5.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.67 0.271 . . . . 0.0 111.52 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.86 -60.68 0.45 Allowed Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.529 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 116' ' ' ALA . . . . . 0.463 ' HA ' ' CE2' ' F' ' 118' ' ' PHE . . . -96.44 26.97 4.03 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.041 0.448 . . . . 0.0 111.683 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 117' ' ' THR . . . . . 0.842 HG21 HG23 ' F' ' 112' ' ' THR . 0.0 OUTLIER -87.01 74.85 9.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.155 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . 0.6 ' HB3' ' HB1' ' F' ' 70' ' ' ALA . 63.3 m-85 -94.97 92.96 7.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.768 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 25.6 m -136.35 68.9 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.796 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.81 150.29 28.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.629 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -107.34 67.6 0.7 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.136 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . 0.615 ' O ' ' HB3' ' F' ' 69' ' ' ALA . 0.2 OUTLIER -79.15 114.66 18.27 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.69 -179.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 12.1 m -73.95 127.97 34.29 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.742 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . 0.571 HD21 ' O ' ' F' ' 20' ' ' ALA . 4.0 tp -92.11 132.21 36.77 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.602 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -127.1 151.07 49.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.63 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' F' ' 61' ' ' CYS . 3.1 t30 -69.1 112.05 5.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.951 0.405 . . . . 0.0 110.646 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . 0.492 ' CA ' HG21 ' B' ' 4' ' ' THR . . . 142.51 -138.9 8.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.687 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 128' ' ' THR . . . . . 0.727 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 87.7 m -98.76 82.59 2.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.664 0.269 . . . . 0.0 110.792 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 129' ' ' ASN . . . . . 0.495 ' N ' ' HB2' ' C' ' 116' ' ' ALA . 2.3 t30 -71.85 148.19 46.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.893 0.377 . . . . 0.0 111.094 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 130' ' ' THR . . . . . 0.704 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.2 OUTLIER -138.63 148.66 44.34 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.154 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 131' ' ' ILE . . . . . 0.74 HG21 HG11 ' F' ' 71' ' ' VAL . 15.6 mt -110.05 112.17 57.86 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 132' ' ' PRO . . . . . 0.753 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.6 Cg_endo -81.78 136.98 9.75 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.612 1.541 . . . . 0.0 112.587 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -149.0 136.1 19.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.773 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -111.42 158.45 19.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.037 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . 0.676 ' O ' HG22 ' F' ' 52' ' ' VAL . . . -154.2 111.35 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.924 0.392 . . . . 0.0 111.674 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 136' ' ' ARG . . . . . 0.482 ' HB3' ' CA ' ' F' ' 51' ' ' ALA . 19.8 ptt180 -108.86 174.0 6.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.382 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 137' ' ' TYR . . . . . 0.705 ' HB3' HD21 ' F' ' 42' ' ' LEU . 1.7 m-85 -81.37 137.62 35.69 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.122 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 138' ' ' PHE . . . . . 0.517 ' HB3' HG21 ' F' ' 85' ' ' VAL . 0.9 OUTLIER -131.51 124.16 29.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.096 -179.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 139' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' F' ' 47' ' ' ALA . . . -108.52 130.15 55.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.868 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 140' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' F' ' 45' ' ' GLU . 0.2 OUTLIER -77.37 -28.01 52.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.557 179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -164.46 -96.41 0.11 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.81 -0.71 . . . . 0.0 113.005 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -104.01 98.51 8.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.583 0.23 . . . . 0.0 110.648 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 143' ' ' ALA . . . . . 0.567 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -56.66 148.92 18.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.674 0.274 . . . . 0.0 111.377 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 144' ' ' THR . . . . . 0.728 ' CG2' ' CD ' ' F' ' 145' ' ' PRO . 90.3 m -125.48 157.0 69.61 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.213 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 145' ' ' PRO . . . . . 0.728 ' CD ' ' CG2' ' F' ' 144' ' ' THR . 1.4 Cg_endo -83.36 136.22 7.56 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.552 2.168 . . . . 0.0 111.978 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 146' ' ' GLY . . . . . 0.585 ' O ' ' HG3' ' E' ' 15' ' ' GLU . . . 163.61 -127.56 1.69 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.457 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 147' ' ' ALA . . . . . 0.656 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -110.85 132.92 53.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.864 0.364 . . . . 0.0 111.414 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 148' ' ' ALA . . . . . 0.764 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -124.25 43.65 2.94 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.126 0.489 . . . . 0.0 110.459 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 149' ' ' ASN . . . . . 0.523 ' HB2' ' CG ' ' F' ' 89' ' ' GLN . 9.3 m120 -92.34 144.28 25.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.54 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 150' ' ' ALA . . . . . 0.684 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -160.6 178.9 9.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.995 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 151' ' ' ASP . . . . . 0.627 ' OD1' ' HA ' ' E' ' 11' ' ' HIS . 15.7 t70 -147.02 144.97 29.54 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.215 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 152' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -133.73 139.76 46.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.114 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 153' ' ' THR . . . . . 0.951 HG23 HG22 ' E' ' 9' ' ' THR . 0.2 OUTLIER -101.07 135.26 42.81 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.078 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 154' ' ' PHE . . . . . 0.543 ' HB3' ' H ' ' E' ' 8' ' ' GLY . 0.2 OUTLIER -81.58 152.13 27.36 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.013 0.435 . . . . 0.0 110.152 -179.052 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . 0.413 ' O ' HG13 ' F' ' 71' ' ' VAL . 15.2 mmtm -134.22 146.86 50.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.897 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 156' ' ' VAL . . . . . 0.626 HG23 HG23 ' E' ' 5' ' ' VAL . 33.0 m -139.14 140.76 37.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.853 0.359 . . . . 0.0 111.632 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 157' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' E' ' 3' ' ' THR . 0.9 OUTLIER -134.5 132.74 39.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.266 0.555 . . . . 0.0 110.42 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . 0.567 ' CE1' ' HB2' ' F' ' 21' ' ' CYS . 10.9 m-85 -107.31 128.1 54.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.493 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.886 179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 120.168 0.032 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.65 77.1 0.19 Allowed 'General case' 0 N--CA 1.462 0.17 0 O-C-N 123.132 0.27 . . . . 0.0 110.976 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.8 m -117.36 119.27 34.6 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.397 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.683 HG23 ' HG3' ' B' ' 157' ' ' GLN . 4.0 m -98.41 127.22 44.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.515 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.921 HG21 HG12 ' B' ' 17' ' ' VAL . 1.6 m -146.14 171.02 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.6 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.04 114.69 23.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.601 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' B' ' 155' ' ' LYS . . . -69.65 -57.77 6.98 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.791 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 9' ' ' THR . . . -163.52 -144.6 4.08 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.9 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 1.04 HG22 HG23 ' B' ' 153' ' ' THR . 17.1 p -155.69 140.51 17.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.818 0.342 . . . . 0.0 111.4 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.561 HG13 HG23 ' B' ' 32' ' ' VAL . 29.9 t -130.38 117.55 40.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.26 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.55 117.05 29.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.336 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -89.96 107.12 18.92 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.8 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.76 113.28 26.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.45 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.44 ' HA3' ' OH ' ' B' ' 137' ' ' TYR . . . -144.43 166.99 27.12 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.889 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.675 ' CG ' ' O ' ' B' ' 146' ' ' GLY . 30.2 tt0 -155.66 135.23 12.52 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.053 0.454 . . . . 0.0 110.286 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.698 HG23 ' HB2' ' B' ' 148' ' ' ALA . 66.4 t -96.59 138.38 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.293 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.657 HG21 HE21 ' B' ' 36' ' ' GLN . 2.6 m -140.85 -173.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.832 0.349 . . . . 0.0 110.977 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.15 173.46 12.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.034 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.519 ' HA ' ' HB3' ' B' ' 38' ' ' ARG . . . -85.86 39.83 0.82 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.042 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.639 ' HB1' ' CD2' ' A' ' 124' ' ' LEU . . . -114.36 -33.57 5.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.349 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.739 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.9 OUTLIER -161.16 149.97 16.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.953 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.64 112.08 4.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.07 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.669 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 3.1 p -59.9 153.42 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.065 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.76 152.76 28.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.674 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.52 80.83 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.349 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.81 15.75 61.93 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.939 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -113.06 -21.32 11.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.909 0.385 . . . . 0.0 110.815 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -44.61 -64.77 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.364 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.28 135.61 38.95 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.925 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.02 128.73 19.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.059 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.79 111.8 23.83 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.012 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.2 t -110.82 114.77 48.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.141 0.496 . . . . 0.0 110.494 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.68 124.51 46.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.649 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.49 -45.73 14.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.619 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.37 -161.91 12.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.534 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -99.77 129.7 45.91 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.649 0.261 . . . . 0.0 110.828 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p -110.05 147.47 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.948 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.42 ' HB2' ' HB2' ' A' ' 41' ' ' SER . 0.7 OUTLIER -86.76 131.24 34.19 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.94 0.4 . . . . 0.0 111.766 179.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.708 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 4.8 t -54.1 -45.1 71.76 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.757 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.443 ' N ' HG23 ' A' ' 39' ' ' THR . . . -61.01 -39.31 89.26 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.069 0.461 . . . . 0.0 110.875 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 38' ' ' ARG . 0.4 OUTLIER -70.55 -23.19 62.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.19 -179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.675 HD23 ' HB2' ' A' ' 139' ' ' ALA . 1.4 mp -124.63 51.62 1.6 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.586 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.59 29.95 7.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.418 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.84 128.36 48.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.41 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 140' ' ' THR . 29.4 tt0 -52.88 102.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 111.097 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.415 ' HA2' ' HE1' ' A' ' 138' ' ' PHE . . . 96.05 39.01 4.42 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.126 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -80.1 146.72 31.74 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.62 125.01 19.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.95 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.428 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 32.4 m -101.91 -166.35 1.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.644 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.01 133.02 55.7 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.845 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.547 ' HA ' ' HB3' ' A' ' 136' ' ' ARG . . . -92.66 120.13 32.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.26 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 135' ' ' ALA . 18.3 m -65.71 162.59 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.946 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.85 124.11 5.27 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.592 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -155.9 146.56 21.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.684 0.278 . . . . 0.0 110.948 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.564 ' HB2' HG22 ' A' ' 130' ' ' THR . 3.4 p30 -136.83 160.19 39.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.576 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 56' ' ' ILE . 1.6 tp -100.56 116.93 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.562 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.61 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -70.07 124.56 24.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.766 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.669 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 1.6 mp -133.72 87.44 2.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.23 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 4.9 p30 -73.61 174.54 8.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.949 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.82 79.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.818 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.739 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 93.6 m -127.59 159.37 34.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.61 ' OD2' HG23 ' A' ' 65' ' ' VAL . 5.6 t70 -130.23 167.12 18.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.238 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.656 HG23 ' HA ' ' A' ' 125' ' ' ASN . 0.2 OUTLIER -114.32 -41.7 3.44 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.154 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.51 -22.61 65.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.047 0.451 . . . . 0.0 111.735 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.61 HG23 ' OD2' ' A' ' 62' ' ' ASP . 81.3 t -70.43 -74.12 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.601 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 124' ' ' LEU . . . -120.75 131.36 54.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.571 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -48.58 6.13 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.863 0.363 . . . . 0.0 110.997 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.631 ' HE3' ' HB3' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -96.18 161.58 13.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.556 179.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.17 124.58 6.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.606 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.725 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -100.35 154.98 18.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.094 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.851 HG11 HG21 ' A' ' 131' ' ' ILE . 2.3 t -132.76 148.31 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.696 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.442 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -145.64 150.12 35.76 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.599 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.558 ' HB2' HD13 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -119.92 137.02 54.29 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.568 0.223 . . . . 0.0 111.022 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.627 HD21 HG21 ' D' ' 130' ' ' THR . 0.9 OUTLIER -96.0 139.46 32.16 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.966 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' A' ' 113' ' ' LEU . . . 178.5 179.84 48.48 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.733 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.546 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.3 OUTLIER -111.0 156.38 21.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.559 0.218 . . . . 0.0 110.807 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.674 ' O ' ' HB2' ' A' ' 87' ' ' ALA . . . -73.78 131.34 41.46 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 116.338 -0.392 . . . . 0.0 112.02 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.639 ' CG2' ' HB ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -67.79 -41.36 85.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.808 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.439 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -141.14 40.79 1.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.791 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.439 ' CB ' ' HA2' ' D' ' 108' ' ' GLY . . . 66.4 -80.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.102 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.83 -24.94 43.2 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.663 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.07 64.03 1.37 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.957 0.408 . . . . 0.0 110.45 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.548 HG23 ' HB2' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -68.5 -16.84 64.02 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.576 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.693 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 18.0 p-10 -70.46 -20.21 62.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.317 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.639 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 14.7 t -106.86 130.76 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.117 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.782 HD22 ' HB1' ' A' ' 150' ' ' ALA . 0.5 OUTLIER -67.61 148.22 51.69 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.387 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 77' ' ' ALA . . . -89.63 -167.52 1.88 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.842 0.353 . . . . 0.0 111.743 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.658 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 1.5 mm? -78.3 157.27 29.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.04 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.66 -78.37 0.02 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.354 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.583 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 0.4 OUTLIER -167.13 0.54 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.032 0.444 . . . . 0.0 111.425 179.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.53 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 1.7 m -71.89 83.02 0.92 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.568 ' HB3' ' HB3' ' D' ' 34' ' ' LEU . . . -66.75 -13.9 61.94 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.827 0.346 . . . . 0.0 111.643 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.71 27.61 5.21 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.609 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.74 15.76 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.903 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.658 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . 3.0 m -100.86 -172.78 2.24 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.833 0.349 . . . . 0.0 110.613 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.9 167.63 9.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.832 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.514 ' H ' ' HB ' ' A' ' 144' ' ' THR . 2.3 m -121.59 128.41 51.93 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.314 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.456 ' HB3' ' H ' ' A' ' 141' ' ' GLY . 75.8 m-20 64.22 34.57 10.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.371 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.489 HG13 HD23 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -139.96 136.44 38.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.704 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.12 -156.83 8.33 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.546 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' A' ' 86' ' ' LEU . 3.2 p -137.82 116.72 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 122.942 0.497 . . . . 0.0 111.605 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 1.1 tt0 -91.91 150.39 21.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.841 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.689 HD12 ' HB3' ' A' ' 111' ' ' LEU . 0.5 OUTLIER -113.86 131.3 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.531 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -106.2 130.15 54.12 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.646 0.26 . . . . 0.0 111.041 -179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.736 ' HB3' HG22 ' A' ' 107' ' ' THR . 5.1 t0 -76.08 156.99 33.39 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.661 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.741 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 3.5 ttp180 -71.29 -17.51 62.46 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.731 0.3 . . . . 0.0 111.03 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.736 HG22 ' HB3' ' A' ' 105' ' ' ASP . 6.2 t -67.29 -17.91 64.97 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.028 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.68 -45.61 1.17 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.78 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.1 163.11 23.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.737 0.303 . . . . 0.0 111.114 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -84.16 127.38 33.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.104 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.689 ' HB3' HD12 ' A' ' 103' ' ' ILE . 12.1 tp -86.28 156.07 20.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.306 0.574 . . . . 0.0 110.6 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.88 HG23 HG21 ' A' ' 117' ' ' THR . 0.5 OUTLIER -106.17 139.09 41.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.179 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.604 HD13 ' HG ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -73.89 76.4 1.64 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.691 0.281 . . . . 0.0 110.789 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.42 -17.17 14.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.625 0.25 . . . . 0.0 111.561 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.31 -51.77 1.24 Allowed Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.615 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.01 18.88 21.58 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.832 0.349 . . . . 0.0 111.544 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.88 HG21 HG23 ' A' ' 112' ' ' THR . 0.2 OUTLIER -85.81 84.68 7.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 -179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.725 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 95.7 m-85 -101.42 98.74 9.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.785 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.7 m -130.82 62.35 1.61 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.825 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.27 145.88 30.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.687 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.631 ' HB3' ' HE3' ' A' ' 68' ' ' LYS . 3.5 mm-40 -121.43 71.32 0.96 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.177 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.73 134.78 34.73 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.715 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.2 m -83.83 113.69 21.11 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.683 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.639 ' CD2' ' HB1' ' A' ' 20' ' ' ALA . 18.9 tp -73.99 142.97 45.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.651 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.656 ' HA ' HG23 ' A' ' 63' ' ' THR . 0.9 OUTLIER -138.67 162.13 35.42 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.557 179.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.66 113.1 12.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.717 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.51 -139.95 9.53 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.752 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 6.7 m -101.64 96.76 7.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.726 0.298 . . . . 0.0 110.804 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -83.58 148.58 27.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.92 0.391 . . . . 0.0 111.086 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.61 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -138.64 143.43 39.24 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.09 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.851 HG21 HG11 ' A' ' 71' ' ' VAL . 55.1 mt -104.63 112.39 65.33 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.741 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.6 Cg_endo -81.87 141.89 12.27 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.825 1.683 . . . . 0.0 112.522 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.58 141.09 22.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.847 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.46 152.64 22.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.079 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.644 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -153.54 100.99 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.867 0.365 . . . . 0.0 111.567 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.547 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 17.4 ptt180 -107.15 177.27 4.9 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.385 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.498 ' HB3' HD21 ' A' ' 42' ' ' LEU . 4.7 m-85 -85.96 124.15 32.09 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.011 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.46 ' HB3' HG11 ' A' ' 85' ' ' VAL . 1.2 t80 -118.93 112.38 19.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.024 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.675 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -102.96 133.91 47.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.867 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.617 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -81.1 -28.82 35.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.531 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.456 ' H ' ' HB3' ' A' ' 98' ' ' ASN . . . -160.18 -111.04 0.28 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.961 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.87 110.56 21.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.607 0.203 . . . . 0.0 110.77 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.708 ' HB3' ' HA ' ' A' ' 39' ' ' THR . . . -65.63 134.21 52.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.763 0.316 . . . . 0.0 111.376 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.514 ' HB ' ' H ' ' A' ' 97' ' ' THR . 57.2 m -105.78 149.4 37.93 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.31 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.488 ' CD ' ' CG2' ' A' ' 144' ' ' THR . 1.4 Cg_endo -82.93 125.49 4.17 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.53 2.153 . . . . 0.0 112.057 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.8 -126.37 1.38 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.43 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -111.07 128.4 55.86 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.729 0.3 . . . . 0.0 111.348 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.44 52.18 1.64 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 0.0 110.441 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.82 151.98 20.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.564 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.782 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -158.32 169.54 24.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.942 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -131.03 128.65 40.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.212 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.496 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -122.22 144.09 49.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.229 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.34 145.32 31.83 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -96.89 134.72 39.86 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.055 0.455 . . . . 0.0 110.009 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -124.26 148.13 47.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.902 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 131' ' ' ILE . 29.8 m -135.19 144.78 33.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.867 0.365 . . . . 0.0 111.733 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.48 126.09 28.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.279 0.561 . . . . 0.0 110.389 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 21' ' ' CYS . 5.1 m-85 -106.0 128.75 54.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.498 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.567 ' HG3' ' C ' ' A' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.877 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.246 0.07 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.63 77.07 0.19 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.693 -0.231 . . . . 0.0 111.037 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 10.7 m -117.33 119.23 34.49 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.439 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.677 HG23 ' HG3' ' C' ' 157' ' ' GLN . 4.0 m -98.32 127.17 44.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.548 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.88 HG21 HG12 ' C' ' 17' ' ' VAL . 1.6 m -146.12 171.08 4.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.58 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.14 114.72 23.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.548 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' C' ' 155' ' ' LYS . . . -69.84 -57.58 7.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.736 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.428 ' O ' HG23 ' B' ' 9' ' ' THR . . . -163.65 -144.63 4.09 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.989 -0.625 . . . . 0.0 111.854 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 1.041 HG22 HG23 ' C' ' 153' ' ' THR . 17.0 p -155.64 140.45 17.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.826 0.346 . . . . 0.0 111.364 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.552 HG13 HG23 ' C' ' 32' ' ' VAL . 29.2 t -130.35 117.53 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.241 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -91.51 116.97 29.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.409 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -89.88 107.08 18.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.916 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.81 113.28 26.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.435 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.436 ' HA3' ' OH ' ' C' ' 137' ' ' TYR . . . -144.42 167.01 27.11 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.898 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.689 ' CG ' ' O ' ' C' ' 146' ' ' GLY . 30.3 tt0 -155.64 135.21 12.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.926 0.393 . . . . 0.0 110.318 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' C' ' 148' ' ' ALA . 66.2 t -96.54 138.35 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.304 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.921 HG12 HG21 ' A' ' 5' ' ' VAL . 2.7 m -140.78 -173.33 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 111.056 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.12 173.48 12.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.074 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' C' ' 38' ' ' ARG . . . -85.82 39.71 0.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.639 ' HB1' ' CD2' ' B' ' 124' ' ' LEU . . . -114.28 -33.53 5.61 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.434 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.745 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.9 OUTLIER -161.13 150.03 16.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.965 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' C' ' 36' ' ' GLN . . . -149.68 112.02 4.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.079 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.675 ' HA ' ' HA ' ' B' ' 58' ' ' LEU . 3.1 p -59.94 153.37 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.029 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.73 152.8 28.18 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.628 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.56 -41.42 81.03 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.296 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.84 15.68 62.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.03 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.94 -21.35 11.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.937 0.398 . . . . 0.0 110.831 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 89.3 t -44.65 -64.82 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.316 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.26 135.71 38.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.958 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.06 128.73 19.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.061 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.74 111.81 23.82 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.029 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.561 HG23 HG13 ' A' ' 10' ' ' VAL . 4.2 t -110.85 114.76 48.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.074 0.464 . . . . 0.0 110.489 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.78 124.42 46.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.681 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.4 -45.67 14.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.647 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.33 -161.88 12.82 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.572 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.657 HE21 HG21 ' A' ' 17' ' ' VAL . 1.8 mt-30 -99.87 129.68 45.99 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.619 0.247 . . . . 0.0 110.865 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.494 ' CG1' HG22 ' A' ' 16' ' ' VAL . 11.9 p -110.01 147.43 14.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.99 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.519 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -86.67 131.23 34.2 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.015 0.436 . . . . 0.0 111.786 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.698 ' HA ' ' HB3' ' B' ' 143' ' ' ALA . 4.8 t -54.18 -45.05 72.04 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.721 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.445 ' N ' HG23 ' B' ' 39' ' ' THR . . . -60.99 -39.36 89.37 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.146 0.498 . . . . 0.0 110.933 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' B' ' 38' ' ' ARG . 0.4 OUTLIER -70.52 -23.22 62.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.169 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.665 HD23 ' HB2' ' B' ' 139' ' ' ALA . 1.4 mp -124.55 51.63 1.59 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.639 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.6 29.92 7.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.356 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.85 128.41 48.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.348 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' B' ' 140' ' ' THR . 29.3 tt0 -52.95 103.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.815 0.34 . . . . 0.0 111.093 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.421 ' HA2' ' HE1' ' B' ' 138' ' ' PHE . . . 96.02 38.93 4.45 Favored Glycine 0 CA--C 1.518 0.262 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.137 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' B' ' 139' ' ' ALA . . . -80.0 146.66 31.91 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.64 125.0 19.03 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.918 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 32.4 m -101.89 -166.28 1.28 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.604 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.99 133.02 55.7 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.871 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.553 ' HA ' ' HB3' ' B' ' 136' ' ' ARG . . . -92.67 120.21 32.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.264 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.641 HG22 ' O ' ' B' ' 135' ' ' ALA . 18.5 m -65.77 162.69 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.939 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.9 124.11 5.26 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.648 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -155.87 146.64 22.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.719 0.295 . . . . 0.0 110.901 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.566 ' HB2' HG22 ' B' ' 130' ' ' THR . 3.3 p30 -136.91 160.25 39.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.515 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.564 HG23 ' O ' ' B' ' 56' ' ' ILE . 1.6 tp -100.71 117.0 45.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.516 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . 0.625 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -70.05 124.6 24.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.731 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.675 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 1.6 mp -133.82 87.5 2.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.184 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 4.9 p30 -73.63 174.57 8.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 57.72 79.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.811 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' CYS . . . . . 0.745 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 93.6 m -127.57 159.41 34.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.859 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . 0.62 ' OD2' HG23 ' B' ' 65' ' ' VAL . 5.5 t70 -130.27 167.1 19.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.295 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.662 HG23 ' HA ' ' B' ' 125' ' ' ASN . 0.2 OUTLIER -114.31 -41.71 3.44 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.139 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.51 -22.63 65.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.086 0.469 . . . . 0.0 111.723 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.62 HG23 ' OD2' ' B' ' 62' ' ' ASP . 82.4 t -70.44 -74.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.608 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' B' ' 124' ' ' LEU . . . -120.67 131.3 54.5 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.665 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.22 -48.59 6.12 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.936 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . 0.633 ' HE3' ' HB3' ' B' ' 121' ' ' GLU . 0.1 OUTLIER -96.23 161.48 13.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.595 179.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.05 124.72 6.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.584 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.698 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -100.44 155.02 18.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.069 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.827 HG11 HG21 ' B' ' 131' ' ' ILE . 2.3 t -132.73 148.34 31.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.673 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.442 ' HA ' HD21 ' B' ' 111' ' ' LEU . . . -145.63 150.1 35.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.698 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.569 ' HB2' HD13 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -119.98 137.05 54.3 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.549 0.214 . . . . 0.0 111.055 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.624 HD21 HG21 ' E' ' 130' ' ' THR . 0.9 OUTLIER -96.06 139.52 32.12 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.892 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.423 ' CA ' ' HB3' ' B' ' 113' ' ' LEU . . . 178.45 179.82 48.44 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.807 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.3 OUTLIER -110.92 156.47 21.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.493 0.187 . . . . 0.0 110.848 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.676 ' O ' ' HB2' ' B' ' 87' ' ' ALA . . . -73.83 131.35 41.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.029 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.65 ' CG2' ' HB ' ' B' ' 85' ' ' VAL . 0.9 OUTLIER -67.74 -41.37 85.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.823 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.435 ' N ' HG23 ' B' ' 78' ' ' ILE . 0.6 OUTLIER -141.15 40.65 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.81 -179.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.435 ' HB3' ' HA2' ' E' ' 108' ' ' GLY . . . 66.49 -80.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.68 -24.99 42.19 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.725 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.06 64.03 1.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.925 0.393 . . . . 0.0 110.451 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' THR . . . . . 0.556 HG23 ' HB2' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -68.43 -16.9 64.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.567 -179.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . 0.69 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 18.0 p-10 -70.44 -20.18 62.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.339 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.65 ' HB ' ' CG2' ' B' ' 78' ' ' ILE . 14.7 t -106.92 130.77 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.126 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.776 HD22 ' HB1' ' B' ' 150' ' ' ALA . 0.5 OUTLIER -67.68 148.19 51.67 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' B' ' 77' ' ' ALA . . . -89.6 -167.58 1.9 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.736 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.654 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 1.5 mm? -78.22 157.26 29.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.73 -78.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.356 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . 0.586 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 0.4 OUTLIER -167.08 0.51 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.972 0.415 . . . . 0.0 111.459 179.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . 0.546 ' HA ' ' HB2' ' D' ' 25' ' ' ALA . 1.7 m -71.95 83.03 0.94 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.746 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' E' ' 34' ' ' LEU . . . -66.62 -13.98 61.83 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.921 0.391 . . . . 0.0 111.749 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.69 27.59 5.21 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.567 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.69 15.63 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.899 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' SER . . . . . 0.654 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . 3.0 m -100.88 -172.85 2.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.842 0.353 . . . . 0.0 110.604 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.88 167.6 9.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.849 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.522 ' H ' ' HB ' ' B' ' 144' ' ' THR . 2.3 m -121.51 128.38 52.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.341 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . 0.463 ' HB3' ' H ' ' B' ' 141' ' ' GLY . 75.9 m-20 64.24 34.5 10.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.415 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . 0.489 HG13 HD23 ' B' ' 42' ' ' LEU . 0.5 OUTLIER -139.92 136.46 38.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.744 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.08 -156.88 8.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.524 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' B' ' 86' ' ' LEU . 3.2 p -137.8 116.71 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 123.011 0.525 . . . . 0.0 111.665 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 1.2 tt0 -91.94 150.39 21.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.847 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.681 HD12 ' HB3' ' B' ' 111' ' ' LEU . 0.5 OUTLIER -113.81 131.31 66.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.505 179.487 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 0.3 OUTLIER -106.26 130.17 54.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.733 0.302 . . . . 0.0 111.025 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . 0.713 ' HB3' HG22 ' B' ' 107' ' ' THR . 5.1 t0 -76.12 156.97 33.33 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.703 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . 0.708 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 3.4 ttp180 -71.2 -17.55 62.52 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.763 0.316 . . . . 0.0 111.085 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.713 HG22 ' HB3' ' B' ' 105' ' ' ASP . 6.2 t -67.19 -18.02 65.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.071 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.73 -45.6 1.17 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.784 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.11 163.07 23.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.691 0.281 . . . . 0.0 111.172 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -84.13 127.4 33.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.107 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.681 ' HB3' HD12 ' B' ' 103' ' ' ILE . 12.1 tp -86.28 156.12 20.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.323 0.582 . . . . 0.0 110.595 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.892 HG23 HG21 ' B' ' 117' ' ' THR . 0.5 OUTLIER -106.25 139.16 41.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.167 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.625 HD13 ' HG ' ' B' ' 86' ' ' LEU . 1.0 OUTLIER -73.92 76.49 1.66 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.707 0.289 . . . . 0.0 110.718 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.45 -17.2 14.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.519 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -51.79 1.24 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.642 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.95 18.83 21.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.933 0.397 . . . . 0.0 111.604 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.892 HG21 HG23 ' B' ' 112' ' ' THR . 0.2 OUTLIER -85.84 84.71 7.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.051 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.698 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . 95.7 m-85 -101.41 98.76 9.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.772 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 38.2 m -130.83 62.34 1.61 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.989 0.423 . . . . 0.0 110.91 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.28 145.85 30.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.658 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.633 ' HB3' ' HE3' ' B' ' 68' ' ' LYS . 3.5 mm-40 -121.35 71.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.217 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.67 134.79 34.76 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.74 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 15.2 m -83.86 113.67 21.11 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.7 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.639 ' CD2' ' HB1' ' B' ' 20' ' ' ALA . 18.9 tp -73.98 142.92 45.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.552 -0.294 . . . . 0.0 110.649 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.662 ' HA ' HG23 ' B' ' 63' ' ' THR . 0.9 OUTLIER -138.55 162.13 35.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.53 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.8 113.13 12.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.65 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.59 -139.92 9.48 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.711 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 6.6 m -101.72 96.85 7.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.688 0.28 . . . . 0.0 110.8 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -83.67 148.61 27.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.898 0.38 . . . . 0.0 111.019 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.625 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -138.65 143.32 39.18 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.16 -179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' ILE . . . . . 0.827 HG21 HG11 ' B' ' 71' ' ' VAL . 54.9 mt -104.51 112.34 65.35 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' PRO . . . . . 0.708 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.95 142.05 12.25 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.697 1.598 . . . . 0.0 112.503 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.68 141.12 22.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.851 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -104.48 152.63 22.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.107 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.641 ' O ' HG22 ' B' ' 52' ' ' VAL . . . -153.57 101.09 2.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.949 0.404 . . . . 0.0 111.586 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . 0.553 ' HB3' ' HA ' ' B' ' 51' ' ' ALA . 17.5 ptt180 -107.19 177.28 4.9 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.436 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . 0.503 ' HB3' HD21 ' B' ' 42' ' ' LEU . 4.7 m-85 -85.96 124.08 32.02 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.019 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . 0.453 ' HB3' HG11 ' B' ' 85' ' ' VAL . 1.2 t80 -118.85 112.45 19.7 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.972 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.665 ' HB2' HD23 ' B' ' 42' ' ' LEU . . . -102.99 133.97 47.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.842 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' THR . . . . . 0.62 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 0.1 OUTLIER -81.11 -28.89 35.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.506 179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . 0.463 ' H ' ' HB3' ' B' ' 98' ' ' ASN . . . -160.17 -111.07 0.28 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.894 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.91 110.54 21.49 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.502 0.191 . . . . 0.0 110.712 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' ALA . . . . . 0.698 ' HB3' ' HA ' ' B' ' 39' ' ' THR . . . -65.57 134.22 52.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.781 0.325 . . . . 0.0 111.45 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.601 ' O ' ' CG1' ' A' ' 16' ' ' VAL . 57.2 m -105.81 149.46 38.01 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.309 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.493 ' CD ' ' CG2' ' B' ' 144' ' ' THR . 1.4 Cg_endo -82.95 125.47 4.16 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.592 2.195 . . . . 0.0 112.011 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . 0.675 ' O ' ' CG ' ' A' ' 15' ' ' GLU . . . 168.83 -126.3 1.37 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.423 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.448 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -111.12 128.45 55.89 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.817 0.342 . . . . 0.0 111.296 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . 0.698 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -125.45 52.12 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.188 0.518 . . . . 0.0 110.474 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.74 151.92 20.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.607 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.776 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -158.23 169.51 24.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.982 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.9 128.69 41.06 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.289 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . 0.483 ' HB2' HD11 ' B' ' 86' ' ' LEU . . . -122.25 144.07 49.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.153 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 1.04 HG23 HG22 ' A' ' 9' ' ' THR . 0.6 OUTLIER -106.36 145.32 31.83 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.41 ' HB3' ' H ' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -96.88 134.63 39.96 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.095 0.474 . . . . 0.0 110.052 -179.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.416 ' HA ' ' H ' ' A' ' 7' ' ' GLY . 9.9 mmtt -124.17 148.03 47.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.944 -178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' VAL . . . . . 0.521 HG23 HG23 ' A' ' 5' ' ' VAL . 30.0 m -135.04 144.85 33.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.81 0.338 . . . . 0.0 111.757 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.683 ' HG3' HG23 ' A' ' 4' ' ' THR . 0.0 OUTLIER -134.5 126.14 28.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.215 0.531 . . . . 0.0 110.386 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' B' ' 21' ' ' CYS . 5.2 m-85 -106.05 128.77 54.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.494 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . 0.565 ' HG3' ' C ' ' B' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.898 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.284 0.088 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.66 77.09 0.19 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.007 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 10.9 m -117.39 119.31 34.71 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.394 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' THR . . . . . 0.677 HG23 ' HG3' ' D' ' 157' ' ' GLN . 4.0 m -98.36 127.2 44.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.538 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.918 HG21 HG12 ' D' ' 17' ' ' VAL . 1.6 m -146.14 170.99 4.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.574 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.05 114.75 23.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.611 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . 0.414 ' H ' ' HA ' ' D' ' 155' ' ' LYS . . . -69.75 -57.64 7.02 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.801 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . 0.421 ' O ' HG23 ' C' ' 9' ' ' THR . . . -163.56 -144.59 4.08 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.892 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . 0.986 HG22 HG23 ' D' ' 153' ' ' THR . 17.2 p -155.75 140.45 17.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.863 0.363 . . . . 0.0 111.396 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.559 HG13 HG23 ' D' ' 32' ' ' VAL . 29.5 t -130.28 117.49 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.212 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.59 117.09 29.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.392 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -89.88 107.02 18.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.911 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.71 113.29 26.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.454 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . 0.44 ' HA3' ' OH ' ' D' ' 137' ' ' TYR . . . -144.37 167.0 27.09 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.889 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' GLU . . . . . 0.676 ' CG ' ' O ' ' D' ' 146' ' ' GLY . 30.2 tt0 -155.73 135.18 12.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.975 0.417 . . . . 0.0 110.343 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' D' ' 148' ' ' ALA . 66.5 t -96.53 138.35 21.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.317 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.88 HG12 HG21 ' B' ' 5' ' ' VAL . 2.6 m -140.85 -173.37 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.849 0.357 . . . . 0.0 110.996 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.09 173.46 12.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.967 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . 0.528 ' HA ' ' HB3' ' D' ' 38' ' ' ARG . . . -85.8 39.74 0.82 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.089 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . 0.631 ' HB1' ' CD2' ' C' ' 124' ' ' LEU . . . -114.24 -33.68 5.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.382 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' CYS . . . . . 0.675 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.9 OUTLIER -161.12 149.96 16.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.979 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' D' ' 36' ' ' GLN . . . -149.57 112.12 4.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.061 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . 0.665 ' HA ' ' HA ' ' C' ' 58' ' ' LEU . 3.1 p -59.97 153.4 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.04 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.76 152.83 28.12 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.624 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.53 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -57.58 -41.38 81.0 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.365 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.88 15.7 62.12 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.992 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.96 -21.39 11.14 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.927 0.394 . . . . 0.0 110.805 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 89.8 t -44.6 -64.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.334 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.26 135.61 38.94 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.913 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.0 128.8 19.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.043 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.71 111.71 23.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.111 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.552 HG23 HG13 ' B' ' 10' ' ' VAL . 4.2 t -110.74 114.79 48.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.103 0.478 . . . . 0.0 110.464 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.81 124.49 46.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.665 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.5 -45.7 14.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.603 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.32 -161.83 12.84 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.612 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . 0.666 HE21 HG21 ' B' ' 17' ' ' VAL . 1.8 mt-30 -99.85 129.7 45.97 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.557 0.218 . . . . 0.0 110.873 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.494 ' CG1' HG22 ' B' ' 16' ' ' VAL . 11.9 p -110.04 147.44 14.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.914 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' ARG . . . . . 0.513 ' HB3' ' HA ' ' B' ' 19' ' ' ALA . 0.7 OUTLIER -86.72 131.26 34.19 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.997 0.427 . . . . 0.0 111.804 179.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.697 ' HA ' ' HB3' ' C' ' 143' ' ' ALA . 4.8 t -54.12 -45.12 71.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.693 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.439 ' N ' HG23 ' C' ' 39' ' ' THR . . . -61.02 -39.36 89.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.114 0.483 . . . . 0.0 110.856 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' C' ' 38' ' ' ARG . 0.4 OUTLIER -70.63 -23.1 62.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.17 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.668 HD23 ' HB2' ' C' ' 139' ' ' ALA . 1.4 mp -124.61 51.58 1.6 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.583 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.66 29.95 7.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.326 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.84 128.45 48.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.32 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' C' ' 140' ' ' THR . 29.3 tt0 -53.0 102.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.114 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . 0.414 ' HA2' ' HE1' ' C' ' 138' ' ' PHE . . . 96.06 39.03 4.41 Favored Glycine 0 C--N 1.331 0.255 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.114 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' C' ' 139' ' ' ALA . . . -80.08 146.7 31.77 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.66 125.09 19.11 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.876 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 31.9 m -102.01 -166.27 1.27 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.625 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.96 133.03 55.71 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.836 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . 0.554 ' HA ' ' HB3' ' C' ' 136' ' ' ARG . . . -92.74 120.21 32.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.299 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.623 HG22 ' O ' ' C' ' 135' ' ' ALA . 18.4 m -65.76 162.63 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.974 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.86 124.15 5.28 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.609 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -155.93 146.56 21.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.713 0.292 . . . . 0.0 110.932 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.578 ' HB2' HG22 ' C' ' 130' ' ' THR . 3.3 p30 -136.8 160.27 39.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.54 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.567 HG23 ' O ' ' C' ' 56' ' ' ILE . 1.6 tp -100.68 116.95 45.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.502 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.613 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.0 OUTLIER -70.09 124.56 24.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.763 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . 0.665 ' HA ' ' HA ' ' C' ' 23' ' ' VAL . 1.6 mp -133.68 87.42 2.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.231 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 4.9 p30 -73.67 174.54 8.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.918 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.8 79.32 0.2 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' CYS . . . . . 0.675 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 93.2 m -127.62 159.39 34.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.836 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . 0.607 ' OD2' HG23 ' C' ' 65' ' ' VAL . 5.5 t70 -130.22 167.07 19.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.354 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.667 HG23 ' HA ' ' C' ' 125' ' ' ASN . 0.2 OUTLIER -114.24 -41.75 3.44 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.5 -22.61 65.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.018 0.437 . . . . 0.0 111.714 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.607 HG23 ' OD2' ' C' ' 62' ' ' ASP . 81.4 t -70.4 -74.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.626 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' C' ' 124' ' ' LEU . . . -120.71 131.34 54.49 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.656 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.19 -48.63 6.11 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.81 0.338 . . . . 0.0 110.924 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' LYS . . . . . 0.634 ' HE3' ' HB3' ' C' ' 121' ' ' GLU . 0.1 OUTLIER -96.22 161.54 13.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.561 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.1 124.66 6.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.608 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.724 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -100.44 154.98 18.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.054 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . 0.829 HG11 HG21 ' C' ' 131' ' ' ILE . 2.3 t -132.72 148.3 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.713 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . 0.459 ' HA ' HD21 ' C' ' 111' ' ' LEU . . . -145.62 150.15 35.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.66 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' PHE . . . . . 0.568 ' HB2' HD13 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -119.95 137.0 54.31 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 121.237 -0.185 . . . . 0.0 111.077 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.624 HD21 HG21 ' F' ' 130' ' ' THR . 0.9 OUTLIER -96.08 139.52 32.14 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.874 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . 0.425 ' CA ' ' HB3' ' C' ' 113' ' ' LEU . . . 178.51 179.85 48.49 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.764 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.562 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.3 OUTLIER -110.94 156.42 21.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.545 0.212 . . . . 0.0 110.848 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . 0.668 ' O ' ' HB2' ' C' ' 87' ' ' ALA . . . -73.76 131.26 41.39 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.365 -0.38 . . . . 0.0 112.023 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . 0.649 ' CG2' ' HB ' ' C' ' 85' ' ' VAL . 0.9 OUTLIER -67.69 -41.37 85.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.865 179.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' ASP . . . . . 0.437 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.6 OUTLIER -141.18 40.84 1.78 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.8 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . 0.434 ' HB3' ' HA2' ' F' ' 108' ' ' GLY . . . 66.35 -80.69 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.027 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.66 -24.95 41.86 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.723 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.12 64.04 1.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.953 0.406 . . . . 0.0 110.469 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . 0.545 HG23 ' HB2' ' C' ' 77' ' ' ALA . 0.2 OUTLIER -68.44 -16.99 64.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.53 -179.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' ASN . . . . . 0.702 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 18.0 p-10 -70.35 -20.28 62.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.361 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.649 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 14.7 t -106.91 130.75 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.158 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.767 HD22 ' HB1' ' C' ' 150' ' ' ALA . 0.5 OUTLIER -67.56 148.19 51.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.431 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' C' ' 77' ' ' ALA . . . -89.64 -167.49 1.87 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.764 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.659 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 1.5 mm? -78.37 157.29 29.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.114 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -78.34 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.345 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . 0.576 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 0.5 OUTLIER -167.1 0.53 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.018 0.437 . . . . 0.0 111.48 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' SER . . . . . 0.545 ' HA ' ' HB2' ' E' ' 25' ' ' ALA . 1.7 m -71.92 83.02 0.93 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' F' ' 34' ' ' LEU . . . -66.77 -13.88 61.95 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.879 0.371 . . . . 0.0 111.688 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.67 27.54 5.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.638 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.65 15.63 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.973 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' SER . . . . . 0.659 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 3.0 m -100.85 -172.84 2.25 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.766 0.317 . . . . 0.0 110.627 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.91 167.65 9.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.824 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . 0.515 ' H ' ' HB ' ' C' ' 144' ' ' THR . 2.3 m -121.57 128.43 51.98 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.295 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . 0.457 ' HB3' ' H ' ' C' ' 141' ' ' GLY . 75.9 m-20 64.14 34.48 11.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.498 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' VAL . . . . . 0.478 HG13 HD23 ' C' ' 42' ' ' LEU . 0.5 OUTLIER -139.87 136.6 38.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.709 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.19 -156.91 8.37 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.498 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' VAL . . . . . 0.492 HG13 ' HB2' ' C' ' 86' ' ' LEU . 3.2 p -137.81 116.77 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 122.951 0.5 . . . . 0.0 111.644 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' GLN . . . . . 0.578 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 1.1 tt0 -91.91 150.36 21.07 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.873 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.67 HD12 ' HB3' ' C' ' 111' ' ' LEU . 0.5 OUTLIER -113.76 131.31 65.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.601 179.415 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 0.3 OUTLIER -106.24 130.19 54.15 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.664 0.269 . . . . 0.0 111.054 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . 0.743 ' HB3' HG22 ' C' ' 107' ' ' THR . 5.1 t0 -76.2 157.0 33.12 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.694 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . 0.71 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 3.5 ttp180 -71.24 -17.44 62.5 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.763 0.316 . . . . 0.0 111.101 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . 0.743 HG22 ' HB3' ' C' ' 105' ' ' ASP . 6.2 t -67.27 -17.99 65.01 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.069 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 123.75 -45.62 1.17 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.766 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.14 163.11 23.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.727 0.298 . . . . 0.0 111.159 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -84.15 127.39 33.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.098 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' LEU . . . . . 0.67 ' HB3' HD12 ' C' ' 103' ' ' ILE . 12.1 tp -86.22 156.02 20.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.304 0.573 . . . . 0.0 110.638 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' THR . . . . . 0.892 HG23 HG21 ' C' ' 117' ' ' THR . 0.5 OUTLIER -106.14 139.17 41.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.151 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.624 HD13 ' HG ' ' C' ' 86' ' ' LEU . 1.0 OUTLIER -73.91 76.43 1.65 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.679 0.276 . . . . 0.0 110.706 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.41 -17.17 14.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.558 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.27 -51.75 1.25 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.648 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.03 18.84 21.66 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.941 0.4 . . . . 0.0 111.554 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . 0.892 HG21 HG23 ' C' ' 112' ' ' THR . 0.2 OUTLIER -85.8 84.6 7.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.057 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' PHE . . . . . 0.724 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . 95.7 m-85 -101.38 98.77 9.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.795 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 38.7 m -130.79 62.28 1.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.839 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.25 145.86 30.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.715 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . 0.634 ' HB3' ' HE3' ' C' ' 68' ' ' LYS . 3.5 mm-40 -121.39 71.25 0.95 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.217 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.69 134.77 34.75 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.703 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 14.8 m -83.79 113.66 21.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.776 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . 0.631 ' CD2' ' HB1' ' C' ' 20' ' ' ALA . 18.9 tp -74.0 142.9 45.77 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.657 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . 0.667 ' HA ' HG23 ' C' ' 63' ' ' THR . 0.9 OUTLIER -138.57 162.1 35.41 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.573 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.73 113.2 12.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.7 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.48 -139.91 9.5 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.734 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 6.7 m -101.69 96.76 7.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.698 0.285 . . . . 0.0 110.773 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.59 148.48 27.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.895 0.379 . . . . 0.0 111.093 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . 0.613 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -138.55 143.43 39.45 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.207 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 131' ' ' ILE . . . . . 0.829 HG21 HG11 ' C' ' 71' ' ' VAL . 55.1 mt -104.62 112.41 65.34 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 132' ' ' PRO . . . . . 0.71 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.5 Cg_endo -81.95 141.98 12.2 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 121.719 1.612 . . . . 0.0 112.526 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.401 ' HZ ' HD22 ' C' ' 111' ' ' LEU . 0.3 OUTLIER -150.63 141.06 22.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.85 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.49 152.53 22.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.131 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.623 ' O ' HG22 ' C' ' 52' ' ' VAL . . . -153.52 101.08 2.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.98 0.419 . . . . 0.0 111.6 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.554 ' HB3' ' HA ' ' C' ' 51' ' ' ALA . 17.5 ptt180 -107.18 177.2 4.92 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.42 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 137' ' ' TYR . . . . . 0.497 ' HB3' HD21 ' C' ' 42' ' ' LEU . 4.7 m-85 -85.93 124.15 32.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.008 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 138' ' ' PHE . . . . . 0.466 ' HB3' HG11 ' C' ' 85' ' ' VAL . 1.2 t80 -118.9 112.38 19.57 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.959 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 139' ' ' ALA . . . . . 0.668 ' HB2' HD23 ' C' ' 42' ' ' LEU . . . -102.97 133.95 47.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.873 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 140' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 0.1 OUTLIER -81.1 -28.9 35.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.529 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . 0.457 ' H ' ' HB3' ' C' ' 98' ' ' ASN . . . -160.15 -111.06 0.28 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.926 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.85 110.56 21.49 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.537 0.208 . . . . 0.0 110.766 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 143' ' ' ALA . . . . . 0.697 ' HB3' ' HA ' ' C' ' 39' ' ' THR . . . -65.65 134.29 52.93 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.83 0.348 . . . . 0.0 111.343 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 144' ' ' THR . . . . . 0.602 ' O ' ' CG1' ' B' ' 16' ' ' VAL . 56.4 m -105.82 149.39 37.93 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.346 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 145' ' ' PRO . . . . . 0.49 ' CD ' ' CG2' ' C' ' 144' ' ' THR . 1.4 Cg_endo -82.91 125.54 4.2 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.497 2.131 . . . . 0.0 112.023 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . 0.689 ' O ' ' CG ' ' B' ' 15' ' ' GLU . . . 168.78 -126.33 1.38 Allowed Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.407 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 147' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -111.07 128.43 55.87 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.758 0.313 . . . . 0.0 111.317 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 148' ' ' ALA . . . . . 0.686 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -125.41 52.15 1.64 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.15 0.5 . . . . 0.0 110.492 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -98.78 151.93 20.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.597 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 150' ' ' ALA . . . . . 0.767 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -158.28 169.6 24.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.009 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -130.98 128.63 40.8 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.291 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . 0.479 ' HB2' HD11 ' C' ' 86' ' ' LEU . . . -122.21 144.06 49.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.228 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . 1.041 HG23 HG22 ' B' ' 9' ' ' THR . 0.6 OUTLIER -106.37 145.34 31.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 154' ' ' PHE . . . . . 0.402 ' HB3' ' H ' ' B' ' 8' ' ' GLY . 0.5 OUTLIER -96.9 134.67 39.93 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.068 0.461 . . . . 0.0 110.019 -178.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . 0.416 ' HA ' ' H ' ' B' ' 7' ' ' GLY . 9.9 mmtt -124.15 148.14 47.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.895 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 156' ' ' VAL . . . . . 0.521 HG23 HG23 ' B' ' 5' ' ' VAL . 29.9 m -135.15 144.77 33.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.742 0.306 . . . . 0.0 111.791 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . 0.677 ' HG3' HG23 ' B' ' 4' ' ' THR . 0.0 OUTLIER -134.46 126.06 28.7 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.273 0.559 . . . . 0.0 110.399 -179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' C' ' 21' ' ' CYS . 5.2 m-85 -106.02 128.75 54.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.502 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . 0.56 ' HG3' ' C ' ' C' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 111.142 0.053 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.64 77.12 0.19 Allowed 'General case' 0 C--O 1.232 0.16 0 O-C-N 123.172 0.295 . . . . 0.0 110.983 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' THR . . . . . . . . . . . . . 10.9 m -117.41 119.32 34.75 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.387 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . 0.682 HG23 ' HG3' ' E' ' 157' ' ' GLN . 4.0 m -98.37 127.21 44.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.535 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.92 HG21 HG12 ' E' ' 17' ' ' VAL . 1.6 m -146.1 171.03 4.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.601 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -86.02 114.61 23.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.599 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' GLY . . . . . 0.407 ' H ' ' HA ' ' E' ' 155' ' ' LYS . . . -69.61 -57.71 7.05 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.813 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . 0.43 ' O ' HG23 ' D' ' 9' ' ' THR . . . -163.59 -144.61 4.08 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.87 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . 1.038 HG22 HG23 ' E' ' 153' ' ' THR . 17.1 p -155.7 140.46 17.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 111.371 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' VAL . . . . . 0.546 HG13 HG23 ' E' ' 32' ' ' VAL . 30.1 t -130.34 117.48 39.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.294 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.5 116.98 29.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.349 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -89.86 107.08 18.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.883 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.75 113.32 26.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.451 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' GLY . . . . . 0.441 ' HA3' ' OH ' ' E' ' 137' ' ' TYR . . . -144.42 166.98 27.12 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.919 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' GLU . . . . . 0.676 ' CG ' ' O ' ' E' ' 146' ' ' GLY . 30.2 tt0 -155.68 135.2 12.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.966 0.412 . . . . 0.0 110.32 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.699 HG23 ' HB2' ' E' ' 148' ' ' ALA . 65.8 t -96.53 138.36 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.275 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.918 HG12 HG21 ' C' ' 5' ' ' VAL . 2.7 m -140.85 -173.38 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.872 0.368 . . . . 0.0 111.002 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.08 173.41 12.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.075 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' ALA . . . . . 0.513 ' HA ' ' HB3' ' E' ' 38' ' ' ARG . . . -85.82 39.76 0.82 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.041 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.639 ' HB1' ' CD2' ' D' ' 124' ' ' LEU . . . -114.31 -33.46 5.63 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.459 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.9 OUTLIER -161.18 149.98 16.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.935 -179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.64 112.09 4.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.102 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . 0.664 ' HA ' ' HA ' ' D' ' 58' ' ' LEU . 3.0 p -59.93 153.34 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.082 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.68 152.75 28.27 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.686 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.546 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -57.53 -41.46 80.93 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.357 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.81 15.7 62.06 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.968 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.95 -21.35 11.16 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.914 0.387 . . . . 0.0 110.814 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 90.1 t -44.58 -64.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.364 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.29 135.69 38.85 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.885 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.04 128.77 19.29 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.044 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.83 111.83 23.85 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.014 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.559 HG23 HG13 ' C' ' 10' ' ' VAL . 4.2 t -110.82 114.81 48.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.139 0.495 . . . . 0.0 110.519 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.75 124.45 46.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.649 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 92' ' ' ALA . 0.9 OUTLIER -82.49 -45.74 14.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.574 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.37 -161.86 12.84 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.571 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' GLN . . . . . 0.645 HE21 HG21 ' C' ' 17' ' ' VAL . 1.8 mt-30 -99.83 129.69 45.95 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.648 0.261 . . . . 0.0 110.881 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.493 ' CG1' HG22 ' C' ' 16' ' ' VAL . 12.0 p -110.02 147.44 14.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.995 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . 0.528 ' HB3' ' HA ' ' C' ' 19' ' ' ALA . 0.7 OUTLIER -86.78 131.29 34.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.053 0.454 . . . . 0.0 111.69 179.301 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.693 ' HA ' ' HB3' ' D' ' 143' ' ' ALA . 4.8 t -54.09 -45.13 71.71 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.753 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.449 ' N ' HG23 ' D' ' 39' ' ' THR . . . -60.93 -39.37 89.16 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.137 0.494 . . . . 0.0 110.939 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' D' ' 38' ' ' ARG . 0.4 OUTLIER -70.62 -23.15 62.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.134 -179.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' D' ' 139' ' ' ALA . 1.4 mp -124.59 51.57 1.6 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.669 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.59 29.9 7.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.38 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.84 128.46 48.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.33 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' D' ' 140' ' ' THR . 29.5 tt0 -52.95 103.05 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.871 0.367 . . . . 0.0 111.117 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . 0.419 ' HA2' ' HE1' ' D' ' 138' ' ' PHE . . . 95.94 39.03 4.44 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.193 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' D' ' 139' ' ' ALA . . . -79.98 146.66 31.92 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.63 124.97 19.01 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.973 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 32.3 m -101.9 -166.31 1.28 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.626 179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.04 132.99 55.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.848 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' ALA . . . . . 0.549 ' HA ' ' HB3' ' D' ' 136' ' ' ARG . . . -92.64 120.24 32.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.321 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' VAL . . . . . 0.631 HG22 ' O ' ' D' ' 135' ' ' ALA . 18.5 m -65.84 162.66 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.905 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.8 124.14 5.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.649 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.442 ' N ' HG21 ' A' ' 76' ' ' THR . 54.0 p90 -155.93 146.55 21.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.705 0.288 . . . . 0.0 110.942 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' ASN . . . . . 0.568 ' HB2' HG22 ' D' ' 130' ' ' THR . 3.4 p30 -136.84 160.24 39.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.589 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.58 HG23 ' O ' ' D' ' 56' ' ' ILE . 1.6 tp -100.63 117.02 45.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.536 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' GLN . . . . . 0.611 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.0 OUTLIER -70.12 124.58 24.46 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.736 179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . 0.664 ' HA ' ' HA ' ' D' ' 23' ' ' VAL . 1.6 mp -133.77 87.54 2.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.181 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 4.9 p30 -73.65 174.61 8.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.006 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.81 79.24 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.815 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' CYS . . . . . 0.801 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 93.6 m -127.58 159.4 34.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.862 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . 0.612 ' OD2' HG23 ' D' ' 65' ' ' VAL . 5.5 t70 -130.24 167.11 18.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.28 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.661 HG23 ' HA ' ' D' ' 125' ' ' ASN . 0.2 OUTLIER -114.35 -41.66 3.44 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.47 -22.71 65.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.063 0.459 . . . . 0.0 111.723 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . 0.612 HG23 ' OD2' ' D' ' 62' ' ' ASP . 81.5 t -70.38 -74.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.635 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' D' ' 124' ' ' LEU . . . -120.76 131.33 54.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.634 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.21 -48.54 6.14 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.857 0.361 . . . . 0.0 110.981 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' LYS . . . . . 0.631 ' HE3' ' HB3' ' D' ' 121' ' ' GLU . 0.1 OUTLIER -96.25 161.54 13.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.555 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.09 124.63 6.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.642 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . 0.726 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -100.32 155.0 18.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.098 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . 0.849 HG11 HG21 ' D' ' 131' ' ' ILE . 2.3 t -132.75 148.22 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.745 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' ALA . . . . . 0.445 ' HA ' HD21 ' D' ' 111' ' ' LEU . . . -145.57 150.18 35.93 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.59 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' PHE . . . . . 0.557 ' HB2' HD13 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -119.99 136.96 54.35 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.053 179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.9 OUTLIER -96.05 139.54 32.08 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.937 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . 0.429 ' CA ' ' HB3' ' D' ' 113' ' ' LEU . . . 178.53 179.83 48.5 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.745 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . 0.548 ' H ' HD23 ' D' ' 86' ' ' LEU . 0.3 OUTLIER -111.0 156.39 21.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.534 0.207 . . . . 0.0 110.832 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.668 ' O ' ' HB2' ' D' ' 87' ' ' ALA . . . -73.78 131.3 41.41 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.04 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 78' ' ' ILE . . . . . 0.646 ' CG2' ' HB ' ' D' ' 85' ' ' VAL . 0.9 OUTLIER -67.72 -41.3 85.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.874 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.424 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.6 OUTLIER -141.17 40.75 1.78 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.808 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 66.44 -80.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.7 -24.96 42.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.688 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -99.1 64.04 1.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.448 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 83' ' ' THR . . . . . 0.542 HG23 ' HB2' ' D' ' 77' ' ' ALA . 0.2 OUTLIER -68.5 -16.86 64.03 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.584 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . 0.693 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 18.0 p-10 -70.36 -20.3 62.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.359 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.646 ' HB ' ' CG2' ' D' ' 78' ' ' ILE . 14.7 t -106.87 130.74 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.136 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.78 HD22 ' HB1' ' D' ' 150' ' ' ALA . 0.5 OUTLIER -67.66 148.18 51.69 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' D' ' 77' ' ' ALA . . . -89.62 -167.54 1.89 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 111.713 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.659 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 1.5 mm? -78.32 157.23 29.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.094 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -78.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.418 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.18 0.6 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.971 0.415 . . . . 0.0 111.483 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . 0.537 ' HA ' ' HB2' ' F' ' 25' ' ' ALA . 1.7 m -71.91 82.94 0.93 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.65 -13.96 61.84 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.917 0.389 . . . . 0.0 111.749 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.61 27.61 5.23 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.581 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.67 15.6 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.946 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 95' ' ' SER . . . . . 0.659 ' HB3' ' HG ' ' D' ' 88' ' ' LEU . 3.0 m -100.9 -172.81 2.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.715 0.293 . . . . 0.0 110.635 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.86 167.62 9.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . 0.517 ' H ' ' HB ' ' D' ' 144' ' ' THR . 2.3 m -121.51 128.36 51.99 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.34 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 98' ' ' ASN . . . . . 0.461 ' HB3' ' H ' ' D' ' 141' ' ' GLY . 76.0 m-20 64.28 34.44 10.71 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.468 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 99' ' ' VAL . . . . . 0.503 HG13 HD23 ' D' ' 42' ' ' LEU . 0.5 OUTLIER -139.92 136.46 38.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.738 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.08 -156.92 8.36 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.523 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 101' ' ' VAL . . . . . 0.497 HG13 ' HB2' ' D' ' 86' ' ' LEU . 3.2 p -137.8 116.8 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.132 0.491 . . . . 0.0 111.647 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 102' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 1.2 tt0 -91.86 150.35 21.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.847 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 103' ' ' ILE . . . . . 0.688 HD12 ' HB3' ' D' ' 111' ' ' LEU . 0.5 OUTLIER -113.85 131.34 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.494 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 104' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 0.3 OUTLIER -106.29 130.16 54.19 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.68 0.276 . . . . 0.0 110.958 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . 0.738 ' HB3' HG22 ' D' ' 107' ' ' THR . 5.1 t0 -76.14 156.99 33.28 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.679 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 106' ' ' ARG . . . . . 0.741 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 3.5 ttp180 -71.19 -17.55 62.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.738 0.304 . . . . 0.0 111.078 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 107' ' ' THR . . . . . 0.738 HG22 ' HB3' ' D' ' 105' ' ' ASP . 6.2 t -67.17 -18.07 65.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.021 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 108' ' ' GLY . . . . . 0.439 ' HA2' ' CB ' ' A' ' 80' ' ' ALA . . . 123.7 -45.57 1.17 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.74 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.07 163.05 23.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.7 0.286 . . . . 0.0 111.154 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -84.13 127.41 33.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.08 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 111' ' ' LEU . . . . . 0.688 ' HB3' HD12 ' D' ' 103' ' ' ILE . 12.1 tp -86.24 156.11 20.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.258 0.551 . . . . 0.0 110.633 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 112' ' ' THR . . . . . 0.891 HG23 HG21 ' D' ' 117' ' ' THR . 0.5 OUTLIER -106.23 139.15 41.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.123 179.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 113' ' ' LEU . . . . . 0.602 HD13 ' HG ' ' D' ' 86' ' ' LEU . 1.0 OUTLIER -74.03 76.55 1.71 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.755 0.312 . . . . 0.0 110.742 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.54 -17.09 14.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.516 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.23 -51.86 1.25 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.664 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.99 18.86 21.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.858 0.361 . . . . 0.0 111.509 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 117' ' ' THR . . . . . 0.891 HG21 HG23 ' D' ' 112' ' ' THR . 0.2 OUTLIER -85.81 84.64 7.5 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.079 -179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.726 ' HB3' ' HB1' ' D' ' 70' ' ' ALA . 95.7 m-85 -101.37 98.77 9.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.759 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 38.1 m -130.77 62.33 1.6 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.28 145.74 30.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.735 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . 0.631 ' HB3' ' HE3' ' D' ' 68' ' ' LYS . 3.5 mm-40 -121.25 71.3 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.179 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 134.78 34.72 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.684 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 15.1 m -83.82 113.7 21.11 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.701 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . 0.639 ' CD2' ' HB1' ' D' ' 20' ' ' ALA . 19.0 tp -74.08 142.96 45.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.772 0.32 . . . . 0.0 110.61 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 125' ' ' ASN . . . . . 0.661 ' HA ' HG23 ' D' ' 63' ' ' THR . 0.9 OUTLIER -138.53 162.12 35.32 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.59 179.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.8 113.18 12.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.684 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.54 -140.02 9.57 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.688 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 128' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 6.6 m -101.66 96.87 7.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.72 0.295 . . . . 0.0 110.773 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.65 148.54 27.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.843 0.354 . . . . 0.0 111.097 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 130' ' ' THR . . . . . 0.627 HG21 HD21 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -138.61 143.4 39.31 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.123 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 131' ' ' ILE . . . . . 0.849 HG21 HG11 ' D' ' 71' ' ' VAL . 55.1 mt -104.57 112.36 65.34 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 132' ' ' PRO . . . . . 0.741 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.4 Cg_endo -82.01 141.98 12.13 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.675 1.583 . . . . 0.0 112.458 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.404 ' HZ ' HD22 ' D' ' 111' ' ' LEU . 0.3 OUTLIER -150.61 141.12 22.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.897 179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.48 152.55 22.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.097 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.631 ' O ' HG22 ' D' ' 52' ' ' VAL . . . -153.53 101.08 2.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.954 0.407 . . . . 0.0 111.578 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 136' ' ' ARG . . . . . 0.549 ' HB3' ' HA ' ' D' ' 51' ' ' ALA . 17.5 ptt180 -107.18 177.19 4.92 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.379 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 137' ' ' TYR . . . . . 0.49 ' HB3' HD21 ' D' ' 42' ' ' LEU . 4.7 m-85 -85.92 124.04 31.94 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.089 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 138' ' ' PHE . . . . . 0.455 ' HB3' HG11 ' D' ' 85' ' ' VAL . 1.2 t80 -118.8 112.39 19.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.991 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 139' ' ' ALA . . . . . 0.685 ' HB2' HD23 ' D' ' 42' ' ' LEU . . . -102.97 134.0 47.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.828 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 140' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 0.1 OUTLIER -81.12 -28.86 34.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.507 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . 0.461 ' H ' ' HB3' ' D' ' 98' ' ' ASN . . . -160.19 -111.09 0.28 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.917 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.88 110.57 21.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.549 0.214 . . . . 0.0 110.744 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 143' ' ' ALA . . . . . 0.693 ' HB3' ' HA ' ' D' ' 39' ' ' THR . . . -65.69 134.27 52.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.808 0.337 . . . . 0.0 111.341 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 144' ' ' THR . . . . . 0.602 ' O ' ' CG1' ' C' ' 16' ' ' VAL . 56.4 m -105.8 149.42 37.96 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.341 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 145' ' ' PRO . . . . . 0.487 ' CD ' ' CG2' ' D' ' 144' ' ' THR . 1.3 Cg_endo -82.96 125.52 4.17 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.519 2.146 . . . . 0.0 112.001 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . 0.676 ' O ' ' CG ' ' C' ' 15' ' ' GLU . . . 168.8 -126.37 1.38 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.412 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 147' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -111.1 128.45 55.89 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.813 0.339 . . . . 0.0 111.322 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 148' ' ' ALA . . . . . 0.688 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -125.46 52.14 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.15 0.5 . . . . 0.0 110.398 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -98.71 152.05 20.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.545 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 150' ' ' ALA . . . . . 0.78 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -158.38 169.46 24.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.959 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.96 128.67 40.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.256 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 152' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' D' ' 86' ' ' LEU . . . -122.19 144.06 49.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.251 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 153' ' ' THR . . . . . 0.986 HG23 HG22 ' C' ' 9' ' ' THR . 0.6 OUTLIER -106.34 145.34 31.8 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.209 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 154' ' ' PHE . . . . . 0.415 ' HB3' ' H ' ' C' ' 8' ' ' GLY . 0.5 OUTLIER -96.84 134.67 39.84 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.052 0.454 . . . . 0.0 110.121 -179.081 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . 0.414 ' HA ' ' H ' ' C' ' 7' ' ' GLY . 9.9 mmtt -124.24 148.07 47.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.854 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 156' ' ' VAL . . . . . 0.515 HG23 HG23 ' C' ' 5' ' ' VAL . 29.7 m -135.06 144.83 33.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.783 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 157' ' ' GLN . . . . . 0.677 ' HG3' HG23 ' C' ' 4' ' ' THR . 0.0 OUTLIER -134.51 126.06 28.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.283 0.563 . . . . 0.0 110.36 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . 0.563 ' CE1' ' HB2' ' D' ' 21' ' ' CYS . 5.2 m-85 -106.02 128.77 54.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.474 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 159' ' ' GLN . . . . . 0.563 ' HG3' ' C ' ' D' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 111.169 0.062 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.7 77.1 0.19 Allowed 'General case' 0 N--CA 1.462 0.146 0 O-C-N 123.1 0.25 . . . . 0.0 110.989 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 3' ' ' THR . . . . . . . . . . . . . 10.7 m -117.36 119.24 34.52 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.472 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 4' ' ' THR . . . . . 0.693 HG23 ' HG3' ' F' ' 157' ' ' GLN . 3.9 m -98.34 127.2 44.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.575 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.884 HG21 HG12 ' F' ' 17' ' ' VAL . 1.6 m -146.11 171.02 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.592 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -86.05 114.73 23.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.573 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 7' ' ' GLY . . . . . 0.411 ' H ' ' HA ' ' F' ' 155' ' ' LYS . . . -69.67 -57.75 6.98 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.923 -0.655 . . . . 0.0 112.829 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . 0.428 ' O ' HG23 ' E' ' 9' ' ' THR . . . -163.52 -144.6 4.08 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.901 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 9' ' ' THR . . . . . 1.025 HG22 HG23 ' F' ' 153' ' ' THR . 17.1 p -155.73 140.46 17.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.855 0.36 . . . . 0.0 111.385 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 10' ' ' VAL . . . . . 0.557 HG13 HG23 ' F' ' 32' ' ' VAL . 30.0 t -130.31 117.45 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.238 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.5 117.0 29.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.435 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -89.79 107.11 18.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.878 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.84 113.26 26.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.449 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 14' ' ' GLY . . . . . 0.426 ' HA3' ' OH ' ' F' ' 137' ' ' TYR . . . -144.41 166.98 27.11 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.933 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 15' ' ' GLU . . . . . 0.685 ' CG ' ' O ' ' F' ' 146' ' ' GLY . 30.2 tt0 -155.7 135.17 12.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.985 0.421 . . . . 0.0 110.294 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 16' ' ' VAL . . . . . 0.688 HG23 ' HB2' ' F' ' 148' ' ' ALA . 66.1 t -96.48 138.31 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.264 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . 0.92 HG12 HG21 ' D' ' 5' ' ' VAL . 2.7 m -140.81 -173.34 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 111.06 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.13 173.41 12.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.052 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 19' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' F' ' 38' ' ' ARG . . . -85.73 39.73 0.81 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.641 ' HB1' ' CD2' ' E' ' 124' ' ' LEU . . . -114.34 -33.54 5.59 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.424 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 21' ' ' CYS . . . . . 0.667 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.9 OUTLIER -161.13 150.01 16.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.933 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.6 112.1 4.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.02 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 23' ' ' VAL . . . . . 0.667 ' HA ' ' HA ' ' E' ' 58' ' ' LEU . 3.1 p -60.02 153.41 4.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.989 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.76 152.81 28.12 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.665 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -57.5 -41.48 80.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.351 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.77 15.65 62.11 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.049 -0.596 . . . . 0.0 113.032 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -113.05 -21.2 11.19 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.902 0.382 . . . . 0.0 110.809 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 28' ' ' VAL . . . . . . . . . . . . . 89.9 t -44.65 -64.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.298 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.23 135.69 38.8 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.957 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.02 128.78 19.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.059 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.78 111.79 23.82 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.058 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.546 HG23 HG13 ' D' ' 10' ' ' VAL . 4.2 t -110.81 114.74 47.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.479 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.68 124.55 46.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.703 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' B' ' 92' ' ' ALA . 0.9 OUTLIER -82.54 -45.62 14.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.661 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.31 -161.86 12.83 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.583 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 36' ' ' GLN . . . . . 0.647 HE21 HG21 ' D' ' 17' ' ' VAL . 1.8 mt-30 -99.83 129.68 45.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.604 0.24 . . . . 0.0 110.862 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.49 ' CG1' HG22 ' D' ' 16' ' ' VAL . 11.8 p -110.11 147.5 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.924 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . 0.513 ' HB3' ' HA ' ' D' ' 19' ' ' ALA . 0.7 OUTLIER -86.77 131.24 34.18 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.974 0.416 . . . . 0.0 111.765 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 39' ' ' THR . . . . . 0.699 ' HA ' ' HB3' ' E' ' 143' ' ' ALA . 4.8 t -54.08 -45.09 71.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.772 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.45 ' N ' HG23 ' E' ' 39' ' ' THR . . . -61.01 -39.35 89.4 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.052 0.453 . . . . 0.0 110.854 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 41' ' ' SER . . . . . 0.401 ' HB2' ' HB2' ' E' ' 38' ' ' ARG . 0.4 OUTLIER -70.62 -23.16 62.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.178 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.678 HD23 ' HB2' ' E' ' 139' ' ' ALA . 1.4 mp -124.55 51.61 1.59 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.616 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.69 30.02 7.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.383 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.85 128.45 48.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.294 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' E' ' 140' ' ' THR . 29.5 tt0 -52.97 102.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.899 0.38 . . . . 0.0 111.139 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . 0.428 ' HA2' ' HE1' ' E' ' 138' ' ' PHE . . . 96.05 39.02 4.42 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.098 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 47' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' E' ' 139' ' ' ALA . . . -80.08 146.77 31.74 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.68 125.0 18.97 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.957 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 32.1 m -101.93 -166.31 1.28 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.589 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.99 133.04 55.72 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.861 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 51' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' E' ' 136' ' ' ARG . . . -92.7 120.21 32.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.237 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 52' ' ' VAL . . . . . 0.638 HG22 ' O ' ' E' ' 135' ' ' ALA . 18.5 m -65.78 162.69 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.924 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.86 124.08 5.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.688 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 54' ' ' PHE . . . . . 0.455 ' N ' HG21 ' B' ' 76' ' ' THR . 53.7 p90 -155.92 146.54 21.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.713 0.292 . . . . 0.0 110.951 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 55' ' ' ASN . . . . . 0.559 ' HB2' HG22 ' E' ' 130' ' ' THR . 3.4 p30 -136.79 160.31 39.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.529 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 56' ' ' ILE . . . . . 0.57 HG23 ' O ' ' E' ' 56' ' ' ILE . 1.6 tp -100.69 116.94 45.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.563 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 57' ' ' GLN . . . . . 0.619 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.0 OUTLIER -70.0 124.64 24.57 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.766 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . 0.667 ' HA ' ' HA ' ' E' ' 23' ' ' VAL . 1.6 mp -133.79 87.49 2.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.204 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . 0.564 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 4.9 p30 -73.62 174.56 8.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.98 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.86 79.3 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.734 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 61' ' ' CYS . . . . . 0.667 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 93.4 m -127.62 159.44 34.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.88 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . 0.616 ' OD2' HG23 ' E' ' 65' ' ' VAL . 5.6 t70 -130.3 167.1 19.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.226 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 63' ' ' THR . . . . . 0.662 HG23 ' HA ' ' E' ' 125' ' ' ASN . 0.2 OUTLIER -114.26 -41.73 3.44 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.143 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.49 -22.64 65.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.013 0.435 . . . . 0.0 111.725 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . 0.616 HG23 ' OD2' ' E' ' 62' ' ' ASP . 83.1 t -70.43 -74.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.593 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' E' ' 124' ' ' LEU . . . -120.73 131.39 54.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.603 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.18 -48.6 6.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.956 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 68' ' ' LYS . . . . . 0.629 ' HE3' ' HB3' ' E' ' 121' ' ' GLU . 0.1 OUTLIER -96.23 161.51 13.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.606 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.09 124.67 6.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.633 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . 0.709 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -100.39 154.98 18.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.098 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . 0.834 HG11 HG21 ' E' ' 131' ' ' ILE . 2.3 t -132.72 148.28 31.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.715 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . 0.437 ' HA ' HD21 ' E' ' 111' ' ' LEU . . . -145.57 150.2 35.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.61 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 73' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -119.98 136.97 54.34 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 121.214 -0.195 . . . . 0.0 111.051 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 74' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.9 OUTLIER -95.95 139.48 32.08 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.956 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' E' ' 113' ' ' LEU . . . 178.5 179.84 48.48 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.797 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 76' ' ' THR . . . . . 0.549 ' H ' HD23 ' E' ' 86' ' ' LEU . 0.3 OUTLIER -110.98 156.37 21.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.449 0.166 . . . . 0.0 110.839 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 77' ' ' ALA . . . . . 0.671 ' O ' ' HB2' ' E' ' 87' ' ' ALA . . . -73.75 131.25 41.38 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.03 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 78' ' ' ILE . . . . . 0.649 ' CG2' ' HB ' ' E' ' 85' ' ' VAL . 0.9 OUTLIER -67.61 -41.48 85.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.831 179.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 79' ' ' ASP . . . . . 0.435 ' N ' HG23 ' E' ' 78' ' ' ILE . 0.6 OUTLIER -141.13 40.78 1.79 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.805 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 66.49 -80.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.003 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.73 -24.91 42.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.659 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -99.12 64.02 1.36 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 0.0 110.511 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 83' ' ' THR . . . . . 0.554 HG23 ' HB2' ' E' ' 77' ' ' ALA . 0.2 OUTLIER -68.48 -16.86 64.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.528 -179.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 84' ' ' ASN . . . . . 0.687 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 18.0 p-10 -70.41 -20.22 62.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.385 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.649 ' HB ' ' CG2' ' E' ' 78' ' ' ILE . 14.7 t -106.87 130.73 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.18 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 86' ' ' LEU . . . . . 0.786 HD22 ' HB1' ' E' ' 150' ' ' ALA . 0.5 OUTLIER -67.65 148.2 51.67 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 87' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' E' ' 77' ' ' ALA . . . -89.59 -167.52 1.88 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.846 0.355 . . . . 0.0 111.77 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.658 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 1.5 mm? -78.28 157.31 29.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.099 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.69 -78.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.34 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.09 0.53 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.016 0.436 . . . . 0.0 111.462 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 91' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' E' ' 95' ' ' SER . 1.7 m -71.84 82.9 0.91 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.68 -13.92 61.85 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.872 0.368 . . . . 0.0 111.725 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.62 27.55 5.24 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.683 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.69 15.66 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.489 -0.862 . . . . 0.0 112.909 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 95' ' ' SER . . . . . 0.658 ' HB3' ' HG ' ' E' ' 88' ' ' LEU . 3.0 m -100.94 -172.8 2.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.782 0.325 . . . . 0.0 110.587 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.91 167.7 9.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.818 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . 0.52 ' H ' ' HB ' ' E' ' 144' ' ' THR . 2.3 m -121.56 128.46 52.03 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.338 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 98' ' ' ASN . . . . . 0.446 ' HB3' ' H ' ' E' ' 141' ' ' GLY . 75.9 m-20 64.13 34.59 10.97 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.432 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 99' ' ' VAL . . . . . 0.491 HG13 HD23 ' E' ' 42' ' ' LEU . 0.5 OUTLIER -139.96 136.44 38.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.745 179.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.12 -156.94 8.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.536 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 101' ' ' VAL . . . . . 0.485 HG13 ' HB2' ' E' ' 86' ' ' LEU . 3.2 p -137.76 116.69 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 122.971 0.508 . . . . 0.0 111.653 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 102' ' ' GLN . . . . . 0.582 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 1.2 tt0 -91.86 150.37 21.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.943 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 103' ' ' ILE . . . . . 0.683 HD12 ' HB3' ' E' ' 111' ' ' LEU . 0.5 OUTLIER -113.81 131.35 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.535 179.458 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 104' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 0.3 OUTLIER -106.22 130.14 54.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.673 0.273 . . . . 0.0 110.997 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . 0.713 ' HB3' HG22 ' E' ' 107' ' ' THR . 5.1 t0 -76.11 156.99 33.33 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.739 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 106' ' ' ARG . . . . . 0.712 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 3.5 ttp180 -71.22 -17.51 62.5 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.795 0.331 . . . . 0.0 111.087 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . 0.713 HG22 ' HB3' ' E' ' 105' ' ' ASP . 6.2 t -67.3 -17.94 64.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.997 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 108' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' B' ' 80' ' ' ALA . . . 123.73 -45.59 1.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.804 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.1 163.09 23.41 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.76 0.314 . . . . 0.0 111.12 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -84.14 127.37 33.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.064 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.683 ' HB3' HD12 ' E' ' 103' ' ' ILE . 12.1 tp -86.29 156.07 20.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.29 0.567 . . . . 0.0 110.596 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 112' ' ' THR . . . . . 0.898 HG23 HG21 ' E' ' 117' ' ' THR . 0.5 OUTLIER -106.21 139.14 41.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.157 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 113' ' ' LEU . . . . . 0.619 HD13 ' HG ' ' E' ' 86' ' ' LEU . 1.0 OUTLIER -73.93 76.48 1.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 110.765 179.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.48 -17.17 14.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.511 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.28 -51.8 1.24 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.638 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.95 18.77 21.75 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.929 0.395 . . . . 0.0 111.599 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 117' ' ' THR . . . . . 0.898 HG21 HG23 ' E' ' 112' ' ' THR . 0.2 OUTLIER -85.73 84.61 7.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.113 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . 0.709 ' HB3' ' HB1' ' E' ' 70' ' ' ALA . 95.7 m-85 -101.39 98.77 9.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.795 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 39.2 m -130.84 62.46 1.61 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.3 145.82 30.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.704 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 121' ' ' GLU . . . . . 0.629 ' HB3' ' HE3' ' E' ' 68' ' ' LYS . 3.5 mm-40 -121.37 71.28 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.212 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.74 134.86 34.73 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.752 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 14.8 m -83.83 113.72 21.14 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.749 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . 0.641 ' CD2' ' HB1' ' E' ' 20' ' ' ALA . 18.9 tp -74.07 143.0 45.63 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.708 0.289 . . . . 0.0 110.619 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 125' ' ' ASN . . . . . 0.662 ' HA ' HG23 ' E' ' 63' ' ' THR . 0.9 OUTLIER -138.61 162.03 35.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.624 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.72 113.24 12.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.675 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.49 -139.94 9.52 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.73 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 128' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 6.6 m -101.69 96.8 7.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.677 0.275 . . . . 0.0 110.755 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.64 148.49 27.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.897 0.379 . . . . 0.0 111.185 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 130' ' ' THR . . . . . 0.624 HG21 HD21 ' B' ' 74' ' ' LEU . 0.2 OUTLIER -138.55 143.46 39.46 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.081 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 131' ' ' ILE . . . . . 0.834 HG21 HG11 ' E' ' 71' ' ' VAL . 54.9 mt -104.57 112.3 65.33 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 132' ' ' PRO . . . . . 0.712 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.5 Cg_endo -81.93 141.93 12.21 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.737 1.624 . . . . 0.0 112.502 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 133' ' ' PHE . . . . . 0.404 ' HZ ' HD22 ' E' ' 111' ' ' LEU . 0.3 OUTLIER -150.59 141.1 22.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.829 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -104.52 152.6 22.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.111 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . 0.638 ' O ' HG22 ' E' ' 52' ' ' VAL . . . -153.57 101.06 2.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.923 0.392 . . . . 0.0 111.602 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 136' ' ' ARG . . . . . 0.552 ' HB3' ' HA ' ' E' ' 51' ' ' ALA . 17.4 ptt180 -107.18 177.24 4.91 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.408 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 137' ' ' TYR . . . . . 0.493 ' HB3' HD21 ' E' ' 42' ' ' LEU . 4.7 m-85 -85.98 124.12 32.08 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.027 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 138' ' ' PHE . . . . . 0.46 ' HB3' HG11 ' E' ' 85' ' ' VAL . 1.2 t80 -118.87 112.36 19.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.048 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 139' ' ' ALA . . . . . 0.678 ' HB2' HD23 ' E' ' 42' ' ' LEU . . . -102.93 133.94 47.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.882 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 140' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 0.1 OUTLIER -81.04 -28.92 35.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.553 179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' E' ' 98' ' ' ASN . . . -160.21 -111.01 0.28 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.88 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.92 110.6 21.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.547 0.213 . . . . 0.0 110.703 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 143' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' E' ' 39' ' ' THR . . . -65.68 134.27 52.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.831 0.348 . . . . 0.0 111.368 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 144' ' ' THR . . . . . 0.593 ' O ' ' CG1' ' D' ' 16' ' ' VAL . 56.9 m -105.87 149.43 38.01 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.304 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 145' ' ' PRO . . . . . 0.485 ' CD ' ' CG2' ' E' ' 144' ' ' THR . 1.4 Cg_endo -82.91 125.47 4.18 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.542 2.161 . . . . 0.0 112.028 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 146' ' ' GLY . . . . . 0.676 ' O ' ' CG ' ' D' ' 15' ' ' GLU . . . 168.79 -126.32 1.37 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.456 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 147' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -111.13 128.42 55.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.812 0.339 . . . . 0.0 111.294 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 148' ' ' ALA . . . . . 0.699 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -125.45 52.15 1.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.115 0.483 . . . . 0.0 110.412 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -98.75 152.0 20.16 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.611 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 150' ' ' ALA . . . . . 0.786 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -158.29 169.56 24.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.946 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.99 128.64 40.8 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.258 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 152' ' ' ALA . . . . . 0.49 ' HB2' HD11 ' E' ' 86' ' ' LEU . . . -122.17 144.08 49.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.269 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 153' ' ' THR . . . . . 1.038 HG23 HG22 ' D' ' 9' ' ' THR . 0.6 OUTLIER -106.34 145.34 31.81 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.182 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 154' ' ' PHE . . . . . 0.402 ' HB3' ' H ' ' D' ' 8' ' ' GLY . 0.5 OUTLIER -96.9 134.69 39.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.077 0.465 . . . . 0.0 110.069 -178.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . 0.407 ' HA ' ' H ' ' D' ' 7' ' ' GLY . 9.9 mmtt -124.22 148.08 47.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.863 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 156' ' ' VAL . . . . . 0.506 HG23 HG23 ' D' ' 5' ' ' VAL . 29.9 m -135.15 144.79 33.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 120.82 0.343 . . . . 0.0 111.685 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 157' ' ' GLN . . . . . 0.682 ' HG3' HG23 ' D' ' 4' ' ' THR . 0.0 OUTLIER -134.49 126.11 28.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.223 0.535 . . . . 0.0 110.362 -179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . 0.568 ' C ' ' HG3' ' E' ' 159' ' ' GLN . 5.2 m-85 -106.01 128.71 54.01 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.525 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 159' ' ' GLN . . . . . 0.568 ' HG3' ' C ' ' E' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.123 -0.941 . . . . 0.0 110.914 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 120.296 0.093 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.69 77.11 0.19 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.979 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 10.7 m -117.4 119.27 34.57 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.372 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 4.0 m -98.39 127.21 44.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.503 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -146.1 171.0 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.629 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -86.07 114.75 23.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.163 0.506 . . . . 0.0 110.602 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.79 -57.6 7.03 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.786 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . 0.425 ' O ' HG23 ' F' ' 9' ' ' THR . . . -163.62 -144.64 4.1 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.884 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 9' ' ' THR . . . . . 0.425 HG23 ' O ' ' F' ' 8' ' ' GLY . 17.1 p -155.7 140.41 17.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.872 0.367 . . . . 0.0 111.375 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 29.7 t -130.26 117.52 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.274 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -91.51 117.03 29.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.423 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -89.89 107.05 18.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.826 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 2.5 tttm -101.76 113.3 26.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.491 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -144.41 166.98 27.11 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.916 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -155.65 135.26 12.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.975 0.417 . . . . 0.0 110.341 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 66.0 t -96.63 138.3 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.248 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 17' ' ' VAL . . . . . 0.884 HG12 HG21 ' E' ' 5' ' ' VAL . 2.6 m -140.8 -173.3 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.873 0.368 . . . . 0.0 111.008 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.15 173.42 12.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.094 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.76 39.74 0.81 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.064 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . 0.631 ' HB1' ' CD2' ' F' ' 124' ' ' LEU . . . -114.29 -33.57 5.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.445 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 21' ' ' CYS . . . . . 0.672 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.9 OUTLIER -161.18 150.04 16.28 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.971 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.69 112.08 4.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.105 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 23' ' ' VAL . . . . . 0.674 ' HA ' ' HA ' ' F' ' 58' ' ' LEU . 3.1 p -59.97 153.34 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.01 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -80.72 152.8 28.19 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.647 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -57.52 -41.55 81.11 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.292 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.72 15.72 61.91 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.984 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 3.2 t -112.98 -21.36 11.15 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.967 0.413 . . . . 0.0 110.848 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 90.1 t -44.55 -64.84 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.357 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.29 135.6 38.97 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.976 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -143.0 128.74 19.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.062 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.82 111.85 23.86 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.152 -0.477 . . . . 0.0 112.048 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.557 HG23 HG13 ' E' ' 10' ' ' VAL . 4.2 t -110.88 114.7 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.168 0.508 . . . . 0.0 110.506 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -100.67 124.51 46.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.643 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 34' ' ' LEU . . . . . 0.588 ' HB3' ' HB3' ' C' ' 92' ' ' ALA . 0.9 OUTLIER -82.54 -45.65 14.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.578 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.31 -161.95 12.8 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.618 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 36' ' ' GLN . . . . . 0.668 HE21 HG21 ' E' ' 17' ' ' VAL . 1.8 mt-30 -99.79 129.65 45.92 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.622 0.248 . . . . 0.0 110.922 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.498 ' CG1' HG22 ' E' ' 16' ' ' VAL . 11.8 p -109.98 147.5 14.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.954 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 38' ' ' ARG . . . . . 0.508 ' HB3' ' HA ' ' E' ' 19' ' ' ALA . 0.7 OUTLIER -86.79 131.19 34.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.0 0.429 . . . . 0.0 111.8 179.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 39' ' ' THR . . . . . 0.686 ' HA ' ' HB3' ' F' ' 143' ' ' ALA . 4.8 t -54.03 -45.16 71.5 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.758 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . 0.446 ' N ' HG23 ' F' ' 39' ' ' THR . . . -60.92 -39.39 89.2 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.078 0.466 . . . . 0.0 110.943 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 41' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' F' ' 38' ' ' ARG . 0.4 OUTLIER -70.54 -23.22 62.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.157 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . 0.67 HD23 ' HB2' ' F' ' 139' ' ' ALA . 1.4 mp -124.59 51.54 1.6 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.651 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.6 30.0 7.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.43 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.86 128.49 48.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.308 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . 0.622 ' HA ' ' O ' ' F' ' 140' ' ' THR . 29.2 tt0 -53.05 103.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 111.072 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . 0.413 ' HA2' ' HE1' ' F' ' 138' ' ' PHE . . . 96.01 39.05 4.42 Favored Glycine 0 C--N 1.332 0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.101 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 47' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' F' ' 139' ' ' ALA . . . -80.14 146.68 31.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 17.8 p -139.64 125.1 19.15 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.897 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 49' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 32.5 m -101.98 -166.29 1.28 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.614 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.98 133.06 55.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.869 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 51' ' ' ALA . . . . . 0.552 ' HA ' ' HB3' ' F' ' 136' ' ' ARG . . . -92.72 120.18 32.85 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.726 0.298 . . . . 0.0 111.246 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 52' ' ' VAL . . . . . 0.63 HG22 ' O ' ' F' ' 135' ' ' ALA . 18.6 m -65.85 162.67 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.888 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -124.83 124.07 5.26 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.635 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 54' ' ' PHE . . . . . 0.455 ' N ' HG21 ' C' ' 76' ' ' THR . 54.1 p90 -155.86 146.56 22.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.643 0.258 . . . . 0.0 111.027 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 55' ' ' ASN . . . . . 0.579 ' HB2' HG22 ' F' ' 130' ' ' THR . 3.3 p30 -136.87 160.26 39.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.528 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 56' ' ' ILE . . . . . 0.574 HG23 ' O ' ' F' ' 56' ' ' ILE . 1.6 tp -100.65 116.91 45.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.555 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 57' ' ' GLN . . . . . 0.614 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.0 OUTLIER -70.04 124.61 24.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.76 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . 0.674 ' HA ' ' HA ' ' F' ' 23' ' ' VAL . 1.6 mp -133.77 87.48 2.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.216 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 59' ' ' ASN . . . . . 0.572 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 4.9 p30 -73.69 174.57 8.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.931 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 57.82 79.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.763 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 61' ' ' CYS . . . . . 0.672 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 93.2 m -127.66 159.43 34.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.817 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . 0.604 ' OD2' HG23 ' F' ' 65' ' ' VAL . 5.5 t70 -130.27 167.07 19.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.288 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 63' ' ' THR . . . . . 0.662 HG23 ' HA ' ' F' ' 125' ' ' ASN . 0.2 OUTLIER -114.24 -41.7 3.45 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -67.57 -22.63 65.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.989 0.423 . . . . 0.0 111.694 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . 0.604 HG23 ' OD2' ' F' ' 62' ' ' ASP . 82.8 t -70.4 -74.08 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.657 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 66' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' F' ' 124' ' ' LEU . . . -120.75 131.34 54.45 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.629 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.24 -48.62 6.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.907 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 68' ' ' LYS . . . . . 0.632 ' HE3' ' HB3' ' F' ' 121' ' ' GLU . 0.1 OUTLIER -96.2 161.51 13.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.617 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.09 124.72 6.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.641 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 70' ' ' ALA . . . . . 0.722 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -100.46 154.97 18.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.061 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 71' ' ' VAL . . . . . 0.825 HG11 HG21 ' F' ' 131' ' ' ILE . 2.3 t -132.73 148.33 31.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.69 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 72' ' ' ALA . . . . . 0.458 ' HA ' HD21 ' F' ' 111' ' ' LEU . . . -145.6 150.15 35.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.644 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 73' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -119.91 137.02 54.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.488 0.185 . . . . 0.0 111.059 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 74' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.9 OUTLIER -96.14 139.5 32.21 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.918 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . 0.434 ' CA ' ' HB3' ' F' ' 113' ' ' LEU . . . 178.54 179.81 48.49 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.833 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 76' ' ' THR . . . . . 0.546 ' H ' HD23 ' F' ' 86' ' ' LEU . 0.3 OUTLIER -110.9 156.42 21.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.507 0.194 . . . . 0.0 110.856 179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 77' ' ' ALA . . . . . 0.676 ' O ' ' HB2' ' F' ' 87' ' ' ALA . . . -73.81 131.26 41.35 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 78' ' ' ILE . . . . . 0.642 ' CG2' ' HB ' ' F' ' 85' ' ' VAL . 0.9 OUTLIER -67.69 -41.45 85.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.799 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 79' ' ' ASP . . . . . 0.427 ' N ' HG23 ' F' ' 78' ' ' ILE . 0.6 OUTLIER -141.12 40.77 1.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.773 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 66.45 -80.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.996 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -55.65 -24.99 41.92 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.696 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -99.01 63.93 1.37 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.851 0.358 . . . . 0.0 110.455 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 83' ' ' THR . . . . . 0.548 HG23 ' HB2' ' F' ' 77' ' ' ALA . 0.2 OUTLIER -68.5 -16.79 64.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.535 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 84' ' ' ASN . . . . . 0.703 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 18.0 p-10 -70.42 -20.25 62.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.329 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 85' ' ' VAL . . . . . 0.642 ' HB ' ' CG2' ' F' ' 78' ' ' ILE . 14.6 t -106.92 130.7 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.165 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 86' ' ' LEU . . . . . 0.788 HD22 ' HB1' ' F' ' 150' ' ' ALA . 0.5 OUTLIER -67.61 148.21 51.71 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.472 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 87' ' ' ALA . . . . . 0.676 ' HB2' ' O ' ' F' ' 77' ' ' ALA . . . -89.65 -167.47 1.87 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.87 0.367 . . . . 0.0 111.732 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . 0.657 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 1.5 mm? -78.34 157.22 29.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.054 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.61 -78.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.345 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 90' ' ' SER . . . . . 0.401 ' H ' ' H ' ' F' ' 91' ' ' SER . 0.5 OUTLIER -167.05 0.47 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.021 0.438 . . . . 0.0 111.469 179.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 91' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' F' ' 95' ' ' SER . 1.7 m -71.82 82.93 0.91 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.66 -13.95 61.87 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.863 0.364 . . . . 0.0 111.688 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.64 27.61 5.23 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.632 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -166.63 15.59 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.487 -0.864 . . . . 0.0 112.928 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 95' ' ' SER . . . . . 0.657 ' HB3' ' HG ' ' F' ' 88' ' ' LEU . 3.0 m -100.86 -172.82 2.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.713 0.292 . . . . 0.0 110.639 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -103.89 167.66 9.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.788 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . 0.522 ' H ' ' HB ' ' F' ' 144' ' ' THR . 2.3 m -121.59 128.3 51.82 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.343 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 98' ' ' ASN . . . . . 0.462 ' HB3' ' H ' ' F' ' 141' ' ' GLY . 75.9 m-20 64.27 34.56 10.65 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.415 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 99' ' ' VAL . . . . . 0.485 HG13 HD23 ' F' ' 42' ' ' LEU . 0.5 OUTLIER -139.99 136.5 38.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.683 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -160.13 -156.87 8.34 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.577 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 101' ' ' VAL . . . . . 0.482 HG13 ' HB2' ' F' ' 86' ' ' LEU . 3.2 p -137.77 116.72 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 122.973 0.509 . . . . 0.0 111.616 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 102' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 1.2 tt0 -91.93 150.43 21.03 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 103' ' ' ILE . . . . . 0.666 HD12 ' HB3' ' F' ' 111' ' ' LEU . 0.5 OUTLIER -113.87 131.32 66.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.542 179.481 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 104' ' ' LEU . . . . . 0.539 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 0.3 OUTLIER -106.29 130.1 54.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.645 0.259 . . . . 0.0 111.014 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . 0.737 ' HB3' HG22 ' F' ' 107' ' ' THR . 5.1 t0 -76.02 156.97 33.54 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.697 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 106' ' ' ARG . . . . . 0.721 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 3.5 ttp180 -71.31 -17.47 62.45 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.691 0.281 . . . . 0.0 111.061 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . 0.737 HG22 ' HB3' ' F' ' 105' ' ' ASP . 6.2 t -67.19 -18.03 65.08 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 108' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' C' ' 80' ' ' ALA . . . 123.74 -45.63 1.17 Allowed Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.748 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -81.09 163.12 23.39 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.671 0.272 . . . . 0.0 111.181 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -84.16 127.45 33.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.067 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . 0.666 ' HB3' HD12 ' F' ' 103' ' ' ILE . 12.1 tp -86.28 156.18 20.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.317 0.58 . . . . 0.0 110.614 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 112' ' ' THR . . . . . 0.901 HG23 HG21 ' F' ' 117' ' ' THR . 0.5 OUTLIER -106.31 139.09 41.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.095 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 113' ' ' LEU . . . . . 0.626 HD13 ' HG ' ' F' ' 86' ' ' LEU . 1.0 OUTLIER -73.92 76.49 1.66 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.697 0.284 . . . . 0.0 110.746 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.45 -17.2 14.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.507 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.25 -51.8 1.25 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.647 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.05 18.89 21.57 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.918 0.39 . . . . 0.0 111.52 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 117' ' ' THR . . . . . 0.901 HG21 HG23 ' F' ' 112' ' ' THR . 0.2 OUTLIER -85.77 84.64 7.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . 0.722 ' HB3' ' HB1' ' F' ' 70' ' ' ALA . 95.7 m-85 -101.42 98.74 9.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.741 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 39.3 m -130.84 62.44 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.802 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.3 145.83 30.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.655 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 121' ' ' GLU . . . . . 0.632 ' HB3' ' HE3' ' F' ' 68' ' ' LYS . 3.5 mm-40 -121.34 71.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.223 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.77 134.7 34.72 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.738 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 15.2 m -83.81 113.68 21.09 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.739 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . 0.631 ' CD2' ' HB1' ' F' ' 20' ' ' ALA . 19.0 tp -74.01 142.96 45.75 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.751 0.31 . . . . 0.0 110.589 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 125' ' ' ASN . . . . . 0.662 ' HA ' HG23 ' F' ' 63' ' ' THR . 0.9 OUTLIER -138.59 162.02 35.63 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.615 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -75.66 113.12 12.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.718 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.55 -139.9 9.48 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.779 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 128' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 6.7 m -101.75 96.78 7.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.726 0.298 . . . . 0.0 110.795 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 129' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -83.61 148.56 27.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.925 0.393 . . . . 0.0 111.112 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 130' ' ' THR . . . . . 0.624 HG21 HD21 ' C' ' 74' ' ' LEU . 0.2 OUTLIER -138.57 143.4 39.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.158 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 131' ' ' ILE . . . . . 0.825 HG21 HG11 ' F' ' 71' ' ' VAL . 54.9 mt -104.66 112.45 65.33 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 132' ' ' PRO . . . . . 0.721 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.4 Cg_endo -81.93 141.94 12.22 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.758 1.639 . . . . 0.0 112.492 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.67 141.1 22.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.845 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -104.48 152.63 22.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.091 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . 0.63 ' O ' HG22 ' F' ' 52' ' ' VAL . . . -153.54 101.03 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.931 0.396 . . . . 0.0 111.615 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 136' ' ' ARG . . . . . 0.552 ' HB3' ' HA ' ' F' ' 51' ' ' ALA . 17.4 ptt180 -107.11 177.32 4.89 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.428 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 137' ' ' TYR . . . . . 0.49 ' HB3' HD21 ' F' ' 42' ' ' LEU . 4.6 m-85 -86.02 124.08 32.06 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.979 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 138' ' ' PHE . . . . . 0.46 ' HB3' HG11 ' F' ' 85' ' ' VAL . 1.2 t80 -118.81 112.38 19.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.016 -179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 139' ' ' ALA . . . . . 0.67 ' HB2' HD23 ' F' ' 42' ' ' LEU . . . -102.95 133.95 47.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.921 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 140' ' ' THR . . . . . 0.622 ' O ' ' HA ' ' F' ' 45' ' ' GLU . 0.1 OUTLIER -81.05 -28.89 35.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.547 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' F' ' 98' ' ' ASN . . . -160.18 -111.11 0.28 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.864 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.78 110.61 21.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.511 0.196 . . . . 0.0 110.784 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 143' ' ' ALA . . . . . 0.686 ' HB3' ' HA ' ' F' ' 39' ' ' THR . . . -65.69 134.31 52.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 111.336 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 144' ' ' THR . . . . . 0.604 ' O ' ' CG1' ' E' ' 16' ' ' VAL . 56.7 m -105.9 149.42 38.01 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.268 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 145' ' ' PRO . . . . . 0.483 ' CD ' ' CG2' ' F' ' 144' ' ' THR . 1.5 Cg_endo -82.84 125.45 4.22 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.541 2.161 . . . . 0.0 112.03 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 146' ' ' GLY . . . . . 0.685 ' O ' ' CG ' ' E' ' 15' ' ' GLU . . . 168.77 -126.32 1.37 Allowed Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.418 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 147' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -111.05 128.46 55.87 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.772 0.32 . . . . 0.0 111.355 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 148' ' ' ALA . . . . . 0.688 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -125.48 52.09 1.66 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.162 0.506 . . . . 0.0 110.402 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -98.68 151.94 20.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.627 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 150' ' ' ALA . . . . . 0.788 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -158.27 169.51 24.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.986 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -130.93 128.67 40.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.249 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 152' ' ' ALA . . . . . 0.497 ' HB2' HD11 ' F' ' 86' ' ' LEU . . . -122.21 144.04 49.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.233 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 153' ' ' THR . . . . . 1.025 HG23 HG22 ' E' ' 9' ' ' THR . 0.6 OUTLIER -106.3 145.38 31.72 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 154' ' ' PHE . . . . . 0.419 ' HB3' ' H ' ' E' ' 8' ' ' GLY . 0.5 OUTLIER -96.98 134.69 40.0 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.107 0.48 . . . . 0.0 110.053 -179.024 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . 0.411 ' HA ' ' H ' ' E' ' 7' ' ' GLY . 9.9 mmtt -124.22 148.06 47.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.88 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 156' ' ' VAL . . . . . 0.523 HG23 HG23 ' E' ' 5' ' ' VAL . 29.8 m -135.12 144.85 33.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.818 0.342 . . . . 0.0 111.787 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 157' ' ' GLN . . . . . 0.693 ' HG3' HG23 ' E' ' 4' ' ' THR . 0.0 OUTLIER -134.54 126.04 28.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.304 0.573 . . . . 0.0 110.362 -179.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' F' ' 21' ' ' CYS . 5.2 m-85 -106.0 128.73 54.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.559 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 159' ' ' GLN . . . . . 0.556 ' HG3' ' C ' ' F' ' 158' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.259 -0.876 . . . . 0.0 110.817 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.258 0.075 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.61 71.05 0.5 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.992 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' B' ' 157' ' ' GLN . 4.9 m -114.68 127.37 55.72 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.431 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.3 m -117.71 106.76 13.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.704 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.459 HG21 HG12 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -133.9 174.61 12.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.58 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.1 119.87 36.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.528 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.27 -49.49 15.47 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.827 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.3 -154.89 11.32 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.866 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.711 HG22 HG23 ' B' ' 153' ' ' THR . 2.6 p -142.39 140.01 31.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.949 0.404 . . . . 0.0 111.223 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.69 113.82 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.23 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.08 110.32 20.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.404 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.24 111.56 22.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.75 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HG2' HD22 ' B' ' 149' ' ' ASN . 3.6 tmtm? -102.98 110.59 22.56 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.438 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.26 168.33 22.63 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.952 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.684 ' O ' ' HA ' ' B' ' 36' ' ' GLN . 3.6 tt0 -158.98 133.08 7.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.898 0.38 . . . . 0.0 110.417 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.892 HG23 ' HB2' ' B' ' 148' ' ' ALA . 13.0 t -99.64 143.17 13.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.25 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.536 HG13 ' HG2' ' B' ' 36' ' ' GLN . 3.9 m -141.41 -172.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.912 0.387 . . . . 0.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.46 -176.97 5.22 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.083 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.87 46.94 1.36 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.055 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.75 -29.98 2.56 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.443 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.999 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -163.11 158.45 21.92 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.907 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' B' ' 36' ' ' GLN . . . -161.39 118.53 2.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.026 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -66.27 153.1 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.025 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.75 158.75 20.64 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.603 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.03 -34.4 74.79 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.347 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.1 12.99 63.72 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.91 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.77 -22.4 10.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.791 0.329 . . . . 0.0 110.77 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.482 HG11 ' HE3' ' A' ' 13' ' ' LYS . 19.6 t -43.93 -64.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.359 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.05 135.83 41.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.968 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.17 125.72 20.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.088 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.76 106.53 18.81 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.066 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.74 117.06 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.074 0.464 . . . . 0.0 110.418 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.7 131.03 45.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.584 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.77 -47.37 7.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.586 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.41 -163.53 12.16 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.562 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -101.07 126.62 47.77 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.684 0.278 . . . . 0.0 110.833 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 42' ' ' LEU . 14.9 p -110.42 146.84 15.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.923 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -82.85 139.18 33.62 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.74 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.494 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 5.4 t -62.79 -37.42 86.6 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.746 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.46 71.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.108 0.48 . . . . 0.0 110.829 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.03 -17.76 45.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.112 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.725 HD23 ' HB2' ' A' ' 139' ' ' ALA . 4.3 mp -125.65 33.1 5.17 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.668 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.74 18.87 18.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.312 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.87 130.3 52.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.431 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 140' ' ' THR . 22.5 tt0 -56.38 107.38 0.37 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.866 0.365 . . . . 0.0 111.016 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.53 30.57 5.84 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.214 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 138' ' ' PHE . . . -76.57 136.65 39.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.978 0.418 . . . . 0.0 112.081 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 52.3 p -134.87 134.73 41.04 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.869 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.448 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 70.9 m -108.79 -168.22 1.32 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.637 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.0 t -63.89 128.45 35.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.795 0.331 . . . . 0.0 110.799 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' A' ' 134' ' ' GLN . . . -80.41 130.0 34.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.436 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.728 HG22 ' HB3' ' A' ' 135' ' ' ALA . 2.8 m -74.84 151.22 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.925 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.98 119.22 5.67 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.577 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -153.86 152.09 30.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.729 0.3 . . . . 0.0 110.925 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -148.74 162.94 38.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.633 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 56' ' ' ILE . 1.2 tp -105.98 114.82 46.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.548 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.872 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -70.69 124.53 24.48 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.721 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -132.32 88.81 2.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.203 -179.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.601 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 0.1 OUTLIER -75.31 169.47 18.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.895 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' B' ' 38' ' ' ARG . 0.4 OUTLIER 66.39 68.23 0.44 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.773 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.999 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 56.3 m -117.11 155.03 30.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.763 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.622 ' HB2' HH22 ' B' ' 38' ' ' ARG . 20.0 t70 -135.76 155.69 49.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.214 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -111.15 -34.23 6.24 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.141 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.08 -22.13 66.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.967 0.413 . . . . 0.0 111.755 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.6 -59.54 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.696 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB3' HD23 ' A' ' 124' ' ' LEU . . . -116.84 129.18 55.92 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.646 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -60.31 2.19 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.856 0.36 . . . . 0.0 110.964 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.28 -175.33 2.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.499 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.0 131.36 9.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.52 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.466 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -106.04 151.14 25.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.036 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.607 HG11 HG21 ' A' ' 131' ' ' ILE . 2.0 t -129.46 158.31 42.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.714 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.633 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -152.66 143.09 22.62 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.579 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.608 ' HB3' HD23 ' A' ' 113' ' ' LEU . 0.1 OUTLIER -112.32 141.47 46.0 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.683 0.278 . . . . 0.0 111.019 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.026 HD21 HG21 ' D' ' 130' ' ' THR . 0.3 OUTLIER -107.64 139.47 42.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.012 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.75 -179.54 46.85 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.816 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.768 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.3 OUTLIER -103.85 156.35 17.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.634 0.254 . . . . 0.0 110.823 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.34 118.35 21.17 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.93 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.557 HG22 ' HB3' ' A' ' 82' ' ' HIS . 0.4 OUTLIER -59.03 -29.11 40.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.81 179.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.446 ' HB2' HG21 ' A' ' 140' ' ' THR . 0.1 OUTLIER -151.74 50.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.805 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.22 -89.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.079 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.07 -32.55 42.9 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.584 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.557 ' HB3' HG22 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -81.12 62.84 5.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.892 0.377 . . . . 0.0 110.384 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.63 -18.18 60.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.585 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.71 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 20.4 p-10 -75.91 -7.48 54.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.266 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.487 ' HB ' ' CG2' ' A' ' 78' ' ' ILE . 24.1 t -117.7 124.22 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.214 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.931 HD22 ' HB1' ' A' ' 150' ' ' ALA . 0.5 OUTLIER -66.19 139.33 58.11 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.278 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 78' ' ' ILE . . . -84.85 -165.42 1.19 Allowed 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.705 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.776 ' HG ' ' HB3' ' A' ' 95' ' ' SER . 0.7 OUTLIER -71.91 168.67 17.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.963 179.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.86 -79.24 0.06 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.335 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.775 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 2.4 p -168.84 6.0 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.016 0.436 . . . . 0.0 111.545 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.612 ' O ' ' HB2' ' A' ' 95' ' ' SER . 69.8 m -77.57 83.27 3.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.906 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' D' ' 50' ' ' SER . . . -55.07 -34.65 63.78 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.882 0.373 . . . . 0.0 111.626 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.27 31.51 6.31 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.604 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.59 7.46 0.23 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.919 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.776 ' HB3' ' HG ' ' A' ' 88' ' ' LEU . 0.6 OUTLIER -110.78 -174.32 2.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.921 0.391 . . . . 0.0 110.588 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.431 ' O ' HD21 ' A' ' 88' ' ' LEU . . . -97.75 179.07 4.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.968 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.785 ' H ' ' HB ' ' A' ' 144' ' ' THR . 1.1 m -132.31 125.97 32.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.331 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 97' ' ' THR . 66.2 m-20 66.61 25.88 9.87 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.45 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.66 130.4 70.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.657 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.14 -161.35 10.74 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.508 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.494 ' CG2' ' HB1' ' A' ' 135' ' ' ALA . 0.8 OUTLIER -130.84 131.94 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 123.096 0.559 . . . . 0.0 111.825 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.721 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 1.5 tt0 -98.48 151.44 20.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.923 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.525 ' N ' ' HG2' ' A' ' 102' ' ' GLN . 0.3 OUTLIER -117.34 128.62 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.542 179.485 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.801 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 0.3 OUTLIER -103.01 133.51 48.01 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.713 0.292 . . . . 0.0 111.034 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.718 ' HB3' HG22 ' A' ' 107' ' ' THR . 7.1 t0 -87.71 158.39 18.82 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.659 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 106' ' ' ARG . 7.9 ttp85 -70.47 -27.67 64.41 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.78 0.324 . . . . 0.0 111.081 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.718 HG22 ' HB3' ' A' ' 105' ' ' ASP . 2.8 t -51.76 -25.67 8.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.047 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.08 -39.18 1.74 Allowed Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.603 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.33 157.97 17.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.862 0.363 . . . . 0.0 111.032 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.801 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -70.33 137.12 50.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.079 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.633 HD21 ' HA ' ' A' ' 72' ' ' ALA . 13.5 tp -87.54 158.41 18.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.29 0.567 . . . . 0.0 110.555 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.998 HG23 HG21 ' A' ' 117' ' ' THR . 0.5 OUTLIER -101.74 142.0 33.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.116 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.608 HD23 ' HB3' ' A' ' 73' ' ' PHE . 1.9 mt -82.41 65.57 7.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.71 0.291 . . . . 0.0 110.702 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.09 -14.93 21.23 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.52 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.25 -54.16 0.7 Allowed Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.596 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.2 28.92 8.27 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 121.016 0.436 . . . . 0.0 111.651 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.998 HG21 HG23 ' A' ' 112' ' ' THR . 0.0 OUTLIER -88.72 76.54 8.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.169 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.597 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 91.6 m-85 -91.01 96.75 10.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.743 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 68.0 m -132.67 78.25 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.818 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.7 136.9 3.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.667 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.01 76.2 0.98 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.275 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.83 135.51 33.68 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.732 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.7 m -77.08 96.35 4.42 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.71 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.734 ' O ' HG23 ' A' ' 63' ' ' THR . 10.8 tp -68.21 132.95 48.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.567 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -128.46 166.86 17.95 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.582 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 61' ' ' CYS . 6.3 t30 -79.45 105.75 10.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.656 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.03 -137.04 5.21 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.749 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 3.7 m -103.61 83.47 2.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.753 0.311 . . . . 0.0 110.825 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.694 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 1.7 t30 -71.03 139.88 50.6 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.911 0.386 . . . . 0.0 111.158 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.872 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -133.95 139.66 46.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.158 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.607 HG21 HG11 ' A' ' 71' ' ' VAL . 61.7 mt -98.07 110.53 56.29 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -81.8 135.15 8.79 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.777 1.651 . . . . 0.0 112.528 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.72 152.71 41.63 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.791 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.583 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 50.6 mt-30 -119.0 156.85 28.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.067 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.728 ' HB3' HG22 ' A' ' 52' ' ' VAL . . . -151.39 101.79 2.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.372 . . . . 0.0 111.65 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.6 168.37 9.14 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.364 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -80.11 123.26 27.72 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.194 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 1.3 t80 -126.16 119.13 26.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.026 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.725 ' HB2' HD23 ' A' ' 42' ' ' LEU . . . -112.02 125.2 53.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.888 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -68.93 -48.19 63.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.51 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.431 ' H ' ' HB3' ' A' ' 98' ' ' ASN . . . -133.1 -120.0 2.08 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.043 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.42 111.94 18.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.597 0.237 . . . . 0.0 110.68 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.707 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -61.89 113.82 3.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.781 0.324 . . . . 0.0 111.447 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.785 ' HB ' ' H ' ' A' ' 97' ' ' THR . 75.1 m -88.31 145.25 35.43 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.32 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 144' ' ' THR . 1.3 Cg_endo -82.83 134.26 7.2 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.458 2.106 . . . . 0.0 111.987 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.87 -135.59 4.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.553 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.691 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -96.21 134.21 39.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.889 0.376 . . . . 0.0 111.301 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -129.78 50.5 2.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.135 0.493 . . . . 0.0 110.499 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -99.01 146.17 26.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.503 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.931 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -154.99 174.12 15.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.932 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.495 ' C ' HD11 ' A' ' 86' ' ' LEU . 26.8 t70 -139.33 128.45 23.82 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.16 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 74' ' ' LEU . . . -118.4 133.29 56.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.159 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.92 147.41 22.99 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.25 130.28 53.42 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.131 0.491 . . . . 0.0 110.07 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -126.69 143.99 51.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.871 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.523 HG12 ' CD1' ' A' ' 131' ' ' ILE . 27.3 m -127.4 151.9 34.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.645 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.36 121.12 13.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.263 0.554 . . . . 0.0 110.404 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' A' ' 21' ' ' CYS . 1.2 m-85 -98.28 121.65 40.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.548 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.822 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 111.188 0.07 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.62 71.07 0.5 Allowed 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.148 0.28 . . . . 0.0 110.93 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' C' ' 157' ' ' GLN . 4.9 m -114.67 127.43 55.76 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.464 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 20.5 m -117.75 106.85 13.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.623 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.454 HG21 HG12 ' C' ' 17' ' ' VAL . 0.0 OUTLIER -134.0 174.66 12.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.612 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.13 119.89 36.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.501 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.23 -49.55 15.42 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.835 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.28 -154.87 11.3 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.976 -0.63 . . . . 0.0 111.845 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.721 HG22 HG23 ' C' ' 153' ' ' THR . 2.7 p -142.41 140.04 31.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.974 0.416 . . . . 0.0 111.224 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 43.4 t -120.76 113.82 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.177 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.08 110.3 20.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.365 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -90.18 111.53 22.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.78 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.498 ' HG2' HD22 ' C' ' 149' ' ' ASN . 3.6 tmtm? -102.96 110.52 22.46 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.49 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.19 168.35 22.59 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.0 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.686 ' O ' ' HA ' ' C' ' 36' ' ' GLN . 3.6 tt0 -159.01 133.06 7.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.473 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.891 HG23 ' HB2' ' C' ' 148' ' ' ALA . 13.1 t -99.62 143.22 13.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.25 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.538 HG13 ' HG2' ' C' ' 36' ' ' GLN . 3.9 m -141.48 -172.15 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.838 0.352 . . . . 0.0 110.992 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.43 -177.02 5.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.083 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.77 46.91 1.36 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.092 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.77 -29.93 2.56 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.498 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER -163.18 158.41 21.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.94 -179.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' C' ' 36' ' ' GLN . . . -161.39 118.54 2.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.041 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' B' ' 58' ' ' LEU . 0.8 OUTLIER -66.27 153.05 8.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.018 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.75 158.73 20.65 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.582 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.02 -34.39 74.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.345 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.14 13.07 63.6 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.914 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.81 -22.43 10.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.84 0.353 . . . . 0.0 110.782 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.485 HG11 ' HE3' ' B' ' 13' ' ' LYS . 19.8 t -44.08 -64.21 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.348 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.09 135.85 41.89 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.005 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.15 125.67 20.51 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.058 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.8 106.54 18.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.058 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.68 117.07 53.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.455 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.71 131.05 45.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.597 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.8 -47.32 7.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.658 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.34 -163.61 12.15 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.561 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 3.7 mt-30 -100.98 126.6 47.65 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.65 0.262 . . . . 0.0 110.817 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.451 HG21 HD13 ' B' ' 42' ' ' LEU . 14.9 p -110.4 146.89 15.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.9 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.622 HH22 ' HB2' ' A' ' 62' ' ' ASP . 2.9 mtp180 -82.92 139.17 33.53 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.655 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.489 ' HA ' ' HB3' ' B' ' 143' ' ' ALA . 5.4 t -62.77 -37.44 86.67 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.778 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.51 -31.45 71.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.072 0.463 . . . . 0.0 110.818 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.05 -17.75 45.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.171 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.741 HD23 ' HB2' ' B' ' 139' ' ' ALA . 4.3 mp -125.66 33.11 5.17 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.662 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.74 18.89 18.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.341 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.92 130.26 52.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.387 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' B' ' 140' ' ' THR . 22.5 tt0 -56.27 107.29 0.35 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.832 0.349 . . . . 0.0 111.095 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.52 30.56 5.84 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.195 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' B' ' 138' ' ' PHE . . . -76.6 136.76 39.22 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.986 0.422 . . . . 0.0 112.093 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' B' ' 137' ' ' TYR . 51.6 p -134.99 134.69 40.74 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.822 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 70.8 m -108.74 -168.14 1.31 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.65 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 23.3 t -63.93 128.44 35.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.774 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.586 ' HB1' ' HB3' ' B' ' 134' ' ' GLN . . . -80.41 129.96 34.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.451 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.72 HG22 ' HB3' ' B' ' 135' ' ' ALA . 2.8 m -74.87 151.26 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.922 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.05 119.25 5.67 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.512 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.81 152.12 30.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.783 0.325 . . . . 0.0 110.951 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -148.75 162.96 38.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.661 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.609 HG23 ' O ' ' B' ' 56' ' ' ILE . 1.2 tp -105.94 114.87 46.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.573 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . 0.865 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -70.72 124.51 24.46 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.749 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 0.2 OUTLIER -132.32 88.78 2.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.242 -179.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.587 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 0.1 OUTLIER -75.31 169.44 18.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' C' ' 38' ' ' ARG . 0.4 OUTLIER 66.38 68.25 0.44 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.788 179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' CYS . . . . . 1.013 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 56.3 m -117.11 155.0 30.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.816 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . 0.621 ' HB2' HH22 ' C' ' 38' ' ' ARG . 19.9 t70 -135.74 155.65 50.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.311 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.733 HG23 ' O ' ' B' ' 124' ' ' LEU . 0.2 OUTLIER -111.11 -34.17 6.26 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.12 -22.17 66.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.008 0.433 . . . . 0.0 111.735 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.54 -59.54 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.767 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.548 ' HB3' HD23 ' B' ' 124' ' ' LEU . . . -116.76 129.16 55.94 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.706 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.16 -60.29 2.2 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.921 0.391 . . . . 0.0 111.019 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.26 -175.38 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.479 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.96 131.3 9.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.55 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -105.95 151.2 24.9 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.067 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.625 HG11 HG21 ' B' ' 131' ' ' ILE . 2.0 t -129.45 158.31 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.788 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.628 ' HA ' HD21 ' B' ' 111' ' ' LEU . . . -152.73 143.1 22.57 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.558 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.612 ' HB3' HD23 ' B' ' 113' ' ' LEU . 0.1 OUTLIER -112.3 141.49 45.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.648 0.261 . . . . 0.0 111.034 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.979 HD21 HG21 ' E' ' 130' ' ' THR . 0.3 OUTLIER -107.67 139.51 42.13 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.966 -179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.76 -179.46 46.91 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.851 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.767 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.3 OUTLIER -103.96 156.33 17.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.602 0.239 . . . . 0.0 110.782 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.4 ' HB2' HG23 ' B' ' 83' ' ' THR . . . -79.33 118.42 21.23 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.943 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.563 HG22 ' HB3' ' B' ' 82' ' ' HIS . 0.4 OUTLIER -59.05 -29.07 40.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.446 ' HB2' HG21 ' B' ' 140' ' ' THR . 0.1 OUTLIER -151.75 50.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.771 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.14 -89.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.118 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.06 -32.49 42.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.652 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.563 ' HB3' HG22 ' B' ' 78' ' ' ILE . 0.3 OUTLIER -81.15 62.83 5.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.938 0.399 . . . . 0.0 110.43 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' THR . . . . . 0.4 HG23 ' HB2' ' B' ' 77' ' ' ALA . 0.2 OUTLIER -74.65 -18.13 60.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.557 -179.578 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . 0.701 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 20.4 p-10 -76.01 -7.38 54.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.279 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.486 ' HB ' ' CG2' ' B' ' 78' ' ' ILE . 23.9 t -117.68 124.12 72.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.235 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.991 HD22 ' HB1' ' B' ' 150' ' ' ALA . 0.5 OUTLIER -66.21 139.34 58.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' B' ' 78' ' ' ILE . . . -84.87 -165.42 1.19 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.674 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.77 ' HG ' ' HB3' ' B' ' 95' ' ' SER . 0.7 OUTLIER -71.86 168.67 17.41 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.086 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.94 -79.18 0.06 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.279 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . 0.764 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 2.4 p -168.88 5.91 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.048 0.452 . . . . 0.0 111.572 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . 0.61 ' O ' ' HB2' ' B' ' 95' ' ' SER . 69.9 m -77.56 83.22 3.96 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.952 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' E' ' 50' ' ' SER . . . -55.02 -34.68 63.69 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.88 0.372 . . . . 0.0 111.617 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.22 31.49 6.33 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.571 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.58 7.49 0.23 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.943 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' SER . . . . . 0.77 ' HB3' ' HG ' ' B' ' 88' ' ' LEU . 0.6 OUTLIER -110.73 -174.33 2.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.943 0.401 . . . . 0.0 110.581 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.432 ' O ' HD21 ' B' ' 88' ' ' LEU . . . -97.83 179.09 4.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.914 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.785 ' H ' ' HB ' ' B' ' 144' ' ' THR . 1.1 m -132.42 125.99 32.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.296 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' B' ' 97' ' ' THR . 66.1 m-20 66.66 25.84 9.79 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.422 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.69 130.44 70.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.686 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.08 -161.36 10.74 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.535 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.496 ' CG2' ' HB1' ' B' ' 135' ' ' ALA . 0.8 OUTLIER -130.87 131.97 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 123.056 0.542 . . . . 0.0 111.756 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.727 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 1.5 tt0 -98.52 151.49 20.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.901 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.524 ' N ' ' HG2' ' B' ' 102' ' ' GLN . 0.3 OUTLIER -117.36 128.67 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.513 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . 0.791 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 0.3 OUTLIER -103.03 133.55 47.97 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.707 0.289 . . . . 0.0 111.01 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . 0.719 ' HB3' HG22 ' B' ' 107' ' ' THR . 7.2 t0 -87.78 158.46 18.76 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.601 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' B' ' 106' ' ' ARG . 7.9 ttp85 -70.47 -27.75 64.46 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.733 0.301 . . . . 0.0 111.026 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.719 HG22 ' HB3' ' B' ' 105' ' ' ASP . 2.8 t -51.73 -25.74 8.05 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.036 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.26 -39.25 1.73 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.58 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.31 158.05 17.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.863 0.363 . . . . 0.0 111.0 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.791 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -70.36 137.11 50.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.063 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.628 HD21 ' HA ' ' B' ' 72' ' ' ALA . 13.5 tp -87.55 158.29 18.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.333 0.587 . . . . 0.0 110.563 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.989 HG23 HG21 ' B' ' 117' ' ' THR . 0.5 OUTLIER -101.62 141.96 33.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.147 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' B' ' 73' ' ' PHE . 1.9 mt -82.32 65.54 7.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.734 0.302 . . . . 0.0 110.801 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.08 -14.94 21.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.542 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.28 -54.18 0.7 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.623 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.19 28.99 8.2 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.02 0.438 . . . . 0.0 111.69 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.989 HG21 HG23 ' B' ' 112' ' ' THR . 0.0 OUTLIER -88.8 76.6 7.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.124 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.601 ' HA ' ' O ' ' B' ' 71' ' ' VAL . 91.4 m-85 -91.06 96.77 10.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.747 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 68.6 m -132.64 78.32 1.79 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.797 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.76 136.81 3.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.703 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -114.97 76.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.252 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.93 135.6 33.61 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.691 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 11.8 m -77.12 96.28 4.44 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.703 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.733 ' O ' HG23 ' B' ' 63' ' ' THR . 10.8 tp -68.12 132.94 48.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.589 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -128.47 166.74 18.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.601 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' B' ' 61' ' ' CYS . 6.2 t30 -79.38 105.78 10.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.697 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.03 -137.06 5.22 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.675 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 3.7 m -103.63 83.47 2.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.707 0.289 . . . . 0.0 110.773 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . 0.692 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 1.7 t30 -71.09 139.84 50.48 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.979 0.418 . . . . 0.0 111.148 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.865 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.2 OUTLIER -133.91 139.6 46.27 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.133 -179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' ILE . . . . . 0.625 HG21 HG11 ' B' ' 71' ' ' VAL . 61.8 mt -97.99 110.48 55.93 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -81.74 135.13 8.85 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 121.75 1.633 . . . . 0.0 112.574 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.76 152.65 41.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.756 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' GLN . . . . . 0.586 ' HB3' ' HB1' ' B' ' 51' ' ' ALA . 50.5 mt-30 -118.96 156.9 28.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.065 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' B' ' 102' ' ' GLN . . . -151.41 101.66 2.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.352 . . . . 0.0 111.659 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.58 168.33 9.17 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.35 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' B' ' 48' ' ' THR . 0.3 OUTLIER -80.06 123.32 27.75 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.173 179.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' B' ' 47' ' ' ALA . 1.3 t80 -126.2 119.12 26.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.948 -179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.741 ' HB2' HD23 ' B' ' 42' ' ' LEU . . . -111.99 125.16 53.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.919 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.22 63.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.507 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . 0.425 ' H ' ' HB3' ' B' ' 98' ' ' ASN . . . -133.1 -119.99 2.08 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.111 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.4 111.95 18.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.558 0.218 . . . . 0.0 110.738 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' ALA . . . . . 0.714 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -61.91 113.82 3.01 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.784 0.326 . . . . 0.0 111.409 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.785 ' HB ' ' H ' ' B' ' 97' ' ' THR . 74.1 m -88.25 145.23 35.47 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.302 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 144' ' ' THR . 1.3 Cg_endo -82.82 134.19 7.17 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.546 2.164 . . . . 0.0 112.019 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.88 -135.58 4.41 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.529 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.678 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -96.16 134.2 39.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.86 0.362 . . . . 0.0 111.361 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . 0.892 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -129.81 50.45 2.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.207 0.527 . . . . 0.0 110.506 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.495 HD22 ' HG2' ' A' ' 13' ' ' LYS . 3.4 m120 -98.93 146.15 26.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.551 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.991 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -154.91 174.08 15.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.883 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . 0.494 ' C ' HD11 ' B' ' 86' ' ' LEU . 26.6 t70 -139.31 128.49 23.93 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.171 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' B' ' 74' ' ' LEU . . . -118.45 133.27 56.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.169 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.711 HG23 HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -91.93 147.39 23.0 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.153 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.27 130.32 53.43 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.195 0.521 . . . . 0.0 110.037 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -126.64 143.89 51.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.931 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' VAL . . . . . 0.513 HG12 ' CD1' ' B' ' 131' ' ' ILE . 27.3 m -127.42 151.89 34.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.746 0.307 . . . . 0.0 111.709 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -141.39 121.1 13.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.32 0.581 . . . . 0.0 110.342 -179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . 0.578 ' CD2' ' HB ' ' A' ' 3' ' ' THR . 1.2 m-85 -98.21 121.64 40.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.577 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.86 -179.984 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.307 0 N-CA-C 111.176 0.065 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.59 71.06 0.5 Allowed 'General case' 0 C--O 1.232 0.132 0 O-C-N 123.122 0.264 . . . . 0.0 111.023 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.687 ' O ' ' HA ' ' D' ' 157' ' ' GLN . 4.9 m -114.71 127.42 55.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.447 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 20.8 m -117.84 106.77 13.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.609 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.456 HG21 HG12 ' D' ' 17' ' ' VAL . 0.0 OUTLIER -133.92 174.65 12.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.615 179.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.07 119.82 36.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.607 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.17 -49.5 15.75 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.835 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.32 -154.92 11.36 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.854 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . 0.74 HG22 HG23 ' D' ' 153' ' ' THR . 2.7 p -142.4 139.98 31.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.927 0.394 . . . . 0.0 111.292 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.74 113.93 41.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.155 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -87.16 110.3 20.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.313 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.23 111.54 22.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.776 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.494 ' HG2' HD22 ' D' ' 149' ' ' ASN . 3.7 tmtm? -102.94 110.61 22.59 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.435 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.32 168.38 22.64 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.058 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' GLU . . . . . 0.674 ' O ' ' HA ' ' D' ' 36' ' ' GLN . 3.6 tt0 -159.01 133.09 7.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.817 0.341 . . . . 0.0 110.413 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.872 HG23 ' HB2' ' D' ' 148' ' ' ALA . 13.3 t -99.74 143.27 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.203 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.526 HG13 ' HG2' ' D' ' 36' ' ' GLN . 4.0 m -141.42 -172.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.852 0.358 . . . . 0.0 111.074 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.56 -176.94 5.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.058 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.8 46.84 1.36 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.039 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.76 -29.96 2.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.924 0.392 . . . . 0.0 111.485 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' CYS . . . . . 0.988 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER -163.12 158.33 21.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.996 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' D' ' 36' ' ' GLN . . . -161.33 118.62 2.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.042 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' C' ' 58' ' ' LEU . 0.8 OUTLIER -66.28 153.07 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.086 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.78 158.73 20.62 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.613 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.562 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -61.01 -34.4 74.77 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.316 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.16 13.07 63.58 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.887 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.8 -22.44 10.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.801 0.334 . . . . 0.0 110.733 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.487 HG11 ' HE3' ' C' ' 13' ' ' LYS . 19.8 t -43.98 -64.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.336 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.04 135.83 41.87 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.949 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.21 125.72 20.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.066 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.74 106.53 18.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.15 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.75 117.05 53.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.067 0.461 . . . . 0.0 110.482 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.69 131.05 45.93 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.576 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.81 -47.31 7.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.607 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.33 -163.6 12.15 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.551 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . 0.686 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 3.7 mt-30 -100.98 126.59 47.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.634 0.255 . . . . 0.0 110.841 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.445 HG21 HD13 ' C' ' 42' ' ' LEU . 14.9 p -110.4 146.8 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.926 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' ARG . . . . . 0.621 HH22 ' HB2' ' B' ' 62' ' ' ASP . 2.8 mtp180 -82.8 139.08 33.74 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.757 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.5 ' HA ' ' HB3' ' C' ' 143' ' ' ALA . 5.5 t -62.74 -37.42 86.5 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.778 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.47 -31.49 71.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.125 0.488 . . . . 0.0 110.847 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.04 -17.73 45.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.102 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.743 HD23 ' HB2' ' C' ' 139' ' ' ALA . 4.3 mp -125.72 33.11 5.16 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.604 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.76 18.96 18.03 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.372 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.96 130.23 52.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.355 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' C' ' 140' ' ' THR . 22.5 tt0 -56.27 107.33 0.36 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.883 0.373 . . . . 0.0 111.088 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.6 30.51 5.83 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.133 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' C' ' 138' ' ' PHE . . . -76.58 136.62 39.25 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' C' ' 137' ' ' TYR . 52.2 p -134.91 134.73 40.95 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.848 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 71.1 m -108.76 -168.15 1.31 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.665 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 23.1 t -63.96 128.46 35.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.854 0.359 . . . . 0.0 110.756 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' C' ' 134' ' ' GLN . . . -80.4 129.98 34.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.43 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.715 HG22 ' HB3' ' C' ' 135' ' ' ALA . 2.8 m -74.86 151.21 6.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.993 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.01 119.26 5.68 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.547 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.91 152.08 30.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.731 0.301 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -148.72 162.95 38.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.694 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.609 HG23 ' O ' ' C' ' 56' ' ' ILE . 1.2 tp -105.96 114.82 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.534 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.886 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.0 OUTLIER -70.67 124.54 24.51 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.703 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' C' ' 23' ' ' VAL . 0.2 OUTLIER -132.34 88.79 2.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.235 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . 0.577 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 0.1 OUTLIER -75.28 169.44 18.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' ASP . . . . . 0.411 ' CG ' ' HD2' ' D' ' 38' ' ' ARG . 0.4 OUTLIER 66.37 68.24 0.44 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.802 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' CYS . . . . . 0.988 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 56.3 m -117.13 155.04 30.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.809 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . 0.625 ' HB2' HH22 ' D' ' 38' ' ' ARG . 20.0 t70 -135.8 155.63 50.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.25 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.738 HG23 ' O ' ' C' ' 124' ' ' LEU . 0.2 OUTLIER -111.08 -34.22 6.25 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.121 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.13 -22.12 66.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.012 0.434 . . . . 0.0 111.705 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -87.57 -59.65 2.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.669 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . 0.56 ' HB3' HD23 ' C' ' 124' ' ' LEU . . . -116.69 129.1 55.93 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.72 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.13 -60.28 2.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.914 0.388 . . . . 0.0 111.033 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.23 -175.34 2.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.49 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.93 131.38 9.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.604 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -106.05 151.18 24.99 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.841 0.353 . . . . 0.0 111.056 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . 0.621 HG11 HG21 ' C' ' 131' ' ' ILE . 2.0 t -129.47 158.32 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.766 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . 0.657 ' HA ' HD21 ' C' ' 111' ' ' LEU . . . -152.66 143.06 22.6 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.61 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' PHE . . . . . 0.612 ' HB3' HD23 ' C' ' 113' ' ' LEU . 0.1 OUTLIER -112.29 141.5 45.92 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.643 0.259 . . . . 0.0 111.068 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.97 HD21 HG21 ' F' ' 130' ' ' THR . 0.3 OUTLIER -107.71 139.45 42.26 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.955 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.79 -179.48 46.92 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.837 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.765 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.3 OUTLIER -103.97 156.38 17.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.607 0.241 . . . . 0.0 110.811 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.37 118.38 21.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.981 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' C' ' 82' ' ' HIS . 0.4 OUTLIER -59.02 -29.09 40.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.887 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' ASP . . . . . 0.45 ' HB2' HG21 ' C' ' 140' ' ' THR . 0.1 OUTLIER -151.76 50.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.822 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.25 -89.9 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.069 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.06 -32.59 42.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.573 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . 0.564 ' HB3' HG22 ' C' ' 78' ' ' ILE . 0.3 OUTLIER -81.04 62.78 5.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.856 0.36 . . . . 0.0 110.438 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.58 -18.21 60.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.61 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' ASN . . . . . 0.706 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 20.4 p-10 -75.86 -7.49 54.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.329 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.492 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 23.9 t -117.68 124.16 72.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.217 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.986 HD22 ' HB1' ' C' ' 150' ' ' ALA . 0.5 OUTLIER -66.14 139.36 58.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.697 0.284 . . . . 0.0 110.244 179.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' C' ' 78' ' ' ILE . . . -84.9 -165.44 1.2 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.605 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.76 ' HG ' ' HB3' ' C' ' 95' ' ' SER . 0.7 OUTLIER -71.88 168.65 17.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.012 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.93 -79.17 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.337 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . 0.769 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 2.3 p -168.86 5.95 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 111.525 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' SER . . . . . 0.611 ' O ' ' HB2' ' C' ' 95' ' ' SER . 69.7 m -77.54 83.21 3.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.971 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' F' ' 50' ' ' SER . . . -54.99 -34.67 63.59 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.89 0.376 . . . . 0.0 111.63 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.29 31.48 6.32 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.586 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.59 7.48 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.94 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' SER . . . . . 0.76 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 0.6 OUTLIER -110.74 -174.32 2.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.888 0.375 . . . . 0.0 110.612 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . 0.432 ' O ' HD21 ' C' ' 88' ' ' LEU . . . -97.76 179.0 4.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.904 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . 0.771 ' H ' ' HB ' ' C' ' 144' ' ' THR . 1.1 m -132.29 125.98 32.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.356 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' C' ' 97' ' ' THR . 66.0 m-20 66.57 25.92 9.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.396 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.7 130.37 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.705 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.07 -161.39 10.76 Favored Glycine 0 C--O 1.229 -0.21 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.501 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' VAL . . . . . 0.486 ' CG2' ' HB1' ' C' ' 135' ' ' ALA . 0.8 OUTLIER -130.88 131.95 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 123.094 0.558 . . . . 0.0 111.866 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' GLN . . . . . 0.726 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 1.5 tt0 -98.49 151.46 20.58 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.897 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.525 ' N ' ' HG2' ' C' ' 102' ' ' GLN . 0.3 OUTLIER -117.33 128.64 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.58 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 0.3 OUTLIER -102.98 133.46 48.05 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.654 0.264 . . . . 0.0 111.033 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . 0.71 ' HB3' HG22 ' C' ' 107' ' ' THR . 7.2 t0 -87.74 158.44 18.79 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.636 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' C' ' 106' ' ' ARG . 7.9 ttp85 -70.5 -27.72 64.42 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.714 0.293 . . . . 0.0 111.02 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . 0.71 HG22 ' HB3' ' C' ' 105' ' ' ASP . 2.8 t -51.68 -25.68 7.73 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.096 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.16 -39.29 1.73 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.617 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.26 157.99 17.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.836 0.351 . . . . 0.0 111.065 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -70.32 137.07 50.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.111 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' LEU . . . . . 0.657 HD21 ' HA ' ' C' ' 72' ' ' ALA . 13.5 tp -87.56 158.47 18.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.382 0.611 . . . . 0.0 110.499 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' THR . . . . . 0.998 HG23 HG21 ' C' ' 117' ' ' THR . 0.5 OUTLIER -101.76 141.97 33.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.123 179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' C' ' 73' ' ' PHE . 1.9 mt -82.43 65.6 7.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 0.0 110.708 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.08 -14.93 21.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.528 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.19 -54.11 0.71 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.678 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.17 28.83 8.35 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.017 0.437 . . . . 0.0 111.721 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . 0.998 HG21 HG23 ' C' ' 112' ' ' THR . 0.0 OUTLIER -88.72 76.6 8.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.24 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' C' ' 71' ' ' VAL . 91.3 m-85 -91.13 96.77 10.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.724 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 68.6 m -132.65 78.25 1.79 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.818 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.67 136.88 3.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.692 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.02 76.19 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.267 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.88 135.56 33.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.703 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 11.8 m -77.05 96.33 4.4 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.73 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . 0.738 ' O ' HG23 ' C' ' 63' ' ' THR . 10.8 tp -68.25 132.92 47.99 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.627 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -128.49 166.83 18.02 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.569 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' C' ' 61' ' ' CYS . 6.3 t30 -79.43 105.76 10.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.696 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.05 -137.06 5.22 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.655 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 3.7 m -103.62 83.49 2.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.688 0.28 . . . . 0.0 110.778 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 129' ' ' ASN . . . . . 0.686 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 1.7 t30 -71.12 139.92 50.45 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.959 0.409 . . . . 0.0 111.099 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . 0.886 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.2 OUTLIER -134.0 139.7 46.23 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.024 -179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 131' ' ' ILE . . . . . 0.621 HG21 HG11 ' C' ' 71' ' ' VAL . 61.9 mt -98.07 110.55 56.37 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 132' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -81.79 135.13 8.78 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.753 1.635 . . . . 0.0 112.596 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.71 152.67 41.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.773 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 134' ' ' GLN . . . . . 0.595 ' HB3' ' HB1' ' C' ' 51' ' ' ALA . 50.6 mt-30 -119.01 156.9 28.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.07 179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.726 ' HA ' ' O ' ' C' ' 102' ' ' GLN . . . -151.43 101.67 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 0.0 111.633 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.61 168.28 9.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.359 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 137' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' C' ' 48' ' ' THR . 0.3 OUTLIER -79.98 123.23 27.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.192 179.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 138' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' C' ' 47' ' ' ALA . 1.3 t80 -126.11 119.05 26.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.085 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 139' ' ' ALA . . . . . 0.743 ' HB2' HD23 ' C' ' 42' ' ' LEU . . . -111.95 125.21 53.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.954 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 140' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.17 64.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.543 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . 0.439 ' H ' ' HB3' ' C' ' 98' ' ' ASN . . . -133.15 -120.0 2.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.043 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.43 111.89 18.19 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.559 0.219 . . . . 0.0 110.708 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 143' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -61.88 113.78 2.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.794 0.331 . . . . 0.0 111.39 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 144' ' ' THR . . . . . 0.771 ' HB ' ' H ' ' C' ' 97' ' ' THR . 75.5 m -88.18 145.24 35.65 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.366 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.87 134.19 7.12 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.499 2.132 . . . . 0.0 112.005 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.93 -135.55 4.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.502 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 147' ' ' ALA . . . . . 0.703 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -96.24 134.23 39.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.881 0.372 . . . . 0.0 111.336 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 148' ' ' ALA . . . . . 0.891 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -129.85 50.49 2.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.161 0.505 . . . . 0.0 110.456 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 149' ' ' ASN . . . . . 0.498 HD22 ' HG2' ' B' ' 13' ' ' LYS . 3.5 m120 -98.95 146.15 26.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.555 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 150' ' ' ALA . . . . . 0.986 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -154.9 174.11 15.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.986 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 151' ' ' ASP . . . . . 0.488 ' C ' HD11 ' C' ' 86' ' ' LEU . 26.9 t70 -139.28 128.48 23.95 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.186 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' C' ' 74' ' ' LEU . . . -118.43 133.35 55.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.11 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . 0.721 HG23 HG22 ' B' ' 9' ' ' THR . 0.2 OUTLIER -91.97 147.41 22.98 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.118 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.26 130.25 53.44 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.125 0.488 . . . . 0.0 110.062 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -126.67 143.9 51.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.954 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 156' ' ' VAL . . . . . 0.524 HG12 ' CD1' ' C' ' 131' ' ' ILE . 27.3 m -127.35 151.92 34.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.69 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . 0.683 ' HA ' ' O ' ' B' ' 3' ' ' THR . 0.0 OUTLIER -141.34 121.15 13.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.298 0.57 . . . . 0.0 110.37 -179.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . 0.577 ' CD2' ' HB ' ' B' ' 3' ' ' THR . 1.2 m-85 -98.26 121.63 40.42 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.56 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.808 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 111.261 0.097 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.62 71.14 0.5 Allowed 'General case' 0 N--CA 1.462 0.157 0 O-C-N 123.107 0.254 . . . . 0.0 110.96 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' E' ' 157' ' ' GLN . 4.8 m -114.68 127.32 55.69 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.475 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 20.2 m -117.7 106.77 13.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.633 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.458 HG21 HG12 ' E' ' 17' ' ' VAL . 0.0 OUTLIER -133.91 174.64 12.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.567 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.13 119.83 36.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.586 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.2 -49.49 15.71 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.839 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.26 -154.82 11.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.848 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . 0.709 HG22 HG23 ' E' ' 153' ' ' THR . 2.7 p -142.49 140.04 31.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.983 0.421 . . . . 0.0 111.176 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.73 113.89 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.151 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.14 110.39 20.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.363 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.3 111.48 22.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.74 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' LYS . . . . . 0.492 ' HG2' HD22 ' E' ' 149' ' ' ASN . 3.6 tmtm? -102.96 110.5 22.44 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.453 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.19 168.31 22.6 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.014 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' GLU . . . . . 0.687 ' O ' ' HA ' ' E' ' 36' ' ' GLN . 3.6 tt0 -158.99 133.07 7.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.93 0.395 . . . . 0.0 110.4 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.89 HG23 ' HB2' ' E' ' 148' ' ' ALA . 13.2 t -99.65 143.14 14.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.286 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.539 HG13 ' HG2' ' E' ' 36' ' ' GLN . 3.9 m -141.33 -172.11 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.862 0.363 . . . . 0.0 111.074 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.49 -176.91 5.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.034 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.87 46.95 1.36 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.106 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.77 -29.97 2.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.988 0.423 . . . . 0.0 111.467 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER -163.14 158.38 21.74 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.915 -179.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . 0.565 ' HB1' ' O ' ' E' ' 36' ' ' GLN . . . -161.35 118.54 2.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.103 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' D' ' 58' ' ' LEU . 0.8 OUTLIER -66.25 152.99 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.065 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -84.68 158.77 20.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.611 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.559 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -61.03 -34.47 74.9 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.344 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.05 13.03 63.77 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.929 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.78 -22.43 10.7 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.776 0.322 . . . . 0.0 110.773 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . 0.485 HG11 ' HE3' ' D' ' 13' ' ' LYS . 19.8 t -44.04 -64.25 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.339 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.04 135.9 41.74 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.932 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -139.26 125.64 20.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.049 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.77 106.56 18.84 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.044 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.78 117.08 53.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.105 0.478 . . . . 0.0 110.431 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.74 131.09 45.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.527 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.8 -47.35 7.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.631 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.38 -163.56 12.16 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.564 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' GLN . . . . . 0.674 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 3.7 mt-30 -101.0 126.61 47.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.703 0.287 . . . . 0.0 110.83 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.455 HG21 HD13 ' D' ' 42' ' ' LEU . 14.9 p -110.42 146.83 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.934 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . 0.625 HH22 ' HB2' ' C' ' 62' ' ' ASP . 2.9 mtp180 -82.87 139.17 33.6 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.7 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.484 ' HA ' ' HB3' ' D' ' 143' ' ' ALA . 5.4 t -62.78 -37.53 87.03 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.745 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.4 -31.5 71.41 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.125 0.488 . . . . 0.0 110.896 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.99 -17.77 45.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.165 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.742 HD23 ' HB2' ' D' ' 139' ' ' ALA . 4.3 mp -125.66 33.11 5.17 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.609 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.76 18.9 18.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.298 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.94 130.26 52.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.34 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' D' ' 140' ' ' THR . 22.5 tt0 -56.29 107.32 0.36 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.884 0.373 . . . . 0.0 111.088 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.62 30.5 5.84 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.111 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' D' ' 138' ' ' PHE . . . -76.56 136.71 39.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.973 0.415 . . . . 0.0 112.109 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' D' ' 137' ' ' TYR . 52.3 p -134.94 134.71 40.88 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.879 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.527 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 70.7 m -108.76 -168.16 1.31 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.641 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 92' ' ' ALA . 23.3 t -63.99 128.52 36.17 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.743 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' D' ' 134' ' ' GLN . . . -80.42 130.02 34.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.467 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' VAL . . . . . 0.775 ' HB ' ' HA ' ' A' ' 90' ' ' SER . 2.8 m -74.85 151.28 6.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.04 119.23 5.66 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.516 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -153.9 152.12 30.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.788 0.328 . . . . 0.0 110.837 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -148.77 162.94 38.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.693 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.606 HG23 ' O ' ' D' ' 56' ' ' ILE . 1.2 tp -105.91 114.76 46.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.563 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' GLN . . . . . 0.859 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.0 OUTLIER -70.65 124.51 24.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.744 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' D' ' 23' ' ' VAL . 0.2 OUTLIER -132.28 88.69 2.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.281 -179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . 0.598 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 0.1 OUTLIER -75.25 169.47 17.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.92 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' ASP . . . . . 0.401 ' CG ' ' HD2' ' E' ' 38' ' ' ARG . 0.4 OUTLIER 66.26 68.32 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.78 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' CYS . . . . . 0.996 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 56.2 m -117.13 155.07 29.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.778 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . 0.624 ' HB2' HH22 ' E' ' 38' ' ' ARG . 19.9 t70 -135.75 155.66 50.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.277 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.729 HG23 ' O ' ' D' ' 124' ' ' LEU . 0.2 OUTLIER -111.11 -34.25 6.24 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.05 -22.14 66.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.952 0.406 . . . . 0.0 111.729 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.62 -59.49 2.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.74 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.575 ' HB3' HD23 ' D' ' 124' ' ' LEU . . . -116.82 129.16 55.91 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.623 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.21 -60.23 2.22 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.878 0.371 . . . . 0.0 111.001 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.21 -175.34 2.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.456 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.96 131.36 9.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.59 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . 0.462 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -105.96 151.18 24.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.104 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . 0.615 HG11 HG21 ' D' ' 131' ' ' ILE . 2.0 t -129.52 158.3 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.754 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' ALA . . . . . 0.627 ' HA ' HD21 ' D' ' 111' ' ' LEU . . . -152.68 143.08 22.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.584 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' PHE . . . . . 0.603 ' HB3' HD23 ' D' ' 113' ' ' LEU . 0.1 OUTLIER -112.33 141.46 46.02 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.691 0.281 . . . . 0.0 111.004 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.3 OUTLIER -107.69 139.52 42.13 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.018 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.79 -179.44 46.94 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.816 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.98 156.28 17.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.613 0.245 . . . . 0.0 110.767 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.3 118.38 21.17 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.969 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 78' ' ' ILE . . . . . 0.559 HG22 ' HB3' ' D' ' 82' ' ' HIS . 0.4 OUTLIER -59.01 -29.1 40.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.871 179.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.449 ' HB2' HG21 ' D' ' 140' ' ' THR . 0.1 OUTLIER -151.76 50.47 0.81 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.774 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.17 -89.88 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.09 -32.51 42.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.621 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . 0.559 ' HB3' HG22 ' D' ' 78' ' ' ILE . 0.3 OUTLIER -81.08 62.86 5.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 110.406 179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.63 -18.18 60.59 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.558 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . 0.716 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 20.4 p-10 -76.04 -7.4 54.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.176 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.489 ' HB ' ' CG2' ' D' ' 78' ' ' ILE . 24.0 t -117.73 124.14 72.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.243 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.955 HD22 ' HB1' ' D' ' 150' ' ' ALA . 0.5 OUTLIER -66.15 139.35 58.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.713 0.292 . . . . 0.0 110.243 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' D' ' 78' ' ' ILE . . . -84.88 -165.44 1.2 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.693 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.774 ' HG ' ' HB3' ' D' ' 95' ' ' SER . 0.7 OUTLIER -71.84 168.65 17.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.067 179.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.96 -79.23 0.06 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.263 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 2.3 p -168.81 5.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.986 0.422 . . . . 0.0 111.472 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' D' ' 95' ' ' SER . 70.3 m -77.47 83.22 3.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.11 -34.62 63.84 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.878 0.371 . . . . 0.0 111.633 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.24 31.5 6.32 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.687 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.57 7.39 0.23 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.881 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 95' ' ' SER . . . . . 0.774 ' HB3' ' HG ' ' D' ' 88' ' ' LEU . 0.6 OUTLIER -110.71 -174.33 2.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 110.651 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 96' ' ' ALA . . . . . 0.418 ' O ' HD21 ' D' ' 88' ' ' LEU . . . -97.78 179.01 4.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.931 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . 0.788 ' H ' ' HB ' ' D' ' 144' ' ' THR . 1.1 m -132.24 125.92 32.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.369 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 98' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' D' ' 97' ' ' THR . 66.0 m-20 66.68 25.87 9.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.38 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.66 130.34 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.691 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.13 -161.38 10.76 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.485 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 101' ' ' VAL . . . . . 0.483 ' CG2' ' HB1' ' D' ' 135' ' ' ALA . 0.8 OUTLIER -130.84 131.94 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 123.12 0.568 . . . . 0.0 111.842 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 102' ' ' GLN . . . . . 0.724 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 1.5 tt0 -98.52 151.45 20.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.906 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 103' ' ' ILE . . . . . 0.525 ' N ' ' HG2' ' D' ' 102' ' ' GLN . 0.3 OUTLIER -117.3 128.65 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.499 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 104' ' ' LEU . . . . . 0.802 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 0.3 OUTLIER -102.94 133.5 47.94 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.559 0.219 . . . . 0.0 111.051 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . 0.723 ' HB3' HG22 ' D' ' 107' ' ' THR . 7.1 t0 -87.73 158.47 18.79 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.685 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 106' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -70.56 -27.71 64.34 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.806 0.336 . . . . 0.0 111.047 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 107' ' ' THR . . . . . 0.723 HG22 ' HB3' ' D' ' 105' ' ' ASP . 2.8 t -51.69 -25.7 7.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.09 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.19 -39.27 1.73 Allowed Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.557 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.27 158.0 17.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.352 . . . . 0.0 111.013 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -70.37 137.17 50.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.099 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 111' ' ' LEU . . . . . 0.627 HD21 ' HA ' ' D' ' 72' ' ' ALA . 13.5 tp -87.56 158.35 18.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.304 0.574 . . . . 0.0 110.529 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 112' ' ' THR . . . . . 1.035 HG23 HG21 ' D' ' 117' ' ' THR . 0.5 OUTLIER -101.72 142.01 33.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.095 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 113' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' D' ' 73' ' ' PHE . 1.9 mt -82.45 65.63 7.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 0.0 110.775 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.07 -15.01 21.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.485 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.23 -54.14 0.71 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.705 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.16 28.88 8.31 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.068 0.461 . . . . 0.0 111.756 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 117' ' ' THR . . . . . 1.035 HG21 HG23 ' D' ' 112' ' ' THR . 0.0 OUTLIER -88.81 76.62 7.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.186 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' D' ' 71' ' ' VAL . 91.5 m-85 -91.06 96.79 10.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.733 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 67.8 m -132.69 78.31 1.79 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.704 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.7 136.85 3.8 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.717 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -115.02 76.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.307 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.98 135.54 33.62 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.662 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 11.7 m -77.05 96.33 4.4 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.764 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . 0.729 ' O ' HG23 ' D' ' 63' ' ' THR . 10.8 tp -68.15 132.92 48.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.628 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -128.49 166.81 18.06 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.561 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 126' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' D' ' 61' ' ' CYS . 6.2 t30 -79.44 105.76 10.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.665 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.03 -136.99 5.19 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.734 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 128' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 3.7 m -103.72 83.44 2.14 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.716 0.293 . . . . 0.0 110.808 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 129' ' ' ASN . . . . . 0.694 ' HB2' ' SG ' ' D' ' 61' ' ' CYS . 1.7 t30 -71.04 139.85 50.57 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.899 0.38 . . . . 0.0 111.17 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 130' ' ' THR . . . . . 1.026 HG21 HD21 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -133.92 139.57 46.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.147 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 131' ' ' ILE . . . . . 0.615 HG21 HG11 ' D' ' 71' ' ' VAL . 61.8 mt -97.9 110.49 55.83 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 132' ' ' PRO . . . . . 0.768 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 7.6 Cg_endo -81.88 135.18 8.72 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.772 1.648 . . . . 0.0 112.562 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.74 152.65 41.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.802 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 134' ' ' GLN . . . . . 0.588 ' HB3' ' HB1' ' D' ' 51' ' ' ALA . 50.6 mt-30 -118.94 156.95 28.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.092 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.733 ' HB3' HG22 ' D' ' 52' ' ' VAL . . . -151.42 101.71 2.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 111.648 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.56 168.29 9.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.352 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 137' ' ' TYR . . . . . 0.486 ' O ' ' HA ' ' D' ' 48' ' ' THR . 0.3 OUTLIER -80.11 123.34 27.8 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.149 179.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 138' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' D' ' 47' ' ' ALA . 1.3 t80 -126.19 119.05 26.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.998 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 139' ' ' ALA . . . . . 0.742 ' HB2' HD23 ' D' ' 42' ' ' LEU . . . -111.98 125.17 53.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.904 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 140' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.23 63.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.494 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . 0.444 ' H ' ' HB3' ' D' ' 98' ' ' ASN . . . -133.06 -120.03 2.08 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.137 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.36 111.94 18.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.628 0.252 . . . . 0.0 110.718 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 143' ' ' ALA . . . . . 0.709 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -61.96 113.84 3.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.82 0.343 . . . . 0.0 111.377 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 144' ' ' THR . . . . . 0.788 ' HB ' ' H ' ' D' ' 97' ' ' THR . 75.4 m -88.27 145.28 35.56 Favored Pre-proline 0 CA--C 1.532 0.266 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.323 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.86 134.17 7.12 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.533 2.156 . . . . 0.0 111.992 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.93 -135.63 4.42 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.499 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 147' ' ' ALA . . . . . 0.689 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -96.13 134.26 39.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.905 0.383 . . . . 0.0 111.362 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 148' ' ' ALA . . . . . 0.872 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -129.89 50.51 2.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.413 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 149' ' ' ASN . . . . . 0.494 HD22 ' HG2' ' C' ' 13' ' ' LYS . 3.5 m120 -98.99 146.14 26.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.489 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 150' ' ' ALA . . . . . 0.955 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -154.95 174.17 15.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.92 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 151' ' ' ASP . . . . . 0.495 ' C ' HD11 ' D' ' 86' ' ' LEU . 26.8 t70 -139.34 128.4 23.74 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.184 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 152' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' D' ' 74' ' ' LEU . . . -118.37 133.34 55.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.126 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 153' ' ' THR . . . . . 0.74 HG23 HG22 ' C' ' 9' ' ' THR . 0.2 OUTLIER -91.97 147.42 22.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.127 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.27 130.33 53.43 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.169 0.509 . . . . 0.0 110.022 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -126.67 143.97 51.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.945 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 156' ' ' VAL . . . . . 0.523 HG12 ' CD1' ' D' ' 131' ' ' ILE . 27.4 m -127.45 151.87 34.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.85 0.357 . . . . 0.0 111.643 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 157' ' ' GLN . . . . . 0.687 ' HA ' ' O ' ' C' ' 3' ' ' THR . 0.0 OUTLIER -141.36 121.22 13.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.295 0.569 . . . . 0.0 110.372 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . 0.57 ' CD2' ' HB ' ' C' ' 3' ' ' THR . 1.2 m-85 -98.29 121.67 40.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.564 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.804 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 111.27 0.1 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.64 71.06 0.51 Allowed 'General case' 0 N--CA 1.462 0.149 0 O-C-N 123.109 0.256 . . . . 0.0 110.959 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 3' ' ' THR . . . . . 0.688 ' O ' ' HA ' ' F' ' 157' ' ' GLN . 4.9 m -114.7 127.36 55.71 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.499 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 20.8 m -117.74 106.86 13.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.577 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.453 HG21 HG12 ' F' ' 17' ' ' VAL . 0.0 OUTLIER -133.98 174.66 12.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.601 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -97.05 119.81 36.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.581 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.2 -49.49 15.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.822 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.32 -154.88 11.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.755 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 9' ' ' THR . . . . . 0.723 HG22 HG23 ' F' ' 153' ' ' THR . 2.7 p -142.43 139.95 31.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.904 0.383 . . . . 0.0 111.291 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 43.5 t -120.71 113.83 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.161 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -87.11 110.32 20.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.36 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -90.21 111.51 22.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.752 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 13' ' ' LYS . . . . . 0.497 ' HG2' HD22 ' F' ' 149' ' ' ASN . 3.6 tmtm? -102.98 110.56 22.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.488 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.22 168.36 22.59 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.053 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 15' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' F' ' 36' ' ' GLN . 3.6 tt0 -159.02 133.08 7.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.923 0.392 . . . . 0.0 110.438 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 16' ' ' VAL . . . . . 0.896 HG23 ' HB2' ' F' ' 148' ' ' ALA . 13.2 t -99.67 143.15 14.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.261 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . 0.524 HG13 ' HG2' ' F' ' 36' ' ' GLN . 3.9 m -141.34 -172.13 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.874 0.368 . . . . 0.0 111.057 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.48 -176.96 5.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.046 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.73 46.85 1.36 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.77 -30.0 2.56 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.9 0.381 . . . . 0.0 111.466 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 21' ' ' CYS . . . . . 1.014 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER -163.07 158.45 22.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.943 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 22' ' ' ALA . . . . . 0.568 ' HB1' ' O ' ' F' ' 36' ' ' GLN . . . -161.42 118.49 2.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.044 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 23' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' E' ' 58' ' ' LEU . 0.8 OUTLIER -66.23 153.02 8.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.05 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -84.7 158.74 20.7 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.59 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . 0.554 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -61.04 -34.34 74.72 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.388 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.18 13.07 63.54 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.936 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.76 -22.44 10.7 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.798 0.333 . . . . 0.0 110.746 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 28' ' ' VAL . . . . . 0.492 HG11 ' HE3' ' E' ' 13' ' ' LYS . 19.8 t -44.02 -64.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.319 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.0 135.72 42.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.02 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -139.11 125.72 20.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.78 106.53 18.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.108 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.78 117.06 53.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.147 0.499 . . . . 0.0 110.44 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.67 131.01 45.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.61 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.75 -47.29 7.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.682 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.3 -163.61 12.15 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.573 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 36' ' ' GLN . . . . . 0.687 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 3.7 mt-30 -100.97 126.61 47.64 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.717 0.294 . . . . 0.0 110.842 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.453 HG21 HD13 ' E' ' 42' ' ' LEU . 14.9 p -110.38 146.85 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.983 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . 0.624 HH22 ' HB2' ' D' ' 62' ' ' ASP . 2.9 mtp180 -82.96 139.23 33.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.632 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 39' ' ' THR . . . . . 0.501 ' HA ' ' HB3' ' E' ' 143' ' ' ALA . 5.4 t -62.78 -37.52 86.99 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.724 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.48 -31.47 71.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.12 0.486 . . . . 0.0 110.867 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.99 -17.74 45.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.196 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.741 HD23 ' HB2' ' E' ' 139' ' ' ALA . 4.3 mp -125.68 33.05 5.18 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.631 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.71 18.86 18.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.333 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.92 130.29 52.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.309 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' E' ' 140' ' ' THR . 22.4 tt0 -56.35 107.38 0.37 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.362 . . . . 0.0 111.059 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.52 30.53 5.85 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.183 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 47' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' E' ' 138' ' ' PHE . . . -76.61 136.75 39.21 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.976 0.417 . . . . 0.0 112.123 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' E' ' 137' ' ' TYR . 52.2 p -134.96 134.69 40.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.888 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.53 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 71.6 m -108.82 -168.21 1.32 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.565 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 50' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' B' ' 92' ' ' ALA . 23.1 t -63.9 128.43 35.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.783 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 51' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' E' ' 134' ' ' GLN . . . -80.38 129.99 34.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.447 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 52' ' ' VAL . . . . . 0.764 ' HB ' ' HA ' ' B' ' 90' ' ' SER . 2.8 m -74.87 151.22 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.9 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.01 119.22 5.67 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.578 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.85 152.1 30.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.728 0.299 . . . . 0.0 110.966 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -148.77 162.89 38.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.653 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 56' ' ' ILE . . . . . 0.603 HG23 ' O ' ' E' ' 56' ' ' ILE . 1.2 tp -105.87 114.86 46.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.567 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 57' ' ' GLN . . . . . 0.855 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.0 OUTLIER -70.72 124.58 24.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.695 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' E' ' 23' ' ' VAL . 0.2 OUTLIER -132.36 88.76 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.242 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . 0.592 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 0.1 OUTLIER -75.34 169.41 18.11 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 60' ' ' ASP . . . . . 0.409 ' CG ' ' HD2' ' F' ' 38' ' ' ARG . 0.4 OUTLIER 66.38 68.3 0.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.746 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 61' ' ' CYS . . . . . 1.014 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 56.1 m -117.15 155.03 30.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.797 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . 0.618 ' HB2' HH22 ' F' ' 38' ' ' ARG . 20.1 t70 -135.8 155.65 50.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.274 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 63' ' ' THR . . . . . 0.73 HG23 ' O ' ' E' ' 124' ' ' LEU . 0.2 OUTLIER -111.08 -34.22 6.25 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.12 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.05 -22.18 66.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.067 0.46 . . . . 0.0 111.718 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.63 -59.49 2.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.709 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . 0.559 ' HB3' HD23 ' E' ' 124' ' ' LEU . . . -116.86 129.18 55.91 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.628 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -60.35 2.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.896 0.379 . . . . 0.0 110.978 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.15 -175.37 2.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.537 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.96 131.32 9.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.588 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -105.97 151.19 24.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.073 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . 0.622 HG11 HG21 ' E' ' 131' ' ' ILE . 2.0 t -129.44 158.35 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.778 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . 0.628 ' HA ' HD21 ' E' ' 111' ' ' LEU . . . -152.71 143.06 22.56 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.599 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 73' ' ' PHE . . . . . 0.608 ' HB3' HD23 ' E' ' 113' ' ' LEU . 0.1 OUTLIER -112.29 141.43 46.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.542 0.21 . . . . 0.0 111.105 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 74' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.3 OUTLIER -107.7 139.49 42.18 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.992 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.76 -179.43 46.92 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.815 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -104.01 156.34 17.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.619 0.247 . . . . 0.0 110.79 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.35 118.37 21.19 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.934 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 78' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' E' ' 82' ' ' HIS . 0.4 OUTLIER -58.97 -29.14 40.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.895 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 79' ' ' ASP . . . . . 0.449 ' HB2' HG21 ' E' ' 140' ' ' THR . 0.1 OUTLIER -151.72 50.4 0.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.838 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.25 -89.9 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.103 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.03 -32.53 42.53 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.64 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 82' ' ' HIS . . . . . 0.564 ' HB3' HG22 ' E' ' 78' ' ' ILE . 0.3 OUTLIER -81.12 62.81 5.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.826 0.346 . . . . 0.0 110.376 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.61 -18.09 60.61 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.599 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 84' ' ' ASN . . . . . 0.705 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 20.4 p-10 -76.1 -7.37 54.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.239 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.476 ' HB ' ' CG2' ' E' ' 78' ' ' ILE . 23.8 t -117.75 124.14 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.172 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 86' ' ' LEU . . . . . 0.982 HD22 ' HB1' ' E' ' 150' ' ' ALA . 0.5 OUTLIER -66.14 139.38 58.14 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.262 179.409 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 87' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' E' ' 78' ' ' ILE . . . -84.92 -165.41 1.19 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.667 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.771 ' HG ' ' HB3' ' E' ' 95' ' ' SER . 0.7 OUTLIER -71.92 168.64 17.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.977 179.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.89 -79.23 0.06 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.308 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p -168.81 5.94 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.918 0.389 . . . . 0.0 111.506 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 91' ' ' SER . . . . . 0.612 ' O ' ' HB2' ' E' ' 95' ' ' SER . 70.2 m -77.57 83.22 3.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.932 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.07 -34.7 63.83 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.875 0.369 . . . . 0.0 111.57 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.23 31.5 6.32 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.635 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.58 7.44 0.23 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.965 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 95' ' ' SER . . . . . 0.771 ' HB3' ' HG ' ' E' ' 88' ' ' LEU . 0.6 OUTLIER -110.69 -174.32 2.45 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.911 0.386 . . . . 0.0 110.669 179.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 96' ' ' ALA . . . . . 0.432 ' O ' HD21 ' E' ' 88' ' ' LEU . . . -97.76 178.96 4.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . 0.796 ' H ' ' HB ' ' E' ' 144' ' ' THR . 1.1 m -132.25 125.99 32.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.368 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 98' ' ' ASN . . . . . 0.438 ' HB3' ' H ' ' E' ' 141' ' ' GLY . 66.1 m-20 66.64 25.84 9.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.45 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.74 130.37 70.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.691 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.15 -161.38 10.77 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.463 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 101' ' ' VAL . . . . . 0.497 ' CG2' ' HB1' ' E' ' 135' ' ' ALA . 0.8 OUTLIER -130.89 131.97 64.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.025 0.53 . . . . 0.0 111.773 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 102' ' ' GLN . . . . . 0.724 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 1.5 tt0 -98.48 151.47 20.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.882 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 103' ' ' ILE . . . . . 0.527 ' N ' ' HG2' ' E' ' 102' ' ' GLN . 0.3 OUTLIER -117.36 128.73 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.498 179.439 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 104' ' ' LEU . . . . . 0.796 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 0.3 OUTLIER -103.03 133.5 48.05 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.62 0.248 . . . . 0.0 111.108 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . 0.716 ' HB3' HG22 ' E' ' 107' ' ' THR . 7.1 t0 -87.73 158.37 18.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.67 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 106' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' E' ' 106' ' ' ARG . 7.9 ttp85 -70.49 -27.68 64.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.778 0.323 . . . . 0.0 111.096 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . 0.716 HG22 ' HB3' ' E' ' 105' ' ' ASP . 2.8 t -51.71 -25.72 7.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.058 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.21 -39.31 1.72 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.572 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.25 158.01 17.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.852 0.358 . . . . 0.0 111.074 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . 0.796 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -70.36 137.17 50.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.119 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.628 HD21 ' HA ' ' E' ' 72' ' ' ALA . 13.5 tp -87.52 158.31 18.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.347 0.594 . . . . 0.0 110.49 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 112' ' ' THR . . . . . 1.043 HG23 HG21 ' E' ' 117' ' ' THR . 0.5 OUTLIER -101.73 141.98 33.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.107 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 113' ' ' LEU . . . . . 0.608 HD23 ' HB3' ' E' ' 73' ' ' PHE . 1.9 mt -82.43 65.61 7.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 0.0 110.778 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.04 -15.05 21.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.478 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.29 -54.21 0.7 Allowed Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.668 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.06 28.79 8.39 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.028 0.442 . . . . 0.0 111.741 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 117' ' ' THR . . . . . 1.043 HG21 HG23 ' E' ' 112' ' ' THR . 0.0 OUTLIER -88.74 76.66 7.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.225 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' E' ' 71' ' ' VAL . 91.6 m-85 -91.11 96.75 10.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.781 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 68.6 m -132.62 78.24 1.79 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.828 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.67 136.91 3.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.662 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.06 76.21 0.98 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.294 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.88 135.59 33.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.674 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 11.8 m -77.09 96.36 4.43 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.738 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . 0.73 ' O ' HG23 ' E' ' 63' ' ' THR . 10.8 tp -68.24 132.97 48.07 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.591 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -128.5 166.78 18.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.603 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' E' ' 61' ' ' CYS . 6.3 t30 -79.4 105.66 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.683 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.08 -137.08 5.22 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.652 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 128' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 3.7 m -103.65 83.44 2.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.688 0.28 . . . . 0.0 110.832 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 129' ' ' ASN . . . . . 0.693 ' HB2' ' SG ' ' E' ' 61' ' ' CYS . 1.7 t30 -71.0 139.87 50.65 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.905 0.383 . . . . 0.0 111.163 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 130' ' ' THR . . . . . 0.979 HG21 HD21 ' B' ' 74' ' ' LEU . 0.2 OUTLIER -133.91 139.66 46.3 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.161 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 131' ' ' ILE . . . . . 0.622 HG21 HG11 ' E' ' 71' ' ' VAL . 61.8 mt -98.03 110.48 56.01 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 132' ' ' PRO . . . . . 0.767 ' HB3' ' HA ' ' B' ' 76' ' ' THR . 7.6 Cg_endo -81.86 135.16 8.73 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 121.792 1.661 . . . . 0.0 112.533 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.76 152.64 41.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.815 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 134' ' ' GLN . . . . . 0.587 ' HB3' ' HB1' ' E' ' 51' ' ' ALA . 50.5 mt-30 -118.97 156.86 28.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.099 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . 0.728 ' HB3' HG22 ' E' ' 52' ' ' VAL . . . -151.39 101.71 2.85 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 111.649 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.58 168.32 9.17 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.404 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 137' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' E' ' 48' ' ' THR . 0.3 OUTLIER -80.04 123.24 27.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.175 179.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 138' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' E' ' 47' ' ' ALA . 1.3 t80 -126.13 119.13 26.74 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.064 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 139' ' ' ALA . . . . . 0.741 ' HB2' HD23 ' E' ' 42' ' ' LEU . . . -111.98 125.22 53.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.867 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 140' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 0.2 OUTLIER -68.89 -48.24 63.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.546 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . 0.438 ' H ' ' HB3' ' E' ' 98' ' ' ASN . . . -133.1 -119.96 2.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.085 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.42 111.96 18.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.612 0.244 . . . . 0.0 110.718 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 143' ' ' ALA . . . . . 0.719 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -61.95 113.89 3.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.803 0.335 . . . . 0.0 111.361 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 144' ' ' THR . . . . . 0.796 ' HB ' ' H ' ' E' ' 97' ' ' THR . 73.7 m -88.34 145.31 35.49 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.324 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 145' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' E' ' 144' ' ' THR . 1.3 Cg_endo -82.86 134.22 7.14 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.463 2.109 . . . . 0.0 112.019 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.87 -135.62 4.43 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.535 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 147' ' ' ALA . . . . . 0.679 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -96.12 134.19 39.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.392 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 148' ' ' ALA . . . . . 0.89 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -129.8 50.51 2.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.131 0.491 . . . . 0.0 110.474 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 149' ' ' ASN . . . . . 0.492 HD22 ' HG2' ' D' ' 13' ' ' LYS . 3.5 m120 -98.97 146.13 26.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.501 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 150' ' ' ALA . . . . . 0.982 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -154.96 174.13 15.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.875 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 151' ' ' ASP . . . . . 0.483 ' C ' HD11 ' E' ' 86' ' ' LEU . 26.7 t70 -139.3 128.45 23.88 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.192 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 152' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' E' ' 74' ' ' LEU . . . -118.41 133.29 56.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.193 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 153' ' ' THR . . . . . 0.709 HG23 HG22 ' D' ' 9' ' ' THR . 0.2 OUTLIER -91.91 147.36 23.03 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.22 130.3 53.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.182 0.515 . . . . 0.0 110.054 -179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -126.63 143.91 51.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.911 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 156' ' ' VAL . . . . . 0.517 HG12 ' CD1' ' E' ' 131' ' ' ILE . 27.2 m -127.42 151.82 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.775 0.322 . . . . 0.0 111.729 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 157' ' ' GLN . . . . . 0.684 ' HA ' ' O ' ' D' ' 3' ' ' THR . 0.0 OUTLIER -141.34 121.19 13.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.326 0.584 . . . . 0.0 110.341 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . 0.573 ' CD2' ' HB ' ' D' ' 3' ' ' THR . 1.2 m-85 -98.31 121.66 40.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.532 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.82 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.251 0.072 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.72 71.03 0.51 Allowed 'General case' 0 CA--C 1.528 0.124 0 O-C-N 123.11 0.256 . . . . 0.0 110.972 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 4.9 m -114.69 127.38 55.73 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.433 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 20.7 m -117.82 106.74 13.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.587 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.86 174.71 12.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.577 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -97.11 119.89 36.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.553 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.34 -49.41 15.47 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.834 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.27 -154.87 11.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.982 -0.628 . . . . 0.0 111.862 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -142.46 140.07 31.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.985 0.421 . . . . 0.0 111.222 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 43.6 t -120.79 113.8 41.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.18 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -87.07 110.35 20.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.358 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -90.32 111.55 22.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.744 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 13' ' ' LYS . . . . . 0.485 ' HE3' HG11 ' F' ' 28' ' ' VAL . 3.7 tmtm? -102.97 110.6 22.58 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.39 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.25 168.38 22.6 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.962 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -159.09 133.02 7.53 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.893 0.378 . . . . 0.0 110.446 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 13.1 t -99.62 143.19 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.258 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 17' ' ' VAL . . . . . 0.453 HG12 HG21 ' E' ' 5' ' ' VAL . 3.9 m -141.41 -172.12 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.867 0.365 . . . . 0.0 110.987 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.51 -177.0 5.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.073 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . -90.83 47.01 1.37 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.073 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.77 -29.98 2.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.434 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 21' ' ' CYS . . . . . 0.992 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER -163.19 158.33 21.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.906 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.34 118.61 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.045 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 23' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' F' ' 58' ' ' LEU . 0.8 OUTLIER -66.29 153.06 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.986 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -84.82 158.72 20.58 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.606 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . 0.562 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -60.99 -34.43 74.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.386 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.08 13.11 63.65 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.97 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 2.4 t -112.83 -22.43 10.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.796 0.332 . . . . 0.0 110.701 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 28' ' ' VAL . . . . . 0.485 HG11 ' HE3' ' F' ' 13' ' ' LYS . 19.8 t -44.05 -64.2 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.368 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.1 135.92 41.78 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.925 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -139.23 125.72 20.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.008 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.79 106.51 18.79 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.06 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 t -108.76 117.05 53.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.196 0.522 . . . . 0.0 110.445 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -99.66 131.06 45.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.607 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -90.79 -47.41 7.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.616 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.39 -163.62 12.15 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.581 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 36' ' ' GLN . . . . . 0.688 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 3.7 mt-30 -100.97 126.59 47.63 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.688 0.28 . . . . 0.0 110.863 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.444 HG21 HD13 ' F' ' 42' ' ' LEU . 14.9 p -110.36 146.84 15.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.912 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 38' ' ' ARG . . . . . 0.618 HH22 ' HB2' ' E' ' 62' ' ' ASP . 2.8 mtp180 -82.9 139.14 33.59 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.678 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 39' ' ' THR . . . . . 0.506 ' HA ' ' HB3' ' F' ' 143' ' ' ALA . 5.4 t -62.71 -37.51 86.78 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.762 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.46 -31.49 71.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.095 0.474 . . . . 0.0 110.837 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.03 -17.73 45.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.147 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . 0.739 HD23 ' HB2' ' F' ' 139' ' ' ALA . 4.3 mp -125.69 33.08 5.17 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.671 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -100.7 18.84 18.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.365 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -122.95 130.36 52.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.313 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' F' ' 140' ' ' THR . 22.5 tt0 -56.36 107.32 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.864 0.364 . . . . 0.0 111.027 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.64 30.42 5.86 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.179 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 47' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' F' ' 138' ' ' PHE . . . -76.57 136.7 39.26 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.95 0.405 . . . . 0.0 112.071 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' F' ' 137' ' ' TYR . 52.3 p -134.92 134.66 40.87 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.891 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 49' ' ' SER . . . . . 0.538 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 70.8 m -108.68 -168.23 1.32 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.657 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 50' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' C' ' 92' ' ' ALA . 23.1 t -63.89 128.47 35.94 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.807 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 51' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' F' ' 134' ' ' GLN . . . -80.44 130.02 34.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.406 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 52' ' ' VAL . . . . . 0.769 ' HB ' ' HA ' ' C' ' 90' ' ' SER . 2.8 m -74.84 151.25 6.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.97 119.21 5.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.622 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 54' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -153.86 152.1 30.26 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.711 0.291 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 55' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -148.77 162.99 38.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.643 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 56' ' ' ILE . . . . . 0.605 HG23 ' O ' ' F' ' 56' ' ' ILE . 1.2 tp -105.92 114.76 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.585 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 57' ' ' GLN . . . . . 0.889 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.0 OUTLIER -70.61 124.51 24.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.761 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' F' ' 23' ' ' VAL . 0.2 OUTLIER -132.35 88.81 2.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.192 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 59' ' ' ASN . . . . . 0.585 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 0.1 OUTLIER -75.35 169.52 17.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.918 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.34 68.26 0.44 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.787 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 61' ' ' CYS . . . . . 0.992 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 56.3 m -117.13 155.02 30.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.829 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -135.8 155.67 49.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.227 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 63' ' ' THR . . . . . 0.726 HG23 ' O ' ' F' ' 124' ' ' LEU . 0.2 OUTLIER -111.13 -34.23 6.24 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -63.09 -22.1 66.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.069 0.461 . . . . 0.0 111.759 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 41.2 t -87.61 -59.56 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.744 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 66' ' ' ALA . . . . . 0.569 ' HB3' HD23 ' F' ' 124' ' ' LEU . . . -116.74 129.12 55.93 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.617 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.17 -60.27 2.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.959 0.409 . . . . 0.0 111.052 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.22 -175.41 2.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.47 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.93 131.34 9.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.607 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 70' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -106.02 151.19 24.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.025 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 71' ' ' VAL . . . . . 0.631 HG11 HG21 ' F' ' 131' ' ' ILE . 2.0 t -129.48 158.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.704 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 72' ' ' ALA . . . . . 0.657 ' HA ' HD21 ' F' ' 111' ' ' LEU . . . -152.66 143.02 22.57 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.626 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 73' ' ' PHE . . . . . 0.603 ' HB3' HD23 ' F' ' 113' ' ' LEU . 0.1 OUTLIER -112.23 141.44 45.94 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.663 0.268 . . . . 0.0 111.049 179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 74' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.3 OUTLIER -107.63 139.54 42.01 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.981 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.76 -179.51 46.87 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.83 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.92 156.34 17.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.535 0.207 . . . . 0.0 110.819 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.34 118.44 21.25 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.877 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 78' ' ' ILE . . . . . 0.564 HG22 ' HB3' ' F' ' 82' ' ' HIS . 0.4 OUTLIER -59.1 -29.08 40.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.834 179.612 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 79' ' ' ASP . . . . . 0.43 ' HB2' HG21 ' F' ' 140' ' ' THR . 0.1 OUTLIER -151.7 50.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.781 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 63.2 -89.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.095 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.09 -32.54 42.97 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.596 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 82' ' ' HIS . . . . . 0.564 ' HB3' HG22 ' F' ' 78' ' ' ILE . 0.3 OUTLIER -81.14 62.86 5.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.886 0.374 . . . . 0.0 110.414 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.53 -18.23 60.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.633 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 84' ' ' ASN . . . . . 0.705 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 20.4 p-10 -76.02 -7.4 54.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.258 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 85' ' ' VAL . . . . . 0.49 ' HB ' ' CG2' ' F' ' 78' ' ' ILE . 23.8 t -117.72 124.14 72.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.224 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 86' ' ' LEU . . . . . 0.959 HD22 ' HB1' ' F' ' 150' ' ' ALA . 0.5 OUTLIER -66.18 139.38 58.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.715 0.293 . . . . 0.0 110.266 179.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 87' ' ' ALA . . . . . 0.453 ' HB2' ' HA ' ' F' ' 78' ' ' ILE . . . -84.85 -165.37 1.17 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.741 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . 0.756 ' HG ' ' HB3' ' F' ' 95' ' ' SER . 0.7 OUTLIER -71.87 168.65 17.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.056 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.91 -79.18 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.351 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 2.4 p -168.87 6.0 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.032 0.444 . . . . 0.0 111.549 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 91' ' ' SER . . . . . 0.609 ' O ' ' HB2' ' F' ' 95' ' ' SER . 69.4 m -77.62 83.24 4.01 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.04 -34.67 63.73 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.606 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -121.26 31.5 6.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.58 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.63 7.59 0.23 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.907 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 95' ' ' SER . . . . . 0.756 ' HB3' ' HG ' ' F' ' 88' ' ' LEU . 0.6 OUTLIER -110.87 -174.32 2.45 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.834 0.349 . . . . 0.0 110.553 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 96' ' ' ALA . . . . . 0.431 ' O ' HD21 ' F' ' 88' ' ' LEU . . . -97.76 179.0 4.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.909 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . 0.784 ' H ' ' HB ' ' F' ' 144' ' ' THR . 1.1 m -132.32 125.98 32.24 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.316 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 98' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' F' ' 97' ' ' THR . 66.1 m-20 66.66 25.8 9.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.451 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.66 130.35 70.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.711 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -157.11 -161.37 10.75 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.492 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 101' ' ' VAL . . . . . 0.486 ' CG2' ' HB1' ' F' ' 135' ' ' ALA . 0.8 OUTLIER -130.89 131.88 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 123.122 0.569 . . . . 0.0 111.868 -179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 102' ' ' GLN . . . . . 0.721 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 1.5 tt0 -98.41 151.52 20.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.897 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 103' ' ' ILE . . . . . 0.518 ' N ' ' HG2' ' F' ' 102' ' ' GLN . 0.3 OUTLIER -117.36 128.65 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.503 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 104' ' ' LEU . . . . . 0.809 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 0.3 OUTLIER -103.04 133.52 48.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.647 0.261 . . . . 0.0 111.083 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . 0.702 ' HB3' HG22 ' F' ' 107' ' ' THR . 7.2 t0 -87.71 158.37 18.83 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.658 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 106' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' F' ' 106' ' ' ARG . 7.9 ttp85 -70.4 -27.75 64.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.778 0.323 . . . . 0.0 111.082 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . 0.702 HG22 ' HB3' ' F' ' 105' ' ' ASP . 2.8 t -51.72 -25.72 7.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.056 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 134.26 -39.37 1.71 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.574 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.26 158.01 17.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.849 0.357 . . . . 0.0 111.079 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . 0.809 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -70.3 137.11 50.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.034 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . 0.657 HD21 ' HA ' ' F' ' 72' ' ' ALA . 13.5 tp -87.53 158.38 18.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.338 0.589 . . . . 0.0 110.533 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 112' ' ' THR . . . . . 1.043 HG23 HG21 ' F' ' 117' ' ' THR . 0.5 OUTLIER -101.76 141.93 33.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.107 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 113' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' F' ' 73' ' ' PHE . 1.9 mt -82.33 65.58 7.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.7 0.286 . . . . 0.0 110.725 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.08 -14.97 21.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.521 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 103.21 -54.11 0.71 Allowed Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.661 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -111.19 28.97 8.22 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.066 0.46 . . . . 0.0 111.719 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 117' ' ' THR . . . . . 1.043 HG21 HG23 ' F' ' 112' ' ' THR . 0.0 OUTLIER -88.85 76.61 7.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.17 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . 0.608 ' HA ' ' O ' ' F' ' 71' ' ' VAL . 91.6 m-85 -91.07 96.77 10.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.746 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 67.8 m -132.6 78.22 1.79 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.764 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.7 136.97 3.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.688 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -115.09 76.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.276 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.9 135.59 33.62 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.635 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 12.0 m -77.09 96.25 4.41 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.763 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . 0.726 ' O ' HG23 ' F' ' 63' ' ' THR . 10.8 tp -68.19 132.97 48.11 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.582 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -128.47 166.77 18.12 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.552 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' F' ' 61' ' ' CYS . 6.3 t30 -79.41 105.74 10.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.743 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 157.02 -137.09 5.24 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.689 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 128' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 3.7 m -103.59 83.45 2.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.686 0.279 . . . . 0.0 110.847 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 129' ' ' ASN . . . . . 0.7 ' HB2' ' SG ' ' F' ' 61' ' ' CYS . 1.7 t30 -70.98 139.87 50.7 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.887 0.375 . . . . 0.0 111.165 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 130' ' ' THR . . . . . 0.97 HG21 HD21 ' C' ' 74' ' ' LEU . 0.2 OUTLIER -133.96 139.69 46.27 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.109 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 131' ' ' ILE . . . . . 0.631 HG21 HG11 ' F' ' 71' ' ' VAL . 61.8 mt -98.08 110.55 56.39 Favored Pre-proline 0 CA--C 1.539 0.546 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 132' ' ' PRO . . . . . 0.765 ' HB3' ' HA ' ' C' ' 76' ' ' THR . 7.6 Cg_endo -81.82 135.13 8.76 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.796 1.664 . . . . 0.0 112.558 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -143.74 152.68 41.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.727 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 134' ' ' GLN . . . . . 0.589 ' HB3' ' HB1' ' F' ' 51' ' ' ALA . 50.5 mt-30 -119.0 156.9 28.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.096 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . 0.722 ' HB3' HG22 ' F' ' 52' ' ' VAL . . . -151.42 101.69 2.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.808 0.337 . . . . 0.0 111.641 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -105.59 168.33 9.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.373 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 137' ' ' TYR . . . . . 0.488 ' O ' ' HA ' ' F' ' 48' ' ' THR . 0.3 OUTLIER -80.09 123.3 27.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.113 179.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 138' ' ' PHE . . . . . 0.479 ' HA ' ' O ' ' F' ' 47' ' ' ALA . 1.3 t80 -126.18 119.05 26.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.051 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 139' ' ' ALA . . . . . 0.739 ' HB2' HD23 ' F' ' 42' ' ' LEU . . . -111.98 125.17 53.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.853 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 140' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' F' ' 45' ' ' GLU . 0.2 OUTLIER -68.9 -48.26 63.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.508 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . 0.434 ' H ' ' HB3' ' F' ' 98' ' ' ASN . . . -133.09 -120.05 2.08 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.058 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.27 111.91 18.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.548 0.213 . . . . 0.0 110.815 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 143' ' ' ALA . . . . . 0.709 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -61.91 113.86 3.03 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.815 0.341 . . . . 0.0 111.405 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 144' ' ' THR . . . . . 0.784 ' HB ' ' H ' ' F' ' 97' ' ' THR . 75.1 m -88.28 145.22 35.4 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.317 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.81 134.17 7.17 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.524 2.149 . . . . 0.0 111.978 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.94 -135.59 4.4 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.537 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 147' ' ' ALA . . . . . 0.71 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -96.21 134.2 39.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.966 0.412 . . . . 0.0 111.312 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 148' ' ' ALA . . . . . 0.896 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -129.82 50.48 2.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.184 0.516 . . . . 0.0 110.469 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 149' ' ' ASN . . . . . 0.497 HD22 ' HG2' ' E' ' 13' ' ' LYS . 3.5 m120 -98.92 146.16 26.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.491 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 150' ' ' ALA . . . . . 0.959 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -154.91 174.12 15.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.876 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 151' ' ' ASP . . . . . 0.482 ' C ' HD11 ' F' ' 86' ' ' LEU . 26.8 t70 -139.34 128.49 23.87 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.225 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 152' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' F' ' 74' ' ' LEU . . . -118.41 133.38 55.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.159 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 153' ' ' THR . . . . . 0.723 HG23 HG22 ' E' ' 9' ' ' THR . 0.2 OUTLIER -92.02 147.42 22.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.19 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.24 130.28 53.42 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.143 0.497 . . . . 0.0 110.085 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -126.71 144.02 51.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.874 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 156' ' ' VAL . . . . . 0.526 HG12 ' CD1' ' F' ' 131' ' ' ILE . 27.3 m -127.42 151.9 34.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.677 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 157' ' ' GLN . . . . . 0.688 ' HA ' ' O ' ' E' ' 3' ' ' THR . 0.0 OUTLIER -141.35 121.18 13.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.237 0.542 . . . . 0.0 110.365 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . 0.575 ' CD2' ' HB ' ' E' ' 3' ' ' THR . 1.2 m-85 -98.25 121.65 40.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.539 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.802 -179.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.213 0.054 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.7 ' H ' ' HA ' ' B' ' 159' ' ' GLN . . . 65.93 74.71 0.36 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.533 0.206 . . . . 0.0 110.94 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.589 ' OG1' ' HB2' ' B' ' 158' ' ' TYR . 6.2 p -117.73 97.5 5.88 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.499 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.607 HG22 ' HB2' ' B' ' 157' ' ' GLN . 68.4 p -87.86 108.7 19.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.576 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.63 172.77 13.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.592 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -77.2 110.77 12.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.587 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' B' ' 155' ' ' LYS . . . -65.69 -59.41 7.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.772 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.56 151.71 14.94 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.818 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.513 HG23 ' O ' ' B' ' 152' ' ' ALA . 24.2 m -103.54 143.13 33.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 111.279 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.441 HG12 ' HG3' ' B' ' 30' ' ' GLN . 1.2 m -130.94 115.61 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.208 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.62 105.77 14.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.398 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.448 ' HD2' HD21 ' B' ' 34' ' ' LEU . 52.1 m-85 -83.25 105.55 14.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.782 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.52 145.05 41.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.455 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.75 -179.72 42.55 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.958 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.15 134.23 22.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.0 110.376 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.635 HG11 ' O ' ' B' ' 144' ' ' THR . 3.3 t -90.85 127.14 43.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.286 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' A' ' 20' ' ' ALA . 12.1 m -126.25 168.77 18.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.823 0.344 . . . . 0.0 111.03 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -100.42 81.79 2.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.154 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' B' ' 40' ' ' ALA . . . 53.3 58.17 5.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.071 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB3' HG21 ' A' ' 17' ' ' VAL . . . -108.55 -62.86 1.4 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.36 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.781 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.9 OUTLIER -171.56 -159.94 0.16 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.915 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.634 ' HA ' ' HB2' ' B' ' 36' ' ' GLN . . . -156.88 74.01 0.78 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.456 ' N ' HD23 ' A' ' 58' ' ' LEU . 7.4 p -45.35 140.61 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.04 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.544 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -63.42 140.74 58.9 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.661 179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.36 -51.15 69.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.311 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.11 -18.04 74.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.919 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.96 -6.39 58.04 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.832 0.349 . . . . 0.0 110.786 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 24' ' ' ASP . 50.9 t -72.63 -36.37 53.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.426 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.95 110.82 14.05 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.969 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.78 146.05 48.6 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.033 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.21 113.84 27.67 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 112.127 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.61 HG11 HG11 ' A' ' 52' ' ' VAL . 3.3 t -105.08 121.93 57.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.108 0.48 . . . . 0.0 110.448 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.86 106.41 17.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.683 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.79 -44.74 89.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.592 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.62 -156.9 15.99 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.568 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -91.07 107.01 18.91 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.596 0.236 . . . . 0.0 110.847 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.572 ' CG1' HD21 ' A' ' 42' ' ' LEU . 4.3 t -92.34 120.63 41.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.918 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.6 mtm105 -85.71 132.49 34.13 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.746 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.0 p -71.45 -23.32 61.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.756 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.03 -19.19 64.88 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.965 0.412 . . . . 0.0 110.793 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.8 t -90.53 -36.55 14.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.183 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -121.52 70.52 0.94 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.58 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 142' ' ' ALA . . . -104.76 28.18 7.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.38 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.772 ' HG3' ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -150.58 142.01 23.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.384 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HG3' ' HA ' ' A' ' 140' ' ' THR . 2.7 tt0 -62.7 101.79 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.777 0.322 . . . . 0.0 111.136 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.3 4.27 8.41 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.062 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.772 ' HB2' ' HG3' ' A' ' 44' ' ' GLN . . . -91.76 121.2 33.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.002 0.43 . . . . 0.0 111.985 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 137' ' ' TYR . 5.8 t -110.3 151.2 27.68 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.806 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -95.7 -57.62 2.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.594 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.24 -174.88 4.7 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.853 0.359 . . . . 0.0 110.817 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.476 ' HB2' ' CD ' ' A' ' 136' ' ' ARG . . . -127.05 143.87 51.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.387 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.61 HG11 HG11 ' A' ' 32' ' ' VAL . 48.3 t -120.85 116.86 51.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.972 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.19 122.64 6.19 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.67 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -128.58 138.83 52.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.33 . . . . 0.0 110.978 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.472 HD22 ' CG2' ' A' ' 130' ' ' THR . 1.6 m120 -117.86 150.95 38.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.657 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.574 ' HB ' HG13 ' A' ' 131' ' ' ILE . 9.3 mm -106.78 103.67 15.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.57 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.21 132.23 52.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.783 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.757 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 1.0 OUTLIER -137.31 151.87 49.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.256 -179.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -138.45 171.27 14.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.983 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.446 ' O ' ' HA ' ' A' ' 21' ' ' CYS . 5.9 m-20 50.1 68.42 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.849 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.781 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -106.59 141.14 38.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.764 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.84 117.89 33.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.24 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.7 p -91.12 -13.18 33.52 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.62 -38.95 82.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.069 0.462 . . . . 0.0 111.765 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.65 -54.11 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.645 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.7 84.31 3.35 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.582 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.98 -41.21 10.13 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.805 0.336 . . . . 0.0 111.023 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.63 159.96 17.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.518 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.7 160.4 39.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.616 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.02 152.91 45.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.133 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.89 136.54 53.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.722 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.0 107.45 5.04 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.555 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.475 ' CD2' HD13 ' A' ' 103' ' ' ILE . 43.1 t80 -73.65 136.66 43.86 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.605 0.24 . . . . 0.0 111.025 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 153' ' ' THR . 6.6 tt -113.56 111.41 21.84 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.978 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.649 ' HA3' HD11 ' A' ' 113' ' ' LEU . . . -131.29 -178.49 15.5 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.864 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.659 ' H ' HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -104.32 137.58 42.0 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.461 0.172 . . . . 0.0 110.857 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.98 114.78 23.89 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.992 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.618 ' O ' ' HG2' ' D' ' 134' ' ' GLN . 1.2 tt -95.7 -36.73 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.867 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.897 ' CB ' HG21 ' A' ' 140' ' ' THR . 0.4 OUTLIER -143.38 130.23 20.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.746 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.92 -7.18 47.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.046 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.33 -29.19 68.39 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.587 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.34 -32.64 4.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.88 0.371 . . . . 0.0 110.459 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.435 ' O ' HG22 ' A' ' 83' ' ' THR . 3.5 m 60.49 19.42 9.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.589 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.631 ' HB3' ' HG2' ' A' ' 102' ' ' GLN . 0.6 OUTLIER -139.37 -16.99 1.03 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.296 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.709 ' HB ' ' HA3' ' A' ' 100' ' ' GLY . 0.9 OUTLIER -66.67 118.02 8.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.244 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.659 HD12 ' H ' ' A' ' 76' ' ' THR . 10.7 tp -69.72 144.17 52.87 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.264 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.452 ' HB3' ' OG1' ' A' ' 76' ' ' THR . . . -80.2 138.09 36.78 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.917 0.389 . . . . 0.0 111.721 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.686 ' HB3' ' HA ' ' A' ' 148' ' ' ALA . 0.0 OUTLIER -84.95 -146.62 0.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.068 179.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 149' ' ' ASN . 0.0 OUTLIER -48.53 155.02 0.58 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.268 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.566 ' O ' HG22 ' D' ' 52' ' ' VAL . 32.4 p -86.73 -11.92 49.75 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.923 0.392 . . . . 0.0 111.503 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.42 114.08 5.16 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.589 ' HA ' ' HB3' ' D' ' 50' ' ' SER . . . -83.38 22.19 1.06 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.951 0.405 . . . . 0.0 111.683 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.21 21.97 1.21 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.698 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.64 -32.27 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.017 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.654 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 15.9 t -65.14 166.73 9.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.866 0.365 . . . . 0.0 110.616 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.465 ' O ' HD13 ' A' ' 88' ' ' LEU . . . -89.65 163.44 15.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.851 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.42 169.66 17.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.34 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 57.4 29.34 16.78 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.383 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.573 ' HB ' ' HB1' ' A' ' 143' ' ' ALA . 7.2 p -156.38 150.6 10.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.825 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.709 ' HA3' ' HB ' ' A' ' 85' ' ' VAL . . . -164.2 176.93 40.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.609 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.617 HG22 ' CE1' ' A' ' 137' ' ' TYR . 3.0 t -107.63 111.29 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.018 0.527 . . . . 0.0 111.713 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.631 ' HG2' ' HB3' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -75.97 179.75 5.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.958 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.492 HD11 ' HA ' ' A' ' 113' ' ' LEU . 6.0 pt -150.36 116.54 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.457 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.501 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 12.9 tp -97.22 122.54 40.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.724 0.297 . . . . 0.0 111.068 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.91 150.08 42.92 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.739 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.506 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -71.43 -17.58 62.38 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.824 0.345 . . . . 0.0 111.121 179.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.43 HG21 ' HA ' ' A' ' 120' ' ' SER . 76.1 p -76.62 -37.22 56.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.11 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.52 -68.81 0.32 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.732 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.61 123.2 18.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.795 0.331 . . . . 0.0 111.129 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.74 117.99 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.184 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.514 HD11 ' O ' ' A' ' 117' ' ' THR . 2.1 tp -67.87 144.1 55.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.43 0.633 . . . . 0.0 110.491 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.428 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -75.11 140.45 43.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.071 179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.649 HD11 ' HA3' ' A' ' 75' ' ' GLY . 1.3 tp -85.18 97.75 10.08 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.701 0.286 . . . . 0.0 110.668 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -152.78 -59.01 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.645 0.26 . . . . 0.0 111.582 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.556 ' HA3' ' OG1' ' D' ' 130' ' ' THR . . . 135.73 -26.63 3.14 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.615 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.731 ' HB2' ' HA ' ' D' ' 129' ' ' ASN . . . -101.27 28.78 5.15 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.994 0.426 . . . . 0.0 111.692 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.514 ' O ' HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -106.58 67.34 0.72 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.075 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.4 81.0 8.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.737 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.04 97.45 3.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.888 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.43 ' HA ' HG21 ' A' ' 107' ' ' THR . 2.0 t -165.54 144.79 6.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.587 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.28 50.22 0.9 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.204 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.8 94.18 5.74 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.715 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.69 110.38 12.47 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.679 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.602 ' HG ' ' ND2' ' A' ' 129' ' ' ASN . 0.3 OUTLIER -70.2 154.15 42.26 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.578 179.42 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.6 144.77 51.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.552 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.74 125.67 24.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.653 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.1 -102.01 1.1 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.725 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 86.9 m -106.23 128.45 53.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.655 0.264 . . . . 0.0 110.831 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.602 ' ND2' ' HG ' ' A' ' 124' ' ' LEU . 20.1 t-20 -121.15 158.13 28.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.874 0.368 . . . . 0.0 111.129 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.472 ' CG2' HD22 ' A' ' 55' ' ' ASN . 0.2 OUTLIER -155.81 143.08 19.27 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.996 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.607 HD13 HG11 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -115.22 110.79 45.14 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.506 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.4 Cg_endo -82.21 151.85 15.95 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.618 1.546 . . . . 0.0 112.5 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.01 146.77 17.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.797 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 0.8 OUTLIER -114.38 145.83 41.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.108 179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.77 91.17 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.873 0.368 . . . . 0.0 111.679 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.57 ' HE ' HG21 ' A' ' 48' ' ' THR . 28.0 mtm-85 -88.34 153.6 21.07 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.405 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.617 ' CE1' HG22 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -91.29 111.06 22.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.071 179.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.608 ' CD1' ' HB2' ' A' ' 102' ' ' GLN . 8.8 m-85 -108.08 172.19 6.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.962 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.574 ' HB2' ' HB2' ' A' ' 42' ' ' LEU . . . -123.42 143.65 50.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.851 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.897 HG21 ' CB ' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -98.73 44.39 1.03 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.565 179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.48 89.07 1.07 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.978 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . . . 60.09 88.08 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.709 0.255 . . . . 0.0 110.689 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.573 ' HB1' ' HB ' ' A' ' 99' ' ' VAL . . . -70.61 161.73 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.0 111.405 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 158.73 60.65 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.226 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.76 149.18 12.55 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.54 2.16 . . . . 0.0 112.06 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.72 -119.73 0.86 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.479 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.654 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -123.94 127.71 48.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.861 0.362 . . . . 0.0 111.417 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.686 ' HA ' ' HB3' ' A' ' 88' ' ' LEU . . . -120.85 67.17 0.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.117 0.484 . . . . 0.0 110.389 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 89' ' ' GLN . 47.5 t-20 -128.47 114.77 17.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.6 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.424 ' HB2' ' C ' ' A' ' 88' ' ' LEU . . . -158.83 146.97 18.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.984 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.39 140.3 32.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.171 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -136.19 169.28 17.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.176 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.466 ' O ' ' HB3' ' A' ' 74' ' ' LEU . 9.3 t -155.11 150.52 27.25 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.442 ' HE1' HG13 ' A' ' 56' ' ' ILE . 1.1 p90 -118.97 149.27 41.91 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.121 0.486 . . . . 0.0 110.083 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.436 ' HE3' HD13 ' A' ' 74' ' ' LEU . 4.7 mttt -113.53 156.68 23.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.869 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.607 HG11 HD13 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -136.48 137.98 47.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.684 -179.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -107.5 128.03 54.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.318 0.58 . . . . 0.0 110.37 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -107.87 107.43 18.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.542 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.851 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.209 0.052 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.727 ' H ' ' HA ' ' C' ' 159' ' ' GLN . . . 65.84 74.75 0.36 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.579 0.228 . . . . 0.0 110.98 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.6 ' OG1' ' HB2' ' C' ' 158' ' ' TYR . 6.2 p -117.74 97.56 5.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.46 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.606 HG22 ' HB2' ' C' ' 157' ' ' GLN . 67.9 p -87.91 108.61 19.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.527 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.51 172.75 13.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.59 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -77.24 110.86 12.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.494 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . 0.409 ' H ' ' HA ' ' C' ' 155' ' ' LYS . . . -65.76 -59.42 7.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.765 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.56 151.64 14.79 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.81 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.513 HG23 ' O ' ' C' ' 152' ' ' ALA . 24.2 m -103.44 143.09 33.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 111.357 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.438 HG12 ' HG3' ' C' ' 30' ' ' GLN . 1.2 m -130.98 115.63 30.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.186 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.65 105.71 14.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.349 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . 0.45 ' HD2' HD21 ' C' ' 34' ' ' LEU . 52.2 m-85 -83.17 105.47 14.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.783 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.46 145.07 41.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.446 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.74 -179.69 42.57 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.932 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.19 134.27 22.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.94 0.4 . . . . 0.0 110.306 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.635 HG11 ' O ' ' C' ' 144' ' ' THR . 3.3 t -90.9 127.16 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.264 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' B' ' 20' ' ' ALA . 12.1 m -126.25 168.75 18.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.86 0.362 . . . . 0.0 111.037 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.48 81.82 2.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.12 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' C' ' 40' ' ' ALA . . . 53.38 58.15 5.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.997 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.537 ' HB3' HG21 ' B' ' 17' ' ' VAL . . . -108.57 -62.82 1.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.442 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.9 OUTLIER -171.54 -159.86 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.914 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.64 ' HA ' ' HB2' ' C' ' 36' ' ' GLN . . . -156.84 74.07 0.79 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.107 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.463 ' N ' HD23 ' B' ' 58' ' ' LEU . 7.4 p -45.44 140.62 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.958 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.553 ' O ' HG23 ' B' ' 28' ' ' VAL . 0.5 OUTLIER -63.43 140.81 58.91 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.642 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.44 -51.15 69.5 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.307 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.08 -18.01 74.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.964 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -88.0 -6.32 58.05 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.827 0.346 . . . . 0.0 110.756 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.553 HG23 ' O ' ' B' ' 24' ' ' ASP . 50.5 t -72.78 -36.31 52.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.359 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.03 110.85 14.03 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.002 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' GLN . . . . . 0.441 ' HG3' HG12 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -123.85 146.01 48.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.021 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.19 113.84 27.68 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.128 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.623 HG11 HG11 ' B' ' 52' ' ' VAL . 3.3 t -105.08 121.91 57.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.105 0.478 . . . . 0.0 110.475 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.84 106.37 17.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.721 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.448 HD21 ' HD2' ' A' ' 12' ' ' PHE . 0.6 OUTLIER -64.69 -44.75 89.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.642 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.58 -156.91 16.0 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.558 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.634 ' HB2' ' HA ' ' A' ' 22' ' ' ALA . 3.7 mt-30 -91.1 106.98 18.9 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.629 0.252 . . . . 0.0 110.851 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.578 ' CG1' HD21 ' B' ' 42' ' ' LEU . 4.4 t -92.32 120.59 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.938 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' A' ' 19' ' ' ALA . 4.6 mtm105 -85.67 132.51 34.14 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.71 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 17' ' ' VAL . 29.4 p -71.54 -23.21 61.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.755 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' A' ' 19' ' ' ALA . . . -68.08 -19.06 64.83 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.996 0.427 . . . . 0.0 110.844 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -90.6 -36.6 14.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.167 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' B' ' 139' ' ' ALA . 0.2 OUTLIER -121.48 70.54 0.94 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.61 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' B' ' 142' ' ' ALA . . . -104.7 28.11 7.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.423 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 0.77 ' HG3' ' HB2' ' B' ' 47' ' ' ALA . 0.0 OUTLIER -150.53 141.99 23.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.45 179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' B' ' 140' ' ' THR . 2.7 tt0 -62.66 101.8 0.28 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.769 0.319 . . . . 0.0 111.104 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.26 4.26 8.44 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.099 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.77 ' HB2' ' HG3' ' B' ' 44' ' ' GLN . . . -91.74 121.32 33.27 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.982 0.42 . . . . 0.0 112.015 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' B' ' 137' ' ' TYR . 5.8 t -110.41 151.22 27.75 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.786 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -95.69 -57.67 2.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.596 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.23 -174.85 4.69 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.76 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.48 ' HB2' ' CD ' ' B' ' 136' ' ' ARG . . . -127.05 143.86 51.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.315 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.623 HG11 HG11 ' B' ' 32' ' ' VAL . 48.3 t -120.9 116.91 51.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.959 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.25 122.67 6.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.66 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -128.62 138.86 52.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.784 0.326 . . . . 0.0 111.0 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.472 HD22 ' CG2' ' B' ' 130' ' ' THR . 1.6 m120 -117.85 150.93 38.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.677 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.59 ' HB ' HG13 ' B' ' 131' ' ' ILE . 9.3 mm -106.77 103.66 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.607 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -61.15 132.27 53.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.798 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.762 ' HB3' ' SG ' ' B' ' 21' ' ' CYS . 1.0 OUTLIER -137.39 151.86 49.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.208 -179.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -138.38 171.34 14.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.972 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' B' ' 21' ' ' CYS . 5.9 m-20 49.98 68.48 0.74 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.872 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' CYS . . . . . 0.888 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 0.0 OUTLIER -106.63 141.08 38.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.8 117.88 33.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.231 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 23.3 p -91.26 -13.02 33.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.69 -38.89 82.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.114 0.483 . . . . 0.0 111.79 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 76.4 t -107.75 -54.07 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.618 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.66 84.39 3.38 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.583 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -41.25 10.05 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.949 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.6 159.96 17.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.529 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.68 160.45 39.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.609 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.09 152.91 45.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.167 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.97 136.54 53.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.688 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.02 107.53 5.06 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.556 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.476 ' CD2' HD13 ' B' ' 103' ' ' ILE . 43.2 t80 -73.75 136.69 43.68 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.562 0.22 . . . . 0.0 111.02 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.457 ' HB3' ' O ' ' B' ' 153' ' ' THR . 6.6 tt -113.55 111.44 21.9 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.98 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.628 ' HA3' HD11 ' B' ' 113' ' ' LEU . . . -131.38 -178.6 15.56 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.841 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.654 ' H ' HD12 ' B' ' 86' ' ' LEU . 0.2 OUTLIER -104.28 137.61 41.94 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.478 0.18 . . . . 0.0 110.844 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.98 114.77 23.87 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.895 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.614 ' O ' ' HG2' ' E' ' 134' ' ' GLN . 1.2 tt -95.76 -36.75 6.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.782 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.889 ' CB ' HG21 ' B' ' 140' ' ' THR . 0.4 OUTLIER -143.33 130.22 20.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.839 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.93 -7.26 47.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.21 -29.31 68.33 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.665 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 -32.67 4.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.945 0.402 . . . . 0.0 110.502 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' THR . . . . . 0.424 ' O ' HG22 ' B' ' 83' ' ' THR . 3.5 m 60.52 19.39 9.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.633 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . 0.642 ' HB3' ' HG2' ' B' ' 102' ' ' GLN . 0.6 OUTLIER -139.35 -17.03 1.03 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.312 179.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.696 ' HB ' ' HA3' ' B' ' 100' ' ' GLY . 0.9 OUTLIER -66.65 118.08 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.2 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.654 HD12 ' H ' ' B' ' 76' ' ' THR . 10.7 tp -69.75 144.13 52.82 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.374 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.447 ' HB3' ' CB ' ' B' ' 76' ' ' THR . . . -80.05 137.98 36.9 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.868 0.366 . . . . 0.0 111.773 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.69 ' HB3' ' HA ' ' B' ' 148' ' ' ALA . 0.0 OUTLIER -84.99 -146.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.11 179.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' B' ' 149' ' ' ASN . 0.0 OUTLIER -48.59 155.09 0.58 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.256 -179.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . 0.576 ' O ' HG22 ' E' ' 52' ' ' VAL . 32.5 p -86.79 -11.91 49.58 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.971 0.415 . . . . 0.0 111.496 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.41 114.13 5.19 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.952 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.601 ' HA ' ' HB3' ' E' ' 50' ' ' SER . . . -83.45 22.24 1.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.907 0.384 . . . . 0.0 111.653 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.26 21.98 1.2 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.679 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.65 -32.33 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.024 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' SER . . . . . 0.663 ' HA ' ' HB3' ' B' ' 147' ' ' ALA . 15.9 t -65.08 166.68 9.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.791 0.329 . . . . 0.0 110.666 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.465 ' O ' HD13 ' B' ' 88' ' ' LEU . . . -89.64 163.46 15.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.875 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.4 169.65 17.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.322 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 57.36 29.36 16.76 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.349 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . 0.575 ' HB ' ' HB1' ' B' ' 143' ' ' ALA . 7.2 p -156.42 150.54 10.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.794 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . 0.696 ' HA3' ' HB ' ' B' ' 85' ' ' VAL . . . -164.17 176.95 40.07 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.541 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.608 HG22 ' CE1' ' B' ' 137' ' ' TYR . 3.0 t -107.63 111.32 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 123.038 0.535 . . . . 0.0 111.666 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.642 ' HG2' ' HB3' ' B' ' 84' ' ' ASN . 0.0 OUTLIER -75.99 179.75 5.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.955 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' B' ' 113' ' ' LEU . 6.0 pt -150.34 116.59 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.474 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' B' ' 134' ' ' GLN . 12.8 tp -97.31 122.61 40.54 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.765 0.317 . . . . 0.0 110.967 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.88 150.13 42.68 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.639 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . 0.512 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -71.5 -17.55 62.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.763 0.316 . . . . 0.0 111.098 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.436 HG21 ' HA ' ' B' ' 120' ' ' SER . 75.8 p -76.64 -37.29 56.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.081 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.55 -68.72 0.32 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.689 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.67 123.26 18.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.831 0.348 . . . . 0.0 111.1 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.77 117.98 2.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.18 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.515 HD11 ' O ' ' B' ' 117' ' ' THR . 2.1 tp -67.82 144.1 55.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.417 0.627 . . . . 0.0 110.494 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.427 ' HA ' ' ND2' ' B' ' 84' ' ' ASN . 0.2 OUTLIER -75.14 140.51 43.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.079 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.628 HD11 ' HA3' ' B' ' 75' ' ' GLY . 1.3 tp -85.2 97.75 10.09 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.693 0.282 . . . . 0.0 110.619 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -152.83 -58.96 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.584 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . 0.555 ' HA3' ' OG1' ' E' ' 130' ' ' THR . . . 135.73 -26.58 3.15 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.632 -0.795 . . . . 0.0 112.67 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . 0.751 ' HB2' ' HA ' ' E' ' 129' ' ' ASN . . . -101.35 28.81 5.16 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.998 0.427 . . . . 0.0 111.641 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.515 ' O ' HD11 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -106.57 67.28 0.72 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.059 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.42 81.02 8.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.803 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.06 97.47 3.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.794 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.436 ' HA ' HG21 ' B' ' 107' ' ' THR . 1.9 t -165.61 144.79 6.35 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.546 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.34 50.36 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.139 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.79 94.18 5.73 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.676 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.73 110.31 12.46 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.723 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.604 ' HG ' ' ND2' ' B' ' 129' ' ' ASN . 0.3 OUTLIER -70.13 154.09 42.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.657 179.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -131.51 144.76 51.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.629 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.71 125.64 24.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.688 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.09 -102.06 1.11 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.734 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 86.9 m -106.16 128.48 53.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.633 0.254 . . . . 0.0 110.859 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . 0.604 ' ND2' ' HG ' ' B' ' 124' ' ' LEU . 20.1 t-20 -121.14 158.18 28.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.896 0.379 . . . . 0.0 111.126 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.472 ' CG2' HD22 ' B' ' 55' ' ' ASN . 0.2 OUTLIER -155.82 143.08 19.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.982 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' ILE . . . . . 0.598 HD13 HG11 ' B' ' 156' ' ' VAL . 0.1 OUTLIER -115.16 110.64 45.43 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' PRO . . . . . 0.512 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -82.14 151.83 16.1 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.609 1.539 . . . . 0.0 112.553 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.01 146.76 17.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.852 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' B' ' 104' ' ' LEU . 0.8 OUTLIER -114.28 145.9 41.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.088 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.89 91.13 1.9 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.913 0.387 . . . . 0.0 111.686 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . 0.566 ' HE ' HG21 ' B' ' 48' ' ' THR . 28.1 mtm-85 -88.33 153.59 21.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.374 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . 0.608 ' CE1' HG22 ' B' ' 101' ' ' VAL . 0.7 OUTLIER -91.24 111.01 22.31 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.129 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . 0.608 ' CD1' ' HB2' ' B' ' 102' ' ' GLN . 8.8 m-85 -108.08 172.17 6.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.029 -179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' B' ' 42' ' ' LEU . . . -123.43 143.68 49.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.862 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' THR . . . . . 0.889 HG21 ' CB ' ' B' ' 79' ' ' ASP . 0.2 OUTLIER -98.81 44.36 1.03 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.47 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.57 89.08 1.08 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.929 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' B' ' 43' ' ' ALA . . . 59.94 88.1 0.08 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.745 0.272 . . . . 0.0 110.777 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' ALA . . . . . 0.575 ' HB1' ' HB ' ' B' ' 99' ' ' VAL . . . -70.63 161.7 30.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.815 0.34 . . . . 0.0 111.379 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.635 ' O ' HG11 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -124.48 158.73 60.64 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.213 179.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.511 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 1.4 Cg_endo -83.81 149.22 12.49 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.502 2.135 . . . . 0.0 112.057 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.69 -119.78 0.86 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.483 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.663 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -123.95 127.67 48.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.874 0.369 . . . . 0.0 111.413 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . 0.69 ' HA ' ' HB3' ' B' ' 88' ' ' LEU . . . -120.8 67.16 0.85 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.428 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' B' ' 89' ' ' GLN . 47.5 t-20 -128.45 114.75 17.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.637 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.429 ' HB2' ' C ' ' B' ' 88' ' ' LEU . . . -158.77 147.05 18.26 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.034 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.45 140.3 32.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.121 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 9' ' ' THR . . . -136.19 169.31 17.84 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.208 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.457 ' O ' ' HB3' ' B' ' 74' ' ' LEU . 9.4 t -155.13 150.49 27.19 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.439 ' HE1' HG13 ' B' ' 56' ' ' ILE . 1.1 p90 -119.03 149.21 42.05 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.024 0.44 . . . . 0.0 110.107 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.447 ' HE3' HD13 ' B' ' 74' ' ' LEU . 4.7 mttt -113.42 156.56 23.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.914 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' VAL . . . . . 0.598 HG11 HD13 ' B' ' 131' ' ' ILE . 0.2 OUTLIER -136.43 138.02 47.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.699 -179.116 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.607 ' HB2' HG22 ' A' ' 4' ' ' THR . 64.1 tt0 -107.46 128.02 54.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.285 0.564 . . . . 0.0 110.369 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . 0.589 ' HB2' ' OG1' ' A' ' 3' ' ' THR . 60.9 m-85 -107.81 107.37 18.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.519 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . 0.7 ' HA ' ' H ' ' A' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.19 -0.91 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.272 0.082 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.71 ' H ' ' HA ' ' D' ' 159' ' ' GLN . . . 65.93 74.7 0.36 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.529 0.204 . . . . 0.0 110.929 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' D' ' 158' ' ' TYR . 6.0 p -117.74 97.5 5.88 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.479 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' THR . . . . . 0.629 HG22 ' HB2' ' D' ' 157' ' ' GLN . 67.8 p -87.92 108.74 19.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.529 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.61 172.71 13.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.571 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.15 110.76 12.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.567 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.73 -59.37 7.71 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.792 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.5 151.71 15.02 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.827 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . 0.5 HG23 ' O ' ' D' ' 152' ' ' ALA . 24.1 m -103.48 143.11 33.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.855 0.36 . . . . 0.0 111.313 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.44 HG12 ' HG3' ' D' ' 30' ' ' GLN . 1.1 m -130.97 115.65 30.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.134 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -83.62 105.72 14.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.367 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' PHE . . . . . 0.456 ' HD2' HD21 ' D' ' 34' ' ' LEU . 52.2 m-85 -83.19 105.46 14.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.756 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.39 145.06 41.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.422 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.71 -179.68 42.56 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.974 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.23 134.27 22.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.971 0.415 . . . . 0.0 110.358 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.634 HG11 ' O ' ' D' ' 144' ' ' THR . 3.3 t -90.92 127.11 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.238 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' C' ' 20' ' ' ALA . 12.1 m -126.23 168.82 18.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.831 0.348 . . . . 0.0 111.022 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.53 81.88 2.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.046 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . 0.445 ' HA ' ' HG2' ' D' ' 38' ' ' ARG . . . 53.27 58.24 5.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.015 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . 0.525 ' HB3' HG21 ' C' ' 17' ' ' VAL . . . -108.61 -62.8 1.41 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.385 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.9 OUTLIER -171.57 -159.93 0.16 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.957 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . 0.625 ' HA ' ' HB2' ' D' ' 36' ' ' GLN . . . -156.88 74.0 0.78 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.059 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . 0.47 ' N ' HD23 ' C' ' 58' ' ' LEU . 7.4 p -45.3 140.56 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.061 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.554 ' O ' HG23 ' C' ' 28' ' ' VAL . 0.5 OUTLIER -63.45 140.79 58.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.615 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.43 -51.16 69.43 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.287 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.03 -18.04 74.23 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.966 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -88.0 -6.27 58.07 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.807 0.337 . . . . 0.0 110.794 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.554 HG23 ' O ' ' C' ' 24' ' ' ASP . 50.7 t -72.74 -36.43 52.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.332 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.94 110.92 14.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.95 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' GLN . . . . . 0.438 ' HG3' HG12 ' B' ' 10' ' ' VAL . 0.4 OUTLIER -123.86 146.05 48.67 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.987 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.18 113.84 27.68 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.113 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.625 HG11 HG11 ' C' ' 52' ' ' VAL . 3.3 t -105.13 121.92 57.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 110.404 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.85 106.42 17.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.641 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.45 HD21 ' HD2' ' B' ' 12' ' ' PHE . 0.6 OUTLIER -64.79 -44.73 89.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.555 179.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.61 -156.8 16.03 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.6 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . 0.64 ' HB2' ' HA ' ' B' ' 22' ' ' ALA . 3.7 mt-30 -91.09 106.93 18.86 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.663 0.268 . . . . 0.0 110.922 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.578 ' CG1' HD21 ' C' ' 42' ' ' LEU . 4.3 t -92.28 120.51 41.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.94 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' B' ' 19' ' ' ALA . 4.6 mtm105 -85.59 132.49 34.17 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.759 179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.436 HG23 ' O ' ' B' ' 17' ' ' VAL . 29.1 p -71.48 -23.34 61.79 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.768 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' B' ' 19' ' ' ALA . . . -67.93 -19.2 64.96 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.935 0.397 . . . . 0.0 110.817 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 13.8 t -90.61 -36.56 14.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.159 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.591 ' HB2' ' HB2' ' C' ' 139' ' ' ALA . 0.2 OUTLIER -121.45 70.55 0.94 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.623 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' C' ' 142' ' ' ALA . . . -104.79 28.16 7.37 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.379 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . 0.752 ' HG3' ' HB2' ' C' ' 47' ' ' ALA . 0.0 OUTLIER -150.62 141.93 23.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.402 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . 0.449 ' HG3' ' HA ' ' C' ' 140' ' ' THR . 2.7 tt0 -62.62 101.78 0.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.764 0.316 . . . . 0.0 111.133 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.24 4.25 8.46 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.094 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.752 ' HB2' ' HG3' ' C' ' 44' ' ' GLN . . . -91.73 121.33 33.27 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.942 0.401 . . . . 0.0 112.016 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' C' ' 137' ' ' TYR . 5.8 t -110.41 151.16 27.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.815 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 5.2 t -95.66 -57.68 2.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.544 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.2 -174.88 4.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.87 0.367 . . . . 0.0 110.8 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . 0.475 ' HB2' ' CD ' ' C' ' 136' ' ' ARG . . . -127.06 143.82 51.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.395 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.625 HG11 HG11 ' C' ' 32' ' ' VAL . 48.3 t -120.85 116.85 51.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.006 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.16 122.61 6.19 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.685 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -128.58 138.82 52.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 111.022 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.483 HD22 ' CG2' ' C' ' 130' ' ' THR . 1.6 m120 -117.8 150.98 38.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.621 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.589 ' HB ' HG13 ' C' ' 131' ' ' ILE . 9.2 mm -106.83 103.64 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.617 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -61.07 132.25 53.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.751 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . 0.763 ' HB3' ' SG ' ' C' ' 21' ' ' CYS . 1.0 OUTLIER -137.44 151.81 48.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.244 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -138.35 171.39 14.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.962 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' C' ' 21' ' ' CYS . 5.9 m-20 49.97 68.51 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.791 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 0.0 OUTLIER -106.62 141.07 38.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.794 179.825 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.79 117.83 33.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.254 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 23.5 p -91.13 -13.1 33.65 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.58 -39.02 82.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.14 0.495 . . . . 0.0 111.76 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 75.8 t -107.63 -54.15 6.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.627 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.7 84.38 3.37 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.596 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.02 -41.27 10.08 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.911 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.69 159.98 17.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.459 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.71 160.38 39.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.612 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.01 153.01 44.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.18 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.95 136.46 54.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.73 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -141.95 107.4 5.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.618 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' PHE . . . . . 0.468 ' CD2' HD13 ' C' ' 103' ' ' ILE . 43.0 t80 -73.57 136.68 44.02 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.502 0.191 . . . . 0.0 111.082 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' C' ' 153' ' ' THR . 6.6 tt -113.6 111.4 21.81 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.003 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . 0.64 ' HA3' HD11 ' C' ' 113' ' ' LEU . . . -131.35 -178.54 15.53 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.765 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.665 ' H ' HD12 ' C' ' 86' ' ' LEU . 0.2 OUTLIER -104.28 137.55 42.02 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.5 0.191 . . . . 0.0 110.878 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.93 114.81 23.88 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.997 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . 0.613 ' O ' ' HG2' ' F' ' 134' ' ' GLN . 1.2 tt -95.75 -36.72 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' ASP . . . . . 0.902 ' CB ' HG21 ' C' ' 140' ' ' THR . 0.4 OUTLIER -143.39 130.28 20.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.722 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.95 -7.2 47.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.97 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.3 -29.18 68.28 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.637 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.31 -32.73 4.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.903 0.382 . . . . 0.0 110.432 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . 0.421 ' O ' HG22 ' C' ' 83' ' ' THR . 3.5 m 60.59 19.41 9.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.574 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' ASN . . . . . 0.638 ' HB3' ' HG2' ' C' ' 102' ' ' GLN . 0.6 OUTLIER -139.39 -16.94 1.03 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.314 179.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.691 ' HB ' ' HA3' ' C' ' 100' ' ' GLY . 0.8 OUTLIER -66.71 118.08 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.736 -0.666 . . . . 0.0 112.172 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.665 HD12 ' H ' ' C' ' 76' ' ' THR . 10.7 tp -69.79 144.14 52.75 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.27 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.455 ' HB3' ' OG1' ' C' ' 76' ' ' THR . . . -80.07 138.0 36.89 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.777 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.691 ' HB3' ' HA ' ' C' ' 148' ' ' ALA . 0.0 OUTLIER -84.99 -146.67 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.068 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' C' ' 149' ' ' ASN . 0.0 OUTLIER -48.48 155.02 0.57 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.312 -179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . 0.577 ' O ' HG22 ' F' ' 52' ' ' VAL . 33.1 p -86.79 -11.87 49.7 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.991 0.424 . . . . 0.0 111.489 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.42 114.08 5.16 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' ALA . . . . . 0.597 ' HA ' ' HB3' ' F' ' 50' ' ' SER . . . -83.38 22.25 1.05 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.919 0.39 . . . . 0.0 111.728 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.28 21.98 1.2 Allowed 'General case' 0 N--CA 1.461 0.091 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.699 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.75 -32.23 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.974 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' SER . . . . . 0.661 ' HA ' ' HB3' ' C' ' 147' ' ' ALA . 16.0 t -65.15 166.71 9.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.805 0.336 . . . . 0.0 110.682 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . 0.452 ' O ' HD13 ' C' ' 88' ' ' LEU . . . -89.64 163.46 15.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.892 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.37 169.63 17.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.347 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 57.35 29.36 16.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.378 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' VAL . . . . . 0.564 ' HB ' ' HB1' ' C' ' 143' ' ' ALA . 7.2 p -156.35 150.57 10.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.839 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . 0.691 ' HA3' ' HB ' ' C' ' 85' ' ' VAL . . . -164.19 176.93 40.08 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.584 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' VAL . . . . . 0.615 HG22 ' CE1' ' C' ' 137' ' ' TYR . 3.0 t -107.6 111.29 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.06 0.544 . . . . 0.0 111.74 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' GLN . . . . . 0.638 ' HG2' ' HB3' ' C' ' 84' ' ' ASN . 0.0 OUTLIER -75.98 179.73 5.4 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.979 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' C' ' 113' ' ' LEU . 6.0 pt -150.35 116.62 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.418 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' C' ' 134' ' ' GLN . 12.8 tp -97.23 122.55 40.38 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.676 0.274 . . . . 0.0 111.015 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.96 150.07 43.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.718 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . 0.529 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -71.47 -17.56 62.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.793 0.33 . . . . 0.0 111.087 179.559 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . 0.44 HG21 ' HA ' ' C' ' 120' ' ' SER . 74.3 p -76.52 -37.29 56.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.152 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.55 -68.74 0.32 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.705 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.69 123.27 18.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.811 0.339 . . . . 0.0 111.14 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.66 117.98 2.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' LEU . . . . . 0.522 HD11 ' O ' ' C' ' 117' ' ' THR . 2.1 tp -67.83 144.06 55.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.473 0.654 . . . . 0.0 110.502 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' THR . . . . . 0.435 ' HA ' ' ND2' ' C' ' 84' ' ' ASN . 0.2 OUTLIER -75.08 140.43 43.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.127 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.64 HD11 ' HA3' ' C' ' 75' ' ' GLY . 1.3 tp -85.18 97.75 10.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 110.62 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -152.79 -59.03 0.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.68 0.276 . . . . 0.0 111.555 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . 0.57 ' HA3' ' OG1' ' F' ' 130' ' ' THR . . . 135.77 -26.63 3.14 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.577 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' ALA . . . . . 0.748 ' HB2' ' HA ' ' F' ' 129' ' ' ASN . . . -101.36 28.78 5.19 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.055 0.455 . . . . 0.0 111.656 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . 0.522 ' O ' HD11 ' C' ' 111' ' ' LEU . 0.2 OUTLIER -106.56 67.31 0.72 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.05 -179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.38 80.96 8.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.77 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.96 97.46 3.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' SER . . . . . 0.44 ' HA ' HG21 ' C' ' 107' ' ' THR . 2.0 t -165.59 144.83 6.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.6 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.34 50.4 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.144 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.88 94.11 5.78 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.685 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.73 110.4 12.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.729 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . 0.607 ' HG ' ' ND2' ' C' ' 129' ' ' ASN . 0.3 OUTLIER -70.13 154.13 42.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.65 179.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -131.58 144.73 51.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.623 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.77 125.66 24.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.663 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.1 -102.02 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.715 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 86.4 m -106.23 128.55 54.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.652 0.263 . . . . 0.0 110.786 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 129' ' ' ASN . . . . . 0.607 ' ND2' ' HG ' ' C' ' 124' ' ' LEU . 20.1 t-20 -121.19 158.14 28.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.902 0.382 . . . . 0.0 111.116 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . 0.483 ' CG2' HD22 ' C' ' 55' ' ' ASN . 0.2 OUTLIER -155.79 143.09 19.3 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.986 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 131' ' ' ILE . . . . . 0.601 HD13 HG11 ' C' ' 156' ' ' VAL . 0.1 OUTLIER -115.22 110.73 45.2 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 132' ' ' PRO . . . . . 0.529 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.5 Cg_endo -82.1 151.77 16.18 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.632 1.554 . . . . 0.0 112.573 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.02 146.79 17.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.872 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 134' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' C' ' 104' ' ' LEU . 0.8 OUTLIER -114.4 145.8 41.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.088 179.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.76 91.22 1.92 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.936 0.398 . . . . 0.0 111.674 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.58 ' HE ' HG21 ' C' ' 48' ' ' THR . 28.0 mtm-85 -88.33 153.55 21.11 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.345 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 137' ' ' TYR . . . . . 0.615 ' CE1' HG22 ' C' ' 101' ' ' VAL . 0.7 OUTLIER -91.22 111.04 22.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.103 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 138' ' ' PHE . . . . . 0.596 ' CD1' ' HB2' ' C' ' 102' ' ' GLN . 8.8 m-85 -108.13 172.21 6.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.939 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 139' ' ' ALA . . . . . 0.591 ' HB2' ' HB2' ' C' ' 42' ' ' LEU . . . -123.45 143.6 50.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.87 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 140' ' ' THR . . . . . 0.902 HG21 ' CB ' ' C' ' 79' ' ' ASP . 0.2 OUTLIER -98.71 44.47 1.03 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.529 179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.5 89.06 1.07 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.936 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 142' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' C' ' 43' ' ' ALA . . . 60.02 88.09 0.08 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.7 0.25 . . . . 0.0 110.693 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 143' ' ' ALA . . . . . 0.564 ' HB1' ' HB ' ' C' ' 99' ' ' VAL . . . -70.64 161.75 30.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.775 0.321 . . . . 0.0 111.444 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 144' ' ' THR . . . . . 0.635 ' O ' HG11 ' B' ' 16' ' ' VAL . 0.2 OUTLIER -124.49 158.71 60.73 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.191 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 145' ' ' PRO . . . . . 0.53 ' HA ' ' HB ' ' B' ' 16' ' ' VAL . 1.5 Cg_endo -83.72 149.25 12.63 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.501 2.134 . . . . 0.0 112.072 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.7 -119.76 0.86 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.949 -0.644 . . . . 0.0 112.52 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 147' ' ' ALA . . . . . 0.661 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -123.91 127.71 48.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.828 0.346 . . . . 0.0 111.418 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 148' ' ' ALA . . . . . 0.691 ' HA ' ' HB3' ' C' ' 88' ' ' LEU . . . -120.83 67.19 0.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.41 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 149' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' C' ' 89' ' ' GLN . 47.3 t-20 -128.49 114.78 17.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.599 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 150' ' ' ALA . . . . . 0.425 ' HB2' ' C ' ' C' ' 88' ' ' LEU . . . -158.87 146.93 18.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.0 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.33 140.31 32.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.148 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . 0.513 ' O ' HG23 ' B' ' 9' ' ' THR . . . -136.26 169.23 17.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.18 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' C' ' 74' ' ' LEU . 9.3 t -155.09 150.54 27.32 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 154' ' ' PHE . . . . . 0.427 ' HE1' HG13 ' C' ' 56' ' ' ILE . 1.1 p90 -119.05 149.21 42.05 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.077 0.465 . . . . 0.0 110.075 -179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . 0.42 ' HE3' HD13 ' C' ' 74' ' ' LEU . 4.7 mttt -113.48 156.64 23.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.908 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 156' ' ' VAL . . . . . 0.601 HG11 HD13 ' C' ' 131' ' ' ILE . 0.2 OUTLIER -136.45 138.03 47.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.663 -179.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . 0.606 ' HB2' HG22 ' B' ' 4' ' ' THR . 64.1 tt0 -107.5 128.05 54.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.363 0.601 . . . . 0.0 110.365 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . 0.6 ' HB2' ' OG1' ' B' ' 3' ' ' THR . 60.9 m-85 -107.85 107.46 18.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.541 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . 0.727 ' HA ' ' H ' ' B' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.884 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.312 0.101 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.714 ' H ' ' HA ' ' E' ' 159' ' ' GLN . . . 65.87 74.72 0.36 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.937 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' E' ' 158' ' ' TYR . 6.2 p -117.71 97.48 5.88 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.489 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . 0.62 HG22 ' HB2' ' E' ' 157' ' ' GLN . 68.1 p -87.87 108.72 19.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.559 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.401 HG11 HG12 ' E' ' 17' ' ' VAL . 15.3 m -126.63 172.74 13.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.612 179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.13 110.81 12.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.566 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' E' ' 155' ' ' LYS . . . -65.67 -59.51 7.58 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.747 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.52 151.68 14.92 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.809 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . 0.507 HG23 ' O ' ' E' ' 152' ' ' ALA . 24.2 m -103.45 143.08 33.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 111.319 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' VAL . . . . . 0.426 HG12 ' HG3' ' E' ' 30' ' ' GLN . 1.1 m -130.93 115.63 30.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.182 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.63 105.67 14.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.392 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' PHE . . . . . 0.445 ' HD2' HD21 ' E' ' 34' ' ' LEU . 52.0 m-85 -83.21 105.47 14.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.8 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.41 145.13 41.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.452 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.74 -179.67 42.58 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.98 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.26 134.2 22.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.937 0.399 . . . . 0.0 110.406 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.625 HG11 ' O ' ' E' ' 144' ' ' THR . 3.3 t -90.9 127.2 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.174 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.543 HG21 ' HB3' ' D' ' 20' ' ' ALA . 12.1 m -126.31 168.78 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.929 0.395 . . . . 0.0 111.025 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.49 81.85 2.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.092 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' ALA . . . . . 0.447 ' HA ' ' HG2' ' E' ' 38' ' ' ARG . . . 53.31 58.19 5.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.057 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.543 ' HB3' HG21 ' D' ' 17' ' ' VAL . . . -108.6 -62.83 1.41 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.36 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' CYS . . . . . 0.872 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.9 OUTLIER -171.53 -159.88 0.16 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . 0.635 ' HA ' ' HB2' ' E' ' 36' ' ' GLN . . . -156.86 74.03 0.78 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.098 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . 0.465 ' N ' HD23 ' D' ' 58' ' ' LEU . 7.4 p -45.36 140.57 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.081 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.555 ' O ' HG23 ' D' ' 28' ' ' VAL . 0.5 OUTLIER -63.49 140.79 58.91 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.656 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.4 -51.14 69.45 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.302 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.11 -17.98 74.33 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.937 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.96 -6.42 58.03 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.859 0.362 . . . . 0.0 110.818 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . 0.555 HG23 ' O ' ' D' ' 24' ' ' ASP . 50.5 t -72.7 -36.36 52.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.364 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.0 110.88 14.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.008 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' GLN . . . . . 0.44 ' HG3' HG12 ' C' ' 10' ' ' VAL . 0.4 OUTLIER -123.76 146.07 48.57 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.977 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.25 113.83 27.66 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.084 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.612 HG11 HG11 ' D' ' 52' ' ' VAL . 3.3 t -105.15 121.91 57.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.149 0.499 . . . . 0.0 110.433 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.84 106.37 17.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.669 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.456 HD21 ' HD2' ' C' ' 12' ' ' PHE . 0.6 OUTLIER -64.73 -44.74 89.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.595 179.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.6 -156.91 15.99 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.54 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' GLN . . . . . 0.625 ' HB2' ' HA ' ' C' ' 22' ' ' ALA . 3.7 mt-30 -91.06 106.95 18.88 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.656 0.265 . . . . 0.0 110.899 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.574 ' CG1' HD21 ' D' ' 42' ' ' LEU . 4.4 t -92.29 120.63 41.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.839 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . 0.445 ' HG2' ' HA ' ' C' ' 19' ' ' ALA . 4.6 mtm105 -85.68 132.46 34.14 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.742 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.425 HG23 ' O ' ' C' ' 17' ' ' VAL . 29.5 p -71.5 -23.23 61.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.753 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.443 ' CB ' ' HB2' ' C' ' 19' ' ' ALA . . . -68.13 -19.07 64.79 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.974 0.416 . . . . 0.0 110.823 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -90.59 -36.65 14.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.16 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' D' ' 139' ' ' ALA . 0.2 OUTLIER -121.44 70.62 0.94 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.555 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' D' ' 142' ' ' ALA . . . -104.79 28.18 7.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.392 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' GLN . . . . . 0.77 ' HG3' ' HB2' ' D' ' 47' ' ' ALA . 0.0 OUTLIER -150.59 141.92 23.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.437 179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' D' ' 140' ' ' THR . 2.7 tt0 -62.69 101.78 0.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.819 0.342 . . . . 0.0 111.145 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.29 4.23 8.43 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.115 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.77 ' HB2' ' HG3' ' D' ' 44' ' ' GLN . . . -91.67 121.28 33.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.932 0.396 . . . . 0.0 112.03 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' D' ' 137' ' ' TYR . 5.9 t -110.42 151.18 27.8 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.826 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.504 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 5.1 t -95.62 -57.59 2.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.632 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.589 ' HB3' ' HA ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -148.23 -174.85 4.69 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.875 0.369 . . . . 0.0 110.756 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' ALA . . . . . 0.482 ' HB2' ' CD ' ' D' ' 136' ' ' ARG . . . -127.11 143.86 51.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.352 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' VAL . . . . . 0.612 HG11 HG11 ' D' ' 32' ' ' VAL . 48.2 t -120.84 116.86 51.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.974 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . 0.414 ' O ' HG21 ' A' ' 76' ' ' THR . . . -111.15 122.67 6.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.699 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -128.63 138.84 52.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.812 0.339 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' ASN . . . . . 0.479 HD22 ' CG2' ' D' ' 130' ' ' THR . 1.6 m120 -117.86 150.99 38.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.585 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.575 ' HB ' HG13 ' D' ' 131' ' ' ILE . 9.3 mm -106.86 103.77 15.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.547 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.11 132.28 53.23 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.788 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . 0.752 ' HB3' ' SG ' ' D' ' 21' ' ' CYS . 1.0 OUTLIER -137.49 151.81 48.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.205 -179.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -138.32 171.36 14.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.977 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' D' ' 21' ' ' CYS . 5.9 m-20 50.0 68.55 0.73 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.743 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' CYS . . . . . 0.872 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 0.0 OUTLIER -106.67 141.11 38.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.792 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.78 117.83 33.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.254 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 23.4 p -91.21 -13.04 33.55 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -38.98 82.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.081 0.467 . . . . 0.0 111.707 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 75.8 t -107.67 -54.11 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.64 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.69 84.32 3.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.576 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.05 -41.23 10.08 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.955 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.57 159.99 17.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.517 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.7 160.4 39.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.586 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.07 152.94 45.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.157 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.9 136.55 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.699 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.04 107.46 5.03 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.565 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' PHE . . . . . 0.474 ' CD2' HD13 ' D' ' 103' ' ' ILE . 42.9 t80 -73.62 136.61 43.92 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.532 0.206 . . . . 0.0 111.06 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' D' ' 153' ' ' THR . 6.6 tt -113.55 111.39 21.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.006 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . 0.628 ' HA3' HD11 ' D' ' 113' ' ' LEU . . . -131.26 -178.5 15.5 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.883 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . 0.664 ' H ' HD12 ' D' ' 86' ' ' LEU . 0.2 OUTLIER -104.37 137.54 42.1 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.493 0.187 . . . . 0.0 110.825 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.96 114.74 23.84 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.961 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.74 -36.78 6.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.842 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.9 ' CB ' HG21 ' D' ' 140' ' ' THR . 0.4 OUTLIER -143.32 130.19 20.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.8 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.83 -7.28 47.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.991 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.37 -29.14 68.38 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.557 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.33 -32.61 4.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 110.482 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 83' ' ' THR . . . . . 0.428 ' O ' HG22 ' D' ' 83' ' ' THR . 3.5 m 60.47 19.43 9.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.58 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . 0.614 ' HB3' ' HG2' ' D' ' 102' ' ' GLN . 0.6 OUTLIER -139.31 -16.94 1.04 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.409 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.699 ' HB ' ' HA3' ' D' ' 100' ' ' GLY . 0.9 OUTLIER -66.77 118.03 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.206 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.664 HD12 ' H ' ' D' ' 76' ' ' THR . 10.7 tp -69.7 144.13 52.91 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.275 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.454 ' HB3' ' OG1' ' D' ' 76' ' ' THR . . . -80.14 138.06 36.84 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.892 0.377 . . . . 0.0 111.71 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.698 ' HB3' ' HA ' ' D' ' 148' ' ' ALA . 0.0 OUTLIER -84.96 -146.62 0.1 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.079 179.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 89' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' D' ' 149' ' ' ASN . 0.0 OUTLIER -48.48 155.03 0.57 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.293 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 32.4 p -86.77 -11.91 49.67 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.912 0.387 . . . . 0.0 111.533 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . . . . . . . . . 8.2 t -66.43 114.15 5.22 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.936 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.34 22.09 1.07 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.932 0.396 . . . . 0.0 111.706 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.2 21.97 1.21 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.73 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.7 -32.3 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.957 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 95' ' ' SER . . . . . 0.659 ' HA ' ' HB3' ' D' ' 147' ' ' ALA . 15.8 t -65.16 166.64 9.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.799 0.333 . . . . 0.0 110.654 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 96' ' ' ALA . . . . . 0.466 ' O ' HD13 ' D' ' 88' ' ' LEU . . . -89.59 163.53 15.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.827 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.45 169.7 17.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.276 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 98' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 57.26 29.42 16.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.38 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 99' ' ' VAL . . . . . 0.553 ' HB ' ' HB1' ' D' ' 143' ' ' ALA . 7.1 p -156.39 150.54 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.833 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 100' ' ' GLY . . . . . 0.699 ' HA3' ' HB ' ' D' ' 85' ' ' VAL . . . -164.14 176.95 40.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.587 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 101' ' ' VAL . . . . . 0.614 HG22 ' CE1' ' D' ' 137' ' ' TYR . 3.0 t -107.62 111.32 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 123.078 0.551 . . . . 0.0 111.663 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 102' ' ' GLN . . . . . 0.614 ' HG2' ' HB3' ' D' ' 84' ' ' ASN . 0.0 OUTLIER -76.0 179.72 5.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.942 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 103' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' D' ' 113' ' ' LEU . 6.0 pt -150.33 116.56 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.43 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 104' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' D' ' 134' ' ' GLN . 12.8 tp -97.21 122.55 40.36 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 111.068 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.91 150.11 42.86 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.65 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 106' ' ' ARG . . . . . 0.509 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -71.5 -17.54 62.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.846 0.355 . . . . 0.0 111.102 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 107' ' ' THR . . . . . 0.426 HG21 ' HA ' ' D' ' 120' ' ' SER . 76.1 p -76.62 -37.29 56.62 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.111 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.57 -68.74 0.32 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.677 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.55 123.17 18.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.772 0.32 . . . . 0.0 111.191 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.79 118.0 2.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.939 0.4 . . . . 0.0 111.15 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 111' ' ' LEU . . . . . 0.506 HD11 ' O ' ' D' ' 117' ' ' THR . 2.1 tp -67.88 144.09 55.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.43 0.633 . . . . 0.0 110.46 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 112' ' ' THR . . . . . 0.433 ' HA ' ' ND2' ' D' ' 84' ' ' ASN . 0.2 OUTLIER -75.15 140.46 43.37 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.095 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 113' ' ' LEU . . . . . 0.628 HD11 ' HA3' ' D' ' 75' ' ' GLY . 1.3 tp -85.15 97.78 10.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.748 0.308 . . . . 0.0 110.596 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -152.83 -59.07 0.14 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.65 0.262 . . . . 0.0 111.494 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.77 -26.61 3.14 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.552 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.34 28.82 5.15 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.045 0.45 . . . . 0.0 111.676 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 117' ' ' THR . . . . . 0.506 ' O ' HD11 ' D' ' 111' ' ' LEU . 0.2 OUTLIER -106.57 67.38 0.72 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.03 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.43 80.89 8.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.739 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -134.95 97.55 3.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.881 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 120' ' ' SER . . . . . 0.426 ' HA ' HG21 ' D' ' 107' ' ' THR . 2.0 t -165.66 144.79 6.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.531 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.32 50.34 0.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.204 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.81 94.11 5.73 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.714 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.69 110.26 12.38 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.69 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . 0.602 ' HG ' ' ND2' ' D' ' 129' ' ' ASN . 0.3 OUTLIER -70.1 154.1 42.35 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.558 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.58 144.77 51.32 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.584 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.75 125.63 24.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.645 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 115.1 -101.99 1.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.701 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 128' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 116' ' ' ALA . 86.6 m -106.25 128.5 54.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.662 0.267 . . . . 0.0 110.773 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 129' ' ' ASN . . . . . 0.731 ' HA ' ' HB2' ' A' ' 116' ' ' ALA . 20.1 t-20 -121.15 158.25 28.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.874 0.368 . . . . 0.0 111.109 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 130' ' ' THR . . . . . 0.556 ' OG1' ' HA3' ' A' ' 115' ' ' GLY . 0.2 OUTLIER -155.87 143.08 19.21 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.057 -179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 131' ' ' ILE . . . . . 0.603 HD13 HG11 ' D' ' 156' ' ' VAL . 0.1 OUTLIER -115.28 110.75 45.05 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 132' ' ' PRO . . . . . 0.509 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.4 Cg_endo -82.16 151.83 16.06 Favored 'Trans proline' 0 C--N 1.357 0.996 0 C-N-CA 121.666 1.577 . . . . 0.0 112.499 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.07 146.72 17.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 134' ' ' GLN . . . . . 0.618 ' HG2' ' O ' ' A' ' 78' ' ' ILE . 0.8 OUTLIER -114.36 145.92 41.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.031 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.85 91.09 1.9 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.41 . . . . 0.0 111.735 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 136' ' ' ARG . . . . . 0.565 ' HE ' HG21 ' D' ' 48' ' ' THR . 28.1 mtm-85 -88.32 153.52 21.13 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.443 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 137' ' ' TYR . . . . . 0.614 ' CE1' HG22 ' D' ' 101' ' ' VAL . 0.7 OUTLIER -91.1 110.96 22.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.173 179.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 138' ' ' PHE . . . . . 0.607 ' CD1' ' HB2' ' D' ' 102' ' ' GLN . 8.8 m-85 -108.08 172.16 6.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.253 0.549 . . . . 0.0 111.971 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 139' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' D' ' 42' ' ' LEU . . . -123.39 143.64 49.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.89 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 140' ' ' THR . . . . . 0.9 HG21 ' CB ' ' D' ' 79' ' ' ASP . 0.2 OUTLIER -98.78 44.46 1.03 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.514 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.54 88.97 1.08 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.966 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' D' ' 43' ' ' ALA . . . 60.08 88.04 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.745 0.273 . . . . 0.0 110.73 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 143' ' ' ALA . . . . . 0.553 ' HB1' ' HB ' ' D' ' 99' ' ' VAL . . . -70.59 161.73 30.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.784 0.326 . . . . 0.0 111.479 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 144' ' ' THR . . . . . 0.634 ' O ' HG11 ' C' ' 16' ' ' VAL . 0.2 OUTLIER -124.54 158.77 60.69 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.203 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 145' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' C' ' 16' ' ' VAL . 1.4 Cg_endo -83.83 149.22 12.47 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.491 2.127 . . . . 0.0 111.995 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.71 -119.75 0.86 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.519 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 147' ' ' ALA . . . . . 0.659 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -123.95 127.65 48.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.799 0.333 . . . . 0.0 111.452 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 148' ' ' ALA . . . . . 0.698 ' HA ' ' HB3' ' D' ' 88' ' ' LEU . . . -120.86 67.2 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.124 0.488 . . . . 0.0 110.376 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 149' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' D' ' 89' ' ' GLN . 47.5 t-20 -128.54 114.77 17.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.607 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 150' ' ' ALA . . . . . 0.432 ' HB2' ' C ' ' D' ' 88' ' ' LEU . . . -158.8 147.01 18.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.994 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.4 140.31 32.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.173 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 152' ' ' ALA . . . . . 0.5 ' O ' HG23 ' C' ' 9' ' ' THR . . . -136.2 169.29 17.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.183 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 153' ' ' THR . . . . . 0.467 ' O ' ' HB3' ' D' ' 74' ' ' LEU . 9.3 t -155.15 150.52 27.2 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 154' ' ' PHE . . . . . 0.441 ' HE1' HG13 ' D' ' 56' ' ' ILE . 1.1 p90 -119.06 149.25 41.98 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.066 0.46 . . . . 0.0 110.059 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . 0.432 ' HE3' HD13 ' D' ' 74' ' ' LEU . 4.7 mttt -113.48 156.67 23.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.924 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 156' ' ' VAL . . . . . 0.603 HG11 HD13 ' D' ' 131' ' ' ILE . 0.2 OUTLIER -136.49 138.04 47.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.627 -179.073 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 157' ' ' GLN . . . . . 0.629 ' HB2' HG22 ' C' ' 4' ' ' THR . 64.1 tt0 -107.41 128.01 54.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.27 0.557 . . . . 0.0 110.37 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . 0.594 ' HB2' ' OG1' ' C' ' 3' ' ' THR . 61.0 m-85 -107.85 107.45 18.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.49 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 159' ' ' GLN . . . . . 0.71 ' HA ' ' H ' ' C' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 120.281 0.086 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . 0.718 ' H ' ' HA ' ' F' ' 159' ' ' GLN . . . 65.96 74.63 0.36 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.978 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 3' ' ' THR . . . . . 0.592 ' OG1' ' HB2' ' F' ' 158' ' ' TYR . 6.1 p -117.74 97.53 5.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.482 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 4' ' ' THR . . . . . 0.61 HG22 ' HB2' ' F' ' 157' ' ' GLN . 68.3 p -87.89 108.67 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.562 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.59 172.75 13.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.627 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.16 110.86 12.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.567 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 7' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' F' ' 155' ' ' LYS . . . -65.85 -59.37 7.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.737 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.59 151.7 14.91 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.804 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 9' ' ' THR . . . . . 0.511 HG23 ' O ' ' F' ' 152' ' ' ALA . 24.2 m -103.46 143.1 33.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.799 0.333 . . . . 0.0 111.316 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 10' ' ' VAL . . . . . 0.427 HG12 ' HG3' ' F' ' 30' ' ' GLN . 1.1 m -130.97 115.67 31.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.171 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -83.65 105.78 14.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.347 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 12' ' ' PHE . . . . . 0.437 ' HD2' HD21 ' F' ' 34' ' ' LEU . 52.3 m-85 -83.15 105.5 14.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.804 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.45 145.04 41.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.4 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.75 -179.59 42.63 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.942 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.27 134.21 22.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.913 0.387 . . . . 0.0 110.35 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 16' ' ' VAL . . . . . 0.637 HG11 ' O ' ' F' ' 144' ' ' THR . 3.3 t -90.93 127.11 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.232 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . 0.533 HG21 ' HB3' ' E' ' 20' ' ' ALA . 11.9 m -126.22 168.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.811 0.339 . . . . 0.0 111.08 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -100.43 81.78 2.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.133 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 19' ' ' ALA . . . . . 0.436 ' HA ' ' HG2' ' F' ' 38' ' ' ARG . . . 53.35 58.15 5.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.078 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.533 ' HB3' HG21 ' E' ' 17' ' ' VAL . . . -108.58 -62.8 1.41 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.44 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 21' ' ' CYS . . . . . 0.821 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.9 OUTLIER -171.54 -159.87 0.16 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.946 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 22' ' ' ALA . . . . . 0.631 ' HA ' ' HB2' ' F' ' 36' ' ' GLN . . . -156.86 74.05 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.098 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 23' ' ' VAL . . . . . 0.466 ' N ' HD23 ' E' ' 58' ' ' LEU . 7.4 p -45.38 140.6 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.06 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 24' ' ' ASP . . . . . 0.539 ' O ' HG23 ' E' ' 28' ' ' VAL . 0.5 OUTLIER -63.45 140.82 58.91 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.614 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.08 69.83 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.288 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.13 -17.97 74.36 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.939 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.99 -6.37 58.03 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 120.843 0.354 . . . . 0.0 110.757 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 28' ' ' VAL . . . . . 0.539 HG23 ' O ' ' E' ' 24' ' ' ASP . 50.5 t -72.7 -36.34 52.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.365 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -126.02 110.81 13.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.984 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 30' ' ' GLN . . . . . 0.426 ' HG3' HG12 ' D' ' 10' ' ' VAL . 0.4 OUTLIER -123.79 146.01 48.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.994 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.15 113.77 27.56 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.132 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.621 HG11 HG11 ' E' ' 52' ' ' VAL . 3.3 t -105.03 121.98 57.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.175 0.512 . . . . 0.0 110.398 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.95 106.44 17.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.623 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.445 HD21 ' HD2' ' D' ' 12' ' ' PHE . 0.6 OUTLIER -64.75 -44.73 89.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.643 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.53 -156.86 16.05 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.587 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 36' ' ' GLN . . . . . 0.635 ' HB2' ' HA ' ' D' ' 22' ' ' ALA . 3.7 mt-30 -91.11 106.93 18.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.656 0.265 . . . . 0.0 110.828 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.575 ' CG1' HD21 ' E' ' 42' ' ' LEU . 4.4 t -92.33 120.61 41.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.874 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . 0.447 ' HG2' ' HA ' ' D' ' 19' ' ' ALA . 4.5 mtm105 -85.65 132.49 34.15 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.756 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 39' ' ' THR . . . . . 0.433 HG23 ' O ' ' D' ' 17' ' ' VAL . 29.5 p -71.49 -23.37 61.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.733 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' D' ' 19' ' ' ALA . . . -68.0 -19.1 64.89 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.987 0.422 . . . . 0.0 110.842 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -90.61 -36.53 14.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.181 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.581 ' HB2' ' HB2' ' E' ' 139' ' ' ALA . 0.2 OUTLIER -121.47 70.58 0.94 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.621 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 43' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' E' ' 142' ' ' ALA . . . -104.74 28.17 7.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.49 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 44' ' ' GLN . . . . . 0.778 ' HG3' ' HB2' ' E' ' 47' ' ' ALA . 0.0 OUTLIER -150.57 141.95 23.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.469 179.639 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . 0.434 ' HG3' ' HA ' ' E' ' 140' ' ' THR . 2.7 tt0 -62.74 101.81 0.29 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.839 0.352 . . . . 0.0 111.111 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.33 4.22 8.41 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.121 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 47' ' ' ALA . . . . . 0.778 ' HB2' ' HG3' ' E' ' 44' ' ' GLN . . . -91.78 121.24 33.23 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.008 0.433 . . . . 0.0 111.966 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' E' ' 137' ' ' TYR . 5.9 t -110.35 151.18 27.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.868 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 5.1 t -95.59 -57.66 2.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.62 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 50' ' ' SER . . . . . 0.601 ' HB3' ' HA ' ' B' ' 92' ' ' ALA . 0.2 OUTLIER -148.31 -174.82 4.69 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.918 0.389 . . . . 0.0 110.739 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 51' ' ' ALA . . . . . 0.476 ' HB2' ' CD ' ' E' ' 136' ' ' ARG . . . -127.09 143.83 51.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.359 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 52' ' ' VAL . . . . . 0.621 HG11 HG11 ' E' ' 32' ' ' VAL . 48.3 t -120.85 116.81 51.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 53' ' ' GLY . . . . . 0.402 ' O ' HG21 ' B' ' 76' ' ' THR . . . -111.18 122.69 6.22 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.653 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -128.63 138.79 52.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 111.001 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 55' ' ' ASN . . . . . 0.474 HD22 ' CG2' ' E' ' 130' ' ' THR . 1.5 m120 -117.82 150.9 38.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.654 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 56' ' ' ILE . . . . . 0.588 ' HB ' HG13 ' E' ' 131' ' ' ILE . 9.2 mm -106.77 103.72 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.549 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 57' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -61.13 132.26 53.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.774 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . 0.761 ' HB3' ' SG ' ' E' ' 21' ' ' CYS . 1.0 OUTLIER -137.47 151.8 48.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.223 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -138.33 171.35 14.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.98 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 60' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' E' ' 21' ' ' CYS . 6.0 m-20 50.01 68.47 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.83 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 61' ' ' CYS . . . . . 0.821 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 0.0 OUTLIER -106.63 141.09 38.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.95 0.405 . . . . 0.0 110.722 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.74 117.79 33.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.288 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 23.4 p -91.11 -13.18 33.55 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.6 -38.85 82.36 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.071 0.462 . . . . 0.0 111.849 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 76.4 t -107.71 -54.14 6.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.612 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.72 84.3 3.35 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.581 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.98 -41.26 10.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.97 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.65 159.99 17.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.457 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.76 160.38 39.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.582 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.05 152.93 45.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.102 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 1.7 t -116.9 136.53 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.714 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.0 107.5 5.05 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.61 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 73' ' ' PHE . . . . . 0.479 ' CD2' HD13 ' E' ' 103' ' ' ILE . 43.2 t80 -73.7 136.72 43.77 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.569 0.224 . . . . 0.0 110.995 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 74' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' E' ' 153' ' ' THR . 6.6 tt -113.61 111.39 21.78 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.947 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . 0.632 ' HA3' HD11 ' E' ' 113' ' ' LEU . . . -131.29 -178.55 15.53 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.843 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 76' ' ' THR . . . . . 0.658 ' H ' HD12 ' E' ' 86' ' ' LEU . 0.2 OUTLIER -104.28 137.54 42.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.479 0.18 . . . . 0.0 110.837 179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.97 114.81 23.91 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.021 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.77 -36.73 6.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.825 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 79' ' ' ASP . . . . . 0.889 ' CB ' HG21 ' E' ' 140' ' ' THR . 0.4 OUTLIER -143.36 130.21 20.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.756 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.89 -7.23 47.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.04 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.28 -29.25 68.38 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.606 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.34 -32.62 4.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 110.442 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 83' ' ' THR . . . . . 0.429 ' O ' HG22 ' E' ' 83' ' ' THR . 3.5 m 60.53 19.46 9.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.574 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 84' ' ' ASN . . . . . 0.619 ' HB3' ' HG2' ' E' ' 102' ' ' GLN . 0.6 OUTLIER -139.43 -16.94 1.02 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.323 179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.694 ' HB ' ' HA3' ' E' ' 100' ' ' GLY . 0.9 OUTLIER -66.69 117.99 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.243 179.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 86' ' ' LEU . . . . . 0.658 HD12 ' H ' ' E' ' 76' ' ' THR . 10.6 tp -69.71 144.15 52.89 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.291 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 87' ' ' ALA . . . . . 0.448 ' HB3' ' OG1' ' E' ' 76' ' ' THR . . . -80.1 138.06 36.87 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.892 0.377 . . . . 0.0 111.677 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.7 ' HB3' ' HA ' ' E' ' 148' ' ' ALA . 0.0 OUTLIER -85.0 -146.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.115 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 89' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' E' ' 149' ' ' ASN . 0.0 OUTLIER -48.54 155.04 0.58 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.807 0.337 . . . . 0.0 111.263 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 31.9 p -86.71 -11.9 49.84 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.549 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.43 114.05 5.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.975 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.35 22.17 1.06 Allowed 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.007 0.432 . . . . 0.0 111.714 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.28 22.05 1.19 Allowed 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.729 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.7 -32.29 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.537 -0.84 . . . . 0.0 113.001 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 95' ' ' SER . . . . . 0.646 ' HA ' ' HB3' ' E' ' 147' ' ' ALA . 15.8 t -65.12 166.7 9.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.652 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 96' ' ' ALA . . . . . 0.461 ' O ' HD13 ' E' ' 88' ' ' LEU . . . -89.67 163.43 15.13 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.35 169.68 17.1 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.378 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 98' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 57.32 29.37 16.72 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.415 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 99' ' ' VAL . . . . . 0.563 ' HB ' ' HB1' ' E' ' 143' ' ' ALA . 7.1 p -156.46 150.6 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.75 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 100' ' ' GLY . . . . . 0.694 ' HA3' ' HB ' ' E' ' 85' ' ' VAL . . . -164.18 176.85 40.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.583 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 101' ' ' VAL . . . . . 0.606 HG22 ' CE1' ' E' ' 137' ' ' TYR . 3.0 t -107.63 111.36 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 123.011 0.524 . . . . 0.0 111.709 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 102' ' ' GLN . . . . . 0.619 ' HG2' ' HB3' ' E' ' 84' ' ' ASN . 0.0 OUTLIER -76.02 179.75 5.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.943 -179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 103' ' ' ILE . . . . . 0.494 HD11 ' HA ' ' E' ' 113' ' ' LEU . 5.9 pt -150.39 116.56 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.387 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 104' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' E' ' 134' ' ' GLN . 12.9 tp -97.21 122.54 40.35 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.714 0.292 . . . . 0.0 111.095 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -62.91 150.16 42.74 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.724 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 106' ' ' ARG . . . . . 0.504 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -71.48 -17.6 62.35 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.792 0.33 . . . . 0.0 111.076 179.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . 0.432 HG21 ' HA ' ' E' ' 120' ' ' SER . 75.4 p -76.62 -37.23 56.73 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.129 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.52 -68.76 0.32 Allowed Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.715 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.66 123.23 18.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.83 0.348 . . . . 0.0 111.106 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.7 118.01 2.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.509 HD11 ' O ' ' E' ' 117' ' ' THR . 2.1 tp -67.91 144.12 55.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.39 0.614 . . . . 0.0 110.528 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 112' ' ' THR . . . . . 0.429 ' HA ' ' ND2' ' E' ' 84' ' ' ASN . 0.2 OUTLIER -75.13 140.48 43.43 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.133 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 113' ' ' LEU . . . . . 0.632 HD11 ' HA3' ' E' ' 75' ' ' GLY . 1.3 tp -85.25 97.79 10.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.732 0.301 . . . . 0.0 110.606 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -152.81 -58.94 0.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.579 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.75 -26.62 3.14 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.583 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.42 28.85 5.16 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.007 0.432 . . . . 0.0 111.626 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 117' ' ' THR . . . . . 0.509 ' O ' HD11 ' E' ' 111' ' ' LEU . 0.2 OUTLIER -106.59 67.31 0.72 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.087 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -82.44 81.07 8.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.709 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.13 97.47 3.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.872 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 120' ' ' SER . . . . . 0.432 ' HA ' HG21 ' E' ' 107' ' ' THR . 1.9 t -165.5 144.77 6.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.597 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.28 50.35 0.9 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.214 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.88 94.11 5.78 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.713 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.63 110.38 12.4 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.741 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . 0.605 ' HG ' ' ND2' ' E' ' 129' ' ' ASN . 0.3 OUTLIER -70.19 154.13 42.28 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.567 179.418 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.62 144.75 51.28 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.564 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.75 125.69 24.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.647 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . 0.528 ' HA3' HG21 ' A' ' 4' ' ' THR . . . 115.03 -102.0 1.1 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.737 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 128' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' B' ' 116' ' ' ALA . 87.1 m -106.21 128.46 53.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.604 0.24 . . . . 0.0 110.849 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 129' ' ' ASN . . . . . 0.751 ' HA ' ' HB2' ' B' ' 116' ' ' ALA . 20.1 t-20 -121.15 158.18 28.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.881 0.372 . . . . 0.0 111.147 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 130' ' ' THR . . . . . 0.555 ' OG1' ' HA3' ' B' ' 115' ' ' GLY . 0.2 OUTLIER -155.83 143.1 19.26 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.009 -179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 131' ' ' ILE . . . . . 0.609 HD13 HG11 ' E' ' 156' ' ' VAL . 0.1 OUTLIER -115.23 110.83 45.07 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 132' ' ' PRO . . . . . 0.504 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.3 Cg_endo -82.21 151.86 15.96 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.634 1.556 . . . . 0.0 112.548 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.08 146.79 17.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.795 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 134' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' B' ' 78' ' ' ILE . 0.8 OUTLIER -114.37 145.87 41.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.068 179.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.87 91.14 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.962 0.41 . . . . 0.0 111.713 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 136' ' ' ARG . . . . . 0.568 ' HE ' HG21 ' E' ' 48' ' ' THR . 28.2 mtm-85 -88.27 153.54 21.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.41 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 137' ' ' TYR . . . . . 0.606 ' CE1' HG22 ' E' ' 101' ' ' VAL . 0.7 OUTLIER -91.26 111.14 22.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.059 179.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 138' ' ' PHE . . . . . 0.607 ' CD1' ' HB2' ' E' ' 102' ' ' GLN . 8.7 m-85 -108.22 172.21 6.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.968 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 139' ' ' ALA . . . . . 0.581 ' HB2' ' HB2' ' E' ' 42' ' ' LEU . . . -123.47 143.64 50.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.823 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 140' ' ' THR . . . . . 0.889 HG21 ' CB ' ' E' ' 79' ' ' ASP . 0.2 OUTLIER -98.72 44.43 1.03 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.567 179.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.51 89.07 1.07 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.963 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 142' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' E' ' 43' ' ' ALA . . . 60.03 88.04 0.08 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.696 0.248 . . . . 0.0 110.769 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 143' ' ' ALA . . . . . 0.563 ' HB1' ' HB ' ' E' ' 99' ' ' VAL . . . -70.62 161.73 30.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 111.458 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 144' ' ' THR . . . . . 0.625 ' O ' HG11 ' D' ' 16' ' ' VAL . 0.2 OUTLIER -124.48 158.73 60.65 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.23 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 145' ' ' PRO . . . . . 0.51 ' HA ' ' HB ' ' D' ' 16' ' ' VAL . 1.4 Cg_endo -83.76 149.23 12.57 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.569 2.179 . . . . 0.0 112.022 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.69 -119.72 0.86 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.582 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 147' ' ' ALA . . . . . 0.646 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -123.95 127.73 48.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.877 0.37 . . . . 0.0 111.384 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 148' ' ' ALA . . . . . 0.7 ' HA ' ' HB3' ' E' ' 88' ' ' LEU . . . -120.85 67.16 0.86 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.434 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 149' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' E' ' 89' ' ' GLN . 47.5 t-20 -128.51 114.82 17.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.594 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 150' ' ' ALA . . . . . 0.416 ' HB2' ' C ' ' E' ' 88' ' ' LEU . . . -158.85 147.0 18.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.03 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.48 140.28 32.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.218 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 152' ' ' ALA . . . . . 0.507 ' O ' HG23 ' D' ' 9' ' ' THR . . . -136.21 169.23 17.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.149 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 153' ' ' THR . . . . . 0.453 ' O ' ' HB3' ' E' ' 74' ' ' LEU . 9.4 t -155.06 150.54 27.35 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 154' ' ' PHE . . . . . 0.442 ' HE1' HG13 ' E' ' 56' ' ' ILE . 1.1 p90 -119.05 149.3 41.9 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.1 0.476 . . . . 0.0 110.025 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . 0.447 ' HE3' HD13 ' E' ' 74' ' ' LEU . 4.7 mttt -113.53 156.74 23.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.85 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 156' ' ' VAL . . . . . 0.609 HG11 HD13 ' E' ' 131' ' ' ILE . 0.2 OUTLIER -136.51 138.01 47.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.653 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 157' ' ' GLN . . . . . 0.62 ' HB2' HG22 ' D' ' 4' ' ' THR . 64.1 tt0 -107.46 128.05 54.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.307 0.575 . . . . 0.0 110.328 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . 0.594 ' HB2' ' OG1' ' D' ' 3' ' ' THR . 61.0 m-85 -107.89 107.5 18.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.531 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 159' ' ' GLN . . . . . 0.714 ' HA ' ' H ' ' D' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.276 0.084 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.82 74.75 0.36 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.973 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 6.2 p -117.75 97.53 5.9 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.504 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 69.1 p -87.84 108.64 19.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.592 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 15.4 m -126.55 172.72 13.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.618 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -77.24 110.85 12.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.572 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.79 -59.37 7.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.75 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.56 151.71 14.96 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.763 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 24.2 m -103.53 143.09 33.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.898 0.38 . . . . 0.0 111.253 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.92 115.62 30.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.241 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -83.59 105.79 14.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.397 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -83.21 105.5 14.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.76 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.49 145.09 41.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.43 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.75 -179.64 42.6 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.969 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.27 134.18 22.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 110.387 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 t -90.92 127.19 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.257 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 17' ' ' VAL . . . . . 0.531 HG21 ' HB3' ' F' ' 20' ' ' ALA . 12.0 m -126.25 168.74 18.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.887 0.375 . . . . 0.0 111.042 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -100.42 81.83 2.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.149 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . 53.23 58.27 5.43 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.05 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . 0.531 ' HB3' HG21 ' F' ' 17' ' ' VAL . . . -108.61 -62.85 1.41 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.376 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 21' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.9 OUTLIER -171.57 -159.92 0.16 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.884 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -156.86 74.0 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.085 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 23' ' ' VAL . . . . . 0.468 ' N ' HD23 ' F' ' 58' ' ' LEU . 7.4 p -45.35 140.64 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.015 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 24' ' ' ASP . . . . . 0.547 ' O ' HG23 ' F' ' 28' ' ' VAL . 0.5 OUTLIER -63.45 140.79 58.91 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.679 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.41 -51.08 69.7 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.341 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.14 -18.06 74.45 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.871 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 4.3 m -87.94 -6.37 58.06 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.865 0.364 . . . . 0.0 110.835 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 28' ' ' VAL . . . . . 0.547 HG23 ' O ' ' F' ' 24' ' ' ASP . 50.6 t -72.66 -36.39 53.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.403 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.92 110.88 14.13 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 30' ' ' GLN . . . . . 0.427 ' HG3' HG12 ' E' ' 10' ' ' VAL . 0.4 OUTLIER -123.84 146.04 48.66 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.982 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 2.9 p -105.17 113.84 27.67 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.208 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.631 HG11 HG11 ' F' ' 52' ' ' VAL . 3.3 t -105.11 121.95 57.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.141 0.496 . . . . 0.0 110.457 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.83 106.39 17.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.633 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 34' ' ' LEU . . . . . 0.437 HD21 ' HD2' ' E' ' 12' ' ' PHE . 0.6 OUTLIER -64.77 -44.69 89.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.62 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.53 -156.97 16.01 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.561 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 36' ' ' GLN . . . . . 0.631 ' HB2' ' HA ' ' E' ' 22' ' ' ALA . 3.7 mt-30 -91.04 106.97 18.89 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.628 0.251 . . . . 0.0 110.911 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.58 ' CG1' HD21 ' F' ' 42' ' ' LEU . 4.4 t -92.35 120.55 41.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.92 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 38' ' ' ARG . . . . . 0.436 ' HG2' ' HA ' ' E' ' 19' ' ' ALA . 4.5 mtm105 -85.59 132.5 34.17 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.753 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 39' ' ' THR . . . . . 0.435 HG23 ' O ' ' E' ' 17' ' ' VAL . 29.4 p -71.56 -23.22 61.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.729 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' E' ' 19' ' ' ALA . . . -68.04 -19.19 64.87 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.007 0.432 . . . . 0.0 110.815 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 13.8 t -90.54 -36.6 14.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.16 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . 0.58 HD21 ' CG1' ' F' ' 37' ' ' VAL . 0.2 OUTLIER -121.43 70.56 0.94 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.648 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 43' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' F' ' 142' ' ' ALA . . . -104.82 28.11 7.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.331 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 44' ' ' GLN . . . . . 0.754 ' HG3' ' HB2' ' F' ' 47' ' ' ALA . 0.0 OUTLIER -150.54 142.01 23.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.392 179.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . 0.449 ' HG3' ' HA ' ' F' ' 140' ' ' THR . 2.7 tt0 -62.71 101.84 0.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.786 0.326 . . . . 0.0 111.084 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.21 4.27 8.47 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.197 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 47' ' ' ALA . . . . . 0.754 ' HB2' ' HG3' ' F' ' 44' ' ' GLN . . . -91.8 121.33 33.32 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.953 0.406 . . . . 0.0 111.981 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . 0.582 ' HA ' ' O ' ' F' ' 137' ' ' TYR . 5.9 t -110.41 151.13 27.86 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.836 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 49' ' ' SER . . . . . 0.494 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 5.2 t -95.63 -57.6 2.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.6 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 50' ' ' SER . . . . . 0.597 ' HB3' ' HA ' ' C' ' 92' ' ' ALA . 0.2 OUTLIER -148.24 -174.81 4.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.806 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 51' ' ' ALA . . . . . 0.474 ' HB2' ' CD ' ' F' ' 136' ' ' ARG . . . -127.13 143.84 51.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.284 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 52' ' ' VAL . . . . . 0.631 HG11 HG11 ' F' ' 32' ' ' VAL . 48.2 t -120.84 116.87 51.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.015 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 53' ' ' GLY . . . . . 0.41 ' O ' HG21 ' C' ' 76' ' ' THR . . . -111.18 122.69 6.21 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.648 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -128.63 138.85 52.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.78 0.324 . . . . 0.0 110.934 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 55' ' ' ASN . . . . . 0.479 HD22 ' CG2' ' F' ' 130' ' ' THR . 1.6 m120 -117.88 150.97 38.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.607 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 56' ' ' ILE . . . . . 0.592 ' HB ' HG13 ' F' ' 131' ' ' ILE . 9.3 mm -106.82 103.7 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.585 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 57' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -61.13 132.22 53.04 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.769 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . 0.761 ' HB3' ' SG ' ' F' ' 21' ' ' CYS . 1.0 OUTLIER -137.4 151.74 48.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.253 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -138.3 171.43 14.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.026 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 60' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' F' ' 21' ' ' CYS . 5.9 m-20 49.95 68.52 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.812 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 61' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 0.0 OUTLIER -106.68 141.08 38.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.984 0.421 . . . . 0.0 110.736 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.74 117.83 33.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.266 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 23.4 p -91.15 -13.16 33.49 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.61 -38.95 82.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.033 0.444 . . . . 0.0 111.753 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 76.2 t -107.64 -54.1 6.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.65 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.76 84.33 3.34 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.604 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.97 -41.26 10.1 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.969 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -110.64 159.97 17.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.436 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.73 160.41 39.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.592 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.03 152.9 45.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.156 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.95 136.55 53.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.682 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.04 107.46 5.03 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.525 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 73' ' ' PHE . . . . . 0.467 ' CD2' HD13 ' F' ' 103' ' ' ILE . 43.0 t80 -73.63 136.7 43.91 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.58 0.228 . . . . 0.0 111.049 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 74' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' F' ' 153' ' ' THR . 6.6 tt -113.62 111.4 21.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.939 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . 0.635 ' HA3' HD11 ' F' ' 113' ' ' LEU . . . -131.31 -178.55 15.53 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.836 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 76' ' ' THR . . . . . 0.677 ' H ' HD12 ' F' ' 86' ' ' LEU . 0.2 OUTLIER -104.32 137.62 41.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.51 0.195 . . . . 0.0 110.79 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.02 114.73 23.88 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.935 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 tt -95.69 -36.75 6.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.866 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 79' ' ' ASP . . . . . 0.9 ' CB ' HG21 ' F' ' 140' ' ' THR . 0.4 OUTLIER -143.38 130.26 20.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.752 -179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -71.94 -7.23 47.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.973 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -60.31 -29.2 68.34 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.636 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.28 -32.73 4.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.863 0.364 . . . . 0.0 110.455 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 83' ' ' THR . . . . . 0.427 ' O ' HG22 ' F' ' 83' ' ' THR . 3.4 m 60.55 19.37 9.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.632 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 84' ' ' ASN . . . . . 0.62 ' HB3' ' HG2' ' F' ' 102' ' ' GLN . 0.6 OUTLIER -139.36 -16.92 1.03 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.413 179.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 85' ' ' VAL . . . . . 0.686 ' HB ' ' HA3' ' F' ' 100' ' ' GLY . 0.8 OUTLIER -66.71 117.97 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.196 179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 86' ' ' LEU . . . . . 0.677 HD12 ' H ' ' F' ' 76' ' ' THR . 10.7 tp -69.67 144.1 52.98 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.36 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 87' ' ' ALA . . . . . 0.454 ' HB3' ' OG1' ' F' ' 76' ' ' THR . . . -80.1 138.03 36.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.904 0.383 . . . . 0.0 111.762 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . 0.683 ' HB3' ' HA ' ' F' ' 148' ' ' ALA . 0.0 OUTLIER -84.94 -146.55 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.083 179.453 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 89' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' F' ' 149' ' ' ASN . 0.0 OUTLIER -48.66 155.1 0.59 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 32.8 p -86.78 -11.97 49.47 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.403 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 91' ' ' SER . . . . . . . . . . . . . 8.1 t -66.38 114.04 5.11 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.976 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -83.34 22.21 1.05 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.877 0.37 . . . . 0.0 111.667 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.28 22.06 1.19 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.692 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -159.69 -32.28 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.605 -0.807 . . . . 0.0 113.053 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 95' ' ' SER . . . . . 0.644 ' HA ' ' HB3' ' F' ' 147' ' ' ALA . 16.0 t -65.14 166.69 9.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.345 . . . . 0.0 110.616 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 96' ' ' ALA . . . . . 0.467 ' O ' HD13 ' F' ' 88' ' ' LEU . . . -89.61 163.49 15.15 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.87 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.41 169.61 17.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.329 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 98' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 57.36 29.36 16.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.414 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 99' ' ' VAL . . . . . 0.563 ' HB ' ' HB1' ' F' ' 143' ' ' ALA . 7.0 p -156.38 150.6 10.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.77 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 100' ' ' GLY . . . . . 0.686 ' HA3' ' HB ' ' F' ' 85' ' ' VAL . . . -164.22 176.96 40.11 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.604 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 101' ' ' VAL . . . . . 0.609 HG22 ' CE1' ' F' ' 137' ' ' TYR . 3.0 t -107.66 111.37 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 123.04 0.536 . . . . 0.0 111.706 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 102' ' ' GLN . . . . . 0.62 ' HG2' ' HB3' ' F' ' 84' ' ' ASN . 0.0 OUTLIER -76.04 179.68 5.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.922 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 103' ' ' ILE . . . . . 0.488 HD11 ' HA ' ' F' ' 113' ' ' LEU . 6.0 pt -150.34 116.57 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.464 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 104' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' F' ' 134' ' ' GLN . 12.8 tp -97.18 122.53 40.3 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.743 0.306 . . . . 0.0 111.075 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -62.89 150.12 42.72 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.499 -0.318 . . . . 0.0 111.696 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 106' ' ' ARG . . . . . 0.526 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -71.38 -17.69 62.4 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.772 0.32 . . . . 0.0 111.052 179.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . 0.446 HG21 ' HA ' ' F' ' 120' ' ' SER . 75.7 p -76.61 -37.28 56.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.08 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 151.57 -68.77 0.32 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.685 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.68 123.27 18.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.875 0.369 . . . . 0.0 111.105 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.7 117.98 2.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.122 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . 0.514 HD11 ' O ' ' F' ' 117' ' ' THR . 2.1 tp -67.77 144.04 55.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.429 0.633 . . . . 0.0 110.532 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 112' ' ' THR . . . . . 0.432 ' HA ' ' ND2' ' F' ' 84' ' ' ASN . 0.2 OUTLIER -75.08 140.46 43.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.13 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 113' ' ' LEU . . . . . 0.635 HD11 ' HA3' ' F' ' 75' ' ' GLY . 1.3 tp -85.22 97.85 10.15 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.764 0.316 . . . . 0.0 110.582 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -152.8 -59.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.674 0.273 . . . . 0.0 111.595 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 135.79 -26.66 3.13 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.61 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -101.28 28.74 5.19 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.643 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 117' ' ' THR . . . . . 0.514 ' O ' HD11 ' F' ' 111' ' ' LEU . 0.2 OUTLIER -106.57 67.39 0.72 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.052 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -82.43 80.95 8.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.735 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.01 97.5 3.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.803 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 120' ' ' SER . . . . . 0.446 ' HA ' HG21 ' F' ' 107' ' ' THR . 1.9 t -165.53 144.8 6.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.576 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -100.29 50.36 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.232 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.87 94.12 5.78 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.659 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.73 110.35 12.5 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.643 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . 0.603 ' HG ' ' ND2' ' F' ' 129' ' ' ASN . 0.3 OUTLIER -70.13 154.15 42.27 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.579 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -131.62 144.77 51.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.552 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -61.76 125.64 24.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.667 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . 0.526 ' HA3' HG21 ' B' ' 4' ' ' THR . . . 115.03 -101.93 1.1 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.749 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 128' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' C' ' 116' ' ' ALA . 86.0 m -106.32 128.5 54.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.672 0.272 . . . . 0.0 110.782 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 129' ' ' ASN . . . . . 0.748 ' HA ' ' HB2' ' C' ' 116' ' ' ALA . 20.1 t-20 -121.08 158.21 28.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.129 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 130' ' ' THR . . . . . 0.57 ' OG1' ' HA3' ' C' ' 115' ' ' GLY . 0.2 OUTLIER -155.9 143.07 19.17 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.014 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 131' ' ' ILE . . . . . 0.613 HD13 HG11 ' F' ' 156' ' ' VAL . 0.1 OUTLIER -115.19 110.74 45.24 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 132' ' ' PRO . . . . . 0.526 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.4 Cg_endo -82.12 151.88 16.16 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.597 1.531 . . . . 0.0 112.514 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -159.0 146.76 17.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.84 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 134' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' C' ' 78' ' ' ILE . 0.8 OUTLIER -114.41 145.95 41.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.093 179.277 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.85 91.15 1.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.891 0.377 . . . . 0.0 111.682 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 136' ' ' ARG . . . . . 0.572 ' HE ' HG21 ' F' ' 48' ' ' THR . 28.0 mtm-85 -88.33 153.56 21.1 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.403 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 137' ' ' TYR . . . . . 0.609 ' CE1' HG22 ' F' ' 101' ' ' VAL . 0.7 OUTLIER -91.19 111.03 22.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.101 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 138' ' ' PHE . . . . . 0.607 ' CD1' ' HB2' ' F' ' 102' ' ' GLN . 8.8 m-85 -108.11 172.17 6.99 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.978 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 139' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' F' ' 42' ' ' LEU . . . -123.41 143.71 49.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.807 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 140' ' ' THR . . . . . 0.9 HG21 ' CB ' ' F' ' 79' ' ' ASP . 0.2 OUTLIER -98.85 44.5 1.03 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.501 179.753 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 87.45 89.13 1.07 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.946 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 142' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' F' ' 43' ' ' ALA . . . 60.04 88.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.678 0.239 . . . . 0.0 110.694 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 143' ' ' ALA . . . . . 0.563 ' HB1' ' HB ' ' F' ' 99' ' ' VAL . . . -70.54 161.72 30.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.783 0.325 . . . . 0.0 111.431 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 144' ' ' THR . . . . . 0.637 ' O ' HG11 ' E' ' 16' ' ' VAL . 0.2 OUTLIER -124.46 158.65 60.88 Favored Pre-proline 0 CA--C 1.534 0.327 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.292 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 145' ' ' PRO . . . . . 0.528 ' HA ' ' HB ' ' E' ' 16' ' ' VAL . 1.4 Cg_endo -83.75 149.19 12.58 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.499 2.132 . . . . 0.0 112.079 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.71 -119.73 0.86 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.563 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 147' ' ' ALA . . . . . 0.644 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -123.92 127.64 48.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 111.48 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 148' ' ' ALA . . . . . 0.683 ' HA ' ' HB3' ' F' ' 88' ' ' LEU . . . -120.77 67.1 0.85 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.139 0.495 . . . . 0.0 110.449 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 149' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' F' ' 89' ' ' GLN . 47.4 t-20 -128.47 114.73 17.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.667 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 150' ' ' ALA . . . . . 0.424 ' HB2' ' C ' ' F' ' 88' ' ' LEU . . . -158.77 146.92 18.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.056 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -98.37 140.29 32.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.181 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 152' ' ' ALA . . . . . 0.511 ' O ' HG23 ' E' ' 9' ' ' THR . . . -136.23 169.29 17.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.216 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 153' ' ' THR . . . . . 0.452 ' O ' ' HB3' ' F' ' 74' ' ' LEU . 9.4 t -155.09 150.56 27.33 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 154' ' ' PHE . . . . . 0.436 ' HE1' HG13 ' F' ' 56' ' ' ILE . 1.1 p90 -119.06 149.24 42.0 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.089 0.471 . . . . 0.0 110.103 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . 0.426 ' HE3' HD13 ' F' ' 74' ' ' LEU . 4.7 mttt -113.5 156.67 23.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.886 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 156' ' ' VAL . . . . . 0.613 HG11 HD13 ' F' ' 131' ' ' ILE . 0.2 OUTLIER -136.5 138.05 47.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.667 -179.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 157' ' ' GLN . . . . . 0.61 ' HB2' HG22 ' E' ' 4' ' ' THR . 64.1 tt0 -107.5 127.99 54.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.307 0.575 . . . . 0.0 110.344 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . 0.592 ' HB2' ' OG1' ' E' ' 3' ' ' THR . 60.9 m-85 -107.82 107.43 18.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.565 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 159' ' ' GLN . . . . . 0.718 ' HA ' ' H ' ' E' ' 2' ' ' ALA . 1.1 mt-30 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.903 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.686 ' H ' ' HA ' ' B' ' 159' ' ' GLN . . . 56.66 88.54 0.05 OUTLIER 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.052 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' B' ' 157' ' ' GLN . 0.2 OUTLIER -103.08 110.35 22.26 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.419 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.37 136.14 38.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.55 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.64 HG23 HG23 ' B' ' 156' ' ' VAL . 0.0 OUTLIER -152.01 -175.3 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.61 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.51 130.04 38.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.677 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.77 -59.25 0.91 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.822 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.37 166.16 27.94 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.897 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.621 ' HA ' HG22 ' B' ' 153' ' ' THR . 26.8 m -94.36 121.11 35.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.904 0.383 . . . . 0.0 111.287 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.65 115.59 36.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.223 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -99.55 137.45 38.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.369 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.573 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 76.0 m-85 -127.49 97.73 4.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.806 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.22 175.8 6.56 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.428 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.91 149.49 5.78 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.923 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.33 108.63 13.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.776 0.322 . . . . 0.0 110.358 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' B' ' 37' ' ' VAL . 23.5 t -86.67 129.15 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.203 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 22' ' ' ALA . 18.8 m -127.38 163.5 30.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.041 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -86.0 61.52 6.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.07 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.484 ' HB3' HG21 ' A' ' 65' ' ' VAL . . . 44.93 52.63 8.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.075 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -127.29 -54.51 1.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.407 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.809 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.1 OUTLIER 177.7 111.74 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.866 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.502 ' HB2' HG22 ' A' ' 17' ' ' VAL . . . -105.63 126.08 51.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.073 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.86 145.64 7.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.055 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.623 ' O ' HG23 ' A' ' 28' ' ' VAL . 4.0 m-20 -74.83 147.23 41.34 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.696 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.67 -43.66 17.87 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.34 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.98 -20.0 60.16 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.84 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.2 t -79.54 -26.07 41.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.863 0.363 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 24' ' ' ASP . 57.5 t -49.19 -48.46 17.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.331 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.84 93.08 5.36 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.023 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.63 116.42 28.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.009 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 p -95.6 115.62 27.69 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.151 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.503 ' CG1' HG11 ' A' ' 52' ' ' VAL . 1.6 t -117.18 101.16 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.131 0.491 . . . . 0.0 110.402 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -105.62 126.96 52.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.655 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.26 -55.62 11.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.63 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.03 -111.6 3.91 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.519 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.11 115.28 16.76 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.514 0.197 . . . . 0.0 110.875 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 67.0 t -131.01 105.8 11.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.875 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -96.64 154.12 17.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.757 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.643 ' HA ' HD12 ' A' ' 42' ' ' LEU . 8.2 p -78.75 -19.84 51.35 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.759 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -19.52 65.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.066 0.46 . . . . 0.0 110.885 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.7 p -92.0 -21.27 20.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.207 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.715 ' CB ' ' HB2' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -139.14 62.36 1.54 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.58 179.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' A' ' 142' ' ' ALA . . . -101.13 9.12 42.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.321 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.19 136.0 24.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.37 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.593 ' N ' ' HA2' ' A' ' 141' ' ' GLY . 16.5 tt0 -58.48 121.37 10.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.915 0.388 . . . . 0.0 111.082 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.28 -25.46 8.23 Favored Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.149 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.75 137.29 58.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.939 0.4 . . . . 0.0 112.034 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.92 157.99 44.59 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.955 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.93 -166.21 1.09 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.621 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.8 m -65.23 156.19 32.68 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.767 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 134' ' ' GLN . . . -90.45 126.66 35.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.324 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.503 HG11 ' CG1' ' A' ' 32' ' ' VAL . 62.4 t -75.68 118.52 21.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.007 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.79 135.6 13.72 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.731 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.49 ' HD2' HG12 ' A' ' 52' ' ' VAL . 46.2 p90 -170.74 142.1 1.92 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.0 110.915 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.676 ' HA ' ' O ' ' A' ' 131' ' ' ILE . 11.5 p30 -126.52 163.92 22.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.602 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.582 ' O ' ' HA ' ' A' ' 130' ' ' THR . 20.9 mm -105.13 120.03 55.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.525 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.7 ' HA ' HG22 ' A' ' 130' ' ' THR . 0.0 OUTLIER -82.15 115.66 21.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.712 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.639 HD11 HG13 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -128.24 107.46 9.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.288 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.37 176.97 8.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.889 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.05 66.13 0.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.797 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.809 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 3.3 m -109.69 154.48 22.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.679 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.523 ' HA ' ' OD1' ' A' ' 126' ' ' ASN . 0.5 OUTLIER -154.71 138.3 16.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.263 -179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -97.54 -11.9 23.19 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -72.27 -48.69 40.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.003 0.43 . . . . 0.0 111.713 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 19' ' ' ALA . 10.8 t -69.1 -48.6 68.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.695 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.552 ' HB1' ' O ' ' A' ' 159' ' ' GLN . . . -138.02 153.26 49.39 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.599 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.19 18.66 4.48 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.95 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 159' ' ' GLN . 10.6 tppt? -142.88 149.9 39.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.486 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.868 ' HB2' HD12 ' A' ' 124' ' ' LEU . . . -150.0 110.72 4.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.661 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 121' ' ' GLU . . . -108.05 169.99 8.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.1 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.414 HG21 HG21 ' A' ' 131' ' ' ILE . 0.5 OUTLIER -130.38 150.98 35.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.61 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.697 ' HB1' ' HA ' ' A' ' 116' ' ' ALA . . . -135.62 100.13 4.4 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.58 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.435 ' HB2' HD22 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -77.42 133.98 38.52 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.571 0.224 . . . . 0.0 111.107 179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.746 HD11 ' HG2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -124.17 115.05 20.48 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.025 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.31 -173.23 26.45 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.729 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.6 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 7.0 m -112.59 149.03 33.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.583 0.23 . . . . 0.0 110.755 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 85' ' ' VAL . . . -98.97 133.81 42.72 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.942 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.786 ' HB ' ' HA ' ' A' ' 87' ' ' ALA . 16.1 tt -72.93 -37.98 55.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.17 167.64 12.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.834 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' D' ' 106' ' ' ARG . . . -70.17 -53.83 15.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.073 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.35 28.63 6.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.595 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.816 ' HB3' ' HB ' ' A' ' 85' ' ' VAL . 10.2 m170 -111.33 -45.62 3.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.874 0.369 . . . . 0.0 110.427 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.482 HG22 HH21 ' D' ' 106' ' ' ARG . 0.0 OUTLIER 46.42 -86.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.589 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -42.28 -42.4 3.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.239 179.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.816 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 21.3 t -61.29 126.57 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.093 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.062 HD22 ' HB1' ' A' ' 150' ' ' ALA . 0.2 OUTLIER -81.25 164.41 22.28 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.786 ' HA ' ' HB ' ' A' ' 78' ' ' ILE . . . -104.78 -177.49 3.38 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.672 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.09 -174.57 5.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.982 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.57 -170.71 3.24 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.372 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.869 ' HA ' HG13 ' D' ' 52' ' ' VAL . 27.4 p -74.77 7.81 2.84 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.914 0.387 . . . . 0.0 111.462 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.421 ' HB2' ' HB3' ' A' ' 95' ' ' SER . 0.8 OUTLIER -96.96 80.39 2.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.632 ' HA ' ' HB2' ' D' ' 50' ' ' SER . . . -66.87 -41.13 87.76 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.624 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' D' ' 36' ' ' GLN . . . -103.73 25.96 9.16 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.675 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.8 -22.63 0.33 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.929 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 91' ' ' SER . 1.0 OUTLIER -107.68 175.18 5.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.906 0.384 . . . . 0.0 110.587 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.38 177.12 2.99 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.497 ' O ' HG12 ' A' ' 99' ' ' VAL . 0.2 OUTLIER -138.58 167.86 21.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.21 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.584 ' HA ' ' HB ' ' A' ' 140' ' ' THR . 32.4 m-80 44.19 51.65 7.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.502 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 97' ' ' THR . 6.0 p -169.38 124.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.72 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.61 -164.74 11.5 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.634 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.8 91.16 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 122.97 0.508 . . . . 0.0 111.722 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.704 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER -71.4 116.65 11.98 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.885 -179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.659 HD12 HD11 ' A' ' 113' ' ' LEU . 6.6 mt -89.64 120.59 38.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.492 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 1.0 OUTLIER -95.88 152.31 18.61 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.691 0.281 . . . . 0.0 111.092 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.16 159.99 14.68 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.613 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.537 ' CZ ' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -68.71 -13.73 62.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.92 0.39 . . . . 0.0 111.146 179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.6 p -74.41 -18.87 60.59 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.067 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.99 -40.11 2.23 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.664 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.41 164.67 13.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.781 0.324 . . . . 0.0 111.099 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -77.37 139.68 39.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.132 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.564 HD21 ' HB ' ' A' ' 117' ' ' THR . 5.9 tt -84.18 128.58 34.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.458 0.647 . . . . 0.0 110.506 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.435 ' HA ' HD22 ' A' ' 84' ' ' ASN . 1.4 m -68.11 132.38 47.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.1 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.659 HD11 HD12 ' A' ' 103' ' ' ILE . 4.7 mp -88.04 99.83 12.46 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.621 0.248 . . . . 0.0 110.741 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' D' ' 130' ' ' THR . 0.8 OUTLIER -144.13 -32.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 121.134 -0.226 . . . . 0.0 111.502 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.498 ' CA ' HD23 ' A' ' 74' ' ' LEU . . . 146.46 -81.3 0.21 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.625 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.697 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . . . -97.22 64.1 1.9 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.959 0.409 . . . . 0.0 111.603 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.564 ' HB ' HD21 ' A' ' 111' ' ' LEU . 2.8 m -94.4 72.39 3.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.141 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -66.76 119.04 11.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.835 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.89 -49.05 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.852 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.57 84.69 6.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.547 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 70' ' ' ALA . 3.5 mt-10 -110.2 86.95 2.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.29 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.99 159.3 17.68 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.815 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -66.96 138.39 57.23 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.727 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.868 HD12 ' HB2' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -86.55 159.49 19.24 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.622 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.58 176.19 10.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.588 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 62' ' ' ASP . 0.9 OUTLIER -85.93 161.49 19.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.697 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.53 -121.0 5.71 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.775 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 74.4 m -119.54 140.31 50.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.682 0.277 . . . . 0.0 110.768 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.45 ' O ' HD12 ' A' ' 58' ' ' LEU . 5.1 t-20 -133.73 154.67 50.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.117 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.7 HG22 ' HA ' ' A' ' 57' ' ' GLN . 27.9 p -133.41 154.33 50.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.164 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.676 ' O ' ' HA ' ' A' ' 55' ' ' ASN . 1.0 OUTLIER -111.09 116.9 50.93 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.537 ' HG2' ' CZ ' ' A' ' 106' ' ' ARG . 7.5 Cg_endo -81.24 129.48 6.78 Favored 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.614 1.543 . . . . 0.0 112.581 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.459 ' HB3' ' CE1' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -140.89 146.9 38.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.794 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.526 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 19.3 mm-40 -116.5 158.33 23.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.011 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 103' ' ' ILE . . . -159.42 105.53 1.68 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.914 0.388 . . . . 0.0 111.524 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.7 172.61 6.71 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.414 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.2 147.79 24.25 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.131 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.67 159.03 35.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.277 0.561 . . . . 0.0 111.923 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.715 ' HB2' ' CB ' ' A' ' 42' ' ' LEU . . . -116.33 141.24 48.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.936 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.584 ' HB ' ' HA ' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -107.75 27.23 9.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.482 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.593 ' HA2' ' N ' ' A' ' 45' ' ' GLU . . . 97.55 83.6 1.71 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.971 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . . . 57.88 93.47 0.03 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.688 0.244 . . . . 0.0 110.746 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.554 ' HA ' ' HB2' ' A' ' 98' ' ' ASN . . . -80.0 165.37 22.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 111.403 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.7 p -108.34 168.87 7.22 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.153 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.61 133.54 6.14 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.569 2.179 . . . . 0.0 111.979 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.55 -119.24 0.81 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.471 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.81 121.7 13.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.894 0.378 . . . . 0.0 111.281 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.34 85.68 3.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.442 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -104.55 131.21 52.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.601 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 1.062 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -136.08 148.44 48.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.935 179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.17 120.17 20.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.216 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.63 140.05 24.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.159 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.6 p -105.2 171.21 7.44 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.503 ' HZ ' HG21 ' A' ' 56' ' ' ILE . 13.7 p90 -138.2 147.39 43.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.038 0.447 . . . . 0.0 110.119 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.746 ' HG2' HD11 ' A' ' 74' ' ' LEU . 13.6 mmtt -100.89 172.01 7.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.901 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.49 ' HB ' ' CZ ' ' A' ' 158' ' ' TYR . 0.4 OUTLIER -135.51 111.4 12.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.82 0.343 . . . . 0.0 111.728 -179.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -109.04 141.26 41.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.346 0.593 . . . . 0.0 110.414 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.49 ' CZ ' ' HB ' ' A' ' 156' ' ' VAL . 23.1 m-85 -135.36 105.58 6.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.583 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.617 ' HB3' ' HB3' ' A' ' 68' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.92 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.695 ' H ' ' HA ' ' C' ' 159' ' ' GLN . . . 56.58 88.57 0.05 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.056 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' C' ' 157' ' ' GLN . 0.2 OUTLIER -103.08 110.38 22.29 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.393 179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 136.18 38.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.552 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.652 HG23 HG23 ' C' ' 156' ' ' VAL . 0.0 OUTLIER -152.05 -175.33 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.591 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.43 130.04 38.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.666 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.8 -59.33 0.91 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.756 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.4 166.2 28.04 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.894 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.624 ' HA ' HG22 ' C' ' 153' ' ' THR . 26.7 m -94.38 121.1 35.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.89 0.376 . . . . 0.0 111.269 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.69 115.64 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.24 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -99.54 137.55 37.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.351 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . 0.575 ' HA ' ' O ' ' C' ' 32' ' ' VAL . 76.0 m-85 -127.61 97.71 4.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.22 175.78 6.57 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.472 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.01 149.4 5.75 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.941 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.24 108.68 14.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.852 0.358 . . . . 0.0 110.414 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' C' ' 37' ' ' VAL . 23.6 t -86.71 129.19 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.175 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' B' ' 22' ' ' ALA . 18.7 m -127.45 163.51 30.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.033 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -85.95 61.35 6.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.027 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.483 ' HB3' HG21 ' B' ' 65' ' ' VAL . . . 45.02 52.64 8.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.053 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' B' ' 61' ' ' CYS . . . -127.24 -54.54 1.37 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.451 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.1 OUTLIER 177.73 111.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.893 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.499 ' HB2' HG22 ' B' ' 17' ' ' VAL . . . -105.67 126.05 51.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.083 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.81 145.61 7.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.035 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.608 ' O ' HG23 ' B' ' 28' ' ' VAL . 4.0 m-20 -74.82 147.27 41.32 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.68 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.8 -43.57 18.47 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.323 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.97 -20.07 60.06 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.809 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 45.3 t -79.58 -26.01 41.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.608 HG23 ' O ' ' B' ' 24' ' ' ASP . 57.4 t -49.21 -48.46 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.344 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.86 93.08 5.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.031 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.61 116.36 28.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.026 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.55 115.67 27.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.209 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 12' ' ' PHE . 1.7 t -117.23 101.07 11.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.182 0.515 . . . . 0.0 110.429 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -105.58 126.93 52.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.715 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.15 -55.66 11.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.62 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.02 -111.65 3.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.539 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.548 ' HG3' ' HA ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -77.05 115.29 16.71 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.501 0.191 . . . . 0.0 110.907 -179.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 68.4 t -131.05 105.86 11.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.833 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.6 154.05 17.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.782 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.665 ' HA ' HD12 ' B' ' 42' ' ' LEU . 8.2 p -78.77 -19.79 51.4 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.702 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.51 -19.53 65.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.144 0.497 . . . . 0.0 110.899 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 96.5 p -92.01 -21.27 20.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.19 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.711 ' CB ' ' HB2' ' B' ' 139' ' ' ALA . 0.2 OUTLIER -139.0 62.27 1.54 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.707 179.721 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.727 ' HA ' ' HA ' ' B' ' 142' ' ' ALA . . . -101.09 9.14 42.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.363 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.19 136.03 24.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.335 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.579 ' N ' ' HA2' ' B' ' 141' ' ' GLY . 16.5 tt0 -58.59 121.33 10.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 111.154 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.4 -25.54 8.14 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.166 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.67 137.19 58.2 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.91 158.04 44.45 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.904 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -166.19 1.09 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.598 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 48.9 m -65.2 156.13 32.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.816 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.539 ' HB1' ' HB3' ' B' ' 134' ' ' GLN . . . -90.5 126.7 36.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.339 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.506 HG11 ' CG1' ' B' ' 32' ' ' VAL . 63.2 t -75.6 118.5 21.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.019 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.79 135.74 13.86 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.626 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . 0.5 ' HD2' HG12 ' B' ' 52' ' ' VAL . 46.3 p90 -170.85 142.08 1.86 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.815 0.341 . . . . 0.0 110.905 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.673 ' HA ' ' O ' ' B' ' 131' ' ' ILE . 11.5 p30 -126.52 163.93 22.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.54 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' B' ' 130' ' ' THR . 20.7 mm -105.17 119.97 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.503 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . 0.703 ' HA ' HG22 ' B' ' 130' ' ' THR . 0.0 OUTLIER -82.16 115.74 21.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.731 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.648 HD11 HG13 ' B' ' 131' ' ' ILE . 0.0 OUTLIER -128.33 107.47 9.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.252 -179.584 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.37 176.99 8.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.86 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.03 66.21 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.714 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' CYS . . . . . 0.816 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 3.3 m -109.73 154.46 22.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.711 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . 0.531 ' HA ' ' OD1' ' B' ' 126' ' ' ASN . 0.5 OUTLIER -154.74 138.26 15.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.271 -179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' B' ' 66' ' ' ALA . 0.2 OUTLIER -97.55 -11.81 23.28 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.08 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.25 -48.68 40.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.115 0.483 . . . . 0.0 111.78 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' B' ' 19' ' ' ALA . 10.6 t -69.02 -48.7 68.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.764 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.555 ' HB1' ' O ' ' B' ' 159' ' ' GLN . . . -137.93 153.36 49.5 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.637 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.29 18.67 4.43 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.868 0.366 . . . . 0.0 110.906 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . 0.61 ' HB3' ' HB3' ' B' ' 159' ' ' GLN . 10.6 tppt? -142.9 149.93 39.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.469 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.867 ' HB2' HD12 ' B' ' 124' ' ' LEU . . . -150.03 110.72 4.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.687 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' B' ' 121' ' ' GLU . . . -108.1 169.92 8.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.05 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.436 HG21 HG21 ' B' ' 131' ' ' ILE . 0.5 OUTLIER -130.35 150.93 35.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.63 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.698 ' HB1' ' HA ' ' B' ' 116' ' ' ALA . . . -135.62 100.16 4.41 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.518 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.438 ' HB2' HD22 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -77.35 133.84 38.63 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.572 0.225 . . . . 0.0 111.189 179.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.731 HD11 ' HG2' ' B' ' 155' ' ' LYS . 0.0 OUTLIER -124.15 115.16 20.67 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.984 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.37 -173.24 26.53 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.777 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.606 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 7.0 m -112.6 149.04 33.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.565 0.221 . . . . 0.0 110.755 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' B' ' 85' ' ' VAL . . . -98.99 133.78 42.77 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.908 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.769 ' HB ' ' HA ' ' B' ' 87' ' ' ALA . 16.1 tt -72.91 -37.94 55.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.948 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.16 167.58 12.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.836 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' E' ' 106' ' ' ARG . . . -70.11 -53.85 15.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.42 28.74 6.08 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.564 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.808 ' HB3' ' HB ' ' B' ' 85' ' ' VAL . 10.2 m170 -111.38 -45.62 3.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.45 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' THR . . . . . 0.487 HG22 HH21 ' E' ' 106' ' ' ARG . 0.0 OUTLIER 46.41 -86.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.59 -179.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' B' ' 82' ' ' HIS . 0.0 OUTLIER -42.3 -42.35 3.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.299 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.808 ' HB ' ' HB3' ' B' ' 82' ' ' HIS . 21.3 t -61.33 126.62 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.145 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 1.061 HD22 ' HB1' ' B' ' 150' ' ' ALA . 0.2 OUTLIER -81.31 164.33 22.27 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.281 179.471 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.769 ' HA ' ' HB ' ' B' ' 78' ' ' ILE . . . -104.74 -177.52 3.39 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.841 0.353 . . . . 0.0 111.67 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.03 -174.51 5.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.052 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.63 -170.68 3.22 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.394 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . 0.898 ' HA ' HG13 ' E' ' 52' ' ' VAL . 27.4 p -74.85 7.95 2.8 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.92 0.39 . . . . 0.0 111.408 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' B' ' 95' ' ' SER . 0.8 OUTLIER -97.07 80.4 2.95 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.621 ' HA ' ' HB2' ' E' ' 50' ' ' SER . . . -66.83 -41.18 87.87 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.841 0.353 . . . . 0.0 111.664 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' E' ' 36' ' ' GLN . . . -103.76 26.07 9.05 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.698 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.81 -22.66 0.33 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.922 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' B' ' 91' ' ' SER . 1.0 OUTLIER -107.64 175.21 5.56 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.93 0.395 . . . . 0.0 110.606 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.53 177.18 3.04 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.848 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.498 ' O ' HG12 ' B' ' 99' ' ' VAL . 0.2 OUTLIER -138.59 167.89 20.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.27 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . 0.578 ' HA ' ' HB ' ' B' ' 140' ' ' THR . 32.2 m-80 44.12 51.63 7.2 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.53 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . 0.498 HG12 ' O ' ' B' ' 97' ' ' THR . 6.1 p -169.31 124.12 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.823 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.5 -164.68 11.5 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.619 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.86 91.12 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 122.925 0.49 . . . . 0.0 111.695 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.719 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 0.6 OUTLIER -71.42 116.58 11.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.919 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.656 HD12 HD11 ' B' ' 113' ' ' LEU . 6.6 mt -89.51 120.63 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.534 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . 0.499 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 1.0 OUTLIER -95.88 152.31 18.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.758 0.313 . . . . 0.0 111.041 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.23 160.12 14.58 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.573 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . 0.533 ' CZ ' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -68.83 -13.69 62.56 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.858 0.361 . . . . 0.0 111.032 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 44.8 p -74.45 -18.85 60.58 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.03 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.93 -40.15 2.22 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.659 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.34 164.69 13.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.774 0.321 . . . . 0.0 111.078 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -77.37 139.65 39.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.154 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.542 HD21 ' HB ' ' B' ' 117' ' ' THR . 5.9 tt -84.09 128.59 34.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.438 0.637 . . . . 0.0 110.462 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.439 ' HA ' HD22 ' B' ' 84' ' ' ASN . 1.4 m -68.13 132.38 47.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.111 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.656 HD11 HD12 ' B' ' 103' ' ' ILE . 4.7 mp -88.1 99.74 12.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.726 0.298 . . . . 0.0 110.748 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . 0.504 ' O ' ' O ' ' E' ' 130' ' ' THR . 0.8 OUTLIER -144.1 -32.34 0.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.495 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . 0.495 ' CA ' HD23 ' B' ' 74' ' ' LEU . . . 146.44 -81.23 0.21 Allowed Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.68 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . 0.698 ' HA ' ' HB1' ' B' ' 72' ' ' ALA . . . -97.24 64.02 1.88 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.986 0.422 . . . . 0.0 111.602 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.542 ' HB ' HD21 ' B' ' 111' ' ' LEU . 2.8 m -94.28 72.28 3.87 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.212 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.73 119.05 11.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.82 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.96 -48.97 0.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.57 84.68 6.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.559 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' B' ' 70' ' ' ALA . 3.5 mt-10 -110.19 87.0 2.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.227 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.09 159.32 17.6 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.802 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -67.0 138.35 57.18 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.666 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.867 HD12 ' HB2' ' B' ' 69' ' ' ALA . 0.4 OUTLIER -86.49 159.5 19.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.665 179.4 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.62 176.25 10.23 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.602 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' ASN . . . . . 0.531 ' OD1' ' HA ' ' B' ' 62' ' ' ASP . 0.9 OUTLIER -85.94 161.49 19.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.641 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.5 -121.03 5.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.756 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 73.2 m -119.5 140.32 50.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.661 0.267 . . . . 0.0 110.779 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . 0.462 ' O ' HD12 ' B' ' 58' ' ' LEU . 5.1 t-20 -133.76 154.63 50.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.06 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.703 HG22 ' HA ' ' B' ' 57' ' ' GLN . 28.4 p -133.32 154.25 50.87 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.217 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' ILE . . . . . 0.673 ' O ' ' HA ' ' B' ' 55' ' ' ASN . 1.0 OUTLIER -110.95 116.89 51.22 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' PRO . . . . . 0.533 ' HG2' ' CZ ' ' B' ' 106' ' ' ARG . 7.6 Cg_endo -81.2 129.46 6.79 Favored 'Trans proline' 0 C--N 1.358 1.028 0 C-N-CA 121.672 1.581 . . . . 0.0 112.594 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.463 ' HB3' ' CE1' ' B' ' 54' ' ' PHE . 0.1 OUTLIER -140.9 146.84 37.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.78 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' GLN . . . . . 0.539 ' HB3' ' HB1' ' B' ' 51' ' ' ALA . 19.5 mm-40 -116.57 158.38 23.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.022 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' B' ' 103' ' ' ILE . . . -159.41 105.52 1.68 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.39 . . . . 0.0 111.515 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.71 172.55 6.74 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.417 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.25 147.75 24.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.081 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.6 159.01 35.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.031 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.711 ' HB2' ' CB ' ' B' ' 42' ' ' LEU . . . -116.26 141.33 48.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.913 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' THR . . . . . 0.578 ' HB ' ' HA ' ' B' ' 98' ' ' ASN . 0.3 OUTLIER -107.86 27.27 9.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.467 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . 0.579 ' HA2' ' N ' ' B' ' 45' ' ' GLU . . . 97.49 83.6 1.7 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.015 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . 0.727 ' HA ' ' HA ' ' B' ' 43' ' ' ALA . . . 57.89 93.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.607 0.204 . . . . 0.0 110.821 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' B' ' 98' ' ' ASN . . . -80.05 165.51 22.47 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.709 0.29 . . . . 0.0 111.448 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 29.6 p -108.43 168.81 7.29 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.204 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.66 133.52 6.09 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.579 2.186 . . . . 0.0 111.987 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.61 -119.22 0.81 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.427 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.82 121.64 13.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.842 0.353 . . . . 0.0 111.306 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.32 85.7 3.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.5 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -104.6 131.23 52.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.56 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 1.061 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -136.1 148.47 48.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.949 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -133.19 120.21 20.87 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.197 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.61 140.01 24.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.199 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.621 HG22 ' HA ' ' A' ' 9' ' ' THR . 70.7 p -105.16 171.18 7.46 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.511 ' HZ ' HG21 ' B' ' 56' ' ' ILE . 13.6 p90 -138.16 147.44 43.86 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.104 0.478 . . . . 0.0 110.124 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.731 ' HG2' HD11 ' B' ' 74' ' ' LEU . 13.6 mmtt -100.94 172.02 7.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.892 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' VAL . . . . . 0.64 HG23 HG23 ' A' ' 5' ' ' VAL . 0.4 OUTLIER -135.51 111.38 12.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.738 0.304 . . . . 0.0 111.681 -179.043 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.563 ' HA ' ' O ' ' A' ' 3' ' ' THR . 1.8 tt0 -109.06 141.28 41.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.369 0.604 . . . . 0.0 110.383 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . 0.485 ' CZ ' ' HB ' ' B' ' 156' ' ' VAL . 23.2 m-85 -135.39 105.55 6.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.553 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . 0.686 ' HA ' ' H ' ' A' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.855 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.672 ' H ' ' HA ' ' D' ' 159' ' ' GLN . . . 56.66 88.58 0.05 OUTLIER 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.988 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' D' ' 157' ' ' GLN . 0.2 OUTLIER -103.05 110.38 22.28 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.428 179.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.4 136.24 38.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.523 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.646 HG23 HG23 ' D' ' 156' ' ' VAL . 0.0 OUTLIER -152.08 -175.28 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.63 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.54 130.08 38.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.595 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.81 -59.29 0.91 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.804 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.41 166.23 28.08 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.864 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . 0.626 ' HA ' HG22 ' D' ' 153' ' ' THR . 27.0 m -94.46 121.16 35.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 111.219 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.6 115.61 36.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.258 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -99.56 137.51 37.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.311 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' PHE . . . . . 0.579 ' HA ' ' O ' ' D' ' 32' ' ' VAL . 75.8 m-85 -127.56 97.73 4.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.845 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.21 175.84 6.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.442 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.93 149.46 5.77 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.914 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.28 108.58 13.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.773 0.321 . . . . 0.0 110.432 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' D' ' 37' ' ' VAL . 23.1 t -86.6 129.07 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.283 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' C' ' 22' ' ' ALA . 18.7 m -127.39 163.55 30.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-O 120.826 0.346 . . . . 0.0 110.993 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -86.0 61.41 6.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.069 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . 0.49 ' HB3' HG21 ' C' ' 65' ' ' VAL . . . 44.95 52.64 8.09 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.102 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' C' ' 61' ' ' CYS . . . -127.29 -54.43 1.36 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.467 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.1 OUTLIER 177.73 111.65 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.92 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . 0.494 ' HB2' HG22 ' C' ' 17' ' ' VAL . . . -105.64 126.06 51.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.8 145.66 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.022 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.61 ' O ' HG23 ' C' ' 28' ' ' VAL . 4.0 m-20 -74.86 147.24 41.27 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.693 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.78 -43.64 18.43 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.337 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.88 -20.01 60.32 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.946 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 45.2 t -79.62 -26.04 41.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.857 0.36 . . . . 0.0 110.833 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.61 HG23 ' O ' ' C' ' 24' ' ' ASP . 57.5 t -49.08 -48.58 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.341 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.82 93.07 5.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.069 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.59 116.41 28.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.994 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 9.1 p -95.63 115.66 27.75 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.115 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' B' ' 12' ' ' PHE . 1.7 t -117.19 101.1 11.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.059 0.457 . . . . 0.0 110.438 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.55 126.9 52.67 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.688 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.19 -55.71 11.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.611 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.06 -111.71 3.94 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.471 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . 0.546 ' HG3' ' HA ' ' B' ' 24' ' ' ASP . 0.0 OUTLIER -77.02 115.32 16.72 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.516 0.198 . . . . 0.0 110.894 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' B' ' 16' ' ' VAL . 67.2 t -130.99 105.83 11.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.881 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.71 154.1 17.48 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.748 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.656 ' HA ' HD12 ' C' ' 42' ' ' LEU . 8.3 p -78.7 -19.86 51.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.779 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.53 -19.49 65.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.064 0.459 . . . . 0.0 110.879 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 97.5 p -92.06 -21.26 20.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.143 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.716 ' CB ' ' HB2' ' C' ' 139' ' ' ALA . 0.2 OUTLIER -139.06 62.31 1.54 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.62 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . 0.726 ' HA ' ' HA ' ' C' ' 142' ' ' ALA . . . -101.26 9.2 42.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.23 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.25 136.07 24.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.306 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . 0.589 ' N ' ' HA2' ' C' ' 141' ' ' GLY . 16.5 tt0 -58.54 121.32 10.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 111.139 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.32 -25.43 8.22 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.189 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.8 137.27 58.22 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.937 0.398 . . . . 0.0 112.034 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.9 158.0 44.55 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.935 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.92 -166.23 1.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.627 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 48.8 m -65.18 156.25 32.35 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.782 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . 0.525 ' HB1' ' HB3' ' C' ' 134' ' ' GLN . . . -90.56 126.63 36.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.309 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.501 HG12 ' HD2' ' C' ' 54' ' ' PHE . 62.9 t -75.64 118.52 21.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.982 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.85 135.71 13.81 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.632 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . 0.501 ' HD2' HG12 ' C' ' 52' ' ' VAL . 46.3 p90 -170.76 142.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.755 0.312 . . . . 0.0 110.929 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' C' ' 131' ' ' ILE . 11.5 p30 -126.56 163.91 22.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.569 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.568 ' O ' ' HA ' ' C' ' 130' ' ' THR . 20.8 mm -105.1 119.89 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.519 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.694 ' HA ' HG22 ' C' ' 130' ' ' THR . 0.0 OUTLIER -82.09 115.69 21.33 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.761 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . 0.643 HD11 HG13 ' C' ' 131' ' ' ILE . 0.0 OUTLIER -128.23 107.45 9.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.295 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.36 176.99 8.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.954 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.03 66.24 0.75 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.734 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' CYS . . . . . 0.763 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 3.3 m -109.75 154.4 22.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.668 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . 0.516 ' HA ' ' OD1' ' C' ' 126' ' ' ASN . 0.5 OUTLIER -154.65 138.33 16.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.295 -179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' C' ' 66' ' ' ALA . 0.2 OUTLIER -97.54 -11.9 23.19 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.07 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -72.26 -48.71 40.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.026 0.441 . . . . 0.0 111.732 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.49 HG21 ' HB3' ' C' ' 19' ' ' ALA . 10.6 t -69.0 -48.73 68.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.716 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' C' ' 159' ' ' GLN . . . -137.93 153.36 49.5 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.672 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.28 18.67 4.43 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.847 0.356 . . . . 0.0 110.878 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' LYS . . . . . 0.623 ' HB3' ' HB3' ' C' ' 159' ' ' GLN . 10.6 tppt? -142.9 149.95 39.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.41 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.864 ' HB2' HD12 ' C' ' 124' ' ' LEU . . . -150.02 110.71 4.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.671 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' C' ' 121' ' ' GLU . . . -108.07 169.97 8.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.083 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . 0.439 HG21 HG21 ' C' ' 131' ' ' ILE . 0.5 OUTLIER -130.38 150.96 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.632 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . 0.695 ' HB1' ' HA ' ' C' ' 116' ' ' ALA . . . -135.55 100.06 4.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.62 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' PHE . . . . . 0.436 ' HB2' HD22 ' C' ' 111' ' ' LEU . 0.2 OUTLIER -77.41 133.95 38.54 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.552 0.215 . . . . 0.0 111.117 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.748 HD11 ' HG2' ' C' ' 155' ' ' LYS . 0.0 OUTLIER -124.15 115.08 20.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.968 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.42 -173.24 26.57 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.761 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.609 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 7.1 m -112.61 149.0 33.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.618 0.247 . . . . 0.0 110.737 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' C' ' 85' ' ' VAL . . . -98.96 133.78 42.73 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.936 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . 0.758 ' HB ' ' HA ' ' C' ' 87' ' ' ALA . 16.1 tt -72.89 -38.01 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.13 167.61 12.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.802 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' F' ' 106' ' ' ARG . . . -70.21 -53.78 15.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.08 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.4 28.66 6.13 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.546 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . 0.822 ' HB3' ' HB ' ' C' ' 85' ' ' VAL . 10.2 m170 -111.3 -45.67 3.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.853 0.358 . . . . 0.0 110.46 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . 0.476 HG22 HH21 ' F' ' 106' ' ' ARG . 0.0 OUTLIER 46.48 -86.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.552 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' C' ' 82' ' ' HIS . 0.0 OUTLIER -42.19 -42.48 3.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.277 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.822 ' HB ' ' HB3' ' C' ' 82' ' ' HIS . 21.3 t -61.25 126.56 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.148 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 1.064 HD22 ' HB1' ' C' ' 150' ' ' ALA . 0.2 OUTLIER -81.22 164.39 22.32 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 179.413 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.758 ' HA ' ' HB ' ' C' ' 78' ' ' ILE . . . -104.79 -177.54 3.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.84 0.352 . . . . 0.0 111.661 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.03 -174.53 5.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.049 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.63 -170.66 3.22 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.317 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . 0.909 ' HA ' HG13 ' F' ' 52' ' ' VAL . 26.9 p -74.85 7.85 2.86 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.989 0.423 . . . . 0.0 111.408 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' SER . . . . . 0.409 ' HB2' ' HB3' ' C' ' 95' ' ' SER . 0.8 OUTLIER -96.97 80.45 2.98 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.84 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' ALA . . . . . 0.613 ' HA ' ' HB2' ' F' ' 50' ' ' SER . . . -66.83 -41.24 87.78 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.853 0.359 . . . . 0.0 111.618 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' F' ' 36' ' ' GLN . . . -103.7 25.98 9.12 Favored 'General case' 0 N--CA 1.46 0.068 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.707 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.83 -22.69 0.33 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.947 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' SER . . . . . 0.409 ' HB3' ' HB2' ' C' ' 91' ' ' SER . 1.0 OUTLIER -107.66 175.18 5.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.913 0.387 . . . . 0.0 110.593 179.544 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.41 177.1 3.01 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . 0.505 ' O ' HG12 ' C' ' 99' ' ' VAL . 0.2 OUTLIER -138.52 167.88 20.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.269 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . 0.58 ' HA ' ' HB ' ' C' ' 140' ' ' THR . 32.5 m-80 44.17 51.7 7.26 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.48 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' VAL . . . . . 0.505 HG12 ' O ' ' C' ' 97' ' ' THR . 6.0 p -169.39 124.12 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.767 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' C' ' 86' ' ' LEU . . . -129.55 -164.72 11.5 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.638 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.77 91.15 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 122.975 0.51 . . . . 0.0 111.7 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' GLN . . . . . 0.7 ' HA ' ' HA ' ' C' ' 85' ' ' VAL . 0.6 OUTLIER -71.45 116.63 12.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.858 -179.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.647 HD12 HD11 ' C' ' 113' ' ' LEU . 6.6 mt -89.68 120.61 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.445 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 1.0 OUTLIER -95.81 152.27 18.63 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.689 0.28 . . . . 0.0 111.164 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.16 160.07 14.62 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.601 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . 0.533 ' CZ ' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -68.8 -13.68 62.55 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.827 0.346 . . . . 0.0 111.066 179.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 45.0 p -74.37 -18.92 60.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.081 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.91 -40.01 2.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.71 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.41 164.71 13.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.816 0.341 . . . . 0.0 111.116 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -77.35 139.58 39.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.174 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' LEU . . . . . 0.553 HD21 ' HB ' ' C' ' 117' ' ' THR . 5.9 tt -84.08 128.48 34.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.435 0.636 . . . . 0.0 110.519 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' THR . . . . . 0.442 ' HA ' HD22 ' C' ' 84' ' ' ASN . 1.4 m -68.14 132.39 47.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.126 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.647 HD11 HD12 ' C' ' 103' ' ' ILE . 4.7 mp -87.99 99.69 12.35 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.791 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' ASP . . . . . 0.502 ' O ' ' O ' ' F' ' 130' ' ' THR . 0.8 OUTLIER -144.03 -32.49 0.43 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.626 0.25 . . . . 0.0 111.568 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . 0.491 ' CA ' HD23 ' C' ' 74' ' ' LEU . . . 146.5 -81.25 0.21 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.669 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' ALA . . . . . 0.695 ' HA ' ' HB1' ' C' ' 72' ' ' ALA . . . -97.25 64.0 1.88 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.975 0.417 . . . . 0.0 111.659 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . 0.553 ' HB ' HD21 ' C' ' 111' ' ' LEU . 2.8 m -94.26 72.28 3.88 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.18 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -66.69 119.04 11.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.9 t -143.95 -48.96 0.29 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.809 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 3.0 m -88.57 84.7 6.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.584 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' C' ' 70' ' ' ALA . 3.5 mt-10 -110.25 86.92 2.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.287 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.95 159.27 17.73 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.833 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -66.93 138.34 57.21 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.699 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . 0.864 HD12 ' HB2' ' C' ' 69' ' ' ALA . 0.4 OUTLIER -86.56 159.48 19.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.636 179.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.56 176.28 10.19 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.562 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' ASN . . . . . 0.516 ' OD1' ' HA ' ' C' ' 62' ' ' ASP . 0.9 OUTLIER -85.92 161.52 19.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.681 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.5 -121.0 5.7 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.756 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 72.4 m -119.47 140.36 50.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.675 0.274 . . . . 0.0 110.815 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 129' ' ' ASN . . . . . 0.46 ' O ' HD12 ' C' ' 58' ' ' LEU . 5.1 t-20 -133.8 154.64 50.86 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.876 0.37 . . . . 0.0 111.087 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . 0.694 HG22 ' HA ' ' C' ' 57' ' ' GLN . 28.0 p -133.37 154.29 50.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.133 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 131' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' C' ' 55' ' ' ASN . 1.0 OUTLIER -111.0 116.84 51.19 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 132' ' ' PRO . . . . . 0.533 ' HG2' ' CZ ' ' C' ' 106' ' ' ARG . 7.7 Cg_endo -81.12 129.4 6.83 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.662 1.574 . . . . 0.0 112.675 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.464 ' HB3' ' CE1' ' C' ' 54' ' ' PHE . 0.1 OUTLIER -140.87 146.89 38.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.813 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 134' ' ' GLN . . . . . 0.525 ' HB3' ' HB1' ' C' ' 51' ' ' ALA . 19.4 mm-40 -116.47 158.39 23.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.043 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' C' ' 103' ' ' ILE . . . -159.48 105.53 1.67 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.91 0.386 . . . . 0.0 111.545 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.72 172.5 6.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.399 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.16 147.72 24.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.128 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.58 158.99 35.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.057 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 139' ' ' ALA . . . . . 0.716 ' HB2' ' CB ' ' C' ' 42' ' ' LEU . . . -116.27 141.28 48.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.934 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 140' ' ' THR . . . . . 0.58 ' HB ' ' HA ' ' C' ' 98' ' ' ASN . 0.2 OUTLIER -107.83 27.23 9.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.471 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . 0.589 ' HA2' ' N ' ' C' ' 45' ' ' GLU . . . 97.63 83.59 1.71 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.97 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 142' ' ' ALA . . . . . 0.726 ' HA ' ' HA ' ' C' ' 43' ' ' ALA . . . 57.9 93.41 0.03 OUTLIER 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.666 0.233 . . . . 0.0 110.8 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 143' ' ' ALA . . . . . 0.547 ' HA ' ' HB2' ' C' ' 98' ' ' ASN . . . -80.02 165.38 22.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.764 0.316 . . . . 0.0 111.392 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 144' ' ' THR . . . . . . . . . . . . . 29.8 p -108.35 168.87 7.22 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.228 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.68 133.56 6.09 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.533 2.155 . . . . 0.0 112.015 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . 0.62 ' HA2' HG12 ' A' ' 5' ' ' VAL . . . 169.6 -119.25 0.81 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.477 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.8 121.73 13.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.887 0.375 . . . . 0.0 111.339 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.42 85.71 3.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.419 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -104.61 131.24 52.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.548 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 150' ' ' ALA . . . . . 1.064 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -136.06 148.51 48.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.971 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.24 120.19 20.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.205 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.64 140.0 24.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.207 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . 0.624 HG22 ' HA ' ' B' ' 9' ' ' THR . 70.7 p -105.16 171.19 7.45 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 154' ' ' PHE . . . . . 0.51 ' HZ ' HG21 ' C' ' 56' ' ' ILE . 13.9 p90 -138.21 147.41 43.73 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.114 0.483 . . . . 0.0 110.074 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . 0.748 ' HG2' HD11 ' C' ' 74' ' ' LEU . 13.7 mmtt -100.89 171.94 7.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.936 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 156' ' ' VAL . . . . . 0.652 HG23 HG23 ' B' ' 5' ' ' VAL . 0.4 OUTLIER -135.47 111.41 12.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.84 0.352 . . . . 0.0 111.716 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . 0.556 ' HA ' ' O ' ' B' ' 3' ' ' THR . 1.8 tt0 -108.96 141.29 41.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.349 0.595 . . . . 0.0 110.409 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . 0.484 ' CZ ' ' HB ' ' C' ' 156' ' ' VAL . 23.0 m-85 -135.37 105.47 6.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.595 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . 0.695 ' HA ' ' H ' ' B' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 111.495 0.183 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.68 ' H ' ' HA ' ' E' ' 159' ' ' GLN . . . 56.69 88.54 0.05 OUTLIER 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.713 -0.222 . . . . 0.0 110.963 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' E' ' 157' ' ' GLN . 0.2 OUTLIER -103.08 110.38 22.29 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.383 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.36 136.2 38.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.592 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.646 HG23 HG23 ' E' ' 156' ' ' VAL . 0.0 OUTLIER -152.05 -175.35 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.562 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.44 130.05 38.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.685 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.81 -59.23 0.91 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.8 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.34 166.18 27.93 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.868 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . 0.612 ' HA ' HG22 ' E' ' 153' ' ' THR . 27.0 m -94.38 121.15 35.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 0.0 111.197 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.73 115.61 36.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.208 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -99.54 137.51 37.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.374 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' E' ' 32' ' ' VAL . 76.0 m-85 -127.6 97.74 4.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.792 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.31 175.76 6.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.428 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.0 149.45 5.77 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.948 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.29 108.58 13.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.855 0.359 . . . . 0.0 110.35 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' E' ' 37' ' ' VAL . 23.5 t -86.59 129.1 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.243 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' D' ' 22' ' ' ALA . 18.8 m -127.35 163.54 30.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.815 0.34 . . . . 0.0 111.011 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -85.97 61.4 6.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.052 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' ALA . . . . . 0.487 ' HB3' HG21 ' D' ' 65' ' ' VAL . . . 44.88 52.64 7.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' D' ' 61' ' ' CYS . . . -127.22 -54.42 1.37 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.49 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.1 OUTLIER 177.64 111.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.879 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . 0.498 ' HB2' HG22 ' D' ' 17' ' ' VAL . . . -105.69 126.06 51.71 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.108 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.81 145.65 7.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.003 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.612 ' O ' HG23 ' D' ' 28' ' ' VAL . 4.0 m-20 -74.77 147.26 41.44 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.692 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.74 -43.62 18.19 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.396 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.96 -20.01 60.17 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.863 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 45.1 t -79.54 -26.12 41.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.899 0.381 . . . . 0.0 110.887 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . 0.612 HG23 ' O ' ' D' ' 24' ' ' ASP . 57.3 t -49.1 -48.53 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.33 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.82 93.01 5.32 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.093 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.55 116.42 28.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.038 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.66 115.62 27.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.173 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' C' ' 12' ' ' PHE . 1.6 t -117.14 101.08 11.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.072 0.463 . . . . 0.0 110.469 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.58 126.97 52.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.698 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.602 HD21 ' HB3' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -68.2 -55.67 11.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.653 179.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.02 -111.69 3.94 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.498 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' GLN . . . . . 0.538 ' O ' ' HB3' ' A' ' 93' ' ' ALA . 0.0 OUTLIER -77.04 115.26 16.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.513 0.197 . . . . 0.0 110.947 -179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' C' ' 16' ' ' VAL . 67.6 t -131.0 105.83 11.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.888 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.67 154.1 17.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.722 179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.637 ' HA ' HD12 ' D' ' 42' ' ' LEU . 8.3 p -78.7 -19.86 51.43 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.775 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -19.53 65.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.14 0.495 . . . . 0.0 110.888 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 96.8 p -92.05 -21.2 20.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.184 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.718 ' CB ' ' HB2' ' D' ' 139' ' ' ALA . 0.2 OUTLIER -139.08 62.25 1.54 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.602 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . 0.728 ' HA ' ' HA ' ' D' ' 142' ' ' ALA . . . -101.15 9.17 42.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.36 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.17 136.06 24.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.359 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . 0.587 ' N ' ' HA2' ' D' ' 141' ' ' GLY . 16.4 tt0 -58.53 121.37 10.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.844 0.354 . . . . 0.0 111.133 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.25 -25.44 8.25 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.209 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.75 137.22 58.21 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.83 158.07 44.32 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.95 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.05 -166.23 1.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.512 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.632 ' HB2' ' HA ' ' A' ' 92' ' ' ALA . 48.9 m -65.17 156.11 32.79 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.769 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' D' ' 134' ' ' GLN . . . -90.46 126.7 35.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.358 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' VAL . . . . . 0.869 HG13 ' HA ' ' A' ' 90' ' ' SER . 63.2 t -75.66 118.53 21.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.999 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.84 135.69 13.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.672 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.538 ' H ' HG21 ' A' ' 76' ' ' THR . 46.3 p90 -170.77 142.11 1.9 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' ASN . . . . . 0.68 ' HA ' ' O ' ' D' ' 131' ' ' ILE . 11.6 p30 -126.58 163.88 22.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.526 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.584 ' O ' ' HA ' ' D' ' 130' ' ' THR . 20.7 mm -105.08 119.93 54.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.516 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' GLN . . . . . 0.698 ' HA ' HG22 ' D' ' 130' ' ' THR . 0.0 OUTLIER -82.15 115.65 21.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.761 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . 0.64 HD11 HG13 ' D' ' 131' ' ' ILE . 0.0 OUTLIER -128.21 107.42 9.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.298 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.35 177.0 8.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.951 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.11 66.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.756 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' CYS . . . . . 0.839 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 3.3 m -109.66 154.39 22.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.742 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . 0.522 ' HA ' ' OD1' ' D' ' 126' ' ' ASN . 0.5 OUTLIER -154.66 138.37 16.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.214 -179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' D' ' 66' ' ' ALA . 0.2 OUTLIER -97.64 -11.82 23.14 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.12 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.19 -48.82 40.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.03 0.443 . . . . 0.0 111.746 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . 0.487 HG21 ' HB3' ' D' ' 19' ' ' ALA . 10.5 t -68.92 -48.71 68.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.742 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' D' ' 159' ' ' GLN . . . -137.97 153.32 49.46 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.637 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.27 18.68 4.44 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.926 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' LYS . . . . . 0.621 ' HB3' ' HB3' ' D' ' 159' ' ' GLN . 10.6 tppt? -142.84 149.9 39.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.573 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' ALA . . . . . 0.869 ' HB2' HD12 ' D' ' 124' ' ' LEU . . . -149.97 110.75 4.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.633 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' D' ' 121' ' ' GLU . . . -108.06 169.95 8.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.131 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . 0.431 HG21 HG21 ' D' ' 131' ' ' ILE . 0.5 OUTLIER -130.4 150.96 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.642 -179.507 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' ALA . . . . . 0.685 ' HB1' ' HA ' ' D' ' 116' ' ' ALA . . . -135.57 100.1 4.4 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.555 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' PHE . . . . . 0.435 ' HB2' HD22 ' D' ' 111' ' ' LEU . 0.2 OUTLIER -77.46 133.94 38.49 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.599 0.238 . . . . 0.0 111.128 179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' LEU . . . . . 0.749 HD11 ' HG2' ' D' ' 155' ' ' LYS . 0.0 OUTLIER -124.15 115.08 20.53 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.932 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.35 -173.22 26.48 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.821 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -112.62 149.06 33.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.681 0.277 . . . . 0.0 110.739 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' D' ' 85' ' ' VAL . . . -98.95 133.79 42.72 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.939 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 78' ' ' ILE . . . . . 0.787 ' HB ' ' HA ' ' D' ' 87' ' ' ALA . 16.1 tt -72.96 -37.95 55.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.89 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.21 167.63 12.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.834 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.22 -53.83 15.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.08 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.36 28.71 6.07 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.536 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . 0.832 ' HB3' ' HB ' ' D' ' 85' ' ' VAL . 10.3 m170 -111.33 -45.7 3.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.928 0.394 . . . . 0.0 110.453 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.39 -86.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.603 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' D' ' 82' ' ' HIS . 0.0 OUTLIER -42.19 -42.46 3.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.268 179.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.832 ' HB ' ' HB3' ' D' ' 82' ' ' HIS . 21.3 t -61.3 126.53 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.135 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.997 HD22 ' HB1' ' D' ' 150' ' ' ALA . 0.2 OUTLIER -81.22 164.42 22.3 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.432 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.787 ' HA ' ' HB ' ' D' ' 78' ' ' ILE . . . -104.84 -177.53 3.39 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.852 0.358 . . . . 0.0 111.618 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.01 -174.53 5.32 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.009 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.64 -170.72 3.24 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.367 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 27.8 p -74.76 7.87 2.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.905 0.383 . . . . 0.0 111.46 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . 0.421 ' HB2' ' HB3' ' D' ' 95' ' ' SER . 0.8 OUTLIER -97.06 80.41 2.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.809 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.84 -41.2 87.81 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.82 0.343 . . . . 0.0 111.636 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.72 26.01 9.1 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.682 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.77 -22.64 0.33 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.892 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 95' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' D' ' 91' ' ' SER . 1.0 OUTLIER -107.65 175.18 5.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 110.661 179.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.35 177.1 2.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . 0.497 ' O ' HG12 ' D' ' 99' ' ' VAL . 0.2 OUTLIER -138.6 167.85 21.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.278 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 98' ' ' ASN . . . . . 0.585 ' HA ' ' HB ' ' D' ' 140' ' ' THR . 32.4 m-80 44.2 51.68 7.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.489 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 99' ' ' VAL . . . . . 0.497 HG12 ' O ' ' D' ' 97' ' ' THR . 6.0 p -169.34 124.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.702 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.61 -164.65 11.47 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.58 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 101' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.84 91.13 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.202 0.525 . . . . 0.0 111.73 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 102' ' ' GLN . . . . . 0.706 ' HA ' ' HA ' ' D' ' 85' ' ' VAL . 0.6 OUTLIER -71.43 116.65 12.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.857 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 103' ' ' ILE . . . . . 0.666 HD12 HD11 ' D' ' 113' ' ' LEU . 6.6 mt -89.61 120.64 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.457 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 104' ' ' LEU . . . . . 0.517 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 1.0 OUTLIER -95.84 152.32 18.6 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.691 0.281 . . . . 0.0 111.126 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.14 160.09 14.6 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.629 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 106' ' ' ARG . . . . . 0.536 ' CZ ' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -68.89 -13.6 62.53 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.835 0.35 . . . . 0.0 111.075 179.53 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 107' ' ' THR . . . . . . . . . . . . . 45.3 p -74.42 -18.9 60.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.144 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.0 -40.15 2.22 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.669 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.3 164.7 13.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.338 . . . . 0.0 111.119 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -77.4 139.66 39.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.148 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 111' ' ' LEU . . . . . 0.554 HD21 ' HB ' ' D' ' 117' ' ' THR . 5.9 tt -84.18 128.59 34.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.404 0.621 . . . . 0.0 110.503 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 112' ' ' THR . . . . . 0.437 ' HA ' HD22 ' D' ' 84' ' ' ASN . 1.4 m -68.13 132.36 47.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.17 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 113' ' ' LEU . . . . . 0.666 HD11 HD12 ' D' ' 103' ' ' ILE . 4.7 mp -88.06 99.74 12.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.693 0.282 . . . . 0.0 110.737 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.06 -32.43 0.43 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.539 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . 0.497 ' CA ' HD23 ' D' ' 74' ' ' LEU . . . 146.45 -81.29 0.21 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.666 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 116' ' ' ALA . . . . . 0.685 ' HA ' ' HB1' ' D' ' 72' ' ' ALA . . . -97.23 64.12 1.89 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.0 0.429 . . . . 0.0 111.624 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 117' ' ' THR . . . . . 0.554 ' HB ' HD21 ' D' ' 111' ' ' LEU . 2.8 m -94.42 72.31 3.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.143 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.76 119.07 11.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.828 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.89 -49.03 0.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.57 84.75 6.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.575 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' D' ' 70' ' ' ALA . 3.6 mt-10 -110.16 86.94 2.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.268 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.0 159.32 17.66 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.83 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -67.07 138.33 57.07 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.68 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . 0.869 HD12 ' HB2' ' D' ' 69' ' ' ALA . 0.4 OUTLIER -86.47 159.46 19.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.68 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.55 176.28 10.19 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.635 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 126' ' ' ASN . . . . . 0.522 ' OD1' ' HA ' ' D' ' 62' ' ' ASP . 0.9 OUTLIER -85.98 161.52 18.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.639 179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.53 -121.06 5.73 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.764 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 128' ' ' THR . . . . . 0.566 HG21 ' HE2' ' A' ' 155' ' ' LYS . 74.1 m -119.5 140.3 50.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.659 0.266 . . . . 0.0 110.765 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 129' ' ' ASN . . . . . 0.452 ' O ' HD12 ' D' ' 58' ' ' LEU . 5.1 t-20 -133.74 154.63 50.83 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.912 0.387 . . . . 0.0 111.087 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 130' ' ' THR . . . . . 0.698 HG22 ' HA ' ' D' ' 57' ' ' GLN . 28.2 p -133.36 154.32 50.83 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.167 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 131' ' ' ILE . . . . . 0.68 ' O ' ' HA ' ' D' ' 55' ' ' ASN . 1.0 OUTLIER -111.07 116.86 51.01 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 132' ' ' PRO . . . . . 0.6 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 7.7 Cg_endo -81.11 129.36 6.82 Favored 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.704 1.603 . . . . 0.0 112.667 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.46 ' HB3' ' CE1' ' D' ' 54' ' ' PHE . 0.1 OUTLIER -140.87 146.87 38.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.81 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 134' ' ' GLN . . . . . 0.529 ' HB3' ' HB1' ' D' ' 51' ' ' ALA . 19.5 mm-40 -116.48 158.4 23.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.979 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' D' ' 103' ' ' ILE . . . -159.48 105.61 1.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.931 0.396 . . . . 0.0 111.539 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 136' ' ' ARG . . . . . 0.417 ' HG2' ' H ' ' D' ' 136' ' ' ARG . 1.2 ptt180 -103.68 172.57 6.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.405 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.23 147.72 24.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.086 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.58 159.05 35.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.005 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 139' ' ' ALA . . . . . 0.718 ' HB2' ' CB ' ' D' ' 42' ' ' LEU . . . -116.36 141.31 48.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.85 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 140' ' ' THR . . . . . 0.585 ' HB ' ' HA ' ' D' ' 98' ' ' ASN . 0.2 OUTLIER -107.78 27.2 9.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.496 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . 0.587 ' HA2' ' N ' ' D' ' 45' ' ' GLU . . . 97.55 83.6 1.71 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.014 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . 0.728 ' HA ' ' HA ' ' D' ' 43' ' ' ALA . . . 57.87 93.49 0.03 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.7 0.25 . . . . 0.0 110.759 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 143' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' D' ' 98' ' ' ASN . . . -79.97 165.44 22.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.81 0.338 . . . . 0.0 111.375 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 144' ' ' THR . . . . . 0.405 ' HB ' ' CD ' ' D' ' 145' ' ' PRO . 29.4 p -108.37 168.85 7.25 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.234 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 145' ' ' PRO . . . . . 0.405 ' CD ' ' HB ' ' D' ' 144' ' ' THR . 1.3 Cg_endo -83.62 133.56 6.14 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.544 2.162 . . . . 0.0 112.002 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . 0.609 ' HA2' HG12 ' B' ' 5' ' ' VAL . . . 169.56 -119.25 0.81 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.477 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.84 121.69 13.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.787 0.327 . . . . 0.0 111.327 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.33 85.7 3.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.14 0.495 . . . . 0.0 110.506 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -104.57 131.21 52.25 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.597 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 150' ' ' ALA . . . . . 0.997 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -136.08 148.49 48.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.951 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.16 120.24 20.95 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.194 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.7 140.0 24.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.164 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 153' ' ' THR . . . . . 0.626 HG22 ' HA ' ' C' ' 9' ' ' THR . 70.7 p -105.2 171.18 7.46 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 154' ' ' PHE . . . . . 0.51 ' HZ ' HG21 ' D' ' 56' ' ' ILE . 13.5 p90 -138.18 147.4 43.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.138 0.494 . . . . 0.0 110.112 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . 0.749 ' HG2' HD11 ' D' ' 74' ' ' LEU . 13.7 mmtt -100.9 171.92 7.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.912 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 156' ' ' VAL . . . . . 0.646 HG23 HG23 ' C' ' 5' ' ' VAL . 0.4 OUTLIER -135.4 111.42 12.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.714 -179.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 157' ' ' GLN . . . . . 0.564 ' HA ' ' O ' ' C' ' 3' ' ' THR . 1.8 tt0 -109.03 141.32 41.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.273 0.559 . . . . 0.0 110.398 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . 0.48 ' CZ ' ' HB ' ' D' ' 156' ' ' VAL . 23.1 m-85 -135.43 105.43 6.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.555 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 159' ' ' GLN . . . . . 0.672 ' HA ' ' H ' ' C' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.899 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 111.48 0.178 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . 0.686 ' H ' ' HA ' ' F' ' 159' ' ' GLN . . . 56.56 88.6 0.05 OUTLIER 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.038 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 3' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' F' ' 157' ' ' GLN . 0.2 OUTLIER -103.14 110.34 22.24 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.411 179.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.31 136.26 38.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.57 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.66 HG23 HG23 ' F' ' 156' ' ' VAL . 0.0 OUTLIER -152.11 -175.28 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.616 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.54 130.06 38.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.646 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.73 -59.38 0.91 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.805 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.38 166.23 28.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.806 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 9' ' ' THR . . . . . 0.609 ' HA ' HG22 ' F' ' 153' ' ' THR . 27.0 m -94.47 121.18 35.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.939 0.4 . . . . 0.0 111.205 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.69 115.58 36.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.21 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -99.52 137.56 37.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.327 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 12' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' F' ' 32' ' ' VAL . 76.2 m-85 -127.61 97.78 4.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.815 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.3 175.8 6.55 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.378 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.97 149.46 5.77 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.91 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.29 108.61 13.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 0.0 110.345 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 16' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' F' ' 37' ' ' VAL . 23.4 t -86.62 129.16 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.213 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' E' ' 22' ' ' ALA . 18.7 m -127.43 163.53 30.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.787 0.327 . . . . 0.0 111.028 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -85.95 61.36 6.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.032 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 19' ' ' ALA . . . . . 0.491 ' HB3' HG21 ' E' ' 65' ' ' VAL . . . 45.0 52.64 8.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.051 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' E' ' 61' ' ' CYS . . . -127.27 -54.47 1.37 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.426 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 21' ' ' CYS . . . . . 0.818 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.1 OUTLIER 177.68 111.67 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.901 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 22' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' E' ' 17' ' ' VAL . . . -105.71 126.0 51.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.86 145.68 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.003 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 24' ' ' ASP . . . . . 0.607 ' O ' HG23 ' E' ' 28' ' ' VAL . 3.9 m-20 -74.9 147.28 41.14 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.652 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.73 -43.71 18.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.331 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.85 -20.06 60.27 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.865 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 45.1 t -79.58 -26.09 41.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.872 0.367 . . . . 0.0 110.851 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 28' ' ' VAL . . . . . 0.607 HG23 ' O ' ' E' ' 24' ' ' ASP . 57.8 t -49.13 -48.49 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.361 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.89 93.09 5.35 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.976 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.63 116.38 28.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.04 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.54 115.58 27.63 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.178 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' D' ' 12' ' ' PHE . 1.7 t -117.17 101.14 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.168 0.509 . . . . 0.0 110.463 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.58 126.91 52.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.711 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.613 HD21 ' HB3' ' B' ' 92' ' ' ALA . 0.3 OUTLIER -68.15 -55.71 11.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.619 179.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.03 -111.69 3.93 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.471 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 36' ' ' GLN . . . . . 0.545 ' HG3' ' HA ' ' D' ' 24' ' ' ASP . 0.0 OUTLIER -77.02 115.34 16.73 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.524 0.202 . . . . 0.0 110.902 -179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' D' ' 16' ' ' VAL . 67.5 t -131.11 105.85 11.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.819 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.6 154.11 17.47 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.77 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 39' ' ' THR . . . . . 0.665 ' HA ' HD12 ' E' ' 42' ' ' LEU . 8.4 p -78.71 -19.92 51.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.753 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.38 -19.58 65.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.125 0.488 . . . . 0.0 110.923 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 97.1 p -92.01 -21.24 20.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.156 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.701 ' CB ' ' HB2' ' E' ' 139' ' ' ALA . 0.2 OUTLIER -139.06 62.39 1.54 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.661 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 43' ' ' ALA . . . . . 0.727 ' HA ' ' HA ' ' E' ' 142' ' ' ALA . . . -101.23 9.12 42.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.246 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.15 136.02 24.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.32 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . 0.59 ' N ' ' HA2' ' E' ' 141' ' ' GLY . 16.5 tt0 -58.5 121.24 10.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.889 0.376 . . . . 0.0 111.159 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.36 -25.47 8.19 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.196 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.66 137.24 58.22 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.93 157.93 44.75 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.919 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.97 -166.19 1.09 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.583 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 50' ' ' SER . . . . . 0.621 ' HB2' ' HA ' ' B' ' 92' ' ' ALA . 48.7 m -65.22 156.23 32.53 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.789 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 51' ' ' ALA . . . . . 0.544 ' HB1' ' HB3' ' E' ' 134' ' ' GLN . . . -90.57 126.66 36.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.274 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 52' ' ' VAL . . . . . 0.898 HG13 ' HA ' ' B' ' 90' ' ' SER . 63.3 t -75.61 118.46 21.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.016 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.78 135.65 13.77 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.663 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 54' ' ' PHE . . . . . 0.531 ' H ' HG21 ' B' ' 76' ' ' THR . 46.2 p90 -170.77 142.04 1.89 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.831 0.348 . . . . 0.0 110.907 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 55' ' ' ASN . . . . . 0.674 ' HA ' ' O ' ' E' ' 131' ' ' ILE . 11.6 p30 -126.5 163.87 22.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.621 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 56' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' E' ' 130' ' ' THR . 21.0 mm -105.1 119.93 54.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.52 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 57' ' ' GLN . . . . . 0.675 ' HA ' HG22 ' E' ' 130' ' ' THR . 0.0 OUTLIER -82.18 115.74 21.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.744 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . 0.648 HD11 HG13 ' E' ' 131' ' ' ILE . 0.0 OUTLIER -128.28 107.45 9.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.267 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.34 177.09 8.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.924 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 62.95 66.13 0.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.818 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 61' ' ' CYS . . . . . 0.818 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 3.3 m -109.65 154.42 22.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.785 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . 0.512 ' HA ' ' OD1' ' E' ' 126' ' ' ASN . 0.5 OUTLIER -154.68 138.35 16.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.258 -179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 63' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' E' ' 66' ' ' ALA . 0.2 OUTLIER -97.63 -11.81 23.17 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.131 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.23 -48.72 40.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.993 0.425 . . . . 0.0 111.733 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' E' ' 19' ' ' ALA . 10.7 t -69.02 -48.67 68.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.712 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . 0.554 ' HB1' ' O ' ' E' ' 159' ' ' GLN . . . -137.94 153.39 49.49 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.616 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.3 18.62 4.43 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.802 0.334 . . . . 0.0 110.91 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 68' ' ' LYS . . . . . 0.611 ' HB3' ' HB3' ' E' ' 159' ' ' GLN . 10.6 tppt? -142.83 149.94 39.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.448 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 69' ' ' ALA . . . . . 0.863 ' HB2' HD12 ' E' ' 124' ' ' LEU . . . -150.01 110.65 4.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.729 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' E' ' 121' ' ' GLU . . . -108.01 169.92 8.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.067 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . 0.43 HG21 HG21 ' E' ' 131' ' ' ILE . 0.5 OUTLIER -130.34 150.95 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.681 -179.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . 0.701 ' HB1' ' HA ' ' E' ' 116' ' ' ALA . . . -135.59 100.13 4.4 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.528 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 73' ' ' PHE . . . . . 0.437 ' HB2' HD22 ' E' ' 111' ' ' LEU . 0.2 OUTLIER -77.39 133.94 38.56 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.594 0.235 . . . . 0.0 111.136 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 74' ' ' LEU . . . . . 0.731 HD11 ' HG2' ' E' ' 155' ' ' LYS . 0.0 OUTLIER -124.17 115.06 20.49 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.971 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.35 -173.22 26.48 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.79 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 7.0 m -112.66 149.03 33.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.624 0.25 . . . . 0.0 110.715 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 77' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' E' ' 85' ' ' VAL . . . -98.95 133.8 42.71 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.852 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 78' ' ' ILE . . . . . 0.778 ' HB ' ' HA ' ' E' ' 87' ' ' ALA . 16.1 tt -72.95 -37.98 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.908 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.19 167.6 12.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.907 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.09 -53.86 15.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.4 28.67 6.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.597 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 82' ' ' HIS . . . . . 0.825 ' HB3' ' HB ' ' E' ' 85' ' ' VAL . 10.2 m170 -111.36 -45.57 3.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 0.0 110.446 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.4 -86.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.567 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 84' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' E' ' 82' ' ' HIS . 0.0 OUTLIER -42.17 -42.4 2.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.402 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.825 ' HB ' ' HB3' ' E' ' 82' ' ' HIS . 21.3 t -61.25 126.57 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.151 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 86' ' ' LEU . . . . . 1.029 HD22 ' HB1' ' E' ' 150' ' ' ALA . 0.2 OUTLIER -81.23 164.4 22.31 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 87' ' ' ALA . . . . . 0.778 ' HA ' ' HB ' ' E' ' 78' ' ' ILE . . . -104.77 -177.51 3.39 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.688 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.03 -174.56 5.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.974 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.59 -170.73 3.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.401 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 27.5 p -74.67 7.73 2.85 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.96 0.41 . . . . 0.0 111.464 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 91' ' ' SER . . . . . 0.402 ' HB2' ' HB3' ' E' ' 95' ' ' SER . 0.8 OUTLIER -96.93 80.42 2.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.86 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.87 -41.17 87.7 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.849 0.356 . . . . 0.0 111.623 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.7 25.94 9.17 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.664 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.8 -22.63 0.33 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.889 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 95' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' E' ' 91' ' ' SER . 1.0 OUTLIER -107.71 175.2 5.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.928 0.394 . . . . 0.0 110.597 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.37 177.08 3.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.881 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . 0.496 ' O ' HG12 ' E' ' 99' ' ' VAL . 0.2 OUTLIER -138.56 167.87 21.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.305 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 98' ' ' ASN . . . . . 0.57 ' HA ' ' HB ' ' E' ' 140' ' ' THR . 32.4 m-80 44.15 51.68 7.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.526 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 99' ' ' VAL . . . . . 0.496 HG12 ' O ' ' E' ' 97' ' ' THR . 6.0 p -169.36 124.17 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.753 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.53 -164.65 11.49 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.594 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.9 91.07 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 122.997 0.519 . . . . 0.0 111.735 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 102' ' ' GLN . . . . . 0.708 ' HA ' ' HA ' ' E' ' 85' ' ' VAL . 0.6 OUTLIER -71.38 116.65 11.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.901 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 103' ' ' ILE . . . . . 0.666 HD12 HD11 ' E' ' 113' ' ' LEU . 6.5 mt -89.66 120.59 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.511 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 104' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 1.0 OUTLIER -95.85 152.32 18.6 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.738 0.304 . . . . 0.0 111.105 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.08 160.07 14.61 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.553 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 106' ' ' ARG . . . . . 0.535 ' CZ ' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -68.81 -13.7 62.56 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.83 0.348 . . . . 0.0 111.064 179.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 44.8 p -74.4 -18.95 60.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.097 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.0 -40.12 2.23 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.89 -0.672 . . . . 0.0 112.639 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.36 164.63 13.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.774 0.321 . . . . 0.0 111.116 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -77.38 139.66 39.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.128 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.556 HD21 ' HB ' ' E' ' 117' ' ' THR . 5.9 tt -84.16 128.58 34.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.449 0.642 . . . . 0.0 110.477 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 112' ' ' THR . . . . . 0.431 ' HA ' HD22 ' E' ' 84' ' ' ASN . 1.4 m -68.13 132.38 47.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.081 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 113' ' ' LEU . . . . . 0.666 HD11 HD12 ' E' ' 103' ' ' ILE . 4.7 mp -88.12 99.79 12.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.723 0.297 . . . . 0.0 110.699 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.09 -32.4 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.528 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . 0.497 ' CA ' HD23 ' E' ' 74' ' ' LEU . . . 146.42 -81.24 0.21 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.645 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 116' ' ' ALA . . . . . 0.701 ' HA ' ' HB1' ' E' ' 72' ' ' ALA . . . -97.24 64.03 1.88 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.038 0.447 . . . . 0.0 111.678 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 117' ' ' THR . . . . . 0.556 ' HB ' HD21 ' E' ' 111' ' ' LEU . 2.8 m -94.37 72.48 3.83 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.165 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.84 119.09 11.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.783 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.92 -49.03 0.29 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.83 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 3.0 m -88.55 84.73 6.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.573 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 121' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' E' ' 70' ' ' ALA . 3.5 mt-10 -110.26 86.95 2.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.263 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.06 159.32 17.62 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.801 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 2.5 t -67.04 138.38 57.14 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.734 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . 0.863 HD12 ' HB2' ' E' ' 69' ' ' ALA . 0.4 OUTLIER -86.53 159.54 19.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.636 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.66 176.22 10.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.595 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . 0.512 ' OD1' ' HA ' ' E' ' 62' ' ' ASP . 0.9 OUTLIER -85.89 161.47 19.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.703 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.51 -121.01 5.71 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.718 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 128' ' ' THR . . . . . 0.584 HG21 ' HE2' ' B' ' 155' ' ' LYS . 72.4 m -119.47 140.33 50.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.75 0.309 . . . . 0.0 110.788 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 129' ' ' ASN . . . . . 0.462 ' O ' HD12 ' E' ' 58' ' ' LEU . 5.1 t-20 -133.77 154.62 50.85 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.112 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 130' ' ' THR . . . . . 0.675 HG22 ' HA ' ' E' ' 57' ' ' GLN . 28.0 p -133.41 154.24 50.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.188 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 131' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' E' ' 55' ' ' ASN . 1.0 OUTLIER -110.88 116.79 51.49 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 132' ' ' PRO . . . . . 0.606 ' HB3' ' HA ' ' B' ' 76' ' ' THR . 7.6 Cg_endo -81.15 129.38 6.8 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.663 1.576 . . . . 0.0 112.667 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 133' ' ' PHE . . . . . 0.461 ' HB3' ' CE1' ' E' ' 54' ' ' PHE . 0.1 OUTLIER -140.81 146.89 38.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.796 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 134' ' ' GLN . . . . . 0.544 ' HB3' ' HB1' ' E' ' 51' ' ' ALA . 19.3 mm-40 -116.49 158.33 23.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.033 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' E' ' 103' ' ' ILE . . . -159.47 105.48 1.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.898 0.38 . . . . 0.0 111.589 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.67 172.53 6.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.457 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.18 147.77 24.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.051 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.65 159.0 36.02 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.994 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 139' ' ' ALA . . . . . 0.701 ' HB2' ' CB ' ' E' ' 42' ' ' LEU . . . -116.31 141.27 48.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.897 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 140' ' ' THR . . . . . 0.57 ' HB ' ' HA ' ' E' ' 98' ' ' ASN . 0.2 OUTLIER -107.81 27.22 9.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.499 179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . 0.59 ' HA2' ' N ' ' E' ' 45' ' ' GLU . . . 97.5 83.57 1.7 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.031 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 142' ' ' ALA . . . . . 0.727 ' HA ' ' HA ' ' E' ' 43' ' ' ALA . . . 57.98 93.41 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.67 0.235 . . . . 0.0 110.765 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 143' ' ' ALA . . . . . 0.531 ' HA ' ' HB2' ' E' ' 98' ' ' ASN . . . -79.94 165.51 22.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.733 0.301 . . . . 0.0 111.453 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 144' ' ' THR . . . . . . . . . . . . . 29.6 p -108.49 168.86 7.22 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.202 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 145' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -83.59 133.54 6.16 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.572 2.181 . . . . 0.0 111.981 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 146' ' ' GLY . . . . . 0.626 ' HA2' HG12 ' C' ' 5' ' ' VAL . . . 169.55 -119.23 0.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.475 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.8 121.7 13.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.904 0.383 . . . . 0.0 111.382 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.34 85.68 3.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.541 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -104.58 131.25 52.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.58 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 150' ' ' ALA . . . . . 1.029 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -136.1 148.51 48.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.94 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.18 120.23 20.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.213 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.69 139.99 24.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.171 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 153' ' ' THR . . . . . 0.612 HG22 ' HA ' ' D' ' 9' ' ' THR . 71.0 p -105.21 171.17 7.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 154' ' ' PHE . . . . . 0.51 ' HZ ' HG21 ' E' ' 56' ' ' ILE . 13.6 p90 -138.18 147.39 43.78 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.096 0.474 . . . . 0.0 110.143 -179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . 0.731 ' HG2' HD11 ' E' ' 74' ' ' LEU . 13.7 mmtt -100.92 171.94 7.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.919 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 156' ' ' VAL . . . . . 0.646 HG23 HG23 ' D' ' 5' ' ' VAL . 0.4 OUTLIER -135.44 111.37 12.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.754 0.311 . . . . 0.0 111.789 -179.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 157' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' D' ' 3' ' ' THR . 1.8 tt0 -108.97 141.28 41.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.312 0.577 . . . . 0.0 110.438 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . 0.487 ' CZ ' ' HB ' ' E' ' 156' ' ' VAL . 23.0 m-85 -135.36 105.52 6.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.613 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 159' ' ' GLN . . . . . 0.68 ' HA ' ' H ' ' D' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.116 -0.945 . . . . 0.0 110.903 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 111.486 0.18 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.57 88.66 0.05 OUTLIER 'General case' 0 C--O 1.232 0.172 0 O-C-N 123.095 0.247 . . . . 0.0 110.995 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.11 110.45 22.4 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.397 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.49 136.11 38.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.534 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.99 -175.31 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.601 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.57 130.1 38.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.665 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -98.8 -59.26 0.91 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.794 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.4 166.22 28.06 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.899 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 26.9 m -94.44 121.15 35.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.893 0.378 . . . . 0.0 111.196 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.68 115.66 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.229 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -99.55 137.5 37.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.361 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -127.62 97.8 4.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.748 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -94.26 175.74 6.58 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.458 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.04 149.48 5.78 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.897 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -121.32 108.6 13.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 110.407 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 23.4 t -86.61 129.15 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.183 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 17' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' F' ' 22' ' ' ALA . 18.7 m -127.39 163.54 30.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.06 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -85.93 61.37 6.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.041 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 19' ' ' ALA . . . . . 0.486 ' HB3' HG21 ' F' ' 65' ' ' VAL . . . 44.99 52.6 8.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' F' ' 61' ' ' CYS . . . -127.3 -54.42 1.36 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.44 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 21' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.1 OUTLIER 177.68 111.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.962 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 22' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' F' ' 17' ' ' VAL . . . -105.69 126.09 51.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.053 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.83 145.68 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.968 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 24' ' ' ASP . . . . . 0.623 ' O ' HG23 ' F' ' 28' ' ' VAL . 4.0 m-20 -74.86 147.24 41.27 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.66 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.77 -43.61 18.34 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.32 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.92 -20.01 60.25 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.896 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 45.6 t -79.6 -26.08 41.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 28' ' ' VAL . . . . . 0.623 HG23 ' O ' ' F' ' 24' ' ' ASP . 57.4 t -49.16 -48.52 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.279 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -100.84 93.04 5.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.965 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -93.54 116.42 28.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.035 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p -95.62 115.63 27.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.155 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' E' ' 12' ' ' PHE . 1.7 t -117.21 101.1 11.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.133 0.492 . . . . 0.0 110.426 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -105.6 126.91 52.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.671 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 34' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' C' ' 92' ' ' ALA . 0.3 OUTLIER -68.15 -55.65 11.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.659 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.97 -111.67 3.93 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.555 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 36' ' ' GLN . . . . . 0.547 ' HG3' ' HA ' ' E' ' 24' ' ' ASP . 0.0 OUTLIER -77.0 115.28 16.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.52 0.2 . . . . 0.0 110.928 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' E' ' 16' ' ' VAL . 67.6 t -131.03 105.87 11.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.779 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -96.68 154.12 17.46 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.762 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 39' ' ' THR . . . . . 0.66 ' HA ' HD12 ' F' ' 42' ' ' LEU . 8.0 p -78.8 -19.81 51.25 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.724 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.42 -19.54 65.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.085 0.469 . . . . 0.0 110.913 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 96.6 p -92.08 -21.23 20.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.182 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . 0.702 ' CB ' ' HB2' ' F' ' 139' ' ' ALA . 0.2 OUTLIER -139.0 62.28 1.54 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.686 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 43' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' F' ' 142' ' ' ALA . . . -101.15 9.21 42.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.321 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -145.25 136.0 24.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.36 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . 0.586 ' N ' ' HA2' ' F' ' 141' ' ' GLY . 16.5 tt0 -58.6 121.36 10.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.942 0.401 . . . . 0.0 111.109 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.32 -25.4 8.23 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.139 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.86 137.25 58.22 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.909 0.385 . . . . 0.0 112.018 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 5.9 t -133.85 157.98 44.56 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.945 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.92 -166.16 1.09 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.642 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 50' ' ' SER . . . . . 0.613 ' HB2' ' HA ' ' C' ' 92' ' ' ALA . 48.9 m -65.2 156.15 32.73 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.818 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 51' ' ' ALA . . . . . 0.533 ' HB1' ' HB3' ' F' ' 134' ' ' GLN . . . -90.47 126.73 36.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.32 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 52' ' ' VAL . . . . . 0.909 HG13 ' HA ' ' C' ' 90' ' ' SER . 63.1 t -75.66 118.55 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.981 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.78 135.68 13.8 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.687 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 54' ' ' PHE . . . . . 0.536 ' H ' HG21 ' C' ' 76' ' ' THR . 46.3 p90 -170.76 142.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.83 0.348 . . . . 0.0 110.948 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 55' ' ' ASN . . . . . 0.676 ' HA ' ' O ' ' F' ' 131' ' ' ILE . 11.5 p30 -126.59 163.95 22.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.594 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 56' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' F' ' 130' ' ' THR . 20.8 mm -105.16 119.91 54.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.516 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 57' ' ' GLN . . . . . 0.711 ' HA ' HG22 ' F' ' 130' ' ' THR . 0.0 OUTLIER -82.09 115.69 21.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.736 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . 0.645 HD11 HG13 ' F' ' 131' ' ' ILE . 0.0 OUTLIER -128.25 107.45 9.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.261 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.38 177.0 8.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.902 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 63.06 66.1 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.782 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 61' ' ' CYS . . . . . 0.776 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 3.3 m -109.68 154.42 22.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.729 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . 0.531 ' HA ' ' OD1' ' F' ' 126' ' ' ASN . 0.5 OUTLIER -154.66 138.33 16.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.234 -179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 63' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' F' ' 66' ' ' ALA . 0.2 OUTLIER -97.57 -11.85 23.2 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.13 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -72.21 -48.78 40.37 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.095 0.474 . . . . 0.0 111.764 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . 0.486 HG21 ' HB3' ' F' ' 19' ' ' ALA . 10.6 t -69.02 -48.66 68.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.729 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 66' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' F' ' 159' ' ' GLN . . . -137.97 153.4 49.45 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.64 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 1.7 p -132.25 18.59 4.45 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.907 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 68' ' ' LYS . . . . . 0.612 ' HB3' ' HB3' ' F' ' 159' ' ' GLN . 10.6 tppt? -142.87 149.89 39.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.444 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 69' ' ' ALA . . . . . 0.865 ' HB2' HD12 ' F' ' 124' ' ' LEU . . . -150.01 110.71 4.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.714 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 70' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' F' ' 121' ' ' GLU . . . -108.05 169.95 8.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.034 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 71' ' ' VAL . . . . . 0.433 HG21 HG21 ' F' ' 131' ' ' ILE . 0.5 OUTLIER -130.37 150.95 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.647 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 72' ' ' ALA . . . . . 0.68 ' HB1' ' HA ' ' F' ' 116' ' ' ALA . . . -135.57 100.11 4.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.558 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 73' ' ' PHE . . . . . 0.438 ' HB2' HD22 ' F' ' 111' ' ' LEU . 0.2 OUTLIER -77.46 133.94 38.49 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.552 0.215 . . . . 0.0 111.154 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 74' ' ' LEU . . . . . 0.743 HD11 ' HG2' ' F' ' 155' ' ' LYS . 0.0 OUTLIER -124.16 115.11 20.58 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.975 -179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -158.34 -173.22 26.47 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.77 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 7.1 m -112.68 149.04 33.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.647 0.261 . . . . 0.0 110.726 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 77' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' F' ' 85' ' ' VAL . . . -98.91 133.72 42.79 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.002 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 78' ' ' ILE . . . . . 0.761 ' HB ' ' HA ' ' F' ' 87' ' ' ALA . 16.1 tt -72.89 -37.99 55.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.907 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 79' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.17 167.62 12.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.832 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.2 -53.86 15.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.027 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.34 28.73 6.05 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.6 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 82' ' ' HIS . . . . . 0.824 ' HB3' ' HB ' ' F' ' 85' ' ' VAL . 10.2 m170 -111.35 -45.62 3.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 0.0 110.434 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.43 -86.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.577 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 84' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' F' ' 82' ' ' HIS . 0.0 OUTLIER -42.19 -42.4 3.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.343 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 85' ' ' VAL . . . . . 0.824 ' HB ' ' HB3' ' F' ' 82' ' ' HIS . 21.3 t -61.35 126.54 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.165 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 86' ' ' LEU . . . . . 1.031 HD22 ' HB1' ' F' ' 150' ' ' ALA . 0.2 OUTLIER -81.19 164.41 22.34 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.247 179.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 87' ' ' ALA . . . . . 0.761 ' HA ' ' HB ' ' F' ' 78' ' ' ILE . . . -104.83 -177.58 3.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.903 0.383 . . . . 0.0 111.644 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -174.53 5.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.026 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -85.68 -170.69 3.23 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.356 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 27.9 p -74.74 7.76 2.86 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 111.42 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 91' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' F' ' 95' ' ' SER . 0.8 OUTLIER -96.91 80.37 3.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 179.832 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.86 -41.16 87.8 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.858 0.361 . . . . 0.0 111.606 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.74 26.0 9.12 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.687 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.78 -22.78 0.33 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.902 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 95' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' F' ' 91' ' ' SER . 1.0 OUTLIER -107.65 175.24 5.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.929 0.395 . . . . 0.0 110.646 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.51 177.11 3.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.849 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . 0.506 ' O ' HG12 ' F' ' 99' ' ' VAL . 0.2 OUTLIER -138.53 167.78 21.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.277 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 98' ' ' ASN . . . . . 0.581 ' HA ' ' HB ' ' F' ' 140' ' ' THR . 32.5 m-80 44.15 51.69 7.23 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.515 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 99' ' ' VAL . . . . . 0.506 HG12 ' O ' ' F' ' 97' ' ' THR . 6.0 p -169.37 124.19 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.787 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.55 -164.72 11.5 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.616 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.85 91.12 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.192 0.52 . . . . 0.0 111.758 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 102' ' ' GLN . . . . . 0.704 ' HA ' ' HA ' ' F' ' 85' ' ' VAL . 0.6 OUTLIER -71.37 116.61 11.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.836 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 103' ' ' ILE . . . . . 0.654 HD12 HD11 ' F' ' 113' ' ' LEU . 6.6 mt -89.59 120.62 38.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.5 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 104' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 1.0 OUTLIER -95.81 152.3 18.61 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.679 0.276 . . . . 0.0 111.083 -179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -100.11 160.07 14.61 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.645 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 106' ' ' ARG . . . . . 0.533 ' CZ ' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -68.79 -13.71 62.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.873 0.368 . . . . 0.0 111.082 179.481 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 44.9 p -74.37 -18.96 60.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.075 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 121.0 -40.08 2.23 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.682 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -91.32 164.68 13.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 0.0 111.107 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -77.36 139.63 39.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.1 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . 0.556 HD21 ' HB ' ' F' ' 117' ' ' THR . 5.9 tt -84.13 128.55 34.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.469 0.652 . . . . 0.0 110.477 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 112' ' ' THR . . . . . 0.44 ' HA ' HD22 ' F' ' 84' ' ' ASN . 1.4 m -68.14 132.41 47.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.133 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 113' ' ' LEU . . . . . 0.654 HD11 HD12 ' F' ' 103' ' ' ILE . 4.8 mp -88.06 99.69 12.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.684 0.278 . . . . 0.0 110.778 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.04 -32.48 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.628 0.252 . . . . 0.0 111.541 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . 0.491 ' CA ' HD23 ' F' ' 74' ' ' LEU . . . 146.53 -81.37 0.21 Allowed Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.575 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 116' ' ' ALA . . . . . 0.68 ' HA ' ' HB1' ' F' ' 72' ' ' ALA . . . -97.1 63.99 1.92 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.986 0.422 . . . . 0.0 111.649 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 117' ' ' THR . . . . . 0.556 ' HB ' HD21 ' F' ' 111' ' ' LEU . 2.8 m -94.29 72.35 3.87 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.169 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -66.79 119.12 11.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.821 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 46.8 t -143.95 -49.05 0.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.778 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 2.9 m -88.55 84.69 6.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.606 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 121' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' F' ' 70' ' ' ALA . 3.6 mt-10 -110.23 87.06 2.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.236 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.04 159.27 17.66 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.802 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 2.6 t -67.01 138.34 57.15 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.654 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . 0.865 HD12 ' HB2' ' F' ' 69' ' ' ALA . 0.4 OUTLIER -86.47 159.44 19.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.692 179.389 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 125' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -147.53 176.28 10.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.64 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . 0.531 ' OD1' ' HA ' ' F' ' 62' ' ' ASP . 0.9 OUTLIER -85.91 161.5 19.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.667 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 87.46 -121.07 5.72 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.718 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 128' ' ' THR . . . . . 0.573 HG21 ' HE2' ' C' ' 155' ' ' LYS . 72.0 m -119.42 140.28 50.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.714 0.292 . . . . 0.0 110.821 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 129' ' ' ASN . . . . . 0.462 ' O ' HD12 ' F' ' 58' ' ' LEU . 5.1 t-20 -133.68 154.66 50.76 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.883 0.373 . . . . 0.0 111.122 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 130' ' ' THR . . . . . 0.711 HG22 ' HA ' ' F' ' 57' ' ' GLN . 28.0 p -133.4 154.3 50.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.091 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 131' ' ' ILE . . . . . 0.676 ' O ' ' HA ' ' F' ' 55' ' ' ASN . 1.0 OUTLIER -111.02 116.8 51.2 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 132' ' ' PRO . . . . . 0.609 ' HB3' ' HA ' ' C' ' 76' ' ' THR . 7.6 Cg_endo -81.14 129.43 6.83 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.665 1.576 . . . . 0.0 112.641 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 133' ' ' PHE . . . . . 0.463 ' HB3' ' CE1' ' F' ' 54' ' ' PHE . 0.1 OUTLIER -140.86 146.86 38.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.807 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 134' ' ' GLN . . . . . 0.533 ' HB3' ' HB1' ' F' ' 51' ' ' ALA . 19.2 mm-40 -116.52 158.34 23.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.008 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' F' ' 103' ' ' ILE . . . -159.37 105.45 1.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.847 0.356 . . . . 0.0 111.533 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -103.66 172.54 6.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.439 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.18 147.82 24.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.066 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.68 159.02 36.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.949 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 139' ' ' ALA . . . . . 0.702 ' HB2' ' CB ' ' F' ' 42' ' ' LEU . . . -116.3 141.21 48.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.9 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 140' ' ' THR . . . . . 0.581 ' HB ' ' HA ' ' F' ' 98' ' ' ASN . 0.2 OUTLIER -107.79 27.22 9.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.462 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . 0.586 ' HA2' ' N ' ' F' ' 45' ' ' GLU . . . 97.56 83.56 1.7 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.846 -0.693 . . . . 0.0 113.025 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 142' ' ' ALA . . . . . 0.711 ' HA ' ' HA ' ' F' ' 43' ' ' ALA . . . 57.9 93.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.531 0.205 . . . . 0.0 110.813 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 143' ' ' ALA . . . . . 0.535 ' HA ' ' HB2' ' F' ' 98' ' ' ASN . . . -80.01 165.42 22.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.772 0.32 . . . . 0.0 111.37 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 144' ' ' THR . . . . . . . . . . . . . 29.8 p -108.42 168.86 7.23 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.196 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.58 133.56 6.18 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.56 2.174 . . . . 0.0 112.007 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 146' ' ' GLY . . . . . 0.616 ' HA2' HG12 ' D' ' 5' ' ' VAL . . . 169.53 -119.22 0.81 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.456 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 147' ' ' ALA . . . . . . . . . . . . . . . -141.85 121.7 13.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.866 0.365 . . . . 0.0 111.27 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -97.35 85.65 3.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.485 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -104.5 131.29 52.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.581 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 150' ' ' ALA . . . . . 1.031 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -136.14 148.49 48.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.958 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -133.18 120.21 20.89 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.226 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 152' ' ' ALA . . . . . . . . . . . . . . . -147.65 140.02 24.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.188 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 153' ' ' THR . . . . . 0.609 HG22 ' HA ' ' E' ' 9' ' ' THR . 70.5 p -105.24 171.13 7.48 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 154' ' ' PHE . . . . . 0.507 ' HZ ' HG21 ' F' ' 56' ' ' ILE . 13.7 p90 -138.13 147.42 43.92 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.152 0.501 . . . . 0.0 110.054 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . 0.743 ' HG2' HD11 ' F' ' 74' ' ' LEU . 13.6 mmtt -100.91 171.93 7.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.928 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 156' ' ' VAL . . . . . 0.66 HG23 HG23 ' E' ' 5' ' ' VAL . 0.4 OUTLIER -135.48 111.44 12.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.813 0.34 . . . . 0.0 111.717 -179.136 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 157' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' E' ' 3' ' ' THR . 1.8 tt0 -109.01 141.24 41.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.318 0.58 . . . . 0.0 110.431 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . 0.482 ' CZ ' ' HB ' ' F' ' 156' ' ' VAL . 23.0 m-85 -135.38 105.44 6.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.613 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 159' ' ' GLN . . . . . 0.686 ' HA ' ' H ' ' E' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.58 100.21 0.04 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.02 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' B' ' 158' ' ' TYR . 7.3 m -104.81 78.63 1.45 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.493 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.34 122.36 29.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.543 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.646 HG23 HG23 ' B' ' 156' ' ' VAL . 5.0 m -137.91 162.94 30.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.564 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.425 ' HB3' ' OE2' ' B' ' 15' ' ' GLU . 44.1 t-20 -84.29 114.57 21.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.626 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.481 ' HA3' ' CZ ' ' B' ' 154' ' ' PHE . . . -83.43 -41.48 8.39 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.719 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.446 ' N ' ' CE1' ' B' ' 154' ' ' PHE . . . -175.59 162.29 31.55 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.863 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' B' ' 153' ' ' THR . 99.0 m -90.75 137.84 32.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.929 0.395 . . . . 0.0 111.282 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.46 114.34 46.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.163 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.409 ' HD2' ' OD2' ' B' ' 151' ' ' ASP . 4.6 m80 -99.37 148.58 24.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.33 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.818 ' HB3' HD21 ' B' ' 34' ' ' LEU . 60.8 m-85 -133.8 113.09 11.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.786 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.76 ' HG2' ' HA ' ' B' ' 33' ' ' GLN . 0.0 OUTLIER -107.19 105.94 16.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.332 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.25 169.46 28.91 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.999 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.552 ' HB2' ' HG3' ' B' ' 36' ' ' GLN . 33.6 mt-10 -140.73 -171.02 3.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.839 0.352 . . . . 0.0 110.4 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.577 HG13 HG23 ' B' ' 37' ' ' VAL . 0.5 OUTLIER -139.24 152.86 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.209 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.735 ' O ' HG23 ' B' ' 39' ' ' THR . 0.0 OUTLIER -137.51 155.37 31.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.87 0.367 . . . . 0.0 111.061 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -85.23 53.1 2.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.041 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.679 ' HA ' ' HG2' ' B' ' 38' ' ' ARG . . . 61.46 92.67 0.05 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.066 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.575 ' H ' ' HG2' ' B' ' 38' ' ' ARG . . . -164.77 -47.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.476 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.654 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 1.6 m -159.8 176.83 11.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.009 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.611 ' HB2' ' HE ' ' B' ' 38' ' ' ARG . . . -147.27 111.93 5.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.137 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.618 HG13 ' HB3' ' A' ' 27' ' ' SER . 43.0 t -67.37 143.19 15.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.989 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.548 ' O ' HG23 ' A' ' 28' ' ' VAL . 17.0 m-20 -91.18 168.05 11.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.63 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.31 -50.0 74.31 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.468 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.42 -16.62 73.76 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.923 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.618 ' HB3' HG13 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -84.32 -24.36 29.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.907 0.384 . . . . 0.0 110.77 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.553 HG11 ' HG3' ' A' ' 13' ' ' LYS . 85.6 t -58.09 -37.24 60.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.33 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -140.38 106.02 5.12 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.03 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.433 HE21 ' HA ' ' A' ' 27' ' ' SER . 5.4 mt-30 -109.07 106.97 17.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.125 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.8 95.63 9.03 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.019 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.537 HG11 HG21 ' A' ' 52' ' ' VAL . 51.6 t -85.84 138.25 19.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.055 0.455 . . . . 0.0 110.358 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -113.15 132.6 55.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.701 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.545 ' N ' HD22 ' A' ' 34' ' ' LEU . 1.9 mm? -94.54 -71.47 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.594 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.87 -111.32 0.72 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.518 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -160.96 105.77 1.37 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.61 0.243 . . . . 0.0 110.879 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 m -91.1 142.35 13.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.978 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 38' ' ' ARG . 0.7 OUTLIER -81.05 162.53 23.73 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.771 179.251 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.442 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 82.5 p -80.35 -16.92 53.43 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.761 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.73 -31.26 63.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.073 0.463 . . . . 0.0 110.828 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.01 -28.48 39.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.145 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 1.7 mp -133.14 70.05 1.47 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.67 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . -103.67 11.21 36.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.448 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.04 146.83 27.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.341 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.48 121.25 13.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.369 . . . . 0.0 111.091 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.52 -10.39 12.77 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.179 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 138' ' ' PHE . . . -68.83 142.22 54.92 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.44 HG21 ' NH2' ' A' ' 136' ' ' ARG . 6.9 t -134.69 140.86 46.31 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.904 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.0 m -106.04 -152.77 0.48 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.569 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.9 178.57 1.05 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.908 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.05 168.9 15.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.733 0.301 . . . . 0.0 111.308 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.71 HG22 ' HB3' ' A' ' 135' ' ' ALA . 14.9 m -118.1 132.22 68.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.21 107.67 3.57 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.633 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.604 ' HD1' HG23 ' A' ' 52' ' ' VAL . 55.5 p90 -140.34 132.03 27.31 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.764 0.316 . . . . 0.0 110.914 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.522 ' HB2' HG22 ' A' ' 130' ' ' THR . 1.6 p-10 -117.8 176.89 4.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.628 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.768 ' HB ' HD12 ' A' ' 131' ' ' ILE . 51.7 mm -119.05 121.74 67.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.478 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.37 122.59 30.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.829 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.584 ' HB2' ' HB3' ' A' ' 129' ' ' ASN . 0.9 OUTLIER -131.08 93.72 3.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.228 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.549 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 0.4 OUTLIER -77.1 160.85 28.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.899 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.2 87.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.756 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.654 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 69.8 m -120.52 131.87 54.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.75 97.87 9.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.255 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 1.5 m -77.41 -20.0 55.26 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.04 -27.53 68.4 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.023 0.439 . . . . 0.0 111.719 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.42 -35.71 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.626 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 63' ' ' THR . . . -131.03 131.29 44.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.642 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.45 -37.32 7.65 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.909 0.385 . . . . 0.0 110.932 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -121.72 171.37 8.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.553 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.55 136.15 15.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.587 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.706 ' HB3' ' HB3' ' A' ' 157' ' ' GLN . . . -94.57 157.97 15.75 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.028 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.38 106.24 20.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.713 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.83 ' HB3' ' HB3' ' A' ' 155' ' ' LYS . . . -109.58 164.26 12.69 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.619 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.661 ' HB2' HD11 ' A' ' 111' ' ' LEU . 6.6 t80 -142.2 141.1 32.52 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.497 0.189 . . . . 0.0 111.129 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.737 HD11 ' HG2' ' D' ' 57' ' ' GLN . 0.1 OUTLIER -122.7 103.35 8.61 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.008 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.503 ' HA3' HD23 ' A' ' 113' ' ' LEU . . . -153.44 -166.37 14.55 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.895 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.48 136.26 46.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.535 0.207 . . . . 0.0 110.726 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.677 ' H ' ' HB3' ' D' ' 132' ' ' PRO . . . -81.4 156.08 25.6 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.845 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.469 HG12 ' OG1' ' A' ' 140' ' ' THR . 3.1 tt -92.51 -20.69 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.773 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.557 ' HB2' HG21 ' A' ' 140' ' ' THR . 0.4 OUTLIER 176.15 179.76 0.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.829 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' D' ' 107' ' ' THR . . . -79.0 -33.81 44.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.974 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.42 -43.91 95.55 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.618 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.463 ' NE2' ' O ' ' A' ' 139' ' ' ALA . 43.7 m-70 -97.8 -64.41 1.04 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.827 0.346 . . . . 0.0 110.47 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.432 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 1.2 m 62.36 7.83 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.623 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.427 ' O ' HD12 ' A' ' 103' ' ' ILE . 6.5 m120 -115.11 -25.47 8.09 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.238 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . 0.5 OUTLIER -79.56 143.74 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.189 179.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.631 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -76.68 148.6 36.73 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.995 -0.282 . . . . 0.0 110.251 179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.9 178.22 4.4 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.85 0.357 . . . . 0.0 111.651 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.644 HD22 ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -84.66 176.23 8.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.116 179.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 149' ' ' ASN . 22.8 pt20 -75.33 178.72 5.64 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.32 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.527 ' O ' HG12 ' D' ' 52' ' ' VAL . 1.0 OUTLIER -73.36 -11.46 60.49 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.989 0.423 . . . . 0.0 111.411 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 0.3 OUTLIER -64.68 87.26 0.05 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.931 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.89 -7.14 53.83 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.879 0.371 . . . . 0.0 111.667 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.477 ' HB1' ' HB1' ' C' ' 22' ' ' ALA . . . -133.11 19.91 4.07 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.644 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.62 -15.6 0.16 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.897 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 91' ' ' SER . 1.0 OUTLIER -97.35 174.98 6.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.906 0.384 . . . . 0.0 110.619 179.542 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.644 ' O ' HD22 ' A' ' 88' ' ' LEU . . . -114.12 157.87 22.03 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.823 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.53 HG23 HD11 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -112.96 162.73 15.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.319 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 69.26 41.66 1.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.415 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.3 p -177.67 130.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.827 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.06 179.45 28.6 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.623 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.497 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 1.6 t -98.98 95.34 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.026 0.531 . . . . 0.0 111.71 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 1.9 tt0 -69.87 159.83 32.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.881 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.433 HG12 ' CE2' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -121.72 98.38 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.513 179.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.679 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 1.1 tp -84.65 119.36 25.15 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.716 0.293 . . . . 0.0 111.122 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.24 158.12 31.92 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.642 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.553 ' HB2' ' HB2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -61.2 -33.93 74.26 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.87 0.366 . . . . 0.0 111.043 179.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.554 HG23 ' HA ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -48.75 -38.17 20.96 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.013 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.69 -88.87 0.11 Allowed Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.591 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.19 -176.33 5.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.868 0.366 . . . . 0.0 111.104 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.679 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -79.9 143.93 33.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.126 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.661 HD11 ' HB2' ' A' ' 73' ' ' PHE . 0.6 OUTLIER -90.14 157.54 17.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.387 0.613 . . . . 0.0 110.522 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.448 ' HB ' HG21 ' A' ' 117' ' ' THR . 29.4 m -81.04 150.46 28.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.201 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 113' ' ' LEU . 3.0 mp -102.75 57.7 0.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.757 0.313 . . . . 0.0 110.72 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.43 19.65 15.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.532 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.26 -93.1 0.88 Allowed Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.631 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' D' ' 125' ' ' ASN . . . -102.71 69.67 1.08 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.028 0.442 . . . . 0.0 111.596 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 72' ' ' ALA . 5.8 p -89.69 97.3 11.11 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.19 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.15 102.81 5.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.752 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.4 -82.69 0.65 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.554 ' HA ' HG23 ' A' ' 107' ' ' THR . 0.1 OUTLIER -63.26 100.87 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.611 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.9 79.11 7.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.228 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.428 HG21 ' CD ' ' A' ' 132' ' ' PRO . 4.7 p -82.55 159.18 22.85 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.769 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 16.2 m -85.28 139.74 31.38 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.764 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.46 136.18 33.43 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.69 0.281 . . . . 0.0 110.591 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -120.86 143.57 48.83 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.604 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.13 148.93 34.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.688 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.66 -106.17 2.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.704 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -85.15 153.24 22.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.731 0.3 . . . . 0.0 110.804 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.584 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 23.2 t-20 -148.45 120.7 8.37 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.942 0.401 . . . . 0.0 111.109 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.522 HG22 ' HB2' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -104.21 147.26 27.67 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.139 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.768 HD12 ' HB ' ' A' ' 56' ' ' ILE . 89.8 mt -116.61 119.25 36.08 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 106' ' ' ARG . 7.7 Cg_endo -80.83 119.06 3.54 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 121.704 1.602 . . . . 0.0 112.574 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.04 147.35 29.49 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.783 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.15 155.94 47.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.043 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.71 ' HB3' HG22 ' A' ' 52' ' ' VAL . . . -140.07 115.66 10.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.882 0.372 . . . . 0.0 111.639 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.44 ' NH2' HG21 ' A' ' 48' ' ' THR . 0.5 OUTLIER -111.27 148.98 31.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.477 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.6 151.29 45.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.158 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -144.52 164.56 30.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.002 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.635 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -124.43 145.76 49.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.783 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.557 HG21 ' HB2' ' A' ' 79' ' ' ASP . 0.2 OUTLIER -117.84 13.0 14.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.48 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.79 79.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.919 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.64 92.15 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.598 0.199 . . . . 0.0 110.788 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.08 154.78 33.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.704 0.288 . . . . 0.0 111.38 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 38.9 p -116.68 166.17 13.42 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.29 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.27 151.49 12.16 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.474 2.116 . . . . 0.0 112.018 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.6 -106.33 0.46 Allowed Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.417 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -139.06 163.26 32.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.834 0.349 . . . . 0.0 111.411 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.98 79.93 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.504 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 89' ' ' GLN . 87.1 m-20 -99.98 142.51 31.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.51 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.521 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -127.81 168.98 14.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.073 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -165.53 110.04 0.86 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.2 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.631 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -146.99 145.4 29.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.118 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -93.67 164.17 13.26 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.627 ' CZ ' HG21 ' A' ' 56' ' ' ILE . 15.4 p90 -110.83 151.6 27.63 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.061 0.458 . . . . 0.0 110.162 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.83 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -109.7 160.84 15.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.961 -178.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.14 112.91 3.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.756 0.312 . . . . 0.0 111.699 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.706 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -91.87 124.41 35.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.295 0.569 . . . . 0.0 110.447 -179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -117.13 135.48 53.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.515 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.889 179.894 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.55 100.24 0.04 OUTLIER 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.0 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.551 ' HB ' ' HB2' ' C' ' 158' ' ' TYR . 7.4 m -104.81 78.6 1.44 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.416 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.33 122.39 29.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.533 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.644 HG23 HG23 ' C' ' 156' ' ' VAL . 5.0 m -137.93 162.86 30.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.539 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.434 ' HB3' ' OE2' ' C' ' 15' ' ' GLU . 44.0 t-20 -84.28 114.48 21.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.692 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . 0.496 ' HA3' ' CZ ' ' C' ' 154' ' ' PHE . . . -83.3 -41.54 8.43 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.703 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.444 ' N ' ' CE1' ' C' ' 154' ' ' PHE . . . -175.56 162.32 31.61 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.824 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' C' ' 153' ' ' THR . 99.2 m -90.81 137.91 31.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.925 0.393 . . . . 0.0 111.264 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.49 114.27 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.241 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' HIS . . . . . 0.409 ' HD2' ' OD2' ' C' ' 151' ' ' ASP . 4.5 m80 -99.31 148.54 24.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.364 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . 0.834 ' HB3' HD21 ' C' ' 34' ' ' LEU . 60.6 m-85 -133.8 113.1 11.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.714 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.757 ' HG2' ' HA ' ' C' ' 33' ' ' GLN . 0.0 OUTLIER -107.19 105.86 16.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.392 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.18 169.45 28.87 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.99 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.541 ' HB2' ' HG3' ' C' ' 36' ' ' GLN . 33.8 mt-10 -140.73 -171.08 3.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.85 0.357 . . . . 0.0 110.425 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.569 HG13 HG23 ' C' ' 37' ' ' VAL . 0.5 OUTLIER -139.21 152.81 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.222 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.729 ' O ' HG23 ' C' ' 39' ' ' THR . 0.0 OUTLIER -137.42 155.43 31.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.834 0.35 . . . . 0.0 111.031 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -85.25 53.12 2.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.956 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.663 ' HA ' ' HG2' ' C' ' 38' ' ' ARG . . . 61.37 92.7 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.111 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.577 ' H ' ' HG2' ' C' ' 38' ' ' ARG . . . -164.74 -47.65 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.447 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.588 ' O ' HG21 ' B' ' 17' ' ' VAL . 1.6 m -159.83 176.82 11.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.009 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.609 ' HB2' ' HE ' ' C' ' 38' ' ' ARG . . . -147.24 111.89 5.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.15 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.618 HG13 ' HB3' ' B' ' 27' ' ' SER . 43.1 t -67.3 143.08 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.052 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.533 ' O ' HG23 ' B' ' 28' ' ' VAL . 16.9 m-20 -91.11 168.16 11.83 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.622 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.02 74.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.39 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.4 -16.62 73.72 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.92 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.618 ' HB3' HG13 ' B' ' 23' ' ' VAL . 0.4 OUTLIER -84.35 -24.38 29.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.921 0.391 . . . . 0.0 110.782 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.539 HG11 ' HG3' ' B' ' 13' ' ' LYS . 86.1 t -58.14 -37.13 60.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.339 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -140.35 106.08 5.14 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.997 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' GLN . . . . . 0.435 HE21 ' HA ' ' B' ' 27' ' ' SER . 5.4 mt-30 -109.03 106.92 17.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.12 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.74 95.55 8.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.069 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.554 HG11 HG21 ' B' ' 52' ' ' VAL . 51.2 t -85.76 138.21 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 110.451 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.76 ' HA ' ' HG2' ' A' ' 13' ' ' LYS . 3.2 mt-30 -113.18 132.54 55.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.64 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.818 HD21 ' HB3' ' A' ' 12' ' ' PHE . 1.8 mm? -94.45 -71.54 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.625 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.88 -111.3 0.71 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.524 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.552 ' HG3' ' HB2' ' A' ' 15' ' ' GLU . 3.6 tt0 -161.0 105.74 1.36 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.653 0.263 . . . . 0.0 110.919 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.577 HG23 HG13 ' A' ' 16' ' ' VAL . 5.7 m -91.06 142.35 13.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.966 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.679 ' HG2' ' HA ' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -81.07 162.49 23.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.707 179.248 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.735 HG23 ' O ' ' A' ' 17' ' ' VAL . 82.5 p -80.35 -16.85 53.58 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.784 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.77 -31.17 63.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.175 0.512 . . . . 0.0 110.899 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.04 -28.49 39.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.12 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.65 ' HB3' ' HB2' ' B' ' 139' ' ' ALA . 1.7 mp -133.23 70.09 1.47 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.673 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' B' ' 39' ' ' THR . . . -103.65 11.17 36.39 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.432 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.06 146.82 27.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.371 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.49 121.25 13.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 0.0 111.099 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.55 -10.4 12.72 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.15 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' B' ' 138' ' ' PHE . . . -68.85 142.27 54.87 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.851 0.357 . . . . 0.0 111.951 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.441 HG21 ' NH2' ' B' ' 136' ' ' ARG . 6.8 t -134.77 140.82 46.2 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.846 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . 0.403 ' OG ' HD11 ' B' ' 42' ' ' LEU . 17.2 m -106.06 -152.77 0.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.52 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.86 178.54 1.05 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.03 168.92 15.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.349 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.706 HG22 ' HB3' ' B' ' 135' ' ' ALA . 14.5 m -118.0 132.26 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.977 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.27 107.61 3.56 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.623 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . 0.591 ' HD1' HG23 ' B' ' 52' ' ' VAL . 55.6 p90 -140.34 132.06 27.35 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.812 0.339 . . . . 0.0 110.871 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.509 ' HB2' HG22 ' B' ' 130' ' ' THR . 1.6 p-10 -117.78 176.81 5.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.636 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.791 ' HB ' HD12 ' B' ' 131' ' ' ILE . 51.8 mm -119.05 121.73 67.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.556 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.35 122.78 30.8 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.753 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' B' ' 129' ' ' ASN . 0.9 OUTLIER -131.27 93.71 3.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.246 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' B' ' 22' ' ' ALA . 0.4 OUTLIER -77.03 160.89 28.75 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.87 -179.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.17 87.55 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.745 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' CYS . . . . . 0.587 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 69.9 m -120.44 131.88 54.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.71 97.9 9.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.269 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' B' ' 66' ' ' ALA . 1.5 m -77.47 -19.96 55.14 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.06 -27.48 68.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.062 0.458 . . . . 0.0 111.768 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.39 -35.76 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.643 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' B' ' 63' ' ' THR . . . -131.05 131.28 44.16 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.64 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.46 -37.31 7.65 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.892 0.377 . . . . 0.0 110.948 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -121.69 171.39 8.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.559 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.56 136.1 15.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.552 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.702 ' HB3' ' HB3' ' B' ' 157' ' ' GLN . . . -94.5 158.04 15.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.062 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.41 106.28 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.679 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.83 ' HB3' ' HB3' ' B' ' 155' ' ' LYS . . . -109.6 164.29 12.67 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.65 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.674 ' HB2' HD11 ' B' ' 111' ' ' LEU . 6.5 t80 -142.27 141.03 32.41 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.502 0.191 . . . . 0.0 111.174 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.727 HD11 ' HG2' ' E' ' 57' ' ' GLN . 0.1 OUTLIER -122.71 103.38 8.62 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.993 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.503 ' HA3' HD23 ' B' ' 113' ' ' LEU . . . -153.45 -166.37 14.56 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.875 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.54 136.3 46.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.585 0.231 . . . . 0.0 110.709 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.673 ' H ' ' HB3' ' E' ' 132' ' ' PRO . . . -81.52 156.13 25.42 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.879 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.47 HG12 ' OG1' ' B' ' 140' ' ' THR . 3.1 tt -92.51 -20.71 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.811 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.554 ' HB2' HG21 ' B' ' 140' ' ' THR . 0.4 OUTLIER 176.18 179.76 0.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.818 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' E' ' 107' ' ' THR . . . -78.91 -33.89 45.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.007 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.44 -43.84 95.64 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.6 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.452 ' NE2' ' O ' ' B' ' 139' ' ' ALA . 43.5 m-70 -97.86 -64.38 1.04 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.829 0.347 . . . . 0.0 110.435 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' THR . . . . . 0.43 ' HA ' ' HB1' ' B' ' 77' ' ' ALA . 1.2 m 62.33 7.83 2.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.647 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . 0.422 ' O ' HD12 ' B' ' 103' ' ' ILE . 6.5 m120 -115.15 -25.41 8.09 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.203 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.782 ' HA ' ' HA ' ' B' ' 102' ' ' GLN . 0.5 OUTLIER -79.62 143.75 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.152 179.622 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' B' ' 152' ' ' ALA . 0.3 OUTLIER -76.69 148.52 36.77 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.306 179.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.8 178.15 4.39 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.876 0.369 . . . . 0.0 111.734 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.658 HD22 ' O ' ' B' ' 96' ' ' ALA . 0.0 OUTLIER -84.6 176.13 8.8 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.071 179.386 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . 0.542 ' HB3' ' HB2' ' B' ' 149' ' ' ASN . 22.8 pt20 -75.19 178.62 5.62 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.355 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . 0.535 ' O ' HG12 ' E' ' 52' ' ' VAL . 1.0 OUTLIER -73.34 -11.44 60.49 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.023 0.44 . . . . 0.0 111.409 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . 0.514 ' HB3' ' HB3' ' B' ' 95' ' ' SER . 0.3 OUTLIER -64.72 87.27 0.06 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.909 179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.86 -7.2 53.93 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.633 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . 0.465 ' HB1' ' HB1' ' D' ' 22' ' ' ALA . . . -133.09 19.87 4.07 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.641 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.66 -15.53 0.16 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.932 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' SER . . . . . 0.514 ' HB3' ' HB3' ' B' ' 91' ' ' SER . 1.0 OUTLIER -97.32 174.96 6.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.898 0.38 . . . . 0.0 110.583 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.658 ' O ' HD22 ' B' ' 88' ' ' LEU . . . -114.13 157.88 22.02 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.83 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.544 HG23 HD11 ' B' ' 88' ' ' LEU . 0.2 OUTLIER -113.03 162.7 15.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.308 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 69.42 41.5 1.3 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.46 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 10.4 p -177.62 130.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.825 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.04 179.52 28.53 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.598 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' B' ' 86' ' ' LEU . 1.6 t -99.15 95.33 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.009 0.524 . . . . 0.0 111.672 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.782 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 1.9 tt0 -69.85 159.82 32.94 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.954 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.435 HG12 ' CE2' ' B' ' 73' ' ' PHE . 0.9 OUTLIER -121.69 98.41 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.56 179.457 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . 0.686 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 1.1 tp -84.8 119.38 25.23 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.792 0.33 . . . . 0.0 111.113 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.18 158.04 32.09 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.643 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . 0.555 ' HB2' ' HB2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -61.05 -33.93 74.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.913 0.387 . . . . 0.0 111.117 179.42 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.554 HG23 ' HA ' ' B' ' 120' ' ' SER . 0.0 OUTLIER -48.76 -38.25 21.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.972 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.73 -88.78 0.11 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.59 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.2 -176.35 5.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.892 0.377 . . . . 0.0 111.066 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.686 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -79.98 143.94 33.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' B' ' 73' ' ' PHE . 0.6 OUTLIER -90.09 157.56 17.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.363 0.601 . . . . 0.0 110.561 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.451 ' HB ' HG21 ' B' ' 117' ' ' THR . 29.7 m -81.12 150.43 28.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.111 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.606 HD12 ' N ' ' B' ' 113' ' ' LEU . 3.0 mp -102.7 57.66 0.78 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.691 0.281 . . . . 0.0 110.738 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.49 19.67 15.23 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.477 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.24 -93.05 0.88 Allowed Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.634 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' E' ' 125' ' ' ASN . . . -102.71 69.66 1.08 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.03 0.443 . . . . 0.0 111.592 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' B' ' 72' ' ' ALA . 5.9 p -89.62 97.22 11.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.142 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.17 102.82 5.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.764 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.44 -82.74 0.65 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.554 ' HA ' HG23 ' B' ' 107' ' ' THR . 0.1 OUTLIER -63.22 100.93 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.614 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -88.87 79.02 7.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.143 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.436 HG21 ' CD ' ' B' ' 132' ' ' PRO . 4.6 p -82.52 159.17 22.9 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.737 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 16.0 m -85.33 139.71 31.37 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.746 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.36 136.15 33.44 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.609 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -120.8 143.56 48.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.644 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.2 148.95 34.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.371 . . . . 0.0 110.63 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.67 -106.11 2.29 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.746 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -85.16 153.16 22.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.812 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . 0.597 ' HB3' ' HB2' ' B' ' 58' ' ' LEU . 23.1 t-20 -148.4 120.76 8.43 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.93 0.395 . . . . 0.0 111.112 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.509 HG22 ' HB2' ' B' ' 55' ' ' ASN . 0.2 OUTLIER -104.24 147.26 27.68 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.151 -179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' ILE . . . . . 0.791 HD12 ' HB ' ' B' ' 56' ' ' ILE . 89.9 mt -116.58 119.19 36.23 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' PRO . . . . . 0.555 ' HB2' ' HB2' ' B' ' 106' ' ' ARG . 7.6 Cg_endo -80.79 119.14 3.57 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.632 1.555 . . . . 0.0 112.535 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.05 147.3 29.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.775 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.13 155.88 47.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.04 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.706 ' HB3' HG22 ' B' ' 52' ' ' VAL . . . -140.06 115.67 10.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.938 0.399 . . . . 0.0 111.648 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . 0.441 ' NH2' HG21 ' B' ' 48' ' ' THR . 0.5 OUTLIER -111.26 148.93 31.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.535 179.655 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.48 151.27 45.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.119 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' B' ' 47' ' ' ALA . 0.2 OUTLIER -144.52 164.58 30.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.033 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.65 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -124.45 145.68 49.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.809 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' THR . . . . . 0.554 HG21 ' HB2' ' B' ' 79' ' ' ASP . 0.2 OUTLIER -117.77 13.01 14.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.545 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.83 79.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.97 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.73 92.14 0.02 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.619 0.21 . . . . 0.0 110.769 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.08 154.8 33.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.698 0.285 . . . . 0.0 111.393 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.527 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 39.3 p -116.76 166.22 13.34 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.223 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.485 ' HA ' ' HB ' ' A' ' 16' ' ' VAL . 1.4 Cg_endo -84.27 151.5 12.16 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.467 2.112 . . . . 0.0 111.976 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.62 -106.29 0.46 Allowed Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.401 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -139.06 163.32 32.72 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.839 0.352 . . . . 0.0 111.386 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -166.01 79.93 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.546 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.542 ' HB2' ' HB3' ' B' ' 89' ' ' GLN . 87.2 m-20 -99.92 142.47 31.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.557 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.512 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -127.76 169.02 14.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.01 178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . 0.409 ' OD2' ' HD2' ' A' ' 11' ' ' HIS . 4.2 t70 -165.6 109.94 0.85 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.261 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . 0.632 ' HB2' HD21 ' B' ' 86' ' ' LEU . . . -147.02 145.45 29.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.14 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -93.66 164.22 13.24 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.276 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.622 ' CZ ' HG21 ' B' ' 56' ' ' ILE . 15.4 p90 -110.89 151.66 27.63 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.141 0.496 . . . . 0.0 110.137 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.83 ' HB3' ' HB3' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -109.75 160.88 15.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.932 -178.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' VAL . . . . . 0.646 HG23 HG23 ' A' ' 5' ' ' VAL . 1.4 m -142.1 112.92 3.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-O 120.786 0.326 . . . . 0.0 111.706 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.702 ' HB3' ' HB3' ' B' ' 70' ' ' ALA . 0.3 OUTLIER -91.87 124.44 35.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.352 0.596 . . . . 0.0 110.426 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . 0.55 ' HB2' ' HB ' ' A' ' 3' ' ' THR . 57.3 m-85 -117.19 135.54 53.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.525 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.866 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.55 100.26 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.984 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' D' ' 158' ' ' TYR . 7.4 m -104.82 78.63 1.45 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.406 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' D' ' 156' ' ' VAL . 0.2 OUTLIER -85.31 122.39 29.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.599 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.646 HG23 HG23 ' D' ' 156' ' ' VAL . 5.0 m -137.94 162.94 30.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.472 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . 0.427 ' HB3' ' OE2' ' D' ' 15' ' ' GLU . 44.0 t-20 -84.37 114.55 21.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.615 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . 0.49 ' HA3' ' CZ ' ' D' ' 154' ' ' PHE . . . -83.47 -41.39 8.42 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.679 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . 0.443 ' N ' ' CE1' ' D' ' 154' ' ' PHE . . . -175.61 162.26 31.49 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.908 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' D' ' 153' ' ' THR . 99.2 m -90.79 137.92 31.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.981 0.42 . . . . 0.0 111.231 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.46 114.23 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.233 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' HIS . . . . . 0.412 ' HD2' ' OD2' ' D' ' 151' ' ' ASP . 4.5 m80 -99.29 148.56 24.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.347 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' PHE . . . . . 0.814 ' HB3' HD21 ' D' ' 34' ' ' LEU . 60.8 m-85 -133.83 113.07 11.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.723 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.738 ' HG2' ' HA ' ' D' ' 33' ' ' GLN . 0.0 OUTLIER -107.14 105.86 16.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.395 179.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.18 169.44 28.87 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.992 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' GLU . . . . . 0.551 ' HB2' ' HG3' ' D' ' 36' ' ' GLN . 33.8 mt-10 -140.73 -171.07 3.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.913 0.387 . . . . 0.0 110.391 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.583 HG13 HG23 ' D' ' 37' ' ' VAL . 0.5 OUTLIER -139.24 152.77 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.251 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.715 ' O ' HG23 ' D' ' 39' ' ' THR . 0.0 OUTLIER -137.42 155.35 31.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.888 0.375 . . . . 0.0 111.047 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -85.13 53.11 2.63 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . 0.671 ' HA ' ' HG2' ' D' ' 38' ' ' ARG . . . 61.33 92.74 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.098 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . 0.583 ' H ' ' HG2' ' D' ' 38' ' ' ARG . . . -164.8 -47.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.438 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' CYS . . . . . 0.754 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 1.6 m -159.81 176.83 11.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.951 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . 0.61 ' HB2' ' HE ' ' D' ' 38' ' ' ARG . . . -147.28 111.99 5.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.115 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . 0.604 HG13 ' HB3' ' C' ' 27' ' ' SER . 43.0 t -67.44 143.22 15.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.015 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.546 ' O ' HG23 ' C' ' 28' ' ' VAL . 17.0 m-20 -91.2 168.1 11.86 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.629 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.36 -50.0 74.35 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.42 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.38 -16.64 73.69 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.907 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . 0.604 ' HB3' HG13 ' C' ' 23' ' ' VAL . 0.4 OUTLIER -84.31 -24.44 29.83 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.876 0.37 . . . . 0.0 110.742 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.546 HG23 ' O ' ' C' ' 24' ' ' ASP . 85.1 t -58.04 -37.23 60.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.359 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -140.37 105.91 5.09 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.043 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' GLN . . . . . 0.447 HE21 ' HA ' ' C' ' 27' ' ' SER . 5.4 mt-30 -108.95 106.95 17.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.155 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.79 95.6 9.02 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.047 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.546 HG11 HG21 ' C' ' 52' ' ' VAL . 51.7 t -85.82 138.24 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.099 0.476 . . . . 0.0 110.37 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.757 ' HA ' ' HG2' ' B' ' 13' ' ' LYS . 3.2 mt-30 -113.2 132.6 55.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.651 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' B' ' 12' ' ' PHE . 1.8 mm? -94.53 -71.43 0.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.627 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.83 -111.31 0.72 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.544 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . 0.541 ' HG3' ' HB2' ' B' ' 15' ' ' GLU . 3.6 tt0 -161.06 105.84 1.35 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.721 0.296 . . . . 0.0 110.874 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.569 HG23 HG13 ' B' ' 16' ' ' VAL . 5.6 m -91.15 142.37 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.937 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' ARG . . . . . 0.663 ' HG2' ' HA ' ' B' ' 19' ' ' ALA . 0.7 OUTLIER -81.18 162.55 23.57 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.694 179.319 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.729 HG23 ' O ' ' B' ' 17' ' ' VAL . 82.6 p -80.39 -16.79 53.66 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.765 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.81 -31.16 63.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.157 0.503 . . . . 0.0 110.839 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.09 -28.5 39.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.11 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.636 ' HB3' ' HB2' ' C' ' 139' ' ' ALA . 1.7 mp -133.21 70.13 1.47 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.601 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' C' ' 39' ' ' THR . . . -103.67 11.18 36.33 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.5 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.01 146.83 27.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.466 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.5 121.28 13.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.871 0.367 . . . . 0.0 111.152 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.52 -10.47 12.75 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.114 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' C' ' 138' ' ' PHE . . . -68.78 142.21 54.98 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.874 0.369 . . . . 0.0 111.976 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . 0.44 HG21 ' NH2' ' C' ' 136' ' ' ARG . 6.8 t -134.75 140.81 46.21 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.852 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 17.0 m -105.96 -152.79 0.48 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.56 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 1.4 t -65.94 178.6 1.06 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.859 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.11 168.82 15.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.805 0.336 . . . . 0.0 111.28 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' C' ' 135' ' ' ALA . 14.7 m -117.98 132.24 68.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.913 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.21 107.62 3.57 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.683 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . 0.591 ' HD1' HG23 ' C' ' 52' ' ' VAL . 55.6 p90 -140.31 132.09 27.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.741 0.305 . . . . 0.0 110.932 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.531 ' HB2' HG22 ' C' ' 130' ' ' THR . 1.5 p-10 -117.83 176.83 5.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.565 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.794 ' HB ' HD12 ' C' ' 131' ' ' ILE . 51.7 mm -119.02 121.68 67.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.533 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.29 122.71 30.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.826 0.346 . . . . 0.0 110.831 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . 0.588 ' HB2' ' HB3' ' C' ' 129' ' ' ASN . 0.9 OUTLIER -131.23 93.75 3.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . 0.534 ' O ' ' HB3' ' C' ' 22' ' ' ALA . 0.4 OUTLIER -77.08 160.82 28.76 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.871 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.26 87.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.74 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' CYS . . . . . 0.754 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 70.2 m -120.52 131.8 54.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.813 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.61 97.91 9.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.343 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' C' ' 66' ' ' ALA . 1.5 m -77.44 -19.96 55.23 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.04 -27.56 68.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.978 0.418 . . . . 0.0 111.711 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 16.9 t -95.36 -35.76 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.613 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' C' ' 63' ' ' THR . . . -130.9 131.29 44.41 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.706 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.45 -37.27 7.67 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.912 0.387 . . . . 0.0 110.983 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -121.74 171.36 8.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.503 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.58 136.15 15.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.593 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.728 ' HB3' ' HB3' ' C' ' 157' ' ' GLN . . . -94.52 157.99 15.74 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.086 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.44 106.28 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.693 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . 0.839 ' HB3' ' HB3' ' C' ' 155' ' ' LYS . . . -109.6 164.31 12.65 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.597 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' PHE . . . . . 0.671 ' HB2' HD11 ' C' ' 111' ' ' LEU . 6.6 t80 -142.26 141.03 32.42 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.147 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.726 HD11 ' HG2' ' F' ' 57' ' ' GLN . 0.1 OUTLIER -122.66 103.37 8.63 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.981 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . 0.504 ' HA3' HD23 ' C' ' 113' ' ' LEU . . . -153.47 -166.38 14.58 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.909 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.5 136.27 46.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.574 0.226 . . . . 0.0 110.746 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . 0.685 ' H ' ' HB3' ' F' ' 132' ' ' PRO . . . -81.39 156.08 25.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.878 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . 0.472 HG12 ' OG1' ' C' ' 140' ' ' THR . 3.1 tt -92.56 -20.65 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.796 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' ASP . . . . . 0.563 ' HB2' HG21 ' C' ' 140' ' ' THR . 0.4 OUTLIER 176.15 179.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.821 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' F' ' 107' ' ' THR . . . -79.02 -33.76 44.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.988 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.39 -44.0 95.45 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.564 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . 0.447 ' HB3' HG23 ' C' ' 85' ' ' VAL . 43.3 m-70 -97.74 -64.42 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.787 0.327 . . . . 0.0 110.47 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . 0.439 ' HA ' ' HB1' ' C' ' 77' ' ' ALA . 1.2 m 62.32 7.81 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.597 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' ASN . . . . . 0.419 ' O ' HD12 ' C' ' 103' ' ' ILE . 6.6 m120 -115.02 -25.51 8.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.308 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.79 ' HA ' ' HA ' ' C' ' 102' ' ' GLN . 0.5 OUTLIER -79.53 143.63 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.214 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' C' ' 152' ' ' ALA . 0.3 OUTLIER -76.59 148.57 36.9 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.294 179.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.87 178.25 4.37 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.721 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.643 HD22 ' O ' ' C' ' 96' ' ' ALA . 0.0 OUTLIER -84.71 176.19 8.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.124 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' GLN . . . . . 0.547 ' HB3' ' HB2' ' C' ' 149' ' ' ASN . 22.9 pt20 -75.18 178.69 5.56 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.352 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . 0.53 ' O ' HG12 ' F' ' 52' ' ' VAL . 1.0 OUTLIER -73.36 -11.45 60.49 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.002 0.429 . . . . 0.0 111.461 179.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' C' ' 95' ' ' SER . 0.3 OUTLIER -64.72 87.27 0.06 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.92 -7.09 53.75 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.688 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' ALA . . . . . 0.47 ' HB1' ' HB1' ' E' ' 22' ' ' ALA . . . -133.15 19.92 4.06 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.614 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.64 -15.6 0.16 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.96 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' C' ' 91' ' ' SER . 1.0 OUTLIER -97.35 174.93 6.45 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 110.594 179.547 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . 0.643 ' O ' HD22 ' C' ' 88' ' ' LEU . . . -114.06 157.85 22.0 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.83 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . 0.54 HG23 HD11 ' C' ' 88' ' ' LEU . 0.2 OUTLIER -112.9 162.78 15.43 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.325 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 69.33 41.52 1.32 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.366 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 10.3 p -177.58 130.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.828 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.06 179.45 28.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.604 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' C' ' 86' ' ' LEU . 1.6 t -99.07 95.27 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 123.072 0.549 . . . . 0.0 111.703 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' C' ' 85' ' ' VAL . 1.9 tt0 -69.88 159.8 33.0 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.9 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.432 HG12 ' CE2' ' C' ' 73' ' ' PHE . 0.9 OUTLIER -121.66 98.36 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.574 179.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' LEU . . . . . 0.678 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 1.1 tp -84.64 119.36 25.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.695 0.283 . . . . 0.0 111.148 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.13 158.08 32.12 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.677 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . 0.55 ' HB2' ' HB2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -61.13 -33.93 74.18 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.914 0.388 . . . . 0.0 111.085 179.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . 0.553 HG23 ' HA ' ' C' ' 120' ' ' SER . 0.0 OUTLIER -48.8 -38.22 21.45 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.972 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.75 -88.82 0.11 Allowed Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.544 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.17 -176.32 5.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.82 0.343 . . . . 0.0 111.143 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.678 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -79.98 143.89 33.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.136 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' LEU . . . . . 0.671 HD11 ' HB2' ' C' ' 73' ' ' PHE . 0.6 OUTLIER -90.07 157.51 17.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.389 0.614 . . . . 0.0 110.557 179.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' THR . . . . . 0.448 ' HB ' HG21 ' C' ' 117' ' ' THR . 29.9 m -81.13 150.45 28.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.154 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.603 HD12 ' N ' ' C' ' 113' ' ' LEU . 3.0 mp -102.68 57.64 0.78 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.675 0.274 . . . . 0.0 110.742 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.48 19.72 15.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.562 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.18 -93.08 0.88 Allowed Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.647 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' F' ' 125' ' ' ASN . . . -102.73 69.58 1.08 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.097 0.475 . . . . 0.0 111.631 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' C' ' 72' ' ' ALA . 5.9 p -89.62 97.25 11.08 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.196 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.13 102.72 5.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.723 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.43 -82.69 0.65 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' SER . . . . . 0.553 ' HA ' HG23 ' C' ' 107' ' ' THR . 0.1 OUTLIER -63.16 100.87 0.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.715 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.82 79.01 7.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.208 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.43 HG21 ' CD ' ' C' ' 132' ' ' PRO . 4.5 p -82.56 159.1 22.85 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.729 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 16.3 m -85.17 139.71 31.47 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.825 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.42 136.15 33.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.811 0.338 . . . . 0.0 110.548 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -120.77 143.55 48.76 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.653 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.14 148.94 34.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.742 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.76 -106.21 2.32 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.692 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 1.9 m -85.2 153.25 22.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.734 0.302 . . . . 0.0 110.74 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 129' ' ' ASN . . . . . 0.588 ' HB3' ' HB2' ' C' ' 58' ' ' LEU . 23.2 t-20 -148.45 120.72 8.38 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.898 0.38 . . . . 0.0 111.112 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . 0.531 HG22 ' HB2' ' C' ' 55' ' ' ASN . 0.2 OUTLIER -104.18 147.33 27.58 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.132 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 131' ' ' ILE . . . . . 0.794 HD12 ' HB ' ' C' ' 56' ' ' ILE . 89.8 mt -116.62 119.27 36.02 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 132' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' C' ' 106' ' ' ARG . 7.6 Cg_endo -80.92 119.17 3.53 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 121.652 1.568 . . . . 0.0 112.548 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.12 147.27 29.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.762 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.09 155.98 47.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.02 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.713 ' HB3' HG22 ' C' ' 52' ' ' VAL . . . -140.09 115.7 10.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.93 0.395 . . . . 0.0 111.579 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.44 ' NH2' HG21 ' C' ' 48' ' ' THR . 0.5 OUTLIER -111.26 149.02 31.63 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.432 179.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.67 151.32 45.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.068 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 138' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' C' ' 47' ' ' ALA . 0.2 OUTLIER -144.55 164.56 30.53 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.924 -179.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 139' ' ' ALA . . . . . 0.636 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -124.41 145.74 49.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.923 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 140' ' ' THR . . . . . 0.563 HG21 ' HB2' ' C' ' 79' ' ' ASP . 0.2 OUTLIER -117.8 12.89 14.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.516 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.87 79.82 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.895 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.7 92.11 0.02 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.595 0.197 . . . . 0.0 110.796 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.11 154.83 33.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.75 0.31 . . . . 0.0 111.403 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 144' ' ' THR . . . . . 0.521 ' O ' ' HB ' ' B' ' 16' ' ' VAL . 39.8 p -116.75 166.22 13.34 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.181 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 145' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' B' ' 16' ' ' VAL . 1.3 Cg_endo -84.28 151.4 12.13 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.468 2.112 . . . . 0.0 111.993 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.7 -106.23 0.45 Allowed Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.403 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 147' ' ' ALA . . . . . 0.407 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -139.13 163.23 32.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.764 0.316 . . . . 0.0 111.411 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.89 79.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.502 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 149' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' C' ' 89' ' ' GLN . 87.1 m-20 -99.92 142.47 31.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.576 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 150' ' ' ALA . . . . . 0.526 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -127.77 168.96 14.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.052 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 151' ' ' ASP . . . . . 0.409 ' OD2' ' HD2' ' B' ' 11' ' ' HIS . 4.2 t70 -165.54 109.99 0.86 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.267 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . 0.622 ' HB2' HD21 ' C' ' 86' ' ' LEU . . . -146.94 145.42 29.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.148 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' B' ' 9' ' ' THR . 0.9 OUTLIER -93.61 164.18 13.26 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 154' ' ' PHE . . . . . 0.631 ' CZ ' HG21 ' C' ' 56' ' ' ILE . 15.2 p90 -110.87 151.52 27.77 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.157 0.503 . . . . 0.0 110.187 -179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . 0.839 ' HB3' ' HB3' ' C' ' 72' ' ' ALA . 0.0 OUTLIER -109.6 160.95 15.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.943 -178.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 156' ' ' VAL . . . . . 0.644 HG23 HG23 ' B' ' 5' ' ' VAL . 1.5 m -142.17 112.9 3.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.761 0.315 . . . . 0.0 111.715 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . 0.728 ' HB3' ' HB3' ' C' ' 70' ' ' ALA . 0.3 OUTLIER -91.88 124.38 35.96 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.36 0.6 . . . . 0.0 110.46 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . 0.551 ' HB2' ' HB ' ' B' ' 3' ' ' THR . 57.6 m-85 -117.18 135.47 53.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.493 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.914 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.53 100.1 0.04 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.064 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' E' ' 158' ' ' TYR . 7.3 m -104.74 78.63 1.46 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.48 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.27 122.44 29.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.528 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.643 HG23 HG23 ' E' ' 156' ' ' VAL . 5.1 m -137.95 162.93 30.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.533 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.43 ' HB3' ' OE2' ' E' ' 15' ' ' GLU . 44.0 t-20 -84.34 114.56 21.96 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.594 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' E' ' 154' ' ' PHE . . . -83.41 -41.48 8.4 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.683 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . 0.447 ' N ' ' CE1' ' E' ' 154' ' ' PHE . . . -175.64 162.28 31.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.847 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' E' ' 153' ' ' THR . 98.8 m -90.74 137.81 32.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.92 0.39 . . . . 0.0 111.28 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.43 114.28 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.254 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' HIS . . . . . 0.411 ' HD2' ' OD2' ' E' ' 151' ' ' ASP . 4.6 m80 -99.38 148.49 24.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.312 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' PHE . . . . . 0.814 ' HB3' HD21 ' E' ' 34' ' ' LEU . 60.7 m-85 -133.74 113.08 11.92 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.824 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' LYS . . . . . 0.745 ' HG2' ' HA ' ' E' ' 33' ' ' GLN . 0.0 OUTLIER -107.12 105.82 16.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.39 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.17 169.48 28.86 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.958 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' GLU . . . . . 0.548 ' HB2' ' HG3' ' E' ' 36' ' ' GLN . 33.6 mt-10 -140.75 -171.05 3.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.849 0.357 . . . . 0.0 110.431 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.57 HG13 HG23 ' E' ' 37' ' ' VAL . 0.5 OUTLIER -139.23 152.88 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.144 -179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.723 ' O ' HG23 ' E' ' 39' ' ' THR . 0.0 OUTLIER -137.47 155.39 31.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.856 0.36 . . . . 0.0 111.069 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -85.19 53.06 2.61 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.011 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' ALA . . . . . 0.684 ' HA ' ' HG2' ' E' ' 38' ' ' ARG . . . 61.41 92.64 0.05 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.112 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.58 ' H ' ' HG2' ' E' ' 38' ' ' ARG . . . -164.72 -47.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.469 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 1.6 m -159.86 176.77 11.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.989 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . 0.623 ' HB2' ' HE ' ' E' ' 38' ' ' ARG . . . -147.22 111.91 5.33 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.157 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . 0.625 HG13 ' HB3' ' D' ' 27' ' ' SER . 43.2 t -67.29 143.08 15.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.004 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.547 ' O ' HG23 ' D' ' 28' ' ' VAL . 17.0 m-20 -91.16 168.15 11.83 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.619 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.37 -50.02 74.31 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.443 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.38 -16.61 73.67 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.967 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . 0.625 ' HB3' HG13 ' D' ' 23' ' ' VAL . 0.4 OUTLIER -84.32 -24.44 29.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.892 0.377 . . . . 0.0 110.763 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . 0.547 HG23 ' O ' ' D' ' 24' ' ' ASP . 85.6 t -58.1 -37.19 60.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.346 -179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -140.41 105.98 5.1 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.033 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' GLN . . . . . 0.435 HE21 ' HA ' ' D' ' 27' ' ' SER . 5.4 mt-30 -109.08 106.95 17.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.106 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.74 95.56 8.98 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.096 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.54 HG11 HG21 ' D' ' 52' ' ' VAL . 51.9 t -85.76 138.17 19.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.11 0.481 . . . . 0.0 110.388 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.738 ' HA ' ' HG2' ' C' ' 13' ' ' LYS . 3.1 mt-30 -113.11 132.59 55.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.688 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.814 HD21 ' HB3' ' C' ' 12' ' ' PHE . 1.8 mm? -94.47 -71.48 0.66 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.64 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.83 -111.33 0.72 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.526 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' GLN . . . . . 0.551 ' HG3' ' HB2' ' C' ' 15' ' ' GLU . 3.6 tt0 -160.96 105.83 1.37 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.648 0.261 . . . . 0.0 110.884 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.583 HG23 HG13 ' C' ' 16' ' ' VAL . 5.6 m -91.15 142.42 13.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.878 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . 0.671 ' HG2' ' HA ' ' C' ' 19' ' ' ALA . 0.7 OUTLIER -81.11 162.53 23.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.759 179.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.715 HG23 ' O ' ' C' ' 17' ' ' VAL . 82.4 p -80.34 -16.94 53.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.788 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.71 -31.23 63.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.166 0.508 . . . . 0.0 110.919 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.11 -28.42 39.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.116 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.618 ' HB3' ' HB2' ' D' ' 139' ' ' ALA . 1.7 mp -133.16 70.19 1.47 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.625 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' D' ' 39' ' ' THR . . . -103.71 11.21 36.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.424 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.06 146.85 27.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.38 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.48 121.22 13.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.56 -10.4 12.71 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.09 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' D' ' 138' ' ' PHE . . . -68.8 142.17 54.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.905 0.383 . . . . 0.0 111.97 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . 0.433 HG21 ' NH2' ' D' ' 136' ' ' ARG . 6.9 t -134.72 140.84 46.26 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.816 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 16.8 m -106.02 -152.76 0.48 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.587 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 1.4 t -65.91 178.64 1.04 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.813 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.16 168.9 15.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.283 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' VAL . . . . . 0.681 HG22 ' HB3' ' D' ' 135' ' ' ALA . 14.7 m -118.02 132.25 68.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 88' ' ' LEU . . . -95.2 107.59 3.56 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.647 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.605 ' HD1' HG23 ' D' ' 52' ' ' VAL . 55.5 p90 -140.28 132.05 27.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.707 0.289 . . . . 0.0 110.977 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' ASN . . . . . 0.53 ' HB2' HG22 ' D' ' 130' ' ' THR . 1.6 p-10 -117.81 176.83 5.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.57 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.772 ' HB ' HD12 ' D' ' 131' ' ' ILE . 51.7 mm -118.98 121.7 67.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.532 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' GLN . . . . . 0.737 ' HG2' HD11 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -86.32 122.66 30.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.778 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' D' ' 129' ' ' ASN . 0.9 OUTLIER -131.2 93.71 3.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.234 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . 0.549 ' O ' ' HB3' ' D' ' 22' ' ' ALA . 0.4 OUTLIER -76.98 160.91 28.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.912 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.12 87.61 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.76 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' CYS . . . . . 0.634 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 70.1 m -120.55 131.81 54.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.808 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.61 97.87 9.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.308 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' D' ' 66' ' ' ALA . 1.5 m -77.41 -19.98 55.31 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.06 -27.54 68.42 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.975 0.417 . . . . 0.0 111.701 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 16.8 t -95.4 -35.75 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.608 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' D' ' 63' ' ' THR . . . -130.94 131.24 44.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.716 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.41 -37.35 7.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.885 0.374 . . . . 0.0 110.954 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -121.69 171.4 8.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.577 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.55 136.13 15.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.555 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' D' ' 157' ' ' GLN . . . -94.49 157.95 15.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.087 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 38.1 t -110.42 106.31 20.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.655 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' ALA . . . . . 0.821 ' HB3' ' HB3' ' D' ' 155' ' ' LYS . . . -109.64 164.24 12.72 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.575 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' PHE . . . . . 0.659 ' HB2' HD11 ' D' ' 111' ' ' LEU . 6.5 t80 -142.21 141.11 32.51 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.564 0.221 . . . . 0.0 111.15 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' LEU . . . . . 0.429 HD22 ' NZ ' ' D' ' 155' ' ' LYS . 0.1 OUTLIER -122.72 103.37 8.61 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.991 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . 0.512 ' HA3' HD23 ' D' ' 113' ' ' LEU . . . -153.46 -166.43 14.62 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.889 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.46 136.37 46.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.611 0.243 . . . . 0.0 110.695 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.448 ' HB1' ' HA ' ' D' ' 83' ' ' THR . . . -81.54 156.12 25.4 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.88 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 78' ' ' ILE . . . . . 0.464 HG12 ' OG1' ' D' ' 140' ' ' THR . 3.0 tt -92.52 -20.67 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.83 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.565 ' HB2' HG21 ' D' ' 140' ' ' THR . 0.4 OUTLIER 176.15 179.74 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.825 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.95 -33.85 44.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.975 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.51 -43.82 95.76 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.595 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . 0.457 ' NE2' ' O ' ' D' ' 139' ' ' ALA . 43.6 m-70 -97.78 -64.48 1.04 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.862 0.363 . . . . 0.0 110.438 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 83' ' ' THR . . . . . 0.448 ' HA ' ' HB1' ' D' ' 77' ' ' ALA . 1.2 m 62.45 7.77 2.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.582 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . 0.417 ' O ' HD12 ' D' ' 103' ' ' ILE . 6.5 m120 -115.08 -25.41 8.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.329 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' D' ' 102' ' ' GLN . 0.5 OUTLIER -79.58 143.68 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.171 179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' D' ' 152' ' ' ALA . 0.3 OUTLIER -76.63 148.53 36.86 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.27 179.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.8 178.2 4.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.894 0.378 . . . . 0.0 111.716 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.652 HD22 ' O ' ' D' ' 96' ' ' ALA . 0.0 OUTLIER -84.67 176.16 8.75 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.096 179.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 89' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' D' ' 149' ' ' ASN . 22.8 pt20 -75.24 178.71 5.58 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.38 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.36 -11.5 60.5 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 111.428 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' D' ' 95' ' ' SER . 0.3 OUTLIER -64.62 87.24 0.05 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.891 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.88 -7.15 53.83 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.921 0.391 . . . . 0.0 111.697 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 93' ' ' ALA . . . . . 0.469 ' HB1' ' HB1' ' F' ' 22' ' ' ALA . . . -133.14 19.96 4.06 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.674 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.62 -15.58 0.16 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.942 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 95' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' D' ' 91' ' ' SER . 1.0 OUTLIER -97.33 174.89 6.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.9 0.381 . . . . 0.0 110.59 179.558 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 96' ' ' ALA . . . . . 0.652 ' O ' HD22 ' D' ' 88' ' ' LEU . . . -114.05 157.88 21.95 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.82 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . 0.533 HG23 HD11 ' D' ' 88' ' ' LEU . 0.2 OUTLIER -112.9 162.72 15.5 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.305 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 98' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 69.29 41.62 1.32 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.387 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 99' ' ' VAL . . . . . . . . . . . . . 10.1 p -177.64 130.86 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.792 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.12 179.45 28.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.552 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 101' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' D' ' 86' ' ' LEU . 1.6 t -99.0 95.29 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 123.078 0.551 . . . . 0.0 111.681 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 102' ' ' GLN . . . . . 0.771 ' HA ' ' HA ' ' D' ' 85' ' ' VAL . 1.9 tt0 -69.84 159.79 32.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.892 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 103' ' ' ILE . . . . . 0.433 HG12 ' CE2' ' D' ' 73' ' ' PHE . 0.9 OUTLIER -121.7 98.45 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.522 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 104' ' ' LEU . . . . . 0.684 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 1.1 tp -84.75 119.38 25.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.755 0.312 . . . . 0.0 111.095 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.18 158.09 32.04 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.68 0.276 . . . . 0.0 111.646 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 106' ' ' ARG . . . . . 0.556 ' HB2' ' HB2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -61.19 -33.92 74.23 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.902 0.382 . . . . 0.0 111.048 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 107' ' ' THR . . . . . 0.561 HG23 ' HA ' ' D' ' 120' ' ' SER . 0.0 OUTLIER -48.72 -38.19 20.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.027 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.68 -88.81 0.11 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.603 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.16 -176.35 5.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.867 0.365 . . . . 0.0 111.139 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.684 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -79.96 143.93 33.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.098 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 111' ' ' LEU . . . . . 0.659 HD11 ' HB2' ' D' ' 73' ' ' PHE . 0.6 OUTLIER -90.08 157.58 17.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.386 0.612 . . . . 0.0 110.534 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 112' ' ' THR . . . . . 0.45 ' HB ' HG21 ' D' ' 117' ' ' THR . 30.0 m -81.22 150.47 28.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.099 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 113' ' ' LEU . . . . . 0.608 HD12 ' N ' ' D' ' 113' ' ' LEU . 2.9 mp -102.72 57.67 0.78 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.721 0.296 . . . . 0.0 110.742 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.42 19.57 15.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.552 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.23 -93.04 0.88 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.665 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.68 69.61 1.08 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.021 0.438 . . . . 0.0 111.564 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 117' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' D' ' 72' ' ' ALA . 5.8 p -89.69 97.34 11.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.2 102.83 5.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.786 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.45 -82.72 0.65 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 120' ' ' SER . . . . . 0.561 ' HA ' HG23 ' D' ' 107' ' ' THR . 0.1 OUTLIER -63.2 100.84 0.25 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.614 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.86 79.05 7.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.234 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.43 HG21 ' CD ' ' D' ' 132' ' ' PRO . 4.4 p -82.61 159.15 22.78 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.719 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 16.2 m -85.2 139.68 31.47 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.8 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.34 136.1 33.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.65 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 125' ' ' ASN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 116' ' ' ALA . 25.1 m120 -120.78 143.67 48.7 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.622 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.19 148.98 34.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.638 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.61 -106.12 2.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.75 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 128' ' ' THR . . . . . 0.648 HG21 ' NZ ' ' A' ' 155' ' ' LYS . 1.9 m -85.15 153.14 22.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.654 0.264 . . . . 0.0 110.817 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 129' ' ' ASN . . . . . 0.585 ' HB3' ' HB2' ' D' ' 58' ' ' LEU . 23.3 t-20 -148.39 120.68 8.39 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.874 0.368 . . . . 0.0 111.125 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 130' ' ' THR . . . . . 0.556 ' OG1' HD12 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -104.15 147.33 27.56 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.164 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 131' ' ' ILE . . . . . 0.772 HD12 ' HB ' ' D' ' 56' ' ' ILE . 89.4 mt -116.59 119.15 36.25 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 132' ' ' PRO . . . . . 0.677 ' HB3' ' H ' ' A' ' 77' ' ' ALA . 7.5 Cg_endo -80.95 119.11 3.5 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.645 1.563 . . . . 0.0 112.546 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.01 147.36 29.53 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.795 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.17 155.87 47.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.021 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.681 ' HB3' HG22 ' D' ' 52' ' ' VAL . . . -140.09 115.64 10.06 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.904 0.383 . . . . 0.0 111.575 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 136' ' ' ARG . . . . . 0.433 ' NH2' HG21 ' D' ' 48' ' ' THR . 0.5 OUTLIER -111.27 149.01 31.66 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.543 179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.52 151.27 45.25 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.132 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 138' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' D' ' 47' ' ' ALA . 0.2 OUTLIER -144.49 164.61 30.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.225 0.536 . . . . 0.0 111.993 -179.154 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 139' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -124.5 145.71 49.39 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.901 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 140' ' ' THR . . . . . 0.565 HG21 ' HB2' ' D' ' 79' ' ' ASP . 0.2 OUTLIER -117.74 12.97 14.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.536 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.76 79.74 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.957 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.73 92.17 0.02 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.619 0.209 . . . . 0.0 110.716 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.13 154.86 33.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 0.0 111.357 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 144' ' ' THR . . . . . 0.524 ' O ' ' HB ' ' C' ' 16' ' ' VAL . 39.2 p -116.76 166.16 13.49 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.237 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 145' ' ' PRO . . . . . 0.492 ' HA ' ' HB ' ' C' ' 16' ' ' VAL . 1.3 Cg_endo -84.24 151.49 12.21 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.45 2.1 . . . . 0.0 111.98 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.65 -106.34 0.46 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.453 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 147' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -139.05 163.26 32.88 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.823 0.344 . . . . 0.0 111.354 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.96 79.89 0.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.59 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 149' ' ' ASN . . . . . 0.531 ' HB2' ' HB3' ' D' ' 89' ' ' GLN . 87.1 m-20 -99.97 142.45 31.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.569 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 150' ' ' ALA . . . . . 0.508 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -127.72 168.99 14.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.969 179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 151' ' ' ASP . . . . . 0.412 ' OD2' ' HD2' ' C' ' 11' ' ' HIS . 4.2 t70 -165.55 109.99 0.86 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.214 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 152' ' ' ALA . . . . . 0.628 ' HB2' HD21 ' D' ' 86' ' ' LEU . . . -147.01 145.44 29.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.086 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 153' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' C' ' 9' ' ' THR . 1.0 OUTLIER -93.72 164.23 13.22 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.252 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 154' ' ' PHE . . . . . 0.63 ' CZ ' HG21 ' D' ' 56' ' ' ILE . 15.1 p90 -110.92 151.61 27.7 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.147 0.499 . . . . 0.0 110.108 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . 0.821 ' HB3' ' HB3' ' D' ' 72' ' ' ALA . 0.0 OUTLIER -109.64 160.84 15.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.951 -178.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 156' ' ' VAL . . . . . 0.646 HG23 HG23 ' C' ' 5' ' ' VAL . 1.4 m -142.15 112.93 3.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.803 0.335 . . . . 0.0 111.687 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 157' ' ' GLN . . . . . 0.713 ' HB3' ' HB3' ' D' ' 70' ' ' ALA . 0.3 OUTLIER -91.78 124.4 35.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.264 0.555 . . . . 0.0 110.398 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . 0.542 ' HB2' ' HB ' ' C' ' 3' ' ' THR . 57.6 m-85 -117.21 135.49 53.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.505 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.312 -0.852 . . . . 0.0 110.85 179.915 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.46 100.23 0.04 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.065 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 3' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' F' ' 158' ' ' TYR . 7.4 m -104.8 78.65 1.45 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.422 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.33 122.39 29.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.526 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.631 HG23 HG23 ' F' ' 156' ' ' VAL . 5.0 m -137.92 162.9 30.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.54 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 6' ' ' ASN . . . . . 0.433 ' HB3' ' OE2' ' F' ' 15' ' ' GLU . 44.0 t-20 -84.3 114.52 21.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.599 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 7' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' F' ' 154' ' ' PHE . . . -83.38 -41.52 8.4 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.684 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . 0.444 ' N ' ' CE1' ' F' ' 154' ' ' PHE . . . -175.56 162.29 31.57 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.889 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 9' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' F' ' 153' ' ' THR . 98.9 m -90.78 137.86 32.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.992 0.425 . . . . 0.0 111.269 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.44 114.27 46.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.184 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 11' ' ' HIS . . . . . 0.408 ' HD2' ' OD2' ' F' ' 151' ' ' ASP . 4.6 m80 -99.34 148.44 24.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.343 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 12' ' ' PHE . . . . . 0.825 ' HB3' HD21 ' F' ' 34' ' ' LEU . 60.9 m-85 -133.75 113.12 11.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.794 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 13' ' ' LYS . . . . . 0.762 ' HG2' ' HA ' ' F' ' 33' ' ' GLN . 0.0 OUTLIER -107.23 105.89 16.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.351 179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.23 169.44 28.9 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.023 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 15' ' ' GLU . . . . . 0.559 ' HB2' ' HG3' ' F' ' 36' ' ' GLN . 33.7 mt-10 -140.76 -171.13 3.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.853 0.359 . . . . 0.0 110.39 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 16' ' ' VAL . . . . . 0.585 HG13 HG23 ' F' ' 37' ' ' VAL . 0.5 OUTLIER -139.15 152.82 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.205 -179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . 0.732 ' O ' HG23 ' F' ' 39' ' ' THR . 0.0 OUTLIER -137.47 155.41 31.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.835 0.35 . . . . 0.0 111.038 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -85.23 53.02 2.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.005 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 19' ' ' ALA . . . . . 0.664 ' HA ' ' HG2' ' F' ' 38' ' ' ARG . . . 61.45 92.76 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.574 ' H ' ' HG2' ' F' ' 38' ' ' ARG . . . -164.84 -47.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.43 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 21' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 1.6 m -159.76 176.89 11.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.951 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 22' ' ' ALA . . . . . 0.602 ' HB2' ' HE ' ' F' ' 38' ' ' ARG . . . -147.29 111.9 5.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.13 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 23' ' ' VAL . . . . . 0.629 HG13 ' HB3' ' E' ' 27' ' ' SER . 43.1 t -67.31 143.14 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.998 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 24' ' ' ASP . . . . . 0.544 ' O ' HG23 ' E' ' 28' ' ' VAL . 17.1 m-20 -91.13 168.13 11.85 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.611 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.1 74.01 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.382 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.41 -16.64 73.74 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.929 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . 0.629 ' HB3' HG13 ' E' ' 23' ' ' VAL . 0.4 OUTLIER -84.3 -24.35 29.89 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.944 0.402 . . . . 0.0 110.837 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 28' ' ' VAL . . . . . 0.544 HG23 ' O ' ' E' ' 24' ' ' ASP . 85.0 t -58.08 -37.25 60.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.345 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -140.34 105.97 5.12 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.007 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 30' ' ' GLN . . . . . 0.436 HE21 ' HA ' ' E' ' 27' ' ' SER . 5.4 mt-30 -109.0 106.95 17.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.12 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.77 95.53 8.99 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.071 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.552 HG11 HG21 ' E' ' 52' ' ' VAL . 51.4 t -85.74 138.27 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.074 0.464 . . . . 0.0 110.382 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 33' ' ' GLN . . . . . 0.745 ' HA ' ' HG2' ' D' ' 13' ' ' LYS . 3.2 mt-30 -113.23 132.53 55.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.641 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.814 HD21 ' HB3' ' D' ' 12' ' ' PHE . 1.8 mm? -94.47 -71.46 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.628 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.85 -111.3 0.71 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.578 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 36' ' ' GLN . . . . . 0.548 ' HG3' ' HB2' ' D' ' 15' ' ' GLU . 3.6 tt0 -161.03 105.81 1.36 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.625 0.25 . . . . 0.0 110.897 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.57 HG23 HG13 ' D' ' 16' ' ' VAL . 5.7 m -91.13 142.4 13.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.011 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . 0.684 ' HG2' ' HA ' ' D' ' 19' ' ' ALA . 0.7 OUTLIER -81.11 162.6 23.63 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.691 179.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 39' ' ' THR . . . . . 0.723 HG23 ' O ' ' D' ' 17' ' ' VAL . 82.6 p -80.47 -16.8 53.45 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.783 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.71 -31.22 63.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.197 0.522 . . . . 0.0 110.944 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.06 -28.47 39.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.113 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.648 ' HB3' ' HB2' ' E' ' 139' ' ' ALA . 1.7 mp -133.13 70.02 1.47 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.658 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 43' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' E' ' 39' ' ' THR . . . -103.61 11.19 36.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.451 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.01 146.84 27.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.394 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.47 121.24 13.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.862 0.363 . . . . 0.0 111.146 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.55 -10.37 12.73 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.195 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 47' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' E' ' 138' ' ' PHE . . . -68.86 142.22 54.88 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.444 HG21 ' NH2' ' E' ' 136' ' ' ARG . 6.9 t -134.76 140.81 46.2 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.826 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.405 ' OG ' HD11 ' E' ' 42' ' ' LEU . 16.9 m -106.01 -152.74 0.48 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.615 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.92 178.62 1.05 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.909 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.1 168.81 15.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.784 0.326 . . . . 0.0 111.26 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 52' ' ' VAL . . . . . 0.714 HG22 ' HB3' ' E' ' 135' ' ' ALA . 14.7 m -117.97 132.2 68.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.955 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 53' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' B' ' 88' ' ' LEU . . . -95.18 107.61 3.57 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.627 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 54' ' ' PHE . . . . . 0.603 ' HD1' HG23 ' E' ' 52' ' ' VAL . 55.5 p90 -140.28 132.06 27.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 55' ' ' ASN . . . . . 0.519 ' HB2' HG22 ' E' ' 130' ' ' THR . 1.5 p-10 -117.81 176.75 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.621 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 56' ' ' ILE . . . . . 0.793 ' HB ' HD12 ' E' ' 131' ' ' ILE . 51.6 mm -119.03 121.7 67.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.543 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 57' ' ' GLN . . . . . 0.727 ' HG2' HD11 ' B' ' 74' ' ' LEU . 0.0 OUTLIER -86.28 122.63 30.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.792 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' E' ' 129' ' ' ASN . 0.9 OUTLIER -131.13 93.74 3.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . 0.548 ' O ' ' HB3' ' E' ' 22' ' ' ALA . 0.4 OUTLIER -77.08 160.88 28.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.862 -179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.17 87.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.817 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 61' ' ' CYS . . . . . 0.688 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 70.1 m -120.53 131.84 54.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.783 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.58 97.82 9.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.366 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 63' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' E' ' 66' ' ' ALA . 1.5 m -77.39 -19.95 55.4 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.1 -27.5 68.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.02 0.438 . . . . 0.0 111.715 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.44 -35.75 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.624 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' E' ' 63' ' ' THR . . . -131.05 131.32 44.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.648 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.49 -37.26 7.66 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.947 0.403 . . . . 0.0 110.94 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -121.74 171.39 8.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.558 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.55 136.1 15.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.532 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . 0.707 ' HB3' ' HB3' ' E' ' 157' ' ' GLN . . . -94.54 158.01 15.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.065 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 38.4 t -110.35 106.23 20.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.71 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . 0.821 ' HB3' ' HB3' ' E' ' 155' ' ' LYS . . . -109.58 164.36 12.6 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.594 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 73' ' ' PHE . . . . . 0.672 ' HB2' HD11 ' E' ' 111' ' ' LEU . 6.6 t80 -142.27 141.1 32.42 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.532 0.206 . . . . 0.0 111.131 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 74' ' ' LEU . . . . . 0.425 HD22 ' NZ ' ' E' ' 155' ' ' LYS . 0.1 OUTLIER -122.69 103.4 8.64 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.011 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . 0.506 ' HA3' HD23 ' E' ' 113' ' ' LEU . . . -153.5 -166.43 14.64 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.876 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.45 136.24 46.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.58 0.228 . . . . 0.0 110.741 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 77' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' E' ' 83' ' ' THR . . . -81.35 156.15 25.62 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.935 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 78' ' ' ILE . . . . . 0.462 HG12 ' OG1' ' E' ' 140' ' ' THR . 3.1 tt -92.55 -20.67 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.881 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 79' ' ' ASP . . . . . 0.549 ' HB2' HG21 ' E' ' 140' ' ' THR . 0.4 OUTLIER 176.15 179.72 0.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.808 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.88 -33.87 45.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.009 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.48 -43.87 95.68 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.555 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 82' ' ' HIS . . . . . 0.462 ' NE2' ' O ' ' E' ' 139' ' ' ALA . 43.5 m-70 -97.8 -64.37 1.05 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.849 0.356 . . . . 0.0 110.492 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 83' ' ' THR . . . . . 0.436 ' HA ' ' HB1' ' E' ' 77' ' ' ALA . 1.2 m 62.31 7.85 2.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.609 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 84' ' ' ASN . . . . . 0.426 ' O ' HD12 ' E' ' 103' ' ' ILE . 6.5 m120 -115.13 -25.46 8.08 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.255 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.787 ' HA ' ' HA ' ' E' ' 102' ' ' GLN . 0.5 OUTLIER -79.58 143.71 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.177 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 86' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' E' ' 152' ' ' ALA . 0.3 OUTLIER -76.68 148.54 36.78 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.294 179.476 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.83 178.23 4.36 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.909 0.385 . . . . 0.0 111.694 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.649 HD22 ' O ' ' E' ' 96' ' ' ALA . 0.0 OUTLIER -84.68 176.17 8.74 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.135 179.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 89' ' ' GLN . . . . . 0.537 ' HB3' ' HB2' ' E' ' 149' ' ' ASN . 22.9 pt20 -75.3 178.73 5.61 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.315 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.4 -11.42 60.47 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.999 0.428 . . . . 0.0 111.443 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 91' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' E' ' 95' ' ' SER . 0.3 OUTLIER -64.67 87.26 0.05 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.924 179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.9 -7.13 53.8 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.909 0.385 . . . . 0.0 111.666 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.14 19.87 4.06 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.678 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.6 -15.6 0.16 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.924 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 95' ' ' SER . . . . . 0.51 ' HB3' ' HB3' ' E' ' 91' ' ' SER . 0.9 OUTLIER -97.28 174.95 6.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.886 0.374 . . . . 0.0 110.664 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 96' ' ' ALA . . . . . 0.649 ' O ' HD22 ' E' ' 88' ' ' LEU . . . -114.1 157.83 22.06 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.786 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . 0.544 HG23 HD11 ' E' ' 88' ' ' LEU . 0.2 OUTLIER -112.92 162.68 15.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.359 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 98' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 69.4 41.53 1.3 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.368 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 99' ' ' VAL . . . . . . . . . . . . . 10.5 p -177.6 130.87 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.872 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.15 179.47 28.66 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.521 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 101' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' E' ' 86' ' ' LEU . 1.6 t -99.08 95.27 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.085 0.554 . . . . 0.0 111.65 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 102' ' ' GLN . . . . . 0.787 ' HA ' ' HA ' ' E' ' 85' ' ' VAL . 1.9 tt0 -69.84 159.83 32.91 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.959 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 103' ' ' ILE . . . . . 0.434 HG12 ' CE2' ' E' ' 73' ' ' PHE . 0.9 OUTLIER -121.7 98.49 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.516 179.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 104' ' ' LEU . . . . . 0.685 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 1.1 tp -84.79 119.39 25.24 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.701 0.286 . . . . 0.0 111.046 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.17 158.1 32.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.693 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 106' ' ' ARG . . . . . 0.555 ' HB2' ' HB2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -61.21 -33.83 74.11 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.958 0.409 . . . . 0.0 111.102 179.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . 0.556 HG23 ' HA ' ' E' ' 120' ' ' SER . 0.0 OUTLIER -48.8 -38.23 21.45 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.037 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.76 -88.84 0.11 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.598 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.19 -176.39 5.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.863 0.363 . . . . 0.0 111.116 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . 0.685 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -79.86 143.88 33.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.221 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.672 HD11 ' HB2' ' E' ' 73' ' ' PHE . 0.6 OUTLIER -90.14 157.55 17.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.361 0.601 . . . . 0.0 110.545 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 112' ' ' THR . . . . . 0.451 ' HB ' HG21 ' E' ' 117' ' ' THR . 29.7 m -81.1 150.48 28.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.134 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 113' ' ' LEU . . . . . 0.604 HD12 ' N ' ' E' ' 113' ' ' LEU . 3.0 mp -102.74 57.72 0.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.695 0.283 . . . . 0.0 110.719 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.4 19.58 15.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.566 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.19 -93.04 0.88 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.677 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.77 69.72 1.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.077 0.465 . . . . 0.0 111.566 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 117' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' E' ' 72' ' ' ALA . 6.0 p -89.67 97.25 11.08 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.169 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.06 102.84 5.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.809 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.48 -82.83 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 120' ' ' SER . . . . . 0.556 ' HA ' HG23 ' E' ' 107' ' ' THR . 0.1 OUTLIER -63.09 100.86 0.24 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.62 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -88.9 79.04 7.43 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.196 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . 0.435 HG21 ' CD ' ' E' ' 132' ' ' PRO . 4.6 p -82.54 159.2 22.86 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.667 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 16.1 m -85.27 139.72 31.4 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.731 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.45 136.14 33.46 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.746 0.308 . . . . 0.0 110.594 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 125' ' ' ASN . . . . . 0.532 ' HB3' ' HB3' ' B' ' 116' ' ' ALA . 25.0 m120 -120.77 143.59 48.73 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.613 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.16 148.91 34.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.639 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.71 -106.12 2.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.736 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 128' ' ' THR . . . . . 0.641 HG21 ' NZ ' ' B' ' 155' ' ' LYS . 1.9 m -85.22 153.2 22.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.715 0.293 . . . . 0.0 110.812 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 129' ' ' ASN . . . . . 0.6 ' HB3' ' HB2' ' E' ' 58' ' ' LEU . 23.2 t-20 -148.42 120.73 8.4 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.955 0.407 . . . . 0.0 111.09 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 130' ' ' THR . . . . . 0.568 ' OG1' HD12 ' B' ' 74' ' ' LEU . 0.2 OUTLIER -104.17 147.3 27.6 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.147 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 131' ' ' ILE . . . . . 0.793 HD12 ' HB ' ' E' ' 56' ' ' ILE . 89.8 mt -116.65 119.17 36.11 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 132' ' ' PRO . . . . . 0.673 ' HB3' ' H ' ' B' ' 77' ' ' ALA . 7.6 Cg_endo -80.92 119.09 3.51 Favored 'Trans proline' 0 C--N 1.358 1.033 0 C-N-CA 121.594 1.53 . . . . 0.0 112.553 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.99 147.33 29.52 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.739 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.15 155.96 47.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.066 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . 0.714 ' HB3' HG22 ' E' ' 52' ' ' VAL . . . -140.09 115.71 10.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.912 0.387 . . . . 0.0 111.632 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 136' ' ' ARG . . . . . 0.444 ' NH2' HG21 ' E' ' 48' ' ' THR . 0.5 OUTLIER -111.34 148.99 31.78 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.479 179.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.53 151.31 45.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.113 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 138' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' E' ' 47' ' ' ALA . 0.2 OUTLIER -144.53 164.58 30.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.009 -179.13 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 139' ' ' ALA . . . . . 0.648 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -124.39 145.65 49.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.913 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 140' ' ' THR . . . . . 0.549 HG21 ' HB2' ' E' ' 79' ' ' ASP . 0.2 OUTLIER -117.78 12.95 14.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.513 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.85 79.77 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.914 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.74 92.14 0.02 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.608 0.204 . . . . 0.0 110.756 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.1 154.77 33.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.675 0.274 . . . . 0.0 111.4 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 144' ' ' THR . . . . . 0.523 ' O ' ' HB ' ' D' ' 16' ' ' VAL . 39.1 p -116.68 166.2 13.33 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.244 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 145' ' ' PRO . . . . . 0.484 ' HA ' ' HB ' ' D' ' 16' ' ' VAL . 1.3 Cg_endo -84.33 151.42 12.06 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.495 2.13 . . . . 0.0 111.988 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.73 -106.32 0.46 Allowed Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.414 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 147' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -139.05 163.27 32.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.794 0.331 . . . . 0.0 111.408 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.91 79.88 0.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.508 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 149' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' E' ' 89' ' ' GLN . 87.2 m-20 -99.9 142.48 31.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.557 -179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 150' ' ' ALA . . . . . 0.527 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -127.78 169.0 14.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.008 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 151' ' ' ASP . . . . . 0.411 ' OD2' ' HD2' ' D' ' 11' ' ' HIS . 4.2 t70 -165.55 110.04 0.86 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.201 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 152' ' ' ALA . . . . . 0.628 ' HB2' HD21 ' E' ' 86' ' ' LEU . . . -147.06 145.39 29.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.13 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 153' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' D' ' 9' ' ' THR . 1.0 OUTLIER -93.62 164.23 13.24 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 154' ' ' PHE . . . . . 0.611 ' CZ ' HG21 ' E' ' 56' ' ' ILE . 15.1 p90 -110.98 151.59 27.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.193 0.521 . . . . 0.0 110.124 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . 0.821 ' HB3' ' HB3' ' E' ' 72' ' ' ALA . 0.0 OUTLIER -109.65 160.89 15.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.959 -178.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 156' ' ' VAL . . . . . 0.643 HG23 HG23 ' D' ' 5' ' ' VAL . 1.4 m -142.18 112.83 2.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.791 0.329 . . . . 0.0 111.678 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 157' ' ' GLN . . . . . 0.707 ' HB3' ' HB3' ' E' ' 70' ' ' ALA . 0.3 OUTLIER -91.83 124.39 35.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.338 0.59 . . . . 0.0 110.426 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . 0.539 ' HB2' ' HB ' ' D' ' 3' ' ' THR . 57.6 m-85 -117.17 135.52 53.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.456 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.859 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.55 100.22 0.04 OUTLIER 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.05 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -104.84 78.6 1.44 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.406 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.27 122.41 29.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.659 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 m -137.95 162.89 30.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.567 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -84.28 114.5 21.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.717 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.34 -41.52 8.42 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.678 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.57 162.24 31.49 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.936 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 98.8 m -90.71 137.79 32.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.92 0.39 . . . . 0.0 111.277 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -110.39 114.28 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.219 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -99.33 148.55 24.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.295 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -133.79 113.03 11.84 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.75 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 13' ' ' LYS . . . . . 0.536 ' HG3' HG11 ' F' ' 28' ' ' VAL . 0.0 OUTLIER -107.14 105.81 15.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.404 179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.17 169.5 28.85 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.002 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 15' ' ' GLU . . . . . 0.433 ' OE2' ' HB3' ' E' ' 6' ' ' ASN . 33.5 mt-10 -140.78 -171.07 3.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.853 0.358 . . . . 0.0 110.429 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -139.21 152.82 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.197 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 17' ' ' VAL . . . . . 0.592 HG21 ' O ' ' F' ' 21' ' ' CYS . 0.0 OUTLIER -137.45 155.41 31.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.785 0.326 . . . . 0.0 111.037 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -85.16 52.98 2.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.08 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.43 92.69 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.11 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.75 -47.7 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.413 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 21' ' ' CYS . . . . . 0.708 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 1.6 m -159.74 176.86 11.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.983 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 22' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' F' ' 59' ' ' ASN . . . -147.3 112.0 5.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.155 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 23' ' ' VAL . . . . . 0.623 HG13 ' HB3' ' F' ' 27' ' ' SER . 42.8 t -67.39 143.17 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.946 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 24' ' ' ASP . . . . . 0.545 ' O ' HG23 ' F' ' 28' ' ' VAL . 17.0 m-20 -91.19 168.23 11.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.557 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.43 -50.0 74.44 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.455 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.35 -16.66 73.65 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.941 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 27' ' ' SER . . . . . 0.623 ' HB3' HG13 ' F' ' 23' ' ' VAL . 0.4 OUTLIER -84.32 -24.39 29.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.881 0.372 . . . . 0.0 110.767 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 28' ' ' VAL . . . . . 0.545 HG23 ' O ' ' F' ' 24' ' ' ASP . 85.4 t -58.12 -37.17 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.349 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -140.38 106.01 5.12 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.024 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 30' ' ' GLN . . . . . 0.44 HE21 ' HA ' ' F' ' 27' ' ' SER . 5.4 mt-30 -109.06 106.95 17.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.089 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.81 95.57 9.02 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.059 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.549 HG11 HG21 ' F' ' 52' ' ' VAL . 51.0 t -85.73 138.18 19.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.099 0.476 . . . . 0.0 110.378 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 33' ' ' GLN . . . . . 0.762 ' HA ' ' HG2' ' E' ' 13' ' ' LYS . 3.1 mt-30 -113.17 132.6 55.42 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.674 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 34' ' ' LEU . . . . . 0.825 HD21 ' HB3' ' E' ' 12' ' ' PHE . 1.8 mm? -94.51 -71.49 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.594 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.9 -111.31 0.71 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.512 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 36' ' ' GLN . . . . . 0.559 ' HG3' ' HB2' ' E' ' 15' ' ' GLU . 3.6 tt0 -160.96 105.75 1.37 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.573 0.225 . . . . 0.0 110.888 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.585 HG23 HG13 ' E' ' 16' ' ' VAL . 5.6 m -91.1 142.45 12.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.904 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 38' ' ' ARG . . . . . 0.664 ' HG2' ' HA ' ' E' ' 19' ' ' ALA . 0.7 OUTLIER -81.09 162.52 23.69 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.723 179.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 39' ' ' THR . . . . . 0.732 HG23 ' O ' ' E' ' 17' ' ' VAL . 82.5 p -80.4 -16.88 53.42 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.775 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.74 -31.27 63.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.115 0.483 . . . . 0.0 110.876 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.02 -28.51 39.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.121 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' F' ' 139' ' ' ALA . 1.7 mp -133.11 70.05 1.47 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.686 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 43' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' F' ' 39' ' ' THR . . . -103.65 11.2 36.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.445 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.07 146.84 27.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.394 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -63.43 121.24 13.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 111.158 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.57 -10.48 12.66 Favored Glycine 0 C--N 1.331 0.274 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.146 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 47' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' F' ' 138' ' ' PHE . . . -68.74 142.26 55.01 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . 0.433 HG21 ' NH2' ' F' ' 136' ' ' ARG . 6.9 t -134.85 140.85 46.15 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.826 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 49' ' ' SER . . . . . . . . . . . . . 17.2 m -106.05 -152.75 0.48 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.519 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -65.91 178.52 1.07 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.881 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 51' ' ' ALA . . . . . . . . . . . . . . . -129.02 168.86 15.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.281 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 52' ' ' VAL . . . . . 0.708 HG22 ' HB3' ' F' ' 135' ' ' ALA . 14.6 m -117.94 132.21 68.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.028 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 53' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' C' ' 88' ' ' LEU . . . -95.22 107.68 3.58 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.654 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 54' ' ' PHE . . . . . 0.583 ' HD1' HG23 ' F' ' 52' ' ' VAL . 55.5 p90 -140.35 132.12 27.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.831 0.348 . . . . 0.0 110.912 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 55' ' ' ASN . . . . . 0.523 ' HB2' HG22 ' F' ' 130' ' ' THR . 1.6 p-10 -117.85 176.84 5.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.61 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 56' ' ' ILE . . . . . 0.783 ' HB ' HD12 ' F' ' 131' ' ' ILE . 51.8 mm -119.0 121.7 67.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.549 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 57' ' ' GLN . . . . . 0.726 ' HG2' HD11 ' C' ' 74' ' ' LEU . 0.0 OUTLIER -86.26 122.61 30.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.855 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' F' ' 129' ' ' ASN . 0.9 OUTLIER -131.15 93.73 3.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.265 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 59' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' F' ' 22' ' ' ALA . 0.4 OUTLIER -77.17 160.92 28.6 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 -179.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 53.21 87.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.798 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 61' ' ' CYS . . . . . 0.708 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 69.8 m -120.41 131.88 54.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -96.65 97.91 9.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.321 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 63' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' F' ' 66' ' ' ALA . 1.5 m -77.52 -19.89 55.08 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -27.45 68.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.985 0.422 . . . . 0.0 111.689 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 16.7 t -95.41 -35.76 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.597 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 66' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' F' ' 63' ' ' THR . . . -131.01 131.31 44.26 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.624 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -103.52 -37.3 7.63 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.964 0.412 . . . . 0.0 110.933 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -121.72 171.38 8.91 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.606 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.52 136.06 15.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.575 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 70' ' ' ALA . . . . . 0.725 ' HB3' ' HB3' ' F' ' 157' ' ' GLN . . . -94.47 157.92 15.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.101 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 38.2 t -110.36 106.25 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.682 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 72' ' ' ALA . . . . . 0.843 ' HB3' ' HB3' ' F' ' 155' ' ' LYS . . . -109.53 164.35 12.6 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.64 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 73' ' ' PHE . . . . . 0.67 ' HB2' HD11 ' F' ' 111' ' ' LEU . 6.5 t80 -142.25 141.05 32.44 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.52 0.2 . . . . 0.0 111.151 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 74' ' ' LEU . . . . . 0.434 HD22 ' NZ ' ' F' ' 155' ' ' LYS . 0.1 OUTLIER -122.68 103.32 8.59 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.038 180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . 0.493 ' H ' ' HB3' ' F' ' 113' ' ' LEU . . . -153.42 -166.34 14.51 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.87 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.52 136.22 46.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.604 0.24 . . . . 0.0 110.714 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 77' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' F' ' 83' ' ' THR . . . -81.4 156.09 25.58 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.925 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 78' ' ' ILE . . . . . 0.47 HG12 ' OG1' ' F' ' 140' ' ' THR . 3.1 tt -92.51 -20.65 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.859 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 79' ' ' ASP . . . . . 0.553 ' HB2' HG21 ' F' ' 140' ' ' THR . 0.4 OUTLIER 176.18 179.75 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.757 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.04 -33.76 44.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -58.48 -43.88 95.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.583 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 82' ' ' HIS . . . . . 0.466 ' NE2' ' O ' ' F' ' 139' ' ' ALA . 43.5 m-70 -97.83 -64.38 1.05 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.812 0.339 . . . . 0.0 110.436 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 83' ' ' THR . . . . . 0.429 ' HA ' ' HB1' ' F' ' 77' ' ' ALA . 1.2 m 62.35 7.83 2.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.582 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 84' ' ' ASN . . . . . 0.415 ' O ' HD12 ' F' ' 103' ' ' ILE . 6.5 m120 -115.09 -25.48 8.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.32 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 85' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' F' ' 102' ' ' GLN . 0.5 OUTLIER -79.53 143.75 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.199 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 86' ' ' LEU . . . . . 0.624 HD21 ' HB2' ' F' ' 152' ' ' ALA . 0.3 OUTLIER -76.62 148.57 36.87 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.392 179.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.87 178.22 4.39 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.799 0.333 . . . . 0.0 111.695 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . 0.657 HD22 ' O ' ' F' ' 96' ' ' ALA . 0.0 OUTLIER -84.72 176.2 8.7 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.069 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 89' ' ' GLN . . . . . 0.529 ' HB3' ' HB2' ' F' ' 149' ' ' ASN . 22.8 pt20 -75.29 178.71 5.62 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.36 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.34 -11.48 60.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.052 0.454 . . . . 0.0 111.447 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 91' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' F' ' 95' ' ' SER . 0.3 OUTLIER -64.69 87.28 0.05 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.884 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.95 -7.12 53.84 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 120.961 0.41 . . . . 0.0 111.666 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -133.08 19.86 4.08 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.699 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -146.58 -15.62 0.16 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.895 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 95' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' F' ' 91' ' ' SER . 1.0 OUTLIER -97.34 174.97 6.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.934 0.397 . . . . 0.0 110.572 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 96' ' ' ALA . . . . . 0.657 ' O ' HD22 ' F' ' 88' ' ' LEU . . . -114.14 157.83 22.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.85 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . 0.54 HG23 HD11 ' F' ' 88' ' ' LEU . 0.2 OUTLIER -112.95 162.64 15.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.318 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 98' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 69.39 41.61 1.29 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.406 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 10.4 p -177.65 130.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.8 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.1 179.46 28.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.523 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 101' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' F' ' 86' ' ' LEU . 1.6 t -99.07 95.28 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 123.068 0.547 . . . . 0.0 111.716 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 102' ' ' GLN . . . . . 0.783 ' HA ' ' HA ' ' F' ' 85' ' ' VAL . 1.9 tt0 -69.88 159.82 32.96 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.898 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 103' ' ' ILE . . . . . 0.433 HG12 ' CE2' ' F' ' 73' ' ' PHE . 0.9 OUTLIER -121.65 98.39 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.538 179.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 104' ' ' LEU . . . . . 0.699 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 1.1 tp -84.76 119.39 25.23 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.767 0.318 . . . . 0.0 111.082 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.15 158.08 32.1 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.701 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 106' ' ' ARG . . . . . 0.55 ' HB2' ' HB2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -61.16 -33.86 74.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.881 0.372 . . . . 0.0 111.093 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . 0.534 HG23 ' HA ' ' F' ' 120' ' ' SER . 0.0 OUTLIER -48.77 -38.18 21.13 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.094 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.7 -88.77 0.11 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.597 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -79.23 -176.32 5.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.836 0.351 . . . . 0.0 111.111 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . 0.699 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -79.96 143.92 33.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.125 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' F' ' 73' ' ' PHE . 0.6 OUTLIER -90.1 157.53 17.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.359 0.6 . . . . 0.0 110.566 179.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 112' ' ' THR . . . . . 0.449 ' HB ' HG21 ' F' ' 117' ' ' THR . 29.5 m -81.13 150.4 28.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.127 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 113' ' ' LEU . . . . . 0.596 HD12 ' N ' ' F' ' 113' ' ' LEU . 3.0 mp -102.75 57.77 0.78 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.737 0.303 . . . . 0.0 110.696 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 114' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.47 19.63 15.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.56 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.26 -93.11 0.88 Allowed Glycine 0 C--N 1.328 0.13 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.628 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.7 69.57 1.08 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.083 0.468 . . . . 0.0 111.589 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 117' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' F' ' 72' ' ' ALA . 5.8 p -89.65 97.28 11.11 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.145 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -75.08 102.77 5.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.736 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.5 -82.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 120' ' ' SER . . . . . 0.534 ' HA ' HG23 ' F' ' 107' ' ' THR . 0.1 OUTLIER -63.25 100.89 0.26 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.609 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -88.91 79.07 7.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.186 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . 0.435 HG21 ' CD ' ' F' ' 132' ' ' PRO . 4.6 p -82.56 159.18 22.84 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.701 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 16.1 m -85.29 139.73 31.37 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.708 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.42 136.13 33.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.617 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 125' ' ' ASN . . . . . 0.53 ' HB3' ' HB3' ' C' ' 116' ' ' ALA . 25.0 m120 -120.78 143.65 48.71 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.577 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.27 148.95 34.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.626 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.68 -106.22 2.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.745 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 128' ' ' THR . . . . . 0.647 HG21 ' NZ ' ' C' ' 155' ' ' LYS . 1.9 m -85.18 153.22 22.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.7 0.286 . . . . 0.0 110.757 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 129' ' ' ASN . . . . . 0.597 ' HB3' ' HB2' ' F' ' 58' ' ' LEU . 23.2 t-20 -148.43 120.71 8.39 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.909 0.385 . . . . 0.0 111.035 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 130' ' ' THR . . . . . 0.565 ' OG1' HD12 ' C' ' 74' ' ' LEU . 0.2 OUTLIER -104.19 147.33 27.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.14 -179.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 131' ' ' ILE . . . . . 0.783 HD12 ' HB ' ' F' ' 56' ' ' ILE . 89.7 mt -116.64 119.18 36.12 Favored Pre-proline 0 CA--C 1.54 0.559 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 132' ' ' PRO . . . . . 0.685 ' HB3' ' H ' ' C' ' 77' ' ' ALA . 7.6 Cg_endo -80.96 119.09 3.5 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 121.653 1.569 . . . . 0.0 112.531 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -147.98 147.29 29.49 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.756 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -139.09 155.92 47.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.041 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . 0.708 ' HB3' HG22 ' F' ' 52' ' ' VAL . . . -140.07 115.69 10.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.884 0.373 . . . . 0.0 111.598 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 136' ' ' ARG . . . . . 0.433 ' NH2' HG21 ' F' ' 48' ' ' THR . 0.5 OUTLIER -111.32 149.02 31.72 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.479 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 137' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.64 151.3 45.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.073 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 138' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' F' ' 47' ' ' ALA . 0.2 OUTLIER -144.5 164.6 30.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.97 -179.121 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 139' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -124.46 145.68 49.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.869 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 140' ' ' THR . . . . . 0.553 HG21 ' HB2' ' F' ' 79' ' ' ASP . 0.2 OUTLIER -117.75 12.99 14.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.512 179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 141.81 79.83 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.874 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . 51.59 92.19 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.62 0.21 . . . . 0.0 110.762 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.1 154.81 33.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.756 0.312 . . . . 0.0 111.377 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 144' ' ' THR . . . . . 0.516 ' O ' ' HB ' ' E' ' 16' ' ' VAL . 39.4 p -116.71 166.21 13.33 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.208 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 145' ' ' PRO . . . . . 0.49 ' HA ' ' HB ' ' E' ' 16' ' ' VAL . 1.3 Cg_endo -84.29 151.47 12.14 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 122.445 2.097 . . . . 0.0 111.975 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.64 -106.23 0.45 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.443 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 147' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -139.11 163.26 32.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.783 0.325 . . . . 0.0 111.357 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -165.98 79.9 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.498 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 149' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' F' ' 89' ' ' GLN . 87.2 m-20 -99.93 142.51 31.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.593 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 150' ' ' ALA . . . . . 0.528 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -127.83 169.06 14.32 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.042 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 151' ' ' ASP . . . . . 0.408 ' OD2' ' HD2' ' E' ' 11' ' ' HIS . 4.2 t70 -165.59 109.91 0.85 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.186 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 152' ' ' ALA . . . . . 0.624 ' HB2' HD21 ' F' ' 86' ' ' LEU . . . -146.95 145.4 29.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.123 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 153' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' E' ' 9' ' ' THR . 1.0 OUTLIER -93.63 164.17 13.26 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 154' ' ' PHE . . . . . 0.629 ' CZ ' HG21 ' F' ' 56' ' ' ILE . 15.0 p90 -110.87 151.61 27.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.178 0.513 . . . . 0.0 110.125 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . 0.843 ' HB3' ' HB3' ' F' ' 72' ' ' ALA . 0.0 OUTLIER -109.69 160.95 15.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.893 -178.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 156' ' ' VAL . . . . . 0.631 HG23 HG23 ' E' ' 5' ' ' VAL . 1.5 m -142.19 112.84 2.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.846 0.355 . . . . 0.0 111.688 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 157' ' ' GLN . . . . . 0.725 ' HB3' ' HB3' ' F' ' 70' ' ' ALA . 0.3 OUTLIER -91.82 124.46 35.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.276 0.56 . . . . 0.0 110.429 -179.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . 0.547 ' HB2' ' HB ' ' E' ' 3' ' ' THR . 57.5 m-85 -117.19 135.51 53.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.462 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.888 179.9 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' B' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.254 0.073 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.629 ' H ' ' HA ' ' B' ' 159' ' ' GLN . . . 59.07 55.86 4.22 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.649 0.261 . . . . 0.0 111.027 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.525 HG21 ' HB2' ' B' ' 18' ' ' ASN . 90.2 m -118.7 111.08 18.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.379 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.746 HG23 ' HG3' ' B' ' 157' ' ' GLN . 0.2 OUTLIER -97.77 127.36 43.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.554 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.649 HG23 HG23 ' B' ' 156' ' ' VAL . 0.0 OUTLIER -153.57 171.5 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.578 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.42 122.1 36.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.608 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.424 ' HA2' HE22 ' C' ' 36' ' ' GLN . . . -76.0 -52.18 6.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.855 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.42 -145.43 5.81 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.886 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.535 HG23 HG23 ' B' ' 153' ' ' THR . 0.2 OUTLIER -146.81 139.81 25.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.849 0.357 . . . . 0.0 111.28 -179.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.4 121.6 64.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.136 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.59 106.61 18.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.324 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.437 ' HZ ' ' CZ ' ' B' ' 54' ' ' PHE . 8.9 m-85 -90.65 107.61 19.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.627 ' HG2' HD22 ' B' ' 149' ' ' ASN . 0.1 OUTLIER -103.26 149.25 24.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.383 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.45 -179.07 47.54 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.902 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.67 ' HB3' ' HG3' ' B' ' 36' ' ' GLN . 0.1 OUTLIER -158.97 157.02 30.51 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.845 0.355 . . . . 0.0 110.394 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.8 t -113.71 132.23 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.245 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.558 HG13 ' HG2' ' B' ' 36' ' ' GLN . 5.5 m -136.88 176.58 7.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.887 0.375 . . . . 0.0 111.024 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.46 174.07 9.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.021 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 62' ' ' ASP . . . -83.37 35.35 0.49 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.066 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 61' ' ' CYS . . . -116.89 -15.93 10.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.429 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.98 155.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.97 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.76 126.48 5.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.052 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.741 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -60.87 162.49 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.037 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' A' ' 27' ' ' SER . 18.6 t70 -97.6 161.0 13.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.588 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.11 -40.31 95.92 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.353 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.47 12.76 69.0 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.935 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.575 ' HB3' ' HB3' ' A' ' 24' ' ' ASP . 0.6 OUTLIER -113.79 -25.6 8.57 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.92 0.39 . . . . 0.0 110.837 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.43 HG23 ' H ' ' A' ' 28' ' ' VAL . 9.6 t -41.04 -62.02 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.373 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.57 119.96 39.59 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.033 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -126.09 119.13 26.8 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.033 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.71 103.32 15.48 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.115 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.88 115.12 43.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.168 0.509 . . . . 0.0 110.475 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.53 112.61 24.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.671 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.86 -30.36 58.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.622 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.02 -170.25 27.44 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.562 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.46 141.8 28.05 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.653 0.263 . . . . 0.0 110.871 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.562 HG11 HD22 ' A' ' 42' ' ' LEU . 5.8 p -125.34 157.14 34.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.88 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.53 122.46 29.04 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.704 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -40.39 87.01 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.774 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.51 -35.88 68.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.06 0.457 . . . . 0.0 110.773 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.13 -21.51 33.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.162 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.562 HD22 HG11 ' A' ' 37' ' ' VAL . 3.2 mp -110.51 29.49 7.67 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.579 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 141' ' ' GLY . . . -108.19 25.46 11.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.387 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.66 159.96 23.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.414 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 140' ' ' THR . 11.1 tt0 -82.87 108.66 16.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 0.0 111.166 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.93 10.84 51.54 Favored Glycine 0 C--N 1.33 0.25 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.18 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -66.58 123.48 20.17 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-O 120.957 0.408 . . . . 0.0 112.014 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -120.64 140.28 51.79 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.828 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.562 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 4.6 m -101.65 -167.01 1.36 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.614 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.64 139.7 53.59 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.783 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.86 133.99 35.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.369 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 135' ' ' ALA . 18.8 m -87.0 166.49 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.927 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.7 128.83 7.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.63 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 133' ' ' PHE . 40.7 p90 -160.23 134.48 7.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.731 0.3 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.515 ' OD1' HG21 ' A' ' 130' ' ' THR . 16.0 p30 -132.87 147.73 52.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.494 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.637 HG22 ' HB ' ' A' ' 131' ' ' ILE . 1.0 OUTLIER -96.89 116.82 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.496 -179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.567 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -66.59 122.08 16.79 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.754 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.741 ' HG ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -137.42 88.17 2.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.218 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.715 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 10.5 p30 -79.53 179.31 7.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.955 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.39 64.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.811 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 129' ' ' ASN . 4.4 m -110.53 163.23 13.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.839 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -140.14 155.02 47.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.287 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.24 -25.33 10.66 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -81.96 -16.38 50.64 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.156 0.503 . . . . 0.0 111.822 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.401 HG23 ' OD2' ' A' ' 62' ' ' ASP . 16.6 t -90.65 -48.41 14.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.662 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.11 142.9 36.03 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.637 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.8 -53.79 2.6 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.846 0.355 . . . . 0.0 110.995 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -94.86 158.16 15.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.514 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.934 ' HB2' HD13 ' A' ' 124' ' ' LEU . . . -137.21 120.46 16.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.588 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -97.57 129.17 44.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.096 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.593 HG11 HG21 ' A' ' 131' ' ' ILE . 15.9 t -113.05 152.23 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.672 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.98 146.58 27.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.606 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CD2' HG21 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -111.54 141.89 44.53 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.577 0.227 . . . . 0.0 111.067 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -105.7 103.31 12.8 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.934 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.87 -179.11 25.42 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.837 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.699 ' HA ' ' HB3' ' D' ' 132' ' ' PRO . 0.2 OUTLIER -105.16 157.79 17.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.57 0.224 . . . . 0.0 110.771 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.433 ' H ' ' HB2' ' D' ' 132' ' ' PRO . . . -77.85 132.82 38.17 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.876 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.453 ' CG2' ' HB ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER -66.61 -39.87 84.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.86 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.404 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.7 OUTLIER -146.21 53.55 1.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.788 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' D' ' 106' ' ' ARG . . . 61.42 -87.6 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.038 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.29 -36.55 53.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.594 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -81.34 59.93 4.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.865 0.364 . . . . 0.0 110.445 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.584 HG21 ' OD1' ' A' ' 114' ' ' ASP . 2.1 m -70.59 -20.41 62.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.483 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.891 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 26.5 p-10 -69.45 -13.73 62.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.29 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.681 HG22 ' HB2' ' A' ' 102' ' ' GLN . 40.7 t -108.97 131.2 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.109 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -70.05 142.81 52.65 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.305 179.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.91 -170.52 3.05 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 120.946 0.403 . . . . 0.0 111.709 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 88' ' ' LEU . 1.2 mm? -80.04 161.4 25.42 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.02 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.73 -80.32 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.31 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.456 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 6.6 p -171.33 0.44 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.95 0.405 . . . . 0.0 111.446 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.687 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 73.4 m -76.81 85.65 3.4 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.902 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' D' ' 50' ' ' SER . . . -60.98 -32.34 71.9 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.86 0.362 . . . . 0.0 111.641 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.79 30.52 6.85 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.627 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.78 -3.14 0.11 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.92 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 0.1 OUTLIER -107.57 -176.72 3.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.882 0.372 . . . . 0.0 110.652 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.54 172.68 8.8 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.796 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.605 ' H ' ' HB ' ' A' ' 144' ' ' THR . 1.7 m -126.95 140.47 52.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.29 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.483 ' HB3' ' H ' ' A' ' 141' ' ' GLY . 68.4 m-80 61.96 21.23 12.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.495 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 97' ' ' THR . 2.7 t -120.29 135.99 58.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.724 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.97 -160.62 10.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.531 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 86' ' ' LEU . 4.4 p -145.96 109.88 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 121.173 0.511 . . . . 0.0 111.677 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.681 ' HB2' HG22 ' A' ' 85' ' ' VAL . 0.5 OUTLIER -84.37 147.38 27.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.936 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.613 HG12 ' HG ' ' A' ' 113' ' ' LEU . 1.2 pp -110.72 127.84 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.501 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.93 HD12 ' HB2' ' A' ' 110' ' ' ALA . 1.4 tp -97.37 132.95 42.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.686 0.279 . . . . 0.0 111.045 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.67 ' HB3' HG22 ' A' ' 107' ' ' THR . 4.0 t0 -80.82 143.61 32.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.675 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -65.46 -17.5 64.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.838 0.351 . . . . 0.0 111.083 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.67 HG22 ' HB3' ' A' ' 105' ' ' ASP . 13.2 t -66.89 -20.61 65.95 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.001 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.08 -71.77 0.44 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.68 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.53 160.02 31.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.819 0.343 . . . . 0.0 111.044 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.93 ' HB2' HD12 ' A' ' 104' ' ' LEU . . . -75.66 131.46 39.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.692 HD21 ' O ' ' A' ' 117' ' ' THR . 12.2 tp -88.1 154.18 20.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.351 0.596 . . . . 0.0 110.6 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.891 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.4 OUTLIER -96.37 142.7 28.18 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.145 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.613 ' HG ' HG12 ' A' ' 103' ' ' ILE . 0.8 OUTLIER -80.79 63.65 5.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.715 0.293 . . . . 0.0 110.747 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.584 ' OD1' HG21 ' A' ' 83' ' ' THR . 0.1 OUTLIER -90.63 -30.63 17.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.547 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.518 ' HA3' ' OG1' ' D' ' 130' ' ' THR . . . 115.75 -43.6 1.64 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.721 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.453 ' HB2' ' C ' ' D' ' 128' ' ' THR . . . -110.46 24.39 13.03 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.011 0.434 . . . . 0.0 111.717 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.692 ' O ' HD21 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -82.22 68.35 8.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 -179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.554 ' CD1' ' HB2' ' A' ' 157' ' ' GLN . 40.8 m-85 -82.19 71.96 9.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.744 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.71 81.11 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.797 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.75 131.75 13.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.604 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.427 ' O ' ' HE2' ' A' ' 68' ' ' LYS . 1.5 mm-40 -100.72 52.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.232 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.664 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -72.14 132.02 43.59 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.734 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.81 107.71 15.63 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.638 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.934 HD13 ' HB2' ' A' ' 69' ' ' ALA . 1.0 OUTLIER -88.27 126.53 35.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.563 179.427 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.515 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 1.1 m120 -120.62 -178.95 3.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.544 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.526 ' OD1' ' HA ' ' A' ' 62' ' ' ASP . 3.8 t30 -83.27 120.65 26.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.659 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.16 -121.79 2.53 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.686 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.715 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 75.6 m -122.14 103.41 8.77 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.7 0.286 . . . . 0.0 110.806 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.533 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 1.7 t30 -86.14 157.21 20.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.907 0.384 . . . . 0.0 111.144 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.567 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.3 OUTLIER -143.26 130.27 20.63 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.072 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.637 ' HB ' HG22 ' A' ' 56' ' ' ILE . 57.5 mt -84.21 104.24 4.04 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 7.6 Cg_endo -81.99 112.29 2.3 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.63 1.554 . . . . 0.0 112.629 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 54' ' ' PHE . 1.0 OUTLIER -126.67 158.32 36.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.856 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -126.01 156.04 40.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.083 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.536 ' O ' HG22 ' A' ' 52' ' ' VAL . . . -148.22 105.18 3.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.96 0.409 . . . . 0.0 111.615 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.08 163.46 12.57 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.351 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.562 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 0.3 OUTLIER -81.71 119.73 24.22 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.099 179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.468 ' HB3' HG11 ' A' ' 85' ' ' VAL . 2.1 t80 -108.84 142.62 39.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.213 0.53 . . . . 0.0 112.06 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -132.96 136.0 45.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.904 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' A' ' 45' ' ' GLU . 25.2 p -96.58 -56.16 2.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.519 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.483 ' H ' ' HB3' ' A' ' 98' ' ' ASN . . . -127.06 -129.88 3.31 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.044 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.91 107.12 12.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.647 0.224 . . . . 0.0 110.781 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 97' ' ' THR . . . -65.87 148.03 52.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.687 0.28 . . . . 0.0 111.466 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.605 ' HB ' ' H ' ' A' ' 97' ' ' THR . 48.5 m -114.82 144.68 32.42 Favored Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.284 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.402 ' HD2' HG23 ' A' ' 144' ' ' THR . 1.3 Cg_endo -81.9 130.98 6.84 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.521 2.147 . . . . 0.0 111.982 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 164.82 -116.28 0.69 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.492 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -110.62 150.39 29.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.826 0.346 . . . . 0.0 111.397 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.69 45.93 1.59 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.078 0.466 . . . . 0.0 110.402 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.96 141.07 30.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.505 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.401 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -153.72 162.6 41.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.959 179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -133.99 135.37 43.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.252 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.751 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -134.1 152.51 51.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.174 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.458 ' H ' ' HB3' ' A' ' 74' ' ' LEU . 3.9 m -104.13 148.96 25.68 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.29 141.89 35.13 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.108 0.48 . . . . 0.0 110.106 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.59 152.36 40.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.896 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.586 HG12 HD11 ' A' ' 131' ' ' ILE . 20.1 m -135.7 133.19 51.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.808 0.337 . . . . 0.0 111.704 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.554 ' HB2' ' CD1' ' A' ' 118' ' ' PHE . 1.8 tt0 -130.91 119.77 22.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.271 0.557 . . . . 0.0 110.407 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -101.95 113.31 26.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.57 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.418 ' NE2' ' HB3' ' A' ' 157' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.835 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' C' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 120.24 0.066 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.626 ' H ' ' HA ' ' C' ' 159' ' ' GLN . . . 59.14 55.8 4.21 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.081 0.238 . . . . 0.0 110.992 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.504 HG21 ' HB2' ' C' ' 18' ' ' ASN . 89.7 m -118.64 111.08 18.09 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.467 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.74 HG21 ' HA2' ' F' ' 127' ' ' GLY . 0.2 OUTLIER -97.78 127.33 43.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.572 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.632 HG23 HG23 ' C' ' 156' ' ' VAL . 0.0 OUTLIER -153.54 171.53 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.582 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.48 122.09 36.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.562 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . 0.423 ' HA2' HE22 ' D' ' 36' ' ' GLN . . . -75.84 -52.34 6.47 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.861 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.43 -145.44 5.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.846 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.526 HG23 HG23 ' C' ' 153' ' ' THR . 0.2 OUTLIER -146.76 139.86 25.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.877 0.37 . . . . 0.0 111.254 -179.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 45.3 t -122.4 121.61 64.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.148 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -99.69 106.6 18.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.369 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . 0.42 ' HZ ' ' CZ ' ' C' ' 54' ' ' PHE . 8.8 m-85 -90.6 107.59 19.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.625 ' HG2' HD22 ' C' ' 149' ' ' ASN . 0.1 OUTLIER -103.26 149.21 24.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.376 179.757 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.42 -179.01 47.49 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.98 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.674 ' HB3' ' HG3' ' C' ' 36' ' ' GLN . 0.1 OUTLIER -158.97 157.04 30.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.915 0.388 . . . . 0.0 110.377 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.459 ' O ' HG11 ' A' ' 5' ' ' VAL . 18.0 t -113.77 132.25 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.199 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.619 HG12 HG21 ' A' ' 5' ' ' VAL . 5.5 m -136.9 176.56 7.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.11 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . 0.525 ' HB2' HG21 ' A' ' 3' ' ' THR . 0.4 OUTLIER -74.4 174.1 9.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.038 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' B' ' 62' ' ' ASP . . . -83.39 35.28 0.49 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.014 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' B' ' 61' ' ' CYS . . . -116.81 -15.93 10.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.466 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 180.0 155.23 0.59 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.915 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.4 ' HA ' HG21 ' B' ' 17' ' ' VAL . . . -157.69 126.42 5.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.074 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.735 ' HA ' ' HG ' ' B' ' 58' ' ' LEU . 0.7 OUTLIER -60.82 162.51 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.046 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' B' ' 27' ' ' SER . 18.5 t70 -97.56 161.0 13.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.634 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.45 96.27 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.346 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.39 12.75 69.08 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.953 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' B' ' 24' ' ' ASP . 0.6 OUTLIER -113.79 -25.54 8.6 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.438 HG23 ' H ' ' B' ' 28' ' ' VAL . 9.8 t -41.17 -62.01 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.28 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.56 119.97 39.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.055 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -126.1 119.11 26.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.058 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.71 103.31 15.46 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.158 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.81 115.11 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.11 0.481 . . . . 0.0 110.445 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.53 112.63 24.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.592 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.86 -30.39 58.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.6 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.07 -170.23 27.36 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.622 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.67 ' HG3' ' HB3' ' A' ' 15' ' ' GLU . 0.4 OUTLIER -93.55 141.72 28.15 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.595 0.235 . . . . 0.0 110.88 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.548 HG11 HD22 ' B' ' 42' ' ' LEU . 5.8 p -125.22 157.18 34.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.899 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.56 122.39 28.96 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.735 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -40.52 86.96 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.756 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.44 -35.84 68.31 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.112 0.482 . . . . 0.0 110.842 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.1 -21.55 33.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.175 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.548 HD22 HG11 ' B' ' 37' ' ' VAL . 3.2 mp -110.5 29.49 7.66 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.666 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' B' ' 141' ' ' GLY . . . -108.26 25.55 11.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.364 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.81 159.99 23.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.299 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' B' ' 140' ' ' THR . 11.0 tt0 -82.88 108.65 16.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 111.19 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.95 10.83 51.5 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.202 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' B' ' 139' ' ' ALA . . . -66.62 123.51 20.29 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -120.69 140.24 51.89 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.928 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 4.6 m -101.56 -166.97 1.35 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.686 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.74 139.71 53.38 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.784 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.77 134.01 35.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.321 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.539 HG22 ' O ' ' B' ' 135' ' ' ALA . 18.8 m -87.07 166.44 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.911 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.69 128.83 7.98 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.634 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . 0.437 ' CZ ' ' HZ ' ' A' ' 12' ' ' PHE . 40.6 p90 -160.23 134.5 7.39 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.793 0.33 . . . . 0.0 110.932 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.512 ' OD1' HG21 ' B' ' 130' ' ' THR . 15.9 p30 -132.79 147.69 52.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.58 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.634 HG22 ' HB ' ' B' ' 131' ' ' ILE . 1.0 OUTLIER -96.75 116.78 39.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.589 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . 0.566 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.0 OUTLIER -66.6 122.01 16.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.724 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.735 ' HG ' ' HA ' ' B' ' 23' ' ' VAL . 0.2 OUTLIER -137.45 88.23 2.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.247 -179.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.712 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 10.6 p30 -79.63 179.35 7.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.877 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.3 64.37 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.837 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' B' ' 129' ' ' ASN . 4.4 m -110.48 163.27 13.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.808 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . 0.57 ' HB2' ' O ' ' B' ' 19' ' ' ALA . 0.5 OUTLIER -140.18 155.04 47.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.275 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.23 -25.35 10.65 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -82.02 -16.33 50.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.067 0.46 . . . . 0.0 111.736 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.402 HG23 ' OD2' ' B' ' 62' ' ' ASP . 16.7 t -90.66 -48.49 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.661 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.1 142.94 36.04 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.624 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.79 -53.89 2.59 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.842 0.353 . . . . 0.0 110.912 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' B' ' 121' ' ' GLU . 0.1 OUTLIER -94.77 158.16 15.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.519 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.905 ' HB2' HD13 ' B' ' 124' ' ' LEU . . . -137.17 120.44 16.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.637 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.444 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -97.57 129.13 44.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.124 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.608 HG11 HG21 ' B' ' 131' ' ' ILE . 15.9 t -113.04 152.28 14.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.73 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -149.99 146.57 27.09 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.554 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.476 ' CD2' HG21 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -111.58 141.92 44.55 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.591 0.234 . . . . 0.0 111.098 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' B' ' 152' ' ' ALA . 0.8 OUTLIER -105.62 103.33 12.82 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.96 -179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.91 -179.05 25.4 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.814 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.679 ' HA ' ' HB3' ' E' ' 132' ' ' PRO . 0.2 OUTLIER -105.25 157.78 17.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.533 0.206 . . . . 0.0 110.725 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.439 ' H ' ' HB2' ' E' ' 132' ' ' PRO . . . -77.86 132.75 38.12 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.898 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.446 ' CG2' ' HB ' ' B' ' 85' ' ' VAL . 0.6 OUTLIER -66.68 -39.76 84.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.834 179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.2 53.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.849 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' E' ' 106' ' ' ARG . . . 61.32 -87.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.03 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.33 -36.5 53.17 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.602 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -81.39 59.98 4.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.36 . . . . 0.0 110.447 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' THR . . . . . 0.596 HG21 ' OD1' ' B' ' 114' ' ' ASP . 2.1 m -70.61 -20.49 62.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.512 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . 0.879 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 26.6 p-10 -69.29 -13.74 62.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.352 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.679 HG22 ' HB2' ' B' ' 102' ' ' GLN . 40.8 t -108.97 131.15 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.127 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' B' ' 152' ' ' ALA . 0.6 OUTLIER -70.11 142.84 52.53 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.014 -0.275 . . . . 0.0 110.308 179.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.97 -170.53 3.07 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.891 0.377 . . . . 0.0 111.752 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' B' ' 88' ' ' LEU . 1.2 mm? -80.04 161.43 25.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.037 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.78 -80.24 0.01 OUTLIER 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.315 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . 0.474 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 6.5 p -171.42 0.5 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.993 0.425 . . . . 0.0 111.504 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . 0.675 ' HA ' ' HB2' ' D' ' 25' ' ' ALA . 73.5 m -76.86 85.55 3.44 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.921 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' E' ' 50' ' ' SER . . . -60.88 -32.33 71.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.968 0.413 . . . . 0.0 111.733 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.75 30.47 6.88 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.7 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.74 -3.22 0.11 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.945 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' SER . . . . . 0.603 ' HB2' ' HB2' ' B' ' 91' ' ' SER . 0.1 OUTLIER -107.5 -176.78 3.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 110.661 179.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.39 172.67 8.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.848 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.622 ' H ' ' HB ' ' B' ' 144' ' ' THR . 1.7 m -127.01 140.36 52.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.339 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . 0.5 ' HB3' ' H ' ' B' ' 141' ' ' GLY . 68.4 m-80 62.05 21.3 12.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.441 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 97' ' ' THR . 2.7 t -120.38 135.98 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.723 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.0 -160.77 10.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.569 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.415 HG13 ' HB2' ' B' ' 86' ' ' LEU . 4.5 p -145.84 109.85 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 122.974 0.51 . . . . 0.0 111.767 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.679 ' HB2' HG22 ' B' ' 85' ' ' VAL . 0.5 OUTLIER -84.33 147.33 27.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.881 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.596 HG12 ' HG ' ' B' ' 113' ' ' LEU . 1.2 pp -110.69 127.88 67.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.515 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . 0.978 HD12 ' HB2' ' B' ' 110' ' ' ALA . 1.4 tp -97.46 132.95 42.67 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.637 0.256 . . . . 0.0 111.003 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . 0.652 ' HB3' HG22 ' B' ' 107' ' ' THR . 4.0 t0 -80.76 143.59 32.79 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.739 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -65.43 -17.55 64.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.817 0.341 . . . . 0.0 111.061 179.509 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.652 HG22 ' HB3' ' B' ' 105' ' ' ASP . 13.2 t -66.84 -20.65 65.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.011 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.05 -71.61 0.44 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.769 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.51 159.93 31.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.768 0.318 . . . . 0.0 111.139 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.978 ' HB2' HD12 ' B' ' 104' ' ' LEU . . . -75.54 131.49 40.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.162 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.685 HD21 ' O ' ' B' ' 117' ' ' THR . 12.2 tp -88.1 154.22 20.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.331 0.586 . . . . 0.0 110.553 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.879 ' HA ' ' HA ' ' B' ' 84' ' ' ASN . 0.4 OUTLIER -96.43 142.71 28.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.155 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.596 ' HG ' HG12 ' B' ' 103' ' ' ILE . 0.8 OUTLIER -80.82 63.68 5.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.771 0.32 . . . . 0.0 110.708 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . 0.596 ' OD1' HG21 ' B' ' 83' ' ' THR . 0.1 OUTLIER -90.63 -30.6 17.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.573 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . 0.525 ' HA3' ' OG1' ' E' ' 130' ' ' THR . . . 115.76 -43.58 1.64 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.617 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . 0.456 ' HB2' ' C ' ' E' ' 128' ' ' THR . . . -110.58 24.43 12.97 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.006 0.431 . . . . 0.0 111.634 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.685 ' O ' HD21 ' B' ' 111' ' ' LEU . 0.2 OUTLIER -82.12 68.28 8.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.13 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.54 ' CD1' ' HB2' ' B' ' 157' ' ' GLN . 41.2 m-85 -82.15 71.93 9.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.798 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.74 80.98 1.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.831 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.62 131.75 13.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.614 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . 0.434 ' O ' ' HE2' ' B' ' 68' ' ' LYS . 1.5 mm-40 -100.74 52.15 0.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.151 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.665 ' HB ' ' HB3' ' B' ' 69' ' ' ALA . 0.2 OUTLIER -72.14 131.92 43.46 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.738 -179.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.62 107.59 15.37 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.774 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.905 HD13 ' HB2' ' B' ' 69' ' ' ALA . 1.0 OUTLIER -88.18 126.54 35.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.604 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.502 ' O ' ' HB3' ' B' ' 61' ' ' CYS . 1.1 m120 -120.65 -178.92 3.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.577 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' ASN . . . . . 0.524 ' OD1' ' HA ' ' B' ' 62' ' ' ASP . 3.7 t30 -83.27 120.64 26.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.732 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.13 -121.78 2.53 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.683 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . 0.712 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 75.5 m -122.14 103.38 8.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.734 0.302 . . . . 0.0 110.783 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . 0.526 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 1.7 t30 -86.14 157.28 20.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.157 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.566 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.3 OUTLIER -143.32 130.22 20.51 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.064 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' ILE . . . . . 0.634 ' HB ' HG22 ' B' ' 56' ' ' ILE . 57.3 mt -84.09 104.22 3.96 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -82.09 112.48 2.3 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.611 1.541 . . . . 0.0 112.54 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.422 ' HB3' ' CZ ' ' B' ' 54' ' ' PHE . 1.0 OUTLIER -126.77 158.21 37.16 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.826 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -126.01 156.05 40.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.024 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.539 ' O ' HG22 ' B' ' 52' ' ' VAL . . . -148.17 105.12 3.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.922 0.391 . . . . 0.0 111.659 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -99.04 163.44 12.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.436 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 0.3 OUTLIER -81.67 119.75 24.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.085 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . 0.469 ' HB3' HG11 ' B' ' 85' ' ' VAL . 2.1 t80 -108.9 142.69 39.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.247 0.546 . . . . 0.0 112.012 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' B' ' 47' ' ' ALA . . . -132.97 136.0 45.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.918 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' THR . . . . . 0.655 ' O ' ' HA ' ' B' ' 45' ' ' GLU . 25.3 p -96.53 -56.24 2.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.527 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . 0.5 ' H ' ' HB3' ' B' ' 98' ' ' ASN . . . -127.06 -129.83 3.3 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.03 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.01 107.15 12.57 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.682 0.241 . . . . 0.0 110.695 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' B' ' 97' ' ' THR . . . -65.94 148.12 52.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.765 0.317 . . . . 0.0 111.447 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.622 ' HB ' ' H ' ' B' ' 97' ' ' THR . 48.5 m -114.84 144.65 32.37 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.36 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -81.9 130.95 6.83 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.551 2.168 . . . . 0.0 111.967 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . 0.613 ' O ' ' HG3' ' A' ' 15' ' ' GLU . . . 164.86 -116.2 0.69 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.466 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.63 ' HA ' ' HG3' ' A' ' 15' ' ' GLU . . . -110.77 150.34 29.24 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.932 0.396 . . . . 0.0 111.279 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.6 45.87 1.6 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.108 0.48 . . . . 0.0 110.479 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.627 HD22 ' HG2' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -96.86 141.02 30.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.609 -179.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.401 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -153.75 162.55 41.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.013 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.91 135.46 43.62 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.179 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . 0.747 ' HB2' HD11 ' B' ' 86' ' ' LEU . . . -134.18 152.51 51.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.157 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.535 HG23 HG23 ' A' ' 9' ' ' THR . 4.0 m -104.12 148.91 25.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.23 141.81 35.25 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 121.087 0.47 . . . . 0.0 110.141 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.53 152.34 40.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.905 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' VAL . . . . . 0.649 HG23 HG23 ' A' ' 5' ' ' VAL . 20.2 m -135.76 133.17 51.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 111.705 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.746 ' HG3' HG23 ' A' ' 4' ' ' THR . 1.8 tt0 -130.89 119.8 22.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.269 0.557 . . . . 0.0 110.405 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -101.97 113.19 26.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.564 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . 0.629 ' HA ' ' H ' ' A' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.852 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . 0.59 ' HA ' ' HA ' ' D' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.232 0.063 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.639 ' H ' ' HA ' ' D' ' 159' ' ' GLN . . . 59.07 55.84 4.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.592 0.234 . . . . 0.0 111.018 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.523 HG21 ' HB2' ' D' ' 18' ' ' ASN . 89.2 m -118.61 111.1 18.13 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.448 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' THR . . . . . 0.71 HG23 ' HG3' ' D' ' 157' ' ' GLN . 0.2 OUTLIER -97.78 127.3 43.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.609 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.639 HG23 HG23 ' D' ' 156' ' ' VAL . 0.0 OUTLIER -153.53 171.52 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.589 179.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.39 122.13 36.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.592 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . 0.421 ' HA2' HE22 ' E' ' 36' ' ' GLN . . . -75.96 -52.3 6.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.817 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.4 -145.56 5.86 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.889 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . 0.517 HG23 HG23 ' D' ' 153' ' ' THR . 0.2 OUTLIER -146.75 139.83 25.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.975 0.417 . . . . 0.0 111.277 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.38 121.65 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.152 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -99.71 106.6 18.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.309 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' PHE . . . . . 0.43 ' HZ ' ' CZ ' ' D' ' 54' ' ' PHE . 8.9 m-85 -90.59 107.62 19.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.783 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.624 ' HG2' HD22 ' D' ' 149' ' ' ASN . 0.1 OUTLIER -103.34 149.23 24.95 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.337 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.39 -179.08 47.5 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.922 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' GLU . . . . . 0.664 ' HB3' ' HG3' ' D' ' 36' ' ' GLN . 0.1 OUTLIER -158.96 157.1 30.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.906 0.384 . . . . 0.0 110.311 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.46 ' O ' HG11 ' B' ' 5' ' ' VAL . 17.9 t -113.79 132.08 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.284 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.601 HG12 HG21 ' B' ' 5' ' ' VAL . 5.4 m -136.78 176.62 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.803 0.335 . . . . 0.0 111.058 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . 0.504 ' HB2' HG21 ' B' ' 3' ' ' THR . 0.4 OUTLIER -74.42 174.15 9.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.058 -179.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' C' ' 62' ' ' ASP . . . -83.47 35.43 0.5 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.075 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' C' ' 61' ' ' CYS . . . -116.92 -15.94 10.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.435 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.94 155.31 0.6 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.91 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.78 126.37 5.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . 0.737 ' HA ' ' HG ' ' C' ' 58' ' ' LEU . 0.7 OUTLIER -60.74 162.53 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.112 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' C' ' 27' ' ' SER . 18.7 t70 -97.66 161.0 13.97 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.577 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.687 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -64.07 -40.37 96.12 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.389 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.43 12.79 68.96 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.91 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . 0.563 ' HB3' ' HB3' ' C' ' 24' ' ' ASP . 0.6 OUTLIER -113.87 -25.52 8.58 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.865 0.364 . . . . 0.0 110.808 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.407 HG23 ' H ' ' C' ' 28' ' ' VAL . 9.8 t -41.15 -61.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.35 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.55 119.95 39.56 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.085 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -126.14 119.15 26.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.984 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.69 103.32 15.48 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.078 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.86 115.13 43.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.145 0.498 . . . . 0.0 110.493 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.51 112.59 24.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.656 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.8 -30.4 59.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.692 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.03 -170.17 27.36 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.613 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . 0.674 ' HG3' ' HB3' ' B' ' 15' ' ' GLU . 0.4 OUTLIER -93.51 141.7 28.17 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.522 0.201 . . . . 0.0 110.887 -179.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.536 HG11 HD22 ' C' ' 42' ' ' LEU . 5.7 p -125.29 157.11 34.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.916 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.53 122.41 28.98 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.727 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -40.44 87.01 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.754 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.46 -35.87 68.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.05 0.452 . . . . 0.0 110.797 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.19 -21.39 33.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.16 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.536 HD22 HG11 ' C' ' 37' ' ' VAL . 3.2 mp -110.51 29.45 7.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.566 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' C' ' 141' ' ' GLY . . . -108.2 25.45 11.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.321 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.74 159.92 23.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.341 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . 0.654 ' HA ' ' O ' ' C' ' 140' ' ' THR . 11.0 tt0 -82.8 108.68 16.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.853 0.358 . . . . 0.0 111.168 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.9 10.91 51.52 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.163 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' C' ' 139' ' ' ALA . . . -66.76 123.49 20.27 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.933 0.396 . . . . 0.0 112.061 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -120.65 140.25 51.84 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.874 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 4.6 m -101.62 -167.02 1.36 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.611 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 8.1 t -69.68 139.65 53.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.786 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.82 133.95 35.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.309 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.541 HG22 ' O ' ' C' ' 135' ' ' ALA . 18.7 m -86.94 166.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.016 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.74 128.76 7.94 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.637 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . 0.43 ' CZ ' ' HB3' ' C' ' 133' ' ' PHE . 40.7 p90 -160.17 134.48 7.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.511 ' OD1' HG21 ' C' ' 130' ' ' THR . 15.8 p30 -132.75 147.73 52.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.583 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.631 HG22 ' HB ' ' C' ' 131' ' ' ILE . 1.0 OUTLIER -96.75 116.7 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.621 -179.749 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.557 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.0 OUTLIER -66.58 122.06 16.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.696 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . 0.737 ' HG ' ' HA ' ' C' ' 23' ' ' VAL . 0.2 OUTLIER -137.43 88.17 2.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.23 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . 0.714 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 10.5 p30 -79.6 179.4 7.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.88 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.3 64.46 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.783 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' C' ' 129' ' ' ASN . 4.4 m -110.53 163.26 13.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.786 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . 0.587 ' HB2' ' O ' ' C' ' 19' ' ' ALA . 0.5 OUTLIER -140.21 155.07 47.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.254 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.34 -25.31 10.63 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -82.08 -16.25 50.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.061 0.458 . . . . 0.0 111.745 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.403 HG23 ' OD2' ' C' ' 62' ' ' ASP . 16.6 t -90.66 -48.46 14.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.661 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.11 142.9 36.02 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.639 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.82 -53.81 2.6 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.847 0.356 . . . . 0.0 110.971 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' LYS . . . . . 0.433 ' HE2' ' O ' ' C' ' 121' ' ' GLU . 0.1 OUTLIER -94.79 158.16 15.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.491 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.899 ' HB2' HD13 ' C' ' 124' ' ' LEU . . . -137.22 120.47 16.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.611 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -97.54 129.03 44.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.137 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . 0.6 HG11 HG21 ' C' ' 131' ' ' ILE . 15.8 t -112.96 152.24 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.718 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.01 146.63 27.1 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.588 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' PHE . . . . . 0.474 ' CD2' HG21 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -111.53 141.88 44.54 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.5 0.191 . . . . 0.0 111.092 179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' C' ' 152' ' ' ALA . 0.8 OUTLIER -105.72 103.24 12.7 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.974 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.88 -179.11 25.43 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.789 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.685 ' HA ' ' HB3' ' F' ' 132' ' ' PRO . 0.2 OUTLIER -105.15 157.85 16.98 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.595 0.236 . . . . 0.0 110.73 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . 0.422 ' H ' ' HB2' ' F' ' 132' ' ' PRO . . . -77.89 132.79 38.1 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.881 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . 0.449 ' CG2' ' HB ' ' C' ' 85' ' ' VAL . 0.6 OUTLIER -66.58 -39.88 84.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' ASP . . . . . 0.415 ' N ' HG23 ' C' ' 78' ' ' ILE . 0.7 OUTLIER -146.19 53.58 1.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.824 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' F' ' 106' ' ' ARG . . . 61.42 -87.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.065 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.37 -36.51 53.36 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.576 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -81.37 59.97 4.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.883 0.373 . . . . 0.0 110.451 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . 0.593 HG21 ' OD1' ' C' ' 114' ' ' ASP . 2.1 m -70.53 -20.53 62.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.49 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' ASN . . . . . 0.888 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 26.6 p-10 -69.34 -13.73 62.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.334 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.697 HG22 ' HB2' ' C' ' 102' ' ' GLN . 40.9 t -109.0 131.15 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.129 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.783 HD11 ' HB2' ' C' ' 152' ' ' ALA . 0.6 OUTLIER -70.07 142.85 52.61 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.324 179.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.0 -170.58 3.1 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.882 0.372 . . . . 0.0 111.71 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -79.89 161.44 25.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.102 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.75 -80.33 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.34 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . 0.476 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 6.6 p -171.34 0.49 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.949 0.404 . . . . 0.0 111.481 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' SER . . . . . 0.677 ' HA ' ' HB2' ' E' ' 25' ' ' ALA . 73.5 m -76.84 85.66 3.42 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' F' ' 50' ' ' SER . . . -61.04 -32.23 71.86 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.876 0.369 . . . . 0.0 111.649 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.86 30.47 6.87 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.642 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.64 -3.26 0.11 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.947 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' C' ' 91' ' ' SER . 0.1 OUTLIER -107.54 -176.71 3.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.834 0.35 . . . . 0.0 110.656 179.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.49 172.58 8.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . 0.613 ' H ' ' HB ' ' C' ' 144' ' ' THR . 1.6 m -126.93 140.4 52.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.351 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . 0.492 ' HB3' ' H ' ' C' ' 141' ' ' GLY . 68.4 m-80 61.96 21.39 12.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.472 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' VAL . . . . . 0.543 HG23 ' O ' ' C' ' 97' ' ' THR . 2.7 t -120.44 136.0 58.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.727 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.94 -160.74 10.18 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.532 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' VAL . . . . . 0.407 HG13 ' HB2' ' C' ' 86' ' ' LEU . 4.5 p -145.94 109.85 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 123.067 0.547 . . . . 0.0 111.758 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' GLN . . . . . 0.697 ' HB2' HG22 ' C' ' 85' ' ' VAL . 0.5 OUTLIER -84.27 147.38 27.26 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.93 -179.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.598 HG12 ' HG ' ' C' ' 113' ' ' LEU . 1.2 pp -110.79 127.86 67.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.529 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' LEU . . . . . 0.976 HD12 ' HB2' ' C' ' 110' ' ' ALA . 1.4 tp -97.43 132.94 42.66 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.663 0.268 . . . . 0.0 111.02 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . 0.654 ' HB3' HG22 ' C' ' 107' ' ' THR . 4.0 t0 -80.78 143.58 32.77 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.688 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -65.42 -17.53 64.61 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 120.815 0.341 . . . . 0.0 111.043 179.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . 0.654 HG22 ' HB3' ' C' ' 105' ' ' ASP . 13.2 t -66.83 -20.59 65.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.028 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.08 -71.85 0.44 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.682 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.5 159.97 31.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.825 0.345 . . . . 0.0 111.11 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.976 ' HB2' HD12 ' C' ' 104' ' ' LEU . . . -75.54 131.52 40.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' LEU . . . . . 0.696 HD21 ' O ' ' C' ' 117' ' ' THR . 12.2 tp -88.14 154.22 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.379 0.609 . . . . 0.0 110.514 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' THR . . . . . 0.888 ' HA ' ' HA ' ' C' ' 84' ' ' ASN . 0.4 OUTLIER -96.37 142.66 28.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.147 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.598 ' HG ' HG12 ' C' ' 103' ' ' ILE . 0.8 OUTLIER -80.76 63.61 5.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.783 0.325 . . . . 0.0 110.761 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' ASP . . . . . 0.593 ' OD1' HG21 ' C' ' 83' ' ' THR . 0.1 OUTLIER -90.7 -30.54 17.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.547 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . 0.527 ' HA3' ' OG1' ' F' ' 130' ' ' THR . . . 115.76 -43.57 1.65 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.595 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' F' ' 128' ' ' THR . . . -110.49 24.33 13.11 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.003 0.43 . . . . 0.0 111.679 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . 0.696 ' O ' HD21 ' C' ' 111' ' ' LEU . 0.2 OUTLIER -82.15 68.37 8.52 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.118 -179.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' PHE . . . . . 0.553 ' CD1' ' HB2' ' C' ' 157' ' ' GLN . 41.0 m-85 -82.2 72.0 9.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.801 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.76 80.99 1.86 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.65 131.75 13.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.606 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . 0.433 ' O ' ' HE2' ' C' ' 68' ' ' LYS . 1.5 mm-40 -100.76 52.2 0.86 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.212 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.645 ' HB ' ' HB3' ' C' ' 69' ' ' ALA . 0.2 OUTLIER -72.11 131.89 43.45 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.75 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.7 107.65 15.49 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.745 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . 0.899 HD13 ' HB2' ' C' ' 69' ' ' ALA . 1.0 OUTLIER -88.26 126.58 35.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.561 179.465 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' C' ' 61' ' ' CYS . 1.1 m120 -120.66 -178.93 3.84 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.525 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' ASN . . . . . 0.524 ' OD1' ' HA ' ' C' ' 62' ' ' ASP . 3.8 t30 -83.25 120.61 26.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.784 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.18 -121.67 2.5 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.659 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' THR . . . . . 0.714 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 76.5 m -122.21 103.37 8.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.746 0.308 . . . . 0.0 110.78 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 129' ' ' ASN . . . . . 0.529 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 1.8 t30 -86.21 157.26 20.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.896 0.379 . . . . 0.0 111.091 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . 0.557 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.3 OUTLIER -143.29 130.17 20.5 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.104 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 131' ' ' ILE . . . . . 0.631 ' HB ' HG22 ' C' ' 56' ' ' ILE . 56.8 mt -83.97 104.14 3.79 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 132' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' C' ' 106' ' ' ARG . 7.6 Cg_endo -82.0 112.34 2.31 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.673 1.582 . . . . 0.0 112.582 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.43 ' HB3' ' CZ ' ' C' ' 54' ' ' PHE . 1.0 OUTLIER -126.7 158.29 36.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.828 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 134' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -126.0 156.1 40.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.059 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.541 ' O ' HG22 ' C' ' 52' ' ' VAL . . . -148.15 105.14 3.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.83 0.348 . . . . 0.0 111.609 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.05 163.36 12.61 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.416 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 137' ' ' TYR . . . . . 0.561 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 0.3 OUTLIER -81.64 119.71 24.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.116 179.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 138' ' ' PHE . . . . . 0.463 ' HB3' HG11 ' C' ' 85' ' ' VAL . 2.1 t80 -108.91 142.68 39.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.982 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 139' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' C' ' 47' ' ' ALA . . . -132.98 136.04 45.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.851 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 140' ' ' THR . . . . . 0.654 ' O ' ' HA ' ' C' ' 45' ' ' GLU . 25.1 p -96.6 -56.21 2.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.476 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . 0.492 ' H ' ' HB3' ' C' ' 98' ' ' ASN . . . -127.06 -129.84 3.3 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.013 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -80.03 107.14 12.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.631 0.216 . . . . 0.0 110.702 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 143' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' C' ' 97' ' ' THR . . . -65.89 148.09 52.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.753 0.311 . . . . 0.0 111.434 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 144' ' ' THR . . . . . 0.613 ' HB ' ' H ' ' C' ' 97' ' ' THR . 47.8 m -114.87 144.67 32.42 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.307 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 145' ' ' PRO . . . . . 0.406 ' HD2' HG23 ' C' ' 144' ' ' THR . 1.3 Cg_endo -81.96 130.97 6.78 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.479 2.119 . . . . 0.0 112.009 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . 0.62 ' O ' ' HG3' ' B' ' 15' ' ' GLU . . . 164.89 -116.26 0.69 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.438 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 147' ' ' ALA . . . . . 0.611 ' HA ' ' HG3' ' B' ' 15' ' ' GLU . . . -110.67 150.37 29.12 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.847 0.356 . . . . 0.0 111.351 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.67 45.89 1.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.46 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 149' ' ' ASN . . . . . 0.625 HD22 ' HG2' ' B' ' 13' ' ' LYS . 0.2 OUTLIER -96.83 141.0 30.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.618 -179.509 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 150' ' ' ALA . . . . . 0.411 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -153.7 162.62 41.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.047 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.93 135.5 43.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.198 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . 0.783 ' HB2' HD11 ' C' ' 86' ' ' LEU . . . -134.16 152.51 51.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.23 179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . 0.526 HG23 HG23 ' B' ' 9' ' ' THR . 4.0 m -104.15 148.91 25.74 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.23 141.83 35.21 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.136 0.493 . . . . 0.0 110.165 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.54 152.41 40.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.916 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 156' ' ' VAL . . . . . 0.632 HG23 HG23 ' B' ' 5' ' ' VAL . 19.9 m -135.74 133.22 51.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.798 0.332 . . . . 0.0 111.684 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . 0.711 ' HG3' HG23 ' B' ' 4' ' ' THR . 1.8 tt0 -130.96 119.78 22.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.326 0.584 . . . . 0.0 110.397 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -101.93 113.24 26.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.577 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . 0.626 ' HA ' ' H ' ' B' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.836 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . 0.589 ' HA ' ' HA ' ' E' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.311 0 N-CA-C 111.105 0.039 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.624 ' H ' ' HA ' ' E' ' 159' ' ' GLN . . . 59.11 55.8 4.22 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 123.104 0.253 . . . . 0.0 111.035 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' THR . . . . . 0.524 HG21 ' HB2' ' E' ' 18' ' ' ASN . 89.7 m -118.64 111.07 18.08 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.422 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . 0.74 HG23 ' HG3' ' E' ' 157' ' ' GLN . 0.2 OUTLIER -97.76 127.33 43.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.524 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.657 HG23 HG23 ' E' ' 156' ' ' VAL . 0.0 OUTLIER -153.53 171.46 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.634 179.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.37 122.09 36.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.637 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' GLY . . . . . 0.425 ' HA2' HE22 ' F' ' 36' ' ' GLN . . . -76.0 -52.23 6.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.802 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.46 -145.46 5.83 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.829 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . 0.535 HG23 HG23 ' E' ' 153' ' ' THR . 0.2 OUTLIER -146.82 139.74 25.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.905 0.383 . . . . 0.0 111.299 -179.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.33 121.63 64.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.125 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -99.65 106.66 18.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.361 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' PHE . . . . . 0.432 ' HZ ' ' CZ ' ' E' ' 54' ' ' PHE . 8.9 m-85 -90.65 107.59 19.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.797 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' LYS . . . . . 0.605 ' HG2' HD22 ' E' ' 149' ' ' ASN . 0.1 OUTLIER -103.29 149.18 24.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.404 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.42 -179.05 47.51 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.946 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' GLU . . . . . 0.673 ' HB3' ' HG3' ' E' ' 36' ' ' GLN . 0.1 OUTLIER -158.93 157.01 30.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.912 0.387 . . . . 0.0 110.358 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.461 ' O ' HG11 ' C' ' 5' ' ' VAL . 17.8 t -113.7 132.19 63.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.249 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.606 HG12 HG21 ' C' ' 5' ' ' VAL . 5.5 m -136.85 176.58 7.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.829 0.347 . . . . 0.0 111.008 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' ASN . . . . . 0.523 ' HB2' HG21 ' C' ' 3' ' ' THR . 0.4 OUTLIER -74.36 174.11 9.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.068 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' ALA . . . . . 0.575 ' O ' ' HB2' ' D' ' 62' ' ' ASP . . . -83.4 35.32 0.49 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.059 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' D' ' 61' ' ' CYS . . . -116.92 -15.9 10.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.398 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.99 155.22 0.59 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.962 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.67 126.47 5.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.077 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . 0.74 ' HA ' ' HG ' ' D' ' 58' ' ' LEU . 0.7 OUTLIER -60.9 162.44 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.057 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' D' ' 27' ' ' SER . 18.7 t70 -97.58 160.97 14.0 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.623 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.675 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -64.11 -40.25 95.79 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.398 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.49 12.75 69.02 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.914 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . 0.568 ' HB3' ' HB3' ' D' ' 24' ' ' ASP . 0.6 OUTLIER -113.84 -25.47 8.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.846 0.355 . . . . 0.0 110.787 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . 0.405 HG23 ' H ' ' D' ' 28' ' ' VAL . 10.0 t -41.15 -61.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.306 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.64 120.0 39.65 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.03 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -126.07 119.1 26.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.024 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.76 103.33 15.47 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.083 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.88 115.1 43.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.163 0.506 . . . . 0.0 110.424 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.5 112.56 24.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.646 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.83 -30.34 58.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.626 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.98 -170.23 27.49 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.571 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' GLN . . . . . 0.664 ' HG3' ' HB3' ' C' ' 15' ' ' GLU . 0.4 OUTLIER -93.48 141.79 28.07 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.526 0.203 . . . . 0.0 110.944 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.559 HG11 HD22 ' D' ' 42' ' ' LEU . 5.8 p -125.3 157.14 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.827 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.58 122.39 28.97 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.729 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.45 -40.47 86.94 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.753 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.48 -35.82 68.39 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.053 0.454 . . . . 0.0 110.8 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.25 -21.44 33.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.133 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.559 HD22 HG11 ' D' ' 37' ' ' VAL . 3.3 mp -110.5 29.51 7.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.623 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' D' ' 141' ' ' GLY . . . -108.24 25.44 11.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.34 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.71 159.97 23.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.38 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' D' ' 140' ' ' THR . 11.1 tt0 -82.94 108.73 16.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.916 0.388 . . . . 0.0 111.127 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.97 10.78 51.51 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.116 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' D' ' 139' ' ' ALA . . . -66.66 123.47 20.18 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.94 0.4 . . . . 0.0 111.974 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 77.5 p -120.64 140.3 51.77 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.879 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.573 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 4.6 m -101.68 -167.02 1.36 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.61 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 92' ' ' ALA . 8.1 t -69.63 139.64 53.61 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.791 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.79 133.99 35.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.335 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' VAL . . . . . 0.532 HG22 ' O ' ' D' ' 135' ' ' ALA . 18.9 m -87.04 166.48 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.896 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.77 128.87 7.99 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.614 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.558 ' H ' HG21 ' A' ' 76' ' ' THR . 40.6 p90 -160.2 134.44 7.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.756 0.312 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' ASN . . . . . 0.516 ' OD1' HG21 ' D' ' 130' ' ' THR . 15.9 p30 -132.75 147.67 52.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.623 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.636 HG22 ' HB ' ' D' ' 131' ' ' ILE . 1.0 OUTLIER -96.74 116.75 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.567 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' GLN . . . . . 0.572 ' HA ' HG23 ' D' ' 130' ' ' THR . 0.0 OUTLIER -66.61 122.04 16.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.744 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . 0.74 ' HG ' ' HA ' ' D' ' 23' ' ' VAL . 0.2 OUTLIER -137.4 88.17 2.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.228 -179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . 0.734 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 10.6 p30 -79.58 179.37 7.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.925 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.35 64.37 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.812 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' D' ' 129' ' ' ASN . 4.4 m -110.48 163.26 13.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.954 0.406 . . . . 0.0 110.761 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . 0.575 ' HB2' ' O ' ' D' ' 19' ' ' ALA . 0.5 OUTLIER -140.22 155.07 47.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.237 -179.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.25 -25.36 10.63 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -81.99 -16.41 50.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.083 0.468 . . . . 0.0 111.703 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 t -90.61 -48.48 14.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.696 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.12 142.9 36.01 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.639 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.79 -53.82 2.6 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.848 0.356 . . . . 0.0 110.941 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' D' ' 121' ' ' GLU . 0.1 OUTLIER -94.86 158.1 15.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.482 179.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' ALA . . . . . 0.908 ' HB2' HD13 ' D' ' 124' ' ' LEU . . . -137.14 120.48 16.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.621 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -97.62 129.1 44.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.06 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . 0.594 HG11 HG21 ' D' ' 131' ' ' ILE . 15.9 t -112.99 152.28 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.671 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.05 146.61 27.06 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.522 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' PHE . . . . . 0.474 ' CD2' HG21 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -111.53 141.94 44.46 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.536 0.208 . . . . 0.0 111.092 179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' D' ' 152' ' ' ALA . 0.8 OUTLIER -105.71 103.35 12.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.916 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.96 -179.11 25.5 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.806 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 157.84 17.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.558 0.218 . . . . 0.0 110.732 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.9 132.75 38.07 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.87 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 78' ' ' ILE . . . . . 0.452 ' CG2' ' HB ' ' D' ' 85' ' ' VAL . 0.6 OUTLIER -66.61 -39.79 84.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.42 ' N ' HG23 ' D' ' 78' ' ' ILE . 0.7 OUTLIER -146.22 53.53 1.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.826 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.39 -87.54 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.33 -36.53 53.26 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.58 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -81.31 59.99 4.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.852 0.358 . . . . 0.0 110.472 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 83' ' ' THR . . . . . 0.593 HG21 ' OD1' ' D' ' 114' ' ' ASP . 2.1 m -70.58 -20.53 62.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.575 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . 0.887 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 26.6 p-10 -69.35 -13.7 62.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.296 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.691 HG22 ' HB2' ' D' ' 102' ' ' GLN . 40.8 t -108.96 131.1 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.203 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.758 HD11 ' HB2' ' D' ' 152' ' ' ALA . 0.6 OUTLIER -70.02 142.89 52.69 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.323 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.02 -170.5 3.06 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.884 0.373 . . . . 0.0 111.688 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -80.02 161.44 25.42 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.022 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.76 -80.25 0.01 OUTLIER 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.357 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 6.5 p -171.41 0.48 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.93 0.395 . . . . 0.0 111.445 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . 0.687 ' HA ' ' HB2' ' F' ' 25' ' ' ALA . 73.4 m -76.83 85.55 3.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.912 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.87 -32.32 71.76 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.655 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.83 30.45 6.88 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.641 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.71 -3.12 0.11 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.953 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 95' ' ' SER . . . . . 0.586 ' HB2' ' HB2' ' D' ' 91' ' ' SER . 0.1 OUTLIER -107.57 -176.79 3.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 110.638 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.56 172.58 8.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.811 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . 0.611 ' H ' ' HB ' ' D' ' 144' ' ' THR . 1.7 m -126.86 140.43 52.36 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.288 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 98' ' ' ASN . . . . . 0.48 ' HB3' ' H ' ' D' ' 141' ' ' GLY . 68.3 m-80 61.95 21.36 12.25 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.427 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 99' ' ' VAL . . . . . 0.55 HG23 ' O ' ' D' ' 97' ' ' THR . 2.7 t -120.35 136.02 58.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.742 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.0 -160.77 10.21 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.513 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 101' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' D' ' 86' ' ' LEU . 4.5 p -145.9 109.85 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 121.168 0.509 . . . . 0.0 111.762 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 102' ' ' GLN . . . . . 0.691 ' HB2' HG22 ' D' ' 85' ' ' VAL . 0.5 OUTLIER -84.31 147.36 27.24 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.93 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 103' ' ' ILE . . . . . 0.611 HG12 ' HG ' ' D' ' 113' ' ' LEU . 1.2 pp -110.73 127.81 67.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.49 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 104' ' ' LEU . . . . . 0.937 HD12 ' HB2' ' D' ' 110' ' ' ALA . 1.4 tp -97.37 132.92 42.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.676 0.274 . . . . 0.0 111.093 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . 0.673 ' HB3' HG22 ' D' ' 107' ' ' THR . 4.0 t0 -80.81 143.62 32.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.669 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 106' ' ' ARG . . . . . 0.543 ' HA ' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -65.47 -17.44 64.56 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.762 0.315 . . . . 0.0 111.101 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 107' ' ' THR . . . . . 0.673 HG22 ' HB3' ' D' ' 105' ' ' ASP . 13.3 t -66.87 -20.59 65.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.052 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.07 -71.78 0.44 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.674 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.48 159.93 31.61 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.829 0.347 . . . . 0.0 111.111 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.937 ' HB2' HD12 ' D' ' 104' ' ' LEU . . . -75.56 131.47 40.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.126 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 111' ' ' LEU . . . . . 0.682 HD21 ' O ' ' D' ' 117' ' ' THR . 12.2 tp -88.13 154.21 20.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.372 0.606 . . . . 0.0 110.63 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 112' ' ' THR . . . . . 0.887 ' HA ' ' HA ' ' D' ' 84' ' ' ASN . 0.4 OUTLIER -96.42 142.74 28.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.082 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 113' ' ' LEU . . . . . 0.611 ' HG ' HG12 ' D' ' 103' ' ' ILE . 0.8 OUTLIER -80.82 63.68 5.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.738 0.304 . . . . 0.0 110.704 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 114' ' ' ASP . . . . . 0.593 ' OD1' HG21 ' D' ' 83' ' ' THR . 0.1 OUTLIER -90.65 -30.66 17.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.648 0.261 . . . . 0.0 111.55 -179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.79 -43.6 1.64 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.593 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.56 24.38 13.04 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.996 0.427 . . . . 0.0 111.614 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 117' ' ' THR . . . . . 0.682 ' O ' HD21 ' D' ' 111' ' ' LEU . 0.2 OUTLIER -82.12 68.35 8.49 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 -179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.553 ' CD1' ' HB2' ' D' ' 157' ' ' GLN . 40.8 m-85 -82.21 71.98 9.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.754 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.71 80.99 1.86 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.58 131.75 13.56 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.576 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . 0.431 ' O ' ' HE2' ' D' ' 68' ' ' LYS . 1.5 mm-40 -100.77 52.11 0.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.222 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.666 ' HB ' ' HB3' ' D' ' 69' ' ' ALA . 0.2 OUTLIER -72.06 131.91 43.5 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.73 -179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.69 107.62 15.46 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.742 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . 0.908 HD13 ' HB2' ' D' ' 69' ' ' ALA . 1.0 OUTLIER -88.22 126.58 35.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.558 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 125' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' D' ' 61' ' ' CYS . 1.1 m120 -120.69 -178.94 3.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.575 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 126' ' ' ASN . . . . . 0.52 ' OD1' ' HA ' ' D' ' 62' ' ' ASP . 3.8 t30 -83.23 120.71 26.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.662 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 136.08 -121.72 2.52 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.709 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 128' ' ' THR . . . . . 0.734 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 75.8 m -122.21 103.42 8.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.711 0.291 . . . . 0.0 110.77 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 129' ' ' ASN . . . . . 0.534 ' HB2' ' SG ' ' D' ' 61' ' ' CYS . 1.7 t30 -86.14 157.23 20.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.172 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 130' ' ' THR . . . . . 0.572 HG23 ' HA ' ' D' ' 57' ' ' GLN . 0.3 OUTLIER -143.28 130.17 20.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.136 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 131' ' ' ILE . . . . . 0.636 ' HB ' HG22 ' D' ' 56' ' ' ILE . 57.0 mt -84.0 104.11 3.77 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 132' ' ' PRO . . . . . 0.699 ' HB3' ' HA ' ' A' ' 76' ' ' THR . 7.6 Cg_endo -81.99 112.34 2.31 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.646 1.564 . . . . 0.0 112.568 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.432 ' HB3' ' CZ ' ' D' ' 54' ' ' PHE . 1.0 OUTLIER -126.68 158.25 36.88 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.863 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -125.96 156.09 40.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.116 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.532 ' O ' HG22 ' D' ' 52' ' ' VAL . . . -148.22 105.12 3.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.947 0.404 . . . . 0.0 111.587 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -99.07 163.48 12.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.357 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 137' ' ' TYR . . . . . 0.573 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 0.3 OUTLIER -81.79 119.7 24.21 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.101 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 138' ' ' PHE . . . . . 0.461 ' HB3' HG11 ' D' ' 85' ' ' VAL . 2.1 t80 -108.84 142.68 39.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.056 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 139' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' D' ' 47' ' ' ALA . . . -132.92 136.05 45.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.904 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 140' ' ' THR . . . . . 0.656 ' O ' ' HA ' ' D' ' 45' ' ' GLU . 25.1 p -96.66 -56.14 2.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.474 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . 0.48 ' H ' ' HB3' ' D' ' 98' ' ' ASN . . . -127.11 -129.87 3.3 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.988 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.98 107.05 12.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.652 0.226 . . . . 0.0 110.779 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 143' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' D' ' 97' ' ' THR . . . -65.85 148.09 52.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.714 0.292 . . . . 0.0 111.441 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 144' ' ' THR . . . . . 0.611 ' HB ' ' H ' ' D' ' 97' ' ' THR . 48.6 m -114.79 144.69 32.42 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.297 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 145' ' ' PRO . . . . . 0.411 ' HD2' HG23 ' D' ' 144' ' ' THR . 1.3 Cg_endo -81.97 130.91 6.75 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 122.573 2.182 . . . . 0.0 111.972 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . 0.621 ' O ' ' HG3' ' C' ' 15' ' ' GLU . . . 164.89 -116.25 0.69 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.439 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 147' ' ' ALA . . . . . 0.627 ' HA ' ' HG3' ' C' ' 15' ' ' GLU . . . -110.66 150.4 29.06 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.808 0.337 . . . . 0.0 111.339 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.65 45.88 1.59 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.45 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 149' ' ' ASN . . . . . 0.624 HD22 ' HG2' ' C' ' 13' ' ' LYS . 0.2 OUTLIER -96.85 141.06 30.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.578 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 150' ' ' ALA . . . . . 0.404 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -153.74 162.54 41.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.962 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.87 135.49 43.73 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.239 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 152' ' ' ALA . . . . . 0.758 ' HB2' HD11 ' D' ' 86' ' ' LEU . . . -134.19 152.49 51.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.217 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 153' ' ' THR . . . . . 0.517 HG23 HG23 ' C' ' 9' ' ' THR . 4.0 m -104.09 148.92 25.7 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.25 141.83 35.22 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.106 0.479 . . . . 0.0 110.113 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.57 152.39 40.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.921 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 156' ' ' VAL . . . . . 0.639 HG23 HG23 ' C' ' 5' ' ' VAL . 20.0 m -135.74 133.16 51.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.809 0.337 . . . . 0.0 111.635 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 157' ' ' GLN . . . . . 0.71 ' HG3' HG23 ' C' ' 4' ' ' THR . 1.8 tt0 -130.9 119.74 22.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.302 0.572 . . . . 0.0 110.417 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -101.94 113.31 26.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.587 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 159' ' ' GLN . . . . . 0.639 ' HA ' ' H ' ' C' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.839 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' F' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 111.108 0.04 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . 0.622 ' H ' ' HA ' ' F' ' 159' ' ' GLN . . . 59.16 55.73 4.23 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 123.106 0.254 . . . . 0.0 111.035 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 3' ' ' THR . . . . . 0.524 HG21 ' HB2' ' F' ' 18' ' ' ASN . 89.5 m -118.64 111.1 18.11 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.443 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 4' ' ' THR . . . . . 0.726 HG23 ' HG3' ' F' ' 157' ' ' GLN . 0.2 OUTLIER -97.79 127.38 43.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.575 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.638 HG23 HG23 ' F' ' 156' ' ' VAL . 0.0 OUTLIER -153.57 171.46 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.594 179.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.38 122.07 36.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.632 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.83 -52.37 6.46 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.859 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.41 -145.53 5.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.868 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 9' ' ' THR . . . . . 0.531 HG23 HG23 ' F' ' 153' ' ' THR . 0.2 OUTLIER -146.69 139.85 25.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.371 . . . . 0.0 111.283 -179.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -122.43 121.63 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.121 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.71 106.64 18.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.326 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 12' ' ' PHE . . . . . 0.434 ' HZ ' ' CZ ' ' F' ' 54' ' ' PHE . 8.9 m-85 -90.65 107.66 19.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 13' ' ' LYS . . . . . 0.623 ' HG2' HD22 ' F' ' 149' ' ' ASN . 0.1 OUTLIER -103.29 149.18 24.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.384 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.43 -179.03 47.51 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.971 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 15' ' ' GLU . . . . . 0.662 ' HB3' ' HG3' ' F' ' 36' ' ' GLN . 0.1 OUTLIER -158.96 157.01 30.49 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.849 0.357 . . . . 0.0 110.381 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 16' ' ' VAL . . . . . 0.457 ' O ' HG11 ' D' ' 5' ' ' VAL . 18.1 t -113.77 132.21 63.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.148 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . 0.615 HG12 HG21 ' D' ' 5' ' ' VAL . 5.6 m -136.84 176.55 7.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 111.107 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . 0.524 ' HB2' HG21 ' D' ' 3' ' ' THR . 0.4 OUTLIER -74.36 174.11 9.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.012 -179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 19' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' E' ' 62' ' ' ASP . . . -83.45 35.38 0.5 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' E' ' 61' ' ' CYS . . . -116.93 -15.9 10.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.412 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.99 155.26 0.6 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.961 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.74 126.43 5.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.114 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 23' ' ' VAL . . . . . 0.728 ' HA ' ' HG ' ' E' ' 58' ' ' LEU . 0.7 OUTLIER -60.85 162.54 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.083 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 24' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' E' ' 27' ' ' SER . 18.6 t70 -97.66 160.99 13.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.595 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . 0.677 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -64.12 -40.33 95.97 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.365 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.41 12.73 69.09 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.9 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . 0.573 ' HB3' ' HB3' ' E' ' 24' ' ' ASP . 0.6 OUTLIER -113.84 -25.51 8.59 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.836 0.35 . . . . 0.0 110.785 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 28' ' ' VAL . . . . . . . . . . . . . 9.7 t -41.14 -61.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.336 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.64 120.01 39.67 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.013 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 30' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -126.11 119.14 26.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.01 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.79 103.29 15.43 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.107 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.82 115.11 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.144 0.497 . . . . 0.0 110.534 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.45 112.6 24.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.601 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mp -75.87 -30.4 58.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.615 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.08 -170.2 27.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.581 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 36' ' ' GLN . . . . . 0.673 ' HG3' ' HB3' ' D' ' 15' ' ' GLU . 0.4 OUTLIER -93.47 141.71 28.15 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.608 0.242 . . . . 0.0 110.89 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.552 HG11 HD22 ' E' ' 42' ' ' LEU . 5.8 p -125.24 157.13 34.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.914 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.55 122.43 29.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.799 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.53 -40.42 87.1 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.736 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.44 -35.86 68.34 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.125 0.488 . . . . 0.0 110.87 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -21.54 33.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.14 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.552 HD22 HG11 ' E' ' 37' ' ' VAL . 3.2 mp -110.49 29.38 7.76 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.621 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 43' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' E' ' 141' ' ' GLY . . . -108.16 25.53 11.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.357 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.72 160.0 23.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.342 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' E' ' 140' ' ' THR . 11.1 tt0 -82.92 108.64 16.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.823 0.344 . . . . 0.0 111.131 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.94 10.9 51.39 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.145 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 47' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' E' ' 139' ' ' ALA . . . -66.75 123.47 20.21 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.943 0.401 . . . . 0.0 111.997 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 77.8 p -120.59 140.27 51.77 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.837 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 4.6 m -101.6 -167.01 1.36 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.625 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 50' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' B' ' 92' ' ' ALA . 8.1 t -69.66 139.7 53.55 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.774 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.87 134.03 35.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.348 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 52' ' ' VAL . . . . . 0.532 HG22 ' O ' ' E' ' 135' ' ' ALA . 18.8 m -87.01 166.47 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.962 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.75 128.89 8.01 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.628 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 54' ' ' PHE . . . . . 0.56 ' H ' HG21 ' B' ' 76' ' ' THR . 40.7 p90 -160.29 134.44 7.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.79 0.329 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 55' ' ' ASN . . . . . 0.514 ' OD1' HG21 ' E' ' 130' ' ' THR . 15.9 p30 -132.75 147.75 52.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.636 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 56' ' ' ILE . . . . . 0.636 HG22 ' HB ' ' E' ' 131' ' ' ILE . 1.0 OUTLIER -96.83 116.85 40.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.521 -179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 57' ' ' GLN . . . . . 0.576 ' HA ' HG23 ' E' ' 130' ' ' THR . 0.0 OUTLIER -66.58 122.07 16.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.704 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . 0.728 ' HG ' ' HA ' ' E' ' 23' ' ' VAL . 0.2 OUTLIER -137.49 88.12 2.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.213 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . 0.717 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 10.6 p30 -79.6 179.29 7.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.89 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.42 64.42 0.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.779 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 61' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' E' ' 129' ' ' ASN . 4.4 m -110.56 163.2 13.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.755 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . 0.581 ' HB2' ' O ' ' E' ' 19' ' ' ALA . 0.5 OUTLIER -140.14 155.0 47.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.344 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.2 -25.42 10.63 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.95 -16.35 50.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.127 0.489 . . . . 0.0 111.754 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . 0.403 HG23 ' OD2' ' E' ' 62' ' ' ASP . 16.7 t -90.68 -48.41 14.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.68 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.16 142.92 35.93 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.575 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.82 -53.86 2.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.866 0.365 . . . . 0.0 110.918 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 68' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' E' ' 121' ' ' GLU . 0.1 OUTLIER -94.75 158.13 15.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.549 179.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 69' ' ' ALA . . . . . 0.933 ' HB2' HD13 ' E' ' 124' ' ' LEU . . . -137.19 120.42 16.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.649 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . 0.447 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -97.54 129.13 44.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.111 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . 0.607 HG11 HG21 ' E' ' 131' ' ' ILE . 15.7 t -112.97 152.23 14.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.749 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.01 146.65 27.12 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.52 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 73' ' ' PHE . . . . . 0.475 ' CD2' HG21 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -111.58 141.86 44.63 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.525 0.202 . . . . 0.0 111.063 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 74' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' E' ' 152' ' ' ALA . 0.8 OUTLIER -105.67 103.38 12.88 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.962 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.95 -179.11 25.49 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.813 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.22 157.8 17.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.554 0.216 . . . . 0.0 110.761 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.91 132.75 38.06 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.849 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 78' ' ' ILE . . . . . 0.45 ' CG2' ' HB ' ' E' ' 85' ' ' VAL . 0.6 OUTLIER -66.55 -39.82 84.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.911 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 79' ' ' ASP . . . . . 0.419 ' N ' HG23 ' E' ' 78' ' ' ILE . 0.7 OUTLIER -146.23 53.59 1.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.844 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.36 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.013 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.28 -36.59 53.16 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.566 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 82' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -81.34 59.98 4.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 0.0 110.473 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 83' ' ' THR . . . . . 0.594 HG21 ' OD1' ' E' ' 114' ' ' ASP . 2.0 m -70.56 -20.5 62.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.533 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 84' ' ' ASN . . . . . 0.878 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 26.5 p-10 -69.34 -13.75 62.55 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.297 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.66 HG22 ' HB2' ' E' ' 102' ' ' GLN . 40.8 t -109.01 131.12 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.153 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 86' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' E' ' 152' ' ' ALA . 0.6 OUTLIER -69.99 142.87 52.74 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.05 -170.49 3.06 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.937 0.399 . . . . 0.0 111.668 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' E' ' 88' ' ' LEU . 1.2 mm? -80.01 161.4 25.45 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.985 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.67 -80.34 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.322 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 6.4 p -171.35 0.34 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.958 0.409 . . . . 0.0 111.449 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 91' ' ' SER . . . . . 0.598 ' HB2' ' HB2' ' E' ' 95' ' ' SER . 73.5 m -76.78 85.64 3.38 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.859 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.35 71.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.942 0.401 . . . . 0.0 111.653 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.82 30.45 6.89 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.611 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.72 -3.15 0.11 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.941 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 95' ' ' SER . . . . . 0.598 ' HB2' ' HB2' ' E' ' 91' ' ' SER . 0.1 OUTLIER -107.57 -176.76 3.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.838 0.351 . . . . 0.0 110.641 179.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.46 172.6 8.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.851 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . 0.623 ' H ' ' HB ' ' E' ' 144' ' ' THR . 1.6 m -126.9 140.44 52.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.348 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 98' ' ' ASN . . . . . 0.495 ' HB3' ' H ' ' E' ' 141' ' ' GLY . 68.3 m-80 61.96 21.33 12.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.45 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 99' ' ' VAL . . . . . 0.557 HG23 ' O ' ' E' ' 97' ' ' THR . 2.6 t -120.33 135.98 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.746 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -156.0 -160.73 10.19 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.583 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -145.88 109.89 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 121.181 0.515 . . . . 0.0 111.715 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 102' ' ' GLN . . . . . 0.66 ' HB2' HG22 ' E' ' 85' ' ' VAL . 0.5 OUTLIER -84.34 147.3 27.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.849 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 103' ' ' ILE . . . . . 0.598 HG12 ' HG ' ' E' ' 113' ' ' LEU . 1.2 pp -110.68 127.86 67.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.476 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 104' ' ' LEU . . . . . 0.972 HD12 ' HB2' ' E' ' 110' ' ' ALA . 1.4 tp -97.46 132.99 42.64 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.705 0.288 . . . . 0.0 111.021 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . 0.654 ' HB3' HG22 ' E' ' 107' ' ' THR . 4.0 t0 -80.84 143.62 32.64 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.662 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 106' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' B' ' 80' ' ' ALA . 0.0 OUTLIER -65.42 -17.52 64.61 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.813 0.34 . . . . 0.0 111.084 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . 0.654 HG22 ' HB3' ' E' ' 105' ' ' ASP . 13.3 t -66.81 -20.63 65.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.03 -71.71 0.44 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.741 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.52 159.95 31.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.842 0.353 . . . . 0.0 111.061 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . 0.972 ' HB2' HD12 ' E' ' 104' ' ' LEU . . . -75.56 131.52 40.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.076 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.684 HD21 ' O ' ' E' ' 117' ' ' THR . 12.2 tp -88.17 154.18 20.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.369 0.604 . . . . 0.0 110.549 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 112' ' ' THR . . . . . 0.878 ' HA ' ' HA ' ' E' ' 84' ' ' ASN . 0.4 OUTLIER -96.36 142.75 28.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.09 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 113' ' ' LEU . . . . . 0.598 ' HG ' HG12 ' E' ' 103' ' ' ILE . 0.8 OUTLIER -80.82 63.64 5.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.745 0.307 . . . . 0.0 110.716 179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 114' ' ' ASP . . . . . 0.594 ' OD1' HG21 ' E' ' 83' ' ' THR . 0.1 OUTLIER -90.62 -30.65 17.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.541 -179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.76 -43.58 1.64 Allowed Glycine 0 CA--C 1.517 0.199 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.627 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.56 24.38 13.04 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 121.011 0.434 . . . . 0.0 111.626 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 117' ' ' THR . . . . . 0.684 ' O ' HD21 ' E' ' 111' ' ' LEU . 0.2 OUTLIER -82.11 68.41 8.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.115 -179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . 0.538 ' CD1' ' HB2' ' E' ' 157' ' ' GLN . 41.0 m-85 -82.25 71.92 9.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.769 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.62 80.95 1.85 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.848 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.61 131.7 13.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.611 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 121' ' ' GLU . . . . . 0.432 ' O ' ' HE2' ' E' ' 68' ' ' LYS . 1.5 mm-40 -100.72 52.12 0.87 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.215 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . 0.654 ' HB ' ' HB3' ' E' ' 69' ' ' ALA . 0.2 OUTLIER -72.07 131.93 43.53 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.713 -179.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.75 107.69 15.56 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.675 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . 0.933 HD13 ' HB2' ' E' ' 69' ' ' ALA . 1.0 OUTLIER -88.31 126.53 35.23 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.537 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 125' ' ' ASN . . . . . 0.512 ' O ' ' HB3' ' E' ' 61' ' ' CYS . 1.1 m120 -120.58 -178.92 3.83 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.552 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . 0.524 ' OD1' ' HA ' ' E' ' 62' ' ' ASP . 3.7 t30 -83.29 120.66 26.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.735 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . 0.726 ' HA2' HG21 ' A' ' 4' ' ' THR . . . 136.16 -121.77 2.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.697 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 128' ' ' THR . . . . . 0.717 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 76.7 m -122.19 103.38 8.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.705 0.288 . . . . 0.0 110.764 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 129' ' ' ASN . . . . . 0.532 ' HB2' ' SG ' ' E' ' 61' ' ' CYS . 1.7 t30 -86.06 157.33 20.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.902 0.382 . . . . 0.0 111.127 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 130' ' ' THR . . . . . 0.576 HG23 ' HA ' ' E' ' 57' ' ' GLN . 0.3 OUTLIER -143.4 130.2 20.4 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.029 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 131' ' ' ILE . . . . . 0.636 ' HB ' HG22 ' E' ' 56' ' ' ILE . 57.4 mt -84.06 104.15 3.85 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 132' ' ' PRO . . . . . 0.679 ' HB3' ' HA ' ' B' ' 76' ' ' THR . 7.5 Cg_endo -82.05 112.41 2.3 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 121.609 1.539 . . . . 0.0 112.574 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 133' ' ' PHE . . . . . 0.425 ' HB3' ' CZ ' ' E' ' 54' ' ' PHE . 1.0 OUTLIER -126.64 158.26 36.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.88 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -126.02 156.08 40.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.095 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . 0.532 ' O ' HG22 ' E' ' 52' ' ' VAL . . . -148.23 105.08 3.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 0.0 111.613 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.04 163.47 12.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.415 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 137' ' ' TYR . . . . . 0.57 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 0.3 OUTLIER -81.79 119.75 24.28 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.064 179.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 138' ' ' PHE . . . . . 0.461 ' HB3' HG11 ' E' ' 85' ' ' VAL . 2.1 t80 -108.86 142.63 39.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.067 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 139' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' E' ' 47' ' ' ALA . . . -132.9 136.05 45.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.849 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 140' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' E' ' 45' ' ' GLU . 25.5 p -96.63 -56.16 2.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.534 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . 0.495 ' H ' ' HB3' ' E' ' 98' ' ' ASN . . . -127.14 -129.88 3.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.976 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.97 107.13 12.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.631 0.215 . . . . 0.0 110.782 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 143' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' E' ' 97' ' ' THR . . . -65.88 148.08 52.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.68 0.276 . . . . 0.0 111.447 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 144' ' ' THR . . . . . 0.623 ' HB ' ' H ' ' E' ' 97' ' ' THR . 48.0 m -114.85 144.74 32.55 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.275 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 145' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.0 131.0 6.76 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.499 2.133 . . . . 0.0 111.978 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 146' ' ' GLY . . . . . 0.603 ' O ' ' HG3' ' D' ' 15' ' ' GLU . . . 164.85 -116.25 0.69 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.435 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 147' ' ' ALA . . . . . 0.64 ' HA ' ' HG3' ' D' ' 15' ' ' GLU . . . -110.65 150.38 29.09 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.862 0.363 . . . . 0.0 111.304 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.63 45.92 1.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.449 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 149' ' ' ASN . . . . . 0.605 HD22 ' HG2' ' D' ' 13' ' ' LYS . 0.2 OUTLIER -96.97 141.0 30.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.54 -179.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 150' ' ' ALA . . . . . 0.404 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -153.67 162.59 41.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.006 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.95 135.43 43.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.271 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 152' ' ' ALA . . . . . 0.75 ' HB2' HD11 ' E' ' 86' ' ' LEU . . . -134.17 152.54 51.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.228 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 153' ' ' THR . . . . . 0.535 HG23 HG23 ' D' ' 9' ' ' THR . 4.0 m -104.19 148.92 25.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.21 141.88 35.12 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.088 0.47 . . . . 0.0 110.11 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -122.59 152.39 40.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.863 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 156' ' ' VAL . . . . . 0.657 HG23 HG23 ' D' ' 5' ' ' VAL . 20.2 m -135.75 133.17 51.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.789 0.328 . . . . 0.0 111.674 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 157' ' ' GLN . . . . . 0.74 ' HG3' HG23 ' D' ' 4' ' ' THR . 1.8 tt0 -130.92 119.82 22.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.318 0.58 . . . . 0.0 110.383 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -101.99 113.31 26.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.491 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 159' ' ' GLN . . . . . 0.624 ' HA ' ' H ' ' D' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.849 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.266 0.079 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.05 55.85 4.24 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.69 0.281 . . . . 0.0 111.075 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 89.7 m -118.7 111.11 18.09 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.445 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.79 127.26 43.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.588 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.48 171.5 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.551 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -94.42 122.08 36.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.62 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.95 -52.27 6.46 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.834 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.46 -145.52 5.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.992 -0.623 . . . . 0.0 111.888 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.72 139.8 25.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.851 0.358 . . . . 0.0 111.296 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 45.5 t -122.37 121.6 64.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.149 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -99.72 106.56 18.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.392 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -90.52 107.69 19.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.842 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.28 149.15 25.0 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.457 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.47 -179.05 47.54 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.947 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.88 157.02 30.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.929 0.395 . . . . 0.0 110.368 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 16' ' ' VAL . . . . . 0.457 ' O ' HG11 ' E' ' 5' ' ' VAL . 18.0 t -113.73 132.19 63.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.225 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 17' ' ' VAL . . . . . 0.602 HG12 HG21 ' E' ' 5' ' ' VAL . 5.5 m -136.88 176.58 7.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.883 0.373 . . . . 0.0 110.991 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 18' ' ' ASN . . . . . 0.524 ' HB2' HG21 ' E' ' 3' ' ' THR . 0.4 OUTLIER -74.45 174.13 9.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.036 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 19' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' F' ' 62' ' ' ASP . . . -83.43 35.37 0.5 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.036 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' F' ' 61' ' ' CYS . . . -116.95 -15.9 10.58 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.422 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.98 155.29 0.6 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.961 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.76 126.38 5.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.078 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 23' ' ' VAL . . . . . 0.741 ' HA ' ' HG ' ' F' ' 58' ' ' LEU . 0.7 OUTLIER -60.77 162.46 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.087 179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 24' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' F' ' 27' ' ' SER . 18.6 t70 -97.61 161.02 13.97 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.615 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . 0.687 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -64.1 -40.39 96.1 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.348 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.37 12.74 69.09 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.927 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 27' ' ' SER . . . . . 0.558 ' HB3' ' HB3' ' F' ' 24' ' ' ASP . 0.6 OUTLIER -113.88 -25.46 8.6 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.825 0.345 . . . . 0.0 110.813 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 9.6 t -41.16 -61.95 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.37 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.59 119.9 39.49 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.061 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 30' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -126.02 119.07 26.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.057 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.7 103.3 15.46 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.118 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -101.89 115.13 43.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.147 0.499 . . . . 0.0 110.463 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.51 112.62 24.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.7 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.86 -30.37 58.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.646 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.03 -170.22 27.41 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.625 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 36' ' ' GLN . . . . . 0.662 ' HG3' ' HB3' ' E' ' 15' ' ' GLU . 0.4 OUTLIER -93.54 141.74 28.12 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.628 0.251 . . . . 0.0 110.909 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.544 HG11 HD22 ' F' ' 42' ' ' LEU . 5.7 p -125.29 157.1 34.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.97 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -84.49 122.44 28.99 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.732 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 39' ' ' THR . . . . . 0.436 HG22 ' H ' ' F' ' 39' ' ' THR . 0.0 OUTLIER -59.56 -40.36 87.06 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.784 179.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.81 68.47 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.053 0.454 . . . . 0.0 110.866 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.14 -21.5 33.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.125 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . 0.544 HD22 HG11 ' F' ' 37' ' ' VAL . 3.2 mp -110.52 29.47 7.68 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.59 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 43' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' F' ' 141' ' ' GLY . . . -108.24 25.52 11.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.322 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -119.74 159.96 23.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.386 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' F' ' 140' ' ' THR . 11.0 tt0 -82.86 108.69 16.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 0.0 111.155 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.9 10.86 51.59 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.157 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 47' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' F' ' 139' ' ' ALA . . . -66.67 123.42 20.03 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 77.5 p -120.59 140.29 51.73 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.922 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 49' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 4.6 m -101.63 -167.0 1.36 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.602 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 50' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' C' ' 92' ' ' ALA . 8.1 t -69.77 139.73 53.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.859 0.361 . . . . 0.0 110.751 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.78 134.03 35.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.362 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 52' ' ' VAL . . . . . 0.541 HG22 ' O ' ' F' ' 135' ' ' ALA . 18.7 m -87.06 166.5 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.972 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.78 128.92 8.01 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.585 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 54' ' ' PHE . . . . . 0.564 ' H ' HG21 ' C' ' 76' ' ' THR . 40.8 p90 -160.28 134.42 7.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.775 0.322 . . . . 0.0 110.928 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 55' ' ' ASN . . . . . 0.512 ' OD1' HG21 ' F' ' 130' ' ' THR . 15.8 p30 -132.73 147.69 52.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.621 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 56' ' ' ILE . . . . . 0.631 HG22 ' HB ' ' F' ' 131' ' ' ILE . 1.0 OUTLIER -96.8 116.79 39.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.539 -179.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 57' ' ' GLN . . . . . 0.565 ' HA ' HG23 ' F' ' 130' ' ' THR . 0.0 OUTLIER -66.61 122.12 16.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.703 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . 0.741 ' HG ' ' HA ' ' F' ' 23' ' ' VAL . 0.2 OUTLIER -137.51 88.12 2.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.161 -179.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 59' ' ' ASN . . . . . 0.713 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 10.6 p30 -79.49 179.32 7.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.935 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 62.29 64.46 0.96 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.818 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 61' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' F' ' 129' ' ' ASN . 4.4 m -110.55 163.25 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.821 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' F' ' 19' ' ' ALA . 0.5 OUTLIER -140.19 155.01 47.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.235 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.23 -25.44 10.61 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -81.89 -16.42 50.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.126 0.489 . . . . 0.0 111.734 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . 0.403 HG23 ' OD2' ' F' ' 62' ' ' ASP . 16.8 t -90.68 -48.46 14.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.627 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.13 142.97 35.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.569 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.85 -53.81 2.6 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.882 0.372 . . . . 0.0 110.978 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 68' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' F' ' 121' ' ' GLU . 0.1 OUTLIER -94.85 158.09 15.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.492 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 69' ' ' ALA . . . . . 0.918 ' HB2' HD13 ' F' ' 124' ' ' LEU . . . -137.17 120.47 16.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.592 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 70' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -97.57 129.07 44.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.153 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 71' ' ' VAL . . . . . 0.605 HG11 HG21 ' F' ' 131' ' ' ILE . 15.9 t -112.92 152.24 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.708 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 72' ' ' ALA . . . . . . . . . . . . . . . -150.02 146.62 27.1 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.56 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 73' ' ' PHE . . . . . 0.474 ' CD2' HG21 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -111.5 141.88 44.5 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.557 0.218 . . . . 0.0 111.078 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 74' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' F' ' 152' ' ' ALA . 0.8 OUTLIER -105.7 103.32 12.8 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.934 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.87 -179.08 25.4 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.83 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.2 157.83 17.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.501 0.191 . . . . 0.0 110.766 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.91 132.77 38.06 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.929 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 78' ' ' ILE . . . . . 0.445 ' CG2' ' HB ' ' F' ' 85' ' ' VAL . 0.6 OUTLIER -66.6 -39.83 84.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 179.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 79' ' ' ASP . . . . . 0.418 ' N ' HG23 ' F' ' 78' ' ' ILE . 0.7 OUTLIER -146.15 53.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.845 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 61.38 -87.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.048 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -53.34 -36.52 53.24 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.603 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 82' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -81.3 59.87 4.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.357 . . . . 0.0 110.484 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 83' ' ' THR . . . . . 0.594 HG21 ' OD1' ' F' ' 114' ' ' ASP . 2.1 m -70.58 -20.38 62.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.537 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 84' ' ' ASN . . . . . 0.897 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 26.5 p-10 -69.47 -13.67 62.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.284 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 85' ' ' VAL . . . . . 0.695 HG22 ' HB2' ' F' ' 102' ' ' GLN . 40.8 t -109.01 131.16 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.152 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 86' ' ' LEU . . . . . 0.78 HD11 ' HB2' ' F' ' 152' ' ' ALA . 0.6 OUTLIER -70.09 142.85 52.58 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -83.03 -170.51 3.06 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.873 0.368 . . . . 0.0 111.666 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -79.98 161.39 25.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.963 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.75 -80.24 0.01 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.386 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 6.4 p -171.39 0.44 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.943 0.402 . . . . 0.0 111.391 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 91' ' ' SER . . . . . 0.608 ' HB2' ' HB2' ' F' ' 95' ' ' SER . 73.6 m -76.81 85.58 3.4 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.839 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.28 71.78 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.888 0.375 . . . . 0.0 111.67 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -120.89 30.49 6.85 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.61 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.76 -3.13 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.934 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 95' ' ' SER . . . . . 0.608 ' HB2' ' HB2' ' F' ' 91' ' ' SER . 0.1 OUTLIER -107.51 -176.67 3.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.87 0.366 . . . . 0.0 110.679 179.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -89.6 172.66 8.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.81 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . 0.608 ' H ' ' HB ' ' F' ' 144' ' ' THR . 1.6 m -126.95 140.37 52.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.331 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 98' ' ' ASN . . . . . 0.502 ' HB3' ' H ' ' F' ' 141' ' ' GLY . 68.3 m-80 62.0 21.31 12.25 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.454 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 99' ' ' VAL . . . . . 0.555 HG23 ' O ' ' F' ' 97' ' ' THR . 2.7 t -120.38 135.97 58.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.714 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.94 -160.67 10.14 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.552 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 101' ' ' VAL . . . . . . . . . . . . . 4.5 p -145.93 109.86 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.171 0.51 . . . . 0.0 111.729 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 102' ' ' GLN . . . . . 0.695 ' HB2' HG22 ' F' ' 85' ' ' VAL . 0.5 OUTLIER -84.29 147.35 27.26 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.885 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 103' ' ' ILE . . . . . 0.599 HG12 ' HG ' ' F' ' 113' ' ' LEU . 1.2 pp -110.74 127.87 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.489 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 104' ' ' LEU . . . . . 0.977 HD12 ' HB2' ' F' ' 110' ' ' ALA . 1.4 tp -97.46 133.0 42.63 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.711 0.291 . . . . 0.0 111.017 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . 0.651 ' HB3' HG22 ' F' ' 107' ' ' THR . 4.0 t0 -80.81 143.57 32.73 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.706 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 106' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' C' ' 80' ' ' ALA . 0.0 OUTLIER -65.48 -17.48 64.59 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.802 0.334 . . . . 0.0 111.023 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . 0.651 HG22 ' HB3' ' F' ' 105' ' ' ASP . 13.2 t -66.79 -20.73 66.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.973 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 139.07 -71.81 0.44 Allowed Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.669 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.39 160.01 31.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.826 0.346 . . . . 0.0 111.098 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . 0.977 ' HB2' HD12 ' F' ' 104' ' ' LEU . . . -75.59 131.38 39.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.155 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . 0.689 HD21 ' O ' ' F' ' 117' ' ' THR . 12.2 tp -88.06 154.17 20.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.359 0.6 . . . . 0.0 110.572 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 112' ' ' THR . . . . . 0.897 ' HA ' ' HA ' ' F' ' 84' ' ' ASN . 0.4 OUTLIER -96.41 142.69 28.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.062 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 113' ' ' LEU . . . . . 0.599 ' HG ' HG12 ' F' ' 103' ' ' ILE . 0.8 OUTLIER -80.76 63.61 5.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.723 0.297 . . . . 0.0 110.77 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 114' ' ' ASP . . . . . 0.594 ' OD1' HG21 ' F' ' 83' ' ' THR . 0.1 OUTLIER -90.58 -30.6 17.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.611 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.73 -43.59 1.64 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.686 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -110.61 24.43 12.97 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.988 0.423 . . . . 0.0 111.608 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 117' ' ' THR . . . . . 0.689 ' O ' HD21 ' F' ' 111' ' ' LEU . 0.2 OUTLIER -82.12 68.25 8.45 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.16 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . 0.554 ' CD1' ' HB2' ' F' ' 157' ' ' GLN . 40.9 m-85 -82.07 71.93 9.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.759 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 4.6 m -123.74 81.02 1.86 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.833 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 1.2 m -151.66 131.74 13.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.557 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 121' ' ' GLU . . . . . 0.435 ' O ' ' HE2' ' F' ' 68' ' ' LYS . 1.5 mm-40 -100.7 52.1 0.87 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.197 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . 0.661 ' HB ' ' HB3' ' F' ' 69' ' ' ALA . 0.2 OUTLIER -72.14 131.98 43.54 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.78 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.63 107.54 15.35 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.771 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . 0.918 HD13 ' HB2' ' F' ' 69' ' ' ALA . 1.0 OUTLIER -88.23 126.58 35.23 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.59 179.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 125' ' ' ASN . . . . . 0.507 ' O ' ' HB3' ' F' ' 61' ' ' CYS . 1.1 m120 -120.65 -178.99 3.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.542 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . 0.512 ' OD1' ' HA ' ' F' ' 62' ' ' ASP . 3.8 t30 -83.25 120.68 26.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.695 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . 0.74 ' HA2' HG21 ' B' ' 4' ' ' THR . . . 136.12 -121.77 2.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.657 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 128' ' ' THR . . . . . 0.713 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 76.3 m -122.12 103.44 8.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.727 0.299 . . . . 0.0 110.807 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 129' ' ' ASN . . . . . 0.528 ' HB2' ' SG ' ' F' ' 61' ' ' CYS . 1.8 t30 -86.18 157.26 20.03 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.857 0.36 . . . . 0.0 111.086 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 130' ' ' THR . . . . . 0.565 HG23 ' HA ' ' F' ' 57' ' ' GLN . 0.3 OUTLIER -143.34 130.14 20.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.162 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 131' ' ' ILE . . . . . 0.631 ' HB ' HG22 ' F' ' 56' ' ' ILE . 57.3 mt -83.97 104.14 3.79 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 132' ' ' PRO . . . . . 0.685 ' HB3' ' HA ' ' C' ' 76' ' ' THR . 7.5 Cg_endo -82.08 112.45 2.3 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.535 1.49 . . . . 0.0 112.548 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 133' ' ' PHE . . . . . 0.429 ' HB3' ' CZ ' ' F' ' 54' ' ' PHE . 1.0 OUTLIER -126.69 158.27 36.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.856 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -125.97 156.01 40.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.119 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . 0.541 ' O ' HG22 ' F' ' 52' ' ' VAL . . . -148.14 105.15 3.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 0.0 111.609 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -99.11 163.46 12.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.375 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 137' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 0.3 OUTLIER -81.72 119.69 24.17 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.131 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 138' ' ' PHE . . . . . 0.467 ' HB3' HG11 ' F' ' 85' ' ' VAL . 2.1 t80 -108.82 142.69 39.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.275 0.56 . . . . 0.0 112.058 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 139' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' F' ' 47' ' ' ALA . . . -132.94 136.05 45.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.831 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 140' ' ' THR . . . . . 0.648 ' O ' ' HA ' ' F' ' 45' ' ' GLU . 24.9 p -96.65 -56.26 2.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.423 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . 0.502 ' H ' ' HB3' ' F' ' 98' ' ' ASN . . . -127.04 -129.91 3.31 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.973 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -79.94 107.15 12.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.521 0.201 . . . . 0.0 110.741 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 143' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' F' ' 97' ' ' THR . . . -65.89 148.07 52.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.686 0.279 . . . . 0.0 111.44 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 144' ' ' THR . . . . . 0.608 ' HB ' ' H ' ' F' ' 97' ' ' THR . 48.0 m -114.88 144.72 32.52 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.262 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 145' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' F' ' 144' ' ' THR . 1.4 Cg_endo -81.96 130.96 6.78 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.549 2.166 . . . . 0.0 111.953 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 146' ' ' GLY . . . . . 0.624 ' O ' ' HG3' ' E' ' 15' ' ' GLU . . . 164.82 -116.27 0.69 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.452 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 147' ' ' ALA . . . . . 0.634 ' HA ' ' HG3' ' E' ' 15' ' ' GLU . . . -110.65 150.4 29.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.866 0.365 . . . . 0.0 111.28 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 148' ' ' ALA . . . . . . . . . . . . . . . -142.65 45.82 1.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.128 0.49 . . . . 0.0 110.513 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 149' ' ' ASN . . . . . 0.623 HD22 ' HG2' ' E' ' 13' ' ' LYS . 0.2 OUTLIER -96.85 141.02 30.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.535 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 150' ' ' ALA . . . . . 0.408 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -153.71 162.53 41.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.958 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.85 135.46 43.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.225 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 152' ' ' ALA . . . . . 0.78 ' HB2' HD11 ' F' ' 86' ' ' LEU . . . -134.16 152.51 51.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.17 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 153' ' ' THR . . . . . 0.531 HG23 HG23 ' E' ' 9' ' ' THR . 4.0 m -104.16 148.95 25.7 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.29 141.87 35.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.047 0.451 . . . . 0.0 110.155 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -122.57 152.41 40.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.89 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 156' ' ' VAL . . . . . 0.638 HG23 HG23 ' E' ' 5' ' ' VAL . 20.1 m -135.72 133.13 51.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.79 0.329 . . . . 0.0 111.683 -179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 157' ' ' GLN . . . . . 0.726 ' HG3' HG23 ' E' ' 4' ' ' THR . 1.8 tt0 -130.95 119.86 22.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.339 0.59 . . . . 0.0 110.342 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -102.0 113.28 26.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.523 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 159' ' ' GLN . . . . . 0.622 ' HA ' ' H ' ' E' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.85 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 120.245 0.069 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.93 68.38 0.87 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.569 0.223 . . . . 0.0 111.021 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.38 87.58 6.08 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.475 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.619 ' HB ' ' HA3' ' E' ' 127' ' ' GLY . 3.5 m -90.46 115.43 27.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.602 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 m -127.21 166.97 22.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.604 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.633 ' HA ' ' HE2' ' B' ' 155' ' ' LYS . 19.9 t30 -83.06 115.15 21.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.517 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.33 -71.5 1.06 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.884 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.24 172.78 34.74 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.907 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 m -95.47 136.96 35.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.409 . . . . 0.0 111.305 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -120.84 130.68 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.218 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.53 ' O ' ' HB ' ' B' ' 32' ' ' VAL . 1.3 m80 -103.78 158.0 16.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.459 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 0.6 OUTLIER -145.81 89.57 1.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.84 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.633 ' HD3' HG22 ' B' ' 31' ' ' THR . 0.0 OUTLIER -79.97 135.19 36.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.41 179.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.57 178.39 42.07 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.958 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.634 ' HG2' ' HA ' ' B' ' 147' ' ' ALA . 2.6 mt-10 -156.8 -177.93 6.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.368 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.52 HG22 HG23 ' B' ' 37' ' ' VAL . 2.7 t -142.24 150.13 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.233 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.591 HG11 ' HE2' ' A' ' 158' ' ' TYR . 4.1 m -141.7 168.61 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.333 . . . . 0.0 111.066 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.02 74.73 4.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.058 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.88 91.86 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.027 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.46 -50.98 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.433 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER 179.82 -179.68 0.47 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.965 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.616 ' HA ' ' HB3' ' B' ' 36' ' ' GLN . . . -136.2 116.43 13.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.085 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.422 ' H ' ' CB ' ' B' ' 36' ' ' GLN . 69.2 t -67.08 120.15 13.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.026 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.441 ' O ' HG23 ' A' ' 28' ' ' VAL . 2.4 m-20 -64.39 150.49 46.25 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.585 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' B' ' 33' ' ' GLN . . . -48.37 -50.22 31.54 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.326 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.27 -31.8 81.71 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.895 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.406 ' HA ' HE21 ' A' ' 30' ' ' GLN . 0.4 OUTLIER -69.04 -16.02 63.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.929 0.395 . . . . 0.0 110.847 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 24' ' ' ASP . 48.5 t -72.96 -43.59 58.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.41 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.39 106.04 10.32 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.406 HE21 ' HA ' ' A' ' 27' ' ' SER . 17.0 mt-30 -116.65 134.03 55.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.074 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.49 96.04 6.23 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.058 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.445 HG11 HG21 ' A' ' 52' ' ' VAL . 69.3 t -89.46 131.25 37.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.131 0.491 . . . . 0.0 110.488 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -108.95 106.41 16.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.618 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.482 HD12 ' CE2' ' A' ' 137' ' ' TYR . 0.4 OUTLIER -73.8 -40.87 63.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.649 179.372 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.95 -122.46 6.75 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.595 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -144.52 153.95 42.38 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.699 0.285 . . . . 0.0 110.862 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.57 146.35 34.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.86 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.23 145.97 26.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.717 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.7 p -57.8 -23.02 50.47 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.719 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.93 -33.21 61.94 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.096 0.474 . . . . 0.0 110.844 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -31.15 69.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.124 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.621 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . 0.0 OUTLIER -130.76 86.42 2.37 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.649 179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.7 36.2 4.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.37 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.64 150.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.337 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 140' ' ' THR . 1.7 tm-20 -64.78 134.83 54.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 111.136 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.79 -14.16 53.14 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.137 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 138' ' ' PHE . . . -57.2 129.86 43.64 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.938 0.399 . . . . 0.0 112.002 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.462 ' HB ' ' CE1' ' A' ' 138' ' ' PHE . 14.3 t -130.59 143.31 50.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.909 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.604 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 68.4 m -111.97 -157.16 0.61 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.552 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.9 t -74.62 150.15 39.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.784 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 136' ' ' ARG . . . -103.2 146.64 28.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.322 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.445 HG21 HG11 ' A' ' 32' ' ' VAL . 22.4 m -83.38 148.34 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.915 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.4 121.21 6.21 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.6 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.41 ' CD1' HG23 ' A' ' 52' ' ' VAL . 16.2 p90 -153.83 125.56 7.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.805 0.336 . . . . 0.0 110.928 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.28 156.17 20.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.609 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.6 mm -104.08 135.37 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.486 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.64 125.99 48.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.765 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 129' ' ' ASN . 4.3 mp -131.7 100.0 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.273 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.49 174.81 11.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.946 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.8 65.19 1.58 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.792 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 60.7 m -98.66 142.94 29.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.88 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.59 109.25 15.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.269 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.464 HG23 ' HB3' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -92.44 29.54 1.69 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.03 -59.1 2.28 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.029 0.443 . . . . 0.0 111.819 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.28 -39.8 13.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.706 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.69 101.39 10.7 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.593 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.6 p -90.54 -28.82 18.25 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.902 0.382 . . . . 0.0 110.95 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.448 ' HZ1' ' HB2' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -126.4 166.99 16.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.513 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.9 149.77 29.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.572 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 157' ' ' GLN . . . -112.85 159.79 18.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.092 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.2 t -108.04 123.25 63.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.689 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 155' ' ' LYS . . . -124.64 168.95 12.44 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.596 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.531 ' CB ' HD11 ' A' ' 111' ' ' LEU . 17.1 t80 -150.59 144.39 25.24 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.535 0.207 . . . . 0.0 111.168 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.652 HD12 ' OG1' ' D' ' 130' ' ' THR . 0.4 OUTLIER -121.56 88.64 2.97 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.989 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.514 ' C ' HD23 ' A' ' 113' ' ' LEU . . . -134.69 164.72 24.65 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.773 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.673 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.6 OUTLIER -78.54 147.73 33.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.544 0.211 . . . . 0.0 110.779 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.564 ' H ' ' HB3' ' D' ' 132' ' ' PRO . . . -95.7 140.34 30.65 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.959 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.548 ' CG2' ' HB ' ' A' ' 85' ' ' VAL . 1.1 tt -78.71 -33.05 16.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.851 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.22 179.22 7.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.838 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.68 -27.87 36.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.059 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.25 -32.22 72.21 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.552 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.427 ' HB3' HG23 ' A' ' 85' ' ' VAL . 15.4 m-70 -97.33 -72.69 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.825 0.345 . . . . 0.0 110.464 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.85 -7.24 1.78 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.586 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.754 ' HA ' HD13 ' A' ' 113' ' ' LEU . 3.0 m120 -108.7 -19.13 13.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.364 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 102' ' ' GLN . 50.2 t -80.65 132.03 32.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.124 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -76.52 134.95 39.31 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.355 179.381 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.28 165.18 6.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.828 0.347 . . . . 0.0 111.682 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.729 HD12 ' O ' ' D' ' 51' ' ' ALA . 0.1 OUTLIER -65.75 171.65 4.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.029 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.495 ' OE1' ' HB3' ' A' ' 91' ' ' SER . 8.0 pt20 -72.45 175.75 5.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.349 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.474 ' HA ' ' HB ' ' D' ' 52' ' ' VAL . 0.5 OUTLIER -76.06 -21.26 56.97 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.997 0.427 . . . . 0.0 111.492 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.495 ' HB3' ' OE1' ' A' ' 89' ' ' GLN . 32.0 t -80.92 67.56 6.87 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.45 ' HA ' ' OG ' ' A' ' 95' ' ' SER . . . -72.27 -9.74 58.87 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.901 0.381 . . . . 0.0 111.668 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.892 ' HB1' ' HB1' ' C' ' 22' ' ' ALA . . . -68.08 -22.91 64.9 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.632 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.39 6.76 2.5 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.932 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.699 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 30.7 p -93.73 150.75 20.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 110.637 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.69 167.21 18.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.834 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.65 165.15 14.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.366 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.527 ' HA ' ' OG1' ' A' ' 140' ' ' THR . 85.0 m-20 63.29 45.43 5.0 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.494 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.461 ' HB ' ' CB ' ' A' ' 143' ' ' ALA . 3.5 p -170.63 131.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.787 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.08 -175.96 21.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.556 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.3 t -104.14 91.84 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 122.971 0.509 . . . . 0.0 111.745 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -67.86 131.21 45.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 84' ' ' ASN . 0.7 OUTLIER -99.44 110.52 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.498 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 5.5 tp -91.23 149.94 21.55 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.709 0.29 . . . . 0.0 111.027 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.95 174.68 5.79 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.631 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 106' ' ' ARG . 1.5 ttt180 -72.49 -18.63 61.65 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.719 0.295 . . . . 0.0 110.989 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 47.0 p -69.25 -9.6 53.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.033 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.97 -48.44 0.95 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.625 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.94 163.54 15.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.843 0.354 . . . . 0.0 111.062 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -70.39 125.51 27.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.174 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.531 HD11 ' CB ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -65.36 147.61 53.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.367 0.603 . . . . 0.0 110.564 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.679 ' HB ' HG21 ' A' ' 117' ' ' THR . 0.2 OUTLIER -74.03 144.58 45.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.131 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.754 HD13 ' HA ' ' A' ' 84' ' ' ASN . 10.2 mp -100.28 89.94 4.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.769 0.319 . . . . 0.0 110.663 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.432 ' HB2' ' CG2' ' A' ' 117' ' ' THR . 4.1 m-20 -142.42 11.37 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.657 0.265 . . . . 0.0 111.555 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.439 ' O ' ' HB1' ' A' ' 72' ' ' ALA . . . 96.91 -78.09 0.69 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.669 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' D' ' 125' ' ' ASN . . . -104.27 61.54 0.73 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.973 0.416 . . . . 0.0 111.662 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.679 HG21 ' HB ' ' A' ' 112' ' ' THR . 17.6 p -93.35 95.84 9.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.131 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.79 110.0 5.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.9 m -120.35 -72.92 0.67 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.773 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.4 113.03 25.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.602 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.448 ' HB2' ' HZ1' ' A' ' 68' ' ' LYS . 25.2 mt-10 -99.47 97.53 8.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.207 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.5 132.71 37.52 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.775 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -60.89 146.12 47.75 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.727 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.464 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.2 OUTLIER -85.48 156.56 20.75 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.562 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.78 142.75 40.88 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.54 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.94 113.63 6.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.74 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.59 -90.08 0.32 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.744 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 6.0 m -124.88 152.77 43.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.745 0.307 . . . . 0.0 110.798 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 58' ' ' LEU . 17.1 t-20 -123.0 147.52 46.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.19 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.3 m -126.12 135.7 52.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.098 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 58.4 mt -114.03 115.65 45.47 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.4 ' HB2' ' HB2' ' A' ' 106' ' ' ARG . 7.5 Cg_endo -81.7 115.71 2.81 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.629 1.553 . . . . 0.0 112.567 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.58 150.81 46.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.825 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 1.2 mt-30 -142.48 166.67 24.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.029 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 102' ' ' GLN . . . -158.13 102.94 1.81 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.864 0.364 . . . . 0.0 111.654 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 0.2 OUTLIER -94.68 -173.4 3.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.396 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.604 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 3.8 m-85 -100.78 152.87 19.98 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.068 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.545 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -147.37 160.73 42.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.998 -179.2 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.621 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . . . -126.86 149.61 49.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.925 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -115.34 27.83 9.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.461 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.4 66.75 0.2 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.955 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.99 88.59 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.602 0.239 . . . . 0.0 110.744 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.461 ' CB ' ' HB ' ' A' ' 99' ' ' VAL . . . -60.19 156.88 14.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.709 0.29 . . . . 0.0 111.452 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.545 ' HB ' ' CD ' ' A' ' 145' ' ' PRO . 77.3 p -112.26 173.02 3.08 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.218 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.545 ' CD ' ' HB ' ' A' ' 144' ' ' THR . 1.3 Cg_endo -84.51 145.16 10.45 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.518 2.145 . . . . 0.0 111.995 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.44 -112.7 0.55 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.512 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -124.93 167.67 14.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.892 0.377 . . . . 0.0 111.275 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -157.19 57.54 0.52 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.411 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.85 132.73 36.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.539 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.47 163.13 28.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.937 179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.45 125.58 1.83 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.231 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.794 ' HB2' HD21 ' A' ' 86' ' ' LEU . . . -154.57 165.79 35.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.244 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.9 163.18 12.71 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -119.01 134.6 55.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.102 0.477 . . . . 0.0 110.102 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 0.0 OUTLIER -95.64 166.24 11.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.913 -178.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.24 112.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.793 0.33 . . . . 0.0 111.657 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.613 ' HB3' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -88.77 138.81 31.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.278 0.561 . . . . 0.0 110.403 -179.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.591 ' HE2' HG11 ' A' ' 17' ' ' VAL . 22.5 m-85 -127.65 113.16 15.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.568 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.976 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.241 0.067 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.94 68.26 0.88 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.645 0.26 . . . . 0.0 111.06 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.33 87.63 6.12 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.454 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.612 ' HB ' ' HA3' ' F' ' 127' ' ' GLY . 3.5 m -90.35 115.47 27.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.571 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -127.34 167.02 22.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.588 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.653 ' HA ' ' HE2' ' C' ' 155' ' ' LYS . 20.2 t30 -82.95 115.11 21.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.577 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.39 -71.48 1.06 Allowed Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.827 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.31 172.78 34.78 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.909 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 33.3 m -95.52 137.01 35.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.941 0.4 . . . . 0.0 111.253 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 40.4 t -120.8 130.76 74.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.173 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' HIS . . . . . 0.54 ' O ' ' HB ' ' C' ' 32' ' ' VAL . 1.3 m80 -103.92 157.97 16.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.41 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' C' ' 32' ' ' VAL . 0.5 OUTLIER -145.82 89.67 1.92 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.823 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . 0.627 ' HD3' HG22 ' C' ' 31' ' ' THR . 0.0 OUTLIER -80.04 135.21 36.3 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.431 179.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.57 178.38 42.08 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.953 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.641 ' HG2' ' HA ' ' C' ' 147' ' ' ALA . 2.6 mt-10 -156.78 -177.86 6.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.385 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.512 HG22 HG23 ' C' ' 37' ' ' VAL . 2.7 t -142.35 150.1 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.235 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.572 HG11 ' HE2' ' B' ' 158' ' ' TYR . 4.1 m -141.73 168.57 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.856 0.36 . . . . 0.0 110.996 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -92.93 74.78 4.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.039 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.78 91.87 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.045 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.42 -51.07 0.09 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.421 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER 179.83 -179.8 0.48 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.996 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.603 ' HA ' ' HB3' ' C' ' 36' ' ' GLN . . . -136.14 116.5 13.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.138 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.423 ' H ' ' CB ' ' C' ' 36' ' ' GLN . 69.1 t -67.07 120.15 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.003 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.441 ' O ' HG23 ' B' ' 28' ' ' VAL . 2.4 m-20 -64.36 150.45 46.26 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.605 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.423 ' HB1' ' HB2' ' C' ' 33' ' ' GLN . . . -48.38 -50.1 32.1 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.388 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.36 -31.79 81.55 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.841 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . 0.407 ' HA ' HE21 ' B' ' 30' ' ' GLN . 0.4 OUTLIER -69.07 -15.98 63.58 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.879 0.371 . . . . 0.0 110.831 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 24' ' ' ASP . 48.6 t -72.96 -43.68 58.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.375 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.36 106.11 10.4 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.005 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' GLN . . . . . 0.407 HE21 ' HA ' ' B' ' 27' ' ' SER . 17.0 mt-30 -116.68 134.03 55.31 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . 0.633 HG22 ' HD3' ' A' ' 13' ' ' LYS . 0.9 OUTLIER -105.49 96.09 6.27 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.057 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.53 ' HB ' ' O ' ' A' ' 11' ' ' HIS . 69.3 t -89.53 131.27 37.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.15 0.5 . . . . 0.0 110.456 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.451 ' HA ' ' HG2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -108.97 106.48 16.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.637 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.493 HD12 ' CE2' ' B' ' 137' ' ' TYR . 0.4 OUTLIER -73.79 -40.89 63.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.66 179.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.89 -122.41 6.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.601 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.616 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . 16.3 tt0 -144.6 153.85 42.23 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.586 0.231 . . . . 0.0 110.939 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.52 HG23 HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -128.5 146.32 34.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.909 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.529 ' HE ' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -98.25 146.0 26.07 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.7 179.267 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.563 HG23 ' O ' ' A' ' 17' ' ' VAL . 40.9 p -57.78 -22.99 50.12 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.713 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.01 -33.22 61.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.013 0.435 . . . . 0.0 110.809 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.04 -31.1 69.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.174 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.617 ' HB3' ' HB2' ' B' ' 139' ' ' ALA . 0.0 OUTLIER -130.83 86.34 2.36 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.604 179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.64 36.19 4.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.357 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 177.56 150.85 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.392 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' B' ' 140' ' ' THR . 1.7 tm-20 -64.79 134.81 54.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.884 0.373 . . . . 0.0 111.103 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.79 -14.19 53.12 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.218 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' B' ' 138' ' ' PHE . . . -57.19 129.8 43.36 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . 0.455 ' HB ' ' CE1' ' B' ' 138' ' ' PHE . 14.3 t -130.55 143.34 50.69 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.864 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . 0.594 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 68.6 m -111.95 -157.2 0.61 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.579 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.416 ' H ' ' HB3' ' B' ' 49' ' ' SER . 27.5 t -74.46 150.13 40.05 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.863 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.481 ' HB2' ' HB3' ' B' ' 136' ' ' ARG . . . -103.28 146.61 28.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.328 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' B' ' 134' ' ' GLN . 22.0 m -83.31 148.31 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.981 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.35 121.21 6.22 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.638 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . 0.404 ' CD1' HG23 ' B' ' 52' ' ' VAL . 15.9 p90 -153.81 125.52 7.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.737 0.303 . . . . 0.0 110.955 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.23 156.22 20.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.626 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 22.5 mm -104.04 135.35 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.51 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.75 126.05 48.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.771 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.547 ' HB2' ' HB3' ' B' ' 129' ' ' ASN . 4.3 mp -131.62 99.91 4.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.275 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.43 174.79 11.13 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.71 65.24 1.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.809 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' B' ' 21' ' ' CYS . 60.6 m -98.64 142.86 29.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.822 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.58 109.22 15.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.329 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.473 HG23 ' HB3' ' B' ' 124' ' ' LEU . 0.2 OUTLIER -92.37 29.53 1.67 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.143 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . 0.425 HD22 ' HA ' ' B' ' 64' ' ' ASN . 0.1 OUTLIER -90.0 -59.16 2.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.039 0.447 . . . . 0.0 111.726 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.29 -39.82 13.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.71 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.58 101.3 10.64 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.614 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.1 p -90.58 -28.74 18.27 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.872 0.367 . . . . 0.0 110.971 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.49 166.94 16.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.523 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.82 149.8 29.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.646 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' B' ' 157' ' ' GLN . . . -112.88 159.77 18.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.097 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 51.1 t -108.06 123.25 63.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.693 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.685 ' HB3' ' HB3' ' B' ' 155' ' ' LYS . . . -124.6 168.96 12.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.563 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.534 ' CB ' HD11 ' B' ' 111' ' ' LEU . 17.2 t80 -150.59 144.37 25.23 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.533 0.206 . . . . 0.0 111.205 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.632 HD12 ' OG1' ' E' ' 130' ' ' THR . 0.4 OUTLIER -121.42 88.57 2.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.033 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . 0.514 ' C ' HD23 ' B' ' 113' ' ' LEU . . . -134.75 164.7 24.67 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.813 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.659 ' O ' ' HA ' ' B' ' 86' ' ' LEU . 0.6 OUTLIER -78.51 147.76 33.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.531 0.205 . . . . 0.0 110.775 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.564 ' H ' ' HB3' ' E' ' 132' ' ' PRO . . . -95.79 140.32 30.74 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.887 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.555 ' CG2' ' HB ' ' B' ' 85' ' ' VAL . 1.2 tt -78.7 -33.09 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.873 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.16 179.21 7.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.848 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.66 -27.84 37.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.061 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.26 -32.21 72.17 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.603 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.417 ' HB3' HG23 ' B' ' 85' ' ' VAL . 15.4 m-70 -97.38 -72.63 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 0.0 110.475 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.77 -7.13 1.79 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.599 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . 0.764 ' HA ' HD13 ' B' ' 113' ' ' LEU . 3.1 m120 -108.8 -19.1 13.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.329 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' B' ' 102' ' ' GLN . 49.8 t -80.53 132.06 32.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.183 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.79 HD21 ' HB2' ' B' ' 152' ' ' ALA . 0.4 OUTLIER -76.61 134.91 39.2 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.99 -0.284 . . . . 0.0 110.283 179.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.21 165.16 6.09 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.939 0.399 . . . . 0.0 111.678 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . 0.723 HD12 ' O ' ' E' ' 51' ' ' ALA . 0.1 OUTLIER -65.72 171.7 4.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.025 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . 0.491 ' OE1' ' HB3' ' B' ' 91' ' ' SER . 8.0 pt20 -72.54 175.76 6.02 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.349 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' E' ' 52' ' ' VAL . 0.5 OUTLIER -76.04 -21.24 57.02 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.984 0.421 . . . . 0.0 111.492 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . 0.491 ' HB3' ' OE1' ' B' ' 89' ' ' GLN . 32.1 t -80.94 67.53 6.88 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.446 ' HA ' ' OG ' ' B' ' 95' ' ' SER . . . -72.29 -9.66 58.77 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.637 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . 0.88 ' HB1' ' HB1' ' D' ' 22' ' ' ALA . . . -68.05 -22.9 64.93 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.653 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.46 6.73 2.48 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.917 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' SER . . . . . 0.705 ' HA ' ' HB3' ' B' ' 147' ' ' ALA . 30.5 p -93.69 150.79 20.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.851 0.358 . . . . 0.0 110.632 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.79 167.19 18.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.827 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 165.18 14.26 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.366 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . 0.512 ' HA ' ' OG1' ' B' ' 140' ' ' THR . 85.0 m-20 63.17 45.54 5.08 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.465 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . 0.456 ' HB ' ' CB ' ' B' ' 143' ' ' ALA . 3.5 p -170.63 131.47 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.76 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.11 -176.02 21.27 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.529 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 75.8 t -104.06 91.85 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 122.946 0.498 . . . . 0.0 111.79 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' B' ' 85' ' ' VAL . 0.0 OUTLIER -67.83 131.18 45.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.919 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.518 HD12 ' O ' ' B' ' 84' ' ' ASN . 0.7 OUTLIER -99.4 110.53 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.526 179.533 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 5.5 tp -91.22 149.99 21.54 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.628 0.251 . . . . 0.0 111.053 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.95 174.62 5.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.652 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' B' ' 106' ' ' ARG . 1.5 ttt180 -72.44 -18.54 61.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.796 0.331 . . . . 0.0 111.079 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . . . . . . . . . 46.0 p -69.36 -9.57 54.01 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.005 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.02 -48.43 0.95 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.671 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.91 163.57 15.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 0.0 111.154 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -70.45 125.52 27.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.534 HD11 ' CB ' ' B' ' 73' ' ' PHE . 0.0 OUTLIER -65.35 147.59 53.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.321 0.581 . . . . 0.0 110.607 179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.678 ' HB ' HG21 ' B' ' 117' ' ' THR . 0.2 OUTLIER -73.99 144.56 45.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.136 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.764 HD13 ' HA ' ' B' ' 84' ' ' ASN . 10.2 mp -100.29 89.82 4.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.762 0.315 . . . . 0.0 110.682 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . 0.441 ' HB2' ' CG2' ' B' ' 117' ' ' THR . 4.1 m-20 -142.36 11.47 1.92 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.668 0.27 . . . . 0.0 111.621 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . 0.449 ' O ' ' HB1' ' B' ' 72' ' ' ALA . . . 96.92 -78.14 0.69 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.576 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' E' ' 125' ' ' ASN . . . -104.26 61.56 0.73 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.976 0.417 . . . . 0.0 111.629 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.678 HG21 ' HB ' ' B' ' 112' ' ' THR . 17.7 p -93.38 95.82 9.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.123 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.77 109.97 5.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.781 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.32 -72.89 0.67 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.52 113.07 25.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.583 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.43 97.54 8.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.204 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.47 132.68 37.51 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.761 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 22.2 m -60.92 146.19 47.63 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.74 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.473 ' HB3' HG23 ' B' ' 63' ' ' THR . 0.2 OUTLIER -85.48 156.5 20.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.595 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.77 142.8 40.9 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.515 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.01 113.61 6.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.732 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.59 -90.03 0.32 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.73 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 6.1 m -124.88 152.82 43.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.677 0.275 . . . . 0.0 110.815 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . 0.547 ' HB3' ' HB2' ' B' ' 58' ' ' LEU . 17.0 t-20 -123.04 147.6 46.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.963 0.411 . . . . 0.0 111.096 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.3 m -126.19 135.61 51.84 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.085 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' ILE . . . . . . . . . . . . . 58.6 mt -113.95 115.72 45.6 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' PRO . . . . . 0.401 ' HB2' ' HB2' ' B' ' 106' ' ' ARG . 7.5 Cg_endo -81.74 115.68 2.79 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.67 1.58 . . . . 0.0 112.598 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.58 150.84 46.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.806 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' B' ' 52' ' ' VAL . 1.2 mt-30 -142.46 166.75 23.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.034 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' B' ' 102' ' ' GLN . . . -158.22 102.88 1.79 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 0.0 111.626 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' B' ' 51' ' ' ALA . 0.2 OUTLIER -94.67 -173.41 3.01 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.439 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . 0.594 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 3.8 m-85 -100.83 152.83 20.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.074 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . 0.542 ' HA ' ' O ' ' B' ' 47' ' ' ALA . 0.2 OUTLIER -147.32 160.81 42.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.002 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.617 ' HB2' ' HB3' ' B' ' 42' ' ' LEU . . . -126.92 149.65 49.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.876 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' THR . . . . . 0.512 ' OG1' ' HA ' ' B' ' 98' ' ' ASN . 0.0 OUTLIER -115.41 27.86 9.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.453 179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.46 66.86 0.2 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.879 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.94 88.62 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.568 0.223 . . . . 0.0 110.69 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' ALA . . . . . 0.456 ' CB ' ' HB ' ' B' ' 99' ' ' VAL . . . -60.25 156.94 14.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.764 0.316 . . . . 0.0 111.407 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.543 ' HB ' ' CD ' ' B' ' 145' ' ' PRO . 76.5 p -112.23 173.04 3.07 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.236 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.543 ' CD ' ' HB ' ' B' ' 144' ' ' THR . 1.3 Cg_endo -84.55 145.23 10.43 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 122.552 2.168 . . . . 0.0 111.979 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.37 -112.73 0.55 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.521 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.705 ' HB3' ' HA ' ' B' ' 95' ' ' SER . . . -125.02 167.62 14.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.826 0.346 . . . . 0.0 111.308 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . 0.417 ' HB2' ' CG2' ' A' ' 16' ' ' VAL . . . -157.16 57.52 0.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.459 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -91.84 132.72 36.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.582 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.4 163.13 28.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.023 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.44 125.61 1.83 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.25 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . 0.79 ' HB2' HD21 ' B' ' 86' ' ' LEU . . . -154.51 165.82 35.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.211 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.92 163.11 12.77 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -119.01 134.6 55.09 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.181 0.515 . . . . 0.0 110.069 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.685 ' HB3' ' HB3' ' B' ' 72' ' ' ALA . 0.0 OUTLIER -95.57 166.26 11.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.923 -178.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.29 112.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.81 0.338 . . . . 0.0 111.663 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.625 ' HB3' ' HB3' ' B' ' 70' ' ' ALA . 0.2 OUTLIER -88.73 138.88 31.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.286 0.565 . . . . 0.0 110.423 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . 0.572 ' HE2' HG11 ' B' ' 17' ' ' VAL . 22.6 m-85 -127.73 113.11 15.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.554 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.937 179.992 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.304 0.097 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.96 68.25 0.88 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.62 0.248 . . . . 0.0 110.999 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.31 87.69 6.15 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.46 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' D' ' 157' ' ' GLN . 3.5 m -90.51 115.49 27.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.55 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 13.4 m -127.3 167.01 22.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.589 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . 0.649 ' HA ' ' HE2' ' D' ' 155' ' ' LYS . 19.9 t30 -83.06 115.16 21.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.507 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.34 -71.53 1.06 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.828 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.28 172.75 34.76 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.931 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 33.2 m -95.5 137.0 35.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.972 0.415 . . . . 0.0 111.219 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . . . . . . . . . 40.1 t -120.78 130.75 74.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.225 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' HIS . . . . . 0.539 ' O ' ' HB ' ' D' ' 32' ' ' VAL . 1.3 m80 -103.86 157.99 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.392 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' D' ' 32' ' ' VAL . 0.6 OUTLIER -145.91 89.67 1.91 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.793 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.634 ' HD3' HG22 ' D' ' 31' ' ' THR . 0.0 OUTLIER -80.04 135.15 36.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.437 179.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.5 178.43 42.02 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.898 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' GLU . . . . . 0.64 ' HG2' ' HA ' ' D' ' 147' ' ' ALA . 2.6 mt-10 -156.87 -177.98 7.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.903 0.382 . . . . 0.0 110.327 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.515 HG22 HG23 ' D' ' 37' ' ' VAL . 2.7 t -142.24 150.13 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.253 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.572 HG11 ' HE2' ' C' ' 158' ' ' TYR . 4.1 m -141.72 168.57 15.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 111.025 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.04 74.77 4.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.068 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.82 91.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.011 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.49 -50.97 0.08 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.475 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER 179.87 -179.77 0.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.019 -179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . 0.892 ' HB1' ' HB1' ' A' ' 93' ' ' ALA . . . -136.16 116.43 13.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.168 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . 0.41 ' H ' ' CB ' ' D' ' 36' ' ' GLN . 69.0 t -67.02 120.15 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.043 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.439 ' O ' HG23 ' C' ' 28' ' ' VAL . 2.4 m-20 -64.46 150.47 46.49 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.59 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' D' ' 33' ' ' GLN . . . -48.35 -50.16 31.58 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.343 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.34 -31.77 81.51 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.897 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . 0.408 ' HA ' HE21 ' C' ' 30' ' ' GLN . 0.4 OUTLIER -69.09 -15.93 63.56 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.439 HG23 ' O ' ' C' ' 24' ' ' ASP . 48.6 t -72.94 -43.67 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.36 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.44 106.08 10.34 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' GLN . . . . . 0.408 HE21 ' HA ' ' C' ' 27' ' ' SER . 16.9 mt-30 -116.67 133.98 55.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.026 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' THR . . . . . 0.627 HG22 ' HD3' ' B' ' 13' ' ' LYS . 1.0 OUTLIER -105.5 96.07 6.25 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.069 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.54 ' HB ' ' O ' ' B' ' 11' ' ' HIS . 69.5 t -89.45 131.24 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.154 0.502 . . . . 0.0 110.434 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.457 ' HA ' ' HG2' ' B' ' 13' ' ' LYS . 0.3 OUTLIER -109.02 106.46 16.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.582 -179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.485 HD12 ' CE2' ' C' ' 137' ' ' TYR . 0.4 OUTLIER -73.82 -40.89 63.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.642 179.368 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.98 -122.45 6.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.556 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . 0.603 ' HB3' ' HA ' ' B' ' 22' ' ' ALA . 16.2 tt0 -144.55 153.9 42.31 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.621 0.248 . . . . 0.0 110.913 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.512 HG23 HG22 ' B' ' 16' ' ' VAL . 0.0 OUTLIER -128.51 146.3 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.848 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' ARG . . . . . 0.539 ' HE ' ' HB2' ' B' ' 22' ' ' ALA . 0.0 OUTLIER -98.22 145.96 26.1 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.772 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.56 HG23 ' O ' ' B' ' 17' ' ' VAL . 41.0 p -57.73 -23.03 49.87 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.777 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.94 -33.2 61.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.056 0.455 . . . . 0.0 110.833 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.0 -31.21 69.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.142 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.611 ' HB3' ' HB2' ' C' ' 139' ' ' ALA . 0.0 OUTLIER -130.77 86.41 2.37 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.65 179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.68 36.14 4.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.371 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.6 150.89 0.2 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.343 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' C' ' 140' ' ' THR . 1.7 tm-20 -64.8 134.84 54.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.809 0.337 . . . . 0.0 111.135 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.74 -14.08 53.35 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.143 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' C' ' 138' ' ' PHE . . . -57.27 129.86 43.63 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . 0.469 ' HB ' ' CE1' ' C' ' 138' ' ' PHE . 14.3 t -130.57 143.31 50.67 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.903 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.59 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 68.6 m -111.96 -157.23 0.61 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.565 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . 0.404 ' H ' ' HB3' ' C' ' 49' ' ' SER . 27.7 t -74.59 150.13 39.81 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.816 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' C' ' 136' ' ' ARG . . . -103.24 146.65 28.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.344 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' C' ' 134' ' ' GLN . 22.2 m -83.35 148.35 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.91 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.42 121.17 6.19 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.645 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . 0.414 ' CD1' HG23 ' C' ' 52' ' ' VAL . 16.3 p90 -153.79 125.59 7.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.777 0.322 . . . . 0.0 110.933 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.35 156.17 20.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.543 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 22.4 mm -103.9 135.28 42.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.635 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.7 126.04 48.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.755 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . 0.551 ' HB2' ' HB3' ' C' ' 129' ' ' ASN . 4.3 mp -131.57 100.0 4.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.298 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.41 174.82 11.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.943 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.68 65.28 1.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.804 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' C' ' 21' ' ' CYS . 60.7 m -98.73 142.98 29.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.796 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.66 109.25 15.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.303 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.457 HG23 ' HB3' ' C' ' 124' ' ' LEU . 0.2 OUTLIER -92.43 29.47 1.7 Allowed 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' ASN . . . . . 0.477 HD22 ' HA ' ' C' ' 64' ' ' ASN . 0.1 OUTLIER -89.93 -59.19 2.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.015 0.436 . . . . 0.0 111.752 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.29 -39.87 13.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.654 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.61 101.34 10.67 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.629 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 31.1 p -90.54 -28.83 18.24 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 110.962 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.36 167.05 16.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.531 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.91 149.84 29.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.599 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' C' ' 157' ' ' GLN . . . -112.98 159.74 18.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.104 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.1 123.31 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.678 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . 0.687 ' HB3' ' HB3' ' C' ' 155' ' ' LYS . . . -124.65 169.0 12.38 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.55 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' PHE . . . . . 0.538 ' CB ' HD11 ' C' ' 111' ' ' LEU . 17.2 t80 -150.6 144.39 25.24 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.54 0.21 . . . . 0.0 111.104 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.657 HD12 ' OG1' ' F' ' 130' ' ' THR . 0.4 OUTLIER -121.46 88.62 2.97 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.976 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . 0.521 ' C ' HD23 ' C' ' 113' ' ' LEU . . . -134.78 164.7 24.68 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.779 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.656 ' O ' ' HA ' ' C' ' 86' ' ' LEU . 0.6 OUTLIER -78.55 147.77 33.64 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.571 0.224 . . . . 0.0 110.76 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . 0.558 ' H ' ' HB3' ' F' ' 132' ' ' PRO . . . -95.73 140.26 30.79 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.934 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . 0.56 ' CG2' ' HB ' ' C' ' 85' ' ' VAL . 1.1 tt -78.61 -33.18 16.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.86 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.17 179.28 6.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.69 -27.9 36.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.006 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.15 -32.24 72.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.671 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . 0.407 ' HB3' HG23 ' C' ' 85' ' ' VAL . 15.2 m-70 -97.32 -72.73 0.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 0.0 110.49 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 5.6 m 74.9 -7.25 1.78 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.563 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' ASN . . . . . 0.745 ' HA ' HD13 ' C' ' 113' ' ' LEU . 3.1 m120 -108.77 -19.13 13.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.329 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.56 ' HB ' ' CG2' ' C' ' 78' ' ' ILE . 49.9 t -80.58 132.01 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.162 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.766 HD21 ' HB2' ' C' ' 152' ' ' ALA . 0.4 OUTLIER -76.58 134.98 39.23 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.991 -0.283 . . . . 0.0 110.279 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.34 165.16 6.27 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.903 0.382 . . . . 0.0 111.676 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.738 HD12 ' O ' ' F' ' 51' ' ' ALA . 0.0 OUTLIER -65.72 171.74 4.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.069 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' GLN . . . . . 0.485 ' OE1' ' HB3' ' C' ' 91' ' ' SER . 8.1 pt20 -72.45 175.71 6.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.409 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . 0.467 ' HA ' ' HB ' ' F' ' 52' ' ' VAL . 0.5 OUTLIER -75.98 -21.26 57.13 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.984 0.421 . . . . 0.0 111.518 179.414 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' SER . . . . . 0.485 ' HB3' ' OE1' ' C' ' 89' ' ' GLN . 32.1 t -80.95 67.6 6.92 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.811 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' ALA . . . . . 0.453 ' HA ' ' OG ' ' C' ' 95' ' ' SER . . . -72.28 -9.71 58.83 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.912 0.387 . . . . 0.0 111.681 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' ALA . . . . . 0.894 ' HB1' ' HB1' ' E' ' 22' ' ' ALA . . . -68.14 -22.77 64.85 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.615 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.54 6.75 2.46 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.895 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' SER . . . . . 0.689 ' HA ' ' HB3' ' C' ' 147' ' ' ALA . 31.5 p -93.72 150.82 20.09 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.851 0.358 . . . . 0.0 110.625 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.79 167.14 18.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.58 165.16 14.28 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.367 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . 0.527 ' HA ' ' OG1' ' C' ' 140' ' ' THR . 85.1 m-20 63.24 45.5 5.02 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.443 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' VAL . . . . . 0.472 ' HB ' ' CB ' ' C' ' 143' ' ' ALA . 3.5 p -170.65 131.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.762 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.03 -175.94 21.14 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.531 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' VAL . . . . . . . . . . . . . 76.0 t -104.14 91.88 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 122.981 0.512 . . . . 0.0 111.723 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' C' ' 85' ' ' VAL . 0.0 OUTLIER -67.95 131.16 44.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.916 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.52 HD12 ' O ' ' C' ' 84' ' ' ASN . 0.7 OUTLIER -99.34 110.56 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.535 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' LEU . . . . . 0.466 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 5.4 tp -91.22 149.94 21.55 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.625 0.25 . . . . 0.0 111.086 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.9 174.68 5.79 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.71 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' C' ' 106' ' ' ARG . 1.5 ttt180 -72.53 -18.45 61.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.79 0.329 . . . . 0.0 111.106 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . . . . . . . . . 46.2 p -69.36 -9.67 54.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.996 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.99 -48.34 0.96 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.69 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.95 163.57 15.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 111.072 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -70.49 125.62 27.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.123 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' LEU . . . . . 0.538 HD11 ' CB ' ' C' ' 73' ' ' PHE . 0.0 OUTLIER -65.41 147.65 53.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.356 0.598 . . . . 0.0 110.557 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' THR . . . . . 0.702 ' HB ' HG21 ' C' ' 117' ' ' THR . 0.2 OUTLIER -74.11 144.63 44.85 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.113 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.745 HD13 ' HA ' ' C' ' 84' ' ' ASN . 10.2 mp -100.36 89.84 4.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.799 0.333 . . . . 0.0 110.718 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' ASP . . . . . 0.431 ' HB2' ' CG2' ' C' ' 117' ' ' THR . 4.0 m-20 -142.37 11.5 1.92 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.51 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . 0.438 ' O ' ' HB1' ' C' ' 72' ' ' ALA . . . 96.82 -78.08 0.7 Allowed Glycine 0 CA--C 1.517 0.204 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.638 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' F' ' 125' ' ' ASN . . . -104.24 61.52 0.73 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.013 0.435 . . . . 0.0 111.686 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . 0.702 HG21 ' HB ' ' C' ' 112' ' ' THR . 17.6 p -93.4 95.9 9.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.081 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.86 110.02 5.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.787 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 13.9 m -120.4 -72.85 0.67 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.42 113.04 25.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.666 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -99.39 97.52 8.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.186 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.45 132.71 37.46 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.752 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 22.0 m -60.89 146.15 47.65 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.708 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . 0.457 ' HB3' HG23 ' C' ' 63' ' ' THR . 0.2 OUTLIER -85.41 156.52 20.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.634 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -137.82 142.73 40.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.575 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.9 113.69 6.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.742 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.5 -90.01 0.32 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.702 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' THR . . . . . . . . . . . . . 6.1 m -124.91 152.82 43.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.692 0.282 . . . . 0.0 110.815 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 129' ' ' ASN . . . . . 0.551 ' HB3' ' HB2' ' C' ' 58' ' ' LEU . 17.1 t-20 -123.06 147.53 46.62 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . . . . . . . . . 4.3 m -126.19 135.65 51.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.094 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 131' ' ' ILE . . . . . . . . . . . . . 58.2 mt -113.95 115.68 45.63 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 132' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -81.74 115.72 2.79 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 121.635 1.557 . . . . 0.0 112.54 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.57 150.8 46.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.828 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 134' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' C' ' 52' ' ' VAL . 1.2 mt-30 -142.4 166.74 23.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.032 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' C' ' 102' ' ' GLN . . . -158.22 102.92 1.79 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.927 0.394 . . . . 0.0 111.622 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . 0.485 ' HB3' ' HB2' ' C' ' 51' ' ' ALA . 0.1 OUTLIER -94.69 -173.47 3.02 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.408 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 137' ' ' TYR . . . . . 0.59 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 3.8 m-85 -100.72 152.83 20.0 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.147 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 138' ' ' PHE . . . . . 0.553 ' HA ' ' O ' ' C' ' 47' ' ' ALA . 0.2 OUTLIER -147.3 160.73 42.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.026 -179.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 139' ' ' ALA . . . . . 0.611 ' HB2' ' HB3' ' C' ' 42' ' ' LEU . . . -126.85 149.63 49.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.915 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 140' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' C' ' 98' ' ' ASN . 0.0 OUTLIER -115.33 27.87 9.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.472 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.37 66.79 0.2 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.947 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.93 88.63 0.09 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.58 0.229 . . . . 0.0 110.769 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 143' ' ' ALA . . . . . 0.472 ' CB ' ' HB ' ' C' ' 99' ' ' VAL . . . -60.25 156.86 14.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.758 0.313 . . . . 0.0 111.4 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 144' ' ' THR . . . . . 0.552 ' HB ' ' CD ' ' C' ' 145' ' ' PRO . 77.3 p -112.2 173.05 3.07 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.254 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 145' ' ' PRO . . . . . 0.552 ' CD ' ' HB ' ' C' ' 144' ' ' THR . 1.3 Cg_endo -84.55 145.24 10.43 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.57 2.18 . . . . 0.0 111.923 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.31 -112.7 0.55 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.508 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 147' ' ' ALA . . . . . 0.689 ' HB3' ' HA ' ' C' ' 95' ' ' SER . . . -124.92 167.68 14.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.913 0.387 . . . . 0.0 111.296 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 148' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -157.19 57.45 0.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.466 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -91.81 132.71 36.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.53 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.41 163.16 28.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.988 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.45 125.59 1.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.244 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . 0.766 ' HB2' HD21 ' C' ' 86' ' ' LEU . . . -154.57 165.78 35.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.264 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.88 163.17 12.72 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 154' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -119.02 134.57 55.11 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.061 0.458 . . . . 0.0 110.155 -179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . 0.687 ' HB3' ' HB3' ' C' ' 72' ' ' ALA . 0.0 OUTLIER -95.62 166.28 11.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.914 -178.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.22 112.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.754 0.312 . . . . 0.0 111.713 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . 0.634 ' HB3' ' HB3' ' C' ' 70' ' ' ALA . 0.2 OUTLIER -88.67 138.83 31.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.235 0.54 . . . . 0.0 110.385 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . 0.572 ' HE2' HG11 ' C' ' 17' ' ' VAL . 22.6 m-85 -127.76 113.21 15.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.523 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.913 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.248 0.07 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.96 68.35 0.87 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.935 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' THR . . . . . . . . . . . . . 7.5 m -92.39 87.63 6.09 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.439 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' E' ' 157' ' ' GLN . 3.5 m -90.39 115.48 27.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.542 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -127.3 167.02 22.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.565 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.643 ' HA ' ' HE2' ' E' ' 155' ' ' LYS . 20.0 t30 -83.02 115.19 21.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.554 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.43 -71.49 1.06 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.806 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.3 172.75 34.77 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.897 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . . . . . . . . . 33.1 m -95.45 136.94 35.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.918 0.39 . . . . 0.0 111.265 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.83 130.73 74.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.171 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' HIS . . . . . 0.539 ' O ' ' HB ' ' E' ' 32' ' ' VAL . 1.3 m80 -103.83 157.98 16.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.327 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' E' ' 32' ' ' VAL . 0.6 OUTLIER -145.87 89.68 1.92 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.76 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' LYS . . . . . 0.633 ' HD3' HG22 ' E' ' 31' ' ' THR . 0.0 OUTLIER -79.98 135.16 36.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.436 179.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.54 178.42 42.04 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.948 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' GLU . . . . . 0.652 ' HG2' ' HA ' ' E' ' 147' ' ' ALA . 2.5 mt-10 -156.79 -177.92 6.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.833 0.349 . . . . 0.0 110.414 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.514 HG22 HG23 ' E' ' 37' ' ' VAL . 2.7 t -142.24 150.16 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.27 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.585 HG11 ' HE2' ' D' ' 158' ' ' TYR . 4.2 m -141.76 168.53 14.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.86 0.362 . . . . 0.0 111.034 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -92.98 74.75 4.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.066 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.83 91.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.057 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.43 -51.06 0.09 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.402 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER 179.88 -179.78 0.48 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.005 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . 0.88 ' HB1' ' HB1' ' B' ' 93' ' ' ALA . . . -136.17 116.41 13.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.16 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . 0.423 ' H ' ' CB ' ' E' ' 36' ' ' GLN . 69.3 t -67.01 120.21 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.439 ' O ' HG23 ' D' ' 28' ' ' VAL . 2.4 m-20 -64.42 150.47 46.39 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.573 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' E' ' 33' ' ' GLN . . . -48.36 -50.16 31.66 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.42 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.26 -31.82 81.79 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.93 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . 0.413 ' HA ' HE21 ' D' ' 30' ' ' GLN . 0.4 OUTLIER -69.09 -15.95 63.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.868 0.366 . . . . 0.0 110.821 -179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 24' ' ' ASP . 48.8 t -73.04 -43.56 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.334 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.41 106.1 10.36 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.999 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' GLN . . . . . 0.413 HE21 ' HA ' ' D' ' 27' ' ' SER . 16.9 mt-30 -116.68 133.95 55.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.032 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' THR . . . . . 0.634 HG22 ' HD3' ' C' ' 13' ' ' LYS . 1.0 OUTLIER -105.48 96.05 6.24 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.042 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' C' ' 11' ' ' HIS . 68.9 t -89.39 131.28 37.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.161 0.505 . . . . 0.0 110.469 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.465 ' HA ' ' HG2' ' C' ' 13' ' ' LYS . 0.3 OUTLIER -109.05 106.5 16.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.603 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.484 HD12 ' CE2' ' D' ' 137' ' ' TYR . 0.4 OUTLIER -73.85 -40.88 62.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.678 179.391 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.0 -122.47 6.75 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.522 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' GLN . . . . . 0.611 ' HB3' ' HA ' ' C' ' 22' ' ' ALA . 16.3 tt0 -144.55 153.83 42.23 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.566 0.222 . . . . 0.0 110.874 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.515 HG23 HG22 ' C' ' 16' ' ' VAL . 0.0 OUTLIER -128.46 146.32 34.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.911 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . 0.539 ' HE ' ' HB2' ' C' ' 22' ' ' ALA . 0.0 OUTLIER -98.2 145.99 26.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.768 179.196 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.556 HG23 ' O ' ' C' ' 17' ' ' VAL . 40.8 p -57.74 -23.06 50.09 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.743 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.97 -33.23 61.87 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.053 0.454 . . . . 0.0 110.8 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.02 -31.21 69.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.134 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' D' ' 139' ' ' ALA . 0.0 OUTLIER -130.72 86.37 2.37 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.69 179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.71 36.27 4.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.346 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.56 150.82 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.38 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' D' ' 140' ' ' THR . 1.7 tm-20 -64.75 134.83 55.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.0 111.175 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.78 -14.22 53.16 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.213 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' D' ' 138' ' ' PHE . . . -57.14 129.86 43.61 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . 0.46 ' HB ' ' CE1' ' D' ' 138' ' ' PHE . 14.4 t -130.61 143.35 50.69 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.878 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 68.8 m -111.96 -157.21 0.61 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.596 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.405 ' HB3' ' HB1' ' A' ' 92' ' ' ALA . 27.7 t -74.55 150.06 39.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.834 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' ALA . . . . . 0.729 ' O ' HD12 ' A' ' 88' ' ' LEU . . . -103.19 146.64 28.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.326 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' A' ' 90' ' ' SER . 22.3 m -83.37 148.33 5.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.909 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.38 121.21 6.21 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.633 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.412 ' CD1' HG23 ' D' ' 52' ' ' VAL . 16.3 p90 -153.88 125.54 7.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.855 0.36 . . . . 0.0 110.898 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.28 156.24 20.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.492 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . . . . . . . . . 22.6 mm -104.05 135.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.534 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.66 126.01 48.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.753 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . 0.542 ' HB2' ' HB3' ' D' ' 129' ' ' ASN . 4.3 mp -131.62 99.97 4.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.275 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.46 174.73 11.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.902 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.8 65.26 1.56 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.782 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' D' ' 21' ' ' CYS . 60.7 m -98.71 142.92 29.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.746 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.6 109.2 15.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.301 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.461 HG23 ' HB3' ' D' ' 124' ' ' LEU . 0.2 OUTLIER -92.43 29.65 1.66 Allowed 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' ASN . . . . . 0.456 HD22 ' HA ' ' D' ' 64' ' ' ASN . 0.1 OUTLIER -90.06 -59.27 2.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.069 0.462 . . . . 0.0 111.752 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.18 -39.8 13.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.732 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.64 101.39 10.71 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.586 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 31.3 p -90.58 -28.76 18.25 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.885 0.374 . . . . 0.0 110.999 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' LYS . . . . . 0.449 ' HZ1' ' HB2' ' D' ' 121' ' ' GLU . 0.0 OUTLIER -126.49 166.91 16.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.482 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.8 149.82 29.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.664 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' D' ' 157' ' ' GLN . . . -112.91 159.77 18.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.101 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . . . . . . . . . 52.4 t -108.08 123.31 63.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.662 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' ALA . . . . . 0.679 ' HB3' ' HB3' ' D' ' 155' ' ' LYS . . . -124.61 168.92 12.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.622 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' PHE . . . . . 0.532 ' CB ' HD11 ' D' ' 111' ' ' LEU . 17.2 t80 -150.62 144.41 25.23 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.585 0.231 . . . . 0.0 111.133 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' LEU . . . . . 0.444 HD23 ' O ' ' D' ' 74' ' ' LEU . 0.4 OUTLIER -121.5 88.6 2.97 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.999 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . 0.521 ' C ' HD23 ' D' ' 113' ' ' LEU . . . -134.74 164.72 24.67 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.759 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . 0.665 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.6 OUTLIER -78.56 147.76 33.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.565 0.222 . . . . 0.0 110.774 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.82 140.32 30.77 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.912 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 78' ' ' ILE . . . . . 0.555 ' CG2' ' HB ' ' D' ' 85' ' ' VAL . 1.1 tt -78.65 -33.11 16.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.921 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.16 179.27 7.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.859 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.69 -27.91 36.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.059 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.17 -32.29 72.54 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.619 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . 0.416 ' HB3' HG23 ' D' ' 85' ' ' VAL . 15.3 m-70 -97.28 -72.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.482 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.86 -7.22 1.79 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.592 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . 0.758 ' HA ' HD13 ' D' ' 113' ' ' LEU . 3.1 m120 -108.79 -19.1 13.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.287 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' D' ' 102' ' ' GLN . 50.3 t -80.65 131.98 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.134 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' D' ' 152' ' ' ALA . 0.4 OUTLIER -76.52 134.96 39.31 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.32 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.31 165.19 6.2 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.889 0.376 . . . . 0.0 111.669 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . 0.423 ' H ' ' HG ' ' D' ' 88' ' ' LEU . 0.1 OUTLIER -65.75 171.69 4.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.056 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 89' ' ' GLN . . . . . 0.492 ' OE1' ' HB3' ' D' ' 91' ' ' SER . 8.1 pt20 -72.48 175.67 6.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.412 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.98 -21.19 57.22 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.071 0.462 . . . . 0.0 111.521 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . 0.492 ' HB3' ' OE1' ' D' ' 89' ' ' GLN . 32.1 t -81.02 67.64 7.01 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.825 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 92' ' ' ALA . . . . . 0.449 ' HA ' ' OG ' ' D' ' 95' ' ' SER . . . -72.33 -9.7 58.84 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 120.943 0.401 . . . . 0.0 111.682 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 93' ' ' ALA . . . . . 0.896 ' HB1' ' HB1' ' F' ' 22' ' ' ALA . . . -68.06 -22.88 64.92 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.615 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.51 6.78 2.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.911 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 95' ' ' SER . . . . . 0.699 ' HA ' ' HB3' ' D' ' 147' ' ' ALA . 31.6 p -93.77 150.86 20.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.846 0.355 . . . . 0.0 110.599 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.82 167.24 18.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.834 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.68 165.16 14.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.295 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 98' ' ' ASN . . . . . 0.525 ' HA ' ' OG1' ' D' ' 140' ' ' THR . 85.0 m-20 63.3 45.46 4.98 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.434 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 99' ' ' VAL . . . . . 0.465 ' HB ' ' CB ' ' D' ' 143' ' ' ALA . 3.4 p -170.67 131.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.784 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.05 -175.92 21.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.54 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 101' ' ' VAL . . . . . . . . . . . . . 76.4 t -104.2 91.91 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 121.187 0.518 . . . . 0.0 111.669 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 102' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' D' ' 85' ' ' VAL . 0.0 OUTLIER -67.9 131.25 45.16 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.877 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 103' ' ' ILE . . . . . 0.512 HD12 ' O ' ' D' ' 84' ' ' ASN . 0.7 OUTLIER -99.47 110.64 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.468 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 104' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 5.5 tp -91.33 149.96 21.51 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.633 0.254 . . . . 0.0 111.056 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.87 174.65 5.8 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.714 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 106' ' ' ARG . . . . . 0.459 HH11 ' HD3' ' D' ' 106' ' ' ARG . 1.5 ttt180 -72.47 -18.55 61.67 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.714 0.293 . . . . 0.0 111.033 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 107' ' ' THR . . . . . . . . . . . . . 46.3 p -69.33 -9.58 53.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.06 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.98 -48.41 0.96 Allowed Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.643 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.92 163.56 15.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.063 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -70.47 125.57 27.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.155 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 111' ' ' LEU . . . . . 0.532 HD11 ' CB ' ' D' ' 73' ' ' PHE . 0.0 OUTLIER -65.33 147.64 53.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.328 0.585 . . . . 0.0 110.593 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 112' ' ' THR . . . . . 0.67 ' HB ' HG21 ' D' ' 117' ' ' THR . 0.2 OUTLIER -74.1 144.61 44.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.085 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 113' ' ' LEU . . . . . 0.758 HD13 ' HA ' ' D' ' 84' ' ' ASN . 10.2 mp -100.34 89.89 4.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.727 0.298 . . . . 0.0 110.686 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 114' ' ' ASP . . . . . 0.433 ' HB2' ' CG2' ' D' ' 117' ' ' THR . 4.0 m-20 -142.37 11.44 1.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.569 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . 0.443 ' O ' ' HB1' ' D' ' 72' ' ' ALA . . . 96.88 -78.06 0.69 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.624 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 116' ' ' ALA . . . . . 0.463 ' CB ' HG21 ' C' ' 4' ' ' THR . . . -104.26 61.49 0.73 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.999 0.428 . . . . 0.0 111.706 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 117' ' ' THR . . . . . 0.67 HG21 ' HB ' ' D' ' 112' ' ' THR . 17.5 p -93.41 95.86 9.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.131 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.81 110.05 5.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.746 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.39 -72.9 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.878 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.45 113.05 25.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.622 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . 0.449 ' HB2' ' HZ1' ' D' ' 68' ' ' LYS . 25.2 mt-10 -99.44 97.56 8.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.191 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.5 132.74 37.49 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.752 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -60.94 146.11 47.96 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.709 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . 0.461 ' HB3' HG23 ' D' ' 63' ' ' THR . 0.2 OUTLIER -85.34 156.49 20.87 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.632 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 125' ' ' ASN . . . . . 0.534 ' HB3' ' HB3' ' A' ' 116' ' ' ALA . 32.6 m120 -137.81 142.74 40.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.577 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.97 113.7 6.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.689 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.51 -90.05 0.32 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.701 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 128' ' ' THR . . . . . 0.433 ' HB ' ' HD3' ' A' ' 155' ' ' LYS . 6.2 m -124.94 152.86 43.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.734 0.302 . . . . 0.0 110.82 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 129' ' ' ASN . . . . . 0.542 ' HB3' ' HB2' ' D' ' 58' ' ' LEU . 17.1 t-20 -123.06 147.56 46.57 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.866 0.365 . . . . 0.0 111.158 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 130' ' ' THR . . . . . 0.652 ' OG1' HD12 ' A' ' 74' ' ' LEU . 4.3 m -126.22 135.71 51.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.05 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 131' ' ' ILE . . . . . . . . . . . . . 58.5 mt -114.01 115.7 45.48 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 132' ' ' PRO . . . . . 0.564 ' HB3' ' H ' ' A' ' 77' ' ' ALA . 7.5 Cg_endo -81.67 115.71 2.82 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 121.703 1.602 . . . . 0.0 112.545 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.59 150.79 46.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.802 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 134' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' D' ' 52' ' ' VAL . 1.3 mt-30 -142.5 166.61 24.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.081 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' D' ' 102' ' ' GLN . . . -158.14 102.9 1.81 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.922 0.392 . . . . 0.0 111.638 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 136' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' D' ' 51' ' ' ALA . 0.2 OUTLIER -94.67 -173.41 3.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.415 179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 137' ' ' TYR . . . . . 0.605 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 3.8 m-85 -100.82 152.86 20.0 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.09 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 138' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' D' ' 47' ' ' ALA . 0.2 OUTLIER -147.33 160.73 42.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.083 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 139' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' D' ' 42' ' ' LEU . . . -126.82 149.71 49.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.895 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 140' ' ' THR . . . . . 0.525 ' OG1' ' HA ' ' D' ' 98' ' ' ASN . 0.0 OUTLIER -115.4 27.79 9.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.402 179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.38 66.86 0.2 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.888 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.92 88.61 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.576 0.188 . . . . 0.0 110.759 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 143' ' ' ALA . . . . . 0.465 ' CB ' ' HB ' ' D' ' 99' ' ' VAL . . . -60.2 156.9 14.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.709 0.29 . . . . 0.0 111.438 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 144' ' ' THR . . . . . 0.548 ' HB ' ' CD ' ' D' ' 145' ' ' PRO . 76.9 p -112.21 173.08 3.05 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.213 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 145' ' ' PRO . . . . . 0.548 ' CD ' ' HB ' ' D' ' 144' ' ' THR . 1.3 Cg_endo -84.58 145.2 10.38 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.565 2.177 . . . . 0.0 111.937 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.38 -112.72 0.55 Allowed Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.555 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 147' ' ' ALA . . . . . 0.699 ' HB3' ' HA ' ' D' ' 95' ' ' SER . . . -124.92 167.69 14.32 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.812 0.339 . . . . 0.0 111.394 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 148' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -157.22 57.54 0.51 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.103 0.478 . . . . 0.0 110.468 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.87 132.74 36.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.534 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.48 163.12 28.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.027 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.39 125.6 1.85 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.282 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 152' ' ' ALA . . . . . 0.792 ' HB2' HD21 ' D' ' 86' ' ' LEU . . . -154.59 165.78 35.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.173 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.84 163.16 12.72 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 154' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -119.0 134.48 55.17 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.023 0.439 . . . . 0.0 110.2 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . 0.679 ' HB3' ' HB3' ' D' ' 72' ' ' ALA . 0.0 OUTLIER -95.61 166.3 11.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.91 -178.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.25 112.83 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.832 0.348 . . . . 0.0 111.638 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 157' ' ' GLN . . . . . 0.615 ' HB3' ' HB3' ' D' ' 70' ' ' ALA . 0.2 OUTLIER -88.82 138.84 31.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.331 0.586 . . . . 0.0 110.393 -179.696 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . 0.585 ' HE2' HG11 ' D' ' 17' ' ' VAL . 22.5 m-85 -127.65 113.16 15.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.519 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.962 179.964 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.261 0.076 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.0 68.24 0.88 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.587 0.232 . . . . 0.0 111.022 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 3' ' ' THR . . . . . . . . . . . . . 7.3 m -92.31 87.66 6.13 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.473 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 4' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' F' ' 157' ' ' GLN . 3.5 m -90.5 115.48 27.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.545 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 m -127.22 167.0 22.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.583 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 6' ' ' ASN . . . . . 0.653 ' HA ' ' HE2' ' F' ' 155' ' ' LYS . 20.0 t30 -83.04 115.14 21.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.497 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.41 -71.45 1.07 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.853 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.29 172.78 34.77 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.049 -0.595 . . . . 0.0 111.931 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 9' ' ' THR . . . . . . . . . . . . . 33.4 m -95.49 137.03 35.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.916 0.389 . . . . 0.0 111.284 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -120.85 130.68 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.185 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 11' ' ' HIS . . . . . 0.535 ' O ' ' HB ' ' F' ' 32' ' ' VAL . 1.3 m80 -103.82 157.99 16.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.397 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 12' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' F' ' 32' ' ' VAL . 0.6 OUTLIER -145.84 89.66 1.92 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 13' ' ' LYS . . . . . 0.631 ' HD3' HG22 ' F' ' 31' ' ' THR . 0.0 OUTLIER -79.95 135.21 36.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.477 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.56 178.38 42.07 Favored Glycine 0 N--CA 1.451 -0.367 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.898 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 15' ' ' GLU . . . . . 0.654 ' HG2' ' HA ' ' F' ' 147' ' ' ALA . 2.6 mt-10 -156.81 -177.9 6.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.938 0.399 . . . . 0.0 110.357 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 16' ' ' VAL . . . . . 0.525 HG22 HG23 ' F' ' 37' ' ' VAL . 2.7 t -142.29 150.13 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.239 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . 0.589 HG11 ' HE2' ' E' ' 158' ' ' TYR . 4.1 m -141.71 168.61 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.832 0.349 . . . . 0.0 111.083 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.06 74.74 4.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.087 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.89 91.89 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.051 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.5 -51.01 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.432 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 21' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER 179.82 -179.79 0.47 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.986 -179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 22' ' ' ALA . . . . . 0.894 ' HB1' ' HB1' ' C' ' 93' ' ' ALA . . . -136.16 116.43 13.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.146 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 23' ' ' VAL . . . . . 0.421 ' H ' ' CB ' ' F' ' 36' ' ' GLN . 67.7 t -67.01 120.14 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 24' ' ' ASP . . . . . 0.445 ' O ' HG23 ' E' ' 28' ' ' VAL . 2.4 m-20 -64.38 150.49 46.21 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.602 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.38 -50.18 31.7 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.355 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.3 -31.77 81.58 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.918 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . 0.418 ' HA ' HE21 ' E' ' 30' ' ' GLN . 0.4 OUTLIER -69.02 -16.05 63.62 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.902 0.382 . . . . 0.0 110.859 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 28' ' ' VAL . . . . . 0.445 HG23 ' O ' ' E' ' 24' ' ' ASP . 48.4 t -72.93 -43.61 59.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.401 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.44 106.09 10.35 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.97 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 30' ' ' GLN . . . . . 0.418 HE21 ' HA ' ' E' ' 27' ' ' SER . 16.9 mt-30 -116.62 133.99 55.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.079 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 31' ' ' THR . . . . . 0.633 HG22 ' HD3' ' D' ' 13' ' ' LYS . 0.9 OUTLIER -105.5 96.03 6.23 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.095 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.539 ' HB ' ' O ' ' D' ' 11' ' ' HIS . 69.6 t -89.45 131.27 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.215 0.531 . . . . 0.0 110.437 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 33' ' ' GLN . . . . . 0.456 ' HA ' ' HG2' ' D' ' 13' ' ' LYS . 0.3 OUTLIER -108.99 106.48 16.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.599 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.494 HD12 ' CE2' ' E' ' 137' ' ' TYR . 0.4 OUTLIER -73.89 -40.93 62.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.552 179.419 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.04 -122.48 6.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.564 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 36' ' ' GLN . . . . . 0.612 ' HB3' ' HA ' ' D' ' 22' ' ' ALA . 16.3 tt0 -144.51 153.98 42.43 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.633 0.254 . . . . 0.0 110.881 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.514 HG23 HG22 ' D' ' 16' ' ' VAL . 0.0 OUTLIER -128.57 146.33 34.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.873 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . 0.547 ' HE ' ' HB2' ' D' ' 22' ' ' ALA . 0.0 OUTLIER -98.19 146.0 26.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.731 179.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 39' ' ' THR . . . . . 0.55 HG23 ' O ' ' D' ' 17' ' ' VAL . 40.9 p -57.79 -23.07 50.59 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.709 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.98 -33.21 61.85 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.013 0.435 . . . . 0.0 110.791 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.03 -31.15 69.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.222 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.615 ' HB3' ' HB2' ' E' ' 139' ' ' ALA . 0.0 OUTLIER -130.76 86.44 2.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.598 179.727 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.66 36.16 4.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.337 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 177.59 150.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.365 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' E' ' 140' ' ' THR . 1.7 tm-20 -64.78 134.88 55.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 0.0 111.118 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.8 -14.28 53.07 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.146 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 47' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' E' ' 138' ' ' PHE . . . -57.22 129.92 43.9 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.938 0.399 . . . . 0.0 112.043 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . 0.465 ' HB ' ' CE1' ' E' ' 138' ' ' PHE . 14.3 t -130.67 143.29 50.65 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.874 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 68.9 m -111.87 -157.14 0.61 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.625 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 50' ' ' SER . . . . . 0.408 ' HB3' ' HB1' ' B' ' 92' ' ' ALA . 27.5 t -74.58 150.05 39.86 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.865 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 51' ' ' ALA . . . . . 0.723 ' O ' HD12 ' B' ' 88' ' ' LEU . . . -103.22 146.63 28.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.334 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 52' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' B' ' 90' ' ' SER . 22.1 m -83.41 148.37 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.916 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.44 121.27 6.22 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.601 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 54' ' ' PHE . . . . . 0.406 ' CD1' HG23 ' E' ' 52' ' ' VAL . 16.5 p90 -153.87 125.57 7.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.797 0.332 . . . . 0.0 110.949 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.33 156.19 20.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.59 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 56' ' ' ILE . . . . . . . . . . . . . 22.4 mm -103.95 135.29 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.565 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.72 125.99 48.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.75 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . 0.541 ' HB2' ' HB3' ' E' ' 129' ' ' ASN . 4.3 mp -131.6 99.9 4.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.326 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.32 174.72 11.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.966 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.74 65.3 1.55 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.79 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 61' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' E' ' 21' ' ' CYS . 60.7 m -98.71 142.94 29.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.792 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.64 109.25 15.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.266 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 63' ' ' THR . . . . . 0.473 HG23 ' HB3' ' E' ' 124' ' ' LEU . 0.2 OUTLIER -92.47 29.59 1.68 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.144 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -89.99 -59.26 2.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.085 0.469 . . . . 0.0 111.727 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.25 -39.84 13.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.666 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.6 101.34 10.67 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.597 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 30.8 p -90.56 -28.79 18.25 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.38 167.08 16.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.509 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.95 149.75 29.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.617 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' E' ' 157' ' ' GLN . . . -112.88 159.75 18.72 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.1 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . . . . . . . . . 52.2 t -108.09 123.29 63.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.665 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . 0.677 ' HB3' ' HB3' ' E' ' 155' ' ' LYS . . . -124.63 168.92 12.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.615 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 73' ' ' PHE . . . . . 0.539 ' CB ' HD11 ' E' ' 111' ' ' LEU . 17.2 t80 -150.63 144.4 25.21 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.601 0.239 . . . . 0.0 111.1 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 74' ' ' LEU . . . . . 0.441 HD23 ' O ' ' E' ' 74' ' ' LEU . 0.4 OUTLIER -121.46 88.64 2.98 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.989 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . 0.52 ' C ' HD23 ' E' ' 113' ' ' LEU . . . -134.76 164.7 24.67 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.816 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 76' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.6 OUTLIER -78.57 147.72 33.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.595 0.236 . . . . 0.0 110.708 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.68 140.29 30.71 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.961 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 78' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' E' ' 85' ' ' VAL . 1.1 tt -78.58 -33.16 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.914 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.18 179.18 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.904 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.58 -27.96 37.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.059 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.21 -32.22 72.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.633 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 82' ' ' HIS . . . . . 0.41 ' HB3' HG23 ' E' ' 85' ' ' VAL . 15.3 m-70 -97.29 -72.81 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.931 0.396 . . . . 0.0 110.461 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.88 -7.15 1.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.593 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 84' ' ' ASN . . . . . 0.76 ' HA ' HD13 ' E' ' 113' ' ' LEU . 3.1 m120 -108.83 -19.1 13.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.325 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' E' ' 102' ' ' GLN . 49.6 t -80.55 132.07 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.152 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 86' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' E' ' 152' ' ' ALA . 0.4 OUTLIER -76.63 134.96 39.16 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.304 179.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.25 165.21 6.1 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.867 0.365 . . . . 0.0 111.645 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . 0.424 ' HG ' ' H ' ' E' ' 88' ' ' LEU . 0.1 OUTLIER -65.86 171.79 4.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.998 179.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 89' ' ' GLN . . . . . 0.491 ' OE1' ' HB3' ' E' ' 91' ' ' SER . 8.0 pt20 -72.56 175.71 6.09 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.425 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.04 -21.18 57.1 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.009 0.433 . . . . 0.0 111.498 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 91' ' ' SER . . . . . 0.491 ' HB3' ' OE1' ' E' ' 89' ' ' GLN . 32.0 t -80.91 67.49 6.82 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 92' ' ' ALA . . . . . 0.453 ' HA ' ' OG ' ' E' ' 95' ' ' SER . . . -72.18 -9.77 58.88 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.969 0.414 . . . . 0.0 111.723 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.04 -22.88 64.93 Favored 'General case' 0 N--CA 1.461 0.079 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.669 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.46 6.75 2.48 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.946 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 95' ' ' SER . . . . . 0.692 ' HA ' ' HB3' ' E' ' 147' ' ' ALA . 31.0 p -93.73 150.78 20.11 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.821 0.343 . . . . 0.0 110.688 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.77 167.22 18.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.876 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.66 165.09 14.39 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.365 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 98' ' ' ASN . . . . . 0.514 ' HA ' ' OG1' ' E' ' 140' ' ' THR . 85.0 m-20 63.36 45.42 4.93 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.443 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 99' ' ' VAL . . . . . 0.454 ' HB ' ' CB ' ' E' ' 143' ' ' ALA . 3.4 p -170.64 131.48 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.692 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.04 -175.99 21.18 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.54 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 101' ' ' VAL . . . . . . . . . . . . . 76.3 t -104.07 91.83 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 122.994 0.517 . . . . 0.0 111.708 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 102' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' E' ' 85' ' ' VAL . 0.0 OUTLIER -67.9 131.21 45.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 103' ' ' ILE . . . . . 0.516 HD12 ' O ' ' E' ' 84' ' ' ASN . 0.7 OUTLIER -99.42 110.62 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.475 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 104' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 5.5 tp -91.3 149.93 21.53 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.699 0.285 . . . . 0.0 111.029 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.9 174.65 5.8 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.701 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 106' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' E' ' 106' ' ' ARG . 1.5 ttt180 -72.53 -18.4 61.65 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.759 0.314 . . . . 0.0 111.067 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . . . . . . . . . 46.2 p -69.41 -9.63 54.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.989 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 106.99 -48.38 0.96 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.636 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.88 163.58 15.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 111.11 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -70.53 125.59 27.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.539 HD11 ' CB ' ' E' ' 73' ' ' PHE . 0.0 OUTLIER -65.38 147.57 53.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.353 0.596 . . . . 0.0 110.557 179.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 112' ' ' THR . . . . . 0.671 ' HB ' HG21 ' E' ' 117' ' ' THR . 0.2 OUTLIER -74.03 144.57 45.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.157 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 113' ' ' LEU . . . . . 0.76 HD13 ' HA ' ' E' ' 84' ' ' ASN . 10.2 mp -100.26 89.82 4.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.776 0.322 . . . . 0.0 110.753 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 114' ' ' ASP . . . . . 0.433 ' HB2' ' CG2' ' E' ' 117' ' ' THR . 4.1 m-20 -142.34 11.43 1.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.685 0.279 . . . . 0.0 111.623 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . 0.45 ' O ' ' HB1' ' E' ' 72' ' ' ALA . . . 96.87 -78.1 0.7 Allowed Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.619 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 116' ' ' ALA . . . . . 0.456 ' CB ' HG21 ' D' ' 4' ' ' THR . . . -104.29 61.63 0.73 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.976 0.417 . . . . 0.0 111.666 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 117' ' ' THR . . . . . 0.671 HG21 ' HB ' ' E' ' 112' ' ' THR . 17.6 p -93.5 95.87 9.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.114 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.74 109.92 5.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.819 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.26 -72.96 0.66 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.874 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.43 113.09 25.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.638 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -99.47 97.51 8.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.184 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.45 132.74 37.42 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.724 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 22.3 m -61.01 146.13 48.2 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.691 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . 0.473 ' HB3' HG23 ' E' ' 63' ' ' THR . 0.2 OUTLIER -85.41 156.49 20.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.645 179.419 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 125' ' ' ASN . . . . . 0.534 ' HB3' ' HB3' ' B' ' 116' ' ' ALA . 32.6 m120 -137.83 142.78 40.78 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.542 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.91 113.69 6.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.717 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . 0.619 ' HA3' ' HB ' ' A' ' 4' ' ' THR . . . 128.45 -89.97 0.32 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.731 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 128' ' ' THR . . . . . 0.429 ' HB ' ' HD3' ' B' ' 155' ' ' LYS . 6.2 m -124.92 152.83 43.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.73 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 129' ' ' ASN . . . . . 0.541 ' HB3' ' HB2' ' E' ' 58' ' ' LEU . 17.0 t-20 -123.08 147.54 46.61 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.122 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 130' ' ' THR . . . . . 0.632 ' OG1' HD12 ' B' ' 74' ' ' LEU . 4.3 m -126.13 135.76 52.07 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.043 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 131' ' ' ILE . . . . . . . . . . . . . 58.4 mt -114.04 115.61 45.46 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 132' ' ' PRO . . . . . 0.564 ' HB3' ' H ' ' B' ' 77' ' ' ALA . 7.5 Cg_endo -81.69 115.69 2.81 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 121.698 1.599 . . . . 0.0 112.566 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.6 150.79 46.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.807 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 134' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' E' ' 52' ' ' VAL . 1.2 mt-30 -142.44 166.71 23.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.034 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' E' ' 102' ' ' GLN . . . -158.17 102.93 1.8 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.901 0.382 . . . . 0.0 111.636 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 136' ' ' ARG . . . . . 0.481 ' HB3' ' HB2' ' E' ' 51' ' ' ALA . 0.1 OUTLIER -94.72 -173.42 3.0 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.352 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 137' ' ' TYR . . . . . 0.591 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 3.7 m-85 -100.86 152.87 20.0 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.082 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 138' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' E' ' 47' ' ' ALA . 0.2 OUTLIER -147.35 160.73 42.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.072 -179.183 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 139' ' ' ALA . . . . . 0.615 ' HB2' ' HB3' ' E' ' 42' ' ' LEU . . . -126.82 149.67 49.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.885 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 140' ' ' THR . . . . . 0.514 ' OG1' ' HA ' ' E' ' 98' ' ' ASN . 0.0 OUTLIER -115.35 27.84 9.09 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.484 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.4 66.79 0.2 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.951 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . 62.91 88.61 0.09 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.604 0.24 . . . . 0.0 110.742 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 143' ' ' ALA . . . . . 0.454 ' CB ' ' HB ' ' E' ' 99' ' ' VAL . . . -60.21 156.89 14.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.751 0.31 . . . . 0.0 111.424 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 144' ' ' THR . . . . . 0.555 ' HB ' ' CD ' ' E' ' 145' ' ' PRO . 77.0 p -112.18 173.05 3.07 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.305 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 145' ' ' PRO . . . . . 0.555 ' CD ' ' HB ' ' E' ' 144' ' ' THR . 1.4 Cg_endo -84.6 145.25 10.37 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.477 2.118 . . . . 0.0 112.029 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.37 -112.73 0.55 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.56 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 147' ' ' ALA . . . . . 0.692 ' HB3' ' HA ' ' E' ' 95' ' ' SER . . . -124.98 167.66 14.4 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.88 0.371 . . . . 0.0 111.337 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 148' ' ' ALA . . . . . 0.413 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -157.13 57.46 0.52 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.497 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.86 132.74 36.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.559 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.42 163.13 28.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.037 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.48 125.65 1.82 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.184 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 152' ' ' ALA . . . . . 0.794 ' HB2' HD21 ' E' ' 86' ' ' LEU . . . -154.61 165.71 35.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.204 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.83 163.13 12.74 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 154' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -119.04 134.56 55.12 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.094 0.473 . . . . 0.0 110.108 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . 0.677 ' HB3' ' HB3' ' E' ' 72' ' ' ALA . 0.0 OUTLIER -95.48 166.25 11.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.928 -178.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.33 112.85 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.888 0.375 . . . . 0.0 111.641 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 157' ' ' GLN . . . . . 0.613 ' HB3' ' HB3' ' E' ' 70' ' ' ALA . 0.2 OUTLIER -88.76 138.85 31.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.242 0.544 . . . . 0.0 110.404 -179.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . 0.589 ' HE2' HG11 ' E' ' 17' ' ' VAL . 22.5 m-85 -127.71 113.15 15.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.512 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 159' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.909 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.226 0.06 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.0 68.24 0.88 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.552 0.215 . . . . 0.0 111.049 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 7.4 m -92.36 87.66 6.11 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.469 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 4' ' ' THR . . . . . . . . . . . . . 3.5 m -90.49 115.46 27.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.591 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 m -127.28 166.93 23.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.588 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -82.99 115.23 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.524 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.48 -71.45 1.07 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.801 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -157.3 172.78 34.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.918 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 33.2 m -95.49 136.96 35.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.939 0.399 . . . . 0.0 111.265 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 40.3 t -120.82 130.72 74.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.194 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -103.84 157.96 16.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.432 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -145.84 89.63 1.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 13' ' ' LYS . . . . . 0.428 ' HG2' ' H ' ' F' ' 13' ' ' LYS . 0.0 OUTLIER -79.97 135.19 36.34 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.431 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -168.56 178.38 42.08 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.853 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -156.84 -177.93 6.98 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.862 0.363 . . . . 0.0 110.345 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.25 150.15 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.222 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 17' ' ' VAL . . . . . 0.581 HG11 ' HE2' ' F' ' 158' ' ' TYR . 4.1 m -141.7 168.6 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.876 0.37 . . . . 0.0 111.025 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 18' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -93.02 74.66 4.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.05 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.95 91.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.035 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.46 -51.0 0.09 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.423 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 21' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER 179.88 -179.72 0.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.974 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 22' ' ' ALA . . . . . 0.896 ' HB1' ' HB1' ' D' ' 93' ' ' ALA . . . -136.18 116.51 13.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.161 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 23' ' ' VAL . . . . . . . . . . . . . 70.6 t -67.1 120.23 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.995 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 24' ' ' ASP . . . . . 0.43 ' O ' HG23 ' F' ' 28' ' ' VAL . 2.4 m-20 -64.47 150.45 46.54 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.564 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . . . . . . . . . . . -48.39 -50.07 32.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.343 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.37 -31.73 81.33 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.936 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 27' ' ' SER . . . . . 0.41 ' HA ' HE21 ' F' ' 30' ' ' GLN . 0.4 OUTLIER -69.1 -15.99 63.56 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.923 0.392 . . . . 0.0 110.851 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 28' ' ' VAL . . . . . 0.43 HG23 ' O ' ' F' ' 24' ' ' ASP . 48.7 t -72.99 -43.63 58.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.379 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.41 106.15 10.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.994 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 30' ' ' GLN . . . . . 0.41 HE21 ' HA ' ' F' ' 27' ' ' SER . 17.0 mt-30 -116.78 134.05 55.26 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.03 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 31' ' ' THR . . . . . 0.631 HG22 ' HD3' ' E' ' 13' ' ' LYS . 0.9 OUTLIER -105.47 96.12 6.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.083 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' E' ' 11' ' ' HIS . 69.3 t -89.53 131.24 37.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.139 0.495 . . . . 0.0 110.417 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 33' ' ' GLN . . . . . 0.449 ' HA ' ' HG2' ' E' ' 13' ' ' LYS . 0.3 OUTLIER -108.95 106.49 16.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.616 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 34' ' ' LEU . . . . . 0.481 HD12 ' CE2' ' F' ' 137' ' ' TYR . 0.4 OUTLIER -73.86 -40.91 62.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.637 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.01 -122.45 6.74 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.559 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 36' ' ' GLN . . . . . 0.613 ' HB3' ' HA ' ' E' ' 22' ' ' ALA . 16.1 tt0 -144.55 153.87 42.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.658 0.265 . . . . 0.0 110.936 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.525 HG23 HG22 ' E' ' 16' ' ' VAL . 0.0 OUTLIER -128.46 146.29 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.963 -179.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 38' ' ' ARG . . . . . 0.528 ' HE ' ' HB2' ' E' ' 22' ' ' ALA . 0.0 OUTLIER -98.2 145.94 26.11 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.764 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 39' ' ' THR . . . . . 0.554 HG23 ' O ' ' E' ' 17' ' ' VAL . 40.8 p -57.7 -23.06 49.75 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.721 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.07 -33.09 61.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.022 0.439 . . . . 0.0 110.805 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.11 -31.11 69.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.208 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' F' ' 139' ' ' ALA . 0.0 OUTLIER -130.78 86.44 2.38 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.622 179.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 43' ' ' ALA . . . . . . . . . . . . . . . -116.7 36.23 4.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.411 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 177.6 150.79 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.324 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' F' ' 140' ' ' THR . 1.7 tm-20 -64.72 134.85 55.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.34 . . . . 0.0 111.116 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.74 -14.21 53.3 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.215 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 47' ' ' ALA . . . . . 0.552 ' O ' ' HA ' ' F' ' 138' ' ' PHE . . . -57.22 129.91 43.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.927 0.394 . . . . 0.0 112.052 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . 0.465 ' HB ' ' CE1' ' F' ' 138' ' ' PHE . 14.3 t -130.66 143.35 50.69 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.861 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 49' ' ' SER . . . . . 0.601 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 68.8 m -111.98 -157.21 0.61 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.604 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 50' ' ' SER . . . . . 0.416 ' HB3' ' HB1' ' C' ' 92' ' ' ALA . 27.7 t -74.59 150.12 39.81 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.856 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 51' ' ' ALA . . . . . 0.738 ' O ' HD12 ' C' ' 88' ' ' LEU . . . -103.19 146.7 28.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.301 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 52' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' C' ' 90' ' ' SER . 22.2 m -83.45 148.35 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.915 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.4 121.2 6.2 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.628 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 54' ' ' PHE . . . . . 0.412 ' CD1' HG23 ' F' ' 52' ' ' VAL . 16.2 p90 -153.88 125.55 7.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.852 0.358 . . . . 0.0 110.889 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 55' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.26 156.17 20.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.533 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 56' ' ' ILE . . . . . . . . . . . . . 22.4 mm -103.96 135.38 41.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.583 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 57' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -101.75 126.07 48.54 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.713 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . 0.545 ' HB2' ' HB3' ' F' ' 129' ' ' ASN . 4.3 mp -131.65 99.96 4.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.286 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.4 174.82 11.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.982 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 53.71 65.21 1.58 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.83 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 61' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' F' ' 21' ' ' CYS . 60.6 m -98.68 142.98 29.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.813 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.68 109.21 15.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.261 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 63' ' ' THR . . . . . 0.463 HG23 ' HB3' ' F' ' 124' ' ' LEU . 0.2 OUTLIER -92.42 29.57 1.68 Allowed 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.14 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 64' ' ' ASN . . . . . 0.418 HD22 ' HA ' ' F' ' 64' ' ' ASN . 0.1 OUTLIER -90.05 -59.21 2.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.028 0.442 . . . . 0.0 111.679 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.2 -39.93 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.662 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.58 101.36 10.69 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.543 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 30.9 p -90.59 -28.71 18.27 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.857 0.36 . . . . 0.0 110.963 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.52 166.94 16.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.491 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 69' ' ' ALA . . . . . . . . . . . . . . . -151.79 149.88 29.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.583 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 70' ' ' ALA . . . . . 0.627 ' HB3' ' HB3' ' F' ' 157' ' ' GLN . . . -112.98 159.74 18.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.164 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 71' ' ' VAL . . . . . . . . . . . . . 51.4 t -108.02 123.28 63.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.689 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 72' ' ' ALA . . . . . 0.693 ' HB3' ' HB3' ' F' ' 155' ' ' LYS . . . -124.71 168.99 12.42 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.484 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 73' ' ' PHE . . . . . 0.54 ' CB ' HD11 ' F' ' 111' ' ' LEU . 17.2 t80 -150.58 144.47 25.3 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.562 0.22 . . . . 0.0 111.147 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 74' ' ' LEU . . . . . 0.429 HD23 ' O ' ' F' ' 74' ' ' LEU . 0.4 OUTLIER -121.58 88.61 2.97 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.989 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . 0.524 ' C ' HD23 ' F' ' 113' ' ' LEU . . . -134.74 164.65 24.67 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.777 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 76' ' ' THR . . . . . 0.67 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.6 OUTLIER -78.51 147.8 33.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.547 0.213 . . . . 0.0 110.786 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.78 140.38 30.66 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.838 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 78' ' ' ILE . . . . . 0.562 ' CG2' ' HB ' ' F' ' 85' ' ' VAL . 1.1 tt -78.7 -33.15 16.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.16 179.23 7.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.833 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.71 -27.78 36.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.036 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 81' ' ' GLY . . . . . . . . . . . . . . . -69.3 -32.18 72.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.586 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 82' ' ' HIS . . . . . 0.412 ' HB3' HG23 ' F' ' 85' ' ' VAL . 15.3 m-70 -97.33 -72.72 0.63 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.877 0.37 . . . . 0.0 110.446 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 83' ' ' THR . . . . . . . . . . . . . 5.7 m 74.87 -7.21 1.79 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.582 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 84' ' ' ASN . . . . . 0.748 ' HA ' HD13 ' F' ' 113' ' ' LEU . 3.0 m120 -108.81 -19.08 13.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.311 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 85' ' ' VAL . . . . . 0.562 ' HB ' ' CG2' ' F' ' 78' ' ' ILE . 50.4 t -80.71 132.02 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.206 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 86' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' F' ' 152' ' ' ALA . 0.4 OUTLIER -76.55 135.0 39.26 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.255 179.512 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.27 165.15 6.18 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.923 0.392 . . . . 0.0 111.691 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . 0.439 ' H ' ' HG ' ' F' ' 88' ' ' LEU . 0.1 OUTLIER -65.76 171.78 4.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.018 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 89' ' ' GLN . . . . . 0.493 ' OE1' ' HB3' ' F' ' 91' ' ' SER . 8.0 pt20 -72.56 175.74 6.06 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.427 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.02 -21.22 57.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.002 0.43 . . . . 0.0 111.474 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 91' ' ' SER . . . . . 0.493 ' HB3' ' OE1' ' F' ' 89' ' ' GLN . 32.1 t -81.02 67.6 6.99 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.874 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 92' ' ' ALA . . . . . 0.446 ' HA ' ' OG ' ' F' ' 95' ' ' SER . . . -72.35 -9.67 58.81 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.576 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.04 -22.86 64.94 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.683 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -141.47 6.71 2.47 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.86 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 95' ' ' SER . . . . . 0.69 ' HA ' ' HB3' ' F' ' 147' ' ' ALA . 30.8 p -93.71 150.78 20.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.854 0.359 . . . . 0.0 110.674 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -82.71 167.18 18.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.874 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.64 165.19 14.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.314 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 98' ' ' ASN . . . . . 0.527 ' HA ' ' OG1' ' F' ' 140' ' ' THR . 85.1 m-20 63.2 45.5 5.06 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.489 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 99' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' F' ' 143' ' ' ALA . 3.4 p -170.65 131.43 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.72 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.02 -175.94 21.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.511 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 101' ' ' VAL . . . . . . . . . . . . . 76.4 t -104.19 91.9 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 122.979 0.512 . . . . 0.0 111.656 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 102' ' ' GLN . . . . . 0.552 ' HA ' ' HA ' ' F' ' 85' ' ' VAL . 0.0 OUTLIER -67.88 131.18 45.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.898 -179.704 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 103' ' ' ILE . . . . . 0.52 HD12 ' O ' ' F' ' 84' ' ' ASN . 0.7 OUTLIER -99.45 110.52 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.497 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 104' ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 5.5 tp -91.15 149.98 21.57 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.656 0.265 . . . . 0.0 111.078 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.94 174.55 5.84 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.631 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 106' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' F' ' 106' ' ' ARG . 1.5 ttt180 -72.45 -18.46 61.69 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.75 0.309 . . . . 0.0 111.075 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . . . . . . . . . 46.2 p -69.35 -9.66 54.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.999 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.0 -48.33 0.96 Allowed Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.671 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -88.96 163.57 15.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.779 0.323 . . . . 0.0 111.089 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -70.52 125.59 27.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . 0.54 HD11 ' CB ' ' F' ' 73' ' ' PHE . 0.0 OUTLIER -65.43 147.7 52.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.419 0.628 . . . . 0.0 110.558 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 112' ' ' THR . . . . . 0.705 ' HB ' HG21 ' F' ' 117' ' ' THR . 0.2 OUTLIER -74.16 144.67 44.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.12 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 113' ' ' LEU . . . . . 0.748 HD13 ' HA ' ' F' ' 84' ' ' ASN . 10.2 mp -100.35 89.97 4.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 110.644 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 114' ' ' ASP . . . . . 0.436 ' HB2' ' CG2' ' F' ' 117' ' ' THR . 4.1 m-20 -142.41 11.41 1.91 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.691 0.281 . . . . 0.0 111.6 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . 0.448 ' O ' ' HB1' ' F' ' 72' ' ' ALA . . . 96.91 -78.16 0.69 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.611 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 116' ' ' ALA . . . . . 0.465 ' CB ' HG21 ' E' ' 4' ' ' THR . . . -104.29 61.61 0.73 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.966 0.412 . . . . 0.0 111.62 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 117' ' ' THR . . . . . 0.705 HG21 ' HB ' ' F' ' 112' ' ' THR . 17.6 p -93.42 95.84 9.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.126 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -70.77 110.0 5.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.794 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 13.7 m -120.4 -72.91 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.833 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 120' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.49 113.04 25.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.665 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.36 97.42 8.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.25 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.47 132.66 37.52 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.787 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 21.8 m -60.81 146.15 47.26 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.762 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . 0.463 ' HB3' HG23 ' F' ' 63' ' ' THR . 0.2 OUTLIER -85.51 156.6 20.71 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.547 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 125' ' ' ASN . . . . . 0.535 ' HB3' ' HB3' ' C' ' 116' ' ' ALA . 32.6 m120 -137.91 142.71 40.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.474 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.9 113.73 6.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.704 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . 0.612 ' HA3' ' HB ' ' B' ' 4' ' ' THR . . . 128.44 -90.01 0.32 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.693 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 128' ' ' THR . . . . . 0.439 ' HB ' ' HD3' ' C' ' 155' ' ' LYS . 6.2 m -124.92 152.86 43.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.704 0.287 . . . . 0.0 110.751 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 129' ' ' ASN . . . . . 0.545 ' HB3' ' HB2' ' F' ' 58' ' ' LEU . 17.0 t-20 -123.09 147.58 46.59 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.926 0.394 . . . . 0.0 111.113 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 130' ' ' THR . . . . . 0.657 ' OG1' HD12 ' C' ' 74' ' ' LEU . 4.3 m -126.16 135.69 51.96 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.03 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 131' ' ' ILE . . . . . . . . . . . . . 58.6 mt -114.05 115.68 45.38 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 132' ' ' PRO . . . . . 0.558 ' HB3' ' H ' ' C' ' 77' ' ' ALA . 7.5 Cg_endo -81.7 115.71 2.81 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.604 1.536 . . . . 0.0 112.572 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.57 150.79 46.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.823 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 134' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' F' ' 52' ' ' VAL . 1.2 mt-30 -142.39 166.72 23.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.086 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' F' ' 102' ' ' GLN . . . -158.21 102.9 1.79 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.972 0.415 . . . . 0.0 111.587 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 136' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' F' ' 51' ' ' ALA . 0.2 OUTLIER -94.67 -173.46 3.02 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.397 179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 137' ' ' TYR . . . . . 0.601 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 3.8 m-85 -100.76 152.82 20.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.115 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 138' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' F' ' 47' ' ' ALA . 0.2 OUTLIER -147.28 160.8 42.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.046 -179.227 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 139' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' F' ' 42' ' ' LEU . . . -126.88 149.63 49.67 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.86 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 140' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' F' ' 98' ' ' ASN . 0.0 OUTLIER -115.33 27.83 9.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.491 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.39 66.76 0.2 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.948 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . 63.0 88.57 0.09 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.615 0.207 . . . . 0.0 110.747 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 143' ' ' ALA . . . . . 0.469 ' CB ' ' HB ' ' F' ' 99' ' ' VAL . . . -60.22 156.88 14.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.728 0.299 . . . . 0.0 111.431 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 144' ' ' THR . . . . . 0.548 ' HB ' ' CD ' ' F' ' 145' ' ' PRO . 77.4 p -112.17 173.07 3.06 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.243 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 145' ' ' PRO . . . . . 0.548 ' CD ' ' HB ' ' F' ' 144' ' ' THR . 1.4 Cg_endo -84.6 145.22 10.36 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.543 2.162 . . . . 0.0 111.922 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 151.42 -112.77 0.55 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.495 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 147' ' ' ALA . . . . . 0.69 ' HB3' ' HA ' ' F' ' 95' ' ' SER . . . -124.98 167.68 14.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.903 0.382 . . . . 0.0 111.337 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 148' ' ' ALA . . . . . 0.426 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -157.16 57.49 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.403 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -91.89 132.71 36.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.514 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.41 163.12 28.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.008 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -165.44 125.63 1.84 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.205 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 152' ' ' ALA . . . . . 0.767 ' HB2' HD21 ' F' ' 86' ' ' LEU . . . -154.57 165.79 35.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.215 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -104.83 163.17 12.71 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 154' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -119.03 134.53 55.14 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.11 0.481 . . . . 0.0 110.116 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . 0.693 ' HB3' ' HB3' ' F' ' 72' ' ' ALA . 0.0 OUTLIER -95.51 166.21 11.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.951 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 156' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.23 112.81 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.771 0.32 . . . . 0.0 111.684 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 157' ' ' GLN . . . . . 0.627 ' HB3' ' HB3' ' F' ' 70' ' ' ALA . 0.2 OUTLIER -88.74 138.79 31.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.264 0.554 . . . . 0.0 110.404 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . 0.581 ' HE2' HG11 ' F' ' 17' ' ' VAL . 22.5 m-85 -127.63 113.2 15.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.503 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 159' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.924 179.981 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' B' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 120.27 0.081 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.22 64.95 1.53 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.002 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.514 HG21 ' HB2' ' B' ' 18' ' ' ASN . 57.4 m -111.23 101.02 9.55 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.46 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.651 HG21 ' HA2' ' E' ' 127' ' ' GLY . 60.6 m -86.71 131.93 34.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.56 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.788 HG23 HG23 ' B' ' 156' ' ' VAL . 0.0 OUTLIER -161.18 168.04 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.525 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -100.1 118.78 37.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.539 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.4 -56.31 6.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.748 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.94 -145.38 4.66 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.873 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.831 HG23 HG23 ' B' ' 153' ' ' THR . 0.0 OUTLIER -145.0 142.05 29.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.933 0.397 . . . . 0.0 111.284 -179.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.2 t -121.65 107.32 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.176 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.75 111.0 21.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.386 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.508 ' CD1' HD11 ' B' ' 34' ' ' LEU . 32.0 m-85 -87.61 113.52 23.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.775 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.12 118.61 36.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.412 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.56 175.53 39.77 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.909 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.598 ' HG3' ' HA ' ' B' ' 147' ' ' ALA . 0.1 OUTLIER -151.27 162.14 41.44 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.946 0.403 . . . . 0.0 110.31 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.75 HG23 ' HB2' ' B' ' 148' ' ' ALA . 2.2 t -114.94 119.43 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.29 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.539 HG11 ' NE2' ' B' ' 36' ' ' GLN . 0.3 OUTLIER -121.33 168.14 14.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.818 0.342 . . . . 0.0 111.064 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.459 ' HA ' HG22 ' B' ' 39' ' ' THR . 1.3 t-20 -68.46 -175.27 0.63 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.004 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.593 ' O ' HG21 ' A' ' 65' ' ' VAL . . . -91.14 52.66 2.17 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.167 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.93 -15.74 1.32 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.335 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -176.88 147.6 0.6 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.975 -179.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.508 ' HA ' HG21 ' A' ' 17' ' ' VAL . . . -152.62 110.08 3.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.046 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -52.97 159.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.032 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.37 164.48 14.31 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.578 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.07 -52.29 65.89 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.397 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.43 11.92 66.54 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.858 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.5 t -96.23 -30.79 13.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.989 0.423 . . . . 0.0 110.934 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.421 HG23 ' H ' ' A' ' 28' ' ' VAL . 11.4 t -49.88 -71.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.311 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.54 104.4 15.27 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.02 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.534 HE22 ' HA ' ' A' ' 56' ' ' ILE . 41.6 mt-30 -112.23 140.41 46.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.104 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.79 110.16 21.47 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 112.067 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.18 108.35 25.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.167 0.508 . . . . 0.0 110.42 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.59 112.5 22.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.638 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.549 HD21 ' CG2' ' A' ' 101' ' ' VAL . 5.2 mp -81.15 -41.82 21.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.572 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.67 -171.08 21.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.649 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -93.6 145.95 24.17 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.565 0.222 . . . . 0.0 110.912 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.515 HG22 ' H ' ' A' ' 38' ' ' ARG . 5.0 p -124.86 169.88 15.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.95 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.515 ' H ' HG22 ' A' ' 37' ' ' VAL . 5.2 mtt-85 -98.95 121.42 40.88 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.717 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -61.87 -31.06 71.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.738 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.56 -39.3 84.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.999 0.428 . . . . 0.0 110.81 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.3 m -81.32 -10.35 59.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.204 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.741 ' O ' ' HB2' ' A' ' 143' ' ' ALA . 0.6 OUTLIER -129.36 40.51 3.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.556 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.605 ' HA ' ' H ' ' A' ' 143' ' ' ALA . . . -111.86 10.88 20.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.366 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.53 145.55 48.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.329 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 140' ' ' THR . 18.2 tt0 -63.34 121.17 13.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 111.159 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.02 14.54 33.51 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.15 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.699 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . . . -72.26 121.2 19.0 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.0 p -129.97 133.84 47.06 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.893 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 137' ' ' TYR . 57.8 m -112.52 -166.75 1.11 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.625 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.2 t -59.08 149.48 27.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.818 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.82 153.57 17.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.347 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.649 HG22 ' HB3' ' A' ' 135' ' ' ALA . 3.7 m -103.37 130.31 53.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.963 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.98 121.53 6.57 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.619 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.496 ' HD1' HG23 ' A' ' 52' ' ' VAL . 52.3 p90 -153.7 136.41 15.25 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.779 0.323 . . . . 0.0 110.955 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 131' ' ' ILE . 24.7 p30 -133.59 141.3 47.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.679 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.639 HG21 HD12 ' A' ' 131' ' ' ILE . 1.2 tt -85.13 126.49 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.622 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.609 ' HA ' HG23 ' A' ' 130' ' ' THR . 0.1 OUTLIER -75.77 119.39 19.72 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.773 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -130.69 87.31 2.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.316 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.721 ' HA ' ' HA ' ' A' ' 128' ' ' THR . 5.0 p30 -77.18 173.72 11.54 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.981 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.519 ' HB3' ' HE ' ' B' ' 38' ' ' ARG . 41.5 m-20 62.82 66.38 0.76 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.741 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 34.4 m -115.64 161.96 17.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.732 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.51 ' HA ' ' OD1' ' A' ' 126' ' ' ASN . 0.2 OUTLIER -145.94 157.82 43.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.289 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.481 HG23 ' HA ' ' A' ' 125' ' ' ASN . 0.0 OUTLIER -107.5 -16.74 14.29 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.13 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.39 -33.63 32.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.062 0.458 . . . . 0.0 111.763 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.593 HG21 ' O ' ' A' ' 19' ' ' ALA . 20.1 t -75.21 -41.56 44.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.665 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.91 146.75 29.15 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.558 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.83 -39.37 3.73 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.895 0.378 . . . . 0.0 110.92 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.31 159.53 15.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.477 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.601 ' HB3' ' HB ' ' A' ' 122' ' ' THR . . . -147.2 118.88 8.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.616 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 118' ' ' PHE . . . -96.84 140.72 30.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.096 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 131' ' ' ILE . 3.1 t -118.43 139.71 44.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.798 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.4 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -140.54 133.92 29.86 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.523 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.792 ' HD2' HD13 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -101.26 138.04 38.8 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.575 0.226 . . . . 0.0 111.15 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.734 HD21 HG21 ' D' ' 130' ' ' THR . 6.6 tt -100.99 91.02 4.38 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.001 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.37 -167.37 11.32 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.87 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.662 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -116.75 159.52 22.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.64 0.257 . . . . 0.0 110.752 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB2' HG23 ' A' ' 83' ' ' THR . . . -83.96 137.96 33.37 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.996 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 82' ' ' HIS . 9.0 tt -77.17 -40.52 29.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.88 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.603 ' HB2' HG21 ' A' ' 140' ' ' THR . 0.1 OUTLIER -141.18 55.24 1.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.852 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' D' ' 106' ' ' ARG . . . 52.85 -84.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.081 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . -60.1 -16.12 39.58 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.577 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.46 ' O ' HG22 ' A' ' 78' ' ' ILE . 24.5 m80 -100.6 56.74 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.597 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.526 HG23 ' HB2' ' A' ' 77' ' ' ALA . 1.1 m -71.36 -22.46 61.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.537 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.738 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 8.6 p-10 -57.23 -18.68 17.12 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.338 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.526 HG11 ' HB3' ' A' ' 138' ' ' PHE . 11.6 t -115.19 133.31 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.213 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.912 HD12 HD22 ' A' ' 113' ' ' LEU . 0.8 OUTLIER -72.93 154.12 40.69 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.347 179.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.601 ' N ' HD23 ' A' ' 86' ' ' LEU . . . -90.72 -161.37 0.8 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.846 0.355 . . . . 0.0 111.793 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.31 6.97 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.974 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.65 -83.92 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.312 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.26 20.53 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.415 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.754 ' HB2' ' HB2' ' A' ' 95' ' ' SER . 1.5 m -86.59 79.34 8.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.75 -31.51 38.42 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.916 0.389 . . . . 0.0 111.672 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' D' ' 36' ' ' GLN . . . -128.09 54.53 1.72 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.615 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.89 -17.27 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.975 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.754 ' HB2' ' HB2' ' A' ' 91' ' ' SER . 0.9 OUTLIER -89.47 177.19 6.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.797 0.332 . . . . 0.0 110.622 179.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.69 175.24 8.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.777 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 98' ' ' ASN . 0.2 OUTLIER -137.51 137.98 39.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.269 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 97' ' ' THR . 74.0 m-80 71.69 17.64 5.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.434 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.99 148.93 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.728 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.28 -176.74 35.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.46 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.549 ' CG2' HD21 ' A' ' 34' ' ' LEU . 7.7 p -125.58 111.02 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 122.993 0.517 . . . . 0.0 111.718 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.612 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 0.9 OUTLIER -81.53 147.74 29.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.873 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.792 HD13 ' HD2' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -123.76 115.94 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.489 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.739 ' HA ' ' HA ' ' A' ' 110' ' ' ALA . 0.4 OUTLIER -88.7 140.55 29.34 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.621 0.248 . . . . 0.0 111.031 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 111' ' ' LEU . 2.1 t70 -89.37 152.0 21.75 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.68 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.645 ' HG3' ' HG2' ' A' ' 132' ' ' PRO . 0.0 OUTLIER -71.74 -21.08 61.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.816 0.341 . . . . 0.0 111.101 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.61 ' HB ' ' HA ' ' A' ' 120' ' ' SER . 5.8 t -62.89 -21.94 66.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.064 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.69 -83.09 0.19 Allowed Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.611 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.69 170.67 15.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.776 0.322 . . . . 0.0 111.098 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.739 ' HA ' ' HA ' ' A' ' 104' ' ' LEU . . . -74.82 138.64 42.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.224 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.617 ' HB2' ' HB2' ' A' ' 105' ' ' ASP . 5.1 tp -94.53 153.38 17.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.343 0.592 . . . . 0.0 110.568 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.782 HG22 HG21 ' A' ' 117' ' ' THR . 6.2 t -93.68 148.24 22.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.171 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.912 HD22 HD12 ' A' ' 86' ' ' LEU . 1.4 mp -89.51 64.78 6.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.77 0.319 . . . . 0.0 110.771 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.557 ' HB2' ' OG1' ' A' ' 117' ' ' THR . 0.5 OUTLIER -95.04 -16.1 22.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.606 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.604 ' HA3' ' HG1' ' D' ' 130' ' ' THR . . . 104.44 -56.28 0.56 Allowed Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.66 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' D' ' 125' ' ' ASN . . . -103.56 29.08 5.95 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.994 0.426 . . . . 0.0 111.667 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.782 HG21 HG22 ' A' ' 112' ' ' THR . 3.4 m -87.19 65.85 9.01 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.105 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.519 ' HB3' ' HB1' ' A' ' 70' ' ' ALA . 48.3 m-85 -77.69 73.45 4.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.795 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.5 70.78 0.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.61 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 0.7 OUTLIER -148.63 126.09 11.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.681 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.05 53.21 2.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.25 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 0.2 OUTLIER -74.06 128.34 35.27 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.75 -179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.36 117.89 25.45 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.703 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.51 134.76 33.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.719 0.295 . . . . 0.0 110.538 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.481 ' HA ' HG23 ' A' ' 63' ' ' THR . 0.3 OUTLIER -129.21 163.1 26.33 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.672 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' A' ' 62' ' ' ASP . 1.5 t30 -67.61 125.33 25.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.669 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.61 -141.04 12.21 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.687 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 59' ' ' ASN . 6.3 m -101.73 92.47 4.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.647 0.26 . . . . 0.0 110.729 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.541 ' HB2' ' SG ' ' A' ' 61' ' ' CYS . 1.2 t30 -76.54 145.03 39.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.926 0.393 . . . . 0.0 111.13 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.609 HG23 ' HA ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -134.63 131.81 38.24 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.049 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.687 HD11 HG12 ' A' ' 156' ' ' VAL . 28.4 mt -87.43 109.82 29.03 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.645 ' HG2' ' HG3' ' A' ' 106' ' ' ARG . 7.4 Cg_endo -81.65 112.12 2.38 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 121.578 1.518 . . . . 0.0 112.608 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.28 138.22 51.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.881 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 28.2 mt-30 -110.1 157.5 19.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.062 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.649 ' HB3' HG22 ' A' ' 52' ' ' VAL . . . -152.68 107.91 3.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.97 0.414 . . . . 0.0 111.585 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -102.51 174.4 5.92 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.36 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 0.6 OUTLIER -85.96 120.88 27.84 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.083 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.526 ' HB3' HG11 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -117.67 139.6 50.79 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.076 -179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.699 ' HB3' ' HB3' ' A' ' 47' ' ' ALA . . . -129.88 145.66 51.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.914 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . 0.603 HG21 ' HB2' ' A' ' 79' ' ' ASP . 16.5 p -104.43 -53.4 2.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.483 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.76 -121.48 3.26 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.989 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.12 112.83 24.43 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.517 0.199 . . . . 0.0 110.719 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.741 ' HB2' ' O ' ' A' ' 42' ' ' LEU . . . -61.68 150.85 35.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.805 0.336 . . . . 0.0 111.519 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.558 HG23 ' HD2' ' A' ' 145' ' ' PRO . 60.0 m -126.79 151.49 73.67 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.26 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.558 ' HD2' HG23 ' A' ' 144' ' ' THR . 1.4 Cg_endo -83.03 140.23 9.92 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 122.573 2.182 . . . . 0.0 111.963 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.9 -138.1 6.58 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.539 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 95' ' ' SER . . . -87.21 144.99 26.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.898 0.38 . . . . 0.0 111.367 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -140.73 38.87 1.83 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.527 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.05 153.48 22.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.505 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.588 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -161.87 171.28 17.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.04 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.42 126.8 7.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.239 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' A' ' 86' ' ' LEU . . . -125.35 142.85 51.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.249 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.86 133.17 34.89 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.482 ' HD1' ' HA ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -86.45 127.87 34.89 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.119 0.485 . . . . 0.0 110.079 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.49 150.51 29.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.962 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.687 HG12 HD11 ' A' ' 131' ' ' ILE . 14.2 m -136.23 144.48 32.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.863 0.363 . . . . 0.0 111.571 -179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -136.19 132.76 36.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.32 0.581 . . . . 0.0 110.386 -179.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.494 ' OH ' ' HB3' ' A' ' 21' ' ' CYS . 5.5 m-85 -117.41 119.77 36.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.516 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' C' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.271 0 CA-C-O 120.23 0.062 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.19 64.9 1.55 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.086 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' THR . . . . . 0.532 HG21 ' HB2' ' C' ' 18' ' ' ASN . 59.0 m -111.21 100.99 9.53 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.05 0.452 . . . . 0.0 111.536 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.661 HG21 ' HA2' ' F' ' 127' ' ' GLY . 60.1 m -86.72 131.91 34.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.545 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.809 HG23 HG23 ' C' ' 156' ' ' VAL . 0.0 OUTLIER -161.09 168.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.532 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.17 118.75 37.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.571 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.32 -56.32 6.97 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.759 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.97 -145.36 4.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.923 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.82 HG23 HG23 ' C' ' 153' ' ' THR . 0.0 OUTLIER -144.99 142.1 29.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.927 0.394 . . . . 0.0 111.302 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 44.1 t -121.66 107.37 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.198 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.81 110.95 21.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.365 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . 0.506 ' CD1' HD11 ' C' ' 34' ' ' LEU . 31.8 m-85 -87.58 113.58 23.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.794 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.18 118.55 36.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.338 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.51 175.6 39.73 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.973 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.615 ' HG3' ' HA ' ' C' ' 147' ' ' ALA . 0.1 OUTLIER -151.36 162.08 41.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.967 0.413 . . . . 0.0 110.302 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.732 HG23 ' HB2' ' C' ' 148' ' ' ALA . 2.2 t -114.95 119.38 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.268 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.533 HG11 ' NE2' ' C' ' 36' ' ' GLN . 0.3 OUTLIER -121.28 168.1 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.887 0.375 . . . . 0.0 111.017 -179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . 0.514 ' HB2' HG21 ' A' ' 3' ' ' THR . 1.3 t-20 -68.54 -175.25 0.63 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.91 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.606 ' O ' HG21 ' B' ' 65' ' ' VAL . . . -91.1 52.61 2.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.233 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.95 -15.64 1.32 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.39 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.798 ' SG ' ' SG ' ' B' ' 61' ' ' CYS . 0.0 OUTLIER -176.95 147.63 0.59 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.965 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.494 ' HA ' HG21 ' B' ' 17' ' ' VAL . . . -152.63 110.04 3.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.084 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.528 ' HA ' ' HA ' ' B' ' 58' ' ' LEU . 0.3 OUTLIER -53.0 159.07 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -90.39 164.47 14.3 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.563 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.99 -52.39 65.44 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.369 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.33 11.91 66.35 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.916 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' SER . . . . . . . . . . . . . 18.4 t -96.25 -30.78 13.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.894 0.378 . . . . 0.0 110.908 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.408 ' H ' HG23 ' B' ' 28' ' ' VAL . 11.3 t -49.89 -71.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.341 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.55 104.36 15.24 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.012 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' GLN . . . . . 0.541 HE22 ' HA ' ' B' ' 56' ' ' ILE . 41.8 mt-30 -112.21 140.34 46.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.082 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.82 110.13 21.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.054 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.13 108.42 25.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.157 0.503 . . . . 0.0 110.44 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.66 112.43 22.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.63 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.544 HD21 ' CG2' ' B' ' 101' ' ' VAL . 5.2 mp -81.12 -41.82 21.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.625 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.76 -171.05 21.51 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.603 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' GLN . . . . . 0.549 ' HA ' ' O ' ' A' ' 15' ' ' GLU . 2.4 mt-30 -93.69 145.88 24.25 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.602 0.239 . . . . 0.0 110.908 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.516 HG22 ' H ' ' B' ' 38' ' ' ARG . 5.0 p -124.8 169.89 15.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.94 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.519 ' HE ' ' HB3' ' A' ' 60' ' ' ASP . 5.1 mtt-85 -98.95 121.5 40.99 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.68 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' THR . . . . . 0.541 ' O ' ' HB2' ' B' ' 43' ' ' ALA . 0.6 OUTLIER -62.01 -31.0 71.34 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.705 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.28 84.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.91 0.386 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 70.9 m -81.31 -10.39 59.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.149 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.755 ' O ' ' HB2' ' B' ' 143' ' ' ALA . 0.6 OUTLIER -129.27 40.48 3.61 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.59 179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ALA . . . . . 0.617 ' HA ' ' H ' ' B' ' 143' ' ' ALA . . . -111.86 10.94 20.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.333 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.56 145.52 48.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.326 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' B' ' 140' ' ' THR . 18.2 tt0 -63.3 121.15 13.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.81 0.338 . . . . 0.0 111.133 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.05 14.49 33.56 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.163 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' B' ' 139' ' ' ALA . . . -72.36 121.19 19.08 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' THR . . . . . . . . . . . . . 15.1 p -130.01 133.8 47.0 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.86 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' B' ' 137' ' ' TYR . 57.8 m -112.47 -166.68 1.1 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.592 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 36.2 t -59.07 149.52 27.53 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.76 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.84 153.59 17.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.397 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.655 HG22 ' HB3' ' B' ' 135' ' ' ALA . 3.7 m -103.42 130.31 53.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.92 121.45 6.53 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.64 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . 0.492 ' HD1' HG23 ' B' ' 52' ' ' VAL . 52.1 p90 -153.64 136.41 15.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.816 0.341 . . . . 0.0 110.962 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' B' ' 131' ' ' ILE . 24.8 p30 -133.58 141.31 47.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.707 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.649 HG21 HD12 ' B' ' 131' ' ' ILE . 1.2 tt -85.19 126.45 40.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.59 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . 0.609 ' HA ' HG23 ' B' ' 130' ' ' THR . 0.1 OUTLIER -75.79 119.38 19.71 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.711 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 0.2 OUTLIER -130.64 87.34 2.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.299 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ASN . . . . . 0.721 ' HA ' ' HA ' ' B' ' 128' ' ' THR . 5.1 p30 -77.29 173.71 11.59 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.955 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ASP . . . . . 0.53 ' HB3' ' HE ' ' C' ' 38' ' ' ARG . 41.6 m-20 62.85 66.43 0.75 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.878 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' CYS . . . . . 0.798 ' SG ' ' SG ' ' B' ' 21' ' ' CYS . 34.4 m -115.71 161.96 17.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.736 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ASP . . . . . 0.504 ' HA ' ' OD1' ' B' ' 126' ' ' ASN . 0.2 OUTLIER -145.91 157.86 43.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.35 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.476 HG23 ' HA ' ' B' ' 125' ' ' ASN . 0.0 OUTLIER -107.54 -16.71 14.29 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.13 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.4 -33.7 32.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.057 0.456 . . . . 0.0 111.737 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.606 HG21 ' O ' ' B' ' 19' ' ' ALA . 20.0 t -75.12 -41.62 44.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.675 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.94 146.75 29.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.55 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.75 -39.43 3.74 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.893 0.378 . . . . 0.0 110.951 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.31 159.55 15.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.456 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' ALA . . . . . 0.603 ' HB3' ' HB ' ' B' ' 122' ' ' THR . . . -147.18 118.88 8.02 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.608 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.524 ' HB1' ' HB3' ' B' ' 118' ' ' PHE . . . -96.84 140.79 30.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.025 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.473 HG11 HG21 ' B' ' 131' ' ' ILE . 3.1 t -118.52 139.69 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.762 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.52 133.93 29.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.595 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' PHE . . . . . 0.771 ' HD2' HD13 ' B' ' 103' ' ' ILE . 0.1 OUTLIER -101.28 138.06 38.8 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.623 0.249 . . . . 0.0 111.116 179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.714 HD21 HG21 ' E' ' 130' ' ' THR . 6.6 tt -101.05 91.12 4.41 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.003 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.38 -167.4 11.32 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.886 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . 0.659 ' O ' ' HA ' ' B' ' 86' ' ' LEU . 0.3 OUTLIER -116.7 159.45 22.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.58 0.229 . . . . 0.0 110.761 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.517 ' HB2' HG23 ' B' ' 83' ' ' THR . . . -83.84 137.92 33.46 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.013 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . 0.452 HG22 ' O ' ' B' ' 82' ' ' HIS . 9.0 tt -77.16 -40.47 29.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.894 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . 0.603 ' HB2' HG21 ' B' ' 140' ' ' THR . 0.1 OUTLIER -141.26 55.26 1.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.786 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' E' ' 106' ' ' ARG . . . 52.93 -84.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.008 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' B' ' 79' ' ' ASP . . . -60.07 -16.11 39.27 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.62 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' HIS . . . . . 0.452 ' O ' HG22 ' B' ' 78' ' ' ILE . 24.2 m80 -100.54 56.68 0.9 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.925 0.393 . . . . 0.0 110.619 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' THR . . . . . 0.517 HG23 ' HB2' ' B' ' 77' ' ' ALA . 1.1 m -71.33 -22.42 61.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.587 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . 0.738 ' HA ' ' HA ' ' B' ' 112' ' ' THR . 8.6 p-10 -57.23 -18.71 17.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.305 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' B' ' 138' ' ' PHE . 11.5 t -115.18 133.45 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.211 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' LEU . . . . . 0.923 HD12 HD22 ' B' ' 113' ' ' LEU . 0.8 OUTLIER -73.01 154.03 40.66 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.352 179.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.601 ' N ' HD23 ' B' ' 86' ' ' LEU . . . -90.69 -161.34 0.79 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.823 0.344 . . . . 0.0 111.793 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.23 6.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.016 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.65 -83.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.31 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.26 20.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.453 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' SER . . . . . 0.77 ' HB2' ' HB2' ' B' ' 95' ' ' SER . 1.5 m -86.53 79.35 8.97 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.71 -31.56 38.36 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.808 0.337 . . . . 0.0 111.642 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' ALA . . . . . 0.506 ' HB3' ' O ' ' E' ' 36' ' ' GLN . . . -128.02 54.4 1.72 Allowed 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.663 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.87 -17.3 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.934 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' SER . . . . . 0.77 ' HB2' ' HB2' ' B' ' 91' ' ' SER . 0.9 OUTLIER -89.35 177.21 6.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.768 0.318 . . . . 0.0 110.703 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.71 175.31 8.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.785 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' B' ' 98' ' ' ASN . 0.2 OUTLIER -137.61 137.94 39.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.25 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' B' ' 97' ' ' THR . 74.0 m-80 71.78 17.6 5.38 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.444 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.95 149.0 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.672 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.44 -176.76 35.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.441 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.544 ' CG2' HD21 ' B' ' 34' ' ' LEU . 7.7 p -125.56 111.1 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 122.974 0.51 . . . . 0.0 111.678 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' GLN . . . . . 0.609 ' O ' ' HA ' ' B' ' 135' ' ' ALA . 0.9 OUTLIER -81.67 147.68 29.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.789 -179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.771 HD13 ' HD2' ' B' ' 73' ' ' PHE . 0.9 OUTLIER -123.64 115.91 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.54 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' LEU . . . . . 0.709 ' HA ' ' HA ' ' B' ' 110' ' ' ALA . 0.4 OUTLIER -88.68 140.5 29.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.614 0.245 . . . . 0.0 111.036 -179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ASP . . . . . 0.601 ' HB2' ' HB2' ' B' ' 111' ' ' LEU . 2.1 t70 -89.31 152.01 21.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.708 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . 0.627 ' HG3' ' HG2' ' B' ' 132' ' ' PRO . 0.0 OUTLIER -71.8 -21.03 61.76 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.752 0.31 . . . . 0.0 111.027 179.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' THR . . . . . 0.614 ' HB ' ' HA ' ' B' ' 120' ' ' SER . 5.8 t -62.91 -21.94 66.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.007 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.64 -83.02 0.19 Allowed Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.662 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.69 170.72 15.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.767 0.318 . . . . 0.0 111.05 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.709 ' HA ' ' HA ' ' B' ' 104' ' ' LEU . . . -74.94 138.68 42.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.186 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.601 ' HB2' ' HB2' ' B' ' 105' ' ' ASP . 5.1 tp -94.53 153.47 17.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.385 0.612 . . . . 0.0 110.571 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . 0.805 HG22 HG21 ' B' ' 117' ' ' THR . 6.2 t -93.68 148.28 22.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.105 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.923 HD22 HD12 ' B' ' 86' ' ' LEU . 1.4 mp -89.64 64.9 6.74 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.783 0.325 . . . . 0.0 110.722 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ASP . . . . . 0.556 ' HB2' ' OG1' ' B' ' 117' ' ' THR . 0.5 OUTLIER -95.07 -16.07 22.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.62 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . 0.607 ' HA3' ' HG1' ' E' ' 130' ' ' THR . . . 104.43 -56.24 0.57 Allowed Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.637 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' E' ' 125' ' ' ASN . . . -103.61 29.0 6.03 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 121.029 0.442 . . . . 0.0 111.714 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.805 HG21 HG22 ' B' ' 112' ' ' THR . 3.4 m -87.08 65.85 9.1 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.142 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' PHE . . . . . 0.524 ' HB3' ' HB1' ' B' ' 70' ' ' ALA . 48.3 m-85 -77.65 73.4 4.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.772 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.53 70.86 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . 0.614 ' HA ' ' HB ' ' B' ' 107' ' ' THR . 0.7 OUTLIER -148.69 126.11 11.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.673 179.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.07 53.18 2.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.232 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' B' ' 69' ' ' ALA . 0.2 OUTLIER -73.97 128.28 35.1 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.732 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.33 117.97 25.47 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.675 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.51 134.8 33.76 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.548 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' ASN . . . . . 0.476 ' HA ' HG23 ' B' ' 63' ' ' THR . 0.3 OUTLIER -129.28 163.06 26.49 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.637 179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' ASN . . . . . 0.504 ' OD1' ' HA ' ' B' ' 62' ' ' ASP . 1.5 t30 -67.58 125.43 26.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.66 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.58 -141.06 12.22 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.664 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' B' ' 59' ' ' ASN . 6.3 m -101.74 92.34 4.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.673 0.273 . . . . 0.0 110.788 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . 0.544 ' HB2' ' SG ' ' B' ' 61' ' ' CYS . 1.2 t30 -76.44 145.01 39.57 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.854 0.359 . . . . 0.0 111.164 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.609 HG23 ' HA ' ' B' ' 57' ' ' GLN . 0.0 OUTLIER -134.62 131.81 38.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.073 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' ILE . . . . . 0.677 HD11 HG12 ' B' ' 156' ' ' VAL . 28.4 mt -87.41 109.8 28.86 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' PRO . . . . . 0.627 ' HG2' ' HG3' ' B' ' 106' ' ' ARG . 7.6 Cg_endo -81.52 112.06 2.4 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 121.645 1.563 . . . . 0.0 112.608 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.3 138.24 51.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.875 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' B' ' 52' ' ' VAL . 28.1 mt-30 -110.13 157.48 19.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.035 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.655 ' HB3' HG22 ' B' ' 52' ' ' VAL . . . -152.66 107.84 3.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.905 0.383 . . . . 0.0 111.602 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -102.5 174.38 5.93 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.376 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . 0.475 ' HB2' ' HB2' ' B' ' 49' ' ' SER . 0.6 OUTLIER -85.97 120.87 27.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.105 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . 0.516 ' HB3' HG11 ' B' ' 85' ' ' VAL . 0.2 OUTLIER -117.66 139.57 50.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.062 -179.181 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' B' ' 47' ' ' ALA . . . -129.86 145.57 51.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.913 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' THR . . . . . 0.603 HG21 ' HB2' ' B' ' 79' ' ' ASP . 16.7 p -104.32 -53.41 2.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.513 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.75 -121.54 3.27 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.027 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.04 112.88 24.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.573 0.225 . . . . 0.0 110.729 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' B' ' 42' ' ' LEU . . . -61.69 150.86 35.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.783 0.325 . . . . 0.0 111.481 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.554 HG23 ' HD2' ' B' ' 145' ' ' PRO . 59.6 m -126.79 151.51 73.72 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.274 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' B' ' 144' ' ' THR . 1.3 Cg_endo -83.06 140.24 9.9 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.626 2.218 . . . . 0.0 111.945 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.91 -138.09 6.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.518 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' ALA . . . . . 0.598 ' HA ' ' HG3' ' A' ' 15' ' ' GLU . . . -87.2 144.99 26.58 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.925 0.393 . . . . 0.0 111.351 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' ALA . . . . . 0.75 ' HB2' HG23 ' A' ' 16' ' ' VAL . . . -140.7 38.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.566 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.09 153.59 21.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.546 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' ALA . . . . . 0.607 ' HB1' HD22 ' B' ' 86' ' ' LEU . . . -161.88 171.24 18.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.041 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.45 126.79 7.9 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.251 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . 0.541 ' HB2' ' CD1' ' B' ' 86' ' ' LEU . . . -125.32 142.78 51.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.259 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.831 HG23 HG23 ' A' ' 9' ' ' THR . 0.5 OUTLIER -89.83 133.18 34.87 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' PHE . . . . . 0.403 ' HD1' ' HA ' ' B' ' 154' ' ' PHE . 0.0 OUTLIER -86.41 127.85 34.88 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.118 0.485 . . . . 0.0 110.137 -179.024 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' LYS . . . . . 0.4 ' HE3' HD12 ' B' ' 74' ' ' LEU . 29.1 mmtt -111.54 150.53 29.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.882 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' VAL . . . . . 0.788 HG23 HG23 ' A' ' 5' ' ' VAL . 14.3 m -136.19 144.47 33.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.614 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' B' ' 69' ' ' ALA . 0.0 OUTLIER -136.17 132.75 36.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.253 0.549 . . . . 0.0 110.442 -179.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' TYR . . . . . 0.495 ' OH ' ' HB3' ' B' ' 21' ' ' CYS . 5.5 m-85 -117.45 119.7 35.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.514 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.881 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' D' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 111.123 0.045 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.26 65.02 1.5 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.598 0.237 . . . . 0.0 110.96 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' THR . . . . . 0.525 HG21 ' HB2' ' D' ' 18' ' ' ASN . 57.2 m -111.23 101.0 9.53 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.471 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' THR . . . . . 0.512 ' HA ' ' HG2' ' D' ' 157' ' ' GLN . 61.6 m -86.63 131.85 34.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.67 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.792 HG23 HG23 ' D' ' 156' ' ' VAL . 0.0 OUTLIER -161.11 168.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.607 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.09 118.68 36.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.616 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.26 -56.38 6.96 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.752 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.97 -145.38 4.66 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.909 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . 0.812 HG23 HG23 ' D' ' 153' ' ' THR . 0.0 OUTLIER -145.02 142.06 29.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.399 . . . . 0.0 111.292 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' VAL . . . . . 0.4 HG21 ' HZ ' ' D' ' 73' ' ' PHE . 44.0 t -121.59 107.33 19.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.211 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.73 110.97 21.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.424 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' PHE . . . . . 0.51 ' CD1' HD11 ' D' ' 34' ' ' LEU . 32.0 m-85 -87.59 113.59 23.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.713 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.19 118.53 36.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.379 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.54 175.58 39.76 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.974 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' GLU . . . . . 0.608 ' HG3' ' HA ' ' D' ' 147' ' ' ALA . 0.1 OUTLIER -151.36 162.16 41.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.967 0.413 . . . . 0.0 110.263 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . 0.743 HG23 ' HB2' ' D' ' 148' ' ' ALA . 2.2 t -115.08 119.48 61.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.153 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' VAL . . . . . 0.531 HG11 ' NE2' ' D' ' 36' ' ' GLN . 0.3 OUTLIER -121.31 168.1 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.808 0.337 . . . . 0.0 111.063 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' ASN . . . . . 0.532 ' HB2' HG21 ' B' ' 3' ' ' THR . 1.3 t-20 -68.5 -175.24 0.63 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.976 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . 0.602 ' O ' HG21 ' C' ' 65' ' ' VAL . . . -91.11 52.63 2.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.93 -15.76 1.32 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.361 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' C' ' 61' ' ' CYS . 0.0 OUTLIER -176.91 147.64 0.6 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.926 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . 0.507 ' HA ' HG21 ' C' ' 17' ' ' VAL . . . -152.59 110.04 3.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.097 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' C' ' 58' ' ' LEU . 0.3 OUTLIER -53.08 159.07 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.01 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -90.32 164.46 14.34 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.614 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 91' ' ' SER . . . -57.01 -52.39 65.47 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.357 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.38 11.97 66.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.912 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' SER . . . . . . . . . . . . . 18.3 t -96.29 -30.78 13.25 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.889 0.376 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 11.2 t -49.76 -71.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.341 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.52 104.31 15.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.086 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' GLN . . . . . 0.532 HE22 ' HA ' ' C' ' 56' ' ' ILE . 41.7 mt-30 -112.19 140.36 46.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.113 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.8 110.07 21.35 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 112.142 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 45.8 t -108.04 108.4 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.118 0.485 . . . . 0.0 110.386 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.67 112.42 22.33 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.687 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' LEU . . . . . 0.538 HD21 ' CG2' ' C' ' 101' ' ' VAL . 5.3 mp -81.03 -41.8 22.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.699 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.72 -171.12 21.61 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.604 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' B' ' 15' ' ' GLU . 2.4 mt-30 -93.67 145.91 24.21 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 120.62 0.247 . . . . 0.0 110.913 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.51 HG22 ' H ' ' C' ' 38' ' ' ARG . 5.0 p -124.84 169.94 15.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.94 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' ARG . . . . . 0.53 ' HE ' ' HB3' ' B' ' 60' ' ' ASP . 5.2 mtt-85 -98.93 121.37 40.79 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.71 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' C' ' 43' ' ' ALA . 0.6 OUTLIER -61.96 -30.94 71.27 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.717 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.61 -39.3 84.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.909 0.385 . . . . 0.0 110.764 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' SER . . . . . . . . . . . . . 71.3 m -81.29 -10.4 59.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.163 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.757 ' O ' ' HB2' ' C' ' 143' ' ' ALA . 0.6 OUTLIER -129.34 40.45 3.6 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.577 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' ALA . . . . . 0.618 ' HA ' ' H ' ' C' ' 143' ' ' ALA . . . -111.89 10.91 20.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.355 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.51 145.52 48.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.372 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' C' ' 140' ' ' THR . 18.1 tt0 -63.26 121.12 12.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.814 0.34 . . . . 0.0 111.204 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.07 14.4 33.77 Favored Glycine 0 C--N 1.331 0.304 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.14 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' C' ' 139' ' ' ALA . . . -72.21 121.19 18.93 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' THR . . . . . . . . . . . . . 14.9 p -129.98 133.77 47.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.908 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' C' ' 137' ' ' TYR . 57.8 m -112.44 -166.73 1.1 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.59 179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 36.1 t -59.06 149.46 27.66 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.801 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.82 153.64 17.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.369 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . 0.65 HG22 ' HB3' ' C' ' 135' ' ' ALA . 3.7 m -103.44 130.4 53.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.935 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.97 121.43 6.53 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.662 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . 0.497 ' HD1' HG23 ' C' ' 52' ' ' VAL . 52.2 p90 -153.65 136.39 15.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.776 0.322 . . . . 0.0 110.986 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' C' ' 131' ' ' ILE . 24.7 p30 -133.54 141.33 47.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.637 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.634 HG21 HD12 ' C' ' 131' ' ' ILE . 1.2 tt -85.17 126.52 40.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.62 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.603 ' HA ' HG23 ' C' ' 130' ' ' THR . 0.1 OUTLIER -75.88 119.4 19.81 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.713 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' C' ' 23' ' ' VAL . 0.2 OUTLIER -130.63 87.29 2.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.254 -179.643 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . 0.719 ' HA ' ' HA ' ' C' ' 128' ' ' THR . 5.1 p30 -77.15 173.7 11.55 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.998 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' ASP . . . . . 0.523 ' HB3' ' HE ' ' D' ' 38' ' ' ARG . 41.3 m-20 62.83 66.4 0.75 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' CYS . . . . . 0.799 ' SG ' ' SG ' ' C' ' 21' ' ' CYS . 34.5 m -115.68 161.98 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.742 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' ASP . . . . . 0.51 ' HA ' ' OD1' ' C' ' 126' ' ' ASN . 0.2 OUTLIER -145.94 157.85 43.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.3 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.491 HG23 ' HA ' ' C' ' 125' ' ' ASN . 0.0 OUTLIER -107.54 -16.65 14.31 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.138 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -81.35 -33.67 32.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.124 0.488 . . . . 0.0 111.817 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' VAL . . . . . 0.602 HG21 ' O ' ' C' ' 19' ' ' ALA . 20.0 t -75.14 -41.68 44.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.661 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.84 146.79 29.24 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.595 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.84 -39.35 3.73 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.897 0.379 . . . . 0.0 110.95 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.22 159.54 15.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.467 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' C' ' 122' ' ' THR . . . -147.24 118.87 7.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.578 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' C' ' 118' ' ' PHE . . . -96.81 140.79 30.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.847 0.356 . . . . 0.0 111.107 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' VAL . . . . . 0.479 HG11 HG21 ' C' ' 131' ' ' ILE . 3.1 t -118.51 139.74 44.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.732 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' ALA . . . . . 0.407 ' HA ' HD21 ' C' ' 111' ' ' LEU . . . -140.54 133.91 29.84 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.521 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' PHE . . . . . 0.781 ' HD2' HD13 ' C' ' 103' ' ' ILE . 0.1 OUTLIER -101.25 138.08 38.74 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.538 0.209 . . . . 0.0 111.185 179.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.717 HD21 HG21 ' F' ' 130' ' ' THR . 6.6 tt -101.06 91.09 4.4 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.982 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.37 -167.37 11.32 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.871 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' C' ' 86' ' ' LEU . 0.3 OUTLIER -116.67 159.53 22.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.557 0.218 . . . . 0.0 110.796 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . 0.525 ' HB2' HG23 ' C' ' 83' ' ' THR . . . -83.95 137.95 33.38 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.942 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' ILE . . . . . 0.457 HG22 ' O ' ' C' ' 82' ' ' HIS . 8.9 tt -77.18 -40.5 29.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.905 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' ASP . . . . . 0.62 ' HB2' HG21 ' C' ' 140' ' ' THR . 0.1 OUTLIER -141.18 55.31 1.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.796 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' F' ' 106' ' ' ARG . . . 52.86 -84.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.051 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' C' ' 79' ' ' ASP . . . -60.09 -16.09 39.36 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.621 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' HIS . . . . . 0.457 ' O ' HG22 ' C' ' 78' ' ' ILE . 24.2 m80 -100.64 56.76 0.9 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.931 0.396 . . . . 0.0 110.584 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . 0.525 HG23 ' HB2' ' C' ' 77' ' ' ALA . 1.1 m -71.33 -22.44 61.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.584 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' ASN . . . . . 0.735 ' HA ' ' HA ' ' C' ' 112' ' ' THR . 8.6 p-10 -57.18 -18.72 16.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.341 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.505 HG11 ' HB3' ' C' ' 138' ' ' PHE . 11.6 t -115.19 133.34 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.219 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' LEU . . . . . 0.927 HD12 HD22 ' C' ' 113' ' ' LEU . 0.8 OUTLIER -72.96 154.12 40.67 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.606 ' N ' HD23 ' C' ' 86' ' ' LEU . . . -90.76 -161.4 0.8 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.777 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.27 6.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.966 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.72 -83.84 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.317 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.27 20.39 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.985 0.421 . . . . 0.0 111.468 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' SER . . . . . 0.774 ' HB2' ' HB2' ' C' ' 95' ' ' SER . 1.5 m -86.58 79.25 8.98 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.904 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.67 -31.56 37.84 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.831 0.348 . . . . 0.0 111.611 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' F' ' 36' ' ' GLN . . . -128.1 54.49 1.72 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.661 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.9 -17.23 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.597 -0.811 . . . . 0.0 113.067 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' SER . . . . . 0.774 ' HB2' ' HB2' ' C' ' 91' ' ' SER . 0.9 OUTLIER -89.43 177.22 6.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.707 0.289 . . . . 0.0 110.65 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.77 175.3 8.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.759 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' C' ' 98' ' ' ASN . 0.2 OUTLIER -137.55 137.98 39.14 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.215 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' C' ' 97' ' ' THR . 74.0 m-80 71.69 17.63 5.46 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.465 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.9 148.96 26.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.741 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.39 -176.77 35.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.464 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' VAL . . . . . 0.538 ' CG2' HD21 ' C' ' 34' ' ' LEU . 7.7 p -125.58 111.03 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.01 0.524 . . . . 0.0 111.711 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' GLN . . . . . 0.614 ' O ' ' HA ' ' C' ' 135' ' ' ALA . 0.9 OUTLIER -81.54 147.75 29.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.805 -179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' ILE . . . . . 0.781 HD13 ' HD2' ' C' ' 73' ' ' PHE . 0.9 OUTLIER -123.77 115.94 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.489 179.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' LEU . . . . . 0.721 ' HA ' ' HA ' ' C' ' 110' ' ' ALA . 0.4 OUTLIER -88.73 140.53 29.35 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.634 0.254 . . . . 0.0 111.052 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' ASP . . . . . 0.59 ' HB2' ' HB2' ' C' ' 111' ' ' LEU . 2.1 t70 -89.36 152.06 21.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.711 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' ARG . . . . . 0.621 ' HG3' ' HG2' ' C' ' 132' ' ' PRO . 0.0 OUTLIER -71.76 -21.05 61.79 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.785 0.326 . . . . 0.0 111.075 179.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' THR . . . . . 0.615 ' HB ' ' HA ' ' C' ' 120' ' ' SER . 5.8 t -62.99 -21.84 66.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.959 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.72 -83.08 0.19 Allowed Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.669 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.73 170.66 15.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.833 0.349 . . . . 0.0 111.033 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.721 ' HA ' ' HA ' ' C' ' 104' ' ' LEU . . . -74.77 138.57 42.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.236 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' LEU . . . . . 0.59 ' HB2' ' HB2' ' C' ' 105' ' ' ASP . 5.1 tp -94.45 153.41 17.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.363 0.601 . . . . 0.0 110.557 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' THR . . . . . 0.779 HG22 HG21 ' C' ' 117' ' ' THR . 6.2 t -93.7 148.22 22.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.084 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' LEU . . . . . 0.927 HD22 HD12 ' C' ' 86' ' ' LEU . 1.4 mp -89.51 64.82 6.82 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.729 0.3 . . . . 0.0 110.715 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' ASP . . . . . 0.544 ' HB2' ' OG1' ' C' ' 117' ' ' THR . 0.5 OUTLIER -95.11 -16.05 22.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.588 -179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . 0.617 ' HA3' ' HG1' ' F' ' 130' ' ' THR . . . 104.41 -56.27 0.57 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.64 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' F' ' 125' ' ' ASN . . . -103.57 29.01 6.0 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 121.049 0.452 . . . . 0.0 111.709 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' THR . . . . . 0.779 HG21 HG22 ' C' ' 112' ' ' THR . 3.4 m -87.27 65.87 8.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.145 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' PHE . . . . . 0.527 ' HB3' ' HB1' ' C' ' 70' ' ' ALA . 48.5 m-85 -77.66 73.47 4.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.792 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.57 70.83 0.95 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.837 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' SER . . . . . 0.615 ' HA ' ' HB ' ' C' ' 107' ' ' THR . 0.7 OUTLIER -148.68 126.15 11.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.15 53.25 2.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.202 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' C' ' 69' ' ' ALA . 0.2 OUTLIER -73.93 128.31 35.18 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.698 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.44 117.94 25.55 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.719 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.51 134.78 33.76 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.781 0.324 . . . . 0.0 110.489 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' ASN . . . . . 0.491 ' HA ' HG23 ' C' ' 63' ' ' THR . 0.3 OUTLIER -129.26 163.07 26.45 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.674 179.494 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' C' ' 62' ' ' ASP . 1.5 t30 -67.54 125.37 25.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.82 0.343 . . . . 0.0 110.687 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' GLY . . . . . . . . . . . . . . . 128.62 -141.01 12.17 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.659 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' THR . . . . . 0.719 ' HA ' ' HA ' ' C' ' 59' ' ' ASN . 6.3 m -101.73 92.41 4.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.673 0.273 . . . . 0.0 110.778 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 129' ' ' ASN . . . . . 0.528 ' HB2' ' SG ' ' C' ' 61' ' ' CYS . 1.2 t30 -76.52 145.02 39.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.946 0.403 . . . . 0.0 111.119 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 130' ' ' THR . . . . . 0.603 HG23 ' HA ' ' C' ' 57' ' ' GLN . 0.0 OUTLIER -134.62 131.78 38.22 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.042 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 131' ' ' ILE . . . . . 0.69 HD11 HG12 ' C' ' 156' ' ' VAL . 28.3 mt -87.33 109.79 28.49 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 114.044 1.127 . . . . 0.0 114.044 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 132' ' ' PRO . . . . . 0.621 ' HG2' ' HG3' ' C' ' 106' ' ' ARG . 7.4 Cg_endo -81.67 112.17 2.38 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.585 1.524 . . . . 0.0 112.53 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.36 138.28 51.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.804 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 134' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' C' ' 52' ' ' VAL . 28.2 mt-30 -110.11 157.53 19.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.986 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.65 ' HB3' HG22 ' C' ' 52' ' ' VAL . . . -152.67 107.93 3.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.975 0.417 . . . . 0.0 111.608 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 136' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -102.54 174.41 5.91 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.338 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 137' ' ' TYR . . . . . 0.485 ' HB2' ' HB2' ' C' ' 49' ' ' SER . 0.6 OUTLIER -86.08 120.9 27.96 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.069 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 138' ' ' PHE . . . . . 0.505 ' HB3' HG11 ' C' ' 85' ' ' VAL . 0.2 OUTLIER -117.66 139.61 50.78 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.006 -179.134 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 139' ' ' ALA . . . . . 0.669 ' HB3' ' HB3' ' C' ' 47' ' ' ALA . . . -129.93 145.66 51.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.875 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 140' ' ' THR . . . . . 0.62 HG21 ' HB2' ' C' ' 79' ' ' ASP . 16.5 p -104.38 -53.43 2.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.478 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.7 -121.56 3.27 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.024 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.1 112.97 24.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.59 0.233 . . . . 0.0 110.693 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 143' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' C' ' 42' ' ' LEU . . . -61.82 150.95 35.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.772 0.32 . . . . 0.0 111.42 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 144' ' ' THR . . . . . 0.551 HG23 ' HD2' ' C' ' 145' ' ' PRO . 58.2 m -126.89 151.51 73.96 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.199 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 145' ' ' PRO . . . . . 0.551 ' HD2' HG23 ' C' ' 144' ' ' THR . 1.3 Cg_endo -83.07 140.2 9.87 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.528 2.152 . . . . 0.0 111.936 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.94 -137.98 6.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.574 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 147' ' ' ALA . . . . . 0.615 ' HA ' ' HG3' ' B' ' 15' ' ' GLU . . . -87.23 145.07 26.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.984 0.421 . . . . 0.0 111.307 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 148' ' ' ALA . . . . . 0.732 ' HB2' HG23 ' B' ' 16' ' ' VAL . . . -140.76 38.83 1.83 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.514 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.0 153.52 22.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.486 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 150' ' ' ALA . . . . . 0.604 ' HB1' HD22 ' C' ' 86' ' ' LEU . . . -161.87 171.23 18.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.019 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.4 126.79 7.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.328 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' C' ' 86' ' ' LEU . . . -125.31 142.8 51.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.328 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 153' ' ' THR . . . . . 0.82 HG23 HG23 ' B' ' 9' ' ' THR . 0.5 OUTLIER -89.85 133.17 34.88 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 154' ' ' PHE . . . . . 0.501 ' HD1' ' HA ' ' C' ' 154' ' ' PHE . 0.0 OUTLIER -86.44 127.85 34.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.104 0.478 . . . . 0.0 110.113 -178.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 155' ' ' LYS . . . . . 0.401 ' HE3' HD12 ' C' ' 74' ' ' LEU . 29.0 mmtt -111.43 150.52 29.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.921 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 156' ' ' VAL . . . . . 0.809 HG23 HG23 ' B' ' 5' ' ' VAL . 14.3 m -136.23 144.46 33.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-O 120.859 0.361 . . . . 0.0 111.582 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . 0.583 ' O ' ' HA ' ' C' ' 69' ' ' ALA . 0.0 OUTLIER -136.16 132.73 36.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.34 0.59 . . . . 0.0 110.391 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 158' ' ' TYR . . . . . 0.494 ' OH ' ' HB3' ' C' ' 21' ' ' CYS . 5.6 m-85 -117.45 119.8 36.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.51 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 159' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' B' ' 1' ' ' ALA . 0.9 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.33 -0.843 . . . . 0.0 110.799 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' E' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.235 0.064 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.26 64.86 1.57 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.627 0.251 . . . . 0.0 111.065 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' THR . . . . . 0.518 HG21 ' HB2' ' E' ' 18' ' ' ASN . 57.9 m -111.17 100.96 9.52 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.524 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' THR . . . . . 0.51 ' HA ' ' HG2' ' E' ' 157' ' ' GLN . 61.6 m -86.59 131.91 34.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.609 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.774 HG23 HG23 ' E' ' 156' ' ' VAL . 0.0 OUTLIER -161.16 168.06 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.523 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.19 118.71 37.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.584 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.31 -56.3 7.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.76 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.94 -145.34 4.65 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.919 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' THR . . . . . 0.81 HG23 HG23 ' E' ' 153' ' ' THR . 0.0 OUTLIER -145.02 142.09 29.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 0.0 111.282 -179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' VAL . . . . . 0.4 HG21 ' HZ ' ' E' ' 73' ' ' PHE . 43.8 t -121.66 107.27 19.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.168 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.7 111.03 21.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.366 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' PHE . . . . . 0.511 ' CD1' HD11 ' E' ' 34' ' ' LEU . 32.1 m-85 -87.63 113.53 23.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.777 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.13 118.54 36.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.405 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.48 175.61 39.71 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.887 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' GLU . . . . . 0.594 ' HG3' ' HA ' ' E' ' 147' ' ' ALA . 0.1 OUTLIER -151.38 162.12 41.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.946 0.403 . . . . 0.0 110.313 179.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . 0.749 HG23 ' HB2' ' E' ' 148' ' ' ALA . 2.2 t -114.99 119.45 61.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.214 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' VAL . . . . . 0.539 HG11 ' NE2' ' E' ' 36' ' ' GLN . 0.3 OUTLIER -121.32 168.05 14.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.815 0.341 . . . . 0.0 111.07 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' ASN . . . . . 0.525 ' HB2' HG21 ' C' ' 3' ' ' THR . 1.3 t-20 -68.44 -175.21 0.62 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.984 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' ALA . . . . . 0.589 ' O ' HG21 ' D' ' 65' ' ' VAL . . . -91.24 52.67 2.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.129 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.89 -15.71 1.33 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.374 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' D' ' 61' ' ' CYS . 0.0 OUTLIER -176.91 147.59 0.6 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.928 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . 0.518 ' HA ' HG21 ' D' ' 17' ' ' VAL . . . -152.64 110.04 3.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.114 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' D' ' 58' ' ' LEU . 0.3 OUTLIER -52.97 159.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.023 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -90.38 164.5 14.29 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.6 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' B' ' 91' ' ' SER . . . -57.0 -52.38 65.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.365 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.36 11.87 66.56 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.872 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' SER . . . . . . . . . . . . . 18.7 t -96.14 -30.86 13.28 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.904 0.383 . . . . 0.0 110.929 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 t -49.83 -71.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.355 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.59 104.34 15.25 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.044 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' GLN . . . . . 0.533 HE22 ' HA ' ' D' ' 56' ' ' ILE . 41.7 mt-30 -112.14 140.3 46.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.071 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.77 110.18 21.5 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.028 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.13 108.36 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.155 0.503 . . . . 0.0 110.453 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.56 112.46 22.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.685 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' LEU . . . . . 0.543 HD21 ' CG2' ' D' ' 101' ' ' VAL . 5.2 mp -81.19 -41.72 21.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.673 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.64 -171.05 21.62 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.626 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' C' ' 15' ' ' GLU . 2.4 mt-30 -93.57 145.93 24.17 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.524 0.202 . . . . 0.0 110.979 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.51 HG22 ' H ' ' D' ' 38' ' ' ARG . 4.9 p -124.84 169.89 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.991 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' ARG . . . . . 0.523 ' HE ' ' HB3' ' C' ' 60' ' ' ASP . 5.2 mtt-85 -98.88 121.42 40.8 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.714 179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' THR . . . . . 0.543 ' O ' ' HB2' ' D' ' 43' ' ' ALA . 0.6 OUTLIER -62.01 -31.01 71.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.672 179.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.58 -39.25 84.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.992 0.425 . . . . 0.0 110.852 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' SER . . . . . . . . . . . . . 71.1 m -81.31 -10.45 59.56 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.139 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.736 ' O ' ' HB2' ' D' ' 143' ' ' ALA . 0.6 OUTLIER -129.25 40.42 3.62 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.607 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' ALA . . . . . 0.617 ' HA ' ' H ' ' D' ' 143' ' ' ALA . . . -111.83 10.91 20.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.363 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.51 145.49 48.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.369 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' D' ' 140' ' ' THR . 18.2 tt0 -63.34 121.26 13.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.862 0.363 . . . . 0.0 111.11 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.05 14.38 33.9 Favored Glycine 0 C--N 1.331 0.272 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.155 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' D' ' 139' ' ' ALA . . . -72.17 121.22 18.93 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' THR . . . . . . . . . . . . . 14.9 p -130.04 133.79 46.96 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.919 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' D' ' 137' ' ' TYR . 57.8 m -112.46 -166.73 1.1 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.607 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 36.3 t -59.11 149.47 27.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.897 0.379 . . . . 0.0 110.768 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.76 153.64 17.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.404 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' VAL . . . . . 0.668 HG22 ' HB3' ' D' ' 135' ' ' ALA . 3.7 m -103.41 130.33 53.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.895 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.96 121.5 6.56 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.576 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.492 ' HD1' HG23 ' D' ' 52' ' ' VAL . 52.3 p90 -153.71 136.44 15.27 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.816 0.341 . . . . 0.0 110.94 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' D' ' 131' ' ' ILE . 24.7 p30 -133.57 141.33 47.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.628 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' ILE . . . . . 0.642 HG21 HD12 ' D' ' 131' ' ' ILE . 1.2 tt -85.06 126.42 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.645 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' GLN . . . . . 0.601 ' HG3' HD11 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -75.73 119.41 19.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.742 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' LEU . . . . . 0.531 ' HA ' ' HA ' ' D' ' 23' ' ' VAL . 0.2 OUTLIER -130.68 87.36 2.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.258 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' ASN . . . . . 0.719 ' HA ' ' HA ' ' D' ' 128' ' ' THR . 5.0 p30 -77.3 173.64 11.68 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.956 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' ASP . . . . . 0.524 ' HB3' ' HE ' ' E' ' 38' ' ' ARG . 41.3 m-20 62.91 66.4 0.75 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.844 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' CYS . . . . . 0.788 ' SG ' ' SG ' ' D' ' 21' ' ' CYS . 34.6 m -115.69 161.98 17.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.714 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' ASP . . . . . 0.514 ' HA ' ' OD1' ' D' ' 126' ' ' ASN . 0.2 OUTLIER -145.88 157.92 43.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.323 -179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.491 HG23 ' HA ' ' D' ' 125' ' ' ASN . 0.0 OUTLIER -107.59 -16.67 14.3 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -81.42 -33.65 32.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.028 0.442 . . . . 0.0 111.708 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' VAL . . . . . 0.589 HG21 ' O ' ' D' ' 19' ' ' ALA . 20.0 t -75.19 -41.6 44.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.629 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.93 146.7 29.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.553 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.77 -39.3 3.76 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.972 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.3 159.58 15.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.477 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' D' ' 122' ' ' THR . . . -147.19 118.82 7.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.649 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' D' ' 118' ' ' PHE . . . -96.83 140.74 30.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.093 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' VAL . . . . . 0.457 HG11 HG21 ' D' ' 131' ' ' ILE . 3.1 t -118.5 139.71 44.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.784 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' ALA . . . . . 0.403 ' HA ' HD21 ' D' ' 111' ' ' LEU . . . -140.56 133.94 29.83 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.522 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' PHE . . . . . 0.788 ' HD2' HD13 ' D' ' 103' ' ' ILE . 0.1 OUTLIER -101.21 137.97 38.86 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.509 0.195 . . . . 0.0 111.243 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' LEU . . . . . . . . . . . . . 6.6 tt -100.97 91.08 4.41 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.011 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.43 -167.38 11.31 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.891 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' THR . . . . . 0.675 ' O ' ' HA ' ' D' ' 86' ' ' LEU . 0.3 OUTLIER -116.68 159.56 22.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.585 0.231 . . . . 0.0 110.761 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.52 ' HB2' HG23 ' D' ' 83' ' ' THR . . . -83.96 137.85 33.42 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.018 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 78' ' ' ILE . . . . . 0.45 HG22 ' O ' ' D' ' 82' ' ' HIS . 9.0 tt -77.13 -40.48 30.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.882 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 79' ' ' ASP . . . . . 0.606 ' HB2' HG21 ' D' ' 140' ' ' THR . 0.1 OUTLIER -141.22 55.21 1.54 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.848 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 80' ' ' ALA . . . . . . . . . . . . . . . 52.87 -84.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.075 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' D' ' 79' ' ' ASP . . . -60.09 -16.05 39.19 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.663 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 82' ' ' HIS . . . . . 0.45 ' O ' HG22 ' D' ' 78' ' ' ILE . 24.2 m80 -100.64 56.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.963 0.411 . . . . 0.0 110.568 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 83' ' ' THR . . . . . 0.52 HG23 ' HB2' ' D' ' 77' ' ' ALA . 1.1 m -71.41 -22.42 61.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.563 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 84' ' ' ASN . . . . . 0.739 ' HA ' ' HA ' ' D' ' 112' ' ' THR . 8.6 p-10 -57.17 -18.67 16.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.359 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.518 HG11 ' HB3' ' D' ' 138' ' ' PHE . 11.6 t -115.24 133.34 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.227 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 86' ' ' LEU . . . . . 0.908 HD12 HD22 ' D' ' 113' ' ' LEU . 0.8 OUTLIER -72.93 154.06 40.71 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.341 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.601 ' N ' HD23 ' D' ' 86' ' ' LEU . . . -90.66 -161.41 0.8 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.837 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.69 -178.27 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.01 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -83.88 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.339 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.33 20.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.998 0.427 . . . . 0.0 111.49 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 91' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' D' ' 95' ' ' SER . 1.5 m -86.6 79.35 8.94 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.73 -31.49 38.2 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.913 0.387 . . . . 0.0 111.71 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.08 54.43 1.72 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.646 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.9 -17.29 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.931 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 95' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' D' ' 91' ' ' SER . 0.9 OUTLIER -89.39 177.16 6.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.75 0.309 . . . . 0.0 110.661 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.76 175.3 8.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.812 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' D' ' 98' ' ' ASN . 0.2 OUTLIER -137.52 138.03 39.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.263 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 98' ' ' ASN . . . . . 0.529 ' HB2' ' O ' ' D' ' 97' ' ' THR . 74.0 m-80 71.63 17.6 5.53 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.52 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.86 148.94 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.733 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.35 -176.74 35.65 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.436 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 101' ' ' VAL . . . . . 0.543 ' CG2' HD21 ' D' ' 34' ' ' LEU . 7.7 p -125.59 111.01 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 122.968 0.507 . . . . 0.0 111.759 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 102' ' ' GLN . . . . . 0.616 ' O ' ' HA ' ' D' ' 135' ' ' ALA . 0.9 OUTLIER -81.53 147.71 29.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.826 -179.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 103' ' ' ILE . . . . . 0.788 HD13 ' HD2' ' D' ' 73' ' ' PHE . 0.9 OUTLIER -123.74 115.92 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.478 179.518 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 104' ' ' LEU . . . . . 0.74 ' HA ' ' HA ' ' D' ' 110' ' ' ALA . 0.4 OUTLIER -88.69 140.52 29.37 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.693 0.283 . . . . 0.0 111.051 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 105' ' ' ASP . . . . . 0.605 ' HB2' ' HB2' ' D' ' 111' ' ' LEU . 2.1 t70 -89.26 151.98 21.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.693 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 106' ' ' ARG . . . . . 0.646 ' HG3' ' HG2' ' D' ' 132' ' ' PRO . 0.0 OUTLIER -71.78 -21.07 61.77 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.805 0.336 . . . . 0.0 111.07 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 107' ' ' THR . . . . . 0.616 ' HB ' ' HA ' ' D' ' 120' ' ' SER . 5.8 t -62.9 -21.91 66.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.97 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.68 -83.02 0.19 Allowed Glycine 0 CA--C 1.517 0.219 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.722 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.74 170.7 15.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.834 0.349 . . . . 0.0 111.106 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.74 ' HA ' ' HA ' ' D' ' 104' ' ' LEU . . . -74.84 138.61 42.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.183 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 111' ' ' LEU . . . . . 0.605 ' HB2' ' HB2' ' D' ' 105' ' ' ASP . 5.1 tp -94.37 153.41 17.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.276 0.56 . . . . 0.0 110.604 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 112' ' ' THR . . . . . 0.776 HG22 HG21 ' D' ' 117' ' ' THR . 6.2 t -93.72 148.33 22.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.046 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 113' ' ' LEU . . . . . 0.908 HD22 HD12 ' D' ' 86' ' ' LEU . 1.4 mp -89.7 64.87 6.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.894 0.378 . . . . 0.0 110.758 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 114' ' ' ASP . . . . . 0.541 ' HB2' ' OG1' ' D' ' 117' ' ' THR . 0.5 OUTLIER -94.98 -16.15 22.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.648 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.49 -56.26 0.56 Allowed Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.693 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.53 29.05 5.96 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.949 0.404 . . . . 0.0 111.719 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 117' ' ' THR . . . . . 0.776 HG21 HG22 ' D' ' 112' ' ' THR . 3.4 m -87.26 65.92 8.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.041 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 118' ' ' PHE . . . . . 0.52 ' HB3' ' HB1' ' D' ' 70' ' ' ALA . 48.5 m-85 -77.69 73.42 4.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.808 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.49 70.79 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 120' ' ' SER . . . . . 0.616 ' HA ' ' HB ' ' D' ' 107' ' ' THR . 0.7 OUTLIER -148.64 126.07 11.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.67 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.08 53.27 2.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.198 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' D' ' 69' ' ' ALA . 0.2 OUTLIER -74.04 128.32 35.22 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.715 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.36 117.9 25.45 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.765 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.52 134.8 33.76 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.831 0.348 . . . . 0.0 110.524 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 125' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 116' ' ' ALA . 0.3 OUTLIER -129.24 163.09 26.37 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.654 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 126' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' D' ' 62' ' ' ASP . 1.5 t30 -67.6 125.37 25.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.7 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 127' ' ' GLY . . . . . 0.451 ' HA3' ' HE2' ' A' ' 118' ' ' PHE . . . 128.62 -140.97 12.14 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.718 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 128' ' ' THR . . . . . 0.719 ' HA ' ' HA ' ' D' ' 59' ' ' ASN . 6.3 m -101.8 92.45 4.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.672 0.272 . . . . 0.0 110.772 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 129' ' ' ASN . . . . . 0.54 ' HB2' ' SG ' ' D' ' 61' ' ' CYS . 1.2 t30 -76.5 145.04 39.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.92 0.391 . . . . 0.0 111.147 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 130' ' ' THR . . . . . 0.734 HG21 HD21 ' A' ' 74' ' ' LEU . 0.0 OUTLIER -134.68 131.79 38.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.063 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 131' ' ' ILE . . . . . 0.686 HD11 HG12 ' D' ' 156' ' ' VAL . 28.2 mt -87.32 109.73 28.01 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 132' ' ' PRO . . . . . 0.646 ' HG2' ' HG3' ' D' ' 106' ' ' ARG . 7.5 Cg_endo -81.57 112.13 2.4 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.599 1.533 . . . . 0.0 112.576 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.35 138.2 51.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.844 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 134' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' D' ' 52' ' ' VAL . 28.3 mt-30 -110.1 157.55 19.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.99 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.668 ' HB3' HG22 ' D' ' 52' ' ' VAL . . . -152.68 107.92 3.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.927 0.394 . . . . 0.0 111.568 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 136' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -102.53 174.34 5.94 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.381 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 137' ' ' TYR . . . . . 0.462 ' HB2' ' HB2' ' D' ' 49' ' ' SER . 0.6 OUTLIER -85.99 120.81 27.79 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.097 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 138' ' ' PHE . . . . . 0.518 ' HB3' HG11 ' D' ' 85' ' ' VAL . 0.2 OUTLIER -117.62 139.56 50.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.079 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 139' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' D' ' 47' ' ' ALA . . . -129.88 145.64 51.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.851 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 140' ' ' THR . . . . . 0.606 HG21 ' HB2' ' D' ' 79' ' ' ASP . 16.3 p -104.46 -53.43 2.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.407 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.67 -121.52 3.27 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.014 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.08 112.92 24.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.568 0.223 . . . . 0.0 110.676 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 143' ' ' ALA . . . . . 0.736 ' HB2' ' O ' ' D' ' 42' ' ' LEU . . . -61.78 150.86 35.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.755 0.312 . . . . 0.0 111.453 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 144' ' ' THR . . . . . 0.553 HG23 ' HD2' ' D' ' 145' ' ' PRO . 60.4 m -126.81 151.52 73.77 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.274 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 145' ' ' PRO . . . . . 0.553 ' HD2' HG23 ' D' ' 144' ' ' THR . 1.3 Cg_endo -83.08 140.2 9.85 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 122.613 2.208 . . . . 0.0 111.941 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.94 -138.14 6.59 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.485 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 147' ' ' ALA . . . . . 0.608 ' HA ' ' HG3' ' C' ' 15' ' ' GLU . . . -87.14 145.02 26.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.912 0.387 . . . . 0.0 111.378 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 148' ' ' ALA . . . . . 0.743 ' HB2' HG23 ' C' ' 16' ' ' VAL . . . -140.73 38.79 1.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.545 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.1 153.53 22.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.48 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 150' ' ' ALA . . . . . 0.589 ' HB1' HD22 ' D' ' 86' ' ' LEU . . . -161.86 171.25 18.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.048 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -154.42 126.8 7.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.242 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 152' ' ' ALA . . . . . 0.528 ' HB2' ' CD1' ' D' ' 86' ' ' LEU . . . -125.31 142.85 51.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.257 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 153' ' ' THR . . . . . 0.812 HG23 HG23 ' C' ' 9' ' ' THR . 0.5 OUTLIER -89.84 133.17 34.87 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.173 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 154' ' ' PHE . . . . . 0.501 ' HD1' ' HA ' ' D' ' 154' ' ' PHE . 0.0 OUTLIER -86.46 127.88 34.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.042 0.449 . . . . 0.0 110.096 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.48 150.57 29.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.958 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 156' ' ' VAL . . . . . 0.792 HG23 HG23 ' C' ' 5' ' ' VAL . 14.4 m -136.24 144.39 33.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.826 0.346 . . . . 0.0 111.594 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 157' ' ' GLN . . . . . 0.584 ' O ' ' HA ' ' D' ' 69' ' ' ALA . 0.0 OUTLIER -136.16 132.74 36.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.268 0.556 . . . . 0.0 110.415 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 158' ' ' TYR . . . . . 0.489 ' OH ' ' HB3' ' D' ' 21' ' ' CYS . 5.5 m-85 -117.42 119.78 36.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.505 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 159' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' C' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.844 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 1' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' F' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 120.209 0.052 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.21 64.86 1.57 Allowed 'General case' 0 C--O 1.233 0.196 0 O-C-N 123.126 0.266 . . . . 0.0 111.079 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 3' ' ' THR . . . . . 0.538 HG21 ' HB2' ' F' ' 18' ' ' ASN . 57.8 m -111.17 101.03 9.58 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.42 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 4' ' ' THR . . . . . 0.502 ' O ' HG13 ' E' ' 5' ' ' VAL . 60.0 m -86.72 131.91 34.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.539 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.802 HG23 HG23 ' F' ' 156' ' ' VAL . 0.0 OUTLIER -161.15 168.05 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.513 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.15 118.76 37.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.58 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.36 -56.26 7.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.759 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 8' ' ' GLY . . . . . . . . . . . . . . . -170.01 -145.36 4.66 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.883 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 9' ' ' THR . . . . . 0.811 HG23 HG23 ' F' ' 153' ' ' THR . 0.0 OUTLIER -145.01 142.07 29.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.288 -179.587 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 10' ' ' VAL . . . . . . . . . . . . . 44.0 t -121.64 107.31 19.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.17 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 11' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -88.72 110.93 21.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.431 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 12' ' ' PHE . . . . . 0.501 ' CD1' HD11 ' F' ' 34' ' ' LEU . 32.2 m-85 -87.54 113.48 23.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.15 118.54 36.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.443 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.49 175.49 39.72 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.946 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 15' ' ' GLU . . . . . 0.594 ' HG3' ' HA ' ' F' ' 147' ' ' ALA . 0.1 OUTLIER -151.29 162.13 41.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.994 0.426 . . . . 0.0 110.303 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 16' ' ' VAL . . . . . 0.736 HG23 ' HB2' ' F' ' 148' ' ' ALA . 2.2 t -114.97 119.33 61.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.265 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 17' ' ' VAL . . . . . 0.531 HG11 ' NE2' ' F' ' 36' ' ' GLN . 0.3 OUTLIER -121.26 168.06 14.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.843 0.354 . . . . 0.0 111.039 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 18' ' ' ASN . . . . . 0.518 ' HB2' HG21 ' D' ' 3' ' ' THR . 1.3 t-20 -68.38 -175.26 0.61 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.01 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 19' ' ' ALA . . . . . 0.605 ' O ' HG21 ' E' ' 65' ' ' VAL . . . -91.12 52.59 2.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.95 -15.66 1.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.357 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 21' ' ' CYS . . . . . 0.726 ' SG ' ' SG ' ' E' ' 61' ' ' CYS . 0.0 OUTLIER -176.96 147.55 0.58 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.981 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 22' ' ' ALA . . . . . 0.492 ' HA ' HG21 ' E' ' 17' ' ' VAL . . . -152.57 110.05 3.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.119 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 23' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' E' ' 58' ' ' LEU . 0.3 OUTLIER -53.0 159.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.011 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -90.37 164.46 14.31 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.592 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 25' ' ' ALA . . . . . 0.464 ' HB2' ' HA ' ' C' ' 91' ' ' SER . . . -56.91 -52.42 65.24 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.402 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.35 11.9 66.43 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.881 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 27' ' ' SER . . . . . . . . . . . . . 18.3 t -96.21 -30.77 13.3 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.895 0.379 . . . . 0.0 110.917 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 28' ' ' VAL . . . . . 0.426 ' H ' HG23 ' E' ' 28' ' ' VAL . 11.2 t -49.84 -71.71 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.38 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.47 104.29 15.12 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 30' ' ' GLN . . . . . 0.536 HE22 ' HA ' ' E' ' 56' ' ' ILE . 41.8 mt-30 -112.17 140.4 46.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.07 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.83 110.16 21.46 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.301 -0.409 . . . . 0.0 112.045 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.17 108.46 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.136 0.493 . . . . 0.0 110.434 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.65 112.47 22.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.62 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 34' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' E' ' 101' ' ' VAL . 5.3 mp -81.17 -41.8 21.81 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.67 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.72 -171.02 21.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.632 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 36' ' ' GLN . . . . . 0.55 ' HA ' ' O ' ' D' ' 15' ' ' GLU . 2.4 mt-30 -93.62 145.9 24.21 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.502 0.192 . . . . 0.0 110.969 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.515 HG22 ' H ' ' E' ' 38' ' ' ARG . 5.0 p -124.82 169.88 15.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.942 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 38' ' ' ARG . . . . . 0.524 ' HE ' ' HB3' ' D' ' 60' ' ' ASP . 5.2 mtt-85 -98.94 121.45 40.91 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.701 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 39' ' ' THR . . . . . 0.545 ' O ' ' HB2' ' E' ' 43' ' ' ALA . 0.6 OUTLIER -61.99 -31.03 71.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.675 179.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.3 85.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.987 0.422 . . . . 0.0 110.85 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 41' ' ' SER . . . . . . . . . . . . . 70.5 m -81.36 -10.3 59.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.128 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 42' ' ' LEU . . . . . 0.739 ' O ' ' HB2' ' E' ' 143' ' ' ALA . 0.6 OUTLIER -129.33 40.34 3.62 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.571 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 43' ' ' ALA . . . . . 0.607 ' HA ' ' H ' ' E' ' 143' ' ' ALA . . . -111.87 10.98 20.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.392 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.6 145.47 48.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.35 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 45' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' E' ' 140' ' ' THR . 18.2 tt0 -63.28 121.17 13.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.872 0.367 . . . . 0.0 111.109 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.03 14.48 33.67 Favored Glycine 0 C--N 1.332 0.307 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.113 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 47' ' ' ALA . . . . . 0.692 ' HB3' ' HB3' ' E' ' 139' ' ' ALA . . . -72.14 121.19 18.86 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 48' ' ' THR . . . . . . . . . . . . . 14.9 p -130.03 133.72 46.93 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.906 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 49' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' E' ' 137' ' ' TYR . 57.9 m -112.43 -166.69 1.1 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.623 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 50' ' ' SER . . . . . . . . . . . . . 36.3 t -59.03 149.5 27.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.774 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.84 153.6 17.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.386 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 52' ' ' VAL . . . . . 0.669 HG22 ' HB3' ' E' ' 135' ' ' ALA . 3.7 m -103.45 130.34 53.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.877 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.94 121.4 6.52 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.612 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 54' ' ' PHE . . . . . 0.49 ' HD1' HG23 ' E' ' 52' ' ' VAL . 52.2 p90 -153.6 136.44 15.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.825 0.345 . . . . 0.0 110.97 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 55' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' E' ' 131' ' ' ILE . 24.7 p30 -133.55 141.39 47.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.682 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 56' ' ' ILE . . . . . 0.645 HG21 HD12 ' E' ' 131' ' ' ILE . 1.2 tt -85.18 126.43 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.627 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 57' ' ' GLN . . . . . 0.599 ' HG3' HD11 ' B' ' 74' ' ' LEU . 0.1 OUTLIER -75.8 119.45 19.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.732 -179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 58' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' E' ' 23' ' ' VAL . 0.2 OUTLIER -130.75 87.34 2.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.214 -179.609 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 59' ' ' ASN . . . . . 0.728 ' HA ' ' HA ' ' E' ' 128' ' ' THR . 5.1 p30 -77.2 173.71 11.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.991 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 60' ' ' ASP . . . . . 0.527 ' HB3' ' HE ' ' F' ' 38' ' ' ARG . 41.6 m-20 62.89 66.33 0.75 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 61' ' ' CYS . . . . . 0.726 ' SG ' ' SG ' ' E' ' 21' ' ' CYS . 34.5 m -115.66 161.98 17.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.74 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 62' ' ' ASP . . . . . 0.514 ' HA ' ' OD1' ' E' ' 126' ' ' ASN . 0.2 OUTLIER -145.91 157.82 43.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.333 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 63' ' ' THR . . . . . 0.482 HG23 ' HA ' ' E' ' 125' ' ' ASN . 0.0 OUTLIER -107.51 -16.65 14.31 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.186 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.4 -33.63 32.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.055 0.455 . . . . 0.0 111.755 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 65' ' ' VAL . . . . . 0.605 HG21 ' O ' ' E' ' 19' ' ' ALA . 20.0 t -75.19 -41.55 44.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.668 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.94 146.76 29.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.528 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -39.25 3.74 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.008 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.32 159.61 15.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.431 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 69' ' ' ALA . . . . . 0.601 ' HB3' ' HB ' ' E' ' 122' ' ' THR . . . -147.26 118.87 7.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.612 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 70' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' E' ' 118' ' ' PHE . . . -96.9 140.81 30.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.063 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 71' ' ' VAL . . . . . 0.471 HG11 HG21 ' E' ' 131' ' ' ILE . 3.1 t -118.57 139.74 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.714 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 72' ' ' ALA . . . . . . . . . . . . . . . -140.56 133.9 29.78 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.533 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 73' ' ' PHE . . . . . 0.792 ' HD2' HD13 ' E' ' 103' ' ' ILE . 0.1 OUTLIER -101.16 138.01 38.76 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 122.388 -0.195 . . . . 0.0 111.185 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 74' ' ' LEU . . . . . 0.41 HD12 ' HE3' ' E' ' 155' ' ' LYS . 6.6 tt -100.98 91.02 4.38 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.028 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.37 -167.37 11.32 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.872 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 76' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' E' ' 86' ' ' LEU . 0.3 OUTLIER -116.71 159.48 22.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.631 0.253 . . . . 0.0 110.729 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 77' ' ' ALA . . . . . 0.52 ' HB2' HG23 ' E' ' 83' ' ' THR . . . -83.94 137.94 33.39 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.024 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 78' ' ' ILE . . . . . 0.456 HG22 ' O ' ' E' ' 82' ' ' HIS . 8.9 tt -77.18 -40.48 29.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.911 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 79' ' ' ASP . . . . . 0.601 ' HB2' HG21 ' E' ' 140' ' ' THR . 0.1 OUTLIER -141.22 55.26 1.54 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.882 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 80' ' ' ALA . . . . . . . . . . . . . . . 52.88 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 81' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' E' ' 79' ' ' ASP . . . -60.09 -15.99 38.89 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.652 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 82' ' ' HIS . . . . . 0.456 ' O ' HG22 ' E' ' 78' ' ' ILE . 24.2 m80 -100.68 56.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.929 0.395 . . . . 0.0 110.557 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 83' ' ' THR . . . . . 0.52 HG23 ' HB2' ' E' ' 77' ' ' ALA . 1.1 m -71.32 -22.53 61.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.574 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 84' ' ' ASN . . . . . 0.737 ' HA ' ' HA ' ' E' ' 112' ' ' THR . 8.6 p-10 -57.2 -18.62 16.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.347 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 85' ' ' VAL . . . . . 0.505 HG11 ' HB3' ' E' ' 138' ' ' PHE . 11.6 t -115.23 133.36 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.205 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 86' ' ' LEU . . . . . 0.928 HD12 HD22 ' E' ' 113' ' ' LEU . 0.8 OUTLIER -72.95 154.01 40.72 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.368 179.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 87' ' ' ALA . . . . . 0.602 ' N ' HD23 ' E' ' 86' ' ' LEU . . . -90.67 -161.35 0.79 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.872 0.367 . . . . 0.0 111.781 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.74 -178.24 6.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.925 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.72 -83.82 0.04 OUTLIER 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.364 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.35 20.49 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.989 0.423 . . . . 0.0 111.464 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 91' ' ' SER . . . . . 0.766 ' HB2' ' HB2' ' E' ' 95' ' ' SER . 1.5 m -86.56 79.3 8.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.931 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.7 -31.54 38.14 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.867 0.365 . . . . 0.0 111.624 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.05 54.43 1.72 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.671 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.86 -17.34 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.02 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 95' ' ' SER . . . . . 0.766 ' HB2' ' HB2' ' E' ' 91' ' ' SER . 0.9 OUTLIER -89.41 177.2 6.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.804 0.335 . . . . 0.0 110.67 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.68 175.19 8.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.795 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' E' ' 98' ' ' ASN . 0.2 OUTLIER -137.5 138.01 39.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.275 179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 98' ' ' ASN . . . . . 0.528 ' HB2' ' O ' ' E' ' 97' ' ' THR . 74.0 m-80 71.71 17.52 5.46 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.532 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.87 149.0 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.719 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.34 -176.75 35.65 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.447 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 101' ' ' VAL . . . . . 0.541 ' CG2' HD21 ' E' ' 34' ' ' LEU . 7.7 p -125.63 111.04 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 123.003 0.521 . . . . 0.0 111.736 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 102' ' ' GLN . . . . . 0.611 ' O ' ' HA ' ' E' ' 135' ' ' ALA . 0.9 OUTLIER -81.58 147.67 29.5 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.878 -179.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 103' ' ' ILE . . . . . 0.792 HD13 ' HD2' ' E' ' 73' ' ' PHE . 0.9 OUTLIER -123.64 115.95 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.55 179.488 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 104' ' ' LEU . . . . . 0.714 ' HA ' ' HA ' ' E' ' 110' ' ' ALA . 0.4 OUTLIER -88.77 140.51 29.37 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.688 0.28 . . . . 0.0 111.02 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 105' ' ' ASP . . . . . 0.597 ' HB3' HG22 ' E' ' 107' ' ' THR . 2.1 t70 -89.28 152.02 21.79 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.661 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 106' ' ' ARG . . . . . 0.63 ' HG3' ' HG2' ' E' ' 132' ' ' PRO . 0.0 OUTLIER -71.79 -21.02 61.77 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.819 0.343 . . . . 0.0 111.119 179.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 107' ' ' THR . . . . . 0.615 ' HB ' ' HA ' ' E' ' 120' ' ' SER . 5.8 t -62.89 -21.98 66.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.981 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.69 -83.05 0.19 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.626 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.66 170.68 15.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 111.105 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . 0.714 ' HA ' ' HA ' ' E' ' 104' ' ' LEU . . . -74.85 138.63 42.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.227 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 111' ' ' LEU . . . . . 0.594 ' HB2' ' HB2' ' E' ' 105' ' ' ASP . 5.0 tp -94.45 153.45 17.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.366 0.603 . . . . 0.0 110.577 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 112' ' ' THR . . . . . 0.804 HG22 HG21 ' E' ' 117' ' ' THR . 6.2 t -93.78 148.29 22.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.049 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 113' ' ' LEU . . . . . 0.928 HD22 HD12 ' E' ' 86' ' ' LEU . 1.4 mp -89.53 64.82 6.81 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.773 0.32 . . . . 0.0 110.742 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 114' ' ' ASP . . . . . 0.559 ' HB2' ' OG1' ' E' ' 117' ' ' THR . 0.5 OUTLIER -95.1 -15.95 23.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.662 0.268 . . . . 0.0 111.665 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.34 -56.25 0.57 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.682 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.58 29.05 5.98 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.983 0.42 . . . . 0.0 111.679 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 117' ' ' THR . . . . . 0.804 HG21 HG22 ' E' ' 112' ' ' THR . 3.4 m -87.11 65.82 9.06 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.153 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . 0.52 ' HB3' ' HB1' ' E' ' 70' ' ' ALA . 48.3 m-85 -77.67 73.39 4.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.814 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.54 70.85 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 120' ' ' SER . . . . . 0.615 ' HA ' ' HB ' ' E' ' 107' ' ' THR . 0.7 OUTLIER -148.66 126.08 11.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.679 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.06 53.23 2.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.203 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 122' ' ' THR . . . . . 0.601 ' HB ' ' HB3' ' E' ' 69' ' ' ALA . 0.2 OUTLIER -74.04 128.31 35.2 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.67 -179.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 123' ' ' THR . . . . . . . . . . . . . 4.5 m -86.29 118.0 25.46 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.759 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 124' ' ' LEU . . . . . . . . . . . . . 4.3 tp -88.61 134.82 33.77 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.779 0.323 . . . . 0.0 110.482 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 125' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' B' ' 116' ' ' ALA . 0.3 OUTLIER -129.3 163.08 26.47 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.662 179.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' E' ' 62' ' ' ASP . 1.5 t30 -67.56 125.34 25.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.653 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . 0.651 ' HA2' HG21 ' A' ' 4' ' ' THR . . . 128.59 -140.97 12.14 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.686 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 128' ' ' THR . . . . . 0.728 ' HA ' ' HA ' ' E' ' 59' ' ' ASN . 6.3 m -101.76 92.5 4.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.666 0.27 . . . . 0.0 110.752 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 129' ' ' ASN . . . . . 0.542 ' HB2' ' SG ' ' E' ' 61' ' ' CYS . 1.2 t30 -76.58 144.98 39.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.89 0.376 . . . . 0.0 111.099 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 130' ' ' THR . . . . . 0.714 HG21 HD21 ' B' ' 74' ' ' LEU . 0.0 OUTLIER -134.63 131.81 38.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.05 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 131' ' ' ILE . . . . . 0.685 HD11 HG12 ' E' ' 156' ' ' VAL . 28.3 mt -87.34 109.74 28.16 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 132' ' ' PRO . . . . . 0.63 ' HG2' ' HG3' ' E' ' 106' ' ' ARG . 7.4 Cg_endo -81.61 112.15 2.39 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 121.604 1.536 . . . . 0.0 112.544 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.32 138.21 51.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.849 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 134' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' E' ' 52' ' ' VAL . 28.1 mt-30 -110.03 157.49 19.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.075 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . 0.669 ' HB3' HG22 ' E' ' 52' ' ' VAL . . . -152.65 107.85 3.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 111.636 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 136' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -102.58 174.34 5.94 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.338 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 137' ' ' TYR . . . . . 0.468 ' HB2' ' HB2' ' E' ' 49' ' ' SER . 0.6 OUTLIER -85.9 120.86 27.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.036 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 138' ' ' PHE . . . . . 0.505 ' HB3' HG11 ' E' ' 85' ' ' VAL . 0.2 OUTLIER -117.68 139.64 50.74 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.001 -179.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 139' ' ' ALA . . . . . 0.692 ' HB3' ' HB3' ' E' ' 47' ' ' ALA . . . -129.95 145.62 51.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.915 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 140' ' ' THR . . . . . 0.601 HG21 ' HB2' ' E' ' 79' ' ' ASP . 16.5 p -104.45 -53.33 2.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.464 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.8 -121.49 3.25 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.983 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.07 112.91 24.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.572 0.225 . . . . 0.0 110.723 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 143' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' E' ' 42' ' ' LEU . . . -61.79 150.89 35.71 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.794 0.33 . . . . 0.0 111.406 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 144' ' ' THR . . . . . 0.55 HG23 ' HD2' ' E' ' 145' ' ' PRO . 59.8 m -126.81 151.59 73.89 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.261 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 145' ' ' PRO . . . . . 0.55 ' HD2' HG23 ' E' ' 144' ' ' THR . 1.3 Cg_endo -83.09 140.15 9.82 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.59 2.193 . . . . 0.0 111.956 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.98 -138.01 6.52 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.521 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 147' ' ' ALA . . . . . 0.594 ' HA ' ' HG3' ' D' ' 15' ' ' GLU . . . -87.22 145.01 26.56 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.941 0.4 . . . . 0.0 111.329 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 148' ' ' ALA . . . . . 0.749 ' HB2' HG23 ' D' ' 16' ' ' VAL . . . -140.74 38.84 1.83 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.589 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.09 153.5 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.47 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 150' ' ' ALA . . . . . 0.598 ' HB1' HD22 ' E' ' 86' ' ' LEU . . . -161.88 171.21 18.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.966 179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.42 126.84 7.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.232 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 152' ' ' ALA . . . . . 0.537 ' HB2' ' CD1' ' E' ' 86' ' ' LEU . . . -125.36 142.81 51.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.252 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 153' ' ' THR . . . . . 0.81 HG23 HG23 ' D' ' 9' ' ' THR . 0.4 OUTLIER -89.88 133.2 34.89 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 154' ' ' PHE . . . . . 0.448 ' HD1' ' HA ' ' E' ' 154' ' ' PHE . 0.0 OUTLIER -86.41 127.84 34.88 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.016 0.436 . . . . 0.0 110.148 -179.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 155' ' ' LYS . . . . . 0.41 ' HE3' HD12 ' E' ' 74' ' ' LEU . 29.1 mmtt -111.41 150.55 29.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.96 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 156' ' ' VAL . . . . . 0.774 HG23 HG23 ' D' ' 5' ' ' VAL . 14.2 m -136.23 144.44 33.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.863 0.363 . . . . 0.0 111.551 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 157' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' E' ' 69' ' ' ALA . 0.0 OUTLIER -136.17 132.76 36.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.24 0.543 . . . . 0.0 110.459 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 158' ' ' TYR . . . . . 0.495 ' OH ' ' HB3' ' E' ' 21' ' ' CYS . 5.5 m-85 -117.48 119.79 36.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.537 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 159' ' ' GLN . . . . . 0.555 ' HA ' ' HA ' ' D' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.864 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.223 0.059 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.22 64.84 1.57 Allowed 'General case' 0 C--O 1.233 0.213 0 O-C-N 123.118 0.261 . . . . 0.0 111.033 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 3' ' ' THR . . . . . . . . . . . . . 58.2 m -111.12 101.06 9.61 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.487 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 4' ' ' THR . . . . . 0.497 ' O ' HG13 ' F' ' 5' ' ' VAL . 60.3 m -86.73 131.92 34.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.586 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . 0.497 HG13 ' O ' ' F' ' 4' ' ' THR . 0.0 OUTLIER -161.16 168.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.48 179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -100.13 118.82 37.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.548 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.38 -56.39 6.87 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.704 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.97 -145.36 4.66 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.877 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.02 142.0 29.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 111.311 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 10' ' ' VAL . . . . . . . . . . . . . 44.0 t -121.58 107.36 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.18 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 11' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -88.78 110.95 21.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.421 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 12' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -87.55 113.5 23.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.759 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.16 118.63 36.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.354 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.56 175.48 39.78 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.958 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -151.26 162.15 41.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.957 0.408 . . . . 0.0 110.289 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.01 119.35 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.259 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 17' ' ' VAL . . . . . 0.498 HG21 ' HA ' ' F' ' 22' ' ' ALA . 0.3 OUTLIER -121.26 168.1 14.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 111.039 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 18' ' ' ASN . . . . . 0.538 ' HB2' HG21 ' E' ' 3' ' ' THR . 1.3 t-20 -68.45 -175.2 0.61 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.953 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 19' ' ' ALA . . . . . 0.604 ' O ' HG21 ' F' ' 65' ' ' VAL . . . -91.23 52.64 2.15 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.115 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.9 -15.72 1.33 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.351 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 21' ' ' CYS . . . . . 0.781 ' SG ' ' SG ' ' F' ' 61' ' ' CYS . 0.0 OUTLIER -176.87 147.61 0.61 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.987 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 22' ' ' ALA . . . . . 0.498 ' HA ' HG21 ' F' ' 17' ' ' VAL . . . -152.58 110.02 3.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 23' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' F' ' 58' ' ' LEU . 0.3 OUTLIER -52.98 159.07 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -90.36 164.49 14.31 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.613 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 25' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' D' ' 91' ' ' SER . . . -57.0 -52.36 65.59 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.402 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.41 11.95 66.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.888 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 27' ' ' SER . . . . . . . . . . . . . 18.4 t -96.25 -30.71 13.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.911 0.386 . . . . 0.0 110.95 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 t -49.87 -71.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.299 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -85.54 104.31 15.19 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.094 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 30' ' ' GLN . . . . . 0.541 HE22 ' HA ' ' F' ' 56' ' ' ILE . 41.8 mt-30 -112.12 140.3 46.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.122 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 31' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.72 110.12 21.44 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 112.123 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 45.9 t -108.12 108.44 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.165 0.507 . . . . 0.0 110.429 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.61 112.39 22.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.634 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 34' ' ' LEU . . . . . 0.542 HD21 ' CG2' ' F' ' 101' ' ' VAL . 5.3 mp -81.11 -41.83 21.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.611 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.69 -171.06 21.59 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.638 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 36' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' E' ' 15' ' ' GLU . 2.4 mt-30 -93.63 145.87 24.23 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.536 0.207 . . . . 0.0 110.919 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.517 HG22 ' H ' ' F' ' 38' ' ' ARG . 5.0 p -124.87 169.87 15.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.929 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 38' ' ' ARG . . . . . 0.527 ' HE ' ' HB3' ' E' ' 60' ' ' ASP . 5.2 mtt-85 -98.88 121.4 40.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.703 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 39' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' F' ' 43' ' ' ALA . 0.6 OUTLIER -61.94 -30.99 71.28 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.75 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.57 -39.33 84.91 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.008 0.432 . . . . 0.0 110.774 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 41' ' ' SER . . . . . . . . . . . . . 71.5 m -81.31 -10.32 59.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.2 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 42' ' ' LEU . . . . . 0.751 ' O ' ' HB2' ' F' ' 143' ' ' ALA . 0.6 OUTLIER -129.4 40.42 3.6 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.588 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 43' ' ' ALA . . . . . 0.612 ' HA ' ' H ' ' F' ' 143' ' ' ALA . . . -111.89 10.96 20.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.428 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.52 145.44 48.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.399 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 45' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' F' ' 140' ' ' THR . 18.1 tt0 -63.25 121.25 13.24 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.852 0.358 . . . . 0.0 111.095 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.97 14.44 33.91 Favored Glycine 0 C--N 1.33 0.249 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.176 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 47' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' F' ' 139' ' ' ALA . . . -72.16 121.21 18.91 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 48' ' ' THR . . . . . . . . . . . . . 15.1 p -130.04 133.8 46.97 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.848 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 49' ' ' SER . . . . . 0.483 ' HB2' ' HB2' ' F' ' 137' ' ' TYR . 57.9 m -112.47 -166.71 1.1 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.628 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 50' ' ' SER . . . . . . . . . . . . . 36.1 t -59.07 149.45 27.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.793 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.72 153.63 17.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.39 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 52' ' ' VAL . . . . . 0.672 HG22 ' HB3' ' F' ' 135' ' ' ALA . 3.7 m -103.44 130.4 53.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.0 121.48 6.56 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.621 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 54' ' ' PHE . . . . . 0.498 ' HD1' HG23 ' F' ' 52' ' ' VAL . 52.3 p90 -153.64 136.45 15.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 110.955 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 55' ' ' ASN . . . . . 0.469 ' HA ' ' O ' ' F' ' 131' ' ' ILE . 24.8 p30 -133.56 141.33 47.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.685 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 56' ' ' ILE . . . . . 0.642 HG21 HD12 ' F' ' 131' ' ' ILE . 1.2 tt -85.15 126.49 40.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.634 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 57' ' ' GLN . . . . . 0.607 ' HG3' HD11 ' C' ' 74' ' ' LEU . 0.1 OUTLIER -75.83 119.38 19.74 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.752 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 58' ' ' LEU . . . . . 0.536 ' HA ' ' HA ' ' F' ' 23' ' ' VAL . 0.2 OUTLIER -130.68 87.4 2.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.29 -179.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 59' ' ' ASN . . . . . 0.727 ' HA ' ' HA ' ' F' ' 128' ' ' THR . 5.1 p30 -77.28 173.8 11.49 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.988 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 60' ' ' ASP . . . . . 0.43 ' HB2' ' HB3' ' F' ' 22' ' ' ALA . 41.6 m-20 62.78 66.47 0.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 61' ' ' CYS . . . . . 0.781 ' SG ' ' SG ' ' F' ' 21' ' ' CYS . 34.6 m -115.8 161.91 18.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.659 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 62' ' ' ASP . . . . . 0.514 ' HA ' ' OD1' ' F' ' 126' ' ' ASN . 0.2 OUTLIER -145.87 157.86 43.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.322 -179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 63' ' ' THR . . . . . 0.491 HG23 ' HA ' ' F' ' 125' ' ' ASN . 0.0 OUTLIER -107.49 -16.73 14.29 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.151 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 64' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -81.3 -33.75 32.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.012 0.434 . . . . 0.0 111.689 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 65' ' ' VAL . . . . . 0.604 HG21 ' O ' ' F' ' 19' ' ' ALA . 20.1 t -75.14 -41.64 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.619 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.95 146.74 29.1 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.567 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.86 -39.3 3.73 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.863 0.363 . . . . 0.0 110.945 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -102.28 159.56 15.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.446 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 69' ' ' ALA . . . . . 0.603 ' HB3' ' HB ' ' F' ' 122' ' ' THR . . . -147.22 118.81 7.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.6 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 70' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -96.81 140.75 30.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.066 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 71' ' ' VAL . . . . . 0.482 HG11 HG21 ' F' ' 131' ' ' ILE . 3.1 t -118.55 139.79 44.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.713 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 72' ' ' ALA . . . . . 0.405 ' HA ' HD21 ' F' ' 111' ' ' LEU . . . -140.58 133.91 29.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.562 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 73' ' ' PHE . . . . . 0.773 ' HD2' HD13 ' F' ' 103' ' ' ILE . 0.1 OUTLIER -101.19 138.07 38.71 Favored 'General case' 0 C--O 1.231 0.115 0 O-C-N 122.338 -0.226 . . . . 0.0 111.172 179.603 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 74' ' ' LEU . . . . . 0.402 ' HB3' ' H ' ' F' ' 153' ' ' THR . 6.6 tt -101.07 91.08 4.39 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.003 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.4 -167.41 11.32 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.869 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 76' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' F' ' 86' ' ' LEU . 0.3 OUTLIER -116.74 159.51 22.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.611 0.243 . . . . 0.0 110.701 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 77' ' ' ALA . . . . . 0.519 ' HB2' HG23 ' F' ' 83' ' ' THR . . . -83.93 137.93 33.41 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.984 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 78' ' ' ILE . . . . . 0.459 HG22 ' O ' ' F' ' 82' ' ' HIS . 9.0 tt -77.14 -40.51 30.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.913 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 79' ' ' ASP . . . . . 0.613 ' HB2' HG21 ' F' ' 140' ' ' THR . 0.1 OUTLIER -141.22 55.24 1.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.82 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 80' ' ' ALA . . . . . . . . . . . . . . . 52.94 -84.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.086 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 81' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' F' ' 79' ' ' ASP . . . -60.12 -16.02 39.24 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.611 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 82' ' ' HIS . . . . . 0.459 ' O ' HG22 ' F' ' 78' ' ' ILE . 24.2 m80 -100.64 56.69 0.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.912 0.386 . . . . 0.0 110.566 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 83' ' ' THR . . . . . 0.519 HG23 ' HB2' ' F' ' 77' ' ' ALA . 1.1 m -71.35 -22.47 61.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.567 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 84' ' ' ASN . . . . . 0.735 ' HA ' ' HA ' ' F' ' 112' ' ' THR . 8.6 p-10 -57.12 -18.75 16.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.409 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 85' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' F' ' 138' ' ' PHE . 11.5 t -115.15 133.42 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.25 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 86' ' ' LEU . . . . . 0.925 HD12 HD22 ' F' ' 113' ' ' LEU . 0.8 OUTLIER -73.0 154.05 40.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 87' ' ' ALA . . . . . 0.601 ' N ' HD23 ' F' ' 86' ' ' LEU . . . -90.66 -161.41 0.8 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.823 0.344 . . . . 0.0 111.778 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 88' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -83.76 -178.24 6.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.988 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 89' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -71.67 -83.95 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.282 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 90' ' ' SER . . . . . . . . . . . . . 3.2 p -172.26 20.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.443 179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 91' ' ' SER . . . . . 0.775 ' HB2' ' HB2' ' F' ' 95' ' ' SER . 1.5 m -86.65 79.37 8.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.865 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.76 -31.45 38.29 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.832 0.349 . . . . 0.0 111.665 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 93' ' ' ALA . . . . . . . . . . . . . . . -128.09 54.41 1.73 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.621 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.89 -17.2 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.946 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 95' ' ' SER . . . . . 0.775 ' HB2' ' HB2' ' F' ' 91' ' ' SER . 0.9 OUTLIER -89.39 177.25 6.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.777 0.323 . . . . 0.0 110.672 179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.83 175.18 8.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.735 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' F' ' 98' ' ' ASN . 0.2 OUTLIER -137.46 137.97 39.27 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.289 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 98' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' F' ' 97' ' ' THR . 74.0 m-80 71.75 17.6 5.4 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.433 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.97 149.01 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.701 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.32 -176.74 35.62 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.433 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 101' ' ' VAL . . . . . 0.542 ' CG2' HD21 ' F' ' 34' ' ' LEU . 7.7 p -125.64 111.02 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 122.976 0.51 . . . . 0.0 111.735 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 102' ' ' GLN . . . . . 0.616 ' O ' ' HA ' ' F' ' 135' ' ' ALA . 0.9 OUTLIER -81.59 147.68 29.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.883 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 103' ' ' ILE . . . . . 0.773 HD13 ' HD2' ' F' ' 73' ' ' PHE . 0.9 OUTLIER -123.64 115.86 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.566 179.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 104' ' ' LEU . . . . . 0.719 ' HA ' ' HA ' ' F' ' 110' ' ' ALA . 0.4 OUTLIER -88.63 140.5 29.39 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.661 0.267 . . . . 0.0 111.076 -179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 105' ' ' ASP . . . . . 0.607 ' HB2' ' HB2' ' F' ' 111' ' ' LEU . 2.1 t70 -89.29 151.99 21.8 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.68 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 106' ' ' ARG . . . . . 0.62 ' HG3' ' HG2' ' F' ' 132' ' ' PRO . 0.0 OUTLIER -71.77 -21.11 61.78 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.73 0.3 . . . . 0.0 111.054 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 107' ' ' THR . . . . . 0.6 ' HB ' ' HA ' ' F' ' 120' ' ' SER . 5.9 t -62.88 -21.87 66.3 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.063 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.65 -83.03 0.19 Allowed Glycine 0 CA--C 1.519 0.312 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.695 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.69 170.67 15.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.751 0.31 . . . . 0.0 111.063 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . 0.719 ' HA ' ' HA ' ' F' ' 104' ' ' LEU . . . -74.85 138.61 42.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.225 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 111' ' ' LEU . . . . . 0.607 ' HB2' ' HB2' ' F' ' 105' ' ' ASP . 5.1 tp -94.47 153.4 17.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.329 0.585 . . . . 0.0 110.531 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 112' ' ' THR . . . . . 0.785 HG22 HG21 ' F' ' 117' ' ' THR . 6.2 t -93.71 148.27 22.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.094 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 113' ' ' LEU . . . . . 0.925 HD22 HD12 ' F' ' 86' ' ' LEU . 1.4 mp -89.51 64.73 6.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.784 0.326 . . . . 0.0 110.777 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 114' ' ' ASP . . . . . 0.555 ' HB2' ' OG1' ' F' ' 117' ' ' THR . 0.5 OUTLIER -95.05 -15.96 23.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.723 0.297 . . . . 0.0 111.685 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . . . . . . . . . . . 104.36 -56.21 0.57 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.691 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.59 29.07 5.97 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.961 0.41 . . . . 0.0 111.626 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 117' ' ' THR . . . . . 0.785 HG21 HG22 ' F' ' 112' ' ' THR . 3.4 m -87.23 65.89 9.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.069 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . 0.527 ' HB3' ' HB1' ' F' ' 70' ' ' ALA . 48.5 m-85 -77.68 73.39 4.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.806 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.49 70.91 0.95 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 120' ' ' SER . . . . . 0.6 ' HA ' ' HB ' ' F' ' 107' ' ' THR . 0.7 OUTLIER -148.68 126.06 11.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.696 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -92.04 53.17 2.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.205 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 122' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' F' ' 69' ' ' ALA . 0.2 OUTLIER -73.97 128.32 35.21 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.765 -179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 123' ' ' THR . . . . . . . . . . . . . 4.6 m -86.35 117.86 25.42 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.772 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 124' ' ' LEU . . . . . . . . . . . . . 4.2 tp -88.45 134.79 33.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.761 0.315 . . . . 0.0 110.498 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 125' ' ' ASN . . . . . 0.53 ' HB3' ' O ' ' C' ' 116' ' ' ALA . 0.3 OUTLIER -129.3 163.09 26.43 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.63 179.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' F' ' 62' ' ' ASP . 1.5 t30 -67.61 125.43 26.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.699 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . 0.661 ' HA2' HG21 ' B' ' 4' ' ' THR . . . 128.55 -141.0 12.17 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.707 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 128' ' ' THR . . . . . 0.727 ' HA ' ' HA ' ' F' ' 59' ' ' ASN . 6.3 m -101.74 92.44 4.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.716 0.293 . . . . 0.0 110.809 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 129' ' ' ASN . . . . . 0.529 ' HB2' ' SG ' ' F' ' 61' ' ' CYS . 1.2 t30 -76.55 144.99 39.33 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.881 0.372 . . . . 0.0 111.14 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 130' ' ' THR . . . . . 0.717 HG21 HD21 ' C' ' 74' ' ' LEU . 0.0 OUTLIER -134.61 131.76 38.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.073 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 131' ' ' ILE . . . . . 0.688 HD11 HG12 ' F' ' 156' ' ' VAL . 28.1 mt -87.31 109.81 28.66 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 132' ' ' PRO . . . . . 0.62 ' HG2' ' HG3' ' F' ' 106' ' ' ARG . 7.4 Cg_endo -81.67 112.16 2.38 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 121.617 1.544 . . . . 0.0 112.558 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.36 138.21 51.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.842 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 134' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' F' ' 52' ' ' VAL . 28.2 mt-30 -110.08 157.5 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.007 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . 0.672 ' HB3' HG22 ' F' ' 52' ' ' VAL . . . -152.69 107.87 3.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 111.606 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 136' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -102.47 174.37 5.93 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.378 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 137' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' F' ' 49' ' ' SER . 0.6 OUTLIER -86.04 120.83 27.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.08 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 138' ' ' PHE . . . . . 0.516 ' HB3' HG11 ' F' ' 85' ' ' VAL . 0.2 OUTLIER -117.64 139.67 50.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.056 -179.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 139' ' ' ALA . . . . . 0.683 ' HB3' ' HB3' ' F' ' 47' ' ' ALA . . . -129.96 145.57 51.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.902 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 140' ' ' THR . . . . . 0.613 HG21 ' HB2' ' F' ' 79' ' ' ASP . 16.5 p -104.36 -53.38 2.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.511 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 141' ' ' GLY . . . . . . . . . . . . . . . -116.73 -121.47 3.26 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.995 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 142' ' ' ALA . . . . . . . . . . . . . . . -97.12 112.93 24.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.549 0.214 . . . . 0.0 110.649 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 143' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' F' ' 42' ' ' LEU . . . -61.73 150.88 35.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.76 0.314 . . . . 0.0 111.479 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 144' ' ' THR . . . . . 0.544 HG23 ' HD2' ' F' ' 145' ' ' PRO . 60.1 m -126.85 151.52 73.88 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.27 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 145' ' ' PRO . . . . . 0.544 ' HD2' HG23 ' F' ' 144' ' ' THR . 1.4 Cg_endo -82.96 140.14 9.96 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 122.573 2.182 . . . . 0.0 112.024 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.98 -138.07 6.55 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.529 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 147' ' ' ALA . . . . . 0.594 ' HA ' ' HG3' ' E' ' 15' ' ' GLU . . . -87.22 145.04 26.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.881 0.372 . . . . 0.0 111.344 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 148' ' ' ALA . . . . . 0.736 ' HB2' HG23 ' E' ' 16' ' ' VAL . . . -140.77 38.79 1.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.558 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 149' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -86.04 153.57 22.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.549 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 150' ' ' ALA . . . . . 0.599 ' HB1' HD22 ' F' ' 86' ' ' LEU . . . -161.92 171.2 18.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.997 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 151' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.41 126.79 7.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.193 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 152' ' ' ALA . . . . . 0.528 ' HB2' ' CD1' ' F' ' 86' ' ' LEU . . . -125.34 142.81 51.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.341 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 153' ' ' THR . . . . . 0.811 HG23 HG23 ' E' ' 9' ' ' THR . 0.4 OUTLIER -89.88 133.19 34.89 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 154' ' ' PHE . . . . . 0.517 ' HD1' ' HA ' ' F' ' 154' ' ' PHE . 0.0 OUTLIER -86.34 127.83 34.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.025 0.441 . . . . 0.0 110.131 -179.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 155' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -111.47 150.5 29.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.941 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 156' ' ' VAL . . . . . 0.802 HG23 HG23 ' E' ' 5' ' ' VAL . 14.5 m -136.19 144.42 33.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.871 0.367 . . . . 0.0 111.597 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 157' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' F' ' 69' ' ' ALA . 0.0 OUTLIER -136.23 132.79 36.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.364 0.602 . . . . 0.0 110.382 -179.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 158' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' F' ' 21' ' ' CYS . 5.5 m-85 -117.41 119.78 36.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.563 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 159' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' E' ' 1' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.867 179.975 . . . . . . . . 2 2 . 1 stop_ save_